<SEC-DOCUMENT>0000950170-25-027864.txt : 20250226
<SEC-HEADER>0000950170-25-027864.hdr.sgml : 20250226
<ACCEPTANCE-DATETIME>20250226164800
ACCESSION NUMBER:		0000950170-25-027864
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		134
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250226
DATE AS OF CHANGE:		20250226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviva, Inc.
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30319
		FILM NUMBER:		25670922

	BUSINESS ADDRESS:	
		STREET 1:		1350 OLD BAYSHORE HIGHWAY
		STREET 2:		SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
		BUSINESS PHONE:		6502389600

	MAIL ADDRESS:	
		STREET 1:		1350 OLD BAYSHORE HIGHWAY
		STREET 2:		SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THERAVANCE INC
		DATE OF NAME CHANGE:	20020207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>inva-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-26T16:15:02.6449+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:inva="http://www.inva.com/20241231" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_294f30a8-6751-480d-96f1-de4c00cacdfe" name="dei:AmendmentFlag" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392">false</ix:nonNumeric><ix:nonNumeric id="F_72085d60-06d9-4ecd-b495-7fc40676cedb" name="dei:EntityCentralIndexKey" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392">0001080014</ix:nonNumeric><ix:nonNumeric id="F_fb084d73-4669-436a-9dd8-67bd0b399ccf" name="dei:DocumentFiscalPeriodFocus" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392">FY</ix:nonNumeric><ix:nonFraction id="F_4cabf256-50af-4092-acd1-d2dc789b6957" name="us-gaap:CommitmentsAndContingencies" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_91f0204f-f305-4ef6-8781-73091ff19f29" name="us-gaap:CommitmentsAndContingencies" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_9bdecfd3-61c0-44d4-a26f-95a46485d9fa" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_a7597c02-e3bb-46d9-8544-84ccf95becce">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric id="F_8fa11627-b6cc-4f9b-a343-8d27e9d135d2" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric id="F_88ddddc3-bea2-43a4-a260-09dfd3791459" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric id="F_f0a3b6ae-bc83-48c5-86cb-73ff6b579e00" name="inva:ClaimExpirationDate" contextRef="C_67629f3b-d335-4784-a7d4-56ecd9570134" format="ixt:date-monthname-year-en">October 2023</ix:nonNumeric><ix:nonNumeric id="F_575134d6-a304-419f-b46a-5cbe0a39b7e5" name="inva:LockUpExpirationDate" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441">2023-12-31</ix:nonNumeric><ix:nonNumeric id="F_47da13c9-3667-4443-acf7-9a613c3e52a0" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_dfbfc63b-c8ad-40e9-ad14-a99d3949bb53" format="ixt:date-monthname-day-year-en">August 18, 2022</ix:nonNumeric><ix:nonNumeric id="F_ecf264a2-e5c5-444a-8a7b-06e825278547" name="inva:ExpirationDate" contextRef="C_19f9ae33-8506-491f-9863-f0a3fba13817">2023-03-31</ix:nonNumeric><ix:nonNumeric id="F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric id="F_f4af3d02-580b-4f35-bd4b-6df98811301b" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric id="F_16c95013-f170-4361-bd0d-93944037b675" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_ebb48713-23ce-429f-ae3c-689518f40e91" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_df825393-b260-4cba-9ff7-9fc9a38e03d8" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_017b1701-0383-437f-9b49-4b53a72f5cc5">P36M</ix:nonNumeric><ix:nonNumeric id="F_95673362-d782-4e32-804a-2d906541bf72" name="us-gaap:LeaseExpirationDate1" contextRef="C_935e1701-2c66-4fa4-a9ad-777be38cf9eb" format="ixt:date-monthname-day-year-en">December 31, 2027</ix:nonNumeric><ix:nonNumeric id="F_1f9d0b86-7ca1-4461-b3cf-41c5a7d463c7" name="us-gaap:LeaseExpirationDate1" contextRef="C_05e65131-7bbc-4635-8ca4-c97edca1f54a" format="ixt:date-monthname-day-year-en">March 31, 2029</ix:nonNumeric><ix:nonNumeric id="F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573">http://fasb.org/us-gaap/2024#LiabilitiesAndStockholdersEquity</ix:nonNumeric><ix:nonFraction id="F_8697229b-658d-48d6-b3f9-46eb9028e018" name="us-gaap:NumberOfOperatingSegments" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">One</ix:nonFraction><ix:nonFraction id="F_11be943b-e77c-41bd-aecb-698c8fa9edb8" name="us-gaap:NumberOfReportableSegments" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">One</ix:nonFraction><ix:nonNumeric id="F_729d9a5e-6c01-4f45-8bc1-8b9538c8dbaa" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="inva-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_800010f4-85ba-4487-a1fc-d185935fa9c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80258deb-f35d-49b9-b662-4823ba3839e5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_803eb231-cd56-4e30-91d1-f2707f4586a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1AndD2PreferredStockAndCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_804ca930-b7b7-4a49-a722-aff90380ae53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8072618f-1ec5-41e4-b16b-b78997fa817e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_80aa6909-465c-42c3-b0b3-1b95cbf1839b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_811f0ab4-b358-4bcc-bc70-9137747403ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83aa808a-93a1-4297-9265-8d2fb9dc5612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83b93379-94aa-47ed-9eb3-7b3158980925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_849927e1-65a2-4ab7-97b5-483466c4b437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8510eaea-441e-49f3-858f-a2231a38d968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_851eb81a-bcba-4dbf-a1ff-f67a190bf355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_852cf337-96b0-47de-a072-c0011a29adb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_85da56fa-4ced-4862-83dc-c5baf8401a9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_85db9a42-0ded-4419-91f0-f3010d32ac6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_860a55ea-1154-443a-bb84-a8d6f8251458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_864b213f-0400-4fcb-9947-13500166620f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8696ff04-631e-45ca-b986-6584fe4c098f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_86e15322-fb47-47c5-a35a-fe238e9cb430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_86f5407c-66be-4a09-853c-3167aaf240a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inva:TwoDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_871709ce-1c50-4f9d-87be-84392f7a9aa9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_87613bcc-e02f-4f93-9acc-604a9a71c964"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_887080f2-8412-4508-9e41-bc1a8e2ff95e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:CommercialSupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88782d27-5661-485a-afcf-08cc5c051369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-18</xbrli:startDate><xbrli:endDate>2022-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88a8178e-d76e-4fb2-9885-5ee2c0565071"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_896fcd7e-679c-4d68-a83d-99ad390a46bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a59da43-fe2d-4fbf-88c5-e84ffeb90fd0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b039347-f1bb-483f-9cd7-5caeb7ce8c4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c4fe90e-5515-4c29-8aa9-77a9d2df3e96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inva:OneDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8cd4e397-e9a3-4a8c-aecd-0a7615959c9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d315a2b-2c71-4420-b013-dfe4ca2986c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCAndC2PreferredStockAndCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d72d20d-c777-4e45-a1e5-dce95ab96806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d7370e9-f555-49e2-8db3-20fdc743160e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8db4f7ae-2913-425a-931f-161ffa81bc43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8dc1a082-9478-46f1-b22f-0fda99922d9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-18</xbrli:startDate><xbrli:endDate>2021-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e458ac2-46af-4572-9110-f35e62e6d593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e904088-1404-41dd-83e8-637489e1cb2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:ManufacturingStageTransferAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f0463dc-8f74-4223-9dd0-680a9297636d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f319834-0192-44bb-82e6-228a046acebe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8fcd8c24-bab5-48ed-8f4b-d11e6d6b0426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8fce92ac-4906-42d1-b1ea-f1705723e3e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8fda4892-a74f-4650-8ab9-7f27921d46c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8fdb4c80-a5b2-4d18-b108-58f668bf4204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90c8e4aa-f337-4f23-8ec8-33fc6f9d49fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:OutstandingStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9109116f-9efb-4c72-ab41-742cb8d808be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_912bc1dc-313a-4987-ba8e-17bf34333339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9192d724-db6b-429d-9b34-680a884d5432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_919b16a3-daf9-4bac-9da1-2cf406486d25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_919d35a4-18d4-429f-9131-8121ce8b768d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCAndC2PreferredStockAndCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9208f331-1b10-4449-9538-3f9a7a38627c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_92dff807-84fa-491b-9fee-1e85b08d8746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inva:AmortizationOfInventoryFairValueAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9335e429-20b3-46f5-9a0a-fb45ea5dce99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_935e1701-2c66-4fa4-a9ad-777be38cf9eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:BurlingameCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_93c2cd99-2331-4842-ae83-434ada9a8bca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_93e7294b-aac4-4d69-a3eb-67d0b9c5c363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94e5705b-e6d9-4f93-b4fa-02e92457a43c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_94e7195f-0034-4d0a-b5fd-de56d9a2582b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_954ad86b-4beb-4124-8fb8-95cf9f5505b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_955c4f2a-4a9d-417f-aead-26c430c09653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_95699a2d-0510-488b-b64d-b4503781f140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97c0d4eb-5564-4c2c-b25d-1d764e044c4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97ef981d-8088-4d68-9ed4-8e0a49d39c69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9834684e-a81e-427b-ab67-3dce5473dd17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_985e040f-be7e-4757-85fe-32dfd0c9e971"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_98ece23a-e085-4630-b652-b0ddb682aa35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_999d353c-dc71-4460-9947-95616ca7ef74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_99e72674-f063-419d-aa0e-2560370d3aef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a129dd3-6622-4125-9532-5a2fc9756798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a12f957-a828-4d75-944d-2087cd6938c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:DurlobactamMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:AstrazenecaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a1b43b7-95ef-4fe1-bb0d-965f09120bf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a81efa3-20d3-453d-9d0c-f293d720f3f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b00860e-a4ec-4be9-820d-8a3d8ea443a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9b0d84ea-e834-4ea8-a1b5-32f0bbdd41f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b5e3f73-d7e2-4436-a4cc-ebaba20abb28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bb96ed1-a18c-4f9a-b018-bbafef5054c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inva:AmortizationOfInventoryFairValueAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bf67da7-5977-473a-b529-91f7f67d1f91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9c9d544f-ec3a-45ad-bcd1-76045e398e61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9ccb7bd1-8f8b-4f56-a509-6035ce670328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9cf98973-fc0b-429b-8808-7b5d88eb9637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d2ea10f-79df-4fc6-88b1-7ed97a1f15da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d4df672-9227-4655-9953-e51c14163b1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d4ff33d-434e-42c0-bb77-930403d92261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d98152e-282a-43bb-9c70-92c8e03419ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9dc62cdf-a86b-443a-a322-c99a58facc5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1AndD2PreferredStockAndCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e00bead-30e7-4af5-8f97-cb13619d5c04"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e7d8d10-3492-4cee-a89a-3fb97bcda1d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ecfe93e-28e2-4228-ab4a-d3d1c23258a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f3c3b1f-09d6-4eb0-b566-b7a7e7c47ec8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:AstrazenecaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ZoliflodacinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f5b3843-bdf0-4930-818a-6eed731e4cdf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f830636-16c6-4d83-af5b-754f4ce28030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f8444a3-22dd-4d19-a7e5-92b3a3636dd4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0571dc0-aebf-4847-a254-63bbaa92f9ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a084decd-4deb-4a08-b247-259a786424c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0ab4d8b-b98c-4423-b309-fa00f676612e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:BasileaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a16a85fb-8e15-45a7-9fef-73333497db42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a20abb89-800f-48d0-982d-8e767439c06e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-05</xbrli:startDate><xbrli:endDate>2024-08-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a275ece4-9863-4cde-b812-6441e2e5af07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a2ca99e3-4ee8-4e98-ac8e-a7fbab801fde"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a34b6268-debd-4832-a5a5-28a87b2d6119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a37e3f84-6d29-4645-b6f7-b74dfd018d2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3b40d28-d1d7-4f75-ba62-ba963f654190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a41714b7-a00f-481f-be71-d01b3d66ce35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:SulbactamDurlobactamMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a44e01be-348f-4efc-abce-4d6942d68c4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a4df3b3b-267d-4f2f-ac89-6815c2bbcdeb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6430d44-f5e0-43dc-9348-dfafe12496e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:EquityIncentivePlansAndESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6a8f2c7-57be-445e-a3e7-ce078fc2faae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7597c02-e3bb-46d9-8544-84ccf95becce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a766e556-6ab5-4064-b9f0-b96a29676eab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:CommercialSupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a8b3a821-9b16-4dc5-8726-097101dcbe6d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a8d47eea-b422-4342-9936-7be08f04740f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a96db169-3904-4b64-b638-57e99ca42a24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a995b915-50f7-4ebc-b58c-879c3902fff1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-17</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aa1f7e7b-d2fa-443f-a718-e2d0bbe01a01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aaecb0e5-05bb-4c5d-b308-7ef6aad3d595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:InCardaConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ab15afc8-8530-4712-ba43-3f96b009cf85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ab2043e0-c7f2-40c3-bda1-f3a36db172fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_add68ec5-d86e-40f4-b034-6cf33cfd18b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aea775ec-f212-4854-8a33-38c7dcf9a97c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aeb0943d-6820-41d1-ba88-baf408a51c23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af51ee90-6870-494b-817f-7bb0769ffdb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af5e6a83-99f4-4f15-91c5-d548183e4cf6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:InterimSupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_af75fcbe-c945-4eb9-beb4-d5938e595d4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_af82f89f-5808-49b5-b750-ff7de7d3e2f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_afb144a7-7fa3-45b6-b331-2e2d09168a7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b094271e-5af4-45b7-8a67-ea05cb064571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b0cd00d0-91fb-42d9-9cb7-ff204ac9ab0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b17c7bb3-be30-46ec-8c5d-326914913809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b205310f-0e33-4476-bda5-719485b59ecd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b48017cd-1262-4c03-854d-9e240761aace"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4acd677-0951-457f-af07-c89710826848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b5459326-64cc-447b-92d0-447df34b0037"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b581726d-66c2-491f-be47-b769ac4d4e1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b6038bb2-c129-42b0-94c7-bd3528eb4770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b71bcf3c-4c43-451d-b5f2-24c3afc122f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b79f1674-dd08-4798-a636-6908c319b900"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7b89463-f172-4eb5-8ce7-17774c741e4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b8f36bb1-01c9-4719-9547-cafc116ec017"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b951258b-c9f5-4734-98aa-3ed6338a2801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b98c6805-e143-4159-8b6d-0216ea55b874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:OneOfImaginabsCommonStockholderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-18</xbrli:startDate><xbrli:endDate>2021-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ba0408d0-4257-44bd-b0d4-4cae0cd8ad50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba7b5502-0812-4272-8e9d-d2570169a140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bacd63c0-e919-4307-9a75-797f35ce4073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bace799d-5f2c-4586-81a2-eeadbfadf867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb32bb34-0f53-47f4-9801-880f4c57c7c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bb3e4de1-feb6-492e-8578-81257488368b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bce3ec39-fa5f-485e-b142-ed955411c5d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bcf2c29d-8647-40dc-ba52-d9d8f93eb75a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bd235a25-25e3-4774-9cac-f96204385615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdc03984-0625-41b2-82ca-9caeb5314057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdd67f19-2199-47ba-9bf2-29f87af012ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be611a96-acf7-4e91-8069-ab705ba23648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be6fcc6f-ace4-45c6-be23-2f777937aa77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bed4dd91-bb02-4b5d-a15b-d83a06470288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf2aa827-497e-4734-b273-79d836b4d1eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf2ff2aa-7c34-4e4f-9e97-336a5c293d40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-30</xbrli:startDate><xbrli:endDate>2022-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0508c79-209c-45e5-bf7c-169aef8d5660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0fa79e7-715a-4fda-811d-c8538a6e2a44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c18cffa1-9de9-4afa-a1e1-ba138e813757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c277363b-a707-4b73-871a-b77a92df3c6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2913a02-9488-4628-8d44-e7cd7ed404b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2bdcfd8-c2f9-4e33-9a58-4dc78da2e693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3e70cef-b906-408c-8288-908907c15a65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-18</xbrli:startDate><xbrli:endDate>2021-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c40ea3a9-5b51-4fd2-a6f2-387235c72fe8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCapPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c45aa339-d7d0-43b8-affa-cc16b15eced2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4c638bd-9d2d-49eb-acd3-78cadbac2bb9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c5562d91-0351-4acd-8f6f-1aa83d60f185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c5d2b484-c130-40da-a3ce-df08236a2ace"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c5ef9de9-0775-487e-8f32-e176bb4802f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c61a6de1-f544-4ddd-95a2-ffc7bafdc548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c675336b-670a-4920-8b77-b1a4286084d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c72b6c37-ed89-431f-8860-4f3a0138f363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c79de25e-95f2-4f26-905c-cca404ed5f11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c806d5a2-f390-4c9d-b3ed-a166cdaae201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c82dd715-d624-49e4-bfe0-b1715409db9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesDWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c9475aee-0427-4f76-b24b-da8950b70256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca06b77f-bf5f-4b7f-be32-bdeda8df9e1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ca7032d1-65b7-44f3-9dff-4c953aea281c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca91671c-9ec7-444f-b685-f851204f4fc9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesDWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cac6555f-df17-464f-8fa8-e1233df59df0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_caf4275d-107c-4a04-8eba-47895b8c9c67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cb1c40b3-5c1e-420b-883d-1af63b9dae15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cbc4cdee-389a-4cf9-b9af-2f7d95792201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cc713bc3-dccb-47e9-8743-bf1aadadd990"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:GeorgeWashingtonUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cca319a7-55be-4560-a134-be4a41bd17b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd2bdc94-0cda-4896-afe6-51e360f119eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">inva:InnovivaCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-17</xbrli:startDate><xbrli:endDate>2022-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cf1f2f09-e0ed-462d-82c7-6c2daa899d5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cfb60dba-9194-465f-961c-11b864f3bdc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d03f0f85-cb5e-446d-9bac-86efb022c8e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:AmendedZaiAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d11819a9-3acf-4623-aa96-999f140f76e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d139597a-1533-4bc4-a253-55b573ea0881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d14644b6-e4c0-4ed0-9afe-f0820fb1bd31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d1e16fcd-b412-4137-9d48-7dd6c2506efe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">inva:CommitmentsFor2024ToBeUtilizedIn2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:CordenPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d22b266a-b99c-45a0-8ac0-e3851917bcf6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesC2PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-14</xbrli:startDate><xbrli:endDate>2023-03-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2d0990f-b4c3-4288-a88d-e7a8d66b2f3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2ecd1f3-29e6-42cb-af2b-fc69c9589381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2fcd4b4-d9ae-4307-b911-8ce98ce50b0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d326d4eb-5d26-4172-b306-2eb5433f4c8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d342f539-f5cc-4e65-bc94-3ed13f8a9001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d37f9324-54d5-4067-beb3-18876b2ba3f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:GeorgeWashingtonUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d43c551f-1182-4c6a-9fa0-92a42cfdbdb7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d45b1b16-d9f4-4bd5-a834-1cf791abc22d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d46b31e7-e4aa-47e0-b48d-3af9ff0a4041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d4a55873-42fb-4f4d-8ae0-0c16e81de797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:InterimSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d4eaab11-5036-4fa2-80f4-ac4c6edacc5d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:AmendedZaiAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d53b733f-8e9d-41ed-97c2-c18ed44c87fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d5601efb-6bb1-44cc-bbcc-ebfffed538f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d607948e-3894-43eb-89fa-f4bc7aece440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d61477da-6a47-40a2-8405-d8b3177cc270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7303d1d-5e66-4d3e-b842-3e3d5762046f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d8708151-111b-4172-ac2c-b7620b8c6f75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d8729dff-3a5c-4dcc-af0c-979774e25169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d918b70f-a067-4ecc-8b5c-d40d7a0e5c75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d9d9925a-2c03-40f4-86eb-cfacde988b24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da53c27e-3311-413c-8e97-f6873c7e96fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ExternalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da6eff04-3c1c-4959-abe9-fe3dfca5c630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_db5c50d8-61a0-48fb-b797-e64fdb1a2402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc25f343-8bba-4e07-88b6-893e60ec0518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc5d9fbc-dff8-4e86-8a01-3a68bb65a1f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dc9d2bc8-74c2-44d4-a506-2b243a40e1db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:EquityIncentivePlansAndESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dcb22e50-3b63-484c-8bca-4d66021e8210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-07-01</xbrli:startDate><xbrli:endDate>2014-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dd1d30e1-e047-42a2-bdb5-3ef5926e79da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_de840e76-4090-4f91-aa27-ad5a96814016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_de99671a-3f86-4f93-b929-187c53e350a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df05c425-3a4a-4cd4-aa36-806e2fe0da51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df0dcfdb-f7bf-42d6-8f50-7452f7efb7fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df36bca4-34e2-4f01-a21b-2939200a4237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:FirstAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-31</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df3d0c76-2bea-47b7-b43d-ad369cba9a2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df62ffb5-2697-4ff5-a2f7-2b6a2e6fd05e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">inva:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dfbfc63b-c8ad-40e9-ad14-a99d3949bb53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-17</xbrli:startDate><xbrli:endDate>2022-02-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e189d92a-5bed-4d05-ba08-0b3e9024c9c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e2ddb70e-8dcc-43a9-a5a3-84d4f1674565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2f7f140-5330-4553-9a9c-7f6c89b789b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e3ece156-7a9e-4032-aee8-a8d84b04dbc5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3fb434f-e5ea-4505-bf42-34684b260e8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e45d06f3-4620-495d-8786-74f2c65161c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e58b5b10-01d5-47b4-827c-3e1e08ba781d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e58d532c-c266-4245-9d7b-aef9281419e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e617e900-c4dd-49a9-adae-8c08d9de316f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e708ed8d-1039-4ee7-a8a5-f30c4559229f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7fac056-3186-4a36-b380-99ad43330178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e8870f6b-cc59-4078-9d16-079206fad40d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e917c8c1-bfee-4f3b-9622-29aafad82d9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-12</xbrli:startDate><xbrli:endDate>2024-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e9234eca-e6d0-4621-b0c2-30f2d3521baa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e98b3d3d-da85-482c-b5f8-1a935c74d441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e9b0c0ac-0c84-4a00-8d3e-e6a3c6a553e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ea058057-5a8c-4679-b02b-d77e73b481e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ea7dfa2c-567f-43fd-8303-83212ff97441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ea976f60-5b5b-415c-b0c6-88e63b461b95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCPreferredStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ebd1ba78-29b1-4276-99d0-bd4af1213cd3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-12</xbrli:startDate><xbrli:endDate>2024-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ebebd729-c908-4409-9926-dcda00bed175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:OutstandingStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed5b1702-8224-456a-abea-ea2d003f0c74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_edc9130d-8bac-4385-8abd-4f680377bf65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ee91a4d7-5cf4-4689-95fd-88e803c82bd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ExternalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef03268a-dd7d-4c50-a2c4-e5d9a9311b15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f0562001-bb86-4a5b-b298-0510200a8220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1b73005-95fb-4adb-81f0-96baf40e7109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f204fe66-1d1c-4852-b65c-0af9b8cf2582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f219ac17-5f54-4a96-ad2c-f5c9f69dae24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f2be4dca-4f14-4253-b3c4-7480e0834b43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f35372e3-5a04-485a-8e05-1fd441950552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3ad801f-e4a3-4bf5-9d54-b9f1f833c093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3c6c6c6-c1f1-4aba-b7f2-6491c20659a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3e16894-117c-446b-9f3f-884beaa199ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f48f3ff6-407c-4253-90e5-37f84707a37a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f4a8c22f-aba7-4e11-ad11-162e3d1ad7ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f4ae3171-8820-4834-b2c2-1c6f94927a5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f51e917b-8e9a-4315-958f-c6e9da82aacf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f67ba5e9-a4db-472d-a2ac-c63d64b435b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f68989b1-d857-4210-9ee6-ae27a0818759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:InternalExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f6aacb7c-354f-4850-845b-699f73b3eb83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">inva:NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6bcc262-29e8-498c-850a-47d7bc746ddd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6c0a156-d89e-48f6-bded-f444bcad434a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f77d16f6-54fb-45df-a63a-141a1f1f0379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7d20624-8417-4c34-b875-90b2c207e676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7e50e8e-4e3b-4cb4-86fd-601d62aa2908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7f1eee0-388b-4fa8-9890-63be03fbd551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f92b2439-dd04-4ad1-9985-100056a2a460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f9d8c18f-f9a7-412c-a350-a087bdc10db8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesA1PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9df7c1f-6bde-4e08-b0ca-c088b7bfec4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9e57c23-a271-4b12-b27e-1a3a9f5259fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fa5f811c-b501-4818-ad66-e8e20b51e983"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa7da83e-f568-43a7-8a21-c4860f759a4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fae9051d-e439-4818-ad45-eb74de3471ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb5bc12c-55ad-4da3-a56f-d05ec3ed9dd2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fba802f6-eb69-493f-87f6-f43deb47abf0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbdb8b2c-2b35-4e9d-80d1-25e5b10df0bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fc9a0b8f-f975-48ca-a3e6-9b76b08bd568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:RegulatoryStartingMaterialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fca35291-33d2-4caf-8ebf-8a5264f15a1f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-17</xbrli:startDate><xbrli:endDate>2022-07-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fd08000e-5a41-4289-ae07-073ab3d62ab2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fd3f6642-082d-419b-8eb5-479c4509f29d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ConvertibleNoteAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fdbfc2ab-d5ad-4fa2-8dfc-bcaab55938e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fec8182c-e2df-4822-bd54-8e84d5ba717c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fedeae1b-25e7-447d-871d-311e79d2dae2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ff731cd1-588f-4206-9930-a5931aa2f59c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ff809d6a-b516-4d09-8eb7-0d3d1386fd58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ffeaad30-ebfd-4a04-b9e5-4e0d3bd69603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00161e2a-7110-4a94-93a4-53229f1f240f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0063e106-c957-4aaa-8a37-c9c8915894f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0093bbd6-7e3d-4096-a9d4-884a19df0e1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-01</xbrli:startDate><xbrli:endDate>2017-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00f9e3ac-8ca8-42d6-ab5d-d942ce6aee24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0172277f-4eca-48b9-bece-ad8bb242c5b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_01786403-dae8-45d8-8f44-bb44245b9082"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_017b1701-0383-437f-9b49-4b53a72f5cc5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:BurlingameCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_01a26fdf-093b-428e-8429-70e85e0224c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02d745cd-51ee-4828-8e80-e16af93855c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:InCardaConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03ca5b08-65b3-4660-b083-f365e311c479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03d49736-400f-4d83-9c8a-949362d73529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_04c41611-4dbc-4cb9-9783-2e7266319cc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_04fe922a-6cc7-40ce-935f-5fdc9f946206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_05049684-518e-4c68-a36a-97efe8235878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_050ab59e-aa14-4c4c-8631-471af527ea4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_059d5bd5-1649-484e-8e7c-174600b0cb2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_05e65131-7bbc-4635-8ca4-c97edca1f54a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:WalthamMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_06063be5-bdd2-4157-b66c-78225d3605c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_06dd38c6-e52d-4da1-998f-59918ca542e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_080daca5-b99d-4707-b989-976a8412c9b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">inva:SoftwareAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_082688dc-70ea-4b4e-a75e-e8348b08e789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_082ada48-9042-421f-be9d-be33bf8fec5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_092b5b62-561c-49b9-ba98-6e6b2d653e5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0974ccdc-4028-46c2-914a-582f9004b353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_098b82e6-075b-4b93-995c-661389fb3815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0998f113-0641-45f5-9ff6-c133558e2b1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09aa36b7-7144-467b-9fac-7756cec17a40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09dd24e4-7567-42ee-8451-8c197dcc4414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09f27efd-eb03-4052-a5d2-3f4477a2daa4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b1f96f1-ab6d-47e4-9aef-4751a8f64e5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0cc6ac22-c321-4787-9e00-3da335019c16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:GeorgeWashingtonUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d1b8490-4789-4372-801e-fc2120c8f801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d59aa40-0636-4b3f-ab3a-b5149a08e64b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d85bf14-7ff9-40af-b30b-7e30a1de43fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ea9ec7a-e7e7-4193-b8dc-087d07b87da1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0ee77695-de0f-46b2-86c1-faabdc44e03d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_102e5069-9631-4b2b-b6f6-629950c6ca80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1094e350-01f0-46ea-8b23-ea5467236116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_119ad206-2058-450a-8e97-89fb20b4c812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_11dc5ce4-6d0c-463a-81f6-6f26c160dbca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_11f76295-41b0-4dcd-bce7-3764ae292e78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_120c56d9-bec6-4a6e-9cc8-0e256aaacca2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12297e5a-44ee-441e-b9cb-846681e357f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12d7763c-f468-4d34-a5f1-a55b18acd690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:InternalExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_12f5776d-f333-4f0c-8ece-f5ae431ebdf9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_131d7647-fc17-4fa2-92a5-8461ff6933d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-10</xbrli:startDate><xbrli:endDate>2023-01-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1335d490-17db-400b-806c-c3c9d364a039"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_133952d5-c957-477b-b68f-c01b8094549b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1364b4a6-7f98-434e-8070-02bab731119d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_13694843-7358-454e-8001-380c30620343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_148ad82f-42d4-4125-aa46-2c752917796a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_14d9f964-799a-438f-8197-61ae142e28d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14dff0a8-f6e3-44e8-a3c8-67a93240f124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_154fe60d-7256-40d2-a138-fa133ec0c2ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_155f7dc2-975e-4e6a-bace-6dfb4dbe5000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_16e99f91-f640-4040-b9b5-471378dcd3f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_17017b2a-0317-4eb0-952e-a435e24f4125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_17140411-b5e8-43ef-8ad8-fe25a8045518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_171e97bb-f74a-4c17-8063-b0dca204941d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1731ac46-b6f5-411b-85d1-c11e32e67f0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1816c078-11b5-460a-ad2e-54cbd4e77cbd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_18883a4e-3c50-4f05-b6d4-558b64a471aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19101d97-aca7-45f0-b583-c510e7751aed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_191d279e-0f47-40c7-82d1-36a0fa78870f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_197a7b2b-9367-4d18-a82a-81e4a8afc234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19f9ae33-8506-491f-9863-f0a3fba13817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1a8cdfac-c298-4e05-a31d-4569a79026a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:Outstanding2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1a9f4847-6963-488f-b354-eb7c596994c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1bdd4ad6-2439-4385-82de-5ad820bd7eae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1ca55df9-e12f-4eef-88d2-5127dad03544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d60db24-5501-4ef8-9186-60ebe8c52f24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1df97a3c-6233-4b8a-a866-08d91ec761b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:InternalExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e2ed4aa-4ec1-488a-9c05-da807b81c789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e6b3044-ac2f-457a-a3c3-0254c3c6cfa2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1f0576c0-c074-4ef6-8698-a676d24560da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1fcc8f6c-3778-4f03-9b9f-4a242c10fa7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fff98f9-2913-4a76-9006-53b136b3b233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_206853b6-d741-4c50-9285-74ba6833daf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_20aec05b-661b-4aea-8d88-b14352ed9322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_21159e50-9136-4f4e-a5d7-9312dd7ce1ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:CommercialSupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2115f8b1-9136-4380-851e-2b2dd4d28c47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_22346f7a-9d5b-4adb-8126-334786efe7ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23437773-47f3-4a8c-96df-2a22fdd80f90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2448232b-60b4-48e6-82a0-b32e49c6f1a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_244f0667-3be5-4a0a-8576-8ae545e146fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_24e20d06-ec1f-46a1-aa46-323dcfd90377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_25328d2c-092e-4651-9c58-eeb1fa6d99e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_253ffe46-1c31-4933-9e01-a237c876ecc9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:SarissaCapitalManagementLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_25c30b00-13bd-4d27-89b6-199993a5cac6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_275d36b8-67af-4e37-bb78-b7ec1929c925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_284534cf-6887-4f30-ada1-31c5129ca188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_28894aac-4362-4af5-af9d-30c2bfedaac8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_289ad2e3-11f8-4293-9451-51ca41bb9371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_289bc6be-6e0d-435c-bf28-005e3d396793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-10</xbrli:startDate><xbrli:endDate>2023-07-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_28c9f433-5923-40a8-82f6-7695aff7836d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inva:OneDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2929c53c-75fc-494c-9554-8c5d617baf03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_298130f5-8670-42be-853c-8278eb64b931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b29300e-dbc5-4ba4-9407-04aba97c4829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2b5acdfb-cefd-4c67-9972-a3dda739bb03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2beadbda-6783-4ae4-893a-d09da35b2b25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c77d616-9e5d-408c-b20f-a0aaee7f6140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-13</xbrli:startDate><xbrli:endDate>2024-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2e2ce5a8-4015-4724-a5c6-e1c368237ec7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f675c67-919e-4761-81e6-7accacddcb17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f78b292-f3be-4468-828a-00ca22c1d9e5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_30321d31-1876-4ed6-ab63-b9b2cac929bb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:Outstanding2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_304ecd1f-6a58-4044-a4fe-d0160d63a872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_30c301e3-2dfb-45b3-9f2b-eb72553bc22b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_315a265e-5369-4a49-a2e2-f13fcdd56f9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_315cbf77-929f-4504-ae65-d859fbee4836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_31a5145f-3c5c-445c-8566-35efc89d880a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:CostReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32245f0a-45db-4e0a-9613-eef82b4c01c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_331dc9af-0e1f-47b2-a30d-d84e5a653bda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesC2PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-14</xbrli:startDate><xbrli:endDate>2023-09-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_33718ac7-2f56-451b-aa25-527639d12045"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_352aac51-ea35-49df-addd-f02b0882af4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_352cd91c-df33-43d0-851f-1172751e05a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_353f21fc-32cd-4752-9796-07126db0df6e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3551cf7d-cc96-4d09-9170-a0cd1bd24e95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35c66ecd-abaa-47c4-aeed-995102651f7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35f30426-4799-4508-968e-1f20db7a6efe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_360b25f8-0668-427b-a0a4-5664f61139d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36337589-fa2b-44e1-bff5-12d71d918a11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_364151ca-1164-42c3-99da-d375625b3e9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36498d02-d869-42ba-9764-62160907c5d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_37bbf523-072e-4d93-97c4-9c3c71d7a919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_388e224e-9c7a-4df5-91b8-5e4f6d9f788b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ExternalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3a11ad05-9798-4623-a6d9-25f61cd44da6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3a94b2fa-2178-45d2-a69f-4f779a9e094b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3a966812-a150-488f-a6ce-1883cd6184b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ad95b16-89e1-4def-b1ad-f62ba899efc6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3aea5bf7-3984-4fb0-812f-c886790b0640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ba88775-17f5-4d28-b47f-634aaca4e732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3baecf69-ebf5-4807-8356-b90a92791318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3c13a3c1-d391-437e-ab76-9807135c7a06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:DurlobactamMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:AstrazenecaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d2c4b5a-dd7c-4736-8ce5-464b5a60b336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d95a88c-d5b6-4806-8dd1-644e4672cd1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3e355c7e-7e1e-40b8-829f-9c901683dc89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3e58dc77-93ac-48f8-ad4b-45e787d62643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:EquityIncentivePlansAndESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e6c5798-81a7-4ab8-b212-ef8406a6ab89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ea3009c-970b-499f-ab6e-42fe1c681808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3f07a2ce-f751-4da5-bf13-5630b4c78ccc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">inva:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f3470cf-f3bb-46cd-b659-030c2237a851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3fbaef98-117c-41ce-8102-e48e8c5bfa08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40250a06-ba0d-4b97-9fa8-e40ff2902099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4041c10c-d9db-40fe-83d8-3d345cb6210f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_407f2692-c7b8-407e-92c4-03aef1a4ccda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_40baef25-dae2-4dfa-871a-2daf38c29542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_412a8dbd-f544-4764-ad96-91e826f4e587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:CordenPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_41d2a460-017a-4f09-950d-898d5eed18e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_435c3fdf-dded-4b1c-8c53-e2baf1575828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_43d9c586-5f52-4d19-8160-779b9b10fc41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_43e76568-df93-454e-8619-b61f33c62f7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_43ebbba5-322d-4a57-9b5a-da8637cdeb0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4406a063-c883-4b59-8711-b008bdcbf2f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4567075b-b913-4d0b-920a-5d6cbdb4427a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_45841d41-b3ea-49ad-9f9e-c591d3adde1c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_46be4ed0-3a6f-42b0-b192-15f206bf7393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46c113f9-5e07-4c06-840b-d46df7900549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46def20b-a66d-4411-90eb-b164dbc750ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_476f91df-e117-42e8-94a7-ab3a3ed891d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-10</xbrli:startDate><xbrli:endDate>2023-07-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_476fef44-ae2e-4cc8-8996-5cd189b7399b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_494c4421-3417-4b63-adc9-217af33b40df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_49ed2cfa-e32a-42c5-9d24-b9211f8ade51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:WalthamMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4a162331-f161-4794-bd50-e44d082bee98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-02</xbrli:startDate><xbrli:endDate>2023-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a788214-d295-44db-907c-ec0fa5bd3d73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b154284-9266-4285-aa75-6b79ccaf86ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4bfeee2c-2c81-4b9f-a36f-d4540c545b48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-06</xbrli:startDate><xbrli:endDate>2023-10-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4c137836-1d57-48b3-b853-5989053266bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c6c9a98-3708-403b-b3e3-41b376c009ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4c9bc9df-24d5-48aa-a746-0482bc1e814c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4dd5f666-9958-4324-a0bb-faa2a4d1e877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4e5991ec-66d1-4584-84f0-5ad5de0d9c80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f335e5e-75f0-4807-8256-9c44cb0e8135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f80e919-076e-4576-9834-4ff10cef76db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_510f527b-715b-4a94-923a-54ba359b3544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5113ca40-db4d-493a-87c2-9a406e584ece"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-24</xbrli:startDate><xbrli:endDate>2021-11-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-07</xbrli:startDate><xbrli:endDate>2022-03-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_529c2882-00b1-4936-b580-0e5381a12f59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53205d86-091a-45ec-875f-153f734c0c7b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-07-01</xbrli:startDate><xbrli:endDate>2014-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_53b04726-e41a-4259-a6b3-6fa32a149149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54134174-dac2-4f09-bf74-39a35e6c1945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_54ab6970-91f6-4ad7-97a4-6add8575d58a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54b22293-d908-4db6-bb20-6b71eb916276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54fb9637-236a-4edf-bd9e-20160cd157ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_55ac6c23-a2e6-4ccc-84fe-98d81ce04dce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:ManufacturingStageTransferAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56394c95-e990-4b88-a251-9f022931314e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inva:AmortizationOfInventoryFairValueAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_569e318a-9026-41e3-b966-5d091cfcfca3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56f936fd-c826-462c-938f-240f31460844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5762c44d-7963-4357-b789-7869c9919cc7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57c0f280-1381-409e-9964-9e5c0e176ff4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57dd6d3d-0988-40b1-b84f-ff3d06249917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD2PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_583c4930-0807-43ad-bc97-189170841090"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5844539a-fc91-4105-b8a3-cf46e12ce3bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_586ff5e8-d41c-4176-a904-9624786d8bde"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_58f0fc2b-d399-43f9-94e6-ce77c2852307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58ff6e27-8879-40c6-936f-18c78a254cf0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_59929190-726b-42e1-a7ea-6423d3b27be2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5a824dc9-4da6-4578-80c3-146747709b51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5a95facc-643d-4e5c-a79c-d70b76227248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b6b74d6-5ba3-490c-a58b-c2fa128f4c16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d3d7d01-66b3-48b0-9e0a-4093af97d0e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e383c8b-3da2-4e7d-b954-1e85556222ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e46d5ce-f631-4674-8338-9c89eeeb502a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5ed4602e-2cde-4ad0-8956-178ce6486089"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f34def2-d4ef-45dc-9b5a-7b2dfd3ae646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f6af4c9-41ef-4851-89a6-4144851fcb0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fbfbbeb-63b0-4ede-a5c8-bf29e1de26a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6038b2ea-b8d0-41fb-ab7d-a45db02e7491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61675bce-4ccb-4819-8b97-db41c469c40c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61ad19f2-d970-4839-83ca-b0d913e3f96e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_631eb718-8626-432d-96fb-8270d3650dfb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EquityIncentivePlan2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_63d0bdb3-3078-4052-b347-b162b01e64c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_644fec1f-c78d-47a9-b887-38182f8bfb45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6502e745-ecac-480c-a568-afd26e86b8d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_65a78fed-9696-4e3e-a1e4-e3cc50d0f0d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_663ceb44-07f8-4150-a16b-cc6004609ea5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:Outstanding2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_66693642-95da-475a-a4b4-59d4ac42aae1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_67629f3b-d335-4784-a7d4-56ecd9570134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ParatekPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6785d313-2b28-4dd6-843b-fd6e81cb4e68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_67cd523d-133e-42a5-8657-9f3bb1123823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_67dabe6c-1f60-48af-9f2b-2dac4085e3c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6904c00c-1661-415e-91ce-09c91f2b890e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6909246c-601a-476f-8981-bae18ebb0a34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_69bb9340-c11c-45f9-89b5-1eff93f82a71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCapPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-07-01</xbrli:startDate><xbrli:endDate>2014-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_69dda25f-8fec-4d6f-996d-0711b459c98b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a7b2f2b-6e3e-48ea-ab7f-7e1306be753c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a8af425-4477-456f-9b7d-745f9bdef0b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6abb342a-b250-49ac-bbe0-52e5029809ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b4d38cc-2d5a-43e5-9152-e93c3f2a4d89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b58e123-d309-44b2-808c-8e368c6f5f3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6bf0974e-bd6c-4a97-aa2d-09d4b17083b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ca7b604-74ae-4669-9748-a07e890fea74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:OutstandingStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d0a78b5-48c4-4a35-91c6-e8575ef72b82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d3efb43-3699-4ae8-a66b-6ac082761119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e13c51d-a0c3-477a-982e-4cc4b6d00a3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e23f21f-fd64-45fb-a9b6-a0ca21a8e566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6ea92036-d7da-481b-8027-3362c5292d59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6eebba42-5bd2-4b1d-add7-2b9166a45342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">inva:OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6fd76cbf-78f1-4169-b3c9-f2dee135ca32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_703323c3-fcbe-41ac-9f9b-28b43c769909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_703de750-f5d6-45f2-b263-1f034aa780b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_704606a8-5b42-4a22-98f8-ab51052adab9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_70e43fac-bdea-4cfc-a822-8d3ad323984c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7123baea-0eb2-4315-ab65-b66fb4c1e84c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7136a559-6922-4b61-8d55-1fe4429116c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7140c906-62ed-4fc2-ae57-4d809ddc48a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-09</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7145555a-225b-40f5-a4c1-17e76939a86d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71e50eda-66f4-437b-adb4-80b4249323a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72ca4799-ff83-4650-a66f-e64646a8bbbd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72e33bb8-0153-4002-8937-baf8a5118573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72fa18ae-694c-4d8c-98c2-590805770243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_734bee53-194c-4c05-925f-5a7cf8d9acf6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_73b479b7-bd69-4e75-9afa-4ce0c8d93cbd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ResearchAndDevelopmentSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_73f1df40-a5ad-4f58-8d9d-f8b23a0da0a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_745efcda-116c-4d6a-b708-1361e157d2ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_74764868-362a-469f-82b3-5a8b74607e25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_74893ac7-f1ad-41b2-845f-0c4f0fae42da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_751227a8-ff5f-4419-bc20-3ffdd5766392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_75144e9c-8d8d-4067-a64b-e8ba0c236ce0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7530273c-e395-47f6-b8ce-a7265c4b1b91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_754e1428-1254-4b24-afeb-0530ecdb9559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_765a2763-8b53-4101-ab58-259faa96bbda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_77c52870-1a85-4eaf-9c65-7b65a7c304fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_783d44e6-75e9-4b12-8062-6bfba06d75c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_786faf8b-f50d-4276-973e-9c08430f0704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78745eb2-7d71-4fab-bac2-e5ea9e5f2e5b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_788779b5-a56e-46b0-b6c5-4c88f05e3f22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78c666f2-f708-4225-8f3e-243b11aa5167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79768fb0-1a83-46a5-a213-1d3d9c213d45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79983aa1-6f85-41fc-9342-69b5e86a22d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7abf372b-d434-4499-93a9-de44ea4152e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b46f925-454c-4214-b995-44ba572a8c1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c241491-c363-4e26-b334-863eae0dae59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c641825-cc45-4345-9822-341d08847261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7d99aa1f-7657-4d34-8478-bfbf3e3c3acd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7dd1472a-f27f-4e99-ac46-35b7a204db5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7e8f2964-378b-406a-9a0b-b4b4284256f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f01ba3d-3b8a-46ef-b6ed-b35a2187ddb1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:FirstAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f207f6a-98e7-439a-bc04-1d2e8566d922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-07</xbrli:startDate><xbrli:endDate>2017-08-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f8fbf04-70a3-46c3-b1c4-813bd471a322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001080014</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_Segment"><xbrli:measure>inva:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Director"><xbrli:measure>inva:Director</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Item"><xbrli:measure>inva:Item</xbrli:measure></xbrli:unit><xbrli:unit id="U_Customer"><xbrli:measure>inva:Customer</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_CHF"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="U_Tranche"><xbrli:measure>inva:Tranche</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_Installment"><xbrli:measure>inva:Installment</xbrli:measure></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9" fromRefs="F_da285bb3-aefd-4e23-a795-82b237438fae F_b6caa033-e1b0-42c5-9e67-d5b2c51deb83 F_31dd804c-ed7c-49d3-afe0-753c37a5f180 F_a6ddcf50-d102-4a94-8e1d-30455b13ca59"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_30a29ac4-a358-403f-922e-b22439018a34" fromRefs="F_902daea8-5ff8-4718-bd5d-98cc32f8fb31 F_c33cb1a3-3d6f-4322-af2b-31d51faf766b F_cd66a87e-2be3-4ed8-b423-87c616c33a64 F_3a60c6f3-3651-42b0-8d22-dc356d15606d"/></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="border-top:3pt solid;padding-top:1pt;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3f7f5b05-4355-4cc3-a373-57e675559ad4" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:13.42%;box-sizing:content-box;"/>
    <td style="width:86.58%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Mark One)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_3472c12c-b51e-4414-85b8-072d4b12ff50" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentAnnualReport" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="2" style="padding-top:0in;text-indent:10.1pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10.1pt;padding-left:10.1pt;font-size:8pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span><ix:nonNumeric id="F_9b1ef86e-e08e-4e17-96d6-b2fdbe74a62b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span><ix:nonNumeric id="F_28809184-f074-40ec-a215-a8164a2edb33" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_1bd9bab3-9ecc-43f5-aaf6-467449b64987" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="2" style="padding-top:0in;text-indent:10.1pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10.1pt;padding-left:10.1pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">or</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_7e5ecdca-8cf1-46c8-b15c-409e87ca7fb2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the transition period from              to</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File No. </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b65c3852-b180-43e3-ba12-7bd3c55cdabf" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">000-30319</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_60eeba1d-5313-4d57-a0b1-e878b7355824" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:25.2pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:10.1pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10.1pt;padding-left:10.1pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9bab6314-a758-4e81-bafa-f957012d8296" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>(State or other jurisdiction of<br/>incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_26bff954-5c51-4c07-b159-25a4246c656b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">94-3265960</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>(I.R.S. Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b7805f45-2bc7-4900-a394-9ed16b9e7089" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1350 Old Bayshore Highway, Suite 400</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/></span><span><ix:nonNumeric id="F_e6d150d2-6e85-49a3-a51e-430dea8180be" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Burlingame</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_84ef4248-b2e9-4bef-8a88-3c442ef5ebea" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> <br/></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_80597ea5-824b-4b0b-9dce-5a95348055db" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">94010</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1ed8fdb9-3ce8-4358-83f3-b13ed61e3f20" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">650</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_730033e3-f942-4c41-ba6a-e6a4afb06852" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">238-9600</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:34.167%;box-sizing:content-box;"/>
    <td style="width:1.66%;box-sizing:content-box;"/>
    <td style="width:25.345%;box-sizing:content-box;"/>
    <td style="width:1.48%;box-sizing:content-box;"/>
    <td style="width:37.347%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="text-indent:-10pt;padding-left:10pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of Each Class</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of Each Exchange On Which Registered</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_00a75085-fb3a-47af-8a33-7ba936468e41" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock $0.01 Par Value</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_5551957e-93a8-447f-b395-75b6298dae06" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INVA</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:8pt;"><ix:nonNumeric id="F_2f0a8b3b-e9be-4613-a3bc-2aca91c9cd17" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;Stock Market LLC</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NONE</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is a well&#8209;known seasoned issuer, as defined in Rule 405 of the Securities Act. </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4767a540-30c2-4e9b-9d84-f8a433f95170" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;   No &#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744;   </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7611f6cc-07e0-4899-a200-f8079e0aa12c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe45f748-458c-4ffa-ae00-b5f6df408d9b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;   No &#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d704c259-40e3-4108-b9c3-70dc654f3d80" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;  No &#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of &#8220;accelerated filer and large accelerated filer&#8221; in Rule 12b-2 of the Exchange Act (Check One):</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:31.246%;box-sizing:content-box;"/>
    <td style="width:17.944%;box-sizing:content-box;"/>
    <td style="width:27.586%;box-sizing:content-box;"/>
    <td style="width:23.225%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:0.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10.1pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10.1pt;padding-left:10.1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_a2600bf5-9e24-4f4e-9ef6-96f280184759" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;&#9746;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer &#9744;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non&#8209;accelerated filer &#9744;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">Smaller reporting company </span><span style="font-size:8pt;"><ix:nonNumeric id="F_73e84d96-e9e5-46e0-8e1f-99ffdc510dff" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10.1pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10.1pt;padding-left:10.1pt;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:8pt;"><ix:nonNumeric id="F_f1618eae-2d17-44d6-bdb0-86abaae14c8e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_37198f7a-2898-4820-b43f-272cfe3b6696" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77b5c4bb-4ba0-455b-8268-758d7ba42b31" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive o&#64259;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b&#8209;2 of the Exchange Act). Yes &#9744;   No </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f37134b3-64eb-404f-80dd-01b947821241" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant based upon the closing price of the registrant&#8217;s Common Stock on The Nasdaq Global Select Market on June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_175ec27c-31c2-4b45-8d1e-b79024f968db" contextRef="C_bf2aa827-497e-4734-b273-79d836b4d1eb" name="dei:EntityPublicFloat" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">899,110,517</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This calculation does not reflect a determination that persons are affiliates for any other purpose.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 14, 2025,</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> there were </span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a108891-c729-4583-a149-c59e815eeab8" contextRef="C_94e5705b-e6d9-4f93-b4fa-02e92457a43c" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">62,675,545</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the registrant&#8217;s Common Stock outstanding.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bf1f7360-c792-4404-94b1-106bf817c4b5" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specified portions of the registrant&#8217;s definitive Proxy Statement to be issued in conjunction with the registrant&#8217;s 2025 Annual Meeting of Stockholders, which is expected to be filed not later than 120 days after the registrant&#8217;s fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, are incorporated by reference into Part III of this Annual Report. Except as expressly incorporated by reference, the registrant&#8217;s Proxy Statement shall not be deemed to be a part of this Annual Report on Form 10-K.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="border-top:0.5pt solid;padding-top:1pt;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:3pt solid;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 Form 10&#8209;K Annual Report</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="toc"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:88%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrant_s_common"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_selected_financial_data"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved]</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_management_s_discussion_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_and_qualitative"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_disagreements_with"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign_jur"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_officers_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership_of_certain"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting_fees_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_and_financial_statement"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">156</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16.</span></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10_k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10&#8209;K Summary</span></a></p></td>
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">156</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#exhibits"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">157</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">160</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="special_note_regarding_forward_looking"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special Note Regarding Forward&#8209;Looking Statements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10&#8209;K contains forward&#8209;looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Securities Act&#8221;). Such forward&#8209;looking statements involve substantial risks, uncertainties and assumptions. All statements in this Annual Report on Form 10&#8209;K, other than statements of historical fact, including, without limitation, statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, intentions, expectations, goals and objectives may be forward&#8209;looking statements. The words &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;designed,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;goal,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;pursuing,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions (including the negatives thereof) are intended to identify forward&#8209;looking statements, although not all forward&#8209;looking statements contain these identifying words. We may not actually achieve the plans, intentions, expectations or objectives disclosed in our forward&#8209;looking statements and the assumptions underlying our forward&#8209;looking statements may prove incorrect. Therefore, you should not place undue reliance on our forward&#8209;looking statements. Actual results or events could differ materially from the plans, intentions, expectations and objectives disclosed in the forward&#8209;looking statements that we make. All written and verbal forward&#8209;looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Important factors that we believe could cause actual results or events to differ materially from our forward&#8209;looking statements include, but are not limited to, risks related to: lower than expected future royalty revenue from respiratory products partnered with GSK, the commercialization of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, and ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in the jurisdictions in which these products have been approved; the strategies, plans and objectives of the Company (including the Company&#8217;s growth strategy and corporate development initiatives); the timing, manner, and amount of potential capital returns to shareholders; the status and timing of clinical studies, data analysis and communication of results; the potential benefits and mechanisms of action of product candidates; expectations for product candidates through development and commercialization; the timing of regulatory approval of product candidates; and projections of revenue, expenses and other financial items; the impact of the novel coronavirus (&#8220;COVID-19&#8221;); the timing, manner and amount of capital deployment, including potential capital returns to stockholders; and risks related to the Company&#8217;s growth strategy and risks discussed in &#8220;Risk Factors&#8221; in Item 1A of Part I, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II and elsewhere in this Annual Report on Form 10&#8209;K. Our forward&#8209;looking statements in this Annual Report on Form 10&#8209;K are based on current expectations as of the date hereof and we do not assume any obligation to update any forward&#8209;looking statements on account of new information, future events or otherwise, except as required by law.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We encourage you to read Management&#8217;s Discussion and Analysis of our Financial Condition and Results of Operations and our consolidated financial statements contained in this Annual Report on Form 10&#8209;K. We also encourage you to read Item 1A of Part I of this Annual Report on Form 10&#8209;K, entitled &#8220;Risk Factors,&#8221; which contains a more complete discussion of the risks and uncertainties associated with our business. In addition to the risks described above and in Item 1A of this report, other unknown or unpredictable factors also could affect our results. Therefore, the information in this report should be read together with other reports and documents that we file with the Securities and Exchange Commission (&#8220;SEC&#8221;) from time to time, including on Form 10&#8209;Q and Form 8&#8209;K, which may supplement, modify, supersede or update those risk factors. As a result of these factors, we cannot assure you that the forward&#8209;looking statements in this report will prove to be accurate. Furthermore, if our forward&#8209;looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward&#8209;looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1.   BUSINESS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc. (&#8220;Innoviva&#8221;, the &#8220;Company&#8221;, the &#8220;Registrant&#8221; or &#8220;we&#8221; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#8220;IST&#8221;), and a portfolio of strategic investments in other healthcare assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#8220;GSK&#8221;), including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (fluticasone furoate/vilanterol, &#8220;FF/VI&#8221;) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (umeclidinium bromide/vilanterol, &#8220;UMEC/VI&#8221;). Under the Long-Acting Beta2 Agonist (&#8220;LABA&#8221;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: 15% on the first $3.0 billion of annual global net sales and 5% for all annual global net sales above $3.0 billion; and royalties from the sales of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which tier upward at a range from 6.5% to 10%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial and marketed products include GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(angiotensin II), approved in the United States (&#8220;U.S.&#8221;) to increase blood pressure in adults with septic or other distributive shock, and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(eravacycline) approved in the U.S. for the treatment of complicated intra-abdominal infections in adults. On May 23, 2023, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#8220;FDA&#8221;) and we commenced commercial sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) (&#8220;Basilea&#8221;) for the commercialization of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue our efforts to submit a New Drug Application (&#8220;NDA&#8221;) for zoliflodacin, a potential first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the U.S. FDA in early 2025. Overall, we have a wholly owned robust critical care and infectious disease operating platform with a hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we own other strategic healthcare assets, such as a significant stake in Armata Pharmaceuticals, Inc., a leader in development of bacteriophages with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our focus on capital allocation and shareholder value maximization has led our company to a meaningful transformation over the last two years. In 2022, our financials contained royalty revenues from TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which was divested mid-year in an economically accretive transaction. Additionally, our acquisition and integration of operating companies, Entasis Therapeutics Holding Inc. (&#8220;Entasis&#8221;) and La Jolla Pharmaceutical Company (&#8220;La Jolla&#8221;), and advancement of our therapeutics portfolio further changed the structure of our financials compared to prior years. Through these changes, we believe we are well-positioned to create significant long-term shareholder value.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our headquarters are located at 1350 Old Bayshore Highway, Suite 400, Burlingame, CA 94010. The Company was incorporated in Delaware in November 1996 under the name Advanced Medicine, Inc., and began operations in May 1997. It later changed its name to Theravance, Inc. in April 2002, and rebranded, changing its name to Innoviva, Inc. in January 2016.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategy</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate strategy is currently focused on increasing stockholder value by, among other things, maximizing the potential value of our respiratory assets partnered with GSK, creating value through our critical care and infectious disease platform, optimizing our operations, and augmenting capital allocation. We continue to diversify our royalty management business through actively pursuing opportunistic acquisitions of promising companies and assets in the healthcare industry and enhancing the returns on our capital.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Royalty Product Portfolio</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Relationship with GSK</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LABA Collaboration</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2002, we entered into our LABA Collaboration Agreement with GSK to develop and commercialize once&#8209;daily products for the treatment of chronic obstructive pulmonary disease (&#8220;COPD&#8221;) and asthma. The collaboration has developed three combination products, two of which we still retain rights in. Those two are as follows:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;FF/VI&#8221;) (BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is the proprietary name in the U.S. and Canada and RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is the proprietary name outside the U.S. and Canada), a once-daily combination medicine consisting of a LABA, vilanterol (&#8220;VI&#8221;), and an inhaled corticosteroid (&#8220;ICS&#8221;), fluticasone furoate (&#8220;FF&#8221;), and,</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;UMEC/VI&#8221;), a once-daily medicine combining a long-acting muscarinic antagonist (&#8220;LAMA&#8221;), umeclidinium bromide (&#8220;UMEC&#8221;), with a LABA, VI.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the launch and approval of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S., Japan and Europe, in accordance with the LABA Collaboration Agreement, we paid milestone fees to GSK totaling $220.0 million during the year ended December 31, 2014. The milestone fees paid to GSK were recognized as capitalized fees paid, which are being amortized over their estimated useful lives commencing upon the commercial launch of the products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate that RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (FF/VI) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (UMEC/VI) will compete with a number of approved bronchodilator drugs alone or in combination, including each other and drug candidates under development that are designed to treat asthma and COPD. These include but are not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/Seretide&#153; Diskus</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/HFA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (salmeterol and fluticasone propionate as a combination) marketed by GSK</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Symbicort</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (formoterol and budesonide as a combination) marketed by AstraZeneca</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AirDuo Respiclick</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (salmeterol and fluticasone propionate), a non-substitutable generic version of Advair, marketed by TEVA</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Spiriva</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Handihaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and Spiriva</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Respimat</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (tiotropium) marketed by Boehringer Ingelheim</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dulera</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (formoterol and mometasone as a combination) marketed by Merck</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tudorza</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pressair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (aclidinium) marketed by AstraZeneca and Seebri</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Breezehaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (glycopyrronium) marketed by Novartis outside the U.S. and Sunovion in the U.S.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Incruse</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Ellipta</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (umeclidinium) and Arnuity</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Ellipta</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (fluticasone furoate) (Innoviva is not entitled to any royalties from either product)</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Foradil</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Aerolizer</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/Oxis</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Turbuhaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (formoterol) marketed by a number of companies</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Striverdi</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Respimat</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (olodaterol) marketed by Boehringer Ingelheim</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Onbrez</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Breezehaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (E.U.)/Arcapta</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Neohaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (U.S.) (indacaterol) marketed by Novartis</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ultibro</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Breezehaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (E.U.)/Utibron</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Neohaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (U.S.) (indacaterol combined with glycopyrronium bromide) developed by Novartis and approved and launched in Europe and Japan in the year ended December 31, 2013 as a once-daily treatment for COPD. In the U.S., the product was approved in October 2015 at a lower strength as a twice-daily COPD treatment, and was licensed to Sunovion in December 2016, and launched in May 2017</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stiolto (U.S.)/Spiolto (E.U.) Respimat</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (tiotropium combined with olodaterol) marketed by Boehringer Ingelheim for the treatment of COPD</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bevespi Aerosphere</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (glycopyrronium bromide in combination with formoterol fumarate) marketed by AstraZeneca</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Duaklir</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Genuair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (aclidinium bromide in combination with formoterol fumarate) developed by AstraZeneca as a maintenance bronchodilator treatment for COPD and approved in November 2014 in the EU and March 2019 in the U.S.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Atectura</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Breezhaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (indacaterol in combination with mometasone) marketed by Novartis</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trimbow</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (a fixed-dose, twice daily combination of formoterol, beclomethasone and glycopyrronium) manufactured by Chiesi and indicated for use in COPD in the E.U.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Foster (beclomethasone dipropionate in combination with formoterol fumarate) manufactured by Chiesi and indicated for use in asthma and COPD outside the U.S.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enerzair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Breezehaler</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (a fixed-dose combination of indacaterol, mometasone and glycopyrronium) developed by Novartis as a triple therapy/single inhaler for the treatment of asthma and approved in the E.U., Canada, and Japan</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Breztri</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Aerosphere</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (fixed dose combination of formoterol, glycopyrronium and budesonide) developed by AstraZeneca as a triple therapy single inhaler twice-daily medication for COPD and approved in the U.S. in July 2020</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nucala</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (mepolizumab; an interleukin-5 antagonist monoclonal antibody) developed by GSK for add on maintenance treatment of severe asthma in patients 12 years and older and approved in the U.S. in June 2019</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Xolair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (omalizumab, an anti-IgE antibody) developed by Genentech for patients 6 years of age and older with moderate to severe persistent asthma uncontrolled by inhaled corticosteroids and approved in 2003. Single-dose pre-filled syringes were approved by the FDA in September 2018</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cinqair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (anti-interleukin-5 monoclonal antibody for the add-on maintenance treatment of adults with severe asthma and an eosinophilic phenotype) marketed by TEVA Pharmaceutical Industries Ltd.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dupixent</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (dupilamab, an injectable IL-4 and IL-13 inhibitor) developed by Sanofi Genzyme and approved by the FDA in October 2018 as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fasenra</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (benralizumab, an injectable anti-IL-5 monoclonal antibody) for the treatment of severe asthma in patients 12 years of age and older marketed by AstraZeneca. Fasenra Pen pre-filled auto-injector was approved by the FDA for self-administration in November 2019</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Singulair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (monteleukast), an orally active leukotriene receptor antagonist for the prophylaxis and treatment of asthma in patients 12 months of age and older marketed by Merck</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tezspire</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (tezepelumab-ekko), an injectable monoclonal antibody designed to inhibit thymic stromal lymphopoietin (TSLP), an epithelial cytokine thought to be critical in the initiation and persistence of airway inflammation. Co-developed by Astra Zeneca and Amgen for the treatment of severe asthma. The FDA approved the Tezspire solution for subcutaneous injection in December 2021; it is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ohtuvayre</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ensifentrine), an inhaled dual phosphodiesterase inhibitor indicated for the miantenace treatment of COPD in adults with moderate-to-severe symptoms.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, several firms have developed and launched new formulations of Advair/Seretide (salmeterol /fluticasone propionate) and Symbicort (formoterol fumerate/budesonide) which may be marketed as generics or branded generics relative to the existing products from GSK and AstraZeneca, respectively. All of these efforts represent potential competition for any of our partnered products. Efforts have intensified following the publication of FDA draft guidance for the approval of fully substitutable versions of Advair and Symbicort in late 2013 and mid-2015, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In general, these manufacturers are required to conduct a number of clinical efficacy, pharmacokinetic and device studies to demonstrate equivalence to branded products already approved by the FDA. These studies are designed to demonstrate that the generic product has the same active ingredient(s), dosage form, strength, exposure and clinical efficacy as the branded product. These generic equivalents, which must meet the same exacting quality standards as branded products, may be significantly less costly to bring to market, and companies that produce generic equivalents are generally able to offer their products at lower prices. Thus, after the introduction of a generic competitor, a significant percentage of the sales of any branded product and products that may compete with such branded product is typically lost to the generic product. In addition, in April 2016, the FDA issued a draft guidance document covering Fluticasone Furoate/Vilanterol Trifenatate (FF/VI), the active ingredients used in RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Integrated Critical Care / Infectious Disease Assets</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercial and Marketed Products</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our critical care and infectious disease portfolio was formed through the 2022 acquisitions of Entasis and La Jolla, which we have continued to grow through our license agreement with Basilea. It comprises four differentiated commercial stage products and a pipeline. The following table summarizes our commercial and marketed products:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_0.jpg" alt="img12876764_0.jpg" style="width:696px;height:322px;"/></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For U.S. and European approval.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S.: GIAPREZA is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">European Union: GIAPREZA is indicated for the treatment of refractory hypotension in adults with septic or other distributive shock who remain hypotensive despite adequate volume restitution and application of catecholamines and other available vasopressor therapies.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S.: XERAVA is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (&#8220;cIAI&#8221;) in patients 18 years of age and older.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">European Union: XERAVA is indicated for the treatment of cIAI in adults.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S.: XACDURO is a co-packaged product containing sulbactam, a beta-lactam antibacterial and beta lactamase inhibitor, and durlobactam, a beta lactamase inhibitor, indicated in patients 18 years of age and older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(7)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S.: ZEVTERA is a cephalosporin antibacterial indicated for the treatment of: Adult patients with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including those with right-sided infective endocarditis, adult patients with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP).</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(8)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">European Union: ZEVTERA is a cephalosporin antibacterial indicated for the treatment of hospital-acquired pneumonia (HAP, excluding ventilator-associated pneumonia, VAP) and community-acquired pneumonia (CAP) in patients 18 years of age and older.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (angiotensin II)</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(angiotensin II) injection is approved by the U.S. FDA as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. GIAPREZA is approved by the European Commission (&#8220;EC&#8221;) and by the Great Britain Medicines and Health Care Products Regulatory Agency (&#8220;MHRA&#8221;) for the treatment of refractory hypotension in adults with septic or other distributive shock who remain hypotensive despite adequate volume restitution and application of catecholamines and other available vasopressor therapies. GIAPREZA mimics the body&#8217;s endogenous angiotensin II peptide, which is central to the renin-angiotensin-aldosterone system (&#8220;RAAS&#8221;), which in turn regulates blood pressure. GIAPREZA is marketed in the U.S. by La Jolla and is marketed in Europe and Great Britain by PAION Deutschland GmbH, a subsidiary of the Humanwell Healthcare Group, on behalf of La Jolla.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Angiotensin II for the Treatment of High-Output Shock (&#8220;ATHOS-3&#8221;)</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA was approved by the U.S. FDA, EC and MHRA based on the results of ATHOS-3, which were published in the New England Journal of Medicine in August 2017. ATHOS-3 was a multinational, randomized, double-blind, placebo-controlled study in which 321 adults with septic or other distributive shock who remained hypotensive despite fluid and vasopressor therapy received either GIAPREZA or placebo, both in addition to background vasopressor therapy. The primary endpoint was mean arterial pressure (&#8220;MAP&#8221;) response, defined as a MAP of 75 mm Hg or higher or an increase in MAP from baseline of at least 10 mm Hg without an increase in the dose of background vasopressors at Hour 3 (Khanna et al, New England Journal of Medicine 2017; 377:419&#8211;430).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATHOS-3 Study Design</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_1.jpg" alt="img12876764_1.jpg" style="width:632px;height:261px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MAP=mean arterial pressure</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Khanna et al, New England Journal of Medicine 2017; 377:419&#8211;430</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Standard-of-care vasopressors included norepinephrine, epinephrine, dopamine and vasopressin</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA significantly improved blood pressure response. Specifically, the primary endpoint was achieved by 70% of GIAPREZA-treated patients compared to 23% of placebo-treated patients (p &lt;0.0001).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATHOS-3 Primary Endpoint Results</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_2.jpg" alt="img12876764_2.jpg" style="width:442px;height:338px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MAP response of 75 mm Hg or higher or an increase from baseline of at least 10 mm Hg at Hour 3 without an increase in the dose of background vasopressors</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA provides the ability to rapidly achieve and adjust therapeutic response. GIAPREZA rapidly increased MAP with a median time to MAP response of approximately 5 minutes. The plasma half-life of GIAPREZA is less than 1 minute.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, a positive survival trend was observed. Mortality through Day 28 was 46% on GIAPREZA and 54% on placebo (hazard ratio 0.78; 95% confidence interval 0.57&#8211;1.07).</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Positive Survival Trend Observed (N=321)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1),(2)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_3.jpg" alt="img12876764_3.jpg" style="width:530px;height:304px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Khanna et al, New England Journal of Medicine 2017; 377:419&#8211;430</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patients were treated with either GIAPREZA or placebo, both in addition to background vasopressor therapy</span></div></div>
  <p style="margin-left:4.267%;text-indent:3.482%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The most common adverse reactions that were reported in greater than 10% of GIAPREZA-treated patients were thromboembolic events.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adverse Reactions Occurring in &#8805;4% of Patients Treated with GIAPREZA and &#8805;1.5% More Often than in Placebo-treated Patients</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_4.jpg" alt="img12876764_4.jpg" style="width:542px;height:239px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Including arterial and venous thrombotic events</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XERAVA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline)</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) for injection is approved by the U.S. FDA and Singapore Health Sciences Authority (&#8220;HSA&#8221;) as a tetracycline class antibacterial indicated for the treatment of cIAI due to susceptible microorganisms in patients 18 years of age and older. XERAVA is approved by the EC, MHRA, and the Hong Kong Department of Health (&#8220;DoH&#8221;) for the treatment of cIAI in adults. XERAVA is marketed in the U.S. by our wholly owned subsidiary, Tetraphase Pharmaceuticals, Inc. (&#8220;Tetraphase&#8221;), and is marketed in Europe and Great Britain by PAION on behalf of Tetraphase and is marketed in mainland China, Hong Kong, Macau, South Korea, Singapore, the Malaysian Federation, the Kingdom of Thailand, the Republic of Indonesia, the Socialist Republic of Vietnam and the Republic of the Philippines by Everest Medicines Limited (&#8220;Everest&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cIAIs are the second most common source of severe sepsis in the ICU cIAIs are defined as consequences of perforations of the gastrointestinal tract that result in contamination of the peritoneal space. In July 2024, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">was named as a recommended agent for empiric therapy in the updated 2024 SIS treatment guidelines for the management of complicated intra-abdominal infections. SIS also recommended XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> be reserved for high-risk patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investigating Gram-negative Infections Treated with Eravacycline (&#8220;IGNITE&#8221;)</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XERAVA was approved by the U.S. FDA, HSA, EC, MHRA, and DoH based on the results of IGNITE1 and IGNITE4, which were published in JAMA Surgery in March 2017 and Clinical Infectious Diseases in December 2018, respectively.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IGNITE1 was a multinational, randomized, double-blind, active-controlled study in 538 patients with clinical evidence of cIAIs requiring urgent surgical or percutaneous intervention who received either XERAVA or ertapenem. The primary endpoint was clinical cure, defined as complete resolution or significant improvement of signs or symptoms of the index infection, at the test of cure (&#8220;TOC&#8221;) visit. The TOC visit was conducted 25 to 31 calendar days after the first dose of the study drug was administered.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IGNITE4 was a multinational, randomized, double-blind, active controlled study in 499 patients with clinical evidence of cIAIs requiring urgent surgical or percutaneous intervention who received either XERAVA or meropenem. The primary endpoint was clinical cure, defined as complete resolution or significant improvement of signs or symptoms of the index infection, at the TOC visit. The TOC visit was conducted 25 to 31 calendar days after the first dose of the study drug was administered.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IGNITE1 and IGNITE4 Study Design</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_5.jpg" alt="img12876764_5.jpg" style="width:608px;height:330px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Solomkin et al, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">JAMA Surgery</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 2017; 152(3):224-232</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Solomkin et al, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Infectious Diseases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 2018; 69(6):921-9</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TOC visit was conducted 25 to 31 calendar days after the first dose of the study drug was administered</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XERAVA demonstrated statistical noninferiority in clinical cure rate in the micro-ITT population, which included all randomized subjects who had baseline bacterial pathogens that caused cIAIs and against at least one of which the investigational drug has in vitro (in a test tube) antibacterial activity (N=846).</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IGNITE1 and IGNITE4 Primary Endpoint Results</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_6.jpg" alt="img12876764_6.jpg" style="width:614px;height:296px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Noninferiority margins of 10% and 12.5% were used for IGNITE1 and IGNITE4, respectively</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical cure rates across patients with gram-negative, gram-positive and anaerobic pathogens, including those with resistant strains, are shown in the following tables.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Cure Rates at TOC by Selected Baseline Pathogens in the Micro-ITT Population</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_7.jpg" alt="img12876764_7.jpg" style="width:516px;height:267px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">N=Number of subjects in the micro-ITT Population; N1=Number of subjects with a specific pathogen; n=Number of subjects with a clinical cure at the TOC visit</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comparators included ertapenem and meropenem for IGNITE1 and IGNITE4, respectively</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bacteroides caccae, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Clostridium perfringens, and Parabacteroides distasonis</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The most common adverse reactions that were reported in XERAVA-treated patients in IGNITE1 and IGNITE4 were infusion site reactions.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selected Adverse Reactions Reported in &#8805;1% of Patients Receiving XERAVA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_8.jpg" alt="img12876764_8.jpg" style="width:515px;height:154px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comparators included ertapenem and meropenem for IGNITE1 and IGNITE4, respectively</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Infusion site reactions include: catheter/vessel puncture site pain, infusion site extravasation, infusion site hypoaesthesia, infusion/injection site phlebitis, infusion site thrombosis, injection site/vessel puncture site erythema, phlebitis, phlebitis superficial, thrombophlebitis, and vessel puncture site swelling</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use (formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the FDA on May 23, 2023, and we commenced U.S. commercial sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the third quarter of 2023. In May 2024, XACDURO&#174; was approved in China by the National Medical Products Administration (NMPA) for use in Chinese patients 18 years of age and older. XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is a novel IV antibiotic. The product is a combination of sulbactam, a &#946;-lactam antibiotic, and durlobactam, a novel &#946;-lactamase inhibitor (&#8220;BLI&#8221;) with broad spectrum &#946;-lactamase coverage including Classes A, C and D, that was specifically developed for the treatment of a variety of serious infections caused by carbapenem-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In July 2024, XACDURO&#174; was named as the preferred agent for the treatment of Carbapenem-resistant Acinetobacter baumannii infections, in combination with a carbapenem, in the updated 2024 IDSA treatment guidance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is a Gram-negative, opportunistic human pathogen that predominantly infects critically ill patients often resulting in severe pneumonia and bloodstream infections but also capable of infecting other body sites as well. Once thought to be mostly benign, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is now considered a global threat in the healthcare setting due in part to its ability to acquire multidrug resistance at rates not previously seen in other bacteria. In addition, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> can remain viable for up to 100 days in dry conditions and easily spreads via air or water droplets, which explains why the pathogen can often be found in many locations in the intensive care unit, or ICU, including bedrails, bedside tables, monitors of mechanical ventilators, intravenous pumps, door handles, stethoscopes and many other locations. Of significant concern, one study reported greater than 98% of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> isolates in an ICU from non-clinical sources, such as bedrails and door handles, were determined to be multidrug resistant.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pneumonia and bloodstream infections caused by drug-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> can have mortality rates up to 50%. Antibiotic-resistance rates of Acinetobacter to current standard-of-care treatments are some of the highest reported, between 30% and 50% in the United States and greater than 90% in parts of Europe and Asia. Acinetobacter resistance to &#946;-lactams is primarily driven by the expression of Class&#8239;D &#946;-lactamases, often in combination with Class&#8239;A and/or Class&#8239;C &#946;-lactamases. There are currently no effective antibiotics specifically indicated for the treatment of multidrug-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> infections. Durlobactam is the first clinical-stage BLI with sufficient broad-spectrum activity against class A, C, and D &#946;-lactamases to potentially restore the efficacy of &#946;-lactam antibiotics against multidrug-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sulbactam, the &#946;-lactam antibiotic used in XACDURO has superior microbiological potency against </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> compared to other &#946;-lactam antibiotics based on </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> analyses. Historically, physicians used sulbactam to successfully treat </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> infections before development of broad &#946;-lactamase mediated resistance rendered sulbactam on its own largely ineffective. We believe our data demonstrates that combining durlobactam with sulbactam can effectively restore the activity of sulbactam against multidrug-resistant strains of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter Treatment Trial Against Colistin (&#8220;ATTACK&#8221;)</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed ATTACK, a Phase 3 registration trial of XACDURO for the treatment of patients with carbapenem-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> infections, with positive top-line data announced in October 2021 and published in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Lancet Infectious Diseases </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in May 2023. ATTACK enrolled 207 patients at 95 clinical sites in 16 countries. This was a two-part trial with Part A being the randomized, comparative portion (XACDURO vs colistin) in patients with documented </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VAPB), ventilated pneumonia (VP), or bacteremia, and Part B being an open-labeled portion including </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> infections resistant to, or having previously failed colistin or polymyxin B treatment. Baseline </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> isolates tested were greater than 95% carbapenem resistant.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XACDURO met the primary efficacy endpoint of 28-day all-cause mortality compared to colistin in the CRABC m-MITT population of Part A. XACDURO mortality was 19.0% (12/63) compared to 32.3% (20/62) in the colistin arm (treatment difference of -13.2%; 95% CI: -30.0, 3.5). Similar trends were demonstrated in 28-day and 14-day all-cause mortality favoring XACDURO across all study populations evaluated to date. A statistically significant difference in clinical cure at Test of Cure (TOC) was observed with 61.9% in the XACDURO arm compared to 40.3% in the colistin arm (95% CI 2.9-40.3). In Part B, the 28-day all-cause mortality was 17.9% (5/28) and consistent with that observed in Part A.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Safety analyses from a total of 177 patients treated with XACDURO suggested that XACDURO was generally well-tolerated with a favorable safety profile compared to colistin. XACDURO met the primary safety objective with a statistically significant lower incidence of nephrotoxicity as measured by the RIFLE classification for acute kidney injury. XACDURO nephrotoxicity was 13.2% (12/91) versus 37.6% (32/85) in the colistin arm (p = 0. 0002). Overall adverse events (AEs) in the safety population were comparable between treatment groups with 87.9% (80/91) in the XACDURO arm vs. 94.2% (81/86) in the colistin arm in Part A, 89.3% (25/28) in Part B. Drug related AEs were 12.1% (10.7% in Part B) with XACDURO compared to 30.2% with colistin. The most common non-infectious AEs (&#8805;10%) in the XACDURO arm were diarrhea (16.5%), allergic and hypersensitivity reactions (16.5%), anemia (13.2%) and hypokalemia (12.1%) in Part A. These AEs were also &gt;10% in the colistin arm as was acute kidney injury.</span></p>
  <p style="margin-left:20%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:6pt;margin-right:26.667%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATTACK Study Design</span></p>
  <p style="margin-left:20%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:6pt;margin-right:26.667%;text-align:center;"><img src="img12876764_9.jpg" alt="img12876764_9.jpg" style="width:405px;height:249px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IMI=Imipenem; TOC=Test of cure; HABP=hospital acquired bacterial pneumonia; VABP=ventilator associated bacterial pneumonia; VP=ventilated pneumonia; BSI=blood stream infection; ABC=</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter baumannii-calcoaceticus</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> complex</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2-part study, Part A being the randomized, controlled portion of the study in patients with ABC HABP / VABP or bacteremia. Part B is the single-group portion of the study and includes ABC infections that are resistant to or have failed colistin or polymyxin B treatment, as detailed in the inclusion criteria. Part B is deemed as not relevant to the HABP / VABP indication</span></div></div>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATTACK Primary Endpoint Results</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_10.jpg" alt="img12876764_10.jpg" style="width:345px;height:223px;"/><img src="img12876764_11.jpg" alt="img12876764_11.jpg" style="width:346px;height:223px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IMI=Imipenem</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information. Kaye et al. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lancet Infect Dis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 2023 May 11:S1473-3099(23)00184-6</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selected Adverse Reactions Occurring at a Frequency of &gt;5% in Trial 1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_12.jpg" alt="img12876764_12.jpg" style="width:590px;height:259px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charts, graphs and tables derived from FDA prescribing information</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liver test abnormalities include the following adverse reactions: liver function test abnormal, hepatic function abnormal, increased transaminases, ALT increased, and AST increased; Acute kidney injury includes the following adverse reactions: renal impairment, blood Cr increased, toxic nephropathy, renal failure and acute kidney injury. </span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All-cause mortality: Kaplan-Meier analysis of time to death by day 28</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_13.jpg" alt="img12876764_13.jpg" style="width:665px;height:243px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Kaye et al. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lancet Infect Dis. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023 May 11:S1473-3099(23)00184-6</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftobiprole) was approved by the U.S. FDA on April 4, 2024 as a cephalosporin antibacterial indicated for the treatment of: Adult patients with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including those with right-sided infective endocarditis, adult patients with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP). ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is also approved by the European Commission for the treatment of hospital-acquired pneumonia (HAP, excluding ventilator-associated pneumonia, VAP) and community-acquired pneumonia (CAP) in patients 18 years of age and older.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 14, 2024, a subsidiary of the Company entered into an exclusive distribution and license agreement with Basilea, for the commercialization of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the United States. Under the terms of the agreement, we were granted exclusive marketing rights to ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. in exchange for Basilea receiving a $4.0 million upfront payment in addition to tiered royalties and milestones on net sales in the U.S. if certain targets are met. We anticipate commercializing ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in mid-year 2025.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The efficacy of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the treatment of adult patients with SAB, including right-sided infective endocarditis, was demonstrated in a randomized, controlled, double-blind, multinational, multicenter trial (NCT03138733). In this trial, adult patients were randomized to either ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 667 mg (equivalent to 500 mg of ceftobiprole) IV every 6 hours from study Day 1 to Day 8, and 667 mg IV every 8 hours from study Day 9 onwards) or daptomycin (6 mg/kg up to 10 mg/kg IV every 24 hours) plus optional aztreonam for coverage of gram-negative co-infections (the comparator).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary efficacy outcome in the study was overall success at the post-treatment evaluation (PTE) visit at 70 days post-randomization in the mITT population, as assessed by the independent DRC. Overall success rates at the PTE visit in the mITT population were 69.8% (132/189) in patients treated with ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 68.7% (136/198) in patients treated with the comparator.</span></p>
  <p style="text-indent:2.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_14.jpg" alt="img12876764_14.jpg" style="width:696px;height:243px;"/></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The efficacy of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the treatment of adult patients with ABSSSI was demonstrated in a randomized, controlled, double-blind, multinational, multicenter trial (NCT03137173). Patients were randomized to either ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 667 mg (equivalent to 500 mg of ceftobiprole) IV every 8 hours or vancomycin plus aztreonam (vancomycin 1 gram or 15 mg/kg IV every 12 hours, aztreonam 1 gram IV every 12 hours). Randomization was stratified by study site and type of ABSSSI. Treatment duration was 5 to 14 days. Patients could receive concomitant metronidazole for suspected anaerobic infection. A switch to oral therapy was not allowed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary endpoint, assessed in the ITT population, was early clinical response 48&#8211;72 hours after start of treatment. Early clinical response required a reduction of the primary skin lesion by at least 20%, survival for at least 72 hours, and the absence of concomitant antibacterial treatment or additional unplanned surgery.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary and main secondary outcomes are shown below:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_15.jpg" alt="img12876764_15.jpg" style="width:696px;height:160px;"/></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The efficacy of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the treatment of adult patients with community-acquired bacterial pneumonia (CABP) was demonstrated in a randomized, controlled, double-blind, multinational, multicenter study (Trial 3) (NCT00326287). 638 adults hospitalized with CABP and requiring IV antibacterial treatment for at least 3 days were included in the intent-to-treat (ITT) population, comparing ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 667 mg (equivalent to 500 mg of ceftobiprole) IV every 8 hours to ceftriaxone (2 grams IV every 24 hours) with optional linezolid (600 mg IV every 12 hours) for the coverage of resistant gram-positive pathogens, including methicillin-resistant S. aureus (MRSA). Randomization was stratified by Pneumonia Outcomes Research Team (PORT) classification I to III versus IV to V, and by the need for adjunctive treatment with linezolid or matching placebo. The treatment duration was 5&#8211;14 days. No adjunctive macrolide therapy was allowed. A switch to oral cefuroxime (500 mg every 12 hours) was allowed after at least 72 hours of IV study treatment for patients who met stringent protocol-specified criteria for improvement and were candidates for hospital discharge.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results for clinical cure at the test-of-cure visit at Day 7 to 14 after end of treatment are shown below:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><img src="img12876764_16.jpg" alt="img12876764_16.jpg" style="width:696px;height:103px;"/></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">competes with catecholamines (primarily norepinephrine), which are available as generics and inexpensive and typically used first line to treat distributive shock, and vasopressin, including Vasostrict</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Endo International plc) and vasopressin generic drugs, which are typically used hsecond line. In the randomized, Phase 3 study ATHOS-3, GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> demonstrated clinical benefit in patients who were not adequately responding to available vasopressors, including catecholamines and vasopressin. GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s principal competition as a treatment in patients not adequately responding to available vasopressors is the use of these same vasopressors at increased doses. If we are unable to successfully change treatment practices, the commercial prospects for GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will be limited, and our business may suffer.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> competes with a number of antibiotics that are currently marketed for the treatment of cIAI and other multidrug resistant infections, including: AVYCAZ (ceftazidime and avibactam, marketed by AbbVie Inc.); MERREM IV</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (meropenem, marketed by AstraZeneca PLC); PRIMAXIN</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (imipenem and cilastatin, marketed by Merck &amp; Co., Inc.); RECARBRIO&#153; (imipenem, cilastatin, and relebactam, marketed by Merck &amp; Co., Inc.); TYGACIL</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (tigecycline, marketed by Pfizer Inc.); VABOMERE&#153; (meropenem and vaborbactam, marketed by Melinta Therapeutics, Inc.); ZERBAXA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftolozane and tazobactam, marketed by Merck &amp; Co., Inc.); ZOSYN</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (piperacillin and tazobactam, marketed by Pfizer Inc.); and current and future generic versions of marketed antibiotics. If we are unable to successfully change treatment practices, the commercial prospects for XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will be limited, and our business may suffer.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> competes with a number of antibiotics that are used to treat carbapenem-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">infections in the absence of other products indicated for these infections, including: FETROJA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (cefiderocol, marketed by Shionogi &amp; Co., Ltd.), UNASYN</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ampicillin and sulbactam, marketed by Pfizer Inc.), colistin (polymyxin E), and other current and future generic versions of marketed antibiotics. There are at least two additional early-stage clinical programs developing investigational therapies for multidrug-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">infections. If we are unable to successfully change treatment practices, the commercial prospects for XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will be limited, and our business may suffer.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> competes with a wide range of generic and branded antibiotics that are used to treat the various infection types for which it is indicated, including: vancomycin, daptomycin, TEFLARO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftaroline, marketed by Allergan Sales, LLC). If we are unable to successfully change treatment practices, the commercial prospects for ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will be limited, and our business may suffer.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulatory Exclusivity</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are New Chemical Entities (&#8220;NCEs&#8221;) approved by the U.S. FDA. In the U.S., NCEs approved by the FDA are eligible for market exclusivity under the U.S. Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), which can prevent the approval of generic versions of the NCE for 5 to 7.5 years from the date of the initial approval of the NCE. Specifically, the FDCA provides a 5-year period of marketing exclusivity within the U.S. to the applicant that gains approval of an NDA for an NCE. A drug is an NCE if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an Abbreviated New Drug Application (&#8220;ANDA&#8221;) or a 505(b)(2) NDA submitted by another company for another version of such drug where the applicant does not own or have a legal right of reference to all of the data required for approval. However, an application may be submitted 4 years after the NDA approval of the NCE if it contains a certification of patent invalidity or non-infringement. Should the NDA holder commence litigation against the ANDA filer within 45 days of receipt of the certification notice, an automatic stay of the approval of any generic competition goes into effect until the earlier of: (i) 30 months from the receipt of the certification; or (ii) a court ruling of patent invalidity or non-infringement for the relevant patents. In the absence of a court ruling, the 30-month stay will be extended by such amount of time (if any) that is required for 7.5 years to have elapsed from the date of NDA approval of the NCE.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was provided ten years of market exclusivity by the FDA from the date of its approval in April 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 15, 2022, La Jolla received a paragraph IV notice of certification (the &#8220;Notice Letter&#8221;) from Gland Pharma Limited (&#8220;Gland&#8221;) advising that Gland had submitted an Abbreviated New Drug Application (&#8220;ANDA&#8221;) to the FDA seeking approval to manufacture, use or sell a generic version of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. prior to the expiration of U.S. Patent Nos.: 9,220,745; 9,572,856; 9,867,863; 10,028,995; 10,335,451; 10,493,124; 10,500,247; 10,548,943; 11,096,983; and 11,219,662 (the &#8220;GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents&#8221;), which are listed in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;). The Notice Letter alleges that the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents are invalid, unenforceable and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Gland&#8217;s ANDA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2022, La Jolla filed a complaint for patent infringement of the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents against Gland and certain related entities in the United States District Court for the District of New Jersey in response to Gland&#8217;s ANDA filing. In accordance with the Hatch-Waxman Act, because GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is a new chemical entity and La Jolla filed a complaint for patent infringement within 45 days of receipt of the Notice Letter, the FDA cannot approve Gland&#8217;s ANDA any earlier than 7.5 years from the approval of the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> NDA unless the District Court finds that all of the asserted claims of the patents-in-suit are invalid, unenforceable and/or not infringed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 22, 2023, La Jolla received a paragraph IV notice of certification (the &#8220;Second Notice Letter&#8221;) from Gland advising that Gland had amended its ANDA filing to include a paragraph IV certification alleging that all claims of the newly-issued and Orange Book-listed U.S. Patent No. 11,559,559 (&#8220;the &#8217;559 Patent&#8221;), which covers GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, are invalid, unenforceable and/or not infringed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 22, 2023, La Jolla filed a First Amended Complaint in this litigation adding Gland&#8217;s marketing and distribution partners for its ANDA angiotensin II product, Fresenius Kabi USA LLC and Fresenius Kabi SwissBiosim GmbH (collectively, the &#8220;Fresenius Kabi Defendants&#8221;), as co-defendants. On April 7, 2023, La Jolla filed a Second Amended Complaint in response to the Second Notice Letter, adding claims that the manufacture, use, sale, offer for sale, or import of Gland&#8217;s ANDA angiotensin II product will infringe the &#8217;559 Patent. On November 14, 2023, La Jolla filed a Third Amended Complaint adding additional infringement claims against the Fresenius Kabi Defendants.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2025, La Jolla, as well as The George Washington University (collectively, with the La Jolla entities, the &#8220;Plaintiffs&#8221;) entered into a settlement agreement (the &#8220;Settlement Agreement&#8221;) with Gland and the Fresenius Kabi Defendants (collectively, &#8220;Defendants&#8221;) resolving the Hatch-Waxman Act concerning Gland&#8217;s ANDA filing. Under the terms of the Settlement Agreement, Plaintiffs granted Defendants a perpetual, royalty-free and fully paid-up, non-exclusive, non-sublicensable, non-transferable right and license solely to make, have made, use, sell, offer to sell, import, and/or distribute the product that is subject to Gland&#8217;s ANDA in the United States commencing in the early 2030s, subject to certain exceptions as is customary in these type of agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required by law, the settlement is subject to review by the U.S. Department of Justice and the Federal Trade Commission.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Generating Antibiotic Incentives Now (&#8220;GAIN&#8221;) provisions of the FDA Safety and Innovation Act (&#8220;FDASIA&#8221;), the FDA may designate a product as a qualified infectious disease product (&#8220;QIDP&#8221;). In order to receive this designation, a drug must qualify as an antibacterial or antifungal drug for human use intended to treat serious or life-threatening infections. We obtained a QIDP designation for the IV formulation of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for cIAI in July 2013. Upon approving an application for a QIDP, the FDA will extend by an additional 5 years any non-patent marketing exclusivity period awarded, such as a 5-year exclusivity period awarded for an NCE. This extension is in addition to any pediatric exclusivity extension awarded. XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> has been awarded this 5-year exclusivity under FDASIA.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Pipeline</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the status of our primary product candidate:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><img src="img12876764_17.jpg" alt="img12876764_17.jpg" style="width:691px;height:80px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Global Antibiotic Research and Development Partnership (&#8220;GARDP&#8221;) fully funded the Phase&#8239;3 clinical trial and pharmaceutical development activities and has commercial rights in WHO defined low-income and specified middle-income countries. We have retained commercial rights in major markets in North America, Europe and Asia-Pacific</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Zoliflodacin</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Zoliflodacin is a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea caused by the bacterial pathogen </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Gonorrhea is an area of significant medical need and zoliflodacin is the only novel single dose treatment in development that provides a potential monotherapy oral alternative to intramuscular injections of ceftriaxone for the treatment of gonorrhea, including infections caused by drug-resistant strains. Zoliflodacin targets the validated mechanism of action of the fluoroquinolone class of antibiotics but does so in a novel manner to avoid existing fluoroquinolone resistance. In November 2023, we reported positive top-line data results of a pivotal Phase 3 trial. The study demonstrated statistical non-inferiority of microbiological cure at the urogenital site when compared to treatment with intramuscular infection of ceftriaxone and oral azithromycin, a current global standard of care regimen. We continue to advance zoliflodacin following its successful Phase 3 clinical trial results and expect to submit an NDA to the U.S. FDA in early 2025. This trial was initiated in 2019 in collaboration with GARDP, who funded all the Phase 3 clinical trial and pharmaceutical development costs and in return received commercial rights for zoliflodacin in WHO-defined low-income and select middle-income countries. We retained commercial rights in all other countries, including the major markets in North America, Europe and Asia-Pacific.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Gonorrhea</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Uncomplicated gonorrhea is an </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N.&#8239;gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> infection of the urethra, cervix, pharynx or rectum, and is more common than complicated gonorrhea, which includes spread of the infection to other tissues and potentially the bloodstream. Gonorrhea can be associated with serious complications, including pelvic inflammatory disease, ectopic pregnancy and infertility, as well as an increased risk of human immunodeficiency virus, or HIV. Despite the continued use of effective antibiotics, it remains one of the most common sexually transmitted bacterial infections in the world with an estimated 82&#8239;million people worldwide infected each year, including over 1 million people each year in the United States. The occasional absence of symptoms, more frequent in women, is thought to be one reason for sustained levels of infection. Antibiotics remain the mainstay for treating uncomplicated gonorrhea</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">caused by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is the bacterial pathogen responsible for gonorrhea and has a strong propensity for uptake of chromosomal DNA from other genera of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Neisseria</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which allows the bacteria to accumulate many mutations in chromosomal genes leading to frequent resistance of antibiotics. For example, penicillin was introduced for </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">infections in 1943, and initial resistance was reported in 1945. Fluoroquinolone antibiotics were first used to treat gonorrhea in 1949 and have been one of the most successful classes of antibiotics against </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, but even so resistance was identified in 1969. One member of this class, ciprofloxacin, was introduced in 1980 and resistance was identified in 1990. More recently cephalosporin antibiotics, notably cefixime, had been widely used for the treatment of gonorrhea due to their oral administration along with a favorable efficacy and safety profile, although resistance by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has been reported since 2007. As widespread use of these antibiotics drove the emergence of drug-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> strains, treatment guidelines have subsequently been amended. Ceftriaxone is currently the only CDC-recommended option for the treatment of gonorrhea and, until recently, was administered with azithromycin, a broad-spectrum antibiotic, to provide coverage against other sexually transmitted diseases that tend to occur concurrently with gonorrhea. However, rising resistance of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to azithromycin recently prompted the CDC to now recommend 500mg ceftriaxone monotherapy. Ceftriaxone is administered by intramuscular injection, which can be painful and may require patient monitoring by a healthcare administrator. Although ceftriaxone remains effective in most of the U.S., in Hawaii and Massachusetts as well as in several countries, including China, Japan, Vietnam, South Korea, France and Spain, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> strains with resistance to azithromycin and ceftriaxone have been reported, prompting concerns that multidrug-resistant gonorrhea may become a major community health issue.</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Market Opportunity</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is an immediate global public health threat with 82.4 million cases worldwide in 2020 (WHO estimate). Cases of gonorrhea in the United States have reached an estimated 1.6 million per year. The CDC estimates that the cases of gonorrhea in the United States have been increasing at least 10% per year since 2009.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of a 2017-2018 survey of countries reporting decreased susceptibility, DS, or resistance, R, of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to current antibiotics are reflected in the table below.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><img src="img12876764_18.jpg" alt="img12876764_18.jpg" style="width:458px;height:168px;"/></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historically, to reduce the risk of spreading drug-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the CDC has changed treatment guidelines when resistance rates to recommended first-line treatments reach 5%. Since 2015, there has only been one recommended treatment on CDC guidelines for gonorrhea: 250mg intramuscular injection of ceftriaxone plus 1g of oral azithromycin. In 2020 the CDC once again updated its treatment guideline, now recommending a 500mg intramuscular injection of ceftriaxone for treatment of uncomplicated gonorrhea. This follows a 2019 update in the United Kingdom where recommended empirical treatment of gonorrhea is now 1g intramuscular ceftriaxone monotherapy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that as resistance to ceftriaxone continues to grow both in the US and around the world, there is an increasing unmet medical need for drugs effective against resistant strains of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N. gonorrhoeae</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and also for an oral therapy for those patients who cannot get an in-office intramuscular injection or prefer a more convenient option.</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Completed Clinical Trials</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 3 registrational trial:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We completed a global, multi-center Phase 3 registrational trial in collaboration with GARDP who conducted and funded all Phase 3 clinical trial and pharmaceutical development costs. The Phase 3 trial enrolled a total of 930 patients with uncomplicated gonorrhea, including women, adolescents, and people living with HIV, making it the largest clinical trial ever conducted for a new treatment against gonorrhea infection, with 16 trial sites in regions with a high prevalence of gonorrhea across five countries, including Belgium, the Netherlands, South Africa, Thailand, and the U.S. The trial compared a single, oral, 3g dose of zoliflodacin to a globally recognized standard of care regimen (500mg ceftriaxone IM plus 1g oral azithromycin) for the treatment of uncomplicated gonorrhea.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Zoliflodacin met the prespecified statistical test for non-inferiority when compared to ceftriaxone and oral azithromycin (5.31% (95%CI 1.38, 8.65%)). Non inferiority of zoliflodacin was demonstrated within the pre-specified margin of 12% and, furthermore, within the margin of 10% as specified in U.S. Food and Drug Administration guidance.<br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 3 trial design</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><img src="img12876764_19.jpg" alt="img12876764_19.jpg" style="width:275px;height:268px;"/><img src="img12876764_20.jpg" alt="img12876764_20.jpg" style="width:289px;height:268px;"/></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TOC=Test of Cure; IM=intra-muscular; CRO-AZI=ceftriaxone and azithromycin</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Efficacy and safety results from Phase 3 trial</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img12876764_21.jpg" alt="img12876764_21.jpg" style="width:331px;height:239px;"/><img src="img12876764_22.jpg" alt="img12876764_22.jpg" style="width:256px;height:236px;"/><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:3.35pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TEAE=Treatment emergent adverse event; CRO-AZI=ceftriaxone and azithromycin</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company data, published on November 6, 2023</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase&#8239;2 clinical proof-of-concept trial: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have completed a multi-center, randomized, open-label Phase&#8239;2 clinical trial comparing a single oral dose of 2.0g or 3.0g of zoliflodacin to 500mg intramuscular ceftriaxone for the treatment of uncomplicated gonorrhea. In this trial, 179 randomized patients received treatment and zoliflodacin was generally well tolerated, with efficacy outcomes comparable to ceftriaxone. Microbiological eradication and clinical cure in urogenital infections with a single dose of zoliflodacin, the primary endpoint of the trial, was comparable to ceftriaxone, with 100% cure rate in both the 3.0g zoliflodacin and ceftriaxone groups in the per-protocol population. The results of this clinical trial were published in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The New England Journal of Medicine</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in 2018.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 1 clinical trial: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We evaluated zoliflodacin in two Phase&#8239;1 clinical trials studying 72 healthy volunteers in total. In one trial, we evaluated PKs and tolerability in 48 subjects and food effects in 18 subjects, and in the second trial, we evaluated absorption, distribution, metabolism and excretion in six subjects. Zoliflodacin was generally well tolerated in these trials at doses we would expect to be clinically active for treating uncomplicated gonorrhea. Administration of a high-fat meal was associated with an increase in zoliflodacin plasma concentration, suggesting that zoliflodacin could be administered with or without food.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Data</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have generated biochemical, microbiological and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> data on zoliflodacin. The data suggest that zoliflodacin retains potent activity against contemporary clinical isolates in the U.S., Europe, China, Thailand and South Africa that are resistant to other antibiotic classes including fluroquinolones, which was expected given its novel mechanism of action. In addition, the data show significant resistance against two of the four standard antibiotics indicated for gonorrhea, ciprofloxacin, a fluoroquinolone, and azithromycin, a macrolide.</span></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are initially developing zoliflodacin as a single oral dose treatment for uncomplicated gonorrhea. Gonorrhea is commonly treated with 500mg intramuscular ceftriaxone, a generically available agent. Additional generic cephalosporins and fluoroquinolones are also prescribed but not recommended as primary treatment options given current resistance rates. Gepotidacin, currently under development for a variety of infections by GlaxoSmithKline&#8239;plc, is the only potentially competitive product candidate in late-stage clinical development that we are aware of that is being developed for the treatment of uncomplicated urogenital gonorrhea. A Phase 3 clinical trial (EAGLE-1) was initiated by GlaxoSmithKline in October 2019. A prior Phase 2 clinical trial revealed the emergence of resistance to gepotidacin in 2 urogenital microbiological failures following administration of a single oral dose. In an attempt to overcome this resistance, gepotidacin will be given in two oral doses in the EAGLE-1 clinical trial; a 4-tablet 3000 milligram (mg) oral dose at the study site followed by another 4-tablet 3000mg oral dose as an outpatient.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (FF/VI) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (UMEC/VI) is performed by GSK.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third-party manufacturers to produce GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and expect to continue to do so in the foreseeable future to meet our development and commercial needs. In all of our manufacturing agreements, we require that contract manufacturers produce active pharmaceutical ingredients (&#8220;APIs&#8221;) and drug products in accordance with the FDA&#8217;s current Good Manufacturing Practices (&#8220;cGMPs&#8221;) and all other applicable laws and regulations. We maintain confidentiality agreements with potential and existing manufacturers in order to protect our proprietary rights related to GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The long-term commercial success of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will depend in part on the ability of our contract manufacturers to supply cGMP-compliant API and drug product without interruption.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We exclusively license ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (pre-packaging and labeling) from Basilea for the U.S. marketing rights. Our distribution and license agreement with Basilea requires that the drug product is manufactured in accordance with the FDA&#8217;s cGMPs and all other applicable laws and regulations. The long-term commercial success of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will depend in part on the ability of Basilea to supply the drug product without interruption.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to our product candidates, we currently rely on third-party contract manufacturers for our required raw materials, drug substance, and finished drug product for our preclinical research and clinical trials. Although we have contracts with these third parties to meet our current clinical supply needs, we do not have any current contractual relationships with these third parties for the manufacture of commercial supply of our product candidates after they are approved. As our product candidates approach potential approval by any regulatory agency, we intend to enter into agreements with third-party contract manufacturers for the commercial production of those products. We currently employ internal resources to manage our manufacturing vendor relationships and processes.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government authorities in the United States, at the federal, state and local level, and in other countries extensively regulate, among other things, the research, development, testing, manufacture, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and reporting, import and export of our products and reimbursement. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulation require the expenditure of substantial time and financial resources.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Government Regulation</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local statutes and regulations requires the expenditure of substantial time and financial resources. The failure to comply with the applicable requirements at any time during the product development process, approval process or after approval may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#8217;s refusal to approve pending applications, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters and untitled letters, product recalls, product seizures, total or partial suspension of production or distribution injunctions, fines, refusals of government contracts, restitution, disgorgement of profits or civil or criminal penalties.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Approval Processes</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the FDA regulates drugs under the Federal Food, Drug and Cosmetic Act, or the FDCA, the Public Health Service Act, or PHSA, and implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulation require the expenditure of substantial time and financial resources. Failure to comply with the FDCA and other applicable U.S. requirements at any time during the product development process, approval process or after approval may subject us to a variety of administrative or judicial sanctions, any of which could have a material adverse effect on us. These sanctions could include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to approve pending applications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of an approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposition of a clinical hold;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warning letters, untitled letters and similar communications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizures or recalls; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">total or partial suspension of production or distribution, or injunctions, fines, restitution, disgorgement of profits or civil or criminal investigations and penalties brought by the FDA and the Department of Justice, or DOJ, or other </span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process required by the FDA before a drug may be marketed in the United States generally involves the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of preclinical laboratory tests, animal studies and formulation studies conducted according to Good Laboratory Practices or other applicable regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an IND application, which must become effective before human clinical trials may begin;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval by an independent institutional review board, or IRB, representing each clinical site before each clinical trial may be initiated;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the proposed drug for its intended use, conducted in accordance with current good clinical practices, or cGCP, which are ethical and scientific quality standards and FDA requirements for conducting, recording and reporting clinical trials to assure that the rights, safety and well-being of trial participants are protected;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation and submission to the FDA of an NDA;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product is produced to assess compliance with current good manufacturing practices, or cGMP, requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s safety, identity, strength, quality and purity; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of the NDA.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a pharmaceutical candidate is identified for development, it enters the preclinical testing stage. Preclinical tests include laboratory evaluations of product chemistry, toxicity and formulation, as well as animal studies. An IND sponsor must submit the results of the preclinical tests, together with manufacturing information and analytical data, to the FDA as part of the IND. Some preclinical or nonclinical testing may continue even after the IND is submitted. In addition to including the results of the preclinical studies, the IND will also include one or more protocols detailing, among other things, the objectives of the clinical trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated if the first phase lends itself to an efficacy determination. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, places the IND on clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin. A clinical hold may occur at any time during the life of an IND and may affect one or more specific studies or all studies conducted under the IND.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All clinical trials must be conducted under the supervision of one or more qualified investigators in accordance with cGCP. They must be conducted under protocols detailing, among other things, the objectives of the trial, dosing procedures, subject selection and exclusion criteria and the safety and effectiveness criteria to be evaluated. Each protocol and any amendments must be submitted to the FDA as part of the IND, and progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA and more frequently in other situations, including the occurrence of serious adverse events. An IRB at each institution participating in the clinical trial must review and approve the protocol and any amendments before a clinical trial commences or continues at that institution, approve the information regarding the clinical trial and the informed consent form that must be provided to each trial subject or his or her legal representative, monitor the study until completed and otherwise comply with IRB regulations. Information about certain clinical trials must be submitted within specific timeframes to the National Institutes of Health for public dissemination on their ClinicalTrials.gov website.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human clinical trials are typically conducted in three sequential phases that may overlap or be combined:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1. The drug is initially introduced into healthy human subjects and tested for safety, dosage tolerance, absorption, distribution, metabolism and elimination. In the case of some products for severe or life-threatening diseases, such as multidrug-resistant infections, especially when the product may be inherently too toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients with the target disease or condition.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 2. Clinical trials are initiated in a limited patient population intended to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 3. Clinical trials are undertaken to further evaluate dosage, clinical efficacy and safety in an expanded patient population at geographically dispersed clinical study sites. These studies are intended to establish the overall risk-benefit ratio of the product and provide an adequate basis for regulatory approval and product labeling.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1, Phase 2 and Phase 3 testing may not be completed successfully within any specified period, if at all. The FDA or the sponsor may suspend or terminate a clinical trial at any time for a variety of reasons, including a finding that the research subjects or patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the development of a new drug, sponsors are given opportunities to meet with the FDA at certain points, including prior to submission of an IND, at the end of Phase 2 and before an NDA is submitted. Meetings at other times may also be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice and for the sponsor and the FDA to reach agreement on the next phase of development. Sponsors typically use the end-of-Phase 2 meeting to discuss their Phase 2 clinical results and present their plans for the pivotal Phase 3 clinical trial or trials that they believe will support approval of the new drug.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pediatric Research Equity Act, or PREA, requires a sponsor to conduct pediatric studies for certain drugs and biologics. Specifically, PREA requires original NDAs, biologic license applications, or BLAs, and supplements thereto for a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration to contain a pediatric assessment unless the sponsor has received a deferral or waiver.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concurrent with clinical trials, companies usually complete additional animal safety studies and must also develop additional information about the chemistry and physical characteristics of the drug and finalize a process for manufacturing the product in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate and the manufacturer must develop methods for testing the quality, purity and potency of the final drugs. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf-life.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of product development, preclinical studies and clinical trials, along with descriptions of the manufacturing process, analytical tests conducted on the chemistry of the drug, proposed labeling and other relevant information are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. The submission of an NDA is subject to the payment of user fees, but a waiver of such fees may be obtained under specified circumstances. The FDA reviews all NDAs submitted to ensure that they are sufficiently complete for substantive review before it accepts them for filing. It may request additional information rather than accept an NDA for filing. In this event, the NDA must be resubmitted with the additional information. The resubmitted application also is subject to completeness review before the FDA accepts it for filing.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once the submission is accepted for filing, the FDA begins an in-depth review. NDAs receive either standard or priority review. A drug that, if approved, would represent a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious disease or condition may receive priority review. Requests for priority review generally must be submitted at the time of NDA submission. The FDA has agreed to specified performance goals in the review process of NDAs. Under that agreement, 90% of applications seeking approval of new molecular entities, or NMEs, are meant to be reviewed within ten months from the date on which FDA accepts the NDA for filing, and 90% of applications for NMEs that have been designated for &#8220;priority review&#8221; are meant to be reviewed within six months of the filing date. For applications seeking approval of drugs that are not NMEs, the ten-month and six-month review periods run from the date that FDA receives the application. The review process may be extended by the FDA for three additional months to consider a major amendment to the application following the original submission.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA reviews an NDA to determine, among other things, whether a product is safe and effective for its intended use and whether its manufacturing complies with cGMP requirements to assure and preserve the product&#8217;s safety, identity, strength, quality and purity. The FDA may refer the NDA to an advisory committee for review and recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendation of an advisory committee, but it generally follows such recommendation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving an NDA, the FDA will typically inspect the facility or facilities where the product is manufactured and tested. These pre-approval inspections may cover all facilities associated with NDA submission, including drug component manufacturing (such as active pharmaceutical ingredients), finished drug product manufacturing, and control testing laboratories. Additionally, before approving an NDA, the FDA will typically inspect one or more clinical sites to assure compliance with cGCP. In addition, the FDA may require, as a condition of approval, risk evaluation and mitigation strategies, or REMS (which may include requirements for, restricted distribution and use), enhanced labeling, special packaging or labeling, expedited reporting of certain adverse events, pre-approval of promotional materials, restrictions on direct-to-consumer advertising or commitments to conduct additional research post-approval.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the basis of the FDA&#8217;s evaluation of the NDA and accompanying information, the FDA may issue an approval letter or a complete response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. If the FDA ultimately decides that the NDA does not satisfy the criteria for approval, the FDA will issue a complete response letter to indicate that the agency will not approve the NDA in its present form. The complete response letter usually describes all of the specific deficiencies in the NDA identified by the FDA. If a complete response letter is issued, the applicant may either resubmit the NDA, addressing all of the deficiencies identified in the letter, or withdraw the application.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expedited Review and Approval</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA has various programs, including Fast Track and priority review, which are intended to expedite or simplify the process for developing and/or reviewing drugs. Even if a drug qualifies for one or more of these programs, the FDA may later decide that the drug no longer meets the conditions for qualification or that the time period for FDA review or approval will not be shortened. Generally, drugs that may be eligible for these programs are those for serious or life-threatening conditions, those with the potential to address unmet medical needs and those that offer meaningful benefits over existing treatments. For example, Fast Track is a process designed to facilitate the clinical development and expedite the review of drugs to treat serious diseases with the potential, based on nonclinical or clinical data, to fill an unmet medical need. Priority review is designed to give drugs that offer a significant improvement in safety or effectiveness of treatment for a serious condition an expedited review within eight months from the completed submission (six months from filing) as compared to a standard review time of twelve months from the completed submission (10 months from filing) for a standard new molecular entity NDA. Although Fast Track and priority review do not affect the standards for approval, the FDA will attempt to facilitate early and frequent meetings with a sponsor of a Fast Track designated drug and expedite review of the application for a drug designated for priority review.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Generating Antibiotic Incentives Now Act, or GAIN Act, is intended to provide incentives for the development of new QIDPs. A new drug that is designated as a QIDP after a request by the sponsor that is made before an NDA is submitted will be eligible, if approved, for an additional five years of exclusivity beyond any period of exclusivity to which it would have previously been eligible. In addition, a QIDP will receive priority review and qualify for a Fast Track designation. QIDPs are defined as antibacterial or antifungal drugs intended to treat serious or life-threatening infections, including those caused by an antibacterial or antifungal resistant pathogen or qualifying pathogens identified by the FDA. XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> have been designated by the FDA as a QIDP. Zoliflodacin has also been designated as a QIDP by the FDA for the treatment of uncomplicated gonorrhea.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Term Restoration and Data Exclusivity</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration and specifics of FDA approval of the use of our drugs, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. As noted above, the Hatch-Waxman Amendments permit a patent restoration term of up to five years for a single patent for an approved product as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date and only those claims covering such approved drug product, a method for using it or a method for manufacturing it may be extended. Only one patent applicable to an approved drug is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. We have applied for restoration of patent term for one U.S. Patent covering XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and, in the future, we may apply for restoration of patent term for other currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant NDA.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Data exclusivity provisions under the FDCA also can delay the submission or the approval of certain applications. The FDCA provides a five-year period of non-patent data exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an abbreviated new drug application, or ANDA, or a 505(b)(2) NDA submitted by another company using the drug entitled to data exclusivity as the reference listed drug, or RLD. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement. The FDCA also provides three years of data exclusivity for an NDA, 505(b)(2) NDA or supplement to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, for new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the use or conditions of use associated with the new clinical investigations and does not prohibit the FDA from approving ANDAs for drugs containing the original active agent for other uses or conditions of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct its own preclinical and clinical studies in support of its application or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as described above, under the GAIN Act a new drug that is designated as a QIDP is eligible for an additional five years of exclusivity to be added to certain other exclusivity periods that the application may qualify for upon approval, specifically five-year exclusivity, three-year exclusivity, and orphan exclusivity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pediatric Exclusivity</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Best Pharmaceuticals for Children Act provides for an additional six months of exclusivity, which is added on to patent and exclusivity periods in effect at the time the pediatric exclusivity award is granted, if a sponsor conducts clinical trials in children in response to a written request from the FDA, or a Written Request. The FDA may request studies on approved indications in separate Written Requests. The issuance of a Written Request does not require the sponsor to undertake the described studies. To date, we have not received any Written Requests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-approval Requirements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems, including safety issues, with a product may result in restrictions on the product or even complete withdrawal of the product from the market. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further FDA review and approval. In addition, the FDA may require testing and surveillance programs to monitor the effect of approved products that have been commercialized, and the FDA has the power to prevent or limit further marketing of a product based on the results of these post-marketing programs. The FDA and other authorities also strictly regulate the promotional claims that may be made about prescription products. Under the FDCA the sponsor of an approved drug in the United States may not promote that drug for unapproved, or off-label, uses, although a physician may prescribe a drug for an off-label use in accordance with the practice of medicine. If we are found to have promoted off-label uses, we may be subject to significant liability, including sanctions, civil and criminal fines and penalties, and injunctions prohibiting us from engaging in specified promotional conduct.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, any drug products manufactured or distributed pursuant to FDA approvals are subject to continuing regulation by the FDA, including, among other things:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">record-keeping requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reporting of adverse experiences with the drug;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">providing the FDA with updated safety and efficacy information;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">drug sampling and distribution requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">notifying the FDA and gaining its approval of specified manufacturing or labeling changes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">complying with certain electronic records and signature requirements; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">complying with FDA promotion and advertising requirements.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and some state agencies for compliance with cGMP requirements and other laws.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to comply with the FDCA and other applicable U.S. requirements at any time during the product development process, approval process or after approval may subject us to a variety of administrative or judicial sanctions, any of which could have a material adverse effect on us. These sanctions could include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to approve pending applications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of an approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposition of a clinical hold;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warning letters, untitled letters and similar communications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizures or recalls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">total or partial suspension of production or distribution; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.269%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.481630819692681%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions, fines, restitution, disgorgement of profits or civil or criminal investigations and penalties brought by the FDA and DOJ, or other governmental entities.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, legislation is drafted, introduced and passed in Congress that could significantly change the statutory provisions governing the approval, manufacturing and marketing of products regulated by the FDA. In addition, FDA regulations and guidance are often revised or reinterpreted by the agency in ways that may significantly affect our business and our products. It is impossible to predict whether legislative changes will be enacted, or FDA regulations, guidance or interpretations changed or what the impact of such changes, if any, may be.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Regulation</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to regulations in the United States, we will be subject to a variety of foreign regulations governing clinical trials and commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we must obtain approval by the comparable regulatory authorities of foreign countries or economic areas, such as the EU, before we may commence clinical trials or market products in those countries or areas. The approval process and requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from place to place, and the time may be longer or shorter than that required for FDA approval.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under EU regulatory systems, a company may submit marketing authorization applications under the centralized, decentralized or mutual recognition procedures, or under the purely national route of approval. The centralized procedure is compulsory for medicinal products produced by biotechnology or those medicinal products containing new active substances for specific indications such as the treatment of acquired immune deficiency syndrome, or AIDS, cancer, neurodegenerative disorders, diabetes, viral diseases, and designated orphan medicines, and is optional for other medicines that are highly innovative. Under the centralized procedure, a marketing application is submitted to the European Medicines Agency, or EMA, where it will be evaluated by the relevant scientific committee, in most cases the Committee for Medicinal Products for Human Use, and a favorable opinion typically results in the grant by the European Commission of a single marketing authorization that is valid for all EU member states and, by extension (after national implementing measures), in Norway, Iceland and Liechtenstein. In general, an initial marketing authorization is valid for five years, but once renewed is usually valid for an unlimited period. The decentralized procedure allows marketing authorization applications to be submitted simultaneously in two or more EU member states, whereas the mutual recognition procedure must be used if the product has already been authorized in at least one other EU member state. Both the decentralized and mutual recognition procedures provide for approval by one or more &#8220;concerned&#8221; member states based on an assessment of an application performed by one-member state, known as the &#8220;reference&#8221; member state.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the decentralized approval procedure, an applicant submits an application, or dossier, and related materials to the reference member state and concerned member states. The reference member state prepares a draft assessment and drafts of the related materials within 120 days after receipt of a valid application. Within 90 days of receiving the reference member state&#8217;s assessment report, each concerned member state must approve the assessment report and related materials, unless they identify a serious risk to public health. Under the mutual recognition procedure, the concerned member states have the same 90-day period to recognize the marketing authorization in the reference member state. In either case, concerns about serious risks to public health escalate through the relevant EMA scientific committees, and the disputed points may eventually result in a consensus opinion from the Committee for Medicinal Products for Human Use that is referred to the European Commission, whose decision is binding on all member states. The purely national procedure results in a marketing authorization in a single EU member state.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the result of a referendum in 2016, the United Kingdom left the EU on January 31, 2020, and as of January 1, 2021, the United Kingdom and EU operate separate regulatory regimes. The UK and EU announced on December 24, 2020, that they had agreed a Trade and Cooperation Agreement, or TCA, to govern their future relationship. The TCA remains provisional until formally ratified by the EU. The TCA sets out the new arrangements for trade of goods, including medicines and medical devices, which aims to ensure goods continue to flow between the EU and the UK and also has implications for product regulation and mutual recognition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the United Kingdom&#8217;s departure from the EU, if a company wishes to sell its products in the United Kingdom, it will need to seek and maintain appropriate national marketing authorizations. The TCA does not provide for wholesale mutual recognition of the regulatory regimes and so products exported from the UK to the EU must comply with the EU&#8217;s regulatory requirements. In the pharmaceutical context, this has had a number of implications. From January 31, 2020, the UK no longer participated in EU institutions and their decision-making, including approval decisions under the centralized procedure. Moreover, the movement of finished pharmaceutical products into the EU from the UK is treated as an import from a third country. Since the TCA does not provide for mutual recognition of batch testing and release, products must be quality control tested and released in the EU. However, the UK has unilaterally waived batch testing requirements for UK imports from the EU for products placed on the market prior to January 2023. It remains to be seen how these developments will impact regulatory requirements for product candidates and products in the United Kingdom.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reimbursement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of products approved by the FDA and other government authorities. Sales of products will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage, and establish adequate reimbursement levels for, such products. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, and reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, or formulary, which might not include all the approved products for a particular indication. For example, in the U.S. and most major foreign markets, drugs like GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that are administered in the hospital must be purchased by the hospital and generally are not reimbursed by third-party payors. Hospitals instead are reimbursed for patient cases based on patients&#8217; diagnosed conditions under the U.S. Medicare diagnosis-related group (&#8220;DRG&#8221;) system or other like systems for non-Medicare patients in the U.S. and in most major foreign markets. Adoption of new drugs that are administered in the hospital generally occurs more slowly than adoption of new drugs that are taken on an outpatient basis, which generally are paid for by third-party payors.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies to demonstrate the medical necessity and cost effectiveness of the product, in addition to the costs required to obtain FDA or other comparable regulatory approvals. Nonetheless, product candidates may not be considered medically necessary or cost effective. Additionally, a payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a drug product does not ensure that other payors will also provide coverage for the drug product. Third-party reimbursement may not be sufficient to maintain price levels high enough to realize an appropriate return on investment in product development.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Health Care Laws Governing Interactions with Healthcare Providers</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to FDA restrictions on marketing of pharmaceutical products, several other types of state and federal laws restrict our business activities, including certain marketing practices. These laws include, without limitation, anti-kickback laws, false claims laws, data privacy and security laws, as well as transparency laws regarding payments or other items of value provided to healthcare providers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or in return for purchasing, leasing, ordering or arranging for the purchase, lease or order of any healthcare item, good, facility or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. This statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers, among others, on the other. Although there are several statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution or other regulatory sanctions, the exceptions and safe harbors are drawn narrowly, and practices that involve remuneration that are alleged to be intended to induce prescriptions, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the federal Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the federal Anti-Kickback Statute has been violated. Additionally, the intent standard under the federal Anti-Kickback Statute was amended by the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010, collectively the Affordable Care Act, or ACA, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the ACA codified case law that a claim for payment for items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal false claims laws, including the civil False Claims Act, and civil monetary penalties laws prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false claim for payment to the federal government, or knowingly making, or causing to be made, a false statement to have a claim paid. Pharmaceutical and other healthcare companies have been prosecuted under these laws for, among other things, allegedly inflating drug prices they report to pricing services, which in turn were used by the government to set Medicare and Medicaid reimbursement rates, and for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. In addition, certain marketing practices, including off-label promotion, have also been alleged to violate false claims laws.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, created additional federal requirements that prohibit among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. As with the federal Anti-Kickback Statute, the ACA amended the intent standard for certain healthcare fraud under HIPAA such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it to have committed a violation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may be subject to data privacy and security regulations promulgated by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and its implementing regulations, impose certain requirements on covered entities (i.e., certain healthcare providers, health plans and healthcare clearinghouses) relating to the privacy, security and transmission of individually identifiable health information. Among other things, HIPAA&#8217;s security standards apply directly to business associates, independent contractors or agents of covered entities that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HIPAA's civil and criminal penalties also directly apply to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">What is more, the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, require certain manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the children&#8217;s health insurance program (with certain exceptions) to annually report information related to certain payments or other transfers of value provided to covered recipients, including physicians, as defined by such law, and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals&#8217; covered recipients and information related to certain ownership and investment interests held by physicians and their immediate family members.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The majority of states also have statutes or regulations similar to the aforementioned federal laws, some of which are broader in scope and apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government. In addition, some state laws require drug manufacturers to report information related to payments to clinicians and other healthcare providers or marketing expenditures and drug pricing. Further, some state and local laws require the licensure of pharmaceutical sales representatives. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, outside the United States, the European Union General Data Protection Regulation (2016/679) (&#8220;GDPR&#8221;) contains provisions specifically directed at the processing of health information. The GDPR provides for potentially significant sanctions and contains extraterritoriality measures intended to bring non-EU companies under the regulation. In addition, many countries around the world have enacted similar data privacy legislation. This legislation imposes increased compliance obligations and regulatory risk, including the potential for significant fines for noncompliance.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare and Other Reform</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, there have been and continue to be a number of significant legislative initiatives to contain healthcare costs. Federal and state governments continue to propose and pass legislation designed to reform delivery of, or payment for, healthcare, which include initiatives to reduce the cost of healthcare. For example, in March 2010, the United States Congress enacted the ACA, which expanded health care coverage through Medicaid expansion and the implementation of the individual mandate for health insurance coverage and which included changes to the coverage and reimbursement of drug products under government healthcare programs. Under the first Trump administration, there were ongoing efforts to modify or repeal all or certain provisions of the ACA. For example, tax reform legislation was enacted at the end of 2017 that eliminated the tax penalty established under the ACA for individuals who do not maintain mandated health insurance coverage beginning in 2019. The ACA has also been subject to judicial challenge. In December 2018, a federal district court, in a challenge brought by a number of state attorneys general, found the ACA unconstitutional in its entirety because, once Congress repealed the individual mandate provision, there was no longer a basis to rely on Congressional taxing authority to support enactment of the law. In December 2019, the federal appellate court upheld the district court ruling that the individual mandate was unconstitutional and remanded the case back to the district court to determine whether the remaining provisions of the ACA are invalid as well. The case was appealed to the U.S. Supreme Court, which did not make a decision on the issue of severability as it determined the state attorney generals did not have standing.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were other reform initiatives under the first Trump Administration, including initiatives focused on drug pricing. For example, the Bipartisan Budget Act of 2018 contained various provisions that affect coverage and reimbursement of drugs, including an increase in the discount that manufacturers of Medicare Part D brand name drugs must provide to Medicare Part D beneficiaries during the coverage gap from 50% to 70% starting in 2019. As another example, in 2018, President Trump and the Secretary of the HHS, released a &#8220;blueprint&#8221; to lower prescription drug prices and out-of-pocket costs. Certain proposals in the blueprint, and related drug pricing measures proposed since the blueprint, could cause significant operational and reimbursement changes for the pharmaceutical industry. HHS has solicited feedback on some of these measures and, at the same, has implemented others under its existing authority. On November 20, 2020, CMS issued an interim final rule through the CMS Innovation Center whereby Medicare Part B reimbursement for &#8220;certain high-cost prescriptions drugs&#8221; would be no more than most-favored-nation price (i.e., the lowest price) after adjustments, for a pharmaceutical product that the drug manufacturer sells in a member country of the Organization for Economic Cooperation and Development that has a comparable per-capita gross domestic product. On December 28, 2020, the United States District Court in Northern California issued a nationwide preliminary injunction against implementation of the interim final rule. While some of these and other measures may require additional authorization to become effective, it is not yet clear what steps the Trump Administration will take or whether such steps will be successful.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have also been state legislative efforts to address drug costs, which generally have focused on increasing transparency around drug costs or limiting drug prices and address price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2019, the DISARM Act of 2019 was introduced in Congress as new legislation to provide financial incentives for pharmaceutical companies to develop new antibiotics. This new legislation was guided by input from the IDSA and will help to ensure that patients can access new antibiotics when they are clinically appropriate, require hospitals to establish antibiotic stewardship programs, and spur improved reporting of antibiotic use and resistance to more rapidly identify challenges and inform best practices. More recently, this legislation was reintroduced in the U.S. House of Representatives in June 2021 which aims to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General legislative cost control measures may also affect reimbursement for our product candidates. The Budget Control Act, as amended, resulted in the imposition of 2% reductions in Medicare, but not Medicaid, payments to providers in 2013 and will remain in effect through 2029 unless additional Congressional action is taken. There was a temporary suspension of the 2% reduction during the pandemic; that temporary suspension is scheduled to expire on March 31, 2021. Any significant spending reductions affecting Medicare, Medicaid or other publicly funded or subsidized health programs that may be implemented and/or any significant taxes or fees that may be imposed on us could have an adverse impact on our results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legislation was introduced to the U.S. Senate in September 2020 which aims to reinvigorate innovation for the development of new antibiotics through a subscription contract program managed by HHS. The PASTEUR Act was introduced to provide a mechanism for funding designated &#8216;critical need antimicrobial&#8217; drugs post FDA approval. In return, patients covered by federal insurance programs will receive these drugs at no cost. These Contracts under the PASTEUR Act could range from $750 million to $3 billion in value. It is unclear when or if the PASTEUR Act or similar incentive programs will become law. In October 2021, the PACCARB authored a letter to the Honorable Xavier Becerra, Secretary, Department of Health and Human Services recommending the passage of both DISARM and PASTEUR and the antimicrobial stewardship provisions contained within each act.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adoption of new legislation at the federal or state level could affect demand for, or pricing of, our current or future products if approved for sale. We cannot, however, predict the ultimate content, timing or effect of any changes to the ACA or other federal and state reform efforts. There is no assurance that federal or state health care reform will not adversely affect our future business and financial results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Laws and Regulations</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to a variety of financial disclosure and securities trading regulations as a public company in the U.S., including laws relating to the oversight activities of the SEC and the regulations of the Nasdaq Capital Market, on which our shares of common stock are traded. We are also subject to various laws and regulations relating to safe working conditions, laboratory practices and the experimental use of animals.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success depends in part on our ability to obtain and maintain proprietary or intellectual property protection for our product candidates, our core technologies, and other know-how. To accomplish this we rely on the skills, knowledge and experience of our scientific and technical personnel, as well as that of our advisors, consultants and other contractors. To help protect our proprietary know-how that is not patentable, we rely on trade secret protection and confidentiality agreements to protect our interests. We require our employees, consultants and advisors to enter into confidentiality agreements prohibiting the disclosure of confidential information and requiring disclosure and assignment to us of the ideas, developments, discoveries and inventions important to our business. We file patent applications directed to our key product candidates to establish intellectual property positions. These patent applications are intended to protect new chemical entities relating to these product candidates as well as their manufacturing processes, intermediates and uses in the treatment of diseases.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The intellectual property portfolios for our commercial products, advanced product candidates, and various compounds are summarized below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 14, 2025, the licensed intellectual property portfolio relating to GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">included 12 issued U.S. patents, 2 pending U.S. patent applications, 9 issued foreign patents and 13 pending foreign patent applications. The issued U.S. patents, and patents that may issue from the pending U.S. patent applications, will expire between 2029 and 2034, absent any disclaimers, extensions, or adjustments of patent term. The foreign patents, and patents that may issue from the pending foreign patent applications, will expire in 2034, absent any disclaimers, extensions, or adjustments of patent term.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 14, 2025, the intellectual property portfolio relating to GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also included 4 issued U.S. patents, 7 pending U.S. patent applications, 8 issued foreign patents and 11 pending foreign patent applications. The issued U.S. patents, and patents that may issue from the pending U.S. patent applications, will expire between 2034 and 2040, absent any disclaimers, extensions, or adjustments of patent term. The foreign patents, and patents that may issue from the pending foreign patent applications, will expire between 2034 and 2040, absent any disclaimers, extensions, or adjustments of patent term.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">XERAVA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 14, 2025, we owned 2 issued U.S. patents, 1 pending U.S. patent application, 17 issued foreign patents and 4 pending foreign patent applications relating to XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The issued U.S. patents, and the patent that may issue from the pending U.S. patent application, will have an expiration date of August 7, 2029, absent any disclaimers, extensions, or adjustments of patent term. The term of one of the U.S. patents has received 508 days of patent term adjustment. The foreign patents, and patents that may issue from the pending foreign applications, will likewise have an expiration date of August 7, 2029, absent any disclaimers, extensions, or adjustments of patent term.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 14, 2025, we also filed applications for Supplementary Protection Certificates based on European Patent No. 2323972 covering the composition of matter and use of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Some applications have been granted and others are pending.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as of February 14, 2025, we also owned 2 issued U.S. patents, 1 pending U.S. patent application, 8 granted foreign patents and 7 pending foreign patent applications that relate to crystalline forms of eravacycline. Any U.S. patent that may issue from the pending patent application will expire in 2037 absent any disclaimers, extensions, or adjustments of patent term. Likewise, any foreign patents that may issue from the pending foreign patent applications will expire in 2037. We also owned 4 issued U.S. patents, 1 pending U.S. patent application, 43 issued foreign patents and 9 pending foreign patent applications relating to other tetracycline-related intellectual property.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 14, 2025, we owned 4 issued U.S. patents, 118 issued foreign patents, 2 pending foreign patent applications, and 1 pending priority patent cooperation treaty (&#8220;PCT&#8221;) application relating to XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The issued U.S. patents have an expiration date of April 2, 2033 and November 17, 2035, absent any disclaimers, extensions, or adjustments of patent term. The foreign patents, and patents that may issue from the pending foreign applications, will likewise have an expiration date of April 2, 2033 and November 17, 2035, absent any disclaimers, extensions, or adjustments of patent term. An issued patent arising from the pending priority PCT application will have an expiration date of May 16, 2045, absent any disclaimers, extensions, or adjustments of patent term.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:16.48%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:11.46%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:11.46%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:14.52%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:11.46%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:11.46%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:14.52%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">United States</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pending</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pending</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GIAPREZA</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">&#174;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 - 2040</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2034 - 2040</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XERAVA</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">&#174;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 - 2037</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 - 2037</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">&#174;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2033 - 2035</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2033 - 2035</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 - 2037</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2039 - 2037</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zoliflodacin</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our intellectual property portfolio for zoliflodacin contains patent applications directed to compositions of matter for zoliflodacin and other chemical analogs, as well as synthetic methods and methods of use and modes of treatment. As of February 14, 2025, we owned seven issued U.S. patents, 75 issued foreign patents as well as one pending foreign patent application. The issued foreign patents are in several jurisdictions, including Australia, Brazil, Canada, China, Eurasia, the European Union, Hong Kong, India, Israel, Japan, Mexico, New Zealand, Philippines, Singapore, South Africa, South Korea, Taiwan and the United Kingdom. Issued U.S. and foreign patents and patents issuing from pending U.S. and foreign applications have expiration dates of October 2029, January 2034 and May 2035.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trademarks, Trade Secrets and Know-How</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our trademark portfolio currently consists of various registered trademark and service mark rights in several jurisdictions, including the United States, the European Union, Japan, Argentina, Australia, Brazil, Canada, India, Mexico, Norway, the Russian Federation, South Korea, Switzerland, Taiwan, Turkey and the United Kingdom, and pending applications in other jurisdictions. In connection with the ongoing development and advancement of our products and services in the United States and various international jurisdictions, we routinely seek to create protection for our marks and enhance their value by pursuing trademarks and service marks where available and when appropriate. In addition to patents and trademark protection, we rely upon unpatented trade secrets and know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect our proprietary information, in part, using confidentiality agreements with our commercial partners, collaborators, employees, and consultants, and invention assignment agreements with our employees. These agreements are designed to protect our proprietary information and, in the case of the invention assignment agreements, to grant us ownership of technologies that are developed through a relationship with a third party. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our commercial partners, collaborators, employees, and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategic Partnership with Sarissa Capital</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Advisory Agreement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, we entered into a Strategic Advisory Agreement (the &#8220;Services Agreement&#8221;) with Sarissa Capital Management LP (&#8220;Sarissa Capital&#8221;), pursuant to which Sarissa Capital provides a variety of strategic services to us in order to assist us in the development and execution of our acquisition strategy intended to diversify our assets and the potential sources of revenue. Sarissa Capital is considered to be a related party due to its investment in Innoviva and its representation on our board of directors.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Partnership Agreement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, Innoviva Strategic Partners LLC, our wholly owned subsidiary (&#8220;Strategic Partners&#8221;), entered into a subscription agreement and an Amended and Restated Limited Partnership Agreement (the &#8220;Partnership Agreement&#8221;) pursuant to which Strategic Partners became a limited partner of ISP Fund LP (the &#8220;Partnership&#8221;). The general partner of the Partnership is an affiliate of Sarissa Capital and, pursuant to an investment management agreement, Sarissa Capital acts as the investment adviser to the Partnership. Strategic Partners made a $300 million initial contribution to the Partnership. The Partnership was formed for the purposes of investing in equity securities in the healthcare, pharmaceutical and biotechnology industries.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, Strategic Partners received a distribution of $110.0 million from the Partnership to provide funding to us for a strategic repurchase of shares held by GSK. Pursuant to the letter agreement entered into between Strategic Partners, the Partnership, and Sarissa Capital Fund GP LP on May 20, 2021, Strategic Partners agreed to make additional capital contributions to the Partnership in an aggregate amount equal to the amount of the May 2021 distribution prior to March 31, 2022. A $110.0 million contribution was made during the first quarter of 2022.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, we made an election to unwind the capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human Capital</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 127 employees, all of whom were full-time employees. None of our employees are represented by a labor union or covered by a collective bargaining agreement, and we consider our relations with our employees to be good. We also hire consultants and contract with third parties, as needed, to provide additional resources to support our business activities.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our key human capital management objectives are to identify, recruit, integrate, retain and motivate our new and existing employees. We believe that our compensation and benefit programs are appropriately designed to attract and retain qualified talent. Employees receive an annual base salary and are eligible to earn performance-based cash bonuses. To create and maintain a successful work environment, we offer a comprehensive package of additional benefits that support the physical and mental health and wellness of all of our employees and their families and flexible working arrangements. Additionally, we grant equity awards in order to allow employees to share in the performance of the Company. The Chief Executive Officer regularly updates our board of directors and our committees on the operation and status of these human capital trends and activities.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have created an environment that fosters individual development while maintaining consistency in our corporate values and code of conduct. We offer seminars from external resources and promote the fair treatment and full participation of all people in our workplace.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The management team and Board of Directors are keenly aware of the importance of the Company&#8217;s need to conduct business with high standards. Our mission as an organization is to be patient-centric and develop innovative treatments to find solutions for patients suffering from rare and underserved diseases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our employees, partners, and investors expect us to honor our values and take action to promote a more equitable and sustainable world for future generations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we further build our organization behind our portfolio of royalties and innovative healthcare assets, we intend to strive to understand the perspectives of the clients and communities we will serve, and as such, we are intensifying our efforts to drive a culture of belonging throughout our organization. We will strive to comply with all applicable environmental laws, regulations and policies concerning environmental protection in all our business activities and in the selection of partners we choose to work with. We are committed to strengthening our local community by contributing through volunteerism and will continue, as we have been doing, to provide donations to parties we believe will support our goal of improving patient health and well-being. We are also committed to good corporate governance. All of our employees, officers and directors must conduct themselves according to the language and spirit of our Code of Conduct, and our Board of Directors is dedicated to providing effective corporate oversight including through oversight committees such as the Nominating and Governance Committee, the Audit Committee and the Compensation Committee. As our Company grows, we will continue to integrate policies and programs that further foster this effort.</span></p>
  <p style="margin-left:4.267%;text-indent:-3.608%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Health, Safety and Wellness</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We strive to provide pay, benefits and other employee services that are competitive to market in the life sciences industry and create incentives to attract and retain employees. Our compensation package includes market-competitive pay, stock options and restrictive stock units, bonuses, employee spot awards, health care and retirement benefits, paid time off and family leave. We utilize third party consultants to review and update our compensation practices annually. We are also committed to the continued development of our people, providing opportunities for employees to further their career development through internal training and education programs and third party online training programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about our Executive Officers</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the name, age, and position of each of our executive officers as of February 14, 2025:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:54.189%;box-sizing:content-box;"/>
    <td style="width:1.84%;box-sizing:content-box;"/>
    <td style="width:9.318%;box-sizing:content-box;"/>
    <td style="width:1.84%;box-sizing:content-box;"/>
    <td style="width:32.813%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Age</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Positions Held</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pavel Raifeld</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Basso</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marianne Zhen</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Accounting Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pavel Raifeld</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, CFA, was appointed Chief Executive Officer in May 2020. Prior to his appointment, Mr. Raifeld, served on the investment team at Sarissa Capital Management LP. Earlier, he was a senior member of the healthcare investment banking team at Credit Suisse Securities (USA) LLC. Previously, Mr. Raifeld worked as a consultant, primarily specializing in advising biopharmaceutical companies, at McKinsey &amp; Company, Inc. and The Boston Consulting Group Ltd. Mr. Raifeld earned an AB degree from Harvard University and an MBA degree from Columbia University.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stephen Basso </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">was appointed Chief Financial Officer of the Company in August 2023. Prior to joining Innoviva, Mr. Basso served as the Chief Financial Officer and Chief Operating Officer at Cybrexa Therapeutics and has held a variety of financial leadership positions at Inozyme Pharma, Alexion Pharmaceuticals and Pfizer. He received a BS in business from Providence College and an MBA from Boston College.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marianne Zhen</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, CPA, was appointed Chief Accounting Officer in July 2018. Prior to joining Innoviva in October 2014, Ms. Zhen held various financial leadership roles across different industries, including at companies such as Model N and Mosys. Previously, Ms. Zhen served as a member of the board of directors of CalCPA Peninsula Silicon Valley Chapter. Ms. Zhen earned a Bachelor of Science degree in Business Administration with a concentration in Accounting from San Francisco State University. She is a member of the American Institute of Certified Public Accountants (AICPA) and a member of the California Society of Certified Public Accountants (CalCPA).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Code of Business Conduct</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has adopted the Innoviva, Inc. Code of Business Conduct that applies to all directors, officers and employees. The Code of Business Conduct, as amended through January 24, 2023, is available on the corporate governance section of our website at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.inva.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company makes any substantive amendments to the Code of Business Conduct or grants a waiver from any provision of such code to any executive officer or director, the Company will promptly disclose the nature of the amendment or waiver, as required by applicable law.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Available Information</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our web page address is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.inva.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our investor relations website is located at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">http://investor.inva.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We make available free of charge on our investor relations website under &#8220;SEC Filings&#8221; our Annual Reports on Form 10&#8209;K, Quarterly Reports on Form 10&#8209;Q, Current Reports on Form 8&#8209;K, our directors&#8217; and officers&#8217; Section 16 Reports and any amendments to those reports after filing or furnishing such materials to the SEC. The information found on our website is not part of this or any other report that we file with or furnish to the SEC. Innoviva and the Innoviva logo are registered trademarks of Innoviva, Inc. Trademarks, tradenames or service marks of other companies appearing in this report are the property of their respective owners.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1A.   RISK FACTORS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary of Risk Factors</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to a number of risks that if realized could affect its business, financial condition, results of operations, cash flows and access to liquidity materially. The Company&#8217;s business is subject to uncertainties and risks including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> face substantial competition for their intended uses in the targeted markets from products discovered, developed, launched and commercialized both by GSK and by other pharmaceutical companies, which could cause the royalties payable to us pursuant to the GSK Agreements to be less than expected, which in turn would harm our business and cause the price of our securities to fall.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are dependent on GSK for the successful commercialization and development of the products developed under the GSK Agreements. If GSK does not devote sufficient resources to the commercialization and development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our debt including our convertible subordinated notes and convertible senior notes are senior in capital structure and cash flow, respectively, to our common stockholders. Satisfying the obligations relating to our debt could adversely affect our liquidity or the amount or timing of potential distributions to our stockholders.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK has indicated to us that it believes its consent may be required before we can engage in certain royalty monetization transactions with third parties, which may inhibit our ability to engage in these transactions.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If clinical trials of our product candidates fail to demonstrate safety and efficacy to the satisfaction of the FDA, the EMA or other comparable regulatory authorities, or do not otherwise produce favorable results, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of that product candidate.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on collaborations with third parties for the development of both our product and commercial candidates, and we may seek additional collaborations in the future. If those collaborations are not successful, we may not be able to capitalize on the market potential of these product or commercial candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receives marketing approval, such product candidate may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations could be disrupted by failure of our information systems or cyber-attacks.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we engage in future acquisitions or strategic collaborations, this may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities and subject us to other risks.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we complete the necessary preclinical studies and clinical trials, the regulatory approval process is expensive, time-consuming and uncertain and may prevent us or any future collaborators from obtaining approvals for the commercialization of some or all of our product candidates. As a result, we cannot predict when or if, and in which territories, we, or any future collaborators, will obtain marketing approval to commercialize a product candidate.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to our Business and Industry</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Currently, we derive most of our revenues from GSK and our near-term success depends in large part on GSK&#8217;s ability to successfully develop and commercialize the products in the respiratory programs partnered with GSK.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the GSK Agreements, GSK is responsible for the development and commercialization of products in the partnered respiratory programs. Royalty revenues from RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are expected to represent the majority of our foreseeable future revenues from GSK. The amount and timing of revenue from such royalties are unknown and highly uncertain. Our near-term success depends in large part upon the performance by GSK of its commercial obligations under the GSK Agreements and the commercial success of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have no control over GSK&#8217;s marketing and sales efforts, and GSK might not be successful, which would harm our business and cause the price of our securities to fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our quarterly royalty revenues may fluctuate due to a variety of factors, many of which are outside of our control. The amount of royalties and milestone payments, if any, we receive will depend on many factors, including but not limited to the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent and effectiveness of the sales and marketing and distribution support GSK provides to our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">market acceptance and demand for our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the treatment paradigm or standard of care for COPD or asthma, for instance through changes to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the competitive landscape of generic and branded products and developing therapies that compete with our products owned by GSK (such as Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) but which are not partnered with us and pricing pressure in the respiratory markets targeted by our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size of the market for our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the mix of sales of our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decisions as to the timing of product launches, pricing and discounts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reprioritization of GSK&#8217;s commercial efforts on other products owned by GSK, which are not partnered with us;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK&#8217;s ability to expand the indications for which our partnered products can be marketed;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a satisfactory efficacy and safety profile as demonstrated in a broad patient population;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acceptance of, and ongoing satisfaction with, our partnered products by the medical community, patients receiving therapy and third-party payors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">timing and amounts of payor rebate adjustments and prior period rebate adjustments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seasonal fluctuations of demand;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability of patients to be able to afford our partnered products or obtain health care coverage that covers our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safety concerns in the marketplace for respiratory therapies in general and with our partnered products in particular;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory developments relating to the manufacture or continued use of our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the requirement to conduct additional post&#8209;approval studies or trials for our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK&#8217;s ability to obtain regulatory approval of our partnered products in additional countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the unfavorable outcome of any potential litigation relating to our partnered products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general economic conditions in the jurisdictions where our partnered products are sold, including microeconomic disruptions or slowdowns; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if our royalty revenue or operating results fall below the expectations of investors or securities analysts or below any guidance we may provide to the market, the price of our common stock could decline substantially.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">When the FDA or other applicable regulatory authorities approve generic products, including but not limited to generic forms of Advair, that compete with RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> or a generic form of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, the royalties payable to us pursuant to the GSK Agreements will be less than anticipated, which in turn would harm our business and the price of our securities could fall.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once an NDA or marketing authorization application outside the United States is approved, the product covered thereby becomes a &#8220;listed drug&#8221; that can, in turn, be cited by potential competitors in support of approval of an ANDA in the United States. Agency regulations and other applicable regulations and policies provide incentives to manufacturers to create modified, non-infringing versions of a drug to facilitate the approval of an ANDA or other application for generic substitutes in the United States and in nearly every pharmaceutical market around the world. Numerous companies have brought to market generic forms of the ICS/LABA drug Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> since certain patents covering the Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> delivery device expired in 2016. In general, these manufactures are required to conduct a number of clinical efficacy, pharmacokinetic and device studies to demonstrate equivalence to Advair, per FDA&#8217;s September 2013 draft guidance document. These studies are designed to demonstrate that the generic product has the same active ingredient(s), dosage form, strength, exposure and clinical efficacy as the branded product. These generic equivalents, which must meet the same exacting quality standards as branded products, may be significantly less costly to bring to market, and companies that produce generic equivalents are generally able to offer their products at lower prices. Thus, after the introduction of a generic competitor, a significant percentage of the sales of any branded product and products that may compete with such branded product is typically lost to the generic product.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2019, Mylan announced that the FDA approved Wixela&#153; Inhu&#153; (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of ADVAIR DISKUS</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In that same month, Teva announced that the FDA approved two of their products for adolescent and adult patients with asthma, one of which is AirDuo&#153; RespiClick</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (fluticasone propionate and salmeterol inhalation powder), a non-AB substitutable generic version of Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In January 2020, Astra Zeneca launched an authorized generic version of Symbicort. In December 2020, Hikma/Vectura announced that it received FDA approval and launched its generic version of GSK&#8217;s Advair Diskus</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2016, the FDA issued draft guidance documents covering Fluticasone Furoate/Vilanterol Trifenatate (FF/VI), the active ingredients used in RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Introduction of generic products that compete against ICS/LABA products, like RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, would materially adversely impact our future royalty revenue, profitability and cash flows. We cannot yet ascertain what impact these generic products and any future approved generic products will have on any sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, if approved.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reduced prices and reimbursement rates due to the actions of governments, payors, or competition or other healthcare cost containment initiatives such as restrictions on use, may negatively impact royalties generated under the GSK Agreements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The continuing efforts of governments, pharmaceutical benefit management organizations (&#8220;PBMs&#8221;), insurance companies, managed care organizations and other payors of health care costs to contain or reduce costs of health care has adversely affected the price, market access, and total revenues of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and may continue to adversely affect them in the future. These organizations, together with governments, have increasingly imposed utilization management tools favoring the use of generic products. As these practices expand, we may face difficulty in obtaining or maintaining timely or adequate pricing or formulary placement of our products. In addition, we have experienced and expect to continue to experience increased competitive activity, which has resulted in lower overall prices for our products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (together, &#8220;PPACA&#8221;) and other legislative or regulatory requirements or potential legislative or regulatory actions regarding healthcare and insurance matters, along with the trend toward managed healthcare in the U.S., could adversely influence the purchase of healthcare products and reduce demand and prices for our partnered products. This could harm GSK&#8217;s ability to market our partnered products and significantly reduce future revenues. For example, when GSK launched RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the treatment of COPD in the U.S. in October 2013, GSK experienced significant challenges gaining coverage at some of the largest PBMs, healthcare payors, and providers and lower overall prices than expected. Recent actions by U.S. PBMs in particular have increased discount levels for respiratory products resulting in lower net sales pricing realized for products in our collaboration. In addition, in certain foreign markets, the pricing of prescription drugs is subject to government control and reimbursement may in some cases be unavailable. We believe that pricing pressures will continue and may increase. This may make it difficult for GSK to sell our partnered products at a price acceptable to us or GSK or to generate revenues in line with our analysts&#8217; or investors&#8217; expectations, which may cause the price of our securities to fall.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">More recently, the presidential administration and the U.S. Congress have and may continue to take actions in an effort to modify or replace PPACA and to implement or pass other reforms to the healthcare system, including proposed legislation related to the pricing of pharmaceuticals. There is uncertainty with respect to any potential changes that may be proposed and what the impact, if any, will be on our business, including the impact on coverage and reimbursement for healthcare items and services covered by plans that were authorized by PPACA. However, we cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that additional state and federal healthcare reform measures will be considered and potentially adopted, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products once approved or additional pricing pressures and may adversely affect our operating results.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A portion of our current revenues are from royalties derived from sales of our respiratory products partnered with GSK, RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">. If the treatment paradigm for the indications our partnered products are approved for change or if GSK is unable to, or does not devote sufficient resources to, maintain or continue increasing sales of these products, our results of operations will be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently depend, in part, on royalties from sales of our products partnered with GSK to support our existing operations. The treatment paradigm for COPD and asthma constantly evolves. For instance, in November 2018, the GOLD guidelines were revised to favorably position bronchodilator monotherapy and LABA/LAMA treatment ahead of ICS/LABA for the treatment of COPD unless the patient has frequent exacerbations, or an eosinophil count greater than 300 per cubic microliter. The use of ICS in COPD is also recommended for patients requiring triple therapy (LABA, LAMA, ICS). If the treatment paradigms were to change further, causing our partnered products to fall out of favor, or if GSK were unable, or did not devote sufficient resources, to maintain or continue increasing RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> sales, our results of operations would likely suffer, and the price of our securities could fall.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If the commercialization of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in the countries in which they have received regulatory approval encounters any delays or adverse developments, or perceived delays or adverse developments, or if sales or payor coverage does not meet investors&#8217;, analysts&#8217;, or our expectations, our business will be harmed, and the price of our securities could fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under our agreements with our collaborative partner GSK, GSK has full responsibility for commercialization of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. GSK has launched RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in a number of countries, including the United States, Canada, Japan, the United Kingdom, and Germany, among others. The commercialization of the products in countries where they are already launched and the commercialization launch in new countries are still subject to fluctuating overall pricing levels and uncertain timeframes to obtain payor coverage. Any delays or adverse developments or perceived additional delays or adverse developments with respect to the commercialization of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> including if sales or payor coverage does not meet investors&#8217;, analysts&#8217;, or our expectations, would significantly harm our business and the price of our securities could fall.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are dependent on GSK for the successful commercialization and development of products under the GSK Agreements. If GSK does not devote sufficient resources to the commercialization or development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK is responsible for all clinical and other product development, regulatory, manufacturing and commercialization activities for products developed under the GSK Agreements, including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our royalty revenues under the GSK Agreements may not meet our, analysts&#8217;, or investors&#8217; expectations, due to a number of important factors. GSK has a substantial respiratory product portfolio in addition to the partnered products that are covered by the GSK Agreements. GSK may make respiratory product portfolio decisions or statements about its portfolio which may be, or may be perceived to be, harmful to the respiratory products partnered with us. For instance, GSK has wide discretion in determining the efforts and resources that it will apply to the development and commercialization of our partnered products. In addition, GSK may determine to focus its commercialization efforts on its own products. For example, in January 2015, GSK launched Incruse</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (UMEC) in the U.S., which is a LAMA for the treatment of COPD. GSK may determine to focus its marketing efforts on Incruse, which could have the effect of decreasing the potential market share of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and lowering the royalties we may receive for such product. Alternatively, GSK may decide to market to eventually compete directly against sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In the event GSK does not devote sufficient resources to the commercialization of our partnered products or chooses to reprioritize its commercial programs, our business, operations and stock price would be negatively affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any adverse change in FDA policy or guidance regarding the use of LABAs to treat asthma could significantly harm our royalty revenues and the price of our securities could fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2010, the FDA announced that LABAs should not be used alone in the treatment of asthma and it will require manufacturers to include this warning in the product labels of these drugs, along with taking other steps to reduce the overall use of these medicines. The FDA now requires that the product labels for LABA medicines reflect, among other things, that the use of LABAs is contraindicated without the use of an asthma controller medication such as an inhaled corticosteroid, that LABAs should only be used long term in patients whose asthma cannot be adequately controlled on asthma controller medications, and that LABAs should be used for the shortest duration of time required to achieve control of asthma symptoms and discontinued, if possible, once asthma control is achieved. In addition, in March 2010, the FDA held an Advisory Committee to discuss the design of medical research studies (known as &#8220;clinical trial design&#8221;) to evaluate serious asthma outcomes (such as hospitalizations, a procedure using a breathing tube known as intubation, or death) with the use of LABAs in the treatment of asthma in adults, adolescents, and children. Further, in April 2011, the FDA announced that to further evaluate the safety of LABAs, it required the manufacturers of currently marketed LABAs to conduct additional randomized, double blind, controlled clinical trials comparing the addition of LABAs to inhaled corticosteroids versus inhaled corticosteroids alone. These post&#8209;marketing studies have been completed and the FDA stated that treating asthma with LABAs in combination with ICS did not result in significantly more serious asthma-related side effects than treatment with ICS alone. The FDA subsequently removed the black box warning from the ICS/LABA package inserts. Although this concern appears to be resolved, it is unknown at this time what, if any, future concerns could impact the use of ICS/LABA and its potential impact on the prospects for FF/VI. Any adverse change in FDA policy or guidance regarding the use of LABAs to treat asthma could significantly harm our business and the price of our securities could fall.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any adverse developments to the regulatory status of either RELVAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> or ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> in the countries in which they have received regulatory approval, including labeling restrictions, safety findings, or any other limitation to usage, would harm our business and may cause the price of our securities to fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are approved and marketed in a number of countries, it is possible that adverse changes to the regulatory status of these products could occur in the event new safety issues are identified, treatment guidelines are changed, or new studies fail to demonstrate product benefits. A number of notable pharmaceutical products have experienced adverse developments during commercialization that have resulted in the product being withdrawn, approved uses being limited, or new warnings being included. In the event that any adverse regulatory changes were to occur to any of our products, our business would be harmed, and the price of our securities could fall.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any adverse developments or results or perceived adverse developments or results with respect to the ongoing studies for FF/VI in asthma or COPD, for UMEC/VI in COPD, or any future studies would significantly harm our business and the price of our securities could fall, and if regulatory authorities in those countries in which approval has not yet been granted determine that the ongoing studies for FF/VI in asthma or COPD or the ongoing studies for UMEC/VI for COPD do not demonstrate adequate safety and efficacy, the continued development of FF/VI or UMEC/VI or both could be significantly delayed, they might not be approved by these regulatory authorities, and even if approved they may be subject to restrictive labeling, any of which might harm our business, and the price of our securities could fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we have announced the completion of, and reported certain top&#8209;line data from, the Phase 3 registrational program for FF/VI in COPD and asthma, additional studies of FF/VI are underway or may commence in the future. Any adverse developments or perceived adverse developments with respect to any prior, current or future studies in these programs could significantly harm our business and the price of our securities could fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the FDA, the European Medicines Agency, the Japanese Ministry of Health, Labour and Welfare and Health Canada and other jurisdictions have approved ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, it has not yet been approved in all jurisdictions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any adverse developments or results or perceived adverse developments or results with respect to other pending or future regulatory submissions for the FF/VI program or the UMEC/VI program might significantly harm our business and the price of our securities could fall. Examples of such adverse developments include, but are not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not every study, nor every dose in every study, in the Phase 3 programs for FF/VI achieved its primary endpoint and regulatory authorities may determine that additional clinical studies are required;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safety, efficacy or other concerns arising from clinical or non&#8209;clinical studies in these programs having to do with the LABA VI, which is a component of FF/VI and UMEC/VI;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">analysts adjusting their sales forecasts downward from previous projections based on results or interpretations of results of prior, current or future studies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safety, efficacy or other concerns arising from clinical or non&#8209;clinical studies in these programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities determining that the Phase 3 programs in asthma or in COPD raise safety concerns or do not demonstrate adequate efficacy; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any change in FDA (or comparable foreign regulatory agency) policy or guidance regarding the use of LABAs to treat asthma or the use of LABAs combined with a LAMA to treat COPD.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">RELVAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> face substantial competition for their intended uses in the targeted markets from products discovered, developed, launched and commercialized both by GSK and by other pharmaceutical companies, which could cause the royalties payable to us pursuant to the LABA Collaboration Agreement to be less than expected, which in turn would harm our business and cause the price of our securities to fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK has responsibility for obtaining regulatory approval, launching and commercializing RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for their intended uses in the targeted markets around the world. While these products have received regulatory approval and have been launched and commercialized in the U.S. and certain other targeted markets, the products face substantial competition from existing products previously developed and commercialized both by GSK and by other competing pharmaceutical companies and can expect to face additional competition from new products that are discovered, developed and commercialized by the same pharmaceutical companies and other competitors going forward. For example, sales of generic Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, GSK&#8217;s approved medicine for both COPD and asthma, continue to have a negative impact on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the pharmaceutical companies competing in respiratory markets are international in scope with substantial financial, technical and personnel resources that permit them to discover, develop, obtain regulatory approval and commercialize new products in a highly efficient and low-cost manner at competitive prices to consumers. In addition, many of these competitors have substantial commercial infrastructure that facilitates commercializing their products in a highly efficient and low-cost manner at competitive prices to consumers. The market for products developed for treatment of COPD and asthma continues to experience significant innovation and reduced cost in bringing products to market over time. There can be no assurance that RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> will not be replaced by new products that are deemed more effective at lower cost to consumers. The ability of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to succeed and achieve the anticipated level of sales depends on the commercial and development performance of GSK to achieve and maintain a competitive advantage over other products with the same intended use in the targeted markets.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are less than anticipated because of existing or future competition in the markets in which they are commercialized, including competition from existing and new products that are perceived as lower cost or more effective, our royalty payments could be less than anticipated, which in turn would harm our business and cause the price of our securities to fall.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to utilize all of our net operating loss carryforwards.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have net operating loss carryforwards and other significant U.S. tax attributes that we believe could offset otherwise taxable income in the U.S. The net operating loss carryforwards available in any year to offset our net taxable income will be reduced following a more than 50% change in ownership during any period of 36 consecutive months (an &#8220;ownership change&#8221;) as determined under the Code. Transactions involving our common stock, even those outside our control, such as purchases or sales by investors, within the testing period could result in an ownership change. We have conducted an analysis to determine whether an ownership change had occurred since inception through December 31, 2024 and concluded that it is more likely than not that the Company did not experience an ownership change during the testing period. Subsequent changes in our ownership or sale of our stock could have the effect of limiting the use of our net operating losses in the future. There may be certain annual limitations for utilization based on the above-described ownership change provisions. In addition, we may not be able to have sufficient future taxable income prior to their expiration because certain net operating losses have carryforward periods. Future changes in federal and state tax laws pertaining to net operating loss carryforwards may also cause limitations or restrictions from us claiming such net operating losses. If the net operating loss carryforwards become unavailable to us or are fully utilized, our future taxable income will not be shielded from federal and state income taxation absent certain U.S. federal and state tax credits, and the funds otherwise available for general corporate purposes would be reduced.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If any product candidates in any respiratory program partnered with GSK were not approved by regulatory authorities or are determined to be unsafe or ineffective in humans, our business would be adversely affected and the price of our securities could fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA must approve any new medicine before it can be marketed and sold in the U.S. Our partner GSK must provide the FDA and similar foreign regulatory authorities with data from preclinical and clinical studies that demonstrate that the product candidates are safe and effective for a defined indication before they can be approved for commercial distribution. GSK will not obtain this approval for a partnered product candidate unless and until the FDA approves an NDA. The processes by which regulatory approvals are obtained from the FDA to market and sell a new product are complex, require a number of years and involve the expenditure of substantial resources. In order to market medicines in foreign countries, separate regulatory approvals must be obtained in each country. The approval procedure varies among countries and can involve additional testing, and the time required to obtain approval may differ from that required to obtain FDA approval. Approval by the FDA does not ensure approval by regulatory authorities in other countries, and approval by one foreign regulatory authority does not ensure approval by regulatory authorities in other foreign countries or by the FDA. Conversely, failure to obtain approval in one or more country may make approval in other countries more difficult.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical studies involving product candidates partnered with GSK may reveal that those candidates are ineffective, inferior to existing approved medicines, unacceptably toxic, or that they have other unacceptable side effects. In addition, the results of preclinical studies do not necessarily predict clinical success, and larger and later&#8209;stage clinical studies may not produce the same results as earlier&#8209;stage clinical studies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Frequently, product candidates that have shown promising results in early preclinical or clinical studies have subsequently suffered significant setbacks or failed in later clinical or non&#8209;clinical studies. In addition, clinical and non&#8209;clinical studies of potential products often reveal that it is not possible or practical to continue development efforts for these product candidates. If these studies are substantially delayed or fail to prove the safety and effectiveness of product candidates in development partnered with GSK, GSK may not receive regulatory approval for such product candidates and our business and financial condition could be materially harmed and the price of our securities might fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Several well&#8209;publicized Complete Response letters issued by the FDA and safety&#8209;related product withdrawals, suspensions, post&#8209;approval labeling revisions to include boxed warnings and changes in approved indications over the last several years, as well as growing public and governmental scrutiny of safety issues, have created a conservative regulatory environment. The implementation of new laws and regulations and revisions to FDA clinical trial design guidance have increased uncertainty regarding the approvability of a new drug. Further, there are additional requirements for approval of new drugs, including advisory committee meetings for new chemical entities, and formal risk evaluation and mitigation strategy at the FDA&#8217;s discretion. These laws, regulations, additional requirements and changes in interpretation could cause non&#8209;approval or further delays in the FDA&#8217;s review and approval of any product candidates in any respiratory program partnered with GSK.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if product candidates in any respiratory program partnered with GSK receive regulatory approval, as is the case with RELVAR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, commercialization of such products may be adversely affected by regulatory actions and oversight.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if GSK receives regulatory approval for product candidates in any respiratory program partnered with GSK, this approval may include limitations on the indicated uses for which GSK can market the medicines or the patient population that may utilize the medicines, which may limit the market for the medicines or put GSK at a competitive disadvantage relative to alternative therapies. These restrictions make it more difficult to market the approved products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, at the joint meeting of the Pulmonary&#8209;Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee of the FDA regarding the sNDA for BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as a treatment for asthma, the advisory committee recommended that a large LABA safety trial with BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> should be required in adults and in children ages 12&#8209;17, similar to the ongoing LABA safety trials being conducted as an FDA Post&#8209;Marketing Requirement by each of the manufacturers of LABA containing asthma treatments. The FDA did not concur with the recommendation. A pediatric program including patients 5&#8209;17 years of age is currently ongoing.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the manufacturing, labeling, packaging, adverse event reporting, advertising, promotion and recordkeeping for the approved product remain subject to extensive and ongoing regulatory requirements. If we or GSK become aware of previously unknown problems with an approved product in the U.S. or overseas or at contract manufacturers&#8217; facilities, a regulatory authority may impose restrictions on the product, the contract manufacturers or on GSK, including requiring it to reformulate the product, conduct additional clinical studies, change the labeling of the product, withdraw the product from the market or require the contract manufacturer to implement changes to its facilities. GSK is also subject to regulation by regional, national, state and local agencies, including the Department of Justice, the Federal Trade Commission, the Office of Inspector General of the U.S. Department of Health and Human Services and other regulatory bodies, as well as governmental authorities in those foreign countries in which any of the product candidates in any respiratory program partnered with GSK are approved for commercialization. The Federal Food, Drug, and Cosmetic Act, the Public Health Service Act and other federal and state statutes and regulations govern to varying degrees the research, development, manufacturing and commercial activities relating to prescription pharmaceutical products, including non&#8209;clinical and clinical testing, approval, production, labeling, sale, distribution, import, export, post&#8209;market surveillance, advertising, dissemination of information and promotion. Any failure to maintain regulatory approval would limit GSK&#8217;s ability to commercialize the product candidates in any respiratory program partnered with GSK, which could materially and adversely affect our business and financial condition, and which may cause the price of our securities to fall.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pharmaceutical research and development are very costly and highly uncertain; we may not succeed in developing, licensing, or acquiring commercially successful products.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are many difficulties and uncertainties inherent in pharmaceutical research and development, the introduction of new products and indications, business development activities to enhance or refine our product pipeline, and commercialization of our product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is a high rate of failure inherent in drug discovery and development. Failure can occur at any point in the process, including in later stages after substantial investment. New product candidates that appear promising in development or prior to being acquired may fail to reach the market or may have only limited commercial success because of efficacy or safety concerns, inability to obtain or maintain necessary regulatory approvals or payer reimbursement or coverage, failure to obtain placement on guidelines or recommendations published by third-party organizations that are commensurate with clinical data, the application of pricing controls, limited scope of approved uses, label changes, changes in the relevant treatment standards or the availability of newer better, or more cost-effective competitive products, difficulty or excessive costs to manufacture, insufficient infrastructure to support detection, diagnostic or other requisites for treatment, ineffectiveness in reaching healthcare professionals, including digitally given the increase in virtual engagements, or infringement of the patents or intellectual property rights of others. We may also fail to allocate research and development resources efficiently, fail to pursue or invest sufficiently in product candidates or indications that may have been successful, or fail to optimally balance trial design, conduct, and speed to accomplish desired outcomes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulatory agencies establish high hurdles for the efficacy and safety of new products and indications. Delay, uncertainty, unpredictability, and inconsistency in drug approval processes across markets and agencies can result in delays in product launches, lost market opportunities, impairment of inventories, and other negative impacts. In addition, it can be very difficult to predict revenue growth rates of, or variability in demand for, new products and indications, which in some cases leads to difficult meeting product demand or, on the other hand, excess inventory and related financial charges.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot state with certainty when or whether our products now under development will be approved or launched; whether, if initially granted, such approval will be maintained; whether we will be able to develop, license, or otherwise acquire additional product candidates or products; or whether our products, once launched, will be commercially successful.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to successfully develop and market new products in the short term or long term would have a material adverse effect on the Company&#8217;s business, results of operations, cash flow, financial condition and prospects.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acquisitions or strategic investments we have made or may make could turn out to be unsuccessful.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our strategy, we frequently monitor and analyze acquisition or investment opportunities that we believe will create value for our shareholders.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Existing or future acquisitions and investments could involve numerous risks that may prevent us from fully realizing the benefits that we anticipated as a result of the transaction. These risks include the failure to derive any commercial value from the acquired technology, products and intellectual property including as a result of the failure to obtain regulatory approval or to monetize products once approved, as well as risks from lengthy product development and high upfront development costs without guarantee of successful results. Patents and other intellectual property rights covering acquired technology and/or intellectual property may not be obtained, and if obtained, may not be sufficient to fully protect the technology or intellectual property. We may be subject to liabilities, including unanticipated litigation costs, that are not covered by indemnification protection we may obtain. As we pursue or consummate a strategic acquisition or investment, we may value the acquired or funded company incorrectly, fail to successfully manage our operations as our asset diversity increases, expend unforeseen costs during the acquisition or integration process, or encounter other unanticipated risks or challenges. Once an investment is made, we may fail to value it accurately, properly account for it in our consolidated financial statements, or successfully divest it or otherwise realize the value which we originally invested or have subsequently reflected in our consolidated financial statements. Any failure by us to effectively limit such risks as we implement our acquisitions or strategic investments could have a material adverse effect on our business, financial condition or results of operations and may negatively impact our net income and cause the price of our securities to fall.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have a significant amount of debt including our convertible subordinated notes and convertible senior notes that are senior in capital structure and cash flow, respectively, to our common stockholders. Satisfying the obligations relating to our debt could adversely affect our liquidity or the amount or timing of potential distributions to our stockholders.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had $453.5 million in total debt outstanding, comprised primarily of $192.5 million in principal outstanding under our convertible senior notes due 2025 (the &#8220;2025 Notes&#8221;) and $261.0 million in principal outstanding under our convertible notes due 2028 (the &#8220;2028 Notes&#8221;) (the 2025 Notes and 2028 Notes, hereinafter, the &#8220;Notes&#8221;). The Notes are unsecured debt and, with the exception of the 2028 Notes, are not redeemable by us prior to the maturity date. Holders of the Notes may require us to purchase all or any portion of their Notes at 100% of their principal amount, plus any unpaid interest, upon a fundamental change. A fundamental change is generally defined to include a merger involving us, an acquisition of a majority of our outstanding common stock. In addition, to the extent we pursue and complete a monetization transaction or a transaction that modifies our corporate structure, the structure of such transaction may qualify as a fundamental change under the Notes, which could trigger the put rights of the holders of the Notes, in which case we would be required to use a portion of the net proceeds from such transaction to repurchase any Notes put to us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Satisfying the obligations of this debt could adversely affect the amount or timing of any distributions to our stockholders. We may choose to satisfy, repurchase, or refinance this debt through public or private equity or debt financings if we deem such financings available on favorable terms. If any or all of the Notes are not converted into shares of our common stock before the maturity date, we will have to pay the holders the full aggregate principal amount of the Notes then outstanding. Any of the above payments could have a material adverse effect on our cash position. If we fail to satisfy these obligations, it may result in a default under the indenture, which could result in a default under certain of our other debt instruments, if any. Any such default would harm our business and the price of our securities could fall.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we lose key management personnel, or if we fail to retain our key employees, our ability to manage our business may be impaired.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our performance is substantially dependent on the continued service and performance of our management team, who have extensive experience and specialized expertise in our business.  None of our employees have employment commitments for any fixed period of time and all may leave our employment at will. If we fail to retain our qualified personnel or to replace them when they leave, our ability to manage our business may be impaired, which may cause the price of our securities to fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To continue to commercialize our products, and advance the research, development, and commercialization of additional modalities, indications, and product candidates, we have expanded, and may need to further expand, our workforce. Our failure to compete effectively for talent could negatively affect sales of our current and any future approved products, and could result in material financial, legal, commercial, or reputational harm to our business.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Uneven economic growth or downturns or international trade and other global disruptions, geopolitical tensions, or disputes could adversely affect our business and operating results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Economic slowdowns could lead to decreased utilization of our products, affecting our sales. Declining tax revenues and increased government spending on other programs attributable to uneven economic growth or downturns increase the pressure on governments to reduce healthcare spending, leading to increased control of drug prices or lower utilization. Also, if our customers, suppliers, or business partners experience financial difficulties, we could experience slower customer collections, greater bad debt expense, and performance defaults by suppliers or business partners. Similarly, uneven economic growth or downturns could limit our ability to access capital markets.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, trade and other global disputes and interruptions, including related to tariffs, trade protection measures, import or export licensing requirements, the imposition of trade sanctions or similar restrictions by the U.S. or other governments, international tension and conflicts, as well as cost inflation, strains on global transportation, manufacturing, and labor markets, and public health outbreaks, epidemics, or pandemics, affect our ability to do business. For example, the financial impact of higher energy prices, defense spending, and inflation due, in part, to geopolitical and economic disruptions, has further exacerbated financial pressures on governments with single-payer or government funded healthcare systems, leading to increased impetus for increases in rebates, clawbacks, and other reforms to reimbursement systems, particularly in Europe. These and similar events have adversely affected, and may continue to adversely affect, us, our business partners, and our customers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to developments related to our business or financial results, or those of our competitors, uneven economic growth, downturns, or other negative global developments, could also undermine our growth or result in significant and sudden declines in the trading price of our common stock and market capitalization.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we rely on third parties for several important aspects of our business. During challenging and uncertain economic times and in tight credit markets, there may be a disruption or delay in the performance of our third-party contractors, suppliers or partners. If such third parties are unable to satisfy their commitments to us, our business and results of operations would be adversely affected.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our success in preclinical studies or clinical trials may not be indicative of results in current or future clinical trials.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success in preclinical testing and early clinical trials does not ensure that later clinical trials will generate the same results or otherwise provide adequate data to demonstrate the efficacy and safety of a product candidate. Certain product candidates may fail to show the necessary safety and efficacy in clinical development despite positive results in preclinical studies or having successfully advanced through initial clinical trials.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In addition, the design of a clinical trial can determine whether its results will support approval of a product, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. We have limited experience designing clinical trials and may be unable to design and execute a clinical trial to support regulatory approval. There is a high failure rate for drugs and biologic products proceeding through clinical trials. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials even after achieving promising results in preclinical testing and earlier-stage clinical trials. Data obtained from preclinical and clinical activities are subject to varying interpretations, which may delay, limit or prevent regulatory approval. In addition, we may experience regulatory delays or rejections because of many factors, including to changes in regulatory policy during the period of our product candidate development. Any such delays could negatively impact our business, financial condition, results of operations and prospects.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If clinical trials of our product candidates fail to demonstrate safety and efficacy to the satisfaction of the FDA, the EMA or other comparable regulatory authorities, or do not otherwise produce favorable results, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of that product candidate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, or our potential collaborators, may not commercialize, market, promote, or sell any product candidate without obtaining marketing approval from the FDA, the EMA or other comparable regulatory authority, and we may never receive such approvals. Even if our product candidates appear sufficiently effective and/or safe in patients in well-controlled clinical trials, it is impossible to predict if or when these product candidates will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete preclinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. Clinical testing is expensive, difficult to design and implement, can take many years to complete and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We may experience numerous unforeseen events prior to, during, or because of, clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA, the EMA or other comparable regulatory authority may change from the views they have expressed to us as to the design, implementation, and/or interpretation of our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulators or institutional review boards may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not reach agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials of product candidates may produce negative or inconclusive results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not be able to complete our clinical trials in a timely manner, if at all, for example because the number of patients required for clinical trials of our product candidates may be larger than we anticipate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">enrollment in these clinical trials may be slower than we anticipate, participants may drop out of these clinical trials at a higher rate than we anticipate, or we may fail to recruit suitable patients to participate in a trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may fail to comply with regulatory requirements applicable to them, to the FDA&#8217;s or other comparable regulatory authority&#8217;s, satisfaction;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulators may issue a clinical hold, or regulators or institutional review boards may require that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of clinical trials of our product candidates may be greater than we anticipate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA, the EMA or other comparable regulatory authorities may fail to approve the manufacturing processes or facilities of third-party manufacturers with whom we enter into agreements for clinical and commercial supplies;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product candidates, once exposed to greater numbers of patients, may have undesirable side effects or other unexpected characteristics, causing us or our investigators, regulators or institutional review boards to suspend or terminate the clinical trials or cause regulatory authorities to refuse to approve our product candidates or approve them only with significant restrictions on distribution or use;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">even if our clinical trials are successful, the FDA, the EMA or other comparable regulatory authorities may determine that the overall risk-benefit profiles of our product candidates are insufficient to support marketing authorization; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approval policies or regulations of the FDA, the EMA or other comparable regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials or other testing of those product candidates, or if the results of these trials or tests are not positive or are only modestly positive or if there are safety concerns, we may:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be delayed in obtaining marketing approval for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not obtain marketing approval at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain approval for indications or patient populations that are not as broad as intended or desired;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings, such as black box warnings or a REMS program;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be subject to additional post-marketing testing requirements; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be required to remove the product from the market after obtaining marketing approval.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product development costs may also increase if we experience delays in testing and we may be required to obtain additional funds to complete clinical trials. We do not know whether any of our preclinical studies or clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Significant preclinical study or clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our product candidates. In addition, many of the factors that cause, or lead to, delays of clinical trials may ultimately lead to the denial of regulatory approval of a product candidate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are not successful in discovering, developing, and commercializing additional product candidates, our ability to expand and achieve our strategic objectives would be impaired.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have chosen to devote a substantial amount of our effort on the continued clinical testing and potential regulatory approval of our product candidates. However, an element of our strategy may include the development of novel product candidates in other therapeutic areas. Our efforts to identify and develop product candidates require substantial technical, financial and human resources, whether or not any product candidates are ultimately identified. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for many reasons, including but not limited to the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the research methodology used may not be successful in identifying potential product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">competitors may develop alternatives that render our product candidates obsolete or less attractive;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product candidates we develop may nevertheless be covered by third parties&#8217; patents or other exclusive rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a product candidate may on further study be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors, if applicable; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA, the EMA or other regulatory authorities may not approve or agree with the intended use of a new product candidate.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to develop and successfully generate revenue from other current and future product candidates, our future prospects may be harmed, and we will be more vulnerable to any problems that we or potential collaborators may encounter in developing and commercializing our current product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we or our collaborators experience delays or difficulties in the enrollment of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed or prevented.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to initiate, continue or complete clinical trials of our product candidates that we develop if we and our collaborators are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA, the EMA or other comparable regulatory authority. We have limited experience enrolling patients in our clinical trials and cannot predict how successful we will be in enrolling patients in future clinical trials.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For instance, patients involved in our clinical trials are often in the hospital setting and the decision to participate can be made by the caregiver or doctor. Accordingly, seeking consent for patient participation may become difficult when the family and/or the patient may not be available to consider participation in a clinical trial and the providers/investigators seeking the consent often have no established relationship with the family or patient. In addition, some of our competitors have ongoing clinical trials to treat the same indications as our product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors. If we are not successful at enrolling patients in one clinical trial, it may affect when we are able to initiate the next clinical trial, which could result in significant delays in our efforts to pursue regulatory approval of and commercialize our product candidates. Patient enrollment is affected by other factors including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size and nature of the patient population;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the severity of the disease under investigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proximity and availability of clinical trial sites for prospective patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the eligibility criteria for participation in the clinical trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the design of the clinical trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the perceived risks and benefits of the product candidate under study;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to recruit clinical trial investigators with appropriate experience;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of drugs approved to treat the diseases under study;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patient referral practices of physicians;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and maintain patient consents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to monitor patients adequately during and after treatment;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the risk that patients enrolled in clinical trials will drop out of the trials before completion; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of public health epidemics, such as the COVID-19 pandemic.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our inability to enroll a sufficient number of patients for clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether. Enrollment delays in these clinical trials may result in increased development costs for our product candidates, which would reduce the capital we have available to support current and future product candidates and may result in the need to raise additional capital earlier than planned and could cause the value of our common stock to decline and limit our ability to obtain additional financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval, limit the commercial potential or result in significant negative consequences following any potential marketing approval.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the conduct of clinical trials, patients report changes in their health, including illnesses, injuries and discomforts (generally referred to as adverse events), to their doctor. We are required to report adverse events to the FDA and other regulatory authorities. Often, it is not possible to determine whether the product candidate being studied caused these conditions. Regulatory authorities may draw different conclusions or require additional testing to confirm or refute these observations, if they occur. In addition, it is possible that as we test our product candidates in larger, longer and more extensive clinical programs, or as use of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts and other adverse events that were observed in earlier trials, as well as conditions that did not occur or went undetected in previous trials, will be reported by subjects. Many times, side effects are only detectable after investigational drugs are tested in large-scale, Phase&#8239;3 clinical trials or, in some cases, after they are made available to patients on a commercial scale after approval. If additional clinical experience indicates that any of our current product candidates or any future product candidates, have side effects or causes serious or life-threatening side effects, the development of the product candidate may fail or be delayed, or, if the product candidate has received regulatory approval, such approval may be revoked, which could harm our business, prospects, operating results and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, if we elect, or are required, to delay, suspend or terminate any clinical trial of our product candidates, the commercial prospects of our product candidates may be harmed and our ability to generate revenue through their sale may be delayed or eliminated. Any of these occurrences may significantly harm our business, financial condition and prospects.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, if any of our product candidates receive marketing approval, regulatory authorities may require the addition of labeling statements, such as a &#8220;black box&#8221; warning or a contraindication, or the adoption of a REMS program to ensure that the benefits outweigh its risks, which may include, among other things, a medication guide outlining the risks of the drug for distribution to patients and a communication plan to health care practitioners, and/or significant restrictions on distribution or use of the drug. Furthermore, if we or others later identify undesirable side effects caused by our product candidates, several potentially significant negative consequences could result, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may suspend or withdraw approvals of such product candidate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may require additional warnings on the label or impose distribution or use restrictions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be required to change the way a product candidate is administered or conduct additional clinical trials, including one or more post-market studies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could be sued and held liable for harm caused to patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be required to implement a REMS, including the creation of a medication guide outlining the risks of such side effects for distribution to patients, and/or other elements to assure safe use;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may need to conduct a recall; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reputation may suffer.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these events could prevent us from achieving or maintaining market acceptance of the affected product candidate, if approved, or could substantially increase commercialization costs and expenses, which could delay or prevent us from generating revenue from the sale of our products and harm our business and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interim &#8220;top-line&#8221; and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may announce interim top-line or preliminary data from our clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and/or more patient data become available. Preliminary or top-line data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed with caution until the final data are available. Differences between preliminary or interim data and final data could significantly harm our business prospects and may cause the trading price of our common stock to fluctuate significantly.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our operations could be disrupted by failure of our information systems or cyber-attacks.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our operations could be disrupted if our information systems fail, if we are unsuccessful in implementing necessary upgrades, or if we are subject to cyber-attacks. Our business depends on the efficient and uninterrupted operation of our computer and communications systems and networks, hardware and software systems and our other information technology. We collect and maintain information, which includes confidential and proprietary information as well as personal information regarding our employees and business contacts, in digital form. Data maintained in digital form is subject to risk of cyber-attacks, which are increasing in frequency and sophistication. Cyber-attacks could include the deployment of harmful malware, viruses, worms, and other means to affect service reliability and threaten data confidentiality, integrity and availability. As discussed below in Item 1C, our systems have been subject to security incidents, none of which have been material. Despite our efforts to monitor and safeguard our systems to prevent data compromise, the possibility of a future data compromise cannot be eliminated entirely, and risks associated with intrusion, tampering, and theft remain. A failure of our systems, or an inability to successfully expand the capacity of these systems, or an inability to successfully integrate new technologies into our existing systems could have a material adverse effect on our business, results of operations, financial condition, and cash flows.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Company and its vendors&#8217; sophisticated information technology operations are spread across multiple, sometimes inconsistent, platforms, which pose difficulties in maintaining data integrity across systems. The ever-increasing use and evolution of technology, including cloud-based computing, creates opportunities for the unintentional or improper dissemination or destruction of confidential information stored in the Company&#8217;s systems.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any breach of our security measures or the accidental loss, inadvertent disclosure, unapproved dissemination, misappropriation or misuse of trade secrets, proprietary information or other confidential information, whether as a result of theft, hacking, fraud, trickery or other forms of deception, or for any other cause, could adversely affect our business position. Further, any such interruption, security breach, loss or disclosure of confidential information could result in financial, legal, business and reputational harm to the Company and could have a material adverse effect on our business, financial condition, results of operations, cash flows and stock price.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The use or anticipated use of artificial intelligence (&#8220;AI&#8221;) technologies, including generative AI, by us or third parties, may increase or create new operational risks.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AI technologies offer numerous potential benefits, such as creating or increasing operational efficiencies, and we expect the use of AI and generative AI by us, third parties on our behalf, and other market actors, including our competitors, to increase.  However, the deployment of such technologies also poses certain risks, including that the algorithms may be flawed, misused or otherwise function in an unexpected manner&#894; data sets may be insufficient, of poor quality, or contain biased information&#894; and inappropriate or controversial data practices by data scientists, engineers, and end-users could impair results. The relative newness of the technology, the speed at which it is being adopted, and the paucity of laws, regulations or standards expressly and specifically governing its use increases these risks. If the analyses that AI-based applications assist in producing are deficient or inaccurate, we could be subjected to competitive harm, potential legal liability and brand or reputational harm. Our competitors may also adopt AI or generative AI more quickly or more effectively than we do, which could cause competitive harm. Furthermore, use of AI-based software may lead to the release of confidential information which may impact our ability to realize the benefits of our intellectual property.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological or hazardous materials.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with applicable data protection, privacy, and similar consumer protection laws and regulations, we could become subject to fines or penalties, or incur other costs that could harm our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Numerous federal and state laws and regulations in the U.S. address consumer privacy, regulating the collection, use, disclosure, and security of personal information. Such laws are evolving, many are recently enacted, and all are subject to potentially differing interpretations. For example, the California Consumer Privacy Act (&#8220;CCPA&#8221;), which initially came into effect on January 1, 2020, created new individual privacy rights for consumers (as that word is broadly defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA was then amended, and those amendments, which went into effect on January 1, 2023, included new rights and established a new agency in California, the California Privacy Protection Agency (&#8220;CPPA&#8221;), to implement and enforce the CCPA. Today, the CCPA requires covered companies to provide new disclosures to California consumers, provide such consumers new ways to opt-out of certain sales of personal information, and allow for a new cause of action for data breaches, among other things. The CPPA is currently considering rules that would potentially broaden the scope of the requirements in areas such as cybersecurity and so-called automated decision-making technologies. The CCPA may significantly impact our business activities and require substantial compliance costs that adversely affect business, operating results, prospects and financial condition. We cannot predict what new regulations CPPA might adopt, or what amendments the California legislature may enact. And while some states have already enacted very similar privacy laws, we cannot predict what other states may enact their own privacy laws, what the scope and requirements of such laws may be, or how they will affect our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Increased scrutiny of our corporate citizenship and sustainability will likely result in additional costs and risks and may adversely impact our reputation, employee retention and willingness of customers and suppliers to do business with us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is an increasing focus from certain customers, consumers, employees and other stakeholders concerning matters relating to corporate citizenship and sustainability. If our practices fail to meet regulatory requirements or stakeholders&#8217; evolving expectations and standards for responsible corporate citizenship in areas including environmental stewardship, support for local communities, human capital management, employee health and safety practices and corporate governance and transparency, reputation and employee retention may be negatively impacted, and customers and suppliers may be unwilling to do business with us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The standards for tracking and reporting on corporate citizenship and sustainability matters are relatively new, have not been harmonized and continue to evolve. The disclosure frameworks we choose to align with, if any, may change from time-to-time and may result in a lack of consistent or meaningful comparative data from period to period. Ensuring there are systems and processes in place to comply with various tracking and reporting obligations will require management time and expense. In addition, our processes and controls may not always comply with evolving standards for identifying, measuring and reporting metrics, our interpretation of reporting standards may differ from those of others and such standards may change over time, any of which could result in significant revisions to our goals or reported progress in achieving such goals.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to adopt corporate citizenship and sustainability standards or practices as quickly as stakeholders desire, fail, or be perceived to fail, in our achievement of such initiatives or goals, or fail in fully and accurately reporting our progress on such initiatives and goals, our reputation, business, financial performance and growth may be adversely impacted. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Our business could be negatively impacted by such matters. Any such matters, or related corporate citizenship and sustainability matters, could have a material adverse effect on our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on third parties to conduct the clinical trials for our product candidates, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials or failing to comply with applicable regulatory requirements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have engaged contract research organizations, or CROs, to conduct our ongoing and planned clinical trials. We also expect to engage CROs for any of our other product candidates that may progress to clinical development. We expect to rely on CROs, as well as other third parties, such as clinical data management organizations, medical institutions and clinical investigators, to conduct those clinical trials. Agreements with such third parties might terminate for a variety of reasons, including a failure to perform by the third parties. If we need to enter into alternative arrangements, our product development activities would be delayed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our reliance on these third parties for research and development activities will reduce our control over these activities but will not relieve us of our responsibilities. For example, we will remain responsible for ensuring that each of our clinical trials is</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with regulatory standards, commonly referred to as good clinical practices, or GCPs, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. Similar regulatory requirements apply outside the United States, including the International Council for Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use, or ICH.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also required to register certain ongoing clinical trials and post the results of certain completed clinical trials on government-sponsored, publicly accessible databases, such as ClinicalTrials.gov, within specified timeframes. Failure to do so by us or by third parties can result in FDA refusal to approve applications based on the clinical data, enforcement actions, adverse publicity and civil and criminal sanctions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, these third parties may also have relationships with other entities, some of which may be our competitors. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for our product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our product candidates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and may receive cash or equity compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA concludes that the financial relationship may have affected the results of the trial, the integrity of the data generated at the applicable clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection by the FDA of any NDA we submit. Any such delay or rejection could prevent us from commercializing our product candidates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also expect to rely on other third parties to store and distribute product supplies for our clinical trials. Any performance failure or regulatory noncompliance on the part of our distributors could delay clinical development or marketing approval of our product candidates or commercialization of our products, resulting in additional losses and depriving us of potential product revenue.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We depend on information technology and a failure of, or significant disruption to, those systems, or a failure to adequately adopt emerging technologies such as artificial intelligence, could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on sophisticated software applications and complex information technology systems (including cloud services) to operate our business, which are inherently vulnerable to malicious intrusion, random attack, loss of data privacy, disruption, degradation or breakdown. Certain of these applications and systems are managed, hosted, provided or used by third parties. Data privacy or security breaches of our internal systems or those of our information technology vendors may in the future result in the failure of critical business operations. Such breaches may cause sensitive data, including intellectual property, trade secrets or personal information belonging to us, our patients, customers, employees or business partners, to be exposed to unauthorized persons or to the public. To date, neither our business nor operations have been materially impacted by such incidents, however, the healthcare industry remains a target of cyber&#8208;attacks. Cybersecurity attacks and incidents are increasing in their frequency, sophistication and intensity and, due to the nature of some of these attacks, there is a risk that they may remain undetected for a period of time. Our investments in the protection of our data and information technology and our efforts to monitor our systems on an ongoing basis may be insufficient to prevent compromises in our information technology systems that could have a material adverse effect on our business. Such adverse consequences could include loss of revenue or the loss of critical or sensitive information from our or third-party providers&#8217; databases or information technology systems and could also result in legal, financial, reputational or business harm to us and potentially substantial remediation costs. In addition, our cyber insurance may not be sufficient to cover the financial, legal, business or reputational losses that may result from an interruption or breach of our systems or those of our third&#8208;party vendors. Additionally, we utilize artificial intelligence (AI) and other emerging technologies in select applications to support our operations. These technologies may present opportunities for our business but may also entail risks, including that AI&#8208;generated analyses utilized by us could be deficient or exacerbate regulatory, cybersecurity or other significant risks. Further, our failure to effectively implement these technologies could hinder our ability to compete, as competitors&#8217; advancements in AI may lead to more efficient operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on collaborations with third parties for the development of both our product and commercial candidates, and we may seek additional collaborations in the future. If those collaborations are not successful, we may not be able to capitalize on the market potential of these product or commercial candidates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have limited capabilities for drug development, and our product development programs and the commercialization of our product candidates will require substantial additional cash to fund expenses. As a result of these factors, we are, and expect to continue to be, dependent on collaborations relating to the development of our existing and future product candidates. We have had and will continue to have discussions on potential partnering opportunities with various pharmaceutical companies. In addition, we may seek third-party collaborators for the development and commercialization of our product candidates, particularly for the commercialization of our product candidates outside the United States. Likely collaborators for any collaboration arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies and we may face significant competition in seeking appropriate collaborators. If we fail to enter into or maintain collaborations on reasonable terms or at all, our ability to develop our existing or future product candidates could be delayed, the commercial potential of our products could change, and our costs of development and commercialization could increase. If we enter into any future collaboration arrangements with any third parties, we will likely have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of our product candidates. Our ability to generate revenues from these arrangements will depend on our collaborators&#8217; abilities to successfully perform the functions assigned to them in these arrangements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our collaborations and any future collaborations we might enter into may pose a number of risks, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators often have significant discretion in determining the efforts and resources that they will apply to these collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not perform their obligations as expected or contractually obligated;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not pursue development and commercialization of any product candidates that achieve regulatory approval or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborators&#8217; strategic focus or available funding, or external factors, such as an acquisition, that divert resources or create competing priorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product candidates discovered in collaboration with us may be viewed by our collaborators as competitive with their own product candidates or products, which may cause collaborators to cease to devote resources to the commercialization of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a collaborator with marketing and distribution rights to one or more of our product candidates that achieve regulatory approval may not commit sufficient resources to the marketing and distribution of such products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disagreements with collaborators, including disagreements over proprietary rights, contract interpretation or the preferred course of development, might cause delays or termination of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not properly maintain or defend our or their intellectual property rights or may use our or their proprietary information in such a way as to invite litigation that could jeopardize or invalidate such intellectual property or proprietary information or expose us to potential litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may be subject to geo-political actions, natural disasters or other occurrences, including public health epidemics such as the COVID-19 pandemic;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborations may be terminated for the convenience of the collaborator and, if terminated, we could be required to raise additional capital to pursue further development or commercialization of the applicable product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators&#8217; decisions may limit the availability of the product supplies required for development, clinical and commercial activities.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Collaboration agreements may not lead to development or successful commercialization of product or commercial candidates in the most efficient manner or at all. If a present or future collaborator were to be involved in a business combination, the continued pursuit and emphasis on our drug development or commercialization program could be delayed, diminished or terminated.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our reliance on third parties to manufacture our product candidates increases the risk that we will not have sufficient quantities of our product candidates or products or such quantities at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not own or operate manufacturing facilities to produce clinical or commercial supplies of the product candidates that we are developing or evaluating. We have limited personnel with experience in drug manufacturing and lack the resources and the capabilities to manufacture any of our product candidates on a clinical or commercial scale. We currently rely on third parties for supply of our product candidates, and our strategy is to outsource all manufacturing of our product candidates and approved products, if any, to third parties.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To conduct clinical trials of our product candidates, we will need to identify suitable manufacturers with the capabilities to manufacture our compounds in large quantities in a manner consistent with existing regulations. Our third-party manufacturers may be unable to successfully increase the manufacturing capacity for any of our product candidates in a timely or cost-effective manner, or at all. In addition, quality issues may arise during scale-up activities and at any other time. If our manufacturers are unable to successfully scale up the manufacture of our product candidates in sufficient quality and quantity, the development, testing and clinical trials of that product candidate may be delayed, or infeasible, and regulatory approval or commercial launch of that product candidate may be delayed or not obtained, which could significantly harm our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we can establish and maintain arrangements with third-party manufacturers, reliance on third-party manufacturers entails risks, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reliance on the third party for regulatory compliance and quality assurance;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible breach of the manufacturing agreement by the third party;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible misappropriation of our proprietary information, including our trade secrets and know-how;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">supply chain disruptions due to geo-political actions, natural disasters or public healthy crises, including epidemics such as the COVID-19 pandemic.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our product candidates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current and anticipated future dependence upon others for the manufacture of our product candidates may adversely affect our future profit margins and our ability to develop product candidates and commercialize any products that receive marketing approval on a timely and competitive basis.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to win government or non-profit contracts or grants to fund our product development activities.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historically, we have relied in part on funding from contracts or grants from government agencies and non-profit entities and it is part of our strategy to continue to do so. Such contracts or grants can be highly attractive because they provide capital to fund the ongoing development of our product candidates without diluting our stockholders. However, there is often significant competition for these contracts or grants. Entities offering contracts or grants may have requirements to apply for or to otherwise be eligible to receive certain contracts or grants that our competitors may be able to satisfy that we cannot. In addition, such entities may make arbitrary decisions as to whether to offer contracts or make grants, to whom the contracts or grants will be awarded, and the size of the contracts or grants to each awardee. Even if we can satisfy the award requirements, there is no guarantee that we will be selected to receive any contract or grant. If we are not successful in achieving this form of funding for our clinical trials, we will need to seek alternative means of funding which may not be available to the same extent, if at all.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our reliance on government funding for certain of our programs adds uncertainty to our research, development and commercialization efforts with respect to those programs and may impose requirements that increase the costs of the research, development and commercialization of product candidates developed under those government-funded programs.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aspects of certain of our development programs are currently being supported, in part, with funding from the NIH, NIAID, CARB-X and the DOD. Contracts and grants awarded by the U.S. government, its agencies and its partners, including our awards from the NIH, NIAID, CARB-X, and the DOD, include provisions that reflect the government&#8217;s substantial rights and remedies, many of which are not typically found in commercial contracts, including powers of the government to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terminate agreements, in whole or in part, for any reason or no reason at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provide grant support to potential competitor programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduce or modify the government&#8217;s obligations under such agreements without the consent of the other party;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">claim rights, including intellectual property rights, in products and data developed under such agreements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">audit contract-related costs and fees, including allocated indirect costs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suspend the contractor or grantee from receiving new contracts pending resolution of alleged violations of procurement laws or regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">impose U.S. manufacturing requirements for products that embody inventions conceived or first reduced to practice under such agreements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suspend or debar the contractor or grantee from doing future business with the government;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">control and potentially prohibit the export of products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursue criminal or civil remedies under the False Claims Act, False Statements Act and similar remedy provisions specific to government agreements; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit the government&#8217;s financial liability to amounts appropriated by the U.S. Congress on a fiscal-year basis, thereby leaving some uncertainty about the future availability of funding for a program even after it has been funded for an initial period.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not have the right to prohibit the U.S. government from using certain technologies developed by us, and may not be able to prohibit third-party companies, including our competitors, from using those technologies in providing products and services to the U.S. government. The U.S. government generally takes the position that it has the right to royalty-free use of technologies that are developed under U.S. government contracts.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, government contracts and grants, and subcontracts and subawards awarded in the performance of those contracts and grants, normally contain additional requirements that may increase our costs of doing business, reduce our profits, and expose us to liability for failure to comply with these terms and conditions. These requirements include, for example:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">specialized accounting systems unique to government awards;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mandatory financial audits and potential liability for price adjustments or recoupment of government funds after such funds have been spent;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adhering to stewardship principles imposed by CARB-X as a condition of the award;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">public disclosures of certain award information, which may enable competitors to gain insights into our research program; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mandatory socioeconomic compliance requirements, including labor standards, non-discrimination and affirmative action programs and environmental compliance requirements.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As an organization, we are relatively new to government contracting and new to the regulatory compliance obligations that such contracting entails. If we fail to maintain compliance with those obligations, we may be subject to potential liability and termination of our contracts.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a U.S. government contractor, we are subject to financial audits and other reviews by the U.S. government of our costs and performance on our contracts, as well as our accounting and general business practices related to these contracts. Based on the results of its audits, the government may adjust our contract-related costs and fees, including allocated indirect costs.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Commercialization of Our Product Candidates</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receives marketing approval, such product candidate may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we obtain approvals from the FDA, the EMA or other comparable regulatory agencies and can initiate commercialization of a product candidate we develop, the product candidate may not achieve market acceptance among physicians, patients, hospitals, including pharmacy directors, and third-party payors and, ultimately, may not be commercially successful. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on several factors, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the efficacy and potential advantages compared to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential and perceived advantages and disadvantages of the product candidates, including cost and clinical benefit relative to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the convenience and ease of administration compared to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acceptance by physicians, patients, operators of hospitals, including in-hospital formularies, and treatment facilities and parties responsible for coverage and reimbursement of the product;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of coverage and adequate reimbursement by third-party payors and government authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to manufacture our product in sufficient quantities and yields;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength and effectiveness of marketing and distribution support;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitations or warnings, including distribution or use restrictions, contained in the product&#8217;s approved labeling or an approved REMS;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the product is designated under physician treatment guidelines as a first-line therapy or as a second- or third-line therapy for particular infections;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approval of other new products for the same indications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing of market introduction of the approved product as well as competitive products;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the emergence of bacterial resistance to the product; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rate at which resistance to other drugs in the target infections grow.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure by any of our product candidates that obtains regulatory approval to achieve market acceptance or commercial success could have a material adverse effect on our business prospects.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing, or commercializing products before or more successfully than we do.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development and commercialization of new drug products is highly competitive. We face competition from major multi-national pharmaceutical companies, biotechnology companies, specialty pharmaceutical companies and generic drug companies with respect to our current and future product candidates. There are several large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of product candidates for the treatment of drug-resistant infections. Potential competitors also include academic institutions, government agencies and other public and private research organizations. Our competitors may succeed in developing, acquiring or licensing technologies and drug products that are more effective, more effectively marketed and sold or less costly than our product candidates, which could render our product candidates non-competitive and obsolete.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our competitors obtain marketing approval from the FDA, the EMA or other comparable regulatory authorities for their product candidates more rapidly than we do, it could result in our competitors establishing a strong market position before we are able to enter the market.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulation of generic and biosimilar products varies around the world and such regulation is complex and subject to ongoing interpretation and implementation by regulatory agencies and courts. Particularly for biosimilars, health authority guidelines and legislative actions could make it less burdensome for competitor products to enter the market and further incentivize uptake of biosimilars. In the U.S., the FDA has issued several &#8220;interchangeability&#8221; designations for biosimilar products and is expected to continue doing so in the future. These designations could &#8211; subject to state law requirements &#8211; enable pharmacies to substitute biosimilars for innovator biological products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of such our competitors have greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do as an organization. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any product candidates that we may develop. Our competitors also may obtain approval from the FDA, the EMA or other comparable regulatory agencies for their product candidates more rapidly than we may obtain approval for ours, which could result in product approval delays if a competitor obtains market exclusivity from the FDA or the EMA, or our competitors establish a strong market position before we are able to enter the market. In addition, our ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic drugs. Additional drugs may become available on a generic basis over the coming years. If our product candidates achieve marketing approval, we expect that they will be priced at a significant premium over competitive generic drugs.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Counterfeit versions of our products could harm our patients and have a negative impact on our revenues, earnings, reputation and business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our industry continues to be challenged by the vulnerability of distribution channels to illegal counterfeiting and the presence of counterfeit products in a growing number of markets and over the Internet. Third parties may illegally distribute and sell counterfeit versions of our products. To distributors and patients, counterfeit products may be visually indistinguishable from the authentic version. Counterfeit medicines pose a risk to patient health and safety because of the conditions under which they are</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufactured - often in unregulated, unlicensed, uninspected and unsanitary sites - as well as the lack of regulation of their contents.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The industry&#8217;s failure to mitigate the threat of counterfeit medicines could adversely impact our business and reputation by impacting patient confidence in our authentic products, potentially resulting in lost sales, product recalls, and an increased threat of litigation. In addition, diversion of our products from their authorized market into other channels may result in reduced revenues and negatively affect our profitability.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Coverage and adequate reimbursement may not be available for our current or any future product candidates, which could make it difficult for us to sell profitably, if approved.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market acceptance and sales of any product candidates that we or our collaborators commercialize will depend in part on the extent to which reimbursement for these drugs and related treatments will be available from third-party payors, including government health care programs (such as Medicare and Medicaid), government health administration authorities, managed care organizations and other private health insurers. Third-party payors decide which therapies they will pay for and establish reimbursement levels. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement policies. However, decisions regarding the extent of coverage and amount of reimbursement to be provided for any product candidates that we develop will be made on a payor-by-payor basis. One payor&#8217;s determination to provide coverage for a drug does not assure that other payors will also provide coverage and adequate reimbursement for the drug. Additionally, a third-party payor&#8217;s decision to provide coverage for a therapy does not imply that an adequate reimbursement rate will be approved. Each payor determines whether it will provide coverage for a therapy, what amount it will pay the manufacturer for the therapy, and on what tier of its list of covered drugs, or formulary, it will be placed. The position on a payor&#8217;s formulary generally determines the co-payment that a patient will need to make to obtain the therapy and can strongly influence the adoption of such therapy by patients and physicians. Patients who are prescribed treatments for their conditions and providers prescribing such services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our drugs, and providers are unlikely to prescribe our drugs, unless coverage is provided, and reimbursement is adequate to cover a significant portion of the cost of our drugs and their administration.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A primary trend in the United States healthcare industry and elsewhere is cost containment. Third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. We cannot be sure that coverage and reimbursement will be available for any drug that we commercialize and, if reimbursement is available, what the level of reimbursement will be. Inadequate coverage and reimbursement may impact the demand, or the price of, any drug for which we obtain marketing approval for. If coverage and adequate reimbursement are not available, or are available only to limited levels, we may not be able to successfully commercialize our current and any future product candidates that we develop.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercially sell any drugs that we may develop. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced resources of our management to pursue our business strategy;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decreased demand for any product candidates or products that we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injury to our reputation and significant negative media attention;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of clinical trial participants;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">initiation of investigations by regulators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product recalls, withdrawals or labeling, marketing or promotional restrictions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant costs to defend the resulting litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">substantial monetary awards paid to clinical trial participants or patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of revenue; and</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to commercialize any drugs that we may develop.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently hold product liability insurance coverage in an amount that may not be adequate to cover all liabilities that we may incur. We may need to increase our insurance coverage as we expand our clinical trials or if we commence commercialization of our product candidates. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">There are a variety of risks associated with marketing our product candidates internationally, which could affect our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We or our collaborators may seek regulatory approval for our product candidates outside of the United States and, accordingly, we expect that we will be subject to additional risks related to operating in foreign countries if we obtain the necessary approvals, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">differing regulatory requirements in foreign countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential for so-called parallel importing, which is what happens when a local seller, faced with high or higher local prices, opts to import goods from a foreign market with low or lower prices rather than buying them locally;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">economic weakness, including inflation, or political instability in foreign economies and markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign taxes, including withholding of payroll taxes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident to doing business in another country;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulties staffing and managing foreign operations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced level of reimbursement, pricing and insurance regimes compared to the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">business interruptions resulting from geo-political actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods, fires, and public health epidemics, such as the COVID-19 pandemic.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These and other risks associated with our international operations may compromise our ability to achieve or maintain profitability.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Managing Our Growth</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have pursued and may continue to pursue acquisitions. Acquisitions could be difficult to integrate, divert the attention of key personnel, disrupt our business, dilute stockholder value and impair our financial results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our business strategy, we have pursued and intend to continue to pursue acquisitions of complementary businesses, products, services or technologies that we believe could accelerate our ability to compete in our existing markets or allow us to enter new markets. Any of these transactions could be material to our financial condition and results of operations. If we fail to properly evaluate or integrate acquisitions, we may not achieve the anticipated benefits of any such acquisitions, and we may</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incur costs in excess of what we anticipate. The failure to successfully evaluate and execute acquisitions or otherwise adequately address these risks could materially harm our business and financial results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisitions also frequently result in the recording of goodwill and other intangible assets which are subject to potential impairments which could harm our financial results. As a result, if we fail to properly evaluate acquisitions or investments, we may not achieve the anticipated benefits of any such acquisitions, and we may incur costs in excess of what we anticipate. The failure to successfully evaluate and execute acquisitions or investments or otherwise adequately address these risks could materially harm our business and financial results.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we engage in future acquisitions or strategic collaborations, this may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities and subject us to other risks.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may evaluate various acquisitions and strategic collaborations, including licensing or acquiring complementary drugs, intellectual property rights, technologies or businesses, as deemed appropriate to carry out our business plan. Any potential acquisition or strategic collaboration may entail numerous risks, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased operating expenses and cash requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the assumption of additional indebtedness or contingent liabilities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assimilation of operations, intellectual property and drugs of an acquired company, including challenges associated with integrating new personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the diversion of our management&#8217;s attention from our existing drug programs and initiatives in pursuing such a strategic partnership, merger or acquisition;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">retention of key employees, the loss of key personnel and uncertainties in our ability to maintain key business relationships;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing drugs or drug candidates and regulatory approvals; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our inability to generate revenue from acquired technology and/or drugs sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain patent protection for our technology and product candidates, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and drugs similar or identical to ours, and our ability to successfully commercialize our technology and product candidates may be adversely affected.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect to our product candidates. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our technology and product candidates. If we do not adequately protect our intellectual property, competitors may be able to use our technologies and erode or negate any competitive advantage that we may have, which could harm our business and ability to achieve profitability. To protect our proprietary positions, we file patent applications in the United States and abroad related to our novel technologies and product candidates that are important to our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent application and prosecution process are expensive and time-consuming. We, our current licensees, or any future licensors and licensees may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. We or our current licensees, or any future licensors or licensees may also fail to identify patentable aspects of our research and development before it is too late to obtain patent protection.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Therefore, these and any of our patents and applications may not be prosecuted and enforced in a manner consistent with our best interests. It is possible that defects of form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, such as with respect to proper priority claims, inventorship, claim scope or patent term adjustments. If our current licensees, or any future licensors or licensees, are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised, and we might not be able to prevent third parties from making, using and selling competing products. If there are material defects in the form or preparation of our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patents or patent applications, such patents or applications may be invalid and/or unenforceable. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how. Any of these outcomes could impair our ability to prevent competition from third parties.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. No consistent policy regarding the breadth of claims allowed in biotechnology and pharmaceutical patents has emerged to date in the United States or in many foreign jurisdictions. For example, European patent law currently restricts the patentability of methods of treatment of the human body more than United States law does. In addition, the determination of patent rights with respect to pharmaceutical compounds and technologies commonly involves complex legal and factual questions, which has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Furthermore, recent changes in patent laws in the United States, including the America Invents Act of 2011, may affect the scope, strength and enforceability of our patent rights or the nature of proceedings that may be brought by us related to our patent rights.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be aware of all third-party intellectual property rights potentially relating to our current and future product candidates. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#8239;months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions. Similarly, should we own any patents or patent applications in the future, we may not be certain that we were the first to file for patent protection for the inventions claimed in such patents or patent applications. As a result, the issuance, scope, validity and commercial value of our patent rights cannot be predicted with any certainty. Moreover, we may be subject to a third-party pre-issuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or become involved in derivation, ex-parte reexamination, or inter partes review proceedings in the USPTO or similar proceedings elsewhere, challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or product candidates and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. If the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our pending and future patent applications may not result in patents being issued that protect our technology or product candidates, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Even if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection against competing products or processes sufficient to achieve our business objectives, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our owned or licensed patents by developing similar or alternative technologies or products in a non-infringing manner. Our competitors may seek to market generic versions of any approved products by submitting abbreviated new drug applications to the FDA in which they claim that patents owned or licensed by us are invalid, unenforceable and/or not infringed. Alternatively, our competitors may seek approval to market their own products similar to or otherwise competitive with our products. In these circumstances, we may need to defend and/or assert our patents, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with jurisdiction may find our patents invalid and/or unenforceable.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate, a patent being held unenforceable, and/or in one or more or in patent claims being narrowed or invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and products or limit the duration of the patent protection of our technology and products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patents have a limited lifespan. In the U.S., if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest filing date of a non-provisional application to which the patent claims priority. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired for a product candidate, we may be open to competition from competitive medications, including generic medications. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting our candidates might expire before or shortly after our candidates are commercialized. Depending upon the timing, duration and conditions of any FDA marketing approval of our product candidates, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Amendments, and similar legislation in the European Union, as discussed above. As a result, our revenue from applicable products could be reduced. Further, if this occurs, our competitors may take advantage of our investment in development and trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case, and our competitive position, business, financial condition, results of operations, and prospects could be materially harmed.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may need to license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A third party may hold intellectual property rights, including patent rights, that are important or necessary to the development of our product candidates. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our product candidates, in which case we would be required to obtain a license from these third parties. Such a license may not be available on commercially reasonable terms, or at all, and we could be forced to accept unfavorable contractual terms. If we are unable to obtain such licenses on commercially reasonable terms, our business could be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may be required to expend significant time and resources to redesign our technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected technology and product candidates, which could materially harm our business, financial condition, results of operations, and prospects.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competitors and other third parties may infringe our issued patents, trademarks, copyrights or other intellectual property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming and divert the time and attention of our management and scientific personnel. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents, trademarks, copyrights or other intellectual property. In addition, in a patent infringement proceeding, there is a risk that a court will decide that a patent of ours is invalid or unenforceable or that one or more claims of a patent are invalid, in whole or in part, and that we do not have the right to stop the other party from using the invention at issue. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. There is also a risk that, even if the validity of such patents is upheld, the court will construe the patent&#8217;s claims narrowly or decide that we do not have the right to stop the other party from using the invention at issue on the basis that our patents do not cover the invention. An adverse outcome in a litigation or proceeding involving our patents could limit our ability to assert our patents against those parties or other competitors and may curtail or preclude our ability to exclude third parties from making and selling similar or competitive products. Similarly, if we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In any infringement litigation, any award of monetary damages we receive may not be commercially valuable. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Moreover, there can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for years before they are concluded. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Even if we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive because of the proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, despite our efforts, we may not be able to prevent third parties from infringing, misappropriating or successfully challenging our intellectual property rights. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a negative impact on our ability to compete in the marketplace.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could significantly harm our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is a substantial amount of intellectual property litigation in the biotechnology and pharmaceutical industries, and we may become party to, or threatened with, litigation or other adversarial proceedings regarding intellectual property rights with respect to our technology or product candidates, including interference proceedings before the USPTO. Intellectual property disputes arise in several areas including with respect to patents, use of other proprietary rights and the contractual terms of license arrangements. Third parties may assert claims against us based on existing or future intellectual property rights. The outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are found to infringe a third-party&#8217;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product candidate or product. Alternatively, we may be required to obtain a license from such third party to use the infringing technology and continue developing, manufacturing or marketing the infringing product candidate. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative effect on our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States could be less extensive than those in the United States. In some cases, we may not be able to obtain patent protection for certain licensed technology outside the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, even in jurisdictions where we do pursue patent protection. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, even in jurisdictions where we do pursue patent protection or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competitors may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our product candidates and preclinical programs and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents, if pursued and obtained, or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to seeking patent and trademark protection for our product candidates, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties prior to beginning research or disclosing proprietary information. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets. Despite these efforts and the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information due to our reliance on third parties, increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for any such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, our competitors may independently develop knowledge, methods and know-how equivalent to our trade secrets. Competitors could purchase our products and replicate some or all the competitive advantages we derive from our development efforts for technologies on which we do not have patent protection. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Regulatory Approval of Our Product Candidates and Other Legal Compliance Matters</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we complete the necessary preclinical studies and clinical trials, the regulatory approval process is expensive, time-consuming and uncertain and may prevent us or any future collaborators from obtaining approvals for the commercialization of some or all of our product candidates. As a result, we cannot predict when or if, and in which territories, we, or any future collaborators, will obtain marketing approval to commercialize a product candidate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates and the activities associated with their development and commercialization, including their design, research, testing, manufacture, safety, efficacy, quality control, recordkeeping, labeling, packaging, storage, approval, advertising, promotion, sale, distribution, import, export, and reporting of safety and other post-market information, are subject to comprehensive regulation by the FDA, the EMA and other foreign regulatory agencies. Failure to obtain marketing approval for a product candidate will prevent us or a potential collaborator from commercializing the product candidate. We will rely on third parties to assist us in the process of filing and supporting the applications necessary to gain marketing approvals. Securing marketing approval requires the submission of extensive preclinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. Our product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. We may not be able to successfully manufacture our products in compliance with applicable requirements such as GMPs. If any of our product candidates receives marketing approval, the accompanying label may limit its approved use more narrowly than we anticipate, which could limit sales of the product.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process of obtaining marketing approvals, both in the United States and abroad, is expensive and may take many years, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Securing marketing approval requires the submission of extensive preclinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. The FDA, the EMA or other regulatory authorities may determine that our product candidates are not safe and effective, only moderately effective or have undesirable or unintended side effects, toxicities or other characteristics that preclude us from obtaining marketing approval or prevent or limit commercial use. Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data is insufficient for approval and require additional preclinical, clinical or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit or prevent marketing approval of a product candidate. Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. Any marketing approval that we, or any future collaborators, ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we experience delays in obtaining approval or if we fail to obtain approval of our product candidates, the commercial prospects for our product candidates may be harmed and our ability to generate revenues will be impaired.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to obtain marketing approval in foreign jurisdictions would prevent certain of our product candidates from being marketed in these territories. Any approval we are granted for our product candidates in the United States would not assure approval of our product candidates in foreign jurisdictions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To market and sell our products in the European Union, or EU, and any other jurisdictions, we must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain approval from the FDA. The regulatory approval process outside the United States generally includes all the risks associated with obtaining approval from the FDA. In addition, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country. We may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. However, denial of approval in one jurisdiction may impact the ability to obtain approval elsewhere. We may not be able to file for marketing approvals and may not receive necessary approvals to commercialize our products in any market.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we obtain marketing approvals for our product candidates, the terms of approvals and ongoing regulation of our products may limit how we or our collaborators manufacture and market our products and compliance with such requirements may involve substantial resources, which could materially impair our ability to generate revenue.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if marketing approval of a product candidate is granted, an approved product and its manufacturer and marketer are subject to ongoing review and extensive regulation, including the potential requirements to implement a REMS or to conduct costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product. We must also comply with requirements concerning advertising and promotion for any of our product candidates for which we obtain marketing approval. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#8217;s approved labeling. Thus, we will not be able to promote any products we develop for indications or uses for which they are not approved. In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to comply with extensive FDA requirements including ensuring that quality control and manufacturing procedures conform to cGMP, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements, among other things. We and our contract manufacturers could be subject to periodic unannounced inspections by the FDA to monitor and ensure compliance with cGMP. We must also comply with FDA requirements for adverse event reporting for commercial products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, assuming we receive marketing approval for one or more of our product candidates, we and our contract manufacturers will continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control. If we are not able to comply with post-approval regulatory requirements, we could have the marketing approvals for our products withdrawn by regulatory authorities and our ability to market any future products could be limited, which could adversely affect our ability to achieve or sustain profitability. We could also be subject to other civil or criminal penalties. Thus, the cost of compliance with post-approval regulations may have a negative effect on our operating results and financial condition.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any product candidate for which we obtain marketing approval could be subject to post-marketing restrictions or recall or withdrawal from the market, and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our product candidates, when and if any of them are approved.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA and other federal and state agencies, including the U.S. DOJ, closely regulate compliance with all requirements governing prescription drug products, including requirements pertaining to marketing and promotion of drugs in accordance with the provisions of the approved labeling and manufacturing of products in accordance with cGMP requirements. The FDA and DOJ impose stringent restrictions on manufacturers&#8217; communications regarding off-label use and if we market our products for indications other than their approved indications, we may be subject to enforcement action for off-label marketing. Violations of such requirements may lead to investigations alleging violations of the Food, Drug and Cosmetic Act and other statutes, including the False Claims Act and other federal and state health care fraud and abuse laws as well as state consumer protection laws.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our failure to comply with all regulatory requirements, and later discovery of previously unknown adverse events or other problems with our products, manufacturers or manufacturing processes, may yield various results, including but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">litigation involving patients taking our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on our products, manufacturers or manufacturing processes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the labeling or marketing of a product;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on product distribution or use;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requirements to conduct post-marketing studies or clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warning or untitled letters;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of the products from the market;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to approve pending applications or supplements to approve applications that we submit;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recall of products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, restitution or disgorgement of profits or revenues;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suspension or withdrawal of marketing approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">damage to relationships with any potential collaborators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unfavorable press coverage and damage to our reputation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to permit the import or export of our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-compliance by us or any future collaborator with regulatory requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with regulatory requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-compliance with U.K. and EU requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, also can result in significant financial penalties. Similarly, failure to comply with the U.K.&#8217;s or EU&#8217;s requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our current and future relationships with healthcare professionals, principal investigators, consultants, customers and third-party payors in the United States and elsewhere may be subject, directly or indirectly, to applicable anti-kickback, fraud and abuse, false claims, physician payment transparency, health information privacy and security and other healthcare laws and regulations, which could expose us to penalties.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current and future arrangements with healthcare professionals, principal investigators, consultants, customers and third-party payors may expose us to broadly applicable fraud and abuse and other healthcare laws, including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act, that may constrain the business or financial arrangements and relationships through which we research, sell, market and distribute any product candidates for which we obtain marketing approval. In addition, we may be subject to physician payment transparency laws and patient privacy and security regulation by the federal government and by the states and foreign jurisdictions in which we conduct our business. The applicable federal, state and foreign healthcare laws that may affect our ability to operate include the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal civil and criminal false claims laws, including the federal False Claims Act, which impose criminal and civil penalties, including through civil whistleblower or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">qui tam</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, to the federal government, including the Medicare and Medicaid programs, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the civil monetary penalties statute, which imposes penalties against any person or entity who, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, which created additional federal criminal and civil statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of whether the payor is public or private, knowingly and willfully embezzling or stealing from a health care benefit program, willfully obstructing a criminal investigation of a health care offense and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by the HITECH Act of 2009, and their respective implementing regulations, which impose obligations on &#8220;covered entities,&#8221; including certain healthcare providers, health plans, and healthcare clearinghouses, as well as their respective &#8220;business associates&#8221; that create, receive, maintain or transmit individually identifiable health information for or on behalf of a covered entity, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Physician Payments Sunshine Act, created under Section&#8239;6002 of Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA, and its implementing regulations, which created annual reporting requirements for manufacturers of drugs, devices, biologicals and medical supplies for certain payments and &#8220;transfers of value&#8221; provided to covered recipients, including physicians, as defined by such law, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">analogous state and foreign laws, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; state and foreign laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or to adopt compliance programs as prescribed by state laws and regulations, or that otherwise restrict payments that may be made to healthcare providers; state and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures and drug pricing; state and local laws requiring the licensure of pharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, the ACA, among other things, amended the intent requirement of the federal Anti-Kickback Statute and certain criminal statutes governing healthcare fraud. A person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it. In addition, the ACA provided that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Efforts to ensure that our future business arrangements with third parties will comply with applicable healthcare laws and regulations may involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, including, without limitation, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, additional reporting or oversight obligations if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with the law and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and pursue our strategy. If any of the physicians or other healthcare providers or entities with whom we expect to do business, including future collaborators, are found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from participation in government healthcare programs, which could also affect our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future legislation, and/or regulations and policies adopted by the FDA, the EMA or comparable regulatory authorities, may increase the time and cost required for us or our collaborators to conduct and complete clinical trials of our current and future product candidates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA and the EMA have each established regulations to govern the product development and approval process, as have other foreign regulatory authorities. The policies of the FDA, the EMA and other regulatory authorities may change. For example, in December&#8239;2016, the 21st&#8239;Century Cures Act, or Cures Act, was signed into law. The Cures Act, among other things, is intended to modernize the regulation of drugs and spur innovation, but not all its provisions have yet been implemented. Additionally, in August&#8239;2017, the FDA issued final guidance setting forth its current thinking with respect to development programs and clinical trial designs for antibacterial drugs to treat serious bacterial diseases in patients with an unmet medical need. We cannot predict what if any effect the Cures Act or any existing or future guidance from the FDA or other regulatory authorities will have on the development of our product candidates.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently enacted and future legislation, including relevant provisions of the Inflation Reduction Act, may increase the difficulty and cost for us and our collaborators to obtain marketing approval of and commercialize our product candidates and affect the prices we may obtain.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other federal health reform measures have been proposed and adopted in the United States. For example, the Medicare Access and CHIP Reauthorization Act of 2015 ended the use of the statutory formula for clinician payment and established a quality payment incentive program, also referred to as the Quality Payment Program. This program provides clinicians with two ways to participate, including through the Advanced Alternative Payment Models, or APMs, and the Merit-based Incentive Payment System, or MIPS. In November 2019, CMS issued a final rule finalizing the changes to the Quality Payment Program. It is unclear how payment reductions or the introduction of the Quality Payment Program will impact overall physician reimbursement under the Medicare program. It is also unclear if changes in Medicare payments to providers would impact such providers&#8217; willingness to prescribe and administer our products, if approved.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Heightened governmental scrutiny over the manner in which drug manufacturers price their marketed products and the practices of pharmacy benefit managers and other supply chain entities has also resulted in several U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, require advance notice of list price increases, establish upper payment limits or other restrictions by drug affordability review boards, allow the importation of drugs from other countries, address pharmacy benefit manager practices, and reform government program reimbursement methodologies for drug products. In particular, the Inflation Reduction Act contains provisions designed to limit the prices paid by Medicare for various prescription drugs.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us or our collaborators from being able to generate revenue, attain profitability, or commercialize our drugs.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for drugs. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business is subject to increasing government price controls and other public and private restrictions on pricing, reimbursement, and access for our drugs, which could have a material adverse effect on our results of operations, reputation or business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Public and private payers continue to take aggressive steps to control their expenditures for pharmaceuticals by placing restrictions on pricing and reimbursement for, and patient access to, our medicines. These pressures have negatively affected, and could continue to negatively affect, our consolidated results of operations. Governments and private payers worldwide have intensified their scrutiny of, and actions intended to address, pricing, reimbursement, and access to pharmaceutical products and are demanding greater commercial and clinical value from pharmaceutical companies in the form of strong product differentiation and demonstrated value. Additional policies, regulations, legislation, or enforcement, including because of the regulatory priorities of the U.S. presidential administration and regulatory authorities worldwide, could adversely impact our business and consolidated results of operations. The effect of reducing prices and reimbursement for certain of our products would significantly impact our business and consolidated results of operations. Within the U.S., state level transparency initiatives, importation rules, reporting requirements, and mandated programs, including the establishment of drug affordability boards with the power to set upper payment limits on certain drugs in state-regulated plans, may also increase administrative costs, in some cases, compromise confidential business practices and otherwise detrimentally impact our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outside of the United States, particularly in the European Union, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. To obtain coverage and reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. If reimbursement of our products is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, restrictive or unfavorable pricing, coverage, or reimbursement determinations for our medicines or product candidates by governments, regulatory agencies, courts, or private payers, including in relation to the implementation of the Inflation Reduction Act, reference pricing, and compulsory licensing, may adversely impact our business and financial results. In addition, government price reporting and payment regulations are complex, and require ongoing assessment of the methods by</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which we calculate and report pricing. Calculation methodologies are inherently subjective and are subject to review and challenge by government agencies. If agencies disagree with our calculations, or the methodologies and assumptions underlying them, we may need to restate previously reported data and could be subject to financial and legal liability, which may be significant. In addition, changes to calculation methodologies could adversely affect our financial position or consolidated results of operations in any given period.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to our Alliance with GSK</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Because a portion of our current revenues and near-term projected revenues have historically been derived from products under the GSK Agreements, disputes with GSK could harm our business and cause the price of our securities to fall.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historically, all of our current and near-term projected revenues have been derived from products under the GSK Agreements. We expect royalties from such products will likely continue to comprise a portion of our revenues in the future. Any action or inaction by either GSK or us that results in a material dispute, allegation of breach, litigation, arbitration, or significant disagreement between the parties may be interpreted negatively by the market or by our investors, could harm our business and cause the price of our securities to fall. Examples of these kinds of issues include but are not limited to non&#8209;performance of contractual obligations and allegations of non&#8209;performance, disagreements over the relative marketing and sales efforts for our partnered products and other GSK respiratory products, disputes over public statements, and similar matters.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Because GSK is a strategic partner, it may take actions that in certain cases are materially harmful to our business or to our stockholders.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK is a strategic partner with rights and obligations under the GSK Agreements that cause its interests to differ from our interests and those of our stockholders. In particular, GSK has a substantial respiratory product portfolio in addition to the partnered products that are covered by the GSK Agreements. GSK may make respiratory product portfolio decisions or statements about its portfolio which may be, or may be perceived to be, harmful to the respiratory products partnered with us. For example, GSK could promote its non&#8209;GSK/Innoviva respiratory products or a partnered product for which we are entitled to receive a lower percentage of royalties, delay or terminate the development or commercialization of the respiratory programs covered by the GSK Agreements, or take other actions, such as making public statements, that have a negative effect on our stock price. In this regard and by way of example, sales of Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, GSK&#8217;s approved medicine for both COPD and asthma, continue to be significantly greater than sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and GSK has indicated publicly that it intends to continue commercializing Advair</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Also, given the potential future royalty payments which GSK may be obligated to pay under the GSK Agreements, GSK may seek to acquire us in order to reduce those payment obligations. The timing of when GSK may seek to acquire us could potentially be when it possesses information regarding the status of drug programs covered by the GSK Agreements that has not been publicly disclosed and is not otherwise known to us. As a result of these differing interests, GSK may take actions that it believes are in its best interest but which might not be in our best interest or the best interest of our stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GSK has also indicated to us that it believes its consent may be required before we can engage in certain royalty monetization transactions with third parties, which may inhibit our ability to engage in these transactions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GSK indicated to us that it believes that its consent may be required before we can engage in certain transactions designed to monetize the future value of royalties that may be payable to us from GSK under the GSK Agreements. GSK has informed us that it believes that there may be certain covenants included in these types of transactions that might violate certain provisions of the GSK Agreements. Although we believe that we can structure royalty monetization transactions in a manner that fully complies with the requirements of the GSK Agreements without GSK&#8217;s consent, a third party in a proposed monetization transaction may nonetheless insist that we obtain GSK&#8217;s consent for the transaction or restructure the transaction on less favorable terms. We have obtained GSK&#8217;s agreement that (i) we may grant certain pre&#8209;agreed covenants in connection with monetization of our interests in RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and vilanterol monotherapy, and (ii) it will not unreasonably withhold its consent to our requests to grant other covenants, provided among other conditions, that in each case, the covenants are not granted in favor of a pharmaceutical or biotechnology company with a product either being developed or commercialized for the treatment of respiratory disease. If we seek GSK&#8217;s consent to grant covenants other than pre&#8209;agreed covenants, we may not be able to obtain GSK&#8217;s consent on reasonable terms, or at all. If we proceed with a royalty monetization transaction that is not otherwise covered by the GSK Agreement without GSK&#8217;s consent, GSK could request that its consent be obtained or seek to enjoin or otherwise challenge the transaction as violating or allowing it to terminate the GSK Agreements. Regardless of the merit of any claims by GSK, we would incur significant cost and diversion of resources in defending against GSK&#8217;s claims or asserting our own claims and GSK may seek concessions from us in order to provide its consent. Any uncertainty about whether or when we could engage in a royalty monetization transaction, the potential impact on the enforceability of the GSK Agreements or the loss of potential royalties from the respiratory programs partnered with GSK, could impair our ability to pursue a return of capital strategy for our stockholders ahead of our receipt of significant royalties from GSK, result in significant reduction in the market price of our securities and cause other material harm to our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Risks Factors</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions, whether brought about by material global crises, health epidemics, military conflicts or war, geopolitical and trade disputes or other factors, may adversely affect our business and financial results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is sensitive to global economic conditions, which can be adversely affected by epidemics and other public health crises, political and military conflict, trade and other international disputes, significant natural disasters (including as a result of climate change) or other events that disrupt macroeconomic conditions. Adverse macroeconomic conditions, including inflation, slower growth or recession, new or increased tariffs and other barriers to trade, changes to fiscal and monetary policy or government budget dynamics (particularly in the pharmaceutical and biotech areas), tighter credit, higher interest rates, volatility in financial markets, high unemployment, labor availability constraints, currency fluctuations and other challenges in the global economy have in the past adversely affected, and may in the future adversely affect, us and our business partners and suppliers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, military conflicts or wars (such as the ongoing conflicts between Russia and Ukraine and in the Middle East) can cause exacerbated volatility and disruptions to various aspects of the global economy. The uncertain nature, magnitude, and duration of hostilities stemming from such conflicts, including the potential effects of sanctions and counter-sanctions, or retaliatory cyber-attacks on the world economy and markets, have contributed to increased market volatility and uncertainty, which could have an adverse impact on macroeconomic factors that affect our business and operations, such as worldwide supply chain issues. It is not possible to predict the short and long-term implications of military conflicts or wars or geopolitical tensions which could include further sanctions, uncertainty about economic and political stability, increases in inflation rate and energy prices, cyber-attacks, supply chain challenges and adverse effects on currency exchange rates and financial markets.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, the operations of our suppliers and manufacturers may be located in areas that are prone to earthquakes, wildfires and other natural disasters. Such operations and facilities are also subject to the risk of interruption by drought, power shortages, nuclear power plant accidents and other industrial accidents, terrorist attacks and other hostile acts, ransomware and other cybersecurity attacks, labor disputes, public health crises, and other events beyond the Company&#8217;s control. Global climate change is resulting in certain types of natural disasters occurring more frequently or with more intense effects. Such events can create delays or interruptions to the Company&#8217;s development efforts and inefficiencies in the Company&#8217;s supply and manufacturing chain. Significant delays in our development efforts could materially impact our ability to obtain regulatory approval and to commercialize our products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Without limiting the foregoing, we have experienced and/or may in the future experience:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in receiving authorization from regulatory authorities to initiate any planned clinical trials, inspections, reviews and approvals of products;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays or difficulties enrolling patients in our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in or disruptions to the conduct of preclinical programs and clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">constraints on the movement of products and supplies through the supply chain, which can disrupt our ability to conduct clinical trials and develop our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">price increases in raw materials and capital equipment, as well as increasing price competition in our markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adverse impacts on our workforce and/or key employees; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased risk that counterparties to our contractual arrangements will become insolvent or otherwise unable to fulfill their contractual obligations.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to maintain proper and effective internal control over financial reporting or if the interpretations, estimates or judgments utilized in preparing our financial statements prove to be incorrect, our operating results and our ability to operate our business could be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Sarbanes-Oxley Act requires, among other things, that we establish and maintain effective internal control over financial reporting and disclosure controls and procedures. Under the SEC&#8217;s current rules, we are required to perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Our independent registered public accounting firm is also required to report on our internal control over financial reporting. Our testing and our independent registered public accounting firm&#8217;s testing may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses and render our internal control over financial reporting ineffective. We have and expect to continue to incur substantial accounting and auditing expense and to expend significant management time in complying with the requirements of Section 404. If we are not able to maintain compliance with the requirements of Section 404 in a timely manner, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to investigations or sanctions by the SEC, FINRA, The Nasdaq Global Select Market or other regulatory authorities. In addition, we could be required to expend significant management time and financial resources to correct any material weaknesses that may be identified or to respond to any regulatory investigations or proceedings.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also subject to complex tax laws, regulations, accounting principles and interpretations thereof. The preparation of our financial statements requires us to interpret accounting principles and guidance and make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue generated, and expenses incurred during the reporting periods. Our interpretations, estimates and judgments are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for the preparation of our financial statements. U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) presentation is subject to interpretation by the SEC, the Financial Accounting Standards Board and various other bodies formed to interpret and create appropriate accounting principles and guidance. In the event that one of these bodies disagrees with our accounting recognition, measurement or disclosure or any of our accounting interpretations, estimates or assumptions, it may have a significant effect on our reported results and may retroactively affect previously reported results. The need to restate our financial results could, among other potential adverse effects, result in our incurring substantial costs, affect our ability to timely file our periodic reports until such restatement is completed, divert the attention of our management and employees from managing our business, result in material changes to our historical and future financial results, result in investors losing confidence in our operating results, subject us to securities class action litigation, and cause our stock price to decline.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our employees or third-party providers, or employees or third-party providers of our portfolio companies may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements and insider trading.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to the risk of fraud or other misconduct by employees, third party providers, or employees or third-party providers of our portfolio companies. Misconduct by employees, third party providers, or employees or third-party providers of our portfolio companies could include intentional failures to comply with applicable regulations, provide accurate information to regulatory authorities, comply with federal and state fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, the health care industry is subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. It is not always possible to identify and deter misconduct by employees, third party providers, or employees or third party providers of our portfolio companies, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred litigation and may incur additional litigation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have been subject to various legal proceedings, and, in the future, we may be exposed to, or threatened with, litigation, claims and proceedings incident to the ordinary course of, or otherwise in connection with, our business. In addition, agreements entered into by us sometimes include indemnification provisions which may subject us to costs and damages in the event of a claim against an indemnified third party.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regardless of the merit of particular claims, litigation may be expensive, time-consuming, disruptive to our operations and distracting to management. In recognition of these considerations, we may enter into agreements or other arrangements to settle litigation and resolve such disputes. No assurance can be given that such agreements can be obtained on acceptable terms or that litigation will not occur. These agreements may also significantly increase our operating expenses.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If one or more legal matters were resolved against us or an indemnified third party in a reporting period for amounts in excess of management&#8217;s expectations, our consolidated financial statements for that reporting period could be materially adversely affected. Further, such an outcome could result in significant compensatory, punitive or trebled monetary damages, disgorgement of revenue or profits, remedial corporate measures or injunctive relief against us that could materially adversely affect our financial condition and operating results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we maintain insurance coverage for certain types of claims, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to comply with the U.S. Foreign Corrupt Practices Act, or &#8220;FCPA&#8221;, as well as the anti-bribery laws of the nations in which we conduct business, could subject us to penalties and other adverse consequences.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to the FCPA, which generally prohibits U.S. companies from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business and requires companies to maintain accurate books and records and internal controls. In addition, we are subject to the anti-bribery laws of other jurisdictions in which we conduct business. Our employees or other agents may engage in prohibited conduct without our knowledge under our policies and procedures and the FCPA and other anti-bribery laws that we may be subject to for which we may be held responsible. If our employees or other agents are found to have engaged in such practices, we could suffer severe penalties and other consequences that may have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to evolving and complex tax laws, which may result in additional liabilities and affect our results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to income taxes in the U.S. and numerous other jurisdictions, and in the course of our business, we make judgments about the expected tax treatment of various transactions and events. Changes in tax laws, regulations, administrative practices, principles, disclosure obligations, and interpretations, as well as events that differ from our expectations, have affected and may adversely affect our effective tax rates, cash flows, and/or results of operations. In addition, tax authorities in the U.S. and other jurisdictions in which we do business routinely examine our tax returns and are intensifying their scrutiny and examinations of cross-border tax issues, which could unfavorably impact our results of operations. Further, actions taken with respect to tax-related matters by associations such as the Organisation for Economic Co-operation and Development and the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">European Commission could influence tax laws in countries in which we operate, such as the recent enactments by both the EU and non-EU countries of a global minimum tax. Modifications to key elements of the U.S. or international tax framework could have a significant impact on our effective tax rate, results of operations, and cash flows.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The widespread outbreak of an illness or any other communicable disease, or any other public health crisis, could adversely affect our business, results of operations and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pandemics, such as the COVID-19 pandemic, have impacted and may in the future impact our business, operations and financial condition and results. Related risks and challenges for our business include, among others: uncertainty regarding the severity and duration of a pandemic&#894; impacts to business operations&#894; decreased demand for certain of our products&#894; increased costs of doing business&#894; manufacturing disruptions and delays&#894; supply chain disruptions and shortages, including challenges related to reliance on third-party suppliers resulting in reduced availability of materials or components used in the development, manufacturing, distribution or administration of our products&#894; evolving macroeconomic factors and conditions, including general economic uncertainty, unemployment rates and recessionary pressures&#894; changes in labor markets, including challenges related to our human capital and talent development&#894; unknown consequences on our business performance and initiatives stemming from the substantial investment of time and other resources to any potential pandemic response&#894; increased difficulty and uncertainty regarding predicting or estimating future performance&#894; pace of post-pandemic recovery, disruption and volatility within the financial or credit markets&#894; and our financial performance in general.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Under the Services Agreement with Sarissa Capital, we may rely on Sarissa Capital to assist in our strategic investing activity.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, we entered into the Services Agreement pursuant to which Sarissa Capital provides substantial assistance to us in connection with our acquisition strategy. Pursuant to the terms of the Services Agreement, and subject to the limitations set forth therein, Sarissa Capital will, among other things: (i) assist Innoviva in the development of an overall acquisition and investment process and strategy; (ii) advise Innoviva on market trends, market dynamics and merger and acquisition activity; (iii) identify potential transaction targets; (iv) assist in due diligence of transaction targets and the negotiation and execution of transactions; (v) advise on the growth and operational plans, performance and integration of target companies once an investment or acquisition is made; and (vi) assist in the identification of director and officer candidates for target companies. The services are provided by Sarissa Capital personnel and we have limited or no ability to control the manner upon which the services are provided. In the event that Sarissa Capital fails to adequately perform the required services, our investment activity operations and financial performance may be negatively impacted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our investment into the Partnership, managed by Sarissa Capital, could subject us to various risks and uncertainties, any of which could impact our investment results and could materially and adversely affect our business, financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historically, we have invested our cash reserves in short-term investments and marketable securities, primarily corporate notes, government securities, government agencies, and commercial papers. On December 11, 2020, we entered into the Partnership Agreement and invested $300 million of our cash reserves to be managed by Sarissa Capital as the investment manager to the Partnership.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we expect that a portion of our revenues will continue to be derived from our royalty management business and the sales of our products, as a result of this investment, we may derive a material portion of our income from assets managed by Sarissa Capital. The investment strategy of Sarissa Capital will focus on a concentrated portfolio of &#8220;long&#8221; positions in publicly or privately traded securities (debt or equity) and derivatives of, and other financial instruments related to, each of the foregoing, specifically in the areas of healthcare, pharmaceuticals and biotechnology. The risks associated with this investment strategy may be substantially greater than the risks associated with traditional fixed-income investment strategies or other low-yield strategies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have limited rights to remove the general partner of the Partnership and do not have any right to participate in the management of the Partnership or the investment activity of Sarissa Capital. We are solely dependent on Sarissa Capital&#8217;s management of our investment in the Partnership. We cannot provide assurance that Sarissa Capital will be successful in meeting our investment objectives. Unexpected market volatility or losses in the Partnership&#8217;s securities portfolio could significantly and negatively affect our investment in the Partnership and therefore our investment results, financial condition or results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, we made an election to unwind the capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The price of our securities has been volatile and may continue to be so, and purchasers of our securities could incur substantial losses.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The price of our securities has been volatile and may continue to be so. Between January 1, 2024 and December 31, 2024, the high and low sales prices of our common stock as reported on The Nasdaq Global Select Market varied between $14.33 and $21.28 per share. The stock market in general and the market for biotechnology and biopharmaceutical companies in particular have experienced extreme volatility that has often been unrelated to the companies&#8217; operating performance, in particular during the last several years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be unable to or elect not to return capital to our stockholders.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The payment of, or continuation of, capital returns to stockholders is at the discretion of our Board of Directors and is dependent upon our financial condition, results of operations, capital requirements, execution of our strategic initiatives, general business conditions, tax treatment of capital returns, potential future contractual restrictions contained in our credit agreement and other agreements and other factors deemed relevant by our Board of Directors. Future capital returns may also be affected by, among other factors: our views on potential future capital requirements for investments in acquisitions and our working capital and debt maintenance requirements; legal risks; stock or debt repurchase programs; changes in federal and state income tax laws or corporate laws; and changes to our business model. Our capital return programs may change from time to time, and we cannot provide assurance that we will continue to provide any particular amounts. Our announcement of future capital return programs does not obligate us to repurchase any specific dollar amount of debt or equity or number of shares of common stock. A reduction, suspension or change in our capital return programs could have a negative effect on our stock price.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti&#8209;takeover provisions in our charter and bylaws and in Delaware law could prevent or delay a change in control of our company.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions of our Certificate of Incorporation and Bylaws may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These provisions include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requiring supermajority stockholder voting to effect certain amendments to our Certificate of Incorporation and Bylaws;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restricting the ability of stockholders to call special meetings of stockholders;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prohibiting stockholder action by written consent; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at meetings.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, some provisions of Delaware law may also discourage, delay or prevent someone from acquiring us or merging with us.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1B.   UNRESOLVED STAFF COMMENTS</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_0b2d2c3f-ad52-49a7-9aa4-f3c923d74352" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_0b2d2c3f-ad52-49a7-9aa4-f3c923d74352_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1C.   CYBERSECURITY</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk Management and Strategy</span></p><div><ix:nonNumeric id="F_ad440032-f2ef-4246-a6f6-5ad298bc79e1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e7ab994c-b055-44ae-a938-d58a5e0b495a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.</span></p></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_0b2d2c3f-ad52-49a7-9aa4-f3c923d74352_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conduct risk assessments to identify cybersecurity threats at least annually, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats.  These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards.  We devote internal and external resources and designate high-level personnel to manage the risk assessment and mitigation process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with human resources, IT, legal, and management. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3f9b90e3-642d-41f9-be24-6d1e3c6cf61f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We engage internal auditors and other third parties in connection with our risk assessment processes. These service providers assist us in designing and implementing our cybersecurity policies and procedures, as well as to monitor and test our safeguards.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4c816ae2-2a8f-4c8a-a56c-bb5fe1217027" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_20c4379b-0682-43b0-987b-8899fc462e69" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, we did not identify any risks from known cybersecurity threats, including because of any prior cybersecurity incidents, that have materially affected us. However, in the future, we may face certain ongoing cybersecurity risks or threats that, if realized, are reasonably likely to materially affect us. Additional information on cybersecurity risks we face is discussed in Part I, Item 1A, &#8220;Risk Factors,&#8221; under the heading &#8220;Our operations could be disrupted by failure of our information systems or cyber-attacks.&#8221;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9691eef6-feca-4e9c-a93c-aec9a5b52807" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true"><div><ix:nonNumeric id="F_a1788fb6-d97f-4120-9e7f-853b03c0dc51" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_87949837-74e8-4c3d-a3d7-62c337048daf" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_2146197e-a8e0-4a18-a9b3-7e4e3d937617" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e11eb156-fdbb-486e-bb9d-2e3bc0c08979" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9cac1718-8a6e-43e1-96f3-12da9890e43a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.</span></p></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_facd3f06-686e-49d5-b48e-2bffed33b135" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They oversee our cybersecurity policies and processes, including those described in &#8220;Risk Management and Strategy&#8221; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They provide briefings to the audit committee regarding our company&#8217;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.</span></div></div></ix:nonNumeric></div></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 2.   PROPERTIES</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our headquarters consist of a lease of 2,111 square feet of office space in Burlingame, California, which expires in December 2027. Our other material leased property is an office space of approximately 15,500 square feet located in Waltham, Massachusetts, which expires in March 2029. We believe that these facilities are sufficient for our current operational needs and that suitable additional space will be available on commercially reasonable terms to accommodate expansion of our operations, if necessary.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 3.   LEGAL PROCEEDINGS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information called for by this Item is incorporated herein by reference in Item 8. &#8220;Financial Statements and Supplementary Data,&#8221; Note 13, &#8220;Commitments and Contingencies&#8221;.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 4.   MINE SAFETY DISCLOSURES</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II</span></p>
  <p style="text-indent:-9.17%;padding-left:8.4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_5_market_for_registrant_s_common"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 5.   MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock was traded on Nasdaq under the symbol &#8220;THRX&#8221; from October 5, 2004 until January 8, 2016. Upon changing our corporate name to Innoviva, Inc. on January 7, 2016, we changed the stock ticker symbol to &#8220;INVA&#8221; effective January 11, 2016.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 14, 2025, there were 61 stockholders of record of our common stock. As many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.3</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not paid any cash dividends on our common stock since September 30, 2015. The payment of cash dividends in the future will be dependent upon our revenues and earnings, capital requirements and general financial condition. The payment of any cash dividends will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, our ability to declare dividends may be limited by restrictive covenants contained in any of our existing or future indebtedness.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Authorized for Issuance Under Equity Compensation Plans</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Authorized for Issuance Under Equity Compensation Plans: See Part III, Item 12 of this Form 10-K for additional information required.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchases of Equity Securities by the Issuer</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, we did not repurchase shares of our common stock other than as disclosed in our Quarterly Report on Form 10-Q for the quarters ended March 31 and June 30, 2024.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Performance Graph</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The graph set forth below compares the cumulative total stockholder return on our common stock for the period commencing on December 31, 2019 and ending on December 31, 2024, with the cumulative total return of (i) the Nasdaq Composite Index, (ii) the Nasdaq S&amp;P Small Cap 600 Pharma Index and (iii) the Nasdaq Biotechnology Index over the same period. This graph assumes the investment of $100.00 on December 31, 2019 in each of (1) our common stock, (2) the Nasdaq Composite Index, (3) the Nasdaq S&amp;P Small Cap 600 Pharma Index and (4) the Nasdaq Biotechnology Index, and assumes the reinvestment of dividends.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The comparisons shown in the graph below are based upon historical data. We caution that the stock price performance shown in the graph below is not necessarily indicative of, nor is it intended to forecast, the potential future performance of our common stock. Information used in the graph was obtained from sources believed to be reliable including Nasdaq, Bloomberg and Reuters, but we are not responsible for any errors or omissions in such information.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding anything to the contrary set forth in any of our previous or future filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, that might incorporate this Annual Report on Form 10&#8209;K or future filings made by us under those statutes, this Stock Performance Graph section shall not be deemed filed with the SEC and shall not be deemed incorporated by reference into any of those prior filings or into any future filings made by us under those statutes.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Among Innoviva, Inc., the Nasdaq Composite Index, Nasdaq Biotechnology Index, and Nasdaq S&amp;P Small Cap 600 Pharma Index.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><img src="img12876764_23.jpg" alt="img12876764_23.jpg" style="width:687px;height:426px;"/></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">_________________________________________________________</span></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*    $100 invested on December 31, 2019 in stock or index, including reinvestment of dividends.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_6_selected_financial_data"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 6.   [</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reserved]</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:-9.17%;padding-left:8.4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_7_management_s_discussion_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 7.   MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) is intended to facilitate an understanding of our business and results of operations. This discussion and analysis should be read in conjunction with our consolidated financial statements and notes included in this Annual Report on Form 10&#8209;K. The information contained in this discussion and analysis or set forth elsewhere in this Annual Report on Form 10&#8209;K, including information with respect to our plans and strategy for our business, our operating expenses, and future payments under our collaboration agreements, includes forward&#8209;looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are based upon current expectations that involve risks and uncertainties. You should review the section entitled &#8220;Risk Factors&#8221; in Item 1A of Part I above for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward&#8209;looking statements contained in the following discussion and analysis. See the section entitled &#8220;Special Note Regarding Forward Looking Statements&#8221; above for more information.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management Overview</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc. (and where context requires, together with its subsidiaries referred to as &#8220;Innoviva&#8221;, the &#8220;Company&#8221;, the &#8220;Registrant&#8221; or &#8220;we&#8221; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#8220;IST&#8221;), and a portfolio of strategic investments in other healthcare assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#8220;GSK&#8221;), including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (fluticasone furoate/vilanterol, &#8220;FF/VI&#8221;) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (umeclidinium bromide/vilanterol, &#8220;UMEC/VI&#8221;), and up until July 2022, TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the combination FF/UMEC/VI). We sold our 15% ownership interest in Theravance Respiratory Company, LLC (&#8220;TRC&#8221;) on July 20, 2022, and are no longer entitled to receive royalties on sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> products. Under the Long&#8209;Acting Beta2 Agonist (&#8220;LABA&#8221;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: 15% on the first $3.0 billion of annual global net sales and 5% for all annual global net sales above $3.0 billion; and royalties from the sales of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which tier upward at a range from 6.5% to 10%.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expanded our portfolio through the acquisition of Entasis Therapeutics Holdings Inc. (&#8220;Entasis&#8221;) on July 11, 2022 and the acquisition of La Jolla Pharmaceutical Company (&#8220;La Jolla&#8221;) on August 22, 2022. Following the acquisitions, our commercial and marketed products include GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) approved for the treatment of complicated intra-abdominal infections in adults. Our new commercial and marketed product, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#8220;FDA&#8221;) on May 23, 2023 for the treatment of hospital-acquired and ventilator-associated pneumonias caused by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in adults. We commenced commercial sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) (&#8220;Basilea&#8221;) for the commercialization of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue to further advance our pipeline and are on track to submit a New Drug Application (&#8220;NDA&#8221;) for zoliflodacin, potentially first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the U.S. FDA in early 2025. As such, we have a wholly owned robust critical care and infectious disease operating platform with hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we own other strategic healthcare assets, such as a large equity stake in Armata Pharmaceuticals (&#8220;Armata&#8221;), a leader in development of bacteriophage with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our focus on capital allocation and shareholder value maximization has led our company to a meaningful transformation over the last two years. In 2022 our financials contained royalty revenues from TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which was divested mid-year in an economically accretive transaction. Additionally, our acquisition and integration of operating companies and advancement of our therapeutics portfolio further changed the structure of our financials compared to prior years. Through these changes, we believe we are well-positioned to create significant long-term shareholder value.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our company structure and organization are tailored to our focused activities of managing our respiratory assets partnered with GSK, commercializing our marketed products, developing our product candidates, optimizing capital allocation, and providing for certain essential reporting and management functions of a public company. As of December 31, 2024, we had 127 employees.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Highlights</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Royalty revenue: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fourth quarter 2024 gross royalty revenue from GSK was $66.0 million and full year was $255.6 million, compared to $69.6 million for the fourth quarter of 2023 and $252.7 million for the full year 2023.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net Product Sales: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fourth quarter 2024 net product sales were $28.9 million, which included U.S. net product sales of $24.9 million, compared to $19.7 million for the fourth quarter of 2023, and ex-U.S. net product sales of $4.0 million. U.S. net product sales consisted of $15.9 million from GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $3.1 million from XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and $5.9 million from XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Full year 2024 net product sales were $97.5 million, which included U.S. net product sales of $80.9 million, compared to $55.1 million for full year 2023, and ex-U.S. net product sales of $16.6 million. U.S. net product sales consisted of $53.4 million from GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $12.8 million from XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and $14.7 million from XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">License revenue: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fourth quarter 2024 license revenue of $0.4 million included product development cost-sharing reimbursements from our partner. Full year 2024 license revenue of $19.5 million consisted of an $8.0 million milestone payment and $11.5 million cost-sharing reimbursements, compared to $11.0 million milestone payments in full year 2023.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity and long-term investments: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fourth quarter and full year 2024 changes in fair values of equity and long-term investments of $19.6 million and $123.4 million, respectively, were primarily attributable to share price depreciation of Armata and other equity investments.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net income: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fourth quarter 2024 net income of $20.3 million ($0.32 basic net income per share) and full year 2024 net income of $23.4 million ($0.37 basic net income per share) were driven primarily by higher revenue, offset by the negative impact of changes in the fair values of equity investments.  </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Totaled $305.0 million. Royalty and net product sales receivables totaled $86.4 million as of December 31, 2024.</span></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Business and R&amp;D Highlights</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftobiprole):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> an advanced-generation cephalosporin antibiotic that is approved in the U.S. for three specific treatment indications. ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is the only FDA-approved methicillin-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Staphylococcus aureus</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (MRSA) cephalosporin antibiotic for treating adult patients with </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Staphylococcus aureus</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> bloodstream infections (bacteremia) (&#8220;SAB&#8221;) and endocarditis. ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is indicated for the treatment of adult patients with SAB, including right-sided infective endocarditis, adult patients with acute bacterial skin and skin structure infections (ABSSSI) and for adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP).</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the fourth quarter of 2024, Innoviva licensed U.S. commercialization and distribution rights to ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from Basilea.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company anticipates launching ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. in mid-2025.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Zoliflodacin: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a potential first-in-class, single dose, oral antibiotic is currently being developed in partnership with The Global Antibiotic Research &amp; Development Partnership (&#8220;GARDP&#8221;) for the treatment of patients with uncomplicated gonorrhea.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2024, the Company reported positive Phase 3 data for zoliflodacin, in which a single dose of oral zoliflodacin achieved a statistically non-inferior microbiological cure rate compared to the current global standard of care. Oral zoliflodacin was generally well tolerated and emergent adverse events were comparable between treatment arms. No deaths or other serious adverse events were reported.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company remains on track to submit the zoliflodacin NDA to the FDA in early 2025. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use: a targeted antibacterial treatment for patients with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter baumannii-calcoaceticus </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">complex.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was approved in China by the National Medical Products Administration for use in Chinese patients 18 years of age and older in May 2024.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was named as the preferred agent for the treatment of Carbapenem-resistant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter baumannii</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> infections, in combination with a carbapenem, in the updated 2024 IDSA treatment guidance. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was nominated for the prestigious Prix Galien USA award for Best Biotechnology Product. </span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Update on Strategic Healthcare Assets</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our portfolio of strategic assets under the Company&#8217;s various subsidiaries was valued at $501.5 million as of December 31, 2024. In the fourth quarter 2024, we continued to support product developments and invested $10.9 million in Gate Neurosciences, Inc., a leader in developing precision medicines targeting synaptic health. </span></div></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Collaborative Arrangements with GSK</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LABA Collaboration</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2002, we entered into the LABA Collaboration Agreement with GSK to develop and commercialize once&#8209;daily LABA products for the treatment of chronic obstructive pulmonary disorder (&#8220;COPD&#8221;) and asthma (the &#8220;LABA Collaboration Agreement&#8221;). For the treatment of COPD, the collaboration has developed three combination products:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;FF/VI&#8221;) (BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is the proprietary name in the U.S. and Canada and RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is the proprietary name outside the U.S. and Canada), a once&#8209;daily combination medicine consisting of a LABA, vilanterol (VI), and an inhaled corticosteroid (&#8220;ICS&#8221;), fluticasone furoate (&#8220;FF&#8221;),</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;UMEC/VI&#8221;), a once&#8209;daily medicine combining a long&#8209;acting muscarinic antagonist (&#8220;LAMA&#8221;), umeclidinium bromide (&#8220;UMEC&#8221;), with a LABA, vilanterol (VI), and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the combination FF/UMEC/VI), a once&#8209;daily combination medicine consisting of an ICS, LAMA and LABA.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the launch and approval of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S., Japan and Europe, in accordance with the LABA Collaboration Agreement, we paid approval and launch milestone payments to GSK totaling $220.0 million during the year ended December 31, 2014. Although we have no further milestone payment obligations to GSK pursuant to the LABA Collaboration Agreement, we continue to have ongoing commercialization activities under the LABA Collaboration Agreement, including participation in the joint steering committee that are expected to continue over the life of the agreement. The milestone fees paid to GSK were recognized as capitalized fees, which are being amortized over their estimated useful lives commencing upon the commercial launch of the products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are entitled to receive royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: 15% on the first $3.0 billion of annual global net sales and 5% for all annual global net sales above $3.0 billion. On sales of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, royalties are upward tiering and range from 6.5% to 10%. We no longer receive royalties on sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> after we sold our royalty rights along with the sale of our ownership in TRC in July 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As mentioned above, on July 20, 2022, we sold our ownership interest in TRC, which received royalty payments from GSK stemming from sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We retained our royalty rights with respect to RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategic Partnership with Sarissa Capital</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Advisory Agreement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, we entered into a Strategic Advisory Agreement (the &#8220;Services Agreement&#8221;) with Sarissa Capital Management LP (&#8220;Sarissa Capital&#8221;), pursuant to which Sarissa Capital provides a variety of strategic services to us in order to assist us in the development and execution of our acquisition strategy. The services are provided free of charge to us. Sarissa Capital is considered to be a related party due to its investment in Innoviva&#8217;s common stock and its representation on our board of directors.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Partnership Agreement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, Innoviva Strategic Partners LLC (&#8220;Strategic Partners&#8221;), our wholly owned subsidiary, entered into a subscription agreement (the &#8220;Subscription Agreement&#8221;) and an Amended and Restated Limited Partnership Agreement (the &#8220;Partnership Agreement&#8221;) pursuant to which Strategic Partners became a limited partner of ISP Fund LP (the &#8220;Partnership&#8221;). The general partner of the Partnership (the &#8220;General Partner&#8221;) is an affiliate of Sarissa Capital and, pursuant to an investment management agreement, Sarissa Capital acts as the investment adviser to the Partnership. Strategic Partners made a $300.0 million initial contribution into the Partnership. The Partnership was formed for the purposes of investing in equity securities in the healthcare, pharmaceutical and biotechnology industries. The Partnership Agreement provides for Sarissa Capital to receive a customary one percent management fee from the Partnership, payable quarterly in advance, measured based on the Net Asset Value of Strategic Partners&#8217; capital account in the Partnership. In addition, the General Partner is entitled to a customary 10% annual performance allocation based on the Net Profits of the Partnership during the annual measurement period. The Partnership Agreement includes a lock-up period of thirty-six months after which Strategic Partners is entitled to make withdrawals from the Partnership as of such lock-up expiration date and each anniversary thereafter, subject to certain limitations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, Strategic Partners received a distribution of $110.0 million from the Partnership to provide funding to Innoviva for a strategic repurchase of Innoviva common shares held by GSK. On March 30, 2022, Strategic Partners made an additional capital contribution of $110.0 million to the Partnership pursuant to the letter agreement entered into between Strategic Partners, the Partnership and Sarissa Capital Fund GP LP on May 20, 2021. The capital contribution is subject to a 36-month lock-up period from the contribution date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The lock-up period for our initial contribution of $190.0 million expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. In October 2024, we made an election to unwind the capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Policies and Estimates</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#8217;s judgments and estimates.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combinations</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We use the acquisition method of accounting under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combinations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each acquired company&#8217;s operating results are included in our consolidated financial statements starting on the acquisition date. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired, liabilities assumed and any noncontrolling interest in the acquiree as of the acquisition date are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Amounts allocated to assets and liabilities are based upon fair values. Such valuations require us to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. We make estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. Significant estimates and assumptions may involve projected future revenues, earnings, cash flows, estimated probabilities of certain milestone achievements, discount rates, asset lives, among other items. Our estimates may also impact our deferred tax assets and liabilities. Unanticipated events and circumstances may occur that may affect the accuracy and validity of such assumptions, estimates or actual results. Our estimates are based on available historical information as well as future expectations, and the estimates are inherently uncertain. The separately identifiable intangible assets generally include marketed products, in-process research and development and collaboration agreement.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition from Royalties</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the royalty revenue on net sales of products with respect to which we have contractual royalty rights in the period in which the royalties are earned. The net sales reports provided by our partner are based on its methodology and assumptions to estimate rebates and returns, which it monitors and adjusts regularly in light of contractual and legal obligations, historical trends, past experience and projected market conditions. Our partner may make significant adjustments to its sales based on actual results recorded, which could cause our royalty revenue to fluctuate. We conduct periodic royalty audits to evaluate the information provided by our partner. Royalties are recognized net of amortization of capitalized fees associated with any approval and launch milestone payments made to GSK.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition from Product Sales</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We apply the guidance on principal versus agent considerations under ASC Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to determine the appropriate treatment for the transactions between us and third parties. The classification of transactions under our arrangements is determined based on the nature and contractual terms of the arrangement along with the nature of the operations of the participants. Any consideration related to activities in which we are considered the principal, which includ</span><span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">es being in control of the good or service before such good or service is transferred to the customer, are accounted for as product sales.</span><span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to recognizing any revenue from product sales, we identify the contract, performance obligations, and transaction price, and allocate the transaction price to the performance obligations. Revenue from product sales is recognized when our customers obtain control of the product and is recorded at the transaction price, net of estimates for variable consideration consisting of chargebacks, discounts, returns and rebates. Variable consideration is estimated using the expected-value amount method, which is the sum of probability-weighted amounts in a range of possible consideration amounts. Actual amounts of consideration ultimately received may differ from our estimates. If actual results vary materially from our estimates, we will adjust these estimates, which will affect revenue from product sales and earnings in the period such estimates are adjusted. These items may include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chargebacks: Chargebacks are discounts we provide to distributors in the event that the sales prices to end users are below the distributors&#8217; acquisition price. This may occur due to a direct contract with a health system, a group purchasing organization (&#8220;GPO&#8221;) agreement or a sale to a government facility. Chargebacks are estimated based on known chargeback rates and recorded as a reduction of revenue on delivery to our customers.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Discounts: We offer customers various forms of incentives and consideration, including prompt-pay and other discounts. We estimate discounts primarily based on contractual terms. These discounts are recorded as a reduction of revenue on delivery to our customers. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Returns: We offer customers a limited right of return, generally for damaged or expired product. We estimate returns based on an internal analysis, which includes actual experience. The estimates for returns are recorded as a reduction of revenue on delivery to our customers. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rebates: We participate in Medicaid rebate programs, which provide assistance to certain low-income patients based on each individual state&#8217;s guidelines regarding eligibility and services. Under the Medicaid rebate programs, we pay a rebate to each participating state, generally within three months after the quarter in which product was sold. Additionally, we may offer customer incentives and consideration in the form of volume-based or other rebates. The estimates for rebates are recorded as a reduction of revenue on delivery to our customers. </span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to assess our estimates of variable consideration as we accumulate additional historical data and will adjust these estimates accordingly.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Capitalized Fees Paid</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We review our Capitalized Fees for impairment on a product&#8209;by&#8209;product basis for each major geographic area when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The recoverability of Capitalized Fees is measured by comparing the asset&#8217;s carrying amount to the expected undiscounted future cash flows that the asset is expected to generate. The determination of recoverability typically requires various estimates and assumptions, including estimating the useful life over which cash flows will occur, their amount, and the asset&#8217;s residual value, if any. We derive the required cash flow estimates from near&#8209;term forecasted product sales and long&#8209;term projected sales in the corresponding market. Based upon our analyses of past, current and future sales and trends, there have been no indicators of impairment and no impairment charges have been recorded on the Capitalized Fees as of December 31, 2024.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary beneficiary of a variable interest entity (&#8220;VIE&#8217;) is required to consolidate the assets and liabilities of the VIE. When we obtain a variable interest in another entity, we assess at the inception of the relationship and upon occurrence of certain significant events whether the entity is a VIE and, if so, whether we are the primary beneficiary of the VIE based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. To determine whether a variable interest that we hold could potentially be significant to the VIE, we consider both qualitative and quantitative factors regarding the nature, size and form of our involvement with the VIE.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, we consider all the facts and circumstances, including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE&#8217;s economic performance and identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, we consider all of our economic interests that are deemed to be variable interests in the VIE. This assessment requires us to apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity and Other Investments</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our investments in Armata include a convertible note (the &#8220;Armata Convertible Note&#8221;) and term loans issued in July 2023 and March 2024 (the &#8220;July 2023 Armata Term Loan &#8221; and the &#8220;March 2024 Armata Term Loan&#8221;, respectively), all of which are classified as Level 3 financial instruments. The Armata Convertible Note is measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. We measure the July 2023 Armata Term Loan and the March 2024 Armata Term Loan at fair value using an income approach based on the discounted value of expected future cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Level 3 financial instruments include the Gate convertible promissory note and private placement positions held by ISP Fund LP as these securities are not publicly traded and the assumptions used in the valuation model for valuing these securities are based on significant unobservable and observable inputs including those of publicly traded peer companies. We measure the Gate convertible promissory note at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of equity value of Gate, risk-free rate, expected stock price, volatility of its peer companies, and the time until a financing is raised. Valuation models applied for the private placement positions held by ISP Fund LP may include the Black-Scholes-Merton pricing model, the Monte Carlo simulation model and other applicable valuation models. Key assumptions involve inputs to the Black-Scholes-Merton pricing model, probability rates of certain events and scenarios applied in the Monte Carlo simulation model and discount rates, as appropriate. The Monte Carlo simulation model also incorporates assumptions made based on transaction details such as the security&#8217;s stock price, the expected term, maturity, risk-free interest rates and dividend yield, as well as volatility.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also hold preferred stock warrants in InCarda Therapeutics Inc. (&#8220;InCarda&#8221;), a privately held, clinical-stage biopharmaceutical company. The preferred stock warrants are classified as Level 3 financial instruments and recorded at fair value subject to remeasurement at each balance sheet date. We use the Black-Scholes-Merton pricing model to estimate the fair value of the warrants with the following input assumptions: the exercise price of the warrants, the risk-free interest rate computed based on the U.S. Treasury yield, the remaining contractual term as the expected term, and the expected stock price volatility calculated based on the historical volatility of the common stock of its public peer companies. As of December 31, 2024, the fair value of these warrants was minimal.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Factors Affecting Comparability</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our historical financial condition and results of operations for the periods presented may not be comparable, either between periods or going forward due to the factors described below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting consolidation of Entasis on February 17, 2022 and purchase of remaining noncontrolling interest in Entasis on July 11, 2022; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sale of our 15% ownership interest in TRC on July 20, 2022; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisition of La Jolla on August 22, 2022.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;, to the Consolidated Financial Statements for more information related to our acquisitions of Entasis and La Jolla and the sale of our ownership interest in TRC.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Revenue</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Royalty Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total royalty revenue, net, as compared to the prior years, was as follows:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:28.743%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.727%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.448%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.727%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.448%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; RELVAR/BREO</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207,925</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,042</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215,034</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(117</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(6,992</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; ANORO</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,631</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,627</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,405</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,004</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,222</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; TRELEGY</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,029</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(72,029</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalties</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,556</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,669</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">325,468</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,887</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(72,799</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(22</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: amortization of capitalized<br/>&#160;&#160;&#160;fees paid</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,823</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,823</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,823</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total net royalty revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241,733</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">238,846</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,645</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,887</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(72,799</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(23</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*    Not Meaningful</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total royalty revenue, net, increased to $241.7 million for the year ended December 31, 2024, compared to $238.8 million for the year ended December 31, 2023. The increase in total net royalty revenue was primarily due to the sales growth in ANORO&#174; ELLIPTA&#174;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total royalty revenue, net, decreased to $238.8 million for the year ended December 31, 2023, compared to $311.6 million for the year ended December 31, 2022. The decrease in total net royalty revenue was primarily due to the sale of our ownership interest in TRC, which received royalties stemming from sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net Product Sales</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total product sales, net, as compared to the prior years, was as follows:</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:28.749%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.728999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.45%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.968999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.201%;box-sizing:content-box;"/>
    <td style="width:8.989%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="13" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GIAPREZA&#174;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,037</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,294</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,214</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,743</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,080</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XERAVA&#174;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,385</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,320</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,480</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,065</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,840</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XACDURO&#174;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,070</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,067</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;Total net product sales</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97,492</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,617</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,694</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,875</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,923</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*    Not Meaningful</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We derived our net product sales:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately 83% from customers located in the U.S. and 17% from the rest of the world for the year ended December 31, 2024;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately 91% from customers located in the U.S. and 9% from the rest of the world for the year ended December 31, 2023; and,</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately 96% from customers located in the U.S. and 4% from the rest of the world from the date of acquisition of La Jolla, which occurred on August 22, 2022, to December 31, 2022.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our net product sales increased during the periods presented, driven by higher sales volume resulting from our strategic commercialization efforts and dedications to delivering our critical care products to healthcare systems.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">License and Other Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized $8.0 million in license and other revenue for the year ended December 31, 2024 as a result of the achievement of a regulatory milestone under our license agreement with Zai Lab. We also recognized $8.1 million and $3.4 million in license and other revenue under the Amended Zai Agreement and a manufacturing stage technology transfer agreement with Zai Lab, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized license and other revenue of $8.0 million and $3.0 million for the year ended December 31, 2023 as a result of achievement of regulatory milestones under our license agreements with Everest and Zai Lab, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Products Sold</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of products sold, as compared to the prior years, were as follows:</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.156%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.446%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.446%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.446%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.086%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.926%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.086%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.906%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of product sold</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,598</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,040</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,793</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,442</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(11</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,247</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of products sold also includes the inventory step-up value  from the acquisition of La Jolla, which is recorded upon the sale of such inventory. The step-up value included above amounted to $13.8 million, $27.2 million, and $10.0 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our cost of products sold increased during the periods presented, driven by higher product sales volume.  As of December 31, 2024, our total inventory included the remaining net fair value adjustments resulting from the acquisition of La Jolla of approximately $9.2 million, which will be recognized as cost of products sold when sales occur in future periods.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research &amp; Development</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses, as compared to the prior years, were as follows:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.15%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.443%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.443%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.443%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.083%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.9239999999999995%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.083%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.9239999999999995%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,654</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,922</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,432</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(20,268</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(60</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(7,510</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses consisted of the following:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.15%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.443%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.443%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.443%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.083%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.9239999999999995%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.083%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.9239999999999995%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">External services</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,408</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,051</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,666</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(12,643</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(63</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,615</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(19</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation and related personnel costs</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,948</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,081</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,863</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,133</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(51</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,782</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(27</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facilities related</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,483</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,255</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,750</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(70</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">228</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">565</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,307</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">648</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(742</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(57</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">659</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,654</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,922</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,432</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(20,268</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(60</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(7,510</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses for the year ended December 31, 2024 were mainly attributable to post marketing commitments required by the FDA and ongoing product development. Research and development expenses for the year ended December 31, 2023 and 2022 were mainly attributable to our product development efforts for XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Research and development expenses for the year ended December 31, 2024 decreased compared to the same period in 2023 primarily due to the FDA approval of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in May 2023 and resource reallocation from the research development function to general and administrative function after the FDA approval. External services costs consist primarily of fees paid to consultants, contractors and contract manufacturing organizations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Selling, General &amp; Administrative</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selling, general and administrative expenses, as compared to the prior years, were as follows:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.161%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.448%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.448%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.448%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.087999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.9079999999999995%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.101%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.087999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.9079999999999995%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling, general and administrative</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">115,690</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98,232</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,538</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,458</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,694</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selling, general and administrative expenses increased by $17.5 million for the year ended December 31, 2024, compared to the year ended December 31, 2023. The increase was mainly due to the reallocation of resources from the research and development function, focusing on regulatory compliance since May 2023 after the FDA approval of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and enhanced commercial strategies resulting from our ongoing efforts to promote and deliver our marketed critical care products to healthcare systems and patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selling, general and administrative expenses for the year ended December 31, 2022 were lower than those for the year ended December 31, 2023, because this amount included only partial-year expenses for Entasis, which we began consolidating on February 17, 2022, and for La Jolla, which we acquired on August 22, 2022.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest and Dividend Income and Other Expense, Net</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest and dividend income and other expense, net, as compared to the prior years, were as follows:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:27.375%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.899000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.699%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.899000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.678999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(19,141</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(15,818</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(6,369</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,323</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(9,449</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">148</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expense, net</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,997</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,969</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,373</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,972</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(40</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,596</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest and dividend income increased for the years ended December 31, 2024 and 2023, due to higher interest rates and higher average balances of our cash equivalents, money market funds and other interest-bearing investments.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other expense, net, primarily consisted of expenses incurred by ISP Fund LP.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense, as compared to the prior years, was as follows:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:27.375%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.899000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.699%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.899000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.678999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,209</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,157</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,789</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,052</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,368</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The interest expense for the periods presented included the contractual interest expense and the amortization of debt issuance costs for our convertible senior notes due 2025 (the &#8220;2025 Notes&#8221;) and our convertible senior notes due 2028 (the &#8220;2028 Notes&#8221;), as well as effective interest expense on our deferred royalty obligation related to GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The year-over-year increases from 2022 to 2024 were primarily due to a higher effective interest rate on our deferred royalty obligation, driven by stronger sales performance of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loss on Debt Extinguishment</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2022, we recognized a loss of $20.7 million due to the total premium payment of $20.4 million and the write-off of $0.3 million debt issuance costs in connection with the repurchase of $144.8 million aggregate principal amount of our 2023 Notes in March 2022.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Gain on Sale of TRC</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized a net gain of $266.7 million for the year ended December 31, 2022 due to the sale of our ownership interest in TRC to Royalty Pharma, consummated on July 20, 2022.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Fair Values of Equity Method Investments and Equity and Long-Term Investments</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in fair values of equity method investments and equity and long-term investments, net, as compared to the prior years, were as follows:</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:27.369%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:9.216%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.897%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.697%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="12" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity<br/>&#160;&#160;&#160;method investments, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,253</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(77,392</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">161,749</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,645</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(239,141</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(148</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity <br/>&#160;&#160;&#160;and long-term investments, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,161</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(11,129</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(8,462</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,290</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,667</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:13.158%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*    Not Meaningful</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The changes in fair values of equity method investments for the year ended December 31, 2024 were unfavorable mainly due to the decrease in Armata&#8217;s stock price. We recorded $64.3 million in unrealized losses, $77.4 million in unrealized gains and $152.5 million in unrealized losses associated with equity investments in Armata for the years ended December 31, 2024, 2023 and 2022, respectively. The changes in fair values of equity method investments for the year ended December 31, 2022 also included $9.2 million in unrealized losses from our then equity investments in Entasis before the acquisition in July 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The changes in fair values of equity and long-term investments year over year reflect the realized gains and losses and net unrealized gains and losses in our strategic investments in Armata, InCarda, Gate and ImaginAb, and those investments managed by ISP Fund LP. We recorded $2.3 million in unrealized losses and $23.8 million in unrealized gains for the year ended December 31, 2024 and 2023 related to our other long-term investments in Armata.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 6, &#8220;Equity and Long-Term Investments and Fair Value Measurements&#8221;, to the Consolidated Financial Statements for more information.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income tax expense, net, as compared to the prior years, was as follows:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:27.369%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.2170000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.897%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.697%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.897%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.697%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(380</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(52,311</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(78</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, 2023 and 2022, we had net operating loss carryforwards for federal income taxes of $520.6 million, $543.5 million and $411.5 million, respectively. As of December 31, 2024, 2023 and 2022, we also had state net operating loss carryforwards of approximately $1.0 billion which will expire beginning 2030. As of December 31, 2024, we had state research and development tax credits of $33.3 million.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024, 2023 and 2022, we recognized $14.0 million, $14.4 million and $66.7 million, respectively, of income tax expense, mainly based on the taxable income generated during those years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our total unrecognized tax benefits as of December 31, 2024, 2023 and 2022 were $61.3 million, $19.4 million and $16.3 million, respectively. The increase of $41.9 million in 2024 was primarily due to our strategic intercompany intellectual property alignment across different jurisdictions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Utilization of net operating loss and tax credit carryforwards is subject to rules, provided by the Internal Revenue Code and similar state provisions, governing annual limitations tied to ownership changes. We conducted an analysis of the Company through December 31, 2024 to determine whether an ownership change had occurred since inception. The study concluded that it is more likely than not that the Company did not experience an ownership change during the testing period. If we ever undergo an ownership change, the utilization of the pre-ownership change net operating loss carryforwards or pre-ownership change tax attributes, such as research tax credits, to offset the post-ownership change income may be subject to an annual limitation, pursuant to Sections 382 and 383 of the Internal Revenue Code of 1986, as amended. Similar rules may apply under state tax laws.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, $154.8 million of Entasis&#8217; federal net operating losses and $365.8 million of La Jolla&#8217;s federal operating losses from the acquisitions in 2022, both subject to annual limitations, were available for future utilization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Organization for Economic Co-operation and Development (&#8220;OECD&#8221;) Inclusive Framework on Base Erosion and Profit Shifting (&#8220;BEPS&#8221;) addresses the tax challenges arising from the digitalization of the global economy. It aims to restore confidence in the international tax system by ensuring that profits are taxed where economic activities take place and value is created. On April 25, 2024, the OECD published the Consolidated Commentary (&#8220;Commentary&#8221;) to the Pillar Two Global Anti-Base Erosion (&#8220;GloBE&#8221;) Model Rules, incorporating all agreed Administrative Guidance that has been released by the Inclusive Framework from March 2022 through December 2023. The Commentary aims to provide tax administrations and taxpayers with guidance on the interpretation and application of the GloBE Model Rules. The Company is not subject to Pillar Two this fiscal year; however, it will continue to monitor the tax implications of the legislative changes if and when its non-U.S. footprint expands in the future.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Income Attributable to Noncontrolling Interest</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net income attributable to noncontrolling interests for the year ended December 31, 2022 was $6.3 million, which consisted of share of noncontrolling interests in TRC and Entasis. There were no noncontrolling interests for the years ended December 31, 2024 and 2023.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since our inception, we have financed our operations primarily through private placements and public offerings of equity and debt securities and payments received under collaborative arrangements. For the year ended December 31, 2024, we generated gross royalty revenues of  $255.6 million, net product sales revenues of $97.5 million and license and other revenue of $19.5 million. Cash and cash equivalents totaled  $305.0 million, royalties receivable from GSK totaled $66.0 million and accounts receivable associated with our marketed products and related arrangements totaled $20.4 million, as of December 31, 2024.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had two outstanding convertible notes, the 2025 Notes and the 2028 Notes, in an aggregate principal amount of  $453.5 million, of which $192.5 million and $261.0 million will become due in August 2025 and March 2028, respectively. Future interest payments associated with these notes total $24.2 million.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, Strategic Partners received a distribution of $110.0 million from the Partnership to provide funding to Innoviva for a strategic repurchase of Innoviva common shares held by GSK. On March 30, 2022, Strategic Partners made an additional capital contribution of $110.0 million to the Partnership pursuant to the letter agreement entered into between Strategic Partners, the Partnership and Sarissa Capital Fund GP LP on May 20, 2021. The capital contribution is subject to a 36-month lock-up period from the contribution date. The lock-up period for our initial contribution of $190.0 million expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. In October 2024, we made an election to unwind the capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adequacy of Cash Resources to Meet Future Needs</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that our cash and cash equivalents will be sufficient to meet our anticipated debt service and operating needs for at least the next 12 months based upon current operating plans and financial forecasts. Our long-term capital requirements will depend on many factors including the amount of our royalty revenues, sales growth of our currently marketed products, timing of regulatory approval of our product candidate and outcome of our acquisitions and strategic investments. If our current operating plans and financial forecasts change, we may require additional funding sooner in the form of public or private equity offerings or debt financings. Furthermore, if in our view favorable financing opportunities arise, we may seek additional funding in the form of public or private equity offerings or debt financings at any time. However, future financing may not be available in amounts or on terms acceptable to us, if at all. This could leave us without adequate financial resources to fund our operations as currently planned. In addition, from time to time we may restructure or reduce our debt, including through privately negotiated repurchases, tender offers, redemptions, amendments, or otherwise, all allowable with the terms of our debt agreements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash flows, as compared to the prior years, were as follows:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:31.859%;box-sizing:content-box;"/>
    <td style="width:1.341%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.288%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.341%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.288%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.341%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.288%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.341%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.288%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.341%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.288%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by operating activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">188,690</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141,064</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">201,726</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,626</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(60,662</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(63,786</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(66,761</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(56,634</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,975</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(10,127</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in financing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,453</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(171,839</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(55,568</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158,386</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(116,271</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows from Operating Activities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash provided by operating activities for the year ended December 31, 2024 was  $188.7 million, consisting primarily of our net income of $23.4 million adjusted for net noncash items of $172.2 million, partially offset by net changes in operating assets and liabilities of $6.9 million. Noncash items included a $123.4 million net decrease in fair values of equity method investments and equity and long-term investments, $25.9 million in amortization of acquired intangible assets, $14.0 million of amortization of capitalized fees and depreciation of property and equipment, $13.8 million in inventory fair value adjustments included in cost of products sold, $6.4 million in stock-based compensation expense, and $2.1 million in amortization of debt discount and issuance costs, partially offset by $12.6 million of deferred income taxes. The changes in operating assets and liabilities included increases in other assets of $38.2 million, inventory of $6.8 million, accounts receivable of $5.9 million, and a decrease in accounts payable of $4.6 million, partially offset by an increases in income tax payable of $41.5 million and accrued liabilities of $3.0 million and a decrease in receivables from collaboration arrangements of $3.6 million.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash provided by operating activities for the year ended December 31, 2023 was $141.1 million, consisting primarily of our net income of $179.7 million, partially offset by net non-cash items of $13.9 million and net changes in operating assets and liabilities of $24.8 million. Non-cash items included a $88.5 million net increase in fair values of equity method investments and equity and long-term investments, partially offset by $27.2 million in inventory fair value adjustments included in cost of products sold, $21.8 million in amortization of acquired intangible assets, $13.9 million of amortization of capitalized fees and depreciation of property and equipment, $5.8 million in stock-based compensation expense, $4.4 million of deferred income taxes and $2.1 million in amortization of debt discount and issuance costs. The changes in operating assets and liabilities included increases in receivables from collaboration arrangements of $14.9 million, inventory of $12.0 million, accounts receivable of $5.1 million, other assets of $3.0 million and a decrease in personnel-related, interest and other accrued expenses of $2.4 million, partially offset by a decrease in prepaid expenses of $7.9 million and increases in accounts payable of $3.8 million and income tax payable of $1.7 million.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash provided by operating activities for the year ended December 31, 2022 was $201.7 million, consisting primarily of our net income of $220.3 million and net changes in operating assets and liabilities of $6.9 million, partially offset by net non-cash items of $25.4 million. Non-cash items included a net gain of $266.7 million recognized on the sale of TRC, partially offset by net non-cash charges of $241.3 million. Non-cash charges included a $153.3 million net decrease in fair values of equity method investments and equity and long-term investments, $25.0 million of deferred income taxes, $13.9 million of amortization of capitalized fees and depreciation of property and equipment and $5.6 million in amortization of acquired intangible assets, $20.7 million in loss on the extinguishment of debt, $7.3 million in stock-based compensation expense, $10.0 million in inventory fair value adjustments included in cost of products sold and $2.1 million in the amortization of debt discount and issuance costs. The changes in operating assets and liabilities included an increase in prepaid expenses of $21.4 million, a decrease in receivables from collaboration arrangements of $13.3 million and increases of $11.9 million and $10.0 million in accrued personnel-related expenses and other accrued liabilities and in income tax payable, respectively.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows from Investing Activities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2024 of $63.8 million included $59.6 million for purchases of trading securities, $32.3 million for purchases of equity investments managed by ISP Fund LP and $43.5 million in net purchases and sales of other investments managed by ISP Fund LP. Net cash used in investing activities was partially offset by $75.8 million in sales of equity investments managed by ISP Fund LP</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2023 of $66.8 million included $65.1 million for purchases trading securities, $31.2 million for purchases of equity investments managed by ISP Fund LP, $41.3 million in net purchases and sales of other investments managed by ISP Fund LP and $1.2 million for purchases of equity and long-term investments. Net cash used in investing activities was partially offset by $72.5 million in sales of equity investments managed by ISP Fund LP.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2022 of $56.6 million included $159.1 million in cash paid for the acquisition of La Jolla, net of cash acquired, $58.7 million in purchases of equity and long-term investments, $60.9 million in purchases of equity investments managed by ISP Fund LP, $50.0 million in purchases of a trading security managed by ISP Fund LP and $23.4 million in net purchases and sales of other investments managed by ISP Fund LP. Net cash used in investing activities was partially offset by $248.2 million in net proceeds from the sale of our ownership interest in TRC, $24.3 million in sales of equity investments managed by ISP Fund LP and $23.1 million in cash acquired through the consolidation of Entasis.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows from Financing Activities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in financing activities for the year ended December 31, 2024 of $13.5 million included $14.8 million for the repurchases of our common stock under the stock repurchase program, partially offset by $1.5 million in net proceeds from issuances of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in financing activities for the year ended December 31, 2023 of $171.8 million consisted mainly of the repayments of $96.2 million upon maturity of the 2023 Notes in January 2023 and $75.7 million for the repurchases of our common stock under the stock repurchase program.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in financing activities for the year ended December 31, 2022 of $55.6 million included $165.1 million for the repurchase of convertible subordinated notes due 2023, $69.8 million in distributions to noncontrolling interest, $43.9 million for the purchase of Entasis noncontrolling interest, $21.0 million for purchases of capped call options associated with our 2028 Notes and $8.5 million for the repurchase of common stock. Net cash used in financing activities was partially offset by $252.5 million in net proceeds from the issuance of our 2028 Notes.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contractual Obligations</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our notes payable obligation included $192.5 million related to our 2025 Notes and $261.0 million related to our 2028 Notes, which are due in 2025 and 2028, respectively. Under the terms of the 2025 Notes and 2028 Notes, we will make interest payments of 2.5% and 2.125%, respectively, of outstanding principal. Refer to Note 12, &#8220;Debt&#8221; to the Consolidated Financial Statements for more information.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our short-term and long-term obligations also include contractual payments related to our operating leases amounting to $3.0 million, with approximately $1.7 million payable in 2025 and approximately $0.4 million payable in each of the years 2026 through 2028. Refer to Note 13, &#8220;Commitments and Contingencies&#8221; to the Consolidated Financial Statements for more information.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our acquisition of La Jolla, we recognized its deferred royalty obligation in connection with La Jolla Royalty Agreement with HCR. Under the terms of the Agreement, HCR is entitled to receive quarterly royalties on worldwide net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> until either January 1, 2031 or when the maximum aggregate royalty payments have been made, whichever occurs first. Quarterly payments to HCR under the Royalty Agreement start at a maximum royalty rate, with step-downs based on the achievement of annual net product sales thresholds. The maximum royalty rate through December 31, 2023 was 14%. Starting January 1, 2024, the maximum royalty rate was increased to 18% based on the terms of the Agreement. The La Jolla Royalty Agreement is subject to maximum aggregate royalty payments to HCR of $225.0 million.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we have certain contingent payment obligations under various in-license agreements which we are required to make royalty payments or milestone payments upon successful completion and achievement of certain milestones. Refer to Note 4, &#8220;License and Collaboration Arrangements&#8221; to the Consolidated Financial Statements for more information.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also entered into a Commercial Supply Agreement with Corden Pharma CHEN&#212;VE SAS (&#8220;Corden&#8221;), under which we engaged Corden to manufacture and supply certain products related to XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and to perform certain services and studies. Under the agreement, we committed to minimum purchases through December 31, 2027. As of December 31, 2024, we have approximately $26.4 million U.S. dollar equivalent in outstanding purchase commitments under this agreement.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also enter into agreements in the normal course of business with vendors for manufacturing, clinical trials and pre-clinical studies, and other services and products for operating purposes.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_7a_quantitative_and_qualitative"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our debt bears fixed interest rates and we had no outstanding debt with variable interest rates. Our cash flows on these debt obligations are not subject to variability as a result of changes in interest rates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to changes in the fair value of certain of our investments in equity and debt securities. Fluctuations in the underlying fair value of the investments could result in material gains or losses. Refer to Note 6 &#8220;Equity and Long-Term Investments and Fair Value Measurements&#8221; to the Consolidated Financial Statements for more information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inflation has increased during the period covered by this Annual Report on Form 10-K and could continue to increase for the near future. Inflationary factors, such as increases in the cost of our raw materials, supplies, interest rates and overhead costs may adversely affect our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, we may experience some effect in the near future if inflation rates continue to rise. Significant adverse changes in inflation and prices in the future could result in material losses.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may face foreign exchange risk as a result of entering into transactions denominated in currencies other than U.S. dollars, including contracts with international vendors related to raw material purchases. Our royalty revenue from RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is also indirectly exposed to foreign exchange risk as GSK also markets and sells the products outside the U.S. The majority of our cash and cash equivalents, investments, and the majority of our vendor relationships are denominated in U.S. dollars. Therefore, we do not believe that the risk of a significant impact on our operating income from foreign currency fluctuations is substantial.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:93.8%;box-sizing:content-box;"/>
    <td style="width:6.2%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:0.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and December 31, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_income"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Income for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_comprehensive"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Comprehensive Income for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_stockholders"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_consolidated_financial"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#reports_of_independent_registered_1"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID </span><span><ix:nonNumeric id="F_cfe69821-5da8-4889-8e61-dffc8135c80c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:AuditorFirmId"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">34</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">)</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;" id="consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED BALANCE SHEETS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:67.313%;box-sizing:content-box;"/>
    <td style="width:1.5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.843%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.843%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6efc04c5-f61c-4ceb-8193-75e1f9df53bf" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">304,964</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cdff214-b793-4b31-8011-94ad3600aae9" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193,513</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7474de17-3465-4e61-8fbe-bce6f1b49159" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AccountsReceivableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d11e5421-a48a-46e5-9163-55b89058731e" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AccountsReceivableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,454</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivable from collaboration arrangements</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_366fc998-e441-4f0f-9828-83852eb83b9f" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:ReceivablesLongTermContractsOrPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,974</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af90d6ae-a967-4179-b43d-01cda3b7e284" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:ReceivablesLongTermContractsOrPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,621</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7e42af4-a471-4c7c-800f-846063601f49" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,725</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_680aa328-dbc5-40cb-b726-9a40358fae5c" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,737</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c433b6a-0490-4ed4-9711-f8bce27802b3" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,063</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2eba860-4336-4af1-8d2c-35305d712f46" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,630</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of ISP Fund investments (Note 5)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a4267a8-af81-4603-982e-5f98bef36505" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CurrentPortionOfISPFundInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,532</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15143c8b-79cc-4a96-ae5f-b2c405884256" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:CurrentPortionOfISPFundInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58cbb85d-f19b-4a01-8038-578a1b9d8112" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">656</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9682b8f2-a5ed-4371-b59b-b67534483f16" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,264</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f6b12d3-8abb-4b6e-b599-43511e60dcd4" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">554,306</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fc7d6fe-81fb-4ee3-b2ed-67bcb400f393" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">344,219</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_338c18f7-c46e-41ab-950d-f9336e0e4907" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">514</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af4cc16f-9132-497f-9562-d61cd2283861" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">483</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity method investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_782ef824-fe3f-400e-a5b1-d992c4e3250b" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:EquityMethodInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,293</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f817785-fa0b-44c9-bd50-f533610ca037" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:EquityMethodInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116,546</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8bf4f67-d8c9-4e83-8792-ecf3dd644781" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">341,664</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14c059b2-6bf0-44cf-8ad8-c9687f7f6cfd" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:LongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">444,432</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized fees paid, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98431724-6e88-4518-a336-0102a0111c22" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CapitalizedContractCostNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,961</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb393a9c-a24d-46a7-b9d9-b6547210cc8f" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CapitalizedContractCostNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,784</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65f9e7a6-e2cb-4c4f-b38d-5a4e26f167c5" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,453</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c575f671-e242-4624-91d0-f587863b48b8" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,536</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_395cf1d1-cd2e-4712-b039-9262e95fd38c" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4fe4457-1a3e-4197-b741-8d20185e5a93" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a8fa20e-c010-4214-80b5-b8b8d83eb664" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,433</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b04e15b-4b14-442f-a2cd-110c14b3c378" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">230,335</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_895cc1ee-7db4-44ce-b4c2-3eca57f4feab" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredIncomeTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,054</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ae67f68-81aa-41b0-81f1-7f919c1a449a" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredIncomeTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19830fff-a9b4-44ee-bebe-f117992f9f30" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,477</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_105ae972-70d5-4ff4-b688-1d4ef25c3247" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,267</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2477546b-9d03-4c6f-bd6b-c659b39b8f12" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,301,060</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63a33105-5dc3-41eb-812c-5b4899dba618" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,243,507</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders&#8217; Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f28ce32-2301-4ce8-9ef6-ed269db6425e" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,132</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b434930f-70d8-4f21-bc01-c06aeae684d2" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,717</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued personnel-related expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d1943d2-50de-4feb-ae8c-961eefe8584b" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,376</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72f24409-36bd-42f4-8714-80a7b643bb78" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,020</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued interest payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a27725d4-dd09-451b-9448-61c941676f98" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,422</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8088685b-932e-4c8b-b36f-11bb6c03d141" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,422</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdbbee2c-7dfe-4ae3-8419-4eb619e5470f" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,126</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05881e29-a873-4dea-a283-2b30e8a5f9dd" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,277</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible notes, due 2025, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2cf11a3-48e7-413d-9fcf-19e8d49a7d03" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,028</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b9a9b6f-cccc-4195-8ada-4af525d64bf9" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3983122-f55e-4544-afd1-d9caa4068fc1" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,999</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2523184a-2f52-4f2c-b230-e38459633cbb" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,698</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0349524d-abe3-4eec-afe6-74a5c9d00150" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">236,083</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8aaa8331-4ef0-45ea-8315-4c3c1c69635e" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,134</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt, net of discount and issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59e1cafd-f426-42a0-b214-8832bc893e75" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256,316</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4b53fb3-dc59-4e39-b02d-c0d79b802820" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446,234</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c36f33b-9277-4c8e-90fb-54ea5b2c94cb" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,275</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb458f91-6d60-4625-8d50-d93e365b8b54" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71,870</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3b567a5-cfbc-4795-a241-c4b785685a44" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_202bfc5c-0f63-4632-84db-d3eee3286900" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">563</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax payable, long-term</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1021085d-4ed9-4f75-93de-49844687a5ec" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AccruedIncomeTaxesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,227</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca9ce562-a75a-4eee-8c08-65128ca0e205" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AccruedIncomeTaxesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,751</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_4cabf256-50af-4092-acd1-d2dc789b6957;"><span style="-sec-ix-hidden:F_91f0204f-f305-4ef6-8781-73091ff19f29;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 13)</span></span></span></span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock: $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46f43e95-41c8-44ac-ab27-2b1d35d0ea2c" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_85d1374e-8e63-4ef9-aa45-a1d124eb229c" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b09f74f-fc9f-416a-9acb-4cbeba6370e8" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d2766d4b-bf2e-4bb1-86b5-6ecb7a1eabbc" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">230</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized,<br/>&#160;&#160;&#160;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ec2c3c5-cd83-42da-af51-ea61fcfeb831" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_649bf47c-f400-42f0-aba6-615c2d6b0eec" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_10793e8b-8370-4ac6-b3ca-a30c1a397fe0" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2021b38f-88ec-4afd-a1ea-857767bffb12" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4da6ea6c-6c33-4585-a353-008d3e7b1911" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52cfac3d-833d-4c4e-bee1-8e6b508b09d4" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock: $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ba12bfd-b22a-440a-9717-57c460ad1c1d" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d435975d-2ee3-47b6-9d67-4773b58925b2" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03d94cc5-efed-464b-8274-cf3038f45ab9" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_aa670dbe-3a6c-4e5f-9228-884ed3dcbae3" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">200,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized, <br/>&#160;&#160;&#160;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84d935dc-c25a-49a3-9ebb-cebd69ae2c94" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_86f8dc61-f6e9-4c06-ac47-c7b92b6ab79a" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,665</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88b3667b-705e-451d-bd95-6350d2e791cb" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f5e555b9-99c1-4f88-9c87-b241f05a82a7" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,307</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;issued and outstanding as of<br/>&#160;&#160;&#160;December 31, 2024 and 2023 respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_556ccef1-96d1-4c2d-8906-26ab2a4867bb" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">627</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad25d3c4-e215-4221-926c-c052c79e1da6" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">633</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Treasury stock: at cost, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf03d94c-318d-466e-bc32-998ea1b3a797" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen">nil</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38b11c1f-c9b4-4cc2-afb4-42e26350b00e" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,005</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares as of December 31, 2024<br/>&#160;&#160;&#160;&#160;and 2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdbf2b56-90a8-4f6b-94ff-163e28a0d530" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:TreasuryStockCommonValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41384e48-7ee6-480a-ac5e-b815d8651cd4" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:TreasuryStockCommonValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">393,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66844d2b-8b98-4f28-9435-74ad6cfab7c5" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">692,329</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55b69e26-a5a9-4fcc-aaa8-6aa504840bca" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,093,340</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db062873-86cf-4121-a498-da24140baaf9" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,797</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81bde384-166c-4920-92c0-26ef5ed0492d" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,189</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3bf571c1-8436-4f37-a27b-a0d549a3e3f5" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691,159</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e112ca8-439b-41b6-b799-1e32d2a01bda" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">674,955</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5d79021-45ed-41fb-8948-d811c623a779" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,301,060</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36b7f0ba-c80a-4263-9607-208dd6c6c163" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,243,507</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_of_income"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF INCOME</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:51.311%;box-sizing:content-box;"/>
    <td style="width:1.481%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.75%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.481%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.75%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.481%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.75%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty revenue, net of amortization of <br/>&#160;&#160;&#160;capitalized fees paid of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3aaa2fa4-c851-4082-95ee-98b84fecd99f" contextRef="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_82006692-f098-460d-927c-fee0cc4a62ee" contextRef="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_85551e47-991e-4c65-9f4b-b2d525d56dd9" contextRef="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,823</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;in <br/>&#160;&#160;&#160;each of the years ended December 31,<br/>&#160;&#160;&#160;2024, 2023 and 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_717792be-0d1b-4f66-8e5a-633fb3a14936" contextRef="C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_024c23a0-3c27-4771-bc3d-f925a9035a4e" contextRef="C_fd08000e-5a41-4289-ae07-073ab3d62ab2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238,846</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fb1c5cd-4522-4573-bb01-06c3ced0fa95" contextRef="C_f2be4dca-4f14-4253-b3c4-7480e0834b43" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311,645</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net product sales</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_847ca1f2-29ea-4e6c-9b40-2ef44c297fdb" contextRef="C_360b25f8-0668-427b-a0a4-5664f61139d0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,492</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d8872b7-82e6-470d-916e-4336bcd35c37" contextRef="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,617</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a91be984-9d80-4959-ac79-dc6926b60eef" contextRef="C_5762c44d-7963-4357-b789-7869c9919cc7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">License and other revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f0257e0-f2b2-4cbe-9aab-0b499cbc2615" contextRef="C_be611a96-acf7-4e91-8069-ab705ba23648" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,486</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e02a6d1e-66a6-41fa-bdef-9f9bf1339810" contextRef="C_54ab6970-91f6-4ad7-97a4-6add8575d58a" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6321bc33-ecca-49a5-bd76-5cc5635ee559" contextRef="C_9208f331-1b10-4449-9538-3f9a7a38627c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aec191e7-34c1-4eef-9b02-3641ca11ba08" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">358,711</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93b42d11-12c7-4463-be51-bc9f067a5ab3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">310,463</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4017a9a6-c7ed-4673-9d46-0d6407284dda" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">331,339</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold (inclusive of<br/>&#160;&#160;&#160;amortization of inventory fair value<br/>&#160;&#160;&#160;adjustments, excluding amortization<br/>&#160;&#160;&#160;of intangible assets)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e00a9dc0-6005-4ce0-ad32-05e5251b5e7b" contextRef="C_360b25f8-0668-427b-a0a4-5664f61139d0" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,598</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3e005a9-284c-4211-8b32-079f02488381" contextRef="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,040</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82794611-2501-4d7c-82cf-99a309fc7bfb" contextRef="C_5762c44d-7963-4357-b789-7869c9919cc7" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,793</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of license revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05da7c49-a595-437f-8cea-dfc0692cb954" contextRef="C_d918b70f-a067-4ecc-8b5c-d40d7a0e5c75" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0311e90-7d60-4bd3-99a0-b2e692094f59" contextRef="C_72fa18ae-694c-4d8c-98c2-590805770243" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,600</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2550378-0576-4d34-9af9-3af4e66b2ae0" contextRef="C_be6fcc6f-ace4-45c6-be23-2f777937aa77" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling, general and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf4a05bb-c3b0-47eb-8070-59d73e192d59" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">115,690</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deac4a49-72dc-4969-87a7-16e84eb2daa6" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">98,232</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a58089bc-9470-4dd2-bea9-3fe9763fcc65" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,538</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52067835-2a94-4990-92ef-13c2eeb68180" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,654</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_907b4ca6-4a36-4ec0-ac8c-79b1a7f57bdb" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,922</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d14fa612-7302-4493-b814-7c32eb92ff14" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,432</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of acquired intangible assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29be79fb-db8f-4ba2-8195-40dacb43182a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,902</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_878f11e0-8842-4df0-9a54-a5b1937d1743" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,784</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ab3e33f-e2b0-42ce-a24c-15931ac1d77a" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,581</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of Theravance Respiratory<br/>&#160;&#160;&#160;Company, LLC (&#8220;TRC&#8221;)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63cd1610-16d8-414a-853e-a8d9399c551e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ec1723a-3485-4232-b482-75381fe3c9a9" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69ae3e8b-5792-447f-877b-b9258fd80777" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">266,696</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47232574-e52f-4a6f-bd8f-eb52f39ed0d0" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_495b5c81-65ae-4ed4-9372-538222d35857" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8067ca8-04c9-4287-84b1-a2c2f943dc65" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">20,662</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity method<br/>&#160;&#160;&#160;investments, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a729d5c2-0287-40b9-9361-8a5710aa4f8b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64,253</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bedfb541-cb56-458f-881d-91349680b2b8" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a059835-0fd8-4998-8c26-487b75a24ca1" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">161,749</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value of equity and<br/>&#160;&#160;&#160;long-term investments, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19e01537-c04b-49a6-8c74-fd1ac1ca10ae" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">59,161</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b3036f8-9c15-43fc-9cdf-c189ac925c60" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,129</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07bbf06a-e38a-45c7-9e6c-ce293db5b540" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,462</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04138e6f-d778-4998-9548-8a28b1c74e80" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,141</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f22a80b-dde4-497d-ba8c-a5f640a76c69" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,818</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dd6f2bb-c14d-4df7-abb9-e1eb70a34aa2" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,369</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1e8f25b-18b6-47f2-93c2-06985961ebdc" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,209</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0b573c5-36bd-4433-adc4-6713a1f816b6" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,157</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab078df5-ee5b-4cd5-bc9d-48ab3c553bea" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,789</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expense, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48641dcd-0be2-481e-acf2-de932afcb3bd" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,997</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59f96815-b5a7-417a-8f33-8c88e3395083" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,969</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af017015-c8f3-48bc-9f6c-30299d710d14" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,373</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_486d070d-80f7-491c-b445-14e6c4ec87c9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">321,323</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0ca2ff7-8de9-4ad9-a350-e21f77a5ad8a" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116,365</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a02ccbc-1869-4a90-8791-9b053ebdbf87" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,390</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income before income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1a580c5-776d-4c10-a908-25d3035c6e15" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,388</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1af5e54d-f87d-4227-8ed6-119451651c14" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194,098</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21eaf675-f15d-4d45-b392-be2b3d6e1b59" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">286,949</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d7402e1-3986-4417-96cd-49477c09cf9a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,996</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3534fb2f-760f-4bac-9c87-dee280e54b06" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,376</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5a883d8-d26d-418b-bc6b-47fb780f76c6" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,687</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7f67375-6090-461e-9c0c-f03cc944f618" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ba8177d-084a-420c-b4da-778e330c233d" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5236b33-7d20-4bee-9e71-b27e164c32eb" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,262</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to noncontrolling<br/>&#160;&#160;&#160;interests</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74824545-f55f-4e8d-a542-525c750db85d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa4e4f2a-bd37-4221-a896-252ba600441c" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0db8f0cf-3dd8-45cd-b2f8-5efb5c428c83" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,341</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva<br/>&#160;&#160;&#160;stockholders</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b47707d2-2bb3-4c51-a43a-abec7360e96f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42888d88-7770-43a2-8426-faf9f80c6594" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5ae664f-30d2-493f-9ef7-805c98d7e3d3" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">213,921</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic net income per share attributable to<br/>&#160;&#160;&#160;Innoviva stockholders</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_442b276c-4af9-44f1-a1ff-00c398461887" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.37</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0ff928c-2e15-4806-a8b6-e8fc782cc747" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00e2ffa2-e243-4106-aa34-169c3f454f42" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.07</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted net income per share attributable to<br/>&#160;&#160;&#160;Innoviva stockholders</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83b542de-5925-472d-b065-d44d38f08f34" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.36</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deacf18a-4b7b-4ab6-80bf-e3bf46b8b592" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.20</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e3a6160-0159-4165-8df3-6bbdea834c04" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.37</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares used to compute Innoviva <br/>&#160;&#160;&#160;basic and diluted net income per share:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares used to compute basic <br/>&#160;&#160;&#160;net income per share</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0ff05c8-acb4-442d-aefb-e052ef555f81" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,726</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ecac543-68d6-4240-b3a6-df64a528c189" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,435</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d52f204-33aa-4c2b-9f69-ad7db1664642" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,644</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares used to compute diluted <br/>&#160;&#160;&#160;net income per share</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ac6e2ea-c646-439e-b1b4-7e65f6ea77b9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,187</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ca8a0ca-f100-4c79-9125-bc63c7027066" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,876</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ac58a85-99ae-4d55-b31c-a7bf190c0af9" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,248</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_of_comprehensive"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:51.311%;box-sizing:content-box;"/>
    <td style="width:1.481%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.75%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.481%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.75%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.481%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.75%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d30ba2fb-3de8-40f2-9548-5fe29e395ef7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_572996a8-9117-47dd-8e5c-9fc623eb0a56" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32843a60-d6e5-42b4-9aad-d27a31b98c98" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,262</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive income</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea34b6ae-8081-43f5-bc5e-3f37081cf7e2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8bd8fb9-6c40-4f6d-88a3-aeafca316240" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fff29128-b948-45c9-9dd5-b2c4d046bb51" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,262</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive income attributable to noncontrolling interests</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57aa9935-73a1-4668-92f2-06def322291e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7574888-cfa5-4c45-b137-2c4068086c9c" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee29a015-4299-41b2-8fba-77232a677a83" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,341</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive income attributable to Innoviva stockholders</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fc0dfd6-087b-407b-aad9-65e6f5ef7672" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08eef643-ee9a-45ad-ab35-b6153a4caa04" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df290648-168b-4f7f-aacc-76bd161218c3" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">213,921</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.21in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.3in;z-index:-3;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_of_stockholders"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:19.992%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.198%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.818%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.037%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.617%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.198%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.437%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.896%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.817%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Treasury Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Noncontrolling</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders&#8217;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Interest</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of January 1, 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7eb6c4e3-87f6-40bf-aae7-3a0527912624" contextRef="C_1364b4a6-7f98-434e-8070-02bab731119d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,566</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7c8347f-f398-4810-9778-b4b7fc5f2b19" contextRef="C_1364b4a6-7f98-434e-8070-02bab731119d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">696</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f083c03e-60aa-4cfc-b8a2-c52e1285031f" contextRef="C_5fbfbbeb-63b0-4ede-a5c8-bf29e1de26a1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,264,024</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8db3131-5177-4e69-877a-eaf3f7d953ee" contextRef="C_b951258b-c9f5-4734-98aa-3ed6338a2801" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">456,148</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3ee797b-c0ef-4d48-b6f7-a3a5998508de" contextRef="C_852cf337-96b0-47de-a072-c0011a29adb6" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,005</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fea47ba-f705-40f8-bff2-d2eb65efe781" contextRef="C_852cf337-96b0-47de-a072-c0011a29adb6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">393,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d18f12f-411c-43e6-b115-606ab4912c98" contextRef="C_7d99aa1f-7657-4d34-8478-bfbf3e3c3acd" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,192</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4f5e19a-eee9-471e-989a-0123b63d7cb5" contextRef="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">525,935</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;"><span style="-sec-ix-hidden:F_9bdecfd3-61c0-44d4-a26f-95a46485d9fa;"><span style="-sec-ix-hidden:F_8fa11627-b6cc-4f9b-a343-8d27e9d135d2;"><span style="-sec-ix-hidden:F_88ddddc3-bea2-43a4-a260-09dfd3791459;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cumulative adjustment due to adoption of <br/>   ASU 2020-06</span></span></span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c5f267a-d338-4578-bb66-7619855505c7" contextRef="C_583c4930-0807-43ad-bc97-189170841090" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e50d7752-3072-4791-8d99-1f74a8e9f941" contextRef="C_583c4930-0807-43ad-bc97-189170841090" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bf1bfec-fd3f-44b0-942a-0d1a22a867e8" contextRef="C_ff809d6a-b516-4d09-8eb7-0d3d1386fd58" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">65,467</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21e8594a-177d-447e-ba78-aabd382aa24d" contextRef="C_af51ee90-6870-494b-817f-7bb0769ffdb3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,238</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d79c8d34-093e-41c2-8c4e-e99cbb69fef2" contextRef="C_4f80e919-076e-4576-9834-4ff10cef76db" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ce31115-ddcc-4951-b350-4fbeb749b899" contextRef="C_4f80e919-076e-4576-9834-4ff10cef76db" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f50ce7b-de82-4e15-95a9-3b5648c5602f" contextRef="C_092b5b62-561c-49b9-ba98-6e6b2d653e5c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1194c3b0-3562-4f1a-8c54-18b70d376f0a" contextRef="C_17017b2a-0317-4eb0-952e-a435e24f4125" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">28,229</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Distributions to noncontrolling interests</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76b26c19-a055-48ef-9dd0-25e39c7095a4" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1d96c87-8b9f-43fe-8ecf-1c35cdcd4ac3" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47a13618-6a72-44ed-bcee-d2381ed950db" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5caca0de-63b8-4dd4-aa82-6b2379fe4f43" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0e363de-e435-4434-b14f-8b302a437299" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_600492ce-5d76-4eaa-9353-e3a3628826ae" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dce01298-221f-434e-8167-f052e081c196" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,811</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d7512a1-2e9d-45be-9fef-892286525a05" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,811</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Recognition of noncontrolling interest upon<br/>&#160;&#160;&#160;initial consolidation of Entasis</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d8e999a-45ca-45fd-b0ae-b1e880b2bab1" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa657369-fb5e-48f1-9e27-0e34144919be" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb9cc19c-bf12-4ae1-919c-b912e649f35a" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8aab755-1956-47fd-8e0e-f32ebc3ec6c6" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcc70339-3b55-4870-b06e-5cd422b24018" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f21143cd-23d3-4cc7-ab3b-30986470b5ce" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ba10049-49aa-4381-ba62-00f3f8430c31" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,471</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea98fe6d-0a58-4380-bfad-dcf3b13b027f" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,471</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity activity of noncontrolling interests in <br/>&#160;&#160;&#160;a consolidated variable interest entity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f310e8f-d62b-4edd-a67b-cf51b16304fa" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8f886fc-c7c0-4d8f-96f8-1388dc64b5ac" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da0fbccf-0b7a-4093-80ce-9c54ee76e1e2" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78f61478-664b-4b67-b5c8-2ac32c6e3a38" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derecognition of noncontrolling interests upon <br/>&#160;&#160;&#160;sale of TRC</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9f9c99f-6689-4e27-b973-0a4735c02c9a" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_325bf534-c0e6-427f-a12e-5927c28b73a1" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60836452-f3f6-4056-94d7-4ee22841cf7c" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3857a655-23b5-4df3-9d28-f25d784281c7" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f66c51f3-e8ff-4523-a437-b4feea291017" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_322daa27-b87f-4e5f-aaec-6ba95d5f214e" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdcde935-a606-4167-be89-504ca3143658" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">61,304</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d5769a6-bc71-4a85-a65b-ee9a994f0144" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">61,226</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derecognition of noncontrolling interests upon <br/>&#160;&#160;&#160;acquisition of Entasis noncontrolling interest</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e91e9e0-ee65-492a-a402-c93f02fa13e0" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06bd7c7f-82ce-4634-8098-6bd0f0797575" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cfa63bc-79c8-4eac-bbfd-6c17309ff993" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,153</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98111606-1a2c-49a3-899f-c96ec24bd3ce" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75d6d93c-505c-45cb-9794-a35cc98f1c01" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c010e405-1277-4da5-904a-20ffb87548c1" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91fef696-ed5c-470b-a51d-ea086ed5f938" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">28,009</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebab3a7e-16f7-4b28-a302-d6a4df428263" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">42,162</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of stock options and issuance of <br/>&#160;&#160;&#160;common stock units and stock awards, net of<br/>&#160;&#160;&#160;repurchase of shares to satisfy tax withholding</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf513847-e10d-40e9-be29-e1016e4f63e8" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">269</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63910498-d935-48a0-a2d4-2b90eb62cdeb" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5262eb77-6c8d-4be4-8509-38a8a72f5f0d" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">286</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1fc999b-8020-4c2c-bc0c-04c89e1ae824" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2b83c49-63cd-46ac-ba47-4c734f80ce13" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb2f5f0e-2a2e-4a91-b7cb-16658ad0d9cf" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8262cec5-5396-4ef6-bec6-50c80c99e2db" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_356e6a87-81b6-4efe-b1a3-7552d76f7e59" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">288</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capped call options associated with convertible <br/>&#160;&#160;&#160;senior notes due 2028</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4cc0364-3aa9-4c69-8ea0-83e798aefc15" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a092e585-8143-448f-ac72-34de6fb22001" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec5ef41d-0e73-414c-a53b-9022a295238d" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16,585</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc1ef9ad-149d-4dc9-8e98-bc4888090345" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb2b4773-f59f-4aab-b595-92b1176532b9" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4a48c99-74f4-44c2-9c4e-35b3d34dbf67" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4319a80-d4dd-411d-a7e0-f7042796433d" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebe2b7af-d23d-479a-8355-2dd256bd9f0b" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16,585</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible subordinated notes <br/>&#160;&#160;&#160;due 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67b7afb8-5da1-4800-91db-ea6f2b9a7fa3" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2dd344b-9479-4c76-adcb-511249f8bddf" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5525a15b-d88e-4fc8-8013-97d5f17afb88" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d437e55d-61db-40e0-8378-9b040097d757" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4714561-69ee-49f4-8903-fcd2c97fe0af" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95bb5768-782f-4402-8be2-044d3d548609" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cfc9d27-a0ed-47e2-97a3-f291164def93" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1bc9282-542f-4c36-acca-65e3231972c6" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b5d448d-0c0d-46fc-8ace-a4cdb8b7f183" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:TreasuryStockSharesAcquired" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2210cb2a-722c-4e4c-b8a2-4a4592cdc6ed" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:TreasuryStockValueAcquiredCostMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d80cbd0-2ce7-43f6-94c4-09e28d9b620d" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:TreasuryStockValueAcquiredCostMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,497</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95987b19-2a0d-46c7-930a-3e914982ec99" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:TreasuryStockValueAcquiredCostMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56684150-76d2-48b1-b8a7-68f1435cb5be" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:TreasuryStockValueAcquiredCostMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02939fc6-90f5-4b4e-aa67-e273f884f9ef" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:TreasuryStockValueAcquiredCostMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,503</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1a7f62d-095c-4f51-87c1-5ebed5f1da4d" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35435e6e-40e6-45cf-9642-64dde87d5a5d" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_802a3915-8ef1-46ec-a30e-3a80abd09176" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,225</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d572309-e3e8-43c9-90a7-2d6e16bdc5c6" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_541d9a86-be85-41c7-8d09-472d344ef011" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_299c64a4-d880-447d-9a42-6e774a79c00b" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea773859-edbd-4eda-93e9-f54bc3540484" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,122</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8ced32c-68c5-4df2-b00a-6032daba756b" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,347</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d69fe57a-c036-4086-a575-dc99aca7046f" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:ProfitLossShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cbce144-6147-487c-9ed4-22abc7c245bb" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8de13b37-899a-4399-80a9-64372d7ef038" contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29ea490f-de38-4b8e-80e6-88e2f90274a3" contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">213,921</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5b0ec52-b6e3-4494-91c6-f7b042c215b9" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="inva:ProfitLossShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b463432-0f36-4afb-ad5e-e6dbf030be2c" contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_545b6e23-d71a-41d6-9f56-6cb576cf962c" contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,341</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7a044a5-8d05-4232-8c12-99e09723b3b6" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,262</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b22bb6a-d041-4c3f-b43c-fed5a6d3084b" contextRef="C_1f0576c0-c074-4ef6-8698-a676d24560da" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,188</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c39f0e64-2947-40d1-a8c8-7588b678d19c" contextRef="C_1f0576c0-c074-4ef6-8698-a676d24560da" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">692</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e5161f8-85ed-488e-aa44-676c0cc7025c" contextRef="C_83aa808a-93a1-4297-9265-8d2fb9dc5612" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,163,836</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee859403-23ad-470c-b36b-f355e586a1a8" contextRef="C_aeb0943d-6820-41d1-ba88-baf408a51c23" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">204,911</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5db05310-02e9-4801-99cc-d3a8d54fe73e" contextRef="C_3d95a88c-d5b6-4806-8dd1-644e4672cd1a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,005</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a9bdde1-761c-4405-9b62-5db5cefdcf9d" contextRef="C_3d95a88c-d5b6-4806-8dd1-644e4672cd1a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">393,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75b1c059-e2b9-4a57-b787-97a6b3741bef" contextRef="C_85db9a42-0ded-4419-91f0-f3010d32ac6f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ca33411-c544-47f6-bffc-4afe03ddb7ad" contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">565,788</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of stock options and <br/>&#160;&#160;&#160;issuance of common stock units <br/>&#160;&#160;&#160;and stock awards, net of <br/>&#160;&#160;&#160;repurchase of shares to satisfy <br/>&#160;&#160;&#160;tax withholding</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cf91f63-27f6-43d8-b301-5d869a3f047a" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eadbbaef-ce33-400c-8000-05c3e264679c" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4375fa17-2406-45ef-a932-b17baa5d67a6" contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b3a9e95-2b5a-435f-8435-fce005d8996f" contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_388a6be0-7362-4b29-80c8-5c6f5ec513b9" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25b3f73f-b26d-40c2-887f-705a53605049" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6f44651-ca67-43d6-a615-8a5c29e0788e" contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9cd3156-27b7-4e5d-bf51-d289e6a2ace2" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of common stock, including accrued <br/>&#160;&#160;&#160;excise tax</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25b9607c-e13e-4ba4-a467-e44353be24a5" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax" unitRef="U_shares" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,174</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_acae5009-d1e0-4238-9001-23fe932c763e" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">62</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d655eac1-4b98-4d0d-8fb6-41e7024cfe09" contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">76,422</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88ff295e-530f-4a30-b980-9b961aa22740" contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a26d8b52-aa1c-43f6-b87f-0c69b4df7138" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6417e35d-b487-4683-a695-1a961d1cacce" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee891ab3-14bb-4c50-a8df-971eda478425" contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a316f2d-a059-4718-b677-558c513e1231" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">76,484</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_040ce5e7-37c5-467d-bbc8-04f70fc455b5" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12d00278-15ae-4d18-bbae-6066cca7af0e" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_594b0e04-3e14-4a8f-8416-ba212e6fb806" contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,837</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c93c7b3-f560-4b8a-b7c2-2799fc6fa6c5" contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79d6d807-de65-4509-b6a5-a3fceb8c1197" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="us-gaap:TreasuryStockSharesAcquired" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_923406b0-51a3-412c-9c7c-34f19fb6cd98" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0577b77-efb2-4397-845d-ee44273f9737" contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33eaf641-bd49-437d-a5b8-0c576a07dbd1" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,837</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_347ba7ee-fb55-4e5f-9d64-338f4bbc9839" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="inva:ProfitLossShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cef67391-37b3-4e50-a510-8a5f35161ebb" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_efe781f8-4173-4763-b1f6-4a276a7f70fc" contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e27aa83-d643-41e0-99e0-c94737836d68" contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8229114-c5c2-4d5c-869c-fb3afdaf2f63" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="inva:ProfitLossShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3b5ba93-6557-48a6-9835-998fd8a9c220" contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1710383-0f68-43fb-a40d-88fa721d5ee5" contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_acc33b04-c6e3-43b0-9073-d739448e6bff" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_878081e4-b1e9-452a-b396-8e68b58b1012" contextRef="C_97c0d4eb-5564-4c2c-b25d-1d764e044c4b" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,307</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d0acf33-a1c2-4dd3-92e3-83ce521c5223" contextRef="C_97c0d4eb-5564-4c2c-b25d-1d764e044c4b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">633</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb28dc19-d34a-40aa-9b76-eec686d85453" contextRef="C_6b58e123-d309-44b2-808c-8e368c6f5f3f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,093,340</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9be625f4-2448-4827-b84e-3cd70ea61ce1" contextRef="C_9335e429-20b3-46f5-9a0a-fb45ea5dce99" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,189</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75ba76a5-ce7d-4186-b5d2-b62a8e94f4e6" contextRef="C_9a129dd3-6622-4125-9532-5a2fc9756798" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,005</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_512206e7-2108-45fe-a648-d994808821d7" contextRef="C_9a129dd3-6622-4125-9532-5a2fc9756798" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">393,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_402dbf1d-8c13-4610-bdc5-bd6f8dcbdb7c" contextRef="C_9b0d84ea-e834-4ea8-a1b5-32f0bbdd41f3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9feeb81d-a056-474c-870a-4159926438fa" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">674,955</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of stock options and <br/>&#160;&#160;&#160;issuance of common stock units <br/>&#160;&#160;&#160;and stock awards, net of <br/>&#160;&#160;&#160;repurchase of shares to satisfy <br/>&#160;&#160;&#160;tax withholding</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c55d95f-cd28-4ec9-9e77-f1e4d8cf79bc" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a822e95b-5ef3-473a-a892-436c5e763481" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb9173a7-e12b-4829-8b72-f9b0ea6b5952" contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,321</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e01aab47-1365-4d8b-a0ea-1cb711ef459f" contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad3158c6-195a-426c-ad4f-02d37d1837c3" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d6dfd12-d375-4a79-9ef4-9d9fa56bbc01" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8da533a-cdcc-4181-96f9-6d48df2e5b5a" contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_353ea91c-efbd-4689-82c8-755aba4747a2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,324</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of common stock, including accrued <br/>&#160;&#160;&#160;excise tax</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cf2e7ea-8a0b-4437-8e59-1744118ae63e" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax" unitRef="U_shares" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">987</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdec26d9-0872-4524-b0fd-6d56c20d2a80" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5285ae1-dfed-4cb7-abd8-c16719662d58" contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,916</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11e45415-1b62-4c90-a686-b404646db863" contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2b6de88-e0d0-4f1a-9978-b9764212d6e9" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ca3ed85-d6bc-4beb-898c-47bca67a23fe" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfe5318d-5ac7-44ce-a95a-b8e5a80d346f" contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_daa5db42-9de9-4acd-9102-f16681e14028" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,925</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued excise tax on common stock repurchase<br/>&#160;&#160;&#160;applied against tax liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89e4a158-514a-4926-8440-53fad7766c37" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73753983-02af-40a3-b6a5-5ca267af4be6" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5250ece2-af91-472a-aff4-a77314c0819f" contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1e4ba87-1417-41cd-bd28-7e674743911f" contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4e0a033-283e-442a-bee4-8039ead41e83" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c17ebea-2889-42d6-aba9-ef50675cdae0" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4aa3785-496f-4a20-b75e-e5c4e62d8b96" contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91a8e7ce-2ac5-46bd-950e-985102eaff20" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fb75378-4c88-4ee4-8478-e2d97296c8c5" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0211dfb3-6262-4d8f-9549-4273e4a9fa06" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adad260b-7e7a-41bc-9014-89fa0cfda43f" contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c90a06c8-1c8f-4c6e-9499-88b97f19f69d" contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de62fa0e-b36b-4859-98e0-96325a50aeea" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f690c85-5115-4e3a-8cd8-0e2647a3b2de" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5941b57a-5f3c-4018-bf57-515d6efe34cd" contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bcf2717-8510-46d3-8703-08b1d91e4d2f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Retirement of treasury stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a1b7c82-559c-4420-923b-97168254822d" contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">393,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfbe6c9e-3b05-433f-809d-48b0c3767297" contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa2158ba-a995-4933-acdb-2ce34ed4c025" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="U_shares" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,005</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0b547b7-1b0f-4709-94cb-13ae627eb105" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">393,829</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82a9e0ef-3ce7-44a9-832b-2ca383178b9e" contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49449a02-fe5b-45a3-8571-8114738dc66d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_078c4d6b-d554-4a2c-898d-c5fd785697df" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="inva:ProfitLossShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab7f10f4-f2df-4284-8098-7ef91eab0392" contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a547f69-8295-4cad-a113-b6ae32c87deb" contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dcb128e-7484-4e02-8ea2-c55801b32709" contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ab0f72a-0136-4f1c-a22e-1a5504b8f30c" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="inva:ProfitLossShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4e57bc4-7965-4603-9ffc-396d71de184c" contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07baafa5-e0e5-45c6-9259-b3899e281308" contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96bb9393-d229-49c8-bd01-4cdd3f32bf35" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71845428-3f2d-4a42-b3b1-75cd930acf85" contextRef="C_8d72d20d-c777-4e45-a1e5-dce95ab96806" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,665</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d89118af-a636-4eb8-b507-f36f40eda570" contextRef="C_8d72d20d-c777-4e45-a1e5-dce95ab96806" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">627</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ac62ed0-cc1f-4ef3-b6f3-0a45c7430f43" contextRef="C_13694843-7358-454e-8001-380c30620343" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">692,329</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_723aad25-7c91-44e6-a2f4-e3392c7e1da0" contextRef="C_b4acd677-0951-457f-af07-c89710826848" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,797</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4a7d09f-091a-46dc-88c8-44b37350abdf" contextRef="C_fec8182c-e2df-4822-bd54-8e84d5ba717c" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9847d1e3-152c-4958-a868-fa1e7efb5c98" contextRef="C_fec8182c-e2df-4822-bd54-8e84d5ba717c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fe40571-b2de-47f1-9f34-1f9f947c39e9" contextRef="C_e2ddb70e-8dcc-43a9-a5a3-84d4f1674565" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a08e912a-458b-47f0-aa54-ee6d8290a883" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691,159</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.22in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.3in;z-index:-3;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.22in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.3in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_of_cash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:52.619%;box-sizing:content-box;"/>
    <td style="width:1.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.435%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.435%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.435%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01c337c1-8787-4f02-9754-c89a0a0346ab" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37b21f87-4c1c-49ca-a5ef-e852c0540025" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c3489a1-8453-4a18-8428-f46017223c6d" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,262</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net income to net cash provided by operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3f61748-1d6d-4ee4-9704-cf5dc7494641" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12,617</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b711070d-8112-479a-8167-fe8782ffe6c6" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,400</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03000c65-ff0e-4927-80a8-5b870366dcce" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,006</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of capitalized fees and depreciation of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca6f7f15-24b9-4eb4-869c-e5b4eb820473" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,951</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9361aef1-01f2-448a-8bba-2bee02362ac9" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,921</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84ce82e0-cf23-437a-897c-3a29ecf26201" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,931</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of acquired intangible assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc76706e-82a9-4293-9735-6c8eb08dab39" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,902</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a149552-d1f4-4668-8fc6-548cf09b818e" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,784</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e1b2964-9544-4edc-b07a-6fe92399db24" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,581</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory fair value step-up adjustment included in cost of products sold</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4d8874f-b0b6-41ef-af8b-8d3ae093a4b7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,820</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9ff0552-3891-4f77-867c-d3cfd0d5a93b" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,164</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af6484cb-3d34-408a-89ef-228302aa4cb7" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,023</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0fee87e-aa05-4c0f-b22d-0b5260fadef1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7f4a8b1-95f9-4b2f-8c58-db2ca1b221c1" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,837</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_321f99d4-d8f0-4491-8498-3fb4a25c9a58" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,347</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt discount and issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea7be3c2-1a84-4513-a6d0-dc92cfb14108" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,110</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1258932d-7a74-4f1e-a79c-39a02a5d70ce" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,065</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0978a45-717e-42b9-a0cf-c4cc1c6641c3" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,055</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity method investments, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eef40542-edeb-4532-abd2-d93d515da468" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64,253</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48a99c7c-0874-4e8b-ae7f-9e05847d9167" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,392</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5c1aaf5-ba52-48ec-85f8-0a93a5b99bfc" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">161,749</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and long-term investments, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_788c2eca-2eeb-45af-b246-486b7001afd2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:UnrealizedOtherGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">59,161</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6c81b0e-3db8-40ba-8ba8-b991dc7d3dc6" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:UnrealizedOtherGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,129</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_671ab517-6bda-4858-a060-790aae64d88f" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:UnrealizedOtherGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,462</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e495e88-aa67-4bbc-99ef-2449236b49e1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d544f800-5f00-42f1-9c64-04befbd12e48" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b097a7a7-5ee3-4c18-8580-9b86df2bc483" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">20,662</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net gain on sale of TRC</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97a675ba-af25-468e-b28e-367a68f37449" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84270da9-5648-4f33-b0c7-134209eba715" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdfc2281-44d5-41be-b471-76b18426b9ea" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">266,696</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other non-cash items</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28aab1d9-eb01-4f44-8b38-a078e8a23874" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35e270ba-f82c-4e4b-959f-f140ea90ac80" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">517</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6bd122b-a8ce-4d52-ad31-caba7e6bb102" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,402</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8751e79c-6c2d-4912-b527-faf55f955652" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,938</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5117241e-e120-4b6e-88d3-7dfcd9b8657b" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,053</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48f83545-a638-4398-9e40-09a1daa026a9" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,525</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables from collaboration arrangements</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8387934-389e-4908-a7ba-9bd8752e6d8c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,647</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3f58800-1c5b-4302-9cba-ec548242d2a5" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,949</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b86c0cd-6843-499d-be1e-cdd72aa84c08" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,319</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68592f4a-f4c2-45b7-8247-e111e9f584b9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,808</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_403434e5-d86b-4e98-b31b-a0de69bd39f0" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,004</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_281797c7-e07b-418d-9e9c-27330700c6da" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">280</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98a7ced2-a3d7-467a-9456-947092d5b831" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">567</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9200db4d-383b-4dfa-85a0-76f512f9f1e3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,929</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03e454df-b1fc-45c6-b8fd-202d0690e1be" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,350</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae2849fe-b647-499a-95cf-e1389f83a182" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,186</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cd72af9-a3c6-4b5f-982f-f159d5762366" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,965</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d01379a3-b51b-4767-8a0e-af066e072810" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,341</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_102aa722-f1db-4016-8f3e-69c12a36057c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,585</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c5b8710-5663-4d68-a5d7-a9aebd641062" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,778</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f10c7ab-9c16-4654-8b36-39710a829323" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued personnel-related expenses and other accrued liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae753f8d-68a0-4789-8786-5b8cb0e1a090" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,044</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a7c0b2f-9044-42d4-b88c-dbb4c0f030cb" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,498</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_782db940-b0db-4eb4-b5b8-9f03ada12c40" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,913</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued interest payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1865efba-d4b4-44fb-b3ed-65cfe92e108a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInInterestPayableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_217415d5-dbb4-4adc-a7ea-28370d5a1795" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInInterestPayableNet" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">937</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8cc9298-e97b-4020-ac9b-e5b3dabad432" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInInterestPayableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">207</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_498a6ecc-1e66-47f8-bb9f-bdf6c217a177" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">151</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce881f60-a06f-41b8-882c-df7851dfb328" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">817</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fce8cdc4-decc-4eb4-9417-c55d6540fad5" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">755</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54d7251c-6d78-4cee-a12b-ec72f055b2ab" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,476</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a484f1f-5547-4987-a9af-2ae92c2bdb01" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,725</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72a95d3b-2bf4-4c82-80b9-877d18e7cf9f" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,026</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0d5e72a-b25e-4c86-9974-dddaa666988e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">188,690</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a9ec184-7948-438d-8737-77a370a3d4a3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141,064</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63fda1a8-e504-4710-955b-11d029f698bf" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,726</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisition of intangible asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f05cf97c-c1eb-4f27-a353-14571c3c6151" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ee57ffa-4138-40b4-83a6-baee8c9dd74f" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_440bf0c6-221c-49e2-bcdb-154523cec0f7" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of equity method investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd17745b-4e00-4eee-9139-d2e5665d559a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2c8ce56-e74d-4fc7-ad59-adcb03e73db9" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83563459-73af-45fd-a438-6c107dcedddc" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50a04a3c-d99c-4d29-bb52-2c9ca1ea70d5" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,617</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ba5bb57-34b5-439e-af1e-f5778224c0c3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,132</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e19afc3f-a560-4747-85ec-dedf4bd8eea5" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of equity and long-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e03c33f-1a76-4d63-9e48-dd0688b6d675" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7b9d564-1b2e-481b-a525-3bec50aa41bc" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bd62ec8-ff7c-437f-90cf-43266b0abd8f" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,725</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of equity investments managed by ISP Fund LP</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51a9523f-91f8-4a94-bea2-a60e4d9fe5d9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:PurchasesOfEquityInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,270</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_745cfead-128d-4062-a50c-f3ea3be4f185" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:PurchasesOfEquityInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,164</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69b10899-8e75-4984-aea8-8a4610555acd" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:PurchasesOfEquityInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,910</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading security managed by ISP Fund LP</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d196778-a3f5-48d6-92b2-599f61b0ce2b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:PurchasesOfTradingSecurityManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1b84d49-f8f0-460e-b0f1-571d0b9b56f6" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:PurchasesOfTradingSecurityManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a7a0342-2e6c-481b-bdba-aff7340c1894" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:PurchasesOfTradingSecurityManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sales of equity investments managed by ISP Fund LP</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3639f57f-421d-4b0b-9666-b9299d88c45d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:SaleOfEquityInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,756</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67cbc89b-0ecd-4873-a7fa-062c436202b5" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:SaleOfEquityInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,500</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae0d56a2-fe6d-43bc-95d9-f11fdfdb3566" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:SaleOfEquityInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,281</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases and sales of other investments managed by ISP Fund LP, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67b72745-ac69-418a-b985-caf5dd560520" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,486</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b120828-93cd-486f-b7aa-a4fe2d07ad68" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,336</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b17791a-0b28-4320-9562-cbe02607d37e" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,371</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91a0910b-14d3-42c3-a455-acfc9d36f42f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">270</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e51a33b-8f42-4ab7-85e6-6604f3fb6134" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">411</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_781d9693-1cc5-477f-8156-ea5bf2fd6971" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa81f8aa-63af-4200-ad44-293fc5fd4fc9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76c4902e-0d20-484f-980b-91f06f719dbe" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_069c6251-3944-4ca2-97d8-3df5d3cd1328" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from sale of ownership interest in TRC, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45261734-c870-4106-b101-0d27dc95dace" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:NetProceedsFromSaleOfVariableInterestEntityEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d5c1105-c7c7-44f8-a66c-3a93feaa3c5d" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:NetProceedsFromSaleOfVariableInterestEntityEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5a84d62-3076-49cb-beac-49b682790964" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:NetProceedsFromSaleOfVariableInterestEntityEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">248,191</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash acquired through the consolidation of Entasis</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18a868bd-4016-404a-aacf-b555095da781" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CashAcquiredFromAcquisition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38b96089-b1f2-457c-a9b4-7c6f6db1a265" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:CashAcquiredFromAcquisition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f982f0d5-d32f-4d45-9a74-9309b8e9bac5" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:CashAcquiredFromAcquisition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,070</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for the acquisition of La Jolla, net of cash acquired</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85a70bc8-9b47-49f1-9b13-502ea406e40f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_161c7afc-b6bd-4d0f-9e0e-b277a4b5237e" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49e8d66d-8f67-4f38-a37d-01883e663b2b" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">159,103</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_366d2b07-9e0a-4af1-822a-15d584c1766e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">63,786</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00960ff2-28e2-4433-9109-a7b522df8140" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">66,761</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0efceba-0e27-4f24-a235-c0d228c3df49" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">56,634</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Distributions to noncontrolling interests</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53de62fe-c8fa-40b3-b6ec-99996bb3ff2c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsToMinorityShareholders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9475619d-1945-4ef3-b0d8-abe50e55374a" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsToMinorityShareholders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ecfbb09-53d5-4d27-a2ca-7f0ab8ca681c" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsToMinorityShareholders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,811</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of Entasis noncontrolling interest</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f31421c9-5c3b-40e6-92bd-ebc0e191013e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:PurchaseOfEntasisNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72ca3c9f-497a-41b4-b6a2-e568ccf29474" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:PurchaseOfEntasisNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41be75d3-96ab-4a9c-bf4e-1419531835d6" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:PurchaseOfEntasisNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,910</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb5f6456-e2d2-4a7e-b409-62012a7cb4e1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsForRepurchaseOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,777</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_641010f0-0aa8-4eb4-9c33-c7682e8da496" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,728</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_012c1619-9c27-4ab4-9eb3-400aaa78af22" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsForRepurchaseOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,503</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of shares to satisfy tax withholding</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8292aa3c-28e3-40ad-bf56-4d066083f0e5" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">142</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2bc4d61-39da-4ee5-9d99-ab34bb89110a" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ead2877-1755-416a-84da-054c659c0498" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuances of common stock, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d535bbde-b7d5-4f9c-93dd-83d8b5f84729" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,466</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1057d14-313a-4527-956b-956fcf643267" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c220479-469c-4473-a13a-f270c8edb270" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">370</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment for repurchase of convertible subordinated notes due 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_103f48bb-b8b6-42b0-abaa-9b5e13c49354" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:RepaymentsOfUnsecuredDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73e3ed55-ecbf-4fe5-97bf-c5f63c6958aa" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:RepaymentsOfUnsecuredDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">96,204</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e6175a5-009d-461b-a033-3daaccdce998" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:RepaymentsOfUnsecuredDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,131</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of capped call options associated with convertible senior notes due 2028</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2916c962-69a0-4adf-93c2-2d79e66dc0a1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39eb5ff0-cdeb-4f83-ba7c-b798f4e38ba3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ec0237a-94c5-4148-b75d-8e5a6af91228" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,037</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of convertible senior notes due 2028, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_025d55ce-7d6c-459b-89a3-74dd10518b42" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bf191b5-3dbe-4dd3-85c9-f67dc935afc4" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fba12e3d-85bc-46e4-902d-53b2b8728426" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252,536</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d4f71ac-c0ba-4a85-bfa9-9674c5b248b8" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,453</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8314d379-7f3b-482b-ba41-6d96ca515d5b" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">171,839</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1ac6d85-a144-422a-be32-0d9a226ebeed" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,568</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa16bf42-3452-48cc-8197-be61d0c6f981" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,451</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c713d10-487a-4c3b-8440-1c72b91acef3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">97,536</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58b6f11a-7c0e-415e-9e20-0dcc984f5634" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,524</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at beginning of period</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_240e74aa-79d4-4b03-996e-b09827537397" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193,513</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91b2b110-f392-41f0-bbdb-6e26d3b9ae67" contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">291,049</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a45762a7-48e6-4bb2-9a39-369d99112026" contextRef="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,525</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at end of period</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c792b8b-5405-4acf-929f-5afeeaec57ff" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">304,964</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b15f947-dc0a-4475-b94f-b06d7a8f1189" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193,513</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b6c5be7-93d0-4ff4-bd29-b27b47122463" contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">291,049</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.3in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.3in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:52.619%;box-sizing:content-box;"/>
    <td style="width:1.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.435%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.435%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.435%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental Disclosure of Cash Flow Information:</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45a70a8b-168f-4ad0-9240-e322c1175767" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,359</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bea8cc5-b3ce-46a0-9bdf-6113a50bc293" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,381</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7803804d-9750-44ac-8268-8ae5ad704463" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,736</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for income taxes</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00d97622-428e-4cf0-898a-8f912f82ad3d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,793</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_978913d5-c9eb-4114-bf7c-92df642438ba" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b93e15e-1cef-4da0-aafa-8bb4f96662fd" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,855</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental Disclosure of Non-cash Investing and Financing Activities:</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued interest income converted to long-term investments</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6390ab0-7c7d-45f6-837b-44211bed6437" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:AccruedInterestIncomeIncludedInLongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,584</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac35d5dd-bb1e-4e14-8d19-7b59c7e638d5" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:AccruedInterestIncomeIncludedInLongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,666</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35235357-6675-4aa1-b12e-e25f44037dd8" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:AccruedInterestIncomeIncludedInLongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adoption of ASU 2020-06</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff499806-35a5-4802-a051-5a0212b8740d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:NonCashActivity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05d73bc9-049f-44ed-b883-be5b135c59ad" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:NonCashActivity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_301c2958-1f79-435b-af31-5c6588e156c9" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:NonCashActivity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">28,228</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.3in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_consolidated_financial"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <div><ix:nonNumeric id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_1"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.  DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a92186d-b738-4487-9394-191a0b398c81" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:DescriptionOfOperationsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Operations</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc. (and where context requires, together with its subsidiaries referred to as &#8220;Innoviva&#8221;, the &#8220;Company&#8221;, or &#8220;we&#8221; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#8220;IST&#8221;), and a portfolio of strategic investments in other healthcare assets. Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#8220;GSK&#8221;), including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(fluticasone furoate/vilanterol, &#8220;FF/VI&#8221;) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(umeclidinium bromide/vilanterol, &#8220;UMEC/VI&#8221;), and up until July 2022, TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the combination FF/UMEC/VI). We sold our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_979bd953-2c70-4680-8456-a52cd2cb3e06" contextRef="C_79768fb0-1a83-46a5-a213-1d3d9c213d45" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest in Theravance Respiratory Company, LLC (&#8220;TRC&#8221;) on July 20, 2022, and are no longer entitled to receive royalties on sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> products. Under the Long-Acting Beta2 Agonist (&#8220;LABA&#8221;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4227de1b-daf5-4784-a300-b83faf8f6409" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementRoyaltyRateDefinedLevelOne" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1bb9ae4-645e-40e4-9ea9-e29747feefd9" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion of annual global net sales and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4de1a91-132a-40f0-8683-cfd955851e2b" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementRoyaltyRateDefinedLevelTwo" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for all annual global net sales above $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02fc6644-7d62-41b7-9e6e-3d6ce2f9ecda" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion; and royalties from the sales of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which tier upward at a range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c85e187b-cbb2-432b-b621-87c217b7f597" contextRef="C_12297e5a-44ee-441e-b9cb-846681e357f4" name="inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a30fa50e-db97-47d5-a5b5-a9681a7eee86" contextRef="C_a4df3b3b-267d-4f2f-ac89-6815c2bbcdeb" name="inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expanded our portfolio through the acquisition of Entasis Therapeutics Holdings Inc. (&#8220;Entasis&#8221;) on July 11, 2022 and the acquisition of La Jolla Pharmaceutical Company (&#8220;La Jolla&#8221;) on August 22, 2022. Our commercial and marketed products include GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Our new product, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#8220;FDA&#8221;) for the treatment of hospital-acquired and ventilator-associated pneumonias caused by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in adults and we commenced commercial sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd., (&#8220;Basilea&#8221;) for the commercialization of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue to further advance our pipeline and are on track to submit a New Drug Application (&#8220;NDA&#8221;) for zoliflodacin, potentially first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the FDA in early 2025. Overall, we have a wholly owned robust critical care and infectious disease operating platform with a hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we own other strategic healthcare assets, such as a large equity stake in Armata Pharmaceuticals, a leader in development of bacteriophages with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c818bc4d-4d48-498a-beba-8cd835206285" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of Innoviva, our wholly owned subsidiaries and certain variable interest entities (&#8220;VIE&#8221;) for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entity by the respective noncontrolling party.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_48d44cd6-cfc1-43b9-af59-995f60e20f15" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:FactorsAffectingComparabilityPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Factors Affecting Comparability</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our historical financial condition and results of operations for the periods presented may not be comparable, either between periods or going forward due to the factors below and as discussed in Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;.</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting consolidation of Entasis on February 17, 2022 and purchase of remaining noncontrolling interest in Entasis on July 11, 2022;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sale of our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60e406a3-f758-488e-9a18-f48dbac1b036" contextRef="C_79768fb0-1a83-46a5-a213-1d3d9c213d45" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest in TRC on July 20, 2022; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisition of La Jolla on August 22, 2022.</span></div></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_1" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3e894d42-2a01-40ca-b850-fbcf734b269f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Management&#8217;s Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Management evaluates its significant accounting policies and estimates on an ongoing basis. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. These estimates also form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f77af13b-4ad6-4b19-88cd-5710ca744a87" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk and of Significant Suppliers and Partners</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and equity and long-term investments. Although we deposit our cash with multiple financial institutions, our deposits, at times, may exceed federally insured limits.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are dependent on third-party manufacturers to supply active pharmaceutical ingredients (&#8220;API&#8221;) and drug products for commercial and research and development programs. These programs could be adversely affected by significant interruption in the supply of API or drug products.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Currently, we derive most of our revenues from GSK and our near-term success depends in large part on GSK&#8217;s ability to successfully develop and commercialize the products in the respiratory programs partnered with GSK. Our near-term success depends in large part upon the performance by GSK of its commercial obligations under the GSK Agreements and the commercial success of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If GSK does not devote sufficient resources to the commercialization or development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed. GSK is responsible for all clinical and other product development, regulatory, manufacturing and commercialization activities for products developed under the GSK Agreements, including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our royalty revenues may fluctuate due to a variety of factors, many of which are outside of our control. Our royalty revenues under the GSK Agreements may not meet our, analysts&#8217; or investors&#8217; expectations, due to a number of important factors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenue for the periods include product sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Hospitals and other healthcare organizations generally purchase our products through a network of specialty distributors. These specialty distributors, which are located in the U.S., are considered our customers for accounting purposes. We do not believe that loss of one of these distributors would significantly impact our ability to distribute our products, as we expect that sales volume would be absorbed by new or remaining distributors. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_641eeb89-ea6c-4920-86ef-3d2820be8077" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:NumberOfMajorCustomers" unitRef="U_Customer" decimals="0" format="ixt-sec:numwordsen">Three</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of our customers each account for approximately:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e655e60-d625-4a6b-a578-a4a40c574ecc" contextRef="C_b79f1674-dd08-4798-a636-6908c319b900" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">31</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d5495be-ed29-4b9e-8550-630247de435c" contextRef="C_765a2763-8b53-4101-ab58-259faa96bbda" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">24</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fbdf35b-c554-4ccb-9dd4-8560c273ff28" contextRef="C_275d36b8-67af-4e37-bb78-b7ec1929c925" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">24</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2024; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05b95612-fd00-4056-a84e-b7ac7fd37061" contextRef="C_8fdb4c80-a5b2-4d18-b108-58f668bf4204" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">31</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c38d86b8-07e7-45b5-aa67-6310116a51bf" contextRef="C_80258deb-f35d-49b9-b662-4823ba3839e5" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">27</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0e121d8-4bda-44d7-a41e-0872fe2daf8e" contextRef="C_148ad82f-42d4-4125-aa46-2c752917796a" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">27</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2023; and, </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f39c4a47-ddb6-4d40-8c9e-ef61c5244f3f" contextRef="C_9f830636-16c6-4d83-af5b-754f4ce28030" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">33</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed025c42-a9ec-4d78-8857-036f8fc82d6c" contextRef="C_fa5f811c-b501-4818-ad66-e8e20b51e983" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">29</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ea2ec8c-f41a-43f9-8bcb-90f0cc10aee5" contextRef="C_a8d47eea-b422-4342-9936-7be08f04740f" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">28</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2022. </span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These same customers account for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcc31c6e-4e21-4624-9f81-b771259b2587" contextRef="C_d46b31e7-e4aa-47e0-b48d-3af9ff0a4041" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">31</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_508d4a30-caea-4def-bcf3-19a4699ea4a2" contextRef="C_586ff5e8-d41c-4176-a904-9624786d8bde" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">18</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c9601c2-ec2f-4108-b82d-f837c8fb85a6" contextRef="C_6d0a78b5-48c4-4a35-91c6-e8575ef72b82" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our receivables from net product sales, which are included in &#8220;Accounts receivables, net&#8221; in our consolidated balance sheet as of December 31, 2024. These same customers account for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ae7b428-7215-4b0c-bd69-8a7dcbda0391" contextRef="C_510f527b-715b-4a94-923a-54ba359b3544" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">29</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bbebe34-f9ae-46fe-ad87-19745899a3db" contextRef="C_d342f539-f5cc-4e65-bc94-3ed13f8a9001" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">19</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_048ea3f7-f138-4f9d-8755-8b56337b8f7b" contextRef="C_73f1df40-a5ad-4f58-8d9d-f8b23a0da0a3" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our receivables from net product sales, which are included in &#8220;Accounts receivables, net&#8221; in our consolidated balance sheet as of December 31, 2023.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e05eaf80-618f-4d61-96ef-3fa117cc8a1f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are identified as components of an enterprise about which separate discrete financial information is made available for evaluation by the chief operating decision maker (&#8220;CODM&#8221;) in making decisions regarding resource allocation and assessing performance. Refer to Note 15, &#8220;Segment Reporting&#8221;, for more segment information.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">106</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_2" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_25b22b4e-d130-43df-95b3-af07a5b9a641" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ConsolidationVariableInterestEntityPolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary beneficiary of a variable interest entity (&#8220;VIE&#8221;) is required to consolidate the assets and liabilities of the VIE. When we obtain a variable interest in another entity, we assess at the inception of the relationship and upon occurrence of certain significant events whether the entity is a VIE and, if so, whether we are the primary beneficiary of the VIE based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, we consider all the facts and circumstances, including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE&#8217;s economic performance and identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, we consider all of our economic interests that are deemed to be variable interests in the VIE. This assessment requires us to apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e101f542-8f3e-4232-8f45-86efce3f9e01" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:BusinessCombinationsPolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When we acquire an entity in a business combination, we recognize the fair value of all assets acquired, liabilities assumed, and any non-controlling interest in the acquiree and establish the acquisition date as the fair value measurement point. We recognize and measure goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair value of the identified net assets acquired. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use the income method. This method starts with a forecast of all of the expected future net cash flows for each asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Some of the more significant estimates and assumptions inherent in the income method or other methods include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows and the assessment of the asset&#8217;s life cycle and the competitive trends impacting the asset, including consideration of any technical, legal, regulatory, or economic barriers to entry. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may even be considered to have indefinite useful lives.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_df90ebea-25e4-4058-8252-84ba8b4dc6f3" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consider all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_852cc198-5373-4117-b702-1667395b7ade" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounts receivable are recorded net of estimates for prompt-pay discounts, chargebacks, returns and rebates. Allowances for prompt-pay discounts and chargebacks are based on contractual terms. We estimate the allowance for credit losses based on existing contractual payment terms, actual payment patterns of customers and individual customer circumstances.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2360c1a4-ea02-4d31-8a16-433faa0caddc" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:InventoryPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inventory</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inventory is stated at the lower of cost or estimated net realizable value on a first-in, first-out basis. We periodically analyze inventory levels and write down inventory as cost of products sold when the following occurs: inventory has become obsolete, inventory has a cost basis in excess of its estimated net realizable value, or inventory quantities are in excess of expected product sales.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">107</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_3" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_4"><div><ix:nonNumeric id="F_d04ca374-5c0f-41bb-9472-2e8a80392b30" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, which consist of laboratory equipment, computer equipment, software, office furniture and fixtures, and leasehold improvements, were not material as of December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02bc4870-5857-4ebb-b956-31fa25ce41b7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock" escape="true" continuedAt="F_02bc4870-5857-4ebb-b956-31fa25ce41b7_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">over the estimated useful lives of the respective assets as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:49.17%;box-sizing:content-box;"/>
          <td style="width:1.66%;box-sizing:content-box;"/>
          <td style="width:49.17%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease terms or useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment, furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_514ee2f2-674c-40e2-950e-e58ba56bec9d" contextRef="C_3f07a2ce-f751-4da5-bf13-5630b4c78ccc" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#8211; </span><span><ix:nonNumeric id="F_06846153-fb52-4b49-a581-473c23731142" contextRef="C_df62ffb5-2697-4ff5-a2f7-2b6a2e6fd05e" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_799c07d9-d2ec-418a-8967-d61fcd244871" contextRef="C_080daca5-b99d-4707-b989-976a8412c9b0" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3 years</span></ix:nonNumeric></span></p></td>
         </tr>
        </table></ix:nonNumeric></div></ix:nonNumeric></div><div><ix:continuation id="F_02bc4870-5857-4ebb-b956-31fa25ce41b7_1"></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7412cf45-3835-4425-8c89-c78daf361543" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EquityMethodInvestmentsPolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity and Long-Term Investments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We invest from time to time in equity and debt securities of private or public companies. If we determine that we have control over these companies under either voting or VIE models, we consolidate them in our consolidated financial statements. If we determine that we do not have control over these companies under either voting or VIE models, we then determine if we have an ability to exercise significant influence via voting interests, board representation or other business relationships.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may account for the investments where we exercise significant influence using either an equity method of accounting or at fair value by electing the fair value option under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method, we apply it to all our financial interests in the same entity (equity and debt, including guarantees) that are eligible items. All gains and losses from fair value changes, unrealized and realized, are presented as changes in fair values of equity method investments, net, and changes in fair values of equity and long-term investments, net, within the consolidated statements of income.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we conclude that we do not have an ability to exercise significant influence over an investee, we may elect to account for the security without a readily determinable fair value using the measurement alternative method under ASC 321, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments &#8211; Equity Securities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This measurement alternative method allows us to measure the equity investment at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also invest in ISP Fund LP, which investments consist of money market funds and equity and debt securities in the healthcare, pharmaceutical and biotechnology industries. Pursuant to the Partnership Agreement entered in December 2020, we became a limited partner of this partnership, and our contributions were subject to a 36-month lock-up period, which restriction prevented us from having control over and access to the contributions and related investments. The lock-up period for a certain portion of our contributions expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. These investments were classified as long-term investments in the consolidated balance sheet as of December 31, 2023. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of these investments, which consist mainly of cash and money market funds that we expect to be distributed in the next 12 months, were classified as &#8220;Current portion of ISP Fund investments&#8221; in the consolidated balance sheet as of December 31, 2024.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_5b5ab305-43ae-4153-90b8-e60d830c55de" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true" continuedAt="F_5b5ab305-43ae-4153-90b8-e60d830c55de_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">108</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_4" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5b5ab305-43ae-4153-90b8-e60d830c55de_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. We classify these inputs into the following hierarchy:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Quoted prices for identical instruments in active markets.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Quoted prices for similar instruments in active markets; quoted prices for identical 3or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unobservable inputs and little, if any, market activity for the assets.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments include cash equivalents, accounts receivable, receivables from collaborative arrangements, accounts payable, and accrued liabilities, equity investments and convertible promissory notes. The carrying values of cash equivalents, receivables from collaborative arrangements, accounts payable, and accrued liabilities approximate their estimated fair values due to the relatively short-term nature of these instruments.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d41678b7-3661-44ae-91aa-5ee69cad7d01" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:CapitalizedFeesPaidPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Capitalized Fees Paid</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We capitalize fees paid to licensors related to agreements for approved products or commercialized products. We capitalize these fees as capitalized fees paid (&#8220;Capitalized Fees&#8221;) and amortize them on a straight-line basis over their estimated useful lives upon the commercial launch of the product, shortly after its regulatory approval. The estimated useful lives of these Capitalized Fees are determined on a country-by-country and product-by-product basis, as the later of the expiration or termination of the last patent right covering the compound in such product in such country and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_221feadc-738d-4ed3-a75a-4f6fcec8453f" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeePaidEstimatedUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from first commercial sale of such product in such country, unless the Collaboration Agreement is terminated earlier. Consistent with our policy for classification of costs under the research and development collaborative arrangements, the amortization of these Capitalized Fees is recognized as a reduction of royalty revenue. We review our Capitalized Fees for impairment on a product-by-product basis for each major geographic area when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The recoverability of Capitalized Fees is measured by comparing the asset&#8217;s carrying amount to the expected undiscounted future cash flows that the asset is expected to generate. The determination of recoverability typically requires various estimates and assumptions, including estimating the useful life over which cash flows will occur, their amount, and the asset&#8217;s residual value, if any. We derive the required cash flow estimates from near-term forecasted product sales and long-term projected sales in the corresponding market.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_303849a5-d3ad-4833-963d-704ae2642ef9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Goodwill and Intangible Assets</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Goodwill is recognized as the excess of the purchase consideration of an acquired entity over the fair value assigned to assets acquired and liabilities assumed in a business combination. In addition to recognizing intangible assets acquired in a business combination, we capitalize milestone payments related to in-licensing agreements for approved products as an intangible asset when the contingency for the milestone is resolved and the consideration is issued or becomes issuable. Goodwill and intangible assets with indefinite useful life are not amortized and are tested for impairment at least annually on the first day of December of each year or more frequently if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#8217;s carrying asset amount may not be recoverable. Intangible assets with definite useful lives are amortized on a straight-line basis over their respective remaining useful lives and are tested for impairment only if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable. Significant judgment may be involved in determining if an indicator of impairment has occurred.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a662f7d-29e9-4179-b777-fadaaef2d07c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent our right to use an underlying asset over the lease term and include any lease payments made prior to the lease commencement date and are reduced by lease incentives. Lease liabilities represent the present value of the total lease payments over the lease term, calculated using an estimated incremental borrowing rate. Lease expense is recognized on a straight-line basis over the expected lease term.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">109</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_5" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_6"><div><ix:nonNumeric id="F_07af8a48-2cb4-4eda-9ac3-92d66d3fc6e9" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true" continuedAt="F_07af8a48-2cb4-4eda-9ac3-92d66d3fc6e9_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We apply the guidance on principal versus agent considerations under ASC Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to determine the appropriate treatment for the transactions between us and third parties. The classification of transactions under our arrangements is determined based on the nature and contractual terms of the arrangement along with the nature of the operations of the participants. Any consideration related to activities in which we are considered the principal, which includ</span><span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">es being in control of the good or service before such good or service is transferred to the customer, are accounted for as product sales.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is recognized when our customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized through a five-step process: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price for the contract; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue as a performance obligation is satisfied.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalty Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the royalty revenue on net sales of products with respect to which we have contractual royalty rights in the period in which the royalties are earned. The net sales reports provided by our partner are based on its methodology and assumptions to estimate rebates and returns, which it monitors and adjusts regularly in light of contractual and legal obligations, historical trends, past experience and projected market conditions. Our partner may make significant adjustments to its sales based on actual results recorded, which could cause our royalty revenue to fluctuate. We conduct periodic royalty audits to evaluate the information provided by our partner. Royalties are recognized net of amortization of capitalized fees associated with any approval and launch milestone payments made to GSK.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Product Sales</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Revenue from product sales is recognized when our customers obtain control of the product and is recorded at the transaction price, net of estimates for variable consideration consisting of chargebacks, discounts, returns and rebates. Variable consideration is estimated using the expected-value amount method, which is the sum of probability-weighted amounts in a range of possible consideration amounts. Actual amounts of consideration ultimately received may differ from our estimates. If actual results vary materially from our estimates, we will adjust these estimates, which will affect revenue from product sales and earnings in the period such estimates are adjusted. These items may include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chargebacks: Chargebacks are discounts we provide to distributors in the event that the sales prices to end users are below the distributors&#8217; acquisition price. This may occur due to a direct contract with a health system, a group purchasing organization (&#8220;GPO&#8221;) agreement or a sale to a government facility. Chargebacks are estimated based on known chargeback rates and recorded as a reduction of revenue on delivery to our customers.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Discounts: We offer customers various forms of incentives and consideration, including prompt-pay and other discounts. We estimate discounts primarily based on contractual terms. These discounts are recorded as a reduction of revenue on delivery to our customers.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Returns: We offer customers a limited right of return, generally for damaged or expired product. We estimate returns based on an internal analysis, which includes actual experience. The estimates for returns are recorded as a reduction of revenue on delivery to our customers. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rebates: We participate in Medicaid rebate programs, which provide assistance to certain low-income patients based on each individual state&#8217;s guidelines regarding eligibility and services. Under the Medicaid rebate programs, we pay a rebate to each participating state, generally within three months after the quarter in which product was sold. Additionally, we may offer customer incentives and consideration in the form of volume-based or other rebates. The estimates for rebates are recorded as a reduction of revenue on delivery to our customers. </span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to assess our estimates of variable consideration as we accumulate additional historical data and will adjust these estimates accordingly.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">110</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_6" continuedAt="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_7"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_07af8a48-2cb4-4eda-9ac3-92d66d3fc6e9_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the inception of a licensing arrangement that includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price. We generally recognize these milestone payments as revenues when they are achieved because there is considerable uncertainty in the research and development processes that trigger receipt of these payments under our agreements. Similarly, we recognize regulatory approval milestone payments as revenues once the product is approved by the applicable regulatory agency. For delivery of other goods or services related to a licensing arrangement, we determine whether the performance obligation is satisfied over time or at a point in time. If the performance obligation is satisfied over time, we use judgment in determining the appropriate method of measuring progress for purposes of recognizing revenue. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6bf9541e-bec5-400c-9a22-e2a152051509" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses are recognized in the period that services are rendered or goods are received. Research and development expenses consist of salaries and benefits, laboratory supplies, facilities and other overhead costs, research-related manufacturing costs, contract service and clinical-related service costs performed by third party research organizations, research institutions and other outside service providers. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized. Such amounts are recognized as an expense as the related goods are delivered or the related services are performed. We also utilize significant judgment and estimates to record accruals for estimated ongoing research costs based on the progress of the studies and progress of research manufacturing activities.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c71711e4-1279-470c-8bad-f145dc687b91" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:InterestExpensePolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense on Deferred Royalty Obligation</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense related to the deferred royalty obligation is recognized over the expected repayment term of the deferred royalty obligation using the effective interest method. The assumptions used in determining the expected repayment term of the deferred royalty obligation require us to make estimates that could impact the effective interest rate. Each reporting period, we estimate the expected repayment term of the deferred royalty obligation based on forecasted net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Changes in interest expense resulting from changes in the effective interest rate, if any, are recorded on a prospective basis. Refer to Note 12, &#8220;Debt&#8221;, for more information.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_19e0222a-7a29-45b7-af77-66c6449fc57c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Stock&#8209;Based Compensation Awards</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use the Black-Scholes-Merton option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our employee stock purchase plan (&#8220;ESPP&#8221;). The Black-Scholes-Merton option valuation model requires the use of assumptions, including the expected term of the award and the expected stock price volatility. We use the &#8220;simplified&#8221; method as described in Staff Accounting Bulletin No. 107, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Share-Based Payment</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#8221; for the expected option term. We use our historical volatility to estimate expected stock price volatility.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted stock units (&#8220;RSUs&#8221;) and restricted stock awards (&#8220;RSAs&#8221;) are measured based on the fair market values of the underlying stock on the dates of grant.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense is calculated based on awards ultimately expected to vest and is reduced for estimated forfeitures at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differed from those estimates. Our estimated annual forfeiture rates for stock options, RSUs and RSAs are based on our historical forfeiture experience.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of stock options, RSUs and RSAs is expensed on a ratable or straight-line basis over the expected term of the grant or expected term of the vesting. Compensation expense is recorded over the requisite service period based on management&#8217;s best estimate as to whether it is probable that the shares awarded are expected to vest.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation expense for purchases under the ESPP is recognized based on the fair value of the common stock on the date of offering, less the purchase discount percentage provided for in the plan.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">111</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148_7"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_977b97c8-e0c6-4ed6-a6c4-e14a742b8e3d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and the tax basis of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The recognition and measurement of tax benefits requires significant judgment. Our judgment might change as new information becomes available. We continue to evaluate our deferred tax assets each reporting period to determine whether adjustments to our valuation allowance are required and deferred tax assets will be realized based on the consideration of all available positive and negative evidence, including the differences between our anticipated and actual future operating results, using a &#8220;more likely than not&#8221; standard.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we determine whether the factors underlying the sustainability assertion have changed and whether the amount of the recognized tax benefit is still appropriate.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc79b18a-7d36-4152-9ac9-c87820a9330d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:RelatedPartyTransactionsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Parties</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sarissa Capital ow</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6744bd4a-f95b-45bb-8f56-a9b8f2a78456" contextRef="C_253ffe46-1c31-4933-9e01-a237c876ecc9" name="inva:RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">11.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of o</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ur outstanding common stock as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Transactions with Sarissa Capital are described in Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;. Sarissa Capital is considered to be a related party because two of its principals are members of our board of directors.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c07e5ee0-4e98-4ed1-9237-f83470c17924" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncement</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Reportable Segment Disclosures (Topic 280).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This ASU update requires enhanced segment disclosures, primarily related to significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. We adopted ASU 2023-07 for the 2024 fiscal year and provided the enhanced disclosures for the comparative years. The adoption of ASU 2023-07 did not have a material impact on the Company's financial statements. Enhanced disclosures related to significant segment expenses are included in Note 15, &#8220;Segment Reporting.&#8221;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Adopted</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Income Tax Disclosures (Topic 740)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The ASU requires the disclosure of income taxes paid disaggregated by jurisdiction and enhanced disclosures for the entity&#8217;s effective tax rate reconciliation as well as other income tax related disclosures. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. The Company has not early adopted the ASU during 2024 and does not expect the adoption of the amendments to have a significant impact on its financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement &#8212; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the statement of income as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company in annual reporting periods beginning after December 15, 2027, and interim reporting periods beginning after December 15, 2027. We are currently evaluating the potential impact that ASU 2024-03 may have on our financial statement disclosures.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-04, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which clarifies the assessment of whether a transaction should be accounted for as an induced conversion or extinguishment of convertible debt when changes are made to conversion features as part of an offer to settle the instrument. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. We are currently evaluating the potential impact that ASU 2024-04 may have on our financial statements and related disclosures.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">112</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f5c4c6d8-f169-4b6d-8ec1-bc33a7a1f311" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.  NET INCOME PER SHARE</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net income per share attributable to Innoviva stockholders is computed by dividing net income attributable to Innoviva stockholders by the weighted-average number of shares of common stock outstanding. Diluted net income per share attributable to Innoviva stockholders is computed by dividing net income attributable to Innoviva stockholders by the weighted-average number of shares of common stock and dilutive potential common stock equivalents then outstanding. Dilutive potential common stock equivalents include the assumed exercise, vesting and issuance of employee stock awards using the treasury stock method, as well as common stock issuable upon assumed conversion of our convertible subordinated notes due 2023 (the &#8220;2023 Notes&#8221;) up until its maturity date on January 15, 2023, our convertible senior notes due 2025 (the &#8220;2025 Notes&#8221;), and our convertible senior notes due 2028 (the &#8220;2028 Notes&#8221;) using the if-converted method. If the results attributable to Innoviva stockholders are in a net loss position, diluted net loss per share attributable to Innoviva stockholders is computed by dividing the net loss attributable to Innoviva stockholders by the weighted-average number of shares of common stock outstanding for the period, without consideration for potential dilutive common stock equivalents.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35c9fc3e-6758-406f-9af6-4e618068da41" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the computation of basic and diluted net income per share for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, 2023 and 2022:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:50.79%;box-sizing:content-box;"/>
        <td style="width:1.48%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.077%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.48%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.077%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.48%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.617%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands except per share data)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15f64797-53a3-4030-b447-aed34274ae2f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e307567-4cda-406d-8228-f24f7c6619eb" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33a8ba6b-1d6c-4bd4-9570-bc97074e91b5" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">213,921</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2023 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_341d202f-62fa-4877-86c0-79294b27a220" contextRef="C_7530273c-e395-47f6-b8ce-a7265c4b1b91" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e12cbf2-a507-400f-b006-a51b85cce1a8" contextRef="C_1816c078-11b5-460a-ad2e-54cbd4e77cbd" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b868b5bb-d552-4e82-8763-bcede9fb1724" contextRef="C_fdbfc2ab-d5ad-4fa2-8dfc-bcaab55938e9" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,439</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2025 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb3a3e07-49d9-4371-b3f4-417c9331e4e1" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,468</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7be38120-613b-4bed-909f-df366b7f1c30" contextRef="C_6909246c-601a-476f-8981-bae18ebb0a34" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,116</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85bf2107-e3b3-4e0e-9473-a4c9a9b6f0f1" contextRef="C_b205310f-0e33-4476-bda5-719485b59ecd" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,583</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2028 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20127f5e-c790-477a-93ea-5d990bfb3d0e" contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0b3925b-ccdc-4a86-8d6c-f4126b88861c" contextRef="C_6abb342a-b250-49ac-bbe0-52e5029809ff" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,377</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89d55016-61d5-4a5a-b19c-677aff04ff8a" contextRef="C_1fff98f9-2913-4a76-9006-53b136b3b233" name="us-gaap:InterestOnConvertibleDebtNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,626</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83a38207-608c-4ea7-9a4a-16269495b668" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,860</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11ca738e-4c47-419b-b268-26234abcf033" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">191,304</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58e19d5d-d4c7-40a5-b404-d70bce49b79e" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225,569</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used to compute basic net income<br/>&#160;&#160;&#160;per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_046e3d1d-3f00-4a56-98ad-8151e1d5c2a7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,726</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c59c163-93cc-4567-b854-f23360a6bcc9" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,435</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0d04b52-67fc-496a-a5c2-c2bda084bcbc" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2023 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_135fa4b8-f046-4582-89f6-244741ad37b0" contextRef="C_7530273c-e395-47f6-b8ce-a7265c4b1b91" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59da97e5-2eda-4f54-aec9-ca902bddb361" contextRef="C_1816c078-11b5-460a-ad2e-54cbd4e77cbd" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">187</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_946d7af0-0f77-4cdf-ab20-380fe59bff60" contextRef="C_fdbfc2ab-d5ad-4fa2-8dfc-bcaab55938e9" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,188</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cdaca4b-1063-495e-bbd3-ec794d0b322c" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,150</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11f0a485-353e-4779-847a-c909297997fc" contextRef="C_6909246c-601a-476f-8981-bae18ebb0a34" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,150</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04c8c967-096c-4ca0-8397-b53e4e92a1a6" contextRef="C_b205310f-0e33-4476-bda5-719485b59ecd" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,150</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6017e34-26e9-49f2-8016-b7bedf0933bf" contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fe2e3c8-5ff4-4f33-a36d-e70d2ea00303" contextRef="C_6abb342a-b250-49ac-bbe0-52e5029809ff" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,955</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc1be64f-a95e-403f-86bd-3f6328f1b9c6" contextRef="C_1fff98f9-2913-4a76-9006-53b136b3b233" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,158</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of options and awards granted under equity<br/>&#160;&#160;&#160;incentive plan and employee stock purchase plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06f68677-1e77-4c2d-ae6b-41faf146621f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">311</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8bf8780-1956-49e1-9ac2-c5726327b67f" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">149</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fe8ac1a-5bad-40af-8e81-436612f7570e" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">108</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used to compute diluted net income<br/>&#160;&#160;&#160;per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6e29c33-c212-44e4-b11b-a585f5eb54b8" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,187</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67c45bf3-2dc5-454d-95f9-2279dcdeaaa0" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c4bc91d-a5d6-45cd-95cb-0906d2fec17d" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,248</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1d6d1c9-5154-491d-8a30-8f12fd51c880" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.37</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b30d6b18-cf7b-45bd-acbc-a65c6c998fc3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.75</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52e67727-c6e2-4c92-bfd1-c419da4b2d0e" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.07</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1441e747-1881-4636-ae00-e662c5265fd4" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.36</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f84a374f-f54b-42ec-8474-c5a2d1ec5342" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.20</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3d27864-0a1f-4e16-a591-c72f5db1ba33" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.37</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti&#8209;dilutive Securities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_53ddee8e-8c70-43b2-967a-9c109987cbac" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti&#8209;dilutive for the periods presented:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.28%;box-sizing:content-box;"/>
        <td style="width:1.02%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.02%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.02%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding options and awards granted under equity incentive<br/>&#160;&#160;&#160;plan and employee stock purchase plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_388e68fe-04e6-427a-b8f7-4b8a38db556d" contextRef="C_a6430d44-f5e0-43dc-9348-dfafe12496e7" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,196</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81746d52-e64d-4592-9155-41c2d616ffaf" contextRef="C_dc9d2bc8-74c2-44d4-a506-2b243a40e1db" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,333</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfe3f447-4372-4940-918a-6df1f54b0c5d" contextRef="C_3e58dc77-93ac-48f8-ad4b-45e787d62643" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">648</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding stock warrant</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_000c1398-f8a8-4be6-9412-fa9ef812a33f" contextRef="C_90c8e4aa-f337-4f23-8ec8-33fc6f9d49fc" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">591</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85fb08ca-3f24-4823-b197-bd8dd0350980" contextRef="C_6ca7b604-74ae-4669-9748-a07e890fea74" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">591</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_958934e0-16aa-411a-9c77-791dc19c16c6" contextRef="C_ebebd729-c908-4409-9926-dcda00bed175" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">282</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding 2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd57dc4e-e2a8-45db-9469-e5548fd9356f" contextRef="C_663ceb44-07f8-4150-a16b-cc6004609ea5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,955</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c0ac956-975d-4c4c-a40a-121664d8eedc" contextRef="C_1a8cdfac-c298-4e05-a31d-4569a79026a1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a42cf85-2098-432b-ab08-fa344fa04a96" contextRef="C_30321d31-1876-4ed6-ab63-b9b2cac929bb" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deaf9a88-d74e-4fed-9539-3685c057830a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,742</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da2139c2-586c-4f71-9a20-a47153a6295d" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,924</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84ef3799-a51d-4843-8e3d-9227dd448fd7" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">930</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">113</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_6a1ecc75-eb21-4e3e-acb2-49e941e83194" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:RevenueFromContractWithCustomerTextBlock" escape="true" continuedAt="F_6a1ecc75-eb21-4e3e-acb2-49e941e83194_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.  REVENUE RECOGNITION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Revenue from Collaboration Arrangement</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 13, 2022, Innoviva&#8217;s wholly owned subsidiary, Innoviva TRC Holdings, LLC (&#8220;ITH&#8221;) entered into an equity purchase agreement (&#8220;TRC Equity Purchase Agreement&#8221;) with Royalty Pharma Investments 2019 ICAV (&#8220;Royalty Pharma&#8221;) to sell our ownership interest in TRC. As a result of the sale of our ownership interest in TRC, which was consummated on July 20, 2022, we are no longer entitled to receive 15% of royalty payments made by GSK stemming from sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We retained our royalty rights with respect to RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cbdc41d8-c2a4-4b2c-b7aa-9a4ee3141e91" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DisaggregationOfRevenueTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net revenue recognized under our GSK Agreements was as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; RELVAR/BREO</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cae112d-7498-4bbe-ac21-11bdcd2060eb" contextRef="C_476fef44-ae2e-4cc8-8996-5cd189b7399b" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">207,925</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48d10e53-6cfc-40d3-b136-c6c137d1c337" contextRef="C_87613bcc-e02f-4f93-9acc-604a9a71c964" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,042</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebb8ccf0-ea0d-4603-ad17-23f49ed23be1" contextRef="C_e189d92a-5bed-4d05-ba08-0b3e9024c9c0" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215,034</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; ANORO</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd5033e0-78cd-4ac6-bf59-5af92837813a" contextRef="C_9a1b43b7-95ef-4fe1-bb0d-965f09120bf8" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,631</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c072c096-bb48-4b4c-992a-c1940cacdf0e" contextRef="C_0ea9ec7a-e7e7-4193-b8dc-087d07b87da1" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,627</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f75f6991-bea4-4850-ad15-3ab6348b2c67" contextRef="C_7f8fbf04-70a3-46c3-b1c4-813bd471a322" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,405</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; TRELEGY</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_865eaeea-092b-4cc5-8765-4bae882a3da6" contextRef="C_8a59da43-fe2d-4fbf-88c5-e84ffeb90fd0" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_beaeaf77-cc14-4411-a10b-ceb8f949eead" contextRef="C_b6038bb2-c129-42b0-94c7-bd3528eb4770" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_143cd3bb-67de-4486-8bca-78d53c1c3530" contextRef="C_c0fa79e7-715a-4fda-811d-c8538a6e2a44" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,029</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalties</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a39b54a-8059-42e9-a430-773c7c5d0a44" contextRef="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">255,556</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7c87e6f-464e-45ee-9241-c4950c6a67b6" contextRef="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252,669</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7d420a9-22ab-457b-8038-24abc04fc2b6" contextRef="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e" name="inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">325,468</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: amortization of capitalized<br/>&#160;&#160;&#160;fees paid</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a34a669b-1a10-489f-8fcc-d3e26fcff193" contextRef="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,823</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d529a04-86f8-4b54-9c23-0822b618ef22" contextRef="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,823</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16822020-4193-494b-8bb6-d30164b1a85e" contextRef="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,823</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalty revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf4abedf-9dd2-469b-bb00-6c92ba21d4a5" contextRef="C_e58b5b10-01d5-47b4-827c-3e1e08ba781d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241,733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d5f44b5-cc17-480d-b35e-da29531dcaa1" contextRef="C_9c9d544f-ec3a-45ad-bcd1-76045e398e61" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238,846</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9720dc0-4289-491e-9f1a-08c9aa84bde1" contextRef="C_37bbf523-072e-4d93-97c4-9c3c71d7a919" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311,645</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   The year ended December 31, 2022 represents the period from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC.</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LABA Collaboration</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the launch and approval of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S., Japan and Europe, we paid milestone fees to GSK totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2fef565-0b07-4b2a-8d93-986d05aa3fd2" contextRef="C_af75fcbe-c945-4eb9-beb4-d5938e595d4b" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">220.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended December 31, 2014. The milestone fees paid to GSK were recognized as capitalized fees paid, which are being amortized over their estimated useful lives commencing upon the commercial launch of the product. The amortization is recorded as a reduction to the royalties from GSK.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are entitled to receive annual royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8cd56e8c-e4ff-43fb-92fe-2f617f7bc710" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementRoyaltyRateDefinedLevelOne" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16bf4309-0283-4dd1-ae5a-0506de8271af" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion of annual global net sales and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cf4973f-2556-4f32-9936-11dc7490fc50" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementRoyaltyRateDefinedLevelTwo" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for all annual global net sales above $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f562bfe-8a4e-4ad3-a81c-6c24056428c3" contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a" name="inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion. Sales of single&#8209;agent LABA medicines and combination medicines would be combined for the purposes of this royalty calculation. For other products combined with a LABA from the LABA Collaboration, such as ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, royalties are upward tiering and range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42030cc6-0998-47d2-bfa9-8b97625f0bbb" contextRef="C_12297e5a-44ee-441e-b9cb-846681e357f4" name="inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97768eb6-6411-47b0-93bd-aaaf8769dd6b" contextRef="C_a4df3b3b-267d-4f2f-ac89-6815c2bbcdeb" name="inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab2e9365-6cbd-4af8-b7ba-e9e2ea1d82de" contextRef="C_69dda25f-8fec-4d6f-996d-0711b459c98b" name="inva:PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of royalty payments made by GSK under its agreements originally entered into with us, and since assigned to TRC in connection with the Spin-Off, including TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through July 20, 2022, which royalties were upward tiering and ranged from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c330fe29-7676-4005-9754-e7aff32e419a" contextRef="C_a6a8f2c7-57be-445e-a3e7-ce078fc2faae" name="inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fb2dce7-ad08-40f3-a02f-bc224d92a213" contextRef="C_0d1b8490-4789-4372-801e-fc2120c8f801" name="inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Product Sales</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b0b3ecc-c286-4275-92ae-aee0065e3859" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total net product sales was as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.09%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.683%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.683%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.683%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GIAPREZA&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bda63b53-b8e7-4a48-b513-dc5a83c69e4a" contextRef="C_22346f7a-9d5b-4adb-8126-334786efe7ee" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,037</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03de6407-949e-44c9-9cc9-9f862b137834" contextRef="C_5e383c8b-3da2-4e7d-b954-1e85556222ef" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,294</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf688683-aa7a-461b-9df8-18095ffe8a04" contextRef="C_e2f7f140-5330-4553-9a9c-7f6c89b789b9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,214</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XERAVA&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd0ea8d2-55f0-43e4-aac1-de7f79fce4d3" contextRef="C_8072618f-1ec5-41e4-b16b-b78997fa817e" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,385</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_119a0f49-a5f2-4d4b-81c7-4758e83697ad" contextRef="C_c0508c79-209c-45e5-bf7c-169aef8d5660" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,320</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0280738f-f6eb-4464-936c-741cc7a13fa9" contextRef="C_70e43fac-bdea-4cfc-a822-8d3ad323984c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,480</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XACDURO&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cdbe933-b238-4ccc-913c-5fcb9c4bad42" contextRef="C_ca06b77f-bf5f-4b7f-be32-bdeda8df9e1b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,070</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b37f600-6f3a-46e5-93e2-4ed996e8ff7e" contextRef="C_783d44e6-75e9-4b12-8062-6bfba06d75c3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,003</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae8d3a31-c790-4c93-8fa0-9a347abe85e0" contextRef="C_bb3e4de1-feb6-492e-8578-81257488368b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;Total net product sales</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9336f4a7-d488-49ed-9bb1-cd7b17130fa5" contextRef="C_360b25f8-0668-427b-a0a4-5664f61139d0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,492</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e18a596-e93b-4761-a7db-e8cd4426503a" contextRef="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,617</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80602424-a6e3-4b42-b9a0-c0dfe18c1824" contextRef="C_5762c44d-7963-4357-b789-7869c9919cc7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,694</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">114</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_6a1ecc75-eb21-4e3e-acb2-49e941e83194_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We derived our net product sales:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fd8ce7e-bc2e-4a8e-958e-e2ad65fea7f9" contextRef="C_871709ce-1c50-4f9d-87be-84392f7a9aa9" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">83</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from customers located in the U.S. and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9257c100-e433-4757-bdc1-b35adaee92ae" contextRef="C_860a55ea-1154-443a-bb84-a8d6f8251458" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">17</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from the rest of the world for the year ended December 31, 2024; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5017a651-e841-4679-be34-84d7116ff337" contextRef="C_6a7b2f2b-6e3e-48ea-ab7f-7e1306be753c" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">91</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from customers located in the U.S. and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e6d117-e3fd-4b2a-9116-59a807b462aa" contextRef="C_b094271e-5af4-45b7-8a67-ea05cb064571" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from the rest of the world for the year ended December 31, 2023; and, </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1d9bf81-90af-4e78-a4cf-617f57fef41b" contextRef="C_9ccb7bd1-8f8b-4f56-a509-6035ce670328" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">96</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from customers located in the U.S. and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34689d5b-1e48-4067-9b87-587b1f3957e9" contextRef="C_954ad86b-4beb-4124-8fb8-95cf9f5505b6" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from the rest of the world from the date of acquisition of La Jolla, which occurred on August 22, 2022, to December 31, 2022.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License and Other Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to the out-license agreement with Zai Lab and Everest in Note 4, &#8220;License and Collaboration Arrangements&#8221;.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:LicenseAndCollaborationArrangementsDisclosureTextBlock" escape="true" continuedAt="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. LICENSE AND COLLABORATION ARRANGEMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Out-License Agreements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zai Lab</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entasis entered into a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. (&#8220;Zai Lab&#8221;) (Nasdaq: ZLAB), pursuant to which Zai Lab licensed exclusive rights to durlobactam and SUL-DUR, in the Asia-Pacific region (&#8220;the Zai Agreement&#8221;). Under the terms of the Zai Agreement, Zai Lab will fund most of the registrational clinical trial costs in China for SUL-DUR, with the exception of Phase 3 patient drug supply of licensed products. Zai Lab will conduct development activities and plan and obtain regulatory approval in a specified number of countries in the Asia-Pacific region beyond China after receipt of regulatory approval of a licensed product in China. Zai Lab is also solely responsible for commercializing licensed products in the Asia-Pacific region and will commercialize licensed products for which it has obtained regulatory approval. We are obligated to supply Zai Lab with the licensed products for clinical development and, if the licensed product is approved, for commercial use for a certain period unless Zai Lab notifies otherwise. Zai Lab may take over manufacturing responsibilities for its own commercialization activities within a specified time period following the effective date of the Zai Agreement.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We ar</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e eligible to receive up to an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3b3eaa8-d1bf-45c3-b7b0-faaaa46739a8" contextRef="C_73b479b7-bd69-4e75-9afa-4ce0c8d93cbd" name="inva:FuturePotentialMilestonePayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">91.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in research and development support payments and development, regulatory and sales milestone payments related to SUL-DUR, imipenem and other combinations with the licensed products. Zai Lab will pay us a tiered royalty equal to from a high-single digit to low-double digit percentage based on annual net sales of licensed products in the territory, subject to specified reductions for the market entry of competing products, loss of patent coverage of licensed products and for payments owed to third parties for additional rights necessary to commercialize licensed products in the territory.  Payments received for research support and reimbursable clinical trial costs are recorded as a reduction to research and development expense during the period in which the qualifying expenses are incurred. Such amounts recorded </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the years ended December 31, 2024 and 2023 were not material. SUL-DUR was approved by China&#8217;s National Medical Products Administration in May 2024, and we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0edb051-2b50-4f2b-9b46-ac36c27a38f9" contextRef="C_a41714b7-a00f-481f-be71-d01b3d66ce35" name="inva:LicenseRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in license revenue for the year ended December 31, 2024 under this agreement. Following the approval of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by the FDA in May 2023, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7733501c-40b5-450d-aff3-4df016ac398a" contextRef="C_cb1c40b3-5c1e-420b-883d-1af63b9dae15" name="inva:LicenseRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license revenue for the year ended December 31, 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2024, we entered into an amendment to the Zai Agreement (the &#8220;Amended Zai Agreement&#8221;), pursuant to which Zai Lab shall share costs associated with certain new manufacturing and technology transfer activities for XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#8220;Services&#8221;), which were not contemplated under the Zai Agreement and are crucial for regulatory approval in the Asia-Pacific region. We determined that the Amended Zai Agreement falls within the scope of ASC 606 and Zai Lab is a customer in this arrangement as the Services are an output of our ordinary activities. We have determined that the Services represent the only performance obligation and are distinct from the performance obligations under the original Zai Agreement. In addition, the expenses we incur in performing the Services most accurately depict the transfer of value to Zai Lab and maximize the use of observable inputs for measuring progress, therefore, we recognize revenue from this arrangement as the expenses related to Services are incurred. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d71ae962-47ee-4f60-954f-0aba3bede805" contextRef="C_d4eaab11-5036-4fa2-80f4-ac4c6edacc5d" name="inva:LicenseAndOtherRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license and other revenue for the year ended December 31, 2024 under the Amended Zai Agreement, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14cab333-e1ef-4fce-bdd4-2eb3754aeaa1" contextRef="C_d03f0f85-cb5e-446d-9bac-86efb022c8e6" name="us-gaap:AccountsReceivableNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is included in &#8220;Accounts receivable&#8221; in our consolidated balance sheet as of December 31, 2024.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">115</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_1" continuedAt="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2024, we entered into an interim supply agreement with Zai Lab, under which Zai Lab shall purchase XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inventory (the &#8220;Supplied Inventory&#8221;) for their commercial launch. We have determined that this agreement falls within the scope of ASC 606. Zai Lab is a customer and the Supplied Inventory is an output of our ordinary activities. We have also determined that the Supplied Inventory represents the only performance obligation and is distinct from the performance obligations under the Zai agreements discussed above. Furthermore, we evaluated that the performance obligation is satisfied over time and that a cost-to-cost measure of progress would be the measure of progress that most accurately depicts the transfer of value to Zai Lab and maximizes the use of observable inputs to measure progress. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16a7b5e5-f650-418d-952e-0b30017cf962" contextRef="C_af5e6a83-99f4-4f15-91c5-d548183e4cf6" name="inva:AmountOnNetProductSalesRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net product sales for the Supplied Inventory for the year ended December 31, 2024, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47de6dc4-c446-4613-b5eb-5ec6eee8058e" contextRef="C_d4a55873-42fb-4f4d-8ae0-0c16e81de797" name="us-gaap:AccountsReceivableNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is included in &#8220;Accounts receivable&#8221; in our consolidated balance sheet as of December 31, 2024.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also entered into a manufacturing stage transfer agreement with Zai Lab in June 2024, which was amended in September 2024 (the &#8220;Zai Manufacturing Stage Transfer Agreement&#8221;). Pursuant to this agreement, Entasis shall provide assistance to Zai Lab for building out Zai Lab&#8217;s manufacturing site for XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and be compensated for Entasis' services and associated costs. We have determined this agreement falls within the scope of ASC 606. Zai Lab is a customer and the transfer service is an output of our ordinary activities and represents our only performance obligation, which is distinct from the performance obligations under the Zai agreements. Furthermore, we have evaluated that the performance obligation is satisfied over time and that the costs we incur in performing the transfer service most accurately depicts the transfer of value to Zai Lab and maximizes the use of observable inputs for measuring progress, therefore, we recognize revenue from this arrangement as the services are provided and the costs are incurred. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba064afb-85a2-4a0a-acdb-d71b9d4d8d37" contextRef="C_8e904088-1404-41dd-83e8-637489e1cb2c" name="inva:LicenseAndOtherRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license and other revenue for the year ended December 31, 2024 under the Zai Manufacturing Stage Transfer Agreement, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_badc3593-da50-4f80-8cd7-56ab6f6628aa" contextRef="C_55ac6c23-a2e6-4ccc-84fe-98d81ce04dce" name="us-gaap:AccountsReceivableNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is included in &#8220;Accounts receivable&#8221; in our consolidated balance sheet as of December 31, 2024.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, we entered into a letter agreement pursuant to which Zai Lab will purchase regulatory starting material (&#8220;RSM&#8221;) supply  for use in the production of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_606a79ce-4d88-4804-80f5-b77f98a4d22d" contextRef="C_fc9a0b8f-f975-48ca-a3e6-9b76b08bd568" name="inva:LetterAgreementForPurchaseOfMaterialUsedForProductionValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. We will supply the RSM while we continue to work on executing a commercial supply agreement with Zai Lab in accordance with the Zai Agreement. Based on our assessments, this agreement does not modify any of our existing contracts with Zai Lab discussed above and should be accounted for separately. We have also determined that this agreement falls within the scope of ASC 606. However, this does not meet the definition of a contract with a customer since the contract does not identify each party&#8217;s rights regarding goods or services. Accordingly, we deferred the consideration received amounting to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad8ea90a-1248-41f0-84a9-9e29e075adf9" contextRef="C_de99671a-3f86-4f93-b929-187c53e350a3" name="inva:BusinessCombinationDeferredConsideration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2024 in &#8220;Other accrued liabilities&#8221; until the execution of a commercial supply agreement, which will include all the required terms necessary for identifying each party&#8217;s rights regarding goods or services.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GARDP</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entasis entered into a collaboration agreement with the Global Antibiotic Research and Development Partnership (&#8220;GARDP&#8221;) for the development, manufacture and commercialization of the product candidate zoliflodacin in certain countries (&#8220;the GARDP Collaboration Agreement&#8221;). Under the terms of the GARDP Collaboration Agreement, GARDP will use commercially reasonable endeavors to perform and fully fund the Phase 3 registrational trial, including the manufacture and supply of the product candidate containing zoliflodacin, in uncomplicated gonorrhea. We recorded immaterial reimbursements from GARDP under this agreement as reduction to research and development expense during the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the GARDP Collaboration Agreement, GARDP was granted a worldwide, fully paid, exclusive and royalty-free license, with the right to sublicense, to use our zoliflodacin technology in connection with GARDP&#8217;s development, manufacture and commercialization of zoliflodacin in low-income and specified middle-income countries. We retained commercial rights in all other countries worldwide, including the major markets in North America, Europe and Asia-Pacific. We also retained the right to use and grant licenses to our zoliflodacin technology to perform our obligations under the GARDP Collaboration Agreement and for any purpose other than gonorrhea or community-acquired indications. If we believe that the results of the Phase 3 registrational trial of zoliflodacin would be supportive of an application for marketing approval, we are obligated to use our best efforts to file an application for marketing approval with the FDA within six months of the completion of the trial and to use commercially reasonable endeavors to file an application for marketing approval with the European Medicines Agency (&#8220;EMA&#8221;). Each party is responsible for using commercially reasonable efforts to obtain marketing authorizations for the product candidate in their respective territories.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">116</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_2" continuedAt="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_3"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PAION Pharma GmbH</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the PAION AG and PAION Deutschland GmbH (together and individually &#8220;PAION&#8221;) License, La Jolla granted PAION an exclusive license to commercialize GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the European Economic Area, the United Kingdom and Switzerland (collectively, the &#8220;PAION Territory&#8221;). We are entitled to receive potential commercial milestone payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c2d3e34-4490-46bf-bd19-3af8ff1a7a43" contextRef="C_f4ae3171-8820-4834-b2c2-1c6f94927a5e" name="inva:FuturePotentialMilestonePayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">109.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and double-digit tiered royalty payments. Royalties payable in a given jurisdiction under the PAION License will be subject to reduction on account of generic competition and after patent expiration in that jurisdiction. Pursuant to the PAION License, PAION will be solely responsible for the future development and commercialization of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the PAION Territory. PAION is required to use commercially reasonable efforts to commercialize GIAPREZA&#174; and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the PAION Territory. We have not recognized any revenue from PAION related to commercial milestones from the date of acquisition of La Jolla to December 31, 2024. Royalty revenue recognized under this agreement for the year ended December 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccab0dd6-6e1e-4fb2-8601-c5e33aab8536" contextRef="C_80aa6909-465c-42c3-b0b3-1b95cbf1839b" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Royalty revenue recognized under this agreement for the year ended December 31, 2023 and from the date of acquisition of La Jolla to December 31, 2022 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4c8542c-6c31-49a7-8ef0-547ded8443cf" contextRef="C_56f936fd-c826-462c-938f-240f31460844" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_7d754cf8-91b3-46cc-b096-1f1b8c7b0865" contextRef="C_cbc4cdee-389a-4cf9-b9af-2f7d95792201" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">La Jolla also entered into the PAION commercial supply agreement (the &#8220;PAION Supply Agreement&#8221;) whereby La Jolla will supply PAION a minimum quantity of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through July 13, 2024. The PAION supply agreement will automatically renew until the earlier of July 13, 2027, or until a new supply agreement is executed. During the initial term of the supply agreement, we will be reimbursed for direct and certain indirect manufacturing costs at cost. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e01973a6-78c7-4ff9-8e5a-15e0047e7e70" contextRef="C_31a5145f-3c5c-445c-8566-35efc89d880a" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cost reimbursements under this agreement for the year ended December 31, 2023. Amounts recognized under this agreement for the year ended December 31, 2024 and from the date of acquisition of La Jolla to December 31, 2022 were not material.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAION filed for insolvency in Germany on October 27, 2023 and the insolvency proceedings commenced on January 1, 2024. PAION announced on December 22, 2023 that it concluded negotiations with Humanwell Healthcare Group and entered into an agreement on the sale of the essential business operations of PAION with the approval of the insolvency administrator in both procedures. In early 2024, the sale of business operations of PAION was completed and starting February 2024, PAION has continued its business as a subsidiary of the Humanwell Healthcare Group as an independent company under the name PAION Pharma GmbH.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Everest Medicines Limited</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Everest Medicines Limited (&#8220;Everest&#8221;) License, La Jolla granted Everest an exclusive license to develop and commercialize XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the treatment of complicated intra-abdominal infections (&#8220;cIAI&#8221;) and other indications in mainland China, Taiwan, Hong Kong, Macau, South Korea, Singapore, the Malaysian Federation, the Kingdom of Thailand, the Republic of Indonesia, the Socialist Republic of Vietnam and the Republic of the Philippines (collectively, the &#8220;Everest Territory&#8221;). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Everest License, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b893009-0f31-4ad1-8e29-f51f5300b24c" contextRef="C_9b5e3f73-d7e2-4436-a4cc-ebaba20abb28" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license revenue for the year ended December 31, 2023 as a result of an achievement of a regulatory milestone during the period. We are eligible to receive additional sales milestone payments of up to an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5586f9f7-2a1b-49c3-a0cd-3bde9bcb0800" contextRef="C_811f0ab4-b358-4bcc-bc70-9137747403ac" name="inva:SalesMilestonePaymentsReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also entitled to receive tiered royalties from Everest at percentages in the low double digits on sales, if any, in the Everest Territory of products containing eravacycline. Royalties are payable with respect to each jurisdiction in the Everest Territory until the latest to occur of: (i) the last-to-expire of specified patent rights in such jurisdiction in the Everest Territory; (ii) expiration of marketing or regulatory exclusivity in such jurisdiction in the Everest Territory; or (iii) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_50e4c2ab-ac0c-43d1-9c58-e81419cc9e38" contextRef="C_c806d5a2-f390-4c9d-b3ed-a166cdaae201" name="inva:RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years after the first commercial sale of a product in such jurisdiction in the Everest Territory. Royalty revenue recognized under this agreement for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8aadc97a-e41b-44e6-b0c9-e8663191c7c4" contextRef="C_43ebbba5-322d-4a57-9b5a-da8637cdeb0f" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a639f375-65f7-4f8b-b21f-88b6c75c246e" contextRef="C_f7f1eee0-388b-4fa8-9890-63be03fbd551" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Royalty revenue recognized under this agreement from the date of acquisition of La Jolla to December 31, 2022 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9ceba01-186c-40d4-91b9-16cc419e7963" contextRef="C_0b1f96f1-ab6d-47e4-9aef-4751a8f64e5a" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">La Jolla also entered into the Everest commercial supply agreement (the &#8220;Everest Supply Agreement&#8221;) whereby La Jolla will supply Everest a minimum quantity of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and will transfer to Everest certain XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-related manufacturing know-how. We were eligible to be reimbursed for direct and certain indirect manufacturing costs at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8a3f718-6b45-42a1-8fa9-a2fdc51bba5e" contextRef="C_a766e556-6ab5-4064-b9f0-b96a29676eab" name="inva:PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">110</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of cost through December 31, 2023. W</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d42874ea-6cf9-43bc-bcdc-4d6343efe8ca" contextRef="C_21159e50-9136-4f4e-a5d7-9312dd7ce1ce" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84216071-e239-458c-bd4f-f1bed5dbd481" contextRef="C_a766e556-6ab5-4064-b9f0-b96a29676eab" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in revenue under this agreement for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023, respectively. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a0f6cf6-4d36-43dc-abf3-0c951fe1b47d" contextRef="C_887080f2-8412-4508-9e41-bc1a8e2ff95e" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in revenue under this agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the acquisition of La Jolla to December 31, 2022.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">117</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_3" continuedAt="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_4"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-License Agreements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basilea</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2024, we entered into an exclusive distribution and license agreement with Basilea under which we were granted exclusive marketing rights to ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the U.S. The agreement will remain in effect until the expiration of market exclusivity of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. in 2034 (the &#8220;initial term&#8221;), subject to automatic renewal unless either party provides notice. We paid an upfront fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0898315-d1a6-4219-91f7-bc0c1a4f69c7" contextRef="C_a0ab4d8b-b98c-4423-b309-fa00f676612e" name="inva:UpfrontPaymentUnderIntangibleAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which we recognized as an intangible asset and will be amortized over the initial term of the agreement. We will exclusively purchase ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(pre-packaging and labeling) from Basilea throughout the term. We are also obligated to pay Basilea tiered royalties ranging from the high-teens to mid-twenties, as well as tiered milestones, on annual net sales in the U.S. We anticipate commercializing ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in mid-year 2025 and, therefore, have not incurred any royalties or sales milestone payments for the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">George Washington University</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the George Washington University (&#8220;GW&#8221;) License, GW exclusively licensed to La Jolla certain intellectual property rights relating to GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including the exclusive rights to certain issued patents and patent applications covering GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Under the GW License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We are obligated to pay a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4621f784-f14f-405f-ad9c-c5e8297434bb" contextRef="C_cc713bc3-dccb-47e9-8743-bf1aadadd990" name="inva:PercentageOfRoyaltyPayableOnNetSales" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% royalty on net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5be5751-bbe7-4b9d-839e-6c51d365e76b" contextRef="C_cc713bc3-dccb-47e9-8743-bf1aadadd990" name="inva:PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on payments received from sublicensees. The obligation to pay royalties under this agreement extends through the last-to-expire patent covering GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e53cb569-ddd8-4250-9dca-37390524676a" contextRef="C_cc713bc3-dccb-47e9-8743-bf1aadadd990" name="inva:AccruedRoyaltyObligations" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1849341b-2905-48f8-82d0-adaae10357e1" contextRef="C_0cc6ac22-c321-4787-9e00-3da335019c16" name="inva:AccruedRoyaltyObligations" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023, respectively, under this agreement. Amounts recognized from the date of acquisition of La Jolla to December 31, 2022 were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63b44398-e854-4f5b-bb7f-dc3f52c2b653" contextRef="C_d37f9324-54d5-4067-beb3-18876b2ba3f8" name="inva:AccruedRoyaltyObligations" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Harvard University</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Harvard University (&#8220;Harvard&#8221;) License, Harvard exclusively licensed to La Jolla certain intellectual property rights relating to tetracycline-based products, including XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including the exclusive rights to certain issued patents and patent applications covering such products. Under the Harvard License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell tetracycline-based products, including XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. For each product covered by the Harvard License, we are obligated to make certain payments for the following: (i) up to approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b992b57-6fdd-4dbb-b809-18d1aefa63fa" contextRef="C_119ad206-2058-450a-8e97-89fb20b4c812" name="inva:ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon the achievement of certain clinical development and regulatory milestones; (ii) a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dfc1e84-d780-48be-88c8-8d01cb967293" contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8" name="inva:PercentageOfRoyaltyPayableOnNetSales" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% royalty on direct U.S. net sales of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; (iii) a single-digit tiered royalty on direct ex-U.S. net sales of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, starting at a minimum royalty rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88293212-e852-45dc-ab71-6bc6bc999642" contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8" name="inva:PercentageOfMinimumRoyaltyRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, with step-ups to a maximum royalty of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_134761c6-4712-491d-93a3-b2e80d632e39" contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8" name="inva:PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% based on the achievement of annual net product sales thresholds; and (iv) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37def845-16cf-44b1-b11c-0ee8d9fdcd75" contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8" name="inva:PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on payments received from sublicensees. The obligation to pay royalties under this agreement extends through the last-to-expire patent covering tetracycline-based products, including XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a9bb652-130b-459a-bfac-1f3d3dcd7fdc" contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year ended December 31, 2024 under this agreement. For the year ended December 31, 2023, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a04d338-a431-49c6-82d9-a7561842e810" contextRef="C_74764868-362a-469f-82b3-5a8b74607e25" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as cost of license revenue under this agreement as a result of the license revenue we earned under the out-licensing agreement with Everest for the same period. For the years ended December 31, 2024 and 2023 and from the date of acquisition of La Jolla to December 31, 2022, royalties recognized under this agreement were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70600ceb-96b1-470b-a30f-40902132ff33" contextRef="C_2f78b292-f3be-4468-828a-00ca22c1d9e5" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_bd1ab1ec-c6bb-4e0b-a5b9-f48278363a24" contextRef="C_f51e917b-8e9a-4315-958f-c6e9da82aacf" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f3f84c2d-fd61-404f-9f5b-7b61b87e10a3" contextRef="C_d2ecd1f3-29e6-42cb-af2b-fc69c9589381" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Paratek Pharmaceuticals, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Paratek Pharmaceuticals, Inc. (&#8220;Paratek&#8221;) License, Paratek non-exclusively licensed to La Jolla certain intellectual property rights relating to XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including non-exclusive rights to certain issued patents and patent applications covering XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We were obligated to pay Paratek a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68893a42-ca95-44c5-aa0d-bb5faab91982" contextRef="C_8072618f-1ec5-41e4-b16b-b78997fa817e" name="inva:PercentageOfRoyaltyPayableOnNetSales" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% royalty based on direct U.S. net sales of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our obligation to pay royalties with respect to the licensed product was retroactive to the date of the first commercial sale of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and continued until there are no longer any valid claims of the Paratek patents, which expired in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f0a3b6ae-bc83-48c5-86cb-73ff6b579e00;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 2023</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. For the year ended December 31, 2023, and from the date of acquisition of La Jolla to December 31, 2022, amounts recognized under this agreement were not material.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">118</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_4" continuedAt="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_5"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Transfer and Subscription Agreement with AstraZeneca</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entasis entered into a Business Transfer and Subscription Agreement with AstraZeneca, AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP (collectively, &#8220;AstraZeneca&#8221;) (the &#8220;AstraZeneca Agreement&#8221;) in 2015, which was amended and restated through 2018, pursuant to which Entasis obtained, among other things, worldwide rights to durlobactam and zoliflodacin. Under the AstraZeneca Agreement, we are obligated to pay AstraZeneca a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ae098ce-9cb3-4ad3-b104-c44c9043a81d" contextRef="C_9a12f957-a828-4d75-944d-2087cd6938c1" name="inva:SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9668eeb9-4465-4ef7-9be0-cc7c83b60b76" contextRef="C_9a12f957-a828-4d75-944d-2087cd6938c1" name="inva:TermOfMilestonePaymentForNetSales" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of achieving a specified cumulative net sales milestone for durlobactam. We are also obligated to pay AstraZeneca a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24fbffaa-d446-43b6-ac9c-22e47547acaa" contextRef="C_9f3c3b1f-09d6-4eb0-b566-b7a7e7c47ec8" name="inva:SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ef8fa4d-8568-474e-be31-02799ff99c5e" contextRef="C_9f3c3b1f-09d6-4eb0-b566-b7a7e7c47ec8" name="inva:TermOfMilestonePaymentForCommercialSale" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of achieving the first commercial sale of zoliflodacin. Additionally, we are obligated to pay AstraZeneca tiered, single-digit royalties on the annual worldwide net sales of durlobactam and, the lesser of tiered, single-digit royalties on the worldwide annual net sales of zoliflodacin and a specified share of the royalties we receive from sublicensees of zoliflodacin. Royalties on sales of zoliflodacin do not include sales by GARDP in low-income and specified middle-income countries as discussed above. Our obligation to make these royalty payments expires with respect to each product on a country-by-country basis upon the later of (i) the 10-year anniversary of the first commercial sale of a product in each such country or (ii) when the last patent right covering a product expires in each such country.</span></p></ix:continuation></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8_5"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Royalty expense on durlobactam arising from our net sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the year ended December 31, 2024 and 2023 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0be2146f-b3eb-45ee-9403-e2b36395d1c7" contextRef="C_9a12f957-a828-4d75-944d-2087cd6938c1" name="us-gaap:RoyaltyExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_dfe84146-7fd8-4a11-ab50-6bab5f6e0708" contextRef="C_3c13a3c1-d391-437e-ab76-9807135c7a06" name="us-gaap:RoyaltyExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div><ix:nonNumeric id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:ConsolidatedEntitiesAndAcquisitionsTextBlock" escape="true" continuedAt="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. CONSOLIDATED ENTITIES AND ACQUISITIONS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Consolidated Entities</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Theravance Respiratory Company, LLC</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Up until July 20, 2022, we consolidated TRC under the VIE model as we determined that TRC was a VIE and we were the primary beneficiary of the entity because we had the power to direct the economically significant activities of TRC and the obligation to absorb losses of, or the right to receive benefits from, TRC. We held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b37bed71-7cb7-4e88-92a5-4652d43876bd" contextRef="C_3ad95b16-89e1-4def-b1ad-f62ba899efc6" name="inva:OwnershipInterestInConsolidatedEntities" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest of TRC. The primary source of revenue for TRC is the royalties generated from the net sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by GSK.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 3, &#8220;Revenue Recognition&#8221;, on July 13, 2022, ITH entered into the TRC Equity Purchase Agreement to sell our ownership interest in TRC. Upon the closing of the transaction on July 20, 2022, we received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_697f482f-5397-4e67-a2da-c419084ee5e3" contextRef="C_4f335e5e-75f0-4807-8256-9c44cb0e8135" name="inva:ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">277.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash from Royalty Pharma. We are also entitled to receive up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef0c0c6d-d0dc-4eef-b68f-e2fa3005cc97" contextRef="C_f35372e3-5a04-485a-8e05-1fd441950552" name="inva:ContingentSalesBasedMilestonePayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in contingent sales-based milestone payments in the future. In connection with the closing of the transaction, we also received our portion of TRC&#8217;s remaining cash balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f95743f8-f4ff-4ede-b0cc-595ebbed7efc" contextRef="C_c72b6c37-ed89-431f-8860-4f3a0138f363" name="inva:CashDistributionReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from Royalty Pharma rather than through a cash distribution from TRC.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the closing of the transaction and as part of the agreement, TRC distributed its ownership interests and investments in InCarda Therapeutics (&#8220;InCarda&#8221;), Inc., ImaginAb, Inc. (&#8220;ImaginAb&#8221;), Gate and Nanolive SA (&#8220;Nanolive&#8221;), which had a total carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2fe53d2-8c3a-4579-a7b0-88bcd3d8f4fc" contextRef="C_4f335e5e-75f0-4807-8256-9c44cb0e8135" name="inva:OwnershipInterestsAndInvestmentsCarryingValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">39.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to ITH. We accounted for the transaction similar to an upstream sale between a parent and a VIE under ASC 810-10. As such, ITH recorded the transferred investments at their respective carrying values and no gain or loss was recognized in the consolidated statement of income.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The summarized financial information of TRC from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC, is presented as follows:</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_96930374-e703-4469-914e-9870bfcf9f25" contextRef="C_d326d4eb-5d26-4172-b306-2eb5433f4c8d" name="inva:ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" escape="true">
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:75.96%;box-sizing:content-box;"/>
        <td style="width:2.2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:19.84%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5fbd848-9346-4cdb-9e51-bf473eee5e7c" contextRef="C_f9df7c1f-6bde-4e08-b0ca-c088b7bfec4d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,029</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f04b225-21cb-4cc0-86c4-bbcb52794fbf" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">332</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income from operations</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af726a8a-09f0-40e1-8f5c-58d02a84d212" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71,697</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e08ba2d0-981a-4584-a06c-00a27c2c906e" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Realized loss</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4dad297-b482-48af-970a-621fbb6b9952" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="inva:RealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,386</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd48f752-a4c2-4331-94d7-f88e477bde32" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and<br/>&#160;&#160;&#160;long-term investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7c7a849-00e7-42ab-ac33-4cdd89bfe71c" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="us-gaap:GainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,884</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc55800a-5ef2-4716-a92d-aafff3ca89a8" contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,438</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">119</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_1" continuedAt="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_2"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ISP Fund LP</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2020, Innoviva Strategic Partners LLC, our wholly owned subsidiary (&#8220;Strategic Partners&#8221;), contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_333bd71b-e4b0-4ca3-88f9-0dd1eb6ed114" contextRef="C_5f34def2-d4ef-45dc-9b5a-7b2dfd3ae646" name="us-gaap:LimitedPartnersContributedCapital" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">300.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to ISP Fund LP (the &#8220;Partnership&#8221;) for investing in &#8220;long&#8221; positions in the healthcare, pharmaceutical and biotechnology sectors and became a limited partner. The general partner of the Partnership (&#8220;General Partner&#8221;) is an affiliate of Sarissa Capital.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Partnership Agreement provides for Sarissa Capital to receive management fees from the Partnership, payable quarterly in advance, measured based on the Net Asset Value of Strategic Partners&#8217; capital account in the Partnership. In addition, General Partner is entitled to an annual performance fee based on the Net Profits of the Partnership during the annual measurement period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Partnership Agreement includes a lock-up period of thirty-six months after which Strategic Partners is entitled to make withdrawals from the Partnership as of such lock-up expiration date and each anniversary thereafter, subject to certain limitations. The lock-up period for the initial contribution of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc12f8d5-f529-41fe-bfbd-a424290a31ec" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441" name="inva:LimitedPartnersInitialContributionSubjectToLockUp" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">190.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which excludes the amount discussed below, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expired in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_575134d6-a304-419f-b46a-5cbe0a39b7e5;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2023</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, Strategic Partners received a distribution of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_515b9259-a21a-42fa-9455-385c748b5c5e" contextRef="C_bd235a25-25e3-4774-9cac-f96204385615" name="us-gaap:LimitedPartnersCumulativeCashDistributions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">110.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from the Partnership to provide funding to Innoviva for a strategic repurchase of shares held by GSK. On March 30, 2022, Strategic Partners made an additional capital contribution of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15461ce1-8d27-4b47-943f-ba240346bf7c" contextRef="C_d5601efb-6bb1-44cc-bbcc-ebfffed538f5" name="us-gaap:LimitedPartnersContributedCapital" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">110.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to the Partnership pursuant to the letter agreement entered into between Strategic Partners, the Partnership and Sarissa Capital Fund GP LP on May 20, 2021. The capital contribution is subject to a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3a4d4c7d-8d73-4925-92be-776eff3703fc" contextRef="C_bf2ff2aa-7c34-4e4f-9e97-336a5c293d40" name="inva:PartnershipAgreementLockUpPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> lock up period from the contribution date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consolidate ISP Fund LP under the VIE model as we have determined that ISP Fund LP is a VIE and we are the primary beneficiary of the entity via our related party relationships with Sarissa Capital entities. Our maximum exposure to loss is equal to the amount we invested in the entity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ISP Fund LP is determined to be an investment company under ASC 946, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Services &#8211; Investment Companies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as it meets all fundamental characteristics of an investment company, and its activities are consistent with those of an investment company. Since ISP Fund LP is subject to investment company industry specific guidance, we have retained the industry-specific guidance applied by the Partnership. In addition, as our investment in the Partnership is a passive investment for the Company and is not part of our main operations, the investments are presented as part of &#8220;Equity and long-term investments&#8221; in our consolidated balance sheets. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of our investments, which consist of cash and money market funds that we expect to be distributed in the next 12 months, were classified as ISP Fund investments in the consolidated balance sheet as of December 31, 2024, and the remaining equity investments managed by ISP Fund LP are expected to be distributed through April 2026. We report in our consolidated statements of income any investment gains and losses by the Partnership as part of &#8220;Changes in fair value of equity and long-term investments, net&#8221;, any interest and dividend income as part of &#8220;Interest and dividend income&#8221; and any investment expenses as part of &#8220;Other expense, net&#8221;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we continued to hold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_715ac01f-ce7b-4128-95c8-0d343128fd49" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441" name="inva:PercentageOfEconomicInterestInPartnership" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the economic interest of Partnership. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, total assets of the Partnership were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deca3025-49cc-440f-8aea-50043cc0f5cb" contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef" name="us-gaap:Assets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">255.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdfcb537-1b6d-41d7-98c6-36dabe8590c5" contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb" name="us-gaap:Assets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">311.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, of which the majority was attributable to equity and long-term investments. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, total liabilities of the Partnership w</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ere $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b7e735b-65f2-42c4-8e41-2289d9619aa0" contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> mill</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ion and $</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_98becb02-2e73-443f-8fdb-42c5c8b60d5a" contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The Partnership</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s assets can only be used to settle its own obligations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Partnership incurred</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57cb9c28-0ac6-4494-9162-e3bfb6e47dfa" contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322" name="inva:NetInvestmentRelatedIncomeExpensesEarnedInccured" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million in net investment-related expenses, generated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56e05bd9-225d-4f7a-8584-fe4158de14f0" contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million interest income, recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a1c45e5-9e41-46e8-b74d-a41d88acd347" contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322" name="us-gaap:GainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">5.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net realized losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75c61cdc-f2bf-4dea-96fc-f0dc8b15b6ab" contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">51.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. During the year ended December 31, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Partnership incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_727dec8a-6454-4364-aec5-c94af2d486b8" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441" name="inva:NetInvestmentRelatedIncomeExpensesEarnedInccured" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net investment-related expenses, generated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_383d5c7b-5855-4c35-aa3a-af9144e7b63f" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million interest income, recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6512d0e6-c77a-4d60-8f8f-f2cdca421d10" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441" name="us-gaap:GainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net realized losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0b13562-9ba6-42e7-be3d-2f6142b3ceff" contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">6.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. During the year ended December 31, 2022, the Partnership incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5aa10a2-c075-4701-90b2-5552aac417b6" contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad" name="inva:NetInvestmentRelatedIncomeExpensesEarnedInccured" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net investment-related expense, generated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a902d9b-69ad-4a58-88ad-5cf2e81df696" contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million interest income, and recorded net $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_681c3404-9791-40ef-9a7c-b6fedf41b893" contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad" name="us-gaap:GainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million realized gains and net $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5b93ba0-7c01-4966-a3d0-ca46ebe65c68" contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">9.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. We account for the long-term investments held by ISP Fund LP as of December 31, 2024 and 2023 and 2022 as equity investments measured at fair value.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">120</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_2" continuedAt="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_db5811f8-fb31-4969-9031-fcebfaaf8cf3" contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322" name="us-gaap:InvestmentTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of individual investments held by ISP Fund at each balance sheet date:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:61.232%;box-sizing:content-box;"/>
        <td style="width:1.78%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.603%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.78%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.603%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">In thousands</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock - Publicly traded healthcare companies</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d0d5da1-0c57-4f10-894c-7a9cea39e25b" contextRef="C_0d59aa40-0636-4b3f-ab3a-b5149a08e64b" name="inva:InvestmentsInCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84,039</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d5253ec-bf5b-4f64-8cdc-7353a4fec0ed" contextRef="C_40250a06-ba0d-4b97-9fa8-e40ff2902099" name="inva:InvestmentsInCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184,926</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United Kingdom</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6283b86e-2d9c-4427-a0bb-f6aa79ee2661" contextRef="C_6904c00c-1661-415e-91ce-09c91f2b890e" name="inva:InvestmentsInCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,989</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37f29caf-97ae-495d-b3ed-f677e5884983" contextRef="C_85da56fa-4ced-4862-83dc-c5baf8401a9d" name="inva:InvestmentsInCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,942</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcce0013-823b-4233-a35f-b4243ed9ccd2" contextRef="C_7abf372b-d434-4499-93a9-de44ea4152e4" name="inva:InvestmentsInCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,028</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee2fd56f-8771-49b5-a28d-dddd149bf9e9" contextRef="C_f204fe66-1d1c-4852-b65c-0af9b8cf2582" name="inva:InvestmentsInCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187,868</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock - Privately held healthcare companies</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0892b071-64da-440d-acba-6972bce7bae3" contextRef="C_2b29300e-dbc5-4ba4-9407-04aba97c4829" name="inva:InvestmentsInPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,591</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f634160-731c-45ed-a2c5-802dfcb19885" contextRef="C_95699a2d-0510-488b-b64d-b4503781f140" name="inva:InvestmentsInPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,530</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants - Privately held healthcare companies</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_176f2ea3-dfcc-435a-b2c6-2f9388a89bf2" contextRef="C_f7d20624-8417-4c34-b875-90b2c207e676" name="inva:InvestmentsInWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,507</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_833aca18-8cec-4525-99f2-ed3b87d00843" contextRef="C_bce3ec39-fa5f-485e-b142-ed955411c5d7" name="inva:InvestmentsInWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,075</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market fund and cash</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a17e55bd-55bd-4e3b-8c28-65a26be1457f" contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef" name="inva:MoneyMarketFundAndCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,532</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_783650c7-00e6-4a18-a886-bae2c3ad47ed" contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb" name="inva:MoneyMarketFundAndCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,339</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Total investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62dcc76a-eed1-435a-a88b-fe7903b52b07" contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef" name="us-gaap:Investments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">255,658</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5659cf6-b010-4bd3-81d4-40ecd61f1b93" contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb" name="us-gaap:Investments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311,812</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acquisitions</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Entasis Therapeutics Holdings Inc.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We started investing in Entasis in 2020 as part of our capital allocation strategy of deploying cash generated from royalty income and investing in different life sciences companies. Entasis at the time was an advanced, late clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products. Effective in June 2020, after certain conditions were met with respect to the sales of Entasis equity shares, Innoviva had the right to designate </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3c0886a-1832-4fbd-bded-b9c24b167c1a" contextRef="C_c5562d91-0351-4acd-8f6f-1aa83d60f185" name="inva:SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" unitRef="U_Director" decimals="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> members to Entasis&#8217; board. Our investment in Entasis consisted of shares of common stock and warrants to purchase shares of Entasis common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of Entasis&#8217; common stock was measured based on its closing market price at each balance sheet date. We used the Black-Scholes-Merton pricing model to estimate the fair value of the warrants.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 17, 2022, Innoviva Strategic Opportunities, LLC (&#8220;ISO&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> entered into a securities purchase agreement with Entasis pursuant to which ISO purchased a convertible promissory note for a total purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc0d7cc0-73e4-4bbb-9f37-77707490a020" contextRef="C_1ca55df9-e12f-4eef-88d2-5127dad03544" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The note bore an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2229348-6219-46b5-8e92-c2ffc9716f8b" contextRef="C_1ca55df9-e12f-4eef-88d2-5127dad03544" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.59</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and was due to mature and become payable on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_47da13c9-3667-4443-acf7-9a613c3e52a0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 18, 2022</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unless it was converted at a conversion price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6b4e121-53fd-48b2-86bb-bcf28c0ff136" contextRef="C_1ca55df9-e12f-4eef-88d2-5127dad03544" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.48</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> before the maturity date. With this financing, we determined that we had both (i) the power to direct the economically significant activities of Entasis and (ii) the obligation to absorb the losses, or the right to receive the benefits, that could potentially be significant to Entasis and therefore, we were the primary beneficiary of Entasis. Accordingly, we consolidated Entasis&#8217; financial position and results of operations effective on February 17, 2022. Our equity ownership interest remained at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad425fce-0af0-40af-864b-24743ba82172" contextRef="C_d7303d1d-5e66-4d3e-b842-3e3d5762046f" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">59.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% as of February 17, 2022, and the fair values of our holdings of Entasis common stock and warrants were remeasured and estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d064c47-041b-4341-af36-634649f4e163" contextRef="C_800010f4-85ba-4487-a1fc-d185935fa9c8" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">64.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b26cc93c-e390-4ca6-b5ad-62b6a67bc0fd" contextRef="C_d2fcd4b4-d9ae-4307-b911-8ce98ce50b0e" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">31.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The remeasurement resulted in a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29a93a59-e2ce-4947-88cf-4bc7c8044609" contextRef="C_43e76568-df93-454e-8619-b61f33c62f7f" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loss in the first quarter of 2022 which was included in changes in fair values of equity method investments, net, in the consolidated statement of income for the year ended December 31, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed our acquisition of Entasis&#8217; noncontrolling interest on July 11, 2022. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17df0877-0b41-4ee8-a6bb-2379904df645" contextRef="C_fca35291-33d2-4caf-8ebf-8a5264f15a1f" name="us-gaap:RepaymentsOfConvertibleDebt" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> payments were made toward the convertible promissory note through the date of acquisition of Entasis. In connection with the acquisition, all of the Entasis warrants were replaced with Innoviva warrants (the &#8220;Replacement Warrants&#8221;) of equivalent value and bearing the same terms. The Replacement Warrants were classified as equity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized the difference between the acquisition price and the carrying value of the acquired noncontrolling interest on July 11, 2022 in our additional paid-in capital.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values assigned to assets acquired and liabilities assumed as of February 17, 2022 were based on management&#8217;s best estimates and assumptions. After the acquisition in July 2022, we adjusted the purchase price allocation based on new and additional information related to product sales forecast provided by Entasis and deferred tax liabilities.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">121</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_3" continuedAt="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_4"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, we recorded measurement period adjustments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d454d72-bda0-4b4d-ba20-a3c73e449ebb" contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million decrease in goodwill, primarily related to a decrease in estimated purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccaba7db-619e-4b89-8c1f-cdc4ce84f919" contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188" name="inva:MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, an increase in noncontrolling interests of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9d2aa61-b189-412c-aa43-cd0cf85969cc" contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and an increase in intangible assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d68244bf-30a4-4f7d-9cbc-98a2337a4247" contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188" name="us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The cumulative impact of the measurement period adjustments included in the consolidated net income for the year ended December 31, 2022 was not material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2023, we recorded a measurement period adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fcc22f3-d56b-458a-be61-5f41e3f868e2" contextRef="C_de840e76-4090-4f91-aa27-ad5a96814016" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million increase in goodwill, primarily related to a decrease in intangible assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48f86a9c-fff7-4223-b352-6e955ee20a43" contextRef="C_de840e76-4090-4f91-aa27-ad5a96814016" name="us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and an increase in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff15a809-0a71-438f-8e12-c65a7c4ff0c7" contextRef="C_de840e76-4090-4f91-aa27-ad5a96814016" name="inva:IncreaseDecreasesInDeferredTaxLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The measurement period adjustment did not impact the consolidated net income for the year ended December 31, 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b3f51e3-ff2b-4d79-a1f3-0ca4de09507d" contextRef="C_c5562d91-0351-4acd-8f6f-1aa83d60f185" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the adjusted fair values of the assets acquired and liabilities assumed by us in the transaction:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.757%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">February 17, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06c1f39b-0bed-4c66-833f-80010985bad6" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,070</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4a2d7a6-a81c-4a13-9e22-d7d9bea0fb13" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,554</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbd172c5-b57c-44e7-a8f4-23cd965ab6fa" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,959</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46922f01-017f-457e-861b-2d614eb95fd1" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">185</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef39d7e8-0363-4a51-8670-50ecc8770427" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">959</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a21391b9-ecb6-4e79-971e-3100849d6b66" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,493</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cba967e5-a982-4476-a748-091f405a1e82" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_888f2304-3564-41a4-9822-4a42791176b2" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">302</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15966662-c873-4e16-9f08-49ebc00eb6a6" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,222</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dac0e20-bbf7-4424-b94a-e88e30653315" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,583</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued personnel-related expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_867423e1-97fe-43e9-80da-82d91c851fad" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,058</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d85413d-12af-4b77-85b9-70e466ee50d8" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,096</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8e6a041-5c86-4252-a635-ebdac952eaf7" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,769</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa895bdc-9d6a-446c-ab56-bd7424270bea" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,506</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d167af79-5c6f-4751-8b3b-748378467238" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">134,716</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The goodwill arising from the acquisition of Entasis is primarily attributable to Entasis&#8217; assembled workforce and the value associated with growing our business more efficiently. The goodwill from this acquisition is not expected to be deductible for tax purposes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 8, &#8220;Goodwill and Intangible Assets&#8221;, for more discussion on the intangible assets recognized as part of this acquisition.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the consolidation, we recognized a non-controlling interest of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd3cacb6-f602-4167-a2b6-97c937203dc4" contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">38.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of February 17, 2022. Our consolidated net income for the year ended December 31, 2022 included the net loss attributable to noncontrolling interest since the consolidation date until the date of acquisition of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1822e133-332f-4ac4-ba9a-0ca67d39f908" contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">13.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical Company</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 22, 2022, ISO acquired La Jolla for a total consideration of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e78995a0-a415-4840-94a4-e7893c49d6c7" contextRef="C_8db4f7ae-2913-425a-931f-161ffa81bc43" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">206.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. ISO acquired La Jolla at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2432ef9f-c1ba-42ca-9d87-f66f3f071af6" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessAcquisitionSharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.23</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. La Jolla brought to Innoviva an established product portfolio, including GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) for the treatment of complicated intra-abdominal infections (cIAIs). We incurred approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29777e0f-ef6c-4c20-94bc-53969be1d551" contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae" name="us-gaap:AcquisitionCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in acquisition-related costs in connection with this acquisition during the year ended December 31, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values assigned to assets acquired and liabilities assumed as of August 22, 2022 were based on management&#8217;s best estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">122</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_4" continuedAt="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_5"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, we recorded measurement period adjustments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb6a49df-aca3-4c8f-8ea9-387b3224c677" contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million increase in goodwill, primarily related to a decrease in inventory and intangible assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d592ba6-6e66-495f-af57-9258fc6830cc" contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">7.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b45c9f5-8980-4947-929c-9cd4149e0764" contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, and an increase in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f24d74e3-475c-4396-be73-245e85a68fb3" contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae" name="inva:IncreaseDecreasesInDeferredTaxLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, partially offset by a decrease in other long-term liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2eea392e-215b-4302-89bc-722d80681067" contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae" name="inva:MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">8.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The cumulative impact of the measurement period adjustments included in the consolidated net income for the year ended December 31, 2022 was not material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, we recorded a measurement period adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bd845ff-54bf-49a3-863e-449ef2cc9d0e" contextRef="C_315cbf77-929f-4504-ae65-d859fbee4836" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">13.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million decrease in goodwill, primarily related to an increase in deferred tax assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bc826ff-eaad-4783-8c55-4b9f125e6dcd" contextRef="C_315cbf77-929f-4504-ae65-d859fbee4836" name="inva:IncreaseDecreaseInDeferredTaxAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a decrease in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52c809ff-f17e-4786-b142-9994a5ac6d14" contextRef="C_315cbf77-929f-4504-ae65-d859fbee4836" name="inva:IncreaseDecreasesInDeferredTaxLiabilities" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In August 2023, we recorded a measurement period adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec0bf23a-5086-4df2-a165-02bb9aa333b3" contextRef="C_0998f113-0641-45f5-9ff6-c133558e2b1b" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million increase in goodwill, primarily related to a decrease in deferred tax assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82258c20-0469-4084-98f5-afa1f4be7ab4" contextRef="C_0998f113-0641-45f5-9ff6-c133558e2b1b" name="inva:IncreaseDecreaseInDeferredTaxAssets" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and an increase in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cbb1230-4b9f-46dd-87af-7928cf88b36e" contextRef="C_0998f113-0641-45f5-9ff6-c133558e2b1b" name="inva:IncreaseDecreasesInDeferredTaxLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The cumulative impact of the measurement period adjustments included did not impact the consolidated net income for the year ended December 31, 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29085341-6979-4499-8f0b-b0d3f9181aa6" contextRef="C_9ecfe93e-28e2-4228-ab4a-d3d1c23258a2" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the adjusted fair values of assets acquired and liabilities assumed by us in the transaction:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.757%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">August 22, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38e95b21-f133-4eaa-91b1-91a7b8f89c29" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,415</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term marketable securities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5853e499-db84-4fa7-9f19-4196228a352f" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">471</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7503420-1f41-4e45-aece-cdc61a604942" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5949d34-1d22-4bb2-8153-e76af6de86ac" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,200</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18596d08-5858-4334-9b91-931d0083b8d3" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,261</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9eabe2a-1f61-4092-9f1b-bd66f5d3935d" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">907</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3072101a-fa28-4f5e-8cad-9aa376c51e72" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eaa2d84c-beba-4486-8092-da5036c2a1d6" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">226</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a53b5f4c-88eb-4f2a-91a6-e9772f2fce34" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,411</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35e3d696-7ee8-47f0-bd04-2bc6041e4788" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_349e30af-03f5-45c6-b8f7-858fc58097cc" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,461</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79f42eff-5394-4843-9392-a246e9102c81" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">710</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41447f48-1c79-4f6a-a1ed-af7da47989c6" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">287,951</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3cd75ed-44bc-4478-90eb-db41d7dc3cac" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,237</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_beac0d53-6d6e-4f4a-abd2-f3557414f97b" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,849</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49c9fa11-f076-44e7-9292-a12dd392ade2" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,362</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3619de69-3b83-4097-99fa-9ede85d15a9e" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,944</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1933d0aa-6873-4a63-8c9a-623b949c2c85" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6399dfe7-811e-43ef-a3e1-8a475e2afa90" contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206,559</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The goodwill arising from the acquisition of La Jolla is primarily attributable to La Jolla&#8217;s assembled workforce and the value associated with leveraging the workforce to develop and commercialize new drug products in the future and growing our business more efficiently. The goodwill from this acquisition is not expected to be deductible for tax purposes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 8, &#8220;Goodwill and Intangible Assets&#8221;, for more discussion on the intangible assets recognized as part of this acquisition.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">123</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288_5"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pro Forma Financial Information</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_364b819c-798c-46d3-be48-7b0483d31068" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents certain unaudited pro-forma financial information for the year ended December 31, 2022 as if the consolidation of Entasis and La Jolla occurred on January 1, 2021. The unaudited pro forma financial information is presented for informational purposes only, and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place on January 1, 2021, or of results that may occur in the future. The unaudited pro forma financial information combines the historical results of the Entasis and La Jolla with the Company&#8217;s consolidated historical results and includes certain adjustments including, but not limited to, fair value adjustments to equity investments in Entasis&#8217; common stock and warrants, fair value adjustments to inventory, amortization of intangible assets, and interest expense on deferred royalty obligations and acquisition-related costs.</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.46%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_195e75d0-f36e-4220-8b0b-d843c69fd8bc" contextRef="C_5e46d5ce-f631-4674-8338-9c89eeeb502a" name="us-gaap:BusinessAcquisitionsProFormaRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,880</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68cfe885-9a28-4f5b-9667-75a9122588eb" contextRef="C_5e46d5ce-f631-4674-8338-9c89eeeb502a" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">204,987</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3617c870-ab2c-4b52-bc34-324b7940ec7d" contextRef="C_5e46d5ce-f631-4674-8338-9c89eeeb502a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214,390</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" escape="true" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. EQUITY AND LONG-TERM INVESTMENTS AND FAIR VALUE MEASUREMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity and Other Investments in Armata</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the first quarter of 2020, Innoviva acquired </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_066d7869-fd08-4b0f-9824-460634f22116" contextRef="C_bace799d-5f2c-4586-81a2-eeadbfadf867" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,710,800</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock as well as warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9486adca-9315-4706-b44e-f64be924bd40" contextRef="C_74893ac7-f1ad-41b2-845f-0c4f0fae42da" name="inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,710,800</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of common stock of Armata Pharmaceuticals, Inc. (&#8220;Armata&#8221;) for approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f22b335b-d37a-4ec9-8117-50c3e897ebc8" contextRef="C_d8708151-111b-4172-ac2c-b7620b8c6f75" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash. Armata is a clinical stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the first quarter of 2021, ISO entered into a securities purchase agreement with Armata to acquire </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42e4d9d2-2955-4999-b59d-f4191421a8a0" contextRef="C_04c41611-4dbc-4cb9-9783-2e7266319cc4" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,153,847</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Armata common stock and warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_566919a8-4edc-43e2-81b0-86691e661627" contextRef="C_5ed4602e-2cde-4ad0-8956-178ce6486089" name="inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,153,847</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of Armata common stock for approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2ca8916-76ef-42e4-b156-c47b8f62047f" contextRef="C_e708ed8d-1039-4ee7-a8a5-f30c4559229f" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Armata also entered into a voting agreement with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d895bd4-aec7-43c8-9889-12c45c211874" contextRef="C_93e7294b-aac4-4d69-a3eb-67d0b9c5c363" name="inva:VotingAgreementMaximumVotingRightsPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">49.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total number of shares of Armata&#8217;s common stock for voting on the matters related to election or removal of Armata&#8217;s board members. The voting agreement will expire on the earlier of the second anniversary of the agreement effective date and approval by the FDA of any of Armata&#8217;s product candidates for marketing and commercial distribution. During the fourth quarter of 2021, ISO also purchased an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e1af145-30fa-42b0-8ea6-44e8ab999065" contextRef="C_3d2c4b5a-dd7c-4736-8ce5-464b5a60b336" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,212,122</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Armata common stock for approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c519449d-adcf-4477-a3cd-42260cb0330d" contextRef="C_3d2c4b5a-dd7c-4736-8ce5-464b5a60b336" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 9, 2022, ISO entered into a securities purchase agreement with Armata to acquire </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3061b1d3-2f18-4bea-aeee-c6d0f590d81f" contextRef="C_24e20d06-ec1f-46a1-aa46-323dcfd90377" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Armata common stock and warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3abf3d0-54c7-4cb1-9a39-2a46adb127cf" contextRef="C_407f2692-c7b8-407e-92c4-03aef1a4ccda" name="inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of common stock with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d74e61f-f188-49ce-bfec-ad898310a8f6" contextRef="C_a34b6268-debd-4832-a5a5-28a87b2d6119" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa4a3d45-4b70-460d-a2b3-1f7f7fca30b4" contextRef="C_9f8444a3-22dd-4d19-a7e5-92b3a3636dd4" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">45.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The investment closed in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_409b9d9b-9f85-4c56-a950-1affe1927e00" contextRef="C_7140c906-62ed-4fc2-ae57-4d809ddc48a5" name="inva:SecuritiesPurchaseAgreementNumberOfTranches" unitRef="U_Tranche" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tranches on February 9, 2022 and March 31, 2022. The investment is intended to aid Armata in advancing its clinical pipeline and strengthening its bacteriophage platform.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 9, 2022, Armata also entered a second amended and restated voting agreement with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cee157c-35a0-4e8e-9c3d-e3dd355ad9d6" contextRef="C_30c301e3-2dfb-45b3-9f2b-eb72553bc22b" name="inva:VotingAgreementMaximumVotingRightsPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">49.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total number of shares of Armata&#8217;s common stock for voting on the matters related to election or removal of Armata&#8217;s board members or amend the bylaws of Armata to reduce the maximum number of directors or set the number of directors who may serve on the board of Armata. The voting agreement will expire the earlier of the second anniversary of the agreement effective date and approval by the FDA of any of Armata&#8217;s product candidates for marketing and commercial distribution. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8f766307-f2b2-4e45-abac-09c2dcfa0eb4" contextRef="C_30c301e3-2dfb-45b3-9f2b-eb72553bc22b" name="inva:SpecialTermReDesignatingBoardMemberToBoardOfInvestee"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b1d3dd5-95fe-42b6-907e-6a517b0fe28c" contextRef="C_86f5407c-66be-4a09-853c-3167aaf240a0" name="us-gaap:VariableInterestEntityOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding shares of Armata&#8217;s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata&#8217;s board of directors, and for so long as the Company and ISO hold at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81c845f8-900e-4ade-870c-8866aa1d3d77" contextRef="C_8c4fe90e-5515-4c29-8aa9-77a9d2df3e96" name="us-gaap:VariableInterestEntityOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, but less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6d846c5-0208-43af-83e9-b41ac5b04da7" contextRef="C_28c9f433-5923-40a8-82f6-7695aff7836d" name="us-gaap:VariableInterestEntityOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, of the outstanding shares of Armata&#8217;s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata&#8217;s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">124</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_1" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armata entered into an amendment to the amended and restated investor rights agreement with the Company and ISO, pursuant to which the Company and ISO agreed that the voting agreement will expire on the earlier of the fifth anniversary of the original agreement&#8217;s effective date, January 26, 2021, or the approval by the FDA of any of Armata&#8217;s product candidates for marketing and commercial distribution.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b41afd55-f962-4950-8b1b-cf2524ffc9fb" contextRef="C_f67ba5e9-a4db-472d-a2ac-c63d64b435b3" name="inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" unitRef="U_Director" decimals="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the seven </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">members of Armata&#8217;s board of directors are also members of the board of directors of Innoviva. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023, we owned approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f55e82d-a651-4836-b831-c6e34de5a68a" contextRef="C_e3ece156-7a9e-4032-aee8-a8d84b04dbc5" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">69.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0932ce3-804a-4e70-94a4-190152c07bef" contextRef="C_35f30426-4799-4508-968e-1f20db7a6efe" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">69.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of Armata&#8217;s common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1bcb3b54-a09d-4a56-8afd-9a0a5794d692" contextRef="C_131d7647-fc17-4fa2-92a5-8461ff6933d6" name="us-gaap:DebtInstrumentDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the &#8220;Credit Agreement&#8221;) with Armata, under which we invested in a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a61368d4-8e3a-440e-b787-f27e425138c6" contextRef="C_131d7647-fc17-4fa2-92a5-8461ff6933d6" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> convertible note (the &#8220;Armata Convertible Note&#8221;) in an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_524c7cdd-1c82-4869-b9c1-d4fb7d55f5ad" contextRef="C_a8b3a821-9b16-4dc5-8726-097101dcbe6d" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million at an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8bde519-f1a7-4fe5-9719-54e68f990405" contextRef="C_a8b3a821-9b16-4dc5-8726-097101dcbe6d" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">8.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pursuant to the Credit Agreement, the balance on the Armata Convertible Note, including all accrued and unpaid interest thereon, will convert into shares of Armata</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s common stock upon the occurrence of a qualified financing, as defined in the Credit Agreement. Any portion of the balance on the Armata Convertible Note, including all accrued and unpaid interest thereon, may also be converted into shares of Armata&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s common stock at our option once a registration statement covering the resale of such securities has been declared effective by the SEC. The Armata Convertible Note is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On July 10, 2023, ISO and Armata executed an amendment to the Armata Convertible Note extending the maturity date from January 10, 2024 to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a0b7c10e-04a7-4631-b6b1-0f34930da22c" contextRef="C_476f91df-e117-42e8-94a7-ab3a3ed891d1" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On November 12, 2024, ISO and Armata executed an amendment to the Armata Convertible Note extending the maturity date from January 10, 2025 to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2fec8c6f-1f87-4047-9c53-3b8bab5ed824" contextRef="C_e917c8c1-bfee-4f3b-9622-29aafad82d9f" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, ISO and Armata entered into a Credit and Security Agreement (the &#8220;July 2023 Credit and Security Agreement"), under which we extended a term loan to Armata (the &#8220;Armata July 2023 Term Loan&#8221;) in an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_652c16ba-c4ae-4320-8466-ddb7a9003232" contextRef="C_8e458ac2-46af-4572-9110-f35e62e6d593" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Armata July 2023 Term Loan is subject to an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_040d9587-9e85-45f2-9472-0d11e3edc609" contextRef="C_8e458ac2-46af-4572-9110-f35e62e6d593" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum and is due to mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_899bdbae-a252-4825-b79e-8bc5781da80a" contextRef="C_289bc6be-6e0d-435c-bf28-005e3d396793" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The July 2023 Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On November 12, 2024, ISO and Armata executed an amendment to the Armata July 2023 Term Loan extending the maturity date from January 10, 2025 to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_df2f8618-75cc-47b9-99c6-52ace48dc7d1" contextRef="C_ebd1ba78-29b1-4276-99d0-bd4af1213cd3" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 4, 2024, ISO and Armata entered into a Credit and Security Agreement (the &#8220;March 2024 Credit and Security Agreement&#8221;), under which we extended a term loan to Armata (the &#8220;Armata March 2024 Term Loan&#8221;) in an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15d3484e-d7da-4f0a-8384-23c3b2b5830d" contextRef="C_63d0bdb3-3078-4052-b347-b162b01e64c8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">35.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Armata March 2024 Term Loan is subject to an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_844be063-1d7b-4667-92c5-5f7823405045" contextRef="C_63d0bdb3-3078-4052-b347-b162b01e64c8" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum and is due to mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c01af864-5b59-46ca-84a9-d77d8d586404" contextRef="C_d53b733f-8e9d-41ed-97c2-c18ed44c87fd" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 4, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The March 2024 Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The investments in Armata&#8217;s common stock and warrants provide Innoviva and ISO the ability to have significant influence, but not control, over Armata&#8217;s operations. Armata&#8217;s business and affairs are managed under the direction of its board of directors, which Innoviva and ISO do not control. Based on our evaluation, we determined that Armata is a VIE, but Innoviva and ISO are not the primary beneficiaries of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for Armata&#8217;s common stock and warrants under the equity method using the fair value option. The fair value of Armata&#8217;s common stock is measured based on its closing market price. The warrants purchased in 2020, 2021 and 2022 have an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ca50fff-c2d5-4aba-bd73-e229c2bce3b8" contextRef="C_af82f89f-5808-49b5-b750-ff7de7d3e2f1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.87</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b6da923-08f8-4249-9247-cccf90ec834a" contextRef="C_8fce92ac-4906-42d1-b1ea-f1705723e3e7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4470e94e-c0ba-473f-b4e7-22667115532f" contextRef="C_edc9130d-8bac-4385-8abd-4f680377bf65" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, respectively. All warrants are exercisable immediately within </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b7fbecb-f970-49a3-9bdc-331f215cafe2" contextRef="C_2e2ce5a8-4015-4724-a5c6-e1c368237ec7" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_237c3c17-cf4b-4400-af70-6db71a5439cf" contextRef="C_704606a8-5b42-4a22-98f8-ab51052adab9" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_42deb166-ebbd-4d11-8fa6-4ad840908994" contextRef="C_0063e106-c957-4aaa-8a37-c9c8915894f5" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the issuance date of the warrants and include a cashless exercise option. We use the Black-Scholes-Merton pricing model to estimate the fair value of these warrants with the following input assumptions: Armata&#8217;s closing market price on the valuation date, the risk-free interest rate computed based on the U.S. Treasury yield, the remaining contractual term as the expected term, and the expected stock price volatility calculated based on the historical volatility of the common stock of Armata and its peer companies. We account for the Armata Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. We account for the Armata July 2023 Term Loan and the Armata March 2024 Term Loan as trading securities, measured at fair value using income approach based on the discounted value of expected future cash flows.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">125</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_2" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_3"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the fair values of our holdings of Armata common stock, warrants, the Armata Convertible Note, the Armata July 2023 Term Loan and the Armata March 2024 Term Loan were estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd7a8334-969f-4df0-9de5-30f636bf4050" contextRef="C_e8870f6b-cc59-4078-9d16-079206fad40d" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">46.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02080103-213b-4fdf-9a75-53a9d877ad2f" contextRef="C_4567075b-b913-4d0b-920a-5d6cbdb4427a" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81a05dd8-d621-4db0-9cb0-aa04e71c2022" contextRef="C_78c666f2-f708-4225-8f3e-243b11aa5167" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">42.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e0b2381-cef2-42f2-a249-57daea12a370" contextRef="C_304ecd1f-6a58-4044-a4fe-d0160d63a872" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million  and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cc93a1c-daae-4533-b8c3-65428b1677d4" contextRef="C_120c56d9-bec6-4a6e-9cc8-0e256aaacca2" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">39.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2023 the fair values of our holdings of Armata common stock, warrants, the Armata Convertible Note and Armata July 2023 Term Loan were estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29e03d07-d98a-4ae8-999c-3aab06daec72" contextRef="C_171e97bb-f74a-4c17-8063-b0dca204941d" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">81.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf74cb9c-00b1-4e9c-b241-837cfeb54a7b" contextRef="C_896fcd7e-679c-4d68-a83d-99ad390a46bd" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">35.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_027b87ad-2faa-440b-90f5-1d8cd7d1744d" contextRef="C_3aea5bf7-3984-4fb0-812f-c886790b0640" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">51.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04d94f18-3421-4ff2-8a78-a56ff2d9a72c" contextRef="C_71e50eda-66f4-437b-adb4-80b4249323a3" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">27.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata common stock and warrants, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bcbed72-7bb6-4be0-8960-b881ae4fab3b" contextRef="C_46c113f9-5e07-4c06-840b-d46df7900549" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">64.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e34f16b-a6d5-4214-8484-e09b76e8853f" contextRef="C_352aac51-ea35-49df-addd-f02b0882af4a" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">77.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94446927-e595-40f4-b19d-78a7ea8e828f" contextRef="C_6b4d38cc-2d5a-43e5-9152-e93c3f2a4d89" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">152.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses as changes in fair values of equity method investments, net, in the consolidated statements of income for the years ended December 31, 2024, 2023 and 2022, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata Convertible Note, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf7de83d-e3ef-4769-a7f0-2133bd931345" contextRef="C_09f27efd-eb03-4052-a5d2-3f4477a2daa4" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21ff3b8f-213a-4827-a052-e94e4cf54203" contextRef="C_7e8f2964-378b-406a-9a0b-b4b4284256f1" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata July 2023 Term Loan, we rec</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">orded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0be6d38-26c0-47f6-9547-7c5375a021d6" contextRef="C_61ad19f2-d970-4839-83ca-b0d913e3f96e" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_931a95a1-1718-4622-ab44-6b18b25524ee" contextRef="C_12f5776d-f333-4f0c-8ece-f5ae431ebdf9" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata March 2024 Term Loan, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25379660-4c47-426b-a50e-f4482cd54790" contextRef="C_d11819a9-3acf-4623-aa96-999f140f76e3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the year ended December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2fe2f2e1-8b1f-4516-b580-d944c03e3e54" contextRef="C_494c4421-3417-4b63-adc9-217af33b40df" name="inva:ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The summarized financial information, including the portion we do not own, is presented for Armata on a one quarter lag as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Balance Sheet Information</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"/>
        <td style="width:2.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.799999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.799999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">September 30,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bcd61f7-2f74-4236-b822-ebdbd87c771a" contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,389</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d1ad89f-d775-4984-972d-7090c8be1722" contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,585</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3499dc80-ec42-4c93-b382-b724cdce3b06" contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921" name="us-gaap:AssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,848</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df5c513e-0d0a-43e1-ba22-027aaf04b173" contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809" name="us-gaap:AssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,176</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0165831b-081e-4bcf-8e3b-6089bd96be9e" contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,204</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_595809b4-9149-4120-ba95-832b9a413541" contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,884</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ee793c6-3218-4643-9beb-d0977b8621a0" contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921" name="us-gaap:LiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,006</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db87b8a4-c6cb-4c76-8e2d-1814d40e8076" contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809" name="us-gaap:LiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,263</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement Information</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Twelve Months Ended September 30,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ee860cd-9712-49eb-8710-9dccc73f7bb2" contextRef="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,467</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8a69214-2682-42a8-9065-6205f59ea1bf" contextRef="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,052</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a36f799-e7cd-4ec5-831d-f1aeaf1b162b" contextRef="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,446</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f373ea6-92c3-49da-86a1-0b5581a373e9" contextRef="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,476</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fdef1bc-1777-4448-9ecf-483ef2425956" contextRef="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">41,639</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00184b25-96fa-4599-a598-1daca5bc1c9b" contextRef="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,666</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da232f12-f918-4986-992d-de11898fe3e5" contextRef="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">41,363</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dc22819-3f90-4e8a-90b2-9762bc3f74b6" contextRef="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">59,512</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46f7590a-11bc-42b0-9a2c-2f65663cfdcd" contextRef="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,650</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Method Investment in Entasis</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the consolidation of Entasis&#8217; financial position and results of operations in February 2022, we accounted for Entasis as an equity method investment. Refer to Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;, for more information.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">126</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_3" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_4"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Investment in InCarda</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the third quarter of 2020, TRC purchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6463227-dc0f-4ac2-9c78-1b442901b498" contextRef="C_098b82e6-075b-4b93-995c-661389fb3815" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">20,469,432</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series C preferred stock and a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_647299f3-8d85-448c-8da3-eb1a422a3064" contextRef="C_098b82e6-075b-4b93-995c-661389fb3815" name="inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,117,358</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of Series C preferred stock of InCarda Therapeutics, Inc. (&#8220;InCarda&#8221;) (the &#8220;InCarda 2020 Warrant&#8221;) for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7c4e329-e82b-4b23-b3e8-75ba7ef3fce1" contextRef="C_ea976f60-5b5b-415c-b0c6-88e63b461b95" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which included $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dd5e6c4-1113-4e62-bea3-7ff29d2caff1" contextRef="C_098b82e6-075b-4b93-995c-661389fb3815" name="inva:DebtInstrumentTransactionCost" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of transaction costs. InCarda is a privately held biopharmaceutical company focused on developing inhaled therapies for cardiovascular diseases. The investment is intended to fund the ongoing clinical development of InRhythm</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (flecainide for inhalation), InCarda&#8217;s lead program, for the treatment of a recent-onset episode of paroxysmal atrial fibrillation. On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to Innoviva&#8217;s wholly-owned subsidiary, Innoviva TRC Holdings, LLC (&#8220;ITH&#8221;) all of TRC&#8217;s ownership interests and investments in InCarda. ITH has the right to designate one member to InCarda&#8217;s board of directors. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2311dee3-688b-4955-84e1-7e00b78a8ab6" contextRef="C_059d5bd5-1649-484e-8e7c-174600b0cb2b" name="inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" unitRef="U_Director" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ITH designee is serving on InCarda&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b6946ab-df5d-480a-8f9e-ffb56d790fca" contextRef="C_059d5bd5-1649-484e-8e7c-174600b0cb2b" name="inva:NumberOfBoardMembersOfInvestee" unitRef="U_Director" decimals="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-member board. We did not exercise the InCarda 2020 Warrant which expired in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ecf264a2-e5c5-444a-8a7b-06e825278547;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2023</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and wrote off its carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb41fd39-b9c2-4470-8901-bc4d51fb9fba" contextRef="C_79983aa1-6f85-41fc-9342-69b5e86a22d2" name="inva:WarrantCarryingValueWriteOffAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 9, 2022, TRC entered into a Note and Warrant Purchase Agreement (the &#8220;InCarda Agreement&#8221;) with InCarda to acquire a convertible promissory note (the &#8220;InCarda Convertible Note&#8221;) and warrants (the &#8220;InCarda 2022 Warrant&#8221;) for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_409d7706-cb06-4774-b49b-4e464fbbc3e7" contextRef="C_fd3f6642-082d-419b-8eb5-479c4509f29d" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.  The InCarda 2022 Warrant expires on March 9, 2027 and is measured at fair value.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 15, 2022, the principal amount and the accrued interest of the InCarda Convertible Note were converted into equity securities. In addition, TRC participated in InCarda&#8217;s Series D preferred stock financing by investing $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cccb609-63fc-4bad-a411-fdc6ddde3160" contextRef="C_dd1d30e1-e047-42a2-bdb5-3ef5926e79da" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In connection with the new round of financing, InCarda recapitalized its equity structure resulting in TRC owning </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bca483f6-a913-44ca-858e-c4c1032f60f8" contextRef="C_1e2ed4aa-4ec1-488a-9c05-da807b81c789" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,093,886</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of InCarda&#8217;s common stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bb9a919-e797-4b21-84d3-de42b310a434" contextRef="C_f9d8c18f-f9a7-412c-a350-a087bdc10db8" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">37,350</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series A-1 preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a9b5d91-b704-4cc3-b297-86fb83cb232a" contextRef="C_5844539a-fc91-4105-b8a3-cf46e12ce3bc" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">20,469,432</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series C preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae5817f4-0275-40d1-959b-37420000ab1d" contextRef="C_3a966812-a150-488f-a6ce-1883cd6184b4" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,771,780</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series D-1 preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e601537d-50db-4c54-8c6c-a6179d493d5c" contextRef="C_57dd6d3d-0988-40b1-b84f-ff3d06249917" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,369,802</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series D-2 preferred stock, a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3389b1c7-bdbd-4f75-b2b9-dc2fcda10258" contextRef="C_88a8178e-d76e-4fb2-9885-5ee2c0565071" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,117,358</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series C preferred stock at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f622170e-7e71-40f1-b706-18f2d84fbc64" contextRef="C_c4c638bd-9d2d-49eb-acd3-78cadbac2bb9" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.73</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40a5d21e-0476-41f4-9040-84b6850cf4a3" contextRef="C_9834684e-a81e-427b-ab67-3dce5473dd17" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,490,033</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series D-1 preferred stock at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9833b9ea-95f7-4822-baf0-087808e50f5b" contextRef="C_97ef981d-8088-4d68-9ed4-8e0a49d39c69" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, we held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f354c60c-c3b4-48cb-9002-588580f11eb8" contextRef="C_3fbaef98-117c-41ce-8102-e48e8c5bfa08" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">9.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_854f3a42-763a-4ccd-9520-b1cb872dd472" contextRef="C_65a78fed-9696-4e3e-a1e4-e3cc50d0f0d5" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">8.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of InCarda equity ownership, respectively. Our investment in InCarda does not provide us with the ability to control or have significant influence over InCarda&#8217;s operations. Based on our evaluation, we determined that InCarda is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With the exception of the InCarda Series D Warrants, which is measured at fair value, we account for the aforementioned investments in InCarda under the measurement alternative. Under the measurement alternative, the equity investment is initially recorded at its allocated cost, but the carrying value may be adjusted through earnings upon an impairment or when there is an observable price change involving the same or a similar investment with the same issuer. Due to InCarda&#8217;s equity recapitalization in the second quarter of 2022, TRC reassessed the value of its investments in InCarda using the Option Pricing Model Backsolve valuation methodology. Key assumptions used in the valuation model included an expected holding period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e23cc441-9bee-4f71-b85c-114836f22ea8" contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808" name="inva:ExpectedHoldingPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bce0223-708f-49a1-81d8-308d1e3a50f8" contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808" name="inva:RiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef9cf080-401b-47c8-809b-9d188ea8bcca" contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808" name="inva:DividendYield" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and an estimated volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edcf5405-e9da-44a9-b7e9-66851b330038" contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808" name="inva:PercentageOfEstimatedVolatility" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">122.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The estimated volatility was calculated based on the historical volatility of a selected peer group of public companies comparable to InCarda. We recognized an impairment charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86a9157d-9b40-42c8-aaa3-65e58d4ca6e2" contextRef="C_67cd523d-133e-42a5-8657-9f3bb1123823" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the second quarter of 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to certain changes in InCarda&#8217;s business operations during the second quarter of 2023, ITH reassessed the value of its investments in InCarda using the Option Pricing Model methodology. Key assumptions used in the valuation model included an expected holding period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5bb94c00-8ee3-4bfe-8322-a8396bff079b" contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59" name="inva:ExpectedHoldingPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_750d5032-04b9-48d9-a377-ed4c236b1667" contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59" name="inva:RiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59a98e0d-7c9a-4ec0-9c7a-6ac40ddcf8ca" contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59" name="inva:DividendYield" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and an estimated volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23cfa633-24b5-4097-8f63-4ba7df883196" contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59" name="inva:PercentageOfEstimatedVolatility" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">114.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The estimated volatility was calculated based on the historical volatility of a selected peer group of public companies comparable to InCarda. We recognized an impairment charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ec164b1-72fb-4d09-b0a5-138b75e99c56" contextRef="C_23437773-47f3-4a8c-96df-2a22fdd80f90" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the second quarter of 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 17, 2024, ITH purchased a secured convertible promissory note (the &#8220;InCarda Convertible Note&#8221;) from InCarda for a total purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6320c1e7-21f7-4987-83f9-bb0fa76b070f" contextRef="C_aaecb0e5-05bb-4c5d-b308-7ef6aad3d595" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The InCarda Convertible Note bears an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f6d1f0a-7988-4afb-a577-018a086771f7" contextRef="C_aaecb0e5-05bb-4c5d-b308-7ef6aad3d595" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and shall be due and payable upon the earlier to occur of certain events defined in the InCarda Convertible Note. The InCarda Convertible Note will convert into equity securities or shadow equity securities of InCarda depending upon the occurrence of a qualified event or a qualified financing event as also defined in the InCarda Convertible Note. The InCarda Convertible Note is secured by certain intellectual property rights of InCarda. We account for the InCarda Convertible Note as a trading security, measured at fair value.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">127</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_4" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_5"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, we recorded as equity and long-term investments in the consolidated balance sheets $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c21fc4a-b69e-4367-a87a-ffbfa2f92a72" contextRef="C_2448232b-60b4-48e6-82a0-b32e49c6f1a9" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_225279b2-89e7-44e9-bb3c-9321d2de240f" contextRef="C_9f5b3843-bdf0-4930-818a-6eed731e4cdf" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.8</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in carrying amount of InCarda&#8217;s Series C preferred stock and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d45cd3a9-3e19-48fe-9593-4c462a8d4b41" contextRef="C_ca91671c-9ec7-444f-b685-f851204f4fc9" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ee49dd51-6db8-4347-a941-4438f8bc43e8" contextRef="C_c82dd715-d624-49e4-bfe0-b1715409db9e" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in fair value of the InCarda Series D Warrants. As of December 31, 2024 and 2023, we recognized as equity and long-term investments in the consolidated balance sheets $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_039199a8-80d5-4b61-ab02-60a40d9f38a2" contextRef="C_803eb231-cd56-4e30-91d1-f2707f4586a4" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f433663a-60f1-4cfd-8b43-e4bc393e3293" contextRef="C_9dc62cdf-a86b-443a-a322-c99a58facc5a" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, for InCarda&#8217;s Series D-1 preferred stock, Series D-2 preferred stock, and common stock using the measurement alternative. As of December 31, 2024, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_569e0a12-f649-4546-b4ca-089006d2c786" contextRef="C_02d745cd-51ee-4828-8e80-e16af93855c7" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in fair value of the InCarda Convertible Note as equity and long-term investments in the consolidated balance sheet. During the year ended December 31, 2024, there were immaterial changes in the carrying amount of our investments. We recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b65f1d3c-82ba-45ad-a5ad-d53dcfb9f8c9" contextRef="C_912bc1dc-313a-4987-ba8e-17bf34333339" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62772999-edf0-4d90-bd35-84303fab4b22" contextRef="C_fa7da83e-f568-43a7-8a21-c4860f759a4b" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in unrealized loss as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2023 and 2022, respectively.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Investment in ImaginAb</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 18, 2021, TRC entered into a securities purchase agreement with ImaginAb, Inc. (&#8220;ImaginAb&#8221;) to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dc39e81-25a4-4f53-89bf-9f10ec4c3519" contextRef="C_8dc1a082-9478-46f1-b22f-0fda99922d9a" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,051,724</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb Series C preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5552ef12-6b3a-4803-92b8-1e6cfb5bb34a" contextRef="C_8dc1a082-9478-46f1-b22f-0fda99922d9a" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On the same day, TRC also entered into a securities purchase agreement with one of ImaginAb&#8217;s common stockholders to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d305b822-1414-47e7-9c10-65513db2af6b" contextRef="C_b98c6805-e143-4159-8b6d-0216ea55b874" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,097,157</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb common stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ceb0646-4e14-4ebc-ae1d-417fe890b906" contextRef="C_b98c6805-e143-4159-8b6d-0216ea55b874" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. ImaginAb is a privately held biotechnology company focused on clinically managing cancer and autoimmune diseases via molecular imaging. $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19ef5546-1ae7-4985-96b1-a94319bc7256" contextRef="C_c3e70cef-b906-408c-8288-908907c15a65" name="inva:TransactionCostsIncurredInConnectionWithEquityInvestment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was incurred for investment due diligence costs and execution and recorded as part of the equity investment in the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#8217;s ownership interests and investments in ImaginAb.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 14, 2023, ITH entered into a securities purchase agreement with ImaginAb to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb1e08d1-e279-4d87-863b-183fcf6eb5ae" contextRef="C_d22b266a-b99c-45a0-8ac0-e3851917bcf6" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">270,568</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb Series C-2 preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce5ac1f7-a167-4106-8e58-4bcf0d49e00e" contextRef="C_d22b266a-b99c-45a0-8ac0-e3851917bcf6" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On September 14, 2023, ITH entered into a securities purchase agreement with ImaginAb to purchase another </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15f6b1a3-f087-4397-a38f-c7a60c47ff63" contextRef="C_331dc9af-0e1f-47b2-a30d-d84e5a653bda" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">405,852</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb Series C-2 preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65372e8b-1400-48f0-8c7b-b569a337d12f" contextRef="C_331dc9af-0e1f-47b2-a30d-d84e5a653bda" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 23, 2024, ITH purchased a subordinated convertible promissory note (the &#8220;ImaginAb Convertible Note&#8221;) from ImaginAb for a total purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c56e1eda-42f8-4528-8c84-62ece3ff1d02" contextRef="C_ea058057-5a8c-4679-b02b-d77e73b481e6" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The ImaginAb Convertible Note bears an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31c0a236-f9ed-462d-91af-13a9d330b6fd" contextRef="C_ea058057-5a8c-4679-b02b-d77e73b481e6" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and shall be due and payable upon the earlier to occur of January 31, 2025 and certain events defined in the ImaginAb Convertible Note. Under certain circumstances, the ImaginAb Convertible Note is convertible at the option of ITH into ImaginAb&#8217;s equity securities at defined conversion prices. The ImaginAb Convertible Note is subordinate to certain existing indebtedness of ImaginAb as defined in the ImaginAb Convertible Note. On October 31, 2024, ITH entered into an agreement with ImaginAb to amend the ImaginAb Convertible Note. Pursuant to the agreement, the principal amount of the ImaginAb Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09952456-f8fe-4cb4-809b-3f71b8c4b278" contextRef="C_67dabe6c-1f60-48af-9f2b-2dac4085e3c8" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1df2d361-8ef5-4675-a068-ace57b431431" contextRef="C_7f01ba3d-3b8a-46ef-b6ed-b35a2187ddb1" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal as of February 23, 2024, accrued interest as of amendment date, commitment fees and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bea244e0-244a-4b68-bec3-f291a1d2ea53" contextRef="C_df36bca4-34e2-4f01-a21b-2939200a4237" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On January 13, 2025, ITH and ImaginAb executed an amendment to the ImaginAb Convertible Note extending the maturity date from January 31, 2025 to May 30, 2025. All other material terms of the ImaginAb Convertible Note were unchanged during the aforementioned amendments to the ImaginAb Convertible Note. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6112f21b-6860-4d93-8529-48849d41c55c" contextRef="C_da6eff04-3c1c-4959-abe9-fe3dfca5c630" name="inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of ImaginAb&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84a59838-ed64-46a3-b710-ba6a0abfafaf" contextRef="C_da6eff04-3c1c-4959-abe9-fe3dfca5c630" name="inva:NumberOfBoardMembersOfInvestee" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen">six</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> board members was designated by ITH. As of December 31, 2024 and 2023, we held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67bba561-b4d0-4fa7-8503-f330f583d402" contextRef="C_6d3efb43-3699-4ae8-a66b-6ac082761119" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">11.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1dd3553-d4ec-4ecd-8273-98decbeb14d7" contextRef="C_83b93379-94aa-47ed-9eb3-7b3158980925" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of ImaginAb equity ownership.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our investment in ImaginAb does not provide us with the ability to control or have significant influence over ImaginAb&#8217;s operations. Based on our evaluation, we determined that ImaginAb is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because ImaginAb&#8217;s equity securities are not publicly traded and do not have a readily determinable fair value, we account for our investment in ImaginAb&#8217;s Series C preferred stock, Series C-2 preferred stock and common stock using the measurement alternative. We account for the ImaginAb Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. As of December 31, 2024 and 2023, our investment in ImaginAb&#8217;s Series C preferred stock, Series C-2 preferred stock and common stock amounted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bf9036b-7e4c-4e3c-bf10-4a3c4248c957" contextRef="C_8d315a2b-2c71-4420-b013-dfe4ca2986c3" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c91b0ef7-93b9-410a-ab76-1f2acb685867" contextRef="C_919d35a4-18d4-429f-9131-8121ce8b768d" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.6</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and recorded as equity and long-term investments in the consolidated balance sheets. As of December 31, 2024, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38636861-f4cd-401c-810f-4452469df099" contextRef="C_c277363b-a707-4b73-871a-b77a92df3c6f" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in fair value of the ImaginAb Convertible Note as equity and long-term investments in the consolidated balance sheets. During the year ended December 31, 2024, we recorded </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ce1b8c8-18c8-42b5-9fba-5cc0c70eea46" contextRef="C_1fcc8f6c-3778-4f03-9b9f-4a242c10fa7e" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net unrealized gain</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on the ImaginAb Convertible Note as changes in fair values of equity and long-term investments, net, in the consolidated statements of income. There was no change in the carrying amount of our equity investments in ImaginAb.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">128</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_5" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_6"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Promissory Note in Gate Neurosciences</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 24, 2021, TRC entered into a Convertible Promissory Note Purchase Agreement with Gate to acquire a convertible promissory note (the &#8220;Gate Convertible Note&#8221;) with a principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2dd9dfe-a3ce-4d00-a233-6f2b615afdc5" contextRef="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Gate is a privately held biopharmaceutical company focused on developing the next generation of targeted nervous system therapies, leveraging precision medicine approaches to develop breakthrough drugs for psychiatric and neurologic diseases. The investment is intended to fund Gate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s ongoing development and research. The Gate Convertible Note bears an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_801fbc8a-3dc1-44b8-aed0-51f24a9070fd" contextRef="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and will convert into shares of common stock of Gate upon a qualified event or into shares of shadow preferred stock of Gate (&#8220;Shadow Preferred&#8221;) upon a qualified financing. A qualifying event can be a qualified initial price offering, a qualified merger, or a merger with a special-purpose acquisition company (&#8220;SPAC&#8221;). Shadow Preferred means preferred stock having identical rights, preferences and restrictions as the preferred stock that would be issued in a qualified financing.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c9984c34-21f4-45f5-b7a9-bd1dc0c431a7" contextRef="C_5113ca40-db4d-493a-87c2-9a406e584ece" name="inva:NumberOfCommonStockIssuedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of common stock shares to be issued in a qualified event shall be equal to the amount due on the conversion date divided by the lesser of a capped conversion price (the &#8220;Capped Conversion Price&#8221;) and the qualified event price (the &#8220;Qualified Event Price&#8221;). The Capped Conversion Price is calculated as $50.0 million divided by the number of shares of common stock outstanding at such time on a fully diluted basis. The Qualified Event Price is the price per share determined by the qualified event. A qualified financing is a sale or series of sales of preferred stock where (i) at least 50 percent of counterparties are not existing shareholders, (ii) net proceeds to Gate are at least $35.0 million, and (iii) the stated or implied equity valuation of Gate is at least $80.0 million.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#8217;s debt investments in Gate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 2, 2023, ITH entered into a Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78beef4d-5fae-4c27-bc0c-2850779a7760" contextRef="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7331d16-7f42-4f61-80b1-4c75476f3c4a" contextRef="C_94e7195f-0034-4d0a-b5fd-de56d9a2582b" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the original principal, accrued interest as of the amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21ab9bcc-84f2-41cd-b9a4-5ab1b03dad62" contextRef="C_4a162331-f161-4794-bd50-e44d082bee98" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 6, 2023, ITH entered into a Second Note Amendment Agreement with Gate to amend the Note Amendment Agreement. Pursuant to the Second Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25b8ae9f-e89c-4e9b-a299-494cf4d63b8e" contextRef="C_df05c425-3a4a-4cd4-aa36-806e2fe0da51" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbfdf9ba-e6b3-4a51-b39c-11129e7aaee7" contextRef="C_5b6b74d6-5ba3-490c-a58b-c2fa128f4c16" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">27.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the amended principal as of February 2, 2023, accrued interest as of the second amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a72bb9b9-a5e8-45a2-a919-8c8386a57204" contextRef="C_4bfeee2c-2c81-4b9f-a36f-d4540c545b48" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 13, 2024, ITH entered into a Third Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Third Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58a39e78-d383-4b34-9dda-80922941a9ff" contextRef="C_b0cd00d0-91fb-42d9-9cb7-ff204ac9ab0a" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">27.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00f38900-2749-4fb3-824c-644916bb64e8" contextRef="C_289ad2e3-11f8-4293-9451-51ca41bb9371" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">33.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal and accrued interest as of the third amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a69ed5dc-700a-4234-9e6d-69ff50c7a074" contextRef="C_8fda4892-a74f-4650-8ab9-7f27921d46c6" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2024, ITH entered into a Fourth Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Fourth Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0af8e27c-93ac-449e-962b-45ae08c55bcb" contextRef="C_c2913a02-9488-4628-8d44-e7cd7ed404b7" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">33.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fc3a244-a9e9-47e2-a46a-fafe6cb5d204" contextRef="C_191d279e-0f47-40c7-82d1-36a0fa78870f" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">39.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal and accrued interest as of the fourth amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dccb276-d9e1-4f34-8024-736e17fdd2b8" contextRef="C_a20abb89-800f-48d0-982d-8e767439c06e" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2024, ITH entered into a Fifth Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Fifth Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2aa177a5-ea56-4cba-b36a-f6017ae0703b" contextRef="C_7b46f925-454c-4214-b995-44ba572a8c1e" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">39.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dcb16ca-71de-424f-8c7a-5a889b35c332" contextRef="C_f4a8c22f-aba7-4e11-ad11-162e3d1ad7ef" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal and accrued interest as of the fifth amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da4d4e9c-bb2d-4f3b-8b19-71190ddaad05" contextRef="C_2c77d616-9e5d-408c-b20f-a0aaee7f6140" name="us-gaap:PaymentsToAcquireLongtermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms, except for the conversion terms of the Gate Convertible Note, remained unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">129</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_6" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_7"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have accounted for the Gate Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of equity value of Gate, risk-free rate, expected stock price, volatility of its peer companies, and the time until a financing is raised. As of December 31, 2024 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and 2023, the fair value of the Gate Convertible Note was estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5799ce00-3288-4592-b9e3-5748d7f6323e" contextRef="C_ca7032d1-65b7-44f3-9dff-4c953aea281c" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b3db199-5715-4dfe-8c61-2be221120a6d" contextRef="C_14d9f964-799a-438f-8197-61ae142e28d6" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">28.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, and recorded as equity and long-term investments in the consolidated balance sheets. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4781041a-b914-43f0-8824-6b879ba6a389" contextRef="C_aea775ec-f212-4854-8a33-38c7dcf9a97c" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of unrealized loss and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d09fa8c-71d8-4043-a142-3c6efe383b9e" contextRef="C_9b00860e-a4ec-4be9-820d-8a3d8ea443a4" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of unrealized gain as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2023 and 2022, respectively. The change in fair value is not material for the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Investment in Nanolive</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2022, TRC entered into an investment and shareholders agreement with Nanolive to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd622081-5e87-4eb9-a813-1823ca7f2301" contextRef="C_88782d27-5661-485a-afcf-08cc5c051369" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">18,750,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Nanolive Series C preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9aaae79-11cc-49a9-a5b4-3b1bdf3c591a" contextRef="C_88782d27-5661-485a-afcf-08cc5c051369" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (equivalent to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5033e18-c72d-427b-a7ce-ea38952d5fc0" contextRef="C_88782d27-5661-485a-afcf-08cc5c051369" name="inva:SecuritiesPurchaseAgreementAmount" unitRef="U_CHF" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million CHF). Nanolive SA is a Swiss privately held life sciences company focused on developing breakthrough imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_339db0ea-8dbc-4dd6-9e1d-0ef26c891644" contextRef="C_bed4dd91-bb02-4b5d-a15b-d83a06470288" name="inva:EquityInvestmentTransactionCostsIncurred" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was incurred for investment due diligence costs and execution and recorded as part of the equity and long-term investment in the consolidated balance sheets. On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#8217;s ownership interests and investments in Nanolive. ITH has the right to designate one member to Nanolive&#8217;s board. ITH also has the right to designate another member, who will be mutually acceptable to ITH and another stockholder, to Nanolive&#8217;s board. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ccc0386-67d4-4241-80f8-86069ce2dbb9" contextRef="C_1d60db24-5501-4ef8-9186-60ebe8c52f24" name="inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Innoviva designee is serving on Nanolive&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_668a9cdc-57cb-4262-8574-66ec91f40058" contextRef="C_1d60db24-5501-4ef8-9186-60ebe8c52f24" name="inva:NumberOfBoardMembersOfInvestee" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen">six</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-member board. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8cff52f-f33d-4786-9951-75004a08b8e4" contextRef="C_529c2882-00b1-4936-b580-0e5381a12f59" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">13.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9eb829e2-a096-498b-b766-ec59870c528c" contextRef="C_9e00bead-30e7-4af5-8f97-cb13619d5c04" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">15.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of Nanolive equity ownership, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our investment in Nanolive does not provide us with the ability to control or have significant influence over Nanolive&#8217;s operations. Based on our evaluation, we determined that Nanolive is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because Nanolive&#8217;s equity securities are not publicly traded and do not have a readily determinable fair value, we account for our investment in Nanolive&#8217;s Series C preferred stock using the measurement alternative. As of December 31, 2024 and 2023,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_232d6afa-0745-40bc-b5ae-a6f3ef357e70" contextRef="C_1d60db24-5501-4ef8-9186-60ebe8c52f24" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_acd34ff2-e383-42f9-a317-dc78a5a70489" contextRef="C_864b213f-0400-4fcb-9947-13500166620f" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.6</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of investment in Nanolive was recorded as equity and long-term investments in the consolidated balance sheets, and there was no change to the carrying amount of our investment.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reconciliation of Equity and Long-Term Investments Balances</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_21967ecb-23da-4ec1-af6f-b87098fa3d55" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the change in balances in &#8220;Equity and Long-Term Investments&#8221; as of each balance sheet date:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.757%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2022</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a691f90d-1183-423f-b333-32087f1e685d" contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6" name="us-gaap:LongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">363,859</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aefe94fd-4a40-461c-9259-d4ca91265df5" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of equity and long-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adf68b8f-ff39-4267-9f95-a3d4170de6aa" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_296ab560-25bc-456c-a8b8-e814067862e7" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,129</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62264d24-ce36-4d38-bb7c-59fdeac0421c" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:OtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">428</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26571227-4def-4252-abe5-38c0382d710c" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:LongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">444,432</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a8f2f54-80ff-48c3-bea4-fe19da337aa8" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,201</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34217f67-61f0-4b31-aace-8b1833301757" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">59,161</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reclassification of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90d7d66b-0c95-4abb-ab6a-051832f826a7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:ReclassificationOfCurrentPortion" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">107,532</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a896ddf-19d6-486c-b1b2-58ccce75ad3c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">724</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_605b09c7-10bc-4002-baa4-8d525d7566de" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">341,664</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">130</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_7" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_8"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Available-for-Sale Securities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7a1d75f3-2ec4-41d1-8d98-f13fca597da4" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of available-for-sale securities is based on quoted market prices for these or similar investments that were based on prices obtained from a commercial pricing service. Available-for-sale securities are summarized below:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gains</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6ddcf50-d102-4a94-8e1d-30455b13ca59" contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6caa033-e1b0-42c5-9e67-d5b2c51deb83" contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da285bb3-aefd-4e23-a795-82b237438fae" contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31dd804c-ed7c-49d3-afe0-753c37a5f180" contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc5bf26d-6d4a-4b03-95d0-42db730ede56" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18519a41-0925-4323-9bca-92845a573119" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e156b13c-7eb4-4132-bf75-660365de1573" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26d0c69d-a6f1-41bb-82a0-bcac4f6b60ca" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets</span></ix:footnote><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></div></div>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gains</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_902daea8-5ff8-4718-bd5d-98cc32f8fb31" contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a60c6f3-3651-42b0-8d22-dc356d15606d" contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c33cb1a3-3d6f-4322-af2b-31d51faf766b" contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd66a87e-2be3-4ed8-b423-87c616c33a64" contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0173130c-f0a7-42fc-8cad-5a1ba94c6798" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de35246e-4f10-412c-9601-291c0772a31b" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_506aa7cd-4544-433c-97e4-1ed2b02df587" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8556233-73c5-4cd8-b7d7-fddf1a0eee6d" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_30a29ac4-a358-403f-922e-b22439018a34" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets.</span></ix:footnote></div></div></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all available-for-sale securities were money market funds, and there was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6fb727b-a5d3-480a-ad3c-759960702832" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_3f7aa2fc-c53b-4650-8b7e-ed2635d709fb" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> credit loss recognized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">131</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_8" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_9"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><div><ix:nonNumeric id="F_145a9961-b122-4e87-a465-04d7b5fd8cf1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" escape="true" continuedAt="F_145a9961-b122-4e87-a465-04d7b5fd8cf1_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our available-for-sale securities, equity and long-term investments and contingent value rights are measured at fair value on a recurring basis and our debt is carried at amortized cost basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:39.772%;box-sizing:content-box;"/>
        <td style="width:1.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.678%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.678%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.678%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.678%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Fair Value Measurements as of December 31, 2024 Using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted Price<br/>in Active<br/>Markets for</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identical</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Types of Instruments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3046f8d-dfbc-4a06-833a-4282202c4a61" contextRef="C_2b5acdfb-cefd-4c67-9972-a3dda739bb03" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ad52966-fbd3-4a97-ae49-67a65c003154" contextRef="C_4406a063-c883-4b59-8711-b008bdcbf2f3" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce0c14b5-e8e4-48fd-952d-20ec68d3a90e" contextRef="C_4041c10c-d9db-40fe-83d8-3d345cb6210f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3cf1f78-1bf2-4fbc-9040-414e4fc18cea" contextRef="C_add68ec5-d86e-40f4-b034-6cf33cfd18b4" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f278d5ba-0634-4fd6-8034-1e552ac5a517" contextRef="C_e3fb434f-e5ea-4505-bf42-34684b260e8f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193,560</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_287765d0-416b-43d4-9dfe-e52935b38b92" contextRef="C_0d85bf14-7ff9-40af-b30b-7e30a1de43fa" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09ecfb1e-96f6-4fbe-ad7a-234505a46892" contextRef="C_45841d41-b3ea-49ad-9f9e-c591d3adde1c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,098</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2a7a877-4136-48a0-a12f-bd7ab8807352" contextRef="C_a96db169-3904-4b64-b638-57e99ca42a24" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">255,658</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Common Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21a71114-454d-403f-8d57-5b1c6d03b58f" contextRef="C_df0dcfdb-f7bf-42d6-8f50-7452f7efb7fc" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8343322-4e7e-4740-b7e1-e94976bfb976" contextRef="C_17140411-b5e8-43ef-8ad8-fe25a8045518" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08e464bf-57e3-4b45-aa24-46dffa3c4fd6" contextRef="C_786faf8b-f50d-4276-973e-9c08430f0704" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d7ba603-ea23-48f4-8b5a-0768f045c4e6" contextRef="C_8696ff04-631e-45ca-b986-6584fe4c098f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3dd86b63-34fd-4509-abd6-8a07d6e6dad4" contextRef="C_c5ef9de9-0775-487e-8f32-e176bb4802f2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_279a8b78-aef1-4f85-8e2e-97ba2f808545" contextRef="C_7123baea-0eb2-4315-ab65-b66fb4c1e84c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,901</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc4ee9d8-5066-4f03-8179-5009949109f0" contextRef="C_db5c50d8-61a0-48fb-b797-e64fdb1a2402" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73664b4e-40da-4060-8547-e1ce550ffec7" contextRef="C_8cd4e397-e9a3-4a8c-aecd-0a7615959c9e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,901</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - InCarda Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bdf4f2c-fe2b-4120-832d-cf6a500ad30d" contextRef="C_9d4ff33d-434e-42c0-bb77-930403d92261" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc349cb6-02b7-49ca-a664-f5b909f44d90" contextRef="C_09aa36b7-7144-467b-9fac-7756cec17a40" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d61a1f9c-7dfe-4cef-ae4f-f78430973666" contextRef="C_78745eb2-7d71-4fab-bac2-e5ea9e5f2e5b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a6542f3-76af-4c95-85aa-c7fc50f6f212" contextRef="C_2f675c67-919e-4761-81e6-7accacddcb17" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Armata Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea3a6652-a73a-47fe-8a6e-e3cf757789b3" contextRef="C_435c3fdf-dded-4b1c-8c53-e2baf1575828" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_657a92a3-3899-4d3f-b7f8-bb39050a1c01" contextRef="C_9d2ea10f-79df-4fc6-88b1-7ed97a1f15da" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bcb534f-2835-46e4-bc07-96a9951d26dc" contextRef="C_d14644b6-e4c0-4ed0-9afe-f0820fb1bd31" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,095</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_681c2a36-2787-4908-9f46-27016d54aa60" contextRef="C_afb144a7-7fa3-45b6-b331-2e2d09168a7c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,095</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata July 2023 Term Loan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82022a35-612e-458d-ad29-c816e56f7b17" contextRef="C_6502e745-ecac-480c-a568-afd26e86b8d5" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18f4d843-9309-4f9a-9ca3-b83c035ba0df" contextRef="C_8d7370e9-f555-49e2-8db3-20fdc743160e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b86879b-7d06-4ce1-8967-5322b49615dd" contextRef="C_09dd24e4-7567-42ee-8451-8c197dcc4414" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,197</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f64871f-a763-4d77-9830-28f9d453edb1" contextRef="C_9d98152e-282a-43bb-9c70-92c8e03419ba" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,197</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata March 2024 Term Loan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f73e2fd0-2e97-4a98-97ee-f31ce1fabfed" contextRef="C_ba0408d0-4257-44bd-b0d4-4cae0cd8ad50" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6045c0ce-4fac-4454-8800-17ebe2059b17" contextRef="C_4dd5f666-9958-4324-a0bb-faa2a4d1e877" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38084763-9a92-4131-a5b9-fa3a3b34d1f5" contextRef="C_244f0667-3be5-4a0a-8576-8ae545e146fc" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,275</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c852fb1-64ad-439c-b9c6-06f39dd70ecb" contextRef="C_9a81efa3-20d3-453d-9d0c-f293d720f3f5" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,275</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - InCarda Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb7bc76a-bf3e-43e8-b051-af27982f0be8" contextRef="C_1bdd4ad6-2439-4385-82de-5ad820bd7eae" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0eafad33-93f0-4e6f-8618-fe51335f2106" contextRef="C_133952d5-c957-477b-b68f-c01b8094549b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a7fc13c-9ea0-4712-8274-e073bbba158d" contextRef="C_6a8af425-4477-456f-9b7d-745f9bdef0b7" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">436</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a7a898b-21cb-43e7-8add-0b2487ac8891" contextRef="C_c675336b-670a-4920-8b77-b1a4286084d6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">436</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - ImaginAb Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca64fc1b-44f2-4991-8a32-d453c34646d4" contextRef="C_9e7d8d10-3492-4cee-a89a-3fb97bcda1d1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8655b034-cdc3-449a-8cab-e20b6c1e899d" contextRef="C_40baef25-dae2-4dfa-871a-2daf38c29542" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86645270-00e7-4cfa-a961-d801c3e2a0f9" contextRef="C_d61477da-6a47-40a2-8405-d8b3177cc270" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,950</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d6a3252-8860-4b21-87b4-7e3bd910c3ef" contextRef="C_c79de25e-95f2-4f26-905c-cca404ed5f11" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,950</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Gate Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f87b5f0b-2a59-4351-bdb6-0db29946fca6" contextRef="C_cf1f2f09-e0ed-462d-82c7-6c2daa899d5f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04519928-49eb-4da4-a27a-3707ca374aea" contextRef="C_ffeaad30-ebfd-4a04-b9e5-4e0d3bd69603" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dedeb2b-0a62-4811-a676-ad7547bd4d6d" contextRef="C_4b154284-9266-4285-aa75-6b79ccaf86ed" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,881</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37da4e51-f87e-4c9b-8aba-8992ec9b3292" contextRef="C_3f3470cf-f3bb-46cd-b659-030c2237a851" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,881</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at estimated fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aad5a691-8ca8-4c63-9b28-859a9c11c4e9" contextRef="C_6bf0974e-bd6c-4a97-aa2d-09d4b17083b0" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">529,393</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9504b00a-cd37-4bc3-9e7c-42b5fadb7bdc" contextRef="C_2115f8b1-9136-4380-851e-2b2dd4d28c47" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,901</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76b8364b-7163-46ac-9cb8-2bb1332b2349" contextRef="C_754e1428-1254-4b24-afeb-0530ecdb9559" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">229,991</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f29fa6e4-4184-49d8-9bc7-9f9d154d50f8" contextRef="C_206853b6-d741-4c50-9285-74ba6833daf1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">765,285</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c14c28f-423b-4ffe-b9d5-27d4a7a78652" contextRef="C_3a94b2fa-2178-45d2-a69f-4f779a9e094b" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17c30288-0e16-4a49-8b55-47ad75aeb04a" contextRef="C_01a26fdf-093b-428e-8429-70e85e0224c8" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222,353</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59504922-037d-43a1-89b6-3976d385d419" contextRef="C_fba802f6-eb69-493f-87f6-f43deb47abf0" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d4dce5f-1815-45f2-8b76-d8d026a128d5" contextRef="C_353f21fc-32cd-4752-9796-07126db0df6e" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222,353</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_accc7aa4-a9ed-4db5-a2b4-96cccab65a16" contextRef="C_6e23f21f-fd64-45fb-a9b6-a0ca21a8e566" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b220a54d-c2b3-453a-b248-8bc07a7e46c7" contextRef="C_ab2043e0-c7f2-40c3-bda1-f3a36db172fc" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">251,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98fe71f2-361f-4b68-b45b-3fa1f3675747" contextRef="C_54fb9637-236a-4edf-bd9e-20160cd157ce" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_516805db-982b-4d84-ba89-630c442b518c" contextRef="C_6785d313-2b28-4dd6-843b-fd6e81cb4e68" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">251,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;Total fair value of debt</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_278232c3-ce53-4f3b-9642-b317e479ba50" contextRef="C_06dd38c6-e52d-4da1-998f-59918ca542e1" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28eb54cd-3740-4b56-83c6-6c2e64f0bfdc" contextRef="C_35c66ecd-abaa-47c4-aeed-995102651f7a" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473,566</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f54ae97-c32b-4d4d-b0ce-a05692cbf887" contextRef="C_d43c551f-1182-4c6a-9fa0-92a42cfdbdb7" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1902c7d-69de-4fdd-a4df-8371adcd17c6" contextRef="C_41d2a460-017a-4f09-950d-898d5eed18e9" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473,566</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">132</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_9" continuedAt="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_10"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_145a9961-b122-4e87-a465-04d7b5fd8cf1_1">
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.222000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Fair Value Measurements as of December 31, 2023 Using:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">in Active</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Markets for</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identical</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Types of Instruments</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_782531b0-89fb-4b5a-b1e6-abaec5e4d9b9" contextRef="C_e58d532c-c266-4245-9d7b-aef9281419e4" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17dddc20-0d4d-4cf2-9d25-2f36aac0e013" contextRef="C_bcf2c29d-8647-40dc-ba52-d9d8f93eb75a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b56773e-e316-4908-8c69-996e81019be1" contextRef="C_d139597a-1533-4bc4-a253-55b573ea0881" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd1b2d2e-b816-44cb-97ae-21fd6b60483d" contextRef="C_e9234eca-e6d0-4621-b0c2-30f2d3521baa" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a728cd8-52e8-4b47-9c38-ca203dd8d8d5" contextRef="C_1094e350-01f0-46ea-8b23-ea5467236116" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">251,207</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_410297da-3105-44f2-a59d-f5d4802544bc" contextRef="C_f3e16894-117c-446b-9f3f-884beaa199ad" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d16c126-fd30-4f79-aa86-547e05d1a083" contextRef="C_43d9c586-5f52-4d19-8160-779b9b10fc41" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,605</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6de6e7b2-1cca-4c69-a4cd-4073bb74e6cf" contextRef="C_58f0fc2b-d399-43f9-94e6-ce77c2852307" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311,812</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Common Stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_460bbc4e-be63-4742-abf1-67ca2764efe6" contextRef="C_ed5b1702-8224-456a-abea-ea2d003f0c74" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,249</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3c47ba1-91e4-44cc-a8b2-925f97a73e7b" contextRef="C_f1b73005-95fb-4adb-81f0-96baf40e7109" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76261403-738e-4521-b44e-8c86c6dfadfe" contextRef="C_5a95facc-643d-4e5c-a79c-d70b76227248" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d683f1e9-fd8f-4aed-b874-0e8e11520ab5" contextRef="C_569e318a-9026-41e3-b966-5d091cfcfca3" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,249</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Warrants</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b6674ca-f9bd-49f2-9c33-cd416874a03a" contextRef="C_bdc03984-0625-41b2-82ca-9caeb5314057" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f2f2c45-f59f-4fe0-8a69-3d46e7c7f40e" contextRef="C_082688dc-70ea-4b4e-a75e-e8348b08e789" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,297</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8152af6c-5618-41b1-a6f9-ae0eb25c56f6" contextRef="C_32245f0a-45db-4e0a-9613-eef82b4c01c1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d586c660-5509-4feb-8897-86b96ed492ce" contextRef="C_f77d16f6-54fb-45df-a63a-141a1f1f0379" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,297</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Armata Note</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2c7400a-7246-41bf-a183-6a4b60aa7211" contextRef="C_0172277f-4eca-48b9-bece-ad8bb242c5b2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b759089-f579-48f4-91e4-3ae3112ba23a" contextRef="C_6e13c51d-a0c3-477a-982e-4cc4b6d00a3b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a35830f7-33d6-4eac-a766-69f4624c6715" contextRef="C_919b16a3-daf9-4bac-9da1-2cf406486d25" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,883</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d60b52e9-0473-4955-9df1-b47268fe0ddb" contextRef="C_46def20b-a66d-4411-90eb-b164dbc750ec" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,883</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata July 2023 Term Loan</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f8a0fbd-ec09-404c-87be-f40e22df7e88" contextRef="C_fae9051d-e439-4818-ad45-eb74de3471ee" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c54112aa-2a8f-48bd-9504-1962dd6314c7" contextRef="C_d607948e-3894-43eb-89fa-f4bc7aece440" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d61ba7f8-24d7-4b7e-9af6-721f47702c73" contextRef="C_e9b0c0ac-0c84-4a00-8d3e-e6a3c6a553e3" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,044</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cbd6d09-4e37-49b7-8fcf-8a19c2642171" contextRef="C_703de750-f5d6-45f2-b263-1f034aa780b0" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,044</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Gate Note</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5003560-05c5-4f7f-9880-095b9642090f" contextRef="C_9cf98973-fc0b-429b-8808-7b5d88eb9637" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_448da115-13eb-4247-96e0-814fbc427120" contextRef="C_3551cf7d-cc96-4d09-9170-a0cd1bd24e95" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca7e3069-9d0f-4666-9b93-591091deb768" contextRef="C_54134174-dac2-4f09-bf74-39a35e6c1945" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,972</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5737e9d6-3bfe-4188-9cc0-26a3f17c9f93" contextRef="C_b7b89463-f172-4eb5-8ce7-17774c741e4c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,972</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at estimated fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_955de5d6-20de-4a5b-85de-d9b367851ad9" contextRef="C_082ada48-9042-421f-be9d-be33bf8fec5e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">503,162</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_923f7448-ef70-4ffb-abe8-8126279a3f60" contextRef="C_f92b2439-dd04-4ad1-9985-100056a2a460" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,297</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b4faaed-229b-4c18-a2f2-b8d6ddb950c9" contextRef="C_a3b40d28-d1d7-4f75-ba62-ba963f654190" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">167,504</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6b1fc95-d726-4af1-99c6-7dd0d7aec6af" contextRef="C_1731ac46-b6f5-411b-85d1-c11e32e67f0c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">705,963</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Debt</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 Notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a85acb7c-1aa9-4c08-868e-fa6d3635ea3a" contextRef="C_4a788214-d295-44db-907c-ec0fa5bd3d73" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16d9586d-ecba-40f6-b549-aa41844f4457" contextRef="C_a37e3f84-6d29-4645-b6f7-b74dfd018d2c" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200,407</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b330e70c-63ef-481f-a27f-8a3e33f746af" contextRef="C_cca319a7-55be-4560-a134-be4a41bd17b8" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72a04057-48cb-4757-9b08-49b2e8e5aeec" contextRef="C_59929190-726b-42e1-a7ea-6423d3b27be2" name="inva:ConvertibleSeniorDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200,407</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028 Notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5525e443-42c7-4a30-ae12-e543bff0b21f" contextRef="C_dc5d9fbc-dff8-4e86-8a01-3a68bb65a1f5" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d4acec4-9b39-4bad-a26e-2d38d02407f3" contextRef="C_b71bcf3c-4c43-451d-b5f2-24c3afc122f4" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227,070</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3101570-940b-4955-ac82-7746ea3ef0a2" contextRef="C_f9e57c23-a271-4b12-b27e-1a3a9f5259fc" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b45ad7-5d55-47ef-85f9-f570e177c0b8" contextRef="C_98ece23a-e085-4630-b652-b0ddb682aa35" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227,070</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total fair value of debt</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0da81e7d-d228-4633-b64e-9eff90767b56" contextRef="C_8b039347-f1bb-483f-9cd7-5caeb7ce8c4c" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9807f4e9-da5f-4ac5-bb76-425313cf19fa" contextRef="C_851eb81a-bcba-4dbf-a1ff-f67a190bf355" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">427,477</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5642d027-4b1a-4f21-9a53-c342ce09eb09" contextRef="C_644fec1f-c78d-47a9-b887-38182f8bfb45" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_160c912f-1067-4fcc-b248-067aba69eae8" contextRef="C_788779b5-a56e-46b0-b6c5-4c88f05e3f22" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">427,477</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent value rights</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35648e06-c52f-4bd7-8366-7ba38f27daaf" contextRef="C_e45d06f3-4620-495d-8786-74f2c65161c0" name="inva:ContingentValueRightsLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aedf22ad-62d9-4bb6-807d-3e49616c8157" contextRef="C_2929c53c-75fc-494c-9554-8c5d617baf03" name="inva:ContingentValueRightsLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_880d9234-afe6-4085-b150-c9b241880fc3" contextRef="C_955c4f2a-4a9d-417f-aead-26c430c09653" name="inva:ContingentValueRightsLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c2eeab4-fa6e-49d8-b9fd-03d80a9d3fc0" contextRef="C_0ee77695-de0f-46b2-86c1-faabdc44e03d" name="inva:ContingentValueRightsLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities at estimated fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ae12be5-ef50-4f04-8213-fca9089f0042" contextRef="C_e45d06f3-4620-495d-8786-74f2c65161c0" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a61a23cb-d136-4017-820d-bd2be17bd978" contextRef="C_2929c53c-75fc-494c-9554-8c5d617baf03" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">427,477</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c16995c3-1b64-413a-8d09-0f8eee8eb8c1" contextRef="C_955c4f2a-4a9d-417f-aead-26c430c09653" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3844a02-d596-43dd-b44d-9d23e5a42aaf" contextRef="C_0ee77695-de0f-46b2-86c1-faabdc44e03d" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">427,836</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93000ec0-9241-4e74-9ce0-54ea01f8d3fb" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2bcb30eb-6b03-41f6-ae6c-d558e4fb5a1d" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> transfers between Level 1, Level 2 or Level 3 during the periods presented.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values of our equity investments in Armata&#8217;s common stock and publicly traded investments held by ISP Fund LP are based on the quoted prices in active markets and are classified as Level 1 financial instruments. The fair values in the warrants in Armata classified within Level 2 are based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Gate Convertible Note, the Armata Convertible Note, the Armata July 2023 Term Loan, the Armata March 2024 Term Loan, The Incarda Covertible Note, the InCarda Warrants, the ImaginAb Convertible Note, private placement positions and convertible notes held by ISP Fund LP, and contingent value rights are classified as Level 3 financial instruments as these securities are not publicly traded and the assumptions used in the valuation model for valuing these securities are based on significant unobservable and observable inputs including those of publicly traded peer companies.</span></p></ix:continuation></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span><ix:continuation id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1_10"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values of our 2025 Notes and 2028 Notes are based on recent trading prices of the respective instruments.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div><ix:nonNumeric id="F_6ce4c1b3-4cf3-4be1-bb4d-45730b874682" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:CapitalizedFeesPaidDisclosureTextBlock" escape="true" continuedAt="F_6ce4c1b3-4cf3-4be1-bb4d-45730b874682_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. CAPITALIZED FEES PAID</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c91dde8f-6682-4b82-82bd-da0610fbb6e4" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CapitalizedContractCostTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized fees paid, which consist of registrational and launch-related milestone fees paid to GSK, were as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:14.749%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization period</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2030</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_645cf53b-e203-456c-a69a-ce3bc90e581b" contextRef="C_5d3d7d01-66b3-48b0-9e0a-4093af97d0e0" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">120,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c73eb1f4-b0f7-47f5-850e-f37aa581c697" contextRef="C_1e6b3044-ac2f-457a-a3c3-0254c3c6cfa2" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">120,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Europe</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2029</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c0eb1c6-bcda-41f7-9bd8-2d52fdbbfeaf" contextRef="C_ab15afc8-8530-4712-ba43-3f96b009cf85" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5719ba07-5307-4f1e-8df4-ef7c2c3fde57" contextRef="C_28894aac-4362-4af5-af9d-30c2bfedaac8" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Japan</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2029</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8f53041-7434-402c-aa38-c77683bfad02" contextRef="C_dc25f343-8bba-4e07-88b6-893e60ec0518" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18f35462-c6f3-46ca-8121-b3db920e47dc" contextRef="C_e7fac056-3186-4a36-b380-99ad43330178" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross carrying value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3673aa2b-6956-4cc8-879c-43efa4cde5e2" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1848c29-6713-448d-95b1-d4838b669ceb" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CapitalizedContractCostGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated amortization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e77c9775-3251-4c9d-bad7-ea0cd56667b0" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CapitalizedContractCostAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,039</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_880bb2c2-ff55-4459-84c7-86ec677e1415" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CapitalizedContractCostAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136,216</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b1d9378-2ec2-4608-9b85-6d8f141d472c" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:CapitalizedContractCostNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,961</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d0878ad-694e-40d7-a54f-3d41be1514cf" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:CapitalizedContractCostNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,784</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">133</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_6ce4c1b3-4cf3-4be1-bb4d-45730b874682_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These milestone fees are amortized over their estimated useful lives commencing upon the commercial launch of the product in their respective regions with the amortization recorded as a reduction in revenue from collaborative arrangements. As of December 31, 2024, the weighted average remaining amortization period wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_83446b30-a91b-4ab5-8861-bbfa081c9149" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:CapitalizedFeesPaidWeightedAverageUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5.2</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional information regarding these milestone fees is included in Note 3, &#8220;Revenue Recognition&#8221;. Amortization for each of the years ended December 31, 2024, 2023 and 2022 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb310e24-3c70-413c-b78b-b7ee05d73d99" contextRef="C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fa860355-336b-498e-9e0e-76a75d1e3c10" contextRef="C_fd08000e-5a41-4289-ae07-073ab3d62ab2" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6b89bb1c-e11d-4a1d-9fd3-80e6f67efe39" contextRef="C_f2be4dca-4f14-4253-b3c4-7480e0834b43" name="us-gaap:CapitalizedContractCostAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.8</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The remaining estimated amortization is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45485649-dbc6-42d5-9134-68ef639d2d17" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_11b5f225-d096-4096-b8a5-6ed2ab39fb3c" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_32035da7-f2d3-42e3-8a6d-82e861e2885b" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.8</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for each of the years from 2025 to 2027, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08ccb9f5-36f1-44f2-9a1d-579e6e8ce4b7" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year 2028, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06aa85f3-e40a-4591-9fda-ec736c7b3f77" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year 2029 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_443d895d-3277-4ca1-bb7b-997b51be263d" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million thereafter.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_5b3cc799-51d2-4904-aa0b-823327111504" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. GOODWILL AND INTANGIBLE ASSETS</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Goodwill and intangible assets acquired are recognized at fair value as of the acquisition date. The carrying amount of goodwill as of December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4017f011-e6f1-4e22-a306-9157541b626e" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:Goodwill" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c40a4503-e774-43a0-87cc-f38ed06e72b5" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:Goodwill" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.9</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83813e9c-fa63-451c-bfef-72be37a151b0" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:GoodwillImpairmentLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ddfc70bc-bdb4-4f49-acc8-c6fcf3fa5af8" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:GoodwillImpairmentLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recognized any impairment losses related to goodwill and intangible assets during the periods presented.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets with definite lives are amortized over their estimated useful lives. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dd80c770-280d-4ac3-963f-7c192b1737dc" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" escape="true" continuedAt="F_dd80c770-280d-4ac3-963f-7c192b1737dc_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying basis and accumulated amortization of recognized intangible assets as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 were as follows:</span></ix:nonNumeric></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:continuation id="F_dd80c770-280d-4ac3-963f-7c192b1737dc_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.86%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:14.24%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful Life</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketed products</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2a8533ef-13d1-46c4-ad5a-f79ca8fb9c8a" contextRef="C_849927e1-65a2-4ab7-97b5-483466c4b437" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><ix:nonNumeric id="F_40805486-e197-49bd-82ec-7e9470b9f2f2" contextRef="C_0974ccdc-4028-46c2-914a-582f9004b353" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a23f775b-5209-40f4-ab71-895918b092cc" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsMarketedProductsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">223,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c06def7d-5bf0-45de-9110-368786d6631c" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsMarketedProductsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,559</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cf88438-c5cc-4a72-9b28-bc518fe75f68" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsMarketedProductsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176,141</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68a170f1-d638-45e2-8b0d-247b54002571" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsInProcessResearchAndDevelopmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_884aa6c6-453c-47bd-84f7-0348bcd86410" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e9258b2-e542-470c-8f75-450571807b33" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsInProcessResearchAndDevelopmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration agreement</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0ff834ce-2aa2-4a4b-9f04-5c998432b07d" contextRef="C_df3d0c76-2bea-47b7-b43d-ad369cba9a2e" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e193b76-8648-4397-954f-306f0c4efa72" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsCollaborationAgreementGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,400</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04a9c988-fb68-4214-a4f7-7594b91da9f3" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsCollaborationAgreementAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">5,708</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_510f602a-81d2-4938-88dc-5b88f6197105" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:IntangibleAssetsCollaborationAgreementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,692</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28336321-7d0c-43e5-96e8-a1aec900baeb" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">261,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f73cd78b-19de-4d88-944f-cb5fcf90307b" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,267</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8c91f4a-0dbc-4a0c-9e42-932a781eb915" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,433</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.86%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:14.24%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.56%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful Life</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketed products</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f006c530-7e18-4900-80f7-383478fa1910" contextRef="C_f6c0a156-d89e-48f6-bded-f444bcad434a" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><ix:nonNumeric id="F_6c6df5b9-2495-4b2c-b04f-0d34d82a193e" contextRef="C_6038b2ea-b8d0-41fb-ab7d-a45db02e7491" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ae78e59-1ed1-49c7-a65f-4837188b4445" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsMarketedProductsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">219,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5030fb6-0b61-49f5-ab43-15589f081494" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsMarketedProductsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,204</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52f86863-d085-4950-bddb-f12b553d4d4e" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsMarketedProductsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194,496</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1290aee3-7569-4ed5-8ed9-6bb1db19f96c" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsInProcessResearchAndDevelopmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_603997ce-ca3e-45ad-b6f7-08d87ac5dca2" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70f21428-786c-4831-b645-7e63854e2798" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsInProcessResearchAndDevelopmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration agreement</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_add43aba-7fcc-4535-9ba7-88bfd56092c1" contextRef="C_58ff6e27-8879-40c6-936f-18c78a254cf0" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a89b1c9c-0bb4-4578-b94c-6b7e88edb7d3" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsCollaborationAgreementGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,400</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da5c5bf3-c051-4da9-98b5-c52d05ab4457" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsCollaborationAgreementAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,161</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a8908ad-5310-4cf7-a143-3cd69c9380d5" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:IntangibleAssetsCollaborationAgreementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,239</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8492fd14-eb0b-448b-9d8d-7443581d06e9" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e50b963d-4218-4489-a375-9bb388a46632" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">27,365</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e41a5525-eb77-4149-a991-04b27f08070e" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">230,335</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets recognized as a result of the acquisition of Entasis amounted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b98b6b3-a495-48b1-9ca6-67c8e421d176" contextRef="C_bacd63c0-e919-4307-9a75-797f35ce4073" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">106.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which consisted of Entasis&#8217; in-process research and development related to its antibacterial therapeutic product candidates and a collaboration agreement amounting to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98e0a1ee-8b1f-49b7-9055-489f27e83d28" contextRef="C_01786403-dae8-45d8-8f44-bb44245b9082" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">71.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_176b08a8-502d-4ff0-946a-842c85b2958c" contextRef="C_364151ca-1164-42c3-99da-d375625b3e9b" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">35.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Following the FDA approval of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in May 2023, we started amortizing $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d5e0cc6-ca9c-4218-af83-57067abf22b1" contextRef="C_14dff0a8-f6e3-44e8-a3c8-67a93240f124" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">68.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the then in-process research and development as a marketed product, as well as the collaboration agreement, over their estimated useful lives. The useful life of the remaining in-process research and development of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33a41af4-c8e3-416d-b5db-73ded26a9603" contextRef="C_a44e01be-348f-4efc-abce-4d6942d68c4e" name="us-gaap:AcquiredFiniteLivedIntangibleAssetResidualValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million will be determined upon commercialization of the underlying product candidate; thus, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83b0ee80-00dd-43a4-89bc-c833f90d76af" contextRef="C_2beadbda-6783-4ae4-893a-d09da35b2b25" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ca7400d8-d90f-47d1-914d-4c2b92e5c9f6" contextRef="C_f3c6c6c6-c1f1-4aba-b7f2-6491c20659a0" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amortization expense for this intangible asset was recognized </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the periods presented.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets recognized as a result of the acquisition of La Jolla amounting to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3074bcd3-fc0a-4c1d-b27a-3ddb2ce5d4d2" contextRef="C_9192d724-db6b-429d-9b34-680a884d5432" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">151.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million pertain to product rights and developed technologies on La Jolla&#8217;s currently marketed products. These are intangible assets with determinable lives and are amortized over their estimated useful lives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 4 &#8220;License and Collaboration Arrangements&#8221;, we capitalized the upfront fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_232eb9bd-fdf3-4bce-a8f8-b6b40b31593a" contextRef="C_a0ab4d8b-b98c-4423-b309-fa00f676612e" name="inva:UpfrontFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that we paid to Basilea under our exclusive distribution and license agreement as an intangible asset. This amount is included in marketed products in the table above and will be amortized over the term of the agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized amortization expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_450448db-fb21-4f3c-811b-4d29c65da7cf" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1baaa7d2-8026-496f-a661-61737a622e2e" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4102519b-8525-4e00-af6f-466617bfe846" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024, 2023 and 2022, respectively. Future amortization expense is expected to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82baa809-24b5-4517-a715-e7cbe3652c5c" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5af9e7da-c2b7-4825-a54d-9b70af22e121" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_826e7ddb-2397-4968-bb6b-ea98941f2584" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ef4e0b8c-c910-4323-81cb-a925a2cb0b9a" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_293348e0-6847-4d32-b731-df3a400d9619" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">26.3</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for each of the years from 2025 to 2029 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1221db2a-bbac-480b-81e6-10779454ae13" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">74.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million thereafter.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">134</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_04447cee-7d13-4015-91c6-276e7f72c42d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. BALANCE SHEET COMPONENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inventory</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_f40bdedb-4b15-44bf-843d-b02897e0b4c6" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inventory consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Raw materials</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7ed8c7e-1b38-4c1e-9671-b50937d11efa" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:InventoryRawMaterialsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,113</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b6ff7b5-7ce5-4924-aec3-559ea273562f" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:InventoryRawMaterialsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,257</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Work-in-process</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5a4c02f-3654-4ea6-8fe9-c17388ba5579" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:InventoryWorkInProcessNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,529</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a733dfbf-2170-4068-a64b-d9d25d690805" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:InventoryWorkInProcessNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,670</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finished goods</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98a30e34-dd9b-48f0-966f-7068891d6af2" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:InventoryFinishedGoodsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,083</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a71d86df-dfc5-46f5-9632-cc039bc109a0" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:InventoryFinishedGoodsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,810</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total inventory</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da1e0627-2eab-4771-8cf6-ab3e5960c31b" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,725</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15099d74-0937-4110-8176-c9f4a82e3773" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,737</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023, total inventory included net fair value adjustments resulting from the acquisition of La Jolla of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_517cd027-5ac1-4e18-9234-42f1cfe1269e" contextRef="C_c9475aee-0427-4f76-b24b-da8950b70256" name="inva:FairValueAdjustmentsOfInventoryFromAcquistion" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d325dc9-add0-4fc5-b332-a2471cb1cbf9" contextRef="C_d45b1b16-d9f4-4bd5-a834-1cf791abc22d" name="inva:FairValueAdjustmentsOfInventoryFromAcquistion" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">23.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which will be recognized as cost of products sold when sales occur in future periods. The fair value adjustments recorded as part of cost of products sold amounted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da63cab2-bea0-442c-a2ce-b8f42c58a2a3" contextRef="C_fedeae1b-25e7-447d-871d-311e79d2dae2" name="inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million, $27</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30b99f6c-e4c6-40b5-a8e1-e2d696a20858" contextRef="C_93c2cd99-2331-4842-ae83-434ada9a8bca" name="inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcc4c130-d54e-4ad7-9710-7df5cccc645e" contextRef="C_315a265e-5369-4a49-a2e2-f13fcdd56f9a" name="inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million for the years ended December 31, 2024, 2023 and 2022, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Accrued Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_332f5756-45a3-4416-bb81-2b0531ac23e5" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other accrued liabilities consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued contract manufacturing expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32aa1158-28ac-4f73-8929-0bfd32642106" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:AccruedContractManufacturingLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,071</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20a4c573-26cd-4ae8-8bf9-13a8c196de71" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:AccruedContractManufacturingLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,966</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical and research expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f512ab9-c6b3-4f3e-9fdc-2ed2875c662e" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:AccruedClinicalAndResearchLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">611</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_945910e3-d9e7-4293-bd68-f9f70f0060e1" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:AccruedClinicalAndResearchLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">776</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93685282-1ae3-4eb4-b508-d994620ba085" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:AccruedProfessionalServices" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,682</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21bf64d9-6794-418a-91cc-c95fc2c49e3b" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:AccruedProfessionalServices" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0;"><span style="-sec-ix-hidden:F_f4af3d02-580b-4f35-bd4b-6df98811301b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of lease liabilities</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84b90ed4-0bf9-453a-b75c-f1edb534842e" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,572</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c78feae-3938-4cbd-a1cb-909900064633" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,207</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty obligation payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24908566-f6ae-4677-9924-31fbf055318e" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AccruedRoyaltiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,951</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6237f38c-413b-4269-b816-10a760459d0b" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AccruedRoyaltiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,928</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of deferred royalty obligation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7334ce6d-c2f9-4092-9d2e-65d88231c501" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:DeferredRoyaltyObligationCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,438</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0b0de8c-fb8f-447a-8f41-8820abba1214" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:DeferredRoyaltyObligationCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued license fees and royalties</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07bf2d3f-79c6-49d6-8d7b-156f1ef07cc3" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:AccruedLicenseFeesAndRoyalties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,727</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c567e91c-38bf-47ca-9c6d-448950ed07dd" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:AccruedLicenseFeesAndRoyalties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,575</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_591a04fc-692e-4fa4-a6bf-3295403dd797" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,947</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0801b02-8f2a-40ec-b166-6aa4b59cb536" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,370</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other accrued liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_928b3c3a-c82a-4c6a-bd5f-9a1b9da65ee9" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,999</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4d34d38-daf4-48e5-9df5-8fc963d8a092" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,698</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amount in &#8220;Other&#8221; as of December 31, 2024 includes $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_356c78c0-27a6-4814-b647-9f61c055121e" contextRef="C_de99671a-3f86-4f93-b929-187c53e350a3" name="inva:BusinessCombinationDeferredConsideration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in consideration received under a letter agreement we have entered into with Zai Lab as discussed in Note 4, &#8220;License and Collaboration Arrangements&#8221;.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Long-Term Liabilities</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_344fa777-0608-4b09-b34c-5bbbbb7370e8" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" escape="true" continuedAt="F_344fa777-0608-4b09-b34c-5bbbbb7370e8_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other long-term liabilities consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion of deferred royalty obligation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3dea4e3-1b45-4472-8e05-ac8185b12a4a" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:DeferredRoyaltyObligationNonCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,096</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b075695c-c7c6-4259-ad67-8b00c8472d35" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:DeferredRoyaltyObligationNonCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_16c95013-f170-4361-bd0d-93944037b675;"><span style="-sec-ix-hidden:F_ebb48713-23ce-429f-ae3c-689518f40e91;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion of lease liabilities</span></span></span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99563687-8710-4bc2-940e-5d674dbd1143" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,179</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ede02b61-c403-4ee6-a1ea-f5522002d0fb" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,635</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent value rights liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e3f693c-4ef1-4ddf-9efc-bc5f2a2722fe" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:ContingentValueRightsLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51197126-5f0d-4367-a427-d2cd7f490f27" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:ContingentValueRightsLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other long-term liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e5b1f27-c162-4b6f-8e8b-7eb4653d6906" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,275</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dbb2fc4-734d-4c09-9005-9cfe0bfe0cb6" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71,870</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:continuation id="F_344fa777-0608-4b09-b34c-5bbbbb7370e8_1"></ix:continuation></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">135</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_bf540891-3da8-47b9-9101-a332fd32eb49" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_bf540891-3da8-47b9-9101-a332fd32eb49_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. STOCK&#8209;BASED COMPENSATION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Incentive Plans</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2012, we adopted the 2012 Equity Incentive Plan (the &#8220;2012 Plan&#8221;). The 2012 Plan provides for the grant of incentive stock options, nonstatutory stock options, RSAs, RSUs and Stock Appreciation Rights to employees, non-employee directors and consultants. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total shares remaining available for issuance under the 2012 Plan were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b9164f9-d73a-4e7e-8cc8-4e96c310951b" contextRef="C_631eb718-8626-432d-96fb-8270d3650dfb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,758,450</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the 2004 Employee Stock Purchase Plan (the &#8220;2004 ESPP&#8221;), our employees may purchase common stock through payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75258d1e-7fd6-411e-9330-c51408840480" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lower of the fair market value of the stock at the beginning of the offering period or at the end of each applicable purchase period. The 2004 ESPP provided for consecutive and overlapping offering periods of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c1e808a7-5dc2-438e-b703-fa46a7244bac" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24 months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in duration, with each offering period composed of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72c90b81-2c62-4fa9-8995-59ab937c9351" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" unitRef="U_Item" decimals="0" format="ixt-sec:numwordsen">four</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consecutive </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18b24ba3-6b9e-4119-b0c4-8a3b0f66cede" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> purchase periods. The purchase periods ended on either May 15 or November 15. The 2004 ESPP contributions were limited to a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b503faf1-06f9-42d4-a257-74de7ebf639f" contextRef="C_61675bce-4ccb-4819-8b97-db41c469c40c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of an employee&#8217;s eligible compensation. The maximum number of shares that an employee may purchase in any purchase period was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_467dc054-949d-4530-aebc-6f70a4d96c9a" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. An employee may not purchase shares with a value greater than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4843c4bd-6f46-4ad4-b6d7-596fe3800730" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in any calendar year.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 13, 2023, the Board of Directors adopted the 2023 ESPP (the &#8220;2023 ESPP&#8221;). The 2023 ESPP, which supersedes the 2004 ESPP, was approved by the Company&#8217;s stockholders on May 22, 2023. Under the 2023 ESPP, eligible employees may purchase common stock through payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61c2ee83-6319-4554-827c-8ed1c5d7e639" contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lower of the fair market value of the stock at the beginning or end of each applicable purchase period. The 2023 ESPP provides for offering periods of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b3d46490-9c86-496f-b5d6-71d13e689a40" contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which ends on either May 15 or November 15. The 2023 ESPP contributions are limited to a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1f7cb8b-90e0-4897-90ce-bfa9e22931ab" contextRef="C_36498d02-d869-42ba-9764-62160907c5d0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of an employee&#8217;s eligible compensation. The maximum number of shares that an employee may purchase in any purchase period is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35c1319d-2c62-44d8-a128-3603c26786a0" contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. An employee may not purchase shares with a value greater than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f588b73b-6c85-4377-a938-5129b31c3682" contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in any calendar year. A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ee24fdb-3aa4-4d86-a3ca-aa9484564b6a" contextRef="C_36498d02-d869-42ba-9764-62160907c5d0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" scale="6" decimals="INF" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of our common stock was reserved and available for issuance under the 2023 ESPP.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total shares remaining available for issuance under the 2024 ESPP were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6c1ee99-d489-47c9-8e5f-ff91ba3024d1" contextRef="C_36498d02-d869-42ba-9764-62160907c5d0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,467,596</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Director Compensation Program</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our non-employee directors receive compensation for services provided as a director. Each member of our board of directors who is not an employee receives both cash and equity compensation for services as a director, member of a committee of the board of directors, lead independent director and chairman, as applicable. In October 2017, both the cash and equity components of the compensation program were amended, effective immediately (the &#8220;October 2017 Amendments&#8221;).</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of our independent directors receives periodic automatic grants of equity awards under a program implemented under the 2012 Plan. These grants are non&#8209;discretionary. Only our independent directors or affiliates of such directors are eligible to receive automatic grants under the 2012 Plan. Under the program, each individual who first became a non-employee director will, on the date such individual joins the board of directors, automatically be granted a one&#8209;time grant of RSUs covering a number of shares of our common stock calculated as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e22cbc32-4aac-4e0d-ab80-c70dae02380a" contextRef="C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">125,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cfebef6-fde5-4449-a984-b20911c40003" contextRef="C_0093bbd6-7e3d-4096-a9d4-884a19df0e1b" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, rounded down to the nearest whole share (the &#8220;Initial RSUs&#8221;), plus a one&#8209;time grant of RSUs covering a number of shares of our common stock calculated as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7ea986e-1b68-4f38-aebf-3360d8ce8bae" contextRef="C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">225,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3875c2c6-f5a9-401f-a6c4-0f3129a36def" contextRef="C_0093bbd6-7e3d-4096-a9d4-884a19df0e1b" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, which would be pro-rated for the number of whole months remaining until the anniversary of the prior year&#8217;s stockholders&#8217; meeting, rounded down to the nearest whole share (the &#8220;Pro Rata RSUs&#8221;). The Initial RSUs vest in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41d3d148-5aa2-418e-9104-6adcf824248d" contextRef="C_aa1f7e7b-d2fa-443f-a718-e2d0bbe01a01" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" unitRef="U_Installment" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> equal annual installments, while Pro Rata RSUs vest in a single installment at the sooner of the next annual stockholder meeting or the one-year grant anniversary, in each case subject to the non-employee director&#8217;s continuous service through the applicable vesting date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annually, upon his or her re&#8209;election to the board of directors at the Annual Meeting of Stockholders, each non-employee director is automatically granted an RSU covering a number of shares of our common stock calculated as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e71cf4d-ae87-4862-be99-03e4581a190b" contextRef="C_3e6c5798-81a7-4ab8-b212-ef8406a6ab89" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">225,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbe1612a-bb95-455d-9d58-1074788d15c8" contextRef="C_745efcda-116c-4d6a-b708-1361e157d2ba" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, rounded down to the nearest whole share. These RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the non-employee director&#8217;s continuous service through the applicable vesting date. Following the amendment to our non-employee director compensation program, both the annual RSUs and Initial RSUs described above remained unchanged with the exception that the number of shares of our common stock subject to each award has been reduced.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">136</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_bf540891-3da8-47b9-9101-a332fd32eb49_1" continuedAt="F_bf540891-3da8-47b9-9101-a332fd32eb49_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These RSUs will vest in full upon the director&#8217;s death, the occurrence of a change in control or, with respect to awards made after the October 2017 Amendments, the director&#8217;s disability before the director&#8217;s service terminates. Director RSUs carry dividend equivalent rights to be credited with an amount equal to all cash dividends paid on the underlying shares of common stock while unvested. Dividend equivalents are subject to the same terms and conditions, including vesting, as the RSUs to which they attach and are paid in cash upon vesting.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock&#8209;Based Compensation Expense</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_552d45bc-2438-41ac-96dc-07ca940287eb" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock&#8209;based compensation expense is included in the consolidated statements of income as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.01%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.203%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.203%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.583%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling, general and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40d0b2e3-4b91-4452-a7fc-9b16c1f52d73" contextRef="C_9d4df672-9227-4655-9953-e51c14163b1a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,040</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8cd9a48-b5cb-4059-9632-26faf15c780b" contextRef="C_6fd76cbf-78f1-4169-b3c9-f2dee135ca32" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,645</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa8704b1-f69b-43c8-a866-dde997ac2020" contextRef="C_8f0463dc-8f74-4223-9dd0-680a9297636d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,305</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edea5dfb-6c2e-4dd4-907b-f2adb7a4642e" contextRef="C_c61a6de1-f544-4ddd-95a2-ffc7bafdc548" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55301987-78ea-476e-88ff-920457f37384" contextRef="C_ef03268a-dd7d-4c50-a2c4-e5d9a9311b15" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,192</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03a8349d-0779-43bd-ab41-7a232fa19187" contextRef="C_fbdb8b2c-2b35-4e9d-80d1-25e5b10df0bf" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,042</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35204d44-e281-46b5-9374-bb4bea679136" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,374</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf0841fe-0622-462a-95fa-3c12dd299461" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,837</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c54e65cb-926d-41da-995e-4ae0114d011d" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,347</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a49ddfdc-2be0-4416-b3d8-29b1202681a1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock&#8209;based compensation expense included in the consolidated statements of income by award type is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bb1041b-5383-4d10-8194-e2f86b073ba1" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,738</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_670a6b3b-80c7-4aa4-88da-1ad6fe43637b" contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,980</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63a0676e-d4a4-4bb4-b3b7-08c14cdfb149" contextRef="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,057</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32f5e993-2f79-4c3f-ae3c-3d9939667d60" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,348</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9631e6b8-9564-485f-a2a4-5fc46f8956f9" contextRef="C_00f9e3ac-8ca8-42d6-ab5d-d942ce6aee24" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,663</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bb7f088-a531-4bc2-88c4-3a8fe78811de" contextRef="C_cac6555f-df17-464f-8fa8-e1233df59df0" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,053</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37595fc5-5136-4e3a-a203-377ac1cc3186" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70aff440-0e58-4c15-acbc-1d1f05f234b3" contextRef="C_7dd1472a-f27f-4e99-ac46-35b7a204db5a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_911bdda2-3425-441c-8021-cdf68387b399" contextRef="C_c45aa339-d7d0-43b8-affa-cc16b15eced2" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ESPP</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93804a52-3a70-4064-a810-9c22f6a4b2e3" contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13b9e597-44f2-4996-9b55-fb609326fb96" contextRef="C_197a7b2b-9367-4d18-a82a-81e4a8afc234" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_188647dc-3562-4e6c-92a7-935ab423daba" contextRef="C_19101d97-aca7-45f0-b583-c510e7751aed" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b0e93b6-773c-42e0-b96a-2394c5149488" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,374</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fa43418-6ceb-4420-83f9-bbf9a89524c2" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,837</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0459527-63b9-4726-bf71-6de317dbad69" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,347</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4bbf8940-14cd-4153-bbb2-6b7b17161860" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:60.2%;box-sizing:content-box;"/>
        <td style="width:1.82%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.36%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrecognized Compensation Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Amortization Period (Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fd95ee4-59c7-4838-8e21-b8d1679a4f43" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,765</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_f98b3ad6-e00d-4e46-807d-f9a55e42fc5a" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.8</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1c56812-dbdc-4ee3-8da2-805ee2228707" contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,996</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_542cb177-4569-4dc6-89fa-c076a4e3fe61" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08d13012-5303-4a49-9d46-1a4f05accf24" contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">98</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_e9e0d8b7-08b4-4df7-893f-a9881f52734e" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total unrecognized compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad3b13ab-fa5d-46bd-afc9-2808f0c7a863" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,859</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation Awards</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_44ff3c1b-32d1-49aa-968b-6eb6ae178c42" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:32.386%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.642%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.02%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.7219999999999995%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.642%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.02%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.7219999999999995%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.642%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.02%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.182%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except per share data)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding options</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Exercise Price of Outstanding Options</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding RSUs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Fair Value per Share at Grant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding RSAs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Fair Value per Share at Grant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccaaa0c9-0a16-454d-bea4-e6c613d81638" contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,499</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69deb5df-6bdc-456d-b9c4-af433368eed0" contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.09</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fec639d-9660-41d2-811a-3da09fb5905a" contextRef="C_16e99f91-f640-4040-b9b5-471378dcd3f6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">482</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c68490cb-88c3-423c-b590-185f2912ac92" contextRef="C_16e99f91-f640-4040-b9b5-471378dcd3f6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.62</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_797b027f-3f7b-47bf-a217-ec882c825a3f" contextRef="C_9bf67da7-5977-473a-b529-91f7f67d1f91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bc4573a-1576-4f1f-8987-44b6feaa5496" contextRef="C_9bf67da7-5977-473a-b529-91f7f67d1f91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.93</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48169b9f-2976-4161-ad2e-a939c36038ad" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,062</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b356f98c-2e5c-4a14-be25-9f85f81ba7e0" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">16.67</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc2922f6-9cd7-4a53-9b18-bfd8d0b4acf6" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">502</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1053ccda-0612-4ad4-a6d3-0b2de61f12a8" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.77</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de8a6c2d-2298-465b-b955-d1c18a79f0fe" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a5f8cd7-916b-43f4-b554-0726f53a74d5" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67924428-7ef8-46ef-8d29-3c81dc13621f" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9468681-6fb0-4d15-9f17-1791c69dd7ad" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.88</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb28978b-ff59-4145-b261-829e1fe8ce63" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffb9f631-68a9-4965-8030-2ded00c83fe7" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a16638df-2e69-48d8-b2ca-efcdccbb1040" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0c937a9-73f7-49d6-acd9-cb23d6e69135" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Released RSUs and RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fc2dd3d-242a-47e8-92e4-8e767d35929f" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95be6d7e-1bf4-4857-9be9-34cadc00b574" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d98741d-a525-4b53-a451-1b6acd59c7ec" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">241</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a70ac2d-4475-4a8f-a1c7-bad3782be7bb" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.52</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_450c04ef-f7fa-44bd-b2db-05018dcc39e8" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eea14fb6-d9d1-46d9-a086-cdd4cfcedf36" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">14.46</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26e4bb1a-1b02-4be2-b9be-6779bca6e603" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">414</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44a761aa-ae5c-4864-b791-2e390912f9ab" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.24</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff89771d-85cd-464f-ba7b-85f648b8eb10" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">145</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e6c60cb-9566-4273-b705-dfda97dfbb13" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.86</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0d09111-dff3-431d-968b-834f52b32887" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f1ba242-ab81-424d-8978-2cd7c2e31c4c" contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fcd86d1-40bd-4e93-b6f7-d5fb3ee76b9c" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,067</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f18a35d-af97-47fd-ac23-d5d6201f9cb4" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.23</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d05b6c5-b387-4136-b8ee-1c7ded82fe1b" contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">598</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95e1385c-0ae1-4495-b5dc-41a8adc3ac8b" contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.00</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f06b7a7c-05dc-4d2d-8a02-f22f53b9a0de" contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f3a5a4-9400-4a89-9bbc-65e0dd55334c" contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.50</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest <br/>&#160;&#160;&#160;as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be0c165a-b1d7-4de6-8e59-bd37ca258204" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,067</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e6dc385-6302-4790-863e-b109eda3a9c5" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.23</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_549f7a6b-eeab-4ecb-85cf-cad7151f4a5c" contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">598</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78f061e0-6644-4bb3-b3ee-08395ff64026" contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.00</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1da55e46-a776-4a98-9a0a-3a4705562cac" contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee51d477-1c55-4611-b931-4d329f1d7107" contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31" name="inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">137</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_bf540891-3da8-47b9-9101-a332fd32eb49_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the aggregate intrinsic value of options outstanding and options exercisable was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89125a4f-c4af-4017-90ff-0c2e2e375dd5" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_696636b8-6d91-4fe1-b050-d10d43b38ae7" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2023, the aggregate intrinsic value of options outstanding and options exercisable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b8e6ddd-d15d-40ea-9166-7a5aad794588" contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_046df138-c655-4159-bcba-2115c5614012" contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0aa63f51-f974-4e6d-9ee3-81100d6f516a" contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">759,904</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options were exercisable. The weighted average remaining contractual term of options outstanding was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d5ea5632-37a1-4f4d-ac72-56989e5ee154" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.04</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_80791177-965b-42ca-9a68-986a164bb766" contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.96</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years as of December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total intrinsic value of the options exercised was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b22d499c-2984-48ad-9163-0a2c3d74321c" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9ad14a2f-4ab5-4a21-9eed-ec65ca1de1fe" contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a5e84bfd-09db-49f4-a00e-8f4f4196dc5f" contextRef="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material for the year ended December 31, 2024, 2023 and 2022. The total estimated fair value of options vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f23b21ef-62b9-4958-b0e0-ccce8d18c8aa" contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_308ca2b4-ff66-491a-8f8e-a1493d5a0a97" contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023, respectively. The total estimated fair value of options vested was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33c9c901-d5fc-4385-b7a7-1e331a96c23b" contextRef="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material for the year ended December 31, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total estimated fair value of RSUs vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca672681-4df8-4921-b581-ad09e0566873" contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46342afd-5fa2-4295-806f-64d41ae36718" contextRef="C_00f9e3ac-8ca8-42d6-ab5d-d942ce6aee24" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d1c1f59-375e-480b-848f-ef37dc6b5ae5" contextRef="C_cac6555f-df17-464f-8fa8-e1233df59df0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years December 31, 2024, 2023 and 2022, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total estimated fair value of RSAs vested was not material for the year ended December 31, 2024, 2023, and 2022.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Valuation Assumptions</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc8ebe57-7f27-4c75-9d3c-60a460745c0d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Black-Scholes-Merton weighted-average</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.748999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.748999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.748999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe942303-622b-4de2-a1bf-2d7d05f4e450" contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c349816-5a7d-431b-8765-c2559386a2fe" contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26131211-4376-4edb-a530-19d3f3d6fe54" contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_4fd7778f-0e96-419b-9247-c6ea5bdb984f" contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.10</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_21472da6-48ac-4a63-93ea-833c2ba57358" contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.09</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_cc81885c-511f-4ad7-bec9-73fe1be29afe" contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.04</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a54eac19-2b74-4e9c-9f4d-2bc6246220f5" contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">35.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc3e33a6-0026-4591-a76a-5da34c482a6d" contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">37.8</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfeb0550-7050-4f1c-be57-906daf44ef9e" contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">38.6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3767e7e-2e8f-4e4a-9754-5a78ce7bb30e" contextRef="C_155f7dc2-975e-4e6a-bace-6dfb4dbe5000" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_effb1076-23b0-487e-a0fd-5676ebb35eba" contextRef="C_caf4275d-107c-4a04-8eba-47895b8c9c67" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56cc01eb-126a-4d38-b762-7ea16daa8669" contextRef="C_04fe922a-6cc7-40ce-935f-5fdc9f946206" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average estimated fair value of stock options granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8506c1f-98b7-45ea-bcda-dcece5689ca6" contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.17</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23030091-2c23-4edf-be5c-1da1114a57fe" contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.57</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_860f51ec-021d-49eb-8d6a-779c445b7e5f" contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.43</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4368d926-cd46-4d74-a649-2c08e9b55247" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 31, 2022, our board of directors authorized a share repurchase program under which we may repurchase up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0e7abb4-3a2e-40d6-bdae-5a58cf029676" contextRef="C_75144e9c-8d8d-4067-a64b-e8ba0c236ce0" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of our outstanding shares of common stock. The repurchase program authorized the repurchase by the Company of its common stock in open market transactions, including pursuant to a trading plan in accordance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), privately negotiated transactions, in block trades, accelerated share repurchase transactions, exchange transactions, or any combination thereof or by other means in accordance with federal securities laws. The authorization permitted management to repurchase shares of the Company&#8217;s common stock from time to time at management&#8217;s discretion. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so because of self-imposed trading blackout periods or other regulatory restrictions. From program inception through December 31, 2022, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f62fed8-b2cf-4377-b111-107afebbcb70" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">647,394</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares in the open market at an average price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6cab45d-c912-4326-84ef-6678a9b55498" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="inva:CommonStockAcquiredAverageCostPerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.13</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a total amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4d21d01-77f3-469f-846d-6ab9b487ca45" contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">8.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. For the year ended December 31, 2023, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8eed979b-b021-46e4-b7b9-df9446122f3f" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,173,565</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares in the open market at an average price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd008c01-c1a9-47ce-ae59-df050cc06a85" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="inva:CommonStockAcquiredAverageCostPerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.39</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a total amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dc19806-f2c1-4179-a6f5-dbd5e1b24bf3" contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">76.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. From January to April 2024, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f15d507-350c-4a42-b78c-e7b233808f22" contextRef="C_46be4ed0-3a6f-42b0-b192-15f206bf7393" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">986,928</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares in the open market at an average price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_467dcf97-ffe6-46d9-91ad-6c7dc33f3d21" contextRef="C_46be4ed0-3a6f-42b0-b192-15f206bf7393" name="inva:CommonStockAcquiredAverageCostPerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.12</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a total amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95487564-655f-47f6-8207-92ca0ff5d290" contextRef="C_46be4ed0-3a6f-42b0-b192-15f206bf7393" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The share repurchase program was completed in April 2024. All of the repurchased shares were retired.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2024, we retired all shares held in treasury resulting from our strategic buyback of GSK&#8217;s common shares in the Company in 2021. We recorded the corresponding cost of treasury stock of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c29e387-ac9e-4e75-94b2-1d0272b4c5db" contextRef="C_298130f5-8670-42be-853c-8278eb64b931" name="us-gaap:TreasuryStockCommonValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">393.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in additional paid-in capital.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">138</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DebtDisclosureTextBlock" escape="true" continuedAt="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. DEBT</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ac7d110e-442c-47ff-ab48-b3871af31485" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our debt consists of the following:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"/>
        <td style="width:2.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.799999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.799999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75ce4a83-e91a-42a2-b32f-74c57450bb6d" contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddb7e79f-5101-41ac-b5cb-1e2a963917a4" contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6adf6eff-c582-4000-ab97-c7dcff6cf1f4" contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">261,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c2aa834-95b8-424d-a74d-1fcc75a2b807" contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">261,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23a6ddb6-0876-4cb2-8a4f-ef52321da7b3" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">453,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_075d984f-0e4c-4326-a934-8c0929a9ba9f" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">453,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;Less: Unamortized debt discount and issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a22d033b-c5b4-4ce1-b368-0225c84fa04d" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,156</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd5d39c3-9500-4036-869b-8a4b334edfae" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,266</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e42b33e8-8ab1-43a6-ab62-ea820f3be6c2" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">448,344</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d02c596c-8c4b-4b7f-82ea-542cdda045bd" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446,234</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;Less: Current portion of long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43b02dea-4d60-481e-97ea-a613b565de6e" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,028</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5dfdc9e2-d128-454e-a603-03c2a9eaf87d" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fe2c6c2-a318-4725-a8e1-c1a2eac9bf1f" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256,316</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d515821-77c0-4daf-b74f-38423fe761fe" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446,234</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Subordinated Notes Due 2023</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2013, we completed an underwritten public offering of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a88c4c0-1f67-485c-ae5c-d050701791e0" contextRef="C_d8729dff-3a5c-4dcc-af0c-979774e25169" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">287.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of our 2023 Notes, which matured on January 15, 2023. The 2023 Notes bore interest at the rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a5e30aa-2b01-463a-a37b-4ee4949ca0c1" contextRef="C_d8729dff-3a5c-4dcc-af0c-979774e25169" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="5" format="ixt:num-dot-decimal">2.125</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per year that is payable semi-annually in arrears in cash on January 15 and July 15 of each year, beginning on July 15, 2013.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2023 Notes were convertible, at the option of the holder, into shares of our common stock at an initial conversion rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dca08aca-57ea-4729-99c5-8c1f395a2dec" contextRef="C_4c9bc9df-24d5-48aa-a746-0482bc1e814c" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:num-dot-decimal">35.9903</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares per $1,000 principal amount of the 2023 Notes, subject to adjustment in certain circumstances, which represented an initial conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f1d9608-c611-422d-bb0c-56f5dd1ca724" contextRef="C_3a11ad05-9798-4623-a6d9-25f61cd44da6" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">27.79</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the offering of the 2023 Notes, we entered into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea841b57-0e4a-4d56-ab21-687711731d32" contextRef="C_25c30b00-13bd-4d27-89b6-199993a5cac6" name="inva:NumberOfDerivativeInstrumentsPurchased" unitRef="U_Item" decimals="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> privately negotiated capped call option transactions with a single counterparty. The capped call option transaction was an integrated instrument consisting of a call option on our common stock purchased by us with a strike price equal to the initial conversion price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ec3a8dc-042f-40d3-b65f-1a8f5e219532" contextRef="C_05049684-518e-4c68-a36a-97efe8235878" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">27.79</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for the underlying number of shares and a cap price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6568997e-c157-4909-92e3-ca4a6890be55" contextRef="C_c40ea3a9-5b51-4fd2-a6f2-387235c72fe8" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">38.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, both of which were subject to adjustments consistent with the 2023 Notes. The cap component was economically equivalent to a call option sold by us for the underlying number of shares with an initial strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_259b111e-fb64-4c07-a5d2-8901876d1379" contextRef="C_c40ea3a9-5b51-4fd2-a6f2-387235c72fe8" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">38.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As an integrated instrument, the settlement of the capped call coincided with the due date of the convertible debt. Upon settlement, we would receive from our hedge counterparty a number of shares of our common shares that would range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82b87417-252a-485f-98f9-9a3cc435ab76" contextRef="C_d2d0990f-b4c3-4288-a88d-e7a8d66b2f3f" name="inva:NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, if the stock price was below $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89aef650-7118-447d-a33f-3ed6869ee727" contextRef="C_05049684-518e-4c68-a36a-97efe8235878" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">27.79</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, to a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_997511d9-0d9c-4d81-be83-eca4e2ff6941" contextRef="C_a275ece4-9863-4cde-b812-6441e2e5af07" name="inva:NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,779,659</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, if the stock price was above $38.00 per share. However, if the market price of our common stock, as measured under the terms of the capped call transactions, exceeded $38.00 per share, there was no incremental anti-dilutive benefit from the capped call.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the partial conversion by certain holders of the 2023 Notes in July 2014, and dividends declared and paid in 2014 and 2015, the conversion rate with respect to our 2023 Notes was adjusted in total to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9195a39a-d792-44e7-94fa-169ed0f0f0cc" contextRef="C_53205d86-091a-45ec-875f-153f734c0c7b" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:num-dot-decimal">50.5818</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our common stock per $1,000 principal amount of the 2023 Notes, which represented a conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_184086f6-6776-425b-9ed1-9498d5ce8044" contextRef="C_cfb60dba-9194-465f-961c-11b864f3bdc4" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">19.77</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As a result of the conversion rate adjustments, the capped call strike price and cap price were also adjusted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8740b220-3931-47e9-8fa0-183a1d3a4a85" contextRef="C_dcb22e50-3b63-484c-8bca-4d66021e8210" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">19.77</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e751bf9-013f-4b27-b712-b8e7d2b456ce" contextRef="C_69bb9340-c11c-45f9-89b5-1eff93f82a71" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">27.04</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2016, we retired a portion of our 2023 Notes with a face value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff89e749-8d85-4a73-aaf3-db4bfd216298" contextRef="C_703323c3-fcbe-41ac-9f9b-28b43c769909" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42259109-6001-4006-8073-8f22da2520ad" contextRef="C_703323c3-fcbe-41ac-9f9b-28b43c769909" name="us-gaap:DebtInstrumentRepurchaseAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million by way of purchase in the open market.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 7, 2022, we used $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_649584df-cd7c-487f-8df5-0d792d46c6f9" contextRef="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992" name="us-gaap:RepaymentsOfUnsecuredDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">165.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from the sale of the 2028 Notes to repurchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed075219-2e8a-46ba-a9c9-c367a36f5d23" contextRef="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992" name="inva:DebtInstrumentRepurchasePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">60</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the 2023 Notes with a face value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fea30da-24e9-4f90-8351-7739d19d78c4" contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">144.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The carrying value of the repurchased 2023 Notes was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a93c72f8-26ea-409c-bfdc-557d4e6b7b56" contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220" name="us-gaap:DebtInstrumentRepurchaseAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">144.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Accrued interest was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81576866-06e7-4689-b27c-4bf68d29fb62" contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and unamortized debt issuance costs were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a28fb5f-dd7a-4d16-a9a8-ae634e1fdb69" contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220" name="us-gaap:UnamortizedDebtIssuanceExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the date of repurchase. We recognized a loss on the extinguishment of the 2023 Notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_287d5ed7-fa9f-41f8-9588-6f803be5b719" contextRef="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">20.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in other expense, net, in the consolidated statement of operations. The repurchase reduced the outstanding principal balance to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_632d5367-fd05-4a8f-ba7d-f5422edc2323" contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">96.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and unamortized debt issuance costs to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4cce0402-7a96-475b-9d12-0b7f16f0c084" contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The annual effective interest rate of the 2023 Notes changed from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ebb008b-e6b0-4f7e-920c-b4b1f8ecc35a" contextRef="C_6eebba42-5bd2-4b1d-add7-2b9166a45342" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.36</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89bf768a-6198-4dad-a80b-df1dbeb782a4" contextRef="C_f6aacb7c-354f-4850-845b-699f73b3eb83" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.37</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 18, 2022, certain 2023 Notes holders converted their notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a5a5066-622e-4cd1-9f02-ae76968209a0" contextRef="C_cd2bdc94-0cda-4896-afe6-51e360f119eb" name="us-gaap:DebtConversionConvertedInstrumentAmount1" unitRef="U_USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand into Innoviva&#8217;s common stock. The outstanding principal balance was reduced slightly to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e162dab2-7f38-4c67-a065-5e142496f4fc" contextRef="C_5a824dc9-4da6-4578-80c3-146747709b51" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">96.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. This remaining balance was fully paid upon the maturity date in January 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">139</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_1" continuedAt="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7614b8e4-51cc-4bcd-8378-2b8a8d8e1a88" contextRef="C_7530273c-e395-47f6-b8ce-a7265c4b1b91" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2023 Notes for the years ended December 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023 and 2022:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:61.216%;box-sizing:content-box;"/>
        <td style="width:1.779%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.614%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.779%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.614%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ff93b1a-d3d5-4441-8e58-7d9abcb5eb08" contextRef="C_8f319834-0192-44bb-82e6-228a046acebe" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_446c5ad2-2e2b-4d19-be86-7c17d9caac3f" contextRef="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,617</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a218a6f-2db6-4027-865f-6b1d5dd3ae69" contextRef="C_8f319834-0192-44bb-82e6-228a046acebe" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8654f4a0-c890-4253-8aa7-715267e5decb" contextRef="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">302</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fdeb87a-85db-4170-8719-009eee790289" contextRef="C_8f319834-0192-44bb-82e6-228a046acebe" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">96</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38c17918-19d6-4f84-8d9a-6685ffda5674" contextRef="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,919</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Senior Notes Due 2025</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 7, 2017, we completed a private placement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be0a71c9-7310-42c5-8218-51ea2f51deaa" contextRef="C_f219ac17-5f54-4a96-ad2c-f5c9f69dae24" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">192.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of our 2025 Notes. The proceeds include the 2025 Notes sold pursuant to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f50a8b4f-e482-4dcb-9aee-063d41943d71" contextRef="C_f7e50e8e-4e3b-4cb4-86fd-601d62aa2908" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cbc24b7f-2267-4d72-8e54-c760807f8f5e" contextRef="C_f7e50e8e-4e3b-4cb4-86fd-601d62aa2908" name="inva:PortionOfDebtInstrumentFaceAmountExercised" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over-allotment option granted by us to the initial purchasers, which option was exercised in full. The 2025 Notes were sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2025 Notes are senior unsecured obligations and bear interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d21e5a9-2c61-47db-b97f-6e9bb3d60361" contextRef="C_f219ac17-5f54-4a96-ad2c-f5c9f69dae24" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per year, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2018.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2025 Notes are convertible, based on the applicable conversion rate, into cash, shares of our common stock or a combination thereof, at our election. The initial conversion rate for the 2025 Notes is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d9ceb0e-92ba-4368-b479-84272e397896" contextRef="C_7f207f6a-98e7-439a-bc04-1d2e8566d922" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:num-dot-decimal">57.9240</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our common stock per $1,000 principal amount of the 2025 Notes (which is equivalent to an initial conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40b648e5-fafa-4936-aa2f-6d44ba9531ea" contextRef="C_7145555a-225b-40f5-a4c1-17e76939a86d" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">17.26</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), representing a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e82d1242-fb9f-4189-abf1-e2d8602ed6c9" contextRef="C_7145555a-225b-40f5-a4c1-17e76939a86d" name="inva:DebtInstrumentConvertibleConversionPremium" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% conversion premium over the last reported sale price of the Company&#8217;s common stock on August 1, 2017, which was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_697ce70e-c604-4e49-bc05-c55d81242aac" contextRef="C_66693642-95da-475a-a4b4-59d4ac42aae1" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.28</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The conversion rate is subject to customary anti-dilution adjustments in certain circumstances. The 2025 Notes will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7f3a1115-8d0b-4b9e-bd62-a29385576993" contextRef="C_7f207f6a-98e7-439a-bc04-1d2e8566d922" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 15, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, unless repurchased or converted in accordance with their terms prior to such date. Prior to February 15, 2025, the 2025 Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, as described below. From, and including, February 15, 2025, until the close of business on the second scheduled trading day immediately preceding the maturity date, the 2025 Notes will be convertible at any time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders of the 2025 Notes may convert all or a portion of their 2025 Notes prior to the close of business on February 15, 2025 only under the following circumstances:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after September 30, 2017, if our closing common stock price for at least 20 days out of the most recent 30 consecutive trading days of the preceding quarter is greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d18c4d75-d314-4559-a32c-bf7dce9c22aa" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">130</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the current conversion price of the 2025 Notes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for five consecutive business days, if the average trading price per $1,000 of Notes during the prior 10 consecutive trading days is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac30c096-74ef-406f-9195-384380aacc73" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="inva:DebtConversionConvertedInstrumentAverageTradePricePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">98</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the product of our closing common stock price and the conversion rate of the 2025 Notes on such day; and,</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental changes (as defined in the indenture governing the 2025 Notes) or a transaction resulting in our common stock converting into other securities or property or assets. </span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On or after February 15, 2025, holders of the 2025 Notes may convert their 2025 Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2025 Notes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of default or a fundamental change (as defined above), holders of the 2025 Notes may require us to repurchase all or a portion of their 2025 Notes at price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c904243f-1b98-4922-b2a2-8f54f3552ab1" contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648" name="inva:DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective January 1, 2022, we adopted ASU 2020-06 using a modified retrospective method, under which financial results reported in prior periods were not adjusted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Prior to the adoption of ASU 2020-06, we separately accounted for the liability and equity components of the 2025 Notes by allocating the proceeds between the liability component and the embedded conversion option (&#8220;equity component&#8221;) due to our ability to settle the conversion obligation of the 2025 Notes in cash, common stock or a combination of cash and common stock, at our option. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature using the income approach. The allocation was performed in a manner that reflected our non-convertible debt borrowing rate for similar debt. The equity component of the 2025 Notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f6f94e2-f82b-461f-9d27-f7da46794759" contextRef="C_00161e2a-7110-4a94-93a4-53229f1f240f" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">67.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">was recognized as a debt discount and represents the difference between the proceeds from the issuance of the 2025 Notes and the fair value of the liability of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">140</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_2" continuedAt="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_3"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025 Notes on the date of issuance. The excess of the principal amount of the liability component over its carrying amount (&#8220;debt discount&#8221;) was amortized to interest expense using the effective interest method over the term of the 2025 Notes. The equity component was not remeasured as long as it continued to meet the conditions for equity classification. Additionally, we separated the total issuance costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2c0764f-ca63-4cb4-8c3f-790ea71e80d2" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million incurred into liability and equity components in proportion to the allocation of the initial proceeds, resulting in liability issuance costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f04f137e-18fc-49b8-ba1d-b1ef06dc691e" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and equity issuance costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5b52997-08dd-4818-9f2d-33c962675111" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Issuance costs attributable to the liability component were amortized on a straight-line basis, which approximated the effective interest rate method, to interest expense over the term of the 2025 Notes. The issuance costs attributable to the equity component were netted against the equity component in additional paid-in capital. The annual effective interest rate of the liability component of the 2025 Notes was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2400a7f2-d5f8-473e-b1fd-1d4f7edf7656" contextRef="C_a2ca99e3-4ee8-4e98-ac8e-a7fbab801fde" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.87</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon adoption of ASU 2020-06 on January 1, 2022, we combined the liability and equity components of the 2025 Notes assuming that the instrument was accounted for as a single liability from inception to the date of adoption. We similarly combined the liability and equity components of the issuance costs. The issuance costs are presented as a deduction from the outstanding principal balance of the 2025 Notes and are amortized on a straight-line basis over the term of the 2025 Notes under the effective interest rate method. Beginning January 1, 2022, the annual effective interest rate on the 2025 Notes is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09f223a6-cce3-4266-9b0e-cb750b9c548e" contextRef="C_03ca5b08-65b3-4660-b083-f365e311c479" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.88</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_548b439f-6091-418e-8554-708bf8dee293" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:ConvertibleDebtTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our outstanding 2025 Notes balances consisted of the following:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"/>
        <td style="width:2.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.799999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.799999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c609b121-7589-4e51-960a-87dda3749d52" contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fa7996a-7a65-4b3d-8cd8-57f9bc353157" contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt discount and issuance costs, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36bb787f-0bd8-43f4-974a-93b9b84deb62" contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">472</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d274aa7-aa01-4a49-ba34-dff875272229" contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,205</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef267a8c-f8c2-4d74-9960-b1afc9fd3bb4" contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,028</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16d09e1a-4fda-4a3f-ad18-7306a9775a36" contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">191,295</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_88b3d759-e1af-4b3a-9a50-b7626e22678a" contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2025 Notes for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, 2023 and 2022:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9c7d341-eb05-45bf-85d6-7c13e5f9ec4f" contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,813</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14c2149a-368c-4c5b-96d1-36820b0a7daf" contextRef="C_bdd67f19-2199-47ba-9bf2-29f87af012ba" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,813</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85627261-8553-4b5c-8c83-9cf299db2fea" contextRef="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,813</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_760e16a3-9f72-4f51-b83f-bb4966bf16f5" contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_490b2737-85de-4090-a9fb-3dc275c6bbb7" contextRef="C_bdd67f19-2199-47ba-9bf2-29f87af012ba" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">712</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3667ceb-6b0a-4f28-b471-0c17d8808ee1" contextRef="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">692</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fdf89c6-b910-4352-bb13-fb8833902df9" contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,546</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_821a42a3-76af-4636-811f-b57866ae5e94" contextRef="C_bdd67f19-2199-47ba-9bf2-29f87af012ba" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,525</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dd53857-fe55-4076-9b9c-ae3147ca88db" contextRef="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,505</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Senior Notes Due 2028</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March 2022, we completed a private placement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0fde742-e28f-487c-9191-0ea9e6405dc4" contextRef="C_4c137836-1d57-48b3-b853-5989053266bc" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">261.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of our 2028 Notes, which will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3a08eb5b-95de-45e4-9f64-e314a27f0c2a" contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 15, 2028</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The proceeds include the 2028 Notes sold pursuant to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e0c64a4-cf87-4fb3-b12e-24f9961e407f" contextRef="C_bb32bb34-0f53-47f4-9801-880f4c57c7c4" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">45.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over-allotment option granted by us to the initial purchasers, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6508ed3-901b-4c93-ac6b-ac5677155dcc" contextRef="C_bb32bb34-0f53-47f4-9801-880f4c57c7c4" name="inva:PortionOfDebtInstrumentFaceAmountExercised" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was exercised. The 2028 Notes were sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net proceeds from the sale of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a857ad4-8334-4cf9-af33-83945228de58" contextRef="C_4c137836-1d57-48b3-b853-5989053266bc" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">261.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of 2028 Notes were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_241ca83d-89e4-4075-ada9-6cdaa1fdd355" contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">252.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting the initial purchasers&#8217; discounts and commissions and our estimated offering expenses. We used approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_370babbc-c61d-4cf6-ae0a-2ae5dee2124c" contextRef="C_03d49736-400f-4d83-9c8a-949362d73529" name="inva:CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the net proceeds from the offering to fund the cost of entering into the capped call transactions described below. In addition, we used $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b7ae553-c408-4afa-b2c9-26480d1dbc8c" contextRef="C_7c241491-c363-4e26-b334-863eae0dae59" name="us-gaap:RepaymentsOfUnsecuredDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">165.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the remaining net proceeds to repurchase $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e892e12a-e989-4c36-8a4f-1d103d81b30c" contextRef="C_b5459326-64cc-447b-92d0-447df34b0037" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">144.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of the 2023 Notes in separate and individually negotiated transactions with certain holders of the 2023 Notes, which closed concurrently with the issuance of the 2028 Notes. We expect to use the remaining net proceeds for general corporate purposes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2028 Notes bear interest at an annual rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a46150f-586b-4961-a1e7-23238fa94905" contextRef="C_c2bdcfd8-c2f9-4e33-9a58-4dc78da2e693" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="5" format="ixt:num-dot-decimal">2.125</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% that is payable semi-annually in arrears in cash on March 15 and September 15 of each year, beginning on September 15, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2028 Notes are convertible, based on the applicable conversion rate, into cash, shares of our common stock or a combination thereof, at our election. The initial conversion rate was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_018d3804-fe74-4460-b891-173c4bd5bbe9" contextRef="C_25328d2c-092e-4651-9c58-eeb1fa6d99e9" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:num-dot-decimal">38.1432</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares per $1,000 principal amount of the 2028 Notes, subject to customary anti-dilution adjustment in certain circumstances, which represented an initial conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c7e3d1f-19da-46c8-adcd-fbf0664ae2da" contextRef="C_4e5991ec-66d1-4584-84f0-5ad5de0d9c80" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">26.22</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">141</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_3" continuedAt="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_4"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to September 15, 2027, the 2028 Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, and will be convertible on or after September 15, 2027, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2028 Notes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders of the 2028 Notes may convert all or a portion of their 2028 Notes prior to the close of business on September 15, 2027, only under the following circumstances:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after March 31, 2022, if our closing common stock price for at least 20 days out of the most recent 30 consecutive trading days of the preceding quarter is greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_045a7799-823b-4eb5-bec6-6ed12078f7c5" contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968" name="inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">130</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the current conversion price of the 2028 Notes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for five consecutive business days, if the average trading price per $1,000 of Notes during the prior 10 consecutive trading days is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88563c3f-ce0b-4b06-86a9-976890d9c6e3" contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968" name="inva:DebtConversionConvertedInstrumentAverageTradePricePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">98</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the product of our closing common stock price and the conversion rate of the 2028 Notes on such day; and,</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental changes (as defined in the indenture governing the 2028 Notes) or a transaction resulting in our common stock converting into other securities or property or assets.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On or after September 15, 2027, holders of the 2028 Notes may convert their 2028 Notes at any time until the close of the business on the second day immediately preceding the maturity date of the 2028 Notes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2028 Notes will be redeemable, in whole or in part, at our option at any time, and from time to time, on or after March 20, 2025, and on or before the 75th scheduled trading day immediately before the maturity date but only if the last reported sale price per share of our common stock exceeds 130% of the conversion price for a specified period of time. The redemption price will be equal to the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, calling any 2028 Note for redemption will constitute a make-whole fundamental change (as defined in the indenture governing the 2028 Notes) with respect to that 2028 Note, in which case the conversion rate applicable to the conversion of that 2028 Note will be increased in certain circumstances if it is converted after it is called for redemption.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we undergo a fundamental change, subject to certain conditions, holders may require us to purchase for cash all or any portion of their 2028 Notes. The fundamental change purchase price will be </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_109c374d-023c-4d01-b66a-5e334f004059" contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968" name="inva:DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of the 2028 Notes to be purchased plus any accrued and unpaid interest to, but excluding, the fundamental change purchase date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fdfd3327-733d-4307-9e1d-8add12aa01cd" contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8" name="us-gaap:LineOfCreditFacilityCovenantTerms"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture governing the 2028 Notes contains customary terms and covenants, including a merger covenant and that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Notes to be due and payable immediately.</span></ix:nonNumeric></span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions. The cap price of the capped call transaction is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3267d2ed-ab38-4b70-ac12-8f913ca30081" contextRef="C_f3ad801f-e4a3-4bf5-9d54-b9f1f833c093" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">33.9850</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and is subject to certain adjustments under the terms of the capped call transactions. The capped call transactions cover, subject to customary adjustments, the number of shares of common stock initially underlying the 2028 Notes. The capped call transactions are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes or at our election (subject to certain conditions) offset any cash payments we are required to make in excess of the aggregate principal amount of converted 2028 Notes, as the case may be, with such reduction or offset subject to a cap.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The annual effective interest rate on the 2028 Notes is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dc65869-d084-46f8-8024-b91bd114cba9" contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.70</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_5c65e906-305e-4493-a366-72984682dcf8" contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8" name="us-gaap:ConvertibleDebtTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our outstanding 2028 Notes balance consisted of th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31655a4c-9e55-407f-ac91-116382946781" contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">261,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b70cb1c-d6a7-49fd-b90f-4e0ab4375fc3" contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9" name="inva:DebtInstrumentPrincipalAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">261,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt discount and issuance costs, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b1afe08-5083-4a83-a4de-37055e90cf1c" contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,684</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ef467cf-f9e1-4406-9cb7-07f4d8c745f2" contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,061</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15619afb-bc1c-455a-8916-a7bd71647dc3" contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256,316</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8f62a28-0670-4476-bea6-cf5d306fd669" contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">254,939</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">142</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_4" continuedAt="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_332f31b9-0188-4e38-bb47-ee2a9a9d86f4" contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2028 Notes for the years ended December 31, 2024,  2023, and from the issuance through December 31, 2022:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Issuance Through</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f1103b4-0344-41a8-ba7d-639a7e77b7b5" contextRef="C_d9d9925a-2c03-40f4-86eb-cfacde988b24" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,546</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91816b6e-92cb-481d-965c-b331547072e9" contextRef="C_c18cffa1-9de9-4afa-a1e1-ba138e813757" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,546</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dece48b3-3ed3-4a3c-bdfb-19019be9cccc" contextRef="C_1335d490-17db-400b-806c-c3c9d364a039" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,514</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt discount and issuance costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db619b73-f844-499b-b4c1-6355845d5ed6" contextRef="C_d9d9925a-2c03-40f4-86eb-cfacde988b24" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,377</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cddc3415-96fc-4c0e-811f-45f869f22ec5" contextRef="C_c18cffa1-9de9-4afa-a1e1-ba138e813757" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,342</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fc535af-1b46-4efb-828e-88623d555799" contextRef="C_1335d490-17db-400b-806c-c3c9d364a039" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,061</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25808314-614e-4853-bb52-767d1f032e3f" contextRef="C_d9d9925a-2c03-40f4-86eb-cfacde988b24" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,923</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a84032af-faaa-434a-a888-9d3326fffcac" contextRef="C_c18cffa1-9de9-4afa-a1e1-ba138e813757" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,888</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35ea951a-47dd-406a-a6b4-b6bfff04711a" contextRef="C_1335d490-17db-400b-806c-c3c9d364a039" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,575</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Maturities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8cf58b6c-bc21-44cd-9e18-40dc323b62e5" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate scheduled maturities of our convertible debt as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.46%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_862aa8f9-bd98-431d-9391-1b34672e35f5" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93d4f0b9-a608-464a-b43a-2a626aa9a480" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_064917e2-b9b5-4abe-bcc2-6bf7e491de83" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0569c93-2054-4459-85c7-cccb938ef94f" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">261,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afba9856-af19-40f7-8b62-8b7a29a92f58" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">453,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Royalty Obligation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our acquisition of La Jolla, we recorded the fair value of its deferred royalty obligation in connection with La Jolla&#8217;s royalty financing agreement (&#8220;La Jolla Royalty Agreement&#8221;) with HealthCare Royalty Partners (&#8220;HCR&#8221;). Under the terms of the La Jolla Royalty Agreement, HCR is entitled to receive quarterly royalties on worldwide net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> until either January 1, 2031 or when the maximum aggregate royalty payments have been made, whichever occurs first. Quarterly payments to HCR under the Royalty Agreement start at a maximum royalty rate, with step-downs based on the achievement of annual net product sales thresholds. The maximum royalty rate through December 31, 2023 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ac8e9df-fc9e-48e1-bf2a-235a2abe3388" contextRef="C_985e040f-be7e-4757-85fe-32dfd0c9e971" name="inva:RoyaltyAgreementMaximumPotentialPayoutPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Starting January 1, 2024, the maximum royalty rate was increased to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2c8c18b-0aa9-4cf6-a30b-179c645688ae" contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa" name="inva:RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">18</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% based on the terms of the Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The La Jolla Royalty Agreement is subject to maximum aggr</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">egate royalty payments to HCR of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56ed81cd-5d12-435c-ab2a-05d3b70096f1" contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa" name="inva:MaximumAggregateRoyaltyPaymentsDue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">225.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, we recognized interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b677d94-38e6-4981-97eb-dd681ad0abe5" contextRef="C_b581726d-66c2-491f-be47-b769ac4d4e1d" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b9d1799-7909-4458-9fc9-fe1636b88823" contextRef="C_72ca4799-ff83-4650-a66f-e64646a8bbbd" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, on the deferred royalty obligation. From the date of our acquisition of La Jolla through December 31, 2022, we recognized interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70900131-7acc-4714-a18e-12a79ca77a86" contextRef="C_a995b915-50f7-4ebc-b58c-879c3902fff1" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the deferred royalty obligation. The carrying value of the deferred royalty obligation as of December 31, 2024 and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddae86cf-8e7a-40b2-84d5-a228fdb553d4" contextRef="C_3baecf69-ebf5-4807-8356-b90a92791318" name="inva:DeferredRoyaltyObligations" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">69.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd23b317-6a64-4cbb-8cf1-b6d712c9b5c0" contextRef="C_11dc5ce4-6d0c-463a-81f6-6f26c160dbca" name="inva:DeferredRoyaltyObligations" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">69.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, (refer to Note 9 &#8220;Balance Sheet Components</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). During the years ended December 31, 2024 and 2023, we made royalty payments to HCR of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43cbb733-4e91-4f1d-ab6b-b92ce8e1a96b" contextRef="C_b581726d-66c2-491f-be47-b769ac4d4e1d" name="inva:RoyaltyPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b88a745-2109-4158-8fa9-6fd6bac858ca" contextRef="C_72ca4799-ff83-4650-a66f-e64646a8bbbd" name="inva:RoyaltyPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. From the date of acquisition of La Jolla through December 31, 2022, we made royalty payments to HCR of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_276bde09-e41a-4d7e-b7b2-ca95c201ecd5" contextRef="C_a995b915-50f7-4ebc-b58c-879c3902fff1" name="inva:RoyaltyPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The deferred royalty obligation was valued using Level 3 inputs, and its carrying value as of December 31, 2024 and 2023 approximates fair value. The fair</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">143</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a_5"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">value </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the deferred royalty obligation was calculated as the discounted deferred royalty obligations based on revenue projections for GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2024, the annual effective interest rate of the deferred royalty obligation is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3e1bd1d-3fa4-4fda-a15a-15aa017a4d8c" contextRef="C_b581726d-66c2-491f-be47-b769ac4d4e1d" name="inva:InterestRateOfDeferredRoyaltyObligation" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.44</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the terms of the La Jolla Royalty Agreement, if we are unable to meet certain obligations, including the obligation to use commercially reasonable and diligent efforts to commercialize GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, HCR would have the right to terminate the La Jolla Royalty Agreement and demand payment of either $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9624bec2-3032-4de8-8db9-f95ddbbf3ad8" contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa" name="inva:RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">125.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8e96e9f-c0f8-48b9-91ea-080ba0e7ad7a" contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa" name="inva:RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">225.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (depending on which obligation we have failed to meet) less aggregate royalties already paid to HCR. As of December 31, 2024, inclusive of the aggregate royalties paid to HCR by La Jolla under the La Jolla Royalty Agreement prior to our acquisition, La Jolla paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81bccf4f-9107-49a8-ae15-400a4e98e347" contextRef="C_f6bcc262-29e8-498c-850a-47d7bc746ddd" name="inva:TotalPaymentsMadeForRoyaltyAgreement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">27.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">aggregate royalties to HCR. In the event that we fail to pay such amount if and when due in a timely manner, HCR would have the right to foreclose on the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-related assets. HCR has no recourse against any asset other than GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain contract provisions within the La Jolla Royalty Agreement that could result in an acceleration of amounts due under the La Jolla Royalty Agreement are recognized as embedded derivatives that require bifurcation from the deferred royalty obligation and fair value recognition. We determined the fair value of each derivative by assessing the probability of each event occurring, as well as the potential repayment amounts and timing of such repayments that would result under various scenarios. As a result of this assessment, we determined that the fair value of the embedded derivatives is immaterial and, therefore, not recognized as of December 31, 2023 and 2022. We estimate the fair value of the embedded derivatives for each reporting period until either the features lapse or the La Jolla Royalty Agreement is terminated, whichever occurs first. Any material change in the fair value of the embedded derivatives will be recorded as either a gain or loss in the consolidated statements of income.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_4b176a5a-7dac-4757-9c5a-9b7d91fbc9a8" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_4b176a5a-7dac-4757-9c5a-9b7d91fbc9a8_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. COMMITMENTS AND CONTINGENCIES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Lease</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have operating leases for our corporate headquarters, office spaces and laboratory facilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2019, we entered into an operating lease for our headquarters in Burlingame, California for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d2d3a09-9909-4630-82c7-6413b729c86c" contextRef="C_017b1701-0383-437f-9b49-4b53a72f5cc5" name="us-gaap:NetRentableArea" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">2,111</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> rentable square feet. The lease commenced in November 2019 with an initial term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_df825393-b260-4cba-9ff7-9fc9a38e03d8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">thirty-six</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> calendar months, which was subsequently amended to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_95673362-d782-4e32-804a-2d906541bf72;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2027</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our operating leases include a facility lease consisting of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d4d7c0c-e4f6-4f4f-bf9d-e77d647d49f2" contextRef="C_49ed2cfa-e32a-42c5-9d24-b9211f8ade51" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">15,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Waltham, Massachusetts, which expires in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1f9d0b86-7ca1-4461-b3cf-41c5a7d463c7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2029</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_76abbcd4-ea72-4f47-8965-650a8aacc3b2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of lease costs are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.863%;box-sizing:content-box;"/>
        <td style="width:1.281%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.764000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.281%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.764000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.281%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.764000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Straight line operating lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbbf5295-c34c-4390-a71b-017e97905b26" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,200</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1318f8bc-2de0-484e-b0b9-00e7338ba1fe" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,428</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7604488-7409-49c6-929f-aa3339915d41" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,585</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e15de377-9342-4acb-9512-b78d575f059c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57a78b62-da5e-4909-9d6a-ddc5bc4504f7" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">189</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28d40695-1b18-4dea-ab1f-44c3535f1ab6" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3be7df5-92a4-4a3c-9f84-cecd646e87f7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,214</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a2a192b-89d3-4a01-ba52-6feaec786da8" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,617</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdcb1bcc-f8c7-4f96-9ca3-2aa3ee85c394" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,740</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_42b0ea03-db85-4d48-b988-c97542996744" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplemental cash flow information related to leases are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.863%;box-sizing:content-box;"/>
        <td style="width:1.281%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.764000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.281%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.764000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.281%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.764000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of <br/>&#160;&#160;&#160;operating lease liabilities:</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19e4743f-abda-4a3f-94b8-837c6e3e7920" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,464</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_170c9c48-92ec-4b11-90c6-37bfd820c95e" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,542</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_385518b2-f169-42a3-b030-54bf871f2b22" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">790</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets obtained in exchange <br/>&#160;&#160;&#160;for operating lease obligations</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9326d8b4-dd20-4102-8bda-1940fa286194" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,156</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e4ff0f2-9ed0-4219-93e1-137e2bf0e01e" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe6b7451-3d48-42b8-8bee-59d026e8ed79" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,323</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained through acquisitions</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c183254-f3af-490e-88f8-a81f89faf082" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="inva:RightOfUseAssetsObtainedThroughAcquistions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b691edfe-58df-4203-b63f-145bf0d8f5ce" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="inva:RightOfUseAssetsObtainedThroughAcquistions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5dd537fb-9611-47bb-b649-239bef2e37b2" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="inva:RightOfUseAssetsObtainedThroughAcquistions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,185</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our operating leases have weighted-average remaining term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35d63408-5d3e-4e3e-b70b-1ccbccebc9d8" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.6</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and the weighted-average discount rate on our operating lease liabilities was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07eb7392-8992-4e37-811e-cc419cfeefbb" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">144</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_4b176a5a-7dac-4757-9c5a-9b7d91fbc9a8_1" continuedAt="F_4b176a5a-7dac-4757-9c5a-9b7d91fbc9a8_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_92baabad-9756-4276-abd7-85f363c60ca6" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future minimum lease payments on our operating leases as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.757%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_069ee9ed-0b3f-4eb8-9a63-dd9f8f08ca11" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,705</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99296a35-2853-4d39-934d-34ceb71e1d87" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">435</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e116d6e-b541-456a-9783-dccafeb9eead" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">455</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c05d2854-af2a-48e0-aac0-273fdfe7834d" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba4ab82c-3228-4445-bd7e-cddd604661a5" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_205f7dac-df43-47e0-904a-52430e34a05d" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,004</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21d59bca-9611-4e0b-9bf8-30e20a82e4b3" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">      </span><span><span style="-sec-ix-hidden:F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21051b1d-6c3a-4e99-bc23-e9341fbee20d" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,751</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Purchase Commitments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2024, we entered into a Commercial Supply Agreement with Corden Pharma CHEN&#212;VE SAS (&#8220;Corden&#8221;), under which we engaged Corden to manufacture and supply certain products related to XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and to perform certain services and studies. Under the agreement, we committed to minimum purchase commitments through December 31, 2027.  As of December 31, 2024, we have approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_385d5d59-aeed-47ac-9f98-b5eb408650a0" contextRef="C_d1e16fcd-b412-4137-9d48-7dd6c2506efe" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million U.S. dollar equivalent in outstanding purchase commitments under the agreement for the year 2024, which will be utilized in early 2025. We also have approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1de52ed5-ddd1-40bb-bdff-037cba1aaff2" contextRef="C_412a8dbd-f544-4764-ad96-91e826f4e587" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fadff23-ea8b-4df1-862e-73cecc04e36f" contextRef="C_412a8dbd-f544-4764-ad96-91e826f4e587" name="us-gaap:PurchaseObligationDueInSecondYear" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15789bd9-01e7-4cf7-8a3e-90858291628a" contextRef="C_412a8dbd-f544-4764-ad96-91e826f4e587" name="us-gaap:PurchaseObligationDueInThirdYear" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million U.S. dollar equivalent in purchase commitments under the agreement for the years 2025, 2026 and 2027, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company is involved in legal proceedings in the ordinary course of its business. We are not currently a party to any material legal proceedings except as discussed below.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 15, 2022, La Jolla received a paragraph IV notice of certification (the &#8220;First Notice Letter&#8221;) from Gland Pharma Limited (&#8220;Gland&#8221;) advising that Gland had submitted an Abbreviated New Drug Application (&#8220;ANDA&#8221;) to the FDA seeking approval to manufacture, use or sell a generic version of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. prior to the expiration of U.S. Patent Nos.: 9,220,745; 9,572,856; 9,867,863; 10,028,995; 10,335,451; 10,493,124; 10,500,247; 10,548,943; 11,096,983; and 11,219,662 (the &#8220;GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents&#8221;), which are listed in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;). The First Notice Letter alleges that the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents are invalid, unenforceable and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Gland&#8217;s ANDA.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2022, La Jolla filed a complaint for patent infringement of the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents against Gland and certain related entities in the United States District Court for the District of New Jersey in response to Gland&#8217;s ANDA filing. In accordance with the Hatch-Waxman Act, because GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is a new chemical entity and La Jolla filed a complaint for patent infringement within 45 days of receipt of the First Notice Letter, the FDA cannot approve Gland&#8217;s ANDA any earlier than 7.5 years from the approval of the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> NDA unless the District Court finds that all of the asserted claims of the patents-in-suit are invalid, unenforceable and/or not infringed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 22, 2023, La Jolla received a paragraph IV notice of certification (the &#8220;Second Notice Letter&#8221;) from Gland advising that Gland had amended its ANDA filing to include a paragraph IV certification alleging that all claims of the newly-issued and Orange Book-listed U.S. Patent No. 11,559,559 (&#8220;the &#8217;559 Patent&#8221;), which covers GIAPREZA&#174;, are invalid, unenforceable and/or not infringed.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 22, 2023, La Jolla filed a First Amended Complaint in this litigation adding Gland&#8217;s marketing and distribution partners for its ANDA angiotensin II product, Fresenius Kabi USA LLC and Fresenius Kabi SwissBiosim GmbH (collectively, the &#8220;Fresenius Kabi Defendants&#8221;), as co-defendants. On April 7, 2023, La Jolla filed a Second Amended Complaint in response to the Second Notice Letter, adding claims that the manufacture, use, sale, offer for sale, or import of Gland&#8217;s ANDA angiotensin II product will infringe the &#8217;559 Patent. On November 14, 2023, La Jolla filed a Third Amended Complaint adding additional infringement claims against the Fresenius Kabi Defendants.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">145</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4b176a5a-7dac-4757-9c5a-9b7d91fbc9a8_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2025, La Jolla, as well as The George Washington University (collectively, with the La Jolla entities, the &#8220;Plaintiffs&#8221;) entered into a settlement agreement (the &#8220;Settlement Agreement&#8221;) with Gland and the Fresenius Kabi Defendants (collectively, &#8220;Defendants&#8221;) resolving the Hatch-Waxman Act concerning Gland&#8217;s ANDA filing. Under the terms of the Settlement Agreement, Plaintiffs granted Defendants a perpetual, royalty-free and fully paid-up, non-exclusive, non-sublicensable, non-transferable right and license solely to make, have made, use, sell, offer to sell, import, and/or distribute the product that is subject to Gland&#8217;s ANDA in the United States commencing in the early 2030s, subject to certain exceptions as is customary in these type of agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required by law, the settlement is subject to review by the U.S. Department of Justice and the Federal Trade Commission.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications and Other Contingencies</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, we may provide indemnifications of varying scope and terms to vendors, directors, officers, and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by us, our negligence or willful misconduct, violations of law, or intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. No material demands have been made upon us to provide indemnification under such agreements, and thus, there are no claims that we are aware of that could have a material effect in our consolidated financial statements. We also maintain director and officer insurance, which may cover certain liabilities arising from our obligation to indemnify our directors. To date, we have not incurred any material costs and, as of December 31, 2024, we have not accrued any liabilities in the consolidated financial statements as a result of these provisions.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_6120dcf2-ba3e-49bd-9471-d7acc302da80" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_6120dcf2-ba3e-49bd-9471-d7acc302da80_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. INCOME TAXES</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d7d397c5-31fa-43da-b00c-9490f3af807b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income tax expense consists of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76ac2340-0bbe-400e-b390-99f4617c8a91" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,438</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7568dfab-3623-4645-b4c6-92b395ae8aab" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,799</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_420d2166-a67c-4042-ab3c-473d41fc3d30" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,822</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ee74c0b-356b-45d9-96a3-45d04a3a35c3" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,175</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bf07140-720d-4993-9de2-3c593394098a" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,177</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7df1fe75-f0ef-4c98-9eb1-eefb0211c8e2" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">464</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f762221a-f6c6-497b-b858-7da6c441c5bd" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,613</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3726b4b7-b861-40de-a6d6-baf89b22abe5" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,976</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea5be693-b20c-444d-ac51-486aef656b01" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,286</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7263619-96da-4028-9daf-cc74e623ed05" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12,606</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2b98607-2010-46e5-9dff-9f346529e747" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,594</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ea9e7cb-e1bb-44d9-b1f3-350101be6c9b" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,026</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f0e99e4-c6d0-4ead-bc1a-ab06e73acbb6" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">11</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec6cadca-904a-466f-afc0-22da86fd8024" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,194</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7386e27-ef48-4d6f-8adc-937baf52c9a7" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">625</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c45856a2-ba91-4ca7-bfed-3aa75c43956c" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12,617</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9b901bd-4d1d-4607-9e9e-83ee77a650b3" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,400</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d9a6960-6969-489a-8032-1523a1a64d96" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,401</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c540b3a6-a71c-4c33-a20e-cff3bfaf4b4f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,996</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccbe621a-8d60-49ad-9d9d-22108c3fbe47" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,376</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d55f9a2-44eb-4c65-a214-17d489793562" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,687</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_4f2757c4-1bfd-46b7-8609-c5e082078002" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true" continuedAt="F_4f2757c4-1bfd-46b7-8609-c5e082078002_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The impacts of the differences between the expected U.S. federal statutory income tax to our income tax expense are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.75%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected tax at federal statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a45a3ce-2a85-4a7a-b928-e1de0e68ccf2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,846</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61aa29ba-06fc-4ca5-bb50-e989383f55d0" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,747</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18d6f8a0-3ff4-4f22-bacc-ae3d51f35fdb" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,928</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income tax expense (benefit), net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ac661d6-1044-41aa-8a44-55baf7b08060" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,864</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69f216db-61f4-4f3c-b0aa-8cb556eefbef" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,433</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1de16e0b-e7a9-4549-b108-8df9927261ee" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,414</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal and state research credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef2f3d26-7aa9-4ca9-ac9e-4635b8fd6d88" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_759ac3fa-941f-4585-be13-f2a23bad85b4" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,582</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b5c6420-abf9-446d-b72c-a756f1a01711" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,453</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign derived intangible income deduction</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71b6405f-fba0-4495-a852-0fbcec7f1ac1" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,767</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c973ce9-4f55-4c99-b78e-cb87c2688245" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,274</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2a9aa56-7254-49bb-83c5-0b4dabca600d" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7582bb63-7e93-409a-bb77-32fd883a5b1e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49c0e703-d52e-4a51-90b3-f9f864de1cd1" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4ccd62a-c4d4-4bda-a57a-057662886bf4" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,468</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impact of consolidation and deconsolidation of subsidiaries</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14ed9d95-6af5-4d17-ac1f-5479c8be1db2" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e35297e-1710-4eae-9774-b421c2800191" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68e2b35c-eb65-4eb5-a1bf-d96604804efd" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,897</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da4fb752-669a-4f64-94e2-b73cf0a83b12" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,243</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed725343-0831-4628-a5d4-233213566883" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,219</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09da17b8-8eef-495d-a05c-c737c37c8227" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">125</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03e89a2f-8677-47aa-9a30-3667c092b5ad" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,386</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33568365-6f46-4d2a-81a2-81830d986dff" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12,167</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36b1a80c-bb7f-4c15-bb65-f0b9b818cb09" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,180</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax expense, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd3c1826-e6de-4070-ba84-5c9088d1430f" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,996</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56cb5eba-0981-4417-af90-07515fc67b85" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,376</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a7254ba-61c6-4572-81e3-1c6db1a9d8a1" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,687</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">146</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_6120dcf2-ba3e-49bd-9471-d7acc302da80_1" continuedAt="F_6120dcf2-ba3e-49bd-9471-d7acc302da80_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4f2757c4-1bfd-46b7-8609-c5e082078002_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span><ix:nonNumeric id="F_5ca2d38d-6383-464b-a815-07824fd143d7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_5ca2d38d-6383-464b-a815-07824fd143d7_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of our deferred tax assets and deferred tax liabilities are as follows:</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5ca2d38d-6383-464b-a815-07824fd143d7_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:60.84%;box-sizing:content-box;"/>
        <td style="width:1.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9df1c4e0-3403-4079-8680-d260987c8062" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176,989</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec71c0e1-8d72-48dd-887e-9558deabf7ac" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">182,013</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credit carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0639af32-7c04-48e4-83c4-b40b253a88df" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,359</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f24fe8be-f805-4c78-93cc-14025264f152" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,357</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized loss on investment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_962151ea-8e19-4075-9044-64509dce91b3" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,481</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_856e0b8c-1aa8-4fd4-a13e-f66e184348e0" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred royalty obligation, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3bee1a8-29c5-4624-950f-125462a29679" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:DeferredTaxAssetsDeferredRoyaltyObligationNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,452</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f037d8f-e1b3-45e9-8400-039af414e7e8" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:DeferredTaxAssetsDeferredRoyaltyObligationNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,084</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7496d903-19c7-4628-b7e8-a6180cab84c8" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,832</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e5ce3e3-59ae-4e32-9ffd-f0c1929545df" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,467</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2505352-6e80-48a1-bbfa-243217c02579" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">234,113</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97aa4bb4-659b-4e1d-8be7-9cc976ba2961" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227,921</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5eafab08-1532-4c12-88da-64241824dbec" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187,635</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05f34d16-b8cf-4c74-8751-2069c3251ec7" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">169,249</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d060f6b-c2ba-480e-864f-5075f06a0625" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,478</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85ccd4d5-86aa-40fd-b93f-8f40989ec587" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,672</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78532558-5073-4bcd-8902-90896d8383bd" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:DeferredTaxLiabilitiesDepreciationAndAmortization1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,626</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af6e6c59-d3a4-4282-bdd0-1ab32c785c90" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:DeferredTaxLiabilitiesDepreciationAndAmortization1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,064</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on investment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cbcc8a7-fe4d-48eb-932a-cac2362751e7" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxLiabilitiesInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f44ff207-87ea-4f2e-a6d4-0c9feb2e0d3e" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredTaxLiabilitiesInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,747</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory fair value adjustment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93688aae-bc58-420d-b582-2bd1bfcfde47" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="inva:DeferredTaxLiabilitiesInventoryFairValueAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,798</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f061d41-662e-4162-8244-9b44ba86c200" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="inva:DeferredTaxLiabilitiesInventoryFairValueAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,424</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets (liabilities)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0b4e400-b53d-43f0-bfea-fd9c1e4d8e89" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,054</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c649257-957c-413f-8a17-1e735d7e2b37" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">563</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We record deferred tax assets if the realization of such assets is more likely than not to occur. Significant management judgment is required in determining whether a valuation allowance against the deferred tax assets is required. We have considered all available evidence, both positive and negative, such as our historical operating results and predictability of future taxable income, in making such determination. We are also required to exercise significant management&#8217;s judgment in forecasting future taxable income. Specifically, we evaluate the following criteria when considering a valuation allowance:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the history of tax net operating losses in recent years;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">predictability of operating results;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">profitability for a sustained period of time; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">level of profitability on a quarterly basis.</span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_918ecbb4-70c1-47ef-97cb-ebf9fc1c6b35" contextRef="C_06063be5-bdd2-4157-b66c-78225d3605c7" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">520.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4945da08-e157-4b99-b466-3d513d992649" contextRef="C_06063be5-bdd2-4157-b66c-78225d3605c7" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">456.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which do not expire.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As of December 31, 2024, we also had state net operating loss carryforwards of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef60d6c2-ecda-4b44-91cd-214970fd7fe7" contextRef="C_7c641825-cc45-4345-9822-341d08847261" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which will expire beginning 2030 and state research tax credits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75996d1d-1d96-402a-a79d-b11b0d275b48" contextRef="C_3ba88775-17f5-4d28-b47f-634aaca4e732" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">33.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which do not expire.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Utilization of net operating loss and tax credit carryforwards may be subject to a substantial annual limitation due to ownership change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in expiration of net operating loss and tax credit carryforwards before some or all of such amounts have been utilized.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted an Internal Revenue Code of 1986, as amended, Section 382 (&#8220;Section 382&#8221;) analysis of the Company through December 31, 2024 to determine whether an ownership change had occurred since inception. The Section 382 study concluded that it is more likely than not that the Company did not experience an ownership change during the testing period. If we ever undergo an ownership change, the utilization of the pre-ownership change net operating loss carryforwards or pre-ownership change tax attributes, such as research tax credits, to offset the post-ownership change income may be subject to an annual limitation, pursuant to Sections 382 and 383 of the Internal Revenue Code of 1986, as amended. Similar rules may apply under state tax laws.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_962aa5ac-3e7d-4a60-83fe-7e39b6c57225" contextRef="C_5f6af4c9-41ef-4851-89a6-4144851fcb0c" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">154.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of Entasis&#8217; federal net operating losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_555fc802-18fc-4315-a243-0c6a95c60c93" contextRef="C_154fe60d-7256-40d2-a138-fa133ec0c2ef" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">365.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of La Jolla&#8217;s federal operating losses from the acquisitions in 2022, both subject to annual limitations, were available for future utilization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">147</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_6120dcf2-ba3e-49bd-9471-d7acc302da80_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our policy is to recognize interest and/or penalties related to income tax matters in income tax expense. As of December 31, 2024 and 2023, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0931dd73-e67c-4826-ae82-cfac058d34a2" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d9c1b224-18e3-4f33-911d-e9521630ee6f" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest or penalties due to the Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s net operating losses available to offset any tax adjustments.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have any tax positions for which a significant change in the total amount of gross unrecognized tax benefits is reasonably possible within 12 months of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Uncertain Tax Positions</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a95df2ba-51fc-413f-ad98-91c220612a3d" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:76.46%;box-sizing:content-box;"/>
        <td style="width:2.34%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:19.2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2021</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80f5c765-c2a6-4cb9-bb04-6359492fc546" contextRef="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,872</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2022</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee5e4140-c77f-419e-b4e5-66f2eaf976e7" contextRef="C_a084decd-4deb-4a08-b247-259a786424c0" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,452</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2022</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68315894-009a-4197-9889-a10b5fc5881c" contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,324</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ebbbb5d-4cc0-469a-981f-ea19189d619e" contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,119</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da0215cd-176f-4eee-ba93-cd727140c0fd" contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,443</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f7bfacc-89c8-4d11-acb4-f10947965002" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,851</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9afaf13-cb51-4a26-8631-28669985b420" contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,294</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The increase of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64b8a79f-50a9-40b3-adc1-e3008fe6fbf7" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">41.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in 2024 was primarily due to our strategic intercompany intellectual property alignment across different jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to taxation in the U.S. and various state and foreign jurisdictions. The tax years 2006 through 2013, 2015 and forward remain open to examination by the federal and most state tax authorities due to net operating loss and overall credit carryforward positions. We are not currently subject to any income tax audits by federal or state taxing authorities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2021, the Organization for Economic Cooperation and Development (&#8220;OECD&#8221;) enacted model rules for a new global minimum tax framework (&#8220;BEPS Pillar Two&#8221;), and various governments around the world have enacted, or are in the process of enacting legislation. We are in the process of evaluating whether and when these new rules may come into effect and apply to us, including the eligibility to qualify for safe harbor rules</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We plan to treat the tax if any as a period cost. We do not believe that the Pillar Two rules apply to us yet.  As such, the potential future quantitative impact of the enacted or substantively enacted legislation is not yet reasonably estimable.</span></p></ix:continuation></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_0fa354ad-114d-43a5-9e1c-6758b54dd54e" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true" continuedAt="F_0fa354ad-114d-43a5-9e1c-6758b54dd54e_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15. SEGMENT REPORTING</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We operate as a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8697229b-658d-48d6-b3f9-46eb9028e018;"><span style="-sec-ix-hidden:F_11be943b-e77c-41bd-aecb-698c8fa9edb8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating and reportable segment, focused on creating value for our stockholders. We achieve this by maximizing the value of our respiratory royalty portfolio and growing our investments in innovative healthcare assets that address critical unmet medical needs.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_729d9a5e-6c01-4f45-8bc1-8b9538c8dbaa;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as the </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5cd89d4f-99d7-446b-a323-dcde68dc080b" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief operating decision-maker (&#8220;CODM&#8221;), evaluates the company&#8217;s financial performance and operational efficiency using consolidated net income.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This helps guide decisions related to commercial operations, product development, and regulatory compliance, ensuring resources are allocated effectively to support growth initiatives. Consolidated net income also helps inform reinvestment strategies to strengthen our market position and drive innovation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the segment are the same as those described in Note 1, &#8220;Description of Operations and Summary of Significant Accounting Policies&#8221;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenues are generated primarily from our collaborative arrangements and royalty payments from GSK, located in Great Britain. We also generate revenue from net product sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as well as license and other revenues. Refer to Note 3, &#8220;Revenue Recognition&#8221;, for more information on our revenues for the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our long-term assets are located within the United States. The CODM does not review assets at a different level or category than the amounts disclosed in the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">148</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_0fa354ad-114d-43a5-9e1c-6758b54dd54e_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c64ab752-3487-427f-a6dc-1a9cf55a84bc" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents the financial information used by the CODM to assess performance, which reconcile to the consolidated net income:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.371%;box-sizing:content-box;"/>
        <td style="width:1.42%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.122%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.42%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.122%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.42%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.122%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb3f1440-4527-46fe-b37b-18ea3652618c" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">358,711</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_354c26fe-1545-47e0-90cf-9c6c7fcb07ba" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">310,463</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_791138d5-053e-47af-9218-703a204f878c" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">331,339</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86dbcfb2-5092-4fe1-a0bc-e7e9f12f2054" contextRef="C_77c52870-1a85-4eaf-9c65-7b65a7c304fa" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,921</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0b44906-7723-425a-a478-f3a493e08beb" contextRef="C_804ca930-b7b7-4a49-a722-aff90380ae53" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,535</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8039637d-4ef1-4c5e-9492-4e2b251ee766" contextRef="C_fb5bc12c-55ad-4da3-a56f-d05ec3ed9dd2" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,488</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - Rest of the world</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2550fe2-be38-48aa-a018-dd174333e2e6" contextRef="C_33718ac7-2f56-451b-aa25-527639d12045" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,857</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a3ae593-98da-4eda-a24c-6f7af31fd37e" contextRef="C_a0571dc0-aebf-4847-a254-63bbaa92f9ed" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,341</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0948381d-b408-4d2e-a654-0c72629e7cb7" contextRef="C_b48017cd-1262-4c03-854d-9e240761aace" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,282</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - Amortization of inventory fair value adjustments</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1387ef84-6144-4089-b656-bcf0f00723b9" contextRef="C_56394c95-e990-4b88-a251-9f022931314e" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,820</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2e266d3-870f-4c9c-b694-f29e3112f2c4" contextRef="C_92dff807-84fa-491b-9fee-1e85b08d8746" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,164</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2b2227a-aca8-4235-896e-e9fa5d3761e8" contextRef="C_9bb96ed1-a18c-4f9a-b018-bbafef5054c4" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,023</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of license revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e321e76d-8e5e-405c-a053-008b55b1e91d" contextRef="C_11f76295-41b0-4dcd-bce7-3764ae292e78" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e00e0b0-c536-46bd-81ea-4b883a039976" contextRef="C_8fcd8c24-bab5-48ed-8f4b-d11e6d6b0426" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,600</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68a6ee5a-21e9-4765-9eb6-d363820ac608" contextRef="C_9109116f-9efb-4c72-ab41-742cb8d808be" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling and marketing</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a375d4a-7c2e-4c03-94ca-142adc96b794" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,441</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_395f3310-4083-432b-bca1-63f3f717fa54" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,739</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be249d86-d962-4114-9a5d-b74dda26634a" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,886</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd27f518-7b86-44e2-8618-18351946b2c0" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84,249</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e98a7e47-3eb6-4c1e-9876-d1e398a32ed1" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67,493</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27a47f7c-b788-4b0e-9156-06ef57c8ca54" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,652</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development - External services</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0151fdca-a93c-458b-a0c8-0d3a19c01f68" contextRef="C_da53c27e-3311-413c-8e97-f6873c7e96fe" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,408</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64b11ba4-ec0e-495b-b941-9fc9b8315f46" contextRef="C_388e224e-9c7a-4df5-91b8-5e4f6d9f788b" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,051</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db820155-15b2-4351-9453-f0e0262962b0" contextRef="C_ee91a4d7-5cf4-4689-95fd-88e803c82bd5" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,666</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development - Internal expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a8d26fd-1eea-4f67-a867-9320763b4c41" contextRef="C_f68989b1-d857-4210-9ee6-ae27a0818759" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8cd3289-6740-4d1b-9e1b-f3bde5a69464" contextRef="C_12d7763c-f468-4d34-a5f1-a55b18acd690" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,871</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38cef5ac-7325-4e0a-97d8-932e718baaea" contextRef="C_1df97a3c-6233-4b8a-a866-08d91ec761b6" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,766</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of acquired intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_362b7372-90fa-4e1c-80c2-942c31b82383" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,902</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b3d95e4-a452-4667-b355-7800981ec2b7" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,784</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c206550-1977-479a-ab72-0f73383cd0d2" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,581</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity method investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccde8b54-f42d-4978-baae-0cfdcbf86717" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64,253</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88caec07-c514-487d-8ffc-d9e40f26e6c5" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37d3348f-d791-4707-9e72-948711cd2bde" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">161,749</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and long-term investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45d3e359-be7c-40a6-a30c-f0d926eb3ffc" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">59,161</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30d2db1d-18d9-42ed-b547-1c2a6615d877" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,129</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66b6f972-8fdf-4520-b603-d9daba0eb563" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="inva:GainLossOnOtherInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,462</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90abfb63-8a5b-4682-ac54-61cc37a4d933" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,141</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ace8676a-49d6-47b2-abb6-c916c44db854" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,818</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dc70f40-ecc5-4b03-b27d-3333fd96276d" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,369</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deb2a782-c7d1-430f-863d-b12e0f1a80af" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,209</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64ad77b9-96f2-4e04-8e30-168dac1357e6" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,157</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5105ccc-91c2-4744-aa7f-6bac01dee148" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,789</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of TRC</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_659dccd5-c508-4775-b2ac-ec37ea3f3c5a" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3e4bdcd-efc9-4c35-98b1-44c5d19c1145" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a74fa75-3bc8-4316-9eff-972785c13e0d" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:DeconsolidationGainOrLossAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">266,696</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_684e0e1f-e60e-4daf-9255-1fe4b8606647" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bea92c4-ca6f-4406-aed8-d2860e1df48c" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_206ba068-ec41-47c6-904f-ae9d52eb39fd" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">20,662</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c215d9d1-b121-4b0b-bd01-a8496ddefa01" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,997</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce1f6b2c-74fc-43a9-9d32-e25496a7bbb0" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,969</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87f5e646-d5a3-4144-a913-ea3dcb7bd9cf" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,373</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb5954cb-796f-4fbe-a999-e2df98442e6a" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,996</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54d95d7c-7410-47fe-9019-5033d116f64b" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,376</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c02bc7f-4017-4386-8341-2ba5f6673be1" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,687</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b627d5af-bb6b-44b8-a67f-88c2458e9e1b" contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a5fb1ee-c286-40bb-ab35-866cfb77e9d1" contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179,722</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c382a929-3840-4792-a689-a47711e12294" contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,262</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">149</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="reports_of_independent_registered_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REP</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Stockholders and the Board of Directors of Innoviva, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33aa48d7-8b68-4e69-93ed-9788296f0549" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:AuditorOpinionTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Innoviva, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, stockholders&#8217; equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 26, 2025, expressed an unqualified opinion on the Company's internal control over financial reporting.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matter</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Consolidated Entities and Equity and Long-term Investments&#8212;Primary Beneficiary Determination for Variable Interest Entities&#8212;Refer to Notes 1, 5, and 6 to the consolidated financial statements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Critical Audit Matter Description</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company invests in equity and debt securities of private and public companies. The Company evaluates its interests in these entities to determine whether they meet the definition of a variable interest entity (VIE) or a voting interest entity (VOE) and whether the Company is required to consolidate these entities. A VIE is consolidated by its primary beneficiary, which is the party that has both 1) the power to direct the activities that most significantly impact the economic performance of the VIE and 2) a variable interest that absorbs losses or receives benefits from the VIE that could potentially be significant to the VIE. To determine whether a variable interest that the Company holds could potentially be significant to the VIE, the Company considers both qualitative and quantitative factors regarding the nature, size and form of the Company&#8217;s involvement with the VIE. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE. The Company will reconsider whether an entity is a VIE and whether the Company is the primary beneficiary of the entity upon the occurrence of certain types of events. The determination of the primary beneficiary of a VIE requires significant management judgment.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">150</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We identified the primary beneficiary determination for the Company&#8217;s VIEs as a critical audit matter due to the complexity of the accounting principles related to the determination of the primary beneficiary of a VIE and the significant judgment required by management in evaluating the Company&#8217;s role in establishing the VIE, their ongoing rights and responsibilities and identifying which party, if any, has power over those activities. This required a high degree of auditor judgment and an increased extent of effort, including the involvement of professionals with consolidation accounting expertise, when performing audit procedures to evaluate the Company&#8217;s determination of whether it is the primary beneficiary for its VIEs.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">How the Critical Audit Matter Was Addressed in the Audit</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit procedures related to the primary beneficiary determination for VIEs included the following, among others:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We tested the effectiveness of controls over the Company&#8217;s primary beneficiary determination for its VIEs, including management&#8217;s determination of the party that has the power to direct the activities that most significantly impact the economic performance of the VIE and a variable interest that absorbs losses or receives benefits from the VIE that could potentially be significant to the VIE.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We evaluated the appropriateness of the Company&#8217;s accounting conclusions for consolidated and unconsolidated VIEs through the following:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Evaluated the investment structures and terms of the agreements, including reading the purchase agreements and other related documents which govern the formation and activities of the entity (the Contractual Arrangements).</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tested whether the Company appropriately determined the primary beneficiary by evaluating the Contractual Arrangements of the entity to determine if the Company has the power to direct activities that most significantly impact the economic performance of the VIE, and if the Company has the obligation to absorb losses of the entity or the right to receive benefits from the entity that could be significant to the VIE.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For certain VIEs, with the assistance of professionals with expertise in consolidation accounting, evaluated the appropriateness of the Company&#8217;s determination of the primary beneficiary of the VIE.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the Company&#8217;s disclosures related to the primary beneficiary determination of its consolidated entities and unconsolidated VIEs.</span></div></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Jose, California</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2022.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">151</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:-8.696%;padding-left:8%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_9_changes_in_and_disagreements_with"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_9a_controls_and_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 9A. CONTROLS AND PROCEDURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted an evaluation as of December 31, 2024, under the supervision and with the participation of our management, including our chief executive officer and chief accounting officer, of the effectiveness of the design and operation of our disclosure controls and procedures, which are defined under SEC rules as controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Securities Exchange Act of 1934 (Exchange Act) is recorded, processed, summarized and reported within required time periods specified in the Commission&#8217;s rules and forms and controls and procedures that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer&#8217;s management including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decision regarding required disclosure. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance levels.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management&#8217;s Report on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a&#8209;15(f) of the Exchange Act. Internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on criteria established in the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Control&#8212;Integrated Framework</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Management&#8217;s assessment included evaluation of such elements as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control environment. Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2024.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our independent registered public accounting firm, Deloitte &amp; Touche LLP, has audited our internal control over financial reporting as of December 31, 2024. Their attestation report on the audit of our internal control over financial reporting is included below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitations on the Effectiveness of Controls</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefit of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Innoviva have been detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have been no material changes to our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) for the year ended December 31, 2024 which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">152</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Stockholders and the Board of Directors of Innoviva, Inc.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on Internal Control over Financial Reporting</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the internal control over financial reporting of Innoviva, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2024, based on criteria established in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> issued by COSO.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2024, of the Company and our report dated February 26, 2025, expressed an unqualified opinion on those financial statements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definition and Limitations of Internal Control over Financial Reporting</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98910cfa-a59a-472b-aea7-5533f89cad32" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deloitte &amp; Touche LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bddc5245-0385-4773-9ba1-b43de9bfe3b0" contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Jose, California</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">153</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_9b_other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 9B. OTHER INFORMATION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Arrangements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None of the Company&#8217;s directors or officers </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0c66f456-e52e-4147-9338-afe16bd5835d" contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_ff26e74d-98df-4697-843b-1edfa8e80bbe" contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3bc7d8c4-7ede-4242-b3bf-b39218859684" contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1" name="inva:Rule10B51ArrModifiedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_34d543d8-447f-4067-a3e1-cb8f7d903d51" contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1" name="inva:NonRule10B51ArrModifiedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">modified</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7dfc5668-707b-4d68-9555-0b066febc6e8" contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_3220bf1d-2dbd-4fc5-b876-dfc28ff5a5b8" contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terminated</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company&#8217;s fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_9c_disclosure_regarding_foreign_jur"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 9C. DISCL</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">154</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_10_directors_executive_officers_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item is incorporated by reference from our proxy statement for our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 11. EXECUTIVE COMPENSATION</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item is incorporated by reference from our proxy statement for our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-9.012%;padding-left:8.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_12_security_ownership_of_certain"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than with respect to the Securities Authorized for Issuance under Equity Compensation Plans below, the information required by this Item is incorporated by reference from our proxy statement for our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Authorized for Issuance under Equity Compensation Plans</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides certain information with respect to all of our equity compensation plans in effect as of December 31, 2024:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:55.418%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.816%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.559%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.816%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.559%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.816%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.019%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Plan Category</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities to be issued upon exercise of outstanding options and vesting of outstanding restricted stock units and restricted stock awards</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted&#8209;average exercise price of outstanding options</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation plans approved by security holders</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,665,849</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.23</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,226,046</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">&#160;(3)</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 2,067,062 shares issuable upon exercise of outstanding options and 598,787 shares issuable upon vesting of outstanding RSUs and RSAs.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Does not take into account outstanding restricted stock units as these awards have no exercise price.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 2,467,596 shares of common stock available under our Employee Stock Purchase Plan.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_13_certain_relationships_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item is incorporated by reference from our proxy statement for our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_14_principal_accounting_fees_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item is incorporated by reference from our proxy statement for our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">155</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;" id="part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_15_exhibits_and_financial_statement"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a)   The following documents are filed as part of this Annual Report on Form 10&#8209;K:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.    Financial Statements:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following financial statements and schedules of the Registrant are contained in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; of this Annual Report on Form 10&#8209;K:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:93.8%;box-sizing:content-box;"/>
    <td style="width:6.2%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:0.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;text-indent:7.2pt;vertical-align:bottom;padding-bottom:0in;"><p style="text-indent:-7.2pt;padding-left:7.2pt;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_income"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Income for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_comprehensive"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Comprehensive Income for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_stockholders"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_consolidated_financial"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#reports_of_independent_registered_1"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID 34)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.    Financial Statement Schedules:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All schedules have been omitted because of the absence of conditions under which they are required or because the required information, where material, is shown in the financial statements, financial notes or supplementary financial information.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)   Exhibits required by Item 601 of Regulation S&#8209;K:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item is set forth on the exhibit index that follows the signature page of this report.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;" id="item_16_form_10_k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 16. FORM 10&#8209;K SUMMARY</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">156</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="exhibits"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.58%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:55%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.4%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:0.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed Herewith</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date/Period</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">End Date</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000114036122020321/ny20004305x1_ex2-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger, dated as of May 23, 2022, by and among Innoviva, Inc., Innoviva Merger Sub, Inc. and Entasis Therapeutics</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/24/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000114036122025657/ny20004741x1_ex2-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger, dated as of July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc. and La Jolla Pharmaceutical Company</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/11/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465916115299/a16-9600_1ex99d2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4/28/2016</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465923000897/tm231444d1_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws, amended and restated as of January 1, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/4/2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465907015079/a07-1942_1ex4d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen certificate representing the common stock of the registrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/31/2006</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465913004773/a12-25051_9ex4d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Indenture, dated as of January 24, 2013 by and between Theravance, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/25/2013</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465913004773/a12-25051_9ex4d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of 2.125% Convertible Subordinated Note Due 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/25/2013</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465917049927/a17-18560_4ex4d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Indenture (including form of Note) with respect to Innoviva&#8217;s 2.50% Convertible Senior Notes due 2025, dated as of August 7, 2017, between Innoviva and The Bank of New York Mellon Trust Company, N.A., as trustee</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/7/2017</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465920022807/ex-4d9.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/19/2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465922031613/tm228653d1_ex4-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Indenture (including form of Note) with respect to Innoviva&#8217;s 2.125% Convertible Senior Notes due 2028, dated as of March 7, 2022, between Innoviva, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/8/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914058343/a14-13984_1ex10d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Collaboration Agreement between the registrant and Glaxo Group Limited, dated as of November 14, 2002</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/30/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746904020116/a2136994zex-10_13.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Investors&#8217; Rights Agreement by and among the registrant and the parties listed therein, dated as of May 11, 2004</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S&#8209;1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/10/2004</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746914001691/a2218387zex-10_13.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Strategic Alliance Agreement between the registrant and Glaxo Group Limited, dated as of March 30, 2004</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/31/2013</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746910001540/a2196645zex-10_22.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of Cash Bonus Program, as amended</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/31/2009</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746910001540/a2196645zex-10_47.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Change in Control Severance Plan effective December 16, 2009</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.47</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/31/2009</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746910001540/a2196645zex-10_48.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2009 Change in Control Severance Plan adopted December 16, 2009</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.48</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/31/2009</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465910060202/a10-21843_1ex10d2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amendment to Amended and Restated Governance Agreement among the registrant, Glaxo Group Limited, GlaxoSmithKline plc and GlaxoSmithKline LLC, dated as of November 29, 2010</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11/29/2010</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746912001614/a2207068zex-10_34.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Strategic Alliance Agreement, dated October 3, 2011</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.34</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/31/2011</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465912053222/a12-11849_1ex10d38.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2012 Equity Incentive Plan, as approved by the board of directors February 8, 2012 and approved by stockholders May 16, 2012 and forms of equity award</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.38</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/30/2012</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465913003879/a12-25051_8ex10d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Base Capped Call Transaction, dated January 17, 2013</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/23/2013</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465913003879/a12-25051_8ex10d2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Additional Capped Call Transaction, dated January 18, 2013</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/23/2013</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914017128/a14-7412_1ex10d1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Master Agreement by and among Theravance, Inc., Theravance Biopharma, Inc. and Glaxo Group Limited, dated March 3, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/6/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914017128/a14-7412_1ex10d2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Collaboration Agreement Amendment by and between Theravance, Inc. and Glaxo Group Limited, dated March 3, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/6/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914017128/a14-7412_1ex10d3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Strategic Alliance Agreement Amendment by and between Theravance, Inc. and Glaxo Group Limited, dated March 3, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/6/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914044231/a14-14482_1ex10d2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Transition Services Agreement between Theravance and Theravance Biopharma, dated June 2, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/5/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914044231/a14-14482_1ex10d3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Tax Matters Agreement between Theravance and Theravance Biopharma, dated June 2, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/5/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">157</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.58%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:55%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.4%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914044231/a14-14482_1ex10d4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employee Matters Agreement between Theravance and Theravance Biopharma, dated June 1, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/5/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465914044231/a14-14482_1ex10d5.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Theravance Respiratory Company, LLC Limited Liability Company Agreement between Theravance and Theravance Biopharma, dated May 31, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/5/2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465915036218/a15-7167_1ex10d64.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment/Clarification to Transition Services Agreement between Theravance and Theravance Biopharma, dated March 2, 2015</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.64</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/31/2015</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465915054328/a15-16369_1ex10d2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">First Amendment to 2009 Change In Control Severance Plan (Renamed 2009 Severance Plan)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/29/2015</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000104746918001016/a2234562zex-10_76.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Notice of Performance&#8209;Based Restricted Stock Award and Restricted Stock Award Agreement under 2012 Equity Incentive Plan (director form)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.76</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/23/2018</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465918047409/a18-14089_1ex10d81.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amendment to 2009 Severance Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10&#8209;Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.81</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/26/2018</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000089914018000502/i25948910b.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter with Marianne Zhen, dated September 7, 2018</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9/11/2018</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000089914020000275/i35135265b.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated May 20, 2020</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/26/2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000089914022000493/i5271437b.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated April 29, 2022</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/2/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.27</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000119312520316331/d69428dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/14/2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.28</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000119312520316331/d69428dex102.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Limited Partnership Agreement of ISP Fund LP, dated as of December 11, 2020, by and among ISP Fund LP, Sarissa Capital Fund GP LP, Innoviva Strategic Partners LLC and the other parties named therein</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8&#8209;K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/14/2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.29</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000089914021000501/i052021b.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Share Repurchase Agreement, dated as of May 2021, by and between Innoviva, Inc. and Glaxo Group Limited</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/20/2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.30</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000089914021000501/i052021c.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Letter Agreement, dated as of May 20, 2021, by and among Innoviva Strategic Partners LLC, ISP Fund LP and Sarissa Capital Fung GP LP</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/20/2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.31</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465922031613/tm228653d1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Capped Call Confirmation dated March 2, 2022, by and among Innoviva, Inc., Bank of America, N.A., Goldman Sachs &amp; Co. LLC and Deutsche Bank AG, London Branch</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/8/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.32</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000114036122020321/ny20004305x1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 1 to the Investor Rights Agreement, dated May 23, 2022, by and among Innoviva, Inc. and Entasis Therapeutics Holdings Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/24/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.33</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000114036122025657/ny20004741x1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and Kevin C. Tang Foundation</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/11/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.34</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000114036122025945/ny20004764x1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Equity Purchase Agreement, dated July 13, 2022, by and among Innoviva, Inc., Innoviva TRC Holdings LLC and Royalty Pharma Investments 2019 ICAV</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/13/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.35</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000114036122025945/ny20004764x1_ex10-2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/13/2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.36+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000095017023019835/inva-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Transition Agreement between Larry Edwards and Innoviva Specialty Therapeutics, Inc., dated February 23, 2023, and Release of Claims form signed by Larry Edwards, dated April 5, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/9/2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.37</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/d488837ddef14a.htm/000119312523127442/0001193125-23-127442-index.html"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2023 Employee Stock Purchase Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DEF 14A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4/28/2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.38+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1080014/000110465923095406/tm2324789d1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between Innoviva, Inc. and Stephen Basso dated July 28, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/25/2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="inva-ex19.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Insider Trading Policy and Guidelines with Respect to Certain Transactions in Securities (effective as of March 15, 2023)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="inva-ex21_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">List of Subsidiaries</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="inva-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consent of Ernst &amp; Young LLP Independent Registered Public Accounting Firm of Armata Pharmaceuticals, Inc.**</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#power_of_attorney"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Power of Attorney (see signature page to this Annual Report on Form 10&#8209;K)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">158</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.58%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:55%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.4%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="inva-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rule 13a&#8209;14 under the Securities Exchange Act of 1934</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="inva-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rule 13a&#8209;14 under the Securities Exchange Act of 1934</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="inva-ex32.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certifications Pursuant to 18 U.S.C. Section 1350</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1080014/000095017024023237/inva-20231231.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Innoviva Clawback Policy (effective as of October 2, 2023)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/29/2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audited Consolidated Financial Statements of Armata Pharmaceuticals, Inc. at December 31, 2024, for the year ended December 31, 2024**</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.CAL</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.DEF</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.LAB</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.PRE</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+     Management contract or compensatory plan or arrangement required to be filed pursuant to Item 15(b) of Form 10&#8209;K.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*     Confidential treatment has been granted for certain portions which are omitted in the copy of the exhibit electronically filed with the Securities and Exchange Commission. The omitted information has been filed separately with the Securities and Exchange Commission pursuant to Innoviva, Inc.&#8217;s application for confidential treatment.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">**   To be filed by amendment to this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">#     Furnished herewith.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">159</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.42%;box-sizing:content-box;"/>
    <td style="width:3.42%;box-sizing:content-box;"/>
    <td style="width:49.16%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: February 26, 2025</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ PAVEL RAIFELD</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pavel Raifeld<br/></span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;" id="power_of_attorney"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">POWER OF ATTORNEY</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Pavel Raifeld, as their true and lawful attorney&#8209;in&#8209;fact and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to the Annual Report on Form 10&#8209;K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney&#8209;in&#8209;fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she could do in person, hereby ratifying and confirming all that said attorney&#8209;in&#8209;fact and agent, or his substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:37.808%;box-sizing:content-box;"/>
    <td style="width:3.001%;box-sizing:content-box;"/>
    <td style="width:37.828%;box-sizing:content-box;"/>
    <td style="width:3.001%;box-sizing:content-box;"/>
    <td style="width:18.364%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:0.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Signature</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">    </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ PAVEL RAIFELD</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pavel Raifeld</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer<br/>(Principal Executive Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ STEPHEN BASSO</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Basso</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer (Principal<br/>Financial Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ MARK DIPAOLO</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mark DiPaolo, Esq.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chairman of the Board</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ ODYSSEAS KOSTAS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Odysseas Kostas, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ JULES HAIMOVITZ</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jules Haimovitz</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ SARAH SCHLESINGER</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sarah Schlesinger, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ SAPNA SRIVASTAVA</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sapna Srivastava, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ DEREK SMALL</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td rowspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td rowspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td rowspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derek Small</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">160</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19
<SEQUENCE>2
<FILENAME>inva-ex19.htm
<DESCRIPTION>EX-19
<TEXT>
<html>
 <head>
  <title>EX-19</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.88in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 19</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc.</font></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;border-bottom:0.5pt solid;margin-right:33.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDED AND RESTATED <br>INSIDER TRADING POLICY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Guidelines with Respect to <br>Certain Transactions in Securities</font></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;border-bottom:0.5pt solid;margin-right:33.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective as of September 1, 2016<br>And As Amended Through March 15, 2023</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.7%;box-sizing:content-box;"></td>
    <td style="width:3.3%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INTRODUCTION</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal prohibitions on insider trading</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Detection and prosecution of insider trading</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Penalties for violation of insider trading laws and this Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compliance Officer</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reporting violations</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personal responsibility</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PERSONS AND TRANSACTIONS COVERED BY THIS POLICY</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Persons covered by this Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Types of transactions covered by this Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Responsibilities regarding the non-public information of other companies</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Applicability of this Policy after your departure</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No exceptions based on personal circumstances</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MATERIAL NON-PUBLIC INFORMATION</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;Material&#x201d; information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;Non-public&#x201d; information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">POLICIES REGARDING MATERIAL NON-PUBLIC INFORMATION</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Confidentiality of non-public information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No trading on material non-public information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No disclosing material non-public information for the benefit of others</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Responding to outside inquiries for information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TRADING BLACKOUT PERIODS</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Quarterly blackout periods</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Special blackout periods</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No &#x201c;safe harbors&#x201d;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PRE-CLEARANCE OF TRADES</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADDITIONAL RESTRICTIONS AND GUIDANCE</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short sales</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative securities and hedging transactions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Using Company securities as collateral for loans</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holding Company securities in margin accounts</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.7%;box-sizing:content-box;"></td>
    <td style="width:3.3%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Placing open orders with brokers</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LIMITED EXCEPTIONS</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transactions pursuant to a trading plan that complies with SEC rules</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receipt and vesting of stock options, restricted stock units, restricted stock and stock appreciation rights</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of stock options for cash</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases from the employee stock purchase plan</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock splits, stock dividends and similar transactions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Bona fide </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">gifts and inheritance</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in form of ownership</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other exceptions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">COMPLIANCE WITH SECTION 16 OF THE SECURITIES EXCHANGE ACT</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Obligations under Section 16</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notification requirements to facilitate Section 16 reporting</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personal responsibility</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADDITIONAL INFORMATION</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Availability of Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:2.227%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amendments</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE I (Individuals subject to pre-clearance requirements)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE II (Individuals subject to Section 16 reporting and liability provisions)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE III (Requirements for 10b5-1 Trading Plans)</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTRODUCTION</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc.  (together with its subsidiaries, including Innoviva Specialty Therapeutics, Inc.  (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IST</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) opposes the unauthorized disclosure of any non-public information acquired in the course of your service with the Company and the misuse of material non-public information in securities trading.  Any such actions will be deemed violations of this Amended and Restated Insider Trading Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal prohibitions on insider trading</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The antifraud provisions of U.S. federal securities laws prohibit directors, officers, employees and other individuals who possess material non-public information from trading on the basis of that information in breach of a fiduciary duty or other relationship of trust and confidence.  Transactions will be considered &#x201c;on the basis of&#x201d; material non-public information if the person engaged in the transaction was aware of the material non-public information at the time of the transaction.  It is not a defense that the person did not &#x201c;use&#x201d; the information for purposes of the transaction.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosing material non-public information directly or indirectly to others who then trade based on that information or making recommendations or expressing opinions as to transactions in securities while aware of material non-public information (which is sometime referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">tipping</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is also illegal.  Both the person who provides the information, recommendation or opinion and the person who trades based on it may be liable.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These illegal activities are commonly referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">insider trading</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;.  State securities laws and securities laws of other jurisdictions also impose restrictions on insider trading.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, a company, as well as individual directors, officers and other supervisory personnel, may be subject to liability as &#x201c;controlling persons&#x201d; for failure to take appropriate steps to prevent insider trading by those under their supervision, influence or control.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Detection and prosecution of insider trading</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Financial Industry Regulatory Authority (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and the NASDAQ Stock Market use sophisticated electronic surveillance techniques to investigate and detect insider trading, and the SEC and the U.S. Department of Justice pursue insider trading violations vigorously.  Cases involving trading through foreign accounts, trading by family members and friends and trading involving only a small number of shares have been successfully prosecuted.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Penalties for violation of insider trading laws and this Policy</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Civil and criminal penalties.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the effective date of this Policy, potential penalties for insider trading violations under U.S. federal securities laws include:</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">damages in a private lawsuit;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disgorging any profits made or losses avoided;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imprisonment for up to 20 years;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">criminal fines of up to $5 million for individuals and $25 million for entities;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">civil fines of up to three times the profit gained or loss avoided;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a bar against serving as an officer or director of a public company; and</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an injunction against future violations.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Civil and criminal penalties also apply to tipping.  The SEC has imposed large penalties in tipping cases even when the disclosing person did not trade or gain any benefit from another person&#x2019;s trading.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Controlling person liability.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the effective date of this Policy, the penalty for &#x201c;controlling person&#x201d; liability is a civil fine of up to the greater of $2.479 million or three times the profit gained or loss avoided as a result of the insider trading violations, as well as potential criminal fines and imprisonment.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company disciplinary actions.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company has a reasonable basis to conclude that you have failed to comply with this Policy, you may be subject to disciplinary action by the Company, up to and including dismissal for cause, regardless of whether or not your failure to comply with this Policy results in a violation of law.  It is not necessary for the Company to wait for the filing or conclusion of any civil or criminal action against an alleged violator before taking disciplinary action.  In addition, the Company may give stop transfer and other instructions to the Company&#x2019;s transfer agent to enforce compliance with this Policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Officer</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Please direct any questions, requests or reports as to any of the matters discussed in this Policy to the Chief Executive Officer, Chief Accounting Officer or to the senior Legal Officer of the Company (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compliance Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  The Compliance Officer(s) are generally responsible for the administration of this Policy.  A Compliance Officer may select others to assist with the execution of his or her duties, including involvement of the Company&#x2019;s outside corporate law firm.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reporting violations</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is your responsibility to help enforce this Policy.  You should be alert to possible violations and promptly report violations or suspected violations of this Policy to a Compliance Officer.  If your situation requires that your identity be kept secret, your anonymity will be preserved to the greatest extent reasonably possible.  If you wish to remain anonymous, you may (i) send a letter addressed to: Compliance Officer at Innoviva, Inc., 1350 Old Bayshore Highway, Suite 400, Burlingame, CA 94010; or (ii) leave an anonymous message on the Company&#x2019;s compliance hotline (which number is published in the Company Code of Conduct and will also be made available on the Company&#x2019;s internal webpages).  If you make an anonymous report, please provide as much detail as possible, including any evidence that you believe may be relevant to the issue.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Personal responsibility</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ultimate responsibility for complying with this Policy and applicable laws and regulations, and for ensuring that any covered family member or related entity likewise complies, rests with you.  You should use your best judgment at all times and consult with your personal legal and financial advisors, as needed.  We advise you to seek assistance if you have any questions at all.  The rules relating to insider trading can be complex, and a violation of insider trading laws can carry severe consequences.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PERSONS AND TRANSACTIONS COVERED BY THIS POLICY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Persons covered by this Policy</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to all directors, officers, employees and agents (such as consultants and independent contractors) of the Company.  References in this Policy to &#x201c;you&#x201d; (as well as general references to directors, officers, employees and agents of the Company) should also be understood to include members of your immediate family, persons with whom you share a household, persons that are your economic dependents and any other individuals or entities whose transactions in securities you influence, direct or control (including, for example, a venture or other investment fund, if you influence, direct or control transactions by the fund).  You are responsible for making sure that these other individuals and entities comply with this Policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Types of transactions covered by this Policy</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, this Policy applies to </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">all </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transactions </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">involving </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the securities of the Company or the securities of other companies as to which you possess material non-public information obtained in the course of your service with the Company.  This Policy therefore applies to purchases, sales and other transfers of common stock, options, warrants, preferred stock, debt securities (such as debentures, bonds and notes) and other securities of the Company or of such other companies.  This Policy also applies to any arrangements that affect economic exposure to changes in the prices of these securities.  These arrangements may include, among other things, transactions in derivative securities (such as exchange-traded put or call options), hedging transactions, short sales and certain decisions with respect to participation in benefit plans.  This Policy also applies to any offers with respect to the transactions discussed above.  You should note that there are no exceptions from insider trading laws or this Policy based on the size of the transaction.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Responsibilities regarding the non-public information of other companies</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy prohibits the unauthorized disclosure or other misuse of any non-public information of other companies, such as the Company&#x2019;s distributors, vendors, customers, corporate partners or collaborators, suppliers and competitors.  This Policy also prohibits insider trading and tipping based on the material non-public information of other companies.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Applicability of this Policy after your departure</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are expected to comply with this Policy until such time as you are no longer affiliated with the Company </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">and </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">you no longer possess any material non-public information subject to this Policy.  In addition, if your transactions in Company securities are subject to a blackout period at the time of the termination of your service to the Company, then the blackout period will continue to apply to your transactions in the Company&#x2019;s securities until the end of such blackout period.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No exceptions based on personal circumstances</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There may be instances where you suffer financial harm or other hardship or are otherwise required to forego a planned transaction because of the restrictions imposed by this Policy.  Personal financial emergency or other personal circumstances are not mitigating factors under securities laws and will not excuse a failure to comply with this Policy.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MATERIAL NON-PUBLIC INFORMATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Material&#x201d; information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information should be regarded as material if there is a substantial likelihood that a reasonable investor would consider it important in deciding whether to buy, hold or sell securities or would view the information as significantly altering the total mix of information in the marketplace about the issuer of the security.  In general, any information that could reasonably be expected to affect the market price of a security is likely to be material.  Either positive or negative information may be material.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is not possible to define all categories of &#x201c;material&#x201d; information.  However, some examples of information that could be regarded as material include information with respect to:</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial results, financial condition, earnings pre-announcements, guidance, projections or forecasts, particularly if inconsistent with the Company&#x2019;s current guidance or with the expectations of the investment community;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restatements of financial results, or material impairments, write-offs or restructurings;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in independent auditors, or notification that the Company may no longer rely on an audit report;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business plans or budgets;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Creation of significant financial obligations, or any significant default under or acceleration of any financial obligation;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impending bankruptcy or financial liquidity problems;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant developments involving important business relationships or important corporate partnerships/collaborations, including execution, modification or termination of significant agreements or significant orders with customers, suppliers, distributors, manufacturers or other business partners;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain regulatory filings, regulatory approvals and denials or significant regulatory developments such as changes in regulatory guidance with respect to pre- or post- approval requirements, the contents of advisory committee meeting briefing documents, or the results of meetings between the Company and regulatory authorities;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain important pre-clinical or clinical study results or developments;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Product introductions, modifications, defects or recalls or significant pricing changes or other product developments of a significant nature;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant developments in research and development or relating to intellectual property;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant legal developments, whether actual or threatened;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major events involving the Company&#x2019;s securities, including calls of securities for redemption, adoption of stock repurchase programs, option repricings, stock splits, changes in dividend policies, public or private securities offerings (unless pursuant to a plan or arrangement that has already been publicly announced or understood by the investment community, e.g.  the quarterly top-up rights held by Glaxo Group Limited), modification to the rights of security holders or notice of delisting;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The existence of a special blackout period;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant corporate events, such as a pending or proposed merger, joint venture, tender offer or important corporate partnering / collaboration agreement, a significant investment, the acquisition or disposition of a significant business or asset (including products or product candidates) or a change in control of the company; and</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major personnel changes, such as changes in executive management or lay-offs.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you have any questions as to whether information should be considered &#x201c;material&#x201d;, you should consult with a Compliance Officer.  In general, it is advisable to resolve any close questions as to the materiality of any information by assuming that the information is material.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Non-public&#x201d; information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information is considered non-public if the information has not been broadly disseminated to the public for a sufficient period to be reflected in the price of the security.  As a general rule, information should be considered non-public until at least two full trading days have elapsed after the information is broadly distributed to the public in a press release, a public filing with the SEC, a pre-announced public webcast or another broad, non-exclusionary form of public communication.  However, depending upon the form of the announcement and the nature of the information, it is possible that information may not be fully absorbed by the marketplace until a later time.  Any questions as to whether information is non- public should be directed to a Compliance Officer.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">trading day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a day on which national stock exchanges are open for trading.  A &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">full</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; trading day has elapsed when, after the public disclosure, trading in the relevant security has opened and then closed.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">POLICIES REGARDING MATERIAL NON-PUBLIC INFORMATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Confidentiality of non-public information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The unauthorized use or disclosure of non-public information relating to the Company or other companies is prohibited.  All non-public information you acquire in the course of your service with the Company may only be used for legitimate Company business purposes.  In addition, non-public information of others should be handled in accordance with the terms of any relevant nondisclosure agreements, and the use of any such non-public information should be limited to the purpose for which it was disclosed.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You must use all reasonable efforts to safeguard non-public information in the Company&#x2019;s possession.  You may not disclose non-public information about the Company or any other company, unless required by law, or unless (i) disclosure is required for legitimate Company business purposes, (ii) you are authorized to disclose the information and (iii) appropriate steps have been taken to prevent misuse of that information (including entering an appropriate nondisclosure agreement that restricts the disclosure and use of the information, if applicable).  This restriction also applies to internal communications within the Company and to communications with agents of the Company.  In cases where disclosing non- public information to third parties is required, you should coordinate with the Legal Department.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All officers, employees and agents of the Company are required to sign and comply with an agreement addressing confidential information and invention assignment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No trading on material non-public information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, you may not, directly or indirectly through others, engage in any transaction involving the Company&#x2019;s securities </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">while aware of </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">material non-public information relating to the Company.  It is not an excuse that you did not &#x201c;use&#x201d; the information in your transaction.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Similarly, you may not engage in transactions involving the securities of any other company if you are aware of material non-public information about that company (except to the extent the transactions are analogous to those presented in the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below).  For example, you may be involved in a proposed transaction involving a prospective business relationship or transaction with another company.  If information about that transaction constitutes material non-public information for that other company, you would be prohibited from engaging in transactions involving the securities of that other company (as well as transactions involving Company securities, if that information is material to the Company).  It is important to note that &#x201c;materiality&#x201d; is different for different companies.  Information that is not material to the Company may be material to another company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No disclosing material non-public information for the benefit of others</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not disclose material non-public information concerning the Company or any other company to friends, family members or any other person or entity not authorized to receive such information where such person or entity may benefit by trading on the basis of such information.  In addition, you may not make recommendations or express opinions on the basis of material non-public information as to trading in the securities of companies to which such information relates.  You are prohibited from engaging in these actions whether or not you derive any profit or personal benefit from</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">doing so.  This prohibition against disclosure of material non-public information includes disclosure (even anonymous disclosure) via the Internet, blogs, investor forums, chat rooms, social media, or the like.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Responding to outside inquiries for information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you receive an inquiry from someone outside of the Company, such as a stock analyst, for information, you should refer the inquiry to the Chief Accounting Officer or the Investor Relations Department.  The Company is required under Regulation FD (Fair Disclosure) of the U.S. federal securities laws to avoid the selective disclosure of material non-public information.  In general, the regulation provides that when a public company discloses material non-public information, it must provide broad, non- exclusionary access to the information.  Violations of this regulation can subject the company to SEC enforcement actions, which may result in injunctions and severe monetary penalties.  The Company has established procedures for releasing material information in a manner that is designed to achieve broad public dissemination of the information immediately upon its release in compliance with applicable law.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TRADING BLACKOUT PERIODS</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To help prevent insider trading, you may not trade securities of the Company during any &#x201c;blackout period.&#x201d; Blackout periods occur during each quarter around the time the Company files its SEC reports.  In addition, the Company may impose other special trading blackout periods, as needed from time to time.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regardless of whether there is a blackout period in effect, you still may not trade in Company securities if you are aware of material non-public information and or in violation of any other restriction set out in this Policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quarterly blackout periods</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, directors, officers and all other employees must refrain from conducting transactions involving the Company&#x2019;s securities during quarterly blackout periods.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quarterly blackout periods start at the beginning of the 15 calendar days before the close of each fiscal quarter and end at the beginning of the third full trading day following the date of public disclosure of the financial results for that fiscal quarter.  This period is a particularly sensitive time for transactions involving the Company&#x2019;s securities from the perspective of compliance with applicable securities laws due to the fact that, during this period, individuals may often possess or have access to material non-public information relevant to the expected financial results for the quarter.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special blackout periods</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may also prohibit directors, officers, employees and agents from engaging in transactions involving the Company&#x2019;s securities when, in the judgment of a Compliance Officer, a trading blackout is warranted.  The Company will generally impose special blackout periods when there are material developments known to the Company that have not yet been disclosed to the public.  For example, the Company may impose a special blackout period in anticipation of announcing interim earnings guidance or a significant transaction or business development.  However, special blackout periods may be declared for any reason.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will notify those persons subject to a special blackout period.  Each person who has been so identified and notified by the Company may not engage in any transaction involving the Company&#x2019;s securities until instructed otherwise by a Compliance Officer, and should not disclose to others the fact of such suspension of trading.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No &#x201c;safe harbors&#x201d;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no unconditional &#x201c;safe harbors&#x201d; for trades made at particular times, and all persons subject to this Policy should exercise good judgment at all times.  Even when a quarterly blackout period is not in effect, you may be prohibited from engaging in transactions involving the Company&#x2019;s securities because you possess material non-public information, are subject to a special blackout period or are otherwise restricted under this Policy.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PRE-CLEARANCE OF TRADES</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In general, except as provided in the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, employees, directors and officers should refrain from engaging in any transaction involving the Company&#x2019;s securities without first obtaining pre-clearance of the transaction from a Compliance Officer.  However, certain employees and agents have been designated by the Company as being required to obtain pre-clearance from a Compliance Officer before engaging in a transaction involving Company securities, based on their access to material non-public information.  A Compliance Officer must obtain pre-clearance from another executive officer or outside counsel before engaging in a transaction involving Company securities.  Individuals subject to pre-clearance requirements as of the effective date of this policy are listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule I</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  From time to time, the Company may identify other persons who should be subject to the pre- clearance requirements set forth above, and a Compliance Officer may update and revise </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule I</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as appropriate.  Schedule I, as updated from time-to-time will be maintained by the Company&#x2019;s Stock Administrator under supervision of the Compliance Officer(s).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These pre-clearance procedures are intended to decrease insider trading risks associated with transactions by individuals with regular or special access to material non-public information.  In addition, requiring pre</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clearance of transactions by directors and officers facilitates compliance with Rule 144 resale restrictions under the Securities Act of 1933, as amended, and the liability and reporting provisions of Section 16 under the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Pre- clearance of a trade, however, is not a defense to a claim of insider trading and does not excuse you from otherwise complying with insider trading laws or this Policy.  Further, pre-clearance of a transaction does not constitute an affirmation by the Company or a Compliance Officer that you are not in possession of material non-public information.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Compliance Officer is under no obligation to approve a transaction submitted for pre-clearance, and may determine not to permit the transaction.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADDITIONAL RESTRICTIONS AND GUIDANCE</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This section addresses certain types of transactions that may expose you and the Company to significant risks.  You should understand that, even though a transaction may not be expressly prohibited by this section, you are responsible for ensuring that the transaction otherwise complies with other provisions in this Policy that may apply to the transaction, such as the general prohibition against insider trading as well as pre- clearance procedures and blackout periods, to the extent applicable.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short sales</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short sales (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">i.e., </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sale of a security that must be borrowed to make delivery) and &#x201c;selling short against the box&#x201d; (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">i.e., </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a sale with a delayed delivery) with respect to Company securities are prohibited under this Policy.  Short sales may signal to the market possible bad news about the Company or a general lack of confidence in the Company&#x2019;s prospects, and an expectation that the value of the Company&#x2019;s securities will decline.  In addition, short sales are effectively a bet against the Company&#x2019;s success and may reduce the seller&#x2019;s incentive to improve the Company&#x2019;s performance.  Short sales may also create a suspicion that the seller is engaged in insider trading.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Derivative securities and hedging transactions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not engage in transactions in publicly traded options on the Company&#x2019;s securities, such as puts, calls and other derivative securities, on an exchange or in any other organized market.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain forms of hedging or monetization transactions, such as zero-cost collars, forward sale contracts and many others, involve the establishment of a short position in the Company&#x2019;s securities and limit or eliminate your ability to profit from an increase in the value of the Company&#x2019;s securities.  Such transactions are complex and involve many aspects of the federal securities laws, including filing and disclosure requirements.  Entering into or altering a hedging transaction or position also may prevent you from relying on the affirmative defense for transactions conducted under Rule 10b5-1 trading plan.  Therefore, the Company requires that if you wish to enter into such an arrangement, you must first pre-clear the proposed transaction with a Compliance Officer.  Any request for pre-clearance must be submitted at least two weeks prior to the proposed execution of documents evidencing the proposed transaction.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Using Company securities as collateral for loans</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you are required to comply with Section 16 of the Exchange Act or pre-clearance requirements under this Policy (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">i.e., </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if you are listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule I</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), you may not pledge Company securities as collateral for loans without the approval of a Compliance Officer.  If you default on the loan, the lender may sell the pledged securities as collateral in a foreclosure sale.  The sale, even though not initiated at your request, is still considered a sale for your benefit and, if made at a time when you are aware of material non-public information or otherwise are not permitted to trade in Company securities, may result in inadvertent insider trading violations, Section 16 violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company.  For these same reasons, even if you are not prohibited from pledging Company securities as collateral for loans, you should exercise caution when doing so.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holding Company securities in margin accounts</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities held in a margin account or pledged as collateral for a loan may be sold without your consent by the broker if you fail to meet a margin call or by the lender in foreclosure if you default on the loan.  A margin or foreclosure sale that occurs when you are aware of material nonpublic information may, under some circumstances, result in unlawful insider trading.   Because of this danger, you should exercise extreme caution in holding Company securities in a margin account or pledging Company securities as collateral for a loan.  If you wish to pledge Company securities as collateral for a loan, you must submit a request for approval to a Compliance Officer at least two weeks prior to the proposed execution of documents evidencing the proposed pledge, providing details of the material terms of the pledge arrangement.  You also must ensure that you are not aware of material nonpublic information at the time you enter into the arrangement and that you comply with other applicable requirements, such as Section 16.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Placing open orders with brokers</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except in accordance with an approved trading plan (as discussed below), you should exercise caution when placing open orders, such as limit orders or stop orders, with brokers, particularly where the order is likely to remain outstanding for an extended period of time.  Open orders may result in the execution of a trade at a time when you are aware of material non-public information or otherwise are not permitted to trade in Company securities, which may result in inadvertent insider trading violations, Section 16 violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company.  You should inform any broker with whom you place any open order at the time it is placed that you are subject to the blackout periods and provide the dates, or otherwise ensure that your open order will close before the blackout period commences.  If you are subject to pre-clearance requirements, your order may remain open only for the period of time approved by a Compliance Officer.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LIMITED EXCEPTIONS</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are certain limited exceptions to the restrictions imposed by the Company under this Policy.  </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Please be aware that even if a transaction is subject to an exception to this Policy, you will need</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">to</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">separately assess whether the transaction complies with applicable law.  For example, even if a transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">is indicated as exempt from this Policy, you may need to comply with the &#x201c;short-swing&#x201d; trading restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">under Section 16 of the Exchange Act, to the extent applicable.  You are responsible</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">for complying with</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">applicable law at all times.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions pursuant to a trading plan that complies with SEC rules</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC has enacted rules that provide an affirmative defense against alleged violations of U.S. federal insider trading laws for transactions pursuant to trading plans that meet certain requirements.  In general, these rules, as set forth in Rule 10b5-1 under the Exchange Act, provide for an affirmative defense if you enter into a contract, provide instructions or adopt a written plan for trading securities when you are not aware of material non-public information.  The contract, instructions or plan must (i) specify the amount, price and date of the transaction, (ii) specify an objective method for determining the amount, price and date of the transaction and/or (iii) place any subsequent discretion for determining the amount, price and date of the transaction in another person who is not, at the time of the transaction, aware of material non-public information.  In addition, a purchase or sale of a security must comply with the rule&#x2019;s restriction on hedging transactions, and for plans adopted on or after February 27, 2023, the required cooling-off period, certification requirement (applicable only to officers and directors), and limitations on multiple overlapping trading arrangements and single trade arrangements.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions made pursuant to a written trading plan that (i) complies with Rule 10b5-1 and (ii) is approved in advance by a Compliance Officer or the Company&#x2019;s Legal Department, are not subject to the restrictions in this Policy against trades made while aware of material non-public information or to the pre- clearance procedures or blackout periods established under this Policy.  In approving a trading plan, a Compliance Officer or the Legal Department will impose criteria described in </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule III</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, attached hereto, which are in addition to the requirements of Rule 10b5-1 and may be updated from time-to-time.  You should confer with a Compliance Officer or the Legal Department well in advance of the time you wish to enter into any trading plan, as establishing these plans can take several weeks or longer.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC rules regarding trading plans are complex and must be complied with completely to be effective.  The description provided above is only a summary, and the Company strongly advises that you consult with your personal legal advisor if you intend to adopt a trading plan.  While trading plans are subject to review and approval by the Company, the individual adopting the trading plan is ultimately responsible for compliance with Rule 10b5-1 and ensuring that the trading plan complies with this Policy.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading plans must be filed with and approved in writing, in advance by a Compliance Officer or the Legal Department.  The Company may publicly disclose information regarding trading plans that you may enter.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Receipt and vesting of stock options, restricted stock units, restricted stock and stock appreciation rights</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions under this Policy do not apply to the grant or award of stock options, restricted stock units, restricted stock or stock appreciation rights issued or offered by the Company.  The trading restrictions under this Policy also do not apply to the vesting, cancellation or forfeiture of stock options, restricted stock units, restricted stock or stock appreciation rights in accordance with applicable plans and agreements.  The trading restrictions under this Policy also do not apply to your election to &#x201c;sell-to-cover&#x201d; or &#x201c;sell all&#x201d; that you make at the time of receiving restricted stock unit or restricted stock awards.  The trading restrictions and pre-clearance requirements do apply, however, to any subsequent sales of any such securities or the common stock underlying such securities.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of stock options for cash</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions and pre-clearance requirements under this Policy do not apply to:</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the exercise of stock options for cash under the Company&#x2019;s equity incentive plans;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the exercise of stock options in a stock-for-stock exercise with the Company; or</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an election to have the Company withhold securities to cover tax obligations in connection with an option exercise.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">However, the trading restrictions and pre-clearance requirements under this Policy do apply to:</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sale of any securities issued upon the exercise of a stock option;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a &#x201c;cashless exercise&#x201d; of a stock option through a broker, since this involves selling a portion of the underlying shares to cover the costs of exercise; and</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other market sale of Company securities for the purpose of generating the cash needed to pay the exercise price or taxes associated with the exercise of an option.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchases from the employee stock purchase plan</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions and pre-clearance requirements in this Policy do not apply to elections with respect to participation in the Company&#x2019;s employee stock purchase plan or to purchases of securities under the plan.  However, the trading restrictions and pre-clearance requirements do apply to any subsequent sales of any such securities acquired therefrom.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock splits, stock dividends and similar transactions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions and pre-clearance requirements under this Policy do not apply to a change in the number of securities held as a result of a stock split or stock dividend applying equally to all securities of a class, or similar transactions.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bona fide </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">gifts and inheritance</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions under this Policy do not apply to </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">bona fide </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">gifts involving Company securities or transfers by will or the laws of descent and distribution.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Change in form of ownership</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions that involve merely a change in the form in which you own securities are not subject to the trading restrictions under this Policy.  For example, you may transfer shares to an </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter vivos </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trust of which you are the sole beneficiary during your lifetime.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other exceptions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any other exception from this Policy must be approved by a Compliance Officer.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPLIANCE WITH SECTION 16 OF THE SECURITIES EXCHANGE ACT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obligations under Section 16</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 16 of the Exchange Act, and the related rules and regulations, set forth (i) reporting obligations, (ii) limitations on &#x201c;short-swing&#x201d; transactions and (iii) limitations on short sales and other transactions applicable to directors, officers, large shareholders and certain other persons.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board of Directors of the Company has determined that those persons listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are required to comply with Section 16 of the Exchange Act, and the related rules and regulations, because of their positions with the Company.  A Compliance Officer may amend </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from time to time as appropriate to reflect the election of new officers or directors, any change in the responsibilities of officers or other employees, any promotions, demotions, resignations or departures, and any applicable change in regulatory requirements.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is not necessarily an exhaustive list of persons subject to Section 16 requirements at any given time.  Even if you are not listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, you may be subject to Section 16 reporting obligations because of your shareholdings, for example.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notification requirements to facilitate Section 16 reporting</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To facilitate timely reporting of transactions pursuant to Section 16 requirements, each person subject to Section 16 reporting requirements must provide, or must ensure that his or her broker provides, the Company with detailed information (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">e.g., </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trade date, number of shares, exact price, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">etc.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) regarding his or her transactions involving the Company&#x2019;s securities, including gifts, transfers, pledges and transactions pursuant to a trading plan, both prior to (to confirm compliance with pre-clearance procedures, if applicable) and promptly following execution.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Personal responsibility</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The obligation to file Section 16 reports, and to otherwise comply with Section 16, is personal.  The Company is not responsible for the failure to comply with Section 16 requirements.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADDITIONAL INFORMATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Availability of Policy</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy will be made available to all directors, officers, employees and agents of the Company when they commence service with the Company.  Each director, officer, employee and agent of the Company is required to acknowledge that he or she understands, and agrees to comply with, this Policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendments</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are committed to continuously reviewing and updating our policies and procedures.  The Company therefore reserves the right to amend, alter or terminate this Policy at any time and for any reason, subject to applicable law.  A current copy of the Company&#x2019;s policies regarding insider trading may be obtained by contacting a Compliance Officer or the Legal Department and will also be available on the Company&#x2019;s internal website.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*	*	*</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nothing in this Amended and Restated Insider Trading Policy creates or implies an employment contract or term of employment.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The policies in this Amended and Restated Insider Trading Policy do not constitute a complete list of Company policies or a complete list of the types of conduct that can result in discipline, up to and including discharge.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE I</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDIVIDUALS SUBJECT TO <br>PRE-CLEARANCE REQUIREMENTS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	DIRECTORS</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All members of the Board of Directors of Innoviva, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	OFFICERS (including officers who are also directors)</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All officers at the Vice President level and above of Innoviva, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.	OTHERS</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All employees of Innoviva, Inc.</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A full and complete list shall be maintained by the Company&#x2019;s stock plan administrator under the direction of a Compliance Officer and any updates or changes shall be recorded by the Company&#x2019;s stock plan administrator under the direction of a Compliance Officer</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE II</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDIVIDUALS SUBJECT TO<br>SECTION 16 REPORTING AND LIABILITY PROVISIONS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	DIRECTORS</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All members of the Board of Directors of Innoviva, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	OFFICERS (including officers who are also directors)</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each person deemed to be an &#x201c;officer&#x201d; of Innoviva, Inc.  in accordance with Rule 16a-1(f) of the Securities Exchange Act of 1934.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE III</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INNOVIVA, INC.<br>REQUIREMENTS FOR RULE 10B5-1 TRADING PLANS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc.  (the &#x201c;Company&#x201d;) has adopted an Amended and Restated Insider Trading Policy that generally prohibits directors, officers, employees and other persons covered by the Policy from trading in Company securities while aware of material nonpublic information, and requires them to obtain pre-clearance of certain transactions relating to Company securities.  However, transactions that are executed pursuant to an approved &#x201c;10b5-1 plan&#x201d; are not subject to these prohibitions or pre-clearance requirements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 10b5-1 under the Securities Exchange Act of 1934 provides an affirmative defense from insider trading liability under the federal securities laws for transactions that are entered into pursuant to a written trading plan that meets certain requirements.  In general, a 10b5-1 plan must be entered into while an individual is not aware of material non-public information.  Once the plan is adopted, the individual who adopted the plan must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded or the date of the trade.  Compliance with Rule 10b5-1 of the Securities and Exchange Commission will not protect an executive officer or director from liability under Section 16 of the Securities Exchange Act of 1934.  Covered persons may adopt 10b5-1 plans on their own (&#x201c;Voluntary Plan&#x201d;) or through entering into a 10b5-1 plan in connection with the grant of an equity award under the Company&#x2019;s equity plans (&#x201c;Equity Award Plans&#x201d;).  Except as expressly provided below, these guidelines apply both to Voluntary Plans and Equity Award Plans.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company requires that all Voluntary Plans be filed with and approved by a Compliance Officer in advance and in writing after consultation with the Company&#x2019;s outside counsel.  If a Compliance Officer seeks to enter into a Voluntary Plan, it must be approved in writing by another Compliance Officer in advance and in writing after consultation with the Company&#x2019;s outside counsel.  Once adopted, 10b5-1 plans may be amended, suspended or terminated only with the written advance approval of the Compliance Officer and in compliance with the procedure set forth below.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Directors and officers of the Company who anticipate selling any shares of the Company&#x2019;s common stock are strongly encouraged to do so pursuant to a 10b5-1 plan.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A 10b5-1 plan will not be approved unless (except to the extent otherwise approved by the Company&#x2019;s Board of Directors) the plan provides that, or the Company&#x2019;s internal procedures ensure that:</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	A Voluntary Plan may be adopted only when the person adopting the plan is not aware of material non- public information.  An Equity Award Plan may be adopted only if (A) the person adopting the plan is not then aware of material non-public information or (B) if, as of the date any sales are effected pursuant to the Equity Award Plan, the person will not effect such sales while aware of material non-public information of which the person was aware at the time he or she entered into the equity award agreement and adopted the Equity Award Plan.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	The first transaction under the plan cannot take place until the later of (A) the next trading window following the date the plan was adopted or (B) the 61st day following the date of adoption.  For plans adopted on or after February 27, 2023, the first transaction under the plan may not take place until the expiration of a cooling-off period.  For officers and directors, the cooling-off period expires the later of (i) 90 days after the adoption of the plan, or (ii) 2 business days after disclosure of the Company&#x2019;s financial statements on Form 10-K or 10-Q for the fiscal quarter in which the plan was adopted.  For persons who are not officers or directors, the cooling-off period expires 30 days after the adoption of the plan.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.	The plan clearly specifies the amount, pricing and timing of transactions (including by formula or algorithm, which must be straightforward in design and simple to implement).  The individual approving the plan as specified in the third paragraph of these requirements, and the Company&#x2019;s outside counsel have sole discretion to determine if the requirements set forth in this item 3 are met.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.	If the specified number of shares is not sold or purchased because the trigger price has not been reached prior to the closing of the quarterly trading blackout period or the designated period to effect transactions under the plan, the unsold shares may be added to the order(s) for the following designated period(s) to effect transactions under the plan.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5.	The plan may be terminated or suspended by a Compliance Officer, the Company&#x2019;s Board of Directors or its Compensation Committee if it determines that doing so is in the best interests of the Company or that not doing so would cause a violation of applicable law.  For example, but without limitation, continued trades could interfere with lock-up obligations imposed on &#x201c;insiders&#x201d; in connection with an underwritten public offering or cause a violation of Regulation M when the Company is engaged in a public offering of its securities.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6.	For plans adopted on or after February 27, 2023, an officer or director must include a representation in the plan certifying that, on the date of adoption of the plan, the individual officer or director is not aware of any material nonpublic information about the security or the Company and that the individual officer or director is adopting the plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5 under the Securities Exchange Act of 1934.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.	The plan must provide that transactions thereunder will be consummated through a single broker that is acceptable to the Company.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.	For plans adopted on or after February 27, 2023, the person adopting the plan must not have outstanding (and may not subsequently adopt) any additional plan that would qualify for the affirmative defense in Rule 10b5-1 for purchases or sales of the Company&#x2019;s securities.  Certain exceptions are available, including (i) an arrangement involving a series of separate contracts with different brokers acting on behalf of the person which may be treated as a single plan, (ii) a person may maintain two separate plans at the same time, provided that trading under the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">later-commencing plan is not authorized to begin until after all trades under the earlier-commencing plan are completed or expire without execution, and (iii) plans providing for the sale of securities by a broker as necessary to satisfy tax withholding obligations arising exclusively from the vesting of certain compensatory awards (an &#x201c;eligible sell-to- cover transaction&#x201d;), provided the person adopting such plan does not exercise control over the timing of such sales.  These exceptions are complex, and you must consult with and obtain the approval of the Compliance Officer before acting on any of them.  It is recommended that you consult with your personal legal advisor before acting on any of these exceptions.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9.	For plans adopted on or after February 27, 2023, a plan (other than one providing for an eligible sell- to-cover transaction) may be designed to effect the open-market purchase or sale of the total amount of securities in a single transaction, provided that the person adopting such a plan may only adopt one such plan in any 12-month period.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10.	The plan must have a termination date.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11.	Public disclosure of the plan, if any (and the level of detail of such disclosure) shall remain in the sole discretion of the Legal Department and the Company&#x2019;s outside counsel.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12.	A Voluntary Plan may be amended or terminated by the individual only if the individual is not aware of material non-public information at the time of such amendment or termination.  For plans adopted before February 27, 2023, t he individual will not be allowed to trade under the amended Voluntary Plan, to start a new Voluntary Plan or to terminate an existing Voluntary Plan until the later of the end of the next quarterly trading blackout period or the 91st day following the individual&#x2019;s adoption of the amendment or the new Voluntary Plan, or approval of the termination (excluding a termination that occurs automatically under the terms of the plan, including an automatic expiration of the plan following the last scheduled transaction).  For Voluntary Plans adopted on or after February 27, 2023, an amendment that modifies or changes the amount, price, or timing of the purchase or sale of securities (or modifies or changes a written formula or algorithm, or computer program that affects the amount the amount pricing or timing of the purchase or sale of the securities) will start a new cooling off period, and the individual will not be allowed to trade under the amended Voluntary Plan, start a new Voluntary Plan or terminate an existing Voluntary Plan until such cooling-off period expires.  In the meantime, the original Voluntary Plan will remain in effect.  Equity Award Plans may not be amended or terminated by their adopters; provided, however, once per year during the First Open Window (as defined below) an adopter may elect either the minimum statutory tax rates or the maximum statutory tax rates in the applicable jurisdictions to satisfy the tax withholding due upon vesting.  The term &#x201c;First Open Window&#x201d; shall mean the period commencing on the first Permissible Trading Day (as defined below) of the fiscal year and ending no later than February [18]</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of such fiscal year.  &#x201c;Permissible Trading Day&#x201d; means a day that satisfies each of the following requirements:</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a.	The Nasdaq Global Market is open for trading on that day;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b.	The adopter is not aware of material non-public information that would make it illegal for him or her to sell shares of the Company&#x2019;s common stock on that day under Rule 10b-5 of the Securities and Exchange Commission; and</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c.	Under the Company&#x2019;s Amended and Restated Insider Trading Policy, the adopter is permitted to sell shares of the Company&#x2019;s common stock on that day.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13.	Any Voluntary Plan must provide for automatic termination in the event of death, a personal bankruptcy filing, the filing of a divorce petition, the last scheduled transaction under the plan, the public announcement of a merger, recapitalization, acquisition, tender or exchange offer, or other business combination or reorganization resulting in the exchange or conversion of the shares of the Company into shares of another company, or the conversion of the Company&#x2019;s shares into rights to receive fixed amounts of cash or into debt securities and/or preferred stock (whether in whole or in part).  In addition, the Voluntary Plan shall provide for automatic termination, or the Company&#x2019;s internal processes shall cause the Voluntary Plan to terminate, in each case in the event of termination of employment with the Company (or Parent, Subsidiary or Affiliate, as such terms are defined in the Company&#x2019;s 2012 Equity Incentive Plan), in which case such automatic termination will occur at the beginning of the Company&#x2019;s next open trading window.  Notwithstanding the preceding sentence, the Voluntary Plan shall not terminate in connection with termination of employment if the former employee continues to consult for the Company or any of its subsidiaries, or for Theravance Biopharma, Inc.  or any of its subsidiaries (&#x201c;TBPH&#x201d;), or is employed by TBPH.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14.	The plan must contain a provision requiring timely notification to the Company of all transaction pursuant to the plan to assure compliance with applicable reporting requirements.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>inva-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 21.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LIST OF SUBSIDIARIES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:60.552%;box-sizing:content-box;"></td>
    <td style="width:1.64%;box-sizing:content-box;"></td>
    <td style="width:21.104%;box-sizing:content-box;"></td>
    <td style="width:1.64%;box-sizing:content-box;"></td>
    <td style="width:15.063%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jurisdiction</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ownership<br>Interest</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Advanced Medicine East, Inc</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Innoviva Strategic Partners LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Innoviva Royalty Sub LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Innoviva TRC Holdings LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Innoviva Strategic Opportunities LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ISP Fund LP</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Innoviva Specialty Therapeutics Holdings LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Innoviva Specialty Therapeutics Inc.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ISTx, LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entasis Therapeutics Holdings Inc.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entasis Therapeutics Inc.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entasis Therapeutics Security Corporation</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Massachusetts</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entasis Therapeutics (Ireland) Limited</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ireland</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical Company</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">La Jolla Pharma, LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tetraphase Pharmaceuticals, Inc.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical Holdings, LLC</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical I B.V.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Netherlands</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical II B.V.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Netherlands</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical III B.V.</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Netherlands</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100%</font></p></td>
   </tr>
  </table>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>inva-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in Registration Statement Nos. 333-275502, 333-119559, 333-129669, 333-150753, 333-159042, 333-173923, 333-181763, and 333-197950 on Form S-8 of our reports dated February 26, 2025, relating to the financial statements of Innoviva, Inc. and the effectiveness of Innoviva, Inc.'s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Jose, California</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 26, 2025</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>inva-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 302 of the Sarbanes&#x2011;Oxley Act of 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Pavel Raifeld, certify that:</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.           I have reviewed this Annual Report on Form 10&#x2011;K of Innoviva, Inc.;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.           The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#x2011;15(e) and 15d&#x2011;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#x2011;15(f) and 15(d)&#x2011;15(f)) for the registrant and have:</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c)            Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d)           Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5.            The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5%;box-sizing:content-box;"></td>
    <td style="width:44%;box-sizing:content-box;"></td>
    <td style="width:2%;box-sizing:content-box;"></td>
    <td style="width:49%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:0.7pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ PAVEL RAIFELD</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="2" style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pavel Raifeld</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="2" style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="2" style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>inva-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certification of Principal Accounting Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 302 of the Sarbanes&#x2011;Oxley Act of 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Stephen Basso, certify that:</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.           I have reviewed this Annual Report on Form 10&#x2011;K of Innoviva, Inc.;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.           The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#x2011;15(e) and 15d&#x2011;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#x2011;15(f) and 15(d)&#x2011;15(f)) for the registrant and have:</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c)           Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d)           Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5.           The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b)          Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5%;box-sizing:content-box;"></td>
    <td style="width:44.44%;box-sizing:content-box;"></td>
    <td style="width:1.78%;box-sizing:content-box;"></td>
    <td style="width:48.78%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 26, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ STEPHEN BASSO</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Basso</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>inva-ex32.htm
<DESCRIPTION>EX-32
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AND PRINCIPAL ACCOUNTING OFFICER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES&#x2011;OXLEY ACT OF 2002</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Pavel Raifeld, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes&#x2011;Oxley Act of 2002, that the Annual Report of Innoviva, Inc. on Form 10&#x2011;K for the fiscal year ended December 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Annual Report on Form 10&#x2011;K fairly presents in all material respects the financial condition of Innoviva, Inc. at the end of the periods covered by such Annual Report on Form 10&#x2011;K and results of operations of Innoviva, Inc. for the periods covered by such Annual Report on Form 10&#x2011;K.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:3%;box-sizing:content-box;"></td>
    <td style="width:47%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: February 26, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ PAVEL RAIFELD</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pavel Raifeld</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Stephen Basso, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes&#x2011;Oxley Act of 2002, that the Annual Report of Innoviva, Inc. on Form 10&#x2011;K for the fiscal year ended December 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Annual Report on Form 10&#x2011;K fairly presents in all material respects the financial condition of Innoviva, Inc. at the end of the periods covered by such Annual Report on Form 10&#x2011;K and results of operations of Innoviva, Inc. for the periods covered by such Annual Report on Form 10&#x2011;K.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:3%;box-sizing:content-box;"></td>
    <td style="width:47%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:0.7pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: February 26, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ STEPHEN BASSO</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Basso</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;text-indent:3pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:0.56%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A signed original of this written statement required by Section 906 has been provided to Innoviva, Inc. and will be retained by it and furnished to the Securities and Exchange Commission or its staff upon request.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img12876764_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_0.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'I!"(# 2(  A$! Q$!_\0
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M-4?\-]_'[_HHMU_X VG_ ,:KY_HH^JX?_GVON0<S[GT!_P -]_'[_HHMU_X
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M7S_11]5P_P#S[7W(.9]SZ _X;[^/W_11;K_P!M/_ (U1_P -]_'[_HHMU_X
MVG_QJOG^BCZKA_\ GVON0<S[GT!_PWW\?O\ HHMU_P" -I_\:H_X;[^/W_11
M;K_P!M/_ (U7S_11]5P__/M?<@YGW/H#_AOOX_?]%%NO_ &T_P#C5'_#??Q^
M_P"BBW7_ ( VG_QJOG^BCZKA_P#GVON0<S[GT!_PWW\?O^BBW7_@#:?_ !JC
M_AOOX_?]%%NO_ &T_P#C5?/]%'U7#_\ /M?<@YGW/H#_ (;[^/W_ $46Z_\
M &T_^-4?\-]_'[_HHMU_X VG_P :KY_HH^JX?_GVON0<S[GT!_PWW\?O^BBW
M7_@#:?\ QJC_ (;[^/W_ $46Z_\  &T_^-5\_P!%'U7#_P#/M?<@YGW/H#_A
MOOX_?]%%NO\ P!M/_C5,N/V_?C^L$C#XC70(4D?Z!:?_ !JO JBNO^/:7_=/
M\J/JN'_Y]K[D%WW/M7]I7]L_XT>"/C!J&CZ'XYN+#38].TN9+=;.V8!Y=/MY
M9#EHR>7=F_&O+_\ AOOX_?\ 11;K_P  ;3_XU6)^U_\ \E[U7_L$Z+_Z:[6O
M&JPP^&H.C!NFMET78;D[[GT!_P -]_'[_HHMU_X VG_QJC_AOOX_?]%%NO\
MP!M/_C5?/]%;_5</_P ^U]R%S/N?0'_#??Q^_P"BBW7_ ( VG_QJC_AOOX_?
M]%%NO_ &T_\ C5?/]%'U7#_\^U]R#F?<^@/^&^_C]_T46Z_\ ;3_ .-4?\-]
M_'[_ **+=?\ @#:?_&J^?Z*/JN'_ .?:^Y!S/N?0'_#??Q^_Z*+=?^ -I_\
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MO^BBW7_@#:?_ !JOG^BCZKA_^?:^Y!S/N?0'_#??Q^_Z*+=?^ -I_P#&J/\
MAOOX_?\ 11;K_P  ;3_XU7S_ $4?5</_ ,^U]R#F?<^@/^&^_C]_T46Z_P#
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MU7S_ $5O]5P__/M?<A<S[GT!_P -]_'[_HHMU_X VG_QJC_AOOX_?]%%NO\
MP!M/_C5?/]%'U7#_ //M?<@YGW/H#_AOOX_?]%%NO_ &T_\ C5'_  WW\?O^
MBBW7_@#:?_&J^?Z*/JN'_P"?:^Y!S/N?0'_#??Q^_P"BBW7_ ( VG_QJC_AO
MOX_?]%%NO_ &T_\ C5?/]%'U7#_\^U]R#F?<^@/^&^_C]_T46Z_\ ;3_ .-4
M?\-]_'[_ **+=?\ @#:?_&J^?Z*/JN'_ .?:^Y!S/N?0'_#??Q^_Z*+=?^ -
MI_\ &J/^&^_C]_T46Z_\ ;3_ .-5\_T4?5</_P ^U]R#F?<^@/\ AOOX_?\
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M/JN'_P"?:^Y!S/N?0'_#??Q^_P"BBW7_ ( VG_QJC_AOOX_?]%%NO_ &T_\
MC5?/]%'U7#_\^U]R#F?<^@/^&^_C]_T46Z_\ ;3_ .-4?\-]_'[_ **+=?\
M@#:?_&J^?Z*/JN'_ .?:^Y!S/N?0'_#??Q^_Z*+=?^ -I_\ &J/^&^_C]_T4
M6Z_\ ;3_ .-5\_T4?5</_P ^U]R#F?<^@/\ AOOX_?\ 11;K_P  ;3_XU1_P
MWW\?O^BBW7_@#:?_ !JOG^BCZKA_^?:^Y!S/N?0'_#??Q^_Z*+=?^ -I_P#&
MJDM_V^?CZUQ"I^(MT5:101]AM>A(_P"F5?/=26O_ !]V_P#UU3_T(4?5</\
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MKU"/X>Z9XJUGQIX3\+-K%M<7FD:1K5Z\5U?P0MM:1"$*+N(.T.P+=JN?M+?
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M<\ _]"/X;_\ !1;_ /Q%'_"G/ /_ $(_AO\ \%%O_P#$5E/-J%2_-2?W^O\
MFP]FUU/R)\ ?MK3^'6\,WWBCP/:^+]?\-ZY?ZUI>I_VA)9^2;UV>XC:-5(?+
M,Q4GA>.#BE^&_P"VA!X%T_P:+_X>V^NZMX2NM3DTK4#JLEOY<-ZSM+&T80AF
M!?ASV'W<\U^NO_"G/ /_ $(_AO\ \%%O_P#$4?\ "G/ /_0C^&__  46_P#\
M16;S+"RO>B]?/U_S?WCY)=S\88_VC]'U'X<Z)H7B7X::3XHU[P_IMUI.BZU?
M7<@BM[>9RP,ML!ME>,D[&W+CJ0:Y?XM?&"#XL>'? =O/X=&FZYX9T>+0YM4B
MO&=+ZWB!$682H$;#)R0QSGMBOW&_X4YX!_Z$?PW_ ."BW_\ B*/^%.> ?^A'
M\-_^"BW_ /B*UCF]"+YE2?WB]F^Y_/?M/I1M/I7]"'_"G/ /_0C^&_\ P46_
M_P 11_PISP#_ -"/X;_\%%O_ /$5O_;T/^?;^\/9ON?SW[3Z4;3Z5_0A_P *
M<\ _]"/X;_\ !1;_ /Q%'_"G/ /_ $(_AO\ \%%O_P#$4?V]#_GV_O#V;[G\
M]^T^E&T^E?T(?\*<\ _]"/X;_P#!1;__ !%'_"G/ /\ T(_AO_P46_\ \11_
M;T/^?;^\/9ON?SW[3Z4;3Z5_0A_PISP#_P!"/X;_ /!1;_\ Q%'_  ISP#_T
M(_AO_P %%O\ _$4?V]#_ )]O[P]F^Y_/?M/I1M/I7]"'_"G/ /\ T(_AO_P4
M6_\ \11_PISP#_T(_AO_ ,%%O_\ $4?V]#_GV_O#V;[G\]^T^E&T^E?T(?\
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M?\^W]X>S?<_GOVGTHVGTK^A#_A3G@'_H1_#?_@HM_P#XBC_A3G@'_H1_#?\
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M ?\ H1_#?_@HM_\ XBC^WH?\^W]X>S?<_GOVGTHVGTK^A#_A3G@'_H1_#?\
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M /!1;_\ Q%']LPP_[GD;Y=-^V@>S;U/Y[]I]*-I]*_H0_P"%.> ?^A'\-_\
M@HM__B*/^%.> ?\ H1_#?_@HM_\ XBC^WH?\^W]X_9ON?SW[3Z4;3Z5_0A_P
MISP#_P!"/X;_ /!1;_\ Q%'_  ISP#_T(_AO_P %%O\ _$4?V]#_ )]O[P]F
M^Y_/?M/I1M/I7]"'_"G/ /\ T(_AO_P46_\ \11_PISP#_T(_AO_ ,%%O_\
M$4?V]#_GV_O#V;[G\]^T^E&T^E?T(?\ "G/ /_0C^&__  46_P#\11_PISP#
M_P!"/X;_ /!1;_\ Q%']O0_Y]O[P]F^Y_/?M/I1M/I7]"'_"G/ /_0C^&_\
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MA[KOAQ?"']FW&L6FDV\LZZO+):6SV+JRM;VA0)$K[?F53G)R6/ 'Z\_\*<\
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M_P"83;^G^Y1_;T/^?;^\/9ON=A'=0O&K+-&RD @A@0:*^'_@[(__  J+P/\
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MS>-((]RD ,F,+MH ^M]8\::3H/B/P_H5[<-%J>O/-'81"-F$C11&60%@,+A
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M+>.[MY8)D$D4BE'4]"I&"/RJ/3]/M=)L;>RLK>*TL[>-8H8(4")&@& J@<
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M?SF(C*#;T&/O6]_X\Y_^N;?RIK<#X>^#O_)(O __ & ['_TG2BCX._\ )(O
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M]UBQ6)8+N: %E$1S%GLVP\KN!VGD8KMJ* .._P"%.^"?^$V_X2__ (1C3O\
MA)?,\[^T/)&_S-NSS<=/,V_+OQNQQG%5O"/P+^'W@/74UGP]X0TG1]42%[=+
MJUMPC(CD,X7^[N(!8CEL<YKNJ* ..\*_![P3X(UZ[UO0?#&FZ3JMT&62ZM8
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M@#MH ]G7X,^!E^(!\<#PKI8\6GKJ_P!G7S]VW9OS_?V_+N^]CC..*HR?L_\
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MBN7_ .%I>#/^ANT'_P &</\ \51_PM+P9_T-V@_^#.'_ .*HY)=@.HHKE_\
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M /%4?\+2\&?]#=H/_@SA_P#BJ.278#J**Y?_ (6EX,_Z&[0?_!G#_P#%4?\
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M!_AU?!:V4%WM\*27L]IYUR93<RW<;I<R7);)E9_,=B2?O-GIQ72?\+2\&?\
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M_F?WA9'/?\,^_"[_ *)MX0_\$5K_ /&Z/^&??A=_T3;PA_X(K7_XW4UO\;O
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M5AP000015JCVM3^9_>%D<!_PS[\+O^B;>$/_  16O_QNC_AGWX7?]$V\(?\
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MX7?]$V\(?^"*U_\ C='_  S[\+O^B;>$/_!%:_\ QNN_HH]K4_F?WA9' ?\
M#/OPN_Z)MX0_\$5K_P#&Z/\ AGWX7?\ 1-O"'_@BM?\ XW7?UD>+/%FD>!O#
M]UK>NWJ:=I5KL\ZYD#%4W.$7( )Y9E'3O1[6I_,_O"R.7_X9]^%W_1-O"'_@
MBM?_ (W1_P ,^_"[_HFWA#_P16O_ ,;K>\??$#P[\+?"=[XF\5:K#HNA66S[
M1>W&2D>]U1<@ GEF4<#O6_'(LT:NC!T8!E93D$'H11[6I_,_O"R."_X9]^%W
M_1-O"'_@BM?_ (W1_P ,^_"[_HFWA#_P16O_ ,;KOZY3Q_\ %/PK\+]+M-0\
M3:O'IUO>3"WM56-YY;B0@MMCBC5G<[02=JG !)XH]K4_F?WA9&7_ ,,^_"[_
M *)MX0_\$5K_ /&Z/^&??A=_T3;PA_X(K7_XW4.I?M#_  ZTGP7H_BN?Q1:R
M:'K$ABT^:UCEGDN9 &+HD,:M(64*VY=N4VG=C!JWX@^.GP_\*^ ;+QMJOB[2
M[/PK?)&]IJ;3@QW(<@*(P,ER21PH)]N#1[6I_,_O"R(O^&??A=_T3;PA_P""
M*U_^-T?\,^_"[_HFWA#_ ,$5K_\ &ZL_$+XT>#/A6]C'XHUR/3I[Y7>WMTAE
MGF=$ +R>7$K,$7(RY 49&3S75Z3JUEKNF6FHZ==0WUA=Q+/;W5NX>.6-AE65
MAP000011[6I_,_O"R.+_ .&??A=_T3;PA_X(K7_XW1_PS[\+O^B;>$/_  16
MO_QNN_HH]K4_F?WA9' ?\,^_"[_HFWA#_P $5K_\;H_X9]^%W_1-O"'_ ((K
M7_XW7?T4>UJ?S/[PLC@/^&??A=_T3;PA_P""*U_^-T?\,^_"[_HFWA#_ ,$5
MK_\ &Z[^BCVM3^9_>%D<!_PS[\+O^B;>$/\ P16O_P ;H_X9]^%W_1-O"'_@
MBM?_ (W7?T4>UJ?S/[PLC@/^&??A=_T3;PA_X(K7_P"-T?\ #/OPN_Z)MX0_
M\$5K_P#&Z[^BCVM3^9_>%D<!_P ,^_"[_HFWA#_P16O_ ,;H_P"&??A=_P!$
MV\(?^"*U_P#C==_11[6I_,_O"R. _P"&??A=_P!$V\(?^"*U_P#C=17?[/\
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M@[3))AAAAYC#/-=EH.@Z?X8T+3]&TNUCLM+T^WCM+6UC^[%$BA409[!0!^%
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M9>3QR:B\7?LW_#?QUJEUJ&M>%[>[N+N*"&Y5)YH8IUA_U)DC1U1V3 "LP+*
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M63V=S-:20PL@1HA)"Z-Y;*J@H3M.T9' KI+'P[I>F^'X="MM/MXM&AMA9QV
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M]QX@\67-N&_LVW:**"TMXS' AW,2TA!9G?@$D  !10!Z=1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW=Q%X;AMVL);N#3YX8EN(IS'"8,O)'O0QC<@P-YR10!-HW[4^L>.X_#2^"?
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M-1N[VRLY;/7(KJ[5[:%IMUQ;HI$*NJ/CYRP^7<HW<9/@G]J?5?$%CX1U+6?
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MZ5\+/!NG^&M&^T/96>]C-=R>9//*[M)++(_\3N[LQ..K'@4 =-1110 4444
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M&_"33'OM.CO_  C=ZA<74\3,ZYGM[N.-H@5&XJT\9(;' /X@&]XB_:<\,?\
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M'\:?J_S-8[(****YQA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 -D_U;?2O'/V._P#DVGP)_P!><G_H
MZ2O8Y/\ 5M]*\<_8[_Y-I\"?]><G_HZ2NB/\&7JORD+J>RT445SC"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#Q?]C[_ )(-IG_85UG_ -.MW7JVK>)M'T&:WAU/5;'3I;@A88[NX2)I2650
M%#$9^9U''=@.XKRG]C[_ )(-IG_85UG_ -.MW5CQ]\.G\4_M%_#?7[K08=4T
MC1=)U;-Y<1I(EI=2/:&$@-R'(23# <;3R*Z,1_&GZO\ ,4=D>C6OC;P]>ZEJ
M.GV^O:9/?Z:I>]M8KR-I;51U,JALH!ZL!1HOC;P]XDO;FSTC7M,U2[M462>W
MLKR.:2)6&59U5B5!'0GK7QSHOPY^(>N>)='U&_\ !-YHU[#I'B:TU."TL+&T
ML([BYB!BC@:-S+.LCC=YDA()Y."3CH;G]G76;?P7X2TWPOX9M_#FL2?"S4O#
M]Y=VR1V_E7\L%F(HIG3DDNDOS<X(8YYYYQGT)I'QF\.>(OB%#X4T>\AU>232
MIM5.HV%Q%-;(L4R0M$S*QP^9 <8Z UNZ?X]\,ZMIMYJ-CXBTF]T^S;9<W=O?
M1210-Z.X;"GD<$]Z^2-4^$OB3Q]-KJ>%OAI=?#E;CX:S>'D-Y]FM5EO!<0L+
M7]R[?+L1U$AX(8]A4WQ(^%>N?$C2/'U]X:^&=YX1TVZ\%)X>.A7$=O;R:C=_
M:HY%"Q1.4*0QB1!(Q&?-(7@4 ?5*_$[P<T:N/%FAE&O/[/##4H<&Y_YX9W?Z
MSD?)UYZ5!<?$K2-)OM;CUVZLO#MGIUU%:I?:CJ-LD=PSQ"0 #S-R'!(VR!6.
MTD K@U\[?%#]G5=0U3X[2Z1X!L'74_!UC::"T%G HDO$6\WK".-C@M!\W'\'
M/R\+XW\.^-M%N/B0EGX3U6^7Q;J^D6QU2QMX;F:SM4TN&.ZNXT9QF12CQ(>S
MN&Y .0#Z5D^(7A:*UTNY?Q+HZ6VJG;I\S7\02\.0,0G=B0Y(^[GK6)\5?C-X
M<^$OA_4;_5+R&XOK.V%V-'@N(A>31EPFY(V8$@$]>G!KYC^(7P3OKS4G.C^$
MO$UKX(U/P?;>'-,T/2],TY[G3_*DG#P2?:MWV;>)(G$R'JF6Y5:/BO\ "3Q*
MVE?%;0C\-[_QAK7B*32[K1O$0:UE\J&""UB,4DSNK))$\,SX48?S21]XX /M
M>L;1O&?A_P 1"^.DZ[INIBQ8I=_8[N.;[.PSD2;2=AX/!QT-<LWQ O\ Q5)\
M2]#T/0))-6\-H+6T?4&466I7$EH)D0,K<*&94<'!'XBOE"W^"OQ!\6Z?XB6T
M\+7^BM?^ (=+>UN[.QTNVENHKY)9+&..W8X1H_-C5Y"1MD/S8R2 ?67B;X]>
M /"?A6'Q)>>*]*ET274(-,6]M;R*:/[1+(J*FY6QQO#-S\J@L> 36SHWCRQU
M?Q!?:7NMX&C>,6<OVZWD^WJT*S%HT1RX"JW\2@D?,,J0:^?_ !]X1;QU\-M?
MO/#GP:NO#5Q;ZMH6H/9W%K9P7FK):744LJK"CE<QQ!D4NPWY*CC&:OC+X<^+
M5\3^/?'_ (?\+W4FKZ7KFC>(= L2(XY=0CCTU+:ZM5^;Y"T;RQD' W*.N!0!
M])ZEX\\-:/:"ZO\ Q%I-C:FY:S$US>Q1IYZDAHMQ8#>"#E>HP>*W P8 @Y!Z
M&OC/Q!\ ?$WA*+P%<RVFK:S8P^&[ZSU:WT33K'4)AJEW.MS<R&*[&S;*QE0R
M+R,*&^5C7J7_  HWQ.OP9;1=)\8^(M.O/^$-;0[70]1N+62&&X-H8DDEFCA#
MF16(RR/MR,@8H ]AT?QIX>\10WTNE:]IFIQ6+%+M[.\CF6W89)$A5CL(P>N.
MAING^.O#6K:,VKV7B'2KS25E$+7]O>Q/ )"0 AD#;=V648SG)'K7S+JOP[O/
M''PCU?1?#WP:E\':O;:1IEG<F\^R6IU1+>YCEFTU&C<^9&R)(HD<A#YN.A;%
M#QQ\*-8^(UOX_P!3TCX>7?A_0-:3PW8KX>O88(9;Z2UU,37-R\".455@98\D
MY81GC 7(!]$>*OCMX"\'^%1XDOO%.EOHIU"'2_MEK=QRQBYDD6,1DJV,@N"W
M]U06/ -=+!XRT"ZOH[*'7--FO9(_.2WCNXVD>/8'WA0<E=K*V>F&!Z&OF7XH
M?!'4HYOBM+X?\%QRZ=/J/A?5K*PL884%]]CG5[H0H2%\SRX]O.W=P,U-XR^!
MNM>.)?CYJ.E^&H]/U?Q-8:5!HUU>+'!-<0)9QB:T\P$F)6*O$P.!EN<@9H ]
MM\8?&SPQX7^'>L^,K*_M_$VF:4R).-%NHISN:1$VY#;01O!P3TK0T?XF:9JW
MBSQKH;I)8GPH;;[;>73(D#+- )PP;/ 53R6QT]*^9/B%\+_$?Q T_P"(>M^$
M_AW?>$K"?PK9Z7'H$Z6UI/J5Y!>"XRD4<A3]W$#&KL1N+X'RC-:/Q1^&WC3Q
MK??%I=-T#5+6#Q!+X<UVU9DMS]K@MA$+JR*NQ7S\1L/+D&QL@$D$T ?3B^._
M#4GAQ_$"^(=*;0$X;5!>Q&U7YMO,N[;][CKUXK*\!_%+2/']KXEN[(F"RT+5
M)M,FNII$\J7RXXY#,C!B/+*R#!..AKYHC^%>M06]IXG_ .$0\2>(=,B\9V^M
M:IH&K6NGV\][&E@]L+B"SAVQ@QR-%(5<[W,6\<A<]9X+^%UW>?!'XRZ+JW@#
M4=-L?$7B#4+RT\-VMU!;7,MK+'!M,;JQC1F*LP4G&1M/% 'KGB7X_?#[PII>
MB:G>^+-);3=8U)-*M+RWO(I86G;/!<-@!<?,<X7(SUKKV\3:0D%Q.VJV*PV\
MRVTTAN$VQRMMVQL<\,=Z84\G<OJ*^05^'_C.\\-1ZC=>![K5+#1O&^DZQ#]H
MTBRLM:U.TBB\NX>:"%A$[H6 ##875#\O SH>-/"/C0/\0_"]I\/]7U%->\<Z
M9XDMM6A>W%D+)9-/,A8M('\Q/L\F8]F<#(.* /H3Q]\9O#GP_N;.RN+R&^U6
M?4;+3VTRUN8C<P_:9EB25XRP8("X)..G3-=5;^)-)NX=/E@U2RFBU D6;QW"
M,MR0I8B,@_/@*3\N> 3VKY(UGX8>(H]:N-*/PUN]1US_ (6?!XG_ .$M1;8P
MMI[7R2K)YI<2;HX<0F+;P(^,C%=)\#_"LK?'_P 1Z 88'\,?#2>\;1I(&5D6
M;566X,0Q]UK>/S8]IZ+.O8T ?4M%%% !1110 4444 %%%% #)O\ 5/\ [IKQ
MS]C?_DUWX;_]@F/_ -":O8YO]4_^Z:\<_8W_ .37?AO_ -@F/_T)JZ(_P9>J
M_*0NIT?Q$^,47@OQ%IGAC2O#^I^,/%NHV\E[#H^E&)#':QLJ//++,Z1QH&=5
M&6RQ. #SC"L_VEM$-KI+:IHVJ^';RYUUO#U_9ZNL<+:;<+;27)>5]Y1HC''D
M21LRD./?%#Q]IWB+X?\ QUMOB/I?AF_\8:'?^'UT'4K/1VB-]:/'<--#-''(
MZ"2-O-D5P&W#"'!&:Y_Q5H?C'XU7'P^O_%'@*.PT>T\;"]CTB\,<T\&FK8W"
M)->J':,2&9P=B%MH9,Y.<<XSV=OB!IUU/X<;2I+;6M,UJ66--2L[^W,*".-W
M+#+@RC*%<1AB.I  )%W1_''ASQ%J$ECI7B#2]3O8XEG>VL[V.:18VQM<JK$A
M3D8/0Y%?-7AOX.^(M%\;:0]OX9>RTFS\?>(M3C6%8TBAL[C3I8X954'A7D?
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MT^!/^O.3_P!'25T1_@R]5^4A=3V6BBBN<84444 %%%% !1110 4444 %%%%
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M:6[(R%N[@1L+GC>LHPR[L  ^OM+T73]$TN+3=.L+:PTZ)2D=I;0K'$BDDD!
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MM:\1^(?%'A"^O-=:341,=*U!(HWMYM@ ^QG[2SPF'"AEW+MRA-:"_'R\\:>
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M:SBNO.D,"7*IL\QMH<*3G&>N,XI)-,L;FUG@>TMY;>Y)::-HU*2DXR6&,-G
MZ^E?-O[4GPH\&>)_BS\%+W5_"^E:E>:IXJ-E>SW-JKO<P+IEZZQ2$CYE#*K
M'C*BCQ1\;-<\+?$O2[#PS>PWWA"T\3Z=X1N-,MM#9+2T\T)&ZM>-(,S(TB$+
M&A0 *IY)(YQGTI#8V<<=NL5O L=MQ J(H$7&W"X^[QQQ7&^,OA'9^*O$6EZ_
M9:UJWA?6]/AN+:.\T9XAYD4Y1I5>.6.2-LM&C!MNX%>O)!^<](^-_BGPAHMS
M:Z5;:)8C79/$&GZ!;6]AY<0UJ+6&@A+@-\_F).LC#C)BD.>>-S3_ -I'Q'X@
M\.W$W]KV>C75O9Z7HDICTF2]F?Q!-+*+J&&%&&YE2+Y4)V@OECA30!]"^!/A
MWHGP[\':7X9TJ!GT[3BSQ&[;S9#(TC2/*S'^-G=F)&.6.,#BMN?2;&Z%R)K*
MWF%TH2<21*WFJ.@?(^8#)ZU\K^'_ (X_$OQ7_P (YX=M]1L=(UJX\::IX9N]
M3U+2,R&WM[%[F.4VZR[5E^X,!]IQG SBO2/!'Q:U:Q^"GC'7O&.KZ7%J7A:^
MU73I]:^R2):R_99GCCG>!&9AD!-R(22<A>HH ]BCTZTACMHX[6&-+;B!5C $
M7&/E&/EXXX[5QOC+X2V?BKQ#I6OV>LZMX7UO3HKFWBO-&>(;XYRAE5XY8Y(V
MRT:-NV[@5X/)!^>KO]H3XDZ!HOCO3I[J&36=)?P[-8:CKNB?8,KJ%[]FE62W
M64G8-K%22K#<0<XR=KQ3\9/B/X-OO%/A4ZWHNIZUIOB#P[9VNM3::8HOL^IS
M;'CEA63[\>UL%6&0Z9YY(![WX+^&6@>!?!6F^%K&T^U:58LTD8O\3N\K2-*\
MK%AR[2.[9 '+'  XJ/5/A7X?UCQIIOB6[MO-N;'3[G38[-E0VK1SRQ2NS1E>
M6W0J0<]SUS7@GB'XQ?$SP_>ZIX+AUS1[SQ%9^,M(T*/Q%-I1$3VM];^<=]NL
MN/-CY'#@,-A(&34_BCXT_$#1-&^('B^#5M*;1_A_JL.CW.ARZ?B;5]D=NUQ,
M9?,_<NYN"8E52!M7.[=P >[:A\+]"U7Q]%XMO(&NK^/2SI"VTP5[;R3,LV[8
M5^^&08.>!VKJ#!"LQN#&@FV;#+M&[:#G&?3-?/.C_'+Q/-XYM?!%]/96^M:7
MXCU,ZY=-;X7^P[>'[1#.%S\A=;FS3=R,B3\/,?%GQL\5>*O!OCO1]2O_ .V/
M#WB#X=:SK^GZA_8C:9&OEJ@3[/OD:22%H[A2&D56^56'#8 !]FV^GV&FO<W$
M%M;VCW#>9/+'&J&1O[S$=3SU-#:3836,EFUG;R64N6> Q*8WW'<25Q@Y//UK
MY]^-/@*3XA>%_A/I]O<Z#J5]:_Z;'X,\37#PV>OJEGAD8H&.Z+<)%)1U!&2O
M0CSS0?C!=^#]'T+P!X!T#6?"=]+K^KV>IZ>L*ZZ^CR6T<4S6]FOF*C0M]HC9
M>0$4N-H(P #[%.CV#0^2;&V,6]9?+\E=N]<;6QCJ,#![8%3PVL-N93%$D9E;
M?)L4#>Q &3ZG '/M7S+HOQ*^+OCKQ#X:\--?:7X!U>Y\*7NK:A]NTL7,BW$%
M\MO&RQ^=A$=2'9"S%0^,Y&10^#GQ"\7_ !7^./@7Q!/KSZ7I.J_#U-7N_#T,
M :V:;[4L;E&8Y&6.X-R0N!D@T ?3CZ'I'F0!]/LMZ1&"(- F1'W1>/N^PXKS
M;5/V<M U35-2%QKVNC1=6UB/7KSP[]JC-I/=QNCALF,S!=\4;%%D"Y4< 9%>
M7?M&_"GP[XJ\4ZU8:9#<^)OC!XDB@.BW$DA_XI.WCVI]L21<?9HE</)_?FD.
MP;A]WA/BMH]EJ6B_M!>.]3D=_B#X.UVSMO#^I,["XTY(K>S>V6 9^19I)9"P
M'$GFL#D<4 ?:&I>&="U:[\R_TG3KVZ8?>N;:.1R![D9JPVDZ8SV<;65H7LQN
MM5,2Y@ XR@Q\O0#BOESXJ?"70=>^)$NG^&ENM<^+M_K5GK=QXGED)?PK8)+&
M=@E7 C0Q1R1QVX^:0RNS97<U8_Q;\-^%=/UG3OB1X9M[:^T]?&4+>(?'::E)
M+K&FS)?+;O8P1%1F#?M@:/?A4=R(W/) /K.^\(:#J=P]Q>:)IUW<.<M+/:1N
MS<8Y)&3TIMSX+\/WDQFN-"TV>4]9)+.-F/XE:V:* $50J@ 8 X %+110 444
M4 %%%% !1110 5!>_P#'G/\ ]<V_E4]07O\ QYS_ /7-OY4UN!\/?!W_ ))%
MX'_[ =C_ .DZ44?!W_DD7@?_ + =C_Z3I17T%3XWZF*V/H/]CW_DVWP3_P!<
M)O\ THEKV6ODO]F#]I+P)X3^!'A32=1O-4CO;6*995AT2]F4$SR'ATB*G@CH
M:]2_X:T^&_\ S_ZQ_P"$]J'_ ,8KS:]"JZLVH/=]/,T35CV*BO'?^&M/AO\
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M\-_^?_6/_">U#_XQ1]7K?R/[@NCV*BO'?^&M/AO_ ,_^L?\ A/:A_P#&*/\
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M5^1@5&T$#(KAO^&M/AO_ ,_^L?\ A/:A_P#&*/\ AK3X;_\ /_K'_A/:A_\
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MQ_X3VH?_ !BC_AK3X;_\_P#K'_A/:A_\8H^KUOY']P71[%17CO\ PUI\-_\
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MPH^/6G_%37=5TN'2KO2Y;0LT+7!!\^-=F20/NMB2,[>1\W7(( !ZE17$:?\
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ML>/7K2\T.[\-Z_H%Z+#4]+NI(YO)D:))D*2QDI(K1R(V001D@@$4 =W1110
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M7[)]F$>=W7%SNQMW#KFOI"SO+?4;2&ZM)X[FUF02130N'212,AE8<$$=Q4U
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MX/*NIKR*&6-8()W,EN4DW*S8(P1N8XQT?B+XJ?$3X<ZAXU\-7WB73]<ODO\
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MY\G=S\W\6:[73]/M=(T^VL;&VAL[*VC6&"WMT"1Q(HPJJHX     H L4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% #9/]6WTKQS]CO\ Y-I\"?\
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MWQ4U7XA0:'HOB&]N-7L=-\?7$_VBYLH[:[N+/2;+[9.LL41,99+L)$-O4 9
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M R* /G'7M6O=4_8A^&E[X7\6ZUIQ6]\/VC:G.D;W4P&H06[AR2PP&R>&(8*
M2RL<W/BYXW\:I:?'F"ZUG2]3\.>#=&M8X-)U#189Q>SS64<K2SEOE*A\D1A<
M?,<G  KZ5UCP#X;U_P '2>$[_0[&X\-/ ML=*,"BW$2XVH$ PH7:,8QC QTJ
MG)\*_",VFZUI\N@64MGK4$5MJ44B;A=QQ1B*-9,\L%0!1GL* /"O'GQR\3:+
M\1K5]!U::_T"S\3Z5X9U#3UT>)+*%[@Q+,CW3R"1YU\]''E+L4;5(/S$=Y^R
MRH3P/XG Z?\ "9>(/_3E/757_P #? &J>)I/$5WX2TNXUN2X@NVO)( 7,\)4
MQ2^GF+L7#_>PH&<5T'AWP7H?A*ZU>XT;2[?39M7NVO[]K=-HN+A@ TK#IN.!
MD]^IYH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** &3?ZI_]TUXY^QO_
M ,FN_#?_ +!,?_H35['-_JG_ -TUXY^QO_R:[\-_^P3'_P"A-71'^#+U7Y2%
MU/9J***YQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %07O_'G/_P!<V_E4]07O_'G/_P!<V_E36X'P
M]\'?^21>!_\ L!V/_I.E%'P=_P"21>!_^P'8_P#I.E%?05/C?J8K8[']F']I
MSX<^$/@3X4T?5=9O8-0M8IEFCCT6_F529Y#PZ0%3P1T)KU'_ (; ^%/_ $'M
M0_\ "?U+_P"1Z=^QZ2?V;?!.>?W$W_I1+7LE>;7E1]K.\7N^J[^A:O8\9_X;
M ^%/_0>U#_PG]2_^1Z/^&P/A3_T'M0_\)_4O_D>O9J*PYJ/\K^]?_(E:GC/_
M  V!\*?^@]J'_A/ZE_\ (]'_  V!\*?^@]J'_A/ZE_\ (]>S44<U'^5_>O\
MY$-3QG_AL#X4_P#0>U#_ ,)_4O\ Y'H_X; ^%/\ T'M0_P#"?U+_ .1Z]FHH
MYJ/\K^]?_(AJ>,_\-@?"G_H/:A_X3^I?_(]'_#8'PI_Z#VH?^$_J7_R/7LU%
M'-1_E?WK_P"1#4\9_P"&P/A3_P!![4/_  G]2_\ D>C_ (; ^%/_ $'M0_\
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MPI_Z#VH?^$_J7_R/1_PV!\*?^@]J'_A/ZE_\CU[-11S4?Y7]Z_\ D0U/&?\
MAL#X4_\ 0>U#_P )_4O_ )'H_P"&P/A3_P!![4/_  G]2_\ D>O9J*.:C_*_
MO7_R(:GC/_#8'PI_Z#VH?^$_J7_R/1_PV!\*?^@]J'_A/ZE_\CU[-11S4?Y7
M]Z_^1#4\9_X; ^%/_0>U#_PG]2_^1Z/^&P/A3_T'M0_\)_4O_D>O9J*.:C_*
M_O7_ ,B&IXS_ ,-@?"G_ *#VH?\ A/ZE_P#(]'_#8'PI_P"@]J'_ (3^I?\
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MZ_\ D0U/&?\ AL#X4_\ 0>U#_P )_4O_ )'H_P"&P/A3_P!![4/_  G]2_\
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M.=QZ,0#N [ULW?P=N_&UU>W4'P[N-+\$:M\1=%U"/PS?V,<(6WM[<1W5W+;
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MPW!9:%/X=T37_&TVJ:2^O&TT*U0S6E@C!'EF662/#!\H(P2Y9' 7Y37AVE^
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M2:%I>GB=Y?#FI65@K3I)<2R(DH1',(5755CB<;%55/(- 'ME%%% #)O]4_\
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M(W*2(2/XE964CL014&L>+=$\/:AI5AJ>JV=A?:M,;>PMKB94DNI ,E8U)RQ
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MLB  GAGSD#H/3EO&O[5?BB3X9Z7XQ\./9Q7=OX2MO%&I^'X]&N+]@906"RW
M=$MX66.4*Q)<X+;<+SSC/J?2?#FD^'[>:#2]+L]-AF<R2QVEND2R,>K,% R3
MZFFZ;X9T?1M-FT_3])L;&PF+&6UMK9(XGW##;E  .1P<CFO(=*\>?$#Q_P"/
M/$[^'+_P_I'A[PQJMIIDVFZK:RR37P>W@N)Y//5QY6%N%6,!&!*'=PW'EFD_
M%[Q[\/?"GCB[NM=D\3WVH?$F;POI8;2GG;3E:3YI%B23=*JH#MA!7Y@.<$T
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M'D\P30>1)(Y/EE%8.#@B0 \@D@'L5%%% !1110!XO^Q]_P D&TS_ +"NL_\
MIUNZ]7UCPWI/B&/R]5TNRU./:4V7ENDHVD@D88'@E0<>P]*\H_8^_P"2#:9_
MV%=9_P#3K=U[171B/XT_5_F*.R*%QH.F7C6IGTZTG-HK+;F2!6\D,NU@F1\H
M*_*<=1Q2QZ%IL<<L::=:I'-"MM(JP* \2@A8R,<J 2 IX )J]17.,RK[PGHF
MJ30S7FC:?=S0Q&"*2>U1VCC(P44D<*?0<5!I7@O1]%UW7-9M;-5U/6O)%]<-
MR95B39&GLJ@M@?[3'O6Y10!3@T;3[5K4PV-M";6,PVYCA5?)C.,HF!\JG:O
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MC=;>TC0,KG+J<#D,0"1WQS6O10!!8V-MI=G#:6=O%:6D*".*"! B1J. JJ.
M!Z"IZ** "BBB@ HHHH **** &3?ZI_\ =->.?L;_ /)KOPW_ .P3'_Z$U>QS
M?ZI_]TUXY^QO_P FN_#?_L$Q_P#H35T1_@R]5^4A=3V:BBBN<84444 %%%%
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MD[<5A_%7XZVGPF\7Z_)?_P!K:A9:1X4_MR32[." QR#[7Y.Y')$AE.0-I.S
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M0#*YZ$$4 =IX;^"?@GPA?>'+S1=!CTVX\.V,NF:8]O-*ODVLC!FA(W8=-P!
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MOK:5/LUQ,8U=VAE8*RLCJT9(8'!&0<UU.M?M!0>!]<\5R>(8=4AGT_3]&9=
M/V4HEW>RS110Q3AAN=G0!FD8(H4$$#=0![E17A*_M7Z;)I]ND'A;5;_Q"_B!
M?#4NBZ?<6L[QW3VC743><LOE-$T2@[]WRY.0,&LK4OVH-?O+SP)#H?@2Z^T:
MGXJN_#.M:?J%W DUE-!;S2LJ,'*/G8KAP2I4$<,10!]%T5YWJ_Q@^P?%Z'P!
M:>&=6U6[_LR/5[K4K8Q"VM+=I)8QOW.&9]T6 B*Q.[/0&N&N?VNM,T>Q\72:
MWX4U;2;_ ,/Z*/$!TPSVL]Q/:&4Q8Q%*PCE#8!B<@C<.O. #WVBO$[C]I^TT
M.W\6CQ)X-U_P]?Z%:6E]!I\_V>:;48KJ9H+80^7(RB1YE\LHY!4D9XYKG]/_
M &C]8T7QI\0CXKT'5-,M-(M=#AL/#:QV\UU+>WLD\:QQ2QN5D\QA$ 2^%VMG
M&#0!]&45XCJ'[4%KH.GZK'K'@_7++Q+I>IZ;IMUX?C:"><_;Y-EK+%(LGER(
MQ#?Q @HP(&*HVW[6 6ZN(]4^'OB/2(=+UN#0==NII;1XM,N)S$+<Y28F96%Q
M"28PVP/ST- 'OE%>":C^T)=^#_!7B[Q(NCZMXNL=%\0ZCIMP'EL[26$Q2JD<
M$*Y7SMS,$C_C8D!N2*L>(/VL-#\,^(+C3[_1;R&VTQ[&WUR[:ZM5_LRXNA&4
MB,1EWS%/.CWF(,%#<9P< 'N=%?.GC[]H[6)M2TVW\+Z%J=KHR^-[+PQ/XCFC
M@>VN6%TL5W$L98R*H.^,2[0-RD ]"?:OB!XYTOX:>"]7\4:T\J:9ID!GE$";
MY'Y 5$7NS,0H'<D4 =#17D5S\?[G0?#M[>^)? /B+P_JBW=G8Z?I4AMYFU2X
MNCMAB@ECD,>X-D/N9=F"3Q@G-U#]J2RT6QN8=0\(:Y#XHL]<L=!NO#L)@EN$
MENQNMI4D$GEO$Z\[@PQA@0-IH ]OHKYO\4_M2^(X-/T0:/X NX-=_P"$R@\*
MZQH^J7=NKVYDB$RF.1)#&^]'0JP) Y!%=->_M/6&GW7C03^%-=^P^&=0CT9[
MV,0,M_J,A@$-I;+YFYW8W*#<0JK@Y:@#VJBOGKQK^T-J_P#9,UA;:5>>#?%^
ME^(=!M-1T[4!!<YL[Z\2,21R(S(RN@E7(.Y65NA -6+3]H2;PG#\0KKQ$7U5
MK/QM_P (UH5C;B&!I&>UMY(X3(Y5 ,O*QD=N%!YX H ]]HKP^Q_:GT[7+'3+
M;1O#.I:QXLO=5NM';P]:W%L7@FMHUEN':?S/),:QR1,&#'=YJ #)(&]^SCX^
MUCXD_#Z\UG7/-6\&N:I:)#/ D,D,4-Y+%'&ZKQN55"D\YQG)ZT >I45\Y?'C
M]I'5_#N@^.(/!NAZE*_ANXL["[\3+'!):6MW+) S0^6[;WVQ3+N8(0ID'H<=
M3KW[2^F:#K&L,?#VK7/A/0]4BT75O%$1A^S6EVY12OEEQ*Z(TL:NZJ0I8]=K
M$ 'LE%>5S?M!:3#I>I7QTN^,=CXOC\'NN4RUP\T4(F'S?ZO,H/\ >P#Q7$_#
MW]H[5XM2O+3Q3H>I76ES>-[_ ,+VWB.&.!+:&073Q6D+1AA(RG"Q^;M(W$ G
MJ: /HJBOG;PG^TE<Z3\/]'GUV)O$'BK6M?UG3M/LX9+>R5XK2[G4L\DC)&BQ
MQ1H"2<L2HP2:](\ _'?P9\0-%T&\MM:LM.O=9\U;;2;^[A2\:2*5XI8UC#G>
M5DCD7*;@=I()% 'H-%%% #)O]4_^Z:\<_8W_ .37?AO_ -@F/_T)J]CF_P!4
M_P#NFO'/V-_^37?AO_V"8_\ T)JZ(_P9>J_*0NI[-1117.,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J"]_X\Y_\ KFW\JGJ"]_X\Y_\ KFW\J:W ^'O@[_R2+P/_ -@.Q_\ 2=**
M/@[_ ,DB\#_]@.Q_])THKZ"I\;]3%;'T'^Q[_P FV^"?^N$W_I1+7LM>-?L>
M_P#)MO@G_KA-_P"E$M>RUXV(_C3]7^9K'9!1117.,**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!LG^K
M;Z5XY^QW_P FT^!/^O.3_P!'25[')_JV^E>.?L=_\FT^!/\ KSD_]'25T1_@
MR]5^4A=2;XN?L\0?%?5M?OI==FTPZMX;'ATQQVRR")1="X\X$L,G(V[?QS3O
MBA^SW!\3+SQ7<2:Y-I_]O:3I^ELJ6ZOY M;M[D.,L,EB^W';&:W?'WQW\%_#
M/6O['U_4[B'5?L#:I]CM-/N+N7[*K['FVPQM\JGJ>PY-9OBG]IOX;^#Y(DU#
MQ TK2Z5%KB?V?87-X#82%@MUF&-P(OD8EN@ R<9%<XS%UC]FF"X^)6I^*=+U
M6PT^+5[^WU+4(+K0+6]NO.B1$;R+F4$PJZ11@@J^"&*%2V:U?"'P8UKP/XED
M_LGQQ<VW@MM5NM8_X1X:?$9/-N&>22(W))/D^;(\@4(&R0-^!BM7Q%\?O GA
M:\M;>_UP8GM8;YKBVMIKB"WMYFVPS3RQHR0QN?NM(5!P3T!(OW_Q@\):98^(
M+RYU81VV@:C#I6HOY$A\BYE\GRX\!?FS]HBY7(^;KP< ' >&?V8(M#L/"NEW
MGB-]3T;PWJ6IW-E:M9"-VM;V">)K:1P_S%?M#D2  D  CO4>B_LR75O#HEEK
M'C6YUO2O#6E76D^'K=K".%[1)H#;>9.ZM^_=(3L!P@Y)().1OZQ^U-\,M!UZ
M[TB_\1M;W5GJ#:3<N=/N3!!>!0P@>81[!(P8;5W9<D!<DXJ[;?M%> ;KPB?$
M2:Q,++^T?[(%L^GW*WIO<9^S"U,?G&0KAMNS.WYON\T 4['X$G3+?P.MIXDN
MK2Y\*^&;CPY;W<-O'YCF2.W07(#;E5E-N&"D,#NYZ<\GI?P!\7?#^/7]5\*^
M)["/Q5K][I:W5Q9Z-#86*6UO+F=VMPSAYI8VD5I 0QR@&T+FNUO/VDOAY8^'
M])UB777-KJEY-IUK%'8W#W+7<2LTEN8%C,B2J$;Y&4-QTY%-TOXZ:!XJU+P;
M+H.M:?+H^N-J,;+>07,-T9+5,R(J% (VC96#K-M(QQDT 5?C9X/ECOM.^(&E
M>))/"VNZ':SZ?]H&GK?QW-O<O%F%H6=,MYJ0E2&&",'()%<$O@?Q!K'Q*U#3
M--\0^(/#'B:;PU%8ZSK6I6-A>QZK;1S2)#<*L4H\BX)DN"N4VE<Y0E!7<7GQ
M \-_'G0=1T#PKJ;_ -LPI::O;1:C8W%H)XH[E9(ID\U%\R%WAV[TR.?<9ZBZ
M\ WL5SXAU#3-8>VU77+RU>:XFB5Q#:Q!%:WC'8%!+ANH:4MV% 'SQX5\-^"/
M%WA7Q+I&BWNL:-H_B/P]IWP^M?M%O#/]BC2&Z6WF9TD(+L)"&C;:ZL%#*NZO
M4_B!^S5;^/9M6D?Q!-9?VAX?L-!(2V5]BVMV;D2\L,EB=NWMUS4FA_ !_"Z:
M;!::K]LB35+&YGDD@2#%O9AS"NU!AY69EWRG!8?0"O9J /(?&W[/,'C/_A:F
M_79K3_A/-/L["3;;*WV(6Z2(&7YOG+>9G!QC%8'CG]E_4O%NJ^+UL_'MQH_A
MWQ1?6.J7^E+I<4SFYMA;@;9V;(C=;:/*8SDDA@#BO?:* /)+O]G^"ZT+Q;IO
M]N3*OB#Q5!XH:3[.N8&BEM9/) W?,#]E W<'YSQQ5#_AG%[+5;'5M,\3O::K
M9>+[[Q5#--8K+'MNXWBFM63>,C9(0'!!! ..U>U44 > _!7X5W2?%GXI^,=6
MT>\TW1=7NOL>CZ3JPC9EB8*]],$4L!'<3@,%8Y.S) W8K6^)G[-MIXX\1:7J
MFE:G:>'XK/2KO238/H\%Y;K'.ZNTT$;D+%,"N-^&R"017M%% 'A6D_LVZQX-
MATY?"'Q N?#L_P#PC^G>']4N/[+AN'NTLT*0W$6]L0S;'D7)#K\R_*2N3S/Q
MT_9[\3R>%_';^#M>NKJP\1ZA9:K=>&!9PM)-=I+;+*Z7#,"B-' C,F"<H=K#
M=BOINB@#P3Q1^S#J6O:UXA^R^/;G3?#.N:_9^);G1ETR*1_M<#V[%1<%MWE/
M]E3Y<9!)^;'%;>@_L[P:'XYT_P 2+KLTSV?B/5O$(MC;* S7T'E&+=NX"=0W
M?T%>P44 >'>%_P!E^S\)>+I;RRU.P7P\]]>7_P#9YT&V-\6N2[21-?',AB#R
MNPPH< A=Y48+/ ?[-NI^#O$7@*ZN_'ESK.B^!X;JST;2Y--BB86\L/DHLTJM
MF1XT"J& 4$#E<G->Z44 %%%% !1110!XO^Q]_P D&TS_ +"NL_\ IUNZZ#XC
M_"C4?$_BC2O%?A;Q,WA#Q786LNG&]:P2]@N;21E=H9869<X=%965E(.>H)%<
M_P#L??\ )!M,_P"PKK/_ *=;NM+XF_'2V^%_Q,\*>']2MV?3-9T[4+MI;6VG
MNKKS+=H L<4,2LSY$SDX' 2NC$?QI^K_ #%'9%'3_P!F^TL?!_@_PS+X@O+S
M2])UQO$6JK-"F[6KLRR7'[S&%CC%S()=BJ1^[1>F2=CXC?#'Q=XF\0?VGX6^
M)%_X/6XLQ97=FUC'?08#,1- LA'DSX=AO^8$!<J=HK)F_: M-4\46%OX?GTZ
M^\-ZAX/O?$]OK4C2%,PRQ(H95&[9B1BPQO!7&,\4VX_:J^'_ (<TNQ/B#Q J
MZ@='L]8O#INFWD\$-O<1EEN21$2D!VN=SXV@?-@USC-B;X.Z#X.^$=QX=\-Z
M+%-<Z?H$VE:?-*BO=N/(=%4RD9+,6.3D ECZUYEX#_9AUW7/AUH5MXW\87[W
MEOX(;PU8VMO9Q6T^C_:;>)+EVE1CYLP\I$#84 *>"6)KL/CA^U!X9^%/ASQ(
M;.[CU3Q)I>E#4DM!!/);+O!,"SSQH4B\S!VAF!;M7K\=\JZ:MY/^[00^:^ 3
MM&W)H ^>H?V.HKC1_%EGJ/B> 2:]X=MM ']CZ'!I\-IY$LDL<Z1(QW'<X)5B
M<[< @<#H/%G[,R>.Y-?O->\0K=ZKJUIHZ^>FFQ^1%=Z?++-'/Y+LZNCO+\T3
M$C:",\Y%BS_;!^%.I10/9^(+N[^U6GVZS2#1KUWOH>-S6RB',^S<-XCW%,_-
MBNTT7XP^#_$4UI'IFM17IN]%'B&!HHW*O8%MOG [<=>-OWO:@#C-&_9X>S;P
MW->:[9M<:/XB_M]8])T.#3[9L6LMN(%CC.0,2EB[L[$C&0, &H?LZO)<1W^F
M^)GL=6M_&4WB^VN);%9HT:6!H)+=H]XW*8W<!L@@D'M@Y_B#]J*PT>3Q+JMI
M8-K/A33/ ]OXQM;BSCD^TWBRR3JJ!-N54K$IW$?+N); %:L?[1V@6\<>M:M?
M0Z'X<'A?_A([B&_L[J._MXQ,(VD9#'M\H9Q_>)Y V\T ;OB#X.P>(/&OB;Q!
M)K%U:'7/#*^&GBM0$DMU$DS^?')G(?\ ?G''!4&O)[/]BM5T/5=/NO%T.;[P
MJ/"JMINA0V:1QB991.55SOD.W#;C@DDC;TKU/1_VBO &N6/B.[M]:DBB\/PI
M<Z@MY87-O(D+[A'*B21JTJ.48*R!@Q&!DUSWB[]J[PGX;T/3M2M+/6-6\_Q#
M:^';JRBTNYCN[&:;:098&B\P?(ZLJ[<N"-N<T :'Q)_9]M?B1J7B"]FURZTZ
M74](L=.@:VA0M:3V=V]W!<J6R&(E9<H1@A,9YK!F_9DU#7+CQ7J7B+QW<ZCK
M^M'29[?4+338K9=.N=.E>6WEBCW.&7>^61R<_,,\C'4_\+TT+1?^$FFU_5K.
M.WT_68M(M;>QM;J2[::2WBF2W:+R]TDY$A;;$& 7&<$-AUU^TE\/++P_I>LR
MZ\_V34[V;3;:)+&X>Y:\B1GDMF@$9D24!&^1E#<=.10!STO[-UQK-Q>ZKK_B
MV34_$E]K.D:G<WT.GK;P^3ITWFP6T<.]MJDM)EBS$F0GH !=U[]G>#7+'QQ;
MMKLT(\4>([#Q$["V4_9VM?LF(A\WS!OL@^8XQO/'%;,?[0O@:X\)Z9XBM=2N
M[^RU*YFL[:WL],NIKQYXMWG1&V6,RJT>Q]P91MV\]JA\-_&BU\8_%'2-#T1K
M74?#>J>%CXCMM6B9MTG^DI$JA2.%PQ)SR",$4 <GJ/[-&KKK%I?:1XUBM8;?
MQ+J/BC[#J&C"[@>[N2/*8J)D), +[#G[SAL95<3ZE^S*;OQY>>)K?7--M[C5
MIK2[U<S>'+:ZFEN(8TC9[:64L;<2)&@*D2;<$J58YKTKX@?$[PW\+['3[SQ+
MJ!T^#4+Q;"UVV\DS37#([K&JQJS%B$; QR1CJ17*>&_VGOAOXLU?2],TW7I9
M+O4;I["%9M.NH42[7=NM97>,+%/\C?NI"KG' Y&0#FKK]F*^?5HXK7QS<VOA
M*+Q9'XOBT,Z=$[K<_:/M$L)N-VXQ-*78#:&4M]Y@,5TLWPQUSXB_#?QMX6^(
M&JM<0ZWJ-VVGR6:I'-861D#6JY4;6DC*A@2#G@-GFNAT_P",'A+5+'0+RVU8
M26VO:C-I.G/Y$@\^ZB,PDCP5RN/L\O+8!V\'D9\Q\$_M71:Q#\*;;5_#UZFI
M^.EOBKZ7;S3V]H;>1E&6"'.<#/(VCDX'- &_JGP/\2>+O#LUMXH^(<^J:U;W
MUEJ6D:A::3#:Q:;<VK;DD$.6\PNQ;S [8*G"A.M5%_9MDOM2.MZUXIDU+Q+<
M>(]-U^\OHK%8(9%L@5@M8X0Y\M &;+%F8EF/H!H6?[1GAC2?"6EZGXAUBWN+
MO4)[]((O#]A>71DCM9WCE<1"(RA8PH#N5VANA(*YUM<_:'\ >'TT^2ZUX26]
M[8Q:HMS:6LUQ##9RG$=Q/)&C+#$QZ/(5'#?W3@ P?%G[.I\03ZW?67B633=6
MN_%-EXKL[AK)9H[6>W@BA$;1EAYB,L;9Y4C?QTJ;4?V=K35/#OC73I==NH;G
MQ!XBC\36U];PHKZ=>1"W,)16R'"O;*V&ZAB/>M#7?VEOAUX;\3WF@:AKSPZC
M8W=O8WA6PN7@M)9UC,(FF6,QQJ_FQX9F"DMC/6J.@_M,>&-2U+XBP:E;ZAH%
MIX)OQ97=]?V<RPSYCB8&,[.6+3!5C&6;Y2H(9: ,?6/V:=0\2:?XAO=7\:O=
M>,]5N]+N4UF'3$CM[5=/G\^VB6UWG<F]I"^9,MYAY&  >)?V7(?$@\4K-X@1
MX]4\16WBJPBNM+CGCL=0C@6&3>K-B>&15QY; %=S8;.".FOOVE/A[I/APZU?
MZS/8VRZFNC/;W&FW27<=ZT9D2!K8Q^:'9!E05^;(QG(IVJ?'?2M+^+_ASP"^
ME:M)<ZWI,VK17Z6,QAB5'B4(_P GRY\PDDD!, -@L* .<7]G'4;.W\-W^F>+
MK?2?%>AW]W=6]_9:!;PV1AN46.6V^R(5&S;'&0Q<N&0$LP^6K/@/X1^+OAC<
M>$M*TKQ6VIZ''JNK:KXAN+VTB22_^U-)+'&H4?(RRRYRN!M0@CD"KOAO]HCP
MQ\0-6\*-X4UNSO=&U>YNK8S75G=PO<M%;&8BV9HPC;<'>6.T8(!W#%9OB[]J
M3PU!\//&6M>%9FU35]"T676H++4+.XM$O(%)59HVD1?,B+#&^/(Y'J,@%'Q]
M^S#?>+9O&=IIGCJYT'PWXLO;?5-2TM=-BN&^UQ>2&:.9F!5)%MX@R8)R"0RY
M(JWX@_9I;6K[Q#81^*[BT\#^(]7CUO5O#XLD>26X#1O(L=R6W1Q2/%&S+M8_
M>VLH;CVBQN#=6<$S *9(U<@=LC-3T >":I^S!J%[XBOY(/'ES:^&+OQ7;^+V
MT7^S(G?[7'+%(\9N"VXQ,T60 H*D_>(&*DT_]F2^M]>C-UXYN;OPHOBR;Q@=
M#_LZ)'-VT[3Q1_: V[RDD*MMV[F*CY@.*]WHH ^?KK]DV&;3;"$>(+6ZN='U
MW4=7TA]5T6*[AAAOG9Y[::%G F&YR5D!1AA>N#N]1\#_  UL/"F@:-:7L=CK
M&J::C!-3_LRWM6#,[,?+CB0+$N6.%7MU).2>PHH **** &3?ZI_]TUXY^QO_
M ,FN_#?_ +!,?_H35['-_JG_ -TUXY^QO_R:[\-_^P3'_P"A-71'^#+U7Y2%
MU/9J***YQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %07O_'G/_P!<V_E4]07O_'G/_P!<V_E36X'P
M]\'?^21>!_\ L!V/_I.E%'P=_P"21>!_^P'8_P#I.E%?05/C?J8K8^@_V/?^
M3;?!/_7";_THEKV6O&OV/?\ DVWP3_UPF_\ 2B6O9:\;$?QI^K_,UCL@HHHK
MG&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 V3_ %;?2O'/V._^3:? G_7G)_Z.DKV.3_5M]*\<_8[_
M .3:? G_ %YR?^CI*Z(_P9>J_*0NIRWQ(@\;?\-02R^#-,TK4+J7P$]LW]M3
M36\"LU\=K"2.-\E3R4P"1T(JUX/_ &<=8\&VM[I\5_9WEG_PKJS\(032%E=[
MJ$W):1EVG;&?.7&"2.1CCGZ$HKG&?)>J?LG:^K2HMGI?B&WUKPYI6BZE;WFO
MZCI]O;2VL'D.QBMMHNHG1B0KE&!&,@,<:_CCX#_$74;KQ[HFB?\ "-MX9\3Z
M_IVO"_O;J=+J 0&S$EN(5C*DD6A*R;_X\%<\U].T4 ?/UU\ _$4UGJ<2W.GA
MKGXF6WC%,R/C[''+;NR'Y/\ 6XB; Z=/FJ+4O@7XNL?&VH^,=(FTFZU.V\9/
MXCT^PO)Y(XKFVDTN.PEBD<(3%(,.RL%<< 'J<?0U% 'SUX5^ OBBR\9>'?%.
MIW&E1W[>+M0\4:M9V<DC16ZSZ<;..&%B@,A 6,LS!,DN0.@JM_PS[XQM_$-E
MJ>G:MINFW5MJ_BG48;L%I&@.HHPM7"%,,R,0SJ3CC@FOHZB@#YY^!_P4\9^$
M_BA!XN\4M9>9_P (JFB7+)K=WJ=Q<72W"R-.7G10J-@D*H&W.,=,?0U%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B_P"Q]_R0;3/^
MPKK/_IUNZM_%+P3XUNOBIX0\:^$+?1-0.BZ9J-C<6&L7<ML9C<-;E"DB1OMP
M823E3QQ[BI^Q]_R0;3/^PKK/_IUNZ]HKHQ'\:?J_S%'9'S%X=_9J\6^%+/PY
M#%>Z/J+CPGK>A:K(9)(1%<WTXNED@&QM\8EW1X8J0I#<GY:T?#O[//B72O"O
MC;3)KK36GUKX?Z9X6MRLKE1=6]I<PR,_R<1EIEP1DXSP*^C**YQGRUXV_9^^
M(TN@_$70?#C^&KFQ\;Z3903W6IW,\4EA<P6<=K(JHD;"5'6)"IRI5BV0PKV?
M0[WQ1K&M^-="O])M[/0+*WMK;1]2#.'O'>W)GW@CHC[0&7@Y(Z@UWU% 'A'P
MW^!OB#PC??!B6]N;!T\&^%;O1-0$,CG?/*MH%:+*C*?Z.^2<'E>/3C/"O[/?
MQ)^'MEX5;16\,ZC>P^$;CPMJ*W]W/%' SW)G2XC*Q$RC#$%#L/3#5]544 ?,
M6D?LU^+++01HDUWI)MM0^%T?@B]NDFDWVUY$LH65$V8DB;SVZE6&P<'/$/C+
M]GGQUX\\.W(NQH>FZI<^ !X5>".\EEB6[6Z20.',0)C*)G.W()Q@]:^HZ* /
M#OBM\)?&^O\ B/Q9KGA+5[72K_4- TW3+68W,D$I:"]EGGC,B(3$)(I#&)%R
MREB0.!7"P_LV>-K>#Q/JEO'HT&JW7BS1?$^GZ;+JUW=1LMDD2R0374J&3<VQ
ML.%89QP!7U710!\[ZA\"_&%MXQU#QEICZ1-JT'C#_A);'3;JXD6&X@?2DL9H
M9)!&3'(/G96"L.%R/F.'^&/@+XIM?&/A_P 5:I/I46H2>,+[Q1JMG9RR-%;I
M-IILHX86* R, L99F"9)<@=!7T+10!\XWWP3^(%A=P_V9?65QH]QXFUO5=1T
ME-7NM.6YBNY UK(\T*;V,7S[H>%;?]X[15#X5_ [QM\%(?"&I@:/JLFA^"[[
M0[V"":=B+C[1]I@:$>66E1B-C [6&01N/%?3M% 'D6L^$O%GQ-T+X/ZQJUE8
MZ)KND:K:ZYK>G^<S)"WV.:.6*(X.XAY@!G' /-<U'\ O$2V,<)N=.W+\3G\9
M']Z^/L1G:0)]S_6X(XZ9_BKZ"HH ^9/"?P+^(VCZIX&TB\/AO_A%O"?BN^UQ
M+^&ZG:\O8;C[8R+Y1C"1LAN@"-[!MN01TJ?P+\"/''@NV^$C,NBWEQX)U'5+
M>=$O)46ZL+O<%N$)B.V905)B(VGD;^AKZ4HH ^:?"'P-\?\ PMN?#VO: F@:
MUK5G::SI=WI]_>S6\!AN]2>]@ECE6)CN4[5="G()PWRC-?XA_LW^)_%'BK6-
M;FM-&\0S^)]"L]+U>UDUO4M*L[>>$2*[B*W;-Q ZS-^[=@PVXW88X^GJ* /G
M[Q%^S_KVI>%_BYI5I/IJ'Q5J6GW6FAY'"QQ6\%G&PD^4D'-L^,;N"N3UK/\
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M1110 4444 %%%% !4%[_ ,><_P#US;^53U!>_P#'G/\ ]<V_E36X'P]\'?\
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MAR;1?#UGH'@^#P3OBDNM2G_M6UE2T81A8S"%9<JC!V=3AL[01BO+_AS\9/[
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M#?RWT=I E[,H22Y6)1(ZCH"V,D# ZTL>G6D/D>7:PIY&?*VQ@>7GKMXXS[4
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M$UO$UV -BR3(D9E&"V -V7R?M#3/"NCZ/X:M/#UGIMM#H=K;I:PV'EAHEB4
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MDP!EPI;!R:] ^ _BSQQ?WFMKX;\2:%XPW:)8W<6F:KXNFU-EN6E(>=YTM?\
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MSG_ZYM_*IZ@O?^/.?_KFW\J:W ^'O@[_ ,DB\#_]@.Q_])THH^#O_)(O _\
MV ['_P!)THKZ"I\;]3%;'T'^Q[_R;;X)_P"N$W_I1+7LM>-?L>_\FV^"?^N$
MW_I1+7LM>-B/XT_5_F:QV04445SC"BBB@ HHHH **** "BBB@ HHHH ****
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M0!M4444 %%%% !1110 R;_5/_NFO'/V-_P#DUWX;_P#8)C_]":O8YO\ 5/\
M[IKQS]C?_DUWX;_]@F/_ -":NB/\&7JORD+J>S4445SC"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M@O?^/.?_ *YM_*IZ@O?^/.?_ *YM_*FMP/A[X._\DB\#_P#8#L?_ $G2BCX.
M_P#)(O __8#L?_2=**^@J?&_4Q6QV?[,_P"TW\,O _P.\+:%KOBB/3=6LXID
MN+6:TN-\9,\C '$?H0?QKT[_ (;&^#G_ $.]M_X"7/\ \;KV>BO)G4HSDYN+
MU\U_\B::GC'_  V-\'/^AWMO_ 2Y_P#C='_#8WP<_P"AWMO_  $N?_C=>ST5
M'-1_E?WK_P"1'J>,?\-C?!S_ *'>V_\  2Y_^-T?\-C?!S_H=[;_ ,!+G_XW
M7L]%'-1_E?WK_P"1#4\8_P"&QO@Y_P!#O;?^ ES_ /&Z/^&QO@Y_T.]M_P"
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M=>ST4<U'^5_>O_D0U/&/^&QO@Y_T.]M_X"7/_P ;H_X;&^#G_0[VW_@)<_\
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M-U[/11S4?Y7]Z_\ D0U/&/\ AL;X.?\ 0[VW_@)<_P#QNC_AL;X.?]#O;?\
M@)<__&Z]GHHYJ/\ *_O7_P B&IXQ_P -C?!S_H=[;_P$N?\ XW1_PV-\'/\
MH=[;_P !+G_XW7L]%'-1_E?WK_Y$-3QC_AL;X.?]#O;?^ ES_P#&Z/\ AL;X
M.?\ 0[VW_@)<_P#QNO9Z*.:C_*_O7_R(:GC'_#8WP<_Z'>V_\!+G_P"-T?\
M#8WP<_Z'>V_\!+G_ .-U[/11S4?Y7]Z_^1#4\8_X;&^#G_0[VW_@)<__ !NC
M_AL;X.?]#O;?^ ES_P#&Z]GHHYJ/\K^]?_(AJ>,?\-C?!S_H=[;_ ,!+G_XW
M1_PV-\'/^AWMO_ 2Y_\ C=>ST4<U'^5_>O\ Y$-3QC_AL;X.?]#O;?\ @)<_
M_&Z/^&QO@Y_T.]M_X"7/_P ;KV>BCFH_RO[U_P#(AJ>,?\-C?!S_ *'>V_\
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M_P"AWMO_  $N?_C='_#8WP<_Z'>V_P# 2Y_^-U[/11S4?Y7]Z_\ D0U/&/\
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M_P -C?!S_H=[;_P$N?\ XW7L]%'-1_E?WK_Y$-3QC_AL;X.?]#O;?^ ES_\
M&ZCN?VP_@[);RH/&]MED('^B7/I_USKVNBCFH_RO[U_\B&I\0_!_2[V/X2^"
>4>SN%9=#L05:)@0?LZ<=**^WJ*Z)8MR;?*3RG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img12876764_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_1.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,.!V<# 2(  A$! Q$!_\0
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M\T?O_KO^?9G].=%?S&?\1<G_  1X_P"AM_:%_P##"Z__ /+.C_B+D_X(\?\
M0V_M"_\ AA=?_P#EG1_9>8_] =?_ , 8<\/YH_?_ %W_ #[,_ISHK^8S_B+D
M_P""/'_0V_M"_P#AA=?_ /EG1_Q%R?\ !'C_ *&W]H7_ ,,+K_\ \LZ/[+S'
M_H#K_P#@##GA_-'[_P"N_P"?9G].=%?S&?\ $7)_P1X_Z&W]H7_PPNO_ /RS
MH_XBY/\ @CQ_T-O[0O\ X877_P#Y9T?V7F/_ $!U_P#P!ASP_FC]_P#7?\^S
M/Z<Z*_F,_P"(N3_@CQ_T-O[0O_AA=?\ _EG1_P 1<G_!'C_H;?VA?_#"Z_\
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M *&W]H7_ ,,+K_\ \LZ/[+S'_H#K_P#@##GA_-'[_P"N_P"?9G].=%?S&?\
M$7)_P1X_Z&W]H7_PPNO_ /RSH_XBY/\ @CQ_T-O[0O\ X877_P#Y9T?V7F/_
M $!U_P#P!ASP_FC]_P#7?\^S/Z<Z*_F,_P"(N3_@CQ_T-O[0O_AA=?\ _EG1
M_P 1<G_!'C_H;?VA?_#"Z_\ _+.C^R\Q_P"@.O\ ^ ,.>'\T?O\ Z[_GV9_3
MG17\QG_$7)_P1X_Z&W]H7_PPNO\ _P LZ/\ B+D_X(\?]#;^T+_X877_ /Y9
MT?V7F/\ T!U__ &'/#^:/W_UW_/LS^G.BOYC/^(N3_@CQ_T-O[0O_AA=?_\
MEG1_Q%R?\$>/^AM_:%_\,+K_ /\ +.C^R\Q_Z Z__@##GA_-'[_Z[_GV9_3G
M17\QG_$7)_P1X_Z&W]H7_P ,+K__ ,LZ/^(N3_@CQ_T-O[0O_AA=?_\ EG1_
M9>8_] =?_P  8<\/YH_?_7?\^S/Z<Z*_F,_XBY/^"/'_ $-O[0O_ (877_\
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M.O\ ^ ,.>'\T?O\ Z[_GV9_3G17\QG_$7)_P1X_Z&W]H7_PPNO\ _P LZ/\
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MX_Z&W]H7_P ,+K__ ,LZ/^(N3_@CQ_T-O[0O_AA=?_\ EG1_9>8_] =?_P
M8<\/YH_?_7?\^S/Z<Z*_G,^$W_!TQ_P2@^-/Q4^&?P<\#^)_CQ/XT^+/Q!\&
M_#/PA#J7P1US3M-E\4>._$6G>%] BU#4)-1>.QLI-5U.U6[O'1UM;<R3LC+&
MPK^C.N>OAL1AG%5Z4Z3DFXJ<;<R6C:[VZE*2ELT_0****P&%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA_96E?\ 0*TS_P %]G_\9H_LK2O^@5IG_@OL_P#XS5^BCV-'_GU2_P#!<?\
M+R7W 4/[*TK_ *!6F?\ @OL__C-']E:5_P! K3/_  7V?_QFK]%'L:/_ #ZI
M?^"X_P"7DON H?V5I7_0*TS_ ,%]G_\ &:/[*TK_ *!6F?\ @OL__C-7Z*/8
MT?\ GU2_\%Q_R\E]P%#^RM*_Z!6F?^"^S_\ C-']E:5_T"M,_P#!?9__ !FK
M]%'L:/\ SZI?^"X_Y>2^X"A_96E?] K3/_!?9_\ QFC^RM*_Z!6F?^"^S_\
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M_P O)?<!0_LK2O\ H%:9_P""^S_^,T?V5I7_ $"M,_\ !?9__&:OT4>QH_\
M/JE_X+C_ )>2^X"A_96E?] K3/\ P7V?_P 9H_LK2O\ H%:9_P""^S_^,U?H
MH]C1_P"?5+_P7'_+R7W >E_LG6EI:_\ !0?_ ()V?9;6UM?,_;._9T\S[-;P
MV_F;?C/X!V[_ "43?MR=N[.W)QC)S_LZU_C(_LJ_\I"/^"=/_9YW[.O_ *N?
MP#7^S=7\J>,,8QXH<8Q48JC2LHI)*^%PC=DK)7;;]3VLO_@O_$_S84445^3'
M<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS;G-TX5$I1YI."BXQ3=ME:[:TWV/];BOXX/^"]7_  7+_:>_9#_:MT#]F/\
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M1QRV^(P)?[;_ (7?MH:5^U9_P36U;]LCX3?;/"5]XF_9P^(_C:PL9)(;K4/
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MN2:DXIY8*<84Z]"6E2TY<MGM&G&+5]KIJ]M[:G\]?_!J7_RDB\6_]FU>,/\
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M&:^&\+)3EG?':<IM2P.*G--M\TUC*R4Y7WDE.:4GJN:6OO._5C/X>$_Q0_\
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M<Z3>Q6WQ%E^+GA"X\0PI=:%-<Z+.JW$R_/I<\MF"2D3G:<?T#_L+?\'+VJ_
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M)(56)P!R>.*_LA_X.0I8X?\ @CQ^U1)-(D4:WOP4W/(P1!GXZ_#@#+,0!DD
M9/6N'CN4X^+?""4IJT^'TDFU93SK%1FDNTTW&2VDFT[ICPMOJ%?_ +?_  I0
M_(_#S_@SY _X3S]O8XY_X1;]G@9[X_M3XO<5_/I\(K/3?B[_ ,%=O!EG\<K&
M6[TWQI^W3-_PG^GW-Y)>RW'D?$;4)[6&>\LT22Y!N].TIG,* /&/)D5H_,S_
M $"?\&>=S;7'CO\ ;X$$\,Q3PM^SOO$4B2;=VJ?%_&[:3C.#C/7!K\U_^"Z?
M_!.WXX_L'?MJ>-/VG? NE>(U^ GQ7^(J_%[X;_%GP]:7US8_"_Q]<:C!JMUX
M-\4:B3??V)J.EZ[#%>^'=0UJX6S\26MU]FB99XY-/KZ?"8S"P\2^.,IJXB&$
MQN<9/E-'+ZTY.$_;4LIPZG3HRT?M;5XXB,(^_+ZNW#6-GC*+>$P]1)RA3J3<
MTM4TZBM?R=G%MZ+FUW/])?QEHVB:WX-\4:!K]AI=_P"'=4\-ZSI>KZ;J]G:7
MFC76D7>FW%M>VFHV-XCV5SITEJ\D=S;7,;6TEN7CE4QDBO\ *Q_X)A:;HFC?
M\%=OV8]'\-7MIJ7AS2OVHI--T#4;"19K&_T6RU;5[;3+RRF2:X26TN+..&6W
MD2>97B96660$,?UP^'O_  <(_P#!3/\ ;H\!^'_V'?@A\#_AAXA^/_Q6T"Y^
M&^O_ !@T&S\2W6J0:!JNDR:+JOCV31H-0D\.>$;^"*62^UKQ#JMM-X9L?,F:
MVTVUD-N8_P ?/^"6FBQ^"O\ @K;^RKX&N]3T^]U'PC^TO#X6O)[29/)NKW0K
M_4],NIK="QD$4L]L[QJPW!&&0*\?@SA3-.%<GXWP^;5<-'$XK*:M2E@\/B88
MB2P]#"YC!8VK&&M*&(E-PH>T4*DE3J\T(N-EIB*\*]3"RIJ3BJL;R<6M7.D^
M5=&U]JS=KJV[/TY_X.O/$GB;4_\ @H7\.=!U22<Z#X5_9WT:/PE;M$\=OY6K
MZ_J.I:O/'R$NY7U1Y(I+@ O&L:VNX!-M?U\?\$1/!?@KP3_P2P_8TM/ MM:Q
M:;KWPFT[Q9J=W;7 NCK'B3Q!=WEWKNKW-PI,<MW>7N_[08UC1&C$8C4H<_F!
M_P '(W_!*'XC?MB>"O!7[6'[.?A^7Q9\9?@7X9U;P]XW^'VGK++KOQ"^%C7,
MVM1GPE91 )J'B[PQJ<MW>)82;[O6M)E;3[!TGM88;C\ /^">G_!PW\?O^"<?
MP!N?V3?%?P-T/XH6/PZU'5+3P!#XNU/5O /BKX<BZG>ZOO"'BW1Y;1;R[L],
MU&:66VLIK;2=:LQ/-;W=PY\OR_)>78CCCPUX>RWAN5&MC\DQ,(9CESKTL/-.
M,<32=6:J3A"TG6AB*<YM1J1J55&3JPE!7SQPN,JSK74*J;A.S:UY-._1IVO:
MROH[G"_\'+WACPKX8_X*J?$NZ\*VUG:W?B?X:?#/Q9XJ6R,/[[Q?-IEU83W5
MU' J^7?7&G:5I$DZRYGF)6=V8S U_0M_P5+\1>)/%W_!M5\&?%'C!YI/%6O_
M  8_9-U;Q#)<Q/!</K%]X9T2XOVFAD)DBD-P\F^-R64Y!.17\T_P#_9H_; _
MX+X?MZ^+?B_KNC7.A^%_B#XML?$?QA^+EIHMY9?#;X;^!-$73M&MO"OA&]N(
MGL=9\0V7A^QLM$T+0K:YNM0O]0#ZOKLD,<FI:BO]=O\ P<0>#/"_PL_X(P^-
M/A]X5M(=%\(>!+WX.^$?#E@9G:*PT30+N+2]+M!-<2/(XAM+6*,/+(\C;<LQ
M))KT\[K4,#F'A5PO5Q%+$YQE&/RIYA[*:J?5;+!T%2G.]X^TG&7)!I2E2H0J
M2C",J7--).<,;62:IU(SY5LGHWIT=NKVO)I;,_*'_@T&T+1I/$W[9_B633+)
M_$%MI_PWT*WUAX$;4(-'F:_OYM-AN""\=I+>@7,L2$"2549]VQ0/BO\ X.O;
M.SMO^"AO@B[MK2UM[J^_9K\*2WUS!;PQ7%[);^)?%T$$EW/&BRW+P0(L,+3M
M(T42K&A5 %K[B_X,_;FWN+K]M?R)X9MLOPSW>5(DFW-K?XW;2<9[9KX>_P"#
MLF\M+?\ X*#_  ]2>Y@A8_LS^&6"RRI&Q7_A*_& R S XSWZ5TX!R?C?F:;D
M[99%)-OX?[,R]V2[7N[;7UW)G_R+H/I[5?\ IR1_9G_P2(T;2M._X)B?L5:;
M96%K;Z?<? #PA=3V:1@VTUQK%K-J.JRR1/N1SJ%]>W=U=!@5EFN)F*X<BO\
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M6;7-/TKQ/$NF:NFEV@GO[C2(Y(K[4C"MG8S132JX_<;_ (-^M)DU_P#X(T_
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M-]H\6MZGX]U":SGUEM;O9=0NVTR?0M0TJ#24$0\F\D:1Z_>C_@Y&T70O'O\
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MS5-.NK/7--UFSN&M+K2KO3)8A=QW\-TC6[6WE&1I0%C#[E)_TH/^":/[,O\
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M-2GBTS2VTZ1+B]MQ!')%(+A#(Z/^[85_HT?\$G_CQ\8OCC_P2<^#?QR^+GQ
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M*/C'_P E3+_KS2_]1,&>UE_\%_XG^;"BBBOR4[@HHHH **** "BBB@ HHHH
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M\-^"_"?A^_>%K=[W1/#FCZ5=M;N59X&N;"SMYFA9E5FB+E&*J2I(&&ZU\/O
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MS%T/PWX=\,6KV/AK0=%\/64DS7$EGH>EV.DVLD[@!IWM[""WA:9@H#2,A=@
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MWN(XIC$[QF6-5<QNR;MK$'B_&6I^&/@=\*_B%XTT3P9&FC^!_"7BOQY=^%?
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MHH<YN7.Y2<[I\[DW*ZM9\U[W5E9WTLK#LMK:=CS7P1\&OA'\-)[NZ^'?PP\
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M_P!N"[\?:'X'U1_%?A7P!^T!K2?#_P <>+;^RN/[*^%G@KP]XP:75/$\^N7
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MT",'_AJ^XX/_ &%_#=?W1?\ !P2&/_!$GXM[3M<:7^ST5;^ZX^(/@,HW_ 6
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M>+/"'B+P/H-]!8^;>Z?\-]%\4OK.OII-S?E=;O-8TNUTZWU;3YX9OS%^)O\
MP5[_ ."F?Q=\,W?@[QK^V9\99/#>HBXCU73/#_B!_"ZZQ:7=O);7&FZK-HBV
ML]]I4L4C%M/ED^S^8$E"[T4C\XB69G=W>2261Y9997>66665S)+--+(S22S2
MR,TDLLC-))(S.[,S$GZ7*N%,]K5L?5XGS3 5<-C,MQ&6++,DP5/!X7V>*I3H
MUL14K3H0K.LZ<YJ,8IQYW&4I.-*%,QG5I)15&G)2C.,^>K)SE>-G%))M6NM=
M4]--[G^FI_P6G_X)6ZA_P5N^"GP8\5? CXK^$?#OQ"^&4FI>*/AU?^(Y+VY^
M&_Q"\->.K#2Q+;:GKFA6FK:EI,(LX(]4TC5]-TC5A*\AM[BT,4JS0]U_P1%_
MX)N67_!,OX%^._A+XP^('A3Q[^T9\0?$FE?$/XW/X*EU&;PUX=4V$^D>!_#^
MCOJUM9:C<V-GH\-TZ:O?:9HMQK,\UQ,-)@CMA+-_GF? ;_@I-^WG^S'X)N/A
MK\"OVJ?B[X!^'\L-[%9^#K'Q-=7N@Z#)J4]S=7][X9LM0:X7P_J-W<W4MQ->
MZ<8I3*(67;Y,87^O/_@T]^)/Q)^+OA+]OCQ[\5_'GC#XE^--5^*_P?BU/QAX
MYUV_\1Z_?B#P%K)BCNM4U"66:3RQ([*FX ;V;;\V:_->*>%.)>&^",PR_$9_
MA,5P]@,5AZN#PE'".GC*_P!9S"DHT\35DK4Z-.K7EBG2C4KMUXQM-4XI+LH5
MZ5;$QFJ4HUI1DI2<KP5H[Q75V7+>T=+W6Q\7_L_?M'^$/V</^#HK]HVZ\?:E
MHF@>$/BYXT\9_"+4?%/B#4HM*T[P[J>N>"/#NJ>%IGNKADM5;6/$^E:7H!:Z
MFA@A34VG:4&,*W[,?\%IO^"&^M?\%0?B?\'?C=\.OC9IWPP\=> /!1^%FOZ5
MXKT:XUGPMJ_@=O$FK>*K+5=);2_+U"S\2:?J>O:HMQ'</<Z?JUB]E C:7-:2
MW%Y_%)_P6B#Q_P#!53]MO.^*6+XQE@06CEBDC\,^'61U(VO'(C@,K*59& 8$
M$ UPFA_\%6O^"D?ASX:ZA\(])_;1^/,7@;4; Z1]BN/&E_>:IIFCFVALSH^A
M:_<,^K:-I;6L MVL[*YCB,4UTO\ R\REOKJG!V<XV?"G%'#>;8;*\RH<-95@
M,0L90E7I5*+P-./M(1Y*T92]E6G"5*<(Q?LZ4H3C/F9S1KPC&O1JTW4A*M.:
MY7RM-3T3=UI>-[W[IIZ(_P!)?]@CX _#S]E3]@FU_9G^'?Q5C^,T7P*T;XD_
M#;QKXXBT]=(2Z^)FA?VF/'>FIHZ378TE=*UR>:S333J&J/:(BQ2:C=2!GK\N
M?^#7[Q!X(O\ ]BW]I'PGX:U/05^*VA_M>_&Z_P#&ME'"K:WIVF^(+R _#N]U
MP!%DN=.N(+#6&TI?-D5(X+V,")G8/_"U\,OV[_VV_@MX+E^&_P (?VMOV@OA
MI\/Y]0UW5I_!O@[XE:]H_A^?5?%%W/?^)-2GL8IV6>^UZ^N;B[U:YE9Y;VXF
MEEF9F8FO//@G^TA\?/V;_B(OQ8^!'Q<\=?"WXAM+/)>^)?"6NWFFW6LI=SM<
MWUIK\,4@MM;L;^:21KZTU"*:.X$DBM@2-GDGX5YE5R_BC"U\\H5\3G>88',:
M&*EAYPYZ^$JXRK46.I0C"$(XEXN4N7#<\:,XQ:C4C!1EHL;%2H25)I4HRA**
M=[*2@ER-ZOEY;>]:Z[']O7[/G_!-K_@L.?\ @H!I/[27[=/[;)'P \%?%N/Q
M-J&@^'?B_P"+X?!WQ"S?6FF^ _#GACX16JV'@SPOH.L:O<:!83V&HP0727<.
MW[-J>HSI>3>:_P#!X1_R2;]A#_LKGQD_]0#P_7\H7QK_ ."E/[?'[1%YX1O/
MB]^U?\8_% \ ^)-!\:>#+"'Q5>Z+I'ASQMX7O)K_ ,.>--.TK27M;-/%6BW<
M[3:?K,D<ES R0[?]3'M\H^./[7/[5'[3=EX<TW]H[]HKXP_'33_!][?ZGX3L
M?BCXUU3Q;:^&]1U2VBLM2OM&BU&1UL;J_LX8;6ZFBPTT$:1MPHKU<MX&SVGQ
M%P_G^9YADB63T,1AG@,IR^>"H1HSPM?#TO8VBE4J.5=SK3J1I*,81ITH<L5?
M.6(INC4I0A5_>24N:I-3E=2BW?5V5EHE?JV[L_T,?^#=SXA^'?CC_P $@OAY
M\/\ 1)_[-U?X=CXE?!/Q-'<2VUS<VFJQ75\\&MFQAF\Z+3M1M-;AN].2Y\E[
MJ.";:<*2/YFO@-\ OB__ ,&]'_!5W]EW5OVG_&'AG5/@_P#$ZP\5^&[SX@?#
M>]DN]%UWX=^)9M1\&"X\4Z9X@M]%U+0+KP?K<_A7QMXFM$6ZL;.T, TG5]=:
MWN81^$O[/W[4?[1G[*?BVX\<?LX?&GXA?!SQ)?V]O9:Q=>"?$-]I=GXATVUN
MTOX=)\1:6DIT_6M+^V1QW$EE>V[QR21IO)4 5M_M,?MA?M,_MC^(?#WBG]IK
MXP>*?BYK/A+29]#\,R^(YXFM="TV[N?M=[#IUE D=M;R7]P(I+^=4\VZ-O;"
M4D0)C?!\"YA@\ZXG:Q^#J\-<61QDLRP<J-19C3J8BGBO9?5ZK4Z2="MBZDE4
M<[2A9NC&I&#BI8F,J=!<LU6P_(H3NN1J+A>ZO?WE!:<N_6Q_H*?\%A_^"=7[
M8/[=%U\)/CW_ ,$_?VP_$WPVUK2_"B>%=<\#:7\9O&G@CX4^.O"EQ?ZEK^F^
M.=%U;P)<7EH_BN&>]_LN66>TFL]6TG[ HO+-K&1Y_BKPU_P1K^('P#_9*\5_
M&[_@HW_P5:_;%\$>*_"FC:UXA\8?\*D_:1\4VWPYT#1X89?L/AJWN?&"2:EX
MM\0:HH6Q00#3(KV_NDLK.VN$/G/_ !_? #_@HQ^W7^RWHMMX7^ _[4_Q@\ ^
M#;.*_BLO ]IXKOM0\%6;:E<F\O+JT\-:E)<Z=;WKW32S1W<4:R0-/<>5L$S@
M\I^TE^V]^UQ^V!/I+_M*_M ?$CXM66@-YF@^'_$6OW7_  BVC7+6ZVL][IWA
MNV>'2H+^\@5%OKLV[RW11'D.]0U>;@> ^+<%1PF3PXARFEDN$K\\,90RFD\[
MGAE4E-8:4JU*='7F:YI5IN&BYJM."I2N6)H2E*HZ,W4DK.+J/V5[15TDT^G\
MJO;HVF?U\?\ !HK=:5?:)_P4?OM!?6Y=!OOC#\&[S0I?$\D4OB:;1+K0_B;/
MI,OB6:W+6\OB*33Y+9]<E@9H)-4:Z>%FC92?YQ_^"[L0E_X*Q_MH1." _C;P
M^C ?*V&\"^&QP>Q]#7PY\#OVM?VI?V8[;Q+9_LX_M#_%_P"!5IXSNM-O?%UM
M\+?&FJ>$H/$UYHT%U;:1=:W'ITB+?SZ9;7MY!922Y:"*ZG1.)#7NG[*/[/?[
M0'_!5O\ ;5\.?"K5/B?KFO\ Q6^+TNKZWX\^-OQ%&I>.+W1]'\+^'I[JY\4^
M+G6^L=2U:*..PTWP]9(+Z!Y+[4-+M/.C1MR_0X;AZ61<6\1\:XW,,-#+,5E4
M*<H.-;V^%AA*&7^UKUI*#C**C@*DE&ES3?/!1BY71C*K[2A2P\82<HS>NEI.
M4I625^O.EK9:.^A_H8?L.:YX"_X*K?\ !/#]A3XM_$#5(;_5_AAXT^&7Q#\8
M6&@Z?-:Z3<?&C]GX:MX8U;PY>6VM+<71T>/7F>]EEM[B5KAH;62VO9K:0M)_
M+[_P=:_M2/\ $G]KWX6?LQ:)J$TGAO\ 9]\ GQ/XEM8S$]A<_$#XD2*]NQ8%
MIAJ&@^&M+%K+&1$B1ZX<^<S9A_IA_8M_9Z^$/_!!7]@+QQ#\?_VE1XLT#1=8
M\2_$WQ+XA\02_P#",^&CX@N[*-(O!WPE\&7>H:K?6LNN/96S+I-K<ZGJ.K:_
M>W>I7'R/(\?^;K^U3\?=>_:H_:3^.'[1OB6"6TU;XR?$;Q!XT^P32/)+I>E7
M<R6?AS2I2[N%GTWPY9:39721D0K=PS^2JQ%17Y[X<91A\=QCG.<8&56OP[D]
M?,8Y%5G1G2HNOF576-&-2%.3='"NJIMP4XJ5"4HP<H(Z\5-QP].G/W:U10=5
M)W=H);M-[R2ZZI,\#HHHK^@CS HHHH **** "BBB@ HHHH **** "BBB@#U+
M]E7_ )2$?\$Z?^SSOV=?_5S^ :_V;J_QD?V5?^4A'_!.G_L\[]G7_P!7/X!K
M_9NK^4?&/_DJ9?\ 7FE_ZB8,]K+_ ."_\3_-A1117Y*=P4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?CG_ ,%:O^"Q7P>_
MX);>$/#&GZIX8O?BK\=_B7I>LW_PZ^%^E:C:Z;;V^GZ<?L2^+_'&IR&2XTCP
MLNKR+;6R06QO-?>PUBRTV>WN+*25/YV?@]_P=V?&67XJ^'E^/O[+_P )-.^!
M=QKT&D^+=6^&.M>-I/'_ (?L]0>-+:_M3XCU6[\.ZC>:?%(U_<Z*T%O=ZM;Q
M&#3Y;:1UF'VF3^'W%>>Y<\UR[+'4P;51T9U*]"A4Q7LFXR^K4JM2-2LN>+IQ
MDHJ,YIPA)M-+FJ8NA2GR3G:6E[)M1O:W,TK+=.V]M;6/N+]HK_@Z&/P#_:[^
M)G[+'_#%-QXI'P[^-EM\'O\ A.!\>+;2%U;[1K.D:1_PD \/M\+=0>R"?VK]
MH_LTZM<LP@\O[8#)O3^M"O\ (N_;&^)7@;XS?\%+/B_\6OAEK\'BGX>?$?\
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M>_:=U'5-:UB_>*.65;33]/M9[J=HXI'$<;;48X%?NK\=O^#NKXKP_%#7[?\
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MXE^'?C:TMK:XUCP=XCA0",WED+J"XL[^W!L]6TRYM-1MO+$\EO!_FT_MR_\
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M)$&Y?ZN/^";G_!3;]GS_ (*:_"/4/B-\&VU7PWXH\)7=CI'Q,^%7BM[4>+/
MNLWME'=0[WM6\C6_#MZ_VJWT?Q-9Q06NIR6%X/LUJ\8C/JY]P'Q/PYA5C<SP
M"C@^:,)XK#8BABJ5*<WRPA6="I.5)RE:*E.*@Y-04N=J+SI8JC6ERPG[UK\L
MDXMI6;M=:V35TM5VT9^C-%%%?'G0%%5-0U"PTFPO=5U6]M-,TS3;2YO]1U'4
M+F&SL-/L+.%[B[O;V\N7CM[6TM;>.2>YN9Y(X8(8WEE=45F'\=7[:W_!V/X/
M^'_C;6O W[%/P2T7XP:;H.H)8#XO?%/6=7T7P1XFN (H;J#PUX6T(Z?XF>"W
MU 7%I;:G=Z@L6J*()K:SC5\'W\@X8SOB?$5,/DV"GBI45&5>JYTZ.'H1FVH>
MUKU90IQE-J7)!-U)J,G&#4)-95:U.BDZDK7T2LVW:U[))O2ZN]E?5G]D%%?Q
M"_L^?\'</C6V\<V^@_MB_LG^'O#WA2YUC3;34_$/P6U;Q/;ZYX(T>Z5#=ZUK
M/A#Q[-?7_B VRDW4>G:9<Z5//:'?'*[)B3^S;X:_%?X>_%WX8^$OC'\/?%6D
M>)/AKXW\,67C'PYXLLKR!M)O/#]]:"\2^>Z\SR;<6T8DCOTF=6L;B"XM[D1R
MP2JNW$'".?\ #$J"SC NA3Q+:P^(I5:6(P]:48J4H1JT9SBJB4D_9SY)M7E&
M+C[PJ6(I5[^SE=K>+34EK:]G;3S6ST>NAZ)17\A/[='_  =5^!/A1\0O%/PG
M_8N^"=G\<]3\+ZQ-X<?XK>/=7O\ 2_AQK?B&QUA],O;'PIX?\./'XG\2:9-Y
M)&D:_;ZC:PZK-=6ZV]@41C-\T_!G_@[<^+FA^-8-,_:V_8W\.Z7X4N9+5+B;
MX/ZGXNT3Q?H=E//;B?6)?#_Q(FN_[>AMK;[7+%IED^FSW\H@AAO8CO)]NAX7
M\:XC!1QL,HY8U(>UIX>KBL)1QDX-1DFL-4K1J1;4DU"?)4Z.";2>;QN'4N7G
MOYJ,G'[TK/Y7_,_N,HKQ7]G;]H3X3_M5?!CP#\??@CXHM_%WPT^)&A6VO>'-
M7B7R+E(IAMN--U:P9FGTO6M+N5ELM5TNYVW%E>0R1." KM_*7J/_  <^?$;P
MK^W#XN_9P^(/P.^$/@[X.?#[]H_QW\*O&GQ7N]=\7W.K:/\ #GX?>/-9\/:W
MXP_LR*^%M/K1T#1IM0@L8H9(9-1=(([>5"L3>%E'">>YY6S+#Y?@G/$933E4
MQU"K.%"M1Y93A*'LJKC4G54Z<X.E",JG,N7ENTC2I7I4E!SE93:46M4[VUNM
M$M4[O2Q_8]17\)GQJ_X.]?BJOQ5UW3?V<OV:/A%J7PGT[5KVST2_^*_B+Q</
M'_B+2;34IH[?7'TWPMJUCIVA?VGI:PW$>E7<-Y<6%Q+MN+F9!BOZ!/\ @D!_
MP6<^&'_!4;PQXH\,WWA9?A+^T;\-K"SU/QS\-#J!U+1M9\/7TS6EIXU\":G,
M%N+S0YKV.2TOM+O3)JNAW CCNY;F*9+BO2S?P]XLR/+?[6S'+'2P<8TY5I4\
M10K5<-&JU&$L11I5)5*4>:482DXN,)R49N+9%/%T*L^2$[RUM>,DG;LVE?>Z
M[K57/M#]KS_@H_\ L7?L':CX$TG]K#XV:=\)-0^)EGX@O_!%O?>%?'GB0Z[:
M>%IM)M]>FB?P;X7\11V@T^;7-*1UU![5YOM:FW698YC'['^S5^T_\"_VO_A3
MI/QN_9T\>6WQ(^%^N:AJVEZ5XJM-'\0Z'!=W^A7LFG:K;KI_BC2=$U>,VEY%
M)"SS:?''(5WPO)&5<_YMO_!<'_@H]\0/V]_VAK7P9XW^%OA[X<VG[)?Q%_:&
M^$_A?4-#NM;N)_&FEGX@66@?VSJJZN[0P7(@\!65P$TX+;^;J-R#E%@"_I!_
MP;_?\%AOB+\+_$?[+O\ P36M/@IX6UGX=>+_ (F^+]-U;XIG5=<B\3Z;=>+(
M=>\5Q,EK&[:#&MG?1V=N8;F,2SV3RE"LTL$@^PQWA1B,-P=ALXHK$SSV,*F+
MS+"3QF!>!HY?".+K>UH6I1G.K]7IX6?(L54DYU:D>1-<L,(XY/$.F[>R;482
MY9<[F^1)/5JW,Y:\JLDOG_?=17\W_P#P6K_X+>?%7_@EM\;O@S\*O 'P1\ _
M%+3OB=\*-<^(FH:IXMUKQ!IE[IE[I/BY_#D>G6<6CW,,,MM- GVAY)D:42G:
MIV<5^:G[27_!V5XN^'_@OX-Z?\$_@=\'O&?Q7U3X?:3XN^.=_P"*_$7BV'X<
M>$O%6KQ:E)+\-?!]II=_9>(+W6?#T4.EW>LZW?:I>:7+'J/V6UA6XC=D^2RS
MPZXLS?"9=CL!E\*V%S-598:K]:P\$H4G.,YUU*HI4(\\'"+J).<Y144^8WJ8
MNA2E.,YM2@TFN5O5I-6TUT:;MMKV/[:Z*_./PW_P40^'/@?_ ()P_#?_ (*"
M?M27VC?#GPUK_P '_!?Q%\6Z;X4CO=4C;7O%]M:"S\)^!-+O[I]7U_4]1U&[
MCL]&TXW$EW,N^XN9HK2WNKJ'^7WXI_\ !VU\>O$7C.YLOV7/V+O!]UX2MQ(8
M8/BEJWC;Q3XSO;>-O+34WL?AO)I]KI=O<MB06EQ#<RVHD6WENI9E9CRY/P-Q
M-GM7&4\NP"J0P&)JX3%8FKB*&'PL,31ERU*,:]:I"-6<=')4N?EC*$I\JG!R
MJIB:-)1<Y6<DI))-RL]FTEHO6W7LS^YZOE+]N#]IS_AC;]E7XS?M,?\ "&-\
M0O\ A4GA8^)?^$-775\--KV+ZSLOL8UQ]+UI=.S]K\SSSIEX/W>WROFW#^=_
M_@GS_P '27PQ_: ^(W@WX*_M=?"&W^ GB[QIJ-CX<T;XG^#];FUCX3R^+M0O
MQ8VVCZY8:[(/$7@VP9SY?]MZEJ.I0+?,EC/;VY9ID_7+_@MXRO\ \$J_VR'1
ME='^%A9'4AE96US1RK*P)#*P((()!!!!Q3EPIF>3<1Y-E/$.7SH0QV8X&DX^
MTC.CBL-5QE&C6]CB<-4<9)QFXR=.I&K2<ES*$FA*O"I1J5*4T^6$GMK&2BVK
MQ:^>JL_-'RM_P2,_X+G'_@J;\7?B1\*S^S+-\$/^%?>!++QK_;DGQ7@\?C5O
MMFK1Z7_9HT^+P)X4-F8_,\_[4;NY#8\OR%SO'R;^T-_P<W'X#?MO_$C]C?\
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M(R".00>A![@T +17Z'?\$O\ ]@F3_@I)^U/9_LT1?$Y/A+Y_@3Q1XZN/%O\
MPCR>*IXK;PT;&/[#;Z*^I:4DTEW-?QCS9+V)(DC<_,V%KTW_ (*[?\$R(O\
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M:>)_$NKW$"1)'XGN_&>I2^+-1TZVC"6<*16<UA8VD;M!:&2:0S/_ .#O\?$
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M:LZ_U>,G6=&?[V+M!WC%)+WK.3T2:BM5>^ES^>S_ (-:OV4OA;\>/VQOB?\
M%/XG>']&\7Q_LZ?#K2-8\#^&M>TJ#4]+MO''C#6OL.G^,A%<![?^T/#FF:1J
M]MI\4\,L0GUHWRA;FQ@=?VL_X.D_V2?@YK?[$&D_M,:7X,\.>'_B[\(OB-X,
M\/Z?XITG2K?3K[5/!'B^_NK/7?#.I/80Q"]MUN!;ZCIINPXLKN.1HW19G5OY
MH?\ @CK^WNW_  2+_;4^(L/[2/@3QQIGA+Q%X;U;X3_&3PE:Z>]MXT\"^*=!
MUBWO]'UV;P]J#6KZB^D7UEJ&DW>G-+;2M8ZW/J%K-+):1VMU^@O_  7P_P""
MXW[//[='P"\&_LQ_LL-XPU?PG>>,M$^(GQ-\=>(]'NO"-FI\+^?)H/A+3M+O
M\:GJ,LE_<R7>K3S1V^G"*&V2![R0NB?;YQD_%&*\4\GS;!T\95R6*R^I#&T9
MMX*C@(TO]NHSG&7LU[>3KM4Y:UU7IN*DI1MSTZE!8*<&XJI[RY7\3E=<LE?7
MW5:[V5FF?9/_  :'?%[Q!?\ @;]KKX%ZA/=7?AWPUXI\&?$3PRLMT[VVC2:_
MI]SIFOV-M:N[+&-3O8;749)(EC0R1L'5F(:OYGO&/PV\.?&;_@LAXR^#_C%)
MY/"/Q5_X*:>+/AWXH2U<1W3^'O&'[3&IZ%JZVTAP$G:QO9Q$Y/RN0>U?V%?\
M&N?[#WQ+_9Q_9A^)O[07Q<T'4O".O?M.>(- U/P/X3US3O[/UW3_ (:>%]/F
MM](U_489D^V6\?C.YO&U?3;.X-O-#I\$$T]K_I,$K?R:^%_^4\FC_P#:6]O_
M %K&XKHR3%X:KQKXF8K+:L7&&5X7]_0DG'ZWA\,X8B<)+1RAB:<TY1TE4C*2
M<K\SFK%K#X-26\I:-?8E.-DT^CB]GLG;38_OS_;Q_P""=W['_BK_ ()]?'OX
M3:9\"/AAX*T#P1\%O&7B?P/?^%O ^@6.M^$=;^'WAG5?$F@:CI.K1VL6J&\B
MN-/:WEGN;^9[B"[N1<M,7.?XG/\ @U\UC4A_P5<^%L4-W/;VVO? 7XUR:M:0
MR%;>^^S>&M(O;5+A/^6JVMT[30!ON2'=UK_0^_:^_P"33/VH?^S=OC9_ZK7Q
M-7^==_P:]_\ *5_X+?\ 9 ?CA_ZA^BU\9P-B\5B?#_Q%AB<16Q$88.M5@J]2
M57EJ5LOQ;JS3FY/FJ.E2E)WUE",M)7;Z<5&,<5@W%)7DD[*UTJE.RT[7=O4_
M2G_@[N\-^'/#_P 2?V&I= \/Z%H<NK>%_P!H:]U:;1](T_3)]4O&UOX42&YU
M*:RMH);^?S)IY!+=O,ZR7%PZD//,7_8W_@VC\$^"[S_@EQ\(?$]UX/\ "MQX
MEB^(?Q7D3Q%-X=T>37A+!XRU"*"4ZPUD=1:6"$"&&5KDR10*D,;+$BH/R^_X
M._\ P#XHN&_8A^*D6FS/X)T)OC'X U36%BE:VM/%'BL>"-?T+3IIPA@BEO\
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M4U1P="I&%.4W.<>:<;V7-4OLTV[*RN]%T/W1_P""+/\ P1]_9;^,/ASXL_\
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M$L1ZG\0?'EH&"^*=&O-2CGBTK0M3F&@75I:7<FNZ7>)Y:-^H_P */^"A'_!
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M7Q-^!.H7<OEV]E\4_@Y?WEPY+&.WM/'7A>ZNKB1B2S;(HY)78DDX+,<DFO\
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ME3<93C3<,\/:&'KXA1C.I"48QYE=03Y+RL[:^\VW?:-M+N_VCH?[,W_!(O\
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M7_!%?_@HE\"/$O[-N@?M;>+?#^F>!OVB?VEOA;^SKX<U"Q^/6L?%J]TKQ?\
M$G4+FSM-<7PGJT,4*VVDZ;;:G-<:JFXVTDEM9/A=1&?Z6/VJ/V<_^"*W_!!O
MX _";Q]\0/V.](^/GQ6U/7[O2OAIK/B;P_I?BSXE^//&FE06>H>([^_\:>*E
MD\.>#].L;/4I+ZUM;B.+3[>%X=(TVVF6)6AG-<30J91PMP]+B3.>*\3B,3C(
M4H\-.C0GG5"A*"CA\PQU7&5?91PD%4I.JJM6\'*OB*5Z"J-P34ZU;V-*A%*-
M_;7:I.2WA#E5W)ZVLOY4];'T%\)O@+_P25_X+M?LC^*/B=\-?V8]#^&EY+KF
MI>"!XUM?AMH'PP^*_@WQMX1M@-,E@\2^#=O_  DGABVFO(95TR;4[G3-3M%E
MM=2TJSE**O\ /7_P;H?LC_!_QA_P4F_;*_9^_:-^&GPN^/NE_!3X0?$+PS#:
M_$'P/HGB[PP_B_P#^T#X5\!7?B[1-$\3V>J0:9<W]O;ZBMM.JF]@T[4)+-KA
MDDE#_P!='_!(G]N3P-^WU^SAKGQ@^%G[-T_[-'PRTOQ[JWA+PKX6?_A'FM=?
MDTR*%]9\06,OA;3]-T2>WDOI?L[36L4K/-')YUQ*XX_G!_X-W_\ E-K_ ,%1
MO^P+^TC_ .MC:/7SF78[-<'D_B;E4JF8X&CEN%P=3"8#$YC]>Q&5U)XQ4YTH
M8VDTN;D485'1<8MQ2E>47)ZRC"53!3M"3GS<THPY8SM%--Q?G>U]KGZS?M)Z
M/_P0C_X)=_'36_B%\??AI\!?"WQ:^*FB>'=6\!_#'0_@SI.OR>%/!GANQ?PX
M^I^#O!6G:1)X6\,7&NZTVO7FM^)-FCZOKYD^P/-=VFF0QC\B/^";7_!*3]FG
M_@IW^VC^VK^W!X[M)]8_8HTS]I/Q/_PH#P/X?BN?!7AKXH 36NL27>IQ6B6.
MI6'@GPPAM=.N?#UJ=(:]U$7=E>M<:5YL,OQK_P '5'/_  4Q\.$Y)'[.'@-0
M22=J_P!N>)&VKGHNYF;:,#<S-C+$G^BC_@V#\1:!JW_!)^W\.Z*MMK/B+PG\
M8/CE:>*-!%U$)'U'6M=FUS1K&Z)S]B35="O=-$?GC!CD-S@Q2"NW$T\?P[X?
M8;BC!9QF]?-\_P -EF78G$5\5[2&!P=5SK+ZE>*GAYQAA:>&5:55R_?U)J4:
MDH2C,7"MBW0E3IJG2E.:2C9SDN7X];-7FW:UM%TN>&:;_P %7?\ @WTTKX]:
MI^QGI/[,_P --+\)77C?6?ACJWQ 3]FSX9:7\#K_ ,7RZ@FA:E \KI%J<^AW
MVJ0OH]SKU[H%LDM_:.KVSV8AOI/Q[_X.*?\ @D1\*OV&-0^'?[37[,?AR3P?
M\#_BMXLO? _C?P0=8FOM*\$_$W4;74/$6@CPG;ZC-<:E;:#XITS3?$4HTJ.Y
MDTW0)=#-M816EC<VEK#]F>+O^#A3]B_P7\4M=^$.N_\ !'B^3XEZ%XZU/P*_
MAEX/A(OB;5/%6F^(;K0HX]+T>Y\(#6;^XU75+1IM*DBMYI;X21W,$DP;SCQW
M_!<K_@H?^TW^T5^Q*?@]\3O^"7O[0_[)7A<_$KP+KUU\4OC5K7A"_P##ME#I
M5OK<6GZ)H46A2FZ/B359Y1';Y:0+I5MJC/& #(O?D. S_)>)>'ZN$P&:99@,
M>_8YM2SKB?*\PAFE*<8+ZYAZ$*]*I.K2=3VJC0I5Y<[I1A:,Y1J34E2J4:JE
M.%2<?>@Z=&<'#9\KE:UG:VK2:NWMI_'%1117[\>:%%%% !1110!ZE^RK_P I
M"/\ @G3_ -GG?LZ_^KG\ U_LW5_C(_LJ_P#*0C_@G3_V>=^SK_ZN?P#7^S=7
M\H^,?_)4R_Z\TO\ U$P9[67_ ,%_XG^;"BBBOR4[@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH \/_:&_9L^!O[5WPRUGX/?M
M"?#;PW\4/A[K@9[C0O$5H9&LKX6]Q:P:SH>I6[P:IX?UZRANK@:?KNBWECJM
MB99#;7<6]L_EO\'O^#>3_@E9\&/'>C?$/1O@'J'BO7?#FHV6K>'[7XA^/O&'
MC#0--U'3[H7=I=OX>U'5?['U:2":.W>,:Y::E'&]M%+'&LV^1_VXHKU<%GN=
M9=AJV#P&;9C@L+7;=;#X7&8BA1J.2Y9.5.G4C'FE%*,G:\HI*3:5C.5*G-J4
MZ<)26SE%-K6^[7=7/R1^+O\ P0U_X)F?'3XX^+?VC?B=^S_?^(?B_P".?&FG
M?$'Q+XH3XL?%W2H[_P 5Z2-)%AJ*:)I'CBQT*SCMUT33%6QL].@L&6VVO;,)
M)0_ZV.B2(\<B+)'(K))&ZAT='!5D=6!5E920RD$$$@@@TZBL,7F>98^GA:6.
MS#&XRE@J?LL'3Q6*K8B&%I<M.'L\/&K.:HPY:5*/)348\M."M:,;.-.$')PA
M&+D[R<8J+D^[LE=ZO?N^[/Q'_:&_X-ZO^"7W[0WBN_\ '-]\$;OX8>*M7OY-
M0UF]^$'B?5_!6DZG+-O:?S/"5O-<^$K)YIW:YFGTG1-/N)IF=II9 V!]#_L:
M_P#!(3]@7]A'Q!/XV^ GP0TZV^(LR/%%\2/&NIZEXZ\::7#+"UO<6_AO5O$=
MQ>CPK!>0-Y5^GAR#2VU!%47SW&T5^F-%=];B?B+$8+^SJ^>9K6P+A[.6%J8[
M$3I2IJUJ<XRJ/GII))4Y\T$DDHI$JC14N=4J:E>_,H13OW3MH]-]PK\DOVHO
M^"'7_!-?]KCQUJ7Q/^)_P M-)^(FN7LNH>(?%GPX\1>(/A]>>)+ZYDDEO;_Q
M#IWAN_L]#U?4[^:3SKW6+S2Y-7N)4#O?DO,)?UMHK@R_,\QRJL\3EF.Q> KN
M/(ZN#Q%7#SE!M-PE*E*+E!M)N,KQ;2=BYPA-6G&,U>]I)-7[Z]3\S[;_ ((^
M_P#!.^Q_9IU[]DC3?V=]&TGX'^+-=\-^)O%VA:/XD\8Z1X@\6^(/"*&/P_J_
MB7QSINOVOC/6;O3T9UC:]UR6,B216C*NP/KG[&/_  3U_9,_X)^Z)X^\._LI
M?#2X^&^D_$[6]'\1>-+:X\9^-O&)U;5]!TV72-+N5G\:>(-?GL!;6$TD)AT^
M2V@F+>9-')(%<?:E%;5L[SG$8?$87$9MF5?"XNLL1BL/6QN)J4,373IM5J]*
M=24*M5.C2M4G&4E[.G9^Y&R5.FFI*G!2BG&+48IQ3W2:6B\EW?=GY*6'_!#C
M_@F=IO[0-O\ M0V?[/\ >Q_&RU^,!^/$'BUOBK\6Y85^*)\7/XY/B%O#\OC9
M_#KQGQ.[:@='?2VT8J?L9L/L7^CUR?[0O_! O_@F'^TI\1M?^+'C7X#W/A[Q
MSXLU.]UGQ5J7P[\:>*?!5AX@U;4',UWJ5]X?TK4E\/Q7]Q=-)=W%W8:993W5
MQ+*]V\^5"?LO175#BGB6G6IUX9_G$:U*BL-3J?VEBW.&'34E0BW5=J*DE)4U
M[BDDTKI,ET*+33I4[-\S7)'67?;?SW/FO]EG]D']G/\ 8M^&EG\)?V:_A=X?
M^&?@Z!HI[Y-,CFN]<\1ZA%%Y(UCQ;XFU&6[U[Q1K!BQ%_:6MZA>W*0A8(GC@
M1(U^?OVP_P#@E)^PM^WIXU\._$/]J3X/7?Q$\6^%/#TOA70M3M_B%\1O"*V>
MAS7CW\EFUEX.\5:%8W!:ZD>3[1<V\MP =@EV */T5HKAHYMFF'QL\RH9ECJ.
M8U'-SQ]+%UX8R;J*U1RQ,:BK2<UI.\WS+1W13IP<5!PBX*UHN*Y59W5HVMH_
M(\G^!GP1^&O[-_PF\$?!#X/Z!)X7^&OPZT=-!\(Z!+JNKZY)IFEI/-<+;MJN
MNWVI:O>D37$K^=?7UQ,=VTR%0H'PW^V1_P $=_\ @G_^W3XF3Q[\=/@?8-\2
M0NRZ^(_@35-2\!^,-918$MH5\47_ (<GLX/%GV2&-([&7Q):ZG<6**([2:&,
MLC?IY11A<US/!8R6883,,;AL=.4YU,91Q-:GB:DJLN:JZE:,U.I[23YJG/*7
M/+65V$H0E%0E",HJUHM)Q5MK+96Z6V/Q'_9]_P"#>K_@E[^SYXGTWQM8?!"]
M^)?BO1=4M]5T;4?BUXKUOQCIVG3VCI+;*OA66XM?"=ZL,Z"8/JFB7TI;"%_*
M!0_MA:6EK86MM8V-M;V=E9V\-K9V=K#';VMK:V\:PV]M;6\*I%!!!$B10PQ(
ML<<:JB*JJ +%%/,LWS7.*L:V:9CC,PJ03C3EB\15K^SB[7C34Y.-.+LKJ"BF
MU=JX0IPIJT(1CWY4E?U:U?S"BBBO.+/SN_;$_P""5'[#/[>OC+PUX_\ VI/@
M_=_$7Q7X1\/S>%] U*W^(/Q%\(K9:)/>-?RVC6?@[Q5H-E<EKIVD^T75O-<#
M.P2A %K@?C'_ ,$7?^"=/QS^#/PG^!GCKX#02>$O@9HA\-?"G5]*\5>*]/\
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M\??$>XT#3/#$VO0?$OXG^%4;1=(B:'3[3^R_"7C#1-*!@C9@9ULA<2YS+*Y
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M>UZ[LHTTC2;*W:VM;BWLQY!G:'SGDD;^+#]@?X>V'[??_!R3\;OCKI'V2_\
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MMM(NH'CFLI[+PQ?31^$1=V%Q$MU9:C/H4^HVUP%DBND*+C]H0         ,
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M;?\ !UM^SCX,\;>(M-@_9!^)_@7X Z5X:T/2?A7X!^&UO\*[34K35FNKN_\
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M_A_5M3T#7]$U"TU;1-=T6]GT[5]&U73YTN;#4],O[9DGM+VSN(XYH)XV!5U
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M32E)SLYMR;G7JU)0E.5W3:<$DE&+33TBM-XIZWVML?NO_P %Q?\ @JY\'_\
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M>>!_^AS\*?\ A1:1_P#)E'_">>!_^AS\*?\ A1:1_P#)E?AU_P 0PW_!#O\
MZ,BL?_#Z?M*?_/AH_P"(8;_@AW_T9%8_^'T_:4_^?#0!^XO_  GG@?\ Z'/P
MI_X46D?_ "91_P )YX'_ .AS\*?^%%I'_P F5^'7_$,-_P $._\ HR*Q_P##
MZ?M*?_/AH_XAAO\ @AW_ -&16/\ X?3]I3_Y\- '[B_\)YX'_P"AS\*?^%%I
M'_R91_PGG@?_ *'/PI_X46D?_)E?AU_Q##?\$._^C(K'_P /I^TI_P#/AH_X
MAAO^"'?_ $9%8_\ A]/VE/\ Y\- '[B_\)YX'_Z'/PI_X46D?_)E'_">>!_^
MAS\*?^%%I'_R97X=?\0PW_!#O_HR*Q_\/I^TI_\ /AH_XAAO^"'?_1D5C_X?
M3]I3_P"?#0!^XO\ PGG@?_H<_"G_ (46D?\ R91_PGG@?_H<_"G_ (46D?\
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M%_X3SP/_ -#GX4_\*+2/_DRC_A// _\ T.?A3_PHM(_^3*_#K_B&&_X(=_\
M1D5C_P"'T_:4_P#GPT?\0PW_  0[_P"C(K'_ ,/I^TI_\^&@#]Q?^$\\#_\
M0Y^%/_"BTC_Y,K8TS6M&UI)9='U;3-6CA8)-)IE_:WZ1.PW*DKVLLJQLR\A6
M()'(&*_"+_B&&_X(=_\ 1D5C_P"'T_:4_P#GPU\T_P#!#S]GSX2?LC_\%0/^
M"ZW[,/[/?ABX\ ? GX5>+/V#SX ^'P\1^)_$UAX<E\6_ GQ?XF\2SVVH^+=8
MUW6[BXU?7+^YN[FXOM2NI_+%K9K*+.QLX(0#^H:BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O\M__ (.8_P#E.=\7
M/^R#_ [_ -5[;5_J05_EO_\ !S'_ ,ISOBY_V0?X'?\ JO;:OO?#/_DL<H_Z
M_P!/_P!/T3EQG\"7]?99^+]%%%?V6>"%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >
MI?LJ_P#*0C_@G3_V>=^SK_ZN?P#7^S=7^,C^RK_RD(_X)T_]GG?LZ_\ JY_
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M^HW&E:_>7MU?ZA=6=QH'C3PEJNDVNM:AJ6KZ'=?VOILNK7]H;1;;^B/]J_\
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M-LI1?* ']D<-A8VUU>7MO96D%[J+0-J%W#;0Q75^UK"+>U:\N$19;IK: ""
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MVG0FXU#5]8OK73-,L+<,JF>]O[V6"UM80S*IEGEC0,R@MDBOY(/^"87_  0
M_9 _:5_9/_9X_:[_ &\8?'/[3?[1GQ<^$_PXU^2^\5^-]2M_!OPZ\(:%I]I;
M_#SP!X#\.Z*]I96&B>'?#ECIUK.LCR175Q->[;2W,LIE_2/_ (*]?\$K?C%_
MP4V\5?L_^'M2_;+UWX$_L<> M9FU']H3X+^&;.XT34OBCITLZWEQ>MXQM;Z*
MVGO4&FZ1HFC67B2VDT3PU;ZAX@UZVBO]4N+>T(!^G7A;]LO]D7QQXPM?A_X-
M_:?^ 'BKQQ?7AT_3_"?A_P"+O@+5]?U+4%E2'[!INF6.O3W6HWQED5$L[*.>
MX=MVR-MC[?H;4]4TS1-.OM8UG4;'2-)TRUFOM2U34[NWL-.T^RMHVEN+R^O;
MJ2*VM+6")6DFN)Y8XHHU9W=5!-?QO_\ !1[_ ((L_P#!"?X#_L6?$BX^'/BO
MP-^S?\??A3\/_%7Q"^#WQ1T#X[++\5]7\;^!])N=1TC2M2@O?$SR>(TUK4(X
M=&:&&SLKR"]O8;ZPGCOK&+'UE_P3R_:5\??M7_\ !M3X@^(7Q6U?6/%7C?1/
MV8?CW\,=?\4>);\ZOK/BL> -)\0Z%8:SJM[-NEN[F?2X[*UEENC)<S"U$MS)
M+-(\C@']"6N?M)?L[^&?!>D?$?Q#\>?@UHGP^\0O?Q>'_'&J_$[P58^$M?FT
ML3'4H-"\0W.MQZ3K%Q8?9YQ=V^FW=U- T,JR1JR,!N_"[XU?![XWZ-=>(?@W
M\4_A[\5=#L+E;*_U7X>>,?#_ (PL=/O&#LEGJ%QH&H7\=C=.B/)';W9AFDB'
MFHC1D,?XC_\ @WF_X(Z_LZ?M^?L!?"K]H?\ ;PM?$'QSTCPGK7C3X7_L]_!F
M?Q1J^B?"?X<_#SP_XKN-?UC6[GPQH5Y:1ZK\0/&GC;7?$KZ]K]W)%=-X?MM'
MTXK(%,PEU[]D[0/^"%/_  7W_83T#]C'QEXQT7]F7]OJ'7/"GQ+^ >KZ[?:O
MINF7$M[J>FWL=G<7I%M=Z/I^K'PKX@\)SWBSZ_H36.M:(MZ^EWD7G ']VY(4
M%F(55!+,2   ,DDG@ #DD\ 5\SZ?^VE^R!JOC&/X>Z9^U)^SWJ/CB;4!I$'A
M2R^,/@"ZUVXU8M&@TJWTZ'7WN)]3,LB0#3X4>[-P3;B'SD>-?P2_X.0?VF?C
MW(O[&O\ P3,_98^(A^&?Q8_X*%_%4^ _&7B[3M1ETGQ)H7PEAN].TO4QI>IV
M\D4^G6NN7E[>VVK7-O)!=S6&FS:=:W,+7LLL?I.C?\&L'_!)G3?@/X=^$]S\
M,/&%S\1=#TNW>?\ :2L/'&OZ+\9-1\911BX?QE]OL[Q]'LI$UO.J6&C0::UE
M81)!IXEGBA\UP#YB_9#^,/Q9UG_@[*_X*/?"#5_B7XYU/X4^&?V3="UCP[\-
MK_Q)J=SX)T/5)/"?['\YU'2?#<MPVF6-Z9M:UJ;[3;V\<S2:OJ+,[?:7K^L/
M7_$&@^%-%U+Q'XHUO2/#?A[1;26_UC7M?U*RT?1=)L8!NGO=2U349K:QL;2%
M?FEN;J>*&,<NX%?P2_\ !"KX=?'KX/\ _!RQ^W3\(OVE/'6K?%#XJ?"O]D?Q
M%\.)OB/KUHEEKGCOP)X*US]EWP[\(_%FL0H\N=3U[X4:?X+U*_F>:>6YNKB6
MXEN)Y)6E?[3_ ."FR_$G_@L)_P %DO"?_!'"P^*_B;X6?L>?L[?#;3OC=^U4
M/ &M26&L?%75-2TK1]8@\(7<D:FWE-C9>(-+\.V5M>+=V6DW.J>(-8N+&YU&
MPLHX #^I3PE^U]^RAX^\6)X$\#_M,? /QAXTEFAMK?PKX8^+O@'7->O+F==\
M5O8:7IFOW-WJ%PP/S0644\J-\DB*X*U]$DA068A54$LQ(   R22>  .23P!7
M\RG[1G_!K/\ \$U?$7P(UK1?V9_A_P"*?V??V@/"/AO4]1^$/QG\(?$#Q8OB
M6P\>V&F@^'[WQ/+-J3#6;26^MHX[L0_V?<Q&\N+RTN(;A(BOH?\ P;H?M^?&
MO]M']B;XG_#G]J"_AUC]I3]C7XG>(?V>OB3KYN!=ZKXIT[1=-*^&O$'B>XCS
M:7'B?[58>)/#VJ7EB6M=53P[::RSF[U*[50#]O;W]I7]G;3O >H?%.\^/'P<
M@^&FDZH=$U/X@'XE^#7\&6.M@(W]BW7B6/67T>'5\2QD:8]X+XB1"("&&>A^
M%_QF^$7QNT.?Q-\'/B?X ^*?A^TNWL+O6?A]XNT'Q?IUG?1E@UE>7>@WU]%:
M76$9Q;W#12M'B54:-E<_P#_\&QW_  3'^"7_  4*^ OQN\5_M?0:E\4_@%\!
M/VBO&'@SX4?LZ-J^I:!\-S\1?$WA;PKXB\<_$SQIIN@7^GS^*]=70+_P=X<\
M+?VBXM]!L].O?L.6N9E%K]M#_@GNG_!.[_@L5^SC^P_^P5\<?B7^S%^SG_P5
M?\$3?#GXP>%_#.NZEXAN/"6@ZQXPN=+\77'@XZM<P'2=66VT^!? ^K07C:MX
M4)GCAU![*5[20 _NDM_VS?V1+SQK_P *WM?VH/V?[GQ]_:C:$/!\'Q?\!2^(
M6UM9%A;1DTM->-T^K+.PMFTU(VO1=!K4P"X1XUH_ML_!/0/VC_V2_P!H+X%^
M*OBEK7P3\-_$[X8^)/"VM?%?P_KEMX;U+P+IUY:^9<Z[_;5Y/:VEGI\$<)CU
MD75U;6]UH\M_9S7$$=PTJ?S5_P#!5C_@W7_X)C_"'_@FW^T=\7_@C\+/$7PG
M^-'[,/P%\;?&'P5\6]"\9>(=4\9^)/%'PL\/W'B^&3QY=ZOJ$T&O7/B>31I+
M+5M7ABL-0L[C49=:L"M[:PQ/[)^SG\>_'7[3_P#P:G>)/BI\4]8OO%/C.^_8
M0_:)\#Z[KNME+G4M>7X6R?$3X7V.HZK.TD[7][>Z7X1LY;N^NG>[U"9GO+W_
M $J>84 ?JO\ \$GOV5_ 7[ W[!'P\^"FA?M-6_[2/@[P7/XW\37_ ,<K_P 3
M:3?^%IEU?7M0UK5[?1M2MM:UC2-'\*>&B\MI#;MK,\=B+>ZFNYDD>4+]5?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7^6_\ \',?_*<[XN?]D'^!W_JO;:O]2"O\M_\ X.8_^4YWQ<_[(/\  [_U
M7MM7WOAG_P ECE'_ %_I_P#I^B<N,_@2_K[+/Q?HHHK^RSP0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ"OS(_8<_P""6/P4_8+^.O[8'Q^^&'CSXI>+/%'[9WCR#X@_$+2/'E]X6N]
M\-:K!K'B76EM/!L6@^%]!U"WT\W/BB]B9=:O]9N?(@M5%P&21I #]-Z_ 3_@
MYU_Y0R?M5?[G@3_U,M)K]^Z^-OV^?V)_AU_P4+_9<^(?[*/Q6\3^-?!_@?XD
M#1QJ^O\ P^N=$M/%=E_8NJ6VK6_]G3^(M%\0Z2OFSVJ1SBZTFY#1,P4*Q#
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MB?C-_P#.UKJC@<;)*4<'BI1:NI1P]5IKNFH-->A/-'^:/WK_ #/VRHK\3?\
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M_P!'[?#G_P (GXS?_.UH_P"(C3_@BG_T?M\.?_")^,W_ ,[6CZACO^@+%_\
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M_P#":M_\@'/#^:/_ ($O\S]LJ*_$W_B(T_X(I_\ 1^WPY_\ ")^,W_SM:/\
MB(T_X(I_]'[?#G_PB?C-_P#.UH^H8[_H"Q?_ (35O_D YX?S1_\  E_F?ME1
M7XF_\1&G_!%/_H_;X<_^$3\9O_G:T?\ $1I_P13_ .C]OAS_ .$3\9O_ )VM
M'U#'?] 6+_\ ":M_\@'/#^:/_@2_S/VRHK\3?^(C3_@BG_T?M\.?_")^,W_S
MM:/^(C3_ ((I_P#1^WPY_P#")^,W_P [6CZACO\ H"Q?_A-6_P#D YX?S1_\
M"7^9^V5%?B;_ ,1&G_!%/_H_;X<_^$3\9O\ YVM'_$1I_P $4_\ H_;X<_\
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M;*BOQ-_XB-/^"*?_ $?M\.?_  B?C-_\[6C_ (B-/^"*?_1^WPY_\(GXS?\
MSM:/J&._Z L7_P"$U;_Y .>'\T?_  )?YG[945^)O_$1I_P13_Z/V^'/_A$_
M&;_YVM'_ !$:?\$4_P#H_;X<_P#A$_&;_P"=K1]0QW_0%B__  FK?_(!SP_F
MC_X$O\S]LJ*_$W_B(T_X(I_]'[?#G_PB?C-_\[6C_B(T_P""*?\ T?M\.?\
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MF_\ G:T?\1&G_!%/_H_;X<_^$3\9O_G:T?4,=_T!8O\ \)JW_P @'/#^:/\
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M_A$_&;_YVM'U#'?] 6+_ /":M_\ (!SP_FC_ .!+_,_;*BOSH_9/_P""M?\
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MC7^.W_@FL?\ YHJ_UYJ*/^(M<8?]!D/_  1A_P#Y2'U##]I?^!2_S]?Z6O\
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MK_2U_P AG_ATE_P6:_Z1K_';_P $UC_\T5'_  Z2_P""S7_2-?X[?^":Q_\
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M&'_09#_P1A__ )2'U##]I?\ @4O\_7^EK_D,_P##I+_@LU_TC7^.W_@FL?\
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MK'_YHJ/^'27_  6:_P"D:_QV_P#!-8__ #15_KS44?\ $6N,/^@R'_@C#_\
MRD/J&'[2_P# I?Y^O]+7_(9_X=)?\%FO^D:_QV_\$UC_ /-%1_PZ2_X+-?\
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M_P"$)\'_ /0MZ3_X#?\ V==117V/]GY?_P! &!_\),/_ /*_)?<8<TOYY_\
M@4O\_+\^[.7_ .$)\'_]"WI/_@-_]G1_PA/@_P#Z%O2?_ ;_ .SKJ**/[/R_
M_H P/_A)A_\ Y7Y+[@YI?SS_ / I?Y^7Y]V<O_PA/@__ *%O2?\ P&_^SH_X
M0GP?_P!"WI/_ (#?_9UU%%']GY?_ - &!_\ "3#_ /ROR7W!S2_GG_X%+_/R
M_/NSE_\ A"?!_P#T+>D_^ W_ -G1_P (3X/_ .A;TG_P&_\ LZZBBC^S\O\
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M$F'_ /E?DON#FE_//_P*7^?E^?=G+_\ "$^#_P#H6])_\!O_ +.C_A"?!_\
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M11_9^7_] &!_\),/_P#*_)?<'-+^>?\ X%+_ #\OS[LY?_A"?!__ $+>D_\
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M_P (3X/_ .A;TG_P&_\ LZZBBC^S\O\ ^@# _P#A)A__ )7Y+[@YI?SS_P#
MI?Y^7Y]V<O\ \(3X/_Z%O2?_  &_^SH_X0GP?_T+>D_^ W_V==111_9^7_\
M0!@?_"3#_P#ROR7W!S2_GG_X%+_/R_/NSE_^$)\'_P#0MZ3_ . W_P!G1_PA
M/@__ *%O2?\ P&_^SKJ**/[/R_\ Z ,#_P"$F'_^5^2^X.:7\\__  *7^?E^
M?=G+_P#"$^#_ /H6])_\!O\ [.C_ (0GP?\ ]"WI/_@-_P#9UU%%']GY?_T
M8'_PDP__ ,K\E]P<TOYY_P#@4O\ /R_/NSE_^$)\'_\ 0MZ3_P" W_V='_"$
M^#_^A;TG_P !O_LZZBBC^S\O_P"@# _^$F'_ /E?DON#FE_//_P*7^?E^?=G
M+_\ "$^#_P#H6])_\!O_ +.C_A"?!_\ T+>D_P#@-_\ 9UU%%']GY?\ ] &!
M_P#"3#__ "OR7W!S2_GG_P"!2_S\OS[LY?\ X0GP?_T+>D_^ W_V='_"$^#_
M /H6])_\!O\ [.NHHH_L_+_^@# _^$F'_P#E?DON#FE_//\ \"E_GY?GW9R_
M_"$^#_\ H6])_P# ;_[.C_A"?!__ $+>D_\ @-_]G7444?V?E_\ T 8'_P )
M,/\ _*_)?<'-+^>?_@4O\_+\^[.7_P"$)\'_ /0MZ3_X#?\ V='_  A/@_\
MZ%O2?_ ;_P"SKJ**/[/R_P#Z ,#_ .$F'_\ E?DON#FE_//_ ,"E_GY?GW9R
M_P#PA/@__H6])_\  ;_[.C_A"?!__0MZ3_X#?_9UU%%']GY?_P! &!_\),/_
M /*_)?<'-+^>?_@4O\_+\^[.7_X0GP?_ -"WI/\ X#?_ &='_"$^#_\ H6])
M_P# ;_[.NHHH_L_+_P#H P/_ (28?_Y7Y+[@YI?SS_\  I?Y^7Y]V<O_ ,(3
MX/\ ^A;TG_P&_P#LZ/\ A"?!_P#T+>D_^ W_ -G7444?V?E__0!@?_"3#_\
MROR7W!S2_GG_ .!2_P _+\^[.7_X0GP?_P!"WI/_ (#?_9T?\(3X/_Z%O2?_
M  &_^SKJ**/[/R__ * ,#_X28?\ ^5^2^X.:7\\__ I?Y^7Y]V<O_P (3X/_
M .A;TG_P&_\ LZ/^$)\'_P#0MZ3_ . W_P!G7444?V?E_P#T 8'_ ,),/_\
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MQ=B?SIF=3['_ %\C^I_831117G&@4444 %%%% !1110 4444 %%%% !1110
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MBI)QO9IZ:72>C304445]*9!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ']!W_!I=_RF'^,_P#V
M9?\ $#_U9'P.K_2RK_--_P"#2[_E,/\ &?\ [,O^('_JR/@=7^EE7\7^(W_)
M79M_V$5?_3]8]_!_[M2_P1_])04445\.=(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5_'MHO_*Y1XN_[,4MO_57^&*_L)K^/;1?^5RCQ
M=_V8I;?^JO\ #%>CEVV/_P"Q=B?SIF=3['_7R/ZG]A-%%%><:!1110 4444
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M[4X'N-)LO$LEM]LT!=82(-.FCW6KVEG::K<6R275KI\]Q<6L4MQ%'&WX>_\
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M(%DDM&\8^,[:^LX_%6A:E;&,ZW+J&H/9?VE)?VVD:=I<&GZ=--+X%_P5<_8
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M )L:/^'MW_!+3_I(S^Q%_P")0?!G_P";&@#]"Z*_/3_A[=_P2T_Z2,_L1?\
MB4'P9_\ FQH_X>W?\$M/^DC/[$7_ (E!\&?_ )L: /T+K^>#_@F9_P INO\
M@X9_[&W_ ()V_P#K-?B.OT4_X>W?\$M/^DC/[$7_ (E!\&?_ )L:_*__ ((_
M?%/X9_&S_@K_ /\ !?CXH_!SX@^#/BK\-/%GBC_@GS/X7^('P\\2:3XO\&>(
M8M-_9]\7:-J3Z)XDT*ZO=(U1=.UC3]0TJ]>RNYTM]0L;JUD82PNH /Z6Z***
M "BBB@#_ !_?^"HW_*8/_@II_P!G-?$#_P!/25\@U]??\%1O^4P?_!33_LYK
MX@?^GI*^0:_M3P]_Y)'*/^O=;_U(JGSV)_CU/5?^DH****^T, HHHH ****
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M!XP\<3V[:%H,%HLUW81S7OB&2+['H]P3_6W_ ,' '_!1OPS_ ,$_?V7/"7[
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MU:S;P?XP\._#?PE+'XJ\2Z^+/Q#;QRPBVL-/BD2(VD\]Y!*ZVL$I)*_Z2/\
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MKO=-1O?57?>Y_,)1117[T><%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?T'?\&EW_ "F'^,__
M &9?\0/_ %9'P.K_ $LJ_P TW_@TN_Y3#_&?_LR_X@?^K(^!U?Z65?Q?XC?\
ME=FW_815_P#3]8]_!_[M2_P1_P#24%%%%?#G2%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?Q[:+_ ,KE'B[_ +,4MO\ U5_ABO[":_CV
MT7_E<H\7?]F*6W_JK_#%>CEVV/\ ^Q=B?SIF=3['_7R/ZG]A-%%%><:!1110
M 4444 %?R0_M)?\ !PC^V[X4_P""E'[1G_!.W]D;_@G58?M3>+_@9JD:P7&B
M>--7T_7=3\.1^$?"_B/4->U6V>*#2-+M[2Y\1I8J7OHUF;[-%&'N9A&W];U?
MQ6?\$ZF8?\';'_!5X!B WPHN@P!(# :+\ 6 8#@@, 0#G! /4"@#V7QA_P '
M!'_!3_\ 9CLM/^('[:7_  1$^,'@#X*?VK!!XG\<^ ?&%WX@N?"6A6T-S>^(
M?$.I6MEHOBBSAM='TJ"74DEUVZ\-:-.UHVGW&O6,EY#<P?TI?L>?M?\ P*_;
ML_9\\!_M-?LY>*9?%?PN^(-I<2:;<WMC)I>M:/JNG7#66N>&?$FDR/*VE^(_
M#^HQS:=J]BL]S#%=1,UK=W=J\-S+[CX\D\&0^!_&4OQ';04^'L?A7Q"_CM_%
M)M!X97P:NDW9\3'Q%]O_ -!_L,:+]M_M;[9_HOV#S_M'[K?7\A7_  :)-_8?
M[.__  47\5>&+?Q!>? ^/]KOQ)=_";3;87=^;O1=&\+"ZN8_#6D.VZ6[NM.D
MT6UV6Y5[^^CBMW)FB+4 ?V045_(7X:_;'_X.$?\ @IU\9_BY!^QC\+_ '_!.
MS]E_X3^/M0^&_P#PF/[4'P^EU+XF>*=:TBX-Q+<1Z-KVE7ES<W$=HUK+K<'A
M>P_L73([VPLEUR_N9[H'O/V9?^"D7_!4?]C+_@I-\#?^";/_  5CT[X0_%?P
MU^UA!XFN?V>OVK?A;9V7A&VNM0T33+Z2UT+4M#LX+&SO#/KFFQZ%J>F7^G6?
MB;2KOQ5X4U!)[[2+HY /Z#/VT_VR_@G^P-^SWXO_ &F_V@[[Q!I_PP\$W&CV
M>KR^%M$;Q%KTMWKVHPZ9IMMI^DK<V8N9);J90V^ZA1(U=V?@ ^P_!OXK>%OC
MI\*?AY\9/ ZZFO@_XF^$M$\:^&1K5FFGZL=$\0646H:<VH6,=Q=):73VLT;R
MP"XF\MFVER0:_DC_ .#L'PQ_P46D_9<^+WB;PS\3O@Q:_P#!/2+3/A1:>+OA
MG?\ A&UE^,5WX]'B3$NJ:=XLFM9IXM+;4FTV2.UM[BU>.W@ND;S8YW"_?7_!
M#;P9_P %<='^&WP-UW]K7XS_ +/'C+]C^^_9K\'CX1^!_AYX$L-$^(FB2S:3
MHK>#O[?U^RT^R^V"P\/I+!JWF/=/>7TRRR.LT4K2@'T=^QO^V'_P4E^+W_!1
MW]L;]GG]HW]CC1_@]^R/\(=)>Z^"'QLM!K8NO&%R->TNT\-QR^(+S5[[0_&=
MSXU\-W^I^(KB#0-'T6/PH-%^P7[K=DQZC^S]?SM_\$]/^"BW[4?[1'_!9K_@
MJ'^Q=\3_ !+X5U+X"_LLZ7IEU\(=$TOP7I.C:_I<]YK?A.S=M7\36F-1UQ1:
M:O>QE+_?F5TE4Q^6L=<;_P %,O\ @JM^U[?_ +9_A[_@E%_P2:\#>$?&_P"U
MO?>&M)\7?'7XU>,[4:SX#_9C\-:I)I>L6QUO3KB)M'.L2>$[NSU2_N-:6]MK
M:W\6>&[+2=.O_$%R;>U /Z5J*_CY^,_QX_X.3_\ @E_X5?\ :?\ VCM<_9H_
M;J_9;\ 1:7K_ ,=O"_P\\,:?X,^(_A;PQ<WMCI^MZAX?FL](T;4KF+1+65[V
M:_5=2TZVE07=Y8BP^VR#]GOCS_P40LO&G_!'+XV?\%(OV0]:2WFC_9-^(OQP
M^$E_XKT*TOY=$\2>&_#NJW5O8^)O#=V\UI-=Z+KFFSV.HZ;<F2"62V8D202+
MN /UHHK^-']C?]M/_@X$_P""L?[,'PH^)O[*/B7]G;]GOP3HGA?5O#GQ+_:#
M^*_@&PDU_P".'QFTC4;N[UB+X=> +>SU?3O#?P_T.VGT?PLGB"WM+?\ M'7[
M/79"S00-%%[?_P $X/\ @JK_ ,%&/A=_P4=N/^"4G_!7[PMX!F^+'CKPD_BS
M]G[XV_#G3--T;0_&T=EIK:G%IN-'BM=&\0Z?K>EV6M&'5K6QT[5-(\1:#JFB
M:O;2RGS(0#]Y/V\O^"@7[/'_  3C^$.C_&S]I/4/%=CX,U[QOH/P^TM?!OAP
M^)]9N?$7B)I5L8QI_P!MT]$M(U@EENKE[E1#&I*I(WRU]@>&=?L?%?AOP_XI
MTQ;A--\2Z)I.OZ>EY$L%VECK-A;ZC:+=0K)*L-PMO<QB>)99%CE#()' #'^%
MO_@[*\+_ /!2.#P''XA\6?%'X)WW["-_\?OA;;_"3X>6'A"RMOBQH?CH:5,E
MKJ'B#Q,]F]YJ.E?VJNISSP1WBP-;36D,UJ3 CO\ T4?\$H_"/_!6#PGH.J:E
M_P %$OC+^S[\2?AA>?"SP!+\%M+^#O@:S\+:UX=ECL8+B[?Q+?65C81ZA =
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M4=0UWQDFGZC)I/@^^2#3XXY-%GAMXG:!4ANE:Z6V&?) !_037XO?MS?MA_\
M!2?X*?M[?L0_ K]F']C?1OC-^RW\:?$>G:=\>OC->#6KF\\%VD^O1Z?XE(U3
M3M8L=(\!VG@SPK.WC(ZCXBTC7!XDFMQI>F1^;#-8WGY6?!#X[?\ !Q-_P4QT
M/X1?M*?L[:[\"OV1/V2=7T[X7:OX8MOB)H6@ZM\2_C?9Z2MK'X\\>W]A!IFJ
MW'A[PYXSN3J=UHOAZ"ZT[3FTY+*.V)=3=G[+_P""G'_!1G]J3]F#_@K'_P $
MG/V2?A%XE\*Z5\%_VM_%6HZ5\9](UCP7I&NZSJUE:>,= TA4T;Q!>C^T- <Z
M=J%S$LFGO&RS,L[^:45  ?2G_!8W_@J1XH_X)>^#?V9?%/ACX4:'\59?C[\?
M=&^#-]:ZWKE]HD?AZTU6*WE;6K5[%)&N[F/SF1+:4+$S;2[*NXU^P^EW;:AI
MFG7[((VO;&TNVC4DK&US;QS% 3R0I?:">2!7\A'_  > ^(=)\(_L_P#[ 7BW
M7Y9X-!\+?MG:%XCUN>UMS=W4.D:+I5OJ.I2VUHKQM=7$=G;3/#;JZ&:0+&'4
MMD=E\/\ QY_P<>_\% O"O_#4'[-OBK]GW]@K]GG7]$T_4_V<O@E\8?!UAXU^
M)WC[P5'N_L+Q5X\O;G1=8;P[=^*]/MK'58;:^:VL_L&HJUKI\=LZS3@']:=%
M?SK?\$??^"MGQ\^/WQR^,O\ P3A_X*-?#2P^$/\ P4%_9]M;W7;NZT&QBTSP
M-\:/ 5I/91-XI\,V<<KV]KJ*07]GK=NFF%](UWPM?0:OIZ6<VGZK:HH_X*,_
MM2'_ (.+&_X)Q_\ "2^%?^&6Q^R__P +4'AO_A"](_X2G_A+/[%6[^T?\)G_
M ,AC[-]K)D^R;_LWE?NO*S^\H _HHHKX_P#^"@/Q@\=_L_?L3_M0_&WX87VG
MZ9\0OA=\&?&WC/P=J&K:7!K>FV>OZ)I4MWI]Q?:3<LEOJ-M'.BM+:3.L<R@J
MQ -?DY^QA^TK_P %.?\ @H'_ ,$6OA%\?O@5\4_@UX5_;B^(NO"XD\>>-_A[
MI:?#B/PUH_CV[T_7[9_"%I;WFG17\OAJW\BUGBM6WW:&58X'E5HP#])_V,/^
M"D_[,_[>?CW]J/X;_ *]\:W?B7]D#XE1?"GXQ1^+/"W_  CMG;^*YM9\;:%&
M/#EU_:-]_;>FMJ'P_P#$:B]\NT/EQ6TGD_Z0 GS1_P %9OVO?^"C?[*^L_LD
M6?[ _P"R'I'[4-A\5_BS<^$_C/=ZG;Z]?CP;HJMH46BV)&AZQHG_  B\?B*'
M4M>O%\;:J^IZ-I$OAP1ZA9)'*L6H?QZ?\$0_ ?\ P6H\0_M$_P#!5NW_ &)_
MCQ^S+X!\?Z-^U'9VO[66I?$OX>Z=XAT;QC\36\=?'6,:M\/[(Z5.FC: FLV_
MCVY%A:?886M=0TJ&-4%NGE_T[?\ !>;_ (*)_M5_L W7_!.:T_9W\3^$M!E_
M:*_:=T_X4?%H^(?!6D^+5U3PU/<>"+>>'2#JG_(%GW:UJ9%W9@7!$L6V2,PJ
M2 ?T.:=-=W.GV%Q?V@T^^GL[6:]L!.MR+*[E@1[FT%RBHEP+:9GA$ZHBRA/,
M55# "Y7\]?\ P7"_;H_;2_X)SZW^QK^TS\(]?\(WG[(.I?&'PM\+?VL/ >L^
M$?#E[K\T'BO6[231M<T'Q?J9_M30UOM)36]-G%EMM[*XL;.\=]T[HW[^:=X@
MT?5_#]CXITN_M[_0-3T:U\0:=JEI(L]K>Z/>V2:C:7]M+&62:WN;*6.XADC+
M+)&ZLA((- &Q17\VW_!%3_@I%^UK_P %+_VL_P#@HMXZU[Q7X5E_83^!?Q4N
MOA+^S;HNG?#W3-+UWQ'>G7M7D@\07?C:V)OKY;'P;HNCZO?:7>RW$COX_P!.
M8&!=. F^??CG_P %0O\ @IA_P4)_;3^+O[&O_!%S2/AMX*^%W[,5Y=Z!\>/V
MS/BIHUKXG\'ZIXYA2:UNO!?A%+_3[_2K4VVH[[/3A:6E_K^I3:3J^K/)IVBI
M8M=@']9=%?R%>+?^"@G_  6>_P""/7CWP%XQ_P""K=M\'_VK/V%O'WCGP]X"
M\0?'[X">&[/0/'?PDU?Q+8RF&_U'PU96>C&ZTJVUF>.W6#6K5SK,&G7-GHFI
MP7UW96U?UM^&_$.C>+O#N@^*_#FH6^K>'O$^BZ7XAT+5+.1)K34M&UJQ@U+2
M]0M9HV:.6WO+&Y@N()$9D>*165B"#0!M45S_ (L\3Z-X)\+>)?&?B.Z^P^'O
M"/A_6?$^O7NQI?L>C:!IUSJNJ77E("\GV>QM)Y=B L^S:H)(K^/W]G7]M+_@
MNU_P6<UOXG_'K]@[X@_L]?L3?L5>%_B#XA^'/PROOB5X,M/B)XR\>W?A:>:.
M[UJ_NI-'U._>::SOM..I16*Z=HMAJ.;2SANFMI+MP#^R*OQ9U+_@JMXIL/\
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M=W$4$,=Q=F*. W4R1JLMP88@(H3.X:0Q1@1QEMB#:!0!/1110 4444 %%%%
M'\>__!RY_P G^_\ !OA_V>U-_P"K>_97K^PBOX]_^#ES_D_W_@WP_P"SVIO_
M %;W[*]?V$5ZV-_Y%N3_ /7O&_\ J4R(_'4]8_\ I*"BBBO)+"OFSX]_L;?L
ME_M47&@7?[2_[-/P+^/MUX4@N[7PS<_&'X6^#/B)/X?MKZ1)KVWT>7Q5H^J2
M:=#=RQ1RW$5HT232(KNK,H(^DZ* /SE_X<_?\$I?^D;_ .Q#_P"(Q_![_P"9
M&C_AS]_P2E_Z1O\ [$/_ (C'\'O_ )D:_1JB@#\Y?^'/W_!*7_I&_P#L0_\
MB,?P>_\ F1H_X<_?\$I?^D;_ .Q#_P"(Q_![_P"9&OT:HH _.7_AS]_P2E_Z
M1O\ [$/_ (C'\'O_ )D:/^'/W_!*7_I&_P#L0_\ B,?P>_\ F1K]&J* /SE_
MX<_?\$I?^D;_ .Q#_P"(Q_![_P"9&C_AS]_P2E_Z1O\ [$/_ (C'\'O_ )D:
M_1JB@#\Y?^'/W_!*7_I&_P#L0_\ B,?P>_\ F1H_X<_?\$I?^D;_ .Q#_P"(
MQ_![_P"9&OT:HH _.7_AS]_P2E_Z1O\ [$/_ (C'\'O_ )D:/^'/W_!*7_I&
M_P#L0_\ B,?P>_\ F1K]&J* /SE_X<_?\$I?^D;_ .Q#_P"(Q_![_P"9&C_A
MS]_P2E_Z1O\ [$/_ (C'\'O_ )D:_1JB@#\Y?^'/W_!*7_I&_P#L0_\ B,?P
M>_\ F1H_X<_?\$I?^D;_ .Q#_P"(Q_![_P"9&OT:HH _.7_AS]_P2E_Z1O\
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M2E_Z1O\ [$/_ (C'\'O_ )D:_1JB@#\Y?^'/W_!*7_I&_P#L0_\ B,?P>_\
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M0. OI7AG_@LM\*+'_@K3\0/^"I/C#]D?Q!XOGUSPCI>C?#OX0/\ %#PW%<>
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M&1GX7<'!(R.<$TG_ !&%^"_^D?/C;_Q(?PM_\ZZOX@Z*\_\ XA3P'_T))?\
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M("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /Z#O^#2[_E,/\9_^S+_ (@?^K(^!U?Z65?YIO\
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M5J=OXUGMM<\(74\<&@Z+XBU'Q/I&RVTR]E+:_HNE ^047<SQ>9YI_P %%_\
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M1!_8::.**-IM!^,4LS1QI&TTO_#0_P 6X_-F9%4RR^7'''YDA9_+CCCW;(T
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MT9!*_@/@;7?^#@G_ ()"^-OC9\+;#]G/7?\ @KY^S?XP\;ZU\1OA+\:]4^,
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M] U30O%\,^L?9/%NK>(]/\,_8IM/M1K%G;7VMQ7\%M<QV-TOV^*6.@#]3O\
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MX<TOPAXOTW3M.5-/UOQQ9KXETR._U"."UDCU+6[^;X;?;7AC>^TV.^G^W:@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4:L)RK<WLXW<'-5%R%0H59QC*,5RR^&4IPBF[VLN:2=[Z)6N_34_EIHK[O\
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M4DZ:WJ5F)GU*?39CI&FRWE[:Z96.7<7</YK'$5,#CI5,-A,']>Q&-J87%8?
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M-.OE;1M.ME2^KT;]H?\ X(1>!IOV:_BE^UE_P3P_;4\$?MI> /@[%>:S\1/
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M@KX:Z#<Q1:E9RK=:G<RJEQ&G[YHT^B/V>_V)? _[&7_!P+^R;^R'!\5E^/\
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MF3]L/_I)5\6__$<_V3/_ )TM??-%']K8K_GUEG_AER;_ .8 ]G'O/_P94_\
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MF!N);'2;6VT^WDD,-I"D2HH^^_\ @FK_ ,$?_P#@I9^U#XU\)_%OX$:?XO\
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MH9[E]HN3E7RR3K5:"4?>:Q6$^LX9Q32FZJC+W6T9T)1C42G\%1.E+TFTD_\
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MU7Q)<R:[?^"TGO=1UGQ1<V=^SR:GXQO-*MY9IQ'?7%C)K4DB6LLEI%'7U?\
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MV[O+2?\ %S_@U?\ CYXW\3?L<_M'?L@>/-1U+Q#>?L)_'WQI\'/"OBB_OQJ
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M]M)H_BZ^\%Z7JNE>'_$,<UO*+CPY?7\>NV4?E3W^GVL-Q;R2_6G[%'_!2?\
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MV5_87ML\MO=V=W;RQSVUS!))#/#(DL3LC*Q_CV_X,W@%_9B_;[   '[<NO@
M#& /A]X3P/H.P[5[%_P:I?&WXPR_ C]L+]A;XS>,-4\?ZI_P3^_::\1?!OP9
MXEU*"2'[)X&-UK&D1>%[,W;/J8TW2O%7A#Q3J>EV>J23W6D:=KMOHT<WV'3[
M.WM_'O\ @S?_ .38OV_/^SYO$'_JOO"= '])7[(O_!0']D_]NJY^,MI^R_\
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MU'QOH<=RLOB'PG8Z#<:WH5M'->ZG:6UC$]R/$OV./^"^W_!+G]NKXN6/P*^
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M/XC^&NN?%SPOHWQ!L_ OBV.:'Q'X:\*>*?&K:MX&T_5H+@":"['@VYT*5X'
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M&-(HD5%51^/G[1G_  0&_P""3?[47Q#UGXK?$[]DCP;;>/\ Q)J%CJ?B;7_
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MLSZQJ7A?4M*CUB6[BMDM;RYU6VO;R:W:0"X25A*OL?[(W_!-G]AG]A*+4O\
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M7Q!\1?#WQ!=60865]>Z!>&!=0L\\&WO[5K>[387C0S-&CNJ!S]0_\$Y/A?\
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ML0JJ.Y8@#UH ?138Y$E1)8G22.1%DCDC8.DB. R.CJ2K(RD,K*2&!!!(-.H
M***AEN+> Q">>&$SRK!")94C,TS_ '(8@[+YDKX.V-,NW8&@":BBB@ HHHH
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ME,,CQNL<RJCM"[*0LJI(&C<QL0X5U9&(PP*DBOQF_P""4O['?_!1G]ESQO\
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M*>@_0S]L_P#X+(_M^_MW>&KWX>_&KXN0Z9\*+^>QGNOA=\.-$LO!7A?4/[/
M>&'7Y=+6+4O$UL;S=??9M9N;B!9O)C$9AMH4'Y==.  !V & /8 < >PI9!E.
M:4<RS?/<Y>#I8[-Z> PZP.73JU<+A<-E\*JHNIB*T*4L3BYNO-5*BHPIPA&,
M*=XR=G4G!PITZ?-RT^=\TTE*4IV;=DVHI6VO=MML****^L,0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /Z#O\ @TN_Y3#_ !G_ .S+_B!_ZLCX'5_I95_FF_\
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M$?1-.^/_ (#\$O<MJ$TFL>$)6UF.7P+?ZG)!</)XB\.1/)=JB:#K>G7$T[R
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M(NI:QK?PQ?6?&-M<S1_"F_N[EIO#4-N^IRI:002(EM%!;1Q,$B1$_4[X"?\
M*X;^U?\ ]F66O_J+?!NM'_@O=S_P6-_X(3#(R?BUJ_&1GGQ5HH'YG@>IX'-
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M7:Y\+O%5O!XA@TRY2]N+B[>VN(=9\&6]C9WFF/80S:-JU^FIZ:\UNMR/#?\
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M &%?'-A^TQX4U_3FOH_$=EX1\+V=T/'T6B3644QCETVR&F>.7DE6%8'\%0W
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M8[.>*ZMK9;!)KV^:W$3S"437$IK\M?\ @KA_RLT_\$,_^Q6O/_4S^)E?V,T
M%?YW/_!RA_P3)\ _"']KW]B7XF:=\<OV@?$-]^WC^W)XV7Q=H?B?Q]J&L:#\
M)D\7^//AE?79^#EC<S,/")TV7QM>II,=HT<=G;Z;H]M (H-/@1?]$:OXZ/\
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MJ.BZ+XY\-W>G323/J,(_X2#0'FOK7PO;WTV)I7_!MUJ.O:7IVN:)_P %H?\
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M,3JWA;5K=$:$)<, ?-O[==E^V;\=_P#@Y@^)_P"QW^S!^TAXL^ MK\:_V4/
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M$23XH:%JL-M::W!#XDTS0="TJ>ZMS<2:C*UOJO@?Q)87S7"&*SOHS;K/(\K
M?I+_ ,'&?Q?^&WPA_P"".W[8\GQ&NM+)^(W@O2?A9X'\/W^J)IEWXK\>>+/$
MVD'1],T7,D<M]J&CV6GZKXSN+&WWR2:/X7U21D>**12 ?,7_  6[_:DB^.W_
M  ;Z>,?VL/@IXA\4>"K'XN?#[X*_$KPEJGA_Q#?Z'XCT>Q\5Z[H.H_8#K.@7
M=G=)-;BXDL;Y()TBG\N6*:,QLT=?K/\ \$M]2U/6?^"=/[%NJZSJ>I:UJNH?
MLZ_#.ZU#5M9U"\U75=0NYO#MH\UWJ&I:A-<WU]=3.2\US=3S3RN2TDC,2:_F
MU_;'^%OCKX9?\&@WPY\">,?#NI:1XL\._LX? C4O$6B3V=Q'?Z#%J?BC2=9$
M>K6[Q+):2V=MJEK'?&0"**X<J)&4JS?T5_\ !)#6='U__@F9^P]JF@ZKIVM:
M9+^SG\.8(M1TJ\@O[*2>QT6&QO84N;9Y(6EL[VVN+.ZC#;X+J":"4+)&Z@ _
M##2_'OCMO^#N;6O #>./&1\!)^Q4-67P.?%6O'P:NIGPW;YU >%SJ']AB\R-
MXN!8>:)29@PE8N<'_@NY\;_CA\>/^"FW["__  2*T_\ :+\1_L@_LS_M&^"&
M\>?&3XH>%=7'AOQ'\1"_B'Q4EGX)LM=:YLXX;**;P#9V&F6AOK**Z\0ZS<'4
MTO+2WM+2Y\M^$GQ7\!_%C_@\1^*4_@#7[#Q+8_#_ /98U;X9^(=3TNZMK_34
M\8>'?!NA7FOZ9:7UG+-;W,FB3ZLFCZJJR>98ZW8ZGI=PD=S8S(O[7_\ !37_
M ()_?\$R_P#@JGXW\(_LO_M(^-]!TS]K+P3X1UCQM\,A\-_B+H.A?M%^"_ [
MW%C-JFJ+X:N%U>2^\ WFJ3:5<W<>O^'9+::9"^A:EIEU+=W1 /RS^/G_  ;J
M?&/]G31/ ?QX_P""0?[:7[1_A;]I;X?>*M%URS\-_'#XX:AXJ^%OQ&\/WGEV
MFKP:J;J&/2XHTTR65Q97VGZIIVM:?/<V1:VG^Q74?]6?PMD^(,OPU\ O\6;?
M1K7XH_\ "'^'4^(L7AR3S/#O_";QZ3:Q^*)= 8O(XT.XUI+VXTB.5VGBT^6W
MBN#YZ2"OXK/VP_\ @GM_P5,_X(=_ ?Q+^U_^Q!_P4]^)/QL^!'P!L+77_&'[
M/7[25K)KMK9^$Y[K2]"NX=&_M77M:T?6=)LDGBN1HVFKX/O;) 1HD<]WOF?^
ML?\ X)[?M0WW[:G[$_[-?[4^J^&X/"&K_&OX7Z)XPUKPY:3O<V6EZT[W.FZQ
M%I\LI,QTZ74]/NKG3TF:2>*RF@BGEEE1Y' /KV_L;/5+&]TS4;6"]T_4;2XL
M;^RN8UFMKNSNX7M[JUN(G!26"X@D>*6-@5>-V5@037B_P$_9G^ 7[+?A;5/!
M'[/'PH\'?"#PAK6OWWBG5/#G@G31I.DWGB'4RIU#5I+1'>-;N[**9GC"!RHR
MO%>YU_,9_P %?/\ @J]\2-<^+NF_\$A?^"8T4?Q&_;R^.RW'@SXB>/M(NKIO
M#'[*_@[5K-T\2:_KVNZ66&E>-=+T&6YU&XN'E2+P/:".^OA+KL^F:5( ?$W_
M  64\70?\%H/^"D7[)O_  2+_9G8>*_"7[,WQ5L_V@_VPOC1X>N--U/PY\,K
M+2+.YT+4O#T>K6\\L</B'1-'U+4M)N=.N%"7OC#Q)X:T>!C<VM^(?[1YYX;:
M&:YN9HK>WMXI)[BXGD2*&"&)#)+--+(5CBBB16>21V5$12S$ $U^4_\ P29_
MX),_ O\ X)6? P^"_!97QY\<O'BV^M?'WX^ZW;F3Q;\2?%DI-W>6]O=W337V
MF^#M.OYKAM&T4W#R3R,^K:O)=:K<R21>)?\ !PUXE_;9LO\ @G#XX^'7["'P
MA\:?%SXK?'OQ3IWP3\80_#[2=2UKQ9X+^$?BWPWXLN_'/BK2[+35,B/>1Z/I
M_@F:\F9(;&#Q?)=(WVF*W! /RJ^'S:O_ ,' 7_!8(?&5=^M_\$L?^"7WC.YT
M;X9SLD-YX._:(_:.L1IUW<ZT()))+/6]$ANX[;7;:[$8EL_"MCX3BDA23Q1J
M,<=C_@C^2?\ @Y4_X+L$DD_V99C)))P/'7@P <]@  !T   X KYN_8 _X*"_
M\%2?^">?[*/PF_94^$O_  ;H?'2ZT/X<:!%;:WXK_P"%B^)]'U3X@^,+QC=^
M)_'>O6<7P)O_ "M5\2:K+/>R6YU"]2P@:WTZVN&M;2$#\VO^"?O_  4@_;T^
M%G_!8O\ X*2_M"?#S_@EE\2?BY\;_CH-.M/C5^S1HWC77;3Q)^SI:'Q9X;GE
MOM;U>V^&FKWNM*+JVMK5DN?#>@ O=JZR(B%' /\ 3-HKG_"6KWWB#PKX9U[5
M-(N/#^IZWX?T;5]1T&[\W[5HE]J6G6UY=Z1<^=#;3?:--N)I+.;S;>"7S(6\
MR&)LHO04 %%%% '\>_\ P<N?\G^_\&^'_9[4W_JWOV5Z_L(K^/?_ (.7/^3_
M '_@WP_[/:F_]6]^RO7]A%>MC?\ D6Y/_P!>\;_ZE,B/QU/6/_I*"BBBO)+"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@;6?^4HOPW_
M .S!OC7_ .M#_ &OOFO@;6?^4HOPW_[,&^-?_K0_P!KT\K_B8S_L69A_ZC3(
MGM'_ !P_-'WS1117F%A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!_C^_\%1O^4P?_!33_LYKX@?^GI*^0:^OO^"HW_*8/_@II_V<
MU\0/_3TE?(-?VIX>_P#)(Y1_U[K?^I%4^>Q/\>IZK_TE!1117VA@%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#VI^$=$C-U+/#86A5Q-^I'_!)_\ X(V_"_\ X)E)\4?B9K/Q3\=?M.?M;_M
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M<>*["&?^S]0L[R1+6+4O^$<\/^&M8UVWT^&RUK7;W1KB?1Z_JNHH \8^//P
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MFN^(+CXUS7]ZTNH2&XN'\R,SR !P8PJ+_;710!_)9;?\$/\ _@MW#<VTTO\
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MZ/\ Q&7BK_J%_P#!&&_^9OZN_*T_V?0_O?\ @4_+^_Y/[_(_Q<?^%"_MJ?\
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M]_D?XN/_  H7]M3_ *,1_:Z_\,%\7O\ Y@:/^%"_MJ?]&(_M=?\ A@OB]_\
M,#7^T=11_P 1EXJ_ZA?_  1AO_F;^KORL?V?0_O?^!3\O[_D_O\ (_Q<?^%"
M_MJ?]&(_M=?^&"^+W_S T?\ "A?VU/\ HQ']KK_PP7Q>_P#F!K_:.HH_XC+Q
M5_U"_P#@C#?_ #-_5WY6/[/H?WO_  *?E_?\G]_D?XN/_"A?VU/^C$?VNO\
MPP7Q>_\ F!H_X4+^VI_T8C^UU_X8+XO?_,#7^T=11_Q&7BK_ *A?_!&&_P#F
M;^KORL?V?0_O?^!3\O[_ )/[_(_Q<?\ A0O[:G_1B/[77_A@OB]_\P-'_"A?
MVU/^C$?VNO\ PP7Q>_\ F!K_ &CJ*/\ B,O%7_4+_P"",-_\S?U=^5C^SZ']
M[_P*?E_?\G]_D?XN/_"A?VU/^C$?VNO_  P7Q>_^8&C_ (4+^VI_T8C^UU_X
M8+XO?_,#7^T=11_Q&7BK_J%_\$8;_P"9OZN_*Q_9]#^]_P"!3\O[_D_O\C_%
MQ_X4+^VI_P!&(_M=?^&"^+W_ ,P-'_"A?VU/^C$?VNO_  P7Q>_^8&O]HZBC
M_B,O%7_4+_X(PW_S-_5WY6/[/H?WO_ I^7]_R?W^1_BX_P#"A?VU/^C$?VNO
M_#!?%[_Y@:/^%"_MJ?\ 1B/[77_A@OB]_P#,#7^T=11_Q&7BK_J%_P#!&&_^
M9OZN_*Q_9]#^]_X%/R_O^3^_R/\ %Q_X4+^VI_T8C^UU_P"&"^+W_P P-'_"
MA?VU/^C$?VNO_#!?%[_Y@:_VCJ*/^(R\5?\ 4+_X(PW_ ,S?U=^5C^SZ'][_
M ,"GY?W_ "?W^1_BX_\ "A?VU/\ HQ']KK_PP7Q>_P#F!H_X4+^VI_T8C^UU
M_P"&"^+W_P P-?[1U%'_ !&7BK_J%_\ !&&_^9OZN_*Q_9]#^]_X%/R_O^3^
M_P C_%Q_X4+^VI_T8C^UU_X8+XO?_,#1_P *%_;4_P"C$?VNO_#!?%[_ .8&
MO]HZBC_B,O%7_4+_ .",-_\ ,W]7?E8_L^A_>_\  I^7]_R?W^1_BX_\*%_;
M4_Z,1_:Z_P##!?%[_P"8&C_A0O[:G_1B/[77_A@OB]_\P-?[1U%'_$9>*O\
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M@OB]_P#,#7^T=11_Q&7BK_J%_P#!&&_^9OZN_*Q_9]#^]_X%/R_O^3^_R/\
M%Q_X4+^VI_T8C^UU_P"&"^+W_P P-'_"A?VU/^C$?VNO_#!?%[_Y@:_VCJ*/
M^(R\5?\ 4+_X(PW_ ,S?U=^5C^SZ'][_ ,"GY?W_ "?W^1_BX_\ "A?VU/\
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MU_JVHSI:Z?IEE=:C?W4F?+MK.R@DN;J>3 )V0P122-@$[5. :_D1^-/[?O\
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M>_:RT;P7J'P]TWXMZ/>ZO;>$=4U&VU:^TA+/5+S3#%/?VD<4%P9&M&E5HXU
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M>E2Z(=5\5V<TNO6FEZ^^F:]IOB2Q"7NGQZ)J7A>QO)A<5_470 4444 %%%%
M!1110!_'O_P<N?\ )_O_  ;X?]GM3?\ JWOV5Z_L(K^/?_@Y<_Y/]_X-\/\
ML]J;_P!6]^RO7]A%>MC?^1;D_P#U[QO_ *E,B/QU/6/_ *2@HHHKR2PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX&UG_E*+\-_^S!OC
M7_ZT/\ :^^:^!M9_Y2B_#?\ [,&^-?\ ZT/\ :]/*_XF,_[%F8?^HTR)[1_Q
MP_-'WS1117F%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?Q[:+_RN4>+O^S%+;_U5_ABO[":_CVT7_E<H\7?]F*6W_JK_  Q7HY=MC_\
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M;KGC+X676D^!? &C3:]XEO[/3/&-E=ZG>6VF6Y$TUOIUHCW5VT8=XX$9E1R
MI]3U;_@GUH_[:'_!&#X:_L)?'[1]6^'^N>)?V4/A)X4NQK.FL/$/PK^+'@_P
M=H%YX:UR\TDSPL^I^"/&NE65W?Z2US$M['9W>F32B&YD- 'W)^P[X1\)> OV
M,_V4_!_@2#2K?P?H'[/'P>L?#PT1+"/2[C3E\ Z#)%?VG]E_\2^5-3:1M1>X
MLRT%U+=27*.XEWM_,W_P<A:/I?@G_@H'_P $0/CAX):PTSXVG]IP> _[6T^T
M,_BF;P-;^)O!U]!!($#F;1[6\\0^(4B1XCY4^I7KJ^TR!>"_92_;G_X+%?\
M!(7X3:9^Q+^U9_P3-^+_ .V!X,^"&DCP)^SW^T%^SBL^KZ1XC\$:3J$GA_P3
MH?B*ZAT_4;+[#IUC#IL6D"1=.\466B7NF:;JNDI)91S2^O?LA?L@_P#!1/\
MX*;_ /!3+X9?\%.O^"EWP)B_97^!G[,>AWEK^RQ^RKKNK37/C.V\9EI8(/%G
MB32)8H]0LQ%?>;XHU*X\16UC)J5_-HVGZ/9)IVC3.X!R'_!<S_E/E_P;W?\
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M!;ZU/J.F+>.[)JT'B'7=?:SDLTCO8GLVEA4H)93[7^W7^RI^TGX]_P"#E_\
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MR]E,JS:9XCU?XD:)X7U>6V,:E'>Z\%ZUXGM)(YRL1AE>0$SQ0@_G9X,^'O\
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M/XSTR71O$FA7A\0ZM/'!J>FS_OK666WEBG2.4+)Y4J%T5B5 !^-7[,L42?\
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M@\R4()&_ES_:]_X*>?\ !3S_ (*>_LX?$#]B+]EW_@CG\?\ X:>+/V@-*O\
MX3?$7XF_M$Z?;6GPU\ :#?"V3Q9=0WVJZ;I>AZ?J7E";3-,UOQ)?VD6@75]9
MZY9)<:O8V=N_]$?_  36_85O?V)/^"</P3_8L\1^*(M;\2^$_A9J>@^.O$>E
M*9].7QGXX74]6\9-X>%S%!)<:-IFNZ[J%OHCW<44UU8VMM+<QQO*Z* ?B_\
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MNZ'?:7KD&IQL55["73+JY2[4LN8#)\R]1_+E_P %*OV _P!N?]C[_@HU8_\
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MJ6X\$%EG\277PU\$^)67J/!7BOQ]H>E^* ?WD?RR:=*T3<O\LA_=OTK]#/\
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M(=0\.74U];7K:<EQ<7L6A:OI%]<W]E:7E[H>KZ9);2Z?>)\9?\%8G_X+&?\
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M[5M7TG0=.NM7UW5-.T72;)%DO-4U:]MM.TZT1Y$A1[J]O)8;:W1Y9(XE:65
MTCH@)9E! -&BJ>G:CI^KV-IJFDW]GJFFW\$=U8ZCIUU!>V-Y;2J&BN+2[MGE
MM[B"12&CEAD>-U(*L1S5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCT?\(KX8_P"A<T'_ ,$^G_\ R/7![3)_^@3,O_#CA?\ YV#M5_FI_P#@$O\
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M)]/_ /D>C_A%?#'_ $+F@_\ @GT__P"1Z/:9/_T"9E_X<<+_ /.P+5?YJ?\
MX!+_ .6>O]/3Y,_X>._\$_\ _H];]EK_ ,/I\-O_ )HJ/^'CO_!/_P#Z/6_9
M:_\ #Z?#;_YHJ^L_^$5\,?\ 0N:#_P""?3__ )'H_P"$5\,?]"YH/_@GT_\
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M_P#Y'H]ID_\ T"9E_P"''"__ #L"U7^:G_X!+_Y9Z_T]/DS_ (>._P#!/_\
MZ/6_9:_\/I\-O_FBH_X>._\ !/\ _P"CUOV6O_#Z?#;_ .:*OK/_ (17PQ_T
M+F@_^"?3_P#Y'H_X17PQ_P!"YH/_ ()]/_\ D>CVF3_] F9?^''"_P#SL"U7
M^:G_ . 2_P#EGK_3T^3/^'CO_!/_ /Z/6_9:_P##Z?#;_P":*C_AX[_P3_\
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M%%%?/FP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTGQWXHUGP3>V[IX(L/"/@WQ*MMJ]YK&GR7":=/::2-3M=4AM;V2XN+9+VSO
M#^Z:ZNK6QM;F^OKFWL[*SMYKJ\O+J:.WM;6UMXVFN+FYN)F2*"W@B1Y9II76
M.*-6=V55)'Y->+O^"[G_  2)\"^/==^&WBC]O'X%Z=XI\,ZSJ'A[7XH];U#4
M=)TS6M)GN;74;";Q!IFF7FARR6=W:S6DTMKJ$]LMR!$)BV<?EY^VC^TO^TU^
MV1_P:QZC^TE\,I?$-G\:?B9^S-\-[_XHW'AK?+XGU_P[H/CW0O"'QXU72O[%
MMH%M$\6>']#\4:]K5I9V\:6OAC4=:TJW_>"&0_.__!';QC_P;@?&C]ACX0_L
M]ZKH/[*5A\83\)](TGXZ>$OVBM+T#PY\7=>^(.H:)Y7Q&U"T\7>-$T[4]<BD
MU6&_N+;4? FLC3])L);#^SQIX\M% /Z__AM\3/A[\8_ WAOXF?"KQIX:^(7P
M_P#&&EVVL^&/&'A'5[/7- UO3+N-98+JQU&QEF@E!5MLL999K>4/!<1Q31O&
MOR-^U9_P4\_8'_8BU_1/"?[4G[4/PO\ A'XL\0V\][I7A77-7FO/$DMC;K"T
MM]=:+HMMJ5_IUH?M-N(9]1@M$N?.0VQF7<5\5_X)4_\ !,+X;?\ !,'X;?%/
MX?? _P"-_CSXJ?"/XK>/[OXE^#/#GC"\M-2T#X<6^H1R+!HW@:\L+^ZMY-&N
M;>2*74+M$236KV)-4N#]JDF:7^17_@G#\7O^"<7PH_X*B_\ !3RR_P""UMKX
M.B_:T\5?M):[I'PL\<?M0>&IM8^%]I\-QXA\1VJVUI?>(K.Z\(^$X)='A\$/
MHFJ^)H[:W_X1&#38-)U"UBLM224 _N,_97_;U_8X_;<L=?OOV4?VBOAG\<%\
M*"S/B>S\%:ZEUJV@+J$4<MJ^JZ+=1VFK6D,@ECB-Q)9_9TN6^RO*MQ^[KZ'^
M('Q#\"?"CP=K_P 0OB9XP\.> _ WA73KG5_$7BOQ7J]EH>A:/IUG"\]Q=7VH
MZA-!;PJD<;%4+F69P(H4DE94/X<?!7_@DG_P3]UG]O?X>?\ !3?]@SXQ:'\-
M9_"F@WWAWQW\,OV:];\,ZE\#_BM-JVD7-NT_BW3/#NK-9:<LVB:UI=X^C:=!
M!I=QJ>D^&?$?V1;^S:2[_.3_ (*_6-W_ ,%1O^"T'['O_!'/6_&NJZ)^S/\
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M_P!(L!MGDEE^73["U3)D*MMW1A(RJ+^IU '\1/\ P3Y_X) :E_P6LT'XD_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K^/;1?^5RCQ=_V8I;?^JO\,5_837\>VB_\KE'B
M[_LQ2V_]5?X8KT<NVQ__ &+L3^=,SJ?8_P"OD?U/[":***\XT"BBB@ HHHH
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M8:=I3VFF7-G\5]9\22R:.?M6IW&BPMHL>BZR+2'4K76=8_LO2D%Z?2?V$/\
M@DG^P3_P3?75[W]E;X&Z7X4\9>(+6>PU_P")WB34]3\;_$_6--N9H+JYTJY\
M;>);B^U>#2)[RWCO)-)T^6RTXW'S?90JQHGOG[8'[%?[,W[>/P?U/X&?M4?"
MO0?BG\/[^?[=:6VIK-9ZWX:U@02VL7B#P?XFT^2VUWPIX@@MYYX(M7T.^L[P
M0RR0M(T3LA /YPO^"KO_  1K_P""%^D_LH_%7]IO0[OX7_L<>-? _@CQ%XP^
M&OQB^"7Q(?1-/U'QE:Z9J&J>$=)TWP+I.OWVB^,)]8UO[-!IVG>$=(A\23JT
M<>E7L=O;B-/ OV9/AY^US_P4Z_X-//B=\/?B-/XH^*/QBO=%\:W?P4N_%DNH
M7OBKXC^$O@+X^T#QQX#TZVU>6=K_ ,1ZM>:MX/U?PCX>O]2N91=7MC8Z;?2M
M:VSD?HSX%_X-4/\ @DEX0\86?B;6_ OQA^)>D:/XAM->T+X?_$/XS^,-<\!V
M26+I);:/J&B)<VI\0:0"K)/::S<7*WEO)):WGGVTDD3_ -#W@?P-X-^&?@_P
MU\/OAYX6T'P3X&\&Z-8^'O"GA'POI=GHGA[P]H>F0);6&E:1I5A%!9V-E:P(
ML<4$$2( "Q!9F8@'\:W_  0G^ ?_  0O_;H_8B^$&C_$_P#9H_93B_:_^$_A
MZV^%WQ_\"^.+:WT#XE:CXQ\&K)I/_"<W&BZ[J]GJ.NQ^,]-LK;Q!JFKZ3#=6
M5MKMWJNF70T^\LY;"#["\0>&_P#@W4_9V_;Q_9H_9-^''[(GPD^(O[4WQ*\3
M6^J^#I_V??!>C?$K3/A'K6AWAN-*UGXH:OI?C CP>\5Y9O>01OIVJW6G0VHU
M75+.PL/)NW^R/VM_^#=C_@ES^V'\3_$'QL\:_!K7OAW\6_%FJ_VSXH\;?!7Q
MSXA^&D_B/4;B>WEU>^UK1=#N4\/7VHZVL#+J6J-I::E-/-+>"Z%U)+))]!?L
M(_\ !&K_ ()[_P#!.77-2\9_LS_ ^WTOXEZO:W5A?_%CQQKNL?$'XE_V?J$=
MO'J6F6'BOQ/<WM[HNEZE]FA>^TW1A86=U(@::)R3D _4>BBB@#_-Q^/'QUU/
M_@A)\<?^"U/_  3V\'3:[-X=_;%\!:%X_P#V-].2RU;6[4>)_C,/[%U_1H;'
M1M.MUGU<^$/$6H>$[2>"*Q2/5/"5A:B6^#VZ/_:E_P $;?V0H/V'O^";G[+G
MP%GTV#3O%EC\/=.\9_$8QZ4=&NKSX@^/47Q-XBEU6PDS<1:M9-?6VBWOVMGN
M@^E*DI4H(TZ;]JG_ ()3?L/_ +:/[0?P0_:@_:)^$T_CCXO_ +/:Z7'\-]93
MQ9XGT72K:'1/$S^,-(@U_P .Z/J=GHWB>#3O$,DFH6D6MVEXL3R21#]R[1G]
M%J /\_K]B#X"?LI?\%-?^"UG_!3Z\_X*\>)8?$_Q?^!WQ?/AC]FG]FCXF^-]
M<\#>!K_X>:'XMUO0+'6M&T%]:TQ=5BT3PQX=^&MR/!EIJPTKQ,/'NK>)=5\-
MZM'-/-:]K_P<_P#P_P#^"6'[(O["NC?L^?LK?!3]F7X?_M/?$?XA>#]>CM?@
M[X'\))\3-%^#?AF._/BO7/%/BS0-,O?$&D^$]2UA?"VDQZ?KVM6-GXBU"9[N
MVCO9M*NV7^E?_@H'_P $/?\ @GY_P4A\66?Q.^._PTU;0_C/IVF66C6OQB^%
MWB74_ ?CFXTNPN?.M;+7;G29%T_Q+%;027=G9/KUC?3V%O=R+9S0F. Q>*^#
M/^#;G_@E5X2_9]\<_L[7GP?\8^+M ^)WB#P?XD^('CGQ+\4/&DWQ4\17G@3[
M6_AO3$\>6.IV6M:)X5L[F_O;V3PGH<VGZ#>7MU)=WUG<W&R10#WGXD?MY_"+
M_@G%_P $QOV?_P!I7XX^%?B=XK^'FC_!_P" _AS5+?X6^$X/%NKV$_B'P3H5
MI::CJ]M=ZII%GIOAZ&0$:EJUW>"*W#1Q1PW-U/;VTWR/\4?^"9/_  0%_P""
M@_P-T_\ :0UKX7?LT>&O"?Q+T*W^(I^-/PE\<:/\&;O3KO6K!I[_ %#5]6\*
MZOX<T3^U+2[O;E->T[Q5H\X_MR*676--&K0[HOW&OO@/\)-:^"<?[.GBCP-H
M?C/X+CP'I_PSO? /C2T3Q3H>L^"M,TJVT6VT37;?61=C6(3I]I!'/)?&::>1
M//D<S?/7X"Z[_P &H/\ P2.UGQ9)K5MX-^-V@>$[O4M5U+4OA=H'QR\;:?X%
MNFU2=KK[!:6BW;:EI&DVEQ)*UM8Z9J-N$A<6ZR+''$$ /SY_X-?M8\:>(O&_
M_!6+]CGPO\=O''[1?[!OPE\4:5X _9U^(GBZ>_U728]/U^7XB>$)(?">J7+6
MQCL]6\"Z/X=N]3T+0GL]"@:PT[6M)T_18M?4WVM_P;6?M-^#?V(?&?[7O_!(
MK]KOQ%X1^"/[0_PO_:.\7>)?AGI?BZ^/AG3OB=H'B!X8;V+PQXA\0W%IIOB.
M_>[M[36/#,%C]GF\0^&-8L;[2(=36"ZG']7'[+7[(_[.7[%?PJT_X+?LP?";
MPI\(?AU87+:C)HGA>Q$$NL:U-:VEG=^(?$.I3-+J6O\ B"_@L;5+[6-5NKJ]
MN!!&K2[$15^5/V]/^"/G[ O_  4BO]%\2?M/_!F/6?B%X<M+/3]"^*G@S7M7
M\!_$FPTS3Y[JYLM*;Q3X=N+6[O\ 2[:XO+B:*QU-+R"-V5HU0PP&, _-_P#X
M.2_^"B?P.^#G_!/?XQ?LN^$_'_A7QW^TA^UMI+? +P+\*/!^MZ+XG\716WC:
M6VT[Q!K6N:)IU]<W^@Z;%I%Q-9Z=>ZA;0F_U>]L[+3Q+<,S1?G'_ ,%GOV;/
M$O[(?_!K3^SW^SCXU<CQE\+I_P!G/3O%L+2)+_9_BG5/$=_XIU[1_-1(DE&C
M:OK-WI"RJNV060<&0-N;]Q?V-/\ @WT_X)B_L2?$73/C)\//@MJ'C_XPZ'<Q
MWOA_XC_&SQ9K7Q/UKPQJ%M<W$UAJGA:R\0SS:)X>U>QAN#:0ZQIFF0ZF85#/
M=-)M9?C/_@[K_P"4.WC?_LMWP6_]2.:@#]'_ /@DU_P41_9__;2_8=^!WQ!\
M/?$CPAIOCKPI\-/"GA+XU_#O6_$VBZ?XQ^&/Q!\):/;^'_%.D^*-$NVTK4=/
ML3J^E7TVB:Q=:3IUAK>E^5?V2A#)'%^ '[5'QD\(?\%4/^#CC]@+X7_LK7&C
M_%OX9_\ !/(7/Q+^._Q:\):K;Z[X'2X35[77=2TS3?$>F78TZ\CTF_@T/PX+
MBPN;N&]\07MU!9S7<=E.B_H[JG_! '_@G%^WA\*/V?/CY\4?AYXQ\$?%[Q-^
MSK\$M.\8^+_@UX]USX;#QNND>"M$6VU+Q?HFBR+HFN:^;$G2Y=?N+%=5GT]+
M:&YN9_L5F8/U=_89_P""<7['?_!.+X>ZC\-_V2/@_I/PXTO7;S[?XI\03W=]
MXC\=>,+M)KB6U?Q5XUUV>]\0ZU%IPN98-*L[J]-CIEL1!8VT"#! /YQ_^#@?
M_E-1_P &Y_\ V<PW_J]_V<Z_L:KX;_:6_P""='[*W[6_QY_9?_:3^-_@W7O$
M/Q:_8\\6KXV^!&MZ7XV\4^&[#PWXA7Q)X6\6"ZU30]$U.STKQ+#_ &WX-T&=
MK37+:]MGAMI;5XVM[JXC?[DH _SQ?^"8/[*__!.?X ?\%'_V_O\ @G5_P55^
M!GP%'Q"O?B]J/Q,_9@^(OQRMY=*TCQEX'U>[U&2U\/\ A7Q9K^HV6E0Z9JVA
MR:;XD\/6NHW-O>:Q>3:K9Q/<ZE:BRC_<#]NO]F[_ (-MO^">7P;U'XR?'?\
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MAH=K#X1U:ZCC@MK?5/!VB:.^I:+H0M_#Y.EV&O:?I.EQZT'OOO;Q'_P:B_\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %? VL_\I1?AO\ ]F#?&O\
M]:'^ -??-? VL_\ *47X;_\ 9@WQK_\ 6A_@#7IY7_$QG_8LS#_U&F1/:/\
MCA^:/OFBBBO,+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*_CVT7_E<H\7?]F*6W_JK_#%?V$U_'MHO_*Y1XN_[,4MO_57^&*]'+ML?_V+
ML3^=,SJ?8_Z^1_4_L)HHHKSC0**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBOYI?V2OC]\;_P!KG_@X._;BCL?%7Q*M/V5/V&O@UHGP5LO!;^*[[3?A
MU=_'+7;BP35-=G\'V=Y]CUW4M3TN[\326%]K-HWV"/0X[BV\B?[*9@#^EJBO
MYU_^";/_  42_:;_ &DO^"N7_!4K]D?XI^(/#FH_!?\ 99OM#@^$>E:9X:M-
M+UC38]0U>.UN!JVLPR//JW[ABJ&9(RI)//%?T44 %%%% !117G_Q8^(6E_"7
MX7?$;XIZY%-/H_PW\#>*_'6J06R;[BXL/"FA7VN75O;ID;IYX;%XH@2H,CKE
ME&2 #T"BOYY?^#;OQY^T%^T!^QU\6OVO/VAO%WQ$\3ZK^U!^TI\3?&_PSM_'
MGBV^\00:#\']+U#^S?!^D^%]'DN[G2O"VC6-Y-KNE"RTI8/MCZ6L]TL@CMI7
M_H:H **** "BO@S_ (*9^$?VU_'/[%?QF\-?\$\_&^A_#[]K"_L=!;X<>(M>
M;2X(EM[?Q+I,_BO3],U+6[6^T;1O$&I>%8]7M-"U75+*XL;74Y+<3FU67[=:
M^A_L,^&_VIO"'[)GP,\.?MK>-/#WQ"_:ATKP/IUO\8/%WABUL[72]7\3;I9&
M=AIEGIVE7.I6UF]K9ZO?Z1INGZ5J&J07=[IUE;V<\,8 /K"BBB@ HHHH *^;
M_P!J;]DC]GS]M3X72?!7]IGX=Z;\4OA?/KND^)+KPAJ]UJ-IIUWK&A/++I-U
M<2:7=V-XWV*>8W$2)<HOFJC/N52I^D** ,'PMX8T#P3X:\/^#O"FEVNA^&/"
MNC:;X>\/:-9!UL]*T71[.&PTS3K59'D<6]G9V\-O"'=V$<:[F8Y)WJ_G]_X.
M+?\ @H!^T'^PA^QSX"3]EO4]-\)?&S]H[XT^&O@=X9^).J64&HQ?#BTUR"XF
MU+Q%IUG=07MHVNEQ96FFW5YINJ6MA#-?7ATZYN8;51Z7_P $IO\ @G[^W1^R
M?XE\5_%7]K__ (*/_$#]LJ7XJ?#7PY92?#G7O#\^E>$? 'BVWOXM3?6O#M_?
M:Q?S:@K:7--I;26^B^%FE:1I;NTO"L#0@'[;T444 %%%% !1110 444?Y_S^
M8H **** "BBB@ HHK\?O^"POPV_X*K?$CX8?!&R_X)5?%KPK\*?'^F?&+3+O
MXNW?B%O#5M/J/P]DM6@AD@N?%>CZUIMUI&DZDWVWQ'H=O;0ZKK&G[8M/FFDB
M:TG /V!HKG_"4'B6U\*^&;7QG?Z;JGC"V\/:+!XKU/1K66RTC4?$L.FVT>NW
M^E64S/-::;>:HMU<6-K*[2V]K)%%(S.A)Z"@ HHHH CCABB,ABBCC,LAEE,:
M*ADE8 -)(5 WR,  7;+$  G@5)110 4444 %%?SZ?\'!G_!0/]I/_@GY\)/V
M3_%O[-GB#P_X?UGXK_M/>&/AAXRF\0>'+3Q'%=>$]4ABDNK:SANW1;.Z9B0M
MVA+HK' S@C]\_#UW/J&@:'?W+!KF]T?3+NX95"AI[FRAFE8*.%!D=B%' !P*
M -BBBB@ HKB/B79^.-1^'/CW3_AEJNF:%\1[WP;XFM/ 6M:U;&\T?2?&=QHM
MY%X9U'5;10QN-/L]9>RN+R((Y>W20>7)GRV_,K_@CO\ #O\ X*A_#?\ 9V\7
M:3_P54^*GA?XI?&6\^)>MWG@>ZT-O#M[JFB> @D=O#9ZYKGA33-'T/4XKZ_B
MFU/084L?[2TO2[E;/4YVF"6]J ?K91110 4444 %%%% !1110 4444 %%%%
M!1110!_'O_P<N?\ )_O_  ;X?]GM3?\ JWOV5Z_L(K^/?_@Y<_Y/]_X-\/\
ML]J;_P!6]^RO7]A%>MC?^1;D_P#U[QO_ *E,B/QU/6/_ *2@HHHKR2PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX&UG_E*+\-_^S!OC
M7_ZT/\ :^^:^!M9_Y2B_#?\ [,&^-?\ ZT/\ :]/*_XF,_[%F8?^HTR)[1_Q
MP_-'WS1117F%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^*I4K0G7E3ARP3<$N:\FV_M#_B*P_P""D_\ TB4T3_PO_B'_ /,=1_Q%8?\
M!2?_ *1*:)_X7_Q#_P#F.KXOR?4_F:,GU/YFOT+_ (E!X _Z''$'_@6 _P#F
M7^KORM^;?\3C<:?]$KPQ_P"!YMY?]1WE^+[GVA_Q%8?\%)_^D2FB?^%_\0__
M )CJ/^(K#_@I/_TB4T3_ ,+_ .(?_P QU?%^3ZG\S1D^I_,T?\2@\ ?]#CB#
M_P "P'_S+_5WY6/^)QN-/^B5X8_\#S;R_P"H[R_%]S[0_P"(K#_@I/\ ](E-
M$_\ "_\ B'_\QU'_ !%8?\%)_P#I$IHG_A?_ !#_ /F.KXOR?4_F:,GU/YFC
M_B4'@#_H<<0?^!8#_P"9?ZN_*Q_Q.-QI_P!$KPQ_X'FWE_U'>7XON?:'_$5A
M_P %)_\ I$IHG_A?_$/_ .8ZC_B*P_X*3_\ 2)31/_"_^(?_ ,QU?%^3ZG\S
M1D^I_,T?\2@\ ?\ 0XX@_P# L!_\R_U=^5C_ (G&XT_Z)7AC_P #S;R_ZCO+
M\7W/M#_B*P_X*3_](E-$_P#"_P#B'_\ ,=1_Q%8?\%)_^D2FB?\ A?\ Q#_^
M8ZOB_)]3^9HR?4_F:/\ B4'@#_H<<0?^!8#_ .9?ZN_*Q_Q.-QI_T2O#'_@>
M;>7_ %'>7XON?:'_ !%8?\%)_P#I$IHG_A?_ !#_ /F.H_XBL/\ @I/_ -(E
M-$_\+_XA_P#S'5\7Y/J?S-&3ZG\S1_Q*#P!_T..(/_ L!_\ ,O\ 5WY6/^)Q
MN-/^B5X8_P# \V\O^H[R_%]S[0_XBL/^"D__ $B4T3_PO_B'_P#,=1_Q%8?\
M%)_^D2FB?^%_\0__ )CJ^+\GU/YFC)]3^9H_XE!X _Z''$'_ (%@/_F7^KOR
ML?\ $XW&G_1*\,?^!YMY?]1WE^+[GVA_Q%8?\%)_^D2FB?\ A?\ Q#_^8ZC_
M (BL/^"D_P#TB4T3_P +_P"(?_S'5\7Y/J?S-&3ZG\S1_P 2@\ ?]#CB#_P+
M ?\ S+_5WY6/^)QN-/\ HE>&/_ \V\O^H[R_%]S[0_XBL/\ @I/_ -(E-$_\
M+_XA_P#S'4?\16'_  4G_P"D2FB?^%_\0_\ YCJ^+\GU/YFC)]3^9H_XE!X
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ML/\ @I/_ -(E-$_\+_XA_P#S'5\7Y/J?S-&3ZG\S1_Q*#P!_T..(/_ L!_\
M,O\ 5WY6/^)QN-/^B5X8_P# \V\O^H[R_%]S[0_XBL/^"D__ $B4T3_PO_B'
M_P#,=1_Q%8?\%)_^D2FB?^%_\0__ )CJ^+\GU/YFC)]3^9H_XE!X _Z''$'_
M (%@/_F7^KORL?\ $XW&G_1*\,?^!YMY?]1WE^+[GVA_Q%8?\%)_^D2FB?\
MA?\ Q#_^8ZC_ (BL/^"D_P#TB4T3_P +_P"(?_S'5\7Y/J?S-&3ZG\S1_P 2
M@\ ?]#CB#_P+ ?\ S+_5WY6/^)QN-/\ HE>&/_ \V\O^H[R_%]S[0_XBL/\
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MKPQ_X'FWE_U'>7XON?:'_$5A_P %)_\ I$IHG_A?_$/_ .8ZC_B*P_X*3_\
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M%]S[0_XBL/\ @I/_ -(E-$_\+_XA_P#S'4?\16'_  4G_P"D2FB?^%_\0_\
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MC_B*P_X*3_\ 2)31/_"_^(?_ ,QU?%^3ZG\S1D^I_,T?\2@\ ?\ 0XX@_P#
ML!_\R_U=^5C_ (G&XT_Z)7AC_P #S;R_ZCO+\7W/M#_B*P_X*3_](E-$_P#"
M_P#B'_\ ,=1_Q%8?\%)_^D2FB?\ A?\ Q#_^8ZOB_)]3^9HR?4_F:/\ B4'@
M#_H<<0?^!8#_ .9?ZN_*Q_Q.-QI_T2O#'_@>;>7_ %'>7XON?:'_ !%8?\%)
M_P#I$IHG_A?_ !#_ /F.H_XBL/\ @I/_ -(E-$_\+_XA_P#S'5\7Y/J?S-&3
MZG\S1_Q*#P!_T..(/_ L!_\ ,O\ 5WY6/^)QN-/^B5X8_P# \V\O^H[R_%]S
M[0_XBL/^"D__ $B4T3_PO_B'_P#,=1_Q%8?\%)_^D2FB?^%_\0__ )CJ^+\G
MU/YFC)]3^9H_XE!X _Z''$'_ (%@/_F7^KORL?\ $XW&G_1*\,?^!YMY?]1W
ME^+[GVA_Q%8?\%)_^D2FB?\ A?\ Q#_^8ZC_ (BL/^"D_P#TB4T3_P +_P"(
M?_S'5\7Y/J?S-&3ZG\S1_P 2@\ ?]#CB#_P+ ?\ S+_5WY6/^)QN-/\ HE>&
M/_ \V\O^H[R_%]S[0_XBL/\ @I/_ -(E-$_\+_XA_P#S'4?\16'_  4G_P"D
M2FB?^%_\0_\ YCJ^+\GU/YFC)]3^9H_XE!X _P"AQQ!_X%@/_F7^KORL?\3C
M<:?]$KPQ_P"!YMY?]1WE^+[GVA_Q%8?\%)_^D2FB?^%_\0__ )CJ/^(K#_@I
M/_TB4T3_ ,+_ .(?_P QU?%^3ZG\S1D^I_,T?\2@\ ?]#CB#_P "P'_S+_5W
MY6/^)QN-/^B5X8_\#S;R_P"H[R_%]S[0_P"(K#_@I/\ ](E-$_\ "_\ B'_\
MQU'_ !%8?\%)_P#I$IHG_A?_ !#_ /F.KXOR?4_F:,GU/YFC_B4'@#_H<<0?
M^!8#_P"9?ZN_*Q_Q.-QI_P!$KPQ_X'FWE_U'>7XON?:'_$5A_P %)_\ I$IH
MG_A?_$/_ .8ZC_B*P_X*3_\ 2)31/_"_^(?_ ,QU?%^3ZG\S1D^I_,T?\2@\
M ?\ 0XX@_P# L!_\R_U=^5C_ (G&XT_Z)7AC_P #S;R_ZCO+\7W/M#_B*P_X
M*3_](E-$_P#"_P#B'_\ ,=1_Q%8?\%)_^D2FB?\ A?\ Q#_^8ZOB_)]3^9HR
M?4_F:/\ B4'@#_H<<0?^!8#_ .9?ZN_*Q_Q.-QI_T2O#'_@>;>7_ %'>7XON
M?:'_ !%8?\%)_P#I$IHG_A?_ !#_ /F.H_XBL/\ @I/_ -(E-$_\+_XA_P#S
M'5\7Y/J?S-&3ZG\S1_Q*#P!_T..(/_ L!_\ ,O\ 5WY6/^)QN-/^B5X8_P#
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M $;Q/\/M%T_1;S1-:\/Z9;V]IJ6G^-GU,W7VDS(+:T6.*1+F1HOZFZ_SV/\
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M ^*_$'[6/QFL9]3-MH;^#M$8QQ6M[IL@6.^N=/B\+C45DW2,T&IBT@VR234
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MF3< >#?LW_\ !(W_ (*S?\%!/A;IG[6'[<W_  5I_:I_9]\>?&ZRM/B7X+^
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M$=C?WEU81V.H^4EJK:/J\@D8V%QY(!O?\'*'[87[7?[)W[0/_!+RZ_9.\?\
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M* /:?^#>#_E8'_:E_P"S,O$'_J0_L[5_H3U_GL?\&\'_ "L#_M2_]F9>(/\
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MAJ,<NEMKVG:3JK1)#=QQNUWIUJ[2HY6)4*U^A-% 'X7_  G_ ."6GQF\ ?\
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M2QBU?1M$$^I>')=8URTT+2M)T.VTW3+F7_A(;C7?$>L7+74'U'_P70_X)?\
MQC_X*E_ [X$?"[X-?$+X:?#O6/A5\?-"^+.M:A\3O^$I&F:CHNDZ5?V4FG:6
M?"NB:Y=?VH]Q=12HMW;P6CPI(C7,3LKK^X-% 'X,?\%V/^"4?QJ_X*H_LA_
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MU_H%HH _D5^)W_!-[_@XZ_;B\(:I^SW^UO\ \% _V8O@Y^SGXJ2R\(?%>X^
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M<>'+6+_A'O&WAFYE3Y;S2=1B\UK2ZC-KJFG2W>F7L?DW3E/Y_?AE_P $\O\
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MU_1O!FAV&G0>((EE@MY((M6GDN9X8&1ML(CD6:6.1&K'_P""Y.N6?AG]I/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%!_^"^W_  17_:._9W\17.L>$-8\)>-O#NOZ'K-HVD^+_ 'CC0;C7O\ A(O
MWC30IF-QI/B#1_MEG+)&^ZWO+.[M+ZRFFMIU>@#^[^BO OVGOVG_ ('?L;_!
M#QS^T3^T7X\TWX=?"?X>Z<M_X@\0ZBD]S+)-/(MMIFBZ-I=E'/J.N>(=;OI(
M=.T31--M[B_U*_GBM[>)BQ9?YL[/_@ZBT?Q5X:O?BM\,_P#@EC^WQ\0OV?\
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M !1110 5\#:S_P I1?AO_P!F#?&O_P!:'^ -??-? VL_\I1?AO\ ]F#?&O\
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MC:GIVKS3>%_#FA>'+&X@T?3EU3419VTBZ78O?76H:I':V$%RURBO"&MO-?\
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M7:B,WEOC:0#J/^#4S_E"%^RY_P!CA^T9_P"M"_$JOA7_ (+0_P#*Q7_P0/\
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M5\5>'-8MH[W2=?\ #GB#3KC2=;T75+.4&*ZT_5-,N[FQO;>0%)[:>2-@58T
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M\DK_ %+12QSQQS0R)-#,B2Q2Q.LD<L<BAXY(Y$)5T=2&1U)5E(()!!K\0_\
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M/M-@ ?NE_P &[?\ RAK_ &&O^R6/_P"I!K%?M77XI_\ !NTRM_P1K_8:*L&
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MWXM^,OA[87]W*1O(L_"?@KP[I=O#N,<,=FS1JK329^$/^"P.@:+X._X.._\
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MZUO0=2\16\7VJ[AL;&Y /Z+O"7@;P=X#\&:#\._!OAC0_#7@7PQH-GX7\/\
MA+1]-M+'0-)\/:?:+86FCV6EV\26<-A#:((!;K$(V3<'5MS$_P 3/[#/[,GP
MX_91_P"#M/\ :7^'WPFTS3?#W@/Q/\ O&GQ3T?PEHNEPZ1H_A"X\?:%X=U36
MM TJTMYI(%TY-<34M2M%@BLH+:'45L(+.*&T1Y/T0^$O_!V-_P $R/%GP-M?
M&?Q.U'XH_#+X]Z=:Q:/XH_9JE^'?B'7/'<WQ @MXH+[P]X1O=-MI-'U>QN-<
M9M,TVZU&[T?4_,S%>Z/;W,3Q'\B?^"3/Q$^/GQB_X.;_ (H?'#]I+X?P_"#Q
M_P#'G]EOQ/\ %CP_\)9KLSZ]\/?ACK_AWPW!\./#/BM);'3IX/%UKX1LM*OO
M$5M+;^;#>ZB6E\EI?LT(!_?M7P!_P4RD_P""?]I^R?XQU?\ X*6V'PZU#]E_
M1M3T?4-:M_B/;ZG=6,OB>-YQX=M_#]OH+IXDNO%5S*;F'2;3P\W]J7(:XCC5
MH?.Q]_U_*E_P=@_LX_'3XR_LF?LX_%/X9> O$/Q?^%O[,WQ^MOBC^T7\(_#<
MMS/>^+?AN;73;<WT^A0+.-9T_2#9ZA8W[BQOY](M?$$NI+:FUBO9$ ,WP/\
M\'+G[)-CX3T3X6_L ?\ !.+]O?\ :)^&W@:PM/!/@%O@7^SQ#I_POAT_1[:&
MRLM%T,0:M>ZY +1I+*"XMKKPQ!=DWB7,AN+B8B7Y7_X-=/B1XD\?_P#!0?\
MX+3:WJ7PRUCX"6/COXA?#SXCW7P#UBTM]-OOAIJNM^+?BE=6NAZUH]O:64.B
M^)]+T[5FL?$.FQVEI+9ZB)]/OXFN+!/+_0#X9?\ !S;_ ,$=M)^!/A2/X/ZI
MXNL_&EMX6T/P]\/OV2/ 7P=\0Q?$2^\3&SL=(\-?"KPCIVCZ0OA6>]N-4>R\
M.Z3);ZHEO,%CFCM\^7;-^>'_  :_>+?B/XZ_X*7?\%K_ !G\8O"9^'WQ4\9>
M.O!OC'QO\.IK^UU*]^'NK^)_B%\4-8D\":C?V4-O;WVI^#%NU\+ZK>PPJESJ
M>DW<I:1V9V /[=J*** "BBB@ HHHH _CW_X.7/\ D_W_ (-\/^SVIO\ U;W[
M*]?V$5_'O_P<N?\ )_O_  ;X?]GM3?\ JWOV5Z_L(KUL;_R+<G_Z]XW_ -2F
M1'XZGK'_ -)04445Y)84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5\#:S_P I1?AO_P!F#?&O_P!:'^ -??-? VL_\I1?AO\ ]F#?&O\
M]:'^ ->GE?\ $QG_ &+,P_\ 4:9$]H_XX?FC[YHHHKS"PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HK'T3Q%X?\ $UK/?>&]=T?Q!96M
M_?:5<WFB:G9:K:V^J:9</::EIL]Q83W$,5_I]U&]M?6<CK<6EPCPW$<<BE1L
M4VG%N,DXR3LTTTT^S3U3]0/\OGXE_P#*:W_@L#_V7+Q%_P"II+7NU>$_$O\
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MG3G[.$ES<U6-E?\ )ZBBBOI#YP***:SHF-S*N<XW,!G'7&2,XR,_6@!U%%%
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M@#ZDT +12*RL,JP8>JD$?F*6@ HII95QN95R<#) R?09ZGZ4Z@ HHHH *.<
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MS":P^$K9AF-.MB,16Q6.J2C0P& RK!T88C'8F?M90^M86,:+C4E4I_DR&4G
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MC.&/_5)@0HHHK\M/O0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/"WCOPS>AA=:!XOT'2_$>D3EXI("[Z?JUK=VOFB*:6-9A$)461PCKN-=<2
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MN+$J\TLB_9I(PLKF50),,/0:* &HB1HL<:JB(JHB(H5$10%5550 JJ  J@
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MX(_^7E<7_P ,4_L;?]&E?LR_^&&^%G_S*4?\,4_L;?\ 1I7[,O\ X8;X6?\
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M@C_@ZC^!/Q/.B> /VZ/!O_#/OC28VUA_PMKPQ]L\0?!S5+AFBA%[KT1C?7_
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M>+O&/Q#^((LF?5RTUWII-K>7]O<N3)J-C?W<6CZ:D=CHEI<10'S&D5S\I_\
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MM83QZI:Q1S##>*?L)Z)^P/H'A'XB?&']L'Q/I_BOQ/X4:XB\!? "1-26?Q1
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M'V+5M22WNH=#EO-3BNF16>(WZ:%I,,=MX>MWCMYI)+B[KR?XW_#/]C7]K_\
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M0R6A4]MF=3"UXXCDPE"I'$?CU=6*_M@_M.^'?"?PA^%O@CX*V/Q,\6:/X/\
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MQ.[-=Z=!J%_ISO&FI7FNWMM=SZ:]^[:5I>D6EMJKQO-=[1^,(&(V"X&-X '
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M7A6UTZQMH7N;BZO'UZP,$45O&#),VY=Y2,%MB,P^Z2/WW_X*C:GILW_!1?\
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M,EM8=1BGM);H/86EGIVG7-M<:EJ]S;2S:AJ5Q'I-FB.A>NI_X+!3Z=;> /\
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M6[&">UM[7Q#'I5PDMW;O/#:B]>PN;]=0(6")I!<M*:[;_@G]I3ZE_P $T/\
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MX?\ C0_LFZ)XH_9V^-W@7P]>:_)X/U4W<ND>9=S/%IJ:W!-?ZW8ZSHTTVGB
MWN@:N;G1$UE9[JTEN##9CQLTPN+X8S?.,]\0J/B#@:BXMGC<N\4.%<_J9EP_
M@<CJ9O?*\LS+AZ&-J4\JRK#48T<JS#"8G),?3E5JU).LYSH2J>SEF)PG$N4Y
M/D?A]6\/\=2?"=/!YCX8\49!#+<_QN>4\IBLTS++>(9X*%3-<TQ%:5;-<!C,
M/G67U(4Z5*"H\D:\*?R!_P $NOV3OA9\>]?^,'Q1^.MA/XF^''P!\(IXGNO
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MO/AG+\?1P6;K*:-&G@\-7Q$*L88J>%HPI2Q6'IUJ,:-6&ORI^T#^V!^Q+=_
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MP^^&O@/XO'P)IFD^%],BTK2[O5]#\&^)=.UG5R$9DNWU/7&;[+<@*#&84C'
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M>/CK'_"/#PPOQS^')U$Z_P"9Y/\ 88_XJ'[.=8-T?L(TP3F].I?\2T0?;_\
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M0!2TU[86MS:1KM9I@&4GZJK^%K_@X9_X(^?LB?\ !/O]EW0O^"D7[!7AJ_\
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M$FDZHK1-Y^E7M[;C!E##^?3_ (A1_AC_ -)//^"D_P#X=_3/_E57]8=? O\
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MP!X<:UO$@4K&9H4\-V,>TAD9S<7#?OW+4 ?V 5YMXQ^,WP?^'GBCP/X'\?\
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MJMU;0ZSH%[?V!O+-V$5[9F<75G-F&ZABE#(/0J_BN_X(?>!M*_82_P""^O\
MP56_X)I?!/6_%O\ PS!X?^%WACXP^#?!OB+55U6#PSKD47P:UR&WMI9E,^=-
M@^.6M>';2]C*7.IZ-I&F2:X]W?P1S+_:C0!_'[_P=Y?$+Q]\/_@[_P $\IO
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M1110 4444 %%%% '\>__  <N?\G^_P#!OA_V>U-_ZM[]E>O["*_CW_X.7/\
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M#$YMY/&OVC?V]OV?-$_9PUW]D7]ACX8^*?AW\./%VLRW?C[QMXHO)[3Q!KT
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MH ]I_P"#>#_E8'_:E_[,R\0?^I#^SM7^A/7^>Q_P;P?\K _[4O\ V9EX@_\
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M *3\4X+GX%7=UXDM'L;O3IO#-WX>DU27PXD$F]=)O=9OKA9X+)X=3@BLX8
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M=_!::#I5E(EIJ'DQ"XUR_P!*TVVD>6Z=4^Q-,^/7Q"_X)&_\$1/@#\4OC/\
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M_4RTBOM[X _\$POV=OV</VU/VFOV\/ .M?%.\^-'[5]O96WQ+TOQ-XGT34O
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M3?:!X.F\5+ BV\UM9>(;-KV..>]:,_0GBO\ X-#_ /@GKK#:AH'A7X\_MJ>
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M<Q66L0:#XW\/:CX9UB;2;R>VO(+34XM/U.X>PN9K2ZB@NEBEDMIT0Q-\O?\
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M:U::$!"XD6338?@3_P $X?V,M-L]=\2^(='_ &>_V3/@[8:=>^*/$4-YXO\
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M];&_\BW)_P#KWC?_ %*9$?CJ>L?_ $E!1117DEA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '^7S\2_P#E-;_P6!_[+EXB_P#4TEKW
M:O"?B7_RFM_X+ _]ER\1?^II+7NU?ZU?1U_Y-'PQ_BS;_P!6^./\K/I-_P#)
MY>)?^P3A[_UG\M"BBBOVX_ @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]<^ WP:\1_
MM"_&#P)\%O".H:5I7B3X@:I=Z5I6HZX;@:3:366CZEK<TMZ;5)+CRS:Z7.B"
M%&<S/&-N"<>1U]X_\$P?^3_/V9?^QQU__P!5_P",*^>XNS+%9-PGQ3G&!E".
M-RGAO/<SP<JD(U:<<7E^58O%X:52G+W:D(UJ,'.G+W9Q3B]&SZ#A++L+G'%G
M"^48V,Y8+->(\BRS&1IS=.I+"X_-,+A,1&%2/O4YNC6FHSCK"34EJCQ#]IG]
MF;XH?LH?%'4?A5\4K&U75+>UMM3TC7M(:6X\.^)]&O%)M]3T>[EC1OE=7AO+
M&<+>6$RB.YC4NF? 88S-/;P*0&N+BWME8]%>XF2%6;'.U6<%L<X!QS7]<O[8
MW@WP'_P4+M/VA?V<+&TL=&_:9_9:U4>)?A?//=K!_P ))I6LZ5'=0PIM>2>7
M2M5"-H.LB:!UL=4-G=VBJKO)7\ETNF:CHGB3^Q=8LKC3=7T;Q+%I&K:;=H8K
MK3]4TS64L=0L;F,\I<6EW!-;S+R!)&V"1@GX;PC\1,1QWP[%9WAH9;Q=E>%R
MZ>>9?%1A3KT,SP5+'Y3GF!AS2_X3\XP56->FDVL/B8XG"MVI0<ONO%OP\PW
MO$3>28BIF/"6:8K'PR3'S;G4HU\MQM3 YMDF-GRQMF&48RG*A4;2>(PTL/BE
MK5G&'U)^UO\ L9_$/]CC5_ VB_$/Q)X4\17?C[09_$>DOX6&H^5;:=#.+?\
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M6VG6EM:S37+QK)YE?EQ\4OV3OV]_@MX<E\7_ !&\!_&'1?#5MAKS6;'Q'?\
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M3_9/PL_Y-IP!_P!D9PQ_ZI,"%%%%?EI]Z%%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '^7S\2_^4UO_!8'_LN7B+_U
M-):]VKPGXE_\IK?^"P/_ &7+Q%_ZFDM>[5_K5]'7_DT?#'^+-O\ U;XX_P K
M/I-_\GEXE_[!.'O_ %G\M"BBBOVX_ @HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^\?
M^"8/_)_G[,O_ &..O_\ JO\ QA7P=7W-_P $S[^PTO\ ;P_9MU#4[ZRTVPM?
M%VOR75]J%U!8V5M&? 'BY \]U=2100JTC)&ADD7?*Z1)ND=%/R'B%&4N ..H
MQ3E*7!G%,8QBFY2D\BQZ226K;>B2U;T1]=X?M1X^X&E)J,8\9<+.4FTDDL]P
M#;;>B26K;T2U/H/]M;XZ>//V;?\ @J3\3/C'\.+M;?Q+X5UO1R]K*%-KK>BW
MFC6D6M>'[U75XS;:O8A[7S'1_LTK17*#='@^U?\ !1+X(^"?V@_AS\//^"C_
M .SEIEH?"_C=]#'QWT&QN7OM5T+Q4=2TO2TU2_L[2-X[6YT>X232/%$DD-BS
M1#3-=FBBM[EW/Q3_ ,%0]0T_5?VYOCAJ&E7]CJEA<ZAHCV]]IMY;7]G.O]CV
MX)BNK26:"0J?E<+(2C JX5@0/4O^"7?[8ME\!/B5=_!7XI+%K?[/OQVO+;PY
MXET;5([6?1?#?B75Y8M/M_%5VEV?+CTBYMY&L?$D:@++;-#?2;I+&(5^0?V#
MFN7\"^''B-PKA'5XIX4X*R*CFF5P<J4^*N$YY5A*N:Y!6MI+&81QEF62SJPJ
M>PQU*<(TY3Q"2_8%GV58_CGQ&\.N*<7&CPMQ5QGG=?+,SDHU8\+\5PS3$T\K
MSVC=^[A,6FLNSF%*4'7P-6$Y5(QH-OZ6_P""[7/C_P#9I]#\)+K]=4->,_L_
M_P#!2[]L#X._!WP)\,_ ?[/7A'QEX0\'Z.NDZ!XDOOAKX]U2\U+3TFDDC>XU
M+1733;YXVD:,7$*EG  D=BHQZ_\ \%V=9\-ZO\4/@&GAG7-&URQT_P"'.KV1
M?1]6L=62V$6MR+%%<265Q/Y3F(*5\TJT@RRY&37Q=\*?^"I/[8/P6^'?A3X6
M^ ?$?PZL_!_@K2HM&T"VU/X::/JNHQ6,+NZ"\U*6ZBEOI]TC;[B5!(XP&)P#
M7E\#\,U>)? OP]P*X1X?XKE0J8W%2R[BG-,?DM#")YCG$5BJ-7 Y=F-:>*M5
M5+V,Z5*FZ56<_:-QC%^CQMQ+2X:\<?$#&_ZW9_PK"O# X:.8<+Y7@,ZKXMK+
M\FF\-5I8[,<NH1PUZ3J^VA5J5/:TH04$I2E'[5_X>\?MV_\ 1J?@?_PT_P 4
M?_CM?D;^TE\5_&_QQ^-OCKXJ?$?PM8^"O&OBVYTB;7/"^FZ5J>B66DOI?A_2
MM%LXH-+UDMJ=KY^G:=:7<GVMF>:6=YU)CE0G[?\ ^'S/[>/_ $-GPL_\-)HG
M_P G5^?WQE^,'CCX^?$SQ1\7/B3=:7>^-O&$NFS:[=:+I%OH6F32:3H^GZ%9
MM;:5:L\%KC3M,M%G*.S3W EN9&,DSFOO?#G@:IPQG.+QT_#W@KA%5LKJX3^T
M.&N(LWS?&XASQ6"K?4JV&S#)LNHT\+/V#KRKPK3J1JX>A35)PJ3G3^$\1..*
M?$V383 P\0N-.+71S.EBWE_$?#N491@J"AA,70^N4<3@,XS"M4Q4/;>PA0E1
MA3E2Q%:HZL94X0G]Q_\ !(;_ )/P^%/_ &#/&/\ Z8IJ\)_;^_Y/>_:G_P"R
MQ^(__1-A7M/_  27U/3-(_;E^%VH:OJ6GZ380:7XP\Z^U2^M=.LXBVA3!%>Z
MO)88%=V^6-#('D<A$5F(!\,_;UNK34OVT?VHKS3[VVO;*\^+OB*6TO["YAN[
M6XADM['9/:W5N\L$Z'JLD3NFX$9R"!KA(3_XCWF]1QDJ;\*,LA[3E?)S+BO$
M-Q4K6<DG=QO>VMK&6+G#_B V3TU*+J+Q5S6;@I+G4'PKA(J3C>ZBY)I2:LWI
M>YZ7X#_X*:?M8?"WX%>%?V?/AIXPT3P9X4\&V[V.DZUI6@:?+XO32YKS4=1N
M+!M5NXYS!YVH:D]R;ZVCAOT$$5O'<+;R3QR?9?\ P3[_ ."F7[0VN?M!>$_A
M#\=_%=S\8?AQ\8=0'@N_L_$UI:7M_H5]J5M/#97UA*8T^TV%U-LL=6TNZ,EI
M-9W,DZQ^=$-W2_!GX;_LG?M]?L=^"/@KX6U?X:_ ']K#X7Q?:98I;6#1H_&<
MMA]IL(]3O&E>.Z\0Z7KL.H6[WTD%S->Z?KC7,\=N(6C%=M^SW_P3^^'7[!_Q
M%T_]I_\ :P_:0^%TNB?"NWN]>\*>$_"$\LVIZWXC>QN[2S:6SO9GO-3($T\>
MDZ;IMLTEUJZVPFFB10:_,.*\V\(<3E/'F0YKP-A\FX[Q6*SZCA<D?#E6OQ-G
MF=XB4Y93GF3YG@,!5G76:XV>'QN'Q='%J%+]Y[5RIJ7M/T[A3*?%S"YMP)GN
M5\<U\YX%PV&R&OBLZ_UCIT.&LCR7#QI+-,DSC+<=CZ<:#RO!PK8/$82MA.>H
ME#V7+4<?9_#G[0_[%4.I?\%+]?\ V4OA<L>@Z'XW\6Z1K>FF2*%++P=X6\3Z
M:?$>JBUA1@)++1K,7$6F18>:2:6VCDC*;\?I+^T%_P %'_A_^Q+J%A^R!X!^
M'FK_ +1-S\&[;3M!\8^,OC=XEN->V:Q#I=K+#I.FPWL5P^^RLY[%B]H]MI=C
M"PTVTL@86EK\KE_;UU"]_P""AMM^VKK.A7<WA^'QI$B^%8K>S&MV_P +;:QD
MT"PTA&4BVEU^QTAH[UKGB6YN(FM3B23(_1C]HS_@GE\//VYOB3J'[3W[*'[2
M7PT;1?BS''XE\9^'_&.I33WVE^)6MK2TFGLH+25+_2H9(88;?4=&U.W1]/U&
M%DMG='D 7$^$PM+'^&V \;?K?^J>7^'V$=3&1>8SR^7B/2CAJ&8PSK,LHC]=
MA566PG+!)U:6%Q6)=6:E6J1FHUPQB\55P/B1C_!18-\69AQ_BE3P<_[/CF"\
M.JDL17R^>2Y=FTE@Y4GF,HQQKC3J8K#894J;C1A*%^ZM_B9X._X+(? /QU\,
MM%B\6? GXT?!G1U\2Z%\.M&\:*?A=X_M8X)AI)OO#:0+;7>F0ZPL-A-,=(DU
M3PK/-IDUOJ\MOJ4EDW\STT,MO/<6TX"SVEQ<6EPJG<JW%K-);SJK$ LJRQ.%
M8@%@ <#.!_2?\$/ 'PL_X(^?#[XK?%SXK_%_PE\4/CQXWTJ+PGX(^'W@![>4
MV]MN-]81R174\NI#[9J,$5]K>H7GV73;73["VAMHYKF9F/\ -G=W#7EY?7KJ
M%>^OKV_=!C"/>W4UTZ#'&$:8J,=A7VW@K'!4<;QSA.$8XR7AC1S'*:O!U?%4
M\8J53,,1@ZU3BBGEE?,H0S'%9;2QBP;HUL3[2"K5*]/#UJE.&GQ7C3+&U\#P
M-B^+982/B96R_-:7%^'PM3"2JT\OP^+H4^&*F94,NE/ 83,JF#>+5:CAW3E[
M&%"I7HPJ3U@HHHK]Z/P4**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#VG_@W@_Y6
M!_VI?^S,O$'_ *D/[.U?Z$]?Y['_  ;P?\K _P"U+_V9EX@_]2']G:O]">O\
M>?&K_DZ'&O\ V46=?^K7&G^R?A9_R;3@#_LC.&/_ %28$****_+3[T**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_CVT7_E<H\7?]F*6W
M_JK_  Q7]A-?Q[:+_P KE'B[_LQ2V_\ 57^&*]'+ML?_ -B[$_G3,ZGV/^OD
M?U/[":***\XT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /X]_^#ES_D_W_@WP_P"S
MVIO_ %;W[*]?V$5_'O\ \'+G_)_O_!OA_P!GM3?^K>_97K^PBO6QO_(MR?\
MZ]XW_P!2F1'XZGK'_P!)04445Y)84444 %%%% !1110 4444 %%%% !1110
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MK_\  K4/_GF4?\0GOB;_ *3&?MU_^!6H?_/,H^K8#_H9K_PCK_YAS3_Y]O\
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M_P#".O\ YAS3_P"?;_\  H_UW_IZ?V$T5_'M_P 0GOB;_I,9^W7_ .!6H?\
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M!6H?_/,H_P"(3WQ-_P!)C/VZ_P#P*U#_ .>91]6P'_0S7_A'7_S#FG_S[?\
MX%'^N_\ 3T_L)HK^/;_B$]\3?])C/VZ__ K4/_GF4?\ $)[XF_Z3&?MU_P#@
M5J'_ ,\RCZM@/^AFO_".O_F'-/\ Y]O_ ,"C_7?^GI_8317\>W_$)[XF_P"D
MQG[=?_@5J'_SS*/^(3WQ-_TF,_;K_P# K4/_ )YE'U; ?]#-?^$=?_,.:?\
MS[?_ (%'^N_]/3^PFBOX]O\ B$]\3?\ 28S]NO\ \"M0_P#GF4?\0GOB;_I,
M9^W7_P"!6H?_ #S*/JV _P"AFO\ PCK_ .8<T_\ GV__  */]=_Z>G]A-%?Q
M[?\ $)[XF_Z3&?MU_P#@5J'_ ,\RC_B$]\3?])C/VZ__  *U#_YYE'U; ?\
M0S7_ (1U_P#,.:?_ #[?_@4?Z[_T]/[":*_CV_XA/?$W_28S]NO_ ,"M0_\
MGF4?\0GOB;_I,9^W7_X%:A_\\RCZM@/^AFO_  CK_P"8<T_^?;_\"C_7?^GI
M_8317\>W_$)[XF_Z3&?MU_\ @5J'_P \RC_B$]\3?])C/VZ__ K4/_GF4?5L
M!_T,U_X1U_\ ,.:?_/M_^!1_KO\ T]/[":*_CV_XA/?$W_28S]NO_P "M0_^
M>91_Q">^)O\ I,9^W7_X%:A_\\RCZM@/^AFO_".O_F'-/_GV_P#P*/\ 7?\
MIZ?V$T5_'M_Q">^)O^DQG[=?_@5J'_SS*/\ B$]\3?\ 28S]NO\ \"M0_P#G
MF4?5L!_T,U_X1U_\PYI_\^W_ .!1_KO_ $]/[":*_CV_XA/?$W_28S]NO_P*
MU#_YYE'_ !">^)O^DQG[=?\ X%:A_P#/,H^K8#_H9K_PCK_YAS3_ .?;_P#
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M]%)PC_X-SKR_ZD_F_N\SY/HKZP_XA@/^"P__ $DX^"?_ (*/B-_\Q5'_ !#
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MQ]_T4G"/_@W.O+_J3^;^[S/D^BOK#_B& _X+#_\ 23CX)_\ @H^(W_S%4?\
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M)WQ]_P!%)PC_ .#<Z\O^I/YO[O,^3Z*^L/\ B& _X+#_ /23CX)_^"CXC?\
MS%4?\0P'_!8?_I)Q\$__  4?$;_YBJ/^)NO#G_H6<2?^"<K\O^IGY_@^P?\
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M9^?X/L'_ !)WQ]_T4G"/_@W.O+_J3^;^[S/D^BOK#_B& _X+#_\ 23CX)_\
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MG*_+_J9^?X/L'_$G?'W_ $4G"/\ X-SKR_ZD_F_N\SY/HKZP_P"(8#_@L/\
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M_@G*_+_J9^?X/L'_ !)WQ]_T4G"/_@W.O+_J3^;^[S/D^BOK#_B& _X+#_\
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M_P!)./@G_P""CXC?_,51_P 0P'_!8?\ Z2<?!/\ \%'Q&_\ F*H_XFZ\.?\
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MB_8(M+J&.XM;K]LR"WN;>90\,]O/\/M=CFAE0\/'+&S(ZGAE8@\&@#[EM?\
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M4X?#N8[][;4I;F\@N+.*'4)C9VYE5?W'_P"">W_!0#X%?\%)_P!F+PO^U%\
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MW]M'/%XNN_"UOX8TR>ZTN.%QJ$[+=6MJNGN&CU&5E5Y@#^KFBOQ=_P""?_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P ',EA::K_P7/\ BMI=_"+BQU)_@?87L#$J)[2\T?2;>YA+*0P$D,CH2I!
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M$Z3\._#'BE]-TR#7K/4+>R_M+5?%=Y)J$MM!#/.EM:1O.\:*B?A3-\)/AS\
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MU3X>7DPU?X6>.M5CL3IWAR^U]()[FQTE[H?VOH]]>7>GI<26NHI#]$_MH?\
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MI'A?286222&,:6(6ECDEN47Z3^'?_!;?X*>!_P!EW2?V5-"_X(&_$.3X0/\
M#:#P)J-JG@&*XD\0V5]X>_LG4?$E[?3^!)]1O]<U5;FXU(:Q<ZK-J2SW"O#J
M"%(W3[6_X.V/^"2WQV_:HM?@]^W/^S!X*U[XD>-?@QX-O?AO\6O O@W3_M7B
MW_A7VGZKK7C3P_X^T6SM9QJ6N3^'-3U76-/U6RTZTN-5@L+K3KNW$]O9RI:_
M!_P:_P"#RCXM_"+]F+3OA'\7OV/+KQ;^U#\/O!47@BQ\=/XIE\*^$=9\0:-
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M&I?!MY;J[=3,JRR%[>$PL@A:(QH=SE%(_H]_X.@4=_\ @C-^TZD:/([7GP[
M2-'D8D^,M,_A0,<#J3C ')('-?B%_P &F'P,T/\ :/\ ^"6O_!27]GSQA!Y?
MA_XQ^.;KX=:J;RVD:%+;Q7\)KC2A</$Z#SXK:6YCGD1,EA&4!5^@!^:O_!GI
M^QE\"OVE/VOOV@?C+\</#GA+XD7G[/\ \,='?P%X!\;:%9>(],/BKXC:Y/I]
MU\09+'5%N+&\NO#6B:-JNAP0W]G>0"?QB-058[[3[.9/K?\ X/+/V'?V9O@Q
MI?[*?[3GPA^&GA?X7_$KXC>)?&7PQ\>VW@;2-,\,^'?%VA>%O#^AZIX;U.\\
M.Z3!9Z=%KFB?:;K3FU6SM$EO=.N;6WOV<V5HY_%+]F']H?\ ;N_X-DO^"@_Q
M-T/QU\%?^$@6]L=4^'_CCP3XMBUSPYX*^.?PUL/$(O/#GQ"^%OCB&POH8X+J
MZTV'4/#_ (GM=-\016$-YJWA_7-&34UOK.QZ_P#X+A?M_?MM?\%6_A]\"/VM
M_BU^SG/^S1^R?X8\0ZY\-O@'X(NKSQ'X@O/%_C76_#>@>*?'OCNQ\4ZOX3\*
M1^*]+O\ 2XO#MK:ZKI>C:=HUE;6MOI<,NJ:A#?7C '[[)_RIEM_V(3_^K>-?
M,W_!FK^PM^SS\=+K]K;]I;XV?"KP;\4/$WPMU?X;?#SX7Q>.=+TCQ5HWAUO%
M.F^*]9\7ZM#X9U:"\LX]8DBTO0K*QU6[M)-EK/J,5D5E69T^FPKI_P &9KK(
MCQLO@-P5D1HV!'Q>(Y5PIQZ'&".02"#7\]__  0L_P""@/[9O_!+GPA^U#^V
M)\'?V>%_:4_91TV\^''PW_:3\)+XLU'PO-X2\4^)+?Q9J/PH\<G4=+TCQ1+H
MEE:W&E:_HM[KM_X3U73&35TT1[K2KO5+6[4 ^]/^#Q']BGX&?LU_M2?LX_'+
MX'^!_#7PQN?V@_ 7BJ#Q_P"&_!6DV_A[0;[Q9\--3T>TM/%]OI.FPVVEZ;J.
MHZ%K^EZ7?#38+9+E]#@OIXS=SSSS;7_!=+]K_P")_P 0O^"&'_!$[P/JOBS7
M;D_&KX8V?CKXKF[>>5O&>J_"[PQH_A;0+S5KT^;%=FVUB?5M5A@DN&NO-EM[
MFY0.BD?G/^V#^U+^W]_P<S_MO_#/PW\,?@/<:-I7A^"R\#?#+X9>&YM2U[P/
M\'-&\02?;O$_C;XG_$^XT+2K>,ZK/I=UJ6JZ_J.FZ+ VF:-I^AZ%HMUJ-K''
MJ7]D'_!:S_@A=XC_ &BO^"3G[-/[.W[*.E6&H_%?]@CPQI#_  T\#Q3I _Q(
MTB'PMIN@>/?#>DZOJMS;JFN:M)8#Q#HZZM.B:IJ-L;26XAO+R,R 'J/_  ;4
M_L!_LQ^!/^"2OP'^(FI_"#X=>./&_P"TYHVN?$OXF>(_&O@SP_XIU+5EO]<U
M/P]IGAEY]=TV\=?#NE:3HENEOI*8LFN+F\NG266X:0_Q>?M ^'=-_P""8G_!
MS2?#?[*5E=>&_#'PR_;(^")\*^#_  X!9Q1^$?C7H?P[UGQM\,=+A^T7"IHM
MUI'Q(\1^"=.AGEE:+3GM6E5;B+:GU9_P35_X.6/VB_\ @DM^S?>?L-?M ?L?
M:Y\2-3^$-YKUK\+E\4^*=?\ A5XL\&+?7UQ>3^"/&FB:WX5UZ>XT33]7FO;G
M3[W2X]-N;*"26P.GWF]+V"/_ ((L?L!?M<_\%??^"J=E_P %.OVF_ GB'0?@
M+IOQGO\ ]IGQ1\1M5T6\T7PCX_\ '?@_Q-:77@#X3_#)[^W/_"0:5X=UVQT:
MPOIXUO=.L?"?@O4M*U?59-<N((;L X3_ (/%',G_  57T5RC1E_V;_A@YC?A
MT+3Z\2C <!E)VM[@U^L?_!W#_P HNO\ @E9_V,?AW_UGC3J_*3_@\4M[B;_@
MJUI1BM[B51^SE\,@6C@E=,FYU_@.J%21CD DKD9 R,_J_P#\';L,TW_!+O\
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M:^+_ !;X4\%MML-'UO7H->UJ.X<2SV%H-3NVTNPL'9&3]<*_AK_8H_X+[?\
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MHM[2Q\87D.B:AX@L;2WO-1@ /YD/^">W_!3S]L+_ ((6? WP]^PG_P %"/\
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MH:1J6AW<E_/>VD(T.TOM8\3ZUXXUS3]/TJ>0"WU2ZCE ,9K^VROPN_X)"?\
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M$%WJ,.CI'+K#2Q6UYJ$MO<Q6:'[38C45%A)L?\$"_P!C_P#:@\=_M1_MF?\
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M%Y?QV\J1ZA+!IS7:2MIMFT,7_!R/\-_ 'BG_ (*9_P#!$Z^\3>#] \07.O\
MQH3PAKK:Q8I?Q:SX5LO'/A[6+7P_J=I<%[.]TJ'5+R[O5M9[=U:6YG$A>*1H
MSVG_  :HI(GC;_@K\7BEC#_MS^)&7S8I(MR_;?$HROF*NX9!P1D$8(X()?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /QD^(W_!>'_@C!X&\>>,/ 'Q)_
M;,^$FF^//A]XFU_P+XOT?5O WQ*U&^T+Q+X3UB]T37M$GNX/AW>VLSZ7K%G?
M6DCV=W<6;RQR26TTL3K(^0O_  <8_P#!%!555_;Y^&*JH"JJ^#_B\%50,!5
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M++_@XB_X(@Z;&\6G?MV?"73XI'\R2.R\#_%BUC>3:%WND'PVC5GVJJ[F!;:
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MN;;P!\4X+@>8"LF)HOAHD@WJS*^&^8$AL@FOUG_X9[^ ?_1#_A!_X;3P9_\
M*6C_ (9[^ ?_ $0_X0?^&T\&?_*6@#\8?C3_ ,'+W_!(CP+\(/BCXS^&?[8'
MP\^*/Q'\*_#_ ,7Z_P" /AM9>&_BK87/CWQKI6@W]YX6\'I?WO@*SM-/7Q%K
MD-CI4M_<W4$-E#=274DBK":_SK_^"F__  64_:>_X+1>/O@9X>_:#7X)_ _P
M%\.]3N].\*Z7X5TWQ1I_@7PQJOC2\LK+Q#X]\7ZYJEUXX\9W2)IEEI4-_%8F
MYL[2QTEI]-T/[9<W'G?Z]W_#/?P#_P"B'_"#_P -IX,_^4M'_#/?P#_Z(?\
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M_P""(&F(\>G?MU_"73XY&#R1V7@;XL6B2.!M#NL'PVC5F X#,"0.,XK]7_\
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MX%T'PK\1]+NM7GM?$^EWMU!9RZKX&TK2('CMHI[AC=7MK&RQN YD*JWY!?\
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M%2W?_!P]_P $/M0BB@O_ -NGX1WL,!!@AN_ OQ7N8H2%V Q1S?#5TC(3Y1L
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M44 %4[W3M/U%$BU"QL[^..02QQWMM!=)'* 5$B).DBI(%9E#J P!(S@FKE%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#X:^$WCZ[36/L$D5U;WUS:PWEGJ'A@7]IJJV6G^)Y]"OTTK7K_7TB6\;W_\
MX.9_C)XR\2?M0?\ !-;]@'Q[\=_$/[,?[$O[6'B[7$_:;^*'A[7O^$8&M:)9
M^(= \-W'A;Q%K\DL>F6WA>VTK7)KB^LO$27'AZ:\U*PU;5K>:ST29" ?UP>'
M_B3\.O%L\EMX5\>^"_$MS$T:2V^@>*=#UF>-Y1(T2R0Z=?7,B-*L4IC#*"XB
MD*@A&QVM?R+_ !N_X-:/V)]5^#?AWXK?\$J?B;XO_9T_:A\(W^B>,/@K\?\
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MJZ8)[JU.I6 N;&$W-[;F\MQ/9VX19#/=1&3S+>$1LKF6940(RL6VD$_R(?\
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M1E='4.CJP961AE65@2&5@00P)!!R#BOY/OAO_P &A?\ P3L7X50V?Q_\:?M
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MIT<S7EI%<QNKP23PQI,IS&S8.-FOY[_^"BG_  0GU/\ :O\ VGKW]NS]EO\
M;@^/W[%'[7[^#?"W@E/%/@:\74OAYJVB>%+M;JVL-?\ #NDW7A?Q+=V>K+%;
MP:UIMQXJO_#E\UE83WGAN\2WN;6_ /Z$**_A1^-G_!8K_@L7_P $5/$NG>"?
MVY?&W[#W_!1#X?0:QK>E/JOP^^*?A;P#^TC8VMG<6ZZ3)XR\*:);:3?^&;B>
M&<P&*]^%?BLO<6]PEQXDNIK2:\OOZCO^"6W_  4H^&O_  5._9BLOVE?AIX
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M;P:7JEQI>K3^&/%WA'P)HNL0Z=JL):XTZZ>RNIE@NH/G@E(E0;AD_C'^S?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?\&O-H]_\?/^"^MC'GS+S]M/[(FT@-ON/&G[3D*X)X!W.,$\ ]:_LIK\EO\
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M-I-+97<+R6UQ''/ [-%,B2(RC^FC]GS_ )()\$/^R0_#7_U#-%KXC_X*L_\
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MS?:[EXY6D9@D,46V-0#\2O\ @ME_RGO_ ."$W_8Q>)O_ %(Z_L(K\F_VQ_\
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MWO\ V=0__J1^,:_9G_@G-_P2A\(_\$[_ (T_MK_&;PW\9_%?Q0OOVT?BO/\
M%77="\0^%M$\/V?@2\F\0^+_ !!_9&CWFE7MU/K%LC>+9+%;J^CM9#!IUO*T
M1GFN':?_ ()X_P#!*CPE_P $^?C7^V5\:/#OQE\5?$V^_;$^);?$G6]!\0>%
M]$T"S\$7;:IK6I?V9I-YI=[=3ZO /[8-L+B\BM7\JTA<Q&:29W /S&_X.]?^
M45%C_P!G(_!S_P!.5]7E'_!R[\'O%OQ3_P"#?WX.>(/"NF:EJD'P2UK]EGXM
M>*TTT+)]B\*1_#G5OAW?:E?P[6FETVQO_B%IDUP;=2UJPBOK@I96MU(G[@_\
M%6_^":_AC_@JA^S'#^S/XM^*WB/X.Z5#\0?"OC\>+/"_AS2?$^I-<^%9;F6#
M3CINLWEC:"&Y>XW//Y^^-HD_=RH7C;[8L?@UX,G^!^G? 'QKIEA\0? *?#+3
MOA5XDTKQ+IUM/I_B_P -6OAJ#POJ$&LZ9\]L8M8L(I#=6R$I&9V$+@HC@ _D
M]_8\_P"#=/\ X)<?MB?LR?!7]I+X8_'7]K?4O"OQ7^'_ (;\3QQV/[0E_>-H
MVK7FEVS:[X=U$622Q6>KZ#JWVO3-2T]_+FL[FW>&2&(@(/:_V?\ _@C'_P $
M;?V.?^"CW[/^DZ5^TW\3]:_;?\!Q'XL?"?X,_$+XSW_B3Q!?:;:V^H+'JD^C
M/IS%M.$*7]ZFFW-];/>6]M-?+;2VUN\RL_XAG_&GP$\7>)]0_P""=?\ P4^_
M:E_8V^&WC37-0O-5^#NF,/%GA/0=,U8W4U_#X9GEUS3L7(DDMK:"2]TW[8]G
M$GVG5I9K>(O]\?\ !-C_ ((:? 3_ ()^?%'Q3^TIXG^*_P 5?VMOVM_&6FWN
MB:Q^T%\<[V+4-9TS1;Z=)9K+PCHTMQJ[^'9YH5.G76H+K=[<S:3MTR#['9>;
M#, ?MW7\>7_!RS=_\,__ +:__!&K]N'Q?HNJZA\%?A'^T#J'A#XE:W"\$>B>
M%&U+6?#&K:;>:G/-;W"6MS<Z6_B/5[9723[=:>$M0BA\B: 2G^PVOG/]K#]E
M'X&_ML? ;QY^SA^T3X*L/'/PQ^(&FM9ZCI]TJQZAH^IPJ[Z1XI\,ZD%:XT3Q
M3X>O&74-%UBT(FM;E#'(L]I/<VTX![IX>\0Z%XMT'1O%/A?6--\0^&_$6F6.
MM:#KNCWD&H:5K&D:G;1WFGZEIU]:O);W=E>6LT5Q;7$$CQ2Q2*Z,00:_D+^
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M]FUJUAI6AZOXJT#7X+2]216EMIK[0+;Q@+>]*20*(64@7$=NK_M7_P $O?\
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M0+/P1=OJ>L:E_9FDWFEWEU/J\"_VN;87%Y':OY5K"YB,SS2. ?B__P $$?\
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M ((AV@O_ /@N'_P7UL2[1B]\;):&1" \8N?&VJPET)X#)OW*3QD#-)_P:_\
MCG0O@C\?_P#@JW^P+\2(I/!GQ]\%_M6^(OB;IWAWQ+>6=KKWC/P1?:GXBTR3
M5-)T]HX;J]CTBRB\.Z[<W$3W$5UI7C+3M0M88;:.YD;]L_V+/^"4GA']C+]M
M;]MW]M#1/C-XJ\=ZW^VOKD6N:]X"UCPMHNCZ-X"EBU^[UT0Z/K-A>W&H:RNZ
MZ%EOOK>UQ!#'(4,S2._B?_!23_@A%\!?V]/C#X:_:J^'_P 5?B1^Q]^V)X2L
M[*SL?V@?@D\5IJGB&'2Y+3^RO^$UT>*[TAM<O-/L+5]$M=5CU6SN_P"QKDZ=
MJ*ZK8VMG9P@'T5_P6E_:'^&/[-/_  3#_;&\:_%'4M'M-/\ $_P2\>_"OPMI
M6K7*0R>*/'/Q,\,:KX4\,Z#I,#'S+[53<W\FK16L"F1;72KNZ<I!;2RI^#7P
MB^ 7Q*^$_P#P9]_$_P ">*/#VH0>+_%/[*OQ*^)=KX=%A<0ZO:Z#XW\8CQEI
M2WEC*!/'=+X>FCU&=2JL+=A)L'W:^F?"7_!M,OQ;^*/A3XD_\%,/^"@/[1_[
M?NC^!-=CUGPS\(O&5PWA;X;W,^EWD,FCW'B6TM]8U*34DGL8GL-;TVQM=+%]
M:7=W9-JDMM,X;^FG5? O@_7/!-_\-M7\-Z3J'@+4_#,_@R_\)W%I&^B77A6Y
MTQM&FT&2RP(_[.?2V-CY"A52WPB%=JD 'XQ_\&WWC/PEXM_X(Q_L267ACQ)H
MNOWG@WP#X@\*>++72M0M[RY\.>);7Q_XMO[G0M:@B=I=.U.&RU"QNVM+E(Y&
MMKNWN$#0S1NWX@_M%?'OX7_&[_@\8_8,TGX9>*=)\6M\#_@QXJ^#OCV]T2^A
MU*PTWX@:=\)_VI?&6L^'S=6VZ W^B67C32[#5K>.69K+4XKNRG:.YMY[>'Z:
MN?\ @U+TWX;>,_B6G['G_!2?]J;]E/X'?%_4[N;QA\&/!T2WMI::-=M'G1]+
M\06WBC0Y+WR(#-9V6I:IIIU6ULUMK>6^OHHBE?:GP8_X-U/V8OV<OVXOV/OV
MRO@C\3O'/A.+]DCX<>)O!,7PVU;0]#\2WOQ>\1>,O^%TR>)_B7\2?B9//8^(
MM3\8ZS=?&:[DO+N73;K_ $;PSHUA!)!:EUC /A/_ (+_ /\ REQ_X(5_]EGU
M+_U*=!K^P.OR=_;J_P""5'A+]N/]JG]BK]J37OC+XJ^'NK?L8>+;CQ9H?@_1
M/"^B:WI?CN>XU;3M5:TU?4]1O;:]T= =/^R^;8PW1,-Q*_EB9(I$_6*@ K\S
MOVPO^"K/[,O[#'[27[,W[-G[05OX]\-ZM^U7<R:=\./B/;^'[63X6V&KPZW!
MH$VE^*_%=[JEA!HT]K?:AHDE^QBN$L-/UJQU"Z,=NS,/TQKX6_X*!_\ !.G]
ME[_@I?\  ^7X%?M0>#9M=T6RU./Q!X,\6Z%=KH_CSX=^)HE2,:[X-\1""XET
MZ:\MT^P:Q8RQ7&FZUIS-::A:2F.VEMP#[6U+2=&U^RDL]7TS3-:TZ\MY(9K7
M4K*TU*RNK6YC*2Q2074<T$]O<1.4D1E:.6-BK!E8@_QE_P#!&"/PE\)O^#AK
M_@K-\!OV3$V?L>/X&M?%&I^'O"$IO/A/X3^*%GJWP\=G\-W6FW%SH4-S'JOB
M#QGHME;QS?:GM9=5LHHGM=!#6OM-O_P;,?M'Z;X;7X4:9_P6S_;4A^!\]LVE
MW_@Z2SD.J-H4]P9[O1[75!X]=8HI!%;P0R!$@@A,D:V'V9%M)/W8_P""=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#&2;KQ7DGW/<UQO_  9M0Q)_P23\33+%&LTO[7OQA665459)5B\%?"3REDD
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M6NW\(17 LI--MKCPUI!OM,%Q'!?K%<*S0K<$)ZA_P7F_Y0\?\%"/^S<O&/\
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MB1X<_:G^$$WPMF^QQW'B :I?3ZG!K<7A^X.9[25M.CBN+LP*PN!:V\,BG*$
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M\MK#-;$P+(_V]_P7OL=+TK_@LK_P00\5^")_)^,=_P#&+Q)H&MC1-/4^)O\
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M(;_3-7T>YFT[4!%:_O5%''#''%"B10Q(D<442JD<<:*%C2-$ 5$10%15 55
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MC_BQ<XXXX/BSPP"/H02#Z@XH ^[OA!^UK\(/B_\ LE^"OVSM-UN/0_@QXO\
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MQFN;JW.C&;P;H]VWV^W^:&]U_2YG?$#0R^J?\%=_^"C?[=_[/OQ5^!7['?\
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M)^);^72K.WA\1Z;9V]A#;V]CJFK1/J&E:_IT&K7&AM+JFC7UW%8SVL/Z&_\
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M=(U'Q'>^(?AQ+I=S=27PDMYK>\M_^$9@L%N[9D=]1DM[=TFO)*_L1H _"/\
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M3:7M[-ITX!^HG_!*/]NW_@I#XP_:4^/7[!O_  4X_9_BT;XM_![39?%_@_\
M:@^&GABXT;X(?%/P_=7VG-8:#:S0Q'1#K]UH^L0:QH3Z1.CSZ?HWB6TUVRT_
M6-*$=U_057\X'_!+W_@NEX]_:;_:H\0?\$[?VZ_V6O$O[(7[;_ASPWJ?BBR\
M.S27%[X-\;Z?IT;ZU+!I8O434])OQX3N+36[%W?4]&UFTL]4FL]6CGBCLF_H
M_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _E>_X*D?L _\ !0#X+_\
M!2'X:_\ !9'_ ()E>%?#'Q[^)&D^ +'X1_'7]E[Q5=Z9I%_XS\%P)=V-WJ7A
M#6M8U'2[4G4=&NH8KZVM=6TO6M(U+0]-U'28?$45]J&A2^*?''XP_P#!>+_@
MK?\  'XS?LVVG[ ,/_!/?X3:Y\.O&P^(OQ \8^/=$\5_$CXH3:/H$]_I7P2^
M&6CZR?#\>D77Q&UBXT72M0\5ZA96VE:?I2:HJ^*+*836TO\ 8910!^ W_!$_
M]D#]I#]EO_@C%I_[,?Q[^&-]\//CK#H/[05G)\/[S7?"FLWBW'C&X\1/X9C.
MK^&M=UGPYNU5+VU9"NL,EOYH%VT&U]O-_P#!LE^QE^TS^PI_P3BUOX)_M8?"
MO4/@_P#%"Z_:3^)WCBW\)ZEK_A'Q'<R^%=>\*_#:PTG5_P"T/!6O^)-'6.\O
M-$U6!;9M1%Y&;-GGMXDEA:3^AVB@#^9K_@OC^PM^U=^UY^U+_P $;/'W[.7P
M@U+XF^$/V9OVK[SXA_'+6K#Q'X+T.+P#X.D^(G[.FM1ZW>6OBKQ)H5]J\+:7
MX*\47?V;P[;:Q?A=)DC-IYUQ9QW'],M%% 'YQ?\ !7CX)_%']H__ ()H_MF?
M SX*>$[CQU\5OB=\$O$WA;P+X0M-0T?2KG7]?OC;?9=.AU'Q!J.DZ+:23!'V
MS:CJ5G;+MP\Z9%?%G[*G[(?[1WP__P"#=R;]C#QA\,K[1/VG&_81_:+^$J_"
MJ;7?"MS?GXB>-/#?Q1L?"_AK_A(+#7+KPB)]6NM?TB&.^_M_^R[<WJM=WT"1
M3M'^^%% 'XD_\&\?[+/Q\_8R_P""5?P+_9^_:9^'=[\+/C!X3\6?&K4?$/@O
M4-9\-:]=:;9>*/B[XQ\1Z#/)J?A'6O$&A3#4-%U*QOD2UU2>2%)UBN4AN%DA
M3Y/_ ."IO["_[5WQ^_X+0?\ !'C]I[X0?"#4O&GP)_9K\1F]^-WQ M?$?@O3
M+/P':GX@V.L&6\TC7/$>F>(]6']F12707P]H^KN0IC*B4A#_ $S44 ?@1_P7
M!_X)/_$O]NC2?@=^U!^Q_P"-[#X5?M]_L:^)3XV^ _BN_>&RTGQ=:I?Z=K%U
MX(U[4)+:[@MITU/2+'4_#.H:I9:CIEM=#4]&U"VCTKQ'J=Q%\&ZA_P %%O\
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MK6FW>@W-[?Z)<:-KNDS6D:\O\8_CA_P<D?\ !3GPUIW[/7PR_8ML_P#@EO\
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M2\36LT&IZ7>^*;?2M:U:U5[O;:Z?J>K:S>:!<Z7I=I/IEGX/>?4+J\']C-%
M'XG?\%H/V2OV_/CM\-?@K\6/^";W[0&O?##X\_LO?$?3_BA8_!67Q1-X9^%O
M[0.E:(]MJ:>#O%]M"L>E:OJ=I>Z38KX>T7Q>TG@G5+>[U32=8&F/>VNN:;^8
M7C3_ (*5_P#!QQ\7_A_XI^!'@3_@C%I_PC^-WB'2G\#ZA\:_$7Q3\.:M\-/
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MFRXM?#WBQ?#^KZU9^(-!O)+)-"OK?Q+:^%]+TO2M0U35;'0=6U6?2KRU_J^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img12876764_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_2.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /U!2X# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[!_X)8?\
M!+#X%?\ !1CX%?$C]H#]H#XD_'R#XAV_Q[\6^"[J[\&^+_!EO;:S:VO@KX=>
M+WUG6I?&/PZ\:ZQ?>(;W5O&FK?;K\ZO'!/;Q60%G'<1W%Q=?IA_Q#>?L._\
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M_.,H_P"(;S]AW_HJG[5O_A<?"'_YQE?T#T4?VYFW_0?7^^/_ ,B']EY?_P!
MM+[G_F?S\?\ $-Y^P[_T53]JW_PN/A#_ /.,H_XAO/V'?^BJ?M6_^%Q\(?\
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M_P#"X^$/_P XRC_B&\_8=_Z*I^U;_P"%Q\(?_G&5_0/11_;F;?\ 0?7^^/\
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M_P#T"TON?^9_/Q_Q#>?L._\ 15/VK?\ PN/A#_\ .,H_XAO/V'?^BJ?M6_\
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MS]AW_HJG[5O_ (7'PA_^<97] ]%']N9M_P!!]?[X_P#R(?V7E_\ T"TON?\
MF?S\?\0WG[#O_15/VK?_  N/A#_\XRC_ (AO/V'?^BJ?M6_^%Q\(?_G&5_0/
M11_;F;?]!]?[X_\ R(?V7E__ $"TON?^9_/Q_P 0WG[#O_15/VK?_"X^$/\
M\XRC_B&\_8=_Z*I^U;_X7'PA_P#G&5_0/11_;F;?]!]?[X__ "(?V7E__0+2
M^Y_YG\_'_$-Y^P[_ -%4_:M_\+CX0_\ SC*/^(;S]AW_ **I^U;_ .%Q\(?_
M )QE?T#T4?VYFW_0?7^^/_R(?V7E_P#T"TON?^9_/Q_Q#>?L._\ 15/VK?\
MPN/A#_\ .,H_XAO/V'?^BJ?M6_\ A<?"'_YQE?T#T4?VYFW_ $'U_OC_ /(A
M_9>7_P#0+2^Y_P"9_/Q_Q#>?L._]%4_:M_\ "X^$/_SC*/\ B&\_8=_Z*I^U
M;_X7'PA_^<97] ]%']N9M_T'U_OC_P#(A_9>7_\ 0+2^Y_YG\_'_ !#>?L._
M]%4_:M_\+CX0_P#SC*/^(;S]AW_HJG[5O_A<?"'_ .<97] ]%']N9M_T'U_O
MC_\ (A_9>7_] M+[G_F?S\?\0WG[#O\ T53]JW_PN/A#_P#.,H_XAO/V'?\
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M ,XRC_B&\_8=_P"BJ?M6_P#A<?"'_P"<97] ]%']N9M_T'U_OC_\B']EY?\
M] M+[G_F?S\?\0WG[#O_ $53]JW_ ,+CX0__ #C*/^(;S]AW_HJG[5O_ (7'
MPA_^<97] ]%']N9M_P!!]?[X_P#R(?V7E_\ T"TON?\ F?S\?\0WG[#O_15/
MVK?_  N/A#_\XRC_ (AO/V'?^BJ?M6_^%Q\(?_G&5_0/11_;F;?]!]?[X_\
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MG_F?S\?\0WG[#O\ T53]JW_PN/A#_P#.,H_XAO/V'?\ HJG[5O\ X7'PA_\
MG&5_0/11_;F;?]!]?[X__(A_9>7_ /0+2^Y_YG\_'_$-Y^P[_P!%4_:M_P#"
MX^$/_P XRC_B&\_8=_Z*I^U;_P"%Q\(?_G&5_0/11_;F;?\ 0?7^^/\ \B']
MEY?_ - M+[G_ )G\_'_$-Y^P[_T53]JW_P +CX0__.,H_P"(;S]AW_HJG[5O
M_A<?"'_YQE?T#T4?VYFW_0?7^^/_ ,B']EY?_P! M+[G_F?S\?\ $-Y^P[_T
M53]JW_PN/A#_ /.,H_XAO/V'?^BJ?M6_^%Q\(?\ YQE?T#T4?VYFW_0?7^^/
M_P B']EY?_T"TON?^9_/Q_Q#>?L._P#15/VK?_"X^$/_ ,XRC_B&\_8=_P"B
MJ?M6_P#A<?"'_P"<97] ]%']N9M_T'U_OC_\B']EY?\ ] M+[G_F?S\?\0WG
M[#O_ $53]JW_ ,+CX0__ #C*/^(;S]AW_HJG[5O_ (7'PA_^<97] ]%']N9M
M_P!!]?[X_P#R(?V7E_\ T"TON?\ F?S\?\0WG[#O_15/VK?_  N/A#_\XRC_
M (AO/V'?^BJ?M6_^%Q\(?_G&5_0/11_;F;?]!]?[X_\ R(?V7E__ $"TON?^
M9_/Q_P 0WG[#O_15/VK?_"X^$/\ \XRC_B&\_8=_Z*I^U;_X7'PA_P#G&5_0
M/11_;F;?]!]?[X__ "(?V7E__0+2^Y_YG\_'_$-Y^P[_ -%4_:M_\+CX0_\
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MO_A<?"'_ .<97] ]%']N9M_T'U_OC_\ (A_9>7_] M+[G_F?S\?\0WG[#O\
MT53]JW_PN/A#_P#.,H_XAO/V'?\ HJG[5O\ X7'PA_\ G&5_0/11_;F;?]!]
M?[X__(A_9>7_ /0+2^Y_YG\_'_$-Y^P[_P!%4_:M_P#"X^$/_P XRC_B&\_8
M=_Z*I^U;_P"%Q\(?_G&5_0/11_;F;?\ 0?7^^/\ \B']EY?_ - M+[G_ )G\
M_'_$-Y^P[_T53]JW_P +CX0__.,H_P"(;S]AW_HJG[5O_A<?"'_YQE?T#T4?
MVYFW_0?7^^/_ ,B']EY?_P! M+[G_F?S\?\ $-Y^P[_T53]JW_PN/A#_ /.,
MK\$O^"G'[,>A_P#!,O\ :=\*?#7]F3XI?&K3=-\7_ ?P]XYUG7M=\:V-KXJE
MOM:^(/Q"T"[TA=3\ ^'O =L_A];?P/HM[#876GW,ZZB;JXDO)8S:PVG]^E?Q
M0_\ !R!_R?'\*_\ LU'P/_ZM[XYU[G#^98[&9C&ABL34KT94:KE3J<LHMQ2:
M;7+T9Y>;X+"X;!NK0HPI5%4II3A=22;=[.^ES]5_^#;S_DQWXJ?]G6^./_50
M_ ROZ!Z_GX_X-O/^3'?BI_V=;XX_]5#\#*_H'KP\\_Y&V/\ ^O[_ /28GJ97
M_P B_"?]>E^;"BBBO*.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K^*'_ (.0/^3X_A7_ -FH^!__ %;WQSK^
MUZOXH?\ @Y _Y/C^%?\ V:CX'_\ 5O?'.OH^%?\ D;0_Z\5__24>-GW_ "+Y
M?]?:7YL_5?\ X-O/^3'?BI_V=;XX_P#50_ ROZ!Z_GX_X-O/^3'?BI_V=;XX
M_P#50_ ROZ!ZX<\_Y&V/_P"O[_\ 28G5E?\ R+\)_P!>E^;"BBBO*.\****
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MH3DZ<HTW27,JZ2YIK6+ONCFGB8PKPH.,G*:34E:RNVM;Z[KI<_O$HHK\T?\
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M&P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTK2=3MKB*Z^*=MX[TKP;?743;H]/U8>(M T_3M0M9R0)K"2X7SUP,8K^D/\
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M_A7_ -FH^!__ %;WQSK^UZOXH?\ @Y _Y/C^%?\ V:CX'_\ 5O?'.OH^%?\
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M ?AWI=U?&,6WC,Z1=6NI-XAU"P47VFZ-!=6\R6=S:WUP'@D"'^32Z_X+G?\
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M-"G3I1E-<U2I-V:E,)5\95G:M*E3ALH73WO%.S3;LFY-OLDNI_'W_P $VO\
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MTZ$I4:ON3A!+GE/>'UFG2Q$:UWR4YNG5YDW=1?:3EVE%O5:IN]DOYH?V2/\
M@Y*_;,\'>-?''C7]J#XH6WQ#\(^'OA=XQ7P/\/+?PGH=A;>*OBMJ=@;7P*FM
M7.D6%CJL/A_3=4 NM7GL[RW,%L2[LPP*T_V!?^"V_P#P4\_:3_X*-_L]>#OB
M1\<]1T[X2_%OXP);>(?A?I'P[\.V/@^QT&^L;R=/#>DZ[=^'/[;73+9X8_(N
MIM7DO9,$M<L"*_,__@BU^RQ\/OVRO^"D'P)^"/Q5TZ+6?A]]D\8?$;Q-H-Q+
M)%:^(K'X=:7%KG]@WOE*S366IL1#<VS8CN(\I(Z+DU_J#Z;^S7^S[HT?AZ+2
M/@O\--,7PG+93^&GL/!VB6L^B3Z='Y5C-IUQ!9I<6TMM'\D4B2AU!/S')KZ_
MCO'\&<)8S$9=3X4P6)S#-<I?[V&'P=*AEU*:Q&'PU7#TI8>HOK#K1J5JLX*E
M4:A2BJUDHQY\-#$UXJ7UB484ZB5FY<TVN634FFKQY;12=];Z=3\X_P#@KU_P
M5W^&O_!+CX8Z!,_AY/B;\=_B8-1M?AG\,K?4X;%((K:VN _C;QA+DW%IX/TV
M^C2WD$/D7.L72R:;87$5SET_C,U[_@N]_P %K?VG/&>L:U\#_%>L^%K2V8R7
M'@CX&_"C2?%/AW18I=D<,)O?$^C:[J99-N?])U*6X+R.9>JUX#_P7L^.'B/X
MY_\ !43]H>YU>YOAHGPXN]#^&?@[2;N=IET31_#^FVT&K"R&[9%'J^KQ7>L&
M-0H6:YP2<9/[4?\ !/K_ (. _P#@ES^P?^R_\-O@-X3_ &;?V@+;7M!T2TF^
M(OB;2/!7@*YF\;>/9H5/B#Q+>ZK/XNM;S4#>7086K3PP^3:K'$L2L'9]\HX3
MPW#?"N59AA>$*?&&?9I2HXC$1Q$*-6A@Z6)I1Q"@X5U5I0A2A*G1C[.DZE:L
MZDW5C!1BE4KNK7E&6(>'I0;4;-IR<6ETLVV[O5V2MI?;YE_8Q_X.<_VSO@5X
M_P!(\"?MO:-%\9_ =OKZ:+X\U^Z\,Q>$/B[X3C?4&BU#4(]+TVTTK2K\Z/&[
M(=,_LWS+N* >5*7/FG^^WX:?$_P1\7?AQX0^+/@+7;76_ ?CGPWI_BSP[KL;
MJEO=:)J5HMY!<R%FQ T<3%;E';-O)'(DA!0U_F4?\%K/V_?V*_\ @HK\4_AO
M\;/V:?A/\2/A?\1=.T.^\+?%:\\;Z%X9\.:?XRTF)_/\/ZD8/#VL:JVH^(M/
M8_V>^HWK1N-)CAM@6\M37]8__!L1\5M;^-/_  3'N?AWXXN+/6=.^&7Q$\=?
M#325CF N!X&O45K#1[V%':2,6L$]Y#%=%E:YCF+!5,63\_XB\*X&/#>7<5X?
M(WPUCI8BGA\VRF*A&G#V[J0C4ITZ?+14HU::<'2C252E6BYTXRB[:X2O+VTJ
M#J^VARMTZE]?=4=+N\M4]4W)IK1V9^<__!57_@YM\<>#/BEXT_9Z_8(TSPY%
M9>!]5O?"OC'X[>*;1M3O+SQ-I=W]GU.T^'>B^8^GBRL+^";3WU35[6_CU.,-
M<V*P+*BC\B=7_P""MG_!?OPGX+M/B]XG^*_QLT?X6M?VKIXRUKX'^!;+P?<F
M299XK"75#X122.WNXP8/,81GR7)659"K5^]/[8?P_P#^#;']A_XNZ?:_%'PQ
MH^L_&SP%XHM_'=U\+/ %]K?BJ[FU6*Z-ZMAXPM$E7PW<6K7@V7GAW4]62Z23
M=%=VL9#BO)/VTO\ @YR_85^+/[./Q7^ 'PY_9S^)7B9_'7A?4? UI;_$#0/"
MGASX?VVGZCI\EI#J\ T_7=1O#-I%R;*?3+-=/M09X$8RQK$J2>WD<,N6$RC#
M\.^&.)S3"5Y4EF&:Y_@<+&K5IR=.,L5AZV(5>-3VB<ZL7"5+#07+"G"2NXY5
M'*\W6QJIS7PPI2DTGH^5J-K6:2ZMW;=CZ$_X(P?\'#7B?]L3XR:)^RA^UIX6
M\,^&/B=XITK4;CX;_$SPJ);#P[XNU72(FNKGPUK^GW4[IIFNWEH4_LB:V$5O
MJ=WBRB@,[;C^[W_!1+]OKX3?\$Z/V<?$GQ[^)ZR:Q=PR)HO@/P+8W,=KK'CW
MQC>(QT[0-.FE22.W5@CW%Y=RKY=O;Q-_RT>,'_+^_P"":%W?Z7_P4/\ V%7L
MKVYM;AOVI/@_8S3V\ABDFM;KQ1:175N[+R8;F(F.:/HZ$J>#7]R7_!T1^S1\
M3?CC^PKX7\<_#/3_ !-XKN?@I\4-'\4>)? OAS1[C6I]0\+7]I>6NJ>)%L["
M*XU*:Y\-R0VABBM;>13!?W4L[)'!N'C<7\&<.X+CWAK Q@LORG/'"6+P]*<H
M4H585YTW&C.3;H4\4_94VHM1I.4I0=--<FN'Q%:6%K2;YJE*RBW9NS2=WW<=
M7KO9;['\W'B/_@O3_P %F_VM/B5?:9^S7K.K^%[EY]2U73?AQ\%?AIH?C&^L
M] #NUO'J<WB#2=7FD-C;[5FNQ/$L\J,RA@0M+X3_ ."_G_!8;]E#XI:-I?[2
M^KZEXPGT6<:IXA^%WQB^'FA^!]4US1+Z-D2WBN=$TK29;7 #/87L$S"*8!KC
M<J[3\J_\$B_^"L>M_P#!+KXD?$#78?A3X<^+'@WXFZ;8:5XILY94TKQCH5QI
M%T\T-UHNMI!<RM#EGANM#N4BMGDS.T@F5-O] _Q._P""N/\ P0B_X*8>)?A-
M>?ML_!_XB_#SQ%X+DU."R\5>,=%$&A:-]OAA^TV6LZOX-OM1U?6?#]W<PH+*
M.72I&AF9I'@B&YC]SFV783*<=+ _\0QP69\-K"\JS#*\+A<3F?/[#FDG1Y88
MI-5+T[^U]KJJU.K*3C3.6G*4XJ7UV4*SE\,Y24+7BKW=XO2SO:U]++I_3;_P
M3[_;B^&7_!0G]F+P'^T?\,XYM+@\1V\UCXJ\(WTJ2:MX+\7:7/)9:UH&H;#\
MRQW$+76FW. M]I=Q:7B#;-7XP?\ !93_ (.$-/\ V#/'\_[-/[-'@OPU\5/V
M@-/L+/4_&_B;Q3?S3?#OX9QW9NU'AW5+#2I[;4M5\920I;W_ -DCO([72+=X
M3J=O<?;$2/\ 63]DSX7_ +&G[)7[+/C7Q[^Q+8^'M1^"NL:+JWQ?B'@_Q,/$
M&C:Y>6'A@7@6UNO.G_LVYGL[2W@O+"98;JRN6DCO+:&Y22)?\L[7/B9HOQ+_
M &H]=^+O[1,OB/Q;X9\5?&W5_%_Q432GAG\3Z[X;7Q9<3WFDV;7LT5M)<S:/
M;6^CXGFBB:!6^9<U^<\ \(9%Q!Q#G^,J8/&5,CRBIS8/*\8G#%5*N(E5E1PV
M*C"?--X:%&I!TW43K5'251N+J1?9BL15HTJ45*/M:BO*<?A27+=QOT;DM;-)
M7:Z'ZOG_ (+._P#!=;XCZ=KGQ,\%?%GXI)X#A%S>W5]X.^"?A+4O"6C6MG&9
M;LV^HW?A*ZNI;6WB5I))/.N3L!*LW?\ 97_@E/\ \',OC?XE?%GP1^SS^W7H
M?AVVA\=7MMX9\(?'#PM93:88/%%XT%MI.G^/-&>1+:VM]5N/,B;5K*WM(K*[
MFCBGB9&1%]E\!?\ !TC_ ,$O/A?X*\/?#GP!^S!^T+X5\$>%='L]!T'PYI/P
M^^'=KINGZ58P+;6]K';IXVVN!$@\QY-\DSEI)7=W9C_'M_P4'^.?[.7QJ_:U
M^)?[0'[('@SQ7\*?ASXQU/3_ ![8>$/%]AI&D7OA[Q_:^3?:I/I&CZ'?7FG:
M?H<^K64&I6UE!=']_-=[MHDK[_!Y!A.*5C\JSCPZI\+T%0G++,UP]/"TJT)I
MQIP56>&ITI.NE*-51DZ]":A.$E=J4N259T.2=/&>W?,N>$F[-:;)MZ:6TLTM
M=;6/]?,$$ @@@@$$'((/(((X((Z&EKXS_P"">'Q9USXY?L0_LO\ Q2\3SVEU
MXD\5_!KP/=:_=V,JRP7FL6^B6EEJ%[\I812WES;274UON/V>69X<D(#7V97\
MOXO#SP>*Q.$JV=3"UZV'J..L7.C4E3DT^S<7;R/;C)2C&2VDE)>C5T?P*?\
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MQ/H=G?VFKI;6&KP&-&6=8O[+URS??#!)*]G>),C,I_UR?V9/CQX,_:>_9_\
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M9].\+>'-8U^'3;:--)T.^U:>&RMH+9[B/3;"6\:$&*-!EUA*("-JDC  %?Y
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M(((;2_CM;ZW2WN+*\CANHKBTN8I(WZ21R(\<A*\[6'\)W['_ /P<A_MP:/\
M&?1_$/[4?Q?MO%7P@T;PAXQUC4_"UAX.T"SG\3^)[/1S-X3T'[7I^G6UW:0:
MEJH$$]Q%,ABC))/3']*GP_\ C+XF^//_  ;JW'Q&\9WMIJ/BJ^_9%OM*UW4+
M-U9+V]T&"+2C=2QHSBVN9H;:%Y[8LQB<]>17\%__  3/_9[\+?M4?MP?LO\
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M'P@TSQ9=Z3=>&M!U=O[:GU VLT\=SJ.G7-PJ21C)C\S:&.5 Q7]6WAC]DO\
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METC0?&^C,[6)O-?NY8M.TR_T>"PM(&6-KM')=CM?&S_@Z,_X)[CX-^-/@O\
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M_P"R(^)/Y7%?(<)JWA#Q>NU;,5]U# (Z*^N88=_W8_\ I3/]&BOR=_X+A_\
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M/UM<WEIX,\#> -6\<7^F>:?[/U7Q-KUY:0:9J:P A5GTG2DN;%68$E;N0#
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M:2A&<DG&FU=0E9M75CS\1-4\:IR3:BHMI6O\-M+M+\3_ %B_VH/A]\)/B=\
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M9+;2=8U""._N6EMTDEMX8X4(FG"$1HYW8!S7^O'H'[//P1\-_"R/X+:5\+/
MEG\,?^$;?PK<^"[;PUID6@W>BSVAL[NSN;);?;,ES$S^;)*S3EF\SS1(JN/T
M/CG%\&<%9EEM7_4_+<QQ>,P]1>P5'#8?"8;"TZ]IUWAY8:M1KXJLY3IPE.FG
M"-%)5()M2Y,+'$8F$O\ :)PC%Q=[MRE+E32NFFHI)7UU;>CLK?Q8_P#!+/\
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M2E*,7Y[_ 'NZ_#<_MD^(_P#R3WQW_P!B=XF_],M[7^>I_P &R/\ RF!^*?\
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M_@C-#HD/_!,K]D)=!:W:U;X3Z-+=&VE>9!JDGF-J8=G)*S"[,@FC!VQR!E4
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M.E4^O^TY'[/1\^EM*2CW[Z'\N?\ P<X?\I0?%O\ V2WP?_Z0PU_8I_P;Z?\
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M ((7?!O_ (*3BW^*7@_7[?X*?M,Z#I[VMMX]LM(AN]$^(5E;0L-/\/?$.SC
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MAYX@DC5/M^ER2F/[9I]T(XH]5T6XF2SU&*.,2[9(HW7^*'XP?\&L_P#P4/\
MASXDN4^$?CCX9?%+PO=W5Q!INL:-XEUKP9XE73XCB%O$UC-'IEJLTZ%28=/N
MKZU!W*6X(K['*^*,EXJX5RS),?Q-B>$<YRB-&A#%TJU:C1Q5'#T50IMSA5H4
MZL)T8P<Z-2M3J4Z]/FIN4)6ESU*-6A7G4A1C7IU&WRM)N+DTWNFU9W=TG=.S
MU/U*_;H\=?\ !N9^PYXYT'X;ZM^R?X#^,_C#4;:[N_$.G?"G4]<UNW\%11+&
M;&'7]0@\1S6L=[J>Z1H;.-VDAAC264CS@H_:'_@C_P"+_P!@[QW^S#XC^,7[
M WP+UCX*_#?QGXJOKSQAX<GT#7+&^UGQ?X8L!I<TMB-6OKYM;,%E;Q6-O<Z>
M\5O-+B!8_,!8_P S7[*?_!IY^T!XE\8:=K?[8OQC\&^$_ %MJ=A/JOA;X<WF
MJ>(?&WB?3(QYFH:=>:WJ5NEIHZW.4MH+VVO;F[B"SN857R2_]PWP4^"_PV_9
MY^%W@OX-_"/PS9>$OA_X!T.QT#P]HUD@_=VEE"D1N;R? DO=2O75KK4+^<M/
M>7<LL\AW/@?)<;8SAW#97A<IRKB//.),P=6$\?C*^9XNIE<J=.\N7ZK5<Z,Z
MKGR>R5*4U15-RG5G4=GOAHUI5'4J4:=&%O=BH14[M*_O+WDM[W2N[Z)6/Y5O
MVB/^"^__  2-_:BU>7X(_M2_LK>,_'>@:1X]OO!%WJGC/PG;37/A:[LO$4WA
MN_U.VO[6.S\1:-91W,3W&I1:?J5K_HB-)<B40#'??M0_\$"?^"._BO\ 9_\
M%/QH^$7Q'TK]GOPY9>'-0\6Z)\2_#WQ*M-;^'\-L US9"_\ [;NM4ENM&9]E
MDD=M>_;]D@5&FG 5C_@J/_P;0^&OVJ/BCXP_:&_9,^(FA?!_XB^-$GU7Q5\-
M?%.G3'X<>(O%TA!FUZTU#2[>ZU+P])J: ?;[.TLGM6O5:]#AKJ98_P *;?\
MX-B_^"I]SK]KX2GU'X:VVAW+10RZ]=?$KQ#-X.LXG&]C<Z3%--=26\)&'A@T
MJ7+ >7$QQ7U643X0>#R[$\.<>YCPA*BU6S'*\;BJV)A.I[DJD(8?$5*.&<HR
M51*K3AB:=:,XN5+FCRF%3ZQS2C6PT,1?2%2,5&RNDFVKOS2;BTU9,_$3X$>*
MO&_PK_:<^$7BOX.>(K^U\=^#OCAX7L_ GBOPW%Y]]=H/&MMHIU'2H&27[1;:
MUH4EU.('CD5[.Z+,A*Y'^G1_P4N_X*R? 7_@FM!\-])^.OP_\=^-;+XP:?K$
M%F?#FDV]]HABLD%MJ&EZM)=PS6DLUY#+(3ISHWGV9E9T:(,*_-[_ ()6?\&W
M7P[_ &-?B/I'[0?[3?C?1OCO\7O##>=X#\):5I#0_#/P'JR*@C\46KZA%;ZE
MX@UV/,JV!U&Q@@TK"S6[3/-(B?LW_P %"_\ @GS\$/\ @H_\ M1^!GQGAO--
M:WOEU_P'X]T6*%_$WP\\70VT]K:^(=%$SQQ7'^CW$UK?Z;/+';:E9RR6TS(&
M#KYO'/%O"'$7$V00KQQ.-R7+88FAF./PJGAZM98ITW!X>\(UJE+!5*?M6N6*
MJ.K65!.ZE4O#4,12HU6N6%2?*X1E9I<JUYK-I.5[;NR2OMI^#G[,_P 'O^""
M7_!:.P^)FI^#/V?=#^#WQ?T37+K4-<TB+5+KP%XVCL[](57Q7H6E6VH0^&[G
M2+R7=%+;VNC&.QFC5_)C68D_S;?\%L_^"?G[,7[ 'QT\$^"?V:/C.GQ#TGQ/
MX;N;KQ9X#U/7--\0^*OAYK.G300JVK7VE)#;I::Y',UQ:VL\$5U"T4BNI0*[
M_:7QH_X-7/V_OAMJTMS\%/BA\-OBOX>ENI;.SN[#7=>\!>-#:*[&&[UJT6/3
MM+6.:)49[>PU*\6&<NN-GELW:_L]_P#!J)^V%X\\10WO[2OQI\!_"[PB5LI+
MQ_#-WJGCSX@73-)')=VJKJ:'2HTCMB\(GEU02"Z_U:M$#)7V64YIPSD6->:4
M/$G$8K(52DJ7#^,J5\;6C*5*,$E.K*>+M2J+VE.G#"4YJRC*<H\[ESU(5ZL5
M!X-1JIJ]:"4$U>+Z6CKJFW)JRT1^FW_!J#XR^(_B?]C7X_>!-5U74]0^'_@O
MXAWFF?#K3+F%%TK1+K5]+FEUK3M)NO+#")YULYI[02-!;22;T1&FD+?Q<?M"
M+JWPH_;6^-+>)-&NDUOX;_M)^*+K6_#[.+>[:]\.>+3=W.F+-*NR*2;R?*CN
M&1H@6#_,H-?ZQO[)/[)GP6_8I^!_A/X!_ GPQ;^'/!GA>W#W$Y5'U?Q+KDT4
M2ZGXG\1WP42ZCK>JR1+)<W,S,4C2*WBVPPQJ/Y]/^"PO_!NL_P"VU\6O$?[4
M_P"R]\1- ^'7QI\4Z?I=MXU^'GC&RDMOAUXSO]*ADC_X2>'5])M[G4M%\3WT
M&V&]7[&UEJ]Y)]OU"]A=":^7X3X^R*EQKQ/CL8GEV5<1<BH5JL':E4H248RQ
M*HJ7L_K<95:M6HN94ZK7/.TI36];"U?JU"$??G1W2ZWU]V[5^5I))[KIT/T8
M^"__  6P_P"";_B#]FCPW\6-7_:7^''@^;0? 6D7'B;X=:[XCL8_B'HNKV6C
MQI)X<7PYN2^U+5+FZM9+33!9PM#?RE"CQKYGE_YO?_!03]H[3?VN/VN_VA_V
MBM"T[5M*\.?$SQQJ^K^%M/UQ8DU6V\,I+)'HR7:Q1Q(&-J0P&PL V&=R-U?T
M%_LY?\&FG[47B7QGHE[^TW\6OA7X%^'$.MV4GB/2O 4FJ^(/&VK:1;2+->V]
MH;K3X=%MC?(#:6]S+?K<VVZ681KB,M[[^WC_ ,&O_P"TE\9_VB/$/BK]EKQY
M^SO\._@/9^"_ O@GX>^$_&VI>.V\5:=IWA#0QI4DVN3Z1X8O+*\OKR4&>6\6
MXDEN"Q:8AABO=X6Q?AMP?GF-E@>(GB9X[#5'/%XAMX+!T8XBC.."I5:5!/$5
MJTY<_/9J-+#^_)2E[^5>.,Q%)<U'E46DHKXY-QMS--Z*.WJ]+V/WC^$O_*"[
MP]_V9CJ?_IAU&O\ /O\ ^"27_*2O]D3_ ++%:_\ I7+7^E9X'_91^(/AK_@F
MWI7['U]K?A6;XDV/[/UY\*9=>MI=2;P@WB"XTR[LDOHY9+--5.E"6=&9FLA<
M[ V(2V ?Y<OV&O\ @V@_;E_9G_:\^!7Q\\=?%_\ 9KUCPA\,?'T'BG7=,\,Z
MA\09->O+".=Y'ATQ-1\+6MDUUM8!1<7$46<Y<#K\_P &<1Y%@,N\0*6-S3"X
M:KF>(Q\LOA4=2^+C4H8V-.5+EIR34I5()<SB_>6AIB:-6<\(XPDU",5-K[+4
MJ;=_DG]Q_<G7\'__  =N? #Q;I/QF_9S_:9M-%:3X?>(O"FI_"[7_$42RE+'
MQI:74>H^']+O<[XT_M#1;?49[64>2@^QR1R%W9*_O KP;]I;]FKX._M;_!SQ
MA\"OCIX0L/&7P_\ &=A):7UC>1I]JTZ\".+'6]%O"K2Z9K>E3,+G3]0MRLL$
MRC.Z-G1OS3@SB)<+\0X'-YTI5L/3]K0Q5*%O:2PV(@Z=5T[M)U*=U5IJ3492
M@HMI.Z[<31]O1E332EI*+>W-%IJ_D]GY,_BG_P"#?SP'_P $HOVHO@OKGP7_
M &M?A5\(+O\ :8\#^(M2NM%O_'WB&\T35?B!\/[B*&>"_P!*1-8TNUNI?#]V
M+F'55!:>**]L'P4)*_I/^W]X)_X-Z?\ @GIH.D7/Q(_9I^%'C[QOK>MP:/9_
M"[X=:[K.N^-8;>2WNKBYUW4["T\33MI>AV!MDM;J]NP@2\N[2W"%Y24_)C]I
M;_@U'_:X\!>--3O/V6/BYX*^*?PXVW,^A'QC?W_@KXG6"LWFKH]Z=.0:3=0Q
MQ,MG#J$.JO-?-;&YU"&!Y44\U\!?^#57]N?XA^(-.U'X^_%#X;_"SPFFIV]O
MK&W6=;\;^/YM,$\37TVDH\-[I0#VWF>0M[JELS7"H67:&9?V?&5.$,PS.KQ!
M_P 1)S+#95B)/$ULCP^-QU"M"I**;I45&K]8H4Y37,Z,<'*4&W"%6,;6\^/U
MB$%26#@YQ7*JLHQE=*R3=_=D[/?FZ7:OH?T'?\$5/BC_ ,$J/VB/&WQ2\=_L
M%?LL:Q\#/'?P\\/:/I?C?7M1TGQ%9V5S8^*;F^2+0['5;_5;S3-5NH1IGVF]
MAAA$UG'/;LQ42J3_ $45\9?L(_L*_ W_ ()Z_ 31?@%\"]+N(M&M+ZZUWQ+X
MGU<QS^)O&WBK48[>+4?$?B&]4%IKJXBM+:W@MU<P65K;PP0C"L[_ &;7X9Q)
MCL'F&<XS$9=4S&K@.>-+!U,TQ53&8V5&E!04ZM6JW-*<E*I"DW+V,)JFY2<6
MWZ5&,HTXJ:@IVO)0BHQN^B2TTV;Z[G\J7_!VA_R9-\%_^RVP?^D%M7Y,_P#!
MJ'X(\$^./VHOVE[/QKX-\*>,;6U^"NES6=OXJ\.Z1XAALYF\7Z*KS6D6KVEW
M';2NA,;R0JCM&S(25)%?TR_\%Q/^"<7QK_X*5_L[?#[X2? [Q;\.O"'B+PI\
M18O%VH7WQ)GUZWTF?3DM8H3!:MX?TS5+HW9>,D"6%(MO\>>*^-_^"%W_  1=
M_:>_X)E_&OXQ_$CXZ?$'X,^,-%^(7PZLO".CVGPTN_%MQJ-KJ-MKVG:H\^H+
MXAT/2K=;0V]I*BF"664RL@*!<FOTW*N(LGPWA1F632S.C1SBK5Q4J."4JD<1
M)3QN&J1<7&'*N:G&<E[ZNDUY''4I5'CH3]G)T_=O.RY5:+6NO?R/S[_X.D/^
M";N@^&=+^'G[=OP6\):9X<TC2(;+X6_&?POX2\/Z7HNA0VUW>33^%/'4EEI%
MI:Q_VC+=7!T/5KR5/+2PL[-F)D=V/&?\&L?_  463PCXV\2_\$]?B7J4HT;Q
MY)J/CWX!:E=WN^*W\46T+WGB[P);V\C%E&J:;#>>);>96$,;:=]CCC\VY&?[
M3?C]\$_!/[1GP:^(WP2^(FE6.L>$?B/X6U7PSJMKJ%G%?01#4+62&WOTMY2%
M:YT^Y,5Y;,&1EFA0AA7\-WA#_@UP_P""D/P8^,6A_$_X,_M'_LWZ=>?#OQW!
MXH^'VN7&J_$G0_$1LM+U1;W3[?4CIGA.Y@L)+VS0:;J45E-/#]FDEC1I%8YV
MX<XER//N!\?PGQ3F5' XG"*V4XS%^U?657!S4X0FW+!U^:E43<7/"5533:YF
M*M1J4L3'$48.:E\<8_\ ;JEIM[R5T^DE<_=C_@YE_9]\8?&W_@FQXD\2>!]$
M;7M6^"7C3P_\2]7MH%F:[M/!5A-Y?C#5;=(]PD&F:8HO+B)HI'DAB<1;&&3_
M "#?\$+]:_8)UC]IC7?A+^WWX)\!>(/A[\4O#UM!\.O&'Q!U.YTC0?#/Q!MK
MJW73]+N;^UO+'R$\1VIGT^T^T3I"VJ7-K&Y7=D?Z:7A71_$.N?#/1- ^,6F>
M&-3\2ZGX2M-)^(FEZ6UQK'A+4M1N-.6SU^WM#J]I;7%]H]](TX5;^SBDD@E*
M31 YS_'/_P %$/\ @U<U;Q=\1/$'Q5_8&\?^$O"NB^+-:FUK5/@;\1!>:=H7
MA&XN)!-=-\/?$6FPWEP;6>[D>Z@TC5!8V^DQQF*QN)I&7./ /%F4T<BS/@W.
M\QK9/3Q%:O5R_.L+4J0]C4JNES1]O2=Z3A5HQKT:DK4:L)5*564;QYWBJ%1U
M88BE!5+**G3DKWLW9V;5U9M-;II-)ZGZ@_M,?L9?\$"OV3_A#XA^,WQ8^"O[
M/MEX=T?0M2UG2M-L/%NI7^O>,KBPBG,&A>$M,M?%<MQK&LZI=P-IVGVMLC>;
M?'R69"DA3\]?^">G[2O_  0>_:7_ &KOA/\ "[X!_L'^(?A_\;M1UV?6?A_X
MCFT?Q5<6>A7/AW3;S7FUW5-1BUQ[?1(8!I_V>)[Z)XIKR:*V.6?:?R@\#_\
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M.A7Y,_X):_\ !LI?_ WXK^!?VB?VU_''AWQ?XB^'>MQ>)/"'P9\%1/?>$O\
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MLH2BXR?M+1=KZJRZ]3_,;_X(??\ *47]D'_L=9?_ $GCK_0 _P""G'_!7/\
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M#7^7]6?E?](:*_-[_AV[IG_1[?\ P4=_\2X\3_\ REH_X=NZ9_T>W_P4=_\
M$N/$_P#\I:/JF5?]#>7_ (;J_P#\M#FG_P ^U_X&O\OZL_*_Z0T5^;W_  [=
MTS_H]O\ X*._^)<>)_\ Y2T?\.W=,_Z/;_X*._\ B7'B?_Y2T?5,J_Z&\O\
MPW5__EH<T_\ GVO_  -?Y?U9^5_TAHK\WO\ AV[IG_1[?_!1W_Q+CQ/_ /*6
MC_AV[IG_ $>W_P %'?\ Q+CQ/_\ *6CZIE7_ $-Y?^&ZO_\ +0YI_P#/M?\
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M */;_P""CO\ XEQXG_\ E+1_P[=TS_H]O_@H[_XEQXG_ /E+1]4RK_H;R_\
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M_@H[_P")<>)__E+1_P .W=,_Z/;_ ."CO_B7'B?_ .4M'U3*O^AO+_PW5_\
MY:'-/_GVO_ U_E_5GY7_ $AHK\WO^';NF?\ 1[?_  4=_P#$N/$__P I:/\
MAV[IG_1[?_!1W_Q+CQ/_ /*6CZIE7_0WE_X;J_\ \M#FG_S[7_@:_P OZL_*
M_P"D-%?F]_P[=TS_ */;_P""CO\ XEQXG_\ E+1_P[=TS_H]O_@H[_XEQXG_
M /E+1]4RK_H;R_\ #=7_ /EH<T_^?:_\#7^7]6?E?](:*_-[_AV[IG_1[?\
MP4=_\2X\3_\ REH_X=NZ9_T>W_P4=_\ $N/$_P#\I:/JF5?]#>7_ (;J_P#\
MM#FG_P ^U_X&O\OZL_*_Z0T5^;W_  [=TS_H]O\ X*._^)<>)_\ Y2T?\.W=
M,_Z/;_X*._\ B7'B?_Y2T?5,J_Z&\O\ PW5__EH<T_\ GVO_  -?Y?U9^5_T
MAHK\WO\ AV[IG_1[?_!1W_Q+CQ/_ /*6C_AV[IG_ $>W_P %'?\ Q+CQ/_\
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M^)<>)_\ Y2T?\.W=,_Z/;_X*._\ B7'B?_Y2T?5,J_Z&\O\ PW5__EH<T_\
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M7_0WE_X;J_\ \M#FG_S[7_@:_P OZL_*_P"D-%?F]_P[=TS_ */;_P""CO\
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MM?\ @:_R_JS\K_I#17YO?\.W=,_Z/;_X*._^)<>)_P#Y2T?\.W=,_P"CV_\
M@H[_ .)<>)__ )2T?5,J_P"AO+_PW5__ ):'-/\ Y]K_ ,#7^7]6?E?](:*_
M-[_AV[IG_1[?_!1W_P 2X\3_ /REH_X=NZ9_T>W_ ,%'?_$N/$__ ,I:/JF5
M?]#>7_ANK_\ RT.:?_/M?^!K_+^K/RO^D-%?F]_P[=TS_H]O_@H[_P")<>)_
M_E+1_P .W=,_Z/;_ ."CO_B7'B?_ .4M'U3*O^AO+_PW5_\ Y:'-/_GVO_ U
M_E_5GY7_ $AHK\WO^';NF?\ 1[?_  4=_P#$N/$__P I:/\ AV[IG_1[?_!1
MW_Q+CQ/_ /*6CZIE7_0WE_X;J_\ \M#FG_S[7_@:_P OZL_*_P"D-%?F]_P[
M=TS_ */;_P""CO\ XEQXG_\ E+1_P[=TS_H]O_@H[_XEQXG_ /E+1]4RK_H;
MR_\ #=7_ /EH<T_^?:_\#7^7]6?E?](:*_-[_AV[IG_1[?\ P4=_\2X\3_\
MREH_X=NZ9_T>W_P4=_\ $N/$_P#\I:/JF5?]#>7_ (;J_P#\M#FG_P ^U_X&
MO\OZL_*_Z0T5^;W_  [=TS_H]O\ X*._^)<>)_\ Y2T?\.W=,_Z/;_X*._\
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MIJ=655RDZE1--.3BDM&M7J<^&H2PT91C%RYFG=RBK62CT7E^?D?I#17YO?\
M#MW3/^CV_P#@H[_XEQXG_P#E+1_P[=TS_H]O_@H[_P")<>)__E+7Q?U3*O\
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M;NF?]'M_\%'?_$N/$_\ \I:/^';NF?\ 1[?_  4=_P#$N/$__P I:/JF5?\
M0WE_X;J__P M#FG_ ,^U_P"!K_+^K/RO^D-%?F]_P[=TS_H]O_@H[_XEQXG_
M /E+1_P[=TS_ */;_P""CO\ XEQXG_\ E+1]4RK_ *&\O_#=7_\ EH<T_P#G
MVO\ P-?Y?U9^5_TAHK\WO^';NF?]'M_\%'?_ !+CQ/\ _*6C_AV[IG_1[?\
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M?]'M_P#!1W_Q+CQ/_P#*6C_AV[IG_1[?_!1W_P 2X\3_ /REH^J95_T-Y?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME?\ R+\)_P!>E^;"BBBO*.\**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K^*'_@Y _Y/C^%?_9J/@?_ -6]\<Z_
MM>K^*'_@Y _Y/C^%?_9J/@?_ -6]\<Z^CX5_Y&T/^O%?_P!)1XV??\B^7_7V
ME^;/U7_X-O/^3'?BI_V=;XX_]5#\#*_H'K^?C_@V\_Y,=^*G_9UOCC_U4/P,
MK^@>N'//^1MC_P#K^_\ TF)U97_R+\)_UZ7YL****\H[PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OXH?^#D#
M_D^/X5_]FH^!_P#U;WQSK^UZOXH?^#D#_D^/X5_]FH^!_P#U;WQSKZ/A7_D;
M0_Z\5_\ TE'C9]_R+Y?]?:7YL_5?_@V\_P"3'?BI_P!G6^./_50_ ROZ!Z_G
MX_X-O/\ DQWXJ?\ 9UOCC_U4/P,K^@>N'//^1MC_ /K^_P#TF)U97_R+\)_U
MZ7YL****\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OXH?^#D#_ )/C^%?_ &:CX'_]6]\<Z_M>K^*'_@Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1K,+<SW'F2.-OX:_\'5O[&OP7_8MA_9B_P""H'[+'ANQ^"'[1ND_M*:%X?\
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M:[P#^LBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI\4?VF2L'@-M1L$CU'0_A!H\KQV-S8W:W$A^S>+]3-W?3Q2012F*QLR?D*9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLQ+'DU]85#;V\%I;P6MM%'!;6T,5O;P1(L<4,$*+'%%%&H"I''&JHB* JJH
M  %34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5_%#_P<@?\ )\?PK_[-1\#_ /JW
MOCG7]KU?Q0_\'('_ "?'\*_^S4? _P#ZM[XYU]'PK_R-H?\ 7BO_ .DH\;/O
M^1?+_K[2_-GZK_\ !MY_R8[\5/\ LZWQQ_ZJ'X&5_0/7\_'_  ;>?\F._%3_
M +.M\<?^JA^!E?T#UPYY_P C;'_]?W_Z3$ZLK_Y%^$_Z]+\V%%%%>4=X4444
M %?G[_P4P_:(_:J_9=_9;\1?%S]CK]GBR_:=^,6CZ]X?L[7X67IU]A?:'J%Z
M+?6-2MK?PTT>JW5SIT!$\5O%)&DAR)9$3+K^@5% '\4G_#]+_@X;_P"D)&G?
M^"3XS?\ R\KYC^/O_!U!_P %=?V6]>\#>%OV@O\ @EW\+?A1XD^):W3> ="\
M7-\7].U7Q9]BO[+2[E-#L3K;W-_+'J&I6%H(H8VD>>\MXXU9I5!_NV^+'Q/\
M&_!3X9>/?BY\0]8M?#_@;X;^%-<\9>*M9O95AMK#1= L)M0O9I)&^4$Q0F.,
M'[\KH@!+"OX;O^"2'PX\4?\ !>S_ (*E?'3_ (*H_M2Z#+K/[,?[-_B0>%OV
M9/A-XJN=0O='TC7'OY=2\"1:9;FWM])U&/P9IVGG7_$E]:^2;OQ==:2UY;2>
M2!& ?VD?"KXTZO<_LL> OV@?VA=(TKX.ZO=?!G0?BG\6-#GN+J/2OAY-=>%K
M?Q+XCTZXFU/;?1)H223030WH%[%+"]M.GVE66OY>)O\ @Y%_;._:^^(OC_1O
M^"1W_!-W5/VE_A3\,M;DT'7_ (M?$V_US1=*UBX:>Z33;S2;30;_ $V/38M9
MM(1J%EIVJWSZM%9JTMU:Q^:HC^G?^#M#X]:_\'_^"4/BGPAX6NM1T_6/C?\
M$GP7\/+F^L)9(5'AEKPW_B73[B2*2*39JUDD=B$W%)%DD61'4E3^BO\ P1$_
M9G\*_LK_ /!,3]DOX?\ A_1AI>KZS\*?#7COQW=2V=M:ZAK'C?Q?81:QKNH7
MQ@4R/FXN?*M([BXNGM;1(H%F**% !\<?\$N_^#@'P'^VY\>/$?[%?[1_P2\3
M?L@?MI^#+:2WU/X9>,KAO["\5:_I-N)/$ND^$[G4$@U2UN[ [;S3+#64%QK>
MDW-M>Z9)<AL/^OG[;'[87PB_8-_9G^*7[4?QMU">U\#?#'0_[1ET[3PDFM^)
M=9O+F#3M!\,:#:L=USJFM:K=VMI'M61;2W>XU"X46EG<,O\ ([_P=6Z;H/['
M_P"U1_P3)_X*-?#;P/I-E\6O#GQEFLO$GB'27?1M3\8P_#6ZT'Q3H6E^(;VT
M@V3((=1N[".^N_/GDLY&LI4EM8%C'US_ ,'8]]K7CS_@E;\ _'.BP:Q>_#>X
M_:8^"/C/XJWGAX^99V?PXU7PGXJF-[?L^QGL&UO4-#ALB8R7U*:P#1X8@ '-
M7_\ P7^_X*7_  4^''P[_;9_:O\ ^"7&F^ _^"=/Q*U&SDTWQUX,\?R:K\<O
M#OA/Q7YZ> _%/BCPA?ZS)!I=IJ0^Q:C<?VAH>EV^H:=<J^DW3-+;23?U8_"#
MXL^ OCO\+O /QE^%VOVGBGX=_$SPMI'C'P=XALF#6NK:#K=I'>6-W$02!NCD
MVNN3LD5T))7-?A5_P5R^*'PBT?\ X-Y/BSKEMK^E7?@CQK^Q]\/O"'PYO99=
M.O1JNI^(_!_AZS\'VEL=S0MJK%(LBT'VFSGAF=%B,#E/GS]D/]L^/_@F3_P;
M3_L]?M!_&"\TZU\567P!TO2?@?X;M!<G4_%'B_QXMZOPN\-QVES#NGUZ 7$V
MO:M882,:5HNI-$X6'- 'W%J7_!4WXD_$O_@KQH7_  3;_97^'WPZ^(?P^^&/
MP^;QY^V#\:]?N?%MT/A7=2K=7.G>"/#K^&7;0QXIU2W&G6-JGB$_9EU:[N(9
M<+92(_[>U^!7_!OC^P]X]_9H_9.U[]HC]HR.>_\ VO\ ]N3QCJ7[0WQSUG5(
M[=]6T^'Q//)<>#/"L=S"-T6G6^@-:>('TUG==/U77=0M@Q$*A?WUH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "OXH?^#D#_D^/X5_]FH^!_P#U;WQSK^UZOXH?
M^#D#_D^/X5_]FH^!_P#U;WQSKZ/A7_D;0_Z\5_\ TE'C9]_R+Y?]?:7YL_5?
M_@V\_P"3'?BI_P!G6^./_50_ ROZ!Z_GX_X-O/\ DQWXJ?\ 9UOCC_U4/P,K
M^@>N'//^1MC_ /K^_P#TF)U97_R+\)_UZ7YL****\H[PHHHH **** /Y*O\
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M:U_M_5X+J"SMFB1I6_T M.LDTW3[#3HF+1V%E:V4;$ %DM8$@1B!P"5C!('
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M /T:%^T/_P"%%\.O_EG7\&%%'_$(^!O^A;BO_#EC?_EWK_2U/KV)_P"?D?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K^*'_ (.0/^3X_A7_ -FH^!__ %;WQSK^
MUZOXH?\ @Y _Y/C^%?\ V:CX'_\ 5O?'.OH^%?\ D;0_Z\5__24>-GW_ "+Y
M?]?:7YL_5?\ X-O/^3'?BI_V=;XX_P#50_ ROZ!Z_GX_X-O/^3'?BI_V=;XX
M_P#50_ ROZ!ZX<\_Y&V/_P"O[_\ 28G5E?\ R+\)_P!>E^;"BBBO*.\****
M"BBB@#\[O#G_  2N_8J\*_MU^*/^"D&D?#/4D_:S\86MU::WX\NO&GBN]TF5
M+SPKI7@N::V\&7.JR>%K*Z_X1W1K"RCNK;3(YXFCDGC=9I9';]$:** "OQH_
M:T_X(!?\$J?VU/B7-\7OC9^S+IJ>/[Y+IM;USX;^*?%7PI/B:]O;M[VZUCQ/
M:> =5T*SU[6YIW8R:MJ,,][(K,))F+NS?LO10!\7?L8?\$]OV0?^"?G@W4O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K^*'_@Y _Y/C^%?_9J/@?_ -6]\<Z_M>K^*'_@Y _Y/C^%?_9J
M/@?_ -6]\<Z^CX5_Y&T/^O%?_P!)1XV??\B^7_7VE^;/U7_X-O/^3'?BI_V=
M;XX_]5#\#*_H'K^?C_@V\_Y,=^*G_9UOCC_U4/P,K^@>N'//^1MC_P#K^_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5_%#_ ,'('_)\?PK_ .S4? __ *M[XYU_:]7\4/\
MP<@?\GQ_"O\ [-1\#_\ JWOCG7T?"O\ R-H?]>*__I*/&S[_ )%\O^OM+\V?
MJO\ \&WG_)COQ4_[.M\<?^JA^!E?T#U_/Q_P;>?\F._%3_LZWQQ_ZJ'X&5_0
M/7#GG_(VQ_\ U_?_ *3$ZLK_ .1?A/\ KTOS84445Y1WA1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_L\>/OV:?#'[?'[>OP]M/VC_ -IO]IC4=0^*6GS?%6ZU#Q!IW@3P]?ZIJ/\
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M@ HHHH ^,O\ @HM_R83^V/\ ]FV?&+_U!M:K_'\TG_D%:9_V#[+_ -)HJ_V
M_P#@HM_R83^V/_V;9\8O_4&UJO\ '\TG_D%:9_V#[+_TFBK^E? O_D4Y]_V,
M<)_ZC3/(S+^)1_P3_P#2HFA1117[F><%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'NW[
M+7_)SW[./_9=/A1_ZG6A5_LE5_C:_LM?\G/?LX_]ET^%'_J=:%7^R57\Y>.O
M^^<.?]@V9?\ IW"'K9;\%7_%'\F%%%%?@AZ04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?Q0_\ !R!_R?'\*_\ LU'P/_ZM[XYU_:]7
M\4/_  <@?\GQ_"O_ +-1\#_^K>^.=?1\*_\ (VA_UXK_ /I*/&S[_D7R_P"O
MM+\V?JO_ ,&WG_)COQ4_[.M\<?\ JH?@97] ]?S\?\&WG_)COQ4_[.M\<?\
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M46_Y,)_;'_[-L^,7_J#:U7^/YI/_ ""M,_[!]E_Z315_L!_\%%O^3"?VQ_\
MLVSXQ?\ J#:U7^/YI/\ R"M,_P"P?9?^DT5?TKX%_P#(IS[_ +&.$_\ 4:9Y
M&9?Q*/\ @G_Z5$T****_<SS@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]V_9:_Y.>_9
MQ_[+I\*/_4ZT*O\ 9*K_ !M?V6O^3GOV<?\ LNGPH_\ 4ZT*O]DJOYR\=?\
M?.'/^P;,O_3N$/6RWX*O^*/Y,****_!#T@HHHH **** "BBB@ HHHH ****
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M=^'_  [X1>QT^XT&UCL98+JX\_5+VR=;R\CN%DQ9)'/^PGA/PMH/@?PQX?\
M!WA?3+/1O#GA?1].T'0])L(([6RT_2]+M8K.RM+:WB58XHH8(41410!CU)KH
M** /Y?\ XY_\$/OVN/@E^W!\2_VZO^"/_P"U;\,_V6_&/[0B:E%\=OA-\6?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH ]V_9:_Y.>_9Q_[+I\*/_4ZT*O\ 9*K_ !M?V6O^3GOV<?\
MLNGPH_\ 4ZT*O]DJOYR\=?\ ?.'/^P;,O_3N$/6RWX*O^*/Y,****_!#T@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR!H[=/(M7W3NK)$N9&!52* .DHK_ #//^":W_!.3]K;_ (+=^/?VV/VCHO\
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MCURT75[+5;&>UET6T:)XXYE']8- !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]L)+37-+T6VL]2L+2TDB@74;VXN]634@WER?7G_!%_QAXO\ V'O^"NG[;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_%#_ ,'('_)\
M?PK_ .S4? __ *M[XYU_:]7\4/\ P<@?\GQ_"O\ [-1\#_\ JWOCG7T?"O\
MR-H?]>*__I*/&S[_ )%\O^OM+\V?JO\ \&WG_)COQ4_[.M\<?^JA^!E?T#U_
M/Q_P;>?\F._%3_LZWQQ_ZJ'X&5_0/7#GG_(VQ_\ U_?_ *3$ZLK_ .1?A/\
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M10!\9?\ !1;_ ),)_;'_ .S;/C%_Z@VM5_C^:3_R"M,_[!]E_P"DT5?[ ?\
MP46_Y,)_;'_[-L^,7_J#:U7^/YI/_(*TS_L'V7_I-%7]*^!?_(IS[_L8X3_U
M&F>1F7\2C_@G_P"E1-"BBBOW,\X**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /=OV6O\
MDY[]G'_LNGPH_P#4ZT*O]DJO\;7]EK_DY[]G'_LNGPH_]3K0J_V2J_G+QU_W
MSAS_ +!LR_\ 3N$/6RWX*O\ BC^3"BBBOP0](**** "BBB@ HHHH **** "B
MBJM]?66F65WJ6I7EKI^GV%M->7U]>SQ6MG9VEM&TUQ=75S.R0V]O!$CRS32N
MD<<:L[LJ@D %JBOP[^-__!QG_P $B?@+XXN?A]XH_:GT/Q/K^GWLVG:L_P -
M]*OO'&DZ/?V\JP7-IJ6K:3FSAFMY699@CRHICDPY"&OTH_98_;+_ &8OVU_
M#_$S]E[XR^"OC!X1MKPZ;JEYX4U:"\NM#U18HYGTS7-.W+>Z7>I'*C&*ZA17
M!S$\@!( /IRBBB@ HKS[XI?%CX9_!'P/KGQ+^+WCKPO\./ /ANV-WKOBWQAJ
M]GHFAZ; H9MUQ>WLD<>]@K%(4+S2!6V1MM./Q2;_ (.9?^"-Z^/_ /A /^&J
MM/,OVO[)_P )>OAS6#X SMW?:?\ A*A']D^R=O/\O;NXQ0!^]U%<)\,OB?\
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M6^./_50_ ROZ!ZX<\_Y&V/\ ^O[_ /28G5E?_(OPG_7I?FPHHHKRCO"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^,O^"BW_)A/[8__ &;9\8O_ %!M:K_'\TG_
M )!6F?\ 8/LO_2:*O]@/_@HM_P F$_MC_P#9MGQB_P#4&UJO\?S2?^05IG_8
M/LO_ $FBK^E? O\ Y%.??]C'"?\ J-,\C,OXE'_!/_TJ)H4445^YGG!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110![M^RU_R<]^SC_P!ET^%'_J=:%7^R57^-K^RU_P G
M/?LX_P#9=/A1_P"IUH5?[)5?SEXZ_P"^<.?]@V9?^G<(>MEOP5?\4?R84445
M^"'I!1110!\^?M/?M4? 3]C7X2:Q\=/VD_B%8?#'X5Z!>Z=IVK>+-1T[6]5M
MK2]U:<VVG6YLO#^FZMJ<LEU./+C$%E)\V Q&17RI\>O^"P?_  3D_9G^$WPM
M^-7QC_:=\&^%_!'QM\*V7C;X3%++Q#JGB3QUX8U*U-WI^L:1X2TW2+GQ'!87
ML8*PWFJZ;IUH)0\<T\31R[/S]_X.HO\ E#K\<O\ L:O '_IVEKX6_P"#?3_@
MD5\*?C=^RM\,?V\_V_O#]A^TY\;OBEX6T31_A+H_Q/LCJ?ASX+_!3X?))X0\
M!^%]!\.EHM EDU+2M(@UR>8:<8ECU%4G2?47OKJ0 _<C]C__ (+5?\$U?VY_
M%2> /V>_VF/"NN?$.>[BL[#P%XDL=9\&>*-7GN%G>V30K+Q+8:?%KLEPEK<,
MEOI-S>72"%O-@CW1[_U1K^-W_@X?_P""*'[//A+]F7Q5_P %#_V+/!VE_LT?
MM)_LLW>C_$W5[WX60ZAX>T_QQX3TFZMM.FMK71-'NK?3]#\4:%=W6G:OI^M:
M5!8"73K75K34DO#-;&+]]?\ @D'^V?%^WS_P3R_9P_:.N+Q[WQ7K_@V/PQ\1
M)9;=K65OB)X&N)O"GB^X:W<LRIJ.KZ5/J=O(#LN+>]BN(PL<JJ #]+:*_&[_
M (*'?\%U?V ?^"<O]I^$_B5\2D^(_P =;=)8-._9_P#A/Y7BOXB2:M)827ND
MVGB.WL6GA\&V&K2(MG#JVLKY<=Q(L8MI92L3?S\:Y\6O^#A#_@N]>7OA[X)>
M#KO_ ()@_L.:]<7&G7WCOQ''JVC_ !"\5>$M4B8I.FL3KIWBGQ==:?>6)@G;
MX=CP5#;-<)YE_N21) #^Q;PG^U7^SMX]^-?BS]G7P1\7?!GB_P",_@3P_;>)
M_&G@;PUJB:WJ'A;2;J^GTZ%M=NM.6XTS3;_[9;RPRZ1<WL>JP%0T]E&C*Q_F
M@_X.I?VS/BYX7^'/[//_  38_9YU9M"^*?[>OC#1_"NN:Q8ZK?:7K%OX%N?%
MFG>'K71K>73E>Y32_%WB*5=%\0,H+3:,+RUC23SI4/Z9_P#!);_@B)\ O^"4
MQ\>^-_"WC_XB?&CX[_%_2="M?B?\4_B)J-O-->W5A]HO-4AT"PM+>&2WTW5-
M9NY]0EDUN[UK5Y'2)I=0R9%/X*?\%9-)\/\ Q@_X.@_^"9W@/Q3;:BFF> ]&
M^'>NVC_;C'#<ZOHGB74O'>BR6BMM$$$&L6UJ;F"-B;F:)SR9"" ?M1^QE_P;
MI?\ !,?]GG]G?P'\./BI^RG\'?C[\4(_#NGS?$GXG?%/PI9>,?$&O>+KNRC;
M7I-*O=5CDFT;1HKZ2XCTNRL/L_V>!8Y-QE *?SG?M;_ Z;_@V?\ ^"L?[-G[
M1O[(]UXJT_\ 8F_:WU?3/ /Q8^%6I7=_J^C:/:WVMZ?:>,O#-G>3Y34KC3X?
M,\?^!(+D"YT2>!=(A=]/MU>O]"*OXWO^#TG3;.;]@C]G76VB<:MX>_:1ANM%
MOXIYX9M.N;KPCJ=K//"870>:T+%$=LM$V'B*N U ']A^C:K::[H^E:W8%VL=
M9TVQU6S:1=CM::A:Q7=N73G:YAF0LN?E.1VK2KP7]EC7+OQ-^S/^S[X@OQ&+
MW6/@Q\-+^Z$1=H_/N/!VCO*5:5GD8%B3EV9B22237O5 '\)?_!7#6_B1_P %
MG/\ @MA\'_\ @CWX6\67'A3]F[]G2";XA?'C^Q-9U"VF\274$&BZAXVEU>TM
M4:WEU3P[HUSI.B>$A._EV,_B;4KL[+F2,'^AG6?^#?+_ ((_:U\(KGX.O^Q!
M\']-TZY\/IX?/CO1M#ATSXM0*BJ/[9MOB3 H\1P^(69?,?5A<F9G9LKM(4?S
M]_\ !$72/#_Q*_X../\ @K%\:-1M=0MO%'AQO&>C:!#=WQFDM]/\3^)=(L];
M6Y5BKW+2+X7TLP.4(MXU"#:&Y_N?H _A$_X(Z^._BQ_P1Y_X+*_&/_@B_P"-
M?%7B/QK^S)\7[W4/'7[/]WKL%R;S3-;U"RAN/#&N:; [&VM+'Q+HFF:CH/BF
M:S<VL^J^%;&[C02O<*OZJ_\ !T=^W_\ $W]CK]A?0?A)\"IKBT^,?[8OC,_!
M+1M9TF]>W\0^&?#%W9_;/$]]HUO'M::]\1V*/X+M9?,0V<VO&\B)FMTQ^9G_
M  5ZNAX+_P"#HG_@E)XVT2W6+7M2T?X<Z/J5R\]TD>H:9;^)_&MK;65PD4J
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M% !1110 4444 %%%% !1110!\9?\%%O^3"?VQ_\ LVSXQ?\ J#:U7^/YI/\
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M6>%-0GM+B^T35(S-))974MC-<6QGC21/,6.9]C$HV&4@?HU10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7\4/_!R!_R?'\*_^S4? _\ ZM[XYU_:
M]7\4/_!R!_R?'\*_^S4? _\ ZM[XYU]'PK_R-H?]>*__ *2CQL^_Y%\O^OM+
M\V?JO_P;>?\ )COQ4_[.M\<?^JA^!E?T#U_/Q_P;>?\ )COQ4_[.M\<?^JA^
M!E?T#UPYY_R-L?\ ]?W_ .DQ.K*_^1?A/^O2_-A1117E'>%%%% !117X9?\
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M/]6TF+POXDNITTS59+_2K.^U*U\FXV7%E97,T+R!%# '[A_\';GQOU[X5_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *_BA_P"#D#_D^/X5_P#9J/@?_P!6]\<Z_M>K
M^*'_ (.0/^3X_A7_ -FH^!__ %;WQSKZ/A7_ )&T/^O%?_TE'C9]_P B^7_7
MVE^;/U7_ .#;S_DQWXJ?]G6^./\ U4/P,K^@>OY^/^#;S_DQWXJ?]G6^./\
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M6/$?@?5O#NLZ_9P0VL"6=IK=[?V]D(Q]DCAR<_4?[//[-WP-_90^%V@_!?\
M9X^&GAGX4_#/PVK_ -E^%O"UE]EM%GE5%GOKV>1Y;W4]2N1%&+G4=1N;J]N!
M'&)9W"*  >WT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?&7_  46_P"3"?VQ_P#LVSXQ?^H-K5?X_FD_\@K3/^P?9?\ I-%7^P'_
M ,%%O^3"?VQ_^S;/C%_Z@VM5_C^:3_R"M,_[!]E_Z315_2O@7_R*<^_[&.$_
M]1IGD9E_$H_X)_\ I430HHHK]S/."BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#W;]EK_
M ).>_9Q_[+I\*/\ U.M"K_9*K_&U_9:_Y.>_9Q_[+I\*/_4ZT*O]DJOYR\=?
M]\X<_P"P;,O_ $[A#ULM^"K_ (H_DPHHHK\$/2"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K^*'_@Y _P"3X_A7_P!FH^!__5O?'.O[
M7J_BA_X.0/\ D^/X5_\ 9J/@?_U;WQSKZ/A7_D;0_P"O%?\ ])1XV??\B^7_
M %]I?FS]5_\ @V\_Y,=^*G_9UOCC_P!5#\#*_H'K^?C_ (-O/^3'?BI_V=;X
MX_\ 50_ ROZ!ZX<\_P"1MC_^O[_])B=65_\ (OPG_7I?FPHHHKRCO"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ^,O^"BW_ "83^V/_ -FV?&+_ -0;6J_Q_-)_
MY!6F?]@^R_\ 2:*O]@/_ (*+?\F$_MC_ /9MGQB_]0;6J_Q_-)_Y!6F?]@^R
M_P#2:*OZ5\"_^13GW_8QPG_J-,\C,OXE'_!/_P!*B:%%%%?N9YP4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >[?LM?\ )SW[./\ V73X4?\ J=:%7^R57^-K^RU_R<]^
MSC_V73X4?^IUH5?[)5?SEXZ_[YPY_P!@V9?^G<(>MEOP5?\ %'\F%%%%?@AZ
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?Q0_\'('_
M "?'\*_^S4? _P#ZM[XYU_:]7\4/_!R!_P GQ_"O_LU'P/\ ^K>^.=?1\*_\
MC:'_ %XK_P#I*/&S[_D7R_Z^TOS9^J__  ;>?\F._%3_ +.M\<?^JA^!E?T#
MU_/Q_P &WG_)COQ4_P"SK?''_JH?@97] ]<.>?\ (VQ__7]_^DQ.K*_^1?A/
M^O2_-A1117E'>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\9?\%%O^3"?VQ_\
MLVSXQ?\ J#:U7^/YI/\ R"M,_P"P?9?^DT5?[ ?_  46_P"3"?VQ_P#LVSXQ
M?^H-K5?X_FD_\@K3/^P?9?\ I-%7]*^!?_(IS[_L8X3_ -1IGD9E_$H_X)_^
ME1-"BBBOW,\X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /=OV6O^3GOV<?\ LNGPH_\
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M &=;XX_]5#\#*_H'K^?C_@V\_P"3'?BI_P!G6^./_50_ ROZ!ZX<\_Y&V/\
M^O[_ /28G5E?_(OPG_7I?FPHHHKRCO"BBB@ HHH) !). .23T ]30 45^+_[
M5W_!P/\ \$I/V-_&UY\.?BS^T[HVL>-=*,L.N:!\*=&U;XK7GA^_M]1NM+NM
M(U[_ (0J#5(M)UFSN;.8WFF7DD=W;0&*::-$ECW?5O[%'_!37]B+_@H3H;ZM
M^RG\>/"GQ%U*TTB'7=9\$--)HGQ#\.:7/.+:.Z\0^"=56VU[2HQ<,L$C3VNV
M*9DCE9&D0, ?>=%%?BS^UG_P<&?\$I?V,?']]\+_ (O?M+6&J^.]'O9],\0^
M'_A7X<UWXJ77AC5+22>*[TOQ')X,M=2M])U&TD@:.YM+F99H)'CBE596V  _
M::BOC?\ 8^_X* _L@?MZ>$[CQ?\ LJ_''P9\5K73K+3;[7]%TC4$A\6>%8]6
MB\VQC\4^%KORM9T.>0;HFCO;6,)<));LPFC=!]5>*?%'ASP1X;UWQAXOUO3/
M#7A;PQI5]KGB'Q!K-Y#8:5HVD:9;R7=_J.H7EPR0VUK:V\4DLLLC *JGJ2 0
M#>HK\+OAC_P<A?\ !(3XL_'2U_9_\,_M0VMCXLU#5=0T33/%'BOPEXE\*?"[
M5-2L VRWL/B3K=C:>%K@:G*HMM'F%\L.I74D4-O(S2+G]S8I8IXHYX)(YH9H
MTEAFB=9(I8I%#QR1R(2DD<B$,CJ2K*0RD@@T 245\1?%#_@H3^S3\)?VN/@[
M^PYXBU[Q5JW[2/QPT&Z\5>#O _@[P3X@\6QV'A>QENX[SQ'XQUC1[6XT[PAH
MULEA=W4U]K<]M&ME ]T,PX8_;M !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!\9?\%%O^3"?VQ_^S;/C%_Z@VM5_C^:3_P @K3/^
MP?9?^DT5?[ ?_!1;_DPG]L?_ +-L^,7_ *@VM5_C^:3_ ,@K3/\ L'V7_I-%
M7]*^!?\ R*<^_P"QCA/_ %&F>1F7\2C_ ()_^E1-"BBBOW,\X**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /=OV6O^3GOV<?^RZ?"C_U.M"K_ &2J_P ;7]EK_DY[]G'_
M ++I\*/_ %.M"K_9*K^<O'7_ 'SAS_L&S+_T[A#ULM^"K_BC^3"BBBOP0](*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^S=X9O9?#UK;:.98X6TN36K[3KW1[A8$>WOM,TF"^@E9-1D>3^J2OYO?C_\
M\%S/V6_V"OB9HW_!/3]E3]F3XY_ME_%#X"^ =)TGQ3\.?V9?#%I<VGPY\.>%
M?#]LUPVK7<&GS65Q=Z;ID,%YXA&FVD@LKV[(OGCE>=X_TQ_X)V_\%.OV8O\
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ME6]K"19M+I^SS)3 @2'_ ()_:O9^'/\ @ZE_X*/> _A+_9FE_#O6_@7K>O\
MQ1\.^'G:PT.;XCZ;XH^'_F:WJ-C! UO<>*;>\UB_A="]NBQ:MJMPBO(K _7O
M[2/_  0G_:%\'_MJ>//V[?\ @E!^V5I7[%'Q4^.<.H6OQU\$^)?AYIGB_P"%
MGB#[3:V+'5M$\-6VDW=DVK:GK,5]KVJG6["[%OK-W+JNE7%K=W5V9/N+_@E)
M_P $C?!/_!.33?B9\2O&?Q"U;]H;]L/]H36;CQ)^T!^T9XHCFCU/Q3J%W>R:
MD^C:!9W,LTNE>'X=1GN+S8[F\O))(ENW9+2W50#]B**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /C+_@HM_R83^V/_P!FV?&+_P!0
M;6J_Q_-)_P"05IG_ &#[+_TFBK_8#_X*+?\ )A/[8_\ V;9\8O\ U!M:K_'\
MTG_D%:9_V#[+_P!)HJ_I7P+_ .13GW_8QPG_ *C3/(S+^)1_P3_]*B:%%%%?
MN9YP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 >[?LM?\G/?LX_\ 9=/A1_ZG6A5_LE5_
MC:_LM?\ )SW[./\ V73X4?\ J=:%7^R57\Y>.O\ OG#G_8-F7_IW"'K9;\%7
M_%'\F%%%%?@AZ04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKO5+BXD@T;P]:QVN@V,4+B*9=/:[Y:<D_IU110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?Q0_P#!R!_R?'\*_P#LU'P/_P"K>^.=?VO5_%#_ ,'('_)\?PK_ .S4
M? __ *M[XYU]'PK_ ,C:'_7BO_Z2CQL^_P"1?+_K[2_-GZK_ /!MY_R8[\5/
M^SK?''_JH?@97] ]?S\?\&WG_)COQ4_[.M\<?^JA^!E?T#UPYY_R-L?_ -?W
M_P"DQ.K*_P#D7X3_ *]+\V%%%%>4=X4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG X?_P"B-SC_ ,.6#_\ E']6?E?_ $VZ*_S)/^&QOVO?^CJ/VA?_  [?C/\
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M_E']6?E?_3;HK_,D_P"&QOVO?^CJ/VA?_#M^,_\ Y:T?\-C?M>_]'4?M"_\
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M_27_ .30<0_]AF0_^KO G\T5%%%?ZUG^8(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?NM_P;O?\G_:W_V;_P".O_4A\(U^%-?NM_P;O?\ )_VM_P#9O_CK_P!2'PC7
MY3XY_P#)G_$7_LE\P_\ 28'Z;X,_\G3X%_[*' _^G#^Y*BBBO\73_6L****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_BA_X.0/^3X_A7_V
M:CX'_P#5O?'.O[7J_BA_X.0/^3X_A7_V:CX'_P#5O?'.OH^%?^1M#_KQ7_\
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M+Y?]?:7YL_5?_@V\_P"3'?BI_P!G6^./_50_ ROZ!Z_GX_X-O/\ DQWXJ?\
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M?^RG_P!DP^(?_J4:/7]&_11_Y/;PU_V <2?^J#,3\%^DO_R:#B'_ +#,A_\
M5W@3^:*BBBO]:S_,$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH%]8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /=OV6O^3GOV<?\
MLNGPH_\ 4ZT*O]DJO\;7]EK_ ).>_9Q_[+I\*/\ U.M"K_9*K^<O'7_?.'/^
MP;,O_3N$/6RWX*O^*/Y,****_!#T@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OX]/^#F/_DM_[*?_
M &3#XA_^I1H]?V%U_'I_P<Q_\EO_ &4_^R8?$/\ ]2C1Z_HWZ*/_ ">WAK_L
M XD_]4&8GX+])?\ Y-!Q#_V&9#_ZN\"?S14445_K6?Y@A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5^ZW_!N]_R?]K?_9O_ (Z_]2'PC7X4U^ZW_!N]_P G_:W_ -F_
M^.O_ %(?"-?E/CG_ ,F?\1?^R7S#_P!)@?IO@S_R=/@7_LH<#_Z</[DJ***_
MQ=/]:PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^*'_@
MY _Y/C^%?_9J/@?_ -6]\<Z_M>K^*'_@Y _Y/C^%?_9J/@?_ -6]\<Z^CX5_
MY&T/^O%?_P!)1XV??\B^7_7VE^;/U7_X-O/^3'?BI_V=;XX_]5#\#*_H'K^?
MC_@V\_Y,=^*G_9UOCC_U4/P,K^@>N'//^1MC_P#K^_\ TF)U97_R+\)_UZ7Y
ML****\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /C+_@HM_R83^V/_V;9\8O
M_4&UJO\ '\TG_D%:9_V#[+_TFBK_ & _^"BW_)A/[8__ &;9\8O_ %!M:K_'
M\TG_ )!6F?\ 8/LO_2:*OZ5\"_\ D4Y]_P!C'"?^HTSR,R_B4?\ !/\ ]*B:
M%%%%?N9YP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 >[?LM?\G/?LX_]ET^%'_J=:%7^
MR57^-K^RU_R<]^SC_P!ET^%'_J=:%7^R57\Y>.O^^<.?]@V9?^G<(>MEOP5?
M\4?R84445^"'I!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %?QZ?\',?_);_P!E/_LF'Q#_ /4HT>O[
M"Z_CT_X.8_\ DM_[*?\ V3#XA_\ J4:/7]&_11_Y/;PU_P!@'$G_ *H,Q/P7
MZ2__ ":#B'_L,R'_ -7>!/YHJ***_P!:S_,$**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "OW6_X-WO\ D_[6_P#LW_QU_P"I#X1K\*:_=;_@W>_Y/^UO_LW_ ,=?^I#X
M1K\I\<_^3/\ B+_V2^8?^DP/TWP9_P"3I\"_]E#@?_3A_<E1117^+I_K6%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?Q0_\ !R!_R?'\
M*_\ LU'P/_ZM[XYU_:]7\4/_  <@?\GQ_"O_ +-1\#_^K>^.=?1\*_\ (VA_
MUXK_ /I*/&S[_D7R_P"OM+\V?JO_ ,&WG_)COQ4_[.M\<?\ JH?@97] ]?S\
M?\&WG_)COQ4_[.M\<?\ JH?@97] ]<.>?\C;'_\ 7]_^DQ.K*_\ D7X3_KTO
MS84445Y1WA1110 4444 %%%% ",RJK,S!54%F9B JJ!DLQ.   "22< <FOPI
M_:J_X.._^"5/[)'Q(U3X2^,OC7KWQ(\=^'[Z[TKQ1I'P+\'7?Q0C\+:MI\\M
MM?Z7KNHZ7>6NG6E_9SQ>5<6\5S<-'(Z)DL)!&_\ X.+_ -M7QA^P]_P2\^,O
MCWX::\OA_P")OQ#O-&^#W@[4(O*.HV)\>R3Z7KNKZ8)"-EWI&C/<W"7"9DMI
M&CE0%PHKYG_X-X?^"2_[-WP(_P""?/PB^,?Q)^$W@GXA?'K]ICPKHOQ:^('B
M_P ::79>,-1LK7Q! ^H:!X9T^;68+R/3(M-LKL'5(].D,6HZHTEY/--($* '
MZ_?L2?\ !2S]BW_@H=X:O?$'[*?QL\.?$*\T;3],U'Q1X-9GTCQ[X/AU:(R6
M<?B?PI?;-1TR7<KP3?+-%!<QR6\LJR@*?L;QMXV\(_#?PAXD\?>/?$6D^$?!
M?@_1K_Q#XG\3:[>1:?I&B:+I=N]U?:C?W<S+'#!;P1LQY+NVV.)'E=$;^$?_
M (*R? GX4?\ !##_ (*R?L1?\%#/V8+S4/@Q\+OVB_B==:%^T3\-/#ME.G@6
M71[?4M,?XD?V1IEFGDVEAXH\/ZFMW<Z':0L+'6(Y]6L8T>\D0_J)_P '9?Q>
M\5Z#_P $P/A]X*\%:\=$T']IK]I#X2_"KQA=R74MA'=^"M7TKQ%XV-M>,A5C
M9R:AX8TB>]BD.U887=U;R]I /I[X;_\ !S/_ ,$EOB9\8=+^$-C\9/&?A5-=
MUO4?#V@_%?Q]\.=8\)_!36M4L#-'!%I_Q$OIVL9(=8N8&L]%NIK6&VOKJ2&/
MS8EF1S^^]M<VU[;P7EG/#=6EU#'<6US;RI-;W%O,@DAG@FC9HY8I8V5XY$9D
M=&#*2"#7\U/_  5C_9'_ &<M&_X-X/&O@27X=>!K+2?@1^RGX)\9_"ZXT.TL
M-+BT#X@^'?"VCWMEXBT+4(8(YYKC6-5GO+W4"'\S7FOIY+SS992P]R_X)0_M
M@VOPU_X(,?L__M4_M":UK-OIOP>_9JEU7Q-XC\:2R6]]XBM/"$$]EH,T>H79
M:2^'B67^RM'T?49F=K^YNK=F=B^Z@#[Y^*'_  4:_9T^%G[:'P=_8%U#_A8/
MBS]I+XT^&KKQGH7ACP!X+N?%.E>%O"%D][]L\3?$/6K>\@A\(Z/;6^GW5]+=
M7<,V+%([@(1-")/O*OY:/^#>KX$>,OVB_%/[17_!:C]I/P_<K\8?VS/&6O:9
M\ +#Q#-+J>H?#']G'PY?S:#I.DZ1)?H+C27U>\T^]L)6LR+?4="T[3KJ*1X;
MY]W]2] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!\9?\%%O^3"?VQ_^S;/C%_Z@VM5_C^:3_P @K3/^P?9?^DT5?[ ?_!1;_DPG
M]L?_ +-L^,7_ *@VM5_C^:3_ ,@K3/\ L'V7_I-%7]*^!?\ R*<^_P"QCA/_
M %&F>1F7\2C_ ()_^E1-"BBBOW,\X**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /=OV6O
M^3GOV<?^RZ?"C_U.M"K_ &2J_P ;7]EK_DY[]G'_ ++I\*/_ %.M"K_9*K^<
MO'7_ 'SAS_L&S+_T[A#ULM^"K_BC^3"BBBOP0](**** "BBB@ HHHH ****
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MWO?$>LM:Z7:QP(TK23Y121BOQ3_X-W/V7?B8_P *?CK_ ,%//VF=#=?VL/\
M@HAXQOOB="=<TNR&J>#/@_ON[KP!X?T2\D9]3T[2/$<%[;:I?Z+>+9M&NF:,
M)K<&$$ %_P"/'_!=#X._LD_&>/\ X)X_L-_L<_&O]N?XG_L]>!--TOQGX.^!
M(LM&T'X=:!X0T&U%S:W>K1^'M;@O;S1M*AMWUG[)IUO'%J,DML6:9967](_^
M";G_  5+_9R_X*:>!/%NO_" >(_!GQ#^&>L_\([\6_@G\0K$Z-\2/AQK'*1I
MK>ENJ%]/NKF*\M++4$2-9[BPO(G@@>(*WX$?\&M$VCZU^T%_P6,\2>*M<TZ^
M^.%Q^V9XUL?$>G3BSF\0P^%K;Q3X@2WOC=!WO%T0:^FI:7:01G[ LEB5B+&)
M0L'[ FN6]M_P=8?\%'_#?PLFL;+P)>? G7KWXJ:/H@N;#1+KXC:=XG^':3:K
MJEI:QFRO?&$-[?WD37-V49K>]UB2-FE#  ']E%%%% !1110!R?BSQIHW@R"S
MN=9%^8[Z>2W@^P6,U\PDCB,K>8L()C38.&;@M\HYKB/^%Y^!_P"YXA_\$%]_
M\37L+*K?>56QTW ''Y@TWR8O^>4?_?"_X5VT:N C34:^#Q%:JF^:I3QD:,6F
M]+4WA:K5EH_?=VKZ7LI:G?222[.+?;KS+SZ=?(\@_P"%Y^!_[GB'_P $%]_\
M31_PO/P/_<\0_P#@@OO_ (FO7_)B_P">4?\ WPO^%'DQ?\\H_P#OA?\ "MO;
MY5_T+\7_ .'&'_S#Z_T]%:I_/'_P!^7]_P G]_D>0?\ "\_ _P#<\0_^""^_
M^)H_X7GX'_N>(?\ P07W_P 37K_DQ?\ /*/_ +X7_"CR8O\ GE'_ -\+_A1[
M?*O^A?B__#C#_P"8?7^GH6J?SQ_\ ?E_?\G]_D>0?\+S\#_W/$/_ ((+[_XF
MC_A>?@?^YXA_\$%]_P#$UZ_Y,7_/*/\ [X7_  H\F+_GE'_WPO\ A1[?*O\
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MB'X'\*PZMI]UI>ERZ_XF\,:EI.E1ZAJ4D<D=C9O>W4*W%VZ.L$1:0HVW:?\
M/EL/^#=;_@IQ;6-E;R^%?@F);>TMX) OQ?LV4210I&^UO[%^8;E.#W'-?Z@G
MDQ?\\H_^^%_PH\F+_GE'_P!\+_A7V?"_B%7X1P^*PV4Y;3E3QE:G7K?7,2Z\
MN>E#DCR.%"BHQY6[IIW=M5TYZV$5=QE4J.\4TN6*6]F[W;W:_0_S!O\ B'=_
MX*:?]"K\%/\ P[UG_P#*6C_B'=_X*:?]"K\%/_#O6?\ \I:_T^?)B_YY1_\
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M?\0[O_!33_H5?@I_X=ZS_P#E+7^GSY,7_/*/_OA?\*/)B_YY1_\ ?"_X4?\
M$;\\_P"A7E_3[53R\O)_CWT/[-I_\_*GX?UT_/NS_,&_XAW?^"FG_0J_!3_P
M[UG_ /*6C_B'=_X*:?\ 0J_!3_P[UG_\I:_T^?)B_P">4?\ WPO^%'DQ?\\H
M_P#OA?\ "C_B-^>?]"O+^GVJGEY>3_'OH?V;3_Y^5/P_KI^?=G^8-_Q#N_\
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M_P#*6C_B'=_X*:?]"K\%/_#O6?\ \I:_T^?)B_YY1_\ ?"_X4>3%_P \H_\
MOA?\*/\ B-^>?]"O+^GVJGEY>3_'OH?V;3_Y^5/P_KI^?=G^8-_Q#N_\%-/^
MA5^"G_AWK/\ ^4M'_$.[_P %-/\ H5?@I_X=ZS_^4M?Z?/DQ?\\H_P#OA?\
M"CR8O^>4?_?"_P"%'_$;\\_Z%>7]/M5/+R\G^/?0_LVG_P _*GX?UT_/NS_,
M&_XAW?\ @II_T*OP4_\ #O6?_P I:/\ B'=_X*:?]"K\%/\ P[UG_P#*6O\
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M_P!\+_A1[?*O^A?B_P#PXP_^8?7^GH6J?SQ_\ ?E_?\ )_?Y'D'_  O/P/\
MW/$/_@@OO_B:/^%Y^!_[GB'_ ,$%]_\ $UZ_Y,7_ #RC_P"^%_PH\F+_ )Y1
M_P#?"_X4>WRK_H7XO_PXP_\ F'U_IZ%JG\\?_ 'Y?W_)_?Y'D'_"\_ _]SQ#
M_P"""^_^)H_X7GX'_N>(?_!!??\ Q->O^3%_SRC_ .^%_P */)B_YY1_]\+_
M (4>WRK_ *%^+_\ #C#_ .8?7^GH6J?SQ_\  'Y?W_)_?Y'D'_"\_ _]SQ#_
M .""^_\ B:/^%Y^!_P"YXA_\$%]_\37K_DQ?\\H_^^%_PH\F+_GE'_WPO^%'
MM\J_Z%^+_P##C#_YA]?Z>A:I_/'_ , ?E_?\G]_D>0?\+S\#_P!SQ#_X(+[_
M .)H_P"%Y^!_[GB'_P $%]_\37K_ ),7_/*/_OA?\*/)B_YY1_\ ?"_X4>WR
MK_H7XO\ \.,/_F'U_IZ%JG\\?_ 'Y?W_ "?W^1Y!_P +S\#_ -SQ#_X(+[_X
MFC_A>?@?^YXA_P#!!??_ !->O^3%_P \H_\ OA?\*/)B_P">4?\ WPO^%'M\
MJ_Z%^+_\.,/_ )A]?Z>A:I_/'_P!^7]_R?W^1Y!_PO/P/_<\0_\ @@OO_B:/
M^%Y^!_[GB'_P07W_ ,37K_DQ?\\H_P#OA?\ "CR8O^>4?_?"_P"%'M\J_P"A
M?B__  XP_P#F'U_IZ%JG\\?_  !^7]_R?W^1Y!_PO/P/_<\0_P#@@OO_ (FO
MY[O^"S_[(_QJ_;K^)7P+\5?L_P"F:'>Z3\/?!/BW0?$;>,=8/A2XCU#6M;T^
M_LELK>ZM9VO(3;6TIEE0J(I-J$$MQ_3AY,7_ #RC_P"^%_PH\F+_ )Y1_P#?
M"_X5]?P)Q]5\.^)<%Q7P_EL)9K@*6,HT(YCB7BL(X8["U<'7]I1I4,-.35&O
M4]FU6BHS49-22<7\MQEP=E?'7#^+X:SVIBEEN-J86K6>!J1PV)Y\'B*6*H\E
M6I"O&*]M1CSITI<T6XIK1K_/S_X<O?MU_P#0O_#'_P .';?_ "NH_P"'+W[=
M?_0O_#'_ ,.';?\ RNK_ $#/)B_YY1_]\+_A1Y,7_/*/_OA?\*_>_P#B<WQ*
M_P"A3PQT_P"8/%_W?^HSR?W^;/Q7_B5/PO\ ^?W%'_AVPO\ \[#_ #\_^'+W
M[=?_ $+_ ,,?_#AVW_RNH_X<O?MU_P#0O_#'_P .';?_ "NK_0,\F+_GE'_W
MPO\ A1Y,7_/*/_OA?\*/^)S?$K_H4\,=/^8/%_W?^HSR?W^;#_B5/PO_ .?W
M%'_AVPO_ ,[#_/S_ .'+W[=?_0O_  Q_\.';?_*ZC_AR]^W7_P!"_P##'_PX
M=M_\KJ_T#/)B_P">4?\ WPO^%'DQ?\\H_P#OA?\ "C_B<WQ*_P"A3PQT_P"8
M/%_W?^HSR?W^;#_B5/PO_P"?W%'_ (=L+_\ .P_S\_\ AR]^W7_T+_PQ_P##
MAVW_ ,KJ/^'+W[=?_0O_  Q_\.';?_*ZO] SR8O^>4?_ 'PO^%'DQ?\ /*/_
M +X7_"C_ (G-\2O^A3PQT_Y@\7_=_P"HSR?W^;#_ (E3\+_^?W%'_AVPO_SL
M/\_/_AR]^W7_ -"_\,?_  X=M_\ *ZC_ (<O?MU_]"_\,?\ PX=M_P#*ZO\
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M_P"HSR?W^;#_ (E3\+_^?W%'_AVPO_SL/\_/_AR]^W7_ -"_\,?_  X=M_\
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M_P##AVW_ ,KJ/^'+W[=?_0O_  Q_\.';?_*ZO] SR8O^>4?_ 'PO^%'DQ?\
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M(=TDD<:YT&] W2.J+DD8 W,,D\ 9)X%>N^3%_P \H_\ OA?\*/*B_P">4?\
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M3[-+%YR ,2$EW*K8=0' 8 ']=G_"9^#_ /H;/#7_ (/=+_\ DJC_ (3/P?\
M]#9X:_\ ![I?_P E5_#C^RQ_P:._LY_';]FSX$_&?7OVQ_VA],USXI?"GP1X
M\U?3].TW1FL++4?$^@V6KW=K9F?51,;:VFNF@B,GSLD89N6->]_\08O[+O\
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M,Q^!_BBMG%+##;_$GP1%!HWBA%BF1'"SSQQ7JN 8I/M1>%WC(:OU*H ****
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M#6MZLGE2Z;INOZ]X9UA]:T:P$L;YO[/3M5>-Y0QLF W* ?VIT5_)=_P;B_\
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M^RU/I]_?6$I_:RB1I+&\N;1W0_"3XADI(;>6/S$R P23<H8*X 900 ?V$?\
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M6]G&[XSL5[B2-6;'.T$G'.*_!G_@O5_P64B_X)3_  -\*:;\*]'T+Q[^U?\
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M(EG3[+J]A/83[H'*I,HBN&)B9E5P-K$ DU_!3_P;%>(K3]A[_@JE_P %'/\
M@GI\8KNWT'XG^.-:6[\)VR6ZVVDZ[>_"W7O%&HRV>G7=YY%SYUQX<\;1ZAIU
ME%$ZWL$-R\;.+0,0#^\7Q_X_\$_"OP7XF^(WQ'\4:+X*\">#-'O/$'BOQ9XB
MOH=-T+P_HFGQ&>^U35;^X98;2RM85:2>>5@D: LQ %?E[XV_X+!_\$7OB1X1
M\2> ?'?[?'[''BGP;XOT>^T#Q-X<UCXM>%+K3-9T?4H6M[W3[VW:] D@N(79
M& *L#AD97 8?H[\</@SX"_:(^$GQ ^"'Q1TVXUGX>?$[PSJ7A#QCI-M>2Z?-
MJ.@ZM";>_LTO(/WT'GPLR,\?S!2<5_/I\3/^#7O_ ((]>&?AG\0M?TCX >*1
MJN@> _%NKZ7*WQ(\23.NH:7X>U"[LI=K,RR2)<P1. RL&<#*L"00#]:_^">_
MC/\ X)XZY\'+WP9_P3>\5_ CQ%\&?AOK0T;5[#X"ZQI>MZ#H'B'58#K MM;O
M=/GNIY-8O;:?[8)-2N9[N2W92)/+50/X_?\ @L+_ ,K77_!.3_L4?V<O_4U^
M+-?1'_!D4!_PR-^VJ<#)_:.\& GN0/AE9X&?09./3)]:^=_^"PO_ "M=?\$Y
M/^Q1_9R_]37XLT ?WSZIJFG:)IFHZSK%[;:;I.DV-UJ6IZC>S);V=AI]C!)<
MWEY=3R%8X;>VMXI)II7(6.-&9B #7\''_!)?0]:_X+ ?\%^/VI?^"EWBE6@^
M#?[(FI)X4^$FEW,[WDK:J+G6_#WP\32KJ0RVS6.G6&F>*_$NII;+%LG\2:8T
M7EM-*S_T'?\ !P[^W/IG[#/_  3(^.&O6^JQV/Q&^-VC:A\!_AA:&(2W%YK7
MC_3+O3-?N[4L56&;0_"4NM:PEP&\RVEM8IXE=H\5_)'_ ,$D?@O_ ,'*'[*_
M[)^@ZC^P9\%?@AI_P<^/-^_QBMM?^(&@_#K5?'7B+^VK2VTZQFU74-=U*#6(
M]-BM=,%QI.EW2[+/[==W$8!OI"0#[%_X*>Z>?^".O_!PI^RY^W=X(CUO1/@M
M^V+J]M8_&\Q26VD^#8;[Q5J\'@KX@)?7,-M';2F""\C^)-[;WOFWD\UM<74,
MPE<RK_>EINHV&L:=8:MI=W!?Z9JEE:ZCIU]:R++;7MC>P)<VEW;RJ2LD%Q;R
MQS12*2KQNK#@U_F??\%C/@#_ ,'('[5W[,:^,/\ @H#\&_A+?_!W]FG4M0^+
M,NK?#73?AYHOB/086TBXT/6=1N9=#U274+[1+73;U[J_L4!16MX;S8\EL@']
M=/\ P;B_MS6G[;O_  3%^#=[J^K2ZE\4?@5;M\$OB>;B%+>6;4O"T4<GAS4X
M8D)!L[WPK=Z1;QR[BTMQ8W3OM9MH /YF_!/Q_P#@?^S/_P '9W[0'Q5_:$^*
M_@;X,_#;2H/B)97_ (W^(>N6_A[PW;7^H_#Y;;3;&;4[K]Q%<ZA=,EM:I*R)
M),ZJSH"6']?Y_P""W7_!(E06/_!1?]DLA06(7XP>%V; &3A5NRS' X5023P
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MKE^;(_"F74-(6Z-O;Q68.K_$R\;_ $/3-&N;.PGF2?[;$@!\0?M=_&GXQ_\
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M_&G_  =V?M'^+/C_ /%?]DO_ ()/_ 2&?Q7\3O&'C'1/B-XM\*Z?L@N)M?\
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M:-X6UG4O#MQ?7NFPZS9V6HSQ33:?+?Z;?VB7**8VGM)XP=T;5]DU^5?[<O\
MP1A_8$_X*+?%'PW\8OVJ?A?K/C7QWX4\%6_P^T;4M.\7:OX?@A\,6NL:GKMO
M9RV>GLL4\L.HZSJ,J7#YD5;EXQ\IH _E'_X*(_M^?L1?$C_@X?\ ^"8_[1G@
M3]JOX(>*_@1\--+NH_B+\6=$\;Z?J'@7P/*-*\10I%XEU^V\RRT]Y9)[=4S(
MZAKB)9&1BRK_ %[?#O\ X*Z_\$P_BWXZ\)_#'X9?MV?LS>.OB%X[UW3O#'@W
MP=X9^*?AS5/$'B7Q#JUPEKIFC:/IUM=//>ZA?7,B06UM$K22R,JJ"37\0O[<
MW_!'C]@SX&?\%X_^">W[&OP_^&6O6'[/WQ_TV2;XG^#KWQCJ>H/JDL&D:Z\;
MZ9J5RC7>DEGL[:681-*))XVD&W>0/ZO/@A_P;C?\$IOV>/C%\,OCO\+?@EXC
MT3XC_"+QIH?C_P $:K/\0/$%_;6'B;PY=K?:3=W-A<.8+R*VNTCG^SS#8TD:
M,>5% '[J5Q_Q"\$Z-\2O GC'X>^(ED?0O&WAG6_"VKK"Y2;^S]<T^XTZZ:)P
M1ME2*X9XSTWJN<C(KL*^</VN/VF?!_['/[._Q0_:7^(>@^*?$/@+X0^'+KQ=
MXQM/!MC:ZCKMKX=T\;]2U."SO+RQAFAL(?WUR/M"LL09P"%. #_/L^$OCG_@
MJS_P:\_%_P#:"\(K^R]-\??V,?B-\1]/\43>/IK#Q1JWAZ]\-Z1>:UIWA[4?
M"WB?0+W^S/!'B;4+/7K9/$EAK.D7D4MPD"3QN]O%<0?N'^SC_P 'B7_!.OXG
M3^'-%^/'@7XN_LW>)-7DAL-2;4],3QWX7T/4YM06RBDU'7=&MM-EL]'DMV34
MYM1FT\C3K9S'=QYBDF'[Y?L _MV? /\ X*@?LNZ%^TK\%]*UMOAWXEUKQ%X4
MU#PQ\0M'TV#7='U[PU<1VNKZ/K>FP7>K:9(Z+<6\T<EO=W=K<6]S')'*ZL:\
M8_:=_P"")O\ P3!_:WT_7XOBS^R-\+8?$?B*UDM;GXA>!M"L_ WQ#LQ)O/G:
M;XHT&"WNK6XC=S)%(T<HCD^95&6# 'U+^S!\0_V,_P!H/2M3_:,_9/U'X&>/
M8O'<C?\ "3?%3X5Z5X3;7_$%W.XN9K?Q;K^D6,&O7=\TZ&6:'79WF>>)G(=X
MRP_C$_X+12S_ +4/_!RQ_P $X_V9_B98Z'J_PB\$ZG\'[<^%+ZUGNM,\2:7J
M_C.]\7>*+?7;9I2D]SK4<2Z+YB!84L8+821MMD+><_\ !-'X:^*?^"/W_!R/
MX@_X)X?!#XA>*OB!^SQ\:O"UY;ZWH.JW\+V^CZ3J'AZ[\>^%M3UNR-R+6X\3
M>#)=(/AX:S;1+J-S::W<K- 8[B4Q>@_\'"$&O?L0?\%U/^"=O_!0WQ-HKV/P
M*O-2^&T>O>-+F7[;ISZGX"\5W,7CS039INO+.]T_P9>Z?JJR6UO)$L&H03QR
M&X5X@ ?WUPPQ6\,5O BQ0P1I##&@PD<42A(T4=E1%"J.P J2L3PUXCT/QAX>
MT3Q5X9U2QUOP]XCTJPUO1-7TRZ@OM.U+2]2MH[NRO;*\MGEM[FWN+>6.2*:&
M1XW5@58BMN@#_/>_X*366@_LD?\ !U_^R+\7_"U_'X9T_P"+%Y\+M?\ &MMI
MTRZ+'?ZOXJTWQ)X+\02:O<HJVVH1^(7NM/EF2ZBE:6XC7S"TP@D3Z _X/./'
M'C#Q#;_L$?LU65_:Z7X,^('Q$U?Q!J]P$N)+BYUJ>ZLO"^G"]B2013Z;ID4[
MWT4,:+<-=.Y\PKL4>!?M0/X7_P""GO\ P==?!KP-\*M5MO%OPX_9=L_#=M\1
M]<L-.MM8T[3]1^#J:MJ'B^2"X@EEM-4TV+QAJ/A?1(M1:=;:WNYY?*D,T<44
MGU=_P>A? GQGJ'P-_9(_:K\'Z9K<VG_!GXFZGX8\<^(["YMXK+P?9^)?[/N/
M!.H2I),ER+W4O%"SV-K/:PSB*5(O.\M2K4 ?V'_L]?#GPQ\(?@3\'_AAX+TZ
MVTGPKX$^&_@[PUH>GV=O%:VUM8:9H5E;QB*V@2.&$2,K2LD:*H>1L"O8:^7_
M -BKX]>"OVGOV3_V?OCO\/=4BU?PK\1_A9X0UVPNHY&D=)VT>VMM1M+D2*DT
M5W9ZA!<V]Q#<1QSI)&?-C5CBOJ"@#Y#^%7[!7[(/P2^/'Q2_:=^%_P "?!OA
M7X]_&C5M6UOXD?$^W34KWQ+X@U'7I+2;6)$FU._O;?1X-1FLK>:ZLM#M]-LY
M)4>0P;I9B_UY7\\GP*_X+S:)\=/^"O?Q=_X)?>$?@;<^*-#^'M_JVFZ=\=?!
M/BB+7]*#>$;*)_&FJ>*=.6V2TT_1-.U>]TW0[&^TS4-06>_N3#<>0_EJ_P#0
MW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?QC_P#![%_R8+^RS_V=I#_ZJ3XB5_9Q7\8__![%_P F"_LL
M_P#9VD/_ *J3XB4 ?JE^Q3_P6,_X)5^ _P!D+]F7P7XN_P""@/[+&@^*?"_P
M-^&>A^(=#U3XK^'K'4M&UG3O"6EVVHZ7J%G=SP7%M>V%TDMK=0RQ*4GB<*70
M*[>-_P#!2C_@XD_X)A?"C]DGXZ6?PH_:2^''[27Q3\8_#CQ9X"\$?#OX0>(K
M7Q/<7OB#QMX>O]!L;[6-3LUDL-.T'2!J!U+5;KS96:.V_LZ/R[NY1H_$/V-_
M^#9C_@D7\2?V4?V=_B'XN^!_C#6/%7CKX/\ @3Q?XDU2\^)OB)I[[7?$?A^Q
MU?59P(O*CB@:^NY_LEM'&J6MJ(;9"RQ!C^A?P9_X-X/^"0GP1U;3-<\/_L>^
M _%>K:-=?;M,O?B5]H\>26M\EU'>6UXD>MM+;O<6,T2-8R2PO]F ^09P0 ?E
M=_P:+?L;>.?@;^PU\9_VD?B;X2U#PCXA_:C\;7.L>#;;4HYK:?5?AAX:T@0:
M3KHLIPLEK;ZCXCN_$45DDJ"62ULH[DL8[B/'SY_P:T_\G]?\%=O^RG7_ /ZG
MNKU_;1-86.E^'Y]-TRSM=.TZPTB>TL;"QMXK2SL[6"T>."VM;:!(X;>"&-52
M*&)$CC10J*  *_B7_P"#6G_D_K_@KM_V4Z__ /4]U>@#Z(_X*[_MI?\ !1G]
MI?\ X*._#3_@D'_P3H\4W'P*M-<T.P\1?&3]HRVT34)M0T>..&74_%=G'JLL
M9LHM \(>&[S1M3U*RTH1ZQJ=[J5K:PW\!>$)XW\6?^#9O]N?P3\/M<^)_P #
MO^"O/[4/B/\ :%\,:9J/B_3M-\7>,?&J>#O%GB6QLKG49]&LK.'Q,XTHZU=J
MUEICW\>H:?8/<0_:K66",@?6'[=?_!>KXRZ7^W5K?_!.O_@EE^R1H7[6W[47
MAC1M;;Q_XDUO7M/\,:=X6UC2+*SU'6;/13?O866OQ:#IDUK)KUWJ6M6%FDLD
M=K;+=2Q.(_%M3^%O_!VK^T/X:UFP\;?'C]DS]ESPUKVCZE#J=SHNGZ=IGB;P
MGI&JV<D]X]EJ_A[1]=NWUC1+93:VU[]N1$NOWS7,,+S7,8!],?\ !LO_ ,%/
M/VC/VZ/@K\=_@G^UUJ4GB[X^_LI?$!O"6K?$22TLK.\\3^&[QI+&SM/$0TZ"
MUL;KQ)H6MZ7K=A<:C:VT"W^FKITTZ/=BXED^)_\ @IA_P43_ &^O^"A?_!22
M]_X(Z_\ !+?QS!\%]/\ AU=:I:_M(?M :7?6MU?0Q:.+>#QC%<:@EL]UX<T'
MP5<7 TZXT[1Y+?Q#X@\2"WLK;5+:VE6*7QC_ (,X=,US0OB#_P %.]%UC6F\
M3^)=&\>Z%I>J^(I)6N'\1:YIVN>+;6^UN2:1F:=M6OXI;YI9&+2F<N[$L34'
M_!MY9ZD__!<3_@KM>>-M,MK/XAVI^(D.J17$$<&JV G^-VG_ -L01P[VEAMG
MO8M.%YM#()Q:I(X9T5@#M?VBO^"&7_!37_@G]\$O$?[6O[&G_!4S]HWXJ?'3
MX1Z&/&GBSP-\0O$NJZKX9\7:1HUHVH^+O^$>T?Q/?^(M+FNHQ'>7>FZ+JMA?
MR:C;'^S5N!<R"1_U^_87_P""U\WQ4_X(^>-O^"B?[3WPTU'X=>+?@)X<UK3_
M (E:-=6UQX6T#XB>*M"FM=&T/4O!%UK$)%K:>/-;O=/L([1TN4TC5;N2W$LU
MNL3U_0+J=Y8:?IVH:AJLL%OIEC975YJ,]SC[/!8VL$D]W-/N!'DQ01R22Y!&
MQ6R#7\AW_!?7]LG]G/\ ;F_X(C_M%>-?V)?B?IOQ8^'7P_\ B5\+M.^)FJ^"
M])UW1-'TF*\\2QK;VNIQ:SHVB_:8O[4%EYJ6\4RP736AG,;O#N /A#]D?]G#
M_@K)_P '%,GBW]LKX\?MH?$K]CC]D#4O%6OZ;\"_AA\&-3U#P[J%_:Z9-<6@
MCT670[K2KBXT/0KQ8[?5?$'B>XUBY\0:N=0CTZ.QAL5CM^F_:";_ (*M?\&V
M/C7X-_%BX_:R\3?MN?\ !.[QS\0=(\$_$70_BY#=:WXG^'L^JSJ)9;K5+VYO
M/$L>H-H5MJE]H&K:?JT&A3:A:PZ3J.EM+)#,.1_X)??L;?\ !PYXW_8)_9L\
M7?L@?MT_LQ_";]G#Q%X)N]4^%_@"^/BF'4O#^E3>)-;CU*WU1-(^'6LV U.?
MQ!%J]WJ'E:E=-]LN)S*R2EXT]%_;1_X)"?\ !P9^U#\$-2^%/[8/_!2+]B^^
M^#-_K&F:EJ,'C'Q/XR\+Z.VK:?(TVF&35KSX86D4<R2*[0Q^<K/\^ 1F@#]O
M/^"_OC;0/B9_P0X_:2^(OA6Z^V^%_'WP?\)^,O#MY@*USH?BB/3-:TJ=E!8(
M\MC>P.Z9.QR5/(-?S'?\$:OV)?\ @J5_P53_ &'/AQX9C_;?UK]CC_@G]\);
M^;X9>%_!_P '[2YT_P"(WQ4U+PY=R7_B?6V\0Z?>6>KZ+<6&M-I0DO;N_FTK
M4X[F_L[3241;AZ_:3]OKX%>,_P!F;_@UX\6_ ;X@_$3P?\5_%WPQ^!%AX9U;
MQ_X UJ[\1>#?$)M?$]W):3^'M9OH8+J]TZUL9K:PA>6&(Q_96A5 D:U^BO\
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MU=)/:W**Z,T4BA@&!QS7\??_  2Y_;\_8E^%G_!P!_P5H_:&^(_[5'P2\$_
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MB--=\1W\VF_9?#GB3PUX=\07+:M>ZE8RW;7EG'<%;2XU&QCW0RVA99/XO/\
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M=75W+<WK/*L97]D** /RB_X*^?\ !*;X4?\ !67]F*\^"GC+5T\!_$3PW?\
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M7#M'$FO^&]2BMM3M(I9$:.&]2&:PF?"1732'8 #[:HK\K/\ @K1_P4%^)O\
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M2XM7U+X8>(;;4/"OCFTLY&92]MI>MVUK;ZV8BDAN%\/WFJ26T<;S7*0PJ7H
M_3FBOSX_X*;_ +7GQ:_83_9/\=_M2?"[X%1?M V7PGBC\1?$CP;'XF/AC5M+
M^'MNZ?\ "0^,--G>SNX+R'PM9&;5]7M9#'+_ &9;3RVPED0I7KO[$W[6_P -
M/VYOV8?A)^U!\*+VWG\*_%'PQ9ZQ)ID=];7U]X7UORU76O"NM?9V)M=8T2\W
M6]W:7"0W"*897A1)D) /JJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OXH?\ @Y _Y/C^%?\
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M&B,.D>&/!]OX>TJ$XS%INBZ*FFV,1VA5S':VT2':JCC@ <5_$M\(YM2^-O\
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MJ-O>Z5>>7/'#<3R6%XR>1?0S1N0/\^K_ ((H_&#_ (*8?M(?!'Q3_P $P?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_%#_P<@?\
M)\?PK_[-1\#_ /JWOCG7]KU?Q0_\'('_ "?'\*_^S4? _P#ZM[XYU]'PK_R-
MH?\ 7BO_ .DH\;/O^1?+_K[2_-GZK_\ !MY_R8[\5/\ LZWQQ_ZJ'X&5_0/7
M\_'_  ;>?\F._%3_ +.M\<?^JA^!E?T#UPYY_P C;'_]?W_Z3$ZLK_Y%^$_Z
M]+\V%%%%>4=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-86/PH^%/BGQ#:W5LJ--%KTEDVE>%E0.R(#-XEU#2(-Q.5\S*I(^V-OYN/\
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M'G0",Q12YE5S&K_D[_P_D_X+&_\ 2!O]I7_PCOB3_P#*6OZ^Z* /Y<_V:/\
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MX.?#VS\)^)-4\'75_>^&KN_MKJZF:32;K5+#2[^>V\N9 )+G3[1V8,?)08%
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M5OHNLZC)>.]U=76L:)%IVIR7T[M+?FZ^V2,SSLQ_E%^%2:C^TE_P>(?%+6;
MW=[:_LV^#?$-IJ4]K/9O!8VG@?P]IWASR[UDB 2W2]\6Q6OV9S]M^TO&&D(!
M _MB\>^+OA_^S9\#O%?C;4+.#PW\+_@=\,]4UVXT_1[>&"UT'P3\/O#DMS]B
MTRV+1V\%KIFBZ6+>TA+)!##!&A*QID?R!?\ !K!\&?B3^T)\<?V\?^"O/Q2U
M.>5_VC/B3XE^'_@4.\<L^NI'X@DU_P 9:EJ!*I+ ND^7X2TNP* QW;/?ESNM
M5  /[6**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_BA_X.0/^3X_A7_V:CX'_ /5O?'.O[7J_
MBA_X.0/^3X_A7_V:CX'_ /5O?'.OH^%?^1M#_KQ7_P#24>-GW_(OE_U]I?FS
M]5_^#;S_ ),=^*G_ &=;XX_]5#\#*_H'K^?C_@V\_P"3'?BI_P!G6^./_50_
M ROZ!ZX<\_Y&V/\ ^O[_ /28G5E?_(OPG_7I?FPHHHKRCO"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y0_;>_8[^$O[>_[,
M'Q5_95^-=K>S> _BCHT%G/?:7.UMJV@:YI-_:ZUX9\3:3," -0\/Z]86&IP1
M2YM[H6[VERK6\\JFQ^Q1^S/-^QW^R_\ "+]FJ3XH^,?C'!\)/#:>%M-\>^/1
M9?\ "3ZGI5O=7$NFVM\UA%%"\>E6LT>G6;,'E%I;0H[G8H7ZGHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#\S?\ @J#_ ,$X[/\ X*=_!SPO
M^SWXS^-_Q!^$/PCM_&ND>+OB-HWPY-K#J'Q.LM%F66S\'^(;F\5XO^$<\[.H
M/ B>9_:=M870.ZUC*_=OPB^%7@;X&_"_P#\'OAIH5AX:\!_#;PGH?@WPMHNG
M6MM9V]GH^@:?!IUINBM8H8GNYT@^TW]T8Q+>WLUQ=SL\\TCMZ+10 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)(TE
MCDBD4-'*C1NIZ,CJ593CG!4D5^57[#/_  2E^&?_  3\_:,_:D^,7P)^)GCN
MV^&?[4NM1^,=?_9^U5=,G\"^"O'0U">\G\0>$[N.W35466*[OK407T\[K!=F
M)Y95@@*_JQ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P;_P
M4=_8JO\ _@H+^S'XJ_9;;XU>-O@9X3^(5U8P>//$_P /$M&\3ZSX7M91->^$
M4>_62T&B^(5S9:]!-&ZWFG-):LICDD5O:/V3?V7OA5^QE^SU\+OV:O@OHZ:/
M\/OA7X9L?#FD[X;9-2U>6VB47NOZ]<6\47]HZ[K%R'N]3U"</<7$S_/(RH@'
MT510 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5_%#_P<@?\ )\?PK_[-1\#_ /JWOCG7]KU?
MQ0_\'('_ "?'\*_^S4? _P#ZM[XYU]'PK_R-H?\ 7BO_ .DH\;/O^1?+_K[2
M_-GZK_\ !MY_R8[\5/\ LZWQQ_ZJ'X&5_0/7\_'_  ;>?\F._%3_ +.M\<?^
MJA^!E?T#UPYY_P C;'_]?W_Z3$ZLK_Y%^$_Z]+\V%%%%>4=X4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\ X28?_P"5A]>QO_09BO\
MPHJ__)A_P^X_X*@?]'._^86_9[_^=/1_P^X_X*@?]'._^86_9[_^=/111_9F
M6_\ 0NP/_A)A_P#Y6'U[&_\ 09BO_"BK_P#)A_P^X_X*@?\ 1SO_ )A;]GO_
M .=/1_P^X_X*@?\ 1SO_ )A;]GO_ .=/111_9F6_]"[ _P#A)A__ )6'U[&_
M]!F*_P#"BK_\F'_#[C_@J!_T<[_YA;]GO_YT]'_#[C_@J!_T<[_YA;]GO_YT
M]%%']F9;_P!"[ _^$F'_ /E8?7L;_P!!F*_\**O_ ,F'_#[C_@J!_P!'._\
MF%OV>_\ YT]'_#[C_@J!_P!'._\ F%OV>_\ YT]%%']F9;_T+L#_ .$F'_\
ME8?7L;_T&8K_ ,**O_R8?\/N/^"H'_1SO_F%OV>__G3T?\/N/^"H'_1SO_F%
MOV>__G3T44?V9EO_ $+L#_X28?\ ^5A]>QO_ $&8K_PHJ_\ R8?\/N/^"H'_
M $<[_P"86_9[_P#G3T?\/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\
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M/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\ X28?_P"5A]>QO_09BO\
MPHJ__)A_P^X_X*@?]'._^86_9[_^=/1_P^X_X*@?]'._^86_9[_^=/111_9F
M6_\ 0NP/_A)A_P#Y6'U[&_\ 09BO_"BK_P#)A_P^X_X*@?\ 1SO_ )A;]GO_
M .=/1_P^X_X*@?\ 1SO_ )A;]GO_ .=/111_9F6_]"[ _P#A)A__ )6'U[&_
M]!F*_P#"BK_\F'_#[C_@J!_T<[_YA;]GO_YT]'_#[C_@J!_T<[_YA;]GO_YT
M]%%']F9;_P!"[ _^$F'_ /E8?7L;_P!!F*_\**O_ ,F'_#[C_@J!_P!'._\
MF%OV>_\ YT]'_#[C_@J!_P!'._\ F%OV>_\ YT]%%']F9;_T+L#_ .$F'_\
ME8?7L;_T&8K_ ,**O_R8?\/N/^"H'_1SO_F%OV>__G3T?\/N/^"H'_1SO_F%
MOV>__G3T44?V9EO_ $+L#_X28?\ ^5A]>QO_ $&8K_PHJ_\ R8?\/N/^"H'_
M $<[_P"86_9[_P#G3T?\/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\
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M/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\ X28?_P"5A]>QO_09BO\
MPHJ__)A_P^X_X*@?]'._^86_9[_^=/1_P^X_X*@?]'._^86_9[_^=/111_9F
M6_\ 0NP/_A)A_P#Y6'U[&_\ 09BO_"BK_P#)A_P^X_X*@?\ 1SO_ )A;]GO_
M .=/1_P^X_X*@?\ 1SO_ )A;]GO_ .=/111_9F6_]"[ _P#A)A__ )6'U[&_
M]!F*_P#"BK_\F'_#[C_@J!_T<[_YA;]GO_YT]'_#[C_@J!_T<[_YA;]GO_YT
M]%%']F9;_P!"[ _^$F'_ /E8?7L;_P!!F*_\**O_ ,F'_#[C_@J!_P!'._\
MF%OV>_\ YT]'_#[C_@J!_P!'._\ F%OV>_\ YT]%%']F9;_T+L#_ .$F'_\
ME8?7L;_T&8K_ ,**O_R8?\/N/^"H'_1SO_F%OV>__G3T?\/N/^"H'_1SO_F%
MOV>__G3T44?V9EO_ $+L#_X28?\ ^5A]>QO_ $&8K_PHJ_\ R8?\/N/^"H'_
M $<[_P"86_9[_P#G3T?\/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\
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M/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\ X28?_P"5A]>QO_09BO\
MPHJ__)A_P^X_X*@?]'._^86_9[_^=/1_P^X_X*@?]'._^86_9[_^=/111_9F
M6_\ 0NP/_A)A_P#Y6'U[&_\ 09BO_"BK_P#)A_P^X_X*@?\ 1SO_ )A;]GO_
M .=/1_P^X_X*@?\ 1SO_ )A;]GO_ .=/111_9F6_]"[ _P#A)A__ )6'U[&_
M]!F*_P#"BK_\F'_#[C_@J!_T<[_YA;]GO_YT]'_#[C_@J!_T<[_YA;]GO_YT
M]%%']F9;_P!"[ _^$F'_ /E8?7L;_P!!F*_\**O_ ,F'_#[C_@J!_P!'._\
MF%OV>_\ YT]'_#[C_@J!_P!'._\ F%OV>_\ YT]%%']F9;_T+L#_ .$F'_\
ME8?7L;_T&8K_ ,**O_R8?\/N/^"H'_1SO_F%OV>__G3T?\/N/^"H'_1SO_F%
MOV>__G3T44?V9EO_ $+L#_X28?\ ^5A]>QO_ $&8K_PHJ_\ R8?\/N/^"H'_
M $<[_P"86_9[_P#G3T?\/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\
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M/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\ X28?_P"5A]>QO_09BO\
MPHJ__)A_P^X_X*@?]'._^86_9[_^=/1_P^X_X*@?]'._^86_9[_^=/111_9F
M6_\ 0NP/_A)A_P#Y6'U[&_\ 09BO_"BK_P#)A_P^X_X*@?\ 1SO_ )A;]GO_
M .=/1_P^X_X*@?\ 1SO_ )A;]GO_ .=/111_9F6_]"[ _P#A)A__ )6'U[&_
M]!F*_P#"BK_\F'_#[C_@J!_T<[_YA;]GO_YT]'_#[C_@J!_T<[_YA;]GO_YT
M]%%']F9;_P!"[ _^$F'_ /E8?7L;_P!!F*_\**O_ ,F'_#[C_@J!_P!'._\
MF%OV>_\ YT]'_#[C_@J!_P!'._\ F%OV>_\ YT]%%']F9;_T+L#_ .$F'_\
ME8?7L;_T&8K_ ,**O_R8?\/N/^"H'_1SO_F%OV>__G3T?\/N/^"H'_1SO_F%
MOV>__G3T44?V9EO_ $+L#_X28?\ ^5A]>QO_ $&8K_PHJ_\ R8?\/N/^"H'_
M $<[_P"86_9[_P#G3T?\/N/^"H'_ $<[_P"86_9[_P#G3T44?V9EO_0NP/\
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3M.4E>%2M4E%VO9V<FKKH]T?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img12876764_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '( QL# 2(  A$! Q$!_\0
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M_P 'M_\ _'J[JBCGEW#E78X7_A2GA3_GEJW_ (/;_P#^/4?\*4\*?\\M6_\
M![?_ /QZNZHHYY=PY5V.%_X4IX4_YY:M_P"#V_\ _CU'_"E/"G_/+5O_  >W
M_P#\>KNJ*.>7<.5=CA?^%*>%/^>6K?\ @]O_ /X]1_PI3PI_SRU;_P 'M_\
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M_P"#V_\ _CU'_"E/"G_/+5O_  >W_P#\>KNJ*.>7<.5=CA?^%*>%/^>6K?\
M@]O_ /X]1_PI3PI_SRU;_P 'M_\ _'J[JBCGEW#E78X7_A2GA3_GEJW_ (/;
M_P#^/4?\*4\*?\\M6_\ ![?_ /QZNZHHYY=PY5V.%_X4IX4_YY:M_P"#V_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB'XU\+^*/@_>W-_IEKX!^,'@;4K.ZG2V2VM[N>=2GFR_(,^5B1B3TSWK[O\
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MG"-:ZELW?\3YV5*IAVW'[F>U12!UR#3RU?/_ .S1^T%:?$.QD\'ZVAT7Q]H
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M%:R2;N]?%?AWQAXJ_8RTG6K75_A];P?#V[\6321:S;ZJ@2TM[F8!"8%0L%0
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MWXK[=VA6)4 'UKYW\4?L@RZQJOBB/2/BAXP\,>$O%5W->ZSX9TY[=H9Y)O\
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M +#6I_\ I=/6U/J1+<]*^"G_ "3^+_L(ZE_Z7W%=U7"_!3_DG\7_ &$=2_\
M2^XKNJSE\3''9!1114E!7COQ0^.6J^$_&%WX<\+>$I/%VI:7I/\ ;NK*+U+5
M;:T+,J(A8'S)GV2%4X'R')&17L5?/GQ+\,^-O"?Q8\3>*_"?AC_A+8/%'AR'
M16ACO8K=K*\A>8Q22>81F%EG.XKEAL^Z<T =SXB^-^BZ'\$;CXH00W.J:$NE
M+JL,-NH$LT;*I1<$_*<L <\#DGI5+X1?&B]^(&O>(?#VM:#'H6O:+%:W,J6>
MH)?VLD-PK-&5F4#YQL8,I'3!&0PK@]<^%/C.R_9N/PCT*V5+NQ\-65I'K'VQ
M8X=0E5@+FS 'SQAXU==Y XE]C4_[-_PNO_!7CSQ+J^G^"U^&/@V_TZTMHO#/
MVF*5IKV,OYEUMC+(@\LI'@,2VS<0.,@'H'[2Q_XQY^)6?^A<O_\ T0]=;\/S
M_P 4'X;Y_P"8;;?^BEKD?VDCC]GGXDEE&/\ A'-0) /0?9WK"^"_@GXAZ3IO
MAF^UGXF#Q!HPTV'.D?V!;V^[,(VCSD;=\O';G% 'M5%-3.T9ZTZ@ HHHH **
M** (V"DG(Z5@>,O!^F^-O#.HZ+J=NL]A?0O;S)G!*NI4X/8X/45T!4<\9--*
MY_AY]:-U9E0DZ<E*.Y\8^$O%DW['?Q,F\'>*_$$*_#B_@N=3TR>:*XN)K7#H
MB6[2Y;@+N/3M7V)IM_;ZMI]K>VLOG6]Q&LL4BYPRD94_D:X[XV>"SX^^%_BC
M04ECM9]0TZ:W2XE7<(R5/)[XKC?V4_BE8^.OA!X5MY]6TZ?Q#;V0BN;.UF7S
M(Q&QC#&/.Y00%Z^M1K<]G$VQE!8JUI)VEY]4SM_C%\/XOBA\-?$7A265K<:I
M9R0+*@!:-B,JPSQU'X5X+\/_ (Y^/OA#<_#CP1\6?#%OIRZKG2XO$D>IK<>;
M.B_NP\:1_*7^5>2.3[5]6_>7!X)Y-<=\4OA/X=^,'AU-#\36TEU81SI=((9G
MAD65#E6#H0RX]C7I8;$4XQ]A6C>#?S6EM#YR=.5^>#LSKHYN.N1T].:F5CCD
MU\\ZE^Q+X!N=/N4M)/$4-Z\+I%.WB.^8(Y4A6(,O."0:Q=&^'W[0OPW\ P:9
MIWC7PKJR:/8[(4FTJ>6YN?+4X4L9!EFQC)[D5"H4II<E37S5O\Q>TG%>]'[C
MZ@W^AS3E8]Z^9-!_:O\ $FC>"[6Z\7?"/QS%J5I9B75+BVTV(6Z.JYE9<RYV
MCDCZ5ZMX"^//@CXA:1H=WIGB72OM&K6\<\&GO?1&Y!=0P0QAB=PSR*SGAJM/
M5K3NM2HU8R=NIZ,IS2U&L@['CUIRR!N_/TKGVW-QU+2 BEH **** "BBB@ H
MHHH **** "BBB@ HHHH **** $90P(/0UP^O? _P#XGUB[U;5?">F7VI7;*]
MQ=2PC?*P4("Q[D*JKD]E [5W-%.[6P'F_P#PSC\,O^A*TG_OS_\ 7H_X9Q^&
M7_0E:3_WY_\ KUZ111S,#S?_ (9Q^&?_ $)6D_\ ?C_Z]'_#./PS_P"A*TG_
M +\?_7KTBBGS/N!YO_PSC\,_^A*TG_OQ_P#7I/\ AG#X9?\ 0E:3_P!^/_KU
MZ311S/N!YO\ \,X_#+_H2M)_[\?_ %Z/^&<?AG_T)6D_]^/_ *]>D44<S[@>
M;_\ #./PS_Z$K2?^_'_UZ/\ AG'X9_\ 0E:3_P!^/_KUZ111S/N!YO\ \,X_
M#/\ Z$K2?^_'_P!>C_AG'X9_]"5I/_?C_P"O7I%%+F8'F_\ PSC\,_\ H2M)
M_P"_'_UZ/^&<?AG_ -"5I/\ WX_^O7I%%/F?<#S?_AG'X9_]"5I/_?C_ .O1
M_P ,X_#/_H2M)_[\?_7KTBBES,#S;_AF_P"&1_YDK2?^_'_UZ/\ AF_X8\#_
M (0G2..G[CI7I-%/F?<#S<_LX?#)N3X*TDG_ *X?_7I/^&</AE_T)6D_]^/_
M *]>DT4<TNX'F_\ PSC\,_\ H2])_P"_/_UZ3_AF_P"&/_0DZ1_WX_\ KUZ3
M11S/N!YO_P ,X_#+_H2M)_[\?_7H_P"&<?AG_P!"5I/_ 'X_^O7I%%',^X'F
M_P#PSC\,_P#H2M)_[\?_ %Z/^&<?AG_T)6D_]^/_ *]>D44<S[@>;_\ #./P
MS_Z$K2?^_'_UZ/\ AG'X9_\ 0E:3_P!^/_KUZ111S/N!YO\ \,X_#/\ Z$K2
M?^_'_P!>C_AG'X9_]"5I/_?C_P"O7I%%',^X'F__  SA\,L8/@G23_VQ_P#K
MUU?A+P+X?\!Z=)8>'M(M='LY)C</#:1A%:0@ N?4X51GV'I6[12NP$''%+11
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>]+_ -=K
M/_8:U/\ ]+IZ^A*^>]+_ -=K/_8:U/\ ]+IZVI]2);GI7P4_Y)_%_P!A'4O_
M $ON*[JN%^"G_)/XO^PCJ7_I?<5W59R^)CCL@HHHJ2@IK+GMFG44 -V@]11L
M7TIU% 'FW[22C_AGOXE\?\RWJ'_I,]=1\/0&\ >&B><Z9:_^BEKF?VDO^3>_
MB9_V+>H_^DTE=-\._P#DG_AC_L%VO_HI: .@I:** "BBB@ HHHH *3%+10!6
MN(1(C*PRA&"#R#7SKXL_9JUG2?B=9^,/A;J'A[P7.--DT^X@DTGS%FWRB0OA
M&7GY>IKZ/9=Q.:0QC;0XIG11Q%3#WY'OT>WW'@3^#?VA1G;\1?"FW/!_L!Q_
M[5K"\%?'+QKX#^+7_"!?%18KG^UI1'HFOV=HMK:3E8MTB'=(26W$ >I-?3!4
M,A&,\5XO^TU\+=:^(OAG09O#-AI]]K^BZS::G -1D\I=D;Y=1)ABN<#H*B4;
M*Z/0PN(I59^RKQCRRZVM;SN>T(P.,TI&[-?,<?[4/B3X?^.6T+XJ>&(- A:Q
M6[M[S0C<ZDDC%RI1ML0P>,_C70S?ML?"^SCWS:CJEM$&56EGT:[1%R0HRQCP
M!DXYIW5CGEEV(NN6-T^JU/=;RPBOK66WN(DG@F0I)'(,JRD8(([@Y->*?$#]
MD?P/XJCTF;0[*'P)JVEWRW]OJWAVS@@N5958!=Q0\?-G'M7MMO<">-''W64$
M9J;:/ZUK3JU*>L)-'ERIPEI)'S!J'PY^-7PN\9:7JWA7Q3J'Q*T8VL\>H:9X
MHU**W5)"5\MTV1<X&[]*[;]G/]HRP^.&CW4,]K_8WBS3<C5=&V/_ *+EW5"&
M=5W*P0D$5[,8Q7BOC;]F6'Q1\1-1\8:9XX\3>$]1U"V@M;F/1)XXXY$ASLR&
M0G/S'OWKOC6I8B')72B^C2_-(P<)T[>RU1[2)#MYX_K]*<)!MSFOF[QA^S3X
MTA\,ZFWA[XS^.)-=^S2?8DO-0B$+3A3M#D1Y"YK#\5?'3XT_!#P78ZSXV\%>
M'9M#LFMK?4=1L]7FN9U0LJ/.8Q$,X&YCS6<,)[5+V,TWVO9_C8J5;E=IQL?6
M*_=%.K/TC5K?6M,M+^T82VMU$L\3C^)& *G\B*N;NG%<+BT[,Z$TU<DHIN[M
M0K%J0QU%)S2TP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFOF7QYX9_:#\'^&9]6TGQ]:>*[RWDC8:1%H$-NTZ%P' =I, A=Q_"O4_@_\
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M!@>AKGN:CJ*8:533 =1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!\W!P:X,?L?Z%R?^$R\='GOXDN?\:]\91N)[_6E4TK=3KABZ]./)&3L>!_\
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M!GG)_.@#O5SM&>M+2+P!2T %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML=9^'$&AZ!_9%N/[837XKEL"!=A\E8P?FP.,\9H ]SHIJ<J#C'UIU !1110
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M4=CP68*!DX Y-=!10!P7Q[_Y(=\0S_U+NH_^DTE:/PF4'X5^#2>IT6RR<_\
M3!*H_'@!O@?\0P?^A=U'_P!)I*O?"/\ Y)3X+_[ ME_Z(2@#JP O X%+110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F*-HI:*
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M_@X !_P@U@?H7_\ BJ7_ (8W^#?_ $(EA_X__P#%4O>(Y,+_ #2^Y?YGJ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 3%&T4M% ";11M%+10 FT4;12T4 )M%&T4M% ";11M%+10 F!1M%+10
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MQAJWBOQ)XIT(ZAINNZGICVW]JHF_<[9)"280_+DGIZUV=O\ M1_#^X\8^/\
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MOA/#\0_#[ZQXET-[S^SWM]&TB>ZO8+@?>22W1=ZX')R !D>M 'MM%?/GPO\
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M\+[76K?Q1X5\ ?\ "%6T">)/!&@BYU>[NO+7=9/<K$\D(S@; 5 W9/7(X/\
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M^ OV^KCX?_LZ?##Q/\2_"'B:2\\0SV^G+J48MY&U!GBWF[CB1\^62<!,!N@
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M(Q5_;;^#=]XC_;5\->"_"^I?9M.^+5O9CQ5I=JHR8[*?>9WQT&Q,\G^$^HH
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M9OAW_P %*/C!IE_NCA\:^';/7=-D?Y1,(66)U7U(8M]-IH _.75/%OA#P_\
M"/5/'6I>)M=L?VJ-/\7,\BS37(E6%9<E7!_=B,#/'!+87IQ7U3^VAH/BW]H#
MXR?"2X/P<USXF>&+/P@-4N+'3YGL+::YN5W/&;M>$*;(SM!R<X .:W/'G[(G
M[1?Q6U+7/ 'BJ3PC?^$=6UN.ZNOB(T$*:Q/IZ.KI:$(H8X* X*\'^+;7NWQF
M\(?M'?#WXB:/K?P5O=)\4^#(=)CTR3P7KLJ6Z6TB+M6=9,J6X5?X^#N&W!!
M!\UZ39^#?B'^R5X1B^&7P\\06G@W0?B!%-X^\"0RS:C>[%4B:/:QWSIDPMLX
MZ'C(K:^&^DZWJ?PA\&_ S7([KPQHOB#6M1\3ZM9ZH6@ETGPA!<>9%!*'/[A9
MGVQ@,>%+ C%?3W[%O[/.M?L]?#O7F\5WMOJ'C+Q1J\^OZS_9X)@CFDQ^ZBR!
MD#'7N3Q7C?Q ^!/Q"^+OP'^-/C"X\/7$'Q \;W]K]C\.73B*>'1;&Z0PV3$G
M"O+&DKLN<,90* /M3PCXET'Q5H-O>^%]4TW5]&_U<-SI,\<]O\O&U60E>/3M
M7QG^UE_:'[0'[7'PX^ $^N:EH?@BXTB;Q!K:Z7+Y4M_CS D)8<A<1X_X&>"0
M#7>_L/\ P\UWPI??%7Q%?>#KCX<^&_$^M0W>B^$KN)(Y+*-(1'*YBCRB;VQP
M/[O-3_M5?LZ^-O%7Q#\'_%_X2ZG86'Q'\*Q261L]5!^S:G9N23"S#[I!9\9P
M/F/(P#0!6^&?_!/WP7\$?BYH_C/X;^(?$'A"SM$:._\ #\=XUS::ED8 D,NX
M@?3VP5(->!_LZ_#NQ^*VB?MM^%KJ)3#J/B"Y6%V7)CE47#PR#/=756!]1FO<
M_A;:?M9^-OBYHFM_$"3PO\._!&FA_M>@Z*5O9=3)' 9BS[.WS!A@ X4Y%8WP
M5^&OB;]F_3OVH_&?C*SAL-)UK4;S7=/D2Z24RVZI.VY@IRI^9>&P>: /2_V"
M_BY>?&K]E?P1XAU*5Y]5C@;3;N:0Y:26W8Q[S[L%4GZU]"CI7RU_P34\ WWP
M^_8[\$6U_&\5UJ0FU4QNI!6.>5GCR"/[FT_C7U+F@!:*3/\ G%&?\XH 6BDS
M_G%&?\XH 6BDS_G%,DDV\DX% $E%-5BPR>#Z4Z@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>]+_UVL_]
MAK4__2Z>OH2OGO2_]=K/_8:U/_TNGK:GU(EN>E?!3_DG\7_81U+_ -+[BNZK
MA?@I_P D_B_[".I?^E]Q7=5G+XF..R"BBBI*"DQ2T4 )M!&,<=*3:/2G44 <
M7\:%'_"G/'G'_,!O_P#TG>D^"?/P;\"'O_8-C_Z3I3OC3_R1SQW_ -@&_P#_
M $GDIOP1_P"2,^ _^P#8_P#I.E ':TC#(I:* /,/C-\';WXM0Z5#9^/O$_@0
MV+R.TGAB[6W>YWA1B0E3D#''^]7F/_#&6O'K^T+\5_\ P<1__$5].8YSWHH
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M\P_\,8Z]_P!'"_%?_P '$?\ \11_PQCKW_1POQ7_ /!Q'_\ $5]/44 ?,/\
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M40 !5 \O@  "I/\ AC'7O^CA?BO_ .#B/_XBOIZB@#YA_P"&,=>_Z.%^*_\
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M] IH ].HJII>I0:OI]O>VLJSVUQ&LT4T?*NC %6'L00:MT %%%% !7SWI?\
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M!^;'BS7]9U#]B4_"WQ!J36OC/X>^.M(\+7=W;-^\V+>1_9+F/<. 864KD?\
M+/'K7U+)^Q=!XDO-/_X3[XJ>//B)H=C=1WBZ!KMW!'9331L&C:588D,@4C.T
MDK[5[7J'PM\'ZM?ZC?7OA31;VZU*2WEO)Y]/B=[F2 Y@:0E?G,9Y4G.WM74Q
MQA5'KS0!\,^%?@7X=^-G[7W[2C:]?:_8RZ;-H4<$FA:W<Z:1OL7R6\EU5R,#
M&\''/8FHOV>]/L?@G=?&SX0^(;:'_A/[72KG5+7Q-<N7O/$NE&)Q%/([DEGB
M/[ME4X!R<=37VM8>%M*TC6-4U:QTJSL]4U0QF_O+>!4FO#&NV,RN!E]JD@;B
M< X%5]4\#^']8UNVUF_T'3;W5[:WDM8-0GM8WN(H9 1)$KD;@C D%0<'/(H
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M:VA01Q0PH$2-0,!5 X  ["@"<=*6BB@ HHHH **** "BBB@ HII;G&>V:-U
M#J*9N]Z-WS$9H ?13=V.XI<_+F@!:*;N'7M2>8/6@!]%,\P<G(Q^=!;:,D\4
M /HI@;/>G9H 6BBD+!>M "T4W=GZ4WS O5E_.@"2BF[N^>/I2;O4T /HIN\<
M#-.H **** "BBB@ HHHH **** &DFH;B218G,7S.!\H/3.*GZFFE%[\TD^HG
MJK'R_=?$S]J)+J=8?A-X7D@61A&[:W@LH)VDC/!(P:B_X6=^U/\ ]$C\+?\
M@\_^O7U(OZ4M>DL7!+^#%_?_ )G)[&3=^=_U\CY:_P"%G?M3_P#1(O"__@\_
M^O2'XH?M3J#CX1>%BV#@'7/;ZU]34QD#-R!^5/ZY#;V$?Q_S&Z4EJIO\#(\)
M7NKZAX9TR?7K.'3]9DMT:\M+:3S(X9L#>JMW .1FO ?VOI(=-\;? C5=<*IX
M+LO&2'4Y9R!;PS-!(MG)+GA5$Q'S'@$CD5]+CC%4?$/AW3/%FBWFD:SI]MJN
MEWD?E7-E>1++#*I[,C @BO.;N[V.I;'S#^W'XV\<> ?AQJOB6'2OA_XC\ 6
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M\PKS_7[#X[>&_CMX'^'FD_M!7_BG5+X?VOK<%UX4TV"&PTF-MK2.Z(6#RO\
MNT48R=QR-O/9_"?Q!IOQV_:ZUKXF>%)9-3\%Z+X5C\/6^N>4Z6]]>2W!FE6$
ML!O6-44,P&,L0.F:T?V1H3XX\;_&GXI7@\RZUSQ/+HEBY7F+3]/'DQ(/3,GF
ML>QX/6@#M]/^(6K^'?VD+WP%KET+K2O$&DC6_#DS1*K0F%ECN[5B -_6.52<
ML [@DX%>RKT%?-GQK_T[]L/]GFUM4\VZLH?$%_<,O6&V-M%'ECZ,[*H]Q]*^
MDH_]6OTH =1110 4444 %%%% !1110 QFZBD+':<&E91S5>[$C02I$P60J0G
M?'OBCT!:NQ(K;O4?48IV[WKYFN/@O\>)[F:2/XTQP1.[,D7]BQ_(I)(7\!Q3
M?^%)_'O_ *+:G_@EB_QK.\OY3V8Y?0:N\1%?^!?Y'TWN'K^M-\SYL!ORQ7S+
M_P *4^/:_P#-;%_\$D?^--_X4C\>6S_Q>R-6(X;^Q(_SZU-Y7MR_U]Y7]GT+
M?[Q'\?\ (^G5;IFN)^-'QBT3X%>!;GQ9X@@U"ZTZ&>"V$&EV_GW$DDLBQQJB
M9&XEF Z]ZZ'PG8:EIOAW3;75K\:KJ4$"1W%Z$"":0##-M'3)[5X!_P %#?M7
M_#.DGV P)?GQ#HOV=KH$Q"7[?#L+@<E<XS@YK8\:2Y6U>YOZ1^V'X9N?$6D:
M3KOA;QMX&&K726-EJ'BG0)+.SFN'.$A\[+*KL> &QD]Z]%\ _%;1OB1?^++/
M2#=>?X9U>31+\7$/E@W"(C-Y?)W+AUP?K7C/B#X*_%_XRZAX<LOB;XG\'6GA
M72-8M-;>S\)Z;=)<WLUNXDBC>2>5A&FX DJ,G':O%Y/% T/1?C)ID&HZ[;7_
M (B^,;Z5;67AEDBO=39K>%VM$G9U%N'5&W2DY"A@.302??WG'TQ]>/QI?,/O
MTST/Y5^>_AGQEXU^"OC;XV:7HFAWOAX:;\/3XBL?#%[XC?7C!>H\BK-N8DQ,
MRC/E D':#WKT[P3X)T#X>Z/\-/'VF?%#6;CQ#KUJ6GAU+5)+Z+Q=/+:/+Y0B
M9RD3!UWJT:C;LVG@T ?71D^7.3QW_P#U5R'@_P"*VB>-?&7C+PQIWVK^T_"=
MS!::B9HML?F2PB5?+;/S#:1D\8/%?GGX3USXD:A\'?#OQ?2"ZL?&%_?073^,
M]5\>*FG2O)<A&LGT[!54()A$(7>".N1FO7_#/PD\-?$_]I#]H]_$'B;6-)_L
M^ZTYX[;2]8EL%M<Z?&?MK>6R[F4KM!?*@)@KS0!]N>=W&2/:D$VYB >G7O7P
M?\.?&.N_M"S_  .\(^/?$.I6VBZMX9U'5;DV5W)8S>(+FWNA!#NEC*L1Y/[X
MHI&[?GH.?9?V8;VZT+XE?&+X?VVKWVO>$/"NH6,>DW6H737<MLT]MOGM/.8E
MG$3@<,25#@'H* /H]>5!/6G4B_=%+0 4444 %%%% !7SWI?^NUG_ +#6I_\
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M -D=VC@_*3$?+<8.=B'(P:]!AM(58R+"B2-]YE !/.>2.M3>6OIFE "@ =*
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M "BBB@ HHHH **** "OGO2_]=K/_ &&M3_\ 2Z>OH2OGO2_]=K/_ &&M3_\
M2Z>MJ?4B6YZ5\%/^2?Q?]A'4O_2^XKNJX7X*?\D_B_[".I?^E]Q7=5G+XF..
MR"BBBI*"OE_XH>'K;XI_'?QOH?B&\OH=+\-^#K>_TJ&VO9+98;J9[C?>?(PW
M.GDQJI.0.>.37U!7FWQ+^ _A3XK:M#?ZY#>Q7<=N;%Y]-OI;1[FU8Y>WF,9'
MF1$\[3ZG&,T 4?@OKWB'X@?LZ^#M7EO_ +'XDU;P_;RMJ+P"79<-"/WQC) ?
MYOFVYP<]JYC]D&RO]+\._$#3M2US4/$=U8>--4M3J6IRAYIMICYP %49SA0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7SWI?\
MKM9_[#6I_P#I=/7T)7SWI?\ KM9_[#6I_P#I=/6U/J1+<]*^"G_)/XO^PCJ7
M_I?<5W5<+\%/^2?Q?]A'4O\ TON*[JLY?$QQV04445)04F*6B@!-HSG'-&T>
ME+10!R7Q<_Y)3XT_[ M[_P"B'K._9_\ ^2$_#O\ [%ZP_P#2=*T?BW_R2OQE
M_P!@6]_]$/6;^S[_ ,D)^'?_ &+UA_Z3I0!W]%%)0 M%%)0 M%%% !112>M
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2T
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MA=NS/(YS7;#Q]\;5SM^$>AX[?\5<O_R-0![317B__"??&WO\(]$S_P!C<O\
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M9-9N$G66ZP4)+,H3:,N#G  .+O[2NM?$>WT'2])^'NAZA?\ ]ISM%JVJZ3+
MMWI]J!\QMUF94,KYVACG:,M@D 5Y=XCA\>Z-\+?"7@WP#\,/$OA3P[<-<1ZZ
MUI?V;:S! &SB*1IBOG3LSL9MS,N6(&[H ?0WPA^)5G\6_ .F^)[&VGL8KHR1
M26=QM,EO+%(T4L98$AMKQN-P.#C-=HO2N)^#5A!I7PUT'3[7PG/X(M;.'[/%
MH5R\;R6JH2H#-&S*Q.-V[<2=V3R37;+TH *6BB@#EOB/XTD\ ^%+[68M)O\
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M5P .!TIU% "*H48 XI:** "BBB@!K(K=1FD\I?3BGT4 -,:GJ*4#;P.E+10
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MWW[9UA9VL7B!_ OB8?#B74UTD>,W6!+;S&G^SB40&3SC$93M#A3D<XQS7/\
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M_P#_ !FBBM_91EJ9<[6@?\+K\*?\]=6_\$5__P#&:/\ A=?A3_GKJW_@BO\
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M17__ ,9HHH]C$/:,;_PNCPG_ ,]-5_\ !%?_ /QFD_X7-X3'2;5O7_D!W_\
M\9HHH]C$/:,/^%S>$MN/,U7T_P"0%?\ _P 9K#\/^+?AAX3U'6+_ $71Y=)O
MM8N/M>I7-GX8O(I+V8Y_>3,L +MR>6SUHHH]C$/:,W/^%S>$BI!EU8@_]0._
M_P#C-(?C)X2*E?,U7;C&W^PK_'_HFBBCV,0]HP_X7-X3SGS=6S_V K[_ .,4
MO_"Y_">,>;JW_@BO_P#XS111[&(>T8?\+F\)\CS=6P>W]A7^/_1-)_PN;PGG
M/FZMG_L!7_\ \9HHH]C$/:,<OQH\)JN!+JW_ ((K_P#^,TC?&;PFV?WNJ_\
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M;_D!7_\ \9H_X7+X3_Y[:M_X(K__ .,T44>QB'M&'_"YO"?_ #VU;_P17_\
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.([T45,H*FKH%)R>I_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img12876764_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_4.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +.!ED# 2(  A$! Q$!_\0
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M_05UC_P2W'_Q= 'TU17S+_PUQ\&/^@KK'_@EN/\ XNC_ (:X^#'_ $%=8_\
M!+<?_%T ?35%?,O_  UQ\&/^@KK'_@EN/_BZ/^&N/@Q_T%=8_P#!+<?_ !=
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M1_Q$W_\ !*+_ **3\3__  U.M_\ R51_J3Q?_P!$UG7_ (;\3_\ *P^LX?\
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M_P#X)1?]%)^)_P#X:G6__DJC_B)O_P""47_12?B?_P"&IUO_ .2J/]2>+_\
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M  W6J_\ R31_Q!GQ8_Z-UQC_ .&',/\ Y1Y_GV8?\19\,O\ HO.%?_#U@?\
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M_P#E'G^?9A_Q%GPR_P"B\X5_\/6!_P#EQ^T5%?B[_P /\_\ @G1_T//Q _\
M#=:K_P#)-'_#_/\ X)T?]#S\0/\ PW6J_P#R31_Q!GQ8_P"C=<8_^&',/_E'
MG^?9A_Q%GPR_Z+SA7_P]8'_Y<?M%17XN_P##_/\ X)T?]#S\0/\ PW6J_P#R
M31_P_P _^"='_0\_$#_PW6J__)-'_$&?%C_HW7&/_AAS#_Y1Y_GV8?\ $6?#
M+_HO.%?_  ]8'_Y<?M%17XN_\/\ /_@G1_T//Q _\-UJO_R31_P_S_X)T?\
M0\_$#_PW6J__ "31_P 09\6/^C=<8_\ AAS#_P"4>?Y]F'_$6?#+_HO.%?\
MP]8'_P"7'[145^+O_#_/_@G1_P!#S\0/_#=:K_\ )-'_  _S_P""='_0\_$#
M_P -UJO_ ,DT?\09\6/^C=<8_P#AAS#_ .4>?Y]F'_$6?#+_ *+SA7_P]8'_
M .7'[145^+O_  _S_P""='_0\_$#_P -UJO_ ,DT?\/\_P#@G1_T//Q _P##
M=:K_ /)-'_$&?%C_ *-UQC_X8<P_^4>?Y]F'_$6?#+_HO.%?_#U@?_EQ^T5%
M?B[_ ,/\_P#@G1_T//Q _P##=:K_ /)-'_#_ #_X)T?]#S\0/_#=:K_\DT?\
M09\6/^C=<8_^&',/_E'G^?9A_P 19\,O^B\X5_\ #U@?_EQ^T5%?B[_P_P _
M^"='_0\_$#_PW6J__)-'_#_/_@G1_P!#S\0/_#=:K_\ )-'_ !!GQ8_Z-UQC
M_P"&',/_ )1Y_GV8?\19\,O^B\X5_P##U@?_ )<?M%17XN_\/\_^"='_ $//
MQ _\-UJO_P DT?\ #_/_ ()T?]#S\0/_  W6J_\ R31_Q!GQ8_Z-UQC_ .&'
M,/\ Y1Y_GV8?\19\,O\ HO.%?_#U@?\ Y<?M%17XN_\ #_/_ ()T?]#S\0/_
M  W6J_\ R31_P_S_ ."='_0\_$#_ ,-UJO\ \DT?\09\6/\ HW7&/_AAS#_Y
M1Y_GV8?\19\,O^B\X5_\/6!_^7'[145^+O\ P_S_ ."='_0\_$#_ ,-UJO\
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M_P#EQ^T5%?B[_P /\_\ @G1_T//Q _\ #=:K_P#)-'_#_/\ X)T?]#S\0/\
MPW6J_P#R31_Q!GQ8_P"C=<8_^&',/_E'G^?9A_Q%GPR_Z+SA7_P]8'_Y<?M%
M17XN_P##_/\ X)T?]#S\0/\ PW6J_P#R31_P_P _^"='_0\_$#_PW6J__)-'
M_$&?%C_HW7&/_AAS#_Y1Y_GV8?\ $6?#+_HO.%?_  ]8'_Y<?M%17XN_\/\
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MMCP__P"2,X<_[%M+_P!*F?.XG_>*_P#U\?Y(****^P,0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH _1?_@D/_P I0OV#_P#LY7X:_P#I\@K]
M-_\ @J1_RD/_ &N?^RN:C_Z:M)K\R/\ @D/_ ,I0OV#_ /LY7X:_^GR"OTW_
M ."I'_*0_P#:Y_[*YJ/_ *:M)K[?P9_Y.OF?_9NJG_K3X(_F'Z57_)#\/?\
M96+_ -4V./@FBBBOZY/X-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ K]WO^#>#_ )/NUS_LBOBS_P!.&EU^$-?N]_P;P?\ )]VN?]D5\6?^
MG#2Z_)_'7_DSWB)_V3.-_.F?IO@S_P G4X$_[*'!?G(_N*HHHK_%\_UK"OA;
M]N/_ )%_X??]AW6?_3;!7W37PM^W'_R+_P /O^P[K/\ Z;8* /SHHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;H?H?Y4M(W0_0_RH
M _FF_P"#J_\ Y2&?"'_LT7P#_P"I]\1Z_F9K^F;_ (.K_P#E(9\(?^S1? /_
M *GWQ'K^9FO[8\/_ /DC.'/^Q;2_]*F?.XG_ 'BO_P!?'^2"BBBOL#$****
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M&7_A&VT9/'.B7OB'PV8];\06FF7OVW2M/UC0;J=A;3N8#'J< CEVNPD *G\
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MM:?*W_!T/_P5 TL:4O\ P3:^#6N:5JFH7\VC>)OVI=7L9+U[SPS#87.C>)_
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M+?ZQKNL7D.G:/I-C$2HEO-2U&YMK.UC+*))YXT+*#D?ZK'PGM_@1_P $8O\
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M4E6V2QNNY25;&Y25()_O\_X)(_\ **SX'?\ 9./&W_IY\2U_$'\$?V;?C/\
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M1M9\>WM[I][ +G:R:1?:'=V][H]W;L;&32IK6ZL)&M&B<_UG?!G_ ((H?\$
MOC'9_#?P[H'[2>C>*_BAX]T'0GA^'WA3]LWPCK7BC4O$EWH$>KZMI&D^$]/U
MN]UNYN[-HM0EETZ&SFN;6"TG,R*MO*R_2G_!6S_@WD\+_P#!0KXM:G^U7\ /
MC)I7PE^-?C'P]I%KXRTKQ;IU_P"(OA=\2;O1-(L-(\+>)VU/1I[K6/"=Y#H%
MC9:7J#Z)I6LZ?KMK#9:@+2SU"&\N=6L?\$E?^#>[P5_P3C^+%Y^U+\=?BWX>
M^+'Q9\->'-1L?!;:#I$WAKX?_#BUU+3 GB[Q'->ZT\5]JVI/;+=6=IJ-_;Z;
M:Z3I(GN&C:XNI6M_S[-N.LHQ_"F5U<OXHS3(\YR[+E0GE&6T:\*N+Q\</AZ,
M*-6HXQHK"TZU.4Z==59/V-2=H*M>B=,,-4C7DIT(5:<Y7]I-Q:C#FNVEJW)I
MZQ[K6ZU/YYO^"]__  2V_96_X)HZ_P#L@VW[,VG^-[+_ (6]K?CQ_&4GC/QA
M>^*WF7PAJ/P__L1-/%W%"M@(FUW4C<&-2;C?$'8B)0/ZY_\ @L3_ ,H2/VL?
M^S7=!_\ 1_A"OXY?^#@__@HK\.?V\/VT/ /ACX'ZK9^)_@O^S7$/ VB^.K(,
M]AX]\<ZQXHL[GQQK^@73)&;KPM9O8Z;X>TB[C6:TU5](N];L+J6RU&!4_L:_
MX+$_\H2/VL?^S7=!_P#1_A"N/.EFZP_A#+/:F)JYI4SBK6Q,\9*4L3:OFV6U
ML/&LYMS4X8:=&#A*TJ?+[.48N+2=+DYL?[))4U!**CMI3DG;R<E)^=[]3^)W
M_@WB_977]IO_ (*:?";4]:T=-4\!_L[V&I_'OQ5]NT6ZU/1WU?PL]OI_PZT^
M>\B>*TTK5O\ A.M4T?Q+H[WKR"Z3PIJ*06LYAEDM_P"G?_@Y?_9\_;,_:V^&
MW[-7P0_90^ /Q)^*=EH7CSQ'\6O''B_P7K&DV&F>'-3T30V\->#=$O\ 3M3U
M/2_[2U&ZN?$.I^(M.NU>>'29M B<PBXN[>6'A/\ @T\_9=C^'W[)GQ=_:HUJ
MPMX_$/[0WQ$D\+^&KT_VK#?1_#;X2/=Z-!;W-M>)#IQAOO&U_P"+=2L[_34G
M%[I[61FO'$,4%O\ ('[5_P#P=1_'3X5_M+_'/X7?!?X#_!_Q5\,/AK\2_%/@
M'PGXI\4ZOXBDUGQ+:^$=2FT&\U]Y- U:729-/UC4K&\O]&DM6!?1Y[%KA([D
MS(O;FV(S_/O$W$8KAS!83,GP?AX86%+'5_88.-:4:E/$3FXU:,I58XO$5XP2
MG>2PL7*\(<I,%1IX-*K*4%B)<SY5S2:T:TLTERQ5^W-O=G]$5G\$?B?^VW_P
M2)3X _M.?#K5/A_\;/B5^S(/ GC3P=XRDL+O4-$^*WAK1EMO#FL:A=6-U-9W
M(D\6:#H?B1[FWND\R.9U,D3EBO\ EI>&=%U7PW\5O"7AO7K6YL=<\._%CPIH
M.LV=Y;RVEU:ZIH_CK3-/OH;BUG59[>5;FWDW0RJ)$R PSR?]'/\ X(??\%H/
M%O\ P5 UCX[^ OBYX!\$_#CXC?"VU\+>*O#NG^";G6I].U_P1KQN]+O;N=M;
MGGD.HZ5K]D8IX[60*EG?V3RQJ75W_DY_X+I?LBZA^RM_P5GUK5]/T3^SOAM^
MT;\2? /QW\ WD$;K837WBGQCHP^(FEQ#F"VGTGQW%K+1Z?;L([;2+W2)EB@2
MZ2%.KPWKXW(^(N*.%,WH4<!B<5%9QAL'1J>TPU*K*"G6I86?//GA/"XC#RA[
M\Y*GA)*<FX2:6,4:E&C7A)RBE[-R:M)W:2<E96:E%K9*\M-&?W^_\%$OV+],
M_;__ &4/B'^R_JWCK4?AQ;>.IM!NH_%VF:7::U<:;<:#J]MJL2MIMY+!%<P7
M'V=H95$\,BAPZ/\ *5;\J/\ @G5_P;Q?LY?\$]/C5I_[3_C#XR^)?C-X\\":
M=J<G@RX\4Z7H?@[P9X%N[RTO[+4?%(MK6>:6ZU*/1KE[:&YU/4/LNG!KJYBC
M!E!C^@O^#A7QGXP^'_\ P2T^.?BSP%XK\2>"?%.E:S\/GTSQ+X2UK4/#VO:<
M\OBNQAE:QU;2KBUOK4RPN\4AAG0O&[(V58@_YKGC']I3]H[XAZ%<>%_'_P"T
M!\:O&_AF[E@FNO#WBOXG^,]>T6YFMG$EO+/INI:Q<6DLD$@#Q,\3&-N5P:^;
M\/\ AOB/B#A?'8?+^)EE&3XG,<3A<;@HX&-:K6<L-A/;SC74Z551K49PI2I*
MK"$E!QDW&<D;8JM2I5XN='VDXP4HRYVDO>=DXV:T:;3LS^AC_@Z%_P""D7PF
M_:R\?^ /V8O@/XET_P =^"/V=)_''B#X@>-](=[C0-2^*VJ:9+X97P]X<U !
M(-5MO"FCIJT.KZK:_:-.N=0U2&#3+N:.TNI)?[:[[X%^ OVF?V!= ^ GQ0N=
M3LO 'Q2_9O\  /A?Q3>Z-J2:1JEGIESX+\/SO=V6I2))%:36TMO%.))HWA*Q
MLDR-$S@_Y &LC&CZK_V#;\^Y)MI223U))Y)/)/)YK_4Z_P""B+R1_P#!#CXS
M/%))%(O[&7@DK)%(\4B'_A'?!W*21LKH>V58'!(SS7K^('#U#),#X<Y!EF(J
MT%2S;%T*6-DE*O'%8FOEDYXUQBX)U%7JNM&$9144HTU)**D1A:KJ2Q=6:4KP
MBW'9<L8R7+L]+*UW?JSRK]CK_@WK_P""<?[+?QB\'_M!^"(_'OQ8\;?#?5HM
M8\ W/COQ['XC\,>%?$]I;R);Z]%HFCVUAINHZ[IOVB.ZTJ?5A=C2;H1WMK E
MQY<J?@A_P<R_\%6?AM^T/<6/[ GP,-QXCT#X2_$2+Q5\<O'EU9:AI=B/B5X2
M34=-TOX>^&[+4;>TO+\^&Y+Z^NO$>N2VR:?)=RVMGH[WL*27[<;_ ,&NG_!1
M./X*?'?7?V(?BGXF2T^'G[1M]#KGPBN-7FW+IOQUM[.VLY/#L5[+&TY_X6'X
M?L8[2TM[BZD637-$TFVL886N[MY='_@Z6_X)Z1_!OXV>&?V[?AMH,MM\/OV@
M+Z/PC\:?L<7_ !+M!^,]E8@>'O$,_EVL4-DGQ#T*RFM9FFN[JZU'Q'H\C110
M1.0=,GRVOE_BAA<%QAF>-SC%4\&JO#.8XF<H8>M5:<X)T92J>SG#_:H0I4ZO
M(L;3O)574IR)G.,\$Y4(1IQ<DJ\([I67VM+JW+=M7Y7NK-']4W_!(V70(?\
M@D3^Q_-XL6W;PM%^S)I<OB5;N&2YM&T"/3M2?65NK>&.6:>W.G"Y$T,44DDL
M99$C=F"G\?X_C3_P:*F-#'X<_8\\O:NS'[.7QB VX&W /PQSC&*_7/\ X)0:
M!=>*_P#@CQ^R?X6L9K>VO?$O[*]KH%G<7?F?9;>ZUG1]6TZWFN?)227[/%+<
MI)-Y2/)Y:ML1FP#_ "E0?\&B_P"W9%#%&?VF_P!DHE(U0D)\8L$J ,C/@7..
M*^5R*GP]4SKB[^W.*LVX;DLZK_5HY9CIX-8R/UO'>UE64,)B?:.@U35-MPY/
M:RLI<VFU1UE3P_LJ%.LO91YG.*DXZ0M;WHVNKWWV7H_AG_@MQXP_X)9>+OB'
M\"YO^"7.G?"?3_!MEX/\2Q_%;_A57@#Q=X"LY?$DNL1-HG]KVOBOP]X=DU"X
M335D^SSV4%PD4;-'+,#M1?S?_8V_9$^,'[<W[0W@+]G'X)Z2;WQ1XQU"*76M
M;N R:+X$\%VD\+>)_'/B*Z$,ZV^FZ#IS2SP0>3--JFI&STNUAEENOD^X/^"E
MW_!%_P#:#_X)<?#[X>?$?XT_%CX,_$/2?B1XIU3PGI%A\,%\;C4K"]TK2DU>
MXNM2_P"$K\/:+;&T>!Q%$+6::?SOO1A/FK^S7_@WK_X)I^$?V+_V2/#'QW\0
MMH7BGX]_M6^#O"/Q+UOQ;9V$9?PE\,/%&BZ?XF\!_#71-1N$:_%M#I^H6NN^
M*Y(FM+;4_$=Q'"]G(FA6-Y/^K9GQ=E/"?!&&Q63YG7SV55XC Y/B\;4GB:V*
MQ2JU)UJV*JRI4'.G@N:7->G#G4*5!?$YKCIT)U\2XU(*G9*=2,4HJ,;1245=
MVYO5J_,[Z6-K]LK]HOX _P#! #_@FIX$^%WP=T6/4/&_]C77PT^ 7A*XN$?5
M/&/Q'N[&2^\4_%/QI=W$K75SIFC7MVWBCQ1=DW5S<75UI&@6J1V]TD]C_FJ>
M-/&GB_XD>,/%/Q"^('B/5?%_CGQQX@U;Q5XO\4ZY=R7VKZ_XBUR]FU#5=4U"
MZE)>6XNKN>61CPJ@A$5455']P?\ P4J_X(,_\%-?^"D/[4/B;X_>//VD/V2_
M#_AVTAE\)?"+X?0S_&.\M? 'PVLKZXN-*TN6Z_X0...^\0:K)(VL^*=1BBB@
MN-8NIH;.-;*V@+_C/^V/_P &XG[6G[$_[-_Q,_:;^(OQX_9S\6>#OA;I=EJN
ML^'O!:_$P>)M2AOM6L-(CATK^V_".GZ5YR3W\<S_ &R]MX_)CDVN9-B-Y?AY
MF7".3X:*Q'$.#QW%'$.)IU<QK-XFI5JXO%5?W.!A4E1Y7R5:K]I4YE&KB:E2
M;FZ<:7+>*C7F[JE*-"E&T%=)**2O)J^]EHM6HJRU>O@?_!!']E9?VJ_^"FGP
M+TW6='CU;P%\%9[[X^>.DO\ 1;S5M$EC\ ^0_@[2=1GMWBM]*O-0\<7NA:EH
MUS?2&.:?0+F**WN&1_*_K0_X.6/@/^U_^U;\!?@%\ /V4_@+\1/BVK_%'4?B
ME\0/$/@W5M+T_3O"Z>$/#UWH?A/2=5L=2U+3!JUQK=_XLU+5;)EEEBTJ;PS'
M/+ T]W:2P?-G_!I5^R[%X2_9Z^/7[76LV%NNM_&CQW%\+_!MZ3JL.H0^ OA<
M#)JT5Q:W*1:7-9ZIXTU2\O-.U*P6YDG@LS#+=!85@3PO]M'_ (.D?C?\$?VK
M?CU\&/@E\#/A#XP^&GPG^(FM_#S0?%OBG6/$$NJ^)KCPK*-*UK6XY?#VJR:5
M)I-_K%O>RZ*\)28Z:8/M<<=SYB#Q\\Q&>Y_XF3J\.X+"YE+@[#PI1HXZO[#!
MK$24E7J3E&M1DZL,7B7",8S3D\'%S3IP<7=-4J>#M5E**Q+O>,;RMI;HTDXQ
M3NUIS=S^@3X1_!KXJ?M=?\$BM'_9V_:W^&^L^ /C!XY_9JO_ (._$3PCXUDL
M;W4K3Q=X>T>X\->'?$=_=Z?=7-K>/J5QI&@>*Y;F&X60W%S,C,DJ,]?Y77B?
MPKKO@3Q/XF\#>*+:XL_$O@KQ%K?A'Q!;75M+9W$6L^'-2N=(U#S+6<": 2W-
MG)-&DGS>3)&V6#!C_HY?\$0O^"VOC/\ X*=>._CA\*OC%\/? OPV\>?#SP[X
M<\;^#K;P1=:Y/9>(/"=]>3Z-KQO&UR>X)U+3-6-BR16CKBQN6EEC( >OY5O^
M#C']D/4/V8_^"D'Q"\<Z9HGV#X:_M06EO\9?"=_ )#9R^*KM4T[XDZ8Q),%K
M=VWB2V?4(]/@(5--U&SN?*B6X"GK\-J^/R/BOB/A?.,/1P&(QZCG.&P="I[3
M#4ZTK5:E'"3YZCG"6$Q$''WYRC#!N,W*4&TL6HU*-&O3;E&/[N4I*S:V3DK+
M7F5MDKRTWL_P:K_4>_X)&WL?P^_X(>?LP>*-&@:WN](_9+USQQNL?*M+J;6$
MT[Q1X@EN4F$3J+V2Z4;+J6.5]ZQR2B0@@_Y<-?Z?_P#P00\<^'_C=_P1R_9Q
M\-Z/)=(W@WP-XW^!7B%[M'C,.O\ A;6=<T;4# 7C<M9B"_M9+.14DC-NT9C#
MH M>EXU1E_J]E-1Q<J-+/L.ZW\O*\)C4E)].;6*T>K(R_P#CS5[-TI6_\#@?
MYDNB2FX\>Z'<$$&Y^(ND7+ X)#7/C*VG8$@*"V9#N(4 G) &<5_J>?\ !6/X
MN?$#X"?\$J/CG\:?A5X@O?"WQ%^&/P\^&'C#PEKEA/+;S6NJ:3XX\!2_9YFB
M97DT_4[8W&E:M;9VW>EWUY;-@2Y'^7=XA\':_P##SXZZKX!\5V#Z5XG\%?&V
M3POX@TR21)7L-7T7XA+8WUH\L1,<C0SPLA=#M;&5X.*_TR?^"XG_ "A4_:S_
M .R)>!O_ %,/ =<WB?&EB.(/#:,HPK4*^<.,HR2J4JM&KC<E3BT[QG3J4Y6:
MUC*+ZIA@KQI8K=2C1]&FHS_%,\CU*W_9T_X.-?\ @E=(;5M&\-?%)-/>2UW&
M74M4_9Y_:>T'0-R6UR0-/NK[P[?-J*PWBPO'!K_@G7'\F9;^));7Z3^ ?PR\
M;_!;_@BZOPC^)6B7'ASQ]\-OV,OC#X*\7:+<JX:QUWP[X.\=:9?K#(Z)]IL9
MIK<W.G7T:_9]0T^:VOK9GM[B)V_@E_X(Q?\ !2_6/^":O[5^G>+-?GO[W]GK
MXMC2_!'Q_P##EG!->SQ:*ES-_P (Y\0-'LXYD#^(/ .HWT]X%$<\FH>';WQ!
MHT:13:A!>6O^E=^TSK^B^*_V-/V@_$_AS4[/6O#WB/\ 9E^+&N:%K&G3I<V&
MJZ/JWPLU^^TW4;*XC)CGM;VSGAN+>5"5DBD5@<&OS[C;)<PX5Q^"R&G*=3AK
M%9S2SC)G4YIO"UG:CB\$JC;:=/VM-RC)OG@J%;2I4KI]F&G&M%U6DJT:?LZE
MOM):QG;SL_1W6J2;_P RK_@BO_P4%\"_\$U/VGKW]H3XA^!O&'Q"\/ZS\ _$
MGPN30/!,]E;ZLNH^(_$/P^\0VNH3MJ ^SOIUO'X1N(IDXD%Q<6LJY$; _P!2
M_P#Q%S?LK_\ 1JW[0'_@R\+?_$U_,5_P0O\ VP/V9_V(OVL;[XR?M7:??:E\
M,=0_9Y\5>!;*WT_P-_PL&<>+M;\0_#S5M*D;0O(G\N+^S?#^M1-J.P?9VF6$
ML%N6!_K7_P"(B?\ X(F?]"9XF_\ $78__E?7Z'Q]E.&QO$$ZU7@'/.(Y?5,/
M!YCE^8XK#8=J,IVH>RHX6M#VE)/WI<]Y<\4TK*_'A:CA226*I4=;\DXQ;>D=
M;N2T=K?>^AXI>?\ !V_^RS<V=W;)^RW^T% ]Q;3P).FI>&-\+S1/&LJE0&#1
MLP<%2&!&1S7\%FJS1:CJVJZAY7R7NM:MJD"RJK20B_U"ZNX\D@[9DCN CLN/
MFW8.#7^AAJG_  <2_P#!%9],U%+'P5XI>]>PO%LTC_9BAMY'NFMI!;I'<26"
MQP.\Q15F=E2)B'=E521_GI:I<1WFK:Q>P!E@OM9U>^MU90K+;WNI75U;JRC(
M1EAF160$A6!4' %>WX;Y=0P']L>QX1S7A9U?J'-_:>-KXOZ]R+%V]C[>A0]F
ML/SRY^7GY_;POR\JYL\5-S=.]>G7LIZPBH\E_9[V;NY-76UK/Y?W)?\ !GU_
MR2#]NK_LK_PB_P#5?ZS7X _\%^E#?\%@_P!IM& 97U[X3(RGHRMX-\+JRGV*
MD@^QK]_O^#/K_DD'[=7_ &5_X1?^J_UFOY]/^#@U2_\ P5O_ &L45VC9I_AV
M$D0D/&__  KW0=DB$$$/&V'1@0590000#7DY!_R>/C#_ +$U#_TUD)K6_P!Q
MP_\ C?\ [D/]%#XZ>&/V?]0_83U2Q_:1T<ZE^SQX6^"_A;Q1\1_#5M'=RV^J
M>$? >A:1XC_L-[*RD2YO[.>31[2W;3%FBCOU5;.XFCMY97'\W_[-G_!UG\%-
M=^,W@/X0:]^R!/\  _\ 9Y\0^*=(\#^%_%^C^./#4/\ PK7P_JES#IFB:]XG
M\*0Z-HWAZTT."[FAN-=M-(U&PA\-:5=3W(N-4;2I4O\ ]$?^"9G[0/P)_P""
MOW_!)N7]E_QMXG@/Q TGX$P?LX?M">#4UF\F\8^'Y=,T%?"WA?X@8>XTK5]7
MT[Q)INFZ-XHBUB.2.QO=<&K:'/?2O:SRS?B9^SQ_P:>?M&^'?VB? U_\?OCI
M\$M>^ G@_P 7Z/XE\03>$--\3:GXD^(6A^'M>T[41X3G\-Z]I>EZ?H[^+-,@
MGT_6[N2_O;31GFN6L8]8C2W2X_.\ARWA' T^*,JXZQ&(P^/R[&5_J6%J5<;1
MC%2I24L9@*6'E[*OB\0Z=!IUHSA4H1PKA[2C.I;JJSQ$O83PR3C**YI)1;O=
M6C-O51C=Z*S3<KV:1]/_ /!TA_P3U^#5O\#M#_;]^&OAG0?!GQ)\/^./"G@K
MXLW.@VD5A9_$CPQXWNIM+T'6-0LK'R;&?Q1H_B&YL2VO-#)>:CI%Y<6]W+*8
M;:6/^%F1AM95=1)@A1N4'<>G4U_?)_P=1?MN_"OPK^S1X?\ V#?#.N:5KGQ>
M^)GB[P/XW\<>&M.O$FNOAY\-/!&H+XET/4-?CAMKF.RO_%/B73=&M=!TBYN=
M.OKO2;?5-83S;&U2*]X#_@A?^RA_P2?_ ."@/[".B^$/B#^SU\+]8_:@^&.C
MZY\/?C7=SZEJ-O\ $R\^VW.J1>'?BK9B'4HE@BUS2KN&72M3M[*YAT[5=.:"
MZ5)HT@;[S@_BC%\,>'F"S;/,%F>.PBS.KAL+*BH3JT,KG&'U6O55>I3:PJQ$
M:]"C+F:Y9X>$/W<J9RUZ*K8N5.E*$7R*3OI%S3]Y*R?O---JVZD]7<]&_P""
M=7[:/_!NY\);C]G>W\'Z/\ _A?\ M1:EX,^'W@G7/B1??!G7]%:/XD3Z?HD>
MISWOC[6M GT[1+O4?%]HLO\ PE%Q=Z=9V][(MS+J>GV;,Z>?_P#!T%^Q[^V?
M\1_AII7[46B_&1/'G[*?P3C&H>*_@'IEBOAM? /]IW,=BGQ=FDMKF6V^(Q@%
MW;Z9?MJIBO\ PO8SF\\/VUQ%<Z@$^1KW_@T7_:/B^,-I9:;^U)\&;KX"GQ=8
M37.OWVB>-[3XI0>!UU))[^!/#5K82^'I?%$6G*]I8&/Q=!8S7!ANY=2LGW^7
M^_G_  7%_:.^#W[%_P#P2V^)OP=G\6:3:>._B3\)[3X"_ CP1K][>>(O$GBV
M:.QTS0;F\N+::]EUR^L-!\,6EWJ&M^*=1N)(+:]2UDU*^ENKQ%G^6GBLHPG&
M?"^8<'YQC.)\;F&*E1QV'S.$\=+"87$5:,7[&O6PU*M@I1H5<3_#C*>&IT7.
MI.-)SIU=U&I+#5H5Z<:,813BX/DYI)=8J34KR2O=KF;22O9K^&+_ ((E:]>>
M&_\ @JS^Q/J-@J-/<?%I=#D$C.J_8_$GAW6] OR#&5;<++49RBD[&<*L@9"P
M/]27_!WG;0M^RC^R/>E/](A_:8U>TCDST@N_A%XUGG3'??)8VS GIL('WC7\
MVW_!OS\)=4^*7_!5S]ENWT^R%YI7PWOO%?Q1\23RS^5_9VD^#/".K/I]X0LD
M,MQ)+XFNM L4BBW_ +R\66>)K6.<#^@K_@[X^)&CP_";]C7X/>?;'Q#JGQ2\
M=?% 6WVB(WBZ+X9\%S^$'F%IN\X6KW_C2%&N2GE&9$B#!]P/V/$G+5\7>#:=
M)<U6CEE6=;EWC2Y<VFN>STM!3G9_9DGLT<]'3 XEO2]2*7F[4EIWUT/X8***
M*_93A"BBB@ HHHH **** "BBB@#]%_\ @D/_ ,I0OV#_ /LY7X:_^GR"OTW_
M ."I'_*0_P#:Y_[*YJ/_ *:M)K\R/^"0_P#RE"_8/_[.5^&O_I\@K]-_^"I'
M_*0_]KG_ +*YJ/\ Z:M)K[?P9_Y.OF?_ &;JI_ZT^"/YA^E5_P D/P]_V5B_
M]4V./@FBBBOZY/X-"BBB@ HHHH **** "BBB@ HHHH AN/\ CWG_ .N,O_H#
M5_I$_"'X8VGQI_X)P?!SX2WVJW.A6GQ%_8Y^%7A"?6;.&&YNM,37/A!X<L?M
ML-O<?N9WMS*)!%(0LFTKN7.X?YNUQ_Q[S_\ 7&7_ - :O]#74]1U#2/^"0.A
MZKI-_>:7JFG?L%^!+S3]2T^YFL[^QO+?X*Z!+;W5G=V[QSVUQ!(JR131.DD;
MJ&5@0#7\:?2_I8BO1\**.#Q"PF+K<8UZ6%Q3@JJPV(J0RZ%#$.E+W:BHU7&I
MR2TGR\KT9_6?T6:E"C4\2JV*H?6L+2X6A4Q.&4W3>(H0>,E6H>T6L/:TU*GS
MK6/-S+5'PW^S)_P;V?!+X'_%3P;\4OB+\8?%'Q:C\ ZQ8^(M&\(3^']+\->'
M;K6=(EMKO1[S6Y8+F]O[N'3K^#[6+*.X@@N'6 3,1$PD\!_X. OV\OA=KWPV
MT[]C3X8>)]+\8^+=0\7:#XJ^+=WHEPM_I/A/1_#8&KZ!X=FU&W)L[CQ#JNLR
M:;J,MK:SW*Z98:;-'?K#>7-ND?\ ,E?_ +1W[0_B#1KC1]=^//QDUG2-5LOL
MNIZ7JGQ*\7WVGZA:S1J)K:]M+C5I(;F"4<212HRN.H->/]R268DY9F9F9CZL
MS$LQZ#)). !T K[3A_P*XFQ/'62\>>*'B'5XWQ_##]ID&7X;*:.58'"XJ,O:
M4L355*I[-JC7MB%2H86E4K8BCAJE?%5*5'ZO/Y+/?&?AW#\'9OP7X=<"4N#\
M'Q$O9YWCZ^9U<RQF(P\H^SJT*;JT_:?O:*=!U*V(JPI4*M>%'#0JU?;1_P!
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MK7+ZDDFI_9G@T\Z?#<R7,MG^47_!1/P-X4^$_P"V_P#"SX2^%/VIOBU^U"/
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M;B34U\.ZUKLL\<JQLJW4EWEEN721RX620.P.?\]NO] W_@DEXLTCXP?\$O\
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M_P"'\PO/"\2R@KA@8V<,"I##&1S7\=UTZ7-U=3[<K/>W5VBN 63S[F6=,YR
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MZ"LW_!3;]H)4;:[>'O@VJ-_=8_![P<%;OT.#T/2OE^#_ /E,/Q+_ .R#P_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM>3<G9=+MO09+%'-')#*@DBE1XI(V^Z\<BE71L8.&4D'D<&OO/QE_P %0_\
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M*HVY04G;75K11NKW:36B=MA" 000""""" 00>""#P01P0>".M?</@S_@I?\
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ME.<DME*4I>75O6VE]S^T_P#X-8_V>OA3\,/#?Q=_;H^+WC_X;^&?$7C.WO\
MX/?"33O$7C?POINKZ=X-T+58K[XC>()])O[^#4+"36_$>E:5I-F\T6^73] N
M)K4BVU%_._!3_@M'^WY;_P#!0S]N+QQ\3/"&I37OP2^'=G'\*O@:'@EM5O\
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MQ"RO,\PRY8NE[#%+ XS$83ZS1=_W5?V%2G[6G[TO<J<T=7IJQ%4*H51A5 4
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MJ%66'J4W4I2E&+=.;<&TFU=#554544!510JJ.@51@ >P  %.HHKT3SPHHHH
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MS/K6BODK_AQI_P %2_\ I,9JO_AG]6_^;ZC_ (<:?\%2_P#I,9JO_AG]6_\
MF^H_U=R7_HML@Z?\P?$7E_U)?-_<P]K5_P"@:KT^W1\O^GGF_N9]:T5\E?\
M#C3_ (*E_P#28S5?_#/ZM_\ -]1_PXT_X*E_])C-5_\ #/ZM_P#-]1_J[DO_
M $6V0=/^8/B+R_ZDOF_N8>UJ_P#0-5Z?;H^7_3SS?W,^M:*^2O\ AQI_P5+_
M .DQFJ_^&?U;_P";ZC_AQI_P5+_Z3&:K_P"&?U;_ .;ZC_5W)?\ HML@Z?\
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M #Z?_@4/_DO/\^S/XW:*_LB_X@__ (H?]'S^!?\ PQNO?_/&H_X@_P#XH?\
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M%_\ #&Z]_P#/&H_X@_\ XH?]'S^!?_#&Z]_\\:C_ (B?P)_T/Z7_ (0YG_\
M,7G^?9A]3Q/_ #Z?_@4/_DO/\^S/XW:*_LB_X@__ (H?]'S^!?\ PQNO?_/&
MH_X@_P#XH?\ 1\_@7_PQNO?_ #QJ/^(G\"?]#^E_X0YG_P#,7G^?9A]3Q/\
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M\^G_ .!0_P#DO/\ /LS^-VBO[(O^(/\ ^*'_ $?/X%_\,;KW_P \:C_B#_\
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M/X%_\,;KW_SQJ/\ B#_^*'_1\_@7_P ,;KW_ ,\:C_B)_ G_ $/Z7_A#F?\
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M #Z?_@4/_DO/\^S/XW:*_LB_X@__ (H?]'S^!?\ PQNO?_/&H_X@_P#XH?\
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M%_\ #&Z]_P#/&H_X@_\ XH?]'S^!?_#&Z]_\\:C_ (B?P)_T/Z7_ (0YG_\
M,7G^?9A]3Q/_ #Z?_@4/_DO/\^S/XW:*_LB_X@__ (H?]'S^!?\ PQNO?_/&
MH_X@_P#XH?\ 1\_@7_PQNO?_ #QJ/^(G\"?]#^E_X0YG_P#,7G^?9A]3Q/\
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M0/G^'K;^?2BOZ"_^(5;]I?\ Z2+>'/\ PR6M_P#SQ*/^(5;]I?\ Z2+>'/\
MPR6M_P#SQ*/^)M?";_H,S+_P@Q'E_P!._/\ !]@_XE)X\_Z'?#7_ (-S#R_Z
M@?/\/6W\^E%?T%_\0JW[2_\ TD6\.?\ ADM;_P#GB4?\0JW[2_\ TD6\.?\
MADM;_P#GB4?\3:^$W_09F7_A!B/+_IWY_@^P?\2D\>?]#OAK_P &YAY?]0/G
M^'K;^?2BOZ"_^(5;]I?_ *2+>'/_  R6M_\ SQ*/^(5;]I?_ *2+>'/_  R6
MM_\ SQ*/^)M?";_H,S+_ ,(,1Y?]._/\'V#_ (E)X\_Z'?#7_@W,/+_J!\_P
M];?SZ45_07_Q"K?M+_\ 21;PY_X9+6__ )XE'_$*M^TO_P!)%O#G_ADM;_\
MGB4?\3:^$W_09F7_ (08CR_Z=^?X/L'_ !*3QY_T.^&O_!N8>7_4#Y_AZV_G
MTHK^@O\ XA5OVE_^DBWAS_PR6M__ #Q*/^(5;]I?_I(MX<_\,EK?_P \2C_B
M;7PF_P"@S,O_  @Q'E_T[\_P?8/^)2>//^AWPU_X-S#R_P"H'S_#UM_/I17]
M!?\ Q"K?M+_])%O#G_ADM;_^>)1_Q"K?M+_])%O#G_ADM;_^>)1_Q-KX3?\
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MO$/A_4K+6=#UK2K^%+BQU/2=6TZ>YL-2T^\MY$GM+VSN)K:XA=)8971@QUZ
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M5^?/_!.']N4?MS?!GQAXC\5>!X_A)\=?@K\7?B#\!_VA_@R=7BUFX^''Q-\
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M?#F@WGQ8\::+X+UV"Y\,OK?C636?"^BW&KR6=\?*\*&)!!>6HE0 _I\_8O\
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MP\%_!7QI\5_CK#X=^)%C\/-"LO!_A[Q=8-\1/ 7A#5)+_2=!CL[&"[USP?\
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M_P 0-(T[Q5-X8TVZ\6V&KPZ=HOA:.[M-'BBTR.&._O[34-8DDEDU.0UJWO\
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M!8X+,67@JSMI+=$ >W2QC&/LS;OZN?VMOAAXW^-G[+W[0?P>^&NK^&] \?\
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MNV%RZ0Q^%9=%T[RKRW\?>(K>+^OA$2-$CC18XXU5$1%"HB* JHBJ JJJ@!5
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M_!GPDOK>Y&W3W\.ZO\</#V@3W(-N8KHWZ6'Q+\01J6E:%@EFKH8TD23^TF@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MYPO^#G;_ ),6^#__ &>+^S[_ .I+)7]'M?SA?\'.W_)BWP?_ .SQ?V??_4ED
MKZS@7_DL.'O^QE1_]N.?%_[O5_P_JC^AOPA_R*7A?_L7=$_]-EK715SOA#_D
M4O"__8NZ)_Z;+6NBKY6?QR_Q2_-F\=EZ+\@K^9?_ ()G_P#*>K_@M=_V _@9
M_P"C]4K^FBOYE_\ @F?_ ,IZO^"UW_8#^!G_ */U2OK>&O\ D4<;?]DY0_\
M6@R4QK?Q,/\ ]?7_ .FJA_311117R!N%?Q=?\$6/^5D?_@N)_P!@;4__ %:7
M@>O[1:_.;]G'_@ES^S#^RW^V'^TK^W%\+V^)!^-O[5MM=6OQ4'B3QA#K'@X1
M7>O:7XCE_P"$;\/IHUE-I+#4=(M!$T^IZAY-L9K>(*LA( /T9K^+3]E+_E<=
M_P""@G_9OWAW_P!9_P#V<:_M+K\X_ W_  2V_9@^'O\ P4,^*O\ P4W\/O\
M$G_AI;XQ>%+;P;XP6^\917/PZ_L>U\*>#?!L7]E^$%T:&6SNQH_@70_W\NL7
M06[-_<1QH+QHU /I+]L#_DTO]J+_ +-U^-O_ *K3Q-7X#?\ !H9_RAU\(_\
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M &-OANFL7,"6MQJB^"?B1\,?#@U":VB9X[>6\_L[[0\*.ZQ-(45V"[C^Q_\
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M.N7'Q=\.>([/X^77P\M[1W0R7%CXC-YX0M8[@Q2WSVL/VB."2=TC^BOV+?\
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M9I)Y))68@'\V7_!R_P#\I./^""7_ &<D/_5R? >OMO\ X.XO^4,7Q1_[+7\
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M3X?>&5L?&,5K\.SX?CTCQ9HBC4O"7]C23WMY]B\9ZR3,-9AA:X%G.;??;#>
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M1&=%C74IKD(J.ZJH 5F !/X+?"/_ (-BO^">?PP^(WPW\6Z]XM_:?^-7P_\
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MSN?$30S$F)$B_I$H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB_9W_P"#EK_@L/\ L\:C ]F/C3HDGQ3\*BY8VIN]-TOQ-H_BZ&2V34_^)AJ
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M^U27?UE_P3M_X(C_ /!/S_@F1J-YXN_9V^%U_JGQ7U*PN-+O?C/\4=87QO\
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M=A?V$\E?UY4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5_.%_P<[?\F+?!_\ [/%_9]_]262OZ/:_G"_X.=O^3%O@_P#]
MGB_L^_\ J2R5]9P+_P EAP]_V,J/_MQSXO\ W>K_ (?U1_0WX0_Y%+PO_P!B
M[HG_ *;+6NBKG?"'_(I>%_\ L7=$_P#39:UT5?*S^.7^*7YLWCLO1?D%?S+_
M /!,_P#Y3U?\%KO^P'\#/_1^J5_317\4GPM_X*3?LI?\$\_^"W__  5V\9_M
M-^*?%GAO0_B+J'PP\%^%9?#'@#Q1XWGN]>\)6K:IKL%U;>&[&^GL(+>TU?3W
MM[NYC2WO&DE2*3S(&4_;<'X+%YA@>,<'@<-7QF*K<.T8T</AJ4ZU:K*.>Y/4
MDH4X*4I-0A.;23M&,I/1-G/B)1A*A*4E&*JN[;LE>G-;OS:7JS^UNBOY[?\
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M_P!2.,/^B8SW_P -F+_^5>:^\/K.'_Y_4O\ P./^?FOO/Z$J*_GM_P"(G_\
MX)'?]%4^+W_B/?Q6_P#F?H_XB?\ _@D=_P!%4^+W_B/?Q6_^9^C_ %(XP_Z)
MC/?_  V8O_Y5YK[P^LX?_G]2_P# X_Y^:^\_H2HK^>W_ (B?_P#@D=_T53XO
M?^(]_%;_ .9^C_B)_P#^"1W_ $53XO?^(]_%;_YGZ/\ 4CC#_HF,]_\ #9B_
M_E7FOO#ZSA_^?U+_ ,#C_GYK[S^A*BOY[?\ B)__ ."1W_15/B]_XCW\5O\
MYGZ/^(G_ /X)'?\ 15/B]_XCW\5O_F?H_P!2.,/^B8SW_P -F+_^5>:^\/K.
M'_Y_4O\ P./^?FOO/Z$J*_GM_P"(G_\ X)'?]%4^+W_B/?Q6_P#F?H_XB?\
M_@D=_P!%4^+W_B/?Q6_^9^C_ %(XP_Z)C/?_  V8O_Y5YK[P^LX?_G]2_P#
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M53XO?^(]_%;_ .9^C_B)_P#^"1W_ $53XO?^(]_%;_YGZ/\ 4CC#_HF,]_\
M#9B__E7FOO#ZSA_^?U+_ ,#C_GYK[S^A*BOY[?\ B)__ ."1W_15/B]_XCW\
M5O\ YGZ/^(G_ /X)'?\ 15/B]_XCW\5O_F?H_P!2.,/^B8SW_P -F+_^5>:^
M\/K.'_Y_4O\ P./^?FOO/Z$J*_GM_P"(G_\ X)'?]%4^+W_B/?Q6_P#F?H_X
MB?\ _@D=_P!%4^+W_B/?Q6_^9^C_ %(XP_Z)C/?_  V8O_Y5YK[P^LX?_G]2
M_P# X_Y^:^\_H2HK^>W_ (B?_P#@D=_T53XO?^(]_%;_ .9^C_B)_P#^"1W_
M $53XO?^(]_%;_YGZ/\ 4CC#_HF,]_\ #9B__E7FOO#ZSA_^?U+_ ,#C_GYK
M[S^A*BOY[?\ B)__ ."1W_15/B]_XCW\5O\ YGZ/^(G_ /X)'?\ 15/B]_XC
MW\5O_F?H_P!2.,/^B8SW_P -F+_^5>:^\/K.'_Y_4O\ P./^?FOO/Z$J*_GM
M_P"(G_\ X)'?]%4^+W_B/?Q6_P#F?H_XB?\ _@D=_P!%4^+W_B/?Q6_^9^C_
M %(XP_Z)C/?_  V8O_Y5YK[P^LX?_G]2_P# X_Y^:^\_H2HK^>W_ (B?_P#@
MD=_T53XO?^(]_%;_ .9^C_B)_P#^"1W_ $53XO?^(]_%;_YGZ/\ 4CC#_HF,
M]_\ #9B__E7FOO#ZSA_^?U+_ ,#C_GYK[S^A*BOY[?\ B)__ ."1W_15/B]_
MXCW\5O\ YGZ/^(G_ /X)'?\ 15/B]_XCW\5O_F?H_P!2.,/^B8SW_P -F+_^
M5>:^\/K.'_Y_4O\ P./^?FOO/Z$J*_GM_P"(G_\ X)'?]%4^+W_B/?Q6_P#F
M?H_XB?\ _@D=_P!%4^+W_B/?Q6_^9^C_ %(XP_Z)C/?_  V8O_Y5YK[P^LX?
M_G]2_P# X_Y^:^\_H2HK^>W_ (B?_P#@D=_T53XO?^(]_%;_ .9^C_B)_P#^
M"1W_ $53XO?^(]_%;_YGZ/\ 4CC#_HF,]_\ #9B__E7FOO#ZSA_^?U+_ ,#C
M_GYK[S^A*BOY[?\ B)__ ."1W_15/B]_XCW\5O\ YGZ/^(G_ /X)'?\ 15/B
M]_XCW\5O_F?H_P!2.,/^B8SW_P -F+_^5>:^\/K.'_Y_4O\ P./^?FOO/Z$J
M*_GM_P"(G_\ X)'?]%4^+W_B/?Q6_P#F?H_XB?\ _@D=_P!%4^+W_B/?Q6_^
M9^C_ %(XP_Z)C/?_  V8O_Y5YK[P^LX?_G]2_P# X_Y^:^\_H2HK^>W_ (B?
M_P#@D=_T53XO?^(]_%;_ .9^C_B)_P#^"1W_ $53XO?^(]_%;_YGZ/\ 4CC#
M_HF,]_\ #9B__E7FOO#ZSA_^?U+_ ,#C_GYK[S^A*BOY[?\ B)__ ."1W_15
M/B]_XCW\5O\ YGZ/^(G_ /X)'?\ 15/B]_XCW\5O_F?H_P!2.,/^B8SW_P -
MF+_^5>:^\/K.'_Y_4O\ P./^?FOO/Z$J*_GM_P"(G_\ X)'?]%4^+W_B/?Q6
M_P#F?H_XB?\ _@D=_P!%4^+W_B/?Q6_^9^C_ %(XP_Z)C/?_  V8O_Y5YK[P
M^LX?_G]2_P# X_Y^:^\_H2HK^>W_ (B?_P#@D=_T53XO?^(]_%;_ .9^C_B)
M_P#^"1W_ $53XO?^(]_%;_YGZ/\ 4CC#_HF,]_\ #9B__E7FOO#ZSA_^?U+_
M ,#C_GYK[S^A*BOY[?\ B)__ ."1W_15/B]_XCW\5O\ YGZ/^(G_ /X)'?\
M15/B]_XCW\5O_F?H_P!2.,/^B8SW_P -F+_^5>:^\/K.'_Y_4O\ P./^?FOO
M/Z$J*_GM_P"(G_\ X)'?]%4^+W_B/?Q6_P#F?H_XB?\ _@D=_P!%4^+W_B/?
MQ6_^9^C_ %(XP_Z)C/?_  V8O_Y5YK[P^LX?_G]2_P# X_Y^:^\_H2HK^>W_
M (B?_P#@D=_T53XO?^(]_%;_ .9^E'_!S]_P2-)P?BK\71[G]GOXKX'Y>'B?
MR!H_U(XP_P"B8SW_ ,-F+_\ E7FOO#ZSA_\ G]2_\#C_ )^:^\\S_P"#6O\
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M-?>'UG#_ //ZE_X''_/S7WG]"5%?SV_\1/\ _P $CO\ HJGQ>_\ $>_BM_\
M,_1_Q$__ /!([_HJGQ>_\1[^*W_S/T?ZD<8?]$QGO_ALQ?\ \J\U]X?6</\
M\_J7_@<?\_-?>?T)45_/;_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'_$3_\
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MP_\ S^I?^!Q_S\U]Y_0E17\]O_$3_P#\$CO^BJ?%[_Q'OXK?_,_1_P 1/_\
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M'&'_ $3&>_\ ALQ?_P J\U]X?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\
M\$CO^BJ?%[_Q'OXK?_,_1_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_
M $3&>_\ ALQ?_P J\U]X?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO
M^BJ?%[_Q'OXK?_,_1_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&
M>_\ ALQ?_P J\U]X?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?
M%[_Q'OXK?_,_1_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\
MALQ?_P J\U]X?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q
M'OXK?_,_1_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?
M_P J\U]X?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q'OXK
M?_,_1_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?_P J
M\U]X?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q'OXK?_,_
M1_Q$_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?_P J\U]X
M?6</_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q'OXK?_,_1_Q$
M_P#_  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?_P J\U]X?6</
M_P _J7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q'OXK?_,_1_Q$_P#_
M  2._P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?_P J\U]X?6</_P _
MJ7_@<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q'OXK?_,_1_Q$_P#_  2.
M_P"BJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?_P J\U]X?6</_P _J7_@
M<?\ /S7WG]"5%?SV_P#$3_\ \$CO^BJ?%[_Q'OXK?_,_1_Q$_P#_  2._P"B
MJ?%[_P 1[^*W_P S]'^I'&'_ $3&>_\ ALQ?_P J\U]X?6</_P _J7_@<?\
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M#_\ /ZE_X''_ #\U]Y_0E17\]O\ Q$__ /!([_HJGQ>_\1[^*W_S/T?\1/\
M_P $CO\ HJGQ>_\ $>_BM_\ ,_1_J1QA_P!$QGO_ (;,7_\ *O-?>'UG#_\
M/ZE_X''_ #\U]Y_0E17\]O\ Q$__ /!([_HJGQ>_\1[^*W_S/T?\1/\ _P $
MCO\ HJGQ>_\ $>_BM_\ ,_1_J1QA_P!$QGO_ (;,7_\ *O-?>'UG#_\ /ZE_
MX''_ #\U]Y_0E17\]O\ Q$__ /!([_HJGQ>_\1[^*W_S/T?\1/\ _P $CO\
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M1[^*W_S/T?\ $3__ ,$CO^BJ?%[_ ,1[^*W_ ,S]'^I'&'_1,9[_ .&S%_\
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M17\]O_$3_P#\$CO^BJ?%[_Q'OXK?_,_1_P 1/_\ P2._Z*I\7O\ Q'OXK?\
MS/T?ZD<8?]$QGO\ X;,7_P#*O-?>'UG#_P#/ZE_X''_/S7WG]"5%?SV_\1/_
M /P2._Z*I\7O_$>_BM_\S]'_ !$__P#!([_HJGQ>_P#$>_BM_P#,_1_J1QA_
MT3&>_P#ALQ?_ ,J\U]X?6</_ ,_J7_@<?\_-?>?T)45_/;_Q$_\ _!([_HJG
MQ>_\1[^*W_S/T?\ $3__ ,$CO^BJ?%[_ ,1[^*W_ ,S]'^I'&'_1,9[_ .&S
M%_\ RKS7WA]9P_\ S^I?^!Q_S\U]Y_0E17\]O_$3_P#\$CO^BJ?%[_Q'OXK?
M_,_1_P 1/_\ P2._Z*I\7O\ Q'OXK?\ S/T?ZD<8?]$QGO\ X;,7_P#*O-?>
M'UG#_P#/ZE_X''_/S7WG]"5?SA?\'.W_ "8M\'_^SQ?V??\ U)9*ZO\ XB?_
M /@D=_T53XO?^(]_%;_YGZ_'G_@M;_P6D_8(_;R_9C^&OP@_9T\<_$'Q!X[T
M;]I/X-^/KS3_ !%\)?''@^P7PSX9\0>=K-RNK>(=-L;.2[ACEB-M81-)<7;%
MU15*C=]+P=PCQ1@^*,CQ6+X?SC#8:ACZ52M7K9?B:=*E35[SJ3E34815U>3:
M2NC'$UZ$J%2,:M.4G&R2G%MNZ=DKZZ']NWA#_D4O"_\ V+NB?^FRUKHJY7P)
M=0WW@CP;>VQ9K>\\*^'KJ!G1HW:&XTBSFB+QMAD8HZED8!E.5/(-=57YI434
MYIZ-3DFNS3=SLCLO1?D%?RW?\$]O W@GQM_P7A_X+2V?C+P;X3\6VEEI?P1N
M[*V\3^'-&UZ&SNIY-2BN+FTCU6RNUMI[B-42YE@"/<+'$)F?RH]O]2-?S+_\
M$S_^4]7_  6N_P"P'\#/_1^J5]=PQ*4,JXUE"4HR7#E"THMQDO\ C(,E6C5F
MM.QC62<\/=7_ 'K_ /350_H,_P"&?_@/_P!$3^$?_AM_!O\ \IJ/^&?_ (#_
M /1$_A'_ .&W\&__ "FKURBOE?K6)_Z"*_\ X.J?_)&UEV7W(\C_ .&?_@/_
M -$3^$?_ (;?P;_\IJ/^&?\ X#_]$3^$?_AM_!O_ ,IJ]<HH^M8G_H(K_P#@
MZI_\D%EV7W(\C_X9_P#@/_T1/X1_^&W\&_\ RFH_X9_^ _\ T1/X1_\ AM_!
MO_RFKURBCZUB?^@BO_X.J?\ R0679?<CR/\ X9_^ _\ T1/X1_\ AM_!O_RF
MH_X9_P#@/_T1/X1_^&W\&_\ RFKURBCZUB?^@BO_ .#JG_R0679?<CR/_AG_
M . __1$_A'_X;?P;_P#*:C_AG_X#_P#1$_A'_P"&W\&__*:O7**/K6)_Z"*_
M_@ZI_P#)!9=E]R/(_P#AG_X#_P#1$_A'_P"&W\&__*:C_AG_ . __1$_A'_X
M;?P;_P#*:O7**/K6)_Z"*_\ X.J?_)!9=E]R/(_^&?\ X#_]$3^$?_AM_!O_
M ,IJ/^&?_@/_ -$3^$?_ (;?P;_\IJ]<HH^M8G_H(K_^#JG_ ,D%EV7W(\C_
M .&?_@/_ -$3^$?_ (;?P;_\IJ/^&?\ X#_]$3^$?_AM_!O_ ,IJ]<HH^M8G
M_H(K_P#@ZI_\D%EV7W(\C_X9_P#@/_T1/X1_^&W\&_\ RFH_X9_^ _\ T1/X
M1_\ AM_!O_RFKURBCZUB?^@BO_X.J?\ R0679?<CR/\ X9_^ _\ T1/X1_\
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M _\ T1/X1_\ AM_!O_RFKURBCZUB?^@BO_X.J?\ R0679?<CR/\ X9_^ _\
MT1/X1_\ AM_!O_RFH_X9_P#@/_T1/X1_^&W\&_\ RFKURBCZUB?^@BO_ .#J
MG_R0679?<CR/_AG_ . __1$_A'_X;?P;_P#*:C_AG_X#_P#1$_A'_P"&W\&_
M_*:O7**/K6)_Z"*__@ZI_P#)!9=E]R/(_P#AG_X#_P#1$_A'_P"&W\&__*:C
M_AG_ . __1$_A'_X;?P;_P#*:O7**/K6)_Z"*_\ X.J?_)!9=E]R/(_^&?\
MX#_]$3^$?_AM_!O_ ,IJ/^&?_@/_ -$3^$?_ (;?P;_\IJ]<HH^M8G_H(K_^
M#JG_ ,D%EV7W(\C_ .&?_@/_ -$3^$?_ (;?P;_\IJ/^&?\ X#_]$3^$?_AM
M_!O_ ,IJ]<HH^M8G_H(K_P#@ZI_\D%EV7W(\C_X9_P#@/_T1/X1_^&W\&_\
MRFH_X9_^ _\ T1/X1_\ AM_!O_RFKURBCZUB?^@BO_X.J?\ R0679?<CR/\
MX9_^ _\ T1/X1_\ AM_!O_RFH_X9_P#@/_T1/X1_^&W\&_\ RFKURBCZUB?^
M@BO_ .#JG_R0679?<CR/_AG_ . __1$_A'_X;?P;_P#*:C_AG_X#_P#1$_A'
M_P"&W\&__*:O7**/K6)_Z"*__@ZI_P#)!9=E]R/(_P#AG_X#_P#1$_A'_P"&
MW\&__*:C_AG_ . __1$_A'_X;?P;_P#*:O7**/K6)_Z"*_\ X.J?_)!9=E]R
M/(_^&?\ X#_]$3^$?_AM_!O_ ,IJ/^&?_@/_ -$3^$?_ (;?P;_\IJ]<HH^M
M8G_H(K_^#JG_ ,D%EV7W(\C_ .&?_@/_ -$3^$?_ (;?P;_\IJ/^&?\ X#_]
M$3^$?_AM_!O_ ,IJ]<HH^M8G_H(K_P#@ZI_\D%EV7W(\C_X9_P#@/_T1/X1_
M^&W\&_\ RFH_X9_^ _\ T1/X1_\ AM_!O_RFKURBCZUB?^@BO_X.J?\ R067
M9?<CR/\ X9_^ _\ T1/X1_\ AM_!O_RFH_X9_P#@/_T1/X1_^&W\&_\ RFKU
MRBCZUB?^@BO_ .#JG_R0679?<CR/_AG_ . __1$_A'_X;?P;_P#*:C_AG_X#
M_P#1$_A'_P"&W\&__*:O7**/K6)_Z"*__@ZI_P#)!9=E]R/(_P#AG_X#_P#1
M$_A'_P"&W\&__*:C_AG_ . __1$_A'_X;?P;_P#*:O7**/K6)_Z"*_\ X.J?
M_)!9=E]R/(_^&?\ X#_]$3^$?_AM_!O_ ,IJ/^&?_@/_ -$3^$?_ (;?P;_\
MIJ]<HH^M8G_H(K_^#JG_ ,D%EV7W(\C_ .&?_@/_ -$3^$?_ (;?P;_\IJ/^
M&?\ X#_]$3^$?_AM_!O_ ,IJ]<HH^M8G_H(K_P#@ZI_\D%EV7W(\C_X9_P#@
M/_T1/X1_^&W\&_\ RFH_X9_^ _\ T1/X1_\ AM_!O_RFKURBCZUB?^@BO_X.
MJ?\ R0679?<C^6G_ (-C_A?\,O&7[$WQ]OO%_P ./ /BF^M/VV_CC8VM_P"(
MO!OAS6KZWL(=*\"F"PAO-2TVYN8[&W+.;:S646UL9)3!%&99"W]'7_#/_P !
M_P#HB?PC_P##;^#?_E-7\_W_  :U_P#)CG[0O_9\OQT_]-/@2OZ7:^MX[Q%>
M'%^?QC7K1BLPJ)1C4FDER0T24DE\C##)>PI:+X%T1Y'_ ,,__ ?_ *(G\(__
M  V_@W_Y34?\,_\ P'_Z(G\(_P#PV_@W_P"4U>N45\E]:Q/_ $$5_P#P=4_^
M2-[+LON1Y'_PS_\  ?\ Z(G\(_\ PV_@W_Y34?\ #/\ \!_^B)_"/_PV_@W_
M .4U>N44?6L3_P!!%?\ \'5/_D@LNR^Y'D?_  S_ / ?_HB?PC_\-OX-_P#E
M-1_PS_\  ?\ Z(G\(_\ PV_@W_Y35ZY11]:Q/_017_\ !U3_ .2"R[+[D>1_
M\,__  '_ .B)_"/_ ,-OX-_^4U'_  S_ / ?_HB?PC_\-OX-_P#E-7KE%'UK
M$_\ 017_ /!U3_Y(++LON1Y'_P ,_P#P'_Z(G\(__#;^#?\ Y34?\,__  '_
M .B)_"/_ ,-OX-_^4U>N44?6L3_T$5__  =4_P#D@LNR^Y'D?_#/_P !_P#H
MB?PC_P##;^#?_E-1_P ,_P#P'_Z(G\(__#;^#?\ Y35ZY11]:Q/_ $$5_P#P
M=4_^2"R[+[D>1_\ #/\ \!_^B)_"/_PV_@W_ .4U'_#/_P !_P#HB?PC_P##
M;^#?_E-7KE%'UK$_]!%?_P '5/\ Y(++LON1Y'_PS_\  ?\ Z(G\(_\ PV_@
MW_Y34?\ #/\ \!_^B)_"/_PV_@W_ .4U>N44?6L3_P!!%?\ \'5/_D@LNR^Y
M'D?_  S_ / ?_HB?PC_\-OX-_P#E-1_PS_\  ?\ Z(G\(_\ PV_@W_Y35ZY1
M1]:Q/_017_\ !U3_ .2"R[+[D>1_\,__  '_ .B)_"/_ ,-OX-_^4U'_  S_
M / ?_HB?PC_\-OX-_P#E-7KE%'UK$_\ 017_ /!U3_Y(++LON1Y'_P ,_P#P
M'_Z(G\(__#;^#?\ Y34?\,__  '_ .B)_"/_ ,-OX-_^4U>N44?6L3_T$5__
M  =4_P#D@LNR^Y'D?_#/_P !_P#HB?PC_P##;^#?_E-1_P ,_P#P'_Z(G\(_
M_#;^#?\ Y35ZY11]:Q/_ $$5_P#P=4_^2"R[+[D>1_\ #/\ \!_^B)_"/_PV
M_@W_ .4U'_#/_P !_P#HB?PC_P##;^#?_E-7KE%'UK$_]!%?_P '5/\ Y(++
MLON1Y'_PS_\  ?\ Z(G\(_\ PV_@W_Y34?\ #/\ \!_^B)_"/_PV_@W_ .4U
M>N44?6L3_P!!%?\ \'5/_D@LNR^Y'D?_  S_ / ?_HB?PC_\-OX-_P#E-1_P
MS_\  ?\ Z(G\(_\ PV_@W_Y35ZY11]:Q/_017_\ !U3_ .2"R[+[D>1_\,__
M  '_ .B)_"/_ ,-OX-_^4U'_  S_ / ?_HB?PC_\-OX-_P#E-7KE%'UK$_\
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M?6L3_P!!%?\ \'5/_D@LNR^Y'D?_  S_ / ?_HB?PC_\-OX-_P#E-1_PS_\
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MKE%'UK$_]!%?_P '5/\ Y(++LON1Y'_PS_\  ?\ Z(G\(_\ PV_@W_Y34?\
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M_P#@ZI_\D%EV7W(\C_X9_P#@/_T1/X1_^&W\&_\ RFH_X9_^ _\ T1/X1_\
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M^M8G_H(K_P#@ZI_\D%EV7W(\C_X9_P#@/_T1/X1_^&W\&_\ RFH_X9_^ _\
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MHH^M8G_H(K_^#JG_ ,D%EV7W(\C_ .&?_@/_ -$3^$?_ (;?P;_\IJ/^&?\
MX#_]$3^$?_AM_!O_ ,IJ]<HH^M8G_H(K_P#@ZI_\D%EV7W(\C_X9_P#@/_T1
M/X1_^&W\&_\ RFH_X9_^ _\ T1/X1_\ AM_!O_RFKURBCZUB?^@BO_X.J?\
MR0679?<CR/\ X9_^ _\ T1/X1_\ AM_!O_RFH_X9_P#@/_T1/X1_^&W\&_\
MRFKURBCZUB?^@BO_ .#JG_R0679?<CR/_AG_ . __1$_A'_X;?P;_P#*:C_A
MG_X#_P#1$_A'_P"&W\&__*:O7**/K6)_Z"*__@ZI_P#)!9=E]R/(_P#AG_X#
M_P#1$_A'_P"&W\&__*:C_AG_ . __1$_A'_X;?P;_P#*:O7**/K6)_Z"*_\
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M"BBB@ HHHH **** "BBB@ HHHH **** /S/_ ."OO[=?BW_@FS^P#\9_VQ?
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M!AAO]WI?X$%%%%?(FX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS0SC^CVOQ%_X-_\ _@G;_P .[O\ @GK\._#'C#3/(^/WQQ:+XX?M :G=Q?\
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MM[FUMO+@ME@B_J]H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#\X?^"OW_ "B]_;N_[-I^)O\ Z8IZP_\ @C#_ ,HL_P!B
M+_LB.C?^G/5JW/\ @K]_RB]_;N_[-I^)O_IBGK#_ .",/_*+/]B+_LB.C?\
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MD5O%JNEWEE>VVHZ%KUK!%;:E9RO#+#::I8ZGIUE^DM?Q5?\ !,_P[9_L+?\
M!T3_ ,%'?V-?A]=_V?\ !K]HCX3/\<;3PA9Q/9Z/I'BS4;?P3\8_#]IIUC;6
MR6:6GA;3?B3\0_#]D[HC+:74<;7LTT92X /[5:\Y^+WQ;^'7P%^%WC_XT?%S
MQ7I7@?X9?"_PIK7C;QQXLUJ<0:=HGAW0+*6_U"[E/,D\QBB,-E8VR37VHWTM
MMI]A;W%[<P02>C5_*7_P=_?&KQ=X%_X)E>$?@MX-.II=?M-_M$> /A_X@&G9
M<ZGX7\-0ZCXV?P\]O'^^N9=5\6:1X0GMXD5U<Z;)&5\R2(@ \7\(_P#!=#_@
ML%_P4&\0>,?&O_!*;_@FAH7B#]E?POK^M:7X:^,WQ\UN?0[OXB#P[;*+NVLH
M[CQ!X:T6'4-3NXYA::=X?D\1)I$\D6CZWK4&I6]TH_17_@E5_P %P;W]M'XX
M_$/]B']K_P#9VUW]B_\ ;R^&&G7>M:C\(M?GU&?P_P".-%TR5$UB^\&7NK6T
M-[%=:7#<66H'3;BYU.WU?1[E]9T#6-4L+2ZDB_77]CO]GOP=^RA^RO\ L_\
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MU\8?@;I7Q*M9+WPWK/C30]3-[;"9[">WU.[T?4!'?/!:W.FJ]AK;"P'ZD?\
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MKZ9Y!=I(X!_0#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %?SA?\'.W_)BWP?\ ^SQ?V??_ %)9*_H]K^<+_@YV_P"3%O@_
M_P!GB_L^_P#J2R5]9P+_ ,EAP]_V,J/_ +<<^+_W>K_A_5']#?A#_D4O"_\
MV+NB?^FRUKHJYWPA_P BEX7_ .Q=T3_TV6M=%7RL_CE_BE^;-X[+T7Y!7\R_
M_!,__E/5_P %KO\ L!_ S_T?JE?TT5_,O_P3/_Y3U?\ !:[_ + ?P,_]'ZI7
MUO#7_(HXV_[)RA_ZT&2F-;^)A_\ KZ__ $U4/Z:****^0-PHHHH **** "BB
MB@ HHHH **** "BBB@#^>3_@ZC_Y0>?M<_\ 8=_9T_\ 6D_A/7W1_P $9O\
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M/^SY\6['QA^U[XIE^-WBSX_^)([+QU:?$*&&ZNX_#MO<ZCXO\.WE]I6G:?J
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M[X'\7:=;:AX_UB[T^XOO#OB2QTW5[2"_M)([JSDN+2-;BWD2:+<C D _)O\
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MVYO+/0]'N-7\.^(?#VJ:@HM;CQ';:?>^*O#LVK*\^C0VQN)'N/UB_P""7_\
MP7NTO]LW]HWQ-^PG^U;^S9XV_8H_;D\,66LZFGPG\737=_X?\4V>@V%MJFJV
M>AZMJMAHVK6GB"#2I9M<MM)O],DM]6T&VN=3T?5;Z.VE4?FE^S/_ ,%S/^"C
M_P#P3^\'VW[*?_!4;_@F[^V;\<OC9X"\0:]H6E?M#_"CPO?^,]-^+FE37JZA
MH]VNL6>B7'A?Q??*=3^Q6VL^%->:W.DQZ5:7ND6.KV][;+J?L2? #]M__@J[
M_P %EOAS_P %A/VE?V4?$_[#/[.7[.?PTA\$_!/X?^/R=(^+?Q'U73;/Q=::
M6==TZ]T7P[XGU.QAUKQQXEUW5?%.N>&M TRY\/P^%_"?AM]=LH;R_M0"M_P4
M[_Y6I/\ @CW_ -BC'_Z!\4:_6?\ X+I?\$B?%W_!4/X7_!/Q3\"_BK:?!?\
M:K_91\;:G\1/@;XSU*.ZBT:_N]4;0+O4O#VJZIID<NIZ)=#5/"?AW6?#.O06
M]]'I&L:<R7%G]BU.^N(?SZ_X*+?L[_'_ ,9_\'*O_!*GXW>#_@A\6_%7P9^'
M_A:*W\=?%KP[\._%FM?#7P;/M^(X,/BGQOIVDW/AOP_*OVVSS'JVI6C?Z7;
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MW.OKI%S>Z5!JMU-8Z?>7-K9QS. ?OI1110!_-%_P:U_\F.?M"_\ 9\OQT_\
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M7PU^"?C[6;+4/LYO&C\0W&A7>E>%8H[01S?:9+GQ-J&DVR0F*17,N)%\L.0
M?S ?\&AUO/<WW_!5W78(FET>^_:]-O::DN#;W$ZS>+[PQ1DD.6%K=VTYW(!Y
M<Z$')8#^S^OYE?\ @U _9M\0?!3_ ();:;\5O&N@WVA^-OVM?BQXT^/FH27U
M]:W/]M^&M0^Q>&_!&O6MI:O(FDVFL:%HBZG!82.)S'=K>30V\ETT2_TU4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^</
M_!7[_E%[^W=_V;3\3?\ TQ3UA_\ !&'_ )19_L1?]D1T;_TYZM6Y_P %?O\
ME%[^W=_V;3\3?_3%/6'_ ,$8?^46?[$7_9$=&_\ 3GJU?7+_ )(.7_971_\
M5-,P_P"8E?\ 7A_^G(GZ=4445\B;A1110 4444 %%%% !1110 4444 %%%%
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M&CQI<?Q8\-&\-QM=/,M=I7SHVWJ^5RC8X_H]K\[O^"LW[--]^UY_P3B_:_\
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M+BV:Z_X0?XF>'YH];\ >+A%%BYDM-+\1V=FFN6MI)!<ZIX;NM:T>.XA&H-(
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M 2"0"1T) R,]<'MGVI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
M HP  /0  <G)X'J>?K2T44 %%%% !1110 4@ &< #)R< #)]3ZGWI:* "BBB
M@!  HP  /0  <G)X'J>?K2T44 (0#C(!P<C(!P?4>A]Z6BB@ HHHH 3 !)
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MX8T/P=X4T6V+&#2_#_AW3;;2=)LD=RTDGV>RM88VFE9I9G#2RN\CLQ["BB@
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M67_S)TH_X)X?\%\@0?\ A\3X/X.>?A#9,/Q!\)X(]C7]*E%'^NF:?] /#?\
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M5:*/]=,T_P"@'AO_ ,1C(O\ Y@\OS[L/JT/YJW_@ZI_\E_5WY6_FJ_X=W_\
M!?+_ *3$^$/_  T5E_\ ,G1_P[O_ ."^7_28GPA_X:*R_P#F3K^E6BC_ %TS
M3_H!X;_\1C(O_F#R_/NP^K0_FK?^#JG_ ,E_5WY6_FJ_X=W_ /!?+_I,3X0_
M\-%9?_,G1_P[O_X+Y?\ 28GPA_X:*R_^9.OZ5:*/]=,T_P"@'AO_ ,1C(O\
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M5:*/]=,T_P"@'AO_ ,1C(O\ Y@\OS[L/JT/YJW_@ZI_\E_5WY6_FJ_X=W_\
M!?+_ *3$^$/_  T5E_\ ,G1_P[O_ ."^7_28GPA_X:*R_P#F3K^E6BC_ %TS
M3_H!X;_\1C(O_F#R_/NP^K0_FK?^#JG_ ,E_5WY6_FJ_X=W_ /!?+_I,3X0_
M\-%9?_,G1_P[O_X+Y?\ 28GPA_X:*R_^9.OZ5:*/]=,T_P"@'AO_ ,1C(O\
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M5:*/]=,T_P"@'AO_ ,1C(O\ Y@\OS[L/JT/YJW_@ZI_\E_5WY6_FJ_X=W_\
M!?+_ *3$^$/_  T5E_\ ,G1_P[O_ ."^7_28GPA_X:*R_P#F3K^E6BC_ %TS
M3_H!X;_\1C(O_F#R_/NP^K0_FK?^#JG_ ,E_5WY6_FJ_X=W_ /!?+_I,3X0_
M\-%9?_,G1_P[O_X+Y?\ 28GPA_X:*R_^9.OZ5:*/]=,T_P"@'AO_ ,1C(O\
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M$^$/_#167_S)U_2K17S/^NF:?] /#?\ XC&1?_,'E^?=FOU:'\U;_P '5/\
MY+^KORM_-5_P[O\ ^"^7_28GPA_X:*R_^9.C_AW?_P %\O\ I,3X0_\ #167
M_P R=?TJT4?ZZ9I_T \-_P#B,9%_\P>7Y]V'U:'\U;_P=4_^2_J[\K?S5?\
M#N__ (+Y?])B?"'_ (:*R_\ F3H_X=W_ /!?+_I,3X0_\-%9?_,G7]*M%'^N
MF:?] /#?_B,9%_\ ,'E^?=A]6A_-6_\ !U3_ .2_J[\K?S5?\.[_ /@OE_TF
M)\(?^&BLO_F3H_X=W_\ !?+_ *3$^$/_  T5E_\ ,G7]*M%'^NF:?] /#?\
MXC&1?_,'E^?=A]6A_-6_\'5/_DOZN_*W\U7_  [O_P""^7_28GPA_P"&BLO_
M )DZ/^'=_P#P7R_Z3$^$/_#167_S)U_2K11_KIFG_0#PW_XC&1?_ #!Y?GW8
M?5H?S5O_  =4_P#DOZN_*W\U7_#N_P#X+Y?])B?"'_AHK+_YDZ/^'=__  7R
M_P"DQ/A#_P -%9?_ #)U_2K11_KIFG_0#PW_ .(QD7_S!Y?GW8?5H?S5O_!U
M3_Y+^KORM_-5_P .[_\ @OE_TF)\(?\ AHK+_P"9.C_AW?\ \%\O^DQ/A#_P
MT5E_\R=?TJT4?ZZ9I_T \-_^(QD7_P P>7Y]V'U:'\U;_P '5/\ Y+^KORM_
M-5_P[O\ ^"^7_28GPA_X:*R_^9.C_AW?_P %\O\ I,3X0_\ #167_P R=?TJ
MT4?ZZ9I_T \-_P#B,9%_\P>7Y]V'U:'\U;_P=4_^2_J[\K?S5?\ #N__ (+Y
M?])B?"'_ (:*R_\ F3H_X=W_ /!?+_I,3X0_\-%9?_,G7]*M%'^NF:?] /#?
M_B,9%_\ ,'E^?=A]6A_-6_\ !U3_ .2_J[\K?S5?\.[_ /@OE_TF)\(?^&BL
MO_F3H_X=W_\ !?+_ *3$^$/_  T5E_\ ,G7]*M%'^NF:?] /#?\ XC&1?_,'
ME^?=A]6A_-6_\'5/_DOZN_*W\U7_  [O_P""^7_28GPA_P"&BLO_ )DZ/^'=
M_P#P7R_Z3$^$/_#167_S)U_2K11_KIFG_0#PW_XC&1?_ #!Y?GW8?5H?S5O_
M  =4_P#DOZN_*W\U7_#N_P#X+Y?])B?"'_AHK+_YDZ/^'=__  7R_P"DQ/A#
M_P -%9?_ #)U_2K11_KIFG_0#PW_ .(QD7_S!Y?GW8?5H?S5O_!U3_Y+^KOR
MM_-5_P .[_\ @OE_TF)\(?\ AHK+_P"9.C_AW?\ \%\O^DQ/A#_PT5E_\R=?
MTJT4?ZZ9I_T \-_^(QD7_P P>7Y]V'U:'\U;_P '5/\ Y+^KORM_-5_P[O\
M^"^7_28GPA_X:*R_^9.C_AW?_P %\O\ I,3X0_\ #167_P R=?TJT4?ZZ9I_
MT \-_P#B,9%_\P>7Y]V'U:'\U;_P=4_^2_J[\K?S5?\ #N__ (+Y?])B?"'_
M (:*R_\ F3H_X=W_ /!?+_I,3X0_\-%9?_,G7]*M%'^NF:?] /#?_B,9%_\
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M,9%_\P>7Y]V'U:'\U;_P=4_^2_J[\K?S5?\ #N__ (+Y?])B?"'_ (:*R_\
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M /!?+_I,3X0_\-%9?_,G7]*M%'^NF:?] /#?_B,9%_\ ,'E^?=A]6A_-6_\
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M#PW_ .(QD7_S!Y?GW8?5H?S5O_!U3_Y+^KORM_-5_P .[_\ @OE_TF)\(?\
MAHK+_P"9.C_AW?\ \%\O^DQ/A#_PT5E_\R=?TJT4?ZZ9I_T \-_^(QD7_P P
M>7Y]V'U:'\U;_P '5/\ Y+^KORM_-5_P[O\ ^"^7_28GPA_X:*R_^9.C_AW?
M_P %\O\ I,3X0_\ #167_P R=?TJT4?ZZ9I_T \-_P#B,9%_\P>7Y]V'U:'\
MU;_P=4_^2_J[\K?S5?\ #N__ (+Y?])B?"'_ (:*R_\ F3K\DO\ @LA^R;_P
M5'^"_P"SC\,_%/[7W_!070/VD_AE<_M'_![1M.\"Z9\/[3P_<Z?XOU#Q#&NA
M>*#=KH>F_:8]%DCEE:R>X,<_F;&0AF(_O"K^<+_@YV_Y,6^#_P#V>+^S[_ZD
MLE?2<'\5YAC.)\DPM3!Y#"G7Q]*G.>'X?R?#5XQ:=W2KT,'"K2FK:3ISC):V
M>K,<10A"A4DI56U'9U9M;I:IR:?HU^EOZ%/ T<\7@KP?%<W'VJYC\+>'X[BZ
M\M8?M,Z:3:++<>2F4B\Z0-)Y:G;'NVKP!74USOA#_D4O"_\ V+NB?^FRUKHJ
M_+Y_'/\ Q2\NKZ+0[8[+T7Y!7\R__!,__E/5_P %KO\ L!_ S_T?JE?TT5_,
MO_P3/_Y3U?\ !:[_ + ?P,_]'ZI7UO#7_(HXV_[)RA_ZT&2F-;^)A_\ KZ__
M $U4/Z:****^0-SG)?&/A&"62"?Q3X<AFB=HY89=<TR.6*1"5=)(WNE='5@0
MRL RD$$ U'_PFW@S_H;O#'_@_P!*_P#DNOYLOBW_ ,&EO_!*_P"-'Q2^(OQ>
M\8ZQ^U2OBSXG^-?$WCWQ*NE?&#PU;:6NN^+-8N];U1=-MKOX9WUQ:V"WM[,M
MG:RWERUM;B. 2NL8-?S,?\$Z_P#@A3^Q!^U-_P %@O\ @I;^PW\2;WXX6_P2
M_9/L+RZ^%4WASX@:'IOC>1K?QMX;\/H/%>OW'@B^L=9!L-6N6/V31-)_?B.3
M&U2A /\ 3!L/$GAW59_LNF:_HNI76QI/LUAJMC>3^6F-\GDV\\DFQ,C<VW:N
M1DC(JTFK:5+?RZ5'J>GR:I @DGTU+VV>_A0HD@>6S60W$:%)(W#/& 4=&SAE
M)_#K_@GQ_P &\G[ G_!-']H2']IC]G+4OC[=?$>#P7XF\!I%\1?B/H7B;PX=
M#\6'3CJC/I>F^!O#MP]ZITRV^RS-J!BA/F,T$K%"GX[_ +-6KZ1X=_X/!O\
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M?$3P/\0=/M9GM[F]\%>*M#\46MM/&0'AN)]$OKV.&52R[DD96&Y>.1G^%_\
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M[*'PQU+XS?M"^/\ 2OA?\+-$U'2=+USQSKT&HOH.B76N7:Z?I3:S=Z=97O\
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MBBBOD3<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)@#_ $VZH:AJNEZ3$L^JZE8:9 [B-)M0O+>RB>0@L(UDN9(T9R 2%#%L G&
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MN.?%_P"[U?\ #^J/Z&_"'_(I>%_^Q=T3_P!-EK715SOA#_D4O"__ &+NB?\
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MJ$,B07<,.NZ3;6&OZ=-+;1P3P7\D-K+<+9RR5^5?_!W-^T'X9\2_LU_L_?\
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MIN@:%I=J&%MINCZ/90:=IFGVX=G<06=E;06\(=V81QKN9CDD _@!_P""9_\
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MKNKZ?!96\<L]QC1!J-ZZ0H9 EF70$KM(!^=/_!%3_@@U^R5\2?V1? /[9/\
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M=IEPNJ:_X.\&V<E[H^@ZWK&D6,DE[8#Q#XDUFV.EB[@"7>D:+X@O%V);0RR
M'KG_  =Z:UI_B;_@C-X;\2:5/%=Z7K_[2GP#US3+J%_-AN+#5O"WQ!OK.XAE
MVKOCFMKB-XY J[T<' SBO3O^":/_  0G_9+\=_LU^ _VE_\ @H3\.?#?[:?[
M6W[3?@;P'\4_B1XV^,=F=>TGP'9:WX/T63PQ\*_AUHD%U'H^C^'/ 7AX:=X>
MAO[6 7.H/8LULUEI*6&FVOB7_!V/X3F\!?\ !#SX;>!;B[BU"X\%_'3]FGPG
M/?P1M%#>S>'/ OCC1Y;N&)_GBBN7LVFCC?YD1PK<@U^W/_!(3]J7P)^V#_P3
MC_9,^,7@?4= GDD^#?@?P?XWT'0=1LK]/!/Q$\%>'M.\.>,?!^H)9P6GV&\T
MG5;"5HK:>PL99--N;"]2U2WNX&8 _F&_:X_9\\*_\&\?_!67]B/]IK]CO_A)
M_AU^QC^VWXZ3X&?M%_ K3=8O-9\&P:S<7^GZ? N@:)?RO.EG90>(+7QCH9O+
M^\NM"U72=3MM&*Z??SV!_0C_ (.?_P!KKX@^ OA'^R;^P7\'_BF/@IXR_P""
MAWQOL?A=XV^+<^ICP[I?@7X*6FI>&] \82ZQXFFU#2H=%TO7-3\<:&FM3_;K
M99?"NC^)[6[OM.MKGS)OE+_@Y#^(^A_M1?\ !03_ ()&_P#!.;X3W%GXR^+^
MD_M,>'?C3\0]&T*[6[U+P9X;FU?0K>VCUO[.MPFDW$WAC1?%?B4Q749F@TW3
M8+Z>..VG@:?)_P"#MOX#?#Q_B3_P2R_:K^/.@^)O$_[*/@7X_#X.?M1:?X?-
M]%<VOPW\4>(/"7C&:&QO=+EM=0LM4\1^%?#?Q'T^WN8+NTG6[T_38[*=+N9#
M0!]F_!;_ (),_P#!M;\*?@9HWP<\2ZQ^Q7\8]=A\-C2/%/QE^)'Q_P#AW??%
M3Q3KES;,NK>*$U^R\>6K>&+RYOY;B]TZQ\.+8V>BQFWLK99(+5"WP1_P1U\>
M>#/^";/_  6O^-'_  2G^!?[34/[0G[#WQ]^'E_\9OV?[+1O%>C?$/2?AI\2
M6T^+Q==>%/[=T"_U'3;*[C\,6?B;3==O[*YA&NC2/"FHZKIT>L7EU<']/?!O
M_!L?_P $(OB-X3\.^// 7P$N_%_@OQ?H]AXA\+^*/#G[07Q;U;0M>T35+=+O
M3]3TK4K/QQ-;7EE=V\B2PS0RNK*<$A@0.-_80_8L_P"#?#]GO_@I==_"/]C%
M(8/V\_V?/#/B+Q'>:%IWQ)^+/C6PT'2]1T5=!\5V4FHZUJVK^!M1U?2M+\30
M0:UI*WDNIZ)->PI/';W:-$@!^2'[?/[.-U^UY_P==^'OV9KCQ_XG^'G@'XN_
MLR>$]+^,]WX*U>_\-^*/&'P;\/\ PV\3>,?'WPRL/$FDO#JNB6WQ%TKPXGA;
M5[VQFBE.DWUU"7V.17[=?ML?\&Y?_!*OQU^QQ\7O!7PP_99^'WP4^(?ACX6^
M)-9^'7Q<\"0WVF>-]'\7>$?#5]J/A^\U_6Y[J]F\2Z9J&H65O%XHM-9CO3JE
MG/=NC07I@N8OSJ\5?\KHOPL_[-'UC_UG;XF5_7E\<O\ DBGQA_[);\0?_43U
M>@#\!/\ @U1_:!^*/QV_X)0>$]-^*WB._P#%>K? OXL_$'X'>'=:U2=+N^;P
M5X430]5\-Z9->F-;N\BT*U\0/HUC/?R3W2Z=8V=MYH@MX(T^!O\ @ARJC_@X
M=_X+GX '-ST 'WOBMI9;IZGD^IY/-?2/_!GO_P HP/B/_P!G@_&/_P!,7@&O
MF_\ X(<_\K#O_!<_ZW'_ *M72Z /U _X*"?\$+/AQ_P4-_;I^%O[5W[6?[2?
MCCQ+^S!\(O"GV;_AD.]@M/#_ ( 34](M;>:"^3QE9:K87%EHFM:FVL:_X^>]
MT^?7=8@.GZ!::_I7A^SDMW_)O_@N9^PU_P $"O!_[!OQGUWX*:U^QC^SU^U+
M\*O# \7? Z/X*_$WP3H_Q%\2^+M,U.RN[7P?/X,\*Z]J.N^*[/7UOY;3S'T6
MYFT2YO;/61?6$-F9E\;\8_"7Q;_P7._X+U?MI_L7_MD_M(_%;X<_LJ_L9_VR
MOPQ_9L^'GB2#P'+\0[31+S0?#PU&QBO7U:UOGU.:1/''B7Q*VDZSK=QI-S86
M>C1^&]/D:XTSZV_X*J_\$?O^"(G_  31_P"":W[27Q9TS]G7P1X9^+!^%VN^
M#O@SXO\ B!X\\>^._''B#XN:]9RZ7X5_X1G2?&'B_4=#E\017=[_ &A<S:1X
M?M+;3[.TDU.>*$6J2  _:K_@A3^T#X]_::_X)1_L;_%;XGZC<:UX[NOAE'X6
M\0:_=RK->:_-X'U;4?"5GK-ZZHFZ]OM-TBR>]=]TDUT)IY'=Y6)_6VOP?_X-
MH_\ E"_^QS_V ?&G_J?>)*_>"@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _FB_X-:_^3'/VA?^SY?CI_Z:? E?TNU_-%_P:U_\
MF.?M"_\ 9\OQT_\ 33X$K^EVOKN/?^2QX@_[&%3_ -(@88;_ '>E_@04445\
MB;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_%K_
M ,$-O^5B+_@N[_V&O$__ *NZWKGO^#O7]H&U^#/Q&_X)-ZCXCT"Z\4^ _AQ^
MT=?_ !]\6^%+:XLX3XNLOAUK_P /+JX\/(UW;S1PW-_I$.KZ?;W%QYEFAU1S
M/;R*IST/_!#;_E8B_P""[O\ V&O$_P#ZNZWKM_\ @[_^ ^OZS\!OV-/VNK#P
M?/XM\$_LK?M!0W/QDM]/L8[[4+?P'XTN_"[64TR36YM%TB;6O#G]B7,NIW<&
MGKJ7B#2;>16^V.Z #]!_9?\ ^#CO_@I;X9C_ &I=8_;_ -"_X)K>"OB!;)XI
M^!?[,7P^\.ZE?:WHGPXU>YNM6\'1_$_6= _L>[MO$D^B:G$]W)J-_P")]0N;
M=-+_ +2L-'G0Z3I'J/\ P3 _X*D?MP? ;]N>[_X(\_\ !8.+1?$'[0FM:>GB
M#]FS]I7PM)I$?A_XLZ =)N;ZTT76IH+;0EUJ;6H-(U6;PYKZ:-8^)/[:L]3\
M->)M&\Y;'44_I4_9S^-OPJ_:+^"'PQ^,_P %/%NB^-?AIX^\&Z!K_A?7-"NK
M:XM7T^^TVVE2SN([=V_L_4M/+&RU+2YUBNM-O8)[.XABEA9!_'9_P42^+WA#
M]M[_ (.:/^"7WP6_9>UBS\9>*OV/I;_5_CGX[\)#3/$>C>&4LM8N?&WB+0[V
M]M))H9)O!^C:8FGZR)I6CTS6/%D5@HCOH[F, ']OU%%% '\7'_!L2UQ\6/V_
M_P#@MM^TMX@<:OXC\3?M!IX.AU[4,1ZTEA#\0/B7J<UHUG&KV]M!/!;Z,LLD
M5PS2OI\,;H%@5F_2G_@YM_8B^*?[:?\ P36U<_!#0)_%_P 5OV;_ (E>&/VB
M/#'@VPT]M2UGQ38^$]/UK1/%FFZ#;1;KBXUJV\*^(M6U>QTZVAGN-9?3#H]O
M']HOHF7\VO\ @V=AN/@M_P %&_\ @MW^RAK'EMJWA7X\KXYM[B,_:/M%M)\0
MOB'I5Q&U]F#S&@AU#1V,8L8]SW$SK*RJ57^C_P#X*8_M\:;_ ,$UOV7M<_:J
M\1_!?XC?&WP7X1\2>'=)\::)\,CIB:WX:T+Q!=MIW_"77\NKRP:?!HFG:C)8
M6E[-<3PHDFH6^Z5%+,H!^:G_  3D_P"#BG_@FQ\?/V8_A>?C%^T?\._V</CK
MX-^'NBZ'\6_A;\7;VY\#2Z/XF\)Z7;Z/K=WX<UC6;6#P_P"(=&U6ZL9=0T>U
MTK5;K6X+:>.RU#2[6]B:)OY./^"^?_!46T_X*:?M=?LD>+/V2O VL^*/V4_V
M1_CGI7PU^'WQZU/2M7\-:;\9?C_\2M?\'^)=?TKP^=6_LB_A\-6>B?#SPO'I
M-O):VFNVT4M[K^NKI-GXD\-VQ_L9^''_  3E_P""('_!53P!\-_VZ=$_8\^!
M'CZ'XMZ;IWCB;7="M+OP;?-XENFEU/7]#^)F@_#7Q#HGA[5_&>E:UJ%]8^,[
M;Q#::M+J.HQ&2^GU*T^Q7#?CQ_P4)\-_!']JC_@KQ_P2B_X))_L-^ / ^C?"
M']B3XIO^U%^U)H?PFTCP[H/PN\":?IEWX3U^30KV]\+:>TFE^.='\&>$]3LI
MWN)5M]4\3_%;PEHFI33:[!=)IP!_;)17GGQ6^+7PQ^!?P^\3_%;XQ^//"OPR
M^&W@O39=7\5>-_&FLV6@>'-"TZ' >YU#4[^6&WA4L5CBCW&6>5DA@CDE=4/$
M>)?B+9_%3]FWQE\2/V<?&.A>/3XK^$?BW7OA#XP\$ZII/B/1M<UB\\*:C<>$
MK_1=0A>]TJ^\S5&L3$DOFP^=^YNHN)(P ?P;?%G]ISQE_P $Q_\ @M#^U%IO
M_!$:?Q#^W/K7[07B+4M:_:V_8NT7X5>.?&'P\^&_Q3A\3:M/XJGM/B/X/U&U
MEBUCPOXHU'4?^)E!8SZ+X'D\6:_X:\0^(+Y[>?1[+CO^"F__  41_;#_ &Z_
MB?\  O\ 8V_X*U?!KQ]_P2-_82\3_$[P_P")/B!XQA^%?C#XB/X\ETA9]2T3
M3]1^)<B)I-E'I]G--!)'X5T_7H-)UB_M=<\3^'Y[?14BM_U _P"#,[Q#\#Y/
MV1OVG-!:\\.1_M>/^TIXAU3XQ6NJEH/BM?\ @";PUX;7P)<:VNIE-7O=(M?%
M$/Q'$@B5_L.MSZC_ &L(KNZMC)^O_P#P<-ZU^S!I_P#P29_:UTS]IV[\(C3]
M7^'EZGPHTS7[K3H?$%]\;+5TN_AE)X%BN6&HOXBM/$L-I-,VC@7+:$NLVUT_
M]F7-]'( ?JM\%O!_PE\/_ CX7^ OA =#U7X'Z/\ "[PEX4^'!T;4+?7/#VI_
M#2R\,6.E>&3I^J6TDUKJVEWOAR.T,-]#+)#?6\HF1F60&OYTO$__  ;=^)=,
MC^)?P)_9X_X*5?M-_LZ_\$^OC-X@\3>*/'_['WA&PT+4[&SN?&-P7\3>&O!O
MC749Q<Z3X+UBV6*UN](U#2=4EGBCBCOI[](1YGV+_P &WC?%UO\ @C%^Q2/C
M+)</KD?@[Q7!X0COK9K74;?X4VWQ!\56_P ++>]0Q0K(D?@F+1SI,R)F3P^V
MD&>2:Z\^:3SK_@NA^WQ\4OAEX:^&?_!.O]B2\DUC_@H!^W7J2_#WP/%H%W>+
MK/P5^%>K?:+'QG\:]6GTI9KWP]'IFGQ7\>CZLR++I]O::YXBM$DET&)9 #\J
M-7^$'@+_ (*S?MB?"G_@E!^S7;WGA[_@B[_P2(/A2\^/WC/1=4O+_2/C[\;_
M  "L^DZ3\&U\9R3VR:O86:W6NV>KZM92WXF2W^('C/\ M"*YO_A]<)_7?\+/
MCQ^S1XZOO^%;_!3XR_ [QCJ7@_2H;3_A!/AA\0_ ?B&^\,Z'HXCTJ"W_ .$9
M\*ZO>7&CZ5I8ABTZ*+[%;VEGY<=H@CV+&/Y$_P#@M%^S2/\ @DG_ ,&_WPG_
M &._V=M5U'2D^,G[0WPA^%_[4GQ5T*^U&R\1_$:_\;Z+XG\7_%3QGJVK74\N
MHK:^.?%?@?0O#L^G27%O9_\ ")7<?AJ6W&ERW5E/P'_!9G_@F=^R3_P25^$_
M_!/3]J[_ ()_>#+CX)?M!?"?]J7X._#F'QOX:\6^(KK7/C)H7B$74NM)XS76
M=?U.TUK4-;N;:XN+R]LK+)TW5;W1]J:$EC9V8!_<_7\6W_!-<K\#?^#K;_@K
M-\&?#X\WPQ\5/AL/'.HV]MC3;"TU_P 0:3\%_C%-J#Z; #;WE_%J'B_7]--Z
M^R:4ZG?WK'S+N53_ &<Z3=7%]I6F7MW;&SN[S3[*ZNK,DDVMQ<6T<TUL2P#$
MP2.T1+ $E>0#7\9?_!,.$_'O_@Z=_P""NOQ[T".6_P#!OPH\%3?#"Z\0Z8C/
MH47B_P -P?"3X/2^'+V[1;B :UYO@'Q8[V;3P2FX\/ZM)L4VDEN #^T2BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _.'_@K
M]_RB]_;N_P"S:?B;_P"F*>L/_@C#_P HL_V(O^R(Z-_Z<]6K<_X*_?\ *+W]
MN[_LVGXF_P#IBGK#_P"",/\ RBS_ &(O^R(Z-_Z<]6KZY?\ )!R_[*Z/_JFF
M8?\ ,2O^O#_].1/TZHHHKY$W"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K^*W_@X]_Y2[?\$)/^RS:?_P"KG^&]?VI5_%;_ ,''
MO_*7;_@A)_V6;3__ %<_PWH _M2K^6'_ (/!_P#E$)>_]G(?!G^?B:OZGJ_E
MA_X/!_\ E$)>_P#9R'P9_GXFH _H+_8T_P"30_V6_P#LWCX,?^JZ\.U])U\V
M?L:?\FA_LM_]F\?!C_U77AVOI.@#^2#_ (/+/'E_X<_X)?> /!EC?7UG%\0O
MVF_ UOJD-JJBWU'3?#7ACQCK!LK^;S%D6 :B=.O(X%1TGN+2)I"OD+N_IV_9
MN\":5\+OV>?@5\-M#TZSTG1_ 7P?^&_A#3=+TYF;3]/L_#O@_1]*@L[)F2-F
MM+=+41V[-&A,2H2B9VC^93_@\E^'-WXJ_P""6W@WQU:;F'PQ_:6\ 7NH1"4(
MHTWQ3H/BSP^]P8O*<SM#J$FF1@"6(QK</)B0*0O]+_[+WQ&T_P",'[-?[/WQ
M6TG/]F?$CX+?#'QQ8$Q>1FU\3^"]%UF$K")9Q&A2\!1!-*%0J/,?[Q /=:_B
M<N5/_!=O_@X5CMRO_"3_ + O_!) .&)4WW@[XA_&ZTUE&GPS6UYHVJ-XA^(.
MCPPE!<6]Q/X(^&4=U <7SB3]M_\ @OG_ ,%#_P#AW9_P3U^)/C+PEJ(A^//Q
MG\SX(?L_Z;;/G5G\<^,[.>TO_$VGVR21W$I\%>'WO]<CEM]SQ:NNBQ;2;I%:
MK_P0%_X)W#_@G?\ \$^/AWX6\7Z9Y/Q]^-AC^-OQ_P!4O(E.M/XT\7VD-UIW
MA?4;R6TMK^4>"]">RT62WNY;I8]:_MR\MYBNH.2 ?MM14<LL5O%+//+'#!#&
M\LTTKK'%%%&I>2661RJ1QQHI=W<A54%F( )KQ/X(_M+_ +/G[2FG>*-6_9_^
M,_PV^,>G>"?%&J>"O%UW\._%NC^*8O#OBK1IC;ZEHFKG2KJX:RO+>564"95C
MG"L]M),BE@ ?RB_\$E]/L/$/_!SO_P %L_%6O7W]H^)_#G@N#1] 6^>">[BT
MBX\3_"O2KF>T:8&[CBT?3=$T70H6MBL%O87L=G-Q);+7]E5?Q)ZAXWM/^"6?
M_!UIX]\9?%Z73/!G[/\ _P %.?A)IVE>'/B-KODZ7X;TKQ#?Z7X1MFL)=9:&
M+3(+P?&'X:6%EKCWMS9'2M*\;Z-J6I3/'=V\MY_8E\:?CG\*_P!GSX0>-OCM
M\6O&>A^$/A?X \+:CXP\0^*=3U&SM[!=(TZPEU!5L)IIXXM0O]2CC6WT:PM9
M)+G5;V>VM+))IKB)6 /Y//\ @@_IC^!O^"ZO_!P'\/\ 2Y+2'PY-\7I_%":?
M8VJVEI!+=?&#QUJ6DVT4*LPC72++Q7?Z<=F(Y7+RHD*L(Q^P?_!0S_@D6/VM
MOCAX _;&_9O_ &FOB3^Q+^VQ\-O!MY\-]+^.?PWT^P\0V/BWX=ZA<RS2^#_'
MWA+4I[.'6;&S%[J;:;<6U_9RHUYY5ZEY#!9BT_'O_@U6\(>*_CS\2_\ @J1_
MP5)\7:'J&AV7[8/[2FK:7\/(;V&2Q%WI5OXC\2_$KQIJ%O;%$AO+ ZCXZ\*Z
M);:A:AK.'4_#WB#3;>9Y;6[C@_J<_:H_:<^$?[''P ^)W[2/QQ\26GA?X<?"
MWPU>^(-9O+B:..YU*YB3R])\.Z+ YWW^O^(M3>UT?1=/A5Y;F_NX5VB,2.@!
M_*=^U#X+NO\ @AU\-O&O@G]G/XM_%']N+_@MM_P5O\7Z)\-_"OQ*^(=Q9:C\
M0AIFGH-'O?'MGX5L2]AX=\)^!1J=Y'X8GUF\2WO?%%Y:7^H:C=>%OA]J^G:?
M^S7_  37_9H_8_\ ^"-'[,?@+]E7QC^T/\&M'^./C&?_ (6/\9?%_P 1?B3X
M-\)>-/B[\5?%LD4&KZY9V/BC6['7K[PW87:IX9\'0O',WV"R6YG\S7=4UBXN
MO@C_ ((P_LX?&?\ :@^*'Q>_X+K?MN>'KB'XV_M Z!J>G?L6?"O7+G6YHOV<
M?V:88-7ATE=$TK43%8V-S\1=,EM+NQNXX)YYM$N]0UX26=[XVU>W/Y@?\$7/
M^";7[)W_  5@_8T_;V_;D_;\^'UW\7OVI/C3^T3\?_#VK>-?%GC/Q3'K/P?A
M\.^&_#?BO28O!0L-?TRUT*?0=;\131VLEU;&"WT70M-\.6\<'AJ&?3)@#^\R
M*6.:..:&1)89426*6)UDCECD4,DD;J2KHZD,CJ2K*002"#7\7?\ P=4!_A!^
MU/\ \$9/VMO#S[?&/PT_:2U/PO#96^;"YU:RN/%/PR\66AEUJ _:H%TR?0[^
MWLH55D1M>OIN[*_Z$_\ !K+\5OB7\2/^"6.A>'OB)K^K^+[7X+?&SXM_!OX?
M^*]:NS>WFI_#_P (ZU;MX?L%N<NLEIH"7\NDV 6:98K""VMUD,<*&OSW_P"#
MI83_ !K_ &Q/^"+W['_AJ)]4\5?$+]HG4_%]UIVEQO<:S8Z;%XL^&?AFRN#'
M")YH;?4(K[Q#-;2BRGC)T&^EDDB2T990#^T:BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *_G"_X.=O^3%O@_P#]GB_L^_\
MJ2R5_1[7\X7_  <[?\F+?!__ +/%_9]_]262OK.!?^2PX>_[&5'_ -N.?%_[
MO5_P_JC^AOPA_P BEX7_ .Q=T3_TV6M=%7.^$/\ D4O"_P#V+NB?^FRUKHJ^
M5G\<O\4OS9O'9>B_(*_F7_X)G_\ *>K_ (+7?]@/X&?^C]4K^FBOYE_^"9__
M "GJ_P""UW_8#^!G_H_5*^MX:_Y%'&W_ &3E#_UH,E,:W\3#_P#7U_\ IJH?
MTT4445\@;A7Y+?LD_P#!)+X8_LC_ +?7[8'[?OACXM?$#Q;XW_;#M+RT\6>
MO$&F>&K;PIX26[\3:-XFW^'[W3+*'6+EH)M&BLXAJ%Q(#;3RM,)9UCD7]::*
M "OR3^&O_!(_X8_#3_@JQ\;O^"KFG?%SX@ZC\2OC?X'L_ ^L_"F\TSPQ'X!T
M:SLO!'P_\#Q7VG:E!8KXDENA9_#^SO@EQ>F'[5J=ZCJ\,=JL7ZV44 <'\5/
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M(BC5<"O=:* /RM^#/_!*KX<?!C_@J!^TA_P5$TGXK^/M:^(G[2/PLB^%6O\
MPNU/3?#47@7PWID4OPKE34]&U&TL8_$4]\K?"NPVQW][+!_Q.M3WJXBL1;^L
M_P#!2[]@/P5_P4Q_9,\8_LE?$'Q_XM^&?ACQEK_@_7[SQ9X)LM$U#7[67P?K
MEOKEM:06WB"UN].:WOY;<6UVS1"=(79K>6*4*X^^:* /E'X4_LG^&_A1^Q;X
M1_8LT[Q=XAU?PIX1^ $7[/\ ;>.-0MM*B\47FBQ>#9?!@\17-I:VT>C)K!M9
M3>F"&T6P^U ((/)RE?A)H_\ P:S_ ++G@?\ 9?\ AU\'_A3^T)\;/A?^T'\'
MOB)XQ\?_  W_ &R_ \&@>$?C-:6?C-M-FU'X?>*3X531K7Q7X(BNM*MKBQMM
M1NO[2TV5[A;"^AM+J[LKG^HFB@#^8']FW_@V3^#_ (?_ &@M _:=_;S_ &I_
MCE_P4.^)G@R]MM3\#Z-\9M1NH? 7A_5M.U"RU'2]3N-(DU?5[[5TM+BR2?\
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ML+ZVD[,"LMO<0M%=65U%!>6<\%W;PS1]_10!_(9XA_X--?!O@WQ-KJ?LB?\
M!1[]L;]EWX1^*-1QJ/PB\.^)]0U;2=*T"]VOK&FZ5J]GXC\.W.HS7,Z^=;W6
MOVM]=+YLT=W>7:OFOU__ ."7?_!%K]CS_@E/HGB.[^"NF^(?'GQA\=V\5O\
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M7.MZ?=ZC:PO<>'8M/=M+FA86=Y<NNVZ6":+]<:* "OS?_P""IO\ P3<\ ?\
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M7[_N?+BO^?M'_P %3\O^GGK^'F?D?_Q$J_\ !(C_ *.)U+_P@/%/_P AT?\
M$2K_ ,$B/^CB=2_\(#Q3_P#(=?KA_P ,N?LT_P#1O?P3_P##6^"/_E)1_P ,
MN?LT_P#1O?P3_P##6^"/_E)1]:X'_P"A-Q+T_P"9]E_E?_F1^OW_ ''+BO\
MG[1_\%3\O^GGK^'F?D?_ ,1*O_!(C_HXG4O_  @/%/\ \AT?\1*O_!(C_HXG
M4O\ P@/%/_R'7ZX?\,N?LT_]&]_!/_PUO@C_ .4E'_#+G[-/_1O?P3_\-;X(
M_P#E)1]:X'_Z$W$O3_F?9?Y7_P"9'Z_?]QRXK_G[1_\ !4_+_IYZ_AYGY'_\
M1*O_  2(_P"CB=2_\(#Q3_\ (='_ !$J_P#!(C_HXG4O_" \4_\ R'7ZX?\
M#+G[-/\ T;W\$_\ PUO@C_Y24?\ #+G[-/\ T;W\$_\ PUO@C_Y24?6N!_\
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M ,(#Q3_\AU^N'_#+G[-/_1O?P3_\-;X(_P#E)1_PRY^S3_T;W\$__#6^"/\
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M\%3\O^GGK^'F?D?_ ,1*O_!(C_HXG4O_  @/%/\ \AT?\1*O_!(C_HXG4O\
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MN*_Y^T?_  5/R_Z>>OX>9^1__$2K_P $B/\ HXG4O_" \4__ "'1_P 1*O\
MP2(_Z.)U+_P@/%/_ ,AU^N'_  RY^S3_ -&]_!/_ ,-;X(_^4E'_  RY^S3_
M -&]_!/_ ,-;X(_^4E'UK@?_ *$W$O3_ )GV7^5_^9'Z_?\ <<N*_P"?M'_P
M5/R_Z>>OX>9^1_\ Q$J_\$B/^CB=2_\ " \4_P#R'1_Q$J_\$B/^CB=2_P#"
M \4__(=?KA_PRY^S3_T;W\$__#6^"/\ Y24?\,N?LT_]&]_!/_PUO@C_ .4E
M'UK@?_H3<2]/^9]E_E?_ )D?K]_W'+BO^?M'_P %3\O^GGK^'F?D?_Q$J_\
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M(C_HXG4O_" \4_\ R'7ZX?\ #+G[-/\ T;W\$_\ PUO@C_Y24?\ #+G[-/\
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M )GV7^5_^9'Z_?\ <<N*_P"?M'_P5/R_Z>>OX>9^1_\ Q$J_\$B/^CB=2_\
M" \4_P#R'1_Q$J_\$B/^CB=2_P#" \4__(=?KA_PRY^S3_T;W\$__#6^"/\
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M_P"CB=2_\(#Q3_\ (='_ !$J_P#!(C_HXG4O_" \4_\ R'7ZX?\ #+G[-/\
MT;W\$_\ PUO@C_Y24?\ #+G[-/\ T;W\$_\ PUO@C_Y24?6N!_\ H3<2]/\
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M/R_Z>>OX>9^1_P#Q$J_\$B/^CB=2_P#" \4__(='_$2K_P $B/\ HXG4O_"
M\4__ "'7ZX?\,N?LT_\ 1O?P3_\ #6^"/_E)1_PRY^S3_P!&]_!/_P -;X(_
M^4E'UK@?_H3<2]/^9]E_E?\ YD?K]_W'+BO^?M'_ ,%3\O\ IYZ_AYGY'_\
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M?]QRXK_G[1_\%3\O^GGK^'F?D?\ \1*O_!(C_HXG4O\ P@/%/_R'1_Q$J_\
M!(C_ *.)U+_P@/%/_P AU^N'_#+G[-/_ $;W\$__  UO@C_Y24?\,N?LT_\
M1O?P3_\ #6^"/_E)1]:X'_Z$W$O3_F?9?Y7_ .9'Z_?]QRXK_G[1_P#!4_+_
M *>>OX>9^1__ !$J_P#!(C_HXG4O_" \4_\ R'1_Q$J_\$B/^CB=2_\ " \4
M_P#R'7ZX?\,N?LT_]&]_!/\ \-;X(_\ E)1_PRY^S3_T;W\$_P#PUO@C_P"4
ME'UK@?\ Z$W$O3_F?9?Y7_YD?K]_W'+BO^?M'_P5/R_Z>>OX>9^1_P#Q$J_\
M$B/^CB=2_P#" \4__(='_$2K_P $B/\ HXG4O_" \4__ "'7ZX?\,N?LT_\
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M/R_Z>>OX>9^1_P#Q$J_\$B/^CB=2_P#" \4__(='_$2K_P $B/\ HXG4O_"
M\4__ "'7ZX?\,N?LT_\ 1O?P3_\ #6^"/_E)1_PRY^S3_P!&]_!/_P -;X(_
M^4E'UK@?_H3<2]/^9]E_E?\ YD?K]_W'+BO^?M'_ ,%3\O\ IYZ_AYGY'_\
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M4_+_ *>>OX>9^1__ !$J_P#!(C_HXG4O_" \4_\ R'1_Q$J_\$B/^CB=2_\
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MGK^'F?D?_P 1*O\ P2(_Z.)U+_P@/%/_ ,AT?\1*O_!(C_HXG4O_  @/%/\
M\AU^N'_#+G[-/_1O?P3_ /#6^"/_ )24?\,N?LT_]&]_!/\ \-;X(_\ E)1]
M:X'_ .A-Q+T_YGV7^5_^9'Z_?]QRXK_G[1_\%3\O^GGK^'F?D?\ \1*O_!(C
M_HXG4O\ P@/%/_R'1_Q$J_\ !(C_ *.)U+_P@/%/_P AU^N'_#+G[-/_ $;W
M\$__  UO@C_Y24?\,N?LT_\ 1O?P3_\ #6^"/_E)1]:X'_Z$W$O3_F?9?Y7_
M .9'Z_?]QRXK_G[1_P#!4_+_ *>>OX>9^1__ !$J_P#!(C_HXG4O_" \4_\
MR'1_Q$J_\$B/^CB=2_\ " \4_P#R'7ZX?\,N?LT_]&]_!/\ \-;X(_\ E)1_
MPRY^S3_T;W\$_P#PUO@C_P"4E'UK@?\ Z$W$O3_F?9?Y7_YD?K]_W'+BO^?M
M'_P5/R_Z>>OX>9^1_P#Q$J_\$B/^CB=2_P#" \4__(='_$2K_P $B/\ HXG4
MO_" \4__ "'7ZX?\,N?LT_\ 1O?P3_\ #6^"/_E)1_PRY^S3_P!&]_!/_P -
M;X(_^4E'UK@?_H3<2]/^9]E_E?\ YD?K]_W'+BO^?M'_ ,%3\O\ IYZ_AYGY
M'_\ $2K_ ,$B/^CB=2_\(#Q3_P#(='_$2K_P2(_Z.)U+_P (#Q3_ /(=?KA_
MPRY^S3_T;W\$_P#PUO@C_P"4E'_#+G[-/_1O?P3_ /#6^"/_ )24?6N!_P#H
M3<2]/^9]E_E?_F1^OW_<<N*_Y^T?_!4_+_IYZ_AYGY'_ /$2K_P2(_Z.)U+_
M ,(#Q3_\AT?\1*O_  2(_P"CB=2_\(#Q3_\ (=?KA_PRY^S3_P!&]_!/_P -
M;X(_^4E'_#+G[-/_ $;W\$__  UO@C_Y24?6N!_^A-Q+T_YGV7^5_P#F1^OW
M_<<N*_Y^T?\ P5/R_P"GGK^'F?D?_P 1*O\ P2(_Z.)U+_P@/%/_ ,AT?\1*
MO_!(C_HXG4O_  @/%/\ \AU^N'_#+G[-/_1O?P3_ /#6^"/_ )24?\,N?LT_
M]&]_!/\ \-;X(_\ E)1]:X'_ .A-Q+T_YGV7^5_^9'Z_?]QRXK_G[1_\%3\O
M^GGK^'F?D?\ \1*O_!(C_HXG4O\ P@/%/_R'1_Q$J_\ !(C_ *.)U+_P@/%/
M_P AU^N'_#+G[-/_ $;W\$__  UO@C_Y24?\,N?LT_\ 1O?P3_\ #6^"/_E)
M1]:X'_Z$W$O3_F?9?Y7_ .9'Z_?]QRXK_G[1_P#!4_+_ *>>OX>9^1__ !$J
M_P#!(C_HXG4O_" \4_\ R'1_Q$J_\$B/^CB=2_\ " \4_P#R'7ZX?\,N?LT_
M]&]_!/\ \-;X(_\ E)1_PRY^S3_T;W\$_P#PUO@C_P"4E'UK@?\ Z$W$O3_F
M?9?Y7_YD?K]_W'+BO^?M'_P5/R_Z>>OX>9^1_P#Q$J_\$B/^CB=2_P#" \4_
M_(='_$2K_P $B/\ HXG4O_" \4__ "'7ZX?\,N?LT_\ 1O?P3_\ #6^"/_E)
M1_PRY^S3_P!&]_!/_P -;X(_^4E'UK@?_H3<2]/^9]E_E?\ YD?K]_W'+BO^
M?M'_ ,%3\O\ IYZ_AYGY'_\ $2K_ ,$B/^CB=2_\(#Q3_P#(='_$2K_P2(_Z
M.)U+_P (#Q3_ /(=?KA_PRY^S3_T;W\$_P#PUO@C_P"4E'_#+G[-/_1O?P3_
M /#6^"/_ )24?6N!_P#H3<2]/^9]E_E?_F1^OW_<<N*_Y^T?_!4_+_IYZ_AY
MGY'_ /$2K_P2(_Z.)U+_ ,(#Q3_\AT?\1*O_  2(_P"CB=2_\(#Q3_\ (=?K
MA_PRY^S3_P!&]_!/_P -;X(_^4E'_#+G[-/_ $;W\$__  UO@C_Y24?6N!_^
MA-Q+T_YGV7^5_P#F1^OW_<<N*_Y^T?\ P5/R_P"GGK^'F?D?_P 1*O\ P2(_
MZ.)U+_P@/%/_ ,AT?\1*O_!(C_HXG4O_  @/%/\ \AU^N'_#+G[-/_1O?P3_
M /#6^"/_ )24?\,N?LT_]&]_!/\ \-;X(_\ E)1]:X'_ .A-Q+T_YGV7^5_^
M9'Z_?]QRXK_G[1_\%3\O^GGK^'F?D?\ \1*O_!(C_HXG4O\ P@/%/_R'1_Q$
MJ_\ !(C_ *.)U+_P@/%/_P AU^N'_#+G[-/_ $;W\$__  UO@C_Y24?\,N?L
MT_\ 1O?P3_\ #6^"/_E)1]:X'_Z$W$O3_F?9?Y7_ .9'Z_?]QRXK_G[1_P#!
M4_+_ *>>OX>9^1__ !$J_P#!(C_HXG4O_" \4_\ R'1_Q$J_\$B/^CB=2_\
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MC_:NN_;Y/[/0:V9V^QS&.SN%$C1?O;0 4444 %%%% !17Y8?\%=_^"G^@?\
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MLC^]5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_-%_P:U_\F.?
MM"_]GR_'3_TT^!*_I=K^:+_@UK_Y,<_:%_[/E^.G_II\"5_2[7UW'O\ R6/$
M'_8PJ?\ I$###?[O2_P(****^1-PHHHH **** "BBB@ HHHH **** "BBB@
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M&U*/PMKMO9$7\-OXCM[>?2K:^L6%Q8ZA<V=T5E@CGAE^2?\ @CU_P4?\/?\
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MIUUK=Q937&E:!<:5-9ZC=<QX!_X+J_\ !0O]A3]I+X6? K_@O%^RA\+/V?\
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M\1>&KV;Q#IVI1VEE,K^F_$;_ (*L?'7]GG_@MU\*O^"<'QR\$?#<?LY_M0^
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M1V8 _JSHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^:+_@UK_Y,<_:%_[/
ME^.G_II\"5_2[7\T7_!K7_R8Y^T+_P!GR_'3_P!-/@2OZ7:^NX]_Y+'B#_L8
M5/\ TB!AAO\ =Z7^!!1117R)N%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?CM;?\$2?V._$O[?WQ3_X*+?'K19_VB/C3XN\0^%M8^&&@
M_$FU%_\ #OX(VOA+PWI>AZ7'X<\(3WM]I'B/7(+S3FUJPU[Q%:2QZ)?/:W&A
M:1INIV*:K+^Q-% '\7?_  ;#@#_@H9_P7A "JH_:A<*JJ%55'Q>^/(5550%5
M5  55 50    !7]HE?Q=_P#!L1_RD-_X+Q?]G12?^K?^/-?HK_P<:_\ !4/6
M?V%OV7M"^ GP(\2Z)IW[8/[96J+\)_A5_:&M6&A2> _!WB*X7PYXP^*4^LZG
M>Z=IGAMK!M1M_#WA[Q'J^H:?IVC:WJC>(9;V&/PY<,H!^>7QYOKS_@X<_P""
MO.G?LI^&KRYN?^"9/_!+KQ=8^._CQXHTFX?6/"'[07QU%Q%I]CX,8PR6NEM%
M+/8>,?!6B7D5SJLD'A+3/B/X@M01K]A:A/\ @TTL;#3/C#_P68TW2K&STO2]
M._:_BL=-TS3[>*SL-.L+3Q1\7;>SL;&T@2."UL[2WCCM[:WA1(H(8TBC1450
M/U/_ ."2VD_\$S/^"8?[&7P__9W\,?MN_L?ZMX[O(E\<?'+QW+^TA\$FU+QU
M\7O$5E:/XIU&:\C\9&:?1]'FB3P_X8MYIIOLNAZ;;.SM=7-Y--^+7_!K?^T+
M\ /A_P#'7_@K=:^._CK\&O!=U\2_VQ[9OAO:^+/BCX&\.W7Q"CU'QA\58[";
MP+;:OKMG-XN@O9-0T^.TG\/QZA#<2:A81PN[WELLH!_<G1110!_&G_P2RU^[
M_;E_X.1O^"H7[7FHMI^O^#/V6?!2?LW_  MU"YLA(-+MV\0Q>$+.31"2D5IJ
M+6O@3Q?+J%TL+71AUZZA,ZB]F\_]Z?\ @M5\-OB=\7?^"5/[='P]^#UIK&J?
M$#Q#\ ?&$>D:'H$"7.L>([.RBAU'7O#MC SH\TVM:!::G8>3 6NKA9FMK:.6
M:9(V_GZ_X-05BNOV@O\ @LKJVKA'\:7/[5CPZK/>'RM;>P7Q?\3YHEN[1C')
M% +Z6[97:VC!N&F3<2A1?Z _^"QG_!0V+_@F)^P5\7/VHK#0[+Q1X^TX:3X)
M^$_AK4FF&EZG\2?&MXNC^';G5Q#L>;0_#IDN/%&N6:7-G/J&DZ->6%I=17ES
M;D@'Y_\ _!L3^T#^REKG_!)_X _"WX9>-O!.B_$SX56WB[2?CUX#O=4LM#\8
M:3\2I/$NK:OK>NZQH>J746I366J:3=:5=V^N10'39+>/[.DD<EE/#%^;O_!3
M#QG\.OVK?^#DO_@DMX&_8\;1/'WQC_9O\5:)XM_:P^(7PMG34)/#/P]T#QYI
M_B34_!GQ"\2Z CPA?#W@+3O$\5[8ZA>RPQ6GQ%LO#MV8SJILCR/[%_\ P;)7
M?[;/A32OV^?^"B/[27CW0?CM^U%X?D^)EQ\-_P!FG2?!?PH\+^$?"7Q)M;;Q
M!H6FWVI^'=)6.\OKG1M2=]0TK3+&TTV"TOX=.U"XU>^M;B[;RY?A+\;O^#4G
M]L3X"ZWX?^(6A?M"?\$Y?VTOB!HWPQ^*_C'X@^ _#VD?%SX8:Q:7[7.I/=>+
MM M)-7\V"QU^Y\<:;'9SSZ%XS@\)ZGINJ:!I=_I&G:@X!_?-6=K&IVNB:1JF
MLWTT5M9:1IU]J=Y<3L4@M[6PMI;JXFF< E8HH8GDD8 E44G!Q5V*6*XBBG@E
MCF@FC26&:)UDBEBD4/'+%(A9)(Y$8.CH2K*0RD@@UY#^T1I6JZ[\ /CCHFA"
M1M;UCX0?$K2](6%YHIFU2_\ !FM6M@(I+=7GCD-U+$$>!6F5L&-6<*" ?Q<_
M\$/?VD?V1O!-I_P4"_X+M_\ !0GXN?#_ ,)>/?V@?VL/B+\)?A%XT\?W,NH>
M)]$\(^$O#VF^*KKP!\(M!NX=0\77ER_A/Q!X3\*V6G:%:3ZG!X3\):7HEP8[
M43K/^KGC/_@I=_P0T_X+G_#WQI_P3RU3]HJQU.^^, L](\)Z?XM\(>)/A7XM
M;QK8WT5_X:UGX1:]\2_"MGI=QXXT^_M5ETVVT\SWFIV37VDO:W5EJ-U:S_SM
M?\&G?_!+SX&?ME:#\7OVC_VL=&@^-?@7]G[XE1^$?@;\#O&5U>ZO\-O#GQ!\
M2:9I?B'QW\2-3\(W$W]CW^KW5II'@[3+&&ZMIK2Y.G27.IV]U)8Z8+?^BW_@
MN)_P1E_8P^.'[#'Q\^,7PR^"OPU^ 7[1?[-WPO\ %WQT^%GQ9^$?AC3OAKJ5
ME<_"71+_ ,<ZIX?UBW\$VFDVFKZ?KND:+?VMI)<VIO\ 2=>_L;6+&_MFL)8[
M@ _7W]EW]CW1_P!D_P#8P\%?L9^#/B1XX\;>'/AQ\./$/PT\'>.OB%)I%WXO
MMM!U$ZTGAZUOG\/Z;H6G30>$;#5+71-($%E;SG2=(L4N9Y[L374O\??_  31
M_P""D'P#_P""-W[#W[6?_!-?]MW2OC!X*_:K^&WQ9_:-7P'X1F^$OC?6(_V@
MK?Q]I-E:^!=1\$:WHVD:QHTG_"5W36LQ;4=2\J'2KZ/6//N+&&Z>#^B'_@WO
M_; ^(G[;?_!*;]F_XO\ Q>URX\4?%318_&'PK\=^*;Z[EO=4\4:I\-O%.I>'
MM,\1ZU<S11/+KFM^&(M!U'6Y1YBS:K<7<ZR$2[5_3']H3Q5\!/@[\._%7[2'
MQ\LO!%AX3^ WAG5_B!?^._%.B:'?:AX0T_P_;R:A)<^']1U6 W5EJ]Q,J6NC
MVVFW5O>:AJ]U:6-GON[J)& /Y$?V8/VCOC%_P0Z_X(%_!GPWXE\&:OJ/[?'[
M9?Q-^(J_LG_LR:A8SS>+M%\9_&SQ!>3^$K[5?"B3Q:W/I'A#1YM#\7>(=-^S
M:7/)XK\3Z'X*N6L;O5UU!?WB_P""+W_!,^#_ ()S_LR7'_"Q-4F\=?M=_M%:
MO_PN+]K?XL:E>WFI:QXM^)_B&:_UF70VOKR>;S=/\'R:YJ&F_:H4A_MK6)M8
MUZYWR:C&L/X)_ [XRV'Q \4?M&_\'1W_  43\*^)=+^!/P/T*]\ ?\$Q?V>Y
MX;=]0/@;4M4N? WASXAVNGZA<W5A;^-/B5XB\31Z#HFJR10V^GZWJWBOQA,[
M:-H'A.^@^K=,_P"#A']L_P"#=E\!/CW^W=_P2[\0_L]_L.?M)^*?#/A_P1\=
M?#OQ1T_Q=XE\%Z?\0+J*[\">(OB+X0DL[>33;+5/"\IUX6DW]D7>H6D-Q+8A
M+J./2I@#^L3KUK^,#_@C3>7'['O_  <,_P#!7_\ 8%TBZGT_X3_$B>Z_:$\'
M^%M[W=I8>*-6N_"7Q*T]]-D0V=G96%KX-^+NNZ2\$6GSW(33-&TVYOII-)>:
M;^S2PO[/5+&RU/3KB*\T_4;2VO[&[@;?#=6=W"EQ;7$+CAHIX9$EC;^)&![U
M_&)/MD_X/0- .F;76']DK51KYT[#+&Y^ /B;RQK?V3(1R\FD[/[1PVY]+V_,
MUGD _M&HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<Z404U%E;^U"OP__ ."VW_!(P?\ !3;X1^ _%WPB\:1_"']L_P#9FUR3Q_\
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M5TCX5>"M-TK5=2BB2.7Q'XONH_M_C#Q1>; JO>>(/$5SJ&HSN%4'SE4(BJ%
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M _A/\.>+?CG_ ,&RO_!1+]K+7_&W[/7Q=^-?_!+S]M'QE#\1_"WQ ^$.C?\
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M7Q%GU";2M(U'4X;"%_'?[+026^EL;:X2TC8)(ZO<-&ICAN)0?+MYGC_LNHH
M*_C)_P""IWPH_:>_X)0?\%<O#7_!;;]F[X+^*OV@_P!G3XM> 3\,?VQOAGX!
M@>3Q+X?MH-"M+'5]::VL].OY;32-0L_"'A;QQIWBN\@GT^W\8^']1T#7;G1-
M.UO3KV?^S:B@#^4OQ)_P<G_#K]LWPWI_[-W_  3+_9T_:4^*_P"UY\=K#_A
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ME1)8I4:.2.15>.2-U*NCHP*NCJ2K*P*LI(((-*JJBJB*J(BA410%554 *JJ
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M_"]W>>/_ !'IJR#3_$'Q)\8ZSJ/B_P =ZCISSP6]W+I">(M:O=/T!KV)+Q-
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M66BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZEH*W&HP27-_H&OZ3:S>'IIGTV"\UE;>.ZN,O_@DI^SC^VE_P4<_X*F>)_\
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M?'M_%);>#? NC06%K=S)>>)-;-M8R7TL2V6E637>JZC/;V%E<3Q_DA_P0O\
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MDS_I+#^S7_X9*S_^=)1_PQ)_P<F?])8?V:__  R5G_\ .DH_U7R__HM.%?\
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M_AB3_@Y,_P"DL/[-?_ADK/\ ^=)1_JOE_P#T6G"O_@>>>7_4D\W]WF'MY_\
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MG_!R9_TEA_9K_P##)6?_ ,Z2C_AB3_@Y,_Z2P_LU_P#ADK/_ .=)1_JOE_\
MT6G"O_@>>>7_ %)/-_=YA[>?_0-7^ZGY?]//-_=YG],U%?S,_P##$G_!R9_T
MEA_9K_\ #)6?_P Z2C_AB3_@Y,_Z2P_LU_\ ADK/_P"=)1_JOE__ $6G"O\
MX'GGE_U)/-_=YA[>?_0-7^ZGY?\ 3SS?W>9_3-17\S/_  Q)_P ')G_26']F
MO_PR5G_\Z2C_ (8D_P"#DS_I+#^S7_X9*S_^=)1_JOE__1:<*_\ @>>>7_4D
M\W]WF'MY_P#0-7^ZGY?]//-_=YG],U%?S,_\,2?\')G_ $EA_9K_ /#)6?\
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MP<F?])8?V:__  R5G_\ .DH_X8D_X.3/^DL/[-?_ (9*S_\ G25\S_JOE_\
MT6G"O_@>>>7_ %)/-_=YFWMY_P#0-7^ZGY?]//-_=YG],U%?S,_\,2?\')G_
M $EA_9K_ /#)6?\ \Z2C_AB3_@Y,_P"DL/[-?_ADK/\ ^=)1_JOE_P#T6G"O
M_@>>>7_4D\W]WF'MY_\ 0-7^ZGY?]//-_=YG],U%?S,_\,2?\')G_26']FO_
M ,,E9_\ SI*/^&)/^#DS_I+#^S7_ .&2L_\ YTE'^J^7_P#1:<*_^!YYY?\
M4D\W]WF'MY_] U?[J?E_T\\W]WF?TS45_,S_ ,,2?\')G_26']FO_P ,E9__
M #I*/^&)/^#DS_I+#^S7_P"&2L__ )TE'^J^7_\ 1:<*_P#@>>>7_4D\W]WF
M'MY_] U?[J?E_P!//-_=YG],U%?S,_\ #$G_  <F?])8?V:__#)6?_SI*/\
MAB3_ (.3/^DL/[-?_ADK/_YTE'^J^7_]%IPK_P"!YYY?]23S?W>8>WG_ - U
M?[J?E_T\\W]WF?TS45_,S_PQ)_P<F?\ 26']FO\ \,E9_P#SI*/^&)/^#DS_
M *2P_LU_^&2L_P#YTE'^J^7_ /1:<*_^!YYY?]23S?W>8>WG_P! U?[J?E_T
M\\W]WF?TS45_,S_PQ)_P<F?])8?V:_\ PR5G_P#.DH_X8D_X.3/^DL/[-?\
MX9*S_P#G24?ZKY?_ -%IPK_X'GGE_P!23S?W>8>WG_T#5_NI^7_3SS?W>9_3
M-17\S/\ PQ)_P<F?])8?V:__  R5G_\ .DH_X8D_X.3/^DL/[-?_ (9*S_\
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M_P"&)/\ @Y,_Z2P_LU_^&2L__G24?ZKY?_T6G"O_ ('GGE_U)/-_=YA[>?\
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MP5^_Y1>_MW?]FT_$W_TQ3UA_\$8?^46?[$7_ &1'1O\ TYZM7X.?MZ_LD?\
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M?17\S/\ PQ)_P<F?])8?V:__  R5G_\ .DH_X8D_X.3/^DL/[-?_ (9*S_\
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MG_!R9_TEA_9K_P##)6?_ ,Z2C_AB3_@Y,_Z2P_LU_P#ADK/_ .=)1_JOE_\
MT6G"O_@>>>7_ %)/-_=YA[>?_0-7^ZGY?]//-_=YG],U%?S,_P##$G_!R9_T
MEA_9K_\ #)6?_P Z2C_AB3_@Y,_Z2P_LU_\ ADK/_P"=)1_JOE__ $6G"O\
MX'GGE_U)/-_=YA[>?_0-7^ZGY?\ 3SS?W>9_3-17\S/_  Q)_P ')G_26']F
MO_PR5G_\Z2C_ (8D_P"#DS_I+#^S7_X9*S_^=)1_JOE__1:<*_\ @>>>7_4D
M\W]WF'MY_P#0-7^ZGY?]//-_=YG],U%?S,_\,2?\')G_ $EA_9K_ /#)6?\
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M2P_LU_\ ADK/_P"=)1_JOE__ $6G"O\ X'GGE_U)/-_=YA[>?_0-7^ZGY?\
M3SS?W>9_3-17\S/_  Q)_P ')G_26']FO_PR5G_\Z2C_ (8D_P"#DS_I+#^S
M7_X9*S_^=)1_JOE__1:<*_\ @>>>7_4D\W]WF'MY_P#0-7^ZGY?]//-_=YG]
M,U%?S,_\,2?\')G_ $EA_9K_ /#)6?\ \Z2C_AB3_@Y,_P"DL/[-?_ADK/\
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M44 %%%% !7\X7_!SM_R8M\'_ /L\7]GW_P!262OZ/:_G"_X.=O\ DQ;X/_\
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MJV\5IH5J;UH469[@^'M'T38UXTL_V7[.J.+9;>-/V!_X*F>$].\;_P#!-_\
M;B\,ZJ+,V-_^S#\8IYA?VL=[:[]+\%ZKJ]OYEM,\<;L+FPA,+%P8IQ',F7C5
M2 >K_L5_M.^%OVSOV4?@'^U'X-@ELM"^-GPT\-^.(],G,9N=%U'4K)5UO0[H
M123(MQHVM0W^FR@2-DVV[)# GZ?K^=3_ (-4]8U'6?\ @B=^S-)J-P;A]/\
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ME;0R2?B=_P $AOA-'X*U+XI?\%TO^"KOCWP'\'/VHOVX!%IOPLT7XM^(M \
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MP\-ZC8VWAV3Q=K.H:EXAAU>PT6UA7^J>D)P"0,D D#KG Z<<_E0!_*I\9O\
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M8/$/AB#QOXA\2>'-*\1Z<SZ;JJ:#)-:2/&NX_1?_  <(>-?BI^TE_P %3O\
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M[>Z@OK?PY:O=:3K5C 4O;FWLK;5-7UN#3=/D2PL%MH($! /E[_@X3^)7A_\
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MM+>PTW3=.LH4MK*PT^QM8XK6SLK2WCC@M;6WBC@@AC2*)$154?B5_P $^?\
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M/AI#JC6FA^*],O8'@U:WLCK.HQVU_:76FZM]BG&EW5[=Z5!!8Q]M_P $U/\
M@D3\#O\ @F[JGQ@^)&B?$+XI_M"?M&_M :C!>_&']HOXXZS;ZY\0_%=M97ES
M>V&CPM:P0VNEZ7%/<++=I&9[K4YK2P>]NI(["RAMP#H/^"UOQ0TKX/\ _!)K
M_@H%XRUB\M;&SN/V8_B3X#CGO06A?4OBSI1^%.BV@&#_ *3J&L^-+"PLB< 7
MES;DD#D?(W_!L1\*=;^%/_!%[]E"/Q%IU_I.J?$%OB9\4/[.U*-XKF+2?%OQ
M)\3#PS>I&P 6RUSPOI^B^(=.9&=9M/U:UN"5>5XH_D[_ (.;_B-XO^/OA?\
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MU;G_  5^_P"47O[=W_9M/Q-_],4]8?\ P1A_Y19_L1?]D1T;_P!.>K5]<O\
MD@Y?]E='_P!4TS#_ )B5_P!>'_Z<B?IU1117R)N%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7!_%'XH_#OX*?#SQC\6?BSXQT#X
M??#;X?Z#?^)_&7C/Q/?PZ9H?A_0],A,UW?7UW,0  H$5O;Q++=7MU)!9V4%Q
M=W$$$G>5^?'_  4U_P""=OPW_P""H?[,%]^RO\5_B'\2/AKX,U'QQX3\<WVN
M_"Z[T*U\0W=SX1;4)++2+H>(]&U[2;G1[J>_6YNK>?3I'^TV5E/#)%) K4 ?
MRW67A'XW_P#!T=^UM)\1O'>O^*O@Q_P1&_9O^(-W8_#KPQ)<OX3\2_M4>,/#
M4PM-1U,VKSK<->ZDQE35-;NDDMOAKX;OAX;T*.3QIJ.MWT/]K_@'P[\/OAUX
M/\'_  T^'=EX?\-^#?!'AW1?!_@SPKHD]NEAHGASP[IL&EZ+HVFVXFDE%MIV
MFV<%M"K-)*8X=\CN^]S_ "9Z1_P9Q_LDZ!IUMH^A?MV?M[Z)I%F9C::7I'C7
MX::;IUJ;F:2YN#;6-G\.H;: SW$LMQ,8HE\V:225]TCLQ^C/V6_^#7C]GK]E
MC]HCX._M%^'/VV/VW_&VO?!OQUHOCO2O"7C?QSX)O/"/B&\T68RQ:5XBM=/\
M$V-[<:3=[C%>06UY;2RQ%D$JAC0!_3S1110!_%[_ ,&W4%Q\#O\ @J/_ ,%P
M/V3]6:)]0T/XUM\0K*>,^=Y]O-\1?'%M<(;N7R)Y3%:>(-%<(+0(S23R>9M"
M[O[0J_D(_;6T#3O^"7W_  <-?LQ?\%$=?LCIW[-/[?7@V?\ 96^+OBBWAFM=
M$^'WQ<U&WT/1] U_Q)+;:>NG06NNWFD>#+^;4]7U&.40?\)=J3/'::-<"3^O
M2.1)426)TDBD19(Y(V#I(C@,CHZDJR,I#*RDA@002#0!_%=_P<E?\I8_^"%'
M_9:K/_U<GPRK^T75=5TO0M,U'6]<U*PT;1M(LKK4M6U?5;RWT[3-,TZRA>YO
M;_4;^[DAM;*RM+>.2>ZNKF6*"WAC>661$5F'Y9?MX?\ !)'X+_M^?M(_L?\
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MT7Y!7\R__!,__E/5_P %KO\ L!_ S_T?JE?TT5_&K\ _V^/V3?V&_P#@N/\
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M0GQ1_P#F+H_U2XI_Z)O/O_#3C_\ Y1Y_GV8>WH?\_J7_ (,A_F?M717XJ?\
M$0__ ,$??^CPO#W_ (0GQ1_^8NC_ (B'_P#@C[_T>%X>_P#"$^*/_P Q='^J
M7%/_ $3>??\ AIQ__P H\_S[,/;T/^?U+_P9#_,_:NBOQ4_XB'_^"/O_ $>%
MX>_\(3XH_P#S%T?\1#__  1]_P"CPO#W_A"?%'_YBZ/]4N*?^B;S[_PTX_\
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M/;T/^?U+_P &0_S/VKHK\5/^(A__ ((^_P#1X7A[_P (3XH__,71_P 1#_\
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M(?YG[5T5^*G_ !$/_P#!'W_H\+P]_P"$)\4?_F+H_P"(A_\ X(^_]'A>'O\
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M?M717XJ?\1#_ /P1]_Z/"\/?^$)\4?\ YBZ/^(A__@C[_P!'A>'O_"$^*/\
M\Q='^J7%/_1-Y]_X:<?_ /*//\^S#V]#_G]2_P#!D/\ ,_:NBOQ4_P"(A_\
MX(^_]'A>'O\ PA/BC_\ ,71_Q$/_ /!'W_H\+P]_X0GQ1_\ F+H_U2XI_P"B
M;S[_ ,-./_\ E'G^?9A[>A_S^I?^#(?YG[5T5^*G_$0__P $??\ H\+P]_X0
MGQ1_^8NC_B(?_P""/O\ T>%X>_\ "$^*/_S%T?ZI<4_]$WGW_AIQ_P#\H\_S
M[,/;T/\ G]2_\&0_S/VKHK\5/^(A_P#X(^_]'A>'O_"$^*/_ ,Q='_$0_P#\
M$??^CPO#W_A"?%'_ .8NC_5+BG_HF\^_\-./_P#E'G^?9A[>A_S^I?\ @R'^
M9^U=%?BI_P 1#_\ P1]_Z/"\/?\ A"?%'_YBZ/\ B(?_ ."/O_1X7A[_ ,(3
MXH__ #%T?ZI<4_\ 1-Y]_P"&G'__ "CS_/LP]O0_Y_4O_!D/\S]JZ*_%3_B(
M?_X(^_\ 1X7A[_PA/BC_ /,71_Q$/_\ !'W_ */"\/?^$)\4?_F+H_U2XI_Z
M)O/O_#3C_P#Y1Y_GV8>WH?\ /ZE_X,A_F?M717XJ?\1#_P#P1]_Z/"\/?^$)
M\4?_ )BZ/^(A_P#X(^_]'A>'O_"$^*/_ ,Q='^J7%/\ T3>??^&G'_\ RCS_
M #[,/;T/^?U+_P &0_S/VKHK\5/^(A__ ((^_P#1X7A[_P (3XH__,71_P 1
M#_\ P1]_Z/"\/?\ A"?%'_YBZ/\ 5+BG_HF\^_\ #3C_ /Y1Y_GV8>WH?\_J
M7_@R'^9^U9 (((!!&"#R"#U!'<&O+?A7\#O@M\"]-US1O@G\(_AG\(-'\3:_
M=^*_$>D_##P+X8\!Z9KWB>_CAAOO$6L6'A;2]+M=2UR\BMX([K5;R*:^N$AB
M6:=Q&H'Y3?\ $0__ ,$??^CPO#W_ (0GQ1_^8NC_ (B'_P#@C[_T>%X>_P#"
M$^*/_P Q='^J7%/_ $3>??\ AIQ__P H\_S[,/;T/^?U+_P9#_,_:NBOQ4_X
MB'_^"/O_ $>%X>_\(3XH_P#S%T?\1#__  1]_P"CPO#W_A"?%'_YBZ/]4N*?
M^B;S[_PTX_\ ^4>?Y]F'MZ'_ #^I?^#(?YG[5T5^*G_$0_\ \$??^CPO#W_A
M"?%'_P"8NC_B(?\ ^"/O_1X7A[_PA/BC_P#,71_JEQ3_ -$WGW_AIQ__ ,H\
M_P ^S#V]#_G]2_\ !D/\S]JZ*_%3_B(?_P""/O\ T>%X>_\ "$^*/_S%T?\
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M&W( %>IU^*G_ !$/_P#!'W_H\+P]_P"$)\4?_F+H_P"(A_\ X(^_]'A>'O\
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MY]F'MZ'_ #^I?^#(?YG[5T5^*G_$0_\ \$??^CPO#W_A"?%'_P"8NC_B(?\
M^"/O_1X7A[_PA/BC_P#,71_JEQ3_ -$WGW_AIQ__ ,H\_P ^S#V]#_G]2_\
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M_B(?_P""/O\ T>%X>_\ "$^*/_S%T?ZI<4_]$WGW_AIQ_P#\H\_S[,/;T/\
MG]2_\&0_S/VKHK\5/^(A_P#X(^_]'A>'O_"$^*/_ ,Q='_$0_P#\$??^CPO#
MW_A"?%'_ .8NC_5+BG_HF\^_\-./_P#E'G^?9A[>A_S^I?\ @R'^9^U=%?BI
M_P 1#_\ P1]_Z/"\/?\ A"?%'_YBZ/\ B(?_ ."/O_1X7A[_ ,(3XH__ #%T
M?ZI<4_\ 1-Y]_P"&G'__ "CS_/LP]O0_Y_4O_!D/\S]JZ*_%3_B(?_X(^_\
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M_:NBOQ4_XB'_ /@C[_T>%X>_\(3XH_\ S%T?\1#_ /P1]_Z/"\/?^$)\4?\
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M2OV<?_#,?#[_ .9^C_AA3]BK_HTK]G'_ ,,Q\/O_ )GZ^K**/[2S'_H/QO\
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M'_H/QO\ X55__E@<D/Y8_P#@*_R/E/\ X84_8J_Z-*_9Q_\ #,?#[_YGZ/\
MAA3]BK_HTK]G'_PS'P^_^9^OJRBC^TLQ_P"@_&_^%5?_ .6!R0_EC_X"O\CY
M3_X84_8J_P"C2OV<?_#,?#[_ .9^C_AA3]BK_HTK]G'_ ,,Q\/O_ )GZ^K**
M/[2S'_H/QO\ X55__E@<D/Y8_P#@*_R/E/\ X84_8J_Z-*_9Q_\ #,?#[_YG
MZ/\ AA3]BK_HTK]G'_PS'P^_^9^OJRBC^TLQ_P"@_&_^%5?_ .6!R0_EC_X"
MO\CY3_X84_8J_P"C2OV<?_#,?#[_ .9^C_AA3]BK_HTK]G'_ ,,Q\/O_ )GZ
M^K**/[2S'_H/QO\ X55__E@<D/Y8_P#@*_R/E/\ X84_8J_Z-*_9Q_\ #,?#
M[_YGZ/\ AA3]BK_HTK]G'_PS'P^_^9^OJRBC^TLQ_P"@_&_^%5?_ .6!R0_E
MC_X"O\CY3_X84_8J_P"C2OV<?_#,?#[_ .9^C_AA3]BK_HTK]G'_ ,,Q\/O_
M )GZ^K**/[2S'_H/QO\ X55__E@<D/Y8_P#@*_R/E/\ X84_8J_Z-*_9Q_\
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M_HTK]G'_ ,,Q\/O_ )GZ^K**/[2S'_H/QO\ X55__E@<D/Y8_P#@*_R/E/\
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M^IV6AZ?I?@I[#1[2]UK2[VXM],L7N+AK2RA=+>!IYC'&#(V?Z(/^&%/V*O\
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M/V*O^C2OV<?_  S'P^_^9^C_ (84_8J_Z-*_9Q_\,Q\/O_F?KZLHH_M+,?\
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M?H_X84_8J_Z-*_9Q_P##,?#[_P"9^OJRBC^TLQ_Z#\;_ .%5?_Y8')#^6/\
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M9Q_\,Q\/O_F?KZLHH_M+,?\ H/QO_A57_P#E@<D/Y8_^ K_(^4_^&%/V*O\
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M/U]645\G_:68_P#0?C?_  JK_P#RPWY(?RQ_\!7^1\I_\,*?L5?]&E?LX_\
MAF/A]_\ ,_1_PPI^Q5_T:5^SC_X9CX??_,_7U911_:68_P#0?C?_  JK_P#R
MP.2'\L?_  %?Y'RG_P ,*?L5?]&E?LX_^&8^'W_S/T?\,*?L5?\ 1I7[./\
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M  JK_P#RP.2'\L?_  %?Y'RG_P ,*?L5?]&E?LX_^&8^'W_S/T?\,*?L5?\
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M^&8^'W_S/T?\,*?L5?\ 1I7[./\ X9CX??\ S/U]644?VEF/_0?C?_"JO_\
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M644?VEF/_0?C?_"JO_\ + Y(?RQ_\!7^1\I_\,*?L5?]&E?LX_\ AF/A]_\
M,_1_PPI^Q5_T:5^SC_X9CX??_,_7U911_:68_P#0?C?_  JK_P#RP.2'\L?_
M  %?Y'RG_P ,*?L5?]&E?LX_^&8^'W_S/T?\,*?L5?\ 1I7[./\ X9CX??\
MS/U]644?VEF/_0?C?_"JO_\ + Y(?RQ_\!7^1\I_\,*?L5?]&E?LX_\ AF/A
M]_\ ,_1_PPI^Q5_T:5^SC_X9CX??_,_7U911_:68_P#0?C?_  JK_P#RP.2'
M\L?_  %?Y'RG_P ,*?L5?]&E?LX_^&8^'W_S/T?\,*?L5?\ 1I7[./\ X9CX
M??\ S/U]644?VEF/_0?C?_"JO_\ + Y(?RQ_\!7^1\I_\,*?L5?]&E?LX_\
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M.?A]]A^(>F:GJ_A[^Q/%=MXEN-3F^QZ3JVBW1OT.C6Z6LOVT11"25GBE.T
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M1ZC8:>&@M(K:WMUL88F2U+G^IZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M+%(H>.2-U)5T=2&1U)5E(()!!K\)?^#D+]DSPO\ M6_\$FOVD8]4M=/7Q?\
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MZ_O-(G^V:3<S-IUU9W)ETV^6+4+,B8"&]M[:Y ,D*$>"?!?_ ()<_P#!._\
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M\.=7;1+J?Q-I^D6EE=3SP:<^B7EO=7G_ ![VMW=Z2EY]GL[B>]MP#T?]G?\
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M7RL_CE_BE^;-X[+T7Y!7\R__  3/_P"4]7_!:[_L!_ S_P!'ZI7]-%?S+_\
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MWQBBE6,R_O"N_FM.B@ HHHH *_!;]N[_ ()O_M#ZG_P4?_9$_P""H/["UQX
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M:[8X88UBBC7KM2- J(N2>% %2444 %(0&!5@"I!!! (((P00>""."#P12T4
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MMTMK@VNHZ9J,6L3WUV55)8+J&,$L!7]O=?S+_P#!,_\ Y3U?\%KO^P'\#/\
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M_*__ (.GY>?E_5E;^:'_ (9J_P"#EO\ Z/O_ &1?_#3W'_RKH_X9J_X.6_\
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M]<<7_P!"7A7_ ,1S+/+_ *<^7XON'U:/_/RO_P"#I^7GY?U96_FA_P"&:O\
M@Y;_ .C[_P!D7_PT]Q_\JZ/^&:O^#EO_ */O_9%_\-/<?_*NOZ7J*/\ 7'%_
M]"7A7_Q',L\O^G/E^+[A]6C_ ,_*_P#X.GY>?E_5E;^:'_AFK_@Y;_Z/O_9%
M_P##3W'_ ,JZ/^&:O^#EO_H^_P#9%_\ #3W'_P JZ_I>HH_UQQ?_ $)>%?\
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MRO\ ^#I^7GY?U96_FA_X9J_X.6_^C[_V1?\ PT]Q_P#*NC_AFK_@Y;_Z/O\
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M_H^_]D7_ ,-/<?\ RKH_X9J_X.6_^C[_ -D7_P -/<?_ "KK^EZBC_7'%_\
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M_*__ (.GY>?E_5E;^:'_ (9J_P"#EO\ Z/O_ &1?_#3W'_RKH_X9J_X.6_\
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M]<<7_P!"7A7_ ,1S+/+_ *<^7XON'U:/_/RO_P"#I^7GY?U96_FA_P"&:O\
M@Y;_ .C[_P!D7_PT]Q_\JZ/^&:O^#EO_ */O_9%_\-/<?_*NOZ7J*/\ 7'%_
M]"7A7_Q',L\O^G/E^+[A]6C_ ,_*_P#X.GY>?E_5E;^:'_AFK_@Y;_Z/O_9%
M_P##3W'_ ,JZ/^&:O^#EO_H^_P#9%_\ #3W'_P JZ_I>HH_UQQ?_ $)>%?\
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MRO\ ^#I^7GY?U96_FA_X9J_X.6_^C[_V1?\ PT]Q_P#*NC_AFK_@Y;_Z/O\
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ME?\ \'3\O/R_JRM_-#_PS5_P<M_]'W_LB_\ AI[C_P"5='_#-7_!RW_T??\
MLB_^&GN/_E77]+U%'^N.+_Z$O"O_ (CF6>7_ $Y\OQ?</JT?^?E?_P '3\O/
MR_JRM_-#_P ,U?\ !RW_ -'W_LB_^&GN/_E71_PS5_P<M_\ 1]_[(O\ X:>X
M_P#E77]+U%'^N.+_ .A+PK_XCF6>7_3GR_%]P^K1_P"?E?\ \'3\O/R_JRM_
M-#_PS5_P<M_]'W_LB_\ AI[C_P"5='_#-7_!RW_T??\ LB_^&GN/_E77]+U%
M'^N.+_Z$O"O_ (CF6>7_ $Y\OQ?</JT?^?E?_P '3\O/R_JRM_-#_P ,U?\
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M^?E?_P '3\O/R_JRM_-#_P ,U?\ !RW_ -'W_LB_^&GN/_E71_PS5_P<M_\
M1]_[(O\ X:>X_P#E77]+U%'^N.+_ .A+PK_XCF6>7_3GR_%]P^K1_P"?E?\
M\'3\O/R_JRM_-#_PS5_P<M_]'W_LB_\ AI[C_P"5='_#-7_!RW_T??\ LB_^
M&GN/_E77]+U%'^N.+_Z$O"O_ (CF6>7_ $Y\OQ?</JT?^?E?_P '3\O/R_JR
MM_-#_P ,U?\ !RW_ -'W_LB_^&GN/_E71_PS5_P<M_\ 1]_[(O\ X:>X_P#E
M77]+U%'^N.+_ .A+PK_XCF6>7_3GR_%]P^K1_P"?E?\ \'3\O/R_JRM_-#_P
MS5_P<M_]'W_LB_\ AI[C_P"5='_#-7_!RW_T??\ LB_^&GN/_E77]+U%'^N.
M+_Z$O"O_ (CF6>7_ $Y\OQ?</JT?^?E?_P '3\O/R_JRM_-#_P ,U?\ !RW_
M -'W_LB_^&GN/_E71_PS5_P<M_\ 1]_[(O\ X:>X_P#E77]+U%'^N.+_ .A+
MPK_XCF6>7_3GR_%]P^K1_P"?E?\ \'3\O/R_JRM_-#_PS5_P<M_]'W_LB_\
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M3\O/R_JRM_-#_P ,U?\ !RW_ -'W_LB_^&GN/_E71_PS5_P<M_\ 1]_[(O\
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M=?TO44?ZXXO_ *$O"O\ XCF6>7_3GR_%]P^K1_Y^5_\ P=/R\_+^K*W\T/\
MPS5_P<M_]'W_ +(O_AI[C_Y5T?\ #-7_  <M_P#1]_[(O_AI[C_Y5U_2]11_
MKCB_^A+PK_XCF6>7_3GR_%]P^K1_Y^5__!T_+S\OZLK?S0_\,U?\'+?_ $??
M^R+_ .&GN/\ Y5T?\,U?\'+?_1]_[(O_ (:>X_\ E77]+U%'^N.+_P"A+PK_
M .(YEGE_TY\OQ?</JT?^?E?_ ,'3\O/R_JRM_-#_ ,,U?\'+?_1]_P"R+_X:
M>X_^5='_  S5_P '+?\ T??^R+_X:>X_^5=?TO44?ZXXO_H2\*_^(YEGE_TY
M\OQ?</JT?^?E?_P=/R\_+^K*W\T/_#-7_!RW_P!'W_LB_P#AI[C_ .5='_#-
M7_!RW_T??^R+_P"&GN/_ )5U_2]11_KCB_\ H2\*_P#B.99Y?].?+\7W#ZM'
M_GY7_P#!T_+S\OZLK?S0_P##-7_!RW_T??\ LB_^&GN/_E71_P ,U?\ !RW_
M -'W_LB_^&GN/_E77]+U%'^N.+_Z$O"O_B.99Y?].?+\7W#ZM'_GY7_\'3\O
M/R_JRM_-#_PS5_P<M_\ 1]_[(O\ X:>X_P#E71_PS5_P<M_]'W_LB_\ AI[C
M_P"5=?TO44?ZXXO_ *$O"O\ XCF6>7_3GR_%]P^K1_Y^5_\ P=/R\_+^K*W\
MT/\ PS5_P<M_]'W_ +(O_AI[C_Y5T?\ #-7_  <M_P#1]_[(O_AI[C_Y5U_2
M]11_KCB_^A+PK_XCF6>7_3GR_%]P^K1_Y^5__!T_+S\OZLK?S0_\,U?\'+?_
M $??^R+_ .&GN/\ Y5T?\,U?\'+?_1]_[(O_ (:>X_\ E77]+U%'^N.+_P"A
M+PK_ .(YEGE_TY\OQ?</JT?^?E?_ ,'3\O/R_JRM_-#_ ,,U?\'+?_1]_P"R
M+_X:>X_^5='_  S5_P '+?\ T??^R+_X:>X_^5=?TO44?ZXXO_H2\*_^(YEG
ME_TY\OQ?</JT?^?E?_P=/R\_+^K*W\T/_#-7_!RW_P!'W_LB_P#AI[C_ .5=
M'_#-7_!RW_T??^R+_P"&GN/_ )5U_2]11_KCB_\ H2\*_P#B.99Y?].?+\7W
M#ZM'_GY7_P#!T_+S\OZLK?S0_P##-7_!RW_T??\ LB_^&GN/_E71_P ,U?\
M!RW_ -'W_LB_^&GN/_E77]+U%'^N.+_Z$O"O_B.99Y?].?+\7W#ZM'_GY7_\
M'3\O/R_JRM_-#_PS5_P<M_\ 1]_[(O\ X:>X_P#E71_PS5_P<M_]'W_LB_\
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M?M"_]GR_'3_TT^!*_I=K^:+_ (-:_P#DQS]H7_L^7XZ?^FGP)7]+M?7<>_\
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M\4+7_A&])TK0_B)XL\(^'Y+.;78M<U*X?5M$\/V.N3R3WB&.74VMA;0_9SN
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M-DUFVA6XN=)COK5]3M[=UC9)Y[!93=10NLT3++)$J,LL9#$.N=*O\^;XC_\
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M<;/#_A#4?#.A6FOZWXW\768%LE]HNC:9=F7;?ZWX:T.TN1%>:]KEMID,T%R
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M+.Z@E"RP7FGSR36%Y!(JR0W5M-&ZAE( ![A117\RO_!=K]O#]JBW^,'[,?\
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MYHO^#6O_ ),<_:%_[/E^.G_II\"5_2[7UW'O_)8\0?\ 8PJ?^D0,,-_N]+_
M@HHHKY$W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#^0[_@ZP^#GQ-\,:9^P%_P4B^'O@NY\?Z/^P5\>6U_XGZ)I\-]/=Z;X'\5Z
MYX(UT>(KQ;:41PZ#!KO@#3-$U34# \NF3Z[I]]+)#IL.H2)^X?P&_P""P?\
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M#//Q1>:+\#/V_/V=9I;FZTOX*?MA:T?#DOF#^S+72]:T:/1)]/T^V?-S O\
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MF.QULV=DMS;WD]GH?A'^W-5U.ZMUDALECM5N@%NXED]!_P"" 7[-FO?LJ?\
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MZ/KMUXITO4?#5H\<US>1WGB;0%>*VAUR&:$ ]R\;_#;_ (/ M"\.2_M&Z?\
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M+#!NEB>)_P"R71;5K'1M)LGR7M-,L+5B>#NM[6*)LC P<H<\#GL* -.BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_G"_X.
M=O\ DQ;X/_\ 9XO[/O\ ZDLE?T>U_.%_P<[?\F+?!_\ [/%_9]_]262OK.!?
M^2PX>_[&5'_VXY\7_N]7_#^J/Z&_"'_(I>%_^Q=T3_TV6M=%7.^$/^12\+_]
MB[HG_ILM:Z*OE9_'+_%+\V;QV7HOR"OYE_\ @F?_ ,IZO^"UW_8#^!G_ */U
M2OZ:*_F7_P""9_\ RGJ_X+7?]@/X&?\ H_5*^MX:_P"11QM_V3E#_P!:#)3&
MM_$P_P#U]?\ Z:J']-%,E$ABD$+(DQC<1/(ADC20J0C21J\;2(K8+(LD9905
M#H3N#Z*^0-S\1_\ @E9_P1LT_P#X)T?&?]K_ /:5\>_'R[_:9_:"_:^\;2>(
MO$_Q!N_AU;?#:+P[H%SKFJ^*M0\/6.C6_BWQ@EU<ZOXFUB74=5U:*\TV*ZAT
MW1;5=+B^PM--^W%%% 'X>?MW_P#!'+4_VKO^"@W['G_!1?X/?M*2?LU?&3]E
MAM*L=9AL/A</&L7Q=\+Z;XDN-2N/#&O:I:^/O!%YI5EK?A;6?%?@'6)O*UB2
MY\,^(Y[9%B%I A^FO^"G?_!+3]G#_@JI\#M.^$/QY77_  YK_@[63XJ^%7Q<
M\"S6=CX^^&7BDQ)#<7NB7%_;7EI>Z1JT,4-OKN@W\3VNHQ6]I<0S6.JZ?INI
MV?Z4T4 ?R 7'_!O]_P %<];\.2_L[>*O^"\OQDU7]DN^LK;P_J^C0>#O%5O\
M2]2\%1:=/I-UX,:]F^(=PR:/?Z3=W.EW5K=>,=0T:Y06MY?Z%?"UBT\?T,?\
M$[O^">O[/7_!,S]FKPW^S/\ LZZ->0>']/O;CQ)XR\8:])#=>,OB;X^U.TL;
M/6_'7C&^MXH+>;5K^VTW3["ULK*WM=*T71].TW1]*M+>RLHD/W/10!^+G["W
M_!(?_AB[_@H-^W3^W9_POMOB)_PVE,\I^&1^&Z^%_P#A7>_Q8GB<+_PEP\;:
M]_PE&W9]A!_X1SP_D'[0P)'E4?\ !6;_ ((I_!#_ (*D_P#"M_B+)\0?%_[.
M/[5/P4!3X2_M)_#6 7'B?1K"&XO=6TWP[XATU=2T6;7- TKQ+=_\)%I/V'6]
M"UW1K^34AH^MV,6L:DEQ^T=% '\LGPT_X(._MX?%GQ5X'T;_ (*=_P#!6CXI
M?M>?LS_#;Q/X=U^W_9PT'0=7\*^'_C&OA:Y@N])LOC;XAN_$!O\ Q#I<LUE:
MC6],O+3Q#?ZRD]\3XDLIYIKBZ_0[_@D3_P $E;#_ ()46'[5>E:5\8K/XJ:7
M^TG\<;CXP:;I>F_#*'X::;\.+!X=0MK/P;I]E;^,?%D&J66GV]Y';VMW"NB0
MQ06L<46F1(0%_8VB@#\6/^"K?_!%3X,_\%-+[P#\7M,^)7CG]F;]L#X+V:6O
MP;_:7^&4UR-:T""#5DUJTTWQ-H=GJF@S>(M.L+_[5<:/<V6NZ%KNASW]Z^GZ
MNEM=75E<?E3XA_X-VO\ @HY^U':Z7\)/^"@W_!:?XQ?'+]ES0KO1+F?X9^$?
M#&K:3KGQ!CTN^2[\OQKJ6N>);G3)]0MA'C3]>U^S\?:A!.YN(TMYD\R3^OVB
M@#Q?]GK]GGX._LJ_!KP'\ ?@+X'T?X>?"KX;Z)!H7A?PQH\.R&"W0M+=7U_<
MONN=5UK5[R2XU+6]8OY9]0U;4[JZOKV>6>=V/\X/QY_X-T/BUX"_:@^(W[5_
M_!)W]O\ ^(/[ OBGXRZAJWB+XJ?"\Z/?^+OAGK_BC5[^?4[R[TR&QUG3OL>A
MW>H7FH:BWAWQ'H?B^'2M2O)9_#]YI-BL&F0?U344 ?S ?LX_\&\'CW7OVFOA
M7^V)_P %4?V\_B?_ ,%"/BU\$]3LO$'PF\!:KI,_A;X/^!]>T[4EUBPG&F7^
MLZS<:KIMCK5KIFOP:+HVF^"=(O-7L8'\06&O6\;0S?H[_P %CO\ @F#_ ,/9
M?V4[#]F3_A=!^!0L?B5X9^(7_"9#P$/B*)?^$=MM3M_[).@GQ=X+*"[_ +1W
M_;1K!,!@"_9IA(=OZQ44 ?&7Q<_8;^#7[1/[$K?L+?'VRF\??"[4?A%X,^%F
MOW]GO\/:Q-<>"='T6RT7QGH$L,U\_A_Q!INLZ%8^(]((GOX;*]@BMKH:C9&X
MAN?YS/ O_!OS_P %7_V9-'N_@M^QK_P7#^)'PU_9B.JZA!X9\%^*_ &JZIXK
M^'_A*ZDV6>G>&[VU\47&GVVJ6-A(T,L_A>3P'IEW?6T.I66FZ*UP;>S_ + *
M* /QE_X)3?\ !%_X.?\ !,2\^*?Q0D^*?Q#_ &E_VJ?CU(DWQG_:-^*DH77_
M !'F_DU>[L-"T?[;J\^BZ=J6LR-J^JS:KK_B77]4OEA-]KLUM:VEK!^S5%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_-
M%_P:U_\ )CG[0O\ V?+\=/\ TT^!*_I=K^:+_@UK_P"3'/VA?^SY?CI_Z:?
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M_LVGXF_^F*>L/_@C#_RBS_8B_P"R(Z-_Z<]6K<_X*_?\HO?V[O\ LVGXF_\
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ML\UQ);6T+W$[2?3- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\
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MWR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\
M#_/_ ()$?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5
M'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q
M7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$
M?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@G
MY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P#
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M"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\
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MWR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\
M#_/_ ()$?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5
M'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q
M7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$
M?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@G
MY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P#
M*G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_
M ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK
M_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P# *G_RSU_I
MZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)WXC__
M #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7
M_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/
M_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)WXC__ #%U]8?\
M.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M.
M _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'
MK_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_
M $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM
M_P##AD_E_P!2WR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )
MWXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_
M .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E
M_P!2WR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%
MT?\ #_/_ ()$?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_
M ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W
M^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_
M ()$?]'K_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N
M#_@GY_T9+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'
M_P# *G_RSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K
M_#W_ ,)WXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9
M+^RK_P"&%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P# *G_R
MSU_IZ?)__#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)W
MXC__ #%U]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&
M%^&7_P S5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P# *G_RSU_IZ?)_
M_#_/_@D1_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)WXC__ #%U
M]8?\.X/^"?G_ $9+^RK_ .&%^&7_ ,S5'_#N#_@GY_T9+^RK_P"&%^&7_P S
M5'M. _\ H$XM_P##AD_E_P!2WR?W^06Q7\V'_P# *G_RSU_IZ?)__#_/_@D1
M_P!'K_#W_P )WXC_ /S%T?\ #_/_ ()$?]'K_#W_ ,)WXCC^?@ROK#_AW!_P
M3\_Z,E_95_\ #"_#+_YFJ4?\$X/^"?@(/_#$O[*G!SS\!?AD1QZ@^&B"/8@@
M]Z/:<!_] G%O_APR?R_ZEOD_O\@MBOYL/_X!4_\ EGK_ $]/Y>?^#?\ _P""
MHG[!?[('[)WQG^'W[1_[1GA3X6^,?$W[6?Q;^(6A:'K6D>+;VYU'P;XBT[PC
M#HNNPR:)X>U2W6VOY=.O4CCFFCN4,#>;"@9"W[J_\/\ /_@D1_T>O\/?_"=^
M(_\ \Q=?DY_P;=_LB_LK_&[]C?XZ^)?C'^SC\$/BGXBTK]LKXR^&=,UWX@_#
M#P;XOU?3O#FE:7X,?3-!L=0U[1[ZZM=(L'N[I[33H)4M8'N)FCB!<FOZ$_\
MAW!_P3\_Z,E_95_\,+\,O_F:KZ;C*?!RXHSM8[#<2SQ:QT_;RPN-RNGAW/EA
M?V,*N J5(PMHE.<I:O78QPZQ'L:?+*CR\JMS0FW;SM-*^_3MZGR?_P /\_\
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M3^7_ %+?)_?Y!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\
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M?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71_P /\_\ @D1_T>O\/?\
MPG?B/_\ ,77UA_P[@_X)^?\ 1DO[*O\ X87X9?\ S-4?\.X/^"?G_1DO[*O_
M (87X9?_ #-4>TX#_P"@3BW_ ,.&3^7_ %+?)_?Y!;%?S8?_ , J?_+/7^GI
M\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71_P /\_\ @D1_T>O\/?\ PG?B/_\
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M\/?_  G?B/\ _,71_P /\_\ @D1_T>O\/?\ PG?B/_\ ,77UA_P[@_X)^?\
M1DO[*O\ X87X9?\ S-4?\.X/^"?G_1DO[*O_ (87X9?_ #-4>TX#_P"@3BW_
M ,.&3^7_ %+?)_?Y!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?
MB/\ _,71_P /\_\ @D1_T>O\/?\ PG?B/_\ ,77UA_P[@_X)^?\ 1DO[*O\
MX87X9?\ S-4?\.X/^"?G_1DO[*O_ (87X9?_ #-4>TX#_P"@3BW_ ,.&3^7_
M %+?)_?Y!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71
M_P /\_\ @D1_T>O\/?\ PG?B/_\ ,77UA_P[@_X)^?\ 1DO[*O\ X87X9?\
MS-4?\.X/^"?G_1DO[*O_ (87X9?_ #-4>TX#_P"@3BW_ ,.&3^7_ %+?)_?Y
M!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71_P /\_\
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M3^7_ %+?)_?Y!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\
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M?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71_P /\_\ @D1_T>O\/?\
MPG?B/_\ ,77UA_P[@_X)^?\ 1DO[*O\ X87X9?\ S-4?\.X/^"?G_1DO[*O_
M (87X9?_ #-4>TX#_P"@3BW_ ,.&3^7_ %+?)_?Y!;%?S8?_ , J?_+/7^GI
M\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71_P /\_\ @D1_T>O\/?\ PG?B/_\
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M\/?_  G?B/\ _,71_P /\_\ @D1_T>O\/?\ PG?B/_\ ,77UA_P[@_X)^?\
M1DO[*O\ X87X9?\ S-4?\.X/^"?G_1DO[*O_ (87X9?_ #-4>TX#_P"@3BW_
M ,.&3^7_ %+?)_?Y!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?
MB/\ _,71_P /\_\ @D1_T>O\/?\ PG?B/_\ ,77UA_P[@_X)^?\ 1DO[*O\
MX87X9?\ S-4?\.X/^"?G_1DO[*O_ (87X9?_ #-4>TX#_P"@3BW_ ,.&3^7_
M %+?)_?Y!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71
M_P /\_\ @D1_T>O\/?\ PG?B/_\ ,77UA_P[@_X)^?\ 1DO[*O\ X87X9?\
MS-4?\.X/^"?G_1DO[*O_ (87X9?_ #-4>TX#_P"@3BW_ ,.&3^7_ %+?)_?Y
M!;%?S8?_ , J?_+/7^GI\G_\/\_^"1'_ $>O\/?_  G?B/\ _,71_P /\_\
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MGI\G_P##_/\ X)$?]'K_  ]_\)WXC_\ S%T?\/\ /_@D1_T>O\/?_"=^(_\
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M'_#_ #_X)$?]'K_#W_PG?B/_ /,77UA_P[@_X)^?]&2_LJ_^&%^&7_S-4?\
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M&7_S-4>TX#_Z!.+?_#AD_E_U+?)_?Y!;%?S8?_P"I_\ +/7^GI\G_P##_/\
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M/_H$XM_\.&3^7_4M\G]_D%L5_-A__ *G_P L]?Z>GR?_ ,/\_P#@D1_T>O\
M#W_PG?B/_P#,71_P_P _^"1'_1Z_P]_\)WXC_P#S%U]8?\.X/^"?G_1DO[*O
M_AA?AE_\S5'_  [@_P""?G_1DO[*O_AA?AE_\S5'M. _^@3BW_PX9/Y?]2WR
M?W^06Q7\V'_\ J?_ "SU_IZ?)_\ P_S_ ."1'_1Z_P /?_"=^(__ ,Q='_#_
M #_X)$?]'K_#W_PG?B/_ /,77UA_P[@_X)^?]&2_LJ_^&%^&7_S-4?\ #N#_
M ()^?]&2_LJ_^&%^&7_S-4>TX#_Z!.+?_#AD_E_U+?)_?Y!;%?S8?_P"I_\
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M(B+=V4LKV\ZJ%DC()!^DX/GP<^)\D6!PW$L,7]?I?5Y8K&Y74PZJV?*ZT*.
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M?[/EET1(SIBI]M;[66M_VLC?S(XY,8WHCXSG&Y0V,\9QG&<4 /HHHH ****
M"BBB@ HHHH **** "BBB@ HKX4_X*8_MEWG_  3X_8:^/_[8MA\/;?XJW?P1
MT+PQK,/P_N_$TG@ZW\1GQ%X_\)>"&MY?$L.A^)9-*6S3Q,VI"5-#U S-9"U\
MN,3F>+I?^"??[5=U^W!^QC^SS^UE>^!X/AM=?'3X?6/CB?P+;>('\50>&7O+
MN\MCIL7B&31] DU98Q:AQ=MHVGEO,VFW7;D@'V-1110 4444 %%%% !1110
M4444 %%%% !17X*?\$T/^"@'_!2?]I_]N+]MCX'?M8_L6VWP"_9^^"NLZM:?
M!GXBQ^&_&^B7NJK8>+;G1]%TO5/$OB34;OP]\0[KQ7X8^S>+;;4O"FE^';?3
M;0$/:7,-S%(G[UT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\T7_!K7_R8Y^T+_P!G
MR_'3_P!-/@2OZ7:_FB_X-:_^3'/VA?\ L^7XZ?\ II\"5_2[7UW'O_)8\0?]
MC"I_Z1 PPW^[TO\  @HHHKY$W"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HK\*?^"E/_!3+_@H?^Q]\?M#^%O[*G_!([XO?MT?#
M?4OACX?\9ZA\8_ OBWQ5H>BZ5XMU7Q#XMTK4_ 4MGHGPC\=VKZAHNF:%HNM3
MW$FL0SO#XDMD;3X4CCGN?SX_X?N?\%I_^E<']I'_ ,.+\0O_ *&^@#^MVBOY
MY_\ @C9_P6W^*O\ P4_^//[4OP!^+'[&-Q^RAXM_9<TS3%\66EW\3]2\?ZBG
MB^?Q3J7A?6?!FMV-Y\-? \6@ZOHESIERUQ"U[?7#R131&UC6%Y1_0Q0 45#<
M7$%I!/=74T5O;6T,MQ<7$SK%#!!"C23332.0D<44:L\CN0J(I9B ":_ C_@E
M1_P4,_:%_P""G'[6?[;OQ=\*:UH^D?\ !./X#>/V^!7[.]O9>%M%GU;XT>-M
M'MXU\4_$.?QXES=7<WAE;6*V\2Z'I-A%;LVE^-/#!U"XCGM;VQD /W]HHK\5
M/^"UO_!9OX;?\$>_@MX"\6WW@6W^-7QL^+OBEM"^%WP43QBG@N?6M%T5[*;Q
MOXRU?7(M!\4WVE^'_#EI?V%A!+;>'=0?4O$FM:+I2BW@FO;ZR /VKHK\S?\
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MQF&2ZT+Q)IT&I61GA;YH+J*.?R+N!OF@N8I8FY0UZG0 4444 %%%% !1110
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M3PQX(T'4KVYTZQ\2>-GTR0:@TERUEJ.H6NG23Z1I]IH^F76OZ]K.GZ.BO/\
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MR+P_??"'X;Z5XLOM,\)6/AJYO_%?@I_LNNP^'[:S:QLVG\K3]'MW\E(3++,
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M8\,:9<ZOK.HS"-7FF-O96DS16MO'+=7<WEVMI#-<S11/_!MX0^''CS_@KAX
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M'N(-"EFN[Y2TTUO=:\FOWUM:2%$MFN9G2,&X+-^H_P#P5&_X)+?#;_@JE/\
MLS6'Q<^+OQ!\$>!OV=/BE)\4KGX>^%-/T'4?#?Q0U)O[)@BL/%L6M0S-;QVV
MEV6KZ-;7EBIN(M.\4:Y$J[IT=/F;_@V#&BC_ ((N_LI?V,-/ +?$@ZI_9_E8
M.M'XA>(?[0-YY?\ S$-VS[5YG[W=MW]J_H H HQQZ9HFF1PPQV.D:/I%BD<4
M4:6]AIFEZ986X5(XT416ME8V5K$%1%$5O;6\0 "1H /XU?\ @A??:%\8O^"[
MW_!9[]H[]FW3+=_V2-7NAX/E\6^&Y8H?!7BWXIS>-]/U%=8TN $&^;7KG2OB
M#XGM+JVB2VBLM7-QB--4MT;J?^"N_P#P4P^,G[?OQ]_X<F?\$G=2U?Q!\1/&
M>L#PU^V-^TOX-G:3PQ\'_AW!=C3_ (@>$-/\06MQ:VZ0Z=:32VWQ$UR#5;$S
MR+_PKG0+FXUK5]1%K_1%_P $Y?\ @GQ\"O\ @F;^R[X)_9A^!-A-/IFA"?6/
M&WCO5X+5?%OQ0\?:KME\0>-O%5S;(JM=7DJI9Z3IL1:R\/Z!9Z9H6GC[+8(\
M@!]VU^:W_!8_Q[-\-/\ @E9_P4 \6V\RVT\7[*_Q>\/Q7#7$=JT+^-?"M]X*
M66&XEDB$5RA\0[K1HW6X-R(EM<W)B!_2FO)OCG\#OA'^TG\*?&/P.^.W@;0O
MB5\*/B%96FF>+_!'B6*2?1M>MM/U2QUW3X[J.*6"4O8ZQI6GZI:212I)!>6,
M$Z,&B% '\4G_  1J_P""ZO\ P3$_X)??\$H?V4O@O\;?BAXKUOXUZO=?%/QC
M\0_AU\*/!%UXWUOP/<^)_B?XRO/#\OBJ\-]I.@V;ZKX-M?#&IPV5OK%WJL$6
MIVT=]I]JXEV?U9?L#?\ !4#]B[_@I9X+U3QA^R?\6[+QA=>'%@;Q?X"UNTD\
M-?$KP:EU(T5I/XC\'7[F_MK"[<;+;5K-[[2)I6%NE^;C,(ZOX&?\$X/V#?V;
M?!<OP^^"W[)/P%\%>%KJ]N-2O[.#X;>&=5N]5U&Z00S7VKZQKEAJ>KZK=&V6
M.SCFO[ZX>&QAM[*$QVMO#$G\CG_!4_\ 9Q\$_P#!'G_@M!_P3:_;7_8OL?\
MA37AO]KOXPZ?\(OCI\,?#%M#:?#W48=9\5>$/"?CB?2?#MDKI86/B'PMXPM]
M5N_#UEIIL(?%&B6NN:0;2_N)(T /V;_X.9_V0/C)^UC_ ,$[=*U'X$^'/$_C
M[QY^S/\ 'OX=?M)GX8>$8#=ZW\1/#/@VQ\2^'_%6C6%C&WVK4;S2-#\67?BN
MSTVP@N]1O[G0([;3[.YO'AA?\H/V_?VY=#_X+X7?[#_[%7[%GP3_ &DM/^(&
MA_M/_#7XP?M.Z[\1/A5X@\ :'^S5X4\%1FXUT^(?$.J@:5/K<)N-3DT:)I(3
MJ)T^T2R22^U&*SC_ +?NM?A)_P %L/\ @H3XA_8\^&/@_P#9F_9)T"S\5?\
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M@-C^ZJJJ*J(H5$4*JJ %55&%50.     . !@4 .HHHH **** "BBB@ HHHH
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M67_!TS_T<E_P3\_\-[+_ /,;1_JG2_Z*SA#_ ,.>,_\ G:'MW_SXQ'_@$?\
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M *.2_P""?G_AO9?_ )C:/^%9?\'3/_1R7_!/S_PWLO\ \QM'^J=+_HK.$/\
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M\$_/_#>R_P#S&T?ZITO^BLX0_P##GC/_ )VA[=_\^,1_X!'_ .3_ *L_*_\
M3+17\S7_  K+_@Z9_P"CDO\ @GY_X;V7_P"8VC_A67_!TS_T<E_P3\_\-[+_
M /,;1_JG2_Z*SA#_ ,.>,_\ G:'MW_SXQ'_@$?\ Y/\ JS\K_P!,M%?S-?\
M"LO^#IG_ *.2_P""?G_AO9?_ )C:/^%9?\'3/_1R7_!/S_PWLO\ \QM'^J=+
M_HK.$/\ PYXS_P"=H>W?_/C$?^ 1_P#D_P"K/RO_ $RT5_,U_P *R_X.F?\
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M (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\
M@$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\
MT<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO
M_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+
M_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO
M^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z
M*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY
M_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^
M=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_
M (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\
M@$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\
MT<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO
M_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+
M_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO
M^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z
M*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY
M_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^
M=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_
M (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\
M@$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\
MT<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO
M_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+
M_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO
M^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z
M*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY
M_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^
M=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_
M (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\
M@$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\
MT<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO
M_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+
M_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO
M^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z
M*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY
M_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^
M=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_
M (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\
M@$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\
MT<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO
M_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+
M_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO
M^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z
M*SA#_P .>,_^=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY
M_P"&]E_^8VC_ (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^
M=H>W?_/C$?\ @$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_
M (5E_P '3/\ T<E_P3\_\-[+_P#,;1_JG2_Z*SA#_P .>,_^=H>W?_/C$?\
M@$?_ )/^K/RO_3+17\S7_"LO^#IG_HY+_@GY_P"&]E_^8VC_ (5E_P '3/\
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M_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\ HK.$/_#GC/\ YVA[=_\
M/C$?^ 1_^3_JS\K_ -,M%?S-?\*R_P"#IG_HY+_@GY_X;V7_ .8VC_A67_!T
MS_T<E_P3\_\ #>R__,;1_JG2_P"BLX0_\.>,_P#G:'MW_P ^,1_X!'_Y/^K/
MRO\ TRT5_,U_PK+_ (.F?^CDO^"?G_AO9?\ YC:/^%9?\'3/_1R7_!/S_P -
M[+_\QM'^J=+_ **SA#_PYXS_ .=H>W?_ #XQ'_@$?_D_ZL_*_P#3+17\S7_"
MLO\ @Z9_Z.2_X)^?^&]E_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\
MHK.$/_#GC/\ YVA[=_\ /C$?^ 1_^3_JS\K_ -,M%?S-?\*R_P"#IG_HY+_@
MGY_X;V7_ .8VC_A67_!TS_T<E_P3\_\ #>R__,;1_JG2_P"BLX0_\.>,_P#G
M:'MW_P ^,1_X!'_Y/^K/RO\ TRT5_,U_PK+_ (.F?^CDO^"?G_AO9?\ YC:/
M^%9?\'3/_1R7_!/S_P -[+_\QM'^J=+_ **SA#_PYXS_ .=H>W?_ #XQ'_@$
M?_D_ZL_*_P#3+17\S7_"LO\ @Z9_Z.2_X)^?^&]E_P#F-H_X5E_P=,_]')?\
M$_/_  WLO_S&T?ZITO\ HK.$/_#GC/\ YVA[=_\ /C$?^ 1_^3_JS\K_ -,M
M%?S-?\*R_P"#IG_HY+_@GY_X;V7_ .8VC_A67_!TS_T<E_P3\_\ #>R__,;1
M_JG2_P"BLX0_\.>,_P#G:'MW_P ^,1_X!'_Y/^K/RO\ TRT5_,U_PK+_ (.F
M?^CDO^"?G_AO9?\ YC:/^%9?\'3/_1R7_!/S_P -[+_\QM'^J=+_ **SA#_P
MYXS_ .=H>W?_ #XQ'_@$?_D_ZL_*_P#3+17\S7_"LO\ @Z9_Z.2_X)^?^&]E
M_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\ HK.$/_#GC/\ YVA[=_\
M/C$?^ 1_^3_JS\K_ -,M%?S-?\*R_P"#IG_HY+_@GY_X;V7_ .8VC_A67_!T
MS_T<E_P3\_\ #>R__,;1_JG2_P"BLX0_\.>,_P#G:'MW_P ^,1_X!'_Y/^K/
MRO\ TRT5_,U_PK+_ (.F?^CDO^"?G_AO9?\ YC:/^%9?\'3/_1R7_!/S_P -
M[+_\QM'^J=+_ **SA#_PYXS_ .=H>W?_ #XQ'_@$?_D_ZL_*_P#3+17\S7_"
MLO\ @Z9_Z.2_X)^?^&]E_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\
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M_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\ HK.$/_#GC/\ YVA[=_\
M/C$?^ 1_^3_JS\K_ -,M%?S-?\*R_P"#IG_HY+_@GY_X;V7_ .8VC_A67_!T
MS_T<E_P3\_\ #>R__,;1_JG2_P"BLX0_\.>,_P#G:'MW_P ^,1_X!'_Y/^K/
MRO\ TRT5_,U_PK+_ (.F?^CDO^"?G_AO9?\ YC:/^%9?\'3/_1R7_!/S_P -
M[+_\QM'^J=+_ **SA#_PYXS_ .=H>W?_ #XQ'_@$?_D_ZL_*_P#3+17\S7_"
MLO\ @Z9_Z.2_X)^?^&]E_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\
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M_P#F-H_X5E_P=,_]')?\$_/_  WLO_S&T?ZITO\ HK.$/_#GC/\ YVA[=_\
M/C$?^ 1_^3_JS\K_ -,M%?S-?\*R_P"#IG_HY+_@GY_X;V7_ .8VC_A67_!T
MS_T<E_P3\_\ #>R__,;1_JG2_P"BLX0_\.>,_P#G:'MW_P ^,1_X!'_Y/^K/
MRO\ TRU_.%_P<[?\F+?!_P#[/%_9]_\ 4EDKE_\ A67_  =,_P#1R7_!/S_P
MWLO_ ,QM?DO_ ,%C/!G_  6XT/\ 9O\ AS=_M]_&']E'QM\&7_:,^#UOH^E?
M![PF-'\50_$&7Q !X5O[BXD\/Z8\NB6DPG;4K>.<K(C()4<>6!])PAPW3PG$
M^28A<2\,8IT<?2FL/A<PQ53$UK7]RC3E@*<9U'?W8N<4^Z,<15<J%2/L:T;Q
MWE"*2U3U:F]/O_*_]U?A#_D4O"__ &+NB?\ ILM:Z*N4\!BZ7P/X-6^>*2^7
MPIX=%Y)"NR&2Z&D68N'B3^&)IM[1K_"A [5U=?ET])S6_O2U6SU>QVQV7HOR
M"OYE_P#@F?\ \IZO^"UW_8#^!G_H_5*_IHK^9?\ X)G_ /*>K_@M=_V _@9_
MZ/U2OK>&O^11QM_V3E#_ -:#)3&M_$P__7U_^FJA_311117R!N%%%% !1110
M 4444 %%%8OB3Q+X<\':!K'BKQ=K^B^%?"_A[3[K5M?\2>)-5L=#T#0]*LHF
MGO=3UC6-3GM=.TS3[2%&FNKV]N(+:WB5I)94120 ;5%<[X3\7^$_'OAS2?&'
M@7Q1X=\:>$M?M?MNA>*?">M:;XC\.:U9&22$7>DZWH]S>:9J-KYL4L7VBSNI
MHO,CD3?N1@.BH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN#\1_%/
MX8^#_%/A'P-XN^(_@/PMXU\?S7-OX#\'^(_%_A[1/%/C:XLC"MY!X1\/ZGJ-
MKJWB2:T:X@%S%HUI>O 9X1*J&5-W>4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !17!^-/BG\,?AO=>%['XA_$;P'X"OO&^LQ>'/!=GXT\7^'_"UUXO
M\0SO!'#H/A>WUS4;&;7]9FDNK:.+2])2[OI'N($2 M+&&[R@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YHO^#6O_ ),<
M_:%_[/E^.G_II\"5_2[7\T7_  :U_P#)CG[0O_9\OQT_]-/@2OZ7:^NX]_Y+
M'B#_ +&%3_TB!AAO]WI?X$%%%%?(FX4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 445XC8_M)_ 75/C=JO[-FF?%?P
M7J7QZT'0D\3Z]\*-/U>*^\::%X>EM[:ZAUG6](M1+-I&GSP7MF\%SJ)MHYS>
M6B0EY+F%7 /;J*** "BBB@ HHK&UOQ'X>\,VAU#Q)KNC>'[ '!O=;U2QTJT!
MW(F#<W\]O"#NDC7!?[SHO5E! -FBJ>GZCI^K65MJ6E7UGJ>G7L*7%G?Z?<PW
MEE=P2#*3VUU;/)!/"XY22*1T8<AC5R@ HK"B\4^&)]>N?"L/B/09O$]G EU=
M^'(M7T^37K6UDBBFCN;G1TN#J$$#PSP2I-+;K&T4T4BL4D0G=H ***\7^)?[
M1?P+^#/BOX<^"/BQ\5?!7PY\4?%W5YO#_P ,M+\8ZU;: WC?7X3"'T/P_=ZB
M8+"^UDFYMQ%I:70OIS-$(()"Z@@'M%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?G#_P %?O\ E%[^W=_V;3\3?_3%
M/6'_ ,$8?^46?[$7_9$=&_\ 3GJU;G_!7[_E%[^W=_V;3\3?_3%/6'_P1A_Y
M19_L1?\ 9$=&_P#3GJU?7+_D@Y?]E='_ -4TS#_F)7_7A_\ IR)^G5%%%?(F
MX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%>(^,/VD_@+X ^+/@3X$>,OBOX,\/_&;XG64^I?#_ .&-]JT0
M\:>+=-M9;F&ZU#1=!B$M]=6-L]E>?:+P1+;P):74LLB16\SI[=0 45S-[XU\
M&Z;KEIX8U'Q;X9L/$M_]G-CX>O=>TJUUR]%V\D=J;329[N._N/M+PS);^3;O
MYSQ2+'N*,!TU !1110 4444 %%%86D>*/#/B"YU.ST'Q%H6MW>B7366LVND:
MOI^I7.D7J22Q/::G!9W$TMA=++!/$UO=K%*LD,J% T;@ &[1110 45XQ<_M%
M? NR^-=G^SA?_%7P5IWQWU/PV_C#2/A3J6M6VG>--;\,1AC+K6@Z/>M!/KEC
M (YVN)-(^VFW6UO6F6,65V8?9Z "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_G"_X.=O^3%O@_P#]GB_L^_\ J2R5_1[7
M\X7_  <[?\F+?!__ +/%_9]_]262OK.!?^2PX>_[&5'_ -N.?%_[O5_P_JC^
MAOPA_P BEX7_ .Q=T3_TV6M=%7.^$/\ D4O"_P#V+NB?^FRUKHJ^5G\<O\4O
MS9O'9>B_(*_F7_X)G_\ *>K_ (+7?]@/X&?^C]4K^FBOYE_^"9__ "GJ_P""
MUW_8#^!G_H_5*^MX:_Y%'&W_ &3E#_UH,E,:W\3#_P#7U_\ IJH?TT4445\@
M;G^?E^VG^QEHG_!1[_@Z;_: _9%^)GQL^//PK^&M[^S_ /#OQT+OX+^-;?0=
M:MM6\+_L\?"R\M;:TB\0Z7XE\/VUC?37DTNHK'H9GFE)F26.:665_P!$/%?_
M  :(_!O2/#^J7_P'_P""C7[?7@/XIP6SMX5\2>+_ (A>%/$?ANSO<95-7TGP
MEX/\ Z_<6<Y CD:P\36<D0/F>5<[?);Y:\;_ +0/P2_9E_X/!/C]\5OV@?BC
MX-^$'PXT[]EKPAI5YXR\=:Q!HFA0ZGK'[.WPBM=+T]KV?Y/M=_/F.VA'S2%7
M/ 4FOZ)/B1_P7P_X)!_##PIJ?BS6?V[/@CKL.GVEW=0Z'X'UNY\:>*=7DLX#
M.UCH^@Z!9WEY=WLPVQVZ.(('FDCC:="XH _.K_@WV_X*#?M7^+OBK^UE_P $
MKO\ @H1XAC\9?M5?L2:SLT#XEW=[%?:Y\2/AM'J(T.Y75[ZTB>WUZX\-W+:'
MJ=CXIN;A-2UC0?&.DVVH1W-_I5Y>2_TY>*_%WA7P)X?U3Q9XV\2:#X0\+Z):
M37VL>(O$VK6&AZ)I=E;QM+/=:AJFISVUE:011([O+/,B*JDD\5_'#_P;D^$/
MBE^UW_P42_X*4?\ !8?Q)\.?$/@3X*_M%:S?^"O@'>>+;,Z?JGB/2[[Q1:ZM
MJ"Z5 ICBO])\.^'?#OA33;_6X$N["ZUJ>>PM+Z:ZTS4@GF?[6%IH_P#P7(_X
M+8?&K]C/X[_M%S?";_@G-_P3LT?1(O&/PWC\<6'@'_A>7QD6XT^W\1P@:E?:
M;)+>VWB/4-2\/GQ!/!JR>'O#_@IIO#Z6-]XP-W( ?UB?"G_@HA^P7\=?&<?P
MY^#'[9G[,/Q4\?3-*D/@OP#\</ASXJ\3SR0EUEC@T31O$-WJ,TD;1R*T<5N[
M@HPVY!K[!N;FWL[>>[NYXK:UM89;FYN)Y%B@M[>!&EFGFE<JD<44:M))(Y"H
MBEF( )K^2/\ ;1_X-Y_^",7Q"^ 7B*']D7Q+\+_V4/VD/!.DGQ1\(_BWX+_:
M$U'5&'C?PQ"-2T.'Q;8>)/B)K2S:?J=[9QPW&J: =&UO1;N>+7-,N'GT^*RG
M^M?^""__  4!^(/[?_\ P2;\6:Y\;?%DGCCX^_ *?XM_ 3XL^+)[%;.X\5W'
MAGP])K'@KQ3=2P@6NJW^J^!-<T"WUK6K=8AJOB'3=9O9H(KB652 ?L1>_MQ?
ML9Z;\)M0^/6H?M5_L]67P2TK74\+ZE\6KKXO^!(/AW9>))'MT30+CQ?)KBZ%
M'K+-=VP&F->_;/W\1\G#@U\N_M?^'_V-_P#@J[_P34^-_A./]I[PU9_LK?%O
M0;BSU3]I'X;>-/#X\,^&I_AEX]TW6)]6_P"$HU&4>'+C2=%\8^$(=-\2V=_<
M16&I:?'J6DS7,,=WYZ?QB?\ !LO_ ,$D_A'_ ,%*?V?_ !%\1OVUM9\1?$[]
MG+]GOXJ^)O#OP9_9FL/$&K^&/!5W\0?&>DZ!K'Q ^(OCFZ\-W^EZUJ=V^GVN
MAZ#HMG;7MG,(([F6;41;6]O92?U$_P#!4O\ 96^ G[&?_!!7]NGX _LU?#^S
M^&/PA\-_!+XAZQH'@NPU37=9LM*O/%GB^V\2:Z;>_P#$FJ:QK$D5WK&HWEV(
M[K4;@0>=Y,)2%(XU /M'_@EA^S+^SS^PS^P+\+/A#\ _CI'\<O@?X1M/&OBR
MR^.6H>)?#NL:+XCCU'Q'K.K>)]8M-7\/7$GABQ\/Z+?Q:A8"#3[E[334TRX%
MW</=K>2M],_\-B?LG?\ "H=0_: _X:5^!8^!NDW=U8:E\7S\4_!8^&UE?V31
M)>6-QXS.LC0([RU::(7%JU_Y\)D3S(UW"OQ&_P""*P'_ !#1?!T8&#^RE^UK
MD=CGX@?'TG\R3FOYX?\ @VP_X)3>'/\ @IG^S5IOC;]N#7-7\?\ [''[,WQ0
M^('A_P" G[+NGZCJ_ACPOXI^*7C6+1]?^)'Q4\?:SX=U/3M8U06EM<Z;X3T3
M3K2[L+G9:7)GNHK.UBBU( _O&^ W[;7['?[4FJ:UH?[-O[4?P!^/.M>'+:VO
M=>TCX2?%GP1X_P!3T>SNVF2VN]1L/#.M:E=6EM.UO.L<\T2Q,T3C=D5\^?\
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M6'QA\9MX^UM;#PCK^A7FJ^./B!\28M>U6_U"6ZA@M]"L= M)8]0=(?[.Y?\
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M\2ZEJFFS:\W@^)O$<=W>27EM9^'84MA,L=G)%Y8=OD;]L?\ X($Q_P#!0/\
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MMXM\?^*-%\(^'=.MK:%[BXFN]8UV]L;&%(8(Y)I"\XV1([D!5)'B'P._;O\
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M@K8:_#&D>M-!YALM,\2:[9RZIJ\MR(%B\,>#M7ED?[)=N2 ?,_\ P:%?L_\
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MAJST[6'US3=*U[3[?4M%;Q-I.DZC<ZG>Z%Y>LZ)K?AZ_U6_N]%UNT6ZN[>Y
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M-Q>):R'2O ^M#X@:_-I^H:_)JOBK1+71K_1+:TM@/[TJ_FF_;7_X-XHOB?\
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M+$:EJNJ:B]I>LNHZE?3(DX_-G_@@AX=_9A\&_P#!Q?\ \%3/!/[&]EX?T_\
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MJR31:K%XOO/!NBW'B--4BN+:SGAU(:Q)>"^AFM;>6&Z\V*2&-T*C\ ?V//\
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M'_U33,/^8E?]>'_Z<B?IU1117R)N%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7\,?\ P4._9K_X+D>+/^"V4G[=/PP_X)]>$/VL
MOA!^S"B>%/V-]'\?_%3X;>'?AWIFG_V/:WJ?$1_#L?QO\$>+9_%5MXJU/7=0
M4:[!:6K:C;:7<OILJ:1I<B_W.44 ?PF?\%'_ -MC_@Y&\=?L'?M8^#_VF?\
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M$GO^CZ/@5_X4<_\ \A4?\/O_ /@D]_T?1\"O_"CG_P#D*C_5OB+_ *$.<_\
MALQOE_TX\T'MJ/\ S]I?^#(_Y^:^\_1WXG>"+?XF?#;XA?#B[OY]*M?B!X'\
M6>"+G5+6**>ZTVW\5Z#J&@S7]M!-^YFGLX[]KB&*7]U))&J2?(37Y[_\$E_^
M"8O@W_@E!^S+?_LU^"?BGXI^+FF:E\0_$/Q"G\3>*]%TC0;V&[U^WTZU?3;>
MQT=YH?LEO'IL<@EFGEGDFFEY2(1QKE?\/O\ _@D]_P!'T? K_P *.?\ ^0J/
M^'W_ /P2>_Z/H^!7_A1S_P#R%1_JWQ%_T(<Y_P##9C?+_IQYH/;4?^?M+_P9
M'_/S7WGZJT5^57_#[_\ X)/?]'T? K_PHY__ )"H_P"'W_\ P2>_Z/H^!7_A
M1S__ "%1_JWQ%_T(<Y_\-F-\O^G'F@]M1_Y^TO\ P9'_ #\U]Y^JM%?E5_P^
M_P#^"3W_ $?1\"O_  HY_P#Y"H_X??\ _!)[_H^CX%?^%'/_ /(5'^K?$7_0
MASG_ ,-F-\O^G'F@]M1_Y^TO_!D?\_-?>?JK17Y5?\/O_P#@D]_T?1\"O_"C
MG_\ D*C_ (??_P#!)[_H^CX%?^%'/_\ (5'^K?$7_0ASG_PV8WR_Z<>:#VU'
M_G[2_P#!D?\ /S7WGZJT5^57_#[_ /X)/?\ 1]'P*_\ "CG_ /D*C_A]_P#\
M$GO^CZ/@5_X4<_\ \A4?ZM\1?]"'.?\ PV8WR_Z<>:#VU'_G[2_\&1_S\U]Y
M^JM%?E5_P^__ ."3W_1]'P*_\*.?_P"0J/\ A]__ ,$GO^CZ/@5_X4<__P A
M4?ZM\1?]"'.?_#9C?+_IQYH/;4?^?M+_ ,&1_P _-?>?JK17Y5?\/O\ _@D]
M_P!'T? K_P *.?\ ^0J/^'W_ /P2>_Z/H^!7_A1S_P#R%1_JWQ%_T(<Y_P##
M9C?+_IQYH/;4?^?M+_P9'_/S7WGZJT5^57_#[_\ X)/?]'T? K_PHY__ )"H
M_P"'W_\ P2>_Z/H^!7_A1S__ "%1_JWQ%_T(<Y_\-F-\O^G'F@]M1_Y^TO\
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M_P#R%1_JWQ%_T(<Y_P##9C?+_IQYH/;4?^?M+_P9'_/S7WGZJT5^57_#[_\
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M_P"'W_\ P2>_Z/H^!7_A1S__ "%1_JWQ%_T(<Y_\-F-\O^G'F@]M1_Y^TO\
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MS\U]Y^JM%?E5_P /O_\ @D]_T?1\"O\ PHY__D*C_A]__P $GO\ H^CX%?\
MA1S_ /R%1_JWQ%_T(<Y_\-F-\O\ IQYH/;4?^?M+_P &1_S\U]Y^JM%?E5_P
M^_\ ^"3W_1]'P*_\*.?_ .0J/^'W_P#P2>_Z/H^!7_A1S_\ R%1_JWQ%_P!"
M'.?_  V8WR_Z<>:#VU'_ )^TO_!D?\_-?>?JK17Y5?\ #[__ ()/?]'T? K_
M ,*.?_Y"H_X??_\ !)[_ */H^!7_ (4<_P#\A4?ZM\1?]"'.?_#9C?+_ *<>
M:#VU'_G[2_\ !D?\_-?>?JK17Y5?\/O_ /@D]_T?1\"O_"CG_P#D*C_A]_\
M\$GO^CZ/@5_X4<__ ,A4?ZM\1?\ 0ASG_P -F-\O^G'F@]M1_P"?M+_P9'_/
MS7WGZJT5^57_  ^__P""3W_1]'P*_P#"CG_^0J/^'W__  2>_P"CZ/@5_P"%
M'/\ _(5'^K?$7_0ASG_PV8WR_P"G'F@]M1_Y^TO_  9'_/S7WGZJT5^57_#[
M_P#X)/?]'T? K_PHY_\ Y"H_X??_ /!)[_H^CX%?^%'/_P#(5'^K?$7_ $(<
MY_\ #9C?+_IQYH/;4?\ G[2_\&1_S\U]Y^JM%?E5_P /O_\ @D]_T?1\"O\
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M6BORJ_X??_\ !)[_ */H^!7_ (4<_P#\A4?\/O\ _@D]_P!'T? K_P *.?\
M^0J/]6^(O^A#G/\ X;,;Y?\ 3CS0>VH_\_:7_@R/^?FOO/U5HK\JO^'W_P#P
M2>_Z/H^!7_A1S_\ R%1_P^__ ."3W_1]'P*_\*.?_P"0J/\ 5OB+_H0YS_X;
M,;Y?]./-![:C_P _:7_@R/\ GYK[S]5:*_*K_A]__P $GO\ H^CX%?\ A1S_
M /R%1_P^_P#^"3W_ $?1\"O_  HY_P#Y"H_U;XB_Z$.<_P#ALQOE_P!./-![
M:C_S]I?^#(_Y^:^\_56BORJ_X??_ /!)[_H^CX%?^%'/_P#(5'_#[_\ X)/?
M]'T? K_PHY__ )"H_P!6^(O^A#G/_ALQOE_TX\T'MJ/_ #]I?^#(_P"?FOO/
MU5HK\JO^'W__  2>_P"CZ/@5_P"%'/\ _(5'_#[_ /X)/?\ 1]'P*_\ "CG_
M /D*C_5OB+_H0YS_ .&S&^7_ $X\T'MJ/_/VE_X,C_GYK[S]5:^<_C-^R-^S
M7^T1XV^$GQ%^./P<\&_%'QC\"/$#>*_A%JWC"SN-6C\"^)6GLKH:[I&E37/]
MCMJD=QIUE-!>7NGW<UN]M&T#1X.?C;_A]_\ \$GO^CZ/@5_X4<__ ,A4?\/O
M_P#@D]_T?1\"O_"CG_\ D*C_ %;XB_Z$.<_^&S&^7_3CS0>VH_\ /VE_X,C_
M )^:^\_56BORJ_X??_\ !)[_ */H^!7_ (4<_P#\A4?\/O\ _@D]_P!'T? K
M_P *.?\ ^0J/]6^(O^A#G/\ X;,;Y?\ 3CS0>VH_\_:7_@R/^?FOO/U5HK\J
MO^'W_P#P2>_Z/H^!7_A1S_\ R%1_P^__ ."3W_1]'P*_\*.?_P"0J/\ 5OB+
M_H0YS_X;,;Y?]./-![:C_P _:7_@R/\ GYK[S]5:*_*K_A]__P $GO\ H^CX
M%?\ A1S_ /R%1_P^_P#^"3W_ $?1\"O_  HY_P#Y"H_U;XB_Z$.<_P#ALQOE
M_P!./-![:C_S]I?^#(_Y^:^\_56BORJ_X??_ /!)[_H^CX%?^%'/_P#(5'_#
M[_\ X)/?]'T? K_PHY__ )"H_P!6^(O^A#G/_ALQOE_TX\T'MJ/_ #]I?^#(
M_P"?FOO/U5HK\JO^'W__  2>_P"CZ/@5_P"%'/\ _(5'_#[_ /X)/?\ 1]'P
M*_\ "CG_ /D*C_5OB+_H0YS_ .&S&^7_ $X\T'MJ/_/VE_X,C_GYK[S]5:*_
M*K_A]_\ \$GO^CZ/@5_X4<__ ,A4?\/O_P#@D]_T?1\"O_"CG_\ D*C_ %;X
MB_Z$.<_^&S&^7_3CS0>VH_\ /VE_X,C_ )^:^\_56BORJ_X??_\ !)[_ */H
M^!7_ (4<_P#\A4?\/O\ _@D]_P!'T? K_P *.?\ ^0J/]6^(O^A#G/\ X;,;
MY?\ 3CS0>VH_\_:7_@R/^?FOO/U5HK\JO^'W_P#P2>_Z/H^!7_A1S_\ R%1_
MP^__ ."3W_1]'P*_\*.?_P"0J/\ 5OB+_H0YS_X;,;Y?]./-![:C_P _:7_@
MR/\ GYK[S]5:*_*K_A]__P $GO\ H^CX%?\ A1S_ /R%1_P^_P#^"3W_ $?1
M\"O_  HY_P#Y"H_U;XB_Z$.<_P#ALQOE_P!./-![:C_S]I?^#(_Y^:^\_56B
MORJ_X??_ /!)[_H^CX%?^%'/_P#(5'_#[_\ X)/?]'T? K_PHY__ )"H_P!6
M^(O^A#G/_ALQOE_TX\T'MJ/_ #]I?^#(_P"?FOO/U5HK\JO^'W__  2>_P"C
MZ/@5_P"%'/\ _(5'_#[_ /X)/?\ 1]'P*_\ "CG_ /D*C_5OB+_H0YS_ .&S
M&^7_ $X\T'MJ/_/VE_X,C_GYK[S]5:*_*K_A]_\ \$GO^CZ/@5_X4<__ ,A4
M?\/O_P#@D]_T?1\"O_"CG_\ D*C_ %;XB_Z$.<_^&S&^7_3CS0>VH_\ /VE_
MX,C_ )^:^\[?_@K]_P HO?V[O^S:?B;_ .F*>L/_ ((P_P#*+/\ 8B_[(CHW
M_ISU:OS_ /\ @IG_ ,%=?^":_P 8_P#@GY^V!\+?AE^V'\'/&7Q!\>? ;Q]X
M9\'^%-&UV6?5O$&OZIH\T&GZ7I\+6L:RW5W.RQQ*74%CUK(_X)9_\%;O^";O
MP4_X)Y_LF?"KXI_M?_![P3\0_ _PETO1/%OA/6]=E@U;0=6@U#4I)K#4($M9
M%BN(TEC<J';Y71L\XKZE9#GG^I+P_P#8V:_6'Q5"M[#^S\7[;V/]D2A[7V?L
M>?V?.U#VEN7G:C>^AC[6E]83]I3M[%J_/&UW.+2O>UVM4C^E&BORJ_X??_\
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MS&^7_3CS0>VH_P#/VE_X,C_GYK[S]5:*_*K_ (??_P#!)[_H^CX%?^%'/_\
M(5'_  ^__P""3W_1]'P*_P#"CG_^0J/]6^(O^A#G/_ALQOE_TX\T'MJ/_/VE
M_P"#(_Y^:^\_56BORJ_X??\ _!)[_H^CX%?^%'/_ /(5'_#[_P#X)/?]'T?
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M_P"'W_\ P2>_Z/H^!7_A1S__ "%1_JWQ%_T(<Y_\-F-\O^G'F@]M1_Y^TO\
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MJ/\ S]I?^#(_Y^:^\_56BORJ_P"'W_\ P2>_Z/H^!7_A1S__ "%1_P /O_\
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M-![:C_S]I?\ @R/^?FOO/U5HK\JO^'W_ /P2>_Z/H^!7_A1S_P#R%1_P^_\
M^"3W_1]'P*_\*.?_ .0J/]6^(O\ H0YS_P"&S&^7_3CS0>VH_P#/VE_X,C_G
MYK[S]5:*_*K_ (??_P#!)[_H^CX%?^%'/_\ (5'_  ^__P""3W_1]'P*_P#"
MCG_^0J/]6^(O^A#G/_ALQOE_TX\T'MJ/_/VE_P"#(_Y^:^\_56BORJ_X??\
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M4?VYG7_0XS3_ ,.&+_\ EP>RI?\ /NG_ . 1_P O)?<?GQ_PZ@_X)M_]&6?
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M'4'_  3;_P"C+/@!_P"$)IU?H/11_;F=?]#C-/\ PX8O_P"7![*E_P ^Z?\
MX!'_ "\E]Q^?'_#J#_@FW_T99\ /_"$TZC_AU!_P3;_Z,L^ '_A":=7Z#T4?
MVYG7_0XS3_PX8O\ ^7![*E_S[I_^ 1_R\E]Q^?'_  Z@_P"";?\ T99\ /\
MPA-.H_X=0?\ !-O_ *,L^ '_ (0FG5^@]%']N9U_T.,T_P##AB__ )<'LJ7_
M #[I_P#@$?\ +R7W'Y\?\.H/^";?_1EGP _\(33J/^'4'_!-O_HRSX ?^$)I
MU?H/11_;F=?]#C-/_#AB_P#Y<'LJ7_/NG_X!'_+R7W'Y\?\ #J#_ ()M_P#1
MEGP _P#"$TZC_AU!_P $V_\ HRSX ?\ A":=7Z#T4?VYG7_0XS3_ ,.&+_\
MEP>RI?\ /NG_ . 1_P O)?<?GQ_PZ@_X)M_]&6? #_PA-.H_X=0?\$V_^C+/
M@!_X0FG5^@]%']N9U_T.,T_\.&+_ /EP>RI?\^Z?_@$?\O)?<?GQ_P .H/\
M@FW_ -&6? #_ ,(33J/^'4'_  3;_P"C+/@!_P"$)IU?H/11_;F=?]#C-/\
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M4?VYG7_0XS3_ ,.&+_\ EP>RI?\ /NG_ . 1_P O)?<?GQ_PZ@_X)M_]&6?
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M'4'_  3;_P"C+/@!_P"$)IU?H/11_;F=?]#C-/\ PX8O_P"7![*E_P ^Z?\
MX!'_ "\E]Q^?'_#J#_@FW_T99\ /_"$TZC_AU!_P3;_Z,L^ '_A":=7Z#T4?
MVYG7_0XS3_PX8O\ ^7![*E_S[I_^ 1_R\E]Q^?'_  Z@_P"";?\ T99\ /\
MPA-.H_X=0?\ !-O_ *,L^ '_ (0FG5^@]%']N9U_T.,T_P##AB__ )<'LJ7_
M #[I_P#@$?\ +R7W'Y\?\.H/^";?_1EGP _\(33J/^'4'_!-O_HRSX ?^$)I
MU?H/11_;F=?]#C-/_#AB_P#Y<'LJ7_/NG_X!'_+R7W'Y\?\ #J#_ ()M_P#1
MEGP _P#"$TZC_AU!_P $V_\ HRSX ?\ A":=7Z#T4?VYG7_0XS3_ ,.&+_\
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IVACM[:VMXTA@MX(46.&""&-5CBABC58XXXU5$1555"@"I:**\LT/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img12876764_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_5.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /?!R$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+REQ%=,'@(P=GWE4CN>QZ?3/UJ2Q25(L.Z-%Q]G"CE8NP9NY_/Z]J +M%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*^UV,3Z=X6OUU.UMY!E+DG!:, @J^>!AAC'IQ7YI_P#!3GQ%=Z!J7P_M]-U
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M']&_@/XJ^"OB98ZMK'@&_P#[4&CZC]@N)MRO DI/*12(6#1XZ8.,9[5^2O\
MP75_9"\0_M(_LW^$O'7@^Q@/BKX%^*X_BC/<0X2YEL_#\/VL0!T'F2+NC("
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M@]_P6T\6:A^U-\9_V?OV&OAZ;F[E\2>,9=$^)IAW&VM;&\$+1&65,HL?R?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*K9Z;L@8[8!/7GIT)(KR;XD?%7PU\%O#EWK'BJYAAM$25K2:9DWR3J"PC!?
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M36ZZ:K7L.+Y6GV=S];HHXUM[>YB.Y[I$D#D<[)U#K@G.  W'Z^M?B%_P6O\
MMA^#%HXF,:VEI.68!1R73V&>^<\#ZU^X%I&!96L<9R+.UAMSGOY"+'GZ_+SZ
M^E?B)_P6S+-\$K:/.U;JSN!D9SQ(A/?V_.OG\QO!RM=;6ZIZQNVORZ?@?I/A
M(_;<>93"K[RFJ[BW;IAYWT[VNFMK&E_P191C^SKJQ3_EIJMB[G^^3 /FYX]2
M?KGZ_M9$C)*RH2%\K[N.,D?UX_\ KBOQ:_X(IH4_9RU1<YV:G8C)))&+<#'^
M'.,9Z8K]J?-5;EE&/]2.#Z^N/3T _'FNO!7E""72FO3=Z_D>9XB0=?BK-)1T
MC2Q567NJVD8TT[]]4E=KIT*4EJ)9(967,L#$Q.008R<\CM]?K^-.BLA&[RQK
MB24DR.!RQ/4G!/7/^%:47.3CJ#C\ 3_@:E7 ([#VKTHJRL_^&_K\SX:-1U%S
M2W>F]]C/CLUB&U!M7<7"C& Y.2W)]?\ /I"]JHEF<+\UP MP0.95'3/TYZ>V
M.*W:844DD]_I_A^/UJBAL"*D4:( JJN% Z >E.CZ'ZG]<4\< #TI  !@4 +1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH_N&^<_9RBEE2.-L@C#9&  >F>,^]?RY_P#!P+=QVVK?#>ZFE6%H]+O/]&)
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MDDAB'EKD;P,8&>.OT&:8C^H'7/%_ASPW:JWB+Q%IVBM<*=D%],D4DAR!M7+
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MPB[0^'?[^OS_ ")R,@CU&*:H(X)'M_G%.HI$C<-GKQZ8_P _SIU%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\'>,-%\17^F7LZW-SIEXDT99@JCA"<%2-O3G!XK]-_@5_P %5/V;?VX-/O\
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MW8P=H'OQC_/M4U=T(RBK2WW?W(^8;3U7E]]M?Q&,I)R,=,<T8?U'^?PI]%4
M#..>O>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S)8
M[AVN L4*G(\J0+B0Y]6XY_PK3HH H2I$(XQ,K^9L )CSU(P<D'UY/^%5DM7B
M81DF.$G<LL3,LSD_PN0<[/4=/YUL8!ZC-%&P%%7D\UHHHU*Q\.\F<MD=CG)Z
M],_7%? W[>7["_A+]LCP#=Z+J),?B6&%$TVY=HXTC6/+"/S7'R L!P#@Y^F?
MT&) Y/\ ]<_XTSS%'7C\O\FG=]V!_$#XR_X(-_M*:!K1OM%U<+8)>&*V@M=2
MDVB-'PC.B9 ^4#)X_6J;?\$4/VMS<37+:S+APOE(-2G ! ],<9]./3.:_M_:
M3?(%BBC(R,DH&'7D]!Z=?I4[>4@Y6(L>@"K@G]?I1=]W][ _A]A_X(K?MC>:
M)9]86%%!,+V^IS+/@9V@D ,,D<]>O:ODOX\_LH_MI_LGZG'J6JZKKUI8V>R:
M+4M(O;X(Q0;T6>X3 VX ,@+<?05_H5W<CK&#;VRO,V C>6K!,\9/&>_ Z5\!
M?\%'M=^&/AC]E_QG<_%F/2YVN]+U2VTAI%@@E_M%[*;[.L3D;R0Q4?+@,W09
M!R@/RV_X(I?\%!/%OQ4?4_@U\6=2EU#5=*@MK70;M)9+J26ZD?:RW<KODC:"
M,]B<]@#_ $I.OWG1=TJX W%L#(SP,XQ[<XQC@5_'K_P05_9PU_4?BEXO^,"K
M)'X6^UB]TK>C;"D=Y(,+(1AN, =>OX5_8C0!GQAD+&X!:9LA?XD"DX'7I^''
MTJ1!*I1 B9!_>''0<'(/]/Z\5<HH SXW\S[5'&'9A)TESL_X"<]/IP<=Z9#&
MGFF:16\[88POS%,8]#Q^?0>]:>!Z44 4Q$S*5F55CY_=QD[6]F'.<]QTS20N
MS[XUB58HSL13D J?Q_3''8<9J[10!A3O=03?8[&%)=ZF9C/DQ@'[RKDX_P"
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M^.>*^D-/TW3M.MH[71[&VTNRAQM@L(4MHMJ<;-D01< 8&,<_I0!XC^S=\ /
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MGM0"",B@!:*C=F3YL J.H[X_SD_AS4+O,)8F!C2V()E,A"OG'RXSTYZ_A[T
M6J*J1RR@MYX7:6^1DZ%3]TY[Y_\ KCBK0SCGK0 M%(2 0/6EH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "B@]#CTI%.0#_ )ZT +14>YLD
M\;0#P.I(].IZ?A5=;EIDD$:E95#!=XPNX=,D]C^- %RBJD,DH@7[0\(GYWE&
M&Q?3/H.F<]OT<;E5=8V^9W7<I7E3[YST/7/I0!9HJK"\^PB<Q"0N2 I&/+SQ
MWZX'/^<603DC' Q@T +13 Q+8XQD_IFD>0)G)4#:2-Q R>PY/?\ .@"2BJHG
M)A+959"#L5\+N/8 '&<^@_\ KTL$SRJ 5PZ\/D$#/MZCZ9H LT50N+LV["1\
M?9V(C']_S2<#C^[ZGK_59[MK=85=6::X<QQ[%)16(R"YZ =.M %ZBH(9=X9&
MQYL9VR8Z;O;VJ>@ HII)!'N<4Z@ HHJDURS7!MD&UT 9V<$(RG'",>K#TZT
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M# (]">?KP=:B@"N)"05\F0 # RI[<#J/ZG//-0R/(OW89#]%)^@^Z?Y5>HH
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MP:L44 57GD! 6&3'<[&_3BCSI/\ GG)_WP?_ (FK5% %<2O@DQR=.!L(.?\
MOD?U_"A9GP=\4F?9&_H*L44 5VE?'RQR _[C?U'^??I5)X)GD$R!HI^ TI4L
MK1CJ@3. << XZUJT4 9\ID4CRHY&9L"5S&RAA@#N./>DAB\E]\4;HKY:56!9
MF;L1D''?I[#TK1HH JN\A'"/R>/E)P/RZ_7_ .N'QLP&&5_^^3_A_G\34]%
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M4SLBEH9$) .QE;*_[))'4?Y]H'$A8E4<#TV''YXZ?C^/>M"B@"ODH(\(['N
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M[_P4]_:L_P""< _9"/[,>M^#-'_X7*?C]_PF_P#PEW@S3_%WVG_A7G_"E/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5I"6$7B#4)X-1\;>,-.\2^*(O$ND:3K/AKQ!^5G_  =X?\G)?LC?]D/\9?\
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MEC_U1O@6OMJOB7_@FC_RCD_8!_[,I_98_P#5&^!:^VJ_F;-O^1KF?_8PQO\
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M_2RHHHK^;SU@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5^LRITVJDE!595/:MM151RT4F=%.=OK_ #2M:4^6\MOXB5KO3HE;R\C\QO\
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MFI[+#NS6'H2=>I&>'A[DH*,&K12*H047C6G*]/VL8^\]O?5WW:Y5KW/Y[O\
M@W6_:K_:A^-WP7_X*IZK\9_VD?CW\7=3^'GP5^&^J^ -2^)_QA^(?CZ_\#:I
M?>%/VD+F^U+P=>>*_$6K7'AF_O+C0M$GNKS19+*XN)M'TJ6:1WT^T:'\@O\
M@G7^V[_P61^/7QG\6_L\?LT?M-?'?XH_%OXQ>#-0T#3M?^,_QN\4^//#'PA\
M+:5JVGZSXN\?V5M\5+WQEX=\-:H--M(_#L'BRQTL^)M+BUJ2T\)J_B74=):'
M] O^#8?_ )(1_P %A/\ L@WPL_\ 4._:DKQ?_@U _P"4E7Q<_P"S//B?_P"K
ME^ 5>MCX8'+L9XIXQ95EN)_LZCP]7PN&Q.$I3PL:BR>A.*E248ITG6Y:E6E%
MQC6LXS=I,B/-.."CSS7.ZL9.,FI6]I;?TT78\!_:?\6_\%H/^",'[37@NY^+
M?[6/Q)\7ZUXJBLOB!HVNQ_&_XG?&'X'?&2RL;])/$&B^)-#^(;Z)>:S/IVH7
M=SHWB2RU_P ,Z'XAL/[2;5?#NHPVNK:/XAN_[<?C+^V7^T5XR_X)C^"OVM/V
M*O@/>?%/X\_'+X2_##Q7\/?AGI]W:>*U\#:G\3]!T[5=5U+6FA33+;Q%_P *
MU2\O8KJQ,6G1:AKEC;6E_;V]J]W;#^?S_@\+_P"07_P3X_Z__P!J;_TG_9XK
MN_VA/^"B'QL_X)__ /! [_@G5>?L]7%CX>^*'QN^&O@;P+9?$.\L+'5[CP%H
M&D^#/[:US4O#^EZG#=:5-XGU%FT_2].O=5L=1LM+L9]6NX;-=772;^Q^:S'"
MOB[)/#W.(93E#SK,<VQ."KT_92P> Q=#!UL5&4<8L.U5>']G@/:SC!RG",ZU
M/#Q2J*#UC+V%3%4W.I[.%-23OS3BY*/PWTO>=D]%HF]KGRM\*/\ @E]_P<#_
M +9/ASQE^T1\6/VSOB[^S[\3M-UFZT[P5\-_B;\7?C/\.O$^JWOA@F1+S2M#
M^'MK;>#?ASX7N+_9_P (KJ6B031:MJ7]I:S/I^G6DMOK>K^R?\&Y_P#P5@_:
ML^*7[26O_L/?M/\ Q%\2_';1M3\(>+/$OP^^(7C'71XV\=^%_$_@JXL&U30]
M4\>WNISZEXM\':WI$FJ7=MJ.I7_B+4[#6+'38--F;1M5NI-.\V_9&_X)0?MC
M_P#!2C]EW0?VQ_VQ/^"M7Q:\+_"7XDZ1XK\5:AX.O_%'C/XAZ78?#K3+[Q/8
M^)G\3ZUXI^*OA'X=?#?3K1+?7+B[T*Q\+>(/#.@:'<7EK?)II6]TZU^ _P#@
MV[M='L?^"O7AJR\/7LVHZ#:> OC=;:+J%P-MQ?:5!IBQ6%W,/(M<2W%JL4T@
M^S6^&<_N8_N#W<?2P&;</\<X7%U\CS&OD>$E*CALIR*KEU'(<5AH8GEH4,PK
M0A+%OVF'Y6J3:A&%2$Y2IUE2CG%RIU<,XJI!59*[G44W5B^7WG%?#OU\NQ^?
M7_!4W]GS]J[]F?\ :PUOX9_ME_&__AH'XRQ^$_#&NR_$#_A97Q(^*V_PQK-O
M<7'AW1O^$K^*FBZ#XJ;^R;16@_LYK :?8Y\JQFEC):O[:?V;?V9_^"C7[#?_
M  38_P""DNK_ +87[7FL_&_XD7?[.7QD\>?!/QSX<^/WQU^)7B'X8?\ "+_
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M%?6;77+E=.N+);B.2-?XO/\ @U(F6X_X*8_%:= 0L_[(OQ3F4'J%D^+WP*<
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M-RE4J?5:56I93YN>4)I\W*_=3G%M-VLGKN[N[L?+/_!8GPO_ ,%.?V>/A[\
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MX>ZM9ZGZQT445^)GHA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXMG_ ))'_P +3_X2S_A:?_"LO^JG?#C^PO["_P"%<_\ 49_M/^V?^8=_9_\
MIW[7T54^.>*JF,RO,*F;3J8S)88N&6XBIA<#4J4(XZE[#%<_/A9+$RK4O=<\
M4J\XOWH2C/W@^K45&<%"T:G*YI2E9\KO'[6EGTC9'Y\_"C_@GOX!\)_\$Y=!
M_P""<GQ1\57_ ,4/ %M\&-6^#/B?QII6CIX"UC6]/U674IU\1Z+I$NK>,X?#
M>MZ3<WT&H:.+C4_$-M;:GIUK<W,=[ 9+-OP/_9U_X-<O$G[-7[9?P:_:(\$_
MMKBY\ ?!?XY>"_BKH_A^[^$M_9>/M;\+>#_$]AXDD^'^LZYI/Q$LM%:;Q)IE
MG-X'\0>([6P@TZ]TS4;_ %IO!WV>X?P@?Z]J*RP'&7$>61S6.#S%TX9U.O5S
M*G+#X2K3KUL2IJO6C3JT)TZ-2HIRBW0C37+RQM:$%%RP]*?(Y0NZ:2@[M-*.
MRNG=I>=_Q9_-5_P4]_X-XO\ AX_^U9K?[3G_  U]_P *:_MCP9X,\(_\(1_P
MH#_A8?V?_A$=/EL/[0_X27_A=G@;SO[0\SS?LG]@1?9-NS[3<YWCZE_X+#_\
M$=_^'L0_9U'_  T3_P *#_X4%_PMO_FD?_"T_P#A+/\ A:0^&0_Z*=\.?["_
ML+_A7/\ U&?[3_MG_F'_ -G_ .G?MA112XRXDH3R2I2S+EGPY1Q&'R:7U/ 2
M^IT<7AXX3$0M+"M8CVF'A&GS8I5Y0MSPE&;<F/#T6JB<-*K3J>]+WG%N2?Q:
M6;O[MO/0^6OV)OV:?^&.OV4_@A^S'_PFO_"Q?^%->#(?"/\ PF__  CG_"(_
M\)'Y6H7]_P#VA_PC7]O>)_['W?;O*^R?V_JF/*W_ &D[]B?C3^P[_P &_/\
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MP?V3_:WV/[-J?V#[5>?MC^VO^S5_PV'^RG\;OV8_^$T_X5W_ ,+D\%S>$/\
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M@;>&VU[4"]JLZ132-$TH81!3[[\// /A#X4^ ? _PN^'VBP>&_ 7PW\(>&O
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M_P#!23_AK;^V_P"T_P!HSXR_'_\ X4Q_PH7^S?(_X6YJ7CG4/^$2_P"%B_\
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MJR7M*^"JU9WJ3G*\ZDGK9.R22GA:%23G.G>4MWS35[*VRDELNB/QX_X)(_\
M!)FT_P""7/PT^-?PVO\ XX6_[0MC\9O%.B^(;VXN_A/'\.+32[32] N=!N-&
MNM)F^(?Q'AURWU*&Z=YI);FPC6/=;26EPKF0?E-^TS_P:H_#;Q'\4[CXH_L8
M_M,^(?V9X+O7;G6(/ &N>&M5\::9X-:Y@0JOP_\ &VF>,?#GC#2+.SNUN1;Z
M=K;>(KLVNH+%'X@M8],2#4/ZX**YL-QOQ1A,TQV<4,UG''9DJ:Q\OJ^$>'Q:
MI4U1I>VP3P_U-NG37)"4:$9P4I\LDZDW)RPU&4(TW#W87Y-97C=W=I7YM7OK
MV[(_EO\ V%?^#8OX._L^?&3PQ\?OVIOCKJW[5?C'P9K-GXD\,>"'\''PG\.H
M_$.C/C0-3\:/K'B;QCXA^(,>CO;:=JNGZ3+/X8T1+^S@T_6].\2Z+#-:7W[>
M?MZ?L&_ K_@HC\ ]5^ ?QTL=2@TYM1L_$7@[QMX9;3K?QI\._%VG;TM/$/A:
M^U.PU.RC>XLYKO1M:T^\LKBRU?0]0OK*18+HV6H6/VI17+F'%?$.9YEA<WQF
M:5YX_ N+P5:FJ>'CA.27-%8>CAX4Z%--VY^6G>JDE5<T5&A2A"5.,%R2^).[
MYO5MM^FNG2Q_%W\*_P#@T)T#3?'4-]\9OVTK_P 5?#G3M7M)6\/?#WX.)X0\
M5>*=&BOB]U;7/B/7?B#XKT_P?=76GQ)"&M-"\6^1<7LLD<^-/C.H?=O[&?\
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MX*/?\&_W_#P3]L>V_:T_X:T_X5)]GT/X>Z-_P@'_  H;_A/=_P#P@9!^T_\
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MOB!]J^Q?\(-_9_\ 97]B6_VC^U/M?]I0?8OLUW_1!17/7XQXCQ/]LJOF//\
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MG?9K/[+]ON/E_P#X)1?\$$?^'8?[2_BW]HG_ (:M_P"%W_\ "4_"#Q3\*?\
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M'_#K7]G_ ,>? O\ X75_PO3_ (3?XQ:O\6?^$I_X5Q_PK'^S/[5\%>!?!_\
M8']B?\)Y\0OMOD?\(5_:/]J_VO:>;_:?V3^S8_L?VJ[_ %.HKQJ_$V>8K+\7
ME5?&\^ QV85,UQ5#ZMA(^UQ]6:J5*_M88>-:'-.*?LJ=2%%6M&FE=&BHTXS4
MU&THP4$[RTBE9*S=MNK5_,_G%_:^_P"#?K_AJW_@HV__  4!_P"&M?\ A M_
MCKX%^-?^%2_\*&_X2G'_  I;P]X!T'^S/^$\_P"%S^'<_P#"2_\ "#_:OMG_
M  A@_L;^U/(^R:K]B\Z[_0#_ (*;_P#!+#X%?\%._A'HO@;XDZEJ?@'XB^ Y
M;^^^%GQC\-:7IVIZ[X2O=1LC;7FEZQI%^]LGBCP1JEQ%I]_K7AA-7T&]N;K2
M[*72_$>BS?:9KC].J*TEQ9Q#*IDM;^TJD:O#V'CA<GJ4J.%I2PF'C3ITE2O2
MH0>(BZ5.%.?UKV[J0YHU')3FI'L*5JBY$U5?-43;?,[WOJW;756M9[;'\=/[
M./\ P:4>!O!'CK2?&'[0O[54GQ1T/0-334;/X>>#_A+%X;T;7Y;*$SZ:GBS6
MM?\ &GB*:]T275!;G6_#5EH=H^J:3;7&GKXAM6U,SV'WI_P2D_X('I_P3#_:
M9\6?M$Q_M5CXUIXF^$7BKX5)X+7X%_\ "M5TY/$OB_P+XJ76QXA_X7%X^^TB
MP'@H:>-+_L.W^TC4OM7]H6_V/[-=?T145Z.8>(/%^:4,;A<;G$JV%S"A'#8K
M#_5,!"E.C!R:C!0PL71;<Y.=2C*G5J>ZISDH048CA:$'&4:=G!WB^:5[Z:OW
MM=MG=+HC\ O^"I/_  ;_ '[/G_!1/QG<_&[PCXUO/V=OV@[[3Q;>)?&.C^&8
M_%WA+XD364&GVNC7'CCPC)K?A]X]6L=/L7TI/$GA_5-/OI;>YAN=9L_$#:9:
M6K?F/\$/^#2:RB\=:%J_[4O[8VJ?$#X>>'2+4>!/A?X'O/#>N:YI%F]Z=+TA
M/'?BSQ+XBB\(Z2C?8IM1T[2O!^JW$UM<ZGINDZOHETEKKY_LUHHP/B#Q?EN7
M0RO!YS5IX2E3=*@IT,+6KX>DUR^SH8JM0J8BE",;1IJ-1>QBHJ@Z:BK$L+0G
M/GE33DW=V<DF_.*:3\]->MSXL^/_ .Q3X%^*O[#OCS]AKX97>F? WP!XD^%=
MM\*/"5[HWAC_ (233O FAV)T];"2W\-'7?#KZS]GAL%CDBF\0V%Q=2RO<W%\
M\Q=I/A?_ ((]_P#!&[_AT_??M WO_#1O_"_/^%ZVGPPM?*_X5#_PJS_A%O\
MA6\WC^7S-_\ PM#XC?VW_;/_  G.W;LTC^SO[+SNOOMN+3]NZ*\6EQ!G%'*\
MPR:&-E_9V:XB&*S"A.EAZL\3B*=2C5C5GB:E*>*C+VE"E.7LZ\%-Q?.I*4^;
M1TJ;G&HX^_!<L6FTDM=.5-1ZO='\\?[2_P#P06_X:)_X*@>'_P#@I%_PU9_P
MA_\ 87Q6_9U^)W_"F?\ A1G_  D'VK_A06G_  ZL?[$_X6)_PN'1/(_X2S_A
M ?-_M+_A!9O["_M;9_9^L_8-]Y]Q_P#!6'_@G'_P] _9L\-?L]?\+D_X4?\
M\([\8?#/Q8_X2_\ X5Y_PLO[9_PCGA/QWX7_ + _L#_A./A_]G^V?\)M]N_M
M7^VY_L_]F?9O[-G^V_:+3].:*Z'Q5GTJ^2XEX^];AZA2PV3S^JX+_8Z%&$84
MH<JP_)B.6,(KFQ4:\Y6O*3;;:]A2M47+I5;E47-+WFW>^^FO\MD?A?X1_P""
M+7_"*_\ !)'Q]_P2S_X:4^W_ /"<:T=7_P"%Z_\ "G/LO]EY^,?AWXM?9_\
MA6/_  M2X^V_\@#_ (1_S?\ A85I_P ??]J^5^X_LV;,_8$_X(F7'["_[*O[
M9G[-%K^U%-\1+K]K7P9XH\)VWQ!M_@V_@6X^&EQXB^''B#P##K,'A^/XM>*I
M/%$VER:XNMQ6\?B+PN\SV:V27ELTPOH?WCHJY\7<0U,/C\)/,.;#YGFBSG'4
M_JF!7M\R52A56)YEAE.G^\PU"7L:4J>'?)9TN64U)*A23C)0UA#V<7S2TA9J
MV]GI)ZN[UWV/XH#_ ,&>)))/_!10DDDDG]DC))/)))_:<R23U->P?L\_\&H_
M_"AOC]\#?CE_PWI_PE?_  ICXP_#/XL?\(O_ ,,N?V%_PDG_  KKQIHGB_\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y]_P#!2O\ X*">#O\
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MH)\-?A_X;\.>-/&B?#<^-?!/@_Q=X$\9_";XA76H#P_9Z=X]\):SKGB&/4M
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M5*?/.--V4HQG*,923G#FQIXFE4ER+F4FKQ4HN/,NZONM^VS/UCHK^./]N/\
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M/@/;>(O%_B3P/\5-;^*5MX(\??#7X7^/OB!J,5YX>^+NB^'[S6-)C\7^(?\
MA'([;P68T@M-+M[RPU:Y2XFO>Z_X)L?\%I_V]OV]?V^? /@[Q+^SMH?PH_8M
M\?GXI'PWKMC\-/B#=WDD'A[P1XN\6>#-/U?XRZUJC^$-9\43C3[ :JWA_1-
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MJQ4G3E44)N/-4QBDZ2HR:YJL8RYH6YHMVNKIZ>:U77='^FA1117XP>@%%%%
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M?[2_Q_\ #W[)O[;7P^\%^$/'OQ#UV_\ #WPT^*/P_L-5\*:1_P ):L;2Z?\
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M?@WXE:7;VZVTT4SPW,/@KQA<2SSV0M],\&:@8IYIY([&[_,C_@IO_P $@?\
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M\LI?BIX9^'OPMTRT:\ECB/\ :%]J;ZW\0KJROX98X3%;:BQBE^U1-!^Z?_!
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M:5^&/!&K?MM_M >)=:BTJZ\=>%?V<KD^"8+Z6REU"RT_7/B#X1L/&&N:/87
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MIC,MF\EH\$C>?_\ !-?_ )5EO^"I/_9;OB=_ZJO]EBOWZ_X+#_L ?$CXO_\
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M<*MJ;J*<8+EJQ4JC:E%-7U7DM+:I.ZYG]N[_ ()R?\'"/_!1H_#:;]IKX&?
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M@$J52E'!RY)3]DY.<8KF:YI*5M.UVNUU:]G<^H?^#OO_ )*+^Q)_V)7QD_\
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M9.I"'L^:-6[NIV[*E.3QD9*+Y70E%SY7RJ3YU9RM:]K:7O:Q^'7_  :3^'/
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MQ%2DU7?L52E*K"H^3]ZL-/#>PJN:DFY*-XVYU*]UJWT22>FM[)G]6G_!#O\
MY14?L8_]DL7_ -/^LU^KM?BE\#T^,W_!-[_@APT_Q(T&U\ ?'C]FW]E'XC:B
MNA7VH^$O&%CH/Q*L-/\ $EQX*AOKS0M?U/PKKUB/$E[H+WD&G:Y>Q7EL\MI
M;BZ=;5^:_P"""'[:O[6?[>_[,/Q)^._[4VI^%;^:'XP:CX%^'A\+^%=/\)V\
MV@^'O#'AN^U;49+.PC=;I9=?UN^TU+J:]>3S=)N819VR1+<7OXQG648C&U.)
M^)</6PE3*\/Q%B<*JD:_-/$5,9BJM6C+"\D)4JU-TI*JYJJE[/WH\R/1IU%'
MV-%J2FZ496MLHQ2?-=W3NK6MN?L_\1_'WACX4?#SQY\4O&M\VF>#?AMX,\4>
M/O%NI+$T[:?X8\':'?>(M>OEA4AIFM-*TZ[G$2D-(8P@()!K^)SX;?\ !9+]
MN3]L3X^>.?"'_!('_@F?^S=X9O-*T+5[.#QWJ?@/PY+\3=!\%WU_97$>I>*O
MB3)XL^$WPC\%?\)?=^';>_3P9XB;Q#8WVH6-OING7_BB_P! BU67^T3XY?"K
M2/CM\%/C!\$-?U+4=&T+XR?"WX@?"K6]8T<6QU?2M(^(?A/5_".I:EI8O8;F
MS.HV-GJ\UU8B[MY[8W,47GPRQ;T;^%']FO\ X)^?\%_O^"3?QS^*VC?L>_"'
MPO\ $[0/B59:+X>U+Q=IFK?##Q+\+/'=CI=QJ;>#O$C0^.?%/@?Q-X4UOPI<
M:]KD03Q':^'K:SDO]2EU.SUCP_-I^H3^_P  4,AJX#/Y8RIDLL\A##?V5AN(
M\=5P63U:7,_K$JRA5HPQ,HIN]*4I2LHJ/LX3JU%CBG54J2BJGL[OGE1BI5%M
M9)ZM>NGS:2/R3_X+!VG[?,7[6-OJ7_!1NY\+_P#"_P#7?AKX9U.UT;P?/X0F
MT3PUX#74M?T[PYHUO_P@ZR:!&WG6&IZDRQ:CJ]XZZBLVHZ@U]+/;V_ZZ?\'9
MVK^*)?VF/V2-!N;:\7P78?LS_P!KZ+>/,AT^;Q1JWC_Q19^)[:W@$0DCO+;2
MM%\(RWDS3.DL%U8HD430R/+YS^W/_P $0?\ @M]^T?\ %3PW\=/B9X3TG]IG
MXM_$SX>Z1X@^)^K>'_BQ\"_"'A_X7>(DUGQ!IFE?"#2-+\6^+OAO:,GA3P9I
M_A>\U.X\%Z'?^"CKFLZI!H_B7Q+)!=ZS=_U)_P#!8[_@DOI/_!3C]G[P=8^'
M]=LO W[17P2LM:U'X3>(M3663P]K?]M:7IZZ]\.O&#6DH:#1O$-_HFBR6'B2
M.#4[GPGJ%K+=V5C=66J:U9WWZ-BN*\@R[,_#K$5<PR.M2P.&SW!9@\BE&6"R
MNIB:&7X>E4I86$I8C#X3VM.<*4JT(RJ895:\8SLXG+&C5G3Q24*B<I4I1]HK
M2G9R;O+1.5G=VZV6A]O_ +!W@7X;Z-^P5^ROX&\'Z7X=U/X9W'[-7PML+.S@
MATO5] \2Z%K?@'29+Z\OC!%)IGB&/Q2E]<W^L7TR7,?B";4;N]O'N7O9GD^-
M?^"?O[+W_!%/X,?'7Q)XL_X)X>)/V=]5^/=[\._$.A^)K+X4?M=:]\=?$T7P
MWO/$WA.^\12W?@?4OC5\0[73-'C\3Z;X1CNM>C\/VLFG7DEAIJ:C;)JCVMW_
M "]>'?V:/^#GCX%_!C5/V#OAYX7^)47P/FM]7\)Z6GA3Q!^SMJ6G1>%M8O93
MJ6G^%OC9J>J1>,?"7AC73KD<J65SXM\.WND:8MSID-KH%C:>(M,3]^_^"#W_
M  1L\3_\$WO"_CCXP_'W6-#UC]I7XR:%HVB7_A_PS?OJV@_";P5:W#:S-X07
M7D2"V\2>*]9U9[&Y\:ZE9+>^';6ZT#2M,\*:AJ5E:WOB'Q%^?9SDV#R3+N(<
M8^.</BYYMB>; Y7D.8RQ"S:E5K5*GM,ZI4YQA&-.%6<VIJK3C)580K3J58Q?
M53J2J3I1^K.*A'WIU86Y&DE:FVM=5;HWHVDDS^73]J3_ )65-+_[22_LZ_\
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M*7,L2L1)JI5]DHUIJ%YQE-67-IU1PT8SY_:5F[M\KJ7CKY6V737MV1_G$?\
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MI_S=_P %Y?\ @D/_ ,%#_P!L_P#;SU7XT?LU?L]_\+)^&ES\,?A]X>@\2_\
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M'?MG_MY:I\9_V:OV>_\ A9/PTN/AC\/_  ]#XD_X6Q\#_!V_6-$T^>#5+/\
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MK'?=)NSLKMV2/VNHHHK\:.\**** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\=?_ )L*/^(*\3?]!67?^#)?Y>O]/0_M"CVG]W]?TGY7_P!B*BO\=W_AO/\
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M*^.O_P V%'_#>?\ P4:_Z27?\%$O_$ROCK_\V%>__P 05XF_Z"LN_P#!DO\
M+U_IZ9?VA1[3^[^OZ3\K_P"Q%17^.[_PWG_P4:_Z27?\%$O_ !,KXZ__ #84
M?\-Y_P#!1K_I)=_P42_\3*^.O_S84?\ $%>)O^@K+O\ P9+_ "]?Z>A_:%'M
M/[OZ_I/RO_L145_CN_\ #>?_  4:_P"DEW_!1+_Q,KXZ_P#S84?\-Y_\%&O^
MDEW_  42_P#$ROCK_P#-A1_Q!7B;_H*R[_P9+_+U_IZ']H4>T_N_K^D_*_\
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M !!7B;_H*R[_ ,&2_P O7^GH?VA1[3^[^OZ3\K_[$5%?X[O_  WG_P %&O\
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M_P O7^GH?VA1[3^[^OZ3\K_[$5%?X[O_  WG_P %&O\ I)=_P42_\3*^.O\
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MWG_P4:_Z27?\%$O_ !,KXZ__ #84?\-Y_P#!1K_I)=_P42_\3*^.O_S84?\
M$%>)O^@K+O\ P9+_ "]?Z>A_:%'M/[OZ_I/RO_L145_CN_\ #>?_  4:_P"D
MEW_!1+_Q,KXZ_P#S84?\-Y_\%&O^DEW_  42_P#$ROCK_P#-A1_Q!7B;_H*R
M[_P9+_+U_IZ']H4>T_N_K^D_*_\ L145_CN_\-Y_\%&O^DEW_!1+_P 3*^.O
M_P V%'_#>?\ P4:_Z27?\%$O_$ROCK_\V%'_ !!7B;_H*R[_ ,&2_P O7^GH
M?VA1[3^[^OZ3\K_[$5%?X[O_  WG_P %&O\ I)=_P42_\3*^.O\ \V%'_#>?
M_!1K_I)=_P %$O\ Q,KXZ_\ S84?\05XF_Z"LN_\&2_R]?Z>A_:%'M/[OZ_I
M/RO_ +$5%?X[O_#>?_!1K_I)=_P42_\ $ROCK_\ -A1_PWG_ ,%&O^DEW_!1
M+_Q,KXZ__-A1_P 05XF_Z"LN_P#!DO\ +U_IZ']H4>T_N_K^D_*_^Q%17^.[
M_P -Y_\ !1K_ *27?\%$O_$ROCK_ /-A1_PWG_P4:_Z27?\ !1+_ ,3*^.O_
M ,V%'_$%>)O^@K+O_!DO\O7^GH?VA1[3^[^OZ3\K_P"Q%17^.[_PWG_P4:_Z
M27?\%$O_ !,KXZ__ #84?\-Y_P#!1K_I)=_P42_\3*^.O_S84?\ $%>)O^@K
M+O\ P9+_ "]?Z>A_:%'M/[OZ_I/RO_L145_CN_\ #>?_  4:_P"DEW_!1+_Q
M,KXZ_P#S84?\-Y_\%&O^DEW_  42_P#$ROCK_P#-A1_Q!7B;_H*R[_P9+_+U
M_IZ']H4>T_N_K^D_*_\ L145_CN_\-Y_\%&O^DEW_!1+_P 3*^.O_P V%'_#
M>?\ P4:_Z27?\%$O_$ROCK_\V%'_ !!7B;_H*R[_ ,&2_P O7^GH?VA1[3^[
M^OZ3\K_[$5%?X[O_  WG_P %&O\ I)=_P42_\3*^.O\ \V%'_#>?_!1K_I)=
M_P %$O\ Q,KXZ_\ S84?\05XF_Z"LN_\&2_R]?Z>A_:%'M/[OZ_I/RO_ +$5
M%?X[O_#>?_!1K_I)=_P42_\ $ROCK_\ -A1_PWG_ ,%&O^DEW_!1+_Q,KXZ_
M_-A1_P 05XF_Z"LN_P#!DO\ +U_IZ']H4>T_N_K^D_*_^Q%17^.[_P -Y_\
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M$5%?X[O_  WG_P %&O\ I)=_P42_\3*^.O\ \V%'_#>?_!1K_I)=_P %$O\
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M  WG_P %&O\ I)=_P42_\3*^.O\ \V%'_#>?_!1K_I)=_P %$O\ Q,KXZ_\
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M[Z_@;-?^1IF7_8?C/_4BH?2T_P"'3_P1_P#24%%%%<!84444 %%%% !1110
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M*K3J5,/.:;A&M",G*E*23<8U%%R2;2:0VFDFTTGLVFD_1]?D%%%%;B"BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _AM_X/+?\
MD:/^"6G_ %^?MI_^F;]FFOXT:_LN_P"#RW_D:/\ @EI_U^?MI_\ IF_9IK^-
M&OZS\&_^2,A_V,\?^=$\3'_[Q_VY']0HHHK]5.(**** "BBB@ HHHH ****
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M[\,O'?[5W]N^!_B+^T5\$_ GC+1/^%%_LUZ9_;'A3Q=\2_#/A_Q#I7]I:/\
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M:Q2Y?K5%Q4;Q=?25*FYUJ'L8QA3I<\:MGS\R2=Y2OJFV]/)^=OR3_P""?_\
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M$5Y2ITN6E&-Y5.;E3DE:4HQNYO=)>ZK+O8^)OV_/^"'O[$'C7]@R^_X*-?\
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M4I4X0IQTA"$*^'E",%[6E-OEC*,4U%2YH*3O&][6?V>EW<_..Q_9)_X)<?M
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MXJ/LZ=5-+F2:JR<>5\RVDVEU3=[G6_M7?\&_/_!([]E_Q'\&/B]\9OCSXO\
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M445^JG$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_1S_P:U_\
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M#FJ>*[/P-INH/<1Q^)_'"W<NIW,$UO9W<-[C0X?Q1_85M_V@/AE_P5U_8_\
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M@>VM/$]KI>HZEJ,EKX=N?$UZ=+L[VWT>STO36UF?3SXA\/KJGR^+S3.*U/Q
MQW^N.89?7X:S_'2RK+X8F@J4Z:Q<Z5.C7I58RJXC#35..&PF'BU0IUE.4J=9
MS<#90@GA8_5XS5:E#GERNZ?*FVFFDFKWD]VK:KK^/GP(_P""4GQ.\=_\%(=;
M_P"">?QD\=>#/@SKOPYUS6I/BCX\U74U&C)X'\.'3KZ37_ 9U6'33KMWXQT/
M5M)U/P/;:I%I/VFRU>UU#5H;*&UO+=/Z2;3_ ()??\&XEK\>-!_8!7XL?$WQ
M5^U3XET.?0M+U?1_B/\ $+Q!K,GB2Z\-:CKD5U<^+?"/@Z?X :3XVL=)M)]>
M@T/5]*MM#CNK>STW4] N;B\CT:]Y[7/^">7P!_X*<_\ !P;^WHGQAN=;U;X,
M_ CPW\$=2\2^#_"NICPZOCCQI%\+/A]X.N?#6N^(M)O[7Q%I6CQ:KX=\4/K#
M^&7L==N[JVC0:_H4H9;[WKX#?M7_ +"GPY_X*GZ3^P9^QS_P1\\&Z3\4/AG\
M5O%G@'Q1^TAJ?ASP/X?\8_#/1/ ME-H/BWXJ>&ISX*\<>+G\(ZIIS:O9Z7KV
MH_$GP5<^)])USP[<W2W.J^+O^$<3LSWB'-<WAAG@LQSZEC<'PAA,[S#!9+5P
M.3X' XK%8*EC/K>/Q^-Q/M<50BJL>;+Z5!OV?)&C6]M*HB:5*$&U*-)QE7E3
MA*HI3E*,9.-HQBK)Z/WF[7W5C\O_ (>_\$N_V4_^";G_  6@^&'P@_;#^*OB
MG4_@;XITCP?\7/V*?&EAI7C4:_XD^-/_  O?P-HWPI^&GQ*?P)X*U?2QKFGW
MVE^*;/Q1>VZZ+X.U#3#X>\3:C?\ @IO$5IX>L/V=_P"#D?PE_P $\?$?P,\*
MWW[77Q0\=> OC[HOPS^-U]^QQH_A/3_&-YIWB_Q]:V'A*^O-&\12Z%\._&GA
MZVTW4M9M/!FC7LOB[5/"\$>FZG?2Z9JMA<QS:KI_R%_P<"_\I9?^"0G_ &/_
M ,)__6E/#58O_!VY\-OB+XPT[]C/Q3X2\ ^-?%'ACP3HWQ[O/&?B/P[X5UW6
M]!\(V<[_  GD@NO$^KZ9876GZ!;3);7+Q3ZK<6D4B6\[(Y$4A7SL'5Q6>\1>
M&F9YCFV/HXK,,LS&5:O0KT*"IU,OCBJ:^KQE0E3I?VC[*-/'P:DJZJ3A25+F
MC:Y*-*EC(1A%J,X633=U-Q>NMWR7]WM97N?*?Q8_X)?_   \'_\ !O%HW[7M
MGXW_ &@=3^(<7PZ^#?Q@LO!NM?%W4[KX,Z;XX^)'Q7\&>$]=U33OA9;Z?9^&
M[6:V\/>.=?TW2[U(CJ\4=P)K[4]0NI;R>[X#_@E[_P $5_V6O$7['M__ ,%(
MO^"G_P 3=?\ AK^SN+35]<\'^!+34=1\$0:AX-L;F^\-6OB[QOJT&D77CC6)
M?%^O/'+\+O!?PV@L]9\4B'PSJ.G:MXK@\8V_A9/U;_:%_P"53C1_^S:OV6__
M %?'P<K['^'WQ0\#0_\ !O\ _LW?$;P_^RMX._X*#^$? 7[+/P'@\7_ "6]T
M%]&UG4?AKHWA[P[\3+FY_M+P9\0+>?6_A9XFT'Q!=ZYI]KX3U75HM3\/ZI$%
MAEM[BXCJKQ-G]/)L;1H8W&^TS'Q(Q^3SQ=&O0H8JA@50PE18/!XO%\N%P52M
M.<O95ZLZ<*34Y.2BYM)4J3G%N,;1P<*EFFXN5VG*48W<DENDM?4_(GQ;_P $
M4_\ @E7_ ,%"?V:?'?Q=_P""0GQF\3I\2/AC97PD\*>(-4^(6J:!XCUV*$ZE
M#X4\8>&?B9X:MOB1X5UK5K*SO+7PKK6CJ=$OKJ6)WT_5;.3^T+;YD_X(-_\
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M5+EE!5$D[7]ZS>MK]W\S?L@?\$3O^"(VO:IJ?[*/Q$_:+M_VA_VUO#<>K/\
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MZ^(J8BJITH2ISE1EM4Y)8JMSTTU&$>6;ISG#F<8M2JJ+U2^%/1)+757/D?\
M;#_X)2?\$H?C?^Q#XZ_;:_X)=_M*PZ-_PJ/0M<U/Q%\./B!XUU>XTKQ9%X+:
MYO\ Q5H-QX?^)6FZ7\7/ OQ.?2[RUNO#D5\M[X:\5V-MX=@TG0+:V\51>-9?
MY.+![&.^LY-3M[N\TU+NW?4+2PO(=.OKJQ69&N[>SU"XL-4@L+N> 216]Y/I
MFHPVLS)/+87B(UO)_?M\4OV#/^"5'_!3O_@FS\4?VS_@!^RFW[''BK0/A?\
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M.K[*G22IJ+LXU*=:GM?FYE:=]=[::W;M?^-6BBBOWT\T**** "BBB@ HHHH
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M[ZJ^]O7JMFM-C]R_C/\ \%Y_VCOBQ^W9\ ?V_;/X'?LX^%?BQ^S=X.\9> O
M>E_V)\1M9T?Q#X9\<>%/%_AJ^T_XCWB_$;1]6\0Q^'YOB!XVUGP<GAZZ\'1:
M1?:[(FIQ:\BSF[^)?VW/^"BGQ]_;M_:5\/\ [5WQ%MO!OPQ^+?A3P]X,T#PU
MJ'P+A\:>"[70)? 6L:EKWAGQ)HUWKGC?Q?XFTOQ3I^JZFU[!K&G^([9K2YM+
M&YT^&SN;<S2?!U%:X/AS(\!5PU;"9;AZ-7!X&668:HN><Z6 E5J5Y852J3FY
M4G5JU)M3YG><M;:"E5J234IMJ4N=KO*R7-IULD?U%_!S_@Z\_;Q\"^%+'PW\
M3_A3\ ?C3J.E:9H^GVWC:^TKQ=X(\6:O-86C6NHZKXL3PWXED\*ZEJ>KNEO>
MR-X>\+^$K*UNVOS'8R6]U:VVG?E'^U=_P5E_:_\ VS_VBOA!^T7\<-=\':GJ
M/P!\8Z5XS^#?PNT'PU/H?PE\!WEAKGA?Q'J&GZ?I$.KS>+M3M/$^K^$-$F\2
MZEXA\;:QXIO[:TMM.M_$5EINFZ-::9^:%%<V!X/X8RW%5<;@<DP.&Q56%2G*
MK3I.\(58.G5C0C*3AAE4IRE3G]7C2<H2E!MQE)-RKUIQ495)-)IV;ZK57ZNS
M5U>]GJ?J)_P4E_X*U?M&_P#!4=?@PO[0'@KX)^#Q\#/^%B?\(E_PIWPYX[\/
MG4?^%F#P*->_X2+_ (37XD?$'[7]D_X5_HW]D?V9_9'D?:=3^V?;_.M?L7HO
MPL_X+;_M5_"/_@GUJ?\ P3<\-_#_ /9\O?@;JWP[^+_PTN/%6N>%/B/<_%=-
M"^-7B'QKXE\4W<.N6'Q7TWP@NKV%_P".]7B\/SR>!9+.UM+;38]1L-5FANI[
MS\=J*Z?]6\B^H8+*_P"S,-_9^78I8W!87EE[+#8J,ZU15Z:YKJ:J8BO*[;5Z
MDM-1>UJ<TI\[YIQY92ZN-DK/Y17W'ZA?\$V?^"MW[4__  3#UWQ@?@J_A#QG
M\./B-/I%WXZ^$?Q,T_5M4\(7VJZ1,D4'BSPY<Z'K.A:YX1\:KHKWNA/JVG:C
M-HNKV5QI[>+_  SXJ?PQX3&A]A^TG_P67_:C^.W[=/@#]OWP7I_A#]GWXP?#
M3P5X:\ ^'[7X:-X@NM'UOPYH.IZ_JU[9^/XO$NL:G'XO@\2/XFU+1=<TTVNE
MZ+<^%[71--.EG4].GUW4/R-HISX<R*KF&(S6IE>$GF&+PT\)BL1*G=XG#U(1
MIU*6(IW]E64Z<(4Y2J4Y3=.*AS<JL'M:BBH<\N6+4HJ^S3NFNJL]?74_JJ@_
MX.UOVY(O D6C2? /]F*Y^(,=FEJ_CB;3/B6NB3SI=C=J,O@BW^(,#"\DTP&)
MT@\40Z>-88ZG'8QZ;CP^/Y^_VP_VS?VA/V[OC/J'QW_:3\9Q^,?'%QI<'AO1
MHK'2=-T#P]X/\&:?J>KZKHO@GPIHNF00PV'AW1;O7-4EM?M<FH:S?W5]>ZMK
M^KZSKE_J&J7?RS16.5<*<.9'7J8K*LHP>"Q-12C*O3@Y55";3G3ISJ2G*E3D
MXJ].DX0=E[N@YUZM16G4E)*VC>FFS:5KOS>H5^YO[8W_  <$?ML_MO\ [+_B
MG]D_XM^"?V=M%^'_ (T7P2OB7Q%X"\(_$W2O'FJCP)XFT'Q?I?GZGXB^+_BK
M0#]NU[PYI=[JV/# \]HG%I]A+*R?AE17=C<HRS,<1@,5CL%0Q6(RRL\1E]:K
M%N>$KN=*HZE)IJTN>A1E=WUIQ?0F-2<%*,9.*FK22^TM59_>_O9^V7[ _P#P
M7K_;/_X)W_ 9?V=/A#X0_9_\=^ +7QEXB\9Z-/\ &#PE\1-<U_P]+XHCTU]4
MT#2+SP5\5OA_IZ^'3JME>:_#!?:5?ZFFL:]K3OJTEC)86&G_  !\"?VROBI^
MS]^U_H/[;'A32_!OB#XMZ!\0_%WQ-ATSQK9>(]6\&:AXC\:P>(8-975;+3?%
M&B^)KNR_XJ74)K<)XKAO_/2WDNK^[VSB?Y,HK*GD&34JN9UJ678:%7.H3AFD
MXQ:>-C452,U7L[/G56IS./*VYR;=W<'5J-03FVJ>L+OX=MON7W'WI_P40_X*
M(_&K_@I?\:/"_P =?CMX7^%WA/Q=X2^%^C?";3=.^$FB>+-!\.3^'-#\5^-/
M&%I>WUIXQ\;>/-3DUN34_'>KP7%S!J]M8O8VVFQ1:;#<0W5U>?JC;_\ !SI^
MVQK'[,7B;]G7XL_"C]GKXVWWBOP)KWPR\0_$?Q_X?\807WB[P7XGT=_#NO0>
M.?"GA+Q?X;T'7-;U#0;[6-.EU/1CX6T^?[387-_H=]<6FHOK?\W5%<^)X6X>
MQ>%R_!8C*L+4PV524LNIM3C]3=XR:HSA.-2,92A!SASN%1P@YQER1LU6JQE*
M2G)2FK3=_B];Z/R[:VW9^OGP[_X+4?M2_#/_ ()Z:C_P35T'P#\ +OX%:GX)
M^)W@.?Q7JWA;XBS_ !931_BMXR\5^-_$5S#KMG\5;#P>NI66K>,-3M]%F?P)
M):VVG06,-]9ZC<Q7%W=>,?\ !.?_ (*:_'G_ ()C>/?B%\1/@+X2^$?B[6_B
M3X1L?!FNVOQ=T'QEKVEVFEZ?K$6MPSZ3!X,\?> ;N"_:[A6.66\OK^W:W+(E
MJDA$H_.JBMGP]DLL/F6%>78=X?.,3/%YG1<9<F,Q-2HJLZU9<VLY5(QFVK)M
M;![6I>$N=WII1@]/=25DE\CW7]IO]H/QG^U;\??BK^T7\0],\,:-XV^+_BV^
M\9>)=+\%V6JZ=X5L=4U!8DF@T.QUS6O$6KVU@HA7RHK_ %S4[A26WW3Y 'Z&
M_P#!-?\ :RU;]@WQ1:?&SX+?M;V/PX\4?$70IOA]XT^#GCKX8>)?&/P[U3Q3
M:W5]<:!K/Q<TS0]9LDO/A)H\5W97^B_$7P-J)^,_A/6=6\6:5IO@+4_#<%_:
M?%#\?:*Y\ZR)YIE,,GPF,6686,:=&I36 P684:N#I4G"GA)8?'TJM-4XSC1F
MJD$JT8TG&G.G.2JP]C(LQRG+\95Q&<Y'_;U"=&4*>&_M/%Y5*C7E5IMXE8C!
MJ4YRC15:%.E.+I>VG2K5(U:5*>&K_P!J_P 3O^#DSXE^/OA?>>#O ?QA^ GP
M<\?>)K.+P%;_ !6T?X(_$O6-0\*_$*VA(U7Q[I_A7Q5XT\8^'M'^"NKW L_[
M&\77Z?$GXCZ'9W^L0W/P5U:_T/1M4\2?C]^P7^UWX5_X)_?M">.OVFOA'^T_
MX&^(GQ/^+/@+Q5\$-;O/VAO@_P#%3Q9:2>.?%'C3P=X]\3?%'Q7/X/\ B1X8
M\07'PNUW7_!FD2VWCZ'7O$?Q.BCUSQ*^J?!C5KW2-*O/%'X4T5\7A/#*> P>
M-P&#XBJ4<)F"4<;2_L'(I?6H0=Z=.O4>%]K.G%Q@_9QG"G%U,6Z4:3KT_J_U
MLN+.")RC*?AQ3YHZIPXOSZ/*W;F=-24U%KGK>S<U4Y?9X'VOM_88W^TOZAO@
ME_P5VD^"'[5'[4'[87@OXK?LQZA\7/VP?^$)\%>*5\=?L\?'6X\->!?&OP^T
M\V!UOP_8^'/CM9ZMHW[.?C#9H][JWB2ZUSQ]\6H[VQ@>U^%EO#X:B@\>_EW^
MTIJWP6_:U^/7Q4_:,^)G[6VGQ^/OC=XQU4WUO9_"#Q3IGA_PU\1Y9(T@O_L9
MUSQ'J-A^S!IFEPZ7H/A/Q!#JWBOXSZ;I$;)K7PZU^^\.P7WCK\O:*[<'P)F.
M7XJ>-P7%F)H8N>$P^!=>.19$ZCP>$IT:6&P\F\(OW5.GA<-&48*'/RUVN5U:
M+PTRXJX&G%1GX;4N7F<FH\7Y^DI3=YN'-SV:=2O[+VGM>3DP/M/;>QQO]I?T
M??\ !.3_ (*8W/\ P3.\%?$3X=_ ']I+X.^+_!?Q9\4:7)'H7QU^ 'Q-UF'P
M=\:]'TE=#UCXB1W7PZ^)O@K4+7X#>-=*MO#=G?:^]WXQ^(]@FC6LFF_!RSGT
M.\E^)7=?L1_\%8[;]@K3_C7HO[/7Q._9<L?#W[07QAUWQK-X:\:?LW?&E= ^
M'7Q9U&WM;.5O#FF^"/C?H,7AW]D>TL;6PL?"=]"?&'QCT2SGNH+SX>ZJOAS3
M_P#A,?YAZ*YL5X<8C&3Q\\3Q-6K2S26'GF#GD.16QD\';ZK/$1AA:<9RI.%-
MN45"4G/%-.+KTWAW'BS@A<B_XAO3CRW2Y.+\^7(IVYU3YU4Y;<];V7/[7D]G
M@?:>V]AC?[2_=_\ 8 _;2?\ X)Q^+_$GB7]FW]M31CH?Q&AM/!?B+X9?%3X,
M>,M?^&FK?$O1;B":#XB>+]"T#Q3INHZ;\'Y85.G:7\1/!6M+\:K'2]:UJPN_
MAC?P:%IJ^+?U_P#BM_P<I_$OQSX8N-!^%7Q;_9^^"NKZ_::SX$LO&LWP,^)7
MC7Q'X8^(S0I#I_Q CLM?\:ZIX0L?@I;%Q=6GB>^\+?$+Q]->7;F^^!\UEX9C
ML/B#_%#1668>&,LUQJS',.(98O&KEO7K\/Y#)U?9QC&G]9A#"0IXFT:=*,O;
M0E>+Q$8>S52BL*X<6\$PCR+PXIQB]U3XOS]<M_B]FY^T<+>TK>RYG4Y?9X'V
MOM_88W^TOL#X^Z-\*?$TOCWXS#]IS6?C%\3_ !KXJU&^\2V>N>!-1TCQ9XN^
M*>L^(3K7Q%^(6H:I+?3:,_PX\0K?ZAK?AK6VNHO&^H^(+R;1M>\"Z%I]C!XD
MUOX_HHK]"RC!8S+\)]7QN9U<UJ1J-T\15PF#P3IT%"G3I8=4<#1H4+04'-SY
M%*4ZD[*%-4Z</CL\QV59AC(U\GR2&0X54(0G@H9CC,SC/$<]2=7$+$8YRK1C
M)3A2IT;R5.E1I\]2M6E5K5"BBBO4/'"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH _TT?^#8C_E"#^Q=_P!?/[2?_K6GQUK][Z_!#_@V(_Y0@_L7
M?]?/[2?_ *UI\=:_>^OX&S7_ )&F9?\ 8?C/_4BH?2T_X=/_  1_])04445P
M%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_#;_P
M>6_\C1_P2T_Z_/VT_P#TS?LTU_&C7]EW_!Y;_P C1_P2T_Z_/VT__3-^S37\
M:-?UGX-_\D9#_L9X_P#.B>)C_P#>/^W(_J%%%%?JIQ!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?:O[!'[=WQ=_P""=?QX_P"&AO@GX<^''BCQ
MI_PAGB#P-_9?Q3TCQ/K?A?\ LGQ)<Z3=7UQ]B\)>+_!&K?VC%)HUJMI-_;?V
M:-))Q-:3LT;1<C^VG^UU\2?V[/VD_B%^U)\7-$\#^'?B!\2HO"$.NZ/\.--U
M[2/!UHO@KP/X;\ Z4=)T_P 3>)?%^MP-<:/X7T^YU WGB&_$NIS7DUL+2UDA
ML[?Y8HKA668".8SS>.%I+,IX7ZC/&)/VTL(JD:JH-WMR>TA&=K7O%:V*YY<B
MA=\BES<O3FM:_K;0_83_ ()U_P#!;']JG_@F7\*_&GPA^ _@#]G[Q;X:\=?$
M"X^)&K7WQ<\*_$;7M<M]<N?#GA[PQ):Z=<^#?BMX"L(=*%AX;L9D@N=,N[P7
MDMW(U\T,D-O!\M?L-_\ !0S]IO\ X)Y_%O4_B[^SEXKL--O/$NGR:1XX\"^*
M+&ZUWX;^/],5[FXTVW\6>&H-2TR>YN?#]_=S7_AW6],U32O$.C23ZA9V6KQZ
M3KGB#3M6^(**YI9!DTI9I*>6X6;SI4EFOM*:G''>Q4E1]O&;E&3I*<G!I)QD
M^9-22:?M:GN>_+]W?DU^&]KV];*Y_45\4/\ @Z\_;R\;?#"]\'^"?A7\ OA'
MX]U73[:QO/BKX:TGQ7XAU#1Y3;%=1U+P=X5\9^(M=\/Z7J%Q=A'T]O$Z>-;3
M3;)I[:2SO[Y[;5K/^?\ ^"W[6/[0?P _:#TK]J3X;?$[Q/I_QPT_Q/?^+-0\
M<:IJEYKFI>+M2UR\DO?$\/CF74YYY?%VG^+I9[I?%-KK<MT-9%U/-<N;HQW$
M?SK16&6\+\/Y10Q6&R[*<'AJ..BX8R"I>T^LTW&472K2K.I.I1Y922HRDZ4>
M>=H)RE>IUJM1Q<YRDXZQZ6>FJM97T6N^A_53;?\ !VM^W+#X$BT:;X!_LQ7?
MQ CLTMF\<3:9\2X]%GG6Z&=1G\$VWQ @/VR3308Y$M_$]OI_]K,=1BL8M. T
M$>0_\$K?VTOVAOV\?^"]?[(WQS_:3\9Q>+_&DD?QH\.:';Z?I&G:!X=\'>#K
M+]G_ ..VJZ3X,\*:-ID$4=CH&D7>LZE+;M>S:CK-_=7EWJFNZOJ^LWM]J5S_
M #:5Z7\'_C'\4/@!\1O#?Q=^#'C?7OAQ\2_"#ZI)X9\:>&;H66N:*^M:+J7A
MS56L;EDD$1OM#U?4],N,HV^UO9TX+9'E5>!L@PV79UA\ERO 9=CLURO,<OAB
M^2<G2>.PM2A93DZM2E0YY1E4IT%&+C'2#:2+6)JN=-U)RG&$X2<;[\K3VT3=
MEN^O4_N+_P""NW_!:K]JC_@F/_P42O\ X>?#31/AY\3/@_XR^"/PX\8:K\.O
MB-INJJ=)\63S^,='N]?\)>)_#>J:1J^DW6J6ND^'X-7L=67Q%H<]MHZG3=)T
MG5+Z^U>;^6K_ (*1?\%;?VJ?^"G&O^&6^-%SX8\&_#;P)<ZA=^"/@_\ #:TU
M;3?!FFZE?L\,GB;7I-9U?6M7\5^,6TOR=+.LZE?1Z=I]LM\/#&@^&X];UN'4
M/BSX^?M(_'7]J/QI:_$7]H3XG>)_BSXYL]"LO#-OXI\77,-YK"Z#IUU?7ECI
MKW45O TT%I<:E>O 9A))&LYB$GDQQ1IXC4<,\$9/D6'RRO5R[+ZF>8+!4\-6
MS*C3E>=2%-TIUJ:FHJ-2<&XRK>RC6E%N,IM-W*V)J5'-*4E3E)M0;V3=[/RO
MK:]KGZ^?&?\ X+4?M3?'+]@OP7_P3O\ %O@'X :=\%? O@?X1> =(\4>'?"W
MQ%M/BC<Z/\%[70K3PM<ZCK>I_%35_"<VIW\?A^R;7YK;P39VMT\MT=.L]*5X
MEAWO^";7_!<;]KK_ ()K>#]7^$_@/3? 7Q;^"FKZ]<^)K?X=?%&TUZ5_!VMW
MUK+'JUU\/O$WA[6M(U'P]:Z_>IINH:[H>J0>(_#CWEE>:CHNC:%KWB+Q'K>J
M?C+17L3X7X?J8#$Y7/*<)+ 8O%3QV(PS@^2>,GR\^)4N;GA7:A%>TIRA)*\4
MTI23S5:JI*:G)2C%13[16R[->33/V$T7_@MK^U_X%_;Z^+O_  4 ^%-E\-OA
M[XR^-UOI.D_$7X/P:+K^N_!CQ=X=\/Z)HFAZ+8>(]%U3Q*?$=QK%N?#]EKDO
MBW0?$WAKQ!%KM[XA30[O0O#/B36/#%U]W_%3_@ZJ_;V\9ZYX,U'P#\,/V>OA
M=IGAG6M,US7]*MM%\>^([GXA#3(=;CB\+>*M<E\=:-J%OX&>YU2SU=]'\,_V
M!KTVJZ1''=>*KKP]J>L>'K[^8RBN;$<&<+8NIAJN)R/ UJF$PM+!4)3IR;CA
MJ%)4:%*?O6K>QI1C"E.M[2I348\DXM)JEB*T4U&I)*4G)V?5N[?E=[I63/W!
MU+_@OK^V)JG[<6A?M^7'PV_9I3XQ^'_@9<?L_67AJ'P=\45^&DO@VY\1WOB>
M34[K1G^,DGBE_$PO[Z6%+V+QE#I0LUCC.BM,&N'\Z\._\%J/VIO#/_!0OQ__
M ,%*K#P#\ )OCI\1O ]AX!UOPI=^%OB+)\)K71].\(^"/!<%SI6A0_%2W\80
M:F^E^ ='N)9KOQW?6K7]SJ<J6:6\UK:V?Y!T5O#A7AZ"G&&4X2,9Y:\GFE&5
MI98ZD:KP;][6C[2,96^*Z^(7MJNGOO2?M%M\=K<VV]C]1+S_ (*U?M&WO_!2
M6U_X*CR^"O@FO[0%IY'E^#X_#GCL?!UO(^";? 9-_A]OB0_C4Y\(.=2;;\05
MSXDQ>#;I?_$G/ZB?\1:?_!1K_HBW[$__ (;GXZ__ $2%?R[T5EC.#N&,P^J?
M7<EP>(^HX.AE^$]I&;]A@L-S>PP\+35J=/GERIW?O.[=QQKUH7Y:DES2<Y6Z
MR=KMZ;NR/T^_X*0_\%8_VB_^"H<_PEN/C]X+^"OA!_@U#XRA\,#X/^'/'.@+
M?IXX?PV^K'7AXT^(_P 0#=-;GPOIXTXZ>VEB(37GVD79D@-O^@'[*W_!SQ^W
MS^SO\.O"_P +?'/ASX4?M&Z#X.\/Q:!HOBKXF6_C&T^*MQ!931II!\1^-]#\
M4PV7B?\ L[2P=+EOM7\,3>)=7\FRU'6?$E]J:ZE=:K_.#15U^$N&\3EV&RBO
MD^#J9=@Y5)X3#.$DL-*M.52JZ%2,E5I^UG.4JG)42FVN:]E9*O6C-S522G*R
MD[WO:R5T]'9+2Z/U:_X*.?\ !8S]KS_@IC_9'AKXQ7WA#P7\'?"^O)XF\*_!
MCX;Z+-IWA:T\1VUMJVF67BK7M8UN]UOQ9XG\50Z)K-YI/VN]UJ#0+2*>^F\/
M^&- ?5=46[^D_P!@#_@X:_;._80^$>F? 2/P]\._CS\*?"T5S!X!T[XGKXE@
M\5^ [&:>*:#PYH?BW0-:LVN_!UBS7YT_0M>TG5[O25NK;3M$UK2O#NEV.A)^
M"5%55X5X<K972R6ID^">5T9JK2PBI<D*=97O6A.#C5C6ES24ZRJ>UJ*4E.<E
M*28J]53=15)<[5G*][KLT]+=E:R/Z3?#?_!T[_P4ET#Q7X[\57GA#]ESQ7_P
MFE]I<VGZ!XE^'GQ)&@> -*TFP%I!X<\%P>&_C)X<U Z5<7DE_K=]=^+=1\5^
M(KG5-3ND.N)I,&EZ5IW\W%S.]U<7%S(%$EQ-+.X0$('FD:1@@8LP4,Q"@LQ
MQDD\U#173E>0Y-DLJ\LIR[#8!XJ-"&(^K0Y%5CA8SA04U=ING&I-)VNW.4I-
MR;9,ZM2I;GFY<MVKN]N:U_OLC_0G_P""<OQ!\9?";_@V-_X6C\.]<N/#'CWX
M=?"S]JKQMX,\16L-G=3Z)XG\,?M!_%C6=#U..TU&VO-.O/L>HV=O.UEJ-G>:
M?>(C6U]:7-K+-!)^*?BK_@ZV_P""@6O_  BG\#Z/\./V>O!WQ)OM,N-(N_C+
MHGAOQ==ZG9)-;WEO'KOAWP;KOB_5?"^G>*X-]C=)>:Q%XC\-_;;>\D'A)+:\
MMK/3?P]\*_MZ?MB^"/@-=?LO>%/VA?B+HG[/=[HOBCP]=_".TU. ^#)]%\:Z
MAJFK>*=/?3)K24&'6=3UK5-0NB)!*+R\DN(9(I1&R?(U?'Y;X>98L?GN-S[!
M9;FLLPS_ !F;Y>Y4ZDIX:ABJCFL/7YHTU4ULYTFZM!R3=G?7HGBY\M.-*4X*
M-*-.6J]YQ5KK>WD]'8^S?V2?V^?VF/V+?VC+O]J3X.^-(KOXK:[:^(--\<7W
MCZR;QG8?$;2/%>K6&O\ B72_&WV^YBU?48];U[2M,UJ]U*QUC3->.IV$%U!J
M\+F;S?V@^*__  =2?M[>/M \%Z?X/^&OP ^%&NZ+XD\%^)/&?B3PQI'CR_N/
M'</@S7=,\0GP4T6J>.'N_#OP_P#%=Y9W^F^+M)LM4O/$E_X;U6YT;3/%^C^=
MJ-YJ?\R5%?3YAPKP[FN*HXW,<GP6+Q5"$:=.M5I>][.%_9PFHN,:L*=W[.-6
M,U3^PHV5L85ZL(N,*DHQ=VTGU>[757ZVL?I=_P % O\ @JK^TE_P49^)7PG^
M+'Q<T7X8_#;QG\%])?2_ ^I? K3?'O@Z6RE_M\>);76GO/$WQ$\<:K;Z]INJ
MI%/IFI:1J6E-9M##+'']IC6<?H%XZ_X.7/VS_BW^R5\1?V7?B_\ "SX _$"]
M^)'PQUGX4:W\6[C0O%N@>([S1M?\/1^'M3\4:GX9\/\ BJQ\)3>/-LNH:S9:
MCH6G^&O"EEKDFFSKX*DT[3I]+U+^<^BE5X4X<K4,NPU3*,)*CE%1U<M@HSB\
M'-U%6E[&<9QJ*,JL8SG!R<)RC%RB^56%7JIS:J2O-6GK\6EM?EI?<_7SQE_P
M6H_:F\<?\$]+;_@FKJW@'X 6_P "[7P/X!\ Q^*].\+?$6+XLMH_PZ\6^&O&
M6B7+Z[<_%2[\'G4[K5/"NGP:K,O@1;6>PFO(K2SL;B2"ZM\7_@G5_P %E?VP
MO^":UGJOA+X17_A/QW\)?$&N6VNZQ\)?BG8ZUK/ABUO@'AU74/"%SHVNZ%JO
MA#5]8MG07MU8W5QIEU>V>GWNIZ+J9MY8;G\G:*UEPUD,\%C,NGE6$G@L?BYX
M[&8:5/FIUL94Y.?$M2;<:S]G"U2#C*/*N5K47MJG-&:G)2C%1BT[6BMH^FNW
MWG](/[5/_!SS^WQ^T-\._$/PO\!^&_A/^SGH/B[0;O0/$7B;X=6/B;5_B9+9
M:I'=V>KV^A^+O$VOWFG^&(+[3+E+2*^T7PS;>*M*N%FU'2/%-C=/;&R^-/\
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MI3YY<TERRE?5QLE9^5DON/TZ_P"";O\ P5E_:E_X)B^(_%MU\$I?"7B_X?\
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M6R'ZS]=^HYW_ *S=/XSL/"VE>*-9TWP7KNH>)_#%C>/:Z3XAU328M!O-:@@
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M@K_$OS1\PT445_4YXH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]U^9_'I17]\/_$&5_P $O_\ HN_[>O\ X=#]GK_Z%RC_ (@RO^"7_P#T7?\
M;U_\.A^SU_\ 0N5^N?\ $;LG_P"A7B/_  HE_P#,?]6?E?A_LZ?\Z_\  ?\
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MZ_\ AT/V>O\ Z%RC_B#*_P""7_\ T7?]O7_PZ'[/7_T+E'_$;LG_ .A7B/\
MPHE_\Q_U9^5S^SI_SK_P'_[8_@>HK^^'_B#*_P""7_\ T7?]O7_PZ'[/7_T+
ME'_$&5_P2_\ ^B[_ +>O_AT/V>O_ *%RC_B-V3_]"O$?^%$O_F/^K/RN?V=/
M^=?^ _\ VQ_ ]17]\/\ Q!E?\$O_ /HN_P"WK_X=#]GK_P"A<H_X@RO^"7__
M $7?]O7_ ,.A^SU_]"Y1_P 1NR?_ *%>(_\ "B7_ ,Q_U9^5S^SI_P Z_P#
M?_MC^!ZBO[X?^(,K_@E__P!%W_;U_P##H?L]?_0N4?\ $&5_P2__ .B[_MZ_
M^'0_9Z_^A<H_XC=D_P#T*\1_X42_^8_ZL_*Y_9T_YU_X#_\ ;'\#U%?WP_\
M$&5_P2__ .B[_MZ_^'0_9Z_^A<H_X@RO^"7_ /T7?]O7_P .A^SU_P#0N4?\
M1NR?_H5XC_PHE_\ ,?\ 5GY7/[.G_.O_  '_ .V/X'J*_OA_X@RO^"7_ /T7
M?]O7_P .A^SU_P#0N4?\097_  2__P"B[_MZ_P#AT/V>O_H7*/\ B-V3_P#0
MKQ'_ (42_P#F/^K/RN?V=/\ G7_@/_VQ_ ]17]\/_$&5_P $O_\ HN_[>O\
MX=#]GK_Z%RC_ (@RO^"7_P#T7?\ ;U_\.A^SU_\ 0N4?\1NR?_H5XC_PHE_\
MQ_U9^5S^SI_SK_P'_P"V/X'J*_OA_P"(,K_@E_\ ]%W_ &]?_#H?L]?_ $+E
M'_$&5_P2_P#^B[_MZ_\ AT/V>O\ Z%RC_B-V3_\ 0KQ'_A1+_P"8_P"K/RN?
MV=/^=?\ @/\ ]L?P/45_?#_Q!E?\$O\ _HN_[>O_ (=#]GK_ .A<H_X@RO\
M@E__ -%W_;U_\.A^SU_]"Y1_Q&[)_P#H5XC_ ,*)?_,?]6?E<_LZ?\Z_\!_^
MV/X'J*_OA_X@RO\ @E__ -%W_;U_\.A^SU_]"Y1_Q!E?\$O_ /HN_P"WK_X=
M#]GK_P"A<H_XC=D__0KQ'_A1+_YC_JS\KG]G3_G7_@/_ -L?P/45_?#_ ,09
M7_!+_P#Z+O\ MZ_^'0_9Z_\ H7*/^(,K_@E__P!%W_;U_P##H?L]?_0N4?\
M$;LG_P"A7B/_  HE_P#,?]6?E<_LZ?\ .O\ P'_[8_@>HK^^'_B#*_X)?_\
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M )U_X#_]L?P/45_?#_Q!E?\ !+__ *+O^WK_ .'0_9Z_^A<H_P"(,K_@E_\
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M&[)_^A7B/_"B7_S'_5GY7/[.G_.O_ ?_ +8_@>HK^^'_ (@RO^"7_P#T7?\
M;U_\.A^SU_\ 0N4?\097_!+_ /Z+O^WK_P"'0_9Z_P#H7*/^(W9/_P!"O$?^
M%$O_ )C_ *L_*Y_9T_YU_P" _P#VQ_ ]17]\/_$&5_P2_P#^B[_MZ_\ AT/V
M>O\ Z%RC_B#*_P""7_\ T7?]O7_PZ'[/7_T+E'_$;LG_ .A7B/\ PHE_\Q_U
M9^5S^SI_SK_P'_[8_@>HK^^'_B#*_P""7_\ T7?]O7_PZ'[/7_T+E'_$&5_P
M2_\ ^B[_ +>O_AT/V>O_ *%RC_B-V3_]"O$?^%$O_F/^K/RN?V=/^=?^ _\
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M_P#^B[_MZ_\ AT/V>O\ Z%RC_B-V3_\ 0KQ'_A1+_P"8_P"K/RN?V=/^=?\
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M7B/_  HE_P#,?]6?E<_LZ?\ .O\ P'_[8_@>HK^^'_B#*_X)?_\ 1=_V]?\
MPZ'[/7_T+E'_ !!E?\$O_P#HN_[>O_AT/V>O_H7*/^(W9/\ ]"O$?^%$O_F/
M^K/RN?V=/^=?^ __ &Q_ ]17]\/_ !!E?\$O_P#HN_[>O_AT/V>O_H7*/^(,
MK_@E_P#]%W_;U_\ #H?L]?\ T+E'_$;LG_Z%>(_\*)?_ #'_ %9^5S^SI_SK
M_P !_P#MC^!ZBO[X?^(,K_@E_P#]%W_;U_\ #H?L]?\ T+E'_$&5_P $O_\
MHN_[>O\ X=#]GK_Z%RC_ (C=D_\ T*\1_P"%$O\ YC_JS\KG]G3_ )U_X#_]
ML?P/45_?#_Q!E?\ !+__ *+O^WK_ .'0_9Z_^A<H_P"(,K_@E_\ ]%W_ &]?
M_#H?L]?_ $+E'_$;LG_Z%>(_\*)?_,?]6?E<_LZ?\Z_\!_\ MC^!ZBO[X?\
MB#*_X)?_ /1=_P!O7_PZ'[/7_P!"Y1_Q!E?\$O\ _HN_[>O_ (=#]GK_ .A<
MH_XC=D__ $*\1_X42_\ F/\ JS\KG]G3_G7_ (#_ /;'\#U%?WP_\097_!+_
M /Z+O^WK_P"'0_9Z_P#H7*/^(,K_ ()?_P#1=_V]?_#H?L]?_0N4?\1NR?\
MZ%>(_P#"B7_S'_5GY7/[.G_.O_ ?_MC^!ZBO[X?^(,K_ ()?_P#1=_V]?_#H
M?L]?_0N4?\097_!+_P#Z+O\ MZ_^'0_9Z_\ H7*/^(W9/_T*\1_X42_^8_ZL
M_*Y_9T_YU_X#_P#;'\#U%?WP_P#$&5_P2_\ ^B[_ +>O_AT/V>O_ *%RC_B#
M*_X)?_\ 1=_V]?\ PZ'[/7_T+E'_ !&[)_\ H5XC_P *)?\ S'_5GY7/[.G_
M #K_ ,!_^V/X'J*_OA_X@RO^"7__ $7?]O7_ ,.A^SU_]"Y1_P 097_!+_\
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M6?E?#^SI_P Z_P# ?_MC^!ZBO[X?^(,K_@E__P!%W_;U_P##H?L]?_0N4?\
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M>(_\*)?_ #'_ %9^5S^SI_SK_P !_P#MC^!ZBO[X?^(,K_@E_P#]%W_;U_\
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M[X?^(,K_ ()?_P#1=_V]?_#H?L]?_0N4?\097_!+_P#Z+O\ MZ_^'0_9Z_\
MH7*/^(W9/_T*\1_X42_^8_ZL_*Y_9T_YU_X#_P#;'\#U%?WP_P#$&5_P2_\
M^B[_ +>O_AT/V>O_ *%RC_B#*_X)?_\ 1=_V]?\ PZ'[/7_T+E'_ !&[)_\
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M^"7_ /T7?]O7_P .A^SU_P#0N4?\097_  2__P"B[_MZ_P#AT/V>O_H7*/\
MB-V3_P#0KQ'_ (42_P#F/^K/RN?V=/\ G7_@/_VQ_ ]17]\/_$&5_P $O_\
MHN_[>O\ X=#]GK_Z%RC_ (@RO^"7_P#T7?\ ;U_\.A^SU_\ 0N4?\1NR?_H5
MXC_PHE_\Q_U9^5S^SI_SK_P'_P"V/X'J*_OA_P"(,K_@E_\ ]%W_ &]?_#H?
ML]?_ $+E'_$&5_P2_P#^B[_MZ_\ AT/V>O\ Z%RC_B-V3_\ 0KQ'_A1+_P"8
M_P"K/RN?V=/^=?\ @/\ ]L?P/45_?#_Q!E?\$O\ _HN_[>O_ (=#]GK_ .A<
MH_X@RO\ @E__ -%W_;U_\.A^SU_]"Y1_Q&[)_P#H5XC_ ,*)?_,?]6?E<_LZ
M?\Z_\!_^V/X'J*_OA_X@RO\ @E__ -%W_;U_\.A^SU_]"Y1_Q!E?\$O_ /HN
M_P"WK_X=#]GK_P"A<H_XC=D__0KQ'_A1+_YC_JS\KG]G3_G7_@/_ -L?P/45
M_?#_ ,097_!+_P#Z+O\ MZ_^'0_9Z_\ H7*/^(,K_@E__P!%W_;U_P##H?L]
M?_0N4?\ $;LG_P"A7B/_  HE_P#,?]6?E<_LZ?\ .O\ P'_[8_@>HK^^'_B#
M*_X)?_\ 1=_V]?\ PZ'[/7_T+E'_ !!E?\$O_P#HN_[>O_AT/V>O_H7*/^(W
M9/\ ]"O$?^%$O_F/^K/RN?V=/^=?^ __ &Q_ ]17]\/_ !!E?\$O_P#HN_[>
MO_AT/V>O_H7*/^(,K_@E_P#]%W_;U_\ #H?L]?\ T+E'_$;LG_Z%>(_\*)?_
M #'_ %9^5S^SI_SK_P !_P#MC^!ZBO[X?^(,K_@E_P#]%W_;U_\ #H?L]?\
MT+E'_$&5_P $O_\ HN_[>O\ X=#]GK_Z%RC_ (C=D_\ T*\1_P"%$O\ YC_J
MS\KG]G3_ )U_X#_]L?P/45_?#_Q!E?\ !+__ *+O^WK_ .'0_9Z_^A<H_P"(
M,K_@E_\ ]%W_ &]?_#H?L]?_ $+E'_$;LG_Z%>(_\*)?_,?]6?E<_LZ?\Z_\
M!_\ MC^!ZBO[X?\ B#*_X)?_ /1=_P!O7_PZ'[/7_P!"Y1_Q!E?\$O\ _HN_
M[>O_ (=#]GK_ .A<H_XC=D__ $*\1_X42_\ F/\ JS\KG]G3_G7_ (#_ /;'
M\#U%?WP_\097_!+_ /Z+O^WK_P"'0_9Z_P#H7*/^(,K_ ()?_P#1=_V]?_#H
M?L]?_0N4?\1NR?\ Z%>(_P#"B7_S'_5GY7/[.G_.O_ ?_MC^!ZBO[X?^(,K_
M ()?_P#1=_V]?_#H?L]?_0N4?\097_!+_P#Z+O\ MZ_^'0_9Z_\ H7*/^(W9
M/_T*\1_X42_^8_ZL_*Y_9T_YU_X#_P#;'\#U%?WP_P#$&5_P2_\ ^B[_ +>O
M_AT/V>O_ *%RC_B#*_X)?_\ 1=_V]?\ PZ'[/7_T+E'_ !&[)_\ H5XC_P *
M)?\ S'_5GY7/[.G_ #K_ ,!_^V/X'J*_OA_X@RO^"7__ $7?]O7_ ,.A^SU_
M]"Y1_P 097_!+_\ Z+O^WK_X=#]GK_Z%RC_B-V3_ /0KQ'_A1+_YC_JS\KG]
MG3_G7_@/_P!L?P/45_?#_P 097_!+_\ Z+O^WK_X=#]GK_Z%RC_B#*_X)?\
M_1=_V]?_  Z'[/7_ -"Y1_Q&[)_^A7B/_"B7_P Q_P!6?E<_LZ?\Z_\  ?\
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MZ_\ AT/V>O\ Z%RC_B#*_P""7_\ T7?]O7_PZ'[/7_T+E'_$;LG_ .A7B/\
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M #F7_P"T]7_!1#_WC]=^'_W',?3"?^GR7\4?^WOR/WJHHHK@*"BBB@ HHHH
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ML&O]*O#)#)!>Z;J,%KJ6DZOI=_;WFD:WHVI6MMJ.CZQ87VF7]O!=VDT2^S4
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MO>>&+3XK^ ?#_CNV\/76K06EA#JESHL.O)IL^HPV-E%>RVS7,=I;I*(4]XH
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MWO=%N9/L20179^UM+:_I10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'X*_P#!L?\ \H1_V-/^O[]I?_UK;X[U^]5?@K_P;'_\H1_V-/\ K^_:
M7_\ 6MOCO7[U5W9I_P C+,?^P[%_^I%0F'P1_P ,?R04445PE!1110 4444
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M1110 445\O?MJ_M-Z7^QE^RC\>/VI]:\)W_CK2_@;\/=7\>W?@_2]3M]%O\
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M1110 45_-]XP_P""K'_!1?\ :$_;S_:;_9._X)I?L@? SXB_#O\ 8G\2>$/
M_P"T)\4_VCOB)KG@V\UKQCK]UJBZGIGPVTO1M4T:TQIRZ!X@L;,7DNN?:#I]
MGK>K3:#::YI6FS?T=V[3-;P-<HD=PT,33QQMN2.8HIE1&R=R*^Y5;)R #DT
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M$WC"S\#7NBV6MWM[K46G_$7^RG\0^,?N_P#X+U_M>?'+]@+_ ()5_M ?'O\
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MOX@EUKPYH^@37&JR:OJVK^(WUO0;G2-.\.:UX*;Q?QK^T'_P57_:<_X+F_\
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M'^#GPE\4>--0M;ZPTFUUW5+C6M=UC5+]CKVJZJMBU_<P:8ME:R&"OG?XO_\
M*VS^RS_VAZ\0_P#J^?VBJ7]A/_E9R_X+D?\ 9!_V&?\ UGWX)T ?)G[)?Q3_
M ."OW_!2W]K/_@K1^S)X+_;6U7]F3]GO]F7]OGXY> K#]H?3O O@OQG\5-$\
M*>&/BGXVT3X3?LX?!OPI_8OA;2='TG0]/\*S^(?B7\3O$'B?5?%E_HESX5\(
M1VM]!J^I:C:_2G[)WQQ_X*,?L _\%?\ X4_\$POVU?VKD_;J^ 7[8GP2^)WQ
M/_9E^-WB3X?>'O 7Q7\*^/OAQI>L^,?$W@[Q9!X>N]4N'T[1_"_@/Q=!=1ZM
M?:OH^MMX@\%:]X6\0>'+RW\4_#VTW_\ @WL_Y.>_X.!/^TPG[1W_ *GWC^C]
MO'_E9N_X(8_]D-_;E_\ 6??C90!]#_#;]J_]H75O^#CO]H+]C'4OB;J]Y^S'
MX8_X)IZ-\=- ^$TVGZ ='TKXK3_%CX(>%YO%UKJPTD>)TN)-"\0ZW9-IC:XV
MAEM2N;O^S/MS+<K\U?'3]JC_ (*#?\%,_P#@I'^T/_P3S_X)R_M'>'_V,?V=
M?V&-/\#6'[7_ .U39_#[1/B3\4_&'Q+\?+J+CX6_#'3/%-M+9: FC2:/XCT,
M:E:/X2U:+Q-\/_&NI2^+]2\/R>'] UN]\)?^5MK]I_\ [0\Z!_ZOC]G:O.?^
M"3'Q-T#]CK_@LI_P6@_81^/$D/PS\;_M+_M*M^W)^S9J/C&_MM+T[XR^#_C+
MXGUR\UK3?!FN:A_9>C^(]3L[[QWX/L?#GASP[_:VNW.HV'Q+T&[\W5?AMXA$
M !] _!'P5_P6:_X)\?MI?!'X8?$KXW>-/^"K7["_[2VJ:CHGCOXG:W\,?#G@
MCXQ_L;^*-+M/#NF6'C/7=0T;4VM=8^'7BG5=>MI+[2YM3\016F@^&?$^LZ5I
M'A/6--OIOB#[)^W5\+?^"SW[5?[7VB_ 7]E[XR^'?^"?/[!/A;P!9>)_&W[7
M?ABU^''QA^-GQI\=7EQIUZ_PX\+_  ]URZL/%GPV_P"$<OK2/3_[2MYO#>CW
MNC2Z]KVI>-?&B:A8_"FU^V_C[_P4I_9=_9X_:J_9L_8F\3>(-=\7?M/?M1Z[
M'I_@/X3_  [TW3?$.O\ AKPR([VXO?B7\2VO=:T:S\%> ;&STK6KZ.]N[BYU
M_7[70/$#^$?#GB)]#U2.U_G^\<V?QN_X*V?\%IOVZ?V$/CA^W;\=_P!C#]G/
M]BCPK\)(_A]^R=^R_P#$Y/A)\4/VHM$\>>$;/Q9XC^*'BSQC']IO/$WA73)M
M4\-:AXET9_"NL6.B^&/B#\-](T9O#NO6FL>-?$H!ZUX9^,'_  4>_P""5?\
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M\*_BM>ZYX@T^TU;PSIFNZAXS\%:3K_\ 9?C*S\.Z5X/\#>._%-UX?;5C<_\
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M^#+/[>_X+.?\ID_^#;?_ ++Q^V9_ZBW[-] 'I_\ P5=_;F_:Z\0?MF?LU_\
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MK,H^MOA1_P $2_\ @EI\:O@-I'[37P\_X*/_ +?FM? S4_"UCXNNOB/_ ,/
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M\:>'#XJT/6==O=7LW\4W6MZ1K.EZ1^J/_! __E#C_P $]?\ LWGP[_Z<M7H
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MK^S#X.^T^;Y'V?\ X2?X<_M0:)Y_G?9;[R?)^W>9YOV*\\O;O^RW&/*?K_\
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MNK:X^KZE>3W4TNMFSBMK6*Q,MY_/'_P<+_#76/@S_P $3?V$/@_XAG@N=?\
MA5^T1^P3\-];N;4*+:XU?P/\/O$7AG4I[<++.H@EO-,FDB"S3+Y;+B60?.?Z
MWX_]7'_N+_Z"* .=\:>,/#7P\\'>+/'_ (TU>WT#P=X&\-:[XP\6:]=K.]IH
MGAKPSI=UK6NZO=);13W+V^FZ7975Y,MO!-.T<+"**20JA_D\_9(U?_@KU_P7
M-\,>)?VVO"7[?FK_ /!-/]B;Q5XV\>>'/V5/@Q\&/A%X)\<_%'Q-X;\!>+M1
M\&77COXH>-M?N+*^EN[O4=)UO0M4T^T\4ZCH4_B?0M0N=!\+>%]+M[:ZU_\
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M_$7P8GB33M(&IVVE1RZS+X:\8QZWK'BK4]'7QMXL^.?^#6S_ )-O_P""D?\
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MC]/L-9TG3-.O=/QHESI_@.!/ S:N8;73KA/%7C_6+4P*]G=Z/X<_-7_@DO\
M\$P_VXOVU_A_\7_^"LOA;_@I#\<_V$/B)_P4<^+_ ,2_BEK_ ,/_  -\*_#O
MCJ[E^'>B?$[QS8_#BTN/%?C7Q#HVIW'AZP2[UUO!$&G>'] T23P--X6FTNRE
MTE-)D0_:A_9*_:3_ ."-_P#P4W_X)K?\%./C?^V=\0_VU/!7Q*^+LW[&W[37
MQ8^)?PQ\/>!9OAO\//B;I#>&_ DGB#_A"-9U.[\2:581^(_'7C6+5+U$N])O
MOACX:T9%URVO[#0@ ?I1_P '#/\ R<A_P0&_[3!?LW_^K ^']>V_\%COVT/V
MLO ?[2'_  3[_P""<W[(OQ.\'_LK>/?^"@OC+Q[INI?ME^/?#.C^,K;X5>&O
MA=8Z5JFM^$_AWX-\<VEA\/O%WQ,\;+J]EHNBZ?=^)O[=_M+4_#OA?1=/T7Q)
MX^\*>,-'\1_X.&"#^T?_ ,$!2#D'_@L#^S>0?4'X@?#\@U]L?\%/_#__  27
M_:R^*?[.O_!./_@HCINBZW\6OCA%XG\:?LU6VK#QSX"U72M;M[2]\/3S^"/C
M?H;^']$TWQ1KM_;P:=9?#*3Q7J3>.-;L?"UOK_@3786\-QW !\]>#OV0_P#@
MM;^QG^T?^SQXS^'O[?>O?\%)?V:O''CS0_!'[6/P;_:,\&?"WX9>+?AIX!_L
M74KS5?C=\*_'-MJZW>IZAI=[#>V.E_#[2+C3;F^US5O!VE>)X?%?AJ36?'?P
MS_HBK^([]LWX8_&/_@WQ^-/[!/B;]CS_ (*,?M0_'KP'\=OVE?"_P"N_^";W
M[5?Q3M_C+8Z_\+O&=S=C7_$OP=TG[5X+M_"%AX.U^_T_0[76-+\/Z??6_C7Q
MQX!;7?%>J::NOZ-XE_MP4EE4D8)4$CT)&<?ATH 6BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#\%?^#8__E"/^QI_U_?M+_\ K6WQWK]ZJ_!7_@V/_P"4
M(_[&G_7]^TO_ .M;?'>OWJKNS3_D99C_ -AV+_\ 4BH3#X(_X8_D@HHHKA*"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\%?^"AO
M_*;+_@WP_P"PI_P5*_\ 62_"-?O57X*_\%#?^4V7_!OA_P!A3_@J5_ZR7X1K
M]ZJ[L7_N^5_]@-3_ -668DQWG_B7_I$0HHHKA*"BBB@ HHHH **** "BBB@
MHHHH *\0_::_Y-N_:#_[(A\5_P#U ]?KV^O$/VFO^3;OV@_^R(?%?_U ]?H
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MYXA^*/BW]F#Q[)\+OB-X(\3?&'3_ !/I/CC6[K7_ -M/X,VNO7MYIWB[P7X
MUB+3?[6TNYAT2['AFWTK6M(AL]>T+4=<T75+#6]0_JX_9%_Y-5_9L_[(1\)O
M_4%T*@#\9_\ @EU^U3^V%_P5@_X)=?%7P[XR^-LW[*G[<_PB^.GB_P#9B^*'
M[0/PS^'_ ()\5GP_X]^$_B[P5XUOM;T/X?ZO+<_#V^NO$WPUUS3?!7B0Z??7
M7A[^UM3U[Q%X<338QIVC:=^3?_!LW^R?^UOJ]O\ M._$71O^"A_Q"\-?"_X/
M_P#!3?XT>%OC)\![3X,^ +_P]^TIXL\+^#OA5<^)?B#XD\:7VJ/XU\$:AXV@
MU'2;6[T7P]J-[IFG+X>MF)U)+_4H;C]#_P#@UX_Y(5_P4R_[2[?M2_\ J _
MZL#_ (-A?%?A?3?A]_P4Y^&^H^)- L/B):_\%9OVF]6NO 5[K&G6OC2VTJ]\
M%_"JQL]3N/"T]S'KD.GW=[X8\2V=M>26*VT]UX>URWBD>;2;]+< Z[]K3]HK
M]N;]L_\ X*S^._\ @E)^S/\ M56O_!/'X;? G]GOP_\ &WQ[\8M#\#^&/'_Q
MR_:%U/QC%X+U;2=&^&.F?$.UT%-&\&>"YM;6Q\2>(OAMJ>IM;WVF:[HOBS7Y
MSX@@\+^&_J7]BSX#_P#!7G]D_P#:_O\ X9?'K]J&T_X* _L#>-OA]XEU_1_C
M1\0_#?@'X8?'WX'_ !337$E\/>#M5T[1-5NM0^(_A:[\.6<UG?:O:V[P7.M:
MS9ZE8Z?X'T_1;W1=:\M_;)_9C_X(S_\ !6O]MGQ]^RA\6[W6]&_X*(_LG?#[
MPCK)\<_#;7?&OP+^/'@CP]XKBC\7>&;[P-XBU"QL_#7Q</@)-2\+>-[/4KCP
MQ\2O#/P]E\<^'I-/O;*Y\3^(--E^$?V<_%_[1_\ P3"_X+<?LY_\$Q_#/[?/
MQL_X*#_L_P#[4/PH\5^)_B/X!_:;\:#XL_&K]E/6?!GP\\6^*/"^L6OC2;5X
MG\*Z'XAM/"&D267A:X@T#1[KPOXFDN(O!VI:_)X3\0ZR ?V 5_/U^R?^UM^T
M[X<_X+L_\%!?V!OVB/B%J'BGX4:_\%OAI^TY^QEH^IV/AVTT_P -_#Z"YL-)
M^(>E^'=0TZRMM<U!YO%7CM=$O;+Q3>ZA>QR_#N^N_#T%IH,<DMQ_0+7\O'_!
M>G7-'_83_:Z_X)<_\%AICK.G^%_@A\7O$'[*G[3$OA71GU+7?$/P*^-?A?Q5
MJ6BG4XK2ZMKC5M!^'U];?$7Q#8Z!?Q7]E<>*]=T2ZTMM,U^&Q.I@'R[\;O\
M@K?^UMX._P"#@/P_X(M_C#-IO_!+?X<?M+_"#]A/Q[X=T_2?!ZZ+XB_:,^-'
MP!\5WEC8ZMJ-YX/E^("7/@[XVWL=OXFU.RUF'P]I%GX7T=[W4H=$U&61?U$_
MX*%_M<?M$-_P5+_X):_\$\OV6OB7??#J[^(VM^+?VG_VM+^TT?PKJ<>I?LT_
M#1K@Z-X.N;G7-"\2:C8:9\3=<\(^//!=]=Z+;Z+?0ZA<^'VM-:A+W-]HWXP>
M$?V+_'7Q(_X-E_V@?VEO&E]>:?\ M(?%7XO?$?\ X+.^$_%'B3PK9>*=<\,^
M.=!\6I\0/#'BV234=-CD\3:EXT^ ?A>>:3Q5J6G0V\-GX\N1=VVI>%;"2UU+
MZ3_X(;_%%?\ @J__ ,%*OVQ/^"P.H^$;_0/A_P" /@E\$/V./V?M(\0:4+J;
M0M>G\%^&?'GQY2#47DET_3==T?Q$FGW$(TB349XM ^)M[IHU:33Y7OO$8!^@
MG[+7[5_[0OC[_@OE_P %0/V4/%_Q-U?6?V>O@+\$/V7O$?PD^&,NGZ!;:/X.
MUSXA?"GX9^(O&&I6U_8Z3:Z]J=QK&LZIJ-ZW]N:MJ:6+7EQ#IJ6=M(8:_!KP
M7^P[^WA=?\'%OQJ^"ME_P5D^+.E_'2'_ ()Y6WQ#N_VK8?V=/@[=>+=1^'+?
M$;X.Z3'\&)_AS?7EQX%M=&BU2]T[75\3Z;%8ZN\NB6UM+;.U[J5Y=?J]^Q3_
M ,K//_!9_P#[-U_8K_\ 5'?"2L'1O%7A?P)_P=E_%2Z\<>)-!\&VWBW_ ()-
MVFD>%+GQ7K&G^'8/$VJI\6_A'J+Z9X>FU>XLX]:U!-/\,^)+YK+36N;E;/P_
MK=T8A!I-^]N >'_\%]KCX^?"W]M3_@W;M_A%IVB?'O\ :-\._%#]I#POX.D\
M?WE[X-\+>-OB-=>%?V:_"\7C/Q]/HD>NZGHWA2TU&\E\;>,K31C>:D-!T_5+
M#3+V.\D@OH]']OW]G;_@NE^P%^SUX]_X*!_"O_@KOXC_ &D/%?P6:V^*GQF_
M9F\;?LY?#C0/@_X@\"R:QI][\0['P+ ^LZVVD^&?"=K-?7+:'%#X?\2#X?V^
MJR^$O&_AWQ9I&DVFN>^_\%K"#_P5M_X-RR""#^T5^UB01R"#X4^ ."#W!K]3
M?^"QW_**C_@H7_V:-\</_4%U>@#Z5_8Z_:(TC]K;]E3]GC]IO0["XTG3OCM\
M'?A_\4(]'NX#;76BS^,?#6G:U>:-<0_:+Q!-I-Y=SZ?*T%[?6LCVQDM;Z\MV
MBN9?/_\ @HA^VAX+_P"">W[&/Q\_:\\<6']MV'PA\&/J'A_PLMQ+:OXR\?:]
MJ%EX6^'?@\W5O;7MU86?B+QKK6AZ=K.L6VGZC)X>T*;5/$,EA=6^E3Q-X%_P
M1!_Y1&?\$[_^S4/@[_ZB&G5\Q?\ !S#\ O'W[0O_  1V_:<T#X9^'-7\7^+?
M 4WP_P#BY'X;T)!/JE_X>\ ^,])OO&UW!:>1,]]'X>\%7/B'Q3>6L,EK<O9:
M'<26LES<1Q:=? 'QQ\$_V./^"]/[;WP \)?M8_%/_@K[??L@?%SXL>%M,^(O
MPR_9R^#/[//@;6?@[\._"7B"SM?%?@CPIX[N;V[T+Q#JOB":'49;/Q9=:K_P
MGE]HL<]O83:QXUM=%CL+G<^/OQI_;N^*_P#P0!_X**Z!_P %&/@<_P )_P!I
M;X1_"[XB_#G6O&NC:9'I'P^_:"\-Z1=Z4?#7QH\#Z4)Y)-%C\16+FT\0Z2]M
MI=L^OZ=>Z]I/A_PKHFNZ;X3T+]M/V'OVYO@3^V'^QK\+OVK_  9X_P#!MGX.
MU?X3Z-XT^(ZW?B31;2/X0ZGIV@M<^/?#WQ#FEU2>U\*77@+4M,U[3O$$VJWX
ML+5=%O;U-0N=.1;Z3\G?VY?^"A?[//\ P4:_X(H?\%4OB;^S'-XTU[X9_##P
MQ\4?@L?'WB7PW%X;\/\ C[Q!X4B\+:E?^(?AXD^IW.M:QX+NK'7M+GT[6]6T
MC09KAYYK.33X+^PU"UM #Y3_ &OOVJ?V@/V,_P#@UK_84^.W[,OQ*U;X3_%G
M0?V9?V -(TKQCHUAH.J75MIGB#X5^$M.UBR?3O$NDZWHMU!>VCF-UO--N/*=
M8[B Q7$,4J?6?_!?']M3]L#]D'3_ /@F-J_[(>OW\GCGXR_MF_#KX;>*/AI%
M-H%AIOQVTG6YO#<D'PEUO6=;\.>)!X8L/'&J21^'I_$^C:?'K.A0:M<WFGR@
MJT,GYE?\%6_^51#]BS_LW;_@G/\ ^JX\'U]U?\'!7_)4/^""/_:5W]F#_P!3
M+P!0!P'[8/[*'_!=C]E[]G#XK?M\^&?^"PMY\0_C1\$_">O?M"_$+]F"3]GW
MP!H/[,<_@WPKI6H>*?BA\.O!\NM:AJ^J7>B>$O!<&KP^&=2UGP_8>(_%/]A1
MW=N?"'B[5[#4]%^BOVZ/^"EWQI\1?\&XNO?\%+/V?O$,WP/^.WBOX'?LV?$#
M3M5\/V&F:TG@/QAXV^-?P?\ "'Q&T?1+?QAI6L:?JFE0C7/%?AW3[W5=*GDN
M=+GCU"..WNVADA_53_@J+_RC-_X*)_\ 9BO[7'_J@/B#7\N_QS_Y4IK#_LW7
M]FS_ -:X^$- '[1_M]_\%.?%G[ G_!*3X._M%:5I<'Q5_:C^./A7X'?"CX#>
M%]?2>>T\<_'WXK^%+2^BU;Q-%IK6UP^D:-867B+Q3?012:=:ZYJ]EI'A%]6T
M&3Q-;:K9_'FL?\$\?^#@:[^#Z_M#R?\ !:*\M_VN+'0#X^N/V;M"_9V^'ES^
MS%J&NZ;93W5E\)=+OK+3]*NO[/NK"&PT:7Q-=?#'5+G4]76[O;S2[B]U)M?M
MO&O^"V^B>,_!'_!-/_@D/^VIX7\$>(/B!H'[!G[0O[&/[0OQ1T7PY%%=7=A\
M-]!\/:!J6H:Y=6<KV8>Q'B/0O"_AIKG^UK".SN_%%G)= 6+W6HZ5_2^G[8_[
M,'_#,UU^V)-\<?ARO[-6F^!+?XC:I\7X?$5I=^$+#PQ=:=9ZC!/+=6C7%R^I
MW2ZA8V5AX=AMI?$>HZO?6&AV&E7.LWUI83 'RM\&_P!I7_@H)\1?^":LWQNU
MG]BNV\,?\%$=+^'FLZ>_[+7C3Q7I_P ._!/BGXP:'=G1(M7T;Q-KFO7UOH_P
M]\4*@\=:%HFN>+XKZ'39H_ VJ>.[+44G\80_EOX-_P""<7_!P%XY^%9^.GQ/
M_P""UGB3X2?M::UH%SXPL_V>?!7[.7P3\4?L_>!O$T6FA_#WPLU6]^UV?A;Q
M% J06^C>)/%EKX.U#2;35;NZU9;?X@G37USQ3ZO_ ,%!O^"P_B74?^"%OQ3_
M ."F/[ OAOQIH1\4&Q\)?#KQC\5O"VD:1KG@32-7^+L7P<UKXLCP;'JOB.SO
M/LNK"ZLO :ZQ=)9SZMJWASQ3?Z;JVA0G1]:^7-$_X(R_L :G^RMX>_;+_P""
MDO\ P4[_ &LOVU_A_J7P^TSXH_$;XP?$?]L+Q;H?[-OC#0KW2EU=K3P%X:\(
M:B_B2'PCJ6DR:CH7AOPGHGCW7O$NI6^M7VD>&C'J%YI&FZ< )>_\% /B)_P4
ME_X-A?VNOVAOB]X=T70/BO9?!CXM_#'XAS>&E^S^'?$WB;X?>(++1;GQ?H^F
MD9T6#Q+;K:ZI=:(K26^E:C/>V=C+)816KG]P/^"07_**7_@FS_V8O^RM_P"J
M3\%U_)S_ ,$Z!:C_ (-%/VY18X^Q"/\ :>%G@N1]E'B[2!;X,I,I'D[,&0ES
MU<ELU_6-_P $@O\ E%+_ ,$V?^S%_P!E;_U2?@N@#T7_ (*'?MG^"_\ @GQ^
MQE\>_P!KOQS8_P!M6'PA\&2:AH'A=9Y;5_&7CW7;^R\,?#WP@;JWM[VZL;/Q
M#XTUG0].UC5[:PU"3P_H4VJ>(9+&ZM]*GB;\,_A9^Q)_P7M_;$^"'AG]IKXO
M?\%>]5_8Z^.'Q&\/0>-O!G[,_P '?V=OAWK?P9^%VBZF_P#PD'@WP9XQU8ZS
MIVM^)]9DM+M8/%FK:G_PF5WHSW8TG^TO'.G>'[==4^M/^#EWX!>/OVA?^"._
M[3OA_P"&?AS5O%_BWP))X!^+47AO0T$VJ:AX?\!>,M*OO&EU;VGD2M>Q^'O!
M=QX@\47=K#);7#V6B7#VLES<QQ:=??GU^QM_P1O_ ."97[8O[+GPY_:9^&7_
M  4"_P""A6L^#_$?PZT7Q=XNFL/V[9;6/X=ZA_8PO/%.@>-K%=&U$^"=3\(W
M]KJNG:]I6MWXET2?2KV&ZN9%M))R ?9'[&7[<?[9_P"WK^Q!_P %"/V>O$3:
M'\#/^"I/[$^I_%+]GS7/%?PW,%WX/\1?&7PCHNI7GPO^)OAG2=8TK6DT[PWX
M^\1Z'-H>IVCZ5KVDWL5IJVM:#9R:5J=AH-C]3_\ !#']OB;_ (*(?\$Z/@O\
M7_%'B.?Q-\9O UH?@K^T-J5]'H=KJ=Y\:/AWI^FV7B;7M1T_P_+_ &?ILGC:
MRNM(\>VEI'8Z,!IGBFQFBT73+:6"UC^<?^"%7P$_X)@?#W4_VT?BA_P3=^.?
MQ^_:*;Q/\4/"_P 'OC]\4/C+XC\0>.]#UGQS\&K7Q'JFDGP%\1=4\!^%M(\<
M6DNF_$R>_NM>T'7?%-I?Z5>^';Z.:UL;O3Y]1_"K]M']I:\_X(K?M5_\%L?V
M5/!6G7&GZ5_P4;^!7A/]HW]B#P5X9T74=0V_'#X\:X?@7\6;#PMINFPI>6/B
MFXUWQ-XR\4>#M"M&U#PG!I/P6L-/TRWTW4;NW\(:N ?KO_P3-_;#_:\_;8A_
MX*X_MNZ]\9?$4O[(^@>*OC!\+?V!? 5OI_@K2K'0="^%6@^)[G5/B7+)HGA\
M:SJFHZFD?@=--NM4\2ZM#8:[:>-H1_:$4]K>+Z)_P3!_X*8>.M,_X($:#_P4
MB_;1\9Z_\8O%_@3PY^TGXM\=:Z+3POH/B'QJ/ G[07Q/\#>!?#%E!I.G:!X:
MLK^_M=+\+^#].N!80)YCV]U>BZN6GDG^O?V1_P!DQ/V'/^"-WA3]F.:V^R^(
M?AU^Q_XZE\?H)K*>.;XI>+O!'B7QK\4[RWET_-HUK??$+Q#XDO+41S7;+;SQ
M+)?7TH>[F_GM_96^!?B_]H__ (,S?&?PI\!Z1J&O^*[SP7^T=XWTO1-):,:K
MJH^$'[<_CKXP7]CIL#V]U)J%_<:9X$O8[31[2WEU+6KAH](TL#4KVU8 'UA^
MR9\ /^"W?_!2KX/>'O\ @H%XO_X*L:Q^PTOQ\TO3?BE^SI^R]\%_@+X.\?\
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M &E@_9$_]1GXTT ?4W_!:#_@HK\;?V2O#/[,7[-_[%^E>$==_;F_;T^+-O\
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MU*X\NSFYS]C/X;_\%:_^"NG[,^F_M\:;_P %DM7_ &4=4^+6J>,KSX4_L[_
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M16.K:EH^GWL'T?X$_8V_9N^&?[3GQS_;(\$?#C^Q/VD/VD]!\"^&?C5\1O\
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ML1D:.9_"&E?$RUTNRM0Q@:31=(33?#]R+2..ZTF>*YU*.^_?*B@#D/A_\/\
MP/\ "GP/X3^&GPT\)^'_  '\/O GA_2_"G@SP9X4TJST3PWX8\-Z):16&DZ)
MHFDV$4%GI^G6%G#%;VUM;Q(B(@X)))Z^BB@#XR^&/_!/?]CSX-?M9?&7]N3X
M:?!?3_"_[4_[0/AY_"OQ<^*T/BSQ_J-QXJT":Z\)7UWI\7A+6/%FH^ O#:ZA
M?^!?"=_JMQX4\+:'=ZK?:-!>:E<75S-=RW&E\:OV#?V3/VB?C]^SY^U%\9?@
M_I_C7X[?LKZA?:I\!_'EQXH\=:/+X'O]0O;/4I;B3P]X=\4:1X3\5FWU&PM=
M0TN/QMH/B.+1;])+S2([&YN+B67Z[HH \ _:C_9<^!/[:/P)\=?LT?M+^!O^
M%D_!+XE?\(S_ ,)KX*_X2;QCX._MK_A#O&/A_P ?>'/^*C\ ^(/"OBW3O[.\
M6^%M!U;_ (E.O6'VO[!]@O\ [5IEU>6=QZUH'@[PSX8\':+\/]&TFW@\'>'O
M#6G>#]*T*Z>?5;6+PUI6EPZ+8Z3<R:M-?76I6\>EP16<SZE/=SWD89KR:XDD
MD=Y](\4^&-?OM<TS0O$>@ZUJ7AB_32O$NGZ1J^GZE?>'M3DB%PFG:Y:6=Q-/
MI-^\#"9+._CM[AHB)!&4(:MZ@#\V_P!E3_@D=_P3^_8?_: ^('[2W[)_P&MO
M@A\1_BAX)U'P!XTLO"'C7X@'X=W^@:IXGT'Q;<C3/A?JWBC4_ 7A>YBU;PUI
M"Z<?"N@Z+::/8QWMCI-I90:OJZWWT/\ LB?L:_LW?L(?!K3_ -GW]E/X<?\
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M+;X?CI3Y^3DH?Q.?VGL/WWM/K>8_73_7V,OXG!' %3F_B_\ &/U:'M>?^/\
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M_>JN[-/^1EF/_8=B_P#U(J$P^"/^&/Y(****X2@HHHH **** "BBB@ HHHH
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MU\7Z?K\6@7<^H#1ULK76M=MM3P/@C_P0U_X):?LZWW[/NM?"/]E;1_"WB?\
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M\8_\)+I%L;&QO8M-75K<:BW[QT4 ?!/P[_X)B?L-_"C]D;QW^PEX ^!X\/\
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MJ?!CQM^SQX3\,_ [2? G[/\ \./@5\,?#$VC^"])^"GA_6_"UGJMUJ-[;ZC
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MX"@HHHH **** "BBB@ HHHH *_!7_@@]_P YE_\ M/5_P40_]X_7[U5^"O\
MP0>_YS+_ /:>K_@HA_[Q^N_#_P"XYCZ83_T^2_BC_P!O?D?O51117 4%%%%
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M_$UAIFMV'V3Q5X3URQB^VV,'VJ&VCO;;S;2Y@FDY/X5?MT?LT?&G]J+]H?\
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M9/\ B-X8UBXTZ^BBCBL8_%7CKQOX?A&EF32([G0+RWL&2.$P0_V5_L$_LV_
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MH>BZG;>*_$VL>+/'.@:/9^#M%:Z\2A7U'6+C38/#^DZCJ]O[;^PA^WM\ ?\
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MP5@_8S_;PBTO7_BQKO[+'PG^"?C&?]H_Q1=>"_'WPTO;KX5W/A;Q[JOB+6?
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M2]"U;XHZ7X:^)GBK0].B:[O!966C^*O%NLZ=;:9%)%;Z7#;)I]O9V$%M'90
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MZ)H6K0ZCI=EXZ\3WUP9=,\):R)_KG_@NY=75]_P29_X)$7E[<SWEY=?MV?\
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MD6?A[0IM+N=!TB7PNMM87WA1X-*,7A_5-*TK4-/@BGT^V*?P>^"?&'C?4O\
M@T-_X*'_  M\7>*+KQ7I7[.G[0B?!+X?7]]$R7MKX&T+]K/X ^(=.TN626XN
MYWM=/U'Q-JD&D6LEU-%HVBKIVA6)CT[3+.*, _JH\$_\%X?^"<7Q._:N\!_L
M8?#'XH>+?B)\;_'>H:;H26GA7X=^)+OP;X3\6ZCX;UKQ;+X*\8^.[R"Q\,Z9
MXLT?0?#^K3:[I-C?ZJVDZG8:AX;NI5\3Z3K.C:=^QM?!G_!,;X!_"/\ 9O\
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M(UGY>A^$_$%]_;M_X1M?#3?V?]F366O+JRM[G]UJ* /PH_X+Y?L;?M(_MJ_
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MF?L$?&[]G#]G_P#X*(?"#]L;X1V_A32OVF/V\_VD_B3H/A>[\8^"?%MKX\^
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M#XO_  R\5ZG\$_AMH7Q3^$7C#Q?\:OBE\5M?\?\ A_3OB=XPUO2?#-[H^G>
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M?VR_&'PX_L?]FW]H+X*?LQ^$?A#\1_\ A+_ >H?\)=XA^'GPN^'OASQAI_\
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MJ^FA.D:K=C1-4U#2=.U&ZU?1K.;6+&P6OY_=-_;%_P"#C7P-\(M._9R\4_\
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M(?#.I[(YHV^T:/K.H6C;L+.6# ?I510!_.5^V[_P3B_;B^#O_!0"Y_X*J_\
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M#VNV@OK&PU30=:_76B@#^7GQK^V%_P '*?Q-^&6O?LZ>#?\ @DM\+?@'\?\
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M]=^'_P!QS'TPG_I\E_%'_M[\C]ZJ***X"@HHHH **** "BBB@ HHHH ****
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MPIXBT#P#XLUIY+GQE\/]<T75];U)]1FL+'4/#UK)H)L=8\.^);_PUJM_X?\
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M\9?AE\'/V7+WXH?M+V'[.7P<UCQ3\=].\6?"+X0ZQX3T77? &H7B>!?"5O\
M#_1[FR\.6-[H=G<ZCJ]OI5O>W%U9S7>IPWH!_>M17X0_\%<_V[/VKOA]\8_V
M2_\ @FW_ ,$YG\$Z?^W+^VQ<^,];@^*GQ#TRSUKP?^S;\#/AWIEUJ'BSXN:K
MHNLV6HZ#JNM7G]GZZWA2UU71O%VG7*^"O$NC/X2UGQ)KG@VPO_AW]J3X.?\
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M (JL/$5[L\.:!KKK_-?_ ,'&_P"S7^T[JO[=O_!*_P =Z3^W1XY\/^ _C?\
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MEII]]XZ\0VB7%A'J.E>%YM4T+1[336U"$3^+O&'A2:_M+_P[;:_"OPA\0/\
M@GA_P7Q^%?PFU']HKP-_P6O\2?&O]JCP+X;D^(NH_L[ZU^RW\.K+]G?XH:[I
MNE37GB;X0^'M/T)&NK6UU:S-WH/A#7+/X<:7?:SK4.GWUKHGPWU76+?6_!P!
M_4117\U]_P#\%<O&'[77_!O!\<_^"C?P-U,_!;]H;P9\%_&-MXFM_#20Z@GP
MM^//PXU[3-,\0+HD/B*#6;.\T#5XWL/&/ABPU@ZZR^#?%FC:9XADNM5CU6!/
M#?V7_P!F_P#X+6?\%*/V0OV?/VK_ !I_P56\6?L1ZA\0OV;OA/=?"_X1?"/X
M.^#O&R>*K=?AIHFS]H#XW>-KFZ\$S7GB[]H'Q*;CXHW'@?PGH$.@?#CP=KVB
M^&]&U;4-1.I"S /ZPJ*_"[_@A!^W9^TW^U]\$OVDOA1^VU)X6U+]KO\ 88_:
MG^(W[*7QG\7^"M/TS3?#WQ!O_ IM;:'QE]D\/Z=HWA6UU:?7K?Q9X?OX/"NC
MZ3H-W:^'=-\066EZ6NO-IEE^Z- !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'X*_\&Q__ "A'_8T_Z_OVE_\ UK;X
M[U^]5?@K_P &Q_\ RA'_ &-/^O[]I?\ ]:V^.]?O57=FG_(RS'_L.Q?_ *D5
M"8?!'_#'\D%%%%<)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 ?@K_P4-_Y39?\ !OA_V%/^"I7_ *R7X1K]ZJ_!7_@H;_RFR_X-
M\/\ L*?\%2O_ %DOPC7[U5W8O_=\K_[ :G_JRS$F.\_\2_\ 2(A1117"4%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45_(
MY^VM^V)_P50U7_@NGXR_X)S?L1_$_1-#\)?%[]C?PS?6FI^/]-T#4O!?[+5[
MJ^L^&KOQY^U)IND_V*?$OCCQEX;\*:3JGA+P)\/9_$-MX3U'QWX\T35]<M?[
M.T_47DJ?M6:'_P %G?\ @B?X!T']NN]_X*'Z]_P4]_9E^'.L^%+7]L+]GSXP
M?"#P/\+O$D7@O6]7MO"</COX3>*=-U3QOX@TEK37/%%ND^GZ5JMK)H5V-"UK
MQ78?$7PA9:Y%X8 /Z[J*_%'_ (*I_P#!4#Q/^S1^RS^SGJ_[&&B>&OC%^U#_
M ,% OB#\-_@_^Q=H^NK.OA"]U#XH66GZDGQ3\0I>RZ'&WA3PMI&L:&775+[3
M+>VUCQ1X>U+7H'\,:?XC6'X?^(?[!O\ P7N^!?PEU+]JCPO_ ,%D;W]H7]I;
MX:>$]7^*/B7]F/Q;^SCX"\._LW?$W4-%\*:OJ?B'X3>'(_#.HZ%-"+\H-"\'
MZX_A[P9!J6KQV>M7,/P_GO%O=  /ZCJ*_F*_:V_X*Y?$OXT_\&W?Q'_X*@?L
MMZM??L^?&RY\,_#.*#^S7T'Q=??#+X@6'[57P\^#'Q2T.S/B70KS2]5T^;/B
MK3]'OM8\.PW%]X<U73]9CLK.YN+:2+T;_@GM^SO_ ,%=_P!H#7_V</V[OVN?
M^"A=[\-_AUK^B>%/&EG_ ,$]_AS\+=(U+PE)\*=4\":@?"FB?%7XR#6/!WB+
M6?BSJ5]K>A>-?'^L'PIJ^G0^(M.U7PWI_G>%;W1M)\) ']%]%?RQ:_\ M*?\
M%%/^"N?[>_[6G[,7["'[4^F?L-_L.?L/^*+3X.?%[]H3PQ\/- ^('QR^,OQU
ML_[3.OZ'X"7Q98?V?H'A3PQXNT"[TBYO_#_B#09-1\,6%EKAUGQ)8>/_ /A'
M/#GOW[*/AW_@L?\ L-?MP^#OV=_VA_BOXD_X*<_L+_'+P[KFH6G[3]U\,=&^
M'?Q7_9:\?:?]HN=*TWX@+I.L7VG^(O VO_9VT2ZC^W>)-1>\U'1_$^ER> =+
MT76?#'B@ _H?HK\$O^"9W[5_[0OQI_X*G?\ !;+X _%#XFZOXP^$/[,7Q#_9
MMTWX$>"]0T_0(+3X>6'C[3?C)?>+;33=2T_2;/6]1@U:Y\/:,Q37M3U46,>G
MPP:;]CMS)$_,?\%/_P!LO]I?X"?\%6_^",WP ^$GQ2O_  =\'_VE?'?QBT?X
MX>";?0/".J67C_3M%LO"J:3;:AJ&N^']4UK3AIXU"\>UDT+4M*FBEG,XD\Y8
MY$ /UH_:8_;5_9V_9#UO]G[PY\=_&5_X6UO]J#XU^$_V??@O8V'A3Q3XE/B;
MXG^--0L]+T+2+NY\/:3J-GX>L9;[4;"&XUC7[G3M-MA=+*]QY45R\'U97\57
M_!R+^S;^TUJO[:/_  3#\?Z3^W)XX\/_  _^,O\ P4-_9Y^'GP0^$-O\)_ E
MYI/[+'Q&FN?A=X=C^,_A/Q'-=IJ'Q$UF/Q-87OCD^&/'5E<:0+_4GTBUN;32
MHIH[S^CGPY\/OVZ?V2_V)?BQ8Z%\4KS_ (*9?MAZ+9^*/$7PHN_BQ8>!/V=K
M?QOK>HBQMO#G@_6VT+4H/!6E:3X;47.H;UU'PJOB..W_ +(N]<\/7NHR^*+<
M _1RBOY=O!O_  3A_P"#@'QQ\*O^%Z?$[_@M;XE^$W[6NM>'[GQA:?L]>"OV
M<O@GXG_9^\#>)XM,#^'OA7JE[]KL_"_B&!4@M]&\2>++3P;J&DVFK7=WJZ6W
MQ!.FOKOBJ'X6_P#!6']HS]J;_@W2^/\ ^WE%=6GPF_:F^%7PY^)?AV\\9^"+
M:P;2YOB+\+/$EEHZ>/\ 0-#U6SU#3M/A\16WV?4KWPW?6E_I=E>W6H:9"EUI
M2P;P#^H^BOY-OV5/V=_^"UG_  4N_8__ &??VK/&O_!53Q9^Q)=^//V>/AE-
M\,OA7\)/@]X-\;2>,HD^'^D@?'[XU^-+BY\$//XH^.OB$S?$63P-X4T&/0OA
M]X2UC2=!TK5;[43?K:?=G_!"[]O/]I;]J7X-?M1?"7]NK4/!]]^U7^P9^TM\
M0?V:/C/X_P#"MGI&B>&?'*^!XX0/'%Y'HEAHOA'3M1&JVWBC1]3'AS2])T&>
MRT"QU^"PTU=8>QM #]W:*_D[^ /Q$_X*D?\ !<WQ%\;OV@O@)^W!J7_!.7_@
MG9X5^*GB;X=_LKQ_"KX2>#_'/QM^/L7@'5;[PYJ_Q0^(.M>,)-*USPCH=[,E
MV8_"5IJMM9IK,\^CW>A7;>"[#QEXH^B_V#OVJ_VX/V3/^"A+?\$A/^"B7Q5T
M#]JG4/'7P8U7]H#]D?\ ;,T_PW!\/O%WQ(\):1K6I:?XB^'GQ2\$VEUJ>D1^
M+-(_LGQ#=Z>^FZO?:KIFD^&VGUK4O$]IXBTC5-/ /Z.:*_EJUO\ :3_X*%?\
M%<_V]?VN_P!F#]A;]JRS_87_ &(OV'M?L_A!\4_V@O"?PS\.?$?XW?&OX^VE
MQ=CQ#X<\%MXOBM['PKX.\+^(M#U33[C6/#6MZ=<:EH.EZ7J37_B+3/B-)H_A
M+F[/]HG_ (**?\$:?VZ/V0_@#^W/^UX?V_/V'OV[_&^L_";P5\=O%OPDMOAS
M\7O@!\;[J^T:P\(:!XFN_#$^OZ)K'A/Q#JGB/POI:7'B#Q,C7EC?^+?%>F67
MA33?AUJ.D^(P#^KFBOP1\$_M8?M":A_P<:?%K]C6[^)VK77[,FC_ /!..U^-
MVD_"B33] ?1K'XH-\2?@_P"'CXLMM6_LG_A)DG;1]=U>U.G#7/[%8ZA/='3C
M>,MPN%_P<'_MD?M*_L;?"W]AKQ#^S5\4+_X7:Q\4/V]?@Y\+/'MY8:#X2UX^
M)/A_KUEX@FUCPQ=P>+M \06T%CJ$MK;M<26,-K>,(E47*KE2 ?T%T5^$'_!:
MW]NW]I?]F'3OV(_V>/V5_$O@CX._%C]O;X^6'P3M_P!JGXE:/IOB'P;^SQIM
ME<^$)]3UR/PUXJTF7X<^(O&GB:#Q&]IX0\/>,]8M4ULZ7J^E:!H.LZM>1ZMX
M6\3N_P!B7_@N1^R)\0/@S\6O@-_P4J\0_P#!1#PF_P 0?!NA?M#_ +-/[27P
MX^%GPUMM:^%MYK]Y=>-?&7PS^(T?B&0>&O$NE>'ELM-T31D6&<ZK)-KUU?\
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MZ\3WOAG1?MS_ ()0_MO?M7ZG^T;^U'_P2V_X*"7OA'QO^U9^QOHW@?Q7X?\
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MH_BKP3\8+KQ[\!V\1ZWX9UJSLY[WQMX1M?"S>*M-T6QUBTNM.BOK1+-FGLV
M/ZO**_EJ_:%_8M_X+P:=\$?'/[9WAK_@KA<>&/VC/"?@:]^-$O['7ACX(^!)
M_P!F2-_"F@2ZY>_!/P]XN\27J76H#^Q+ Z-;>.?%O@Z&U\5^)HGU'7K/PM%K
ML^O^'OM[]DKXV?M"_P#!7S_@DG^SI\<?A=^T3JW[%WQ[^)>GP'QS\6/AQ\.]
M \=#3_&WPM\3^)?AS\4].\.>"/'5ZNAP^'?%/B[PWJUSIL&J7&N?V/I;6T5K
M=ZE<Q6^L  _0O]C?]M7]G;]O?X-P_'K]F+QE?^-_AK-XF\2>#SJVI^%/%'@Z
M]A\0^$]0?3=:L)=(\6Z3H^HE8)U5HKN&WEL[B*5&AN&<2)'\^_LR?M9?MC?%
MS]M;]K_X"_&C]AWQ1\!/V=O@K>:=;? ']HK6-?GU?3?CS:#4[[3;C6-/>WTU
M?#TMMX@L(+/Q5IVG:7J9U7PA87:>'_%=O+KBSFV_G._X-/OV9OVHKO\ 9M\&
M_M!V/[>'CO2?V=-#^/OQWL?$7[&,'PC\ 77@SQIJ,>GZEX8?6]0^*%]=W'CC
M2+B3Q/>6'CDV>AP65@+S2+?2VMY(;O4+RY_7'_@FK^U?^T+\9O\ @JM_P6I_
M9_\ B?\ $W5_%_P?_9F\;_LY6/P+\%:AI^@06GP]L_'=C\7;SQ7;:;J6GZ39
MZYJ$.JSZ#H[%-=U/55LH["&#3A:0&2-P#][J*_E&\%?'K_@I!_P6W_:;_:LT
M_P#8R_;03_@G_P#\$]/V2_BMK/P TCXE_#KX4>%OB;\9_P!I'XL>%X-.O-:U
MF'5O%]QI\WA#PA!:ZA9^(=/;2=4T"3_A'->\.:/K/A?Q!K%WJFK^'.H^#_[4
M/[?/_!+'_@H[^SQ^P'_P4!_:<M_VW/V8_P!N&U\46G[,'[4?B7X9V/PU^*G@
M'XK:%Y-W=_#'QX/#S7VE>)M/O-3U'3M"MY'U3Q5K$-UXR\!ZG%?^$O#DU[X7
MT< _J1HK^27XF_M$_P#!5/\ :*_X+G_MZ?\ !./]F/\ :,B^#?P+\*_"#X!^
M(I/BEK7A;POXG_X9G\*>)O@U\-M<\;WWPQ\(MX>L[SQO\6/B?XL\5M#X8O?&
M'C.TTWP+96_B;Q!IADN+.PTR2'Q?X[_X*A_\$<OV[/V#_"_Q^_;XUC_@H-^Q
M3^W/\:=-_9U\31?%/X7>$O!'Q0^%'Q3\2_8O#W@J;0=0T#4=:U*?3-5\0^(M
M"U8:C9W5SHLFE:5XHT'7_#6@ZA_PCWC'5 #^N"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP5\1_\K,_PW_[0K^,
M/_6S(*_>JOP5\1_\K,_PW_[0K^,/_6S(*[\!OC/^P#$_E$F7V?\ $OU/WJHH
MHK@*"BBB@ HHHH **** "BBB@ K\%?\ @@]_SF7_ .T]7_!1#_WC]?O57X*_
M\$'O^<R__:>K_@HA_P"\?KOP_P#N.8^F$_\ 3Y+^*/\ V]^1^]5%%%<!0444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y%?\
M%[?^4.7_  4+_P"S=O$O_IPTFN:_X(+_ +5_PE_:,_X)/?L<7'A'Q+H-MKOP
M _9N^$/P.^+WA.?7K.3Q!\/?$'P?^'^E>"(=0\9:=,EC>^&[#QUX=\+V?Q+\
M*RZG:0V>H^#?$>EZGIM_JNG,NI3]+_P7M_Y0Y?\ !0O_ +-V\2_^G#2:^ /V
M;O\ @A5_P2\_;_\ V!/^"<'QR_:5_9IM/$/QEU?_ ()\_L067B'XD^$/'_Q*
M^&_B/Q59:!^R[\+O#NC0^+(_ OBW0M%\37&F:'INCZ/8:QK>DWNO66D:+I6C
MVFJP:3:+8D X?_@G+X\T;]MG_@XP_P""F?[:WP0F@\2?LU_L^?LK^!_V$;?X
MHZ?-+>>&?B5\5;CQM\._&/B*\\':G):V5GJFE>&]7^$WCC0VN] F\2Z/JNB+
MX0\<6FO1Z)X[\-17?Y6?\$YO^"7G[,'Q5_;@_P""H/[''[6W[1?[77[-/[3'
MP^_;+^(OQ*^%/PO^%W[29^!^C_&3]G[XK:I]M\!_%#PEH/\ 9LZ_$35M2M(-
M*OM:UC1]+L[NPT'Q/X"LM2M8;F;^S],_N!_9F_98_9X_8V^$?A_X$_LP?"3P
MA\&/A5X:"O8>%?"%C+$+[4396.G7/B+Q/K=_/?>(_&GB_4[33=/BUSQIXPU?
M7?%FO-9V\VM:U?SQ+(/FG]N__@E#^P/_ ,%*8?"DG[8'P!T;XC^(O L+V?@_
MQ[I6O^*_ 'Q"T+2I;F:[G\/KXS\!:YX=UO5O"\MQ=7UROA7Q!=:OX<M-0O[S
M6+#2[36I1J2 'X6W?_!+K_@C1^SK_P %'/V'_@1XV_;'_;E^*?[:EG\5M ^/
M_P"SU\$O&'QZ\1_'B#1/%'P4N;+XLZ3KOQ(T#2?AKK8^'GAG5K+PE=7XU+Q/
M>>$[;7O#6B>)+JWUBWTO2-1U*R]S_81_Y6<?^"YG_9"/V&/_ %GWX)5^HW["
MW_!(#_@G;_P3?U7Q!XG_ &2?V</#W@+Q[XIT\Z1KGQ,\0:[XM^)'Q'FT0W#7
M,N@:3XP^(FO>)M6\)>'KV1;-M9T#P;+X>T;Q%-I&B7WB*QU;4M(L+V#Z0\"?
ML;?LW?#/]ISXY_MD>"/AQ_8G[2'[2>@^!?#/QJ^(W_"7^/-2_P"$TT/X:^'M
M$\*^"K+_ (1#5_%%_P" _#G]BZ#X<T:P^T^$_"^A7>H_8_M6K7%_>W%U<3@'
MXK_\'3'PY^(OB#_@FQX-^-WPV\':CX[U']BS]K_X"?M>>(?#VF^=(S^$/AW;
M^./"&N:EJ-G96=YJ=SX>T4?$2VU;Q1<Z:D+^'?#EGJGB[4KJWT'P]J[C]HOA
M5^VC^S)\8OV7-)_;+\(_&'P0G[.U[\-K'XIZW\0]8\1Z)INE> O#4_A33_&6
MIVOQ&F.HS6_@GQ)X5T;4K<>,/#>N7%MJWAJ_$VGZG;PW490_3EU:VM]:W-C?
M6UO>65Y;S6MY9W4,=Q:W5K<1M#<6US;S*\4]O/$[Q30RHT<L;,CJRL0?P<\3
M?\&R/_!$OQ7\2)OB9??L6Z7IU]=ZBVKWWA'PS\6?C?X4^&]UJ+2S3"2+P'X=
M^(^F^']&TY)9(2OAOP[:Z-X5,5G#;/H;VDU_!>@'R5_P5O\ VL_A[_P53_X-
MS/V]/CE^R1X;^(FN_#A-3\*1>'M8\:^'M/\ !ESXV\*?L^?M.?!GQ?\ $WXD
M>&=)O=<N-3C\%:3H/A7Q?=6__"2VOAWQ9<R>%-9MF\*PW T^._\ U2_9+_X*
M)_L6R_\ !-O]GS]J36OVBOA7X2^$.D?LV?#S5_%6K>(_''A9-5\':GX7^'.F
MGQ=X&U_1='UC6+UOB-X5U+2]5\/:MX'T1=9U^;Q)IUQHVCVFJW;VJW'Z#^'_
M (0?"GPK\*=.^!7AWX<>"-)^"^D^"%^&NG_"FT\,:.OP]M_AZNCMX?/@K_A$
M6M&T.;PO-H;2:3<Z)/92Z?=Z?+-:W4$T4TJO^4?P>_X-Z/\ @CY\"?CM:?M&
M?#G]C3PI9?$G1O%%KXT\)+KWC;XH^,?!'@;Q19WPU6VUCPA\-_%GC;6? >EW
M%EK"0:MH:2>'[JW\)7MI9?\ "&P^'K:T@MXP#\T/^#.?7K/Q5_P3N_:R\3Z?
M'<PV'B/_ (*5_'77K&&\2*.\BL]8^!W[,>H6T=W'!-<0QW*0W"+.D-Q/$LH=
M8YI4 =N^_P"#?OQ5X7TG]M#_ (+\_#G5?$F@Z9\0K_\ X*R?M!>+K#P)J&L:
M?9^,KWPIJ7CSXB3:=XGM/"]S<1ZW<^'K^&">6RUJ&Q?3;J.&5X+F18W(_>;]
MD+]B']E_]@WP)XT^&?[*/PQ_X55X(^(?Q2\1_&GQAHG_  FGQ"\<_P!L?$OQ
M9HWAKP_X@\2_VE\2/%GC#5]/_M#2/!_AVT_L;2[^RT"U_L[S[+2K:YN[Z:Z\
M!^+O_!(3_@GI\:_VL?A[^W+XP_9]TZP_:M^&OC[P-\2=%^,7@?Q?X\^'^M:U
MXH^'=WIMWX9NO'6C>#_$VC^$_'PA&C:3I]]+XNT#5[_4M"T^'P[>WLN@27.F
MS@'X7^.;+XW?\%;?^"TW[=7["/QP_;N^._[&'[.?[$_A7X1Q_#[]DW]E_P")
MR?"/XH?M1:)X\\(V?BSQ'\4/%GC*/[3>>)O"NF3:IX9O_$NC/X5UBPT7PS\0
M?AOI&C-X=UZTUCQKXF^'_CO^QA_P3_\ V&?^"[O_  17^#W[)WQ"\8?$7]H"
M?XR?%WQ#^U3J/Q)^-?BSXT?$C3=,O/#O@ZW^#-CXQO-4O)/#'A6^OM6MOC7X
MC&A:1IFC^);B?7+S5_$MJ="O_ RQ?U(?M]?\$8O^"=G_  4M\2>'/'?[5WP)
M7Q/\2_">@7/A70_B=X/\8>+_ (=^-T\-SO/<V^B:SJ/@_6=+LO%NG:/J%Q-J
M?AVV\8Z;X@3P[=W&I+HHL;/7?$%IJN1\#_\ @AU_P2W_ &<]2_9WU_X0?LK:
M/X3\5?LL^-O&OQ)^#GB^#XB?%ZY\3:9X^^(NF^%](\8^*/%FJ7/C^1_B5=:G
MIW@WP[::?IOQ&C\4Z!X4M;%[/P9I'AVRN[RVN #\[/B__P K;/[+/_:'KQ#_
M .KY_:*I_P#P=T?\H:/B)_V73X#_ /J4W-?NKK'[&O[-VO?M;>%?VZM6^''V
MO]JCP5\'KCX!>&?BE_PE_CR#^S/A+=Z]XC\3W'A/_A"+;Q1#\.;WS-<\6>(+
M[^W=0\(W?B5/[0^S)K*V=K96]LO[77[&W[-W[=_P9U']GS]JSX<_\+4^$.K:
M[H/B74/"/_"7^// _P!HUOPS=->Z'>_V_P##CQ1X0\3Q?8;IVE^S0:U':7.=
MEY!<1@( #^8/_@Y*^ 7@74OV\?\ @D/^T5^T+XK^*_PI_8_D\6?%?]FSX^?'
M[X3>,V^'VL?!+5/B18Z8WPQUC4O'D<*-X$T37]0U+Q'-XB\37,][I<7@WPIX
MKAU"T@ @M];]/_:*_P""*?\ P2?_ &</V<O%_P"TM\>?^"B7_!0/P_\ L^:-
MX>N[W4O&-Y^W->:]H/BJTNK:ZCM_#GA:TL/"5^?'FO\ B<PSZ5H/A/P]!JVJ
M^)+Y_P"S=.L+N9VCK^H/XM_"'X7_ !Z^&OC#X._&CP%X7^)WPN\?Z/+H/C+P
M+XSTBUUSPYX@TN26*X2"^T^\CDC,UI>6]KJ.FWL/E7VE:K9V6JZ9<VFHV5K=
M0_BE\.O^#8K_ ((G?#3XA:3\1M*_8XM/$=_H&KQZWHOA?XB_%GXS_$?X>V][
M;WT5[:0ZMX$\:>/]9\.>--(MQ&;*3P_X^L?%6@ZI8RRPZWINJ.RRJ ?E3_P5
M$_9;^$_PN_X-TOV,?&7_  3HT/XJ_%C]F[]C;]H?X*_\% OAQ%\1;/7;3Q]K
MOPA\2>)_BWXUUGQ1XJTK4/!?ACQ--X7M[_\ : F\1W=[:>&-*71/AY#_ ,)M
M-?7/A70[[5KS^J[X:_MC_LT?%/\ 9GL_VO?#'QC^'Y_9]_X5_!\2?$'Q&O/&
M'AD>'_ OA\>&;+Q9JT'CS5K#5[_2/"^M>%])OX#XITB_U$7>B70>UNE$@3?]
M&?V5I?\ 9?\ 8G]FV']B_8/[*_LC[';_ -E_V7]G^R?V;_9_E_9/L'V3_1?L
M?D_9_L_[GR_+^6OPD\3?\&R7_!$OQ7\2)OB9??L6Z7IU]=ZBVKWWA'PS\6?C
M?X4^&]UJ)EFF$D7@/P[\1M-\/Z-IR220E?#?AVUT;PL8K2&V?0WM9K^"] /R
M9_X)V>%O%/[7?[%7_!SY^UA\&?#/B#6?AY_P4%\9_ML>&?V48-2T?4?#=_\
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M-UX=T+29=8U(W(!^./\ P1I_Y3-_\'(O_9</V,__ %&?VD*3_@L]_P ID/\
M@VX_[+S^V5_ZBW[-]?NQ\&?V-OV;OV??C/\ M(_M"?"'X<?\(C\7_P!KK7/!
MGB3]H;Q=_P )?X\U_P#X6#K7P^M?$EGX0O?[ \3^*-:\,>$_[(MO%WB&/[/X
M'T7PU:7_ /:&_5(+V2TL6MCXT?L:_LW?M"_&3]FW]H#XP?#C_A+_ (N?LB:]
MXS\3_L\>+?\ A+_'F@?\*]USX@VOANR\7WW]@^%_%&B^&?%G]KVOA'P]%]F\
M<:+XEL[#^S]^F6]E)=WSW(!^#7_!QIJVE^%OC7_P0C\;>)]2T_PYX,\)?\%=
M?V=]6\5^+M>O+?2/#'AG2K+QAX0U:\U/Q#K^H26^E:+I]II6DZKJ=U>:E=VU
MM!I^F:A>RR);65S)&_\ X.T]5TO6_P#@BUX^U31=2L-7TRZ^.7P-^S:CI=Y;
MZA8W'D^+[RWF\B[M));>7RIXI89/+D;9-')&V'1E'[]_M0?LH_LZ_MH_!_7_
M ("_M1_";PO\9/A/XCEM[N_\+>)H[Z![/5+..XBL=?\ #?B#1;W2O$_@_P 4
M:?#=WD&F^*?"6M:)XCTZ"]O8++5((KRY27Y!L/\ @C7_ ,$[K;]B.P_X)UZA
M\#]6\0_LC:=XSG^(-O\ #+6?C!\:?M2^+)O$=YXK_M*/QMI7Q TKQU:P1ZY?
M7-XND6'B.TT5Y)97GT^:6XN9)P#\L_\ @XBO-8_9]^//_!&'_@HSJ7AG5]<^
M"_[&G[8>M^'/CSK>FI]IM/ ?@']HA?ACHEYXQUFUCCC:UM=/L_A[JEMI&M:C
MJ>D^'$\67GASPQJMX+[Q=HH'[Y?&/]LO]E_X#_LU^)_VOOB/\:_ .G_LY>%O
M#TWB2Y^*>C^(=-\4>&M:M!<OIUCI_A"\\.7&IQ^,=?US653P_P"'= \--J>K
M:[XAF@T73+6YU"58#[;X]^'_ ('^*?@?Q7\,_B3X3\/^.OA]XY\/:IX4\8^#
M/%6EVFM^&_$WAO6K.73]5T36M)U"*>TU#3K^SFEM[FWN(G21'.1D C\1/#7_
M  ;(_P#!$OPM\2(OB78_L6Z7J%[:ZBNKV/A'Q+\6?C?XI^&]KJ(EAF,DO@/Q
M#\1M2\/ZQISR1S%O#?B&UUCPJ(KN:V30TM(;""S /Q#_ &3OAKXV\&_\&CW[
M=GQ"\;>']1\*/^TM:_M,_M%>%/#VKV=Y9ZC8^"/&7C#P[X=\-7;B^M[*XOM.
M\0VG@YO%'AS6A86=IX@\+ZWHFN:;'-IFH6=Y<_U1_P#!)C_E%A_P34_[,$_8
M\_\ 6>OAY7T_\;_V??@_^T;\$O'/[.7QB\&6_BKX+?$CPJ_@CQCX'M-6U_PE
M:ZGX5D$ .C6VK>"]5\.^(-$MT6UMTADT'5M,N;>.)8X)XX\J>C^$OPL\!_ S
MX5_#3X*?"S0O^$7^&7P?\ >#OA?\.O#/]J:SK?\ PCO@7P#X>T[PIX2T/^V?
M$6HZOX@U?^R= TG3[#^T]=U74]8O_L_VK4]0O+V6:YD /YS/^#>__DZ+_@X$
M_P"TP'[1?_J>^/:_ITKYB_9[_8V_9N_96\4?M ^-/@+\./\ A!/$O[4OQ@\1
M_'OX[ZE_PE_CSQ1_PG7Q9\6W]_JGB#Q7]C\9^*/$6G^&/[0OM4OI_P"PO!UK
MX>\-6GG^59:-;0Q0QQ_3M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'X*_\ !L?_ ,H1_P!C3_K^_:7_ /6MOCO7
M[U5^"O\ P;'_ /*$?]C3_K^_:7_]:V^.]?O57=FG_(RS'_L.Q?\ ZD5"8?!'
M_#'\D%%%%<)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZGI6EV]W-)%X?UZST&72M?U6]GLI],TG2=*O+J_U;60FD6$$]_(D!_J#\>>
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MV/C%^QG_ ,$K?VA?VGOV5+G1-4\?Z5#X-\*Z!\0[>33O$6C_  YL_'WCK1?
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MP:SXO\0ZWJ5II-GI^CVEU!I6G6%G;@'X7_\ !K__ ,D;_P""G7_:6W]IC_U
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M/!NN>$[N2.,:;<Z;<6>B?\)-X4'A^RL&BU+X7:@=7U"UEC?PK;^L_P#!RO\
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M%'I_<\_P?8.;^[+[C]ZJ*_!7_CJ _P"L"O\ YT)H_P".H#_K K_YT)H^H?\
M4;@/_"CT_N>?X/L'-_=E]Q^]5%?@K_QU ?\ 6!7_ ,Z$T?\ '4!_U@5_\Z$T
M?4/^HW ?^%'I_<\_P?8.;^[+[C]ZJ*_!7_CJ _ZP*_\ G0FC_CJ _P"L"O\
MYT)H^H?]1N _\*/3^YY_@^P<W]V7W'[U45^"O_'4!_U@5_\ .A-'_'4!_P!8
M%?\ SH31]0_ZC<!_X4>G]SS_  ?8.;^[+[C]X[JUM;ZUN;&^MK>\LKRWFM;R
MSNH8[BUNK6XC:&XMKFWF5XI[>>)WBFAE1HY8V9'5E8@EK:VMC:VUC8VUO9V5
MG;PVMG9VL,=O:VMK;QK#;VUM;PJD4%O!$B10PQ(L<4:JB*JJ /P<_P".H#_K
M K_YT)H_XZ@/^L"O_G0FCZA_U&X#_P */3^YY_@^P<W]V7W'[U45^"O_ !U
M?]8%?_.A-'_'4!_U@5_\Z$T?4/\ J-P'_A1Z?W//\'V#F_NR^X_>JBOP5_XZ
M@/\ K K_ .=":/\ CJ _ZP*_^=":/J'_ %&X#_PH]/[GG^#[!S?W9?<?O517
MX*_\=0'_ %@5_P#.A-'_ !U ?]8%?_.A-'U#_J-P'_A1Z?W//\'V#F_NR^X_
M>JBOP5_XZ@/^L"O_ )T)H_XZ@/\ K K_ .=":/J'_4;@/_"CT_N>?X/L'-_=
ME]Q^]5%?@K_QU ?]8%?_ #H31_QU ?\ 6!7_ ,Z$T?4/^HW ?^%'I_<\_P '
MV#F_NR^X_>JBOP5_XZ@/^L"O_G0FC_CJ _ZP*_\ G0FCZA_U&X#_ ,*/3^YY
M_@^P<W]V7W'[U45^"O\ QU ?]8%?_.A-'_'4!_U@5_\ .A-'U#_J-P'_ (4>
MG]SS_!]@YO[LON/WJHK\%?\ CJ _ZP*_^=":/^.H#_K K_YT)H^H?]1N _\
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M?_.A-'_'4!_U@5_\Z$T?4/\ J-P'_A1Z?W//\'V#F_NR^X_>JBOP5_XZ@/\
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MT?\ '4!_U@5_\Z$T?4/^HW ?^%'I_<\_P?8.;^[+[C]ZJ*_!7_CJ _ZP*_\
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MG&%*MSSE.:CRI1Y5^?1B;O;27Q)ZH_?*BBBO(+"BBB@ HHHH **** "BBB@
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M *K\49U?@_[>I_\ IR)^HM%%%>,:!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQE^TQHNAP7^I3J8;"TEOEN+R4&.WCD<$5C_!?_@W^_X-H_VD-$O_ !-^SO\
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M_P!7Y=?\$<_^3&/#W_9?_P!LS_UL#XXU\C?\0N/_  0H_P"C&?\ S9G]L/\
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M[;^*?"O[/GPQTOP1J'A'POX@6XN+FPFT!?$7A;7=3\06_B/0?&'B#3?[5DC
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M74S8:<+.W%C9'1]6T"YTDVEIY?V>V.EW-G:7&G&&-#93VMO+;>5)!$R^V_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /P!_X(.?\ (Q_\%LO^T['[=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD_\ 7AXK]_J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<_B[I/[/W[;?[&?CS_A.?V??C#XG\/?\)7X9O[2_;3O^$A\#?$?3D@NKS5-
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M5/A/I7@?4]3G\<_VQX@TC5(K#53X]TF"PET"QUJXB%KJ,MQ:KY=M%=??5?Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUKD7FC6ES#K6I6/B>36],T37M$\)^'K:V\8@']I-%?R-?LQ_%7Q3_P $J?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _ '_ ((.?\C'_P %LO\ M.Q^W7_Z0?">OW^K\ ?^
M"#G_ ",?_!;+_M.Q^W7_ .D'PGK]_J "BBB@ K^"/]GSP'_P38_:Z_X*#_\
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M]-U/3;^"2UOM/U"QNHY;6]L;VUEEMKNTN8I(+B"22&:-XW92 ?QB_'3X>?\
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M6M(U"VDDM[[3=2L[FSNX'>&XADC9E(!_$1^UI\&_^#6O]E?]@#X]77[,EO\
MLF?M#?M#>(_V:OBWX3^"MOX$^*EO^UY\?;CXF^(?A/XML=%^)&J>$Y_'7C4^
M )O UUJ]Q\2?%/B_4="\':=\/;'PS=:SHEOI^K^%_#NDV_[;_P#!'/1=5\2_
M\&__ .S;X<T*QGU/7-?_ &-_%^BZ-IML USJ&JZKH?BRQTZQMU9E5I[N[GAM
MX@S*#)(H+ <U]X_"O_@EK_P3>^"6I>+M8^%7["_[*W@K4_'GAK7/!7BV\TKX
M(^ 'FUKP5XIT5_#OBOP5.;W0[I8?!WBS0Y)=,\6>%;1;?0/$]K-.FNZ=J'GS
M%_L'X??#KX??"7P;H'PZ^%?@7P;\,_A]X4L4TOPMX$^'WAC1/!G@WPUID;.\
M>G:!X8\.6.FZ)H]BCN[I::=8VUNK.[+&"Q) /YIO^#6']JW]G'4O^";GP-_8
MUM_C'X(C_:K^%&M_M+7_ ,0?V?[_ %4:5\4_#FFW'[1OC_Q-'JD_A/5([/4[
MS25T;QOX8N)]5TR*]T^VN-3_ +-N;F+4[+4;.T_&3]@#]AG_ ((Q_LO_ !M_
M:V_8;_X+._"#X._"O]I#P5\??%GC#X%_%O\ :'^*/C_X8_##XV?LU>)X'?P#
MXD^'OCR[\:^%O 5OHUL?#NK,8/$&N0:W+J&JQZ+>LWB^SU_0-'_N:T?]D#]E
M/P[\>-5_:B\/_LX?!'0?VCM=T^^TS7?CCHOPQ\'Z5\4M;M=3\A=1.L>-;#2+
M?7M4N[^&UMK6\U&^O;C4+FQMX+":Z>RBC@5_[0/[(G[*_P"U=IFF:1^TU^SE
M\$OC[8Z&SOH*_%SX9>#_ ![<>'WEDCEGD\/7_B32-0O]!DN6C5;I](N;)[J$
MO!<&6"22-P#^;?\ 8^\&_P#!N['_ ,%/OA;\!O\ @GG^R)X=^-OQL\ >$=:^
M,4W[4W[.7C3Q%\3_ ($? &]T:WU.P@;QKXUUGXP3>'=3EU47-AH^C7_@;3/B
M- OB+Q1HEC<V]@UOJ^I:'@:;^T!X)_X)#?\ !PC^VK?_ +6_B+0/@W^RO_P4
M_P#A%\+/BK\)?COXH;6;?P0/B=\&K,Z#JG@?Q'XBDTK4-&\-:B-4\4?$V\U6
M34?$6G6&DV)^'UU>VMI%X^\/6MK_ $[?L_?LL_LV?LH>%M1\$?LS? ;X2_ 3
MPGK.K2:_K6A?";P#X:\"V&N:Y+!#:-K.N)X>TZP?6M56RMK6PBU#5'N[N'3[
M2ST^&6.RM+:"+H/C-\!/@?\ M&>#;SX=_'[X/_#/XU>!-0'^E>$/BGX'\-^/
M/#SR"2&:.YCTKQ-INI6EO>6]Q;6UU:WUO%%>6EW:VMW:SPW-M!+& ?QF?\'4
M'_!4;]E3]H#]A'_AEO\ 9(^-'P\_:<\2:GX_\$?$[XP>)O@3XR\.?$SP!\+/
MAGX9O9-,TF7Q=XY\+'7O"L6M>+/'7B3PWIVB^'M-\01^(8ETW5+G4H;6Q18;
M_P#MT\.?\B]H/_8&TO\ ](8*^2_"_P#P3F_8 \%_"SQ!\#_#/[$O[*6F?!WQ
M=K>G^)?%WPQ'P ^%MWX'\7>(M(9VT;7O%GAN_P#"]UI?B;6=&$C1:-J>N6U_
M>Z3;[+;3I[:WCCB7[*CCCACCAAC2**)$CBBC14CCC10J1QHH"HB* J(H"JH
M   % #Z*** "OP;_ .#F_P#Y0;?MV_\ 8%^!7_K4/P1K]Y*_!O\ X.;_ /E!
MM^W;_P!@7X%?^M0_!&@#]RO#?_(NZ!_V!=*_](8*VJQ?#?\ R+N@?]@72O\
MTA@K:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ_X(4?\ 1C/_ )LS^V'_ /1!4?\ $+C_ ,$*/^C&?_-F?VP__H@J_?ZB@#\
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M_1C/_FS/[8?_ -$%1_Q"X_\ !"C_ *,9_P#-F?VP_P#Z(*OW^HH _,O]B?\
MX(Y_\$WO^"=7Q%\3_%K]CG]FRT^$'Q%\8^"[CX=^(?%3_%'XV?$2_N_!=WKF
MB^)+S0+:+XK?$GQS9:5:7NN>'-!U&]DTBUL+J\FTBP6YGEBMHXQ^FE%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XH
M_&O_ (-UO^"-O[1'Q;^(WQT^+W[&MIXG^*7Q:\8:[X^^(7B6R^.O[37A&+Q%
MXP\3ZA/JWB'7I/#W@KXT>'?"^G7>L:G<W.H7RZ1HNGV\][<3W+0^;-([>7_\
M0N/_  0H_P"C&?\ S9G]L/\ ^B"K]_J* /P!_P"(7'_@A1_T8S_YLS^V'_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K\NO\ @CG_ ,F,>'O^R_\ [9G_
M *V!\<:_46ORZ_X(Y_\ )C'A[_LO_P"V9_ZV!\<:]G#_ /(@S7_L:Y'_ .HN
M?&;_ (L/^O=7_P!*HGZBT445XQH%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'Q/\1/V@/VC?^&C?&?[/_P"S_P# CX)_$/\ X5Y\$_@O\8O%OBWXQ?M+>._@
ME_R6WQW^T%X*T'P[X=T'P5^RM^T%_:W]D_\ #/NLZGJ^KZGK/A__ )&#3+*S
MTNY^S7=W1_PGG_!1K_HU7]B?_P 3^^.O_P!+3H\!_P#*1K]JK_LR?]@'_P!7
MK_P4LK[8KV<54PF$G2HQRS!U?]BR^M*I5JYE[2=3$X##8FK*7LLPI4U>I5G9
M0IPBHM)+2Y"4G=\\E[TE9*%DE)I;Q;V7?J_*WQ/_ ,)Y_P %&O\ HU7]B?\
M\3^^.O\ ]+3H_P"$\_X*-?\ 1JO[$_\ XG]\=?\ Z6G7VQ17/]=PW_0HR[_P
M;FW_ ,\_ZN_*QRO_ )^3^Z'_ ,A_5WY6^)_^$\_X*-?]&J_L3_\ B?WQU_\
MI:='_">?\%&O^C5?V)__ !/[XZ__ $M.OMBBCZ[AO^A1EW_@W-O_ )Y_U=^5
MCE?_ #\G]T/_ )#^KORM\3_\)Y_P4:_Z-5_8G_\ $_OCK_\ 2TZ/^$\_X*-?
M]&J_L3_^)_?'7_Z6G7VQ11]=PW_0HR[_ ,&YM_\ //\ J[\K'*_^?D_NA_\
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M_5WY6.5_\_)_=#_Y#^KORM\3_P#">?\ !1K_ *-5_8G_ /$_OCK_ /2TZ/\
MA//^"C7_ $:K^Q/_ .)_?'7_ .EIU]L44?7<-_T*,N_\&YM_\\_ZN_*QRO\
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M1K_HU7]B?_Q/[XZ__2TZ/^$\_P""C7_1JO[$_P#XG]\=?_I:=?;%%'UW#?\
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MC5?V)_\ Q/[XZ_\ TM.OMBBCZ[AO^A1EW_@W-O\ YY_U=^5CE?\ S\G]T/\
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M?_8/B!\9O'7_  DO_#;?QU\*^;_PMSXP>.?BO_9?]C?\.\?$GE_\(]_PF?\
M8'V[^U7_ +6_LW^U/L>F_;/[.M?UZHK:.:PAAZN%CE>7*A7JT*]6GSYF^>KA
MHUX49<SS+GCR1Q-=<L9*,O:-R4G&#BN352YYW2:3]S9N+:^"VKBOQM8^)_\
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MZN_*WQ/_ ,)Y_P %&O\ HU7]B?\ \3^^.O\ ]+3H_P"$\_X*-?\ 1JO[$_\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445Q_C#XA>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW2:4DG9M-)[:/L4FGLT_1W"BBBH&%%%% !1110 4444 %%%% !1110 4444
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MU%-MV2U;/UHHK^&7_B,N\;?](K?_ #>+2?\ Z%VC_B,N\;?](K?_ #>+2?\
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M_P#HG,R_\%1_^3#ZSA_^?L/O/[FJ*_AE_P"(R[QM_P!(K?\ S>+2?_H7:/\
MB,N\;?\ 2*W_ ,WBTG_Z%VC_ % XS_Z)S,O_  5'_P"3#ZSA_P#G[#[S^YJB
MOX9?^(R[QM_TBM_\WBTG_P"A=H_XC+O&W_2*W_S>+2?_ *%VC_4#C/\ Z)S,
MO_!4?_DP^LX?_G[#[S^YJBOX9?\ B,N\;?\ 2*W_ ,WBTG_Z%VC_ (C+O&W_
M $BM_P#-XM)_^A=H_P!0.,_^B<S+_P %1_\ DP^LX?\ Y^P^\_N:HK^&7_B,
MN\;?](K?_-XM)_\ H7:/^(R[QM_TBM_\WBTG_P"A=H_U XS_ .B<S+_P5'_Y
M,/K.'_Y^P^\_N:HK^&7_ (C+O&W_ $BM_P#-XM)_^A=H_P"(R[QM_P!(K?\
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M *16_P#F\6D__0NT?\1EWC;_ *16_P#F\6D__0NT?Z@<9_\ 1.9E_P""H_\
MR8?6</\ \_8?>?W-45_#+_Q&7>-O^D5O_F\6D_\ T+M'_$9=XV_Z16_^;Q:3
M_P#0NT?Z@<9_]$YF7_@J/_R8?6</_P _8?>?W-45_#+_ ,1EWC;_ *16_P#F
M\6D__0NT?\1EWC;_ *16_P#F\6D__0NT?Z@<9_\ 1.9E_P""H_\ R8?6</\
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MWXJ_]&^XL_\ #+C/_E1R?\13\,O^CB<#_P#B5Y%_\W']AU%?QX_\1/7[6_\
MTAN_\Z&?#/\ ^<#1_P 1/7[6_P#TAN_\Z&?#/_YP-'_$&_%7_HWW%G_AEQG_
M ,J#_B*?AE_T<3@?_P 2O(O_ )N/[#J*_CQ_XB>OVM_^D-W_ )T,^&?_ ,X&
MC_B)Z_:W_P"D-W_G0SX9_P#S@:/^(-^*O_1ON+/_  RXS_Y4'_$4_#+_ *.)
MP/\ ^)7D7_S<?V'45_'C_P 1/7[6_P#TAN_\Z&?#/_YP-'_$3U^UO_TAN_\
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M.)P/_P")7D7_ ,W']AU%?QX_\1/7[6__ $AN_P#.AGPS_P#G T?\1/7[6_\
MTAN_\Z&?#/\ ^<#1_P 0;\5?^C?<6?\ AEQG_P J#_B*?AE_T<3@?_Q*\B_^
M;C^PZBOX\?\ B)Z_:W_Z0W?^=#/AG_\ .!H_XB>OVM_^D-W_ )T,^&?_ ,X&
MC_B#?BK_ -&^XL_\,N,_^5!_Q%/PR_Z.)P/_ .)7D7_S<?V'45_'C_Q$]?M;
M_P#2&[_SH9\,_P#YP-'_ !$]?M;_ /2&[_SH9\,__G T?\0;\5?^C?<6?^&7
M&?\ RH/^(I^&7_1Q.!__ !*\B_\ FX_L.HK^/'_B)Z_:W_Z0W?\ G0SX9_\
MS@:/^(GK]K?_ *0W?^=#/AG_ /.!H_X@WXJ_]&^XL_\ #+C/_E0?\13\,O\
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MC^&2Q3J?\1"X']E\<?\ C*LBLY_R_P"_?9;YO).*ZG]Y=%?QX_\ $3U^UO\
M](;O_.AGPS_^<#1_Q$]?M;_](;O_ #H9\,__ )P-?BG_ !!OQ5_Z-]Q9_P"&
M7&?_ "H]#_B*?AE_T<3@?_Q*\B_^;C^PZBOX\?\ B)Z_:W_Z0W?^=#/AG_\
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M_HXG _\ XE>1?_-Q_8=17\>/_$3U^UO_ -(;O_.AGPS_ /G T?\ $3U^UO\
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M3G)13T3>S?8_NDHK^&7_ (C+O&W_ $BM_P#-XM)_^A=H_P"(R[QM_P!(K?\
MS>+2?_H7:]K_ % XS_Z)S,O_  5'_P"3,_K.'_Y^P^\_N:HK^&7_ (C+O&W_
M $BM_P#-XM)_^A=H_P"(R[QM_P!(K?\ S>+2?_H7:/\ 4#C/_HG,R_\ !4?_
M ),/K.'_ .?L/O/[FJ*_AE_XC+O&W_2*W_S>+2?_ *%VC_B,N\;?](K?_-XM
M)_\ H7:/]0.,_P#HG,R_\%1_^3#ZSA_^?L/O/[FJ*_AE_P"(R[QM_P!(K?\
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M\%1_^3#ZSA_^?L/O/[FJ*_AE_P"(R[QM_P!(K?\ S>+2?_H7:/\ B,N\;?\
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M[7SG^H'&?_1.9E_X*C_\F:_6</\ \_8?>?W-45_#+_Q&7>-O^D5O_F\6D_\
MT+M'_$9=XV_Z16_^;Q:3_P#0NT?Z@<9_]$YF7_@J/_R8?6</_P _8?>?W-45
M_#+_ ,1EWC;_ *16_P#F\6D__0NT?\1EWC;_ *16_P#F\6D__0NT?Z@<9_\
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ME.I.<FHPIPBG*4Y-1C%.3:2N?J=17\>/_$3U^UO_ -(;O_.AGPS_ /G T?\
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MXS_Y4'_$4_#+_HXG _\ XE>1?_-Q_8=17\>/_$3U^UO_ -(;O_.AGPS_ /G
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M,_\ E0?\13\,O^CB<#_^)7D7_P W']AU%?QX_P#$3U^UO_TAN_\ .AGPS_\
MG T?\1/7[6__ $AN_P#.AGPS_P#G T?\0;\5?^C?<6?^&7&?_*@_XBGX9?\
M1Q.!_P#Q*\B_^;C^PZBOX\?^(GK]K?\ Z0W?^=#/AG_\X&C_ (B>OVM_^D-W
M_G0SX9__ #@:/^(-^*O_ $;[BS_PRXS_ .5!_P 13\,O^CB<#_\ B5Y%_P#-
MQ_8=17\>/_$3U^UO_P!(;O\ SH9\,_\ YP-'_$3U^UO_ -(;O_.AGPS_ /G
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MJV@36FKJWA/3;K5_W?\ ^(GK]K?_ *0W?^=#/AG_ /.!K]/\3>%_$WBBEE&
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M)Z_:W_Z0W?\ G0SX9_\ S@:/^(-^*O\ T;[BS_PRXS_Y4'_$4_#+_HXG _\
MXE>1?_-Q_8=17\>/_$3U^UO_ -(;O_.AGPS_ /G T?\ $3U^UO\ ](;O_.AG
MPS_^<#1_Q!OQ5_Z-]Q9_X9<9_P#*@_XBGX9?]'$X'_\ $KR+_P";C^PZBOXW
M->_X.EOVH_#.AZSXDUO_ ((\?8M%\/Z5J.MZO>_\/!OAW<_9-+TJSFO[^Z^S
MVG[/=Q=W'V>TMY9?)M8)KB79Y<,4DC*C?U,?L@_'[_AJS]E;]G3]IG_A$_\
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MH9X._P#)K^"/^Q#A?SF?Y,>./_)VN._^QY5_],4 HHHK]*/RD**** "BBB@
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MHK^ESR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBVW14I:TX49XITHTTX4X2CK=.<XV3D[OO=+IUZGQ1_PY._X-]/\ I,!X?_\
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M4FJ=6-"3@XRDIS2H4Y48PDE[:M&I.G+K'EMRJVFC6MWYZG\.?_!-WX%_ /\
M:=_;,^"O[.O[1WB+Q[X.^'_QJ\0/\/-.\7_#GQ#X7T#7] \?Z]:RQ_#X2)XN
M\(^+M*UNP\2>*H].\%R:/'#I%_\ :_$UEJ]GJL[Z2= US[1_X+??\$I?#?\
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MG7I\/>(=5T.VM=+?Q;H7B&Q2PTFZL;O1]/\ [B_^"LG[<^A?\$BO"7_!+'X
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M .F^XK_7F_X)4_\ *+[_ ()O_P#9AG[(/_K/OP]K_(9\4?\ (L^(O^P%J_\
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MO4=?AM[&&YN]6T*'PG::=I-T\T;1:9>W-G=1SK!8?9/YKJ_6?#;CS!>)/"6
MXJP6"Q&6QQ53%8;$8#$SC6J83%X.M*A7I*O"%..(I7BITJRITG.G.//2I5%.
MG'\F\2.!,9X<<68_A;&8W#YD\+2PN)P^/PT)4J>+PF,H1KT*KH3G4E0J<LG"
MK1=2JH3A+DJU:;C4D4445]X?"A1110 4444 %%%% !1110 4444 %?=O_!!W
M_E.!XZ_[19>-O_6K_A!7PE7W;_P0=_Y3@>.O^T67C;_UJ_X05_/?TH/^30YU
M_P!AV5_^I)_1WT5O^3N8#_L2YU_ZCP/[HZ***_RK/]0@HHHH **** "BBB@
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MEU>#XB^$$M8[A/'*:>-..G3M$VFM<F]D%V(+=\59MC<BS_(<EQ_&6993E_\
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MI>BSZHEA;^%-&UW6X;G2M/\ $WB/0O/T[6IIK?1-2_;C_@ZG_;%M_BW^UEX
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M2YTF/3=6\-^,-9N+J&+1/"FB7BWT=SX=M(X6>\D@$$UP'@>0Q21?AW7];O\
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MP^%-/N_&6DR^%M&N[SP/KFH>'],U))K30[=KOP_HUQK5I7KOP:\ ?LM>&O\
M@E[\-OB1\:/A;X"O?"7A[X4>"O'OBZ>/PMX7M=;\3:CH^N:/XDM=*;4KG^R3
MJ6I>,O$MM8Z+-9:EJL=OXEN-8?2=5^V6VIW-M<?:5OI'971R3+\P_P!5,UJY
MQ4XTCP/F_#N&Q^ Q.*R[-73=3GP6,P_M<)G%"M94\%.C+#0Q=53BITH1C.?Q
MM'Z.>9UL[Q^7_P"M654LGAP;/C?*>(<3@,=AL+F&51J1IN&-P>(]GB\GK4>;
MVF-A6CB9X6DX2<*DY.$/Y **_H/7QA\$?^"N?[6?P&\!^&OA;KGPU^'?PM\.
M>/?%?Q2L)9]#T34O$GA6SO\ 1(=(T_3+SPO;WC0F_P!7N="T_6$DET^YLM+U
M+5AHNLQ:C!8WDOUO\?/V^_V1/V)_C-8?LLZ'^RSX:O/!^@1Z/;_$C6?#NB^%
M_#UAX53Q'8VFHNVF^%6\*7S>/KK^Q]0M;[6KB\UC1);V>:> 7.HW(D=_4QGC
M/G]'&Y5PY@?##.<RXYQ.28KB+.>%J6>97260930QU?!T:F(S:I3>'Q6*Q<:5
M*O1PM&A"4HXK#483J5ZT*<O+P?@SD-;!YIQ%CO$W)LMX'PV=87A[)^*:N29G
M6>?9K7P5#&5J>'RFG56(PV&PDJM7#UL56KRC&6%Q-:I"G0I3J1_DYHK]Y_\
M@L;^Q%\,?@[8^!/VC_@AX=T/P5X.\<:P/"OC'PCH,,ECH4/B;4K&_P#$'A_7
M_#FEP>;I6E6FK:78ZM::CI&EKI.E6+Z3I]QIMA/)J6HR6_ZJ?MT']D']F?X4
M_#KX\?$C]GKP%XYUGP?XAM+3X;^"M,\.>&- 'B#QMK6B2R13:WJ$6CW2C0])
MTW3+_4)WU#2=>TZWU=-%OO[*EUBVT:XMN>M](/*JV7^'^.R'AC.,^J^(&(SW
M+\'EE#$8/"YCE^;Y']2I5,OQ,*[>&DJV*QM.,L5+%4*&'P:>.J.5-^S711^C
M]FM',./\#GW$V49#2X!P^19AB\RKX?&8K+\?E.=_7*L,PPTZ"6)C['"X*K)8
M6.%KU\1C&L#34:B]H_XQ**_KQTSP?^RU_P %<_V3O$/C/0_A3HWPR^*V@K?>
M&;'6++2].7Q;\//'NA6"Z[INBQ^*-)T?2Y_&?@'44UR*2;3[C3EL+VRUF\N(
M-)T7Q?8P7&E?#_\ P2,_8U^&^I> /B;^UG\;? @^)%CX-O=;T[X;^#)?#1\5
MM<GP-9MJWB/Q-I'AC==)XG\07NHQIX?\*Z5)8B[M=5TB_-NEQ/J=C+:Z4OI
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M273KN632[FWMO[,L9+.\!CL[FSL9/D+_ (*?_LF_"SXA_LLZ'^V[\.?A//\
M WQ]!%X7U_XF>#-2T-_!>H7^B>-[V&QNE\4^%;+1S;'XA:/XKUG2UGUB3^QF
MU2PN]8EUB_U2Z@T.W3SN'?I"8/.LWX>HXWA/'9/P[Q?F<\HX9X@K9UD^,KXO
M&NHZ.%CF60X6H\QR>EC:J]EAZU=U8U)RIN'/2<ZM/T.(?H^8W)LIX@K8/BO
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M\1'EJRH8>C.,S^-6BO[.?V7/B7^R=_P4<^"7Q.\ Z5^SYIG@7P+X6EMO ?\
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M ((OM8^(/Q&UG6[[P3XQM_L4VL:6=0U*TB\)NU[K_C/38X;33;$W$MC\<_\
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M_P 0?&3P!_P01_X(V_L^V?C+X::3\2_%FD:/X'\ :A\*;7Q9K&BZ5\1?C/\
M%5-6\>?%Y!XOU7P9XUN=.T*&9_B'XA@FUOPG%I4MEI^G>%(;30_[2TG3X/\
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M&[;X"> /[;'B/QC_ &)X7A@?Q18/:S:XM];QZA<6T>F7OY0_\'4/[+:?"/\
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MFHG3?SX_X*#^&?VTOAA^Q]=W'[3W[<GA_P 7CXC/X6T&^^!>D? 7X::8-?\
M$D&L:?XENM)TWXA>'K#2==&E>%UT==8NO$<&BZ7;75S9V6C7,$*ZU;"X_#CX
M8?M2?M'?!>P72/A9\;OB;X(T-$N4B\/:)XNUB'PW";NZ-[<S0>');J;0X+N:
MZ:2=[V'3TNS)/<D3@75P)>!^(WQ2^)'Q>\1S>+_BEXZ\5_$'Q--$+<ZUXNUS
M4-=OH;-9IIXM/LY-0GG%AIEO+<3M::98K;Z?:>:ZVMM$AVU\?PAX#YWPUFO#
MU&IB_#JKD'#69?VA1S:CX?9-5XZSBG0Q;Q6!PF99OF&%Q=/!U</)4U'-<MG3
MS.FJ:=.M[7V=>E]?Q=X[Y+Q)E7$%:EA/$.EG_$F6_P!GULJK>(&<TN!\GJ5\
M*L+C<7EN49?BL)4QE/$1=1RRK,H5,MJ.H_:472=2A5_IR_X+#?\ *.KX(_\
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M-X?&83&8/#XFOB</0EB\)C</AL1A:E2IA:UJ%>G3KJG[*O*DJ&(P]2KZN?\
M!7%'"^'P^+SS*:N!P>+Q5?!X3&*OA,5@\9B,-0P^(KQPF*P6(Q&'Q5.G2Q5&
M]>A4J4'4]K0C5=?#XBG2YBBO1OA'\*/'/QQ^)'A+X4?#;1GU[QMXUU(Z9HFF
MK+';QLT-K<:A?WMY=3%8K33=)TNSOM6U2\D.RSTVRNKE@RQ$']0K+_@DBMS?
M7?PX?]M#]E]_VCK9-3M1\#-/\4"[U.;Q#9)/=P>&DU.ZO--U[^TY-,CBN=0B
M'@=I=,G^V1&"ZL;&34Y,^(N/.$N$\12PF?YS2P.*K8=XU8:&'QN-KTL"JDZ4
MLPQ='+\-BJF"RZ-6G4ISS#&1H8*,X3A*NI1DEKP[P)Q;Q7AZN*R#)JN.PM'$
M+!/$2Q&"P5"KCI4X58Y?A:N/Q.%IXW,94JE.I'+\)*OC)0G"<:#C*+?X[T5]
M7?"7]DCQ[X__ &G[+]DWQK,WP?\ B?>:GKF@/'XNTN6[L=-U[1=#O?$<=KJ3
MZ?=^8^FZWI6GRR:!KFC#6K#6'OM#N;$SZ+JHUFV\ ^(7@C6OAIX]\;_#CQ&;
M4^(? 'B[Q)X*UXV,DTMD=9\+:S>:'J9LY;BWM+B2U-[8S_9Y)[6VF>+8TMO"
MY:-?8PN>Y1C<P>5X3,,/B<;_ &5@\\C2HRE4A5RC,*N(H8+,,/B(Q>'Q&&Q%
M7#5HPJ4*M2W+&4E&-2FY^/B<BS?!8!9GB\!B,-@O[4QF22JUHJG.EFV7TJ%?
M&9?B*$I+$8;$X>EB:,ITZ]*FWS24>:5.HH<A17V#^U'^QWXM_93\-_ O5O&W
MBO0-3U_XU^!F\<2>#--MK^'6O =J+'P[<+I_B.6X0V-S=/>ZU?Z4LFF3SP&[
M\/ZDP;R7MWD^HO#_ /P2JU?P]HWA[4/VG_VH/V?OV5]:\9Z1I^N>%/ WQ"\2
M6DGC26PN&E2^?Q%IVIZGX5T_0FL)6LH"+/5M=47,FH6NHMI5SICQ7'SV)\1^
M"L)E>79S5SVC+ 9Q5QU'*I8;"YAC,5F4\LQ$\+F$L!EV#PE?,<72P=:G+ZQ7
MH86="G2<*\JGL*E.I+Z##>'/&N+S3,<GI9%6CC\HI8&MFL<3BL!@\-EL,SP]
M/%9?''9AB\70R_"U<91J1=##U\5"O4J*=!4_;TZE.'Y.45]._M4?LF_%7]D?
MQ]#X-^(UG:7VD:Y:R:OX"\?Z!(][X-\?^'T:('4] U$J MU:"XMEUC1;H1ZE
MI3W5E/+%+I>IZ/J>I?H%XE_X(W^)/AKK=VWQJ_:F^ _P>^'RPZ=IVC_$#QO?
MOH-OXH\9:@OVQ_#GA[2O$>H^'X[VTTS1P;W5=;?6(##=%K.TTN^@LM9U#2HQ
M_B7P+EF"R7,,5Q%A/JG$>'Q6*R*IA:6,Q\LUI8*>%IXM8*C@,-B:]:OAIXW#
MPK86-+ZU3G*I&5%2P^(5*L!X:\<9EC<ZR_"\/8OZWP[B,+A<\IXJK@\!'*ZN
M-CBIX26,K8_$X:A1H8F&#KSHXIU/JLX*G*-9QKX=U?Q@HK['\3_L?:SI?[,.
MI_M3^%O'_AKQUX*T'XQZI\(/$6E:-;S)JN@W%G<W\>G>)+ZX6ZN]+?2M9M6\
M+7EI#9W=U<"/QCI+*9K5);QL#]C_ /90\8_MC?%BZ^%?@WQ#X>\*3Z7X/UOQ
MQK?B#Q,-0?3M.T+1;O2M,D<1:=;7$LT\VJ:[I5LJRO:P1PS3W#W!>&.VN/5E
MQAPU#*<YSV>:T:>5</U\9A<YQ=2GB*:R_$8!4Y8JC7HSHQQ'M*<:U&48PI3=
M:-6E*C[2-2#EYD>#^))YMD^1PRJM/-.(*&$Q.386G5PU3^T,/CG4CA:U"M"M
M+#^SJ2I58RE.K!494JL:WLY4YJ/RO5S3M.U#6-0L-)TFPO-4U75+RUT[3-,T
MZUGOM0U'4+Z=+:RL+"RMDEN;R\N[F6*WM;6WBDGN)Y$BB1Y'53:UZRT[3-<U
MG3M(UB+Q#I-AJNH66F:_!97FFPZYI]K=S066KPZ=J,<.H6$6I6R1WD=G?117
MEJDP@N8TF1U'WA^P/^T?\&?V5;WXT_%[QEX9N/$_QOTWX?-HW[-D4V@PZ]H.
MD>-M:@UFVU/7-:6?4=).F6]H5T&WO=1L-0MM9?PQ>>*-*TIGGU-XGWXAS7'9
M7D.,S3*,GQ6?9C"E067Y11YL-6Q>)Q=>CAL/&O.K3<\'AJ,Z\<1F%>=&4\'@
MZ6(K2HSE2=-\_#^58'-,]P>69MF^%R++YU:[S#-JSCB*.$PV$H5L37E0C2J*
M&+Q%:%"5#+Z-.K&&,QE7#T8UHQJJHOF;Q-^S/^T?X*T&X\4^,OV?OC=X2\,6
MD0GNO$?B;X4^.]!T&V@,3SB:XU?5=!M-/AB,$<DPDDN%3RD>3.Q6(\2K]FOV
M)?V_OVT_BI^UE\*OA]XN^(6H_&+PC\5?%</A/X@_#KQ5IOA'_A&=0\$:E87L
M/BS48+(Z/9V^E?\ "+^'1J/BS['H;:>=<?0QHU[!JEIJ-SIMY^>_[8GA/P%X
M$_:G^/W@[X8M;CP-X;^*GC'2-!M+1;H6>D16>KW,5[X>LC>6EG.]CX<U(7F@
MV4NRYAFM=.BEMM2U>V>'5;SYKASB;B2IQ-B^$N+,MR3#YG3R+#<1X3&<.8_&
MX[ 3P-7'5<MJX;&0S'!8'%83%PQ5)RPL^2IA\?A_;3I2IU<)B:,/I>(N&N'*
M?#6$XLX4S'.L1EM3/<1P[B\'Q%@,%@<?#&TL#2S&EB<'/+\;C<+B\)/#55#%
M0YX8C 8AT8U8U*6+P]:?SYI6E:IKNJ:;H>AZ;?ZSK6LW]GI6D:/I5G<:CJFJ
MZIJ-Q'9Z?INFZ?9QS7=]?WUW-#:V=G:PRW%S<2QP01O*ZJ=CQ=X(\:?#_6'\
M.^/?"/B?P1X@CMX+N30O%V@:KX:UA+6Z4M;7+Z9K-I97JV]PJLT$S0".95)C
M9@#7['_\$^/ GAO]E/X8R?MT?&+2+G_A+/'VNVWP6_9)\+W^E6MZ-5\5>+VD
MLM4^)IMY%^V66F:7;6FI6%OJSWNBQ/X>MO%MG!_:5YXH\)>;Y=_P6IY_;I\4
M'U^'WPZ_],=>9E_B4\U\2ZG!. RR-7)J&69S4GQ$Z\N7%9WD6(RBCFF78*@J
M?LZN'RYYQA\-BL7[67_"C3Q>#C",L)4E+TL?X;1ROPVAQKC\RG2SFMF630AP
M\J$;X;)<\H9K5RS,<;6<_:4J^8+*:^)PN%]E&^7U,+C)3E'%TDOR:KI]:\$>
M,_#FC>&_$?B'PCXGT'P]XQ@O+KPAKVM:!JNEZ-XJM=/:V6_N?#>J7UI!8ZY!
M8M>V:WDVF3W4=LUW;"9D,\6_F*_HG^.7[,6M?M'_ +('_!,U[CQMX.^$OPP\
M ?!+QMJ/Q,^,/Q$U2RTCP9X(@UVR^#UAX8L[N>^OM.CO=;\4ZM:RZ9H&D1W<
M$M_/#=,)46V?=[7&7'.$X-S#A*CF*H4LMX@S/-,!C<=6G6Y\%# \/YIFV'^K
M8>A3JU<9BL9C,%A\!0PM*$J]>IB8TL-3JXB=*G+QN#N",7QCE_%E;+O;U<RX
M?RS+,?@L#1C14,9+&\097E.(^LXBO4I4L'A<%@\;B,?7Q52<*-"GAI5<14I8
M>%6I'^=BBOTD_:)_X)P>)O@]\&+G]HSX8_&SX2_M&_!'2+_3=&\3^+OAUJT:
M7OAW5M1UG^PA]HT];S5M*OM+AU2]\/:9+-I_B.?78]1UZ#S_  W!I-M-K!\!
M_9:_8^^+O[7.N^*]*^&A\+:-H_@+18M?\<^.O'NM3^'O!'A'3KK[8;%];U:T
MT[5[R*6_CTS59[:*VTRZ/V72M3O)S#:V4\R=V$X\X0QV0X[B>AGV#CD>68BI
MA,RQV)5?!++\92E0A/!8[#8VEA\7A,9SXK#1AA*]"GB*DL3AU3I2=>ES\.+X
M#XOP6?8'AFOD6,>=YGAZ>+RW X9T<;_:&#J1KSCC,%B<'5Q&$Q6#Y,-B93Q=
M"O4P]..&Q#J58JC5Y?EFBOULUG_@E/>>)O"WB'6?V8OVJ/@+^U)XG\)6%QK/
MB#X=_#_7+"+Q@-'@A9A<Z/8V6O>)!?W5Q<[+.TM=0.C07MPXMK*^N+_99/\
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M?C^TTZ!98+KPU\./!_B'Q\^DZW+)8:C!:^'_ !3JGAS2_!^KRSQ0&XM_$/\
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ML]*UZ[O=;BT6*\31X;70/$%P=2DM3#H&N2!=*N_GG_@N4(OV??@O_P $LO\
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M_P#[,,_9!_\ 6??A[7\_^.?QY#_AQ/YQ/4R[:IZK\D?P9W?_ ">#_P %4?\
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M7[&GB'Q!#%XDOM.MM6=_AAXKUJRN+FP@\.:[<2VGA[2M0UK4;"VU?3M*&O\
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MU=8KB:,+(WZ3Z-\=?^"=?Q^^%OP@\'?M.?#;XJ?!;XB?"#P5'X2/C[]F[1_
M&E^'_'ME;7UQ<O)KFB7&C7UO9ZOJNHZA?>*[^2U\*HLOB#5?$=P=;A@NK73Y
MON.,<HE_8'!#>4<6?6LC]BZ.;<$U,)_;W"]?^PJN!E6I97B:6(I9I@\5&<\M
MQF$6%Q480JQJRH2A!RC\/P=F\7GW&T5F_"?U;/%6]ME7&U/%/(>)Z']NT<=&
MC5S3#U:%7*\9AI0AF6$QCQ6%G.=*5*->,YJ,O./VO/V4?'?P&^"OPK\9>!?V
MD4_:2_9%\6Z[<VG@W7=!U/4=&\+>'/B++'K]W>:<WPXN?%7B33=*U.\@LO$S
M#5M,N);U+ZP\1Z=XCM-"OC;0ZM^;M?I5^U5^V1\)/%W[/GPO_9!_97\#>.?!
MGP'\ ZLGC'7-=^*.H6,OQ)\=>,V761)+J]OX:UG4O#L&ER7FN:EKE_%'-):W
MVL2Z4-'T3PEIOARTLK[\U:^G\.GQ++AQSXJH3HYA/-LWGAJF*P>79?FN-RJ6
M.JO+<?GF!RBV687.<7AG&IC:6#C"FFX2G3IUY581^9\1%PU'B*,>%J\*V AE
M.40Q5/"XS,<PRK!YK' THYE@,CQN;7S/%9/A<0I4\%5QDIU&E.,*E2A&E.11
M117W9\*%%%% !7W;_P $'?\ E.!XZ_[19>-O_6K_ (05\)5]V_\ !!W_ )3@
M>.O^T67C;_UJ_P"$%?SW]*#_ )-#G7_8=E?_ *DG]'?16_Y.Y@/^Q+G7_J/
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M8(=.O?L^D:8I\N_X)^_&/_@@C_P3U^(7Q'\:?#[_ (*'_M'?$'0OBW\*M?\
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MNFT/08]#33M8U.RN[>SU&#3[_P ')!>R7*/J/BJ[L+%_#=S^6G@?QEK'P_\
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MO?'O[+__  3'_8*_9O\ VAM9DF_MCX]:)\--)U[Q-!'J5C>KKUWX8M-+\/\
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MAHK] OVTOV*]&_9XT'X7_&3X/?$1_B_^SA\:]-6\\!^.;S33HNNV.IB![M]
M\0:7+':3">:PC:\M+M]-T>[2>WU?1]5T/2K[1]^H?G[7T'#_ !!E7%&58?.<
MFQ$L1@L1*O2_>T*^%Q.'Q.%KU,-C,'C,'BJ=+$X3&83$TJN'Q.&Q%*G5I5:<
MDXV<9/P.(.'\UX8S2OD^<8>.'QM"%"K^ZKT,7AL1AL70IXG"8S!XS"U*N&Q>
M#Q>&JTJ^'Q.'JU*52G--2YE******]H\4**** "BBB@ HHHH **** "BBB@
MHHHH **** "ONW_@@[_RG \=?]HLO&W_ *U?\(*^$J^[?^"#O_*<#QU_VBR\
M;?\ K5_P@K^>_I0?\FASK_L.RO\ ]23^COHK?\G<P'_8ESK_ -1X']T=%%%?
MY5G^H04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_B'>
MO^17LO\ K[UG_P!/6H5_MXU_B'> O^17LO\ K[UG_P!/6H5^X^!O_(YSO_L6
M4?\ U*@>=F/\.G_C?_I+.QHHHK^ESR HHHH **** "BBB@ HHHH *_1W_@G]
M_P %0OVDO^"=^J^++#X8#P=\0?@_\2VME^*WP"^+6AMXI^%_CJ.&VETYKY[!
M+FSU#0/$)TN>6R.K:/>PVNJ1P:7;^+=)\4Z7HVG:7!^<5%<F.P.#S+"U<'C\
M-2Q6%K)*I1K14H2Y9*4)+K&<)QC.G4BXSISC&<)1E%-5&4H24HMQDMFG9_\
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M%?M-U[_"O_)1Y+_V,<-_Z<1G5_A3_P +/X :***_ND^;"BBB@ HHHH ****
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M\FD>%--UCX1_"G3[[Q)JJ1O'(^FZ':W$NJ7R))&[6MK*%=&(8>OK_P $=/\
M@G654M_P7D_9*5BH)7_A75F=I(R1G_A>PS@\9P,^@KR;_@N=<^"[/_@MM^T-
M=_$BPUC5?AW:_$+X"W/CW2_#KQ1^(-2\%P?"?X3R^*;#0I)[W388]8O-#6^M
M],>;4;");V2!I+VU0&>/UH?'[_@VEP-W[#'[?9.!DCXG:2 3CD@?\-!\#->_
M1K9K2X;X0675.(:<7P[E;J_V)EN1X^#:P&#Y?K$LW:G3G;F5-4/=DG)SU43"
MT'5K<ZI/][*WM)U(_:=[>S^YW\K'Q7^W-^PA^R=^RQ\,?#7C3X&_\%*_@O\
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MI:P*L^KZM,/M^MWXFU+4IV=HTA^8_P#@EA_P3\^%/_!1+5/VF/@WJWQ6\0>
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MXPQ="K0Q6$A1TE*I"GB+151+Z?\ ^'>7[(G_ $E)^ G_ (2-K_\ /2K\Y?\
MA(-7^ _QDU75_@U\2I[R_P# 'BGQ%IW@CXI^'+<:1+K&GPOJ.AP>)=+M9;C4
MO[/BUS2)Y9H[=KN\:W@O3&+F5E$I_1K_ (6M_P $9O\ HV']JG_PM;+_ .>W
M7Y^>&/AK/^T+^T!;?#7X!^%KK3(?B1X[U&P^'?AG6=0N;Z7P[X=N;N\OK4:_
MJRC4KR:T\+^'89;_ %_4T34+D6.FWMXD=W*HCD^XX.QV<U*>?SXSQ7&E7)J&
M55*F*?'G#O V395#"J-1XZ2EPXYU,3'ZK&H\73QR>$AAN9N\I6/AN,,#D].I
MD%/@W"\%TLXKYI3IX;_4/B'CC.<UGBG*E' Q<>(N6GAI?6I4_JE3 M8N>)Y5
M%J,3J_V>/V??C%^VE\;(?!WAA]6U_P 0>(]4DU_X@>/]<DN]7BT#3;Z^\W7/
M&/BK5+NX$U]=22S3310W%\NH:]JDBVD,IFG>:/Z5_P""GOQ?^'/C'XI_#WX+
M_!R^?4?AC^R]\-='^"VDWK6(6*]USPW+/::Y<:=K%\UQX@UC3+6.WTW18+C4
M;R2QFN=)N]1TE;BWU%]6U3]&_C)^S;\>OV0_@E'^S#^Q'\&_B/XU\8_$+1[>
M[_:/_:9T?PR]IJ7B5[BW98? _@O4I+I9=*T*V@N+I9+73)+BWTFPO/L0U2]\
M2ZAXMO9/Q2U/X(_$O]E_XD?"+Q+^TW\%O%.B>#[CQQHNN7_AGQ-IUHC^.?#/
MA77M$U#QAHEK;W=S]FNA>Z7<#3YDO)(;60Z@D<LHC,C+XO#'$N4\=<2X;BVC
MFN5/+<DP6:87P^X1P^.R^GGN9RK85T\QX@QN6RK_ %C"U,5A,+/"Y#@)TZ-3
M"955Q&,QL*,\9*E0]OB;AK-N!>&L3PG6RK-%F6=XS*\3X@\78C YA4R/+(4L
M5&KE^08+,H4/J^)IX7%XJGBL^QT*E:GB\TI8?!X.=:&#C5K?H#\,K,_\$Z?V
M.]0^/%^Z:3^UU^U+I1\,?"/1[V:TCUWX5_"*XG:XU'QS_9.4U"WU'Q%%:PW5
MM=RSLMI>3^$%%G;7FB^([&\S?^"B\CS?L<_\$PY96+R2_!#59)'8Y9W?P_\
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M_DQXX_\ )VN._P#L>5?_ $Q0"BBBOTH_*0HHHH **** "BBB@ HHHH ****
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M^H\#^Z.BBBO\JS_4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT:[4?=3JPD^73;0****[S@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH \J^.W_)$/C)_P!DJ^(?_J(ZQ7]YW_!(/_E%9_P3H_[,L_9N_P#53^%J
M_@Q^.W_)$/C)_P!DJ^(?_J(ZQ7]YW_!(/_E%9_P3H_[,L_9N_P#53^%J_@CZ
M9_\ OW!/_8)F?_IZD?W_ /0T_P"1#QM_V-\K_P#4*N?HO1117\/']HA1110
M4444 %?R;?\ !XM<P67_  3;_9NO+E_*MK3_ (*%_!ZYN)-KOY<$'P&_:=EE
M?9&KR/LC1FVHK.V,*K,0#_6317=EF.EEN88/,(TU5E@Z].O&E*3A&<J;YE%R
M2DTF]VDW;;N3./-&4;VNK7/\07_A97@G_H-?^4[5O_D"C_A97@G_ *#7_E.U
M;_Y K_;ZHK]D_P"(YYQ_T(\M_P#!^*_S.#^SJ?\ S\G]T?\ (_Q!?^%E>"?^
M@U_Y3M6_^0*/^%E>"?\ H-?^4[5O_D"O]OJBC_B.><?]"/+?_!^*_P P_LZG
M_P _)_='_(_Q!?\ A97@G_H-?^4[5O\ Y H_X65X)_Z#7_E.U;_Y K_;ZHH_
MXCGG'_0CRW_P?BO\P_LZG_S\G]T?\C_$%_X65X)_Z#7_ )3M6_\ D"C_ (65
MX)_Z#7_E.U;_ .0*_P!OJBC_ (CGG'_0CRW_ ,'XK_,/[.I_\_)_='_(_P 0
M7_A97@G_ *#7_E.U;_Y H_X65X)_Z#7_ )3M6_\ D"O]OJBC_B.><?\ 0CRW
M_P 'XK_,/[.I_P#/R?W1_P C_$%_X65X)_Z#7_E.U;_Y H_X65X)_P"@U_Y3
MM6_^0*_V^J*/^(YYQ_T(\M_\'XK_ ##^SJ?_ #\G]T?\C_$%_P"%E>"?^@U_
MY3M6_P#D"C_A97@G_H-?^4[5O_D"O]OJBC_B.><?]"/+?_!^*_S#^SJ?_/R?
MW1_R/\07_A97@G_H-?\ E.U;_P"0*/\ A97@G_H-?^4[5O\ Y K_ &^J*/\
MB.><?]"/+?\ P?BO\P_LZG_S\G]T?\C_ !!?^%E>"?\ H-?^4[5O_D"C_A97
M@G_H-?\ E.U;_P"0*_V^J*/^(YYQ_P!"/+?_  ?BO\P_LZG_ ,_)_='_ "/\
M07_A97@G_H-?^4[5O_D"C_A97@G_ *#7_E.U;_Y K_;ZHH_XCGG'_0CRW_P?
MBO\ ,/[.I_\ /R?W1_R/\07_ (65X)_Z#7_E.U;_ .0*/^%E>"?^@U_Y3M6_
M^0*_V^J*/^(YYQ_T(\M_\'XK_,/[.I_\_)_='_(_Q!?^%E>"?^@U_P"4[5O_
M ) H_P"%E>"?^@U_Y3M6_P#D"O\ ;ZHH_P"(YYQ_T(\M_P#!^*_S#^SJ?_/R
M?W1_R/\ $%_X65X)_P"@U_Y3M6_^0*/^%E>"?^@U_P"4[5O_ ) K_;ZHH_XC
MGG'_ $(\M_\ !^*_S#^SJ?\ S\G]T?\ (_Q!?^%E>"?^@U_Y3M6_^0*/^%E>
M"?\ H-?^4[5O_D"O]OJBC_B.><?]"/+?_!^*_P P_LZG_P _)_='_(_Q!?\
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MI_X;^_9(_P"BL_\ EA_$S_YC*/\ AO[]DC_HK/\ Y8?Q,_\ F,K_ %5J*/\
MB<KCK_HEN$__  './_GF'_$GGAM_T/N./_#CD/\ ]#9_E4_\-_?LD?\ 16?_
M "P_B9_\QE'_  W]^R1_T5G_ ,L/XF?_ #&5_JK44?\ $Y7'7_1+<)_^ YQ_
M\\P_XD\\-O\ H?<<?^''(?\ Z&S_ "J?^&_OV2/^BL_^6'\3/_F,H_X;^_9(
M_P"BL_\ EA_$S_YC*_U5J*/^)RN.O^B6X3_\!SC_ .>8?\2>>&W_ $/N./\
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M@G_H-?\ E.U;_P"0*/\ A97@G_H-?^4[5O\ Y K_ &^J*/\ B.><?]"/+?\
MP?BO\P_LZG_S\G]T?\C_ !!?^%E>"?\ H-?^4[5O_D"C_A97@G_H-?\ E.U;
M_P"0*_V^J*/^(YYQ_P!"/+?_  ?BO\P_LZG_ ,_)_='_ "/\07_A97@G_H-?
M^4[5O_D"C_A97@G_ *#7_E.U;_Y K_;ZHH_XCGG'_0CRW_P?BO\ ,/[.I_\
M/R?W1_R/\07_ (65X)_Z#7_E.U;_ .0*/^%E>"?^@U_Y3M6_^0*_V^J*/^(Y
MYQ_T(\M_\'XK_,/[.I_\_)_='_(_Q!?^%E>"?^@U_P"4[5O_ ) H_P"%E>"?
M^@U_Y3M6_P#D"O\ ;ZHH_P"(YYQ_T(\M_P#!^*_S#^SJ?_/R?W1_R/\ $%_X
M65X)_P"@U_Y3M6_^0*/^%E>"?^@U_P"4[5O_ ) K_;ZHH_XCGG'_ $(\M_\
M!^*_S#^SJ?\ S\G]T?\ (_Q!?^%E>"?^@U_Y3M6_^0*/^%E>"?\ H-?^4[5O
M_D"O]OJBC_B.><?]"/+?_!^*_P P_LZG_P _)_='_(_Q!?\ A97@G_H-?^4[
M5O\ Y H_X65X)_Z#7_E.U;_Y K_;ZHH_XCGG'_0CRW_P?BO\P_LZG_S\G]T?
M\C_$%_X65X)_Z#7_ )3M6_\ D"C_ (65X)_Z#7_E.U;_ .0*_P!OJBC_ (CG
MG'_0CRW_ ,'XK_,/[.I_\_)_='_(_P 07_A97@G_ *#7_E.U;_Y H_X65X)_
MZ#7_ )3M6_\ D"O]OJBC_B.><?\ 0CRW_P 'XK_,/[.I_P#/R?W1_P C_$%_
MX65X)_Z#7_E.U;_Y H_X65X)_P"@U_Y3M6_^0*_V^J*/^(YYQ_T(\M_\'XK_
M ##^SJ?_ #\G]T?\C_$%_P"%E>"?^@U_Y3M6_P#D"C_A97@G_H-?^4[5O_D"
MO]OJBC_B.><?]"/+?_!^*_S#^SJ?_/R?W1_R/\07_A97@G_H-?\ E.U;_P"0
M*/\ A97@G_H-?^4[5O\ Y K_ &^J*/\ B.><?]"/+?\ P?BO\P_LZG_S\G]T
M?\C_ !!?^%E>"?\ H-?^4[5O_D"C_A97@G_H-?\ E.U;_P"0*_V^J*/^(YYQ
M_P!"/+?_  ?BO\P_LZG_ ,_)_='_ "/\07_A97@G_H-?^4[5O_D"C_A97@G_
M *#7_E.U;_Y K_;ZHH_XCGG'_0CRW_P?BO\ ,/[.I_\ /R?W1_R/\07_ (65
MX)_Z#7_E.U;_ .0*/^%E>"?^@U_Y3M6_^0*_V^J*/^(YYQ_T(\M_\'XK_,/[
M.I_\_)_='_(_Q!?^%E>"?^@U_P"4[5O_ ) H_P"%E>"?^@U_Y3M6_P#D"O\
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MRN.O^B6X3_\  <X_^>8?\2>>&W_0^XX_\..0_P#T-G^53_PW]^R1_P!%9_\
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M<<?^''(?_H;/\JG_ (;^_9(_Z*S_ .6'\3/_ )C*/^&_OV2/^BL_^6'\3/\
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MJG_AO[]DC_HK/_EA_$S_ .8RC_AO[]DC_HK/_EA_$S_YC*_U5J*/^)RN.O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQT;X5VGBBQ>/0=?O?&J1W::5XVU:!_RK_P""GWQ=_P"#>OQC^SSX%B_X)8?
MW]J/X#_M1^!O''AV6+Q1XLN_%EQX:\6>"D76;O7I?%]_XR^.GQ!N++Q+I^KS
M:?J_AO7?"6D6&J17:0Z),%\-P6":  ?ZL7[0G[3_ .SM^R;X+TSXB_M,_&KX
M;? CP'K7B>R\%:3XN^*7BS2?!WA_4?%VHZ5K6NV'ARSU/6;FUM9]8O-&\.:]
MJ=O81R&XELM'U"X5#':RLOSK\6?^"J__  3=^!OACX8^,OBK^VQ^SKX2\-_&
M?PO#XX^%6I3_ !)T+5/^$\\%7,]S:0>+_#MIH=QJ=_?>%Y;^ROM,37UM5THZ
MO87VD_:_[2LKJUB_B>_X+#?M0_$']LG_ (-3?^"5W[0/Q6U2YU[XC^(_VMO!
M'@OQEXEOVO9M6\7:Y\%OAU^V]\$;OQGK]WJ.KZY>:EXE\8GX=+XG\3:O+?1K
MK&OZMJ6J0Z9H<%Y'HFG^[?L3_P#!NS^QM^U/_P $5_"'[77[1GB;XO\ B[]J
M+QM^S9XQ^*'@OXE:-X_U+3-)^%WA7P-X.UG2?@W\+=!\"RP2^$M3\(>%="\(
MZ)=Z\FK:5<:_K&NZIXE6T\2V&FS:5%IX!_=+\(_B]\+_ (]_#;P=\8O@OX]\
M+_$[X7?$#1XM>\&^.O!FKVNN>'/$&ER2RV[S6.H6<DD?G6EY;W6G:G8S>5?Z
M3JMG>Z5J=M::C975K#\I_'O_ (*B?\$Z_P!EWQY;?"[]H#]M']G7X6_$>>8P
M7/@?Q+\3?#B>*="8FR$4GB[1;&\O+_P7;7*W\$ME=^+H=$M;^".]N+.:>#3=
M1DM?X??^#5O]L[XJ?!']@G_@M7:6&M7]UX?_ &6_V=KS]K7X665P_P#;-GX3
M\>Z7\)_CI?>)9=-\-ZM/_8MROB*7X;>!;JYM&?3K6ZN= :/4FNX]0\VQ\._X
M-I_^"2?P)_X*[_$+]LC]K;_@H;!XN^/&B^&/&FE6*^';WXA^,?#%W\3_ (S?
M%J7Q5XZ^)/Q#^(GBOP-K_ACX@3ZCI!_L74=.6Q\265KXCUOQ?K-YK?VI-&2S
MNP#[4_X*#?\ !1K]KKPS_P '-/[+_P "?@E^V%\7+7]D[XJ?M%?\$TO^+<>!
M/BOJ]]\&/&O@/XOW/P/_ .$D_LK3-,U2Z\,ZCX1^(FB:S<WE]_9&[1O$,&M7
MFJ?Z2^JW-U<_VRZC^W3^QKH_[14?[(VK_M/_  /TO]I^:_TK2HO@+J/Q&\,V
M/Q2EU/7/"UGXWT33H_!]SJ$6KO?ZQX2U"P\0:59K;&XU#3;ZSGM(YA<PA_\
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M//I/B6;[;X3U:-_B?XPU744\5Q&YL]#TWX?_ &[_ /E9N_X(8_\ 9#/VYO\
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M]FOXW:9;>(]!O(98)K36M$FNDU/2[F*:&6"^M8)8Y8V0. #^E+X;_P#!0/\
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M^,+Z?Q#X ^).I2WGBR"\O2NJ_#&&Y@U%OAKX2E\,@'7?\%V/^"J7P_\ &O\
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M_!/'6_VD?CW\$?AW^T3\1OB1\1?B3\*[0_';P=H/Q6\.^ /A)X.UV6:#X=>
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MYL+?Q/\ #G]F76X;.XEBQ%+/:QWJP2R1@1NZ,R *17QA_P %O/VK?V8O%_\
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MK2/%F@O>0)&UYI5W=Z1=7(TS7=,:9(-8T#4UL]:T:[W66JV%G=QR0+_DQ_\
M!+7XU?\ !#S1]%^-_P 3/^"R7PX_:@_:?_:(^(OQ'UF[\/1Z!J7B^_\ "5GX
M5U?1;:]UKQSK/B+PS\8OAEXP\0?%'QCXO\0>+?[;OO%&I>((--M]%\-Z]H3V
M'B.[U'4'_1#_ (-O_P!K/P%\(O\ @N_XH_9__8OU?XIP_L,_M=S?&KPUX/\
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M6_$?AB"_ENH--O/$?A9+B/Q)H>GZK-8WT6DZCJFE6MAJKV5XNG7%R;6X\O\
MG8_X+D_L3_ _]I?_ (*9_L!_$KX@_P#!6SX<_L/^-?A3H/@1?#WP+\5^.?\
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M/B%I?![Z#H5M.+JQ@\/K;7,36@!_8Y_P56_;W\$?\$\_V*?C/\>=2^(_PO\
M!OQ0M_ 'C"']GG0?B3=M<6?Q(^,%OX?NKWPGX6TGPS8:GIFN>*VFOA:SZC::
M/<PI:6!:\U*]L; 27(_(O_@WS_X+RZC_ ,%&O GB_P +_MJ?%G]ESP#^T[JO
MQIU/P9\$?A#X*OHO /C+Q_X-TSX<^'O%E[J.F>!/$GCKQ/K^N&WOG\2B+5;"
M.WM+E-+O[.!;BXTN[$7YX_"/X<?#7_@HA_P:;:/\4?VL_"E_\5/B/^QS\$/V
MI=2^!_BW4_'GQ"TZ^\-^)O@_?^/O"/P\\0W$7A_Q/HT/B%M!\':3H&@+HGC
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M_FZ8%;]*_P!C#_@AW_P3O_9[_8V\ ?LZ>-_V3OV??C'K%_X'TF3XR>/?B/\
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MHEG_ &7X@O8H)(-'U379)AX:T[4%:YAMKJVO=9@DL=09M,O1;ZA'+:I\M?\
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M$,]Q'*0E?@+X)^#WA#_@JW_P<)?MFZA^U/X<T+XG? #_ ()4?#SX1?#7X%?
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MW^FV6G?\)UX-TK2/%5Y8V,L\.M64=SJTDMGXCT[3M>MIHM2MO/< _H"\>_\
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M_NU31+."32KSP?HFE:)>PW,6C*TGLW_!*#]E+]ES6?\ @M!_P7=\(ZQ^S9\
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M>'_\%U_^E=7_ ,ZY?L>?_,31_P /#_\ @NO_ -*ZO_G7+]CS_P"8F@#\&?\
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MCX1?%WP/X3UTW.G^,VT;4VM/#WCOP%;*SW>EZ1X9U?2_#FKB?QQ>Q_._Q/\
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MX<O^"IO[5_[97_!7CP-^Q$_[-'_!+K]N#P%^RU\)_P#@H5^S5\3/%OCWXX_
M_P 1Z1\:/%/B.TTGX@VEAK_@SX4> +OQ]%:?L_\ @?PSJ'C!_B7\9-5UB\\.
MIXKUWX=:!:WNBW2:S;7_ .L_[:/P2^,_BK_@X?\ ^"-7QL\,?"+XG^(_@U\+
M_@U^V1I?Q,^+>@^ ?%>L?#'X=ZGXH^!OQ?TCPUIWCKQ[I^DW'A7PC?>(M5U/
M3=,T*TU_5=/N-6U#4+&RL([BYNX(I/Z)J* "OYL_^"I/[+W[67[//_!0_P#9
MS_X+6?L6_#3Q3^TO=?"CX37_ .S=^UY^R3X(VS_$CXF? /4-0\4:O;>+?A)I
MC65_J/B?Q;X>U3Q-#J=SX-T%DUC4-;\%?#R32](U32;WQ\R_TF44 ?RU?$K_
M (*\_P#!1O\ ;NLOAQ\ _P#@EA_P3G_;1_9?^*WCKQ=ID7Q2_:P_;_\ V<;#
MX<_ ?X"^"-&GT34?$MSX?NK[6?&OASX@>([^&[DM)=*U2SM_$R^'%N&\(> _
M$'B36K*_\'=3_P %O/@/^U[\+OVLO^"9O_!5?]C[X)_$7]K/Q9^Q'K?Q-\"_
M&[X*> K/3=6^(?B_X3?%/PQ_PCNJ:UX/\-Z5X9O]2O=9O]#UCXB>'=;D\,^'
M-?O=.U'Q)X/UC1/#.EV6C:QJ$?\ 3910!_#=_P %A/VN?^"B/_!7G_@F7\1O
M 7[,7_!*']L#X2_#'3/%_P +]9^+]Q\=OAGXH_X75\2+[2?'?AYM$\"?LQ_!
M/P5H/B#QM\0++2/$LL'C#X@?%/4-/T/PGX<\)^"M=T1T;Q%J:V=I^@?_  6S
M_9]^/7Q6_P""=W_!(_P3\+O@C\7?B3XS^&W[=O[!'B_XB^$? /PV\9^,?$_@
M'PGX.^"7Q6TGQ=XH\:Z!X=T74=5\+>'?"NJ:CI^F^(];UVTL--T/4+ZSL]3N
M;6YNH(W_ *CJ* ,_4],L=:TO4-&U.#[3INK:?=Z9J%MYDT/VBQO[>2UNX/.M
MY(KB+S8)9(_,@EBFCW;HY$<*P_D,_9'^,'[4?_!NWH/B_P#8'^.7[#G[8/[:
M?[(FF?$_QSX[_9$_:H_8L^%FF_%_6)OA]X]O[CQ+=?#GXR^"8;OP=:>$_B!H
MGB2;4M0N[C6/$UI+K,VK:^OA2PU3PAX<T;4[[^P.B@#\1O\ @GW^VM_P49_;
MK_:A^(7Q,\4?L;>(OV+?^":GASX?/H7PST_]J?P5J?A3]L+XT_%N75-.O;;Q
M9;>#(_%-M;_#WX>V_AJ_N'O9[_1?%WA_4)[72K3P;XM\77FK^)KKX<^X6O\
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M 7]FW7B/Q;X='A[1%OK(66IPZ99_\)[\6;OQ+<>&](\&>#3JG]6E% '\%_\
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M[.ZTJ[DAO[>:W3]YO^'A_P#P77_Z5U?_ #KE^QY_\Q-'_#P__@NO_P!*ZO\
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MMO$J?U'?\/#_ /@NO_TKJ_\ G7+]CS_YB:/^'A__  77_P"E=7_SKE^QY_\
M,30!_(7_ ,%??AO_ ,%@_P#@IK^U9^R;^V)XV_X)C_M*?"OX;WECIO@_X7?!
MKPA\(_BO\5?B+\,? /@CXISZA>^)OC[+X?\ A;IMSX!U_P 9ZGKFIZEI6@^+
M+;1=0B\/Z,-1AT.UT6:PUO7OT&_X*W_L<?M=_$G_ (.6_P!A/X\?#K]E;]H_
MQ]\#O"'Q5_X)[:CXL^,O@KX'?$[Q3\*?"^G^"OC)X;U3QE?>(OB)H?A>_P#"
M&B6?A+3()]1\376I:Q;0:#8PRW>JO:6\;R#][O\ AX?_ ,%U_P#I75_\ZY?L
M>?\ S$T?\/#_ /@NO_TKJ_\ G7+]CS_YB: /W^K_ #*O^#J;X<?$/]@__@J/
MJG[4'P,U8>#]&_;\_95\9>"OB!_9VF6]K8ZK<:QX-O?@%\<?"LUJN^VN5\1^
M!'\%>*]1U:$6=]<>*/$EWJ%U#+>12ZAJG]:%U_P4-_X+PO;7"67_  ;MP6]X
MT$RVD]U_P5J_9 O+:"Y:-A!-<6D7A.QENH(Y2CS6\5[9R3QJT275NS"5/X\O
MBU_P1M_X.1_VNOCM\(/BQ_P4$_9/^)O[8GA3X8ZII%I??#SQ!^W!^Q_X!N==
M^'-OXD/B'Q'\/]#\7:'\7=43P.?%HDN--U/Q=I7AB]\0Q6TEO)#*TVEZ2UB
M?V=_\&X_[$UC^Q/_ ,$IOV=M(U'0#H_Q2^/.AQ_M'_%R>\TF?1==F\0?%6VM
M=9\*Z)KNGWDL]]8:AX)^&P\&>#+VQN6MW34M#U"\ETW2[R_N[&']4OVL_P!G
M'P?^U]^S-\=?V8/'UYJ&E^%/CI\,?%OPXU36M(9AJOAY_$>E3VFF^)=,03V\
M5UJ'AK56L=>LK&]=],U"YTZ*QU6WNM-N+NUF_'O3_P#@H!_P7+TJQLM,TW_@
MW+@LM/TZTM[&QL[7_@K;^QS!;6EG:1)!;6UO#'X(6.*&"&-(HHT541%55
MJW_P\/\ ^"Z__2NK_P"=<OV//_F)H _FA_89^(O_  69_P"#;+5OVB/V5-9_
MX)H_$?\ ;@_9X\<?$75/&_P^\<_!S1_'<GA"7XC7&A>'O#</Q"T;XG> ?A7\
M4)KGP_XO\$>%?#J:I\*_&^A^&O$^GWVA)+IUYX9O;7Q7:ZQ^Y/\ P1C^/?\
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M;P,GB+0_&>FZ+K6A:-XBN;W2C'K5WIY@ATJ_768(;ZWC2*?\F?\ @VF\>_\
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M,<D<BE'C=+:)71T8!E=6!5E8 J000"*_BW_88_95_:@\(_\ !KO^V?\ L_\
MBO\ 9O\ CWX8^//BF3]I ^&/@EXA^#_Q"T7XN^(QKOBW3+G1#H/PVU+P[;>,
MM7&L6\<EQI7]GZ+<?VA"CRVGG1J6']K-% 'X#2_\$Z?$O[;O_!O#^SW^P-X^
M_M_X(?%76?V$_P!E+0H8_'&@ZWX>UKX;_&/X6^ _AQXBTS0?B!X7U"PCU[1X
M;?Q9X7_X1/QWI-YHTFNZ+IMYK+6VF#7["S2/Y&^ /_!:']L/]D;X+>%OV4/V
MR?\ @D3_ ,%-/BO^V%\#_A]:_#P>+OV:O@/!\7_@K\?M9\$:)=:7H'CS3_B9
MH&J6EO9Z5XVM](T_4_%&K^!_"OCNPT&_NO$)T[1[EM'70V_JRHH _FT\2_LX
M?\%:/^"A?_!%[]M7X:?MBW_A/X6_M:?M42ZWXL^ _P $_!ESHG@FW^#?POTO
MQ%X)\;>"O@%XS\3Z9:-)-K_C%O"_B#PKXDOO%/B?7S'X6\7Z9HGC35].U"V\
M4F#Y@_8R_P""P7CS]G#]F'X3_L4?#C_@A9_P41\'_M>_#GX<Z)X$M/A%X:_9
MYT3X=_LTZO\ $33;"72;;QAK?QMUW7=!U30O!_C8:-<^+M9\>:]\.K]FFDU%
M)-<\1Q0/XLN_ZZJ* /XY?^"6'[-O[7_@S_@C+_P74^'GQY_9[^)/@C]H+XU?
M%/\ X*'ZWX5^'<'PM^)FAW/Q/U7Q]^R3X0T#1[[X)>&O%V@VGC+QYX2\7>,X
M-1T#P!J&E6.J2^([NW&G64MYJ<<T"_N!_P $/?AU\0?A-_P2C_8D^'7Q4\"^
M,?AG\0?"GP:TO2_%/@3X@>&-;\&>,O#6IQZAJ3R:=K_ACQ'8Z;K>C7R)(CO:
M:C8VUPJNC-& P)_5JB@#Y'_;T_91T7]N3]CG]HC]DW7=?N/"=M\;_AMK'A+3
M_%-O UY_PC7B9'M]9\'^(+K3TFMI-5TS1O%FEZ+J.KZ-%>6,NLZ5;7FEQ:AI
M\EVM[!_/)^R+_P %1_VQ/^":'P%^'G["7[>'_!+C_@HG\;/B_P#L[>'K?X-?
M#GXY_L;? R/X[_!KX_>$/!=W>^'OAQK&E^*9=>\*3V=]_P (7!X*TW4Y!_PD
MWBK5=1FN];\1>'_#6KWO_".C^M.B@#\>/^";U_\ \%&OVJ?@A^T3\1/^"EOA
M+3_V?])_:,U/7]"^!7[+GAVPT.S\;_ #X'ZAHVK>'Q_PG.O7'AMM;O\ XF>)
MH]3.HW@\4WVKQ646G:3=GPEX*N[_ %CPC9_A-_P3-_:^_;W_ ."-7PTN/^"8
M?Q]_X)2_MP_M(-\//BW\58OV<_C+^S1\.X/%OPR^('A7QSXXU+QC;"X\5_8+
M/PQI>DR>(/$6N>)]4\2:IXPU#4/">@ZW:P>*M#\/Q:/+#%_;!10!_)3_ ,$<
M/@_^WM8?\%IO^"H?[1?[:O[-FO\ P5O?C7\-OA-J&C:QH'AWQMJ?P0!:+2;K
M2?AUX+^,^L^&-#\(_%#Q3\/?#!TKPQX]U?PC<WFEW7BW1]=N]-+:8]M*WUC_
M ,&Y_P $OC-\$/A+_P %$M-^-/PC^)WPAU'QM_P5!_:'^('@RP^*'@'Q5X O
M?%W@/6_!'PAM-&\;>&+7Q7I.DSZ_X1U>ZTS4K;3/$FE1W>C7]QI][#:WLLEI
M.L?]$M% 'X0_\%G?V*?VC_BGXL_8U_X* ?L7:-IWQ _:B_X)U_$7Q-X\TCX$
M:SJ-GH]E\?\ X5^.K/1M,^)G@#1M:U.VOK#1?'3:#I%U;^%;MX(3+!KNNR6S
M:AXDL?"FEW/RQXU_X+^?M3?%#P!?_"_]D7_@BY_P4V3]M3Q*G_"+>%M&_:#_
M &>U^'W[._@'Q5?SMI#^)O'OQ3N_%=K+%X;\*ZA/:75XOBK1?ASH5\0;/6O&
M/A.V8ZB?ZA:* /RW_:9_;0^-'_!.W_@ECXA_;*_:U\'?#WXJ_'SX+?"KX:ZQ
M\8? ?PHU;7/AS\.?$'Q.\9>*_!G@74O#O@_Q%J>F?%'6-+T2R\2^+X[6SU^\
MT/44U..S_M";2?#]G?-;Z7]O_LW_ !6U;XZ_L^_!#XU:_P"#?^%=ZY\6OA1X
M ^(^K^ 1K5SXD'@O4O&GA?2_$-[X6'B"]\/>$;S6QH-QJ$FF#5KKPMX<N-0%
MM]JET/2WE:RA^5O^"F_["#_\%&?V>_"O[-NI?$%? 7P_N/CU\&OB'\7[9M%_
MMM_B'\*_AUXF_P"$C\4?#*W1KFWATR\\6/!IZ66N74>H6FDW=E#=W.DZI"CV
M,_Z%VUO':6UO:P@B&V@BMX@<$B.&-8T!( !(50#@ >PH _/+_@K#^Q%+_P %
M$_\ @G[^T?\ LF:9K,7A[Q=\1/"%KJ/PZUJZN7M--M/B3X&UO3/&_@:UURX2
MWO3;^&]=\0^'[+PYXEO%T[4KC3= UC4M3TZPN-4L[$#\7OV8_P#@M!^V=^SG
M\$_A;^R;^U7_ ,$<_P#@IGX\_;/^&OP_\&_#2'6_A+\)]"\;_!3XU>(]!T>#
M0[+QYJ'QGL-0TGPUX1T?Q/'8Q:WXLU?P_H'C/PYX-O9=>M[BZ-KH5RZ_U:T4
M ?RA_P#!OG\ /VWOA=^WI_P63^*G[;?P7\8?#+QM^T%XK_9K^(4>OW'@?7=$
M^%7B+Q+K,WQZ\5>,_"GPH\=W&EVOA/XE:=\,;GQ=IGA75M>\'ZIK5H\B6-]<
MW1_M6VEGYGX+^(/VHO\ @WN^+W[2_P '=:_8J_:C_;?_ ."?/QZ^./BC]HKX
M&?&#]CKX?6_Q5^*/P7N?'RO;Z_\ "SXN^!'N-#>[O=.O=,\-65EXMU+Q1H6B
MZK#--K6E3S7NJOX*\-_UQ44 ?@Q^Q3_P4&_X*&_M^?M@6?B3P/\ L1?$#]D+
M_@FMX+\(Z]I?C?Q/^VU\.-0\#?M(?%GXEI%*^B0_"3P=IGC6T7PMIEG=:EI8
MUK7[ZR^*'@B>P\.^)-%AUK3_ !?J$%OX?\_UWX)?&>;_ (.;?"'Q[B^$7Q/E
M^!=M_P $S=4\!7/QHC\ ^*W^$UOXYD^*RZC'X+G^(RZ2?!\7BQ]/_P!.3P[)
MK*ZPUG_I2V9@^>OZ)Z* /YVO^"\OP2^,_P 8/BK_ ,$;]1^$GPC^)_Q2T_X8
M?\%/_@'X_P#B7??#KP#XK\;V?P\\!Z-XV\&W>K^-O'-UX9TG4X/"7A'2K6UN
M;G4O$FOOI^C6-O;SS75[%'#(RI^W9\$OC/XO_P""_/\ P1F^,GA/X1?$_P 4
M?"'X7>!OVJ+3XF?%7P[X!\5ZW\-_AU=^(?@]\4-,T"U\=>.=-TFY\,>$;C7-
M2U"PT_1X?$&J:?)J=]?6EI9+/<7,,;_T344 ?BQ_P<0?"OXG_&S_ ((X?MG_
M  P^#/PX\>?%OXE^*='^#47ACX>?#'P?XA\>^.?$<FE_M&?"#7-3CT'PEX5T
M[5M?U=].T73-2UB_33]/N&M-+T^^U"X$=I:3S1^2?\% _P#@G+\9OVV_^"6G
M[*7@SX.ZA'\._P!KG]D__AGC]H_X(:/X\LCI6EZA\6_@_P"#8XO^%:^.+#78
M%@T;^UGO)X8GUJSMX=/\5:5H]GKMUI>@7&OW"?T!44 ?S#1_\'!_[06B>"+_
M .'OB/\ X(B_\%3V_;+TG3#H$7PX\/? 2YU_X#:K\0K6SACDDB^-ME>)KG_"
MOY[M;K4X/%FD_"_6K.;P[';ZI;R2V-RU_;_3'Q@_8X_;B_X*8_\ !%KXF?LW
M_M]Q?"3X7?MH?&3P?J'BG3_#WPG6ZL? WPZ\;>%O&4/CSX/>"O%FN+XH^(.F
MZO<7 T'0?#7Q.\0>'9-2T72XM:UUO"]KKUQHFG:_JO[PT4 ?RD_LP_\ !9_]
ML[]G#X)?"W]DS]JS_@CI_P %,_'O[9OPT\ >#_AI!KOPD^$^A>./@K\:O$6@
MZ1!H=CX[O_C-8ZAI'AOPCI'B:.QBUGQ7JV@:!XR\.^#;N77+>XNC:Z'<LL'_
M  ;Z_ ']M[X7_M\?\%D/BM^VU\%O&/PQ\:_M!>)_V;?B#'K]QX'UW1?A5XA\
M2:S/\=_%7C+PG\*?'<^EVOA+XE:?\,KCQ;IGA;5M=\(:IK5H\J65]<W1_M2W
MEG_J]HH *_BK_9P^*_CO_@A)^VA_P42T[]IS_@F]^V%^T]!^U/\ M)^*OCO\
M%OVXOV3?@O9?'_Q7\0/AK\1];C?3?A5\1?%&MZMX(/A_4O#VMK'K.I^&7\7:
MAJTGCOQ=K<CZ#/HUSX6\5>)?[5** /Y /@#K?[<W[7?_  <&?LV_MN_%W]@7
MX^?LN?L[']A;QUX$^&-[\0_ /B[^V?#OA=/'/CFZTJS_ &AM=M],F\%?#+XQ
M^*?$.H>(->L/A7<:O;ZWHW@34O!?VZ&]U"ZN-1O/OKX[?\%-/V^_V%?VM/C[
MHG[3_P#P3V_:"_:<_8JU9/#^K_LM_&;_ ()Z?!^;XM^*= T^<>1?>%_CGX2U
MSQ]8SV.O-<2O;:CXFEU?POID>JZ;;)X?\+:CI'B:QOK#^@6B@#^1O]@SX-?&
MG]M'_@MC?_\ !53P1^PO\3_^"=/[*7@C]G.X^$$NG?'?X?:7\%OC7^U=XS\1
MRW5X_C3Q+\*]-L-12WM=.@FTNTNO$+>(+RTO]+\%?#^;2_$>MS7FNZ5H/]<E
M%% '\IGQ6\!?M;?\$:/^"FW[4G[=/P@_9K^./[</["?[?]MH?BGXX?#7]G#P
MY)XZ^/OP#^-7A2[AN+OQC;^#9)%/B7P7J5IKOC_4[5]+;0[*6'4]+T+Q9KF@
M1>!M*U?Q7[[\)/\ @HE_P4?_ ."BW[77P'T+]E']CC]H[]AW]A3P'>R>,OVH
MOC9^W%\%=&^&OQ/^*\6GW#Q6WP>^#OA'5YOB#I'V'4[B.*#6?%6A7MYJHM9-
M:']O^ -2T/2X?%7]&U% '\NG[6OPC_:I_P""7/\ P5'^*_\ P5C_ &?/@#\7
M/VT?V7_VM/A;X;^'O[6/[/WP+M8==^-/PO\ '7@+3_#VF>#?BOX0\&'3+W6/
M'?AA=-T*_-S9Z=J5I;Z%<^+?&=WXAETC1M-\*O/X%^V%\9OVO/\ @X(MOA=^
MPQ\!/V#/VO/V/?V-->\9>%/B'^U]^TG^W1\']0^"%_>^%/!7B5KZW^'?P<T/
M3/%NN:=XUOK^YTXO/)INMZCJP\0G1DU/3_!.A:-?>(M7_L(HH _G&_X*S?L]
M_%KQ;_P40_X(#Z]\)?@Y\2/&_P -_@-\<_CY-\3/%7P_^'?B?Q'X-^$_AN\\
M(?!C3?#NH^/]:\.:1?:)X#T?5&T;4+?2+KQ%=Z797DFFWL-E+*UG.L?7_P#!
MSE\%_C%\?/\ @DY\3_AS\"OA/\2_C3\0M0^)GPGO[#P'\)O GBCXC>,[VQTW
MQ!+-J-[:>%_!^E:SKES:6$)$U[<PV+PVL1$D[QH<U_0510!\0?MU>$_%7B[_
M ()M_MC^!?"?AGQ!XG\;>)_V(/VA?"?AKP=X=T;4=:\5>(?%6M? ;Q?H^C>&
M=#\/:;;7.KZMX@U;5[FVTO3-&L+.XU&_U&X@L;6VEN98XF_DH_X* ?#GXA?"
M3_@T,^ _PZ^*W@/QG\,OB#X5A^!>F^*/ GQ"\+ZWX+\9>&]13QOJCO8:]X8\
M26.FZWH]ZB.CM:ZA8V\ZJZL8P&!/]VU?CY_P71_81^-/_!1W_@GI\0/V7_@!
MJ/@/3?B5XA\:_#SQ+IDWQ'US5O#OAJ2Q\+Z[]MU*"35-&\/>)KJ&\:VD,ELC
MZ:()?*D1[B)S&L@!\$>&/^"R?[5G[%?PC\-?LZ_M4?\ !*S_ (*.?'_]IKX:
M>'K3P!X=^+G[,GP>N/B]^SA^T])X:LK+1_#7Q.T7XM'5D\5>')OB/"MGKVM>
M%YOA_P"*_$_A"XU:*QU&TO;]FM(^M_X)3_L'?M5_!_\ 9H_X*+_M7_MH^&3I
MW[<G_!1G4OBI\3?&_P ,?#MR/$=QX"\+1>%?%UO\+?A191Z=JWBV2:^T^]\2
M^(KG1O#NF>(=5A\/Z1K^A^#H;6'4M%O3<?T<:%93:;HFC:=<%#<6&E:=93F-
MBT9FM;2&"4QL54LA>-MC%5)7!*@\5JT ?SB?\$6?V,/&OBS_ (-_O#W[%7[2
M_@/XH_ ;Q)\4_"O[8OPU\8^&O'O@KQ#X"^)7@K3OBE\:OC-'HOB1_!_C&PT7
M5K:Y32=?TSQ9X?BU6QBT_6;-]/N&6ZTF^!F^6?V1O^"@7[5O_!&SX/\ A+_@
MGI^V_P#\$W?VY/C]!^SU9WW@GX*_M.?L+_!BR^.?PL^,?PCTO4'7P%?7"SZS
M\/[7PKXBTCP]-::1K.BW^JWGBB-;*PU/Q%I.FZAK$L$7]<-% 'Y"?\$R/VEO
M^"D7[7/BKX[_ !M_:O\ V7=/_8T_99UB^T'3OV2_@K\2-$U>R_:LO;#3_M]K
MXK\9?&*WN=<M(?!]CJ<]O92Z/X6U?P/I>NM<W5^+623PWI>C>)?&OY6:!XC_
M &C?^"5?_!:3]N;XH^-_V(_VG/VC/V=?^"FWC']FN'X:?'3]F?P3/\2]"^&.
MJ>%I==T36;/XJ:+I*3WGAN#3KKX@ZK/=R:G>:9J5UIWA*;4O#NC^(;'4WGTK
M^LZB@#^='_@I[^S7^U+\"?V[?V>_^"S'[&WPEUW]IO6/A-\(=5_9Y_:?_90\
M,F./XF^/O@=K&K:GXCMO%_P=M[C3M5N]5\=>'=8U&UFU'PCI$ UC64\/Z!8:
M/83PZMXKO[/R;QU_P6__ &Z?VJ-*\,_!C_@F;_P28_;>\'?M(>,-<T:QUSXH
M_M\_ I_@Y^S'\&-!6X@N]>\1>(_%5AXUOO\ A)4%C::M9V>EWM_X*UJ[2-KG
MPUI7BSQ$MGX/O?ZAZ* ,;P['K\.@:)%XKO-*U#Q/'I6GIXAOM"TZZT?1;S6E
MM8AJ=SI.E7VJZY>:=ITUX)I+.RNM9U2XMK=HXIK^ZD1IGV:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBOYY_P#@MA_P5+_:I_X)Y_M%_P#!,_X5?LS?
M"30?CG/^V)XM_:%\'ZW\*I-.5?&_C[QIX'MO@AIWP;\&^#_&%]XATG0/A_IG
MB7QM\4&TSQ[XOUO2_$$>@^%);K7[2S2XT;RKL _H8HK\B?V,->_X*D?!_P -
M_'WX\?\ !8#XN?L5Z+\)?#_PQ'Q1TC1/V;M/\<:;IWP,L?#H\8^+OBM'\0-9
M\8^'3/JWAWP9X(LO#PT[5=/\7^*I1-9>*(;R[UV.TTOQ-K/YI_!#]KO_ (+[
M_P#!4[X>ZI^U/^Q'X:_8P_8:_96UO7?$]M^S=H_[5_A[XB^,?C7\<_!MG<R6
M6E_$7QG/X5M/&'ASP?X<OKO3A;Z.FA^'K>4S7?B&YLI?'WAFU\)>*M; /ZHJ
M*_&C_@E7_P %)_BI^U9XL_:,_8Z_;'^$6G? G_@H)^Q)J/A#1?C_ .$_"NH?
MVM\+_B%X>\:Z4-3\%?&'X57LMS<ZA9^'/%^F_9=9E\.:E-?2:3IGB#PIJ5KK
M6H1>(9-.T+\]_@C^W'_P6;_X*X67Q>_:$_X)L:Q^Q=^RG^QUX'^)OC_X3_!*
M[_:7\+^-_B)\8OCKJ_@O1-.^U>,?%-_X)F\6^!/#'@J^\4O::?IDWA&UO;O0
M+?5/$T,S?$B7PSI5YJX!_4_17Y@?\$W?VF?VT?B?\)_C7IG_  4E_9[T3]FC
MXV?LY?$G7O!.O>/_  T-8TW]GGXW_#[0]&M[ZU^.WPM\0^,+DW%OX6OY[/Q#
M)K%M=WL]KHVF6VBZQ=W>F3ZW>>&?#7Y._!;]O3_@M!_P5QN/B-\<?^"9VE_L
M??LH?L(^%_'OB#P%\&?BM^U5X<^(WC3XQ?M'7'A;4KO1];\8:;X:\/VU]HOA
M?P6DMO&\NGW_ (=TC4]"UR1_#<'B7QQ=Z?XF'A< _JAKXM_9W_;S^!?[3O[1
MG[8_[+WPRC\;?\+)_8:\2_#3PG\:[CQ#X?M=)\,S:O\ %33?%^I^'$\%ZI'J
M][=Z];VT7@C7(=7GO-,T=;:X6T%J+Z&X\]/SD_X)H_\ !3?]ICQO^UG\:/\
M@EO_ ,%+OA[\*/AQ^W=\#O NG?$_PMX[^"&L:E<?!;]IOX0RS:=8OXX\%6'B
M*0ZOHGB6"'5M$UR]T*9K*]UFQO?$E^O@7X>CP3K_ (<L/GC_ ((R_P#*9?\
MX.2_^R[?L8?^HM^TG0!_3I17XP?\$1_V]?CG_P % O@K^UMXY^/4'@>'7_@5
M^W[\>OV8?!TG@7P_>^';6\^'?PQ\)_"?6/#]]X@MKS6M:6]\57%[XSUAM5U*
MP.EZ=<1BSCM='LA QEP==_X**?'G3/\ @OAX-_X)GP:5\.'_ &>/$7[$%U\?
M[W4YO#^MM\3(O'T'B/Q79H;7Q(GBB/14T0V>A6ELVFS>%IW*27,@NA</%-"
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M](TN9-.FMEDTZQ<-;1 '>T5^._\ P5H_X*-_%O\ 8MF_9/\ V??V5_A5X/\
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M8]6UF*\\+W5SXPTK3FBN_!?AW6/"FOW4>I+XDL;&OTNK\7_VG/V]OCG\'_\
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M_'CQ+^PSXIT?X@>(OC=\,O@5X?\ #]WXDU[0?'?Q&MK/PUIFO?$OPUX3T_\
MMGXA1^&==TW3M.\02:_#X96[TK1K/2KSVW_@HS_P62^*'PL_X(C_  D_X*G?
MLF^&?"_A[Q;\61\"-:T_P3\6=)NO&FBZ!:?$R:?3O%GA?5!I.H>$;G5[CP[J
M:7=CI^O6%SI$>HR:;;ZD+)+.\DT\@']'5%?S&6OQ=_X.2/VI_#.J?M@?LM>%
M/V'?V=?@1XKT^S\??LY?L=?M1:9XXU7]HOQQ\.K)6O="M_C+XA\-6-KX3\ ^
M,/C!HUM:Z[I_ANS^(.BIX3C\56/A3Q)XC\&WNB:AXQE_2G_@DG_P4@_X>2?L
MY^)/&7C3X9:C\"OVD?@+\4?$G[.W[5OP-UA_*N_AY\<O 5KIA\4)I&GWMY/X
MCM/"&JS7[#2(O$MO!JND:UIWBCP9=7>N7OA"]U[4@#]2J*_BV_X)X?\ !3'_
M (."?^"O/[/=GXT_92\)_L3? VR\ ^)O&ND?%;]H[X\>&_&UAX,\?^/K51/X
M5^#OP4^'_AFZ^)VN0Z+X:\,ZEX6\0?$KX@^*=-G^VZ_XFFTKPS=:<O@JZT+Q
MK^O/_!27_@II^T1^S-\6/V0_^"?_ .Q?\*?AQ^T=_P %'OVKM(N/$%OI7Q(U
M?4]'^#/PA^&GA6SN;?Q3\;OBM%X;O/#'B>X\*:GJVA^,)/#^G:!<:++>Z?X%
M\<&WD/B#3_"_@_Q< ?NA17\HO[1_[9G_  7F_P""2OA2S_:U_;GA_8E_;1_8
MGT#Q-X'\-?'>U_9LTGQE\,_C?\*-'\:>+++PI:>._#UKXRL/#7AC7;5=9U?0
M?#]GIMS>ZU+K'B'7]*TR]MO!VC'4/&UA]N?\%-_^"I'C+]BNS_X)J?M??#CQ
M%\-_%O\ P3L_:3^-/@GX>_M*_$;4_#VJ^(I/#GPN^-GA:R\7?"'XV?#_ %70
M-4TW6M,T*V\,V_C+Q/XEN+WP_P"+[75;+3O">EZ7I>F:SJ(L_$P!^[U%?GY_
MP50_;.A_X)^_\$^_VH?VLH)M'7Q3\,?AK?)\,;77[*]U31]3^+_C*\LO!'PE
MT_5-(TV6WU'5='E^(/B/P]-K]G9W5@X\/P:K<W&IZ196]UJME\9^/?\ @IQ\
M9OV'?^".WPA_;7_;D\!Z/XO_ &P_B;X7\#Z9X9_9Y^&/A_4? D_Q ^/OQQU+
M4M7^%'P0T'P]?ZYX[UC3M9\,^#;B"?XAO!?:WKDUGX$\=:UH/AN;6&TWP8P!
M^Y]%?S#:MXJ_X.G+#X=Z=^U,?#W_  3EO_LVE:9\1?$7_!/W0-%^)L'Q0/AB
MUL5O-3^%&B_$F\F\1:/??%NZTV%$NGC\?/X=3Q==ZC%H&H:AI]GI/AW4_I[Q
M1_P6"L_C7_P0]^+7_!5/]DW1X/#?B[PI\(/%'BBP\"?$RQ3Q%;^"OBCX"\1V
M_A[Q;X*\41:7>:2OB+1[;4H+P:;J^GW6B7&O^&;_ $C74M_#][?-IVG@'[MT
M5_)]\)/VI_\ @XW_ &[/V3_AI^VC^RYX6_8<^ ?@2^^!W@GQ+X=^$7QKT3QY
MX@^*O[3GC+1?"&GZA\2O'?A^ST"#7-"^&GP\^)?C"#7-.^ 7A75/%5EXBO\
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M]-2>XB.JZ?'Y9EO+=)/Y^O@+_P %!/\ @J%^R1_P4F_9_P#^">W_  58T?\
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MV]L[626YB /I2BOY;?A3\6_^#F7]M?X,>#_VNO@U#_P3@_9+\"_$W0K#QO\
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M+H"Z_P"-0#^A6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4#V'B'1C/K6L6/A?1[:;PC%K^I:Q9@']8%%?SW?\%H?^"IO[2O\ P3]^.O\
MP3+\ ?LY_"_2_C':?MC>//C/X/\ $WPXCT&&_P#B%XRUSPO9_!VV^%GA?P-K
MFI>+?#/AOP<NO>*OB.UAXP\0Z^NI6NE>'GGU6'[++I9>?Y-_;!_:@_X.//\
M@GI\*==_;H^+MA_P3Y_:&_9[\#:C9^(/C)^S1\)=%^*NE?$#X=>!O$^JV=DG
M]@>-]0T>RNM=L/ MYJ=KI.L^+/-\0W>FV2KXLU3PCKOAZV\0ZCH0!_4_XR\8
M^%?AWX0\5_$#QUXATCPEX(\#>&]=\8^,O%>OWT&F:%X9\*^&=+NM:\0^(=;U
M*Z>.VT_2-%TBQO-2U*^N)$@M+.VFGE=8XV897PT^)WPZ^,W@/PO\4?A+XX\+
M?$CX<>-M)M]<\(^./!6MZ?XC\+^(](N@3!?Z1K.ESW-C>V[%7C9H9F,4T<D,
MH2:-T7\6_P#@K#\1?VE?VD/^"1GQ$^//[#?C7X'Z)\'/BC^Q%\:_BS\8A\;=
M"\4:QK?BK]G'QQ^SCK'BF;3OA:/!LTMGI7Q)O/#%]J2:1JFN:K+X;L[ZXM3=
MV^I0GSK7YM_X-I/#_P#P45LOV(OV7-7^-?Q _97UG]B:\_9VOU^"G@WP%X7^
M(=I^T5HVM3>,["7PG-\0?$VK&V\":AI5KX:C\66VK6NBV O/[2NM \J^O8[2
M_N[H _IOK\T?^"</_!2[PC_P4=L?V@]0\*? 3X\_ F/X!_&'4?A3<V7QW\*0
M^$=:\4K:VD=W;:U;:*;F2_T2^ ,L.M^&M2B:[T&X%O!+?7DLTJ6WZ75^"W_!
M+S_@H[^T1^V'^RE_P4>^+?Q9C\ 6WC+]E+]J3]J#X)?#"Y\(>&;O1[&Y\*?!
M_P"%O@SQ;X3O_%5A?:WK$.J^()-7\07SZO=V1TK3KRW6W@@TJT$;M( ?O317
M\?O[!_[?7_!P!_P5F_95\&_&']F#1OV(?V;+/PI>?$/PWXY^,?QV\.^/KG1?
MCY\0M/\ &_B.#0](^#O@+PU#\1+WPE\/? W@^+PWH7CKQCXFFN=0UCXAMKD/
MA>QO+'2-1L;/I_V3/^"H'_!:#_@I!X<^)?[,'P$^"G[,_P"S3^UW^QO\5?%'
MPS_;6_:1^,9\6ZW^SR^O>'-7UKP[H'@/X'_#S1;7Q1XGU7XCZ_J6C:O>^/(]
M:U.;PQX%T/P]::E#J4ES\1?#6C:2 ?UMT5_/9_P3)_X*(_MR:U^W=^T;_P $
MK?\ @I3X0^$-W^T?\&?AM%\??AK\<O@)9:SHWP^^+?P7O];\,:1)=:AX?U>:
M?^SM7TZ^\;^'H].N[2+0I+BV?4=#U?PW;ZQX7O?$'B3XXU__ (*T?\%6?C-_
MP4;_ ."@G_!,C]C/X0?!/Q1\1OA?XV\%0?!/XZ_$O2-;\/\ P?\ V>_A?:6.
MMZI\3O%W[0>K:3?>(]6\;>(==U"_\">#/A'X9\)>#([RXN;OQ)XAUFWU6R\-
M7D%V ?UM45_+_;_\%"/^"L?_  37_::_9W^&G_!6[P]^S'\:_P!D[]K+XC:#
M\&/ O[6_[*^C>*O![?![XW>-+BST[PGX0^+>G>-[GP]H5EX8NWL]3U1YFT.U
MN&\/RZWXMT_QIK0\'Z[X'TOTO_@K3_P5,_;,_8O_ &]_V%_V7_V4OA#X)^/(
M_:P\!?%BVM_AMK5A+!K^K_$^PTCQ#IOPQOK7QG_PE/AW3_#'@/1O%EQH'B7X
MJ7E_'=LGP\T#Q')I=YI%\RWR@']&M%?D'^S'\1O^"B'[+/P%_:9_:0_X+)?%
MK]E*]\(_#_P/_P +2T/3?V6](\5VUG\._#7A33?%NM>-_#VJ/XR\/>'[WQ7X
MAU"V7POIGA2UL=7UF75M<$F@V+W%U-:ZGKOYM? S]I3_ (.(?^"EWPRC_:S_
M &5K;]@3]B3]F[Q^VI:C^SI\/OV@-&^*'Q$^,'C_ ,"_.-"\<>/M>T'1?$>A
M:5IGB"5%?1+W2/#GAZ[N=,DEO_\ A#[K3ET;7/$8!_5#17XI?\$G_P#@IY\2
M/VV=0_:5_97_ &L/AIX;_9W_ &_/V./$UKX+^/'@;X?ZU%K7@;7;+6TO[?0?
MBE\*)-;O/$LCZ%=7VFW\5QHUWJOC6#1"/#]]J&M7UCXJTRV,O_!''_@H?\7_
M -LFR_; ^!7[5UMX!T']L/\ 8A_:5\8_!?XM>&OAWX;USPWH%[X._M+4[?X<
M>/[&UU/7O%EC)8>*+GP_XQT6UFTWQ)=+>/X0N=56TAT[4=,O=1 /VHHK\-[#
M_@H'^TE\6O\ @N9X@_8!^!EG\/KK]E3]F7]G?0_B!^UWXJU3P7K>K>,;/XK^
M.;#5-1\#>"/#'C>/Q5HV@:&VI:;XG\"ZLUL/#?BV9AX0\>:5+):7K3GP]\U^
M)O\ @H;_ ,%/_P#@H1^U-^T3\!?^"0WA;]F/X;_LZ_LE^.-3^$?Q<_;5_:CL
MO&_B[1O'OQL\._9&\0_#[X*>'_!0N=+OH=$DNB-1OKW2O$MC?^')-*\7)XE\
M,IXA\+Z-X@ /Z7**_GT_8V_X*)_ML_"3]N#PW_P3 _X*N^"?A4WQV^+G@KQ/
M\3?V5_VFOV=TU2'X0?'OPYX:NO%.H^)?"&L^'M:ALK[P=X^\+Z!X>OM0CT^*
MU22;1M+FN-;T_3Q=^'-<\9_.GQK_ ."H_P#P4\\5?\%@_P!KS_@EG^QG\*_@
M;XHN? _P^^#FO_#CXG_$W3=;T;P5\"?#GC/X-^!O&WQ(^+?QDUO3-9U75_'E
M[I/BSQGHOA[X7_#OPKX4L?[;O==DG\17<ND^';U[H _J6HK^1U_^"G__  6L
M_8E_;!\+?\$^/VOO@A^R]^V'\<_VM_!-]K?[$7Q*_9UNO%WPZ\ Z?XQLM1U+
M3M9A^/*>)=,TG4$^'/@+PUH6L?$OQ_'X1\-/XOT32]+ET[1]8\6V_BBRO_!7
M0_%S]NS_ (+9_P#!+/XT_LO>*?\ @HK??L;_ +3'['7[1GQL\%_L\>)?$?[.
MOA?QIX(\??"SQW\0I]47P_?6HUZSTR'48[*QTV]UZ2TN=,UN#Q%IFBZOH]M/
MX<U0VFJ2@']8-%?CI_P59_X*8?$3]C-?V>?V?_V2_@UIG[27[>?[9GBG6/"G
M[.7P@UN_NK/PEI6G>&M,BU;Q=\4/B<=*OM,U2#P3X6LYXKFXM3K?A*'4=.LO
M%.K_ /"6:7I_@W7)$_//XU_M.?\ !P/_ ,$VO!I_;%_;(L?V(/VO?V5?!1T^
MY_:-^%'[*VB>/_!OQ5^%GA#7?$/AO3+OQO\ #K4/'&D:4WC>/P:VI7<<EEJL
MTD,NE)+J7B)M'TN._P#%GAP _J7HK^?G_@L1_P %<?&7['O_  3T_9+_ &Z/
MV2H= \;^%?VC/V@/V>M"B?6_"%WXKU/7/@;\8?AI\0_B+<W7@O0(O$?AJ-?'
MVH:=X;T4>&3J=_<::MY</:WME.EQYD/S_P#'7XM_\'+_ (1^$GBO]MSP;X<_
M8*TCX=^%O"LGQ@O/V#]8T/X@^*/CCIWPST'2&U;6O"5]XZT5(M#\1_%>/P]:
M2ZWK6B>%_&D-C)KC:GHG@F^UZXMM#T'7 #^H:O(O@E\?_@A^TIX'A^)?[/WQ
M8^'_ ,9?A_/JFJ:)'XP^&_BG2/%N@?VSHEV]CJ^E2:CHUU=00ZCIUU&T5W9S
M-'<191VC\N6-W_.;X.?M;_M-_P#!1[_@F5\"OVKOV [_ .!OPC^.OQ?TK1-5
MU+3OV@;/Q9XT^%G@_6?#VI:QX5^,'@R5?!<-MXFUN70O&>C:KHN@:B!H-Q.N
MGQWVJV]BYN-'?\%?^#3WP_\ \%'&_9L\&:YH_P 0?V4H?V"HOCY\=E\<^!]3
M\+?$:X_:6O==&G:C;2S^%?$MJ;7P%IVDGXC-HVH+;:M'J=X?#$.J1"[CO;JT
MM;, _M@HHK^>+]K/_@I-^W+\:/V\_%O_  3,_P""2G@/X!ZA\3/@GX/T/Q=^
MUE^U-^TG<>*-4^$?P/'BNQ&H:!X*\.>'_ \POM?\?36LUBBM+#XHM_[<DUCP
MUJ7A728O#'B/Q/I !_0[7YG_ /!3G_@IQ\,_^"9_PR^&WB/Q'\.O'GQP^+OQ
MX^)6D?!_]GWX!_#.*!?&'Q4^(.L7-E;1:9;:C>13VFDV%O/J>E6,EREGJ^IW
M.KZWH>FZ;HE\]]/-9?EC:?\ !1?_ (*A?\$U?VI/V=?@S_P5YM?V5/B[^S;^
MV!XZLOAA\+OVK_V9+?Q1X*N/A3\5M3:RTW3?"7Q3\)>+H--MY?#5]J=UIDAU
M>#2-/M-'TS6+[Q-=>-M5MM&U7PMX>^%?^#@G0/\ @I3>?\%!/^"7,GA[XC?L
MAVG@37/VUK/_ (8F#^$?B8/%/@WQC;+\+VOYOVA)IKK5]'\5>&-3NC#YR^!H
M[#4C9K<#3WTF>Y@EL0#^J#]A_P#:/^-7[3_PBU#X@?'G]D/XE?L6>-[#QAJ?
MAQ/A-\4?$>D>*==O=(L[#2KZQ\66>L:)INE6$VEZHVHS6D<2VQEMKO3KR":0
MR(RK]D5\Z?LJ:7^U5H_P4\-6/[:'BOX*>,OV@8[WQ"_BS6_V?/#GB[PO\+Y=
M/DU_47\+P:+IWCC4M1\0M=V_AHZ7'K%Q=?9(I-5%XMK;M;I'<W')_MX?M?>"
M_P!@C]D3XY_M=_$#0-6\5>%_@GX2@U^?POH=]I.EZGXCU;6-=TCPGX7T*WU/
M6[BWT_34U?Q1X@T:PNK]Q>W-G9W$]SIVD:YJ,5KHU^ ?6]? /_!2O]OSPY_P
M39_9DU#]I3Q-\&/C#\=K*W\9^%_!%OX)^#'A\:WK<-[XF&HS)KGB2^E)M/"W
MA*QM])N;:?Q!?13V[^(+_P .>'DC%UK]M+%^-FA?$W_@YR^)/P#\/?MK>!9O
M^"<$.E^*/!6A?&7P_P#L/?\ "#_&)_'&I> +WPU=>(H? /\ PGES=7\TGQ<U
M?34T6!-*7Q38Z!/XIUG4X8/$&B:?I5AI.I>^_P#!2C_@J/\ M7_LN_\ !&CP
ME^W[X6^"EM\!OVF+^X^$=IXW^!OQW\*ZOK-KX$\1^*[V;1O''A?4-+74O"NM
MW]CI^IQ7$OAG6FN=&N]2TV/3=3NK"W2\GTX '[R?#WQE:?$7P'X,\?6&EZSH
MECXU\+Z%XJM-&\16L5CK^E6VO:9;:G#I^M64-Q=PVFJ6<=RMO?6\5S<1PW,<
MD:32*H<]A7YO?\%*O^"C/@'_ ()J_L5:[^U7\0- OO&_B*ZD\+^"?A/\,-$^
MT6^H_%/XS^.+*YG\*>"+*]BM;]=)LY(-.UOQ#K6HS13S6OAKP]K TFTUGQ V
MD:'JGY=^#?'G_!S9X>\$Z9^UI\0/"?[!7CGP8;"?XG>,/V /#6E_$?3?C]9_
M#VX$^N7/PP^'_P 2-(TK7/#FK?&G1] \G3M!M=1UK7=$U/7EDL9+OQ%=_9(-
M2 /Z9:*_F7_X)O\ _!97]H7]MK_@E[_P5$_;KU[PS\/_  YXM_9<\5?M9?\
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MT/@-#\5?"7Q+\'?!36_@Q>>'[GQ9X>U_PE\0W\5:OJ^O>+OBY\5-4USP9?\
MQ5\??&OQ9JNM7$^N^-M:^)LEO/;VNE:7;:)::1I&G6%L ?#7Q=_Y6VOV6_\
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M]-TJ\T9--M/M-WJ'VXV5KI^ISSQZ==>Y?L%?L4_"S_@G;^R=\*?V.O@IK_Q
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M[7O_  4 _P""CMW\%M?OO%'PP^&O[<7[1$OQC^"OAGQ'=_V/)%X@_P"$!O\
MPW#=:CJ<%UHUK+=V-]XDE\(>(+>&SLO%'A/6K>P@% 'A?[<MS'>_\',__!"B
M\A6X2*[^ 7[<%S$EU:W5C=)'/^SS\:Y46YLKV&WO;.X57 FM;NW@NK>0-#<0
MQ2HZ+R?P:\6>$OV>?^#K+]MS2_C>UOX5U7]M;]C?X%/^RCXU\;06VDV?B0^
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M[U&ZU_3=*O-&CTVT^TW>H?;C96NGZG<3QZ==?T7_ /!!KXO_  O^-'_!(/\
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M=?B\:Z=H.G03^&M"T^Q\)Q>'M!\-@'Q=_P $3/A1#\#?^"]/_!9#X2K^T?\
M%']K74/ OP9_9;T;Q+\?/C1X[T_XC_$OQGXV'@?P'=>/--\2>)-+BAM+<> ?
M&ESKWPYT;P>%>Y^'6@>$M*^'M]/<WWA>YN)?I_\ X-:?^3:/^"C_ /VF'_:]
M_P#5?_L^5^B?[!__  1I_8__ ."<?QW^,_Q[_9HN/BMI6L_'+X>?#/X=>*_!
M7BOQ7H'B/P/I]M\-=%TC33XKT<_\(?8>.+GQQX^U;2[KQK\1_$'BKQOXG_X2
M'QGXA\0ZO:6FDPWT-C:>Z_L#_P#!/CX,_P#!.KP-\;/ 'P3\3?$[Q1HWQX_:
M3^(_[4GB^Y^*>M>%=;U/3?B!\3]'\':)K^C^&YO"7@OP1:V?@ZSM/!&E2:/I
M^IV6L:W;W%QJ#WOB'4(Y;:*T /QU^+__ "ML_LL_]H>O$/\ ZOG]HJG?MW_\
MK-W_  0Q_P"R&?MS?^L^?&VOV'\2?\$^/@QXH_X*(^ ?^"F.H>)OB?#\=_AS
M^S;>?LN:)X3L]:\*1_"2Z^']]XN\:>,Y=8U709O!=QXQG\8KJGCK5X(]0M/'
MMCHHL+?3HF\/O<0W-U>><_\ !1[_ ()3_LW?\%,=%^&5Q\6-<^+'PH^+WP-U
MC4]?^!W[1'P!\;-\/_C'\+M1UEM+EUB#1-;FT[6=*O-(UF?0]&DU"TU'1Y]0
MM#8"X\,ZOX;U*XGU%P#],J_F,_X.F/\ DV+_ ()S?]IA?V0?_4!_:"K^@[]G
M?X/R?L__  ,^%/P2E^)/Q'^,#?"WP/H'@D?$[XO:W:^)/B9XTCT&RCL8M;\9
MZ_::?ID6KZU<11(L]\]FMU.D<;WMQ>WAGO;CYY_;Y_X)\?!G_@HMX$^"OP]^
M-GB;XG>%]%^!/[27PX_:C\(W7PLUKPKHFJ:C\0/A?I'C'1= T?Q'-XM\%^-[
M2[\'7EKXVU636-/TRRTC6KBXM]/>R\0:?'%<Q78!^.O_  6:_P"4R7_!MM_V
M7?\ ;+_]17]FZG_\'='_ "AH^(G_ &73X#_^I3<U^PW[37_!/CX,?M6?M+_L
M1_M4?$/Q-\3]&^(7[!7BWXF>,O@_H_@S6O"FG>#?$FI_%73_  3IOB&#XDZ?
MKG@OQ%K>L6%G!X"T=]&B\+^(?!UQ;RW.I-?76HI-:QV:_P#!1?\ X)\_!G_@
MIQ^S-K/[*GQZ\3?$[PE\/-<\6>$O&-WK/PBUKPKH/C./4_!M^^HZ7!;ZCXR\
M%^/M#2PGGD*7\4OAV:XEB 6WNK5\N0#+_P""KG_*++_@I/\ ]F ?MB_^LZ_$
M6OY%?V^O^5-O]CG_ +!G[,G_ *G.O5_<3^T'\%/"O[27P"^-_P"SGXYU#Q!I
M7@GX^?!_XE?!3QAJGA.ZTZQ\5:;X5^*?@O6O OB#4/#5]K&E:[I%GX@L](UV
M[N-&NM4T/6=.M]1CMIKW2M0MDELYOY8/^#B_]F+P%^QA_P &Z?A_]EGX7:OX
MOU[X??!#X@_L]>!O"FL>/K_1M4\9:AI-AXOU&>&X\0ZAX>T#PMHEWJ+/<R"6
M;3?#VDVS*$"VB$,6 /ZJ?@3\4_A]\<?@I\)?C)\)KNVO?AC\4OAQX,\>^ )[
M1+"*'_A$?%7A^PUG08/L^F7%WI]G-::==V]K<V%I<S0V%S#+9K(WD5_.#_P;
M^^*-*^-_[>'_  7W_:K^%$XUG]F;XO?ME?#+P5\)O&.F36L_A'QMXN^$FE_%
MD_$WQ7X5N-(N;[P_J6F^*+/QY\/O&%CKUE>OJ6O^'_$WA[5M:M;&XN8;9?>_
MC%_P;I_ CX@:UX^M?A#^W#_P4B_9'^!_Q;\6>+_&7Q&_91_9K_:8;P7^S)=Z
MG\0=8;7?&Z>$/A+J'A/6?#OA"P\27]WJ,MWH7V?6?"EFDUC8Z-X<TS1],ATN
M3]C/V3_V2_V?_P!B'X&>#_V<?V9/AYI_PT^$O@E=0DTG0+2]U/5[Z\U/6+Z;
M4];U_P 0>(==O=2U[Q%K^L:A<2W%]JVL:C=W/EBWL+9K;2[&PL;4 _!C_@T6
M_P"4-G@+_LO'QY_]2FWKE_%>M:-\%O\ @[9^'NH?%2PN9+#]J[_@F)JGPU_9
MW\0ZSI4L^BZ;\1O"GCFZ\9>(]'\-ZY+%?V.FZS'X0^%'CN&^ACN-!OE_X6!9
MZ;)'(/&&EIXE_;'_ ()T?\$^/@Q_P3'_ &:-(_96^ OB;XG^+?A[HOBWQ;XR
MM=9^+NM>%->\92:IXSU!-1U2"XU#P;X+\ Z(]A!.@2PBC\.Q7$41*W%U=/AP
MO[?7_!.C]F7_ (*0_"G2/AA^T3H'B""_\&>((O&/PF^+OPXUQ/!GQJ^"?CB
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MS5\ O@?^SGX%U#Q!JW@CX!?"#X:_!7P=JGBV[TZ_\5:EX6^%G@S1? WA^_\
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M5+#3?&^N:?J8LX9M3M+B\D\&/<#3KRWACN[3W']O3_E9H_X(8_\ 9$_VW_\
MUG_XUU^2WQ]^#/\ P3MT?]O'_@C-^Q!_P2N\=>'_ -IWXO:'_P %$O"/[7G[
M7'Q;T7XSI\?_ !I-X<_9_P!<\)^*-2UKXU?%RRNM6T&_\167@ZR\>QZ)X=TJ
M]T]/#B^%9]+U'0M*U+Q-ILNK?UY?%O\ X)\?!CXS?MS_ +*7_!0+Q1XF^)]A
M\9?V/O"WQ4\)?#/PSH&M>%+7X9:YIOQ>\'^*/!7B6?QUHVH^"]4\5:G?6.E>
M+=2N-#DT#QGX8@MM0@LI;^VU.VCGM+D _/'_ (.B/^4%7[<__7+]FW_UKWX
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MO%_A_3_$%KI^I6UU!:W-O?V<&H1V]W!<6UO-%<1R)+!$ZM&OX-Z5_P &XGP
M\6>.O!OB']KO]N#_ (*4?\% OA[\-_&UAX^\#? /]LO]J&Z^+/P7A\1Z4;N/
M3]1\6>$Y_"]B?$]Q%8W!TVZAMKO0-'UG3+G6-'\0:1JV@ZU=:2O]#=I:6FGV
MEK86%K;V5C96\-I9V=I#';6MI:VT:PV]M;6\*I#!;P0HD4,,2)'%&BHBJJ@
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M=,\,Z19Z+83ZE/9VMC:37\UK9127<MK96=O)<-(\-K;QE8D .NHHHH ****
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M6B:SX5\+^%= \/\ C"[UO2IK[3K^R/AG1O#4EA--)X@;3=#AU/4(/YHO@O\
MLA?\&N/QV\'S_M'_  ^_;.'P.^"'B[4;3XF_%3]CKQ)^W'9? SX;V&L:U+!<
MZCX0^*WP \0>)[7Q9I2W5S9VWA9]"T/Q!_8&K0Z)9Z+X(U'4M'@LGG /?O\
M@WV^-'PQ_:%_X*K?\'"'QB^#>K:+XA^&?C7XS?LTWOA+Q+X=\PZ+XITZRU']
MIW2F\5:?)+8::\\'B:ZL;C71<FV87+7[7"W=^L@OKCVK_@UX_P"2%?\ !3+_
M +2[?M2_^H#\#J\R_P"#<Y/"7Q1_;#_X+4?M8_ 3PU:Z5^QU\4OCS\$O@O\
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M#-K+=7=B^CV@DTZ7Q GA'6;2"ST_Q#X5U>UL8$H P?\ @J-^VK^W%XP_;?\
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M6&E^'K*?0;37M*\2:E:W\MU+J.K:I;O%:P 'P7_P:X?\H0?V0_\ L8/VG/\
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MN+QC%XN.H>#M,A-_/X\N=&^QSW\8T 3RV]Q:_P S'[,W[ 7P2_;\_P""O/\
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MA"]T;R'AT]73E_VMM>^'W_!)S_@OK\)_VT_$,UC\/?V8_P#@I!^S1\4OAO\
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MZ%\,_#GA[6O"EI\-M<M/BCX5\1^$/$$GCK1]2\%ZMXGU.YL]-\3W\^COX?\
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MH'Q ^'7C'0SG1?''PZ\86L+W_A7Q7IP,L*W]HCVU_87-[I&K66HZ/?WMA/\
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MM C\*^(H8(Y[O1O$OB+4I[?PMH.H::9!:ZO;ZMK=H^C:G'<:3JHL]4M;FSB
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MQ5XVBN].\$Z7X776?$]]8:NMMJ_CS7?&FOQ:'X>DU:30-/\ H7Q]_P %;/\
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M7EE<0W$)958QR*653D  UJ*_&K_@M?\ L^?#G]HCX _!?PG\2O\ @HQ\0O\
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M=(^,7[.OQ7\#?&;X8:[<7UGIGC7X?Z_8^(=$EO\ 3)S;:GID]Q9R.]AJVFW
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M6@17D<>G^$K/Q%-8Z[?7_A^SD\2F'20#^H2BOYR?^"4/[>'[7GA/]LOX^_\
M!'7_ (*7>*?!_P 2?VH/@+\/O#WQ;^!'[27@^U@T/2_VD?@5<6F@6MS-XETR
M[329&^)^A)KVAZE<OI6ESW6N1)\0(M8C\WX=3^+_ !Q_1M0 45XU\)/VA_@9
M\>;OXB:=\&_BMX'^(^K?"'QOJGPT^*VB>%M?LM1U[X:?$/1)'AUCP3X]T))!
MJ_A+Q1IEQ%<6M_HFO65AJ%K>6M[:30)<V5U%#G?%G]I_]G;X#^,OA!\//C/\
M:OAM\+_'/[0'B=O!7P1\)^-_%FD^'M?^*OBY-5\,Z&_ASP)INHW,%SXCUA=8
M\9^$]--AIL<]P+WQ%H]OL\R^@5P#W:BOQK_84_9^^'7@7_@H7_P4G^+_ (._
MX*,_$+]JCQAX\\6>%(?BK^ROXJ\76^N6G[(FHZEJWBO5/!WAAM(M->E32-,A
MTO3];\+?#*WN_"/A^ZLO ?A\6(U#Q&\=UK%W]I?M/?\ !0/]B3]BZZT+3OVJ
M?VI/@K\#-;\3V\5]X>\+^//'.CZ;XQUG2I9=2MUU[3_!L4]QXIN?#2WFD:AI
M\OB6/2#H$&J6XTN?48]0FM[:4 ^PJ*^=/@S^T5^SU^V9\)]4\9_LR?M >#/B
MEX(URQU3P]_PL'X,>,M U_4/"VJ7EG<6A821IJ@\-^+-),@OK.P\2:0MQ;7$
M5O/=Z5/;GRY?S-_X)/:#^SE^Q!^P;\6O'9_X*:WW[<GP$B^.GQ.^*NO_ +6W
MQ4\<KKGASP)I6IP^#_#TO@=O%]SXL\8Z?%HO@\:197_BK68];MM+O?'7B'QE
MXDETGPRFI7&C:: ?M[7%:_\ $GX?^%?%W@/P#XD\:>&-#\<?%&Y\16OPX\'Z
MGK5A:>)O'$OA#1)/$?BL^%]$FG74=9@\-:'&-2UZZL;>:VTBWN++[?- ^H6*
M7'\\O_!,+_@OE\&_VK?VAOVU?@E\??VC_P!E7PU+X5_;D\2_ S]A6T\/:_#X
M9U[X_P#P?UCQGJGA/X3:IH4NK^+=8L?B7K'BJ6#0X=-U7PC::=%JEYK=N5T]
M8M1TR-?J/X26%U\<O^"['[87CSQ4UW+I'[!W[&W[-GP'^$&C7>CR2Z!;^(OV
MM]7\;?&OXN>.M(U"ZU*\MK;QJ=%^''PZ\%ZG?:98:=>S>$YK32;B.VM1/=^)
M@#]6?&/QS^"?P\\5^'? ?Q ^,/PL\#>./%\!N?"?@WQC\0?"7AGQ7XHMEFFM
MVN/#OAW6M7LM7UN!9[>X@,NFV=S&)H)HRV^)U75^('Q3^'7PIM/"]_\ $CQG
MX?\ !-CXU\>>#_A?X4O/$>H0Z;:Z[\0_B!JT6@>!_!VGW$Y6*77O%FNSVVBZ
M!8%UEU/5KJTTZU$EY=6\,G\_O_!0KX)_\$G_ -@GPO\ M/\ [1O[<7[,GQ>_
M;J\8_M;7GQG^)7BGQAXX^ -Y^T]XP\&^$/#>F^&%LO@CX*^+>C> M-\/_LI?
M!_P!8ZIX>T_X.S>(/&7@:\TC^R)/$"^/-:UWP8-8TJSI'P \;>+O^#96W^%_
MQ4^)G@CXM_$SPG_P3PUCXB>"/BQX<\0V7C;P[HGB[X9>!]4^*GP$UKPA\0?#
M,LT=[K'PI_L#P/HVC?$GPQ>W]W%J_AA?%&E:AK4FR:^ /Z-Z*^;?V-?C/>_M
M'?LA_LL?M"ZE:-8:A\=?V=/@I\8KZQ984:RO/B7\-O#7C.YM62V)MT:WFUIX
MF6 F%2A$1*!:^DJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBOSX^/O_!6#_@FS^RY\0-1
M^%/Q]_;6_9[^&WQ,T41#7_ .K_$#2KWQ;X9DN+6UO[6V\5:#HCZIJ7A:]N]/
MO;/4;*P\0V^FWMYIUW;:A:P2V<\4[ 'Z#T5XG?\ [2?[/NG? Z?]IF;XU?#&
MY_9WM_#J>+Y/C?I7C30-;^%9\*27,=H/$T/CG1KZ_P##MQX?2XD5)M8M]0ET
M^ "22>XCCBE=/0_ WC?P?\3/!?A'XC_#WQ+HWC/P%X^\,Z%XS\%>+_#E_;ZK
MX?\ %/A/Q-IEKK7A[Q%H>IVCR6NHZ1K6DWMIJ.FWUM(\%W9W,,\+M'(K$ ZF
MBOG;2OVN/V8]>^(?Q>^$N@?';X8Z_P#$WX Z#/XG^-O@70?%>F:UXG^%>AVU
MI'?37WCK2=+FN[KPX$M91(+?4D@NW,=Q&D#2VMRD7SQX]_X*U_\ !,_X8_#_
M .&WQ3\<?MO_ +.FB_#[XQ1^)9_A;XH7XBZ/JNG^.[3P;X@O_"?BJ_\ #:Z-
M+J-UJ.F>'_%&E:EX<U74X;<Z?9Z[8W6DRW*WT+P  _1"BOC7XA_\%#_V&?A3
M\!_!'[4'C_\ :M^!WA[]GOXEW\&D_#SXNR>/M$U#P5XXU6X74G_LSPGJNDW-
M^FOZC;#1M8&HV.F)<W6E-I.IIJ45H^GW:P^A_LV?M:_LS?MB>!KKXD_LN?'/
MX:_';P3I^L7/A[5M<^''BC3O$":%KUHJ2S:)XBL;:7^T_#NK-:36VHV^G:Y9
M:?=WFD7NGZQ:0SZ7J-C>7 !]#T5\4>-O^"D'[!OPX\+?%[QKXW_:S^!WAWPM
M\ _B3%\&OC'K-[XZTEK?X??%N74-1TO_ (5CKZ6TL]Q#X]AN](U8WGA*"&?7
M;&STO4=2O;&WTZQNKN+J?V8OVZOV./VT+37[K]E3]I;X.?'E_"8M'\5:7\.O
M&^C:YXB\+P:A-=0:9>>(_"Z7$?B30M/U6:QOHM(U'5=*M+'5GL;U=.N+HVEQ
MY8!]745_.U_P5W_X+<^#/V#?VA_V+/V??AI\:?V;X_%GC;]KKX0^ OVT?#7C
M_4&U7Q7\#_V<?&,G@[5M=\<ZK!8>*M#@^'8E\%>+8_$UAXD\5VFH60TX6NIV
M]E-8PWHE_;[X$?M%? K]J#P(GQ0_9V^+'@;XT?#F35M0T*'QQ\.M?L?$_A>Y
MU?23"NIZ?:ZUILDUA=W&GR3QPWBVTTHM[C?;2LL\4L: 'L]%?G#\5O\ @K__
M ,$O/@A\0;KX5_%+]O']F7PI\0-.N$L]9\-S?%'P]J=UX<OVO9[!],\57.AW
M.IZ?X5U:UN+>0ZAI7B.[TO4=-M6@O]0M;:QNK:YF^Z+'XD_#_5? '_"U=&\:
M>&->^&C>&[GQC!X\\/:U8:_X4O/"MG8RZG<>(-/US1I[[3]2TI+"":[%Y83W
M,,D,;-$S\9 .VHK\[_'O_!6O_@F?\,?A_P##;XI^./VW_P!G31?A]\84\2S?
M"[Q0OQ%T?5=/\=VO@W7[_P *>*K_ ,-KHTNHW6HZ;X?\4:7J/AS5=3BM_P"S
M[/7+*YTJ6Y6^A> >C?$+_@HA^PQ\*?@-X)_:@\?_ +5WP-\/_L]_$K4(-)^'
MOQ=?Q]HFH^"O&^JW"ZBW]F>%-6TBYOTU[4;8:/JXU&QTQ+FZTI]*U--2BM'L
M+M80#[*HKYX_9K_:U_9E_;%\#W7Q)_9<^.?PT^.W@K3M8N?#^KZW\./%&G>(
M$T+7K14EET7Q%8VTO]I^'=6:TFMM1M].URRT^[O-)O=/UBTAGTO4+&[N.=_:
M<_;D_8]_8OT_0=1_:K_:3^#WP&3Q6;O_ (16P^(WC;1M"U_Q3'I\MK#J=SX:
M\,RW#^(O$%EI,M]8IK%]I&EWEGI+7UG_ &E/:_:K?S #ZIHKYP_9J_:__9<_
M;'\(7_CO]EGX^?"WX\>%M'U!M)UW4/AOXNTKQ%/X<U3=,(M-\3Z3:S_VQX9O
MKN*![W3[37]/TZ?4M->#5;".YTVZMKJ7Z/H **^9OVD_VSOV3?V.M LO$O[4
MG[17P?\ @/I>JG;H:?$KQUH/AO5_$;BY@M)4\+^';R\7Q#XH>TDN8Y+]/#^E
MZDVGVBSW]\+>QMKFXBI?LR?MO?LA_MFZ3K.M?LK_ +1GPE^.UGX<N!;>(H/A
M[XPTO6M7\/RN0(6US0%FCUW2(+K(-E=:CIMM:WR@M9S3JK$ 'U-17\7G_!>[
M]N[]FSXW_MK_ /!//]AG6/V_='^%O[)LGQM^..@_\%"H/@K\9M/\+>)O"?B/
MX>6VA:+X=\ ?&O7O#MW<^(/ VB/KC^)O"%U9:O%IFC1W6L^(-7U,W&I^#],U
M#PQ_2W_P3@^"W[*WP(_9&^''@O\ 8N^)5Q\8?V=KV\\8>+O WQ*N?BC%\9'\
M3IXM\8:WKFIF/X@P33PZQ:Z'J=W=>&;.#?\ :]*M-%ATK57GU>SO[F8 ^Z**
M^5/VS_VN/@Y^Q3\ ?&7QL^,WQ1^''PJL+/3->TGP'J/Q/UN'1?#_ (I^)T?@
M_P 3^)_"?@>T5[W3[O6=8UY?#&HR6V@Z3=1ZOJ5I87RV#)+'YB?F5_P1(_X+
M&?#G_@HE^R[\#_\ A<WQP_9\_P"&ZO&Z_%_4/'7P ^&NJ1:1XDT70O!?Q2\<
MZ/X:U7_A7=[X@\2>)-&T^Z^'.E>%->NK_4;Z2UNWU>"]AD@BU.RM0 ?O!7YL
M>/?^".G_  2P^*'Q*O\ XO>/?V!?V7?$GQ"UC7O^$HU[7+SX4>&H8/$WB*34
M7U>]UKQ7H-E:6OASQ5J.LZE)->>(KGQ%I&IR>)99[D^(#J2W$ZR?DC_P1Z_X
M*@^'/ _[-'[>OQG_ ."CG[85GHGA[PO_ ,%6_P!H3X%?#/QA\=_'+&/2_#VD
M^ OA7KOAOX8^"H;MI;K^R])6Z\1:M9>']%M'M]-MI-2O/)@MQ-(O[_?LT?ME
M_LH_ME>&]5\6?LK_ +0WPE^/6B^'[B"T\2O\-?&NB^(]2\*W-Y-J$&GV_BW0
M;2Y.O>%9M5.E:A/H\?B'3--;6+&V?4=+%W8%+E@#W;PIX2\*> _#FC>#O _A
MGP]X,\(^';"#2_#_ (6\*:+IOAWPYH6F6J[+;3M&T/2+:STS2["W0!(+.RM8
M+>)1MCC4<5T->6?&7XY?!?\ 9U\!ZE\4?CY\6/AU\%OAQH\UO;:CXY^*7C+P
M_P"!?"MM>WI=+#3FUOQ+J&FZ?)JFI2HT&F:7%/)J&IW.+:PMKBX98S\[?LR_
M\%)/V#OVR_$NN^#/V7OVK/@U\:?%_ANPMM5U?PMX.\5VT_B&#3+I[F--1MM&
MODLM1U*QADM)4O;O3+>\@TYGM1J$EM]ML_/ /MRBBOQI_P""CG[/GPY^+?[8
M'_!,_P 7>,/^"C/Q"_9%\5_#[XXS^)_A[^S;X<\80Z/HG[8UQX0U?PCXAU_P
M/%X=M?$'AS4]5OX7;P[HOB_49[?QQID'P\\1:UH1\,Z4WB&Y\01@'[+45\^^
M//VK_P!F;X7?$^T^"WQ)^/'PJ\!_%:^^'M_\6H/ ?B[QKH7A_P 0I\+M*NM7
ML=2^(EW9:I>6QL/!5A?:!K%E=^)KYK;1[>\T^XM);M;@+&WS_P# '_@JQ_P3
MA_:D\?1?"SX ?MG_  "^)GQ(NH9)].\$:)XZTZV\3:RD+%9ET#2-7.FW?B">
MW \RXMM$CO[FW@_TB:)(")* /T"HJCJ>IZ;HNFZAK.LZA8Z3I&DV-WJ>JZKJ
M=W!8:;IFFV$$EU?:AJ%]=216ME8V5K%+<W=W<RQP6\$<DTTB1HS#X#^"W_!6
M3_@FM^T5\5;#X'_!+]MG]GKXC?%C5Y-2@T'P/H'Q!TIM9\376D*\NH6/A,7C
MVMKXKU&&UBN=133O#ESJE]<Z39:AJ]K;S:7IU]=VX!^A5%?SU_\ !LM^T%\<
M/VF?^"9]E\4?V@_BOX]^,OQ$N_CQ\9=&G\9?$7Q+J?BG7FTC0]?AL-(TN._U
M2XN)8-/T^TC6*ULX#';QEI)1'YLTLC_H_P#M#_\ !4C_ ()U_LG^,%^'O[1'
M[9O[/OPN\?J)6O/ NN_$/1;KQEHZ1);2*_B+PMHTVIZYX9CNH[N)].D\06&F
M)JBI<G36NQ97GD 'WK17G'@;XP?"WXG?##1OC3\-O'WA;X@?"?Q%X;;Q?H'Q
M \%ZO:^*/#&M^&TMI;I]5TG4]$>]AU&!(89MZ6AFG6:*2V,0N4:(9_P5^.WP
M9_:/^'^F?%;X!_%#P/\ &#X;:S=ZMI^E^./AYXCTSQ3X:OK[0M3NM&UFS@U7
M2KBXM6NM,U2RNK"]MRXEM[F"2.1 0,@'J]%>)> /VD_@#\5OB5\4?@[\,?C!
M\/\ XA?$_P""-W8:?\8_!7@KQ+IOB;6_A;JFJR7T.F:1\0(-&FO(_"6M:A/I
M>KP6>C:Y+9:I<3Z)KD$5HTNB:JEG[;0 45^*_P#P25^#/PE_9L\ _MC^,O"/
M_!2;QW^W]X1UC]H/QOXI^(OC;XD>+X?%=Y\#O%OAWP]I^I^-/ ?B&YL-=U>U
MMO%VFZ1=Z9K/C(PZ/X3GF\VP=O"^G1K! /IGQ[_P5J_X)H?#'X?_  Y^*GCC
M]M[]G31?A]\7?^$E;X8^*%^(NCZII_CF'P=KU]X6\57GAQ=&EU"ZU'3_  _X
MFTS4/#VK:C%;FPLM;L[G2YKA;V)X  ?H?17B'P=_:6_9[_:#^%,'QS^"'QK^
M&'Q3^#TMG?7TOQ(\$^--!UWPCIT.DVOVS6HM<UBROI+7P_?Z!;[F\1:7KCZ?
MJ7A]XYH=:M+&>":-/XF_VMOVI_\ @G[_ ,%*_P#@M3X^^&'[7?\ P4@TKP__
M ,$YO@G^RMH6M_ <_"_]I"V^%WPF\3_&W5[SP*/%QO\ Q]H&I'1=4\7V;:[X
MJ@N]/FEB\37]CI&E6UK>QZ'X4OK&\ /[TZ\B\$? #X(?#3XB_%3XN?#WX3_#
M_P $_$_XXW'AV[^,7CSPMX6TC1/%'Q-N_"5OJ-KX:N_&VKZ?:P7?B&[T:#5]
M52QN=2DGGB.I7TGF&2ZF=XO UG\,?@)\"/!FEP^-[+3_ (1?"CX:^&](LOB!
MX[\8:?+91>"?"N@66GZ?XD\4>.=3GL],N%ETNUM[S4?$-Y<6]M=/(]X[HLE?
M)_PO_P""M_\ P3+^-?Q=TWX#_";]N+]G'X@_%C7-7OM \/>$?"_Q'T74YO%&
MLZ>9A-IWA/5893H/BJXG6WGETU?#VJ:F-8MXVN=):]M\2D _1*BH+JZMK*VN
M+V]N(+2SM();J[N[J6.WMK6VMXVEGN+B>5DBA@AB1Y)99'6..-6=V55)'YL7
M_P#P65_X)3Z9\21\)+O_ (*!_LK#QT=8M?#YL+?XN^%KW1X]:NUB\K3)O&%E
M>W'@V&[CFF2QNXIO$"&PU02Z3??9]3@FM(P#]+J*^5/VROVN/@U^Q?\  #Q?
M\;_C%\4_AO\ "W2[;2];TWP'JWQ,UR#1_#GBKXE#PAXE\3^$O!=F3?6%SK6J
M^(%\-7\EIH>DW<>JZG:65ZNGNLJ"1/S'_P"")'_!8[X<_P#!1+]F'X*CXT?'
M#]GP?MS^-I/B_>^-/@#\-=4BTCQ)I&@>#/B?XUTCPSJW_"N[[Q#XC\2:/877
MP\TSPMKEU?ZC?/:W;ZK!>PO!'J5G:@ _>.BOQL_X(]?L_?#KX)>'OVL-0^&G
M_!1CX@_\%$=-\<?M+>)[_P 6>(O'_BZW\6:K\'OB%9:5I4OB/X;:S/9Z]JMG
M;>-(+34]&U#Q6$TGPC+,]QIS/X9TV)8(A];?M*?\%*?V!/V/?$EKX+_::_:[
M^ WP;\;W=K;7\?@7Q=\0=$A\=1:;>Q/-8ZM>^"[&XO?$^FZ/?I')]@UC4-*M
M=,OFCDCM+N:1&0 'V[17COP*_:$^!G[3WP[TGXM_L[_%OX??&KX:ZVSQ:?XS
M^&WBK2/%FAF\@6-KS2KRZTBZN?[+US36E2'5]!U1;/6M'NBUGJEA:72/"OCG
MC?\ X*$_L/?#:#XWW'C[]JGX(>$!^S7J?AO1/CS;Z_X]T33K_P"%>M>,IM4M
M_!^C>+]-N+A-0T[5O%DNB:N/#.FFUDO=?33KN72H+N*%W !]BT5\@?LO_M__
M +%'[:<OB*U_94_:>^#?QTU3PBL<OB;0/ ?C/3-1\4:'9S^2+?5=2\*S26WB
M.VT.ZEG6UM->?2QHMU?1W6GV]_+>V5W;P?7] !117FGQ>^,WPB_9_P# &N?%
M7XY_$[P%\'OAIX:6V;7O'OQ+\6:'X*\):4U[<Q65A!>:]XAOM/TV*[U*^G@T
M_3+(W!N]2U"XM["P@N+RXAA< ]+HKX"_9_\ ^"J7_!.+]J?QH/AQ^S_^VG^S
MU\2_B#*(C8>!M'^(NBV?B[7/-%RQ'AGP[K<VEZOXI-LEK*]^/#EIJATV-[:3
M4!;)>6;3_!O_  7N_P""OME_P2^_9CU2Z^#7Q(^!'_#9.L7?@+5_ /P7^*3W
M.OZYK7PYU[Q-K.C:YXULO NC>)?#6N7>D6TGAK6M.BUR2[&DV][9WEO(LEXL
M*H ?O?17S%^S'^V/^S'^V!X=U77OV;/CS\+/CK:>%/[(L?&>H?"OQ9I?B[3/
M#FMZI8_;8M*U*\TBXN[:SOY(DDG6PEG-U';F*66-8YH7D]2^,'QE^%'[/OPX
M\2_%_P".'Q#\(_"CX6^#H]-E\5?$#QYKECX;\)^'HM8UG3O#NE2:OK6I3065
MBFH:[J^EZ3:-/*@GO[^TMDS+,BD ]+HK^;[_ ((\_P#!=[X7?MPW'QV\'?M%
M_'[]F3PM\86_;+^(?PD_9<^&7@W4W\+^*/B?\$+'0/!M_P" ?$ND>%=?\4>(
MO$'BJYU;4M2\40/X@L%MK&X@TF;=9VW]G7D[4_A1^W%XJ^&__!<[_@K_ .#O
MVA_VC[_PC^QY^SA^S?\ LK?$#2=!^(GC$:?\)_A1/XB^%'PWU#Q)KFD6NI3+
M8Z+?>)=<UVY,\.G@7GB'7-5@M(+>^U.[LX' /Z3:*^(/V:?^"E?[ G[8OB>_
M\#_LQ_M<_ KXR^.=.L+C5[GP-X0\>:1-XV;1K-K6.^UJS\(7TMEXCU'1+"6]
MLH-0UG3],NM,L+B\M+>\NH)[F&-_K3QSX\\#_##PCX@^('Q+\9^%/AYX"\)Z
M=+J_BGQOXY\1:1X2\(^&M)MRHGU3Q!XDU^\T_1M&TZ$N@EO=1O;:VC+*'E4L
M,@'5T5^??P/_ ."K7_!-[]I3XH1?!?X$?MH_ #XH?%"ZBU";3?!WA?QYIMUJ
M6MIID\,%XOAV68P6/B.9&G2:&VT*[U&XN[-9K^TBGL;:XN(OT$H **^-OVX_
MV7?B-^UO\(-(^&7PP_:T^.G[&GB'3/'VC>,KCXJ_L^:C:Z9XWU72M+T/Q+I-
MSX(OKB\=(F\-ZM=:]9:S?1!M[:AX>TE@,(V/Y$/V\/V9_P#@H'^R-^WM_P $
MW/V2/#7_  6L_P""AWB[PG^W%XN\<^&/%7BG7/'BV?B+P,G@Z/1IH[SP_%8:
MB--U%K]-8"/!J-LHMVMC(LLPG$<(!_=Q17Y&?L4?\$V/VB?V3OC+)\4/B'_P
M5._;-_:]\,7/A#6O"MU\(_V@]3T?7/!'VC5;W2+ZU\3V203M/I_B31Y-(^SV
M.H0J7&GZEJUDP$5](1^9'QJ_:>_;S_X*_P#[<GQ^_85_X)V_':\_8U_8Y_8U
M\2VG@']K+]LSPG8:BWQ@^(WQ+N)]2T?Q3\*O@AJ=W!IDF@3Z%+8^(+"S\1^%
MKN";3[O0[/Q_<>,I=%\2>"?#NK@']4=S;6U[;7%G>6\%W:7<$MM=6MS%'/;7
M-M/&T4]O<02J\4T$T3M'+%(K1R1LR.K*2#^9]G_P1>_X).:?\0(?B=9_\$\O
MV38/%MOJ3ZO;NOP;\(MX;@U)XI(A=P^!7L&\#1/ TANK18_#BQV6H)#J=FD&
MHV\%U'^.'QC_ ."3W_!7O]B/PYK'[37[!/\ P6&_:]_:N\??"[PU<^)M2_93
M_;9UCQA\>?"?QM@T+2KN\UWPWX8>[\8:M%I_B#68%NX/"GAG3O!T&MZOJUQI
MFGP?$31;ZVM=2?\ 9K_@G3_P4O\ A#^WI^P7X8_;:1X/AYI^C^%?$<WQ^\,7
MUP]^?@_XY^&VGS7'Q3T2\FMHI+Z]T?1OL5UKGA_4)-/M-3USPA>:+K,FC6%Q
MJ/\ 9T(!^D5C8V6F65IIVFV=KI^GV%O#9V-A8V\-I965I;QK%;VMI:VZ1P6]
MO!$B10P0QI%%&JHBJJ@"U7\@7P4OO^"F?_!P;K7C[]H?P5^V'\6/^"9O_!-#
M0O&GC+P1^S78?LUZEJ?AW]HKX^2>#]:B\/:O\1/%OCW3KSPYJ.E^'3K>C:E:
M-80ZG]ET_5K?6/"5MX?NH]/O/&6OU?VI/AU_P4R_X(%^'[#]N#P1_P % /C]
M_P %%_V(_"7BSPIIO[4_P"_;,\2ZC\1OBQH/A;QMXLTSPFGC;X6_$S5]1GN-
M.N=.:Z\/:)IFF17^@:-;>*M7&IZGX?U[3-9U)-& /[!Z*\\^$?Q1\'_&[X6?
M#GXQ_#W5+?6_ GQ3\$^&/B#X.UBUN+:ZMM3\->+M&L]=T6^@N;.:XM+B*ZT^
M^MYHYK:XF@D5P\4KH58\[\6/VA_@9\"=3^&VC_&7XK>!_AEJ7QA\:Z;\./A;
M:>--?LM!D\>^/]8N[*QTCP9X8:_DBCU7Q-JMYJ-G;Z;HUL[7]]+.%M8)=DFP
M ]EHJEJ6I:=HVG7^L:Q?V6E:3I5E=:EJFJ:E=06.G:;IUC!)=7M_?WMU)%;6
M=E9VT4MQ=75Q+'!;P1R332)&C,/Q(_X*3^+?V/\ _@H5_P $\M=U'PK_ ,%2
M+#]E'X"CXN^&+/5OVM/@K\1=&7P9=Z_X;?48I?AAXJ\3P:YH6G:EH&HZC>VU
MW=:=9^+-%EC\7Z!X=\R^G>QN=%OP#]Q**\FT6^\+? WX)Z-??$;XIV/_  A_
MPN^'FF/XO^,GQ.\2Z?HUA+HOAG0X$U3QYXV\6:_J,>FZ?#<V]K)K&LZSJNJ+
M;0^9-<W-X4#2GY$^$'_!7'_@F3\??B?IWP8^#W[<O[.'CSXGZW<W%CX>\(:/
M\2=$34/%.HV\R0MIGA*:_FL[#Q9JLQ<S66E^'+S5-0U&SANK^PMKFQM+JXA
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M  <Q?L'?LI_![X,?\$[?B;^SE\&? 7[*7Q4F_P""BGP&_9UL?BC^RSX-\'_
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M6OCKQ?X.GCN]#\7Z+#X;\:+H_B+2O$$T6D7[_#GP1HMUX6US0M6\7OJ'0?\
M!Q3_ ,$\_P!G3X4?L"^(OV\/V4?A/\*/V6/VM/V&?&?PO^,WPI^,/P1^'OAS
MX8>)I+2/XF^$_#VL>&=7NO ^G:19:[:6Z>(!XH\/1^*M)\1VVFZYH[Z;81Z1
MIWBWQ1=W'H'[>OP$_:T_8,_X*E6/_!9?]DKX%_$C]LGX:?%KX!P_LU_MD_LK
M?"1FOOC0D&B1V%SX%^*_PRT Z3K3>+=+LI?!O@'3]3\.:#I@\7Z1J&CZG);7
M=[X;^(7B&;P?\M_MR?M4?MF?\%Y?AAI/_!.K]C']@C]LG]DCX(_&SQ/X?7]K
MG]KC]O+X'W?P9T+X;?#?P+XH\-_$"#0OACI&@^.=>M_'OBC7]5T#34U/18O$
M4.HWUC]F\)76B6'A[QEJWQ \& 'GW_!9KPGHW_!1+]IC_@U_T'XM#4_"_A;]
MKK3?CQKGQ:T/P%KNM^'Y;KPC\4?A;^R#XJ^)/PXTS7K'4+3Q!8>'O&/A[4M=
M^'VIW4&HIJ1\,ZY?*9Y)G;?UO_!T1^PQ^R%^SE_P3(\-_M _LW_LZ_"']G3X
MW_ 'X\? )?A;\6?@-X \*_"/XB^';&VU#5M'L-)7QKX%TG1/$]UIFDR7<&OZ
M/!/JKR:5XITK2?$5A-!JEIY\GVA_P4H_9;^(L/\ P4I_X-R1\#?@M\3O%?P0
M_98\=?M(^'/''BOP7X"\4>*?!?P:\%6_@/\ 9R\-> Y?B1XH\/Z-<Z!X&T_5
M;/PM?V6BWGB2YT>TU671M2CT\R&QN4AZ[_@Z-^"7QG_:!_X)-^.OAQ\!?A'\
M3_C=\0[SXS_!75;3P'\(O /BOXD^,[K3-*\27$^J:C;^%_!FDZUKD]AIL#":
M_O(K%K>SB(DN)(T(- %[_@I3_P $E_\ @GA\//\ @C]^U[X0\-?LJ?!^WU#]
MGS]C#X[?$;X=?$V?P-X8E^,\7Q(^$GP<\:>,O#WQ#\0?%A-(B\;>)/&>L>)=
M/DU;QGKNK:M/<^*[G5M:;5?-&HR@?%WC3X4?M=_MG?\ !I9\'_ G[.VM^-_&
M'Q]U[]D[X,,^@Z%J^HP^-OBM\.? GBS2+'QM\,['4K77=&N=4N=9^%.C:CIO
M_".W:>(9/B%9::WP_P#[#U+4O%=O<V_]!/\ P4V\)^*O'O\ P3;_ ."@W@7P
M+X9\0>-/&WC3]B#]J_PGX.\'>$]&U'Q'XJ\6>*O$?P&\?:/X>\,^&?#VCVUY
MJ^O>(-=U>\L]+T;1M+L[K4=4U&ZMK&QMI[F>*)ORG_9TT_\ X*3_ +,__!OO
M^R/:_L>_ S1KK]LOX1_![X>2^*/V>_V@_"7B;PMXSU'PKI>NZI+\0/!NB>&]
M;U;P3=>'/BNND2P7^@6GC".:WN+>VU#3+;0=1U_4M"AH _,71?VP?^#:;]H'
M]FJ/_@GA^UM^RI_P['^(7_"'Z9\.&\#?'S]E*'X3?&?X0?$2^T4:%J?Q*\(?
MM!:/\,?$>E^&O&'A_P 0Z$E[?_%GXRGP/-X\N8D?XG^#]3TW5_&'A!?[)?@O
M\/O#OPF^$/PP^%W@_7_$'BGP?\._ 7A/P5X1\0^*_$!\6^)-6\*^&=#LM'\-
MW6M^+'1+CQ3J+:+9V*W/B6_>YU37G0ZKJU_J.I7=W?W/\GW_  4(_P""F7C3
M_@HE^R)\8?V(?#/_  0D_P""E/B3]JSXM_#>[^'^AZ1^T+^RWX?T+X)?!'XB
M^+=/L-.NOBEIOQRU3Q!J,EA;_"S6KNT\8?#KQYJ'A#P'I?BK5=%\*7FJ:CX+
ML=5\^R_HC_X)D?LU?$;]CO\ 8 _9-_9A^+?B;3_%WQ)^"WP<\,^"O%^L:/>2
MZCH::M9+/</H>@:A/I>BW%_X?\*PW4/A?0;VZTNRNKK1]'LI[J(W$DCN ?FG
M_P '-/[0'Q=^#G_!-FR^%GP.UX^$/B)^V]^TC\'_ -B6P\;"]O--_P"$3T;X
MOVOC'Q%XJN)M1T^.ZOK#3O$OAGX?:MX"UV\L=+U?4+?0/%VJR:98KJ:V=]9?
M8OPF_P""*7_!,'X5_LSZ'^RV?V+OV>/&_@JT\$KX2\4>*/&WPH\'ZY\3/'FH
MW5BEOKGCGQ'\2[S3)O'J>.-4OU.KV'B33/$MEJO@^ZATF#P3=^'K+P[X>MM+
MSO\ @M5_P3N\0_\ !3C]@CX@?LZ?#_QE;^ ?C'HWB;PC\8/@=XGU.[O[+P_;
M?%+X=WES<:3IGB6ZTI)-3L=(\2:)J7B'PTNN:>D]UX4U75],\7QZ=K8T!M"U
M/\W/#O\ P7L_:X\!_#"'X2_&?_@BI_P5!UC]O#0?"$?AZ/0O WP(M/%G[.WQ
M*^)>E^'8+-O%J_&CPS>V<>C?#WQ+XML]9U'4]6\%^ /&VA>%] AFET[5=;2T
MN/L@!RO_  ;Y>"XU\,?\%0?^"5WQXTWPE^T/\ ?V /VX=?\  7P0LOBIX>L?
M'6GP_#?Q+KGB_4_#_A6[\.^,+;6=+CL?#NJ^"I/&6F6\ZZG=:/XH\:>);:UU
MB]TVRT62'(_X-0O@/\#E_8J^)_Q;7X,_"@?%;PK^W1^TWX?\,?$T?#OP@/B%
MX<T&/0_!6@QZ)H/C0:/_ ,))H^D1Z'JFIZ,FFZ?J5O9+I.HWVG+"+.[N(9/T
M%_X(:_L-?M#?LJ_!W]HCX]?MFMX6M_VRO^"@7[1/BK]J_P".GA;P>LSZ-\*A
MXQB6\\,_!R*_GU;71J$O@B[U3Q3>2Q6&K7^B^'&\2?\ "&:-J.OV7AE/%GB+
MQ_\ X-F_@G\9O@-^P7\8/!_QR^$?Q.^#'B[4_P!M_P#:+\6:;X6^+'@+Q5\.
MO$>H>%=<A\"C1?$UCHGB_2='U.[\/ZN;.[&EZS!:R:=J!M;@6ES,8)=H!_1#
M7\CO[?'[-'[.-[_P<N_\$>M#O/V?_@E=Z+\9?A/^V]XH^+^CW/PI\"3Z7\5?
M$UI\&/CAXEM/$7Q)T^707M/'.NVOB.237[?5_$\.J:A!K<CZK%<+?NTY_KBK
M^9+_ (++> OVD?@'_P %'_\ @F7_ ,%8?A/^S%\6/VN_A!^R'X=_:&^'7QR^
M%OP TT>(OC'H6G?&+P!XC\#:-XRT3P?#%>:KXDTC3X/'.LZSJ#:=IYT_3#X3
M%MXGUGPSINNV^O6(!Y3_ ,'4/PG\,:9^P/\ \$_O@W\,+:S^"OANZ_X*J?LR
M>$/"A^%6EZ?X+C^'?_"0?##]I2UBUGP3IOAZ'2[#0M2T:_U&36]-?38[/R=5
MC6Z5TF9I:_37]H7_ ((L?\$UO%?[#OQ+_9IM?V3_ (->'](L_@WXJTGPI\4K
M/X?^&+[XY^%/%UAX>U2\T;XKVWQAU33;KX@ZS\3+3Q$Q\2ZQXF\0^(=3NO&=
M_<ZO8^-/[>T3Q!KNF:C\!_\ !;VT^,?[>W[ O_!+#XJ? []F+]I6[U?Q#_P4
M>_8Y^/'C#X/W?P:\:7_Q?^#W@.'X=_&X>)=6^*_@OP[I>LZAX0TGPA?ZSING
M:_XDU%8_#=K+J.ES_P!J&WU;3Y+C^E;XDVMU??#KQ]8V-M<7E[>>"O%-K9V=
MK#)<75U=7&AW\-O;6UO"KRSW$\KI%##$C22R,J(K,P! /XYOV/OV_/C=^SS_
M ,&?VH_M/Z/K]S-\6/A!\,O'_P !/A9XNM((+?6/"-OX@_::F_9N^%?B*T\J
M2ULWU7X2Z1XWT*Z\/W,D#I)'X.TB75K+7+K^T/[4^9O^">?[9W_!NC^S5^QG
M\./A1\1_V6/'_P >_BIXV^'VCZY^T;\8OB9^PKK7QA\3?%7XG>,?#=O<?$&^
ML?'WB?PUJ6JCP"NKZCJ]GX!T;2;VWTW2_#TL>H!K[Q+J_B'Q)K?Z8?\ !)S_
M ()R?$7X[_\ !M=??\$^?VC?!WQ/_9H^(7Q9TG]H[P\^F?%'X?>*?!'C7P#X
MBO\ XV>*O&?PQ\6:_P" ?%EEX<\176@P:_8^&/$ESI,JZ4WBGPR)K2PU2R34
MX-2AA_9R_P""N?[6'_!.OX&>!/V-?V]?^"4W_!0KX@_&+]G#P1I'P=\,?&S]
MCGX(V'QN^ 'Q\\/?#>TG\+^%O&VA^+AJO@*T\/0:CX5T[P?+J-E8V7B#6(;C
M4+R_UOP]X3OVB\+H <'_ ,&T7QP\+R_M+_\ !4#]F/\ 9SM?C.O[ .@>._ G
MQ]_8TT7XJ>&?%_ABU^$6D?%.Z\4W7Q3^%?A[3?&D7]J:7H-EXHO=,L_#VDBX
MF::/PGK?BK4KO6=<\5:KKNH_U\5^6O\ P2X^-?\ P48_:,\#_%WXU?MX_ 7P
MA^R[X0\=^/K?5?V4/@+<Z;JD/[0'@OX/75G=:AY_[0NHS>(9M+7Q'>KJ&A:;
MI7A>;P%\.?&_AF^T+Q6_C;1Y&UG0[+1OU*H _D6_X-NO^5<_XE?7]M;_ --.
ML5:_X-@O^"='[('B[_@E'\ _VDOB]\#_ (<_'KXL?&2X^,FGMXB^.?@[0?BN
M?AQX"\!?M%?%[PIHWPP^%=EX[L]?T[X>^!KG7=*U_P"(^OZ1X1L]%C\3>/?&
MNO:]XB_M6[BTR6R]3_X(!?L_?'KX-?\ !!7X@_![XO\ P1^+OPJ^+EZ?VO/L
M?PM^)/PV\9>!OB-=_P#"2Z7JL?AS[-X(\3Z+I?B:?_A())(TT3RM,?\ M5Y$
M6P\]F4'[._X-Q/A/\4_@=_P1D_8X^%WQK^&GQ ^#_P 3?##?M#_\)+\.OBEX
M-\1_#_QWX>_MO]JKXX^(M&_MSPCXLTW2/$&D_P!K^']6TK7=,^WZ?;_;]'U/
M3]3M?-LKVVGE /@C_@CU\,/!G[(7_!<__@N%^Q?\ ]*_X0G]FS2]%_90^-?A
MGX76L\K^&O!7C/X@?##0/'/B&/P7I8:/3O#6A/J/Q5US2K32-,LX8K?PSHG@
MO0/,DL?">E)%YG_P;]_LP_!__@I)IG[57_!8#]MGX:^ /VD_C;^TW^T=\1?"
M/PCMOC1X8T+XDZ9\$_@+X BT;1/#/A#P]X3\2Z-<^$/#7B*W9[WPNVIZ)8:A
M>V_@?P_H=I8^(+=_$OC33[[[;_8P^"7QG\+?\'$G_!9'XV^)_A%\3_#GP9^)
M_P %_P!C;2OAI\7->\ ^*](^&/Q#U/PO\#?A!I'B;3? WC[4-)M_"OBV_P##
MNJZ9J6F:[9Z!JVH7&D:AI]]9:A';W-I/%'\'?LS>+OVKO^#>CXS_ +87[/GC
M/]A;]LC]LK_@GU\9?VB_$?[1W[.'QJ_9%\$67QL\3?#*Q^)6G_9-1\ ^._!Y
MNM%NK74[2XT3P=X7U:]\0>*O!NE2ZWI&K>,/#NC7Z^.;6WNP#A_^"@?["7P4
M_9#_ ."_O_!$7XC?L^^';#X6^ ?VC_C1\<]7\0?!/P7!;>'OA1X?^*O@+P_\
M/K?QA\3_  EX!TFQLO#_ (7\2_%#P_XN\#:3XWO=(CC_ .$@'PW\-R7=O"VG
M1//R/_!;C]J[]F'QA_P6V_9N_9J_X*%:9\3O%G["G[('[/47[1C?!3X=^"O$
M_P 0[#XS?M+^/M?-AH%U\3O!_A3SV\1?#[PYX0BT:.SM-<MK>TM+BU\9^&KR
M^O/#GQ1UWP]K&O\ %K6_^"@'_!07_@L;_P $>OVVM2_8,_:7^!'['/@+XH_%
M#PU\.=&^(?PNU2[^)OA#PI9>'_"&OZ]\>OVDT\(6>OZ1\!]'^+%]XMT?PC\/
M?!WC;Q(R&/X2>)-<TO5-1AUN::OTQ_X*:?LX?M4?LT_\%"O@7_P6E_8Y^#_B
M#]JJ;X?_  .U3]ES]KG]DWP88W^*OC;X&WVN:WXHTGX@_ ^UETW5[W7_ !MX
M:\0:M9W&K^#-#A.M:\GA;PKI^BZ;+8ZYXYU6P /P(_X*P_MP?\$:_P!H/]F^
MZ\7_ +!'[/OQ8_9L_P""@?P5\2^"?B/^RW\;/@]^Q=XG^ 'B+2O%/ACQEH]_
MJF@^(/&/@3P]H4M_HE_X6D\3#0[?7GN['0/%L^F:[:"#;J,-_P#T[?M7_LB6
MG_!;+_@D?\$!X@N)OA#^T!\1O@G\ /VL/@+\1KQ=3T/7O@3^T=J'P]\/^/-#
MU":702NIZ/:32Z]K'@/Q@NGVM]>:3HFN:EJ^@Z>?%.A^';NQ^+O'7_!;?]O+
M]K2P\(_!7_@E]_P2@_;2\#_M#>,?$.A6WB;XP?\ !0CX&/\ !G]F#X*>%X[B
MWU'Q%XAU[Q)I?C;4O^$K:;3+'6["PTFXU3P=XBNXHVO?"'A_QSXI2Q\#7_V1
M_P %J?C#^W/HG[,_@/\ 9(_87^$_Q%^(W[5/[:FLVOP$UGX]>!?AQ\5M)^#?
M[,G@#Q/IZ^'_ (G_ !T\8?$GPKIOC.Q^#MS;G5[>R\#KK7C+_A)/#%EJ.M>/
M=&U37]5^'EO8:^ ?A+^R#^T3\5?^#E'X]_LQ?LV_M.^'K?PQ^SY_P3.\->'_
M (Q_\%!_""S^ =8\._MA?MD:3K6M_#[X<>'X--\.3:MX>_X4HTGAGQ1XUUJV
MTI+CPOKEGKGQ \"R:.MK=_#/QOIG]S-?R!_M&_\ !*CQ1_P1C/["G[>G_!*;
MX'?$?XZ>/_V4?#&E?LU?MH_!'X4Z+,_Q(_;6_9^^(6L37/B7X@:]X3\#Z#J^
ML>,OB9I7Q,U6P\0W-U9Z%XKNM TNS^'VK75G'X!^!%D-+_K=\*>(;?Q=X7\-
M^*[33M?T>T\3Z!H_B&UTGQ7H.J>%O%&EV^M:=;ZE#IWB3PQKEM9:UX<UZRCN
M5MM8T'6+.TU32-0BN-/U"V@N[>:) #^:O_@Z8_Y-B_X)S?\ :87]D'_U ?V@
MJ\5_X.(O@AX?_:2_X*5?\&^?P*\7ZWXJT'P;\3OC'^V#X8\;7/@KQ#K'A/Q'
MJ?@FZTK]EZ;QCX5L_$GA^_TS7-%M?&WAJ#5/!NKW^DW]K?PZ-KNH&VE$I4'Z
MX_X.1?@E\9OCG^SM^P3HGP3^$?Q.^,6M>#O^"JG[+'Q$\7:1\+/ /BKX@ZIX
M6^'_ (>\$_'*TU_QSXCL/"6DZO=Z'X.T.ZU?2K;6/$VIQ6NBZ9<:GI\-[>P2
M7MLLJ?\ !6?X)?&?XC_\%7_^#?\ ^(WP\^$7Q/\ 'GP]^#/QH_:QU7XP>._!
MG@'Q7XH\&_"G3/$?AKX P>'M2^)/B?0])OM$\"V&O3Z-K$.C7GBB^TNWU272
MM2CL9)WL;I8@#SO_ (+X_P#!+W]@&V_X)$_M1>)?!O[)WP*^%?C/]GKX7V/C
M_P"$/COX3?"[P+\/?&WA'4_!>IZ##%I$7B7P]X>M=2U+PMXBT2&7PYXK\.ZQ
M+?Z?J^G7$>HJEKXHT?PWXAT7K/VOK'P[^T]_P;91_M&?'CP7X'^)WQHN/^"1
M&C?%S3OB%XS\):)XG\4^%_B%\1_V7?"'BGQGXF\(:_X@M-4UOPSJNO:Y':WV
MH:AI.HV]_>36-A)=W5Q+9V\B??/_  6M^'_CWXJ_\$I?VZ?AU\+_  1XN^)'
MQ!\7? ?Q#H_A/P+X"\-:SXP\8^)]6GOM,>'2_#WACP]9:CK>M:C,D<C16.FV
M-S<R*CLD1"L1\H>.O@Y\7;S_ (-G+#X#6GPK^(]U\<D_X(\?#CX8O\&+?P/X
MGG^*Z?$FQ_95\+^';WX>M\.HM+;Q>OCBS\06]QH5UX3.CC7K?6()M,FL$O8G
M@4 [?_@C5X&^"'[.7_!'7]E/X\^"?@M\./"OB>Z_8:^'OQ*^)NN^ O WA'PC
MXQ^)=YHGP[E\:ZG/XJ\2:3I-EJ'B/6-5U.35+Z34?$%U?RR:MJ=WJ-Q(]Q<W
M$LG\KG_!)K_@H=_P29T?PI\9/VPO^"D_PB^)'[3W[?O[7_Q7^('CSXO>,?$W
M[)OB/]H+X>^!O"T7B_4K'P5\./@]+K^D>(/#7ACPGI>D:=93?8- >XNM,L4T
M+P+/J?\ 8?@3P[H>A_V>_P#!)_X:^)O"'_!*O]AGX3?%GP5XH\%>*M$_9&^$
MO@KQ_P" /&NB:WX/\7>'=2B\":?I6O>'/$>@ZK!I?B#P]K%FS7%G?V%Y;V.I
MV$X='2">/Y?P?_9&^,/[47_!NWH'B[]@;XY?L.?MA?MI_LB:7\4/'7CO]D+]
MJC]BSX6:;\7]8F^'OCZ^N/$MU\./C+X)AN_!UIX3^(&B>))M2U"[N=8\36DN
MLS:MKZ^%-/U7P?X;T;4[X ^9_P#@FW^U1^RGI7_!?_P/HO\ P2^^'_QA^$W[
M&W[;O[/_ (\T+]H#X(7WP=\6_!OX.>$/VBOA3X8^('Q/\/\ Q(\,>!=3M++P
MEX:L;[P=X)L/"^CVOA>SLHM*UCQ-XMM[2&#3O$ILK?ZR_8@_9]^&O_!67_@L
M;_P54_:V_;.\$>%_C5X'_8.^.]G^P[^R9\%_B%;2>)_ GP\NOA#KOBG3/'OC
MFX\"ZI'=>&-3N-?U[PU;^+]"EUF77HWU_P =>-+RYT316T?P@+/],/\ @GW^
MVM_P49_;J_:B^(?Q,\4_L;>(?V+?^":GASX>MH7PRT_]J?P5JGA3]L/XT_%N
M75--OK;Q9;>#(_%5M;_#WX>P>&;^=[VXU#1?%OA_4)[72K3P9XM\77FK^)KK
MX=?G[\0?!7[6W_!%3_@IG^UY^VG\+/V9OCO^W+^P!_P44DT#X@?&/P#^S3X9
M?Q_\?_V<_CSX2OHKG5/%K>"I98SXF\#ZM8^)_BAJUC-IDWA[3+B#6M%T#QEX
M@\-K\-M$U?QP ?IMXU_X(O?LR0?MM_LT?MV_LRBS_8S^*OP+O=>M?B)HW[/G
M@7PMX4\'?M)^!=?@\-:9-X!^*OAO3H]-T$:;9Z!I&MZ5::KI6CQZN\OB&VU2
M^N+V^\)>%7TS\H_V^OV:/V<;W_@Y:_X(\Z'>?L__  2N]%^,GPI_;<\3_%[2
M+GX4^!)]+^*OB6S^#'QO\2VGB'XD:?+H+VGCG7+7Q'))K]OJWB>'5+^#6W?5
M8KA;YFG/UE\%?^"A/_!2#_@HO^V1\!M,_9A_8]_:(_89_P""?OPYFF\;?M1?
M&+]M_P"#&C?#;XN_&N6QN);>R^"WP<\'ZO)X_P!+AT?4;R&"#7?%_AR_NM6:
MRD\0'_A*?ASJ_AS1['QKP7_!9;P%^TC\!/\ @HY_P3,_X*P?"?\ 9B^*_P"U
MU\(?V0O#W[0OP[^./PM^ .G#Q%\8]#TWXP^ /$?@;1_&6B>$(8KS5?$FD:?!
MXYUG6=0;3M/.GZ8?"@MO$VL^&=-URWUZQ .2_P"#F;P5X-^'7['G_!,_P5\/
MO"7AGP+X-\/_ /!7W]D.TT'PEX-T'2O#'AG1+23P1^T/=/;:1H.B6ECI6FV[
MW,\]P\-G:0QM/-+*5,DCL9/^"Z]AK7[:7[?7_!([_@D#K.LZAH7[._[3GQ#^
M)O[0G[3NGZ?K6L^'9OBCX(_9Q\*:AX[T?X92:UX<N(M5M]*U#3/"_P 07N+*
M2-K>3QA>_#OQ/97VBZQX+L=7M+?_  6]M?C'^WO^P'_P2S^*GP._9B_:6N]8
M\0_\%'/V.OCOXO\ @]=_!KQI?_%_X/\ @.#X>?&X>)-6^*W@OP[I>M:AX0TC
MPA?ZSING:_XDU 1^&[:74=+G_M3[/JNGO<?2?_!:W]A[]I7XJ^-?V(O^"A_[
M$^G_ /"<?M1?\$W?B?K/Q M/@+-K5CX=7]HKX.>,KCPJ/BK\,M$\0:M8:I8:
M+XQU'P_X8N]#TES:P2ZCX>\6>+XK"6]\76G@O3Y0#UC]O/\ X(M_\$\OV@_V
M*_C/\&?#_P"R1^S5\*_%%A\&?%UG\&?BAX(^#'@SPEXP^$_C70?#$EWX$\1:
M7XG\&Z9X>\7S:1I6OZ+X?G\3^'$\00V'C;0K&Y\/^(%O;"]F0_R[_MA_M.?%
M+]K/_@SN^"'Q.^,VL3^)OB)HGQ<^'GPEU?Q;>W=W?ZMXNTWX/?&CQ=\.?"?B
M'Q#?:A+=:AJ/BF]\(>'M!C\5:WJ%]?7_ (D\1P:IXEO;A;K6);:W_7SXW?\
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M4)M0TNU\.:-?Z3H5ITG['G[.'[>7_!3/_@H1\*/^"J/_  41^"FH?L>_ ?\
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M%9$^&O@CP8OA2[U#]5_^"3WP2^,_PY_X*U?\%^OB1\0OA'\3_ GP[^,GQ?\
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M/WFI>$= ^)OQJ\.> =-:RCTB_P#$-K9:KXIT[0-&;4HO#]A_0]7(^+OA_P"
M_'X\-+X\\$^$?&R^#/%NC>/O!X\7>&]&\2#PIX[\.&X/A[QKX:&LV5Z-"\6Z
M";R[.C>(]+^RZQI9NKC[#>0>?+N /(_V0/@E<_LT?LF_LP_LY7NJPZ]>? +]
MGOX-?!>ZUNW\SR-8N/A?\.O#G@F;5(?-M;*7RM0DT1KN/S+.T?9*-]M V8E^
MBJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** ,+Q1INIZSX:\1:/HNK_ /"/ZQJNA:OINDZ\
M+:XO#HFIWVGW%K8:O]DM-1TBZNO[-NI8KW[-;:MI=Q/Y/E0ZC92,MS%_!?\
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MB)\(OB'9:_X.U+Q/X>4:B][X#\5ZMX6LK+4=4TN'59T\+ZYJDVF6A\2:7##
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M= BM)_'J:.OBJ:VBT&SM-$C@DU9HDTBUMM-5!9P10K_0Y\5O!]S\0OA=\2?
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M!_"3P'XI^)'C.\T_3/$<L^I7]KX7\':5K.N7%GI\!$U]=0V+P6D1$D[QH<T
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M7_X+.?M>_M/^!M8_99^!'_!(?_@H9\&_VT?B1H]]\/[OQ)^T3\)-(\&_LN_
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M?%7XLZ]\:=)CUSXX^#]"^*T?PW\#>!_C[\4/#6F?#KX6:?XZL]?TSP!X/O\
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MW!:>'-1 /M?_ (+1V0TW_@I__P &X^G"]N]2%C^T5^TG9C4+YK9[V]6V\&_
MN$7=V]I;VEJ]S<!!+,]O:V\+2,S1PQJ0@\\_X.//@7\$M1^/?_!'CQMJ'P=^
M%E_XS^)/_!3_ /9V\$_$7Q=>?#[PE=>)_'W@R?Q7X T:;PCXUU^?2'U7Q3X8
MFTBSM-*ET#7;N_TJ33;6VL7M#:P11+Z5_P %"?V5OVA(?VO/^#<*P\/^!/BI
M\;M,_9A\>_%;2?CQ\6_!_@+Q3XM\->$!;_#CX&:#;>,/B3XC\/Z ^C>"M/\
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M=SIFFWVN0P3P72F^:-8);C]F*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *_.;4OV"!K_\ P5)T/_@HYXF^(<FN
M6G@G]D2;]F;X;_"=]*^RVG@O5]7^(]_XV\5?$%=36>=-6U'7-/NUT&W_ -'T
MR?3[.34;>\?6X)M(&@_HS10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img12876764_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" && R@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.TEK9-13UUZ?T^T445^ GJA1110 4444 %%%% !1110 4444 %%%% !1110
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M:?#_ /\ "-\.?_*VNC_8O^HK_P I$^__ '?Q&_\ "W/A3_T4[X>_^%IX;_\
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M%3?"O_HFGP__ /"-\.?_ "MH_P"%3?"O_HFGP_\ _"-\.?\ RMH_V+_J*_\
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M_"IOA7_T33X?_P#A&^'/_E;7?(B1HD<:+''&JHB(H5$10%5$50%554 *H
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ME;S:MXWBT[;_ &=/@A^VE\#OVG?A=;2:%>:7\-_B3I^E_$G]H*+P';?"ZT^
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M^A;^.W_B,'[27_SJ*/\ AHKP%_T+?QV_\1@_:2_^=11]2QG_ $"8G_P15_\
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MZ%OX[?\ B,'[27_SJ*/^&BO 7_0M_';_ ,1@_:2_^=11]2QG_0)B?_!%7_Y
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MJR/\ _V@'1E*LK>#?#;*RL,,K*?&9!4@D$$$$'!XKZ"HH]MAO^@./_@ZM_\
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MYK'AV#_A'C%JOAS5[7Q+;2OH27-_!D,^XZ*** "BBB@ HHHH **** "BBB@
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M"\\[R?R\_P#$7S^T)_T95\&O_#M^-_\ YD:/^(OG]H3_ *,J^#7_ (=OQO\
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MI:Z5;_5GBCX*> _&GQ0\#?%KQ18WFL^)/ASX1^(7@[PCI][>-+X8TVS^*/\
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MT*'[6?\ X:7P5_\ /9K_ #HJ*/\ B#?!G\F:?^%Z\O\ IQY/[_(/K^([T_\
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M *-4^&G_ (<GQ3_\S5'_ !$Q?&+_ *-4^&G_ (<GQ3_\S5?S+44?\2V^"/\
MT0.!_P##KQ#_ //CR_/NP_XF \7_ /HM,7_X;<D_^=G]7?E;^FG_ (B8OC%_
MT:I\-/\ PY/BG_YFJ/\ B)B^,7_1JGPT_P##D^*?_F:K^9:BC_B6WP1_Z('
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M.Z!K/Q4\-ZCXF\5_$JPUOQ?\&/AY';Z3\,7N](TJ/]O/V8?@U\*OV7OVR_\
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M:> -*L6U'1=7M_#VLR>-/B38?$#QEXCO?!?@U/%6MZU9Z&EM. ?EM^V9\/\
MP?X[TS_@O_\ '[QOX8T37/C-^S!X=^#<7[-_CG7M)LKSQ5\'[;X%_LC_  W_
M &G/AA?_  PUV]A_M7P=(WQX\=>+O%-U=^&[RP.MZNYAOI+P6B01Z/[07PL_
M:8^#?[2?BC]H'0?#'A'PCJGQ<^)OQ&U#X1?M"0^(-(OO&?BO7OVH/V8O@Q\$
M?#/PFUGP9:V,_C?^P/V6;GX<?$+]I/Q1-JDT7@]/AS\'/#P\/S7OB;4];MM%
M_3'XO_\ !+OX4?&OQS_PEGBSXQ_M!6F@^-/#?P>\-_M+?#+0O%GA.Q\ ?M<1
M_ FXBNOA]J?QRLI_ ]YKBZH6C_LWQE/\-==^'T?CWPREIX3\51:CH&G:?8VW
MV%XZ^ ?@SXD_%/X:_%#QA<:MJQ^%/A?XF:!X4\%2S6B^#4U7XJZ7I/AGQ!XT
MOK%;,7]UXKL/!-GK_@?0+P:E%9Z9X:\>>.+464T^MK<VH!\J?\$VOV@OA-\4
M/@WI/PC^%'PH^)7P;\/_  ,^&WP3?P9X<^)Z>%9-;\6_!#XF^"'U[X)?%R*^
M\(>(O$EG)+\2_#VD:IJFOZ;K]SI_CC1_%=IKUKXOTBUU)Q<7GZ-5\;_L@_L5
M> _V.=)\5:=X3\>?$_XE7OB33_A]X2M?$'Q6U?P]J^N>&OA9\'O#<OA#X/?"
MG1I_#7AGPI:2^%_AUX=NM0M=.U/6;+5/&&NWVK:KK/BSQ+KNJ7K7*_9% !11
M10 4444 ?RJ?\';O_)B?[/?_ &=GH?\ ZI_XNU_GU5_H*_\ !V[_ ,F)_L]_
M]G9Z'_ZI_P"+M?Y]5?UQX/\ _)$X7_L.S#_T^>'C_P#>)?X8?D%%%%?J!QA1
M110 4444 %%%% $%U_Q[7'_7";_T6U?[0?PA_P"23?"__LG?@G_U&M,K_%\N
MO^/:X_ZX3?\ HMJ_V@_A#_R2;X7_ /9._!/_ *C6F5^ ^._^[\,?]?LW_P#2
M,M/3RW>MZ0_.1Z)1117\ZGJA1110 4444 %%%% '\=7_  <N?\E__9F_[(]X
MO_\ 4U@K^:ROZ4_^#ES_ )+_ /LS?]D>\7_^IK!7\UE?[&?1R_Y,GP!_V+<?
M_P"KO-#_ "G\??\ D[W&O_8=@?\ U3Y<%%%%?MA^/A1110 4444 %%%% 'UO
M^P'_ ,GR_L>_]G*_!G_U/-$K_2QK_-._8#_Y/E_8]_[.5^#/_J>:)7^EC7^<
M7TV_^2KX)_[)['_^K(_OKZ('_),<7_\ 8^P?_JOB%%%%?Q(?U\%%%% !1110
M 4444 %%%% 'XU?\%<+75_%'B;_@GM\/O!'PK\*?M(?$W4/VN+[Q]X;_ &6_
MB3J>G>'/A/\ &3PU\._@=\4_^$\U3XB^+]9L];T?PI9?"33?$]A\2?">I:AX
M.\?+=_$'1O"6CVO@V^O=1M]4T;\S_P#@G;\'OAS\=_C_ /"S]F_]HSX.>%M2
M\,? ?]GC_@HEJ.O_ ++WC3PYIWB?X4? /X[?$W]NG2]$^(_PO^'FGZHNJ^&]
M=\(_"/X5ZYX7\"?"SQGH16RN/AOXT75M L?"5MXLN?#EE_0S^U-^R;X:_:AL
M?AIJ#_$3XG?!3XI?!3QK=^/_ (._&SX-ZGX<TWXA> /$&K>%];\$^(X+6'QE
MX8\:>#?$'ASQ9X1\1:MH/B?POXK\*ZYHNK6DUO-):QWMA8W5O\LW_P#P2<^%
M%MX+\!:3\._C]^U#\(/BEX2U#XVWWBG]H_P#X\\)?\+P^,"?M+:_I7BKX^6W
MQ1UGQ3X \2^%-6'Q \2:#X?UVRNM&\(:%>?#W5/#N@W'PWG\*)ID<+@'PE?_
M !&^(&J?\&W%AK$WB#6H]?U#]G?PW\$]0\4VM[=C7&^&MS\7],^ .JZ[_:ZR
MO>)=S?")[J^N=<6Y\V/?+JBWB[1<KJ?&_P#9<L?#W[5G[2G[+W[(_P &/AIH
MOA'Q9^QY^P9^T=KOP&T6Q\.^ /AU\3?%'[.7[:?BA;[PEJ]JEE'X2T_4?BY\
M%_!4GPMO=4URPCTS5X= \,6_BFZN-"TN\\G]5;K]A#X.W/PLL/V>8]6\=V7[
M,.G_ +*]]^R8G[.UEKEG!\/I?!]RFCV5AX[>_P#[*;QO'\5="T723H^C^+;?
MQ7"MO'J-]JDVGSZZUOJEO/\ LL?L6^'OV9-=^)'C[4?C'\;/VB/C#\4]+\#^
M%O%'QC^/VO>%->\;KX!^&$&O0?#GX?Z3'X+\'>!O#.F>&_#$GBCQ+J\KP^'S
MK7B7Q+XBUOQ)XIU;6-5OO.B /Q ^#OQWF_90\?:!JOQG^#7C'Q=IW[+5I^V)
MX@T?X8?!N\\$>(M!^ ,7Q"^)4G[1O[57BX:QJFN>#_"WB>T_8\^!WQ@^ '[/
MMCI?PZ&KZUJ?B/QA\9_"OP^TK4=)LKBOZA[6Y@O;:WO+65)[6[@AN;:>,Y2:
M">-9894) )22-U=20,@CBOS9\?\ _!+OX-^/_AE\./AK/\3/C7X;/@^+XW:7
MXY\:>&?$'A.W\8_'7PG^T_KMOXG_ &EO"/Q7O-3\&:KIMWIOQH\0V=CJNO:K
MX4TOPMXH\/36%K!X)U[PW:(]O)^D]O;P6EO!:VT206UM#%;V\$2A(X8(46.*
M*-1PJ1QJJ(HX"@ =* )J*** "BBB@ K_ "0O^"L/_*3C]OG_ +.M^,G_ *EM
M]7^M[7^2%_P5A_Y2<?M\_P#9UOQD_P#4MOJ_<? S_D=9Y_V*J7_J92/.S'^'
M3_QO_P!)9^?E%%%?TN>0%%%% !1110 4444 %?UE?\&BW_)XG[4__9M.D_\
MJT?#=?R:U_65_P &BW_)XG[4_P#V;3I/_JT?#=?$^(__ "0_$7_8'2_]3,,=
M&$_WBE_B_1G]^U%%%?Q:?0!1110 4444 %%%% '/>+O^14\3_P#8O:U_Z;;F
MO\KI_P#62?\ 723_ -#:O]47Q=_R*GB?_L7M:_\ 3;<U_E=/_K)/^NDG_H;5
M_H#]!S^!XE_]?>$O_2.)#^'OIC?Q_#W_ *]<4_\ I?#PVBBBO[W/XH"BBB@
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MT%?^#MW_ ),3_9[_ .SL]#_]4_\ %VO\^JOZX\'_ /DB<+_V'9A_Z?/#Q_\
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MB@?L?:7XM@U/XP>)?C5KVN^'/A+\,]$\1^(_#7AWPG/X<^"_P \*7G@SX,^
MY-/\- 66M:UX?TC5=;N_$_CBY6UOO&&N:Q=7[:7HUE#8Z7:_=-%% !1110 4
M444 ?RJ?\';O_)B?[/?_ &=GH?\ ZI_XNU_GU5_H*_\ !V[_ ,F)_L]_]G9Z
M'_ZI_P"+M?Y]5?UQX/\ _)$X7_L.S#_T^>'C_P#>)?X8?D%%%%?J!QA1110
M4444 %%%% $%U_Q[7'_7";_T6U?[0?PA_P"23?"__LG?@G_U&M,K_%\NO^/:
MX_ZX3?\ HMJ_V@_A#_R2;X7_ /9._!/_ *C6F5^ ^._^[\,?]?LW_P#2,M/3
MRW>MZ0_.1Z)1117\ZGJA1110 4444 %%%% '\=7_  <N?\E__9F_[(]XO_\
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M %3_ ,7:_P ^JOZX\'_^2)PO_8=F'_I\\/'_ .\2_P ,/R"BBBOU XPHHHH
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M* "BBB@ HHHH **** /QY_X*U_'C4_A\_P"QY\#(/%7Q_P#"/AW]I?XY^*]
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MUC%IFGV&FPO+)#I]E:V,4D[^9/)%:0)!&\S@+OE98PTC[1N<DX&<4 7****
M"BBB@ K_ "0O^"L/_*3C]OG_ +.M^,G_ *EM]7^M[7^2%_P5A_Y2<?M\_P#9
MUOQD_P#4MOJ_<? S_D=9Y_V*J7_J92/.S'^'3_QO_P!)9^?E%%%?TN>0%%%%
M !1110 4444 %?UE?\&BW_)XG[4__9M.D_\ JT?#=?R:U_65_P &BW_)XG[4
M_P#V;3I/_JT?#=?$^(__ "0_$7_8'2_]3,,=&$_WBE_B_1G]^U%%%?Q:?0!1
M110 4444 %%%% '/>+O^14\3_P#8O:U_Z;;FO\KI_P#62?\ 723_ -#:O]47
MQ=_R*GB?_L7M:_\ 3;<U_E=/_K)/^NDG_H;5_H#]!S^!XE_]?>$O_2.)#^'O
MIC?Q_#W_ *]<4_\ I?#PVBBBO[W/XH"BBB@ HHHH **** "O[)_^#:G_ )-F
M_:$_[+W;_P#JN?"5?QL5_9/_ ,&U/_)LW[0G_9>[?_U7/A*OYL^EE_R9;//^
MQKP__P"K7#G] _1C_P"3MY1_V+,\_P#5=6/Z0:***_R:/]-PHHHH **** "B
MBB@ HK^5/X0?MS^+_A]J/QJ_:;_:'^./_!17PUX^MM(_X*#?%_X&_LY?&_X5
MZ%\-/V(OBSH_P13XX>+_  3\'?AGXBN_A+IOCO7?$O@[X->$M \6I;ZIXVT*
MY\37&D:YKGA:;Q7I6B:M'#^B'[('BW]I;X/_ +2'[/7PD_: _:3\;_M'I^V1
M^QCXP_:-U=/&GAWX>Z18?"KX[_"37/@?;_$#1_A3_P ('X2\)RZ1\(?%NC?'
M:VBT3P=XC?Q+=^'+GP':75IK\]QXBUCS #]G**_G\_:Z^/W[4+>,_P#@I)^T
M#\-?V@?%_P ,/ /_  2MTSX67GA7X(>&]!\!7W@3X]ZMI_P5\+_M-?'F+XW2
M^)?">L>+M5T[Q9\.O'^A_#3P-#X0\4^$&\#ZGI%SXSLCJ&LW!6N;\9?\% OB
MW\*OVV/C9<7?CKQEXUTSPS?_ !8T_P#X9-_LK18O#^F_!W3?V=O@5XD_94^)
M/A6>W\*Q^*;7Q5^T)^TW\26^#UAXFU;Q7>>'O$_B+QG?>"=.TQ;CX8W%Q8 '
M]$]%?+?['/CC2_&/P'\(6#_M!^!_VEOB'X&M_P#A#?C=\1? GBWPMXLTM?C3
M8(EY\1/#\C^$I#8Z%'H>O7]S8:+X<NX;?4M)\-Q:+;WJSR@W=Q]24 %%%% !
M1110!_*I_P ';O\ R8G^SW_V=GH?_JG_ (NU_GU5_H*_\';O_)B?[/?_ &=G
MH?\ ZI_XNU_GU5_7'@__ ,D3A?\ L.S#_P!/GAX__>)?X8?D%%%%?J!QA111
M0 4444 %%%% $%U_Q[7'_7";_P!%M7^T'\(?^23?"_\ [)WX)_\ 4:TRO\7R
MZ_X]KC_KA-_Z+:O]H/X0_P#))OA?_P!D[\$_^HUIE?@/CO\ [OPQ_P!?LW_]
M(RT]/+=ZWI#\Y'HE%%%?SJ>J%%%% !1110 4444 ?QU?\'+G_)?_ -F;_LCW
MB_\ ]36"OYK*_I3_ .#ES_DO_P"S-_V1[Q?_ .IK!7\UE?[&?1R_Y,GP!_V+
M<?\ ^KO-#_*?Q]_Y.]QK_P!AV!_]4^7!1117[8?CX4444 %%%% !1110!];_
M + ?_)\O['O_ &<K\&?_ %/-$K_2QK_-._8#_P"3Y?V/?^SE?@S_ .IYHE?Z
M6-?YQ?3;_P"2KX)_[)['_P#JR/[Z^B!_R3'%_P#V/L'_ .J^(4445_$A_7P4
M444 %%%% !1110 4444 %%?D[_P5H^)GQA\&> /V;/!7P=U7]JKP[=?%K]I3
M3?#GQ#\2?L:_#JQ^(WQTTWX9>&OA1\5?'>K6'A>SUWPSXG\*:$WB3Q3X;\&^
M';GQ%XKM['1M,L]2NIKC4+< D_'/PG^)/Q _:P\6_ ?]DG]F[]O;]K7PWX.T
M?]G_ /:+^/WQ;^/?C_PQ\+;/]KB7XM^#OCWH?P4\*? GXF:#XN^#ECH'@VU^
M$?C27Q\GQ"\')\/])UG7[3PWX6T:37WT74+C5-9 /Z***_&W4/V^/BN__!%V
MW_;?TJWT)?V@=1^ VBZ=:SW.E1_\(K;_ +0&M>*K'X('Q(^A!V@D\+6?Q5O&
M\2#1?.-M-HD(T\W'D.9J^>OBS\6?VD?V/[[]IS]F/Q1^UK\8?BS8V_P8_8__
M &A[#]H[QMX=^&0^*_P0^&WQ7_:DN_V?OVN]:TRX\(_#S1_"+:%X!\%Z5/\
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MD_\ JT?#=?$^(_\ R0_$7_8'2_\ 4S#'1A/]XI?XOT9_?M1117\6GT 4444
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M444 %%%% !7]97_!HM_R>)^U/_V;3I/_ *M'PW7\FM?UE?\ !HM_R>)^U/\
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M )*O@G_LGL?_ .K(_OKZ('_),<7_ /8^P?\ ZKXA1117\2']?!1110 4444
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M>6[UO2'YR/1****_G4]4**** "BBB@ HHHH _CJ_X.7/^2__ +,W_9'O%_\
MZFL%?S65_2G_ ,'+G_)?_P!F;_LCWB__ -36"OYK*_V,^CE_R9/@#_L6X_\
M]7>:'^4_C[_R=[C7_L.P/_JGRX****_;#\?"BBB@ HHHH **** /K?\ 8#_Y
M/E_8]_[.5^#/_J>:)7^EC7^:=^P'_P GR_L>_P#9ROP9_P#4\T2O]+&O\XOI
MM_\ )5\$_P#9/8__ -61_?7T0/\ DF.+_P#L?8/_ -5\0HHHK^)#^O@HHHH
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ME7P3_P!D]C__ %9']]?1 _Y)CB__ +'V#_\ 5?$****_B0_KX**** "BBB@
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M444 %%%% !7]97_!HM_R>)^U/_V;3I/_ *M'PW7\FM?UE?\ !HM_R>)^U/\
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ME]X-D'PAU3Q+#XGO?A>C:%+)<7'[-4 %%%% !1110!_*I_P=N_\ )B?[/?\
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MO] ?H.?P/$O_ *^\)?\ I'$A_#WTQOX_A[_UZXI_]+X>&T445_>Y_% 4444
M%%%% !1110 5_9/_ ,&U/_)LW[0G_9>[?_U7/A*OXV*_LG_X-J?^39OVA/\
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M[\+_ !QX"T[PG\"?"6N_&+P#8_'B;QR]WJ=Q\1/V>_@3X0_:*^+D?B+X<?\
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MG_U/-$K_ $L:_P T[]@/_D^7]CW_ +.5^#/_ *GFB5_I8U_G%]-O_DJ^"?\
MLGL?_P"K(_OKZ('_ "3'%_\ V/L'_P"J^(4445_$A_7P4444 %%%% !1110
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M %]X2_\ 2.)#^'OIC?Q_#W_KUQ3_ .E\/#:***_O<_B@**** "BBB@ HHHH
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M[%N/_P#5WFA_E/X^_P#)WN-?^P[ _P#JGRX****_;#\?"BBB@ HHHH ****
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M_&3_ -2V^K]Q\#/^1UGG_8JI?^IE(\[,?X=/_&__ $EGY^4445_2YY 4444
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MV'QK_P!#'X?_ /"5O?\ YJ*/8T_^@K#_ /@.*_\ F;^K/RN7?9_A_F?S ?\
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M8&C_ (B[P/\ ]!^,_P##=B__ )#U_IZ'U'$_R1_\#CY?YO[O,_SW:*_T(O\
MB$N_8+_Z+5^T]_X4O@+_ .8&C_B$N_8+_P"BU?M/?^%+X"_^8&C_ (B[P/\
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M*_M'_P"(;K]D;_HKGQY_\&O@_P#^92C_ (ANOV1O^BN?'G_P:^#_ /YE*/\
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MTP^+PRP6+CBX.C3PBHSYY*-/DDIJRC9W6MSK**Y/[#XU_P"AC\/_ /A*WO\
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M7E[2.(IU7S1]A&RY8O6[UT\SCQE&I6A"-.-VI7=Y):6MIJ[^A_F_T5_H1?\
M$)=^P7_T6K]I[_PI? 7_ ,P-'_$)=^P7_P!%J_:>_P#"E\!?_,#7[1_Q%W@?
M_H/QG_ANQ?\ \AZ_T]//^HXG^2/_ (''R_S?W>9_GNT5_H1?\0EW[!?_ $6K
M]I[_ ,*7P%_\P-'_ !"7?L%_]%J_:>_\*7P%_P#,#1_Q%W@?_H/QG_ANQ?\
M\AZ_T]#ZCB?Y(_\ @<?+_-_=YG^>[17^A%_Q"7?L%_\ 1:OVGO\ PI? 7_S
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MRW#8+,Z%66$S*&)KJIBL'.C24:2I0NG4FE)\WNI7U/OVBN3^P^-?^AC\/_\
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MP,]UX)UFTL_V<O@Q-HVAW\%O'?/?3ZSJUE->65K#=:8N$NHO3?AM/X@^.O\
MP5:_9B\)>(_V(_!'_!/+XA_LB_#GXI_M":Q/=^.?A7KGQ"_:5^%'Q:\%Z_\
M!!? WPRE^".F77AGQ/\ #;P=X_UC0O%GQC_X2?Q3%?>$_%&A_#*&U\+2-XEL
MM>A /Z"K3QYX&O\ QEK/PZL?&?A2]^(/AS1-)\2^(? MIXBTBY\9:#X<U^XO
MK30M?UGPQ#>/K>EZ)K5UIFI6VDZK?6,%CJ-QI]]#9SS26DZQUK3XD?#N_P#
MDOQ2L/'O@N]^&4.AZAXGF^(MIXIT.Y\"1>&M)AN;G5?$,OBZ&^?P_'H>F6]G
M>3ZAJS:@+"RAM;F6YN(T@E9/Y,_V;_VU?A-=_P#!3_P7^UOI^O>+Y?$/[87[
M8'[2?[&WC>YN/@_\7=#^'[_LVVVB^$?A[^Q'KNG?&+Q!\/['X/>(K34/B?\
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M_LI;C^P1'25$DC=9(Y%5XY$8.CHX#(Z,I*LK*0RLI(8$$$@T .HHHH ****
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M26'[6/PO_9CEUV_^)?B^W\3>&O$>BZ[\#O&W[0#:MI?AW2M,TZ\\1W/AC6M
M\4ZA#::AID6D@']*U%? 7[!?Q/\ CMXL'[4WPE_:&\>^&_BUXZ_9C_:5O?@[
M9?%CP[X&M?AHWC_PKJWP>^$/QDT+4=>\#Z9J6K:+HGB#1D^*ESX5NVT2\&G:
ME:Z#8ZG]G@O+N\#??M !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!\Y_M*?LQ> /VJ_#O@'P3\4]2\4R> /!?Q;\ ?%_6? FB7^F
MV7AGXHZE\,M6'B;PAX/^)]K>Z1J5SX@^'MIXRM-!\7:EX7L;O2(]=U;PSHMK
MK%U>:$-1TC4?F/\ :?\ ^"7/P(_:C\4?'KQ;KGCGXS_##5?VE?A3\(?A?\7D
M^$GB7PKH5CXEN_@%\5M(^+7P:^*+67B3P3XLAC^*_P /]3TN;PII'B=UFL[C
MP+JEWX>U31[\V>B7FE?2G[8OQZ?]E_\ 9;^.WQ]MM*77M6^&/PX\0:_X8\/R
M"4Q^(O&CVW]F^!_#DODD2K%K_B^_T31Y'C(>-+UG#*5R/B#P3^WU\1_!'_!1
M33?V!_CYHF@77A_5OV=?@5>^%/C]HFG2Z)8^(?VJ/$VA?%+Q)XT^&7B.R;5+
MC2]'3X@>#_AAXF\9_"BRLK*SQ_PA/B_09;W6+ZYTJ*V -#7_ /@E-'\0_A[\
M5?A/\;?V_/V_?CS\-OB]X O_  !XC\&_$_QW\ I])T^&\UO0==@\3:$?"/[.
M?A*]M?%&F3Z#':Z=<WMWJ&EQV>HZDEQI%S-);3VOU=^T?^QS\//VD_&GP3^)
MNL>*OB)\-OBC\ +_ .(DOP^^(GPLUC1-%\2Q:!\6? >I?#[XB>!]:_X2'PYX
MITK6/!WB;3;O2=:N=,GTQ;BU\5>$?"6OZ??6EUH^+C'_ &1/VG-2^.WPY^)W
MC3XCIX/\'7'@K]JG]J7X#Z0+&\ETW3]0\/\ P.^-_C;X;>&;^Y?6]0N&DU_4
M]!\-6E]K8MIH[2346NYK*SL[4I;1;O[37CG]I >#/ ND_L9Z!\-O%OQ ^(?Q
M,TOP9JWQ(^(DEUXC^%/P2\$1Z)XA\1>*OB;XO\,^%O%7A7Q+XZDM%T&R\(>&
M_!OASQ)HUUJ/B_Q=H,VK:OI6@V>J7: '*^,/V!_@?XM_8P\"?L,I<^-/#/PI
M^%_AGX(Z#\.O$WAG5M(M/B3X0U7]GG7?!OBGX7>.-*UZ^T#4='_X3/1_$_@3
M0=>O-2N?#MQ9ZG?B_P#M.G&"^EAK>U[]B?X->)/VS_ 7[=>IR>+6^,_P\^$&
MK?!S1=.@UJU@\ WFEZC?ZY<6?B[6?#::7]IO_'GAW3/%WCKPQX=U[^UH8-/\
M->.O%&FMIT[7L$]K\C>!_P!I[]O3XQ?!D^#?A=X"^ EW^TSX0_:\^)/[*7QB
M^-DEEXNU7]E_P1H7PFTC5?$/B+X[:;\/#XVT+XE:_'K0@T#X:V/PKL_'LMWX
M>^+NL:MI.M^-GT'PO>ZA<>=Z)^WG^UQ\1_#WP@_9]\!>'_@'I?[9/CG]I;]I
MW]GWQC\5-0T3Q]XI_9D\/^%OV/2TWQ:^-GAWP/9>*_#WC[7(M=N]3\$^ =$^
M'%W\0M/;PU\2/$^LZ5K?CB_M/!T[ZP ?>GAS]ASX)Z'^RC\4_P!CO4?^$G\7
M_"WXV6_[02?%+4_%.HZ7=>,_&%]^TUXI\<>,/BEK.HZOIVB:9IPU:[U?Q_K?
M]CW,.BQII-I;Z3;1PRKIZ,_T;\,O!$?PS^''@#X<0^(_$GB^'P!X+\+^"H?%
M?C&ZL+WQ=XEA\+:)9:)#KWBB]TK3='TR\\0ZM'8K?:S=V&DZ9:7.HSW$]O86
MD3K GY;>&?V\_C.O@3X+>*_B1H'@/1/$W@?_ (*!S?L"?MD:%X1CU2\\(?V]
MXGOM1^'GPY^)?POU/6I6U_1]#\1>._%GP'\76^B:V=4N]-\)_$#7/#NKWMUJ
M6BQ:X/V!H **** "BBB@ HHHH **** "BBB@ KYT_:U_9E\#_MC_ +.WQ/\
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M7%CXT^$$_CG7?B]\0O$=_;_#_6+OQ?H,,?@3PIKOBAM$U?4)]-T=P#[*MO\
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M:NTL8;.RMK318+A7^RRN_P"SE% 'Y[?&+X>>.]9_X*4?L2?$K2?"6MZC\/\
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M_P#"3>+)_!_P[TV1]&^'^@W%SM_ "']H_P"./B+_ ()O_ GQQ^R[\8/A1?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img12876764_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_7.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,A!@P# 2(  A$! Q$!_\0
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M $/0_P#":\8?_,_0![_17@'_  U'\"?^AZ'_ (37C#_YGZ/^&H_@3_T/0_\
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M )GZ/^&H_@3_ -#T/_":\8?_ #/T >_T5X!_PU'\"?\ H>A_X37C#_YGZ/\
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MS] 'O]%> ?\ #4?P)_Z'H?\ A->,/_F?H_X:C^!/_0]#_P )KQA_\S] 'O\
M17@'_#4?P)_Z'H?^$UXP_P#F?H_X:C^!/_0]#_PFO&'_ ,S] 'O]%> ?\-1_
M G_H>A_X37C#_P"9^C_AJ/X$_P#0]#_PFO&'_P S] 'O]%> ?\-1_ G_ *'H
M?^$UXP_^9^C_ (:C^!/_ $/0_P#":\8?_,_0![_17@'_  U'\"?^AZ'_ (37
MC#_YGZ/^&H_@3_T/0_\ ":\8?_,_0![_ $5X!_PU'\"?^AZ'_A->,/\ YGZ/
M^&H_@3_T/0_\)KQA_P#,_0![_17@'_#4?P)_Z'H?^$UXP_\ F?H_X:C^!/\
MT/0_\)KQA_\ ,_0![_17@'_#4?P)_P"AZ'_A->,/_F?H_P"&H_@3_P!#T/\
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M_5+BO_HF>(?_  RYE_\ ,WFOO#V]#_G]2_\ !D/\S]K:*_%+_B(F_P""./\
MT>&G_A@?VH?_ )R='_$1-_P1Q_Z/#3_PP/[4/_SDZ/\ 5+BO_HF>(?\ PRYE
M_P#,WFOO#V]#_G]2_P#!D/\ ,_:VBOQ2_P"(B;_@CC_T>&G_ (8']J'_ .<G
M1_Q$3?\ !''_ */#3_PP/[4/_P Y.C_5+BO_ *)GB'_PRYE_\S>:^\/;T/\
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M0_\ S?YK[S]6**_*?_A]S_P3 _Z.<7_PS7[07_SJ*/\ A]S_ ,$P/^CG%_\
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M/_!,#_HYQ?\ PS7[07_SJ*/^'W/_  3 _P"CG%_\,U^T%_\ .HH_XA1XI?\
M1M>/_P#Q#N(O_G=YK[P_XB9X<?\ 1P."/_$KR'_YO\U]Y^K%%?E/_P /N?\
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M ,ZBC_A]S_P3 _Z.<7_PS7[07_SJ*/\ B%'BE_T;7C__ ,0[B+_YW>:^\/\
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M'_1SB_\ AFOV@O\ YU%'_#[G_@F!_P!'.+_X9K]H+_YU%'_$*/%+_HVO'_\
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M=UZ].5-5J%!+WG6K4X4U%J;ERM-_FW1117Z ?$!1110 4444 %%%% !1110
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M69SF&58W"95G*J/*LPK4)PPF/5&WM/J]:W)/EYD[7NU=I-1E;FZ*_1[]CO\
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MKDL?*S:>)+JU$@)-R(_WE?EO^T3^RQ\?_P!D[Q?:>!?V@OAKK'PZ\1:CI_\
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M,U^<W_!)/_E'9^RW_P!D^'_IXU2OT9K_  Z\1O\ DX/'/_97\2?^KC&'^QG
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ML157MYXB,I5(TZ2I?FC\*/\ @VNFUKX::;JGQ=_:0O\ PA\3M7TT7LV@^$_
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MTL?CZ.-RA5\=5PM2E&MAL7AIXJIAWA<2\-#'2K1E2G16)5:I&5:?\]W[;O\
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M6[Q]_P!?^F_^F'2J^,/K#PZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-&ZKN-&5&,4E-WG.[YI;:>2TM;M?NV_]"#_@E'_P5<_9%_;2_P""=6N_LO\
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MG&7L/90JJ,:4TG&44K<LGIO>IXJ,^9O#TN:5[RM=W?6[6^_X=M?]!3_@@?\
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M/AUX>OO['N;PV&O^'M9TW4;XWUI-INE>=?\ !N1I?[.?AW]O&7]H3]IGXW_
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M5.<5[LZ4YP>DKK&.)G&LZT4DY-N4=>5I[Q_R?1V9_1!_P<R_&SX,_'G_ (*
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M5/FY8SIN+E./.Z=2I"=4L1*GSIPC.%1WE"6U[WNGT?G9]':Z1_HP_#GXQ_\
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M %%%% ']&G_!NQ_R-G_!2/\ [1Q_&_\ ]':37Q(W4_4_SK[;_P"#=C_D;/\
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M/I%U+)X2\,7LU_9Z5??PNT5_-M+Z+6#E#!Y)F?B9Q[F_ 6 Q-.OA^"<7CW'
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MUF\\+W%U9Z)X-\*WM]:Q'Q'I%MJ:-K][XGT</X>U,VGA^3P[K&L6,EY*/O\
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M74M+\87&M^'O$&C:A;M-;RM;W4%IJ.GW<+2PNR131ET()\7?9O;R]Q3<VPN
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M8SBJG5H\19QE-.<L=CJ5>-:-=4FJ>'6'G45>M^\F\2Z3K5ZM%4\15]O'U_\
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M.:+-8VVIZO>:KXIUC0M$L[2VNM4TZTW76I0M-=WUI:VZ2W$\<;>)>(O#NO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =@?\
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MON?$7C"SN=(L6N?$FI+>7SU^B?Q _P"5:G2O^T37PJ_]9T\'U_+E_P &LO\
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M -':37Q(W4_4_P Z^V_^#=C_ )&S_@I'_P!HX_C?_P"CM)KXD;J?J?YU^M^
M'_(W\2?^POA7_P!56+/XK^EI_P C+@?_ +%N=?\ J9@Q****_I4_D,**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O;_V9?\ DY']
MGS_LM_PH_P#4\T"O$*]O_9E_Y.1_9\_[+?\ "C_U/- KR\\_Y$N<?]BO,/\
MU$K'I9-_R.,J_P"QE@?_ %*I']X'_!6']L/Q=^Q'^RBGQ:^'.C:)J7Q'\0^/
MO#GPS\%ZGXATQ-7TOPQ?^(M'\1:_J6O7%@;NRDNFBT'PEJEG90K.T']K7FFS
MW]I?:?!=6<WS9_P1&_X*"?&G]MCP!\9?#'Q]U"R\4_$#X-ZSX4NT\>V6@:%X
M8;Q'X:^(G_"4RZ58:II'AJUTO0EU7P_>>%-6M!>:7H>D6]SHT^BI=0WFK0:G
MJ=]QO_!QM_R8E\./^SGO /\ ZJ_XR5\>_P#!L?\ \A#]M/\ Z\_V>O\ T?\
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MW%?_ $.\9_Y2_P#E7DON*^K4/^?<?Q_S\OS[L_G/_P"(9?\ 8J_Z.1_;^_\
M#_\ @W_YSU'_ !#+_L5?]'(_M_?^'_\ !O\ \YZOZ,**/]=N*_\ H=XS_P I
M?_*O)?<'U:A_S[C^/^?E^?=G\Y__ !#+_L5?]'(_M_?^'_\ !O\ \YZC_B&7
M_8J_Z.1_;^_\/_X-_P#G/5_1A11_KMQ7_P!#O&?^4O\ Y5Y+[@^K4/\ GW'\
M?\_+\^[/YS_^(9?]BK_HY']O[_P__@W_ .<]1_Q#+_L5?]'(_M_?^'_\&_\
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M -#O&?\ E+_Y5Y+[@^K4/^?<?Q_S\OS[L_G/_P"(9?\ 8J_Z.1_;^_\ #_\
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MC^/^?E^?=G\Y_P#Q#+_L5?\ 1R/[?W_A_P#P;_\ .>H_XAE_V*O^CD?V_O\
MP_\ X-_^<]7]&%%'^NW%?_0[QG_E+_Y5Y+[@^K4/^?<?Q_S\OS[L_G/_ .(9
M?]BK_HY']O[_ ,/_ .#?_G/4?\0R_P"Q5_T<C^W]_P"'_P#!O_SGJ_HPHH_U
MVXK_ .AWC/\ RE_\J\E]P?5J'_/N/X_Y^7Y]V?SG_P#$,O\ L5?]'(_M_?\
MA_\ P;_\YZC_ (AE_P!BK_HY']O[_P /_P"#?_G/5_1A11_KMQ7_ -#O&?\
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M?E^?=G\Y_P#Q#+_L5?\ 1R/[?W_A_P#P;_\ .>H_XAE_V*O^CD?V_O\ P_\
MX-_^<]7]&%%'^NW%?_0[QG_E+_Y5Y+[@^K4/^?<?Q_S\OS[L_G/_ .(9?]BK
M_HY']O[_ ,/_ .#?_G/4?\0R_P"Q5_T<C^W]_P"'_P#!O_SGJ_HPHH_UVXK_
M .AWC/\ RE_\J\E]P?5J'_/N/X_Y^7Y]V?SG_P#$,O\ L5?]'(_M_?\ A_\
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MAWC/_*7_ ,J\E]P?5J'_ #[C^/\ GY?GW9_.?_Q#+_L5?]'(_M_?^'_\&_\
MSGJ/^(9?]BK_ *.1_;^_\/\ ^#?_ )SU?T844?Z[<5_]#O&?^4O_ )5Y+[@^
MK4/^?<?Q_P _+\^[/X?/^"I7_!'/X$?L6Z7^QZOPG^/W[8VJP_M)_MB_"O\
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M_P#\.;\*_P#YQE'_ !"?_P#!-?\ Z*/^U_\ ^'-^%?\ \XROZ;Z*/]?^,_\
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M_P XRC_B$_\ ^":__11_VO\ _P .;\*__G&5_3?11_K_ ,9_]%'F7_@V/_R
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MA7_\XROZ;Z*/]?\ C/\ Z*/,O_!L?_D ^JX?_GU#[G_GY?GW9_,A_P 0G_\
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M,_\ HH\R_P#!L?\ Y /JN'_Y]0^Y_P"?E^?=G\R'_$)__P $U_\ HH_[7_\
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M_#3_ .<C7]+U%'_$2.//^BJSG_PJE_EY+[@_L;*?^A;@O_":EY?W?)'\T/\
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M?TO44?\ $2.//^BJSG_PJE_EY+[@_L;*?^A;@O\ PFI>7]WR1_-#_P 0J_\
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M/[&RG_H6X+_PFI>7]WR1_-#_ ,0J_P#P3M_Z*W^VA_X=OX:?_.1H_P"(5?\
MX)V_]%;_ &T/_#M_#3_YR-?TO44?\1(X\_Z*K.?_  JE_EY+[@_L;*?^A;@O
M_":EY?W?)'\T/_$*O_P3M_Z*W^VA_P"';^&G_P Y&C_B%7_X)V_]%;_;0_\
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M_P *I?Y>2^X/[&RG_H6X+_PFI>7]WR1_-#_Q"K_\$[?^BM_MH?\ AV_AI_\
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M>9_8J_X+ ?\ !+/P-^QM^R7X*\7_ /!0+]DOPYXM\'_LR_ ;PMXH\/:M\;O
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M/AV[@OY[H7_BN[&HK>JET;E8(U !_5A17\L?[7/[??\ P4G_ &\?^"@WQ/\
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M.O _BJ37'N/#OACP3\/?&VJ:PUNP!^]U%?QG?M?1?\'&?_!(GX):Q^W!KO\
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MX<T?Q=KFGO?>/-)N=*TGPKIS6UIXP\&:_P"$/!'B?PCING^*0#^CRBOYB?\
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MV3_V[-!^&VD?MD_L _%C1OAA\3-<^&!2S\-_$/1M;?Q5H^G>*8]*M[BZT?\
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M^#_A%\)O ^G'4O$WCGQOK%MHVBV,3L(K*RMVG;[3JVNZS=O#I?AWPWH]O?\
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MB5[V:%&ECMA(\:LZJ" ?CU^S]_P4#^-O[9__  6<_:8_9G^!WBS1/#W[%/\
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MSJ^H07=U/JLVE/=6\!N=3DA23[)_X(-Z[\(==_X)!?L!-\%[G1I_#NE_LY^
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M\.7_ %]K?^G9GS/^VG_R9Q^UG_V;/\>/_56^*J^&?^""'_*(O]B__L3?'O\
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M2RNKWQ3X\UW1=#\5ZM8#7M675-9O++POX7FT70I=031?"?AO1O#5AI>D:?\
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M->F3PMHGP)AAM=5VZ/XCT#4XC:V !#_P:\_V;JWQE_X+C^-/A^U_<_ OQ/\
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M\'7$6FZIH&F7-A=>'FETJTT[5-)U#17NM-N/QF_X)%_L3_\ !9/_ ()\^,/
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M$E_@[_P59^,W[7W_  6/\*?L0_\ !1[X:?LA_$3P=^W/\0]5_:-\(^/OV;_
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MU&^N[R::>0 Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^>K_@X$_Y!?_!+[_M*+^SC
M_P"B_$=?T*+T'T'\J_GK_P"#@3_D%_\ !+[_ +2B_LX_^B_$=?T*+T'T'\J^
MIS;_ ))GA/US[_U/HF,/XU?_ +A_^DL6BBBOEC8**** "BBB@ HHHH ****
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M&LX=.TC1-$TC3OV(+;3]*TG2M/MK>QT[3K&W@L[*S@AMK:&*&)$4 _K-
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MC6? .@>&-+$B0.+?_A'_ !?XH+N5$@B!+  _="-Q(B2 $!T5P&&& 8!@& )
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M>(]:O-(^%_A>\U^2[O3H7CKQ%K?B*Z\4^%Y=*TCP5I.A?9__  62_P""(W[
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M;C7FM-,TG0=2?QGXWL]9BTN#Q#J7BJTM_ASKWB+Q-)XLL_%JWO\ 9/7X0?\
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M%M  ?LM1110 4444 %%%% !1110 4444 %%%% '\]'_!+K_E+C_P7-_['_\
M9G_]-WQCK^A>OYZ/^"77_*7'_@N;_P!C_P#LS_\ IN^,=?T+U]1QA_R.H_\
M8EX8_P#6:RDPP_\ #E_U]K?^G9GS/^VG_P F<?M9_P#9L_QX_P#56^*J^&?^
M""'_ "B+_8O_ .Q-\>_^KD^(]?;G[<-]:Z9^Q7^U_J5]*(++3_V7/V@+Z\G*
M22"&UM/A/XMGN)2D2O*XCBC=]D:/(V-J*S$ _P [_P#P2'_X+0_\$S_V9O\
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M&3_:1_\ G.T?\1"__!'G_H\?3_\ PR?[2/\ \YVC_5/BK_HF>(/_  S9C_\
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M>WH?\_J7_@R'^9^T%%?B_P#\1"__  1Y_P"CQ]/_ /#)_M(__.=H_P"(A?\
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M&3_:1_\ G.T?\1"__!'G_H\?3_\ PR?[2/\ \YVC_5/BK_HF>(/_  S9C_\
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M\_\ 1X^G_P#AD_VD?_G.T?\ $0O_ ,$>?^CQ]/\ _#)_M(__ #G:/]4^*O\
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M_P"&3_:1_P#G.T?ZI\5?]$SQ!_X9LQ_^9@]O0_Y_4O\ P9#_ #/V@HK\7_\
MB(7_ ."//_1X^G_^&3_:1_\ G.T?\1"__!'G_H\?3_\ PR?[2/\ \YVC_5/B
MK_HF>(/_  S9C_\ ,P>WH?\ /ZE_X,A_F?M!17XO_P#$0O\ \$>?^CQ]/_\
M#)_M(_\ SG:/^(A?_@CS_P!'CZ?_ .&3_:1_^<[1_JGQ5_T3/$'_ (9LQ_\
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MOF_]4^*O^B9X@_\ #-F/_P S&OMZ'_/ZE_X,A_F?M!17XO\ _$0O_P $>?\
MH\?3_P#PR?[2/_SG:/\ B(7_ ."//_1X^G_^&3_:1_\ G.T?ZI\5?]$SQ!_X
M9LQ_^9@]O0_Y_4O_  9#_,_:"BOQ?_XB%_\ @CS_ -'CZ?\ ^&3_ &D?_G.T
M?\1"_P#P1Y_Z/'T__P ,G^TC_P#.=H_U3XJ_Z)GB#_PS9C_\S![>A_S^I?\
M@R'^9^T%%?B__P 1"_\ P1Y_Z/'T_P#\,G^TC_\ .=H_XB%_^"//_1X^G_\
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MT%%?B_\ \1"__!'G_H\?3_\ PR?[2/\ \YVC_B(7_P""//\ T>/I_P#X9/\
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M8/;T/^?U+_P9#_,_:"BOQ?\ ^(A?_@CS_P!'CZ?_ .&3_:1_^<[1_P 1"_\
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M/_\ #)_M(_\ SG:/]4^*O^B9X@_\,V8__,P>WH?\_J7_ (,A_F?M!17XO_\
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MY_Z/'T__ ,,G^TC_ /.=H_XB%_\ @CS_ -'CZ?\ ^&3_ &D?_G.T?ZI\5?\
M1,\0?^&;,?\ YF#V]#_G]2_\&0_S/"/^"77_ "EQ_P""YO\ V/\ ^S/_ .F[
MXQU_0O7\RG_!$[XV_##]HS_@H_\ \%G/C3\&?%">-/AEX_\ %?[,VM>$?$\>
MDZ[H::OIC6OQIMA=+I7B;2]%URR!GMYD\K4=,LY_DW&+8RLW]-==?&M*I1SZ
M5&M3G2JTLHX;IU:56$J=2G4APYE49TZD))2A.$DXRC)*49)II-$89ITVTTTZ
MM5IK5-.K*S3ZIGS+^VLB2?L;?M:QR*KH_P"S+\>4='4,CHWPL\5JRLK AE8$
MAE((()!&*_,#_@AE\ ?@1XO_ ."4G['OB/Q9\%/A)XG\0ZIX0\<2ZEKWB+X;
M^#M:UG49(?B[\0K:*2^U34M&N;Z[>*V@AMXWN)Y&2"&*)2(XT4?J#^VG_P F
M<?M9_P#9L_QX_P#56^*J^&?^""'_ "B+_8O_ .Q-\>_^KD^(]5AJM6EP7CI4
MJE2E)\496G*G.4&U_9.;NS<6FU=)VVND^@-)XF-TG^XGOK_R\IGZ$_\ #+O[
M,W_1NOP*_P##1^ /_F?H_P"&7?V9O^C=?@5_X:/P!_\ ,_7NM%?-_7<9_P!!
M>)_\'U?_ ),VY8_RQ^Y?UT7W'A7_  R[^S-_T;K\"O\ PT?@#_YGZ/\ AEW]
MF;_HW7X%?^&C\ ?_ #/U[K11]=QG_07B?_!]7_Y,.6/\L?N7]=%]QX5_PR[^
MS-_T;K\"O_#1^ /_ )GZ/^&7?V9O^C=?@5_X:/P!_P#,_7NM%'UW&?\ 07B?
M_!]7_P"3#EC_ "Q^Y?UT7W'A7_#+O[,W_1NOP*_\-'X _P#F?H_X9=_9F_Z-
MU^!7_AH_ '_S/U[K11]=QG_07B?_  ?5_P#DPY8_RQ^Y?UT7W'A7_#+O[,W_
M $;K\"O_  T?@#_YGZ/^&7?V9O\ HW7X%?\ AH_ '_S/U[K11]=QG_07B?\
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M ,F'+'^6/W+^NB^X\*_X9=_9F_Z-U^!7_AH_ '_S/T?\,N_LS?\ 1NOP*_\
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MOFPOM&/WP'[+O[,V!_QCM\"N@_YI'X _^9^OQ@_X.!/^07_P2^_[2B_LX_\
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MP!_\S]>ZT4?7<9_T%XG_ ,'U?_DPY8_RQ^Y?UT7W'A7_  R[^S-_T;K\"O\
MPT?@#_YGZ/\ AEW]F;_HW7X%?^&C\ ?_ #/U[K11]=QG_07B?_!]7_Y,.6/\
ML?N7]=%]QX5_PR[^S-_T;K\"O_#1^ /_ )GZ/^&7?V9O^C=?@5_X:/P!_P#,
M_7NM%'UW&?\ 07B?_!]7_P"3#EC_ "Q^Y?UT7W'A7_#+O[,W_1NOP*_\-'X
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MP!_\S]>ZT4?7<9_T%XG_ ,'U?_DPY8_RQ^Y?UT7W'A7_  R[^S-_T;K\"O\
MPT?@#_YGZ/\ AEW]F;_HW7X%?^&C\ ?_ #/U[K7)>.O'_@3X7^%=5\=?$SQK
MX2^'?@C0A9'6_&/CKQ)H_A'PKHPU+4;32-..J^(=?O=/TC3A?ZM?V.F61N[R
M$76HWMI90>9<W,,3GUW&?]!>)_\ !]7_ .3#EC_+'[E_71?<>;_\,N_LS?\
M1NOP*_\ #1^ /_F?H_X9=_9F_P"C=?@5_P"&C\ ?_,_7KOA[Q#H'B[0-$\5>
M%-<T?Q/X7\2Z3IVO^'/$GA[4[+6M \0:%J]I#J&DZUHFL:;/<Z=JNDZI87$%
M[IVHV%Q/9WMI/#<VTTL,J.VQ1]=QG_07B?\ P?5_^3#EC_+'[E_71?<>%?\
M#+O[,W_1NOP*_P##1^ /_F?H_P"&7?V9O^C=?@5_X:/P!_\ ,_7NM%'UW&?]
M!>)_\'U?_DPY8_RQ^Y?UT7W'A7_#+O[,W_1NOP*_\-'X _\ F?H_X9=_9F_Z
M-U^!7_AH_ '_ ,S]>ZT4?7<9_P!!>)_\'U?_ ),.6/\ +'[E_71?<>%?\,N_
MLS?]&Z_ K_PT?@#_ .9^C_AEW]F;_HW7X%?^&C\ ?_,_7NM%'UW&?]!>)_\
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M@5_X:/P!_P#,_1_PR[^S-_T;K\"O_#1^ /\ YGZ]UHH^NXS_ *"\3_X/J_\
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M_7NM%'UW&?\ 07B?_!]7_P"3#EC_ "Q^Y?UT7W'A7_#+O[,W_1NOP*_\-'X
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MRSP30QQZQ96;/+#+&H+QN!Z)1]=QG_07B?\ P?5_^3#EC_+'[E_71?<>%?\
M#+O[,W_1NOP*_P##1^ /_F?H_P"&7?V9O^C=?@5_X:/P!_\ ,_7NM%'UW&?]
M!>)_\'U?_DPY8_RQ^Y?UT7W'A7_#+O[,W_1NOP*_\-'X _\ F?H_X9=_9F_Z
M-U^!7_AH_ '_ ,S]>ZT4?7<9_P!!>)_\'U?_ ),.6/\ +'[E_71?<>%?\,N_
MLS?]&Z_ K_PT?@#_ .9^C_AEW]F;_HW7X%?^&C\ ?_,_7NM%'UW&?]!>)_\
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MK\"O_#1^ /\ YGZ/^&7?V9O^C=?@5_X:/P!_\S]>ZT4?7<9_T%XG_P 'U?\
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MQ+!X,T^Z7XLS>(4\!-;7WC"ZMO"EG.-?,5UXEN(-"@=]4FCM6\<^*7_!2?\
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MCV5Z\,UQ:13+')>6JS?S+^,OA5XE_P"#C#_@KS^TW\(?BUXT\<Z7_P $G/\
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M0S3VUW?^']'UBYUJUL+J*UO#:ZA+8K8W+6&H1P7$DFGWJ0?5E?PA_P#!Q_\
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M0]9&K^#_ !-X?U'7/$P!]6_\%NO^"J_PU_X)U?L9?M!ZMX#^/GP8T']M?3O
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M?0?$'A74[AU5-.\6V6H>(86\*7\:O%<7-IXB.F7%G9307]W'!97$-Q)^"/\
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M?#O4M)_:(^!?AO\ ;$^-WQ VZU\</VF?CW!J&M_%CXF>.;NW@BU77M$OX-7
M^#_AZ%8(-,\)^!/A9<>'-#\*>'+#3-,1]4U&'4-=U3\E/^#331_$OPCO/^"O
M?P3M?&0U/]EWX"?MC'PA\%_[2\02W=KI-_X?U#XK:-\0M>"W-_<Z=IVFZWX.
M\._"+4)=2@D$6HW-KJ%U<W5SY'G* ?UN_%+XP?"7X&^$;OX@?&SXH_#KX/>
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M-XBOVB5/$.OZ/XM^$GQ"LU\3O)'J6L>%W\+?V];7.O6NI>(_$?W+_P %>_\
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MI27XB>'K70_&MIXS/CW^Q+0Z#H_@>RM_$.I?#NPO/B+JWA.WT_P@ >F?MI?
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M\-?#/P^6?5K?Q)KWC^TNOFK_ (,L_P#E&3^T=_V?_P#%#_UG_P#9DH ^A/\
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MX ?$?_@JK_P34\*_$7Q->_"WXD?'OX9_\,T1^$/%^K:Y-?:UHOPV^(>L^/\
M3-.\9:-/8W%KJ7B?1=6\/>'?$UWK&HV7C-OAI\($US4='\3?1'_!/7XC>)/V
MK?\ @O7HOQ._X+2W'CG]G?\ ;^^&'@O5=!_8C_8G\0?!6\\,? *VT632O&['
MQ3\,OBNWC7QM:_$2]T;2(/B'KUO>^)+"ST[Q#XSU6/7O OC[7KSPAI7A?PR
M?W8ZGJ>FZ)INH:SK.H6.DZ/I-C=ZGJNJZG=V]AINF:;80275]J&H7UU)%:V5
MC96L4MS=W=S+%;VT$4DTTB1HS#^5'_@W>U_Q%XO^%/\ P54_X*W_ !$5-4N_
MVO?VG?BMX_T#0](LS;13?";]GRS\5W/AFPT;6-6CBU<V%KJGB7QAX,T33=8C
MD_LFQ\-6=Y-/)?:IJ<<7Z2?\' O[4FG_ +)G_!)']L/QJVJMIOB?XC?#F\^
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MFWO?$OASQ#X>T/P;JW@3P_IOA>3Q'<^*_$)X']J[]FC]IW_@V*\6?!K]M_\
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MCOQ__8=_X-EOV7_A)JGQO^-?P5_8)\(?#RPL-9N].U%O$.BZGJ?C*]T.PO\
M4;OPU\._#^E^*[O6_B#XQG@TR]33_"7@^QUC7[^XMY8;:P=XY-GW=^UG\"(_
MVZOA3=?!/]K7_@GMX$^-GPXGO[;2;72/$OQ3TNRU;P]\5[7*0_%/P5XQ\/2:
M)XU\"?!P6LESIDWQ)\&>(O#_ ,?;C1K_ %30Y_@U-I&JZC97?Y/_  9_X-W/
M^"?GP6\>:?\ $.Q_X)86GQ&U?1M9NM,T71?C+^U!X@^)_@.Q\?7"HD'B*_\
MAWXCUB;P1XS_ &8=/B\]+;5_B%H/BSXORM</<:A\#;^[M]/N+,_MG"?\^,T_
M\,V;?_,8?\0VS_\ Z&? O_BR?#__ .B7S_/LS[F_8.TC]C+2O^";'QG_ &P/
M^"7_ .QAXA_90B^/OP,\=^//"WA;6_AO8?"?XK_$'6/AYX-\<GX4:A>I%KGC
M2TO=(GU34]1O/ASK=EKFM^&;RR\23^(M!>[T_6VNKW\E?^#27]KO]B[X6_\
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MY#^)?[!O[*/Q@_:G^"G[:WQ%^%7_  D7[37[.VA:CX:^#GQ+_P"$Y^)&D_\
M"'Z+JL?B6*_LO^$-T+QAIGP_\0?:$\7^(E^T^*?"FMW<7]HYAGC-I8FV /'O
M^"K_ .UM\=?V%/V(/BO^UC\ ?A#X;^./B+X+MH?B?QCX!\2W^L:;!-\,GU%-
M,\9>([*]T207MO/X.@O[3Q3J,K6U];Q^&])UV26V0(M[:?&W[/?Q$_X(6_\
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M^&C_ -K>^_LW7_#NI6VKZ/?_ &+4OCU>:=>?8]1L[:X^RW]I=65QY?E75M/
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M_P#Z(*ON#]B'_@DA_P $]O\ @G%XH\<>-/V,OV?O^%-^)?B1H.F^&?&FI?\
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M.GA^%[*#4S\-/V==)CUZSN#-K-A)I5W9Z]X6M_CHFGZ;<S7UM<:_X8TZ6_\
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MRTO=)UG2-0MI)+>^TS4[.YL[J!WAN()(V92 ?+?PH_X*"?L-_%_X5>&OB_\
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M[G5;ZRNM6DGOY0#\;_\ @[T^(<GA[_@E7HGPLTFZ@E\4?M _M0_!_P"'&D:
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M^'?_ !*N'/+_ *FGG_5U<]O#^6K_ .":WE_<\_ZNK_T+T5_/1_P\*_X+A_\
M2$NR_P#$M_AI_A1_P\*_X+A_](2[+_Q+?X:?X4?ZH9I_T%\._P#B5<.>7_4T
M\_ZNKGMX?RU?_!-;R_N>?]75_P"A>BOYZ/\ AX5_P7#_ .D)=E_XEO\ #3_"
MC_AX5_P7#_Z0EV7_ (EO\-/\*/\ 5#-/^@OAW_Q*N'/+_J:>?]75SV\/Y:O_
M ()K>7]SS_JZO_0O17\]'_#PK_@N'_TA+LO_ !+?X:?X4?\ #PK_ (+A_P#2
M$NR_\2W^&G^%'^J&:?\ 07P[_P")5PYY?]33S_JZN>WA_+5_\$UO+^YY_P!7
M5_Z%Z*_GH_X>%?\ !</_ *0EV7_B6_PT_P */^'A7_!</_I"79?^);_#3_"C
M_5#-/^@OAW_Q*N'/+_J:>?\ 5U<]O#^6K_X)K>7]SS_JZO\ T+T5_/1_P\*_
MX+A_](2[+_Q+?X:?X4?\/"O^"X?_ $A+LO\ Q+?X:?X4?ZH9I_T%\._^)5PY
MY?\ 4T\_ZNKGMX?RU?\ P36\O[GG_5U?^A>BOYZ/^'A7_!</_I"79?\ B6_P
MT_PH_P"'A7_!</\ Z0EV7_B6_P -/\*/]4,T_P"@OAW_ ,2KASR_ZFGG_5U<
M]O#^6K_X)K>7]SS_ *NK_P!"]%?ST?\ #PK_ (+A_P#2$NR_\2W^&G^%'_#P
MK_@N'_TA+LO_ !+?X:?X4?ZH9I_T%\._^)5PYY?]33S_ *NKGMX?RU?_  36
M\O[GG_5U?^A>BOYZ/^'A7_!</_I"79?^);_#3_"C_AX5_P %P_\ I"79?^);
M_#3_  H_U0S3_H+X=_\ $JX<\O\ J:>?]75SV\/Y:O\ X)K>7]SS_JZO_0O1
M7\]'_#PK_@N'_P!(2[+_ ,2W^&G^%'_#PK_@N'_TA+LO_$M_AI_A1_JAFG_0
M7P[_ .)5PYY?]33S_JZN>WA_+5_\$UO+^YY_U=7_ *%Z*_GH_P"'A7_!</\
MZ0EV7_B6_P -/\*/^'A7_!</_I"79?\ B6_PT_PH_P!4,T_Z"^'?_$JX<\O^
MIIY_U=7/;P_EJ_\ @FMY?W//^KJ_]"]%?ST?\/"O^"X?_2$NR_\ $M_AI_A1
M_P /"O\ @N'_ -(2[+_Q+?X:?X4?ZH9I_P!!?#O_ (E7#GE_U-//^KJY[>'\
MM7_P36\O[GG_ %=7_H7HK^>C_AX5_P %P_\ I"79?^);_#3_  H_X>%?\%P_
M^D)=E_XEO\-/\*/]4,T_Z"^'?_$JX<\O^IIY_P!75SV\/Y:O_@FMY?W//^KJ
M_P#0O17\]'_#PK_@N'_TA+LO_$M_AI_A1_P\*_X+A_\ 2$NR_P#$M_AI_A1_
MJAFG_07P[_XE7#GE_P!33S_JZN>WA_+5_P#!-;R_N>?]75_Z%Z*_GH_X>%?\
M%P_^D)=E_P");_#3_"C_ (>%?\%P_P#I"79?^);_  T_PH_U0S3_ *"^'?\
MQ*N'/+_J:>?]75SV\/Y:O_@FMY?W//\ JZO_ $+T5_/1_P /"O\ @N'_ -(2
M[+_Q+?X:?X4?\/"O^"X?_2$NR_\ $M_AI_A1_JAFG_07P[_XE7#GE_U-//\
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M:?\ 07P[_P")5PYY?]33S_JZN>WA_+5_\$UO+^YY_P!75_Z%Z*_GH_X>%?\
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MC_AX5_P7#_Z0EV7_ (EO\-/\*/\ AX5_P7#_ .D)=E_XEO\ #3_"C_5#-/\
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MV7_B6_PT_P */^'A7_!</_I"79?^);_#3_"C_5#-/^@OAW_Q*N'/+_J:>?\
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MY_U=7_H7HK^>C_AX5_P7#_Z0EV7_ (EO\-/\*/\ AX5_P7#_ .D)=E_XEO\
M#3_"C_5#-/\ H+X=_P#$JX<\O^IIY_U=7/;P_EJ_^":WE_<\_P"KJ_\ 0O17
M\]'_  \*_P""X?\ TA+LO_$M_AI_A1_P\*_X+A_](2[+_P 2W^&G^%'^J&:?
M]!?#O_B5<.>7_4T\_P"KJY[>'\M7_P $UO+^YY_U=7_H7HK^>C_AX5_P7#_Z
M0EV7_B6_PT_PH_X>%?\ !</_ *0EV7_B6_PT_P */]4,T_Z"^'?_ !*N'/+_
M *FGG_5U<]O#^6K_ .":WE_<\_ZNK_T+T5_/1_P\*_X+A_\ 2$NR_P#$M_AI
M_A1_P\*_X+A_](2[+_Q+?X:?X4?ZH9I_T%\._P#B5<.>7_4T\_ZNKGMX?RU?
M_!-;R_N>?]75_P"A>BOYZ/\ AX5_P7#_ .D)=E_XEO\ #3_"C_AX5_P7#_Z0
MEV7_ (EO\-/\*/\ 5#-/^@OAW_Q*N'/+_J:>?]75SV\/Y:O_ ()K>7]SS_JZ
MO_0O17\]'_#PK_@N'_TA+LO_ !+?X:?X4?\ #PK_ (+A_P#2$NR_\2W^&G^%
M'^J&:?\ 07P[_P")5PYY?]33S_JZN>WA_+5_\$UO+^YY_P!75_Z%Z*_GH_X>
M%?\ !</_ *0EV7_B6_PT_P */^'A7_!</_I"79?^);_#3_"C_5#-/^@OAW_Q
M*N'/+_J:>?\ 5U<]O#^6K_X)K>7]SS_JZO\ T+T5_/1_P\*_X+A_](2[+_Q+
M?X:?X4?\/"O^"X?_ $A+LO\ Q+?X:?X4?ZH9I_T%\._^)5PYY?\ 4T\_ZNKG
MMX?RU?\ P36\O[GG_5U?^A>BOYZ/^'A7_!</_I"79?\ B6_PT_PH_P"'A7_!
M</\ Z0EV7_B6_P -/\*/]4,T_P"@OAW_ ,2KASR_ZFGG_5U<]O#^6K_X)K>7
M]SS_ *NK_P!"]%?ST?\ #PK_ (+A_P#2$NR_\2W^&G^%'_#PK_@N'_TA+LO_
M !+?X:?X4?ZH9I_T%\._^)5PYY?]33S_ *NKGMX?RU?_  36\O[GG_5U?^A>
MBOYZ/^'A7_!</_I"79?^);_#3_"C_AX5_P %P_\ I"79?^);_#3_  H_U0S3
M_H+X=_\ $JX<\O\ J:>?]75SV\/Y:O\ X)K>7]SS_JZO_0O17\]'_#PK_@N'
M_P!(2[+_ ,2W^&G^%'_#PK_@N'_TA+LO_$M_AI_A1_JAFG_07P[_ .)5PYY?
M]33S_JZN>WA_+5_\$UO+^YY_U=7_ *%Z*_GH_P"'A7_!</\ Z0EV7_B6_P -
M/\*/^'A7_!</_I"79?\ B6_PT_PH_P!4,T_Z"^'?_$JX<\O^IIY_U=7/;P_E
MJ_\ @FMY?W//^KJ_]"]%?ST?\/"O^"X?_2$NR_\ $M_AI_A1_P /"O\ @N'_
M -(2[+_Q+?X:?X4?ZH9I_P!!?#O_ (E7#GE_U-//^KJY[>'\M7_P36\O[GG_
M %=7_H7HK^>C_AX5_P %P_\ I"79?^);_#3_  H_X>%?\%P_^D)=E_XEO\-/
M\*/]4,T_Z"^'?_$JX<\O^IIY_P!75SV\/Y:O_@FMY?W//^KJ_P#0O17\]'_#
MPK_@N'_TA+LO_$M_AI_A1_P\*_X+A_\ 2$NR_P#$M_AI_A1_JAFG_07P[_XE
M7#GE_P!33S_JZN>WA_+5_P#!-;R_N>?]75_Z%Z*_GH_X>%?\%P_^D)=E_P")
M;_#3_"C_ (>%?\%P_P#I"79?^);_  T_PH_U0S3_ *"^'?\ Q*N'/+_J:>?]
M75SV\/Y:O_@FMY?W//\ JZO_ $+T5_/1_P /"O\ @N'_ -(2[+_Q+?X:?X4?
M\/"O^"X?_2$NR_\ $M_AI_A1_JAFG_07P[_XE7#GE_U-//\ JZN>WA_+5_\
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M_P#$JX<\O^IIY_U=7/;P_EJ_^":WE_<\_P"KJ_\ 0O17\]'_  \*_P""X?\
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MD3C?^RIRO_U4YP-_[S'_ *\5/_3E,_7ZBBBOEC<**** "BBB@ HHHH ****
M"BN8\;^-?"/PU\%^+OB+X_\ $>C^#O ?@'PQK_C7QMXN\17]OI?A_P *^$?"
MNE7>N^)/$>NZG=/':Z=H^AZ-87NIZG?W,B6]G96L]Q,ZQQLP_+'_ (?V_P#!
M'+_I(7^SM_X4NH?_ "IH _76BOS1^$7_  6/_P""7WQ[^)7@_P"#OP;_ &V/
M@C\1/B?\0-630O!G@GPYKM]=:YXBU>2":Y2PTZW?3(DEG-O;SS8:1%$<3L6
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M\,6T>K27HLFU'7=-TH3?VG<I:$ ^BZ*** "BBB@ HHHH _GJ_P"#@3_D%_\
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M^SN8H;BY,H29[:YCMM0M+ZRM0#[<HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _GJ_P""_?3_ ():_P#:3W]G?_TJOZ_H33[B_P"ZO\A7\]G_  7[Z?\
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MOV$_V9OVG_VJ/V4_C%_PM[PSXX_9(^&'@SXA^./$T?A#PSJ7@SQUXA^).@^
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MQ]H_A_2=.U;2M<NK>&#I_#?[1OQ"_P""8G_!H5\'OB1\/O$6LK\8/%GP!L-
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MU:MK%E+?:?IWB#PY8?#&_L[[0]6FT.3X:_&_3H);>P\>V]W7]D( 4!0,
M=  , #Z"@#^5;_@N%!HW[8W_  5,_P""+'_!,*9]7UGP_>_%_P 3?MK?'SP<
M+KR?"VI?#;X3:=J]QX..NP0/]I9O$%EX ^.'@N/47ETI]/AU^73]'N[S5/$
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M3_QQ_P"KC^(U '[?5_-A_P '4/[3_C3X'?\ !,6]^"OPJW7/Q4_;?^+?@O\
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MA[X6^&M!\3R,+&6:$SR^)--U66Z>1UO'N7E?4(H+]KF&, _G!_;7_9[\)_\
M!!7_ (*Z?\$_/VO?V'_#5O\ "O\ 98_;M^)L/[+7[6?P!T/6[;2_A=!?^(/$
M?AO3K+Q-HF@:M>R'0HK2S\7O\1?"VF>'X].T'PQXD^%NHZ,VJ^&_"GQ!O]$U
M#[Y_X.N-6O-*_P"">'P$NM7BU^;X)/\ \%!OV8C^T\NEZ/KNMZ!_PH*VT[XE
MZGKO_"P+;P_97]VO@Y_&ECX#C7?$!>>+)/"NE6/GZSJ.EV=UX=_P=R7-Y/\
M 7_@G-X;T"YN(O&6M?\ !0WX;7'A>&TGDL;I[RQ\+^);&.XMM4+V]MI]Q;:I
MK>CK#//>VKQR7"W$3B.VN)8/ZJ/'_P -_ 'Q?^'WB/X8?%7P9X9^(GP[\;Z#
M-X?\8>"?&6C6'B+PQXDT:]B5;K3=9T;4X+FQOK60A7"3POY<T<4\12:*.10#
M^4?_ (*2:9^S#/\ \%5O^#>J+]B6#X*7'Q2A^-_Q!:]T[]G"3P9/+9?LSP>%
M?!GBO7KO4M'^'\CZ'I_@27P5JWCO7](U"^M(!>Z%-XOO_#-Q/:V^M20^D?\
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M>TJ!+73-"\.Z!I]OI6BZ/IUL@"6]CING6EM9VD" +%!#&B\**_DK^$.M1_\
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M5WX=L;W4+#P_H9M_"FA^-X- T71-"TW1=1^%>H>)YY_[/\3:QCYC_P"";/\
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M3##_ ,.7_7VM_P"G9GS/^VG_ ,F<?M9_]FS_ !X_]5;XJKX9_P"""'_*(O\
M8O\ ^Q-\>_\ JY/B/7W-^VG_ ,F<?M9_]FS_ !X_]5;XJKX9_P"""'_*(O\
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M3+>UM8_+M;6VMDV1#9;V\$*XCAC5=Z@#_/4_X(*?\%0_ '_!%#]E?P9\"?\
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M\6:7X1M#8ZVC^'OAUX>\:ZOI^E:Q?VNCWGCFS\(1:I(G@_6O$L=OI/9?!/\
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M_#WBS5OB-K6H3>%O!'BJWM/[1_$WA;PSXTT2]\,^,?#FA>+/#>I_9O[1\/\
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M^?\ 8?LF[3_*^T_:9/(_5VB@#\S/^"SW_*)K_@HK_P!F@?'/_P!035Z^=/\
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MQA_&K_\ </\ ])8ZBBBOEC8**** "BBB@ HHHH **** "BBB@ HHHH _S?\
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M00Q*L<4,2+'&BJB*%  _->/_ ()PZ9J'_!4Z\_X*?^+?C!K7B+Q!HW[-UO\
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M$MO@]X1DDDM+'1()9VU9FM_+O8XK;_2'HH 9%&L4<<2DE8T2-2V"Q5%"@D@
M9P.< #/0"OEO]N7X+W'[1G[%_P"UA\!K(3_VI\8/V=/C+\.]#DM;274+FW\0
M^*OA]K^D>';RWTZ+4=);4Y[+7+K3[N'3'U.PAU&2!;&XNHK>>1Q]3T4 ?S5?
M\&HOQLM/B1_P20\!?"R\OS)XX_9>^+'QA^"7CG1KO2)]$U;0+S_A-=1^(OA^
MPU"TN$A^U&+PGX]T2W74;>!(FN+:[TV\EN-;TO5Y3S/_  5H_:7_ ."@G_!,
MS]O3X(_MY^&M*^//[1O_  2ROO UYX8_:S^!7PNL(O$LGP:\06&F:IIY^*=G
MIDMW:QZ#826*^&]?L]6\07ND_#RZUO2/$GAGQ'K?A/7/&?ASQ'7V%^QO_P $
MX_C/^Q'_ ,%1?VYOC?\ "G5/ ,W["?[<ND^'_C%KW@&Z\3>+8/'OPO\ VI+#
M4[R3Q9/X8\,7EEK7AJ_\+>/[KQ%XP\4:KJ=EK'A;^S+:\\)>#+'0SI/@;39+
MS]N: /Y ?VFO^#H7X3_M*_#.\_9Q_P""0'PJ^/G[2O[<OQS%S\/_ (:Z'+\,
M?$GA.P^'%KK>G75OKGQ1O;Z#4X+Q[GP99RG4+"\-]HWACPS/&_C3QGXGTSPS
MX:O;75OVX_X(X?\ !/J#_@FC^P+\'/V;-4N+#5/B@+:_^(GQUU_3+F6\T_6O
MC+X\F76?&,>EWDD%G]NT'PN[6?@CPQJ#:=IESJ7AGPQI&H:E91ZK=7SO^E&B
M^%?#'AMKIO#OAS0= :^\K[:VBZ/I^E->>093!]J-C;P&X\DSS&+S2_EF:4IC
MS'SO4 ?QF?"3_@M#^U7_ ,$@?VC/VCOV6_\ @N/;_'7XF?"O4?B+JWB+]DG]
MM30?A)HM]HOC7P3Y$%O8^%YAX#LO#'A34M/O-#M-+\20V>B6FI>,O!?BW5?%
MGAWQPBVXTI=%\!_;J_:ZU_\ X.??'7P!_8"_X)Z?"/XXVG[&?@GXV>$OBK^U
M[^V3XY\)S^!O!WAVST31[ZQD\*^'#,-7LI_$&F>%?&6N77AWPKXHFMM>\<>/
M7T>:U\)V'@;PEJ/Q F_NCU/2],UJQGTS6-.L=6TVZ$8N=/U.TM[^QN!%*D\0
MGM+J.6"81SQ1S1B2-MDL:2+AT4ANEZ3I>B6,.F:+INGZ1IMN9#;Z?I=G;:?8
MP&:5YYC#:6D<,$1EGDDFD*1KOED>1LNS$@'Y7?\ !67]OZX_X)%_L&W'[1G@
MWX$:W\=H_!?B7X;_  OTOPC9Z^?#V@^'=.UQIM.A\4^//%4UMK>IZ/X8LK?2
MH] M[VQTC7M0O/&/B#PGI<UM%9:C?:MI_._''PYX@_X+,_\ !&#QCIGA/PGX
MA^ /C']LO]F+2_%'@WP;\3HW@NO"GC2=-)\<^$="\1ZA'8)._A+6?$FB:9IY
M\76^B)=S^$-53Q1:>'A<M%H]?KY=6MM>VUQ97MO!=V=W!+:W=I=11W%M=6UQ
M&T4]O<02J\4T$T3O'+%(C1R1LR.K*Q!F          P !P  .  .@H _B5_X
M)T?\'!'PF_X)C?LW> ?^">'_  5=^ GQY_92_:(_9,\*Z3\+]+-G\+M<\0>&
M_BEX"T&^UK1O"7B_08TU&XNRJ:%I&FV^H>)M.NM6\">.KMV\6> =8.BZD=#T
M'@?V@OV@O%W_  <S_MQ_L3_#;]BGX._%;PM^PK^QC\7=+^.WQV_:G^*FE7G@
M32/$]S;>)O#4E_X9\$Z:$\0:1+XA.C^%+W0O =MJ,>J>)KS7O$&M:GK7AOPS
MX0\,ZMJ.J?W&:WX6\,^)A;#Q'X<T+Q +(S&S&MZ1I^JBT-QY0G-L+^WN! 9Q
M##YQBV>;Y46_=Y:8U;2TM+"UMK&PM;>RLK."*UM+.TACMK6UMH$6*"WMK>%4
MA@@AC58XHHD6.-%5$4* * /F_P#:[_:G^$O[#O[,WQ:_:=^-.KC3/A[\'/!>
MH>(KRV2ZL+?6/%&J6UO]G\->"/#0U&XLK&Z\6^-]>DT[PQX;M+FYM;6;6-4M
M3>7-G8K<W4'XP_\ !$S]E/XR?%3Q[\8?^"S?[<WAB]T']K#]M2U6S^"OPOU>
M_P!0NHOV8?V2(I[>X\"> M)TN^CC;1=;\<6=AH_B'7([EY[Z'0K+PP;VR\,^
M,-7^(FFWW]&U% '\7?[-'[77[/7_  1/_P""HO\ P6B;_@I%XO\ $WP5_P"&
MN?C7HO[2O[.GCZ_^&7Q \;Z3\8_A'JOBOXGZII7A_P &ZWX!T'QE=:A=^"+G
MQY;>&I-'O186&BWD&MQ%M-&DZ]!IOZ$_\&QOPS^(?A/]B/X]?%?Q=X-\1_#[
MP/\ M3_MO?'O]HKX"^#O%^FW'AWQ/HWP6\3V_@[PKX=;5?"$ZB+PHNK:SX-\
M1:WI.GZ=+=Z3J>A:EIGB72[V[L=<@N)/Z)=9T'0O$5JECX@T72==LHYTNH[/
M6=.L]3M4N8TDB2X2WO89X5G2.::-)502*DLB!@KL#2\7W'B>Q\(^*+OP-I6D
MZYXSL_#FMW'@_0]<U*;1=#U?Q/;Z9<R^']*UC6+:SU"XTG2=0U5+2SU#4K>P
MO9K"SFFNHK.Y>)87 /Y'K!M._:\_X.\[O7=&MO$FKZ!_P3J_8ZGT*^\16]O.
M/#&E>.O$7AV\TJ70Y=0.J36P##]HKQG8Q:=):Z==7FO>'?$%Q9Z->VNC7GB&
M7^P2OQ3_ ."+W_!-KXD_L,>!OVC_ (O?M.:GX*\1_MJ?MK_'OQS\<OVC]=^'
MES-JW@JRFO/%OBF]\%^%/".OZMI&E>)]4T&RLM?U7Q5+%KZS2Z;XE\9>([&T
MDGMXEOKW]K* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^>C_@EU_RE
MQ_X+F_\ 8_\ [,__ *;OC'7]"]?ST?\ !+K_ )2X_P#!<W_L?_V9_P#TW?&.
MOZ%Z^HXP_P"1U'_L2\,?^LUE)AA_X<O^OM;_ -.S/F?]M/\ Y,X_:S_[-G^/
M'_JK?%5?#/\ P00_Y1%_L7_]B;X]_P#5R?$>OMK]N2WN+S]BC]L*TM+Q].NK
MK]EK]H&WMM0BC662QN)_A-XNBAO(XF9%D>VD99DC9E5V0*6 .1_,-_P2I_X)
MN?MR?&O_ ()_?LW_ !0^%?\ P5X^/7[.O@#Q;X<\57?ASX+^$OAA;:[X=\"V
MUE\1?&.DW5CIFK2?%30'O(M1U&PO-<F<Z19>7<ZI/"$D$8FD]'*<)@\7P?F%
M/&YIALJIQXERR<:^)P^.Q,9S65YK%4E# 8;$U%*492FI2@H)4Y)R4G!2F<I1
MQ$'&#F_8S5HN*:7M*>MY2BOE>]WVNU_8[17\]7_#HK_@I+_TGC_:=_\ #,V?
M_P ^RC_AT5_P4E_Z3Q_M._\ AF;/_P"?97G_ -B9#_T6>5?^&OB/_P"=!7M*
MO_0/4_\  Z/_ ,L]?Z>G]"M%?SU?\.BO^"DO_2>/]IW_ ,,S9_\ S[*/^'17
M_!27_I/'^T[_ .&9L_\ Y]E']B9#_P!%GE7_ (:^(_\ YT![2K_T#U/_  .C
M_P#+/7^GI_0K17\]7_#HK_@I+_TGC_:=_P##,V?_ ,^RC_AT5_P4E_Z3Q_M.
M_P#AF;/_ .?91_8F0_\ 19Y5_P"&OB/_ .= >TJ_] ]3_P #H_\ RSU_IZ?T
M*T5_/5_PZ*_X*2_])X_VG?\ PS-G_P#/LH_X=%?\%)?^D\?[3O\ X9FS_P#G
MV4?V)D/_ $6>5?\ AKXC_P#G0'M*O_0/4_\  Z/_ ,L]?Z>G]"M%?SU?\.BO
M^"DO_2>/]IW_ ,,S9_\ S[*/^'17_!27_I/'^T[_ .&9L_\ Y]E']B9#_P!%
MGE7_ (:^(_\ YT![2K_T#U/_  .C_P#+/7^GI_0K17\]7_#HK_@I+_TGC_:=
M_P##,V?_ ,^RC_AT5_P4E_Z3Q_M._P#AF;/_ .?91_8F0_\ 19Y5_P"&OB/_
M .= >TJ_] ]3_P #H_\ RSU_IZ?T*T5_/5_PZ*_X*2_])X_VG?\ PS-G_P#/
MLH_X=%?\%)?^D\?[3O\ X9FS_P#GV4?V)D/_ $6>5?\ AKXC_P#G0'M*O_0/
M4_\  Z/_ ,L]?Z>G]"M%?SU?\.BO^"DO_2>/]IW_ ,,S9_\ S[*/^'17_!27
M_I/'^T[_ .&9L_\ Y]E']B9#_P!%GE7_ (:^(_\ YT![2K_T#U/_  .C_P#+
M/7^GI_0K17\]7_#HK_@I+_TGC_:=_P##,V?_ ,^RC_AT5_P4E_Z3Q_M._P#A
MF;/_ .?91_8F0_\ 19Y5_P"&OB/_ .= >TJ_] ]3_P #H_\ RSU_IZ?T*T5_
M/5_PZ*_X*2_])X_VG?\ PS-G_P#/LH_X=%?\%)?^D\?[3O\ X9FS_P#GV4?V
M)D/_ $6>5?\ AKXC_P#G0'M*O_0/4_\  Z/_ ,L]?Z>G]"M%?SU?\.BO^"DO
M_2>/]IW_ ,,S9_\ S[*/^'17_!27_I/'^T[_ .&9L_\ Y]E']B9#_P!%GE7_
M (:^(_\ YT![2K_T#U/_  .C_P#+/7^GI_0K17\]7_#HK_@I+_TGC_:=_P##
M,V?_ ,^RC_AT5_P4E_Z3Q_M._P#AF;/_ .?91_8F0_\ 19Y5_P"&OB/_ .=
M>TJ_] ]3_P #H_\ RSU_IZ?T*T5_/5_PZ*_X*2_])X_VG?\ PS-G_P#/LH_X
M=%?\%)?^D\?[3O\ X9FS_P#GV4?V)D/_ $6>5?\ AKXC_P#G0'M*O_0/4_\
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M ,,S9_\ S[*/^'17_!27_I/'^T[_ .&9L_\ Y]E']B9#_P!%GE7_ (:^(_\
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M)X_VG?\ PS-G_P#/LH_X=%?\%)?^D\?[3O\ X9FS_P#GV4?V)D/_ $6>5?\
MAKXC_P#G0'M*O_0/4_\  Z/_ ,L]?Z>G]"M%?SU?\.BO^"DO_2>/]IW_ ,,S
M9_\ S[*/^'17_!27_I/'^T[_ .&9L_\ Y]E']B9#_P!%GE7_ (:^(_\ YT![
M2K_T#U/_  .C_P#+/7^GI_0K17\]7_#HK_@I+_TGC_:=_P##,V?_ ,^RC_AT
M5_P4E_Z3Q_M._P#AF;/_ .?91_8F0_\ 19Y5_P"&OB/_ .= >TJ_] ]3_P #
MH_\ RSU_IZ?T*T5_/5_PZ*_X*2_])X_VG?\ PS-G_P#/LH_X=%?\%)?^D\?[
M3O\ X9FS_P#GV4?V)D/_ $6>5?\ AKXC_P#G0'M*O_0/4_\  Z/_ ,L]?Z>G
M]"M%?SU?\.BO^"DO_2>/]IW_ ,,S9_\ S[*/^'17_!27_I/'^T[_ .&9L_\
MY]E']B9#_P!%GE7_ (:^(_\ YT![2K_T#U/_  .C_P#+/7^GI_0K17\]7_#H
MK_@I+_TGC_:=_P##,V?_ ,^RC_AT5_P4E_Z3Q_M._P#AF;/_ .?91_8F0_\
M19Y5_P"&OB/_ .= >TJ_] ]3_P #H_\ RSU_IZ?T*T5_/5_PZ*_X*2_])X_V
MG?\ PS-G_P#/LH_X=%?\%)?^D\?[3O\ X9FS_P#GV4?V)D/_ $6>5?\ AKXC
M_P#G0'M*O_0/4_\  Z/_ ,L]?Z>G]"M%?SU?\.BO^"DO_2>/]IW_ ,,S9_\
MS[*/^'17_!27_I/'^T[_ .&9L_\ Y]E']B9#_P!%GE7_ (:^(_\ YT![2K_T
M#U/_  .C_P#+/7^GI_0K17\]7_#HK_@I+_TGC_:=_P##,V?_ ,^RC_AT5_P4
ME_Z3Q_M._P#AF;/_ .?91_8F0_\ 19Y5_P"&OB/_ .= >TJ_] ]3_P #H_\
MRSU_IZ?T*T5_/5_PZ*_X*2_])X_VG?\ PS-G_P#/LH_X=%?\%)?^D\?[3O\
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M[6J_83;?L[KGI77N];SL[ZM6;\[']"U%?SU?\.BO^"DO_2>/]IW_ ,,S9_\
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M=_\ #,V?_P ^RC_AT5_P4E_Z3Q_M._\ AF;/_P"?91_8F0_]%GE7_AKXC_\
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M=_\ #,V?_P ^RC_AT5_P4E_Z3Q_M._\ AF;/_P"?91_8F0_]%GE7_AKXC_\
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M=_\ #,V?_P ^RC_AT5_P4E_Z3Q_M._\ AF;/_P"?91_8F0_]%GE7_AKXC_\
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MS9__ #[*/[$R'_HL\J_\-?$?_P Z ]I5_P"@>I_X'1_^6>O]/3^A6BOYZO\
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MS9__ #[*/[$R'_HL\J_\-?$?_P Z ]I5_P"@>I_X'1_^6>O]/3^A6BOYZO\
MAT5_P4E_Z3Q_M._^&9L__GV4?\.BO^"DO_2>/]IW_P ,S9__ #[*/[$R'_HL
M\J_\-?$?_P Z ]I5_P"@>I_X'1_^6>O]/1O_  2Z_P"4N/\ P7-_['_]F?\
M]-WQCK^A>OY?/^"%_P ,_'GP=_X*$?\ !8[X;?$WXQ>(/C_XZ\)^)?V9=-\1
M_%_Q3I2Z)K_CF_%O\:YCK&I:6FK:ZMG<-%-%;F)=5O1MMU;S?FVK_4'5\;0A
M3S^=.G5C7IPRGAN%.O"-2$*T(\.94HU8PJQA5C&I%*:C4A"<4[2C&2:2PVM-
MMJS=2K=.UU^\EH[76FVC:['S/^VG_P F<?M9_P#9L_QX_P#56^*J^&?^""'_
M "B+_8O_ .Q-\>_^KD^(]?<W[:?_ "9Q^UG_ -FS_'C_ -5;XJKX9_X((?\
M*(O]B_\ [$WQ[_ZN3XCU%+_DB<;_ -E3E?\ ZJ<X&_\ >8_]>*G_ *<IGZ_4
M445\L;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY'@NK.YAGB=HY%) .IHK^7#XL_\ !S;H/@C]IS]IK]F+X6?\$W_VQOVG]?\
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MM9+SP]XCT/4[SP]J_P#9>K:%JD]W!!!%;^*M&\*:]++H-O\ JC0 445^/_\
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M_P""77_*7'_@N;_V/_[,_P#Z;OC'7]"]?4<8?\CJ/_8EX8_]9K*3##_PY?\
M7VM_Z=F?,_[:?_)G'[6?_9L_QX_]5;XJKX9_X((?\HB_V+_^Q-\>_P#JY/B/
M7W-^VG_R9Q^UG_V;/\>/_56^*J^&?^""'_*(O]B__L3?'O\ ZN3XCTZ7_)$X
MW_LJ<K_]5.< _P#>8_\ 7BI_Z<IGZ_4445\L;A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5_'#^RSXKLOC5_P ':O\ P4)^*WBWQ)X/\.>#OV4O
MV6-#^#?A)=7UBVT74;K6KW1_@IHL\44>H7.COJP&JZA\5KV_U!K:^L],AFT+
M2XX[L3Z;K:_V/5_GD?\ !(3_ ()-_L=_\%P/CA_P5=_;>_:R7QIXV\.^*/V[
M/']O\'8/A[X_UGPKIVF6'B+Q!XR^).NW2:Q!>7.H^(-&OO#_ (Y^'>F>&;34
M-)TZ+0=*\.@65Y?_ -JW-EHP!_?W_P +3^&/_11_ ?\ X5_A[_Y8U\H?\%(O
MV_?A'_P3-_9&^)/[6GQBL]0U_2?!RZ9HGA'P)HEW96/B'XD_$7Q-<G3_  CX
M(T6[U M;V37]T)]2UW5C;Z@_A[PEI/B+Q&FDZN='_LR[_)?PC_P:=_\ !'GP
M5XK\,>,M(^'/QGFU;PEXAT7Q-I<.J_&KQ#JFERZCH.I6VJV4>I:9=VCVNHV#
MW-I$MY87*/;WEN9+>96CD8'[@_X+9?\ !,%?^"L_[$&J_LS:5XWTCX<_$+PY
M\1O"7QC^$OC'Q'9ZUJ/AG2O'OA+3O$GAPVOB.RT*]M;Z32-?\&^-?%_AN:\%
MKK8T2?6+?Q!!H&K7NDVEL0#\MK;]I_\ X.J_C'\+X/VH/A)^R7_P3D^&WP_U
M_P ,1_$3X=_LT^.?%/CKQE\<O$/@RXMAXA\-:=K.O:3\2-&\%7GBGQ?H=S:>
M3:OXD^&-W;QS6]CJ^@^#/$4=];1_L'_P2?\ ^"C$'_!2C]B[P_\ M/\ B/X4
M>)/V?_%FE:]XD\!?%CP-XPM=7T_1=#\8^#;+2]2UC6?!_B#Q'IFAR>(? &J:
M+K6DZS8ZW]F,.CW<^L>$M1OKS5_"VJW<GX+>)/\ @HM_P<B_\$NOA]%XM_;W
M_89^!O[:W[.GPQ\-Z=??$3]H?]GKQA_9/Q!L/#^C78TGQ#XH\;)H=_J ADM]
M+MH/%>IZX_[//A7PK96NHSZAJ_B"RM[/6K7PW]Q_\%2O^"E6B_%?_@W,^.G[
M?O[+.J>)]"T_XZ_!3P1X?\(7D-\UGXM\"3_%WXR^$/@/\1-(U;7/!=[J]EX?
M\6?#^77O&GA[4+JUUF.VMO%NB?V/%J4.HW%M&P!Y/X^_X+(_\%!/V]_CG\0O
M@A_P0=_9H^#WQB^$7P1\8V?@GXP_M_?M(>(KZR_9[N?%36%]J%]X;^%&AZ9K
MWA'5_%MCI\EIIUO)XQ\-S_$J_P!6L=;MM7MOAWHG@O5?"'Q*\14?V6_^"QO_
M  44^!'_  4D^%W_  3-_P""QG[/?P/\!^(?VBM.G/[.?[2/[-Q\5Q_#;QCX
M@GBOI]#TG4HO$GB7Q*NL66NZS87G@!+C3;7PCXG\*>+;CPA#XF\$S^'/%'_"
M;VWZQ?\ !%;]G?PQ^R]_P2J_86^%?A>"V03_ +/7@+XF>)[FVDNIX]2\?_&K
M2H_B]X_U!;J^)OKJVD\7^-M8ATQKE8/L^CP:=8VMEIMA:6FFVGZ'>(?AK\.?
M%WB;P7XU\6> /!/B?QE\-[C5[OX=^+?$/A70M:\3> KK7[>TM->N?!>O:E87
M.J^%KC6[6PL;;5YM#N[&34K>RM(;QIH[>%4 /X]/^#J3XU>"=$_:O_X(D_"'
MQ=9>+O$WANP_:IN_CO\ $SP9\/O#NM>(OB%K_A+PCX\^"NAZ)X:^'NBZ5HMS
M>>)O'_Q M[KX@^%_!&A:5JUL[^*8])@UV*RLM4TW6;+W[]J7]K__ (.BO 7P
MY^)'[67P^_8K_8=\"?!7P-IMQXWL_P!F'7M?\7?&G]IW3_ASHT0U?5+SQC=^
M"OB)X8\(>+O$=GHXN[S7]#^'>JZ)KJ6=E+I7AOPWJ&OVZ7&J\_\ %BS@_:?_
M .#O;]GOPY-I37V@_L#?L%ZMXZU2QEL+#5M.D\3^*]/\=1V'B74_[2TFVDTY
M=-N_VC_AV^C26%WK1TWQ1X:T'5+"\T^^OM2MM/\ Z O^"F7Q2M_@G_P3K_;G
M^*LUY!93^"/V2_V@-8T>2XDCBCN/$P^%_B:V\)Z8LD]GJ,"3ZQXGN-)TFU-Q
M87EO]IO8?M%M-#O1@#RW_@DW_P %%]&_X*:?L(?#7]L2Y\&0_"75-:F\8>'/
MB-X1FUDZGH?ACQ9\/M:O='\07>E>(;VUTUKGPSJ5K:VOB73Y;Z".?2;'4_[)
MU&YO+K2[F_N?R:\??\%D/^"@G[>WQT^(7P0_X(._LT?![XQ?"/X(^,+/P5\8
MOV_OVD/$-]9?L]W'BIK"^U"^\-_"C1-,U[PCJ_BVQT^2TT^WD\8>&Y_B5?ZM
M8ZW;:O;?#O1?!FJ^$/B5XA_.WX'Z_P"-_P!AG_@S&\7?%'P-JGB;1/B1\6?"
M'BS4DU33;O5]-NO#EI^T?^UC:_!J'5-!U;3-)T_4O#L</PDUNQUBSU"\N6BN
M/%%T\>E:^]MJVAQCT_\ X)I:%_P<I_LV_L(_LP?"_P#94_9+_P""4%C\!T^$
M_A?QMX#N_'OB'XQO\1/$-A\3;&/XB7'BKXBW&@_'S3-&N/'7B2\\33ZMXF;2
MM/L]*@U*YELM)M+32K6RM80#Z\_9E_X*_P#_  4F_9W_ &_/@;_P3Z_X+/?L
MU?!7X;WW[5\%U8?LS?M$_LT7.M:OX+\3>,P]NEEX9\4Z0?&7C^>2WO-?O(O
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M_3M/LX);BYN;B5(XXT/)) /7=*_E[_X.W/BY\0/ ?_!+KPO\*_AWJU_H5_\
MM5?M6?"']GKQ)J=K>:WI-H/!^K>'OB)X_P!1T[5-5TBUF0Z=K6K_  _T#2=6
MT2YDW:WX?N];5+'4[2SU"UH X70_^"KG_!8S_@IQXN\0>*?^"-/[(OP%\'?L
M3^$_%'B[PEH?[8'[;VI^)--M_CQK/A*XL["XO_A]\/\ 1-<\-^+_  YX8N;Z
MYU*UM6C\&?$&-KC16MO%/B_X>^+;77OAU8^S?\$O?^"QO[77Q+_;M^*?_!*[
M_@J3^SW\/_@+^V)X)\'7GCOX;>+_ (0G7%^%OQF\-Z)!:7]\-+L];\2^,I7O
M=7\*78\=>'/$FAZ_-X=U?3=&\:Z+K.C^ O%/AF#PWJO[\?L]_!7P9^S=\"/@
MU^S[\.[3[#X%^"?PP\#?"SPE;GS6E_L'P)X:TWPUIL]W+<3W5U<W]U;:='=:
MA>7EW=WM[>S7%W>7=U=32SR=5-\-?AS<_$"T^+-QX \$S_%2P\,MX*L?B7-X
M5T*7X@67@U[^YU5_"5IXR>P;Q';>&7U.\N]1;08=232FO[JYO#:&XGED8 _$
M?_@I[_P6=\2?LL?M _#C_@GY^PW^SS>?MJ?\%&/C!HMIXAT/X36&LVVE> /A
M3X>O9VGL=;^,?B%=1TQ-(EU+0K'5_$:Z/>Z[X4M/#OA&"T\>>./$_A;PMJ_A
MFY\2_GU\9O\ @H3_ ,')G_!/_P"'UK^V+^VQ^R)^PW\7?V6O#-_'<?';X5_L
MU:]XXT_XQ_"[PEK,[6=OXCB\07_C#QQHEGI_AO5[C2XM0U2SM/BOI\.DS7!\
M0'1[*2Z\<>'+/_!MYX-B^.W[9?\ P6F_X*+_ !&6#6_C'X^_;,\;_LZ^&M1O
M99[[4_ 'PQ\(Z]/XPO?!6AZC.J2?\(S?6%U\)O#T5K.TTD>G_"+PNB+;?9Y&
MN_VB_P""V_Q)\#_"K_@D9_P44\4?$)E70-2_9/\ B[\.;$M;6ET#XV^,7AJZ
M^$7PS7RKR:"%6?XC^./"B+<([75FS"[L8;B^@M[>4 ]WN_VU/A'XL_8 \3_M
M^_#7Q)<7?P:7]EWQM^TOH'B.\TF^@U"T\)^&?AQK/CN>74]!&FZOJ,&K:-#I
M-S;ZKHZ:1JUU#J-E<V,=AJ,BK!-^''_!ISX(T#X"?\$2].^,WB*8Z/X>^*_Q
MA_:-_:"\2ZJ9KS6!%I'@C4H/@YJFJ#2["UN+ZU%GI?P*=?[(L;:[N[LV9OK:
M&6?4U@KXBT_6O$7['7_!E=9Q^)-)OT\0_$3]GO7M'T73-1MFT:XN?#O[9O[5
M6NW^C:M&9++7HC81_#'XP?\ "6Z7<S):+XBTRVM!:7N@WFL6<]E^BEXVI?L(
M_P#!JG/#JNC_ -C>*M"_X)@+I-YI;""*;P_\1/VC/A^FCF2\B@T*]M)]1T#Q
MO\6!>ZE9W&FW%IJ%_8W-IJ6L-!<7/B$ 'U=_P03_ ."C7[0__!4C]BWQ9^U%
M^T9X$^%'P^UF7]H;XA_#_P"'NC?"'1_'&D:%<?#3PGX<\!RZ??:XWCKQ7XON
M]6\4KXLU;QCIFHZQHE_8Z!=66FZ9%#HVF:G;ZI"?VSK\4?\ @W3^#][\$O\
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M#^%OAGXNNOBI'XHN-*M]%U?P;=:/<Z9JOA>6/6[[3=,U"\\7Q7H\*Z/H<][
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MBYO&>KP:0Z> ]!T?5-=^(EQINCZKJ/BK3I/$VN7>K)I@U'1_#>JZAH_]>G[
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M'_B^[2>>V.F7>@Z-J>EROJD,4VG_ -9'A'PGX<\!>%/#/@?P=HUAX<\(^#=
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MP[X=\+Z7IO\ :2C!U5QG#JK#/7# $9QD9P>>37^=Q^W?_P $Q?B3\$/VZ?\
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M?#_@+5?%]Y?ZT]U<RV&CZ4;*"Z\:^$O@YXX\7:4FBOKVAQ^+DUG7O$G]B5%
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M\'Z+%IUM<R_;[F+4O%.@6MXEH;-]5L_M F7Z*HH _P ]+_@F]^R5_P '(?\
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M+G6_BO\ MM_&?X2_LA_#_2K!= FOKF_^(.KW?BC5H%@\0W=O:16VO:)X'O?
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ME6=K86%G B16]K;Q11JJ(!7] 7[!7CW]M3XP?LWV>N_\%$?V<_ /[./Q_O\
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MI[VTF^,O^#;#]I[2?VF?^"0_[,$4$MK'XI_9ZT2Z_9?\=Z1!K/\ ;4VB:O\
M!@P>'_#4=[*Y6XL+C7/AN_@?Q9'I$\,*Z7:>(;:SLOM.FQ65[<_O#7Y^?LD?
M\$ZOA/\ L7?'G]L3XT?!OQI\2+;0?VS?B99_&7QK\%-8U/1[_P"%O@GXI7,>
MH/XT\8_#^V;1E\2Z3>>/=0U WFM:=<>(;K1+&"RTO2-%TW3](TC2K.R /PG^
M.'_!.;_@J-_P3/\ V^?CU^WK_P $?-!\ ?M)?!3]K/6[_P =?M)?L0?$?QII
MW@F\_P"%@ZK?ZOKNN>)?!.H^(]:\+^'7L[76M4U?7?"MWI'BC3?$.B)XBO\
MP+'X)\4:%9Z=<2>:?M#W_P#P<K?\%7/AUJ/[&GB?]BGX,?\ !-OX$_$]K71?
MV@_CKK7Q5\-_$+Q-J7PVU#4M.M=7\'^$M)T;QWJ^MRB_TMM7OM<TG2_#<,GB
MFVL;3PS>_$#P+I.J:A%XE_LFHH _.KX;_P#!,O\ 9Y^&G_!-F/\ X)@Z7#JM
M]\"I/@AXF^#.J:M=1Z7:>)]6F\8V^J7/B7X@W9T2QTG2U\9:GXNUC4/',]W;
M6,$,GB29KN:.0M(7_GA_9M\.?\'&O_!&_P"'T7[%/PK_ &._@I_P4O\ V:O
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MX5_X6%_8'_">?\([HW_":?\ "*_;O^$8_P"$I_LZW_M__A'O[3_XF/\ 8O\
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M3_T$<4_^$>4^7_4=Z_AYA_M/:A_X%4_^1]?Z6OO_ /P\;_X)Z?\ 1^'[&?\
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M_P##QO\ X)Z?]'X?L9_^)0?!'_YN*/\ AXW_ ,$]/^C\/V,__$H/@C_\W%>
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MP:_\!?$/_P OZ/\ AR9_P2F_Z,A^#7_@+XA_^7]')P3_ -!'%/\ X1Y3Y?\
M4=Z_AYA_M/:A_P"!5/\ Y'U_I:^__P##QO\ X)Z?]'X?L9_^)0?!'_YN*/\
MAXW_ ,$]/^C\/V,__$H/@C_\W%> ?\.3/^"4W_1D/P:_\!?$/_R_H_X<F?\
M!*;_ *,A^#7_ ("^(?\ Y?T<G!/_ $$<4_\ A'E/E_U'>OX>8?[3VH?^!5/_
M )'U_I:^_P#_  \;_P"">G_1^'[&?_B4'P1_^;BC_AXW_P $]/\ H_#]C/\
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M/^'C?_!/3_H_#]C/_P 2@^"/_P W%> ?\.3/^"4W_1D/P:_\!?$/_P OZ/\
MAR9_P2F_Z,A^#7_@+XA_^7]')P3_ -!'%/\ X1Y3Y?\ 4=Z_AYA_M/:A_P"!
M5/\ Y'U_I:^__P##QO\ X)Z?]'X?L9_^)0?!'_YN*/\ AXW_ ,$]/^C\/V,_
M_$H/@C_\W%> ?\.3/^"4W_1D/P:_\!?$/_R_H_X<F?\ !*;_ *,A^#7_ ("^
M(?\ Y?T<G!/_ $$<4_\ A'E/E_U'>OX>8?[3VH?^!5/_ )'U_I:^_P#_  \;
M_P"">G_1^'[&?_B4'P1_^;BC_AXW_P $]/\ H_#]C/\ \2@^"/\ \W%> ?\
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M^C(?@U_X"^(?_E_1R<$_]!'%/_A'E/E_U'>OX>8?[3VH?^!5/_D?7^EK[_\
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M_P"7]')P3_T$<4_^$>4^7_4=Z_AYA_M/:A_X%4_^1]?Z6OO_ /P\;_X)Z?\
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MGA74_M6JW(;3-2-M ;A81#,?+79,G.?VN'_!$S_@E.0/^,(?@UT'_+KXA_\
ME_7T>91X2_U?X9]K7XC6'3SGZLZ>%RQUF_KM+V_MXRQBA&T_X7LY2YHZSY7H
M\H>W]K5LJ-_W=[RG;X=+>[VOOU/H#_AXW_P3T_Z/P_8S_P#$H/@C_P#-Q1_P
M\;_X)Z?]'X?L9_\ B4'P1_\ FXKP#_AR9_P2F_Z,A^#7_@+XA_\ E_1_PY,_
MX)3?]&0_!K_P%\0__+^OG.3@G_H(XI_\(\I\O^H[U_#S-?\ :>U#_P "J?\
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M_"/*?+_J.]?P\P_VGM0_\"J?_(^O]+7W_P#X>-_\$]/^C\/V,_\ Q*#X(_\
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M"/\ \W%'_#QO_@GI_P!'X?L9_P#B4'P1_P#FXKP#_AR9_P $IO\ HR'X-?\
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MM??_ /AXW_P3T_Z/P_8S_P#$H/@C_P#-Q1_P\;_X)Z?]'X?L9_\ B4'P1_\
MFXKP#_AR9_P2F_Z,A^#7_@+XA_\ E_1_PY,_X)3?]&0_!K_P%\0__+^CDX)_
MZ".*?_"/*?+_ *CO7\/,/]I[4/\ P*I_\CZ_TM??_P#AXW_P3T_Z/P_8S_\
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M]'_#DS_@E-_T9#\&O_ 7Q#_\OZ.3@G_H(XI_\(\I\O\ J.]?P\P_VGM0_P#
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M\$IO^C(?@U_X"^(?_E_7SG)P3_T$<4_^$>4^7_4=Z_AYFO\ M/:A_P"!5/\
MY'U_I:^__P##QO\ X)Z?]'X?L9_^)0?!'_YN*/\ AXW_ ,$]/^C\/V,__$H/
M@C_\W%> ?\.3/^"4W_1D/P:_\!?$/_R_H_X<F?\ !*;_ *,A^#7_ ("^(?\
MY?T<G!/_ $$<4_\ A'E/E_U'>OX>8?[3VH?^!5/_ )'U_I:^_P#_  \;_P""
M>G_1^'[&?_B4'P1_^;BC_AXW_P $]/\ H_#]C/\ \2@^"/\ \W%> ?\ #DS_
M ()3?]&0_!K_ ,!?$/\ \OZ/^')G_!*;_HR'X-?^ OB'_P"7]')P3_T$<4_^
M$>4^7_4=Z_AYA_M/:A_X%4_^1]?Z6OO_ /P\;_X)Z?\ 1^'[&?\ XE!\$?\
MYN*/^'C?_!/3_H_#]C/_ ,2@^"/_ ,W%> ?\.3/^"4W_ $9#\&O_  %\0_\
MR_H_X<F?\$IO^C(?@U_X"^(?_E_1R<$_]!'%/_A'E/E_U'>OX>8?[3VH?^!5
M/_D?7^EK[_\ \/&_^">G_1^'[&?_ (E!\$?_ )N*/^'C?_!/3_H_#]C/_P 2
M@^"/_P W%> ?\.3/^"4W_1D/P:_\!?$/_P OZ/\ AR9_P2F_Z,A^#7_@+XA_
M^7]')P3_ -!'%/\ X1Y3Y?\ 4=Z_AYA_M/:A_P"!5/\ Y'U_I:^__P##QO\
MX)Z?]'X?L9_^)0?!'_YN*/\ AXW_ ,$]/^C\/V,__$H/@C_\W%> ?\.3/^"4
MW_1D/P:_\!?$/_R_H_X<F?\ !*;_ *,A^#7_ ("^(?\ Y?T<G!/_ $$<4_\
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M^"4W_1D/P:_\!?$/_P OZ/\ AR9_P2F_Z,A^#7_@+XA_^7]')P3_ -!'%/\
MX1Y3Y?\ 4=Z_AYA_M/:A_P"!5/\ Y'U_I:^__P##QO\ X)Z?]'X?L9_^)0?!
M'_YN*/\ AXW_ ,$]/^C\/V,__$H/@C_\W%> ?\.3/^"4W_1D/P:_\!?$/_R_
MH_X<F?\ !*;_ *,A^#7_ ("^(?\ Y?T<G!/_ $$<4_\ A'E/E_U'>OX>8?[3
MVH?^!5/_ )'U_I:^_P#_  \;_P"">G_1^'[&?_B4'P1_^;BC_AXW_P $]/\
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M_P#_  \;_P"">G_1^'[&?_B4'P1_^;BC_AXW_P $]/\ H_#]C/\ \2@^"/\
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M_AXW_P $]/\ H_#]C/\ \2@^"/\ \W%> ?\ #DS_ ()3?]&0_!K_ ,!?$/\
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M]!_*OJ<V_P"29X3]<^_]3Z)C#^-7_P"X?_I+%HHHKY8V"BBB@ HHHH ****
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M%^^G_!+7_M)[^SO_ .E5_7]":?<7_=7^0KZG-O\ DF>$_7/O_4^B8P_C5_\
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MA+P]XO\ B!X8N)M/NH]=UC[1I%AH/P$^&@\+7D3?V7-H&H0Q:(NFV=O+I%H
M>C?MU?'']JK_ (*L_P#!17Q;_P $=_V,?C+XA_9G_9K_ &<?#WACQU_P4<_:
MG^&FI^(]&^+5_#K\ULUE^S5\-=;ATRPM/#^I>(;&\BAU.YMM4O\ 3_$L:^*(
MM=GN_#7@#Q5\.?B-\T?MQ?\ !K/^P+^S7^Q5\7?C]^R1\1?VA?@1^TM^RG\&
M?%OQM\&?'35OC?>K+K>M?!WPGKWC'5]0\?2Z?X>T^R\.2>(=)T^\6?7/A?9?
M#S_A'-8M-&U;3K>'2+77-#U[XC_8/_X)%_L5?\%*_P#@JG_P72\'_MZ2^-M9
M^-OPK_;6\:^+?A[X/\.?$C4?A[J5W\*/'WQ5^,-]_P )KI>A0SZGJFL>&9+&
M3X>6T9&K:O;>#-,U;P?I=X=.E\0:<VJ_?W[7'_!O;_P;?_L(?#2R^+_[6_B;
MXF_!3X?:IXHT;P5I&M>(?CG\0]3O-;\4:],8K#1]"\.>%]"UWQ/KEQ% ESJN
MK/I.C7EOX?\ #]AJOB77IM-\/Z3J>IV@!]Q_LZ_\%&OBM\7/^#:#7/\ @H%\
M3=5T_4_CA8?L1?M,IJ/B.?3UT.T\5?%;X077Q6^"?AWQ5K-AI>OZ>L-WXT\7
M^"=(U[Q$/#6I^'Q>:CK&H2^%-&\,_:-+\.:=R'_!!N*Q_8G_ .#<CP%\<?$T
MXT>70O@?^U1^UOXNU&*:?6[:UTJSU_XI>.=!U.WM+32M6N 8/AKX;\*7%]I%
MKI&KW"ZK'J$*6.H7$AMI/!_^"[OP^^ __!-O_@VZ\3_LK?LMWNK>!?A)XM\2
M?"WX6_"JWU?QEK5YXJUNU^)OQR?]HGQ[I\>M:[JUAX@U>X\8:5IGQ#OM>T(6
M][&?"%]X@TA_#]GX:M;K^R_<?^"G[V7[!W_!L!XK^&.F07.H77AG]B?]G3]F
M.UBO+J-+S4=1^)"_##X0>*M8NKN&S\0:=%<P:?XB\3>*I[6#R=/N9;-M&T;5
M-(:ZTV]M0#DO^#3OX/>)/AY_P1'TSQ?X%ET+2?&O[1'Q?_:/^+/A75/%::CX
ME\+Q^*](U&#X">']3\1>'])U/0-5/A^SU#X*6":QX>TO7=)U#4K"SNKJRU?3
MKG5H[FWXWP%_P;4^%/CMXG^)/[2W_!</]J?QO^VE\<_$?CGQ9-H-OX7^*'C#
MX7? #X:_#>_UR:+PAHWAS3VB\.>(/#EU>K/;:E-X3\-ZEX:\ >#[J\M/!>AZ
M7XGCT>3QEXG\:_:X_:I^.?\ P2$_X-L?^"=O@SX(ZYIOP>_:+^-_@[]GCX,6
MGC'5;'3W/P?O?BWX \1?&7XJ>+9;FZT[^P](US1&AO\ P[=:Q=:=K-YHVI>(
M+K7].74]3TI?$5M]*>#?^#77]@BP\'6'Q2_X*0_M"_M-?MN?$?POHVI>-/B[
M\5/V@/VC?&/A#X;VK0VUYK_CW4[)]/US2_&'@_P-+,MUX@UW4?$OQ5UK61):
MW&LZCXHMH))[:$ ^*?\ @C[X;\"_L/?\'"'[6_\ P3\_8(^,FH?%;]@'Q7^S
M4?CAXD^'5EX\MOB3X1^#7Q2TR'X364FHVWBZ'4-7&K^(=%U773X'N]3@N[34
M[CP]XZ\.>$_'W_"3>(?AQI&NP_VY5_#7_P &PWPL_9B\6?\ !4W_ (*^?M$_
ML;>$]/\ !G[*WPJT_P  _LW?LZ6&GMXKU?3M<^'/BGQ=K%P/%.D^)O'L^L>-
M+T>*8OV>- \=:O#XBUPZ]+)XYTNY\062W@MH[+^Y2@#^=O\ X+Y_\%%?VA_V
M<-%_9H_85_8/(C_;P_X*$?$*#X9?"WQ2+=;@?"/P2NLZ'HGB7XANUQI&LZ?I
MUY<WFNVVE6OB'4+&:S\&^'+7QOX]=[6[\(V$U?/GP_\ ^#2/_@GKJW@*]O/V
MN?B/^T[^U9^TQXUT_2+SXC_M&>+/C1KVDZ^WBZ#0M,TO5+GP3I,$-W;IX>$]
M@SZ):?%&?XI>(+*S>.RNO$=Y:V]I;VOE/_!0KQ=X%^%/_!U[_P $G_B%\=+Z
M'P[\+=<_8[\1_#KX;^*?$MZL'@RP^.?B/6OVL?"^E6I6>\CM+?6=6OO'?P_\
M,6EW+9SK_;WBGP9*YA:QAU+2/ZH?CM\=_A+^S1\)O''QP^.'CGP_\//AG\//
M#^I^(_$OB7Q'J=CIEI%::997%]]@L#?7%N-3UW4Q;M9:%H=FTNIZWJ<MMINF
MVUS>W,,+@'\U_P#P;M_'O]H7X9_'S_@HO_P2!_:(^*'BCX\VW_!/GXDZ=!^S
MS\8?%]U-JGBJZ^!^JZKK/AO2?!GB'4+W7=2NK/2M)T?3/ WB/P)X9#:X_@Z'
MQ5XO\#KXCC\*^$O VBV7@'[<>E)_P1[_ .#A?]F#_@H=:+K.G?LF?\%-[>[_
M &:_VH+RUBO?^$:\#?%B\M_"_AW3/%&O:M<ZEIOA?0-*N-7M?A?\5)O[8N+W
M5[WP_P"#/CY>^&-%OKJS"VGJW_!LOX+^)7[0WQ,_X*7?\%@/B/HVI:#X=_X*
M _M :A9?L_Z9J^C^'=.O5^$OPS\:?$""ZNDGT:[OFFL]+U#4=$^%SC,3SZY\
M*->U'5-4\5WMY#JMKXE_P5B\2?$W_@X*_:KUG_@C_P#L0WO@ZT_9Y_9$\02_
M$W]M']KOQ-X(TWQKX6\!_'C1O#?CO0/A?\-O NJG7+>^AFEUZ3Q/X \27GA2
M.R\9ZEJ \?"P:]^'WP^\:6?C  ]'\3V>H_\ !R;^WS:^';:/Q)%_P1+_ ."?
M_C?6+3Q=JEIJVJ:=X<_X* _M/:5<7ME';>&];\/ZNNBZY\(O"4$6G7.GZSID
ME_K-CX)U#6;F#4M$U3XZZ%)\.XO^"[?AO1OV7_\ @K/_ ,&_W[8OA^VT[P[X
M6T[X[0_LI>+K>!+[0O#/@_X?:KXO\$:-H\MA'HUN--T^QTGPA\4_BC.VD1K9
MI=6.A66G1VM_I:WJ:=]$?\&K7[4-IXZ_8$UK]B/QIX:\.?#C]H'_ ()Y?%#Q
MY\#OB9\/=+D\/66HRZ=J7C3Q+XFT_P :7^BZ)>3K]OOO%=_XV\*>)]?CCFMO
M$GC#PEK?B&34KZ_UJZ=;G_!VE\']9\??\$E=9^*_ABSAE\2_LJ_M!_!/X\V.
MH)9"]U/2[-]9U'X2WMU8PG='/;6MQ\4=.U;5[6]M=0TO^SM*EU"_LL:;#?6(
M!^D7_!9;_@H7I'_!,K_@GU\;OVF$N].'Q.?34^&?[/>BZBEM<1^(?CQX^M-0
MLO RG3KPQVVLZ=X.M[36OBAXIT5Y[>74_!7@+Q-:6DPO9+9'_-W_ ()*_P#!
M$GP-X6_X(_\ BW]G#]LG3_$VJ_%'_@H%<:9\;OVP-3L/%+1^/KF^U37M'\8^
M"/ MUXYCDUB[FN?#&DZ7ILGB.Y2[OGE\9>)/B#>6.H,=62]'Q#X+\?6G_!Q%
M_P %BO@)XGT..XU+_@G%_P $OOAU\-?CUXGCL=037? ?Q2_:Z^(6F:#XQ\*>
M [J\B\1P:;XC@\-ZS!%'>WE[X#CE30OA#\2_ OBO2-%A^)VDR'^JG]M[XQ-^
MSS^QE^UG\>(KFYM+KX-?LV?&_P")NGS6-W:V&HG5?!'PU\2^(M(M]*NKW_1(
MM7N]3T^TM-(\X.DFI3VL0CD9Q&P!_!C_ ,$#O^"%'_!/O_@IIX'_ &W/CQ\8
MO!_CJY^$7@_]L7QK\'?V;],\(_%G6=*U/1/!'AS1M)\9-8>(-8TZ\U"'Q4(O
M#7Q \ V^GZX\8EN[BVU:Z;4-02ZC6S_=3_@L_P#M=_M3_&']KG]FC_@AA_P3
MC\;W/P0^+?[07A9_'/[27[0/ARSNX+KX$?LZVNG:^)M)T"ZTR&SF\-WEUX<\
M/:SKMS?:+K?A;7+FY3X=^ ?#?B32;OXA7$L/J'_!IMX"\.>$/^"*OP(\2:)?
M?:]3^*_Q._:$\?>,+?SUF.E^(M.^+_BCX7VMB8Q/*;;S/"?PX\+ZGY#1VS-_
M:/VD0,MPMS<?)OP#\7^!/AO_ ,'@_P"WEIOQAOH?#_BGXV_L:_"GP]^R_>>)
M[U5L_$DEC\*?V7M5\7>&?!:W%XT4.L:D?AY\0]1MK>&SCFGC\(>-D@N()=0E
MM]; /5]6_P"#0W_@F7??"S7]'B\:?M/WO[1>JG7O$%G^UEXL^+M[K_Q'@^(^
MK27NJ6/B[6?"VF6?ACP%KUKIGB2ZAU2:Q_L73/$VKVUKY%[XX&LW-QXB?L?^
M#>7_ (*3_%'XE_\ !/']IF+]OOXAWVK>.?\ @FE\1OBG\//C)\?/$][J7BO4
M/$'PE^&WA>;QO+XQ\<>(XI]4\0^-/%G@FQTSQGH6LZ['HK:OXE\+^&/">MZC
M<^*?&VL>)=2N?VD_;_\ VX_@S_P3S_9:^*G[3/QG\1Z3IEAX(\+ZK=^$/"MS
MJ.F6_B+XE>.?L_D^&/ ?@[2;_4]+GU[6]<UB>QMY;:RN$_L[3'O=9U">RTK3
M[V^M_P"13]BS]DK]H+X7_P#!K=_P4N^.WQ!COH_C1^W=X+^,W[8M^)=#TK3[
M^7X+:OX6\,Z@NLW%MX;U#3HOL7CCX?Z%XX^)MD4?3M*TOPUXYL(T\(O!:7]I
MK@![5^RY^R9\6?\ @YS3Q)^WI_P4#^*/Q>^$G_!/ZX\8:YX0_8Z_88^"OCB_
M\+^']9TWX>>)=0T+6OB7\7-?O_#MSI7C+4FUJUUGP_<>)/#]C!XFU/Q78:Y9
MZ7KW@+PCX0TGP?K'LK?\$$_CE_P38_X*)?LD?M3?\$8-;U7PW^SYXF\;>%_
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M48KK^U=7UKQ!<VT_D6>GZE<Z9I.GZMXDELFT[0K^:#Y0_P"#93X<_$OX8?\
M!%/]C30OB;I$^@7FNZ7\3_B/X.T>[2!+R+X:_%7XQ>/?B1X"U:8V\2J]OXO\
M/>*;3QKI+R3W<YT/Q'I@FDMI VG60!^]5?R$^&;RT_:"_P"#QOXD6FMZ5?ZC
M+^P[_P $_P"P@\(75]=6!M]"O/%GA#X<ZC<ZKHT+!;@6,ME^UOXFT:6U4O??
MVGK&J7N1II8)_7M7\A7P_MY/@7_P>.?'2XUJVOX$_;*_X)^Z._A&6\T^^>VO
M4\+^$?@K:7-QI-R;73K>*Q27]EOQ+:2WZS:[8_VG:ZCI9N8=2D-EI !]-_\
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MOI_P2U_[2>_L[_\ I5?U_0FGW%_W5_D*^IS;_DF>$_7/O_4^B8P_C5_^X?\
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MS6O#.DZ3XKTJ'Q)+_0Q10!^=G_!2#_@F1^S]_P %2/AO\)_A+^TCXA^*NF>
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M1>@^@_E7V.;?\DSPGZY]_P"I]$\.'\:O_P!P_P#TEBT445\L;!1110 4444
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M_P#\IQ_S/YZ/^'^FK?\ 2)O_ (*D_P#B.]S_ /)M'_#_ $U;_I$W_P %2?\
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M?\/]-6_Z1-_\%2?_ !'>Y_\ DVOZ%Z*/[6X:_P"B2C_X?<Q_^1]?Z6IR5O\
MG_\ ^4X_YG\]'_#_ $U;_I$W_P %2?\ Q'>Y_P#DVC_A_IJW_2)O_@J3_P"(
M[W/_ ,FU_0O11_:W#7_1)1_\/N8__(^O]+4Y*W_/_P#\IQ_S/YZ/^'^FK?\
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M_P#\IQ_S/YZ/^'^FK?\ 2)O_ (*D_P#B.]S_ /)M'_#_ $U;_I$W_P %2?\
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M[6X:_P"B2C_X?<Q_^1]?Z6IR5O\ G_\ ^4X_YG\]'_#_ $U;_I$W_P %2?\
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M]?Z6IR5O^?\ _P"4X_YG\]'_  _TU;_I$W_P5)_\1WN?_DVC_A_IJW_2)O\
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M'>Y_^3:/^'^FK?\ 2)O_ (*D_P#B.]S_ /)M?T+T4?VMPU_T24?_  ^YC_\
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M?_$=[G_Y-K^A>BC^UN&O^B2C_P"'W,?_ )'U_I:G)6_Y_P#_ )3C_F?ST?\
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MCO<__)M?T+T4?VMPU_T24?\ P^YC_P#(^O\ 2U.2M_S_ /\ RG'_ #/YZ/\
MA_IJW_2)O_@J3_XCO<__ ";1_P /]-6_Z1-_\%2?_$=[G_Y-K^A>BC^UN&O^
MB2C_ .'W,?\ Y'U_I:G)6_Y__P#E./\ F?ST?\/]-6_Z1-_\%2?_ !'>Y_\
MDVC_ (?Z:M_TB;_X*D_^([W/_P FU_0O11_:W#7_ $24?_#[F/\ \CZ_TM3D
MK?\ /_\ \IQ_S/YZ/^'^FK?](F_^"I/_ (CO<_\ R;1_P_TU;_I$W_P5)_\
M$=[G_P"3:_H7HH_M;AK_ *)*/_A]S'_Y'U_I:G)6_P"?_P#Y3C_F?ST?\/\
M35O^D3?_  5)_P#$=[G_ .3:/^'^FK?](F_^"I/_ (CO<_\ R;7]"]%']K<-
M?]$E'_P^YC_\CZ_TM3DK?\__ /RG'_,_GH_X?Z:M_P!(F_\ @J3_ .([W/\
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M $24?_#[F/\ \CZ_TM3DK?\ /_\ \IQ_S/YZ/^'^FK?](F_^"I/_ (CO<_\
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M?_$=[G_Y-K^A>BC^UN&O^B2C_P"'W,?_ )'U_I:G)6_Y_P#_ )3C_F?ST?\
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MIH;%XQ96MS=%A!!+(IJOQ(^'>A^*M(\":WX]\%Z/XWU^"&ZT'P;JOBG0]/\
M%6MVUS/=VUO<:1X>N[Z'5]2@GN-/O[>&:SLYHY9[*[B1FDMIE3^5G]E6XU#]
MH_\ X.T/^"@GQ(OA:7/@W]C/]C3P5\$_!MQ::E-'>V_B;Q58_!B]NHM1L_[1
MU2UOX$U;Q!\=+>5; :/;V!B\/'4-*37CJ5Q<MU&XE_:3_P"#POP_8N\-Q:?\
M$^/^">5_J5K;6NJR6L>G:E\0=!GL[[4K_3O[2U"'4-8OM/\ VQ;#3YK<6>A3
M2:1!X?OY;*XCT.VU/5 #^MRBOBK]L_\ X*+_ +$G_!/3PMHOB_\ ;'_:)\#?
M!.P\33O!X6T;5$UWQ1X]\5K;W-I9ZA>^%/ACX#T?Q5\2/$^DZ+<:AIZ>(=:T
M'PIJ&D>'!?V,FNWNG17=N\GQ3^RK_P '#'_!)3]LGXR>%?V?_@O^U K?%KQY
M?)I/@/POX]^&?Q3^&UOXRUEX+F>/0M#\3^,_!VD>$6\079MEM=(T&_UZPUCQ
M'J5W9:3X:LM8U2X%F #]JZ**R=?UW2/"^A:UXF\07\&E:#X=TG4==UO5+HLM
MMIND:19S:AJ5_<%%=Q!9V5O-<3%49A'&Q56. 0#6HK\=?&W_  7U_P""3G@+
M]FWP!^UAKG[5VF+\'?BOK_BKPW\+KI?AM\7K'QQ\0]1\":Y:^'?&]QX4^%NN
M> M(^)&H:#X2U>[BLM=\5-X7@\,6ER1:#6)+V2"VE]6_88_X+$?\$Z/^"CNO
MZUX,_9*_:-T7Q[\0_#ND7/B#6?AKKWA?QO\ #GQ[;Z!9WMO8W6NZ?X=^(7AO
MPU<^)-&M)K[31J&J^%7URPTEM4T^WU>XL+RY6V !^FE%?*?[47[;G[,'[& ^
M#X_:3^)W_"O)OC[\4M$^"OPALK?P7\0O'.I^-OB9XCXT?PU8Z5\.O"?B[4K'
M[4YBA?6=8M=.T"TN+FSM[W5;>>]M(YOS9^.'_!R7_P $;?V?/C#XF^"'C_\
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M)?5M)\7^*M ^)7Q-N_A1<Z%=ZMIT%WXYM;?1O!"KHLVJIX5\3_#F]&G>(=%
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M'[76D^ M8O-+UCXQ7>JI\+/'<&FZO;W6J6&@:U9:?#\0_@QX<\!_:M#\4O\
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M1]<TV^O/B+XJ^(>L:=K.HZ!KFH1^&#X5OO#S:CXGM]$T349AHFK:PLW]*_\
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M,VJZKX8\*:+XJ\/ZS<R)%:W^FR^(_!6JZ5J^N?VOXT\4_#W0_B'X2N3XEOM
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M (<O^OM;_P!.S/F?]M/_ ),X_:S_ .S9_CQ_ZJWQ57PS_P $$/\ E$7^Q?\
M]B;X]_\ 5R?$>ON;]M/_ ),X_:S_ .S9_CQ_ZJWQ57PS_P $$/\ E$7^Q?\
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M%'PW\.:JVA6&GW;:SX,OKV+PMX:GTGP!X1NM#TNR\31>(OUB_84_80\>^/\
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MHNNVWAO6S<V=D ?DO_P;&7$'QO\ VA_^"XG[< \0GQ?!^T'^WIJ'A?PMKO\
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MOXL^$'C?4;?1M1F\3>#?%/AKP[J96VTBPM-0_1/_ ()>?\%D_P!@3X1?L*?
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MU#38?$WCOX@>&K/XA137%E%J?AC6?%NA^([.VTO5]7T,@'T1\&/C#_P:Y?\
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MOP+_ ."W_P"V_P#!34/B;K@\2_$6\^$MEXL^'5WX]\0+-?W$6M^-+KP?\?\
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M;X?? SPA=2:CJ'A?1[[7- GM=9U6TN-0TKQ-%JLDNCZ3+\2]&^'_ ,-]/O\
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M]+IVK1Z!K&J?V5J!M_P3_P""C&K>'?@=_P ''G_!([XR?M#>)O#_ ,,OV0-
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M;6:^U6#3-,L/^%/2:]%#;Z3?[#9ZE^T!9PV%K+=V\VK7+SI8:5KATZ^DT?\
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M_P ,:7]J^'=AI5A]OU:_T[2K+[3<V6GVIFC,\]O;HTB?GA_P<?)!^U!\5O\
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M_P .>)[[Q1?Z9<2:5IVJ_M9_P4U_X)G^(OVB?^"*7C+]@7X9:Q/XA^)/PN^
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M5QJW@Z[\>>&+VRT34O$?A.XN=ES?>#/$K6\VJZ?IVK&"]FTF<:!XC$<MAK8
M.<_X(M6OAJS_ ."2W_!.>+PI;06NG2?L=? *ZOH[>&X@1_$M[\.= N_%URZ7
M*J[3W?BB;5[FYF0&WGN)99K5GMY(F/XN_P#!W)<RV?[.O_!/N\T18'\;6O\
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MM$U:6#Q/^U+J/A^XAFM;;QOK^O64L^C:F(KW4=)UL2:7:^)-8TOX9_#_ %=
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M%_Q'UCPUH^F:CXX\476H:UK-]<:_XFN=4U::\U;4[J2[:>_NGE]7HH \*_:
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M_P XZC_A1W_!RI_T>C_P3S_\-MXK_P#G'5_0M17G_P"M5?\ Z$G"W_B/9?\
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M%_S]K_\ @V7]?\._*W\]/_"CO^#E3_H]'_@GG_X;;Q7_ /..H_X4=_P<J?\
M1Z/_  3S_P##;>*__G'5_0M11_K57_Z$G"W_ (CV7_\ ROR_/NP]@O\ G[7_
M /!LOZ_X=^5OYZ?^%'?\'*G_ $>C_P $\_\ PVWBO_YQU'_"CO\ @Y4_Z/1_
MX)Y_^&V\5_\ SCJ_H6HH_P!:J_\ T).%O_$>R_\ ^5^7Y]V'L%_S]K_^#9?U
M_P ._*W\]/\ PH[_ (.5/^CT?^">?_AMO%?_ ,XZC_A1W_!RI_T>C_P3S_\
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M /..H_X4=_P<J?\ 1Z/_  3S_P##;>*__G'5_0M11_K57_Z$G"W_ (CV7_\
MROR_/NP]@O\ G[7_ /!LOZ_X=^5OYZ?^%'?\'*G_ $>C_P $\_\ PVWBO_YQ
MU'_"CO\ @Y4_Z/1_X)Y_^&V\5_\ SCJ_H6HH_P!:J_\ T).%O_$>R_\ ^5^7
MY]V'L%_S]K_^#9?U_P ._*W\]/\ PH[_ (.5/^CT?^">?_AMO%?_ ,XZC_A1
MW_!RI_T>C_P3S_\ #;>*_P#YQU?T+44?ZU5_^A)PM_XCV7__ "OR_/NP]@O^
M?M?_ ,&R_K_AWY6_GI_X4=_P<J?]'H_\$\__  VWBO\ ^<=1_P *._X.5/\
MH]'_ ()Y_P#AMO%?_P XZOZ%J*/]:J__ $).%O\ Q'LO_P#E?E^?=A[!?\_:
M_P#X-E_7_#ORM_/3_P *._X.5/\ H]'_ ()Y_P#AMO%?_P XZC_A1W_!RI_T
M>C_P3S_\-MXK_P#G'5_0M11_K57_ .A)PM_XCV7_ /ROR_/NP]@O^?M?_P &
MR_K_ (=^5OYZ?^%'?\'*G_1Z/_!//_PVWBO_ .<=1_PH[_@Y4_Z/1_X)Y_\
MAMO%?_SCJ_H6HH_UJK_]"3A;_P 1[+__ )7Y?GW8>P7_ #]K_P#@V7]?\._*
MW\]/_"CO^#E3_H]'_@GG_P"&V\5__..H_P"%'?\ !RI_T>C_ ,$\_P#PVWBO
M_P"<=7]"U%'^M5?_ *$G"W_B/9?_ /*_+\^[#V"_Y^U__!LOZ_X=^5OYZ?\
MA1W_  <J?]'H_P#!//\ \-MXK_\ G'4?\*._X.5/^CT?^">?_AMO%?\ \XZO
MZ%J*/]:J_P#T).%O_$>R_P#^5^7Y]V'L%_S]K_\ @V7]?\._*W\]/_"CO^#E
M3_H]'_@GG_X;;Q7_ /..H_X4=_P<J?\ 1Z/_  3S_P##;>*__G'5_0M11_K5
M7_Z$G"W_ (CV7_\ ROR_/NP]@O\ G[7_ /!LOZ_X=^5OYZ?^%'?\'*G_ $>C
M_P $\_\ PVWBO_YQU'_"CO\ @Y4_Z/1_X)Y_^&V\5_\ SCJ_H6HH_P!:J_\
MT).%O_$>R_\ ^5^7Y]V'L%_S]K_^#9?U_P ._*W\]/\ PH[_ (.5/^CT?^">
M?_AMO%?_ ,XZC_A1W_!RI_T>C_P3S_\ #;>*_P#YQU?T+44?ZU5_^A)PM_XC
MV7__ "OR_/NP]@O^?M?_ ,&R_K_AWY6_GI_X4=_P<J?]'H_\$\__  VWBO\
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M^#E3_H]'_@GG_P"&V\5__..K^A:BC_6JO_T).%O_ !'LO_\ E?E^?=A[!?\
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MT?\ @GG_ .&V\5__ #CJ/^%'?\'*G_1Z/_!//_PVWBO_ .<=7]"U%'^M5?\
MZ$G"W_B/9?\ _*_+\^[#V"_Y^U__  ;+^O\ AWY6_GI_X4=_P<J?]'H_\$\_
M_#;>*_\ YQU'_"CO^#E3_H]'_@GG_P"&V\5__..K^A:BC_6JO_T).%O_ !'L
MO_\ E?E^?=A[!?\ /VO_ .#9?U_P[\K?ST_\*._X.5/^CT?^">?_ (;;Q7_\
MXZC_ (4=_P '*G_1Z/\ P3S_ /#;>*__ )QU?T+44?ZU5_\ H2<+?^(]E_\
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M%_S]K_\ @V7]?\._*W\]/_"CO^#E3_H]'_@GG_X;;Q7_ /..H_X4=_P<J?\
M1Z/_  3S_P##;>*__G'5_0M11_K57_Z$G"W_ (CV7_\ ROR_/NP]@O\ G[7_
M /!LOZ_X=^5OYZ?^%'?\'*G_ $>C_P $\_\ PVWBO_YQU'_"CO\ @Y4_Z/1_
MX)Y_^&V\5_\ SCJ_H6HH_P!:J_\ T).%O_$>R_\ ^5^7Y]V'L%_S]K_^#9?U
M_P ._*W\]/\ PH[_ (.5/^CT?^">?_AMO%?_ ,XZC_A1W_!RI_T>C_P3S_\
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M /..H_X4=_P<J?\ 1Z/_  3S_P##;>*__G'5_0M11_K57_Z$G"W_ (CV7_\
MROR_/NP]@O\ G[7_ /!LOZ_X=^5OYZ?^%'?\'*G_ $>C_P $\_\ PVWBO_YQ
MU'_"CO\ @Y4_Z/1_X)Y_^&V\5_\ SCJ_H6HH_P!:J_\ T).%O_$>R_\ ^5^7
MY]V'L%_S]K_^#9?U_P ._*W\]/\ PH[_ (.5/^CT?^">?_AMO%?_ ,XZC_A1
MW_!RI_T>C_P3S_\ #;>*_P#YQU?T+44?ZU5_^A)PM_XCV7__ "OR_/NP]@O^
M?M?_ ,&R_K_AWY6_GI_X4=_P<J?]'H_\$\__  VWBO\ ^<=1_P *._X.5/\
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ME+?V206GB/PSKNBZII^L>%?%^GVUO8ZQ;2WNFW-KI7B;0?$OA_1>$_X)>_\
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M_$?7XKRYTGP9X,TFYO--T]KQM/TW4]7U'4=7U/3=+T_2]-N?])N=6N=(TC5
M#[SHK^4+XB?\%Y/^"K/P:\!7?[3'QB_X(#_&CX?_ +).A6]CXF\9^)M0_:#T
MFX^+O@KX<3F--0\7>*?AB?A=:^*O#5YH=JTFO:]HWBSPQX<L?#MK!-IWBCQ'
MH-E!<^*K?^CC]E#]J+X/_MI_LZ?";]J3X":]-XC^%'QD\+Q^)O"U]>6\=GJM
MD\%]>Z+X@\->(+&&XO(=.\4>#O%&E:UX2\5:;!>WMOI_B/1-4LH+Z\A@2ZE
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MX]_&'Q'!X2^%WP?\#^(_B%XZ\0SQ371T[PYX7TRXU74#9V%JDM]JVJW,5O\
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MT+2O$NG26&M:;>/9WT%UHVM:==AD*20M.UO<Q0W,4L2?KA^RI_R:_P#LX_\
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M\)PS_9+G2]<U;P=?:=I?C;0+&2YGAM[+6[W1;.R.KV]YID-W_:VF7]K:_?-
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M'5E8@^H_\*L^&/\ T3CP'_X2'A[_ .5U '\[WA__ (.T/^".?B77M$\.:?\
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M7A[P)#H+7QAT2-O$FF^(?$-]XDMS9ZWX<-E;:+>6NIPZC;_-_P"VW_P<)?\
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M2RZ9+IB0?)__  75G\(/_P %V/\ @B_IG[:.JZ=8?\$]KG1_%FH)!XVEMO\
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M7*:WX<F_9XT^'Q!I#0WSKJ6B2W]E%JMF9K"2[MEN#,GDO[2FG?MJ_P#!%O\
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MX;\(PVUU-?6]I?2W,$>CK%/+>6MM=22HS7%O#,7C4 _F1_;M\#Z7_P %%O\
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M%H(O/#7Q TC2/$MMI$VHZ=XGUS1[B^.K27XU^\OCK5T;C[+8@'U+_P %<_\
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M$:=^SW_P0!^,/[1A^.,]W\8_&W[64?[3'ACP3KG[1,_BC4-2U'PGXENM/O\
MX!>(]<MO#6B>&]0@TSPEIFH^)M;@CBEU7Q';W'VWQ5JT]U_1C^S7_P $X[CQ
M?_P;_?"K_@G+XQ;7OA1XP^)O[!FF>#/%A\5:1?'7/A7\:/BMX,?Q[KR>)/#<
ME]97]P?A[\7/$UW'K'A@ZAIDU[::+<Z)Y^E^=FV_&W]C+_@L%^VQ_P $K/V?
M/AS_ ,$__P!N;_@D+^V;XH^(/[,_A?1_@]\.OBE^S;X/F^(/PV^+F@Z;;M'\
M-5L-<M;&;PE=W3^'TMM$U'7/ _C3QR=1U72-1>Y\/:'K\&L>&-) /+?^"AOC
M'_@K]_P5>^('[ _AG5_^"(_Q8_91C_9U_;'^&7QEN/B]J/QR\'_$S5-/T:#6
M](L-8L+;5)/ /PH?P5H,2I:>)O$&H#5KZ"ZN/#&A7$\%L='AN1]8_MQZ##_P
M41_X.;/V+/V+/B3%HOBK]FC]@_\ 9RUW]J?QI\,-9L/#6L:5XI^)WB:.74%E
M\0V%_:7T>LZ9=7LG[.UO/X7\2V>H1P^'](\62Z3;Z=#XUOM1?]!/^"=_QY_X
M+&_MM?M4:E^TK^T5\$1_P3M_X)]^'OA_=>&? W['_P 3_#FA>*OVA/C3XZU'
M[4D7Q&\8>(M8\-^$OB3\*CX;N4^VR:7J.C^%-)GTY])\*V7@KQE<3ZO\3[#X
M8_X+#_ G]O#]BC_@J!\"_P#@MO\ L*_ ?Q/^UOX5T7X*3? 7]K7]G'P;;WEW
MXNU/P=:ZC=V5KJ>G0:%;>)_'-QI'B#3_ !%H&I0:IX(^'_B5/A=XG^$5KXT\
M<V.O>!]>UK2( #^MVOSTTSX>_P#!/?\ X(X?LR?'SXL>%?!7P\_9,_9PT?7]
M6^./Q@N?#EMJJZ--XKUZ/P]X2MSI&BM<ZI=?VEK]W:^%O!O@;X?>$;:WL+C6
M[W2O#WA'P[%J&KBWNOPA^*'_  68_P""G?\ P4.\!WW[./\ P2Z_X)>?M>?L
M]_%_Q_,_@CQC^U=^U=X5B^%_PJ_9UC4V4'CR_P!+\1ZMI\OAV_\ &_AO3-7M
M;[2[>YU!O'5I;/+JGAKX5>*M>ATS2G^CO^"SG_!.O]M+XV?\$+4_9.^&WQ6\
M:?M8_M*?#5OAG\1/BWXC\3BQM_'?[3$O@?4=3\5_$32O"NE6EK!:P7(\3:A;
M>(_AIX%$USJYT#P7X?\  MKJWB;Q0]K<:T >$_!K_@MO\<?BEX=UNX_X)!?\
M$!_CI\0?@UXC\7ZWXD?XK>))OA[^R#\*O'6L7HL[7_A.=&2P\%:SX2^(6N^(
MM-\-WUEXAOH?',&L>'O[/\'6VM7-_<ZO8:1;_$?[&?CS]KG]M3_@ZJ\,>.OV
MY?@-X'_9R^-_[&?[$7C"2P^!OP\^(NF?%$_"KP?KVBZKI'AB'X@_$#P;J?B/
MPEXN\4^(]/\ VMM4\4^=87FD:39:%XR\&V$UI9^(=+DL+K[<_9;_ ."^W[2W
MC3X9^$?V:_@__P $,?VZ&_:D^'_@[0/AE8?#.;PQ9?"S]G7PAKWA#2K/PO';
M>-_BUXZT'P=:_!GP?IL^DWMK';^+/".F6NES65EX6_M&*ZN%N[;E/^#>;]F_
M]NVS_P""CG_!7']K_P#;]^%?C7P=\4_B!K?@'X<Z7X_\0_"7Q=\*_A_\3;NW
M\4>-/^$PD_9]3QMX?T_5_%?P5\+6G@#P%I7@KQ3'?+-KG@V;P1JVOV]UK]]=
MIHX!I_M+7,/[1_\ P=R_L*_#JVLYM9\,?L5_L:>,OB3XTL+B..[M--\9^*O#
M/QFO=*U?;;Z^Z:=!97?Q!^!U]:7D^E6FK2ZW:16UW8WNB3:1JD+/^"J5W8_M
M$?\ !RK_ ,$/_P!EU-+NO$"? /PMX_\ VK-=1H(K[0M"N);SQ7XRT2^G*Z[&
M-.UG3-5_9=T#5)'O--TUHY+_ ,&RVMQXEN+^ST>T]G_X)S? #]HSQ7_P<.?\
M%A/VX?C!\%_BE\,_AO:_#WP#^S-\$/%GC[P!X\\%>$OB;X4M;KX>Z,VM_"/5
MO$[GP]XX\/-!^SAI_B/Q%K'A.XU33XM2\8Z9JBKX<C\4QZ7=K\"O@)^TI\4/
M^#H[]KS]JKXA_!;XE^#/V;/@+^QWX5^"GP*^+'BKX?\ CSP[X*^).N:]HOPC
MOM3M/!/C#5F'@SQF;'7_ !!\:WU";PI>W%GI=I8Z3;:IH%MXBN;[5HP#0_X+
M\?L _MJ_&'XY_P#!/_\ X*(_L)_#OP5^T)\5_P!@'QGX@\7:M^S?\1-6TF*Q
M\9V:>(O!/C/PWXA\#Z/KDV@:7>^(M%O_  OK#ZXEOXQTSQI-/%X#O_AM9W7B
MOP]'#=>)0?\ !R1X.\-^*_#_ .S)_P %G?\ @E]\=/V)M&^)%GIOASQ#XM^)
MWA,_&']G?7]5:^/FZMJ>D^*/ _AJXU?X:37&ERZA'J7@^T^+TNBZG;'3+F+4
M;?1M0\40>J_M;?M]_P#!7#_@FK_P4:^-7CGXN?LW_&K]N_\ X)4_$?P/HFH_
M!*T_9:^#GA74_%_[.GB&WM_"B:ZOC75?#?A=_%LDEE?V'C:VU.'XH>*I_#7B
MJW\1>"_$/A#Q9X6N;37OA_8?"'[<_CK]OK_@Y*TWX9_L7_ __@GQ\?/V)_V1
M?!'QE^'WQ6_:%_:9_;-T2;X9>)[D:=8^)="3PG\-_!&H:5+;^(+K1-'\0ZSX
MBFMO"6J>,M7U77/^$-L_%$GPN\,R3WWC( _MDT'0=!\+Z/I_A_PQHND^'= T
MJW6UTO1-"TVSTC1]-M0S.MO8:;I\-O96< 9V80V\$<89F(7)).O6#X5\-Z9X
M-\+^&_"&B1>1HWA70='\-Z1#Y=O%Y.F:'I]OIEA%Y=I!:VD?EVMK$NRVMK>W
M3&V&"*,+&N]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ?SU?\ !P)_R"_^"7W_ &E%_9Q_]%^(Z_H47H/H
M/Y5_/7_P<"?\@O\ X)??]I1?V<?_ $7XCK^A1>@^@_E7U.;?\DSPGZY]_P"I
M]$QA_&K_ /</_P!)8M%%%?+&P4444 %%%% !1110 4444 %%%% '\5W_  6Y
M_;.^"_[=?_!1WX'?\$8_&'[3_P 'OV>/V-_A;K_ASXU_\%&OBG\3OB1X7^%.
MB^*+SPF=.\9:!^SAX=\=^,?$WA+2;K7[G2;W0H;B#P]J>J7>B^-_%]IK=[87
M&H_!7Q'H8L_\')_[7_\ P3H\:?\ !&6__9Q_9%_:M_8V\>3>#/'?[/7AWX??
M!7X _'WX,>-=4T'P!X"OX]*L-.\-^!? ?B[5M2MO#7A30;*RLT2RTT6&DZ=;
MP(YAA1<?O'\:_P#@A?\ \$H/VC/BMXY^-_QL_8X\%?$'XJ_$G7)_$GC?QEJ_
MC+XL6^H:_K5S'%%+>W%OI?C^PTVVQ###!%;6-E:VEO!%'#;P11(J#\%_^"\O
M_! S]CKX6?\ !/#QIXI_X)S_ /!/76-3_:8'Q&^&.G:/:_ S0OC9\8?B'_PB
M=WX@W>+)-.\'VVM^-[HV*64,7]J:I;:(9+*S9U>[MX)YA( ?TP?\$]OVG/V;
M/V@OV=/A7H7P$_:%^!WQOUOX7_!?X*Z9\2]&^$/Q9\!?$K5?AWJ6J^"HK33-
M.\=:=X,U_6KOPE?:E=^&_$5K86FOPZ?<7EQH.M0V\<DFEWRP?(O@;_@WH_X)
M"^"OBC\5_B_>?L>>"_B9XN^,'B'5O$OB"+XU:MXD^+_AS1=0UW59-<UG_A$?
M#'CW5M;T703J&L33WLM^EG<ZU"D\NFVFJ6^CM_9P]T_X)@_\$Z/V4?V!_@CH
M-Y^SQ\ +3X&>.OC%\*_@E-\=@VI^/+WQ!XE\4^"O"NH2V:^)[/QUX@UN[TS5
M]$U?QGXP%W;P0:=<"\U6\BU&*22"!+?^>OX6?%__ (*W_P#!!CXZ?M*?"OXO
M?LP_M=?\%3OV!_B=\2-3^(7[.GQG^&_B/Q9\=OBS\,X+]++3M.\/^,=0O[#Q
MCXOT:TF\/V_AKPUXC\.^,AX:\*VWC?0[[Q+\-M0U>+Q5K3:R >,?\%]O^"??
MP?\ ^"/NK?LO?\%?O^":_A_3/V8OB#\)OCWX/\!?$CX2^ ;W4_#GPT^)6B^)
M+?Q-XA18_#VFI)#I-IXAL-"U?P!\1/#EG<V7A?Q+X*UNU$&D66IZ5=3:W_5;
M_P %(_VKXOV5_P#@F[^U9^UCX:U_1-+U7P+^SMXK\3_#/6_$,]UIFDR?$+Q5
MH::!\(TG1C97[S:MX_\ $?A2PT_2$ET[4-4U"]M='@NM/N[Q+F#^93XX>'/^
M"@/_  <O?&7]G7X5?$3]A[XL_L#?\$L/@)\6]%^+?QD\0_M%KJWA3XQ?'7Q1
MH6F7.E7OAOP1X;U"P\):[!+=^'/$7C'X?^&==\*:7KOA7P@VK>*_&GBKQW=^
M)(O#GPLB^V?^#G37'^(/P7_8$_X)B>!M)U%_$G_!0?\ ;*^&7P^;2_#-EJ,%
MQIGP:^$VL>%Y_'NI:1<V%A>>'M#D\+ZWXX^&>KR7OB33]5T/1_#FGZ[K$GA^
MY@T>;4]# /MS_@W2_9UE_9L_X(Z_L7:!?7T&I:Q\4_AV_P"T;JMY;6EK9QF/
M]H75+WXL>&[%EMY;B2>?1?!?B?PSH5U=WEU-=7-SIDLOEZ=;M;Z3I_HOQL_X
M(8?\$Q?VDOVOO$?[;_Q]_9QM/B]\</%UMHD7B2/QSXR\;:O\-M:NO#'@KPK\
M._#>HZI\+6UZ/P1J4^B>#O"-AI5K8W^D7.AW$]S=ZWJ.DWWB"+2]5TW]6/#?
MA_2/"?A[0?"WA^P@TK0?#6C:9H.B:7:@BVT[2=(LH=/TZPMPS,P@M+.WAMX@
MS,1'&H))YK^5']N.S_X*O?\ !,;_ (*<^.O^"B'[/?PW^.__  4+_8$^/7A3
MP]HGQC_9H\+^-O$'CWQM\ M8M/\ A&-.UO5/AA\-)[;Q%X@T;2530I_%>@WW
MP^T*Z\(K;7FO>'/B=)X3TS2O"'B&8 QO^"[7_!"G]B#0_P!A3XH_M8_L?_"3
MP9^QO^TE^QGX>O/V@? GCKX"6+?"^WUVR^'UQ:>)O$&A^(;/PC! DFN6^F:9
M/K7P]\6Z=%IOBGPQXXTO0FM_$5EX?N]>L[S]0/V1?^"G7A>Q_P""(WP:_P""
MF/[5GB:U@L_#_P"S3I7BWXM:[:0W%K+XJ^(/AR_;X:SZ=I=I<0*1XF^)/Q+L
M;30=&LHT_LZ;Q-XEL[6SN&TV2&Z/XD_M@?MR?\%1O^"X/P>U+]@/]C[_ ()>
M_M'?LA?#SXUZIH/A[]HO]I_]K_1=8\ >%O!WPUMM=TW5-<T7PW_:GAW0++4+
MJ[%OIESXDCT"_P#&'C.\\+MJ7A_1/ +SZY;^(M-_I3\ ?\$S_P!EGP[_ ,$]
M/AU_P31\?^!K;XM?LV^#?AO\/_ 7B3P]XDN=7T<_$/4/ VO:'XYE\8:[+X:U
M?3-0L-8\1?$S1(_B#J5MH^I6EA%K-S-9V\*:3BQ(!_-+_P $+/VD?V+?&?Q'
M_:&_X+$_\%%OV[/V&_"O[<?[8'B;5]$^'WPO\?\ [2WP-\'Z[^RO^SYX7U&Z
M\.:'X#T+PIXE^(-GKWA>Y\3:;I&BZ<G_  D.G/XI_P"%?^$_"5W>ZM/K'C/Q
M[<Z[P/[+/[;O[%_A[_@[ _X*2_M&:_\ M=_LP:'^SYXZ_8@\"^$_!'QVUCX^
M_"G3/@UXQ\56?@W]@>UN_#/A7XGWOBR#P3XA\06MSX.\76]QHVD:Y>:C!/X5
M\20RVRR:'J:VO[R_\0XO_!$[_HP;X<?^%O\ &;_YY5?@-\ O^""W[-NJ?\'"
M?[;OPJ^(_P#P3S\9Q?\ !-'PW^ROX3UOX ZIKWA;XZ:/^S]<?&"?PS^R)-K,
M/@KXROJEE8^*O%*ZMKWQK%WX?A\<ZQ+;W,'BV Z;$?#<L>E@']T&DZMI>O:7
MINN:'J6GZSHNLV%GJND:QI-Y;:CI>JZ9J%O'=V&I:;J%G)-:7UA?6LL5S9WE
MK-+;W-O+'-#(\;JQT*P/"GA?0O!'A?PYX,\+V/\ 9?AKPEH.D>&?#VF_:;R]
M_L_1-"L+?2]*L?MFH7%W?W7V6QM8(/M-[=7-W/Y?FW,\TS/(V_0!_'[_ ,&8
MEL%_X)]_M87FM-='QY/^WS\1+;Q6FK75V_B!5M?@E\!);9M9L;Z9KJWN6UB[
M\2"2ZNK>.[N[U+Z&YFGDLMEO]!_\'!O[6/Q)\7^-_P!EW_@C/^SE\-O@]XL^
M//\ P4+U.WNM:\=_M$_#?0/BK\*OA/\ "K0]4U8/XITKP5XET7Q3HFH_$"SU
M?POJGB6T\2:IX5\1IX#T+PA?WVAZ'/XQUWPUXE\&^&?\&_T%U^Q[_P %0?\
M@M3_ ,$TO%NGZWX<GM_C?-^U?\!M$OGTM['5O@GXB\3ZGI47BF)-/L-(MDO+
MSP5XW^ ANI-(LGTK[3=76E&UT.XT06^H?2__  7._P""?7[9?CK]H#]C#_@J
M?_P3GTK1OB)^U7^PQ?W]AK?P&\2SZ+#;_&#X2ZAJ=QJ.H:7X7F\17FFZ2FL6
M^FZ[X_T#Q+HT>HZ=XJ\2>&/&1O?AQKFD?$+PAX<T_P 2@'PO=_\ !G+\/(?V
M>K'X5:5_P4B_:GN_%6AZ?;:CHNE>(M#\*ZG^S$OCRWU-]<GU67]G2YN[P0^'
M=1UBXU"ZDT23X@ZE=P7.HSWU[J>ML;JUO_O#_@WD_;9^)'C31/VF/^"8G[2G
MPM^%7PF_:6_X)G>-+;X6ZG#\#_AYIGPL^$_Q+^'\NIZ]H5O\0O#'@W2+/P_I
M-KJ^K>,/#FO^*/$.K>'/ _@7P9XHT;Q[X&\6>&]!MY=>UBTT_P (L_\ @Y&_
M:ZU;P[:>&-%_X(*?\%'[[]H"YT>WTUO"%U\./'^E>!H?B(EFD>KV%QX@F^%<
M_B.R\*Z5JB7TDNIW_AJUOH])LVGU2UTD_:9;/Z"_X('_ /!-_P#:@^ /B?\
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M:E:76F-:3_!KP%XT\4 'S#^SSXM\9_\ !&#PO\)/AD?@9K'_  4*_P""[_\
MP5XUSQA^T-\5/!J>-? 'P5N3?:=HNJ>/O$7A_P ;_$CQ1<7?A_P?X#^%5O+X
MUA\.V.F:1IVA>./$V@?$2XL#X)TRWTRTTW]D?^"<_P#P5&\5?M;_ !>^/7[(
MG[4/[+OB#]BC]N3]FS3?"GBCXA? ?5/B+X<^,GAO7OASXRTO2+S0OB+X$^*7
M@[3[#PWK>GR7>K6=MK.CVJWT>AG5M#BM?$7B&XN-631O@C_@J7\(OC1^S7_P
M5Z_83_X+!^%/V??C=^U!\#/A9\"?&_[+7QW\"_LV>$I_B5\8_AW9ZLOQAUSP
MO\3;+X:6$,.J^)/"GG_%'5(_$E_9:A'::':^'=VH3:?=7^BV^O4O^"8NB?&[
M]M/_ (+#_M6?\%;]>_9E^/?[)7[.]]^R-X0_9#^#?@_]J'P9%X#^+_Q8U23Q
MOX/\7>+?')\&P:CJ!\):1X-OOA@VAW-K+>:[I^M_\)3HU[HOB.YN;#Q%I.C
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MX+%_\%!=%_X)G?\ !/\ ^-W[3+W>GCXCQZ6OPZ^ >BZ@MM.GB+XZ>.K6_LO
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M544 *JA5 Z!5& ![ #%?QR^*?'W_  5G_P"")7[=7[3_ ,1=4^ 7[3__  5
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M*RV2P6ZP""/\I_\ @MG\1/B5_P %//V\?AI_P0/^ 7ASX.^$$'@T?'G]I?\
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MV,<PLYPOW+_P2A_8#\)?\$U?V&O@M^R_H(L[[Q9HF@P^*/C+XKLY9;F+QO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!_/5_P<"?\ (+_X)??]I1?V<?\ T7XCK^A1>@^@_E7\]?\ P<"?\@O_
M ()??]I1?V<?_1?B.OZ%%Z#Z#^5?4YM_R3/"?KGW_J?1,8?QJ_\ W#_])8M%
M%%?+&P4444 %%%% !1110 4444 %%%% !1110 4444 %?#WQ>_X)^_ KXY?M
ME?LV_MP_$6_^(FJ_%7]D[PYXPT+X*^&+3Q3:Z9\,M!O_ !Y::MIOBGQ;J'A^
MRT6+6]:\2ZII>IV^FR&_\42: EMHFBM'H*W5O=W-[]PT4 %%%% !1110 444
M4 %%%% 'Y0_M$_\ !,V3XC_\%'?V2_\ @I7\%OBCI/PA^+GP/TC7?A=\;_#U
M]X M/$6C_M#_  *\2VUY:S>&M3U;3]6\/ZMH?C'PRFI7\GACQ%J!\2V<<B:#
M'+IUO:^'8[;4OU>HHH **** "BBB@ HHHH **** "BBB@ HHHH _([2O^"9>
MN^+?^"M.I_\ !43X_P#Q<TGXB'X8_!H_!']C?X*:'X1O/#VF_ 31]8BU>U\;
M>-M<\4)K[/X\\<>*;3Q/X[LQ<7NB6]EIVD_$/5]%D&I0^%_!5YI'ZXT44 %%
M%% !1110 4444 %%%% !1110 4444 ?SU?\ !?OI_P $M?\ M)[^SO\ ^E5_
M7]":?<7_ '5_D*_GL_X+]]/^"6O_ &D]_9W_ /2J_K^A-/N+_NK_ "%?4YM_
MR3/"?KGW_J?1,8?QJ_\ W#_])8ZBBBOEC8**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KX>TW_@G[\"K']O;Q)_P4<O+_XB:[^T-K?P:L?@+I,&
ML>*;4_#SP1\-[6YTK4;K2O"?A33-%TR<76KZSICZUJ-]XDUCQ',NHZIJK:;_
M &?:SV]K:_<-% !1110 4444 %%%% !1110!^3GP!_X)D-^S%_P4W_:N_;H^
M#7Q0T?PS\(?VTO ?A6;XZ?LX+\/K2);WX]^$=0GEM/BWX;\9Z5JVE1Z?'K<6
MK^,-?\5Z=K'A_P 0:IKOC?QYXMUR?64BO-/M=,_6.BB@ HHHH **** "BBB@
M HHHH **** "O!/VI/A]\6OBQ^SQ\7_AE\"OB9I'P:^+'C_P3JWA'P?\5-<\
M+-XUL? =UKZ)INH>(T\+KJ6D+JVIV&C7&I/HD<]_%:V^M'3[R\BN[6WFLY_>
MZ* /@O\ X)H_L'> _P#@FY^QO\(_V4_ ^H?\)%<^"](?4_B%XW,%W9M\0OBG
MXBD_M7X@>-X]-O+[4IM%L-=\13WD^C: +^\C\/Z(NG:+'=72V(N)?O2BB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _GH_X)=?\I<?^"YO_8__ +,_
M_IN^,=?T+U_/1_P2Z_Y2X_\ !<W_ +'_ /9G_P#3=\8Z_H7KZCC#_D=1_P"Q
M+PQ_ZS64F&'_ (<O^OM;_P!.S/EO]N2PMM5_8H_;"TN\5GL]2_9:_:!L+M$=
MHW>VO/A-XMMYU61"'C9HI&"NI#*2&4@@&OYA?^"5/_!!;]@']K3_ ()_?LW_
M +0_Q=TKXOW'Q&^)GASQ5J7B>;PY\4]3T#17NM)^(OC'PW:&PTB"PEBLHQIF
MBV2R(DC"2<2S$AI"!_4-^VG_ ,F<?M9_]FS_ !X_]5;XJKX9_P"""'_*(O\
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MW9_/3_Q#%_\ !+K_ * GQZ_\/7K'_P K*/\ B&+_ ."77_0$^/7_ (>O6/\
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MM;_Y+R_/NP^K4/\ GS3_ / 5_73\^[/YZ?\ B&+_ ."77_0$^/7_ (>O6/\
MY64?\0Q?_!+K_H"?'K_P]>L?_*ROZ%J*/]=N+O\ HH\X_P#"VM_\EY?GW8?5
MJ'_/FG_X"OZZ?GW9_/3_ ,0Q?_!+K_H"?'K_ ,/7K'_RLH_XAB_^"77_ $!/
MCU_X>O6/_E97]"U%'^NW%W_11YQ_X6UO_DO+\^[#ZM0_Y\T__ 5_73\^[/YZ
M?^(8O_@EU_T!/CU_X>O6/_E91_Q#%_\ !+K_ * GQZ_\/7K'_P K*_H6HH_U
MVXN_Z*/./_"VM_\ )>7Y]V'U:A_SYI_^ K^NGY]V?ST_\0Q?_!+K_H"?'K_P
M]>L?_*RC_B&+_P""77_0$^/7_AZ]8_\ E97]"U%'^NW%W_11YQ_X6UO_ )+R
M_/NP^K4/^?-/_P !7]=/S[L_GI_XAB_^"77_ $!/CU_X>O6/_E91_P 0Q?\
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M ,$NO^@)\>O_  ]>L?\ RLH_XAB_^"77_0$^/7_AZ]8_^5E?T+44?Z[<7?\
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M7_0$^/7_ (>O6/\ Y65_0M11_KMQ=_T4><?^%M;_ .2\OS[L/JU#_GS3_P#
M5_73\^[/YZ?^(8O_ ()=?] 3X]?^'KUC_P"5E'_$,7_P2Z_Z GQZ_P##UZQ_
M\K*_H6HH_P!=N+O^BCSC_P +:W_R7E^?=A]6H?\ /FG_ . K^NGY]V?P\_\
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M_A;6_P#DO+\^[#ZM0_Y\T_\ P%?UT_/NS^>G_B&+_P""77_0$^/7_AZ]8_\
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ME"E[22E>?LXMQC>]HMK9F4*%%U:J=*#4?9V7*K*\;O[[:_\ !9_/7_Q#%_\
M!+K_ * GQZ_\/7K'_P K*/\ B&+_ ."77_0$^/7_ (>O6/\ Y65_0M17SO\
MKMQ=_P!%'G'_ (6UO_DO+\^[-?JU#_GS3_\  5_73\^[/YZ?^(8O_@EU_P!
M3X]?^'KUC_Y64?\ $,7_ ,$NO^@)\>O_  ]>L?\ RLK^A:BC_7;B[_HH\X_\
M+:W_ ,EY?GW8?5J'_/FG_P" K^NGY]V?ST_\0Q?_  2Z_P"@)\>O_#UZQ_\
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M_A;6_P#DO+\^[#ZM0_Y\T_\ P%?UT_/NS^>G_B&+_P""77_0$^/7_AZ]8_\
ME91_Q#%_\$NO^@)\>O\ P]>L?_*ROZ%J*/\ 7;B[_HH\X_\ "VM_\EY?GW8?
M5J'_ #YI_P#@*_KI^?=G\]/_ !#%_P#!+K_H"?'K_P /7K'_ ,K*/^(8O_@E
MU_T!/CU_X>O6/_E97]"U%'^NW%W_ $4><?\ A;6_^2\OS[L/JU#_ )\T_P#P
M%?UT_/NS^7S_ ((7_ #X>_LM_P#!0C_@L=\!/A5#K,'P_P#AKXE_9ET#PQ%X
M@U:77-833UM_C7=A;[59HXI;V;SKJ4F5XU.TJN,**_J#K^>C_@EU_P I<?\
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MX\!_#'Q?\>M$^#'P$\8^*OA9^R/\*%\!>&[WQM>_!KP5HW@+7/"^N7XTW1M
MM/".G?&F'3-!\3^(-6TVU\=>,_#'B35[J[27S;_@F7X<_P""I/\ P7B_83^$
MGQ)_:&_;^^,_[&WP.^']MKGP<BU#]E:2S\)?'K]L;Q3X.\3W5OXB^-?Q'^*-
ME-I\_@GPMI_AJXLOA"O@/2K+6(?'GC[PSX\^(_B>WT[2[O0= U, _M*HK^,[
M_@DYXB_;;_8/_P""YOQ\_P""2GQ?_;0^)W[:O[.]S^SYJ_QU\"ZK\4]9U[Q[
MXQ^']U=2^"==\*MK>K>*M6UG5_A[J,6D:UK.B>)=!T#7+SP-XJOM:\.>,(-
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M:UX:?<WFGKKWAJ]FN=!UM;"\O+%=5TZ[6SO+JV$5Q)_-!K7_  5$_P""M_\
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MVUW7]#\%^&M5FDRFG#POXK\2?$K1="\/V4MSI6C^%K;0ETR:&VN!I]C]T_\
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M71?';>%-0\:^-+C4=<O==\4:=IWC^+_A&O"J>%U$.I'Q?%KFD_O/^P__ ,'
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MGK>LWX%]J?B*Y^&NA>"/^$AGNS+-#K*WME]JODM4OKG\$_@[\:_^"D/[-O\
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MP52_X*__ +5'@']KWP#_ ,$L_P#@E1\&/!WQX_;F\8:%IWC'XH>+/&TM_?>
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MO@NV\(^'=.U6XTOX=:-KOPKUWQ/\/+&"]T?1O'5QH_B2XM-'^]/^"??_  1
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MF7/@^VU/2+3Q+:@'XK?MZ_LT?\%8_P#@W[^!5S^V3^S7_P %=_B%^T=^SO\
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MXB6PU;7?$.H+K>H>(K;S?[4*)H]M<B^OM2_7>@ HHHH **** "BBB@ HHHH
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M)^ _[4.G_MZ?MQ_M<?%?_@HU^VGH&CMH_@#XA_%?2QX=\ ?"6UDBN8X7\">
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M??\ "X?.^(/P&\=_\(M_PD/_  L7P7_PK[;_ ,*2_LK^V_[#\;Y_X2;[=_9
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M-8+X!\#07_P%^*5[J1O- TOP?H%QXC6\T"\DT[P[="2SEE\3:X]QX7_P5_\
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MHOM!M/$7A#POJ_B!+B6TU+]HCX=ZHVGV^CZO;MX@_K?1!&B1KG:BJBYY.%
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MLH]?ATG^QI[RUGLK>^EO;6]MK;[BK^<?]MG_ (( W'Q1_:M\0?MZ_P#!/?\
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M@3PN)+1[:ZFUSQ9H]M#)-;'4HU]D_;)_X-_;_P >?M7^,?V[?^"<W[:OQ/\
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M#H_Q'^+8_:3L;6+3+?Q;!\8;KQOJK6EQXX2PCCEN+N;X8Q?#ZV\*7M\9KL^
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MUXN-N-7UZ?3$U/7[C0M%C2V5].\/S>)->^SW]WK.L7&I7>JZ[JEW<@'X3?\
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M_P S]\**_ __ (B7/^"27_1:OB!_X8_XI?\ S.4?\1+G_!)+_HM7Q _\,?\
M%+_YG*/]2^+O^B:SS_PV8O\ ^5!]8H?\_J?_ (&O\S]\**_ _P#XB7/^"27_
M $6KX@?^&/\ BE_\SE'_ !$N?\$DO^BU?$#_ ,,?\4O_ )G*/]2^+O\ HFL\
M_P##9B__ )4'UBA_S^I_^!K_ #/WPHK\#_\ B)<_X))?]%J^('_AC_BE_P#,
MY1_Q$N?\$DO^BU?$#_PQ_P 4O_F<H_U+XN_Z)K//_#9B_P#Y4'UBA_S^I_\
M@:_S/WPHK\#_ /B)<_X))?\ 1:OB!_X8_P"*7_S.4?\ $2Y_P22_Z+5\0/\
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M_P#Y4'UBA_S^I_\ @:_S/WPHK\#_ /B)<_X))?\ 1:OB!_X8_P"*7_S.4?\
M$2Y_P22_Z+5\0/\ PQ_Q2_\ F<H_U+XN_P"B:SS_ ,-F+_\ E0?6*'_/ZG_X
M&O\ ,_?"BOP/_P"(ES_@DE_T6KX@?^&/^*7_ ,SE'_$2Y_P22_Z+5\0/_#'_
M !2_^9RC_4OB[_HFL\_\-F+_ /E0?6*'_/ZG_P"!K_,_?"BOP/\ ^(ES_@DE
M_P!%J^('_AC_ (I?_,Y1_P 1+G_!)+_HM7Q _P##'_%+_P"9RC_4OB[_ *)K
M//\ PV8O_P"5!]8H?\_J?_@:_P S]\**_ __ (B7/^"27_1:OB!_X8_XI?\
MS.4?\1+G_!)+_HM7Q _\,?\ %+_YG*/]2^+O^B:SS_PV8O\ ^5!]8H?\_J?_
M (&O\S]\**_ _P#XB7/^"27_ $6KX@?^&/\ BE_\SE'_ !$N?\$DO^BU?$#_
M ,,?\4O_ )G*/]2^+O\ HFL\_P##9B__ )4'UBA_S^I_^!K_ #/WPHK\#_\
MB)<_X))?]%J^('_AC_BE_P#,Y1_Q$N?\$DO^BU?$#_PQ_P 4O_F<H_U+XN_Z
M)K//_#9B_P#Y4'UBA_S^I_\ @:_S/WPHK\#_ /B)<_X))?\ 1:OB!_X8_P"*
M7_S.4?\ $2Y_P22_Z+5\0/\ PQ_Q2_\ F<H_U+XN_P"B:SS_ ,-F+_\ E0?6
M*'_/ZG_X&O\ ,_?"BOP/_P"(ES_@DE_T6KX@?^&/^*7_ ,SE'_$2Y_P22_Z+
M5\0/_#'_ !2_^9RC_4OB[_HFL\_\-F+_ /E0?6*'_/ZG_P"!K_,_?"BOP/\
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M_@:_S/WPHK\#_P#B)<_X))?]%J^('_AC_BE_\SE'_$2Y_P $DO\ HM7Q _\
M#'_%+_YG*/\ 4OB[_HFL\_\ #9B__E0?6*'_ #^I_P#@:_S/WPHK\#_^(ES_
M ())?]%J^('_ (8_XI?_ #.4?\1+G_!)+_HM7Q _\,?\4O\ YG*/]2^+O^B:
MSS_PV8O_ .5!]8H?\_J?_@:_S/WPHK\#_P#B)<_X))?]%J^('_AC_BE_\SE'
M_$2Y_P $DO\ HM7Q _\ #'_%+_YG*/\ 4OB[_HFL\_\ #9B__E0?6*'_ #^I
M_P#@:_S/WPHK\#_^(ES_ ())?]%J^('_ (8_XI?_ #.4?\1+G_!)+_HM7Q _
M\,?\4O\ YG*/]2^+O^B:SS_PV8O_ .5!]8H?\_J?_@:_S/WPHK\#_P#B)<_X
M))?]%J^('_AC_BE_\SE'_$2Y_P $DO\ HM7Q _\ #'_%+_YG*/\ 4OB[_HFL
M\_\ #9B__E0?6*'_ #^I_P#@:_S/WPHK\#_^(ES_ ())?]%J^('_ (8_XI?_
M #.4?\1+G_!)+_HM7Q _\,?\4O\ YG*/]2^+O^B:SS_PV8O_ .5!]8H?\_J?
M_@:_S/WPHK\#_P#B)<_X))?]%J^('_AC_BE_\SE'_$2Y_P $DO\ HM7Q _\
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M?\4O_F<H_P!2^+O^B:SS_P -F+_^5!]8H?\ /ZG_ .!K_,_?"BOP/_XB7/\
M@DE_T6KX@?\ AC_BE_\ ,Y1_Q$N?\$DO^BU?$#_PQ_Q2_P#F<H_U+XN_Z)K/
M/_#9B_\ Y4'UBA_S^I_^!K_,_?"BOP/_ .(ES_@DE_T6KX@?^&/^*7_S.4?\
M1+G_  22_P"BU?$#_P ,?\4O_F<H_P!2^+O^B:SS_P -F+_^5!]8H?\ /ZG_
M .!K_,_?"BOP/_XB7/\ @DE_T6KX@?\ AC_BE_\ ,Y1_Q$N?\$DO^BU?$#_P
MQ_Q2_P#F<H_U+XN_Z)K//_#9B_\ Y4'UBA_S^I_^!K_,_?"BOP/_ .(ES_@D
ME_T6KX@?^&/^*7_S.4?\1+G_  22_P"BU?$#_P ,?\4O_F<H_P!2^+O^B:SS
M_P -F+_^5!]8H?\ /ZG_ .!K_,_?"BOP/_XB7/\ @DE_T6KX@?\ AC_BE_\
M,Y1_Q$N?\$DO^BU?$#_PQ_Q2_P#F<H_U+XN_Z)K//_#9B_\ Y4'UBA_S^I_^
M!K_,_?"BOP/_ .(ES_@DE_T6KX@?^&/^*7_S.4?\1+G_  22_P"BU?$#_P ,
M?\4O_F<H_P!2^+O^B:SS_P -F+_^5!]8H?\ /ZG_ .!K_,YK_@OWT_X):_\
M:3W]G?\ ]*K^OZ$T^XO^ZO\ (5_$K_P5I_X+1?L!_M8C]A3_ (4I\2?%FO\
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M@?\ AC_BE_\ ,Y1_Q$N?\$DO^BU?$#_PQ_Q2_P#F<H_U+XN_Z)K//_#9B_\
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M@?\ AC_BE_\ ,Y1_Q$N?\$DO^BU?$#_PQ_Q2_P#F<H_U+XN_Z)K//_#9B_\
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M _\ #'_%+_YG*/\ B)<_X))?]%J^('_AC_BE_P#,Y1_J7Q=_T36>?^&S%_\
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M6KX@?^&/^*7_ ,SE'^I?%W_1-9Y_X;,7_P#*@^L4/^?U/_P-?YG[X45^!_\
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MZ%'PQ_X(-*_^1*Z>BCVE3_GY/_P*7^8679?U_P ,ON.8_P"$)\&?]"CX8_\
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M"#2O_D2NGHH]I4_Y^3_\"E_F%EV7]?\ #+[CF/\ A"?!G_0H^&/_  0:5_\
M(E'_  A/@S_H4?#'_@@TK_Y$KIZ*/:5/^?D__ I?YA9=E_7_  R^XYC_ (0G
MP9_T*/AC_P $&E?_ ")1_P (3X,_Z%'PQ_X(-*_^1*Z>BCVE3_GY/_P*7^86
M79?U_P ,ON.8_P"$)\&?]"CX8_\ !!I7_P B4?\ "$^#/^A1\,?^"#2O_D2N
MGHH]I4_Y^3_\"E_F%EV7]?\ #+[CF/\ A"?!G_0H^&/_  0:5_\ (E'_  A/
M@S_H4?#'_@@TK_Y$KIZ*/:5/^?D__ I?YA9=E_7_  R^XYC_ (0GP9_T*/AC
M_P $&E?_ ")1_P (3X,_Z%'PQ_X(-*_^1*Z>BCVE3_GY/_P*7^8679?U_P ,
MON.8_P"$)\&?]"CX8_\ !!I7_P B4?\ "$^#/^A1\,?^"#2O_D2NGHH]I4_Y
M^3_\"E_F%EV7]?\ #+[CF/\ A"?!G_0H^&/_  0:5_\ (E'_  A/@S_H4?#'
M_@@TK_Y$KIZ*/:5/^?D__ I?YA9=E_7_  R^XYC_ (0GP9_T*/AC_P $&E?_
M ")1_P (3X,_Z%'PQ_X(-*_^1*Z>BCVE3_GY/_P*7^8679?U_P ,ON.8_P"$
M)\&?]"CX8_\ !!I7_P B4?\ "$^#/^A1\,?^"#2O_D2NGHH]I4_Y^3_\"E_F
M%EV7]?\ #+[CF/\ A"?!G_0H^&/_  0:5_\ (E'_  A/@S_H4?#'_@@TK_Y$
MKIZ*/:5/^?D__ I?YA9=E_7_  R^XYC_ (0GP9_T*/AC_P $&E?_ ")1_P (
M3X,_Z%'PQ_X(-*_^1*Z>BCVE3_GY/_P*7^8679?U_P ,ON.8_P"$)\&?]"CX
M8_\ !!I7_P B4?\ "$^#/^A1\,?^"#2O_D2NGHH]I4_Y^3_\"E_F%EV7]?\
M#+[CF/\ A"?!G_0H^&/_  0:5_\ (E'_  A/@S_H4?#'_@@TK_Y$KIZ*/:5/
M^?D__ I?YA9=E_7_  R^XYC_ (0GP9_T*/AC_P $&E?_ ")1_P (3X,_Z%'P
MQ_X(-*_^1*Z>BCVE3_GY/_P*7^8679?U_P ,ON.8_P"$)\&?]"CX8_\ !!I7
M_P B4?\ "$^#/^A1\,?^"#2O_D2NGHH]I4_Y^3_\"E_F%EV7]?\ #+[CF/\
MA"?!G_0H^&/_  0:5_\ (E'_  A/@S_H4?#'_@@TK_Y$KIZ*/:5/^?D__ I?
MYA9=E_7_  R^XYC_ (0GP9_T*/AC_P $&E?_ ")1_P (3X,_Z%'PQ_X(-*_^
M1*Z>BCVE3_GY/_P*7^8679?U_P ,ON.8_P"$)\&?]"CX8_\ !!I7_P B4?\
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M6I/_ %9X3?/.[>?7?,[NV/HVOKT,H)>VK:?\^_\ TEG,_P#"$^#/^A1\,?\
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ME]QS'_"$^#/^A1\,?^"#2O\ Y$H_X0GP9_T*/AC_ ,$&E?\ R)73T4>TJ?\
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MDBKS1[2I_P _)_\ @4O\PLNR_K_AE]Q5_P"$)\&?]"CX8_\ !!I7_P B4?\
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M #\G_P"!2_S"R[+^O^&7W',?\(3X,_Z%'PQ_X(-*_P#D2C_A"?!G_0H^&/\
MP0:5_P#(E=/11[2I_P _)_\ @4O\PLNR_K_AE]QS'_"$^#/^A1\,?^"#2O\
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M&J1:9\7/B9I4?B2\_M.\FT_X?NR^(X]!U*VTJQXC_@UXG^(/[-WQ]_X*]_\
M!+?6?B3K_P 1_@[^Q)^TAI(^ <VN1V\LVC:3XF\8?&3PQXRG:<B&71_^$OM?
M _P\\47O@_1X/^$3TKQM=>/]<TI4O_$VJZCK?QO_ ,$D_P#@G_X*_P""KO\
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MH-+\1+X<U/4)M U&YMD-[9V.L165S>6#17]K%-9313O_  B_\$?O%7_!,/\
M:^_:C_;W^-?_  7*\5_ 2_\ ^"A_B']IOQ-X%T+X0_MB>,$L?AQ\-/AYI,4>
MEP>!_AO<>//%4/P:\37/A_Q?9ZS\,]$\/F#4O$G@70_ /AJ'PO=0V/CF5=0_
MIB_9J_X(G_LN?LY?\%#M"_X*-?L-?$QO@1\*/%7P@U3P%\0?V7_@MIVDWWP'
M^,USJEOKEK%XJ.LKX@U&PT'1+&^_X0KQ%8^%?!.AZ?IL/C#P#;ZU!J42>(O$
MVGWX!^ZM%%?FO_P5=_8RU#]O#]D'QA^S[)^U]XT_8T\#>(;^RN/BOX\\)V'A
M6ZT[QA\.8H;J#6?AYXVN?$5]X?N[#P?KUU<:?+K)T;Q?X=35K:S?P]XB77?#
M.KZKHEX ;GB?_@K;_P $N/!GBJX\$^)_^"A_[%^C^*++49='U32KG]I'X2L^
MB:M;:C<:3>Z7XANH?%4MCX>U'3=0M;BVU:RUNYL+G23$TFI16L)$A^]?#_B#
M0?%N@Z)XJ\*ZWI'B;PQXFTC3?$'ASQ'X?U*RUG0?$&@ZS9PZCI&MZ)K&G37.
MGZKI&JZ?<V]_INI6%Q<6=]9SPW5K-+!*CM_)'\0/V<_^#1_]E_\ 9T\<_ 7Q
MOXL_88UV;P7X!\4Z#XO\5:?\5_"GQH_:XEURUMK_ $OQ#J6G>*O"FK>*?B+:
M_&!-<M+RZL/"OA>STJ+PYKAATS0?!>@^'4L]&B]-_P"#2+Q]X]M?^",MUXA^
M,WBL2_#_ .'OQ[^.<?PRU#4M4O-03PE\$_#N@^#-:U:RNA/+<MIEEI7Q#F^*
M6HP:=:I';P:9<6T\%N&N&+@'])_PZ^/'P.^+^O?$?PK\)?C-\*/BCXH^#OBF
MX\#_ !=\-_#KXB>$/&VO?"SQK9WFIZ==^#_B/H_AK6-3U#P/XIM=0T36;"X\
M/^)K?2]6@O-(U.UEM%GL+I(CXO?'CX'?L^:#HOBKX]_&;X4?!#PQXD\4Z=X'
M\.^(_B]\1/"'PUT'7O&NL6>IZCI'@_1=8\9ZQHNGZIXIU33]%UB_T[P_8W$^
MK7UGI.IW5M:2P6%T\7\P?_!HGX=U;QA^R3^V9^V)XHMDLO%/[7G[<?Q+\7W-
MHD=S<^7I&@:1HFI*QUW4;:+4=9">,_'/CNR622XOK:(67GB=-5O=9MH*7_!R
M7!9_'S]LC_@A=^PS!>B:7XN_MK1_$KQOIJV4VIKIO@;P5KWPV\/W.L7FG;KB
MRNC<>'_$WQ#.FPWVDWEG+_8NJ+J.I:'I@O)+\ _J ^-?[0OP"_9K\*Z?XZ_:
M+^./P?\ @%X(U;Q!:>$]+\8_&OXE^"_A7X5U+Q3?Z=JNL6/AK3_$/CK6M"TB
M\\07FDZ%KFJ6FC6]Y)J-QIVC:K?0VSVVG7<L/DOB[]OO]BCP)\>/#'[+WBS]
MJ7X'Z/\ M%>,M=T;PSX=^"DOQ"\/W'Q)OO$'B(W2Z'I$WA2RO+G5=-OM5>TD
MCLH-4M[)II);*-?GU'3UN?YI/^#M&+6OCW=_\$F/^">_@B[>#QY^U9^VI%J>
MC7$ND6/B;0M D\,6_AGX2V/B#Q3X<O-6M[>_L+*?]H&[U..VU/2)]'O]%T+Q
M='?:WHMI:7<6I_LK^RK_ ,$/_P#@FO\ L::EX0^+6@_!>U\=?M"^!]8G^)'B
M']K/XV^,/%?CWXU^*_B=<::$\8_%?Q-XO\3^(+G3]*U?Q+<C4->URRT'3]#\
M*0:EJ>L:E;Z-;7.HZC<W0!^H7Q-^*WPN^"G@W5?B+\9?B3X!^$GP^T)8FUOQ
MW\3?&/AWP%X-T=9G\N%M5\3^*M1TK1-/6:0A(C=WT(D?Y4RW%> _ 3_@H!^P
MW^U+KDWA;]G+]KS]G#XV>+(!,\OA#X;_ !C\!^*O& @M[1[Z:\7PGI>N3^(9
M-/CM(;B<ZC'IK6.RTO<7!:QNQ#_&S\"_CY^P+_P7+_;(^,7[97_!5C]M+]F_
MX??L=_LT_%/Q!\)?V%OV!?B_^TCX*^!NE^*-,TZQT'5KC]H?XB^'/%OC'X=^
M-O$6G^,+>[T:^N(;C2$L_%'B./4/A]KVJ3^"/AE/X(UOS_\ X+U?"#_@BA\+
MOV:_#'[8O_!*3]HC]BSX/_MM_L^?%WX:^(O!VF?L5?M+?"H^+?%.AWVNVFBW
MMSI?PT^&GCC5&&N>"[^?2?&<'BCP_HFG7UAINE:__;5Y>V-XZ1@']\?Q1^+'
MPL^!W@37?BE\:OB7\/\ X/\ PR\+_P!F?\)-\1?BCXR\._#_ ,">'?[:UC3_
M  ]HW]N^+O%FI:1X?TC^UO$&K:5H>F?VAJ%O]OUC4]/TRU\V]O;:"3J/#_B#
M0?%N@Z)XJ\*ZWI'B;PQXFTC3?$'ASQ'X?U*RUG0?$&@ZS9PZCI&MZ)K&G37.
MGZKI&JZ?<V]_INI6%Q<6=]9SPW5K-+!*CM_(O_P=!?'/Q7\2/^"-?[(_@>"P
MT_3OBA^W3\=?V6-%N_"$4NHP?8GU?P#K?Q2U=;&PT>[\3-J%EHOC^P\$:#)8
M#4?$.P:S:W5C<:Q>VMI<2?UA?"KP!I?PH^%_PW^%NAR"71?AKX"\(> =(E%K
M;V(DTOP=X>T[P]8.+*S5+2S#VFG1,+6U5;>W!\F%1&B@ &+HGQX^!WB;XL^,
M_@)X;^,WPH\0?'3X<Z1IGB#XA?!;1/B)X0U7XL^ ]!UNST;4-&UOQG\.;#6+
MCQAX7TC5[#Q%X?OM,U+6]&L;*_L]=T:YM9I8=3LGGH?'#]HOX ?LS>$/^$__
M &B_C;\*/@5X*:X:R@\4_%OX@>%OA[HE[J A:==+TV_\5:II<&IZO-&C&UTC
M3VN=2NWVQ6MK-*Z(W\PO_!!RWLOC]_P5\_X+Z_MI6M\-3T)/V@="_9Q\ :L+
M*=TUG0O"7B?QOI^J7MKJ=X;MX]..C?#7X<7.GV5EJ0%S9:A;7&HZ-HD=MHMD
MOYS>&O'W[!_[2?\ P<$_\%)(_P#@NKXT^&>@C]GOQ)IWPH_87^$/[27BW4='
M_9WT_P"&FF:YJ]I8>)Y]4O?$^G_"K3;SQ#X E\#?$EO!7Q$^TZ1XAUWXO^+?
M%ATZV\0>#O,T\ _M4_9V_;@_8Y_:XNO$&G_LP?M0_ ?X^:IX3@@O/%&B_"GX
MH^#_ !KKOAZPNY$AM-3UG0M$U:[U?3=)O+AC:V>K7=E%IMW>1W%G;W4MU;7$
M47U+7\]>E_\ !#K]A'Q%^V!^R%_P41_X)V_$3PE^RF?@3K=Y=>---_9(LO"N
MM?"S]I/PC<3:0S^"=7DT;Q'+X)\,Z=JOAR;Q5X5\8:KX<T#4-6\5>'?&437%
MQ9:IX=\/:K;?T*4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 ?SU?\' G_(+_ ."7W_:47]G'_P!%^(Z_H47H/H/Y
M5_/7_P ' G_(+_X)??\ :47]G'_T7XCK^A1>@^@_E7U.;?\ ),\)^N??^I]$
MQA_&K_\ </\ ])8M%%%?+&P4444 %%%% !1110 4444 %?R??\%(_%O[8'_!
M3W_@J]H__!&W]G[XY_$']D7]EKX(?"+2/VA/VSOC?\-+/Q=X;^)OQ -Y!X5O
M[7X5>"/&*#2-&U.TETCXG_#&TM-+LM7E\.V6I>)_%WC#QE8^/+KX9Z3\.W_K
M!HH _B _;M_X(D_$C_@CG^SMXY_X*)_\$PO^"BG[:GAOXE?LVZ9!XX^)7PZ^
M/WQ"\*?$;P1\8? %OXA\/6E]X?O]/\,^#/AKX;FLM M;O5O$5[X<\>^%OB-I
M'BJ6UL;72X/"NM65IK$W]9'[!/[3J?MH?L7_ +,?[5)T6W\-W_QU^#'@7X@Z
M_P"&[-[F6P\.^*]9T2U;Q=H.F7-X%N[W2=&\3QZMINE:A<(DVH:=;6U[)'&T
MY1?YS?\ @N-^VQXD_;[^+6B_\$!O^"?.L0^,/C/\<?$NC:=^VS\7-$L-=UGP
M=^S5\(?"GB/0O$GB;1=8\1^%M4M5@UJTNM.T^#XJV-TMQHUMI%]#\';V:3QS
MX[NM(\/?TX_LO?L\^ _V3/V=O@M^S3\,H;B/P)\$/AQX5^''AV6]?S-0U"T\
M,Z5;Z?+K.J2;F$NK:Y=Q7&L:K*I"2:A?7+QJB,J* >/?\%$?VY/A1_P3H_9"
M^,'[5WQ;U*QAT[P!X?G@\%^&+BY:+4OB3\4=8BFL_A]\.- MH1)?7FH^)]?,
M$=_-96\Z^'O#-MX@\8:O]D\.^&]9U&R_BE_X(D:_^W_9_P#!>_PE<?MS?$CX
MD_\ "Q/VFOV4_BE^UWXC^#.N^+/&">&_AY#\;)I/%?@[PRWP\U?6[W3/!=SH
MOAN73I[#P1]AL[OX;V-_;^!KNRTW4O#]]9P_I3?*W_!P[_P5NLK>TN)]:_X)
M,_\ !)CQRTNKK-:Z_9^%_P!J_P#:XNX+I([6SFCO+?P_XJ\,^"-3T&RN6NIX
M=6?3?AW!=V:V5GI'[2,5_;[]P /^#Q2S & /^">1  Z #0< 4 ?UUU_++X7?
M6?VS/^#J#QQXBAUK1[OX6_\ !*3]CJP\(:9_8T2ZQ;M\9?VA="N!JECJ%Y<;
M[?2O$DGA[XG>-])UN[T2Y9[&+X9Z;X6O+.+4;CQ.;;^G7QGXP\-?#SP?XK\?
M^,]6M] \'^!_#6N^,/%FNW:SO:Z+X:\,Z7=:UKNK7*6T4]R]OINEV5U>3+;P
M33M'"PBBDD*H?YGO^#7CPO=_%#X'_MO_ /!2/Q7HVOZ?X]_X*+?MN?%WXE17
MNM00PVUW\+O!'B37;/P=IFBR1M.UYI_AGQWXL^+N@^=#=)IEE+9MH6FZ?:QZ
M-+=:@ >,?MJ6G[5W_!9S_@J]\5O^"7WA3X^?%/\ 9#_X)^_L=^#?"7C']H?Q
M-\*(O$/@KXG?M/>*_$=GX6NM4\&Z1K^J0VVGZCX;T"Y\1R:!I"ZCI.O?#_2=
M7T&^\?ZOX>^(T]Y\/8-*^2O^"AW_  2T^-__  0,_9^NO^"D7_!-#_@H-^UI
M=Z9\"/%G@*?X[? /]I_QKH?Q0^'_ ,6?#/CKXB^"_ .F&XL/".@_##0)K*#7
M-;T;1?$.AZGX2UCQ%?Z+K,^N>%/'O@35O#%O_:W]T5?QO?\ !8']J/6_^"R7
M[4?@O_@@W^P;KX\0>"O^$]TOQ7_P4=_:/T+3=6UWP-\(O!GPP\1Z3K[^"--U
MK1]1&@Z_K'AK7M,,FMZ7K-J- U'XRV_PO^'=GXIT77+3QM+X> /ZM_V;/C7H
MO[2?[.WP&_:)\-V%QI7A[X\_!KX9?&70M,NY'FNM.T?XG>"]%\::98W,KVUD
M\L]I9:U#!-(]G:,\D;,UM 28E^2_^"JW_!0SP/\ \$T/V-_B/^T1KQTC6OB-
M+;/X)_9[^&FH_;;FY^+'QT\1VMS#X%\'6VE:3-;ZSJ6FQ7<4FO\ BQ=*GMKV
MW\):/K,EI=PZ@;%9?M7X7?#GP'\ OA#\/?A+X'M+?PQ\,O@Q\.O"OP]\(V-S
M=!;3P]X&^'OANQ\.Z%:SWMTZA;?2M!TBUBENKB0 10-+*X 9J_E%_9PL[W_@
MX#_X*SWG[;NNIJ5W_P $M_\ @F#XQ;P/^R1X:UBQU>R\.?M,_M)6,MSJ.K?&
MM;&:X"SZ7X:UFV\-^-(WNSH]P_A[2O@5X=U?PJUYJ'Q9TM #X+_X-S(?VX_A
MO_P77_:L^!_[</Q<^*7C/XMQ_L#77QJ^(W@_QOXXU[7-/\->/_CGXI_8V^-,
MME=>')]3N?#>D>*_#%C\5;GPWK"Z)9P6>G:@NLZ?I7E:=((V_OWK^0+]D'C_
M (/)/^"IV./^, /AY_Z@W_!..OZ_: "OY._@AXSOO^"H'_!R7\<?%VJ+'K_[
M,_\ P1:^'NN_"KX8:)J<L=W9V'[6/Q6NV\$^.?&D>DVMG]@%ZUUX-^*GA^.7
M6=6U2YL;CX2^ /$.F:=I^M"3_A&/ZQ*_D)_X,_K^;XI_LU_\%!/VHM9TS3K+
MQ;\>/^"@7CZ[\17$5W?7^IM+:_#_ , _$ :9=WMZIDO-.TS4OBSK$FFW4TTE
M[<7%_JDMXB%HVE /T"_X*D?M,?\ !5/Q-^T9X,_X)V_\$M?@]X?\,>+?'?PD
M\%_%WXS_ +>GQ'>+4?A]^S?X$\;^./BGX+L=)TGP_J&CWNC2_$+4)OA1JM_8
M75W:^/=2N-(O+FST+X=IJ"#QOX8_+#_@VJTKX_?#O_@I/_P65^ /[0?[1_Q"
M_:<\6_ SQ1\/?"-[\1O'6M^)KV/7?$3>/?BZOBSQ+HV@^(O$7B7_ (1I?$VH
MV4%U>6EG?MYZVMF+AF^S0QP_VAU_(;_P0T_Y3F_\'$7_ &7#PE_ZLGXUT ?:
M_P#P<$_\%$_V@OV4OAK^S=^R+^Q LR?MT_\ !0WXKQ_!CX)>((H]$,7P]\/6
MVI^%]&\6^+4O=<>XTS1/$5_K'CGP?X9\-ZQKFF'1-%TG4?&_C:35]*O_  +9
MFX^)]0_X-5]9C^'TWQ'\._\ !67_ (*$V?[?MYI<.OZK^T#J/Q<N&^'^M_%"
M&:+6&U.?P_IUI;_&:QTN?6[+3FAU2?XYZ]K^FS6<6O#^TKJ"WTQ&_P#!19;3
MQA_P=<?\$9/ ?BV'4;7P?H'[-WQ%\?:/J<NJ3V6DW7C6VT?]K36-,TVR6:%+
M%=1AUWX>^"1J<5O<RWFLVVJ:3I<\$*_87N?Z]: /YZ_^#?W_ (*7_&K]L_X9
M_M$?LN?ME-:+^W9^P!\5[_X*?'K4[2"QM(?'^F6^L>)?#F@>.IK?2]/TO18/
M$T'B3P1XV\&>,K'0+>;3_M?AK2/%K'35\=6NB:;\9?\ !23X\?M<_P#!3K_@
MJS9_\$3_ -C'XZ_$#]ESX'_!'X9VWQ4_X*!_M _#2ZAT;QS>Z9X@TGPYK5I\
M._">OZ?KFF:M<:/)H_C?P%X0FT?2-9TVXUKQ1X[\:?\ ";>%_$'@SX87D&HK
M_P $S]3G\/?\'/7_  6V\"Z2HMO#WB3X5_"KQMJMMY]](9O$&F:=\(Y(KL+)
M=M;D23^/_$DQ66WE:V-V(-.>QM#/;SY7_!!I;3Q=_P %L/\ @XT\=^)(=1T_
MQMX:_:1\,^ ?#MCJFJ3RW-QX*C^+'[1ND7&I165Y#;W%QIUS9_#WP)>:1+%&
M]GH^E:C96%K/<6MW:W$P!XK^V)_P1$^/O_!(7X)^+/\ @H#_ ,$I_P#@H%^V
M-<^-?V7= USXL_%+X(_M'>/] ^)/@#XK_"_0;6'4/B3#>Z3X7\*_#GPM>V6C
M>$=*F\1:KX?\7>%O$C:G:^'8M1\/:[X9\7:'X9OXOZ?/^";G[;G@[_@HK^Q/
M\ _VO_!FFC0(?BSX1,WBKPD;F6\;P3\1_#.IW_A+XD^#DO+BVL;K4;#P]XXT
M/7=/T/6KG3M.?Q'H$6E>(HK"UMM6@B7Z;^,FFV6L_"'XJZ/J4/VG3M5^&_CG
M3;^W\R6'S[*^\,:I:W4/G6\D4\7FP2R)YD,L<J;MT<B.%8?S7_\ !G]XEU37
M/^"14>DW\HDL_!?[3GQM\.:&@>Y?R-,NU\)^+YHBL]Q-%&3K/BG5IMEI':VY
M$HD>!KM[FYN #^IBOXR/BGK7[3G_  <(?\%.OVJ_V-?AY^T?\:?V6?\ @EI^
MP%JL7PN^.NJ?!#6],\(>/?VBOC-!KFL>'M8T!]:2ZOX=4T/4/$OA;QO)X8FU
M6R\>?#_0O"7P^\,>+-8\#6WB_P"(FE?8O[-Z_D*_X,\%M/$?[(W[=/Q4U:'4
M;#XD>//^"@?Q$C\8Z1K&J3WNK:;9V/PP^%7B'2XM3M[R&VOQJ"Z[XS\86UYJ
M=Y;6\VIW%I)')%'-831H ?,?[:/["?[4O_!N'X9\,_\ !1?_ ()__MC?M*_'
MS]F7X<^+/ WA7]JK]DS]J7Q_8>+M$\2_#_QCXOM-&M]:L=8T'PWX?\(Z;)=>
M+M=L_#6E:]IWPUMO''@36?&*:SI>MZ]HFI^+O#]__1[^VC^W8NE?\$?/C;_P
M4$_9?U5;L:W^R!/\;O@GKNK6CVUSIC>/O"%C>>#];U/2F=WM=;\,MXAM-2O-
M"NVW6^LZ9)I.HA"EPJZG_!:W3++5O^"2?_!1&TU"#[1;Q_LG?&#44C\R:+;>
MZ/X7O-7TV;?!)&Y^S:C8VMQY98Q3>5Y4\<L#R1/\J_\ !$?P+X0_:K_X(%?L
MD?"7XX^'M.\;?#_XC_LY>*OA%XN\.ZE&]W::EX-TWQ9XS\!V-NIOY+U[:]LM
M$TG3Y=.O+=HVTC4[2UO='33S9V4=L ?SM?M$_L=:K^P]_P $8OV6O^"V_P "
MOVJ_VLC_ ,%#;CPW^RE^TO\ $7XO?$?XV>,OB38?%.7]I:Q\)7'B_P"&GC#P
M?XDU6;PQJG@NPN?'UG;H=7TS6-1\1:'X?DTCQ?/KK:W<7UI_3M_P5@_X*CQ_
ML*_L=>!_$WPZTE/%G[9_[6T>A_"_]BKX&V%E_P )7X@\=?&GQQ;^'[&UO8/#
ML'V.ZU_P]X!O?%NA7&K>7;16^K:_JW@[PBZVUYXRTY3\%>(O^""OP8^!?P<7
M0/VL_P#@I)^U#\0/^"6'[*'B"]_:#T?]D/XB1^#K7X:^%_!OPZGU;QJ/"OQ5
M\=:5HFJ>.?BK\.=!@-PEMX)L-,T)9+=/L'AS3K74;BR\KSC]@/Q!H?[47QW^
M(_\ P<*_\%+O%OA']G3]GG35O?A-_P $Q/AY^T7K.C_#3P]\$_@?<O<:=#\9
M9)?%FM0^'Y?B9\<K1KK^QM0T[4-;O?$<VK^*;CP=?7_@N^^&]EHX!^T'_!)W
M]ASQE^PK^R;X8\$_&?XG^*OC1^TQ\1+A_B?^TI\2?$OC+Q7XNL]3^*OB=?MV
MK>'?!B^)M3NX-'\#>!HIHO"7AZ/0]+\,6?B"+2IO&%]X<TG6O$6HV</XQ?MA
M^)G_ ."6?_!Q!^R-^TCHT%_X8_9F_P""LWA*T_9H_:%L/#VGZ!_8^I?M&>&-
M9M_"_P /_'.LV@73H]-D@U;QQ\'IM6\1ZA<0:J='U#XKZ[;:EKH&J: G].7P
M0_:#^!'[3'@B/XE?L[?&7X7_ !S^'\E_-I!\9?"7QUX9^('ARWUJUMK.\O-"
MO=6\+ZEJ=II^O6%MJ%C-J.AWTMOJVG+=VXOK.W:5 ?Y@_P#@\5\.W6F_\$^_
MV;_CWX?G6U\:? 7]MKX::[H5Q->W]M"EGK/@7XD33K%#IQAGEOU\2^'/!UU#
M.E_ILUI8VNJ-:WJ74L*N ?UN=>E%8'A76[;Q+X8\.>(K-)XK37M"TG6;6.Z6
M-+J.WU.PM[V%+A(I9XDG6.=5E6.>9%D#!)9% <[] !1110 4444 %%%% !11
M10 4444 ?SU?\%^^G_!+7_M)[^SO_P"E5_7]":?<7_=7^0K^>S_@OWT_X):_
M]I/?V=__ $JOZ_H33[B_[J_R%?4YM_R3/"?KGW_J?1,8?QJ__</_ -)8ZBBB
MOEC8**** "BBB@ HHHH **** "BBB@ HHHH \8_:/^+_ /PSY^SQ\>?CY_PB
MVH^.?^%(?!CXH_%__A"=(N?L6K>,?^%:^!]=\9_\(MIEY]CU'[)J/B#^Q?[)
MLKG^S[_R+F[BE^QW6SR'_P ^#_@M;XC_ ."Y_P 4?V+#_P %#_VQ/BMJ/[#7
MP?N_CEX0\'? S_@G_P#"75/$'AWQCX<T;Q1H_B[^RO'/Q<\8Z%JVDZS<>+$T
MC2)A-:^*[S5=0N;[5]5GL_!/PFL)(?"Z?Z0U?RL_\'B'_*(>W_[.H^#?_J.?
M$R@#^D;X:ZW8>'?@+X%\2:S-<1:7H7PG\.ZWJL]O97^J74=AIGA.TO[Z:#3M
M,MKW4]1N$MX)7BLM/M+N_NY L%I;3W$D<3_QN?LJ?L0?M!_\'(FL?%W]N3]O
MK]JO]IW]G?\ 9OT[XD>+/AG^RU^R!^SCXJA^&<_P_P!(\*W&G >,/%H\;^'?
M'7AUM<U73[V2RUW49/!<_B_QEJ>W5AXHT#P7I7A;P>G]F_P6_P"2/_"O_LG?
M@S_U'=.KH/'GCSP5\+O!7BKXC_$?Q5H/@?P#X'T'5/%/C#QAXIU2TT7P[X:\
M.Z+:2W^JZSK6JW\L-G8:?86<,MQ<W-Q*B(B'DD@$ _C)L?#'[2'_  ;S?\%1
M?V OV>_#W[8OQL_:A_X)V?\ !1/QYJ?P2T+X1?M#ZP/&'CGX0^/$OOA[X'TR
M^T'Q'8+!I4$^G^-/B+\/=436/#'A#P1X>U?PGK'B;PKK?@Z35M%TKQ]%_;%7
M\9'[..K:[_P</?\ !7?P9^V[;Z#KFA?\$Q/^"7'B&6/]F+5/$7A[Q)HE_P#M
M _M"2WFBZW_PE5G:ZE>OI=G!I/B;PYH7C_5KBT73-?T;PWX6^"_AGQ1X6_M?
MQ-K\_A_^H[]N/]I+1/V/_P!CW]I3]IO7KR"SM_@O\'/'/C;2Q<1&9-1\66.B
MW,/@?0$B,<L;W/B7QG<Z#X>LQ<*MF+O5(3>RP6@GGC /P/\ ^"3;:S^UU_P6
MZ_X+'_M]7NM:/J?@7X0:SX>_X)__  9FT")=3T34-%^']]ILOC>YTK7[C=.D
M$EW\.O!OBF[_ ++N+S1O$.J^.=0O[.6/2].T,S_"7_!1[XN?\%K_ /@HQ\ ?
MVT_C/X/OYO\ @FC_ ,$VOV9/!GQL\2>&#I=WJ=Q^T/\ MBR?!LSSZ1J:^(+0
M>$O%?A_X<>,[OP_=7^FZCX>N_!_@Z'1=;-M-'\>(;"SU>']A?^#9/]G4_ ;_
M ()'_ KQ/JUAKUKX[_:?UKQI^U'\0+SQ%$(K_7=0^*&K^3X+U^/>9;JYL]4^
M$V@?#R>TU&]N[NXU>';JRO:V][!I]G]K_P#!9+_E%)_P4-_[-%^./_J"ZO0!
M\]_\&Z_B7Q'XP_X(V_L5>)?%NOZWXI\1ZOX2\>7>K>(/$>JWVMZWJETWQ;\>
MJUSJ.JZG/=7][<,JJIFN9Y9"JJ"V *_9G7M>T/PMH>L^)_$^LZ5X<\->'-*U
M'7O$/B'7M1L](T/0=#TBSFU#5M9UG5M0FM[#2]*TNPM[B^U'4;ZX@L[*S@FN
M;F:*&)W7\2_^#;7_ )0I?L,_]B5XZ_\ 5N>/Z^-/^"['[1GQ5_:\^+_PJ_X(
M+_L5>)KC1_CA^U1;V?BC]KWXF66G:Y=Z7\ /V6M-6+Q)J8U_4]#O=.:SN?&]
MI81#5M$O-1TRU\3Z!?>'_AO?7J1_&*QR ?S2?\%&?VY/VP_VZOVRO@O_ ,%!
M/A[\0?BA\+O^"?<W[;GPU_8P_9-TK0_$?CWX>Z=\:?#?@/QFOB'Q[\3[KPDN
MIZ0NK1:YJ6IK#J^OZIH:F;^TK?X:33RW_P +]:L;'_3HM23:VQ)))MX22>22
M8UR2>Y-?Q7?\'$'[./PK_9%_9E_X(H?LV_!/0!X:^&'P@_;8^&G@_P *Z8TS
MW5V]M8_V&]YJNJWT@$VHZYKNI2WFM:[J<_[_ %+5[^]OI\RW#FO[4+3_ (]+
M7_KWA_\ 1:T 6*_E0_X.#OB=XD_:?_:@_P""<?\ P1*\!:A=P6'[9WQ4\/\
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MA? _Q3^R_P#M#>&?VF-7T[P_^SUXC^#'Q)T+XU:]JNI#1K/1/AGJ_A+5=/\
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ME$IU*XU_2["+4=/N](C26U /*T_X-5_AJ54O_P %3/\ @J6'*J6 ^/'A_ ;
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M$TOPSHUSX@U2ZU6;2_#VFS>%[V73]%L)+IK73+*6\NI+:RBAA>XF9#(W]/\
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MKQ3J<.O/INC:S#<7/ZX?\%TOVT/%W[-/_!'K]JS]IK]F#QO]H\7-X=\'^!?
M/Q4^&^L:=J]KX4N/B9\7/"/PAUSQEI/BC2Y=0M-.U#PU:^(M;M]&UG3Y'O=+
M\;0Z1;VT^GZDB7ME]A_MR?\ !-G]BG_@I!X0\+>#/VR/@;HOQ=L/ =QKMYX
MUA]=\6>#_%_@:]\30Z5%KTWA?QAX&U[PWXCTZWUDZ#H$VLZ.VHS:#KLV@Z,=
M<TK4DTVUCCZ_X(_L+?LK?L]_LD:3^PK\.?A)H_\ PRMI7ACQKX.?X2>-=0US
MXE:+K7A_XD>(?$?BSQ[I_B.Z^(&I^)-4UZV\4^(_%_B35+^TU*^GLK4ZH^GZ
M3:Z=I%II^GV8!_-I_P $N?\ @DW_ ,$&;#]A;X0_M??'+6_@!^U/X\^)'PN\
M-_&?]H+]HW]ICXW:5XAT/1O'7B'2M.\9_$?0_$_A_7O&]M\/? )\ ^++[5]
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MJ&D6<>L6.F>(;*VU[23?>']<BU#0-4U33+P _FI_X))_LK^/'_X-5O&GP?\
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MI:V'AR.>ZT[1/'GBK4+NU\(V]W9?;_$&@6VE^,='AO\ PWXH\/7U]YK\'/\
M@V(_X(M?!CX@6_Q&T_\ 9*B^(6J:9?Z;J.@>'OC'\2?B3\4/A_HMQ86EY:W,
M=Q\//$_B>Z\'>-+#6/M8N=2TKXF:/XXTQ+NTLYM+L],$3I+^^5K:VMC:VUC8
MVUO9V5G;PVMG9VL,=O:VMK;QK#;VUM;PJD4%O!$B10PQ(L<4:JB*JJ  #^9#
M_@UR_;._9N\;?\$J?@S^SK9^-_"'@7XV_LJWWQ&\ _&?X4>)-6TCPOXHT/4]
M>^+'CKQOI'B^/1-3?2]0O="\86'B>.ZNM<2P\B+QK!XM\.7=U=:MH=[<W'PW
M_P %NOVBO"W_  6@_:O_ &2_^"(O[$'Q A^)FDGXTO\ &3]MCXM_#/Q%<W7@
M7X8^#OA3:>(-&UOPKK/B/3=!UOPUJUYX:L-4UW6I#>7>H^%8/BT?A'X.>&^\
M:ZE;VFB_M3^U_P#\&\W_  2A_;<^,&I?'OXR_LXR:9\6/$NJ)J_CSQ3\+?'O
MC7X8I\1KT2/-=7GC3P_X6UFT\+W^M:K-+-/KOB[3]%TOQMKUQ*9]8\2WLT4#
MP_<G[%W_  3V_8X_X)[?#T_#3]D3X$^$/A'HET7EU_6[);_7_'_C*ZENIKUK
MKQO\2/%-YK7CKQ:8;FXF.F6FMZ_>:9X?M#%I/AVQTC1K2STZW /YL_\ @NIX
MJ\+_ +$W_!8'_@AK^VS\7-)UJS_9'^&U[X_^"WBKQ;#I,VN>&/A=K%Y$-(T[
M7O$%Z-,O-0@GTC1/&]OXZ@L[C4M4\0:]X?\ A;XKO?!.B7>M^'=8-Y_1S\=/
M^"DO[#/[._[/>I_M0_$/]I_X,R_!RV\+2^+/#WB+P?\ $3PAXUF^(]D8(YM-
ML/A98^'-:OYOB'J^O23VEMHEEX9-^MY+=P3/-!8B:[A]B_:9_98_9X_;)^$?
MB#X$_M/_  D\(?&?X5>)0SW_ (5\7V,LHL=1%E?:=;>(O#&MV$]CXC\%^+],
MM-2U"+0_&G@_5]"\6:"UY<3:+K5A/*TA_(3X.?\ !L1_P1:^#'Q M_B-I_[)
M47Q"U33+_3=1T#P]\8_B3\2?BA\/]%N+"TO+6YCN/AYXG\3W7@[QI8:Q]K%S
MJ6E?$S1_'&F)=VEG-I=GI@B=)0#T-?VA?B+_ ,%;_P#@BA^UA\3_ (?_ +._
MQ1^ VJ_M0?LG_M3>"?@#X \?7N@:MXU^(^D^(OA%XI\*>"O%-OI^D66I2Z=X
M=^)7B6[OM(\-PW.FKK.N^%A8^,_#3OI'B?PMK,_QA_P:\_MQ_LL^*_\ @EQ\
M"?V8%^)/@#X=_M ?LV7OQ2\!?%+X+^+/$>@>$?&]OJ5]\4_&_CZW\8:7X8U>
M?2-8UK0O$>D^*[>_U77;/3)8+'QA'XJT#4KN?4]%O+JX_I^M;6UL;6VL;&VM
M[.RL[>&UL[.UACM[6UM;>-8;>VMK>%4B@MX(D2*&&)%CBC541550!^'O[4G_
M  ;C?\$A_P!KCXK:Q\;/B-^S!'X5^(_BK7CXC\=:O\'_ !YXW^%6D^.]3FVO
MJ-WXB\&^$];L_!,.IZ]=&?4_$WB3P[X=T'Q9XFUJ]O\ 7->U_4-8O;B^< ]#
M\)_\%EO@1\:/^"C.F?\ !.S]E?P9XB_:AUO0/!VK>,?C[\??A;XB\+W7P0_9
MZBT/5M9T35/#_B_Q!-=O-K_B6QU6PT72KFQ\+QWUH-;\8Z#H<&H7&J6?BNU\
M-?A/_P %5_CUX!^"W_!U/_P2D\9_M2^(M'^'/[,_P\_9GO[K2O&GCO6=/TKX
M=:-XX\>+^U?X7TSQOJVOWTFGZ7X5ATWXC2?"RS\0W^N:G'8^'[#PYI/B?59;
M31KE9'_JI_9!_81_9"_8'\ WOPT_9!^ O@?X'^%=6N+.[\0_\(W!J.I>)_%M
MWIJW::9=^-O'GBC4-=\=^-[K2HK^^@TFY\6^)-:GTNWO+JWL)+>"XEC?@/VZ
M_P#@F3^Q)_P4D\+>&O"_[8/P/T7XGGP3<75QX)\4V^JZ_P"$/'G@\:C<:?<:
MQ9>'_&_A#4]%\1V6D:Z=+L4UO1&OYM'U/[+;3W-B]Y9V=S;@'YP?\%L?^"RW
M[(O[+7[%/[1W@'X>_&3P'\:OVGOB?\#_ (A^#/AO\(?A!XQC\;^)O#O_  F>
MA)X0O/BG\0;OX>#Q /AIX*\ Z=XL;QO'J?C*]\(IXT.@3^&O".L#5YIK[2_)
M?^"1_P 5OA?_ ,$K/^#;OX _M0?$[P3\2/$O@WPE\+]4_: ^)&C?"?PS;^+/
MB/XA3XU?&F_N-,U?3-$UG4/!FESVVC^'_&'A9M2U'4M7TG1=#\$^'[C6[[6[
MO3],GU>\^\_AQ_P0:_X)._"CX#_%C]G'P/\ LB^'M'^&WQWT#PWX6^,5S%\0
MOB^OQ(\?^'O"OC#1/'^FZ%J?QBB^($7Q7TKP]/XQ\.Z+KFK^&?"_C'0?#.M/
MIUMINIZ/=:)#'IB_I9X2^#'PK\$?!GPS^SQX=\"^'X?@CX1^&.C?!C0_AGJE
MH?$?A6+X5Z!X5MO!&F>!=1L/$;ZL==\/IX2M(- N[37I-2_M/3A)#JCWGGSM
M( ?B5XJ^!G_!!?\ X+#_ +.OAK]MKXM_##]G'5- ^,7P]TG7M=^*GBKQ5X:^
M"/QL\"RP2VMU?^&OBEX]^'OCG1=2T7Q]\/-?MI/#/B>"_P#&&O:7%<V%_H<.
MJ^(/!VHG^U?R/_X-G=/T#P+_ ,%-/^"J_P &_P!B'XE^/OBA_P $K?AK9^'[
M+X9:SXI\2:AXO\+0?%R[\46"Z9/X"UO[7H_A^[TS4K2U^,=I!K^D^$]2O_&_
M@O0?A]KNM>+KG[/IVH>+/U9\1_\ !K%_P1)\2>.+SQI/^RGKFDPZEJ-YJE_X
M+\.?'7XY:#X'EN;Z\M+VXBL])T[X@0WV@Z<)(+N&ST?PWJNC:3IEGJMW9Z79
M65M::)%I'[:? +]G?X&?LL?"[PY\%?V=/A3X(^#7PL\*6Z0:-X+\!:#9Z%I2
MS^1!!=:QJ;6T8O-?\3:O]FBN?$/BO7[K4_$WB74?-U7Q!JVI:G<7%W* >S5_
M$A_P5'N/A+_P4%_X.#OAC_P3C_;K^/?B+X,_L)?!3]FG2?B/8?"Z\^(UE\(_
M W[0/QSU^-/%5M!=>*;N_P!+-Y?ZKI6MZ;HEG<+=S:OI]M\+O$6@^ CX;UWQ
M5K^NW7]M]?FK_P %!/\ @D9^P5_P4ZMO"DW[6_P87Q;XO\!V-QI7@CXF>%?$
MWB/P%\1?#>C7NIVVJ7VA+X@\,:C8Q^(/#]Q/#=>1H'C&P\2:/HTVL:WJGAZR
MTC7-3N=58 _ C_@KM\,O^"$/_!+/]A'XM:!\%_V8?V0)_P!K/X@_![Q7X!_9
M@\/Z1X-\(_'?X]:!XFU+PM>Z+8?'6#6O'%WXW\;^&M.^$%OHEYX_N_C!K^K0
MO;>(?#4JPZQJOBW6WT_5OH7]A+X=^*?V;/\ @T[U4_#"WUJ]^(>L_P#!.?\
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M86MC_P )O\/_ !#:_M!1^!_AO^TA\)HM)FO],N](\6>*?AY\0;WQ!X4M-2T
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M,+SQ%HVI?$G1;N?3-%%WHUKJ\-II^N:3'K^KZCIW[Q !0% P%  'H , ?@*
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M$GCOQ=_POO\ :=\,?V[K36MM9->_V!X-^-/A[PQIF;:TMXOL^C:+I]H/+WB
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M>$?!/P=OM \/76G2G3[C2]/GLO.@FU.UF_H__9._8K_9D_8>\#^)?AY^R_\
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MFF$%GI]I%:6T/G7$DL\OEPPHGF32R2OMW22.Y+'6HHH **** "BBB@ HHHH
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M<?9;ZTNK.X\ORKJWF@=XVK_M>?L%_'W]J?\ X+1_\$[_ -H;7_ >F:A^Q/\
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MGUKR3:P?\2OQ"VK:-)L_>Z=)N?=];(BQHJ(,*BJBC).%4 *,DDG  &223W-
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M.K:GJGB;Q#XH:';IL&EV=U%;6*WFOZI+9>'M)U;5++\:_P#@TM^"?QD\!?\
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MEA:2RB&*ZO4^$WBUK6WEF8JL4<TXCC>4D"-6+D@#-?S"?\$J?V@?^"VG@_\
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M_P!(POV5O_$D?!W_ ,^BC_5/%_\ 0WX6_P#$GR7R_P"HSS_!]@]O'_GW7_\
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M  <7_P#2,+]E;_Q)'P=_\^BC_AJ;_@XO_P"D87[*W_B2/@[_ .?11_JGB_\
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M_@^P>WC_ ,^Z_P#X(J__ "/]6?E?^A>BOYZ/^&IO^#B__I&%^RM_XDCX._\
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M?_D?ZL_*_P#0O17\]'_#4W_!Q?\ ](POV5O_ !)'P=_\^BC_ (:F_P"#B_\
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MJ_\ R/\ 5GY7_H7HK^>C_AJ;_@XO_P"D87[*W_B2/@[_ .?11_PU-_P<7_\
M2,+]E;_Q)'P=_P#/HH_U3Q?_ $-^%O\ Q)\E\O\ J,\_P?8/;Q_Y]U__  15
M_P#D?ZL_*_\ 0O17\]'_  U-_P '%_\ TC"_96_\21\'?_/HH_X:F_X.+_\
MI&%^RM_XDCX._P#GT4?ZIXO_ *&_"W_B3Y+Y?]1GG^#[![>/_/NO_P""*O\
M\C_5GY7_ *%Z*_GH_P"&IO\ @XO_ .D87[*W_B2/@[_Y]%'_  U-_P '%_\
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M87[*W_B2/@[_ .?11_PU-_P<7_\ 2,+]E;_Q)'P=_P#/HH_U3Q?_ $-^%O\
MQ)\E\O\ J,\_P?8/;Q_Y]U__  15_P#D?ZL_*_\ 0O17\]'_  U-_P '%_\
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M_$D?!W_SZ*/]4\7_ -#?A;_Q)\E\O^HSS_!]@]O'_GW7_P#!%7_Y'^K/RO\
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MX.+_ /I&%^RM_P")(^#O_GT4?ZIXO_H;\+?^)/DOE_U&>?X/L'MX_P#/NO\
M^"*O_P C_5GY7_H7HK^>C_AJ;_@XO_Z1A?LK?^)(^#O_ )]%'_#4W_!Q?_TC
M"_96_P#$D?!W_P ^BC_5/%_]#?A;_P 2?)?+_J,\_P 'V#V\?^?=?_P15_\
MD?ZL_*_]"]%?ST?\-3?\'%__ $C"_96_\21\'?\ SZ*/^&IO^#B__I&%^RM_
MXDCX._\ GT4?ZIXO_H;\+?\ B3Y+Y?\ 49Y_@^P>WC_S[K_^"*O_ ,C_ %9^
M5_Z%Z*_GH_X:F_X.+_\ I&%^RM_XDCX._P#GT4?\-3?\'%__ $C"_96_\21\
M'?\ SZ*/]4\7_P!#?A;_ ,2?)?+_ *C//\'V#V\?^?=?_P $5?\ Y'^K/RO_
M $+T5_/1_P -3?\ !Q?_ -(POV5O_$D?!W_SZ*/^&IO^#B__ *1A?LK?^)(^
M#O\ Y]%'^J>+_P"AOPM_XD^2^7_49Y_@^P>WC_S[K_\ @BK_ /(_U9^5_P"A
M>BOYZ/\ AJ;_ (.+_P#I&%^RM_XDCX._^?11_P -3?\ !Q?_ -(POV5O_$D?
M!W_SZ*/]4\7_ -#?A;_Q)\E\O^HSS_!]@]O'_GW7_P#!%7_Y'^K/RO\ T+T5
M_/1_PU-_P<7_ /2,+]E;_P 21\'?_/HH_P"&IO\ @XO_ .D87[*W_B2/@[_Y
M]%'^J>+_ .AOPM_XD^2^7_49Y_@^P>WC_P ^Z_\ X(J__(_U9^5_Z%Z*_GH_
MX:F_X.+_ /I&%^RM_P")(^#O_GT4?\-3?\'%_P#TC"_96_\ $D?!W_SZ*/\
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M\21\'?\ SZ*/^&IO^#B__I&%^RM_XDCX._\ GT4?ZIXO_H;\+?\ B3Y+Y?\
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M_P#/HH_U3Q?_ $-^%O\ Q)\E\O\ J,\_P?8/;Q_Y]U__  15_P#D?ZL_*_\
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M /!%7_Y'^K/RO_0O17\]'_#4W_!Q?_TC"_96_P#$D?!W_P ^BC_AJ;_@XO\
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MHO-/NX)9++4+2SU&QE:2TU"TM;R">WC ._HHHH **** "BBB@ HHHH ****
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M?MF? M8?VA/AU:_ SQ#\>_ 5GX(U-;"Z^*/AC0?"5]XRBT7PU<ZI9?\ $O\
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M=NO$MSX>TTS76M:1>Z397>K:AI6D/<HL\^IV^G,;Y0#V2BOB/]A']O[X#?\
M!0[X8>,/B=\#(?'V@?\ "N?B?XK^#GQ*^'GQ:\)_\(%\4_AS\1O!K6AUGPSX
MV\%R:CJ=SH5^D%_9W,4-Q<F4)*]M<QVVH6E]9VOVY0 4444 %%%% !1110 4
M444 %%%% !1110!_/5_P7[Z?\$M?^TGO[.__ *57]?T)I]Q?]U?Y"OY[/^"_
M?3_@EK_VD]_9W_\ 2J_K^A-/N+_NK_(5]3FW_),\)^N??^I]$QA_&K_]P_\
MTECJ***^6-@HHHH **** "BBB@ HHHH **** "BBB@ HKXY_:E_X*#?L7?L2
MZAX0TO\ :P_:*^'?P(OO'UGJM_X,A\?7U]IH\26FASVEOK$NE30V%S!<G3)M
M0L$O8EE$UN+VT>2-4N86?Y0_X?V_\$<O^DA?[.W_ (4NH?\ RIH _76BN.^'
M?Q!\%?%KP!X)^*?PV\2:;XQ^'GQ'\)^'O'7@7Q;HTK3Z1XG\(>*])M-<\.:_
MI<SI&\NGZOI%]:7]G(T:,]O<1LR*20/E']J__@I/^P?^PW-IMC^U=^U+\)O@
MSKFKVZWFE^$_$&O/J7CF^L'ECA74[;P'X:M=<\92:49)57^U1H7]G<2DW.V&
M8H ?;]%?+'[*W[;_ .R1^V_X5U;QG^R;^T#\-?CKH/A^>PMO$I\#:]'=ZSX5
MN=5AFN-+M_%GAB\2R\3^%9]3AM;N33X?$.CZ;)>BSO1;+*UG<B+ZGH **^)M
M&_;X^"'B+]O+Q=_P3KT*P\?:K\>_ /P3T_X]>-M3M- TP_#;POX,U;4M#TS2
MM/U;Q3+X@COXO%FI2>)-&N['P_#H$TUSIMVVHQS-:6E[+;X?[27_  5#_P""
M?G['WQ"B^%/[3O[5GPJ^"GQ%GT#3O%-OX2\=:EJ&F:K<^'=6FO+?3M9MD339
MX;G3[NYT^_MH[B":1/M-G=6[%9H)44 ^]:*_(K_A_;_P1R_Z2%_L[?\ A2ZA
M_P#*FOURBDCFCCFB8/%*B21NO*O&ZAD93W#*01[&@!]%?EU^T'_P6K_X)6_L
ML_$76OA)\<_VVO@YX0^)/AF^N]*\4>#M.NO$/CK6?"NL6#I'?:+XJ@^'N@^*
MD\-:W92N(;O1==DT_5+>9)H9K1)8)DC^Y/@5^T'\#/VGOAUI'Q<_9W^+?P^^
M-/PTUTO'IWC3X;^*=)\5Z&UY"D3WFDWEUI-U<'2]=TQID@UCP_JB66MZ-=[[
M+5;"SNXY($ /8:*** "BOBW1/V\_@7XI_;H\:_\ !/;PG'XV\4?'?X8?!S1O
MC5\4]2T7P_:S_#;X9Z%XDO-,A\->%O&?BZ?5[:;3OB!XDTS7-$\3Z'X6MM'O
M9M2\+:G'K-O<M!8ZNNG?0WQ?^-'PA_9^\ :Y\5OCI\3_  #\'OAGX:6V.O>/
M?B7XMT/P3X2TI[ZYBL=/M[S7O$5]I^FQWFIW\]OI^EV/V@WFIZC<6UA807%Y
M<0P. >F45^7GP4_X+5_\$I?VA_B&?A3\)?V[/@%K_C^2Y6QTSP_K'B:Y\"MX
MDU"2]6PATSP9J7C_ $_POH_C?5;JX8&STOPAJ&MZA>6VZ^M;::R5K@?J$""
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M(X)#!;'0;+46N[NRM5FNX/NJN8\;^"O"/Q*\%^+OAUX_\.:/XQ\!^/O#&O\
M@KQMX1\16%OJGA_Q5X1\5:5=Z%XD\.:[IETDEKJ.CZYHU_>Z9J=A<QO;WEE=
M3V\R-'(RGY8W/Y2O^"!?_!)[]@OX\_L4_#_]OG]IWP-\-/V_/VI/VN9/$OQ,
M^,GQ2_:(T?0?CE9Z-XMN_%7B:TU3P7#X7\:7OC7PK8>)O#D\DVG^,-8N]/B\
M4:GK]L9=0AT>.PTS1M+]-_X*#_\ !O+IVO?M)_LA_MI_\$C-&_9Y_8=_:0^
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M!U?X*>!M0T'4MHF\074%_=:KK4\FH0ZM=T ?UA_L9?M6^ OVXOV8?A!^U?\
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M^*OC_KND?:D$,M]HUU\>/B';6>I) 6\Z*VO7LYY;-ITC-U:&"^MQ+975K<3
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M]YXEO/$MWXID?Q5?Z-J%I:0?&W[27P:^&O\ P0@_X+K?\$]OBG^R5#??"?\
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M33+[3-3TG7M!U;6/#VL:5JUZ ?SI?"'6H_\ @G1_P=1?'']GW2&\/:;\)/\
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M@W.NV&A#QKHWAW5IM2O)_%6CZ7KB2ZQ=2?:K#4M$E,IE_*[_ (*/_P#!L?\
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MHRZ1XW\8Z5JTUO#=-<ZZ]FVG6-VMY?V\Z@'Y3?\ !OQ;Z+^UI^V3_P %@_\
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M;.UUBYL?^$Q\ ^(KGQ+X9\=^'M2O(1IVGW.B6MKJ_P#1;\8_@WX(_P""Y/\
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MJ+>*\U*>*U1D:5+9(DFFGE5YI/Q5_P""YM[:?\%4?^"B/PC_ ."57[%OP3\
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M\?\ JK?%5?#/_!!#_E$7^Q?_ -B;X]_]7)\1Z^YOVT_^3./VL_\ LV?X\?\
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M>*?#2^._V@OBG\(_%?AO]G7]G+X>RWL=UJ7BSX@R>(+*UU"U@U**RU'1S?\
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M]XV^%NC?#'_@F]\"/CW^T5\?G\-2:3\'_P!D3X;? '5OAKI'AA[*V%O:W7Q
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M_4M+TCQ%I6G7/@_Q=X.A\+ZWIGB75->N]>MK:YXL\0_%S_@Z!_;2_9=D\)_
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M?_N'_P"DL6BBBOEC8**** "BBB@ HHHH **** "BBB@#\N/^"R?_  4)T?\
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MC:X^)&B-YKPWUI>^&;^PGLTM;6PO=0X#_@M3\,OVHOV'/^"IO[)__!<?X(?
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M]]/^"6O_ &D]_9W_ /2J_K^A-/N+_NK_ "%?4YM_R3/"?KGW_J?1,8?QJ_\
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MV<_VD_V<O%?Q4^(EUJOQ T.\^(L7B?1M$_:IU"S3P[XGB\$VNG:9IAG^#?A
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M ,.7_7VM_P"G9GS/^VG_ ,F<?M9_]FS_ !X_]5;XJKX9_P"""'_*(O\ 8O\
M^Q-\>_\ JY/B/7VU^W):-?\ [%'[85@EU<V+WO[+7[0-HE]92&&\LVN?A-XM
MA6ZM)1S%<VY<302#E)41ATK^87_@E3_P2C^./[0'_!/[]F_XP>%O^"K/[?'P
M T#QMX<\57NG?"#X2?%'Q/H/PZ\%1Z?\1?&.BRV7AG2+#Q?IMI96VH7&FS:U
M=I#90"34]2O9F5GD:1_1RG"X'%<'YA#'9G3RNE'B7+)1K5,+BL6IS65YI%4E
M#"PG.+<93GSR7*E3<6^:44YJ.4<1!Q@YOV,U92C&R]I3UO)I?+?4_L>HK^>G
M_AR!^TA_TFZ_X*??^'I\9_\ S>T?\.0/VD/^DW7_  4^_P##T^,__F]KS_['
MX=_Z*_#?^&7-_P#Y1_5GY7KVE7_H'E_X,I_Y^O\ 3T_H6HK^>G_AR!^TA_TF
MZ_X*??\ AZ?&?_S>T?\ #D#]I#_I-U_P4^_\/3XS_P#F]H_L?AW_ **_#?\
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M]I5_Z!Y?^#*?^?K_ $]/Z%J*_GI_X<@?M(?])NO^"GW_ (>GQG_\WM'_  Y
M_:0_Z3=?\%/O_#T^,_\ YO:/['X=_P"BOPW_ (9<W_\ E']6?E<]I5_Z!Y?^
M#*?^?K_3T_H6HK^>G_AR!^TA_P!)NO\ @I]_X>GQG_\ -[1_PY _:0_Z3=?\
M%/O_  ]/C/\ ^;VC^Q^'?^BOPW_AES?_ .4?U9^5SVE7_H'E_P"#*?\ GZ_T
M]/Z%J*_GI_X<@?M(?])NO^"GW_AZ?&?_ ,WM'_#D#]I#_I-U_P %/O\ P]/C
M/_YO:/['X=_Z*_#?^&7-_P#Y1_5GY7/:5?\ H'E_X,I_Y^O]/3^A:BOYZ?\
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MI]_X>GQG_P#-[1_PY _:0_Z3=?\ !3[_ ,/3XS_^;VC^Q^'?^BOPW_AES?\
M^4?U9^5SVE7_ *!Y?^#*?^?K_3T_H6HK^>G_ (<@?M(?])NO^"GW_AZ?&?\
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M-_X9<W_^4?U9^5SVE7_H'E_X,I_Y^O\ 3T_H6HK^>G_AR!^TA_TFZ_X*??\
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M'?\ HK\-_P"&7-__ )1_5GY7/:5?^@>7_@RG_GZ_T]/Z%J*_GI_X<@?M(?\
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M/VD/^DW7_!3[_P /3XS_ /F]H_L?AW_HK\-_X9<W_P#E']6?E<]I5_Z!Y?\
M@RG_ )^O]/3^A:BOYZ?^'('[2'_2;K_@I]_X>GQG_P#-[1_PY _:0_Z3=?\
M!3[_ ,/3XS_^;VC^Q^'?^BOPW_AES?\ ^4?U9^5SVE7_ *!Y?^#*?^?K_3T_
MH6HK^>G_ (<@?M(?])NO^"GW_AZ?&?\ \WM'_#D#]I#_ *3=?\%/O_#T^,__
M )O:/['X=_Z*_#?^&7-__E']6?E<]I5_Z!Y?^#*?^?K_ $]/Z%J*_GI_X<@?
MM(?])NO^"GW_ (>GQG_\WM'_  Y _:0_Z3=?\%/O_#T^,_\ YO:/['X=_P"B
MOPW_ (9<W_\ E']6?E<]I5_Z!Y?^#*?^?K_3T_H6HK^>G_AR!^TA_P!)NO\
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M'_#D#]I#_I-U_P %/O\ P]/C/_YO:/['X=_Z*_#?^&7-_P#Y1_5GY7/:5?\
MH'E_X,I_Y^O]/3^A:BOYZ?\ AR!^TA_TFZ_X*??^'I\9_P#S>T?\.0/VD/\
MI-U_P4^_\/3XS_\ F]H_L?AW_HK\-_X9<W_^4?U9^5SVE7_H'E_X,I_Y^O\
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MCU__ (55K?B.>Z2T^*/@+[?XJU+^R_'7APQL^C:G:_8[FW:1C'=Q9Y_6]?\
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M_8_#O_17X;_PRYO_ /*/ZL_*Y[2K_P! \O\ P93_ ,_7^GI_0M17\]/_  Y
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M_P#!E/\ S]?Z>G]"U%?ST_\ #D#]I#_I-U_P4^_\/3XS_P#F]H_X<@?M(?\
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MM17\]/\ PY _:0_Z3=?\%/O_  ]/C/\ ^;VC_AR!^TA_TFZ_X*??^'I\9_\
MS>T?V/P[_P!%?AO_  RYO_\ */ZL_*Y[2K_T#R_\&4_\_7^GI_0M17\]/_#D
M#]I#_I-U_P %/O\ P]/C/_YO:/\ AR!^TA_TFZ_X*??^'I\9_P#S>T?V/P[_
M -%?AO\ PRYO_P#*/ZL_*Y[2K_T#R_\ !E/_ #]?Z>G]"U%?ST_\.0/VD/\
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MZL_*Y[2K_P! \O\ P93_ ,_7^GI_0M17\]/_  Y _:0_Z3=?\%/O_#T^,_\
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M9_[=_P"T=JO_  4"_P""@?\ P2X_;7\9K\3/C?\ LYZY8?&KX#_%2U\$>!O
M%O\ $#]E?Q=IG@6/0UU+0? L=AH[>(/#MQXP\):AJ^I6=G=>;JOC75-#OYM+
MG\-P:6/WTH **** "BBB@ HHHH **** "BBB@#^>K_@OWT_X):_]I/?V=_\
MTJOZ_H33[B_[J_R%?SV?\%^^G_!+7_M)[^SO_P"E5_7]":?<7_=7^0KZG-O^
M29X3]<^_]3Z)C#^-7_[A_P#I+'4445\L;!1110 4444 %%%% !1110 4444
M%%?S4_\ !3S_ (.3_P!G']C36O'OP,_9-\"Z[^W?^U9\/=&\1:_\0_"?PE6^
MUCX0_ [0O!7V.?QSK'QE^)/AFTUMK:;PC93W;:_H_A'3M<A\)ZCI6JZ3\2M?
M^'FH6D5O=_JK_P $M?VQ?%'[?W[!W[/_ .UWXR\'Z#X \1_&;1/$NM:AX0\,
M7NH:CHFAC1_'/B?PO:6MG?:J3?W9:RT2VGN9YUC$EU+.T4,$)CA0 _0&BOYM
M_P#@HA_P7?\ B+\(/VNE_P""<G_!-G]D76_V[/VU]-T677_B)90:[;:9\*?A
M19G3+;4([+Q!J.CWYOK_ %C2DO\ 3F\9+X@U;X<>&?"LVL>'M$/BS5/%&LW&
MB:-X!I?_  7K_;__ &(OB?\ #/PW_P %PO\ @F]8_LE?!7XU^(+?PSX._::^
M!OC_ $CXI?#_ ,"ZW()5&G_$;3?"7C3XN:;(LL<5SK-W%:>/-$\::;X=TG4M
M5TCX>>,;6.XGL #^L>BJEA?V6JV-GJ>FW=O?Z=J-K;WUA?6DJ3VMY9W423VU
MU;3QLT<T$\+I+%*C,CHRLI((-9WBCQ-X?\%>&O$7C+Q9J]AX?\*^$M"U;Q-X
MFU_5)TM=,T/P_H-A<:KK.KZC<OA+:PTW3K2YO;N=R$AMX))&X4T ;E%?RA_\
M$T?^#D?Q)_P4?_X*;>(/V//!_P"SQX:\*?L\7VF_&3Q3\*/C)>Z]XJ'COQOX
M&^'6K2Z7X7\27OAG4=)T_2=+D\5Q0/=:GID$MY_PCUZMSH1O;^ZT^>[D_J\H
M **_!G2OV_/CS\8O^"_>O_L"?"3Q0+?]ES]EW]DB/XD_M*6>G^!=#U+^U_CI
MXNNM-F\)^&]6^(NLZ3->Z+IT/A+XB>#M7T_0_!VIVNIWGB#PKXBM[^YO+'3_
M !/I6ET_^"G?_!9OQE^R_P#'[X?_ + G[!_[-&J_MO?\%#/B9IUGKY^%=GJ5
MWH/@'X.>#M12*;3/%_Q5\1I%:V<<>IQ30W0TVZ\2^#-$\/>';@>,/&OCCPQI
MTOAZQ\5 '[Y45_)!K'_!>/\ X*>?L%^)_A_JO_!9K_@E;'\ ?V=/B/XFMO"X
M_:(_9S\?Z3\5_#OPVO+JXLX4E\<Z9X+\;_&72'?R)-0U6#0;KQGX3\8:_I&F
M:M/X)\->+KS1;ZQ;^I#QG\;/@_\ #GX4:C\=?'_Q/\!^"_@QI'ARR\7:G\4_
M$_BK1=%\!6/AK4UM#IFM3^*;^]@T9;#5&O["'2YQ>,NI7-]96MC]HN+NWBD
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MQA;>#=6N8+FU3Q-HEM8Z]-IVS4-,BLKJ2V ![A17X7?\$2?^"@?QQ_:MT/\
M:R_9C_;!N[;5/VT/V#?V@/%WPA^-?B+2_#OAKPKH7C3P_J7BOQA%\.?%^D:#
MX6:+2M/MKBS\,ZYX=C:PM/[/U2W\-6^O6NI:F^K3RQ_NC0 4444 %%%% !11
M10 4444 %%%% !1110!_/1_P2Z_Y2X_\%S?^Q_\ V9__ $W?&.OZ%Z_GH_X)
M=?\ *7'_ (+F_P#8_P#[,_\ Z;OC'7]"]?4<8?\ (ZC_ -B7AC_UFLI,,/\
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MA[4M5TZ)[31O%NJQV_P[\*V,FJ+I/A#2/&6K:+KGB.T /5/@5^V9_P %7_\
M@FO_ ,%0_P!ES_@G;_P4O^.?P?\ VT/V>_VY%\70_ ;]J+2/"&B?#+XH^$_&
M>B:;=1V?@[6/#7AFPT"R=9O&K>'="U30_$6E>+!<V'Q,\)ZYX,^+TLOA?Q/\
M,++]'/\ @M+_ ,%1?B;^P-X-^ WP4_9+^%5C\?/V^_VT/']U\-OV9/A1J=GJ
ME]H-M%HK:0OC+XB>*H-.N]%MIM+\/3>(O#FDV&FZMXM\'V,]UKMWXKO]8;PG
MX"\9QQ_S.?M??LH?M;?LM?\ !:W_ ((4V?[87_!0_P 7_M]_$#Q]^T9'KVE7
M/B+X9:'\)])^$FDV?Q%^%T5[I/AGPSHGB[Q3%<V?B?6[W4))-;:'P]!=6WAS
M3=/M-$M5TJ5%^DO^"[&A_M/:[_P<5_\ !*C1OV??VCO#/[+WC;Q7^S5X@\(_
M 7XQ>.OAUI'Q3\(^!?C#KFN_M&:/XG5_!'BGPEXI\,ZUJ_Q%T?6?A[\.M)FN
MM/U.3P_KFL:#XB9- ETW3]:8 ^OS^Q1_P=4?#KP7;?%SPQ_P5>_9W^-'Q?M]
M'GU_Q'^S=XX^!WPYT+X>Z[?/I-KK&H>"/#GCVR^$5C:KJLVNB]T'P_>QZ9\+
M=#_<:=+=^*_"^A:IJD6F?K5_P1R_X*?Z-_P50_93N/BYJ/@&[^#_ ,<?A5XY
MU/X*?M(?"#4&>&3P;\6_#.D:-J6K7F@Z=J5P_B>S\%>(8-8CGT.'Q39VNL:/
MJ]EXG\%WMQK5_P"#[[7-1_.S_AA'_@YQ_P"DYOP)_P#$%_V?/_G(U]+_ /!$
MO_@D]\<?^"95Q^V;XJ_:"_:$\%_M#?$?]L#XN>'OB[XD\2>"_!%SX'M8/$EJ
M_CG4O%.H7NFL8-,CG\1Z]XXO+^/3]"TK2M(TJ. P65LEO)#;6H!^%_[$_P"W
M9_P7Z_X*D>*?VQ?V8OV9_P!HGX8_"U?@!^UUX]M/B#^V-\3?AK\)4O\ X>?!
M35)O$'A7X3? /X6?#_PS\)Y=,\7>([K4/!'CSQ+XI\9:[H>H>*M-M5\(QM\0
M/"C74(\0?M/^U)^V]\;O^"'O_!([P-XL_:Z^*5E^W!^V\WB+5?@S\-=>30]3
M\/V?QV^+WCWQGX]\3?#F#6M+\/:6FI6F@?#CX3VUL?%%T4TN]\6R>!DT"W\0
M6GB_QQHVH3_#?_!J-_SEZ_[2)>-/_=@JI_P<YZNOA?\ :Y_X-_?&'CK71HO[
M/7A;_@H/8ZO\9);G^U%TJU6P^)O[,FJ:;KNH3:99RSQC1/!&F_%-D^S7D&J&
MVO;U]-L[UXYI;$ Z#P7^R!_P=7?%_P "1_'7Q;_P50^ 7[-GQ<\5:=?>)_#G
M[+D7[/?PL\1^!/AQ#X@M-8U;2OAUXP\61_!_QE'#>^&+C4=.\,WE_+IWQKU7
M3K2%[^3QOXTU70K2?5ON?_@B]_P5B^*7[:NO_M'_ +&W[:?PZT;X-?\ !0W]
MBKQ5=>%/C+X2\+V]X/!?Q#\*:1=6/A9OBMX4FEGO;2T:Z\7+=P:MINF7]_X8
MO='UKP1XS\$:QJ/A_P 7G2_#/[W5_(W^SS_8^O\ _!X1^W%JOPW74;J#PQ_P
M3Y\*:/\ ''4[1+>VT>/Q?+I/[+,6EZ9<WMJL$>L$:(G@&'[)>2W^I0ZSHFI0
M*D=MX6D32P#X"_X*1_M%_'S]G#_@Z$O-6_9/^$EO\;/VJ/BI^Q1X*^!O[._@
M;5[JVL/!Z?$SXCZ;/;6_C#X@W]QJ.EFU\"_#[PWI_B/QSXA6*[MEOH?#\6EW
M^I^'-)OM1\4Z'][_ !E_9L_X.C?V7_A-X@_:J\*?\%+O@M^U7\0_ VCW_P 0
MOB%^Q[9_L[^!;/P/XBTRTNH=9\4>#/ACXIU#P9X7\1^)K;2-/2_GT:&U3X2^
M,]8TO2O[%\.W8UW5;;1K[C/%&H>$K+_@\V^'-MXCL=-N]8U;]B"^T_P#/?6V
MF3W6F>+8O@YX\U6\OM&EOW2ZLM2D\":9XUTV6YT59=3?2-0U6SE0:/=ZM)'_
M &+75U:V-K<WU]<V]G96=O-=7EY=31V]K:VMO&TUQ<W-Q,R106\$2/+--*ZQ
MQ1JSNRJI( /S,_X)P_\ !4'X._\ !0#_ ()]>'?V]1:_\*H\.Z1X?\<2_';P
MQJ]Y+K*?"'Q5\*+>ZNOB/93:K8V:OKGA^VTBU@\:>&]4MK"/4=2\&:YH5QJ6
MD:3X@DU+0-._![X(?'K_ (+K_P#!<?5O'?[2O[&_[1W@?_@F)_P3XTGQQJG@
MC]G>_P!5^$?AOXF_$K]H32O"OB+7/#_B3XDZA/XLT#5-7N)M-N[.\TW4K?2-
M3\"^ +/78HO 6GV/BKQ-X(\8>.:_._\ X)?7?B;Q+_P0(_X.,/$7P8US4&^$
M.O?%;]K35_AD\%MX@AAD\(/\%?#>K_$BXCBU723JL7_"0?!>Z\,6.J1:H1J=
MM8QQ'Q!%HRYO9/H/_@CE^S/_ ,%R_C1_P39_9<\=?L7_ /!8?X'?!W]G2X\)
M>(-$\#?".]_8W^#'BG5OAK=>&?'/BC0/%GA+7/$/B?X.7_B'6]8L?%^GZY<7
MFM:I?7\FNF[36[34=3TW4;+4;H _0+]FG_@H#_P4K_X)V_MW_ #_ ()T?\%C
M_%?PL_:$\(?MC_;_  [^QS^VO\)M+TCP5_:_C[1_$\ND0?#KXMZ%-X>^'6E7
M'B+5X?$7P^T"6W\/^'9M7T#Q+XI\"6*:U\5&\9ZMXF\/^W_\%G?^"C?[9'PO
M_:A_8K_X)=_\$Z+CX?>!OVL?VVVUO7[[X^?%31;/Q!X?^"GPW\/WUULUKPOX
M>UFPUSPQKOB*_@\*>/M1UV3Q+X:\60:5X<\,#2-!\&Z]XI\:Z-J_A'Y%^(__
M  0U_P""P?[5OQ\_8X^*'[=G_!4_X,?M ^$/V1OV@O!'QK\,>&]*_9B\'?#;
M4X$T?QGX+\0^+K/3KOX9^$/ *ZA?Z]IG@RPL+-?$=U?6%E<1QRP+:":ZDE_3
MC_@L'_P1O\'_ /!3I_@7\3/"/[1OQ"_9"_:[_9TU'5W_ &>OCS\/9I99[&\U
M6^T?Q/?:5JNE:7KO@[Q;<7VGQ^$[S4_"&O\ @GQUX7U[P7?W6K>(9(_$EA!<
M:'. ?FK\7OA9_P ',W_!.[0_!7[1G@[]L7P[_P %9_#&C^,/"UE\;/V1+7]G
M3P5X$\9:KX1U&]M;*\U#X<Z]X9T&Y\;:A):W%Y<Z?>:IX<GL+[P]%=:;XSUK
MP'XR\-:+KUCHGVE_P<BZ_P"(?%?_  0!_:_\4V.@^*/"NL^)?!'[,.OZEX7N
MK>^M/$WANRUC]ICX ZCXHT'7[6&*"[MI-'T:YU73O%5O/####:6^J1ZC%':K
M<H/S/_: ^/G_  <B_P#!%/X<77Q]_:&^(7[-W_!3S]C7X;:EI:>/M=BTO_A7
MGQM\/>'_ !9;:;X;TZY\27VD^#/#&I:=I6A_$"ZLX(O$D<'QGU"6UUV.[\2R
M6&CS-#X)_H_UO2OA!_P5T_X)H2V3CQ5X3^$7[>?[*UCJ-A)=1Q6_C;P!9?%[
MP-;:OHMY<VUG?/I=UXJ^'NL:A97DUDE_J/A?5]7T)K66;6?#MXYO #Y._P""
MW/[:_P 2?V/_ -C/PSH?[,>F^,[#XG?M*^,_"GP-\"?&+X9?"OQ3\7="_9L^
M'^O-92?$+X_W?A+X<VE]K6J)X!^&_P#:<_P[TSP_9WL]WXTN_#=W::9K%AIE
MWI%]_/Q\>/VZO^"<_P #=<_X(1_!S]F;PU^T9HGP>_8=_::FN==TO6?V._VA
M_ OB76]#O?A3XITWQ'XVT?0]=^&6BS?$+QQXI\;:QJ7CCQ[8^%8]5\4ZKK7B
M+6?$0TR^>>\E7^L/_@F$O[0^E?L,?L^_#_\ :O\ !%_X&_:$^"_@Z/X#_$J&
MZEAO;#Q?J7P5N[CX;Z5\4/#NL6]W=P:]X>^*?ASPYHWCZPUJ);!;U_$%QC1]
M'\O^S;7O_P!HO]C'X7_M.?%;]DOXP>/=>\>Z1XE_8V^,&H_&OX8V/A#5/#UA
MH6N^*M3\*:AX/GT_QY;:SX6U_4-4\/IIFI3SPVOA_4_"^HK?)%*^JR6ZO:R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?SU?\' G_(+_ ."7W_:47]G'_P!%
M^(Z_H47H/H/Y5_/7_P ' G_(+_X)??\ :47]G'_T7XCK^A1>@^@_E7U.;?\
M),\)^N??^I]$QA_&K_\ </\ ])8M%%%?+&P4444 %%%% !1110 4444 ?'?B
MK]@K]EGQ[^V)X;_;N\?_  NT;QW^T?X$^%/A/X0?#3Q9XN@M];L?A?X=\)^+
M/B7XQCUGP%HUU;-:Z)XUUG4_BEK=MJWBUS=ZM#I>F:+8Z#+H:?VV^M_SI?\
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M<OVSOV]_VZ/B'\,?@U^SO\"?!MAXO^,O_"J? 7A?1/B;H)\/#Q%K&EZUX/\
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M]!\2>+],\0^);:VC:[G\.Z5JD5H/M+1$ 'X7_P#!87XN?$7_ (*:_MU?!O\
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MMW\$^*;/2=0N]5G2>VU'08]93QO\/[O5=%B\'0_$BR^(VL:/_P )CI/]=E%
M'\Q/[,O_  2,_P""D/QT_;H^ W_!0+_@L?\ M??"WXE^(OV3/[6O_P!F+]F7
M]EC3O$F@?"SPAXA\3:#IEOJ7BCQ/XJN/#WPTU2*_77+*'5O%/ARTTCQDWQ!U
M'0_">F:_\1[CX7^'(OACJ/O'_!4__@E1^T_\</VEO@E_P4?_ .";O[1FC_ +
M]NGX ^&;OP-_PCGQ3E\0:G\#/C?\.;_48Y+[P=XLMK*#Q);>%IFTB]\16=\T
M'@C6[3QI)+X7@O[[P7JWA;0O'6C?O]10!_'[\<_^"=__  <:?\%1O"-]^S9^
MWC^TY^Q7^RM^R;K&O:8OQ1T_]F+0/%_BGQ[\4])T#4TUG38K;3=6AS=^'YM2
MM+.YDTS6OB9X'@^U66EWFJ^%-=6TELW_ *K/@3\%_ 7[./P4^$O[/_PMTZ?2
M?AO\%/AQX,^%G@;3[RY-]?P>%O GA[3_  UHIU/462.74]6FL--AGU;59T%S
MJFI2W6H71:XN96/JU% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!_/5_P ' G_(+_X)??\ :47]G'_T
M7XCK^A1>@^@_E7\]?_!P)_R"_P#@E]_VE%_9Q_\ 1?B.OZ%%Z#Z#^5?4YM_R
M3/"?KGW_ *GT3&'\:O\ ]P__ $EBT445\L;!1110 4444 %%%% !1110 5^%
M'_!-[_@F)\>_V/?^"CW_  57_:_^)GB[X0ZY\-/VYOB1H?C#X2Z'X%U_QGJ?
MCGP]IFF>,/B+X@G@^(NF:_X \,:!I-\]GXNTV*&+PUXF\76[74%\CW4<45O-
M<_NO10!^+_\ P6#_ ."/?A7_ (*@>&_@UX[\%?%G6?V:/VQ/V6?%:^._V:_V
MC/#6G3ZG<>&]9@U;0_$8\/\ BG3+'5-#U"^T=O$/AC0M<\->(-/U2+Q!\./$
M]G_PD?AZ/4;._P#%/A;Q9^:MG\"O^#O'4/#MI\*[[]K;_@F_X>LET>#PC>_'
M2TTCQ#J?CD6MA9I87/CFVAG^ \ME=^*M8AMGOH3-X*TVV;5K]9'L/#T8,VG?
MUE44 ?D'_P $??\ @DIX$_X)7_!_QW:77Q!\0?'/]I_]H?Q!I_C[]JG]H3Q/
M>:Q+?_$SQI87'B&^TNSTZRU?4M3N[?0/#=WXO\57%OJFL7=_XK\4ZYXC\0^)
MO$>HAM4L-#T'X?\ V[_^",'[5>F?MKZE_P %._\ @C_^TOX9_9C_ &L?&NCG
M3OC_ /##XMC6-:^!?[1$<$NA0$ZU FA^-8="GU?0M+>VUG2I_"NH:3=^(=,\
M,>*?"^I?#7Q?!JWC:Z_I<HH _D"UC_@C=_P6-_X*=?$KX>Z5_P %KOVQO@E'
M^QE\,/$]GXX?]ES]D2'5](?XL>*=,BM[>&T\5ZW%X%\!7&BZ/?6D]W#)XKU+
MQ7X_\2Z!:G7](^'_ (<\!W_BR;QQ8?<G_!R5\9I/V5?^"-WQ2^&7P<T_1?!F
MJ?'K4/AA^Q=\+_#OA^:T\'Z3IF@?$.9[3Q!X+\-:3IUM9Z3#IM]\'?"/C7PE
M!H*3Z'HMAH-Y<SRROI^F-I&H?T,UP7CKX5_##XH#PZ/B9\./ 7Q$'A#7[3Q5
MX2'CKP?X>\6CPOXHL,_8?$GAT:_IVH#1-?LLG[)K&F?9M1MLGR;A,T >0_L6
M?L^VG[*'[(?[,G[,]I)I5T?@3\"?A;\++_4]&M(K.PU[6_!?@S1]#\0>)EBB
ML=-\VY\3ZY9ZAX@U"\FL+6[U"_U*YO[V);NYGS_-]_P7:_X(O?\ !43_ (*@
M_M:_!CXD_!3XW?L=67[,W[/FD:!JOPQ^#'[0VH^/FM#\2I]4L]6^(6N>-O!N
M@?L^?$GPSXXT3Q8=#\,Z)<:5XFU_5=,N?#6ES:0="TZ'5=;_ +7_ *W.G2B@
M#^4"S_9B_P"#O/3K2UL+#]O7_@EC8V-C;PVEE96G@;7[:UM+6VC6&WMK:WA_
M8D2*"W@B1(H88D6.*-51%55 '[U?L!>%/V[?!G[.NCZ#_P %&/B7\%OBW^TQ
M;^)?%$VL>-?@+87^F^ ;WPI<ZB9O"=I%::A\/_AE*FK:?I[-:ZDT7A*TA=HX
MF%S>RF6Y?[5HH _%+_@O?_P3?^.'_!4O]A:T_9C_ &?O%7PI\'^/;?XW^ /B
M4^K_ !CUSQ?X?\('0O"NB^,].U&T6_\ !/@;XA:R=6FG\163V4!T!;.2**Z:
M>_MW2%)_V#\":%=^&/!'@_PU?R6TU]X?\+Z!HE[+9O+):2W>E:5:6-Q):R30
MV\SV[RP.T+RP0R-&5+Q1L2@ZJB@#^2_QC_P12_X*3?L%_M2_'_\ :5_X(@_M
M2? [P'\//VG_ !!/XK^*G[)W[3'A_4E\!Z#KUUJ-YJD<_@'4] \*>+M.O;+1
M-8UW7IO"MO-I_@#4_"WA6\;PM<:]XS@@A6XZGX-?\$8O^"A7[8_[5_P8_:__
M ."XW[4WPN^+6D_LQ^([+Q3^S]^QQ^SEI&H6GP4L?%FCW6DZGIWC'QYJ-_X?
M\%Q7;2>(]&AUW7O#;Z'XUU'QQ##X?T3Q#\0+#P%HTWPON?ZIZ*        #
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MX?\ %T&KZ3H>J>(-=U#3K2&YU:_>?ZTH _DUL_@5_P '>-_X=M/A7??M;?\
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M[N&3Q5J?BOQ_XDT"U.OZ1X \.>!+_P 5R^-[#^OVB@#YE_:*^#7CSQ3^R/\
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M3CP[;^,]>\,>'O%GB+2O##:G]F_MF[T/PWK&J1V G%C927!C*_E3_P $@O\
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M;8^,+.S\/^,I;"[M],>/P]JD5QX-\6Z)K.C0:'>PZ3HOB3PM9:SJ'P%\0O\
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M=02P2R1M\+1?\$H_^"9\,44*?L&?LH,D4:1(9?@=\/[B4K&H13+//H<D\TA
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MVG_IQ]U3_/U_I:X/_#WK_@F!_P!'V?LU?^'-T+_X_1_P]Z_X)@?]'V?LU?\
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MC_T87^R9_P"&)^'7_P H*/\ AU1_P31_Z,+_ &3/_#$_#K_Y047X*_EXI_\
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M_P!'V?LU?^'-T+_X_1_P]Z_X)@?]'V?LU?\ AS="_P#C];W_  ZH_P"":/\
MT87^R9_X8GX=?_*"C_AU1_P31_Z,+_9,_P##$_#K_P"4%%^"OY>*?_ \I_\
ME?K_ $M3_:?^G'W5/\_7^EK@_P##WK_@F!_T?9^S5_X<W0O_ (_1_P />O\
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M_P />O\ @F!_T?9^S5_X<W0O_C];W_#JC_@FC_T87^R9_P"&)^'7_P H*/\
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MVG_IQ]U3_/U_I:X/_#WK_@F!_P!'V?LU?^'-T+_X_1_P]Z_X)@?]'V?LU?\
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MG_AB?AU_\H*/^'5'_!-'_HPO]DS_ ,,3\.O_ )047X*_EXI_\#RG_P"5^O\
M2U/]I_Z<?=4_S]?Z6N#_ ,/>O^"8'_1]G[-7_AS="_\ C]'_  ]Z_P""8'_1
M]G[-7_AS="_^/UO?\.J/^":/_1A?[)G_ (8GX=?_ "@H_P"'5'_!-'_HPO\
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M_2U/]I_Z<?=4_P _7^EK@_\ #WK_ ()@?]'V?LU?^'-T+_X_1_P]Z_X)@?\
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M)@?]'V?LU?\ AS="_P#C]'_#WK_@F!_T?9^S5_X<W0O_ (_6]_PZH_X)H_\
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M"8'_ $?9^S5_X<W0O_C];W_#JC_@FC_T87^R9_X8GX=?_*"C_AU1_P $T?\
MHPO]DS_PQ/PZ_P#E!1?@K^7BG_P/*?\ Y7Z_TM3_ &G_ *<?=4_S]?Z6N#_P
M]Z_X)@?]'V?LU?\ AS="_P#C]'_#WK_@F!_T?9^S5_X<W0O_ (_6]_PZH_X)
MH_\ 1A?[)G_AB?AU_P#*"C_AU1_P31_Z,+_9,_\ #$_#K_Y047X*_EXI_P#
M\I_^5^O]+4_VG_IQ]U3_ #]?Z6N#_P />O\ @F!_T?9^S5_X<W0O_C]'_#WK
M_@F!_P!'V?LU?^'-T+_X_6]_PZH_X)H_]&%_LF?^&)^'7_R@H_X=4?\ !-'_
M *,+_9,_\,3\.O\ Y047X*_EXI_\#RG_ .5^O]+4_P!I_P"G'W5/\_7^EK@_
M\/>O^"8'_1]G[-7_ (<W0O\ X_1_P]Z_X)@?]'V?LU?^'-T+_P"/UO?\.J/^
M":/_ $87^R9_X8GX=?\ R@H_X=4?\$T?^C"_V3/_  Q/PZ_^4%%^"OY>*?\
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M_#WK_@F!_P!'V?LU?^'-T+_X_6]_PZH_X)H_]&%_LF?^&)^'7_R@H_X=4?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img12876764_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_8.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '/!@D# 2(  A$! Q$!_\0
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M0*6#J"I^&?\ AM?XI?\ 0O\ @#_P5^(O_FIH _3^BOS _P"&U_BE_P!"_P"
M/_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ: /T_HK\P/\ AM?XI?\ 0O\
M@#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^:F@#]/Z*_,#_ (;7^*7_ $+_
M ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O_FIH _3^BOS _P"&U_BE_P!"
M_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ: /T_HK\P/\ AM?XI?\
M0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^:F@#]/Z*_,#_ (;7^*7_
M $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O_FIH _3^BOS _P"&U_BE
M_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ: /T_HK\P/\ AM?X
MI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^:F@#]/Z*_,#_ (;7
M^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O_FIH _3^BOS _P"&
MU_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ: /T_HK\P/\
MAM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^:F@#]/Z*_,#_
M (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O_FIH _3^BOS
M_P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ: /T_HK\
MP/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^:F@#]/Z*
M_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O_FIH _3^
MBOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ: /T
M_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^:F@#
M]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O_FIH
M _3^BOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B+_YJ
M: /T_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7XB_^
M:F@#]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P5^(O
M_FIH _3^BOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _\%?B
M+_YJ: /T_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P" /_!7
MXB_^:F@#]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\ @#_P
M5^(O_FIH _3^BOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_ ( _
M\%?B+_YJ: /T_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"_P"
M/_!7XB_^:F@#]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\ 0O\
M@#_P5^(O_FIH _3^BOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_ $+_
M ( _\%?B+_YJ: /T_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE_P!"
M_P" /_!7XB_^:F@#]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?XI?\
M0O\ @#_P5^(O_FIH _3^BOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7^*7_
M $+_ ( _\%?B+_YJ: /T_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&U_BE
M_P!"_P" /_!7XB_^:F@#]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\ AM?X
MI?\ 0O\ @#_P5^(O_FIH _3^BOS _P"&U_BE_P!"_P" /_!7XB_^:FC_ (;7
M^*7_ $+_ ( _\%?B+_YJ: /T_HK\P/\ AM?XI?\ 0O\ @#_P5^(O_FIH_P"&
MU_BE_P!"_P" /_!7XB_^:F@#]/Z*_,#_ (;7^*7_ $+_ ( _\%?B+_YJ:/\
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M_K_AGY7_ -#6BO\ /*_XBU/^"BW_ $1/]BK_ ,-Y\<__ *(RC_B+4_X*+?\
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MO_\ 1*?V5/\ PB?B[_\ /QH_XE%\9/\ H!R#_P /N'_^5A_Q-%X4?]!F=_\
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M7Z*_B@_XB1/VW_\ HE/[*G_A$_%W_P"?C1_Q$B?MO_\ 1*?V5/\ PB?B[_\
M/QH_XE%\9/\ H!R#_P /N'_^5A_Q-%X4?]!F=_\ AEK_ /RP_M?HK^*#_B)$
M_;?_ .B4_LJ?^$3\7?\ Y^-'_$2)^V__ -$I_94_\(GXN_\ S\:/^)1?&3_H
M!R#_ ,/N'_\ E8?\31>%'_09G?\ X9:__P L/[7Z*_B@_P"(D3]M_P#Z)3^R
MI_X1/Q=_^?C1_P 1(G[;_P#T2G]E3_PB?B[_ //QH_XE%\9/^@'(/_#[A_\
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M ,_&C_B47QD_Z <@_P##[A__ )6'_$T7A1_T&9W_ .&6O_\ +#^U^BOXH/\
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MS^E^BBBOYY/W4^</VL/^2(^)?^O_ ,._^GZPK\CJ_7']K#_DB/B7_K_\._\
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MH **** "BBB@ HHHH **** "BBB@ HHHH _KB_X*S_\ (I_\$S_^T<?P"_\
M2?5*_'6OV*_X*S_\BG_P3/\ ^T<?P"_])]4K\=:_I?P,_P"34<'_ /8)C_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXE^-5W^UQ8FRN91IUOK7QUUC6HOBCI>BZ7J=]?:MIF@67B'1?#VJZ?;)>ZI
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M$S1/$V@ZA8^(_ <4L/\ )M7^EU_P;GZ#H?PU_P""-GPM\?6&GZ3IUUXMUO\
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M_@JK\+/C)H%Q^R!^SI\/_C)\!++PKI.K^([C4#ID_BS4/$(U+4$\0^'A:O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]AZ_KNL>!=,T;0O[>_MO5M%M-2;5=,TG5+VXT'X!_:(_X+R?\%1?VE?"6K>
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MTO6;IO#UOHK2W-BEJC1:3/>:=<_OV?>&?&U+QMR'Q0X5QG#E7+JF4X'A[B;
M9W+,*>+HY7#$1CF-?*5@Z4J=?%SP*4L$\16HTZ>-IQC7IU</4DX?B.2>(7"%
M3P?SKPXXDPN?TL?#,L9GG#^-RB.!J8:MF,J#E@:&9O%58U*.%CC/=QGL*-6=
M3"3E*A4IUX14OZE/V&?$/AC]O'_@D-8_!'PMXGL-*\767P!U7]FCQ'%,ZM-X
M-\7>&/"LGA/PK>Z]:6\5Q*VDZII]KX=\3YMDDN+W0]1>&*6#54N([3\M_P#@
ME[_P1]_:Z^#'[;/@_P"+7[0'@O3OA_X ^"TGB#7;'5(?%GA+Q.OQ"UN^T/6/
M#>A6/AZ/POXBU&_T^SC?5AXEO;[7+"R>.UTZ+1I]/COM2D.G_P _O[/_ .TS
M\=_V6?&,_CWX _$G7/AOXHO+%=,U"\TJ+3-0L=5TY+J&]2QUG0M>L-6T#6;6
M.Z@CFC@U72[R.-M^Q5664/\ H%\0O^"Y/_!1?X@>$KOPB/BUH7@>'4K&ZTW4
M]?\ A]X%\.^'?%MW:7L5]!.;3Q$]M?W_ (<OA%>QBUUGPBWA[6].ET^QN]-U
M&TO%NKBZ^(QW@SXK\.8GQ#R/PYSK@[_4WQ,Q>.Q.8/B&&9T\ZX>_M6%:CF-/
M+W@Z%;#UHRPV)JX6A6J^WJ.G"A/V6%Q$)8FI]C@O%KPSS^AP)G''N4<5KBSP
M[PN"H8%9%++JF4Y[_9LZ-3 3QRQ5:C7HRCB,/3Q5:E2]A34YUH>UQ-&<</3_
M %D_X*L_'SPCX^_X*D_\$X?@=X;U"/5-5^!_QY^$^I^,IK6YBGM-+\0_$GXN
M_#*XC\/2K'._E:K8Z)X7TC4M01H8V2+6+*!W>6&2*W]>_P"#DK_DUCX(_P#9
M<Q_ZA'B6OX__  ]\2O'?ACXDZ%\8-*\3:BWQ,\.>-M*^(^E^,-7,/B/5?^$X
MT77;?Q+8>(]2/B*'5;;7+Y==M8=2NQKEOJ-OJ4X<:E#=Q331R?2O[2?_  4(
M_:__ &O/"NA^"?VA_B[_ ,+"\,>'-=_X271=,_X0'X8>$_L>M_8;G3?MOVWP
M/X*\-:A<?Z%>7,/V:[NY[3]YYGD>:D<B^O@/ #-<BXC\%,5D^:977R7PSP.8
MT<YGC:F,P^99CC,SQ.+QV+Q&782C@L7AE2JXW&5JD:6)Q]!T:<HT^>JX\TO*
MQWC?EN=9!XNX7-<NS*CF_B%C<!6RJ.#IX2OE^ PF74,)@\-0Q^)JXO#8AU*>
M$P=*$JM#!5E5J)S<::ERQ[__ ()J?LI:Q^US\?\ _A!?!7[1$G[.?Q-\+Z(W
MCGP+XGL=+UVZU^^GT>]M[?5O^$7U30?$7A>\TK7]'M+V+4K=8=4ANKJT6]E@
M>**QNID_H[\0ZW_P7F_9E^)B^ ?".F^"?V[OAG)+X<N-&^)7BGPG\._A[?7=
MM<6^GG6]!NX]'^('A#4?#EU9WYO[ :WXLG\2Q2V[1ZV+TV[-IUA_&IX8\4^)
MO!/B#2?%G@SQ%KOA'Q3H-Y'J.A>)?#&KZAH'B#1=0ASY-]I.LZ5<6FHZ=>1;
MCY=S9W,,Z9.UQDU^K_A'_@NE_P %(?"ND)I%S\8/#OB_RI2T&I^+OAGX%O-7
MB@\J*-;1[W2M%T8WD2/&\XN-1CO-1>6>42WLD*P10^YXM>'/'O%>>T,QR;#>
M&W%F0++7@_\ 5GQ!R2U7*L9*=.4\?D^?Y1@HYVE6]FI5<//-,/1@YUU[+$<]
M#ZKX_AAQ[P5PUDM; 9MB?$#AC.WF"Q7^L/ ^;WIYEA(PFH8+-,DS3%RR=NES
MM4Z\,MKU9*%']Y1Y:RQ/]$/_  7VTKX7WW[ MWK'Q#LM"M_B5I_CKP(WPIE:
M[C36(?%5Q?&'Q-IVE7*M:WNJ:5_PAMQXGEU"P>.73I);?3M4N;-;VPTZXMOY
MC_V?_P#@H]KOPH_9!^,O[$WQ&^%FE_&/X-?%"VOY/#RR^*&\'>(/ASKFHW$6
MK/JVF7P\->*+/6H;#Q38:-XNTBPOM/MVL=>LKJ62]NK2^2TL_D[]H3]J'X^?
MM5^+;7QQ^T!\2]<^)'B+3[*33=+GU*'2],T[1]/ENIKV6RT70/#^GZ3H&CV\
MMU/)++'INF6HE;RQ)O$403P.N_PN\$\-PGX=X/@SC'$T.)*U'B./%5-X6MF&
M'PF2YI0J86K@8Y'BXU<+F-".#K87ZQ'$P^IU*U;%8M3HJE6J0J</B-XOXGB;
MCO%\6\*8>MP_2K9#+AJ:Q-+ XC$YMEM:GB*>,><X65/$X"L\52Q'L)8>?UN%
M*EAL+*%5U*-.4%.,G (&3@$Y('8$@ $XZG SZ#I2445^]GXH?I1^VA_P4<\0
M?M5_"7X&?L\^$/A9H_P-^ ?P'T+1K#PYX!L/%%]X^U/5-9T#1Y?#.BZSJWC#
M6=(TC4Y(-(\,N=.L+#[,]U+>7VMZKK>KZW/>Z?'HWYKT45XG#W#F2\*Y9#*,
MAP,<!@(5\5BO9*MB,35JXK&XBIBL7BL3B\96Q&,Q>)Q%>K.I5Q&*KUJTVU%S
MY8QC'V,]S_-^)<PGFF=XR6-QLZ.&PWM'2H8>G2PV$H0P^%P^'PN%I4,+A</0
MHTX0IT,/1I4HV<E#FE)O^M+_ (-G_B$EQX7_ &I?A5+;VT+Z/X@^'GQ L;KS
MY#>7X\2Z;K_AW4[8VQC$26VD_P#"(Z5*LZRF26767C:-5A1G_$'_ (*S>!8/
MA[_P42_:GT6"W>V35?B--XZ>.3SLO/\ $C2=,\?W%P//NKM]EU/XDDN8]LL<
M(251;VMG!Y=I#+_P2L_:UTO]C;]L?P)\2?%.U/A]XKL-1^%OQ(O @:?2?"?B
M^ZTR>/7H7>_L;>&'P_XGT?PWK>L27 O<^'K#6(K2REU&6RDA_67_ (.'O@WX
M=\8:E\&_VN/AMXCT/Q;I5QX=B^%WCW_A'/$&DZW;V$$-Y?\ B+P'XE^RZ4ES
M<):ZO'K&N:-?ZQ<7YTU'L?#%C!!#=7WF7O\ -=##5N _I2X[&XJE5IY%XK\,
M1HX#%VG'"4\^RVCEZJ86K5?/"6(G+*ZDH0FZ3Y\YPT*5U:$_Z!K8BEQI]&_"
M83#U:<\Y\-.(I5L;A?=EBJF2X^KC?9XFG3BH2C0A',J<9SBJON957G5:;YH?
MJ%_P5C_Y0_>-O^Q/^ 7_ *G7P]K\5?\ @A-_P4/D^!?Q/B_9/^*^N:E+\)_C
M'KME;_#.^OKVW?2?AM\3KY[I!8+%/&MY;Z%\3+N:QTN2.UNYK33O%\6E7D.C
MPKXD\4:W!^;/Q9_X*:?MO?'+X/WWP$^*7QL_X2CX3:C9Z!87OA3_ (5O\(]$
M\ZT\+W^G:GH47]N^'? 6D>)8_L-[I5A/YD6LQRW/D>7>/<0RS1R?!]>CP+]'
M^I@O"OB_PXXZKY1C7Q'Q+F6>X+&Y+4Q6*65SKX++*.6XVE/'8'+:L,PP6*P,
MZDZ5.#H5L/-X:I7J4<3B*1P<9>-]/%^)/"W'W!E'-,(LAX?R_)L9@\VAAL,\
MQA0Q>85<?@ZL,'C,?3G@<7AL9"G"I.:K4J\5B(4:=;#T*A_H _\ !;J..'_@
MF?\ 'R*%$BACG^%J11Q*J1QQK\5/!:HD:( JHJ@!54!0   !7X!?\$G?^'5'
M_"@O'7_#=G_"I/\ A:?_  N#6/\ A&/^$^_X2S^UO^%?_P#"%^!?[/\ LO\
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M'_\ 3/#7XR5^S?\ P04_Y2)^!_\ LGWQ'_\ 3/#7YIXR_P#)J/$3_LD,]_\
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M+KNOZ_X=?>=/17,?\)MX,_Z&[PQ_X/\ 2O\ Y+H_X3;P9_T-WAC_ ,'^E?\
MR71[&K_SZJ?^ 2_R"Z[K^O\ AU]YT]%<Q_PFW@S_ *&[PQ_X/]*_^2Z/^$V\
M&?\ 0W>&/_!_I7_R71[&K_SZJ?\ @$O\@NNZ_K_AU]YT]%<Q_P )MX,_Z&[P
MQ_X/]*_^2Z/^$V\&?]#=X8_\'^E?_)='L:O_ #ZJ?^ 2_P @NNZ_K_AU]YT]
M%<Q_PFW@S_H;O#'_ (/]*_\ DNC_ (3;P9_T-WAC_P '^E?_ "71[&K_ ,^J
MG_@$O\@NNZ_K_AU]YT]%<Q_PFW@S_H;O#'_@_P!*_P#DNC_A-O!G_0W>&/\
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M,?\ ";>#/^AN\,?^#_2O_DNC_A-O!G_0W>&/_!_I7_R71[&K_P ^JG_@$O\
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MUG_X$P?_ !=']HZ?_P _UG_X$P?_ !='MJ7_ #]I_P#@<?\ ,/JV)_Z!Z_\
MX*J?_(^:^\N453_M'3_^?ZS_ / F#_XNC^T=/_Y_K/\ \"8/_BZ/;4O^?M/_
M ,#C_F'U;$_] ]?_ ,%5/_D?-?>7**I_VCI__/\ 6?\ X$P?_%T?VCI__/\
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M^1\U]Y<HJG_:.G_\_P!9_P#@3!_\71_:.G_\_P!9_P#@3!_\71[:E_S]I_\
M@<?\P^K8G_H'K_\ @JI_\CYK[RY15/\ M'3_ /G^L_\ P)@_^+H_M'3_ /G^
ML_\ P)@_^+H]M2_Y^T__  ./^8?5L3_T#U__  54_P#D?-?>7**I_P!HZ?\
M\_UG_P"!,'_Q=']HZ?\ \_UG_P"!,'_Q='MJ7_/VG_X''_,/JV)_Z!Z__@JI
M_P#(^:^\N453_M'3_P#G^L__  )@_P#BZ/[1T_\ Y_K/_P "8/\ XNCVU+_G
M[3_\#C_F'U;$_P#0/7_\%5/_ )'S7WERBJ?]HZ?_ ,_UG_X$P?\ Q=']HZ?_
M ,_UG_X$P?\ Q='MJ7_/VG_X''_,/JV)_P"@>O\ ^"JG_P CYK[RY15/^T=/
M_P"?ZS_\"8/_ (NC^T=/_P"?ZS_\"8/_ (NCVU+_ )^T_P#P./\ F'U;$_\
M0/7_ /!53_Y'S7WEROV;_P"""G_*1/P/_P!D^^(__IGAK\6/[1T__G^L_P#P
M)@_^+K]G_P#@@A>6DW_!17P.D5U;2O\ \*]^)!V1SQ.V!H\.3M5B<#N<<5^:
M^,E6F_"CQ#2J0;?"&>))3BVW]0K:))GZ#X3X>O'Q,X$E*A6C%<4Y,VW3FDDL
M;1NVW&R7FS^]6BBBO\53_7$_F9_X*1_";0?VKO\ @L[^QI^QE\9O$?Q.U;]F
M'XR_LH>/O$OQ0^#'AWXK_$7P5X$\:^(/AGJ7Q>\6^!];U_P]X2\2:1I>H:OX
M?U[3K"]M-3GM'OC]BLX)+AX+.UCA^B/^(;'_ ()$_P#1OGB[_P /K\:?_FXK
MA_VE/^5CO_@G-_V9K\>?_3;\:Z_H6K[[-,]SK*,!POA\JS;,<MH5N'*&)JT<
M#C*^%IU<1+,\TI2KU(4:D(SJRIT:--U))S<*4(-\L4ERTZ=.I*NYPA-JLTG*
M*DTE"F[*Z>EVW;;5]V?A#_Q#8_\ !(G_ *-\\7?^'U^-/_S<4?\ $-C_ ,$B
M?^C?/%W_ (?7XT__ #<5^[U%>-_KEQ;_ -%-GW_AUQO_ ,N\OS[LT^KT/^?-
M+_P"/^7E^?=GX0_\0V/_  2)_P"C?/%W_A]?C3_\W%'_ !#8_P#!(G_HWSQ=
M_P"'U^-/_P W%?N]11_KEQ;_ -%-GW_AUQO_ ,N\OS[L/J]#_GS2_P# (_Y>
M7Y]V?A#_ ,0V/_!(G_HWSQ=_X?7XT_\ S<4?\0V/_!(G_HWSQ=_X?7XT_P#S
M<5^[U%'^N7%O_139]_X=<;_\N\OS[L/J]#_GS2_\ C_EY?GW9^$/_$-C_P $
MB?\ HWSQ=_X?7XT__-Q1_P 0V/\ P2)_Z-\\7?\ A]?C3_\ -Q7[O44?ZY<6
M_P#139]_X=<;_P#+O+\^[#ZO0_Y\TO\ P"/^7E^?=GX0_P#$-C_P2)_Z-\\7
M?^'U^-/_ ,W%'_$-C_P2)_Z-\\7?^'U^-/\ \W%?N]11_KEQ;_T4V??^'7&_
M_+O+\^[#ZO0_Y\TO_ (_Y>7Y]V?A#_Q#8_\ !(G_ *-\\7?^'U^-/_S<4?\
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M #<5^[U%'^N7%O\ T4V??^'7&_\ R[R_/NP^KT/^?-+_ , C_EY?GW9^$/\
MQ#8_\$B?^C?/%W_A]?C3_P#-Q1_Q#8_\$B?^C?/%W_A]?C3_ /-Q7[O44?ZY
M<6_]%-GW_AUQO_R[R_/NP^KT/^?-+_P"/^7E^?=GX0_\0V/_  2)_P"C?/%W
M_A]?C3_\W%'_ !#8_P#!(G_HWSQ=_P"'U^-/_P W%?N]11_KEQ;_ -%-GW_A
MUQO_ ,N\OS[L/J]#_GS2_P# (_Y>7Y]V?A#_ ,0V/_!(G_HWSQ=_X?7XT_\
MS<4?\0V/_!(G_HWSQ=_X?7XT_P#S<5^[U%'^N7%O_139]_X=<;_\N\OS[L/J
M]#_GS2_\ C_EY?GW9^$/_$-C_P $B?\ HWSQ=_X?7XT__-Q1_P 0V/\ P2)_
MZ-\\7?\ A]?C3_\ -Q7[O44?ZY<6_P#139]_X=<;_P#+O+\^[#ZO0_Y\TO\
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M C_EY?GW9^$/_$-C_P $B?\ HWSQ=_X?7XT__-Q1_P 0V/\ P2)_Z-\\7?\
MA]?C3_\ -Q7[O44?ZY<6_P#139]_X=<;_P#+O+\^[#ZO0_Y\TO\ P"/^7E^?
M=GX0_P#$-C_P2)_Z-\\7?^'U^-/_ ,W%'_$-C_P2)_Z-\\7?^'U^-/\ \W%?
MN]11_KEQ;_T4V??^'7&__+O+\^[#ZO0_Y\TO_ (_Y>7Y]V?A#_Q#8_\ !(G_
M *-\\7?^'U^-/_S<4?\ $-C_ ,$B?^C?/%W_ (?7XT__ #<5^[U%'^N7%O\
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MXW_Y=Y?GW9K]7H?\^:7_ (!'_+R_/NS\(?\ B&Q_X)$_]&^>+O\ P^OQI_\
MFXH_XAL?^"1/_1OGB[_P^OQI_P#FXK]WJ*/]<N+?^BFS[_PZXW_Y=Y?GW8?5
MZ'_/FE_X!'_+R_/NS\(?^(;'_@D3_P!&^>+O_#Z_&G_YN*/^(;'_ ()$_P#1
MOGB[_P /K\:?_FXK]WJ*/]<N+?\ HIL^_P##KC?_ )=Y?GW8?5Z'_/FE_P"
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M=ZBC_7+BW_HIL^_\.N-_^7>7Y]V'U>A_SYI?^ 1_R\OS[L_"'_B&Q_X)$_\
M1OGB[_P^OQI_^;BC_B&Q_P""1/\ T;YXN_\ #Z_&G_YN*_=ZBC_7+BW_ **;
M/O\ PZXW_P"7>7Y]V'U>A_SYI?\ @$?\O+\^[/PA_P"(;'_@D3_T;YXN_P##
MZ_&G_P";BC_B&Q_X)$_]&^>+O_#Z_&G_ .;BOW>HH_URXM_Z*;/O_#KC?_EW
ME^?=A]7H?\^:7_@$?\O+\^[/PA_XAL?^"1/_ $;YXN_\/K\:?_FXH_XAL?\
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M7>7Y]V'U>A_SYI?^ 1_R\OS[L_"'_B&Q_P""1/\ T;YXN_\ #Z_&G_YN*/\
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MXAL?^"1/_1OGB[_P^OQI_P#FXH_XAL?^"1/_ $;YXN_\/K\:?_FXK]WJ*/\
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M+O\ P^OQI_\ FXK]WJ*/]<N+?^BFS[_PZXW_ .7>7Y]V'U>A_P ^:7_@$?\
M+R_/NS\(?^(;'_@D3_T;YXN_\/K\:?\ YN*/^(;'_@D3_P!&^>+O_#Z_&G_Y
MN*_=ZBC_ %RXM_Z*;/O_  ZXW_Y=Y?GW8?5Z'_/FE_X!'_+R_/NS\(?^(;'_
M ()$_P#1OGB[_P /K\:?_FXK\RO^"N/_  2V_9(_X)D?L9>)_P!JW]AK3/B]
M^SU\?_#OC3P1X4T;XE>!OV@_C7I_B"QT#Q=J4MAXBTV&Y3QQN6WU2TC2"Y4?
M>10*_L3K^?[_ (.9/^45?Q!_[*K\)?\ T^W->_PKQ/Q'CN)<BP>-S[-\7A,5
MFF"H8G"XG,,57P^(HU*\(U*5:C5JRIU:<XWC.$XN,DVFG=F=:C2C1J2C3A&4
M82<91C%--*Z::5TTTG=:_>S][M$D>71M(EE=Y)9-,L))))&+R2.]I$SN[L2S
M.S$LS,268DDDFM.LG0/^0%HO_8)T[_TCAK6K\\EN_5_F=*V7HC^>G]I3_E8[
M_P""<W_9FOQY_P#3;\:Z_H6K^>G]I3_E8[_X)S?]F:_'G_TV_&NOZ%J^HXE_
MW;A/_LEL-_ZMLY,:/Q8C_K_+_P!-TPK^=#]@K_@I7^U#^T-_P6__ ."E?["/
MQ&U;P;/^S]^RQX.O=6^%>EZ/X0LM+\3QWY\5_##3(IO$/B99YKS6!;V7B76(
M8HA':Q,;E9+A)Y;>W>/^B^OXT_\ @DQ_RM$?\%NO^R>W7_J=_!*OEC<_LLHK
M^(OXJ_$;_@I+^TC_ ,''7_!1O_@G=^S1^V=\7O@+\,/$?P0^!.NZKXN?Q?XP
M\;^'?V8?AAHOP-_99\5_$'Q-\ _@UJ6KIX%\._%#XG>-O%FE^"CXOTZ?PA>Z
M%'\1?%WBFWU2Y\17$"W'#_\ !2_]A7_@I3_P1)^$*_\ !2W]DW_@K3^UU^T3
MX;^#OC;X:R_M _!K]K7XA>)OB!X9\8Z/XT\9:)X+BUO4]+O_ !C/H'C32M7\
M?^*=(\.ZKX;F\.V'C31="\8:EXB\.?$:PU719[ZY /[K*_A^_P"";?CW_@L+
M_P %YO%GQ/\ V\O"/_!2Z_\ V'?V7/AK^U+=?"KP/^S/\,OAG8>(KR3PYX(T
MOX<^-;[P_KTLEYH.G:N^K_#KXK.=1\9>,=:^(-UJGQ"MI8X?".@>$M.\)0>&
M_P"C#X]?!_7_ /@K?^PI^S#XQ^#/[6?[3?["5K\6M(^"W[56D?$']F;QWK7@
MGXEWWA#QY\'M8U2P^&'B+7M'OO"]]?>%KF/XDZ7K>KV,ZV\-UK_A#0;R338I
MK2(6_P#(5_P:L?\ !.;XF_M+_LUW?[3?AG_@H?\ MI_LW^#?A#^WA<6'B#]F
M;X%?%'Q!X0^"?Q=_X0#P%^SQ\0-5O?B!X;T_7;/2M4O_ !]I6O6_@#Q7<7NC
M:C]N\):%I%A<I=VULEJH!_HC45_+%^U?^T+\??#G_!V!_P $R?V<_#WQQ^,&
MA?L^>/?V(/'WBSQU\"=&^)?C32_@UXT\56?@W_@H-=6?B;Q9\,+'6H/!/B/Q
M!:W/@OP=<6VLZQH=YJ,$_A/PS-%<K)H.EM:_M]_P4V\6>*O 7_!-O_@H-XZ\
M"^)O$'@OQMX+_8@_:O\ %G@[QCX3UG4?#GBKPGXJ\.? ;Q]K'A[Q-X9\0Z/<
MV>KZ#X@T+5[.SU31M9TN\M=1TO4;6VOK&Y@N8(I5 /M^BOYI/^"37[:_QG\"
M?\&T/AG]NOXH>(OB!^TO\9OA1\ /VX?C#?ZS\5?&GBOQYXP^(&I_"'XX_M&S
M^%].\9>-_$.I:OXJN=!T[2O"NB:'>ZE-?WEQX=\%Z5LTZ$VVDVEFOYW_ /!-
MS_@G)^UG_P %??V6_"?_  4A_:4_X+/?MU^$?BW\?M8\5ZQX8\%_LG?%EOA?
M\+_@Q8^!O%&L>"-%\+KX0T":'0M-UK3]1\,MXAU/2O"&E^ X[.XU-UO7U;Q+
M<:KXQU8 _MKK\@/V$?!?_!7S0/VT_P!O/7/VZ/BE\)?%_P"QGK?CF^D_8M\*
M^$-)\)6WB/1_#4OB>^F\-W=N_A_0=.\3:+I=E\.5T?0_&^A?$G7?%.JW7C^W
MDU3PMJ$NFG6?$/BOG_\ @CK\+_\ @JQ^S[X5^.7[/7_!2CQ]H?[0'A'X8>-[
M33/V3OVGY/$]IK_Q3^+?PU6;6[?5)_BW'/K>I^)8;Q;>'PIJ_ABX\7RZ_P"-
MUN]6\;:+XK\6:Q9:'X0O]2^"O^",?[0?Q[^*7_!8K_@O1\,?B;\;_B]\1?AK
M\'OC;X8TGX2?#WQW\2O&?B[P/\+=+N/B)\9;&?3?ASX3\0:UJ&@>"-/GLM+T
MRTFL_#.GZ9;R6NG6-N\;16END8!_4I17\@?QV^+G_!0#_@M9_P %,_VA?V&O
MV,?VLOB/^P9^PI_P3Y\3Z?X3_:7^/?P:;5?#_P :OBC\<['4]:T76/ GA;QI
MX4\1:+K=M!::QH?BOPQIF@V_BSP]X<TFST+7/'GQ$T#QWJH\!>";/RK]L7]C
MO_@I;_P0@^&$/_!0C]DO_@HY^U)^VU\'?@]KWA"Z_:A_91_:W\1Z[\1="\3_
M  XUS4-,\->(_&?AF[?6-930&L=8O=)&J7WA[PSI7BCPAX9E;Q7J'C/5_#_@
M[6=*U8 _M1HK^</_ (+)_MQZY\2/^#=#XK?MX?LF_$7XH_!/5_BA\+OV1_BA
M\.O&7@?QEJ_P^^*_@"V^)'[2'P"LO$'AIO%O@/6[74-&\0:?IFO:_P" _&">
M']=EL+Q3KNDI>ZAI%W(US\:?LY_\$P_^"@7_  53_9(^ W[5W[2__!6O]LK]
MG2X^+/P(^%OB/X(_ S]G?QEXBTCP;X$\''P/H-EX)\=_%?77\0>&]=^.7Q(^
M)GAV)OB3XS\1:O%H6M0:[XZU#3-.\67^BVD!N0#^P>BOY/\ _@A+^U1^V[\*
M/V^_V\_^"+G[?'QQU;]J+X@_LK>&-#^,_P '/CQXFU'5->\::U\+M2D^'GVB
MV\5>)]8O-9UG6HO$?AOXS_!WQGHVE^*-=U?Q5X(UC4_''AB^\2^*]-ATH>'/
MZP* "BOYNO\ @Y&_;T_:7_9'^"?[*OP/_95\?Z?\!OB)^W%^T/8_ ;6?VF]:
MAM/[,^"/@6Z@TW3O$.H6FJW]M<6OA'Q#J]QXLTN\A\<HDFK^$O"7AOQMJ?A<
M:9XM70?%?AGYH^+/_! ']O\ ^"WPFUWXN?L5_P#!:3_@H9X\_;4\'VW_  E/
MA[1_CE\<-4NO@S\8-7L[IM3U?P=K?AS7=5UZQTZ;Q2T<3:3)\1-5\<^#I-?M
M[.W\86\.E7]QXBT  _I _;.TG]J+7/V5OCKI/[%7BGPAX*_:KOOA]K$7P.\4
M>.].T_5/#&D>-P(GM)[RRUC3=9T)KV6T2\MM"G\1:-K'AJRUZ?3+WQ)I&J:'
M;ZA8W'F__!-O0?VV_#/[%?P/T7_@HIXJ\*^,OVO[/1]>7XKZWX0BT(:>XD\6
MZ_+X-LM2O?"UGI?A;5_$^G>!'\-67BO5?#>DV&BW7B&'45LGUE(CXCUGY,_;
M%^*'[7GA;_@AA^TG\5_CB!\!/VTO#'[#?Q0\0>/;SX)^,+G2E\!_%_0?!&KB
MX\0_#?QAX2\2:G?:*&O[2+7]!N]'\475_HHNX;==2^UVCLORI_P3R^$_QX_X
M*3?\$!_V.- \2?MP?M7_  5^,OCS1KOQ7XE_:G^&_P 5_&4G[0NJMX6^,OQ%
M@_LO4OB1?^)(O%6IV6K:9:V.C:B+_6[@OI-C:V.UK>"&., ^YO\ @E]_P5+\
M/?\ !32Z_:W3PW\'-9^$UG^RK\?]6^ UQ<:YXRL?%5UXWOM)DU42^(X;2P\/
M:-%X>M)8M/@>/3GO=9F$ES-$UT%M4FNOU<K_ #K_ /@WC_X)H?%G]H3QM^VK
MXO\ #'_!2;]MW]GZS_9R_;G?PWXH\)?![XH>)?#GAS]HB\\*ZO=ZG>>)/C18
MZ?XFTZ+Q/K/BF+39=,U^XU&/4);NPU&^AEFE69E/](/_  7,_;^_:K^".L_L
ME?\ !/[_ ()W?V/9?MW_ /!0#QOKGAWP-X_\1VVAW7A[X+_"_P $Q6%QXW\>
M7@UZ/5+*UUF[&H[]+O[CPCXQMM.\(^%_B5J5IH[>+['P9!? ']!]%?R:'_@W
M9_;M\">"[;QM\&/^"]G[?MC^U58://J5YK_Q&\=^._%GP4\9^+GTFUNKO1M;
M\)77Q"O==LO"^O>+8;J:YU?Q!=_$F?2M.NK#4)O"'B;5M$,>K_H7_P $(_\
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MX56>O7Z:_)X7\.Z_=^-/ABEG?67P[\1:3IOAN^U3QC8_L_\ \$4O^"@?C/\
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M>"_^"6/C_P #VMS@2^)?!OA/]FWQKX#\1^(=."[@]AI'B_\ XD%VTACD6_\
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MACA_X,/^WO\ TJ04445\L;!1110 4444 %%%% !1110 4444 %%%% !1110
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M%'Q ^ -_\)1/XON;Z74/$FA7/PH^,,=[9:A>65M-X@MK[2M<F6&1O*/])_\
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ME'_P3H^(/P7_ &?/$GA?]FFX_:M_:,_:,^,?PWNOBAJV@^%'\8:-X.T'P?\
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MK_Q/^&5SJOAZROKQM2?2+C0O@EX):%WL4BATNYT"7^T+W^T(DMP#^ORBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YY_\ @@)]_P#X*F_]
MI//V@?\ TG\.U_0Q7\\__! 3[_\ P5-_[2>?M _^D_AVOZ&*^IXU_P"2FS+T
MP/\ ZKL(8X?^##_M[_TJ04445\L;!1110 4444 %%%% !1110 4444 %%%%
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M?LE>%['XI_\ !0;]L;Q]IGPQ_9?^&DT5GJMEI!&H6;^+?BKX\TF6>-[?X?\
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M,G_**OX@_P#95?A+_P"GVYKZ?@K_ )*[AO\ ['.7_P#J1 QQ'\"M_P!>Y_\
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MH_;F_P"[9O\ UL/]GVOH#X-_\$I/^%2?\%DOVL?^"MG_  OK_A(/^&H/V?\
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MZ+[1]F@ /Y\/^#4;_G+U_P!I$O&G_NP5\G?\' ?P:UWQ5_P< _\ !)[4-?\
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MXJTJ[T+Q)X<UW3+I)+74='US1K^]TS4["YC>"[LKJ>WF1HY&4_RQ:7_P;O\
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M3XK\4^([^'4? 5WXD\<VME82VOB>71;S3+GQ%K=O?V\$DLS+'=M:0_A_>?\
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MRV=]"\-P;:W,T;+(8(BVQ?PR_P"#CO\ ;N\3_LF_L,)\!_@?<3W?[7'_  4
M\4+^RG^SYH&E7]M8^(X[;QJVGZ%\3_&6DRW-[I9M)](\/^)=+\#:-KMIJEE>
M^%_B!\3_  %XB206NG7<D7;?\&Z'[4^K?M)?\$N_@OX5\>W<Z_&[]DR[UW]D
M+XT:'J$M@^L:%XA^!]TOAWPA#J8M)Y+B>[N_A>? ]QJ.I:C%%=ZAKW]MF2XU
M22"35K[TKXB?\$GKCXT_\%;?AA_P4W^-/[0/_"=^#?V>OAA_P@O[-O[+4/PR
MU+0-*^%WB>XL)?[3^).I_$BV^+-Y8>-O$-_KNO>-M5>*Y^%6BYLK_P $:3=7
MMZWPXTC4;\ ^@?\ @EE^PQX8_P""<W[#'P(_97T P7>L^#/"\>K_ !)U^%;F
M,>*_BOXJ;^W?B%XB\JZU?7#;07GB*[NX-/LX-3N+*QTJUL+*RV6MO%&OWSJ>
MJZ9HMC/J>LZC8:3IMKY?VG4-3O+>PL;?SI8[>+S[NZDB@B\V>6*&/S)%WRR1
MQKEW53?K\>?^"U/_  2BF_X*\_LR^"_V?;3]H7Q#^SQ=^#?BYH'Q*&O6?AN^
M\>>%?$-E9:3K6@:CH_BCP!;^,_ UKKMU9VNN-K/AC4KG6DETC5;"2SA\BUUR
M_N[< _8;KTK^.[X^7!_X+5_\' O@+]F73+G^W?V(/^".1'Q$^-IM+W=H7C[]
MJV\U6V(\,WW]G>)-$U&?_A&/%?A[2O JV]WI>K?V#J7PK^,NGR*^B^/!Y_\
M4CX+^#OC#X7?LM>%O@!\//B_X@NO'_P]^ FC_"'P-\>_BUI:_%/Q3-XP\+?#
MZW\'>&?BY\2]$?5_"R?$;76UJQLO&/C#26U[PXOBZ_\ [0LVU?2!J!O;?XC_
M ."1'_!++PM_P2H_9]\7_"J+XJZC\?\ XJ_%/XH^)_BS\9?CUK?AK5/!^M_$
MCQ-K<_DZ5+?>'-4\?_$J33VT31(K:QFFC\4W;:UJKZKXCNTBO]9NHU /U;
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MHH **** "BBB@ K\6?\ @XE_Y0M_M[_]DQ\*_P#JVOA[7[35\6?\%$_V0/\
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M .:&C_4CB[_HG<U_\)*G^0?6:'_/ZG_X$OZZ_GV9_0M17\]/_$35_P $U_\
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M3_(/K-#_ )_4_P#P)?UU_/LS^A:BOYZ?^(FK_@FO_P ^/[37_AC+S_YH:/\
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MR#ZS0_Y_4_\ P)?UU_/LS^A:BOYZ?^(FK_@FO_SX_M-?^&,O/_FAH_XB:O\
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MT+45_/3_ ,1-7_!-?_GQ_::_\,9>?_-#1_Q$U?\ !-?_ )\?VFO_  QEY_\
M-#1_J1Q=_P!$[FO_ (25/\@^LT/^?U/_ ,"7]=?S[,_H6HK^>G_B)J_X)K_\
M^/[37_AC+S_YH:/^(FK_ ()K_P#/C^TU_P"&,O/_ )H:/]2.+O\ HG<U_P#"
M2I_D'UFA_P _J?\ X$OZZ_GV9_0M17\]/_$35_P37_Y\?VFO_#&7G_S0T?\
M$35_P37_ .?']IK_ ,,9>?\ S0T?ZD<7?]$[FO\ X25/\@^LT/\ G]3_ / E
M_77\^S/Z%J*_GI_XB:O^":__ #X_M-?^&,O/_FAH_P"(FK_@FO\ \^/[37_A
MC+S_ .:&C_4CB[_HG<U_\)*G^0?6:'_/ZG_X$OZZ_GV9_0M17\]/_$35_P $
MU_\ GQ_::_\ #&7G_P T-'_$35_P37_Y\?VFO_#&7G_S0T?ZD<7?]$[FO_A)
M4_R#ZS0_Y_4__ E_77\^S/Z%J*_GI_XB:O\ @FO_ ,^/[37_ (8R\_\ FAH_
MXB:O^":__/C^TU_X8R\_^:&C_4CB[_HG<U_\)*G^0?6:'_/ZG_X$OZZ_GV9_
M0M17\]/_ !$U?\$U_P#GQ_::_P##&7G_ ,T-'_$35_P37_Y\?VFO_#&7G_S0
MT?ZD<7?]$[FO_A)4_P @^LT/^?U/_P "7]=?S[,_H6HK^>G_ (B:O^":_P#S
MX_M-?^&,O/\ YH:/^(FK_@FO_P ^/[37_AC+S_YH:/\ 4CB[_HG<U_\ "2I_
MD'UFA_S^I_\ @2_KK^?9G]"U%?ST_P#$35_P37_Y\?VFO_#&7G_S0T?\1-7_
M  37_P"?']IK_P ,9>?_ #0T?ZD<7?\ 1.YK_P"$E3_(/K-#_G]3_P# E_77
M\^S#_@@9_P A7_@J_P#]I1/VA/\ T9IE?T+5_#Q_P2F_X+6?L9_LFWW[>5Q\
M5;7XUR1_'[]N#XM_'3P'_P (G\,+CQ"R>"/&#V3:0FOB/5[;^R-=40/]LTEC
M.UM\N9WSQ^N/_$35_P $U_\ GQ_::_\ #&7G_P T-?1\6<(\3XOB#'XC#9'F
M5>A46$Y*M/#3E"7)@<-"5I)6?+.,HOLXM=#*AB*,:44ZL$US73:3^)_YH_H6
MHK^>G_B)J_X)K_\ /C^TU_X8R\_^:&C_ (B:O^":_P#SX_M-?^&,O/\ YH:^
M<_U(XN_Z)W-?_"2I_D:_6:'_ #^I_P#@2_KK^?9G]"U%?ST_\1-7_!-?_GQ_
M::_\,9>?_-#1_P 1-7_!-?\ Y\?VFO\ PQEY_P#-#1_J1Q=_T3N:_P#A)4_R
M#ZS0_P"?U/\ \"7]=?S[,_H6HK^>G_B)J_X)K_\ /C^TU_X8R\_^:&C_ (B:
MO^":_P#SX_M-?^&,O/\ YH:/]2.+O^B=S7_PDJ?Y!]9H?\_J?_@2_KK^?9G]
M"U%?ST_\1-7_  37_P"?']IK_P ,9>?_ #0T?\1-7_!-?_GQ_::_\,9>?_-#
M1_J1Q=_T3N:_^$E3_(/K-#_G]3_\"7]=?S[,_H6HK^>G_B)J_P"":_\ SX_M
M-?\ AC+S_P":&C_B)J_X)K_\^/[37_AC+S_YH:/]2.+O^B=S7_PDJ?Y!]9H?
M\_J?_@2_KK^?9G]"U%?ST_\ $35_P37_ .?']IK_ ,,9>?\ S0T?\1-7_!-?
M_GQ_::_\,9>?_-#1_J1Q=_T3N:_^$E3_ "#ZS0_Y_4__  )?UU_/LS^A:BOY
MZ?\ B)J_X)K_ //C^TU_X8R\_P#FAH_XB:O^":__ #X_M-?^&,O/_FAH_P!2
M.+O^B=S7_P )*G^0?6:'_/ZG_P"!+^NOY]F?T+45_/3_ ,1-7_!-?_GQ_::_
M\,9>?_-#1_Q$U?\ !-?_ )\?VFO_  QEY_\ -#1_J1Q=_P!$[FO_ (25/\@^
MLT/^?U/_ ,"7]=?S[,_H6HK^>G_B)J_X)K_\^/[37_AC+S_YH:/^(FK_ ()K
M_P#/C^TU_P"&,O/_ )H:/]2.+O\ HG<U_P#"2I_D'UFA_P _J?\ X$OZZ_GV
M9_0M17\]/_$35_P37_Y\?VFO_#&7G_S0T?\ $35_P37_ .?']IK_ ,,9>?\
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M2I_D'UFA_P _J?\ X$OZZ_GV9_0M17\]/_$35_P37_Y\?VFO_#&7G_S0T?\
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MTTW6#I&JPW%F]_8VVJ:A%:SO$S0"[F,>UF##VM55%55 55 55 P%4#  '8
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M?_"2I_D'UFA_S^I_^!+^NOY]F?T+45_/3_Q$U?\ !-?_ )\?VFO_  QEY_\
M-#1_Q$U?\$U_^?']IK_PQEY_\T-'^I'%W_1.YK_X25/\@^LT/^?U/_P)?UU_
M/LS^A:BOYZ?^(FK_ ()K_P#/C^TU_P"&,O/_ )H:/^(FK_@FO_SX_M-?^&,O
M/_FAH_U(XN_Z)W-?_"2I_D'UFA_S^I_^!+^NOY]F?T+45_/3_P 1-7_!-?\
MY\?VFO\ PQEY_P#-#1_Q$U?\$U_^?']IK_PQEY_\T-'^I'%W_1.YK_X25/\
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MS^A:BOYZ?^(FK_@FO_SX_M-?^&,O/_FAH_XB:O\ @FO_ ,^/[37_ (8R\_\
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M?_-#1_J1Q=_T3N:_^$E3_(/K-#_G]3_\"7]=?S[,_H6HK^>G_B)J_P"":_\
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M .:&C_4CB[_HG<U_\)*G^0?6:'_/ZG_X$OZZ_GV9_0M17\]/_$35_P $U_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\
M]/\ P0,_Y"O_  5?_P"THG[0G_HS3*_H6K^>G_@@9_R%?^"K_P#VE$_:$_\
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M>TO+/4KGP78QZY/I^@_%_P )P^,_M7?"6Y_X(W6FO_MO^./VC?CS_P %-_\
M@L5^U!X4E_8H_80_X65X+\.R0Z/<^)=>;Q*NC?#+X)>!K5[+1M'\,ZKJ\_B;
MQ?JAU>\M[^>^L?!>@67A.+XB>*G\1_<7_!/OPK^Q1_P11^ >E?#K]M/]M#]F
MGPC^W+^T_P"*+CX^_M=?$KXP_&WP1X9\??%KXW_$6YN=5UR_:Z\=>(;#Q3J'
MPY\%WE[>>'M"\2WUCHGAN_O3KGCW4=-\/^)OB!XCAN #]M4^#7PS;X-#]GS4
M?"=CXB^#DGPS/P=U#P+XMGO_ !AIFN_#63PN?!=YX3\37'BF[U?4_%%AJGAA
MI-(UF7Q%?ZG?:U;SW+ZM=7D]S/+)_-!_P;A_%7Q?^SU\1?V^_P#@B_\ %O7?
M%6M^)?V"?CMXQU_X WOB=O#UP]U^R]XWUZ-_#,-E?Z.UI=7<,FJ7UK\1EBU'
M2()=,M/BW8:1%)86FGVGAK0?ZI+.\M-1M+6_T^ZMKZPOK>&[LKVSGBN;2\M+
MF-9K>ZM;F!GAN+>>%TEAFB=XY8W5T9E8$_R'065M\%/^#QS4;O2C=";]KK]@
M6*?Q((;NZGB:X\->#-$TZ 74+36,5E;?9/V:="*VD::S;/>+;WQ@BO+I[C2P
M#^OJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YY_^" GW
M_P#@J;_VD\_:!_\ 2?P[7]#%?SS_ /! 3[__  5-_P"TGG[0/_I/X=K^ABOJ
M>-?^2FS+TP/_ *KL(8X?^##_ +>_]*D%%%%?+&P4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7B'[2_Q/\ &'P4_9X^-_Q=^'GPO\3?&SQ_\-OA
M9XY\:>!_A!X.L-4U/Q/\3?&'A[P[J&I>&? VCV6AZ=K&M377B76H++22=(T?
M6-4BBNI9]/TC4[N.&QN/;Z* /XN_V7_^"*O[8G_!73X=3?MB_P#!9O\ :\_;
MB^"?Q ^*GB'Q!KGPT_8^^#7B&W^!FF? 'P5;ZWJ5EH-AKW@3XC^"?'=KX:U'
M4;/[1=Z5X<3PW:>*]/\ #-UHMWXY\5ZQXNU'7=.TK6_9/MOVG?\ @B9_P63_
M &??^"9VO?M7_%W]J3]@;]MKP'XXUKX$:1\:4UKQQXY^"'B3P]:>*]4TC1+?
M7+6S-I8/:WOA.32?$;^!K31/ 6J6OC.#QMK_ (!\'7$,^IVG[[?\%-?VD/\
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M#/\ P0Q_X) 65M\*OV(/#7Q'"_#SX+?%;XE_"^WM_"UW^TGJ>K^,;_3M F\
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M,@MOAC>ZC\.[4)YEY?-]F6V\,1"T FBC%J(A'9Z?&%L;?]A: "BBB@ HHHH
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M\0:=>0_MXZS_ ,$\]$_X+Y_\$5_@/_P3[^'7[/7@O1O@K^T+X9B^-&I_LT^
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M/&O_ "4V9>F!_P#5=A#'#_P8?]O?^E2"BBBOEC8**** "BBB@ HHHH ****
M"BBB@ HHHH **** /R@_X+)?\%!_C+_P3&_9";]JWX2_LSP_M.:9X:^(?AOP
M]\5-$E\;ZAX)3X=^ ?$5AKEO'\1[VZT_PCXLFO-(M/&,/A7PK?J(+<V4_BNP
MO)=]E'>7%E[Y\#O^"EO[ _[1/PET3XU_"W]KK]GW5_ FL:/;:M>76I?%?P3X
M=U?PE)-HUCKUYH?CWPYK^MZ=KO@3Q/HNFZC:7&O>&O%FGZ3K6BI-&VHV=NDD
M;M]FZ_H&A>*]"UKPMXIT72?$OAGQ+I.I:!XB\.Z_IMGK&A:_H6L6<VG:OHNM
M:1J,-SI^JZ3JNGW-Q8ZEIM];SV=]9SS6MU#+!*Z-^#?CW_@V"_X(E_$+QQ?>
M.]1_8ZC\/76JWXU+5?#?@/XQ?'#P+X'NKEKI[BXCLO"/ACXB:;H_ABPN49;1
MM*\&P>'-+M+:-?[,L[&X,EPX!^6'[+GQ1^'_ .W!_P '5OC_ /:A_83U#0_B
M!^SW\)?V1+?P%^U+\;_!#QIX,^('BJ]\+7GACPTR:S=6EI_PEUS)K.E?#_PO
MHE[I+7UOJVE?".\U72-2O?#NB^<WO_\ P4._X(P_\%8?VA/^"K-S_P %'OV3
MOVW_ -GWX2GX>^%?"W@W]F71_BSX/NOB)J_P8T%?AA8^&/B#;:5X5\4_![XB
M_#RWNO%'C?5_B1XG@U=;/4=9MXO%BR17]C<V]O;V/](G[,_[)W[-W[&WPULO
MA!^R]\&O WP5^'EC/->?V!X+TH6CZEJ%Q++--JGB#6;J2[U_Q/J\C2M&=7\1
MZIJNI_9UBM1="V@@AC^AJ /\_P!_X+5?LL_\'#'PY_X)E_M,^,OVX?\ @IK^
MSI^T%^RYHT7P@/Q1^$/@7X%_#?P=XJ\7KJ'Q[^%NE^#1I7B/0?V9_A_JVFG0
MOB#>^$_$MZ;3Q=I'VO3M&N[&<WUM<S:;>?N9_P &\?PA_P""G/@;]EWX!^-/
MVMOVKOA7\:_V2O'/[%_[-M_^R;\'_"/@'PQX6\9?!/PO=^ ?"NJ>$-"\6:_H
MWPB\&ZKXKN-+^'5WI/AJ_OM:\<^+[A]3TIKQY]2N+V?5C^W'[4/[+WP+_;/^
M!7CK]FG]I7P-_P +)^"?Q*7PVOC;P5_PDWC#P=_;2^$?%^@>//#P_P"$C\ ^
M(/"WBW3O[/\ %?A?0M5SI.O6!N_L/V&^-SIMS>6=QWOPD^%?@+X%_"OX:?!/
MX5Z#_P (M\,?@_X!\'_"_P"'7AG^U-9UO_A'? W@+P_I_A;PGH?]L^(]1U?Q
M!JW]DZ#I5A8?VGKNK:GK%]Y'VK4M0O+R6:XD /0:_D/_ .#AA;_X(_\ !4#_
M ((#_M?Q6>_PQH7[4NH_!CQ[J@OM)M#I6G>*_'/PC73X_*UB^>.?[9X:\0_$
MR]^TP:7:VUE_87DZGXBTR?4=$N+7^O"OQQ_X+O\ _!.]_P#@I3_P3@^-/P7\
M*:-;:I\<? ]I'\:/V=V:TM+C4+CXJ_#ZWN[Z'P;ILU]JNA65G<_%3PO/XD^%
MT%_J>KVNC:-J'B[3_$NJQW<&A+;2 'Z:?'OX6Z=\=/@3\:/@IJT6GSZ3\8OA
M+\1OA;J<.K0RW&E3:=\0O!VL^$[V+4X+=DGGT^2VU>5+V&!UEDMC(D;*[*1_
M*'_P;3_MH_!C]D;X5_%C_@D%^USKWA#]F;]K[]E7XX?%EH-#^)>J1> -)^-W
MA'Q%K$GBT>*_!6M>-[?PNVNZU8)=W]U:Z(]LFI:S\)8?!WQ"\._VMH$_B!?"
MO]$W_!,?X_\ Q&_:<_8._9F^+WQE\ ^/OAE\9M8^&6B:%\8?"'Q)\#^*OA[X
MCM/BGX+1_!_C_4XO#GC*V@UN/P]XB\4:'J7B'PO=S2WRW?A_5-.D:_N;CSV'
M#?MR_P#!(3_@G?\ \%&]1TOQ'^UK^SCX=\?^.M$L--TG2/B7HNN>+/A[\2+3
M1=)N-3N;'0;CQEX!UWPYK&M>'H)-:U=XO#_B&?5]%MY]0EOK:P@U&"SO+8 _
MG:_X.>OVM_@[^V_\./V;_P#@D]^Q?XQ\'_M0_M=_'C]IOP)K?_")?!_QCHOC
M+3/AMI_AK2_%VBI_PL37_#KZOH'AF]NKOQ"^KZK8ZSJVF7'@SP-H&O\ C_Q@
M-&\+P:=?:G_3]^U9^V-^R[_P31_9LTKXQ?M2?$M?AS\)_"]UX+^&6E:I=Z?J
M/B3Q'XC\2ZC:M9Z+X?\ #_ASPUIUUK/B?7Y=+T?5O$%_9Z'I4LEIX?T'Q#X@
MGM[?2='OI[?R#]A?_@C[_P $Z_\ @G!JVO\ BG]DK]G#P]X#\?>*+ Z1K?Q,
M\0:]XN^)/Q&DT5KAKF70=(\7_$37O$VJ>$O#][(MFVL:%X-E\/:1XAFTK1KW
MQ%9ZKJ&DV%Y!]&?MB?L8?LV_M[_!#6?V=_VJ_AQ;_$_X4ZUJND>(7T1M<\2>
M%]1TOQ)X?EEFT/Q%H/B3PCJ^A>(M&U?37GN(UFL-3BAOK"[O]'U:WU#1=2U'
M3KL P?B'^U9!JO[$/C/]L?\ 9!\/Z1^U9;'X%:W\:_@MX7T#Q'<^'++XOVMC
MX<G\1Z9HNGZM)H6K:GI6JZC;V\MJNC7?A\:Y'K<1\-WMCINJF9;3X@_X)9?\
M%M/V4?\ @H[^S1H_Q<U3XA_"WX'?%_2;BXTOXO\ P,\7_$GPUINN?#O67U76
M;;1FM9]=U'3+OQ!X8\0Z=I4E_P"'O$RV-@-5CBNUN=+T;4+2]TFR_5CX/_"#
MX:? 'X7> _@M\'/!VD?#_P"%WPR\,:5X.\#>#M"CE33- \/:+:I:6%G%)<RW
M%[>3^6GG7NIZC=7FJ:K?2W.I:I>WFH75S=2_DO\ M/?\&[O_  2%_:V^*.K_
M !F^*?[)6B:1\1?$L]W>^+=9^$_C3Q_\'=/\7:M?7<M_>^(?$7A7X<>)O#OA
M&_\ %.HW]S>W^M>*UT&'Q)XCOKVXO/$FJ:O<K;RP 'XS?M9_''PM_P %2_\
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MCZ2 ?TD4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_//\
M\$!/O_\ !4W_ +2>?M _^D_AVOZ&*_GG_P"" GW_ /@J;_VD\_:!_P#2?P[7
M]#%?4\:_\E-F7I@?_5=A#'#_ ,&'_;W_ *5(****^6-@HHHH **** "BBB@
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M7A*_U?3K+3?'?@?4;_3+VWL/%_@^\UG1)2EM))=10ZGI4E]_-9\/_BG\,/\
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M<\%SZ[IMR;?4=$UO5O#^I:KX<U>PT_6O#EWI.K6D=[7[?          8  X
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M!WXK_P#!2W]JK]@3_@EIX%\ ?$ZY_9\_X6G;?M0_MQ_%J+POXET3X3:#\,/
M]M/I_A_X>0?%G3M-N8!\1O%.B:CXXTZR\,6DP?3-<\8?"_Q'?0W%G'>:CX8
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M )]5_P#P5+^O^&?E?^A:BOYZ?^%O_P#!S#_T:G_P31_\+'XE_P#S]:/^%O\
M_!S#_P!&I_\ !-'_ ,+'XE__ #]:/]5:O_0]X6_\/^"\O[WG^#[![=?\^J__
M (*E_7_#/RO_ $+45_/3_P +?_X.8?\ HU/_ ()H_P#A8_$O_P"?K1_PM_\
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M^JM7_H>\+?\ A_P7E_>\_P 'V#VZ_P"?5?\ \%2_K_AGY7_H6HK^>G_A;_\
MP<P_]&I_\$T?_"Q^)?\ \_6C_A;_ /P<P_\ 1J?_  31_P#"Q^)?_P _6C_5
M6K_T/>%O_#_@O+^]Y_@^P>W7_/JO_P""I?U_PS\K_P!"U%?ST_\ "W_^#F'_
M *-3_P"":/\ X6/Q+_\ GZT?\+?_ .#F'_HU/_@FC_X6/Q+_ /GZT?ZJU?\
MH>\+?^'_  7E_>\_P?8/;K_GU7_\%2_K_AGY7_H6HK^>G_A;_P#P<P_]&I_\
M$T?_  L?B7_\_6C_ (6__P ',/\ T:G_ ,$T?_"Q^)?_ ,_6C_56K_T/>%O_
M  _X+R_O>?X/L'MU_P ^J_\ X*E_7_#/RO\ T+45_/3_ ,+?_P"#F'_HU/\
MX)H_^%C\2_\ Y^M'_"W_ /@YA_Z-3_X)H_\ A8_$O_Y^M'^JM7_H>\+?^'_!
M>7][S_!]@]NO^?5?_P %2_K_ (9^5_Z%J*_GI_X6_P#\',/_ $:G_P $T?\
MPL?B7_\ /UH_X6__ ,',/_1J?_!-'_PL?B7_ //UH_U5J_\ 0]X6_P##_@O+
M^]Y_@^P>W7_/JO\ ^"I?U_PS\K_T+45_/3_PM_\ X.8?^C4_^":/_A8_$O\
M^?K1_P +?_X.8?\ HU/_ ()H_P#A8_$O_P"?K1_JK5_Z'O"W_A_P7E_>\_P?
M8/;K_GU7_P#!4OZ_X9^5_P"A:BOYZ?\ A;__  <P_P#1J?\ P31_\+'XE_\
MS]:/^%O_ /!S#_T:G_P31_\ "Q^)?_S]:/\ 56K_ -#WA;_P_P""\O[WG^#[
M![=?\^J__@J7]?\ #/RO_0M17\]/_"W_ /@YA_Z-3_X)H_\ A8_$O_Y^M'_"
MW_\ @YA_Z-3_ .":/_A8_$O_ .?K1_JK5_Z'O"W_ (?\%Y?WO/\ !]@]NO\
MGU7_ /!4OZ_X9^5_Z%J*_GI_X6__ ,',/_1J?_!-'_PL?B7_ //UH_X6_P#\
M',/_ $:G_P $T?\ PL?B7_\ /UH_U5J_]#WA;_P_X+R_O>?X/L'MU_SZK_\
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MO_0]X6_\/^"\O[WG^#[![=?\^J__ (*E_7_#/RO_ $+45_/3_P +?_X.8?\
MHU/_ ()H_P#A8_$O_P"?K1_PM_\ X.8?^C4_^":/_A8_$O\ ^?K1_JK5_P"A
M[PM_X?\ !>7][S_!]@]NO^?5?_P5+^O^&?E?^A:BOYZ?^%O_ /!S#_T:G_P3
M1_\ "Q^)?_S]:/\ A;__  <P_P#1J?\ P31_\+'XE_\ S]:/]5:O_0]X6_\
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M_P %Y?WO/\'V-?;K_GU7_P#!4OZ_X9^5_P"A:BOYZ?\ A;__  <P_P#1J?\
MP31_\+'XE_\ S]:/^%O_ /!S#_T:G_P31_\ "Q^)?_S]:/\ 56K_ -#WA;_P
M_P""\O[WG^#[![=?\^J__@J7]?\ #/RO_0M17\]/_"W_ /@YA_Z-3_X)H_\
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MO_\ !S#_ -&I_P#!-'_PL?B7_P#/UH_U5J_]#WA;_P /^"\O[WG^#[![=?\
M/JO_ ."I?U_PS\K_ -"U%?ST_P#"W_\ @YA_Z-3_ .":/_A8_$O_ .?K1_PM
M_P#X.8?^C4_^":/_ (6/Q+_^?K1_JK5_Z'O"W_A_P7E_>\_P?8/;K_GU7_\
M!4OZ_P"&?E?^A:BOYZ?^%O\ _!S#_P!&I_\ !-'_ ,+'XE__ #]:/^%O_P#!
MS#_T:G_P31_\+'XE_P#S]:/]5:O_ $/>%O\ P_X+R_O>?X/L'MU_SZK_ /@J
M7]?\,_*_]"U%?ST_\+?_ .#F'_HU/_@FC_X6/Q+_ /GZT?\ "W_^#F'_ *-3
M_P"":/\ X6/Q+_\ GZT?ZJU?^A[PM_X?\%Y?WO/\'V#VZ_Y]5_\ P5+^O^&?
ME?\ H6HK^>G_ (6__P ',/\ T:G_ ,$T?_"Q^)?_ ,_6C_A;_P#P<P_]&I_\
M$T?_  L?B7_\_6C_ %5J_P#0]X6_\/\ @O+^]Y_@^P>W7_/JO_X*E_7_  S\
MK_T+45_/3_PM_P#X.8?^C4_^":/_ (6/Q+_^?K1_PM__ (.8?^C4_P#@FC_X
M6/Q+_P#GZT?ZJU?^A[PM_P"'_!>7][S_  ?8/;K_ )]5_P#P5+^O^&?E?^A:
MBOYZ?^%O_P#!S#_T:G_P31_\+'XE_P#S]:/^%O\ _!S#_P!&I_\ !-'_ ,+'
MXE__ #]:/]5:O_0]X6_\/^"\O[WG^#[![=?\^J__ (*E_7_#/RO_ $+45_/3
M_P +?_X.8?\ HU/_ ()H_P#A8_$O_P"?K1_PM_\ X.8?^C4_^":/_A8_$O\
M^?K1_JK5_P"A[PM_X?\ !>7][S_!]@]NO^?5?_P5+^O^&?E?^A:BOYZ?^%O_
M /!S#_T:G_P31_\ "Q^)?_S]:/\ A;__  <P_P#1J?\ P31_\+'XE_\ S]:/
M]5:O_0]X6_\ #_@O+^]Y_@^P>W7_ #ZK_P#@J7]?\,_*_P#0M17\]/\ PM__
M (.8?^C4_P#@FC_X6/Q+_P#GZT?\+?\ ^#F'_HU/_@FC_P"%C\2__GZT?ZJU
M?^A[PM_X?\%Y?WO/\'V#VZ_Y]5__  5+^O\ AGY7_H6HK^>G_A;_ /P<P_\
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M_P 'V#VZ_P"?5?\ \%2_K_AGY7_H6HK^>G_A;_\ P<P_]&I_\$T?_"Q^)?\
M\_6C_A;_ /P<P_\ 1J?_  31_P#"Q^)?_P _6C_56K_T/>%O_#_@O+^]Y_@^
MP>W7_/JO_P""I?U_PS\K_P!"U%?ST_\ "W_^#F'_ *-3_P"":/\ X6/Q+_\
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MG_P31_\ "Q^)?_S]:/\ 56K_ -#WA;_P_P""\O[WG^#[![=?\^J__@J7]?\
M#/RO_0M17\]/_"W_ /@YA_Z-3_X)H_\ A8_$O_Y^M'_"W_\ @YA_Z-3_ .":
M/_A8_$O_ .?K1_JK5_Z'O"W_ (?\%Y?WO/\ !]@]NO\ GU7_ /!4OZ_X9^5_
MZ%J*_GI_X6__ ,',/_1J?_!-'_PL?B7_ //UH_X6_P#\',/_ $:G_P $T?\
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M]@]NO^?5?_P5+^O^&?E?^A:BOYZ?^%O_ /!S#_T:G_P31_\ "Q^)?_S]:/\
MA;__  <P_P#1J?\ P31_\+'XE_\ S]:/]5:O_0]X6_\ #_@O+^]Y_@^P>W7_
M #ZK_P#@J7]?\,_*_P#0M17\]/\ PM__ (.8?^C4_P#@FC_X6/Q+_P#GZT?\
M+?\ ^#F'_HU/_@FC_P"%C\2__GZT?ZJU?^A[PM_X?\%Y?WO/\'V#VZ_Y]5__
M  5+^O\ AGY7_H6HK^>G_A;_ /P<P_\ 1J?_  31_P#"Q^)?_P _6C_A;_\
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M $:G_P $T?\ PL?B7_\ /UH_X6__ ,',/_1J?_!-'_PL?B7_ //UH_U5J_\
M0]X6_P##_@O+^]Y_@^P>W7_/JO\ ^"I?U_PS\K_T+45_/3_PM_\ X.8?^C4_
M^":/_A8_$O\ ^?K1_P +?_X.8?\ HU/_ ()H_P#A8_$O_P"?K1_JK5_Z'O"W
M_A_P7E_>\_P?8/;K_GU7_P#!4OZ_X9^5_P"A:BOYZ?\ A;__  <P_P#1J?\
MP31_\+'XE_\ S]:/^%O_ /!S#_T:G_P31_\ "Q^)?_S]:/\ 56K_ -#WA;_P
M_P""\O[WG^#[![=?\^J__@J7]?\ #/RO_0M17\]/_"W_ /@YA_Z-3_X)H_\
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MZ+4RKUDZ-5>SK*].2NZ<DEIU>R7GY/RO_;%H'_("T7_L$Z=_Z1PUK5DZ!_R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_"?["^H_LS_#31/AQJ7Q]_:3_:^^-_AKX*? KX">&_%6G>$]7U=M5G2/Q/\
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MQ!')8.#+';Q6UPQV7* ?"/\ Q%U?\$:/^BA?';_PPWBG_P"2: /Z=**^ O\
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MN%T:T\13Q2ZAX6TF2  _0[_@L-_P5'L_^"3'[/?PB^/NH?!NV^-5A\4/VFO
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MM2FT3X7_  LM[+7O$MSKJIJT5UIFN:A=3V8O+SQ!>23".']IJ_D-_P"#/O\
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M7R>(-82^TJ!_$^E0:;I-SX4UBT>WT[2O'MYIEU:^,IN:_P"#H6+4?BU^T/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!_/3_ ,$#/^0K_P %7_\ M*)^T)_Z,TROZ%J_GI_X(&?\
MA7_@J_\ ]I1/VA/_ $9IE?T+5]3QK_R4V9>F!_\ 5=A#'#_P8?\ ;W_I4@HH
MHKY8V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^&;_ (* _P#!";X/
M?L<?\$C/V_/VN/VGO'&O?ML?\%&/&/PZ\!>(O&_[3OQ>U'4_%;^"_$MQX^^&
MF@ZII?P>M_$327NGZ=8V#S^'M.\9Z_%+XRN?#T-OI^GCPCH$@\*6G]S-?B?_
M ,'&7_*%/]OC_LFO@W_U</PXH ]N_P"")_\ RB0_X)T?]FA_!#_U!])K^>W_
M (-8/A3\./VW->_;K_X*T_M'Z-H/Q8_:\^(/[8'BCP9H>M>.(4\5ZA\(?#>G
M>%OAU\3K*?P(FJW,UCX>26]\8:;X1\*WVF>'=(N_"'A?X9Z;X9\(:AIV@2:A
MHL/]"7_!$_\ Y1(?\$Z/^S0_@A_Z@^DU^)_Q5_X)V_\ !5W_ ().?MD?&[]K
M#_@C%X;\ _M4_LU_M:^,IO'WQ^_8A^+WB[1O#-YX(\;W^JZOXG\2^+?AUJ.O
M^,?AKI1LHHGU+0_!>JZ%XJOO%FG)XKTWPQXG^%_Q.TGPAI'B*T /2?\ @[!_
M9B^#=[_P3_G_ &\-/MM)^'O[6W[(GQ3^"WBCX*_&'P_>:9X9^(&K2Z[\3_"G
MA.X\#RZ@=.N+WQC::,NK0_$G0=*\ZWU;POJ?@237M$U6QT;_ (3#1O$W[_?L
M+?'ZZ_:J_8O_ &4OVD]2M(-.UCXY_L]?"'XI>(-+M7DFMM(\2^-/ NAZ[XDT
M>WN)+#2S=0:3KM[J&G17D>G6<%Y';+<VT"6\L0K^+?\ X+&?!S_@LC^V/^PW
M^T3^T_\ \%6(/A3^PU^RU^RSX3A\7_"C]CGX$>-/"WC_ ,7?%/XYZ[XMT;X<
M_#7Q3\7/'=AXL\?>%+S1+&\^(+VR_P!G^,+:[G@A@T?P[\,=#\1ZU>>+Y/ZV
M?^"07@_6O 7_  2R_P"">OA7Q%';P:UIO['O[/\ )J%O;7"74=K-J/PU\.ZF
M+1KB(>1+<6D=ZEO=/;//:&YBE^RW-U;B*XE /T:K^1WX/KJW[=W_  =8?M">
M.O%2WVK_  A_X)3?LW:9\/\ X2V5W+>0Z7HGQ>^)>A:3IFK:F^AQFWTV?4-4
MN/B!\=$36K]=1N[NU\&^"KJ,G^Q= /AW^N*OX_?^#>JV#_\ !8#_ (.4;SQ$
MUT/%<'[96GV^B)J]W=IJ;>$;KX]?MB21M9V-W,KW.C+IUGX/%A=+;RV]GIKZ
M1%83065]$EP ?NG_ ,%:?^"?WB[_ (*;_L<^(_V1_"W[2.L?LPVGC/QCX1UO
MQEXUTGP'/\1T\3^$?#$][J-QX U;PQ!\0/AJUSI&L:Y_8.L7$S^(VA2?P]:Q
M3:;>1SL8?I_]E[]DOX _L=? #P7^S-\ OAUX?\%?"7P5X?AT*'0[;3;%IO$L
MSV,-EK7B7QK=+;1MXK\6^+&B:^\6^(=86XU#7[^XGGOI) X1?I"OP>_X*D?\
M$(_ 7_!47XG'XF>,_P!LG]K;X*Q/\,= ^%UU\+_AEXOT9_@UJFEZ)XA\0:]+
MJ6L^ ]5TMEU+4=6_X2*XMK\2:JEM))9V%TT4GDO!* ?E9_P0DTSX;^'_ /@N
MG_P6ETO]AW0O#FF_\$_I]-\"0O<?#K1$_P"%4VWQNT/6;![;1OAYK6A^)=5\
M&:9X3M?$'B+]HJ;PGX;\.V\FB'PM)I#^$[#P+X:TNU\+R_V:5_(E_P $2_B-
M\5/^"97[<'CG_@@3^T;X2^#.M/HWPT?X\?LR?M/?"/P'H7PNU+XW^$I;2#5]
M0T[XG>'=,A2Z\5>*[2PD\2V,7BO6I9_%5AJ'PW\6:7K&K^.]*O/#_BU/Z[:
M.:UGP7X.\1W4=[XA\)^&M>O(H%M8KO6="TO5+J*U2269+:.XOK6>5($EGFE6
M%7$:R32N%#2.3^'W_!?3]L#X=?\ !.7_ ()X?$KQOX"\%^"X/VC?C;.G[/\
M^S18:3X0T.7Q#!\3/']A?6]WXYTFVM-*N[Q;CX9>$X->\9:/=OI]YI=QXXL/
M!7AC4U3_ (2FU$G[S5_'-X8TZ/\ X+A?\' FO?$/48;GQ)^P+_P1DN#X/^'C
M$7;>#_B9^UJNOV]YXAU^TGFT+4=#UNWM/'/A>.:]CTOQ'#:ZOX1^#_PA\10Q
M3:9XQU&WN@#]D?\ @A7_ ,$ZK7_@FG_P3P^$?P;US2[>T^-7CN#_ (7'^T/?
M(D1NIOBOXYL+">^\.S7,:XGM_A[H-KH?P_M'C;[-=?\ "-SZM$B2ZI<%_P "
M/^"9W[;G[)?_  3M^&/_  6J_94_X*+^-M#^!OQXU3]LO]JGXTZAX ^+NE)J
M&H_&OX3_ !:^'WAWPWX9M/!$B1ZQ;?&&?7]2\+>)Q)X>T:768[NR\36%^@NK
M/7+V:'^W_ITKYA_:6TO]D_P'X2\1?M4?M-> _@Y<Z9^S[X*U[Q=<_%;XB>!?
M!NO^(/ GAC0;:[U:_C\.>(O$&F7.K:;-<RO-'IVE:1?6\^J:O?165G#-?7T<
M<H!_*5^Q-^UW\9O^"3__  ;M_L:^!M,\"7NO?M]_M<^)OB=X7_8(_9KUJ*XN
MO%'BK6?C-\;->\1>%_&=SX7DCD:W\'^%O!_CW1/BK?VDXM=&O+WQ;X(\+^)=
M4\,7WCF>]TW]]?\ @CU_P3?M/^"<?[+,?AKQOJ>G^//VKOCIXAO/C?\ MC?&
M93/?ZG\1?CCXQ:35-;L(==OQ_:.H>$/ LE]<>'/"V8-(LM5F77?'DGAO0_$?
MCOQ-#-_/[\,/VF/"9N/CQ_P=$_\ !1[P7XPLOASH*+\"O^"4G[+&J>%].TKQ
MMX=^$NJZA+I'@_XAZ#%K.O#2KOXA?&<ZQXKU[4/$)FU2QT;PM-\2?&WA35M=
M\#7?@31M#_57X'?\%DOVHM _:E^ '[-/_!3#_@FSXA_8#B_;#U#Q+HG[+/Q+
ML/VC?AU^T=X9\5^-]&AT2\M/AGX\M?AWHUG<>!-?U"TUFVMK'5=6N;>ZO]=O
M],TV7P=I5@=3UO30#<_X.7_V<K#]H3_@D#^T?J237UCXR_9QG\)_M0?#C5K
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M+>*/%.D6.NVG@>3P#<ZEJ?C#PI8>%_#>F_V=U_!]H'[-WC7_ (-9?VT_@?\
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M!%=M<S)K"76@VENMY TTOV"X.@VNBNMJL=L)+9K>],+/>-<3@'U]_P %$_\
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MR\+S7?A#Q1J\D%S'&T5QJFMZ#?7]TD(:S6YN)18RS6?D2OB_\%&/V@?V/_\
M@FO\%_'O[?OQ)^#?PTU'XPZ0D/@;X8ZIHO@'P2OQL^*WQ4\;17UEX2^&7A?Q
M5+9V7BO4)]=D74M4\0VUAJMQ>6G@O2/%>NQZ=J*Z7+9S@'Y"_MY?'+]IMOV=
MOV'?^"$7[*VIVI_;Y_:@_9M^'W@G]J'QW;WTGB6#]E#]G7PSX#\.:#\8?B)X
MRUB%GL+>^\>PP^(?"^A7MSJ#:I?:;_:%IHJ:?XU\<?"W5;K^AC]C3]DGX0_L
M-?LU_"K]F#X(:#:Z'X$^%WAJUTB.:*!([_Q-KTH-WXF\:>()@6>^\2>+]>GO
M_$&N7LCL9M0OYO+$<"Q11_R\_LX^/_&/_!*CPOX0_:Z_:4^!WB']K[_@MM_P
M6O\ B7;7OAS]G[3M6\,_!CQ#X(\,1:9INKZ'\$KGQ9X_N]8TOX1> OAU:ZAH
M<'C347T6-_[=N?#_ (7UNRO]"^%]AKND?K[^P'_P58^*7Q^_:<^(O[!W[</[
M'NL_L*?MK^"/AS9?&[P[\-F^*WA/XY^ _BA\%M0OM-TM_%WA+XF^!K2+PTNM
M:#K.K6FDZWX62]U9W FO=.U2XO-+\7Z#X0 /S._X.G%US]F&T_X)Q_\ !4_X
M:7.J6'Q0_9!_:OL? M\-(LK&^_M_X=?%3P[K'B+7]-UB/4M-O;.*R-G\.=:\
M)6ES-=:?#"WQ)OXR9KZXTVYTW^K[PUKEEXF\.Z#XCTV;[1I^O:/INLV4_E2P
M>=::E9PWEO+Y,\<4T6^*96\N6*.1,[716! _G8_X.OO[$_X<M_'C^UO^/S_A
M8GP/_P"$<_X^_P#D-_\ "Q]'\S_CV_=?\@+^V_\ C^_T3^[_ *9]DK]COV"+
MK6KW]A[]CZ\\2+<)X@NOV9?@=<:XEW9KI]TNK3?#;PW)J"W-BD%LMG.+MI1+
M:K;P+ X:(0QA=@ /K2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OY_O\ @YD_Y15_$'_LJOPE_P#3[<U_0#7\_P!_P<R?\HJ_B#_V57X2
M_P#I]N:^GX*_Y*[AO_L<Y?\ ^I$#'$?P*W_7N?\ Z2S]Z] _Y 6B_P#8)T[_
M -(X:UJR= _Y 6B_]@G3O_2.&M:OF9;OU?YFL=EZ+\C^>G]I3_E8[_X)S?\
M9FOQY_\ 3;\:Z_H6K^>G]I3_ )6._P#@G-_V9K\>?_3;\:Z_H6KZCB7_ ';A
M/_LEL-_ZMLY,:/Q8C_K_ "_]-TPKYT_:Y_9F^'W[97[,WQM_9=^*5OY_@?XV
M_#_6_!&K3JMS)-H]W>PK<:!XFLXK2_TN>;4?"?B.UTGQ-IL U"UBGO\ 2;:&
MXD^SO*K?1=%?+&Y_ ;_P;P_L)?\ !07Q/_P4"^$?CC_@H/\  GXN_#/X9_\
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ME_=#_@IO\'OVX/CC^R7XQ\$_\$]/VC=&_9D_:5&K:-K&@>,_$&A:;J6E>*-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _GI_X(&?\A7_ (*O_P#:43]H3_T9
MIE?T+5_/3_P0,_Y"O_!5_P#[2B?M"?\ HS3*_H6KZGC7_DILR],#_P"J["&.
M'_@P_P"WO_2I!1117RQL%%%% !1110 4444 %%%% !1110 4444 %%%% !7Y
M"_\ !>OX:?$?XP_\$B?VV?AK\(_A_P"-OBG\1O%?P^\*67A;P!\.?"NN^-_&
MWB6\MOBKX!U&XM- \*^&;#4]=UBY@T^SO+Z:#3K"YEBL[6YNG18()73]>J*
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M^)/"AO;.;QE\)_&UA!JOAK7Y_"WB6.RA:"2R\0"+2WEUB)-+G?7I[VR ,?\
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MX=D;PQ%H5U%KNF3>,]+U*Y9=<T^XT?\ 6X    8   'H!P!0 M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?SS_P#! 3[_ /P5-_[2>?M
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M9OAS<VVERZ]'_:710!_%/\5?!O\ P48_X.,?C_\ LQ:'\6_V&_B3_P $]_\
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M)XPU.WCDD@M]5\7^(I]4\2ZI;VA2QM[_ %2XAL8;>T2&&/\ "SP3^S]\>_\
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M%.NHT^=>V>O.HZ^SIZ6?R=_,_H7HK^>C_B'YTO\ Z2B?\%2?_$CK?_YEZ/\
MB'YTO_I*)_P5)_\ $CK?_P"9>O%_LGAG_HK'_P"&''__ "XUYZW_ #X_\J1_
MR/Z%Z*_GH_XA^=+_ .DHG_!4G_Q(ZW_^9>C_ (A^=+_Z2B?\%2?_ !(ZW_\
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M?_$CK?\ ^9>C^R>&?^BL?_AAQ_\ \N#GK?\ /C_RI'_(_H7HK^>C_B'YTO\
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M  5)_P#$CK?_ .9>C_B'YTO_ *2B?\%2?_$CK?\ ^9>C^R>&?^BL?_AAQ_\
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M/[)X9_Z*Q_\ AAQ__P N#GK?\^/_ "I'_(_H7HK^>C_B'YTO_I*)_P %2?\
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MBL?_ (8<?_\ +@YZW_/C_P J1_R/Z%Z*_GH_XA^=+_Z2B?\ !4G_ ,2.M_\
MYEZ/^(?G2_\ I*)_P5)_\2.M_P#YEZ/[)X9_Z*Q_^&''_P#RX.>M_P ^/_*D
M?\C^A>BOYZ/^(?G2_P#I*)_P5)_\2.M__F7H_P"(?G2_^DHG_!4G_P 2.M__
M )EZ/[)X9_Z*Q_\ AAQ__P N#GK?\^/_ "I'_(_H7HK^>C_B'YTO_I*)_P %
M2?\ Q(ZW_P#F7H_XA^=+_P"DHG_!4G_Q(ZW_ /F7H_LGAG_HK'_X8<?_ /+@
MYZW_ #X_\J1_R%_X(&?\A7_@J_\ ]I1/VA/_ $9IE?T+5_#O_P $IO\ @DS8
M_M*WW[>4$W[<'[<?PA'P6_;@^+GP>CD^$'QBA\+2?$)/##V0'CWXALVB7G]N
M^/M9\W.M:VHMQ=F.,B!-M?KC_P 0_.E_])1/^"I/_B1UO_\ ,O7T?%F6\/U.
M(,?/$<2O#5FL)ST?[%QM;DM@<,H_O(55&7-%1GHER\W*]4S*C.JJ44J5U[VO
MM(J_O/HT?T+T5_/1_P 0_.E_])1/^"I/_B1UO_\ ,O1_Q#\Z7_TE$_X*D_\
MB1UO_P#,O7SG]D\,_P#16/\ \,./_P#EQKSUO^?'_E2/^1_0O17\]'_$/SI?
M_243_@J3_P")'6__ ,R]'_$/SI?_ $E$_P""I/\ XD=;_P#S+T?V3PS_ -%8
M_P#PPX__ .7!SUO^?'_E2/\ D?T+T5_/1_Q#\Z7_ -)1/^"I/_B1UO\ _,O1
M_P 0_.E_])1/^"I/_B1UO_\ ,O1_9/#/_16/_P ,./\ _EP<];_GQ_Y4C_D?
MT+T5_/1_Q#\Z7_TE$_X*D_\ B1UO_P#,O1_Q#\Z7_P!)1/\ @J3_ .)'6_\
M\R]']D\,_P#16/\ \,./_P#EP<];_GQ_Y4C_ )']"]%?ST?\0_.E_P#243_@
MJ3_XD=;_ /S+T?\ $/SI?_243_@J3_XD=;__ #+T?V3PS_T5C_\ ##C_ /Y<
M'/6_Y\?^5(_Y']"]%?ST?\0_.E_])1/^"I/_ (D=;_\ S+T?\0_.E_\ 243_
M (*D_P#B1UO_ /,O1_9/#/\ T5C_ /##C_\ Y<'/6_Y\?^5(_P"1_0O17\]'
M_$/SI?\ TE$_X*D_^)'6_P#\R]'_ !#\Z7_TE$_X*D_^)'6__P R]']D\,_]
M%8__  PX_P#^7!SUO^?'_E2/^1_0O17\]'_$/SI?_243_@J3_P")'6__ ,R]
M'_$/SI?_ $E$_P""I/\ XD=;_P#S+T?V3PS_ -%8_P#PPX__ .7!SUO^?'_E
M2/\ D?T+T5_/1_Q#\Z7_ -)1/^"I/_B1UO\ _,O1_P 0_.E_])1/^"I/_B1U
MO_\ ,O1_9/#/_16/_P ,./\ _EP<];_GQ_Y4C_D?T+T5_/1_Q#\Z7_TE$_X*
MD_\ B1UO_P#,O1_Q#\Z7_P!)1/\ @J3_ .)'6_\ \R]']D\,_P#16/\ \,./
M_P#EP<];_GQ_Y4C_ )']"]%?ST?\0_.E_P#243_@J3_XD=;_ /S+T?\ $/SI
M?_243_@J3_XD=;__ #+T?V3PS_T5C_\ ##C_ /Y<'/6_Y\?^5(_Y']"]%?ST
M?\0_.E_])1/^"I/_ (D=;_\ S+T?\0_.E_\ 243_ (*D_P#B1UO_ /,O1_9/
M#/\ T5C_ /##C_\ Y<'/6_Y\?^5(_P"1_0O17\]'_$/SI?\ TE$_X*D_^)'6
M_P#\R]'_ !#\Z7_TE$_X*D_^)'6__P R]']D\,_]%8__  PX_P#^7!SUO^?'
M_E2/^1_0O17\]'_$/SI?_243_@J3_P")'6__ ,R]'_$/SI?_ $E$_P""I/\
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MT+T5_/1_Q#\Z7_TE$_X*D_\ B1UO_P#,O1_Q#\Z7_P!)1/\ @J3_ .)'6_\
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M!SUO^?'_ )4C_D?T+T5_/1_Q#\Z7_P!)1/\ @J3_ .)'6_\ \R]'_$/SI?\
MTE$_X*D_^)'6_P#\R]']D\,_]%8__##C_P#Y<'/6_P"?'_E2/^1_0O17\]'_
M !#\Z7_TE$_X*D_^)'6__P R]'_$/SI?_243_@J3_P")'6__ ,R]']D\,_\
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M!SUO^?'_ )4C_D?T+T5_/1_Q#\Z7_P!)1/\ @J3_ .)'6_\ \R]'_$/SI?\
MTE$_X*D_^)'6_P#\R]']D\,_]%8__##C_P#Y<'/6_P"?'_E2/^1_0O17\]'_
M !#\Z7_TE$_X*D_^)'6__P R]'_$/SI?_243_@J3_P")'6__ ,R]']D\,_\
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M<*?.[1YY)J-[M6,J\ZKHU4Z-DX2N_:1=E;5VMK;>Q_;'H'_("T7_ +!.G?\
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M=A#'#_P8?]O?^E2"BBBOEC8**** "BBB@ HHHH **** "BBB@ HHHH ****
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M=A#'#_P8?]O?^E2"BBBOEC8**** "BBB@ HHHH **** "BBB@ HHHH ****
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M<^)?LNY-$\%^#O#UC_;7C/Q;J:P7.HGP[X,\/74]MI]OJ.KS6.GZ#I>H7MD
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M\.7MMX@B^+-4_9K_ &F_V8?^#F/_ ()(>$?VNOV[?$W[>7QD\4_#?X@^.?\
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M9^)KQKCQ!XR\3WQ+/?>(/$FHZEJD^1%]H2VBA@B_K)K^<S_@ZU_Y0E?M+_\
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M;>VT>P\;W7B6.VEUB8W'B+6?R!_9RT/_ (*0?\$@-2_X*'?LA^&/^"<_Q?\
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MM;FZBD59+>WFE5(V_A(_X(3_ /!:?2/V&/\ @GAX4^"'PD_8&_;+_;2\?O\
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MJ_B#_P!E5^$O_I]N:^GX*_Y*[AO_ +'.7_\ J1 QQ'\"M_U[G_Z2S]Z] _Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_GI_X(&?\A7_ (*O_P#:43]H3_T9IE?T+5_/3_P0,_Y"O_!5_P#[2B?M"?\
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MN[.2#2-486LSK+J*@16T7R'_ ,$Y_P!@;_@IM^SE_P %$OV\/VC/VK?VX_\
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M\_:!_P#2?P[7]#%?SS_\$!/O_P#!4W_M)Y^T#_Z3^':_H8KZGC7_ )*;,O3
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MZO;R>>YFD:21C7LE%% '\C?[?.@:I_P3\_X.-/V"?^"@$]AIL/P)_;W\+/\
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M:_#:+4-&\*SW=S=>'M3U'0].;3_ W@+2](L?$/C2>]TGQ)X@\6ZAXB7]4_\
M@H1X*_;+^)?[)?Q6^&W[!/C'X7_#7]I/Q_I</A+PK\4?BSXL\8^$-!^&FBZO
M.(?%?B_0[WP+\//B/K]SXXMM"%WIG@U8=,TB/1=;U2V\7?VZMQX:M]&UK[3H
MH ^$O^";_P"P)\)?^":O[)WP[_9;^$LD^KV_AN*XUSQYX[U"W%MK7Q-^)NO"
M*Y\9^/M8@^T7?V276=001:9I0N[N+0- L](T"VN9[72X9&_&5/\ @G#_ ,%=
M_P!@3XW?MF-_P29\<_L-ZS^SW^V[\3O$'QU:T_:SMOB9IGQ$_9E^,7C=OL?B
M>Y\%+\/- U+PQXQ\$:59O;W7@^W\4:=XFFMQI.CV&M>%-1_L?6KGXD_U#T4
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M/?\ 1[7PI_\  3QK_P#,I1_P_%_X)/?]'M?"G_P$\:__ #*5]0?\._?V#/\
MHR3]D7_Q&WX-?_,91_P[]_8,_P"C)/V1?_$;?@U_\QE>)S\$_P#0-Q3_ .%V
M4^7_ %+O7\/,T_VGO0_\!J?_ "7K_3T^7_\ A^+_ ,$GO^CVOA3_ . GC7_Y
ME*/^'XO_  2>_P"CVOA3_P" GC7_ .92OJ#_ (=^_L&?]&2?LB_^(V_!K_YC
M*/\ AW[^P9_T9)^R+_XC;\&O_F,HY^"?^@;BG_PNRGR_ZEWK^'F'^T]Z'_@-
M3_Y+U_IZ?+__  _%_P""3W_1[7PI_P# 3QK_ /,I1_P_%_X)/?\ 1[7PI_\
M 3QK_P#,I7U!_P ._?V#/^C)/V1?_$;?@U_\QE'_  []_8,_Z,D_9%_\1M^#
M7_S&4<_!/_0-Q3_X793Y?]2[U_#S#_:>]#_P&I_\EZ_T]/E__A^+_P $GO\
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M[!G_ $9)^R+_ .(V_!K_ .8RC_AW[^P9_P!&2?LB_P#B-OP:_P#F,HY^"?\
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M_0-Q3_X793Y?]2[U_#S#_:>]#_P&I_\ )>O]/3Y?_P"'XO\ P2>_Z/:^%/\
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M'M?"G_P$\:__ #*4?\/Q?^"3W_1[7PI_\!/&O_S*5]0?\._?V#/^C)/V1?\
MQ&WX-?\ S&4?\._?V#/^C)/V1?\ Q&WX-?\ S&4<_!/_ $#<4_\ A=E/E_U+
MO7\/,/\ :>]#_P !J?\ R7K_ $]/E_\ X?B_\$GO^CVOA3_X">-?_F4H_P"'
MXO\ P2>_Z/:^%/\ X">-?_F4KZ@_X=^_L&?]&2?LB_\ B-OP:_\ F,H_X=^_
ML&?]&2?LB_\ B-OP:_\ F,HY^"?^@;BG_P +LI\O^I=Z_AYA_M/>A_X#4_\
MDO7^GI\O_P##\7_@D]_T>U\*?_ 3QK_\RE'_  _%_P""3W_1[7PI_P# 3QK_
M /,I7U!_P[]_8,_Z,D_9%_\ $;?@U_\ ,91_P[]_8,_Z,D_9%_\ $;?@U_\
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MW]@S_HR3]D7_ ,1M^#7_ ,QE'_#OW]@S_HR3]D7_ ,1M^#7_ ,QE'/P3_P!
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M^8RCGX)_Z!N*?_"[*?+_ *EWK^'F'^T]Z'_@-3_Y+U_IZ?+_ /P_%_X)/?\
M1[7PI_\  3QK_P#,I1_P_%_X)/?]'M?"G_P$\:__ #*5]0?\._?V#/\ HR3]
MD7_Q&WX-?_,91_P[]_8,_P"C)/V1?_$;?@U_\QE'/P3_ - W%/\ X793Y?\
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M/3Y?_P"'XO\ P2>_Z/:^%/\ X">-?_F4H_X?B_\ !)[_ */:^%/_ (">-?\
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M/?\ 1[7PI_\  3QK_P#,I1_P_%_X)/?]'M?"G_P$\:__ #*5]0?\._?V#/\
MHR3]D7_Q&WX-?_,91_P[]_8,_P"C)/V1?_$;?@U_\QE'/P3_ - W%/\ X793
MY?\ 4N]?P\P_VGO0_P# :G_R7K_3T^7_ /A^+_P2>_Z/:^%/_@)XU_\ F4H_
MX?B_\$GO^CVOA3_X">-?_F4KZ@_X=^_L&?\ 1DG[(O\ XC;\&O\ YC*/^'?O
M[!G_ $9)^R+_ .(V_!K_ .8RCGX)_P"@;BG_ ,+LI\O^I=Z_AYA_M/>A_P"
MU/\ Y+U_IZ?+_P#P_%_X)/?]'M?"G_P$\:__ #*4?\/Q?^"3W_1[7PI_\!/&
MO_S*5]0?\._?V#/^C)/V1?\ Q&WX-?\ S&4?\._?V#/^C)/V1?\ Q&WX-?\
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M_P EZ_T]/E__ (?B_P#!)[_H]KX4_P#@)XU_^92C_A^+_P $GO\ H]KX4_\
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M?LB_^(V_!K_YC*.?@G_H&XI_\+LI\O\ J7>OX>8?[3WH?^ U/_DO7^GI\O\
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M_#S#_:>]#_P&I_\ )>O]/3Y?_P"'XO\ P2>_Z/:^%/\ X">-?_F4H_X?B_\
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MG[(O_B-OP:_^8RCGX)_Z!N*?_"[*?+_J7>OX>8?[3WH?^ U/_DO7^GI\O_\
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M:^%/_@)XU_\ F4H_X?B_\$GO^CVOA3_X">-?_F4KZ@_X=^_L&?\ 1DG[(O\
MXC;\&O\ YC*/^'?O[!G_ $9)^R+_ .(V_!K_ .8RCGX)_P"@;BG_ ,+LI\O^
MI=Z_AYA_M/>A_P" U/\ Y+U_IZ?+_P#P_%_X)/?]'M?"G_P$\:__ #*4?\/Q
M?^"3W_1[7PI_\!/&O_S*5]0?\._?V#/^C)/V1?\ Q&WX-?\ S&4?\._?V#/^
MC)/V1?\ Q&WX-?\ S&4<_!/_ $#<4_\ A=E/E_U+O7\/,/\ :>]#_P !J?\
MR7K_ $]/E_\ X?B_\$GO^CVOA3_X">-?_F4H_P"'XO\ P2>_Z/:^%/\ X">-
M?_F4KZ@_X=^_L&?]&2?LB_\ B-OP:_\ F,H_X=^_L&?]&2?LB_\ B-OP:_\
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M>GR__P /Q?\ @D]_T>U\*?\ P$\:_P#S*4?\/Q?^"3W_ $>U\*?_  $\:_\
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M2?LB_P#B-OP:_P#F,H_X=^_L&?\ 1DG[(O\ XC;\&O\ YC*.?@G_ *!N*?\
MPNRGR_ZEWK^'F'^T]Z'_ (#4_P#DO7^GI\O_ /#\7_@D]_T>U\*?_ 3QK_\
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M3_Y+U_IZ?+__  _%_P""3W_1[7PI_P# 3QK_ /,I1_P_%_X)/?\ 1[7PI_\
M 3QK_P#,I7U!_P ._?V#/^C)/V1?_$;?@U_\QE'_  []_8,_Z,D_9%_\1M^#
M7_S&4<_!/_0-Q3_X793Y?]2[U_#S#_:>]#_P&I_\EZ_T]/E__A^+_P $GO\
MH]KX4_\ @)XU_P#F4H_X?B_\$GO^CVOA3_X">-?_ )E*^H/^'?O[!G_1DG[(
MO_B-OP:_^8RC_AW[^P9_T9)^R+_XC;\&O_F,HY^"?^@;BG_PNRGR_P"I=Z_A
MYA_M/>A_X#4_^2]?Z>GR_P#\/Q?^"3W_ $>U\*?_  $\:_\ S*5^,O\ P7I_
MX*??L#_M0?\ !._QI\)O@%^TSX#^)OQ%U'XB?#?5K+PIH%OXECU&XT[1]7GN
M-2NT;4]!L+01VD++)+NN%8@C8K'BOZ.O^'?O[!G_ $9)^R+_ .(V_!K_ .8R
MOPU_X.(OV2OV5/A)_P $T/'7C/X4_LR_L^?#'QA:_$SX7V5MXK^'OP8^''@O
MQ+;V=]K5Q%>VD&N^&_#>FZI%;7D8$=U!'=+%<( DJ.H KZ'A*?"+XGR%87#\
M1QQ+S7!>PEB,9EDZ"J^WI\CJPIX&%25-2OS1A.,FM%)/4RK^W]C5YG1M[.5[
M1G>UM;7E:^^Z_/3^F[0/^0%HO_8)T[_TCAK6K)T#_D!:+_V"=._](X:UJ_-I
M;OU?YG7'9>B_(_GI_:4_Y6._^"<W_9FOQY_]-OQKK^A:OYZ?VE/^5CO_ ()S
M?]F:_'G_ --OQKK^A:OJ.)?]VX3_ .R6PW_JVSDQH_%B/^O\O_3=,***_EJ_
MX)N_MC_M0?%O_@X0_P""L7[,/Q(^-7C3Q=\ /@9X&OKWX2_"K5+NU/A3P/=R
M>,OA%:&YTBUM[2"=ITM=5U.WAEO;B[>W@O[R*!HTN)0WRQN?U*T45_-+\,/V
MQOVFM8_X.@?VB_V,=3^+_B6]_9>\*?L0Z'X[\._!F:+1SX4TGQE<Z+\"=5G\
M26I73%U5=6DO?$FNNUV^HN_DZG<V8Q9E;=0#^EJBBB@ HHK)UG7]"\.6L=]X
MAUO2-!LI;A;6*\UG4K/2[62Z>.69+:.XOIH(GN'B@GE6%7,C1PRN%*QN0 :U
M%%% !163IVOZ%J]UJ5CI.MZ1JE[HMP+76+/3M2L[VZTFZ,EQ"+;4K>VFEEL+
M@RVMU$(;I(I/,MKA-NZ&0+K4 %%?AY_P2N_X*D?%K]O3]L7_ (*X_LX?$/X=
M_#KP;X8_X)Z?M+VOP2^&NN^"_P#A)?[>\;Z#/\4OVEO C:OXX_MS6]4T_P#M
M==/^"6@WB_V!9Z39?;=6U?-L8/L<5M^X= !16#8>*O#&J:I>Z)IGB/0=1UK3
MOM']H:18:QI]YJEA]CN$M+O[;86]Q)=VOV6[DCM;CSXH_(N)$AEVR,JG>H *
M*@NKJUL;6YOKZYM[.RL[>:ZO+RZFCM[6UM;>-IKBYN;B9DB@MX(D>6::5UCB
MC5G=E5217TS5=+UNQ@U/1M2L-7TVY\W[-J&F7EO?V-QY,TEO-Y%W:R2V\OE7
M$4L$OER-Y<T4D38=&4 %^BBL&P\5>&-4U2]T33/$>@ZCK6G?:/[0TBPUC3[S
M5+#['<):7?VVPM[B2[M?LMW)':W'GQ1^1<2)#+MD95(!O45\Q_MG?!WXL_M!
M?LK?'7X+? KXX>(?V;?B_P#$?X?:QX;^'_QP\*M>PZ_\/?$-T(I+75=/O=*N
M[#6M)-VD,NCW&N^'KZQ\3:!::E<:UX:O+77K#3IX_-_^";?[.?QZ_9-_8K^!
M_P  /VF_V@]8_:A^-OP_T?7K3QI\8]:O-:U*;6VU7Q;K^N:'H5EJ_B=Y_%FM
MZ3X)\.:GI/@W3=;\4W4VM:M:Z&E_);Z/9SV?A_20#[DHK)UG7]"\.6L=]XAU
MO2-!LI;A;6*\UG4K/2[62Z>.69+:.XOIH(GN'B@GE6%7,C1PRN%*QN1K4 %%
M%9,VOZ%;ZQ:^'KC6](@U^^MVNK'0YM2LXM8O+5%N6>YM=,>9;VXMU6SO&::&
M!XU6UN26 @E*@&M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '\]/\ P0,_Y"O_  5?_P"THG[0G_HS3*_H6K^>
MG_@@9_R%?^"K_P#VE$_:$_\ 1FF5_0M7U/&O_)39EZ8'_P!5V$,</_!A_P!O
M?^E2"BBBOEC8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK^?W
M]M[_ ()M?\%:_C_^T]\2OBU^S%_P63\5_LH_!#Q4O@P>"_@'IGP9A\667@5M
M"\ >%O#?B1H=??Q?I;7_ /PE'BS1]=\8R V$'V67Q!)9CS1;B:3\?_\ @H7^
MRM_P66_X)S_LA?&/]KKXL_\ !PG\0=7T#X7Z';-HG@_3_@+8:?K/Q!\=>(-1
MM/#_ ('\":-<S>.+UK:X\0^(]1L8-1U6+3=4'AKP]'K7BN\TVZTW0KY* /[@
MJ*_)'_@ACXA_:]\:?\$O_P!F+X@_MP>,->\<_'CXE:#XB^)%SK_BO[*/%5QX
M \=>+M<\3_"U?$2V>E:3'#J!^'^I>'YTM)();FPL9[.PNIEN+:2VM_UNH **
M_F._X.%OVC/B/X[\6_L0_P#!'W]GSQ5XB\+_ !1_X*._&+P[IOQG\3>";Y]"
M\8> /V5O"7BS1[SQUK&D>)C?V9T>;7X]-\0W]XEI9:__ &WX,^'7C[PMJFER
MVWB&UTO7OTO_ ."@_P"W!\-?^"0_['_PZ\4>'?@'\2/C/)-XE\#_ ++W[-G[
M/?P:M)KW7/%7CR7P!XLU3X=^"'OYHM<UC1O#,7AWX:ZG:7^OZ=X?\<>(;.."
MV-AX4\1WTZVK@'ZA45_"M\*/VW?^"Y"?\%O?^"<?PN_X* >-M ^ ?P\_:V\.
M^)?B#;?L<?!R\MH/#/A7X>:3X4^+USX?T7XF Q:SJTGCAO$7AR#4M92X\=^(
M+YX;2RTO5UTB*V;PQI_]U- !15'5-3LM%TS4=8U.?[-INDV%WJ>H7/ES3?9[
M*PMY+J[G\FWCEGE\J"*23RX(I)GV[8XW<JI_B\_9_P#B_P#\%A_^#B+Q!\8?
MCE^SA^UYKO\ P2B_X)X>!O'^I?#GX+R^$OA_:^-/CC\5]8T"VTV\U/6-=O\
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M&NS76M3W]S+_ #Z_\$\/'EQ_P3?_ ."Y7[9/_!)O7-4N-'_9V_:ST6+]M/\
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MX-;O^"87Q._9E@\>?\$SOC-XP^'O[0>GZ98>+?V>_P!LCP5^TAXB^)OA^_\
M%NG0KJFBW&LZIX%UJ3PPOA[Q+;W5O;W7B;X8:?HVO>'HKK3_ !+H,>J1V=QX
M>\0?MG_P4@^*?_!,+78OA#^PQ_P4<G^&WB)?VQO$Z>$O@Y\+/B/X?\22Q^*?
M%AN(/"PUWPQ\0-)L;6S^%7BG0'\6QV6C>.X?&_@?Q5IM_KEKIG@[67\2ZWI.
MG:A^!_[<7_!N5^SQ^PC\"/CA^VK_ ,$Y?VQOVD/V"/B5\!/A[JGQDM]-N_C/
M<:C\%/%NL?"G^VO%OA[1O%D^KI8>+5O-:CO+WP)HLNN>+?%F@++J^G0S^"M;
MEU#Q#:>)P#]<_P!OKPK^T!X&_P"" 7[6_@S]JCX@>&?BM^T-X6_8#^+^@_%C
MXE^$+22P\/\ CSQ5I?@'6K.X\5V=E)H?AHVL^MVL5K?ZE!'H.EV\>J3WJVMH
MEL(2WRE_P2U_:IT?]B'_ (-A?@Q^UEK6DV_B&'X$_LO?&+QUI7AB[U(Z-:^+
M/%EE\6?B9:>"/"%SK"VU[)I,'BWQE>:%X<EU.&PU">P35&NH-/OYHDLYO*_A
M]^U_\;OVZ?\ @U ^/_[1O[14]MJWQ;\1_L9_M=>$O$WB^STI-%M_'X^&.K?$
MGX<Z;XVETRWBATZWUC6M.\,6P\5/HR1:+=^+K;7KS2K#1+.XB\/Z5\^^!_@1
MXQ_:1_X,P[+X6> =&U+Q%XL;]F;6?B/IFA:,5;5]6C^!W[66H_'#4[#2[4VU
MW-JFHW.D_#N_CLM#L;>75=?N&CT72 NJ7]FZ@'.?\$[?^""W@K_@JU\#?"W_
M  4Q_P""POQ?^-?[2?[0/[6WAVY\?>"/!^D?$>Y\'> _@]\'?$=YJ^I?#C0?
M#L'ALRW5I_HNK3>-M%\):'J'A[P#X*MM?M/"C^!9]2T_Q!J.M6O#/A'XE?\
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M^$_BAHW@F?7;]4UG6X_"L.J^()]6UZ[U/7M6_HSK^0+_ (,J?^467Q\_[/\
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MH;6*8 _1S_@F+\4[OXV_\$Z?V'?BQJ5W/?:SX\_95^!7B+7[FZD>:Y?Q'?\
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M*5_$'_@J=I_B[XO3?M!?$CX-V7P0USP=>:_X,D^#=IX3L=/\$:;#J&D^'H/
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M*^*[?2M7U>*WG;51\/+[P'INOZO?7OB3Q3IVOZ_>7U_=_P!#M% 'X*_L,?\
M!NK^P3^Q3\9;3]IC5;WXQ?M:_M+Z9?IJ?A_XS_M7>,M/^(^L^$;^RMM*L-"U
M+PMH=EH&A:!;:[X;L=&L8O#OBO7+/Q#XMT"8W#:!KNE6BZ?8Z=^VOQ(\(7OQ
M \ >,_ VG>.?&OPROO%_AG6O#=K\0_AO<^'[+Q_X*EUFPGL%\2^#+[Q5X=\6
M^';'Q-I'GF\T6]U?PSKEE9W\4%S)IUP8@E=K10!\4?\ !/\ _8!_9U_X)J?L
MX^'_ -F/]F?1-8LO!6E:QJ_BKQ!XF\6W>EZK\0/B-XWU_P"RQZQXZ^(>O:-H
MOAW3]<\47MAIVD:*ES9Z)I5AIWA_0M"\/Z3IUAH^CZ?96_S?^W%_P2"^"O[9
MGQF\,?M.^&?CA^T]^QG^U/X:\ ZO\*KC]H/]CKXG6WPH\>>-_AKK$\$S>"_B
M)<3:!K:^(M+T=UN+CP[>V$FA:]IE^^G7$VL7UOX=\.6>E?K/10!\ _\ !/#_
M ()Q? ?_ ()L?"?Q9\-O@UJ?Q"\<^(?B?X_U3XL_&CXR_&/Q0?&_Q<^,'Q/U
MVQT^RUCQ;XS\4/9V/G/<C3Q<6^EV=K;:?;7U[J^KO'<Z]KVOZOJGX,_L2>#-
M/_X*G_\ !P+^U'_P4X#IXN_98_X)Y^'K7]CK]D[QAIJ7*>'_ !9\9+'PQ=1?
M$B_BNKV^4Z]9^#7^)GQ5URS%MH$.B7,/Q1^'/B32=3FO-$34=:_KDK)T;0-"
M\.6TEEX>T32-"LYKAKJ6TT;3;/2[:6Z>.*)[F2"QA@B>X>*&&)IF0R-'%$A8
MK&@ !K4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
MSS_\$!/O_P#!4W_M)Y^T#_Z3^':_H8K^>?\ X("??_X*F_\ :3S]H'_TG\.U
M_0Q7U/&O_)39EZ8'_P!5V$,</_!A_P!O?^E2"BBBOEC8**** "BBB@ HHHH
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M -CG+_\ U(@8XC^!6_Z]S_\ 26?O7H'_ " M%_[!.G?^D<-:U9.@?\@+1?\
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M2?\ YP]'_#VC_@J'_P!($_C[_P")'Z3_ /.'K^A>BC^W,B_Z(O)__#IQ-_\
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M?K_2U_GH_P"'M'_!4/\ Z0)_'W_Q(_2?_G#T?\/:/^"H?_2!/X^_^)'Z3_\
M.'K^A>BC^W,B_P"B+R?_ ,.G$W_SZ_J[\K'LZO\ T$5/_ */_P K]?Z6O\]'
M_#VC_@J'_P!($_C[_P")'Z3_ /.'H_X>T?\ !4/_ *0)_'W_ ,2/TG_YP]?T
M+T4?VYD7_1%Y/_X=.)O_ )]?U=^5CV=7_H(J?^ 4?_E?K_2U_GH_X>T?\%0_
M^D"?Q]_\2/TG_P"</1_P]H_X*A_]($_C[_XD?I/_ ,X>OZ%Z*/[<R+_HB\G_
M /#IQ-_\^OZN_*Q[.K_T$5/_  "C_P#*_7^EK_/1_P /:/\ @J'_ -($_C[_
M .)'Z3_\X>C_ (>T?\%0_P#I G\??_$C])_^</7]"]%']N9%_P!$7D__ (=.
M)O\ Y]?U=^5CV=7_ *"*G_@%'_Y7Z_TM?YZ/^'M'_!4/_I G\??_ !(_2?\
MYP]'_#VC_@J'_P!($_C[_P")'Z3_ /.'K^A>BC^W,B_Z(O)__#IQ-_\ /K^K
MORL>SJ_]!%3_ , H_P#ROU_I:_ST?\/:/^"H?_2!/X^_^)'Z3_\ .'H_X>T?
M\%0_^D"?Q]_\2/TG_P"</7]"]%']N9%_T1>3_P#ATXF_^?7]7?E8]G5_Z"*G
M_@%'_P"5^O\ 2U_GH_X>T?\ !4/_ *0)_'W_ ,2/TG_YP]'_  ]H_P""H?\
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MZ3_\X>C_ (>T?\%0_P#I G\??_$C])_^</7]"]%']N9%_P!$7D__ (=.)O\
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M^O\ 2U_GH_X>T?\ !4/_ *0)_'W_ ,2/TG_YP]'_  ]H_P""H?\ T@3^/O\
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M .'3B;_Y]?U=^5CV=7_H(J?^ 4?_ )7Z_P!+7^>C_A[1_P %0_\ I G\??\
MQ(_2?_G#T?\ #VC_ (*A_P#2!/X^_P#B1^D__.'K^A>BC^W,B_Z(O)__  Z<
M3?\ SZ_J[\K'LZO_ $$5/_ */_ROU_I:_P ]'_#VC_@J'_T@3^/O_B1^D_\
MSAZ/^'M'_!4/_I G\??_ !(_2?\ YP]?T+T4?VYD7_1%Y/\ ^'3B;_Y]?U=^
M5CV=7_H(J?\ @%'_ .5^O]+7^>C_ (>T?\%0_P#I G\??_$C])_^</1_P]H_
MX*A_]($_C[_XD?I/_P X>OZ%Z*/[<R+_ *(O)_\ PZ<3?_/K^KORL>SJ_P#0
M14_\ H__ "OU_I:_ST?\/:/^"H?_ $@3^/O_ (D?I/\ \X>C_A[1_P %0_\
MI G\??\ Q(_2?_G#U_0O11_;F1?]$7D__ATXF_\ GU_5WY6/9U?^@BI_X!1_
M^5^O]+7^>C_A[1_P5#_Z0)_'W_Q(_2?_ )P]'_#VC_@J'_T@3^/O_B1^D_\
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M?_G#T?\ #VC_ (*A_P#2!/X^_P#B1^D__.'K^A>BC^W,B_Z(O)__  Z<3?\
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M4*5E[S[P;[]>OD?ST?\ #VC_ (*A_P#2!/X^_P#B1^D__.'H_P"'M'_!4/\
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M*/[<R+_HB\G_ /#IQ-_\^OZN_*Q[.K_T$5/_  "C_P#*_7^EK_/1_P /:/\
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M-_\ /K^KORL>SJ_]!%3_ , H_P#ROU_I:_ST?\/:/^"H?_2!/X^_^)'Z3_\
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M .D_AVOZ&*^IXU_Y*;,O3 _^J["&.'_@P_[>_P#2I!1117RQL%%%% !1110
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MB1Y)%4_RX_M<:5\";C_@X=_X(L:E^Q[;_#&X\<V_PK_:&?XV'X(2>')[>Q^
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M]1U1XM+^&LNEZA8+I%K;6>I 'ZN?\&H7PV\8>(_V4/VK?^"@OQ*L=+@\>_\
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M+X@T?P[K\MC>P7%O-?\ AN3Q%<:]X=NMB76B>*=.T/Q%IL]MJ>CV4\?Z^_\
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MNF:G-ILGCC3(Y]"\9>)]"\*R60U'7_#'PMBUGQ%XJ_T70M#UC0[*^U7QMX4
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MNK6]WINIV%U&=EQ9WMM/;S(2LD;#BOX7_P#@HO\ MOZY_P ',L7P;_X)T_\
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M_P 5ZCXIO_!GVW^PQXJ\.^*M,\'7WB?X6:U=KH8\8>$=9\,:S/#I(U5HK?\
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M[::->>(I0#^P2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  E/AS1_$/\ 8VIKLVZCI/\ :UG=_P!G7Z^6FV[L_)N!L3$@VC'644 %%%%
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MW%SJ^IVEK#>ZE/<+I]@LTUY/-)*+&T#LPMH=G2T44 <UXD\%^#O&4=G#XO\
M"?AKQ5%I\\=U81>)-"TO7([&ZBNK2]BN;--3M;I;:>.\L+"[CFA"2)=65I<*
MPEMH73I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _GI_X(&?\ (5_X*O\
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M /YI:_H6HH_UOS;_ *!^'_\ Q%N&O_G5Y+[@^KT^]7_P=5_^3_J[\K?ST_\
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M_/3_ ,.W?^"TG_2<;5/_ !$KX?\ _P TM'_#MW_@M)_TG&U3_P 1*^'_ /\
M-+7]"U%'^M^;?] _#_\ XBW#7_SJ\E]P?5Z?>K_X.J__ "?]7?E;^>G_ (=N
M_P#!:3_I.-JG_B)7P_\ _FEH_P"';O\ P6D_Z3C:I_XB5\/_ /YI:_H6HH_U
MOS;_ *!^'_\ Q%N&O_G5Y+[@^KT^]7_P=5_^3_J[\K?ST_\ #MW_ (+2?])Q
MM4_\1*^'_P#\TM'_  [=_P""TG_2<;5/_$2OA_\ _-+7]"U%'^M^;?\ 0/P_
M_P"(MPU_\ZO)?<'U>GWJ_P#@ZK_\G_5WY6_GI_X=N_\ !:3_ *3C:I_XB5\/
M_P#YI:/^';O_  6D_P"DXVJ?^(E?#_\ ^:6OZ%J*/];\V_Z!^'__ !%N&O\
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M_B)7P_\ _FEH_P"';O\ P6D_Z3C:I_XB5\/_ /YI:_H6HH_UOS;_ *!^'_\
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M2?\ 2<;5/_$2OA__ /-+7]"U%'^M^;?] _#_ /XBW#7_ ,ZO)?<'U>GWJ_\
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M (B5\/\ _P":6C_AV[_P6D_Z3C:I_P"(E?#_ /\ FEK^A:BC_6_-O^@?A_\
M\1;AK_YU>2^X/J]/O5_\'5?_ )/^KORM_/3_ ,.W?^"TG_2<;5/_ !$KX?\
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M_P#)_P!7?E;^>G_AV[_P6D_Z3C:I_P"(E?#_ /\ FEH_X=N_\%I/^DXVJ?\
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MJG_B)7P__P#FEK^A:BC_ %OS;_H'X?\ _$6X:_\ G5Y+[@^KT^]7_P '5?\
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M ,1;AK_YU>2^X/J]/O5_\'5?_D_ZN_*W\]/_  [=_P""TG_2<;5/_$2OA_\
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MX/J]/O5_\'5?_D_ZN_*W\]/_  [=_P""TG_2<;5/_$2OA_\ _-+1_P .W?\
M@M)_TG&U3_Q$KX?_ /S2U_0M11_K?FW_ $#\/_\ B+<-?_.KR7W!]7I]ZO\
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M5/\ Q$KX?_\ S2T?\.W?^"TG_2<;5/\ Q$KX?_\ S2U_0M11_K?FW_0/P_\
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)E%%?);F^Q__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img12876764_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_9.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +J!, # 2(  A$! Q$!_\0
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MJJBOY5?^(O'_ ()E_P#0+^+7_A/K_P#$T?\ $7C_ ,$R_P#H%_%K_P )]?\
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M\1>/_!,O_H%_%K_PGU_^)H_XB\?^"9?_ $"_BU_X3Z__ !-'^KN??]"C,/\
MPFJ__(^:^\/;4O\ GY#_ ,"7EY^:/ZJJ*_E5_P"(O'_@F7_T"_BU_P"$^O\
M\31_Q%X_\$R_^@7\6O\ PGU_^)H_U=S[_H49A_X35?\ Y'S7WA[:E_S\A_X$
MO+S\T?U545_*K_Q%X_\ !,O_ *!?Q:_\)]?_ (FC_B+Q_P""9?\ T"_BU_X3
MZ_\ Q-'^KN??]"C,/_":K_\ (^:^\/;4O^?D/_ EY>?FC^JJBOY5?^(O'_@F
M7_T"_BU_X3Z__$T?\1>/_!,O_H%_%K_PGU_^)H_U=S[_ *%&8?\ A-5_^1\U
M]X>VI?\ /R'_ ($O+S\T?U545_*K_P 1>/\ P3+_ .@7\6O_  GU_P#B:/\
MB+Q_X)E_] OXM?\ A/K_ /$T?ZNY]_T*,P_\)JO_ ,CYK[P]M2_Y^0_\"7EY
M^:/ZJJ*_E5_XB\?^"9?_ $"_BU_X3Z__ !-'_$7C_P $R_\ H%_%K_PGU_\
MB:/]7<^_Z%&8?^$U7_Y'S7WA[:E_S\A_X$O+S\T?U545_*K_ ,1>/_!,O_H%
M_%K_ ,)]?_B:/^(O'_@F7_T"_BU_X3Z__$T?ZNY]_P!"C,/_  FJ_P#R/FOO
M#VU+_GY#_P "7EY^:/ZJJ*_E5_XB\?\ @F7_ - OXM?^$^O_ ,31_P 1>/\
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MFC_B+Q_X)E_] OXM?^$^O_Q-'^KN??\ 0HS#_P )JO\ \CYK[P]M2_Y^0_\
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ME_S\A_X$O+S\T?U545_*K_Q%X_\ !,O_ *!?Q:_\)]?_ (FC_B+Q_P""9?\
MT"_BU_X3Z_\ Q-'^KN??]"C,/_":K_\ (^:^\/;4O^?D/_ EY>?FC^JJBOY5
M?^(O'_@F7_T"_BU_X3Z__$T?\1>/_!,O_H%_%K_PGU_^)H_U=S[_ *%&8?\
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M^:^\/;4O^?D/_ EY>?FC^JJBOY5?^(O'_@F7_P! OXM?^$^O_P 31_Q%X_\
M!,O_ *!?Q:_\)]?_ (FC_5W/O^A1F'_A-5_^1\U]X>VI?\_(?^!+R\_-']55
M%?RJ_P#$7C_P3+_Z!?Q:_P#"?7_XFC_B+Q_X)E_] OXM?^$^O_Q-'^KN??\
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MOZT_R1!]DLO^?&R_\!8/_B*/LEE_SXV7_@+!_P#$5/11=]_ZT_R067;^M/\
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MOZT_R1!]DLO^?&R_\!8/_B*/LEE_SXV7_@+!_P#$5/11=]_ZT_R067;^M/\
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MV7_@+!_\11]DLO\ GQLO_ 6#_P"(J>BB[[_UI_D@LNW]:?Y(@^R67_/C9?\
M@+!_\11]DLO^?&R_\!8/_B*GHHN^_P#6G^2"R[?UI_DB#[)9?\^-E_X"P?\
MQ%'V2R_Y\;+_ ,!8/_B*GHHN^_\ 6G^2"R[?UI_DB#[':GB/3K65S]V**SA>
M1SV"(J%F)] *=_9.HG&/!&M,#]UE\-3LK#U4BWY'^-?3O[$OA[2?%_[7_P #
MO"WB"VCOM#UCQ-:6^H6<JB2*>)KF)2KH>&!#$$$<_3BO]%G]J'1O^":?[!_P
MM\$^,/C7\'_"?]E:EIU@B73:1:KF5[>(N\K;0,[F_P!K/!)YP/B>*.-5PUCL
MNRZ&4XO-<7F4)U*%+"3C&?[N48\J4HOF;MTV-Z.']M&<N>-.--J[DFU]AW\M
M-#_,$:UB@<1WVB?V9,WW(=2TQ+.60>L<<T:L_P" -/\ LEE_SXV7_@+!_P#$
M5_H'?MA?\$M_V%_^"C_[)&J_M+?LK:%:^&_&FAZ%=:UX8N-'6*VT]EL;9[FX
MANH$7#YA&]7W'E74JN!G^'[X2?LC_M&_'GXDZS\,/@_\--?\=:GX=UZZ\/ZW
MJ6D6LLEII\UG+Y4UQ-(L;1!%(+$[@  <\FNKAWC'+>(,)C,0U/*Z^65%2S+"
M9A*%*6#G?W7*I)J+@^6UWROFC)6>C<U</*BX)_O%-)PE#52MR[*]]TNRM^/S
ME]DLO^?&R_\  6#_ .(H^R67_/C9?^ L'_Q%??\ ^T+_ ,$O?VW_ -FJ)-2\
M:_!3Q3=^&([0WNH^);>U>2PTR%4$DAN9(HF5=@/S;B,8STS7AG@']CW]K7XM
M>'6\9?"KX#^,/'/A&.4P2:]I%I--:)*K;70LD3C*L0#R,<U[U'-LMKT(XJCF
M6!GAI.,576*H>R4G;EBYN:49OETC*TG9M)K4SY)+1TYIJVG+)OIKYI66O^>O
MSD;6R )-E8@#DDVL  'J24XJ-(],D8JEOIKL.JI#:LP^H"DU^F_A#_@E+^V4
MFO?"B]\<_!7Q79^&_&_BBQTC5M+:V=+RUTZYFC1[I@4#*JHQ/3CGIW_<3_@I
ME_P;_?#[]G3]DK2OBQ^S+\/_ !=XJ^*,&EVNH>)M*B+3&P1;**>_EE0;R%A=
MGW<#&T^U>-C.,N'\#CLMP%3'TJM7-*LZ.'J8>=&KAZ<Z<HQE]8JJHHTHWLDY
M:2>S>II'#U91E-0:4%%OFNG9\K5EU:2U]/4_D)^R6G\.GVCGLJ6<+,Q]% 3)
M/M3AI.H, 4\$ZS(A^Y)'X;F>-QZHRP$,/<<'M7K/[/\ HT.M_';X=>%_$5ME
M9?$ECI^NZ?(N6AN4O(([JUE4_P <;%D92,YZU_H^_&7P]_P3A_84_91^%7Q@
M^._PA\+RZ%?Z#I-H;LZ-#)-/?2V5K+*TI2/.6:=<$YW8+'&3GDXIXQ7#.)RS
M!PRS%9MBLTG.&&H824(SE*FHOEBI)\SEI9+6ROW'0P_ME.7/&G&G:[E=_P N
M^NEK6ZZG^9*]F("!?>'IM-S]W^T=(%GN^GG1+G\*]>^"/[/'Q/\ VD_&,?P^
M^"?@RW\6>+9!N-A#9QNL2!2^^4QQ_(FWG<Q ]#Z?WX_$S]@[_@G'_P %0OV3
MO&/Q@^ 'A6P\+:IHGAS4]8TF^TVVCL8X)=-TZXOMDX94R)(XB=Q88*A=A+C;
M^4?_  0A^#6B?LV?!_\ ;P_:\NM).J:K\)]&\2:%I-W(BRJDFDPW,"RVC<LD
MK>6,.@';OR/(CXCX?$9-FN+P^ Q&%SC+<1A<$\KQT4K8S&5H4,/&4HM.4'*[
M=K-.#5NI?U-QJ4XN:E"<7+GCUC%1<K=K66K7XW9_-3X?_8A_:5\6_%?7O@=X
M:^$USJOQ)\+/)'KUC:Z0\VGV4L6?,B>]CB,2R J?D9L^PY-=IJG_  3@_:YT
M?PWXU\6WGPGM)-'^'$;2^-4M;9+B_P!(C4$L\MI&AE0  DEEQBOZ7_\ @A1_
MP4\T/XV_MA^(_A+I/PYTO^U/BQJ%[XHUSQ5K-BL^L1SK>7"-!#>R+YBQ%204
MWXZ#M7V-^R1XQL;O_@K]^W_\ /%<BZEX0^(WA768X_#E_F?2HI(+*?#VUH^8
MD;<N> ".QZ5RYGQMQ#EN-S/"XC*<+1>593A<VG&4I5*F*HRQ%"CBN3DDE15I
M5'14N=Q5-.3=RH86E.-.49R:G4E3NM%%I)Q>NKMHG:WRMI_ 4+6SRRMI]I&Z
M$J\<EG"DD;#JKH4RK#T/-*+%9G$-CH3:G=-]RSTW2UO;MQZI;PQ-(P^B]C7L
MO[3VDV/A']J+]H[PY8QI;:5X=^*7B#3K&WC 2*"VAO)$CCC0#"*N<!1P/PK^
MJK_@W4_X)Z?#Y_AK\5/VW/V@?"%IXB'@S1]7O/ VG:Y;1SZ3<VEC8W6HB>2&
M="DN5MO*7CYGD09&<U]GG_$F%X?R59UB*<ZL:E/"O#8:,E&IB*^*C3=*A"35
MKIRCSR2?*DY6:.>C2=:HJ<=&F^:6Z2A:[M?K966Y_'C+81VF4U'1!I4Z_?M=
M4TQ+&ZC!Z&2">-'0'U8#FFQZ?/<+OLO">H:A#QBXL-!>Z@.?26*%D/X&OWK^
M '[+H_X+7_\ !3SXEWN@:+I_@#X0^!_%FHZ?XZT+2+5+*W_L?3]0"JUI$BJD
M9>-"N0!G( )SFOZ:O'VN?\$6O^":E]H?[/7B7PEX5U_55AB74KK48[34;S3'
M15#F]G(!5QR\D9'[LDKO<C)\/-^/*>55\)EU+*,=F>>5\)1QF)RK \M1X&E4
MA";5:ORV<XJSBE&THV=[NQI3PKFG)U(4Z2ERQJ2^VTXK2-]$[=]/OO\ YT_D
M6BN89],M[2X7AK6ZLH8+E#Z/"Z"13[%14GV2R_Y\;+_P%@_^(K^X7_@I9_P1
MV_9'_:'_ &7O$7[;W[#ULMQKT^F'7Q8:*T;Z;<6<433W(@MXAB%[8?ZR,!L*
MRL';+*G\@G@?]CC]K[XE^%KWQK\.?@+XQ\;>#]*O+C3-2\3:39S2V$5_9.L=
M["SI"RAH&9=XSGYAZYKUL@XNRK/\%4QE*K]0EAJZPF,PV83IX:KA<5:/[J;J
M3BFVTU!Z.?*[1NFE%2A.C)1DN;F2E"4$VI1]W6RVM97]/O\ G7[)9?\ /C9?
M^ L'_P 11]DLO^?&R_\  6#_ .(K]$_$/_!*7]NSPW\(Q\9;OX(>+)=!%H;^
MXL8[.5KBVL%&9;IU6$L$B&[=Q_"?P^"=!\-^*/%GB>P\#>%M U'6_&^IW1L;
M'PS:6\S:A/>HWER6XC$99723Y2"O6O<PV88'&1JU,)C<+B84).%>=&M3J1HR
M@DY>U<6U!14;\TK*T6[[D.+BTI0E&Z35TU?:UN[T6F_J87V2R_Y\;+_P%@_^
M(H^R67_/C9?^ L'_ ,17Z<7'_!'?_@H/;?"Y/BBWP&\6LK$EO#0M7_M&. +O
M-PT0C\W8$^;[F,=/;X4\*?!;XR^/?B1=_!?P5\.M=\0?&&P,HO?A_:VTW]M0
M&$L)=T)BWGRRK D*1P<5GA\URW%QKSPN8X+$0PU_K$Z6)HSC04.7FE5:D^2$
M7;WY6@[7N#A*+2E"4>:W+=-7TBTO71:>1YE]DLO^?&R_\!8/_B*/LEE_SXV7
M_@+!_P#$5^A/PR_X)4_M]_$OQ#J?AD_L^>,_#.HZ3 ;B[&HV4R;8]NY>'A&=
MYPJX!Y.>*^5_C5\ _C)^SCXTO/ /QJ\":SX&UZ!V^QQ:O;RP_P!HVZY(NH&>
M-%:-A@@@GK3HYGE^)KO#8;,,%B,1&"J.C0Q-&K4]F^5J2C3G+F5K-M7LM7H[
ML<))*3A*,7HFTTKJUEKZ+[NMSQ[[% ^%M])BNYC]RWM=/CGN'_W(HXR[?@#S
M0; 1';>: ^G2=HM0TI;20_1)8E-?IE_P1O\  WA;XF_\%'_@?X(\;:9;:UX8
MU6Y07^FW<2SV\X-RJ_/$X*L-OJ*_5+_@YF^ /PG^!WQ?\'+\+O"NF^%8M0TV
MR>[MM,M8K6 O(J,_RQJH;EB,X&?TKR<3Q+1PW$V X9EAZLJ^.P4\;#%*4?9T
MXTY<O(X6NV^3>ZZ::EJB_8SKW7+"2CRZW>D6G?[K_+?6_P#+W]DLO^?&R_\
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M<3^<UNI^I_G24K=3]3_.DK^R3Y^.R]%^04444#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **CED$4;R-T12Q^@&:_9+_@
MGC_P1C^*_P#P44\(:WXR\'>+E\,Z;HH4G?@"8N551DC&"S@=L9ST&3PYEF>
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M_8D:/_Z(CK\@*_7_ /X.)_\ E-!\8_\ L2-'_P#1$=?D!7]I>''_ "161_\
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MLITXOV575**DXNR:NB,$TJ>(C>"E+E4?:NT9/JW?=/5]3N_@-\1OV9?VN?\
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M)Z=X5UEO#&N>)&%G),]Q97!58WD"HQ8D8 Y//7I7\2_Q(\>^*OC!XIU?QO\
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M$XWSR>8@5W,DS,S98\DYS7X#VL!MK>&$N9&CC5&D.2SE1C<Q/))]3S7TG"V
MQM'&<39GC,.\)_:N;.6&P[2C)X;"TJ>'AB91WB\0X.=I:R5I/<QK2BXT(1?-
M[.G[TM_>EJXW\KZ?U:Q1117V!D%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 /C^^OUK^U/_@S,_P"20_M@?]E.T_\
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MD-Y^S@U*=OABTWHQ:/6R:5KRT:CVN^EWMYGBU0"W1+D7L.8+P<"YC)64#TW
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M* "BBB@ HHHH _ROO^#B?_E-!\8_^Q(T?_T1'7Y 5^O_ /P<3_\ *:#XQ_\
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M;X??M>Z#X*L?B/9^.?#TFE)X-\EX],TP-"8M+F\K/ER1#"&,MD8Q@]:_._\
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MOXF^'=^)#?Z--?7*BZ=XV!D2-"[8R  !QTQ7NNL?"G_@G#_P2,_9W^''B_\
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MHTXR3A2C9*HN;FY?==1C!RPZ@I0DZ+DVN7:R\M6]VW?331ZGX)?!G]E[X_\
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M%GA+2M;@O]0T32U1I'G>SMY&F$J(I8QE=P/!'%?M7_P3=^(7@_X6:W_P5/\
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MZ+XD\(ZQX,N-;U;4=!01Z9=:U-;L\OF(G#$N><\YP?:OQ)_:=_;-_:;\*_\
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M!'P#T"+P]\1GCF,UMK&JP0+;F9IE8I-MDC)#'=QZ=_Y^M&\2>+/"T\MYX/\
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MXR<J<XN%IV;NM!*K)145R-<_M+M:QE=2O'LG;9WTL?HW_P %?OVEOA;^V?\
MM*2_%#X'3WMUX3;08M/$NI+Y<_VE#$6&"!\OR'L?SK[>_;C_ ."AW[-GQ[_X
M)O\ [*W[,?P\OM7F^*GPC\+0:3XRM[J,K917D=O'&PMWV_,-RL>N,=S7X$Q"
M)%Q (U3TB"JOY)@=OTIOEV\3-)LAC9OO2;41F/\ M/@$_B35KAW+U1R&@GB.
M3AVJZN7?O5S2FZ4J'^TOD_>KDDW9<GO6=P525ZDO=_?*T]--U+W==-5UO;0Z
M/P-XN\1?#;Q7X8\=^%+E[+Q)X6O[*^T^ZC.UXF@GCDEVL#_$B$5_3Q\3OVA_
M^"6'_!5#P#\,K[]JKQSXD^&7QY^%OA.TLO$=[I$12'6[2RAC6Y+S(F))I1&Y
MP6));H>E?RS"6(])8SGIAUY_(TSR(E9I(P(78$/)#MC=U/57=1ET(ZAB16F:
MY'0S2KA,5]9Q>7X_ ^T6%Q^!G&G7IPK1C&I3ESPG&I2G%:P:W:DG?=4YN"E%
M*,X2Y>:,]4^6S3TMK;K]UKG]7_[87_!43_@G7K?_  3(\3_L(?LR7_B&;6-)
MA@L/".IWUMY7]I36:/"]W<N8U;>9-K L<?(N,&OEC]AC]NK]DGXI?L5Z=_P3
M^_X*)WVJ0Z%I$WG^!/'UG'Y^IZ1J!C(14DVNT<<+,-AR.G3'%?SQI'8Q,&1+
M1'!X95A5L_[P .3WJ5HX9L.51V'W9 %9U/JCX)4^X->71X+RG#X"K@:5?,4Z
MN9?VQ''2Q*ECZ.9<L8O$4:_LTH\UKR@XN,E.2:LT6\14E-3_ ';M!4^2WN.&
MCLU=O?9[[:G]/^A?M7_\$U_^"7/[/?Q7^'O[#GBWQ#\9_CG\4;#4]"NO$GBJ
M EM*T75XW2XMK:XD3<$59&7"OCCIG%?,G_!,C_@I-\%_AG\*/C?^RS^VW]NN
MO@=\9[W4)[2]M(_M%SX<N]9D=I);-2)"FR69F)"C&._;\&O*@C;S7";_ /GM
M(%W_ /?Q@#^M#BVG 5Q#,/X0VR3D<C .>1U&.E:+A#+9X3&T,77Q^-Q.88C#
MXO$YI7KQ>8?6,(XO#5:-6%.,*+P]K4U"G9*3333:$J\U*#2A'D3C&"7N<LK<
MUT]6Y=[[M']-6C7?_!#3]A?0OB3XA\#Z[KO[1GQ.\>>%;L^ ?"'BZV^U:#H<
MEW%)]CE5I8V2*>(NF1A2& Z 5XM_P2H_X*,?LK?!?P#^TI\!/VQ?#K:/\&/V
MA]5U.^GT_1;=98] %U-)]EEM(PC@/!$R,A51AE [5_/]]GB+*\BB:1!A))@L
MCQKV6-F&44=E7 I9([>?Y94AFQQM=4DQ^# XXI2X2P=?!XS"X[,<XQ]7'3PM
M6KC:^,MB:,\%.,\-+"<D(TL/[.<5*\:;E*6LI/8%6FG&484X<JDE!1]UJ5N;
MFZMO7R[:'];G[)/[<?\ P1@_X)YQ_$V#]G[Q7XT\<W'Q.M-6BO-6UVS<76EK
MJ-O-'':V[/%D1PF0(N. !D&OD+]EK_@I'^S!\)/@O^V7X&\87^LIK_QNU[Q'
MJ'@1((R8IK;4WF:U-R0IVLPD4GTZ<5_.W]EL8Q_Q[6J#U,,*CVY*CFIC# Y5
MC%$Q7&QC&C%0.FTD'&.V*R7!.5MXNIB,7FV+K8ZI@JF)Q.)Q4*E:I/+YJIA[
M.-&$8J+]V48Q2<++2[8_;U+125.*C=148V24DE+KOO:_6Q^Z?_!$W]OK]G;]
MA1OVB3^T!>ZK9CXE6OBN'PO_ &9&9#(^KK<BR\[ . WFKNZ=>.G/@'_!/#]K
M7X.?LV?MW_$']H'XH7%_!\./$GC;7]=TV>R0M=G3]1>5K8NF"0Q5P",'G/IB
MORIF6V<J+A8'(^Z)A&Q'IM#YQ^%*1;RJ(R(95 P$.QU [ *<C'MBO2K<.9?7
MK9W7F\3SY_AJ.%Q_+52C&E07+#ZNN1NG.S]Z3<KNVB)56452BG&U&3E#O=VO
MS=_)*V_F?O#^S+_P5(^'_P #OV_?VC_B3KRWNL?LF?'B^U%-2TR529S8:GYJ
M3WAB[3I'("I"9[BOHG2/ 7_!OG\*?B;'^U/??$GQ[XSTSQ7/JFKZ3\*;R2]D
MTI]8OS)=-;7UN694@2X*HN5QM/IDU_,LZ0^7Y;I%Y0XV.J>6!Z;2-O3MBH#'
M9L%C=H9(D.8H)#$\,1_Z8Q$;4Z_PBN2OPGA*M257"9AFV5NMA,/@<8LNQ,:*
MQV'PM)4:7MVZ4FJZCHZ]/DFTVKW::<:TDDI1ISM)SCSJ_+)M-\NNU[V3TU7J
M?NU^QM^W]^RW\$/V_P#XF?'[5/"?_"MO@GK&GWVE^$=&\/1EMULZ2):RR)AB
MK$%<@X[CJ*_-;]H#XM>#OB+^W1=_'_PS)</\.IOBQX<\81S3#%W_ &+IFJ+=
MW3%2 ?,$*DJ,<G&*^5FBB=0C1QN@QM5D5E'I@$$#VP*"T4:A&,:*00$)55(/
M4!3@8/<8Q7HX7),%A,95QU)XAUZ^74<KG[2LZD7AJ"2@US)S=:6O/4E)\S=[
M=I<Y2BH2Y;*;GHK/FE;3M:ZLE;:W4_8?]N_]O#X7?%?_ (*9_"_]LCX&+=:O
MX'\!^"_!VC3Q:HFV:74]'AM8M23:RCY!Y3[,C' SG)%?1?\ P5*_:G_X)S_M
MHZ3\./VFOAAX^\9Z'^UYX*T?3(/^$*2%X_#RZG;Q!9IT<($#1R1QE23QDX(%
M?SV1K"JE(5B"9)*QA N3U)5>,GN<4U;:VC<RK!!&YY,BQQJWU+A0?UKDAPQE
M]*>35*%;'4*N1X5X'"SI5HIXC!STGAL8I4I*M3J)OFY5"3NE%HIU9M5$U!JJ
MU*5T]):>]#JMM+MG].EC^U1_P3D_X*7_ +.'PC^!W[=GBSQ+\//C=\+],-II
MOC'0Y)XFU"UM(%13<W$)&6\M. SGG ],?+'[6_Q._P""3WPP_97@_9T_8T\-
MWOQ2^)MMJA@U[XH>+Q.=6M_LTV6>UFF.73*AE.3D8_#\,62#=YX*1R8P+B,H
MDH!X($H^;!Z$9P>E)&MI&Q:(6ZN_WG7RQ(Y/4LPPS$]223FLL/PIAL+7ISH9
MEF\,#1Q<L=1RF&+4,OIXF4Y3G[D*<:KH.4^94'5Y%*]U9I!*LY)WC3YG'E=1
MQO-Q]U+5Z7TM>U]C^E_X1?MG_L/?M[?L8^$OV/?V_-<U3X9>+_A381Z9X ^(
M'A^)3?IH5OA4B\]49@3&@&W=@Y(QZ_67P/\ ^"CG_!)?]B+]DSXV?LG?!K6O
M$FMZSXDT.]TO3?'-Q9G^T?%-S);&VC.HW!C5RJMD8;<&W \;!7\>31(S"0#;
M)C E0 28]-^,X/IFF?9+8D,UO"SCG>\4;/GUW%<Y]\UQXG@;*\4JM">.S:EE
MU3'+,HY70Q,*>#I8U5(UI581=*4U"=1.3I.;@FY224FFJCB*D;-1IN?+R.HX
M^\XV2MII>UU]QK^,+S^U?$WBS5]+^:#5M7N;VP+\$P33.Z[L]PIP?Q&#CG]X
M_A1_P4#_ &:/V8?^"7/Q#_9Z^ 6O:]I?[5'Q6NXKWQ%JT,;0II[84S0V]PH5
MMK'=]UP#UZD5^!HXZ<8Z8[5$((0_FB&(2?\ /01H'_[[QN_6OH,RRG"9K2PE
M#%NLZ&$Q6'QD:-.:C3KU,*XRHPQ$91E[2DI14G#2[6NFAE"4J;DXM7E%Q;:V
M4G[SC;9VOWZ=CW_X:?M9?M&?##Q[X3^)5E\0M=U?6?#FJV6HS:?=7MP;>\;[
M1%)>B0-,0=T8D)#9R?T_7?\ X*,?MT?LA?M9?&[]B[]J?P1J^MP?%;X3+X9/
MQ@T"2 1V'GZ?]F_M&>!E11))F.0@EBQQU.3G\#JB6"!"Q2&)2_WRL:*7_P!X
M@#=^.:SQ.1Y?B<=A<Q]G+#XK"4,7AH3PSA1C5PV,I>RK4*\5!^TIJ-Y0U4HS
MUO;0<9RC&4+WC)Q;YO>:<6FFGNKVL_P/ZK/VSOC1_P $'_V_/%?AKXC_ !9^
M/?Q;\'>)=-T;1[2^TS2+2<VINK.RC@N(UVI@H9 Z\CH!7G7Q^_X*8_L2? +]
MA_5_V*O^"?DVL>,-$\8PO8^*/$GB6#RKUK63<&?+JC%B&)QG.>F.H_F/>STY
M3F2ULU+'JT,*Y/XJ,FI88[.,XMTMD;I^Z6)2<=OD )KQJ/!.7TH8&A5S+.\;
M@<NK4Z^$R[&8NE/!4ZM)ITI.%/#TYS5.6L%.H[.SZEO$3;E+EI1G-6E.*?.T
M^6ZNWUM^*/Z&?^">?_!4_P"!.@_LWZY^Q;_P4!T5_%GP2O\ SQH>OO"MYJ7A
MI9W+)]@WK*\?DJ05VX''M@?0?P \=_\ ! G]BKQS=_M#_#GXA>._BSXTWWFH
M>#/"'B>R:73=-U [I;.'9-"T:QPS>4JC&  2",BOY:)(HI1B6*.1?21%<8^C
M BJOV?3P0OEVGR_=0K#A?]U<<?@*TQ7!V7XBKCIT<=F^7T<SFZF88++\7&CA
M,5.:2J2E3E2G*G*K9*HZ4X<ZT>KN"KSCR7C2FX:0E.-Y15UUOJ[]^K\S[B_X
M*#?MI^,?V_/VC]<^./C'3;;2+>S,^C^$-/LXXHH;?PZAVVD>V%50%8U3J :^
M*Z3@ 8P% XZ  >W8"DWI@MO7:.K;A@?4YP*^DPF$P^!PN'P6$I*CA<+2A0H4
MHWY80@K**OOW?5MW9DVY-RD[RD[R?=]?DM$O*PZBD5E895@P]5((_,9%+70
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MPM=1;NCZO2YH7O&,H3E*$*BE:4+;22MK?9==V?D;J/\ P2:\7_#7]MS]EO\
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M\PCMH3,[,[*IQ@$<XKZ%_P"">'[.%U^UM_P2 ^+/P;M?$5GX4;Q#'%(-9O\
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M98HWD?*Y"AP3@]N37WG_ ,' WC7P?\/_ -EC]G7]EN^\567BOXY>!/"6A?\
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M)]N:MS0SVL\MK=0O;74#;)[>4%989!U1U(!# \$$"O[,_P!OWXK?L.?\$N?
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MG_P9F?\ )(?VP/\ LIVG_P#H-S7\5D?WU^M?VI_\&9G_ "2']L#_ +*=I_\
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M^"WQF^$OQ0F\<^)[JR^'/B>PUR]M%OIB;RVM95=XB-_(901CJ?KU_<3XU?\
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MCF&8SQ6&P<XQ4(5*-%P@E.$?=A)M\JV5]K=:HU)6IQY_C<(<KEJG9N_5J_\
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M>6A$)2IOF@TG9QU5[J6_SZW[^I]X?\$Y?VW=>_8-_:&7XH[)]1^'FK7FK_\
M"8^&XF8QZIIFK7$KSJ\(SYDBV\A X/S<]>*_9A/VGO\ @@YH?Q0T_P#;C@\
M_$IOB?=:Y<Z[9^"H$F&GP>*9V:62YN;4?*+3[5A@2@&T$>]?R\D \$9'H:B$
M,88MMSG^$DE![A#\H)[D"O-S+AG 9GBIXV>(S'!8BM06$Q<\NQ<L*L;A5?\
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M7-?_ /0&K^JUNA^A_E7\J7_!H7_RC,U?_LKFO_\ H#5_5:W0_0_RK^$.(_\
MD?9O_P!C#%?^G9'TM'^%2_Z]P_\ 24+7^;E_P=G_ /*3OX%_]D>B_P#26O\
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M^/=<EF%P=4UVYDN;H3*_F(X=W8@HX#+@CD#TKQLMX+Q%"5.CC(\/PPM'!8C
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M]S70^/OB;\3OB[K5MXE^+OCS7OB-XDL;<6=CK?B.[EN[VULP JV\3R.^V,*
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M\5>*_$_COQ'JWB_QEK>HZ_XAUNY>\O[[4KJ6[D,TC%G\MY69E4ECQGI7UO\
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MQ<\6?"P:LZRZNOA>]DM%U*5#N22Y5'5796Y!8'FO5-7_ &^/V\=?LIM-UO\
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MQ^I3I1AST*SG)NK:,U*G4@TU):W5P5.D[3BZG+"LJ<U)KW[K26G>VJ9^6O\
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M_P!VJ^D?_2XG\YK=3]3_ #I*5NI^I_G25_9)\_'9>B_(****!A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3657&'56'HP##\B#3J* $
M"C   '0  #\A2T44 %%%% !1110 4444 %! /!&1Z&BB@! JK]U0N>N !G\J
M6BB@ HHHH **** "BBB@ HHHH 0JK<, 1Z$ _P Z  !@  #H , ?@*6B@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *1E5AAE##T8 C\CQ2T4 (JJHP
MJA1Z* !^0P*6BB@ HHHH **** 'Q_?7ZU_:G_P &9G_)(?VP/^RG:?\ ^@W-
M?Q61_?7ZU_:G_P &9G_)(?VP/^RG:?\ ^@W-?D7C1_R2E'_L8T?R1VY?_O,O
M^O3_ /2D?VU4445_*A[84444 %%%% !1110!_E??\'$__*:#XQ_]B1H__HB.
MOR K]?\ _@XG_P"4T'QC_P"Q(T?_ -$1U^0%?VEX<?\ )%9'_P!>:G_I:/GL
M5_O5;UC^3"BBBOMC **** "BBB@ HHHH **** "BBB@ HHHH _:K_@C-^U3\
M"?V7M-_:PM_CCXJ;PM-\1?!ESI?@Y1&)!J5])9RQ+$?0F1@.#GVYX_.7X<?'
MK7O@E^USI_QZ^'VHM%9:3\0XO$$[*O.K:+#>-*ULP'198R1Z8/TKYHGM;>Y*
M&XACF,9S'YB!]A]5W X/TJ8* H4 !0,!1P ,8P!]*\J&3X2.-S7&RYZLLYHT
M:&+HU.65#V=&C[!*G'EYES0UES2E[VJM96KFERTX[*DVX-;W;OKTW[?,_JE_
M:4^'/_!+'_@IKXBT#]J2Y_:_U_\ 9R^(DUMI$GQ;\'V>IW$4%\]A%#]LBBA$
MFR,W)60!HE$BY.UADU^>7_!1+QC_ ,$YO#FJ_"/PC^Q[IE]X^TSP5<:</B!X
MJU'4)[Q?%ZV\L2WNZ*=W5?.02,3COG)Q7XOI:Q0B5;<"W2XS]H2(!%G)ZF4#
M[Y^O;/K2P6EM:@BW@CA#9W"-0NXGJ3@#)/>O,P'#'U"KA7_;>;XC!8&-2&"R
M^I5IPHT:=2/*H5*E*G"MB%2B^6C[:<_9I)K74J55R3_=4U*33E-7NVK:I.Z5
M[*Z25]O-_P!,=Q^S7_P2+_:=_P"%(?%[X;?M6:S^RUXA\$V>E:K\1?AQI>HS
M6UM>:EISP3W#*(G4([2Q$EH]K/&7B+&-W1O3?VS_ /@IW^S#\4OVJOV+O#?@
M[Q*FL?"3]F">TM=:^*Q@C%[K:V1CA>2XD +S9$9?+LQ.<]Q7\I\=M%;M(UJ!
M:M-D3& !#*#U$F!\P/<'_P#6U+*TCB>!+>)89"2\810KDY)+ #!)R<D]<FN=
M<'8>>(I5L9FN9X^&%HXVC@*6)E0<L)''TY4J\O;0I1JUYQIS<*3KSJ<L4DT[
M1L_;2LU&G3A?E<G&]I.+3BK-M)75WRI;]=3^B_\ :'_:J_8%^.'_  4NMOB5
M\4$3XD?LZZIX;BT6?6I52-]!NWC2-KZ$XPLD1RX*X/ ]<U];?L[?#_\ X)>?
ML.?M,WO[:?@+]NO7]<\%1Z9=W_A+X*W.H7-W8SS21BXCTR6W>1D:-G5(0CJ4
M3YB@7>Y;^1H65F(#;"VA%NWWH=B^6?JN,4/:0RQ1V\RB:VAQY-M(JM##CIL0
MC"X[8Q16X/HU,+1P-'.,UPV"CE\,LQ.&A*A4IXK"P?6-:E.-"O*[C.M05.4H
MMJ]P5>2ES.G3<N9S4O>7++Y-775)IZZ;'[]?"C_@JK\/Y_\ @K/J?[5WBSP?
M:>&?A-XVU"_T/5IK6&*&+2M&E8P1:N(D&SS)(6,I..<>O7K?C#\2_P!@O]E+
M]O72_P!M?]F;XY_\+X@\>?$.V\0^,?!U[9QM#X7LI[D/<7"!U*[H%8D'&?E/
M.37\[S0Q/$8'C5H2H4Q$ H5 P 5Z8QQCTJK!INGVP=;>SMX1("'$42(&!ZA@
MH&1[&NI\*9<J\*M&OC,-1_LJ&38G!TIPEA\;@:=_91KNI"56,Z=WRSI3@WIS
M76@E6J<K34)/G]I&33O"3M>R6C6EM>CZ:']=/[3_ ,"/^":'[67QZM/V^_$_
M[=FOZ-X6O[WPUKVN_#"UU>YM[>PO-*>"ZDLX;*.8"-%D#1,B*JLJC<#P!XI_
MP4L_;L_8\^,O[4O[)'BKX&>-9-6^&GP>N-!L-=U-T!D@T_2_LZ-=N<$NQ6(L
M2Q)S[#%?S%[91:MIXN)AICDE]-W?Z$^<CYH?NG@]Q4$-A96\;106L$,3##1Q
MQJJ,/0J  1[5Q83@RCAZN$J8C.,RQL<NPV)P674*BPU.CAL+B:*H2@U2HPE5
MJPII1C5FW)V5W:Z*==M24:<(<\HSFU=R<HZJW1*^ZTU^1^P?_!<;]I3X+_M9
M?&#P+XF^ /B5O%NBZ1X073-0N60(8KT6*0^4 ."/,4KG/;I3OVVOVE?@M\5?
M^"8O_!/OX#^ O$IU;XL_!/Q"NI?$7P\4"C288;A)EPP&6W[<<]!7X_P6T%JI
M6WAC@4G)$:A 2>YQBDCMH(I9)XX8TFF_ULBJ \G^^PY/XUZ^&R#!X7#9'A:=
M3$.GD%>6)P;E*#E5J3H5L.UB+12<5"O-I4^1\RCT31#J3<JLK1O624]]+--.
M/GIUNC^I/XG_ +2G[ G[?7_!-[P/\'?C-\<Y?@/\9/A!I\3:-I$%NLG_  DT
MVF6Q-M:NR]!<RQ(G)_CS7\O6MV%E#>ZII>GW1OM,BDN+6SOSUNK=6>**<^AD
MC"OCMGFLJ73=/GE$\UG;RS*05E>)&<$'.0Q&15T      #  Z 5ID^34<DCB
MJ6%Q6*J8;$8JKBZ>&KNG*GA*M:7/56'G&$:KA.?O-59SMM&P3FZEG*,4U%1<
MEO)+;F3TNEIIW]#^A_\ X)J_MW_LU^(/V4_'W[ '[9VN)\-_AG?V4L?@SXC"
M%9I--U"Y1HQ*@<';MDDSD8]C7U!^SGIW_!,3_@D1I_CWXO?#_P#:9_X7Y\9O
M%O@_4K/X<Z<\<3FUCNXI6L[HG!,;H77Y<YR.U?R<7-G:WBJEW;Q7"*<JLR+(
MH(P00&! ((&/2B2UCN'ADN_]+DM5$=J]P!(UM&!@1PEL[$ Z!<5Y.,X/PN*K
M8[V>99C@\!FM>.(S3*\/*C]5QE:*C>7-.G*M259Q3KQA4BIK9)ZE1K2BH)PA
M*5-6A4=^:*NMTFDVE>S>OH?N5\!/VYOASK'["O\ P4L\-?&OQ4UA\=OVCO$L
MFH^ =#*!O[9M/M4DD0+'E0L;*!CT_"OPMTB"6VTO3[>9=DL-I!'(O]UUC 8?
M@1BK<EM!++'/)#&\T/$4C*"\?^ZW4?A4U>]@<LPV75,?/#<Z688FGBJE.7+[
M.C*EA:.$A3HI)-4U2HQTES/FN[VT42E*2CS:\D7%/JTWS-OSNV?:7_!._P"*
M7@7X*?M9_#[XC?$O53HG@[1=3TZ?4M2"[C!%#<J\K =#M0$X_P#K5^W?PT_X
M* _LEZ#_ ,%7/C/^T5JGQ >W^#_BGP=)IFA>(S$";J^:PDA$6SH 92!GG\.M
M?RWR11S(8Y462-NJ. RGZ@\&JYL+-H5MVM8# IRL1C4Q@^H4C&:\_-.&\#F]
M?$XC$U<3">*RV65U%1E!16'G5IU7.*E&7[WFIQ2;?+:]TRH59TTE%1:4_:+F
MO\7;3I^/IN?9OA;XF>"=/_X*36OQTN]3,?PMC^/MQXQ?7=N6'AQ[[SEO=G'6
M/G&.U?HW^WI^WG\&M:_X*)?##]I3X*7Q^(/@GPYJGAI=5>1 GEV=KY'VV8*,
M ^4%;Z\<U^#QBC,7D%%,.W9Y>/DV_P!W;TQ[4V&V@MT,4$,<,; ADC4*I!Z@
M@<'/?-;5LBP6(Q>%Q=65:4L+E=;*8TN9*G4PU>,(SE4LN?VMH*SC)13O[I,9
MSC&45:TIJHWU4ET5U:WXV9_1=_P5=\4?L#?M#^+=!_;>_9Y_:DN;?]H.'0?#
M:2_"]+<*ECJ%A':W%W '4<XF1X.I]Z]W\>^//^">/_!8'X _"6V_:)^.*_LZ
M_M-_"OPG9>&KWQ$D<>_5;"SCCA>Y8M\Q+)'N(SSNQWY_E1BTO3H)?.ALK:*4
MDDR)$BN2>I+ 9)^M3BVB29KF$""Y9=CSQ +*R=T+@9(->9'A&E2PN74*&;YG
M2Q&3RG_9>8?[*\5A*%2*IRP;_<>SKX5P23A5A)NR=[[W[9N4VZ=-JI_$A[UI
M-6?-Y2NKZ67Z?TI?M>?M8_L;?LH_L,P_L ?L8^+8OC'-X\OM/E^+?Q-$,<4]
MQ+:.BO)(R!3)@J3\Q(R>O6O"?VZ_VP_@GX__ .";O[+7P>^"WCI[SXV_"K7]
M'U#5K#RPO]E+920M)*& R>(R,'VQZU^$<-I;P,\D4,:22\RR*H#R$]2[#DY[
MYHCM+:&5IHH(HYGX>1$"NW7JP&3UK;"\*9?AI8.K+$8S$XG"YE5S:KB:\J<J
MF/QM:E[&I+%)04%3]G:$:=*,(QC&*M9--2K3DI*T5%P5-)7M""::Y?.ZW9_4
M[K'Q0_8)_P""LG[,WPC\%?M'?'[5_P!G/]I;X.>&+?P_:>*].OYK2/6+2V@B
M@:YFB1UCD.(RVV16!SR"#7RG^UKX=_X)8_ ']EC1?A!\"?B!K/[0O[0=OJVG
M/J_Q+O\ 5KJ5;=;>ZC::4P22%'"A2P4C Z=#7X'"VC2;[5"H@NL;?M,8"S;3
MU7>,$J?3--CLK6*5IT@B$[Y\R8(HD<GJ6;&23W]:SPO"D,'6I*AG&:T\NH8N
M6-H93"I1AAJ=:<I3E3=6--8F6$YYRE'#NJX*3;MK8;K.2UI4W/EY74=V[*RO
M9W7-9:NWS/Z!?^"D_P"V3^SK\=?V _V>/@[\,O&C>(/B3X*TW2(/$^DF((MG
M-;1QB?##GY2"!G!/\MW_ ((Q_M/?LY>&/V8/VC/V(?V@_B+)\((OCWJ9N='^
M(5JWD7NG3RGRXHH[M2LL2LVW.UAC()S7\[T5I:P2--#;Q1RN27D1 KL3URP&
M33Y((Y)(YBJB>)@T,^ 98G4Y#(QY5@1P0>*TGPK@7DM3)(8C%PHSQSS*GB;T
MWB*.,6(CBJ<X>Y[.4*=:*<82@TXZ2N+VL_:*JU'F4>1Q5^5QMR]TTVK]=^Q_
M8M^Q>W_!,'_@D_XD^,7_  D?[8>L?&;QW\1]#U&"PMKZ]DU"#1X+RTG2TG5Y
M'=6ED,B%G),A)&YC@8^'_P!@S]MW]F;X0:E^W3/\1?'#:1'\7;'Q;#\/W$2M
M_;$FHI<"R![+YF]1U[Y'I7\XUY:QZE<?;-5_XFE]M"?;;T":Y\M?NQ^8V6V*
M,87..*)+.TE\OS;>&3RL>5O16V8Z;<CC'M_2N-<%X6I',)8[,\QQV+S6."CC
M,3/ZO3?^PSC.BJ%.G1C"G&\5&2Y=8MMOFU*^L37*HPIQC#FY(^\[<UKW=[OO
MN[/;0_0?_@E5\9/AQ^SU^WMX8^,/Q>UD^'OAW87?BJ6[UE5#&)-1N[B2T)4\
M?O$=#Z#/XU]K^%OV_?A%\*_^"M,O[1>CR#Q/\%_$WB>\35O$3J%.FZ3=RE!>
MA.!E8Y&<COC'M7X2S0Q7$9BFC26(XS&X#)QT^4\<=J06\"PFW6*,0$8,(4",
MCTV],?A7L8S(,#C\7B\7B)5Y2QF5/**U*,U&E]6YI352.G.JRE)M-RY=(WB[
M,SC.<(QC&UH3]I%O?FTT?]UI'[1_\%1/A1^PQ\5OCM?_ !:_9)_:*O\ XL>,
MOC_XRM(-2\ PV;%M&GU:3RC&HC4G"M(<D XQGW'VM_P5YUF7]E__ ()T_L5?
ML=:#JD)U^PLK;5/'.G(Z?;8H]1MUF5+J$8FB \S'[Q>2,5_-_P#"'QYJGP-^
M(&@_$[P-I>COXG\,W]MJ>E+?VL<EHMY:2"6%W3;C(8#GKWS7H'[2'[2?Q:_:
MU^*FH_&/XS:P;_Q5J5G:V!L+:5O['LK>S01P"RMON1$(H!V@5YJX>Q2Q?#U*
MIC:F,RO(75Q4:F,E2EBZ^*5%87!T7"C2I05+#T93:J:R<E&Z;U+=1<M6T5&=
M5)-0ORI73E*[W;:VOU=CPF.-8D6-1A4 51[#I3Z**^M,@HHHH **** "BBB@
M HHHH **** "BBB@ J"[_P"/*^_Z\KK_ -$/4]07?_'E??\ 7E=?^B'IQW7J
MOS$]OG'\T?Z#/_!H7_RC,U?_ +*YK_\ Z U?U6MT/T/\J_E2_P"#0O\ Y1F:
MO_V5S7__ $!J_JM;H?H?Y5_"'$?_ "/LW_[&&*_].R/I:/\ "I?]>X?^DH6O
M\V7_ (.V=2TZP_X*<_ ^2_OK:SBA^#<$DTEQ(L:1(\ C1I&8@('D8(I8C<QP
M,FO])JOS2_;$_P""1G["/[>/Q!T;XH_M-?!^#Q]XUT#1TT'2]7?49;-[?2T:
M-EM@L<3[@&C4Y)SQ73PIG=/AW/<%F]2C+$1PDI3]C%I.I=<O+=M<NC=GK9VT
M:T%7INK2G334>9)7?2S3_0_R2V\8>$<G_BIM%ZG_ )?H/7_?I/\ A,/"/_0S
M:+_X'0?_ !=?Z@?_ !#8_P#!(?\ Z-I@_P#!]=?_ !BC_B&Q_P""0_\ T;3!
M_P"#ZZ_^,5^W?\1TP'_0AQ'_ (4Q\O\ @_UMYJRV:M^]73IZ?W?7\/,_R_/^
M$P\(_P#0S:+_ .!T'_Q='_"8>$?^AFT7_P #H/\ XNO]0/\ XAL?^"0__1M,
M'_@^NO\ XQ1_Q#8_\$A_^C:8/_!]=?\ QBC_ (CI@/\ H0XC_P *8^7_  ?Z
MV/[-G_S]7W>G]WU_#S/\OS_A,/"/_0S:+_X'0?\ Q='_  F'A'_H9M%_\#H/
M_BZ_U _^(;'_ ()#_P#1M,'_ (/KK_XQ1_Q#8_\ !(?_ *-I@_\ !]=?_&*/
M^(Z8#_H0XC_PICY?\'^MC^S9_P#/U?=Z?W?7\/,_R_/^$P\(_P#0S:+_ .!T
M'_Q='_"8>$?^AFT7_P #H/\ XNO]0/\ XAL?^"0__1M,'_@^NO\ XQ1_Q#8_
M\$A_^C:8/_!]=?\ QBC_ (CI@/\ H0XC_P *8^7_  ?ZV/[-G_S]7W>G]WU_
M#S/\OS_A,/"/_0S:+_X'0?\ Q='_  F'A'_H9M%_\#H/_BZ_U _^(;'_ ()#
M_P#1M,'_ (/KK_XQ1_Q#8_\ !(?_ *-I@_\ !]=?_&*/^(Z8#_H0XC_PICY?
M\'^MC^S9_P#/U?=Z?W?7\/,_R_/^$P\(_P#0S:+_ .!T'_Q='_"8>$?^AFT7
M_P #H/\ XNO]0/\ XAL?^"0__1M,'_@^NO\ XQ1_Q#8_\$A_^C:8/_!]=?\
MQBC_ (CI@/\ H0XC_P *8^7_  ?ZV/[-G_S]7W>G]WU_#S/\OS_A,/"/_0S:
M+_X'0?\ Q='_  F'A'_H9M%_\#H/_BZ_U _^(;'_ ()#_P#1M,'_ (/KK_XQ
M1_Q#8_\ !(?_ *-I@_\ !]=?_&*/^(Z8#_H0XC_PICY?\'^MC^S9_P#/U?=Z
M?W?7\/,_R_/^$P\(_P#0S:+_ .!T'_Q='_"8>$?^AFT7_P #H/\ XNO]0/\
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M9M%_\#H/_BZ_U _^(;'_ ()#_P#1M,'_ (/KK_XQ1_Q#8_\ !(?_ *-I@_\
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MS_Y^K[O3^[Z_AYG^7Y_PF'A'_H9M%_\  Z#_ .+H_P"$P\(_]#-HO_@=!_\
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M_$=,!_T(<1_X4Q\O^#_6Q_9L_P#GZON]/[OK^'F?Y?\ 'XP\([U_XJ?1>O\
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M$A_^C:8/_!]=?_&*/^(;'_@D/_T;3!_X/KK_ .,4?\1TP'_0AQ'_ (4Q\O\
M@_UL?V;/_GZON]/[OK^'F?Y?G_"8>$?^AFT7_P #H/\ XNC_ (3#PC_T,VB_
M^!T'_P 77^H'_P 0V/\ P2'_ .C:8/\ P?77_P 8H_XAL?\ @D/_ -&TP?\
M@^NO_C%'_$=,!_T(<1_X4Q\O^#_6Q_9L_P#GZON]/[OK^'F?Y?G_  F'A'_H
M9M%_\#H/_BZ/^$P\(_\ 0S:+_P"!T'_Q=?Z@?_$-C_P2'_Z-I@_\'UU_\8H_
MXAL?^"0__1M,'_@^NO\ XQ1_Q'3 ?]"'$?\ A3'R_P"#_6Q_9L_^?J^[T_N^
MOX>9_E^?\)AX1_Z&;1?_  .@_P#BZ/\ A,/"/_0S:+_X'0?_ !=?Z@?_ !#8
M_P#!(?\ Z-I@_P#!]=?_ !BC_B&Q_P""0_\ T;3!_P"#ZZ_^,4?\1TP'_0AQ
M'_A3'R_X/];']FS_ .?J^[T_N^OX>9_E^?\ "8>$?^AFT7_P.@_^+H_X3#PC
M_P!#-HO_ ('0?_%U_J!_\0V/_!(?_HVF#_P?77_QBC_B&Q_X)#_]&TP?^#ZZ
M_P#C%'_$=,!_T(<1_P"%,?+_ (/];']FS_Y^K[O3^[Z_AYG^7Y_PF'A'_H9M
M%_\  Z#_ .+H_P"$P\(_]#-HO_@=!_\ %U_J!_\ $-C_ ,$A_P#HVF#_ ,'U
MU_\ &*/^(;'_ ()#_P#1M,'_ (/KK_XQ1_Q'3 ?]"'$?^%,?+_@_UL?V;/\
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MUL?V;/\ Y^K[O3^[Z_AYG^7Y_P )AX1_Z&;1?_ Z#_XNC_A,/"/_ $,VB_\
M@=!_\77^H'_Q#8_\$A_^C:8/_!]=?_&*/^(;'_@D/_T;3!_X/KK_ .,4?\1T
MP'_0AQ'_ (4Q\O\ @_UL?V;/_GZON]/[OK^'F?Y?G_"8>$?^AFT7_P #H/\
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M_P _5]WI_=]?P\S_ "_/^$P\(_\ 0S:+_P"!T'_Q='_"8>$?^AFT7_P.@_\
MBZ_U _\ B&Q_X)#_ /1M,'_@^NO_ (Q1_P 0V/\ P2'_ .C:8/\ P?77_P 8
MH_XCI@/^A#B/_"F/E_P?ZV/[-G_S]7W>G]WU_#S/\OS_ (3#PC_T,VB_^!T'
M_P 71_PF'A'_ *&;1?\ P.@_^+K_ % _^(;'_@D/_P!&TP?^#ZZ_^,4?\0V/
M_!(?_HVF#_P?77_QBC_B.F _Z$.(_P#"F/E_P?ZV/[-G_P _5]WI_=]?P\S_
M "_/^$P\(_\ 0S:+_P"!T'_Q='_"8>$?^AFT7_P.@_\ BZ_U _\ B&Q_X)#_
M /1M,'_@^NO_ (Q1_P 0V/\ P2'_ .C:8/\ P?77_P 8H_XCI@/^A#B/_"F/
ME_P?ZV/[-G_S]7W>G]WU_#S/\OS_ (3#PC_T,VB_^!T'_P 71_PF'A'_ *&;
M1?\ P.@_^+K_ % _^(;'_@D/_P!&TP?^#ZZ_^,4?\0V/_!(?_HVF#_P?77_Q
MBC_B.F _Z$.(_P#"F/E_P?ZV/[-G_P _5]WI_=]?P\S_ "_/^$P\(_\ 0S:+
M_P"!T'_Q='_"8>$?^AFT7_P.@_\ BZ_U _\ B&Q_X)#_ /1M,'_@^NO_ (Q1
M_P 0V/\ P2'_ .C:8/\ P?77_P 8H_XCI@/^A#B/_"F/E_P?ZV/[-G_S]7W>
MG]WU_#S/\OS_ (3#PC_T,VB_^!T'_P 71_PF'A'_ *&;1?\ P.@_^+K_ % _
M^(;'_@D/_P!&TP?^#ZZ_^,4?\0V/_!(?_HVF#_P?77_QBC_B.F _Z$.(_P#"
MF/E_P?ZV/[-G_P _5]WI_=]?P\S_ "_/^$P\(_\ 0S:+_P"!T'_Q='_"8>$?
M^AFT7_P.@_\ BZ_U _\ B&Q_X)#_ /1M,'_@^NO_ (Q1_P 0V/\ P2'_ .C:
M8/\ P?77_P 8H_XCI@/^A#B/_"F/E_P?ZV/[-G_S]7W>G]WU_#S/\OS_ (3#
MPC_T,VB_^!T'_P 71_PF'A'_ *&;1?\ P.@_^+K_ % _^(;'_@D/_P!&TP?^
M#ZZ_^,4?\0V/_!(?_HVF#_P?77_QBC_B.F _Z$.(_P#"F/E_P?ZV/[-G_P _
M5]WI_=]?P\S_ "_/^$P\(_\ 0S:+_P"!T'_Q='_"8>$?^AFT7_P.@_\ BZ_U
M _\ B&Q_X)#_ /1M,'_@^NO_ (Q1_P 0V/\ P2'_ .C:8/\ P?77_P 8H_XC
MI@/^A#B/_"F/E_P?ZV/[-G_S]7W>G]WU_#S/\OS_ (3#PC_T,VB_^!T'_P 7
M1_PF'A'_ *&;1?\ P.@_^+K_ % _^(;'_@D/_P!&TP?^#ZZ_^,4?\0V/_!(?
M_HVF#_P?77_QBC_B.F _Z$.(_P#"F/E_P?ZV/[-G_P _5]WI_=]?P\S_ "_/
M^$P\(_\ 0S:+_P"!T'_Q='_"8>$?^AFT7_P.@_\ BZ_U _\ B&Q_X)#_ /1M
M,'_@^NO_ (Q1_P 0V/\ P2'_ .C:8/\ P?77_P 8H_XCI@/^A#B/_"F/E_P?
MZV/[-G_S]7W>G]WU_#S/\OS_ (3#PC_T,VB_^!T'_P 71_PF'A'_ *&;1?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'_#XW]CK_H;;G_P"N?\ XW7V#_PQ?^RG_P!$$^&__@@@_P#BJ/\ AB_]E/\
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M !WNO%?AJ273[Q#?Z;YE_&K0[XL,K"X1QCC ZU^SW_#XW]CK_H;;G_P"N?\
MXW7UU#^Q-^R7;F1H/V?OAE"93ND,?ARV0R-G.7*D;CGG)R:G_P"&+_V4_P#H
M@GPW_P#!!!_\57HYKG'"^:XZKCJN79Q"=6&'@X1QF%Y4L/AZ.'C;]U=WC24G
M?JW;RBG3KTX*"G3:5]7&5W=\SV?=O[_(^/O^'QO['7_0VW/_ (!7/_QNC_A\
M;^QU_P!#;<_^ 5S_ /&Z^P?^&+_V4_\ H@GPW_\ !!!_\51_PQ?^RG_T03X;
M_P#@@@_^*KSO;\)_] .=?^%F%\O^G7K_ %M=L1_-2_\  9>7][R?W^1\??\
M#XW]CK_H;;G_ , KG_XW1_P^-_8Z_P"AMN?_  "N?_C=?8/_  Q?^RG_ -$$
M^&__ (((/_BJ/^&+_P!E/_H@GPW_ /!!!_\ %4>WX3_Z <Z_\+,+Y?\ 3KU_
MK8MB/YJ7_@,O+^]Y/[_(^/O^'QO['7_0VW/_ (!7/_QNC_A\;^QU_P!#;<_^
M 5S_ /&Z^P?^&+_V4_\ H@GPW_\ !!!_\51_PQ?^RG_T03X;_P#@@@_^*H]O
MPG_T YU_X687R_Z=>O\ 6Q;$?S4O_ 9>7][R?W^1\??\/C?V.O\ H;;G_P
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MU_T-MS_X!7/_ ,;H_P"'QO['7_0VW/\ X!7/_P ;K[!_X8O_ &4_^B"?#?\
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M=?\ 0VW/_@%<_P#QNOL'_AB_]E/_ *()\-__  00?_%4?\,7_LI_]$$^&_\
MX((/_BJ/;\)_] .=?^%F%\O^G7K_ %L6Q'\U+_P&7E_>\G]_D?'W_#XW]CK_
M *&VY_\  *Y_^-T?\/C?V.O^AMN?_ *Y_P#C=?8/_#%_[*?_ $03X;_^""#_
M .*H_P"&+_V4_P#H@GPW_P#!!!_\51[?A/\ Z <Z_P#"S"^7_3KU_K8MB/YJ
M7_@,O+^]Y/[_ "/C[_A\;^QU_P!#;<_^ 5S_ /&Z/^'QO['7_0VW/_@%<_\
MQNOL'_AB_P#93_Z()\-__!!!_P#%4?\ #%_[*?\ T03X;_\ @@@_^*H]OPG_
M - .=?\ A9A?+_IUZ_UL6Q'\U+_P&7E_>\G]_D?'W_#XW]CK_H;;G_P"N?\
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MBBBOG34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]6#@HV=Y[Z-::>O3U/WPHHHK\5/2"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KE/%.O:!8Z5J]IJ.O:+IL\NEW\834=4LK-
ME+VLJAF6>9&"@G+':<#-=77\CW_!S-^RK\8K_P"'6A_M*?!/X@_$7PS_ ,(P
M\K^/++PUK5Y::>;$,WER/!;L%"M'\C#'.T\G.*][AK*:&>9S@\KKX^.6K%S]
MG3Q4Z3K059V]G"45.#7M'[L97?O.*L[F5:HZ5.4U!SY;-Q3L[7U:]$?:/_!
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MU:2]QQC#W5)OXFM=%;I?77Y'54445^9':%%%% !1110 4444 %%%% !1110
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M5A_P2P_Z&3XE_P#A&R?_ "51_P 16'_!+#_H9/B7_P"$;)_\E5_!Q_9.C?\
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M'_!+#_H9/B7_ .$;)_\ )5'_ !%8?\$L/^AD^)?_ (1LG_R57\'']DZ-_P!
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MG_R57\'']DZ-_P! 31__  76W_Q%']DZ-_T!-'_\%UM_\11_Q*WDW_158_\
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M_P L_JS\KG_$R<_^B0A_X=I>7_4)Z_UM_>/_ ,16'_!+#_H9/B7_ .$;)_\
M)5=-X'_X.AO^"8'C[QUX.^'VC>*?B#%KOCC7].\-Z&;[PD]O:2:GJEU%9VD<
MTYN2L:O/-&A8CJP !) K^!+^R=&_Z FC_P#@NMO_ (BH?#VG:7'^T!^R@8=+
MTV!O^%\>#OG@LH(G^75+<@;D0'@@$<\8XKQ.)/HXY1D.09OG4.(\;B997@JF
M,6'EA*=-5O9.-Z;FIMPYDVN:SL];-;^]POX\RXDXARC(7PS'!K-<6L+]:692
MJN@Y4IS4_9/#04US0Y7'FCI)M.Z2/]AVVN([NVM[J$DQ7,$5Q$3P3'-&LB$C
ML2K"IZR= _Y 6B_]@G3O_2.&M:OY(/Z(/R:_;Y_X+-?L<?\ !.3XB>#_ (6_
MM!ZMXLB\9^.=%DU[0-)\,:$VLRW&G1S"%Y75)D92'/3:1@'FOAS_ (BE?^":
MG<_&('N#X"N<CV/[^OS _P""^-AIM[_P6&_9$74M,T[5(A\(-0'D:E9P7D/^
MMO/^6<Z.N<X/3J!7SU<>'_"7VB?_ (HOPB/WTO'_  CVF_WV_P"G>O6J0P&%
MIX3VN&KUZF(PT,1*<<4J44Y3E#D4?8ST7*W=OKUMKFG-N5FDE*UG%OL][K^O
ME;]Q/^(I7_@FI_>^,7_A!7/_ ,?H_P"(I7_@FI_>^,7_ (05S_\ 'Z_#7_A'
M_"?_ $)GA'_PGM-_^1Z/^$?\)_\ 0F>$?_">TW_Y'K+V^6?]"_$?^%R\O^H?
MU_K=VJ?S1_\  7Y?WO7^MOW*_P"(I7_@FI_>^,7_ (05S_\ 'Z/^(I7_ ()J
M?WOC%_X05S_\?K\-?^$?\)_]"9X1_P#">TW_ .1Z/^$?\)_]"9X1_P#">TW_
M .1Z/;Y9_P!"_$?^%R\O^H?U_K<M4_FC_P" OR_O>O\ 6W[E?\12O_!-3^]\
M8O\ P@KG_P"/T?\ $4K_ ,$U/[WQB_\ ""N?_C]?AK_PC_A/_H3/"/\ X3VF
M_P#R/1_PC_A/_H3/"/\ X3VF_P#R/1[?+/\ H7XC_P +EY?]0_K_ %N6J?S1
M_P# 7Y?WO7^MOW*_XBE?^":G][XQ?^$%<_\ Q^C_ (BE?^":G][XQ?\ A!7/
M_P ?K\-?^$?\)_\ 0F>$?_">TW_Y'H_X1_PG_P!"9X1_\)[3?_D>CV^6?]"_
M$?\ A<O+_J']?ZW+5/YH_P#@+\O[WK_6W[E?\12O_!-3^]\8O_""N?\ X_1_
MQ%*_\$U/[WQB_P#""N?_ (_7X:_\(_X3_P"A,\(_^$]IO_R/1_PC_A/_ *$S
MPC_X3VF__(]'M\L_Z%^(_P#"Y>7_ %#^O];EJG\T?_ 7Y?WO7^MOW*_XBE?^
M":G][XQ?^$%<_P#Q^C_B*5_X)J?WOC%_X05S_P#'Z_#7_A'_  G_ -"9X1_\
M)[3?_D>C_A'_  G_ -"9X1_\)[3?_D>CV^6?]"_$?^%R\O\ J']?ZW+5/YH_
M^ OR_O>O];?N5_Q%*_\ !-3^]\8O_""N?_C]'_$4K_P34_O?&+_P@KG_ ./U
M^&O_  C_ (3_ .A,\(_^$]IO_P CT?\ "/\ A/\ Z$SPC_X3VF__ "/1[?+/
M^A?B/_"Y>7_4/Z_UN6J?S1_\!?E_>]?ZV_<K_B*5_P"":G][XQ?^$%<__'Z/
M^(I7_@FI_>^,7_A!7/\ \?K\-?\ A'_"?_0F>$?_  GM-_\ D>C_ (1_PG_T
M)GA'_P )[3?_ )'H]OEG_0OQ'_A<O+_J']?ZW+5/YH_^ OR_O>O];?N5_P 1
M2O\ P34_O?&+_P (*Y_^/T?\12O_  34_O?&+_P@KG_X_7X:_P#"/^$_^A,\
M(_\ A/:;_P#(]'_"/^$_^A,\(_\ A/:;_P#(]'M\L_Z%^(_\+EY?]0_K_6Y:
MI_-'_P !?E_>]?ZV_<K_ (BE?^":G][XQ?\ A!7/_P ?H_XBE?\ @FI_>^,7
M_A!7/_Q^OPU_X1_PG_T)GA'_ ,)[3?\ Y'H_X1_PG_T)GA'_ ,)[3?\ Y'H]
MOEG_ $+\1_X7+R_ZA_7^MRU3^:/_ ("_+^]Z_P!;?N5_Q%*_\$U/[WQB_P#"
M"N?_ (_1_P 12O\ P34_O?&+_P (*Y_^/U^&O_"/^$_^A,\(_P#A/:;_ /(]
M'_"/^$_^A,\(_P#A/:;_ /(]'M\L_P"A?B/_  N7E_U#^O\ 6Y:I_-'_ ,!?
ME_>]?ZV]&_;[_P""E'_!'O\ ;B^//P3^/'BBT^,S:]\([VSN##%X0NK6'4TM
M+DS)]HB6.8,RQD1[F<A@H) .:_7'1/\ @Y^_X)BZ#I&F:+I=M\7K'3M*L;6P
ML[2+P%<>7;V]K"D,<2D2J&V*@!?:"YRQ )(K\21H/A1<[?!OA(9ZX\/Z:,_7
M$%)_PC_A/_H3/"/_ (3^F_\ R/7H8K.Z>-PF P6*H8NKA<MIU*6"I2QRY:%.
MK-5*D8_[/LY7??Y61$:;C*4DXJ4VG)\F[6F][[?TC]RO^(I7_@FI_>^,7_A!
M7/\ \?H_XBE?^":G][XQ?^$%<_\ Q^OPU_X1_P )_P#0F>$?_">TW_Y'H_X1
M_P )_P#0F>$?_">TW_Y'KS_;Y9_T+\1_X7+R_P"H?U_K>[5/YH_^ OR_O>O]
M;?N5_P 12O\ P34_O?&+_P (*Y_^/T?\12O_  34_O?&+_P@KG_X_7X:_P#"
M/^$_^A,\(_\ A/:;_P#(]'_"/^$_^A,\(_\ A/:;_P#(]'M\L_Z%^(_\+EY?
M]0_K_6Y:I_-'_P !?E_>]?ZV_<K_ (BE?^":G][XQ?\ A!7/_P ?H_XBE?\
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M]'_$4K_P34_O?&+_ ,(*Y_\ C]?AK_PC_A/_ *$SPC_X3VF__(]'_"/^$_\
MH3/"/_A/:;_\CT>WRS_H7XC_ ,+EY?\ 4/Z_UN6J?S1_\!?E_>]?ZV_<K_B*
M5_X)J?WOC%_X05S_ /'Z/^(I7_@FI_>^,7_A!7/_ ,?K\-?^$?\ "?\ T)GA
M'_PGM-_^1Z/^$?\ "?\ T)GA'_PGM-_^1Z/;Y9_T+\1_X7+R_P"H?U_K<M4_
MFC_X"_+^]Z_UM^Y7_$4K_P $U/[WQB_\(*Y_^/T?\12O_!-3^]\8O_""N?\
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M3=KVOLU_>/\ \16'_!+#_H9/B7_X1LG_ ,E4?\16'_!+#_H9/B7_ .$;)_\
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MR?\ R57\'']DZ-_T!-'_ /!=;?\ Q%']DZ-_T!-'_P#!=;?_ !%'_$K>3?\
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M $56/_\ "&E_\L_JS\KG_$R<_P#HD(?^':7E_P!0GK_6W]X__$5A_P $L/\
MH9/B7_X1LG_R51_Q%8?\$L/^AD^)?_A&R?\ R57\'']DZ-_T!-'_ /!=;?\
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M5_!Q_9.C?] 31_\ P76W_P 11_9.C?\ 0$T?_P %UM_\17F?\2MY-_T56/\
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M ,(:7_RS^K/RN?\ $R<_^B0A_P"':7E_U">O];?WC_\ $5A_P2P_Z&3XE_\
MA&R?_)5'_$5A_P $L/\ H9/B7_X1LG_R57\'']DZ-_T!-'_\%UM_\11_9.C?
M] 31_P#P76W_ ,11_P 2MY-_T56/_P#"&E_\L_JS\KG_ !,G/_HD(?\ AVEY
M?]0GK_6W]X__ !%8?\$L/^AD^)?_ (1LG_R51_Q%8?\ !+#_ *&3XE_^$;)_
M\E5_!Q_9.C?] 31__!=;?_$4?V3HW_0$T?\ \%UM_P#$4?\ $K>3?]%5C_\
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M.^"/W='_ !*WDO\ T56._P#"&E]W\3^N^P+Z2<[J_"$-6E_R-I=6E_T">O\
M6W^J5^PC^WS\ /\ @HG\'KCXW_LZ:KJNK>"+77[SPW/-K%@=-O(M4L21<0O;
M,[LH4@\D@^U?:S=#]#_*OY7?^#1Z**'_ ()Q^+4ABCA3_A=GB@[(D6-<DR9.
MU0!R>:_JB;H?H?Y5_'V;X.&7YIF&!IR<X8/%U\-&<OBFJ-25/G:Z<W+S6Z7M
M=VN?U#0J>VH4*UN7VU&E5Y;WY?:4XSY;];<UK];7%K_.V_X.@/\ E*U\%?\
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M>G_Z8KG^P'H'_("T7_L$Z=_Z1PUK5DZ!_P @+1?^P3IW_I'#6M7^7)_H:?Q
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M2E^!GC[PS?CX$^-[+_A(=/BD9W6>*<&9 =L1$;.5WMA-[ *"0"<D9_ [XC^
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M6S7'ACPE96&H7EMH]WNM)H[2R@9_MLC2B,(C,\ 7>R[S*%3<W _0/_@WB_:
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M]?L-_P %,_A)^PU\./#W[-?Q _;*\:^*)_"?AWX>Z!HVD?"[PQ++(EUJ,%I
MHU"XT^!OFC8G<SM'_>Y*U^57[67[)/PSE_8]\<?M4?\ !.KXM>,)/@7JK@_%
M#X1I>3LMO<20J,W-AO.P(#\WR #G(QBOS_A_BW-,YQ^49_7XASW +-<Y^J4Z
M>)RAK@N5'ZV\/')85HN-7Z]4HP?LL?*U-XEQBVTC[C..%LORO!YADM+(<FQW
M]GY:J]2I0S1/BCVRPU&O+-9T6G36$IU:D?;X*-YK#+F23U7PM\9OV4/!_@K_
M ()V_LS?M,^'K6[N?B)\7_%MYH&K6T,<DQ9(6D5$2.)796+ +R.3@<GK^>_B
M;PMXI\$WUKIOB_0-3T&]O8%NK2*^L[B 36[C*R*TB*I!!&<$X[XK^HWP-\>_
MAE^SK_P11_9H^(GCKP5I/C?QI9>-+ZX^'FBZ];)<6 U=9'8K<QR(Z@)(!N!
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M'^5?RP_\&D7_ "CE\6_]EK\4?S>OZGFZ'Z'^5?Y1\3?\E%G?_8TQO_J14/\
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MSJ=K%<:9;Z@T+0>?;-)YT2JC?)B,YVM@<5_!'X@\8^./&!0^-/&GB7Q@(_\
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M%M;,A7@^:=C#!_C'6G_MO7O_  SK_P $B_V2?A!K]@H\9>,Q+->QNV)K.":
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M_CUX5OOB7^V;^Q=XO\20^#U^*&K^)AH6LW%REI#)JUY)<I#;F=V54R[*,YR
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M, ROG<".M7]:\3^*_%$R7/BOQ1KGBBYB18XKC7+^>_FBC082-))W=E1!PH&
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MAZQ5C(+'2-2FM+82'K((HV"[SW;K6PWQ4^+TB-%+\5_'<L3J8Y(GUV[,<D;
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MPV%P7#?"='*,/_:F%S''U:N+GC<7B%A)0<</0KUJ2>'HU%&S<>9\OV(MN_\
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MX0OO$FH:+:>+9)DGLM3U.22X@023A@K0RK)AG5NCM@C%?S.^'_''C[P<9?\
MA"O'/BCP>)P!.OAW5KO35F (($@MI8]P! (SGD#TK&N]2U:_OSK%_JM]>:VT
MWVEM9N)WDU%KK.[[0;EF,AFSSO+;L\@UZ%'P>P,,)QAD=3,G_JQQ-BH9C@,K
MH894JV1YE&7.L1A\3S-3IPDHJ%%TU%1BM6]3CK>*^+E7X7S>G@$L_P BHO!X
MW'5<1*K3S; QC*$:&(HNG%QG*%2HIU55E*3FY-:)']I/[3/_  ;T?";]H[XX
MZS\;_ O[1_A[PIX4\7ZI:Z\^@QWD$T0M991<R1I+"DL>VXC;9PZE2QW!6!KM
M/^"D_P"U+^S=_P $_?V'9_V(_@YJFCZYXM\0^&?^$9U>RTB:"X6..XM[87^J
M7$EO(R>=<W$:EEV@HL(#9)?'\95E\>_C[IMA+I=E\:OB/!8S*$,,?B;456)%
M&%2+_2,QJ   %(& !Q@&O/=8USQ%XFO#J7BKQ!JWB;4BNTZAK=Y-?W9&<X,T
M[NY'L3_6N3!^%&?8S%Y#'B_C:KQ!DG#=>EB<MRJEE\,$YU\,H+"SQE>,Y2K^
MQ5./Q\TG;22O)/IQGB;DN%P><OA?A6EDV;9[1J8?'9A4QM7&<E'$.4\3#"4:
ME*,:*J2G+1.*72#2BSFGMVATVXA')*S$?\#9F_K[5_4/I%II7Q2_X(<11:6(
M;W5/A1;27&JQ02++<6:M$Y!EB4[T!]6 !YZC-?S&<'@@$>AZ&OTO_8"_;F\&
M_LN>$OC1\+?C%H6L>./A=\9-'ETV_P!"M9'E6SE%NT4$MO$3MCVN5+8QP.!U
M-?=<>93CLSR_+,7EM*IB<?D6>9=G%+"4N55,73H552Q-"FYSA%5'AJM64>:2
M3E%1NKW7QO!6:X/ XW,<)F-6%#"9UE./RNIB:BDX8>IB*<9T*LU"$Y."Q%&E
M&2C&ZC)M?"?GQ\(G#_$+X=R,RHIU^P+.YVJH^T#EF/"@=R?QK]YO^"V&L:=I
M=[^P5KUOJ6G:E%X?T#0=7O%T^\@NS!'IXLKB1)Q"[&)\1$%7P1_+\#_$UWH\
M_B[Q#J?A"&?2_#MSJ]U=>&;9B5NM/TUY7:UB+=4DC0J"1SD<U%J/B;Q%KT^F
M'Q?XBUOQ-I^FRQ*MOJM[/>-;:<K#S[:R$KOY0:(%55,#H/IZ&99"\TS[A_/G
M7="&48?,(5,%*ES5*_\ :6%]BXJK&=J4Z-W=6DI25DTFV<>6Y['+,JSS*(T8
MU99I6P3IXF-5J%%82O[6ZC[-NHII))MT[;Z[']4W[5/[/G@__@K%^SM\+/BO
M^SI\0M D^)O@_0=*T?7?!NJZQ9Z?Q86JP3E1-*IRFPMTSQQS7U7^RS^R>O[(
M'_!+OX]^!=7\6:=XF\8:YIFKZIKMMI=W!?6^BW;)(TMB9[=G7*=.N>.1GK^9
M7[.'P?\ ^"?'QH^ OAF?X?\ [0WB;]F;XA66T>*;6[\22Z2-1G"@7+QJ+B,L
MLAW!>",'\O5OVC_VI?V>?V(/V.O$_P"S/\!OBK>?''X@?$FZGG\0>-+O4WU9
M88+P'SH1.TLF/O,!S^?;^?,=@<WQ4<%P1D^)SFK@L)Q7AL5A\HQ_#]7"U\)A
M</C?K%26*SKGEA*F!H>]4H>SC[6HI*,F[67[=@\9EN%>,XLS.CE5+$XGARO0
MK9E@L[I8BCB\57P:P]-4,I<(XJGC*RM2K*<G2A9RBKZO^6ZY8K-K3#J-2U8@
M=3D7,Q &.ISZ=:_HV_97O_#/[-7_  2,^)/QDU.'^S]=^.IU'P';7$B>3<7.
MX3P*JEMKE#D8P<<Y'6OYS8\&X6XE^99-0^W7"?WEDE,LR8XR&RPP<YSTK]#?
MVAOVW[#XQ_LI_"[]E[P_H$FA:+\/-3BU:21$,4-W=I_K)-H 5B[$Y).2><&O
MWCC'*<9GD.'\MHTISP+SW XO-ZL9J$:>"P*==0DI:S]IB8T+)77NMM;'XSPK
MFN"RF>=YA6G&&,_LC%8;*XS@YR>+QCA0E.ZTC[.A*LVVUJTDTV?G18QF*W"G
M.2\K<G)^:1FY/XU9/^MM/^OVU_\ 1JTX< #T I?3V((]B.A'N.QK[)N[;[GQ
M]_>YGO>[^^Y_13^W>UC<_P#!&[X&VMOJFEW-Y_PENF;["WOH)KV,"2/+26R.
M954=R5 Z\C%>X_";1/A1_P %+_\ @G3X0_9[\,?$+2O#'QN^#^DI8:;HFIW]
MO81:G-# BQQEYW3(D9=O/K7\O=]XG\8:CI4>A7WBK6[_ $.V8/::'>7\\VEV
MT@(P\5J[F)&7J"J@]/2OVT_8 \#_ + WQ8^$FM>&_$WQ+\2?L_\ QRMRHE\9
M_P!LRZ38WTH ^>"43194,2<#ISQ7XOQ!PO\ ZN\.4JZQV8SQN XKQ7$.!S'+
M,L>-6 J9A52E'&X#VOM,1A(TY2I5I4G[25U*,8VT_8,CXE_MW.9X=X3+UA,5
MP[0R;%X',,P6#^N1PE&DKX;&2IQIT,5*I1A4HJ:Y$XRBY2NC]>_^".O_  3]
M\0_L9:=\>_$?Q0\6:+<^//$7A;4M+'A/1]3M=26SMHK&X6*\=K=W*B7(/S8&
M".P 'Y1_\$Q/!EKXP_X*S?%V?4;0W%EX2UK6O$5RSC$5M%9W,DC2R.0 BJ%Z
MMC\.<_>&B_%C]E;_ ()K?"#XM>)_"O[1FH_M&?&#XD:#<:+HYN=?DUF+2I)+
M>6!92&GE*X+@YQT]>M?D'^RA_P %!?AO^SIX+^/7BFZ\':I??M)_&F+6=.C\
M7V^X6.F:/JQF5HT8<I*JRYR!G/7V^4RO <3YW3\1<WIT\9F=7B7"Y5D> QCR
MZ64*<K0IXG$4L%B:GMJ6 P-*4TZLYRJU&O=4KW/I<?F'#^4U.",KJSPV"AD5
M7,,VQN&6.CF;II5:=>A1JXK#4W2JXS&.DHQITXQIP4KR:22/"?\ @IKXITWQ
MK^W1\;O$6C3PW.FW&JBW@FMW66%OLK-"P6120V"N#SD'.>E;/_!,3]H;0_V;
M_P!KKX<^)/%5JLOA;7-8ATO7+]V"+I5I<[H6NR20,1F0$YR/RKX%N[N]U&_U
M'4]1NY[Z]U&_N[Z>ZNI#+/(]U.TQ#R,2S8+$#)XJ(%E(=':.12&21#AT8<AE
M/9@0"#V(K]T>08:IPS'AC$2=7"_V/3RBI4C>,Y4X8:-!58V>DTXJ:5WJK.^I
M^+O/<13XCEQ#0C&-=9G/,:<&E*',\0ZR@TUK'7E>FJ\S^BO]L#_@D1\<?B;^
MU]<_'7X(:GX9\:?!/XK>*;+QM<^*6UZRB_L73I6AFNHI4#X\R-"P5&(;(Q@\
MBOHK_@OSI#?!']G3_@GOI?A'6%N)_!>HZ7)'K-LX=/.L(HIKKRY(SA@DRR("
M"00F>,U_.#X4_:8_:!\/Z'IGP_L/C!X[LO!\FM6=S<6T.OWR"WMTD3?!$!-\
MEL5',0PA'&,5^P7_  5Q_:)^%7QI_8S_ &)/"G@CQO9>+O&/@RW'_"86D5P+
MC4+"4V;*[7QWLV]G.6+ 9)R>M?E=?A_BG \5>&V'S;,,/G.697BLSP-&6#RZ
MK0E'"K)J]&AB,UJ.I5I>VE!0PZ4(TJ<I<S:DYV7Z;AL^X<QF0<<U\NP57+,?
MCJ&5XNK'%XZE7C.NLXP]:M0R^FJ=*I[)2<ZK=5U*J@HK2,#ZW_;6_9K\4?\
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MM/HH :BA%"+G"\#))/XDY)_$TZBB@ HHHH **** "BBB@#XR_;A_Y%;]G_\
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M_F:;7^DY_G;'9>B_(****!A1110 4444 %%%% !1110 4444 %%%% !1110
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MWX*VKD>$O$.IC5KZ$ !&N0VX$COR.?7ZXKRM$6-%10 J*JC QPHP* 'T444
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M#_\ TZ6]?&^(G_)"\6?]B7%?^V'W?AA_R<+A'_L;T_\ TQ7/]@/0/^0%HO\
MV"=._P#2.&M:LG0/^0%HO_8)T[_TCAK6K_+D_P!#3^('_@O5_P IAOV1?^R0
MZA_Z-NZ\#N/^/B?_ *[2_P#H;5[Y_P %ZO\ E,-^R+_V2'4/_1MW7@=Q_P ?
M$_\ UVE_]#:O2S+X<L_[%M/_ -.U2(;S_P ;_*)#1117FEA1110 4444 %%%
M% "$X!/)P,\ D_@!DD^PJ-)EDSA)5QG[\4B9QZ;E&?;'7M7H?PATVTUOXO\
MPWT34(UFT[5?$EG:7L+C<DL$DB!D9><@C@CO7[._\%(OV=?A9\,=*^#MYX-T
M"STF75]7T.UU 6\*H+F*6:..4OA>?,&2<\G)R#W /P=6=6;:$G!SC+02JO\
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M'TKZ#NHOV,_VM? GBO2O#EK8_";QEHFGWMWH4NIA=-34ULHV*!"PC\QIMH(
M)R6X]P#\26<*P4JY)[JC,H^K $#\33Z_3_\ 9_\ @=X6\2_LU_&W5GT4>(/%
MWAY+ZQT![>'S[FYEM6>))K3 )<.0&!4XQ@U\3ZO^S7\<_"W@FS\<:WX"U]=&
MFB,TT@L)=UI%N),EP=OR*JD9)- 'C%%-1U<95@P!*G!SAEX93Z%3P1V-.H *
M*** "BBB@ HHHH **** /C+]N'_D5OV?_P#LX/P1_P"G2UK^P7_@M]_RA?\
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M[XP?"'XF?LA?LV>%_A]\0-%\5^(M"L-%_MK2=-F22ZTUX(X_-2=5=BI0@@Y
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M4/\ LN_@_P#].EO7QOB)_P D+Q9_V)<5_P"V'W?AA_R<+A'_ +&]/_TQ7/\
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M!NHS1ZCI$@DMK?3C#*2DC*2H<*5')ZC'H: /PM^.X"_&7QV%554:O> *BA5
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M !1110 4444 %%%% 'QE^W#_ ,BM^S__ -G!^"/_ $Z6M?V"_P#!;[_E"_\
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M.%['XL^ M"7Q5\1OA[X4DC:6'Q-XOT71)HE4N7BU"]AMW4J.Q60Y/85^Z/\
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MAE(]00:_8;_@A?<WM_\ M_7%YJ-_?:C=-\(/'69KZ[FNW _LU@ K3LY4
M$ #@5^.M?JO_ ,$7?B%X!^%W[;$OBKXE^*M.\&>&#\*_&>GC6M5E6*T^WW6G
MNEK:AF91YDSD*@SR?I7J\>4IUN#.)X4J4ZM:>2XV%.%*FZE6;=/2$(Q3G)R>
MT8IMOH>7P/5C2XJR*52K&E2CFF!E4E4FJ=.*CB:4G*<I-02BDVY-JR3UL:?_
M  3D_9\\)_M ?\%(?%$'CF5)?"_@_P"*_C?6]2T610\>LK::M?7"6SJP(9=\
M:Y!&/7V^D/VL?^"OW[3MA^V=?_#3X3:KI7@'X-?#+QS#X(@\!VVDV36FK:+8
M74=O+%<($"EYHD*ACELMDGM7YZ_LM?M5/^RI^W-KGQCM8&UWP1-\5/%DVN6M
MH&DDU;0-1UB["SVH0$L'@F$B8!^7'>OV)^*?['O_  3L^/'Q@T[]K'P)^T?X
M8\*:7XRUR'QEXI^%VLW03Q!_;4\D<\UA#!)()%8S,550@Y)!'>O@N(Z6 PG%
M6'Q_%F58G-<EK<*4,'D;CE]3,L)@LT3YL93JT*<*GL<7B*?L_8UZM.RBN2-2
M'*S[S(:^+Q'#N(P?#698;+\VI9Y+$9JOKM+!8G$X&=&C2PU6%:I.FJV'P\O;
MNI1IU&U.49^SGI=?^#C'Q=;>/_@U^PQXWM]%L=!E\0>%Y;Z>ULK2"UVSS6*R
M.3Y*(2FYLHA.$).T"N,\*&S\<?\ !"31M-\46+:J_AKQEJ%YH]W/F1K66.6<
MIL=LD!>  #TR!CMWO_!Q@OA:[^%G[!MAX$S_ ,(Q<Z(NE:-NR7<2PBW@DP.<
M.I0CUKB_VGO[0_9$_P"",WP1^#TLMLWB[XB>)QK&I0.%%Q'I6H%Y%8QYWJ"D
MHY*CZU\IP\H5>!?#' 8:$J6+K\=5Z^"H2<H5:.'P>89O4Q$I2]Z451HRC"I=
MN_.HO?3Z3/5.'%?'V,Q$HU,/2X1I4L36C"$J-:MB<!E%*E&.R?MJZ<X66BBY
M*UC^9R21TTVXD#?.D<VUO=68"OZ=O#GQKTW_ ()S_P#!)OX/?%/X,Z18Z1\=
MOVG3<6<WC>6P@O;C33#&Q\R)Y49HF'WL*V.*_F0EMM]G+;H<>9&Z@^F_)_K7
M]*7[-7B3]G7_ (*!?\$^O#/[%GC_ ,=:!\)_C!\%%EF^'?B?Q3-%#87EQ+&0
M?*:9T!7)^;:W3/-?I_B53ISPG#]?'8;$XS(,+Q)A<1Q#A\/3J5H2R]4,1&E4
MQ6'IQE.OA*..EA:M>FH3O"+;BTG;\U\/JDHXG.J.#Q&'PN=XG),70R2M6G"C
M-8R5;"2G3PU>I:-#$U<''%TZ-3F@XSG92NSZR_X(E?\ !0WXR_M1-^T+\%OC
MS%I'CCQ%I7PSU7Q!;^.;W2+,W(3[)=K]C?,62JCE,Y&X(X^9%(W/^"06B?#R
M[^%G_!1'6/B4L?\ PC&D^,]?FU"U0K#]JM+:2^F>S3:5"I<O%';%1QME(P0!
M7I/_  23_8Y^"7[(^G?M":%;?&CPG\8?VA9_AYJW]HWGA&YBFLK70C;3D1,L
M4LN'"G+;C]XMSVK\N/\ @G[^UE\+_A)^T/\ M*?LR_&R^_L3X=?&S6=?AOO$
M4\GE6.EWUS<S"&6Y8E5VH9 S9./E([9K\2S'!8#.L1XG4^#\%B<-@8PX/Q\:
M6"PM7"U:M'!5XXG'XK+L+4C"<8U*47.A&%."FXMPAM?]?PN,QN5PX J\38O#
M8G%.?%.#G6Q&(AB*-.KBZ2P^$H8W$0<HM*M-*KSRDZ<*D8SE[KM[%\"?VP?^
M"=_[47Q6D_8]U?\ 9(T3X<>']?UO5=$\)>.+.2WBU"+64:6!=46YC G26YE'
MF\,&.2?6L']BW]EJ?]C[_@K=KOPSU.[O-<\+S:?<ZAX?DO[B6YFN=";?-#%Y
MTS,Q'ED)NR,C\ >R^ 7_  3?_9 _9H_:*?\ :C\?_MD_"SQC\.?"VM:KXJ\(
M>%-%U&U.LSS3-)<V=HX2X+-)&2J8 !]02<UYG\"_VY? GQL_X*N>+OC'X_\
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MM$_\$3?'GB;P[\6O$?A#5?!7C"UGMM9U/PCHT%PNCKJD6QVMHXXU6(P^8IP
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M@?ABIZ*5WWWW\Q7>NKUW\_4**** "BBB@ HHHH **** "H[C_CSU#_L'WO\
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MI/S0_P"?M+_P;2_^3\U]Y_GDL/B;+_9L3LO^8>MY?W/ZU[,U**R_[?\ #?\
MT,FA_P#@QMO_ (Y1_;_AO_H9-#_\&-M_\<HYZ?\ S]H_^#J7_P GYK[P^KXC
M_H&Q/_A/6_\ D//\^S-2BLO^W_#?_0R:'_X,;;_XY1_;_AO_ *&30_\ P8VW
M_P <HYZ?_/VC_P"#J7_R?FOO#ZOB/^@;$_\ A/6_^0\_S[,U**R_[?\ #?\
MT,FA_P#@QMO_ (Y1_;_AO_H9-#_\&-M_\<HYZ?\ S]H_^#J7_P GYK[P^KXC
M_H&Q/_A/6_\ D//\^S-2BLO^W_#?_0R:'_X,;;_XY1_;_AO_ *&30_\ P8VW
M_P <HYZ?_/VC_P"#J7_R?FOO#ZOB/^@;$_\ A/6_^0\_S[,U**R_[?\ #?\
MT,FA_P#@QMO_ (Y1_;_AO_H9-#_\&-M_\<HYZ?\ S]H_^#J7_P GYK[P^KXC
M_H&Q/_A/6_\ D//\^S-2BLO^W_#?_0R:'_X,;;_XY1_;_AO_ *&30_\ P8VW
M_P <HYZ?_/VC_P"#J7_R?FOO#ZOB/^@;$_\ A/6_^0\_S[,U**R_[?\ #?\
MT,FA_P#@QMO_ (Y1_;_AO_H9-#_\&-M_\<HYZ?\ S]H_^#J7_P GYK[P^KXC
M_H&Q/_A/6_\ D//\^S-2BLO^W_#?_0R:'_X,;;_XY1_;_AO_ *&30_\ P8VW
M_P <HYZ?_/VC_P"#J7_R?FOO#ZOB/^@;$_\ A/6_^0\_S[,U**R_[?\ #?\
MT,FA_P#@QMO_ (Y1_;_AO_H9-#_\&-M_\<HYZ?\ S]H_^#J7_P GYK[P^KXC
M_H&Q/_A/6_\ D//\^S-2BLO^W_#?_0R:'_X,;;_XY1_;_AO_ *&30_\ P8VW
M_P <HYZ?_/VC_P"#J7_R?FOO#ZOB/^@;$_\ A/6_^0\_S[,U**R_[?\ #?\
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M/^@;$_\ A/6_^0\_S[,U*K:!_P G ?LH?]EW\'_^G2WJI_;_ (;_ .ADT/\
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M[SH:*Y[_ (3;X>?]%%\$?^%%IW_Q^C_A-OAY_P!%%\$?^%%IW_Q^CEE_)/\
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MHKGO^$V^'G_11?!'_A1:=_\ 'Z/^$V^'G_11?!'_ (46G?\ Q^IY9?R3_P#
M)?Y!==U_7_#K[SH:*Y[_ (3;X>?]%%\$?^%%IW_Q^C_A-OAY_P!%%\$?^%%I
MW_Q^CEE_)/\ \ E_D%UW7]?\.OO.AHKGO^$V^'G_ $47P1_X46G?_'Z/^$V^
M'G_11?!'_A1:=_\ 'Z.67\D__ )?Y!==U_7_  Z^\Z&BN>_X3;X>?]%%\$?^
M%%IW_P ?H_X3;X>?]%%\$?\ A1:=_P#'Z.67\D__  "7^077=?U_PZ^\Z&BN
M>_X3;X>?]%%\$?\ A1:=_P#'Z/\ A-OAY_T47P1_X46G?_'Z.67\D_\ P"7^
M077=?U_PZ^\Z&BN>_P"$V^'G_11?!'_A1:=_\?H_X3;X>?\ 11?!'_A1:=_\
M?HY9?R3_ / )?Y!==U_7_#K[SH:*Y[_A-OAY_P!%%\$?^%%IW_Q^C_A-OAY_
MT47P1_X46G?_ !^CEE_)/_P"7^077=?U_P .OO.AHKGO^$V^'G_11?!'_A1:
M=_\ 'Z/^$V^'G_11?!'_ (46G?\ Q^CEE_)/_P  E_D%UW7]?\.OO.AHKGO^
M$V^'G_11?!'_ (46G?\ Q^C_ (3;X>?]%%\$?^%%IW_Q^CEE_)/_ , E_D%U
MW7]?\.OO.AHKGO\ A-OAY_T47P1_X46G?_'Z/^$V^'G_ $47P1_X46G?_'Z.
M67\D_P#P"7^077=?U_PZ^\Z&BN>_X3;X>?\ 11?!'_A1:=_\?H_X3;X>?]%%
M\$?^%%IW_P ?HY9?R3_\ E_D%UW7]?\ #K[SY3_;A_Y%;]G_ /[.#\$?^G2U
MK^P7_@M]_P H7_CM_P!DA\(?^D>FU_&_^VUXK\&7WAO]GZWTSQGX6U6Z/[0?
M@<BTT[6K*ZN2#JMJ 1#'*SD9P,XQD@5_8[_P7"ECB_X(N?'B661(XT^$'A M
M([!44?8]-Y9F( 'N3BO;PB:IY'=-?\*U9V::?\;!=&KD?:J?X8_E(_SB?AS_
M ,D\\%?]@"S_ /0378UYU\.M>\.K\/?!:OXAT6-UT&T#QOJ-L'1@#E64OD,.
MX/(/%=C_ &_X;_Z&30__  8VW_QRO]4L'.F\%@;5:/\ N."_Y>T_^@:BOYNY
M_FAFV'Q/]K9K_LV(_P"1GF'_ "XJ_P#096_N>?\ 5F:E%9?]O^&_^ADT/_P8
MVW_QRC^W_#?_ $,FA_\ @QMO_CE=//3_ .?M'_P=2_\ D_-?>>?]7Q'_ $#8
MG_PGK?\ R'G^?9FI167_ &_X;_Z&30__  8VW_QRC^W_  W_ -#)H?\ X,;;
M_P".4<]/_G[1_P#!U+_Y/S7WA]7Q'_0-B?\ PGK?_(>?Y]F:E%9?]O\ AO\
MZ&30_P#P8VW_ ,<H_M_PW_T,FA_^#&V_^.4<]/\ Y^T?_!U+_P"3\U]X?5\1
M_P! V)_\)ZW_ ,AY_GV9J45E_P!O^&_^ADT/_P &-M_\<H_M_P -_P#0R:'_
M .#&V_\ CE'/3_Y^T?\ P=2_^3\U]X?5\1_T#8G_ ,)ZW_R'G^?9FI167_;_
M (;_ .ADT/\ \&-M_P#'*/[?\-_]#)H?_@QMO_CE'/3_ .?M'_P=2_\ D_-?
M>'U?$?\ 0-B?_">M_P#(>?Y]F:E%9?\ ;_AO_H9-#_\ !C;?_'*/[?\ #?\
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M\_:/_@ZE_P#)^:^\/J^(_P"@;$_^$];_ .0\_P ^S-2BL^36M A($VOZ/$6
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M1_\ +/+\^[,_84/^?%#_ ,$T_P#Y'R7W'\[/_$+G_P $EO\ HE/C+_PM)_\
MY!H_XA<_^"2W_1*?&7_A:3__ "#7]$U%']MYQ_T-<Q_\+,1_\L\OS[L/84/^
M?%#_ ,$T_P#Y'R7W'\[/_$+G_P $EO\ HE/C+_PM)_\ Y!H_XA<_^"2W_1*?
M&7_A:3__ "#7]$U%']MYQ_T-<Q_\+,1_\L\OS[L/84/^?%#_ ,$T_P#Y'R7W
M'\[/_$+G_P $EO\ HE/C+_PM)_\ Y!H_XA<_^"2W_1*?&7_A:3__ "#7]$U%
M']MYQ_T-<Q_\+,1_\L\OS[L/84/^?%#_ ,$T_P#Y'R7W'\[/_$+G_P $EO\
MHE/C+_PM)_\ Y!H_XA<_^"2W_1*?&7_A:3__ "#7]$U%']MYQ_T-<Q_\+,1_
M\L\OS[L/84/^?%#_ ,$T_P#Y'R7W'\[/_$+G_P $EO\ HE/C+_PM)_\ Y!H_
MXA<_^"2W_1*?&7_A:3__ "#7]$U%']MYQ_T-<Q_\+,1_\L\OS[L/84/^?%#_
M ,$T_P#Y'R7W'\[/_$+G_P $EO\ HE/C+_PM)_\ Y!H_XA<_^"2W_1*?&7_A
M:3__ "#7]$U%']MYQ_T-<Q_\+,1_\L\OS[L/84/^?%#_ ,$T_P#Y'R7W'\[/
M_$+G_P $EO\ HE/C+_PM)_\ Y!H_XA<_^"2W_1*?&7_A:3__ "#7]$U%']MY
MQ_T-<Q_\+,1_\L\OS[L/84/^?%#_ ,$T_P#Y'R7W'\[/_$+G_P $EO\ HE/C
M+_PM)_\ Y!H_XA<_^"2W_1*?&7_A:3__ "#7]$U%']MYQ_T-<Q_\+,1_\L\O
MS[L/84/^?%#_ ,$T_P#Y'R7W'\[/_$+G_P $EO\ HE/C+_PM)_\ Y!H_XA<_
M^"2W_1*?&7_A:3__ "#7]$U%']MYQ_T-<Q_\+,1_\L\OS[L/84/^?%#_ ,$T
M_P#Y'R7W'\[/_$+G_P $EO\ HE/C+_PM)_\ Y!H_XA<_^"2W_1*?&7_A:3__
M "#7]$U%']MYQ_T-<Q_\+,1_\L\OS[L/84/^?%#_ ,$T_P#Y'R7W'\[/_$+G
M_P $EO\ HE/C+_PM)_\ Y!K\G]:_X(:_\$_+#_@K7X7_ &-(?!GB>/X(ZM\"
MKWQ_>Z"=>D>^?Q/!8R3P2+J?E!Q"[JC']QA,[-I5=Q_N&K^?'Q3_ ,K#/@7_
M +-;O?\ TU/7TO#.;YK4GGG/F6.GR<-YM.'-BJTN6<:=+EG'FF[2CTENM>[,
M:]&BE2M1HK]_2VI4UU:_E[:>FAC_ /$+G_P26_Z)3XR_\+2?_P"0:/\ B%S_
M ."2W_1*?&7_ (6D_P#\@U_1-17S7]MYQ_T-<Q_\+,1_\L\OS[LW]C0_Y\4?
M_!-/_P"1\E]Q_.S_ ,0N?_!);_HE/C+_ ,+2?_Y!H_XA<_\ @DM_T2GQE_X6
MD_\ \@U_1-11_;><?]#7,?\ PLQ'_P L\OS[L7L*'_/BA_X)I_\ R/DON/YV
M?^(7/_@DM_T2GQE_X6D__P @T?\ $+G_ ,$EO^B4^,O_  M)_P#Y!K^B:BC^
MV\X_Z&N8_P#A9B/_ )9Y?GW8>PH?\^*'_@FG_P#(^2^X_G9_XA<_^"2W_1*?
M&7_A:3__ "#1_P 0N?\ P26_Z)3XR_\ "TG_ /D&OZ)J*/[;SC_H:YC_ .%F
M(_\ EGE^?=A["A_SXH?^":?_ ,CY+[C^=G_B%S_X)+?]$I\9?^%I/_\ (-'_
M !"Y_P#!);_HE/C+_P +2?\ ^0:_HFHH_MO./^AKF/\ X68C_P"6>7Y]V'L*
M'_/BA_X)I_\ R/DON/YV?^(7/_@DM_T2GQE_X6D__P @T?\ $+G_ ,$EO^B4
M^,O_  M)_P#Y!K^B:BC^V\X_Z&N8_P#A9B/_ )9Y?GW8>PH?\^*'_@FG_P#(
M^2^X_G9_XA<_^"2W_1*?&7_A:3__ "#1_P 0N?\ P26_Z)3XR_\ "TG_ /D&
MOZ)J*/[;SC_H:YC_ .%F(_\ EGE^?=A["A_SXH?^":?_ ,CY+[C^=G_B%S_X
M)+?]$I\9?^%I/_\ (-'_ !"Y_P#!);_HE/C+_P +2?\ ^0:_HFHH_MO./^AK
MF/\ X68C_P"6>7Y]V'L*'_/BA_X)I_\ R/DON/YV?^(7/_@DM_T2GQE_X6D_
M_P @T?\ $+G_ ,$EO^B4^,O_  M)_P#Y!K^B:BC^V\X_Z&N8_P#A9B/_ )9Y
M?GW8>PH?\^*'_@FG_P#(^2^X_G9_XA<_^"2W_1*?&7_A:3__ "#1_P 0N?\
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MS_Y"K^ANBK_M3,?^@W$_^#9?Y^2^X7)#^6/W?UV_/NS^>3_B&&_X)8_]"/\
M$G_PX-Y_\A4?\0PW_!+'_H1_B3_X<&\_^0J_H;HH_M3,?^@W$_\ @V7^?DON
M#DA_+'[OZ[?GW9_/)_Q##?\ !+'_ *$?XD_^'!O/_D*C_B&&_P""6/\ T(_Q
M)_\ #@WG_P A5_0W11_:F8_]!N)_\&R_S\E]P<D/Y8_=_7;\^[/YY/\ B&&_
MX)8_]"/\2?\ PX-Y_P#(5'_$,-_P2Q_Z$?XD_P#AP;S_ .0J_H;HH_M3,?\
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M[L_GD_XAAO\ @EC_ -"/\2?_  X-Y_\ (5'_ !##?\$L?^A'^)/_ (<&\_\
MD*OZ&Z*/[4S'_H-Q/_@V7^?DON#DA_+'[OZ[?GW9_/)_Q##?\$L?^A'^)/\
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MM_T2GQE_X6D__P @U_1-11_;><?]#7,?_"S$?_+/+\^[#V%#_GQ0_P#!-/\
M^1\E]Q_.S_Q"Y_\ !);_ *)3XR_\+2?_ .0:/^(7/_@DM_T2GQE_X6D__P @
MU_1-11_;><?]#7,?_"S$?_+/+\^[#V%#_GQ0_P#!-/\ ^1\E]Q_.S_Q"Y_\
M!);_ *)3XR_\+2?_ .0:/^(7/_@DM_T2GQE_X6D__P @U_1-11_;><?]#7,?
M_"S$?_+/+\^[#V%#_GQ0_P#!-/\ ^1\E]Q_.S_Q"Y_\ !);_ *)3XR_\+2?_
M .0:/^(7/_@DM_T2GQE_X6D__P @U_1-11_;><?]#7,?_"S$?_+/+\^[#V%#
M_GQ0_P#!-/\ ^1\E]Q_.S_Q"Y_\ !);_ *)3XR_\+2?_ .0:1O\ @UQ_X)*L
MK(?A3XSVNK(V/&DXRK @C_CQ[@U_1/11_;><?]#7,?\ PLQ'_P L\OS[L?L:
M*_Y<4-/^G-/I;^[Y+[D?'?[$W["O[/7_  3]^$TWP6_9L\-7GA?P+<:Y=^(I
M[&^OSJ-Q)JM\2;FX>Y,,+,7+$D%2<DG-?8;=#]#_ "I:1NA^A_E7G3G.K.52
MI*4YR=Y3DW*4GW;>K9IML+1114 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5_/CXI_P"5AGP+_P!FMWO_ *:GK^@ZOY\?
M%/\ RL,^!?\ LUN]_P#34]?4<+_'GW_9,YO_ .FZ1A7VI?\ 7^E^;/Z#J***
M^7-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#\'/^"J__ "6[]GG_ +&'2?\ TL%?N9X?_P"0#HG_ &"--_\
M2*&OPS_X*K_\EN_9Y_[&'2?_ $L%?N9X?_Y .B?]@C3?_2*&OI\W_P"1%PY_
MUZQO_I^)C#^-5_[=_P#28FO1117S!L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !61X@_P"0#K?_ &"-2_\ 2*:M>LCQ!_R
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M(_\ ''_PD;W_ .1:/^'\7[/?_1'_ (X_^$C>_P#R+7[1_P#"!>!?^A+\)_\
MA.:/_P#(='_"!>!?^A+\)_\ A.:/_P#(='U_A?\ Z)[&_P#AZGY?]0?D_O\
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MB_9[_P"B/_''_P )&]_^1:/^'\7[/?\ T1_XX_\ A(WO_P BU^T?_"!>!?\
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MO7\/,_%S_A_%^SW_ -$?^./_ (2-[_\ (M'_  _B_9[_ .B/_''_ ,)&]_\
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M!>!?^A+\)_\ A.:/_P#(='U_A?\ Z)[&_P#AZGY?]0?D_O\ (.6M_P _8_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M )#S7WA[:E_S\A_X$O+S\T?U045_*_\ \1=7_!,3_GU^+'_A.+_C1_Q%U?\
M!,3_ )]?BQ_X3B_XT?ZO9[_T*,Q_\)*W_P AYK[P]M2_Y^0_\"7EY^:/ZH**
M_E?_ .(NK_@F)_SZ_%C_ ,)Q?\:/^(NK_@F)_P ^OQ8_\)Q?\:/]7L]_Z%&8
M_P#A)6_^0\U]X>VI?\_(?^!+R\_-']4%%?RO_P#$75_P3$_Y]?BQ_P"$XO\
MC1_Q%U?\$Q/^?7XL?^$XO^-'^KV>_P#0HS'_ ,)*W_R'FOO#VU+_ )^0_P#
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M?L5^)OV0OVPO$'C?13X@TWX(?%*Z>?PE9W%W--82:H\OF7J@ ;&V2L0I.,@
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M ,1=7_!,3_GU^+'_ (3B_P"-'_$75_P3$_Y]?BQ_X3B_XT?ZO9[_ -"C,?\
MPDK?_(>:^\/;4O\ GY#_ ,"7EY^:/ZH**_E?_P"(NK_@F)_SZ_%C_P )Q?\
M&C_B+J_X)B?\^OQ8_P#"<7_&C_5[/?\ H49C_P"$E;_Y#S7WA[:E_P _(?\
M@2\O/S1_5!17\K__ !%U?\$Q/^?7XL?^$XO^-'_$75_P3$_Y]?BQ_P"$XO\
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M_P# EY>?FC^J"BOY7_\ B+J_X)B?\^OQ8_\ "<7_ !H_XBZO^"8G_/K\6/\
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M7EY^:/ZH**_E?_XBZO\ @F)_SZ_%C_PG%_QH_P"(NK_@F)_SZ_%C_P )Q?\
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M ()B?\^OQ8_\)Q?\:/\ B+J_X)B?\^OQ8_\ "<7_ !H_U>SW_H49C_X25O\
MY#S7WA[:E_S\A_X$O+S\T?U045_*_P#\1=7_  3$_P"?7XL?^$XO^-'_ !%U
M?\$Q/^?7XL?^$XO^-'^KV>_]"C,?_"2M_P#(>:^\/;4O^?D/_ EY>?FC^J"B
MOY7_ /B+J_X)B?\ /K\6/_"<7_&C_B+J_P""8G_/K\6/_"<7_&C_ %>SW_H4
M9C_X25O_ )#S7WA[:E_S\A_X$O+S\T?U045_*_\ \1=7_!,3_GU^+'_A.+_C
M1_Q%U?\ !,3_ )]?BQ_X3B_XT?ZO9[_T*,Q_\)*W_P AYK[P]M2_Y^0_\"7E
MY^:/ZH**_E?_ .(NK_@F)_SZ_%C_ ,)Q?\:/^(NK_@F)_P ^OQ8_\)Q?\:/]
M7L]_Z%&8_P#A)6_^0\U]X>VI?\_(?^!+R\_-']4%%?RO_P#$75_P3$_Y]?BQ
M_P"$XO\ C1_Q%U?\$Q/^?7XL?^$XO^-'^KV>_P#0HS'_ ,)*W_R'FOO#VU+_
M )^0_P# EY>?FC^J"BOY7_\ B+J_X)B?\^OQ8_\ "<7_ !H_XBZO^"8G_/K\
M6/\ PG%_QH_U>SW_ *%&8_\ A)6_^0\U]X>VI?\ /R'_ ($O+S\T?U05_*!_
MP<2_%+]MS]E6Q\*_&C]F_P 5W-KX'\1-=Z5XUM8C.T>E6KH8I99=B,J+)$Y*
ML2 ">#QQO_\ $75_P3$_Y]?BQ_X3B_XU\M?MF?\ !RI_P2@_:U_9V^)/P/\
M$6@_$W4#XST"ZT[2IKCP_P"2]AJC@&TNHIT5GC(D 1Q]UE<YPP4CZ'A7!9IE
M&>X#&8WA_%8O!*M&GBZ&(P-2I3EAZK49SY90:YJ5U5B][Q2ZF->4*E*48UHQ
MDU>+4TG=6:^^Z7S\C\#?^"8O[77[=_B/X\^$_@9\ ?$\Z^'/B+\0H?$_Q!B@
M,[;'U&X22]OY#&K*J.)'+,V,CKQFO]0KP'I&JZ!X.\.Z/KM[_:&L6&E6MOJ5
M[DG[1>+&//DR<9S(6_SS7^9W_P $9/\ @HQ_P3N_X)R?$7QY\4?C=I/CG4O%
M>KB>P\#2:;IAOX;/0RV+:XEA=63[68,#E@5<[_X<'^E'_B+J_P""8G_/K\6/
M_"<7_&OKO%.EB,VSR-#)\BK+"X2E'VF+P^ G&6,Q%6,92E.<8/G5*/+3CJ]O
M)&&!:A2O4JIRD]$YJT5I:RNK7NKZ7^1_5!17\K__ !%U?\$Q/^?7XL?^$XO^
M-'_$75_P3$_Y]?BQ_P"$XO\ C7YA_J]GO_0HS'_PDK?_ "'FOO.WVU+_ )^0
M_P# EY>?FC^J"BOY7_\ B+J_X)B?\^OQ8_\ "<7_ !H_XBZO^"8G_/K\6/\
MPG%_QH_U>SW_ *%&8_\ A)6_^0\U]X>VI?\ /R'_ ($O+S\T?U045_*__P 1
M=7_!,3_GU^+'_A.+_C1_Q%U?\$Q/^?7XL?\ A.+_ (T?ZO9[_P!"C,?_  DK
M?_(>:^\/;4O^?D/_  )>7GYH_J@HK^5__B+J_P""8G_/K\6/_"<7_&C_ (BZ
MO^"8G_/K\6/_  G%_P :/]7L]_Z%&8_^$E;_ .0\U]X>VI?\_(?^!+R\_-']
M4%%?RO\ _$75_P $Q/\ GU^+'_A.+_C1_P 1=7_!,3_GU^+'_A.+_C1_J]GO
M_0HS'_PDK?\ R'FOO#VU+_GY#_P)>7GYH_J@HK^5_P#XBZO^"8G_ #Z_%C_P
MG%_QH_XBZO\ @F)_SZ_%C_PG%_QH_P!7L]_Z%&8_^$E;_P"0\U]X>VI?\_(?
M^!+R\_-']4%%?RO_ /$75_P3$_Y]?BQ_X3B_XT?\1=7_  3$_P"?7XL?^$XO
M^-'^KV>_]"C,?_"2M_\ (>:^\/;4O^?D/_ EY>?FC^J"BOY7_P#B+J_X)B?\
M^OQ8_P#"<7_&C_B+J_X)B?\ /K\6/_"<7_&C_5[/?^A1F/\ X25O_D/-?>'M
MJ7_/R'_@2\O/S1_5!17\K_\ Q%U?\$Q/^?7XL?\ A.+_ (T?\1=7_!,3_GU^
M+'_A.+_C1_J]GO\ T*,Q_P#"2M_\AYK[P]M2_P"?D/\ P)>7GYH_J@HK^5__
M (BZO^"8G_/K\6/_  G%_P :/^(NK_@F)_SZ_%C_ ,)Q?\:/]7L]_P"A1F/_
M (25O_D/-?>'MJ7_ #\A_P"!+R\_-']4%%?RO_\ $75_P3$_Y]?BQ_X3B_XT
MUO\ @[L_X)B*K-]D^+)VJ6POAL%C@$X !R2<8 ')/%+_ %>SW_H49A_X25O_
M )#S7WA[:E_S\A_X$O+S\T?U14C=#]#_ "KX1_X)[_\ !0OX&?\ !2?X)W/Q
MW^ ']O#P;:>(K[PQ.GB*R^P:A'J>GDB='MS\RJ,<;@#[5]W-T/T/\J\JI3G2
MG*G4C*$XNTHR5I1>]FGLRTTU=:IBU_FW?\':,,,G_!3SX%F2&&7/P=B!$L22
M @6P(!#J<@, P]" >HK_ $D:_P W+_@[/_Y2=_ O_LCT7_I+7WGAA_R6V3?]
M?9_^FY'/C/\ =JOHO_2HG\XK6=CD_P"@6/4_\ND'K_N4GV.Q_P"?"Q_\!(/_
M (BK+=3]3_.DK^RKO^DO+_)'SR2LO1?I_DBO]CL?^?"Q_P# 2#_XBC['8_\
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M (BK%%%WW_K3_)!9=OZT_P D5_L=C_SX6/\ X"0?_$4?8['_ )\+'_P$@_\
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MV/\ SX6/_@)!_P#$58HHN^_]:?Y(++M_6G^2*_V.Q_Y\+'_P$@_^(H^QV/\
MSX6/_@)!_P#$58HHN^_]:?Y(++M_6G^2*_V.Q_Y\+'_P$@_^(H^QV/\ SX6/
M_@)!_P#$58IT4<D\\%K AEN;N:.VM85Y>>YE.V*%!U+R-PH&231=]]OTM^5E
M]P62_#]+?DBK]CL?^?"Q_P# 2#_XBC['8_\ /A8_^ D'_P 17T3'^R#^UM/!
M;W<'P"\;2VMY"ES:3KI]R4N+>4;HID/D8*.O*D=1S3O^&/?VN<$_\,_^., $
MD_V==8 '))_<=JYOKV"_Z#\%_P"%6'TMR_W^FE_1ARO^2?3[,O[O_ ^[S5_G
M3['8_P#/A8_^ D'_ ,11]CL?^?"Q_P# 2#_XBM?Q)H^L^#=4NM!\6Z9=:%K]
MA(L-]I%W%(+NVF9MJQO%L\P,6XP4'->L^&_V9?VEO&>D0^(?"/P6\7Z]H-PG
MF6^J6FGW1@E0KN#*?(Z;>>O3FM9UZ5*$:E2O1I4YVY*E2K3ITY7Y;<LYR49:
M<K7*W=:[!97LDV]-$FVMMUNMEOV/#_L=C_SX6/\ X"0?_$4?8['_ )\+'_P$
M@_\ B*TM7T[5?#FLW?ASQ'IEYHNOZ?(8;[3+V":&:VF4D-&_F1H,@@C^506T
M%U?ZA::3IUK/?ZI?N([*RMHI)IKB1F"A5$2/R6( SW-:*3:4DTX\JDI)IQY;
M)J7,M.6R3YKVMK?<5E]S2ZZ/31]GHM_F5/L=C_SX6/\ X"0?_$4?8['_ )\+
M'_P$@_\ B*][NOV5/VI;#2FUZ]^!GC.VT1(/M;:B^G77DBUVEO/)\C[NWGW'
M>O"VWQSSVD\4MO=VKF*YMYHY(I(9%)5D99%4Y# CI6=.O2K7=&O1K*-E)T:M
M.JHO2RDX2ERO1*SMJO4=DMTUM:Z:OM:U_1?<0?8['_GPL?\ P$@_^(H^QV/_
M #X6/_@)!_\ $58HK2[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H^QV
M/_/A8_\ @)!_\15BBB[[_P!:?Y(++M_6G^2*_P!CL?\ GPL?_ 2#_P"(H%I9
M Y%C8@CH1:0 C\=E6**+O^K>7^2"R[?UI_DB)[>VDQYEK:R8X'F6\3[0.@&Y
M3@#VIGV.Q_Y\+'_P$@_^(JQ11=]_ZT_R067;^M/\D5_L=C_SX6/_ ("0?_$4
M?8['_GPL?_ 2#_XBK%%%WW_K3_)!9=OZT_R17^QV/_/A8_\ @)!_\11]CL?^
M?"Q_\!(/_B*L447??^M/\D%EV_K3_)%?['8_\^%C_P" D'_Q%'V.Q_Y\+'_P
M$@_^(JQ11=]_ZT_R067;^M/\D5_L=C_SX6/_ ("0?_$4?8['_GPL?_ 2#_XB
MK%%%WW_K3_)!9=OZT_R17^QV/_/A8_\ @)!_\11]CL?^?"Q_\!(/_B*L447?
M?^M/\D%EV_K3_)%?['8_\^%C_P" D'_Q%'V.Q_Y\+'_P$@_^(JQ11=]_ZT_R
M067;^M/\D5_L=C_SX6/_ ("0?_$4?8['_GPL?_ 2#_XBK%%%WW_K3_)!9=OZ
MT_R17^QV/_/A8_\ @)!_\11]CL?^?"Q_\!(/_B*L447??^M/\D%EV_K3_)%?
M['8_\^%C_P" D'_Q%'V.Q_Y\+'_P$@_^(JQ11=]_ZT_R067;^M/\D5_L=C_S
MX6/_ ("0?_$4?8['_GPL?_ 2#_XBK%%%WW_K3_)!9=OZT_R17^QV/_/A8_\
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M%6O2FJE)32<7[1+E=/6-EHORM=+S/S*1MZ*^"-RAL'J,C.*?34<.BN!@,H;
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MJ1E.4L1.N[/ZQ+$M<[Q"LK5+778EUZOM56<[5%;;2-MN7E_EZ>=_D?W6VO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ J"[_X\K[_ *\KK_T0]3U!=_\ 'E??]>5U
M_P"B'IQW7JOS$]OG'\T?Z#/_  :%_P#*,S5_^RN:_P#^@-7]5K=#]#_*OY4O
M^#0O_E&9J_\ V5S7_P#T!J_JM;H?H?Y5_"'$?_(^S?\ [&&*_P#3LCZ6C_"I
M?]>X?^DH6O\ -R_X.S_^4G?P+_[(]%_Z2U_I&U_FY?\ !V?_ ,I._@7_ -D>
MB_\ 26OI?##_ )+;)O\ K[4_]-R,L9_NU7TC_P"EQ/YS6ZGZG^=)2MU/U/\
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MB621CA5$<*N_)(&=N._2M#7M4&O>)_&'BI%*1>*/$>K>(XHR,%(]3N'NE0C
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MG_!.GPWXO_8N@L+BPB\4^#/"$=_$=,6!H+;6(IX;9U,TJ8G9P>O.>AK^//\
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M.ET+Q#KGARX$WVK0;^6PN'FAE@,DD3LA9%E1"02I.0"*_K#_ .#?#]J&WL?
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M[A_Z2A:_S<O^#L__ )2=_ O_ +(]%_Z2U_I&U_FY?\'9_P#RD[^!?_9'HO\
MTEKZ7PP_Y+;)O^OM3_TW(RQG^[5?2/\ Z7$_G-;J?J?YTE*W4_4_SI*_LD^?
MCLO1?D%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^EU::KXEUF^T>\-WX4MX&BMYDN;IY/,E>U!D(#%@>GJ?YJ/^"N*_LX+^VO\
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M_P#Z U?U6MT/T/\ *OY4O^#0O_E&9J__ &5S7_\ T!J_JM;H?H?Y5_"'$?\
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M>BN(_P"%@Z'_ - _Q3_X36I__&:/^%@Z'_T#_%/_ (36I_\ QFC^T\L_Z&.
M_P#"NA_\G_5GY7+2_DGT^R^MO_DE^)V]%<1_PL'0_P#H'^*?_":U/_XS1_PL
M'0_^@?XI_P#":U/_ .,T?VGEG_0QP'_A70_^3_JS\KEI?R3Z?9?6W_R2_$[>
MBN(_X6#H?_0/\4_^$UJ?_P 9H_X6#H?_ $#_ !3_ .$UJ?\ \9H_M/+/^AC@
M/_"NA_\ )_U9^5RTOY)]/LOK;_Y)?B=O17$?\+!T/_H'^*?_  FM3_\ C-'_
M  L'0_\ H'^*?_":U/\ ^,T?VGEG_0QP'_A70_\ D_ZL_*Y:7\D^GV7UM_\
M)+\3MZ*XC_A8.A_] _Q3_P"$UJ?_ ,9H_P"%@Z'_ - _Q3_X36I__&:/[3RS
M_H8X#_PKH?\ R?\ 5GY7+2_DGT^R^MO_ ))?B=O17$?\+!T/_H'^*?\ PFM3
M_P#C-'_"P=#_ .@?XI_\)K4__C-']IY9_P!#' ?^%=#_ .3_ *L_*Y:7\D^G
MV7UM_P#)+\3MZ*XC_A8.A_\ 0/\ %/\ X36I_P#QFC_A8.A_] _Q3_X36I__
M !FC^T\L_P"AC@/_  KH?_)_U9^5RTOY)]/LOK;_ .27XG;T5Q'_  L'0_\
MH'^*?_":U/\ ^,T?\+!T/_H'^*?_  FM3_\ C-']IY9_T,<!_P"%=#_Y/^K/
MRN6E_)/I]E];?_)+\3MZ*XC_ (6#H?\ T#_%/_A-:G_\9H_X6#H?_0/\4_\
MA-:G_P#&:/[3RS_H8X#_ ,*Z'_R?]6?E<M+^2?3[+ZV_^27XG;T5Q'_"P=#_
M .@?XI_\)K4__C-'_"P=#_Z!_BG_ ,)K4_\ XS1_:>6?]#' ?^%=#_Y/S_#[
MRTM/=G_X"^O+_FOQ.WHKB/\ A8.A_P#0/\4_^$UJ?_QFC_A8.A_] _Q3_P"$
MUJ?_ ,9H_M/+/^AC@/\ PKH?_)_U9^5RTOY)]/LOK;_Y)?B=O17$?\+!T/\
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M (6#H?\ T#_%/_A-:G_\9H_M/+7OF6!_\*Z'E_?_ *MZ7%&72$O_  %];?\
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M_P +!T/_ *!_BG_PFM3_ /C-'_"P=#_Z!_BG_P )K4__ (S1_:>6?]#' ?\
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M_P!#' ?^%=#_ .3_ *L_*Y:7\D^GV7UM_P#)+\3MZ*XC_A8.A_\ 0/\ %/\
MX36I_P#QFC_A8.A_] _Q3_X36I__ !FC^T\L_P"AC@/_  KH?_)_U9^5RTOY
M)]/LOK;_ .27XG;T5Q'_  L'0_\ H'^*?_":U/\ ^,T?\+!T/_H'^*?_  FM
M3_\ C-']IY9_T,<!_P"%=#_Y/^K/RN6E_)/I]E];?_)+\3MZ*XC_ (6#H?\
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M_P!6?E<M+^2?3[+ZV_\ DE^)V]%<1_PL'0_^@?XI_P#":U/_ .,T?\+!T/\
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MZ_Z-G^#'_A!:#_\ (E'_  PS^QU_T;/\&/\ P@M!_P#D2OJNBK]M5_Y^U/\
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M-G^#'_A!:#_\B5]5T4>VJ_\ /VI_X'+_ #"R[+^O^&7W'RI_PPS^QU_T;/\
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MT;/\&/\ P@M!_P#D2C_AAG]CK_HV?X,?^$%H/_R)7U711[:K_P _:G_@<O\
M,++LOZ_X9?<?*G_##/['7_1L_P &/_""T'_Y$H_X89_8Z_Z-G^#'_A!:#_\
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M(+0?_D2C_AAG]CK_ *-G^#'_ (06@_\ R)7U711[:K_S]J?^!R_S"R[+^O\
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M ,B5]5T4>VJ_\_:G_@<O\PLNR_K_ (9?<?*G_##/['7_ $;/\&/_  @M!_\
MD2C_ (89_8Z_Z-G^#'_A!:#_ /(E?5=%'MJO_/VI_P"!R_S"R[+^O^&7W'RI
M_P ,,_L=?]&S_!C_ ,(+0?\ Y$H_X89_8Z_Z-G^#'_A!:#_\B5]5T4>VJ_\
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M++LOZ_X9?<?*G_##/['7_1L_P8_\(+0?_D2C_AAG]CK_ *-G^#'_ (06@_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M P__ !-'_"&>#_\ H6-%_P# &'_XFC_B!F!_Z'N(Z?\ ,/'RO^OW?>?VE/\
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MRO\ P)?Y^O\ 3T_U%O\ B(\_X)%_]'/:;_X)KO\ ^.4?\1'G_!(O_HY[3?\
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M_@FN_P#XY1_Q$>?\$B_^CGM-_P#!-=__ !RO\NG_ (0SP?\ ]"QHO_@##_\
M$T?\(9X/_P"A8T7_ , 8?_B:/^(&8'_H>XCI_P P\?*_Z_=]Y_:4_P#GRO\
MP)?Y^O\ 3T_U%O\ B(\_X)%_]'/:;_X)KO\ ^.4?\1'G_!(O_HY[3?\ P37?
M_P <K_+I_P"$,\'_ /0L:+_X P__ !-'_"&>#_\ H6-%_P# &'_XFC_B!F!_
MZ'N(Z?\ ,/'RO^OW?>?VE/\ Y\K_ ,"7^?K_ $]/]1;_ (B//^"1?_1SVF_^
M":[_ /CE'_$1Y_P2+_Z.>TW_ ,$UW_\ '*_RZ?\ A#/!_P#T+&B_^ ,/_P 3
M1_PAG@__ *%C1?\ P!A_^)H_X@9@?^A[B.G_ ##Q\K_K]WWG]I3_ .?*_P#
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M^?K_ $]/]1;_ (B//^"1?_1SVF_^":[_ /CE'_$1Y_P2+_Z.>TW_ ,$UW_\
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M_P P\?*_Z_=]Y_:4_P#GRO\ P)?Y^O\ 3T_U%O\ B(\_X)%_]'/:;_X)KO\
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M_P"A8T7_ , 8?_B:/^(&8'_H>XCI_P P\?*_Z_=]Y_:4_P#GRO\ P)?Y^O\
M3T_U%O\ B(\_X)%_]'/:;_X)KO\ ^.4?\1'G_!(O_HY[3?\ P37?_P <K_+I
M_P"$,\'_ /0L:+_X P__ !-'_"&>#_\ H6-%_P# &'_XFC_B!F!_Z'N(Z?\
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M\1'G_!(O_HY[3?\ P37?_P <K_+I_P"$,\'_ /0L:+_X P__ !-'_"&>#_\
MH6-%_P# &'_XFC_B!F!_Z'N(Z?\ ,/'RO^OW?>?VE/\ Y\K_ ,"7^?K_ $]/
M]1;_ (B//^"1?_1SVF_^":[_ /CE'_$1Y_P2+_Z.>TW_ ,$UW_\ '*_RZ?\
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MC_A#/!__ $+&B_\ @##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\
M@2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN_
M_CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,P/\
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MT_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\
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M^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\
M@##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1
M'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\
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M?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\
MZ.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\ Z%C1?_ &
M'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/
ME?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\
M@FN__CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,
MP/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>T
MW_P37?\ \<H_XB//^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\ Z%C1?_ &'_XF
MC_A#/!__ $+&B_\ @##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\
M@2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN_
M_CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,P/\
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MT_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\
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M^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\
M@##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1
M'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\
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M?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\
MZ.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\ Z%C1?_ &
M'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/
ME?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\
M@FN__CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,
MP/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>T
MW_P37?\ \<H_XB//^"1?_1SVF_\ @FN__CE?Y=/_  AG@_\ Z%C1?_ &'_XF
MC_A#/!__ $+&B_\ @##_ /$T?\0,P/\ T/<1T_YAX^5_U^[[S^TI_P#/E?\
M@2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\ \<H_XB//^"1?_1SVF_\ @FN_
M_CE?Y=/_  AG@_\ Z%C1?_ &'_XFC_A#/!__ $+&B_\ @##_ /$T?\0,P/\
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MT_YAX^5_U^[[S^TI_P#/E?\ @2_S]?Z>G^HM_P 1'G_!(O\ Z.>TW_P37?\
M\<IK?\''W_!(I%9V_:>TT*JEF/\ 8]WP%&2?]9V S7^77_PAG@__ *%C1?\
MP!A_^)J&Y\&^$%M+QAX8T8%;.Y92+*$$$0N000N00>01R#R*%X%X%_\ ,]K_
M /A/'?33;O=?UJ?VG+_GRO\ P+O;S_K\O]D?]DK]LO\ 9Z_;@^&DGQ=_9L\=
M6WQ \!1:M<Z(^MVL#P1C4K3/GV^QV8Y3!R<U]1-T/T/\J_E,_P"#06W@M_\
M@F9K0@B2(2?&#Q%*X10H>1U9G=L=68G)/>OZLVZ'Z'^5?S[FF$C@,QQF"C)S
MCA<14H*3WE[.3BY;1W:;6BTZ'JPES0A*UN:,96]5<6O\W+_@[/\ ^4G?P+_[
M(]%_Z2U_I&U_FY?\'9__ "D[^!?_ &1Z+_TEK[#PP_Y+;)O^OM3_ --R,,9_
MNU7TC_Z7$_G-;J?J?YTE*W4_4_SI*_LD^?CLO1?D%%%% PHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *CEEB@0R32)%&.KNP51]2>*DK],O^".G[,/P]_;+_ &]?
M!7P$^*UJ;WP1JVBWFJ7]JI"M*;1))2@)QRXCV@<YS@"N3,,;1RW XS,<3S?5
M\#AZF*K\BO-TJ2YI\B>CE;9-I-CC%SE&$?BG)1C?:[VOY'YDQ2Q3H)(9$EC/
M1T8,I^A'%25^FG_!8W]F#X>?L:?M[>,_@)\*+4V7@C2]#L]5L+9B&:)KM(I
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MH%WS2)$O]YV"C\S7=:A\+_B?I/A*P\?:EX$\2VW@_5%WV.K-HNH[94QDL5,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=_\
M'E??]>5U_P"B'J>H+O\ X\K[_KRNO_1#TX[KU7YB>WSC^:/]!G_@T+_Y1F:O
M_P!E<U__ - :OZK6Z'Z'^5?RI?\ !H7_ ,HS-7_[*YK_ /Z U?U6MT/T/\J_
MA#B/_D?9O_V,,5_Z=D?2T?X5+_KW#_TE"U_FY?\ !V?_ ,I._@7_ -D>B_\
M26O](VO\W+_@[/\ ^4G?P+_[(]%_Z2U]+X8?\EMDW_7VI_Z;D98S_=JOI'_T
MN)_.:W4_4_SI*5NI^I_G25_9)\_'9>B_(****!A1110 4444 %%%% !1110
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M/P.T[]I;POK7[0WP_P#%OQ3\!Z)=6FHP^"O!-K+?:KJE[ ZL+>:VA1V>WE8
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MDO:T\+RJ;K*BO>E%*6N]2L\3-S2;]G^Y^'WM%?EN[.7:^R>AVGQL_9(\(?\
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MOXT\)1:AX#^%,,J-+KFF+JT5UHFDP62VWV62<7?GO(T3*D<+99@Q_B*_#/\
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M.TOX7Q:#JPTN+Q%IF-8M=/:WN8 %6>0QO(MO&'4^5,O[R,@IOW;7_!67Q/\
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M]HWWY(<W^+E7,OE*YXBV^^WI?3\ HHHH&%%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTXJM"=.4HTJ:DN>+BY1:BO>2;L"TLTWHU)7D[::]VK.VOD?V%?\ !?K]OWX
M_M!_L4? GP=^S=\:S=>/M N-)EU>V\(:E)8:I80V]I902Q336THD $L$K%1Q
M@@@DDX_D.U#Q9X_\06ZVOBOXA^-?%=GM4M8>(M=O-3M"V!DF&X=EW>^,YKF;
M.QL+=VGM(U5WR&<.[Y/?AF('X =Z^\_V0/\ @G7^T/\ MSZ#XI\2? X:7_9O
M@RZ%IK)U(@.)=VTF/+#Y<]?3-?/9/E64\%Y+]6EBXPP6'Q-:M+&XZ-.$X3Q=
M1-4W4C%M+G]V%M7>SU-:DYXBJI<MY.*2A3;:M%;ZO7I_6WPV      !@ #
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$AU'_P!K5^ O_!,[XX1?L]_MF_ 'QO=_+I]YX[T33M1GSM2WM'O ))I&X 1
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M.FZM>=2:ITTVHTXN,$K7C?4F4YSMSRNELDE%+:[LM+NU[O4_57_@GG_P5/\
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MGA\35O)RK4*45"G2FG+EY815DTDVGJV9MMI1<FXQ=XK:S=M=.K:_';8_9/\
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M2S6$B:2H=0Q0SA-@9!G<"PQ@Y]:_>/\ X(;^(?"WB;]AW]HKX%?"_P")VC?
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M(OK=IMWZ;7/Y8/VHO#FE>#_VB_BGX7T&%;?1M(\1ZI;V$"+M6.%+^9$"J.
MH  QP*\P\)^!_'OQ$U1= ^&W@W6_'GB%F55T70+:2ZO3O( _=QHQ_B#<BO:?
MVR%V?M4?&1 >%\3ZLH/^[J$XS^E??W_!&_QK^TOX4^)_Q'@_93^".D?$OXD:
MGH+6T?BCQ+!$ND^$-\.U=36[NE,"-$&$A)*X*YZU]QB,=5P.0K'4XT*M:C@<
M/42Q>(CAL.Y2A23E7Q$FN2"YG*35Y/:*;=CFC'FJ<EVDYV]U<TK66D5_25SY
M(^)__!.;]M#X1^#])\<^*/@;XU;0]2TTZK?20Z7*QT"V6/S9/[3V(QA,2$%]
MP&,5]"?\$JO^">'_  WK\2]<\/\ C#P_XD3P5HUCJ4LNM:7"_E)?6=O)(ELS
M@<2><@C(/<]#D5_4;_P3[^%/_!11_B7\7;W]N_XU>!_&G@KQ-X*U^.7X5Z;J
M6DZHD!NH)@#! CRF,1HP3,:J%*G&,5^=W_!)'QSXT^$W_!1#]H?X0> =<_L3
MX<6USXROK?P_'!&8HY@;J6-@^T$>6V#CCI[5\'B.,<SQ65\1X?#ULKEF&5X&
MABZ68Y;5Q$L(X5Y-3C3=6FI>WH:14E%TY[W3N=*P\(U*+E[3DG+E<)I<UU:S
MW>C>OEY7N?S2?M)?L_\ Q%_9V^,'Q&\!^+_ ?B/PAX>\.>*]1TCPI>Z_:M;_
M -K:1;3,EM>1,P'F)*H4JW<<]*\H\!64>K?%/X2Z+. ]IK?Q'\*Z5>1L,I-:
MWNIPPRQL.<JZN01CD5]6_M[?M&?&[XZ?M/?''3?BUXU?Q98^%OB+KFE^'X7M
MXX!I]A;7+I!;J8P-P10HR<DXY/:OF#X6\?&OX&C_ *JUX)_]/-M7Z/@IXJ>5
MT*N,]BL7/ *K5="4Y4W.6%YU*,JJ4W)OWI72M)NUU9OCERIR46^5225]U[RN
MM-++H?V2_MI?MA?\$S_V#?B]X0_9W\8?LWZ3K>O6'PL\*Z[J^I6VB1.EQ-J&
MGPM.X?RB#(Q=FR>2P!'K7Q/\2/V,?V$/^"GG[/OQ%_:;_8!DOO _QF^'%M?:
MQXM^&6L_N#-I%DCR7-U86#$'R@JN5=8R!D<X%?%'_!PDB'_@HSIY95/_ !8W
MP.22H/\ S#K;)R17I'_!N(VO77[87QJTW3?M3>&[SX*:W;ZYDN-#^RM9S"87
M!!%LCX^\67<!G)K\RPV5/*^#\'Q5@,QS.CFE'+\+F.)]MC9U\'C(RJQ5?#5L
M-5O'DK*;4'%J5-I.-^G:ZG/B)4)PIN#G*$;12E%I74DUO9[W_P"&_$CX?_"C
MXM_%G7IO"_PL^'/B7Q]KUGJ\VC7]AX?LI;J:SN;>Z-I-).J(VR-)58MG VCK
MQ7T1\;_V ?VO/V>M.MM=^('P:\80^')-.BU*_P!?339/[.TB&10[)?2JA6)X
MLL) Q&"IK]GOV*-?_:T\&_&+]KWP1^P7\$O">JZEJ7B76HY?BOKXM(M+\(RS
M7URLTEEJ%RHMP0S%_D<8[XX-?L3^QC\&?VT&^#'[5.C_ +?OQ@\(?%RS\1>"
M]5^Q^"]/OM,U8Z'<2VLY,D1B::2%5<Y!3:H S7K9SQKBLKKNHH9/]5I+!-X*
MKC*L\WQ<,8J#E.%&BI0PWL/:MQ5:4?:)>]9<MXIX?VB6M7F=_?44J<7'HV[.
M5WII>SV['\)WAWX7_%/QGX7U#QWX*^'OB/Q5X%T>1H=9\6Z39RSZ1I<L9Q)'
M=7"(R1LAR"&88(/?BL[PIX)\<?$+6HO#/P[\)ZQXU\3S>9Y6@Z';/=7[^2"9
MPL4:LV8@"6XZ#M7]-/\ P1&^)?A!/'_[7?\ P3JU6RTZ+PEXWT;Q=K'AZ&\M
M;>5H]79KPV444\J/(A,@0 (1CL*VO^"/_P  )?V(/&7[=O[2OQ_T)-)C^ DW
MB^;PE?W]DLJ&WU)KI+%K:*Y1XY 4*%=H Z8]!Z..XNG@9Y[1J8*#Q.7PRZME
M.']K+GS6EF;C3PS:M>$XUY<E54E+E5FKMHB%%S]FU/W9\W.[:4W"SETVMW]+
M[L_EIU?1M:\.:I>Z%XCTNZT37=,G>UU32+Y#%>6%W&2);>XC(!22-@0P(XQ7
M[(_\$?/V._V>/C[J/COXY?M.^,M.\/?#?X/1W%_/H=W<1PW6N7-CNFBMX8F9
M6D$VT)M .<_E^4?QI^(K?&'XU_%7XKBX%U:>/O&.J>(M.E"+&OV2^GDDCVQH
M%1!AA@* !T'&*YG2/%/C:QM&\&>$M2U1(?$]W%:'0=+DN VIWMPVR!'@MW4R
M!W('*MDG&*^BS'"XS,,KGA:.+EE>*Q-*A[;$4ES3PR?++%4Z4IVM)1YZ<9R2
M<7[VZURC)1DI./M(J]HO[6J46U^-ON9_73\*_C1_P2D_X*4^/]7_ &-/#GP7
MN?!7B2];5/#G@GQ5I.F"VEGN-(@E$%[-<1HI99F57WEOF!/-?CQ^P_\ \$]/
M!'QE_P""FOQ>_9,\;WMX? ?[/NMW]YJ$D)/VJ_TS2'DE>)^[%XT"D<YS@]:_
M2K]@']E[P_\ \$H/V?O$'_!0/]J V%M\8?$F@S3?!WX?7LB1ZE%>7UDZPW3V
MDW[]?-)5MP )SG)KX]_X(Z:Y\8OC_P#\%+?BS^TOX>T^73]+\4?VCXT^)]P4
M=;*U\.N\TFH6\L^?*""#<"&;M[5^=4)RP&$XPJ9%F.,_L;!97"AA<;C,7+$4
MWGD:D5BIX.I43;C[*U%N+<'6=HLZFN:6'56$?:RFW*$(I/V5E922ZWULW<_3
MBQ_:Q_X)):_^T?+^P<GP(\F%Y#X1B\4KHQ_M :IN&F^<;GR/O"4B0_.3@AB0
M#FOYZ/\ @J?^R3X8_8E_:]USX/>"KN:\\*ZQIQ\6Z,UPP:6"ROR)8(#SP41P
M",9X^IK^J/2OVB/^"$?_  V%+XCTV#2A\9Y[\Z;;W^RU%G_PEIN&MD*W7E["
MW]IDD8?=GZ5_.A_P7*\'?%30?VXM3\0?$JWG:P\0:%'J'@S42KM:2>&;H*^F
MQPSG,;#R&0*%8@C&!TJ.#:]2GG]##4Z.>9?A\3DLZV)PV>U9SEC\?!TW]8P:
MGK:FI2=3ELG&47;2P\0DZ3DW2FXU4HRI1MR1>G+*W?IOUZ'Y 4445^MG&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5!=_\>5]_P!>5U_Z(>IZ@N_^/*^_Z\KK_P!$/3CNO5?F)[?./YH_T&?^#0O_
M )1F:O\ ]E<U_P#] :OZK6Z'Z'^5?RI?\&A?_*,S5_\ LKFO_P#H#5_5:W0_
M0_RK^$.(_P#D?9O_ -C#%?\ IV1]+1_A4O\ KW#_ -)0M?YN7_!V?_RD[^!?
M_9'HO_26O](VO\W+_@[/_P"4G?P+_P"R/1?^DM?2^&'_ "6V3?\ 7VI_Z;D9
M8S_=JOI'_P!+B?SFMU/U/\Z2E;J?J?YTE?V2?/QV7HOR"BBB@84444 %%%%
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MNH,$M=.EUTS[&=I&"XC,^3DG&T\5]>?L%_LO_P#!,K_@G;^T?XL^.&M?MH^
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M[1KJEG);V5Q:Q7=Y=-$R*Z.X4^6LA98DCC"1K_%]/9V]PL2R(3Y)#1%7="C
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MDYV;DY6V6NRW\R3I1117TIF%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5!=_\ 'E??]>5U_P"B'J>H+O\ X\K[_KRN
MO_1#TX[KU7YB>WSC^:/]!G_@T+_Y1F:O_P!E<U__ - :OZK6Z'Z'^5?RI?\
M!H7_ ,HS-7_[*YK_ /Z U?U6MT/T/\J_A#B/_D?9O_V,,5_Z=D?2T?X5+_KW
M#_TE"U_FY?\ !V?_ ,I._@7_ -D>B_\ 26O](VO\^C_@Z3_9/_:R^,'_  4%
M^$/Q#^"'[/?C[XL^%-'^$]MI]WJWA73);RRAU%EB@DL[B>,'R9(U<R#Y)-VT
M@A,9/N^'>+PV XNRK%XRO3P^&HU)2JUJKY84XN/*G)V;MS22>CMN]$V9XI.6
M'J1BG)M*R6[M)/\ )'\J[=3]3_.DKZ"/[$'_  45))_X8=^,7//_ "![OO\
M]NU'_#$'_!17_HQ[XQ?^">[_ /D:OZM_UQX4O;^W\N_\'>GEY_UK;PU0KI)>
MRGLEMZ?YO[F?/M%?07_#$'_!17_HQ[XQ?^">[_\ D:C_ (8@_P""BO\ T8]\
M8O\ P3W?_P C4?ZY<*?]#_+>G_+[O;R\_P"M;'L*_P#SZGT_3_-_<SY]HKZ"
M_P"&(/\ @HK_ -&/?&+_ ,$]W_\ (U'_  Q!_P %%?\ HQ[XQ?\ @GN__D:C
M_7+A3_H?Y;T_Y?=[>7G_ %K8]A7_ .?4^GZ?YO[F?/M%?07_  Q!_P %%?\
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MZGT_3_-_<SY]HKZ"_P"&(/\ @HK_ -&/?&+_ ,$]W_\ (U'_  Q!_P %%?\
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MZ"_X8@_X**_]&/?&+_P3W?\ \C4?\,0?\%%?^C'OC%_X)[O_ .1J/]<N%/\
MH?Y;T_Y?=[>7G_6MCV%?_GU/I^G^;^YGS[17T%_PQ!_P45_Z,>^,7_@GN_\
MY&H_X8@_X**_]&/?&+_P3W?_ ,C4?ZY<*?\ 0_RWI_R^[V\O/^M;'L*__/J?
M3]/\W]S/GVBOH+_AB#_@HK_T8]\8O_!/=_\ R-1_PQ!_P45_Z,>^,7_@GN__
M )&H_P!<N%/^A_EO3_E]WMY>?]:V/85_^?4^GZ?YO[F?/M%?07_#$'_!17_H
MQ[XQ?^">[_\ D:C_ (8@_P""BO\ T8]\8O\ P3W?_P C4?ZY<*?]#_+>G_+[
MO;R\_P"M;'L*_P#SZGT_3_-_<SY]HKZ"_P"&(/\ @HK_ -&/?&+_ ,$]W_\
M(U'_  Q!_P %%?\ HQ[XQ?\ @GN__D:C_7+A3_H?Y;T_Y?=[>7G_ %K8]A7_
M .?4^GZ?YO[F?/M%?07_  Q!_P %%?\ HQ[XQ?\ @GN__D:C_AB#_@HK_P!&
M/?&+_P $]W_\C4?ZY<*?]#_+>G_+[O;R\_ZUL>PK_P#/J?3]/\W]S/GVBOH+
M_AB#_@HK_P!&/?&+_P $]W_\C4?\,0?\%%?^C'OC%_X)[O\ ^1J/]<N%/^A_
MEO3_ )?=[>7G_6MCV%?_ )]3Z?I_F_N9\^T5]!?\,0?\%%?^C'OC%_X)[O\
M^1J/^&(/^"BO_1CWQB_\$]W_ /(U'^N7"G_0_P MZ?\ +[O;R\_ZUL>PK_\
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M%%?^C'OC%_X)[O\ ^1J/^&(/^"BO_1CWQB_\$]W_ /(U'^N7"G_0_P MZ?\
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M/85_^?4^GZ?YO[F?/M%?07_#$'_!17_HQ[XQ?^">[_\ D:C_ (8@_P""BO\
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MA_EO3_E]WMY>?]:V/85_^?4^GZ?YO[F?/M%?07_#$'_!17_HQ[XQ?^">[_\
MD:C_ (8@_P""BO\ T8]\8O\ P3W?_P C4?ZY<*?]#_+>G_+[O;R\_P"M;'L*
M_P#SZGT_3_-_<SY]HKZ"_P"&(/\ @HK_ -&/?&+_ ,$]W_\ (U'_  Q!_P %
M%?\ HQ[XQ?\ @GN__D:C_7+A3_H?Y;T_Y?=[>7G_ %K8]A7_ .?4^GZ?YO[F
M?/M%?07_  Q!_P %%?\ HQ[XQ?\ @GN__D:C_AB#_@HK_P!&/?&+_P $]W_\
MC4?ZY<*?]#_+>G_+[O;R\_ZUL>PK_P#/J?3]/\W]S/GVBOH+_AB#_@HK_P!&
M/?&+_P $]W_\C4?\,0?\%%?^C'OC%_X)[O\ ^1J/]<N%/^A_EO3_ )?=[>7G
M_6MCV%?_ )]3Z?I_F_N9\]-'&_WT1\=-RJV/S!IP  P  !T & /P%?0?_#$'
M_!17_HQ[XQ?^">[_ /D:C_AB#_@HK_T8]\8O_!/=_P#R-1_KEPH_^:@R[I_R
M^_P^7FOP^1["O_SYE]W?E_S_ /)?N^?:*^@O^&(/^"BO_1CWQB_\$]W_ /(U
M'_#$'_!17_HQ[XQ?^">[_P#D:C_7+A3_ *'^6]/^7W>WEY_UK8]A7_Y]3Z?I
M_F_N9\^T5]!?\,0?\%%?^C'OC%_X)[O_ .1J/^&(/^"BO_1CWQB_\$]W_P#(
MU'^N7"G_ $/\MZ?\ON]O+S_K6Q["O_SZGT_3_-_<SY]HKZ"_X8@_X**_]&/?
M&+_P3W?_ ,C4?\,0?\%%?^C'OC%_X)[O_P"1J/\ 7+A3_H?Y;T_Y?=[>7G_6
MMCV%?_GU/I^G^;^YGS[17T%_PQ!_P45_Z,>^,7_@GN__ )&H_P"&(/\ @HK_
M -&/?&+_ ,$]W_\ (U'^N7"G_0_RWI_R^[V\O/\ K6Q["O\ \^I]/T_S?W,^
M?:*^@O\ AB#_ (**_P#1CWQB_P#!/=__ "-1_P ,0?\ !17_ *,>^,7_ ()[
MO_Y&H_URX4_Z'^6]/^7W>WEY_P!:V/85_P#GU/I^G^;^YGS[17T%_P ,0?\
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M"O\ \^I]/T_S?W,^?:*^@O\ AB#_ (**_P#1CWQB_P#!/=__ "-1_P ,0?\
M!17_ *,>^,7_ ()[O_Y&H_URX4_Z'^6]/^7W>WEY_P!:V/85_P#GU/I^G^;^
MYGS[17T%_P ,0?\ !17_ *,>^,7_ ()[O_Y&H_X8@_X**_\ 1CWQB_\ !/=_
M_(U'^N7"G_0_RWI_R^[V\O/^M;'L*_\ SZGT_3_-_<SY]HKZ"_X8@_X**_\
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M^;^YGS[4%W_QY7W_ %Y77_HAZ^B?^&(/^"BO_1CWQB_\$]W_ /(U0W'[#_\
MP45:VN4_X8=^,69+>>,8T:Z)R\3*, VXW')Z9&>F10N,N%+I_P!OY=IK_&[6
M?;S_ *Z#H5[?PI]'MV<7^K^X_N6_X-"_^49FK_\ 97-?_P#0&K^JUNA^A_E7
M\T7_  :Q_ [XS? /_@GAJO@[XX?#CQ%\,?%<OQ4U^_M_#_B>T>RU)]-?>D%X
MT#\JDV,@ L!_>-?TNMT/T/\ *OXRS^I3K9UFE:E)3IU<;7J4YQU4H3FY1DO)
MIIZZK9I,^AI)JG33T:A!->:BDQ:***\@L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
6* "BBB@ I&Z'Z'^5+2-T/T/\J /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img12876764_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_10.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *<! P# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBZ6:ZKYV/])K3[M;^PLKY056\M+:[52,%5N(4F ([$!P"/6K=?@[_P %/?\
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M7W6O0_3*BOY*OBM_P<977P*_:]^)WP1\;_#^XN_#G@1[NWM#;I))<:I.K-%
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M>/VJ=7^,'[%\7[2EYI1L]3E\!W_BO^S#U$MIIC7HAQ[LN/Q_"ORA_P""7O\
MP6C\;_MS?M'^/O@[K_@IO#NE^"[W5XGU!P0)+;2[B9'F.>,;(]Q] #GUK@H\
M,YM7P^<8FG1@Z6124,QDZL$Z4G-P7*MZB<HM7C<MUJ<73BV[U?@T>NSU[;H_
MI/HK^7S]N_\ X."G^$OQ[N/V9OV6OA;<?&+QY97KV-[J%@TDR?;8'$<UG'%$
M6VE) P/RA\8!/:O-_P!GG_@XI\>:+\<?"O[//[8_[./BKX8>(?&>JVMGHWB2
M2PU%;2,W[A(8)2T2Q$ LIW-R.>>@KU*?A_Q15P,,=# 1Y:F'>,IX9XBA'&SP
ML5S.O'"RJ*LX):OW>:VMC-XN@I<O/M+E<K/DYKVMS6MU[V\S^LNBOSX_;U_X
M**?!G]@[X)0_%GQW>1:A?Z[917'@OPNLHCO/$4UQ )X(XE5ED 8/&I"C<6;:
M""#7\U]M_P '*G[5,+CXG7O['_BH_!XWGG->G2]26)=)9]OF^=Y( 01_-YN\
M8(W!QG-<V3<%\0Y]AI8S 8.+PRJ.C"KB*U+#1KUEHZ5#VTH.I-/1J-TI>[>^
MA53$T:4E&<O>:O9)NR?5V5DC^U>BOA/]@#]O3X6?\% ?@S;_ !9^&SK:O!+%
M9Z_H3S"2YT?4)$8M;2@DN"C1R*=PR"N#S7UQ\1?$DWA#P/XI\3P1^;-H6BWV
MI1Q?\]'M('E"?\"*X_&OG\3@<7@\94P&*HSH8NC6]A5H5%:<*MTN6736Z:>S
M336AK&4914HN\6KIKJNYVE%?QX>!?^#F+5QX^^+O@;7OA)J&N^(/"^M:EX=\
M*:)I]O<3W%_J%K)*EO(8[?\ >!'*KN+?*>X(SBA^S9_P="+=?&+6_AK^U+\)
M-1^&5M EX\%W>6UQ!-;W8,AT^Q1) C2-=81%&&&6X[5]E+PTXPC"O-98JGU>
MC3KN%.O1E5JTJD8R4J-)2YZJCS)2:6CTU9S_ %S#WBN>W,^75.R>UF]D_+<_
ML>HK^*OXN_\ !T7\3?AQ\5['4K_]F?7M(^#4NK+IVG7M]:WT*:[I[W*P1:DE
MQ,HYN8V,RE'&T,NW:H3']0GP?_;A^$'Q1_98T_\ :KGU2#0/!+^&VUW65N91
M_P 2N6.W,\EBTCD R [8QN.=QR1TKR\WX-XAR.A@L1C\"XTL?-4L/*C4IXB]
M=V:H25&4^6KJO=>[T3NFBZ>(I57*,):Q5VFG%V[Z]/,^T**_C:^*7_!RY\3_
M ![\1?%GA[]DK]G?6_B!X.\"WUU%J/B6SM+RZBOX[*1TF821)(N&5"0%(49X
M%?H[_P $O?\ @N]\,_V[O%6H_"7XA^$G^#OQ<TMOLD>@:L\D,FKWR,JR1007
M#!UD.6(6-<< ;>IKIQW /%.78">8XG+FJ%&G&KB*<*U&KB<+2FDX3Q&'A-U:
M<6G=WB^5)N5A1Q5"<N2,]6[)M-1D]K)M6;N?T$45_--_P4J_X+>Z_P#L&_M8
M^$/@K>^#GU#PQJD<=]J&I[<D0#]XT2KU8O'T !//?K7SCX;_ .#@_P"-/QG^
M(?B:R^%'[//B2?P3;:6PT*^?2]16.^NA Q>1)7C(8!@65MQXZ=.'AN >)<5@
ML/F-+"4U@L3AEBJ6(GB*4*;IN7(DW*2M4;=^3>R;V6J>*HJ3AS/FC+E:46W?
MTZK7H?TK7?[6WP!L?B!!\+KKXAZ%#XZN+L6,/AY[R!;][EFV",0F3>6+<8VY
M]A7TC7^45\5OVM?C=+_P4*3]H$^$?$T'Q!T+Q4+ZQ\ +>7RB]N([E2L(L@?F
MW'@+L/\ 0?Z$GPJ_X*#R^'_V#Y_VPOVF_#%]\.TTC1Q<:EX?>UG:_:^2T62.
MV2W*^<7N9".0..><D&O5XK\/<5P_0R6MAJKQLLTIT:4Z,94I58XZLX\E&A3I
MRE*M3E?2JERWTOT44,7&JZBDN7DNT];<BTNV]G?HS]4:@NKB.TMKBZF)$5M#
M)/(1R0D2%V('KM4U_%CKW_!RW^TCX^U?7O&?P4_9.\5WOPDT&:2--4GTG4PE
MU96[%OM[S20D$3QAI.6VJ&51@8 _;7_@F'_P5S^&W_!2GP%XITZ'1&\"?%70
M-/NXM5\%W#L\TD:6LZS7B*[%XU\U0"A 'S'&W 6O(S3@3B3)\%+,,=@HQPU)
MTXXET:]&O4PCJ6Y5B:=*<I4GJKMJT7NS2GBJ-22C&6K^&Z:4O\+>C[G>?#[_
M (+,_L;?$K]LA?V&O#>N^(I/C@UQ<6JV,^D^7I33VK[)HQ>^8064X.-N=I!(
MP:\)_:?_ ."V'@7]G+]N7P=^QSJ/@+7[Z\\0W]M876O)92FW5Y9(XV>WD V-
M&6DRC#.5Y]:_F#_8^MH4_P"#G2!O)B65=8U/+B-0P;[4ZL=VT-DX )ZG ST%
M?J]_P4U_;E^"WPI_X*^?!OX&^+/V?=-\7^+]0LO#UWIWQ >VM?/L)KFTM9H2
MS,OFOM( =P&"MM#$%UW?;5>"LHPF=X+ 4,!C<TI8O@R6=U:3QE.E4HXN4)2=
M>,W&$71IV7[K63;TOHCF6)J2I2DYQ@UB(TT^5N\;K2UWJ]=3^H7XD_M'_"'X
M0:)HFO\ Q*\6Z?X0L/$%M#=:<^LS1VC2),BR*I$KKAP'&5Z@@^E>D>"?&WAK
MXA^&]-\7>$=4M]9\/ZM$9M/U&U=9+>YC!QOC=259?<&O\]C_ (.!/VQ/C3\9
M?&&F_#KQ#X&U[P5X/\-W$ T'Q!:37EA;W\(C611&R;(V4AAC:<8 &.E?JM_P
M19_;X_:>U[]DGQ!\.H/A!K36/PE\.W$_@SQ%>)=RGQ+%:V;32".XD4B4L(00
M59O;CFO%QOASBL-PO@L^CB:3Q%>NEB,-.M15*CAZK4:,X55*\YWE%5()7@N9
MO1&L<6I5I4N5V2T:3NVK7NMDM[:ZZ']?E%?S=?\ !)O_ (+5Z_\ MU?M-_%G
M]G#X@>$SX-\2?#D7T"Q3Y1[J\L2XDB4/@[OW;8'7I@8.:H_\%>?^"V^O_L&?
MM"?!KX%?#/P@?'.K>/=0LM*US[-\\FFWFH7*P0H50E]R[T! !(PS8"JQ'SZX
M)X@>>+AY86/]I/"_75#VL/9?5G1==5?;7Y+."TUUDU%:LT^LT?9>VYGR<W+>
MVO->UK>I_2G17D/P'\3>+O&7PH\&>*O'.FOI'B3Q!HMCJU[IS@A[87]K!=0H
M0><^7*">G.>*]>KY6K3E2J5*4G%RISE"3BU*/-!N+Y9+1JZ=FM'N;IW2?=7"
MBBBH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?S?_P#!
MR\<?L4 CMJ$I_+;7Y!_LB?\ !-'P9^W]_P $7M7N-+L$L?C)X3N]1UCPYKUK
M&!J4KZ1;RW\=G#.,/OE6WV(H(YQ7]"O_  6\_8[^.O[9W[,/_"MO@+IFG:IX
MK%W)-Y&I7"V\)1MN/G=E'8]_Q]=3_@B%^R%\;?V,OV-[+X0_'_2]-T[QI'K,
MMW/::?,ES:FU>*5""P+JP;?@J>H)!&*_6LLXCAD_ &#E@,QHTLXP?$=/%PPL
M:J^L.C'63G2WE1FERSOHT[,X:E+VF*:E!NG*BXN33Y;Z:7[H_P ]3]H']K[X
MN>-?AU\._P!D;XUQZ@=<^ 7B"#0-+&I>;]N@@M+O['%]I\Q0W*1 KG( ''I7
M] '_  5;\6^-/"G_  0Z_9,T[P@+EK'Q%JFEV/B98-VQK(LJN)P@QMV$GG'!
MP3UKZC_X+9_\$"_B7^T;\9O"_P >?V,_#NAIXGUO6H-0^(>F7<L-A;NT%RTA
MEB7=&C;TPV0,EB<C/)_6&W_X)FZA\</^"8^@?LC_ !VMK/2/'>E: 8K*[M&2
M>/2=7@M4$#P2_/@-,7!93D$+DC&1]EF?&?"]2AP3FV&EAZ<*&=RQV9Y7"476
MPE2K3E'$U948I-4_;SE6@TO>5FDFSFAAZZ^LTY7;E2Y*=37EDHN/*KOK96LN
MS/GW_@@'\)/@QJ7_  3K=8_"?A74XM4BO(==NI=/LYY&:73+KSXYI'5GC\O<
M[YRG)W?PC'\XG[&6DQ_#[_@X\T/P;\*)%T[PC+XHOC<6>GX33)5;43YR3)'F
M+H<8//MQ7N_@+_@GO_P7(_8*T_Q7\"_V>KU]9^%7BRYO;'1[J&\EE#)>"XMU
MN92LQ$;BWG92."H<U^LW_!&3_@B1\2/V9/B;??M7?M:ZPFL_'Z]OY;^TA2;[
M6ME)=R_:)?WK,Y0(Q*XW9#8 7J1RXG&91D<>-LXJ<1X#-:/$N#Q&'RS X:O*
MOB)5,5&RJ8BB[JE[!R2DWM:R:>BJ,:E7ZM3]C*G*BXRG*2LO=MHGN[KKU_/\
M9?\ @OEIUCJW_!=[]GC2=4M8;[3;_0?!\-]97"A[>Y@>STO,<L9&&4J?F!ZG
MGKT_?[_@M-\"/@[)_P $CO$9M/A]X8TFZT_P]X8?3-1T[2K:WOK II]VTBPW
M,<:S;9R 75G(XQC'3XI_X*N_\$EOVUOVI/\ @K+\&/VIOA#X8T+4/A!X/L/#
M=OK.J7NHQ07L#:;#:Q7:K:L0\F?)_=D,@39R'#_+^UO_  4P_9<^,/[1O_!/
M+Q#\ OA7IUC??$J_T71K.VL[R98K1I[.RN(9P9&91@/(H'S=Z\;%YW@%2\*8
MT<TH1>64,(LQ5/$I+!RAB8.?UE1E:DU&]_:)/E3O[N^D:<W+'7A+WV^2Z?O>
M[;W>]_(_%#_@W1_X32?_ ()__&O1O U]='Q';:9>0^%[<.Q6WNQ;2) T*@G:
MYE9,$#AL'O7QQXP^&_\ P7I?Q+XI?1-8\0+I3ZE<'2 ))OEM#*WE ?+Q\F/7
M/I7[I_\ !!']A#]H[]AKX+^*?!_[1&CZ5I&NZG.KVD6EW*W$;*)XG)9D=P/E
M4X&<\5_0%7F9UQA1ROBKB*O@<%DV=8;'8R%6GB,32CB:=HTX)NA-:6E*[E;=
MZOJ52P\IT**G*I3<8VY8NW5/;Y->?Y_S>^']'_:<T3_@E#\<+7]J^>[N/B"=
M#OSOO23)@V;X^]SMX<#CKGITK\NO^#8;_D#_ +:__8(\1?\ I%>5_61^W=\)
MO&OQO_9=^)_PT^'MO;W?BWQ+HTUGI,%TXCADG>WN(U#N2 HW2+R3TS7X4?\
M!"[_ ()F?M;_ +%&F_M.V_[0&@Z)I4OQ)T[6;?PI_9EVDXGDO+:YB@$VV1]F
M6D4')'?FM,OSS XG@[C#ZQ6P."QN8YI@,10R^G.--RC&M1E4^KT=W3@HMNVR
MOZ@Z4XXK#M*4H0A).;UUTW?F_P!/4_$;_@AUX)\(>/O^"Y/[1^E>-_#VE^*-
M+TZV\3ZG8Z?K-I%>VEOJ,"7TD%TD$RM'YD<BJX)4@D<Y'%?0O_!VG\*OA_X
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M_L70^,?$?P^\+^(?$VI?9$N=5UG2+34+CRXE0JJM<QR <A<,!N!7@C-?<?\
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M:%^!_C[]GS0-#U;PUX+2P77YM3O([>:(P-&9/*5I%+8"G'!''&<U]4?MP_\
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M^B$]G=B+4V9!-"P*N!C'(/%?Z)/A+X9?#SP&%'@OP7X:\+[8%M@=#TBSTYC
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M32BUU/33=ZSX4O-J_N-<$4?V?=(?F16>%!D'AL=,Y'\?WAK_ ()\_P#!>O\
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MU:E_?_\ !M3R_O>7XON?SW?\.J/^"B'_ $E5^)__ (*[S_X_1_PZH_X*(?\
M257XG_\ @KO/_C]?T(T4?ZX9U_U*_P#PR91_\Q>2^X/JU+^__P"#:GE_>\OQ
M?<_GN_X=4?\ !1#_ *2J_$__ ,%=Y_\ 'Z/^'5'_  40_P"DJOQ/_P#!7>?_
M !^OZ$:*/]<,Z_ZE?_ADRC_YB\E]P?5J7]__ ,&U/+^]Y?B^Y_/=_P .J/\
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M /!M3R_O>7XON?SW?\.J/^"B'_257XG_ /@KO/\ X_1_PZH_X*(?])5?B?\
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M9,H_^8O)?<'U:E_?_P#!M3R_O>7XON?SW?\ #JC_ (*(?])5?B?_ ."N\_\
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MGN_X=4?\%$/^DJOQ/_\ !7>?_'Z/^'5'_!1#_I*K\3__  5WG_Q^OZ$:*/\
M7#.O^I7_ .&3*/\ YB\E]P?5J7]__P &U/+^]Y?B^Y_/=_PZH_X*(?\ 257X
MG_\ @KO/_C]'_#JC_@HA_P!)5?B?_P""N\_^/U_0C11_KAG7_4K_ /#)E'_S
M%Y+[@^K4O[__ (-J>7][R_%]S^>[_AU1_P %$/\ I*K\3_\ P5WG_P ?H_X=
M4?\ !1#_ *2J_$__ ,%=Y_\ 'Z_H1HH_UPSK_J5_^&3*/_F+R7W!]6I?W_\
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M0_Z2J_$__P %=Y_\?H_X=4?\%$/^DJOQ/_\ !7>?_'Z_H1HH_P!<,Z_ZE?\
MX9,H_P#F+R7W!]6I?W__  ;4\O[WE^+[G\]W_#JC_@HA_P!)5?B?_P""N\_^
M/T?\.J/^"B'_ $E5^)__ (*[S_X_7]"-%'^N&=?]2O\ \,F4?_,7DON#ZM2_
MO_\ @VIY?WO+\7W/Y[O^'5'_  40_P"DJOQ/_P#!7>?_ !^C_AU1_P %$/\
MI*K\3_\ P5WG_P ?K^A&BC_7#.O^I7_X9,H_^8O)?<'U:E_?_P#!M3R_O>7X
MON?SW?\ #JC_ (*(?])5?B?_ ."N\_\ C]'_  ZH_P""B'_257XG_P#@KO/_
M (_7]"-%'^N&=?\ 4K_\,F4?_,7DON#ZM2_O_P#@VIY?WO+\7W/Y[O\ AU1_
MP40_Z2J_$_\ \%=Y_P#'Z/\ AU1_P40_Z2J_$_\ \%=Y_P#'Z_H1HH_UPSK_
M *E?_ADRC_YB\E]P?5J7]_\ \&U/+^]Y?B^Y_/=_PZH_X*(?])5?B?\ ^"N\
M_P#C]'_#JC_@HA_TE5^)_P#X*[S_ ./U_0C11_KAG7_4K_\ #)E'_P Q>2^X
M/JU+^_\ ^#:GE_>\OQ?<_GN_X=4?\%$/^DJOQ/\ _!7>?_'Z/^'5'_!1#_I*
MK\3_ /P5WG_Q^OZ$:*/]<,Z_ZE?_ (9,H_\ F+R7W!]6I?W_ /P;4\O[WE^+
M[G\]W_#JC_@HA_TE5^)__@KO/_C]'_#JC_@HA_TE5^)__@KO/_C]?T(T4?ZX
M9U_U*_\ PR91_P#,7DON#ZM2_O\ _@VIY?WO+\7W/Y[O^'5'_!1#_I*K\3__
M  5WG_Q^C_AU1_P40_Z2J_$__P %=Y_\?K^A&BC_ %PSK_J5_P#ADRC_ .8O
M)?<'U:E_?_\ !M3R_O>7XON?SW?\.J/^"B'_ $E5^)__ (*[S_X_1_PZH_X*
M(?\ 257XG_\ @KO/_C]?T(T4?ZX9U_U*_P#PR91_\Q>2^X/JU+^__P"#:GE_
M>\OQ?<_GN_X=4?\ !1#_ *2J_$__ ,%=Y_\ 'Z0_\$I_^"B)! _X*K?% >XT
MN\S_ .CZ_H2HH_UPSK_J5_\ ADRC_P"8O)?<'U:E_?\ _!M3R_O>7XON?'7[
M&'[/_P 9?V>/AYJ/A3XU_M :]^T-XCN]3%Y;>+-?MY+>ZM+4+(#9(DC,Q0LZ
MMG)^X*^Q:**^=Q6)JXS$5<36]G[6M+GG[*E3H4^:R7NTJ,84X+3X80BNMC:,
M5%**O9*RNVW\V]6%%%%8#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*'CDC971T895D=2592.002".E/H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]DC5K+X[BVG^*WP0\9:I\+M:U6T(==9L?#;+866HW4H'[V\F$+&5R68@*"<
M5[M_P6ZT36-=_P""?_Q6MM%E>&X@B2ZFD0D;;:*WN3+NQ_#CDGMB@#^;SX3_
M /!,BW_:-_X)E?$+_@HK\0/'GQ"?]N76M:U_QOX3\:VGB_4K?0M"CT?6;?\
MLZQ;1U<1/";.:X\QMPVE$78XD+)^B^N_MS_%OXD_\$:_"_B6PU2Z;QHL<'P;
M^)GB:T>5KB>&.-=,U#5%GBS);R/""3,67;P21UKVK]BRY@/_  0BF<7<3J/
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MJ'H\;JZ'Z,I(/X&@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD?\ @GM_T7;2O_ 27_XNC_A\C_P3V_Z+MI7_ ("2_P#Q='_$+_$C_HA.+?\
MPP9G_P#,P?\ $1N ?^BSX8_\/>7?_-!^H=%?EY_P^1_X)[?]%VTK_P !)?\
MXNC_ (?(_P#!/;_HNVE?^ DO_P 71_Q"_P 2/^B$XM_\,&9__,P?\1&X!_Z+
M/AC_ ,/>7?\ S0?J'17Y>?\ #Y'_ ()[?]%VTK_P$E_^+H_X?(_\$]O^B[:5
M_P" DO\ \71_Q"_Q(_Z(3BW_ ,,&9_\ S,'_ !$;@'_HL^&/_#WEW_S0?J'1
M7Y>?\/D?^">W_1=M*_\  27_ .+H_P"'R/\ P3V_Z+MI7_@)+_\ %T?\0O\
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M+?ZS.8X[>.YN1(@"O+*H(##"X;HPKY)_8^_X*+?MRK^U;X6_9-_X*#_ _P
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M*10\<D;!XW1AE61U)5E(Y!!((I] !1110 4444 %%%% !1110 4444 %%%%
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M\_<D?Y;'Q.T#0K;XM?%2VM-(L;6TL_'_ (D@L[6"!4@M((]3N!%! @&(XHU
M5%'"J *Y+^S;#_GUA_[Y_P#KUZ'\4_\ DL'Q<_[*'XG_ /3I<UQ5?[QY?*2R
M_ -2E=X#!-ZO5_5:6K[L_P 7,RG-X_&7G)VQ%9+WGHN=Z+71>11_LRP_Y](?
M^^:/[,L/^?2'_OFKU%=?//\ FE_X$_\ ,XN>?\TO_ G_ )E'^S+#_GTA_P"^
M:/[,L/\ GTA_[YJ]11SS_FE_X$_\PYY_S2_\"?\ F4?[,L/^?2'_ +YH_LRP
M_P"?2'_OFKU%'//^:7_@3_S#GG_-+_P)_P"91_LRP_Y](?\ OFC^S+#_ )](
M?^^:O44<\_YI?^!/_,.>?\TO_ G_ )E'^S+#_GTA_P"^:/[,L/\ GTA_[YJ]
M11SS_FE_X$_\PYY_S2_\"?\ F4?[,L/^?2'_ +YH_LRP_P"?2'_OFKU%'//^
M:7_@3_S#GG_-+_P)_P"91_LRP_Y](?\ OFC^S+#_ )](?^^:O44<\_YI?^!/
M_,.>?\TO_ G_ )E'^S+#_GTA_P"^:/[,L/\ GTA_[YJ]11SS_FE_X$_\PYY_
MS2_\"?\ F4?[,L/^?2'_ +YH_LRP_P"?2'_OFKU%'//^:7_@3_S#GG_-+_P)
M_P"91_LRP_Y](?\ OFOT1_X)(6%G'_P47_9[9+:%636G=6"#*M@C(/4''%?G
MY7Z'?\$D_P#E(K^S[_V&'_K7QGB/.?\ Q#WCGWI?\DEQ!]I_]"O$^9]AX?RD
M^..$4Y2:?$F2IIMM-?VEAM&KZG^BU1117^'!_L,%%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _)G_@M__P HU?VA?^P?H/\ Z?+.OK?]A3_DS?\ 9H_[(YX(_P#3-;U\
MD?\ !;__ )1J_M"_]@_0?_3Y9U];_L*?\F;_ +-'_9'/!'_IFMZ^HJ_\D9@_
M^RDQ_P#ZK<"8+_>9_P#7J'_I4CZOHHHKY<W"BBB@ HHHH **** "BBB@ KG?
M%_\ R*7BC_L7=;_]-EU715SOB_\ Y%+Q1_V+NM_^FRZK?"_[SA_^O]'_ -.1
M,J_\"M_UZJ?^D2/\N[XI_P#)8/BY_P!E#\3_ /ITN:XJNU^*?_)8/BY_V4/Q
M/_Z=+FN*K_>;+_\ D7Y?_P!@&"_]1:1_BSF7_(PQO_836_\ 2Y!11176<044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Z'?\$D_P#E(K^S[_V&
M'_K7YXU^AW_!)/\ Y2*_L^_]AA_ZU\9XC_\ )O>.?^R2X@_]5>)/L/#[_DN>
M$/\ LI,E_P#5EAC_ $6J***_PZ/]B HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_++_ (*5?MJ?L>_ WX&^
M/=!^/'BSPMK4EM-I,&I?#:[8W.HZGY]\D8BELWC$;0QJ7>3YV. !M(8D?I]J
MNIV>C:;?ZMJ$JP6.FVEQ?7<S$!8K>VB:6:1B2  J(Q))'2OP<_;+_9/_ .">
MG_!1WX9_%7QIJOB#2+?4-"U"UD\5>.OMX1=)EL+C,T<DJR&.(.5(8,W<^P !
M]6? /]M#_@F7X5^'W@S5OAO\1/@7\-K?6/"^C7RZ7I%C9Z+?68NM/ADDM+MK
M+31(\\)9XI6>:1VVG>Q)(KRO2_\ @KW\(?B3_P %#OA7^Q;\"]4T[XJZ+XO\
M%:GXE\4^.?#*S7>C^'+RT2XDCT^YO&@15E>.) 4?9AV8 , &/RIX)_96_P""
M+6@^"?"'AZX\3> +ZYT'0;'3)]0;Q!#YE]+!"BR7,A$O+2,&)//M7VS^Q3\,
M/^"87PN^(=Q9?LM6WPZN/BGJ\4]W)J>EW<%]XA^R8?S8X91,9([<J2741MDC
M[P'% 'ZG:=X6\-:1J-]J^E:!HVFZIJF/[2U&PTVTM+V_P01]KN8(4EN,$ CS
M7;D UO444 %%<UXO\8^&/ /AW4_%?C'7--\.^'M'M9[O4-4U6[@LK2"*"&2=
MP9KAXT,C1Q/Y<08O(PVHI/%?S^^(_P#@YF_X)_\ AK7M:TFXT#XZ7NE:#K4^
MBWOC#3_AW=W/A3S+:Z6TDO(]66;R'L1(RD7&[8496SS0!_1/17AO@;]HOX4?
M$?X)VW[0'@WQ/8ZY\.+CP@WC5M3LIX)Y;728[!]0G2\ABD<VUW!#%*LD$I5@
M\;8RN#7XAZI_P<W?\$_;;7M:T+0O#OQY\9_V%J5SI5[JGA3X<7FK:6;JUF:"
M98KN"8HX$BL 1U S0!_1=17SC^RS^TWX'_:U^$NC_&+X>Z5XHT?PWK4DD5M9
M>+](ET368VC5&)GL9B7C!#C!)Y.:^A+Z]M=-LKS4;Z>.ULK"UN+V\N96"16]
MK:Q//<3RL>%CBAC>1V/"JI)Z4 6J*_";QO\ \'#?[ 7@;XQZC\(+[4/B%J0T
MC7HO#FJ?$/2/"TE[\.K#4996@V7/B5)_LL:1RKLD9B"K$ CD5^N?B?X^_"_P
MG\%[OX^:IXELO^%;6WA%O&D6M0S1.E]HPL_MJ&Q!<"XGEC(1(HV),A(Z F@#
MV:BOQP_9!_X+B_L8?MG?%R/X,_#B7Q_X=\5WJ74FC2^._#+^'=+UY+5WC=M)
MO+B8I=*[(?+9,A@0<X.:^O?VJ_V\_@+^Q[KWPH\,?%G5-377_C-XB'AKP5I>
MB60U&[N[]GB16FB616B@+3*!)@YP2!TH ^TJ*SM)U*#6=,L-5MEE2WU"UANX
M4F0QRK'.@=1(AY5P#\RGD&M&@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#\F?^"W_P#RC5_:%_[!^@_^GRSK
MZW_84_Y,W_9H_P"R.>"/_3-;U\D?\%O_ /E&K^T+_P!@_0?_ $^6=?6_["G_
M "9O^S1_V1SP1_Z9K>OJ*O\ R1F#_P"RDQ__ *K<"8+_ 'F?_7J'_I4CZOHH
MHKY<W"BBB@ HHHH **** "BBB@ KG?%__(I>*/\ L7=;_P#39=5T5<[XO_Y%
M+Q1_V+NM_P#ILNJWPO\ O.'_ .O]'_TY$RK_ ,"M_P!>JG_I$C_+N^*?_)8/
MBY_V4/Q/_P"G2YKBJ[7XI_\ )8/BY_V4/Q/_ .G2YKBJ_P!YLO\ ^1?E_P#V
M 8+_ -1:1_BSF7_(PQO_ &$UO_2Y!11176<04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7Z'?\$D_^4BO[/O\ V&'_ *U^>-?H=_P23_Y2*_L^
M_P#88?\ K7QGB/\ \F]XY_[)+B#_ -5>)/L/#[_DN>$/^RDR7_U988_T6J**
M*_PZ/]B HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH P?%-GI&H>&]>L=?4MH=WI&H6^KJ"P)TV6VD2\&5!89@
M+\J"?0$U_.?XE_;4_P""%?P'T3XN?LT:]\3#X=T_QCJ-S%\1_#ZZ?XIGFN+Y
MI',ZK?0V)\OY]W,08>^*_I*FABN(98)XTFAFC>*6*10R21NI5T=3PRLI*L#P
M02#7P)^T;\!OV ?A)X&\;?'CXV_ #X)?V/H%K)JOB'Q#K/@7P]<7EU*Q/EI)
M<W%HS2W%U,1''N+%G;H>E '\\\/Q@_X-E;>*.&+X@WBQQ*$0;?&QPHZ<G3.:
M^Y?^"=_Q!_X(D>(/VEM'M/V*O%MSJ_QUNM&U Z9:R#Q,$?3+:,?;6QJ=E!:@
MHD@^\X8YX!(K\[O$O_!8W_@E3X>\1)X?C_X)*>)M7&I7LEGX5U*P^#/A5[+Q
M;&&VP7>C.?#3>?!=##PLK/N4@Y-?;_\ P3A_X*7?L&?M _M::5\$?@Y_P3V\
M1?LW?%\Z-JUX?%FL_#;0/#$FD6MM#')/:2W]EHEA=1F\C8!4650^T@@T ?TR
M4444 >0_'+X&_#S]HKX=ZK\+?BCIMUJ_@[6IK:;4+"TO9=/FF:U,AB'VF$%P
MG[QPZ 8<'!XKY+_:&_9__9'^!'[$WQ9\*ZU\/? ?ACX1^'/AUK$.HSWNB:*U
MS% T4:1W,FHW-JMQ-J!N%MRDWF"5FC4@'::^\?%?BOP]X'\/:MXJ\5:K::+H
M.B65QJ&I:E?3)!;VUM:PO/*[R.54'9&VT9!8C K^5#XQ^*?V@O\ @N]\<K[X
M$?">#5_AY_P3T^'&OQ6_Q5^(4DJ6A^*@M;ZTCO='T&Y4HVH'<C/Y$1DVQ!V*
MA$9@ >,?\$?]=\0?##_@D!_P40\3ZSK6HWO@;4]1^)$/P4EUF>=(SX=U'1/$
M&G:5;Z>]T0L=J)[RV:,0GRP$^7I7.?\ !$+_ (*2_P#!+?\ 9E_8J\&^ ?V@
MOB5X&TWXWZUXL\1W?C*'7? D.IO8W=WK$D5C:/K;:;<(\1#[VD>X"[F&0 @-
M?T:_&W]C?]D+PK^Q"O[*/CG6;3X2?L_V7ARS\(S:O#?V^A3^1#;O LUSJ.T(
MU[/N>5Y9,DOCG  KY.N/^"3O_!,+P'_P3P\4?#_P[\./AMX@^&VD_#'Q5JNF
M?&?4[#2]4\3W5PD%]?6NO'Q4B">:X6_6.VB E* @*$\W#  _:3X?ZWX(\3^#
M]!\2_#FXT.\\'>(-.M=7T.\\.QV<>EW=C?0I/!/ MBJP M&Z[U"AD8%' 92*
M^%_^"K7Q=U7X,_L0?&KQ+HVHMI6H:EX6U;PU'?(S))#'KFF7ME.8W4AD<Q2,
M%8$%3R#FOR,_X-7?'/Q'U_\ 8W^)_A#Q-KNN>*_ _@+XR^+="^'7B+79IKF6
M7P_;7C06MC9S39)L[:".+R41BJAN..GZA_\ !9'X?S?$+]@CXSV$4,L\>CZ)
M<Z_<I"I9UMM-M+F660@ G:BDECCN!SG% 'X^_L@_LF?"'7/^#?WQEX<USPSH
M^KWWC33?&/BK7/%=[I]E<>)9]2?5;+4([R/6Y83?I) (O+@83CRTEE50-Y)\
M<^$/B+XD_M)_\$29M/\ "5[J?B&R^ 7BZ\T'5+>"6>:[?P3X8<O=VD^PM)=)
M':1_-&0P<?+BOK3]B[XM^ A_P;[:WXX?6;2+PMH?A?QEI&J7TDJI'8SP:A9:
M?)%.68%9%DN(05.&/F X(KW/_@WA^$,'A+]@W7+?5=*%UX=^)7CK7?$EK!J5
MN);/6=$UF)UWF&92D]K<Q2;2&4JRD@B@#\D-/_:2_9O_ &N_BQ^PGX<_8ZTV
M-_&_P%\'OK'Q>NM*\*-X5;P_;>'U635[?5+^.V@^V.P@E!,SL7Y/-??/[)NE
MK_P48_X*&>-_VJ_B!/8ZE^SI\ [>RT#X.VNMO$FG_P#">:3/#:ZI-8I>?N)7
MCGBDEDEC;Y1'G=N*J?=?^"JNH?"']DWX56?PM_92^%'PZ\#?M-_M%:WI7A;0
M/^$-\,Z5HVOWWAC5KZXT_P 2W9ET^VCN95\IV5M[;"=S,"=I'Y@C]CB^^,/Q
MS^$?_!+'5OB-XX^"_P /?AQH+_%;7/$'PTU*70O$?B;Q5K^D2W>IVNI7,,D#
M7(CN[F0[6D;#*"<8H _M MI;6:%'LY();?:!&]L\;P[1T"-$2FT#IM.*GK^<
MO_@AG\4OB/HOBC]IG]D_Q7XSUGXC^%_@7\1]5\/>#?%6OW<FHZVNE:?)-##;
MZG=R,[&<HB[P7/SCOBOZ-* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /R9_X+?\ _*-7]H7_ +!^@_\ I\LZ
M^M_V%/\ DS?]FC_LCG@C_P!,UO7R1_P6_P#^4:O[0O\ V#]!_P#3Y9U];_L*
M?\F;_LT?]D<\$?\ IFMZ^HJ_\D9@_P#LI,?_ .JW F"_WF?_ %ZA_P"E2/J^
MBBBOES<**** "BBB@ HHHH **** "N=\7_\ (I>*/^Q=UO\ ]-EU715SOB__
M )%+Q1_V+NM_^FRZK?"_[SA_^O\ 1_\ 3D3*O_ K?]>JG_I$C_+N^*?_ "6#
MXN?]E#\3_P#ITN:XJNU^*?\ R6#XN?\ 90_$_P#Z=+FN*K_>;+_^1?E__8!@
MO_46D?XLYE_R,,;_ -A-;_TN04445UG$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5^AW_  23_P"4BO[/O_88?^M?GC7Z'?\ !)/_ )2*_L^_
M]AA_ZU\9XC_\F]XY_P"R2X@_]5>)/L/#[_DN>$/^RDR7_P!66&/]%JBBBO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"1?E__ & 8+_U%I'^+.9?\C#&_]A-;_P!+D%%%%=9Q!1110 4444 %%%%
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M!S@GI0!]LT5G:1J4.L:78:K;I+'!J%K#=Q1SILF2.9 ZK*AY5P#AE['(K1H
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M=FT)(DD$$H241C&#N4\Y.0.!^IU !1110 4444 %%%% !1110 4444 %%%%
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M%JWP[_X)V_#CQ!';_$WQV\JVS?%G[)>VD=YI&AW"[&OLLA<Q1[PL>]B!&K$
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MYH8;;4KR1G+SE4&_YVRPYZ5_1O0 4444 %%%% !1110 4444 %%%% !1110
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M$(]+MVL-6M[M[D;;6%L216[+$6E="'8X)VD?7?\ P2B_X+J?L]?M%6/P=_9
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M_P#A:^&O_EG7^,]_PFGQ/_Z*U\2__"NU3_X_1_PFGQ/_ .BM?$O_ ,*[5/\
MX_1_Q B'_13+_P -DO\ YJ]?Z>A_:<O^?'_DZ_R/]F'_ (6]\)O^BH?#O_PM
M?#7_ ,LZ/^%O?";_ **A\.__  M?#7_RSK_&>_X33XG_ /16OB7_ .%=JG_Q
M^C_A-/B?_P!%:^)?_A7:I_\ 'Z/^($0_Z*9?^&R7_P U>O\ 3T/[3E_SX_\
M)U_D?[,/_"WOA-_T5#X=_P#A:^&O_EG1_P +>^$W_14/AW_X6OAK_P"6=?XS
MW_":?$__ **U\2__  KM4_\ C]'_  FGQ/\ ^BM?$O\ \*[5/_C]'_$"(?\
M13+_ ,-DO_FKU_IZ']IR_P"?'_DZ_P C_9A_X6]\)O\ HJ'P[_\ "U\-?_+.
MC_A;WPF_Z*A\._\ PM?#7_RSK_&>_P"$T^)__16OB7_X5VJ?_'Z/^$T^)_\
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M$5_H:?\ !V3_ ,H\/#G_ &4ZR_\ 1%O7^>7#_JHO^N:?^@BOZV\'?^2)H_\
M8TS'\Z!X./\ ][E_U[@24445^I'*%%%% !1110 4444 %%%% !1110 4444
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M>_M5>,]5T'0/A+^S;K'P/U,6/P/T*9H(;7Q'+93!M3_LW>"@W,6\P1CUR :
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MW*#@$4 ?V=6=U97EO'/I]Q:W5JP BFLYHI[=E X$<D+-&0!C&TXQ5JOYP_\
M@A?\2?B#X?\ %G[3W[*6O^,-9^(?@SX'_$G5?#_@KQ)K]Y)J6LP:58/-##:Z
MC>R-(7F*HH?$C98 ]J_H\H **** "BBB@ HHHH **** "BBB@ HHHH ****
M/Y;_ /@[)_Y1X>'/^RG67_HBWK_/+A_U47_7-/\ T$5_H:?\'9/_ "CP\.?]
ME.LO_1%O7^>7#_JHO^N:?^@BOZV\'?\ DB:/_8TS'\Z!X./_ -[E_P!>X$E%
M%%?J1RA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?[C?[K?R-
M.IK_ '&_W6_D:<=UZK\P/[]O^#1?_DR3XM_]E6'_ *(U"OZQ;J'[3;7%ONV^
M?!-#N_N^;&R;OPW9K^3K_@T7_P"3)/BW_P!E6'_HC4*_K,K^+?$C_DN>)/\
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MNX'EJ><8KWZB@#^9?Q=_P;>>"-8\7^(M+\*_M6?%OP3^S3XK\3)XDUW]FC2
MR^!+V3[0;JXM'C74(T$-Q*%9P(>2H)!K^B3X3?"_PE\%_AQX.^%W@73H=*\*
M^"=!T_0-'LX8UC5+33[=($9@H ,DFS>YY.3C)Q7HE% 'YGZ]_P $UO!/C']M
MWPA^VMXW\>^(_%'B+P!:75IX-\&ZB@ET#0TN&DDW6Z/,Z9261G!\G.>A%<%_
MP44_X)5:%^W%JW@;QOX'^,_C/]FGXJ^#M2O+FY^(WPY0IKFOV%U9FU73-1D6
MZM6:&'<SI\Y7I\H()/ZVT4 ?G]_P3^_X)^_#_P#8)^'.K>$_#OB'5?'WB[Q5
MJKZYXT^(GB) -?\ $NJRAO.NKU_,E8M*[L[YD;)QZ5^@-%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!_+?_P=D_\ */#PY_V4ZR_]$6]?YY</^JB_
MZYI_Z"*_T-/^#LG_ )1X>'/^RG67_HBWK_/+A_U47_7-/_017];>#O\ R1-'
M_L:9C^= \''_ .]R_P"O<"2BBBOU(Y0HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "FO]QO]UOY&G4U_N-_NM_(TX[KU7Y@?W[?\&B__ "9)\6_^
MRK#_ -$:A7]9E?R9_P#!HO\ \F2?%O\ [*L/_1&H5_697\6^)'_)<\2?]A__
M +@HGOX/_=:/^!?FPHHHKX@Z0KF/&GB_0O 'A/Q#XU\3WBZ?X>\,:5=ZSK%Z
M^-MK8641EN)FR0,(BD\D5T]?,_[9?P^U_P"*_P"RI\?_ (;^%5D;Q'XU^%WB
MKP_HJPDK*VH:AITD5N(V7D,7( (YSTH _&Y?^"BW_!0SX^S?%OQE^S#^S9X-
M\5_LY^'8M<B\-^.M8OI(;[Q!IEA:WIOKJS1KE8[F5(;>0Q)'&P=P%VG.#\X_
MLZ_M-:-I/_!+3]MG]I/Q%\-(O','A&?47\6_"CQ*)(],US4EORE_I\RS'BVC
ME9A$P&TCD>W9?\$YO^"AW[-G[(O[$1_9/_:!\22^ OC)\"?#_B[PQKNA:AI&
MH27'B/4+DZQ=6CPRQP,+FYO'ECM0SD*VZ,$J%Y^8M(\?3_$G_@B!_P %'_&W
M_"$WWA"VUE]3N]*TA-+G@N-0TZ;4V:VU"&S6(2R?:8R)#M0GUH \(_X+0?&/
MXV^.O^"8/_!/#7/@9\%O#7@SX!_%+Q=\+_$-_P"'+"[>)-(\2:E<W$FE^#(E
M21"=+O)A="0X"L!@YP /IS_@M+K_ .V)X _X(Z6N@Z'\$?!W@#0=8L_ 47Q4
MAT.]6.3P]YLUBMO%8^3*K,+^9(8;AL$KDKG#G/CO[?US/%_P0F_X)/-'9ZJQ
MD^)W[/I>V@L;M[F(K=:AAKBVCC,L(CR<M(H"9YQFOUC_ .#@V>:/_@CG\194
MBO;B1Q\(-\5I;SW-U)NO[!FS#"K2O\P#/E3@@%N: -;]CGX_ZE^QQ_P33^'_
M ,5_VA/A?X6^%.K6_P +?"3^$=*T*=&/B]IO#MG/IUQ>,&W_ &K4(Y[2[FW$
MN3,V?O;AX?'_ ,%7/VZO!N@^%/CS\6?@;\*]&_9F\5ZKI<5IKNF^(1-XIATK
M5;NX@AN); WC,LJQV[NZF/Y=RDC!%='^W3\!?&'QX_X)9?LBZGX=M]0OK/X8
M_#/X:>,O%.DQ"87%]HUIX*\,Q36\L.TR,8Q;.OE,N1G&.*^([/Q?_P $V/%O
MP0^'NDZW\6?$OB+Q5<W>D:?=_!R2'5##INMRSRVWV$6T@\I!;S0@A@@"^>3Q
MF@#] ?VUO^"POQ/^&7Q,_9E^&'[*'PFTSXNZO^TG]BBT"XU*66.WL[FY$;2Q
MS/#,BJ(O,VY)Y*DX'0>^?M#_ /!1OXF_LB?L[>#]?^/_ (#\/:1^T9\2_$47
MA3P+\/\ 2[WSM(N-4NI%BMI;VX$S-%:^8RAI#(%Y.2,5^;WQ*\)Z-X"_;X_X
M)S>'M \,7NDZ-!J5K=:5:SV4TYL;64QO"[7(C*V^Z/;U9<=Z]>_X+N?!?6KK
MQ+\!_C?J6BZEXF^&6A>+M+T_QJUFDT__  A&EPO ;GQ*L,:L4\E-\Q= "2.N
M000#TCPS_P %._VN/@Y\3_AKI7[;/PJ^&/P_^&?Q#NK;3X?$G@[7DU.]LKS4
M9S!IZ20B[D&7)1F5@"0<9%7_ -HK_@J5^TYX?_;)U7]DO]G#X':%\1-4N?">
ME^(_"FKZE/-%'>G4[>.>);LQSHL47S_>XX[]Z^0KS_AVY\<?B)\(_ 7@'XG^
M)OV@=?U+Q!H=_I&ARKJ+?8[C3+R./SO,N"RQ)%)%O*G&<U[O\+H8['_@N!X^
MTV+3;F*VTKX:>'+&P::RE,5G;P6MO'';I=E/+WHF%;8^3SF@#WG]CK_@I'^T
MIX@_:HU;]C_]MWX-^'_A#\5(_ US\1=(N?#-T][H<_AJ&W>Y$TUXT\T8DV*%
M?#X5MP(R*X7Q[_P4@_;K^,'QA\>^&?V"/V=O"?Q6^&/PSU4Z5XC\9>*;R6Q^
MVSQ221RKI#"YBCNI#Y+E(X]['H <9K0^./AR;QG_ ,%?;[P;8V\MMJWB?]DK
M6='T_64M)!]DEN-,N#\E^$VHR@EO+#@Y'3FO$OV"_P!N/X$?L"6'Q7_9@_:K
MU-OA;XW\">+M1GM-8OM(O9V\;P75Y=2+-'<P0L+BY0,@AWL%(=@9%[@'Z)?#
MS_@HW'IW[*'CWX\?M">#+OX;^+?AC;:D/%/AB2"6&WGOK(!(X=,>=BTZR3AA
ME"V4P1CK7Y[0?\%6?V\[CX?Z5^TBGP*^%*_LU:Y?6VHZ=K#^(0/%"^#Y+F>.
M74+BP-X&2YCAMW<H8QC*_+7H7[7OCF]_X*)?L(?$_P :_!/X;ZA'X?\ #=UJ
M6I:7:K9FTG^(%K9&(R1K"D$;RK)&HE"NK$ER0V:_.3X8^-/^"=A_9:\">#O'
M?Q>\36WQ).D6_A[Q;\$#!JBQZ1X@O9KFUDT$6_\ JE\MH@=P3://![T ?UD?
ML]_'7P5^TA\)O"OQ=\ 7@OO#GB>T62&48(2[BCC%[;A@6#""=VC#9&X+G KV
MJOD?]AOX>^$OAA^S3\/?"?@;P[<^%O"]O9RWFE:1=D^?'!?>7,)GW<CS\AP#
MR*^N* "BBB@ KG?%_P#R*7BC_L7=;_\ 39=5T5<[XO\ ^12\4?\ 8NZW_P"F
MRZK?"_[SA_\ K_1_].1,J_\  K?]>JG_ *1(_P N[XI_\E@^+G_90_$__ITN
M:XJNU^*?_)8/BY_V4/Q/_P"G2YKBJ_WFR_\ Y%^7_P#8!@O_ %%I'^+.9?\
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MNM_(TX[KU7Y@?W[?\&B__)DGQ;_[*L/_ $1J%?UF5_)G_P &B_\ R9)\6_\
MLJP_]$:A7]9E?Q;XD?\ )<\2?]A__N"B>_@_]UH_X%^;"BBBOB#I"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG?%__ "*7BC_L
M7=;_ /39=5T5<[XO_P"12\4?]B[K?_ILNJWPO^\X?_K_ $?_ $Y$RK_P*W_7
MJI_Z1(_R[OBG_P E@^+G_90_$_\ Z=+FN*KM?BG_ ,E@^+G_ &4/Q/\ ^G2Y
MKBJ_WFR__D7Y?_V 8+_U%I'^+.9?\C#&_P#836_]+D%%%%=9Q!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?H=_P $D_\ E(K^S[_V&'_K7YXU
M^AW_  23_P"4BO[/O_88?^M?&>(__)O>.?\ LDN(/_57B3[#P^_Y+GA#_LI,
ME_\ 5EAC_1:HHHK_  Z/]B HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/QIT^*VFNET;0KOQ#<1PJSN+?3+.ZEE?:H)(53S@=^* /R,_8\_9A^%.K?\
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M^@BOZV\'?^2)H_\ 8TS'\Z!X./\ ][E_U[@24445^I'*%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4U_N-_NM_(TZFO]QO]UOY&G'=>J_,#^_;
M_@T7_P"3)/BW_P!E6'_HC4*_K,K^3/\ X-%_^3)/BW_V58?^B-0K^LROXM\2
M/^2YXD_[#_\ W!1/?P?^ZT?\"_-A1117Q!TA1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5SOB_\ Y%+Q1_V+NM_^FRZKHJYWQ?\
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MQ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME)DO_JRPQ_HM4445_AT?[$!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5Y=\9?C%X"^ OP^UOXH?$S6[;P[X
M+\.K#)K&L7;B.VL89I!&)9G/"HIY8^@KU&O+/C1\*OAA\:OAQXC^''QCT/2_
M$7P[\16IM_$.DZS/]FTZZM5R<7,_FP^6JY)W&10.N: .6^"_[4?[/?[1%A#J
M7P4^+G@KXC6\UM'=@>&M8M[Z>**2,2@30(1)&Z*3YB%24(.>!FO?*_D9_;!_
M8@_8 _9%MK[Q1^SE^V5J?[*-WI\,NI3^&/A'XA7Q5?L\0,D=N++3;VZD17<>
M6L3A9%#$%,8)^<?V,?\ @L;_ ,%)[#4M7TK2/@-XI_:!_9I\$?:I;GXV>,M*
MU'3?$VJ:/8Y\W4UAD,4SR&)6DV#*M@9!P* /[=**^+OV)/VWOA/^W!\+H?B!
M\.;M[?4+*1[+Q+X:O1Y.IZ)J-NXBGBGMG;SDC\W*HTBCMR<U]HT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M '\M_P#P=D_\H\/#G_93K+_T1;U_GEP_ZJ+_ *YI_P"@BO\ 0T_X.R?^4>'A
MS_LIUE_Z(MZ_SRX?]5%_US3_ -!%?UMX._\ )$T?^QIF/YT#P<?_ +W+_KW
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M-_[":W_I<@HHHKK.(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"RK#_T1J%?UF5_)G_P:+_\F2?%O_LJP_\ 1&H5_697\6^)'_)<\2?]A_\
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MTDCL2S020[,E21TW*" #^G^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _EO_P"#LG_E'AX<_P"RG67_
M *(MZ_SRX?\ 51?]<T_]!%?Z&G_!V3_RCP\.?]E.LO\ T1;U_GEP_P"JB_ZY
MI_Z"*_K;P=_Y(FC_ -C3,?SH'@X__>Y?]>X$E%%%?J1RA1110 4444 %%%%
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M "7/$G_8?_[@HGOX/_=:/^!?FPHHHKX@Z0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YWQ?_P BEXH_[%W6_P#TV75=%7.^+_\
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M -6?E<O4_EC_ .!/R_N^O];^G?;K+_G\M?\ P(B_^+H^W67_ #^6O_@1%_\
M%UYC_P *>\,_\_6L?^!S_P"%'_"GO#/_ #]:Q_X'/_A1['+/^@W$_P#A&O\
MY?\ U9^5R]3^6/\ X$_+^[Z_UOZ=]NLO^?RU_P# B+_XNC[=9?\ /Y:_^!$7
M_P 77F/_  I[PS_S]:Q_X'/_ (4?\*>\,_\ /UK'_@<_^%'L<L_Z#<3_ .$:
M_P#E_P#5GY7+U/Y8_P#@3\O[OK_6_IWVZR_Y_+7_ ,"(O_BZ/MUE_P _EK_X
M$1?_ !=>8_\ "GO#/_/UK'_@<_\ A1_PI[PS_P _6L?^!S_X4>QRS_H-Q/\
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M .-4?\,<?LO?]$/^'G_A.V'_ ,:H_P"(Y91_T),?_P"#J'_R8?V;5_Y^P_\
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MTFLZ=?Z#<-\5@4M=;MI--N9$\C4#YD<-T(W>/H-X&,D<\U_6']NLO^?RU_\
M B+_ .+KQ?0_V<_A-X3MGLO!7A>R\%V$K^;/8>&8H]+M)YN?WTD,"*C28)^8
MC/)]:VO^%/>&?^?K6/\ P.?_  K\5XDS/*^(<]S+.E5Q6$688CVZPTL/&JZ/
M[N$.5U(UHJ?PWNDO\_1HPJ4J4*=HRY$ES7:OJM;6=MW_ %OZ=]NLO^?RU_\
M B+_ .+H^W67_/Y:_P#@1%_\77F/_"GO#/\ S]:Q_P"!S_X4?\*>\,_\_6L?
M^!S_ .%>)['+/^@W$_\ A&O_ )?_ %9^5]+U/Y8_^!/R_N^O];^G?;K+_G\M
M?_ B+_XNC[=9?\_EK_X$1?\ Q=>8_P#"GO#/_/UK'_@<_P#A1_PI[PS_ ,_6
ML?\ @<_^%'L<L_Z#<3_X1K_Y?_5GY7+U/Y8_^!/R_N^O];^G?;K+_G\M?_ B
M+_XNC[=9?\_EK_X$1?\ Q=>8_P#"GO#/_/UK'_@<_P#A1_PI[PS_ ,_6L?\
M@<_^%'L<L_Z#<3_X1K_Y?_5GY7+U/Y8_^!/R_N^O];^G?;K+_G\M?_ B+_XN
MC[=9?\_EK_X$1?\ Q=>8_P#"GO#/_/UK'_@<_P#A1_PI[PS_ ,_6L?\ @<_^
M%'L<L_Z#<3_X1K_Y?_5GY7+U/Y8_^!/R_N^O];^G?;K+_G\M?_ B+_XNC[=9
M?\_EK_X$1?\ Q=>8_P#"GO#/_/UK'_@<_P#A1_PI[PS_ ,_6L?\ @<_^%'L<
ML_Z#<3_X1K_Y?_5GY7+U/Y8_^!/R_N^O];^G?;K+_G\M?_ B+_XNC[=9?\_E
MK_X$1?\ Q=>8_P#"GO#/_/UK'_@<_P#A1_PI[PS_ ,_6L?\ @<_^%'L<L_Z#
M<3_X1K_Y?_5GY7+U/Y8_^!/R_N^O];^G?;K+_G\M?_ B+_XNC[=9?\_EK_X$
M1?\ Q=>8_P#"GO#/_/UK'_@<_P#A1_PI[PS_ ,_6L?\ @<_^%'L<L_Z#<3_X
M1K_Y?_5GY7+U/Y8_^!/R_N^O];^G?;K+_G\M?_ B+_XNC[=9?\_EK_X$1?\
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M^!/R_N^O];^G?;K+_G\M?_ B+_XNN>\77MFWA/Q.!=VQ)\/:T !/$22=-N0
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M0P^'H?ZC9A+V%"A0YO[5H+F]C2IT^:WL-+\K=KMK:[T9_%>)^B#B,1B*U?\
MUXPT?:U)5.7^QJSMS23:O]=\Y;?+H?YE?]E>(O\ H5_$7_@HOO\ XQ1_97B+
M_H5_$7_@HOO_ (Q7^FI_PR9^SO\ ]$H\(_\ @IM/_C5'_#)G[.__ $2CPC_X
M*;3_ .-5M_Q.[DG_ $0F8]/^9K0\O^G'K^/=6P_XD\Q'_1<X;I_S):W]V_\
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M(O\ H5_$7_@HOO\ XQ1_97B+_H5_$7_@HOO_ (Q7^FI_PR9^SO\ ]$H\(_\
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M_C%']E>(O^A7\1?^"B^_^,5_IJ?\,F?L[_\ 1*/"/_@IM/\ XU1_PR9^SO\
M]$H\(_\ @IM/_C5'_$[N2?\ 1"9CT_YFM#R_Z<>OX]U8_P")/,1_T7.&Z?\
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MS+!9A[!916INM]3Q%'$>S4WC)*#G[.45)QDE>[32L>[?;K+_ )_+7_P(B_\
MBZ/MUE_S^6O_ ($1?_%UYC_PI[PS_P _6L?^!S_X4?\ "GO#/_/UK'_@<_\
MA7\,>QRS_H-Q/_A&O_E_]6?E?^QKU/Y8_P#@3\O[OK_6_IWVZR_Y_+7_ ,"(
MO_BZ/MUE_P _EK_X$1?_ !=>8_\ "GO#/_/UK'_@<_\ A1_PI[PS_P _6L?^
M!S_X4>QRS_H-Q/\ X1K_ .7_ -6?E<O4_EC_ .!/R_N^O];^G?;K+_G\M?\
MP(B_^+H^W67_ #^6O_@1%_\ %UYC_P *>\,_\_6L?^!S_P"%'_"GO#/_ #]:
MQ_X'/_A1['+/^@W$_P#A&O\ Y?\ U9^5R]3^6/\ X$_+^[Z_UOZ=]NLO^?RU
M_P# B+_XNC[=9?\ /Y:_^!$7_P 77F/_  I[PS_S]:Q_X'/_ (4?\*>\,_\
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MKQHQJ-4*DZM.RM.=/V<F^ON<T[?^!%*]M4D_)W_1?UU"BBBLAA1110 4444
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M7BS4+[X4:5=:=H?POEV3>";J>?S&2_N[=[C:UQ!(_F(?L[$,.&!K-_X*$_\
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M&W@RUU271Y-8CLKFRB:]AW%TB6Y56ECPI*RIE&'(/-<A^T?^WE^RO^R7XK\
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M^W=^V,[_ !,MO WQ*U7X?_"CX8^)%35_ MGHJO?&TU231KL26KW-ND"E2T3
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MO^":?P"^'UQ%K?B?X9^-;_6/'4&GLMS/X>AO[F%XSJ*1Y>T38%YEP"2<?>H
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MOH3_  3\=W7B3X@:F08XKC24U)3MNI <$;-P&X\9/3-?L%_P4H_Y6 OV(_\
ML3M=_P#1,U>>? OX&VW[2/QA_P""J_P@,6-7\3> ]<@T74(P3=:=<PR33"6U
M*C>LA95"[""3WXH _H<_;1_:_P#"WA;]@D_%JWO8FLOCAX5M_!WAR\MI!B2^
M\=:9=Z=$]JRMDN2TWE;<X(K^47_@VY_9\F_9V_X*+_'WPKKD5VWBBY6;4;FY
MU$$WLNGZG<37]LSNQR3)]J>5B<[GD9N<FL[X/_M$:I^VA-^RO_P24\.ZW>:U
MK?[-WC[PQ?>+;NYD8SSV_A/4C)(ESEC(8[1#(93)D(LGS<'G]1?V,-.MM%_X
M+T_M2Z':01VT6B^%?#NDM#$ J";3[.*UE;"@#):/DXSZT >9?LY6%FG_  =#
M_M"WBVT2W3_"JY5IPH$C#R#P6]*_L5K^/7]G3_E9^_:#_P"R5W/_ *(-?V%4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M^1G_  6F_:=\;_LU_L6>.[KX77BZ=\2_'=K+X4\(Z@6*/97EX\$4D\+CE)42
M4;6'(R<=:^>_^"1O_!*O]GGX;_LD>#O'?QL\$:!\=OC+\<K2V^)7Q%\6_%31
M=.\6:A:ZWJANGDTO2)]5AN7M=.A\PL(T*!F*C;B,$U_^#BGPCXENOV)9?B;X
M=TJZUD_"36XO%-_86D+SR2VB36FYC&F<HHB.XG@<'M7Z$?\ !,3XS>%?CM^P
MO^SGX]\+ZOI6I+>?#O1X-8MM,O(+IM&U>$3+=:7?1PNQM;N# +P2JC -TX.
M#X1A_P""5WQ1^!?_  4>\$?M0_LA^,]!^&G[/?BB5&^//P8MUCTW1KQ864K)
MX9TBW5+6W:3:79(415W8  &*]4_;=_X+.?!7]D'XDV_P9\+_  S^(7[2GQ;C
MLUU'7? ?P?C34M9\.:<PW&[U.%+.]9(U4C<2J;3D<@9/T9^TI_P4;_9S_9T^
M-?P^_9I\8>(;JZ^+GQ<TC69O"^@Z!$FIW=E-:VLQMO[7MX6,MBMS($,4D@&%
M8/M;I7X _P#!!Z"R\6_\%#OVVOB/\1=LGQR?6-?T@+J4F_6K;P8E^!9D6TQ>
M:U@91#'YB",.K>6?E8J0#]R/^">G_!5#X%?\%"M,\46WA#2-?^&'Q'\&:F-+
M\2_"GQ\\=MXRTV<+*9'DL_L]JY2)HF23]T-IQR><?RS_ /!42U^#,/\ P5?^
M,&H?'_1KW6/A#'HVFGQI9:,I_MBZM,1[5M67#;L;NGJ*^O;S2- ^'?\ P=">
M!-+^$F[2=+\=?#WQ)JWQ7TS108],NM?%G?2>;J=M;[+>"X$I) >($-T(-?!7
M_!:0 _\ !0K]H<$#'_"-Z7Q_VSCH _HN_88_::_8._97_P""?6M?&7X-6FN>
M#/@II%]>SZ3H'B6<1>(?$NO0Q[(M'T=9@_G7UY(ZQ0QX.-V[:<8/BWP^_P"#
MD'X-ZWXW\&:'\6?V5?V@_@%X%\<:I!I.E?%?XB:>MMX-CN;R2*.R\ZZ&E0*5
MNS,C18F4$'K7Q7^S-^QKX4_;M_X(T#X.^(?B+I_PK\1Z1XSO-?\ A?XCU+5K
M71;6Y\<V<+W>BV)FN;JU-R+B^BB@,$(GD8N (B,FO*OB?^T5_P %0_V/?V3/
M!_A/_@I9^PW\'/C9^R;\&]8\-^'_ !-\0TO[2ZUV73X-5D@\/^)4L8IY!;W$
M$*QE[B.WAED=D6:1F900#[ _X.:?VTO%?PB_94\'Z'\+='^(ROX^FT[6=,^)
MO@6:ZMM/M-.NX[2_M?.O( H$=U;&)HPS?,+A?7%?'7P*_:L_8;_:OUG]@J\_
M:T^!7QH\-?M*>"_"WA7PUX#\5Z['=):^+;Q71$UXRRA?M-K(QC?S 6!!8DU]
MJ_\ !;KXQ>!?CS_P2-^'GQ1^$]H8OA_XAM/"D^@V<MI&7TO3VM])AM-/C+AF
M6.SC@^R!E*[U@5B!G%?!_P"T8LY^.W_!&O[3:QVY_P"%6^"?*VVL=L9%Q;8<
M[$3S3T^=LGWH _<[]KW_ (+D_LX_L:_$K4/@3K'P^^(/C[XK:=8:<_A[P+X0
M2.?6O%,=S GD1Z1;_8[AY75=JMA7^;\JY[]C[_@O+\&OVG_CY;_LZ^-/@/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JM]'<S
M65W%9S"WNY+>9+:<C(AG:-A%(1@Y".0Q&.<5:HH _!GX)?\ !(KXD2?\% =>
M_;J_:\^-UA\>-7T%[NS^"OA*33ICIG@72)7E-O#):WMNMM)<6Z.FV1-^&3/(
MXK[W_P""B?["OP__ ."@?[-'C+X#>,?LNEZCJEF9?!_BQK<27GA/78GCDM=2
MLI%1IH"C1IO, W$*HQ@5]WT4 ?RXW'_!$;]MCXA_LR_ ']F/XY?MKV7C;PE\
M"_B?H?B6QNH--U&.ZU?P-H-PC6OA>\D>U5YI#;((#)*=N,88 5_37X1\+:1X
M(\,:'X2T"W%KHWA[3;;2].MQTBM;6,1QJ/K@L1V)-='10!^+/[?W_!*K7OVJ
MOVI_V9/VJ_A1\4+;X3^./@AXGM]3\5R/:SSR>-=%@DBVZ3+)!$Y\L6\?D!)6
M$84#! XKR3]M3_@C;X\\=?M":9^V+^PG\;[?]E[]I>:TCL?&&O\ V:YG\-^)
MH=B)<3W6DV4$D<EQ<*'WM+&3EB=QR17] -% '\R'AK_@B]^VC^T)\6? 'B#_
M (*:_MC:5^TQ\)/A[>)J>G_#+0],OM'L-3OX9Q=0MJ<4UG%;7""<#F17*KT4
MX K]4?\ @H+^P/I_[8G[&7B+]D?P3KMA\,-'U'P_;^'M&O+>S_T/2;.QM8;6
MQ1;:UBPPA2"/)$>6(+=2:_1ZB@#^4?X-?\$I/^"X?[/OPO\ !?P8^%G_  4[
M\$Z7\/?AWHL/A[PGIUSX2U&::STFWDEEB@>0Z<Q)5YI#U/6OT/\ ^"=W_!)E
MOV9?B-XL_:@_:7^(<?[0/[7WCR0'Q'\3Y(IX["WC1]Z#2;2[B1[5\\$QJ@ S
MR>E?M310!^-O_!2S_@E+9?MCZ[X7^.GP3\=?\*._:R\"75BWA;XM0K.RBPL8
MHXX;"_AM(FFEBC\F/ .]74D$+CYO@76/^".__!2[]IV^\._#_P#;\_;XT3XS
M_LY6NL6NM>)_AYX<T34-(OM=NK"2*2S5[DV4"&--LH*NX!\UNQ-?U&44 ?D7
M_P % O\ @ESHW[5?[""?L1_"'Q/:?"'PYI]GI&GZ-J+6SW$5K;:08/*,L=O$
MS22R+$V]]F27Y]_N[]DSX)W?[-_[-7P4^!%_K2>([SX4_#_0O!ESKL:-$FJR
MZ1 86O%C<*R+,>0K*"/05]#44 ?@3^U%_P $=_'GBG]O7X<_MT_LB?&FR_9^
M\6VM]'<?&'1([&=K3XBPK<&25;B.T@:*1Y8R5/VC #,>H&3^H7[4?[&OP<_;
M1^"#_!+]HO0H_%VC7.G0K-?1;8+RSUM;6&.36--F9&:"?[3$LZ[/+8A0NY>H
M^M** /Y9-)_X)+?\%@O@YHFK_"+]F[_@I/HG@OX!6<FHZ;X"\*:[H>J:GK/A
MWPO>PFWBTYM0:QD9IH(F<)(C_*=I!R*_2C_@F;_P2;^%G[!&F:Q\0=>U&3XI
M?M1?$9);GXM?&+5I)+J;7M2GN!.QTN*\B$]E"I7[VY6(D9 B[0[?KG10 5\O
M?M8_L=? ;]MCX=6?PK_:%\*2>+_!=CKUAXEMM-CN_L3)JVF2++:7'FB&;(C=
M%)7:,XZBOJ&B@#G?"/A71? _A?P_X.\.6QL]!\,:18:'H]H7WFWT[3;=+6TA
M+X7<8X8T7=@9QG%=%110!^(_[4?_  2=\1_M"?\ !1SX#?MRV7Q7MO#VD?!W
M1-0TFY\#R6<\D^L->HZK,EPD31($+YPSJ>*]"_8R_P"":&M_LN?M4?'W]H35
MOB/;>+=+^,]K<VT7AE+6:(Z4MQ<I,PD>2-4D!0-&P#-G)K]=J* /YVOV*_\
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M%.FSZ3K>E7D:207=E<KMDC82*Z@\ JVTE6 -?S.:9_P12_;X_91\8?$33/\
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M"4GA#P]XU\77_CCQ!9R7AO3=^(M2+M=W@<PP[!(7;Y-K8S]XU]6444 ?B/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img12876764_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_11.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *>! T# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUIIM"UX&XAGDMM3N/(=[>1F#*I53@!<J,9!Y']??[>/_  24_89_:?M-$O\
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M)&W9!(XYR,BHO^"\7_!.WXQ?M?>%?V;/VI/ .LZ9?^,?AMX1TFWU[P?=7?\
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M$DYK_10_:8TF^U[]G_XOZ/IL+7%_J/@/7[6T@0$M+-)9N$10.26/ Q7\ ?\
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M%26'BW*ZEK%?RJVU]W\PHHHK\X.P**** "BBB@ HHHH **** "BBB@ HHHH
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M;/XW?"?6_ NEZI_;9T34=2C=8M4ENWFDS"610=[/\N,\?@*^5;K]A+]LU_\
M@L_HWQF7X%>(C\)X?'K:A-XR$4OV".R^UAQ<%MFW:5^;KR!Q7]Y=%5+Q&S*6
M;YUG$L!@G7SO+EEV(I\U?V=."I^S=6G[_,ZC^*TFXI]+ L)!4Z=-3E:G/G3T
MN^R?DK+SZC< KM89!7!!Z$$8((]^AK^./_@N+_P1T^.'CCX_:'^W#^R1I\VK
M^/\ P\(+B'POI:%;L:K;>7*;E1&I<^8Z;@X4YSCJ#C^QZBOF>'.(L?PSF,<Q
MP'LY3=.="O0K1<J.)P]5)5*-6*:?+)*UTTUTW9M6HQK0Y)76J::W36S1_G0?
M%+XI?\%V/VYOAY9?L@>-OAAXW\->'9YK'0_%>MZ;]OT[4;&*W!L4N);Y(D8B
M)&9R2_OR*_JJ_8D_X)C^)OV<O^"9OC']DGQ-XWU?Q9X[^)/@S4;/6=<UN_FU
M"XM;O4;%!;6?G3LQ!MV>574' 9@N 05'[4P:=86US<WEM96L%W>$-=W,,$<<
M]RRC ,TJJ'D/&<L3D\G)YJY7O9WQWB,SPF&R_+\JRW(\#0QE/,9X? 4W:OC:
M;C*-:I*>MHRCI!632CS:I&5+#*$I3G4G5FX\G-+=1>Z5OSZ;+0_S8?@-^R!_
MP62_X)D_M"^*M _9:^$'B+5?">J:W>69\41032:?<P:G?2L;XJL31M'$DH=L
MY& 16E^TU_P3:_X*E?$+]J?X9_'/XL?#?Q)\5_&>L:Q8ZIX@U^P6=['1K*>X
MBFDLVCV;5:V&0<XQMQVQ7^D917O?\1;S/ZVL?_8>2K'5,++"8O&1I55B<9"4
M.1.K54^:-OB<864G9/1(R^H0Y>7VM3E4N:,;KEB[IZ+SL?R8?\%P?V3_ -IC
MXW?L4_L_^#/A!\*-9\;>+= T'2[?6]&L$=Y]/FBLH$DCE"*Q!5T*G(['OQ7Z
MS_\ !%/X3_$SX+?L%_#'P'\6O"EYX,\::69_[0T*_5DN;;=#;!=ZN W)5ATZ
M@U^M%%?'8SBK%8SAVAP[/#8>&'H9A6S&.(BZGMI5*SFY4VG)PY%SNS23T5VS
MHC0C&JZJ;OR*%G:UE97]=#^-C_@LY_P23_:)MOVB-%_;?_8QTQ]<\86>HQZQ
MX@\,V,.ZXU"XM9#.Q=(T+N'/)R"#D#K7R)\1?VN?^"V_[5'A7P]\"_"W[-]_
MX+U"P%EIOB3Q$=&EMS%# (;:69IO(''E(K$YY()YR*_OBJG;Z=86DT]Q:V5K
M;3W1#7$T$$44DY'0RNBJSG//S$\\]>:]S ^(=>A@L!ALQR3*\YKY33]EEN,Q
ML:OM:%/3EIU(PDHUHP2]U35[I7=E8SEA$Y3E"K.FIZRC'9ORN]/D?GI_P3._
M9V^+7[._[/.A:%\:?$$&O>.]9M;75-7,2%6L;F5&>2TE8@;G0ODD9ZX// ]]
M_;+\,^(?&7[+?QO\+^%-,FUGQ'K?@/5K#2-+@!,U[>S",101@ DL^#C -?35
M%?%5LRK5\S>:5(TW7EBX8MPA%4Z7/"I&<81C&W+!<JC96:7F=*@E#D5[*/+=
MZNUK7?F?Q=_\&\7[&?[6'[/?[0?Q,\0?'/X-:[\/M$U/4=5DL-0U..1(KE);
MNY:)D+HHPZLI_'@U^EO_  <3?\$^OBE^WG^RSX:TKX317FI>)OAQX@?Q)%X?
MLF(FUK;Y,BVH3!W[C#MQ@YSVQ7]"]%?2XOCC,L3Q3AN+*>'PV'QV%=%TZ--3
ME0?LH.FTU.3G:<)-/72]ULC".&A&@\.W*4'=7V>Z:^ZR/X*?V._B[_P5?T/X
M+7O[''AC]EJY\&06GA^_\/WOBVYT(H5MYK>2READN#;C=(\18JQ8\G=TY/IG
M_!!']@3]KS]E[]N/XK^*_C)\(-<\,>%M?OKZ_3Q/>QNMG?75ZQ:=XF*!<,[%
ME /3GUK^X**TM8)9IH+:WAFN6WW$L4,<<D[_ -Z9T4-(WNY)SSUJQ7J8WQ&K
M8C"9U@L+D668"EGU)1QTJ,J\JLJW,IRKJ<YZRYN;EA).$5)M*[;(AA%&5.4J
MLYND_=O:UM+*WRW6NI_$W_P<3?\ !,[]J_XL_M%?#/\ :>_9I\$:G\1KSPI=
M6FLPZ'I<;R36NJ6#[X&<(C,?WD:MT[\=\?K!^P&O[8_[:G[&GQ,^!/[>_P -
M+WP#K&O^#(_"ME/JEJZ9MDMH;2)D$D08R1[(G+ %CL/;FOZ!**\O$\;8O%Y#
MEF25\!@I5<FE&679JE4CCL,HU8U5&+4O9V<HQYO=O*ROUO:PT8U9U8RDE45I
MP^S+2WR_JWE_GQ> _P!G?_@IK_P19^-WCK3_ (!_"._^*WP1U;4[UK6>"P>]
MMBMQ--)&0$BD7)#X!' (Z8YKZA_9H\"_\%>OV[OVN_"?Q9^+_A*3X,_![3M2
M@N;S3KVQ>TAO;**:-WC$;QQKDQ@CGJ>HXY_MTNK2UOH'MKRWANK>3&^&XC26
M)L'(W(X920>0<9!Y%20PQ6\20P11PPQJ%CBB18XT4=%1% 50/0 "O6Q/B17Q
M5.K6JY!D\LYQ&%^J5LYE3J3KSAR*#JNC)NDL0TM:EM[-(B.#46DJM3V:ES*G
M=66VE][:'\S'_!:']D']N#4KGX<?%?\ 8NUO4[R#P18VY\0> ;2XF,.MWUE'
M_K?LB JR.5+;2G1B.G7\/_CY\=_^"K7[:7PEL_V5O%O['<EIK*Q0:/K?B.+P
MUY5U'#&JVK7)N_LH?[IWEL\G)K_0KJA#I6FV]Y/J$%A9PWUR MQ>16\27,P'
M:295#O[Y)R>3FN7)^/999A,'A\3D65YCB,LE*IE^.K*I2Q-&<I<R=65)KVZB
MW=<^NB6RT=3"\\IRC5G!35I15FFEVOM\MC\*O^""G_!-CQ1_P3T_9FO-"^(<
MT[>-_&.IKK-W9L^$TZ&=)9)+:2( #S5DE"DE01M(]17VM_P5#_9<\0_M<_L?
M?%+X1^$;V:R\3ZMHET=)\J0J+F<0N!;,H(#B0L,*<Y(Z5^AU%?-XKB+,L9G\
MN(ZU2#S&6,AC>917LU5IRC*$5#;D7*E;MK>^IM&C"-)44O<4>7S:[W[];]S_
M #Q/^";;?\%0_P#@F_IWB?\ 8[\,_LH7VKGQ9XDGDMO&EUH9N988+AKJ ZNE
MY]G.RVCAN9)" P4$+@9P1?\ V=O^">__  4(\/?\%JO@_P#'3XI_!G7M0\'0
M^(+?6/$/Q#@MG31K."ZN$N)(W?: CV_"!=I##<2RA0&_T(VLK-KM+]K6W:]C
MA:WCNS#&;E(';<T23%?,6-FR2H8 DGCDYLU]K7\4,34K9IB:60Y70Q6=8"O@
M\SQ$98B53$3KT_9RKQ;G^[<8ZQIKW;MWU29SK!1M3BZLY1IR4H*R25FG;SV6
MI^ /_!P9^P=\3_VVOV2[K1/A'9S:OXMT.<31Z';*6N-2A.YS'& "2?EV\=SS
MUK\]O^""/B#_ (*B_!.;PQ^S!^T%\#->\&_ SP:\FGZ%J=_;3(L%N617D:5H
ME!5]H<?,1^=?V#T5\]A>,<11X9K<+XC+L#CL'*M4Q&&KXA5/K&#K5%9U*+A)
M1<DKI.2;2DUZZRPZ=95U.<9))-*W+)*VC\G8*^)O^"BO@KQ=\1/V-_CAX.\"
MZ+<>(O%6N>$KNTT?1[4$SWURX.V*, $[CVXK[9HKY;"8B6$Q6&Q4(QG+#5Z-
M>,97Y92HU(U%&5K.S<;.VMGH;R7-&47M)-?>K'\27_!N-^Q3^US^SI^U#\0_
M$_QY^"NO_#KP[J&CZK!8:IJD4B0W,LJ3^4JEU4$OE<?7C-?V<_$3P+H?Q*\%
M>(_ WB.V2ZT?Q'I5WIEW"X!4K<P/$KD$$'RV8/C'.,9&:[2BO<XEXEQ7$N</
M.:]"C@\0Z="$889U.2#H*T)Q=24I<S>KUM?8RHT8T:?LTW)7;;E;6^^BT/X
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MLXNG))37O2<8>T2O4:O>5FK6.:&#C%PYJDYPIZPIR^&+TMKN[627EH?R>?\
M!T#^RE^TE^T_\&/!VA_L^_"K7/B9?V5[;&\L]#B:6X@A$T32%4&$+!-VQ690
M6 !(&37[1_\ !)'X<>/?A+_P3Z_9R^'_ ,3?#EUX3\;^'/!D%EKV@7BLMSIU
MVKDF&56 8,!@D$ U^D%%?,XOB?$XOAG+N&)X:A##9=C:V-IXB+J>WJ3K0<)0
MFG)T^5)Z.*3T7SVC14:\Z_,W*<5!QTLDK6MUZ$<L4<\4D,R++%*C1R1N R.C
M@JR,IX*LI((/8U_%K_P6$_X(?_&+3/CA<_MJ_L,07C?$"[O_ .U=6\-Z.6AN
MY;Z*1KA?*\E?,"L^"2H*GUSNK^TZBLN&^)<QX8Q[QV7RA)5*;HXK"UHN>'Q=
M"33E1K0NKQ;5TU9Q>J85J,*\>6?1WC);Q?='^<A=_M+_ /!Q]\3M$F_9VU3X
M>^)%T:\TY-"U5(K*ZBO[;2,"%I9;P1JY*Q,<G<<[>?NY'[I?\$-O^"+?C']E
M#Q->?M-?M%7]QJ7Q<UEI+O2;2]?S;S26O&,\R3.X\S*/(R_,1GI@D&OZD(].
ML(;R;48K*UCO[B-8I[Q((UN9HU.5228*)'4$ X+$9 ST&+M?2YOXB8G'9=B<
MKRS)LJR#"XY+Z_\ V;1<*F*T]Z,YO:#=U9:N+M)LRIX2,)JI.I4JRC\'.[J-
MK6^ZVG;HK:'\6_\ P<-_\$N/VG_B_P#M'^#_ -LC]F;POJ/CSQ;HNEZ=I=KH
M>EJ[W%E/81PQI<,(U+XS$#_B#7QWXL^$G_!<[]M']E'4/A=\;O!^N^'? W@G
M3/L"^!&CN(-3\5"UMS!:[',2O(H48'7&XX(ZU_H&456 \2<PP6695E]3*<IQ
MU3)G!9=CL71E/$X:G"7,J=/WN2.ETIJ/.KW3ND*>#C*<YJI4@JEW.,7[LF[;
M]>E[;;G\B'_! C]D']IC]GK]GSX_^%/C%\)=;\!ZGJOA[5;#P[8ZG'(LVHL;
M6>.!4W*I9I"RCUR:^8/^"0?[$/[8'PC_ ."J'C?XI?%#X(^(/"/PXO=4U66S
M\4WT4JV<\<UY<21LK,@7YE92.>X')Z_W'45S5_$''UZO$U66 P:?$U"%#$I2
MK-890BHJ5"\[N3M?]YS(<<)&*H+GD_8.ZO;WM4TG]UM#\\/^"FG[$.D?MW_L
MS^*/A'=/#!KB6UW?^&;J9%80:J(5\HJ6!"LS1J >.<<YQ7\>7[.WBW_@KY_P
M2LTWQ?\  32OV?\ 4?B3X3GO;RV\*^(/[*DO8I"\LL=G)"X@<! K+@ ]Z_T'
M*J7>GV-^(EOK.UO!#()81<P13B*08PZ"16"MP.1C.!GH*X\@XRK9/EU?)L9E
MN#SG*:]:.)6#QOM$J->-OWM&I3:E%NRYH[.Q=7#JI-5(SE3J)6YH]5V:?;H]
MS^1;_@E5^SI_P4V^-/[16H_M#?M<V_\ PKGPQ97BZKIGA:_M7A:Y@GD5XX((
MGC7:VUA]T$J,DX4$U_7I1TZ45Y/$&>U<_P :L7/"83 TZ=*%"AA,%3]G0HTH
M))15[RFWNY3;;+I4E2CRJ4I-N[E)W;?Y+T1^<_\ P5+_ &5K/]K/]C[XI> H
M-$_MWQ;9>'M0U/P79!!))+KB1JL,,*D'$DI"D-VV8[U_"'_P3S_X)'?MZ>,/
MVQ?AEH'[2?P,\5Z'\*_!FKQZA;^)-829]-LUL+]GMEC$J[%#(%.!@!=I!.<#
M_34HKW>'./LTX:RC,<HPE##5J6.=25.O7=7VV"G4I.E.>&Y)**<D^9J2:<MS
M*MA85JD*DI23ANE:TM5\5_2R/E?]J3P+K&I?LB?%7X>>#=,?5=9?X6S>&]!T
MJU7$E[<6MI:VEM;PJH&&=8?E  K^4#_@@G^PC^U1\)_C#\;F^/7P>\1?#;1_
M$T/B*'P_K5ZLL*B\NIKG[%=(Y53M7>D@P>G0GI7]L]%>;E?%.,RK)LXR:C0H
M5*6<3I5*V(J.HJU&5*S3I*,E!W:O)33+G0C.I3J-M>S32CT:??KZ'\*?Q(TO
M_@L)_P $[/VEOB!XRT#P/J/[0WPOUO7-6N;.XN[6?6K:TTB[G<6UNJR1RA?*
MB<  ' QP,8KY7@_8/_;N_P""LW[7?P[^,OQ:^"$OP3\(^'/%&DZW)J*:2-+M
M9[6SNEDE4KY$8+,J':PY&01D=?\ 1-NK6VO8)+6\MX;JVF4I+!<1I+%(I[/&
MX96'<9'!P1@@&BUM;:R@CM;.WAM;:%0D4%O&D44:CH$C0*JCN<#DY)Y-?3T/
M$W$X6FZ^&R/*L/G+PCP+S>C&K3J.BZ?LW+ZO&7L?:M?:M;RV,7@HO1U:CI\W
M-[-VM=-.W-:]M-C^,/\ X.1?V#OVDOB[\,_@!X"_9F^$?B/XH6_@>S\.Z?JL
MFEI)<S1RZ<\"M.WI$6C#29;*Q[F4,0%/Z[^/?V/?B=\;O^",GP\_9KNM+N/#
MOQ+LOA-H4&H:#<*1=6VK:;#J@ETUU89\PM<H ",\U^YE%>#4XTS">69#ERH8
M>#R#,:F98?%?O)5:U>I)2:K1E+DY4U]E)Z+:VNJPT%4JSNW[6"@XZ)))):-:
M]#^ G_@D7X+_ ."N'["O[3/AWX/W7[/7B:#]G_Q)XLDT_P 6:]+;3FVBTF.Z
M0+>EC%L".H\P$D 8'(QFO[]$)958C:6525/4$@$@_3I3J*Y>*>)9<4XZGF%7
M+<%E^)5+V>(E@_:+ZW4O?V]?VDI?O+>[>-E8JA1]A%P4Y35[KFM[JM:RMTZA
M1117S!L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_H=<,_\ A[PW^7G^?9A[>/\ S[K?^"I>7^?]75_Z)**_G;_X7!_P<&?]&_\
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M (,M/_\ DFC_ %4K_P#0ZX9_\/>&_P O/\^S#V\?^?=;_P %2\O\_P"KJ_\
M1)17\[?_  N#_@X,_P"C?_V?_P#P9:?_ /)-'_"X/^#@S_HW_P#9_P#_  9:
M?_\ )-'^JE?_ *'7#/\ X>\-_EY_GV8>WC_S[K?^"I>7^?\ 5U?^B2BOYV_^
M%P?\'!G_ $;_ /L__P#@RT__ .2:/^%P?\'!G_1O_P"S_P#^#+3_ /Y)H_U4
MK_\ 0ZX9_P##WAO\O/\ /LP]O'_GW6_\%2\O\_ZNK_T245_.W_PN#_@X,_Z-
M_P#V?_\ P9:?_P#)-'_"X/\ @X,_Z-__ &?_ /P9:?\ _)-'^JE?_H=<,_\
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M^=O_ (7!_P '!G_1O_[/_P#X,M/_ /DFC_A<'_!P9_T;_P#L_P#_ (,M/_\
MDFC_ %4K_P#0ZX9_\/>&_P O/\^S#V\?^?=;_P %2\O\_P"KJ_\ 1)17\[?_
M  N#_@X,_P"C?_V?_P#P9:?_ /)-'_"X/^#@S_HW_P#9_P#_  9:?_\ )-'^
MJE?_ *'7#/\ X>\-_EY_GV8>WC_S[K?^"I>7^?\ 5U?^B2BOYV_^%P?\'!G_
M $;_ /L__P#@RT__ .2:/^%P?\'!G_1O_P"S_P#^#+3_ /Y)H_U4K_\ 0ZX9
M_P##WAO\O/\ /LP]O'_GW6_\%2\O\_ZNK_T245_.W_PN#_@X,_Z-_P#V?_\
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M=7_HDHK^=O\ X7!_P<&?]&__ +/_ /X,M/\ _DFC_A<'_!P9_P!&_P#[/_\
MX,M/_P#DFC_52O\ ]#KAG_P]X;_+S_/LP]O'_GW6_P#!4O+_ #_JZO\ T245
M_.W_ ,+@_P"#@S_HW_\ 9_\ _!EI_P#\DT?\+@_X.#/^C?\ ]G__ ,&6G_\
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M-'_"X/\ @X,_Z-__ &?_ /P9:?\ _)-'^JE?_H=<,_\ A[PW^7G^?9A[>/\
MS[K?^"I>7^?]75_Z)**_G;_X7!_P<&?]&_\ [/\ _P"#+3__ ))H_P"%P?\
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MO'_GW6_\%2\O\_ZNK_T245_.W_PN#_@X,_Z-_P#V?_\ P9:?_P#)-'_"X/\
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MP<&?]&__ +/_ /X,M/\ _DFC_A<'_!P9_P!&_P#[/_\ X,M/_P#DFC_52O\
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MX;_+S_/LP]O'_GW6_P#!4O+_ #_JZO\ T245_.W_ ,+@_P"#@S_HW_\ 9_\
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M_P#9_P#_  9:?_\ )-'^JE?_ *'7#/\ X>\-_EY_GV8>WC_S[K?^"I>7^?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD:*H:IJ=CHVG7NJZE<Q6EAI]K/>7=S,ZI'#!;QM+*[,Q  5%)]^@K^3CQ/\
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MV]@^HVD=R+<QJ!LDC\P!E(&.* /HVBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;/5#I4[RG3Q"'"R7%T(/+6/:2V\K@@U+^UM\7/\ @B7^U;XQ^%/P4/P+\?\
M[+*Z/K=KX:\,?$NST>Z\/1:K>VD\EDNIW=\L4"R6<TD0E5W=D8F(YW!: /\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2>-/B?\ %.;P3>1W6D^'/&=VEYH&R%E,5O);2WLX:(*@!'EXY.!P#0!]P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJIJ%_9:58WFIZE=
MP6.GZ?;3WE]>W4J0VUI:6T;37%Q/,Y"10PQ(TDCL0JJI).!0!;HK^=_XY_\
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MOB'9RWNBMH%ND\20PR/&QN"Z-M^9" <@<BOSO_XBO/\ @G-_T#_B+_X!6_\
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M9=:^+/BG3;+4M?6[M+!U,S:W<!KB)M-FACV1K(N6^3!+BOP5_8MN/B#\0_\
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MU/11=]W_ %_PR^X++LOZ_P"&7W$'V6V_Y]X/^_,?_P 31]EMO^?>#_OS'_\
M$U/11=]W_7_#+[@LNR_K_AE]Q!]EMO\ GW@_[\Q__$T?9;;_ )]X/^_,?_Q-
M3T47?=_U_P ,ON"R[+^O^&7W$'V6V_Y]X/\ OS'_ /$T?9;;_GW@_P"_,?\
M\34]%%WW?]?\,ON"R[+^O^&7W$'V6V_Y]X/^_,?_ ,31]EMO^?>#_OS'_P#$
MU/11=]W_ %_PR^X++LOZ_P"&7W$'V6V_Y]X/^_,?_P 31]EMO^?>#_OS'_\
M$U/11=]W_7_#+[@LNR_K_AE]Q!]EMO\ GW@_[\Q__$T?9;;_ )]X/^_,?_Q-
M3T47?=_U_P ,ON"R[+^O^&7W$'V6V_Y]X/\ OS'_ /$T?9;;_GW@_P"_,?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?]Q)_E$****_)3T HHHH **** "BBB@ HHHH *_&S_@O3_RC:^+/_8P^"?\
MT[M7[)U^-G_!>G_E&U\6?^QA\$_^G=J][A;_ )*3(?\ L;8#_P!2:9E7_@U?
M\$OR/T!_8Z_Y-4_9Y_[)#X%_],%E7TE7S;^QU_R:I^SS_P!DA\"_^F"RKZ2K
MS,?_ +]C?^PO$_\ IZ9</@C_ (8_D@HHHKD*"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKAOB3\0_#/PJ\$^(_'WB^_BT_0?#.EWFJWTTDBQEHK.%YFBBW'#2
MR!-J+SR<XP* .YHK^7^Z_P"#B72?&7[17PS^%/P[^!?CG2_ 7CWQ)<>'=/\
MB+XBTV1='U>XM[H6SO871MXXF5R<IL.,=VZU^G=G_P %/?ASIO[8WAS]C/QM
MX3U_PUXP\3^'1KVC^+[^-K;PU>JT/G1VJ3R1",S2'"*%E&21P3DD _46BFJR
MNJNA#*ZAE8'(96&00>X(((/I3J "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _@?_X.]_\ DN7[*_\
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MFNI_^D,]?Z2U?YM/_!K+_P I+/$G_9-=3_\ 2&>O]):OY1\:/^2R7_8IR_\
M*J>QEG^[?]Q)_E$****_)3T HHHH **** "BBB@ HHHH *_&S_@O3_RC:^+/
M_8P^"?\ T[M7[)U^-G_!>G_E&U\6?^QA\$_^G=J][A;_ )*3(?\ L;8#_P!2
M:9E7_@U?\$OR/T!_8Z_Y-4_9Y_[)#X%_],%E7TE7S;^QU_R:I^SS_P!DA\"_
M^F"RKZ2KS,?_ +]C?^PO$_\ IZ9</@C_ (8_D@HHHKD*"BBB@ HHHH ****
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M1?!$O[+WC_XA_&![R;]H?Q+CQ9_8>I,+#2-%U.:.73U(C<I%(D$Z,P;:<$'
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M 9?'YUBTC\*:5X'\2Z=J%^\JK%9RP7\&GO%*2P*R+)-!E#\W[Q3M*G->C_\
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MF@^'>KZT?"6CI<2YLI;R\G1H8'#!D665U0*F ,XKY/N?VM_@EX[_ &2O!O\
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M44 %%%% !1110 5^-G_!>G_E&U\6?^QA\$_^G=J_9.OQL_X+T_\ *-KXL_\
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M_%_[S6_Q1_\ 3< HHHK[@YPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#^BK_@UE_Y26>)/^R:ZG_Z0SU_I+5_FT_\&LO_ "DL\2?]DUU/
M_P!(9Z_TEJ_E'QH_Y+)?]BG+_P JI[&6?[M_W$G^40HHHK\E/0"BBB@ HHHH
M **** "BBB@ K\;/^"]/_*-KXL_]C#X)_P#3NU?LG7XV?\%Z?^4;7Q9_[&'P
M3_Z=VKWN%O\ DI,A_P"QM@/_ %)IF5?^#5_P2_(_0']CK_DU3]GG_LD/@7_T
MP65?25?-O['7_)JG[//_ &2'P+_Z8+*OI*O,Q_\ OV-_["\3_P"GIEP^"/\
MAC^2"BBBN0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L#Q+X7T+Q?I4^B>(].@
MU72KH%;BRN5WPS*005=>X()!'H36_7+>-?&GAKX>^&-9\8>+M5M-%T#0K"ZU
M'4;^\E6*&&WM(7GD^9N-Q5"%'=B!Q0!X'+^Q5^R_*[R'X/\ A-'D8NYBLA'O
M=N2S!",DGDGUK;\,?LG?L^>#=7@U[PU\,_#^DZM;,K07MM RS1LIRI4EC@@@
M$5^'.I_\'%_PMU']I+P/\!O!/P*^(E]X>\;^*/\ A&M)^+=W;R-X1U*=9[B%
MVTZ=;6*)E4P?-NEDQYB8(S7Z<:9_P4D^$1_:JTG]DSQ-I6K^%O&VM^'CKVDZ
MSJA$.BZ@H@,R6UNSQ+NEEX1 )B=S#Y3TH _1=5"JJJ,*H"@>@ P!^ %+2*RL
MJLI#*P#*P.05(R"#W!!R#2T %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!_ _\ \'>__)<OV5_^P#??
M^E-U7\C]?UP?\'>__)<OV5_^P#??^E-U7\C]?VAX;?\ )#\/_P#8/7_]2JY\
M_B_]YK?XH_\ IN 4445]P<X4444 %%%% !1110 4444 %%%% !1110 4444
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M7):"^TO,DL+KRC_N5 (((!;UY_&+_@TK_8G^"?Q5_9^^-7[2GQL\"^&?B?\
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M -@&^_\ 2FZK^1^OZX/^#O?_ )+E^RO_ -@&^_\ 2FZK^1^O[0\-O^2'X?\
M^P>O_P"I5<^?Q?\ O-;_ !1_]-P"BBBON#G"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /Z*O^#67_ )26>)/^R:ZG_P"D,]?Z2U?YM/\
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M5LT^GD%%%%><6%%%% !1110 4444 %%%% !1110 4444 %-<E59@,E58@>I
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M^$K>+OA9>^)?A=\3A974?C6T@NY(-/TVZ E^TW#PR"*';;AY/WG'3M7XG?\
M!53QI_P0_P#B3^QWX[_:=^$UCX"T;]HWX@QGQ1I&O:'<12^*9_%.I6IDNC>6
MYO+CS)DN5MUC$$,!R2Q5<[!_7?\ M-_L2_L\_M=?"%/@M\</ VF^*_"5OI5O
MI&GO<V]N^I:;:VUJEFGV*[DB=H6,* ':,9R0 2<_B7HG_!J-_P $OM$\1Z9K
M2Z/\0K_3]*O!?6WAO4O$ NM'$XD\T 0/'L6(-@>7Y1X&,T >*_\ !J#\7OVI
M/B?^RAXAA^-AUB]\ Z+J-S!\/-6UBWGMY;BT%Q$B)"LIYC\E005&"!GT-?;7
M_!67]L#Q3XH\6>#/^"=W[,-^NJ?'OXU7.GQ^)9-.6*]AT/P)>LT.KK<W4+.M
MC-):R.TF62557:2H# _L_P#!3X(_#;]GOX>Z#\,/A5X:L/"_A'P]:I;6-A8V
M\4((153S)C$B>9(P49)&,C(&22?GGX4?\$_OV??A)\=_%7[1^BZ-?ZM\5O%4
MMR\_B+7KE;^XTV*Z\P26VENZ>9:VX61E2-'"@<8QQ0!_'U\3OV;/B;HW[67A
M#_@F[\/OVE;K]E_P)X8TH^*_$?BU]1_LA/$VOS61OK^W;4I)87N UUN4(9&!
MR,>E?J)_P;@?M#?'/QEJ7[7G[/GQ<^*5]\:--^!7Q3OO"_A+QY=7#7D5UIEE
M-/%&L%WYDBR(X4$$,<X]J_1[_@H?_P $;?V?/^"@OB7PWX^\6:QXE\">/_#4
MP>'Q)X1O'TZ]O8N T5U/ \<K@H"N"2"">1W]O_X)X_\ !-/X"?\ !-_P'XD\
M&?!=-3O+GQGJHUSQ7KVMRBXU+5=4.\R323$M(P9G8DNVYNX&<  _1.BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "OEW]L;X47OQK^ 7CGX=:;!8R:EXATRXL[&>_:-(;*XE@DC
MCNU>3A'B9@0P((['N/J*O&_CQX \0_$SX<ZUX2\+ZY)X>UC48F2VU2*1HGMV
M,;J&#I\PP6!X]* /YF_V<OV'_P#@IW^S7X:O?!.A_'ZPUKPTNI7]UHUC-XB1
MH],M[J7>L$8:X.T1J$4!0 -O K[S_9\^&?\ P43TGXG:/??$WXDZ?JGA!)H3
M>V<>LI.TB!OG C$K;B1GM7!'_@E;^U<9[N4_M+:OMFEGDB4:U>X3S"60=>BD
MX^F:^+OAW\./VO?V/OV^? /P]^/OQMU#QA\-?&<5OJ&B7J:O/)9P@RE4L9XG
M9<R[E,9!7DCC(P: /ZWX0PAB#G+B- YZY8*-QS[G)J2H+9TDMK=T;>CP1.C]
M=R-&I5O^! @_C4] !02 "2< <DGH!ZFBOSX_X*9?MD^%?V)?V6O&OQ0\2ZC_
M &/<:O8:CX3\-:S)N^S:1XEU?3Y[?2=1N]BEA;VEU)%.Y!&-@SD9% '\R'_!
MT%^UI\2_C;\*_B+^S'^SLNHW7AGX,ZKI=W^T1J-M)-;VT%LUTKP0P74#J'VL
M%C(#$$$GC.:_3KX-?&R[_9O_ .""7@KQOX3N9(=;NO@7=:-X:O99W,UEJ.I:
M/+96UZDLCEVEMY)#*A+9W+D'.*_%/]J#]H;]CVS_ ."-?QFDUK]I[X8?$G]M
M#XRR6>I^.'T*ZSKFLI=:K)<6NGM$(1YD=C8A!).]R7\T^7]G 'F'ZTU+XG?"
M[XW_ /!OG\,_"'PH^(VD>)/$O@3P1I\7B_3-,D9KO1;RS\PWEI>J!M3R@J@D
ML<DL"%VJ6 //O@E_P2I^"OQ;_P"".7BG]I?Q[HQU?]L;Q8FN^/+?XYS:A?\
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M'PCX\\0>/?!\/B[PMXI\%VL%M8V"WL0FMK"X:"*-3)'N1'!!/7D=: /Z7:*
M<C(Z'D44 %%%% !1110 4444 %%%% !1110 4444 %%%% '\#_\ P=[_ /)<
MOV5_^P#??^E-U7\C]?UP?\'>_P#R7+]E?_L WW_I3=5_(_7]H>&W_)#\/_\
M8/7_ /4JN?/XO_>:W^*/_IN 4445]P<X4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!_15_P:R_\I+/$G_9-=3_ /2&>O\ 26K_ #:?^#67
M_E)9XD_[)KJ?_I#/7^DM7\H^-'_)9+_L4Y?^54]C+/\ =O\ N)/\HA1117Y*
M>@%%%% !1110 4444 %%%% %>[M8+ZVGL[J-9K:YB>&>)ONR12*5=&]F4D&O
M\U;_ (.,?V 3^RY^U-)\<?"]MJLOA;XP7$]Z8HI[V73]/D,LA9"GF&W1BX(
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MH%_T%?"'_@IA_P#B:/\ A_?_ ,% O^@KX0_\%,/_ ,33_P")-_%C_H)X4_\
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M_!0+_H*^$/\ P4P__$T?\2;^+'_03PI_X>*W_P PA_Q-5X:?\^.(O_"#"_\
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M2^!^F6^G_">;QKI.L?%+Q*+IH;JZT")H/MVDL@D7?"Z"4%=I#;OF!XQ^V]%
M'X8_\%%_^"=?BSQ%^SA\*M5_90T"RO?C)^RWIFE7OPI\#2;+?2?$>K6)A-S%
M=R QKNN94+MG&06.>N?EK]B[]D_]OW]I7]MG0_VR_P!O_P"&FB?!>]^'O@R#
MPEX=\'^'KA)K;5I+&$0P7\P21QNE*J[$],GTY_ISHH  ,# Z#@4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '\#_ /P=[_\ )<OV5_\ L WW_I3=
M5_(_7]<'_!WO_P ER_97_P"P#??^E-U7\C]?VAX;?\D/P_\ ]@]?_P!2JY\_
MB_\ >:W^*/\ Z;@%%%%?<'.%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?T5?\&LO_ "DL\2?]DUU/_P!(9Z_TEJ_S:?\ @UE_Y26>)/\
MLFNI_P#I#/7^DM7\H^-'_)9+_L4Y?^54]C+/]V_[B3_*(4445^2GH!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?*/[<_\
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MP?\ !WO_ ,ER_97_ .P#??\ I3=5_(_7]H>&W_)#\/\ _8/7_P#4JN?/XO\
MWFM_BC_Z;@%%%%?<'.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 ?T5?\ !K+_ ,I+/$G_ &374_\ TAGK_26K_-I_X-9?^4EGB3_LFNI_
M^D,]?Z2U?RCXT?\ )9+_ +%.7_E5/8RS_=O^XD_RB%%%%?DIZ 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RC^W/\ \FA?
MM"?]DUUS_P!!BK_,UTW_ %$O_7U<_P#HUJ_TROVY_P#DT+]H3_LFNN?^@Q5_
MF:Z;_J)?^OJY_P#1K5_H]]"+_DD^.?\ LH,M_P#5<S^"?I@?\E%P?_V)<=_Z
MG(T****_MH_CT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M K3_ .MT[_L*Z=_Z51U_IR_LB?\ )L7P,_[)OX;_ /2)*_S&I_\ 6Z=_V%=.
M_P#2J.O].7]D3_DV+X&?]DW\-_\ I$E?P[]-W_DG> _^QUF__J#AC^R?H??\
MCGC+_L69;_ZE53Z,HHHK_.D_N\**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ .<''7''UK^;_P",?[5G_!?O0?BEXZT;X4?L
M/_"CQ-\-]-\17]KX,\07^M&.]U?08G LKZYC%^FR69,LR[5QZ"OZ0*^6OVP_
MVG?#O[)?P2\2_%G7[634'L(9;31=,AQYNHZW-!*;"T1<?-YDRH"HY(S[T ?@
MY_PV!_P<>_\ 1@7P;_\ "@'_ ,LJ^@OV9/VFO^"Y7B[XL:#HO[1/[&OPO\!_
M#&YE4:WXBT?6A<7UG'O4,T4?V^3)V;C]T\CI7YE?%#_@HO\ \%>-+U;X*>)+
M:/1?!7A3]I+Q'/I?@G1]5TJ'[3X?LGN-EE=7C-; [)8F5@6.#GTZ?1_PF_;&
M_P""I/PV_;B\"_L]?M.ZWX>3X;>*K.TOXO&\>GV\&GW/GA'%G%<?9XT,CJP5
M0'))/6@#^JB$R-%$TJA96C0R*.BR%074>P;('TJ2HK=M\$+[Q)OBC;S%^[)N
M13O7'&'SN'L:EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#^!_P#X.]_^2Y?LK_\ 8!OO_2FZK^1^
MOZX/^#O?_DN7[*__ & ;[_TINJ_D?K^T/#;_ )(?A_\ [!Z__J57/G\7_O-;
M_%'_ --P"BBBON#G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /Z*O^#67_E)9XD_[)KJ?_I#/7^DM7^;3_P &LO\ RDL\2?\ 9-=3_P#2
M&>O]):OY1\:/^2R7_8IR_P#*J>QEG^[?]Q)_E$^)/VK_ /@H'^S?^QN^EV7Q
M?\37J:]K 22P\,>';(:SXBFMY!E;H:7%,ES]GV_,90A7'.:P/V4?^"DG[,O[
M8OB+Q#X3^$^N:W!XB\-QK+?:3XKTAM O)$(#$VD5S,SS[5.YMH& #WXJ3Q=^
MPE\$O$W[5L/[:/Q,AMM?\5^%_!5SX9M--\0107WA73M'M[)XFU";3[Q)+3[1
M;PJ93(T3#*?,IZ'\F_"+>'OVG?\ @J7%K_[,/AW3_"WP\^!\SV/Q%\5>%;"+
M2= \8L[BVN8U%G%#;7#!B5 4* 2,*!P/R4] _3O]K'_@JM^QW^QGXI\)^#OC
M+X\GM]<\8ZU;>']+M_#]G'K2Q:I=2+'%;7SP7*BV;<PW;LE>1C(K] /"OB72
MO&/AW1O%.AS-<:1KVGVVIZ?,R[&DM;N)9H69<G:Q1@2,G!XS7\S7_!:C]C;X
M&?"OX4^#_BKH^@2ZIXU\1?';1[^?4-?D75!!+>74<TJV?GH3:I&7 0(3QR,8
M K^A7]F['_"COAH  H'A32 % PJC[%#@*.@ Z #H* ,W]I#]IKX2_LJ?#R[^
M)GQ?UUM&\.6L@A46T2W5_=SD9$-G:>9&\\IX 13DD@ &OA'X'?\ !:O]B7X]
M?$3PY\,/#.O^,M \3^*[DVFA)XS\+S^';.^F$OD[8KF[GVL"Y !4-G(K\V/^
M"N'[0MGH_P"W-\+O@]X[\&ZG\2_!&D^'M-\9:+X"TU'G_MGQ$EO!<16]Q:@,
MDR2R_*592""1@YK"TW]JOX,_'3X]?!WPE^U/^P1J_P"SV)=3A7X;^/M*\/IX
M>@T>X@NT*OJ-U%!;@K)(,_,V2.N<&@#]TOVG_P#@H1^SG^R5>II?Q4UO6&U5
M]-76!IGAO2FUN]7364/]K:"WE5Q"%(8O@KCOP:]&^'G[7?P1^)7P$M_VDM"\
M2FV^%T]K+='5=6B6PN(%A*AHKBVEE_=3$N J,X).0#D&ORV_;6_91^*<?QYC
M_::^$VFZ5\2?#_B3X6Q?#"T\+ZI:Q:M;:<ES8) FO-'/&\>P+F43X&0,D@Y
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MC7X2MYO'E]\'++4KD^!+>.WU2-1H?G+>&-5>WD)*^7Y6S;^\W'97ZD_LA?\
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M;J01!XEM;;9>#()Y=XG8\]>>I-?GG^R:FW_@AK:+Y<:L/AUX@;RP!L$VY&(
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MVLO"MU^P%X \=:E\6)/AAY4L.JVOAW2 VIR6$MQ+"D($5O!+E3, QPJ[F(!
M/KO_ (*4_MY>.=:_9D^!'P=^">M7GA;]HO\ :X@T&/PE?:$[&^T%3)!)J,H$
M3AXRQ8C(8<# XXK]DOV2OAKXZ^%'P#^'/@_XE^,=2\<^.;'PUI+>)M?U5WDN
MKC6)+*)[Y6=V9B$G9UY.001SC-?R:_#CXZ?#KPS\8_C+^WKXST&[^(7PP_9Z
M,>B?L>?"NT7S=5\77EF/LDQ\/1R))NE:XC!C,,<J[\;E89!_:O\ 8!_X+(>'
M_P!L7XGW?P6^)/P+\;?LT_%$Z2==T3PI\06>*]UO22IDBN[1);:V=DF093"D
M9(YQS0!^V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_ __ ,'>
M_P#R7+]E?_L WW_I3=5_(_7]<'_!WO\ \ER_97_[ -]_Z4W5?R/U_:'AM_R0
M_#__ &#U_P#U*KGS^+_WFM_BC_Z;@%%%%?<'.%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?T5?\&LO_*2SQ)_V374_P#TAGK_ $EJ_P V
MG_@UE_Y26>)/^R:ZG_Z0SU_I+5_*/C1_R62_[%.7_E5/8RS_ ';_ +B3_*)_
M,M_P6<_X*>0?#CQ]X>_8H\+Z!\4+/4O&K0R>-/''A'0+^[M;#PY.GEW\$=Y;
M1LJMY,CC ;)/)'0#Z#_X)U_M=_L'_#=_ W[,OP,T#XC1^-/%")_:7B;7?!][
M VNZM.ZR75QJVL3E2 )R=JM'A<9+,2"/VVU7X>> ->U :MKG@;P=K.JA=@U/
M5?#.BZCJ 0]4%[>64UR%_P!GS,>U,T_X<?#S2;V'4M+\!^#--U&W.8+_ $_P
MOH=G>P'UANK:QCGC/NDBFOR4] _&#_@O9I>N:K^S5\+H-"T+5M>N4^,OAZ26
MVTBSEO9XH1);[II(XE9EB7^)R,#N17TIX\_;4\#_ +%7P+_9_P#^%A^&/%FK
M3^-=$\/Z?:6V@:5<7TUE+<6UO%F]2*-C#L<X;=C !]#7Z7:EI&DZQ$EOJ^F:
M=JL$<@ECAU*RMKZ))5Z2)'<Q2HL@[.JAAV-4-5\*>%M=CMH=;\-:!K,-EM^Q
MQ:KHVG:C':;/N_9DN[:98-N!M\H)C'&* /YVO^"B7@C6_ W[0GP-_P""F'AG
MP;J'COP=8Z+X?L=>\-'3WO-1TC1I+6!QJ"6.QB+J. %BI3(9<8]/%_VM?V\_
M#7_!3+Q1\'/V;?V6?A_XZDUS6/$<5UXA\:^)_"MSHX\)1V]W"9([:]D3</EC
M9BZRQJV[.Q>37]3-WHNC7^G_ -DWVDZ9>:4$6,:9=V%K<:>(T&U(_L4T3VVQ
M1PJ>7M4<  5A:/\ #WP!X=NA?>'_  /X/T.^7)%YH_AG1=,N@3U(N+*R@F&>
M^'Y[T ?FS^V!\;O&_P"RO^S)\._A-X.TO6O$OQ/\::#IGPQT_5["SFO6TJ]O
M=-33)M;FD3<%>&25W$C$[2-X(;!'Y/\ [07[/?B']DB/]FFS\7W'BO4O#/CV
MUUB__:7\0>';2YO=2UV]GCDDMX[XPAW_ -'D.U <XP,5_5)?:-H^J/!+J>DZ
M;J,EJXEMI+ZQM;M[>13E9('N(I&A<'D/&58'D&F:IH.AZY&L6MZ-I6L1)G9%
MJFG6>H1KGKM2[AF5<]\ 9H _%/\ X(UZGKFL>%OBC=:+>>++KX40^,M1@\'I
MXNMKFTOH+3=(;:.**Y ?R@JX!  K]#OVX?!OB'QW^S'\4/#OA>V-YJ\^B37$
M%LH+/+':QRRRJBCEG*CY5')-?3^DZ'HF@6QL]"T?2M%M"V\VNDZ?::;;%_[Y
M@LX88BW^T5S[UI.B2(T<B*\;J4='4,CHP(965@596!(*D$$$@C% '\KG[,WQ
MW\/?$G_@EG^VY\"- \)^.;/XC^ OAE\0[+5],U70[NW&HW4FFR6T2:1OC4W+
M-*C!5C#;]P(Z#/VM_P $0O!&MZ]_P1P^#/@/7M)U3PUJ^K^#O&^C2:=JUK)8
M:A:2WFIZ@D/VBWE"R1[W=3\P!*'TK]J+'P3X,TP7ZZ;X1\,:>-55EU06.@:5
M:#4E?[ZWX@M(Q>*^3N%QY@;/(-;&FZ7IFC6<6G:/IUAI6GP9$%CIMG;V-G"&
M.6$5M:QQ01[B23L09/)YH _BI_9:;]FW]@W7/CA\"_V[/ 'C^R^(^H_$?6_%
MWAK4?"&A7U[IE]X9GN9I;:5KF"-T>>2)TRNXGGOW^QK-/%4W[!?[7'Q1_8&^
M%6H?##Q=XDUNRU'PUXE&FRV/BGQ+HMK*)=0N[J I'/)<) 'D0'+%N@K^FCQ#
M\,_ASXMO(]1\4^ _!_B+4(@H2_UKPWI&I7JJHPJ?:KNTEG,8  \LR%,#&VN@
ML/#V@:5IYTG2]#T?3=+9#&VFV&F65GI[(PVLAL[>".V*,."ICP1P1B@#^)^Y
M^//['WC3]BWQAX8U'PY\6?BI^U+_ ,(9%:>++CQ!X>U+?9>,S O]I_8U:+YX
MX[S>$()RH&.QKZX_:J^$?Q*^)?\ P;G^%O!7A3PMJUQXOL[?PEKTWAU[*7^U
M8]-T;Q+J=]=Q_8\>;YL=J4*H5R>..:_IML/@?\'-+U*\U?3_ (7> K34M0+&
M]NX?"VC+)<LV2S2K]D,;,Q)+-LW$]2:] &BZ.-.&D#2=,&DB,Q#2Q86HTX1'
M.8Q9>5]F\LY.4\K:<GCF@#^2#]K/X[Z'^TA^P1^P+:_"_P '^/+F^^'WBKX<
M^%_$^FW_ (?NX;S3M3T#P_X=TC4WDC9"YMA?Z?<E9&10J #G&:^V?^"QFF>(
MM1_88^#5MI'A[6-9ODUCP29K'3;"2ZNH HL][201HS((^=QP-N,'TK][K?P)
MX(M+9+.U\&^%;:SBF^T16MOX>TB&VCN"<F=(([-8DFSSYJJ'SSNS6O?:+HVJ
M6Z6>I:3IFHVD14QVM]86MW;QE,;"D%Q%)$A7 VE5!7 QB@#^=/\ X*PZ;XDN
M?V3_ /@GVFE>&M;UBZL_%/P_;4+/3[":ZN+!%\,^%4D:\BC5F@6-@ZN6 VLC
M ]#CY7_;1^!UI^SQ^TE^S[^TA\6/!>O>*OV:]:\/:<_Q'U31-/N-0\0>'KZ2
MSA9(+:")'EC4%L,%  [^M?UI7NA:)J4%M;:CH^E7]M9,K6=O>Z?:74%HR *C
M6T4\,D<#(JJJF)4*A0!@ 5'K'ASP]XAL/[*U_0=&UO2\ ?V;J^EV6I6& -H'
MV.\@FM\!> /+X' XH _FV_9B^)'[%W[1/[4W@72?V>/@[XIUI_#4\7B63Q!X
MWT.ZLH]'S 9WEMKBZA4>?$2V%# Y &*Z_P#X)UZ7XEL_^"EW[:UWJ/A[6K#3
M+KQ,PL]3O;"6"RO$2251]DN74+*@  &QB,=J_H!\.?#OP!X/E:?PIX)\*>&Y
MW#![C0_#^E:7<,K<%6GL[6&8H1QL+[0.  *WK70]%LKNXO[+1]+M+Z[;==7M
MKI]I;W=RW7=<7,4*33-GO([&@#\4?A/I^NI_P6M^.^H3Z'JD6BR?!?3(K?6Y
M+)UTRXF%I99@BO"H1Y%P04#$Y!]Z_/S_ ()9^/1^R?\ \%*_^"AOPJ^,?A7Q
M?I?B#]H;XTCQ1\--6M-#NI] U#1%O+]F>XOL"*-CYL3!]QP 1M^;(_JU32=*
MCOY-5CTS3X]4FC$4VI)96RW\L0X$<EXL8N'C   1I"HQTK,E\'^$I]5379_"
MWAR;6X_]7K$NB:9)JL?^YJ#VINT_X#,* /G/]N5@W[('[0;#HWPTUMA]"L1'
MZ&O\S;3?]1+_ -?5S_Z-:O\ 3*_;FX_9"_:$ Z?\*UUS_P!!BK_,UTW_ %$O
M_7U<_P#HUJ_T>^A%_P DGQS_ -E!EO\ ZKF?P3],#_DHN#_^Q+CO_4Y&A111
M7]M'\>A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %:?_6Z
M=_V%=._]*HZ_TY?V1/\ DV+X&?\ 9-_#?_I$E?YC4_\ K=._["NG?^E4=?Z<
MO[(G_)L7P,_[)OX;_P#2)*_AWZ;O_).\!_\ 8ZS?_P!0<,?V3]#[_D<\9?\
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M:_\ VA/!_P -YF?6YYX3X;DDTY)"B$)Y=^BO\MR"78MGY=N&^Q/^"G_CB_\
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M5_G2?W>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>CE1N'X'-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!_ _\ \'>__)<OV5_^P#??^E-U7\C]?UP?
M\'>__)<OV5_^P#??^E-U7\C]?VAX;?\ )#\/_P#8/7_]2JY\_B_]YK?XH_\
MIN 4445]P<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
M15_P:R_\I+/$G_9-=3_](9Z_TEJ_S:?^#67_ )26>)/^R:ZG_P"D,]?Z2U?R
MCXT?\EDO^Q3E_P"54]C+/]V_[B3_ "B%%%%?DIZ 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'RC^W/_P FA?M"?]DUUS_T
M&*O\S73?]1+_ -?5S_Z-:O\ 3*_;G_Y-"_:$_P"R:ZY_Z#%7^9KIO^HE_P"O
MJY_]&M7^CWT(O^23XY_[*#+?_5<S^"?I@?\ )1<'_P#8EQW_ *G(T****_MH
M_CT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K3_ZW3O\
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M_@;^SO\  2&T\;>(?!ME9ZUXR\9:/ UQ;^'H["1IKG3VU*-&3*)&=ZAP-P8
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MQ3E_Y53V,L_W;_N)/\HA1117Y*>@%%%% !1110 4444 %%%% !1110 4444
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M[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[%F6_P#J55/HRBBBO\Z3^[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-_\ U!PQ_9/T/O\ D<\9?]BS+?\ U*JGT91117^=)_=X4444 %%%% !1110
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MB&WL]/MX[:!-EN=BD)&-W'WB: .LHHHH **** "BBB@ HHHH **** "BBB@
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M%%% !1110!_ _P#\'>__ "7+]E?_ + -]_Z4W5?R/U_7!_P=[_\ )<OV5_\
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M=-_U$O\ U]7/_HUJ_P!'OH1?\DGQS_V4&6_^JYG\$_3 _P"2BX/_ .Q+CO\
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M@/\ ['6;_P#J#AC^R?H??\CGC+_L69;_ .I54^C****_SI/[O"BBB@ HHHH
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M8_\ OM?\:/.B_P">L?\ WVO^-%GV?]?\.OO DHJ/SHO^>L?_ 'VO^-'G1?\
M/6/_ +[7_&BS[/\ K_AU]X$E%1^=%_SUC_[[7_&CSHO^>L?_ 'VO^-%GV?\
M7_#K[P)**C\Z+_GK'_WVO^-'G1?\]8_^^U_QHL^S_K_AU]X$4_\ K=._["NG
M?^E4=?Z<O[(G_)L7P,_[)OX;_P#2)*_S%IY8O-T_]['QJNG$_.O3[5'SUK_3
MI_9#(/[,/P+(.0?AOX:((Z$?8DYK^'/IO)_ZN\!Z?\SK-_\ U!PQ_9/T/O\
MD<\9?]BS+?\ U*JGT91117^=)_=X4444 %%%% !1110 4444 %%%% !1110
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M_P#GMH?YP_X4>5\8_P#GMH?YP_X5[%11_:'_ % Y=_X2K_Y/R_/NPY/[\_\
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M>#,/B<+PGG=;(,-C:T,1BZ.70ITH8BO3@J=.K54XU&YQ@N1--:-W3>I\MG_
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M_P")A?&3_HN\XZ?:H]+?].O[J_$/^(-^%G_1"9!_X3U?_EY_.%_Q#G_LY_\
M0SZ[_P"!$O\ \71_Q#G_ +.?_0SZ[_X$2_\ Q=?T>T4?\3"^,G_1=YQT^U1Z
M6_Z=?W5^(?\ $&_"S_HA,@_\)ZO_ ,O/YPO^(<_]G/\ Z&?7?_ B7_XNC_B'
M/_9S_P"AGUW_ ,")?_BZ_H]HH_XF%\9/^B[SCI]JCTM_TZ_NK\0_X@WX6?\
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M^</^%>Q44?VA_P!0.7?^$J_^3\OS[L.3^_/_ ,"]/+R_%]SQWROC'_SVT/\
M.'_"CROC'_SVT/\ .'_"O8J*/[0_Z@<N_P#"5?\ R?E^?=AR?WY_^!>GEY?B
M^YX[Y7QC_P">VA_G#_A1Y7QC_P">VA_G#_A7L5%']H?]0.7?^$J_^3\OS[L.
M3^_/_P "]/+R_%]SQWROC'_SVT/\X?\ "G1Q?&'S(_,ET0Q;AYF##NVYYQTY
MQ7L%%']H?]0.7;6_W5?_ ">_Z^K#D_OS_P# O3R\OQ?<K6?VK[-%]MV?:=@\
MWR\;-^.=N.V>E6:**\]N[;T5W>RV7IY%A1112 **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBOC#]O+X2_'WXQ_L\>-/"_[-?Q2O?A-\6!IEW=>
M&/$-D'\R74(XU:WM"8R"HE*LH.X9+ #F@#[/HK^=/_@BG_P4Y\9?&72_B]^R
M/^U_JR:1^TW^RK?W^C^+=>\0S?V?/XXTK3I9_M&N6ZWCHUR84B,S/&&9HV8$
ML54#P>P_:8_:[_X*>?\ !234/!G[)_Q@UKX1_L>?LZ:CO\4>-]/MKD6?Q*UG
M2IXXM0\.AH2T<B2SHT9PS!5?+' +4 ?U245Y5\6?'^E_"/X3>+?&WB+5(K2'
MPQX4U*Z^WW#!%GU*TTFX>U7+$?O+J[A4*.I9N]?QX_\ !)G_ (*;?MK^(OVR
MOB)XQ_;&\9:K#\!?C)XXU3X?_ WPAK"RVMA9W$&IO'8:AIKS%8Y%F@6$8CW,
MSF3G:P% ']L=%?+G[9'[5GP__8Q^ 7C3X\?$:YCBT?PQ:,EA:.^QM6UNXAF;
M3-+0[E;==S1>7\AW<X&"<C^:;X,?"7_@KA_P5EE\1_M6V/[6/BS]AOX5^([O
M['\./A?I%OJ,ZW6C6K,;;5PD;%MMY;2QN9&ZE1EBS<@']?E%?RX_LE_M4?M@
M_P#!/7]LKPW^P!^VWXO\3?M%:)\7VEU_P!^T%<6&H31Z? OVB*'3;F4_)$LS
MA T<V-I'W58#&)_P<<_M0?M9_!_Q-^Q?\,?V6OC3J'P7N/CGX\A\-Z]XBL/,
M$@L[RZ^RI(?+92!&)4D(.?N8["@#^JFBOY7[?_@D)_P5E;PU%XDT_P#X*[^/
M]3U8Z(NMV.C_ &+4_LM_J'V$7UKIIGR(A#=7'EVK2_<"2%\E>:^C?^"3'_!1
MOXO_ !3\7?%S]AC]K6P;1/VH_@!INK-?ZS>.\4WBO2;50EIJZB9OWC.@>[+!
M2V&Y8J%  /Z$Z*_EY_X(8?MB_M._M&?M4?MZ>"OCC\2KWQIX7^&GQ3U71? F
MEW(?9H>EPW=PD5M%O)&U450-N!@"OU _X++_ !D^)WP#_P""=G[07Q4^#OB6
M;PC\0O"^@0W6@:_;[O-L+AI&#2)M(.2!C@T ?J-17\4G[5/[?_[:7AO_ ((1
M_LV_'OPC\9M1T/X]?$7Q'X<T/6_B''YOVN1-2O8(9I3@[L['8<D]?R^B_@Q_
MP2L_X*M_%KX5> /B7<_\%>_'^FS^./"VD>)7T^UL=3GALCJMI%=?9EDC.QC%
MYFT@$X(P3D$  _K0HK^37_@G#^V/^U]^R=_P43\1?\$P/VU?B9?_ !]U7QA%
M<>)?AY\5M3:47$5C!'(8;1!(^62<+C:<KEP<$J"/V7_X*=?\%'/"G_!/#X0:
M?XK?04\<_%#QI?C1OAE\//.DAE\5:PTD<0ME:&2.<#?*B@QD<D\\8H _3.BO
MY&O@_P#L#_\ !9S]L3POJ/[1WCO_ (*!^,OV8;SXH:A=^*?#7P7TZVU&:V\(
MZ/J"F6QTIS$2(DAPBC(Y5F(&!7H7[$7_  4M_:-_8_\ VI_#_P#P3,_X*(/=
M^*O%>MZI-8?"G]H;46GC;XBR7$Z106[O-((Y/F(()#,N2%(!.0#^J.B@$$9!
MR#R".A'K7F/QC^,'@#X"_#GQ-\5_BAK<?AWP-X1LQ?Z]K,J&2.RM3(L0D9 5
M+#>ZC&1UH ].HKQ[X&_'CX8_M&^ -*^)WPC\11>)_!FM1+-IVK0QF-)XWR58
M(68C(4]37L- !17\_/\ P<8_M/\ Q]_93_8W\ ^/?V=_'=U\/_&.I_&WPAX>
MO]7M-_F3Z+?3*MW9G80=LH.#DX]0:_"K_@M-_P %&O\ @H#\&/!_["D/[/OQ
MGU_PYXF^*6C:#/XH320[3:_?76GQ.[W2Y+-;/.^Z<)^](/R,#0!_>W17QE^P
M-\<9?CS^R_\ "_Q9K&K_ -L>-+/POI.F^/;ES^]'BB&U'V]I@3E'D=6=E;D$
M$GK7\AG_  5]_P""KG[<=E_P5#TS]F;]D[XAZEX/^'_P>UW2$^*1T_?]DOK6
MXU6UCGCFEC;;(AM#,NU2&$A0DE P(!_>!17\RG_!<O\ ; _:2_9V_P""<7[,
MGQ;^!GQ'O/!?Q!\8_$+X;:9XC\0VV_S=2T[5K*WDU*!]K XN)&9CDGDU^[_[
M)/BOQ%XX_9S^$OBOQ9J#ZIXBUSP;HNH:MJ#YWW5Y<6,$DTS9YR\C,QSZT ?1
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45^4'_!5_P#X*46/_!/GX(2ZOX/\.)\1?CMXNN[+0_AK\-X_,-SJMWJIN;1=
M3"Q.LCQZ=<+#(8]K(^2'! VL ?J_17\D/PG_ .":_P#P6=_:'^'-G\<?'/\
MP4G\:?!#Q7\1K>3Q?8?":TMM2EM/"]GK%M'J.E:1)+&2D019U@(8@HJAF"J0
M3]R?\$G?^"@'QN\9>.O'W[$'[7?AO6K7XS_!"]D\.Z)\2[RPO5@^*]C9SM$=
M:DN)3Y/F2(K3>8,LP(0D@+M /WZHK$U'Q-X;T>86^K^(-$TN=E#+!J.JV%C,
MRGHPBN;B)RI[$+@]C6I;75K>P1W-G<P7=M*-T5Q;31SP2+_>CEB9XW'NK$4
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MM")\=_B%=^.%\+>)]3L_#XN=_P#H%K%JX@CB7<QX6+Y*_I"H **** "BBB@
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MZEJ7AGPSXGMY+B;X=>&=:>Z5;>RM[P-]EE,,B!%4*HY.TD9'R#^R;\2/%_\
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MPW5O"?Q'\+P>"M5U.WN/$.D1&.YEL[E#&A$C(B;QN5V<-UW9^+O"/@+X]_\
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M_P F%?#3_LX7P+_Z/2OR_P#VJ_".@^/OVRO^".O@_P 3VT=[HNK^'+%)K65
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M\9OVP/V@OC?\7?AIX6T;Q%JOP]^'?AGX9>(KG1M+A&D7#6UM>3V\,\$7[N.
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MQA\1/$.NS6&G_$SQ/'<7%]XMM_"-S/$FMZFMZ-]PK6]J7D$F[Y2 3ZU^<O\
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MK'X9>.?A-!J\\D*^$OB%:FS\16OEY^>>$V]J55NV8EK\R_\ @XK_ .4>^O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN].\)Z'I^A6=S=*GEK<3V^G001RS!/D$CJ6"D@'!--\=?"OX:_$^VM[+XC>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIF\>A_3_ !HWCT/Z?XT
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EC0 ^BF;QZ']/\:-X]#^G^- #Z*9O'H?T_P :-X]#^G^- '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img12876764_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_12.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,)!ND# 2(  A$! Q$!_\0
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M#]L/^%A^$/\ H,VW_?0_QH_X6'X0_P"@S;?]]#_&OQ/_ .$KUS_G^G_[^/\
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MY_S_ $__ '\?_&@#]L/^%A^$/^@S;?\ ?0_QH_X6'X0_Z#-M_P!]#_&OQ/\
M^$KUS_G^G_[^/_C1_P )7KG_ #_3_P#?Q_\ &@#]L/\ A8?A#_H,VW_?0_QH
M_P"%A^$/^@S;?]]#_&OQ/_X2O7/^?Z?_ +^/_C1_PE>N?\_T_P#W\?\ QH _
M;#_A8?A#_H,VW_?0_P :/^%A^$/^@S;?]]#_ !K\3_\ A*]<_P"?Z?\ [^/_
M (T?\)7KG_/]/_W\?_&@#]L/^%A^$/\ H,VW_?0_QH_X6'X0_P"@S;?]]#_&
MOQ/_ .$KUS_G^G_[^/\ XT?\)7KG_/\ 3_\ ?Q_\: /VP_X6'X0_Z#-M_P!]
M#_&C_A8?A#_H,VW_ 'T/\:_$_P#X2O7/^?Z?_OX_^-'_  E>N?\ /]/_ -_'
M_P : /VP_P"%A^$/^@S;?]]#_&C_ (6'X0_Z#-M_WT/\:_$__A*]<_Y_I_\
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M4\S:;3IK3S?E_P '[O,_UMO^&X/V8O\ HJ>@?^!,7_QVC_AN#]F+_HJ>@?\
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M,7_14] _\"8O_CM?Y)/_  T1\7O^ATUW_P #)?\ XJC_ (:(^+W_ $.FN_\
M@9+_ /%4?\0+H_\ 0XJ]/^74?+S]?Q[JQ_:G_3N/WR_R]?Z>G^MM_P -P?LQ
M?]%3T#_P)B_^.T?\-P?LQ?\ 14] _P# F+_X[7^23_PT1\7O^ATUW_P,E_\
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M ([7^23_ ,-$?%[_ *'37?\ P,E_^*H_X:(^+W_0Z:[_ .!DO_Q5'_$"Z/\
MT.*O3_EU'R\_7\>ZL?VI_P!.X_?+_+U_IZ?ZVW_#<'[,7_14] _\"8O_ ([1
M_P -P?LQ?]%3T#_P)B_^.U_DD_\ #1'Q>_Z'37?_  ,E_P#BJ/\ AHCXO?\
M0Z:[_P"!DO\ \51_Q NC_P!#BKT_Y=1\O/U_'NK']J?].X_?+_+U_IZ?ZVW_
M  W!^S%_T5/0/_ F+_X[1_PW!^S%_P!%3T#_ ,"8O_CM?Y)/_#1'Q>_Z'37?
M_ R7_P"*H_X:(^+W_0Z:[_X&2_\ Q5'_ ! NC_T.*O3_ )=1\O/U_'NK']J?
M].X_?+_+U_IZ?ZVW_#<'[,7_ $5/0/\ P)B_^.T?\-P?LQ?]%3T#_P "8O\
MX[7^23_PT1\7O^ATUW_P,E_^*H_X:(^+W_0Z:[_X&2__ !5'_$"Z/_0XJ]/^
M74?+S]?Q[JQ_:G_3N/WR_P O7^GI_K;?\-P?LQ?]%3T#_P "8O\ X[1_PW!^
MS%_T5/0/_ F+_P".U_DD_P##1'Q>_P"ATUW_ ,#)?_BJ/^&B/B]_T.FN_P#@
M9+_\51_Q NC_ -#BKT_Y=1\O/U_'NK']J?\ 3N/WR_R]?Z>G^MM_PW!^S%_T
M5/0/_ F+_P".T?\ #<'[,7_14] _\"8O_CM?Y)/_  T1\7O^ATUW_P #)?\
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M1_Q NC_T.*O3_EU'R\_7\>ZL?VI_T[C]\O\ +U_IZ?ZVW_#<'[,7_14] _\
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M0/\ P)B_^.U_DD_\-$?%[_H=-=_\#)?_ (JC_AHCXO?]#IKO_@9+_P#%4?\
M$"Z/_0XJ]/\ EU'R\_7\>ZL?VI_T[C]\O\O7^GI_K;?\-P?LQ?\ 14] _P#
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MJC_B2;"?]%9B>G_,-3_N_P!WU_'L"^E[C-/^,7P_3_F(G_=_S?W_ '?Z2?\
MPUI\ /\ HH>C?^!$7_QRC_AK3X ?]%#T;_P(B_\ CE?YMG_"\/B9_P!#3K'_
M (%2_P#Q5'_"\/B9_P!#3K'_ (%2_P#Q5'_$DV$_Z*S$]/\ F&I_W?[OK^/8
M%]+W&:?\8OA^G_,1/^[_ )O[_N_TD_\ AK3X ?\ 10]&_P# B+_XY1_PUI\
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M'Z?\Q$_[O^;^_P"[_23_ .&M/@!_T4/1O_ B+_XY1_PUI\ /^BAZ-_X$1?\
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ML?\ @5+_ /%4?\2383_HK,3T_P"8:G_=_N^OX]@7TO<9I_QB^'Z?\Q$_[O\
MF_O^[_23_P"&M/@!_P!%#T;_ ,"(O_CE'_#6GP _Z*'HW_@1%_\ '*_S;/\
MA>'Q,_Z&G6/_  *E_P#BJ/\ A>'Q,_Z&G6/_  *E_P#BJ/\ B2;"?]%9B>G_
M ##4_P"[_=]?Q[ OI>XS3_C%\/T_YB)_W?\ -_?]W^DG_P -:? #_HH>C?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4O1?\ ?7^1JI^UW_R;
M+K/_ &!Y?_1+5;EZ+_OK_(U4_:[_ .39=9_[ \O_ *):O3R/_D>93_V%T_\
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MI\UI?Z?-)9ZI UK?0$I/ ZE6C<$AE((!&".X!IE7Z--=UJGZ#"BBB@ HHHH
M**** "BBB@ HHHH *KW?_'M/_P!<V_E5BJ]W_P >T_\ US;^5..Z]5^8I;/T
M?Y'[F_\ !%G_ )F7_<F_] -=O^U__P CYJ/_ %^2?^AO7$?\$6?^9E_W)O\
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M*%>C5HS:NHU:<Z<FNZ4XQ=OD2T5>T?P[XH\67!M/"FE76KW X,5K"TK@G'&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX^_9_P#&FL^'? V@Z=J.CZ-=S^9I]G"OR0PMAEPK-D$ -R<'! Y JU\*]/\
M#W_!/+]B7P[I_D^3 NBVLO[M=CAWM%;! QSMEQT'Y9KM/V5_VA--_:U^'/C/
MPR%:6UUC3[ZS*S'=\DJ%6XS_ +(QZXZXK^>\US3-<7G>,XFP]?$++\/F2C2E
MSS4%1C5C[O+S6^%;6U?8]:G"G&G"C)+G<%?36[2ZVT_3IY?Y2?Q5^S^'OC/X
M\\-H&CAT?5+NW"$% NRXD4  @=, ?YQ7Z3_\$S?^"=_C']M3XMZ/IMQ82_\
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M$\/>,/&/@/P[%;+X>M+JXN9[*U#$"TC=FWL@YZDDGGCCG(_F!_X+(G_C:O\
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M=3M*PQ2.-V<=40CJ1W_6O4=3_9)_:$T6REU+4?"6I16<*EI)##.0H R?X/\
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M_P"NC?S%<)V$E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!%+T7_ 'U_D:J?M=_\FRZS_P!@>7_T2U6Y>B_[Z_R-
M5/VN_P#DV76?^P/+_P"B6KT\C_Y'F4_]A=/_ -+B14^"7H?YS/Q[_P"2OZ__
M -A"[_\ 1C5YK7I7Q[_Y*_K_ /V$+O\ ]&-7FM?WAA_]VPW_ %XI?^DH^96\
MO7]$%%%%:C"BBB@ HHHH **** "BBB@ JO#IFH>)M1L_#VAQM=:I=7EO"EM%
MEI6$D@7A5YZM^?''-)=SM;V\DR*69!D ?_6K]I_^"-G[+/P3^)?QRT#XB_&3
MQ9I^CZ/IM[;7,UGJ%Q%&C""1)#E96 P?ISD5P9IF-+*,OQ.8UHSG'#4Y3C3I
MPE.=2I&SC%1BF]7O_31&+J3C35E>UV]+*Z3/ZB?^" G_  3U\-_![X6Z;\=?
M%FERZ5XF-O#=F6[4Q;08O.,AWXPH5<D@'@X'4 _O'K?Q3^&7[0NF>/O@UH.M
MV=]J]UI.H:>\$-PCR),8W1254Y7!SGT&??'Y@_\ !2+_ (*,?L]_LE?LI7^C
M? OQEX<O=3;29+#3K'P_=)(T,4%J+2(RN CO<-M+2[$$? *\-M7^2/\ X)*?
M\%3?&_@S]K>;XB?%#Q'/_P ([XEUZX$T%[.YB2VN+@J0PD;:%*L>" ,9]:_F
ME<,Y]QK2SOB^NJ]"IAYN>78:K&<:DW2ESJE",DG:*5D]NW0]CV]+#.GAU9II
M<\ELKV5[I^:U[(^6/^"PW[ _C;]BCX\>+O&6IV5U<Z3XBU.:Y@F8.T0BN9RZ
ML&P5V@'((..G///UI_P0%_8\U/XI_M#>&?BW)://H]E=VEW/E"T:*C*YW#!&
M 5P>_<FOZA/^"L^E?L6_MP?LM7_BN?XA>&KCQ7::#;W>G6\=Y UT"T9(AE1F
MR)(778"&8-&$)"-FOG;_ ((!:A^S3^SY\*?%_P#PE'Q#\-Z1K-M?K9Z?_:EY
M%&HMC+(&=  [%\(JJ""HW,200*^RJ\;YCC/#W%1J83%1SFCRY9B(K#55SPDE
M",X)1;LHZMI.S=SF6&A'&1:E%TG[ZU6CNG_6BVMW/Z)_VF/A%\./C%\.C\/_
M !AXATW0+"%!';_:;N"$(BQ)$J%&=6 5(UP0OKG KQO]CO\ 9M^%G[._VRV\
M'>.-&ULW E1+:VO;=R/-R"3B3)P"<8R20*_BB_X+I?\ !5OXG:C^T#K'P^_9
MX^(%U!X>ANKFW@U#2[UQ$55B%8/"VT\@$$'ZYR<?F]^P-_P51_:C^"_QR\&6
M7Q-^(NK:[X?U/6;9;Y[N^GFCB@DF4$L7<J H).3P.GKGYK+O"[B3%<+_ %B.
M:TZ-+$T7C%E4Z;5224>=W;U4W9JV]]'8VGCJ,:[7(VU)1=2_G%=-[6?4_H)_
MX.H?V-?%7Q-M-/\ BAX6M)&L--CL;J_EA0E"Z1Q/+NV@@Y(;)(.0<@Y'/VQ_
MP;">-M*C_9OU'P%+JEM_:=C;6R"P,J"8SVT@5@%)#$B,R''4G@ FON#]LWX^
M_LH_M(_L(ZZ^I_$?PQ<^(-0\!V>HV=B+V)M3BU)[98IX94;*[6<2,,.SJ @P
M,L!_#;_P3F_;U\3?L1_M0:Y';ZQ-_P (2_BF5%B65A;O9FY920N=A!4G';ZU
MZ.38/-.*O#S'\.3HU*.+R3$J6'C6I2@ZW)9J$7)+FU5E;;IH34E3H8N-:]XU
M8V=G>VW;1;;?*^I]M?\ !PU^PG\1?#'[0^N_'72_#VI:KI]_<W-VOD0RR+AW
M9Q]P,N.0<CC!/UK\#?@)^SU\7?VB?%ND>"-)\&:S:W.M7*6HF^S3KY1D<("6
MVC:<GKDX^E?Z>?A_]JW]A']N3X7:>?BKX@\(_:+NT!FL]4N((98S)&A_=,5E
MS@Y&QHQ@#Y7&>(OAI\+_ /@F1^SQ?'QKX?UWP)!>V;_:K2>2YMF:)E)<&*..
M-?,8'!7,B#(&0<C&^4>)F8Y)DL,FQF0XZIFF I_5</4C1J.G[BY:=[+6SLW;
M==63/!0JU74C5BJ<K2:<M>GX=/UU/X=_VD/^#;SXY_ ;X":C\=_$FOW<=AI=
MOIVIS6$MP256\A:Z$;1L25(5.A (SWZU_7!_P;U7 _X=]:QI2C=+I,-U8OCG
M>\.F:C'P!UR0!Q[=S7X[_P#!?/\ X+/V/B#PAJWP(^#VJQ:AX<U*>*VN3I[(
MZSA6\I7D:+.XA7?&<!0<+M Q7Z9?\&_?[0OP"\#?L30Z5XV^(?A[P]KVJW\-
MQJ-CJM\('>.XM[@2(J@EN3(P8E01QANM8\5XKBK.?#^CC>(*#GB*V;T:F#HX
M>A+VE/#J,6U4IQ3DG>^K3W5[:CH1H4\6XTG91IM2;>G-ILV?Q1?\%=/#WCZ]
M_;:\=?V7X0U._AEU/4!'-#;3.C@RN 58+@_Y^M?O?_P;%?L\?$A_&TOBKQ!X
M>U+0[&Q:2\,EW!)#&RP*SX!<*/FVX'(R2,9)K^D?QK\!?^"7?Q!\9S>.O$WB
MKP3?ZK-.US*\U_9N&9VW$&1HR_7C.WCN*S/BG^W1^PU^P[\,-;?X*ZAX6&IV
MMG/Y<.E/;N9"$R,NNTR,6 ( C3';.<!9GQWB\\X:H<+99D&/6+J8:AA)5ZE&
MI&$7%1C*6JLHMOY6\T.GA8TJSKSJP<4W*R=WI9KSW7X'YR?\%W?VD?#7PX^*
M/A/P7?WL"2W-S8*QD=<H9C$Q4Y[KN(/;TR<BOUL_8HM8/B-^PG=P:%<)<G4O
M#5P(3"P8-(+"28*NT\EBF !R2>!GBO\ ./\ ^"G'[<_BG]N_XNW_ (JAN)K8
M:3JXDLY [+^Z@FRF"#C&U5 [?4"OZ;?^"#__  5I\'>!/A]I/P#^+>M6]K:P
M_9[<7U],JB-43RF8-(5!RC,I&<'N.H%\1<#YEEW V3NA1E5S# 5(8C&8>'O2
M2CRRNE:[2ZJW?3N4<5">*JW:4)+EC+H]KJ_RO_2/Y4/^"E7P^^)^C?M;>/\
M2(_!&L7,;:EJ:17*6LY27,[J"&"XYX(QG.>N<U_5E_P:G?"OQUX:M?$FO>)M
M O\ 1K9=-O=IO()(@_G0O$NTNH!R9%QS^E?O9\1OA+_P3!^.>N1^--<UKX?7
M6M3L+RXNH+R$R2>81*WFI+"Q1R2=Q65@,_*.YM^.?VL_V'/V)/A)K4OPF\0^
M#(+VTL)%@LM&N(Y+F9D0MFY9EB!<,B[1'#C))R, 'DSWC[$\1\,T.&,+D&/I
MXRO3P^'J59TJB@I4^6+EJK)2UMHK==QTL)&C6=>5:#BKM)-7Z>?W_D?SA?\
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M9"".X_TT"O\ 2B\2RVOQW_X)H3:G8Q)?WEY\,/ML42@22?;40H4"KDAC',I
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MW%_W5_D*=34^XO\ NK_(4ZOZU/X>"BBB@ HHHH **** "BBB@ HHHH ****
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M<7.$O=DFXST3NKZ*Q_&G^R)_P3#^,O[9%A/JFB6E]HEO"K.9)XVB3:N2"2^
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M_P"P#]O.3Q#>_LJSCP5YLEL^@!)#8Y"NBVOS;?+P/3IZX%?Q-?LB6_Q5T?\
M;:T%=&LM;19?% _M-A]H*&(W89BY(*D?,O4G .,8!K^O;]B;]MOX'?&_X :1
MX$^*'B72[6_DTI+&Y%_/$K/YD4:'ESE7!!()5LG@C!!'>?#_ .!7["?PD\97
MOQ(7Q1X9;4FFDO+:26YM058N9 R[2S%AA<#Y0<\L.I_'. N.,5X09-Q[P/GG
M".:8_'9A/'8;!U*.!K5*>,=93I0J3J*#4XQO&:>J5M[[_JO&7"6'\3LTX-XP
MR;B;*\)@\+1PE3%TZ^,I0J8.-.="O.-.'/&4:C]FX=K.2:=[M/\ @JU);#]A
M>X.I(AO'L=#V^:H9UF_LI#< $\AO,V9QR2!QQ7(?\$JL_P## ^L9_P"@7KI'
M/;^R;FOR/_X+)?\ !3'P_P"+[ ?!3P!<1:EHGVI8FN+5EDCV(RQAR4RI&T*,
M^G2OTR_X)H?&_P""?A+]A:/1M?\ '&CZ9K-SH6L/>Z?=721SL\^CR+$D2 \/
MYC.#O*C)7&1D5Y.9<%<2</\ @)D\<PRK&1Q.=\=T,VP^$I4*E:M2PDH+EE4I
M0BY4K\NO,K)R5[7/2R_BO(<Y\:LQJX+,L)+"Y9P;B,KJXJI6ITJ57%TZD.>,
M*DI*-3EYDDTW=*5EH[_GK_P2\_Y2$>/_ /L-:C_Z525L?\%Z/$USX ^._P +
M/&EA ]W>::=&FCMHANE=HHH' 51DDG![=QQTKSG_ ()K?$[X;>&?V\?B#K_B
M#Q)9:9HUSJNJ-8ZA<SHD#%YI3"S,3RFXH3L!.T' /(/5_P#!97XO_";Q'^T3
M\(M>T[7=-\6:!I\FC'5HK29;BV94\D."#V$8PX91\P/4"OU:&"QB^D/P_B9Y
M7C<1@X\ 4J=6*P]6-*N_[+:EA76<>2$ZC7)9NZDTFM3\R>,P:\#,[H+,,+2Q
M$N.95(?OZ;JTX+,:?[]4N;FE&,4YII-65TS[A_9P_P""F?@_XW?"_1?AQ\6/
M ][9VDFE6&FW=Q>6TL<;PPVZP*3O 0_NSPQY"DX.*^GOA]^R%^RCX@FU7Q#\
M'[.UM?$NHPRS$P,JNLTJ[B3@@C#'VYZ\#-<G\,=1_8.^-'PDT&TT2;POX4U\
MZ)9"62-H+6Z6[CLHHI&9@P!4R*6QM5@P)RV<CO/@X/@#^S7=:IXAG^+6F7R(
MDTD5D=2A?* ,0@4R,1P,8Q[C' K\$S^MAL-4SR'".6<8\&X^IC)^TX<<,7B,
M'F%7VVCFXQ=.5*32LG9*+TT/VG):5?$4\FEQ/F'"O%>!AA(<F?*>&H8O 4O9
M+2"G+G51)ZV5[WOKH?S-?\%*_P!ESQA\&/VB_"VO^(KJZDL+_5K>6V!D?!26
MX5T(.>001C&01]:_J2^ T,DO[#=BL,<LC2>& 44;MYS9<8[]!Q_]:OYK/^"M
M_P"V=X:^.GQ8\.IX;N8+O3/#EY;JDD!5D*6T@4'<#SD#KDDYR237[P_\$[?V
MP/@CXK_9[T?PAXP\6:-I,]EI-O;3VVHW2QI)'Y(BE0 98/D@J0,<'/85^J^*
M^#XSS#PA\,<TS?*,15S#*\9"ICL-A,/-U*="$HNAS481<E*4=]-'OHD?FWAG
MBN$L%XH^(>797FE"E@LRPTH8/$8JO34*E64;55&K.2C)1E>VJNNCT/Y.?%.E
MWEK^VC))<074(/BPG]ZS[2/MN0<$X^G%?VESDG]D*PSV\/VX_#[*E?C%^VC\
M'?V9]*^+-M\2?!GB_2;B5M62[D%M=0, 3*)"<JQ)P3UP,CD@=OU$@_:+^ <W
M[)]OI+^.]*&J1Z*D/V3[9%Y_FK!MQM+XVX !X#9]N:Y_%K/:O&^4^&&89;E&
M;)8*OA,+BJ4\#B.>C.FJ2?.N2\(Z/5Z>AT>&&34N#\T\1,#F&:98WC*6(Q.'
MJQQE%PJPE*37++FLY.^VKOOW,+_@G Q35/&CKPRB\(/TW&OYE?\ @N'JNJC]
MH8ZREW<QWUOJ[>2R3.@5DG)4@ \$;0 1CK@=:_HB_P""?7QX^!_AV\\9-K?C
M?2M.>8W/V=KF[C2-U9R6&=V26BW!,?QD<C!(_F[_ ."TOBSPIXV^-<U]X)U.
M'6;$ZM(XFMY%E79YK$-E"P]^O4^O ^H\$L#C:7CYF^(Q&7XRC0EE$*<<17PM
M2%%IT(\T%4E'E:E;5)ZM;76GC>*&-P53P?R.A2Q^#K5(YW&<J%/$TISLL1%*
M4J<9.2LKN[6B>^NG]2?_  2-\2ZUXG_89M[[7+B6YNDT*:-9)6+ML_L:ZZEB
M>I&37\9'_!0$Y_:K\<$]]5NNG_7:2OZT_P#@DO\ '3X,^$/V)=/T/Q+XXTC1
M]632IDO+&\NDCN&4Z3,@6%1G#\NOSE1N91G&<?R/_MWZKI6O?M/^,]5T*Z2^
MTN?4[EX;J)@Z.K32$$,N1@@_YYKZ3P#P&)PGC;XNU)X#$83"U,376'G/#5*.
M'G'ZU*RHSG%0E%_%'D;5CYCQGQN'Q/A%X6PCC:&(Q%/"0]O"%>%6M&3P/_+V
M*DY1DF^5\R7O:;I'DWP"POQP\&LYR@U6U.,G_GJN*_T'$'VG]BFT2TC=V_X1
MDY5!\W_'FV>%R>XX_P#UU_G@?#C6H_#'Q$T'Q!.P6&PO8)69N  D@/\ 0_EV
MQFO]!;]@KXC:%\?/V7XK&WECO(X-%%H\:L& 9[9D7*CD$L OU-8_3 PN)HT^
M"L^5&<\#E684GB*B3Y8R=2-HM[)RV3?G8U^BUB:%:IQ9DSJQAB\QR^2H0EO)
M1I<LY);OEW=D]'J?P:_M.PRP?M#0I-&T;?\ "41G#YS@WY Z_EGJ?PK^\'X-
MR7%O_P $XK:YLV*7=O\ #^:>W=205F1+4*P(Y! /!^E?Q8_\%+/"P\&?M@KI
MR6WV6"+Q&DD@VE0$%\K,W08P"3D=,GVK^O\ ^$'[0/P-L_V K'P_=>/M%@U,
M?#R:VGTV2[07AO"L.U43E<9$?#,&^5^.F>3Z1'M\ZX'\&,9@,'B,7"MFF"Q,
MHX:C4Q*A3=/#MNHJ49.,6DU>5D]5<]'P.C0RCBOQ-PN,QF'PM2&58_#QE7K0
MH.52.,Q4?<4Y*\EHTE=[-*S/Q[_X)J_\%']0\$?M(>+_ (1_%+4&NK'5]:N;
M"T%Y)YD:![AHU \PL. XX[@'J,U_5)I7P[\-R:_:>-/#R6ZVNI6JW.ZW"!6%
MP@D5ALX.0X)!Y'0],U_FC>,_&$W@W]H[Q/X^T&0NMCXDN+RSGB8@.BS[E8,I
MY_ X]>@K^US_ ()??\%$_ /Q1^#]KIOQ(\8:=HNM:7:VRQ-J=P(_DAC\MX\D
MELD!3]T\J!P#Q\G])7PCQ.78;+N/.$L#6A2S#+<%A>(,#@Z<YWKSH4U"JL/3
MBW'E5_:.UT[N_0^@\ O$W#8ROB^#.)<;2J3PN-Q&*R3&XNI"+C&$W*K1E7J2
M2?O7<&VDT]C\D/\ @M[*)OB78VT>?MTU^(;-L999C(%0@^N<8XSCC/)%9_P&
M_9"_X*(^)/A#X?UWP7XKUNW\+75O"]A!'<SK&D3(I0* V.%P,@>G3.*R?^"T
M'C_X=>+/B39Z]X(\06FLQ:9J O5:VF253LE\P#Y2PQQVSU/''&C\"?\ @O)?
M?"+X2^'?AQ_88E?0;6.TCN#;!G"1JJD*YCW ';V(SW')K]"RO >(,_![@2CP
M3PSEN<8ZG-O,<)G^$A-X6ER)0G3IUTG3E)Z-K6W0^$S#%\$+Q5XSJ\6Y_F.6
M8*I"FL#B<CQ4X_6:O,KQJ5*#:E!*]DW9O2]]#U0?L5_\%,B>/&.NY_Z^I_\
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M_!"OX2>(=8_:<B\4-93#26U&"=KAHV"!?.\TL&P< >8.O4=J_5O"G)LUX/\
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M_HQJ\UK^\,/_ +MAO^O%+_TE'S*WEZ_H@HHHK484444 %%%% !1110 4444
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M.),VQN<9G5E6Q>-K5*U23;:CSSE*,(WUY*:ERP72*"BBBO:/&"BBB@ HHHH
M**** "BBB@ HHHH **** "OJS]@?_DY'PS_V$+?_ -&I7RG7U9^P/_R<CX9_
M["%O_P"C4KY[B_\ Y)/B3_L48O\ ]-2/HN$O^2DR7_L98+_U)I'^CE\(_P#D
M0/#O_8/MO_1,=>E5YK\(_P#D0/#O_8/MO_1,=>E5_AMF?_(QQW_857_].2/]
MBLN_W#!?]@M#_P!-1/EG]I81IH$DDS^5'Y1^<X X09Y/^>#7Y-G4]#%U<C^T
M[?(E8'YQP<C_ &JP_P#@HC^V_P"+(O$5C\-O >G2WTNI,+57MT9CF3"<; 2"
M2Q/3Z\\5^>\/PT_:>GC6_70=7/V]5N=OD7&%$@WC VGLPY[U[F&X1Q]?#TL3
M6KT,+"NG*BJE2,92BFDW9M/2_GKMN:NO%2<5&4K;V7]?U\K_ *4?VGH7_03M
M_P#OL?\ Q5']IZ%_T$[?_OL?_%5^;G_"M/VH/^A?U?\ [\7'_P 11_PK3]J#
M_H7]7_[\7'_Q%:_ZG5O^ACA.G_+Z'E_>\_ZNA?6%_)/[O3_/^KJ_Z1_VGH7_
M $$[?_OL?_%4?VGH7_03M_\ OL?_ !5?FY_PK3]J#_H7]7_[\7'_ ,11_P *
MT_:@_P"A?U?_ +\7'_Q%'^IU;_H8X3I_R^AY?WO/^KH/K"_DG]WI_G_5U?\
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M_+Z'E_>\_P"KH/K"_DG]WI_G_5U?](_[3T+_ *"=O_WV/_BJ/[3T+_H)V_\
MWV/_ (JOS<_X5I^U!_T+^K_]^+C_ .(H_P"%:?M0?]"_J_\ WXN/_B*/]3JW
M_0QPG3_E]#R_O>?]70?6%_)/[O3_ #_JZO\ I'_:>A?]!.W_ .^Q_P#%4?VG
MH7_03M_^^Q_\57YN?\*T_:@_Z%_5_P#OQ<?_ !%'_"M/VH/^A?U?_OQ<?_$4
M?ZG5O^ACA.G_ "^AY?WO/^KH/K"_DG]WI_G_ %=7_2/^T]"_Z"=O_P!]C_XJ
MC^T]"_Z"=O\ ]]C_ .*K\W/^%:?M0?\ 0OZO_P!^+C_XBC_A6G[4'_0OZO\
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M]75_TC_M/0O^@G;_ /?8_P#BJ/[3T+_H)V__ 'V/_BJ_-S_A6G[4'_0OZO\
M]^+C_P"(H_X5I^U!_P!"_J__ 'XN/_B*/]3JW_0QPG3_ )?0\O[WG_5T'UA?
MR3^[T_S_ *NK_I'_ &GH7_03M_\ OL?_ !5']IZ%_P!!.W_[['_Q5?FY_P *
MT_:@_P"A?U?_ +\7'_Q%'_"M/VH/^A?U?_OQ<?\ Q%'^IU;_ *&.$Z?\OH>7
M][S_ *N@^L+^2?W>G^?]75_TC_M/0O\ H)V__?8_^*H_M/0O^@G;_P#?8_\
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M?YH_ 7[;:?\ />/\Z/MMI_SWC_.OWZ_X<*_&S_H!:A_X#R_X4?\ #A7XV?\
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MM/\ GO'^='VVT_Y[Q_G7[]?\.%?C9_T M0_\!Y?\*/\ APK\;/\ H!:A_P"
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MC_GW^#\O\T?@+]MM/^>\?YT?;;3_ )[Q_G7[]?\ #A7XV?\ 0"U#_P !Y?\
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MSK]^O^'"OQL_Z 6H?^ \O^%'_#A7XV?] +4/_ >7_"C_ %QX9_Z&E#_P./\
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M/B'.,]S7,:<,OS*-..%JIIJ3IJ,9*]^CTZ[??^%^.?ASQ!X@9?DV$R.E&=3
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M^*K]&_\ AT7\>O\ H":E_P" TW_Q%'_#HOX]?] 34O\ P&F_^(H_XF)\,O\
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M?X]M?SD_M"P_Y^XO^^E_^*H_M"P_Y^XO^^E_^*K]&_\ AT7\>O\ H":E_P"
MTW_Q%'_#HOX]?] 34O\ P&F_^(H_XF)\,O\ H<4^G5>7GZ_CW5C_ (ED\1O^
M@:ET^W'R_N^;_'MK^<G]H6'_ #]Q?]]+_P#%4?VA8?\ /W%_WTO_ ,57Z-_\
M.B_CU_T!-2_\!IO_ (BC_AT7\>O^@)J7_@--_P#$4?\ $Q/AE_T.*?3JO+S]
M?Q[JQ_Q+)XC?] U+I]N/E_=\W^/;7\Y/[0L/^?N+_OI?_BJ/[0L/^?N+_OI?
M_BJ_1O\ X=%_'K_H":E_X#3?_$4?\.B_CU_T!-2_\!IO_B*/^)B?#+_H<4^G
M5>7GZ_CW5C_B63Q&_P"@:ET^W'R_N^;_ ![:_G)_:%A_S]Q?]]+_ /%4?VA8
M?\_<7_?2_P#Q5?HW_P .B_CU_P! 34O_  &F_P#B*/\ AT7\>O\ H":E_P"
MTW_Q%'_$Q/AE_P!#BGTZKR\_7\>ZL?\ $LGB-_T#4NGVX^7]WS?X]M?SD_M"
MP_Y^XO\ OI?_ (JC^T+#_G[B_P"^E_\ BJ_1O_AT7\>O^@)J7_@--_\ $4?\
M.B_CU_T!-2_\!IO_ (BC_B8GPR_Z'%/IU7EY^OX]U8_XED\1O^@:ET^W'R_N
M^;_'MK^<G]H6'_/W%_WTO_Q5']H6'_/W%_WTO_Q5?HW_ ,.B_CU_T!-2_P#
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MFBG3IOAD25,^FY&8?K1SS_FE_P"!/_,++LOZ_P"&7W&9_P (]H'_ $!-)_\
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M_#+[C'_X1[0/^@)I/_@NM/\ XS1_PCV@?] 32?\ P76G_P 9K8HHYY_S2_\
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M/7=$[C]:MD@ DG '))Z >IHN^[^]@9W]CZ3_ - O3O\ P"MO_C5']CZ3_P!
MO3O_  "MO_C51OKNB12_9Y-9TJ.<G A?4+1)2>F/+:8/G/;;6FK*ZAT975@"
MK*0RL#T(8$@@]B#BB[[O[V!0_L?2?^@7IW_@%;?_ !JC^Q])_P"@7IW_ (!6
MW_QJK<MQ;P#,\\,(]994C'YNRBN?\0>*M,\.VB7U[(IM&R6G1U,:(.K%QE<
M=3G%%WW?WL#5_L?2?^@7IW_@%;?_ !JC^Q])_P"@7IW_ (!6W_QJLCPWXT\,
M>+HGE\/:S8:GY8_?1VMQ'-)">A$BH3MP>/KZ5U%%WW?WL#._L?2?^@7IW_@%
M;?\ QJC^Q])_Z!>G?^ 5M_\ &JT:*+ON_O8&=_8^D_\ 0+T[_P  K;_XU1_8
M^D_] O3O_ *V_P#C5:-%%WW?WL#._L?2?^@7IW_@%;?_ !JC^Q])_P"@7IW_
M (!6W_QJM&BB[[O[V!G?V/I/_0+T[_P"MO\ XU1_8^D_] O3O_ *V_\ C5:-
M%%WW?WL#._L?2?\ H%Z=_P" 5M_\:H_L?2?^@7IW_@%;?_&JT:*+ON_O8&=_
M8^D_] O3O_ *V_\ C5']CZ3_ - O3O\ P"MO_C5:-%%WW?WL#._L?2?^@7IW
M_@%;?_&J/['TG_H%Z=_X!6W_ ,:K1HHN^[^]@9W]CZ3_ - O3O\ P"MO_C5'
M]CZ3_P! O3O_  "MO_C5:-%%WW?WL#._L?2?^@7IW_@%;?\ QJC^Q])_Z!>G
M?^ 5M_\ &JT:*+ON_O8&=_8^D_\ 0+T[_P  K;_XU1_8^D_] O3O_ *V_P#C
M5:-%%WW?WL#._L?2?^@7IW_@%;?_ !JC^Q])_P"@7IW_ (!6W_QJM&BB[[O[
MV!G?V/I/_0+T[_P"MO\ XU1_8^D_] O3O_ *V_\ C5:-%%WW?WL#\+?^"N=A
MHD<G@%5TFT68-!OD2&--Y-T2O"J ,)M7@#.,GGFON_\ 8=TS0)?@[HH71; 3
M"QM29)+:&4LHC7(^=&Y)*G/&,8Z5\*?\%=O^/GP+_O6__H\5]Y?L+?\ )(=&
M_P"P?;_^@Q5]GCK_ .J.6:O^-6W;_P"?BT]-6<\-,15MI[L?RB?9/]BZ-_T"
M=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G17QEWW?]?\ #+[CIN^[^]F9_8NC
M?] G3/\ P M?_C5']BZ-_P! G3/_   M?_C5:=%%WW?]?\,ON"[[O[V9G]BZ
M-_T"=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G11=]W_7_#+[@N^[^]F9_8NC
M?] G3/\ P M?_C5']BZ-_P! G3/_   M?_C5:=%%WW?]?\,ON"[[O[V9G]BZ
M-_T"=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G11=]W_7_#+[@N^[^]F9_8NC
M?] G3/\ P M?_C5']BZ-_P! G3/_   M?_C5:=%%WW?]?\,ON"[[O[V9G]BZ
M-_T"=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G11=]W_7_#+[@N^[^]F9_8NC
M?] G3/\ P M?_C5']BZ-_P! G3/_   M?_C5:=%%WW?]?\,ON"[[O[V9G]BZ
M-_T"=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G11=]W_7_#+[@N^[^]F9_8NC
M?] G3/\ P M?_C5']BZ-_P! G3/_   M?_C5:=%%WW?]?\,ON"[[O[V9G]BZ
M-_T"=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G11=]W_7_#+[@N^[^]F9_8NC
M?] G3/\ P M?_C5']BZ-_P! G3/_   M?_C5:=%%WW?]?\,ON"[[O[V9G]BZ
M-_T"=,_\ +7_ .-4?V+HW_0)TS_P M?_ (U6G52ZO[&Q4->WMI9J>C75S#;J
M?H97047?=_U_PR^X+ON_O97_ +%T;_H$Z9_X 6O_ ,:H_L71O^@3IG_@!:__
M !JDM]<T2[?RK36-+N9/^>=OJ%I,_P#WQ',S?I6I1=]W_7_#+[@N^[^]F9_8
MNC?] G3/_ "U_P#C5']BZ-_T"=,_\ +7_P"-5HNZ1J7D=411EG=@JJ/4LQ
M^IJO#?6-R2MO>6MPR\$0W$,I!]"(W8C\:+ON_P"O^&7W!=]W][*W]BZ-_P!
MG3/_   M?_C5']BZ-_T"=,_\ +7_ .-5IT47?=_U_P ,ON"[[O[V9G]BZ-_T
M"=,_\ +7_P"-4?V+HW_0)TS_ , +7_XU5B^OK73;2>^O9X[>UMHVDFFE8(B*
MHR22>/85SWACQKX>\8+<OH-_;WR6CE)F@E20*P;:0=I..:+ON_Z_X9?<%WW?
MWLV?[%T;_H$Z9_X 6O\ \:H_L71O^@3IG_@!:_\ QJK=S>6EFGF7EU;6L?\
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M[@N^[^]F9_8NC?\ 0)TS_P  +7_XU1_8NC?] G3/_ "U_P#C5:=%%WW?]?\
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M"KC?NP>>#U';K7Z__P#!4_\ ;O@_8:^"T'BJVV2:[KS75KI\.0)<@+'&R?Q
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MMWQ#X[^&NAQ1>#]-UV>[&KVT85)[>.Z=A)YB  @K@YR>M ']=/[3G[1?AO\
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M1FOY=OA]I?[>O_!1OQ/XF\4?#KQ7KOA#PW#<SW-BXNKJWAD@60F(*0Z*0P(
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MUX9O_&?P8^)GA32]W]HZ_P"#]8TRSVY#?:+FV9(\$<YSZ5_$/_P3C\<>#/\
M@D]^U[\48?VIY(=*L_'6OZE_9VJZB%S;B\NI!'(C3C'R!PPZ#\.: /H/XMZ)
M^W;_ ,$V/#^E_'GXD>,-;\4^'#+:RW=E)=W,R1!B)'1E9V ^7L0#CK7]'_\
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M /PD_8H^+7_!33PE\(+*Q^'7P[F_L-VB>.>PL&VN/+;&YHX]N2"2<DU\N?\
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MY^#5MXQ^!WVQ]2TJ5I[^&T\PM)%"_F,I"=0R'&#UK\LO@S_P<!?#2X^&-O\
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MV7HOR"BBBN<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MATKXL^%;F;Q+X5?5;;RK^]#/(8'E5D;=)EE)3!QP0>"!7]CW[$7[15I^U/\
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MC*4:P\*Z%:%2,%3!IMO&01VQMH [:BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSG_X*D?\
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M)0.@XR?KS7U=X+\#>%OA[HL/A[PAI%MHNCV^##96B!(DP-HPH '0 ?A76T4
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M10 5_.!^V]_R<98_]A6+_P!'"OZ/Z_G%_;?A<?M&V(./^0K%W]9ABOK.#_\
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MFV=AYGW_ ++ D6[G/S%0">?6M2@ HHHH **** "BBB@ HHHH **** "BBB@
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MZMD,#Z&LO1_#>@^'Q,-$TBPTL3G=,+*WC@$ASG+A ,G//UH \,^+?[)G[/\
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M/IUIIMKNW>19PI!%N_O;4 &?>@#3HHHH **** "BBB@ HHHH **** "BBB@
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M?Q[GQ=_P][\"?\^=]_WZ>C_A[WX$_P"?.^_[]/7VC_P[F_9?_P"A+3_R#_\
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M_(/_ ,9H_P"'<W[+_P#T):?^0?\ XS0L9P=I_L&/Z?;A_<\_)ARXC^:'3O\
MW?\ @_CW/B[_ (>]^!/^?.^_[]/1_P />_ G_/G??]^GK[1_X=S?LO\ _0EI
M_P"0?_C-'_#N;]E__H2T_P#(/_QFA8S@[3_8,?T^W#^YY^3#EQ'\T.G?^[_P
M?Q[GQ=_P][\"?\^=]_WZ>C_A[WX$_P"?.^_[]/7VC_P[F_9?_P"A+3_R#_\
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MW/B[_A[WX$_Y\[[_ +]/1_P][\"?\^=]_P!^GK[1_P"'<W[+_P#T):?^0?\
MXS1_P[F_9?\ ^A+3_P @_P#QFA8S@[3_ &#']/MP_N>?DPY<1_-#IW_N_P#!
M_'N?%W_#WOP)_P ^=]_WZ>C_ (>]^!/^?.^_[]/7VC_P[F_9?_Z$M/\ R#_\
M9H_X=S?LO_\ 0EI_Y!_^,T+&<':?[!C^GVX?W//R8<N(_FAT[_W?^#^/<^+O
M^'O?@3_GSOO^_3T?\/>_ G_/G??]^GK[1_X=S?LO_P#0EI_Y!_\ C-'_  [F
M_9?_ .A+3_R#_P#&:%C.#M/]@Q_3[</[GGY,.7$?S0Z=_P"[_P '\>Y\7?\
M#WOP)_SYWW_?IZ/^'O?@3_GSOO\ OT]?:/\ P[F_9?\ ^A+3_P @_P#QFC_A
MW-^R_P#]"6G_ )!_^,T+&<':?[!C^GVX?W//R8<N(_FAT[_W?^#^/<^+O^'O
M?@3_ )\[[_OT]'_#WOP)_P ^=]_WZ>OM'_AW-^R__P!"6G_D'_XS1_P[F_9?
M_P"A+3_R#_\ &:%C.#M/]@Q_3[</[GGY,.7$?S0Z=_[O_!_'N?%W_#WOP)_S
MYWW_ 'Z>C_A[WX$_Y\[[_OT]?:/_  [F_9?_ .A+3_R#_P#&:/\ AW-^R_\
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M>?DPY<1_-#IW_N_\'\>Y\7?\/>_ G_/G??\ ?IZ/^'O?@3_GSOO^_3U]H_\
M#N;]E_\ Z$M/_(/_ ,9H_P"'<W[+_P#T):?^0?\ XS0L9P=I_L&/Z?;A_<\_
M)ARXC^:'3O\ W?\ @_CW/B[_ (>]^!/^?.^_[]/1_P />_ G_/G??]^GK[1_
MX=S?LO\ _0EI_P"0?_C-'_#N;]E__H2T_P#(/_QFA8S@[3_8,?T^W#^YY^3#
MEQ'\T.G?^[_P?Q[GQ=_P][\"?\^=]_WZ>C_A[WX$_P"?.^_[]/7VC_P[F_9?
M_P"A+3_R#_\ &:/^'<W[+_\ T):?^0?_ (S0L9P=I_L&/Z?;A_<\_)ARXC^:
M'3O_ '?^#^/<^+O^'O?@3_GSOO\ OT]'_#WOP)_SYWW_ 'Z>OM'_ (=S?LO_
M /0EI_Y!_P#C-'_#N;]E_P#Z$M/_ "#_ /&:%C.#M/\ 8,?T^W#^YY^3#EQ'
M\T.G?^[_ ,'\>Y\7?\/>_ G_ #YWW_?IZ/\ A[WX$_Y\[[_OT]?:/_#N;]E_
M_H2T_P#(/_QFC_AW-^R__P!"6G_D'_XS0L9P=I_L&/Z?;A_<\_)ARXC^:'3O
M_=_X/X]SXN_X>]^!/^?.^_[]/1_P][\"?\^=]_WZ>OM'_AW-^R__ -"6G_D'
M_P",T?\ #N;]E_\ Z$M/_(/_ ,9H6,X.T_V#']/MP_N>?DPY<1_-#IW_ +O_
M  ?Q[GQ=_P />_ G_/G??]^GH_X>]^!/^?.^_P"_3U]H_P##N;]E_P#Z$M/_
M "#_ /&:/^'<W[+_ /T):?\ D'_XS0L9P=I_L&/Z?;A_<\_)ARXC^:'3O_=_
MX/X]SXN_X>]^!/\ GSOO^_3T?\/>_ G_ #YWW_?IZ^T?^'<W[+__ $):?^0?
M_C-'_#N;]E__ *$M/_(/_P 9H6,X.T_V#']/MP_N>?DPY<1_-#IW_N_\'\>Y
M\7?\/>_ G_/G??\ ?IZ/^'O?@3_GSOO^_3U]H_\ #N;]E_\ Z$M/_(/_ ,9H
M_P"'<W[+_P#T):?^0?\ XS0L9P=I_L&/Z?;A_<\_)ARXC^:'3O\ W?\ @_CW
M/B[_ (>]^!/^?.^_[]/1_P />_ G_/G??]^GK[1_X=S?LO\ _0EI_P"0?_C-
M'_#N;]E__H2T_P#(/_QFA8S@[3_8,?T^W#^YY^3#EQ'\T.G?^[_P?Q[GQ=_P
M][\"?\^=]_WZ>C_A[WX$_P"?.^_[]/7VC_P[F_9?_P"A+3_R#_\ &:/^'<W[
M+_\ T):?^0?_ (S0L9P=I_L&/Z?;A_<\_)ARXC^:'3O_ '?^#^/<^+O^'O?@
M3_GSOO\ OT]'_#WOP)_SYWW_ 'Z>OM'_ (=S?LO_ /0EI_Y!_P#C-'_#N;]E
M_P#Z$M/_ "#_ /&:%C.#M/\ 8,?T^W#^YY^3#EQ'\T.G?^[_ ,'\>Y\7?\/>
M_ G_ #YWW_?IZ/\ A[WX$_Y\[[_OT]?:/_#N;]E__H2T_P#(/_QFC_AW-^R_
M_P!"6G_D'_XS0L9P=I_L&/Z?;A_<\_)ARXC^:'3O_=_X/X]SXN_X>]^!/^?.
M^_[]/1_P][\"?\^=]_WZ>OM'_AW-^R__ -"6G_D'_P",T?\ #N;]E_\ Z$M/
M_(/_ ,9H6,X.T_V#']/MP_N>?DPY<1_-#IW_ +O_  ?Q[GQ=_P />_ G_/G?
M?]^GH_X>]^!/^?.^_P"_3U]H_P##N;]E_P#Z$M/_ "#_ /&:/^'<W[+_ /T)
M:?\ D'_XS0L9P=I_L&/Z?;A_<\_)ARXC^:'3O_=_X/X]SXN_X>]^!/\ GSOO
M^_3T?\/>_ G_ #YWW_?IZ^T?^'<W[+__ $):?^0?_C-'_#N;]E__ *$M/_(/
M_P 9H6,X.T_V#']/MP_N>?DPY<1_-#IW_N_\'\>Y\7?\/>_ G_/G??\ ?IZ/
M^'O?@3_GSOO^_3U]H_\ #N;]E_\ Z$M/_(/_ ,9H_P"'<W[+_P#T):?^0?\
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M>?DPY<1_-#IW_N_\'\>Y\7?\/>_ G_/G??\ ?IZ/^'O?@3_GSOO^_3U]H_\
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MQK?]@M7\C"O\"]5_Z5$_=/\ 9Y_Y)-X7_P"O5?\ T5%7ME>)_L\_\DF\+_\
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M?"MR!@ \\ D4 ?TKT5!;7,-Y;Q7-NXD@G021.O(9#T8$=C4] !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X8_P#!
M7;_CY\"_[UO_ .CQ7WE^PM_R2'1O^P?;_P#H,5?!O_!7;_CY\"_[UO\ ^CQ7
MWE^PM_R2'1O^P?;_ /H,5?:8[_DD<L_Z_5?_ $Y$YX?[Q5_PQ_*)]N4445\6
M= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  5-^(/P.\5VO@?]G[2_^$H\02S+;M#;0"Z<R!Q&3L57(W,2<9X_EW/["/\
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MV]_IUC<L\;!@LEQ;1RLA()Y5BPY]/7- '74444 %%%% !1110 4444 %%%%
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M);>V[GOSWS0!^E_[,7_!7;2;7XDZ9\!?CHEU8^.=0N(;.*6\#0L)Y'6,?-(
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M*TI@C=]DB*20FT,%8M@*H/!.,D#D?L)10!_G9?$7]G?P;^S#_P %\OAMX+\
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MGX3:-:_"JZ^/$UE";_PG"DB7GE*98FM(U96$FW<.@P<CD'TKTK_@AY^T%/\
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M&/\ @FM_P2H^#O\ P35TWQ9I_P ++U[T>+@?M\LD)B;+7$=P3RH)R\8KS/\
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MG[<%O"TH$G_"1D8QW^UCBOZ*_P!JJ:./]@'QC,[8C'PWMF+8/3REYKF?%_\
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MBZ'+&L[Z);6(CB6U"']YY21J !&S<[>YQ7S;\./V@?\ @E]^UIHTNL?$W2O
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MQIXAMGBN-VI+)<B*=&WX22<?PG )'!(X..:_=BSM(+&UMK*VC6*WM8(K>&-
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M_P#>L1_U^J?^ELVCLO1?D%%%%<XPHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,3Q,<>'==)[:/J)_*TEK^-S5-4LA^W0L/F
M_O/^$A Q@]?M1K^S2^M4OK*[LI/]7=VT]L_^Y-&T;?HQK\UY_P#@F7\)I_BJ
M/BLUTW]LB\^V;/*./,\PR=<>I_SU(!]X67B71O"/PYTGQ!K][%I^E6'A^QN+
MFZF8*B(MDLN"3@9*J<#UK^+?X[?'CQ5_P4#_ ."DL/[/UC!/KWPFL?$8C,RI
M)+9!8Y\DEOFB XZ>@YK^S'XH?"JP^)7PROOAK<WDMA8WMA;Z>;J+(D2.W@,
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MXW1K@@;CU8$_6O=OV)_^":GPL_8KU76?%6@78U?7-6AF-[>SQ%F4S*PD(>1
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MA'F_>VJN/7CC]*]UKP7_ (:=^!7_ $4?P[_X'0__ !='_#3OP*_Z*/X=_P#
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MFSX8_##Q'>>*O#.D1V^L7K2-/=&*-9&:4DL2ZC<3DGO4O_#3OP*_Z*/X=_\
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M#_\ %T?4\7_T"XC_ ,$U/+^[YH.:/\T?O7]=5]Y[U17@O_#3OP*_Z*/X=_\
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MX)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\
MHH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T
M4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?
MYH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\
MBZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\
M\71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJ
MBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_
MX)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\
MHH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T
M4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?
MYH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\
MBZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\
M\71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJ
MBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_
MX)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\
MHH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T
M4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\ BZ/J>+_Z!<1_X)J>7]WS0<T?
MYH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\ \71_PT[\"O\ HH_AW_P.A_\
MBZ/J>+_Z!<1_X)J>7]WS0<T?YH_>OZZK[SWJBO!?^&G?@5_T4?P[_P"!T/\
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MX=_\#H?_ (NC_AIWX%?]%'\._P#@=#_\71]3Q?\ T"XC_P $U/+^[YH.:/\
M-'[U_75?>>]45X+_ ,-._ K_ **/X=_\#H?_ (NC_AIWX%?]%'\._P#@=#_\
M71]3Q?\ T"XC_P $U/+^[YH.:/\ -'[U_75?>>]45X+_ ,-._ K_ **/X=_\
M#H?_ (NC_AIWX%?]%'\._P#@=#_\71]3Q?\ T"XC_P $U/+^[YH.:/\ -'[U
M_75?>>]45X+_ ,-._ K_ **/X=_\#H?_ (NC_AIWX%?]%'\._P#@=#_\71]3
MQ?\ T"XC_P $U/+^[YH.:/\ -'[U_75?>>]45X+_ ,-._ K_ **/X=_\#H?_
M (NC_AIWX%?]%'\._P#@=#_\71]3Q?\ T"XC_P $U/+^[YH.:/\ -'[U_75?
M>>]45X+_ ,-._ K_ **/X=_\#H?_ (NC_AIWX%?]%'\._P#@=#_\71]3Q?\
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M_P!!E/\ \)J'_P AY?GW8?5J/\GXOR\_+^K*W\XG_#D/QK_T6F__ / Z[_\
MBJ/^'(?C7_HM-_\ ^!UW_P#%5_1W11_KKQ#_ -!E/_PFH?\ R'E^?=A]6H_R
M?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\ AR'XU_Z+3?\ _@==_P#Q
M5?T=T4?ZZ\0_]!E/_P )J'_R'E^?=A]6H_R?B_+S\OZLK?SB?\.0_&O_ $6F
M_P#_  .N_P#XJC_AR'XU_P"BTW__ ('7?_Q5?T=T4?ZZ\0_]!E/_ ,)J'_R'
ME^?=A]6H_P GXOR\_+^K*W\XG_#D/QK_ -%IO_\ P.N__BJ/^'(?C7_HM-__
M .!UW_\ %5_1W11_KKQ#_P!!E/\ \)J'_P AY?GW8?5J/\GXOR\_+^K*W\XG
M_#D/QK_T6F__ / Z[_\ BJ/^'(?C7_HM-_\ ^!UW_P#%5_1W11_KKQ#_ -!E
M/_PFH?\ R'E^?=A]6H_R?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\
MAR'XU_Z+3?\ _@==_P#Q5?T=T4?ZZ\0_]!E/_P )J'_R'E^?=A]6H_R?B_+S
M\OZLK?SB?\.0_&O_ $6F_P#_  .N_P#XJC_AR'XU_P"BTW__ ('7?_Q5?T=T
M4?ZZ\0_]!E/_ ,)J'_R'E^?=A]6H_P GXOR\_+^K*W\XG_#D/QK_ -%IO_\
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M_P!!E/\ \)J'_P AY?GW8?5J/\GXOR\_+^K*W\XG_#D/QK_T6F__ / Z[_\
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M/_PFH?\ R'E^?=A]6H_R?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\
MAR'XU_Z+3?\ _@==_P#Q5?T=T4?ZZ\0_]!E/_P )J'_R'E^?=A]6H_R?B_+S
M\OZLK?SB?\.0_&O_ $6F_P#_  .N_P#XJC_AR'XU_P"BTW__ ('7?_Q5?T=T
M4?ZZ\0_]!E/_ ,)J'_R'E^?=A]6H_P GXOR\_+^K*W\XG_#D/QK_ -%IO_\
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M_P!!E/\ \)J'_P AY?GW8?5J/\GXOR\_+^K*W\XG_#D/QK_T6F__ / Z[_\
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M/_PFH?\ R'E^?=A]6H_R?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\
MAR'XU_Z+3?\ _@==_P#Q5?T=T4?ZZ\0_]!E/_P )J'_R'E^?=A]6H_R?B_+S
M\OZLK?SB?\.0_&O_ $6F_P#_  .N_P#XJC_AR'XU_P"BTW__ ('7?_Q5?T=T
M4?ZZ\0_]!E/_ ,)J'_R'E^?=A]6H_P GXOR\_+^K*W\XG_#D/QK_ -%IO_\
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M/NP^K4?Y/Q?EY^7]65OYQ/\ AR'XU_Z+3?\ _@==_P#Q5'_#D/QK_P!%IO\
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MB'_H,I_^$U#_ .0\OS[L/JU'^3\7Y>?E_5E;^<3_ (<A^-?^BTW_ /X'7?\
M\51_PY#\:_\ 1:;_ /\  Z[_ /BJ_H[HH_UUXA_Z#*?_ (34/_D/+\^[#ZM1
M_D_%^7GY?U96_G$_X<A^-?\ HM-__P"!UW_\51_PY#\:_P#1:;__ ,#KO_XJ
MOZ.Z*/\ 77B'_H,I_P#A-0_^0\OS[L/JU'^3\7Y>?E_5E;^<3_AR'XU_Z+3?
M_P#@==__ !5'_#D/QK_T6F__ / Z[_\ BJ_H[HH_UUXA_P"@RG_X34/_ )#R
M_/NP^K4?Y/Q?EY^7]65OYQ/^'(?C7_HM-_\ ^!UW_P#%4?\ #D/QK_T6F_\
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M(?\ H,I_^$U#_P"0\OS[L/JU'^3\7Y>?E_5E;^<3_AR'XU_Z+3?_ /@==_\
MQ5'_  Y#\:_]%IO_ /P.N_\ XJOZ.Z*/]=>(?^@RG_X34/\ Y#R_/NP^K4?Y
M/Q?EY^7]65OYQ/\ AR'XU_Z+3?\ _@==_P#Q5'_#D/QK_P!%IO\ _P #KO\
M^*K^CNBC_77B'_H,I_\ A-0_^0\OS[L/JU'^3\7Y>?E_5E;^<3_AR'XU_P"B
MTW__ ('7?_Q5'_#D/QK_ -%IO_\ P.N__BJ_H[HH_P!=>(?^@RG_ .$U#_Y#
MR_/NP^K4?Y/Q?EY^7]65OYQ/^'(?C7_HM-__ .!UW_\ %4?\.0_&O_1:;_\
M\#KO_P"*K^CNBC_77B'_ *#*?_A-0_\ D/+\^[#ZM1_D_%^7GY?U96_G$_X<
MA^-?^BTW_P#X'7?_ ,51_P .0_&O_1:;_P#\#KO_ .*K^CNBC_77B'_H,I_^
M$U#_ .0\OS[L/JU'^3\7Y>?E_5E;^<3_ (<A^-?^BTW_ /X'7?\ \51_PY#\
M:_\ 1:;_ /\  Z[_ /BJ_H[HH_UUXA_Z#*?_ (34/_D/+\^[#ZM1_D_%^7GY
M?U96_G$_X<A^-?\ HM-__P"!UW_\51_PY#\:_P#1:;__ ,#KO_XJOZ.Z*/\
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M?=A]6H_R?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\ AR'XU_Z+3?\
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M?=A]6H_R?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\ AR'XU_Z+3?\
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M?=A]6H_R?B_+S\OZLK?SB?\ #D/QK_T6F_\ _ Z[_P#BJ/\ AR'XU_Z+3?\
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M>3^(OB5X!^$_PZL/%'BK6K+0O#=EHUI)#<7<JQ1F%;5&C1&8A>%P#SP/7O\
MEGXW_P""PGPWT_5)H/ >FV_B_3+>=HI[^R=YXXU5B&<M$Q7@#)SP/I0!^TE%
M?#O[,'[<_P +/VD$-AIFJV%CXC0'?I/VA?.#J 6CV,Y<$<@<')&/<=?^T/\
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M=X:L_#6BQ)#8V4*01(F  B  8Q@8PH[9H ]+JM>745E:75Y,P2&UMYKB5F(
M$<$;2.23CHJFK-?!_P#P4)_:#B_9Z^!&L>)&G%O)J,-YI\3EMGS26^S .1SB
M0_GUH \B\'?\%%?"/QB^.>J_ WP,@;5]"OY;6^DA<N28)6B<M@DC&TDX( Y
M'K^CNM>+] \&:!+JOBC6=/TV*PLOM%R;R[@@D8HF2J1R.'9F;"C"GKD\ FOY
MG/\ @B_\'[?7_B_XW_:*O[=[A_$$FIW<$S[G!:X:5T())Z,P(/XCIQ]*?MZ?
M /\ :6_:N^,EAX8^&FOZEX:\*(RV^H-#//;P/#"H60N594VX!))[9]S0!]=>
M"O\ @J_^S?X[^-Z_ G0]4BN/%CWPL(U2]AD#R&3R\A%7.,^]?3W[67[57@W]
MDKX?#XA>-;.YO-+,LT7EVS;7S"BNW.UNS#M7\ /@O]G_ ,<_LA?\%P/ASX"\
M1:U<ZA/>ZWIXNF>XD<-(;E"Q(+$'G//^)K_0;_:2_9V\'?M*^!U\$^,[.*\T
MSS)9?*E (S,B*>O'1!0!^1EE_P '!'[,U] L\7AS6=K$@#SCG@D?\\.N1[=:
MV-,_X+\?LMWU]#87&GZA8S32)&@GN53)<@#[T0SR:]'TO_@B]^S-IHB#^&[%
M;>)B\GR1X"?>8_@023]:_FI_X*7_ +,7PQ^'O[8/@3X+?"30$GBUC5[*VGN;
M)25B\RX2,[C$, #T..G>@#^WCX/?M#>"/C%\.#\3=%N8[7P\MJ;MIKB9-HA$
M+3$[SM&<*0!W)'O7YM?$+_@MA^SIX ^*:_"^YT^_O[YKXV/V^WG!M@XD\LL6
M$17&?>O,_P!I?X?^./V2_P#@FY::-\/_ +2VNMHNF)="V9S*@O-.CFE5BF6!
M3S&5@<$$'@$''Y'_ +,_@#]EGQE\"M4^(/QGU?2;7XP1175Q;17]Q$+YK\;W
M4*)2)"YD^I_+- ']B7PJ^*GACXN^$M.\6^&+J.:SU"".;R1*KRPB1%<!P,'H
MV.G4'->-?&C]K_X8?!/Q7IW@[Q)>1MK>I-$D-JEPBR;Y=NU?+(+9^;!Z\U^%
MW_!./]KR3X8>'OBS?^,=2$'AOPQ;ZB_ABVN93Y=[' '^S+ KG#;@J[0N21BO
M-/V</!?Q%_X*9?M1ZO\ '+78KO2_!?@?7F:VAG:2.WNK>UNU6/&[;&0X"@8R
M#N '49 /Z<I?&$WBOP#+XI\/)+"$LI=056/S&*&V:YQT!Y5<?6OSQ_95_P""
MF_@CX\_'[Q+^SJT:6OB?PQ->V\TDS!6EDM&==HR1G<5P/S[U^HVF^&]-T?P^
M- L8%ALET\V/EJ!@H;;[.V0!_$N<_6OXZ/VF/".E_L#?MO1_&333_8\WC;Q"
MPDFW&(2B]N@Q S@'<K<8'?DT ?V<@@C(((/0CD'\:*\M^"?C!?'WPJ\#^,$D
M$HU[0K6_\P'.\RALMGOG%>I4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?AC_P %=O\ CY\"_P"];_\ H\5]Y?L+
M?\DAT;_L'V__ *#%7P;_ ,%=O^/GP+_O6_\ Z/%?>7["W_)(=&_[!]O_ .@Q
M5]ICO^21RS_K]5_].1.>'^\5?\,?RB?;E%%%?%G0%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 '3K7QC^U#^W'\&?V
M6]&?4/%^LV=]?H'+:39WL)NUVY^5D7>VXXZ >V<\#VSX[_$JW^%/PU\1>+K@
M@"SL;I8F)QME:WE\M@?4, <_ESBOXI/@/\"/C'_P4 _X*"Z[K/COQ!?:G\)X
MM=N7&E37,KVBVJW#$@QEO+"K&#D$<#GIF@#^@'X:_P#!<C]G7XB>*-.\-)HN
MJ:0VH7"P1WE[-Y<"EG";BSQ*,9.>N,=Z_9GPMXLT#QGHMCKWAW4[34]/U"VB
MN89;6>.;:LJAMKA&)5E)P0P&3R."*_$G]L7_ ()0_!73_@#XLUSX1>'X-!\9
M>$_#MUJ=G>VRI%,\]G K%T9-K9R&<@'( STS7PO_ ,$#OVL?'CZS\1?@M\7-
M>FU"]T;4)M,TA;VX>1XEM[M50*)&)&$0J /7'3- ']8-'3K2*0RA@<A@"#Z@
MC(/Y5S'C?5AH/@WQ5K;.$&D^'M8U#>3@*;2PGG!SVY04 ?GS^V7_ ,%$/!7[
M*_C;P?X OHX[_6?%UQ:VL*PL)'A>Z=$7.TG:1O&<?CQDU]V^!O$BZIX.TCQ3
MJUU!96VL:9::JDEW-'!''#=0"X&YY610%5AU/%?QY?LU>.M+_P""D7[?/B70
M/$\?]M1?#/Q'<K;LS&9;=-/O& (!SM"!/;&.]?T!_MX:1\4=>^&.F?!7X/O=
MZ5J9TZ'3+?4;-I(S%'':I;QX>/! 4*.A &/7F@#KOC-_P4Y_9S^#7C.#P5J_
MB"RU#4)KI;,2VE_ T8F9@F. Q^]GJ<\5]P_#;X@Z)\3O!VE>-= D#Z3JT7G6
M[[PPV[$<DL,# #CFO\_+]LK_ ()Z_'3]G73-'^(7Q2\6:AK&LWFOP7BO<74S
M.HDG$@4EW)R.1CZYYK^RW_@G7JE]>_L'^";Y&>2_3PMJXA.2SFXCTJ(PX.<Y
M\PKCGB@#Z?\ CK^TC\+OV?O!^H^+_''B/2[6UT^)IGM?[0MEG94!+';O8KTP
M 1D]<8'/BO[*O[>_P@_:W^W'X;W'GK8RM%(PN%F!(;;QL45_-E^V;^Q'^UM^
MU7X8^,OBN]\5ZOI'A/PZNI3Q6;W-Q%');1-*R[5+*N"JX'&,$YK?_P"#<?PE
M>_#^_P#%OAC4;F2YN=,OYK6:621G,DD+NI;+,>21U^M ']5?QV^.O@K]G[P3
M=^./&]Y%;:;:K*0C3)$\K1('95W9).",<=Z_.7X/?\%E/V=_BYXU3P=8VUWI
M<D]T;6VOKRX5+>=_,\M3&[1JK GG@_2OA;_@X/\ %7C2#P-X/T?3)[BR\-7&
MJVT6IS*SQQ%'DC6<.R_+CR\9R>AYK\S_ -J_PG^SW\./V6OV9O%'P7UW3;/X
MHZC<:,VMO97$:7=Q<.83*'\LB0DOG.[GUXH _N*L]8T^^TF#6X;F+^S;BU6\
M2Z9U6$6[+N\PR$[0H&><_KQ7QC>?MV_"A/C-:_!C3';5M;N+E;4W=I,LD$<C
M/L^8(K 8/4%LU^<OQ&_;E7X>_L2^#_ LVI+:_$OQ/X&L]'TR5YBMW-=38963
MYMY8AE&X?-C R!Q5/_@DK^R+KR6NK_&KXU6MQ?\ BZ_U 7VE7%]O>18IW::%
ME:7) V%6&.W3- 'ZC?MC?':\^ 7@.R\6VT$L\;73QSB($[(XMC,S8'3#^W3W
MK0_9;_:F\%?M&>%+&]T+4+>;6(K8'4+2.97EB9%RQ=!\RD8(.<=.YS7I/Q^^
M&7A[XI_"[Q?X=\064=XA\/ZQ-9EU#&&ZCLI)4900>6:)5XP><Y[5_)'_ ,$;
M?B3XO^$'[>7QB^&OBW4)X_"LNJ:O8:-:7$SF*-9)YX(MB.0H"AAC:,\=J /[
M1**9%(DT:2QL'CD571AR&5AD$?4&GT %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?G/_ ,%2/^33O&'_ %TB_P#0
M&K]&*_.?_@J1_P FG>,/^ND7_H#5ZN1_\CG+/^PW#_\ IR)%3X)>AX%_P1O_
M .2&2_\ 7S+_ .AO7[*U^-7_  1O_P"2&2_]?,O_ *&]?LK73Q/_ ,C[,O\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYP/VWO\
MDXRQ_P"PK%_Z.%?T?U_.!^V]_P G&6/_ &%8O_1PKZS@_P#Y&-;_ +!:OY&%
M?X%ZK_TJ)^Z?[//_ "2;PO\ ]>J_^BHJ]LKQ/]GG_DDWA?\ Z]5_]%15[97S
M>+_WK$?]?JG_ *6S:.R]%^04445SC"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ H(R"#T/!HHH Y?6-,TZPTCQ!>VEE;V]U)I&I&
M2XBB59F;[),02^,YW 'K7\?^LSS3_MRJTLC.Q\0#))_Z>FK^PWQ+_P B[KO_
M &"-1_\ 226OXZ]49?\ AN11N7/_  D XR,_\?34 ?T@_MH_#_6/BG^QEXC\
M&>'[5KW5-5\,:/':VZJ7+O'II0X YX)XQ7\H/[.W_!-W]J^_LO$/@UI]:\(6
M<VH7,D,T'VFV4HTC$'*;>/\ ]5?V%?&WXY^'OV;/V<G^+/BFV%WHWAS0M'DN
MH"H<.+BR\Q?EZ' 0UP'[$W[:'PA_;/\ A]<^//A]'I=@;2\:UN; &U2XX+@R
MK'@2A5*8<DMRP[ T ?R2?$;XI?MF?\$D?B#X0=[S7_%GA;7-3MX+RYG:ZN(D
M@DE"2%F<LN -P.3CCWR?['_V3/VA-*_:,^#'@GX@6\T0U;6M%M;O5+--H>WN
M7C5G#*OW<DXQ@<@U^4__  75\?\ PB\(?!WPS:^,[+2+[6-2N)4TQ0EM+?1L
MSE8R%7,@!?)4D9.21D8KK?\ @BWHWB2'X3+K=X+M- U&P232HK@.J1Q.%:,(
M&X VD8P* /W(K^:S_@YM^(5_\/?V-?#E]I[LLM[XI>U.TD9#+;C''^\:_I3K
M^:G_ (.;_!&H>-OV-O#-GIT$D\MKXJ>X*QH7("K;')P#@<=?YT ?6W_!#7PB
MD/[#?PQ\;7,0%[XFTX2N2/F91#"Y)[]9>YK]DH--T^VF:Y@L[>*=\[IDC42-
MN^]E\9Y[\\U^0G_!#[7FF_80^%OA>[=4O/#^G10^1D;PKP('++U&/*7L*_8F
M@#^";]M::2?_ (.(? 'FNSA/$]DJ!N0JB\   Z   #';M7]ZZ?<7_=7^0K^"
M']M%T'_!Q#X"!90?^$HL^-PS_P ?H[9S7][,DT=M;27$S!(H(&FE=B %CBC+
MNQ)P  JDDGCB@#YM_:V^,.F_!GX&_$#Q/-?I::M;^'+]M'C\P)+)=F-A&4!(
M)Z,..<U_-'_P2;^&WB+]M?XZ^//C;\9=-DN#X4UBXN="O-1B9VQ%=G[.8FD5
MB<L5P5X]< 4__@LK^U1XL^,OQG\!? KX'W\VI6L>JVVG^)(=-E,P:,W"I.)T
MB9AC+-D,, <<=:_H@_89_9]\/? KX(>#+?3].@LM<UKPYIUUKK10K$[W4L:S
M.)"%!+;L$T ?1?Q'^&7ASXF>";SP/X@LX;K2KFU6W6*9 Z)LA,*':0>BG'2O
MYXOBK_P0)TWQE\0KCQM8_$N7PQX:T^[EU4Z-!=3Q6\T$+&>2-HXAY2*$5L^;
MM4#.2.:_ID) &20 .I/ 'XU^*7_!4O\ ;DO?A5X1M?AG\)]1-YXQ\53S:+J,
M>G2A[J""[;[.R[8F+J  2<@?>.0: /PA^/'@6/Q!\5O#'P/^ -ZVH:'X0O;>
MP\=W=BVZ.>"UE6&[:X>+*L"J.6+GIGIW_I$_9A^-?[&7[/WA3PS\*/#WB[P_
MHGC*XTVP77[2,PBXN-6:)//25UD7&)2>"NXMDDG@#\B?AY\$KC]D'X(ZQ\:M
M:@FU+Q=\4[":\O)KU#)/:3ZC&\S'?(-R%6E/.1[U\J^/?V/]"TK]CCXI?MSM
MX^G/CO1Y;O6-.TN'4F,R,A:X2-(1)N !P  ,8&* /[5=)U?3M<L8-2TJ[BO+
M*YC62&>%@Z.CC*D$$CD>]?QY?\'4]E)X9TO]GWQ7I4IM;R_\26,<YB.PMY-^
M8><8ZJ@)P>IK]2_^" /[3?C+]J/]C:7QAXT:\>_T?Q!'HT#WA<R/!''=A6!<
MG((A%?EY_P '3]U'XTT+]GWPGH+&YU?3O%%LUU%%\[(&U)G VKD_=8'GI^5
M'])G_!/:[FO_ -C']GN[N&+S3_#W2GD<DDLQ\SDD\YK[+KXU_P"">]A<:9^Q
ME^SY87:%+BV^'VE1RJPP0P\PG(/3K7V50 4444 %%%% !1110 4444 %%%%
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M:I\1_MF_'GPI^S?^SQ?:A.NC:VFG^)CI\SO#+ +D+<^<86V,""X.X8VC&..
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MP%;2V?@OPQ:S B6#1K&.0$8(985!&*ZZ@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\Y_\ @J1_R:=XP_ZZ1?\
MH#5^C%?G/_P5(_Y-.\8?]=(O_0&KU<C_ .1SEG_8;A__ $Y$BI\$O0\"_P""
M-_\ R0R7_KYE_P#0WK]E:_&K_@C?_P D,E_Z^9?_ $-Z_96NGB?_ )'V9?\
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M! P,:@;2!Q&>G?GUK^XNF>7'YGF[$\W;L\S:-^W.=N[&<9YQG% '\>7[,?\
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M4$,1^L<:J?U%3T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5_.!^V]_R<98_P#85B_]'"OZ/Z_G _;>_P"3C+'_
M +"L7_HX5]9P?_R,:W_8+5_(PK_ O5?^E1/W3_9Y_P"23>%_^O5?_145>V5X
MG^SS_P DF\+_ /7JO_HJ*O;*^;Q?^]8C_K]4_P#2V;1V7HOR"BBBN<84444
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MP/ZQ**_D[_X2S_@L9_SZZY_WS+_C1_PEG_!8S_GUUS_OF7_&C_4N?_0]R/\
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M'_X5^G]WS_+OH?65_P ^JO3[*Z\OG_>_ _K$HK^3O_A+/^"QG_/KKG_?,O\
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MWOP/ZQ**_D[_ .$L_P""QG_/KKG_ 'S+_C1_PEG_  6,_P"?77/^^9?\:/\
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M .$L_P""QG_/KKG_ 'S+_C1_PEG_  6,_P"?77/^^9?\:/\ 4N?_ $/<C_\
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M #ZJ]/LKKR^?][\#^L2BOY._^$L_X+&?\^NN?]\R_P"-'_"6?\%C/^?77/\
MOF7_ !H_U+G_ -#W(_\ PK]/[OG^7?0^LK_GU5Z?977E\_[WX']8E%?R=_\
M"6?\%C/^?77/^^9?\:/^$L_X+&?\^NN?]\R_XT?ZES_Z'N1_^%?I_=\_R[Z'
MUE?\^JO3[*Z\OG_>_ _K$HK^3O\ X2S_ (+&?\^NN?\ ?,O^-'_"6?\ !8S_
M )]=<_[YE_QH_P!2Y_\ 0]R/_P *_3^[Y_EWT/K*_P"?57I]E=>7S_O?@?UB
M45_)W_PEG_!8S_GUUS_OF7_&C_A+/^"QG_/KKG_?,O\ C1_J7/\ Z'N1_P#A
M7Z?W?/\ +OH?65_SZJ]/LKKR^?\ >_ _K$HK^3O_ (2S_@L9_P ^NN?]\R_X
MT?\ "6?\%C/^?77/^^9?\:/]2Y_]#W(__"OT_N^?Y=]#ZRO^?57I]E=>7S_O
M?@?UB45_)W_PEG_!8S_GUUS_ +YE_P :/^$L_P""QG_/KKG_ 'S+_C1_J7/_
M *'N1_\ A7Z?W?/\N^A]97_/JKT^RNO+Y_WOP/ZQ**_D[_X2S_@L9_SZZY_W
MS+_C1_PEG_!8S_GUUS_OF7_&C_4N?_0]R/\ \*_3^[Y_EWT/K*_Y]5>GV5UY
M?/\ O?@?UB45_)W_ ,)9_P %C/\ GUUS_OF7_&C_ (2S_@L9_P ^NN?]\R_X
MT?ZES_Z'N1_^%?I_=\_R[Z'UE?\ /JKT^RNO+Y_WOP/ZQ**_D[_X2S_@L9_S
MZZY_WS+_ (T?\)9_P6,_Y]=<_P"^9?\ &C_4N?\ T/<C_P#"OT_N^?Y=]#ZR
MO^?57I]E=>7S_O?@?UB45_)W_P )9_P6,_Y]=<_[YE_QH_X2S_@L9_SZZY_W
MS+_C1_J7/_H>Y'_X5^G]WS_+OH?65_SZJ]/LKKR^?][\#^L2BOY._P#A+/\
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M];_^CQ7WE^PM_P DAT;_ +!]O_Z#%7V>-27".6.W_+^J_G[2/^;.>'^\5?\
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M&6.>))H7$D4BAD=3E64]"#Z&I* "BN$\0?$[P#X6NUL/$'BK2-*O'8(MM=W
M24L3C:%P><\8]376Z;J=AJ]G#J&FW45Y9SKNAN(6W1R+URI[]10!>HKR_P"(
M/QH^%WPKC63X@>,]&\,(X!4ZG<>42" 0<8/4'/K5_P !_%7X>_$ZR.H>!/%6
ME>);10"9M.G$JX/?! /Z4 >@T54OK^RTVW>ZO[F&TMXP6>:9PB* ,DDGT')K
MFM$\>^$O$TUS;>']<L=5N;57,L5K+O9"F<YX[8.<9H ["BOECQA^UE\,OAYX
M\T[X?>,M9M-*UW598XK&VGE2.28S,!'M5B"=V0>G3ZU]0V\\5U;P7,#B2"XB
MCGA=3D/%*@=&!&1AE8&@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OSQ_X*@71M_P!DSQJHCB?S9(,F1%8KL24?
M+D'&=_S8QG ]*_0ZOSG_ ."I'_)IWC#_ *Z1?^@-7JY&D\XRQ/;Z[A__ $Y$
MBI\$O0\$_P"".3%O@;*2 /\ 29> ,?QO7[)U^-7_  1O_P"2&2_]?,O_ *&]
M?LK73Q/_ ,C[,O\ L(?Y(5+^%#_"C^7.7_DY7P=_V$K3_P!&QU_3YI/_ ""M
M,_[!]E_Z315_,'+_ ,G*^#O^PE:?^C8Z_I\TG_D%:9_V#[+_ -)HJ]7B[X,J
M_P"P:I_Z5$SP^T_\2_\ 24:%%%</\2_%L'@3P%XK\8W3K';^'=&NM3E=CM54
M@4$DGMR0/J:^,.@_DU_X.1_V[_&OPI@L/@1\+=1O8/&'B%+>&WCTYY3.))51
M2-L3;L[F((QP?U]8_P"#?+]JGQY;_#B#X+_'#4KE_&6I3V]Y:IJDCK=$,L@4
M!9B7Y\T=!SCIZ_(6B^"?!7_!4O\ ;_C\;7M_9WECX'UB43Q321RVZFUG;A@Q
M9< ITK,\=>&_$_[,/_!6+P9=Z=J=O8?#>UNK*U>.VE6&R*I(J'<JD(> * /[
M=II4@BDFE.V.)&D=CT5$!9B<XZ $UYL?C#\/ M\Q\1V(.G!OM:&:'?'LSN&W
MS<DC:>..E&I^+M/\1?"S7O%>BSI/9S>%M6O;>:)PREH]-FF&UU.#@XP0:_A?
M\)?%7]K?XX_MH>-OAYX!U353X277KNUO$BFF,8A^V.AP V -I(]J /[1=-_;
M-_9^U7Q"?#%MXUM/[6$WD&%VA5?,W; -QG_O>W]!7T[8W]GJ=K%>V%S#=VLZ
M*\4T$BR(RL,C#(2,X[9K^/;]OS]A;XV_ 3]GZ]^.O@35-7C\8:-%!>W_ )<T
MP_?/&9_F(.?O1MGG^=?I)_P0D_::^)?QM_9JUNX^+MY++K_A="[R7<C%_(M5
M(D),C$X Z\]J /W.\3^*]!\':5-K/B+4;?3=/@!9YIY(TR%&3L#NF[ Y.#QD
M9QD5\ZZ-^VE^S[KWB!?#6G^-+634WE$2QDPA"Y;:!O\ /]2.W^-?RV_M>?ML
M_'+]M/\ :SU']E+X$>)QI4'A_59;#5GCO/)7RH[AHY<D. .-PZ5]/?$K_@G%
MXV^%/[.M_P#$K0OB+;-\4=$TG^T)PNJQ^:;J--Y!'F[L^9_CUS0!_4Q:W=M?
M6\5U:3Q7%O.BR130NLD;HP!!#*2#P>1G(/!P:X:Z^*/@:RU.YT>[UZSM]0M0
MS36\LT2.H3[W#2 \>X%?SZ_\$6OVWOB)XV3Q/\)/CEK(U/Q+I,KV^ENUT)7(
MMYE3@EF)'EAL^WX$?E__ ,%!_CE^TM>?\% ?^%:?!W4M2BM-1U@07$5M+*%^
MSRW&U@%0@8V'TQQ^8!_72/VQO@'_ ,)8O@L^-+1==>80+;LT 4R%MH&\SCOQ
MT->S>+?B9X+\$Z /$VOZW9VNDO&LL=PLT+^8C*'#(/, ( (SSP>.N<?RN?M!
M?\$_?COX;^ ES\?]"U/5U\?^'/#\OB?42DLP;_0X//DSCG[R]?\ #C\^?^"8
MWQV_;,_X*0^,/%GPY\1:GJTGA'X=74NFZMB:9@$@G%HQ8EB,YQVS0!_;%\/_
M -J'X,?$S4&TOPIXML[R]5Q'Y+R0QDMG&/\ 7$]2!TKQ/]O7X!V7Q^^%\7AR
M]\02^'X8GE<7<,Y@)W '[X(XQCG-?RS_ +:_PF_:,_8 ^)&A?$#P/JNKCPP^
MH64FH*9IA%@RQL^?F Z''/XX%?M=XS_:1\5_$3_@G]HGQ4$\HUR72(3-(KMO
M,JVJ;LMG=G<.>?S[ 'TS_P $]?V>=-^!&E7.DV'BF;Q$J13)YDMS]H(RI'7<
M?7\,?6ON3XD?'+X:?"B,/XU\1V>EL1N\II8FE4<_>0R*RGVQWYK\7O\ @F)\
M5?'OQ'^'/CV..>>;Q.ME?#22S,[^?Y3B/;R23OP1BO@W4?V,/V\OCW^T-K]Y
M\7_%5[I'P\36)?LJ7EV]O']D^T';@2,%QL(QQ[$XH _I@^'7[5_P1^*6K_V'
MX1\76E[J);8L+O#'N8G  /G'K].#UQUKZ/K^-K_@I#\(O%G_  31^%6C_'[X
M9?$"WO;FUO[6WOK6VU1))7E4Q/)E4EW'[_<=LGBOZ"_^"5W[1?B#]J3]COX>
M_%OQ.[R:OK,;Q7#R$LS>3!;D')))Y<GKWSWH _1JBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^<#]M[
M_DXRQ_["L7_HX5_1_7\X'[;W_)QEC_V%8O\ T<*^LX/_ .1C6_[!:OY&%?X%
MZK_TJ)^Z?[//_))O"_\ UZK_ .BHJ]LKQ/\ 9Y_Y)-X7_P"O5?\ T5%7ME?-
MXO\ WK$?]?JG_I;-H[+T7Y!1117.,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "FR-L1W_NHS?\ ?()_I3J1E#*RGHP*GZ$8- '\
MOG_!1G]M;]K;5]7\??"3X%Z#J=S;Z=::A%/=65M.Q1$C=2^^(?P@$YSQ7YF?
M\$)?B'\==3_:6\4:;\6]<U:75?[5G6ZL+Z:<B)S.X9=DKG: <CIVK^RW6?@M
M\/\ PAIWQ%\:6>AV5UK.I>'-<GN)KNVAD^<6%Q("I*DYW#J>:_E$_P"";]T)
M_P#@H#\3KB."*WSXCOR(X5"(O^E.<!0!C&2.] ']&7_!2S]I/Q3^S3^R]XL\
M<^ X)[SQ=#:>7IMO;HTDS%H6Y54RQRVT<?3K7\VW[$O[&_QW_P""H^@>(/C1
M\:?%&O\ A&1;^<65M++<VH9FD<Q*%<@D,!QVQSP :_KX^)WP6\%_&;P];Z)X
MTLQ?:>\$1>!T21&RBDY5_E.23V_6KOPZ^&W@#X$>#9=#\,6MEH'AVQ66]N7(
MAM8E6&-W>20C8GR(';KGDXH _C6^+_B[XR_\$6_C%X,^WZ_JNL>"_%^LPV5I
M/=33/&R/=" _,S8QE6_$&O[(/@#\1Q\7?@W\//B4 !_PF/ANRUH@=,W(8G'Y
M5_&M_P %B?BI%_P4_P#VB_AY^S7\'[![V?X9^)H1=ZIIZF<2"WOS)*6FC# C
M>SXYP!P, 5_8!^R7\/M0^%7[-_P?^'FJ[_[1\*>#-,TF\W@A_.@#D[@><X84
M ?1-?CY_P63_ &PF_9+_ &=X-8LKLV^I^(KV738_+<K((YD6-2 "#]XMBOV#
MK^1G_@O9JG_"\=:\+?",22,-/UZ >4C$YV3C/'/N.G/3(H _0C_@D9\)[L_"
M9_VJM:U:ZO+SQII][J<$$[NW[MX6FE(#9X4..O<XYK\_?^"GG[:W[9OC*/Q-
M\/O@9H.K/X5AFGMKS4K&VG(CB5FC9S)$N.%!.2>E?O=_P3L\ 0^$/V,/A9X&
MG0K!;^'FLI5Q@F.:WA1\@@<D$CI78_%;X/\ @'X?_"#XBWVEZ#8SW5SIEU.\
M]W:PR2"1PY)5BI()+$YSU]\4 ?R]?\$7/&OQ;T[XMQ:)\0]=U2[O;Z]B:[M[
MR65O+E>1/,7;(W'S$CD9'/>OZ-_^"D7[17B_]G3X(S>(_!=M/<ZSJ37=G"EO
M&[R B)-N G(R7[>F>U?@Q^P4Z-^UYJ!CBCA7^WY=J1@*JC[4<  8 _#BOZHO
MBM\'_!WQBTBVT3QE9K>V-K,9XXVC20;SMSD/QSM% '\DWP&_8=_:$_X*)7UY
MXX^+'B3Q!X5T74GGFA+275N@CD8NIY('W<< 9[#)P#YE\2=$_:+_ ."3_P"T
M7X3\-^$]<U;Q+\/M0O[-+R[FGGF06TLB$MDM@ QG^1K^C/\ ;)_;Z_9S_P""
M6G@+PI;^.="U!-#U$P6UA#HJ10G,DQMT>?;;R[FR#SQ@#@<FOY5OVA_^"BTW
M_!5S]J[P1X7^"&FR:1X)MM1T^TNIK]-LI@MY4AW.[@9<H 6; !.< #  !_:C
M\,OCY:?$'X K\4K,E[N#PP=2N4')%TEH)3QR=V_/X]\U_(OX5\)^/O\ @I#^
MV9\7O#FO^-=2\.:/X(;5[S3XC>26T;M9O*\:J"X'.T #_"OZX_V=O@1IGPX^
M!NC?#VZG6\CO-"MH-19"'4F:U59%&.,_,<C.*_FI^)W_  3K_;#^#?[3WQ ^
M(GP%COX-!\9S:A!$]JDBKLO7< EHQ@C#=^.* /:O^"0?[0/BSP7^T%\5OV??
M'&MW%]X:\#2:K8V6HW4[2)BS\U(6$CL5.6C7N,]B.W;?\%)?VN_'WQ,^-_AK
M]FKX.W-U/X>UNYLK35=2TUG=8VEV).SO"Q"?,S9R3C&/6ORW\->&/BM_P3XU
M3X@:U\=Y)I_B)\6OM?\ 8#)N^TK=W[/Y7(^<'>X_'-?L'_P25_9/U2?2=>^.
M_P"T%<V]WXAU_48M0\*PZM-"EW!:W$OVF.93=<B-(U$>!SND7' - 'ZV_LB?
M JY^"'P8TWP?JFH3:K>W]M#>7<MRS2.DD]L0R$MDCF4G&<C'TK^8O]K*RU[_
M ()M_MGV/QUN_$%[_9/Q!\0_N;.25Q;A;V\W;0"P7 +$>G'0<9_L@@D@DC4V
MTD4D2J%0PNKH%48 5D)7  P,'I7\KW_!S7\.F\6_#OX,:K9[HKW2]:BF,L0P
M["*^=E!('8# YZ#I0!_2I\$O'R_%'X4^!?B C*R>*]!M-64J01B?=Z>ZUZG7
MYN_\$L?%=_KW[(OPMTW4I&DGT3PW862%SEO+CB![\_>8_C7Z14 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?AC_P
M5V_X^? O^];_ /H\5]Y?L+?\DAT;_L'V_P#Z#%7P;_P5V_X^? O^];_^CQ7W
ME^PM_P DAT;_ +!]O_Z#%7VF._Y)'+/^OU7_ -.1.>'^\5?\,?RB?;E%%%?%
MG0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!'+*D,;RR'"1J7<^BJ,D_E7X,_\ !17]L']I/P[XR3X5_L]Z%?:M%K:-8W-S
M9VTLC1JV%9M\8..3GG@=SD5^\L\*W$,L#_<E1HVQ_=88/Z5YEI?P?\$Z9XA/
MB<:5;76K N8[BZMXI6C9\_,I=6.X9RISP<$=* /\\K]F+XV_M.^!_P#@L%X.
M^'GQ:UO6[2+7M;M))=*NI;E(@T]PA9/*D; ^\1C'&/PK_0(_:5^++_!SX6>(
M/%MNK/?V]A>FP1069KB*W+H% !.=S+C'?IS7\4O[9;P-_P '$7@"*WM8+2.W
M\3V4:+;QI$I"W:C)5%"\@#H /:O[F/B-\-O#OQ/T0:!XEB::P#NYC #!C(JJ
MP8-P00HXH _C)^$?P\_:8_X*K?M ^,M%^)&J^(/"7@73;Z]^PW6;NVB:UBE<
MJRL=H(\M0>.H[UT7QV_9P^.7_!+3Q_HWC;P;XIUGQ%X+L;BWDNII9[B6(P!U
M8L<G&"G.#CKCUK^O#X8? WX<_!R"X/A#1[/3#*C?:+H10PL5(^=G=0N 1G<6
M;&"<U_-;_P %NOVUO#?B#QYH/[)/A"V@\0Z]XGGM-.DNM-VWCV\T[B)PSQ;]
MNQV./0# ]: /W<_8/_:?3]JGX,V'CXD&Y5+2"ZQU\XPMOS[ED))/)-?;=?F'
M_P $J?V;_$7[-O[.FG^&O$HF6]UA+#5E28,K)'<6YE"X;!&!*O&.*_3R@#XX
M_;J^,UM\&?V</B7XABNQ!K2>'+L:4@<+(T^QG5D^8-D&/' _BSFOPP_X(?VW
MC+]IG4OB5\7?B3J-\]SHVMN=(CNC*08S>@($WD\>62<CCUQQ7M7_  75^+1\
M*:%X6\$F=HT\3110-$'(63SV*8900#G=7U'_ ,$=OA-%\-_@:U]%;K /$5K:
MWAVH$WF5DEW' &<]2?7CM0!P?_!2O]LCX]?"V/6/ /P#T6]U7Q ]O<69%I;R
MS.B['CR#&-W;.<^GM7\Q7[,GQ#_:JC_:@L/$_P 8M6US3M1U+70T^EW+W$:(
MLMUDJ8Y"!CG&",],^W][5[\%/ =UXJO?&VH:3;W^K3QS,YNX8I8\LK$GYPQZ
MU_*;^U0UJO[:%E#:6-K91)X@VK';1+&@"W2XPJ@#M_GN ?UJ_"Z]DU'X>^$;
MV5B\ESHMM([$Y+,=P))]3BL?XU?%OPO\#_AQXB^)'B^[BL]%T"TDGFEE=8U:
M3RY'C3+'!+%#P/3\:F^#3*GPK\$.[*JC0+4EF(50!NR220 !ZFOYL/\ @KO^
MU[J'Q5^*D/[$'@MKS4(O%UY;V5Y=:3YDJ(S,8#N>+( ^<D_RH _GR_;F_P""
MC'[2'QG_ &M]+\4?#;4=:B^#W_"6+;?;+5[D6C0"[51\Z$1[=N>_;VK^]7]C
M/Q?>7W['W@?Q?>3O=WL?A2YU"661BSR2V]FLG))))W+WY.:_DR_:U_8RTO\
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M#PM%XO\ V&?C1I$B!GET8M"V 61_*N!E?0G(SCT]J_&W_@VQO]6\&?##QKX
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M?%O0O#/P>U'Q/I'C37+UTU Z3/=0F*>Z+AB3$R$=#G)P0"I!% '(_P#!:O\
M8'_X* _"[]GF+QW\6_BI>Z[X M?$:+>:6=4:ZB=F1<;E69T&05P#@_*2.AK^
ML/\ X(%36LW_  3<^#OV5-B1QS1O[R);68<_B0?ZU_-#_P %?_VO?VZ/V\?V
M;=!^'_A+X0:O:V-WJEK<7]E9:/<1(SM(F^618XAN8(, MG &. *_J%_X(<?#
M;QG\*?\ @GO\)O"/CW29]%\2VB327UA<1-#+$TEO:?>1P&'*MP10!^OE%%%
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M2UBOK5FQ*C>3 1E#\PP0P.:^T?VB--U#5O@]XVT_2X6N+ZYTJ9((44LSN58
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M 4444 %%%% 'X8_\%=O^/GP+_O6__H\5]Y?L+?\ )(=&_P"P?;_^@Q5\&_\
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M1VJO)NZ$@9('X\9KYF_X(%_M(6WQL^&7CO0O.'VCPC<FQ$).&"V]VL! 4Y/
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M_P G*^#O^PE:?^C8Z_I\TG_D%:9_V#[+_P!)HJ_F%='?]I;P<%5F_P")E:]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "OYP/VWO^3C+'_L*Q?^CA7]']?SB_MOPS+^T98@QN#_ &M$,%2#
MGS@.GXU]9P>U_:-77_F%JF%?X%ZK_P!*B?N=^SS_ ,DF\+_]>J_^BHJ]LKQ7
M]GM'3X3^%@ZLI-HI 8$$CRXAD9[9!&?8U[57S>+_ -ZQ'_7ZI_Z6S:.R]%^0
M4445SC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ !P ,UIT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO&'_ %TB_P#0&K]&*_.K_@J,CO\ LG>,BJLP62+) )QE'QG'K@X]<&O5R/\
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M -"/$?\ A5/R\_+\?6YR5_\ GXNGV5_=_P"#^/<_)C_A]G<?]$DO?^_%W_\
M%4?\/L[C_HDE[_WXN_\ XJOUG_X8Z^ ?_0BZ/_X!0?\ Q-'_  QU\ _^A%T?
M_P  H/\ XFC^TN$?^A'B/_"J?EY^7X^MSDK_ //Q=/LK^[_P?Q[GY,?\/L[C
M_HDE[_WXN_\ XJC_ (?9W'_1)+W_ +\7?_Q5?K/_ ,,=? /_ *$71_\ P"@_
M^)H_X8Z^ ?\ T(NC_P#@%!_\31_:7"/_ $(\1_X53\O/R_'UN<E?_GXNGV5_
M=_X/X]S\F/\ A]G<?]$DO?\ OQ=__%4?\/L[C_HDE[_WXN__ (JOUG_X8Z^
M?_0BZ/\ ^ 4'_P 31_PQU\ _^A%T?_P"@_\ B:/[2X1_Z$>(_P#"J?EY^7X^
MMSDK_P#/Q=/LK^[_ ,'\>Y^3'_#[.X_Z))>_]^+O_P"*H_X?9W'_ $22]_[\
M7?\ \57ZS_\ #'7P#_Z$71__  "@_P#B:/\ ACKX!_\ 0BZ/_P" 4'_Q-']I
M<(_]"/$?^%4_+S\OQ];G)7_Y^+I]E?W?^#^/<_)C_A]G<?\ 1)+W_OQ=_P#Q
M5'_#[.X_Z))>_P#?B[_^*K]9_P#ACKX!_P#0BZ/_ . 4'_Q-'_#'7P#_ .A%
MT?\ \ H/_B:/[2X1_P"A'B/_  JGY>?E^/K<Y*__ #\73[*_N_\ !_'N?DQ_
MP^SN/^B27O\ WXN__BJ/^'V=Q_T22]_[\7?_ ,57ZS_\,=? /_H1='_\ H/_
M (FC_ACKX!_]"+H__@%!_P#$T?VEPC_T(\1_X53\O/R_'UN<E?\ Y^+I]E?W
M?^#^/<_)M/\ @MA<N2!\)+W(4M_J+OM_P(U^/7[3W_!3;4O'GQCM/$S^"KFU
M:+4(Y1 ULZGY958#'E^W'&3U&<G/]>$'[('P#@9F'@+1F+(R<V< P&&">$_P
MK^?+]LO]G;X6Z+^T!9Z?8>&-.M[5M3C4Q)!&%V^<!T"XZ<?YY^BX9QW#%3'5
M%A\GK4IK#U/>EB)2O&RYDDWY+_@O4QK1K<BO43U72S7PK?U_S]/7_A1_P6>O
MM)\!:'ITWPNO;LV%I'")A;W !7:"H^3:I&=Q!QDYZGC'H'_#[.X_Z))>_P#?
MB[_^*K]#?@+^R5\#+KX5^'I;KP-I$L]S:QEY&M82?EC3'5">YXSQ^->M?\,=
M? /_ *$71_\ P"@_^)KP\1F/"2Q%>^28AOVL[VQ4DF^;5JSM9M/YM]'KK&%>
MT?WBV7V=OA_R?XZZGY,?\/L[C_HDE[_WXN__ (JC_A]G<?\ 1)+W_OQ=_P#Q
M5?K/_P ,=? /_H1='_\  *#_ .)H_P"&.O@'_P!"+H__ (!0?_$UC_:7"/\
MT(\1_P"%4_+S\OQ];ODK_P#/Q=/LK^[_ ,'\>Y^3'_#[.X_Z))>_]^+O_P"*
MH_X?9W'_ $22]_[\7?\ \57ZS_\ #'7P#_Z$71__  "@_P#B:/\ ACKX!_\
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M_+S\OQ];G)7_ .?BZ?97]W_@_CW/R8_X?9W'_1)+W_OQ=_\ Q5'_  ^SN/\
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M_%5^L_\ PQU\ _\ H1='_P# *#_XFC_ACKX!_P#0BZ/_ . 4'_Q-']I<(_\
M0CQ'_A5/R\_+\?6YR5_^?BZ?97]W_@_CW/R8_P"'V=Q_T22]_P"_%W_\51_P
M^SN/^B27O_?B[_\ BJ_6?_ACKX!_]"+H_P#X!0?_ !-'_#'7P#_Z$71__ *#
M_P")H_M+A'_H1XC_ ,*I^7GY?CZW.2O_ ,_%T^RO[O\ P?Q[GY,?\/L[C_HD
ME[_WXN__ (JC_A]G<?\ 1)+W_OQ=_P#Q5?K/_P ,=? /_H1='_\  *#_ .)H
M_P"&.O@'_P!"+H__ (!0?_$T?VEPC_T(\1_X53\O/R_'UN<E?_GXNGV5_=_X
M/X]S\F/^'V=Q_P!$DO?^_%W_ /%4?\/L[C_HDE[_ -^+O_XJOUG_ .&.O@'_
M -"+H_\ X!0?_$T?\,=? /\ Z$71_P#P"@_^)H_M+A'_ *$>(_\ "J?EY^7X
M^MSDK_\ /Q=/LK^[_P '\>Y^3'_#[.X_Z))>_P#?B[_^*H_X?9W'_1)+W_OQ
M=_\ Q5?K/_PQU\ _^A%T?_P"@_\ B:/^&.O@'_T(NC_^ 4'_ ,31_:7"/_0C
MQ'_A5/R\_+\?6YR5_P#GXNGV5_=_X/X]S\F/^'V=Q_T22]_[\7?_ ,51_P /
ML[C_ *))>_\ ?B[_ /BJ_6?_ (8Z^ ?_ $(NC_\ @%!_\31_PQU\ _\ H1='
M_P# *#_XFC^TN$?^A'B/_"J?EY^7X^MSDK_\_%T^RO[O_!_'N?DQ_P /L[C_
M *))>_\ ?B[_ /BJ/^'V=Q_T22]_[\7?_P 57ZS_ /#'7P#_ .A%T?\ \ H/
M_B:/^&.O@'_T(NC_ /@%!_\ $T?VEPC_ -"/$?\ A5/R\_+\?6YR5_\ GXNG
MV5_=_P"#^/<_)C_A]G<?]$DO?^_%W_\ %4?\/L[C_HDE[_WXN_\ XJOUG_X8
MZ^ ?_0BZ/_X!0?\ Q-'_  QU\ _^A%T?_P  H/\ XFC^TN$?^A'B/_"J?EY^
M7X^MSDK_ //Q=/LK^[_P?Q[GY,?\/L[C_HDE[_WXN_\ XJC_ (?9W'_1)+W_
M +\7?_Q5?K/_ ,,=? /_ *$71_\ P"@_^)H_X8Z^ ?\ T(NC_P#@%!_\31_:
M7"/_ $(\1_X53\O/R_'UN<E?_GXNGV5_=_X/X]S\F/\ A]G<?]$DO?\ OQ=_
M_%4?\/L[C_HDE[_WXN__ (JOUG_X8Z^ ?_0BZ/\ ^ 4'_P 31_PQU\ _^A%T
M?_P"@_\ B:/[2X1_Z$>(_P#"J?EY^7X^MSDK_P#/Q=/LK^[_ ,'\>Y^3'_#[
M.X_Z))>_]^+O_P"*H_X?9W'_ $22]_[\7?\ \57ZS_\ #'7P#_Z$71__  "@
M_P#B:/\ ACKX!_\ 0BZ/_P" 4'_Q-']I<(_]"/$?^%4_+S\OQ];G)7_Y^+I]
ME?W?^#^/<_)C_A]G<?\ 1)+W_OQ=_P#Q5'_#[.X_Z))>_P#?B[_^*K]9_P#A
MCKX!_P#0BZ/_ . 4'_Q-'_#'7P#_ .A%T?\ \ H/_B:/[2X1_P"A'B/_  JG
MY>?E^/K<Y*__ #\73[*_N_\ !_'N?DQ_P^SN/^B27O\ WXN__BJ/^'V=Q_T2
M2]_[\7?_ ,57ZS_\,=? /_H1='_\ H/_ (FC_ACKX!_]"+H__@%!_P#$T?VE
MPC_T(\1_X53\O/R_'UN<E?\ Y^+I]E?W?^#^/<_)C_A]G<?]$DO?^_%W_P#%
M4?\ #[.X_P"B27O_ 'XN_P#XJOUG_P"&.O@'_P!"+H__ (!0?_$T?\,=? /_
M *$71_\ P"@_^)H_M+A'_H1XC_PJGY>?E^/K<Y*__/Q=/LK^[_P?Q[GY,?\
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M +\7?_Q5'_#[.X_Z))>_]^+O_P"*K]9_^&.O@'_T(NC_ /@%!_\ $T?\,=?
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MQ_T22]_[\7?_ ,51_P /L[C_ *))>_\ ?B[_ /BJ_6?_ (8Z^ ?_ $(NC_\
M@%!_\31_PQU\ _\ H1='_P# *#_XFC^TN$?^A'B/_"J?EY^7X^MSDK_\_%T^
MRO[O_!_'N?DQ_P /L[C_ *))>_\ ?B[_ /BJ/^'V=Q_T22]_[\7?_P 57ZS_
M /#'7P#_ .A%T?\ \ H/_B:/^&.O@'_T(NC_ /@%!_\ $T?VEPC_ -"/$?\
MA5/R\_+\?6YR5_\ GXNGV5_=_P"#^/<_)C_A]G<?]$DO?^_%W_\ %4?\/L[C
M_HDE[_WXN_\ XJOUG_X8Z^ ?_0BZ/_X!0?\ Q-'_  QU\ _^A%T?_P  H/\
MXFC^TN$?^A'B/_"J?EY^7X^MSDK_ //Q=/LK^[_P?Q[GY,?\/L[C_HDE[_WX
MN_\ XJC_ (?9W'_1)+W_ +\7?_Q5?K/_ ,,=? /_ *$71_\ P"@_^)H_X8Z^
M ?\ T(NC_P#@%!_\31_:7"/_ $(\1_X53\O/R_'UN<E?_GXNGV5_=_X/X]S\
MF/\ A]G<?]$DO?\ OQ=__%4?\/L[C_HDE[_WXN__ (JOUG_X8Z^ ?_0BZ/\
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M_/Q=/LK^[_P?Q[GY,?\ #[.X_P"B27O_ 'XN_P#XJC_A]G<?]$DO?^_%W_\
M%5^L_P#PQU\ _P#H1='_ / *#_XFC_ACKX!_]"+H_P#X!0?_ !-']I<(_P#0
MCQ'_ (53\O/R_'UN<E?_ )^+I]E?W?\ @_CW/R8_X?9W'_1)+W_OQ=__ !5'
M_#[.X_Z))>_]^+O_ .*K]9_^&.O@'_T(NC_^ 4'_ ,31_P ,=? /_H1='_\
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MSN/^B27O_?B[_P#BJ/\ A]G<?]$DO?\ OQ=__%5^L_\ PQU\ _\ H1='_P#
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M /%4?\/L[C_HDE[_ -^+O_XJOUG_ .&.O@'_ -"+H_\ X!0?_$T?\,=? /\
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M22]_[\7?_P 57ZS_ /#'7P#_ .A%T?\ \ H/_B:/^&.O@'_T(NC_ /@%!_\
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M@Q3:A:12 ^A1YE8'VQ0!J45#!<V]T@EMIX;B(])()4F0_1XV93^=34 %%%%
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M#(Z%C(&4DDD8VXQG@YKW#_@IG_P4:T#]C/P/);6L+7OB?6#)8V4<!WRQ3O\
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M$YX?[Q5_PQ_*)]N4445\6= 4444 %%%% !1110 4444 %%%% !1110 4444
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MVGPW$\[1+;WDJE  YP %<8Q_]>@#^T>C(]17S1;_ +1/AG3_ -F^Q^/.J74
MTP^$(?$$D;2JK2.1M\H+N#$EAGCJ.^37X\?LS_M6_'7]L7]I*?Q-X&FOK7X5
M:+JYM[N)7D6V>*.<J?E!V8VKC!]OQ /W\\1>*=&\+V\5UK-W':0RN(T>1E12
MQ.,98@5KV%]::G:07UE-'<6MS&LD4L;*ZLK#/!4D9'<9KX9_X*">"O'WBOX+
M7UY\/Y[B#4_#L=YJTYMV97:"")' ^3DXV,>O:OSM_P""17_!0&]^/?BWQ1\!
MO%%TS>(O 27MM/Y\A,CR60D5A\QSDM'CZD#V !_0'1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^='_!4<D?
MLG>,,$C]Y%T_W&K]%Z_.?_@J1_R:=XP_ZZ1?^@-7JY'_ ,CG+/\ L-P__IR)
M%3X)>AX%_P $;_\ DADO_7S+_P"AO7[*U^-7_!&__DADO_7S+_Z&]?LK73Q/
M_P C[,O^PA_^DQ%2_A0_PH_ESE_Y.5\'?]A*T_\ 1L=?T^:3_P @K3/^P?9?
M^DT5?S!R_P#)RO@[_L)6G_HV.OZ?-)_Y!6F?]@^R_P#2:*O5XN^#*O\ L&J?
M^E1,\/M/_$O_ $E&A7\KO_!PZ;:WUWX.7M^XAL8)K5IIV.U8U6Z4L2QP!P,\
MGM7]45?RH_\ !QWIA\3VWPP\*+(;=M5\F$7"G#1F2X"[@1R,9X_.OC#H/U7_
M &"/VEOV<](_9Z\%:?-\4O#-CJ$&CV2W<-]J*(R%85&U53><[L[MP&,  ]17
MV=??M3_LY-8WWF_%[P:T(L[DS"+4P9/*\E]^S<@7>5R%R0-V,D#FOYE_V1/^
M"&-[XW^$/AOQ=/\ &35=+CU?3K::.W2]O&52T:N5"P;]H4,,9P#V/%?45S_P
M0*E^Q7\<?QTU>22:TN$C4W>I+F1HV"KN9 JAFP"6( SDD"@#\9_^"2VI>'O%
M7_!<SXYZWX3O8M5TJXU[6'M[^!Q)$R&XG;<'4D8*C/7H>*_8W_@H=_P41\7?
ML:_M?>#/ -]<SKH'CC5;&.U+.XB\N[EB7C)"X!<CCN/3%?A5_P $)_A5+^S[
M_P %C_BW\+9M1DUE].U;6+=M0FD,KR>6\\08N22<\G_.:_>7_@N]^QS:?%I/
M!'QW6V5)?AI#;WL]VJ9<&RFDF!+ 9!$:*.OZ4 ?T#>'O'.F7/PRT+Q[=W,::
M?>^%M.UMYV8!2+BPCN6&[.,ERR]>,'Z5_.K\._\ @HA\0?C)_P %%=:^"NA"
M[?P;8WTT'VJ-G-N%CE92<KE, +WP>F.E:FG?MY6'BC_@EOXIU;PYJHD\0^!-
M!;1"8Y@;G%C;M$%VABYQNP .!CCFN0_X(+?!_3OBIX)\5_M->)M,C/B>[U2Z
M@MK^>'_26DD,K#$C MG:A(.: .,_X*;?\%9/'W[%_P 6E^'GA^UO-9FU9X[:
M)8-\A228^6.!D\,>O_UZ\^\->*?VROC;\-XOCMI]QKNGPSV:ZI;Z8KW:ET*"
M8*(^,YQC@8_'%>>_MG_#GP[\5_VW-,;Q+IMIJD=IKT0"7B(XQ'=#C$@(Z*!]
M.>>:_K1^"W@+P?HWPC\$Z)I_AW2[?38_#MC";1;2$Q.!&0V]0N&R<]>V!VH
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MPCP(XMI5D(((XQ7X]_\ !OGXW\=?%'_@KI\2O&?Q-TN3PWXLO+_4YKO19(S
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M'HP!R!I6G 'U LX1G\>M &K1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M\X'[;W_)QEC_ -A6+_T<*_H_K^<#]M[_ ).,L?\ L*Q?^CA7UG!__(QK?]@M
M7\C"O\"]5_Z5$_=/]GG_ ))-X7_Z]5_]%15[97B?[//_ "2;PO\ ]>J_^BHJ
M]LKYO%_[UB/^OU3_ -+9M'9>B_(****YQA1110 4444 %%%% !1110 4444
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M)-Q9I:Q3=P2BJ$!&.GO],?"+_@L;^T5/\;;3PC\4/ DF@> =0OHH=)U*;3Q
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MF66"WCB9I!(-SY10>6&??^7[I_\ !,ZR;5_V%/ &E%L&^T+4;!6)^ZMWIUO
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M-FVGZYIEGJMD^=UK?0)<0MD8)*2 C..,]:_)3_@HA\6OV?OV7_A^_AB'X?\
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M#X=;Q&=5B\8^'/"\-OJ5D5(CEU"V0J/E,1<[C@N _)!P1FOS^_:X\&6OCO\
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M_P""G=WJE[^PM/K&JZ?(NN77A\/>V5M$=R2M &90B XY[ =C7SQ_P;R3SS_
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M DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM^(?ASX8>#+S7SKWB2Y2RTV.:.-(0Y9(U4A;=0%&]0 ",# 'MWEY_P $"/\
M@FW>N7?X.K&3VBN847\ +8 5V/PQ_P""(G[ 7PB\:Z+X_P#!7PO?3O$F@7"W
M6FW9NHV$,RLK!MH@4G!13U'2@#]$?C%\:/#7P;^'5Y\1?$/FG2X+(W$*QC+/
M)):-<P*P )(;"A@!GDX(K^4[X9R_%+_@J#^VFT7CFVU6#X)^&_$+7>G"YCE6
MU:WM+HN  P"D%%& ,Y^O%?UG_$+X6^#_ (G>$SX*\6Z?]OT I$AM=P7*PQ>3
M&,D'HG'2N2^$G[.GPH^"4+Q?#[PU;:09-V^55C,I+_>)98T.3[DT ?S"_P#!
M=WX/^-?!?BG]F,?#:QOT^'O@2ZTB36XK")A%):6<T:R+<+'E>8XN=Q/!ZGFO
M'?VK_P!M3X)_'J#X)?"'X2>%19^/],TO1=.U2\L+#R[AKV.*.&5I9$C#;C("
M22<YS^']>WQ5^"OP^^,NCR:+XZT2WU6V:)HD,L<;M&&SDKO5N>3T(ZU\<^!/
M^"5_[(_@'QJGC_2_!"3>)(;A;F"[E$2B&17W@JI23(!'3(% '8?L9>'?$'PL
M_9F@;QW/+'<0:.VHL]XQ#+;C3W95)?!Y) QU]J_D[_X)T-XR^,O_  66^*PU
M:UN#X0T_Q'JTMK<LK&W:.*\D*[6Q@@H,X!K^I'_@I)\2_$'PJ^ ,EEX+TZYN
M+G4(SIB062,3':&+[.BA8UP  #V]\5\K_P#!*S]CNS\&6Z?M#ZMI?V+Q/XO-
MS/<>?%LN0TH#L26 8\R=?7M0!^X5K;I:6\-M%_JX(UC3/]U1@5/110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^
M&/\ P5V_X^? O^];_P#H\5]Y?L+?\DAT;_L'V_\ Z#%7P;_P5V_X^? O^];_
M /H\5]Y?L+?\DAT;_L'V_P#Z#%7VF._Y)'+/^OU7_P!.1.>'^\5?\,?RB?;E
M%%%?%G0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <CXZTRZU;POK%G8EA>O97'V4J2&\_RG$>".^[&/YBOY#[C_@H
MM\7?V&_VTM?M/VH_#VI:K\$KC4KVVLY[JU-Q%!;R2.B30&:*6(21*=\996 =
M5+*1Q7]CU?'W[1W["W[.7[5%M]G^+W@FVUL_-B:,112[B"-Q;R6)()SUY_+
M!^&G[4/_  7@_9(\9?![Q#X$^"GAV;4?&/Q!T>?1M+D.EVL36LEWA5>-;6V1
MO-W!0'+X 9ALS\P[[_@@_P#LM?$#P3HOC?XM_%.RN$G\83OJ>A+>QMN1+NY6
M9=@<<8B<GCH/RK[:\'?\$3/V%/!>N:=KNG?#TRW.DS+/8),8MD+H05.2KYP0
M/X1TK]5O#/AK1?"&B:?X=\/V46GZ3IEO';6EM"BHJ11J%7.U5!;  )QV% &]
M7D7QY\+V_B_X/_$70YTWFY\(>(#",9/GQZ7=/#@>ID50/>O7:HZG9IJ.FW]A
M( 4O;*YM7!Z%;B%XB#GC&&[T ?Q.?\$!YM;^#/[<7[2'A_X@2RV-CJNJ>((-
M$^UMY8<RW4RPB/?@'=PO'J?7%?VW12)-&DL9#)(BNC#D%6 ((^H-?R;?MC_L
M\>./V8/VK?"'Q"^'VD7<MAXJUN"ZOI-.B8($GNP[^:8QV)(.XX^O2OZCOA;J
M\^N_#SP?JMU&T5S=Z#ISW"/G>LWV:,2!L\YW YS@YZT ?S;?\' %S<0>%- ,
M%A=WG_$X@XMXFD/^N/\ =!_SZ5^N/_!*N223]BOX5O)#+;N;1\Q3*4D7_1[/
M[RD BOI_XO\ [-WPF^.=O#:_$;PY#K<,$HEC63R_E<'(/SQOT))XQ7HG@#P#
MX9^&?ABP\(>$+!-,T+3%*VEHFW;&I55P-JJ.B#HHH \&_;=9D_9:^,3)&\K#
MPG>[8XU+.QP.% R2?I7\W7_!!NYNI_'WQ"$VG7EH!KUT UQ"\8;]_)R-RC(/
M;UK^M'Q3X8T?QEH&I>&M>MEO-)U:W>UO;9L8EA?[RG((Y]P:\4^$O[*_P8^"
M5Y>7WP]\+0:+<7\S3W+QB/YY&)8M\D2=R3R30!H?M%_'GPW^SW\.]4\;^(Q,
M\4-I>BR2$99[N&WWQ C!."[)]:_EW_9@\-_$[_@IK^V!=>+_ (NVNJ1?"GPE
MK-QJ.A1W<<@@DM[.9[B-8U?:IW)& HR <\D5_5I\5?A#X)^,OA\>&/'>F_VG
MI =I/L^X*"SA0V258$$* 0165\)_@+\,O@K8'3_A_P"'K?1X2I4LBQ^801@@
MND:'D$@YSP<4 ?RJ?\%M_AUXX\"_M4?LU>(O"UA?_P#"J/ G]@-K%O9PN;62
MWMEM&N%N$0%#D(^X'/?J*X/]J[]L+X._M/?$GX3?#GX&>%CIOBG2[+2+'4KK
M3['RG:[CCABE:1XXU)8."22<^N#7]<7Q?^ 7PU^-^ER:7X]T*WU2-XC$DLD<
M;R1+C'REESD#IAA7RK\+_P#@E[^R=\*/&(\>>'?!*'Q*DZW$=]*(ALD5MRD+
ML<X!]&% 'J?[,7AOQ%X _9GM['Q2\QU2R\.:G?2-<%MZQ)I!E3);D ;&SZ>U
M?RA?LG>+[W]K/_@I!X\\*1Q2R1>$/$5V&?!* 6UVX)!P0 -G8_I7]4G[<'Q<
MU+X._!V\.@:;/>7&L6=WHT,-K&S&.&>V^RA0$!P DA XZ?2OR\_X)'?L+GX7
M_$KQC^TCJFFR6FH^/&OKLBXB*R+)>^8P(W<@[I![\'TH _H#\/:<-(T/2M+
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M J9P!^=?*7_#=W[-G_0]0?\ ?M/_ (]1_P -W?LV?]#U!_W[3_X]1_9>8_\
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M/YH_?_7?\^S/L.BOCS_AN[]FS_H>H/\ OVG_ ,>H_P"&[OV;/^AZ@_[]I_\
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M\.>'\T?O_KO^?9GV'17QY_PW=^S9_P!#U!_W[3_X]1_PW=^S9_T/4'_?M/\
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M#_OVG_QZC^R\Q_Z <7_X(J?_ "/FOO#GA_-'[_Z[_GV9]AT5\>?\-W?LV?\
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M9>8_] .+_P#!%3_Y'S7WASP_FC]_]=_S[,^PZ*^//^&[OV;/^AZ@_P"_:?\
MQZC_ (;N_9L_Z'J#_OVG_P >H_LO,?\ H!Q?_@BI_P#(^:^\.>'\T?O_ *[_
M )]F?8=%?'G_  W=^S9_T/4'_?M/_CU'_#=W[-G_ $/4'_?M/_CU']EYC_T
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M ,CYK[PYX?S1^_\ KO\ GV9]AT5\>?\ #=W[-G_0]0?]^T_^/4?\-W?LV?\
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M_D?-?>'/#^:/W_UW_/LS[#HKX\_X;N_9L_Z'J#_OVG_QZC_AN[]FS_H>H/\
MOVG_ ,>H_LO,?^@'%_\ @BI_\CYK[PYX?S1^_P#KO^?9GV'17QY_PW=^S9_T
M/4'_ '[3_P"/4?\ #=W[-G_0]0?]^T_^/4?V7F/_ $ XO_P14_\ D?-?>'/#
M^:/W_P!=_P ^S/L.BOCS_AN[]FS_ *'J#_OVG_QZC_AN[]FS_H>H/^_:?_'J
M/[+S'_H!Q?\ X(J?_(^:^\.>'\T?O_KO^?9GV'17QY_PW=^S9_T/4'_?M/\
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M_P"&[OV;/^AZ@_[]I_\ 'J/^&[OV;/\ H>H/^_:?_'J/[+S'_H!Q?_@BI_\
M(^:^\.>'\T?O_KO^?9GV'17QY_PW=^S9_P!#U!_W[3_X]1_PW=^S9_T/4'_?
MM/\ X]1_9>8_] .+_P#!%3_Y'S7WASP_FC]_]=_S[,^PZ*^//^&[OV;/^AZ@
M_P"_:?\ QZC_ (;N_9L_Z'J#_OVG_P >H_LO,?\ H!Q?_@BI_P#(^:^\.>'\
MT?O_ *[_ )]F?8=%?'G_  W=^S9_T/4'_?M/_CU'_#=W[-G_ $/4'_?M/_CU
M']EYC_T XO\ \$5/_D?-?>'/#^:/W_UW_/LS[#HKX\_X;N_9L_Z'J#_OVG_Q
MZC_AN[]FS_H>H/\ OVG_ ,>H_LO,?^@'%_\ @BI_\CYK[PYX?S1^_P#KO^?9
MGV'17QY_PW=^S9_T/4'_ '[3_P"/4?\ #=W[-G_0]0?]^T_^/4?V7F/_ $ X
MO_P14_\ D?-?>'/#^:/W_P!=_P ^S/L.BOCS_AN[]FS_ *'J#_OVG_QZC_AN
M[]FS_H>H/^_:?_'J/[+S'_H!Q?\ X(J?_(^:^\.>'\T?O_KO^?9GV'17QY_P
MW=^S9_T/4'_?M/\ X]1_PW=^S9_T/4'_ '[3_P"/4?V7F/\ T XO_P $5/\
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M)5+^%#_"C^-;]IGX&K\;/V@?"^GO--$)[^!,PL5QNE3ICM@C_P"OFOT^LO\
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MEJ"M<V\;@"23C$8S@=A@COGBO1/^'3MM_P!!34O^_LE?K_\ L^R&3X4>%BP
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M[;?]!34O^_LE?O111_K9G?\ T%/[O3_+\?6Y["E_*?@O_P .G;;_ *"FI?\
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M  48_P""?UO\-;[PP8[Z\D2]>(KOD<X#2A>,GJ>O_P!;K]5?LI_\$R[?Q?\
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MT_R_'UN>PI?RGX+_ /#IVV_Z"FI?]_9*/^'3MM_T%-2_[^R5^]%%'^MF=_\
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M_P"_LE'_  Z=MO\ H*:E_P!_9*_>BBC_ %LSO_H*?W>G^7X^MSV%+^4_!?\
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M*_G1\#?\%O/!_C_XH^/_ (0:'/'=>+/#=W>65G;P$22-/ \D2@JF6'S*/?\
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M7Q/XXT+]B;XB0^&Y+RTTVYMX5U"]LA()85*3*#N3Y@"&<Y![5\1?\&W7P/\
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M[(?[ /P8^$7[/.B^ ;_PWHNOW.HZ4ANM7GM(+B<^= JATF()+[BQ;)/IU)P
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MX_M!^BXQTR/KVZ9_T8_AAX1L/ _P_P#"_A^PMTMQ8>']+AG5$";[B.PB$K,
M,;O,W"O\]/2[2U^'G_!>'Q1XM^)-U'X3\,3^+KB2'5M1;[-;.AOG.5EEVH>/
M>@#^Y;]J31-/\'?L0?&VST:%(8(/A7K%PJQJ$4RO:6X) 7'H/\\5_(%_P;,?
MLF?#SXN_%#]HWXG>+(3<ZEHWB;49(8<!@SOJ0A7(;CAI=QSS@'%?UU?M5^._
M _C/]B#X[:AX*\3:7XBTI?A/JZPWFG727*%1:PE=Y0D!R 2R@G!S@D#-?S7_
M /!I]?6UW+^U.MO-'+Y?B.]#A#DH?[9CX./?UH ^[?\ @OA^QW\.M5_9#NO%
M&@V?]E>(M%U*,6MQ:(D,K+'&KKAHPIR"IW9/<'MQW?\ P1M\2:Y)_P $Q_&?
MAW6KJ>YN/#?A/Q/;VTL\C/+Y=UX>O+>3YB2>/+C.<\'KUKZ%_P""W]S':_L:
M:Q)+(L:_VBXRW _U"?XU\Q_\$@[J"X_X)_\ Q<FCE1U'A77RSJ> /[*O3].U
M 'X3?\&_W[-O@7XN_P#!0S]J;Q/XSDGOKS0=;\075C;RMYB^9'>2%,*[$<$E
MC[ \>GZS_P#!>;]A/X*>(OA"WC,PC2];TZ.)H)+55@ERO0[H]IYV@^^1QUKX
M'_X-K-0L[K]O?]KR*WN(Y7CU+Q/O5&!*XN)^#BOVH_X+IW,%O^S_ *DTTBQK
MY47+' ^Y0!YO_P $.?V3OA=)^R$NHZC VK7E_.^FRS7@6=TMV@D!RTF3R,$<
M]N37YC^-O@#X-^!G_!0.R\2>!IY;2[O?%*M-# YCC^:[Y&U2!C!(QCIUK]P?
M^"&$\-Q^QC!)#(LB?VF!N4Y'_'O<=Z_);]HJ]M5_;ITB-IXP_P#PE,8VEAG/
MVP#I0!T?_!;5[C4_%W[/5]+<31SRMHCR;78;F+P YP>>![Y_E^[_ ,%/AYX4
M^+7[&WASP1X_O$M/#-SX:MDN[F:6.)5A-IEW9Y71<*O4;LGL"2*_!O\ X+37
MEI!XH_9S$\R1A_[$QN.,_-#@CI^'K7TQ_P %"_C'\2O@_P#\$H+#Q'\)S=IK
MX\-6Z+<69D5UC-M&"VZ/YL8!/KZYH 6W\1_\$X/V!O%6I_V/I%KXMUH7<TUU
M<6\:78,N\[\LH<=3SR.^:_G&_P""T_\ P4&^!'[1'QM_9^L/@#H-]X1\0Q>)
M=*BU2:VB>R6<OJ2J,E FX!%&?I7ZU?\ !"GX=_LZ?M(?LZWGQ._:V\3:!K'Q
M$N]8>!M'\1:M!;2(L[7#.[FY+2?(8U4)A22V=P"D'\^O^#B;X9?L3_"'XK_L
MTVG[/MOX<T_Q@WB+3/[5.CW$$Z&9M5,D06>, R'R7CR<8#94%@ 2 ?W.?L</
M=2?LM_ N2^D::[?X>:&UQ*[%G>0Q,69F/))]:^E:^7_V*I9)OV3_ (!RRMND
M?X;Z"S-ZDQ/S^5?4% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\DAT;_L'V_\ Z#%7VF._Y)'+/^OU7_TY$YX?[Q5_PQ_*)]N4445\6= 4444
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M_!G5/V(/V;_ARF@:=*WC+Q!#:#Q?JZ1MYI%PJ&Y::4#=T9LECW- 'W#\,O\
M@K9^RO\ #;6?#'[..GZ;<V5[X;MK703<VS106!F@(MVF91!R[LH9W:0EL8X
M '[0^$_%>B^--#L?$&@WD-Y87\$<\3PR+)M$BA@K%>,X/H,U_'M\0?AM^R7#
M^S9=?%K1]:T>Z^.%Q8"_,$-Q";]=0*>9C"L90WF\=,Y^M?KS_P $/_'OQ$\>
M?L\Z[=>/Q="2PU6VM]+^U&1B;0BXVE#)SMVHG3_"@#\J_P!O31++3?VQ;#5K
M5!#>/KREI%&UR3<J3\PYY],^XZ5_4I^S9-)<?!?P/+*Q=VTJ++,<D_*O>OY/
M/VLOB3IGQ9_X*#?\*HT1TFUG3_$;1R0QD-*/+NL<@?-D;?QK^MSX%^'[CPO\
M+/".BW:E;BSTR%)%;.0VQ<@YY[4 >MT444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %?G/_ ,%2/^33O&'_ %TB
M_P#0&K]&*_.?_@J1_P FG>,/^ND7_H#5ZN1_\CG+/^PW#_\ IR)%3X)>AX%_
MP1O_ .2&2_\ 7S+_ .AO7[*U^-7_  1O_P"2&2_]?,O_ *&]?LK73Q/_ ,C[
M,O\ L(?_ *3$5+^%#_"C^7.7_DY7P=_V$K3_ -&QU_3YI/\ R"M,_P"P?9?^
MDT5?S!R_\G*^#O\ L)6G_HV.OZ?-)_Y!6F?]@^R_])HJ]7B[X,J_[!JG_I43
M/#[3_P 2_P#247V&58>H(_,8K\2_VX?^"/\ X9_;1^,/@SXH>*?$ZP#P?J-O
M?6MC-YC ^1,)0B@ J,D<=*_;6BOC#H.1\!>$[3P)X+\+^#;$@VGAK1;#1X"H
MP&CLH%B# 8&-Q!/XU/XS\*Z=XU\,ZQX9U6));+5K*>TD5P&4&6-D5\$'[N[T
MKIZ* /Q5_9D_X)'Z+^SG\<_B/\6=*\6_:;/QZM^LFD*TH2W6]WY&P@(,;^@X
MXQ[GL/@%_P $K?"7P/\ CWXJ^-NGZW'<7OB74);Z2U7>"C22M(1RH'?M^/6O
MUZHH Y[Q#H4>N^'[W0I'"QW=F;4MS@ Q^7GCGIS7Y*_";_@D_P"$OAA^U)/^
MTE:ZY'/J<VH-?&S <-N,OFXY 7_Z]?L710!S?C#P_'XK\*^(/#4S^7%KNDWN
MER.>BI>0/"S'Z!LU^4'[+/\ P2F\)_LU_%[Q+\5-,UR.\N_$.H37TD*A\HTT
MS2D?,,<%B.*_8.B@#R3XT?"ZU^+OP]U7P)>3BW@U.(1M*<D*!$\>3CG^.OAO
M]E;_ ()R>&OV9O'=SXWTW6$O)IKM[QHQOX)?>1EAT_K[5^G]5[P.UI=+'_K&
MMYQ'CKO,3!<?\"Q0!^:__!2'X_? OPM^S=\6?"?C7Q1ID&O:IX5U*STBPDDC
M%T;^2!UB*[CNV\LI4<DL#CBOYK?^#:W]CJYN?BK\9_C+XFMWETXZU>7N@SSQ
M$AXI+T>48V<'(Q(""/7D^OZ!?M;?\$SOB_\ M:_'R+4/$.J:K9^#8M3#M K3
M+;RVXFSM9>%(*\?CS7[J?LG?LJ>!_P!E;X>Z;X.\(V\4<B6%O#J$\<2IY\R*
MA<LP +D,HR2.6!(R,$@'U4JJBJBC"JH4#T51@#\A7X'?\%(O^"(7@;]M_P 0
M0>,O#GB6+P#XM2X-S+J]J)(+B20N9"QE@4-DL?[WK7[YT4 ?DS^RK_P3>U+X
M#?LN>,/V=?$_CZ?QA%XKT.ZT2;5+J6>8I!<V[0G)E+-CD''H.U9O_!,'_@E?
MX3_X)QW/Q1G\,ZW'JW_"R-2GU"X"!QY)FNUNMIWJ.C+CC]:_7BB@#Y'_ &SO
MV6]*_:X^$-W\+-8O5L+2ZN#.9VW8!9%3^$$\;:\X_90_8;T+]F+X$^*O@KI6
MIK>V/B73+[3I;E0V$6]M9K9B0P!X$I/0_CTK[_HH _%K_@G;_P $A_!_[!?Q
MQ^*WQET#7X]4O?B;<:E<75N@D!A.H2.[ [U ^7?V)Y'Y_8?[:_[&NB_M@>!+
MCP5K.H+I\%PJH9&W8 5<9^4$_P#ZJ^XJ* /CO]BK]D_2/V0?A!'\*M&OEU"T
M2Y%QYZA@,A)$Q\P!Z/\ E7RS\0/^"7?A7QS\:[7XOSZTD5Y;:FNHBWP^=PE\
MS'W<$]N3^G7]:J* /R@_;#_X)C>%_P!J[4?A_J&K:TE@W@;[%]G#!\R_9#&1
MC:IZ[.^.N:^G_%/[(?@GQI^S@G[/GB."WO\ 2(]'_LM9YH]Z\0>4'PP8^_3.
M?T^P** /Y&]8_P"#=SQ[X)\9W.K?";XLWVB^&+O4GNQHNGWLL$,6^0D9@CD3
M& YY*#J<=#BY\1_^#:.R^-OC+X?>//B3\49-0U/P;?V>HBWNI[B=G>UDCE5<
MYD4$[,$$Y!X;!K^MBB@#SOX2^ K;X6_#3P5\.[.036O@_0+'0X)0"!)'9H45
M@#SSG->B444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 7Q%XT\1?$OXM?$;3I;6[@UF:?2&NH&4RJUZ A0N,D>6Q88.,#UXK^B7XS?
M/PS\:X;6U\232"UMP%:!5W)*H.<.I(!SR.:Z;X5_"#P?\(=&_L7PCI\%C;,J
MB7R8EB\PK@[F"]22,\]* /4E4*JJ.BJ%'T P/T%+110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?AC_P %
M=O\ CY\"_P"];_\ H\5]Y?L+?\DAT;_L'V__ *#%7P;_ ,%=O^/GP+_O6_\
MZ/%?>7["W_)(=&_[!]O_ .@Q5]ICO^21RS_K]5_].1.>'^\5?\,?RB?;E%%%
M?%G0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<EXU\%>'O'WA_4O#GB33K;4;#4;.XM'CN(UD"">-DWJ&! ()!Z=
MJZVB@#^6KXZ_\&[2^-_B9K7Q!^&?Q8G\##5+FXN!I]A/<VJ@3.6*?NRB 8..
MP&/QKCOA_P#\&Z/BR'QUI/B#XE_&J\\2Z#IL\$LFC7=_/=PW21.&96C\R5?F
M '##'Z5_6-10!X_\#_@MX.^ _@/2O ?@O3K?3]-T^W@CD6VC6))IH8_+\PJJ
MKR<GDC/)KV"BB@#YT_:S\ 'XF_L[_%CP7!;"YO\ 7?"5_8V"[=SBYE*!"G?.
M-W3FOYA_^"-3:[^PW\9OB+\&_B'+/;3>-=?NA86]R'4$37N^+:K\<$#&!@8S
M7]@+*KJ5=5=6&&5@&4CT((((]B*^+/'_ .P_\+?'?Q=TGXPS1#3O$&EW$5RJ
M6L"I'+)&P<EBI &YADC;C\J +7[8?['OP_\ VOOA9J'@CQ#965O=Z@AGM=6>
M$&:)YX@ Y<!FR,JPQCOUXK^<C7?^#:KXAVUT\7A']H+4K'0WEGVZ7%J5W!#%
M#.S!XPC21J 8R%PH/&!CBOZ_H8A##%"OW8HHXE^D:A!^@J2@#\?/^"<__!*?
MPA^Q':W%[JFIV_B_Q'=(6DO[@-/(LQSES)("21DMPQR?:OU/\>^%9/%WA34?
M#MM=&P>\@,,<Z$J8AL9!M(.1M!&/I7:44 ?CQ\ O^"4/A#X0_M%W?[06J:U%
MKVMW%^]\L<P>1U<R&0 F12.#COU%?H1^T3^S_P"$_P!H7P%J/@WQ+;0,;BVE
MAL[F6,,;5Y%(#K\I*[201C%>_P!% '\N6B_\&^VJ:)\59/%;_%&?4_"<]Z+A
M] DNY/L\<7F[S$()7"X"Y7A"#7[M>'O#/P__ &-/@G.MC%:V&EZ1:1&X>-%1
M9KB"!\,>%#$G/7/7OQ7UG7E'QD^$^C?&;P7>^"M=FD@T^];,KQC<W (QC(SU
M]: /Y._V+?V6_$/QA_X*A^(_VGIHY;SP;=:]/=0R,C- %:X9P03\N/Y5_8PD
M:1(L<:A$0!551@ #@ "O!O@5^SQX&^ GA\:'X5M(V8N7>\>%5F;))^]RW4^M
M>^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7YS_\ !4C_ )-.\8?]=(O_ $!J_1BOSG_X*D?\FG>,/^ND
M7_H#5ZN1_P#(YRS_ +#</_Z<B14^"7H>!?\ !&__ )(9+_U\R_\ H;U^RM?C
M5_P1O_Y(9+_U\R_^AO7[*UT\3_\ (^S+_L(?_I,14OX4/\*/Y<Y);.+]I7P>
M;R[AM%_M&U.Z9U0#]ZG=B!_G\1_3;IFK:.NF:<%U73F06-H%;[;;#<HMXP&P
M9.,C!QU&>:_C'_;(C\>/\>O#2^!I+B.X^WP[#;EPV3)&!]WIG.>W-?;UG8_M
M:C1M(,=_K6396^</<=/*7;Z'IC&>HK[7.\BCF.&RBN\?0P]\/47LZGQ?%%WW
MNM-.J.:E5Y'./*WK%W7FHK]?P9_31_;&D_\ 04T[_P #;;_X[1_;&D_]!33O
M_ VV_P#CM?S,_8_VNO\ G_UO_OY<?XT?8_VNO^?_ %O_ +^7'^-?/_ZI0_Z&
MV#^]_P"?K_2UU]O_ -.Y=/QY?+^]^!_3-_;&D_\ 04T[_P #;;_X[1_;&D_]
M!33O_ VV_P#CM?S,_8_VNO\ G_UO_OY<?XT?8_VNO^?_ %O_ +^7'^-'^J4/
M^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?TS?VQI/\ T%-._P# VV_^.T?VQI/_
M $%-._\  VV_^.U_,S]C_:Z_Y_\ 6_\ OY<?XT?8_P!KK_G_ -;_ ._EQ_C1
M_JE#_H;8/[W_ )^O]+4]O_T[ET_'E\O[WX'],W]L:3_T%-._\#;;_P".T?VQ
MI/\ T%-._P# VV_^.U_,S]C_ &NO^?\ UO\ [^7'^-'V/]KK_G_UO_OY<?XT
M?ZI0_P"AM@_O?^?K_2U/;_\ 3N73\>7R_O?@?TS?VQI/_04T[_P-MO\ X[1_
M;&D_]!33O_ VV_\ CM?S,_8_VNO^?_6_^_EQ_C1]C_:Z_P"?_6_^_EQ_C1_J
ME#_H;8/[W_GZ_P!+4]O_ -.Y=/QY?+^]^!_3-_;&D_\ 04T[_P #;;_X[1_;
M&D_]!33O_ VV_P#CM?S,_8_VNO\ G_UO_OY<?XT?8_VNO^?_ %O_ +^7'^-'
M^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?TS?VQI/\ T%-._P# VV_^.T?V
MQI/_ $%-._\  VV_^.U_,S]C_:Z_Y_\ 6_\ OY<?XT?8_P!KK_G_ -;_ ._E
MQ_C1_JE#_H;8/[W_ )^O]+4]O_T[ET_'E\O[WX'],W]L:3_T%-._\#;;_P".
MT?VQI/\ T%-._P# VV_^.U_,S]C_ &NO^?\ UO\ [^7'^-'V/]KK_G_UO_OY
M<?XT?ZI0_P"AM@_O?^?K_2U/;_\ 3N73\>7R_O?@?TS?VQI/_04T[_P-MO\
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M +^7'^-'^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?TS?VQI/\ T%-._P#
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M_P"?_6_^_EQ_C1_JE#_H;8/[W_GZ_P!+4]O_ -.Y=/QY?+^]^!_3-_;&D_\
M04T[_P #;;_X[1_;&D_]!33O_ VV_P#CM?S,_8_VNO\ G_UO_OY<?XT?8_VN
MO^?_ %O_ +^7'^-'^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?TS?VQI/\
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M,W]L:3_T%-._\#;;_P".T?VQI/\ T%-._P# VV_^.U_,S]C_ &NO^?\ UO\
M[^7'^-'V/]KK_G_UO_OY<?XT?ZI0_P"AM@_O?^?K_2U/;_\ 3N73\>7R_O?@
M?TS?VQI/_04T[_P-MO\ X[1_;&D_]!33O_ VV_\ CM?S,_8_VNO^?_6_^_EQ
M_C1]C_:Z_P"?_6_^_EQ_C1_JE#_H;8/[W_GZ_P!+4]O_ -.Y=/QY?+^]^!_3
M-_;&D_\ 04T[_P #;;_X[1_;&D_]!33O_ VV_P#CM?S,_8_VNO\ G_UO_OY<
M?XT?8_VNO^?_ %O_ +^7'^-'^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?T
MS?VQI/\ T%-._P# VV_^.T?VQI/_ $%-._\  VV_^.U_,S]C_:Z_Y_\ 6_\
MOY<?XT?8_P!KK_G_ -;_ ._EQ_C1_JE#_H;8/[W_ )^O]+4]O_T[ET_'E\O[
MWX'],W]L:3_T%-._\#;;_P".T?VQI/\ T%-._P# VV_^.U_,S]C_ &NO^?\
MUO\ [^7'^-'V/]KK_G_UO_OY<?XT?ZI0_P"AM@_O?^?K_2U/;_\ 3N73\>7R
M_O?@?TS?VQI/_04T[_P-MO\ X[1_;&D_]!33O_ VV_\ CM?S,_8_VNO^?_6_
M^_EQ_C1]C_:Z_P"?_6_^_EQ_C1_JE#_H;8/[W_GZ_P!+4]O_ -.Y=/QY?+^]
M^!_3-_;&D_\ 04T[_P #;;_X[1_;&D_]!33O_ VV_P#CM?S,_8_VNO\ G_UO
M_OY<?XT?8_VNO^?_ %O_ +^7'^-'^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O
M?@?TS?VQI/\ T%-._P# VV_^.T?VQI/_ $%-._\  VV_^.U_,S]C_:Z_Y_\
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M<?XT?ZI0_P"AM@_O?^?K_2U/;_\ 3N73\>7R_O?@?TS?VQI/_04T[_P-MO\
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M +^7'^-'^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?TS?VQI/\ T%-._P#
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M_P"?_6_^_EQ_C1_JE#_H;8/[W_GZ_P!+4]O_ -.Y=/QY?+^]^!_3-_;&D_\
M04T[_P #;;_X[1_;&D_]!33O_ VV_P#CM?S,_8_VNO\ G_UO_OY<?XT?8_VN
MO^?_ %O_ +^7'^-'^J4/^AM@_O?^?K_2U/;_ /3N73\>7R_O?@?TS?VQI/\
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M,W]L:3_T%-._\#;;_P".T?VQI/\ T%-._P# VV_^.U_,S]C_ &NO^?\ UO\
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MS?VQI/\ T%-._P# VV_^.T?VQI/_ $%-._\  VV_^.U_,S]C_:Z_Y_\ 6_\
MOY<?XT?8_P!KK_G_ -;_ ._EQ_C1_JE#_H;8/[W_ )^O]+4]O_T[ET_'E\O[
MWX'],W]L:3_T%-._\#;;_P".T?VQI/\ T%-._P# VV_^.U_,S]C_ &NO^?\
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M3\>7R_O?@?TS?VQI/_04T[_P-MO_ ([1_;&D_P#04T[_ ,#;;_X[7\S/V/\
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M]C_:Z_Y_];_[^7'^-'V/]KK_ )_];_[^7'^-'^J4/^AM@_O?^?K_ $M3V_\
MT[ET_'E\O[WX'],W]L:3_P!!33O_  -MO_CM']L:3_T%-._\#;;_ ..U_,S]
MC_:Z_P"?_6_^_EQ_C1]C_:Z_Y_\ 6_\ OY<?XT?ZI0_Z&V#^]_Y^O]+4]O\
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M[7\S/V/]KK_G_P!;_P"_EQ_C1]C_ &NO^?\ UO\ [^7'^-'^J4/^AM@_O?\
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M&V#^]_Y^O]+4]O\ ].Y=/QY?+^]^!_3-_;&D_P#04T[_ ,#;;_X[1_;&D_\
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M\%/]0T>?]D[QFIU:Q$GF0>4BW,+M)F.4M@([?=POUW<="1^4_P!C_:Z_Y_\
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M_P">?_@3_P _)?<%EV7]?\,ON,#_ (17PY_T!=._\!H_\*/^$5\.?] 73O\
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M1=.'_;M'_A7\ZG[;NB^'8_VB[%(=*MXXSJL0*") "//&> ,8Z\>G2OZ2:_G
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M(KX<_P"@+IW_ (#1_P"%;]%'M)_SS_\  G_GY+[@LNR_K_AE]Q@?\(KX<_Z
MNG?^ T?^%'_"*^'/^@+IW_@-'_A6_11[2?\ //\ \"?^?DON"R[+^O\ AE]Q
M@?\ "*^'/^@+IW_@-'_A1_PBOAS_ * NG?\ @-'_ (5OT4>TG_//_P "?^?D
MON"R[+^O^&7W&!_PBOAS_H"Z=_X#1_X4?\(KX<_Z NG?^ T?^%;]%'M)_P \
M_P#P)_Y^2^X++LOZ_P"&7W&!_P (KX<_Z NG?^ T?^%'_"*^'/\ H"Z=_P"
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MOQ[J?Q+^,4?A3PMX!UR\1=(O-3-O%<065RWR"-Y54AE0KTYR?I0!_5[\+/\
M@J3\%/B-XE30;@IH,4DZPQW][/Y<+;R%5@TF%()(/4<>E?I7HNNZ/XCT^#5=
M#U&TU33[A5>&[LYDFA=6 (PR$X.#T.#7\IO_  4'_9Z_9:\*_LZ+J7P;^,6B
MZ-XTT**%6NK'4HHYYYH(\LVZ.0.Q+(/TZ5]#_P#!#3]KC5/&W@>+X/\ B#Q&
MWBK4-.N/(CU.29YV98?D5A(S-U7/<]?7F@#^D&OYP?\ @LSKFJZ7XGT);"ZG
MMU)LP?*D9,YV>A ]<^WU.?Z/J_FW_P""T3V-KXET2[U>X2RTV)+626YD8*BJ
MBJQ)8\ 8'^<T ?I9_P $T=0N&_9RL=1UBX\J,/:DW-Y*(X]OV=BS-+*P4 '&
M26QSUKTNY_;<^%LGQ+/PTT.[@US54NOLLDEE.)55Q)Y9)$>< 'GGL.37\O:_
M\%</#D7P5M/V5_@9KD.I>/-25--A;3I5:Z69P+;=F(EQMD)!YX(K]6_^"6G_
M  3]\<> ?L/QU^--]/J?B'Q(+C48[*_F:2:(7";XG\N0E@N^0@' !VG!R#@
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M_(QK?]@M7\C"O\"]5_Z5$_=/]GG_ ))-X7_Z]5_]%15[97B?[//_ "2;PO\
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MV_X^? O^];_^CQ7WE^PM_P DAT;_ +!]O_Z#%7P;_P %=O\ CY\"_P"];_\
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MC=NX_2OZ:/\ @FU^Q&/V5/@V=&U^\O+SQ)XAM'CUC[4[.ZBXAVSJ2[$@EF(
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M<;"U?T__ /!-C]FCQG\!_@UI=G\2;R^NO&#B&2\-[))(XD,>9<F0D_?X^OZ
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MVOC]^V=^T/\ LY^._A-;7,VC> =4T>XUMH$+*L=K=)))NP.,+G]?I0!]!?\
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MC _;>^&?@KX0_P#!3SP!-\1+6-X=9\46,L4-U$##(LM\A&XN"N""/:OZBO\
M@C=\68_%_P"Q]\-_">LW*GQ9H&G>3J%K(X^T+B&+<)$/S JR$<@=\UY7_P %
M7/\ @EYI?[6EG#\6O!D+1_%?PK&MQHKVZ8F>ZMUW0,A7EB71<^YY'0T ?L)X
M#TGP@G@/PS)HVEZ1;Z%<^&M(GA6&"V%K]D?38'!D8+Y9"Q\2LQZJV\Y!K^+/
M]HG7/A1_P\NFM/@K;6D'C8>)7%ZNEHA?>+LAP3"/7.<GJ:T_[+_X+>^%? EW
M\--%3Q&8K)3HFF.!,2--(,"$'C@18_#MC%?=/_!*7_@D/XX\$?$"3]I3]J!;
MJZ^*5[<M?W,>HAI'%Q(WF$ 29YWGZ 9)YH _HS^$VH7FD_"+P[J?BZ;[+<6.
MAI=ZK/<';Y21Q"1W<L1C"]B1D_45_.[^WY^UQX__ &H?C]HW[*WP)O+O4_ N
MHW<6G>)[S3M[VXPXAN9)6BRHR0^06.T'&<"OVM_;8\-_%GQ)\(-<\*_!]9H=
M2U?1;C3,6@*M&L@=5"[<$$*J 8].G-?GC_P25_8!\:_L^ZCXT\>_&RT?4?%V
MK7,L^GW&IQB:>&6>Y64LCRAB-J%^G?'!'- 'YY_$CP[:? F\TS]CGPU>/IVL
M>+;:!+[58F\J6.YNT"R%I0000[GDGCC '?P+Q?\ "WQY_P $N_$WA#XB)\0-
M1\1R>*]3MI9+0WTET%%W('8% [8QNZ$>F?6OV!_X*??L$?$/XD:R/C-\"8IF
M^(MGF6U6V4F174%D52!D895'!]QBORR^!/["W[</[1WC31-+_:MMM3;1O#VI
M1O;B]1V016\H*D!^/NCMT'I0!_5E\&?B6WQ'_9W\*_$K5"8CKWA%=4NF;*E0
MT3*Q;=C!^7OBOY'OBXK>,_\ @J%X4U+PZ#>6=IXDMO/EC_>*H6[&[)&1P*_J
MC^*5EI?[/O['?BC2+:5;>W\&_#Z>RM &",TL: A4&02<;^!Z&OYQ/^"17P[U
M#]I;XY>/?B[J5E/);^&M>GD2>Z0DX2^"*49L?Q%2".O8^H!_7AI0*Z7IJG@B
MPLP?8BWC!J_4<48BBBB'2.-(Q]$4*/Y5)0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?AC_ ,%=O^/GP+_O
M6_\ Z/%?>7["W_)(=&_[!]O_ .@Q5\&_\%=O^/GP+_O6_P#Z/%?>7["W_)(=
M&_[!]O\ ^@Q5]ICO^21RS_K]5_\ 3D3GA_O%7_#'\HGVY1117Q9T!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <YXO\26?A
M#POKOBC4&"6.A:;<ZE=.>BPVR%W)^@%?#_[-'[>GP"_:_P!=\7?#OPWJ6F:M
MJ.A33V>HZ5=^1+'<F"0QR0O;R\-DJ=HP2Q^7'/'VYXU\+V7C;PGXA\):B2MC
MXBTJ\TJZ*]1#=Q&-R/H#7\9_[2W_  2L_;$_9"^.&M?%/]B"\URXMO$6I2ZA
MJ,=H\S1@3S&9N <8RW_ZLT ?T:?MI?L:?LT^,O@MXKU#5O /@[PQ=Z79SWL6
MNV6FV>G31R;)'P9$1 TC2 .N,,</G(QM_ G_ ((Y?%#Q/HO[86N?![1M;O\
M6/ .GZO=6]HS/++:)''<%$5&)*8"X P<8 Q7@7C[P+_P6X^/FAQ>!O$@\20^
M&M0GMTU-AYZYBP8Y<D?[#-G^5?T!?\$NO^"<^G_LN>"=-\7^-;9G^)]Z8[G4
M+F:,&X$Y4/,9)&P_,AX/))!]* /U4^*O_)./&?\ V ;W_P! %?R-_ 3_ )/;
MN?\ L8#_ .E=?UZ?$#2KG7/!7B;2+($W6HZ1=VMN!U,DB87]:_G4^$?_  3U
M^.?A?]J2?XD:C;7 T!]9-T&*,%$?VCS!STQCW[]30!_2=IO_ "#K#_KRM?\
MT1'5?783<:+J\"C+3:9?1*/4O;2J/U-6[&-H;*SA?[\5K;QM_O)$BM^H-664
M.K*W*LI4CU##!_0T ?Q:_'6]F^$_[<^CKJ4?D+JOB.,1M(-F[S+P $%@,Y![
M?SK^P_PEJ2Q_#GPYJH(*#PSIEV2.1L-E%(Q_(GG\J_DI_P"#@#X9^+O"7[07
MP(^(GP\T^Z^R)JFF76NSVD;;4 NE,K2L@PH.TG)/0BOZ:_V3OB)HOQ8_9^\
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MI.B:IJ*H9'M+*XF1!DEG6-BH ').<5LU%/!#<Q203QK+#*I62-N593U!'<4
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M]HKYO%_[UB/^OU3_ -+9M'9>B_(****YQA1110 4444 %%%% !1110 4444
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M .G(G/#_ 'BK_AC^43[5HHHKXLZ HHHH **** "BBB@ HHHH **** "BBB@
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MGO7SQ^P9^QH/V:_!=_;^*XXM0\4WFH_:1?2;))4CRY/[TY;)++CD9ZU^BU%
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M /GRN/\ OQ1_P\[U_P#Y\KC_ +\5]]_\,&_ O_H$O_WZB_QH_P"&#?@7_P!
ME_\ OU%_C7SO]H<*_P#0OK?<O+_+^K*VO)7_ )X_C_7_  S\K_ G_#SO7_\
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M  )_P\[U_P#Y\KC_ +\4?\/.]?\ ^?*X_P"_%???_#!OP+_Z!+_]^HO\:/\
MA@WX%_\ 0)?_ +]1?XT?VAPK_P!"^M]R\O\ +^K*QR5_YX_C_7_#/RO\"?\
M#SO7_P#GRN/^_%'_  \[U_\ Y\KC_OQ7WW_PP;\"_P#H$O\ ]^HO\:/^&#?@
M7_T"7_[]1?XT?VAPK_T+ZWW+R_R_JRL<E?\ GC^/]?\ #/RO\"?\/.]?_P"?
M*X_[\4?\/.]?_P"?*X_[\5]]_P##!OP+_P"@2_\ WZB_QH_X8-^!?_0)?_OU
M%_C1_:'"O_0OK?<O+_+^K*QR5_YX_C_7_#/RO\"?\/.]?_Y\KC_OQ1_P\[U_
M_GRN/^_%???_  P;\"_^@2__ 'ZB_P :/^&#?@7_ - E_P#OU%_C1_:'"O\
MT+ZWW+R_R_JRL<E?^>/X_P!?\,_*_P "?\/.]?\ ^?*X_P"_%'_#SO7_ /GR
MN/\ OQ7WW_PP;\"_^@2__?J+_&C_ (8-^!?_ $"7_P"_47^-']H<*_\ 0OK?
M<O+_ "_JRL<E?^>/X_U_PS\K_ G_  \[U_\ Y\KC_OQ1_P /.]?_ .?*X_[\
M5]]_\,&_ O\ Z!+_ /?J+_&C_A@WX%_] E_^_47^-']H<*_]"^M]R\O\OZLK
M')7_ )X_C_7_  S\K_ G_#SO7_\ GRN/^_%'_#SO7_\ GRN/^_%???\ PP;\
M"_\ H$O_ -^HO\:/^&#?@7_T"7_[]1?XT?VAPK_T+ZWW+R_R_JRL<E?^>/X_
MU_PS\K_ G_#SO7_^?*X_[\4?\/.]?_Y\KC_OQ7WW_P ,&_ O_H$O_P!^HO\
M&C_A@WX%_P#0)?\ []1?XT?VAPK_ -"^M]R\O\OZLK')7_GC^/\ 7_#/RO\
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M/]H<*_\ 0OK?<O+_ "_JRL^2O_/'\?Z_X9^5_@3_ (>=Z_\ \^5Q_P!^*/\
MAYWK_P#SY7'_ 'XK[[_X8-^!?_0)?_OU%_C1_P ,&_ O_H$O_P!^HO\ &C^T
M.%?^A?6^Y>7^7]65CDK_ ,\?Q_K_ (9^5_@3_AYWK_\ SY7'_?BC_AYWK_\
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M5Q_WXH_X>=Z__P ^5Q_WXK[[_P"&#?@7_P! E_\ OU%_C1_PP;\"_P#H$O\
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M7]65CDK_ ,\?Q_K_ (9^5_@3_AYWK_\ SY7'_?BC_AYWK_\ SY7'_?BOOO\
MX8-^!?\ T"7_ ._47^-'_#!OP+_Z!+_]^HO\:/[0X5_Z%];[EY?Y?U96.2O_
M #Q_'^O^&?E?X$_X>=Z__P ^5Q_WXH_X>=Z__P ^5Q_WXK[[_P"&#?@7_P!
ME_\ OU%_C1_PP;\"_P#H$O\ ]^HO\:/[0X5_Z%];[EY?Y?U96.2O_/'\?Z_X
M9^5_@3_AYWK_ /SY7'_?BC_AYWK_ /SY7'_?BOOO_A@WX%_] E_^_47^-'_#
M!OP+_P"@2_\ WZB_QH_M#A7_ *%];[EY?Y?U96.2O_/'\?Z_X9^5_@3_ (>=
MZ_\ \^5Q_P!^*/\ AYWK_P#SY7'_ 'XK[[_X8-^!?_0)?_OU%_C1_P ,&_ O
M_H$O_P!^HO\ &C^T.%?^A?6^Y>7^7]65CDK_ ,\?Q_K_ (9^5_@3_AYWK_\
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M )X_C_7_  S\K_ G_#SO7_\ GRN/^_%'_#SO7_\ GRN/^_%???\ PP;\"_\
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M%???_#!OP+_Z!+_]^HO\:/\ A@WX%_\ 0)?_ +]1?XT?VAPK_P!"^M]R\O\
M+^K*QR5_YX_C_7_#/RO\"?\ #SO7_P#GRN/^_%'_  \[U_\ Y\KC_OQ7WW_P
MP;\"_P#H$O\ ]^HO\:/^&#?@7_T"7_[]1?XT?VAPK_T+ZWW+R_R_JRL<E?\
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M $"7_P"_47^-']H<*_\ 0OK?<O+_ "_JRL<E?^>/X_U_PS\K_ G_  \[U_\
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M_P#Y\KC_ +\4?\/.]?\ ^?*X_P"_%???_#!OP+_Z!+_]^HO\:/\ A@WX%_\
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M -^HO\:/^&#?@7_T"7_[]1?XT?VAPK_T+ZWW+R_R_JRL<E?^>/X_U_PS\K_
MG_#SO7_^?*X_[\4?\/.]?_Y\KC_OQ7WW_P ,&_ O_H$O_P!^HO\ &C_A@WX%
M_P#0)?\ []1?XT?VAPK_ -"^M]R\O\OZLK')7_GC^/\ 7_#/RO\  G_#SO7_
M /GRN/\ OQ1_P\[U_P#Y\KC_ +\5]]_\,&_ O_H$O_WZB_QH_P"&#?@7_P!
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M]?\ #/RO\"?\/.]?_P"?*X_[\4?\/.]?_P"?*X_[\5]]_P##!OP+_P"@2_\
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M["5I_P"C8Z_I\TG_ )!6F?\ 8/LO_2:*O3XN^#*O^P:I_P"E1(P^T_\ $O\
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MP_:>M?VJ_AC)\0K*&*&".\2T*Q*JKN978<* .B&OL"@ HHHH **** "BBB@
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M=>*=3T7P)\-TUJUL+R:V$\&F)."(I&0G>L#@]!Z]?7J ?UKT5_)GX<_X+O\
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M^33O&'_72+_T!J]7(_\ D<Y9_P!AN'_].1(J?!+T/ O^"-__ "0R7_KYE_\
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ML<H<9VD$$@9YP#BOQ]^+_P#P6/\  7PP\=7WPOO)P?%K7,EI8P(07:7S#'&
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MD<L_Z_5?_3D3GA_O%7_#'\HGVY1117Q9T!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7QO^VKX!\8?$GX6W/A3P?)
M<17>II/;SR6Q82+',FS^'G&"?\:^R*"0.I ^M 'X>_L _P#!)WP;\ /$.I?$
MWQW%;^)?$&LR2SM::M MT5FF8R%F$P;:B,W.<%N@SR1\<?\ !;OX5? ?PEIU
MIXE\-2Z1X>^)2-#-8Z?HQ@AN_M .54PV[!T9G .PJ",@'D5^EW_!4GP'^V)X
MZ^&UK9?LD:E>Z=XF2WD622Q>2-S*6D(W&,@DX*X]AU]/XMO$'P'_ &^?A7\?
M]'^)O[>]YK^L^!])U"WEOFOY+F6R2-+@,WF>:3& 5_O>GI0!_9/_ ,$9/$'C
MSQ!^R[;3^/&O7O(I[6.SDO@XE>V$4H5@9.2"H4U^OM?$W[!WQ;^#WQ<^!^A:
MQ\&4L4\/V=EI]I<+9",(+I+8*^_9QNW*W6OMF@#X&_X*4?$Z7X;?LD_%F\TZ
MX,&LWGAJ]MK$J^V0,T3,"F"&SN0#(QC!ZU^%W_!MKX=U7QQI7QC^(/Q#M#?Z
MS#K4[Z9<W\7F2H)=04*4>0;@!&Q.1UX^H^\?^"TVO:K;?#JUT*VD9;+4K58[
MA0Q"LLFY6W#.#^-;/_!$SP-I?@_X.:Y+IR1*^I"*6X,:JI+M-&WS8 R<COS0
M!^W5Q/%:V\US,RQPV\,D\KL0JI%"C2.Q)X"JBDDG@ 5_&Q_P6"_:4UK]N2\\
M8?LQ_!S4+S[;X3CU*WU5M.=V0K$T@EW&+@CJ.23C'!K]NO\ @K!^V?IW[-GP
M7NK#0_$%G9>+-:EFTWR#=1QSI%=0F# 7<&!^=\^O3Z_!/_!,;]COX;V?PJ^(
M/[5_C/Q9HUYXL^(>AZ]J>R^O+61X&6RDO'+":4-M)(4; S%B,+@T ?DC_P &
M]'P1?X'?%C6- U"X>;Q!:WK1:@9<^;YHD._?GG.00<^W7K7]:/\ P4Q\,>+_
M !A^R'X[TCP2UPFO30020FUWF;8MM<[P-GS8^89^E?SH_P#!+G5/"\G[<'Q5
M=O$6EVMN_B"], -S$D;@74H'EY8+CZ?7Z_V-7=CI/B'29-/N/LVI:==0+'(%
M:.:*6-H]H/!=>5.1GUH _B2_97_:4_9^_9X^%?B+P%^T)HL5W\2+R:\M;&YU
M"T5[O[4Y=(RK2H7SYC#!!^G)KW_]B?\ :=D_9_UGXE_$?Q!=3V?AO7K>\F\%
M6LS-#$[RAWM5A1L _>0+M'Y=:_:?XQ?\$D_V/?B)XGN_B3X_TL6C6#R:I)*1
M;VUG;M#NN'EE9G 94VE@BC<X! ^8@5_/[\:_"?AG]JCXX6_P5^!ENVE^"_A'
MJ(74+VU'EVUW:Z=*H8,Z81PR0GN<C\J /KG]AGX"_$#]O'X_>*?CY\=X;Z'P
M]H&J27WA5+N&0QS0K<$VOE"3 93^Z''&/05_4U8:99Z=IUII=O!"MI9VD%G'
M$(T">5;Q)"@*8P?D09SG/?-?@W\-?^"J?[,W[.5MX3_9^70I$U3P[8V>D:UJ
ME@L<-NU]"3#+-=2+$Q=LC.6? &< $G/[4?"KXK^$?C#X6M/%G@[48+_3KJ**
M0F&9)?*,J[@CE.,@ ]J /Y!OVE_A[:_LJ_\ !10_'FWF>PCUOQ$6\I/W41\R
MYW8&,#D-Z?3TK^O'X*^.D^)/PS\*^,T;>NM:=#<[@<YRB\Y[]:_F*_X+RZ5;
M:;KO@O4K5?)NGUVWW2( K'-P@.3UZ5^_?_!/R9Y_V2OA#+(Q=W\/PDL3DG"H
M.I^E 'V=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5^<_P#P5(_Y-.\8?]=(O_0&K]&*_.?_ (*D?\FG>,/^
MND7_ * U>KD?_(YRS_L-P_\ Z<B14^"7H>!?\$;_ /DADO\ U\R_^AO7[*U^
M-7_!&_\ Y(9+_P!?,O\ Z&]?LK73Q/\ \C[,O^PA_P#I,14OX4/\*/Y<Y?\
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M>Z/XUTGQS\8_B9=^*K73[F&=/#^IW-Q=QLL3 DF)Q)&I)4?>VDY!&1R?Z4/
M7P\\,?#GPAIW@KPUIEK8Z)I]HMJMI#$J12+Y8CD+(H4$,HQTZ>Y- '\0_P#P
M15\;:-_P3_\ VP/CWX3^,LT7A;2_'FNZC%97>I'[/'MFOF>-D>78..&ZD'&#
MQQ7]8?Q__P""A7[.7P4^%>M?$6'XC^$_$ES80P/9:+8:FDUW=27"ET!B1D<
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M7?M;:+H?@/\ 9A\5>&?#>G6^E:#9^'KNVCT^TC6.#R(;4* 44!2S; 6..3R
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M?[//_))O"_\ UZK_ .BHJ]LKYO%_[UB/^OU3_P!+9M'9>B_(****YQA1110
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MC?,;32M*5^:(+P6['Z$5^K^I:5'>:/=:5;D6Z3VKVR,G&P,A0'CTR#^M 'X
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M98G-OY:7193N8%/NCC']*_L&\.:%:^&M%L-$LE"VUA D$048&$ ' P,#CTH
MVZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3RJ5*A4J1^K35XQ;5^:.ET94)17.FTGS)_>DOS/K:BOE'_AL'X2_]!RQ_P#
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M]/\ -'U=17RC_P -@_"7_H.6/_@7'1_PV#\)?^@Y8_\ @7'1_9V/_P"@2O\
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M"7_H.6/_ (%QT?V=C_\ H$K_ /@N0<\?YE]_I_FCZNHKY1_X;!^$O_0<L?\
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MZ/[.Q_\ T"5__!<@YX_S+[_3_-'U=17RC_PV#\)?^@Y8_P#@7'1_PV#\)?\
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M'X2_]!RQ_P# N.C^SL?_ - E?_P7(.>/\R^_T_S1]745\H_\-@_"7_H.6/\
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M_P#H$K_^"Y!SQ_F7W^G^:/JZBOE'_AL'X2_]!RQ_\"XZ/^&P?A+_ -!RQ_\
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M $_S1]745\H_\-@_"7_H.6/_ (%QT?\ #8/PE_Z#EC_X%QT?V=C_ /H$K_\
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M_AL'X2_]!RQ_\"XZ/^&P?A+_ -!RQ_\  N.C^SL?_P! E?\ \%R#GC_,OO\
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M?OY11_K=G?\ S_I?^"*?EY>2#ZO2_E?W_P!=OS[L_ /_ (=,_$S_ *'_ /\
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M$4_+R\D'U>E_*_O_ *[?GW9^ ?\ PZ9^)G_0_P#_ )4C_P#'J/\ ATS\3/\
MH?\ _P J1_\ CU?OY11_K=G?_/\ I?\ @BGY>7D@^KTOY7]_]=OS[L_ /_AT
MS\3/^A__ /*D?_CU'_#IGXF?]#__ .5(_P#QZOW\HH_UNSO_ )_TO_!%/R\O
M)!]7I?RO[_Z[?GW9^ ?_  Z9^)G_ $/_ /Y4C_\ 'J/^'3/Q,_Z'_P#\J1_^
M/5^_E%'^MV=_\_Z7_@BGY>7D@^KTOY7]_P#7;\^[/P#_ .'3/Q,_Z'__ ,J1
M_P#CU'_#IGXF?]#_ /\ E2/_ ,>K]_**/];L[_Y_TO\ P13\O+R0?5Z7\K^_
M^NWY]V?@'_PZ9^)G_0__ /E2/_QZC_ATS\3/^A__ /*D?_CU?OY11_K=G?\
MS_I?^"*?EY>2#ZO2_E?W_P!=OS[L_ /_ (=,_$S_ *'_ /\ *D?_ (]1_P .
MF?B9_P!#_P#^5(__ !ZOW\HH_P!;L[_Y_P!+_P $4_+R\D'U>E_*_O\ Z[?G
MW9^ ?_#IGXF?]#__ .5(_P#QZC_ATS\3/^A__P#*D?\ X]7[^44?ZW9W_P _
MZ7_@BGY>7D@^KTOY7]_]=OS[L_ /_ATS\3/^A_\ _*D?_CU'_#IGXF?]#_\
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MQ+U3X?:)>KXVDMDO+9)%BDOFC(&Q?F"M(IVDDC(X)4\\&O1?^'3/Q,_Z'_\
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M$4_+R\D'U>E_*_O_ *[?GW9^ ?\ PZ9^)G_0_P#_ )4C_P#'J/\ ATS\3/\
MH?\ _P J1_\ CU?OY11_K=G?_/\ I?\ @BGY>7D@^KTOY7]_]=OS[L_ /_AT
MS\3/^A__ /*D?_CU'_#IGXF?]#__ .5(_P#QZOW\HH_UNSO_ )_TO_!%/R\O
M)!]7I?RO[_Z[?GW9^ ?_  Z9^)G_ $/_ /Y4C_\ 'J/^'3/Q,_Z'_P#\J1_^
M/5^_E%'^MV=_\_Z7_@BGY>7D@^KTOY7]_P#7;\^[/P#_ .'3/Q,_Z'__ ,J1
M_P#CU'_#IGXF?]#_ /\ E2/_ ,>K]_**/];L[_Y_TO\ P13\O+R0?5Z7\K^_
M^NWY]V?@'_PZ9^)G_0__ /E2/_QZC_ATS\3/^A__ /*D?_CU?OY11_K=G?\
MS_I?^"*?EY>2#ZO2_E?W_P!=OS[L_ /_ (=,_$S_ *'_ /\ *D?_ (]1_P .
MF?B9_P!#_P#^5(__ !ZOW\HH_P!;L[_Y_P!+_P $4_+R\D'U>E_*_O\ Z[?G
MW9^ ?_#IGXF?]#__ .5(_P#QZC_ATS\3/^A__P#*D?\ X]7[^44?ZW9W_P _
MZ7_@BGY>7D@^KTOY7]_]=OS[L_ /_ATS\3/^A_\ _*D?_CU'_#IGXF?]#_\
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M*_O_ *[?GW9^ ?\ PZ9^)G_0_P#_ )4C_P#'J/\ ATS\3/\ H?\ _P J1_\
MCU?OY11_K=G?_/\ I?\ @BGY>7D@^KTOY7]_]=OS[L_ /_ATS\3/^A__ /*D
M?_CU'_#IGXF?]#__ .5(_P#QZOW\HH_UNSO_ )_TO_!%/R\O)!]7I?RO[_Z[
M?GW9^ ?_  Z9^)G_ $/_ /Y4C_\ 'J/^'3/Q,_Z'_P#\J1_^/5^_E%'^MV=_
M\_Z7_@BGY>7D@^KTOY7]_P#7;\^[/P#_ .'3/Q,_Z'__ ,J1_P#CU'_#IGXF
M?]#_ /\ E2/_ ,>K]_**/];L[_Y_TO\ P13\O+R0?5Z7\K^_^NWY]V?@'_PZ
M9^)G_0__ /E2/_QZC_ATS\3/^A__ /*D?_CU?OY11_K=G?\ S_I?^"*?EY>2
M#ZO2_E?W_P!=OS[L_ /_ (=,_$S_ *'_ /\ *D?_ (]1_P .F?B9_P!#_P#^
M5(__ !ZOW\HH_P!;L[_Y_P!+_P $4_+R\D'U>E_*_O\ Z[?GW9^ ?_#IGXF?
M]#__ .5(_P#QZC_ATS\3/^A__P#*D?\ X]7[^44?ZW9W_P _Z7_@BGY>7D@^
MKTOY7]_]=OS[L_ /_ATS\3/^A_\ _*D?_CU'_#IGXF?]#_\ ^5(__'J_?RBC
M_6[._P#G_2_\$4_+R\D'U>E_*_O_ *[?GW9^ ?\ PZ9^)G_0_P#_ )4C_P#'
MJ/\ ATS\3/\ H?\ _P J1_\ CU?OY11_K=G?_/\ I?\ @BGY>7D@^KTOY7]_
M]=OS[L_ /_ATS\3/^A__ /*D?_CU.3_@DU\3%96_X3[.T@_\A(]O^VU?OU11
M_K=G?_/^E_X(I^7EY(/J]+^5_?\ UV_/NS^,;_@H;_P3U\??#BY\+S:AXGFO
MQJ+1&-Q<M*@_>^7\K!R."I!P3@AAQSCZH_9:_P""8/Q(\5?#W2]8A\836D$U
MI"RJ]XT2Y=%.%S(H)ZG'' X'!Q]D_P#!76XF6?P'&)&"*T&U<\#-QDX'N23^
M)K[R_8:N)I?@_HJ22,Z"PMF"D\ A(P#]0"1^)KZS%\39O#AC+\0JU+VDZU5-
M^QB_=4TDK;+=&,*%/V\U9VC%-:O=J+^9^;)_X),_$PDG_A/^O_42/_QZC_AT
MS\3/^A__ /*D?_CU?OY17R?^MV=_\_Z7_@BGY>7DC;ZO2_E?W_UV_/NS\ _^
M'3/Q,_Z'_P#\J1_^/4?\.F?B9_T/_P#Y4C_\>K]_**/];L[_ .?]+_P13\O+
MR0?5Z7\K^_\ KM^?=GX!_P##IGXF?]#_ /\ E2/_ ,>H_P"'3/Q,_P"A_P#_
M "I'_P"/5^_E%'^MV=_\_P"E_P""*?EY>2#ZO2_E?W_UV_/NS\ _^'3/Q,_Z
M'_\ \J1_^/4?\.F?B9_T/_\ Y4C_ /'J_?RBC_6[._\ G_2_\$4_+R\D'U>E
M_*_O_KM^?=GX!_\ #IGXF?\ 0_\ _E2/_P >H_X=,_$S_H?_ /RI'_X]7[^4
M4?ZW9W_S_I?^"*?EY>2#ZO2_E?W_ -=OS[L_ /\ X=,_$S_H?_\ RI'_ ./4
M?\.F?B9_T/\ _P"5(_\ QZOW\HH_UNSO_G_2_P#!%/R\O)!]7I?RO[_Z[?GW
M9^ ?_#IGXF?]#_\ ^5(__'J/^'3/Q,_Z'_\ \J1_^/5^_E%'^MV=_P#/^E_X
M(I^7EY(/J]+^5_?_ %V_/NS\ _\ ATS\3/\ H?\ _P J1_\ CU'_  Z9^)G_
M $/_ /Y4C_\ 'J_?RBC_ %NSO_G_ $O_  13\O+R0?5Z7\K^_P#KM^?=GX!_
M\.F?B9_T/_\ Y4C_ /'J/^'3/Q,_Z'__ ,J1_P#CU?OY11_K=G?_ #_I?^"*
M?EY>2#ZO2_E?W_UV_/NS\ _^'3/Q,_Z'_P#\J1_^/4?\.F?B9_T/_P#Y4C_\
M>K]_**/];L[_ .?]+_P13\O+R0?5Z7\K^_\ KM^?=GX!_P##IGXF?]#_ /\
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M_P#!%/R\O)!]7I?RO[_Z[?GW9^ ?_#IGXF?]#_\ ^5(__'J/^'3/Q,_Z'_\
M\J1_^/5^_E%'^MV=_P#/^E_X(I^7EY(/J]+^5_?_ %V_/NS\ _\ ATS\3/\
MH?\ _P J1_\ CU'_  Z9^)G_ $/_ /Y4C_\ 'J_?RBC_ %NSO_G_ $O_  13
M\O+R0?5Z7\K^_P#KM^?=GX!_\.F?B9_T/_\ Y4C_ /'J/^'3/Q,_Z'__ ,J1
M_P#CU?OY11_K=G?_ #_I?^"*?EY>2#ZO2_E?W_UV_/NS\ _^'3/Q,_Z'_P#\
MJ1_^/4?\.F?B9_T/_P#Y4C_\>K]_**/];L[_ .?]+_P13\O+R0?5Z7\K^_\
MKM^?=GX!_P##IGXF?]#_ /\ E2/_ ,>H_P"'3/Q,_P"A_P#_ "I'_P"/5^_E
M%'^MV=_\_P"E_P""*?EY>2#ZO2_E?W_UV_/NS\ _^'3/Q,_Z'_\ \J1_^/4?
M\.F?B9_T/_\ Y4C_ /'J_?RBC_6[._\ G_2_\$4_+R\D'U>E_*_O_KM^?=GX
M!_\ #IGXF?\ 0_\ _E2/_P >H_X=,_$S_H?_ /RI'_X]7[^44?ZW9W_S_I?^
M"*?EY>2#ZO2_E?W_ -=OS[L_ /\ X=,_$S_H?_\ RI'_ ./4?\.F?B9_T/\
M_P"5(_\ QZOW\HH_UNSO_G_2_P#!%/R\O)!]7I?RO[_Z[?GW9^ ?_#IGXF?]
M#_\ ^5(__'J/^'3/Q,_Z'_\ \J1_^/5^_E%'^MV=_P#/^E_X(I^7EY(/J]+^
M5_?_ %V_/NS\ _\ ATS\3/\ H?\ _P J1_\ CU'_  Z9^)G_ $/_ /Y4C_\
M'J_?RBC_ %NSO_G_ $O_  13\O+R0?5Z7\K^_P#KM^?=GX!_\.F?B9_T/_\
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M^MV=_P#/^E_X(I^7EY(/J]+^5_?_ %V_/NS\ _\ ATS\3/\ H?\ _P J1_\
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MC:P))90!@<Y]: /Z(?"/B[0?&^@:?XD\.W]OJ&EZE L]O-!*DHPP#;&*$@.
M02#S@@]#72U_()_P2B_:R_:4^%G[4&L?LG?&#1M>N]#\/WUQIMEJ5XEP\!2.
M4P*RR/E?NHN#NZ8]*_JU^(?Q7\"_"W0+GQ!XU\1:7H=M;VQG2*^O(8)IVV%D
MBBC=@[%B",XP "<YP" >C45^0,O_  5[^#<?B2;15T_?80W7V?\ M432?9V&
M_9Y@<-LVGKD9&*_2OX5?&#P1\7_#5EXD\(ZU87\%TBL\$%S')+$[#<%*!MQX
M/8$@@YQ0!ZG17S9^T-^T_P##K]FVQTC4?B#J5MIMKK$@CMY;F984R93%G+$
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\X'[;W_ "<98_\
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MO[:/P<\4_%^]^"NCZDUUXNL+A[6=(Y(WB$B/L(PJDXS[U^;?QF_X*!R_#O\
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MZW_]'BOO+]A;_DD.C?\ 8/M__08J^#?^"NW_ !\^!?\ >M__ $>*^\OV%O\
MDD.C?]@^W_\ 08J^TQW_ "2.6?\ 7ZK_ .G(G/#_ 'BK_AC^43[<HHHKXLZ
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M ]3CI_1[9?\ !%;]D[4=5;4?"&KV.K/',)4CM+N*4IL(89\J1T&,9.&( [T
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M@-7JY'_R.<L_[#</_P"G(D5/@EZ'@7_!&_\ Y(9+_P!?,O\ Z&]?LK7XU?\
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M_P!OR"3XK7,EGJ/B+Q(ILQ=9B4-/=J4P9, #+#G_ .MD _<_PG_P2$\+W'P
MT3PI?W<"^,;K0K.2YUAW_?BZGM4<NTI^;<';)R<COR,5^-_['GQ]^,/[%?\
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M[!?\$IEUI/V2OAK_ &BT\EI+X?LFL9)]V3$(8\ ;NW.>,<D]A0!^F5?R'?\
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M,OP_^RG8+\2?%<+W'Q1UR)9M5FN8PTJW,B9F9V<;@=['&<DD>V:\@_X*^_\
M!,+5OVJHK'XI?"B*6U^)V@H+FPDLE*3/>V_SQ.3& 2695.<\GCGI7[]44 ?P
MR:#8?\%NO _AZ3X6W$GB5C;0)HNCO_I6?L !A3#=.(R>GX>E?K;_ ,$M_P#@
ME7K?PV\:1?M0?M'6\]U\;YKM+XO?1EYA<,QE+$R#<%5^ISGD8YK^B:2TM99H
MKF2WADN(<B&9XD:6//\ <<@LO4D8/!)(P2:L4 ?S;?\ !P)_P3L^-O[>6G?
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M?@%HUQI'PK\+Z/J=K"MQ8Z;:6\BO"H)V01K\X8')!4XR.,D5[8 % 50%4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** /PQ_X*[?\ 'SX%_P!ZW_\
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MHU& B.BJ .G /:I?M]E_S]0?]_%_QK^6S_A/_P#@I'_T+^M?]^9_\*/^$_\
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MH^WV7_/U!_W\7_&OY;/^$_\ ^"D?_0OZU_WYG_PH_P"$_P#^"D?_ $+^M?\
M?F?_  H_U-J?]#;*^G_,1#^[_>\W]WDP^L+^2?W>G^?]75_ZD_M]E_S]0?\
M?Q?\:/M]E_S]0?\ ?Q?\:_EL_P"$_P#^"D?_ $+^M?\ ?F?_  H_X3__ (*1
M_P#0OZU_WYG_ ,*/]3:G_0VROI_S$0_N_P![S?W>3#ZPOY)_=Z?Y_P!75_ZD
M_M]E_P _4'_?Q?\ &C[?9?\ /U!_W\7_ !K^6S_A/_\ @I'_ -"_K7_?F?\
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M_=Z?Y_U=7_J3^WV7_/U!_P!_%_QH^WV7_/U!_P!_%_QK^6S_ (3_ /X*1_\
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MTI)J^JMHW]WDS2.(5E^[GLNC\O\ /^M+_P!2?V^R_P"?J#_OXO\ C1]OLO\
MGZ@_[^+_ (U_+9_PG_\ P4C_ .A?UK_OS/\ X4?\)_\ \%(_^A?UK_OS/_A6
M7^IM3_H;97T_YB(?W?[WF_N\F/ZPOY)_=Z?Y_P!75_ZD_M]E_P _4'_?Q?\
M&C[?9?\ /U!_W\7_ !K^6S_A/_\ @I'_ -"_K7_?F?\ PH_X3_\ X*1_]"_K
M7_?F?_"C_4VI_P!#;*^G_,1#^[_>\W]WDP^L+^2?W>G^?]75_P"I/[?9?\_4
M'_?Q?\:/M]E_S]0?]_%_QK^6S_A/_P#@I'_T+^M?]^9_\*/^$_\ ^"D?_0OZ
MU_WYG_PH_P!3:G_0VROI_P Q$/[O][S?W>3#ZPOY)_=Z?Y_U=7_J3^WV7_/U
M!_W\7_&C[?9?\_4'_?Q?\:_EL_X3_P#X*1_]"_K7_?F?_"C_ (3_ /X*1_\
M0OZU_P!^9_\ "C_4VI_T-LKZ?\Q$/[O][S?W>3#ZPOY)_=Z?Y_U=7_J3^WV7
M_/U!_P!_%_QH^WV7_/U!_P!_%_QK^6S_ (3_ /X*1_\ 0OZU_P!^9_\ "C_A
M/_\ @I'_ -"_K7_?F?\ PH_U-J?]#;*^G_,1#^[_ 'O-_=Y,/K"_DG]WI_G_
M %=7_J3^WV7_ #]0?]_%_P :/M]E_P _4'_?Q?\ &OY;/^$__P""D?\ T+^M
M?]^9_P#"C_A/_P#@I'_T+^M?]^9_\*/]3:G_ $-LKZ?\Q$/[O][S?W>3#ZPO
MY)_=Z?Y_U=7_ *D_M]E_S]0?]_%_QH^WV7_/U!_W\7_&OY;/^$__ ."D?_0O
MZU_WYG_PH_X3_P#X*1_]"_K7_?F?_"C_ %-J?]#;*^G_ #$0_N_WO-_=Y,/K
M"_DG]WI_G_5U?^I/[?9?\_4'_?Q?\:/M]E_S]0?]_%_QK^6S_A/_ /@I'_T+
M^M?]^9_\*/\ A/\ _@I'_P!"_K7_ 'YG_P */]3:G_0VROI_S$0_N_WO-_=Y
M,/K"_DG]WI_G_5U?^I/[?9?\_4'_ '\7_&C[?9?\_4'_ '\7_&OY;/\ A/\
M_@I'_P!"_K7_ 'YG_P */^$__P""D?\ T+^M?]^9_P#"C_4VI_T-LKZ?\Q$/
M[O\ >\W]WDP^L+^2?W>G^?\ 5U?^I/[?9?\ /U!_W\7_ !H^WV7_ #]0?]_%
M_P :_EL_X3__ (*1_P#0OZU_WYG_ ,*/^$__ ."D?_0OZU_WYG_PH_U-J?\
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M4'_?Q?\ &C[?9?\ /U!_W\7_ !K^6S_A/_\ @I'_ -"_K7_?F?\ PH_X3_\
MX*1_]"_K7_?F?_"C_4VI_P!#;*^G_,1#^[_>\W]WDP^L+^2?W>G^?]75_P"I
M/[?9?\_4'_?Q?\:/M]E_S]0?]_%_QK^6S_A/_P#@I'_T+^M?]^9_\*/^$_\
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MH^WV7_/U!_W\7_&OY;/^$_\ ^"D?_0OZU_WYG_PH_P"$_P#^"D?_ $+^M?\
M?F?_  H_U-J?]#;*^G_,1#^[_>\W]WDP^L+^2?W>G^?]75_ZD_M]E_S]0?\
M?Q?\:/M]E_S]0?\ ?Q?\:_EL_P"$_P#^"D?_ $+^M?\ ?F?_  H_X3__ (*1
M_P#0OZU_WYG_ ,*/]3:G_0VROI_S$0_N_P![S?W>3#ZPOY)_=Z?Y_P!75_ZD
M_M]E_P _4'_?Q?\ &C[?9?\ /U!_W\7_ !K^6S_A/_\ @I'_ -"_K7_?F?\
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M_=Z?Y_U=7_J3^WV7_/U!_P!_%_QH^WV7_/U!_P!_%_QK^6S_ (3_ /X*1_\
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M^WV7_/U!_P!_%_QH^WV7_/U!_P!_%_QK^6S_ (3_ /X*1_\ 0OZU_P!^9_\
M"C_A/_\ @I'_ -"_K7_?F?\ PH_U-J?]#;*^G_,1#^[_ 'O-_=Y,/K"_DG]W
MI_G_ %=7_J3^WV7_ #]0?]_%_P :/M]E_P _4'_?Q?\ &OY;/^$__P""D?\
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M-_=Y,/K"_DG]WI_G_5U?^I/[?9?\_4'_ '\7_&C[?9?\_4'_ '\7_&OY;/\
MA/\ _@I'_P!"_K7_ 'YG_P */^$__P""D?\ T+^M?]^9_P#"C_4VI_T-LKZ?
M\Q$/[O\ >\W]WDP^L+^2?W>G^?\ 5U?^I/[?9?\ /U!_W\7_ !H^WV7_ #]0
M?]_%_P :_EL_X3__ (*1_P#0OZU_WYG_ ,*/^$__ ."D?_0OZU_WYG_PH_U-
MJ?\ 0VROI_S$0_N_WO-_=Y,/K"_DG]WI_G_5U?\ J3^WV7_/U!_W\7_&C[?9
M?\_4'_?Q?\:_EL_X3_\ X*1_]"_K7_?F?_"C_A/_ /@I'_T+^M?]^9_\*/\
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M 'O-_=Y,/K"_DG]WI_G_ %=7_J3^WV7_ #]0?]_%_P :/M]E_P _4'_?Q?\
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MD_M]E_S]0?\ ?Q?\:_.[_@J-<V@_9.\7[YDS(\1BPZ_-\CYQSSU'TYK\??\
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M"/R8O^>4?_?"_P"%'DQ?\\H_^^%_PJ2B@"/R8O\ GE'_ -\+_A1Y,7_/*/\
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M"/R8O^>4?_?"_P"%'DQ?\\H_^^%_PJ2B@"/R8O\ GE'_ -\+_A1Y,7_/*/\
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;>5%_SSC_ .^%_P *DHH   . ,#T%%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img12876764_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_13.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +8!\H# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#XZ_X()?\
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M%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
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M_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\ P2R_Z+Y^W_\
M^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M?U^T4 ?R!?\05/_!+
M+_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4
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M7[10!_(%_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\
M#I_LZ_\ T*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_
M $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\ _P"'3_9U_P#H
M5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\ !++_ *+Y^W__
M .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\
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M5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\
M_P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\
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M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\
MT*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\
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M%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
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M_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\ P2R_Z+Y^W_\
M^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M?U^T4 ?R!?\05/_!+
M+_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4
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M7[10!_(%_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\
M#I_LZ_\ T*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_
M $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\ _P"'3_9U_P#H
M5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\ !++_ *+Y^W__
M .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\
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M5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\
M_P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\
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M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\
MT*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\
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M/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M?U^T4 ?PQ_MN_\&BG_!-O]FO]B_\
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M_6=?V5:_K]H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF^;PQ"J\WM:<,'@7/#5<.ZD<2ZU)1Y'S)<F)K0R^6:+,G]5CEV499G=&=/\
MVF./P.;YKALFP;H\G*Z59X^O*C6I5E%T?92DW*,HL_HGHK\J/V</^"7TW[//
MQ1T_XF-^V5^U7\5%L+=[<^#_ (D>.!K'A>ZWDGS;BRV@O(O\)SQ@5^J$]U;6
MJA[FX@MD8[5:>6.%2WH&D903[ YISA2C2H3A6]I4J1FZU+V<H^PDI6C'G?NU
M>>/O7A91^%ZCC*HZM6#I\M*"INE5YXOVKDI.HO9KWJ?LVHJ\F^?FO'9D]%9W
M]L:3_P!!33O_  -MO_CM3P7UE<L4MKRUN& R5@N(96 ]2(W8@?A6)H6J***
M"BBB@ HHHH **** "BBOR*_X+#_MA_$/]D[X!>&X?A8]OIOC;XO>*H/ &E>*
M+U6%EX7_ +0DM8)=4EF"E()(X[IC#(Y4*Z@Y'6N;$5Y47A*5*E+$8K,,PR[*
ML!AXRC!XC,,UQE' 8*BZDVH4HU,3B*:J59OEI4^:;NHV?3A<,\34JIU(T:.&
MP>.S#%UYJ4HX? Y9@J^88ZNX03G4='"8:M4C3@G.I**IP7-)'ZZT5^%OP$_X
M)6?$;1A\./C1JG[??[3OBWQC>6FA^+=;\.W_ (R%[\.M1N-3@MM2O-.MM/CE
M;_B7)YK0V[*S*T8'R@'-?K*G[0WP4M?BM9? "?XE^&S\99=%.L1> 7NI?^$A
MN-,MDVSZBL'D^48048LWG9]J]6KA52G#"^VC5S+VV.I5L!1A.I.$<!3C4K5Z
M-1)+$T8P5:<YTX+V-.A.K548.,CS:6)5:$L72A/^S/JN&Q5/'U>6E'DQ4^2G
M'$46W+"R;G04?:SM.=>-*+=2+B>VT5XKXG_:&^"WA/XCZ)\&_$/Q'\.:/\4_
M%5LTWAOP5=W,J:YJR-$71[.!86C<$%6&95ZBOY[?V;?C[\>M<_:C_P""O7AS
M7/BOXOU/1/AGX#U>[^'.C7=Z7M/!-[%I5S)'/HB9Q;RI(JNK#&&&:\IXA<F9
MU8PE.CEO"G$/%?MXM.EBJ'#F/RO+L;@</45XRQ7UC,XP;NZ=&>'K4ZSC4M$]
M2&$<H4G*I"G5J9[PSD;P\[JM2EQ15JT\#C*D/BCAHPI>VNU>M2G&5'F6I_3Y
M17\V?_!*/_@IO\&/ ?['^@ZA^V9^U5I]OX^U3Q7K%K#J/Q N=2NM2EMQJ5W!
M;1&>RL;U4C7Y(P)C&$PO)!X_?^+XS?"VX^&Z_%ZV\<:#<_#1M,&LKXQM[HS:
M.=,*AQ=B6-&DV;2"5,0D&<% >*];,L&LNE7E+$4:^$PRPBKX^D_]CI5L5@J&
M-6'J5Y?NZ=:G"NH3A.49-Q<DN5IGGT:DJM>6%=*I2Q7UW,\'0PTXM8C%1RS,
M\5ED\3AZ+2J5:%>KA74I2C%^[4A&3YKH]-HKX6^&7_!3']A#XR>.H/AG\-?V
MF/AWXH\=74TMM;>'+6XU2UO;B>%S')% VHZ99V\KJX*X2<Y/W<U]+_%SXV?"
MKX#^$+OQ[\7O'&B>!/"-B,W.M:U-*MNG&?DCMHKBYEP.3Y4+X&,XR,\59K#T
M*6*KOV&&KZT,16_=T*RYU"]*M/EIU/?E&'N2?OM1W:1O3C*KB:F#I1E4Q=)I
M5<+3BYXBFVI22G0BG5@VHR:4HJZC)_9=O4J*_*?XP?\ !7#]CK3/V=?B3\8?
M@Y^T#\/_ !CJ'A?0M0N-""V^N26-WK<$;&VLKB.XTRUD"2R#:QQ@>]>5_P#!
M+'_@KS\(/VV_AAX)TCXA?$[P!IW[37B&;7)-0^%_AVVU:"6'3K"\>.SN8&DL
MC9E9;4)*Y:Z1MQ(V<9K;!X>MCZF:TL-3G*MD]'+,1BJ+C)5:E'-89A5HU,)3
MLYXF%"CEU:OCI4TXX2A5PM:LU3Q-.3C$..%PN#QE6</JV-Q>88*%6,E*-&OE
ME.C/%?6I74</!2K1H0G4:4\3"K05JE.<5^UE%?"/Q%_X*;_L&_"7QS+\-OB-
M^TO\/O"?C:"Y6SGT'4WUD7$-RS!1%+-;Z3/:1MN(&7N ,D<U]%>+_P!H7X)^
M ?AC#\9O&'Q*\,:#\++B"SNH/'-[>D:#);Z@RI9RK=11R';.SJJ90$$X8*0<
M80E&IA88V$E/!5*M.A3Q<6I8:=>LXQI485U>E*K5E*,:=-2<YR:48MNQ<H3C
MB5@I0E'&.$JBPDHM8EPAK.:H->U<(IIRDH6C?5H]DHKX;U?_ (*5_L)Z#XK\
M.^"-7_:8^'%CXF\6_8AX<TZ:[U'&K'455K(6UXFG-8@W 92GFW,?4;L5T/Q*
M_P""@'[&OP>\9:%\/_B5^T)X \)>+?$H@.AZ3J%[>2'4!=!3!Y5W9V5S8KYH
M=-OFW*?>&<5<8RD\.HQE)XO$U<'A%%-O%8NCI6PN'2NZV)I/2K0I\U6G]N*)
M_P"?VJ_V?"QQU?7^#@I\KABZO_/O"S4HN->=J4E)-3::/L.BJ.F:GI^M:?9:
MMI-Y;ZAIFHVT-Y8WUK(LUM=6MPBR0SPR*2KQR(RLK#J#ZU>Z=:4HRA*49IPE
M!N,XR3C*,HMJ2DG9Q<6FFG9IIIDQE&<8SA*,X3BI0E%J491DDXRC)74HR333
M3::::T"BOAKXN_\ !1;]BKX2>+K[X4>//VC? ?A?XE26UW!!X9EGU&ZU..[$
M$FR-FLK"YM(IE89"S7,>"/F(ZU^57_!&']K'Q)XG\&_M?_$_X^_&_4O$OPZ\
M'_%KQ,-%\5^,-0DETK0/#::F?L<=LX61X;-(%81@*2%4\5.!E3QTLSE&K3I8
M++<AEGT\QG./U&M2AFF%RN6&IXA/V2K1J8J-5RE-04(2C?FT.C%X>KA,-AJL
MX3EBL7GN6Y'2RY0DL=*IF>"S+&T<3&@TISHJ.6SI-0BYRG6I<J:N?T=45Y3H
M7QQ^$OB;X7O\:=!\>:#JGPKCTR\UE_&]K/(^AKI=@K->7IG,2R>3;JC&0^5D
M 'BN9T;]J3]GKQ!\,X?C+H_Q:\(7_P +KB9K>'QO%?2#0I)ED,31BYDA1@PD
M!0YC W#&:NI"=&IB*56$J57!SH4\72J1<*F%GB:KH8:&(A)*5">(KIT:$:JB
MZM5.G34IJQA3:K4\/5I-5:6+E4AA:M-J=/$SHT7B*T,/.-XUI4L.G7J1IN3A
M13JR2@G(]\HK\F/^"@'[8'P\U+]E']H&Q^ 7QOTMOBKX0\&6>O+-X-U"676-
M$M-0R]G?I<+$L"+/'EDV3,V/O**Z_P#X)D?&+4M0_P"">OPA^*WQO^($NH7H
MT#4+[Q/XW\6WP$TJ6]U(#/>W,G+LD:[550SMMPJD\4L,E7PW$&+J-86AP_+A
MWVM3$-0IXJEQ%2SNK0KT*CM%4L/_ &)6C5G-J,W6ING)\L[/$IX>KD5",77K
M9[//*=*E27-5P\\EI9'6E&K35YREC*>>X>>&C!-N%.4VN6=-O].**^'?AE_P
M4G_88^,?CW_A6'PV_:2^'WBGQV9S;+X=M)M5MKN2X5BABCFU#3+2SD?<" $N
M6R>E?F'_ ,%C/V@?B9\%?VH/V"+?PI\5_$'PZ\">(_&VJ+X_MM+O?LVEZYI=
MNT+[-60,//ACCW$*,Y&<=:*<7+'\.X.HO84>),VP^587'UO<P=+ZQ"M/ZW*K
M*T:F'I>Q:J2I2DTY+HF:1IN='/)P:G7R+)<USG$8.-WB:D<KP5;&O"QI*\X5
M\3&C*G1YXJ+F]=$[?T/45\7_  B_X*"?L:_&?QNGPG^&W[0G@7Q;\2+6UC-Q
MX5MKB_MM69HXP)"JW]C:V\S[E;*P7$I+9"[LC/7?M ?MJ?LM_LLR6$/[0'QF
M\*?#&;5 K6$.O'4GEN58X5DCT^PO6"DXP6"CFE6<:$</4JRC3I8S_<JM1J%/
M&*\DI86<K1KJ7+*SI.=^5]F9T%/$2JTJ5.<Z^'@IXK#PBYU\*G%2?UFG%.='
ME35W4C%+?8^HJ*\3^!W[1WP-_:5\*_\ ";? KXE^&?B7X7$AB?5O#MS++%%(
M.J30W4-M=0G_ *ZP(/>O'OB]_P %#/V+O@-XYM/AK\6_V@_ _@OQQ>RQP6WA
MW4)-4N+QYI<[(BVG:;>6\;D@@K),I4@A@"#55HRP^(IX3$1E0Q59I4<-63I8
MBJW%32IT9J-2;<)*:48N\6I+1IBI-5Z-;$4&JU##QG+$5Z352E0C3DX5)5JD
M;PI*$TXS<W'EDFI6::/LVBOYVOVU?^"X_P .OV?OVI_V;OA?X"^(_P -M5^$
M_CO6(/\ A<'B;4K+5I;SPIX=EV,=2LF^S1.YV,3A8R0>Q[_K18?MZ_LA:E\'
M8OC]9_'7P?-\()I9;>+QSC54TJ2>#/G1JCZ<MXS1X.X+:D<<$\4J:]IE*SI.
M,,!]?Q^759U)*$\-B,OQTLNE]:@_]WI8O$QE'+ZE5Q6-A%SH\R3-:U*I1QU'
M+W"4\3B,#@<PPZI)U(5Z./H5L31A1E%-5<13P]"=;$4*?-.A2<*E1*$U(^O:
M*^3?@!^W3^R/^U+J=_HOP ^.W@GXF:QIBN]]I>A7%]%?P)'G>YM=2L;&5U3!
MW&-7 P<U9\9?MO\ [)WP^U_Q;X5\9?'3P-H/B7P+IK:OXMT.\O;HZGHFFJ<-
M=W=K#:2R>4IZ^4)&_P!FBLGAW".(3H.KAYXNFJR]DZF$IN*J8J"GRN>'IN45
M4K1O3@Y)2DFT9T_WWM/8_O?8UJ>&J^S]_P!EB*S2I4*G+?DK56TJ=*5IS;7+
M%W/JFBOD+X?_ +?'['7Q3\">)OB9\/\ ]H'P!XG\$^#HS+XFUNPOKI$T= "=
MUS975G;ZB> 2!#:2&NH^ '[8G[,G[4T6K2_L_?&3PA\3_P"P9WM]8A\/7-U]
MJT^:-F1UN+6_M;.Y 5E8%EB9!C[U6J-652M15*HZN'P]+%XBDH2=2AA:\5*A
MB:T$N:EAZT91E2K34:=2+3A)IHB52G"G&M*<(TIXF>"A5E**ISQE-\L\+&;:
MC+$PD^65!-U8O1Q3/I6BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ^ /^"L7_*++_@I9_V8!^V1_P"LZ_$:O\0:
MO]OG_@K%_P HLO\ @I9_V8!^V1_ZSK\1J_Q!J /]/O\ X,J?^467Q\_[/_\
MBG_ZSK^RK7]?M?R!?\&5/_*++X^?]G__ !3_ /6=?V5:_K]H **** "BBB@
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M%"A'$8QX_.<+"5:C&IFV7J&(Q,*M51D<U>FL3FV90R^*S+!XSAC+/];5B?\
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M'JOQ]_9]NOV?-<TS68K+1="NO$EIXD;7-->%Y)-36XM$1;=8Y0D7E.-Q+9'
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MS3;RZ,@1]+:Y!AWR,49,GD8)]K-\9!YAQ7F>%DO[*S#).#>&8X6.&^M5IX[
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M']I65_9Z>\DKA/,> R DD.C &O+?$G[&?[?W[</Q=^&>G?MP:5\+_AW^S_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X _P""L7_*++_@I9_V8!^V1_ZSK\1J_P 0:O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-^S-X$\0Z3XL\'?!+X?^'/$FA3FZT?6M*T.&VU#3;@\F:UG4[HG).=P[U?\
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MP5^Q1\([+PE^TWXS\>_$BZ^,'AK0=;^*GBK3+#^W]:T:^EB6YL;BV62X@19
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM88A8AP7U6=*G6YHKGJPE->R<DJ\8J,HN,YTN:$9/FA&33G3J13@]:+HJ?\
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M@[P]X\T*\\->*+!-3T6_3R[VPE/[FYC/6.5<$/&PX9""K#@@BOQ>_P""POP
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M-1IQC75>HZDH59.NIN#A"ER4W&$E.:<V4445@;A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-G:V46<^5:6\-M'GUV0HBY]\5:HHK%MO=W]35)+96] K\/\ XU?\IX?V.?\
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M+$U(I2H4\5G='-:4\5"+M4G"G3E1FJ3BI3:E&T4T?S]?\%>_V@/&7A_]J_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!+Q#\-8DN!KND>%/"5UINOW,C(1;&SO9+.)(E1\&3+C<O JO\5?"?_!0Z_\
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M "BBB@ HHHH CFBCN(98)5#Q31O%*AZ-'(I1U/LRL0?K7AVEZY\ ?A#XGM_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!DDB0QR2R,$CB1I)'/ 5$4LS$]@J@D^PK\M_VMOV;/BI\9_&GA
M']I#]BWXK_#GPU\?_A_I^I>'=-U+QO:+XI\*#3=1,T5]:WNF6R7)@NOFD11<
M1(1UY'-?J+<01W5O/;3+NAN(98)5R1NCF1HY%R.1E6(R.17XS_&;_@GE^T+\
M._'VL?%O]@_]H/5OA3<:_<MJGC3X8>(0^O>'_%MX9&E9;2>^=HM*#NQ.V-4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA88'&Y73Q&=8VK#+L7@J3=/"8K!1FL-7PU-N%"K3G2@W&"84445Z9\:%%%%
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M33-EBRD$FOX]/V;/V>?B,W[2?[=W[>G[/IOM2^,7[._[0-V=9\'/;S/;>*/
MEE/<3:CIME:SIY<]_)")WC:-&;"#![5_9!^Q/^V1\-?VU?@QHGQ0\!W@BU-8
MDT_QIX8G26+4?"OB:W14U/2+Z*6-&22"XWJ!SP,'ID_047*MP]EM>=-3SNGP
M?P#A<ZP]1NI'*LF7#663R#$Y72E[KPF;)3GCLU4?K#QL'EM25"E3ITZW!G2E
M3XFSF'+[#*:O&/%-7!XNE)*>8Y_#$\N99?F%6-ITGEV'=*>7Y=)^QQ5"M5QZ
M56I2?L?R8_:P_:Z_;2\$_P#!2KP=^QY\-_%>FV'@SX^^';RY\)ZW-9V\ESX
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M=1GGC:"]2-X9Q]I2,22;71OFR&%? O\ P4]_8W^$'_!-[X>:7^VC^Q+IMO\
M +Q]X5\7^'+'7?#7A>28Z/XZT_5-5M[:XL[R*_N+NYW^6Y&(78D8/? ]GB1X
M?!^)6#K8Q/#8'"\;Y!BE++8J-2/%%;-,%3MC*:Y53RFIGE2G1S*.#CB,57P$
ML1AHTXPDYKS.%X2Q7">.PV6*-7,L5E'%.6Y=1QSC5RY\//#YG2P=.G6?M/;X
MN.5N7U!8B%/ *LL-7JU>5R2]?_X+/77A'0? ?[&&A?&34?#:QVGQ&^'0\0W7
MBUK3^PI+C3Y;>+5+C4&O@UNT'G)(TAE!5ADGO7[(?"^']D3Q^T%]\);/]GCQ
M?>Z3'#(+WP%IWP]U>ZT]T50LBS:+;SW%HRD<-NC=>,D&N'N?@A\#/VYO@'\+
M-4_:5^#WA?XCVNM^$/#WB!]&\5VES+%9:CJ&F6UU<2P"WN+66)C-*[J0X(R.
ME?@A^WU^S5X$_P""7?Q\_90^-?[%4^H_"F+XF?&+2? _C/X0Z!J%]+X<\2:5
M=- )Y5L;F[N)<MYC Y# $$;J\[".MA,PAPIFT:>'KYKX@YW/!YCEZ]I&CF'$
M&&R;+\+A\;0?LZBP]+%Y)*FZV$E6]G3Q4*CIJ%*HU%&C3S+!4<_R>K5KQP/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !117A?Q-_::^ 7P9UJS\.?%+XJ^$O ^N:A9
MG4++3-=O9+:ZN;(-M-S$BPR Q!AC=D<]JPQ.*PV#I.OB\10PM%.,76Q-:G0I
M*4G:,74JRC!.3TBF[MZ(]/*<ESC/\9'+LBRG,\ZS"=.I5A@<IP&*S'&2I48\
MU6I'"X.E6KRITH^]4FH.,(ZR:6I[I17 > OBI\._BAX17QY\/O%VC>+/!S&[
M"^(=(N&GTXFP7?>#S61#FW7F7Y?E'K7BUA^V_P#LEZIK=KX;T_X]?#^[UV]U
M7^Q+32X=3E:ZN-6\XV_V"-/LP!N/.!CVY W#&:PJ9IEE&&'J5<QP-*GBTI86
M=3%X>$,3%\MGAY2J*-9/GC9TW)>]'NK^EA."^,<?7S3"X'A/B7&XG))NGG.'
MPF19IB:^45(^U<H9I1HX6=3 3BJ-:\<7&E)>RJW7[N5OJBBO-/B?\8_A?\%M
M&M/$/Q5\;:%X%T2^O5TZTU+7KEK:UN+YUW+;1NL<A,K*<A<#CO6-\+/VA/@I
M\;;C5[7X3_$GPSX\N- 2&368?#]V]R^G)<$"%KD/%'L$A("X)Y(SBKEC\#'%
M1P,L;A(XV23C@Y8FBL5).+FG'#N?M6G"+DFH-<J<MDV<U/ACB2KDU7B.EP]G
ME7AZC-TZV?4\IQ\\FI3C5A0E"KFD<.\#3FJ]2G1<95TU5J0IM<\HI^R45\U^
M-_VQ/V8/AOXEU;P=X[^-G@;POXHT)D75]$U749(;[3VD&Y!<1K;N%+#D88^]
M>N3?$OP';^ F^*,WBG2H_A\ND+KS>+&F8:0-&? 743/LW?9CN7#[,\CBIIYE
MEU:>(ITL?@JM3"J<L53IXJA.>&C!N,Y8B,:CE14'%J;J**BTT[-,UQ7"7%>!
MP^5XO'<,<0X/"YW.A2R7$XK)<RP^'S>IB80J8:GE=:MAH4\?/$4ZE.="&$E5
ME5A.$J:E&46_D/\ :)^,OC_P-^UC^Q]\-O#FO0Z=X1^*&K>,;;QEI3P1R2:Q
M#I>G1SV212M\\/DR,6)3&<X)-?>E?'F@?'K]B[XZ_$KP+_PCWQ#^&OQ ^*&@
M&^N_ /V.[FNM<TXW$(6_FTG,42H9(5 E+9RHX K[#KARB4:U?-\72S/#YEA<
M7CZ=3"_5L2L33P=.& P=">&<H3G3IR=:E4Q')3:5JRFUS2DW]+QY2G@,NX$R
M/&\&YMPAG>1\,XO"9Y+.,GGD^*S_ !>)XGS_ #'#YM&G7H4,5B:5/+L9@\JC
MB,3&53FRZ5&$O8TJ<8E%%%>V?G(4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ? '_  5B_P"467_!2S_L
MP#]LC_UG7XC5_B#5_M\_\%8O^467_!2S_LP#]LC_ -9U^(U?X@U '^GW_P &
M5/\ RBR^/G_9_P#\4_\ UG7]E6OZ_:_D"_X,J?\ E%E\?/\ L_\ ^*?_ *SK
M^RK7]?M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %?,O[8WPIU#XU_LV_%GX;Z1L?5?$GA'5[33;>
M29+>.]OFL;@6UE)+(515N966([B!\W.>A^FJ^?/VK;:\N?V=/C$--NM6L=3@
M\!>(KK2[S0TEEU:VU&WTVXDM)K"*$B66Y28*8HTY=L <XKR<\=&.48^>(A.I
M0I4'7J0INTW&A*-:\+QFI3BX*48.,E4:4.5\UCTLG526:Y="E.%.I4QF'I0G
M44G3BZM6-/\ ><DHS4'S6FX2C.,6Y1DI),_&/XD_LE?&OP1^PY^RCXG^'7P7
MT2?XR?LLWUGXC\0_#.U@LYKCQQ8:?<2O<:7;74*,LDUV@1PY+$ER,X&*E_X)
ME7/[5_QT_; ^,O[47Q)^ &O?LK_"?Q!X1T+PYIWPQU:=#!J>NZ:L$=YJ<=M#
M%%$D\S1--+*J .V>%SBOC#]DG_@OCJWPD^#FC_#+XV?LX?M(>+O%W@N:\T5/
M%;> =<FF\1V=O>W(CU"Y8QNWF,FU1DDE0.<  ?LG^P'_ ,%0_"?[=GBGQAX4
M\.?!?XI?#-_"%G!>37?COPO?:#9WRW+*-ED]U&B2NI?+A,D8)/2OMZ=?&5\W
MS_'T)TLXI8FEGN;4'"#P^&P'^LGU.OGN84Z3=.K46+G&C6>!QCJPP&-G.5&G
M"I3A&GX%>E3P&44LJEAHY.L/7P^1XZI&/ML3CL'E.=RJ93@IUJL9S3P^*ITZ
M.%S."IXZME4UAZU5TZU:4_U6HHHKYX[0HHHH **** "BBB@ K\/_ (U?\IX?
MV.?^S0_C-_Z7ZO7[@5^'_P :O^4\/['/_9H?QF_]+]7H*C]K_"_T/W HHHH)
M*.IZ7IVM:?>:3J]C:ZEIFH6\EI?6%[!'<VEW;3*4E@N()5:.6*125='4JP)!
M!%?,FH_L-?L<:NV[4_V8O@A?-N+9N?ASX9E^8DDMAM/QDDDDXR22>M?5-%3R
M0YN?DCSV2Y^5<UHMN*YK7LFVTKZ-MK<M5*BA[-3FJ?,Y<BE+DYG'E<N6_+S.
M/NMVNXZ7L>7:/\$OA!X?\!/\+=$^&?@G2OAQ(DJ2>!['P[IEOX7=)O\ 6JVC
M);BQ(DQ\X,/S=ZY_X;_LS?L]?!W4KC6/A7\%OAI\/=5NMXN-1\(^$-%T.]FW
MDL_F7%A:0RMN9B6^;DDYZU[C16KJ5'6JXEU)O$5X\M>NYR]M6C9QY:M6_/4C
M9M6G*2LVK69DXQ=*-!QBZ,)NI"BTG2A4<E)SC3:Y(S<DI.22DY)-NZ1^5O[:
MO[:W_!/+X8^*;?X4?MIZ7HE]/!!'JNCVOB[X:7OCK2)1(5PUI)#I&HI!< E3
MC:N>3N!'/Y6? 7PSX4_;F_X*6?!S]H+]F'X2MX!_95_9ITK4[/3O%5KX;;PE
MH_BN_P!1AVJ=/T62UM&@59/[L8RHYR:_IVU[X?> O%-PMUXG\$>$/$=T@"I<
MZ]X:T;5[A%'0+-J%E<2*!V 8 5KZ+X>T#PW:"P\.Z'H^@6(.X66BZ99:5:!O
M46UC!!#GWV9HR2<LJQN%S2J_:YA@%F4\(L-;"X&IB\RRS'9-+'8_#OVU7$XC
M#9;F.*C04:]*DL3.-:5.481IJ\T?U[ XS+*%Z6$S'#X;!XR6(;Q.)IX*GC,)
MC\5A,!43I4\/2QU?!PIUI3I5JL<-.I"$U5:JK8'  ]*XC7/AI\/O$OB'1O%O
MB'P7X9UKQ/X=D$V@^(-3T:QO=7T>48Q)IM_/"]Q9N,#YH)$/%=O14+W9PJ1T
MJ4I.5.:TG3DXR@Y0DO>A)PG.#<6FXRE&]I--;QG!_!4@Z=2'V9P;3<)QVE!M
M)N,DTVD[:(X#XB?"GX:?%S13X<^*'@/PGX_T$MO.D>+="T_7=/W?WA;:A!/&
M#[A16'I'P#^"7A_1=&\.:)\*/ &E:%X=O(]0T'2;'POI%M8:/?0X,5WIMO':
MK'9W$>!LE@",N.#7K=%.FW2<W2;I.=2%:;IOD<ZM)6IU9\MN:I36D)N\H+2+
M0Y-S5-3;FJ49PI*3YE3A4352--._)&HFU.,;*:;4DTV<1I'PT^'N@>)]4\:Z
M)X*\,Z5XNUN%;;6/$NGZ-8VNMZG;H04AOM2AA2ZN8U*@JDLC*"!@<4C?#3X>
MOXN_X3Y_!7AAO&WD-:_\)6VC6)\0?9G7:T']JF$WGE,I*F/S=I'&,5W%%):>
MRMI["E*A1M_RYHSA.E.C2_Y]TI4YSIRIPM"4)S@TXR::>OM+Z^VE"56^OM94
MY0E3E4O\<H2ITY0<KN,J<'&SA&W"^&_AC\.O!TGB";PIX(\+^')?%=S)>>)I
M-&T6PTY]>NY0ZR7.K-;0QF^G=9'5I+@N[!F!.":J_#[X2?#/X4V^JVOPV\#>
M&_!-OKFHSZOK$/AW3+?34U'4[EB\][="!5\V>5B69SU))P,UZ)134I1<FI-.
M5"EAI--IRPU!IT</)K5T*+2=*D[TZ;2<(II!+W[J7O)UGB'S:WQ$HN,J[O>]
M9Q;BZOQN+:<K-G\Q?[:/A2T\6?\ !<C]CG2_$/@ZX\3^%;SP-XLM]4CO]"N-
M2\./'+;RJ8K^9X)+%=P.-D[ /TP<XK^A;X9_ 'X(_!I[Z7X3?"CP#\.9=59G
MU&3P=X8TG09+UG;>YN9-/MH'F+.2S;R<L23R:])FT'0[G48-7N-&TJXU:U5D
MM=4FTZSEU&V1OO+!>O"US"K?Q+'*H/<&M6M,)5^J9%D^3TURU,L6>QK8N#]G
M+&T\YXAS+/8TZD(KF4,,LP6&Y9U*D:CI>U2AS^SB\>WCLWQ.9STI5\OX?P<,
M)+]Y&C6R/+U@?K49.RY\1;VB2IQE2^'GF_>"BBBLA'D7Q.^ /P1^-(LU^+GP
MH\ _$@:<0UC_ ,)GX7TGQ ;0A@P,!U&VG,>& 8;2.1FN]\+^$_#'@C1++PUX
M/T#2?#/A_38Q#8:-H=A;Z;IMG$.B6]I:QQPQ*,#A4'2N@HHA^ZISI4_W=*I4
M]M4IP]RG4JZ_O9PC:,JFK]^2<M7KJ$_WDH2G[\J47"G*?O2IP>\(-W<(NRO&
M+2?8.O6O!+G]EC]FV\\;+\2;OX%_"RY\?K="]7QC-X*T*3Q"+P'(N1JC61NO
M.!&?,\S=GO7O=%$?<JPKP]RO24E3K1]VK34K<RA45IP4K+F49*]E?8)-RIU*
M,GS4:J2JTI:TZBB[I5(/W9I/5*2=GL> _M(^#OC;XR^%FLZ-^SK\0-"^&'Q3
M*1_\(UXJ\1Z9+J^A6$BD!A>Z;!%,UQ$4&T((V&#TK\D)?^"9G[;7[3'BCPG'
M_P %"_VL?!/Q3^%O@W5[#7[/P#\(_"M_X)MM8U/3I!+;_P!N![.U@O+=GR)%
M<,67C!Z5^]M%+"J.$Q?UV,8UJT,12QE!8N*Q='"XNA3A3HXG"T*_/1HUJ3IP
MJTY1A[M>*K)>T]XNM4G5POU12="FZ57#SJX5O#8FKAJ[O5P]3$T>2M*C.+E3
M<.=+V52I3349-'P[^U/\%_VH];^'G@OPS^Q'\7/ OP%U[PG=6D!F\7^&IO$'
MA^YT&UC6-=,&FVMK. 2 22T85B22<FOSQ_X=??MB?M*?$7P7K_\ P40_:E\$
M?%_X>^ =3MM9TCX<?"[PI?>#]%U/4;66.>&36[66SMK:[198PWS!CWP37[X4
M5>%G+"XQ9@F\1C(8Z69T*V-_VR6%S!RC4CC,+]8]HJ->E5BJU"<%^YK7JPM4
M?,1.TL'' TDL)AE@I9;..!2P<JV G&4)X2M4PZISG1G1D\/.+DF\/^YOR)(^
M _VKO@Q^V?K]IX$@_8E^./PZ^!Z^%]*71]3L/'OA*X\4Z1J-G HALTALX+6Y
M2-K:W2-%+H,% 17Q[\(/^"8'QT\>?'+PQ^T'_P %"_C[X>_:!\8?#K4(=3^'
M/AWP/HEYX9\%Z%?0',5Y+H]S:V\+3IM4AHXB3MQD9)'[?44\%4G@<5]>I2=7
M&QQ&(Q>&Q>*?UK$8'$XJ,H5JV J5^>6$J.%2K"$J/+*E&M5]FXN;88E1Q6"6
M7RC&A@WA*6!KT,)%86&,PE*JZL</C/8<CQ-.4N6-2-5M5:=.E3GS0IQBD551
M0J@*J@*JJ  H P  .  . !2T45&^XDDDDDDDK)+1)+9)=$@HHHH&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD;QSR;*WF2G','@,*\;&I&$)K%.C#VRG&DE3C)5.;FC!**>D58\KQ)CPW#Q
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M(%_P94_\HLOCY_V?_P#%/_UG7]E6OZ_: "BBB@ HHHH **** "BBB@ HHHH
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M7KG.E2D^9-MKE?7T_P D?N!11100%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?*W[</\ R:+^T)_V3+Q#_P"B5K9_8]D>7]EKX!/(Q=C\+?"(+,<G":5
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M@U '^GW_ ,&5/_*++X^?]G__ !3_ /6=?V5:_K]K^0+_ (,J?^467Q\_[/\
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M?_&K_E/#^QS_ -FA_&;_ -+]7H*C]K_"_P!#]P****"0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]_\ D^ONFBC_ %LXJ_Z*;B#_ ,/.8_\ S2'^JO#'_1.9#_X9\O\ _F<^%O\
MAV9^P1_T:U\+/_!7>_\ R?1_P[,_8(_Z-:^%G_@KO?\ Y/K[IHH_ULXJ_P"B
MFX@_\/.8_P#S2'^JO#'_ $3F0_\ AGR__P"9SX6_X=F?L$?]&M?"S_P5WO\
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M_P"S_P#XI_\ K.O[*M?U^U_(%_P94_\ *++X^?\ 9_\ \4__ %G7]E6OZ_:
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M^"EW[+'[6_Q>\:?!GX'>++[Q;XD\"Z>VIZOJ4&GE?#\MJDODE['4A*R7!+]
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M2Y)N-FW:,M'=+78R56G*K5H*2=6BJ<JL-;P552=-OI::C)JS>SN%?A_\:O\
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MZ*#!?=7_ /E)^OU%?D#_ ,/C_A!_T;K^UI_X9S4O_DJC_A\?\(/^C=?VM/\
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M'_"#_HW7]K3_ ,,YJ7_R51_Q#KC;_HGL;_X%A_\ Y>'_ !$#@W_HH,%]U?\
M^4GZ_45^0/\ P^/^$'_1NO[6G_AG-2_^2J/^'Q_P@_Z-U_:T_P##.:E_\E4?
M\0ZXV_Z)[&_^!8?_ .7A_P 1 X-_Z*#!?=7_ /E)^OU%?D#_ ,/C_A!_T;K^
MUI_X9S4O_DJC_A\?\(/^C=?VM/\ PSFI?_)5'_$.N-O^B>QO_@6'_P#EX?\
M$0.#?^B@P7W5_P#Y2?K]17Y _P##X_X0?]&Z_M:?^&<U+_Y*H_X?'_"#_HW7
M]K3_ ,,YJ7_R51_Q#KC;_HGL;_X%A_\ Y>'_ !$#@W_HH,%]U?\ ^4GZ^/\
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M\^ OA#XL^ OQ/L]3^'>G2>&S<6?PJU,0ZLMG>W7_ !,-K:;(RM*&!;<3N(R
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M9="TK6-<AU*:WO-6=%D6RC73+*^F$I1E;+QJF#R^:_GD\9_#WPE^RI_P6Q^
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MZ4444$!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 URH1B^ @5BY/3: 2V?;&<U\6>#?V;_V&OBT;_P"(/@SX4_"KQ>R^
M*=0&H>([#2FF<>+-*NE;4#+*[1G[?:794RL$P).A-?:%PI>"9%&6>*15!X!+
M(P )]R:^'?\ @GY\&_'OP/\ @MXE\)?$31;?0M<U#XN_$7Q1;6=M/'<1R:/K
MVJ0W.FW1>(E0]Q$I9T/S*1S7AYA3AB<SRO!XC*\+CL'4H9C7JXG$X6.(6#K4
M/J:P\(2J0G3I2Q*JU;WM*:HKE^&1^D<*XJOE'!W&>?95QKG/#6?X3,N%,OP6
M49/G57*I9_EV9K/Y9I7Q%'"UZ&*QE/*)X' <O(Y4:#S&3K).K3O]4^/?A9\.
M_BCX7'@KXA^$-%\7>%!):RC0=:M?M.G>99+MM'\G<O,"\1\\"N1^&O[.'P*^
M#NKWVO?"[X7>$O ^L:G:+8W^HZ!IWV.YN[-6#K;S/YC;HPP#!<#D"O;**]&>
M P,\1#%SP>$GBZ22IXJ>'HRQ%-1NHJ%=P=6"BI2249)+F=MV?)4>)N(\-E6)
MR+#\09W0R/&3G4Q>34<UQ]+*L54JNG*I4Q.70Q$<'7G4E1I.<JM&4INE3<FW
M"-OG_P ?_LK?LZ?%3Q'<>+OB+\'_  3XP\2W=K%97.M:WI8NKZ:TA4)%!)*9
M%S'&H"J,< 8KTG1?AMX#\.^"$^&VA^%=(TSP'%IT^D1^%K2W\O2$TRY#K<62
MV^XX@E$CAUW<[CSS7;T44\!@*5:MB*6"PE.OB%*->M3PU&%:O&;4IJM4C!3J
MJ<DG)3E)2:3=V5B>*.)L;@<!EF,XBSW%Y;E4Z-3*\OQ.;YA7P.6SP\'3P\\!
MA*N(GA\'.A3;A1EAZ=-TH-Q@XQ=CYJ\*_L=?LO>!_$.D^*_"/P/\ >'_ !'H
M-R;S1]9TW2!!?:==$Y,]K+YI\N0GG=@UWWQ/^!?P@^-$>E1?%7X>^&O'<>AR
MRSZ0GB&Q%X-/FF 662V^=/+:10 QYR*]7HK.&5Y93H5,+3R[ 0PM:2E5PT,'
MAXT*LH\O+*I1C35.<H\L;.46URQL]$=-?C3C'%9GA,ZQ/%G$V(SG+Z<Z. S:
MOGV:5LSP5&I[3VE+"8^IBI8K#4Y^UJ\\*-6$9>UJ<R?/*_F'PQ^"_P *O@Q8
M:CI?PK\">'O FGZO=K?:G:>'[/['#>W:*R)<3KO??*JLRALC@FO,M=_8P_96
M\3:[J7B;7_@3\/M6U_6-0_M75-6O-'$MY?:B7$GVRXE\T;Y_, ?=C[PSBOIR
MBB>5Y95H4L-4R[ 5,-0;=##SPF'G0HMWNZ5*5-TZ;=W?DBKW=Q8?C3C'!YCC
MLWPG%G$N%S;,XPAF6:8?/<TH9CF$*?+[...QM+%1Q.+C3Y(<D:]6HH\D>5+E
M5O'?B#^S[\%?BO8>'M+^(_PU\+>,=/\ "<*P>&[36[ 74.C0I#';I'8IO7R5
M6"*.( 9PB*.U9?P[_9C_ &?_ (2^(7\5_#7X3>#O!GB22SET]]9T+3?LE\UE
M-GS;8R^8V8I,G<N.:]VHJGEF6RQ$<7++\%+%P<91Q3PE!XB,H148.-9T_:1<
M(I1BU).,4DK)6(AQAQ;2RJKD5/BCB*GDE:%:G6R:&=YG#*JM/$U)5L13JY='
M%+"5(5ZLI5:T)47&K4E*<U*3;?S%KO[%_P"RKXFUK5O$6O\ P)^'NJZYKMW+
M?ZQJ=YHXDN]1O)R3-<W,GFCS)9"26; S7>#]G[X*K\-3\'1\-?"P^%[.9#X'
M^P#^P"YD\TM]CW]?,&_.[[W->PT5$,IRNE*K.GEN7TYXB%2G7E#!X:$JU.J[
MU8591IIU(5&DZD9N49O62;-\1QQQKBZ6!H8KC#BG$T<LKX;%9;1Q'$&;5J67
MXK!1Y,'B<#3J8N4,)7PD&X8:M05.I0B^6E*"T/F'1/V+?V4_#FL:5X@T+X$?
M#W2]:T.[AO\ 2-2M-'\NZT^\@(,-Q;2>:=DL9 *M@X]*ZGXB_LR? #XM^((_
M%7Q+^$_@[QIXBALX]/BUC7=-%W>I918\NV67S%Q$F!M7''K7NM%)91E,:,\/
M'*\NC0J3A4J4%@L,J,ZE-6A4G35+DE.";4)RBY13LFBY\>\=5<?0S6IQIQ94
MS/"X>MA,-F4^(\XGC\/A,1)3Q&&H8R6,>(HX>O.,95J-.I&G5E%2G&329X[\
M/?V?/@I\)[/Q!I_PW^&OA;P;9>*X6M_$=MH=A]EBUF%X7@:.^7>WFJT,CQD<
M?*S#O7F$G["G['\OF^9^SS\-7\Z5YI=VB ^9+)(99)&_?<L\A+L>['-?6-%$
M\GRFI3I4:F5Y=.E0YU0I3P.&E3HJI)2J*E"5)QI^TDE*?(ES22<KL,/Q[QUA
M,7C<?A>-.+,-CLRE0EF.-P_$><4<7CY86FZ6%EC<33QD:V*EAJ3=.@Z\ZCHT
MVX4W&.AX_P"-/@!\%_B)X7\.^"O''PW\+^)_"GA+RO\ A&M!U:P%QI^B^3#'
M!%]AAWKY6R&*.-?F.%11VKGO G[*G[.?PQ\36WC+X?\ P>\$^$O%-G!-;6NN
M:-I8MM0@@N%*3Q1S>8V$E4E7&.0<5] T5<LLRV5>&*EE^!EB:?L_9XB6$P[K
MT_9)*ER573=2/LDDJ?+)<B24;)(YZ7&7%]#+L1D]#BKB2CE&+^M?6LJI9YFE
M/+L3]>E*>-^L8&&*6&K?7)SG/%>TI2^L2E*57G<FW\W^*OV/_P!F+QQXCU?Q
M?XN^"7@+Q!XFUZX-WK&MZCI FO\ 4;DYS-<R^:OF.<GG ZUV&D?L_P#P7T#X
M=ZE\)=&^&_A?3OAKK#3OJG@RUL/+T.^:Y:-YVN+3>=YE>&)G^899%/45[!12
MAE664ZE6K#+L!"K7C4C6J0P>'C4K1K:UHU9JFI5(U7K44VU/[295?C7C+$X7
M!X'$\6\38C!9=5PE?+\'7S[-:N%P%;+THX"M@\/4Q<J.%JX))+"5*$(3PR25
M%P2/GWP#^RG^SE\+?$=KXO\ AY\'?!/A#Q-96TMG::WHNEBUOX+69=DL$<WF
M-B.1#M9<'(XK8^)?[.7P,^,>JV&N?%'X7^$O'.KZ5:O9:=J'B#3A>7-G:.Q=
M[>!RZ[(V8EBN.237M5%"RO+%AY8-9=@%A)S566%6$PZP\JBM:I*@J?LG-<L;
M3<7)<JUT03XTXQJ9M2SZIQ9Q-//*.'EA*.<SS[-)9M2PDE-2PU+,98IXRGAY
M*I44J,*RIM5)WC[TK\!X ^%?PZ^%?AD^#/AUX/T3P?X6:6YG;0M$M?LNGF6\
M&VZD,(9LM..)#GYJ\=@_8J_91MM9B\0P? ;X=Q:W#JO]N1:DFC 74>K><;C^
MT%D\WBY\\F7?C[YSBOJ&BG4RS+:T*%*KE^!JT\*K8:G4PF'G##KW=*$)4W&D
MO=CI345[L>R)PO&7%^!Q.98S!<5<28/%YS+GSC%87/,SP^)S6?[SW\RKT<5"
MKCI?O:OO8J55_O*FOOROYW\1_A)\-?B_H4'ACXF^"]"\;>'[:ZBOK?2=>M!=
MV<5W -L5PD19<21KPK9X'%8/PQ_9\^"GP8O-5U#X5_#7PMX$O=<ABM]7N?#]
MA]CEU""!E>**Y;>^](W564<8(!KV*BKE@,#/$QQDL'A)8R"2ABY8>C+$P23B
ME&NX.K%*,I124TDI-+1LYJ7$O$='**O#]'/\[I9!7G*I7R.EFN.IY16G.I3J
MRG5RV-=8*I.56E2J2E.A)NI3IS;<H1:^=O''[)/[-7Q*\2:CXO\ 'GP7\"^*
MO$^KI''J>MZOI0N+^]2)=D:SS>8N\(H"KP,"O4X_AQX%B\"CX91^%M(3P -)
M;01X36VQHPT=L[M.^S;O^/8[CF/=W/-=M12IY?@*52O5I8'!TJN)4HXFI3PU
M&%3$1FW*<:\XP4JJG)MR51R4FVW=LTQ7%7%&-PV6X+&\29_B\'DTZ-7*,)BL
MXS'$8;*JF&A&GAZF6T*N(G2P,Z%.,849X6%*5*$8Q@XQ22X?X>_#7P#\)_#=
MOX/^&WA/1?!?ABTEEGM]#T"S2QT^*:?:9I5@3(\R0JN]B26P,FNXHHKHI4J5
M"G"C1ITZ-*E%0ITJ4(TZ=.$5:,(0@E&$8K11BDDM$CR<9C<9F.*Q&.S#%XG'
M8[%U9U\5C,97JXK%8FO4;E4K8C$5YSK5JM23<IU*DY3DVW*384445H<P4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MELDCO'YML75%95W?(,$CFOT)\+_L;V^C?MN?$+]KV]UYY[KQ;X+T'PC8Z&@
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M:-_X4'BO_P"7='_#HG_@GQ_T;YHW_A0>*_\ Y=T?5O#W_H<<7_\ B/Y/Y?\
M51>O];GUGC[_ *%'"?3_ )GV;>5_^:?]?N^_[3_X7K\$?^BQ_"O_ ,.%X1_^
M6]'_  O7X(_]%C^%?_APO"/_ ,MZ^+/^'1/_  3X_P"C?-&_\*#Q7_\ +NC_
M (=$_P#!/C_HWS1O_"@\5_\ R[H^K>'O_0XXO_\ $?R?R_ZJ+U_K<^L\??\
M0HX3Z?\ ,^S;RO\ \T_Z_=]_VG_PO7X(_P#18_A7_P"'"\(__+>C_A>OP1_Z
M+'\*_P#PX7A'_P"6]?%G_#HG_@GQ_P!&^:-_X4'BO_Y=T?\ #HG_ ()\?]&^
M:-_X4'BO_P"7='U;P]_Z''%__B/Y/Y?]5%Z_UN?6>/O^A1PGT_YGV;>5_P#F
MG_7[OO\ M/\ X7K\$?\ HL?PK_\ #A>$?_EO1_PO7X(_]%C^%?\ X<+PC_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /@#_ (*Q?\HLO^"EG_9@'[9'_K.OQ&K_ !!J_P!O
MG_@K%_RBR_X*6?\ 9@'[9'_K.OQ&K_$&H _T^_\ @RI_Y19?'S_L_P#^*?\
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M@LYS7Z^Y^WQ.&KU:=#*UAG35+"8O*L6XSE4K58P[.BBBOHS\E"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "OQ\_:__P"4G?\ P3A_Z\OBW_Z:C7[!
MU^/G[7__ "D[_P""</\ UY?%O_TU&OM> O\ D=8[_LEN,?\ UE\V/C>.?^11
M@?\ LJ.$/_6FRL_8.BBBOBC[(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML4ME%(K!D=Y%!'0<9K\^/^"+TCR_MH?\%&Y'.Z1OC'KA)( R1>X'   &.,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^2.(H4Y2C"M!R2Y6[-W****^$/M@HHHH **** "BBB@ HHHH **** "BBB@
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MX^?]G_\ Q3_]9U_95K^OV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\ ?\ !6+_ )19?\%+
M/^S /VR/_6=?B-7^(-7^WS_P5B_Y19?\%+/^S /VR/\ UG7XC5_B#4 ?Z??_
M  94_P#*++X^?]G_ /Q3_P#6=?V5:_K]K^0+_@RI_P"467Q\_P"S_P#XI_\
MK.O[*M?U^T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!%/YWD3?9]OG^5)Y&_A/.V-Y>[_ &=^W=[9
MK^0W]OS0?^"G%O\ M%ZMXG^/^O?&2;]C6RU!ET[P;^R[;R:IK>L:6TK\:_$C
MLR1F#8)2HZ@]Z_KWIKHDB-'(JNCJ5='4,CJPPRLK AE8$@@@@@X(Q7'/#/\
MM#!YC"5.I/!4\13C@L;26+RRO]8]E>KB,'*485*]%4K8:K-S5'VE27LYMJW5
M2Q*AA<3@Y1G&&*E2<L3A:GU;'TE251>SP^+49RHTZOM/W\814JG)!*I"VO\
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M7T%7YR? /Q%XOO\ ]OK]L30=4U?Q#=>%='\,_#:3P_I=\;DZ%I\]S:1M>/I
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MBTG%W32:9^G%%?F/_P /AO\ @GW_ -%P7_PD/%__ ,I:/^'PW_!/O_HN"_\
MA(>+_P#Y2UI_J'QM_P!$EQ)_X9<P_P#F?S7WD?Z[\&_]%5P]_P"'C >7_3_S
M1^G%%?F/_P /AO\ @GW_ -%P7_PD/%__ ,I:/^'PW_!/O_HN"_\ A(>+_P#Y
M2T?ZA\;?]$EQ)_X9<P_^9_-?>'^N_!O_ $57#W_AXP'E_P!/_-'Z<45^8_\
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M -%5P]_X>,!Y?]/_ #1^G%%?F/\ \/AO^"??_1<%_P#"0\7_ /REH_X?#?\
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MX)]_]%P7_P )#Q?_ /*6C_A\-_P3[_Z+@O\ X2'B_P#^4M'^H?&W_1)<2?\
MAES#_P"9_-?>'^N_!O\ T57#W_AXP'E_T_\ -'Z<45^8_P#P^&_X)]_]%P7_
M ,)#Q?\ _*6C_A\-_P $^_\ HN"_^$AXO_\ E+1_J'QM_P!$EQ)_X9<P_P#F
M?S7WA_KOP;_T57#W_AXP'E_T_P#-'Z<5\-?\%+P3^P5^U,%>6(_\*IUG$D,K
MPRJ?M%ERDL3+(C?[2,K#L17EG_#X;_@GW_T7!?\ PD/%_P#\I:^3/V[?^"I7
M[$'Q._8__:#\ >#OB_\ VMXI\5_#K5=)T+34\+>)[=KW4)I;9H(//N]+@MH@
MY0[GEE154$C+84^WPQP1QE0XDX>K5N%>(:5*CGF4U:M2ID^/C3ITZ>/P\YSG
M*5!1C"$4Y2E)I*.KT/%XDXSX1K<.9_1I<3Y!4J5<ES2G3IPS; RG4G4P-:,(
M0C&NY2E.4HQC%)MMI)7/U0_8N!'[)/[-X+NY'P9^'V7E=Y9&/_".6'+R.6=V
M/=F8L3R237TW7XH?LN_\%7?V$O!/[./P.\(>(/C,;'7?#7PM\%:+K%E)X3\4
MR/::GI^@V5M?6YDMM+G@D$-S')&LD4KK(JAP1G ]W_X?#?\ !/O_ *+@O_A(
M>+__ )2USYWP/QG5SG-ZM/A3B*=.IF>/J4YQR?'RC.$\75E"49*@U*,HR333
M::::=FCHR;C3A"GE&54ZG%&00J4\MP,)PEF^ C*$XX6C&49)U[J49:-/5.Z>
MS/TXHK\Q_P#A\-_P3[_Z+@O_ (2'B_\ ^4M'_#X;_@GW_P!%P7_PD/%__P I
M:\S_ %#XV_Z)+B3_ ,,N8?\ S/YK[STO]=^#?^BJX>_\/& \O^G_ )H_3BBO
MS'_X?#?\$^_^BX+_ .$AXO\ _E+1_P /AO\ @GW_ -%P7_PD/%__ ,I:/]0^
M-O\ HDN)/_#+F'_S/YK[P_UWX-_Z*KA[_P /& \O^G_FC].**_,?_A\-_P $
M^_\ HN"_^$AXO_\ E+1_P^&_X)]_]%P7_P )#Q?_ /*6C_4/C;_HDN)/_#+F
M'_S/YK[P_P!=^#?^BJX>_P##Q@/+_I_YH_3BBOS'_P"'PW_!/O\ Z+@O_A(>
M+_\ Y2T?\/AO^"??_1<%_P#"0\7_ /REH_U#XV_Z)+B3_P ,N8?_ #/YK[P_
MUWX-_P"BJX>_\/& \O\ I_YH_3BBOS'_ .'PW_!/O_HN"_\ A(>+_P#Y2T?\
M/AO^"??_ $7!?_"0\7__ "EH_P!0^-O^B2XD_P##+F'_ ,S^:^\/]=^#?^BJ
MX>_\/& \O^G_ )H_3BBOS'_X?#?\$^_^BX+_ .$AXO\ _E+1_P /AO\ @GW_
M -%P7_PD/%__ ,I:/]0^-O\ HDN)/_#+F'_S/YK[P_UWX-_Z*KA[_P /& \O
M^G_FCS7_ ())?\WP_P#9XWQ&_P#:5?L%7XO?\$9?$^D>.O"/[7?CSPR=0G\)
M^,OVL/'VN^%]2U#3;O2GU;1[M8FMK^&UO8HI1#*IRK8(/K7[0UU^(\)T^-,Z
MIU(RA4IRP%.I"2<90J0RS!0G"<79QE"2<91:3C)--)HY/#V49\'Y-.+4H3CC
M9PE%IQE">98R4)Q:T<91:E&2NFFFFTPHHHKX@^S"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#X _X*Q?\HLO^"EG_9@'[9'_ *SK\1J_
MQ!J_V^?^"L7_ "BR_P""EG_9@'[9'_K.OQ&K_$&H _T^_P#@RI_Y19?'S_L_
M_P"*?_K.O[*M?U^U_(%_P94_\HLOCY_V?_\ %/\ ]9U_95K^OV@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHK^>O\ X*0VG[0/QA_;P_9A_9N^&_[4
M'Q1_9U\"^.(-4G\4WOPRN8X-4OVM+8R0H/,D106? RQ"@8)(%13]OB,RRK*\
M+0=;$YM7QM&E>I3I4Z4,OR?,L[Q5:I*HU>,,'E>(4(04IU*LJ<(K5M.I*AA\
M#F.8XFLJ&&RW#X>O5?).I.I+%9E@<KH4J<()MSGB<?1UE:,8*4FU97_H4HK\
MK?V<?^"</Q/^ _Q0T[XB>(?V_P#]J/XUZ98V[P2> _B)J=A<>&+UG)(FN(H;
MF1S(F<+A2!BOU2KIJ0I1IT9PKJI4J1FZM)4YQ=!QE:,93DE"HYQ]Y.FVHK23
MOH91E-U:L'2<:<%3=.MSP<:SFI.:4$^>'LFDFYI*?->%TF%?A_\ &K_E/#^Q
MS_V:'\9O_2_5Z_<"OQ"^-:,O_!=[]C9R5Q)^R'\9]H#HS#;J.K@[T5BT?(XW
MA=PP5R""<3:/VO\ "_T/V]HHHH)"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\UH]%\
M0:C_ ,%-_%']IZ7K=]X N_V:M.LY%O[>:Z\%W.I'6(FDMFM[A7TV:_*+F1'C
M:0H.>!Q^E->"P?M >#)_VB+[]G!++4QXYL? -O\ $&:^-NHTIM%N+I;1(5N?
MOFY$K F/H!DUXN<X?"XC^REBL6L*J6<8.M0C**DL7B(0KJG@[-JWME*;OK\%
MN5W/T/P^S3.,KCQS+)\CGG3QOA_GV7YE4A4=*61977Q65U,3Q I*,F_J%2C0
M@HIP;>(34XM:^@I\,/AI$T;Q?#SP-&\+I)$R>$M 1HGC(*/&RZ>"CH0"C*05
M(!!!%:^L>$/"7B)[:3Q!X7\.ZY)9QF*T?6-$TS4WM8CDF.V:]MIV@C)))2(J
MIR>*Z*BO46'PZBXJA1496<HJE!1DX_"VN6SMTNM.A\7+-,SG4IUIYCCY5J2F
MJ566,Q$JE)5$E45.HZCE!322FHM*224KHYS1_!WA'P[/-<^'_"OAO0KFXC$4
M]QH^AZ9ID\\0.1'-+96L$DD8(!".S*#SBLQOAK\.6N#=MX \$M=M/]J:Z;PK
MH1N&N=V_[09S8&4S[_F\TMYF[YMV>:[:BF\/0:471I.,6W&+IPM%NUVERV3=
ME=K>RN)9IF<:E2M',<=&K5C"%6JL7B%4JP@FH0J353FG&";4(R;44VDD96K:
M#H>O68T[7-&TK6=/#(PL-6TZSU&S#1C$;"UO(9H-R#A#LRH^Z15'1O!WA'P[
M/+<^'_"WAS0KF=!%/<:-H>F:7/-&#D1RRV5K!)(@(!".S*",@5T=%4Z5-S51
MTX.<=(S<(N:2V2E:ZM=[/J91QF,A0GA88K$PPU1MU,/&O5C0FVXMN=%35.3;
MC%MRB[N,6]D4XM.T^"[N;^"QLX;Z\5%N[V*U@CN[I8QB-;FY1%FG6,<()78(
M/N@5<HHJDDM$DE=NR5M6[MZ=6]7W9A*<YM.<I3:C&*<I.34814813;;48Q2C
M%;1BDDDD@HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'XI?\ !,GP#X#\3_$7_@H5>>)/!'A#Q!?1?M>^)XTOM;\-Z/JUX(FM'Q%]
MIO[.XE$2E05C5@H)/!XQ^LW_  ISX1?]$K^''_A#^&?_ )5U^8O_  2M_P"1
M]_X*'?\ 9W_B;_TDEK]@:^]\0<7BH<69A"&*Q$(QPV2J,8UZL8Q7]AY:[)*2
M25];(^'X#PN%GPME\YX:A.4L1FSE*5&G*3?]LYAJVXMM^K/./^%.?"+_ *)7
M\./_  A_#/\ \JZ/^%.?"+_HE?PX_P#"'\,__*NO1Z*^,^NXS_H+Q7_A15_^
M3\E]Q]?]2P?_ $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+
M_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\
MD#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+_HE?PX_\(?PS_P#*NO1Z*/KN
M,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__
M "KH_P"%.?"+_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_
M $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+_HE?PX_\(?PS
M_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\ D#SC_A3GPB_Z
M)7\./_"'\,__ "KH_P"%.?"+_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_
M )/R7W!]2P?_ $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+
M_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\
MD#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+_HE?PX_\(?PS_P#*NO1Z*/KN
M,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__
M "KH_P"%.?"+_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_
M $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+_HE?PX_\(?PS
M_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\ D#SC_A3GPB_Z
M)7\./_"'\,__ "KH_P"%.?"+_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_
M )/R7W!]2P?_ $"8;_P12_\ D#SC_A3GPB_Z)7\./_"'\,__ "KH_P"%.?"+
M_HE?PX_\(?PS_P#*NO1Z*/KN,_Z"\5_X45?_ )/R7W!]2P?_ $"8;_P12_\
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M$/X9_P#E77H]%'UW&?\ 07BO_"BK_P#)^2^X/J6#_P"@3#?^"*7_ ,@><?\
M"G/A%_T2OX<?^$/X9_\ E71_PISX1?\ 1*_AQ_X0_AG_ .5=>CT4?7<9_P!!
M>*_\**O_ ,GY+[@^I8/_ *!,-_X(I?\ R!YQ_P *<^$7_1*_AQ_X0_AG_P"5
M='_"G/A%_P!$K^''_A#^&?\ Y5UZ/11]=QG_ $%XK_PHJ_\ R?DON#ZE@_\
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M_*++X^?]G_\ Q3_]9U_95K^OVOY O^#*G_E%E\?/^S__ (I_^LZ_LJU_7[0
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MT/PW/\1?%^E7NM?#WXK^"].AT;PKXIM+$RJ8X;".*(*TICPO!8,P&<=?TO\
MVP_V.? _[:'@70? /COQU\5? 6G>']?3Q#;:E\)?&=WX*UNYN4C6,6M]J%I%
M*]Q8$("ULRA2Q)SS7XP_!CPO\4/^"F7_  4*^&O[:]_\-/$?PN_9T^!GAW5M
M$\#KXRL+C0_%?BB_O))YK>YNM*NML]N"[@LNW:%+<<5_2Q7N5(5?[%X?K9CA
MZ6$SVM0S%YGAJ5*.'DL-2S3%4<FQ.,PD+4\'F&+RR%&MBL/",(\KH5W"-2O-
M+S)2H1SK-J66UZF)RFE2RJ5*K.K+$4J.;U<&YYY@L%BIN4\5@,)B?8QHU'*I
M&G7J8K"PJ2IX>-OP]_X<0?L[_P#1Q?[9W_A^]:_^0Z^0OA)^Q?X!_8K_ ."W
M?[-7AOP#X_\ BWX_@\<_LJ?%O4M4N/BYXRN_&M]I<MC=ZI!#%HMY=K&]I;S(
MBO/$L:@R%CELYK^G^OP_^-7_ "GA_8Y_[-#^,W_I?J]>>=<6W?RB_P DOT7W
M'[@4444$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !69K6IQ:)HVK:S,C20Z1IE_J<L:D!I(K"UENI$4G(#,D14$C
M )!-:=8WB/3H=7\/:]I-Q<BSM]3T75-.GO&*A;6&]L9[:6Y8N50"!)6E)9@H
M"Y8@9-14YE";A;G4)<E[6YK/EO?2U[;Z=S?"JC+$X>.(YO8.O15?EYN;V+J1
M53EY4Y<W)S6Y4Y7V5SY3_8Y_:HUG]K'PAXC\>2_"/Q)\-/"UEXAO]&\)ZGK]
M];W:>,K/3KNYLKG5;!8(8C!;I/;%=DFYOF'->;^/_P!K']ISPMXV\2>&_#7[
M#7Q+\:Z!H^K?8=*\7:=XBTRWL-?LO,5/[3M8)+1Y(H=A,FQV+84C/I[U^R7\
M(O#_ ,#/@=X8^&WA?QM%\0=%T6\UV>T\3PS6MQ%=G4M7N[^:%)+.>YM\6DMP
M\!5)3M9"& ;(KZ3KYS"8+.\7DF51Q6=8G!9HJ%*MF&)PN'RJJZM:I3YJE!1G
MA:^%]E2G+EIU*$%*481<ISO)R_6\]XA\.LD\1>-:V2^'>3\0\%RS+%8'A?*,
MZS3C7 K Y?A,3&EA<QE5PV=Y;G4L=CL/1]KB\/F5>=.C5Q-6-/#4%3IPI^.>
M/OB#XY\+?".;Q[X;^%>N>-?&T>CZ?J$?PPTZ]@M]:EOKN.)[K2EO)8W@$]BS
MNDK^658Q':.17A/P*_:0^/WQ.\=P^&/B)^R+X]^#?AV32KB^?QEXAUO3[_3X
MKR)"T6FM!;6T4AFG8;%<.%!()':OMFBO2K8'&U,7A<13SC%T*%"--5L%##X"
M5'&.$FY2JU*F%GB:;JIJ,U0K4DDER*+NW\?@.(^'L)D6<97BN LCS+,\QJXJ
M>7\18C-.**.89%"O3IPHTL#A,'G>'RG$PP<H3J499G@,;.I*I)8B5:$81C\<
M_M ?M!_'/X5^+M.T#X:_LK>-_C;HEWI7VZZ\4>&]9L-/LK"\W%?[-EANK>5V
MFP-V]6 P>GKZ[\'?B-X]^(/PQ3QIXY^$NO?"SQ:PU0M\/-;O;>\U9/L4>^S!
MNH(XX?\ B8O\D/R?*>6S7M-%.E@L93QU?%3S?%UL-5C-4LOG0P$</AG+DY94
MZM/"PQ<W#EERJM7J)\\N92M&TXWB+A_$\.9;DV&X%R3+\WP56A/&<54,SXEJ
MYIFT*7MO:4<5@<5G-?)*$,1[6G[26!RW#5(?5Z?LIT^:K[3\Z_#?[6_[4&L>
M,M(\/:K^PG\3M T*_P#$7]D7OBNZ\1Z7+8Z9I?VAXO[=FA2T$CVWE*L_EJP;
M:X&[(-?FO9_M=?'[Q;^WY\;_ (V_ C]C'X@?&CP+\,='N?V<M6U/1->L+"2Y
M\4Z#?1:A>:A MQ ZBUV'R0A1B!SNS\U?T>5^/G_!)9F^U?MSIN.Q?VP_'Y5<
MG:I9$W%5Z MM7<0 3@9S@5];PCP]E<<FXES?B:E4XPJY%B.'\=E%#,JU3+*&
M#Q5?&U<).J_[ >5U<0O95)6IXFI5IJ3ORNUGXG&WB1CO[;R/*_#S)\J\+,/Q
M3D'%'#/%#R!YAQ!4SK*ZM#!8^4)RXVQO$:P%55,)3@JN71PT^1S7Q-25G_AO
MK]MS_I%Y\:O_  L-#_\ D"C_ (;Z_;<_Z1>?&K_PL-#_ /D"OUZHKVO]9.'?
M^B!R+_PZ\4>7_4[\OQ];_G/^KO$'_1=9YT_YEG#7E_U)O)_>S\A?^&^OVW/^
MD7GQJ_\ "PT/_P"0*/\ AOK]MS_I%Y\:O_"PT/\ ^0*_7JBC_63AW_H@<B_\
M.O%'E_U._+\?6Y_J[Q!_T76>=/\ F6<->7_4F\G][/R%_P"&^OVW/^D7GQJ_
M\+#0_P#Y H_X;Z_;<_Z1>?&K_P +#0__ ) K]>J*/]9.'?\ H@<B_P##KQ1Y
M?]3OR_'UN?ZN\0?]%UGG3_F6<->7_4F\G][/R%_X;Z_;<_Z1>?&K_P +#0__
M ) H_P"&^OVW/^D7GQJ_\+#0_P#Y K]>J*/]9.'?^B!R+_PZ\4>7_4[\OQ];
MG^KO$'_1=9YT_P"99PUY?]2;R?WL_(7_ (;Z_;<_Z1>?&K_PL-#_ /D"C_AO
MK]MS_I%Y\:O_  L-#_\ D"OUZHH_UDX=_P"B!R+_ ,.O%'E_U._+\?6Y_J[Q
M!_T76>=/^99PUY?]2;R?WL_(7_AOK]MS_I%Y\:O_  L-#_\ D"C_ (;Z_;<_
MZ1>?&K_PL-#_ /D"OUZHH_UDX=_Z('(O_#KQ1Y?]3OR_'UN?ZN\0?]%UGG3_
M )EG#7E_U)O)_>S\A?\ AOK]MS_I%Y\:O_"PT/\ ^0*/^&^OVW/^D7GQJ_\
M"PT/_P"0*_7JBC_63AW_ *('(O\ PZ\4>7_4[\OQ];G^KO$'_1=9YT_YEG#7
ME_U)O)_>S\A?^&^OVW/^D7GQJ_\ "PT/_P"0*/\ AOK]MS_I%Y\:O_"PT/\
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M3OR_'UN?ZN\0?]%UGG3_ )EG#7E_U)O)_>S\A?\ AOK]MS_I%Y\:O_"PT/\
M^0*/^&^OVW/^D7GQJ_\ "PT/_P"0*_7JBC_63AW_ *('(O\ PZ\4>7_4[\OQ
M];G^KO$'_1=9YT_YEG#7E_U)O)_>S\A?^&^OVW/^D7GQJ_\ "PT/_P"0*/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!\ ?\%8O^467_  4L_P"S /VR/_6=?B-7^(-7^WS_ ,%8O^467_!2S_LP
M#]LC_P!9U^(U?X@U '^GW_P94_\ *++X^?\ 9_\ \4__ %G7]E6OZ_:_D"_X
M,J?^467Q\_[/_P#BG_ZSK^RK7]?M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?A_\:O^4\/['/\ V:'\9O\ TOU>OW K\/\ XU?\IX?V
M.?\ LT/XS?\ I?J]!4?M?X7^A^X%%%%!(4444 %%%% !1110 4444 %%%% !
M117$_$+XD>!?A1X7O?&OQ'\4:5X/\*:<\,=]KNM3FWL+9YV*PI)(J.0TK A
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MO]OG_@K%_P HLO\ @I9_V8!^V1_ZSK\1J_Q!J /]/O\ X,J?^467Q\_[/_\
MBG_ZSK^RK7]?M?R!?\&5/_*++X^?]G__ !3_ /6=?V5:_K]H **** "BBB@
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MTTDH4:2A3@DE&*2"BBBM#C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLZ_LJU_7[7\@7_!E3_RBR^/G_9__ ,4__6=?V5:_K]H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH #P"?2OYNOV>]8@_:,_X+=?M'77C> ZOI_P"SUX-T
M!?AWI^I9EM]"U&[$-O=WUE!)^[664L6W[-P;D'(K^D6OYQ/C?IM__P $W/\
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MS+<3E^,P:HX99I'@VC@<!A,3EN)J8A8R6 GG=?-J5&C+#0Q%.O.%6=3R6_\
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MCXCDM/BM\-O$LT>CRZAYL>G>'-=:ZU*[<W5C;(+>SAW23X8N0 %1L\?KK/\
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M5MOJWNWU;\WN?FCY+NT7%7TBFK15]$M-DM%Z+Y?.G_#X+_@F=_T>)\)_^_\
MK_\ \HZ/^'P7_!,[_H\3X3_]_P#7_P#Y1U]%_P##%G[(?_1LGP*_\-=X._\
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MO_#7>#O_ )44?\,6?LA_]&R? K_PUW@[_P"5% >[_>^]?Y>O]/3YW'_!7_\
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M_P#Y1T?\/@O^"9W_ $>)\)_^_P#K_P#\HZ^B_P#ABS]D/_HV3X%?^&N\'?\
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M4=?1?_#%G[(?_1LGP*_\-=X._P#E11_PQ9^R'_T;)\"O_#7>#O\ Y44![O\
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MO7^7K_3T^=/^'P7_  3._P"CQ/A/_P!_]?\ _E'1_P /@O\ @F=_T>)\)_\
MO_K_ /\ *.OHO_ABS]D/_HV3X%?^&N\'?_*BC_ABS]D/_HV3X%?^&N\'?_*B
M@/=_O?>O\O7^GI\Z?\/@O^"9W_1XGPG_ ._^O_\ RCIY_P""O_\ P3."*_\
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MX8L_9#_Z-D^!7_AKO!W_ ,J* ]W^]]Z_R]?Z>GSI_P /@O\ @F=_T>)\)_\
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MY>O]/3YT_P"'P7_!,[_H\3X3_P#?_7__ )1T?\/@O^"9W_1XGPG_ ._^O_\
MRCKZ+_X8L_9#_P"C9/@5_P"&N\'?_*BC_ABS]D/_ *-D^!7_ (:[P=_\J* ]
MW^]]Z_R]?Z>GSI_P^"_X)G?]'B?"?_O_ *__ /*.C_A\%_P3._Z/$^$__?\
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M^O\ _P HZ^B_^&+/V0_^C9/@5_X:[P=_\J*/^&+/V0_^C9/@5_X:[P=_\J*
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M'_#X+_@F=_T>)\)_^_\ K_\ \HZ^B_\ ABS]D/\ Z-D^!7_AKO!W_P J*/\
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M][[U_EZ_T]/G3_A\%_P3._Z/$^$__?\ U_\ ^4=/_P"'O_\ P3.V>9_PV/\
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MZ_R]?Z>GSI_P^"_X)G?]'B?"?_O_ *__ /*.C_A\%_P3._Z/$^$__?\ U_\
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M_@F<K%?^&QOA(V#C='=ZY*A]UDBT5XW'HR,RGL:3_A\%_P $SO\ H\3X3_\
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M]GO^&+/V0_\ HV3X%?\ AKO!W_RHH!\J_FZ=NJ3_ %?W>>GSI_P^"_X)G?\
M1XGPG_[_ .O_ /RCH_X?!?\ !,[_ */$^$__ '_U_P#^4=?1?_#%G[(?_1LG
MP*_\-=X._P#E11_PQ9^R'_T;)\"O_#7>#O\ Y44![O\ >^]?Y>O]/3YT_P"'
MP7_!,[_H\3X3_P#?_7__ )1T?\/@O^"9W_1XGPG_ ._^O_\ RCKZ+_X8L_9#
M_P"C9/@5_P"&N\'?_*BC_ABS]D/_ *-D^!7_ (:[P=_\J* ]W^]]Z_R]?Z>G
MSI_P^"_X)G?]'B?"?_O_ *__ /*.C_A\%_P3._Z/$^$__?\ U_\ ^4=?1?\
MPQ9^R'_T;)\"O_#7>#O_ )44?\,6?LA_]&R? K_PUW@[_P"5% >[_>^]?Y>O
M]/3YT_X?!?\ !,[_ */$^$__ '_U_P#^4='_  ^"_P""9W_1XGPG_P"_^O\
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MA_\ 1LGP*_\ #7>#O_E11_PQ9^R'_P!&R? K_P -=X._^5% >[_>^]?Y>O\
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ML Z,K $>1_\ !$:&*V_X)@?LJ6\$:PP6_A#688(8QMCAAC\6Z\L<4:CA8XT
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M_P""Y/@[QEXY_8ET[1/ GA/7O&>N+^T+\"]0;1O#MC)J&H+IUAXJ>:_OS;Q
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M^(](T#PCXF?PS-)XBB2&349U65UN[-51#]G=8B1N&[YAFOS%^)?Q?^./[?\
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MPF(AA\2_9U:U6M1I/XJ52O07/6H0Q$.;#RKTXWE*@JKJJ,92Y+1DU]+T445
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MQF&R["*4NLL1C,5A\/2C'FE*=5:<JE)??=%%%(H**** "BBB@ HHHH ****
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M@(5JGNP5:M4@\1-*4Z>#AB:M.%2I"-.7XX_$O]GOQ9I_[6G[(7[87QQEO?\
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M.-L?'GC9;^X>>?0;#784N8O#J^9\R1V!=4"X  ''.*^[_P!O#X(?\%(?BO\
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M45F:!1110 4444 %%%% $-Q;P7<,EO=0Q7$$JE)89HUEBD4]5>-P58>Q!%?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ? '_!6+_E%E_P4L_[, _;(_\ 6=?B-7^(-7^WS_P5B_Y19?\
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MG*CB,/6BG)1K8>O3J4*T5*2C5ISBF[7"BBBN4Z HHHH **** "BBB@ HHHH
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M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZX_9._:&T[]L^#X<W.M1?#/7)=.UOX9VT<.AWC/:2,8T:/*.0-BY4GGD'FO
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M(^UZEKVNW.H26]O)-90^9.MG;3E)+@O$ T??&:_J)_84\0?M;^,/@;H/B_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS.5*5JE/$Y=XCYCE-*.#E.,E3P[H3F^6I"I)S4;.,5R'ZB^*_P!O7]F#P/\
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M86B+OD_M,328L98QP\4S!@WRC+<5^,'Q:_;LF^-L_P"TU\)_V-?V;= \??\
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M7@36?VP/^"D/BS5_"VE:IXDLOBQ_9]KJ=_;17306,TM\9H$AG22+YR!\Y7<
M, BN8_X)5_"OX<_\/6_^"@FJ?\(GIC76G^*-773XGB633K(2W9CD^S:6RFPB
M+1.Z9C@0C=QQQ6V PE7%2R; UJT*>-SGPOR[Q 6*I4W.A@L2LFR/-L9ERPTY
MPGBJ&-CFSA2KNMAZF E%Q=/&QA&=33-71R]<2XNG3G5PO#GB#AN#XX:510K9
MAALTS&OEV%Q-3$*$HX*K@9T95:O)1Q4<9#E2CAI2?)^^'[)/[<?[.O[;7A74
M/%OP#\6W6N6NCW!M=8TG6M,FT#Q'I,P;9MU'1+MVN[7+< R  GBOKJOYD?\
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M4FUKKP9X/UC4]*B<96?5HK.5M/A([[YPO'?&*^DJ_)3_ (+;:-XCUK_@GO\
M&&+PY)-%):6]M?ZI)"&+IH]LD[7S87JJH03G(KPN)*];#Y+C)X>3C5J/"X53
M4G3<(XW&8?!U*BJ*\J;A3KSFJL=:?+SK6*/:X<P]#%9YEM'$QC.B\2JE2G)<
MT:JHQE65&4?MQK2IJE*"UFIN*U:/D7_@F+\,/V7O&W@:Q_:L_:>\=_!_Q_\
M'W]H:[N?&%KH/Q.\5^$-6F\+:7>W4L=EHVE>&/$URY@FC**08;9ROR%3N((_
M7O\ :G_:)\!?L>?LZ>*?C!>V6FP^'O"VFPPZ!I&E1VMGI]WJ%^/(T:RLHK18
M[:.WN+AHE7R%$>P@KQC/XD_LZ_\ !*7]BGXX_P#!.GX6_$Z7PR[?%&?X2_\
M"0Z'\6;?7-6M];\/ZO;)/<HUJD%]%9QPPS0!6B>#)Z[@,@_FO\0OC?\ &KX^
M_P#!%KQ):^-]5U'Q*?@S^T7I_@:Z\2SF62?6?#GASQ3%:6)N)<L9-D4:%W+,
M.220>OV7$6#53,<^X8P-3^PY<.YQPODBIX>,'EN7</9WQ1'A&EC<#5ER.6+R
MN49U\5+%X>G]9J5?KD:E9NNSPN%W]=EP[GV.I5,UP_$N+S>OBU6G.&9U<WI9
M3B>(X9?*G>MRX7&X;#3R["QHUYU<)]6IX:K1IQ5)O]0#KW_!6J+X.7O[>=Q\
M?="B\#V^E7/Q /[*(\&V9E7P5:-+=^0OB<Q^<UW/IJK,$W<+SNY-?M-^QQ^T
MUH'[7'[/W@'XV:':_P!F2>*-)AEUG12^]]&UA,I>Z>[9)S%(A(R<A6 KSF]U
MCP^O_!/2ZU=YK;^P(_V;C+-+N0V_D1^#%2;+9*8W*ZD?WLCK7PK_ ,$ ]/\
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MF>#/V:?@1HUQXJ^(UEJ/BBT\+6?B'QGITDD]EIU_?7ES;VLMJZJB26UQ($=
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MM/@C:V]Q\2/C)?:!!XG!OKZ+-KIECILX>.5S*0F%"XP2Q !8=Q^QM^US\=O
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MKEV52H8F*4/KLN(Z->OC)RQ/M:M*IBZ/U*5&%&G%?TH4445Q#"BBB@ HHHH
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M7A,GSO'Y;A,377+"V(K8;"TIXCW(_OW4]U+0****\8]0**** "BBB@ HHHH
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M3S*AC%0>&HY<L)#!1PM6+C4BIT:GE8YX>IP?7QN'JRQ-.AD>&61XK+ZDZE;
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MESYC0^6,B-0%-?K-16,*,(95BLG?-4PF*R2?#3E5DYXK#</3=-O)<%BI?O\
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M4/AO?017$6M^$+>X\R>-KRXFB4SWD=X8I#)"S?(K -D\^(7'_!,/_@H;\2?
M7AO]E3XY_M0_"/7_ -C;PW-I6FQ^'O#GA+4K'XF:IX5T&XBETG3-3U^2QCCN
M)D2%4E9YRA!X/%?T6T5Z,L77J8Z6/KRCB:E2IDN)KX?$0A6P6*Q_#V%HX/)\
MRQ>#E'V&(S'!4,/1C3Q=2$JDG3C*ISM'+"*I8587#WPJA6S2MAL1AI2HXW _
MVW6EB,UI8'&1?M\+0QU>4JU:C3FH>U;JQ4:GO'X^_MZ?\$Q]5_:>^&'[-_PM
M^%'CC1?AQH/P#\3^$-4A35K">\_M+2O"KVP6UC%O#(%N;B&W :5MH\QBQ-=I
M_P %(?V O&?[;?PR^!G@7PG\0-&\$7GPG^(OAKQKJ-_JMC<7D.K6NAQVR2V5
MLD$4C12SF E'=0%#<L,5^IU%9>UJ<E*$IRG['BR?&T9S;G4EQ%4CE<9XRI-W
ME4IS63X&^&DW0O3F_9WJSOK1F\//"5*$84G@>'L1PMA8PA&-.EDN*6-C5PR@
MERN3688I1KM.M#GCRS7)"WY:_MA?\$[+C]H+1O@QX\^'OC6W^'O[2O[/UO8S
M?#KX@O#,^CRZA:VL$#PZ[:6\3W%WISO#O$11\!F4KR*^>]$_X)W_ +97[1OC
MSP/K/_!1OX[?"_XI>!_AAJ]IK_A#P7\)?#-[X8L;_6+"83V=[XDBN+.VBOIX
MI%&96WN0.]?N=158:O4PN+^N4Y*4X9I7SO"4JL55PV79SB<1];KYIEN'FG3P
M6-J8O_:I5:*C_M/[])56Y/"I2A4P-+ 6<*5/*J>1RK4FZ6,Q&34Z<J,,LQ6+
M@XU\1@XT*E6@J=2;:HUJM)25.7*OQ0^-_P#P2W^(GB?]K:]_;2^#/Q>TOP!\
M6]!\&'PC\.["\LKN;PS9V\40AMH_$%C!"XOK14 $D2JV[&,$==O]EG_@G#\8
M+3XX^(_VJ_VZ/BKX6^-/Q\U#0I_"_AQO ^E7.B^"?">CSVQLW?2-)N[:#[->
M-:D1^9%&N#SD!0#^RE%88-+!8:CA*5ZE'"8#'9;@5B6\3++\-FE3%5,U>!G6
M<IX:MF?UW%4\;7IM5:U&O4I<T82:>F)2Q7UIU$H/'U\#5QSHI4GC:>61PD<M
MP6)Y+*K@,!+ X2KA<&U["G6HPJ<K:/Y[?A]_P2S_ &S/@+\2OC3X9^!/[1_P
M\T3]E7X^:W?ZGXV\'Z]X=U"\^(6GQ:P;E=570-=6S>*SGE@NIH8W6X4*DC#(
MR:]!_9V_X(O^&OA7\!?VB?V7_B%\0;CQ]\(/C%X@O?$'AS>)U\1^%[V\9YA=
MO>S1@/=P7+!TDB8Y08W ]?W1HJ8TXQP4L#*]6G4R7!</5JU:3J8NOE.55,)6
MR?"UL5)NM+^Q:N!PT\IJJ4:N!G24J,U+4VJ5ZD\7+&IJC6>>2XDBJ$8T:5+/
M*[Q'U[,J5&"5.&(S18O$QS.T>3'0K5(5X2C.2?X=?LS_ +(/_!4_]FK7?"'P
MTT?]J;X*>*_V7/"%Y'9:?H/B3P=J=]\2H_"MK)&MGI<>OR6!2.:*V4Q,PGV$
MXYP.,OX__P#!-C]K/3OVW'_;3_8K^./PS^'/BCQ;I2:3\2]!^)OAJ^\0V&L0
M&(PS/IT=M:7,<+,C'9YF,'&>YK]V:*Z'7KRQF79E.M5GF66SS"4,QG+FQN,I
MYK@U@,QP^95_BQ^&Q>%YJ=:CB.>$G.<[<\FSG]G25#,L)&C2A@,THX2C7RZ$
M%' 4G@,QIYK@J^#PR_=X3$X;,*-'$T:]!0G3E0HJ+4:<8K\*_P!IG_@FS^UA
MXS^/'PF_;)_9V^._P]\!?M3^%?!=MX-\>:IXN\/7NK>!?$-EA!>_V=H\-I.;
M=)09O+62%-N5R.*=\./^"5'QA\+_ +8OA;]MGQ)\=M/UGXJ:YH5UHGQLL(+.
M\CT'Q!;26?V>U@\,6K0*NGVUJZH4BE$8"+@#I7[I44L+4^I.B\/"G#ZI+.U@
M$X1E'+L)Q#2Q=/-\MP,9)K#99B_KM>J\##]Q"M[.K3C&5.+3Q-\91G0Q,IUH
MU\#EN QLI2?M,QAD\\/4RK$9A434L5C,OGAJ,L-BJC]K3<-V?E3_ ,$_?^"?
M?C/]CSXM_M5_$7Q/\0=&\8V7[07CF/Q7HVG:983VD_A^W5KEC:7LDT2+/(3.
M/FC9Q\IYZ"L[]CK_ ()W>-OV:OVP/VG/VD=>^(FB>)M"^.^KW>I:1X;L+"YM
M[[0DN;@3+%>7$L*13,@&TF-W!)ZXK]9Z*JCB*M#$8#$TVE6RWA:'!F$DXIJ&
M00P& RV.&E%KEJ55A,LPE/ZU-/$<U.4_:<\YMF*7UVCFE#$-SIYSQ#A.*,>E
M[KJYQ@<74QN'KQE&SITXXBK.<J$'&E-/EE%Q22_)W]F[_@GEXU^"/[?G[1_[
M7^K?$/1-;\,_&W0M(TG2?!]I87,.IZ)+ITD;R2W5U)"L,RR!"%"2-C(R!7ZQ
M445*JS6"RG+[_P"RY)E6#R7+X67-2R_ QE##4IS^*K.$9-2JU'*I/>4F.K^^
MQ^99E4UQ>;8OZ]C9[1J8CV%##<\::]RFO8X>E'D@HQO%NUVPHHHK, KQWX^?
M _P-^T;\)?&?P<^(U@-0\*>-M)FTK48P!YT(<K)%<V[$'9-!-&DBL,'@@$9S
M7L5%88K#4,9AZN%Q,%4HUH\E2%Y1;5TU*,XN,X3A)*<*D)1G3G&,X2C**:VP
M^(K82O1Q.'J2I5Z%2-6E4C\4)P:E%J]T]5JFG&2NI)IM'\Z\?_!,O_@HWIW@
MF;]E?2?VM_AL/V-9;HV0T>[\-ZK+\68?")E"_P#".P^)?L)1+7[(#!Y7VCRN
MF<@5]<?&'_@C3^RW\:?@E\'/@7K>K?$?PEX5^"D<$_A:7X?^)W\-W9UF,I(^
MM7,D4$HDO6N5:9)",J6ZDU^N%%=-2<JU)PKMUZT\?@,TQ..JMRS#&YCE4*M/
M+,9C,:FJ^(KX".(Q#PLYRO2GB*]1>_5E)X4TJ-:%3#I8>G1PN8X+#8.@E3P&
M%PV<>S6:4L-@DO84ECXTJ5/$.,+RI4H4DXTURO\ B@_X+)?\$MO W[/'P^^
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MF.6;:H7+'N3C)/<T^BBLV[MM[O5DI**44K)))+LDK)?<%%%% PHHHH ****
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M=ET<+3CAYX2A7;=6=*=-1DL5/W$\4[U^2E1@IJ%.,2GIZWJ6-FFI2Q3:@MK
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MU[]GGQM\1_VAOCMXYTWXK?M/?%P0IXQ\8Z7:3VOA^S@M<&WM="LKJ**:T@7
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M6=K#>PV]WX>U[4K>_MYH_,0VMQI6GW<9DQ_ Y4<C+ \5^0G@76[_ /X*+_\
M!3/P/^V7\//"WB#1OV8?V=O .M:9:_$34;"[TUO&M\)+FY1K&VN((;@P, 0$
MVL2,#DU_2'XD^%/PN\97@U'Q?\-O /BK4 H07_B3P=X=UR\" 8"BZU/3KJ<*
M!P%WX X KH=%\+^&?#>F_P!C>'?#NA:#H^"O]E:+I&GZ7INUAAA]AL;>"UPP
M)!'E8(X/%++I5,%B<-FU24*V<Y71S+^QYQBX9?A\;C\#BLMIYABL,W/$8BMA
M,+BZDJ5*GBJ%"6(DYSIN"A3AKCI4\1@\;E>&C4H9=G&'PF"SAU)QJXRKE].M
MAL3C\'@ZJA3HX>./KX:,'6J4*U:AAGR4YNK>L_R?\;_\%PO^">_A6#Q5HX^*
M][J?CSP])?:4? 5OX2\3G6;[7;=6C32X)!I;6;&:<K&)A<;2K;@.<5\_?\$6
M/@E\3!XL_:6_; \>^$M5^'.G?M(>)_MWA3P-JJM#<VNCV=T9;;5)+=D0Q_;H
M2KC<BMD\Y(K]JY/@7\$I;Y]3E^#OPLDU*2;[1)J$GP^\)/?27&<^>]VVD&X:
M;//FM(7SSNS7IEM;6UG!%:V=O!:VT"+'!;6T4<$$,:C"QQ0Q*L<:*.%1%"@<
M "MLME3P$\=CI0E5S?'9)+A]UU-0P>&R[$XS+\QS+V&&Y95)5\;C,KP5JE>O
M56'H473I14ZE2I+#'\^,H4,O@U1RVCG.'SNI!IU,7B<3@*..P^6T:M:\:4,/
MAH9A7JS5*A"I7KJ#E-4H^S)Z***R*"BBB@ HHHH **** "BBB@#P']HC]I?X
M4?LM>"_^%B_&76;CPYX)BG,%_KL-A>:E'IYP-LD]M8PSW#1DL 3&C%1SM/0_
M@5_P4/\ ^"AOP<_X*!?!=/V3/V(8]7^/OCWXF>(O#UOJMYIGAW6].TKPKH:W
M+&]U.ZN-5TVV_>V\4@D7  7!P2:_I8U_PSX<\5Z?)I/BCP_HGB32Y?\ 6Z;K
M^E6&L:?)_P!=+/4;>YMW_P"!1FN>\-?"SX8^#+HWW@_X<^ _"EZ5*&\\->$/
M#^A710C!0W&EZ=:S%2."I?!'&*Y5@Z&+JNGG$7B\MAC<)BXX/"R>%J8FEA)T
M,3#!XS$2]M)T:N,HWJU,+##UGAI>RA.-2]4[*6.K8!T<5E7)0S*E0K4XXC%1
M^LT*5>JZD(XNCAX.BW4HX>HE"E6J5:+KP52<90;I'YQV'[5?[,O_  3%^#?P
M)^ '[2/Q(N/"6IZ1X L+6VUBXT;6-6LKF>%I'N(9)M+L[MXG2:5XEW(0=@Z
M[J_*W]K/XV^&_P#@KG^TW^RI\./V1M,U[Q?\.O@[\0AXU\>_&8:1J6D:1ID
M^QL;2S;4;2VG8@0'+?*6!)*C( _IX\4?#GX>^-WAD\:>!/!OB^2W7;;OXH\+
MZ)K[P+G.V%M5L;LQ+GG"%1FI_#/@/P-X*CEB\&^#/"GA**?_ %T7AGP[H^@Q
MS=_WJ:59VBR<_P!\&O5CC:V+S^EQ'G-L9CL'G];B3"TL*GA,-4S*.(JXK+YX
MU2=:K.&"Q-18B5/#5,/#$5*-.%1*BZE.?FT</2RS)'D>2<^%H5^')<,XFMC'
M'%U8X'&8&IEF:SPL8QHTX5<9EU6KAZ<J\:_U:5:I6CS5%2=/:T>Q.EZ1I>FF
M0RG3M.L;$RGDR&TMHK<R$GDES'N.?6M&BBN:<Y5)SJ3=YU)2G)[7E)N4G9:*
M[;V+ITXTJ=.E!6A2A"G!-W:C"*C%-];)+4****DL**** "BBB@ HHHH 9*XB
MCDD()$:,Y ZD*"2!^5?E!\1_^"U/[ ?PPU#Q5X6\4_%6]M/'_A>ZO]+N/ Z>
M%/$L^KWFK6K-%#96DT&F264@NIPD4<IN !N)VG:-WZQ$ @@C(/!!Z$>AKS"^
M^"/P8U34)-6U+X1?##4=5EE\^74[[P#X4N]0EGW;O.DO;C29+EY=WS>8TI?=
MSG/-<]2G6J5>1U53PE2C.G5]G!?6X5)-*-7#U9N="+C!S3A6P]9.?))62E&?
M12GAX4INI2J5,0JM&=']ZHX=TX\_MJ=>"A[63J/V?).E6I."4[J3E%Q_GM_X
M)]? +]I'XO?$+]N7]LWPY8/\#-9_:3N)K3X+MXKLYWCMM/EMI8K;7[VQ6$3$
M@,DJCRMPW@8)XI?V>O\ @G?_ ,%E/V:)O%VJ>"?VK?V4O$GBSQSJUQJGB/QK
MXS^&6KZKXENDFN&F&G?;IM+D;[#'E=D70.BGL*_I8M+.TL+:&RL+6WLK.VC6
M*WM+2"*VMH(E&%CA@A5(HHU'"HB*H'0"K%=K=&A4H++X5L)AL)P]E7"^&HRQ
M$ZTHY1E*<J=.<Y**57&XF4\;F$Z,*4,3B))2@J-*E3CS3GB,6\55S)X?%8C'
M9W7X@Q,HX:-*E_:-3#4,#0=.%YR=/ 8#"T,'@E6G5G2A"55SE7J5*LO$?V>]
M*^/.C?#'1K#]I'Q3X-\9?%6)YCKFN^ ](DT3PW=(2OD"ST^6&!XBN'WYC&<C
MTKVZBBGB*[Q->K7=.C2=6;FZ>'I0H4(7^S2HTTH4X+I&*21EAZ*P]&G152M5
M5-653$59UJTM6[U*LVYS>MKR;=DET"BBBL38**** "BBB@ HHHH *^2_VG_V
MVOV>OV.+3P]JO[0GB^;P/H?BB\.GZ3K)TC4]6M'O% +13II=K=3P@;A\YC8'
MTKZTKEO%'@;P3XWMX;3QIX/\+>+[6V<R6]MXH\/Z3K]O!(>LD,.K6EW'$YP,
MNBJW'6LJJKMTG0G2BHUHRK*K3G-5*'+)3IP<*E-TZC;C*-1\\8\K4J<E+3:B
MZ"<_K$*LXNG-0]C4A3G&KHZ<VYTZD9035IPY4Y1;49PE:2_F#_;O_:*\(?\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS0_:I_X*E_
M/]F+Q>OPTM=#\<_''XJ1Q+/J/PV^#6D#Q3XITFW<@1RZA:1,%@#9'!;(R <'
MBOKG]IWXFR_!O]G_ .+?Q0@QY_@KP3K.MP$@D+-;P$1-@ GY7<-[$9K\@?\
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M#WXD^&-9FTC]E'X(_&*S\)V-KB6/_A+_ !SIVI6R3W\4P BNK"58B(VC=XR
M ":_LB^$Y5OA?\.650BGP/X5*H.B@Z'8X4?0<5P9;3GC>'Z^<XB,\+B(\0U<
MLIY?.$HUJ>72R;*\VR_&8Q3C&5'%8ZECW7CAK?NL++#N;<YLVS"NL)Q%1R2B
MX8BB^'89I7QT)J5/^TX9UF64X_+L.XWC4AET\%"CB*Z;C+&.M"E*4*=ST"BB
MBH.@**** "BBB@ HHHH ***CFD6&*65CA8XW=B>@"*6)_2HJ5(4J=2K4:C3I
M0E4G)[1A"+E)OR44V-)MI)7;:22W;>B7S/S*_;B_X*"2?L\^)O"GP*^"O@N?
MXO?M+?$.1(?#?@RR62?3] AN GV?6?%C6S":RTMVD7,A9,*"<G(QZK^QEKO[
M>VNZ;XEN_P!MKP=\&?"%U));2^#K/X4:M?ZG)]DE4/+'KOVR>81748.TK&0
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M#X5)5'-+FSNJ\HR[*<5%1KXO,^(,IRVIA>:SP.4YE0S9T\TQ%DVGBL9EKPF
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M<**** "BBB@ HHHH *\"^-/[4_[.O[.@L#\<_C'X$^%W]J*7TX>+]:ATMKQ
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M]0M_@[XV^''CKQ#=^"M?\9/%H/A+Q)X0O+E%TQ[+7-1E@LVG\I58KO"C<<D
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M<+PPY4)-2I8#&Y-QE_K)C*<:B?/7PE3"J.'PM5TZ=9UV_;4XTXJI+QN'Z/\
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M@8_4/P-H4GAGP;X6T"XCLX[S1O#NC:7>FP@B@M7N[#3K>UN'ACB1$6-Y8G9
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M[+N4Y&<CFNYKR#XZ6WQ>N?AOKP^!5QH%O\3H8?.\,_\ "4NZ:!->(KE(=39
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M=?$7X@W4/@Z#Q3I#>)GMFUJ1X[A-%-TNH20R)\Z210.A7G=UQ_1-7PS\(O\
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ME6OZ_:_D"_X,J?\ E%E\?/\ L_\ ^*?_ *SK^RK7]?M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P5B_Y19?\%+/^S /
MVR/_ %G7XC5_B#5_M\_\%8O^467_  4L_P"S /VR/_6=?B-7^(-0!_9?_P $
M O\ @O[^R+_P1W_9&^,?[*?[5?P>_:OUGXJ:O^UC\0OBE-%\*OA_\,=2TK0-
M,U#X9?!KX<2>'/$2_$7XS?#+Q#IGC#2_$?PQ\1+J^DGP]-;65M+IP.HR7TE]
M8V'[F?\ $:M_P2R_Z('^W_\ ^&L_9U_^BJHHH /^(U;_ ()9?]$#_;__ /#6
M?LZ__154?\1JW_!++_H@?[?_ /X:S]G7_P"BJHHH /\ B-6_X)9?]$#_ &__
M /PUG[.O_P!%51_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJHHH /^(U;_@EE_T0
M/]O_ /\ #6?LZ_\ T55'_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JBB@ _XC5O^
M"67_ $0/]O\ _P##6?LZ_P#T55'_ !&K?\$LO^B!_M__ /AK/V=?_HJJ** #
M_B-6_P""67_1 _V__P#PUG[.O_T55'_$:M_P2R_Z('^W_P#^&L_9U_\ HJJ*
M* #_ (C5O^"67_1 _P!O_P#\-9^SK_\ 154?\1JW_!++_H@?[?\ _P"&L_9U
M_P#HJJ** #_B-6_X)9?]$#_;_P#_  UG[.O_ -%51_Q&K?\ !++_ *('^W__
M .&L_9U_^BJHHH /^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%51_P 1JW_!++_H
M@?[?_P#X:S]G7_Z*JBB@ _XC5O\ @EE_T0/]O_\ \-9^SK_]%51_Q&K?\$LO
M^B!_M_\ _AK/V=?_ **JBB@ _P"(U;_@EE_T0/\ ;_\ _#6?LZ__ $55'_$:
MM_P2R_Z('^W_ /\ AK/V=?\ Z*JBB@ _XC5O^"67_1 _V_\ _P -9^SK_P#1
M54?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ** #_B-6_X)9?\ 1 _V_P#_ ,-9
M^SK_ /154?\ $:M_P2R_Z('^W_\ ^&L_9U_^BJHHH /^(U;_ ()9?]$#_;__
M /#6?LZ__154?\1JW_!++_H@?[?_ /X:S]G7_P"BJHHH /\ B-6_X)9?]$#_
M &__ /PUG[.O_P!%51_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJHHH /^(U;_@E
ME_T0/]O_ /\ #6?LZ_\ T55'_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JBB@ _X
MC5O^"67_ $0/]O\ _P##6?LZ_P#T55'_ !&K?\$LO^B!_M__ /AK/V=?_HJJ
M** #_B-6_P""67_1 _V__P#PUG[.O_T55'_$:M_P2R_Z('^W_P#^&L_9U_\
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MU_\ HJJ** #_ (C5O^"67_1 _P!O_P#\-9^SK_\ 154?\1JW_!++_H@?[?\
M_P"&L_9U_P#HJJ** #_B-6_X)9?]$#_;_P#_  UG[.O_ -%51_Q&K?\ !++_
M *('^W__ .&L_9U_^BJHHH /^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%51_P 1
MJW_!++_H@?[?_P#X:S]G7_Z*JBB@ _XC5O\ @EE_T0/]O_\ \-9^SK_]%51_
MQ&K?\$LO^B!_M_\ _AK/V=?_ **JBB@ _P"(U;_@EE_T0/\ ;_\ _#6?LZ__
M $55'_$:M_P2R_Z('^W_ /\ AK/V=?\ Z*JBB@ _XC5O^"67_1 _V_\ _P -
M9^SK_P#154?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ** #_B-6_X)9?\ 1 _V
M_P#_ ,-9^SK_ /154?\ $:M_P2R_Z('^W_\ ^&L_9U_^BJHHH /^(U;_ ()9
M?]$#_;__ /#6?LZ__154?\1JW_!++_H@?[?_ /X:S]G7_P"BJHHH /\ B-6_
MX)9?]$#_ &__ /PUG[.O_P!%51_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJHHH
M/^(U;_@EE_T0/]O_ /\ #6?LZ_\ T55'_$:M_P $LO\ H@?[?_\ X:S]G7_Z
M*JBB@ _XC5O^"67_ $0/]O\ _P##6?LZ_P#T55'_ !&K?\$LO^B!_M__ /AK
M/V=?_HJJ** #_B-6_P""67_1 _V__P#PUG[.O_T55'_$:M_P2R_Z('^W_P#^
M&L_9U_\ HJJ** #_ (C5O^"67_1 _P!O_P#\-9^SK_\ 154?\1JW_!++_H@?
M[?\ _P"&L_9U_P#HJJ** #_B-6_X)9?]$#_;_P#_  UG[.O_ -%51_Q&K?\
M!++_ *('^W__ .&L_9U_^BJHHH /^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%51
M_P 1JW_!++_H@?[?_P#X:S]G7_Z*JBB@ _XC5O\ @EE_T0/]O_\ \-9^SK_]
M%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JBB@ _P"(U;_@EE_T0/\ ;_\ _#6?
MLZ__ $55'_$:M_P2R_Z('^W_ /\ AK/V=?\ Z*JBB@ _XC5O^"67_1 _V_\
M_P -9^SK_P#154?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ** #_B-6_X)9?\
M1 _V_P#_ ,-9^SK_ /154?\ $:M_P2R_Z('^W_\ ^&L_9U_^BJHHH /^(U;_
M ()9?]$#_;__ /#6?LZ__154?\1JW_!++_H@?[?_ /X:S]G7_P"BJHHH /\
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MK?\ !++_ *('^W__ .&L_9U_^BJHHH /^(U;_@EE_P!$#_;_ /\ PUG[.O\
M]%51_P 1JW_!++_H@?[?_P#X:S]G7_Z*JBB@ _XC5O\ @EE_T0/]O_\ \-9^
MSK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JBB@ _P"(U;_@EE_T0/\ ;_\
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M .BJHHH /^(U;_@EE_T0/]O_ /\ #6?LZ_\ T55'_$:M_P $LO\ H@?[?_\
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M.O\ ]%51_P 1JW_!++_H@?[?_P#X:S]G7_Z*JBB@ _XC5O\ @EE_T0/]O_\
M\-9^SK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JBB@ _P"(U;_@EE_T0/\
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M -%51_Q&K?\ !++_ *('^W__ .&L_9U_^BJHHH /^(U;_@EE_P!$#_;_ /\
MPUG[.O\ ]%51_P 1JW_!++_H@?[?_P#X:S]G7_Z*JBB@ _XC5O\ @EE_T0/]
MO_\ \-9^SK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JBB@ _P"(U;_@EE_T
M0/\ ;_\ _#6?LZ__ $55'_$:M_P2R_Z('^W_ /\ AK/V=?\ Z*JBB@ _XC5O
M^"67_1 _V_\ _P -9^SK_P#154?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ**
M#_B-6_X)9?\ 1 _V_P#_ ,-9^SK_ /154?\ $:M_P2R_Z('^W_\ ^&L_9U_^
MBJHHH /^(U;_ ()9?]$#_;__ /#6?LZ__154?\1JW_!++_H@?[?_ /X:S]G7
M_P"BJHHH /\ B-6_X)9?]$#_ &__ /PUG[.O_P!%51_Q&K?\$LO^B!_M_P#_
M (:S]G7_ .BJHHH /^(U;_@EE_T0/]O_ /\ #6?LZ_\ T55'_$:M_P $LO\
MH@?[?_\ X:S]G7_Z*JBB@ _XC5O^"67_ $0/]O\ _P##6?LZ_P#T55'_ !&K
M?\$LO^B!_M__ /AK/V=?_HJJ** #_B-6_P""67_1 _V__P#PUG[.O_T55'_$
M:M_P2R_Z('^W_P#^&L_9U_\ HJJ** #_ (C5O^"67_1 _P!O_P#\-9^SK_\
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M#_;_ /\ PUG[.O\ ]%51_P 1JW_!++_H@?[?_P#X:S]G7_Z*JBB@ _XC5O\
M@EE_T0/]O_\ \-9^SK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JBB@ _P"(
MU;_@EE_T0/\ ;_\ _#6?LZ__ $55'_$:M_P2R_Z('^W_ /\ AK/V=?\ Z*JB
MB@ _XC5O^"67_1 _V_\ _P -9^SK_P#154?\1JW_  2R_P"B!_M__P#AK/V=
M?_HJJ** #_B-6_X)9?\ 1 _V_P#_ ,-9^SK_ /154?\ $:M_P2R_Z('^W_\
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M5O\ @EE_T0/]O_\ \-9^SK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JBB@
M_P"(U;_@EE_T0/\ ;_\ _#6?LZ__ $55'_$:M_P2R_Z('^W_ /\ AK/V=?\
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/D@N()(YH9'C=6)10!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img12876764_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_14.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &(!&4# 2(  A$! Q$!_\0
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M\2_\53XQ@$'BWQ+:HEKXEU*W0QVVJW$4;ND<H4RE%&]\#<1G%7_[)OO^AO\
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M>7EY?B^X?\1B\4O^B\XF_P##G7\O[WDC]!/^'G7[6W_0X6/_ )7_ /Y?4?\
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MTW3VO9XX)Y(+07!N)DAF>.-EBD*@%S^R;[_H;_'/_A5ZK_\ 'J/[)OO^AO\
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MTKPYX.\3O+XHTW2-2"7J:5?7FH7=O9/*BO(MC*2HV-@ \A_9._:!_:<^"O\
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MOBT_[6G@Y_C;X,\-_!_3?AWK.IS>)Y_&VG7MO,=1N[>.6+P\?"3W&HW?B/\
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ME:OX.U)/"G@+1OAGJ]K=R^)-0\6$#2I;7Q%<:7;V>E6\+FZBN;Y8+F-)(V%
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MEA86]I(Z8)^5GA9EY^Z16A0 4444 %%%% !1110!_.W_ ,' '_)+/A;_ -E
ML_\ TQZC7\L=?U.?\' '_)+/A;_V4"S_ /3'J-?RQU_7/@__ ,D/@_\ L/S/
M_P!26>%CO]YGZ0_](04C*&5E;D,"I'3((P>?H:6G1QR32Q01 -+/-#;PJQVJ
MTT\BPQ*S'A5,CJ&8YVC)P<5^GG(?TO\ _!)W_@H?_P %GOVD/B3\#/V$OV7_
M (W^$O#'PV\"Z#HNDZIK^H_ ?X7^);;X3_!GPPUO:7VO:UJ^K:&UYJMU:V>S
M3=&AOKUK[6-7N+2UC,TC,I^O?^"U_P#P48T7X\?M_P#[$O[#OPYU:Q\8^'/V
M8/VI?@1JWQ6^*"16\5WXJ^-3>./".EWNBZ8NFBWT>UM/#5K)/+KATRSBMQXB
MOYM/L95M-.>!?U _9U_X)M?M*_\ !./_ ()8^)?!/["G@3PS\2O^"@7[2&AZ
M'<?$GXFZQXP\.^"+'P/<^(]+<O+HVK>([J*&YTWX7Z5?76G>%["PQ/J_BFY;
MQ#=[+;RTL_Y6M:_X)&_\% _V'_C7^RQ\<OVK/AYX<T+PGXG_ &Q_@!X8D\2Z
M;\6?"GQ#UW5O&OBKXIZ+J,3ZC:Z->W6JSW.JS6U_=7FJ7 D\RZ9Y+B0RS9;\
M.RZOPCG?$F89OAI9!ET,OCC\%DF#H?4<)F><9E6HS6,S?$48>SQ-:G)2E2R^
ME4C)SYJF)<85;I]\U7IT8TY*K/GY95)/GE"G!-<M-/6*>EYM/M&[1_6__P %
M3O$7_!?W2OVDM+MO^"9?ASPYJW[/!^'6B2:E<:KIW[-UU=+\0&OM0&LQB7XL
M:UI_B;RELA8%5B@.F@D^0YD\W'\UW[8'[:O_  6C_9B_:N_8:^)O_!3!].\,
M:I\)OB'>?$[X9:3H%E\&M*BUCP?<7VB^%/BQ;ZK?_!C4-1BNM+O_  _=Q6%_
MI6O7""XA*F&W>-I''[B_\%H_V)?^"T'[0G[6VC>.OV!/B-\2?"OP1M_A3X=T
M2_TSPG^UE=_!/3'\:6FHZK+JER_A"'Q1HZ37+VD]FLFK?9"URJK$96\K _E?
M_P""D?["7_!5']G7PE\/_BM_P46USQ/XRT'5]?N_AUX U[QG^T7'\=]5T_4[
M_3KKQ#?:-817&O:WJ&A:=>VFCSWER\1@L[BXM8EE#3&*L. ,/DN(PN2T,36\
M/ZM7%8"MAJF&H8.G'BN;Q&%K49TZN(EC).6(E"<XXBV&4IT7.*4+W*Q3J*51
MI8M)334G)NAI*+32Y5I=>[[S2EO=61^H/_!S3^RY)XF_:U_9;_:@^#NGG6]#
M_;?\$>#?!&CW=I$$MM9^(MJ^DVG@L*80Z^;KWA;Q+HLLL[$NYA&=XBW'VK_@
MNI\7Y?\ @GS^R1_P3G_X)H?!3Q-'I_BCX7:+X+^-GQ F@M8)//O_ (>76?!U
M[K%G(LUG>0ZY\2CXJ\3WVDWC2I<W&EZ9=W43QM!(WZ0?\$1-2^#W_!1O_@G3
M^RUIGQKGBUOXA?\ !.'X[6-];M<3P2W=G=>"M,U>[^'M]X@DNTD T?5?#6MP
MW+HIB8OX9L7\U!;,#_&W_P %7_VKI_VS_P!O[]HOXV6^J-JO@]O&EWX%^&D@
M8&VA^'G@)F\-^'6M8U54C%_#8OJ-T5&;B\NIKERTDK,>SA>CBLSSC*^&<PIR
MJ8?P]>9?6IU8)TL;B*E:>#R"5I)IJGELZE>G=Z\MU=$UN6-.=:#M+%\G*DW>
M"2C*LKZ/6HDG:VI_6'_P00_X*N?MS?MS>*OVO=+_ &F?BCX;\;67PG^"-OXS
M\"Q:1\,O W@QM+\127MS"UY<R>&=)L'U2(QQ*/LE\9;8$9$>22?RW_8,_P""
MM?[>/[<W_!3?]B'X,_M,?%?P[XU^'?AS]I37O$^DZ-HOPQ\"^"KF#6M"^'_Q
M,TS3+F75O#&DV&H7,<%C=W$+VT\[P3^:7E1FP:[;_@U7CDD\=_\ !0((CN6_
M9KLHU"*S$R/J5[L0  Y=\':H^9L' .*_*G_@BHK-_P %B?V/0JDG_A>GC8X
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MP;X5NKF?3= \4:%/*OB6&^T2RM[C6X[6YTR\^TI?(T7(_P#!7#_@C-I'Q/\
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M;C5_ !U_PIJD!NW;[-;KJ$5Y:ZSX=UB[V:-=VC7D"WPG95/%A^(<SX8S'CW
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M)\7 001\3O'8((P01XFU,$$'D$'@@]*_4/"?.>)Y<7\5\.9[Q/F'$^%P_"O
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M #J2K UE5_5E&7/1I2]I&MS4J<O;024*O-!/VL$I22A4OSQ2E)*,DE*2U?\
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M$K36?B/::U-K6G>&XM3U#5XH3XMEFNFL3#I%G; BY]I^-G_!6G]JGXB_M/\
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M6K?4K-M2DO[.XDL+6[BN+1Y0#]5?VJ_^"N6C_ +]DGX!?'#PU\#/'>L_&_\
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MWQ!;>#/#5OKWA[1XED2+2- UJ'2TU/1-*C265(]-TNZM;)$EE5( LCANLHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC3Q7J,TC/#+XG\6ZEX3DU?6(M/5VATRUN)_LEA&S^1 LDDDC@'Z[_%O]M_\
M8Q_X)7^ OV?OV?/CU\0/&&AOI_PIT;0?!,VB^ /$'C)]8T3P'9:=X<NM1OI]
M&1HK&>6Z\ME@F(>19"R#"MC\5/\ @J/\>[7XJ?'+]D;]ISXB?"GXU_M-?\$D
M_&?PF'B*P\#> 9/%?@>VUSQK/-X@MM9U/QM9Z;J&CW%GJ^G7-CI=[I5KXEU'
M35.GVUREC?P)).K_ -./@_X;2>,_AK\,I/VG_A_\'?B#\9M-\$:';>/]0N?
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MQ:WFCW5A=:5J6EZE)91R6\J)*0#\<?C%^QGI'[#W_!8G_@F[\)O WQ0^)GQ
M^$M[>:%X@^&F@_%'7[;Q)K/PUTZ3Q'XDT_6?"NEZG:6FF6QT.YUBRFUNU@M]
M(TN&"?4+F-+9RIGE_M,$GDW8EP&\JY\S:>C;)=V#['&*_F$T[_@F%_P4Y^)G
M[='[+/[;G[5'Q4^!_C[Q)X \5V%W\0O#/@_6(O#>B?#GP=X=FFCT?0O 6E6F
MA16'B.XU/[9?:UJ!LAIT4-Y<?9Y9+B5WN(_Z=G?,K.O>0NN0/[Q(R.1]1TH
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M/"-LUC'KGC[QIIVF7EW8FX:]N['3HK[Q3XNN9-4U$2WMM:VT=W<0PRI%#"*
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M7X@Z;/:7&GZ==^$[FZ:+P^WA6WTF6&TBCMC<(NYF^#O^"4GAA_C3_P %,_\
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M ?$U%?;/_#!'B/\ Z+0/_",3_P"7]'_#!'B/_HM _P#",3_Y?T ?$U%?;/\
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MG^<[17^C%_Q# _L+_P#/E^OB[_YMJ/\ B&!_87_Y\OU\7?\ S;4?\1MX5_Z
M,^_\)<#_ //+U_IZ']GXCO2_\"EY?W/-_=YG^<[17^C%_P 0P/["_P#SY?KX
MN_\ FVH_XA@?V%_^?+]?%W_S;4?\1MX5_P"@#/O_  EP/_SR]?Z>A_9^([TO
M_ I>7]SS?W>9_G.T5_HQ?\0P/["__/E^OB[_ .;:C_B&!_87_P"?+]?%W_S;
M4?\ $;>%?^@#/O\ PEP/_P \O7^GH?V?B.]+_P "EY?W/-_=YG^<[2$!@58
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M\7]6R?(*'UK'8EQ>(QF(]EGL?;8JNXQ]K7J<U6IR14I-1B=6*^BMXI8WZO\
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MQ/\ Y?T?\,$>(_\ HM _\(Q/_E_7\7G]:GQ-17VS_P ,$>(_^BT#_P (Q/\
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M8G_R_H_X8(\1_P#1:!_X1B?_ "_H ^)J*^V?^&"/$?\ T6@?^$8G_P OZ/\
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MFC@6*VB98(HT7VVOMG_A@CQ'_P!%H'_A&)_\OZ/^&"/$?_1:!_X1B?\ R_H
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MV/H'[1?CS3[GX5>+]>T4^*_#NB>%?"5CKB_#B?X<^$[=;71;[0M<\/:E/+I
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M5W(CC\1/^"#<7[2^F?M>?\%C/#/[77QBM/CC\>_#/[0OP=T_QSXUT&WU+2O
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M^U5J_B.SMOB%\(/B=^SAJ&MRV-OX*.N?\)#X=U*:]\#:9!<Z)I6FS2Z]J_\
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MGQ!OK*&=_#W@WQI;ZA<V+>([Y8].L-1@9;F9% #?L;^Q1_R2?Q%_V5CXC?\
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MW^S=X)M(;7P_\'OA1X-\&1-%!' ^H:CIVCVW]NZU=K&B>;J.N:W)J&KZC<R
MSW-]>SSSLTLCL>]^-/[/_P %OVC/#WA[PG\<_AKX5^*/AKPGXY\,?$SPYHOB
M[3UU*PT?Q[X+N)KKPKXJLH&9!'JVAW%S<26,YW!#-*K(Z.RGV#ITH YO0?&?
M@_Q3>:]I_ACQ7X:\1W_A;4?[(\3V.@Z[I>KWGAS5MK/_ &7KUMI]U<3:1J.Q
M6?[%J"6]SM5F\K )K\'?^"R/_)[/_!"/_L_[Q-_ZJ'5Z_93X1_LT? /X">(_
MBSXN^#7PH\&_#CQ-\=O&)^(/Q@UKPOI:Z??_ !#\:D7>?$GB697;[=JA.H7S
M&<A,O=W,A7?-(S:?Q*^ 'P7^,7BCX4^-/BA\-_"_CCQ7\#/%TWCSX0Z]K]@+
MS4/A]XQN+!M,G\1>&YBZ_8M2EL&-J\V'!BP-N0" #N_%'C+PAX'T^'5O&OBO
MPWX0TNYOK72[?4O%&N:7X?T^XU.^<QV6G0WFK75I;RWUY("EK:)(UQ<."L,;
ML,5TE? 7_!2+]CJ']N?]GS2_@1+H'@'45N_BW\+?%<WB;QW!>WDGPYTOPGXJ
MM-5\0>-O ]E9 &Z^(5OX=BU71/"R7DT&F176MR7.HO):PR02_?H& !Z#% 'X
MZ_\ !P)_RAJ_X* ?]D3'_J9^%*_17]EW_DVC]GK_ +(A\*?_ %!="KK?B_\
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M93]8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!VG32V^H^,;[2Y=4T'1-&T*WF@N$@;5==M+_4_LE\^E6-['87CP>H?L/?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7RWX6_Y.W^*?\ V2WP;_Z6I7U)7RWX6_Y.W^*?
M_9+?!O\ Z6I0!]24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?&GP4_Y+[^UG_P!C7\/O_4;U.BCX*?\ )??VL_\ L:_A]_ZC
M>IT4 7?V*/\ DD_B+_LK'Q&_].Z5]?5\@_L4?\DG\1?]E8^(W_IW2OKZ@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^/M%_Y/>\9_\ 9#M!_P#3
M_'7P+_P<)?!GQG\5?^":?Q$\7_#NSO-2\:?LS?$/X2?M5Z9I6GQ37-[JFF?
MKQSI7C#Q;:6-A!#/+J&H+X0MM=O--LE5/M%_:6\9D56;/WUHO_)[WC/_ +(=
MH/\ Z?XZ^M=1T^PU?3[[2M4L[74=,U.SN=/U'3[V".YL[^PO8'MKRSN[:97A
MN+6ZMY9(+B"5&CEB=XW5E8@@'XM?\%$/V9O%7_!37]E#]DS]J#]C'QKX2TS]
MHCX&^,_AA^V5^R?KWB:^G/@+Q3>W>AVFI:E\/_%=[ICS/8Z3XW\/7HT2\U%5
MG?2+Z!5F2(>?-!\2?'OPE_P5A_X*]V?P>_9(_:%_8.T;]@/]F31?BM\,?B9^
MUI\4O$WQ_P#!/Q8UKXL:-\+]>MO$L7P\^!GAWP")[K3=/\4^)]*MKJXO?&C0
M7>EZ<-'NTU)[BQO[#4OWT_9+_97\ _L:?!^V^!'PIUSQMJ7PRT+Q3XNUWP'X
M?\:ZQ9:VOPW\.^*M;N-=@^&G@RXM-)TJ6S^'GA*ZO+NU\':1J)U._P!'TR9=
M.;5;JUM[5(/IB@#\)/V\?"/_  44^#_[7'A_]H/X _ BV_X*+_L<^-/A%9?#
M?XD_L(^)?B'X"\&3_#;XI>'-3DO?"WQP^&#?%'3[SP8\FHZ:_P#8GBB.X=K^
M* 79M[:674H+O3]/_@G;^R;^T]XH_:U^,/\ P4M_;9^&OA#]G_XC>._A-X2_
M9X_9P_93\'>*;'QM%^SM\ /#&H2ZY<V'B[Q/HD%MX6O?'OBK7'AN-6M?"*2>
M'M/M[18[.55G6TM/W(HH _)SXY?"KXP?\%3?V&_VU?V6?CQ\ O%?[%NJ>-M0
M\9_"GX6ZSXH\=^"?B<OB[3_#DND>(/AO\<((O 5RZZ9X5U;Q58V3WO@S6)(/
M$::=I]]!/Y;W5O(/S/UCXA_\%Y?B'^R???\ !._5?^"<?PV\,?%35?A4W[.W
MB+]NZ[_:0\!7G[-MQX:7PRO@S5?BOH_PNM=-E^*+ZKJOAS??V6@7&C16\?B6
M:16TB#2EBM$_J3HH _"7]KKPGH'_  2\_P""#_B_]GKP[?WWQ!UGP)^R]IW[
M*'PVAE3&L?$KXJ_%NRC^%>@:=H]C(9F^T:YXI\77%YI>E;II+73H5M?,F:W,
MC?HK_P $]?V?+_\ 91_8:_9/_9PU=XY=;^#?P&^&_@;Q!)$K(DGB+2?#=BOB
M%U5F<C=K3WS'YB-Q)!QBNH^/'[)OPQ_:0^('[/'CGXIW7BG5[#]FOXBW7Q<\
M%?#NWU6VM?AYK_Q+BT>?1_"?B_QUHO\ 9TM]XCOOAZ+S4=4\%V9U6STJPUN^
M?5+^PU.XM;#[+].T %%%% !1110 4444 %%%% !1110 5\D_!O\ Y.9_:S_Z
M^OA!_P"H;=U];5\D_!O_ ).9_:S_ .OKX0?^H;=T ?6U%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7RWX6_Y.W^*?_9+?!O_ *6I7U)7RWX6_P"3M_BG_P!DM\&_^EJ4
M ?4E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0!\S_P#"7_M0_P#1)/!/_A86_P#\L:/^$O\ VH?^B2>"?_"PM_\ Y8U],44
M?,__  E_[4/_ $23P3_X6%O_ /+&C_A+_P!J'_HDG@G_ ,+"W_\ EC7TQ10!
M\S_\)?\ M0_]$D\$_P#A86__ ,L:/^$O_:A_Z))X)_\ "PM__EC7TQ10!\S_
M /"7_M0_]$D\$_\ A86__P L:/\ A+_VH?\ HDG@G_PL+?\ ^6-?3%% 'S/_
M ,)?^U#_ -$D\$_^%A;_ /RQH_X2_P#:A_Z))X)_\+"W_P#EC7TQ10!\S_\
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M_P#A86__ ,L:/^$O_:A_Z))X)_\ "PM__EC7TQ10!\S_ /"7_M0_]$D\$_\
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M_P#A86__ ,L:/^$O_:A_Z))X)_\ "PM__EC7TQ10!\S_ /"7_M0_]$D\$_\
MA86__P L:/\ A+_VH?\ HDG@G_PL+?\ ^6-?3%% 'S/_ ,)?^U#_ -$D\$_^
M%A;_ /RQH_X2_P#:A_Z))X)_\+"W_P#EC7TQ10!\S_\ "7_M0_\ 1)/!/_A8
M6_\ \L:/^$O_ &H?^B2>"?\ PL+?_P"6-?3%% 'S/_PE_P"U#_T23P3_ .%A
M;_\ RQH_X2_]J'_HDG@G_P +"W_^6-?3%% 'S/\ \)?^U#_T23P3_P"%A;__
M "QH_P"$O_:A_P"B2>"?_"PM_P#Y8U],44 ?,_\ PE_[4/\ T23P3_X6%O\
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M "QH_P"$O_:A_P"B2>"?_"PM_P#Y8U],44 ?,_\ PE_[4/\ T23P3_X6%O\
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M_EC7TQ10!\S_ /"7_M0_]$D\$_\ A86__P L:/\ A+_VH?\ HDG@G_PL+?\
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MB/$TESKZW7A^VO=7L;'6;I=5M(;(7$]M9NUS'* <Y_P6S^,O[:OQY_:ET/\
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M'C5/CQX3^%^JFYO+63P3HGC)M,33;32KJ?288IX;ZUFN)]3N[J?US_@O//\
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M_P &]7[+T<B2#]KS_@J.Q1U?:?V^/BRH;:P;!:-4D4'&"4=''565L$ 'A?\
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M$&F3VEEK=I!*RQ2:AX?U)K/7-,$C!%U#3[9G^537Y=_LM?LT7/[:/_!-2/\
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M9_\ 9#M!_P#3_'7U]))'#&\LKI%%$C2222,J1QQHI9W=V(5$1069F(55!)(
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MKN@PZ%X^BTFYT5-3U&ST>^M+;Q!:C3[N>$Z7K$=W8%G\PP%QFOI>B@ HHHH
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ML-5@A-I?PS6TCQM[I10 U$2)$CC18XXU5(XT4(B(@"HB*H"JJJ JJH 4
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M6^L=&TS3=$LM4EL]1U?38Y/V7HH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ&<9P/H'_AL7_JW_ ./7_A$7?^% 'VA17Q?_ ,-B_P#5O_QZ_P#"(N_\*/\
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M_P!6_P#QZ_\ "(N_\* /M"BOB_\ X;%_ZM_^/7_A$7?^%'_#8O\ U;_\>O\
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M\* /M"BOB_\ X;%_ZM_^/7_A$7?^%'_#8O\ U;_\>O\ PB+O_"@#[0HKXO\
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M+_U;_P#'K_PB+O\ PH ^T**^+_\ AL7_ *M_^/7_ (1%W_A1_P -B_\ 5O\
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M1_PV+_U;_P#'K_PB+O\ PH ^T**^+_\ AL7_ *M_^/7_ (1%W_A1_P -B_\
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MHKXO_P"&Q?\ JW_X]?\ A$7?^%'_  V+_P!6_P#QZ_\ "(N_\* /M"BOB_\
MX;%_ZM_^/7_A$7?^%'_#8O\ U;_\>O\ PB+O_"@#[0HKXO\ ^&Q?^K?_ (]?
M^$1=_P"%'_#8O_5O_P >O_"(N_\ "@#[0HKXO_X;%_ZM_P#CU_X1%W_A1_PV
M+_U;_P#'K_PB+O\ PH ^T**^+_\ AL7_ *M_^/7_ (1%W_A1_P -B_\ 5O\
M\>O_  B+O_"@#[0HKXO_ .&Q?^K?_CU_X1%W_A1_PV+_ -6__'K_ ,(B[_PH
M ^T**^+_ /AL7_JW_P"/7_A$7?\ A1_PV+_U;_\ 'K_PB+O_  H ^T**^+_^
M&Q?^K?\ X]?^$1=_X4?\-B_]6_\ QZ_\(B[_ ,* /M"BOB__ (;%_P"K?_CU
M_P"$1=_X4?\ #8O_ %;_ /'K_P (B[_PH ^T**^+_P#AL7_JW_X]?^$1=_X4
M?\-B_P#5O_QZ_P#"(N_\* )?@I_R7W]K/_L:_A]_ZC>IT5QG[+?C#_A-_BO^
MT]XD7P_KWAP:IXA^'UU_8_B*S:PU>R_XDNNVWE7MJ_S03$VIF$9R1#+"Y.'%
M% 'H'[%'_))_$7_96/B-_P"GA*^OJ^0?V*/^23^(O^RL?$;_ -.Z5^/G_!9#
M_@L!^TK_ ,$W?VL?V:O OPO^%OPZ^)WP-\2_!KQO\;_VB8?$%MX@@\=>'/AY
MX!^(WA'POXL\3>#-7TK55LM^@^'O$DNK/I5[H%_]KDM"YNX(E=" ?T@T5Y1X
MR^-/P]\"_!'Q+^T)XA\06-E\+?"WPRU/XMZIXEGG2.PB\$Z7X9E\63ZJ9\LG
ME-H\1GC*EM^Y50.S*#^&_P#P27_X*M?M1_MW^%/^"AOBKXY?"_X<_">__9LM
MOA]KOPE\&^&[77[J]M_#?Q)^$'B'XN^&SX^U'5=79M7U670V\*->V^GV.@K:
M3/J5MB0O%+" ?T/T5_+#^PU\?O\ @XG_ &\/V4_@[^UI\._BW_P2?\(>#?C/
MH%]X@T3PSXQ^#_[3 \3Z/;V.O:MH$EMK']C>,-2TK[2\^DRW"?8=0O(?L\T.
M9O-\R-/M_P#81_;T_;*NOVUOB;_P38_X*,?#;X,:'^T1X5^"UI^T3\*OC%^S
MK?\ B4?"7XV_"=_%:>$=<O[/PMXQDN_$OA+4_#FM7^F:=);ZAJ$TE_/'J;O9
MV,<%LUT ?M_17\]%K^W%_P %0?V^?BU^T=H7_!,/PE^R'\*/V?\ ]EOXX>,/
MV=-?^._[7Y^)OB[5/B]\6OAX+"W^(.E>!OA]\+YM-N_#6@>%=1OH((-=U^]N
MEUV"=+BU2$L(HOH/]CW]MG]M'3?VL+S]@7_@HG\#? F@_&*]^%UU\6OA)^TE
M^S:GC74_V<?C3X:T?4&T_P 3:5):>+K*36OAKXUT.4B1/#^NZO>-J=E%)<P&
M R6BW@!^RE%?C'_P68_;]^/W[&OPY^!/PU_8P\*^ OB)^VK^U/\ %2Z\%?!3
MP'\0;'5=9T&;PSX$\-W_ (Y^*OBJ^T71-:\/ZE=VNA>'[*QTX3C5[.WL+K7[
M?4;@W$-E+;2?9O\ P3S_ &O?#O[=_P"QE\ ?VI_#RVMK+\4? MA>^+-&M,JG
MAGXA:.\N@?$'PR8'FN)[8:)XPTS6+*VAN97N/L*6LLK,90[ 'V?139)$B1Y9
M72..-&DDDD8(D:("SN[L0JHJ@LS,0% )) %?FC^PG^V?XO\ VQ)_VG?VAGN?
M /AO]BGPK\4-?^$_[-7B&6.XL_$OCK3_ (-7VJ^&/C#\;/%7BF_UA-"MO GB
M/QS9WVE> =,CTG3KFQT3PS=ZOJ^H7+:K##:@'Z845P[_ !-^&T>J:%H<GQ"\
M#QZUXHM+*_\ #.COXLT%=4\16.HQB73[W0M/:_%WJ]I?Q$265SI\-Q#=1D/
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MFT_PGX4TP"[32HKJPO?$%T/L=K=P+',X^0_A#^W)_P %$?V9?VV?V</V+O\
M@IMX=_99\=6W[9]E\0(_V?\ XZ_LC)\1/#FCZ+XZ^&NA#Q)KWP\^('@3XES:
MAJ\BW>A1R:E8>+-+OK>Q2:ZLM.>SFD%S-  ?OM17X#?'C]N+_@HQ^T)^WI\<
M_P!A7_@F1X4_9C\%Q_L@>$OAKK_[2/Q\_:X3QOX@\.W?BKXOZ'>^(_!'P_\
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MTNXUN("Q>WG66"3#QL!Z!0 4444 %%%% !1110 4444 %%%% !1110 4444
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M>85,FU=Y0$(7P-Q4'D*6SM!YQC/- #J*_#;]I']K_P#X*/?&?]LSXB_L6_\
M!-3X<_ SP5'^SMX.\&^+OCU^TY^V%X>^)E[\+[_7_B#9WE[X8^%WPH\/^!&T
MK4O%.JP:? -1\1^*+?4;[3M'GBETBYLK:5K>[NO7_P#@F1^WO\8?VGO%W[67
M[+W[5/PZ\$_#S]KK]AOX@>$? ?QC?X5:SJ.N?";Q]I'C[P]<>(_ ?Q&\!R:R
M@UO1;#Q-IEA>W%QX8UJ:[U'1L6\<]V\LLL%L ?K5117YI_\ !5+]O'Q%^P#^
MSEX;\>?#GX91?&'XW?&?XT_#+]FKX!> -2UJ'PWX9UCXP?%_5+C2O"LOC'Q#
M.RC2O#-B;2ZNKV2+;+=3I:6!N-.M[JXU6P /TLHK^<FU_;G_ ."K?[#7QY_9
M(\(?\%.O"'[(/Q/^"7[9WQ:\/?L]^&_B!^R!;?$CP[XH^"WQJ\6Z;>W_ (4T
M7QCX8^(FJ:NWC70-:DL;VVN=6\-/#%I4.FWEZUU=2/8V-[_1M0 45_/-JW[=
M7_!3;]NCXV_M'>"?^"57A/\ 9+\$_ C]E+XB:O\ !OQ1^T7^UFWQ#\4V/QM^
M,7ARSM7\7^#?A9X1^&EUIT^F:'X2O;J*SNO&&L7UU8W]T)($2UE4Q)]"_L<_
MMO?MA_M@_L@?M06=_P# W0/V=_\ @HA^S#XH^('P7\1> _&FE^)?$GP2\1_%
MWP;8M>^&?$GA#5Q-X=N_$GPU^(AA-M;W6DZU=G1)IYI(M5UBSALKO40#]E**
M^0/V$/VN/#G[;_[+OPU_:$T31I_"6L^(;34?#WQ*^'U](9-4^&/Q>\%:E<^%
MOBA\.=4+JDQNO"7C+3-5TV">>*":_P!-2PU)K>%;U8U^OZ "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XU^"I)^/O[6623CQ7\/
M@,G. /#>I #\@!12?!3_ )+[^UG_ -C7\/O_ %&]3HH N_L4?\DG\1?]E8^(
MW_IW2OQI_P""AGPJ\/\ QT_X+B?L1?!3Q7%!-X;^+?\ P3:_;\^'.M)<VZ7<
M*6/B^QTW1&N6MI/DE>RDO([V$'!6>WB=65E5A^RW[%'_ "2?Q%_V5CXC?^G=
M*\U^*/["]Q\1_P#@HY^S!^WROQ,BTBW_ &<_@?\ &;X.2_"YO";7TWBY_BS=
M:?<)X@3Q@/$-JFB)H7V':VF'PWJC:B9 1?V00JX!_.YX-^-/C;X]_P#!)?\
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M/[/W@[4H]$T>ZO;YK"\\47$OB66\UN.UGM+2YT=;V>0@'X_^,/VOOC_\9?\
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M:5W=F8_T$_&CX5^&_CG\(/BC\%_&*,_A3XL?#[QA\.O$/EQ0S31Z1XRT"_\
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MP[X(OO!>A:MX0^+\NO:=X@\ V5@CZ;J3:?8:%?27<EI=6EY>7%O<P_9/9_\
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M!7B>[U^_&LV.L:5X>UV3PO;Z7JL^JVECX1N=*L[&1H[:SF@^O/\ @HM\$?\
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MXI@\57-JXNBK)("9?Z8$T'P#\0++P7\9+SP3X=N_%]CX+FU/P1XHU?0]*O\
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M^PC='>#19([?3=:\(ZZKK%XF\*RRV5OJBQ6\R75M=6T4P /QN_:7_9V\0?\
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M$'_J&W=?6U?)/P;_ .3F?VL_^OKX0?\ J&W= 'T!K_Q#^'_A_P 2^&_ 6O\
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M@?C3_P!'8?$3_P )GPG_ /(M'_"@?C3_ -'8?$3_ ,)GPG_\BT ?6U%?)/\
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M6U%?)/\ PH'XT_\ 1V'Q$_\ "9\)_P#R+1_PH'XT_P#1V'Q$_P#"9\)__(M
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M>_\ !/74O^#?SXC>-]5_;]\6_'/X6-XNT[X>?$'XE^)-9\>_ 0P6NH?'F_\
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MGPM;XN^*1XI\0^ /#UIK/QD_:#\1_"WX+-:>+/$MU;ZUK^F6.E^+=5N+32-
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MR2(PY5E8J1R"17\KUY^S'\.?^"P'_!8#]O+X<?MTKXC\?_LX_L!:)\&_A_\
M!']E8^/_ !1X4\ ZWXA^(WA34/$OB#XV^+=!\):OH.JZ[J%Q)<RZ;X>U7[?
MMHT!L)9KBTLX[-OHC_@GI!9?L0_\%3/VG?\ @E;\+_B#XP\8?LOVO[,_P_\
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M?[+?_!,KXV_%O5?V:?\ @FS^SM^R5)\?OC?\-_AIK_BGPUXB^/L%OK\7P:^
MO[-.DV_@J*;QGXITB\OK"6XU#P+X:6ZU3Q7:W<GG-:SVEIJ-N ?UJZ=JVE:Q
M"USI&IZ?JENDAB>?3KVVOH4E #&-I;:25%D"LK%"P8!@2,$4W4M9T?1DCEU?
M5=-TJ*9S'#)J5]:V*2NH!9(WNI8ED< @E5)(!!(Q7\D7_!*CPI^PS#_P45LO
M$'_!(GXX>(OV=/@W;_#/Q)#^UW_P3H^/.C_'?P9KGC,/:Z9'X!^.?P:\"?%U
M+B^BOM.OQ!:>)_$AU6[3[*&LHEMK6[FMA\$6WQ__ ."7_P"VWXY_:1_:E_X*
M\^(?BW^TIKOC#X]?%_X;_LM_LA?"N/XZ_$72OV9OV>_A!XAN?A_IOQ(N?AU\
M$7L1X6\0^-];TG6KFY\:>+WB_MJ-8HX["Y;,U ']\<<B2HDL3I)%(BR1R1L'
M21' 9'1U)5D92&5E)# @@D&GU^)/_!!_P['X=_9*\6Q?#G]L;2_VSOV3;[XP
M>+[[]D#Q9?:EXIUGXJ_"GX.RR1B#X&?&/4/%MK9ZFGC#X=7P^PKIDEK;C3+6
M<PVMO;:0^DVL'ZA_M*>+/CEX(^"7C[Q+^S5\+=!^-'QSL-+A7X<?#;Q3XOMO
M 7AGQ%KUU?VEH%U_Q;=QR0Z/I6GVD]UJEW+M$MQ'9_8X9(9;A)HP#VS[5:_:
M39?:8/M@@6Z-IYT?VD6S2-$MP8-WFB!I4>-9BGEF160,64@"75M)//:QW$$E
MU;+"]S;)+&T]NEQYAMWGA5C)$LXBE,+2*HE\J386V-C^5;_@E?X3_:W\&_\
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M.A:)=F_T?2?BY\._"OC^QTJ]8;7N=.M_$VEZDEE,Z@!WMA&7 &_.!@ _!_\
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M@[Q78Z[KNN_#FT$$B67Q+FTBTO="\+ZS/<V,&COK-U?RW$BP_9;C[E P !T
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^-/@I_R7W]K/\ [&OX??\
MJ-ZG11\%/^2^_M9_]C7\/O\ U&]3HH \_P#V3/C+\,/"/PWU_2_$7C#3M,OY
M/B;X]OTMY8=0D9K2[U8/;3AH;.6,I,BEEPY./O '('T__P -&_!/_HH.D_\
M@-JO_P KZ\0_8W\+^&=5^%WB&YU/PYH&H7*_%3XAPBXO=&TZZF$4>KKY<7FS
MVSOY<>XA$W;4!PH XKZQ_P"$%\$?]"=X5_\ ">TC_P"0Z //?^&C?@G_ -%!
MTG_P&U7_ .5]'_#1OP3_ .B@Z3_X#:K_ /*^O0O^$%\$?]"=X5_\)[2/_D.C
M_A!?!'_0G>%?_">TC_Y#H \]_P"&C?@G_P!%!TG_ ,!M5_\ E?1_PT;\$_\
MHH.D_P#@-JO_ ,KZ]"_X07P1_P!"=X5_\)[2/_D.C_A!?!'_ $)WA7_PGM(_
M^0Z //?^&C?@G_T4'2?_  &U7_Y7T?\ #1OP3_Z*#I/_ (#:K_\ *^O0O^$%
M\$?]"=X5_P#">TC_ .0Z/^$%\$?]"=X5_P#">TC_ .0Z //?^&C?@G_T4'2?
M_ ;5?_E?1_PT;\$_^B@Z3_X#:K_\KZ]"_P"$%\$?]"=X5_\ ">TC_P"0Z/\
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M$?\ 0G>%?_">TC_Y#H \]_X:-^"?_10=)_\  ;5?_E?1_P -&_!/_HH.D_\
M@-JO_P KZ]"_X07P1_T)WA7_ ,)[2/\ Y#H_X07P1_T)WA7_ ,)[2/\ Y#H
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MD?\ R'0!Y[_PT;\$_P#HH.D_^ VJ_P#ROH_X:-^"?_10=)_\!M5_^5]>A?\
M""^"/^A.\*_^$]I'_P AT?\ ""^"/^A.\*_^$]I'_P AT >>_P##1OP3_P"B
M@Z3_ . VJ_\ ROH_X:-^"?\ T4'2?_ ;5?\ Y7UZ%_P@O@C_ *$[PK_X3VD?
M_(='_""^"/\ H3O"O_A/:1_\AT >>_\ #1OP3_Z*#I/_ (#:K_\ *^C_ (:-
M^"?_ $4'2?\ P&U7_P"5]>A?\(+X(_Z$[PK_ .$]I'_R'1_P@O@C_H3O"O\
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MD?\ R'0!Y[_PT;\$_P#HH.D_^ VJ_P#ROH_X:-^"?_10=)_\!M5_^5]>A?\
M""^"/^A.\*_^$]I'_P AT?\ ""^"/^A.\*_^$]I'_P AT >>_P##1OP3_P"B
M@Z3_ . VJ_\ ROH_X:-^"?\ T4'2?_ ;5?\ Y7UZ%_P@O@C_ *$[PK_X3VD?
M_(='_""^"/\ H3O"O_A/:1_\AT >>_\ #1OP3_Z*#I/_ (#:K_\ *^C_ (:-
M^"?_ $4'2?\ P&U7_P"5]>A?\(+X(_Z$[PK_ .$]I'_R'1_P@O@C_H3O"O\
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M4'2?_ ;5?_E?7H7_  @O@C_H3O"O_A/:1_\ (='_  @O@C_H3O"O_A/:1_\
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MA7_PGM(_^0Z //?^&C?@G_T4'2?_  &U7_Y7T?\ #1OP3_Z*#I/_ (#:K_\
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M_A!?!'_0G>%?_">TC_Y#H \]_P"&C?@G_P!%!TG_ ,!M5_\ E?1_PT;\$_\
MHH.D_P#@-JO_ ,KZ]"_X07P1_P!"=X5_\)[2/_D.C_A!?!'_ $)WA7_PGM(_
M^0Z //?^&C?@G_T4'2?_  &U7_Y7T?\ #1OP3_Z*#I/_ (#:K_\ *^O0O^$%
M\$?]"=X5_P#">TC_ .0Z/^$%\$?]"=X5_P#">TC_ .0Z //?^&C?@G_T4'2?
M_ ;5?_E?1_PT;\$_^B@Z3_X#:K_\KZ]"_P"$%\$?]"=X5_\ ">TC_P"0Z/\
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MH?[2\8>#/$&A7Y-I>B]#3:QIMPQ06]M:73L77[?_ &*/^23^(O\ LK'Q&_\
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M$'QQK^L>.]1M?%-G^UQJ6EZ3=SZAXEOM1O\ 4-)T._BM_L&G3W36T.FVT5C
MD5LJQJ ?WV5\C>*/VR_AIX7_ &U/A;^PI/I'BR]^+OQ2^"?CGX^V.JVVGVR^
M#-$\!^!M=LO#-S_:FJS7D=W)K.JZU>&WTZPL-/NHDAM;F>_N[,M9Q7?\Y/\
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M$?P^_9F^#_A'X2^&];_;7^/OB3Q&OAZTFEUKQ7XAU+X/S7MYK7BSQ-JEQ?\
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M(NM MW)"QV>G>)KW7GM+2&*&WM8;H+"AW,S '] =%%% !7R3\&_^3F?VL_\
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MMHFAW>I:8T?A67PEIL5UI]S>6Z0ZK=R7]LNG6!GO096A6WE /?O^"C__  4
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M77[=;^ZFTR:^TR>PNK*]FMIOJ3]O+_@EMKWQ=^'G['VO_L0?$S1OV8_VE_\
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M:2#P-_;MS\1%U_PS:^'Q%%H-UX>OKN*RFTK6=3U.]8M$FFQ2LF?V'I" P*L
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MM!O;FZCT?Q'>Z--XCT[3;N[T>UU6+2KF:S?VF@#\$OC%_P $1="A_89_8Q^
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MX8D5$50 :M%%% !7R3\&_P#DYG]K/_KZ^$'_ *AMW7UM7R3\&_\ DYG]K/\
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M@ HHHH **** "BBB@ HHHH *^6_"W_)V_P 4_P#LEO@W_P!+4KZDKY;\+?\
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M.OZ+J,*W&GZMHVK6DMAJ6FWUN_RSVE[9SS6UQ$WRR12.AX-;-% 'X<?M(?\
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M97CW&I:A9V$<NBVUUI^G26<Q$LT47Z(T4 ?RX^(O^"?_ /P7&^+_ .SKI/\
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MWWB*ZF\/^(?&T/BB1+NY\"7/@E39Z7?:@TV@!(-9L?.:\35 WD/Q_P#VZ/\
M@GKI'_!*']FCQ1^R;^P/X$\9?!+X[?MA6/P9_8[^"_[0_A'0_A+^S]IWQDB\
M;>)FM/CAXG@MM7U_3]!^&5IXJTOQ#J^F7WVC2M2UV],\<-MIES<+Y@!^B'PL
M_P"#@+_@G?\ $WXJ_#_X2ZAJ_P >/@UJ?Q9UBW\._"WQ=^T#^SW\2_@Y\.OB
M#XAU"2UBT?0_#'C+Q?I%GIUUJ6N/?68TB&Y%HMV+F ^9&)4W>U_M<?\ !8/]
MC#]BGXPZA\ ?C/J_Q1NOC'!X"\(_$30OA[\./A1XL^(WB;QSHGC+7M>T&PM/
M NE^&+:\NO$6LZ8?#.MZQXAL((HET30;%]3O+A4DACD_F$_X+A^,O^"BD7PZ
M_9 \-_MX_M"?\$^M G\4?MC_ +.^M>!_V4/V9O"7BW7/B!J@TWQE$MYXZTOX
MB_$/4#XGTGPCX/5_[)O;FPT33[/7IM4@L;B\WQBT;]E]&\-:%J__  <[7GB#
M5-,MK[6/"G_!(S1KGPY?7*"671[O6/CP^DZE>6)?/D7EUI<]UIKW*8F^PWM[
M;!_*NYE< ^W/VC/^"QO[%7[+V@?!&[^)6K_%6^^('[0G@?2?B5\-?@%X#^$'
MC3QS^T)=^!=7TUM4C\2Z_P#"?0+&Y\0>%=.L[=)8M0;7UL)K>\M[NS6*6XL;
MV.W_ #J_82_;@\&_MG_\%Q_VA/%?P+^,GC/QK\ V_P"">WP?N(?A]JVH>--!
MTWX?_%"U^)6J67C#1O%'PG\2-8Q^"?B?HX:VTSQ/;WFA6NL0LHMY;F>'EKW[
M)&J>&?"O_!QE_P %/-+^.^H:'IWQ@\=_ /\ 9SU/]DQO%MQ:0:UJW[/NE^'+
M:V\?Z9\.+B_:+S[6W^(-M?WNOZ5I!EOB+6[OKB,V=K>/%B_LD>*/@GXL_P"#
MEK_@H+?_  1U'P=JL%C^Q3\'='^*FH>"7TZ;3KCXP:=XT,7B9-4N=+)M+OQ/
M9:>='L?$4Y9[M=1@D@U!VOH;C !XM^T[_P %*O@Y^R-_P0\\=_%W]@+XJ_M@
M^)+_ ,>_%?XK_#KX/_&/XO>'?&'QF\?>#/B1IOQ8^S_$J7QIXH\7Q:C%X-\(
MZ3;P^)-&^'FI^)X[C38KO^Q]+LK2XNI %^]M8_;4_9#_ &C/A/\ \$OOBY\3
M_%G[:'PQU#XB?M5>"_A]\$M+LM"^(OP3UKXB_'O1?"NH02:5\</"3+9W.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ^-/@I_P E]_:S_P"QK^'W_J-ZG11\%/\ DOO[6?\ V-?P^_\
M4;U.B@"[^Q1_R2?Q%_V5CXC?^G=*T_VM/V'_ -D_]NGP'9_#;]K'X'^"_C1X
M6TN[FU#05\1V][9Z_P"%M1N8XX;K4?!_C#0;S2/%WA&_NX8HH+N\\-ZYI=Q=
MP1QPW$DL2*HYK]C'6='L_A7XABN]6TRUE/Q6^(D@CN+^UAD*/JZ%'"22JQ1A
MRK8PPY!(KZV_X23P[_T']%_\&EC_ /'Z /BS]C3_ ()F?L+?\$_(?$'_  R/
M^SMX0^$^J>*XQ;^(_%BWWB;QIX\UC3TF6YBT:]^('Q!UWQ7XTDT""Y5;FWT
M:ZNC07 $\5BDH#U[7^SW^RS\"/V5].^)FD_ ;P)#X#T_XQ?&#QM\>OB-;PZ[
MXEUT>(_BQ\1I;*?QEXL>3Q-K.LRZ=)K,NGV;OI6DO8:)9^2!I^FVJO(&]H_X
M23P[_P!!_1?_  :6/_Q^C_A)/#O_ $']%_\ !I8__'Z /G?X(_L6_LQ?L[>!
M/BK\,/A/\)M$T/X??&_QUX^^)'Q7\(ZS?Z[XWT/QOXN^*#N_CV]UFQ\<ZKXC
MBDT_Q())(KWP_"(?#ZVTCVMMI<%LS1'X1T?_ (-^O^"/N@#XHKI'[$_@.RC^
M+^F2:-XOA3Q;\4I+>STN?58M8N+'P';S^.I8?A9!<7D$,=P/AHGA-IM-0:/(
MS:2S63?KM_PDGAW_ *#^B_\ @TL?_C]'_"2>'?\ H/Z+_P"#2Q_^/T ?-/[1
M?[#/[)7[6WP?T/X#_M'_  +\$_%OX8>%K>PM_">B>*;:\EU+P@^F:8FC65_X
M1\6V=Y:>+_"VL1:5&NGOK6@:[I^K3VI>&XO)4DD5N'_8V_X)I?L-?\$_[;7X
M_P!D?]G;P=\)-1\51K;>)/%4-WXC\7^/-;L(YEN8=(U+X@>/=;\4>-;G0X+E
M%N;?0WUXZ1!<*)XK))0'K[._X23P[_T']%_\&EC_ /'Z/^$D\._]!_1?_!I8
M_P#Q^@#\XOVI_P#@C;_P31_;3^*UG\;_ -I/]E+P5\0/BI;IIT5]XQMM<\=>
M"=0\30Z0($TVW\<0> /%7A>P\>P6=O;0V4,/C*TUQ%TY!II!L2;<_2WQ>_8J
M_93^/'[.\7[)OQ6^!'P]\4_LZ6>DZ+HFD_"<Z,NC>&/#MAX;C2+P[_PBL>@2
M:7>^%;S0411I&I>';O3-1TX[FM;J(R2%OH?_ (23P[_T']%_\&EC_P#'Z/\
MA)/#O_0?T7_P:6/_ ,?H _*'P=_P0:_X)+> OA=XO^$'AC]C?P79>$O'.J^'
M]9\0:A=^+OB?K/Q!:^\+:O:Z]X?_ +(^+&M>.-0^)_AJSTS6+.WU"+3/#GB[
M2M-DN$+W%I,&8'[NTO\ 90^ 6C?M&/\ M::?X#6']H.3X-Z?^S_)\1)/$7BJ
MYNY/A+I6O+XFL?"DFBW6N3>&I!%KB+?MK3Z,?$$[@Q3ZK) 3$?</^$D\._\
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MQ+XPGN+[Q7K>LZ[')J.O7L^J6CVVJP-HMX()=#.G&TM?)\K^&W_!)7_@G_\
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MU16+_P ))X=_Z#^B_P#@TL?_ (_1_P ))X=_Z#^B_P#@TL?_ (_0!M45B_\
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M#^B_^#2Q_P#C]'_"2>'?^@_HO_@TL?\ X_0!M45B_P#"2>'?^@_HO_@TL?\
MX_1_PDGAW_H/Z+_X-+'_ ./T ;5%8O\ PDGAW_H/Z+_X-+'_ ./T?\))X=_Z
M#^B_^#2Q_P#C] &U16+_ ,))X=_Z#^B_^#2Q_P#C]'_"2>'?^@_HO_@TL?\
MX_0!M45B_P#"2>'?^@_HO_@TL?\ X_1_PDGAW_H/Z+_X-+'_ ./T ;5%8O\
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M (_1_P ))X=_Z#^B_P#@TL?_ (_0!M45B_\ "2>'?^@_HO\ X-+'_P"/T?\
M"2>'?^@_HO\ X-+'_P"/T ;5%8O_  DGAW_H/Z+_ .#2Q_\ C]'_  DGAW_H
M/Z+_ .#2Q_\ C] &U16+_P ))X=_Z#^B_P#@TL?_ (_1_P ))X=_Z#^B_P#@
MTL?_ (_0!M45B_\ "2>'?^@_HO\ X-+'_P"/T?\ "2>'?^@_HO\ X-+'_P"/
MT ;5%8O_  DGAW_H/Z+_ .#2Q_\ C]'_  DGAW_H/Z+_ .#2Q_\ C] &U16+
M_P ))X=_Z#^B_P#@TL?_ (_1_P ))X=_Z#^B_P#@TL?_ (_0!M45B_\ "2>'
M?^@_HO\ X-+'_P"/T?\ "2>'?^@_HO\ X-+'_P"/T ;5%8O_  DGAW_H/Z+_
M .#2Q_\ C]'_  DGAW_H/Z+_ .#2Q_\ C] &U16+_P ))X=_Z#^B_P#@TL?_
M (_1_P ))X=_Z#^B_P#@TL?_ (_0!M45B_\ "2>'?^@_HO\ X-+'_P"/T?\
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M !7_ /+>BB@ _P"&'/V;O^A,U+_PK_%?_P MZ/\ AAS]F[_H3-2_\*_Q7_\
M+>BB@"$?L*_LUBX:Y_X0S4_-:,1$GQAXKQL'0 ?VOQ^?ZU-_PPY^S=_T)FI?
M^%?XK_\ EO110 ?\,.?LW?\ 0F:E_P"%?XK_ /EO1_PPY^S=_P!"9J7_ (5_
MBO\ ^6]%% !_PPY^S=_T)FI?^%?XK_\ EO1_PPY^S=_T)FI?^%?XK_\ EO11
M0 ?\,.?LW?\ 0F:E_P"%?XK_ /EO1_PPY^S=_P!"9J7_ (5_BO\ ^6]%% !_
MPPY^S=_T)FI?^%?XK_\ EO1_PPY^S=_T)FI?^%?XK_\ EO110 ?\,.?LW?\
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MS4P\^SS#_P )?XJP?+&%(']K\''7Z#H.*** )?\ AAS]F[_H3-2_\*_Q7_\
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MHH /^&'/V;O^A,U+_P *_P 5_P#RWH_X8<_9N_Z$S4O_  K_ !7_ /+>BB@
M_P"&'/V;O^A,U+_PK_%?_P MZ/\ AAS]F[_H3-2_\*_Q7_\ +>BB@ _X8<_9
MN_Z$S4O_  K_ !7_ /+>C_AAS]F[_H3-2_\ "O\ %?\ \MZ** #_ (8<_9N_
MZ$S4O_"O\5__ "WH_P"&'/V;O^A,U+_PK_%?_P MZ** #_AAS]F[_H3-2_\
M"O\ %?\ \MZ/^&'/V;O^A,U+_P *_P 5_P#RWHHH /\ AAS]F[_H3-2_\*_Q
M7_\ +>C_ (8<_9N_Z$S4O_"O\5__ "WHHH /^&'/V;O^A,U+_P *_P 5_P#R
MWH_X8<_9N_Z$S4O_  K_ !7_ /+>BB@ _P"&'/V;O^A,U+_PK_%?_P MZ/\
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M_P#EO110 ?\ ##G[-W_0F:E_X5_BO_Y;T?\ ##G[-W_0F:E_X5_BO_Y;T44
M'_##G[-W_0F:E_X5_BO_ .6]'_##G[-W_0F:E_X5_BO_ .6]%% !_P ,.?LW
M?]"9J7_A7^*__EO1_P ,.?LW?]"9J7_A7^*__EO110 ?\,.?LW?]"9J7_A7^
M*_\ Y;T?\,.?LW?]"9J7_A7^*_\ Y;T44 '_  PY^S=_T)FI?^%?XK_^6]'_
M  PY^S=_T)FI?^%?XK_^6]%% !_PPY^S=_T)FI?^%?XK_P#EO1_PPY^S=_T)
MFI?^%?XK_P#EO110 ?\ ##G[-W_0F:E_X5_BO_Y;T?\ ##G[-W_0F:E_X5_B
MO_Y;T44 '_##G[-W_0F:E_X5_BO_ .6]'_##G[-W_0F:E_X5_BO_ .6]%% !
M_P ,.?LW?]"9J7_A7^*__EO1_P ,.?LW?]"9J7_A7^*__EO110 ?\,.?LW?]
M"9J7_A7^*_\ Y;T?\,.?LW?]"9J7_A7^*_\ Y;T44 '_  PY^S=_T)FI?^%?
MXK_^6]'_  PY^S=_T)FI?^%?XK_^6]%% !_PPY^S=_T)FI?^%?XK_P#EO1_P
MPY^S=_T)FI?^%?XK_P#EO110 ?\ ##G[-W_0F:E_X5_BO_Y;T?\ ##G[-W_0
MF:E_X5_BO_Y;T44 '_##G[-W_0F:E_X5_BO_ .6]'_##G[-W_0F:E_X5_BO_
M .6]%% !_P ,.?LW?]"9J7_A7^*__EO1_P ,.?LW?]"9J7_A7^*__EO110 ?
M\,.?LW?]"9J7_A7^*_\ Y;T?\,.?LW?]"9J7_A7^*_\ Y;T44 '_  PY^S=_
MT)FI?^%?XK_^6]'_  PY^S=_T)FI?^%?XK_^6]%% !_PPY^S=_T)FI?^%?XK
M_P#EO1_PPY^S=_T)FI?^%?XK_P#EO110 ?\ ##G[-W_0F:E_X5_BO_Y;T?\
M##G[-W_0F:E_X5_BO_Y;T44 >J?"[X"?#'X.'7SX T2ZTK_A)I--DU?[1K&J
@ZIY[:2MZMCY9U*[N3 (AJ%V2(BHD,N7W;$VE%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img12876764_15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_15.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $"!&4# 2(  A$! Q$!_\0
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M\2_\53XQ@$'BWQ+:HEKXEU*W0QVVJW$4;ND<H4RE%&]\#<1G%7_[)OO^AO\
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M4G&*4+)2:7PI[>I^NW_#[W]O7_H<O"__ (+/$/\ \U-'_#[W]O7_ *'+PO\
M^"SQ#_\ -37Y$T$@ DG '))Z >IK]#_U%X._Z)O*/_"2G_EY?GW9R_6:_P#S
M^J?^!/\ KI^?=GZ[?\/O?V]?^AR\+_\ @L\0_P#S4T?\/O?V]?\ H<O"_P#X
M+/$/_P U-?GEHG[-7[2GB;2=/U_PU^SA^T)XDT#5[6*^TC7O#WP/^*6N:'JU
MC.-T%[I>L:5X4N].U&SF7YH;JRN9[>5?FCD8<UD>*?@7\<_ HT@^.?@?\9_
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M9XA_^:FC_A][^WK_ -#EX7_\%GB'_P":FO@;_AD[]K#_ *-5_:=_\1Z^,/\
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M7<>9*ZYDKJ[5[L/K&(_Y^U/_  )]+?Y?U=GZY?\ #[W]O7_H<O"__@L\0_\
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MUM_T.%C_ .5__P"7U'_#SK]K;_H<+'_RO_\ R^K\^Z*T_P"('>$'_1N>$_\
MPTT/+R\OQ?<S_P"(Q>*7_1><3?\ ASK^7][R1^@G_#SK]K;_ *'"Q_\ *_\
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M%+_HO.)O_#G7\O[WDC]!/^'G7[6W_0X6/_E?_P#E]1_P\Z_:V_Z'"Q_\K_\
M\OJ_/NBC_B!WA!_T;GA/_P --#R\O+\7W#_B,7BE_P!%YQ-_X<Z_E_>\D?H)
M_P /.OVMO^APL?\ RO\ _P OJ_6']A7XQ?$?]H/X>7WC;X@>*M:&O_VIJNF-
M<:%J^K:8CV>G7B0VL4@>^NI'$:,W#2[=QW*JY(K^9JOZ&/\ @E+_ ,D/O_\
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MZ&_QS_X5>J__ !ZC^R;[_H;_ !S_ .%7JO\ \>K<56=@J*69B%55!9F8G
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MI>N76EZ&DB([QMJEW:!T1V4E58@ ZC^R;[_H;_'/_A5ZK_\ 'J/[)OO^AO\
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M_3S<UL4 %%%% !1110 4444 %%%% !1110 4Y/OK_O+_ #%-IR??7_>7^8H
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M9&C/=)<2Z5\(/!&EM,T@+W#V6I_%&S$Y+$,QN'M971B 9,,<95@ #UOXR_\
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M0E*:FVH14D55]I[6.F*Y?K,-:DFZ-O:QMRKE5E?X=7IIKI?^AO\ X*%>*O\
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M_P""<BM&X;_A'M,BVLC!O,7QGX1#Q[2,[U)4,N-P.T$9Q7V#^UQ\;? _[/\
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M^"X\/>'[S5K.*V?6].U73EAN+FWCBNC+8RN(&<Q;9-IK]@M+_P"",_[!.O\
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MPV)57#MVII(HHHK[P^*"OZ&/^"4O_)#[_P#[&3Q'_P"G*.OYYZ_H8_X)2_\
M)#[_ /[&3Q'_ .G*.OY3^F/_ ,FBH?\ 989'_P"HF;G]+_12_P"3H5_^R6S;
M_P!3,K/TZ\0<^'?$8/3_ (1W7_\ TT7M?Y]W_!-OP]_P1CU/P!\5'_X*0:]K
M.C?$Z#XERP^ [;2K[XY65N_@D6)\]GB^%FCZAI&5U7S$4W\D=\J#")Y&TU_H
M(^(./#OB,GI_PCNO_P#IHO:_A<_X)&?M7?\ !*OX$?"KXQZ!^W;X(\ >*_B!
MK7Q9?6/!M]XJ_9QA^,]S!X272_L\L5KKK>'M9_LVV;4@\O\ 9RSQK(Q^T",[
MMQ_RS/\ 2$^Z/^"-?A3P5_P\X_:/UC]@#6OB))_P3MT3X?2Z;J[>,[S5CH^L
M^,+V'2V\/6VD6?B@Q>(;YK76EUBZTK4]2LH=>LM,:3^UTAAO+99/JKQ__P %
M=?VTOC)\</C?\/?^":W[%VA?M$?#C]FR]U#2?BA\1_&>J7L*:U?Z3<W5O?S>
M$H+/Q=X-LX(9Y=.U*+1-+CG\4>(]7M;5-772;6*=;(?!7[#WB3X;?'G_ (+?
MP?%7_@F]\/?$_P -/V2+'P3=VGQEN=%\.W7@7P-JMF_A.[LM;OU\+O']@\.6
M^O>*9=#FT/PZL5G>_:K&>^L]/LXQ< _'7P2L?@7^Q'\;OVN_@1^W?\?O^"@O
M[+7B+2?B-K'B/P!=_LL_$/Q+X*\'?%C3)I+MK*\U+2](T#5!J=_K.G2:9?:%
MXNFG726TW4!97<MM):,& /V@^/W_  4\^)O[67_!(3XX_'W]E_P/?^!/B?X3
MOIOAO^T9H-UXBDT[Q)\$M(,$<FO^,?"&LPZIX>O[HW$,ENNCA[:758HYM4LK
MC1I[BP:>3XD_95_X*#?\%&/V.?\ @F+X$^,EY^S;\'-9_9N\%>(/"^A^#_'_
M (JUCQ!JGC/XD:+XU\2^)!XDU6:#0OB0UQIVIZ1JEK%:I>:WH.F6\IU&!Q:W
M@@?S/H?X1?!7]FR\_P""./\ P4.^(/[&6C?M8W5E\<_ 6I:SXCTG]I2*UUGQ
M=K?B?PC$UY=7WA"Z\.^&])LO%*W=OJ]\^LZUILFM)=WUNJO>!X'5K?\ P3K\
M<_ _]O7_ (([?$;]@+P=J&IZE\;/AO\  GQ,_BOP[JOAG4K33=)UZ?Q)J>N_
M#G4M(\12QC3-3EO_ !!I-G$L5A<&\LHVE^TQ!"R, ?1G_!2S_@L_K?[&'B3]
MD2Q^$W@KX=?$+0OC_P"!-.^*GC6X\67.O3ZAHG@36]0T*UT6?PS_ ,([KFFV
M\-S?12>)BE]JB:K:/-IMNL=JZ+<!_I[XW_\ !0OQCX9_X* _LJ?L=?!O0/AU
MXF\*?%GX=7/QB^-GC7Q,OB&YUCP!\,%L+WQ#;^(M"&D:UI6GVL8\,:5J.HSR
M:O8:MN;R66WC1&CE_EM_8A^!_P 0?^"C7PT_;%U'XFVTNL7_ .RA^P=HOP'^
M$B&6YGDM/%/A76KKQ3X/!DVR&2[B?P;JD5W'"T1F@OQ"QF6260_=G_!"OPOX
MY_;5\?\ [57[2'Q%E@;6O!O[*_A3]CKX;:PUQ*LFB7.J_#ZX\*PW$=Q*I" ^
M'='5]3DB\L0MJ\F]6^T&5@#ZKU/_ (++_MU_&O5OC7\3/V%OV#]&^+G[)OP!
MU74].\9_$?QGJVH)XIURS\/_ &FZU;5]!@TWQ9X>MU-QI%LVK0:'HFA^-]3T
MRPD@N=3WF3[.OW!<?\%C?@)%_P $Y4_X*#1>&M<GM)-07P+'\'CJ-I%XC/QB
M-U_9[^!7UK[/);+IT<H;6VU\:>\Q\*+_ &HFDM=,MB?Y=/V6_$?[,G[)_@7X
MZ_ #]N7X^_\ !2O]F[XQ?#7QKXHM-/\ A/\ LY_$W7_!/P\^)ED89+*:"'P^
MOAZ\TC2=;U66W,,FN:]?1Z%K.EW=G<"[\GS /NW]IC]BWX8^(?\ @BG9>+OV
M%/#7[3NH_#_2OVA;/]I3Q!X.^.EJO_"S7TR'PU-\/O%&J:!8Z3X<T*VOO#VD
MVQM/$":MI5C?VL\%MK&JVUU=1GY0#[#T'_@LI^W1\%]3^"?Q'_;U_85T7X._
MLJ_M ZOIVF>"?B;X+U+4?^$DT*VUX1W6D:KX@TS5O&'B'<L6EW$.IW.EZUI/
M@C4;_3DN+[38SA+0_27_  4H_P""J_Q6_8A_:7_9B^#_ ,,?@UX6^./A?X^>
M!)?$B:?;R:[%X_US7M4U[4_#O@_2/!6H6FJV^AVEIK-Z-#EEN=5T+5I5M;J[
MD14*Q!?PTT_Q[_P2I_:1T#X#_![QQ^T9_P %A/C9XJ\>7/A[3_$GP<N_B9>?
M$'0OA;XUM["WL5>+0?$'@>_L_$5M:ZD\NG://X0M-1OM/L3&]R+:)9=OZ"_\
M%*=%T_PI_P %=/\ @CEX6T^:^DT[PQX+\)>'M.DUF0/K#Z?H_C75M)TU]79H
MX"=5D@M(EO6,$!:_$ZB*-E\M0#Z,_9;_ ."L/[5VJ?MUZ'^PS^W;^RGX5_9^
M\<_$71)M:^'TW@O6;W5IM/632-4U[1X?$5P?$OB_1M>L]7L])O=,_M70K_33
MI^M6[P7^G0[;B*T_H%2UN9"H2"5MY"J1&VTEC@8;&W!)ZYQ[U_,G^U_/"G_!
MQQ^PHKR1>9_PJ6PQ$SJ&<M'\871=I.X^8(I2HP=PCD(!"-C[=\5_\$OOCUXD
M_:LG_:)L?^"FO[37ACP9/\5M(^(:_ 32CXJ/@2TT73=6L-0G\!0K'\7+723H
M-]!9RV$^/"J0FWNI2=/D;.\ ^=/B)_P5U_:R^*'[5OQ2^ /_  3H_8[T3]IC
MPI^SY=W-G\7?&7B7Q!)H;ZM/IEZ+'55\(:E)XG\,Z!HL;7UOJ.F:$NK/XAUC
M7[BTEO+70$@ADMVZ[]@C_@KC\5OVS/B5^VIX=UKX-^%OAIX<_9P^'>J^,O!>
MBZE:^([?X@C6-,GU*TN?#?Q*%QK]WICW%A>Z?+:7IT.PT64R(Y$<)(CC_-K]
MAW]K'X>_\$B?VSOV^_@G^V=H_CKP=%\4/B)/X[^&OB+PSX)UCQ/:>*TD\1ZW
MJFBP:5;:8CW5YIWB;2M<L#H>JVD,VG0WD5W;W\]O,JQ4S_@D7X]N_BE^U)_P
M60^)U]X0U?P!-X[^&_Q#\73>#M?LS8:SX67Q#XD\6:K!HVM6V EIJEG!<+'>
MP9PEQ',%+*I:@#ZA_8L_X*Z?\%,?V\/^$5/P'_8H^#FNZ)X=\<:?X?\ C[\2
M+W6]>T/P1X8TC7M4MGTK_A$[36?B+::S/K6G>'(M3U#5XHCXMEFN38F'2+.V
MW"Z]J^-O_!6K]J;X@_M/_$[]E_\ X)E?LH>'_P!IK5_@4]Q;_%7X@>-M6N=/
M\++?V<LMA?6NB11^*O MA86\&KP76FZ?>:IXGNKOQ#/97BZ7HP2W:6L/_@V0
MM;*Q_80\7ZI$H^T7G[0WB4Z@R^668:=X>\,"V5MJA]R0W#E5D9B!("FU6.[X
M8_8N_:9\"?\ !&O]LW]NKX/_ +:VA>-_!WAGXM^-W\<_#?XJZ'X'U;Q!IWBB
MPAU[7=8TQ8(=.66ZO=)US2]:MY]-NK%KF#3]1AOXM3-JQ3< ?L+^PU_P5/\
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M\EY>P2>*IO$9OUM=5N)T$&OPV[7$4!9%C,B5\_ZO_P %M_\ @H3X?^$'@?\
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MG\,K5_$VCR@K<:+J7B'5]6\4'1KQ228[_2X-:AL=0B.&@O8+B%@&C('YK_\
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M'X<?'_\ X*L?M+_$;X>ZWH/Q%^'?CKXM>,KWQMX'\':]H>KIXEE\/^)H=?\
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M:78Z=?7YO_#UGK%Q/J5EJ"W.G7.ARZ!J6J7=P=7-NL=Z89]T?P3-_P %J/\
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M' '_ "2SX6_]E L__3'J-?RQU_7/@_\ \D/@_P#L/S/_ -26>%CO]YGZ0_\
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MY8(%"002:GK-W>WSP0(-D,+3F.)?EC51Q60]K=QQ&>6ROHH  QGELKN* *V
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MN+B02!YI&;G6L=07:&TW4E+ND48?3[R/S)9&"1Q*9(44R2.0J+N!9CBOL_\
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M6=WX[\<>,_'%UIT<L.G7/C/Q7K_BJXT^&9@TT5C-K^H:A)9Q3,H:6.W:-)&
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M+'7]3G_!P!_R2SX6_P#90+/_ -,>HU_+'7]<^#__ "0^#_[#\S_]26>%CO\
M>9^D/_2$%%%%?IYR!1110!_;_P#L=_M+6_['7_!M/X&_:2L?A5\/OBOXZ^'/
MQ?\ '<WPSTKXE:-'K?A70O'VM_&KQ5X=TCQCJ-@)+>ZNW\.66JZG<V<5G>6=
MXUTT"P7MF0+F'R7_ (+/^,M$_;<_X(H?L3_M^^-/AGX.\._M(>*?&GAS0[G6
M_!VEK8>=_:]QXQ\)ZYH%O<7#7NL3>%]7U70K37-,T+4-4OCI%\T"QW,[Q2RW
M'Y@3_P#!1W]FV7_@@U9?\$XEE^(7_#2%O\3+WQ?)&?!4H^'_ /9=Q\7-4\:1
MJOC/^TC$T_\ 8%Y"[1?V>'74-]EM(3[0?8[G_@IG^Q!XT_X)A_\ !/G]A[Q[
M>_%VW\4? #X_?#/QY\=7T_X8R:EH4?@3PQ\0/%OBK7_^$4U-M<MXO$VJ&PU7
M2H[33$BLS>2RW<1G@-L&E_%H</8["YNL\IY3CGCH>(N:XFI7I4\1*K4X=JX:
MM.\:<9<KP6)K-)2C!*K5FDY/F.YU8RI*ESQY?J=*-FXI*LG!6N]5-*_FMSUG
M_@H8;/X&>/\ _@@7^P=HES%]B^!VE_L^_%7QAIZ%%N;/Q]\4OB?X-DN/[1A$
M$,QN);;[>Z33_,ZJPV;D+G^FG]MKQ/\ !7]N7XR?M&_\$;?C5%I.A>)/B'^S
M=X?^-/P"\6S F]/BVSDUA+BZL(I+J,W'B#P)K&G:9XFCMK5K<:KX5GU^QN,V
M]O=/)_"[^VW^WE\/_P!J'_@K':?MH:7)XE7X(^'/C#\!]1\*1W_AV33O%=K\
M)_A%K'AB^DC;PLU[*8=8$=EK<EMIBW<9NG:V5I(GF9E]]_X*E_\ !5;P5\>/
M^"EWP;_;P_8DUKQSI$_P=\'^ H-$O?'/A>?P=J;^)O"NMZO>:II-UI+ZA>/?
M>&]:TJ^_LK4EEFC@U&QOKZQFA> OYDXG@_-<Q?"T73Q&$Q^&R3.,T>8J,XQR
M[B7%X["YO0CB)I)1F\7.K1J1DKNDJMH\R31&O"'MW=2C*I3@H77OT(Q=-\NM
MK<MFK-*[6I^GW_!;GX2^-_@-_P $0/\ @F[\%_B3IPTGQW\+OBQ8>"/%-BD@
MFACU?P]X,^)VG7,UK.ORW%C>&%;RQN4^2XLYX)T^605_.I_P2Q^%NC?&C_@H
MW^QC\-?$-M'>:'KWQX\)7VJ6DRL\-S;>$_M?C,03(OWX9)_#T*S1D%)(BZ.K
M(S*?V5_X+??\%G?V5_\ @I=^R1\ ?AQ\(-+^)^@?%GPG\3-!^(OQ!\/>+O!C
MZ5X:T1G^'WB#1M>TO1?%8U*X@U\Z;XAUB*TL;B&SA74K"-]0Q;X$#?A#^PA\
M<;7]FG]M#]F#X\:A)##I/PS^,_@O7->N+C=Y%IX;NM171/$M_*$#.4T[0=5U
M&_*H-[&V"KR<'Z/A3!9U1X*S:CCL'6P&<XNIQ'B(X><)4YPQ.-EB:M"5)-MN
M$JM2+I34FFK-2>YG7E3>(IN$E.G'V*;3NG&/+>__ &[NOD?O]_P41_X*%>(?
MV,?^#BOQ?^T==>&S\0O#'P6\/>"_A=?^"(;[['<W/P\\2?"FSTSQ79>';NY
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MZ6%PU/+\II3JX>E2AB,-+#R^F_\ @L[_ ,%)=$^$UW\,/V9/AE_PBGCWXV>
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MZ\=!DE19%(/BGP+G*N".1QTS@D="0?A[_@IS^TG\,_VM?VPO'7QP^$3^(I/
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M-GQM_MKPO_8^C-+J.J:O=>%[31M974+C^V/L\$VF>>CVT'DLLB%2;=9)/S[
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M]*\/>&KD/&6AV:H45F*G']'- !1110 4444 %%%% !1110 4444 ?9/[ _\
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M6JW_ /")'_R^H ^+:*^TO^&"/%O_ $6JW_\ ")'_ ,OJ/^&"/%O_ $6JW_\
M")'_ ,OJ /BVBOM+_A@CQ;_T6JW_ /")'_R^H_X8(\6_]%JM_P#PB1_\OJ /
MBVBOM+_A@CQ;_P!%JM__  B1_P#+ZC_A@CQ;_P!%JM__  B1_P#+Z@#XMHK[
M2_X8(\6_]%JM_P#PB1_\OJ/^&"/%O_1:K?\ \(D?_+Z@#XMHK[2_X8(\6_\
M1:K?_P (D?\ R^H_X8(\6_\ 1:K?_P (D?\ R^H ^+:*^TO^&"/%O_1:K?\
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M?W/-_=YG^=52$!@58 A@00>A!&"#[$<5_HK?\0O/[#__ #R/_?7C#_YMZ/\
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M<US>3*]S<2R-_>G_ ,0O/[#_ /SR/_?7C#_YMZ/^(7G]A_\ YY'_ +Z\8?\
MS;T2\9>#95Z>)EE><RQ-*G4HTJ\L#ESK4J5:5.5:G3J/,7.$*LJ5.52,6HS=
M*#DFXQ#ZAB+6YJ:3LVN>=FULVN36UY6^=MS_ #JJ*_T5?^(7G]A__GD?^^O&
M'_S;T?\ $+S^P_\ \\C_ -]>,/\ YMZV_P"(V\*?] 6??^$N!_\ GE_5GY77
M]GXCO2_\"EY?W/-_=YG^=517^BK_ ,0O/[#_ /SR/_?7C#_YMZ/^(7G]A_\
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MXC_^;&C_ (AZ_P!FO_H-+_X ^(__ )L:/^)T/"W_ *$O&_\ X;,F\O\ J?\
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M;?\ SD_JS\K_ ,4]%?VL?\0]?[-?_0:7_P  ?$?_ ,V-'_$/7^S7_P!!I?\
MP!\1_P#S8T?\3H>%O_0EXW_\-F3>7_4_\_P?8/\ B4GQ&_Z&_!__ (<,V_\
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MH>%O_0EXW_\ #9DWE_U/_/\ !]CE_P")2?$;_H;\'_\ APS;_P"<G]6?E?\
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M>+?^BU6__A$C_P"7U 'Q;17VE_PP1XM_Z+5;_P#A$C_Y?4?\,$>+?^BU6_\
MX1(_^7U 'Q;2@X.< CN& 96!X*LIR&5AD,I!# D$$$U]H_\ #!'BW_HM5O\
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MOQ.O=4U(.=/TVV\$7>OQ>(I=0OA')]DLDT\W-P4<11.5('R#X!_:B^-VO?\
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MGC7S-<\1W.E:4F74!KP'<,5^<'CC]O/]HS]C#_@G7^QMXJ^-^EZ7^TS_ ,%
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M^,7[#7P=_8I\._LU_LJ_&/XM_!-;;]J?Q/\ &%?B_P#&3Q%\!V5OB/K&F?\
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MF:O:3>,_#^I>#_$*3Z7IL=KX@L)=#MK8);M&+JXEN?>OA, /^#C7]K<#H/\
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M^-/C.VOV4>M^)[;4M<U6#2_ GA9Y]7L?M)\1ZM*EC'!%^+'PF77M)_X-ZO\
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M\+7?AKQIXCTK1M0M_#]Q\/M,CTD> - T2]L[;PGI TJ;2H=.NII)!^B7C/\
MX)=_MD>!?@A_P3+U_P *Z_\ LS?MS_M&_P#!._X1>/? ?C#]GS]H'6=4O?A3
M\>/#/C>Y@T*Q\3^!O$7B_3]0_P"$1^(O@W1](L/#?A;QQXU\.S645II][8S7
M G6.)_T1^*G_  1)_8A^)OQ=\>_&;2C\?_@AXA^+.HR:W\7?#G[./[0_Q/\
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MOC>QU'Q]I<<WB/XG:=XH\$W-QJFO:YXFU/Q*;R-EU::Y,UPMRWUO_P %+/\
M@F7HOAW_ ()(Z]^Q)^PA\ ;GQ):S?&7X&>*KCX?6>L6NJ>(?&\</QU\%>+/B
MKXT\:^*/'NO6MQXKU[5-'LM7UKQ1JVN:W/J>J1Q206RR%;6T7Z7^!O\ P1%_
MX)^? #X[^&_V@O!7P]\>:GXB^'U[JVJ?!WP'X^^+GQ ^('P=^ VJ:U)"]U??
M!;X8^*=:U'PUX#NK2WA_L[1WT^WD&B:;(]EI*V<0B$0!\+_LF_!SX$_MA?\
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M??[,'_!-K]N+P'_P46^#O[97Q=O/^"=_P;\+>$/A-\3OA/X_\!?L2>"OB?\
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MLNZ+X;U>\URZ\+?L[_#NSFU_5]2UU[S3[%=#\1?$+XA:M=ZQK.A64E];6O\
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MC0O#'A:+5[+1+RVO+N[\0_:;*V2)?$OV-_!?Q;_X)M_\%;[;]G']ISX@:/\
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M*_U+4M0NG::YN[J5SM38B@&U\7OCE\/O@[\/_C!XZ\0ZM::J?@I\*O%WQ?\
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M_!;QYH^J:SH'Q$\+?$.SL-(6[MM-BT35;3Q5:7&FQ'1[N")#-([RQ0?&D/\
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M*#]H3_@J3XZ_;D_X*%>%/B=\)?A3KGPJT;]M*+0_B_=ZK^U-X[\77/[.J?\
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MUM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY-H;9)9$_1G]M;_DS;]K7_LV7X\_^JL\5U\8?\$(?^4/'_!/#_LVKP5_.]H
M^@O^"=?[9]O^W9^S1I/QEOO"$?PV^(N@>-OB!\'OC=\+4U637/\ A67QH^%/
MB:]\*^._!RZO-8Z;-J5M;75M;:GIE[-I]E-<Z3JMA+-;0RLZ#[GK\%?^"35P
M_A[]OS_@NM\*M*6.+P;X;_;/^%/Q$T>TLU1-.M?$OQ@^"&F:]XY**D[@:A>:
MMI-M=ZF?(A+W#[W>1R1'^]5 !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\?:+_R>]XS
M_P"R':#_ .G^.OL&OC[1?^3WO&?_ &0[0?\ T_QU]@T %%%% !1110 4444
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M9_ C06A^'?P)&K65XB7]M?ZAX.\/2:\8[I8\VFLV<L,$,<N&_;NBB@ HHHH
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MX+I_B&YLX#!9:J$A9HEC;=,5<^;*S,\C?,QS7TE_PRA\+_\ G\\;?^%7=_\
MQJN9_8H_Y)/XB_[*Q\1O_3NE?7U 'S/_ ,,H?"__ )_/&W_A5W?_ ,:H_P"&
M4/A?_P _GC;_ ,*N[_\ C5?3%% 'S/\ \,H?"_\ Y_/&W_A5W?\ \:H_X90^
M%_\ S^>-O_"KN_\ XU7TQ10!\S_\,H?"_P#Y_/&W_A5W?_QJC_AE#X7_ //Y
MXV_\*N[_ /C5?3%% 'S/_P ,H?"__G\\;?\ A5W?_P :H_X90^%__/YXV_\
M"KN__C5?3&0.IQV_'THH ^9_^&4/A?\ \_GC;_PJ[O\ ^-4?\,H?"_\ Y_/&
MW_A5W?\ \:KZ8HH ^9_^&4/A?_S^>-O_  J[O_XU1_PRA\+_ /G\\;?^%7=_
M_&J^F** /F?_ (90^%__ #^>-O\ PJ[O_P"-4?\ #*'PO_Y_/&W_ (5=W_\
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MR1P<\@X(^H/!'8TM 'S/_P ,H?"__G\\;?\ A5W?_P :H_X90^%__/YXV_\
M"KN__C5?3&1G&1G&<=\>N/2B@#YG_P"&4/A?_P _GC;_ ,*N[_\ C5'_  RA
M\+_^?SQM_P"%7=__ !JOIBJ]W>6EA;3WM]=6]E9VT;37-W=SQ6UM;Q(,O+//
M,R111J.6>1U51U(H ^;_ /AE#X7_ //YXV_\*N[_ /C5'_#*'PO_ .?SQM_X
M5=W_ /&J^E8I8IXHYH9(YH9HTEBEB=9(I8I%#QR1R(2CQNA#(ZDJRD,I((-/
MH ^9_P#AE#X7_P#/YXV_\*N[_P#C5'_#*'PO_P"?SQM_X5=W_P#&J^F** /S
M/TK]G[P%-^U?XI\%//XI&D6?PDT?6X9%\0W"Z@;^?6D@D\V\\DR26PA.U+<X
M"O\ O-Y'R#Z8_P"&4/A?_P _GC;_ ,*N[_\ C5<MHO\ R>]XS_[(=H/_ *?X
MZ^P: /F?_AE#X7_\_GC;_P *N[_^-4?\,H?"_P#Y_/&W_A5W?_QJOIBB@#YG
M_P"&4/A?_P _GC;_ ,*N[_\ C5'_  RA\+_^?SQM_P"%7=__ !JOIBB@#YG_
M .&4/A?_ ,_GC;_PJ[O_ .-4?\,H?"__ )_/&W_A5W?_ ,:KZ8) !). .23T
M ]37G_PT^*_PR^,WAJ3QE\)?'_A#XE>$HM<U[PU)XE\$>(-,\2Z&OB#PMJES
MH?B313JFDW%U9G4M"UBSN]+U6T$QFL;^VGM;A$FB=  >3_\ #*'PO_Y_/&W_
M (5=W_\ &J/^&4/A?_S^>-O_  J[O_XU7TQ10!\S_P##*'PO_P"?SQM_X5=W
M_P#&J/\ AE#X7_\ /YXV_P#"KN__ (U7TQ10!\S_ /#*'PO_ .?SQM_X5=W_
M /&J/^&4/A?_ ,_GC;_PJ[O_ .-5],55LKZRU*V2\TZ\M;^TD:18[JRN(;JV
MD:&1X952>!Y(F:*:.2*0*Q*2(Z-AE8  ^<?^&4/A?_S^>-O_  J[O_XU1_PR
MA\+_ /G\\;?^%7=__&J^F** /F?_ (90^%__ #^>-O\ PJ[O_P"-4?\ #*'P
MO_Y_/&W_ (5=W_\ &J^F** /F?\ X90^%_\ S^>-O_"KN_\ XU1_PRA\+_\
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M\*N[_P#C5?3%% 'S/_PRA\+_ /G\\;?^%7=__&J/^&4/A?\ \_GC;_PJ[O\
M^-5],5%<7$%I!-=74\-M;6\3S7%Q<2)#!!#$I>26:61ECBBC0%GD=E5%!9B
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M\*N[_P#C5?3%% 'S/_PRA\+_ /G\\;?^%7=__&J/^&4/A?\ \_GC;_PJ[O\
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M5?3%% 'S/_PRA\+_ /G\\;?^%7=__&J/^&4/A?\ \_GC;_PJ[O\ ^-5],44
M?,__  RA\+_^?SQM_P"%7=__ !JC_AE#X7_\_GC;_P *N[_^-5],44 ?,_\
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M_@I)K6CZUX.&J_LH>#OV OV>W\768M9="\::?X#FU[]H_P 7:=;Q.9]+AO\
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M[4/%OA?X5>!OB)\6+0:-XCUZY_L>\TZ72?"&H:H+*'7["WNI8)+\QT >1?\
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M&UG>QBG<1Q29_@MXKG_@X[^+-U&K 7'_  21^&SH71HY1%+^TIJDBJZ, R,
MPW(P#(V00""*^(_^"2/_  51_9$_8>_8O^#O_!/[]J>]\;_!C]MG]GO4_%'P
MA\1?LSK\'_BEK_Q0^(_B)O''B&ZT+Q?X"T_P]X0U#3?%FG?$6WO8]7L-:CUA
M;5VDEN=1O8;>2"\N?MWP7,+C_@X[^+$P26+SO^"27PVF$<T9CEC$O[2>J.$E
M0Y"2KG;(F258$'I0!S/[*G[:_P"SA^RS_P $UOVV/VR? ?A+]IWQ=\-?@5^U
M+^TO+\0?#?QC^*.D_$3XFZYXO\+_ !2TKP3XN?P5K^K:G#HFA?#^/4+F.[\*
M>'KJXM&TK2;:Z%UY]],99^M\)_\ !=_X5Z[\1/@@GB?]D7]L+X6?LN?M(>._
M!WPL^"W[:'Q,^'%EX9^#7C/XB_$"U"^"]&_LF35IO'&BZ/XHUR.]\/Z#XHUO
M0K#2]3N+0:C!G2;F"];\:K-A_P 0UO\ P65/.!^UY^W<#\K9_P"3G=!!XQDC
ML< CK[U^H7_!9K;%_P $K_V03&HC\K]I?_@G$8?*3882OCWP6$,/E@&$H/E0
MQ["B_*I49% 'V1X>\5?!:Y_X+4?$?P1#!^T#_P +[T?]@3PAXQO[V^^)PE_9
MF3X;:I\7[C0[>ST7X3I>B2U^*8UNQ^TZCXMN;%K:30V^QV\R7#S;_&=2_P""
MW.E^(_B)\0--_9O_ &#?VT_VL?@-\(OB-JOPM^)W[4/P4\$^&;[X9Z1XJ\)Z
MA'8?$*#PGI.N>(]*\7?$6U\!%VEUNY\*:1=I,(I8M.^U2A5?D=-L+C5_^#AC
M]HC2+200WFI_\$?_  'I]M,Y=$BN+[]H+7[:"1I$^90DLBL60[U )'(%?$W_
M  2;_P""G'[)_P#P3G_94TW_ ()]?MFZGXN^!O[9'P$^*'Q:\)7OP1?X3_%'
MQ+X\^-\GB3XE>)?$?A#Q[\,(?#7A#5K3QU:?$*VU>*'2M0AU,^?<6<DM[=16
M@6\(!^V7[4/_  4"\3_!+Q9X7^''P2_8J_:J_;!^(WB#P1I'Q*U/1OA#X6T#
MPSX5\&>"=;DU:VTVY\5?$CXFZYX4\'6GBB[O=(GMH/ UE?WWB=5>.ZN[&TM7
MCED_/3]M;]NCX6?M^_\ !"?_ (*7?$WX>>'O&W@+7O 'P@^/'P9^,GPC^)ND
MPZ'\1OA!\7_ NF6L?B[X?>,+"UNKVQ.I:0U]:.M[IE[>:=>13J]O<%TFBB\V
M_P""AG[?WQ,\+_MT2?LX?%S]M77_ /@EG^R-/^S?X,^*/PV^-NG?!&R\4_$+
M]H/XH>(M3>3Q'X"T/QOXS\*>-?"O@[4/AO80PQ:SX/L-$G\4:W-?QQP$*N7_
M #&_9RU8:[_P1'_X.,]>'C?XG_$Z/6OCE^U!JT'Q*^,_@Z/P#\4_B%:ZC\,?
M 5Y:^-O&?@V#2]%CT#5?$]O/'K/V!-'TPI!>1,VGVCLT" ']C_['( _9%_97
M X _9P^!X ] /AEX8Q7T=7SC^QU_R:+^RQ_V;C\#_;_FF7ACL>:^CJ "BBB@
M#X^T7_D][QG_ -D.T'_T_P ==9^UE\&M:^/7P;U;X<Z9^T+\2?V8],U'5]"O
M_&GQ.^$>I:%X>\?#P)I=\EWXJ\+Z)XO\066H6O@@^*--232KKQ?9V<VJZ):R
MRW.G>7<;9%Y/1?\ D][QG_V0[0?_ $_QUA_\% _CC^R_\#_V=?$-U^V7X5\2
M^*/V;/B%<I\-OBLVD?#KQ;\2/#&A>%O$=I>'4=:^)FF^"K/4==TCX?00VC0:
MWKL-A=1V;7%M')$1." #\2_V:O!_B#]D'_@LS\&/V7OV2_VP?VD?VK/V</B7
M^S/\4/'W[5_@?XV_';4_VF-/^#7B[PS>VME\,/%1\=ZI'>3>!-8\8W4UQ:6G
MA1M2MKC51%?7IL9+&YL_LG8:%\+_ !S_ ,%C/VVO^"@&F_%+]IG]J3X%_LQ?
ML*_&33?V5?@U\,?V6?C'JWP,U#Q%\3M+\(66O_%?XI?$+Q;X7MI-7\62S7FM
M:19^$M#O)AI6CV4"M):S2/<F\^(/V=]:_89US_@JO^QI??\ ! &+7+;P#J,O
MBQ/^"D=W\%_#'Q T']E:?X(Z9H=Q>>"K+Q^/'6E:7I+?%I_$^I2S>&O[$W:F
MXEB,I>:"^B7Z@^!_[8?P%_X(Z_MZ?\%1OAC^WOXIN?V??AO^U?\ M(1?MD?L
MU?&#6O!_C36_AU\3-%\<>"],TCQQX-TK7?!_AK7EA\9>"M4\.0)J&@WD4-S+
M]J!M?/EN+47H!]$_\$T?%?[3_P 7_A/_ ,%'O^";WQ)_:D^(=O\ &7]B;X^7
MWP#^'7[7,%AHFM_&O_A3'CS0[7QI\)?$^N-KME<:!K7Q(T?PDUYHLWB+4+6\
M:61;2^O(KR\M#<77RI^TG\"OB-_P2Q_;I_X)BZC^R[^V+^V7\7[_ /:__:9U
M7X*?'7X(?M)_'O6_CWHOQ!^'<V@2^(M>\;:+X;UZQMH?"%YX/D#W]]J_AF#2
MK&R1]-CBBM;.WGM+KUG]@/XZ:3^S?\$_^"M__!9O]H'P?XV^'7P/_:7^/NI_
M&SX6>&-;\*:AH_Q(\3? KX/>$[?X:?##Q1)X6U""VU'2KGXL7"FZ\.6.L16O
MEV=W:ZO<3#2[^"]E^/\ _@G7_P %-/\ @GE\=OVF;'_@HA^W7^W!\&)?VQOB
MK8I\*?V6OV6M+M_&VK^'?V,OA/XSUV*WTKX<Z9?KX.^PZ_\ &_QY<3V/_"SO
M',+Q6K3W!T32Y8M+64* ?T%?\%:?VH-9_9*_8'^//Q(\%1W-W\6_%&A6?P8^
M!.EV+*-1U3XW?&F_@^'7PWCT]&93--I>O:]%XBGAC/FO8:+>&,;E!'@GA_\
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M7!!XNU2'P_X3TQ])M?"MCJ.FZ.J//J]X)YE93\J?\$(O&_Q?U#_AOSX0ZO\
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M^R_XN_9W^%_[0G[)?@SPEX0\'_LDWOA#QC=>,[SXU>'$\+^/?$_B^Y^(&O\
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M!W]DCPIJ=WI7B7_@H?\ M4?!?]C>6[TY)FU&'P#\0-:EU;XK&TD@EADM6O?
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M"?AJR\.>")_[9\23B\\8^*+B>T\,7.G1WFH->7B1BVF_5G]EWQ1X+_X(6?\
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MT@=?Y^_VD_V)_P!J']B_]@!O^"IOA#]O_P#;*\:?MT_!WP+X&_:<^,>C^/\
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M[7XGRVEN_P 3M-\'>)9VTD^+5GU"VGU 7D5I>&W$=O;^L?\ !PKXZU[X<_\
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MBG5I/#,*_#B#P;XTU271]"MK?Q7'JLL[>(+B[@G)TRYT>UC:*"=[>\N#!*B
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M#IME;6,3N!@.\=K%$C.!QN8$XXSBM&B@#S+XT_"/P5\?/A%\3?@C\1],76/
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M0EU:YGN4MKO4)?(:]^RP?<M% !7R3\&_^3F?VL_^OKX0?^H;=U];5\D_!O\
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MJ\?_ !"UG38;S4([&_\ $_B35+V]-DE_>BQM?LMD+NY%OYS_ &+110 4444
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M/PMXUG^''A>W\.36%SX/L9=&M-)U_6[B6?5=1AM+&XGMOV7_ &*/^23^(O\
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MS]K?]F7]N?\ 8%^)/[.'A?XV_!+X<_$OX(^+O!7[4^A?$34OAEXQ^&'Q*O\
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M%?S6\F^&:1&](_X*-_\ !/#Q9^UIXG_9U_:/_9V^,T?[.G[:G['OB7Q)XD^
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MCS_@F;^SKXA_9]_9F\!Q^(/VDOV@OVBW^('@/X8^+;*Z^/GBO3/%-SX#MIO
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MT\(^+?$OA"\U.3P;>7>G7NI7UQ?Z3>^(=+T'4SIJ6]RA:XU+2M.D4QRN\$:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /C3X*?\ )??V
ML_\ L:_A]_ZC>IT4?!3_ )+[^UG_ -C7\/O_ %&]3HH N_L4?\DG\1?]E8^(
MW_IW2OKZO@?PG^RU\>O MEJ&D^$?VE3H>D7VNZMKHL+?P':3*EUJ]S]HN)'E
MNM5FE>1VQO(98RP)6-<XKJ/^%'?M0_\ 1UMQ_P"&_P!,_P#EA0!]H45\7_\
M"COVH?\ HZVX_P##?Z9_\L*/^%'?M0_]'6W'_AO],_\ EA0!]H45\7_\*._:
MA_Z.MN/_  W^F?\ RPH_X4=^U#_T=;<?^&_TS_Y84 ?:%%?%_P#PH[]J'_HZ
MVX_\-_IG_P L*/\ A1W[4/\ T=;<?^&_TS_Y84 ?:%%?%_\ PH[]J'_HZVX_
M\-_IG_RPH_X4=^U#_P!'6W'_ (;_ $S_ .6% 'VA17Q?_P *._:A_P"CK;C_
M ,-_IG_RPH_X4=^U#_T=;<?^&_TS_P"6% 'VA17Q?_PH[]J'_HZVX_\ #?Z9
M_P#+"C_A1W[4/_1UMQ_X;_3/_EA0!]H45\7_ /"COVH?^CK;C_PW^F?_ "PH
M_P"%'?M0_P#1UMQ_X;_3/_EA0!]H45\7_P#"COVH?^CK;C_PW^F?_+"C_A1W
M[4/_ $=;<?\ AO\ 3/\ Y84 ?:%%?%__  H[]J'_ *.MN/\ PW^F?_+"C_A1
MW[4/_1UMQ_X;_3/_ )84 ?:%%?%__"COVH?^CK;C_P -_IG_ ,L*/^%'?M0_
M]'6W'_AO],_^6% 'VA17Q?\ \*._:A_Z.MN/_#?Z9_\ +"C_ (4=^U#_ -'6
MW'_AO],_^6% 'VA17Q?_ ,*._:A_Z.MN/_#?Z9_\L*/^%'?M0_\ 1UMQ_P"&
M_P!,_P#EA0!]H45\7_\ "COVH?\ HZVX_P##?Z9_\L*/^%'?M0_]'6W'_AO]
M,_\ EA0!]H45\7_\*._:A_Z.MN/_  W^F?\ RPH_X4=^U#_T=;<?^&_TS_Y8
M4 ?4_C#P-X)^(>CKX>\?^#O"WCG0$U+2]870_&'A_2?$VCKJ^AWT.IZ+JJZ9
MK5I>V0U+1]2MK?4=+OA +K3[Z"&[M)8;B))%ZFOB_P#X4=^U#_T=;<?^&_TS
M_P"6%'_"COVH?^CK;C_PW^F?_+"@#[0HKXO_ .%'?M0_]'6W'_AO],_^6%'_
M  H[]J'_ *.MN/\ PW^F?_+"@#['O;*SU*SN].U&TMK_ $^_MI[*^L;V"*ZL
M[VSNHG@N;2[MITD@N+:X@D>&>"9'BFB=XY$9&(.5X7\*^&/!'A[2/"/@OPYH
M/A#PIX?LHM-T'PQX7T?3] \/:)IUN"(-/TC1=)M[33=-LH02(K6RMH8(P2$C
M7-?)O_"COVH?^CK;C_PW^F?_ "PH_P"%'?M0_P#1UMQ_X;_3/_EA0!]H45\7
M_P#"COVH?^CK;C_PW^F?_+"C_A1W[4/_ $=;<?\ AO\ 3/\ Y84 ?:%%?%__
M  H[]J'_ *.MN/\ PW^F?_+"C_A1W[4/_1UMQ_X;_3/_ )84 7]%_P"3WO&?
M_9#M!_\ 3_'7V#7P!#^RM^T!!XWO/B#%^TXR>)[_ $*#P[=:J/ -G]HFTFVN
M%NH;-HCJIM?*291('$(FW<ER#BNO_P"%'?M0_P#1UMQ_X;_3/_EA0!]H45\7
M_P#"COVH?^CK;C_PW^F?_+"C_A1W[4/_ $=;<?\ AO\ 3/\ Y84 ?:%%?%__
M  H[]J'_ *.MN/\ PW^F?_+"C_A1W[4/_1UMQ_X;_3/_ )84 ?:%%?%__"CO
MVH?^CK;C_P -_IG_ ,L*/^%'?M0_]'6W'_AO],_^6% 'VA17Q?\ \*._:A_Z
M.MN/_#?Z9_\ +"C_ (4=^U#_ -'6W'_AO],_^6% 'VA17Q?_ ,*._:A_Z.MN
M/_#?Z9_\L*/^%'?M0_\ 1UMQ_P"&_P!,_P#EA0!]H45\7_\ "COVH?\ HZVX
M_P##?Z9_\L*/^%'?M0_]'6W'_AO],_\ EA0!]H45\7_\*._:A_Z.MN/_  W^
MF?\ RPH_X4=^U#_T=;<?^&_TS_Y84 ?:%%?%_P#PH[]J'_HZVX_\-_IG_P L
M*/\ A1W[4/\ T=;<?^&_TS_Y84 ?:%%?%_\ PH[]J'_HZVX_\-_IG_RPH_X4
M=^U#_P!'6W'_ (;_ $S_ .6% 'VA7R3\&_\ DYG]K/\ Z^OA!_ZAMW6+_P *
M._:A_P"CK;C_ ,-_IG_RPKD]'_9:_:"T+Q-XL\6:;^TZ]MK7C1M'?Q!?)X"L
MVFU)M"LFT_33.DFJO!']DMG>*+[/%$-C$.&." #[\HKXO_X4=^U#_P!'6W'_
M (;_ $S_ .6%'_"COVH?^CK;C_PW^F?_ "PH ^T**^+_ /A1W[4/_1UMQ_X;
M_3/_ )84?\*._:A_Z.MN/_#?Z9_\L* /M"BOB_\ X4=^U#_T=;<?^&_TS_Y8
M4?\ "COVH?\ HZVX_P##?Z9_\L* /M"BOB__ (4=^U#_ -'6W'_AO],_^6%'
M_"COVH?^CK;C_P -_IG_ ,L* /M"BOB__A1W[4/_ $=;<?\ AO\ 3/\ Y84?
M\*._:A_Z.MN/_#?Z9_\ +"@#[0HKXO\ ^%'?M0_]'6W'_AO],_\ EA1_PH[]
MJ'_HZVX_\-_IG_RPH ^T**^+_P#A1W[4/_1UMQ_X;_3/_EA1_P *._:A_P"C
MK;C_ ,-_IG_RPH ^T**^+_\ A1W[4/\ T=;<?^&_TS_Y84?\*._:A_Z.MN/_
M  W^F?\ RPH ^T**^+_^%'?M0_\ 1UMQ_P"&_P!,_P#EA1_PH[]J'_HZVX_\
M-_IG_P L* /M"BOB_P#X4=^U#_T=;<?^&_TS_P"6%'_"COVH?^CK;C_PW^F?
M_+"@#[0HKXO_ .%'?M0_]'6W'_AO],_^6%'_  H[]J'_ *.MN/\ PW^F?_+"
M@#[0HKXO_P"%'?M0_P#1UMQ_X;_3/_EA1_PH[]J'_HZVX_\ #?Z9_P#+"@#[
M0HKXO_X4=^U#_P!'6W'_ (;_ $S_ .6%'_"COVH?^CK;C_PW^F?_ "PH ^T*
M*^+_ /A1W[4/_1UMQ_X;_3/_ )84?\*._:A_Z.MN/_#?Z9_\L* /M"BOB_\
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M_IG_ ,L*/^%'?M0_]'6W'_AO],_^6% 'VA17Q?\ \*._:A_Z.MN/_#?Z9_\
M+"C_ (4=^U#_ -'6W'_AO],_^6% 'VA17Q?_ ,*._:A_Z.MN/_#?Z9_\L*/^
M%'?M0_\ 1UMQ_P"&_P!,_P#EA0!]H45\7_\ "COVH?\ HZVX_P##?Z9_\L*/
M^%'?M0_]'6W'_AO],_\ EA0!]H45\7_\*._:A_Z.MN/_  W^F?\ RPH_X4=^
MU#_T=;<?^&_TS_Y84 ?:%%?%_P#PH[]J'_HZVX_\-_IG_P L*/\ A1W[4/\
MT=;<?^&_TS_Y84 ?:%%?%_\ PH[]J'_HZVX_\-_IG_RPH_X4=^U#_P!'6W'_
M (;_ $S_ .6% 'VA17Q?_P *._:A_P"CK;C_ ,-_IG_RPH_X4=^U#_T=;<?^
M&_TS_P"6% 'VA17Q?_PH[]J'_HZVX_\ #?Z9_P#+"C_A1W[4/_1UMQ_X;_3/
M_EA0!]H45\7_ /"COVH?^CK;C_PW^F?_ "PH_P"%'?M0_P#1UMQ_X;_3/_EA
M0!]H45\7_P#"COVH?^CK;C_PW^F?_+"C_A1W[4/_ $=;<?\ AO\ 3/\ Y84
M?:%%?%__  H[]J'_ *.MN/\ PW^F?_+"C_A1W[4/_1UMQ_X;_3/_ )84 ?:%
M%?%__"COVH?^CK;C_P -_IG_ ,L*/^%'?M0_]'6W'_AO],_^6% 'VA17Q?\
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F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img12876764_16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_16.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "F!&4# 2(  A$! Q$!_\0
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M\2_\53XQ@$'BWQ+:HEKXEU*W0QVVJW$4;ND<H4RE%&]\#<1G%7_[)OO^AO\
M'/\ X5>J_P#QZGZ7_P ?OBO_ +';Q9_Z>;FMB@#$_LF^_P"AO\<_^%7JO_QZ
MC^R;[_H;_'/_ (5>J_\ QZMNB@#$_LF^_P"AO\<_^%7JO_QZC^R;[_H;_'/_
M (5>J_\ QZMNB@#$_LF^_P"AO\<_^%7JO_QZC^R;[_H;_'/_ (5>J_\ QZMN
MB@#$_LF^_P"AO\<_^%7JO_QZC^R;[_H;_'/_ (5>J_\ QZMNB@#$_LF^_P"A
MO\<_^%7JO_QZC^R;[_H;_'/_ (5>J_\ QZMNB@#$_LF^_P"AO\<_^%7JO_QZ
MC^R;[_H;_'/_ (5>J_\ QZMNB@#$_LF^_P"AO\<_^%7JO_QZC^R;[_H;_'/_
M (5>J_\ QZO/M7_:"_9^\/:I?Z'XA^/OP,\/ZYI5U+8ZKHFN_&+X<:-K.EWU
MNQ2XLM3TK4O$UK?Z?>0."D]K>6\-Q"X*21JP(JWX<^.7P.\9:O;>'_!WQN^#
M7C#Q!>^8;+0/"?Q6\ >)==O1#&TLQL]'T3Q#?ZE="&)'EE,%M)Y42-(^U%+
M [;^R;[_ *&_QS_X5>J__'J/[)OO^AO\<_\ A5ZK_P#'JVZ* ,3^R;[_ *&_
MQS_X5>J__'J/[)OO^AO\<_\ A5ZK_P#'JUIYX+6">ZNIX;:UM89KFZNKF6."
MVMK:WC::XN;F>5DB@M[>%'FGGE=(H8D>21U168<[X3\;^"/'VFR:SX"\:^#O
M'>C17+V<NL>"/%.@^+M)BO(U5Y+.74_#NH:E8QW<:,KO;/.LZ*RLT84@D N?
MV3??]#?XY_\ "KU7_P"/4?V3??\ 0W^.?_"KU7_X]6W10!B?V3??]#?XY_\
M"KU7_P"/4?V3??\ 0W^.?_"KU7_X]6W7)ZCX_P# .C^)M+\%:QX\\#Z1XUUV
M)+C0O!FK>+_#NF^+]<MY&F2.?1?"][J4&NZM [VURB3:?87$;O;W"*Q:&4*
M:/\ 9-]_T-_CG_PJ]5_^/4?V3??]#?XY_P#"KU7_ ./5MT4 8G]DWW_0W^.?
M_"KU7_X]1_9-]_T-_CG_ ,*O5?\ X]6HEU:R7%S9Q75M+>67D_;;2*XADNK+
M[1&);<7ELCM-:FXB(E@$Z1F:(^9'N3YJGH Q/[)OO^AO\<_^%7JO_P >H_LF
M^_Z&_P <_P#A5ZK_ /'JVZ* ,3^R;[_H;_'/_A5ZK_\ 'J/[)OO^AO\ '/\
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MI]V9)4>- 71E%0X.X%FVH9'D4VDY-1HX>348J\I-)MVBE>3>B5V^H?6,0O\
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MI)))MMM6225VWHE<<?&#Q3DU&/'?$\I-I1BLSQ#;;:222=VVTDDM6_4^^O\
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ME_VYX&\7^$_&^B><UO\ VUX,\2Z)XKT?[0HW-;G5/#]_J-@)U7EH3<>8!R5
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M7FE_M,?$[PQXTLOA-\$8/&G@6/1?AEX*\&-IGB*2]N86N[J3PWIMF^IPF.)
M+2],MN""=F37Y;_L&_\ !6[]O']N?_@IM^Q#\&/VE_BIX9\9?#OP[^TKKOBC
M2='T/X8>"?!5U#K6A?#_ .)FEZ9<RZMX;TVSU"YBAL;RYADM9IF@G\UFE1FP
M1VG_  :KQR2>._\ @H$$1W+?LUV4:A%9B9'U*]V(  <N^#M4?,V#@'%?E3_P
M145F_P""Q/['H523_P +T\;' !)PG@SXB,QP.<*JLS'HJ@DX )K2KD.24,R\
M2_891EM+^SLBP=7 >RP6&A]2J5LBQTZU3"\M-?5Y59+FJ2I<CG)<TFVKB]K5
M<<'>I-\]62E>4GS)5:27-=^]:[2O>WR/ZOOV\O&'_!R[IO[67Q=LOV(?!WA?
M4OV7(-2TD?"J]OM&_99N;N?3VT6Q;5#-/X^\2V/BV0C6#>*#J]K%(  (08/+
M-?AEHGQ'_P""COC+_@NI_P $X/#O_!3B#3=-^/'@?XF?#:'P_I&E:5\--,AL
M/A_XEU/Q)J6G2-)\*KS4/#EX;_4H=4<O+>2:A$$:&=(HRBM^E?\ P4N_8&_X
M+[_%S]M[XZ?$/]D?XI?%W0?V=_$>K:)/\.-(\._MJ2_#'1K.RM_#VG6NHK9>
M!E\::8-!5]4BNG>'[#!Y\A:YVMYNX_E7\'/V0O\ @H/^S!_P6*_X)E:S_P %
M#+[7O$'Q%^*'QS\-'P?XH\4?&FV^.'B'5/#O@F>2VN[&[\1IK.MWUA9Z//KD
M!LM/O+E(U6\GDM8PHF->?PVLJCDM3EQ' ,L9/A+'QA2RG"PI<2>U_L:4JRQ=
M9XRJYU8TXUOK_)0A*4U.3Y(J42JOM/:QNL4H_6(7=23=&WM8VY5RJRO\.NVG
M8_H;_P""A7BS_@X^TW]KSQW8?L#^$O">I?LKI:^#QX%O]9TG]F:X9[V72X3X
MI-Y<^/?$-GXV-M'JAD$AN;(/'$'_ +.651'G\M/^#I:[\ 3^!/V%KCXAGX96
MW[;Z^&-;E^->G_#FYANQ;>'Y=!T"74/MTRC^T'\.1^.%UE?!DFL[)YHSJ[68
M>-9BO8?MO?\ !6'X_?\ !/O_ (+V>-7UGXF^/_$/[+!L/A)X?^)7P5UCQ%K6
MJ^"-*\&>)_#EJ^K^+_!GA:ZN+C3O#_B?0KB9/$L=[H=G!/K<5K=:9=BY2^1H
MN(_X*Z?\$9]+^)7[:'[*G[07['NG3Z_^S[^W[\3?!ND>.+WPP]WKWAOP1XO\
M63IXFN_&VGSJ)XM)\$^-O!B:GXB@M/.^P6&K:3KT=O'86D]C9IQ\-8:GE.:\
M%XS-Z63Y/@WD-7,LOS+*,OGA:N;U)97'ZS@<\QD\2U+$T<._K<>6C*&*J2:A
M*G.?*JK2=2&(C3=2I+VJA.G4FG[-<_NRIP4;6<ER[WCU3LK_ &K_ ,$T?BEX
M/_X)"?\ !-;]@?5_B+IUMIWC#_@H;^U9X:F\67M^ACET+P5XZ6>&PU*X=E4O
M#I?A+3-#U#358JJR>)V7?D\?S2_\%T/V2HOV0?\ @I'\</"^AV+V?@'XK7D7
MQQ\ @1>7:1V'C^:>_P#$6E63!5\V/1O%/]IV\LA!;?. S-P:_IG_ ."OW[;_
M /P2!^$'QO\ AC^R#^U]^QU\:OVBM:_99\ ^#KGX>W'P[\5OX8\*_#Z#6]+T
MQ](TJWM]/^,OPXGN=?L]&\/:!=&[O=)NQ9VD]JEA>+'<7*-\L?\ !?+0_AI^
MWU_P39_8]_X*D?L^Z)XAL_#G@WRO ^OZ1KT4-[XK\/\ PZ\67L^D0:?XONK'
M4M9AMKGP9XRT<V^I7#ZKJ*SW6MVY>[:64O)U\*9CB\)Q#E>>XS+\SP=+C2MF
M-#&XS%1PZP&(K8VL\=P['"2AB:M:]/#47A5[>A07+4?)SQO(5:"=*=*,H2>&
M5/EC%RYDHI0K<UXI;OFNF]5K9Z'\8M%%%?O)YP5^SVE_\F6_L<_]<?C-_P"I
MR:_&&OV>TO\ Y,M_8Y_ZX_&;_P!3DU[W!/\ R<CP]_['6=_^L/Q8?CGC_P#\
MFDXN_P &1_\ K3Y(><T445_:1_FD%%%% !7Z@?\ !(']E;P9^UK^VIX1\%_$
MG3[?6_ASX(\/ZU\3/%_ARZD=(/$MOH#6MKHVB72(5:?3KKQ!J&EG5K4LJW6F
M)=0%AOK\OZ_3_P#X)!_M5>#?V2?VT_"/C7XDZA!HOPX\;^']:^&GC#Q%<QN\
M'ANW\0-:W6CZW<L@9H-.M/$&GZ8-6N=K+;:6]U.5/EU\)XG_ -O?\0[XT_U7
M^L_V_P#ZN9I_9?U/G^N_6/JT[_4O9_O/KOLO:?4_9?O?K/LO9?O.4^T\.O[%
M_P!?.$O]8_8?V)_;^6_VC];Y/JGL/K,+?7/:?N_JGM.3ZU[3]W]7]I[3W.8^
M^/VHO^"XG[2_PC_:H\8?#[]GC3/ACX3_ &?_ (*>.+WP#I_PY/@?29(?&EAX
M.U Z3K3:GK/E'4=!%_=VE]9V \+R:;!9V,5G)Y4UP)Y)OC?]L;XE_"#_ (*=
M?M=_!;3/V0?@EJGPR^(WQ.BTCP7XTN=:CT31-(\5^++V1;FY\2WFBZ&MVUO'
MX7LEU ZEKSW\]SK&BZ?%,=,AOE<2_:G[2O\ P0W_ &A_C'^U?XL^(7P(\1_#
M'7?V</C5XXO?B%#\3E\9Z81X(TKQ;?G5]?BO-$5FO=>GM+BYU"ZTE_#R7]C<
MVT]BEQ<6T@N5A/&Z_P#!/G]@+_@J1^Q]9_ O52FF^ IY-#_:,\4'Q-+XG\%>
M'M<\4Z!?>$--U& W<M_-H^N6=UJ)U[Q?);ZU>:9I6GW?V5+2SDM+@#^>N&<R
M\)LLI9)C?"W*JN9>(6"\-^(L<X\/PKS@L9A,DIUW0\1*="O1J8G,L9F\/J^!
MHYA3Q&,EF$Y*,*7-@JL?W;B++_$W,:F;83Q'S*EE_ N+X]R+!IYY.C&H\)BL
MWG2]MP+4K4*T*& PN6S]OBZV"J4,+'!0BW*HHXFF]E_^"-'["$WQ F_9*T_]
MO'Q!+^W#;^$3JTG@Z71-)_X0=M=33#JKVK:;'X=,\"?8]MZWAW_A8-QXJ@TM
MAJ#V4B$(?1_^"$/[.FB_!G]J3]J;0OB3XPT*W_:'^$FCZM\/=3^%;^$=4O[S
MP_I%AK]@S_$[1?',Z+I#Z9KA>&QMM(MX(-:GT^YBN+D1P2M#7Z"_%WX0?MZR
M?M4^*OBA^SM\"O\ @F6_P[O+>;QWX'_:;\?_  QAE^)R7#Z.C26?B'Q5X=\2
M1>*KW7[B19[6+Q;I]M'HDVFR6\UU>VZ"=(_A+_@D#\0/B-\6O^"F?[>'CGXI
MM\/[SXCZI\,DL?%]S\))_P"T/AY=ZOH?B71?#?VGPM>QZEK0O+"ZCTR FX.I
MW;3WK7&Z02;HU_-,;QAQ;Q3X5>(JQW'5//LNEP+D&;YC0_M#(<9G&79_BLZP
M-+&Y>\/E^28..69)C:%2M"KE>)E4S3+L1@Z='ZU&EB)^V_0L'PMPOPWXD<"/
M!\&3R3'KC#.<JP%98+.L+E6/R3#97B:F$QZKX[-\4\QS;"5J=.=/,:"IX#'4
M<54J/#2G0A[/ZV_8(T/]G;XFZ[^U[XZ\6?MH>)/VS?B7X9\,^(O!VN_$;Q5X
M \2:)-\"OA3J9\7WUQH?P[@\:Z)?ZI8O9W5QX@@U(Z3?ZA9ZC-HMK/:Z9%!<
M&&X_*']E_P#X)0?L>_MA7_[7&J_!S]ICXF7/PV^#&M>#['X9_$K5=.T2QTO5
MK;6O"=SK_BS5/&^D:OX,T'57M="U>RU.R@%C#X<WV-LLSO+N\\^R?\$*!%XD
M\:_\%*?A?97=C;^+?&GAW5;;P_9WUW#;_;'N]9^)6B-)'$S?:9(+&\U"R.H3
M112):Q7,+2$%U!]0_P""=/P0^+O[)_[)O_!6#X4_%/1K/P]\3/!GA6UU'4=.
MTK6K'Q%9VT>M_"#Q7X@TR6'5]$N);2<R:1J%M=2K#.);4R-%<".6.15[LUQ.
M;\!9UXM83A_CG-<!GU"?A'ALGPE:/#M&-7+,WQ.1TL;F5+)\%DV!PGL,MJ8^
M67067X7#8"C2S2M3Q="KBL33KQX\!0RSC7*O#+%9YP;EN-R6LO%"OFV)HO/*
MCI8_*Z&<5<)E]7,\3FF+Q*KYA3P4<?.6-KU\94J9=2GA:U+#4*E%_)O[+G[+
M?['VO_\ !0#X7?"3]A#]MG]I&:WU+X4?%G5?'_QC\$RZ5X.\4:#JF@_V:EEX
M9\+ZKJ?P[T>"]T;7H!<7&L2#2=4M9H(+ V.IMYK.ORUX:_9)^ _CK]I?]L[5
MOVK_ -KBX\!_#;X$^.O&D>HZWX@\3^#;W]H[XZ:_:7-]/M\-Z+K3Q+KFOWB6
MR-J.HVN@WEO=:I?6EG#!"3<SVW7_ /!O^/\ C8QX+P.%^$/Q6)P. /[(TT9.
M.@RP&>F2!U(K]*OV6OV>_A-XU\=?\%5_C3I7P<^&W[1G[77PS^./Q*M/A3\(
M_BC8V&O:/9VB6XO]*U)?!^J2K:ZI)J^L/J,4=U)"ES+=Z/%HNG7NG7=W]H;]
M"XLXCS+@+BKBW+:W$N?XR&"\/^"*%+/IX?AQY_+&YWQMC\'4Q.,S6OE^#RW+
M\.Z,XX6ICL3AY8+*L,HXFGA*N+C&53X;AC(LNXVX9X8Q]+A[),*\7QKQA7J9
M+"MGRR583)^%,!BZ>'PN6T,=BLPQM95(3Q,,%AZ\,5F.);P]3$T\-.48?FE\
M=O\ @G3^SKJ/["EQ^WE^QM\6_BWXD\">&M?DT/QIX(^/>A^%M+\61;=:T_0I
M9M.E\(6]I8VESIUSJ5G>S6<S:G%J&F7 GM;Z">(V\G8> /\ @DSX'_:M_8Z^
M%_[07[%7CSQ[XK^*>H^,] \$_&'X8_$2]\(W%EX,O)YHM-\6:E83Z%I&A7MI
M8^'YYHO$EHFH3:C+JGAB;R(6.HPM))^L7[03?M,>(/\ @B'\>+[]ICP?H7@[
MXK3W4&M7/PQ\%^%='\,6/PP\$KXP\*7.A>'KGPKX>:X.@?8=,236+BVU:6;5
M+2UU&(W\[*$(\V_X)A:5X&_X)6?LD6/[3O[5?B?Q#X5U3]KCQKX&T;PM\/8Y
M9,:-X:O9#'X?\1WOANYN;4/??V;>2^(_$>KB S:-X7:RCS(+CRS\Y_Q$_C:'
M V<8[*N)ZN9\79)XMXWASA'*,+/"<2QXMRU8+!8FKD6+Q."P&6?VOA,)A\3B
M\?3SRAA<)-1PM*,*CA7HM^ZO#KA&?&>5X+,N'*6 X7S?PQP6>\3YGB(8KA]\
M-9@\7B\/2S?"X?%8W,/[,Q.*KX?#8.>45<3B8.6)J2E!2I5(GY#_ +:/[ /P
M=^$O[47PA_8L_94\=_$+XQ_'_P 4W.CZ3\1W\6WWA9?!GAK7_$,5J^FZ1I[Z
M#X=TN]LY["V6_P#$'B)KZZU,:5HK6MO(/[1ANEK[NF_X(Z_\$^O"GQ \/?LK
M_$+]OCQ)8_MD>)-(MA8^%-+TC1(?!_\ PDNJ6@NM(TU]/N?#E\UM+?H\,FGZ
M!JGC[3/$>L6TT$]C:H;F!'A^-?P8L/\ @G+_ ,%?O@?^U1XOUF_UG]F;XV_$
M;6_&FD_$W4[V;4;;0;OX@:%J6B>);+7=;;[0)X?#%QXEMO$%M=R2NUWX6:&X
M!#PR*GTA\:?^"4_QV^*?_!431_VPO"GB_P  W?[,_B'X@^!OC1J7Q,C\9Z>+
M_0-,\*Z?I)U'1;:P61IM0GN)-(D&B:M82R:'%I\]M]NOK1H)U7KS'Q$S%Y;P
M;2J^*^9Y%D.*\+\RXJP_&+PF51Q?%/'^&Q\J.(X;Q:QN7XO#TEE4KP_U>PD*
M.,K1<<+*M5J0IU3EP' F 68<5U*7AIEV<YSA_$3+^&Z_"OUK,I8;AS@BO@8U
M:'$&&>$QN&K5)9DK3>>XF=3"4G&6)C2I4YU(/\F?V<_^"6UUXE_X*->(?V#?
MVCO$?B#PO_PCWA#Q9XK3Q;\-I=+CG\0Z;IEE8:CX7UO2'\1Z5K%O#I.NV=XT
MEQ;76GM>VMQ#+:>:#$9I/N[PC_P1-_8N^).O_&'X!?#C]MOQ1XH_:P^$NG7]
M_P"(/"MOHFE+X.\,S2W4L&CV&M0S>&[>?7#9R&TL/$T_A[Q8+G3+VY5KG3-/
M+P6LOT=\&/CS\/\ ]H;_ (.#=>\4_#'4[/Q!X4\(_L^>+?ALOB339(;G3=>U
M;PGIMHNMW^G7MNSPWNG0:CJ,FEV]XCE)GLI!&3&(V;R/_@E)%*/^"R?[=JF.
M0/':?&/S04;=&6^)OAQ?W@(RI+LJ_-C+,J]2!7'Q+QUXFXC YQG,N*,TX5Q_
M#O@SP3QU7R3!X'+%A:_$6/S3$8;&PQU',,%BL11PN(H7^L8&C4H-5?81G+DP
M\J-7MX?X+\.Z&+RK*8\-Y;Q)@L\\5N+>#J.;XO&9B\31R+!X'"U<)/!UL#C,
M-0JXFC5:='&5*=:/L_;N$>>NJU/\R_V#?^"9>G?M&6/QQ^+'[1_Q4'P$_9S_
M &<M3UCP_P#$;QC9+I\^L:CXBT-+AM8T_1+[4(K[2=.LM"CBMY]1U"?3]8GN
M9+[3]-TS3;F>\,]MV'[7'_!-'X)>%?V7K?\ ;2_8:_:#U7]H?X!Z1JW]A?$!
M?%.GQ6'BGPW.;V/3FU:'R/#_ (7DCM;&^N+2VU;1]:\/:7J5K'>VE];37T$I
M1?U5_P""9?C^V^)?[.'[>O[*/@'3O@EXD_:"T?X]_%7Q_P"%?AM\>?#MOXE^
M'WCW3=>U>QCLAXC\.3W5JVMV%MJ7AV73;ZYC=AHMS>Z+<W4?E;2WB/[;-U_P
M40^ '["'CKP_\6_A5_P3K^ WPI^+MQ)X9\:?"?X)>&AX,\?QW%YJ-D;;6="M
MM*\73>#O$FMW9L;6X9M(BUW4;.QA:2]@A\E2GL/Q%X\Q7BK4RU\3X+*)X?C#
MAW*<#PCF.-RK!9?F_"N.RW"XK&8O#Y=5RNMG>/S#,%7Q&*P.:T,TIX3"5Z=+
M 586J4HGDQX"X*P_AI3Q_P#J[B\TC7X6SS,\9Q3@,)F6,QV6<2X/,,1A\-A:
M^.I9A1RG!8+!.C1PV,RZOE\\3B*$ZF-A*\9R7\OM>M_ [X$_%?\ :2^)&D_"
M/X)^$I/&_P 1-=LM6U#2O#L>K:)HC75EH5A-JFK3_P!I>(M1TK285M+&"6<K
M/?1O+L\N!9)65#Y&!@ >@ YZ\5UO@GQ[XZ^&GB*T\8?#?QIXJ^'_ (ML(;NW
ML?%/@K7]4\,>(;*WOX'M;Z"TUG1[FTU"WAO;622VNHXIU2X@=XI0R,5/]=YB
MLPE@,9'*:F"I9H\-767U,QI5Z^ IXQTY?5IXVCA:V'Q%7"QJ\KKTZ%>C5G34
MHTZD)-27\LY>\!''81YI#%U,M6(HO'T\!5HT<;/"*<?;QPE7$4J]"GB)4^94
M9UJ-6G&?*YTYQ3B_Z5;K_@D)\7F_X)967@^#]E'PF/VYE^,$=[<ZFNJ_#9?'
M9^'HUV:5U?QZ?$HT1[#^RS'$=,773,8 (A:&0&OS\_X)V_L??$WPA_P5/^#W
MP9^-_@]?"/BCX,:N/C!X\T&^U+1=9BT;3?"7AW_A,O#][-J.AZEJ&DSQW&H2
M: T<EM?SB$W2-*H:-XQZQ=?\%0=0?_@EG9?!2']I?XZ#]LV/XP1^(+CQ*-?^
M):>)SX%&NS7#6;?%;[2$>Q_LQHU_L?\ MTL5 M?LA"UH?\$U/&7CKP[\&/\
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M HHHH **** "BBB@ HHHH _G;_X. /\ DEGPM_[*!9_^F/4:_ECK^IS_ (.
M/^26?"W_ +*!9_\ ICU&OY8Z_KGP?_Y(?!_]A^9_^I+/"QW^\S](?^D(*4$J
M0RDJRL&5E)#*RD,K*1@JRL 58$$$ @@BDHK]/.0]RB_:A_:A@CCA@_:>_:3@
MAA1(H88?C[\7(H88HU"1Q111^,5CCCC0!$C151% 55"@"N?\2?'3XZ>,X-/M
MO&?QR^-7C*VTG5+/7-)MO%WQ:^(?B>WTG7-.D$VG:WI<&N^([^+3M9T^8":P
MU6R2#4+*4"6UN(G :O+:*PCA<+&2E'#8>,D[J4:--23[IJ*:8[ON_O/=?^&I
MOVIO^CHOVE__ !('XO\ _P V5<=XR^,/QA^)%E::;\2/B_\ %CXC:;I]T;[3
M]-^(/Q+\;^.-/L+XQ/ ;VQL?%.NZM:V=X8))(#=VT45P89'A,AC=E/ ""Y*+
M(MK=M$[>7',MI<O#)(3@1QS+$8Y)"01Y:,SY!&W((#98IH'$=Q!<6TA7<([F
MWFMI"N<;A'.D;E<\;@I7/&<T1PN%A)2AAZ$)K6,HT:<9+I=-136]M'U"[V;?
MI<[3PG\3OB=X M-6L/ 'Q,^(_@&PU]537['P-X\\6>#K+7D6%[=4URT\-ZQI
MEOK"+;R26ZKJ4=RJP220@")V4\0222222Q+,222S,269B>2S$DDG)))).37Z
M@^%/^":=YK7['G[+O[5WB/XTV'A"_P#VL?VK-"_9J^''PKN/ TNHW[Z/JGBJ
MU\,ZC\5?^$E3Q7:+>:=HPN/[1?PW'H$-Q=1*D)U>V,GFIZ[_ ,%:/^",'Q7_
M ."5EK\+_%.J?$NS^.?PO^);:GHQ^(&D^"9_ L7AGQQIPENX_"6K:/-XG\6,
M?[5T5!J>D:K_ &A EZ]OJED+-&TXS3^13XBR%YC2RV&-HQS#&XC&X6C2="O3
M>)Q.5OV>,I1KRHQHU)X=W@FZK4Y1G"BYRA)*G3J<KGRODBHR;NK14]8MJ]US
M>FF[L?DAX1^(?Q$^'TFI3?#[XA>/OA_-K-H+#69O GC7Q/X,EUBP!+"QU:3P
MUJNEOJ=D&)86E\T]N&)81Y)-9.A>(_$?A;6[+Q-X6\1>(/"_B;3+B2[TSQ+X
M:UO5/#_B+3;N5)(Y;O3M=TB[L]6L+J6.::*6YM+R&:2.::-W9)9%;]1OVI/^
M"6NJ?LR?L ?LJ_MX77QMT_QG8?M0:GH^FVGPP@\!7.A7?@PZMX=\1^(/.G\6
MR>*M4AUX6H\/M9NB:!I)E>[69&"PLDGY0JDDC+'%')-+(RQQ0Q(TDLTKL$CB
MBC0%Y))'*I&B@L[L%4$D"N[ 8[+LTI5\3@:E/$4O;U\'7J*C.GS5\)4EAZ]*
M:K4Z<IJE-3IWM*G)7Y)2B[M2C*#2DK-I26J>DDFGHW:ZL^_<]T_X:F_:F_Z.
MB_:7_P#$@?B__P#-E7)ZU\9_C/XDUWP_XI\2?&7XO>)/%/A*5[CPEXH\0_%#
MQWKGB7PG/(RO)/X6\0:KK]WJ_AR>21$=YM%O;&1W1'9BR*1^Q&O?\$+/C!HW
MQ[_8;_99B^,GA*X^/_[77PSO_C#X]\&W/AFZLM+_ &<? &F:>=5O=3\0:]%X
M@OI/&M[%9V>NPKIUCI/AYY=5T@V,<IANX[Q/+/VR?^"0?Q$_9I^)7[*GA3X2
M_%WPW^U/X%_;(\1R>"O@Q\0O!OA+6?"%U?\ C33/$\'A?Q'H6J^#M2O]9NK5
M=)NI9KNVO;;5[Q=1L].U-WAL7MD6;Q\/Q!PK5KX:AA\5@E6QF'Q%?#VPM2E&
MIAZ#Q=.M4]M+#PI0A-8+&2I*=2/UFCAZU:@JM&+F6Z=9)MQE:+2;NM&^6RM>
M]_?C?31R2=GH?D_XF\5^*_&VLW7B/QMXJ\3^-?$=ZD,=[XC\8^(=8\5>(+V.
MWC$5O'>:YK][J&J726\0$5NEQ=R+!$!'$$0!:[O2?C]\?O#^DZ1H&@?'OXYZ
M#H'AZ.&+P]H.A_&+XD:1H?A^*V1X[:+0='T[Q-;:=HL=O'))';IIEM:K!')(
MD0178'U/]I[]G7P?^S=^UQX\_9B'QFL_'N@?#+X@Z1\.O&?QCT[PA)I.CVNI
MK+IMOXWU'2/#?_"1ZM-JVE^#KB[O889O[<M9->;2Y]L>F&153UG_ (*1?\$^
M/'/_  3F^.FC?"CQ'XQL/BCX,\<> ?#GQ+^%?Q<T?0Y?#>D>/_"FNV^+BYAT
M.;5=<ETF[TC58KO3+FTEU6[:9(8-0C9;:]@!]../RJO/+<*Y4I2S'"3QN6T:
MN&J05?#T:=&525)5:,8TZE.EB:4G0GR5U3E*7LN6%1QAQFN9V:Y9<LVFG:3;
M23LWNTU=7C=6O=J_PIXB\2^)?&&LWWB3QAXE\1>+_$FJ/%)J?B/Q9KNK>)O$
M.IR0PQVT,FI:YKEY?ZK?O#;0PVT+W=W,T5O#%!&5BB1%W(?B9\3+;P;<?#FW
M^)?Q&M_AS=N\EU\.H/'?BR'X?W4DMPEY))<^"(]77PO<227D<=W(\VE.SW<:
M7+$SHL@XFBO2=.FXPBZ<'&FXN$7&+C!PTBX*UHN*TBU;EZ6)N^^^X44458!7
M[/:7_P F6_L<_P#7'XS?^IR:_&&OV>TO_DRW]CG_ *X_&;_U.37O<$_\G(\/
M?^QUG?\ ZP_%A^.>/_\ R:3B[_!D?_K3Y(><T445_:1_FD%%%% !00""",@\
M$'H1Z&BOT7UW_@GOJ6B_\$Z?#/\ P4%_X6O97=AXD\4_\(PGPG7P?/#>VDG_
M  FFL>#OM;>,F\0O!,-^DG4O('AZ(>7<+;>?OB:5O%SCB')\@EE$,WQBP<L^
MSG!\/92G0Q-;ZWG&/A7GA,&GAJ-9476AAZS]OB'2PT.1^TK0<HI^OE.19KGD
M<TEE>$>*CDN4XK/,S:K8>C]5RO!3HT\3BG]8K4O:JE/$45[&A[7$3Y[TZ4DI
M-?$^B?%GXL>&=%/AOPU\5/B;X<\.%)8CX>T#X@>+]%T'RIP5GC_L;3-9M=-\
MN9699H_LVR125<,"17GY ;<6^8NS,Y;YB[.2SNY;)=G8EG9B69B2Q))-?2?Q
MI^$WP,\ >"?AAX@^%?[3-G\</%GC'3;:[\>^!+3X1^.?A_-\+;^;1[.^FTJ;
MQ#XG9]+\9O;:I<7&B?:_#X$,TEF;Z,&VN(L_.8MKLNT0LKXRHH9XA971D13R
M&>,0[U4]F8 'L36V5XG+L90GC\!AZN&AB:U95I8K*L;DV+K5</6J4*E2OA<R
MPF"QLE[2,W1KU:/L\13E&OAZE6A5IU)YYGA\PPE:G@<=B*>)EAZ5)T5ALSPF
M;86E2KTH5H0HXG 8K&82+5-Q56C3J\]&<94:T*=6G.$>\@^+OQ<M?#__  B=
MK\6/BA;>%/LAL/\ A%[?XA^,8/#?V!D\MK'^PHM:32OL;1_(UK]D\@I\AC*\
M5A>%?&OC3P)<W-[X%\9>+?!%[>6HL;R\\&^)M<\+7=Y8AQ(+*[N=!O\ 3Y[F
MT$BK(+:>1X!(H<)N -<R6 !). "0=W!4@X(8'!# \%2 0>",\5+)#<0JKS6U
MU CD!'GMIX48GH%>6-$8GL 23V!KJ^I8)0K4OJF%5/$R<J]/ZO14,1._,Y5H
M<G+5E>S;FI.^MSG^NXZ4Z55XO%RJ8:*C0J>WK.>'ALHTI\]Z4;:)0<5T-O0/
M%GBSPIK/_"1^%?%7B;POXBQ=+_PD/AOQ!J^@Z\5OCNO5.LZ3>6FI%;UOFO%-
MR1=-\TXD/-=$WQ;^+3GQ"7^*WQ.<^+E1/%I?X@^+V/BI([9K*-/$Q;63_;Z1
MV;-9HFK?;%2U9K90(6*'A8[6[E7?#9WLR$D"2&SN9HR1P0)(HG0D'@@-D'@X
M-));74(#3VEW I.T//:W$"%L$[0\L2*6P"0H.2 3C -%3"8&K4YZN&PE6KRP
MI\]2C1G4Y*<U4IPYI1<N6G4C&I"-[1FE.*4DF%/%8ZE3Y*6)Q=*ES3J<M.M6
MA3YZD'3J3Y8R4>:=.3ISE:\H2<9-Q=C7\-^*?%'@S5(]<\&^)_$?@_6X8)K:
M+6O"FNZKX;U>*VN%"7%M'J>BW=C?);W" +/ LXBF55$B, ,:.D?$'X@>'M>O
M_%7A_P ?>.=!\4ZJ9SJOB?1/&'B/2/$>J&Y?S+DZGKNGZE;:KJ!N)/WDYN[N
M8RR?/)N;FN5CAN)D,L-M=31+D-+#:W$T0V_>S+'&T8V_Q9;COBOH_P#8^_9U
MN/VMOVC_ (9?L\V7B^W\"7'Q)OM:LHO%MQHLGB*#2#H_AO5_$)D?1HM2TA[[
M[2-)-DJC4K41/<"9F98S&W)FV(RC+,OS7.,V6'IX# 9=B<7FN*J89XAPRW 4
M:F,Q#JTZ5*M7KTZ-*G4JJA"G5G)IJE3E4DD^G*Z.;9ACLLRK*Y8F>-QN88?#
M97AJ>)^KJ688VK3PU#V52I5I4*%6K4G3INO*I3C%-.I4C!-KRF3XK?%6:W\1
M6DWQ1^)4UIXPD:;Q?:S>/O%LMMXLE:WCM&E\3V\FL-#X@D:TABM&?5TO&:UB
MBMR3#&B#.\3>/O'OC6VTRS\:>.O&OC&ST6-H=&L_%OBSQ!XEM-'A:)(&BTJV
MUO4;Z#38V@BC@:.RC@4PQI$1Y:*H^V?$?[&GPA^&'[6GQM_9D^/'[66G?"/1
M?A#"8-/^+$OP7\:^.+7QMKQ31;B+0H?!G@W4M3U30&DL]4NKDZC>:C=V*?V:
M\)<RW4*CX+U.RMK;6=3TW2;Q]=L[34M0M=-U*VL;JW;5]/M+N:&TU5-.D5[R
MS2_MDBO/LMP#/:"<03GS4:N#)LRX>S=T<3E&'<X2R_+<WPN.>1X_ X6K@<VP
M<:F!KX+,<7@,-A<14G@XPC7P^%Q%3%8*G[*CCJ.&<J<'VYM@,_RN-6AFF(Y9
M+'8_*\3@EG6"QF)IXS+,5*.+HXO 8;'8C$T:<,7*<J%?$4(8;%U/:5<'5KI3
MFM[7OB'\0O%>DZ;H'BKQ_P".?%&@Z-Y8T;0O$OC#Q'K^BZ1Y,(MHO[*TK5M2
MO+#3O*ME6WB^QV\/EP 0IMC 6K=M\4OBC9>&7\%67Q.^(]GX+DM9;*3P=:>.
M_%=MX4>RGSYUD_AN#5X]%:SFR?-M39&"3)WQFOM_]G+_ ()ZZG^T)^R!^TE^
MUG%\5;7P=;_LZ7>K6EY\/[OP7<ZK>>*3I?AK2?$FY->'B#3!H9N5U46:))HV
MI&-H#.Q*R!%_.1&WHK8QN56QZ;@#C]:,LS/AK.L1G&59:\)BJW#.:0P>:X58
M&I2IY?FE7#4<?!1]OAJ5"K5EA\32K_6,)*M!.I9U544HHS' <1Y10RO,LP>+
MPU+B++9XK+<2\=&I4QV6TL14P4W+V.(J5J=*-?#SH^PQ4:4OW::IN'+)[_AK
MQ3XH\%ZG'K?@SQ/XC\':U%!-:Q:SX3UW5?#6KQ6MPJK<6L>IZ)=V-\EM.JJL
M\"SB*4*HD1@HQI:-\0OB#X<UW4?%'AWQ]XY\/^)]7$XU?Q+H7C#Q'H_B+5A=
M3)<70U37-.U*VU341<SQQSW O+N833(DLFZ158<IY-P1&PMKHK,2L+"UN"L[
M#.1"PC*S'@\1EC@$] :9(KPLR31RP2( S1SQ20R*I!(8QRJCX(!P=N#CBO<J
M8;"UI5'5P^'JRK4U2JNI2ISE5I1DVJ51RBW.G&;;4)7BI-NR;/'AB<71C35/
M$8FE&C4=6DH5:L(TJLXI.K349)4ZDH**<XVE*-DVU8V=,\2^)-$UI?$NB>(_
M$&B^)$FGN5\1:/K>J:7KZW%R6-S<#6K&[M]3$]R79KB;[5YD[,S2LY))TO%?
MC[Q[X]FL[CQWXZ\:^.)]/61-/G\9^+/$'BJ6P2;'FI8R:_J.H/:++@>:MN8Q
M)@;P<5^AWAC_ ()L:AK7@K]@OQ'K/QET_P -^(OV[_B/<^#/#?@N3P5+?WO@
M/PU;:G=Z9_PG5]?+XIM?^$BMIW32IX=)ALM()BUB /J*/$PDY[_@HS_P3A^(
MG_!._P 8>#=)\0^++?XF^"/'VC75[X<^(6G>')O"]K+KNENW]M>%[W29=7U[
M[)?V-LUK?6\O]I2+?6=R95BA,#J?BL)Q[P#F'$>79%ALVP53B+'1SJCE5&>
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M_P#'[XK_ .QV\6?^GFYK8H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6(UX0]N[J495*<%"Z]^A&+IOEUM;ELU9I7:U/T[_ ."V_P )O&_P'_X(?_\
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M<NK5VGL[_P JM%%%?K)R!1110 5^SVE_\F6_L<_]<?C-_P"IR:_&&OV>TO\
MY,M_8Y_ZX_&;_P!3DU[W!/\ R<CP]_['6=_^L/Q8?CGC_P#\FDXN_P &1_\
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MGXCO2_\  I>7]SS?W>9_G9T5_HF?\0NO[$_JW_?WQK_\W-'_ !"Z_L3^K?\
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M * L]_\ "7!?_/$7]GXCO2_\"EY?W/-_=YG^=G17^B9_Q"Z_L3^K?]_?&O\
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M /\ B4KQ(_Z&O"'_ (<<U\O^I)YO[O,_BRHK^TW_ (AY?V<O^A@'_@'XF_\
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M(?@WX%:%^SM\:_A9\1]%T6:>'4K+6/AYK=QX3UC2I%:6XLI_[!TO7-(N[6U
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MU3Q%MTM&U4 Z<IN@ ?HM17X+_LE_\%SO@=^T1^WE^U%^Q_J^H3:=8^"_B?\
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M13:JFAC4?LYU3^S8S?-9B9+5HYF210#J:*_F\^-/QT_X*F_\$^?VA_V&-?\
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MM=52QFN+@V_GR 'Z+45\!?M=?#G]OSXG^)] T3]ES]JGX2?LA_#/3_#=[?\
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M"_PA\!:?+J7@;]FOX9VL>HSZE=Z3X$BNS<>/_%]S 3XB\837VK,L.FVMKO\
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M^"277PJ^ FD(3O:>#4=!T'5/&$!MR8[I?$L,P199&4?CO_P5'\8_\$3OC/\
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MJ]:Y:Y1==LY-0LS#B 1_7L<<<,<<,,:111(D<44:*D<<:*%2.-% 5$10%1%
M55     H _SS/AA\+O\ @D;X4_X)4?$KP7^T#<3>&/\ @KA\"+?XL_"7PWX:
M7XF?%IOVN=$_:4\.^.?%J_ X_ OX;1>+8]3TKP_XDU>Y\/ZYH,7@3P]!X2O-
M)NM4U^[:9H;V]C_L/^#W[9'A[X,:/_P3M_93_; \6:EH_P"V[^U3\#X)M/\
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MW%*D\;I(B?*KJ0.E?0E,CCCACCAB18XHD6.*-%"I'&BA41%  544!54
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M;;5O$VNP6SV$^H7&OW>G3P7$$5JX?[PH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OEOPM_P G;_%/_LEO@W_TM2OJ2OEOPM_R=O\ %/\ [);X-_\
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MB/6?@W\.O'>DZ+X.\0M\*[/2=!OT^&L.MZ9=>+_ &A)':K8^']*\<^%K34_
M^J76FVL=UI^AZ]J,FF"&[$$B '<?!#X_?#;]HCX#_#S]I'X6ZAJNL?"OXI>
MM,^)7@S4[[0-6T75]1\)ZQIW]J:?=R^'=3M;?6;.ZN;,B2.PN+1+IBR*L9+K
MG^1?_@I_XR_X(O?%3X:?$+]N/]D7X^0VG_!5#P_XVTSQW^SE9> /BC\3M>^/
M&I?M,V-SI6D:1\/;[]ESQ[K&O:7I<6IJ8=,\8>'X/AGX>-KIL$]W]LA2.7[5
M_9;X/\(^&? 'A/PSX%\&:+8>&_"'@W0=)\+^%_#^E0+;:;HF@:%80:9I&E6%
MNGRPVEA86T%M @SMCC7))R3Q<?P&^!L7CUOBK%\&?A1'\4&N)+QOB1'\._""
M>/6NY59);IO&"Z./$)N)$9DDG.HF5U9E9B"00#YGM/VU/ _P;O/V$_@3^U3K
M<GA#]JK]L?PLND>&/"&D^&==U#2M3^*/@OX?:-XJ^)^EW6IZ;87&E>%[?3;F
M]GCM3K-S9VT]P18V<LLB@'^:*T^#'_!)KPG^W7_P5L\"?\%@YO!.@>*]5_:+
MG_:#^"%Q\>_B7\1O!7@KQ7\#OBO\/-'F/B7X/Z%9^*='\(^(?%_AS4M)NO#?
MB'5O#NGZEXYT^9=)T9)(8'CM)/[*=5\'^$=>UKPYXCUSPMX<UGQ#X/GO[GPE
MKVJZ)IFHZUX6N=4MA9:G<>'-4O+6:^T2?4;-1:7\NF3VLEW; 07#21 )7+>/
M/@M\'/BG?:+J?Q.^$WPS^(VI>&G:3P[J'CSP)X6\7WV@.\T5P[Z+=^(-*U"X
MTIWGAAG9K&2 M-%%(27C1@ ?S/?!7Q-X^\&?\&S'[4NO_'QO'UWX+L_@Q^US
M!\"G^+$=W+\1;W]FC5]<\5:7^SM_PE=OKLDVNQZC<>&=0T6/3K7Q"[:Q;Z4V
ME0LL<4=G$G[Y_L ^'M<\*?L-?L?^&_$KS2:_HO[-7P5L-6:YBC@N!>P_#SP^
M)HYH8OW<4L1_=.@Y5D(8!MPKB/\ @H5^R#XD_;>^!OAG]G?2_'^G?#OX=:S\
M8_A)XG^-Z2:1=:E?^-O@[\/?%MCXP\0_#'0TMKJTL]/G\9WFBZ1I5W?:C'=V
M,&D?;HC92O-&4^ZK6UMK*VM[*S@BMK2T@AM;6V@18X;>VMXUB@@AC0!8XHHD
M6.-% 5$4*  !0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!\:?!3_DOO[6?_8U_#[_U&]3HH^"G_)??VL_^
MQK^'W_J-ZG10!X9^S)\8_&OA'P%K^E:+\"/B%XXLV^)'CB\.M:!/I"6"SW>I
MK)+8$7<T<AN+,@).0"I9AM_B"_17_#1GQ+_Z-8^+G_@5X>_^2JJ_L4?\DG\1
M?]E8^(W_ *=TKZ^H ^2_^&C/B7_T:Q\7/_ KP]_\E4?\-&?$O_HUCXN?^!7A
M[_Y*KZTHH ^2_P#AHSXE_P#1K'Q<_P# KP]_\E4?\-&?$O\ Z-8^+G_@5X>_
M^2J^M** /DO_ (:,^)?_ $:Q\7/_  *\/?\ R51_PT9\2_\ HUCXN?\ @5X>
M_P#DJOK2B@#Y+_X:,^)?_1K'Q<_\"O#W_P E4?\ #1GQ+_Z-8^+G_@5X>_\
MDJOK2B@#Y+_X:,^)?_1K'Q<_\"O#W_R51_PT9\2_^C6/BY_X%>'O_DJOK2B@
M#Y+_ .&C/B7_ -&L?%S_ ,"O#W_R51_PT9\2_P#HUCXN?^!7A[_Y*KZTHH ^
M2_\ AHSXE_\ 1K'Q<_\  KP]_P#)5'_#1GQ+_P"C6/BY_P"!7A[_ .2J^M**
M /DO_AHSXE_]&L?%S_P*\/?_ "51_P -&?$O_HUCXN?^!7A[_P"2J^M** /D
MO_AHSXE_]&L?%S_P*\/?_)5'_#1GQ+_Z-8^+G_@5X>_^2J^M** /DO\ X:,^
M)?\ T:Q\7/\ P*\/?_)5'_#1GQ+_ .C6/BY_X%>'O_DJOK2B@#Y+_P"&C/B7
M_P!&L?%S_P "O#W_ ,E4?\-&?$O_ *-8^+G_ (%>'O\ Y*KZTHH ^2_^&C/B
M7_T:Q\7/_ KP]_\ )5'_  T9\2_^C6/BY_X%>'O_ )*KZTHH ^2_^&C/B7_T
M:Q\7/_ KP]_\E4?\-&?$O_HUCXN?^!7A[_Y*KZTHH ^2_P#AHSXE_P#1K'Q<
M_P# KP]_\E4?\-&?$O\ Z-8^+G_@5X>_^2J^M** /DO_ (:,^)?_ $:Q\7/_
M  *\/?\ R51_PT9\2_\ HUCXN?\ @5X>_P#DJOK2B@#Y+_X:,^)?_1K'Q<_\
M"O#W_P E4?\ #1GQ+_Z-8^+G_@5X>_\ DJOK2B@#Y+_X:,^)?_1K'Q<_\"O#
MW_R51_PT9\2_^C6/BY_X%>'O_DJOK2B@#Y+_ .&C/B7_ -&L?%S_ ,"O#W_R
M51_PT9\2_P#HUCXN?^!7A[_Y*KZTHH ^2_\ AHSXE_\ 1K'Q<_\  KP]_P#)
M5'_#1GQ+_P"C6/BY_P"!7A[_ .2J^M** /R[TSXS>-XOVJ/$WBE/@)\1)M6N
MOA1I&ES>#DGTC^W+.TAU:.=-9F<S_9/L,\F+>,!S)O.X@#@?2'_#1GQ+_P"C
M6/BY_P"!7A[_ .2JI:+_ ,GN^,_^R':#_P"G^,_SK[!H ^2_^&C/B7_T:Q\7
M/_ KP]_\E4?\-&?$O_HUCXN?^!7A[_Y*KZTHH ^2_P#AHSXE_P#1K'Q<_P#
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M^&+&X\*Q3Z-_:^F6]M<H\6I7;&?[,;6[8^7"$D+AL%P 3M_2ZOEOPM_R=O\
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M .&C/B7_ -&L?%S_ ,"O#W_R51_PT9\2_P#HUCXN?^!7A[_Y*KZTHH ^2_\
MAHSXE_\ 1K'Q<_\  KP]_P#)5'_#1GQ+_P"C6/BY_P"!7A[_ .2J^M** /DO
M_AHSXE_]&L?%S_P*\/?_ "51_P -&?$O_HUCXN?^!7A[_P"2J^M** /DO_AH
MSXE_]&L?%S_P*\/?_)5'_#1GQ+_Z-8^+G_@5X>_^2J^M** /DO\ X:,^)?\
MT:Q\7/\ P*\/?_)5'_#1GQ+_ .C6/BY_X%>'O_DJOK2B@#Y+_P"&C/B7_P!&
ML?%S_P "O#W_ ,E4?\-&?$O_ *-8^+G_ (%>'O\ Y*KZTHH ^2_^&C/B7_T:
MQ\7/_ KP]_\ )5'_  T9\2_^C6/BY_X%>'O_ )*KZTHH ^2_^&C/B7_T:Q\7
M/_ KP]_\E4?\-&?$O_HUCXN?^!7A[_Y*KZTHH ^2_P#AHSXE_P#1K'Q<_P#
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M9]#34M?U$LW]HZW/:Z;!_:NH!F%]?+/=!F$NX_T'?\%)/CIXU_9D_8%_:_\
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MXMB\%U\/X/%NDLB6DHN;/26@T\Z1<3V%G>23)6_:'^(?[*8_X(V?\%./A_\
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MH]?U?]F[X+WVK+<3)<3F]F^'OA]IGFGC"I++*?WCR  LSDMELFOK.@ HHHH
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M47?Q1T[X;^$O$VKV_BSXQGX::26OO%5SX6M;>TCFAN-.TZ>^NX)%7"_X)_\
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M\$>$(?A[X<_L;2/A3<:793> =,T6&T9IQ=--7NG_  10\/:SXZ^!GQI_;O\
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M2VDN1/$(//1OZ!XRS(C,-K,BEAD'#$ D9'!P>,C@]J 'T444 %%%% !1110
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MQXV^'&CV:7-]XDUJ%+.7Q!]E\0V6B^(9=.L(];T;4+2%[63]&/\ AI3X!_\
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M0](@TCQQ=>"=#*)'IGA+5O'^HZ(L");WEI>0(D:_I/\ \-*? /\ Z*UX(_\
M!U;_ .-'_#2GP#_Z*UX(_P#!U;_XT >WU^>O[)7_  3&_9<_8J^.W[3G[0WP
M0TSQA9>.OVK/$@\1^/;/Q!X@M=6\+^&-^MZQXFN]!^&VCP:/ITGA;P[J7B37
MM3U[4=/FO=6ENM2G29[L)!#$GTW_ ,-*? /_ **UX(_\'5O_ (T?\-*? /\
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MA96=BDMQ.EG:V]HD]W,]S=S+;Q)"LMU</\\]Q($#S3/\\LA9VY8UXU_PTI\
M_P#HK7@C_P '5O\ XT?\-*? /_HK7@C_ ,'5O_C0!^=O_!-?X"_$[]E[XN?\
M%$_V9_&/P[UE/V?/$'[2FM?M*?L\^/+ZP^V>"O%OA3]I;2U\0?$[X?17%Q<W
M<(U'P/\ $"QUJ#4-"D@C@.F:]:W:Q>7>/&O.0_\ !"[]ESPUXA\1/\'/CO\
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M9+B^U?5[UO@]=:QJUQ"D@L[&?5]3U"ZM+**.!+@X9G_6?_AI3X!_]%:\$?\
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M?-/^"D_[(&H3_P#!/#X;?\$V?V-_@E>Z?\+_ (Q?$?X*?LZ^(;+P;!/%X?\
M@K^SC;^+['Q9\5O'6O:Q/=_:;6.+PUX:O=+2_O)[R_UOQ%XDA2=I[B\FE/Z@
M_P##2GP#_P"BM>"/_!U;_P"-'_#2GP#_ .BM>"/_  =6_P#C0!ZMX=T'3?"W
MA_0O#&C0+:Z1X<T;3-!TJV7[MOIND64&GV,"_P"S%:V\48]EK9KQ#_AI3X!_
M]%:\$?\ @ZM_\:/^&E/@'_T5KP1_X.K?_&@#V^ODGX-_\G,_M9_]?7P@_P#4
M-NZ]'_X:4^ ?_16O!'_@ZM_\:^9/A5\</A!I?[07[3&O:A\1O"EIHWB2Y^%K
M:#J,^J11VFJC3/"EW:ZB;*9@$G%E<D07!0G9(0O/6@#-_;Z_X)D?!C_@HC??
M!#4_BW\4/VA_AU?_ +/OBV]\=_#N;X&_$31O!L-OXRN(8(++Q/JNG>(?!OC/
M2]0UW0(X7_X1S5A8V]_HS7=ZUI<*;EZZK]ES]@W3OV8M=\9ZS=?M6?MG?M*V
M?C?PY'X9U#PK^U7\9-%^+/A'3;,7+SSW>BZ+;> O"ZV>H7T4LEAJ$T\]W!=Z
M>[6LML5.X?0?_#2GP#_Z*UX(_P#!U;_XT?\ #2GP#_Z*UX(_\'5O_C0!^7^@
M?\$$?V(= \16MLOBG]I_6/V>=-^)3_%G1?V(?$'Q]\0:I^QIHOC-=8'B6PFL
M?@_)IZ7<F@:1XI'_  E.F>#]1\5W_A.+Q!_Q,9]%N9.*^D_VL_\ @F#\ _VL
M?BKX-^/L_CCX_?LZ?M!^"_#K>";;XZ?LJ?%2X^#_ ,1_$7P^^U2ZC#\/O&UX
MND>(-"\8>#[+5)Y-4T[3-=T&[ET^^9GLKJ")GA;ZM_X:4^ ?_16O!'_@ZM_\
M:/\ AI3X!_\ 16O!'_@ZM_\ &@#\E?C[_P $JK_X5?L*_M _LT?L*Q^*O$_Q
MG_;0\8^#?"/[2/[2/Q^^+M]XM^,VL_#GQ)JMAH/Q1^(?BCQ[XC07'B?5/#7P
MQCU;0/"W@O1;+2=/"ZH4TS3H9!.\WZZO\#_"$7P"'[.>A7.N^"? L/PJC^$&
MDW?@/5&\,^)/#'AB'PNOA*SN/"FL6\4SZ)K&EZ:D<FDZA%#*UC=Q0W"QN8]I
MJ?\ #2GP#_Z*UX(_\'5O_C1_PTI\ _\ HK7@C_P=6_\ C0!^4/P1_P""#OP?
M_9S\.^%_!7P7_;K_ ."FW@#P#X1UC^V]+\ ^'/VE?!ND^#YKV75O[:U)M3TC
M3O@Q:#4?[<OS+)KLUQ,UYJBSS"YNF+[A]0?M,_\ !+KX2_M)?%*;XUV7Q]_;
M)_9N^)^K^&--\(>-/$W[+7[17B#X5Q?$31-%LFT_1%\:^&KO3/%'A&_U/1K-
MY(-,UW3M TK6[5)'"Z@<\?7W_#2GP#_Z*UX(_P#!U;_XT?\ #2GP#_Z*UX(_
M\'5O_C0!\R^$?^"6_P"Q1X1_8W\6_L)+\)E\3? #XA3:SK'Q'L_&6O:SXC\<
M?$+QQX@U2#7M7^*'B[X@W=V/%&I_$VX\0V=CKT'C)+^VU/3-3T_3I-*:QM["
MTMX?"/A%_P $5_V;OAQ\1_A7\1OB!\</VT/VJF^!6J0>(?@MX&_:N_:-UCXM
M?#7X:^*;!98M'\6:+X/CT/P[9ZOXFT"VFDM-!UCQA+XFNM*@*FU9)E68?HC_
M ,-*? /_ **UX(_\'5O_ (T?\-*? /\ Z*UX(_\ !U;_ .- 'P[_ ,%BOV=/
MB9^T#^QS+K/P*T&\\5?M _LS?%_X0_M:? [PKIK-'J7B[QW\"O%UKXCE\&V$
MB7-HQO/%OA.;Q-H-E;&1H[^_OK2REC*S[X]_]I#_ ()T_ W]NK6O@O\ M)>*
M-5_:*_9@_:/\)>!;/3-%^+O[/?Q'O?@G\<=&\&^)8[?Q!J_PB\<WD>G:_I/B
M#PU::W,UQ>>&O$>B:I'INLPW4FGSVIN+O[1]A_\ #2GP#_Z*UX(_\'5O_C1_
MPTI\ _\ HK7@C_P=6_\ C0!XC^QK^P!\!_V(K?XA:C\-KWXF?$'XF?%_5[#6
M_BY\=OCM\0-5^*OQK^)=YI%O)::%!XG\:ZO';!=(T"SEDM=%T'1--T;1-/A<
MB'3PX#CI?V1?V+?A%^QAH7Q8TOX7WWC?Q)K'QQ^-'C?X]?%+QU\2]?L_%'CK
MQA\0/'=U%-?SZKKMGH^B)/I>C6=M::+X;L&LB=*T:TM[+[1<%#*WI/\ PTI\
M _\ HK7@C_P=6_\ C1_PTI\ _P#HK7@C_P '5O\ XT >:6/[%7P?T_\ ;9\0
M_M\0WWCQ_C=XE^ FD_LYZAIDOBDM\-U\ Z-XJE\7VMU;^$%L$8>)6U29HY=5
MGU2>W%GF.WT^"XEN+F:Q^U_^QE\'_P!MGX9>'?A1\7Y/%6G>&?#'Q9^&'QFT
MZ?P+J>F:#K#^+?A+XHM?%OABWN[S4-$UR&;1)]4M(DUBQ2TBN+NT+16][9RE
M9U]#_P"&E/@'_P!%:\$?^#JW_P :/^&E/@'_ -%:\$?^#JW_ ,: /SY_X*._
M OXE?M5?M _\$X_@%I/PZ\0:E\ /!O[2L?[6G[0GQ&@@-KX4\-V_[.>A76I_
M"7P+=7ZSQK<ZOX\^)'B+3Y%T58)1+HV@:C>2;4A /ZZUXA_PTI\ _P#HK7@C
M_P '5O\ XT?\-*? /_HK7@C_ ,'5O_C0![?17B'_  TI\ _^BM>"/_!U;_XT
M?\-*? /_ **UX(_\'5O_ (T >WT5XA_PTI\ _P#HK7@C_P '5O\ XT?\-*?
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MF6FDV[*MS;Q0?9G_  TI\ _^BM>"/_!U;_XT?\-*? /_ **UX(_\'5O_ (T
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MA_PTI\ _^BM>"/\ P=6_^-'_  TI\ _^BM>"/_!U;_XT >WT5XA_PTI\ _\
MHK7@C_P=6_\ C1_PTI\ _P#HK7@C_P '5O\ XT >WT5XA_PTI\ _^BM>"/\
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MG=B68D\DD]32_P##/_P._P"B1_#O_P )'1/_ )#HHH /^&?_ ('?]$C^'?\
MX2.B?_(='_#/_P #O^B1_#O_ ,)'1/\ Y#HHH /^&?\ X'?]$C^'?_A(Z)_\
MAT?\,_\ P._Z)'\._P#PD=$_^0Z** #_ (9_^!W_ $2/X=_^$CHG_P AT?\
M#/\ \#O^B1_#O_PD=$_^0Z** #_AG_X'?]$C^'?_ (2.B?\ R'1_PS_\#O\
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M'_#/_P #O^B1_#O_ ,)'1/\ Y#HHH /^&?\ X'?]$C^'?_A(Z)_\AT?\,_\
MP._Z)'\._P#PD=$_^0Z** #_ (9_^!W_ $2/X=_^$CHG_P AT?\ #/\ \#O^
MB1_#O_PD=$_^0Z** #_AG_X'?]$C^'?_ (2.B?\ R'1_PS_\#O\ HD?P[_\
M"1T3_P"0Z** #_AG_P"!W_1(_AW_ .$CHG_R'1_PS_\  [_HD?P[_P#"1T3_
M .0Z** #_AG_ .!W_1(_AW_X2.B?_(='_#/_ ,#O^B1_#O\ \)'1/_D.BB@
M_P"&?_@=_P!$C^'?_A(Z)_\ (='_  S_ / [_HD?P[_\)'1/_D.BB@"(?L\_
M D2F<?"#X<^<5V&3_A$=%W%0<[<_8^F>WX=*E_X9_P#@=_T2/X=_^$CHG_R'
M110 ?\,__ [_ *)'\.__  D=$_\ D.C_ (9_^!W_ $2/X=_^$CHG_P AT44
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M\.__  D=$_\ D.BB@ _X9_\ @=_T2/X=_P#A(Z)_\AT?\,__  ._Z)'\._\
MPD=$_P#D.BB@ _X9_P#@=_T2/X=_^$CHG_R'1_PS_P# [_HD?P[_ /"1T3_Y
M#HHH /\ AG_X'?\ 1(_AW_X2.B?_ "'1_P ,_P#P._Z)'\.__"1T3_Y#HHH
M/^&?_@=_T2/X=_\ A(Z)_P#(='_#/_P._P"B1_#O_P )'1/_ )#HHH /^&?_
M ('?]$C^'?\ X2.B?_(='_#/_P #O^B1_#O_ ,)'1/\ Y#HHH /^&?\ X'?]
M$C^'?_A(Z)_\AT?\,_\ P._Z)'\._P#PD=$_^0Z** #_ (9_^!W_ $2/X=_^
M$CHG_P AT?\ #/\ \#O^B1_#O_PD=$_^0Z** #_AG_X'?]$C^'?_ (2.B?\
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M.BB@ _X9_P#@=_T2/X=_^$CHG_R'1_PS_P# [_HD?P[_ /"1T3_Y#HHH /\
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M\,__  ._Z)'\._\ PD=$_P#D.BB@ _X9_P#@=_T2/X=_^$CHG_R'1_PS_P#
M[_HD?P[_ /"1T3_Y#HHH /\ AG_X'?\ 1(_AW_X2.B?_ "'1_P ,_P#P._Z)
M'\.__"1T3_Y#HHH /^&?_@=_T2/X=_\ A(Z)_P#(='_#/_P._P"B1_#O_P )
M'1/_ )#HHH /^&?_ ('?]$C^'?\ X2.B?_(='_#/_P #O^B1_#O_ ,)'1/\
MY#HHH ZOPI\.O 7@4ZB?!G@[PWX7.KM:OJG]A:/8Z8+][)9DM&NA:0Q"8VR7
0$ZPEP?+$TFW&]LE%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>img12876764_17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_17.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #O"!H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBL+Q1J
MC:)X=UO6$!9M-TR[O54=2;>%I ![DK7\77[4G_!R]XS^!?QV\6_"RU\*W-Q!
MX?O+NW298W(802F,'.>?Q_QKZ+A[A;..)ZM>CE%"->>&@JE52G&%HR=DTWOK
MT1E5KTZ"3J.RD[+2_P#6Y_;%17\$O_$5GXY_Z%"Z_P"_3?XT?\16?CG_ *%"
MZ_[]-_C7U7_$).-?^A?3_P#!T?\ +S_/LSG^OX;^=_=_P?/\^S/[VJ*_@E_X
MBL_'/_0H77_?IO\ &C_B*S\<_P#0H77_ 'Z;_&C_ (A)QK_T+Z?_ (.C_EY_
MGV8?7\-_._N_X/G^?9G][5%?P2_\16?CG_H4+K_OTW^-'_$5GXY_Z%"Z_P"_
M3?XT?\0DXU_Z%]/_ ,'1_P O/\^S#Z_AOYW]W_!\_P ^S/[VJ*_@E_XBL_'/
M_0H77_?IO\:/^(K/QS_T*%U_WZ;_ !H_XA)QK_T+Z?\ X.C_ )>?Y]F'U_#?
MSO[O^#Y_GV9_>U17\$O_ !%9^.?^A0NO^_3?XT?\16?CG_H4+K_OTW^-'_$)
M.-?^A?3_ /!T?\O/\^S#Z_AOYW]W_!\_S[,_O:HK^"7_ (BL_'/_ $*%U_WZ
M;_&C_B*S\<_]"A=?]^F_QH_XA)QK_P!"^G_X.C_EY_GV8?7\-_._N_X/G^?9
MG][5%?P2_P#$5GXY_P"A0NO^_3?XT?\ $5GXY_Z%"Z_[]-_C1_Q"3C7_ *%]
M/_P='_+S_/LP^OX;^=_=_P 'S_/LS^]JBOX)?^(K/QS_ -"A=?\ ?IO\:/\
MB*S\<_\ 0H77_?IO\:/^(2<:_P#0OI_^#H_Y>?Y]F'U_#?SO[O\ @^?Y]F?W
MM45_!+_Q%9^.?^A0NO\ OTW^-'_$5GXY_P"A0NO^_3?XT?\ $).-?^A?3_\
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M9G][5%?P2_\ $5GXY_Z%"Z_[]-_C1_Q%9^.?^A0NO^_3?XT?\0DXU_Z%]/\
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MS#Z_AOYW]W_!\_S[,_O:HK^"7_B*S\<_]"A=?]^F_P :/^(K/QS_ -"A=?\
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MK^"7_B*S\<_]"A=?]^F_QH_XBL_'/_0H77_?IO\ &C_B$G&O_0OI_P#@Z/\
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M6[^'GQ7\-:EX?\1V(8S-=V<MM:/L.#LDD4*QSGH<\'KUKS3SH1UFB'_;1/\
M&NVG4A6A"K1J1JTJD5.G4IRYH3B[<LHR6C3TL_)$Z+1JS6C3T:>FGRT_ ?L3
M^ZO_ 'R/\*-B?W5_[Y'^%*"&&5((]001^8I:N[[O^O\ AE]P679?U;_)?<AN
MQ/[J_P#?(_PHV)_=7_OD?X4ZBB[[O^O^&7W!9=E_7_#+[ANQ/[J_]\C_  HV
M)_=7_OD?X4ZBB[[O^O\ AE]P679?U_PR^X;L3^ZO_?(_PJAJB)_9]W\J_P"J
M/\(]1[5HU0U3_D'W?_7(_P Q3@WS1U^U'\U_DON$TK/1;/\ +_@+[C^F_P"
MRK_PZO\ $W _Y UQV'_/M+7\Q]@B;+CY5_X_KW^$?\_#^U?TX_ ;_E%?XF_[
M UQ_Z32U_,A8?<N/^OZ]_P#2AZ^1X6_WCB7_ +'$O_2$;UMZ7_7I?E N;$Y^
M13CL%!)^@QR?85G27IC<J-)U:4 XWPZ5=2(<>CK$5(]P36I:?-KWA>!N8KGQ
M#IEO.AZ212W"(Z'V()K_ $??V=_V5OV ?A!^P3X(^/7QL^$/A6^MCX8LKW5=
M4N;"VDGDD^SQO(Y=XCAB222<@]/<5Q5Q90X4I8"I5P.*S"IF.(>&P]#"SC&;
MJ+ELO>O=NZ22MKIZ%&@Z[FE*,%!7;:TMIY:6_P NQ_FW1WN]@K:5JL(/62?3
M+F&,9[EWC50/J>E6+F98$5TM+F[#=K&TDNRO^\(4?&.^>G>O]$KX2?#_ /X(
MW?\ !5'PWX^^"_[._AGPWH?CS2=.NX[NYTRSMH[ZP,43F2<-#\S>6?F)5$*J
M&/S=*_-S_@CE_P $W_@S\-/^"B/[5'[+_P 7?"^E?$W2OATNKRZ.VO0)=1Q!
MG=8PHE#D;%)*A2 &4'V/AP\2L"L)G%7%Y1F67X_)<-3QE?*L5:%>KA:DZ=.-
M6%3X8KFJ0T=]&FM#3ZG/FIJ-2$XU'95(K1-).S5M-%I==NVO\;T>V2-9#"T1
M;K'-$8I5]GC<!E/L0#3]B?W5_P"^1_A7[2_M<_\ !+;]IWXK?MT_M(Z3^S=\
M*[VW^''A;7KQ=,A33)X].AM8;F7BU=8UC*B-1@KP 1^/Y2_%CX-?$OX%>+6\
M"?$[P]?:-XF6<6T=G-:R0-/+DJ! K@&0,0=I'7MFOM,OSC 9G3H/#8O#RQ%;
M"T,5+"1KPEB*$*U.-51J03NG%-*3Z.+[(YY0E3;YHNR?*I6TDU97775K2RZ+
MMIYIL3^ZO_?(_P *-B?W5_[Y'^%???PA_P""67[;WQY\+P^-/AY\-]1?0+@*
MT$U]IUQ"TJ2<HZ[E&Y2,$,.""#G&*^<_CO\ LT_&W]F'6V\._&3PAJ>C:B&V
MQM]AF2&=]P79"[#$C;B!A3DYXK6EFF6U\1+"4,QPE;%P;4\-2Q$)UHN-KIP3
MNFM+KI;RT3C)+F=.48_S-::)/^K=E\O$-B?W5_[Y'^%&Q/[J_P#?(_PK[9^"
M7_!-W]L7]HW0H/$_PN^'NHW&BW2>9;SWNGSQ[TP&R"0,\=..AS7DW[0G[*7Q
M]_91UFST#XV^"M7T6ZOEW6]VNG3I8],@/.R[ 3@\$CCZ4Z>99?5Q+P=+'X6I
MC(WYL+"O!UURVO[E[^[U72P.,E'F=.2A_-;3I;;Y?<OE\_[$_NK_ -\C_"C8
MG]U?^^1_A7T[^S]^Q9^TG^U2DLWP6\#ZIJ]K"_EM=O83M;DY(RLJKM(!ZX/3
M]-[]HC]@7]JW]D[1[;Q#\:/A_JNGZ1=.$2YM-.N&1"3C,K!2$ [YQP*'F67+
M%+ O,,(L:W:.$]O#V[>EDJ=[WTV\@Y96YE3ER[\UM.EG^7GHM.WR)L3^ZO\
MWR/\*KSS)",K;37+?W+2W:Y<?5(E9A^50:A?FRLFO(U+E6A&P#+#S75"I!Z,
MN_D=C7]O7_!'G_@D/^QOHOPD^&/[1GQ_\7^'?%OB7XJQP76C^ [Z]MIY5>8H
MZPO9.S.IRVTC9T!!P<9\OB3B7 \+X"..QT,16]K4='#X?#0E.I7K1CSN%TFH
M14%=SEHK%TJ,J\^2'*K).4G9)*ZU7?:WK;L?Q&6THN%9FL[JTV_PWMG+:NW^
MZLR*3^ JQL3^ZO\ WR/\*_IE_P"#HC]G_P"$/[/?QV^!-E\&_!&B^!-.\1:,
MLVJ6.AVR6MM<2KE=QC0 \JJD[B3G/:OYG*ZL@SBEG^3X'.:%&IAZ6.IRJ0H5
M91E.GR3=-QE*/NO6%TTEI84Z?LJDZ3LW!I-I63ND].W3[D-V)_=7_OD?X5^W
M7_!#M5'CSXG851_Q+[SH!_S[O7XCU^W7_!#O_D?/B=_V#[S_ -)WKDXL_P"2
M=S/_ *]0_P#3D!TOXU/U_6)^97[8BK_PU-\5?E7_ )"LW8?\]F]J^>-B?W5_
M(?X5]$_MA_\ )TWQ5_["LW_HYJ^<+IBMM<,IPRPR$$=B$)!KV,!?ZE@4G_S!
MX6W_ ((I_J0_BE_B?Y(BN+@6Y 6POKGWL[&:Y4?5HD8#_/XUAJ!) _L;6AGN
M=(NP!]3Y7 K^TC_@W!_9)_9T^.?P$\6^-?C1\/=#\7S:&)[N:YU6UAG,=O 6
M9O\ 6(6QA>F1GU')K]"+;XW?\$,=;^.$O[+^H?#OP;I/Q%UC5+G0+")K"T!-
M\)#;*D3 1[&$K 9*R G'%?!9CXC4\#FF995A^'<US.IE-GC*^#E"4*=.RDZC
MC9RC",5?7HO),Z881SA3J.M3IJI\*DEO[MDFUJ]OP[:_YWHDC,1E$,A8?\L!
M QN?H( OF9]L=:9;2BX#%K*[M=O:]LY;4M_N"9%+?@#Z]*_K._;K_P""2WPD
M_8Y_X*0_LQZ]H!BUSX8?'/Q5;P3>%9T!T^"*74EADB$?,11<D+M!#)A@<$&N
MR_X.'_\ @F\UQ\8?V</!7[&/P;@TN]\1Z=&FKQ>&]*<VDQBEEMXI+I[:,!7>
M-(Y'+G!9F8;0<#T,+Q]DV,Q>1X>BJD</GF"Q6-IXZM.-&CA5@[JM2KQE9\T9
M0<5)-1NEY$2PM2,:C=G*E*,'!:N3GR\K32LM+.WIKI8_D(V)_=7_ +Y'^%&Q
M/[J_]\C_  KZO_:(_87_ &G?V388[GXX>"[W1+.0%OM8LY4MTXSM>5AM5L<@
M''3IV.-^S[^QM^T9^U9<O;?!+P3J>MI&H=KW[!/)98(SQ<*NP\<\$\]?;ZM9
MC@'A?KRQ^%^I?]!:KP]AHTOXE^733\/(QY9747"2GTC;7IM^';17['S3L3^Z
MO_?(_P *-B?W5_[Y'^%?;'QT_P""<'[8/[-&AIXF^+/@"_LM%<$M<VUA.R0J
M,Y:5\8C48Y+8 XS7C7P'_9C^.7[3VIW&C_!SP=JNL7-K(8IISI\[VH=6V$>:
MHVCGGKT!HIYEE]7#2QE+'X6I@X64\5"O!T(/324[V33MIZ;=#EDFHN#4GM&V
MKVV_#MMY'AFQ/[J_]\C_  HV)_=7_OD?X5]R_&[_ ()F_MG_ +./A"7Q[\3_
M (<ZG'X:@YFGT_3KB9XQP27VJVT $$G''K7RO\*OA5\1/CCXIM?!7PS\-:IK
M/B&[VA;:&REF,+/T690N48="&Y!SGV=''X'$T)XK#8["U\+2NJF(I5X2I4W%
M)OGFG:-M-^R$TXM1E!J3M:-M7M:WX=MC@MB?W5_[Y'^%&Q/[J_\ ?(_PK]%O
M&G_!([]O3X>>#[[Q]XE^&E^OAW3;)M0NC!I\[W"VZ(78[ "=P /'8]:_.D^?
M%)<6]W:W-C>6DTMM<6EY$T-Q'- Q20-$X5@ PQTHPN/P6.C*>!QN&QD:;4:D
ML/6C55.35U&7*WRO33T&XRCI.#@VKJZM=:;?A^'RCE:.)2WEF0]HXH_,E;_=
MC4%F_ <]N:H"_8G_ ) VM8_O'2+O;]=WDXQ[]*_H+_X(%_\ !.?X4?MR?%#Q
M#\2/C#XITG2/#GPKG26X\.:M>6ULNM(MTD(5(KJ6*.4%G0N68 1AV)X%?TF>
M$OB9_P $2?BA^TCK?[%/@_X;^$+[XA:7)/X;N]0MK.S>,W^3:B6WF6(^85E&
M[>IP<DC&0*^/SSCW#Y/F.+RS#Y/F><5LNP\<3F53!1M2P-*7*U*I*2::Y6I7
M6G3?;>GA95(QFZD*2F[0YMY;>6C7W+370_SMXS'(H81E<]5DCV.OLRD94^QJ
M38G]U?\ OD?X5^ZW_!=#_@FQH?["7QUAU+X<2F7X>^*X1JJ1%=GV&6ZC\YK9
M4' 6-GVX7(&.N*_"E&#JKCHP##Z$9KZG*,UPF=Y;A<TP,Y2PN+IJ=/FTG!Z<
MT)KI*+5FO*^UC&=-TYRIS2YHNSM;71.Z\MOP#8G]U?\ OD?X5]E?\$[%4?M@
M^ ,*H_>0]A_SU'M7QO7V5_P3L_Y/!\ ?]=(?_1HJ\U_Y%69_]@.(_P#2 BES
MT]/MK^OP1]7?\%K54_M&>%LJ#_H"=A_<%?D+L3^ZO_?(_P *_7O_ (+6_P#)
MQOA;_KP3_P! %?D-7#PRW_J_E.O_ #"Q_._YZEUDO;5-/M+_ -)B5IW$"[A:
MW%P?[MK;/</^*Q*S#\JH_P!H-_T!=;_\$]Y_\:K]_/\ @WC^!'PT_:%_:FU[
MPM\4_#&G^*](@.8;'48DFB7 !.U9 X'<GBOZA_VI/B1_P11_8Z^)]I\+_C3\
M*_!FBZQ=26M@K-IUGY2S73K"A8;(R?F<9Q(N?O8Z"O SOCN&3YV\AH9'F6;X
MV.&ABFL#*+?LY)2NH6<K1LDW]RV+IX9U*:JNK"G%NRYDM_=ZV_K3M8_SB8)4
MF!+6\ULP&1'=V[6\K>RQRJKL3V '-1Q7'FS&$Z??P@?\MY[">*W./2=XQ&1]
M&]/6O[-O^"T?_!)[]F>Z_9]\'?MZ_LS7%OHG@LZMX;ODT33$6&QU'2]4N66%
M@(L1LDGV:X1P2<$$$'Y6/I/_  41_84^$U__ ,$9_@SXZ^"/P<TR/XQ^)M#\
M,SKJ^AZ8LNKW=SJ2.LS3-!&9&7?%'CTR=Q.1C/#^(V48FEDM6GA\3'^U\SJ9
M35A6<:4LLQ=*,)5%B>>W,H)J[CHM+VL-X2I%U$W']W!35E?GBVDK66^FRVT[
M'\1FQ/[J_D/\*-B?W5_[Y'^%?<GCW_@E_P#MM_!KX<:9\2OB)\.=1L_#-QI=
MO?M,NG3B:.!X5D:28$93 R6) QWP<U\R_";X-_$WX[^*(O!?PL\,ZGX@U^6X
M-HT5I9RW203!MI$YB4^6 W!W'CUXK[6EF& KT:F(H8_"UL/1;C5KTJ\)4J3C
M;FYYIVCRVUOM8YW&2:3A)2:NHVU:LG=>6W;IY'FNQ/[J_P#?(_PHV)_=7_OD
M?X5^C7CS_@D3^WK\,O"][XT\5?#:\71-/A^T77V:QGDG6(IYF0@4GA<<X(SQ
MUY'P_P""/A=\1/B5XW3X;^#?"^KZCXN:<6SVD=A-+Y$Q8ILF55)C(88(;H<Y
M["IP^9Y=C*=2MA,PPF)HT5>K5HUX3A222;=22=HI*SN^B\@<91LI4Y1;M9..
MKO:UOP_#Y<+L3^ZO_?(_PHV)_=7_ +Y'^%?H]KW_  2#_;Y\,^$[OQSJ?PTO
M&T&QLI-1N!!87#W*VT2&1B(PI);:#Q@U^>EEH/B34/$D7@VW\/:P/%$VHOI2
M:1)8S+>?;$D\IE-N4$@7?@#(]?PK"YA@<=&I+!8[#8N-'^+*A6A45+2_OV?N
MV2OKT0.,H64X.#=K76^VVGI^'RS-B?W5_P"^1_A1L3^ZO_?(_P *_270?^"/
M?[?WB;PW'XMTKX9WO]CS6OVQ/-T^X68P&+S00A YV9(!QZ'TK\_?&7@[Q7\.
M?%>K^"/'&B:AH7B+0YWMKZ#4+62T5Y48JWDB0#=\P.,?EFEALRR_&SJ4\'C\
M+BJE'^+3H5HU)T]4O?C%MI7LK[72^0XRC9R@XI[-I)/1?\#[EUT.;*HH)*J
M/8?IZGVK/>]*L572=7F _CATJZE0_1TB*D>F#7V'^PK^S?I_[6_[2_@_X,ZS
MKEKX<TJ[U"QN;W4[VX6UMA;>:GG(\SLJ@;2<Y('7FO[??B)I_P#P1M_X)ZZ?
M\/O@C\1?!_A+XC>-M2AL+&ZU/3X+/57>YVQ1N\DL:3?ZQV)Y.>.<'BOG.(>,
M*&0XS"Y=2RS,,XS'$TI8A83 QLZ>'C:]6=22Y;:;73T]#6E0=52G[2%.$6H\
MTNLKK2UK]%:R\^EC_/'@F6?[UI<VQ_NW=J]LQYQP)54G\JL[$_NK_P!\C_"O
M[3_^"SG_  2L^!'C#]F+1_VN_P!E#1++POHYM8]5U#2X8%M +"2%+@,$54&2
M"XQ@].:_BJMYA,L@'WH)I;=_]^!S&_\ X\IKOX;XDP?$^7O'X.%6@Z=:>'Q.
M%K?QL+7IV3IU+:-NUTUHTO0FK2E1GR3L[Q4HR5K-:;?<G_PQ-L3^ZO\ WR/\
M*-B?W5_[Y'^%.HKZ"[[O^O\ AE]QG9=E_7_#+[C]:/\ @BXJC]I?7L*H_P!!
M/0#^Z*^;/^"D"J?VP_'>54\R]0/[X]J^E?\ @B[_ ,G+Z]_UXG_T%:^;/^"D
M'_)X?COZR_\ H8KY.A_R6F-_[$U#_P!*@:O_ ':G_P!?%^2/B;8G]U?^^1_A
M5:XF^SXQ8WESD_\ +G92W('^\84?'X_T-67.$<CJ%8_D#7]7_P#P;1?LN_ W
M]HO3_'S?&+P-I'C)X)+JWM&U2"*<P9R%:/S%8@C@#'?]/2XASRCPYE&)SC$T
M:N(HX5P4J5*48SESR459RT7+H_RV)ITW5J1IQ:BY=6MK->7IZ6/Y.X669=WD
M20GNEQ"87![Y1P&&/IGVJ%[C9.(!I]_("<?:(K":2U'^]<(AB '<EA7]'/\
MP<,?\$L-4_8]\9W'QP^#WAQH/@EJ]I+-<G3K9MNFZA)"6>W*H L:Q2':,#
MR"1C/Z.?L#_LE?L[>.O^""_C_P"-GB3X;Z!JOQ*A\):[J-MXINK2)]5MKFS-
MD+?9,4WJ0MW+N!.[<J$$!3GQ*_'65T\CRG/Z%.KB\+FV887+84J52"JX7$8E
MV:KWT3HM>]&UW[MC18:;JU*3M%TX.;DUI)1MLK=5L^ED?Q33W?DOL&EZG.!_
MRTMM-N)X\^@>.,J2._-,2^+-M;2-7B'=I=*NHU'U9H@!^)Z<U_H"_P#!)_\
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MU[#_ )X0U_,M>=;+_L)6'_I0E?TU?M/?\HM_"7_8%M?_ $1#7R'%'^^<,_\
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MO*J[*G;XM+:#Y)O54Y.W9;6M?[M/FCX$V)_=7_OD?X4;$_NK_P!\C_"OJ?\
M9X_8?_:;_:Q34)_@GX%U35;/2Y98+F^FTZX^R226[M'+Y,^T(X#*>A/45O\
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MNMAZ7M%[2M224G5I1^U322;DM$K,CE>_*[)V;MI&6EHOL]M/3Y?/>Q/[J_\
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M-VM^G3:S/PSMY1.N6L[JV]KNTDMF/T$J*3^ JQL3^ZO_ 'R/\*_KW_X+?_\
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MK_X)(?L_?&GQI^TAK'QD^%_B3PS?S:CK>G>&I[[3;F)KV[WS,B1[Y!(ZNV5
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MC_@E\+O^"O\ ^TEXM\8?$'P_I'@_Q?:Z]8Z+XGO;R*'2YYKGS$@87!8H$=F
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MR3CWK^Z"7]H#X R?\&^&K_#%OBOX0;Q[)\/9XE\(-J-L=:?4"80+3["7WG*
MOOQG<"NWO7F\2<&2RG+<GP=?%8G-\1G7&&'Q>;XJG2E!R=6"IU&HT^9TX*,I
M7G>SE[U[[:4,3SSJ24535+#\M.+:?56[:^1\#?L<?\%&?&?_  6;_P""D/P^
M^$'QH\"^'K;X-:$WVSPI8VUK$S#3K&9C$KILV#='&H YP0>0,&OZ8?VM-._;
MV\ ?%/X=^$OV-!\(_#'P1T%=-M?$>GZW-8V>H&P@2);G]TVUCA0W;'7OU_ST
M/^"0W[4>C_L1?M@?#;XY^*;)Y=%MIH='OH0,>1;W%T\<DKX(PBHVYNG&,G&:
M_O8_:$7]G+]L_5O WQB^&G[8^@> 8M4T^QOO$'AO_A*8[.2*U>.,S130+<H!
M*%#A@5'S<X&<##CW)Z>3\1973PN!I4.':>53H8>%7!5\PP%/&7E[:<J%.=U7
MFG&4:S=G+5(>%J.I1FY3;K.HI2M*,)..G+9]O)[_ (GR)_P7?_9(^&'[2OP;
M^"4^EZI\.]*^-VK:WINE^+M5T6XLO/N)&AM!?2-)"WF;!=2SI\Q7(C&T$<U^
M=_A/_@V*MM:\/Z3JMQ\5O"PDOM/@N67^T(25>2V5P#ANSGGOCK5'_@N5\4OV
M3_A1\+_ WA#]FSXJW_CKXNZ+?03:IKNF:Y)>VOFQ)$)9!(DK!7>9'<\?*6 #
M,!O/\_.F?\%*?VRM+L[>SM?B;XA2""%8HT_M>Y 6,)L _P!8,87C&/RZCVN%
M<IXMJ<,X"&29U++J$<1C)*&8X)PK2A*I%P=.$YRE"BK?NT]>6]ELC.O4H*M+
MVM+GE:&L)-[6;NTM6VM_^"9O[<_[)\_[&_QBU7X82ZWI^O165RT,-UI\R3)@
M.RC<48XZ=\?AFOC:NU^('Q(\:?%;7[GQ3X\U>\UK6KQ_,FN;VX>X?<26.'=F
M8<GU_E7%5^OX*GB:6#P]+&5HXC%PI1CB*\(\D*M1)<THQ3=DW?0X79RDXJT7
M\,>J7;OV_(****Z0"BBB@ JAJG_(/N_^N1_F*OU0U3_D'W?_ %R/\Q50^./^
M*/YH4MGZ/\C^G#X#?\HK_$W_ &!KC_TFEK^9"P^Y<?\ 7]>_^E#U_3?\!O\
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MX)6?&#XL^(/V^OV;?!&J_$#Q)<^"]'UBPBL/#4E_,VEPQB\A4(EN9/+"A>"
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MOI#]L/\ Y.F^*O\ V%9O_1S5\X78+6MPJC+&&4 #N2AP*]C ?[E@?^P3"?\
MIBF0_BG_ (G^2/[PO^#6VT_M3]ECXB:)D*-8M+ZRWG[J>:D@+,3Q@"NBMO\
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MU?KS_P %K?\ DXWPM_UX)_Z *_(:N'AG_DG\I_[!8_F76_C5/\2_])B?T?\
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MX]#^>/PUJ?CZSNQJ'PMN-?L_&'E/]DF\,M*NKJ0"(PGD'S,;@, >@-?T@?\
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M5_PSO? URT6M?\)4$CM=+D(N)D.L,O"HVX@+@# /MVK^[#_@D[\1/V3?'O\
MP2KF_9V^,/QK\%>%?^$UE\2:5KFE:KJ]K::A:VM]- T<BPRR*9!((.02FT $
M9R*YK]G3_@F[_P $9/V)O'-K\>8OCCX%\5^*/"4EUJFD6@U>RE1I$D:[1!"L
MLC.YD&T*0B],,>A]_*N)<-P]4X]R_&9?FF(Q.:9QBYX*EA\#6JTJZE3=&*E4
MY>2,92:O*[]UIKH93H2K+"3C."C3IPYG*235FF]/2_Y$7_!QY;VVO_\ !/+X
M;SZK:1?\)UK>EV5E;2W2C^T([RZLXT1"6&_(E8@CKP<\XKN/^"!7[)OQ'^ G
M_!,GQ?KDFB)_PN#QOX7U&;PE/%!_IDC3:?<OIZJ<;R3</;G@\A6]37X3_P#!
M5+_@H?;_ /!3C]L'X7_!#X5^)[+P/\$?!'BK1QK>K:K/'%I]W#:72+<3*YV0
M[&"NV5"KC[JA0 /W&_X*=?\ !3?2/V"_V!/A3HG[$?Q:\">*/BKHNGZ#I-Q:
M:7?6M^PMK72[)+Z::&,D1O)>&<A,G 'S-SFO*Q&59[A^%>&N#Z6'4<PSW-IY
MG7HU8U?98*E&:J8>CBJL8N%*G/><'NE9I,TC.E*O6Q#DW"E!0C*+5Y.R3<4]
MVM+>?70^_P#]B#X6?M)^/_V3?C3\%_VNM(O(?$7BN;Q%96<MY XC.FZ@)?LP
MC:0,"P"IC9G)XQUS_FW_ +:?P8MOV<?VK/BE\&;*-XK3P_K6I31*ZE3^]O'/
M0@8&#QQC ]:_IT_X)+?\'$/[2/Q3_:"T_P &_MJ>)?#FF> ]<>&UM]27RK>*
MRDE1 99I&V *KL223Q@U\B?\'*/@#]FNW^-GAKXZ_ +Q_P"&?'&O_$N19?%4
M/AN]M[Y;"3[1*DAEDMV/RMLW@E5P'Y&1S]+P7A\YX9XTS'*,WPM*A3SW#+%4
M?[-C4J99#$THK:HXVII4U--/:323=T88F5*MAH5*<FW2DD^>RFTVGM?7R:W3
MZ(_FTHI!T&>N!FEK]K.$**** *=YULO^PE8?^E"5_35^T]_RBW\)?]@6U_\
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M.M!\%Z/<?#W6H+35-=O8;*QNKQK"Y3R%N')4.7.,8))PN1G</Y7?^"R/Q&\
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MU5D3&I:IAXJ45%TI<RO&SM:U_DG;\#[!_P"":W_!3GQ!^TA^VE\:_P!DR_\
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MV^+GQI_X(^7_ .T5XLTW38O&OPN\&WEGH<,*J+2[C\/64(LY9N 6$@/._G&
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M+WH^SFTX];7NF.DK1Q$*-92K*4+5)6BY0TNDWV>E].^QW?QX^%'PJ_X*D_\
M!.[PI\;_ !;X3T;1_'NA:3:Z_?:O:V<*W<M_%!"\T0N$0.T3/&" 6X)/)! 7
MM?#/Q7L?V7_^"3FH_%'0O"VCZOXD^'&GW*^'8[ZVBDC>]L5B2VD=F7(QY4F0
M.#OR<E0:^0/V]_\ @H!^RM^PA^R'X0_9>^ 7CK0_'6J74%IH&K7N@7D=Q'$%
M2.&::8P.P'S,YP<C !SDX%+XQ?M'?L[:Q_P1B\0>%[;XQ>$+GQSK.@?;CX77
M4K<ZN+RZB:1[8VFXN2I8Y?=G<=NP]:^1I9;CZ^#RN%3"8Y9'BN+(RRW"U:5>
M]/ RJ)5>:.LZ=&::24K+EV>[.AS@I3M*/M50M.2Y?C]VW=-J[ZGZ'_L*?MEW
M/[8'_!/[7?VA/C]X"\-WFI:-8ZQ+-I)LH)K-UT^&=[10K(=NUHD;Y1DC@C&*
M^<_^"1__  4:\1?MX>(_VB_@O\1O /AK3? /P_DUC3/!>G6EG;FW;3;=[B!T
MEBV$ _9P^",,K$,#D5\K_P#!+3]H7]GKPG_P26\=>#?%OQ>\(Z!XNN-+\1+%
MX>U#4;>'49)'MYQ D=M(P>3SBY&?EVX& Q; ^.?^#=[XU?!3X:?&C]IF_P#B
M/\2_#7@NRU2]UW^R;G6;V"SAOHIKBY :!Y64,3&Q>-5!WD!<C=N'3B>'<+#!
M>($Z>65XSR_,*"R>,:>(MAX^W7-+!Q2M*\;QE*/,W#1NVI,*TN;"IS3YX-U&
MVKR>GQ/TV3ZGWM_P3&^"_@/X6?\ !1/XY:3X>TFS;3]1U;6;J6W>",Q0;WN"
M(XXV7:44D87&" .,5]$^!?\ @I5X]NO^"KWB;]BC1_ _ART^#\9F9KN*V@2Z
MFN"Y5BX"#.2&)^7'7 /0?-W[$O[1G[.F@_\ !0GXP>)=:^,?A#3/#UW<ZJVG
MZQ=ZE;0V-V6:;R@D[2;0LAQ\XW;0<[3TKXF^%WQM^"%G_P %XO$_Q NOB?X:
MM_A[+/.T/B^2]@329<ROC%P7\O!R.020.Q.!6U;+)9GC\\K9C@\3B9T>#J-;
M#2K4:]EC(4Z2C*'NI2KP6D8ZR5W[KN$9J$:2C)13Q%G9J_*VE;7H];_\,C]+
MO^"CG_!2J_\ V(?VT?@[\*O@C\-?"L%W\1]<L-/\?ZR+"VAO)K2ZNH8IG5EC
M7+,KMQSR/7ITO_!6+]DCX,?M<>/_ -DZX\3:'9:=-XBDTK4[ZXL;6..:]:XG
MCO#'<%$'F!?,"9;[RC+#.<_BC_P6E^,'P<\=?\%(/@+XI\$?$3PYXG\.6.O:
M1-JNMZ5>07-C8HMY TIEN$;:4CPPW$KN S@9P/U=_P""GO[>'[/GPG^&_P"S
M9\6/ 7Q1\+>.]7\"VGAY;W0M$U""[NXT6"T,IECC;=&RMO5D(.W9NW'=@51R
MC$8*/ V)RG"XRAFF-R['QQ.(A"O[6>(E"4:"Q$I)JGRMJ--248I:6T%[12>)
MC4<7",Z;4=&DE*/-R_+>S/T$_:9^&/[2OP$^%WPM^&/[ =I\,?"%MI%AI=OK
M9\2&TL;O4;:%%\Z7$FQI'?))ZG Y[5\X?\%$OV;O ?[4G[#FD6O[1^M?#2P^
M/?A=[?5;S5M!N;'[9<7UM"@>WBEB;S2K&+IG;\P YXJ]XR^,G[-7_!2#X'_"
MOXE^&OVGM$^$7Q$BTNSDO]$?Q''IL\8\H?:([F 3QL"#R,YR200N,M^>7_!2
M'Q?^PK^S;^SGH.G0_&VZ^+WQ:OKNWMKR70/$4E^D=PZC?+=)%,P5%<D')<%0
M2<=*\?),)C7CLIH..*P^=X?-*LJT\/E5=Y@ZJJ/VCQ6.J35*MAI*]GM9V46:
M57'DJ/W72<(\J=1<JTC:T%JG??\ /73]1?V;O'OAC]G+_@EM=?$)_#.E:Q=_
M#71KM] 6ZM89DNK[3XD%E*SLA(!\J5LC[VX=>E?C]_P2[_:L\2_\%R?VI=6N
M_P!J'P9H,'AO]G36-0NO!VE6-M$UM<C3+AGM4N8]H7)*A7)!7.X@MQGZSD_:
M4_9OO?\ @CEK_A1?C'X/'B[4O"]Q-;>%I-2MCK"RRV[&*V>U+[V?#G+D[@R@
M%?FR/YD/^"#?[?/AC]A#]JO6K7QK$L7AGXH^)=3L;[5)24MK*TN[MHA/*^55
M4"OO!SD<$=Z^HR?A^OBLFX\Q]# 5GG]''5X99B9QJT\12IRO]9^JN5E>I3]H
MI.-[WLKV1A4K1C5PM-R2I.$>>*LTW:-N:W9G[T_MK_\ !PW<?LR?MY6?[.W@
MGX?:;%\(/AKJ*:3XWT^&UBCENX([@Q7 M(%158.H8 (H'8*.!7FUW^U'^Q)^
MW'_P4K^ _P 3?@O\,];\'>,+*/3$U>+4](33K'5YFE7]_*D4$-O,RJ=I=47S
M-OF$ L17Z!_';]@#_@E7^TU^T?I/[65W\=_AM;)>2P:WXMTV34].<7KJRW92
M=3(IW2'*R*RED;*@R*JNWPK\8_VD?V&-!_X*;_ KPC\#9_!GAGP-X5BTRSUG
MQIIL=I;Z4SPM&KRO=1A%<94G<Q7<,<+R*SRQ9!5P]&GDF2YYALUH<.8VGF>)
MC[>A1=;V#598N$X-8JI6FY>S4;-1M;:Z<_:J3]I5I2INM!PCHW:ZMRV::22O
M]QTW_!P)I=AI7[1?[.T^B>!$UNYCU?1GDTG2;$7"RL)("1<1(AS$2!N+ @J#
MU'%?HZWC3_@HEJI^"-C\&/#OPX^'?PPCTSP^?$VG:JEKIUR^GK:VT<NR-@A,
MQA0EA@_.S=^OS[^W-^VG^R7X._;9^#GC2_\ '/@OXF^%6BTRRN9+>YM=2LM+
MG^13/(VXHH0G+,0G//3FOL+]J36O@9\=-=^'WQ.\)?M=>!_!W@'2;+2KV]\/
MZ9XAMK)I82D<QLS%%<("R*=AC_A(V\X!KQ)5<1'*>%L'BLK_ '5/ XQQQ>.P
M>*Q=)U:LOX2PL4G&M%I*$YVU::NKFMH^TKRC45W.'NQE&+T4;N_96V7GL[,^
M</\ @N!\"?AWXET3]G;XB:CH>CV'CS2]2TF>\U?2+:%#?7@N8FN1)/$@,J&X
M$I1G).TJ"3M!/$_\%I9&E_X)(^ ';K_PCULOX+91@?I6[_P5B_:-_9C\3?"?
MX(Z1X$^-7A#Q(^C7VF1W,=GJT-W<Q1P/ &GNCN#)(S!RZ_, !D.V2:\(_P""
MOW[0?[/OC/\ X)7>!_"/@SXN^$O$OBRWT*WCD\/Z;J5O/J,<@LXPZ2VZ,6C*
MOE0,N3@D[>E=&04<>WP+&M0QCCAL]Q*_>T*T51I.I=74HOV<'NN9V[.PJCBG
MB;..M./5:NT;ZK=[W^9_(I_P2L@@N?VM_A7#<PQW$3:QI(,4H#(2;@#D$$=Z
M_O/_ ."S_P#P46UO_@FK^SIX&^(GPB\$^'M2^(NJZ'86T-S?6D.V&T:UMT'S
M!"S%91*VXY8@\ \"OX(_^"8.MZ'X4_:M^&&K^+-4MO#^CVFL:2]WJ-](L5O;
MHMPI9I'?:H"CD\FOZ9/^#GSXW?!#XK_LT_#+3?A7\3?"_CW5K32+2*XL=!OX
M+V>'8% \U8B61R!EH\-M/R[B:_0^,LKI9KX@<)87&X2IBLOJ0JQQ4.6I+#N+
M:?+6G#W%%]5*2OHM3BPTW3P=>49*,UL[J^\;-+?36W9GZ@?\$W/V@-9_;)_8
M0^,7[2'Q7\+Z,GCOQ%X;O#=+'!&4B6>V<G8VTXQN[=^ <9S)_P $G_V:/A%^
MSI\._CM^T_?^&;#5-;U.35]62:ZLHYI;-[::6]5+1G4^6'9%0LN2BDE0& (^
M//\ @B9\>OV?/!?_  2\\;^#O'WQ=\)^%/%%WX<N(DT'5=1M[:_9QI\IC6."
M1P\C/,J1E<+M#%N=N#<_X)!?\%&_!WBCQ#\<OV;?BT([CX>W&H:I9:'XBX;3
MOL$MS)%-(TA!CV&UW/D,#D<9&0?SW-LLS&G_ *[4,NPV(HY?A\UP:K8>DJE-
M3RZE*"5'#.6DX0LK*#>B5VSLIU(?[*YR3E*$FI-KXW;65MK^EOP$_P""=?\
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M+X:Z;KUM=V/AW0O$\-O:12(T,NR>"*XC5H0V4(9%! .57.*^"_\ @MC^T'\
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M/@;0_CEJGA];@:YXBBM[5+R]<W(<W,\@7?\ ,L)&X\!FYY 'YD?##]J;X0^
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M?^C5JG5S1/\ D;?!W_8Q6'_HU:4OAG_@G_Z0Q/;YQ_-'^LU_P2N_Y,X^&/\
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M !]1S.EV#QR+A2),\9SG@\U%%'J*M^_\0^(;V'O:WNKWES:MSD!H)9&C8#H
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MAD/H000:B@2Z0-]JU/4]48_<?5+V>^>+WB:=F,9'4%<5/12OT_1?GN%E>_\
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M /\ KI#_ .C17QK7V5_P3L_Y/!\ ?]=(?_1HKAS3_D59G_V XC_TDJ/QT_\
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M[KUTO\*76JW<Z)[HLDA"GT(P>*=''>JY:76M;NXNUM=ZG<W%L/80R.4 [8
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M:RTDVL\MK,;- T<)CDC*,%"[ H4X  P>M?G<FDVJ,&#W1(.<-=SL/R9R*T@
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M2E\,_P#!/_TAB>WSC^:/]9K_ ()7?\F<?#'_ +!-I_Z31U^C5?G+_P $KO\
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M7)^WA^S'K_QKB\02:=XMTN>?3K?3][I;_P!JP(Y:*7L-K(Q.2, $YXK]U_\
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MVU?CUJ7Q(\?^(O$UOK&O>)K$Z1JNH37>GV,$5S*L0MH9794,8"E2H&"JXQ@
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MU^W7_!#O_D?/B=_V#[S_ -)WKY[BS_DG<S_Z]0_].1+I?QJ?K^L3\S/VP_\
MDZ;XJ_\ 85F_]'-7SQ7T/^V'_P G3?%7_L*S?^CFKYXKU\#_ +C@O^P/"_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#.U7_ (\V_P"NL'_HY*_IVUG_ )1/
M6_\ V!%_])A7\Q.J_P#'FW_76#_T<E?T[:S_ ,HGK?\ [ B_^DPKY'BW_F0?
M]CJC_P"XS2A\=;_KW^L3^8C2/^0?!_VT_P#1CUI5FZ1_R#X/^VG_ *,>M*OL
M)_'+_%+\V91V7HOR"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<W^JE_ZYO\
M^@FI*CF_U4O_ %S?_P!!-..Z]5^8']%__!(?_DU+XR?]@S5/_0)*_GQ\9_\
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M8FHJ<JDXJRCRJTH)VY7=.]A+"T*DJ,XQ<83A*4X7W:2:WW_I]SY;_P"":O\
MP1&\%?L&?MD6GQ6\ _$S0_&5LD"V>HZ=;ZG%=WUHR(RR%K?<SQNAR3P"""01
MP:_-#]OKPCXV\:?\'!6D6GP]U6?1M9M(+%FDM6V&9U\L_.5QG)SG().><FN/
M_P""%GQ%_:VUO_@KE\7]-^)MS\2;KP2^O:P@@\0/?-HELAENT/D+-^YV"+;(
M&3( 8#(93CZB^/;%/^#C*S9&*L;6RR5.#G$?IWQ2Y<UP/%F;RS/,Z.<8Q<"5
MZRQ2I1C!PJ0IRC2J03<9N#;3E?WM[6L'N2H4N2#IQ>*2Y?.Z3:ZZ^O<^9/\
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MO_(PSG_L%I_^E,\_,_@I?XW_ .VGQ2XW(RCJ5('X@BOW<_X(U_\ !6_X5_\
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M.;I*C=>S3O:WO7TZ^J_JXM%%%>P2%%%% !1110 4444 %%%% !1110 4444
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M_@H9_P %S?@K^V=^S3\)_@7X/^'FIZ'K?P[U/0K_ %#4+I7$,Z:2;7S(X,@
M+(+9GVDDF21SG# #B_\ @IU_P6C^#W[>7[#/P[_9.\#^!-5\.^*O!FB:/I=[
MJ][O^R/+IFC:=I<CVVY5V":2Q:5P2VYWW#;D+7\[PC13E40'U"@'\P*4(BG<
MJ*K>H4 _F!FM,)P5P[@I99+#8:O!Y1C:^88'FQ52?L\5B>1UISO_ !(-P7+!
MZ1M9=0>(K2Y^:47[2,8R]VUU':VNC7>VO4_HQ_8C_P""V'P:_95_X)P^-OV)
M/$_@/5M7\:>*/#&L:#9ZY:[Q8B?5++[(LMR C>8(7R\>&3:QRVX'%=K^PW_P
M78^"'[*'[%_C3]E[Q7\.M5UKQ'XG?7'M=4MU<VJ'5?-\DS84Y,)D5D(9=IR2
M#D@?S,&-"=Q1"WJ5!/YD9H,<9.2B$^I52?S(I8G@CAW%_7O;X;$2_M',J6;8
MOEQ52//C:-_9U(6^""YG^[6FN_8C7K1Y+2C^[@Z<?=^R[7OKOI_5S^A3_@FM
M_P %S/\ AB#QI\2S\1=#U#QC\+OB'JES=Q^'V:6Y^QV]U-*ZQK$V]%"I( 5*
M[& *LI4D']5-;_X.4/V#_ACX?\82? C]GC^P?'_CK3M0(UE-*BB,6H7L$B1O
M-,L/FE(I)!(JK(@+@%PX5=O\3#(C<,JL/1E!_F*8(8A_ I],JIQCTXX_"N;,
M/#[A?,\9/'8G"8E5JOLE7AA\74H4,1[%15-UZ4/=FURJ[?Q/?R<,3B*<5",H
MV3=G**<E>U[-W??3IW[?TG_L"_\ !P?XL_9\^+GC[Q'^T1I$WB[P-X[U"^:T
MT[3O,,EG9WK.%# $@% XZ@C(.1C@_H-I7_!QQ_P3Z^$/Q.N/'_PY^ NM1Z_K
M)GEU_46@?S9!=*XE\B7!99 '^4\@'J".#_%:R(PPRJ1[@''TR#3!#$/^6:'W
M95)_,C-+'>'G"N/Q-7$U<)B:$J]&%"O1PF+J8>A5ITURPYZ<+)M+?N]6..*Q
M$4DIQ=G=.4;R3=KZOOV_I?U!W/\ P7O^!]Q^VS%^U0/AMJ/_  C"7!G;1S%*
M9L%]^ O!'I@ X]:_.#_@K]_P4/\  '_!2?XTZ)\4/AWX9O?"VF:2D"R6U_N\
M^;R8EC+N2%W,Y7+$*,L<X&<5^3OEQXQL3'IM7'Y8I555X554>B@#^0%>CE_"
M.197CL+F.#P]:&+P6#> P\YXFI4A'#;<CA+24K7]]Z_I$JU6<7"4DXRDIM**
M7O*VJ?Y_EM9U4-4_Y!]W_P!<C_,5?JAJG_(/N_\ KD?YBOIX?''_ !1_-&4M
MGZ/\C^G#X#?\HK_$W_8&N/\ TFEK^9"P^Y<?]?U[_P"E#U_3A\!5)_X)7>)C
MCC^QKGG_ +=I3_2OYC[#[EQ_U_7O_I0]?(\+?[QQ+_V.)?\ I"-JV]+_ *]+
M\H%ZBBBOK#(**** "BBB@ HHHH **** "BBB@ HHHH **** "OVZ_P""'?\
MR/GQ._[!]Y_Z3O7XBU^W?_!#H$^//B=@9_XE]Y_Z3O7SW%G_ "3N9_\ 7J'_
M *<B72_C4_7]8GYE_MA_\G3?%7_L*S?^CFKYXKZ'_;$&/VIOBJ#_ -!6;_T<
MU?/%>O@?]QP7_8'A?_3%,A_%/_$_R04445U %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7V5_P3L_Y/!\ ?]=(?_1HKXUK[*_X)V#/[8/@ #_GI#_Z-
M%<.:?\BK,_\ L!Q'_I(X_'3_ ,:_4^K_ /@M;_R<;X6_Z\$_] %?D-7Z]?\
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M^"_&DOC3P/\ LU3:'J>I,?[9U*QTN.SU&<2@K<.MQ# G[Q@S?,$V^JD$BOR
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MZ:J2UQ>K8SI/(I<HF_(&Q,*,( IR1D_C0(T ("( >H"@ _48I554^ZJKGKM
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M "O?^(?[_@JU_P!$<C_[]2?X4?\ $/\ ?\%6O^B.1_\ ?J3_  K_ %0J*/\
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MXCAQ/_T+\E_\)ZW_ ,O\OS[L/[-H_P#/RK_X$O\ (_RO?^(?[_@JU_T1R/\
M[]2?X4?\0_W_  5:_P"B.1_]^I/\*_U0J*/^(X<3_P#0OR7_ ,)ZW_R_R_/N
MP_LVC_S\J_\ @2_R/\KW_B'^_P""K7_1'(_^_4G^%'_$/]_P5:_Z(Y'_ -^I
M/\*_U0J*/^(X<3_]"_)?_">M_P#+_+\^[#^S:/\ S\J_^!+_ "/\KW_B'^_X
M*M?]$<C_ ._4G^%'_$/]_P %6O\ HCD?_?J3_"O]4*BC_B.'$_\ T+\E_P#"
M>M_\O\OS[L/[-H_\_*O_ ($O\C_*]_XA_O\ @JU_T1R/_OU)_A1_Q#_?\%6O
M^B.1_P#?J3_"O]4*BC_B.'$__0OR7_PGK?\ R_R_/NP_LVC_ ,_*O_@2_P C
M_*]_XA_O^"K7_1'(_P#OU)_A1_Q#_?\ !5K_ *(Y'_WZD_PK_5"HH_XCAQ/_
M -"_)?\ PGK?_+_+\^[#^S:/_/RK_P"!+_(_RO?^(?[_ (*M?]$<C_[]2?X5
M%/\ \&^W_!5J[BDMO^%.QCS5*Y$4G'?T'IZU_JCT4?\ $<.)_P#H7Y-_X3UO
M+_I_Y?U=A_9M'^>K_P"!+_(_S-M'\ ?\%#?A+\/)_P!@6_\ @K ?%6MQ'38Y
M#$V[?*OD<9&X$M)G&<]NAP? 8O\ @WV_X*M6X<?\*<C/FRR7'^JD_P"6SE\=
M#T)/3'TS7]>7QXU.^7_@JEX8=;APT6K6J1D8^54N45 .. H  ^E?TJUZ6/\
M%#-\BIX*M@<LRB$\XPT<PQKE2KS4\3)I-Q7MERQMLM=_4B&!A4OS5*G[M\D;
M-:1LG;8_RO?^(?[_ (*M?]$<C_[]2?X4?\0_W_!5K_HCD?\ WZD_PK_5"HKS
M?^(X<3_]"_)?_">M_P#+_+\^[+_LVC_S\J_^!+_(_P KW_B'^_X*M?\ 1'(_
M^_4G^%'_ !#_ '_!5K_HCD?_ 'ZD_P *_P!4*BC_ (CAQ/\ ]"_)?_">M_\
M+_+\^[#^S:/_ #\J_P#@2_R/\KW_ (A_O^"K7_1'(_\ OU)_A1_Q#_?\%6O^
MB.1_]^I/\*_U0J*/^(X<3_\ 0OR7_P )ZW_R_P OS[L/[-H_\_*O_@2_R/\
M*]_XA_O^"K7_ $1R/_OU)_A1_P 0_P!_P5:_Z(Y'_P!^I/\ "O\ 5"HH_P"(
MX<3_ /0OR7_PGK?_ "_R_/NP_LVC_P _*O\ X$O\C_*]_P"(?[_@JU_T1R/_
M +]2?X4?\0_W_!5K_HCD?_?J3_"O]4*BC_B.'$__ $+\E_\ ">M_\O\ +\^[
M#^S:/_/RK_X$O\C_ "O?^(?[_@JU_P!$<C_[]2?X4?\ $/\ ?\%6O^B.1_\
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M7Y+_ .$];_Y?Y?GW8?V;1_Y^5?\ P)?Y'^5[_P 0_P!_P5:_Z(Y'_P!^I/\
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M\KW_ (A_O^"K7_1'(_\ OU)_A1_Q#_?\%6O^B.1_]^I/\*_U0J*/^(X<3_\
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M?'3X?6W[!FF?!6!?%/AZ,:9*XB;=YD $/89X,6#D]\DGK7^F0Y*HY'4*Q'U
M)%?S6?LR:E?/_P %2/&3-<2$S:M>1R$D?.DDLBNIXZ,I(/L:]++_ !/S?/*>
M.Q&.RS*)U<FPSS# N-*O!0Q,9**E)>V?,K)76A$L%3I."C.I:K)0E=IZ-KRW
M_P K'\AL/_!OM_P5:M8H[?\ X4Y&?*4)GRI.>X['L?7Z5+_Q#_?\%6O^B.1_
M]^I/\*_U0J*\W_B.'$_7+\E_\)ZW_P O\OS[LO\ LVC_ #U?_ E_D?Y7O_$/
M]_P5:_Z(Y'_WZD_PH_XA_O\ @JU_T1R/_OU)_A7^J%11_P 1PXG_ .A?DO\
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MO^B.1_\ ?J3_  H_XA_O^"K7_1'(_P#OU)_A7^J%11_Q'#B?_H7Y+_X3UO\
MY?Y?GW8?V;1_Y^5?_ E_D?Y7O_$/]_P5:_Z(Y'_WZD_PH_XA_O\ @JU_T1R/
M_OU)_A7^J%11_P 1PXG_ .A?DO\ X3UO_E_E^?=A_9M'_GY5_P# E_D?Y7O_
M !#_ '_!5K_HCD?_ 'ZD_P */^(?[_@JU_T1R/\ []2?X5_JA44?\1PXG_Z%
M^2_^$];_ .7^7Y]V']FT?^?E7_P)?Y'^5[_Q#_?\%6O^B.1_]^I/\*/^(?[_
M (*M?]$<C_[]2?X5_JA44?\ $<.)_P#H7Y+_ .$];_Y?Y?GW8?V;1_Y^5?\
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M7Y+_ .$];_Y?Y?GW8?V;1_Y^5?\ P)?Y'^5[_P 0_P!_P5:_Z(Y'_P!^I/\
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MR3J?O)1A*[3T;7DG^)_(?;_\&^G_  5:LXDM_P#A3L9V9Y\J3^)BWH?6IO\
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MP11_X*$_$7_@H1\#_$7Q%^(MM:6VI:7J;6D2VD:1H8Q.\0)"@#)"YZ?GQ7[
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MTK6=)UVT2_T;4;/4[*3[EU97$=Q"WT>-F%:5?Q&?\$%OVT/VI=#_ &N/B/\
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M_P#1=K7U];_DB\'_ -C?$?\ I!SQ_P!YG_U[7YQ/N>BBBOD#H"BBB@ HHHH
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M+F2*3*MQT48)KY&_:&_X*"_$?X7?LH_LQ?&S2+:T;6OB_9:%/K,;HIBC?4C
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M?^"5G_)WGQL_Z^];_G/7](-?S??\$K/^3O/C9_U]ZW_.>OZ0:^HXS_Y'3_[
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M1IU)UHRJ16KIU:=5TFUI>*>Z)]FVZT&FHU&I1DEL[)66EKIJ_I?U/R _9_\
M^"XW[).G?#K0/#'[1/BR;X4?%'POI6G:'KOA^_TJ^D,USIEC%:33Q$*,,\EN
MS%> =ZXP<Y^+/%_B+5/^"PW[:/POU#P'IU^_[._P!\2Q>(],\2SVT]K;ZR\,
MZ3 @2(J-YI1,]<\GI7[N^/O^"=?[%7Q-UF3Q#XT_9Y^'^L:W-.UQ<:G+IKK=
M7$KG+&9A-M8,>2 J\DU]"?"[X*_"GX*Z.= ^%7@70/ ^D%55K+0K3[-$X3&T
M/EW9L$ XW8R <41SWA[+GB,=DN7YC1S;$4JU*$L77P]3!X%XB/)6GA8TX*K*
M7)*<*;J-\L9:A[*K/EC4G!PBTWRIJ4N6UD[W5KJ[MN?SX?M:-:V'_!5C]F/3
M-.LKJ&RL;G1[./R;64VT9MI(826D1/+7[O))_/BOM/\ X+@^-_CEX#_8J\0Z
MS\"GO[;7AK%C#J]]IJ3/<VNC2G;=.!!^\P(A*3@'I^!_4;5?A#\,M<\4Z?XV
MU?P5H6H>+-)<2:;K]S:[]1LY VX/!-O&U@1D':<5U'B;PMX>\9Z+>^'?%.D6
M6NZ'J,9BO=,U"(36MQ&05*R1DC/#$ @@C)KC_P!8J'UOAO$2P7MH9'2I4Z]&
MO*,X8MPK2JR=K62DI6M*_O*[T*]B^6M'FM[1W32LXZ)?H?R2>%M;_P""5>I?
ML,ZEK7Q.F?XB?'63X2ZI?>*(KI-2DUB/QI=:3=Q".*/_ %:I;WK1RN'#N0I"
M@$@UZ%_P2MNH)?\ @A?^TI/86=[:Z0+/XM-HUE-:S1W,>F_8(/L\:0.JROA,
M!<+SCBOW:TS_ ()S?L<:3K5_K5I\$?"6[4T=;RPDL]UA,9 1(6A4J2&!(V[^
MISGM7T7X5^"7PF\$>!;WX9>$O /AW0/ &HQ7,-]X4TZS,.CW45VH2Y2:WWL6
M6=%"R?-\P%>SCN+LOJX.KA</#-Z[KYS@,V;QV)I3I8>&$E4G+#8:E!*---U.
M6,DDN6,4U9(SCAYJ:E)TU:G*'N)IMR27,V]]KOS;[GXF?\$D?%]MX-_X(UP>
M+[Z&6*VT=?B#=S17<3VT@0W]C!ADE",H)E!!.,]*N_\ !$SPW?S7O[0/Q0>*
M2/2O'^OO=:=N5@C*NI%R8V/RLNT Y7U],5]W_M9_L^>(M5_9TU']G?\ 9U\'
MZ5X6\+>+HY=/U2VT: VMKI5I=3I)=20H')4S,B.Y!Y*#/&*]I_8\^ %A^S;\
M!? OPPA@B&I:%I8AU:]5<37MX\KRO)*W!8C<!SZ=:XLPSC"U\NS_ !-.T,3Q
M#G$JT<,YJ=3#X.%1XA.JTK*7M;05K<RU6A4*4HRI1>L:--+FU2<M%HO1:_U;
MZAHHHKX@Z0HHHH **** "OBC_@H[KVK^&/V%_P!J#Q!H-VUCK.D_"C7KO3KM
M"0UO<QM;!)%(YRNXU]KU\)?\%.O^3 /VL/\ LD'B#_T.UK;#.V(P[6ZK4FO_
M  9$'JFNY_E#_ __ (*!_P#!0OX?:=K.J?"_]HS7/"B:QJ^H1:A%#<W"><\-
MQ\Q_=L/E,J$KG)( ).>![M_P];_X*S_]'=^(_P#P-O?_ (NOSL^%_P#R*]Q_
MV,&M?^ELM>A5_9N%X)X6Q6$P>(Q.44:]>MA,/4JU:LYSG.<J4&VY-MMW_3L?
M._6*Z<E&HXI2LE966STV[+_,^T?^'K?_  5G_P"CN_$?_@;>_P#Q='_#UO\
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M_H187_R;R_R_+MJ?6<3_ ,_7]WIY^2/M'_AZW_P5G_Z.[\1_^!M[_P#%T?\
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M\_7]WIY^2/M'_AZW_P %9_\ H[OQ'_X&WO\ \71_P];_ ."L_P#T=WXC_P#
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M_%U\744?ZA<'_P#0BPO_ )-Y?Y?EVU/K.)_Y^O[O3S\D?:/_  ];_P""L_\
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MVS>'O[1.;:G25._73K?S_#S/PW_9K_:>^"GQG_X):_$3P)\,_$EQK?B?P'\
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M.D1K\<K(%^SA0"2<$ _7-?TF?MS_ +(5[XN_X)LW7[,_A*V:\/A?0="ABMH
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M_-GPW7;++N9#R<%2",\8XK\,_P!J*Y9?^"Q7P\C$%VW_ !3FF#SDMI7@&+6
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M%U+X=V_A[3_!8TRY-]+XH33K6QDT]EQ@(MPKG.W( VX_BKY>_9O^$'CKPO\
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MU/'I]"?##X-?"_X,:(GASX7^"M$\&:.H7-EHUM]GC=E4+ODRS$NV 6(P"<X
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M#KUZ=+2<X0O%-*[BF[<TDM7&-Y):V"4X0MS22OM?^MO/8_62BO*=>^-OPO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF2B[6;T>O2V]_0_1:BOEK]G+]KSX0_M+V,X\#ZY;KXBL(_-U7PO<3H=6T]0
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M4_J_M/8^VY7[-U5'FY%+9RY7>RZ%75^6^MKVZVO:_P!YZ51116(PK^9C1O\
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M ,$/^OS1?_0H:_H+\ _\B/X0_P"Q:T3_ --UO7\^G_!6G_DY_P""'_7YHO\
MZ%#7]!?@'_D1_"'_ &+6B?\ INMZ^NSS_D0<,?\ 8/BO_3D3"G_%J^J_)'6T
MC,J@LS!54$EF(  '4DG  '<FEKRKXW:AK.E?"KQO?^'ED?6+;0KZ2Q6+/F><
M(7VE<<Y'7CFODHKFDH[7:5WLKNVIM)\J;WLF[+?0\!^,O[?O[-'P*\0V_ACQ
M[X^TS3]6N)E@6W^U6X82,<!2'D!X/M^5?1WP[^)?@;XP^%(/$O@S6++7M!U*
MW(,MO+'*ABF0ADDV,1AD)![=1Z5_D#_\%3_C9^T/JW[67C#_ (3?Q!X@TH:?
MK-T^EP/=W*)MBN)O+95R!@ * !GOSFOZU?\ @UK_ &S/'7Q#^%WCCX5>+_$,
M^LZII]A=-I$=W<M-.HA4K%L$A)!X&,9]J^AQ61>PP=/$PJ\TFZ:GI[J4VE=/
MLG+5M]&>+2S=3J55*G:$*5:I%1NY_N82FX-;J;4&DE?==&?K+^WK_P $M_\
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M^M[]M.@;[6\Z1F1B9B6+*Q;&&!)QGYQ_;Y_8;\?_ !]_9C^&NJ> 1)IOQO\
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MA3IUJ\,1@&HT5S.,JL8JHTHKF45+S)A3<88;W&FJEY::I.+NW;HVEJS\_/\
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MK1\)OV7OCCHW_!9SXT?M"ZYX3:+X)>*/AA/H>E>(F5O+N]2-GL6W)(VG+G&
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MV!\5/BC\/O@3+\;?!'Q*U^ZU.+Q!<1W%VVE27K2.D4#G+P$,Y"M"Z,A^9&#
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M\*OVS?\ @FE^T_\ &#XF_ KX77/Q@^$7Q;U)[V_TV-+B2+1_.N3.FP18V!)
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MUC2[=K=7E>VM@%8- ZE@0<$''K7O'_!9S]F+XY?M&:A^R#-\&?"S^)8_A_\
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MGYCSW/4_PW_\%B_BS^TK<_M;>-+2XF\0VV@Z?K$<7AQ+47B0&..=ECV>5A"
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MEQIJI-\[BE.5G;W=[7Z_AL&'H5Z]?$XJ-65%SJ.G%."?N1MM?76U]5UWW/\
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MS%(23N&%('4G/&#^_OP^_P"">O[)/PQUB#7?"7PDT*SU*V</#//;V]SM96#
MX:W7HP!Z_2OSD_X(%_#GQU\./V8XM)\=:/<:/J6Q<V]Q$\+<-%_"X!XP1Z\?
M6OWPK+'XBL\5B(JM-PYW9*<N5JRM;78UP="FL/1YJ4%)07V5>ZMOYW7X$%M;
M6]G#';6D$-M;PHL<4$$:111HHPJI&@554#@  "IZ**\X[@HHHH *YSQA_P B
MEXH_[%[6?_3=<UT=<YXP_P"12\4?]B]K/_INN:NG_$I_XX_^E(#^>'_@E9_R
M=Y\;/^OO6_YSU_2#7\WW_!*S_D[SXV?]?>M_SGK^D&OJ.,_^1T_^P+ _^H\3
MGPW\+_MY_H?D+_P65_Y-KL/^PX__ *#:U](_\$X?^32OAO\ ]<)O_1-I7S=_
MP65_Y-KL/^PX_P#Z#:U](_\ !.'_ )-*^&__ %PF_P#1-I5U?^2+PG_8XK_^
MFD$?]YG_ ->U^<3[IHHI&945G=@JJ"S,Q"JJJ,EF)P   222  ,FOD3H(9[:
MVN0@N((9Q&XDC$T:2!'7HZAP<,/45/7(VGC[P1?:A-I5EXKT"ZU*VSY]C!JE
MI)<PXZ^9$LI=<=\BM^SU33=0W?8;ZTO-I(;[-/',%(Z@F-F ([U4HSC\491V
M?O)K1[/5=>G<+KO_ %_31?HKE-8\=^#/#]XNGZYXIT+2;YPI2TO]3M;:X8/C
M;B&617.[(QQSFNDM[JVN[>*[M9XKBVF02Q7$+K)%)&>0Z2(2K+P>02.#0X32
M4G&2C+X9.+2EZ-JS^0$]1>1#YQN/*C\\Q^49MB^:8MV[RR^-VS=\VW.,\XK#
MO/%OAC3[>:[OO$&D6EM;,4N)[B_MHHH7'596>0!&'<-@BI=$\3>'O$D+7/A_
M6]+UF!3AI=-O8+M%^IA=\=1U]1ZBCDFHN7+)1T3EROEUV3=K:] -RF"*(2-*
M(XQ*ZA6E"*)&48PK.!N*C P"2!@8JGJ6JZ;H]J]]JU_::=9Q_P"LNKV>.W@3
M/]Z25E4=#WK+T+Q?X6\3^;_PCOB'2-;\@D3?V9?V]X8R#@AQ#(Y7!X.:%&;B
MY*,G%:.23Y5Y-VM][ Z.BJ%WJFFZ>RK?7]I:,XW*+FXBA+#GD>8RY'!Y]JQ+
M+QQX.U'4'TFP\3Z'>:E$ADDL;;4K6:Z1%^\[0I(7"CG+$8X//%"A-IM0DTE=
MM1;27=NUK>8'545R=YX\\%:>J/>^*M M4DF^S1M/JEG&'GSM\E=THS)NXV?>
M![5^7?Q+_;U\4^$?VN=*^"5@NF2>#+RZCCN-9;RFCBADD"^89\$;0I)#!L'C
M!YKMP66XO'RJ0P]/6E1J5Y.=X)TZ5N?E;3YI*ZM%:LB4XQLWU:2MKJ]OS1M?
ML3?L-Z_^S=^U'^UG\:M2NQ/IGQ[U==1L[<D,(PNHQW?S D\E5((XR#[FOU41
M$C4)&BHBC"HBA54>@50 ![ 5S&D^./!VNW1L=&\3Z'JEXN=UK8ZE:W$XQUS%
M'(SY]L9KIWD2)&DD=8XT4L[NP5$51EF9F("J!R22 !UHS'&XO,,3]8QFM=T<
M/1^#DO3P]&%"E[OE3IQ5^K0X1C!6CM=O>^K=W]]QU%<C9>/_  1J.HMI%AXL
M\/W>J*VQK"WU6SEN@_/RF%)2^[@\8SQ76LRHK.[!54%F9B%5549+,3@   DD
MD  9-<4HRBTI1E%M72DFFT]FDUJF4(Z)(CQR*KQNK(Z, RNK AE93D%6!(((
MP0<&DCC2)$CB18XT4*B(H5$4# 55    X  Q7')\1O 4FH?V5'XQ\./J1?RQ
M8KJUDUT7!QL$(EW[L\8QUKLP0P#*05(!!!!!!&001P01R"."*)1G"RE&4;ZI
M235UW5TK^H$<T$-Q&T,\4<T3XW1R*'1L$,,JP(." 1QP0"*E       P .
M.@ [ 445(!1110!'Y41D$QCC,H78)=B^8$/)4/C<%)_ASCVJ2BB@",Q1&193
M'&954JLI13(JG.55R-P4Y.0"!R?6I*** "BBB@ HHHH **** "BBB@ HHHH
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MJY_P@_[0_P#T;/\ %K_PFM2_^1*/^$'_ &A_^C9_BU_X36I?_(E=7^LO#O\
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MITZ=[?Y_UK:G15S_ (0?]H?_ *-G^+7_ (36I?\ R)1_P@_[0_\ T;/\6O\
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MP[_T.LO_ /!Z\O+S?W>8>RK?\^:G3IWM_G_6MJ=%7/\ A!_VA_\ HV?XM?\
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M *-G^+7_ (36I?\ R)1_P@_[0_\ T;/\6O\ PFM2_P#D2C_67AW_ *'67_\
M@]>7EYO[O,/95O\ GS4Z=.]O\_ZUM3HJY_P@_P"T/_T;/\6O_":U+_Y$H_X0
M?]H?_HV?XM?^$UJ7_P B4?ZR\._]#K+_ /P>O+R\W]WF'LJW_/FITZ=[?Y_U
MK:G15S_A!_VA_P#HV?XM?^$UJ7_R)1_P@_[0_P#T;/\ %K_PFM2_^1*/]9>'
M?^AUE_\ X/7EY>;^[S#V5;_GS4Z=.]O\_P"M;4Z*N?\ "#_M#_\ 1L_Q:_\
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M=?\ ] MJ^E/^"<?_ ":7\-O^N$__ *+M:^KK?\D7@_\ L;XC_P!(,(_[S/\
MZ]K\XGW/1117R!T!1110 4444 %%%% !1110 4444 %%%% #)/\ 5R?[C?\
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M%MZ6YFE>,;])/H^O_!/Z+'1)%9)%5T889'4,K#T92""/8BE5510J*%50%55
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MZ;G*@%F]VR>OK4E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ>UG_P!-US71USGC#_D4O%'_ &+VL_\ INN:NG_$I_XX_P#I2 _GA_X)6?\
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MM?LC1_X*M?'3XK^._A?\!?%'P \1S>$M0^)4&G2PW!G>%$AO&&]6*GG_ %K
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M:22B[6ZCH.U913CRNDW:,N:^JLY=I=/3U/V@HHHK\I.X**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\._:62)_@+\54FACGB;PAJ(DAF4
M/%(I\O*NAR&4]P1@U[C7A_[2O_)!OBI_V*.H?^TZZ<%_OF$_[":'_IV I;/T
M?Y'XQ_\ !&'PMX)U2U^,4=YX&\(SNNKSNDT^A:=<R(!J" QK]HMY0J-N!.T
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M2_AM_P!<)_\ T7:U\U_\%EO^3;-/_P"PZ_\ Z!;5]*?\$X_^32_AM_UPG_\
M1=K7U];_ )(O!_\ 8WQ'_I!SQ_WF?_7M?G$^YZ***^0.@**** "BBB@ HHHH
M **** "BBB@ HHHH 9)_JY/]QO\ T$U_,_\ LQ?\I1O%O_89N?\ T>]?TP2?
MZN3_ '&_]!-?S/\ [,7_ "E&\6_]AFY_]'O7U_"_^Z<2?]BB7_I9SU_CH?\
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MTW_P.M?_ ([1RR_EE]S_ *ZK[P-*BLW^V='_ .@KIO\ X'6O_P =H_MG1_\
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M /':]WB]-\08ZR?_ "YZ/_GS37YF5#^%'^NQI45F_P!LZ/\ ]!73?_ ZU_\
MCM']LZ/_ -!73?\ P.M?_CM?-<LOY9?<_P"NJ^\V-*BLW^V='_Z"NF_^!UK_
M /':/[9T?_H*Z;_X'6O_ ,=HY9?RR^Y_UU7W@:5%9O\ ;.C_ /05TW_P.M?_
M ([1_;.C_P#05TW_ ,#K7_X[1RR_EE]S_KJOO TJ*S?[9T?_ *"NF_\ @=:_
M_':/[9T?_H*Z;_X'6O\ \=HY9?RR^Y_UU7W@:5%9O]LZ/_T%=-_\#K7_ ..T
M?VSH_P#T%=-_\#K7_P".T<LOY9?<_P"NJ^\#2HK-_MG1_P#H*Z;_ .!UK_\
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MM?\ X[1_;.C_ /05TW_P.M?_ ([1RR_EE]S_ *ZK[P-*BLW^V='_ .@KIO\
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M?^U2Z/\ EB*E_"A_A1I45F_VSH__ $%=-_\  ZU_^.T?VSH__05TW_P.M?\
MX[7A<LOY9?<_ZZK[S0TJ*S?[9T?_ *"NF_\ @=:__':/[9T?_H*Z;_X'6O\
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M#D%F9V$=A<1@LY)8D)<@9)))K[Z_MG1_^@KIO_@=:_\ QVC^V='_ .@KIO\
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MIO\ X'6O_P =HY9?RR^Y_P!=5]X&E16;_;.C_P#05TW_ ,#K7_X[1_;.C_\
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M_P#':.67\LON?]=5]X&E16;_ &SH_P#T%=-_\#K7_P".T?VSH_\ T%=-_P#
MZU_^.T<LOY9?<_ZZK[P-*BLW^V='_P"@KIO_ ('6O_QVC^V='_Z"NF_^!UK_
M /':.67\LON?]=5]X&E7\S&C?\I7[G_L-R_^E+U_2L-8T@\#5-.)]!?6Q_\
M:M?S1Z->Z5_P]?N7.K6 A.MR'SC<)Y>/M+<[MV/;@]>]?6\*IJ.>Z/\ Y$^(
M>S[KR_X<PK;T?^OL?S/Z;:*SCK&D#@ZIIP/H;ZV'_M6D_MG1_P#H*Z;_ .!U
MK_\ ':^1Y9?RO[G_ %U1N:5%9O\ ;.C_ /05TW_P.M?_ ([1_;.C_P#05TW_
M ,#K7_X[3Y9?RR^Y_P!=5]X&E16;_;.C_P#05TW_ ,#K7_X[1_;.C_\ 05TW
M_P #K7_X[1RR_EE]S_KJOO TJ*S?[9T?_H*Z;_X'6O\ \=H_MG1_^@KIO_@=
M:_\ QVCEE_++[G_75?>!I45F_P!LZ/\ ]!73?_ ZU_\ CM']LZ/_ -!73?\
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M9E_T!Y/T_P"9;0\O\OZL@^KP_FJ?^!OR_P D?S6?\,%_\%1/^BTZ5_X-HO\
MX]1_PP7_ ,%1/^BTZ5_X-HO_ (]7]*=%'^N69?\ 0'D_3_F6T/+_ "_JR#ZO
M#^:I_P"!OR_R1_-9_P ,%_\ !43_ *+3I7_@VB_^/4?\,%_\%1/^BTZ5_P"#
M:+_X]7]*=%'^N69?] >3]/\ F6T/+_+^K(/J\/YJG_@;\O\ )'\UG_#!?_!4
M3_HM.E?^#:+_ ./4?\,%_P#!43_HM.E?^#:+_P"/5_2G11_KEF7_ $!Y/T_Y
MEM#R_P OZL@^KP_FJ?\ @;\O\D?S6?\ #!?_  5$_P"BTZ5_X-HO_CU'_#!?
M_!43_HM.E?\ @VB_^/5_2G11_KEF7_0'D_3_ )EM#R_R_JR#ZO#^:I_X&_+_
M "1_-9_PP7_P5$_Z+3I7_@VB_P#CU'_#!?\ P5$_Z+3I7_@VB_\ CU?TIT4?
MZY9E_P! >3]/^9;0\O\ +^K(/J\/YJG_ (&_+_)'\UG_  P7_P %1/\ HM.E
M?^#:+_X]1_PP7_P5$_Z+3I7_ (-HO_CU?TIT4?ZY9E_T!Y/T_P"9;0\O\OZL
M@^KP_FJ?^!OR_P D?S6?\,%_\%1/^BTZ5_X-HO\ X]1_PP7_ ,%1/^BTZ5_X
M-HO_ (]7]*=%'^N69?\ 0'D_3_F6T/+_ "_JR#ZO#^:I_P"!OR_R1_-9_P ,
M%_\ !43_ *+3I7_@VB_^/4?\,%_\%1/^BTZ5_P"#:+_X]7]*=%'^N69?] >3
M]/\ F6T/+_+^K(/J\/YJG_@;\O\ )'\UG_#!?_!43_HM.E?^#:+_ ./4?\,%
M_P#!43_HM.E?^#:+_P"/5_2G11_KEF7_ $!Y/T_YEM#R_P OZL@^KP_FJ?\
M@;\O\D?S6?\ #!?_  5$_P"BTZ5_X-HO_CU'_#!?_!43_HM.E?\ @VB_^/5_
M2G11_KEF7_0'D_3_ )EM#R_R_JR#ZO#^:I_X&_+_ "1_-9_PP7_P5$_Z+3I7
M_@VB_P#CU'_#!?\ P5$_Z+3I7_@VB_\ CU?TIT4?ZY9E_P! >3]/^9;0\O\
M+^K(/J\/YJG_ (&_+_)'\UG_  P7_P %1/\ HM.E?^#:+_X]1_PP7_P5$_Z+
M3I7_ (-HO_CU?TIT4?ZY9E_T!Y/T_P"9;0\O\OZL@^KP_FJ?^!OR_P D?S6?
M\,%_\%1/^BTZ5_X-HO\ X]1_PP7_ ,%1/^BTZ5_X-HO_ (]7]*=%'^N69?\
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M )EM#R_R_JR#ZO#^:I_X&_+_ "1_-9_PP7_P5$_Z+3I7_@VB_P#CU'_#!?\
MP5$_Z+3I7_@VB_\ CU?TIT4?ZY9E_P! >3]/^9;0\O\ +^K(/J\/YJG_ (&_
M+_)'\UG_  P7_P %1/\ HM.E?^#:+_X]3X_V#O\ @J)&ZO\ \+HTEMIS@ZM%
M@\$<_ONE?TH44O\ 7+,O^@/)_P#PVT/+_+\?)!]7A_-4_P# WY?Y(_D3U_\
MX(U_\%"?$'Q6MOBS>?%S0G\0VLHFBG;4[8R!U8,"&,N1R >W3J#7TX_[!W_!
M41]O_%Z-)&U%3C5HN=HQD_ONI[^_-?TH45M5XZSBLJ2JX?*9JC!4Z2EEU%\D
M$T^6-V[+\N@EAJ:NTZB;W]]Z^OW'\UG_  P7_P %1/\ HM.E?^#:+_X]1_PP
M7_P5$_Z+3I7_ (-HO_CU?TIT5E_KEF7_ $!Y/T_YEM#R_P OZLA_5X?S5/\
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MTIT4?ZY9E_T!Y/T_YEM#R_R_JR#ZO#^:I_X&_+_)'\UG_#!?_!43_HM.E?\
M@VB_^/4?\,%_\%1/^BTZ5_X-HO\ X]7]*=%'^N69?] >3]/^9;0\O\OZL@^K
MP_FJ?^!OR_R1_-9_PP7_ ,%1/^BTZ5_X-HO_ (]1_P ,%_\ !43_ *+3I7_@
MVB_^/5_2G11_KEF7_0'D_3_F6T/+_+^K(/J\/YJG_@;\O\D?S6?\,%_\%1/^
MBTZ5_P"#:+_X]1_PP7_P5$_Z+3I7_@VB_P#CU?TIT4?ZY9E_T!Y/T_YEM#R_
MR_JR#ZO#^:I_X&_+_)'\UG_#!?\ P5$_Z+3I7_@VB_\ CU'_  P7_P %1/\
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MCWP/\.7/AOPM\7]$M[&ZD,CI'JENH#DGY@%EX/)'T/KG'L'_  P7_P %1/\
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M9;0\O\OZL@^KP_FJ?^!OR_R1_-9_PP7_ ,%1/^BTZ5_X-HO_ (]1_P ,%_\
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M:I_X&_+_ "1_-9_PP7_P5$_Z+3I7_@VB_P#CU'_#!?\ P5$_Z+3I7_@VB_\
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MO#^:I_X&_+_)'\UG_#!?_!43_HM.E?\ @VB_^/4?\,%_\%1/^BTZ5_X-HO\
MX]7]*=%'^N69?] >3]/^9;0\O\OZL@^KP_FJ?^!OR_R1_-9_PP7_ ,%1/^BT
MZ5_X-HO_ (]1_P ,%_\ !43_ *+3I7_@VB_^/5_2G11_KEF7_0'D_3_F6T/+
M_+^K(/J\/YJG_@;\O\D?S6?\,%_\%1/^BTZ5_P"#:+_X]1_PP7_P5$_Z+3I7
M_@VB_P#CU?TIT4?ZY9E_T!Y/T_YEM#R_R_JR#ZO#^:I_X&_+_)'\UG_#!?\
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M9;0\O\OZL@^KP_FJ?^!OR_R1_-9_PP7_ ,%1/^BTZ5_X-HO_ (]1_P ,%_\
M!43_ *+3I7_@VB_^/5_2G11_KEF7_0'D_3_F6T/+_+^K(/J\/YJG_@;\O\D?
MS6?\,%_\%1/^BTZ5_P"#:+_X]1_PP7_P5$_Z+3I7_@VB_P#CU?TIT4?ZY9E_
MT!Y/T_YEM#R_R_JR#ZO#^:I_X&_+_)'\UG_#!?\ P5$_Z+3I7_@VB_\ CU'_
M  P7_P %1/\ HM.E?^#:+_X]7]*=%'^N69?] >3]/^9;0\O\OZL@^KP_FJ?^
M!OR_R1_-9_PP7_P5$_Z+3I7_ (-HO_CU'_#!?_!43_HM.E?^#:+_ ./5_2G1
M1_KEF7_0'D_3_F6T/+_+^K(/J\/YJG_@;\O\D?S6?\,%_P#!43_HM.E?^#:+
M_P"/4?\ #!?_  5$_P"BTZ5_X-HO_CU?TIT4?ZY9E_T!Y/T_YEM#R_R_JR#Z
MO#^:I_X&_+_)'\UG_#!?_!43_HM.E?\ @VB_^/4?\,%_\%1/^BTZ5_X-HO\
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M  ;1?_'J_I3HH_URS+_H#R?I_P RVAY?Y?U9!]7A_-4_\#?E_DC^:S_A@O\
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M?5X?S5/_  -^7^2/YK/^&"_^"HG_ $6G2O\ P;1?_'J/^&"_^"HG_1:=*_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>img12876764_18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_18.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'Y!5T# 2(  A$! Q$!_\0
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M:([9+B"-O1Y8T/Y,P- $]%5OMMG_ ,_=M_W_ (O_ (NC[;9_\_=M_P!_XO\
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M[_Q?_%T?;;/_ )^[;_O_ !?_ !=%GV?]?\.OO LT56^VV?\ S]VW_?\ B_\
MBZ/MMG_S]VW_ '_B_P#BZ+/L_P"O^'7W@6:*K?;;/_G[MO\ O_%_\71]ML_^
M?NV_[_Q?_%T6?9_U_P .OO LT56^VV?_ #]VW_?^+_XNC[;9_P#/W;?]_P"+
M_P"+HL^S_K_AU]X%FBJWVVS_ .?NV_[_ ,7_ ,71]ML_^?NV_P"_\7_Q=%GV
M?]?\.OO LT56^VV?_/W;?]_XO_BZ/MMG_P _=M_W_B_^+HL^S_K_ (=?>!9H
MJM]ML_\ G[MO^_\ %_\ %T?;;/\ Y^[;_O\ Q?\ Q=%GV?\ 7_#K[P+-%5OM
MMG_S]VW_ '_B_P#BZ/MMG_S]VW_?^+_XNBS[/^O^'7W@6:*K?;;/_G[MO^_\
M7_Q='VVS_P"?NV_[_P 7_P 719]G_7_#K[P+-%5OMMG_ ,_=M_W_ (O_ (NC
M[;9_\_=M_P!_XO\ XNBS[/\ K_AU]X%FBJWVVS_Y^[;_ +_Q?_%T?;;/_G[M
MO^_\7_Q=%GV?]?\ #K[P+-%5OMMG_P _=M_W_B_^+H^VV?\ S]VW_?\ B_\
MBZ+/L_Z_X=?>!9HJM]ML_P#G[MO^_P#%_P#%T?;;/_G[MO\ O_%_\719]G_7
M_#K[P+-%5OMMG_S]VW_?^+_XNC[;9_\ /W;?]_XO_BZ+/L_Z_P"'7W@6:*K?
M;;/_ )^[;_O_ !?_ !='VVS_ .?NV_[_ ,7_ ,719]G_ %_PZ^\"S15;[;9_
M\_=M_P!_XO\ XNC[;9_\_=M_W_B_^+HL^S_K_AU]X%FBJWVVS_Y^[;_O_%_\
M71]ML_\ G[MO^_\ %_\ %T6?9_U_PZ^\"S15;[;9_P#/W;?]_P"+_P"+H^VV
M?_/W;?\ ?^+_ .+HL^S_ *_X=?>!9HJM]ML_^?NV_P"_\7_Q='VVS_Y^[;_O
M_%_\719]G_7_  Z^\"S15;[;9_\ /W;?]_XO_BZ/MMG_ ,_=M_W_ (O_ (NB
MS[/^O^'7W@6:*K?;;/\ Y^[;_O\ Q?\ Q='VVS_Y^[;_ +_Q?_%T6?9_U_PZ
M^\"S15;[;9_\_=M_W_B_^+H^VV?_ #]VW_?^+_XNBS[/^O\ AU]X%FBJWVVS
M_P"?NV_[_P 7_P 71]ML_P#G[MO^_P#%_P#%T6?9_P!?\.OO LT56^VV?_/W
M;?\ ?^+_ .+H^VV?_/W;?]_XO_BZ+/L_Z_X=?>!9HJM]ML_^?NV_[_Q?_%T?
M;;/_ )^[;_O_ !?_ !=%GV?]?\.OO LT56^VV?\ S]VW_?\ B_\ BZD\Z'&[
MSHMO][S$Q^><4K/L!+15;[;9YQ]KML^GGQ9_+?1]ML_^?NV_[_Q?_%T[/L_Z
M_P"'7W@6:*K?;;/_ )^[;_O_ !?_ !='VVS_ .?NV_[_ ,7_ ,719]G_ %_P
MZ^\"S15;[;9_\_=M_P!_XO\ XNC[;9_\_=M_W_B_^+HL^S_K_AU]X%FBJWVV
MS_Y^[;_O_%_\71]ML_\ G[MO^_\ %_\ %T6?9_U_PZ^\"S15;[;9_P#/W;?]
M_P"+_P"+H^VV?_/W;?\ ?^+_ .+HL^S_ *_X=?>!9HJM]ML_^?NV_P"_\7_Q
M='VVS_Y^[;_O_%_\719]G_7_  Z^\"S15;[;9_\ /W;?]_XO_BZ/MMG_ ,_=
MM_W_ (O_ (NBS[/^O^'7W@6:*K?;;/\ Y^[;_O\ Q?\ Q='VVS_Y^[;_ +_Q
M?_%T6?9_U_PZ^\"S15;[;9_\_=M_W_B_^+H^VV?_ #]VW_?^+_XNBS[/^O\
MAU]X%FBJWVVS_P"?NV_[_P 7_P 71]ML_P#G[MO^_P#%_P#%T6?9_P!?\.OO
M LT56^VV?_/W;?\ ?^+_ .+H^VV?_/W;?]_XO_BZ+/L_Z_X=?>!9HJM]ML_^
M?NV_[_Q?_%T?;;/_ )^[;_O_ !?_ !=%GV?]?\.OO LT56^VV?\ S]VW_?\
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M_G[MO^_\7_Q=%GV?]?\ #K[P+-%5OMMG_P _=M_W_B_^+H^VV?\ S]VW_?\
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M]A9#_P!"3*__  EA_7?^EKY'M*O_ #]G]_I_E^/K?]#/^'RG_!0?_H?M8_\
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M\%!_^A^UC_P97'_Q=?GG11_860_]"3*__"6']=_Z6I[2K_S]G]_I_E^/K?\
M0S_A\I_P4'_Z'[6/_!E<?_%T?\/E/^"@_P#T/VL?^#*X_P#BZ_/.BC^PLA_Z
M$F5_^$L/Z[_TM3VE7_G[/[_3_+\?6_Z&?\/E/^"@_P#T/VL?^#*X_P#BZ/\
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MJ>TJ_P#/V?W^G^7X^M_T,_X?*?\ !0?_ *'[6/\ P97'_P 71_P^4_X*#_\
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M?^KW/YVBRCJRCZD"E!!Z$'Z'-?K]^R1_P0N_:._;:^&47Q:^']S=1:))-%;
M1ARI>9'D!RJD9Q&?;GC-?(/[5G["_P 1OV+M=N?#GQ FDDNK5WC=I=Z_ZLE3
M]X#H0?SX!KTZ&>Y+BL;5RW#9E0K9A1DXU<)%_O(25KIZVNF]>EON)=.JHJ;@
MU![2;T>VVGG_ $M_D"BJ\%U#<(LD;J0XR "#_+BH[NY^S>2,$^=,D0]B[!03
M],^HKUDFW:VKZ$75K]-/Q_X<+J\%L,^5+-[1(7/Y*#[TEI>?:QGR)H<=ID*?
MS K^DS_@D5_P21TK]JQ8_%7BZ^M+K2[B,2I9/MD<*1NQL.><9'3TSQC/&?\
M!<+_ ()O^&/V$K?1=;\,)#%9ZRJO''$BH5!^7'R@<?*3GH>.U?*PXQR6KGT>
M'*=24LPDVD[/DYXJ[CMNDGY?=KJZ%54_;M6I]5;5*RL[]5=_TC^?.BJEA.;F
MSMISUEB5_P ZG::)#M:1%/H6 -?56=VNW;UL975D^^U_,DHIJNK_ '6#?0YI
MLLJ0H9)"%4$#).!S[TK=._ZA=6O=6[]!Y('4@?6C(/0@U[G\+/V:/B-\; '\
M'Z5?W\;8(>TBDD!!('!13T^O7IQS5KXO_LN_$CX"6@O_ !MI=_I]NREU>\BD
MC4C&>LB@'H<<GVSR*Y_KF#]NL-]9I?6&[*CS+VC>FEKWZZ]K,=I6OR^[WOI;
M37;S_K0\!=MB,^-V/X1RQ^@K+BU42S>5]CNTYP)'B=4/ONVXQ^./>OJ_]C3]
MGVY_:7^,OA7PU!?PV^FZA>V\4R.ZX=7F52 "2#NP?7N/6OZ[_P!J'_@@=\.?
M!G[*DWBWPXMI!XGL=!@O)+M8T4M+/9&X!W[0>JGG//X5X.=\7Y-P_C<%E^/G
M+ZQC9QA!13M3<I1BG/1JUW;YFE.A5K1E.%E&'IKUTZWL]K=C^'?TY!R,\45O
M^-_!6H_#+Q5JOA+5IQ<W-IJ%S;K(IR-L4C(,>@^7^F>YYYG1.68+]2!7TT6I
MQC.#YX32E"2VDFKII;F2?=6:=FGWT_S'45&)8F.!(A/H&%24#"BBB@ HHHH
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M7/Q1\'/^"F?[!7B3QE_PJ?X>KX<MKZWN!ITL-J-,9?.1O*8,FS+?-D$%QZ=
M*_(J'BQQ'C<NJ3P.23Q%:C-RQ&*@G*G0IQ:?+*RMJNNW6R/0> HQFE.HDGM%
MV7-M=KMU\]-VMO\ -C^/O[&_QR_9YO[F/Q+X-U.UTFW\P_;IK298RD9()W%
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MG'J?0U_?'\1_C_\ L3?L#^)M4B^)YT%M=UB\;%S=_86F22249 ^T(_)SU*Y
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M%%%% PHHHH **** +WA#_DHWA3_L(6W_ *.CK_4:_P"",/\ R;CHG_8)M/\
MT&*O\N7PA_R4;PI_V$+;_P!'1U_J-?\ !&'_ )-QT3_L$VG_ *#%7XUXU_\
M(BP7_7]?H=N6_P :IZ2_-'[,4445_+A[85_F"_\ !R)_R>Y-_P!A"3_T8]?Z
M?5?Y@O\ P<B?\GN3?]A"3_T8]?L7@G_R5E7_ +%];\XGGYE_N[_Q1_-'X<+T
M'T'\J6D7H/H/Y4$A1EC@=S7]3'CD5OX9U;QMJVDZ!H,<DU_-JEHHCB!9R&E0
M?='/K7^HI_P0Z_9^M_A-^R+X0U+5--2V\1:A:VC22-$$F"?9\MN)4$Y++CUQ
MGIBO\_+_ ()+_"+6_C!^V7X4T!O#]SJ>BR:K:%I5A,L043*<G@KCK^&1FO\
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M)-MJ^[[W0LQ;^L)7TTTZ;0Z'^I9_P0@;;^Q%H#*,%;.T/'<BUE.>W)K\P_\
M@H7\+?"?Q"_;3\!:GXCE@2YL-?LW@6<KEF2[0J "<Y/_ -?C Q^HO_!!^TG7
M]B'PU))$RQSV]E'&S<!R;63('K@$9/09&>M?@=_P6U\?>)/A+^VM\--:2ZET
MG1[?Q#8/?R.QCC$8NT+9)(4 @-G/'J,8K\MR2C4Q''_$%'#U/9UY_7U"6K;:
MAK!=VW>/S^[OJM1PM)M724+K;K$_LPNM!\+7/P&T30?$;I!X:_X1'1;2X8':
MBVZZ;&JD'. -F6_IVK\3_&W_  2L_P""8'Q,\5GQIXE\9:/;:Y!J!O?*FOH4
MD%R)"Q!#2J>6'8$^@[U^H'P?\;^&/VJOV4/#UEX,\1V=[J&H>"M)M+B2"YC+
M17<-C' S.P8!1D\DG@]>O'\JW[3G_!(K_@H1KGQN-YX!\7>(K;PS<:RUP$M[
MVZ6!K9YBRX\N39L*XP0<8XSTKP.%,/*.+S'#5N)JO#.(IU*G/=N"JI-W33M=
MNS2]4^II7=X0:HJNFE;2[3NNO3_/YG]3OP>\<?L\_ #P1;?#KP'JMM>^'M/B
M$,4D5Q&T;HD1C 8_,"I7=D @$$\\U_%C_P %>_C7X0^%'[>?@CXV^'[*.XT_
M2M>M+NZ%@@9OW=ZKMN,8ZX7GIQ^O])OP0_X)Z_$?X5? JZE^*OBN0:Y9:++<
M75Q=7I>2*6&!R1(6D+(21G#8.0,YP<_RD?%V[^&7CO\ ;FT_X/?$B^M/$&C7
M/B".S:XE=9TB5[P1<LV0._4CCL *^OX#P>74\ZS;&4<77S6G1PN)CC9P3OB:
M4XVG.+MRMRU:N[[>ISXJ4W3IP<53;E'EO]EJVENMG_P]D?V@?L@_\%%?@?\
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MMR_ 5O$<6@:??:/XIT:\73[JYM+::YBEELV,?[\1(73?(AY^[U )R*_S3/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC].?Y<U=CMK>+F.&)#ZJBC^0J>O3RG*,MR+#_5,IPRPN&NW[--RU;N[MZO\
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M ,&+;PH-0A\.VQMK>Z>U25D)B6+=&[QLR'**25(.5!Z@5_-'';P1?ZN&-/\
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M*_V=N^]K:;]>Y_0[^U9_P<9_%_\ :H\+W_AC3+:X\,07<4UHRVB&TC\J3<A
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M;<?_ !NCZ]E__0QP'_A52_\ D@M+^2?_ (#Z?YH\$HKWO_AB']M3_HD6M_\
M@MN/_C='_#$/[:G_ $2+6_\ P6W'_P ;H^O9?_T,<!_X54O_ )(+2_DG_P"
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M_P" ^G^:/!**][_X8A_;4_Z)%K?_ (+;C_XW1_PQ#^VI_P!$BUO_ ,%MQ_\
M&Z/KV7_]#' ?^%5+_P"2"TOY)_\ @/I_FCP2BO>_^&(?VU/^B1:W_P""VX_^
M-T?\,0_MJ?\ 1(M;_P#!;<?_ !NCZ]E__0QP'_A52_\ D@M+^2?_ (#Z?YH\
M$HKWO_AB']M3_HD6M_\ @MN/_C='_#$/[:G_ $2+6_\ P6W'_P ;H^O9?_T,
M<!_X54O_ )(+2_DG_P" ^G^:/!**][_X8A_;4_Z)%K?_ (+;C_XW1_PQ#^VI
M_P!$BUO_ ,%MQ_\ &Z/KV7_]#' ?^%5+_P"2"TOY)_\ @/I_FCP2BO>_^&(?
MVU/^B1:W_P""VX_^-T?\,0_MJ?\ 1(M;_P#!;<?_ !NCZ]E__0QP'_A52_\
MD@M+^2?_ (#Z?YH\$HKWO_AB']M3_HD6M_\ @MN/_C='_#$/[:G_ $2+6_\
MP6W'_P ;H^O9?_T,<!_X54O_ )(+2_DG_P" ^G^:/!**][_X8A_;4_Z)%K?_
M (+;C_XW1_PQ#^VI_P!$BUO_ ,%MQ_\ &Z/KV7_]#' ?^%5+_P"2"TOY)_\
M@/I_FCP2BO>_^&(?VU/^B1:W_P""VX_^-T?\,0_MJ?\ 1(M;_P#!;<?_ !NC
MZ]E__0QP'_A52_\ D@M+^2?_ (#Z?YH\$HKWO_AB']M3_HD6M_\ @MN/_C='
M_#$/[:G_ $2+6_\ P6W'_P ;H^O9?_T,<!_X54O_ )(+2_DG_P" ^G^:/!**
M][_X8A_;4_Z)%K?_ (+;C_XW1_PQ#^VI_P!$BUO_ ,%MQ_\ &Z/KV7_]#' ?
M^%5+_P"2"TOY)_\ @/I_FCQ+P?S\1O"8').H6V .O^NC[5_J0?\ !&2WFC_9
MNT.1XG5#I5F S# )*Q8 SUK_ #3K#]BW]M#P_K6G^*Y_A)K@M]%E2[E)TZYP
M$A=68X\O_9'H,_K_ &<_\$6_^"D_C"QMM#^ /C7PE-I-[&MMI[BYMRC))&8X
M\C<H.1M8=>F?:ORSQ:PD\WR&F\MJX;&+"3]IB%1Q%.<J<4KMV3;>B[7.O 25
M.JW-.//=1NGJWRV_-?>?V%45!:S?:+:WN ,">"*8#T\V-7Q_X]4]?RGL>Z?D
MS_P67#?\,9>.MC;6-I< ,.H'DO7R/_P;Z>#?!.J_LCZQ<ZEX5T/4-3_X291+
M>WVF6EW))&4N3MW7$4A7Y@"<#YNY&,'ZZ_X+*_\ )F?CG_KUN/\ T0]?,G_!
MO)_R:/K?_8RI_P"@7%?H>'E*/AQC7&4HO^W,/K&3C?1*SLU=>7>S.1ZXM>4)
M)?=%_F?N/_PK/X=_]"/X5_\ !%IO_P CT?\ "L_AW_T(_A7_ ,$6G?\ R/7<
M45\#[:M_S]J_^#)?Y^2^XZK+LOZ_X9?<</\ \*S^'?\ T(_A7_P1:=_\CT?\
M*S^'?_0C^%?_  1:=_\ (]=Q11[:M_S]J_\ @R7^?DON"R[+^O\ AE]QP_\
MPK/X=_\ 0C^%?_!%IW_R/1_PK/X=_P#0C^%?_!%IW_R/7<44>VK?\_:O_@R7
M^?DON"R[+^O^&7W'#_\ "L_AW_T(_A7_ ,$6G?\ R/1_PK/X=_\ 0C^%?_!%
MIW_R/7<44>VK?\_:O_@R7^?DON"R[+^O^&7W'#_\*S^'?_0C^%?_  1:=_\
M(]'_  K/X=_]"/X5_P#!%IW_ ,CUW%%'MJW_ #]J_P#@R7^?DON"R[+^O^&7
MW'#_ /"L_AW_ -"/X5_\$6G?_(]'_"L_AW_T(_A7_P $6G?_ "/7<44>VK?\
M_:O_ (,E_GY+[@LNR_K_ (9?<</_ ,*S^'?_ $(_A7_P1:=_\CT?\*S^'?\
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MX5_\$6G?_(]=Q11[:M_S]J_^#)?Y^2^X++LOZ_X9?<</_P *S^'?_0C^%?\
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M=Q11[:M_S]J_^#)?Y^2^X++LOZ_X9?<</_PK/X=_]"/X5_\ !%IW_P CT?\
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MK\<O^7D_YO7R.I)66G1?I_DON.'_ .%9_#O_ *$?PK_X(M._^1Z/^%9_#O\
MZ$?PK_X(M._^1Z[BBI]M6_Y^U?\ P9+_ #\E]P679?U_PR^XX?\ X5G\._\
MH1_"O_@BT[_Y'H_X5G\._P#H1_"O_@BT[_Y'KN**/;5O^?M7_P &2_S\E]P6
M79?U_P ,ON.'_P"%9_#O_H1_"O\ X(M._P#D>C_A6?P[_P"A'\*_^"+3O_D>
MNXHH]M6_Y^U?_!DO\_)?<%EV7]?\,ON.'_X5G\._^A'\*_\ @BT[_P"1Z/\
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M'_X5G\._^A'\*_\ @BT[_P"1Z/\ A6?P[_Z$?PK_ ."+3O\ Y'KN**/;5O\
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M_P#H1_"O_@BT[_Y'H_X5G\._^A'\*_\ @BT[_P"1Z[BBCVU;_G[5_P#!DO\
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M1Z[BBCVU;_G[5_\ !DO\_)?<%EV7]?\ #+[CA_\ A6?P[_Z$?PK_ ."+3O\
MY'H_X5G\._\ H1_"O_@BT[_Y'KN**/;5O^?M7_P9+_/R7W!9=E_7_#+[CA_^
M%9_#O_H1_"O_ ((M._\ D>C_ (5G\._^A'\*_P#@BT[_ .1Z[BBCVU;_ )^U
M?_!DO\_)?<%EV7]?\,ON.'_X5G\._P#H1_"O_@BT[_Y'H_X5G\._^A'\*_\
M@BT[_P"1Z[BBCVU;_G[5_P#!DO\ /R7W!9=E_7_#+[CA_P#A6?P[_P"A'\*_
M^"+3O_D>C_A6?P[_ .A'\*_^"+3O_D>NXHH]M6_Y^U?_  9+_/R7W!9=E_7_
M  R^XX?_ (5G\._^A'\*_P#@BT[_ .1Z/^%9_#O_ *$?PK_X(M._^1Z[BBCV
MU;_G[5_\&2_S\E]P679?U_PR^XX?_A6?P[_Z$?PK_P""+3O_ )'H_P"%9_#O
M_H1_"O\ X(M._P#D>NXHH]M6_P"?M7_P9+_/R7W!9=E_7_#+[CA_^%9_#O\
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M(M._^1Z/^%9_#O\ Z$?PK_X(M._^1Z[BBCVU;_G[5_\ !DO\_)?<%EV7]?\
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M1S1H#,OE*0RLC!QC;SP,"@#].**0D*"S$!5!)).  !DDGL .2:_GQ_X*??\
M!;+P3^R'?7'PW^&,T'B7XJ@RP0Z3 L=W*UT,A$$2K(P^? QCG\<4 ?T'T5_
MY%_P7_\ ^"J.G(GBS7/@)J5OX%2<S7&H-X?8(EADL)=YML >6 <\5_17_P $
MNO\ @KQ\//VX_#TFE>(+^UT;X@V2QK=:9+Y=O)Y^%62+RCL(.XGJI.5XX)H
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M'2N(_:[_ ."8O[//[4OPVU[P9J/A72M$NKZTG%I=V-A;PLEP48I\\2HRDM@
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M:(J.QP %4<=,>G%?WW Y ([C/YT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!G:Q_R"=4_[!U[_P"DTM?QY?$#_D^&#_L8C_Z5U_8;K'_()U3_
M +!U[_Z32U_'E\0/^3X8/^QB/_I77WW G\7-_P#L7S_4Y<3_ ,N_\3_0_KR\
M"?\ (F>&/^P+8?\ HA*ZRN3\"?\ (F>&/^P+8?\ HA*ZROA*G\2I_CE_Z4SI
MCLO1?D%%%%0,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** *6H:?:ZI:R6=[$D]O*,21R*&5AC&"IX(^OT[UXW??LX?!K4KEKN_P#
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M%H- U_PWJMO>7$.CPBUV2!_.((@"#'R'! Z$?0?V5:6BQZ;8HBA46U@"J!@
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MF:;$L-G;Z0!#&JA0%,-MV%??A1"0Q52PZ,5&1]#C- '\-O\ P54_X(U_ /\
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M4 %%%% '&_$/_D1O%?\ V ]0_P#1#5_(Q\+_ /D^.?\ [&/_ -NZ_KG^(?\
MR(WBO_L!ZA_Z(:OY&/A?_P GQS_]C'_[=U^@\%?[KGG_ &"/\CEQ'QT?\3_.
M!_85I7_(+TW_ *\+/_TGCJ_5#2O^07IO_7A9_P#I/'5^OS^6[]7^9U'Y-_\
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M"H\:,/.EMI$B/^GR<[RN,?YSWK_31C_U<?\ N+_Z"* 'T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &=K'_()U3_ +!U[_Z32U_'E\0/^3X8/^QB
M/_I77]ANL?\ ()U3_L'7O_I-+7\>7Q _Y/A@_P"QB/\ Z5U]]P)_%S?_ +%\
M_P!3EQ/_ "[_ ,3_ $/Z\O G_(F>&/\ L"V'_HA*ZRN3\"?\B9X8_P"P+8?^
MB$KK*^$J?Q*G^.7_ *4SICLO1?D%%%%0,**** "BBB@ HHHH **** "BBB@
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M\/[SX7?\$^?AOH&IHT,EN;BY<.I4K']F@<D@XX"\\XK^>_\ X+^^(=0_:/\
MVQOV?_ ?@^Z>6U\-Z_I%MJ"6[,RE8KU#)N$9QR2<YQ_6O[(-!\%:'\!?@#JG
MA[2ECL].\*>"=7N25 C1+B#1)-Q&#CF:)0#QDD5_%K^P5-'^W'_P4=^(:7X;
M4X/ OB6_EC><>:D:V5V[94MD# 4G((_I0!_:G^S-X.MO OP'^%GAV"%8GLO!
M>A+<84*6F>QA=RV.IRW>O;[JXCM+:XNI2%BMH);B1CP%CAC:1R3V 5235/1=
M/32=(TS3(P%CT^PM;1%' "V\*1@?AMK\X/\ @J;^V;I/[&?[.'B'QC>I<R7F
MLZ=J6F62VJ,\@DN+9X$8! 2#N<XQZ4 ?RD?\%U_VG/$7[:7[3/P\_9I^$-_-
M>V^B>(+73->L[%WDC,:7B13B1821\Q+EL\9)/-?UZ?\ !.S]EWPW^S!^SEX
M\-:3IT-CJNH>&-)N=<\N)8W>[>WCD<2X )8, 3G/7GFOY-/^" ?[*.O_ +1?
M[4OQ!_:V^*6FW=YX?UR^U/5]"&L6[MM9YI9[<1>:O!W!0,8 XZ=:_NYM;:&S
MMX+6W01P6\20Q1J,*D<:A44#L   !0!%J()T^^ ZFSN@/J8' K_.<^"45U\+
M_P#@N1X[\0ZW&UK8:GXMO!;RRCRU;S+U@,%\#'S#I[5_HVN@D1XV^ZZLA^C
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M?VA?C7_P0N_:9\5^!/B=I>M+\)?$7B*>2=TMYC:K9R7)W'[I7 0_H<=: /\
M2!N)?)@GFX_=0R2\]/W:,_/MQS7^?!_P6J\26G[4W[?/PL\'>'9!=7WA+Q;8
MBZCA/F%#;7Z!@P0G'(]1U]Z_8#]HW_@YF_9.E^%5[8?!FZU74_'OB#1IK:UM
MPA=K:]O+5H?)B6--WRR2_>8EN%'&"6_+W_@B_P#L=_&+]K']K+Q'^U+\;],O
M_P#A&=1U6YU?2?[4@DVK$]P;B+8)!_<.1CJ![4 ?T@_\% O".H/_ ,$@->\)
MV\+O?6WPE\*V9B"EGWP:6 PVCG.?R-?BC_P:S^(D\+^'_&7@'42(-5D\07:B
M"1@DAS=..$;#'TQWK^O/XI_"30_B/\)-:^%E[#&^D7^B+I<<+J#'MMX#% I7
MD8P ![_G7^?M\5&_:'_X)"?MZS>.[31M6C^!\WB1KR[>QMI?LOV07?F2']VN
MTC9N^GY4 ?Z--?PZ_P#!S1\?++1_VF?@1\*=(D2]U+7;C0[6>*$^:T<DLMNA
M5E7)!7."/7VK]%/&O_!SA^Q4OP7OM7\-ZCJLWQ&NM#\BTTD(-L>K36XCW*%3
MS"1,QVI_"3NR1@5^#G[*_P !OC1_P5S_ &TM'_:*^).FZFW@[PWKL6HZ(=2@
ME,8MH;H7$(4R+C'EA>^,?2@#^U3_ ()K?#>]^'G[,W@B'4(VBN-5T32[XHP(
M8++;!P<$9_B%?<?BSQ-I?@[P[K'B36+F&UL=(TZ\OYI)G"*RVEO).4!)'+[-
MH],\D4WP?X?M?"OA7P]X<LXDAM]%T;3]-C1 %4"TM8XC@#U92?QK^73_ (+B
M_P#!1GQ/:Q:;^S-^SW'J]SXYUF_;2=;>QCE8JETY@F!,8X15XYR2,YX.* /B
MW]JKQY\0_P#@L;^V-H'P<\ ZI=VWPY^&^M"UUJVM#(MC+:65UBX,@C(1@[+(
MS%LY9V8\DFO9OVZ_V@X_V+_$7PO_ .">WP6M%\.>(O&=AIVCZAJ&F@6\TT]W
M%%'YKM$ Y+,^XY.>]?JE_P $7OV"[#]G#X16'Q;\4VJR?$OXC:8+[5YKF$?:
MH'NRLTQ9G&X,2SKV/)/&#7X.?\%POAIX_P#A]_P5/^#_ .U+>Z7>WGPR\)WV
MB7>IR16[R0K%9"V,I+A2H^5#UQ^5 '-_M)?"[]J#_@E!X1\+_M*^)/B%KFNZ
M=XAU*UGN[&>\N9$ADF:.>6$J\C+\BRJ,#&.^:_K>_P""<G[4MO\ M;_LP> O
MBL90VH:MI\1O$)RP;R8FRW?.YFZU_*E_P7$_X*<_L_?M^?LG>$/@=\!EU#6/
M'-UKEK<W=L+?>-.FN+2RADM8412P2*5&7>QY54&T8.?Z O\ @A;\$?$GP6_8
M5^'&D^*XYX-6N;"WD:"="CQIY"$_*P!4Y8 \=J /L;_@H?-%!^R)\7YIF"1I
MX?G+L>@'E2C^M?RG_P#!!VYBU#X]^)9K-O-B7Q'<!F7D#_2FXR,C]?SK^AS_
M (+5?%2S^&W[!/QE87"IJFI:+)!:1*V)6Q#.3M7.22Q4<?R)K\0_^#6?X07_
M (C^&OC;XQ^(+>9))/$-S]G>X1@Y>69VCP6YP0N<YZ?7% ']D]%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <;\0_\
MD1O%?_8#U#_T0U?R,?"__D^.?_L8_P#V[K^N?XA_\B-XK_[ >H?^B&K^1CX7
M_P#)\<__ &,?_MW7Z#P5_NN>?]@C_(Y<1\='_$_S@?V%:5_R"]-_Z\+/_P!)
MXZOU0TK_ )!>F_\ 7A9_^D\=7Z_/Y;OU?YG4?DW_ ,%E?^3,_'/_ %ZW'_HA
MZ^9/^#>3_DT?6_\ L94_] N*^F_^"RO_ "9GXY_Z];C_ -$/7S)_P;R?\FCZ
MW_V,J?\ H%Q7Z#0_Y-OCO^QYA_R1R?\ ,6O\#_\ 28G[_P!%%%?GIUA7%^/_
M (?>%/B;X:OO"?C+2;76-&U")XI[:YBCDP'4HQ0R(^PE3@X'( ST!':44 ?A
M!\:O^#>S]@WXMZM-KX\&?V/JMS*TER8E3RI6>0NQ!B$97DGC8?\ >[5W/P'_
M ."$/["GP*OK36='\#+J.LVKI*MS<1Q>6LD;!E($@D9AD#DA3_,_M-10!S_A
MCPOH7@[1;+P_X=T^WTS2[")8;>VMHDB150!02$506P ,XZ "I_$6@Z;XHT/5
M?#NL0BYTO6;&?3[^ XQ+:W*&.5#D$?,I(Y!K9HH ^*O@-^P#^S7^S?XMUOQM
M\+/!5OH.O^(+F2[U.[C6$-/-*YD=CLB0\N2>2>U?:O2BB@#Y^_:%_9D^$?[3
MOA*7P9\6O#EOK^D212Q*LL<321K*I!VM(CG@DL ".2>>:_%G4O\ @VL_8+N_
M%2:[;^'YK>S^T_:'M%3:02Y<JJ*^P\D@?,!TZ=OZ)Z* /S'\'_\ !(W]BSP7
MX:B\+:9\-[673XDC7=<1V[R,R #?DPL021GJ?J>M?=/PO^$'@CX0>#8_ G@C
M3$TOPY$LB)9($"JLL?E.!M51RG'2O3Z* /BFU_8 _9JL_B'/\4(/!5NOBZXN
M6NI=0VP[FF9_,+$B+=DMSUK[-L[2&QM;>SMUV06L*00I_=CC4*H_ "K-% !3
M)(XY8WBE19(I4:.2-U#(\;J5='4Y#*RDJRD$$$@\4^B@#\D_VM/^",W['7[6
MU]>:]XV\'16OB.X+RK?6L,2 RN23N\L1LH).<@-R!Q@DUXO^S_\ \&_7["7P
M0U*T\1+X+_MGQ!97(GM;B<1M%!L8,G^M60L20"0 H&!R23C]U** .=\*>%="
M\%:#8>&_#EA!IND:;"L%K:P(D:(B*%!(15!;:JC.,X ':OD?XW_\$^_V:/VA
M/&NB?$#XF^";?7/$OA^ZBN],OI%A+031.KHP,D3MPR@]>U?;5% 'YN_\%,M-
ML/#G["_Q"T6P5;;3=)T6RTZSCR%6*UL[*YA@C[#"QHH_"OY??^"-'P,^%'[4
M.K>*_ /Q2T^RU719-3O8EC\N)Y7+2.-JN1E2Q.,G'7GO7]BW[5OP,7]HWX)>
M+/A.UTMDOB2$1&X9MJIB.9.3_P!M?_UU^:G_  3O_P""3,/[$7B?4/$$?B"'
M5#>7\MYL27>1O<N!U/KW_&@#R#5/^#;G]@O4?&[>*/\ A'9X[.2X2Z>Q9 Q$
M@8L5"AQ&PSC!)4$#H#Q7["?LW_LG_!G]E?PO'X4^$GAFUT2Q2%(7E2&%9Y%0
M8R71 R[N V&.1P2037TI10!R'C?P/X>^(6@W7AOQ-9K?:5>(Z3V[8PRNI5NH
M(Y!(Z5\\_!O]B?X _ CQ5>>,OAUX2@T;7;Z222XNHUB#.\I+.?DC4\DYZYSW
MKZUHH *P?$WAG1?&&AZAX=\0V,.HZ3J<#V]W:SQI(CHZE20'5E# $@-C(!(Z
M$UO44 ?@S^T#_P &^'[#OQO\23>+I/"QTK6;RZ:XO?)5$BE#N7?:8MHR2QX*
M# Z$GI]$_LP?\$;/V+?V5;_3]<\!> XI?$-F8Y6U*\2%]\Z!?F5'21@ 5P#O
MRV 2 >*_5VB@".**."*.&%%BBB18XHT4*D<:*%1%48"JJ@  < "OF']H_P#8
M^^!W[5>D6VB?&3PO#XDT^TE2:"&98F"2(0RD>9&XX(S7U%10!YI\(OA+X+^"
M'@/1OAQ\/M,32/"V@QM'IU@@4+"K*BD (JKTC4<#M65\:?@9\//C[X/O_ WQ
M)T>/6O#NI1-#=6<@0K(C@JP.]6'()'(->P44 ?./[-W[*OP<_93\+7G@[X-^
M'(O#>A7UP+JXM8EC >8%CN_=H@_B/4&O9?&7@SPYX]T"_P##/BG3+;5=(U&"
M2"XMKF*.0%)%*L4WJP5B#C('/X#'4T4 ?@7\=_\ @WA_88^,?BIO%Z>%6T?4
MKRY\[48XPHCERY=F0Q[!R6;*E!CC!;)Q]3_LM?\ !'_]C;]DW4;'7?AWX&A;
M7K+RW74;R*%V,R8)8*RR-C<./F!(Y('0?J;10!#);Q2V\EJ4"P20O;F- %41
M.AC** ,* AVJ , 8 &*^"KG_ ()J?LIWWQ,?XM7_ ($@O?&3W9O?M]P(9-LY
MD,A90\3,/GY^]GWK[[HH IZ?86NEV-IIUC"L%G8V\5K;0H %CAA0)&B@< !0
M.E?"_P 3/^";O[*_Q7^+$'QH\5>!+>;QY;W*W<>J0+!$PG5MX?B+?][G[Q^M
M?>E% '&CP%X:;P=+X$GT^*Y\.3:>^FRV,ZK(CVKQB,J0RE<@ $';P0*_%#X[
M?\&]W["?QH\3WOB^3PA_8^L:G<FYU#R418YI&;<[*T6SEB6^4H .,,>@_>&B
M@#\<O@[_ ,$.OV'?A#HB:18^!QJ@PN][I(MNY?02+*2#P<G;SU'2OO?X-_LE
M_!3X#7 N?AOX7M]"D&.8$B0<>T<:5]+44 96MZ)IGB/2;_1-9M(;[3-2MY+6
M[M9T62.6*52K JX9<@'*G!P:_$G]H3_@@-^P[\>O$5YXLU#PF-+UJ^G>>Z:"
M-$CD>1BSD-$4/+,3C8!CN:_<NB@#\@/V8?\ @B9^Q/\ LO:I:^(_"/@>*]\1
MV\D<HU"[BA=5>,Y7:LJ2N1D Y)7!XV]S^NEI86EA9PZ?9V\5M9P0B"&"%%2.
M.-5VA550%''7CDU;HH ^&_B9_P $[_V8?BW\4M(^,7C7P/;ZGXYT.ZCN]/U1
MU@+PSQ2"1&!:%GX8#HU?2/Q,^#G@7XM>"#\/?&NE)J?ADPP0&Q<*5\NWA%O$
M/F5E^6(;>E>IT4 ?,_P0_9*^"O[/6_\ X5CX9AT/S'9V\L1C+/RQ^2-.I/X5
M[WXF\.Z7XMT+4_#FM0"YTO5K5[2]@.,2P2<.IR".1Z@UNT4 ? _P]_X)K_LI
M_##X@R?$[PCX"MM/\6RW7VQ]05( YGWF3?E85;[Q)ZU][@8  Z  ?E2T4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!G:Q_P @G5/^P=>_^DTM
M?QY?$#_D^&#_ +&(_P#I77]ANL?\@G5/^P=>_P#I-+7\>7Q _P"3X8/^QB/_
M *5U]]P)_%S?_L7S_4Y<3_R[_P 3_0_KR\"?\B9X8_[ MA_Z(2NLKD_ G_(F
M>&/^P+8?^B$KK*^$J?Q*G^.7_I3.F.R]%^04445 PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *^*OCE^P%^S?\ M$:[:>(OBCX/
MCU_4;*Y6[MWF\ID29'#JVV2-QU%?:M% ')^!O!/AWX=>%='\&>%+"+3- T*U
M2STZSB552*%.@PH5<]N . *ZRBB@ KY^_:"_9C^$/[37A:3PC\6/#-IKVENC
MQ@R10M,BN""H=XV.!G(&1CL:^@:* /Y[M9_X-N?V -2\4Q:_!X7FM;;[2MS/
M9>6I#,)/,8(JN(V![;BO/8"OUL_9Q_8Y^!7[+.APZ%\)O"-GHUO##'")C#"9
MCY:!-VY8P0QQG[QQV/ -?4M% 'P+_P %$O&'BCPU\ ?$UAX5MKFXU#Q!I.HZ
M7MM0QDV7$#1$87)YWX_.OQ!_X($?L2^)O@;\5?BK\7O%FF7-K>^-'U6X5[N-
M@^^[:1@0SC.?G."/2OZF/$'A;0/%-LMGK^F6VIVRDD0W*;T!/L:30?"GAWPQ
M"+?0=(L]+B QLM8A&,'CU]* .AKYQ_:._97^$/[5'ABW\(_%_0AKVB6LGFQ6
MQ* !]V[)WJX//M7T=10!X;\"_P!G;X5_LZ>%+3P;\+?#MMH.BV<8CABBCB5]
MH&,%HT3/'7.<U[E110 5R'CCP)X7^(OAZ^\+^+=*MM6TC4(7AN+>YBCD^1P5
M;89%;:2#S@<X&>@KKZ* /P:^,7_!O+^P7\5_%,WBQO"#:1?WMQY]_'$B>5*2
MQ9RIBV<N6/RE !_>.<#[(_98_P""6G[)W[(WV>?X7^"K>#4( F+ZY@@,A=<'
M=]UVZC^_G^5?H[10 BJJJ%4!54!550 JJ!@  <  < #@#@4M%% !7YK?\%2O
MV2[;]KC]FK7_  8UJES>:3;WVJVRF,.[&*!7"(""<[HR0!ZYK]*:BFACN(9K
M>90\4\4D,J'D/'*A1U(/!#*Q!]C0!_(#_P $&/C5XT^''QK\6?LH>)-*U#3M
M(\,W5_8V4MVLD=N3#(\4?E[P% /'3C!],5_8&"",@@@]".0?QKXXTG]B_P"%
M7A'XCW/Q/\&Z)9Z1XFOKAKF\O(8DBEED>0R.2R ;LD]S_6OL"UB:&VAB=MSQ
MQJC-ZE1@G\: /&_CU^S_ /#3]I'P)=?#GXJZ)'KWA:\E$T]A*$*LX& <.KKT
M ZBL?]GW]F/X2?LQ^%8_!OPD\/Q>']"B)*6L0C"C/_7-$'3V%?0=% !7PU^U
M3_P3P_9F_;!B<?&'P5:ZK=-&4^VQ0P+/DKC>28PS-T).\9.3QFON6B@#^?[P
M/_P;E?L#^#?&D7BI?"LE[%:7*W-I921K@.CJZJ^]F11QR5W^@&*_:_X3_!OX
M?_!7PS:>$_A]H-IHFD6<:111P0Q(Y1%VJ&>.-,\=?6O4J* "OF/]HS]D/X'?
MM2Z!+X=^+GA*SURTEB>)I3# )]KJ5),C1LQ8 ]<@\"OIRB@#^>RQ_P"#;?\
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M']L^]/[R_P#?0_QHWI_>7_OH?XU_$Q_PIG_@NI_T&_$/_?\ N?\ "C_A3/\
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MT#U?N7E_G^#[']L^]/[R_P#?0_QHWI_>7_OH?XU_$Q_PIG_@NI_T&_$/_?\
MN?\ "C_A3/\ P74_Z#?B'_O_ '/^%'^H>'_Z*WA[_P *'Y>?G^#[!]:E_P!
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M']L^]/[R_P#?0_QHWI_>7_OH?XU_$Q_PIG_@NI_T&_$/_?\ N?\ "C_A3/\
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MT#U?N7E_G^#[']K.J!9-+U)=Z*K6%XI=F"H@-O("SL>%50<LQX R3Q7\?WQ
MM4_X;E@075J0/$62PGCV_P#'W_>W'\>>/7I7E,_P9_X+J#2]2:37/$/V5;:4
MW(\^XYB",7ST_A!'YU^.&O\ @C]OV/XXI9:C?ZFWCYK_ &K*9)?-%R9O<YR)
M!Z?KBOK>%.$:."GF+CQ'DV)]KA)4VJ%9R=--/WYJZM%7[]+JYSU\0Y<EZ-2-
MI=5Z?\-KUOV/],_P6B0^$?#:"6*15T73L21.'C8FVC)VN#@X)*G!X8$=JZ7>
MG]Y?^^A_C7\1NB?!O_@N<_AO1Y+'6_$']FO:Q-9@3W&!$5^0#_@..P_6K?\
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ME_[Z'^-&]/[R_P#?0_QK^)C_ (4S_P %U/\ H-^(?^_]S_A1_P *9_X+J?\
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M1O3^\O\ WT/\:_B8_P"%,_\ !=3_ *#?B'_O_<_X4?\ "F?^"ZG_ $&_$/\
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MO_?0_P :_B8_X4S_ ,%U/^@WXA_[_P!S_A1_PIG_ (+J?]!OQ#_W_N?\*/\
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M/?\ A0_+S\_P?8/K4O\ H'J_<O+_ #_!]C^V?>G]Y?\ OH?XT;T_O+_WT/\
M&OXF/^%,_P#!=3_H-^(?^_\ <_X4?\*9_P""ZG_0;\0_]_[G_"C_ %#P_P#T
M5O#W_A0_+S\_P?8/K4O^@>K]R\O\_P 'V/[9]Z?WE_[Z'^-&]/[R_P#?0_QK
M^)C_ (4S_P %U/\ H-^(?^_]S_A1_P *9_X+J?\ 0;\0_P#?^Y_PH_U#P_\
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M -S_ (4?\*9_X+J?]!OQ#_W_ +G_  H_U#P__16\/?\ A0_+S\_P?8/K4O\
MH'J_<O+_ #_!]C^V?>G]Y?\ OH?XT;T_O+_WT/\ &OXF/^%,_P#!=3_H-^(?
M^_\ <_X4?\*9_P""ZG_0;\0_]_[G_"C_ %#P_P#T5O#W_A0_+S\_P?8/K4O^
M@>K]R\O\_P 'V/[9]Z?WE_[Z'^-&]/[R_P#?0_QK^)C_ (4S_P %U/\ H-^(
M?^_]S_A1_P *9_X+J?\ 0;\0_P#?^Y_PH_U#P_\ T5O#W_A0_+S\_P 'V#ZU
M+_H'J_<O+_/\'V/[9]Z?WE_[Z'^-&]/[R_\ ?0_QK^)C_A3/_!=3_H-^(?\
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M *];C_T0]?,G_!O)_P FCZW_ -C*G_H%Q7Z#0_Y-OCO^QYA_R1R?\Q:_P/\
M])B?O_1117YZ=84$@ DG '))Z >II&954LQ"JH)9B0  .223P !U-?SE_P#!
M6O\ X+=>"/V/+#4/AA\/%C\2_$G4_/TZ"VTYC<7D-PP\M L<3,R'>0>%#=B>
MU ']$\FJ:9$Q674;&-AU62[MT8?4-("*6+4M.G;;#?V4S'HL5U!(W/3A)">:
M_P XS1-"_P""S_[9]Q_PM#X<^+O%WA7P[KCO<V>GF[O[810S$R1C9E0 %8
M5T"^*/\ @KM_P3^G'Q/^-'B+Q9XP\,Z3<I->6;7-]<JT$3Y?*DD8VYZ\ =:
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M_P"^U_QH\Z'_ )ZQ_P#?:_XT ,NKJWLH);J[FCM[>"-I9II75(XXT&69F8@
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MOY9/^"3G[:?[2WQD_:8\3>%?'GB.^U/1+7Q'-;00/<2RJL N2@ 4L0!C]?U
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MP KZN_X)<_\ !8[XX? OXOC]F?\ ;%&HS:T;P:2NJ:R\X\Z82>2K)-,<D^8
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M7_@I7_P4N\,://J=[)X2\)^*[6&^T\.[VCPP7R*Z2)DI@JK Y S[T ?0DO\
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M#^IWXKR:9^S]^Q_XW6WG33$\*?#;6&LBK"/;=QZ>S(J$8 8,1TYX/>OXSO\
M@B[X7^&W[9?[4/QG^.G[1266IZ1\.O$&IW=EJ6KNC)"MC=S31D/,'*J/+&2
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MZ(- !4%U+Y%M<3GI#!+*?^V<;/\ ^RU/67KC[-$UA^FS2]0?/IMM)C_2@#^
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M-?VI3?#%_@U^P5XQ^'T@VR:#\)?$=O(,8(>327# C'J>> ?7FOQM_P"",_\
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M_;O_ ."D?C73?CI/X'\2:5I4&IVEZ-%-I>1(8!,D@7R=@& G'0=..E?W+_\
M!)7PMXI\*_L)Z%H'BG2)](UVVTN_@ELIXFBE\P:3Y:Y1@#EG&.G/XXH _E5\
M'?\ *4;Q%_V-=S_Z<&K^^7P)_P B9X8_[ MA_P"B$K^%?PC\#?CM#_P4S\0>
M))O FJ)X:D\4W,D>IFSF\AHC?,RL'V;<%<'.?QYX_NK\#Q2P>#_#<,Z&.:/1
M[%)$/576!0RGW!ZT =37\MW_  <4?\%(/'/[*O@+PI\._A=J$VD>*?&5T=.^
MU1S-"Y>ZD,,6&5E/ =>AZ]^<5_4C7\S'_!P;_P $Q-?_ &S? &A_$3P1;RR^
M(OA]C5(8+;<999K$><@V("QWL@ '.>E 'Y\?L(_\$E/C]^T]X&\+?&OX_>)M
M3U>Q\<6$6L0&:_D9!%<#?\OF/@_> X.*R/\ @MW_ ,$>_P!E3]GG]BC4?BA:
M7/V?XB:6_EPI<3INN)#$I/DCS"\FTL%8E0OS *6[?-_[-?\ P7^_:U_8E^'F
MF?L[?$#]GK6O$8^'RCP_HUY<Z+>,[V]J(T4I*B(S1MAB%+,H9B0N22?#?^"F
M?[0W[<?_  5$_9KE\=:'\-_$>A:6MS#.OA:*QO(4,(*81;<1]!&%4?*W3G-
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MUG_R;1\;_P#LG/B3_P!(GK^(3_@VB_Y.^^/W_8UZK_Z5SU_8YX@\2>*?BO\
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M?3OASK%SX7'B\S'5$L9S (?MR-OWA"N-HSUZ4 ?Z(GP/_P"20?#G_L4](_\
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M(EV@<X['&,?ZN7AKP_IWA;1-.T/2[>.WM-.M+>UC2-0JGR(4B+X  RVW)^M
M'\9?_!U/\*?$GBSQ1^S[XSTVVN)-)\+WMA=:C,@;R8HH+P2.96 V@ *<@D>]
M?T*?\$G/C+X,^*'[)_P^T[PSJFGWMYX:\/Z99ZC!9R1N\3I;QQ,90A)!5P%Y
M QG&.M>D_P#!0+]C;0/VQ?@CXF\#7<$7]NS:3=PZ1=,J^9%.T<GE^6Y!(;>W
M&,'(&*_B=^#_ ,:OVU/^"%'Q%\6^&)O GB#XD>!=4U*=(E^R7E_;16IE8HF-
MKH%  (QC&,@@C( /]#+Q9XMT#P3HEYX@\2:C;Z9IEE$\LMQ<R+$GR*7VAF(
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M):B4N\:LJ[-ISDC!'I7],GQ!\,^)[C_@GEX<T"WTR:3Q!'\/[.WET]8V,RW
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M!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 9VL?\@G5/^P=>_\
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MY'%[(J^4)AN.2.,>V.U?Z WB;0[7Q-X?UGP_>JKVFL:?<Z?<(X!5HKF-HW#
M@@@@^E?PF_\ !4'_ ()K_'K]BOX_1_M4?LN66HW-B^HKK>I:5HJ3%;HK,;F2
M-H[888EMRD$$YR",T ?WF*RLJNK*490RL""I4C(8$<%2.01QCFOX"_\ @ZHU
MWPAX@^+'P>TCPC<:??\ B>/Q-IZ20Z08S>QRBZB!\SR</D-DDGW]ZZJQ_P"#
MG']K'3O $7P\NOV:]=?Q[!HIT1=1;1+TW1ND@-JLV3']\8RK[=PXPV0#7G7[
M W_!.3]HS_@I%^T?%^TS^T_I^J:9X?MM5_MJQT;65GCCMAYQN$41W"A5P0H
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M([F@#]"J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR>YW9SN\YHB^<\YSUKLJ* &1QQPQI%$BQQQJ%2-%"HBC@*JC   Z <"N1O\
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MY\ KJ:ZTO@[PV-75@ZZD-(LA>A@<AA<^3YH;/.=V<UVG3I110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% &=K'_()U3_L'7O\ Z32U_'E\0/\
MD^&#_L8C_P"E=?V&ZQ_R"=4_[!U[_P"DTM?QY?$#_D^&#_L8C_Z5U]]P)_%S
M?_L7S_4Y<3_R[_Q/]#^O+P)_R)GAC_L"V'_HA*ZRN3\"?\B9X8_[ MA_Z(2N
MLKX2I_$J?XY?^E,Z8[+T7Y!1114#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *:Z)(C1R(KHZE71U#*RD8*LI!!!'!!&#3
MJ* /"?'_ .S-\"?B;;2P>,OAAX0U9Y7\PW4VBV0NA)D$L9A$&;=@9#[AZ8/-
M;'@;X"?!SX;6MK:^"OASX3T$6@ BGLM&LX[G<,?.TXB\PL<#H0!@8 KUZB@
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MH Y.Q\">"]-U1M:T_P +:#9:N[%GU*VTRTAO68G)9KB.)922>22W)ZUUE%%
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M#_HLW@/_ ,'4/^%?S+'_ (-POB9DX_:*UG';_B;77_Q5'_$.%\3?^CB=9_\
M!M=?_%UY'^K_  /_ -%C5_\ #=/R\_7\/,T]KB?^@==/M/\ N^7F_N\F?TT_
M\-6_LX?]%F\!_P#@ZA_PH_X:M_9P_P"BS> __!U#_A7\RW_$.%\3?^CB=9_\
M&UU_\71_Q#A?$W_HXG6?_!M=?_%T?ZO\#_\ 18U?_#=/R\_7\/,/:XG_ *!U
MT^T_[OEYO[O)G]-/_#5O[.'_ $6;P'_X.H?\*/\ AJW]G#_HLW@/_P '4/\
MA7\RW_$.%\3?^CB=9_\ !M=?_%T?\0X7Q-_Z.)UG_P &UU_\71_J_P #_P#1
M8U?_  W3\O/U_#S#VN)_Z!UT^T_[OEYO[O)G]-/_  U;^SA_T6;P'_X.H?\
M"C_AJW]G#_HLW@/_ ,'4/^%?S+?\0X7Q-_Z.)UG_ ,&UU_\ %T?\0X7Q-_Z.
M)UG_ ,&UU_\ %T?ZO\#_ /18U?\ PW3\O/U_#S#VN)_Z!UT^T_[OEYO[O)G]
M-/\ PU;^SA_T6;P'_P"#J'_"C_AJW]G#_HLW@/\ \'4/^%?S+?\ $.%\3?\
MHXG6?_!M=?\ Q='_ !#A?$W_ *.)UG_P;77_ ,71_J_P/_T6-7_PW3\O/U_#
MS#VN)_Z!UT^T_P"[Y>;^[R9_33_PU;^SA_T6;P'_ .#J'_"C_AJW]G#_ *+-
MX#_\'4/^%?S+?\0X7Q-_Z.)UG_P;77_Q='_$.%\3?^CB=9_\&UU_\71_J_P/
M_P!%C5_\-T_+S]?P\P]KB?\ H'73[3_N^7F_N\F?TT_\-6_LX?\ 19O ?_@Z
MA_PH_P"&K?V</^BS> __  =0_P"%?S+?\0X7Q-_Z.)UG_P &UU_\71_Q#A?$
MW_HXG6?_  ;77_Q='^K_  /_ -%C5_\ #=/R\_7\/,/:XG_H'73[3_N^7F_N
M\F?TT_\ #5O[.'_19O ?_@ZA_P */^&K?V</^BS> _\ P=0_X5_,M_Q#A?$W
M_HXG6?\ P;77_P 71_Q#A?$W_HXG6?\ P;77_P 71_J_P/\ ]%C5_P##=/R\
M_7\/,/:XG_H'73[3_N^7F_N\F?TT_P##5O[.'_19O ?_ (.H?\*/^&K?V</^
MBS> _P#P=0_X5_,M_P 0X7Q-_P"CB=9_\&UU_P#%T?\ $.%\3?\ HXG6?_!M
M=?\ Q='^K_ __18U?_#=/R\_7\/,/:XG_H'73[3_ +OEYO[O)G]-/_#5O[.'
M_19O ?\ X.H?\*/^&K?V</\ HLW@/_P=0_X5_,M_Q#A?$W_HXG6?_!M=?_%T
M?\0X7Q-_Z.)UG_P;77_Q='^K_ __ $6-7_PW3\O/U_#S#VN)_P"@==/M/^[Y
M>;^[R9_33_PU;^SA_P!%F\!_^#J'_"C_ (:M_9P_Z+-X#_\ !U#_ (5_,M_Q
M#A?$W_HXG6?_  ;77_Q='_$.%\3?^CB=9_\ !M=?_%T?ZO\  _\ T6-7_P -
MT_+S]?P\P]KB?^@==/M/^[Y>;^[R9_33_P -6_LX?]%F\!_^#J'_  H_X:M_
M9P_Z+-X#_P#!U#_A7\RW_$.%\3?^CB=9_P#!M=?_ !='_$.%\3?^CB=9_P#!
MM=?_ !='^K_ _P#T6-7_ ,-T_+S]?P\P]KB?^@==/M/^[Y>;^[R9_33_ ,-6
M_LX?]%F\!_\ @ZA_PH_X:M_9P_Z+-X#_ /!U#_A7\RW_ !#A?$W_ *.)UG_P
M;77_ ,71_P 0X7Q-_P"CB=9_\&UU_P#%T?ZO\#_]%C5_\-T_+S]?P\P]KB?^
M@==/M/\ N^7F_N\F?TT_\-6_LX?]%F\!_P#@ZA_PH_X:M_9P_P"BS> __!U#
M_A7\RW_$.%\3?^CB=9_\&UU_\71_Q#A?$W_HXG6?_!M=?_%T?ZO\#_\ 18U?
M_#=/R\_7\/,/:XG_ *!UT^T_[OEYO[O)G]-/_#5O[.'_ $6;P'_X.H?\*/\
MAJW]G#_HLW@/_P '4/\ A7\RW_$.%\3?^CB=9_\ !M=?_%T?\0X7Q-_Z.)UG
M_P &UU_\71_J_P #_P#18U?_  W3\O/U_#S#VN)_Z!UT^T_[OEYO[O)G]-/_
M  U;^SA_T6;P'_X.H?\ "C_AJW]G#_HLW@/_ ,'4/^%?S+?\0X7Q-_Z.)UG_
M ,&UU_\ %T?\0X7Q-_Z.)UG_ ,&UU_\ %T?ZO\#_ /18U?\ PW3\O/U_#S#V
MN)_Z!UT^T_[OEYO[O)G]-/\ PU;^SA_T6;P'_P"#J'_"C_AJW]G#_HLW@/\
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M[.'_ $6;P'_X.H?\*/\ AJW]G#_HLW@/_P '4/\ A7\RW_$.%\3?^CB=9_\
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M,/:XG_H'73[3_N^7F_N\F?TT_P##5O[.'_19O ?_ (.H?\*/^&K?V</^BS>
M_P#P=0_X5_,M_P 0X7Q-_P"CB=9_\&UU_P#%T?\ $.%\3?\ HXG6?_!M=?\
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MXG_H'73[3_N^7F_N\F?TT_\ #5O[.'_19O ?_@ZA_P */^&K?V</^BS> _\
MP=0_X5_,M_Q#A?$W_HXG6?\ P;77_P 71_Q#A?$W_HXG6?\ P;77_P 71_J_
MP/\ ]%C5_P##=/R\_7\/,/:XG_H'73[3_N^7F_N\F?TT_P##5O[.'_19O ?_
M (.H?\*/^&K?V</^BS> _P#P=0_X5_,M_P 0X7Q-_P"CB=9_\&UU_P#%T?\
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MG_P;77_Q='_$.%\3?^CB=9_\&UU_\71_J_P/_P!%C5_\-T_+S]?P\P]KB?\
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M7\/,/:XG_H'73[3_ +OEYO[O)G]-/_#5O[.'_19O ?\ X.H?\*/^&K?V</\
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M ,&UU_\ %T?ZO\#_ /18U?\ PW3\O/U_#S#VN)_Z!UT^T_[OEYO[O)G]-/\
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M,/:XG_H'73[3_N^7F_N\F?TT_P##5O[.'_19O ?_ (.H?\*/^&K?V</^BS>
M_P#P=0_X5_,M_P 0X7Q-_P"CB=9_\&UU_P#%T?\ $.%\3?\ HXG6?_!M=?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<C\S_;W\(/A]%\+_ (?>&O!45U)>#1-+M+-[B4EGDDAA1'+$\D[@>>YSUZT
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M ":/K?\ V,J?^@7%?3?_  65_P"3,_'/_7K<?^B'KYD_X-Y/^31];_[&5/\
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MX((R.N?Y5_>[X'@M=.^#WA^VLHDCL[7P=!;P1! $2%;(Q*H08'"^V">2,'%
M'\!/[/\ _P %GOVI_P!F^6__ &7/C1J.HWOQ9FNSI&GM/-*UR+DO]FC*AB6^
M\0<C'Y5[O\1OV2?^"R'[0NEO\8O _BCQ'9Z+?6MYJ]E EQ<KB*& 7JC:&XRC
M8_ESQ7YM_M6>$O#>L?\ !</P_'J%DDT#>,K=V3;A=W]H(<[>G7\<U_I2_#6W
MM-+^$GAJVTZ)(;6R\)PK;QJBA5"61<#:!@\GGCGN* /X</\ @E]_P4X_:M^
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MY&<>G%?@Q_P<9?':\^"?['NFWNC7935=5U^6Q,$;D2-#*ELH)53D@EFXZ<4
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M/G_!N)!##_P5"_:+\L;3_:'B<8SQC=>=NGO_ /6H _T":*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .-^(?\
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MW9; !^NOPH^-7P[^-'A73?&'@/Q%8:MI.J6\-Q T=S 9 )D#A=H<EL XR!^
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MRU+XD>/-3M;#3[-76%9YHXVE=4+95&(+@$ <#&3C/%?Q+?'W_@FM_P %'OV
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M6"X@_LV20"Z!\L#9G.>>._IWH _J"TCQM_P33\*_&:R^&JV7A4_$<7J6UDD
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M(_9^FU*/PW<BWMO$JV7F;'MY''V@2;#C!4OG/X\8H _G\_X)>_!CQ3_P4_\
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M4K)%*BNCJ>H96!!'U'7GK4=I9VEA"+>RMH;6!26$4$:Q(&;[S;4 !8\9)Y(
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M %%%% !1110 4444 %%%% !1110!$L,*NTJPQ+*_WI%C0.W^\X 8_B34M%%
M'\UW[>/["GQ4_:^_:)T[3O$4MY=_#;3]72YCLV,CVPC2?=]P_( 5![?X5^\/
M[.?P@TCX%?"'PC\,]$MTM;'P]8QP)$B! &\N-&)  Y(C'->S"QLQ-]H%M")_
M^>NQ=_K][&:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% '&_$/_D1O%?\ V ]0_P#1#5_(Q\+_ /D^.?\
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M $,.K_\ ?N/_ .(H_P"(@#]A#_H8=7_[]Q__ !%;1_X(,_L)$G_BD;O\HO\
MXNC_ (<,_L)?]"E=_E%_\77D7\-.W$7WT?+_ "?W^1?^V_\ 3GIW_NW_ /;O
MZL8O_$0!^PA_T,.K_P#?N/\ ^(H_XB /V$/^AAU?_OW'_P#$5M?\.&?V$O\
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M<1??1\O\G]_D'^V_].>G?^[?_P!N_JQB_P#$0!^PA_T,.K_]^X__ (BC_B(
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MPX9_82_Z%*[_ "B_^+H_X<,_L)?]"E=_E%_\71?PT[<1??1\O\G]_D'^V_\
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M71?PT[<1??1\O\G]_D'^V_\ 3GIW_NW_ /;OZL8O_$0!^PA_T,.K_P#?N/\
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MZL8O_$0!^PA_T,.K_P#?N/\ ^(H_XB /V$/^AAU?_OW'_P#$5M?\.&?V$O\
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MMO\ TYZ=_P"[?_V[^K&+_P 1 '["'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\
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M'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\ OW'_ /$5M?\ #AG]A+_H4KO\HO\
MXNC_ (<,_L)?]"E=_E%_\71?PT[<1??1\O\ )_?Y!_MO_3GIW_NW_P#;OZL8
MO_$0!^PA_P!##J__ '[C_P#B*/\ B( _80_Z&'5_^_<?_P 16U_PX9_82_Z%
M*[_*+_XNC_APS^PE_P!"E=_E%_\ %T7\-.W$7WT?+_)_?Y!_MO\ TYZ=_P"[
M?_V[^K&+_P 1 '["'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\ OW'_ /$5M?\
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M1??1\O\ )_?Y!_MO_3GIW_NW_P#;OZL8O_$0!^PA_P!##J__ '[C_P#B*/\
MB( _80_Z&'5_^_<?_P 16U_PX9_82_Z%*[_*+_XNC_APS^PE_P!"E=_E%_\
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M%_\ %T7\-.W$7WT?+_)_?Y!_MO\ TYZ=_P"[?_V[^K&+_P 1 '["'_0PZO\
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MX9_82_Z%*[_*+_XNC_APS^PE_P!"E=_E%_\ %T7\-.W$7WT?+_)_?Y!_MO\
MTYZ=_P"[?_V[^K&+_P 1 '["'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\ OW'_
M /$5M?\ #AG]A+_H4KO\HO\ XNC_ (<,_L)?]"E=_E%_\71?PT[<1??1\O\
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MMO\ TYZ=_P"[?_V[^K&+_P 1 '["'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\
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M'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\ OW'_ /$5M?\ #AG]A+_H4KO\HO\
MXNC_ (<,_L)?]"E=_E%_\71?PT[<1??1\O\ )_?Y!_MO_3GIW_NW_P#;OZL8
MO_$0!^PA_P!##J__ '[C_P#B*/\ B( _80_Z&'5_^_<?_P 16U_PX9_82_Z%
M*[_*+_XNC_APS^PE_P!"E=_E%_\ %T7\-.W$7WT?+_)_?Y!_MO\ TYZ=_P"[
M?_V[^K&+_P 1 '["'_0PZO\ ]^X__B*/^(@#]A#_ *&'5_\ OW'_ /$5M?\
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M1??1\O\ )_?Y!_MO_3GIW_NW_P#;OZL8O_$0!^PA_P!##J__ '[C_P#B*/\
MB( _80_Z&'5_^_<?_P 16U_PX9_82_Z%*[_*+_XNC_APS^PE_P!"E=_E%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% ''?$(D>!O%9'7^P]0_\ 1#5_(Q\+R3^W'.3_ -#'_P"W=?US?$/_
M )$;Q7_V ]0_]$-7\C'PO_Y/CG_[&/\ ]NZ_0>"O]USS_L$?Y'+B/CH_XG^<
M#^PK2O\ D%Z;_P!>%G_Z3QU?JAI7_(+TW_KPL_\ TGCJ_7Y_+=^K_,ZC\F_^
M"RO_ "9GXY_Z];C_ -$/7S)_P;R?\FCZW_V,J?\ H%Q7TW_P65_Y,S\<_P#7
MK<?^B'KYD_X-Y/\ DT?6_P#L94_] N*_0:'_ ";?'?\ 8\P_Y(Y/^8M?X'_Z
M3$_?^BBBOSTZPKS+XJ?%[P'\'/"VH^+/'7B#3=&T[3[>6<B\O(;>2;RE+%(U
MD;.<#KMQ^-=/XQ\5:7X*\.:KXEUB>.WL=*M)KJ5Y&"J1%&S[221C.WUK_/<_
M;T_:J_:4_P""IO[;-W^R1\"->U+2_"]CKTVG7MSI\\\<,L'G^2REHBJD%<]\
M>U '[\?%G_@YL_8O^%GBR_\ "L^EZSK<UC-)";K3KD30.8V*DJT=LX(.,\'O
M^%=C\ /^#CO]CGX\^*;3PO86FI^'I[NXCMUN=5NEAA5Y&V#)DMXQ@'KS^O%>
M4?LL_P#!N/\ L]>$? NC1_'71;7Q9XQ-M')J=]<LES,]PR R"1B6;=NR2"0<
MFN'_ &V_^#>7X53?"WQ#JG[,>EQ^%/&EA!->V$VGGR+@R1*TB;/+*N2"N..!
MD?@ ?U ^"?'7A;XAZ!8^)?"6L6.LZ5?P1SQ3V5Q'.JB10VUS&QP1GJ0 >W.0
M.NK^$W_@BG^W5^TK^SE^TQ/^PW\?+75]1CM=8_LRVU;41<.HA23RU*R2@C&T
M?WO7'6O[L%='02*RE"NX.#\I7KG/3&.] #J*^7_B]^V/^SM\$)#:>/OB7X<T
MC4SD)ILU_ EP7R!M97=<=1TW'MP:\D\#?\%+/V1?&VM)H$/Q;\*V&I32+';1
MW&I0!)69@JC(<L"V>-JMGICG- 'WW7!?$WXAZ!\*O!.N^.O$UPEMH^@V<EW=
MRNXC4+&C/C<>!D*?PS74:7KFD:YI<6M:/J%KJ>ESQ&:"^LY5FMY8U7<621>"
M-O/T(-?S_?\ !;W]N#X8^!OV5_B?X M?&VGZ=XKO='OK6&R%XD=Q+,8I$554
M.&SD@ "@#X1_:9_X.2O#.E_$"Z\+?"70;_7+/2M5&F74^E1S7"*RS>4S,\08
M9W'JQ]/P_H:_8'^/^O?M*?!;1_BEK%G<Z?'JD2%;>[1HY$8Q"0EE<!A@'!Z=
M/R_BB_X-U;K_ ()_>(?!WQ-N_P!JVZ\+W7C74]<EGT@^(9HG:5S>+("F_,A8
MH#LVC&XC/'3^WR\^+?[./[/'[.NI>-?#.L:+X8^&=CHM[<Z5<12QP6;.UI((
M#&Q(08(4C!SQCKT />!\9?A^=;;P\NOV+:JDAC:T%S%YH<$J5V!BV01CI7J$
M4BRQI*ARDBAU/JK#(/XBO\YGPM_P5$=_V^=:UJ\^*-N/A^?$%P\#MJ(^RFW^
MV,5QF39MV'\N]?W3_LM_M>_!_P#:.\*Z$_P[\7:9XDO$TZVCO197,<[)+#"J
M2E@C'!!7GWH ^PJ*\$\0_M&_#3PQXO/@O5M=L[;64R7MI)XUD51U)5F!X^G8
MUXAX_P#^"C?[)_P[UZ'POKOQ3\/6^O331P#3Y;^V299)&V(I3S226?Y1TYS0
M!F_MX?MQ^'/V*/A[>^.O$.GR7UM:6QN"B(7X"[N H/;U_P#U>:?\$W?^"E7@
MS_@H'X2U'Q%X7TJ;3O[/F:-_,1D!VDY&" .W'0_7I6S^UOX9_9^_:E^!=Y?^
M.KK3[WP;>:>S"^DDB-OY+(S!C(S;<;2#U]^E<_\ \$O_ ("?LZ_!KX;ZS!\!
MI-.NM/DO@+FXL'CD5&._<K-$2,DG&#SQ[8 !^IU%<WXH\7^&/!>FRZQXKUS3
M]!TR!'DEO-1N%@A58U+.2S<G"@G@&OA3Q#_P4\_9*T?5[G2+/XH^&]3EL7*7
M<D&H0,L;*2'X63@+@\GD]<#I0!^A]%?-GPC_ &M_@!\;(4_X0/XC^'-6OCM5
M].AOX6N0[9&$568,,X&"0P) P1S7M?B[Q+;^%-%N=;NP/LMG%)/.Y/RI%&NY
MF)'0 9.?:@#J**^6?@]^V!\%?C3XFU'P;X1\6Z7>^)M,>2.ZTR"ZBDF22(E7
M1D#EU;(( (ZC!KZ<O;VUTZTGOKV9+>UMHVEGFD.$CC7JS$] * +5%?(Z_ME_
M!W4/'J_#K0?$FG:IXA-P+9K2&YC>82[MI7RT<D$'MC]*^K;:Z$MHMU(!$IC\
MQ]W 10NYBQ/0 9)/08- %NBOD?XO_MQ?LT_!6<Z=XR^*/ABSUHG8NEG481<*
M^=NV0,RD-GC"[N3R0017(>!/^"BW[*7C?48-&A^*_A>PU6Z=%MK:YU&$>=YG
M"A<.S@YXX5LY[8Y /N>BLW2=8TO7;*'4M'O[;4K"X4-#=VDJS0R*0""KKP00
M01[&O,?B?\;? _PFDTZ/Q;JMKISZFZI:K<2I&9"S;1M#$9YXH ]@HKY9\9?M
MF_L[^ =,@O\ Q3\1] TF:Z@\VULKF]ACN)R1E0BLXR">_7T!KR;X>_\ !2O]
ME'Q[XG;PE!\4?#-CK#R^5:PSZC"!,Y8*JG]X6&[/!"GGC'< 'W_16?I>JZ;K
M=E#J6DWMOJ%A<KO@N[602P2J0#E'7@C!!_$5/>7EKI]M->7MQ%:VMNADGN)W
M$<44:]6=VX % %FBOAWXH?\ !1#]E/X6ZL?#^M?%?PO)K:2^5-91:C 6B8'!
M5LNK%P001@ <$$@\=%\*_P!NS]F'XO7D>D^%/BKX7N-;=@@TPZC 9G<G 6,*
M[$L2<88#MR: /L"BF1R1S1I+$ZR12(KQR(0RNC %64C@@@@@T^@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** ,[6/\ D$ZI_P!@Z]_])I:_CR^('_)\,'_8Q'_T
MKK^PW6/^03JG_8.O?_2:6OX\OB!_R?#!_P!C$?\ TKK[[@3^+F__ &+Y_J<N
M)_Y=_P")_H?UY>!/^1,\,?\ 8%L/_1"5UE<GX$_Y$SPQ_P!@6P_]$)765\)4
M_B5/\<O_ $IG3'9>B_(****@84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7/>*?%.A^#=#U#Q#XBU"VTW2]-MY+BXN+F9(
M4"1J6P&<@9.,#KCD]JZ&OY=O^"_O[1OQYT'1;?X(?!JPU+[3XJCM;66_L5G&
MP72!7S)$/EQN)/(Y/Y@'M/[1/_!QS^R!\ /&MWX*NM,UCQ3>V<\UO+<:-<">
M+?"2&YBMY !D>OZ"NL_9<_X.#_V1?VF_%EKX0TR#4/"NHW=PMO#_ &W=)!N=
MFVC"RP1D\]@:^*O^"1'_  1:^$6N?".3XF_M9^"8O'/C;Q ZW$::QEW4W8::
M1F:9'<! 0NT8.6'(YKPG_@LI_P $>_A_\&=*T7XZ?LJZ0OP]FT"3^T;^#39#
M"JO:N'="T0CW @;AP#A@.Q- ']END:OIVNZ;9ZMI5W#>V%_;QW-M<0.LD<D4
MJAE(921T//N*DO\ 4].TJWDNM3O[/3[:)&DDGO;F&VB1$!9F9YG10%4$GGM7
MX*?\$)?VN?$?[0/P;N_!?BR]DO\ 6/ 6FPV4US+(TDCM;RQ0'+,23P3U//6O
M"/\ @LA\7OVH/'/CBW_9O^ =MK&EW&K3QZ>VNZ>+B,(MRXB9O-BV@85CGYAU
MH ^MOVM/^"\/[&_[)'Q LOA_XSUV+4]0OKY;"&YL-2MS TQD$0P5CD&"QZ9/
M'TK].?V</VBO!7[3/PZTCXD^!'9]#UBVBN;9F<2'9*H=<D!>Q'.*_P W;_@K
MO_P2"^)'[,'P.^%GQP^,WBF\\2>*M5U>TGO9I[V2:5'GDBEFMI<NY5AO7<C
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M=O\ &+X32/)X:N988D,DJS-NGCDD3YU1!]V,\8K_ #V_VSO^"/'Q^\-_L?\
MB/\ :2_:3\4ZKK>LZO$NNV$-[=SM+92R$7"*!(Y*E<@$$8QE3D'%?T[_ /!J
MQ:VNG?\ !/4Z9:*RQ6/B&U@&YBQ_=PWRCDDGGKW^M ']'?Q#^(/AOX9>%=5\
M7>*+^"QTS2;26ZE::5(C(L2%RJ;NY"GG!&>.IK^?7QU_P<K?L@>"?B!J/@.7
M0=>OYM,NVM+C4K:8O:!DE,1?>MLRA<C(.[&*Z_\ X+^?$OQEX%^#'A'3?#&H
M36%KXAEEM-4>.1XPT,EQ)$^\J1QL.#D]*^7/V/\ _@EK^QY\2_V&?%'Q5\6^
M%+#Q#X[U?P_>:A=^(&,4DME=_9O-#%V5FR9)&8G<FT*3SF@#]_\ ]DW]L?X5
M?M?>"8_&OPWOXVM7CCD:TDN8Y)T$F." $.02 1MSWQ7T1XY\;>'OAYX7U?Q;
MXGO[?3M(T>SGO+B:XE2%66"-I"BLYQN8*>QQU-?R(_\ !&U-4^$OQ]\4_#3P
MOKCWG@NTUNY'V>*=I(K:V@F8^60"54*HQCH,5['_ ,%ROVZM9\7#1OV3OV?]
M4:^\;:OJAM-<M=+F9[KR+ORX721827 4;A@X')X!)H _7K]FK_@J?\#/VH?B
MEKWPM^'UO>3ZGH-U-:W%[YPFMG>&1HV92L2C&5[,:^^/BM>ZU8>!=9O] W_V
ME:VYGA"9W$(C,0,<Y/ _R*_(G_@D-_P3J\+?LT_"7PW\1_$6D%/B5XNTJ/4-
M7GN%/VE+FX):5G+C>"6W$9Y)!S7[;W%O#=026TZ+)#*ACD1AD,C#!!S[4 ?A
M_P#LL?\ !5/PYX^_:1O/V7O%US%:^,+;47L@+J0+*2LICX5L$9/^%?N*"" 0
M00>00<@CU!'6OX.?^"B7P@NOV-/^"DMA^U!I4\FAZ1JGB5'\WS&AA<270;U"
M\DCKQZ=,U_:'^RS\3XOC%\#/ GQ!AG%S'KVE0S"<,&$A$41+;@3G)8]Z /H2
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#C?B'_R(WBO_ + >H?\ HAJ_D8^%_P#R?'/_ -C'_P"W=?US_$/_
M )$;Q7_V ]0_]$-7\C'PO_Y/CG_[&/\ ]NZ_0>"O]USS_L$?Y'+B/CH_XG^<
M#^PK2O\ D%Z;_P!>%G_Z3QU?JAI7_(+TW_KPL_\ TGCJ_7Y_+=^K_,ZC\F_^
M"RO_ "9GXY_Z];C_ -$/7S)_P;R?\FCZW_V,J?\ H%Q7TW_P65_Y,S\<_P#7
MK<?^B'KYD_X-Y/\ DT?6_P#L94_] N*_0:'_ ";?'?\ 8\P_Y(Y/^8M?X'_Z
M3$_?^BBBOSTZS\WO^"J_BO5/!W['GQ!U;2;B2VNA T(DC8JP62"8$9!'6OYM
MO^#?+X->'=5^/&O?&34K6"Y\37.LW4QO)$5IA(T[L&+,"3\U?T:_\%;M(OM:
M_8Q^(-G80R3SF/?LC4LVU8)L\ $XK\!?^#>GQ7H]K\0]8\'W-W##KD.K7*M9
MR2*MP6$TF1Y>0V22,#'?\@#^R^D95=61@&5@596 *LK#!!!X(()!!X(XI:*
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MV=\??#SPI+\5_@;\;]8U/Q/X20ZG-IL%WJ%O))!9*DNX+,(A(&9""$+$?Q
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M/^"A-A\3;SQ)K&H>"_B1XI)^S223O:Q6]]?$8QN**H20=L8_3^C_ /X*%_\
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MISN8@_0<5]=T <]XMOO[-\,:]J .TV>E7EP#Z&.%V!_2O\\/]J+PE8_M#_\
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M0 4444 %%%% !1110 4444 <;\0_^1&\5_\ 8#U#_P!$-7\C'PO_ .3XY_\
ML8__ &[K^N?XA_\ (C>*_P#L!ZA_Z(:OY&/A?_R?'/\ ]C'_ .W=?H/!7^ZY
MY_V"/\CEQ'QT?\3_ #@?V%:5_P @O3?^O"S_ /2>.K]4-*_Y!>F_]>%G_P"D
M\=7Z_/Y;OU?YG4?DW_P65_Y,S\<_]>MQ_P"B'KYD_P"#>3_DT?6_^QE3_P!
MN*^F_P#@LK_R9GXY_P"O6X_]$/7S)_P;R?\ )H^M_P#8RI_Z!<5^@T/^3;X[
M_L>8?\D<G_,6O\#_ /28G[_T445^>G6>>?%/X?:3\4/ ^O>#-8A2:TU>QN+?
M;(JLHDDB=$8AN."W7^F:_P [?XJM\<_^"/W_  4BO_B[%H>KWOPHU7Q/+-^Z
MCN/L45NUUO9CM7RU55Y.>/PYK_2+KXT_:]_8F^#O[7G@'4_"7COPUI-QJ%S#
M,MIJ\UK&T\,LJ%-S.4=LJ<,K+@@YSG/ !X?^RY_P55_9>_:$^'NB>++SXB^%
M_"VJ7]I!)=:;J&IP0M%*\8+AD>3>A#9! 4C)Z+TKQG]NK_@LC^SK^S+\/-;U
M'PEXQT'QGXD^R3Q65MIE_#<N+AE95\N.-V8D$C!*Y&<@!L8_!3XT?\&N'Q8T
M_7KO5_@S\;]2TG1[N9VCTK3M1NH$M5:4E5$*O&54*P&0NWL#7H/[/?\ P:[^
M*--UZP\1_'+XO7/BRVAGAGDTG4KZXNQ($=79'C=I0,X(^<"@#Y&_X)@:=^UK
M^WC_ ,%!6_:AU[^WM+^&"^)$O(+6X>[2T:V%QYB[5<B,C;S_ )&?WA_X.%/V
M,=;_ &I/V?=*US0;*6_O/A[;SZH+>&-I7<VLTMV %4$G@].^/I7[+?LW_LQ_
M#']F;P)I?@KX?^'].TV.QMXXY[JVMHXI)G1 A.Y44X/4Y&<GKP*]WUW0M*\2
M:5>Z+K5E#?Z;J%O);75M.BNDD4J%'!# C."<<$9Z@]* /Y&/^""O[;OPI;PG
MJ7P!^.;Z#X(UGP9;'2K!O$YAL8YY;.01!2]P%9=XC(!'&XC<=OS5^]GQ_P#V
ML?V./@?\/-6\:WOCGX;W<]I$[VEEI^J:;>SW,J*792D<CA1@ <D,690%;!Q^
M0_[>_P#P;S:9\?\ Q3J/CKX#>.1\+-9N;A[QX=*FDTY[B1G,K M#Y2$DY&"Q
M))^7J,?F5X5_X->?VEO%NL06OQ+_ &A-<O/#MG>QR36]]JUVT4\2,/,0)),=
M^Y>"%4\=J /W5_X)V_\ !6?X?_MK?&#5OAKX0\ PV%CI5Q<10Z_!8)'!.(69
M4=9UC (;;U#<YKUO_@N)/'!^PK\57FD6-!X=U$DL<#B"3K^F,U[K^P/_ ,$Y
M/@[^PWX%L=#\*Z-IMUXHCACCO?$4<"BXF94"N_F%%=F=AG))P,\<\>N?MK?L
MLZ;^UY\$?%'P>U2_73K3Q)I]Q8R7#9P@G1D+< GC=V':@#^;?_@T<O+6\_9Z
M^,[6TT<RKXEP2AW '[:W4CBOZ[/$2L_A_740%G;1M455')+-93A0!ZDD"ORK
M_P""47_!+[PY_P $S/ /C'P1X>UR/6X?%>H_;Y)4WXC/G&;'SJO<D5^M;*KJ
MR. R.I5E/1E8$,#[$$@T ?YTOB;XEP? O_@IQK>L_$6W_P"$>T*?Q3.ZZGJ'
M[BWV-?L0WF2A4((QSTYXK^^#]G[XV_"_XO\ @#PQJ?P^\9:'XDC.BV*S1:;>
MPSS021VZ+(DD<;$C:P/(R!WP>*_)G_@IW_P1*^&_[?$+:AHFJ6O@3Q-(1(^J
MVZM!,9=P9F\R%-W+<Y)ST!/%=!_P2D_X)1>+O^"=T=_:ZW\5[SQ]97"W"V]O
M/=7,Z0+,7V@+.<#8& &/2@#^?C_@K)?6D'_!2O1HI9XXW/B: !68 G_24Z=^
MWI7]F/[(3*_P!\",I#*=/C((.0?W%O7YI?M6?\$</"?[2_[1=A\>M0\11V-]
M9:@E^+4[\EDE$F.%/ICK7Z^_";P!!\,/ FA^"[>83PZ/;K LHZ,%2-,]!V0=
MJ /R$_X+Z3PV_P"PA\3))I%C0:)>DLQP!^Y?N:_/?_@TLN[6[_8]^)+6TT<P
M'C"WR48-@;K[C(]\?G]:_?;]NS]D/2_VT/@=XD^#>KZ@NFVGB"RFM'N6SA!*
MC)GY0QXSZ=S7@'_!*K_@FIX?_P"":?PF\1?#'P_K::U;:]JJZE).F_"LK2,!
MAP/^>A% '\3/[91OC_P67U1/VH+*\'P3D\83+9W.JM*-,CMS?,%<>=^X"[><
MY''MU_NE^ /B3]@SX9_#/PSJ7P[\:_#*PT2/0[6]@+:UI?VL!8%,BFSW+()%
MD5D6/8P) PS*=Q^=?^"GO_!('X9?M_\ AF063V7@_P ;!)63Q!#&(;AKC#&.
M3SD7>&+$9)? /.0*_GB\,_\ !LE^UEHOBFRTM?VB?$">%=.N%5(_[9N_LS6B
ML0$!-QY>P@GH2.] 'R7_ ,%J?VZO _Q:_;S\%^%?AJEA>:39:[IUK+J&GK$8
MI=EQ%$TA>$;3N*EB<@9R3P:_MU_X)XW=II_[*_A+5+J>.*TBTBTN[F=F 2*.
M.P221F). %!)Y/XU^(WA/_@V>^'-GKNB^+?%7B^WUKQ-IKVT\E]/YDTSW$++
M(6\QD8D[QU#=1G)XK^A?X?\ [/,7P_\ @+>_!C2]2V1SZ'+I$%^A8>3YEO\
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M@28VSRHP#H'5@ "V3@9[CT(!^5W_  35_P""NWP/_::^#W@JV^('C70/"'Q
M@T2UM]6M]:U&&T>6_C7#K+Y\@9&(^4,5 R!N(&6'L7_!0'_@I=^SQ^S7\!O%
M.OV_Q \(>*M=U#3;NSL-&TW5;/49)?-@=<F.)W#,SL@0#<1@D@'!'X-?M'_\
M&P7BO5_%NN>-?@+\8;KP7'<3SW5KH^EWUQ9",2.SJB11M$&*Y "J#P.G4CS?
MX(?\&OOQ?U[7M+\0?'OXYZIK^CZ7>)(-$U34+NX2[1)$9@8'>3Y2$(RR@')
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MS;\*+;X)_!GP5\-[10D/A[3(;=4 "A"8HPR@# &"M 'NE%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&_$/\
MY$;Q7_V ]0_]$-7\C'PO_P"3XY_^QC_]NZ_KG^(?_(C>*_\ L!ZA_P"B&K^1
MCX7_ /)\<_\ V,?_ +=U^@\%?[KGG_8(_P CEQ'QT?\ $_S@?V%:5_R"]-_Z
M\+/_ -)XZOU0TK_D%Z;_ ->%G_Z3QU?K\_EN_5_F=1^3?_!97_DS/QS_ ->M
MQ_Z(>OF3_@WD_P"31];_ .QE3_T"XKZ;_P""RH/_  QGXZ../LMQS_VP>OFC
M_@WFBE7]D369&1A&WB9 KD8!.RY. >YP#7Z#0_Y-OCO^QYA_R1R?\Q:_P/\
M])B?OW1117YZ=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,=EZ+\@HHHJ!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_)?3^O\ AV?R^?\ $1+^T!_T;1J?_@GO?_C5'_$1+^T!_P!&T:G_ .">]_\
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M-_\ !3%_C1_K#P7_ -$<^G_,?4\K_K]_W'L<3_T$?^2^G]?\.S^7S_B(E_:
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M4_\ P3WO_P :H_XB)?V@/^C:-3_\$][_ /&J_J#_ .&:/@)_T2CP;_X*8O\
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M,T? 3_HE'@W_ ,%,7^-'^L/!?_1'/I_S'U/*_P"OW_<>QQ/_ $$?^2^G]?\
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M]$<^G_,?4\K_ *_?]Q['$_\ 01_Y+Z?U_P .S^7S_B(E_: _Z-HU/_P3WO\
M\:H_XB)?V@/^C:-3_P#!/>__ !JOZ@_^&:/@)_T2CP;_ ."F+_&C_AFCX"?]
M$H\&_P#@IB_QH_UAX+_Z(Y]/^8^IY7_7[_N/8XG_ *"/_)?3^O\ AV?R^?\
M$1+^T!_T;1J?_@GO?_C5'_$1+^T!_P!&T:G_ .">]_\ C5?U!_\ #-'P$_Z)
M1X-_\%,7^-'_  S1\!/^B4>#?_!3%_C1_K#P7_T1SZ?\Q]3RO^OW_<>QQ/\
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M -$<^G_,?4\K_K]_W'L<3_T$?^2^G]?\.S^7S_B(E_: _P"C:-3_ /!/>_\
MQJC_ (B)?V@/^C:-3_\ !/>__&J_J#_X9H^ G_1*/!O_ (*8O\:/^&:/@)_T
M2CP;_P""F+_&C_6'@O\ Z(Y]/^8^IY7_ %^_[CV.)_Z"/_)?3^O^'9_+Y_Q$
M2_M ?]&T:G_X)[W_ .-4?\1$O[0'_1M&I_\ @GO?_C5?U!_\,T? 3_HE'@W_
M ,%,7^-'_#-'P$_Z)1X-_P#!3%_C1_K#P7_T1SZ?\Q]3RO\ K]_W'L<3_P!!
M'_DOI_7_  [/Y?/^(B7]H#_HVC4__!/>_P#QJC_B(E_: _Z-HU/_ ,$][_\
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M0?\ PS1\!/\ HE'@W_P4Q?XT?\,T? 3_ *)1X-_\%,7^-'^L/!?_ $1SZ?\
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M7^L/!?\ T1SZ?\Q]3RO^OW_<>QQ/_01_Y+Z?U_P[/Y?/^(B7]H#_ *-HU/\
M\$][_P#&J/\ B(E_: _Z-HU/_P $][_\:K^H/_AFCX"?]$H\&_\ @IB_QH_X
M9H^ G_1*/!O_ (*8O\:/]8>"_P#HCGT_YCZGE?\ 7[_N/8XG_H(_\E]/Z_X=
MG\OG_$1+^T!_T;1J?_@GO?\ XU1_Q$2_M ?]&T:G_P"">]_^-5_4'_PS1\!/
M^B4>#?\ P4Q?XT?\,T? 3_HE'@W_ ,%,7^-'^L/!?_1'/I_S'U/*_P"OW_<>
MQQ/_ $$?^2^G]?\ #L_E\_XB)?V@/^C:-3_\$][_ /&J/^(B7]H#_HVC4_\
MP3WO_P :K^H/_AFCX"?]$H\&_P#@IB_QH_X9H^ G_1*/!O\ X*8O\:/]8>"_
M^B.?3_F/J>5_U^_[CV.)_P"@C_R7T_K_ (=G\OG_ !$2_M ?]&T:G_X)[W_X
MU1_Q$2_M ?\ 1M&I_P#@GO?_ (U7]0?_  S1\!/^B4>#?_!3%_C1_P ,T? 3
M_HE'@W_P4Q?XT?ZP\%_]$<^G_,?4\K_K]_W'L<3_ -!'_DOI_7_#L_E\_P"(
MB7]H#_HVC4__  3WO_QJC_B(E_: _P"C:-3_ /!/>_\ QJOZ@_\ AFCX"?\
M1*/!O_@IB_QH_P"&:/@)_P!$H\&_^"F+_&C_ %AX+_Z(Y]/^8^IY7_7[_N/8
MXG_H(_\ )?3^O^'9_+Y_Q$2_M ?]&T:G_P"">]_^-4?\1$O[0'_1M&I_^">]
M_P#C5?U!_P##-'P$_P"B4>#?_!3%_C1_PS1\!/\ HE'@W_P4Q?XT?ZP\%_\
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M_)?3^O\ AV?R^?\ $1+^T!_T;1J?_@GO?_C5'_$1+^T!_P!&T:G_ .">]_\
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M-_\ !3%_C1_K#P7_ -$<^G_,?4\K_K]_W'L<3_T$?^2^G]?\.S^7S_B(E_:
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M4_\ P3WO_P :H_XB)?V@/^C:-3_\$][_ /&J_J#_ .&:/@)_T2CP;_X*8O\
M&C_AFCX"?]$H\&_^"F+_ !H_UAX+_P"B.?3_ )CZGE?]?O\ N/8XG_H(_P#)
M?3^O^'9_+Y_Q$2_M ?\ 1M&I_P#@GO?_ (U1_P 1$O[0'_1M&I_^">]_^-5_
M4'_PS1\!/^B4>#?_  4Q?XT?\,T? 3_HE'@W_P %,7^-'^L/!?\ T1SZ?\Q]
M3RO^OW_<>QQ/_01_Y+Z?U_P[/Y?/^(B7]H#_ *-HU/\ \$][_P#&J/\ B(E_
M: _Z-HU/_P $][_\:K^H/_AFCX"?]$H\&_\ @IB_QH_X9H^ G_1*/!O_ (*8
MO\:/]8>"_P#HCGT_YCZGE?\ 7[_N/8XG_H(_\E]/Z_X=G\OG_$1+^T!_T;1J
M?_@GO?\ XU1_Q$2_M ?]&T:G_P"">]_^-5_4'_PS1\!/^B4>#?\ P4Q?XT?\
M,T? 3_HE'@W_ ,%,7^-'^L/!?_1'/I_S'U/*_P"OW_<>QQ/_ $$?^2^G]?\
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M]$<^G_,?4\K_ *_?]Q['$_\ 01_Y+Z?U_P .S^7S_B(E_: _Z-HU/_P3WO\
M\:H_XB)?V@/^C:-3_P#!/>__ !JOZ@_^&:/@)_T2CP;_ ."F+_&C_AFCX"?]
M$H\&_P#@IB_QH_UAX+_Z(Y]/^8^IY7_7[_N/8XG_ *"/_)?3^O\ AV?R^?\
M$1+^T!_T;1J?_@GO?_C5'_$1+^T!_P!&T:G_ .">]_\ C5?U!_\ #-'P$_Z)
M1X-_\%,7^-'_  S1\!/^B4>#?_!3%_C1_K#P7_T1SZ?\Q]3RO^OW_<>QQ/\
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M -$<^G_,?4\K_K]_W'L<3_T$?^2^G]?\.S^7S_B(E_: _P"C:-3_ /!/>_\
MQJC_ (B)?V@/^C:-3_\ !/>__&J_J#_X9H^ G_1*/!O_ (*8O\:/^&:/@)_T
M2CP;_P""F+_&C_6'@O\ Z(Y]/^8^IY7_ %^_[CV.)_Z"/_)?3^O^'9_+Y_Q$
M2_M ?]&T:G_X)[W_ .-4?\1$O[0'_1M&I_\ @GO?_C5?U!_\,T? 3_HE'@W_
M ,%,7^-'_#-'P$_Z)1X-_P#!3%_C1_K#P7_T1SZ?\Q]3RO\ K]_W'L<3_P!!
M'_DOI_7_  [/Y?/^(B7]H#_HVC4__!/>_P#QJC_B(E_: _Z-HU/_ ,$][_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>img12876764_19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_19.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,D SH# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#XZ_X()?\
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M *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JU_7VCI*B21NLD<BJZ.A#(Z,
MRLK#(96!!!!((.13J0'\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\
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M5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\
M_P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\
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M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\
MT*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\
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M%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
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MA*SK4XPJTIN=252,FN>$H0@TO>?O!.K6G1KRDJ?)!N"7O7;4HV>CT5GKK?\
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MRO!&375_\$*8W;_@L/\ MON "L=AXC+G<HP&U6X48!(+?,P&%!(ZG !([_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!\ ?\%8O^467_!2S_LP#]LC_P!9U^(U?X@U?[?/_!6+_E%E_P %+/\
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M ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\
M$@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\
MAL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1
M,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_
M (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\
MG][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %
M>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I_
M_(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M
MK]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_
M (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T
M_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%
MH%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#
MV4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\
MI&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O
M]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:
M*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\
M?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7
MF=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_
M  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^
M?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X
M._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\
M5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:
MP'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](Q
MO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7
M_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!
M_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_
M ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\
M$@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\
MAL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1
M,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_
M (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\
MG][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %
M>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I_
M_(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M
MK]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_
M (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T
M_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%
MH%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#
MV4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\
MI&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O
M]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:
M*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\
M?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7
MF=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_
M  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^
M?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X
M._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\
M5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:
MP'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](Q
MO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7
M_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!
M_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_
M ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\
M$@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\
MAL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1
M,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_
M (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\
MG][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %
M>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I_
M_(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M
MK]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_
M (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T
M_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%
MH%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#
MV4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\
MI&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O
M]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:
M*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\
M?](QO!W_ (D%H%'_  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7
MF=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_
M  V!_P %>/\ I&-X._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^
M?U7_ ,I__(>O]+7\5O\ AL#_ (*\?](QO!W_ (D%H%'_  V!_P %>/\ I&-X
M._\ $@M K]J:*/[:P'_1,9'T_P"7F=>7_4W\G][#V4O^?U7_ ,I__(>O]+7\
M5O\ AL#_ (*\?](QO!W_ (D%H%=!X2_:Q_X*MZIXHT+3?%'_  3>\)>'O#=[
M?PP:SKL7QXT.^ETJR=U66[2S0;KDQ(6;RUY;&.^:_8FBIEG.!<917#621;BX
MJ2J9SS1;27,N;-FN96NKIJ[U35TVJ<O^?U3[J?E_<]?Z6M:RDN)K.TFO(!:W
M<MM!)=6RN)%M[AXD:> 2#AQ%*6C#CA@NX=:LT45X'X?UYFI\ ?\ !6+_ )19
M?\%+/^S /VR/_6=?B-7^(-7^WS_P5B_Y19?\%+/^S /VR/\ UG7XC5_B#4 ?
MZ??_  94_P#*++X^?]G_ /Q3_P#6=?V5:_K]K^0+_@RI_P"467Q\_P"S_P#X
MI_\ K.O[*M?U^T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '->,O%NA^ O"?B3QMXFN
M_L/AWPGHNH^(-;O=N_[+I>E6LMY>S[<C=Y5O"[XR,XQD5^ 6H_\ !T-_P2@T
MW4M1TR3XB?$BXETV\GLI9[3X=W<]I-+;R-'(]M.NH;9HMRD+(  W45^OO[<
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M(_\ !)[_ *'_ .)__AMKW_Y85_FUX'H/R%&!Z#\A1_Q!?@[_ )^9U_X74/\
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M;:]_^6%'_$4C_P $GO\ H?\ XG_^&VO?_EA7^;7@>@_(48'H/R%'_$%^#O\
MGYG7_A=0_P#F+^KORL?7\1_T[_\  'Y?WO)_?Y'^DI_Q%(_\$GO^A_\ B?\
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M#O\ GYG7_A=0_P#F+^KORL?7\1_T[_\  'Y?WO)_?Y'^DI_Q%(_\$GO^A_\
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M:;DK*5.<HNZ=XM1L]-O1ZG]:-%%%?RB>X%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\ ?\%8O^467_
M  4L_P"S /VR/_6=?B-7^(-7^WS_ ,%8O^467_!2S_LP#]LC_P!9U^(U?X@U
M '^GW_P94_\ *++X^?\ 9_\ \4__ %G7]E6OZ_:_D"_X,J?^467Q\_[/_P#B
MG_ZSK^RK7]?M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!\M_MO?\F>?M._]D-^)?\
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MBU/Q9XCU?3YQ;HDK6>HZM=W=G*?E!1W@E1F7/RDD=J_I@_X)_P#[?G[$%O\
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M^#!='PKXITNUU=X)].UEI<.-.N+06<L^Q 1*THR00J_-W[*'_!2C]DWX<?\
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M.':ER.+2E9-KW=+ZW=M-=#^M.BBBOP$]4**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X _X*Q?\HLO^
M"EG_ &8!^V1_ZSK\1J_Q!J_V^?\ @K%_RBR_X*6?]F ?MD?^LZ_$:O\ $&H
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MQ\_[/_\ BG_ZSK^RK7]?M !1110 4444 %%%% !1110 4444 %%%% !1110
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MVZKR\;#VF(P]._+SJ2O:]O>CTNK_ 'H_GGM/!OCO4;RZTW2_ 'CC5M6T_/\
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MNW9:=#^L^BBBOY8/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^ /^"L7_ "BR_P""EG_9@'[9'_K.
MOQ&K_$&K_;Y_X*Q?\HLO^"EG_9@'[9'_ *SK\1J_Q!J /]/O_@RI_P"467Q\
M_P"S_P#XI_\ K.O[*M?U^U_(%_P94_\ *++X^?\ 9_\ \4__ %G7]E6OZ_:
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MO_\ ",US_P"0*/\ B$&_:4_Z/)^%_P#X1FN?_(%'_$2>!O\ HHL+_P"$^/\
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M_1187_PGQ_\ \R#^J8G_ )\R^^'E_>\_P?8_D?HK^N#_ (A!OVE/^CR?A?\
M^$9KG_R!1_Q"#?M*?]'D_"__ ,(S7/\ Y H_XB3P-_T46%_\)\?_ /,@?5,3
M_P ^9??#R_O>?X/L?R/T5_7!_P 0@W[2G_1Y/PO_ /",US_Y H_XA!OVE/\
MH\GX7_\ A&:Y_P#(%'_$2>!O^BBPO_A/C_\ YD#ZIB?^?,OOAY?WO/\ !]C^
M1^BOZX/^(0;]I3_H\GX7_P#A&:Y_\@4?\0@W[2G_ $>3\+__  C-<_\ D"C_
M (B3P-_T46%_\)\?_P#,@?5,3_SYE]\/+^]Y_@^Q_(_17]<'_$(-^TI_T>3\
M+_\ PC-<_P#D"C_B$&_:4_Z/)^%__A&:Y_\ (%'_ !$G@;_HHL+_ .$^/_\
MF0/JF)_Y\R^^'E_>\_P?8_D?HK^N#_B$&_:4_P"CR?A?_P"$9KG_ ,@4?\0@
MW[2G_1Y/PO\ _",US_Y H_XB3P-_T46%_P#"?'__ #('U3$_\^9??#R_O>?X
M/L?R/T5_7!_Q"#?M*?\ 1Y/PO_\ ",US_P"0*/\ B$&_:4_Z/)^%_P#X1FN?
M_(%'_$2>!O\ HHL+_P"$^/\ _F0/JF)_Y\R^^'E_>\_P?8_D?HK^N#_B$&_:
M4_Z/)^%__A&:Y_\ (%'_ !"#?M*?]'D_"_\ \(S7/_D"C_B)/ W_ $46%_\
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P5B_Y19?\
M!2S_ +, _;(_]9U^(U?X@U?[?/\ P5B_Y19?\%+/^S /VR/_ %G7XC5_B#4
M?Z??_!E3_P HLOCY_P!G_P#Q3_\ 6=?V5:_K]K^0+_@RI_Y19?'S_L__ .*?
M_K.O[*M?U^T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_E%E\?/^S__ (I_^LZ_LJU_7[0 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445EZWJUIH.CZGK5](D5II=C=7UP[L%41VL+S,"3T+!-H]R*BI4A2ISJ
MU)*%.E"52I.3M&$(1<IRD^BC%-M]$BZ=.=6I"E3BYU*DXTX0BKRE.<E&,4EJ
MW*3226[9\Z_M1_M0^"/V8_ TWB3Q%*M[K5V##H7A^"13>7UPP8)*8\[Q;QN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@#_@K%_RBR_X*6?\
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M4UU]ZRMJ1*4I2I/V51<L^9W4=G!K^;O)+[WT=OZ$J*_'+_AG_P#X*]?]'=_
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M /:R_P"?-7ITCY?WO-_<S]C:*_'+_AG_ /X*]?\ 1W?P(_\ "$UK_P"0:/\
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M0+_@RI_Y19?'S_L__P"*?_K.O[*M?U^T %%%% !1110 4444 %%%% !1110
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M_/\ G]T/_D3^J?\ XBX?VU?^C9/@E_X.M>_^3*/^(N']M7_HV3X)?^#K7O\
MY,K^5BBC_B'7!'_1.8'_ ,#Q?E_U$^7XON'UK$_\_P"?W0_^1/ZI_P#B+A_;
M5_Z-D^"7_@ZU[_Y,H_XBX?VU?^C9/@E_X.M>_P#DROY6**/^(=<$?]$Y@?\
MP/%^7_43Y?B^X?6L3_S_ )_=#_Y$_JG_ .(N']M7_HV3X)?^#K7O_DRC_B+A
M_;5_Z-D^"7_@ZU[_ .3*_E8HH_XAUP1_T3F!_P# \7Y?]1/E^+[A]:Q/_/\
MG]T/_D3_ $4_^"(W_!<SXM_\%-/C5\3?@O\ %OX2>#_A]JW@GP7%XSL+_P (
M7NH7=M>6DM]'9"WN#>RR;91OWD)CIZ$5_1+\8_'A^%OPF^)7Q)6T%^? 7@;Q
M1XO%D20+L^'M&O-5%L2N& F-KY9(.0&R*_@1_P"#2S_D_3X__P#9![3_ -/M
MO7]U/[8/_)J7[2'_ &1#XG?^H=J]?SIXA9+E>4\;K+,NPD,)@9PRJ3PU.51P
M3Q$*;K<KG.<TIMMVYG9MVML>K@ZDZF'YIR<I*4US.U[)Z7LDOP/X>KW_ (.Z
M?VO[K4M3ET#]F7X./H0U&]ATE[_6-=2^>SM[F6"-[M%NU59F$>650 ,U!_Q%
MP_MJ_P#1LGP2_P#!UKW_ ,F5_*+I'_'FW_7[J7_IQNJTZ_HV7ASP/&3BN',$
MU&RUGBVW9+5OZSJW;7U?<\E8K$M)^VGJK[1_^1/ZI_\ B+A_;5_Z-D^"7_@Z
MU[_Y,H_XBX?VU?\ HV3X)?\ @ZU[_P"3*_E8HJ?^(=<$?]$Y@?\ P/%^7_43
MY?B^X_K6)_Y_S^Z'_P B?U3_ /$7#^VK_P!&R?!+_P '6O?_ "91_P 1</[:
MO_1LGP2_\'6O?_)E?RL44?\ $.N"/^B<P/\ X'B_+_J)\OQ?</K6)_Y_S^Z'
M_P B?U3_ /$7#^VK_P!&R?!+_P '6O?_ "91_P 1</[:O_1LGP2_\'6O?_)E
M?RL44?\ $.N"/^B<P/\ X'B_+_J)\OQ?</K6)_Y_S^Z'_P B?U3_ /$7#^VK
M_P!&R?!+_P '6O?_ "91_P 1</[:O_1LGP2_\'6O?_)E?RL44?\ $.N"/^B<
MP/\ X'B_+_J)\OQ?</K6)_Y_S^Z'_P B?U3_ /$7#^VK_P!&R?!+_P '6O?_
M "91_P 1</[:O_1LGP2_\'6O?_)E?RL44?\ $.N"/^B<P/\ X'B_+_J)\OQ?
M</K6)_Y_S^Z'_P B?U3_ /$7#^VK_P!&R?!+_P '6O?_ "91_P 1</[:O_1L
MGP2_\'6O?_)E?RL44?\ $.N"/^B<P/\ X'B_+_J)\OQ?</K6)_Y_S^Z'_P B
M?U3_ /$7#^VK_P!&R?!+_P '6O?_ "97P=^W]_P70^,W_!1WX4Z1\)?C3^SA
M\']!T[1/$^F>)[#Q%HMQ?7FMQ-ILIE?28Y[QYI(K"_;;]J2.1%;:"5).:_$F
MBNG!\#<)9?B:.-P61X7#8K#S52A7I5,4JE.:5E*+>(:OONFG=W6HI8BO-.,J
MLI1>C34;-?\ @)_33\+?^#IC]JWX/?#SP=\,/!G[+/P,L_#/@?P_IGAS2(H-
M1U:S#VNEVL5JEQ)!:SPPK/<"/SIV"!GE=F<LQ)/??\1</[:O_1LGP2_\'6O?
M_)E?RL45C/P^X+J3G4J</8*=2I)SG.53%N4IR?-*4G]9U<G=OS;[C6)Q"5E6
MG9:+2'_R)_5/_P 1</[:O_1LGP2_\'6O?_)E'_$7#^VK_P!&R?!+_P '6O?_
M "97\K%%1_Q#K@C_ *)S _\ @>+\O^HGR_%]P^M8G_G_ #^Z'_R)_5/_ ,1<
M/[:O_1LGP2_\'6O?_)E'_$7#^VK_ -&R?!+_ ,'6O?\ R97\K%%'_$.N"/\
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M%% 'P!_P5B_Y19?\%+/^S /VR/\ UG7XC5_B#5_M\_\ !6+_ )19?\%+/^S
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MT.F:?>:E.B_WWALH9Y$3_;90OO288</')$XX:.:-XI4/=9(I%5T8=U=0P/!
M-?U$_P#!*_\ 8P_;5_8H_:V^(&F>#?A5^R;^US\0-<^%;?VQX!O_ (B:-JNE
M^#-.AN0[W=W)<>;'9ZP\B&U>TP)90YA'+C'YO^'?^":7[9?[<WQ@_:9^(/@3
MP1\//AAH'P\\<:_)\1=9\8Z]!X:^&GA:^DU*XDN=/TG7'9+6:TLW9H8R@V[$
M&!BNVGQ5E<L7CJ=3%9?2R_!X7!8F.9/,:+]J\;)PC3EA.55Z"4URTJDN:.(;
MM23L1[*=HOEDY2E)<G([KEMJI7M+1W:6VV^_Y+45^BO[3?\ P2M_:U_9&L_A
M/K/Q8C^'>I^$?C=K5GH'P]\>^!?$L6O^"[Z_OYX[>U:ZUN)V@@MWDE0F4D )
M\W(QGV/Q!_P0J_X*.^'?C)\,?@8_P\\,:WXJ^+OA63QIX2\1^'M974? MKH,
M62\FO>((Y?L^FW!0"3RY73$;(Q !KM_UBR'V5&L\XRY4L1#$U*-26)IQA5A@
MTGBY0E)I/ZLG^^7Q0ZH7LJM[>SG=<MU;9RMRW_Q75K7N?D/17W5<_P#!-W]J
MIOVKKW]BWPSH/A[XB?&K1Y!!XBN? &J#Q#X*\+W&]8Y;?Q!KMNQBT^:V9O\
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M.^&_VFOAA??"_7/%MC_:?ARQOKN&[;4K$*7,Z/  $ 4$E6^8$8(]/W"^.?\
MP2,?_@G7^U%^P!\:_AUXT\6>+O@C\8_&>@P;/B59+HOQ,\,>,Y[NUE71=3TB
M-ML$,=I+$TCCE9=RYX./8?\ @Z_EEE_:$_9A\R223;\/05WNSX+V3,Q&XG!9
MB68CJQ).237GT>,*689]P]@<J=#$Y7G."S.O5Q,X5H8JE7R^;IRHQC*48TVJ
MB<:D:E.4OY9)--TZ$HTJLYWC.G.G%133BXSMJ]-=-FFM'L?RF5],?!?]C/\
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M%1E4HP3J64K2A9Q;N0Z-6,>>2C91C-VFFU&=E%V6MFW\C[Z_X-+/^3]/C_\
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M8ASE&M&+:?3];@ZD9\LTG552<>6"UY4M&GS2:;U;:5HZKM_6Y_P17U2SM_\
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M%% !1110 4444 ? '_!6+_E%E_P4L_[, _;(_P#6=?B-7^(-7^WS_P %8O\
ME%E_P4L_[, _;(_]9U^(U?X@U '^GW_P94_\HLOCY_V?_P#%/_UG7]E6OZ_:
M_D"_X,J?^467Q\_[/_\ BG_ZSK^RK7]?M !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'SC^V%_P FI?M(?]D1^)O_ *B&K5_CZ?!;XB^(
M_A#\0O 7Q1\)3QVNO^"?&=MK-M<2IYB):VNO^?J *]R]I%(J^A.:_P!@O]L+
M_DU+]I#_ +(C\3?_ %$-6K_&ZTC_ (\S_P!?>H?^E]S7]'^!D(5,LXFIU(J=
M.IB<!"<)*\90E1Q,91:>C4HMIKLSR<R^.@^J51I]FI4VC^PG_@IS\%M"_P""
MV?PU^"/[8'[!OQ&^'OB7XI?#OPYI?@#XO_!GQEXIT?P5JTNM7%D@DU>UO-8F
MA$EO8JLJLL6X2>0&+[I"!/J7C'X8_P#!%'_@D[\3OV<O$OQ3\(^.OVV?VB=
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M<^&)YC'I\.MZA8Z9<3SPQW-PXEF=OFC1V9@""!_G9Q7&IVP*66N^(M-@.?\
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MO^TS\17UJZU)-=LT;X>>*M,NP?L]AXDU%!]J:%H#<)<(=Q9FCPR!6#_H7?\
M[!7[._QK\!?\$P?^"EGP%^"OAGX">*?%OQ/\/:3\9/@OX*B ^'>I/J>KW-QJ
M&NPB?]])>0#R3&2OEGS-H4E&8^/BL^SK*LZQE3.GF&#R;ZVL#DG+1ROZIF&(
MPV73KU98MRHSS"%#'UZ,G1JT9TZ=)M4W**2O<:5*I3BZ7+*I;FJZSYH1E.*7
M*K\EXJR::=UK8^%/#O\ P;SW\[?"_P"'GQ#_ &Q_"?PY_:J^,_P[UCXA_#G]
MG.\\.&[OM8@TW2I-3M-)N-="^39W.I,L5LGFX*O+[5^<'[)7_!,;]H_]J?\
M:P\:?LH76E_\*OU7X-S:E/\ M!^,M77[1IWPI\/Z893-KC1LFW5E=(@RPPX8
ME@%SD5_5+^TUJ-ZW_!RQ^S?I@NIFT[0_ NBIHUF"XBT]3:(K1VN#\B/C!1,
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M&EG_ "?I\?\ _L@]I_Z?;>O[J?VP?^34OVD/^R(?$[_U#M7K^5/%/_DXL/\
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MQC3X_?LVZGH?A?XHIH.I^&1J^K:/;ZM9MHVL1M#J%N]G,AC9YD<@.02"%/\
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M^(-7^WS_ ,%8O^467_!2S_LP#]LC_P!9U^(U?X@U '^GW_P94_\ *++X^?\
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M/&GB+X87_B>\CM(-377--UFULT;4;J2."&);C48)/+DD4>7$<8( /Y[^)?\
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M %#M7K^5/%/_ ).+#_KUD?\ Z;I'LX#_ '5_XZGYG^-OI:*]DZNJLIO=2.&
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M&#S7EB:WJK7^F7^N7VK>,X=+N8)DTGQ/K5_JEM<6D3@R:9%)?3SFRM9TRK)
M$4#@+6;1732I1I4:5&/-*-&C3HQE.7-4<*<(TTYS5FYR44YR7*Y2;>EQ;W?5
MMO335N[LO7;?30_HXL/VEO\ @@QXP\*?LYZMK.E?M.?LW_$+X6:AX?\ $OQ,
M\)?".X\0WGA'XB:WI"6<TNEZD7OVM'TYM3M6O(FM[2V55F:&19SF0^?_ +3W
M_!4WX ?MA_\ !4GX#_M0_$[1?%?A+]EW]F:_TB/P##HEB+_QGXIT;28CA-=T
M^56$,MQ.D;."ORAB!@ 8_ >BOFJ7".6TZ\\1+%9MB:OU7'X/#SQ>/>(E@J&9
M_P"^+"2E24XSJ1_=QJ5IUY4Z5H1LHJVKK3:Y;4XKFA)\L+<SA;EYM=M+M*UW
MJ_/] /\ @J'^VA;_ /!0#]L_X@?M(:387NC^$]2LK+PQX+TF]=UF@\+:'^YT
MB:XM2?+M[V6W :Y"*#O)SR37]@7_  :,?\F*_&K_ +. UC_TWU_G^U_H!?\
M!HQ_R8K\:O\ LX#6/_3?7R'BE@\/EWAW+ 82'L\+@\3E&&P\&W)QI4JDH03D
M]9.RUD]6[LWP3<L6I2=Y2C4E)]VTKOR]#^KZBBBOY//<"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X _P""L7_*++_@I9_V8!^V1_ZSK\1J_P 0:O\
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M]7_\$FL?_(-?[+7_  S#^S;_ -$ ^#'_ (;+P9_\IJ/^&8?V;?\ H@'P8_\
M#9>#/_E-1_Q'7!?]$WBO_#G2_P#F(/[-G_S^C_X _+^]Z_AYG^-+]N7_ )\]
M7_\ !)K'_P @T?;E_P"?/5__  2:Q_\ (-?[+7_#,/[-O_1 /@Q_X;+P9_\
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MY?\ GSU?_P $FL?_ "#7^RU_PS#^S;_T0#X,?^&R\&?_ "FH_P"&8?V;?^B
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M]$ ^#'_ALO!G_P IJ/\ AF']FW_H@'P8_P##9>#/_E-1_P 1UP7_ $3>*_\
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MG_S^C_X _+^]Z_AYG^-+]N7_ )\]7_\ !)K'_P @T?;E_P"?/5__  2:Q_\
M(-?[+7_#,/[-O_1 /@Q_X;+P9_\ *:C_ (9A_9M_Z(!\&/\ PV7@S_Y34?\
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M(ZX+_HF\5_X<Z7_S$']FS_Y_1_\  'Y?WO7\/,_QI?MR_P#/GJ__ ()-8_\
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M4+6>T:_L6L,+=P1W$<<AB8\!MN,U_1T?V8/V;2"#\ /@P0>"#\,?!F"/0_\
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M0 4444 %%%% 'P?_ ,%0/^4>W[7O_9#_ !E_Z1K7<?L#?\F2_LI?]D#^%_\
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M_P .S<?_ !FOV>HH_P!:<^_Z&$__  1A?_E'E^?=A[&E_+_Y-+R\_)'XP_\
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M_P#%/_UG7]E6OZ_: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M * \#_X<\)Y?W_/\'V#^T,-_-/\ \%S_ ,C_ $&:*_GG_P""$_\ P5Y^-O\
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MFIW, GAM[J&2(FU\V>0 >3!(W%?U5_\ !*+P5X*_9-_X*D?\% _V4OA]\,_
ML/@_3/"FH?$?PWXTDL@WC:QTR:X41>!/M;*WE^&X/,W);Q,K$( ^5R*^0_\
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MHLO^"EG_ &8!^V1_ZSK\1J_Q!J_V^?\ @K%_RBR_X*6?]F ?MD?^LZ_$:O\
M$&H _P!/O_@RI_Y19?'S_L__ .*?_K.O[*M?U^U_(%_P94_\HLOCY_V?_P#%
M/_UG7]E6OZ_: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_ "U_^#A3_E+U^TE_V!_
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M+36]/_;'\(>%;CP/\.-#M=.>70+W2+&>QBT34+CQ*)<69>R%\TEH%&R18P'
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M?^E,****_/#L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X _P""L7_*++_@I9_V8!^V1_ZSK\1J_P 0:O\
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M3A.4)SI*S5V*.%IWC%JHW*K5I\ZDTHJ%G%M6:;L];V3L^NIXI_P29T71I_\
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M@Y^T+X;U+0_B'>_"?0;J.+4_AFZZ=IZVC1V5NPEM[2RFMXX&R%#F#!&&!/\
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M117YX=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ? '_  5B_P"467_!2S_LP#]LC_UG7XC5_B#5_M\_\%8O
M^467_!2S_LP#]LC_ -9U^(U?X@U '^GW_P &5/\ RBR^/G_9_P#\4_\ UG7]
ME6OZ_:_D"_X,J?\ E%E\?/\ L_\ ^*?_ *SK^RK7]?M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!_GT?\ !:?_ ())?\%'?VD_^"E?QT^-/P+_ &:]8\>?"_Q1IOA*
M#0/%5MK.G6EOJ$FGZ6D-XJ0S-YJF&8,C;@.@()S@?EU_PXA_X*[_ /1GNO?^
M%%I7^-?ZKE%?KN6^,>?Y9E^!RZCEN3U*6 PF'P=*=6GC'4G3PU*%*$JCAC(Q
M<Y1@G+EC%7;LDM#@EE]*4Y3<ZB<I.32<;7;3_EVTMZ-G^5'_ ,.(?^"N_P#T
M9[KW_A1:5_C1_P .(?\ @KO_ -&>Z]_X46E?XU_JN45V_P#$<>)/^A5D?_@O
M'?\ S;Y?GW9/]FTO^?E7[X^7]WR_%]S_ "H_^'$/_!7?_HSW7O\ PHM*_P :
M/^'$/_!7?_HSW7O_  HM*_QK_5<HH_XCCQ)_T*LC_P#!>._^;?+\^[#^S:7_
M #\J_?'R_N^7XON?Y4?_  XA_P""N_\ T9[KW_A1:5_C1_PXA_X*[_\ 1GNO
M?^%%I7^-?ZKE%'_$<>)/^A5D?_@O'?\ S;Y?GW8?V;2_Y^5?OCY?W?+\7W/\
MJ/\ X<0_\%=_^C/=>_\ "BTK_&C_ (<0_P#!7?\ Z,]U[_PHM*_QK_5<HH_X
MCCQ)_P!"K(__  7CO_FWR_/NP_LVE_S\J_?'R_N^7XON?Y4?_#B'_@KO_P!&
M>Z]_X46E?XTA_P""$'_!78@@_L>:\01@C_A(M*Y!_&O]5VBC_B./$G_0JR/_
M ,%X[_YM\OS[L/[-I?\ /RK]\?+^[Y?B^Y_F4_##_@G!_P '%OP/\/0^$/@O
MX.^.?PO\(V\DLUOX9\)_$+3[+1X)9CF66.T821J\AY8@=>1BO-?B7_P1X_X+
ME_&OQ1_PG'QF^ /Q(^*/C,6::<OB?QAXST[4M433XSE+-)7.U8$(!5548(%?
MZD%%<\/&?.:=:>(IY!PU3Q%2_/B(8/$0KSYFG+GK1Q2J2YFES<TG?K</[.IV
M2=6LTK63DFE:UM.6W3^M+?Y4?_#B'_@KO_T9[KW_ (46E?XT?\.(?^"N_P#T
M9[KW_A1:5_C7^JY171_Q''B3_H59'_X+QW_S;Y?GW8?V;2_Y^5?OCY?W?+\7
MW/\ *C_X<0_\%=_^C/=>_P#"BTK_ !H_X<0_\%=_^C/=>_\ "BTK_&O]5RBC
M_B./$G_0JR/_ ,%X[_YM\OS[L/[-I?\ /RK]\?+^[Y?B^Y_E1_\ #B'_ (*[
M_P#1GNO?^%%I7^->;:3_ ,$A?^"DVO?$/Q#\)='_ &:M2O?B5X2M+2_\2>%$
M\0:6+W2K.^B$]I<S9;F.>%@Z': 00037^M+7\UW[-M_J#?\ !PI^VK;-J.H-
M:#X6> T%FU[<-9JJ^'8@H6V,AA &T8 3 P,8KV<H\7.(<RHYS5EE^34WE>4U
M,Q@HTL:U5G#%X3#JG.^-TBXXB4FUK>*W3:><\!2@Z:4ZKYYJ+NXZ*U[_  _W
M?Q?<_CT_X<0_\%=_^C/=>_\ "BTK_&C_ (<0_P#!7?\ Z,]U[_PHM*_QK_5<
MHKQO^(X\2?\ 0JR/_P %X[_YM\OS[LT_LVE_S\J_?'R_N^7XON?Y4?\ PXA_
MX*[_ /1GNO?^%%I7^-'_  XA_P""N_\ T9[KW_A1:5_C7^JY11_Q''B3_H59
M'_X+QW_S;Y?GW8?V;2_Y^5?OCY?W?+\7W/\ *C_X<0_\%=_^C/=>_P#"BTK_
M !H_X<0_\%=_^C/=>_\ "BTK_&O]5RBC_B./$G_0JR/_ ,%X[_YM\OS[L/[-
MI?\ /RK]\?+^[Y?B^Y_E1_\ #B'_ (*[_P#1GNO?^%%I7^-'_#B'_@KO_P!&
M>Z]_X46E?XU_JN44?\1QXD_Z%61_^"\=_P#-OE^?=A_9M+_GY5^^/E_=\OQ?
M<_RH_P#AQ#_P5W_Z,]U[_P *+2O\:/\ AQ#_ ,%=_P#HSW7O_"BTK_&O]5RB
MC_B./$G_ $*LC_\ !>._^;?+\^[#^S:7_/RK]\?+^[Y?B^Y_E1_\.(?^"N__
M $9[KW_A1:5_C1_PXA_X*[_]&>Z]_P"%%I7^-?ZKE%'_ !''B3_H59'_ ."\
M=_\ -OE^?=A_9M+_ )^5?OCY?W?+\7W/\J/_ (<0_P#!7?\ Z,]U[_PHM*_Q
MH_X<0_\ !7?_ *,]U[_PHM*_QK_5<HH_XCCQ)_T*LC_\%X[_ .;?+\^[#^S:
M7_/RK]\?+^[Y?B^Y_E1_\.(?^"N__1GNO?\ A1:5_C1_PXA_X*[_ /1GNO?^
M%%I7^-?ZKE%'_$<>)/\ H59'_P""\=_\V^7Y]V']FTO^?E7[X^7]WR_%]S_*
MC_X<0_\ !7?_ *,]U[_PHM*_QH_X<0_\%=_^C/=>_P#"BTK_ !K_ %7**/\
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M_#'7_!5K_I)AHG_AD](_^+K]G:*/]9,?_P! V2_^&')__F+^KORL>QAWJ?\
M@VIY?WO+^K*WXQ?\,=?\%6O^DF&B?^&3TC_XNC_ACK_@JU_TDPT3_P ,GI'_
M ,77[.T4?ZR8_P#Z!LE_\,.3_P#S%_5WY6/8P[U/_!M3R_O>7]65OQB_X8Z_
MX*M?]),-$_\ #)Z1_P#%T?\ #'7_  5:_P"DF&B?^&3TC_XNOV=HH_UDQ_\
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M_P"DF&B?^&3T?_XJC_ACK_@JU_TDPT3_ ,,GI'_Q=?L[167^LF/_ .@;)?\
MPPY/_P#,7]7?E9^QAWJ?^#:GE_>\OZLK?C%_PQU_P5:_Z28:)_X9/2/_ (NC
M_ACK_@JU_P!),-$_\,GI'_Q=?L[11_K)C_\ H&R7_P ,.3__ #%_5WY6/8P[
MU/\ P;4\O[WE_5E;\8O^&.O^"K7_ $DPT3_PR>D?_%T?\,=?\%6O^DF&B?\
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M_-'[!T5^/G_#^W_@DY_T>!X"_P# 77?_ )64?\/[?^"3G_1X'@+_ ,!==_\
ME91_JOQ+_P!$_G7_ (:\;Y?].?-![>C_ ,_:?_@<?+S\T?L'17X^?\/[?^"3
MG_1X'@+_ ,!==_\ E91_P_M_X).?]'@> O\ P%UW_P"5E'^J_$O_ $3^=?\
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M $3^=?\ AKQOE_TY\T'MZ/\ S]I_^!Q\O/S1^P=%?CY_P_M_X).?]'@> O\
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M%UW_ .5E8_ZK\2_]$_G7_AKQOE_TY\T/V]'_ )^T_P#P./EY^:/V#HK\?/\
MA_;_ ,$G/^CP/ 7_ ("Z[_\ *RC_ (?V_P#!)S_H\#P%_P" NN__ "LH_P!5
M^)?^B?SK_P ->-\O^G/F@]O1_P"?M/\ \#CY>?FC]@Z*_'S_ (?V_P#!)S_H
M\#P%_P" NN__ "LH_P"']O\ P2<_Z/ \!?\ @+KO_P K*/\ 5?B7_HG\Z_\
M#7C?+_ISYH/;T?\ G[3_ / X^7GYH_8.BOQ\_P"']O\ P2<_Z/ \!?\ @+KO
M_P K*/\ A_;_ ,$G/^CP/ 7_ ("Z[_\ *RC_ %7XE_Z)_.O_  UXWR_Z<^:#
MV]'_ )^T_P#P./EY^:/V#HK\?/\ A_;_ ,$G/^CP/ 7_ ("Z[_\ *RC_ (?V
M_P#!)S_H\#P%_P" NN__ "LH_P!5^)?^B?SK_P ->-\O^G/F@]O1_P"?M/\
M\#CY>?FC]@Z*_'S_ (?V_P#!)S_H\#P%_P" NN__ "LH_P"']O\ P2<_Z/ \
M!?\ @+KO_P K*/\ 5?B7_HG\Z_\ #7C?+_ISYH/;T?\ G[3_ / X^7GYH_8.
MBOQ\_P"']O\ P2<_Z/ \!?\ @+KO_P K*/\ A_;_ ,$G/^CP/ 7_ ("Z[_\
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M_;_P2<_Z/ \!?^ NN_\ RLKU?]5^)?\ HG\Z_P##7C?+_ISYHS]O1_Y^T_\
MP./EY^:/V#HK\?/^']O_  2<_P"CP/ 7_@+KO_RLH_X?V_\ !)S_ */ \!?^
M NN__*RC_5?B7_HG\Z_\->-\O^G/F@]O1_Y^T_\ P./EY^:/V#HK\?/^']O_
M  2<_P"CP/ 7_@+KO_RLH_X?V_\ !)S_ */ \!?^ NN__*RC_5?B7_HG\Z_\
M->-\O^G/F@]O1_Y^T_\ P./EY^:/V#HK\?/^']O_  2<_P"CP/ 7_@+KO_RL
MH_X?V_\ !)S_ */ \!?^ NN__*RC_5?B7_HG\Z_\->-\O^G/F@]O1_Y^T_\
MP./EY^:/V#HK\?/^']O_  2<_P"CP/ 7_@+KO_RLH_X?V_\ !)S_ */ \!?^
M NN__*RC_5?B7_HG\Z_\->-\O^G/F@]O1_Y^T_\ P./EY^:/V#HK\?/^']O_
M  2<_P"CP/ 7_@+KO_RLH_X?V_\ !)S_ */ \!?^ NN__*RC_5?B7_HG\Z_\
M->-\O^G/F@]O1_Y^T_\ P./EY^:/V#HK\?/^']O_  2<_P"CP/ 7_@+KO_RL
MH_X?V_\ !)S_ */ \!?^ NN__*RC_5?B7_HG\Z_\->-\O^G/F@]O1_Y^T_\
MP./EY^:/V#HK\?/^']O_  2<_P"CP/ 7_@+KO_RLH_X?V_\ !)S_ */ \!?^
M NN__*RC_5?B7_HG\Z_\->-\O^G/F@]O1_Y^T_\ P./EY^:/V#HK\?/^']O_
M  2<_P"CP/ 7_@+KO_RLH_X?V_\ !)S_ */ \!?^ NN__*RC_5?B7_HG\Z_\
M->-\O^G/F@]O1_Y^T_\ P./EY^:/V#HK\?/^']O_  2<_P"CP/ 7_@+KO_RL
MH_X?V_\ !)S_ */ \!?^ NN__*RC_5?B7_HG\Z_\->-\O^G/F@]O1_Y^T_\
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M?[?/_!6+_E%E_P %+/\ LP#]LC_UG7XC5_B#4 ?Z??\ P94_\HLOCY_V?_\
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M^ L'_P ;H_LW3O\ GPLO_ 6#_P"-U=HHN^[^]A9=E_7_  R^XH/ING;&_P!
MLONM_P NL'H?^F=?Z77_  :_Q10_\$D/A*D,<<2#Q_\ $<A(T5%!-_IV2%4
M9/?CFO\ -2?[C?[K?R-?Z6'_  ;!_P#*)/X3?]C]\1O_ $OTZOR/QI;?"%&[
M;_X6L%U_ZAL<=V7_ .\?]PI_^E4S^A*BBBOY2/;"OX,?^#P>VMKCX[?L3F>W
M@G*_#_QT%,T4<A _MB_.!O5L#//%?WG5_!Q_P> _\EU_8H_[$#QU_P"GB_K]
M*\)-..<LM_T#YE_Z@8@X\?\ [M/_ !4__3D3^/G^S=._Y\++_P !8/\ XW1_
M9NG?\^%E_P" L'_QNKM%?U_=]W][/"LNR_K_ (9?<4O[-T[_ )\++_P%@_\
MC=']FZ=_SX67_@+!_P#&ZNT47?=_>PLNR_K_ (9?<4O[-T[_ )\++_P%@_\
MC=']FZ=_SX67_@+!_P#&ZNT47?=_>PLNR_K_ (9?<4O[-T[_ )\++_P%@_\
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M_3/'WPX\31ZV-;\)ZR)&TW4'@@!MWN%B9)&$3G=M5T+#(W+G(_,"OV'_ ."
M(8_\%:OV:@IVL5UX!L9P?(3G'>O$XFJ5*7#F?5:4YTJM/*,PG3JTY2A4ISCA
MJCC.$XM2A*+2<91:DFKIW-*23JTTU=.I!-/9KF6C/U?^.GQ:_8@^#?\ P58T
M7]@7_AV!^S)J7PEO?B1:>"-3\;!M2'C1--N43?>V=OF1?M8DD)5"S[0 "3RU
M?!/_  6!_P""4VJ_ ;]NG3_@_P#L:> ]=^(EE\6?#[>,?!WPK\,HMWKFB64$
M#76K)%: F1+"QPRQO(JDPJ#SUK[[_P""D?[<O[ G[*W_  5+\;_$/Q)_P3WU
M_P"*?[1?PJ\;KKMC\4C\2YK#1=1\0V\(,-_-X<:3R#%'\O[ADVGJ0>E>7_\
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M?!_A"^^'TOBO4(/ EAH.J3FSO+Y]">;^S5,-NNZ9O*!D+,7+# ']">H_L[>
MOV.?VI?VT?\ @JC;ZKIEC\*/'_[-EOK.@ZI8)"GD^-=4MD>76!+'@7+W4A6(
MR[BV) 2<FC&<>9ME>&P%;'9?EU2IG>1X?,<DCAOKD8ULQK5L+3>65U.K4E*4
M88F,XSINFZG++EBDK"CAHU)349SM2JN%7FY-()-^TC9)+5--.]KK76Y_FZ>.
M? OC3X8>+-8\ _$;PWJ'@[QOX=F%MKWAG5E5-1TJX.?W-TJDJK\'(SQ@U[9\
M%/V+?VO?VE-!NO%?[/W[/'Q ^*WA>RN7LKG7_#UDJZ=%=QG#V_GW9AC>13QA
M&;)Z9KQ'XS_$7Q+\5OB!\2_B;XHUJ[\0:[XO\7ZWJ[:U>2O-=7EC>:Q+-8%Y
M9"795M95"@G 7@5_<W^TE;_!GX+_ /!)_P#X)[Z9+^UMXV_83^'WBN7PQXE\
M6>*?@_X-OM<NOB)XC@M;2^.B:[JFC!6TLW%T2 ]RP%U)+Y#!]I4_4<1<08W)
M*>1T:>%HUL?G&*^J-^QQN(P]"=+"O$XAPPV$C+&UVVG"C3A:76I))2DL:5.-
M5U+R:A3BI7O!.7-+EC>4O<7=O[NS_D__ &0_V$OCE\5/V\/A;^RK\0_@QXRT
MK6+7Q?ILOQD\(7MLEKJWA7P2LH;4=8OUG:))+*-%99'MFE."<=*_I6_;1_X)
MMZ/K_P"W1\-_V'O@O_P3?\'^!/V898_A]K^I_M>>&B/^$MU>2SBMI_%NA7?F
MS@>1*5>&^^3YS*[1C Q67^U;^U?^S3\=?V]?^"6_C7X ZW\9=+^/FG>-_"?@
M'Q[\1M=\&:U\+3\6? K>2EW/K0N%A/BB&_97F9Y3(C),J'[N3I?M>_%;XL:?
M_P './PY\!Z?\4O']AX"_P"$&^'<X\#6?B?48/"8FNM.M/MD@T1)19>9>$DW
M+F,M*>2>6S\#CLYS[-LPP6+=/^R94>#\[S/ZA7>84HTL=@<7"A+%QA3Q-!UI
M2M&6#>)A*%.E.<*U*<USG5&%.G":O[2^(I0YUR-N,DGRZIV6OO)--O5-+0=^
MWW^S]^SE^RI^V[^S_P#!O2_^"3F@^.?V9;VZT^:Y\:?#ZQFU+QY\3O$2V$4,
MWA%-/$\;W"23;KJ= T'F-N"RQY#+_-[^VY\*9?BY_P % OB/\-/V2?V4_'_P
MICU&+3G\+?LU7.BSVOB[PZ8XBM[-<:>3.ME#<R@O%'/<.R(-IED(WM_5I^TE
MXP\8S?\ !R5^S#X4G\7>([CPC9Z+IU_9>$Y]5N9?#MGJ#VD0>_MM*9C;17;@
MD-.J;V!.2:]^^%^C0VO[<'_!<CXN^'-*LKWXV_#SP-:1_#?66LDO=?T6*'P7
MJM\KZ)+M-S;NMW:6XC%NRL794!PQ!\_)^),3D.%P&+JTZF/Q53@_"XWGK9CF
M,J%:OF&=4,'2GBJ&(KUZ<:D)58U*^(I*$N2+IT8TX.Q52E&LYJ+Y(_6'&RA!
M-*-/F:BXI::-).^]W=G\+?QC_88_;/\ V=_# \;?';]FOXC?#'P:96@/B77;
M&.33$G55=H99K,S")U1E8K(5/('7BM#X5?L!?MQ_'7P;I_Q%^#?[+WQ+^(/@
M+6 S:1XJTFRAAT[5 APQLC>M!)/@XXC5B<C&:]_^'W_!0W_@J'XW^"'Q ^!"
MWWC_ .,_P>^)/C\K\2+OQEX-U+Q^/"GB#4M>%K)#'KEZLX\,I _E>99!D"Q1
MA2ORC']0>N>(]?\ V%-"_P"">_P9_:\^)7CSX\?$;XJ>+O L_P"SS\'_ (*0
M7WPB\*?#30;\0F]U+Q?J&B-;VOB5]-<HDNG7P+W4BR(4(&3]]F_$6?9/3H8>
MKA\CQ.:XC$8I4*.#JXZLJV#PF%6(K55AI.DZ%2E=NL\3CZ=&%!>UC*<I1IKE
MITJ=2\E*K&"4;N2@K2E)12<K.Z?3EC=O3;4_B \>?"_XE_"SQLWPR^)/@7Q#
MX,^(ZWUMIG_"$ZM8S+KQU"]G6VL[9;.-&E=[B=TBC94*Y8$G'-?2GC'_ ()Q
M_M_?#SP/JGQ,\<_LF?%/PW\/]#TM-;UKQ/=V,$MKI>CN(BFHWEM;/+>0VY$T
M1R\ (WC/<C^X?XJ?L^?L^>//^#AOPIXN^(>B^']2\:Z-\#M$U3PGH.KPVD^G
MZUJUMI,$ZZA)I-PC0WE_8L!<?:I(W99%$C9.=W\S/[3G[>O_  49^#/_  5&
M_;?T;X ^+?B%\2O$&LZOJG@SQ/\ !G4-+U3XD^#],\(,64V]O\/7,]EIEO @
M@"S);J(PR;OE,8'+E7&>99]/"4<LP674*ZR#!YWCEF5;$TJ$WBL1&B\-A*U)
MOV4(152;Q5>%:*FX0='23*J8>-+F<YS:]K*E%PC%M<JOS23W;;7NQMU=T?D#
MXS_9C_:-^''PST7XU^/_ (->,?"?P>\1P1W6@?$;4[,+X=U2"9/,C>"X3=@L
MG.Q]K@\$ U6\:?LX?M!?#;X9>#_C7\0OA#XN\'?"#XB20Q> OB'K-IY&@>+)
M+A6:W32IB TIF",4)&"!UZ5_6?\ \$ZM(D_X*Q_\$C_BA^P5X@UV]A^-GP;^
M-ND>*?&\6MVT@DTG2M9UT7U]X=TVTN [6%E;QW-Y:+81*D=BLNS;A!7S'_P<
MN_%>V^'EY^RM_P $ZO!5JEM\,_@A\-M"\1LD4H:.#Q)806]BEM)&N [K"C.C
M$$QB5E! /.V"XQQN*XBI\-5,!AH8^GF>8T\>HSK<E')L+AJ%?"YA1<Y>]5QC
MQ%-4XR<J;BI244VDE*@HT764Y.+C#DORZU).S@]%I&SO:S7?J?R\Z'HFM^*-
M>T3PKX8TF_U_Q/XFU.UT3P[H6EV\MUJ&KZO?/Y=G86L,*.QEN)/D0L @/4BO
MJSXF_P#!/3]N_P""O@G7/B7\6_V5OB=X$^'_ (7MA>^)?%6J64,UAH5H9$A%
MQJ*6;S7%N@D=$/F1J06&<"OL?_@AK^S_ /'GX]?MR:5%^SYX^\,?"CQGX0\(
M:YKT/Q'\5^%;3QM9>'I+&*21)++P_?*T#:HQXL[T;7@D(977;FOZZ_V(_B1\
M"?B^O_!1WX2^&YOB5\;=6\'?#?Q;IW[0?Q>^*.NZCK7@'XA?%*STR^_MNR\,
M>"=4DET[PU!;7*"[AM+6)!;B$%0",TN*N-,3P_C9T,)A,+CJ6#P^"Q.90?UE
MXBC2QF+CAX.51.CAL-&<7)4&Y8RM5K:2PU.E%U&Z&'56/,Y2CS.2A\/*W&-]
MK.4M=[<J2M[UV?P3?#;]BK]L#XS>$]+\?_"7]G;XA>/_  +K=Y#IVD^*]#L%
M?2+V_N,>3:I<2;521\C!D*J/XB*P?CM^RK^TW^RY%HEQ^TA\#_&_P<M?$LMQ
M#X=N_%5B4M=9FM$WW,=G<6XDA=HDPQ&_D'"Y/%?V/_L=^+?$O@G_ (-]/VG-
M1\(:S?>'M2TO5/B!;Z-J.E7$EG>:&L?B%Q#+HUQ"RO83P"")8)H2&C5%"]!7
M-_M/WOB?]H'_ (-ZOV<_%WQ%U*+QM\2K;QM\/_#_ (>\9>+(1K6MVU[J6IPZ
M?;74M_=B2XF9OW27NYB;F)%B?*@"N*''>8+-'0JX# ++EQ0^&W.-3$1QJY\.
MJU+%W<I4$HMJ-6'LVVKN#CI9_5HNGS*<^?V*K6M'E^))QVYO-:]EN?RG_#O_
M ()V_MZ_%[P;I'Q%^%W[*7Q0\:>!/$-M]L\/^)M.L8(+/6;7.//L(KMX;BX0
MD8!CB;/;-?<O_!$7]ECP=\4?^"J'A3]G+]K3X0Q:[HL'P_\ B#=>)?AAXWMY
MH5MM<TK3;AK&>^MT,4Q>SN$5E"N@8K@."0P_I)N?%=U^R'^T/_P3J_9W_:F^
M)_Q$_:6_:5\;:UX67X0>$O@Y'J7PC^&GP:^';6UK"^I>*]&T9K?3/%KV=S&\
M,T5W&YG$1=A\U>3>'M/TS2_^#N+6;32[6TLH9OV<+O4+FWLXHX4>^O/"KS7-
MU+'& #/<2.7ED(!=CD]:\W%<:YCF> S_  CP]'#T*O"N=9MEF98*>+HSG#!U
MOJD9T:E:<*U2+<KK$K#8+]["HJ4)4U&;N-"$)47S.3]O2IU(34=.;EEJDK>7
M+>6CU/YBOV\?V+_B]X)_:1_;"\<?"K]G_P 3:/\ LI_"_P"+^O\ A[3O%FD6
MHD\%^#].LI"$TUKGEXHX 5'SX(R*^3]-_9;_ &E-9^#TG[0^D_!7QE?_  %B
M#%_BO#:+_P (J-F-P6Z8@N06483)R0 ,Y%?V9_L:>,O#O[57QI_X+0_\$M?'
M-S=M:?$#XB^,?%.D75Q=/(J#4[I6ET[348D0.[V]LS&)0?W8)Y45\^_\%@+S
M0O\ @F[_ ,$[OV-_^";O@>VUK5]9U7Q5;>,;OP=87,\EUXTTSP]J;3GP_=31
MD/.-3=I ;9@WG$KNR5&._ <:9A'&Y9PX\#1JYI4JY5&$ISK.-;(JN3T\95S2
M=256_P!94HSA)2E[+F;G.U[D2P\>2=93:II3OHFXU/:<JIK2S5FGHK]%V/YI
MO!/_  3@_P""@7Q*\)Z7X]^'_P"R1\5O%7@O7;%=3T/Q#I^GQ+:ZOISJ76[L
M8IVCN)XF0%AY<;'':OI?_@E+X)\">%?VU?%G@?\ :H_8U^('[4,&@^ M7M=1
M^ 7A_P /W&J^*/#_ (AC:0+KU_I"S64K6]FJNK2+<1"-U\S+JAC?^LGPE^V5
M^S)^V=HO[*GP8^&OQD^+W[!W[;'@CP;IL/PC\/>+O"VL^&_A[9ZY;:=#%JVB
M:EX=U-X=$\;V=Y"ACMDG54=I%C(927'SG^P%\$/VFO@9_P '#GQ5MOVH?%/A
MSQ[XM\;_  "\0:OHWQ'\,:-;>&[?QYI<=K-(=4OM!M L>GSAQN,39+29<$\&
MN#$\;YAB\LXDPV:8"CEF(H9/CL9AL%&MF.!S&K3P^)C3C5P^,CS4<10G2]_Z
MU@Z]*K"HIQ5)TESNEAXQG1<)RG%U81E*U.4$Y*]FM&FG]F46FK:IG\B<O[-?
MQL_:2_:)^/\ X?\ V5OV=_'?B*P\.?$;Q)-%\-='L-VJ?#+P_+>G^S?#FNF4
M+#;7.F1_N)D9P$88.*XKXW?LF?M0_LS0Z5=?M#_ SQQ\(K/79X[71;WQ19!+
M/4[F618HH;6ZM_,@D=Y76-0)/O'%?U/?\$W_ -O3]GG]EWXA_P#!33X?_M+_
M  Y^*WA/P1X_^.GQ%LKO]H?X=^%-<U(:K:7FJSV^H:;>>)])57T.33H)&F2\
M\QO*902"P8+#_P %8_V;?VB_&?\ P3J\/?%[X#?M9Z1^U+^PUHGB+3/%_@7P
MIXMT>SN/'W@/PFTSW5M<WOCV9Y=4UK5+"_5K6>RNS',!#!&BM'L->S3XQS"A
MGN"RK&8'#8#+*]3+\)AL?C'C&\;*O@J522P^.IJKA5BH59**PV+A2E4AS2G7
MC57*X]A%TG.,Y2FE*4H1Y7RI2M[T6E+EM?6-[.R2L]/Y8/B1^RK^TU\&_!OA
M[XC?%KX(>-_A]X \76\-WX5\7>(+$V^D:]:W$8EMY[";'[R.:)E=#_=(->#5
M^C'[4'[=_P#P4,_:/^ OPR^$O[35CXAMO@9X*TS3+?X<W.I^ ;CPW:7>G66G
MV]EIDRZU+$B:JRZ=;VL*3EW8PQ1(K!%4#\Y^E?<Y;4S"KAG+,H8"&)5:M&V7
M5ZF(PWLHS:HMSJI3]LX)>VC;EC.ZCHCGER7]QS:LOC2C*]E?1:6[/J@HHHKO
M$-?[C?[K?R-?Z6'_  ;!_P#*)/X3?]C]\1O_ $OTZO\ -/?[C?[K?R-?Z6'_
M  ;!_P#*)/X3?]C]\1O_ $OTZOR/QI_Y)"C_ -CK!?\ J-CCMR__ 'G_ +A3
M_P#2J9_0E1117\IGMA7\''_!X#_R77]BC_L0/'7_ *>+^O[QZ_@X_P"#P'_D
MNO[%'_8@>.O_ $\7]?I7A)_R7.6?]@^9?^H&(./'_P"[3_Q4_P#TY$_D&HHH
MK^OCPPHHHH **** *]TTB0.T0W.-F![%U#?DI8_A7]ZO['/P)^)L/_!$?POK
M?_!+?Q/X13X^76K/XJ\:>)8M-TK6/$6L:EI$L=UJG@N(7T$[QS2;Q;>4VW>F
MXHI521_!=+*L,;2/NVK@':"3\S!1P.2,D9]LU^^?[(O@K_@M-_P39^$?AS]J
M7]E/0HO'/P%^,FH:'/=>%?!#CXI65[;)=I/-ITOAFR6XB\+ZKJ*0M;W5Z8TF
MB<EV.Y"1\1QU@9YAE^7TJ.8Y;@\71S2ABL+A,XG"&6YM5HQDW@L0IZ2]UNI!
M-27-'WHV?-'?#R4*DFX3E%TW%RI_'33?QQZZO1[?A8^=/^"B_P"VO^TI^WG\
M4O!/P.^.O[(WA;X8_M6_#*^M/AY=_P#")Z)/IWC[Q1JK3+ UAJ=NEM#9S27T
MFZ\"0-(D4#^7"$C1$7WD?\&]O[4J7NG>"[S]H7]G/3_CWJ_P^N/B1IW[--SK
MCCXN7.E6NF/JLNF)I(F_Y"8AC, C*\SE5 ;-?T3_ /!0/X@_"?6O$'_!(K]I
MWXR_#?P/^SM^TCXX^/W@KQ=\4O#6HC2['Q=X>\/3)''<#Q3=&."]N[6!VC*7
M6H&1H_/\II6,8V[O[3OVSX?_ /!7W2OB]\%O^"8WC?X[_M :Q\/8];\ _M2O
M\3[W1/A)=^%;/29'O5N[PLV@Z8EI8M+'"9)"ERLA6(2)(P/P]'C+'4,#EF$R
M/+L-D=%99G.)="53!8G"/'9=C(X>I2I8O,\9AZ%/+'452O*IAJM:O&E./LHR
M@G,Z'AXN4Y59RJ/GIQ32G%\DHJ2;C3B[SM[NMDVM7?;^-3]DO_@FG^U7^V'\
M7_&7P9\'^%!\.]9^&D]_;_$[Q+\08I-/\-_#Z33'F6\_X2*Z8QK;B-+>28X?
M/ED8R:]]_:(_X(P?M%? 3]GW6_VG?"_Q=^"G[2OPI\+ZI-I/BG4/@IKD6J77
MA^>VD:&[EOH);EIC%:2*5F\J)B.O3&?Z>/V'/C/%^US\-?\ @KC\*++1_"7P
MM_:R^(OBGQ;=R^"O!WB.SUB>X6.SO?.M?#NO6<C/XA1O*>!6M?,,TDA7'+$?
MS#?"7_@GO_P47^''@&^_:(\7:9XO^%G[(7PW^)LUY\5?#GCKQ9?>"+/Q1I.C
MZJ1K'E>"[YH(O$!U *6CC\MS>%N,Y&?H\'Q1FN-S''0Q6895D<,MK91265XF
MC3KSS-8W"1Q%58?%NM"JYXBK*5# RP_/3O!N2J7,9481A!J-2KSJHW4BVE3Y
M9)*\4FM%K)22>I1^"_\ P1U^.WQ-^!?@7]H7XK?&GX*?LB^"/BGX@'A[X867
M[0&IRZ%K'CR>80FPOM"@#QM+9:F+F VCN@W>:,GM7AGQN_X)O_M*_L]?M<?#
MK]CCXEZ;I^G^+_C!K^E:%\*?B5&)#\.?'MOJ[;(?$&A:D-ZS:3 XVS.T@<$\
M#I7]#G_!?OPCX@_:W^!'_!.+XL?LK>#=?^,WP6N;CP1HV@VGPOTJZ\4VO@K5
MX5TP26FKZ7H\=POAZ>VA>*"=YE00A2DQ2-&8?3/_  4I^(7PXT/QY_P1G_9E
M\4WNFZO^U5X<^(WPUO\ 5+&&2'5/$/A#1(X[%+G1M9NE+7>E7,IB8?8+@)(P
MCQMP%SQ8+C/.ZW]FXBH\-5_M?_62-7*J>&A&OD7]DPJ3P]:K53]O5A1E3C3Q
MD<4HQDZG[OD?*BI8>FN>*<ER.C:;D_WJJ.*DDOA5[MQY=5:VJ/Q@U+_@W!_:
MNT7XO6?P$UK]I;]F;2?BWK6AOK_A+P9?:U<V^L>,;.&%KBZ31;.61)GEM8D)
ME\R,*1AERI!/YN^ /^"<_P"U!\3OVUM:_8'\(>%A?_&OPGXD;P]XZU%48^&O
M ]NC,LGB3Q!<9_T?18RN6EWY 9?6OZL?VE9+^?\ X.R?V;+>2>[FMK3X)^&;
MBQMGD=[>T671K1;N:UB.5B$ZB07+*/G ;<1@U[?^R9JWPY\"_P#!?;_@H=X.
M?5].\-?$OXO>#[\^'&U>Z@M+GQ!K$D!EM;/2+BX=&GN%&RYCLH"TCA 8U9MJ
MGAI<<<0X;+YXG$3PN/K5^"</Q)AX0P4*$<+BJV-6%FIJC+FJX>E1DZ\E*S=2
M#5XTVT7]6I.:BN:*6)=&3<VVXJ-U:^BDWI=7WT74\[_X(6_L$ZG^Q-KG[;GA
MSQ7\:_@/^T#K%SX+O--U^U^%L]OXAD^'FLZ;ITSMIWB478N/L=Q,()=L<9"R
M;&#J>!7\VOP\_P""8_QK_;8^('[5?QB\,^._AG\%O@M\+?'NL0^)?B=\4KY=
M.\,I?MJ<EN=*L8+:07<EU&S!F2&W=0N,<D"OZ%?^"!GP!^/?P:^.G_!7&]^+
M'PY\;>#TU;6O&4EE>>)]'U'3+?Q:\W]HW%K<Z--=Q1IJ\8@27$MN72/SE3(:
M0BN _9B_9#^'_P )/V/?VC/V[= \)>-_VIOCEX+^-OB/5_#7P6\/:[J&H> ;
M*YN]4CL8+?Q;\,K;?IOB66P:<3W*WL+/]U\,%8C@IY[B<JSSBC$PS.ABLPQW
M^JF$P^,IX/#2HUJV+PT9N"I>WA@\/&S]BL15G.G3TJ3IUIKD=NE&=*@N1QC!
MUY2CS232CINDY2?6RMZI'\]O[6W_  26_:1_8_@^!FO>(?$_@7XK_#7]H/4+
M?2_!GQ;^&\EQ<>"M-O+R80V,6LW%QB6%KPLDD((4E'&1D''U7\1?^#?#]H/X
M+:-X)U_XX_M:_LK_  ?TWXCQZ6/!,OC37;FQ_P"$@U'5T@>UT:QS(/-OP+F#
M>!\F7"AL@BOZ$O\ @K3+\3]:_P""6_[%FO\ Q1\)Z=X1\8ZK\;?A7JNN^&?#
MVCIHVC^&/[7NHKG3](&F6Z)#ILL$+" VY53OB=0,J:^%?^#J""\L?A/^P+J$
MUM(TNAV.D:SID5PI,46IV%G;W$3(AX65S&B.,;F0A2-IQ7IY1QCQ%G&(X<P*
MQ>"PM7,LPS_ XS$T<)A\3[196H3P]2C&=J*E)24)RA!0G'][&*;L9U,/2IJK
M)J;4(TI1BY2C\=N:]O>?6RO=;=#\(_VJ/^"4/[1O[(?[2'[/7[,'C_Q-X'\4
M^,_VGVM1\+?$OA)[FY\+W45W-Y$5S=7!#$0A^=P8!T_>*3&=U>6_MZ?L#?$[
M_@G9\5]/^"WQB\?> /&/CN]T6QU^YL/ MS+.=(T_4HUEM&U&.8[XFD5AC(&0
M58 JP-?W;_\ !.S_ (4__P %'OV6_P!C[]K+XGKX:U?XL_LKZ&=-\0:C/]EN
M;CP[<:):/+:VLN[<UA(;:U:3!VM\I;':OX5?^"G?[1>I?M5?MX?M!?%G5K5;
M:2U\9:OX+TO;-]H2?1/#]X;?3YHI<D"%XD7RT!PHZ"O:X3XFSO.\YJY5C8TJ
M3R+"8JEGTXX>G!8G,WC9TL#+"N]Z5"6%@ZDXP3YG:7NQDDLZU&G3IQG%M^UE
M%TDY-\L.5.?-T;3;2;ML^R)_V'/^"<OQX_;[O/']Q\--7\(?#OX?_"_09]?\
M;_%GXC7T5AX+T>&V+&:Q=Q-'=2WJJC-Y<$<I*\@=*]8_:A_X)'_'/]E_]GS0
M/VJ8_BS\)?CQ\!_$'B!?#$?COX3W-Y<Z9IVK/,;=(;\W866,/,K(A**&*G!(
M%?J9_P $*?V8_AOXQ_8M_:D_:WU/PMX^^,GQ9^ WB'4[SP/^SYX3\8:AI6A^
M.I[*U9K2/Q)X1LV\GQ':3RD,\5U$T,B12JS E5?]!/VW+[]I+XB?\&Z.K^(?
MCY\']+^&7Q3UCXO>'-?N?AAX'\&Q^&+3PAX4E\1L^CVUQH%E#$L$UG9R!+Z\
M:,&8F.21CN!KFS+C#,\/Q33R[#8C"/+Z?$&69'BL-6HX>E63QE!U*TZ4I5:N
M+KN"<*CQ,5A\-2;5%4ZLI2<:A0A*ASR4N=TIU4U)N/NM))JRBENN763U;>Q^
M&MM_P;_?M*VW@3X*?$;QO^TA^S?\,O#?[0-OIC?#B7QEK,]BU_JFKV\-U9:
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MM>2%.NYRE4A3C&,I2<K<SN5[:M9)U9V3BU=K1QMRN]KW5EJ?9_QD\>_M(?\
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M&/AK\3/'-CK&J^!/AYXO\::5X<MGO?$FI^&M'N-3LO#]C&"9;S5IX05M+>,
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M:4^&?Q3UWXZ?#SXV^.?"/QI\4PSVWB3XF:7J4B^)M9MKD.MQ;W=T[DF*599
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M*?%3XG1>#-&@L=:U[P_XBTNQL8!K)MR9YX&NX)[TRSKR]PP5B@4#^/;X8_\
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MIQP%2E4I5:BG5Y]$^:$$Z:DJ<JCE.I%M2:]FH*+3TT5[W?/=-7MN>5_M>_\
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M_$WBW3HK^0 1C1[/4]52"\N8\?ZM;*.225&&-H4-UK^WK3?V1_A%^S?\9/\
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M/A!^T-XNF\<?$JV725&NS>(+B\-_+)I.H;0UE;FZ^;RE(& N>17Q.650"64
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M=.\97]OX>M[/<7%I#IZGRTMPY+",' ))%?OMXA_X)I?\$:/#7[%7AW]O*_\
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MC]YD'C%>)?LL_P#!,S]D+X6?LF_MI?%C]N[X1ZW\0?BE^RS\39/#6G:3X?\
M$\^EVFOZ5;W,L=I9L\!"PMK,,8E\XX,!< 8ZU]E_$WX_?"GXA_&_QU\?_P#A
M^)XE\'?LQ^,-"N?&%I^SKX.O;6T^+WAKQ!<V(<>$-'O/)5HK>*ZW1 >:'VG;
MR.*^&_AA^V;^S5<?\$T/V\_ASK/QPO[OXF_$OXFP7_P^T7XD3M=?$;QKHMG(
MT<6JW]Q&3'++)'M=F/.YF/.:^:P];B.M@X4X8W.G"K7X<AC5!YX\71Q%3&*.
M92CC<90P\J$:E!N.,PV#53"453C4I5(1DU+9QI1E=QIZ*KRK]URM**<+PBY)
MM/6,I6D]FG96^?O&_P"S'^Q1^U'_ ,$POB#^V9^R-\#/$'P$^,7PG\;7-CXH
M^'EWXHN/&!OO#NHW<ECH"%G9C;AIQ&3,P!(;!]*^W/V8O^"=G[&?A;5O^"=_
MP=^)OA'Q]X=_:T_:*\+#XD?$KQ+X0\:W^A7.G^&1&\G]EVTMHR/8W$T?S!E(
M< D ]J_/+_@A7^U]\&/V>/C/XW^"O[4VK6^D?L]?'_2;*W\4:MK[%_"OAN\\
M+2C4[&34XPDIC.H7$:PHZ(S MG:_0_5OPU_;Y^#/BK_@N>GQV\:?$W1?"_[+
MW@"\?PU\,?%5YY@T'2/"=I:75G&MK&HS%!,5AD5$ &'6O7S:CQ#2K9UE.'JY
MN\#@,+F&=X''1KXJM6Q-.O@H8?!Y3'$-U*N)>&QTL16E0J2J3E"E3>BM?.FZ
M3C3FU#FFX4YQM%*+4HN52RMRWARJ]K7;5]S(\,?\$ZOV9? _BC]OW]LC]K72
M_$WBS]D3]F;QMK'A;P#X /B*YN/&'Q0U^ZOI++3K74]>8F[MVM)P//NI9!YW
MWCZU\"?M'7?_  2E^+WP\^#/B?\ 9?T7QG^R[\2=7\=V>A_%[X6:C+=^-XM&
M\"O=H9?%VFZI(9!=WDUL?)33D.XNXQS@5^H/AC]L[]EC]H\?\%$O^"?_ ,;O
MBQX?^'/P5^/OQ!U7QQ\"OVB1YJ:#8ZK8:C)J%N?$K#$DEAJ4C 6X5\[.,\YK
MX\T?X%?\$O\ ]AO5?@#\0/&O[1MI^V3\8=+^*]A>^)-.^$3EOA;8> H;J)8A
MK]G=EY)+Z#;'<S87:1&W&#FNC+L5CJ=>I/-*G$;S.E]4>58+ 0Q3P&)P']DT
M7'V\)4YY?[2>+^LO&5<4XXFEB8TU%1@E&4S46ER*CR._M)3Y5)2]HOAL^>W*
MHJ*CHU?K<_0+]E[]BG_@F3^U#^T;I?[*'@7_ ()^?M$1^"=5^%]QJ.F?MN^-
MI?%'A/P]J/C"#11*VH'1;^W33H[>34)%FLH%F:6X$; Q+&T;2)\#_AC%\$/^
M".O_  5Y^#%O?G5;;X8?$K6?"=MJ178U[!8:A<K%,R$ J=F%YZXS7Z%Z-^W3
M\ ]!_;S@_:=\3?\ !4[P'JW[&VM>&_#VA>$/V2?"T:64O@?59=,AAAO=>A@@
M0BQT&0K%=>4-Q$3[]Q55'YBZI^UY^RS;_L0_\%@_AE%\;_"MYXV^-7QF\0:W
M\'M$MQ+Y_P 0M%NKR6:WU+1AT\B2-UP7Y)KY:C5SO'3ITZM+-JN%EB>$<;[+
M$O-<:Z.,IYS%XYRK8_#4.2O1HRC];IX6E#!PC%3I^ZI..]J4-4X*5J\=%"-X
M^S7+91;NG;W7)\SV>K1_-;^S7X'\-_%#XW_ 7X8^-/$%KX3\&?$#QMX7\+^*
M?%-]*D%EH&C:CY<=UJ5U/(1'##$N TCD*N[)[$?TV?M4?L3?\$R?V=O&_P 6
MOV>_B#^Q)\??!%OX<^%8\4?##]LWP/)KWQ#\ >-]2ETD76G:M+!8)+IUM9:I
M.-\F&\N"%RQ.T9/\P?P/T[X2ZA\0OA_HWQ^_X22W^$=]J.E6/CNX\)3&V\16
M.DE8UNKC3[@%6BGMR P=64C:3GBOZ[_V?_CE\,_V7?BC'XVF_P""OG@C]H#]
M@[1/AEKFD6'[)/Q%*ZU\3+O2KCP\UIH'@_SKF*X9KNQ)6SDS+P5X.3D?<<9U
M<=1QF#JX/$9FE3P>(FL#@GF6'AC,3'$49T71QF7T,52>-LI4(X7,J'U*=.;D
MZD7S-<V&46FI1@[R@G*:@W!62=XS:?+>SYH/FOLCXY^%O[/'[.?PW_X)N_L=
M_M:^)-"^(GQ$\1:M^U]X>\)7WA:3QYJ-MX+N] ;5%CM;JS\.F466GZH(A#(T
MR()8GW(3D<?;7_!73X#_  P_;W_X*B_LJ?LFZ%X,U'P)\0/$_@#PCKOBGXLW
M.M2ZE#=?#VVTZ&9?#$&DN6$=S861>$72J&F;!R>,?%?[5W[=O[*_BC_@EM\+
M_#WP;UOP_I'Q#\.?MD:5\3+;]GW3XWCU?P_X,MM:$LM^T6/*6V\G,[ +TR !
MC!]S_:=_;U_9F\ _\%#/V*_^"CO@'XV>#?BSX>M/AOX.\ _$7X3>&!-_PFO@
M"XDTBSM]<OM4,F8A%8/)+&"HX>!^>17R2HYY/,8YHJ&9PQ\7QK0RQ5?K+5'$
MN&$JY=AYQBOJ_LIN514IU%]5KSII*4W""6]Z2@X-PY/]F<W[NJ7QM/XKK=I/
MF72VIJZ5_P $ROV"_CU^T-\<_P!A#X8_L-?M!_!SQIX)\*:E8?#S]LW7H_$=
MWX*\1>.-(L/M;WHTZ>$Z>;"_E@EAB96*AI"650$+?+W[-W_!+WX'_"O]B_XX
M_M)?&?X$Z[^W_P#%WX>_%*X^'\WP!^''B.[T3Q/X%T_2=0?3)M;OK32$DU"Z
MBU3RS>[?)9XE.U$8_*?NCXG_ +07PVUWXP_&[]H'Q)_P7"\2Q?LU:YH-]XL^
M'7[.7PBOX+#XO:;KEQ9@VGA)+IHT AANY529#(3Y4<HYYK\J/V+M=^$OB[X4
M?&CQ/\%_^"DOQ _8._;#U7X@W,^O^)OBYK+/\._BMX1N[YIM/U".T7SD_MVW
ML,+?W'D'_2V=QG&#K@ZN?U,NKN6:9I2P\99#+$QG1XBKS6)=_P"T*57'U</1
MS+"T:]X+&+*H5J&%K1AR.5&K5%)4E-+V<'+]XHV=&/NJW):";A)JSY?:6<EJ
M]4CXE_X*)^#/V._"WCOX>:A^R7X8^)7P>;Q)X%TW5OB+^SQ\4]%U'3/$'PY\
M33;1?Q6M]JJ)=:KI\3AHXKM08W+9!KZ@_P"""'@C0O$/[;/BWQ_XGT)=9TSX
M#_!#Q=\7-+>XMO.L[/Q!X=AN7LY=[*46Y0X*#*M[\X/IG_!;/]J3X ?&OPG^
MRU\)O"7C+PI^T5^T=\)_!.DP?%_]KWP?9QV^E_$*VCC /AIYHXHC+<6TS>8[
M,&)*GGBN-_X-_O%$-M^V+\4?AAJ.MIIEC\:?V>/&_P /=)M+B2.*"^\2:S!<
M)9)&7*EKDX C16R>,*:^HKU\96\/L=5K4\91Q']GXJ,OKM:I7Q4L-'$N$JZK
M3HT<1.%7"\TZ+Q-&GBG1<5B5SN3,5&*Q4%'EDO:1=H)**?*M&DW%6E9/E?+?
MX=+'I7_!-;]F;X"?\%*/VA_^"D7Q'_:;T/7?&<WAK2/&GQ.\!M;ZS-92:1K$
M]M/?6_FLIS+;0RHFVW)V@# ZFO,O^"?7[$7[.'[0'[ W_!0OX]_%/PMJFL?$
M_P#9\D\3CX5:O9ZI)9VFC#3-;GL[,7EHF$O/+MD56+CYB"3UKT?_ ()#?M(_
M!K]AW]M3]L?]GS]I#6IO ?ASXMV7CSX1/\2M222+0O ^M65K-8VM[KX*B0VD
MT\@^:/ *@X8U]7_ 2_\ V,/V%?\ @GO_ ,%!_@)?_MP_!WXY?%?]H'2_$7B'
MX?#X<->_V3);ZAJTES#X>N%G+LVO2AQ,1E8U5GVX"JI\K-L9FF%QF983"3S:
M-'$UN"ZF2+"4L74PZR^$J=/-/8U:$)4:%-P3^MPE*FYPLY1E%J^E.-.2A*7L
M[I8A5>9Q3YO=<+IN[=U[K2TZ/>WE/[0?[-/_  2Z_8J_8*_92^-_Q(_9B\8?
M&_X[_M6>#)QX5TFQ\;7>B6-IXG73R3JSLC*A2&[Q,+;.' V=^<37?V0_^"<G
M_!/GX ?LT^,?VY?@QXF_:"^)_P"UAK6E>)H='T;Q5<>&)/@C\.O$ES%;Z=9S
M0PM&VM3:<UU"'F8,9/+.6R37B_\ P59_:3^"GQ<_8:_X)8^"/@U\3= \9?$G
MX'^'-5_X6#X?T[S&N_!.J_8 +)-6#C:"UP=H5"P( .>2!])?$OXA_LA_\%</
MV7OV2;SXE_M1_#[]DCXZ?LR3>'? GQ&L/BQ]H#>/?"GAFYMKU]5\)BW,:JMV
M+3RH3(#\SKDXSG.E#-*>!RS$YABN(88/&9WG4<[JTL1F4L9A\/0KXVED\*%*
MCS8C"8*?)2;EA::=9NDZSG1DK#=/FE&,:7-&E2]FFJ?*VXP=1MO24D]N9Z=-
M3,\=_P#!#[X<WG_!2[X&_ OP#X[FTO\ 9@^./@9/C?I#W ,^I6/P_P!+M#J>
MM^'))F!D^TO;$0+<MEE(R#UKW7]E']E'_@CK^V=^T=^UC^SAX<_90\7?"JZ_
M9=T+Q;J.@^,'^(U[JJ_%Z?0M/G*O]D8L-+:W:WDU,+&"LB;(6=69@E#QK_P6
M'_9V\/?\%1OV;_$_A31-<\:_L[? KX5#]GN\\8:#976H3:MI^NZ;_9.L>,TA
MM89K@Z39,IN=X3Y82"6'!K["_P""77[-?[,O@/\ :]_;P^.'PQ_:\^%7[0\'
MQ7\"^.]4\!^!?AVEZOB7X9V&IZ->32W'Q CN3_HY^RRR6J*5CQ<(I(!)SXV9
M8_B'#90\1F^+SS!XFGPY@ZF5U,-+%T54Q\LSG3Q$L>\(O9/%/ ?5?:1QW*HJ
M=25)*M>UPA1=1*G&E)>U:FFE+W5!./+S:\JE>W)?5)25C\L?V8/^"<?[.?PX
M_8=\=_MS_M+_  !^)W[7'_"0_$[Q#X-^#/P(^%*:H=9ATVQUVXTZVNM3N=)C
M:=(;6!526:3()0L2,UWOQ=_X)$_!36O&/[%?[3'PI^%7CSX4_LN_M&:]I/@G
MXH?LW^/A?Z;XP^''B*"6"WU:[CU/4$2\O(-1E+B'G"!P0,8%>A?L<?M_>#_B
M/^P9\0/V*K3]L.']@3XZ_"GXP^,=2\!_%_5?+7P_XHTQO$M[)<:??"2.0/',
M0Y^7DAA@CFN:^)G[2?P2^&_QX_8PTOQ+_P %(_B3^UUKOA_QAI'B#XW>-M0U
M2.7X%^'0+NUFEFT/3X@CPS0B/]^VT9"'G-=\\3Q1_:F8*6)Q]+$K&9HH4(T\
MUK4*N4+ .6"5"E3H?V3A_>5.I1QE/%/&_6N:G4@U-Q$HT.2-HQ<>6'O+D4N?
MG2DFV_:2[.#BH6L>^^)?V,/^"+6B?\%'[3_@G%IO[+'CK5]8\26,<$?Q5;Q[
M>P)X/\2W6C?:H-+_ +,W 7T*7&)O/VX(^7H<5\G?LH_\$]_@MX7\&_\ !7K3
M?C ?'_B&Q_90\26S>%/#W@WQIJ'A72_$OA".>4OH?B2WLWCBU22ZLT,*37*L
M8<@CTK0\1?M;?LR7/_!P!I7[2]M\8/#4OP A\3:?>3?%",2_V"EM#H7V9YC_
M ,M-B3XC/<'\Z]5\&?MG?LHV6G_\%OH;WXW^%K=_VA9[?_A20D,P/Q$55N-S
M:*,'=M+(")"N%8G)("G)KB##X3#TH5^(*_US).%L7BIXBKC\35IYC/.\+#'J
MG*?,\-4>$G4^L4:2I\E*'M)1C9S':DY2;5)<M6M&*BHQ7)[/W;K[2NE9OKIZ
M^H?\%?\ XD_LQZ]_P2L_X)V65_\ !C6?"7AGQAI/AFV^&M^WB6:_;X-:8;R&
MVN7GMRY&OSF!9#$C!F>0JJ\XKS[]DK]B7_@F#^TA\?? ?[+/A/\ 8)_:-\4^
M&?$'P[@U.^_;0\6CQ)X+\,7GBIM,,UU);Z3=QI9F%;OY[14/^D1!2@VD5P?Q
MN_:)_8V^+7[!/_!.'4O$?QH^'GB76/V2]4\-W'Q5_9NOHYI/%_BVPL]8B=X=
M/C)\EFME7[6X=2#&ISQU_2*W_;U^"_A[]OKPO^UA<?\ !3_P/-^P_J6@^"-)
M\-?L<^%$BL]<^'^LMH%K:PW&N6\5O&J:3X<NXV35S')OF5F0@>4I/FO^U,OR
M:> P%'/:&)CB.*J\*D<1G-*G]=CCH?4:4(8:A4JXG$5:,HUZ'MJ]/+JO-4G4
ME5JRG*%^Y.JIS]G*/+ADU:F_=Y;S>K2C%25G9.:M9)*U_C#]D+X9:5\&?V%_
M^"TOP6T=S/H/PP\2ZSX)TIY/F>33M,O9XHO,)Y8E&VDD<\GG.:^-OV*=#?\
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M_2_3J_(_&G_DD*/_ &.L%_ZC8X[<O_WG_N%/_P!*IG]"5%%%?RF>V%?P<?\
M!X#_ ,EU_8H_[$#QU_Z>+^O[QZ_@X_X/ ?\ DNO[%'_8@>.O_3Q?U^E>$G_)
M<Y9_V#YE_P"H&(./'_[M/_%3_P#3D3^8?]DNQL]3_:@^!>G:A:6M_8WOQ'\)
MV]U97L*W%G<PRZW9))%<P."DL3JQ5T8$,I(/!K^OK]MC]M;2O@#_ ,%7/@/^
MQU\/_P!G/X"VGP*^)K^'?#?Q?T6\^'7AZXU7Q-?:YI,074M'U,VZRZ)]FM+F
M. 1P[6DDB\YBSLSG^0[]C]6?]JKX!HF0[?$SP@J$#)#'7;( @#DD'!K^M/\
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M%Y#J45SX"\)O<0VV8(;J1RD<61G!QCD_@W\)/^"D?[-GB;]D3XF?\$_?VZ/
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M?_A1X4\*>"OB99>-)(W\%^)]!T72[;3M8BTB&,&3S-1*3.I(Y#+G)%1^+O\
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M3ZS;>.?AQ9_L]Z9X3FF^':Z8S7NF:)XFU#P^F^>,C$-S;W3 3XVD8-?S3_\
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M5/\ RBR^/G_9_P#\4_\ UG7]E6OZ_: "BBB@ HHHH *_DA_X.]?^3.?V;O\
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MVLOAYKWQ$_:X^&FM//\ #3]J"PG@AU>Z\*#=]F\,^.KH+'+JEE$Q$GE[7'F
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MM7WL[ 5'L+&2-(9+.U>&/F.)X(FC0^JH5*K^ %6458T5$541!A44!54>BJ,
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MSXM\?:1X>/C3X\?#'Q%_87PZ\'^+/$5Q;62^&[C2+F59Y)]-NK@>?(BA752
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M1_P5;_:"U[X(7'[9/QG\"?$G4XO#O[+%MXAO=)2\MY]5D62>\L-.N(EU19T
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M_P!CK!?^HV..W+_]Y_[A3_\ 2J9_0E1117\IGMA7\''_  > _P#)=?V*/^Q
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M<!@ #H !^5+117ZB<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#&*/\ AG+]IG_HVKX[?^&XU[_XQ1]:PO\ T%87_P *:'E_T\\T%GVE_P"
MO_+S_/LSR&BO7O\ AG+]IG_HVKX[?^&XU[_XQ1_PSE^TS_T;5\=O_#<:]_\
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M \<>$O$?@KQ!;^._B'+/H/BK2;K1-8@AFOK P336%ZD<\<4ZJ6B=E =02.A
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MY#17KW_#.7[3/_1M7QV_\-QKW_QBC_AG+]IG_HVKX[?^&XU[_P",5?UK"_\
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MVKX[?^&XU[_XQ1]:PO\ T%87_P *:'E_T\\T%GVE_P" O_+S_/LSR&BO7O\
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M[3/_ $;5\=O_  W&O?\ QBC_ (9R_:9_Z-J^.W_AN->_^,4?6L+_ -!6%_\
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MS?ZE=SW^H7<A+2WE]=.9+FZF8DEI9I"7=B268Y)->L?\,Y?M,_\ 1M7QV_\
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MXU[_ .,4?\,Y?M,_]&U?';_PW&O?_&*/K6%_Z"L+_P"%-#R_Z>>:"S[2_P#
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M]GM_^>$/_?I/_B:/L]O_ ,\(?^_2?_$U-10!#]GM_P#GA#_WZ3_XFC[/;_\
M/"'_ +])_P#$U-10!#]GM_\ GA#_ -^D_P#B:/L]O_SPA_[])_\ $U-10!#]
MGM_^>$/_ 'Z3_P")H^SV_P#SPA_[])_\34U% $/V>W_YX0_]^D_^)H^SV_\
MSPA_[])_\34U% $/V>W_ .>$/_?I/_B:/L]O_P \(?\ OTG_ ,34U% $/V>W
M_P">$/\ WZ3_ .)H^SV__/"'_OTG_P 34U% $/V>W_YX0_\ ?I/_ (FC[/;_
M //"'_OTG_Q-344 0_9[?_GA#_WZ3_XFC[/;_P#/"'_OTG_Q-344 0_9[?\
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M_P 31]GM_P#GA#_WZ3_XFIJ* (?L]O\ \\(?^_2?_$T?9[?_ )X0_P#?I/\
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M%_P5-_Z26?M__P#B9'[17_SQJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:BB@
M_P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W_I)9^W__ .)D?M%?_/&H
MHH /^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\
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M%_P5-_Z26?M__P#B9'[17_SQJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:BB@
M_P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W_I)9^W__ .)D?M%?_/&H
MHH /^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\
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M%_P5-_Z26?M__P#B9'[17_SQJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:BB@
M_P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W_I)9^W__ .)D?M%?_/&H
MHH /^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\
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+UFN9Y TK%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>img12876764_20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_20.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,D V(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#XZ_X()?\
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M%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
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M_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\ P2R_Z+Y^W_\
M^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M?U^T4 ?R!?\05/_!+
M+_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4
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M7[10!_(%_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\
M#I_LZ_\ T*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_
M $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\ _P"'3_9U_P#H
M5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\ !++_ *+Y^W__
M .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\
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M5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\
M_P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\
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M****\\L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *^ /^"L7_ "BR_P""EG_9@'[9'_K.OQ&K[_KX _X*Q?\ *++_ (*6?]F
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M?D=[_P &K[SR_ ?XV374!M+N;QM<RW=D>MG</>N9+8XXS$V5/N*_J[K\JO\
M@DI_P3J/_!.S]G:/X?>(/% \9_$7Q1?R^(/&WB%8Q%'+J-XWGR6L8  =8)68
M;QD$]#UQ^JM?G?&>8X7->)\WQ^"J>UPM?%-T:J4HJI"$(T^>*DE+EDXMQYDF
MXM-HZ\/"5.C3C)6DHJZ[-]/5=?,****^8-PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO%WBS7O%/_#=_P"V9H?]N7TM[_8VC_$0V^E:=YKLWV>P@_Y90)NVHG8 5Z.
MPV Q$JBQV9?V<HJ+IR^IUL7[1MV:M1E%PY5K>6^R)DY*W+#GOO[RC;SUW^1^
MT-%?AY_PY6/_ $D"_;=_\.4?\*/^'*Q_Z2!?MN_^'*/^%>E_9G#_ /T4W_F&
MQOE_T\\W]WF1SU?^?7_E2/EY>;^[S/W#HK\//^'*Q_Z2!?MN_P#ARC_A1_PY
M6/\ TD"_;=_\.4?\*/[,X?\ ^BF_\PV-\O\ IYYO[O,.>K_SZ_\ *D?+R\W]
MWF?N'17X>?\ #E8_]) OVW?_  Y1_P */^'*Q_Z2!?MN_P#ARC_A1_9G#_\
MT4W_ )AL;Y?]//-_=YASU?\ GU_Y4CY>7F_N\S]PZ*_#S_ARL?\ I(%^V[_X
M<H_X4?\ #E8_]) OVW?_  Y1_P */[,X?_Z*;_S#8WR_Z>>;^[S#GJ_\^O\
MRI'R\O-_=YG[AT5^'G_#E8_]) OVW?\ PY1_PH_X<K'_ *2!?MN_^'*/^%']
MF</_ /13?^8;&^7_ $\\W]WF'/5_Y]?^5(^7EYO[O,_<.BOP\_X<K'_I(%^V
M[_X<H_X4?\.5C_TD"_;=_P##E'_"C^S.'_\ HIO_ ##8WR_Z>>;^[S#GJ_\
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MRC_A1_PY6/\ TD"_;=_\.4?\*/[,X?\ ^BF_\PV-\O\ IYYO[O,.>K_SZ_\
M*D?+R\W]WF?N'17X>?\ #E8_]) OVW?_  Y1_P */^'*Q_Z2!?MN_P#ARC_A
M1_9G#_\ T4W_ )AL;Y?]//-_=YASU?\ GU_Y4CY>7F_N\S]PZ*_#S_ARL?\
MI(%^V[_X<H_X4?\ #E8_]) OVW?_  Y1_P */[,X?_Z*;_S#8WR_Z>>;^[S#
MGJ_\^O\ RI'R\O-_=YG[AT5^'G_#E8_]) OVW?\ PY1_PH_X<K'_ *2!?MN_
M^'*/^%']F</_ /13?^8;&^7_ $\\W]WF'/5_Y]?^5(^7EYO[O,_<.BOP\_X<
MK'_I(%^V[_X<H_X4?\.5C_TD"_;=_P##E'_"C^S.'_\ HIO_ ##8WR_Z>>;^
M[S#GJ_\ /K_RI'R\O-_=YG[AT5^'G_#E8_\ 20+]MW_PY1_PH_X<K'_I(%^V
M[_X<H_X4?V9P_P#]%-_YAL;Y?]//-_=YASU?^?7_ )4CY>7F_N\S]PZ*_#S_
M (<K'_I(%^V[_P"'*/\ A1_PY6/_ $D"_;=_\.4?\*/[,X?_ .BF_P#,-C?+
M_IYYO[O,.>K_ ,^O_*D?+R\W]WF?N'17X>?\.5C_ -) OVW?_#E'_"C_ (<K
M'_I(%^V[_P"'*/\ A1_9G#__ $4W_F&QOE_T\\W]WF'/5_Y]?^5(^7EYO[O,
M_<.BOP\_X<K'_I(%^V[_ .'*/^%'_#E8_P#20+]MW_PY1_PH_LSA_P#Z*;_S
M#8WR_P"GGF_N\PYZO_/K_P J1\O+S?W>9^X=%?AY_P .5C_TD"_;=_\ #E'_
M  H_X<K'_I(%^V[_ .'*/^%']F</_P#13?\ F&QOE_T\\W]WF'/5_P"?7_E2
M/EY>;^[S/W#HK\//^'*Q_P"D@7[;O_ARC_A1_P .5C_TD"_;=_\ #E'_  H_
MLSA__HIO_,-C?+_IYYO[O,.>K_SZ_P#*D?+R\W]WF?N'17X>?\.5C_TD"_;=
M_P##E'_"C_ARL?\ I(%^V[_X<H_X4?V9P_\ ]%-_YAL;Y?\ 3SS?W>8<]7_G
MU_Y4CY>7F_N\S]PZ*_#S_ARL?^D@7[;O_ARC_A1_PY6/_20+]MW_ ,.4?\*/
M[,X?_P"BF_\ ,-C?+_IYYO[O,.>K_P ^O_*D?+R\W]WF?N'17X>?\.5C_P!)
M OVW?_#E'_"C_ARL?^D@7[;O_ARC_A1_9G#_ /T4W_F&QOE_T\\W]WF'/5_Y
M]?\ E2/EY>;^[S/W#HK\//\ ARL?^D@7[;O_ (<H_P"%'_#E8_\ 20+]MW_P
MY1_PH_LSA_\ Z*;_ ,PV-\O^GGF_N\PYZO\ SZ_\J1\O+S?W>9^X=%?AY_PY
M6/\ TD"_;=_\.4?\*/\ ARL?^D@7[;O_ (<H_P"%']F</_\ 13?^8;&^7_3S
MS?W>8<]7_GU_Y4CY>7F_N\S]PZ*_#S_ARL?^D@7[;O\ X<H_X4?\.5C_ -)
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MO+S?W>9^X=%?AY_PY6/_ $D"_;=_\.4?\*/^'*Q_Z2!?MN_^'*/^%']F</\
M_13?^8;&^7_3SS?W>8<]7_GU_P"5(^7EYO[O,_<.BOP\_P"'*Q_Z2!?MN_\
MARC_ (4?\.5C_P!) OVW?_#E'_"C^S.'_P#HIO\ S#8WR_Z>>;^[S#GJ_P#/
MK_RI'R\O-_=YG[AT5^'G_#E8_P#20+]MW_PY1_PI#_P158[<?\% _P!MX;71
MN/B4>=C!MIXZ-C##N"11_9G#_P#T4W_F&QWE_P!//-_=YASU?^?7_E2/EY>;
M^[S/W$HKR;X(_"L_!?X;^'_AV?&?BOQ^=!B:+_A*O&U]_:7B34]VWY]0O/\
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MY19?\%+/^S /VR/_ %G7XC4 ?X@U%%% '^GW_P &5/\ RBR^/G_9_P#\4_\
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MR6MG"VZ?=G]3W_$6S^W)_P!&[_!C_P #M3_^2:/^(MG]N3_HW?X,?^!VI_\
MR37\ME%?L?\ Q#S@C_HF\!T^UB?+_I_Y/[V>?]9Q/_/^?_DOEY>7X^M_ZD_^
M(MG]N3_HW?X,?^!VI_\ R31_Q%L_MR?]&[_!C_P.U/\ ^2:_ELHH_P"(><$?
M]$W@.GVL3Y?]/_)_>P^LXG_G_/\ \E\O+R_'UO\ U)_\1;/[<G_1N_P8_P#
M[4__ ))H_P"(MG]N3_HW?X,?^!VI_P#R37\ME%'_ !#S@C_HF\!T^UB?+_I_
MY/[V'UG$_P#/^?\ Y+Y>7E^/K?\ J3_XBV?VY/\ HW?X,?\ @=J?_P DT?\
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M$W@.GVL3Y?\ 3_R?WLX?K.)_Y_S_ /)?+R\OQ];_ -2?_$6S^W)_T;O\&/\
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M@.GVL3Y?]/\ R?WL/K.)_P"?\_\ R7R\O+\?6_\ 4G_Q%L_MR?\ 1N_P8_\
M [4__DFC_B+9_;D_Z-W^#'_@=J?_ ,DU_+911_Q#S@C_ *)O =/M8GR_Z?\
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M? '_  5B_P"467_!2S_LP#]LC_UG7XC4 ?X@U%%% '^GW_P94_\ *++X^?\
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MKIW5T[-:=4]&MT]'J2FG_5M]5OW6P4444#"OZOO^#1+_ ).U_:N_[)3X?_\
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M??\ @G-\;/V>OV(?BSXA_P"":G[7DWQS_97U70M1N/&G@^\UM]:O)M#O#NU
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M (*I_P#*.G]L/_LB'BS_ -%0U_D2>'?^0'IG_7JG\S7^NW_P53_Y1T_MA_\
M9$/%G_HJ&O\ (D\._P#(#TS_ *]4_F:_IKP,_P"1%GG_ &-J'_J&CQ\R_BTO
M^O<O_2D;5%%%?MQYY"W_ !_:!_V-'AC_ -/MA7^CI_P4Z_X)I_M!_P#!13]F
M_P#80TOX$?M%^'_@%/\ #WP#X.N_$$FMW5U;S^([?4O ^@00PZ:+5U9[JV*-
M)&&# ,4.UN17^<8RDW>D28^2UU_0KR<_W+:SU:SN;F3_ +9P12/COBOZC/\
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M:_\ 'GB[PMX;B2QT>'_A$X)+^>PL+96");7RP-'-'_$& R:^B?C=_P %*O\
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M- ^$W_@'K/\ \N*/^'1O_!-G_HT#X3?^ >L__+BCDX3_ .?_ !%_X29;Y?\
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MQEO;_P"+7[3^J()[G4]0^#VL7&IWD09KF]D>RNV>2\E0;YBQR6:0DGDD]:^
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MXJ_'[4?VA9/AMX<\5^*H(M5\*>$M&L_%']CB8:?,2!>B! \4H3*R?-FO7/\
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M98?]>L/_ * *T*_6I;OU?YG''9>B_(****0PHHHH *_L?_X,]?\ D>/VW/\
MKR\$_P#I1%7\<%?V/_\ !GK_ ,CQ^VY_UY>"?_2B*O@O$_\ Y(3/_P#!@?\
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M26:U%RR,&*H 2W/M^BO[9&O?&3XE?\$@?%OQ$_X*E_#?1/AU^T!8_%O3;7X
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MU^(U??\ 7P!_P5B_Y19?\%+/^S /VR/_ %G7XC4 ?X@U%%% '^GW_P &5/\
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MN[N]MWN[V5[[]1D<:1(L<:A(T4*BCHJ@8 'T%/HHK8 HHHH **** "O['_\
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M_P"Q(\5_^F&_K_&.\5_\C[\3/^RE>.?_ %(;ZOZ'\"/@XG]<J_\ =X\O,O\
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M\;>$O$/A2YO[=0UQ90>(-*NM*ENH%8A6EMTNFEC4D LH!(!S7\B:?\&>_P
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M>_\ !'IG_P L:/\ B#\^ O\ T=O\7O\ P1Z9_P#+&C_B+/ O_0TQ/_AMQO\
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M'Y\!?^CM_B]_X(],_P#EC1_Q!^? 7_H[?XO?^"/3/_EC1_Q%G@7_ *&F)_\
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M=NMO/[C^%NBO[I/^(/SX"_\ 1V_Q>_\ !'IG_P L:/\ B#\^ O\ T=O\7O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO+F2*WMX4R-TLLB(O=A7D*_M+_LZ.H9/CQ\'F5AD,OQ)\'D$>H(UC!%?-O\
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M,]A!4X45:[;;J.[;:_N]%=?+SL?[+O\ PTK^SM_T7;X/_P#AR/"'_P MZ/\
MAI7]G;_HNWP?_P##D>$/_EO7^-#Y-R>FM>(S_P!S'K/_ ,FTODW/_0:\1_\
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M'_<Q:S_\FT?\0)PG_12XC_PV4_+_ *C?-_=YA_:4_P#GS'I]OTO]GU^[[_\
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M!)( KQ=OVD_V>$DEB?XZ_"!)8)9()HW^(_A!9(IHF*2Q2(=7#))&X*NC ,K
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MT^WZ7^SZ_=]_^R[_ ,-*_L[?]%V^#_\ X<CPA_\ +>C_ (:5_9V_Z+M\'_\
MPY'A#_Y;U_C1>3<_]!KQ'_X46L__ ";1Y-S_ -!KQ'_X46L__)M'_$"<)_T4
MN(_\-E/R_P"HWS?W>8?VE/\ Y\QZ?;]+_9]?N^__ &7?^&E?V=O^B[?!_P#\
M.1X0_P#EO1_PTK^SM_T7;X/_ /AR/"'_ ,MZ_P :+R;G_H->(_\ PHM9_P#D
MVCR;G_H->(__  HM9_\ DVC_ (@3A/\ HI<1_P"&RGY?]1OF_N\P_M*?_/F/
M3[?I?[/K]WW_ .R[_P -*_L[?]%V^#__ (<CPA_\MZ/^&E?V=O\ HNWP?_\
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M?XT7DW/_ $&O$?\ X46L_P#R;1Y-S_T&O$?_ (46L_\ R;1_Q G"?]%+B/\
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MZR%2.XK_ %2/V:?#?Q%^.=_XW\$_M4_ S]GSP5X&U'0[JQTSX):#%X4UO7_
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M"=OP;_X*4M^RO\-M3^(7B;1- O[3P[)X;T@)I9U.Z$#1!_(&\0G#H26;DC(
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M74%+F2@IV:?HMV?QI?\ !6?_ ()P3?\ !-GXZ>%/!&D>*X?&OPZ^)WAL^,?
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M  Z.@:5_:5U-'=7)E\K4H]\?V-VCQ^^Q((R/]4^[CZ%_X)?_ /!;7]F'X(_
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M8C%5/:5:R?U=_O4[QA-6E&/NIZLKZU5O)N-*7.HJ?-#=1LDM]K)W7FC^A_\
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M(75ZD?95.1<EES.1*Q%2*Y7"FTVYQC*FTH.5KNFG;333=)N_2S_IT_X)@?\
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M_P"OM3\PHHHKYXU.(^)G_)-_B#_V)'BO_P!,-_7^,=XK_P"1]^)G_92O'/\
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MT/2+W1+)DNK+2](U:6$_;;66%V#VJ)(R,Y4,K*=R*<;OB/\ X..O"/Q5\/\
M_!3SXPZW\3-.\53> O%J:9-\)S<0:E<Z9<:9%9D7HT@6J.B1EL[QP21QCNWX
M:?LT_P#!2OPE\(_V>OBEXZ^(7CC3?V4-4\0:%+X7\'ZU=R)HQTZ>ZB%M;VMK
M<GS '\IMJ8W#:<XXK\TRG!YO0P61<25>-ZM6MG%'VV+P./G&>!QGUC#NM]2R
MZG35Z6)P\O<]U17-"3E9)HZIRIN=2BL*DJ<DHS@O?CRN*YIWWB]^]G;9G](W
MQ4_X)I?\$4?V3_A1\%O%7[2OAN'0;CXEZ%HD6G:@92HU+5[VSMI9Y'W*<$33
MX('93CC!/Y!?\%B/^"-/P1_9\_9\T_\ ;E_8]\6WOB'X/ZS/IT-UX5P)+6Q.
MKEETL:8ZMF;[0_[DAD5O,1PJE2K-_1W_ ,%%OV0?V OVP_@_^Q9X,_;9^+^K
M_"FXM+;PW/\ "RWTG6GT=_$>MOIUBCZ?(PAE659-RH%8*5#[D96 8?GE_P %
M]OCAX&_9$_9K_98_X)X^"/#.KQ^!/'OBSP->V?C2_5KC39-$\,WXE$DM]L,1
M8AGDG8NOF%1)@J,CXOA3/<XK9IP['#9MGV,Q^-S#'+-L%F%Y954RK#5:CJ2P
M52K?VE6G2A[SHOGA43BU9:]->E34*S=.E&$80]G*'QJI*WQ)+17[WNM4?&/_
M  3^_P"")W[+W@']F/0?VV/^"D_CQ?"7A'Q=IL&H>'? >K316-M)97B,UKYH
MF<2?VE<$ 00QQN"H)?8"I?WOXN?\$7/^"<G[>/P,\7?$7_@FO\28]'^(?P_T
MZ[U*/P19W,4W]M2V<>Y;7580R311W;#9 ZQNC/\ *SHS1+)ZE_P<3>']9\=?
M\$H/V9]:\ V=YXF\#:9;^#KN^F\.I/-8QQ1:9:1B\=+$$F-9()5) (#(^3G.
M/A;_ (-)/"_Q&3]H[X_^/8-)\06GP</PX2PGUR^AO+;09M9AFB9[9%O51?/@
MD7S)#C 523@=?7_M#/<7PYFW'JXEQN%QN S'$PH9/%TEE<:.&Q5*A# U,/*S
MG5K0F[RDO:-Q;CU:R<:4:U/">PC*,X)NIJY\TE=ROV37IW/Y5_$6@ZKX2\3>
M)/!^OVYM->\)ZW?^'M9MR"!'J.F2F"Z5,\E!*"%/I6-(ZQ(TCG"("S'T ZFO
MZ// O[-7_!-+]L?]O+]N"X_:M_:'T_\ 9^\'^$/&ES!\/Y[#4ETNV\3:Q<:D
MR:W)N&%G>T?<TB $-C[R@5\__P#!1;]@7_@G5\(YOA#X3_84_:D3X[>*OBGX
MGL?".J:;#J9U273+C4KK[+!,!&6*!^)/N@("!N(P3^IX;BK U,9A,MKX7-*.
M,K8;#UZLWEN)> I>UPL,5-2QZ7L4H0DU)MKEFG!VDF<;HS4933IN*DTKS7.[
M2Y5[GQ/IYM:]3]0?^""__!'+X!?M2_LX^(OCC^UMX06^.K>*YM%\#6M\_P!E
MCO-.9)!%>0O(R"3YFBV;,[F/9<D?A[_P5]_8UTS]A;]MKQ-\&?"NGW5KX N+
M2Q\1^'[J2)Q:?V7J$T3+:V\KC$C10.>,D\= >*_NF\8?L?\ [2/PY_8+_8U^
M!O[,'CCP/\/?B!\*M0\(ZYX_G\67UIIT.OZ5;!+C5(%66>%I[F4S/'NPV-B@
M\]?R^_X.COV7_$WCC]FOX!_M':?I^E7WB/X?O:V/Q9\2:8L<L4UC%IUJS,EU
M#N#VRWAN4C.XKM1<$X%?E7#7&F)Q7'"JXC-8ULKSW%YEE^'RUUI\F7O#2@L#
MB/9R7)%8N,)>S<&Y2E4M):6.VMAXQPWNP:G2C3DYZ7FW;GBVM=+]>FOK\=?L
M@?#S_@@=JO[._P -[GXYF2Z^+U]9QQ>(X6;_ $ZZUB0*JVD,(0LTDCY$2C)9
ML\DU]Z_MH?\ !+G_ ()-?!G]@7XF?M/:-X*C\$SZKX!OKGX677B64Z=J4OBB
MZCQHD$%M,%>2XN'PZH%QY;+E@3BOPB_X(1?\$Q(/VO/BS=?M-?&NTDT']F?X
M$ >+-4U+4_M,5MXAOM)B;4[:6RQ_K;6V6%I+O8DA\I7PK$;3P?\ P7G_ ."G
MT?[<WQJD^$?PGOM6A_9E^"5P?#GA73--T_5+7P[XDN["Z%O'K+(+>.)C:F%8
M(W=BJQQJN<#->S6RG,,;QI2RK)^)>(*M#!UUF'$-6IC)2P>!IRJ1J4<KHPC:
M,J]=6BX2=J=/=64DLE4A##.I4HTDY+DHI17--I).HVU\*WONV?H/\1?^"7/[
M+_AO_@BCH?[7MIX:$7QJN?"EKK-QK1+[Y+F=I>"#Q@($SR!C&"2"!_)S82O/
M96LSG+RV\4C'_:= Q_4U_?5\=_\ E6^T#_LGFE?^BC7\".E?\@VP_P"O2W_]
M%+7T?A]C\;F&&XBGC<36Q,J'$N84*#K3<W2H0Y>2C3YOAIP^S%:(SQ,8QE1Y
M8J-Z$9.RM=OENWYLOT445^@'.%%%% !7]7W_  :)?\G:_M7?]DI\/_\ IWL*
M_E!K^K[_ (-$O^3M?VKO^R4^'_\ T[V%?%>(W_)#\2?]@5+_ -3L(;X7_>J/
MK+\D?Z 5%%%?Q8?0A1110 5\ ?\ !6+_ )19?\%+/^S /VR/_6=?B-7W_7P!
M_P %8O\ E%E_P4L_[, _;(_]9U^(U '^(-1110!_I]_\&5/_ "BR^/G_ &?_
M /%/_P!9U_95K^OVOY O^#*G_E%E\?/^S_\ XI_^LZ_LJU_7[0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"GPZU/P=XT\7S>&['3;70+JSFM]2L=6N+F&2[N[LVBB:-92Y5G+!AOK]-/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#X _X*I_\HZ?VP_\ LB'BS_T5#7^1
M)X=_Y >F?]>J?S-?Z[?_  53_P"4=/[8?_9$/%G_ **AK_(D\._\@/3/^O5/
MYFOZ:\#/^1%GG_8VH?\ J&CQ\R_BTO\ KW+_ -*1M4445^W'GA1110 4444
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M>D^ ?%%MI^D:'9165I;0QZ#?A$58QO?:  &E=WP -V ,?XWWBO\ Y'WXF?\
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MU^. :9.;>ZN[.3M/8W4]G<*.X6>W>.50>X# &C=.#O6[O%N!R+U+N=;]7/\
MRT6]5Q<K+_TT$@?WKPL5DBQ..S3&O$R@\SR1Y*Z2I)^QBU57UE3YUSR_>O\
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MKQ&_Y(?B3_L"I?\ J=A#?"_[U1]9?DC_ $ J***_BP^A"BBB@ KX _X*Q?\
M*++_ (*6?]F ?MD?^LZ_$:OO^O@#_@K%_P HLO\ @I9_V8!^V1_ZSK\1J /\
M0:BBB@#_ $^_^#*G_E%E\?/^S_\ XI_^LZ_LJU_7[7\@7_!E3_RBR^/G_9__
M ,4__6=?V5:_K]H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^ /^"J?_
M "CI_;#_ .R(>+/_ $5#7^1)X=_Y >F?]>J?S-?Z[/\ P55=(_\ @G/^V*\C
M*B+\#_%A9W8*JCRH>68D #W)K_(7\.ZII@T33,ZA9?\ 'JG_ "\P^I_VZ_IO
MP+3>19Y9-_\ "M0V3?\ S!H\?,FE5I7=OW<M_P#$CJ:*H?VKIG_00LO_  *A
M_P#BZ/[5TS_H(67_ (%0_P#Q=?M_++^67W/^NJ^\\ZZ[K[T7Z*H?VKIG_00L
MO_ J'_XNC^U=,_Z"%E_X%0__ !='++^67W/^NJ^\+KNOO1?HJA_:NF?]!"R_
M\"H?_BZ/[5TS_H(67_@5#_\ %T<LOY9?<_ZZK[PNNZ^]'U!^QOXF\/>"_P!J
M;X->*_%VK6V@^&=%\4Z?=ZOK-X=MK86T=[;O)-,W&%5%9B<\ 5]I_P#!0_XN
M?"[XC_\ !732/C#X!\:Z5XH^%</C?X17TWCC3V+:3'9:--;'5;EGR3LL51C,
M<\8Q7Y$OJ.DRHT<E]8.C##(US 58>A!?!ID=[HT,/V>*[T^.###RDN(%CPWW
MAM#XP>_K7F5LJA6S*.9RG6C5668G*_9QC'V?L<54I5)5;N+E[6+IQ45?D:>J
MU'SVCRWC;GC4O?6\5:WHU\[G[!_\%J?C!\+/C?\ M>IXQ^#_ (VTGQ_X4'AO
M2;4ZYHSE[07,.E6L4L.23\R2HR$9ZJ?I7PW^RU\9O!?P&^+.D^/OB!\-M#^+
M'ABR=3?>$?$-L;JQND P1Y0Y)[D#D],BOF""\T6V3R[>[T^%,YV1W$"KDG).
M _KS4W]JZ9_T$++_ ,"H?_BZ,)E-'"93A\F3KU<-0PD<&IR;IUITU%1NYTN7
MDFU:TJ?*U=6&ZG-.52\5*4N?1W2>EM]UIU]#^AJZ_P""NW[$\PO?*_X)W_"*
M)IXIT@_XI]\0O("(V!_V#@]*_#?XN>,]'^(WQ,\6>.?#WANP\':)XAOFNM/\
M+:7%Y.GZ/"6<K;VT7\" , 1QTZ5Y;_:NF?\ 00LO_ J'_P"+H_M73/\ H(67
M_@5#_P#%UGEN0X'*IU*F"IXJ,JL(PG[?%XK%+E337*J]2:B[V=XI-WM>P2JR
MFDIR@TM5:,8ZJW;T^\_:G_@E)J_[(?B+1OBK\)?CO\0H_P!GSXOWVE3ZG\(?
MVB;NXDLK'PWK;AA9VT]W&\9'EN4RI8@ =*_18_'3PS_P3B^ _P ;/%OCW]O?
M2/V]_P!J'XH>'IO#?PL3P_J\NIZ/X%TZX@>VDO[V(RR!);BW?[P 8LP]\?R<
M7-UH=Y&(KJYTVXC!R$EGMW4'U 9R,^]-BN-"@D\Z*YTY)=H3S!/;AP@^Z@8-
MG:HZ#M7F8_A.GF.,K5Z^.Q;P>)JT*V)RZ6'PM6$Y4'!JG1Q=2D\9A<-7E"$L
M1AZ%2-.HU:R4G>X5W"*C%03BFHS4I)I2ZN*?+*27PMWMOOM_1K_P1.^&/[$N
MG^(_'W[6W[5'[1GPE\&?&_3K[5-2^#OP\^(K>9X=M?$^JM+?1ZYX@LF++/\
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MM/$4+-/]['KZG^E#1117\0'T@4444 %%%% !1110!Q'Q,_Y)O\0?^Q(\5_\
MIAOZ_P 8[Q7_ ,C[\3/^RE>.?_4AOJ_V<?B:0/AO\022 !X'\6$D\  :#?Y)
M/8"O\7_Q7JFFCQ]\3 =0L@1\2_'((^U0\$>(;[/\=?T1X$)N'$]DWKE.RO\
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M_:NF?]!"R_\  J'_ .+HY9?RR^Y_UU7WA==U]Z+]%4/[5TS_ *"%E_X%0_\
MQ=']JZ9_T$++_P "H?\ XNCEE_++[G_75?>%UW7WHOT50_M73/\ H(67_@5#
M_P#%T?VKIG_00LO_  *A_P#BZ.67\LON?]=5]X77=?>B_15#^U=,_P"@A9?^
M!4/_ ,71_:NF?]!"R_\  J'_ .+HY9?RR^Y_UU7WA==U]Z+]%4/[5TS_ *"%
ME_X%0_\ Q=']JZ9_T$++_P "H?\ XNCEE_++[G_75?>%UW7WHOT50_M73/\
MH(67_@5#_P#%T?VKIG_00LO_  *A_P#BZ.67\LON?]=5]X77=?>B_7]7W_!H
ME_R=K^U=_P!DI\/_ /IWL*_DR_M73/\ H(67_@5#_P#%U_6+_P &AEY:7/[6
MW[5ZV]S!.R_"CP\6$,T<A .KV !(1B0"01D\9KXGQ'C)<#<2-II?4J.K3M_O
MN$-\(T\51LUN^OD?Z!5%%%?Q6?1!1110 5\ ?\%8O^467_!2S_LP#]LC_P!9
MU^(U??\ 7P!_P5B_Y19?\%+/^S /VR/_ %G7XC4 ?X@U%%% '^GW_P &5/\
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M+\^[/QI_X< ?\$G_ /HU+PK_ .#'5_\ Y+H_X< ?\$G_ /HU+PK_ .#'5_\
MY+K]EJ*/]:^)_P#HH<Z_\.>,\O\ I]Y(/J]#_GS2_P# (_Y>7Y]V?C3_ ,.
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M_3[R0?5Z'_/FE_X!'_+R_/NS\:?^' '_  2?_P"C4O"O_@QU?_Y+H_X< ?\
M!)__ *-2\*_^#'5__DNOV6HH_P!:^)_^BASK_P .>,\O^GWD@^KT/^?-+_P"
M/^7E^?=GXT_\. /^"3__ $:EX5_\&.K_ /R71_PX _X)/_\ 1J7A7_P8ZO\
M_)=?LM11_K7Q/_T4.=?^'/&>7_3[R0?5Z'_/FE_X!'_+R_/NS\:?^' '_!)_
M_HU+PK_X,=7_ /DNC_AP!_P2?_Z-2\*_^#'5_P#Y+K]EJ*/]:^)_^BASK_PY
MXSR_Z?>2#ZO0_P"?-+_P"/\ EY?GW9^-/_#@#_@D_P#]&I>%?_!CJ_\ \ET?
M\. /^"3_ /T:EX5_\&.K_P#R77[+44?ZU\3_ /10YU_X<\9Y?]/O)!]7H?\
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MU/%5L/[7V=^3VGLIPY^3FER\U[<SMNR)4X3MSPC.VW-%2M>U[73WLC\:?^'
M'_!)_P#Z-2\*_P#@QU?_ .2Z/^' '_!)_P#Z-2\*_P#@QU?_ .2Z_9:BN_\
MUKXG_P"BASK_ ,.>,\O^GWDB/J]#_GS2_P# (_Y>7Y]V?C3_ ,. /^"3_P#T
M:EX5_P#!CJ__ ,ET?\. /^"3_P#T:EX5_P#!CJ__ ,EU^RU%'^M?$_\ T4.=
M?^'/&>7_ $^\D'U>A_SYI?\ @$?\O+\^[/QI_P"' '_!)_\ Z-2\*_\ @QU?
M_P"2Z/\ AP!_P2?_ .C4O"O_ (,=7_\ DNOV6HH_UKXG_P"BASK_ ,.>,\O^
MGWD@^KT/^?-+_P  C_EY?GW9^-/_  X _P""3_\ T:EX5_\ !CJ__P ET?\
M#@#_ ()/_P#1J7A7_P &.K__ "77[+44?ZU\3_\ 10YU_P"'/&>7_3[R0?5Z
M'_/FE_X!'_+R_/NS\:?^' '_  2?_P"C4O"O_@QU?_Y+H_X< ?\ !)__ *-2
M\*_^#'5__DNOV6HH_P!:^)_^BASK_P .>,\O^GWD@^KT/^?-+_P"/^7E^?=G
MXT_\. /^"3__ $:EX5_\&.K_ /R71_PX _X)/_\ 1J7A7_P8ZO\ _)=?LM11
M_K7Q/_T4.=?^'/&>7_3[R0?5Z'_/FE_X!'_+R_/NS\:?^' '_!)__HU+PK_X
M,=7_ /DNC_AP!_P2?_Z-2\*_^#'5_P#Y+K]EJ*/]:^)_^BASK_PYXSR_Z?>2
M#ZO0_P"?-+_P"/\ EY?GW9^-/_#@#_@D_P#]&I>%?_!CJ_\ \ET?\. /^"3_
M /T:EX5_\&.K_P#R77[+44?ZU\3_ /10YU_X<\9Y?]/O)!]7H?\ /FE_X!'_
M "\OS[L_&G_AP!_P2?\ ^C4O"O\ X,=7_P#DNC_AP!_P2?\ ^C4O"O\ X,=7
M_P#DNOV6HH_UKXG_ .BASK_PYXSR_P"GWD@^KT/^?-+_ , C_EY?GW9^-/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %? '_  5B_P"467_!2S_LP#]LC_UG7XC5]_U\ ?\ !6+_ )19?\%+
M/^S /VR/_6=?B-0!_B#4444 ?Z??_!E3_P HLOCY_P!G_P#Q3_\ 6=?V5:_K
M]K^0+_@RI_Y19?'S_L__ .*?_K.O[*M?U^T %%13S);PS7$A(C@BDFD(&2$B
M0NQ [G:IP.]?Q:_%K]N_]O7_ (*0_P#!1;XJ?L5?LO?%GPW^S?X%^#MU>K)K
M_B%DT^\U4V/F;Y\RXENG<Q82"-9)9/E5%)(!^@R#AW$Y_/&NGB,-@L)EN%>,
MQ^-Q<IJCAJ'.J:DXTXSJ5)2G)1481;W;MURJUHTE&ZE*4Y<L(QM>3M?K9));
MML_M/HK^9K_@G]XO_P""L7[/'[7FK_LQ_M;V"_&GX%ZUHUS<Z%\;M$_>66F2
MK;F;^T9;D1;1"JDL\!<2;8RNT-P+_P"R3\8/@E^S;\:_V\?C=XF_X*&CX[:)
MILNI//\ #.ZCU"[A^#VK6[2R6^F^01(&\R6/[*!&-A9OF8*&:N[$<)5:,\9"
MEF&&Q_L<)@\7@IY;1Q&.I8^.-KQH4Z;J4:;^I58MR;ABU3;<>2-Y22(5=/EO
M!PO*49*;47!Q5WH_B[>[?[C^E:BOYA_^"3?_  7;M/VP_C7\3?A'\=?$GAW0
M-8/BBZT[X.Z?I6A36\GB721?30VLTT\,0"2O B-B7)+'!(!)K]<?VNO^"G_[
M'G[$^J6GAKXW?$VUT[QC?0175KX1TBWFU;6S;2E2)[BVLUE:VC\MA(/,&XK@
M[0#D<>8<*9]EV:+)JV7XBKCY4H5J='#4JE?VM*<(S]I2<8+GA#F4:DTN6$TX
MR::94*]*</:*:4+VNVE9]GJ]3]!Z*^6?V:OVTOV;?VN/!5WX]^!/Q,T3QCH.
MF0"?6C'(UI>:)B+S94U2TN DMJT RLI8% 5.&(KXD^(__!=+_@G+\,OB/<?#
M77?C3%=ZII=_)IGB'5-)TJ]O]$T"\CE:%HK_ %"*,P+LD5E=BZ*N"06KBH9%
MG.)Q-?!X?*LPK8K"J^)P]/"5I5J'_7VFH<T&[>ZI).6T;LMU*<4I.<5&7PMR
M5GZ=S]@:*X#X8_%+X?\ QE\%:)\1/ACXITGQCX.\16D=]I&N:-=1W5I=6\HR
MIRC%HWQ]Z.0*Z]UKS+]I7]K'X!_LB^!9/B-\?OB%I'@+PPLIMX;B_D#W5[<[
M0PM[*SC/G3RME0H4!=S*"PS7%3PF*JXA8.EAZ]3%RJ.DL-"E.5=U4VG35)1<
M^=--./+=-.ZT*<HI<S:4;7YFU:W>^UO,^C**_./]DO\ X*L_L4_MH>(KOP9\
M%OBO8WWC2SBFNG\*ZS#)H^JRV4(W"[MHKT1":*2/#H%^9LX4,:_F _X+G?\
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M?^"Z7_!-KQ7\4T^%&E_'C3AJUSJ*Z-IVM7-A=P>'=2UDS) VG6NJ.@@:19'
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MXQ4J:L^9]'IN2J]-U(TXM2YE+WHM-)QM=.W74_HDHK^4?_@NA^VW\=?V8O\
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M?BSXV65]XATZ]ELO$S^';"[UK3_"[Q,48ZM?6<;V\;!U8% _RA<EL\#ZW?\
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M-X;\-Z1%I&B:5:(L=M8:=9PF.WMH$4!5CB0!5  K^*[_ ((\6EK%_P %0_\
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MQU\.OVD_BUX ^&/Q'U/4]5\:?"/0I$M]"U9]46036+F*ZB#6<9D9H]_S$\%
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MV5&\D.R+;LOS\<[A7ZM?\%"_#&L?L:_\$S?$'[.W[)OP:\6>/M3UKP8WPO\
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MPH.K!ZWA.5-RB[NZ:=]3IPL'"A3C)-.UVGHU=WL_-!1117R9T!1110 4444
M%? '_!6+_E%E_P %+/\ LP#]LC_UG7XC5]_U\ ?\%8O^467_  4L_P"S /VR
M/_6=?B-0!_B#4444 ?Z??_!E3_RBR^/G_9__ ,4__6=?V5:_K]K^0+_@RI_Y
M19?'S_L__P"*?_K.O[*M?U^T %%4]1GN;;3[ZXLK8WMY!:7$UK9AQ&;JYCA=
MX;?>>$\Z0+'N/"[L]J_&OQC^VW_P4^T7Q7KVD>&O^"8EYXE\/:??RV^D>(5^
M*^E6JZO:([".[%LT1:'S%"ML))&[!Y%>A@,LQ.9.I'#SP<'22<GB\?@L"GS.
MR4'C*]%5'?=0YFNMKD2G&%K\VO\ +&4NV_*G;?J?M!17X>?\-W?\%6?^D5-[
M_P"'>TC_ .,T?\-W?\%6?^D5-[_X=[2/_C->G_JOF7_/_)?_  _Y+_\ -_FO
MO(]O#M4_\%5/_D?ZL_*_[AT5^'G_  W=_P %6?\ I%3>_P#AWM(_^,T?\-W?
M\%6?^D5-[_X=[2/_ (S1_JOF7_/_ "7_ ,/^2_\ S?YK[P]O#M4_\%5/_D?Z
ML_*_[AT5^'G_  W=_P %6?\ I%3>_P#AWM(_^,T?\-W?\%6?^D5-[_X=[2/_
M (S1_JOF7_/_ "7_ ,/^2_\ S?YK[P]O#M4_\%5/_D?ZL_*_[AT5^'G_  W=
M_P %6?\ I%3>_P#AWM(_^,T?\-W?\%6?^D5-[_X=[2/_ (S1_JOF7_/_ "7_
M ,/^2_\ S?YK[P]O#M4_\%5/_D?ZL_*_[AT5^'G_  W=_P %6?\ I%3>_P#A
MWM(_^,T?\-W?\%6?^D5-[_X=[2/_ (S1_JOF7_/_ "7_ ,/^2_\ S?YK[P]O
M#M4_\%5/_D?ZL_*_[AT5^'G_  W=_P %6?\ I%3>_P#AWM(_^,T?\-W?\%6?
M^D5-[_X=[2/_ (S1_JOF7_/_ "7_ ,/^2_\ S?YK[P]O#M4_\%5/_D?ZL_*_
M[AT5^'G_  W=_P %6?\ I%3>_P#AWM(_^,T?\-W?\%6?^D5-[_X=[2/_ (S1
M_JOF7_/_ "7_ ,/^2_\ S?YK[P]O#M4_\%5/_D?ZL_*_[AT5^'G_  W=_P %
M6?\ I%3>_P#AWM(_^,T?\-W?\%6?^D5-[_X=[2/_ (S1_JOF7_/_ "7_ ,/^
M2_\ S?YK[P]O#M4_\%5/_D?ZL_*_[AT5^'G_  W=_P %6?\ I%3>_P#AWM(_
M^,T?\-W?\%6?^D5-[_X=[2/_ (S1_JOF7_/_ "7_ ,/^2_\ S?YK[P]O#M4_
M\%5/_D?ZL_*_[AT5^'G_  W=_P %6?\ I%3>_P#AWM(_^,T?\-W?\%6?^D5-
M[_X=[2/_ (S1_JOF7_/_ "7_ ,/^2_\ S?YK[P]O#M4_\%5/_D?ZL_*_[AT5
M^'G_  W=_P %6?\ I%3>_P#AWM(_^,T?\-W?\%6?^D5-[_X=[2/_ (S1_JOF
M7_/_ "7_ ,/^2_\ S?YK[P]O#M4_\%5/_D?ZL_*_[AT5^'G_  W=_P %6?\
MI%3>_P#AWM(_^,T?\-W?\%6?^D5-[_X=[2/_ (S1_JOF7_/_ "7_ ,/^2_\
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MW>K#VU/M/7?]U4\M_=Z?IZ7_ '#HK\//^&[O^"K/_2*F]_\ #O:1_P#&:/\
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M"K/_ $BIO?\ P[VD?_&:/^&[O^"K/_2*F]_\.]I'_P 9J?\ 5?,O^?\ DO\
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M^5_W#HK\//\ AN[_ (*L_P#2*F]_\.]I'_QFC_AN[_@JS_TBIO?_  [VD?\
MQFC_ %7S+_G_ )+_ .'_ "7_ .;_ #7WA[>':I_X*J?_ "/]6?E?]PZ*_#S_
M (;N_P""K/\ TBIO?_#O:1_\9H_X;N_X*L_](J;W_P .]I'_ ,9H_P!5\R_Y
M_P"2_P#A_P E_P#F_P U]X>WAVJ?^"JG_P C_5GY7_<.BOP\_P"&[O\ @JS_
M -(J;W_P[VD?_&:/^&[O^"K/_2*F]_\ #O:1_P#&:/\ 5?,O^?\ DO\ X?\
M)?\ YO\ -?>'MX=JG_@JI_\ (_U9^5_W#HK\//\ AN[_ (*L_P#2*F]_\.]I
M'_QFC_AN[_@JS_TBIO?_  [VD?\ QFC_ %7S+_G_ )+_ .'_ "7_ .;_ #7W
MA[>':I_X*J?_ "/]6?E?]PZ*_#S_ (;N_P""K/\ TBIO?_#O:1_\9H_X;N_X
M*L_](J;W_P .]I'_ ,9H_P!5\R_Y_P"2_P#A_P E_P#F_P U]X>WAVJ?^"JG
M_P C_5GY7_<.BOP\_P"&[O\ @JS_ -(J;W_P[VD?_&:/^&[O^"K/_2*F]_\
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M;W_P[VD?_&:/^&[O^"K/_2*F]_\ #O:1_P#&:/\ 5?,O^?\ DO\ X?\ )?\
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M[VD?_&:/^&[O^"K/_2*F]_\ #O:1_P#&:/\ 5?,O^?\ DO\ X?\ )?\ YO\
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M:/\ 5?,O^?\ DO\ X?\ )?\ YO\ -?>'MX=JG_@JI_\ (_U9^5_W#HK\//\
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MOOY@ZM-VO&;MM>E4=MO[G]6]+_N"B)&JHBJB(JHB(H5410 JJH "JH "J
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M9@&;F(?=4EL=\4?ZKYE_S_R7_P /^2__ #?YK[P]O#M4_P#!53_Y'^K/RO\
MN)17DWP0\7_$3QU\-_#_ (F^*OP\?X5^-]1B9]8\$/J4>KMH\@"[8S?Q 1S[
MLMRHQ\M>LU\_5IRI5)TIN+E3E*$G"<*D&XNS<:E.4H3B^DH2E&2U3:-4[I/N
MD]='KW70****@85\ ?\ !6+_ )19?\%+/^S /VR/_6=?B-7W_7P!_P %8O\
ME%E_P4L_[, _;(_]9U^(U '^(-1110!_I]_\&5/_ "BR^/G_ &?_ /%/_P!9
MU_95K^OVOY O^#*G_E%E\?/^S_\ XI_^LZ_LJU_7[0 45POQ0\2WW@SX;>/_
M !?ID4,^H^%_!OB7Q!807.?L\UYH^CWFH6T4^.?*>:W19,<[2:_C)'_!QQ^V
M<9+E/^%9?"7]S>7=N!Y-YD"WN9(5!/F<G:@R0 ">@K]5\./!KC;Q4H9KB.$J
M&6UJ635<)1QSQ^8T<"XSQL*\Z'LXU4W43CAZG,U91?*GN?G''GBIPEX<5<NH
M\35\=1GFM/$5,)]4P4\4I1PTJ4*O.XRBH-.M"R=[IM[(_MPHK^)'_B(W_;._
MZ)E\)?\ OS>?_':/^(C?]L[_ *)E\)?^_-Y_\=K]*_XE#\9?^@+A[_Q(,+_\
M@?GW_$T'A3_T&YU_X9ZO_P M\_S[,_MNHK^)'_B(W_;._P"B9?"7_OS>?_':
M/^(C?]L[_HF7PE_[\WG_ ,=H_P")0_&7_H"X>_\ $@PO_P @'_$T'A3_ -!N
M=?\ AGJ__+?/\^S/[;J*_B1_XB-_VSO^B9?"7_OS>?\ QVC_ (B-_P!L[_HF
M7PE_[\WG_P =H_XE#\9?^@+A[_Q(,+_\@'_$T'A3_P!!N=?^&>K_ /+?/\^S
M/[;J*_B1_P"(C?\ ;._Z)E\)?^_-Y_\ ':/^(C?]L[_HF7PE_P"_-Y_\=H_X
ME#\9?^@+A[_Q(,+_ /(!_P 30>%/_0;G7_AGJ_\ RWS_ #[,_MNHK^)'_B(W
M_;._Z)E\)?\ OS>?_':/^(C?]L[_ *)E\)?^_-Y_\=H_XE#\9?\ H"X>_P#$
M@PO_ ,@'_$T'A3_T&YU_X9ZO_P M\_S[,_MNHK^)'_B(W_;._P"B9?"7_OS>
M?_':/^(C?]L[_HF7PE_[\WG_ ,=H_P")0_&7_H"X>_\ $@PO_P @'_$T'A3_
M -!N=?\ AGJ__+?/\^S/[;J*_B1_XB-_VSO^B9?"7_OS>?\ QVC_ (B-_P!L
M[_HF7PE_[\WG_P =H_XE#\9?^@+A[_Q(,+_\@'_$T'A3_P!!N=?^&>K_ /+?
M/\^S/[;J*_B1_P"(C?\ ;._Z)E\)?^_-Y_\ ':/^(C?]L[_HF7PE_P"_-Y_\
M=H_XE#\9?^@+A[_Q(,+_ /(!_P 30>%/_0;G7_AGJ_\ RWS_ #[,_MNHK^)'
M_B(W_;._Z)E\)?\ OS>?_':/^(C?]L[_ *)E\)?^_-Y_\=H_XE#\9?\ H"X>
M_P#$@PO_ ,@'_$T'A3_T&YU_X9ZO_P M\_S[,_MNHK^)'_B(W_;._P"B9?"7
M_OS>?_':/^(C?]L[_HF7PE_[\WG_ ,=H_P")0_&7_H"X>_\ $@PO_P @'_$T
M'A3_ -!N=?\ AGJ__+?/\^S/[;J*_B1_XB-_VSO^B9?"7_OS>?\ QVC_ (B-
M_P!L[_HF7PE_[\WG_P =H_XE#\9?^@+A[_Q(,+_\@'_$T'A3_P!!N=?^&>K_
M /+?/\^S/[;J*_B1_P"(C?\ ;._Z)E\)?^_-Y_\ ':/^(C?]L[_HF7PE_P"_
M-Y_\=H_XE#\9?^@+A[_Q(,+_ /(!_P 30>%/_0;G7_AGJ_\ RWS_ #[,_MNH
MK^)'_B(W_;._Z)E\)?\ OS>?_':_9O\ X(\_\%+OC=^WYKGQJTWXM^%O!_AV
M#X=V>AW&COX72='N9-2G\J=;L3,P(C7E"O4GH,<_,\8?1O\ $W@;AW,>*<_P
MN34\IRN-"6+GA<YP^*KI8C$T<)2]G0A%2J-UJ]--)Z1;ELCZ'A;QZ\/N,<\P
M/#N2XK,ZF99A*K'#0Q&6U*%)NC0J8B?/5E4DHI4Z4VFT[RM'=G[IT445^#'[
M.%%%% !1110 4444 %%%?QK?&/\ X."_VOOA_P#&'XI^ -(^''PLN=)\$^.O
M$'AG3)[J*\-U-9:5?36UO+<L) IFDC16?:  Q(Q7Z3X<>%/%WBGB<UPG"5'
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M-_VSO^B9?"7_ +\WG_QVC_B(W_;._P"B9?"7_OS>?_':/^)0_&7_ * N'O\
MQ(,+_P#(!_Q-!X4_]!N=?^&>K_\ +?/\^S/[;J*_B1_XB-_VSO\ HF7PE_[\
MWG_QVC_B(W_;._Z)E\)?^_-Y_P#':/\ B4/QE_Z N'O_ !(,+_\ (!_Q-!X4
M_P#0;G7_ (9ZO_RWS_/LS^VZBOXD?^(C?]L[_HF7PE_[\WG_ ,=H_P"(C?\
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M_P#RWS_/LS^VZBOXD?\ B(W_ &SO^B9?"7_OS>?_ !VC_B(W_;._Z)E\)?\
MOS>?_':/^)0_&7_H"X>_\2#"_P#R ?\ $T'A3_T&YU_X9ZO_ ,M\_P ^S/[;
MJ*_B1_XB-_VSO^B9?"7_ +\WG_QVO3_@=_P<"?M=_$CXV?";X<ZU\.?A;;:-
MXY\=:%X:U6XLXKL7D%CJ=Y';W$ULS2%1-&CEDW @G K#%?1,\8,'A<3C*^#X
M?5'"8>OBJSCG^%E)4L/2G6J.,5"\I*$)6BMW9=3HPOTF/"W&8G#X2AC,X=;$
MUJ="DI935C%U*LXP@FW5TO*26S?1)O0_L?HHHK^9S^@ HHHH **** "BBB@
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M^S/[;J*_B1_XB-_VSO\ HF7PE_[\WG_QVC_B(W_;._Z)E\)?^_-Y_P#':/\
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M_P"B9?"7_OS>?_':/^)0_&7_ * N'O\ Q(,+_P#(!_Q-!X4_]!N=?^&>K_\
M+?/\^S/[;J*_B1_XB-_VSO\ HF7PE_[\WG_QVC_B(W_;._Z)E\)?^_-Y_P#'
M:/\ B4/QE_Z N'O_ !(,+_\ (!_Q-!X4_P#0;G7_ (9ZO_RWS_/LS^VZBOXD
M?^(C?]L[_HF7PE_[\WG_ ,=H_P"(C?\ ;._Z)E\)?^_-Y_\ ':/^)0_&7_H"
MX>_\2#"__(!_Q-!X4_\ 0;G7_AGJ_P#RWS_/LS^VZBOXD?\ B(W_ &SO^B9?
M"7_OS>?_ !VC_B(W_;._Z)E\)?\ OS>?_':/^)0_&7_H"X>_\2#"_P#R ?\
M$T'A3_T&YU_X9ZO_ ,M\_P ^S/[;J*_B1_XB-_VSO^B9?"7_ +\WG_QVC_B(
MW_;._P"B9?"7_OS>?_':/^)0_&7_ * N'O\ Q(,+_P#(!_Q-!X4_]!N=?^&>
MK_\ +?/\^S/[;J*_B1_XB-_VSO\ HF7PE_[\WG_QVC_B(W_;._Z)E\)?^_-Y
M_P#':/\ B4/QE_Z N'O_ !(,+_\ (!_Q-!X4_P#0;G7_ (9ZO_RWS_/LS^VZ
MBOXD?^(C?]L[_HF7PE_[\WG_ ,=H_P"(C?\ ;._Z)E\)?^_-Y_\ ':/^)0_&
M7_H"X>_\2#"__(!_Q-!X4_\ 0;G7_AGJ_P#RWS_/LS^VZBOXD?\ B(W_ &SO
M^B9?"7_OS>?_ !VG1?\ !QM^V:]U80-\,OA*%NM1L+1SY-[G9=744+[2).&V
MN=I/ /-#^B'XRI-_4N'M/^J@PO\ \@5'Z3_A5*48K&9S>345_P )%7=M)+^+
MW:/[;**X_P"'FOWGBOP!X'\4ZA%%#?\ B3PAX:UZ]A@SY,5WK&C66H7,<.>?
M*CFN'6//.P"NPK^9*U*="M5H5+<]&I.E.SNN>G)PE9]5=.SZK4_H*E5C6I4J
MT+\E6G"K"ZL^6I%3C=/5.S5UT>@4445F:!7P!_P5B_Y19?\ !2S_ +, _;(_
M]9U^(U??]? '_!6+_E%E_P %+/\ LP#]LC_UG7XC4 ?X@U%%% '^GW_P94_\
MHLOCY_V?_P#%/_UG7]E6OZ_:_D"_X,J?^467Q\_[/_\ BG_ZSK^RK7]?M 'D
MGQ]_Y(;\8O\ LF'CO_U&=3K_ "[E_P"/C4O^PMJG_I=/7^HC\??^2&_&+_LF
M'CO_ -1G4Z_R[E_X^-2_["VJ?^ET]?Z'?0>_Y%'B)_V,.'?_ %'S4_ACZ8?^
M_<#?]@F=_P#I[+R2BBBO[J/XN"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *_J'_P"#9;_D:_VI_P#L'>%/_2ROY>*_J'_X
M-EO^1K_:G_[!WA3_ -+*_!_I,_\ )DN-O^O.4?\ J^RL_:OH\_\ )W>$_P#K
MYF7_ *JL:?UPT445_C^?ZG!1110 4444 %%%% !7^8%^TW_R<W^T+_V5OQC_
M .G6XK_3]K_,"_:;_P"3F_VA?^RM^,?_ $ZW%?W/]!__ )'OB#_V)LD_]3\6
M?QQ],'_D2\%_]C'./_4?+SQ2BBBO]$3^#@HHHH **** "BBB@ HHHH ****
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MZ\Y1_P"K[*S]J^CS_P G=X3_ .OF9?\ JJQI_7#1117^/Y_J<%%%% !1110
M4444 %?Y@7[3?_)S?[0O_96_&/\ Z=;BO]/VO\P+]IO_ ).;_:%_[*WXQ_\
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MMERC6<\1*E];3E.%!J].K?W823_K'A[P<X*SK(^#L/5PW%U+.^*^%ZF=//\
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M>[U"]TWXZ>+-&\/:+ITUR;BPO8]:5!9WMA&RIY<;J&#(5RK(22P(-?56J?\
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M%'2]#N;+78YX8=7>SE,]S9RS)!(;0*\:$[C& 6"\@>$?\%7;7PO#\5/V:_\
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MJ$$UI*VH:C=PV5Q#/#87=]<7%BGE2HY2.UED:")2JE?E08!X]_Z&_A[_ ,%
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ML2L6Z[J_VYC:N,>'=)T*?(L/[7V:J<\O:*/-RQNTBBBBOUL_+ I8?^0AHO\
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M?&WBOQRM@=9M+F[U+RXIK/3[E%>.(J)V.Q""I"D@9KY;_;F_9+_9W\-?M ?
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M<+[=9M/ZU1HX>5++,'3HX>A' TDL2X5G&4:GVT_$;A7'<*9UDU?A_&Y;B?\
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M7^U/_P!@[PI_Z65_+Q7]0_\ P;+?\C7^U/\ ]@[PI_Z65^#_ $F?^3)<;?\
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M^#S;A_@W 4J]>OC<FP6:T,?[:$TJ<L5F=3%8>%.K-OVL/93<GRV4)-QWU?\
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M?$G_  6<^'__  E.F? ?]L=[FXTUOCGX5T^R/@1E,=AX86"T:98;"WP(T@0
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M )(Y\)_^R:^!?_48TNO3*\S^"W_)'/A/_P!DU\"_^HQI=>F5_@KF7_(QQ_\
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M3^&/IA_[]P-_V"9W_P"GLO)****_NH_BX**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K^H?_@V6_P"1K_:G_P"P=X4_]+*_
MEXK^H?\ X-EO^1K_ &I_^P=X4_\ 2ROP?Z3/_)DN-O\ KSE'_J^RL_:OH\_\
MG=X3_P"OF9?^JK&G]<-%%%?X_G^IP4444 %%%% !1110 5_F!?M-_P#)S?[0
MO_96_&/_ *=;BO\ 3]K_ # OVF_^3F_VA?\ LK?C'_TZW%?W/]!__D>^(/\
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M?B3_ ,.V'\O^H+U_K;^E[_B'E_;[_P"@I\(__"FB_P :/^(>7]OO_H*?"/\
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MMOZ7O^(>7]OO_H*?"/\ \*:+_&C_ (AY?V^_^@I\(_\ PIHO\:_FA_X>,_\
M!0S_ *//^.7_ (4]Q_\ %T?\/&?^"AG_ $>?\<O_  I[C_XNC_B)_CK_ -%!
MP%_XC.-_^:P_XEK\*O\ H'XD_P##MA_+_J"]?ZV_I>_XAY?V^_\ H*?"/_PI
MHO\ &C_B'E_;[_Z"GPC_ /"FB_QK^:'_ (>,_P#!0S_H\_XY?^%/<?\ Q='_
M  \9_P""AG_1Y_QR_P#"GN/_ (NC_B)_CK_T4' 7_B,XW_YK#_B6OPJ_Z!^)
M/_#MA_+_ *@O7^MOZ7O^(>7]OO\ Z"GPC_\ "FB_QH_XAY?V^_\ H*?"/_PI
MHO\ &OYH?^'C/_!0S_H\_P".7_A3W'_Q='_#QG_@H9_T>?\ '+_PI[C_ .+H
M_P"(G^.O_10<!?\ B,XW_P":P_XEK\*O^@?B3_P[8?R_Z@O7^MOZ7O\ B'E_
M;[_Z"GPC_P#"FB_QH_XAY?V^_P#H*?"/_P *:+_&OYH?^'C/_!0S_H\_XY?^
M%/<?_%T?\/&?^"AG_1Y_QR_\*>X_^+H_XB?XZ_\ 10<!?^(SC?\ YK#_ (EK
M\*O^@?B3_P .V'\O^H+U_K;^E[_B'E_;[_Z"GPC_ /"FB_QK]L?^",?_  3A
M_:&_80UWXX:C\;[OP=<6WQ!LM"@T$>%M474I%ETZX\VY:[VG$2LIQ&-O)!YY
MK_/P_P"'C/\ P4,_Z//^.7_A3W'_ ,77]8O_  :G?M+_ +2'Q^\8_MA6OQX^
M-_CWXNV_ANT\(-X>A\9ZK+J4>BM<W$8N&L%D9A"9E)63;C<#]<_GGBMQWXLY
MQP#Q!E_$><\(8K)L13P*QM#+<BQ6#QM10S+"5*7L,14Q-2%-QKPIRFY0?-34
MHJSDFOIN#O _P^X2XBR[/\FHYW#,L Z\L-+%YC1KX>]7#U*$_:4X86G*2]G5
MG:TXVE9N]K+^S>BBBOXE/WL**** "BBB@ HHHH *_BI^,_\ P0/_ &Z/'GQG
M^+'CS0]3^%2Z)XS\>^(?$>D"Z\1QQ70T[4[^:YM5N(B28YEB=1(IZ-FO[5J_
MR=/VJ/\ @H)^WQH'[6'[3GA[0?VO_C5I&@:%\:?&>EZ)H]GXEN([+2M-MM1D
M6VL;2+?B."!,)&@P H'&<Y_H/P XDXVX<S#B6KP7C\CP-?%8'+X8^6=Y;6S&
M%2C3Q->5&.'C1JTG2G&I.;J2DVI1<4E=7/S7Q'\/>&/$##Y7AN)89C.EEU;$
MU<*LOQ5/"RY\1&A&K[5U*-927+1ARV47'WE>TF?O;_Q#R_M]_P#04^$?_A31
M?XT?\0\O[??_ $%/A'_X4T7^-?S0_P##QG_@H9_T>?\ '+_PI[C_ .+H_P"'
MC/\ P4,_Z//^.7_A3W'_ ,77]-?\1/\ '7_HH. O_$9QO_S6?E'_ !+7X5?]
M _$G_AVP_E_U!>O];?TO?\0\O[??_04^$?\ X4T7^-'_ !#R_M]_]!3X1_\
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M?\0\O[??_04^$?\ X4T7^-'_ !#R_M]_]!3X1_\ A31?XU_-#_P\9_X*&?\
M1Y_QR_\ "GN/_BZ/^'C/_!0S_H\_XY?^%/<?_%T?\1/\=?\ HH. O_$9QO\
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M\0\O[??_ $%/A'_X4T7^-?S0_P##QG_@H9_T>?\ '+_PI[C_ .+H_P"'C/\
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MW_T%/A'_ .%-%_C7\T/_  \9_P""AG_1Y_QR_P#"GN/_ (NC_AXS_P %#/\
MH\_XY?\ A3W'_P 71_Q$_P =?^B@X"_\1G&__-8?\2U^%7_0/Q)_X=L/Y?\
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M'()5_P"$HN0)(9]9LXIHFQ)RDD;LK#H02#D9%#\3O'5IK_6#@+7_ *IG&_\
MS6./T;?"N,HR6'XD3C*+3_M;#Z-.+3TP7==/PTM_KF_#C0;[PM\/? GAC5&B
M;4O#O@WPQH6H- VZ!K[2=$L;"[,+<[HC/;R&-LG*8.3FNSKRKX%:A?ZM\$O@
M]JNJWD^H:GJ7PN\ 7^HW]RY>XO;Z\\*:3<7=W.YY>:XN)))I6/WG=CWKU6O\
MZL7*<\5B9U'%U)XBM*HXJT7.523FXIW:BY-V5]%9']-T*<:-&C1A?DI4J=.'
M,[RY8048\SZNR5WU>H4445SFH5\ ?\%8O^467_!2S_LP#]LC_P!9U^(U??\
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M\K4FTFK-U$]FME%*^N]V]%8_F,I"0!DD >IX%?M)JW_!-/\ 9:^,?P:^./Q
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M_"3_ ,'@W_)5_P!B?_L6_&7_ *<-0K])\)?^2ZRG_KUF'_J#B#CQ_P#NT_\
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MKBJM%24)SI34N1:VF<'"4E>ZBXQN[*5Y14K..MFKV=FTFK7/GZBOU;_8S_9
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M2S_LP#]LC_UG7XC5]_U\ ?\ !6+_ )19?\%+/^S /VR/_6=?B-0!_B#4444
M?Z??_!E3_P HLOCY_P!G_P#Q3_\ 6=?V5:_K]K^0+_@RI_Y19?'S_L__ .*?
M_K.O[*M?U^T >'?M-_\ )N/QY_[(]\2/_41U>O\ &EM?];JO_8?\0?\ IYO:
M_P!EK]IO_DW'X\_]D>^)'_J(ZO7^-+:_ZW5?^P_X@_\ 3S>U_1_@3_N/$O\
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M)C4E:I*,)67+8%6::M2BDG)NTI7O.R;3:TM;W=[+0_KD_:N_;8^&?P!\1?\
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MNUB"[&+ NXR/7\A;/0K;4_&]IX,DU:WLM,O?&/\ PBDOB9VQ86NG-?-9?\)
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MC'FE>+D^9R4[<R=]+;6/Z1OV_?$_PB^-'@K]AO\ 8N\3?M!^ /BM\7_",/\
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M%% '^GW_ ,&5/_*++X^?]G__ !3_ /6=?V5:_K]K^0+_ (,J?^467Q\_[/\
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MFJ<=E9)--M--;KK>]]C]O_#_ .W5_P $]OV7O@W\>/!G[!_P<^-.@_$CX_\
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MWL]-\-::[)H>GI&ACV/:6FR)@  -N!7SE_:VE_\ 01L?_ J#_P"+H_M;2_\
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MT^"?[*7[&EY\3?@#?^ ]?;Q=\1_%FGZBUE+XMU^ZC9;Y898_FDL6=B8D8D8
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MEZ+\@HHHK 85\ ?\%8O^467_  4L_P"S /VR/_6=?B-7W_7P!_P5B_Y19?\
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M&O\ @E-_T:1X%_[^ZI_\F4?\.&O^"4W_ $:1X%_[^ZI_\F5^OU%=W^M/$O\
MT4&=?^'/&?\ R[R7W$^PH_\ /JG_ . 1\O+R1^0/_#AK_@E-_P!&D>!?^_NJ
M?_)E'_#AK_@E-_T:1X%_[^ZI_P#)E?K]11_K3Q+_ -%!G7_ASQG_ ,N\E]P>
MPH_\^J?_ (!'R\O)'Y _\.&O^"4W_1I'@7_O[JG_ ,F4?\.&O^"4W_1I'@7_
M +^ZI_\ )E?K]11_K3Q+_P!%!G7_ (<\9_\ +O)?<'L*/_/JG_X!'R\O)'Y
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M2_\ 109U_P"'/&?_ "[R7W!["C_SZI_^ 1\O+R1^0/\ PX:_X)3?]&D>!?\
MO[JG_P F4?\ #AK_ ()3?]&D>!?^_NJ?_)E?K]11_K3Q+_T4&=?^'/&?_+O)
M?<'L*/\ SZI_^ 1\O+R1^0/_  X:_P""4W_1I'@7_O[JG_R91_PX:_X)3?\
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M?K]11_K3Q+_T4&=?^'/&?_+O)?<'L*/_ #ZI_P#@$?+R\D?D#_PX:_X)3?\
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M^"4W_1I'@7_O[JG_ ,F5^OU%'^M/$O\ T4&=?^'/&?\ R[R7W!["C_SZI_\
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MIXE_Z*#.O_#GC/\ Y=Y+[C/V%'_GU3_\ CY>7DC\@?\ APU_P2F_Z-(\"_\
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MHH_UIXE_Z*#.O_#GC/\ Y=Y+[@]A1_Y]4_\ P"/EY>2/R!_X<-?\$IO^C2/
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M *.1\*?]^-1_^1J_SQ?L=I_S[0?]^D_PICV]C&-TD%LB^K1H/Z4?\26>&_\
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MFDY6U:3;:3>R;;2ZL****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-$@D1@2"K*5R"""".W?%3?8[3_GV@_[])_A7WW_$EGAQ_P!%%QC_ .#\H_\
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M10 5\ ?\%8O^467_  4L_P"S /VR/_6=?B-7W_7P!_P5B_Y19?\ !2S_ +,
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M,,936.Q\GI[WUC$*;A+33V4::71(CBBBA18X8HX8U 54B18T55&%550!0%'
M   ' XJ2BBOR]MO5N[[L_1=M@HHHH **** "BBB@ HHHH **** "BBB@ KX
M_P""L7_*++_@I9_V8!^V1_ZSK\1J^_Z^ /\ @K%_RBR_X*6?]F ?MD?^LZ_$
M:@#_ !!J*** /]/O_@RI_P"467Q\_P"S_P#XI_\ K.O[*M?U^U_(%_P94_\
M*++X^?\ 9_\ \4__ %G7]E6OZ_: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNXM-5GU&Z4R:S<VTV-]W'(Q>.5AN7H#D5W9;P%E,,YX=R[-,[5:KG-'#8R6
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M;@W&2YH-OE=U=VNW3FJD(S2M=7L^G^?J%%%%>:6%%%% !1110 4444 %%%%
M!7S?^US\<YOV;?V>?B5\:;?3EU>X\#Z,NHV^G."5NII+J"UBB('."\RYQVKZ
M0K\[_P#@JT=O[ _[0DG7R?#%I/CNWDZQ82;1CNVW [Y/'->AE-&GB<TRW#UH
M\]*OCL)1JPNUS4ZE>G"<;IIKFBVKIK<F;:A-K1J,FGYI.Q\$Z)_P4E_;N7P!
M8?&N_P#V3[[Q-\,A8+XAU"W\,V4SZU)X<CMS?7EY:@Y!\BR221N.J_2OUS_9
M1_:B^'W[7GP;\._&;X=I?66D:XDB76BZN%35]#OH)'BGT_4XU5!'<1/&X(VK
MG:3M%?A]\(O^"I6NZ)^R5X4^''@_]FOX@^-/%S_#P^#M"AM8;E;'4=0O]'EL
M+2Y>62VD7[(MQ.CS*'4-$&VE<YKW;]FG]G_XF? '_@G)X[M_C-\2=*_9X\8?
M$R?4_%/BS57C5!X%T_5)KB<Z?IR($8:F;2=RGD RE\D#)K[+.,GPRP]15LOP
MV38M9M1P> ^KXB>(EB\+4E5C6G4P<)UZLO8*-*:JPC&4I3]DE)R2CS4ZCNK2
ME47LW*=XV46DFK2=EKKI\VS]P[/Q+X>U#4+G2;#7-)O-3LPINM/MM0M9[N -
MP#)!'*TBX/#?+\C$*^TD"MB26.)2TLB1J 6+2.J*%499B6(   )))P!R:_B,
M^,/BO]C3X1>#? OQ!_8Y^/7[1/Q!^-_@KQ5IFH>(/&NMZGXHA\)>(KV2]MX+
MU-0MKZW@@EL9Y6F=+93/"B",I,^[:GZ7_P#!2>'XI?'7X]?\$C/ASH7Q.\5_
M#]/C2=0U'X@R>%=7N=+@UJUN_!>A:GJT-U' RB<9NKIK8/GRV8$"N:KP9R8C
M P>.K8?#8N&:2G5Q^75<+7HO*L)+&5F\*ZLYRIUJ<4J4G*$DY+F@K,I8BZFU
M!-Q]G91FI)^TDH+WK633>NZTW/VV^/W[4?PR_9Z^')^)OB>_35_#Z^*-(\)/
M_8EY97$J:IK$S0P*3YI4K&ZCS2N=H9<D9%<O^T9\6OC-H?P:T/Q[^SCX+LO'
MOB;6;C2[E-%O)8)$71[Y(Y9)=Z2B(S1QOD@/PP*XR"*_&'_@J9_P3\^"WP?_
M &+M!TKPUXE^*<L5I\6/!-GOU3QG>:B]VVLZA/\ ;KJY,BQ[K@-&K6SG>8ON
MAL#)]@_:@\ M^R__ ,$_OA9HGPC\=?$/31J_B?PEJ%UK&H>);NYUW-Y#;//9
MQWN?,BL=Q95ME8KLYX)P)PV2Y5.CDV(PN)GBJV,S?$X1T\;A)T\/5HT(4)1]
MHJ>(<HV]I=QA)N?/R\RY/>)5*BYU*/*HPC*\9)M-NVEU9_=MZG[E>"M5UK4O
M!7AK6/%EG%HVO7NA:??:]8EE2'3M1FM8Y;VWWEMJI;S%TW%L87)-:NC>(="\
M10/=:%K&FZQ;Q2R02RZ=>07:1S1,4DCD,+OL=6!!5L'H1D$$_P __P"UUK/Q
M2_:0^*/[&_[$^B^/?$7@3P'XO\+:!XE^,GBC0=4FL/%/B/2Y+"S(LK#4H6$\
M,S>7(\TA;+M*Y).ZOIOX4?\ !+6]_9G_ &AO /Q8_9M^/'CS0/ %I:7-C\5/
MAI\0->U'Q?9^,8Y%,<-UI3R0"#3;P1G$KNJ[I%W[V+';YM7)<%0PL*V,S2&$
MQ>+HXC%X/"1PM6K0=*E4J0ITZN(C-RHU,1*G)4(JE4C%<CJRCS-QM5)2DU&#
ME&+492YDG=I-V32NHI^\[KR1]:_"CXG?M'>(/VA_BUX*^(/P[L-!^#WAZZD3
MX>^,(&0W&N6R*VU[G:[%68[1\RI[>E?5VH>)/#^E7EAI^IZWI=A?:I+Y.G6E
MW?6T%Q>RXW!+>*217E8C[H4'<<*N20*_ 'P?\0_'T_Q5_P""N-K>>.?%4]AX
M5T3Q _ABRDU:X:V\,S):2%9-"B+$:>5D^9/*QMX]*\2_8+_X)OW/[7O[+&G?
M%_\ :A^-7Q=UWXG:M:ZC:> M;\,^.]0TBW\-Z+:>;)HLTMO&K?:-1CG,37$I
M:)FCBV[CO.WT<1D&#5.IC<=CJ&78>A#*L.Z>$P=:O4K5L=E\,5&K&G.O%-Q3
M<L2_:1N]:<?>45*JRNH1BYR?/+WI))*,[-72\_=T\G9']0H((R#D'D$="/6L
M1?$OAY]6;0DUS26UI8S*VEK?VIOUC!P2;82F4$8)*[=P7YBNWFOPR_X)Z?&#
MXRZW^RU^T%\#OBY\6+33?&/P+U7Q5X<LOC+J\XG2T\'*TEKIL]_<2,&FU.TM
M%9A(6WO*>,L17Y _&>Y_88\'?"G6_$OP1_:6_:,^+/[47A;7&\1ZCX]M-3\5
M6?A6;6=/N[BXGMFCEMXK/^QVE,<"PQ7%S%+!&78QY\L+!\'SQ&.QF!J8JLYX
M?$4\/3K8/+Z^+H3C7CST<57J\]&&&P\XN#M*4JUY/]W:+;)5[1C)15G%MJ4U
M%JSUBD]7*U[;)[WL?VR,RKRS*HZY8@<>O)K(TSQ'H&M3W=MI&M:7J=Q82M#>
MP6-];74UK(IPRSQPR.\>#QE@%)R 217\R_[:/B[XV?'KX:_\$NK/3OB;XB\"
MW_QPUOPU9_$[4/#6IW&F2:II<[6\5RJM 5(FDC#%G8@[R2>IKI?VBOV7['_@
MGS^U7^Q]\3?V>?B3\2XY/BE\1KOPE\4/#GC+Q;>^(-$\2Z7'!8L)HK&8)';W
M#O/(6&UP, ^8Q/RY4N%:4J="G6S2-+'XRGF<L+A8X6=2DY974K0JQKXGVL?9
M*M]7J>QE&E.SY7-),;K.[M"\8NFI2<DFE-)IJ-G>W,KJZ\C]POB%^U3\._AO
M^T1\&?V:M=%V?'7QOTCQ/K/A66.6W6QAM?"D+SZ@+SS&$BO(B$6X7'FO\B;F
MR!]'WM_9:=:3W]_=V]E96T337%W=31P6\,2*6>22:1E1%50226%?S2?MW?LI
M?#OXE?\ !8W]@[4-;\1?$2RG^*G@+XC:OKB:+XHNK%-/G\,Z;++IT>@^7SI5
MO<N@74HXE99U!9BV=@](_P""LVA>,?"&L?L^>'/&A^*K?L.^%K1$^)^N?#S5
M-2'C"+6()V6U_M6]L$-W?V;6B1&6)]JRL7XZU2X=P.)GPY0PV-J0K9IE=7&X
MOVE"]JE+%8VDZ>%BZZ5:M/ZLJ%*@G#VDXJ?,G4Y$O;2BJSE%-4ZBA&SZ.,'>
M6FB7-S-ZV3VTN?T$Z-KNC>(;*/4M"U6PU>PESY=WIUU#=P-@D$>9"[@,".5;
M##TK+\<:AKND^#O%&I^%[%-3\1Z?H.J7>AZ=)C9>ZK;V<LEC:OD@;)KA8XV)
M( 5CS7XN_P#!+[PY^RQ!\3_'/BS]D']I;QAXY^&>L>';:+4_@[\1;[4I=?\
M#>L&92VIV,.LQ6MVMO*ZJ'"6ZJK%D4R(HD;]@/C1<W5E\'?BQ>65S-9WEI\-
M/'=S:7=NYCN+6Z@\+:K+;W,$B\QS02HDL3CE756'(KQ,PR^&7YG'!QG6J14J
M#:QF$JX.M!U'%NE7P\Y.490O:3A.49KWH2::MI";E#F:2W^&2DG;JFN_FKKJ
MCRC]D7X@?'+XB_![3O$G[1/@JR^'WQ&EU+4;>]T"R9#;1V<-S(EC,C*[J3-
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M6L9;W5DV_/\ 4_F:_P""0_\ P3K_ ."HW_!/+7?C-^SI<R>![']G#QKKVO\
MB+PO\3K+6K.^\1Z?KVI27;6VKR:,)S)N5)8E:(Q@$KENE>._'K]C7_@L_P"(
M+?XN_!?QK\(O@C^TQX6^)NMZCI_@[XP:K'H.E>(/#^G7)?9J.HL/W]LZ0.TB
MM,R9>(\\&O[,**ZO]?LREF>)S:MEN25L7BUAY5YRP4X2EB,-9PQ4:E.O"M"M
M)Q7M5"I&C4LE*D+ZK#DC34ZJC&]ES)Z/>-FFFNUU==S\A/\ @C9_P3U\7_\
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MKW_2=.AT?2M,TFW+-;Z7I]EIT#/]]H;&VCMHBW^T4B4M[YKV9\7<^"I2JX'
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MAZ6:XMM/N9W*K#%<R.J/(2 JY.17Q1XP^"?[='[37[$?A7X=?&#X3>!?AO\
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M[;W>B7_ "BBBO-+"BBB@ KX _P""L7_*++_@I9_V8!^V1_ZSK\1J^_Z^ /\
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MJU2G9U7]7I9;"C4IMI8:C.M7HOWI5&W<\Y8BHZ\4IWA*JZ=N6*22WMJYWO\
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M_P#:IG2[M3 GQUMUDN1-'L=Q>*#*[!MJ-*<R%205+8/2O<PO".49=7RK%T<
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M,HTV#_@G'XNO+N&P2:/6]-$=[<)$L\(\Z($1SO@H",Y />OFKQ'\,_%_Q/\
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M%% 'XR_\%=M2U>PU#]B^/2M2O=/%Y^T#!!>+:3-"+JW^S:<6BN-I&Z(9)(/
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M!S]HO]D7XB? FX\??OO!GBG50;G0IWE^9-*NYXH6C6YA3EI3*H;)))XKN_\
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M\9_''XK2VD'@[X$Z%-$OBI+R]AC=;34)#&Z1BVDD\N:4J@9@0&7BO*_V?/\
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M'?:I83? V**T"VVFV3W*_P!GQZG&J[;IECV!B0Q.._6OT0_X+-?#/XJ^*?\
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MBZ'POKT_@VQ_8_\ B)IEYXMCL)G\/66JW&HZHT.F7&H@>3#?3JR-% Q#.'!
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M6KY9+7G<XN\4_=D]6M=4]GMH+1117R)T!1110 4444 %%%% !1110 5\ ?\
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MG9KYHT(TBBCC$21QI$J[5B1%6-5'10@ 4*/0#%."(J[5157^Z% 7\@,4ZBD
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M.6I&,TXJI!I2A)I\LDG8F<5.+B[V>]G:Z[/R?4X'X7?#KP_\)OA_X4^'7A>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ\1>%/#VI^,-2\.>$O#NG:OKXT:WN;VVTC3K0"*QL+&UMK7_  ]B_P""IO\
MTDL_;_\ _$R/VBO_ )XU%% !_P /8O\ @J;_ -)+/V__ /Q,C]HK_P">-1_P
M]B_X*F_])+/V_P#_ ,3(_:*_^>-110 ?\/8O^"IO_22S]O\ _P#$R/VBO_GC
M4?\ #V+_ (*F_P#22S]O_P#\3(_:*_\ GC444 '_  ]B_P""IO\ TDL_;_\
M_$R/VBO_ )XU'_#V+_@J;_TDL_;_ /\ Q,C]HK_YXU%% !_P]B_X*F_])+/V
M_P#_ ,3(_:*_^>-1_P /8O\ @J;_ -)+/V__ /Q,C]HK_P">-110 ?\ #V+_
M (*F_P#22S]O_P#\3(_:*_\ GC4?\/8O^"IO_22S]O\ _P#$R/VBO_GC444
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M /\ Q,C]HK_YXU'_  ]B_P""IO\ TDL_;_\ _$R/VBO_ )XU%% !_P /8O\
M@J;_ -)+/V__ /Q,C]HK_P">-1_P]B_X*F_])+/V_P#_ ,3(_:*_^>-110 ?
M\/8O^"IO_22S]O\ _P#$R/VBO_GC4?\ #V+_ (*F_P#22S]O_P#\3(_:*_\
MGC444 '_  ]B_P""IO\ TDL_;_\ _$R/VBO_ )XU'_#V+_@J;_TDL_;_ /\
MQ,C]HK_YXU%% !_P]B_X*F_])+/V_P#_ ,3(_:*_^>-1_P /8O\ @J;_ -)+
M/V__ /Q,C]HK_P">-110 ?\ #V+_ (*F_P#22S]O_P#\3(_:*_\ GC4?\/8O
M^"IO_22S]O\ _P#$R/VBO_GC444 '_#V+_@J;_TDL_;_ /\ Q,C]HK_YXU'_
M  ]B_P""IO\ TDL_;_\ _$R/VBO_ )XU%% !_P /8O\ @J;_ -)+/V__ /Q,
MC]HK_P">-1_P]B_X*F_])+/V_P#_ ,3(_:*_^>-110 ?\/8O^"IO_22S]O\
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M*F_])+/V_P#_ ,3(_:*_^>-110 ?\/8O^"IO_22S]O\ _P#$R/VBO_GC4?\
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M*_\ GC4?\/8O^"IO_22S]O\ _P#$R/VBO_GC444 '_#V+_@J;_TDL_;_ /\
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MR/VBO_GC4?\ #V+_ (*F_P#22S]O_P#\3(_:*_\ GC444 '_  ]B_P""IO\
MTDL_;_\ _$R/VBO_ )XU'_#V+_@J;_TDL_;_ /\ Q,C]HK_YXU%% !_P]B_X
M*F_])+/V_P#_ ,3(_:*_^>-1_P /8O\ @J;_ -)+/V__ /Q,C]HK_P">-110
M ?\ #V+_ (*F_P#22S]O_P#\3(_:*_\ GC4?\/8O^"IO_22S]O\ _P#$R/VB
MO_GC444 '_#V+_@J;_TDL_;_ /\ Q,C]HK_YXU'_  ]B_P""IO\ TDL_;_\
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*,\@:5BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>img12876764_21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_21.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +- ^$# 2(  A$! Q$!_\0
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M=Z*[V1^XN!Z#\A1@>@_(5_,-_P 18O\ P33_ .@#^T!_X;M/_EI1_P 18O\
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M/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\
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M/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\
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M/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\
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M/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\
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M/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\
MY:4?\0_XT_Z)K-?_  G?EY^:#ZWAO^?U/[_Z[_GV9_3S@>@_(48'H/R%?S#?
M\18O_!-/_H _M ?^&[3_ .6E'_$6+_P33_Z /[0'_ANT_P#EI1_Q#_C3_HFL
MU_\ "=^7GYH/K>&_Y_4_O_KO^?9G]/.!Z#\A1@>@_(5_,-_Q%B_\$T_^@#^T
M!_X;M/\ Y:4?\18O_!-/_H _M ?^&[3_ .6E'_$/^-/^B:S7_P )WY>?F@^M
MX;_G]3^_^N_Y]F?T\X'H/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q
M%B_\$T_^@#^T!_X;M/\ Y:4?\0_XT_Z)K-?_  G?EY^:#ZWAO^?U/[_Z[_GV
M9_3S@>@_(48'H/R%?S#?\18O_!-/_H _M ?^&[3_ .6E'_$6+_P33_Z /[0'
M_ANT_P#EI1_Q#_C3_HFLU_\ "=^7GYH/K>&_Y_4_O_KO^?9G]/.!Z#\A1@>@
M_(5_,-_Q%B_\$T_^@#^T!_X;M/\ Y:4?\18O_!-/_H _M ?^&[3_ .6E'_$/
M^-/^B:S7_P )WY>?F@^MX;_G]3^_^N_Y]F?T\X'H/R%&!Z#\A7\PW_$6+_P3
M3_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\ Y:4?\0_XT_Z)K-?_  G?
MEY^:#ZWAO^?U/[_Z[_GV9_3S@>@_(48'H/R%?S#?\18O_!-/_H _M ?^&[3_
M .6E'_$6+_P33_Z /[0'_ANT_P#EI1_Q#_C3_HFLU_\ "=^7GYH/K>&_Y_4_
MO_KO^?9G]/.!Z#\A1@>@_(5_,-_Q%B_\$T_^@#^T!_X;M/\ Y:4?\18O_!-/
M_H _M ?^&[3_ .6E'_$/^-/^B:S7_P )WY>?F@^MX;_G]3^_^N_Y]F?T\X'H
M/R%&!Z#\A7\PW_$6+_P33_Z /[0'_ANT_P#EI1_Q%B_\$T_^@#^T!_X;M/\
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MB3&_^I&".#,?]W7_ %]A^I^#%%%%?U2>,%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%K'P;FTF[UVV\37>MP6$UUI%@LCW5[;6,J&6>*-8I/F0D$KCTS]U_P#!6O\
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M)/'7B3X:?$#3%T;QIX1OGTWQ!I:S+<+9WL3,DD2S* L@5D8;AZ5_5W_P;C_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ=</"LFC^)O#NFS17UG=W#!G^SM;K:[$9D*SR,=PX8?%_P#P21_:0\0?M@?
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M%@O^"F^GW-Q:VNI:QX;N+/3+:X>*"XO[B/Q"))(+9'*O,\,2M+(B!F1%9B
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M%MX-?/\ -\4?B)<_$H?&2Y\5ZA<?%3^W!XG/C68B74SX@$K3C4R7+*91,S.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** (;C_CWG_P"N,O\ Z U?ZB/_
M  ;M_P#*(O\ 92_[ 7B'_P!234J_R[KC_CWG_P"N,O\ Z U?ZB/_  ;M_P#*
M(O\ 92_[ 7B'_P!234J_'/&W_DEL#_V.\/\ ^H>.._+OX\_^O4O_ $N!^VM%
M%%?RT>R5Z*** )UZ#Z#^5+2+T'T'\J6@ K_,F_X.8/\ E+C\2/\ LD7PO_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBK_T=AI?_A-Q?_$4?\0B'Q5_Z.PTO_PFXO\ XBO[N**/^(L\<?\ 0TH_^&_
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M_P"Q7'_U9Y:9U-Z7_7Q?^D3/TKHHHKR30**** "BBB@ HHHH **** "BBB@
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MD @$@$YP"1DXY.!WP.3CI0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?SO?\'1D<<O_!)'XG)+&DB'XG?"LE)$5U)&JW^"58$'';BO\U1;"QP/
M]"M.@_Y=H?3_ '*_TKO^#HC_ )1)_$W_ +*=\+/_ $ZW]?YKB]!]!_*OZN\%
MF_\ 4ZMJ_P#D=X[_ -1L >+F"7MUI_R[C_Z5(J_8+'_GRM/_  &A_P#B*_K,
M_P"#0JVMX/VN/VNFAMX82WP1\)!C%%'&6 \5V> 2B@D>QK^3ZOZQ_P#@T/\
M^3M_VN/^R)>$_P#U*K.OH_$AO_4?B+7_ )A*/_J=A/\ )?<885+ZS0T^V_\
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MQK;/\##X2LHK ZW&L_A-OBR9H_[%34XKA9+!YO)8%/M2!0&)W"OKW_@J79^
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MN?,\V/8@5P!7ZC_\$W)YKC]A7]EUYYY+B1?@]X-C$LKM)(4CTFW2,%V)9@B
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M4*LYXODA.A3C#GC4C&Z7/&M.U3FDH\L834G"SM+=<K>MVK1O9N^JV/4/@/\
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M:U_BO_P44_9Z^"GPF^'OQ/\ B-J6J:#??%6V27P!\.7LI9_'OB.8C,MM:Z-
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MO;01J.%CBAC2-%' 50!7+?$3X>>#_BMX*\2?#SQ]HEIXB\(^+-+NM'US2+U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\6?!7[,/P0U35-6'P8\"7_A_3/$%YX[T;2+RYLH+[5]0U!6GL(-1FM/+,RD
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MQ*^!7_IBN*];+?\ =<[_ .Q7'_U9Y:9U-Z7_ %\7_I$S]*Z***\DT$) !).
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M_P#96\/^$;'P%H_Q+^"-CX.T[2(M!M/#D/C?P6NDQZ1#;K:I8FS_ +4\EX#
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M#XHT.Q_L+P[-I>L6VGMI\EAJ3)',+KS52&.-B01MS_3. % 50%4      #H
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MZMX5\3:5I\ABO]3\/ZSI]E*#M,5W>Z=<VUM(&_A*32(P/;&:_F%_X)-?M6?
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M $;SXJ_\&5M_\<H_XEE\;?\ HB<3_P"''*?_ )N#_B8+PD_Z*RC_ .&_-/\
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M_12=-_[XE_\ C='_ !$2_P#!3C_HI.F_]\2__&Z/^(*<4_\ 05E7_A15\O\
MISY_@^P?VC0_EJ?^ KR\_/\ #UM_I^45_F!_\1$O_!3C_HI.F_\ ?$O_ ,;H
M_P"(B7_@IQ_T4G3?^^)?_C='_$%.*?\ H*RK_P **OE_TY\_P?8/[1H?RU/_
M  %>7GY_AZV_T_**_P P/_B(E_X*<?\ 12=-_P"^)?\ XW1_Q$2_\%./^BDZ
M;_WQ+_\ &Z/^(*<4_P#05E7_ (45?+_ISY_@^P?VC0_EJ?\ @*\O/S_#UM_I
M^45_F!_\1$O_  4X_P"BDZ;_ -\2_P#QNC_B(E_X*<?]%)TW_OB7_P"-T?\
M$%.*?^@K*O\ PHJ^7_3GS_!]@_M&A_+4_P# 5Y>?G^'K;_3\HK_,#_XB)?\
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MV)FMYX\;H[BWD6.Z@)R-K2PHK_P,V#C^9#QS^T _[3GPO_X(\_&?]HW5+_\
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M:O\ \@G4_P#KPN__ $1)6C6=J_\ R"=3_P"O"[_]$25YQ9\A_L.?\DJ\4_\
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ML.CFWO89X=P[-LW#L17Y8_\ #\#_ ()E?]'/^"/_  *'_P 51_P_ _X)E?\
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M15ZBB[[O[V%EV7]?\,ON*/\ 9FF_\^%G_P" T/\ \11_9FF_\^%G_P" T/\
M\15ZBB[[O[V%EV7]?\,ON*/]F:;_ ,^%G_X#0_\ Q%']F:;_ ,^%G_X#0_\
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M*** "BBB@ HHHH **** *E__ ,>5U_UPD_\ 037^IS_P07_Y1J? W_KUO/\
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M1>@^@_E2T %?FI\ /^4C/[<7_8E? K_TQ7%?I77YJ? #_E(S^W%_V)7P*_\
M3%<5ZV6_[KG?_8KC_P"K/+3.IO2_Z^+_ -(F?I71117DF@4444 %9<NN:+!J
M,6D3ZOID.JW 5H-,EO[6/4)@P)4Q6;RBXD# $KMC.X D9Q7S_P#MC?$7QO\
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M3_T$TX[KU7Y@?ZDW_! 7_E&E\%?^N5Y_Z#;U^TM?BU_P0%_Y1I?!7_KE>?\
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M)N*_^2IXE_['^<?^K'$G^S?#/_).</\ _8DRK_U PX4445X![84444 %%%%
M!1110!_E)?\ !;[_ )2F?M0_]A?2O_1$U?E97ZI_\%OO^4IG[4/_ &%]*_\
M1$U?E97]V\-?\DYD/_8FRS_U"H'S=;^+5_Z^3_\ 2F%%%%>V9A1110 4444
M%%%% !1110 4444 %%%% %2__P"/*Z_ZX2?^@FO]3G_@@O\ \HU/@;_UZWG_
M *#;U_EC7_\ QY77_7"3_P!!-?ZG/_!!?_E&I\#?^O6\_P#0;>OQKQM_Y)K+
M_P#L:Q_]1ZAZ&7?Q9_\ 7M_^E1/V2HHHK^7#V HHHH _RZ?V@O\ DX/X\_\
M98/B!_ZD=]7DM>M?M!?\G!_'G_LL'Q _]2.^KR6O]Z,H_P"11E/_ &*\N_\
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M_P!C3&?^GIGT6'_@4?\ KW#_ -)04445\^;!7^7I^TC_ ,G(?M _]EC\??\
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M /L:Q_\ 4>H>AEW\6?\ U[?_ *5$_9*BBBOY</8"BBB@#_+I_:"_Y.#^//\
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M2?1VZKNKZ7\@K.U?_D$ZG_UX7?\ Z(DK1K.U?_D$ZG_UX7?_ *(DKC*/D/\
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MN2OJZO\ ";BO_DJ>)?\ L?YQ_P"K'$G^S?#/_).</_\ 8DRK_P!0,.%%%%>
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M-?YFL'_'W8_]?MO_ .AU_IE?L3?\FE_L_?\ 9,O#G_I,:_B#Z;G_ "3/ _\
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M*?\ L5Y=_P"H= _Q9SG_ )&V9?\ 8=BO_3TPHHHKT#S0HHHH **** "BBB@
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M@?\ LL?C[_T_7=?W5]![_D<^(?\ V*<@_P#4['G\;?3!_P"11P3_ -A^=?\
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M_P#CRNO^N$G_ *":_P!3G_@@O_RC4^!O_7K>?^@V]?Y8U_\ \>5U_P!<)/\
MT$U_J<_\$%_^4:GP-_Z];S_T&WK\:\;?^2:R_P#[&L?_ %'J'H9=_%G_ ->W
M_P"E1/V2HHHK^7#V HHHH _RZ?V@O^3@_CS_ -E@^('_ *D=]7DM>M?M!?\
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MU4O_ /CRNO\ KA)_Z":<=UZK\P/]2;_@@+_RC2^"O_7*\_\ 0;>OVEK\6O\
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M'?5Y+7^]&4?\BC*?^Q7EW_J'0/\ %G.?^1MF7_8=BO\ T],****] \T****
M"BBB@ HHHH **** "BBB@ HHHH ?!_Q]V/\ U^V__H=?Z97[$W_)I?[/W_9,
MO#G_ *3&O\S6#_C[L?\ K]M__0Z_TROV)O\ DTO]G[_LF7AS_P!)C7\0?3<_
MY)G@?_L>YC_ZKX']A_0^_P"2@XQ_[%&!_P#4P^HZ***_SF/[U"BBB@ HHHH
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M +$V6?\ J%0/FZW\6K_U\G_Z4PHHHKVS,**** "BBB@ HHHH **** "BBB@
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MPU555"-)JO*$EA]:Y9*-)WO4G[.5G&[YXPC%MRNGR12NT^NE_>/>_P#@G/\
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M\_\ U,PIY^8_PH?]?%_Z3(_)RBBBOZ@/'"BBB@ HHHH **** "BBB@ HHHH
M**** "JE_P#\>5U_UPD_]!-6ZJ7_ /QY77_7"3_T$TX[KU7Y@?ZDW_! 7_E&
ME\%?^N5Y_P"@V]?M+7XM?\$!?^4:7P5_ZY7G_H-O7[2U_"W%?_)2Y[_V-,9_
MZ>F?18?^!1_Z]P_])04445\^;!7^7I^TC_R<A^T#_P!EC\??^GZ[K_4+K_+T
M_:1_Y.0_:!_[+'X^_P#3]=U_=7T'O^1SXA_]BG(/_4['G\;?3!_Y%'!/_8?G
M7_IC+#QJBBBO]#C^$ HHHH **** "BBB@ HHHH **** "BBB@ IT7_'Q:?\
M7U!_Z&*;3HO^/BT_Z^H/_0Q05#XX_P"*/YH_TP/V&/\ DT']GG_LF>@_^BY*
M^KJ^4?V&/^30?V>?^R9Z#_Z+DKZNK_";BO\ Y*GB7_L?YQ_ZL<2?[-\,_P#)
M.</_ /8DRK_U PX4445X![84444 %%%% !1110!_E)?\%OO^4IG[4/\ V%]*
M_P#1$U?E97ZI_P#!;[_E*9^U#_V%]*_]$35^5E?W;PU_R3F0_P#8FRS_ -0J
M!\W6_BU?^OD__2F%%%%>V9A1110 4444 %%%% !1110 4444 %%%% %2_P#^
M/*Z_ZX2?^@FO]3G_ ((+_P#*-3X&_P#7K>?^@V]?Y8U__P >5U_UPD_]!-?Z
MG/\ P07_ .4:GP-_Z];S_P!!MZ_&O&W_ ))K+_\ L:Q_]1ZAZ&7?Q9_]>W_Z
M5$_9*BBBOY</8"BBB@#_ "Z?V@O^3@_CS_V6#X@?^I'?5Y+7K7[07_)P?QY_
M[+!\0/\ U([ZO):_WHRC_D493_V*\N_]0Z!_BSG/_(VS+_L.Q7_IZ84445Z!
MYH4444 %%%% !1110 4444 %%%% !1110 ^#_C[L?^OVW_\ 0Z_TROV)O^32
M_P!G[_LF7AS_ -)C7^9K!_Q]V/\ U^V__H=?Z97[$W_)I?[/W_9,O#G_ *3&
MOX@^FY_R3/ __8]S'_U7P/[#^A]_R4'&/_8HP/\ ZF'U'1117^<Q_>H4444
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MH ?!_P ?=C_U^V__ *'7^F5^Q-_R:7^S]_V3+PY_Z3&O\S6#_C[L?^OVW_\
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MW@CQ5IDL(U3Q7X5\A)WEBM+6S?[-:,L0)"2$XR-WD_\ P4/^)<?QF_X)P_\
M!.CX\VO@SQOX$\%>#/CA\"M&\0Z/\0]);1=:@BT9]+TPZO<69++_ &-J4]C/
M-IUXP59[?:Y4 YK^@C]MKQSX3TS]A#]H'QE?7ME'X9OO@+XMFM+AY8_LDD>K
M^%KA--6*0G8^Y[B'R@N22HVC(K>G*IDN'R6GA\'AIULRXBS.AFD*V&P^)=>G
MA<5A,-#+).<*O)1]E6G-PHN#E*JI\SY8-)_O74<I-*%&FX-2DDG*+DYJUF]4
MM[Z*Q^4GQE_:^\<_MAZ!_P $NO"7ASQM??"#X??MGR:Q?_&#5O#TWD7<DFB:
M''>/X+L[^1HX[5KC4K2YC(,T;LLRJ@)"BO3O@EXGUG]C_P#X**>.?V:['XL:
MKXN_9RN/V<)?C3J>F>*+];T?#;6=/U&>.[NTU)YYO*M]1M+-O+@N)49VG&U"
M"F<3_@F'^QS\./VB?^"47[,'@_X\>';K48[73[CQEX(U:TNKC2?$'AN6[OKB
M2PU/1=4MF2[M"PW%@CJ)HLHV 01X!\=/V=OA7-\;]0_8>_9?_MUM;\0^'Y?'
MW[;_ ,;K_6KW6=;TWX1^&W:_M/A]9ZO--+)8:CJ5Y:):R:3!. 8;D!XB2P&_
M+E4L1F>0TN>EA<$\XPV)BL+2GAH0AF=2K2S>>*<_:JMA<-[/"T*7(ZE2K"C1
MA-1K3LO?2A5>LI^R:U=W>$4Z:CM:37-)WLE=VT/N+]B3Q#\4OVU?VC?'_P"V
MQXAU/7= _9ST#^T?AS^S9X&E^T6EAXNTBQU"87OQ*U&W+1A[M[R*:VM249&1
M@02!7[,U_-Q\+?CI^V-XF_98\3?M9?LYW/@SX?\ P!^#"W6B_"/X BTM%T[Q
MGX*\$Z@-%U>]UW42J7&EZC=RQ7-_Y4802332-RS'/[I?LT?&S3_VB?@=\.OC
M%IUB^F1^-/#]IJ%UISY(LM35?(U.UB9LL\$-]'/'!(W+Q*K'.<GY?B7 UZ59
MXA1PU/"8>JLKAA</-3GE\\/24XX7%OD@IXF4'*I7K1=2%3$>WBJEX<L=J,DU
MROF<FN?F:^-/[4=7:-[)+1VL[:GNM9VK_P#()U/_ *\+O_T1)6C6=J__ ""=
M3_Z\+O\ ]$25\J;GR'^PY_R2KQ3_ -E5\=?^EEO7V;7QE^PY_P DJ\4_]E5\
M=?\ I9;U]FT %%%% !7^5%_P7/\ ^4J'[2__ %]Z)_Z3R5_JNU_E1?\ !<__
M )2H?M+_ /7WHG_I/)7[1X(?\E'F?_8GG_ZF84\_,?X4/^OB_P#29'Y.4445
M_4!XX4444 %%%% !1110 4444 %%%% !1110 54O_P#CRNO^N$G_ *":MU4O
M_P#CRNO^N$G_ *":<=UZK\P/]2;_ (("_P#*-+X*_P#7*\_]!MZ_:6OQ:_X(
M"_\ *-+X*_\ 7*\_]!MZ_:6OX6XK_P"2ESW_ +&F,_\ 3TSZ+#_P*/\ U[A_
MZ2@HHHKY\V"O\O3]I'_DY#]H'_LL?C[_ -/UW7^H77^7I^TC_P G(?M _P#9
M8_'W_I^NZ_NKZ#W_ ".?$/\ [%.0?^IV//XV^F#_ ,BC@G_L/SK_ -,98>-4
M445_H<?P@%%%% !1110 4444 %%%% !1110 4444 %.B_P"/BT_Z^H/_ $,4
MVG1?\?%I_P!?4'_H8H*A\<?\4?S1_I@?L,?\F@_L\_\ 9,]!_P#1<E?5U?*/
M[#'_ ":#^SS_ -DST'_T7)7U=7^$W%?_ "5/$O\ V/\ ./\ U8XD_P!F^&?^
M2<X?_P"Q)E7_ *@8<****\ ]L**** "BBB@ HHHH _RDO^"WW_*4S]J'_L+Z
M5_Z(FK\K*_5/_@M]_P I3/VH?^POI7_HB:ORLK^[>&O^2<R'_L399_ZA4#YN
MM_%J_P#7R?\ Z4PHHHKVS,**** "BBB@ HHHH **** "BBB@ HHHH J7_P#Q
MY77_ %PD_P#037^IS_P07_Y1J? W_KUO/_0;>O\ +&O_ /CRNO\ KA)_Z":_
MU.?^""__ "C4^!O_ %ZWG_H-O7XUXV_\DUE__8UC_P"H]0]#+OXL_P#KV_\
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MTP/V&/\ DT']GG_LF>@_^BY*^KJ^4?V&/^30?V>?^R9Z#_Z+DKZNK_";BO\
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MY\V/D/\ 8<_Y)5XI_P"RJ^.O_2RWK[-KXR_8<_Y)5XI_[*KXZ_\ 2RWK[-H
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MT'O^1SXA_P#8IR#_ -3L>?QM],'_ )%'!/\ V'YU_P"F,L/&J***_P!#C^$
MHHHH **** "BBB@ HHHH **** "BBB@ IT7_ !\6G_7U!_Z&*;3HO^/BT_Z^
MH/\ T,4%0^./^*/YH_TP/V&/^30?V>?^R9Z#_P"BY*^KJ^4?V&/^30?V>?\
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MR6O]Z,H_Y%&4_P#8KR[_ -0Z!_BSG/\ R-LR_P"P[%?^GIA1117H'FA1110
M4444 %%%% !1110 4444 %%%% #X/^/NQ_Z_;?\ ]#K_ $ROV)O^32_V?O\
MLF7AS_TF-?YFL'_'W8_]?MO_ .AU_IE?L3?\FE_L_?\ 9,O#G_I,:_B#Z;G_
M "3/ _\ V/<Q_P#5? _L/Z'W_)0<8_\ 8HP/_J8?4=%%%?YS']ZA1110 444
M4 %%%% %/4?^0???]>=U_P"B'KY/_8<_Y-ZT#_L9/&W_ *E&I5]8:C_R#[[_
M *\[K_T0]?)_[#G_ ";UH'_8R>-O_4HU*N^E_P BW&?]A>!_]-8TE_''_#+\
MX'UY1117 45Z*** )UZ#Z#^5+2+T'T'\J6@ K\U/@!_RD9_;B_[$KX%?^F*X
MK]*Z_-3X ?\ *1G]N+_L2O@5_P"F*XKULM_W7._^Q7'_ -6>6F=3>E_U\7_I
M$S]*Z***\DT"BBB@#S;XQ:5X^USX6^/-(^%FLVOA[XC7_AK4K?P7K5Z&-IIW
MB%H2=.N+@*"WE"955R.@;)P!FOY^9/VU?^"DEG^SAX\_9F^,G[ 'QA^(_P"T
MGJVC^)_ 6F_$KPXNDR_"SQ/#K*2Z=I?B>?[0AN181VLKW%TAR6 B^[\U?TGT
M?Y_S^0KV<LS6A@*<J>(RK!9BO;TL51G7E7HUJ%:C=)1K8:K2G*A/3VM";<).
M,9+EDKF<X.334Y0T<6E9IIVZ--)Z:-:_(_FPLO\ @D9\81_P1T\)?LJ/K.DV
M_P"T5X+\=+^T)X;EQ)]BTOQU'?OXC7PA"^?W<3SL+!@A$>]40 $;:P_B_P#M
M.?\ !0[]I7]E9/V+M#_86^,WP]^._C3P_I7PQ^)'Q:\2OIB_#70](\I=+\3>
M*;:6%1=R6U_9 3V:F0,I:4-N^7']-=&!G..>F>^!G _#)_,UZD.+<14J2K9A
M@,%F56.:5\XPLZWMZ2PN-Q,H3K<L:%6$:N'E.E2F\/64H<U-._O34LWAXV48
M2E!<BIRM9\T5HKW6CM=77<^3/V6/@?:?L;?LC?#;X.:?$WB*Y^$/PW6SO#IB
M%;CQ/K>G64][>&U# YNM4O<V]N6&"SQ;@>_PQ^QM^S?\6_C%\3_CA^VY^U%X
M>O?"GQ1^)&E>)/AQ\"_ VM/Y\GPG^%%PMS;6,DEOREMK][(Q>>YMU23[)(Z!
MB7!'[,D C! (/4$9!_ TM>1#.,5!9E.T'B\UG?$XQW]LJ<ZKKUZ--)J$(8FK
MR.LU&\H05--0E)/3V<;T]7RTU[L>ETDHM]6XJ]O-WZ'\QG@?3?VI?V;?V4OC
M'^P W['/CWXF>+-8UOQ7H_@7XK:1!ID_@GQGIGBW6C?Q^)];FN(WNI8M)2:4
M.TKO*'C4(R@9K]TOV,?@QKO[/W[-'PH^$_B?4!J?B#PMX;MXM7G5I'CBO[PM
M>W-E$9"6\NPEG:T0 [,0_)\N*^H,#(.!D9 ..0#C(![9P,^N!2UOFF>U<SHS
MI/"T,-[?&/,,9.E*M)XG&2I*DZK56I.-&-N>7LJ2C!3J2^RH1@H4E!I\SE:/
M)&]M(WO;1*^V[U"L[5_^03J?_7A=_P#HB2M&L[5_^03J?_7A=_\ HB2O"-3Y
M#_8<_P"25>*?^RJ^.O\ TLMZ^S:^,OV'/^25>*?^RJ^.O_2RWK[-H **** "
MO\J+_@N?_P I4/VE_P#K[T3_ -)Y*_U7:_RHO^"Y_P#RE0_:7_Z^]$_])Y*_
M:/!#_DH\S_[$\_\ U,PIY^8_PH?]?%_Z3(_)RBBBOZ@/'"BBB@ HHHH ****
M "BBB@ HHHH **** "JE_P#\>5U_UPD_]!-6ZJ7_ /QY77_7"3_T$TX[KU7Y
M@?ZDW_! 7_E&E\%?^N5Y_P"@V]?M+7XM?\$!?^4:7P5_ZY7G_H-O7[2U_"W%
M?_)2Y[_V-,9_Z>F?18?^!1_Z]P_])04445\^;!7^7I^TC_R<A^T#_P!EC\??
M^GZ[K_4+K_+T_:1_Y.0_:!_[+'X^_P#3]=U_=7T'O^1SXA_]BG(/_4['G\;?
M3!_Y%'!/_8?G7_IC+#QJBBBO]#C^$ HHHH **** "BBB@ HHHH **** "BBB
M@ IT7_'Q:?\ 7U!_Z&*;3HO^/BT_Z^H/_0Q05#XX_P"*/YH_TP/V&/\ DT']
MGG_LF>@_^BY*^KJ^4?V&/^30?V>?^R9Z#_Z+DKZNK_";BO\ Y*GB7_L?YQ_Z
ML<2?[-\,_P#).</_ /8DRK_U PX4445X![84444 %%%% !1110!_E)?\%OO^
M4IG[4/\ V%]*_P#1$U?E97ZI_P#!;[_E*9^U#_V%]*_]$35^5E?W;PU_R3F0
M_P#8FRS_ -0J!\W6_BU?^OD__2F%%%%>V9A1110 4444 %%%% !1110 4444
M %%%% %2_P#^/*Z_ZX2?^@FO]3G_ ((+_P#*-3X&_P#7K>?^@V]?Y8U__P >
M5U_UPD_]!-?ZG/\ P07_ .4:GP-_Z];S_P!!MZ_&O&W_ ))K+_\ L:Q_]1ZA
MZ&7?Q9_]>W_Z5$_9*BBBOY</8"BBB@#_ "Z?V@O^3@_CS_V6#X@?^I'?5Y+7
MK7[07_)P?QY_[+!\0/\ U([ZO):_WHRC_D493_V*\N_]0Z!_BSG/_(VS+_L.
MQ7_IZ84445Z!YH4444 %%%% !1110 4444 %%%% !1110 ^#_C[L?^OVW_\
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M_P I&?VXO^Q*^!7_ *8KBOTKK\U/@!_RD9_;B_[$KX%?^F*XKULM_P!USO\
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MZ_:6OX6XK_Y*7/?^QIC/_3TSZ+#_ ,"C_P!>X?\ I*"BBBOGS8*_R]/VD?\
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ME?\ HB:ORLK^[>&O^2<R'_L399_ZA4#YNM_%J_\ 7R?_ *4PHHHKVS,****
M"BBB@ HHHH **** "BBB@ HHHH J7_\ QY77_7"3_P!!-?ZG/_!!?_E&I\#?
M^O6\_P#0;>O\L:__ ./*Z_ZX2?\ H)K_ %.?^""__*-3X&_]>MY_Z#;U^->-
MO_)-9?\ ]C6/_J/4/0R[^+/_ *]O_P!*B?LE1117\N'L!1110!_ET_M!?\G!
M_'G_ ++!\0/_ %([ZO):]:_:"_Y.#^//_98/B!_ZD=]7DM?[T91_R*,I_P"Q
M7EW_ *AT#_%G.?\ D;9E_P!AV*_]/3"BBBO0/-"BBB@ HHHH **** "BBB@
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M-^VM\>/BQ^W=\8?#VK^'-#T/2/%GPP_9 \ >)[*2Q?0M&>*\LQ\3+C3[I?\
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M -++>OLVOC+]AS_DE7BG_LJOCK_TLMZ^S: "BBB@ K_*B_X+G_\ *5#]I?\
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M -2.^KR6O]Z,H_Y%&4_]BO+O_4.@?XLYS_R-LR_[#L5_Z>F%%%%>@>:%%%%
M!1110 4444 %%%% !1110 4444 /@_X^['_K]M__ $.O],K]B;_DTO\ 9^_[
M)EX<_P#28U_F:P?\?=C_ -?MO_Z'7^F5^Q-_R:7^S]_V3+PY_P"DQK^(/IN?
M\DSP/_V/<Q_]5\#^P_H??\E!QC_V*,#_ .IA]1T445_G,?WJ%%%% !1110 4
M444 4]1_Y!]]_P!>=U_Z(>OD_P#8<_Y-ZT#_ +&3QM_ZE&I5]8:C_P @^^_Z
M\[K_ -$/7R?^PY_R;UH'_8R>-O\ U*-2KOI?\BW&?]A>!_\ 36-)?QQ_PR_.
M!]>4445P%%>BBB@"=>@^@_E2TB]!]!_*EH *_-3X ?\ *1G]N+_L2O@5_P"F
M*XK]*Z_-3X ?\I&?VXO^Q*^!7_IBN*];+?\ =<[_ .Q7'_U9Y:9U-Z7_ %\7
M_I$S]*Z***\DT"BBB@ K@?$GQ4^&WA#6-)\.^)O'7A71/$.NWD%AH^@ZAKFG
M6^M:E=W)Q!#::6]P+Z8R_P )2 J>S5L^,='U/Q!X5\0:)HNLW/AW5M5TJ[L=
M/UVR.+O2;JXB:.&_MCVFMF(DC_VE%?R!_MP_L%V'[+?[8'_!/SXF>(OCA\6/
MCC\6?'G[26@?V]XJ^(&N7,T5M9/JVZ/3]+LK>X2W2SB5VA6.6%B44$_>P/HN
M'<GP6<XBKAL3F$\)6]CB)X:C2PTZ]3$3HX>KB'S3<H4J-)*DXRG.3G>2Y*<M
M;959RII.,5)7BI-NR2<E'1;MZ^G=G]CD\\%K#+<W,T5O;P1O-///(D,,,4:E
MY)999"J1QQJ"SN[*JJ"S$ $UX!H7[6'[-WB;QG+\/M"^-7PZU+Q;'/):+I-M
MXITAY+F[A.V6TLI?M7D7ETC?*8+>220M\J*S$ _F/_P7C^-_CKX;?LBZ'\,O
MAEXAO_"OC3]H?XI>"_A''KVFS/!>6>@>)M1^P:ZEO-&0\<T]M.J(R%6!&0PZ
MCP[]K;_@D-^SK\/O^"<.JK\)_!=OX*^/7P,^'=G\2/#_ ,8-*O\ 6(_&DWC3
MPCIQUO5=1OK]M29;DZK<QS&[CDC*E53C"-NZ<MR/+JN#R[%9ICL1A7G&/K8#
M 1P^'A6C2]@Z$*F,Q<JE6FU05;$0IJ%)2J-1J3NN5*4SJS4IQA%2]G!3G=M7
MO=J,;)ZV3>NFJ/WR^(WQ.\!?"7PS>>,/B+XHTGPIX>LA^]O]6NXK999"0%@M
M8G82W=RQ8;;>W224@Y"XR:YOX1?'KX2_'72KO5_A9XUT?Q5;V$[6]_!9SB/4
M;"12 #>:;-Y=[;1N6 CDE@5'S\K&OYFO$7QQN/VA/A!_P1V_:._:,_M/Q!\!
M=.U36[?]H+46BU&^T"/QC!H_]E:-K7BZSTQ))[BPDU*RMY%+QLJ2%F(.3GV+
MP]\>/@!\+?\ @H7\;_VH/@?=KI/[,_P^_9;AMOBSK6CVNJ:7X-\1?$MM6E;P
M_H.FV=_% M]XBG?^S[9S8PLV#MP0/F[)<(RAAZM.4L54S"G3QTN:C2C+ +$8
M+,99?'+I5/C^MXF4/:TE[LK5J$52DI.:GZQ[RTBH-PW;4[3@I<]K6Y8W:?1V
M>NEG_0SJOQ>^'6B_$+1/A3J'BG3HOB%XATV36-+\*I)YNJS:5%*8'U![:,,\
M%H)04\^4(F>^,&O2:_'+_@G%\(?%'BWQ?XS_ &\?VDI+?3_CK^T,)G^'/@?5
M=05-0^%OP@DNICHOA>RTVXE66%]2BCAU*79")?+E4N,."?V-KYG-,)0P&*>$
MHUGB)T(0ABJJY?8O%I?[13P[7QT:,_W2J-OVDH2G'W'$VA)RCS-6N[I=>7I>
M^S:UMT305G:O_P @G4_^O"[_ /1$E:-9VK_\@G4_^O"[_P#1$E><6?(?[#G_
M "2KQ3_V57QU_P"EEO7V;7QE^PY_R2KQ3_V57QU_Z66]?9M !1110 5_E1?\
M%S_^4J'[2_\ U]Z)_P"D\E?ZKM?Y47_!<_\ Y2H?M+_]?>B?^D\E?M'@A_R4
M>9_]B>?_ *F84\_,?X4/^OB_])D?DY1117]0'CA1110 4444 %%%% !1110
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M /@_X^['_K]M_P#T.O\ 3*_8F_Y-+_9^_P"R9>'/_28U_F:P?\?=C_U^V_\
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MCY^R/\6OBU^VS^U1\2?VA]+U[4M!_9"^%SW_ ,-OA#H<7G6T'Q5UZSO93?\
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M?Y>G[2/_ "<A^T#_ -EC\??^GZ[K^ZOH/?\ (Y\0_P#L4Y!_ZG8\_C;Z8/\
MR*."?^P_.O\ TQEAXU1117^AQ_" 4444 %%%% !1110 4444 %%%% !1110
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M *CU#T,N_BS_ .O;_P#2HG[)4445_+A[ 4444 ?Y=/[07_)P?QY_[+!\0/\
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M\0D7P-_Z+MXA_P# "7_XNO[!Z*/]?>,_^BES?_PJE_E_5WY6/JN'_P"?-/\
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M[W__ (*)?_BZ/^(:OP9_T7>__P#!1+_\77]1]%'_ !';QB_Z./Q5_P"'*?\
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M\QXK\3/^"Q7[3GQ^^(?[<VB:5\&OB7XC\#?"7]ESQ'X?\ _$6+PY<S166O\
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MI_\ )=1[3R_'_@'5]47\[_\  ?\ [;U_I:_Z&O\ PL?X>?\ 0^>#/_"HT/\
M^3J/^%C_  \_Z'SP9_X5&A__ "=7^>5ONO\ H)ZQ_P"#C5/_ )+HWW7_ $$]
M8_\ !QJG_P ET>T\OQ_X ?5%_.__  '_ .V]?Z6O^AK_ ,+'^'G_ $/G@S_P
MJ-#_ /DZC_A8_P //^A\\&?^%1H?_P G5_GE;[K_ *">L?\ @XU3_P"2Z-]U
M_P!!/6/_  <:I_\ )='M/+\?^ 'U1?SO_P !_P#MO7^EK_H:_P#"Q_AY_P!#
MYX,_\*C0_P#Y.H_X6/\ #S_H?/!G_A4:'_\ )U?YY6^Z_P"@GK'_ (.-4_\
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M_P"@GK'_ (.-4_\ DNC?=?\ 03UC_P '&J?_ "71[3R_'_@!]47\[_\  ?\
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M4_\ DNC?=?\ 03UC_P '&J?_ "71[3R_'_@!]47\[_\  ?\ [;U_I:_Z&O\
MPL?X>?\ 0^>#/_"HT/\ ^3J/^%C_  \_Z'SP9_X5&A__ "=7^>5ONO\ H)ZQ
M_P"#C5/_ )+HWW7_ $$]8_\ !QJG_P ET>T\OQ_X ?5%_.__  '_ .V]?Z6O
M^AK_ ,+'^'G_ $/G@S_PJ-#_ /DZC_A8_P //^A\\&?^%1H?_P G5_GE;[K_
M *">L?\ @XU3_P"2Z-]U_P!!/6/_  <:I_\ )='M/+\?^ 'U1?SO_P !_P#M
MO7^EK_HFZ1XF\-^(&G70?$&B:VUKM^TKI&JV&I-;[_N>>+*XF,6_^'S-N[MF
MMNOYI_\ @@*93XB_:6\VZO;C_1_!N/M=[=7>SB;.S[3-+LSWV8SWK^EBK3ND
M^YRU(>SFX7O:VMK7ND]M>X4444R HHHH **** "BBB@ HHHH *YK4?&G@[1[
MM[#5_%GAK2[Z-4>2RU'7=+L;M$D&4=[:YNHIE5QRC,@##D$UTM?QC_\ !7]I
MQ^WI\0/+O=2A7_A#_!6([?4KZWB'_$M7)$4%Q'&">I(4$GJ34R?*KVOK8UI4
M_:2<;VLKWM?9I?J?V"_\+'^'G_0^>#/_  J-#_\ DZC_ (6/\//^A\\&?^%1
MH?\ \G5_GE;[K_H)ZQ_X.-4_^2Z-]U_T$]8_\'&J?_)=3[3R_'_@'1]47\[_
M / ?_MO7^EK_ *&O_"Q_AY_T/G@S_P *C0__ ).H_P"%C_#S_H?/!G_A4:'_
M /)U?YY6^Z_Z">L?^#C5/_DNC?=?]!/6/_!QJG_R71[3R_'_ ( ?5%_._P#P
M'_[;U_I:_P"AK_PL?X>?]#YX,_\ "HT/_P"3J/\ A8_P\_Z'SP9_X5&A_P#R
M=7^>5ONO^@GK'_@XU3_Y+HWW7_03UC_P<:I_\ET>T\OQ_P" 'U1?SO\ \!_^
MV]?Z6O\ H:_\+'^'G_0^>#/_  J-#_\ DZC_ (6/\//^A\\&?^%1H?\ \G5_
MGE;[K_H)ZQ_X.-4_^2Z-]U_T$]8_\'&J?_)='M/+\?\ @!]47\[_ / ?_MO7
M^EK_ *&O_"Q_AY_T/G@S_P *C0__ ).H_P"%C_#S_H?/!G_A4:'_ /)U?YY6
M^Z_Z">L?^#C5/_DNC?=?]!/6/_!QJG_R71[3R_'_ ( ?5%_._P#P'_[;U_I:
M_P"AK_PL?X>?]#YX,_\ "HT/_P"3J/\ A8_P\_Z'SP9_X5&A_P#R=7^>5ONO
M^@GK'_@XU3_Y+HWW7_03UC_P<:I_\ET>T\OQ_P" 'U1?SO\ \!_^V]?Z6O\
MH:_\+'^'G_0^>#/_  J-#_\ DZC_ (6/\//^A\\&?^%1H?\ \G5_GE;[K_H)
MZQ_X.-4_^2Z-]U_T$]8_\'&J?_)='M/+\?\ @!]47\[_ / ?_MO7^EK_ *&O
M_"Q_AY_T/G@S_P *C0__ ).H_P"%C_#S_H?/!G_A4:'_ /)U?YY6^Z_Z">L?
M^#C5/_DNC?=?]!/6/_!QJG_R71[3R_'_ ( ?5%_._P#P'_[;U_I:_P"AK_PL
M?X>?]#YX,_\ "HT/_P"3J/\ A8_P\_Z'SP9_X5&A_P#R=7^>5ONO^@GK'_@X
MU3_Y+HWW7_03UC_P<:I_\ET>T\OQ_P" 'U1?SO\ \!_^V]?Z6O\ H:_\+'^'
MG_0^>#/_  J-#_\ DZC_ (6/\//^A\\&?^%1H?\ \G5_GE;[K_H)ZQ_X.-4_
M^2Z-]U_T$]8_\'&J?_)='M/+\?\ @!]47\[_ / ?_MO7^EK_ *&O_"Q_AY_T
M/G@S_P *C0__ ).H_P"%C_#S_H?/!G_A4:'_ /)U?YY6^Z_Z">L?^#C5/_DN
MC?=?]!/6/_!QJG_R71[3R_'_ ( ?5%_._P#P'_[;U_I:_P"AK_PL?X>?]#YX
M,_\ "HT/_P"3J/\ A8_P\_Z'SP9_X5&A_P#R=7^>5ONO^@GK'_@XU3_Y+HWW
M7_03UC_P<:I_\ET>T\OQ_P" 'U1?SO\ \!_^V]?Z6O\ H:_\+'^'G_0^>#/_
M  J-#_\ DZC_ (6/\//^A\\&?^%1H?\ \G5_GE;[K_H)ZQ_X.-4_^2Z-]U_T
M$]8_\'&J?_)='M/+\?\ @!]47\[_ / ?_MO7^EK_ *&O_"Q_AY_T/G@S_P *
MC0__ ).H_P"%C_#S_H?/!G_A4:'_ /)U?YY6^Z_Z">L?^#C5/_DNC?=?]!/6
M/_!QJG_R71[3R_'_ ( ?5%_._P#P'_[;U_I:_P"AK_PL?X>?]#YX,_\ "HT/
M_P"3J/\ A8_P\_Z'SP9_X5&A_P#R=7^>5ONO^@GK'_@XU3_Y+HWW7_03UC_P
M<:I_\ET>T\OQ_P" 'U1?SO\ \!_^V]?Z6O\ H:_\+'^'G_0^>#/_  J-#_\
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MXK]*Z_-3X ?\I&?VXO\ L2O@5_Z8KBO6RW_=<[_[%<?_ %9Y:9U-Z7_7Q?\
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M^#GPQT?5M+_9]^$L9T#3M76VGAL?&/BJ'$&M:O>R(B)>)]OC9]/FF#XA8%'
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M3M\B-.YVX 0..17SG+B&66)V4-#*\3'( +1L58KD],@X]J_;CXX_$+X!VG[
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MT;Q!\>OCE]MO9(=6MH[JX^'OP[ENY18PQ1N0^GZ])&T,JS%1*86&,#%?GO\
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M_ -AXJ^$UGK%UH7ARQBL+/[1)-&$EGCA^26Y6+"O-U<[CWK\Y+(9U+2N,_\
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M0\0:))=ZKX7GT*:XLC-!/J%M;2V=K;0VC-'.D\GRQJV\@9-._;Q^&VI?%/\
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MF5+368&X:*]3&70C@@$5S/V;4O\ H">(/_!#J_\ \AT?9M2_Z GB#_P0ZO\
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MCOM<D3"KL-RP"KM4!5^51PH ]JXHVNHG@Z'KY'H= U<_^V=+]FU+_H">(/\
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M!(,FEI%)MW^9YI^<!@.3[5\D;1@+V P.>>!C@CD'W&#4GV74<D_V'K^3U/\
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MGBM_7?B%XZ\4>+K;Q]XD\4:EK7C:S-BUKXEOG67486TQ=NGE6(V$6BX$0*D
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MA.\*_P#A/:1_\AUU5% 7?=_U_P ,ON.5_P"$%\$?]"=X5_\ ">TC_P"0Z/\
MA!?!'_0G>%?_  GM(_\ D.NJHH"[[O\ K_AE]QRO_""^"/\ H3O"O_A/:1_\
MAT?\(+X(_P"A.\*_^$]I'_R'7544!=]W_7_#+[CE?^$%\$?]"=X5_P#">TC_
M .0Z/^$%\$?]"=X5_P#">TC_ .0ZZJB@+ON_Z_X9?<<K_P (+X(_Z$[PK_X3
MVD?_ "'1_P (+X(_Z$[PK_X3VD?_ "'7544!=]W_ %_PR^XY7_A!?!'_ $)W
MA7_PGM(_^0Z/^$%\$?\ 0G>%?_">TC_Y#KJJ* N^[_K_ (9?<<K_ ,(+X(_Z
M$[PK_P"$]I'_ ,AT?\(+X(_Z$[PK_P"$]I'_ ,AUU5% 7?=_U_PR^XY7_A!?
M!'_0G>%?_">TC_Y#H_X07P1_T)WA7_PGM(_^0ZZJB@+ON_Z_X9?<<K_P@O@C
M_H3O"O\ X3VD?_(='_""^"/^A.\*_P#A/:1_\AUU5% 7?=_U_P ,ON.5_P"$
M%\$?]"=X5_\ ">TC_P"0Z/\ A!?!'_0G>%?_  GM(_\ D.NJHH"[[O\ K_AE
M]QDZ9H&A:*96T?1=)TEIPHG;3--L[ S!/NB4VL,1D"_P[]V.V*UJ**!!1110
M 4444 %%%% !1110 4444 %8%]X4\+ZI<O>ZGX;T#4;QU57N[[1].N[EU081
M7GN+:25E4<*"Y"C@ "M^B@#E?^$%\$?]"=X5_P#">TC_ .0Z/^$%\$?]"=X5
M_P#">TC_ .0ZZJB@=WW?]?\ #+[CE?\ A!?!'_0G>%?_  GM(_\ D.C_ (07
MP1_T)WA7_P )[2/_ )#KJJ* N^[_ *_X9?<<K_P@O@C_ *$[PK_X3VD?_(='
M_""^"/\ H3O"O_A/:1_\AUU5% 7?=_U_PR^XY7_A!?!'_0G>%?\ PGM(_P#D
M.C_A!?!'_0G>%?\ PGM(_P#D.NJHH"[[O^O^&7W'*_\ ""^"/^A.\*_^$]I'
M_P AT?\ ""^"/^A.\*_^$]I'_P AUU5% 7?=_P!?\,ON.5_X07P1_P!"=X5_
M\)[2/_D.C_A!?!'_ $)WA7_PGM(_^0ZZJB@+ON_Z_P"&7W'*_P#""^"/^A.\
M*_\ A/:1_P#(='_""^"/^A.\*_\ A/:1_P#(==510%WW?]?\,ON.5_X07P1_
MT)WA7_PGM(_^0Z/^$%\$?]"=X5_\)[2/_D.NJHH"[[O^O^&7W'*_\(+X(_Z$
M[PK_ .$]I'_R'1_P@O@C_H3O"O\ X3VD?_(==510%WW?]?\ #+[CE?\ A!?!
M'_0G>%?_  GM(_\ D.C_ (07P1_T)WA7_P )[2/_ )#KJJ* N^[_ *_X9?<<
MK_P@O@C_ *$[PK_X3VD?_(='_""^"/\ H3O"O_A/:1_\AUU5% 7?=_U_PR^X
MY7_A!?!'_0G>%?\ PGM(_P#D.C_A!?!'_0G>%?\ PGM(_P#D.NJHH"[[O^O^
M&7W'*_\ ""^"/^A.\*_^$]I'_P AT?\ ""^"/^A.\*_^$]I'_P AUU5% 7?=
M_P!?\,ON.5_X07P1_P!"=X5_\)[2/_D.C_A!?!'_ $)WA7_PGM(_^0ZZJB@+
MON_Z_P"&7W'*_P#""^"/^A.\*_\ A/:1_P#(='_""^"/^A.\*_\ A/:1_P#(
M==510%WW?]?\,ON.5_X07P1_T)WA7_PGM(_^0Z/^$%\$?]"=X5_\)[2/_D.N
MJHH"[[O^O^&7W'*_\(+X(_Z$[PK_ .$]I'_R'1_P@O@C_H3O"O\ X3VD?_(=
M=510%WW?]?\ #+[CE?\ A!?!'_0G>%?_  GM(_\ D.@^!/ Y&#X-\*$'J#X>
MT@@_A]CKJJ* N^[_ *_X9?<106\%K#%;6L$-M;P(L<,$$:0PPQJ,+'%%&JI&
MBCA510H'  J6BB@04444 %%%% !1110 4444 4]1_P"0???]>=U_Z(>OD_\
M8<_Y-ZT#_L9/&W_J4:E7UAJ/_(/OO^O.Z_\ 1#U\G_L.?\F]:!_V,GC;_P!2
MC4J[Z7_(MQG_ &%X'_TUC27\<?\ #+\X'UY1117 45Z*** )UZ#Z#^5+2+T'
MT'\J6@ K\U/V?^?^"C/[<A'(3P7\"5;V+:#<LH/U"DCZ5^E=?*OCK]C[X5>.
MOB)KOQ3EU#QUX7\9^)[#2]-\0ZEX-\5W/A]=8M=%A\C3%OHK>!_.:TBRD;,W
M )P.:]'+\10I0Q]+$2G3CC,%]7C4A!5.2:Q>$Q"<H<T&XN-"4=)74G%VM<B<
M6^5K[,E*VUU:2_6Y]545\<_\,5> ?^BC_'+_ ,.9J/\ \BT?\,5> ?\ HH_Q
MR_\ #F:C_P#(M3[#+_\ H/J_^$3_ /F@+S_D7_@2_P O7^GI]C45\<_\,5>
M?^BC_'+_ ,.9J/\ \BT?\,5> ?\ HH_QR_\ #F:C_P#(M'L,O_Z#ZO\ X1/_
M .: O/\ D7_@2_R]?Z>GV-17QS_PQ5X!_P"BC_'+_P .9J/_ ,BT?\,5> ?^
MBC_'+_PYFH__ "+1[#+_ /H/J_\ A$__ )H"\_Y%_P"!+_+U_IZ?8U%?'/\
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M,5> ?^BC_'+_ ,.9J/\ \BT?\,5> ?\ HH_QR_\ #F:C_P#(M'L,O_Z#ZO\
MX1/_ .: O/\ D7_@2_R]?Z>GV-17QS_PQ5X!_P"BC_'+_P .9J/_ ,BT?\,5
M> ?^BC_'+_PYFH__ "+1[#+_ /H/J_\ A$__ )H"\_Y%_P"!+_+U_IZ?8U%?
M'/\ PQ5X!_Z*/\<O_#F:C_\ (M'_  Q5X!_Z*/\ '+_PYFH__(M'L,O_ .@^
MK_X1/_YH"\_Y%_X$O\O7^GI]C45\<_\ #%7@'_HH_P <O_#F:C_\BT?\,5>
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M45\<_P##%7@'_HH_QR_\.9J/_P BT?\ #%7@'_HH_P <O_#F:C_\BT>PR_\
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M_H/J_P#A$_\ YH"\_P"1?^!+_+U_IZ?8U%?'/_#%7@'_ **/\<O_  YFH_\
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M:C_\BT?\,5> ?^BC_'+_ ,.9J/\ \BT>PR__ *#ZO_A$_P#YH"\_Y%_X$O\
M+U_IZ?8U%?'/_#%7@'_HH_QR_P##F:C_ /(M'_#%7@'_ **/\<O_  YFH_\
MR+1[#+_^@^K_ .$3_P#F@+S_ )%_X$O\O7^GI]C45\<_\,5> ?\ HH_QR_\
M#F:C_P#(M'_#%7@'_HH_QR_\.9J/_P BT>PR_P#Z#ZO_ (1/_P": O/^1?\
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ERM:UN5WO=6%S.2;25DUO>]^5]EM9_A\NNHHHKSBRO1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>img12876764_22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_22.jpg
M_]C_X  02D9)1@ ! @$!( $@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +$ P$# 2(  A$! Q$!_\0
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MG_+F/E_T]\G^/?3#^T:G_/N'3[3\K]/7[_N_U7_^'D?[*/\ T4/0/_![I?\
M\E4?\/(_V4?^BAZ!_P"#W2__ )*K_*@\V[_Z"6K?^#;4?_DFCS;O_H):M_X-
MM1_^2:/^('Y/_P!#;&]/^7,?+_I[Y/\ 'OH?VC4_Y]PZ?:?E?IZ_?]W^J_\
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M_P#X>1_LH_\ 10] _P#![I?_ ,E4?\/(_P!E'_HH>@?^#W2__DJO\J#S;O\
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M /)5?Y4'FW?_ $$M6_\ !MJ/_P DT>;=_P#02U;_ ,&VH_\ R33_ .('Y/\
M]#;&]/\ ES'R_P"GOD_Q[Z']HU/^?<.GVGY7Z>OW_=_JO_\ #R/]E'_HH>@?
M^#W2_P#Y*H_X>1_LH_\ 10] _P#![I?_ ,E5_E,C4&,YMAK5^;E1DP#6[TS
M>IB^U[Q^*U/YMW_T$M6_\&VH_P#R31_Q _)U:^;8WI_RYCY?]/?)^NO?0_M&
MI_S[ATO[S_NWZ>OWKY?ZK_\ P\C_ &4?^BAZ!_X/=+_^2J/^'D?[*/\ T4/0
M/_![I?\ \E5_E0>;=_\ 02U;_P &VH__ "31YUW_ -!+5O\ P;:C_P#)-'_$
M#\G_ .AMC>G_ "YCY?\ 3WR?X]]#^T:G_/N'3[3\K]/7[_N_U7_^'D?[*/\
MT4/0/_![I?\ \E4?\/(_V4?^BAZ!_P"#W2__ )*K_*E9-72&.YDE\1Q6<KM'
M#>R7FKQV4\BC+1P733B&611RR1NS*.2 *B\V[_Z"6K?^#;4?_DFDO!#)O^AO
MC';1_NH/56NOXOD[_/OH?VC4_P"?<.GVGY7Z>OW_ '?ZK_\ P\C_ &4?^BAZ
M!_X/=+_^2J/^'D?[*/\ T4/0/_![I?\ \E5_E0>;=_\ 02U;_P &VH__ "31
MYMW_ -!+5O\ P;:C_P#)-/\ X@?D_P#T-L;T_P"7,?+_ *>^3_'OH?VC4_Y]
MPZ?:?E?IZ_?]W^J__P /(_V4?^BAZ!_X/=+_ /DJC_AY'^RC_P!%#T#_ ,'N
ME_\ R57^5!YMW_T$M6_\&VH__)-'FW?_ $$M6_\ !MJ/_P DT?\ $#\G_P"A
MMC>G_+F/E_T]\G^/?0_M&I_S[AT^T_*_3U^_[O\ 5?\ ^'D?[*/_ $4/0/\
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M=M7U *!ZEC=  >^<56&J*=I&N7V'.V-O[<O=KMTVHWVO#-GC R<\4+P.R?\
MZ&V-Z?\ +F/]W_I[Y?._GH?VE4ZTX=/M/^[?IZ_>C_5J_P"'D?[*/_10] _\
M'NE__)5'_#R/]E'_ **'H'_@]TO_ .2J_P J#SKO_H):M_X-M1_^2:/-N_\
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M('91_P!#7&]/^7,?+_I[Y/UOYZ"S*I_S[AT^T_[M^GK]Z/\ 5K_X>1_LH_\
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M$U^M'_!0O_DW3]A7_L0IO_2)Z_)>_P#^/*Z_ZX2?^@FOUH_X*%_\FZ?L*_\
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MO]H3X%>#O'5F(+#_ (6EXFCN+A[6^A-HDQU*71-<*;]9E"^7+@.&4$5^$O\
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M^Q7C/_3,S2C_ !:7_7R'_I2/QQU;_D8?%O\ V.GC+_U)M5JG5S5O^1A\6_\
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M_P"SE^P+\8?V#;+X)Z7XLTKXO7^HW]Q\2[GQ%+8WVA-J!R4CT=%*7)@Y$;9
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M5?$WQIXB\<:^VA/81:IXEU.XU.ZM=.M?#TL%K96TMRS-#;6\"1Q1Q*0JHB@
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M.D8BI";IQI_#3IJ":3BGK?12;=DK*\M6TWU%HHHK[8YPHHHH **** "BBB@
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M/7Y+W_\ QY77_7"3_P!!-?K1_P %"_\ DW3]A7_L0IO_ $B>O$S/_D9\/_\
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M*M>-Y5Y0IJ+5)Q;<ERI\VMK/2G3]ISMR4%"/-)N[TYE'1)-MZ_/8_BT1U<9
M<>JR1R1./JDBHX_%17M'[/'P%^(G[4/QK\ ? /X4::-4\>_$75TTK18) PMH
M0"C7=Y=R)_J;>TMV:>5VP B$\X-?T-_\%_OV:/V9-'^!G[(7[;G[/'P[M?A6
M_P"T+9V]KXB\):;'Y&GN]Q;QWINOLP"QPS6S.;1#&BK)'&LFU2Q%8?\ P:U>
M"="US]L/]HGXBZI96]WJWP5^ EWXO\+O/&KO::E>SOITDT#,"4;RW&XK@D#!
MRI->77XNA4X.Q_$^$PU2E4PU'$PCA,3RN5+'4<1]2]E4=.3C.$,4X\THM*<$
M[6>BM4&L1"C)I\TH^]'9QE'GNKZKW=K]3\Z==_X).?&J#]O"#]@#PCXU\"^*
M_B7I^E3:KX[\5VNID^#_  %'IUG'J&NP^(-049M)M+LVDD=&!(:)U(R,5SW[
M<'_!,'XL_L8M\(M9M/&O@GXZ_#_XZ:^_@WX;>,OA=J#:[::QXUMY!#=>'?W2
MC%U'.?*50H^;&XCFNW^%?_!0WQ%^S%_P4X^-W[66N^'T\?:;XV\8_$#1?B3X
M8OYY8VUSPWXACN]"U..*X7,L<\=BTK1!>"^ 1WK^@SX7?%?P+^T#\$/@K\0_
M@=^R[<^&/!GPH\5>,YOV'?@GKKS7?B/XE_&SQ%9R1^+/'&HV5\,P^&O RR#7
MK+44"1L(CB3BO*S'.N)\GKY3B,3&CB<MGEV%6*J*&&HT\3F-;#8F>(BZDJT:
MN'E3Q"PKIJG2G0A@OK5>M.*IMQJ$*4XS2NI<[Y5=MQ@G%)V2M*\>;=I\SBE<
M_E9^,G[%'CW]GSXY_"K]G[XL>,? NG^-_B;9^$[N\CT;5UO8?A]+XOE2*STO
MQLYXTO5=.,BG5;=B?LP.3Z5T/[?O_!/SXS?\$\/BCH'PY^+%SHWB'3O&'ARP
M\3^"_'?A:=[WPMXFT^_B,VS3;\@+//:H,SJO &'7<A5C>_X*+_LD?MH?LV?$
M2^^*O[6<'VWQ7\:M8U;Q1IWQ)TF].IZ'JWB$$W-U8V&H)/.L-UI*K&CVJR*L
M#1X4"OW]_P""QFFVGQC_ ."+/_!/'X]:_&9?&?@3PYHGAZ'4)^;NZ2YTJUTB
MXD>1LR2)+%9I)@L0)))&&"2:]&KG^*P^+X0G''8/,<#GE7$Y=C:N$IQ]E+'>
MP=:A7PLU)RC2IUJ=3#3IR;;B^>24U92J:<:ZY91G349Q4KW4.9*2DN[3YD_P
M9_(31117W)@%%%% !1110 4444 ?57["O_)YG[-?_96/!_\ Z?+"O];[7_\
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M_&C^W<D_Z'.5?^''"?\ RX/9U/\ GW4_\ E_EY_GV9^?U%?H#_PZB_X*3?\
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M_C1_;N2?]#G*O_#CA/\ Y<'LZG_/NI_X!+_+S_/LS\_J*_0'_AU%_P %)O\
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M;_HS_P")_P#X#V_^-'_#J+_@I-_T9_\ $_\ \![?_&C^W<D_Z'.5?^''"?\
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M .&K-'_Z%:]_-:/^&K-'_P"A6O?S6OBRBCZO2_E?W_UV_/NP/M/_ (:LT?\
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M0JU</&H\32HUFK4JU6E"G5^Q*2DN9*K!RY%+WM5L[-JUTI6Y6U?5)MGZX_\
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MOU[)?Y@9U%%%8 >/_M _\D]\/_\ 8U2?^B%KX_K[ _:!_P"2>^'_ /L:I/\
MT0M?(*E0REAE0P+ =2H/(_$<5Z.'_A+UE^8'XU_\%:OCCX0T!OV?_P!GWQ3K
M&JZ=X:^(OQ!TSQ'\3GT+2KS7-0T[POX5NH-9TZ2;2]/62[N+74;F%K9PJ;""
M0V5X/%_L"?M!_!33?V^_B[\&_@MJ6K3?"3XRZ1I'CCP+!JOAG4_"4$/C]/(?
MQ9:6=AJL<33;((@S- ".3D '-??NA?LGW$O[7?CC]J;XC>)]&\;0:KX&TOP/
M\/O!<FE?)X,M].N/.DOYGN%:"YNKF(F&22-<GOQ1^T)^R:?BO\1?@!\5_AOK
M^A_"[QU\"_%MQKD6JPZ.I&OZ)J1CCU?1)TM$0$W%HC0P/(I6%GWU]]1S/)H9
M73R*<J_)7RO$+$8Z-5K!T\TQ+AC:<YX3ZFZ]2>'K8?"X%UX5DE24W&,XN3EQ
MNG5<W6LM*D>6%O?=./NVNY62:<IVM>_F?DCJ0Q\(/^"FH]/BG>#_ ,GJ_<_]
MFS_DW+X#_P#9+?"W_I(:^.;[_@G_ *]=^#OVI_"J?$W28I/VCO%<GB73KPZ1
M,4\)I)*LK6MY&.;U\@_O$R#FOO;X8>$)OAY\,_A]\/[F^BU2X\$>$])\-3ZG
M#&88=1ETR$Q/=Q0L2T23'YE0\KTKEX@S+!8W"0IX:NJLUCZ=9Q4*D6J<<HP.
M&<KSA%:5Z52G9/FO%NW*U)W1A*,FY)I<K7SYV_R:9\5_\%47?_ABCXCKNX%W
MIG''_/4>V:^O?@N[-\ /A$K,2H^"_ACCC@?\(ROH*\]_:U^ =_\ M-? SQ-\
M'M-\36GA"\\036LL>NWMH][;6HMG#%7MT^9R_08Z5[+X&\-2>#_AYX.\#3W:
M7\WA7P/I?A"748T,<5[+INE#36OHXC\T<<S#S5C/*KQBO)JXFA+(L%A%-/$4
M<UQN(J4U&2<:57#82%.IS./(^:=.HDE)R3C=I)IO11?MI2M[K@DGTO?;N?@K
M_P $\O&?[<>C?!+Q=8_ [X;^$/$OP_C^-'Q3.G:IK!B^VRRMXMO#<J^_YL(V
M0N>P[U^FO[3OQ_\ &GP&_8G\=_%CXC6EKH?Q67PM>:9::+I@#I+XBU$K9I9:
M<B?ZR86L\\BI&&<E,*"<8^7O@_\ L0?M_P#[/>@>(/!/P=_:[^"FF>!M3\:^
M*_%^EZ=X@^&>H:EJEA_PE&K3ZJ]G<WB_+,ULTHCWKPVTXXKW/XB_LA?'#X\>
M'OV=M#^/?QH\&^)E^$GQ#M?B!\1X/#?AFYTK2_B1/8,PL=-M+.3BRM4B*B:.
M?*R.H;IU^GS3$Y+C,[ACJF*R66 >9/%UG@J.8QS'$4(0=7V6)5;#JBWB)TXT
M9.#M&I54M(*37/3C5C3<%&JI<G*N9PY(MN*O&SOI=RU3VL?BWX&^//[.'P)O
M?V%/B#\,/$/BN\^(.@ZT?"7QZEU/P'X@T!;GPCXVO_[:U"?4=<OH$M+@VFL7
M_P!EC:1SN11L.TJ*_17]O;6_B?:?MM?L?:Y\#]&TSQ'XUO-*74-"TW5"IL;B
MVU"W6ZA,C'*X,$JMGGZ=,?HS^T5^SAX%^/OP2\>_!LZ/H/AM?%ND0:=I.NQ:
M5;"?P_<V4\5QI]Y"T,:R[K=X(@2C;BJD#KS\:?$G]A?]I3Q'-^S3XO\  ?[1
MG@?0/BU^SYX<A\/W'BKQ-X2O-8TGQ.MJBV]I.E@@WP>59I'"P?.YE+?7HIY[
MD^/Q>%Q]::PF(ITL[P5:GFM2IC*=:ECZ-7$86I5JX/!TK8>GB:]7#2IQIN=.
MFZ3BY1NXIT:D(R@ES1;I23@E%IQ<8R2YI.\N5*5V]7TOO]-? [Q9^V?K_B7Q
M%:?'SP#X2\)Z"ND7+:!?:.8VDE\0-Y@@CN%103 LOEDCN,^M?B_X@@T?P?\
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M45/@EZ >33_\?%W_ -?EY_Z52U'4D_\ Q\7?_7Y>?^E4M1U4=EZ+\@"BBBF
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M\7_\(OXH_P"A;US_ ,%T_P#\31_PB_BC_H6]<_\ !=/_ /$U]H?\))K7_/\
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M;R_EC][_ ,O7^GH'Q?\ \(OXH_Z%O7/_  73_P#Q-'_"+^*/^A;US_P73_\
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M?^;\Z/;R_EC][_R]?Z>@?%__  B_BC_H6]<_\%T__P 31_PB_BC_ *%O7/\
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M]O+^6/WO_+U_IZ!\7_\ "+^*/^A;US_P73__ !-'_"+^*/\ H6]<_P#!=/\
M_$U]H?\ "2:U_P _\WYT?\))K7_/_-^='MY?RQ^]_P"7K_3T#XO_ .$7\4?]
M"WKG_@NG_P#B:/\ A%_%'_0MZY_X+I__ (FOM#_A)-:_Y_YOSH_X236O^?\
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MS_PC6MGV;3)F'XAD(/XBOL__ (236O\ G_F_.C_A)-:_Y_YOSH]O+^6/WO\
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M\7_\(OXH_P"A;US_ ,%T_P#\31_PB_BC_H6]<_\ !=/_ /$U]H?\))K7_/\
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MUX;^(>@Q2>;'X>\:Z9--'J6E!\Y;RT1),D#[_0=*^H:_'G_@DG/)9Z[_ ,%
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M)VLZ7;Z+-JMMID@ET[38-+M,VT,%BX^21#N?^*OT!_X17Q'_ - F?_OY!_\
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MLX*IB:TJLHQ?NP3TC3A=MJ%."C"%VWRQ5VW=E1BH1C%;127F_-^;W9@45O\
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MGB3QKJENEOK/BS7->OGU"\O]35>2R3R2"%"S")'V(0HQ7UM_PBOB/_H$S_\
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MRZSJ%J?A'X:N]1UN_N9WGN[G6=6EQ=ZA=7'F/&US<L\H4C!P *_5M?@W\/\
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MXF^.H;<MX>T3PEX,NBU_X<U.[R!'?ZTA0V<!!$@'.>#7ZI_\(KXC_P"@3/\
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MBL13JQM>,Z4()IJ2Y-'+WDD@A5C-72DHVNI27+%K39OU/=?^$L\4?]!_5/\
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M9/\ _'*Y^BCEC_+'[E_71?<!T'_"6>*/^@_JG_@9/_\ '*/^$L\4?]!_5/\
MP,G_ /CE<_11RQ_EC]R_KHON Z#_ (2SQ1_T']4_\#)__CE'_"6>*/\ H/ZI
M_P"!D_\ \<KGZ*.6/\L?N7]=%]P'0?\ "6>*/^@_JG_@9/\ _'*/^$L\4?\
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M4?\ "6>*/^@_JG_@9/\ _'*Y^BCEC_+'[E_71?<!T'_"6>*/^@_JG_@9/_\
M'*/^$L\4?]!_5/\ P,G_ /CE<_11RQ_EC]R_KHON Z#_ (2SQ1_T']4_\#)_
M_CE'_"6>*/\ H/ZI_P"!D_\ \<KGZ*.6/\L?N7]=%]P'0?\ "6>*/^@_JG_@
M9/\ _'*/^$L\4?\ 0?U3_P #)_\ XY7/T4<L?Y8_<OZZ+[@-V3Q;XHV-_P 3
M_5.A_P"7R?\ ^.5Z9XY\1^(+?0O!TD&L:A$\UD3,Z7,RF0[>K$/DGW.37B<G
MW&^E>I^/_P#D >"?^O$_^@U#C'G@K*UI:673EM]W0#C_ /A+/%'_ $']4_\
M R?_ ..4?\)9XH_Z#^J?^!D__P <KGZ*OEC_ "Q^Y?UT7W =!_PEGBC_ *#^
MJ?\ @9/_ /'*/^$L\4?]!_5/_ R?_P".5S]%'+'^6/W+^NB^X#H/^$L\4?\
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MXH_Z#^J?^!D__P <H_X2SQ1_T']4_P# R?\ ^.5S]%'+'^6/W+^NB^X#H/\
MA+/%'_0?U3_P,G_^.4?\)9XH_P"@_JG_ (&3_P#QRN?HHY8_RQ^Y?UT7W =!
M_P )9XH_Z#^J?^!D_P#\<H_X2SQ1_P!!_5/_  ,G_P#CE<_11RQ_EC]R_KHO
MN Z#_A+/%'_0?U3_ ,#)_P#XY1_PEGBC_H/ZI_X&3_\ QRN?HHY8_P L?N7]
M=%]P'0?\)9XH_P"@_JG_ (&3_P#QRO5O@OXCU^\\<P07>L7]Q"=/U)C%+<RN
MA*6,[J=K.1E6 8''!%>$UZ[\#O\ D?K?_L':I_Z;YZBI&/)+W5MV7E_D@.&F
M\6>)Q/<@:_J@"W=VH'VR?@+<R@ ?O.@  %1_\)9XH_Z#^J?^!D__ ,<K#G_X
M^+O_ *_+S_TJEJ.J48V7NK9=%Y?Y+[@.@_X2SQ1_T']4_P# R?\ ^.4?\)9X
MH_Z#^J?^!D__ ,<KGZ*?+'^6/W+^NB^X#H/^$L\4?]!_5/\ P,G_ /CE'_"6
M>*/^@_JG_@9/_P#'*Y^BCEC_ "Q^Y?UT7W =!_PEGBC_ *#^J?\ @9/_ /'*
M/^$L\4?]!_5/_ R?_P".5S]%'+'^6/W+^NB^X#H/^$L\4?\ 0?U3_P #)_\
MXY1_PEGBC_H/ZI_X&3__ !RN?HHY8_RQ^Y?UT7W =!_PEGBC_H/ZI_X&3_\
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MKTTXMQUC))N$I<KM$*L:C:2DFDI6DK-Q>TEW3/1?^$L\4?\ 0?U3_P #)_\
MXY1_PEGBC_H/ZI_X&3__ !RN?HKS.6/\L?N7]=%]QH=!_P )9XH_Z#^J?^!D
M_P#\<H_X2SQ1_P!!_5/_  ,G_P#CE<_11RQ_EC]R_KHON Z#_A+/%'_0?U3_
M ,#)_P#XY1_PEGBC_H/ZI_X&3_\ QRN?HHY8_P L?N7]=%]P'0?\)9XH_P"@
M_JG_ (&3_P#QRC_A+/%'_0?U3_P,G_\ CE<_11RQ_EC]R_KHON Z#_A+/%'_
M $']4_\  R?_ ..4?\)9XH_Z#^J?^!D__P <KGZ*.6/\L?N7]=%]P'HW@OQ1
MXDF\6>'XI=<U*2.34[1'C>ZF975IXPRLID((()!!!K[KU?\ Y"E]_P!=S_Z
MM?GOX'_Y'#PY_P!A6S_]*(Z_0C5_^0I??]=S_P"@)7#B4E*-DEOLK=(@9U%%
M%<P'C_[0/_)/?#__ &-4G_HA:^/P,G ZG@5]@?M _P#)/?#_ /V-4G_HA:^/
MZ]'#?PEZR_,#\^/VB_V>?A3^T/\ &S3+KP/\:M>^#7[7/P_\.V]WIVL>"[N*
MU\0WOA69A'9V6K6]PX.H:,7 VQ0Q2E<EL <UY_\ ![XR?M-?!3]K#X>?L?\
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M\**^)W_0&L/_  ;V?_Q5>Z8_VG_[^/\ _%48_P!I_P#OX_\ \51[:IWC_P"
M/R_O^O\ 6P>%_P#"BOB=_P! :P_\&]G_ /%4?\**^)W_ $!K#_P;V?\ \57N
MF/\ :?\ [^/_ /%48_VG_P"_C_\ Q5'MJG>/_@#\O[_K_6P>%_\ "BOB=_T!
MK#_P;V?_ ,51_P **^)W_0&L/_!O9_\ Q5>Z8_VG_P"_C_\ Q5&/]I_^_C__
M !5'MJG>/_@#\O[_ *_UL'A?_"BOB=_T!K#_ ,&]G_\ %4?\**^)W_0&L/\
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MX_\ \53]M4[Q_P# 'Y?W_7^M@\+_ .%%?$[_ * UA_X-[/\ ^*H_X45\3O\
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M?_XJC'^T_P#W\?\ ^*H]M4[Q_P# 'Y?W_7^M@\+_ .%%?$[_ * UA_X-[/\
M^*H_X45\3O\ H#6'_@WL_P#XJO=,?[3_ /?Q_P#XJC'^T_\ W\?_ .*H]M4[
MQ_\  'Y?W_7^M@\+_P"%%?$[_H#6'_@WL_\ XJC_ (45\3O^@-8?^#>S_P#B
MJ]TQ_M/_ -_'_P#BJ,?[3_\ ?Q__ (JCVU3O'_P!^7]_U_K8/"_^%%?$[_H#
M6'_@WL__ (JC_A17Q._Z UA_X-[/_P"*KW7:2"09"!U.^3 ^IW4F/]I_^_C_
M /Q5'MJG>/\ X _+^_Z_UL'A?_"BOB=_T!K#_P &]G_\51_PHKXG?] :P_\
M!O9__%5[IC_:?_OX_P#\51C_ &G_ ._C_P#Q5'MJG>/_ ( _+^_Z_P!;!X7_
M ,**^)W_ $!K#_P;V?\ \51_PHKXG?\ 0&L/_!O9_P#Q5>Z8_P!I_P#OX_\
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M&L/_  ;V?_Q5>Z8_VG_[^/\ _%48_P!I_P#OX_\ \51[:IWC_P" /R_O^O\
M6P>%_P#"BOB=_P! :P_\&]G_ /%4?\**^)W_ $!K#_P;V?\ \57NF/\ :?\
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MY6N9<LG>U_G9_L[\"-+_ &FOACX*\4:E^VE\:OAS\0-1L9;G5+3Q3X7\)Q^
M-$T/P_!$\K1ZE&Y$<LB*K-Y[$;L8YK"^&W[>'[*/Q;\;0_#SP/\ %/3KOQ1>
MS3V^C1:@JZ?8>)9K8LLZ>&[V5_+U<QE3G[-NXYZ5X]XZ_9871?V)/C/\"/B[
M^U!)<V7C6XCNY/C5XOOOL]OX8D=V72]'O9YB5%A>WC);R0L0DR.T9X-?G1H&
MM^,_V.-4_92\(?M??LP?!?Q+\-+CQ#%X2^"'[3/PKU#38-?CU6Y>*.SU%O#>
MG,9VAU".>%IYVX()D)PV:\?#95@<U685E6C6QKKU:>$PV7TL/E=&M2HX3VWM
M\+A<13I4Z[YERU,%0E2Q%.FG549N<4]'4G#D5N6/*G)S;FTW)*TI1;:T>DG=
M/9O0_HR((.",'W]^1^8Y'J*2I) RLNXYW10R _[$L,<D>??8ZY]ZCKXPZ0HH
MHH **** "BBB@ HHHH **** $;H?H?Y5U&O?\>&B_P#7 _\ H)KEVZ'Z'^5=
M1KW_ !X:+_UP/_H)H YBBBB@ HHHH **** "BBB@ HHHH **** "LK7]>TGP
MKX?UWQ5K]R+/0_#FE7NL:K='GR;2S@>5VQQG<RJG4?>K5KQC]I+P[JWB_P#9
MU^-_A;08I)];U[X<Z_I^EP0@F:6Z>#S%2,#DN5C; ')[5MAX0JXBA3J2Y*=2
MO2IU)_R0G4C&<]=/=BW*[T5M1-V3:ULF[>B/R'\)_&__ (*E?M-_##QW^V!\
M"/&GPQ^'/PB\/:SXCB^&/P'\1>"X]=\4_$CP[X2OI+;4KN;Q)S_9DVI6\;W-
MH9,E$QMK]3?V0OVB](_:P_9V^'WQTTJP_L>7Q/#?Z=KNB-())=)\2^'[G^R]
M>M7P241=3BN!$I_@ QQBODW_ ()G_&3X;:;_ ,$W='\8W_B#2=.T;X4Z=\1M
M$^($-Y=103^'-3TH76FW,.KV[LK6TMQ=$>4KJ3)D$=:Q/^"+6@:MI?[#.@Z]
MJ,$MI9>-_B3\4?$N@6LZF-UT:_\ &.H7-E<K$WS)%>6\T<\1P Z.&'6OL<\H
M4)83.E_9V%P#R;/</E^!G0H*A4J8:K3QRJ8?$324L75A'"8?$^WK.=9.M-N2
MA4BES4G)2I>_*7M:+G--W2DG"S2^S?F<;*R]W:]S]7Z***^(.H**** "BBB@
M HHHH **** "BBB@ KK_  1_R'8_^O:Z_P#1#UR%=?X(_P"0['_U[77_ *(>
MIG\+^7YH#DG_ -9+_P!=IO\ T:]-IS_ZR7_KM-_Z->FU0!1110 4444 %%%%
M !1110 5Y'\??C!H'[/WP7^(?QE\3(TND^!M"N+\6RMM:]U.6.2/2;$-D!/M
ME^(;<L>%$F><5ZY7Y^_\%5?#&M>,/^"?G[0.A^'[>XN]26U\+:R8+56>8Z?H
M.NPZIJDBHGS%8K*WE>3T0,>@-=^54*.*S/+L-B)<M#$8["4*TKVY:56O3A4=
MWHK0D]>FY%1N,)2BKM1;2[M'PE>_'/\ X*M>%?@)I/[>7B#QA\+=0^%=]+9>
M(]:_9>M_!<,'BK1?AG=7[QM>_P#"9\)+J-EIL;WTQ'S,I"\8X_;7X6_$/0?B
M]\,O 7Q6\+,S>&_B%X:T_P 2Z.6.6%M>QC<I.3G9,LB YZ+7YY?%'XW_  PF
M_P""2>H?$VV\1:)+X1\3? I_">B2+=PNMQXBU;1[G0+/28X@Q<WYU,B/R0N]
M7/(R<5]#_P#!/7PSK/@S]A']E#PMXB@FM-<T;X1:-;:E:7"LL]M.\]U.L4BL
M 5(BEC(!'0BO?SJ-.OEL\7+ 87+\1AL^Q664H87#QPJGA88=U'1JP@DJU7!S
MIP@Z\^:O+V[5:<VXM8TFU-1YY34J,9MRDY6DVDFFV[*2;=EIIH?8%%%%?(G2
M%%%% !1110 4444 %%%% &KH?_(8TW_K[A_]"%>EZM_R$[[_ *^&_DM>::'_
M ,AC3?\ K[A_]"%>EZM_R$[[_KX;^2UG4Z?/] ,^BBBLP*GB7_D5[3_L,M_Z
M+KSJO4-<CTYO#5K_ &EK.FZ+$=68Q3ZC.(8I9/+'[E&YS)@YV^E<-Y/A;_H>
M_"W_ ('K_A6L+VV>K[/R7YL#X#_:1_X)S?LP?M7_ !*TOXP?%FW^)MC\1M&T
M"W\+V/B+X=?$'5?!$XT.U;=!:3?V9AI2I/+EAGCCBMW]GC]@/]E_]EWQ+/XV
M^&/A77]6\=3P_9D\<?$GQ%=>.?%MA;]#%IFMZH#=V22#Y9%B8!UX/%?;_D^%
MO^A[\+?^!Z_X4>3X6_Z'OPM_X'K_ (5ZKSG-I82. >8XUX*--48X7VU54%1N
MFJ2@FE[.[3Y/AU=T1[*GS<_)'FO?FLKW[W[GSWX(_9V^%'PZ^,OQ3^/_ (4T
M?4+/XH_&C1=!\/?$/5KC4I;FQU+2O#+;]'BL]/<>7920OS+)&<R]^U>)_M-_
M\$]_V;?VM/%_ASXA_$ZP\::)\0/"\#V6G^-/AQXMO_!7B"YTR4;9=-U+4=,
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MQI&I08^S:IHFJ(&GTW4+<C=#<P8D1N0:]_\ )\+?]#WX6_\  ]?\*/)\+?\
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ML/&4(QG-J<HQ;C",E*;Y?<6L[*S:C6IR4->5S2<8O?7;OOT[GUWY,7_/*/\
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M^>4?_?"_X4>3%_SRC_[X7_"I** (_)B_YY1_]\+_ (4>3%_SRC_[X7_"I**
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M-2/R8O\ GE'_ -\+_A1Y,7_/*/\ [X7_  J2B@"/R8O^>4?_ 'PO^%'DQ?\
M/*/_ +X7_"I** (_)B_YY1_]\+_A1Y,7_/*/_OA?\*DHH C\F+_GE'_WPO\
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M^XM$^ _@/0O@';?LV1+J-_\ #:V\!-\.!_:,RSZO+X>:T-D9);G&TWXA.5F
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MY;SQWX&^%WBK^P_"6O37*E;R4Z< PBFO4:6.X="F])7Z,<U^NO\ PHCXG?\
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M1\3O^@/9_P#@QA_PH]I3_GC]Z\O\T!X])]QOI7J?C_\ Y '@G_KQ/_H-7'^
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MS_\ !C#_ (4>TI_SQ^]>7^: \AHKU[_A1'Q._P"@/9_^#&'_  H_X41\3O\
MH#V?_@QA_P */:4_YX_>O+_- >0T5Z]_PHCXG?\ 0'L__!C#_A1_PHCXG?\
M0'L__!C#_A1[2G_/'[UY?YH#R&BO7O\ A1'Q._Z ]G_X,8?\*/\ A1'Q._Z
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MS_\ !C#_ (4>TI_SQ^]>7^: \AHKU[_A1'Q._P"@/9_^#&'_  H_X41\3O\
MH#V?_@QA_P */:4_YX_>O+_- >0T5Z]_PHCXG?\ 0'L__!C#_A1_PHCXG?\
M0'L__!C#_A1[2G_/'[UY?YH#R&O7?@=_R/UO_P!@[5/_ $WSTO\ PHCXG?\
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M=TFG<_4K[=>_\_=Q_P!_#1]NO?\ G[N/^_AK\]?AO\#?^"G?A/XD:-??&/\
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M>&OO1]WXM5IZZZ?YZ'MGVZ]_Y^[C_OX:/MU[_P _=Q_W\-?+_P !OVOOV?\
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M>_9RT#X;7&F_!KQ-X\;XFZMX3@UNZ42>,WN1>-J%M=JJR6MM]H&];*-1$,D
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MBO4O'>N1Z25V'3+"]ULS3V5H\8\N:*%U2:/Y'4BN^?$^!GETJ<(SHXB.#S'
M*BL%"K]8I8[%XBM[3ZW+&QAAU*GB/WT/J5:HJU-5*55MQ<)5":FG>\>:$[\U
MK.*BK<O+>6JT]Y*SLUW_ !IU77OB;\>?V3_VL?BS\$OV;_V;O@Y^S3?R_%&S
MUWQ[XNU#2-8^(/BW5+(E=8U34M/OP+RQU&Z;Y[&/;NB<8C(ZC*^(Z:3K?_!&
MG]B+6O$4.FZY+IW[2_P:TJWUW4K=+E[;04O_ "FM8KB4$V^EO%\KP\1>7@$
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M!&Z'Z'^5=1KW_'AHO_7 _P#H)KEVZ'Z'^5=1KW_'AHO_ %P/_H)H YBBBB@
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M*'Q^^%5Q_P $D[[XG6GB?0IO#'BGX('P;HJI>0R2S^)M6TFY\/6FCK:J3/\
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MY:__ #XJ_P#@FK_\B%UW7]?\.OO+W_"%ZI_S\Z?_ -_S_A1_PA>J?\_.G_\
M?\_X51_X6-X _P"ART/_ ,#H_P#XNC_A8W@#_H<M#_\  Z/_ .+HY:__ #XJ
M_P#@FK_\B%UW7]?\.OO+W_"%ZI_S\Z?_ -_S_A1_PA>J?\_.G_\ ?\_X51_X
M6-X _P"ART/_ ,#H_P#XNC_A8W@#_H<M#_\  Z/_ .+HY:__ #XJ_P#@FK_\
MB%UW7]?\.OO+W_"%ZI_S\Z?_ -_S_A1_PA>J?\_.G_\ ?\_X51_X6-X _P"A
MRT/_ ,#H_P#XNC_A8W@#_H<M#_\  Z/_ .+HY:__ #XJ_P#@FK_\B%UW7]?\
M.OO+W_"%ZI_S\Z?_ -_S_A1_PA>J?\_.G_\ ?\_X51_X6-X _P"ART/_ ,#H
M_P#XNC_A8W@#_H<M#_\  Z/_ .+HY:__ #XJ_P#@FK_\B%UW7]?\.OO+W_"%
MZI_S\Z?_ -_S_A1_PA>J?\_.G_\ ?\_X51_X6-X _P"ART/_ ,#H_P#XNC_A
M8W@#_H<M#_\  Z/_ .+HY:__ #XJ_P#@FK_\B%UW7]?\.OO+W_"%ZI_S\Z?_
M -_S_A1_PA>J?\_.G_\ ?\_X51_X6-X _P"ART/_ ,#H_P#XNC_A8W@#_H<M
M#_\  Z/_ .+HY:__ #XJ_P#@FK_\B%UW7]?\.OO+W_"%ZI_S\Z?_ -_S_A5V
M/P[XDBC\J+5H8X\8\M+Z54Q_NJP'UXY[UB?\+&\ ?]#EH?\ X'1__%T?\+&\
M ?\ 0Y:'_P"!T?\ \71R5WO0JO\ [@U/_D0NNZ_K_AU]Y?/@W56)9KJP+$DD
MF<DDGJ2<<DTG_"%ZI_S\Z?\ ]_S_ (51_P"%C> /^ART/_P.C_\ BZ/^%C>
M/^ART/\ \#H__BZ.6O\ \^*O_@FK_P#(A==U_7_#K[R]_P (7JG_ #\Z?_W_
M #_A1_PA>J?\_.G_ /?\_P"%4?\ A8W@#_H<M#_\#H__ (NC_A8W@#_H<M#_
M / Z/_XNCEK_ //BK_X)J_\ R(77=?U_PZ^\O?\ "%ZI_P _.G_]_P _X4?\
M(7JG_/SI_P#W_/\ A5'_ (6-X _Z'+0__ Z/_P"+H_X6-X _Z'+0_P#P.C_^
M+HY:_P#SXJ_^":O_ ,B%UW7]?\.OO+W_  A>J?\ /SI__?\ /^%'_"%ZI_S\
MZ?\ ]_S_ (51_P"%C> /^ART/_P.C_\ BZ/^%C> /^ART/\ \#H__BZ.6O\
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M#H__ (NC_A8W@#_H<M#_ / Z/_XNCEK_ //BK_X)J_\ R(77=?U_PZ^\O?\
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MT_\ [_G_  H_X0O5/^?G3_\ O^?\*H_\+&\ ?]#EH?\ X'1__%T?\+&\ ?\
M0Y:'_P"!T?\ \71RU_\ GQ5_\$U?_D0NNZ_K_AU]Y>_X0O5/^?G3_P#O^?\
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M<M?_ )\5?_!-7_Y$+KNOZ_X=?>7O^$+U3_GYT_\ [_G_  H_X0O5/^?G3_\
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M5/\ GYT__O\ G_"C_A"]4_Y^=/\ ^_Y_PJC_ ,+&\ ?]#EH?_@='_P#%T?\
M"QO '_0Y:'_X'1__ !='+7_Y\5?_  35_P#D0NNZ_K_AU]Y>_P"$+U3_ )^=
M/_[_ )_PH_X0O5/^?G3_ /O^?\*H_P#"QO '_0Y:'_X'1_\ Q='_  L;P!_T
M.6A_^!T?_P 71RU_^?%7_P $U?\ Y$+KNOZ_X=?>7O\ A"]4_P"?G3_^_P"?
M\*/^$+U3_GYT_P#[_G_"J/\ PL;P!_T.6A_^!T?_ ,71_P +&\ ?]#EH?_@=
M'_\ %T<M?_GQ5_\ !-7_ .1"Z[K^O^'7WE[_ (0O5/\ GYT__O\ G_"C_A"]
M4_Y^=/\ ^_Y_PJC_ ,+&\ ?]#EH?_@='_P#%T?\ "QO '_0Y:'_X'1__ !='
M+7_Y\5?_  35_P#D0NNZ_K_AU]Y>_P"$+U3_ )^=/_[_ )_PH_X0O5/^?G3_
M /O^?\*H_P#"QO '_0Y:'_X'1_\ Q='_  L;P!_T.6A_^!T?_P 71RU_^?%7
M_P $U?\ Y$+KNOZ_X=?>7O\ A"]4_P"?G3_^_P"?\*/^$+U3_GYT_P#[_G_"
MJ/\ PL;P!_T.6A_^!T?_ ,71_P +&\ ?]#EH?_@='_\ %T<M?_GQ5_\ !-7_
M .1"Z[K^O^'7WE[_ (0O5/\ GYT__O\ G_"C_A"]4_Y^=/\ ^_Y_PJC_ ,+&
M\ ?]#EH?_@='_P#%T?\ "QO '_0Y:'_X'1__ !='+7_Y\5?_  35_P#D0NNZ
M_K_AU]Y>_P"$+U3_ )^=/_[_ )_PH_X0O5/^?G3_ /O^?\*H_P#"QO '_0Y:
M'_X'1_\ Q='_  L;P!_T.6A_^!T?_P 71RU_^?%7_P $U?\ Y$+KNOZ_X=?>
M;VE>$=1M]2LIY+FPV17$;MB;)PIR<# R?2NAU0AM2OF!R#<-@CH>%Y%<+!\0
M/ ]S-%;VWB[1Y[B9PD,,5XC222$X5456)+$X  Y)Z<UUASG+9R>3NSGD9!.>
M>1SS6<U45N>$X;VYH2A?O;F2OTO;;08E%%%0!_.+_P '._QL^+'P._8W_9UU
M_P"$?C;4_ VM:Q^T ^DZGJ.EA//O--_L>>3[)(6(_=[P&QGJ!7\4_P#P\ _;
M2_Z."\7?E%_\77]A'_!V5_R9!^S'_P!G(/\ ^F2XK^#:0NL<C1J&D5'**>C.
M%)53[%L U_6/A-@,#7X+P52O@\)6J/&YBG4JX>C4FTL2U%.<X.3225KNRMH>
M'C926)G:4DK0T4FE\*>R=C[!_P"'@'[:7_1P7B[\HO\ XNC_ (> ?MI?]'!>
M+ORB_P#BZ_4/_@GQ^PE_P1]_:J\+?"_PA\9OVM_C'X*_:B^(%[_9EQ\-_#+6
MT.DPZA(T:P0V4CVTYVLSE7+E=I*8W9.WWS]OS_@EQ_P1A_8:B^)OP\\0_MC?
M'2']H[PGX&O/$WA7P#JTUG=6.J:J]DT^C6E\\5I$IMKJ?RXYBDF0K\9'->W4
MS_A>EF?]CRR/&O'-RY:<.&ZDHSIPJQHRQ%.:H\L\+&;C?$1O32LW)(R5*LX>
MT52/+U;KZIZ-)J]^9KIOT>[/Q _X> ?MI?\ 1P7B[\HO_BZ/^'@'[:7_ $<%
MXN_*+_XNOWS_ .'-O_!)WX,_L>_LS_M0?ME?M9?&[X33?M!^"=%U^&WL+W31
MI(UV_P!-AU'4+'383;221VMLMQ&(_,D+%2"0,X'XO_\ !0OX4_\ !.#X1R_#
M=_\ @GQ^T1XX^/MAJHU=OB;/XUEMY!X;%NJ_V1]@>"*(AKIR1,K*1C!#'H.C
M+,WX:S?%+"X')J\U[;$8?ZW/()4\O57"RG&M'Z[*C[%<LZ;IQ?-[U3E@M6D*
M=.K3CS2J):)\OMKSLU%I\M[]=?)-ZZGEG_#P#]M+_HX+Q=^47_Q='_#P#]M+
M_HX+Q=^47_Q=?T-?L/\ _!M_\+/VEOV(/"OQV^*'Q1^)7@_]HCXA>%/%GB?P
M/X!T2_TVV\.ZC!8VKW'A5_[-NP+^ZMK[,!U&6)@BQS!@2 ,_SZ_LG?LMZ3\;
M/VZO /[(7Q/U/6_#6FZY\8)OA9XMU7056+6]/:SU"?3[VXTX7&$$RR0DQ,_R
MGK3P6<\(9A+.HX3#X2H^'_:O,5_9M)<L*/M5.I0_=_[1"]"I&,H;RBDMT#IU
MX^SYG)*K;D]]ZWY;7U]W=;]->K,__AX!^VE_T<%XN_*+_P"+H_X> ?MI?]'!
M>+ORB_\ BZ_?3]HS_@EQ_P $!_V3OC!XE^ WQV_;T^/7@WXH>$;;3+K7_#]Q
M?:=(]E'K%DFH:>&D6R",\UM(C87@%E!;!#'^:W]H#P_\'O"OQE\<^'OV??%V
MK>/?@SIFHB+P+XPUT(-7UO3B')N+SR_D+\)RO')]:VR7'</YZN;!9+6ITI4(
M8FEB,;D+P>&KT:G+R2H5ZU%4ZSDI1G%0;O#WEHA3A5I_%45[V:C6YI)I)ZI.
MZ[7[^;9Z]_P\ _;2_P"C@O%WY1?_ !='_#P#]M+_ *."\7?E%_\ %U\@T5[_
M /9>6?\ 0NP'_A)A_P#Y7Y+[C/FE_//_ ,"E_GY?GW9]??\ #P#]M+_HX+Q=
M^47_ ,71_P / /VTO^C@O%WY1?\ Q=?(-%']EY9_T+L!_P"$F'_^5^2^X.:7
M\\__  *7^?E^?=GU]_P\ _;2_P"C@O%WY1?_ !='_#P#]M+_ *."\7?E%_\
M%U\@T4?V7EG_ $+L!_X28?\ ^5^2^X.:7\\__ I?Y^7Y]V?7W_#P#]M+_HX+
MQ=^47_Q='_#P#]M+_HX+Q=^47_Q=?(-%']EY9_T+L!_X28?_ .5^2^X.:7\\
M_P#P*7^?E^?=GU]_P\ _;2_Z."\7?E%_\71_P\ _;2_Z."\7?E%_\77R#11_
M9>6?]"[ ?^$F'_\ E?DON#FE_//_ ,"E_GY?GW9]??\ #P#]M+_HX+Q=^47_
M ,71_P / /VTO^C@O%WY1?\ Q=?(-%']EY9_T+L!_P"$F'_^5^2^X.:7\\__
M  *7^?E^?=GU]_P\ _;2_P"C@O%WY1?_ !='_#P#]M+_ *."\7?E%_\ %U\@
MT4?V7EG_ $+L!_X28?\ ^5^2^X.:7\\__ I?Y^7Y]V?7W_#P#]M+_HX+Q=^4
M7_Q='_#P#]M+_HX+Q=^47_Q=?(-%']EY9_T+L!_X28?_ .5^2^X.:7\\_P#P
M*7^?E^?=GU]_P\ _;2_Z."\7?E%_\71_P\ _;2_Z."\7?E%_\77R#11_9>6?
M]"[ ?^$F'_\ E?DON#FE_//_ ,"E_GY?GW9]??\ #P#]M+_HX+Q=^47_ ,71
M_P / /VTO^C@O%WY1?\ Q=?(-%']EY9_T+L!_P"$F'_^5^2^X.:7\\__  *7
M^?E^?=GU]_P\ _;2_P"C@O%WY1?_ !='_#P#]M+_ *."\7?E%_\ %U\@T4?V
M7EG_ $+L!_X28?\ ^5^2^X.:7\\__ I?Y^7Y]V?7W_#P#]M+_HX+Q=^47_Q=
M'_#P#]M+_HX+Q=^47_Q=?(-%']EY9_T+L!_X28?_ .5^2^X.:7\\_P#P*7^?
ME^?=GU]_P\ _;2_Z."\7?E%_\71_P\ _;2_Z."\7?E%_\77R#11_9>6?]"[
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M:7_1P7B[\HO_ (NC_AX!^VE_T<%XN_*+_P"+KY!HH_LO+/\ H78#_P ),/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *E_\ \>5U_P!<)/\
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M OA)J.@Z'\._&W_"O+/QQ8'2+!Y_%=IXIU-+*>VU28VK2206$1)LHPX2,D*
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MI)7LNVI_H8_%#]D[QC\*OV5?^"??[.OPN_:?^"O[,NH_ W5/!7Q!^-^B^/\
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M+XZ^(7C"]\0ZK>^*-,U339+B>\N9IY+;31JL44DEA9,YB@CB!2&,!2%  KZ
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M /3Y85_K?:__ ,A>[_W;3_TAMJ_R0?V%?^3S/V:_^RL>#_\ T^6%?ZWVO_\
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MAOY)?^!S_P#DO+\^[/Y=?^(/[XX?]'O> /\ PV6K?_':/^(/[XX?]'O> /\
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M_45_PO+XD_\ 0:/Z_P"%'_"\OB3_ -!H_K_A1_Q%'CW_ *&V&Z?\RW+O[O\
MU"^OX]P^HX;^27_@<_\ Y+R_/NS^77_B#^^.'_1[W@#_ ,-EJW_QVC_B#^^.
M'_1[W@#_ ,-EJW_QVOZBO^%Y?$G_ *#1_7_"C_A>7Q)_Z#1_7_"C_B*/'O\
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M^#9GXL_'?X9?L^^ =-_:Q\&^'+GX+^'7T2_U*Z\!:E>1:](\!A^T6\"2;K5
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MAOY)?^!S_P#DO+\^[/Y=/^(/[XX?]'O> /\ PV6K?_':/^(/[XX?]'O> /\
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MH_X@_OCA_P!'O> /_#9:M_\ ':_J*_X7E\2?^@T?U_PH_P"%Y?$G_H-']?\
M"C_B*/'O_0VPW3_F6Y=_=_ZA?7\>X?4<-_)+_P #G_\ )>7Y]V?RZ_\ $']\
M</\ H][P!_X;+5O_ ([7W)_P3N_X-M?BK^Q)^TII7QW\0?M4^#_B!IVG>%?&
M'AUO#NF^!=1TFZDE\3>'K_18;I;N:0QA+22\6>1",R(A0<FOVF_X7E\2?^@T
M?U_PKTCX4?%CQQX@\80Z;JNJ&>S:ROY6CP>7ALYI8SR!T=5/7M7+CO$?C;&X
M/$X/%9GAZF'Q-"=&O".7X"$ITZD5&<5.&&C*+:;7-%IIW::N5'!8>,E)0=XM
M-7G-ZIIK1R\OZNS^36]_X-!/C?=:GK-^O[;G@"--4UW6]72+_A6FK,84U75;
MO44A9C+\SQ+<B-V'#,I*@ @57_X@_OCA_P!'O> /_#9:M_\ ':_J-E^./Q)6
M:X4:T<)<W*+U^ZD\B*.G90!3/^%Y?$G_ *#1_7_"NI>*''J2MFV&LDK?\)N7
M;>[_ -0OD_77N3]1PW\C_P# Y_\ R7E_5V?RZ_\ $']\</\ H][P!_X;+5O_
M ([1_P 0?WQP_P"CWO '_ALM6_\ CM?U%?\ "\OB3_T&C^O^%'_"\OB3_P!!
MH_K_ (4?\11X]_Z&V&Z?\RW+O[O_ %"^OX]P^HX;^27_ ('/_P"2\OS[L_EU
M_P"(/[XX?]'O> /_  V6K?\ QVC_ (@_OCA_T>]X _\ #9:M_P#':_J*_P"%
MY?$G_H-']?\ "C_A>7Q)_P"@T?U_PH_XBCQ[_P!#;#=/^9;EW]W_ *A?7\>X
M?4<-_)+_ ,#G_P#)>7Y]V?RZ_P#$']\</^CWO '_ (;+5O\ X[1_Q!_?'#_H
M][P!_P"&RU;_ ..U_45_PO+XD_\ 0:/Z_P"%'_"\OB3_ -!H_K_A1_Q%'CW_
M *&V&Z?\RW+O[O\ U"^OX]P^HX;^27_@<_\ Y+R_/NS^77_B#^^.'_1[W@#_
M ,-EJW_QVC_B#^^.'_1[W@#_ ,-EJW_QVOZBO^%Y?$G_ *#1_7_"C_A>7Q)_
MZ#1_7_"C_B*/'O\ T-L-T_YEN7?W?^H7U_'N'U'#?R2_\#G_ /)>7Y]V?RZ_
M\0?WQP_Z/>\ ?^&RU;_X[1_Q!_?'#_H][P!_X;+5O_CM?U%?\+R^)/\ T&C^
MO^%*/CC\2B0!K1))P!@\D_A1_P 11X]_Z&V&Z?\ ,MR[^[_U"^OX]P^HX;^2
M7_@<_P#Y+R_/NS^73_B#^^.'_1[W@#_PV6K?_':/^(/[XX?]'O> /_#9:M_\
M=K^HMOCA\2E)5M996'4$$$?48I/^%Y?$G_H-']?\*%XH\>Z?\*V&Z?\ ,MR[
M^[_U"^OKKW#ZCAOY)?\ @<__ )+R_/NS^77_ (@_OCA_T>]X _\ #9:M_P#'
M:/\ B#^^.'_1[W@#_P -EJW_ ,=K^HK_ (7E\2?^@T?U_P */^%Y?$G_ *#1
M_7_"C_B*/'O_ $-L-T_YEN7?W?\ J%]?Q[A]1PW\DO\ P.?_ ,EY?GW9_+K_
M ,0?WQP_Z/>\ ?\ ALM6_P#CM'_$']\</^CWO '_ (;+5O\ X[7]1@^-_P 2
MV!*ZPQ"\D@,<?7BF_P#"\OB3_P!!H_K_ (4+Q1X]_P"AMANG_,MR[^[_ -0O
MK^/</J.&_DE_X'/_ .2\OS[L_EU_X@_OCA_T>]X _P##9:M_\=H_X@_OCA_T
M>]X _P##9:M_\=K^HK_A>7Q)_P"@T?U_PH_X7E\2?^@T?U_PH_XBCQ[_ -#;
M#=/^9;EW]W_J%]?Q[A]1PW\DO_ Y_P#R7E^?=G\NO_$']\</^CWO '_ALM6_
M^.T?\0?WQP_Z/>\ ?^&RU;_X[7]17_"\OB3_ -!H_K_A1_PO+XD_]!H_K_A1
M_P 11X]_Z&V&Z?\ ,MR[^[_U"^OX]P^HX;^27_@<_P#Y+R_/NS^77_B#^^.'
M_1[W@#_PV6K?_':/^(/[XX?]'O> /_#9:M_\=K^HK_A>7Q)_Z#1_7_"C_A>7
MQ)_Z#1_7_"C_ (BCQ[_T-L-T_P"9;EW]W_J%]?Q[A]1PW\DO_ Y__)>7Y]V?
MSJ?L^_\ !J5\9/@O\<?A;\6]0_;(\#:_9?#WQAHOB>YT6V^'>J6EQJ<6E7]O
M>/:17+R%('F6$QK(P(4MDCBO[!-:D$NJWC $;7CBP>YAMX82?HQC+ =@<5\C
M>%/C-\0M0\2Z)8W6L%[:ZU"VAF3!^>.25$9>@ZJQ'7WKZVU88U.^_P"OAC^:
MJ3^IKY'B3B3.^)*V%K9WBJ>*J86G4I4)4\/A\.H0J.$YIJA3I*3<HQ=Y)M6T
M=FT;TJ%.BI*FFE)IN\G*[2LMV^AG4445\V:GC_[0/_)/?#__ &-4G_HA:^/Z
M^P/V@?\ DGOA_P#[&J3_ -$+7Q_7HX;^$O67Y@?#VK?'OXEVO_!0+1_V;[*?
M2V^&%]\*=/\ &%Q9G3T;63K=T[K+(FHY\P6Y"@"$8 ^IIO\ P4&^/7Q0_9K^
M$G@SQI\,9=+M-:USXL^ ?!NHRZUIZ:C:MH?B/7H-.U..*%B EP]M(XBF',;_
M #<5\4?M._"77_C%_P %2?"?AKP[\1M8^&5[!\"](N6UW11(;J5/-;]PPC(;
M;QUYQFO$_P#@H/\ LI^//A%\./A7XP\1?M#>+OB1IMO\>OA7"_AG61/]BF:7
MQ5:HLK;SMW1G++QU_,?HV7Y5E-;'\+^VQ&%IRQ67X&I7R^6"KU/KE22K<TJE
M6$70<J_*KN;3]U<VED<4ZM10KVC)J,YI5%)+E2<;)*]]+[+S/W,^-/QY^$/[
M/^G66J?%'Q=9>'H]5\M-'TOS$GUS69O)CDF72],#">\\HN6D\L'8",\4WX3?
M'CX2?''PY?>*OAGXSTK7M*TAG774-Q'#?^'BG+'7+,L9-.&.09@ 17Y#_M)6
M?QC\6_\ !6'5-!\(^#_ GCM_#_P9\&WWPS\._$N]MH-$BU.]TZ#^W[OP[!?9
MM[K43'S="/#QX!8<"NB^%'@3QW\#OC?^U+\<?BY!\+?">@P?!V;5?BG\$?A=
MKEE<WTUIHFG-);ZA>:)8#%G/J())N<EY3R>:\_\ U>P4<LPU1XQO,<1EN#S*
ME3C6HR59XNK2A#"1PBC[=2=.I:.)E45)XF+I.*C)2+]O/GDE#W%.4'H].5?%
MS;;J_*M>5KJ?>W_#>?[*!\8Q^"$^*FERZC)JO]AC6(2DGA9=8\SRO[/DUX/]
ME6Y$H,9CSD-QUXKVGXJ_&WX5_!+PM#XS^)GC'2?#N@7DD,.ES27,3W&MRW !
MMX]&M]P;4'G!S$(<[QTK^=W]H4_$[Q;_ ,$_O&7Q:\,? /X&? 3X!:]8OXI\
M&ZM_:.EZQXPU6>\FBGL+])C_ *79>(+[>)-G^MAE) YKZP>S\->._P!K?_@F
MYX:^.,=KJOP]G_9%AUKPAI7B7$F@ZWX^32+5K"YNTG_T>ZUA)B?LH<^83RN,
MD'LK<,9?"-*O&MB?949YM#'8>G7PV+Q3EE.#IXN=.G.A!T*6(J<[I5*/-7]A
M9SE*333E8B;NK*[]FXRM*,4JDN5-IZN*W3TOL?0]]^WC#X\_:Q_9Y^%OP-\6
MZ'K7PR^('@_7]6^(6EWNG)_PE.FZQI]ZT-@DRN3<:4LD"AA$X_>KEP<=?IGX
MG?MK_LR_"/Q9=>"O&'Q&LAXCT^4)K%AHX75#X=#OL0^(&A;_ (E@((8F?'R9
M;&*_/WXV>$/A)X/_ ."M?[-$/@#2O#WA[Q==_"KQ?>_$#2?#<,%LJ36D\\EH
M^J6UN=D5S]F1OLX;YF  & *YG1O$_BOX_:G^TYXT_9[_ &;_ (+>'?AO8:OX
MCT7XB_&/XF:AIMYKVMZAI=IJ%M<7%WHU^/.M+:(Q,ENN=K.R.O(%.>3Y7B(9
M;B(T,1A\#_8V&Q%6=3$83"5'7Q>98JC2EB<15@U7G*,''#^PH3J8B%*FE&,>
M9I*K4BYQ;3FZC25I2TC"+?*NF]Y<UDG?R/V4?XG?#J/P!_PM63QKX=3X;G3/
M[8'C-M2MQH+6& 3*+_=Y)(8B,KNR)3L^]Q7D'PA_;(_9M^-WC"+P-X$^(5G=
M>))Y%-CI>I!=-GUZ 3>4\OA\3/G4T;!9&@!#(0W0U^ O@W5+B^_X)P_L5>&O
M%VJ.WPHU;]J_5O#OQ5D29QHTG@W^W+M_LMV02B:#+J"P^0CDQ")HT QU_=_Q
MK\(_V.M"\:?L[ZSKNA^"?!7C#3=?TC_A2-SX9>UT/6-8O/L5NMM:V_V3]YJ5
ME)9E)G@;Y'9B_P![FN#,,CR_*_;4,1/,<37JXK-\-@ZF$ITW3I++*CI1GB*4
MH\]2=62YZT:<Z?L*#55<SE8N%:=2SCR12C3<E)M-^T2>CZ))V6CO+3I8^7/A
MU_P4.T?P[\8_VN?!G[1'C+1=-T+X0_&"Y\%_#C1]#TM6\10^&H-.2Z^TZK;Q
M$37<:2%R]\_R@#&1SG]$?!GQ=^&7Q"\ Q?%+PAXTT/5? #V<M_-XE2^A%AI\
M$"-).NI3;BEG/ B,9892&3:<CBOR\_8A^%?PY\8_M@?\%'_$?C#P5X?\3ZP_
MQTO- %SKVGPZ@T.ER:3")((A*#Y;,'(9A@U^?7BNY\2^!_V)_P#@H+X*^&\<
MFD^$](_;4@T8Z?8R-;6FC>'[G5;5)-,C>,XL-%G\V6.^50(EMW??P37IU\@R
MS,<:\+@W5P6)I+AJ&(DU1^I26:X?"4JTJ-**C4C4A5J^VYI3?MYRFI*+:;SC
M6J0CS2M-/VUE=\W[MMJ[UWVMT75G[P^!OVW_ -E_XC^-(/ /A;XFZ9-X@OII
M;?2)+YDL])U^:!BLD>A:C(WDZDP(( A^\>F:^K2"IP00>.#[C(_,$&OY]/C-
M^SS\>?&'P8^%.GWW@S]F?X+>#-,\0?#_ %7P!\5=&\3:-IM[;K:WMI=&TTC4
M;<>==7.MD-:S1*,SR.T;8:OWZT=;]-%T9-5E2?5(]+L8]0GCP8Y[J.VC22:,
MC@I(1N4CJ#GO7SV=9=E^"AA:N Q+JJM/$TJM&6(I8J5*6'=)1J>WH0A2_>JH
MU.C9U*,X24I2C.#>]*I.3DIJUDFG9QO?=6>NCZ]?RT****\ W"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DGW&^E>I^/_\ D >"
M?^O$_P#H->62?<;Z5ZGX_P#^0!X)_P"O$_\ H-0_CAZ3_P#;0/+Z***L HHH
MH **** "BBB@ KE_'/B_2?A[X(\8>/M>8#1O!?AO5_$VHKNV-/;:/9R7DMO$
MQ_Y:S+$4C'4L1745\O?ML:/K>N_LF?'FQ\.0/<ZQ'\/?$5];V\8+/.MEIMQ-
M)$$7F0.HP4_B!(KIP=*%?&82A5ER4ZV*P]*I)NW+"I6A";N]K1D]>FY,VXPE
M)*[2;2/SYTOXK?\ !1#XL>#%_:-^'_Q:^$?@O2-9AG\5?##]E_7=!LKCQ?XY
M\!J[RV<G]O2'S(-0U:WB9;=2"\;NO<&OLKXH?'C]HJS^#/PWOOA3\$I=2^-O
MQ%T(3:MH^LW8M=%^&FHPP$ZK=ZO<3 Q726+Y>&V?!NQ\JC'3\Q/A'^R!\ ]2
M_P"":VF_'_5_C'XUC^)GASX4W?B^S\=Q^/+JSB\#>,-&MKFZT_P9;V(/^C1V
M5W$(#I:C$@(C/!X_6;]C/XA^-_BA^QY\,O&OQ >XF\4:O\/HOMNHW,1AGUR&
M.R(@UF9&^;??)B4L>3G)Y)K[+.X8"@O;X;!X'$4,MSNOEDZ,\OGESYE2E[&A
M4E1K<^8X>'L_:5*M=PQ7.K3DZ5=)<E+GE[KG-2J4E4OS\_6*;2DO<D[VLKQ2
MZ71P/_!.+X[?%_\ :)_9ND\=_':]T/4/B3I7Q)\=^"=8NO#FG1Z7I4D?A;4Q
M8P""TC^3<!NWRC_6'FO:OVK_ (UK^SU^S[\2/BI B3ZYH>ASQ^%;*10ZZAXD
MN3'#I]GM)&XNTA;').WBODC_ ()'?\FM^,/^SB_C3_ZDM:G_  5:CG?]F+P]
M(N[[#;?&+P5<ZUC)1=(CN4^TM-V$()7<3QV->?7P6%J\:5,#[&G2P<\[]D\/
M2BJ=*-%5%)T*<8Z0IR2=-1CM%V5GJ:*<EA5*[<O9+WF];M6NWWUN<M\1_P!H
M/XV_L]_LP_LZ:!HKV_C;]IO]I'7M#TOPQ>:UAM*\/7GCR"/5(KR_CDPD]KH*
MRO +4CYQ%CCK6/??%;]M/]C?XC_!VW_:K^)/@?XU_"7XU^,;#X=7.M>&?"T7
MA&_^'WCK5(S+%!(!\^IV$# QEQ\K8!'45WW[;_@KX:^-O@A^SK)K?Q(7X/>.
M-+\0> =3^!GQ$DM1<:99>.$TR%M$TW4R?W?V"[7Y723$9# ]LU\%_MA?#K]J
MOQ;XZ_9$\-_M&?&;PQXL\1W_ ,:_#2^$/ACX*TVVB.HPQ1+(?B7J=S9%C'9+
ML92)<)F0 GG%>QE5# 8^&'C6I9=1CC:V=3S%8G!U'C:CIJK4PTLJQ$:,H4:.
M#BH\_LJU*-&<:CQ/-"48F51SA=IS;A&DJ=I)15^5-35[MR=[7B[]+6NOZ'KF
M:"VMKV_9C):66GWFJ,Z]9;.RM);UF7'>2"([<=R/K7XX^"_BK^WY^U_%\2/C
M%^S]\3/ 'P9^$?@C6M9T[X?>#_$7A"'Q/JWQ$&@?:5NWN]3/.F)>2V<MO&).
M(S(L@Z&OUOAUGPX7NO!DFN:7=Z[I7AN2'7= MKR.35H=-BTYK2_GEM%_>I$\
M0E59" "QZU^,'PI^'7QG\)V/QW3]BW]I?P98?LYW.O\ B/4?%^F^+]'LIM;^
M#>HO!>OKUC$;LK-+'+$;R2V4 [92C*,X->%D-.BJ.8U)PP,<7'ZC]5KYMA)X
MG QH5*TEB(N#H5Z<<1B8^S6&G.E><8U84)QK.%]:S=Z:]]KWN:-.5I.22<=4
MT[1=[ZZ:7TN>TC]ICXJ_'C]AOQQ\7?!K1^"_CQ\$==33O'FEV;"[TQM8\/7C
M3>);<1Q?)+:W6D6D\L*8"P-*./DK]!/@;\4-,^-GP<^&_P 6M'4)I_COPQ8Z
MQ%&&#>7,%-K=J2,@$W=O,V,Y ..V:_*/_@FEX,A^'G[$/[7NJZQKD_BGPIXW
M\2_%;Q3H/B_5$,:>*-.G\,:S;2:HBR#'DRW_ )JP@9 4H ","OJC_@E;;ZE;
M_L'_  +.HB01W&D:C/I:R9&W36UG4O)$>0,Q\\$<=,5U9_@<%AZ.;1PL(1AE
MW$-+#8><8RBY4,?@:E:MA_>O4Y,-7PO[NG4;G14JD&[N3:HSDY4^:_OT7*2;
M3UC*,4]-/>4MU>[\C]!Z***^/.H**** "BBB@ HHHH *]=^!W_(_6_\ V#M4
M_P#3?/7D5>N_ [_D?K?_ +!VJ?\ IOGJ*GP2] /)I_\ CXN_^OR\_P#2J6HZ
MDG_X^+O_ *_+S_TJEJ.JCLO1?D 4444P"BBB@ KP;]HWXD_$CX8?#V'5/A%\
M-YOBE\0=?UB'PWX?\/K="QL["ZNXF==:U6[8%(-.L\;IFD&PX"GK7O-21NR"
M8H=I:VNE)&.0;>7BM:-2%*M3J5*,,1"$U*5"I*<:=5+[$Y4Y1J*#=N90E%M)
MQNKW%)-II-Q;ZI)M>E]+^I^<?_!.KX^_M"?'/1_CSI_[2%UX9N?&OPN^(EMX
M7LXO"VG16%E86=S;//)83/%\M]+:R*81=<>8$WC[U<?_ ,%)_P!MGXB_LV^&
MM,\%_LY6>E^(/CIJ$%KXEUA-1M$U+3/!7P_^VPV=YXDU:V8[<+([PK#( <LK
M@\5S'[ 'B&;PE_P\%\46VEWFN7.@?%M]2M=&T^)KB^U.[M]+NWM;.U@4AI99
M9Q&H1>2":_,#4OVE+F#X+?M=?$'XV?L]_M$P?M!_'+[1I\OB#4?AMJD?A+X?
M^$;'552QT&SUAV,-OI5Y;Q17+LGR-<-CJ:_0\'DE#%<2XS$K+\-6P6$KY0H9
M725.G0JU\?AL'*470<XOZG04Z^*KI<W,U3I:RJG#*JXT(1YY*4U-^T=VTHR=
MO>2UDW:*\KOH?TK? ?QAKOQ ^#/PX\;>*);:?Q%XE\-V6I:S-90BWM);^6)#
M.]O ORQ1-(6*(. N!7C/[<_QZU3]GG]GS7_%7A=4G\>^(M2TCP?X(M'4/YVJ
M:_?PZ9/<*/[]A#=?:@1D@QYQ6+_P3V^+-E\7/V7/ -_9>%?%_A-?"^FV?AV:
M#QAHT^C3ZI+%;J_]HZ2DY)O--<#"7*81CP*\-_X*BC9I_P"RE=W8/]A6GQUL
M7UTG_4B"3[*EL9ST"^>5"EN-V.^*^;P> I_ZT1P&)H1C2I9C7]IAFH\DH8?V
MN(AA[1;CRU8TX4N5/X9\JL]MY3?U;GC+5PC[RO>[LF^CNF[^I]^^!8[GX:?!
MOP[/\3?$HOKKPEX,36_&GBB]D"B=8[,ZM?7#NY7+Q0.T2*2"S1!0*_+W]E7]
MN[X\_M"?MG>*_ >IZ7I&A?LWWFBOJOPHBETM8_$7B;24<I;^*'U GS?L-\R.
M(H>57;D'UV?^"J?Q4^(6G:%\*/@CX:^'7Q4\2_#7XA7^D7OQC\4_#+PQ>>(M
M0T[PEI]O:7D&D6Z695U.JXDLKM!P8)"&R*^0?A]^US\/XO\ @H5\-AX-^ /Q
MP\(>$[#X3^%_AQH/A/4?A[?Z=JVD0P;+9-4NM.9@]OHYD+3O>-\F&=O4CVLG
MR26(RC,LPK8"EC<1F. S"OAYWH\F71PU6#56$.=>RQ6(JNI&E'E2HX:DWI[:
M%\IUK5*<%)QC"4%):WG=*]]'>,5:^MW)^3/Z,9[BWLH+F\N_^/2R@FNKDYP1
M! I>0Y[?*.M?B9\%/C!_P4)_::M_B#XS\'?M8? 7X2>'H/C#XW\ ^ ? GB3X
M=6.J^(9=%\.7PM]/NGN)")+Z2YC)^<#YSDCTK]BM<\0>#KNS\8:!>:[87LNF
M>'[NX\5Z-IUXDNM:=HMS;%III+>,F6!Y(6*PNP'[S@<BOQ^N/V(?V"?$_P"S
M?\8/BO\ !KQSXZT.QT4>+?%,/C2/XBWT,GA'QW8J;F9C"6#6IBNU'FV@7]YC
M9]?)R"6"I4L7]<H/VU?$9?A\-BJN34,VH8=59U'*,J6*:A"6(<J;C*$95*E.
MG)4[LTK<[<>22M%3<HJJZ;;7+;6*UY==VM6?5O[6WB3X\_!7]F[PK\57\9V>
ML>/OA=XB\/ZI\4]1TO3/[.T7Q-X/AE#^*3%I2_+:,\1'V=OE\G/!XK[=\&^*
MM.\>>#/"'CK2 %TKQIX:TCQ1IR!@^RTUBT2[A0L,@E$D ;D\U^5N@?$[Q%\1
MO^"/WQ3\6_%:Z.IZN/@SXU\.6>LWZ%)O$=GIUK';Z+K;%SF:?4XSYZS<M*<D
M9X-?:7[$-OJEK^R!^SK#K E%Y_PJSPFZB;/F+:OI5N;=>>=HCP%]A6>98/V&
M6U/:PH+%8#/\=ETZE"$:=.M3E0IUVH1BHKDHU8RY(VM2A5Y(I*R'3E>:LVXS
MI1FDVVTT[;O5WOKYH^HZ***^;.@**** "BBB@#J? _\ R.'AS_L*V?\ Z41U
M^A&K_P#(4OO^NY_] 2OSW\#_ /(X>'/^PK9_^E$=?H1J_P#R%+[_ *[G_P!
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MQAK?Q(\-6EU8V7C;Q=XMU#Q#K5S:W9)FBU"ZO0TMXOS,JB1L*C%0 *Y_Q?\
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M'_#/'C;_ *#'A/\ \&8_^*H]M2_GC_7_  _Y]F!X317NW_#/'C;_ *#'A/\
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M+\4/&F@GPUK]Y<ZQ<7&B3Z2SEVBM]&?_ $:WD<G#RI\S#@\<5\Y_$G_@F?\
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M  SQXV_Z#'A/_P &8_\ BJY?;4OYX_U_P_Y]F6>$T5[M_P ,\>-O^@QX3_\
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M_P"ZZ%&_\=8\]NM>Z_\ #/'C;_H,>$__  9C_P"*H_X9X\;?]!CPG_X,Q_\
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M$E)JP_:4[M<\?=7,]=EIJ^VZW/L')]3^9HR?4_F:^-/V=_V\OV?OVE_%.I>
M/!VI:OX7^(NFZ8^N'P%XTLY=)\17VA*"?[7L(;B&!+FU.  (B\F2 5ZX\N\7
M_P#!5#]E7PCXA\=^#5NO%/B?QM\-O$K^&O%WA#PUID^H:UIQB@-S/K;Q16\B
M+I,,88.Y/F!E(Q5QR/.)5ZF%66XMXBC"G4JTO8RYJ=.K+EIU)/X52G)\L:E^
M1RTYKB]K3LI<\>5WL[[M;KU7;<_1S)]3^9HR?4_F:\#^&?[4'P)^+GP<NOCW
MX,^(&CW/PPTJUN;CQ%KMU-]F'AB:SCEDNM/UN&<12VE_"(908)(U=F7"*Q(S
M\R^ ?^"IO[)7Q!\<:%X+M==U[P[:>+M0DTOP5XZ\2Z7=Z=X-\87T<AA%OH^H
MSVD2$S2#9 9W02DC83D5G3RC-*KQ2IY?BYO!2E#%15"?-0G%.4J=2-N95%&,
MI."3DHQ<K<JN-U*:Y;SBN;6.JU3V:\O/OH?HMD^I_,T9;U/YX_F:^*/CG_P4
M _9W_9Z^*VI_ _Q]J>L2_%.Q\&Z1X[T_PEHUG+>ZCXBT36WV6:Z-'#%-YMP
M4>3=A=C@CDBK7PN_;$^"/[5/P7^,GB7X4>,-1T*^\#^%_$]MXQL[NW,'C+X<
MW%M82_\ $YN=.GCBQ/9L!-:%D,4D@49/-/\ LC,EAZ6,G@L3#!U70<<4Z,_8
MN&(:5&HI)7E3FW:$DG&4O<BW-J+/:0<G%2BY*_NWUTW7JNO9:['V<=RG!)S[
M-G]02*3)]3^9K\VO@;^T]\(_@5^QEX=^+WQ=_:!U[XE^%Y]:NK"Q^(WBW3EB
M\2^)=2NIFCLM"M[#3(IE>8R PVP5.2!NP*]2_9^_;X^ 7[1OCB;X8>&)_$'A
M#XD?V=)K.E^"O'&GS:3K/B#185$D^JZ/'-!"EU:P1$22[&9T!PP!JZ^2YA26
M,J4\+B*V%P5:K2JXN.'JPI7HR4:DN6I&-2*AS1=3F@G24E[7DNA*K!\J<E&4
MDFHN2;U5TKIM._2SUZ'VGD^I_,T9/J?S-)17E&@N3ZG\S1D^I_,TE% "Y/J?
MS-&3ZG\S244 +D^I_,T9/J?S-)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S24
M4 +D^I_,T9/J?S-)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S244 +D^I_,T9
M/J?S-)10 ,3@\GH>Y]*ZC7B?L&C<G_4'N?[IKEFZ'Z'^5=1KW_'AHO\ UP/_
M *": .9R?4_F:,GU/YFDHH 7)]3^9HR?4_F:2B@!<GU/YFC)]3^9I** %R?4
M_F:,GU/YFDHH 7)]3^9HR?4_F:2@M%&LDMQ/%:VT$;SW5U.P2"UMHANFN)W)
M"I%"@+N[$*J@DD4 /"R,"P5RHZL Q ^I' _&A1(YPH9L=<9./<GH![FOYV/'
MW_!0']I;XD_M_P#PBTKX)^*9?"O[&,OC?6?AEJ$HLH9F^*7C7PW)'!XB2"YF
M4$:78.Q:UN+;<LO)WMV_1[]K_1_VQOBE\8?AE\#/V=_%6K_ OX3ZS8ZOJ?Q8
M_:%T>QM=1UC1#:QB33=!T.TO6%O+-J))BE+\J>G6OHJ_#>*PE; 4L;B\#A/K
MV"JX^<ZM2I;!4J+FJE+$QC2E-XI<EEAJ$:U64YPIJ/M+Q6*K1ES\L92Y9*"2
M2]YRM9K72/\ >E965]K'Z$LLB<,&7TSD9^AZ'\*;D^I_,U^27[)_Q&^/WPB_
M;-^(O[#OQC^,U_\ M+:)IGA*R\9>%/BCKME9V/BSP]"UL9Y=)\1VNF;[*W-U
MC;:"1ED=23CH*_4WQ=XITGP)X1\4^.-><IHOA+0=2US47&-RP6=M(ZD9XSYO
MECFO.S#+:N!Q-+#JK2Q4<11P^(PM;#^TY,11Q45*A.$*L*=:$I7Y73JTX3C)
M-6M9NX34HMV<>5M23MHX[ZJZ?JFT="21QO4GNHD5G7_?0,63/8.%SU&:?Y<V
M,[),8ST.<>N.N/?&*_&7]FG]I7QOX#_83_:#_P""@/Q?U"X\2:[XOUOQ=KOA
M3P7=2NMK::9X;U8Z)X4TS3HB2(_[0M;BWNIQ&BABI;GK7@%@/VYK_0?#GQC\
M/?\ !0C1-8_:4\11:3XT@_8SO/\ A'8_A]<^#]=:VU"R\)VNM+<"]?5%TFZ^
M>/S/.%Q#MQC(KUX<,5G6QE.KCL)AX83%O >VJQQ,J=;&TZ<)XFE%X>A7]E0P
MTIQA6QF(]EAHN5.3FE-)9^W5HODD^://9.-U%NT79M7<MTE=Z/L?T*Y/J?S-
M/59'SM#,!U(S@?4]!^=8'A*]UC5O#/AJ_P#$FFC1/$5]H^F2:_I8.Y-/UB2U
M@.I01-_'#'=M,L+9^:-5/>OR&^,7C+]HW]I[]NSQ-^R)X"_:/U/]C_X>?#?X
M=1^,+OQ5H-KI4GB3Q]J4MVL$9M6\0R6]@^FQY#.;:9I@RME0,FO*R_+)X^MB
M8/$4,+1P="KB<7B:OM*E.E1HRC"4HPP].M6K-SG",(TJ<V^:[M%-FDIJ*3LY
M.32C%63;?FVDM.[/V78,APY\L^LC",#ZLY50/<D"D)8'&[/T8,/P()!^H)K\
MB/V)_B=\<?BS:_MC?LI?%[X@S?%?7/@EJOB'PEX+^/MA&EM>^(9DTJ<Z*;V6
MP;^SVU:UO6MYG6QGDB;RR"W)%>T_\$SOCAXJ^,'P"\1>%OB'J4FK_$K]GWXC
MZ]\&?&VL77%]KFJ:++-<)JEU'DE'>U>"/C*D*"&YKHQN1U\%3QTY5J-;ZC5P
M*J>RY[3P^8T75PN*ASQA)4Y>[3G"I"%6G.I!2BGS<LQJQDXJS7.I6O;>#2E%
M^>MTU=-)Z[7_ $-R?4_F:,GU/YFDHKQ#47)]3^9HR?4_F:2B@!<GU/YFC)]3
M^9I** %R?4_F:,GU/YFDHH 7)]3^9KK_  03_;L?)_X]KKN?^>+UQ]=?X(_Y
M#L?_ %[77_HAZF?POY?F@.3=F\R7D_ZZ;N?^>KTW)]3^9I7_ -9+_P!=IO\
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M_P"&B+W5A=>,!HUL'^'$>GRFZCM[O6MEM)$I!+6T,IF*=(\8)_3G]GG]B?\
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M?Y5U&O?\>&B_]<#_ .@FN7;H?H?Y5U&O?\>&B_\ 7 _^@F@#F**** "BBB@
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MCCI"BBB@ HHHH **** "NO\ !'_(=C_Z]KK_ -$/7(5U_@C_ )#L?_7M=?\
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M#\A1@>@_(4?5U_//_P E_P#D?7^EJ:^7W?\ !]?Z6OV/_P ))\-O^BBZ7_X
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M@>@_(4?5U_//_P E_P#D?7^EJ:^7W?\ !]?Z6OV/_P ))\-O^BBZ7_X W?\
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M8'H/R%2I!)(I9(F9%.&<(2BGT+ 8![<GK1["*WG+_P E_P#D?7^EJ:^7W?\
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M0?D*,#T'Y"CZNOYY_P#DO_R/K_2U-?+[O^#Z_P!+7['_ .$D^&W_ $472_\
MP!N_\*/^$D^&W_11=+_\ ;O_  KXXP/0?D*,#T'Y"CZNOYY_^2__ "/K_2U-
M?+[O^#Z_TM?L?_A)/AM_T472_P#P!N_\*/\ A)/AM_T472__  !N_P#"OCC
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MC5/$9OO&%W9:-;>)=#A@O?.&GW]^52[G=08$LH26D9P "37QMXV\+>*_B?\
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M17P1VA1110 4444 %%%% !7KOP._Y'ZW_P"P=JG_ *;YZ\BKUWX'?\C];_\
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M4)RE"R['10;=*FWORKY^?]>H4445XYJ%%%% !1110!U/@?\ Y'#PY_V%;/\
M]*(Z_0C5_P#D*7W_ %W/_H"5^>_@?_D</#G_ &%;/_THCK]"-7_Y"E]_UW/_
M * E<.*^*/S_ "B!G4445R@>/_M _P#)/?#_ /V-4G_HA:^/Z_03QUX5T+Q9
MX1TZRUS4[G3+>UUQKF*6WMS<-).8MIC91T7 SN_"O'O^%-?#S_H:]3_\%CUV
M4:L(4U%\UTWM%M:O_@@? OC[X"? GXL:C!K'Q4^#GP\^(VKVMNEG:ZIXO\/6
MVK7]M:1DE+:&XFPZ0H3E4' J3X>_ GX'?".[U&_^%'PA^'_PWOM9@2UUB[\(
M:!;Z3/JMK&<QVU\\6?/AC/*HPP#7WM_PIKX>?]#7J?\ X+'H_P"%-?#S_H:]
M3_\ !8]=O]I5_8_5_K6,^KV2^K^VK^PLFI)>QY_964M4N6R:NE>Q/+&_-RQO
MO>RO?O>US\VI?V3/V7I_&G_"Q9O@'\,I/&OVK^T#K[>&K0WC:CN#C46?[IO0
MX#B?;NW\\5Z1X_\ A=\-/BOH0\,?$[P'X7\>>'597BT?Q-I<&I6-NZ?<>WAE
M&(F3 VE2,?EC[=_X4U\//^AKU/\ \%CT?\*:^'G_ $->I_\ @L>G+,\1.5*<
M\5C)3H)*A.5:O*=!*UE1DYN5)+M!Q6GH')!)I1C9[KE5GZJVOS/A+PE\%O@Y
MX ^RGP+\+?!'A&2QLIM-M)]"T.VL9X=/N5"75FLL8W^1<H-LT><..M;NF_#_
M , :-X6OO NC^"?#.E^!]4-\VI^#[+2X(?#NH/JDGFZH]UIP'E2OJ,O[V\9N
M9G.YCG%?:'_"FOAY_P!#7J?_ (+'H_X4U\//^AKU/_P6/6<L=.HVZE;$S;E&
M3<YU9MR@VX3;E)MR@Y2<9-N46Y.+3D[M1BMHI>B2WW^^R^X^%[[X/?"/4_ B
M_"W4/AIX-N_AI'N\CP)-HUN_AFV+D$O;:<W[N)\@$,I!R!Z51^&7P-^#7P5L
M=2L?A'\,O!_P]CU6WNH[Y_#.D0:=->M-;R1(MU+'EY$7<%4$@*N>U?>W_"FO
MAY_T->I_^"QZ/^%-?#S_ *&O4_\ P6/5?VA5=.=%XC%.C5G[2K2=2LZ=6I=-
MU*D.?EJ3;U<YJ4FUJWI=<L;I\L;I63LKI=D^BT7W'X4?L\?L#^$+"'XT+^TQ
M\*O 'CZ;Q=\4I/%_@F?6;*VUJXL]&(E*1&4X-N"[JS6[9!(R17Z+:3X4\*Z!
MX<MO!VA>&M%T?PC:69TZV\,:?8PV^B0V#)Y;VBV*CRO)D0E74CY@3ZU]@_\
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M\3P]>V\Y*7[6]W/)*EP1C! XQBOU9_X4U\//^AKU/_P6/1_PIKX>?]#7J?\
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M=\\7)-)VLFEOZOY6=['ZGT445X9J%%%% !1110 4444 %%%% !1110 4444
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M_P"(VHW<C6/@K1?!8N3IMWI-[="&SB"1E=F[. <U]B_M3_#7]JS]H_\ 8X\
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MFXN/"-UJ6IOI]M=32IIEK<7J/,EG:[(DRJJ.!7Y<?#+Q'^P?\6_B%^TIX_\
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M^R0T+P\NE1Z /#?A[_A'(8XXHO#9T73SX>2*$AH471OL_P#9X6%P'B M\)(
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M6ZM^T%\%O#6IW7PX\:?&G5['5M1^$MQX(_LK4]0T;2! [WUQ->>&#(FGVS*
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M +[3_P"+HL^S_K_AU]X$-%3>9H7_ $,NF_\ ?:?_ !='F:%_T,NF_P#?:?\
MQ=%GV?\ 7_#K[P(:*F\S0O\ H9=-_P"^T_\ BZ/,T+_H9=-_[[3_ .+HL^S_
M *_X=?>!#14WF:%_T,NF_P#?:?\ Q='F:%_T,NF_]]I_\719]G_7_#K[P(:*
MF\S0O^AETW_OM/\ XNCS-"_Z&73?^^T_^+HL^S_K_AU]X$-%3>9H7_0RZ;_W
MVG_Q='F:%_T,NF_]]I_\719]G_7_  Z^\"&BIO,T+_H9=-_[[3_XNCS-"_Z&
M73?^^T_^+HL^S_K_ (=?>!#14WF:%_T,NF_]]I_\71YFA?\ 0RZ;_P!]I_\
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M:*F\S0O^AETW_OM/_BZ/,T+_ *&73?\ OM/_ (NBS[/^O^'7W@0T5-YFA?\
M0RZ;_P!]I_\ %T>9H7_0RZ;_ -]I_P#%T6?9_P!?\.OO AHJ;S-"_P"AETW_
M +[3_P"+H\S0O^AETW_OM/\ XNBS[/\ K_AU]X$-%3>9H7_0RZ;_ -]I_P#%
MT>9H7_0RZ;_WVG_Q=%GV?]?\.OO AHJ;S-"_Z&73?^^T_P#BZ/,T+_H9=-_[
M[3_XNBS[/^O^'7W@0T5-YFA?]#+IO_?:?_%T>9H7_0RZ;_WVG_Q=%GV?]?\
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M7&JTI1I2TG)+4:K4VU'F2D[*WFTFE?NT].ZU/MS:/5O^^W_^*HVCU;_OM_\
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M_BJ=10 W:/5O^^W_ /BJ-H]6_P"^W_\ BJ=10 W:/5O^^W_^*HVCU;_OM_\
MXJG44 -VCU;_ +[?_P"*HVCU;_OM_P#XJG44 -VCU;_OM_\ XJC:/5O^^W_^
M*IU% #=H]6_[[?\ ^*HVCU;_ +[?_P"*IU% #=H]6_[[?_XJC:/5O^^W_P#B
MJ=10!%(HV-RW3^^__P 57J?C]1_8'@GEO^/$_P 3?W?K7ETGW&^E>I^/_P#D
M >"?^O$_^@U#^.'I/] /+=H]6_[[?_XJC:/5O^^W_P#BJ=15@-VCU;_OM_\
MXJC:/5O^^W_^*IU% #=H]6_[[?\ ^*HVCU;_ +[?_P"*IU% #=H]6_[[?_XJ
MC:/5O^^W_P#BJ=10 W:/5O\ OM__ (JC8/\ :_[[?_XJG5R_CF3Q5#X(\7R>
M!+6WOO' \.ZL/!]K>.L=G)XC-I(-)^U2.0H@%WY9E#<%0<FJC'FE&-XQYI1C
MS2:C&/,TN:4GI&*O>4GHDF^@/1-]NVYUWV.?./*EW;=^S,F[9UW;<YVXYSTQ
M44<#RN(XDDD=NB(9&8_0 DFOP?\ C)^S)\5/@)^SGJ'[5_Q*_:?^+.F?M0Z/
M=6GB"_T)/&MP_P *KC7;N=Y+?X>V'A< 0W,-TZ1V4'EMAB[;<GFOJ/\ :+C_
M &N/C3^RYX&\2> /'-E\$M,U/X(R?$'XO>(+:S/_  ED&O1:8+N/1O#S(#-I
M,DLN8Y)@I"D@GBOH)9#1;PDJ&;X.IA<1C*N J8RI1Q%&C2Q-"%.I4]E&U2IB
MZ,XU(JC4HQ3J3<8RA!24CG5=^\G2DI**FHW3;B^^W*UU3\^S/T]D@>%S'*DD
M;KU1S(K#Z@G(J-O+C5I))!%&BEY)9)62.-%Y9W<MA54=6/ KXE_X)S>(?$OB
MC]D+X;ZOXN\1ZQXLUYI-0M;OQ!K]XU_J]^MNZJDEY=N TKXZDBN<_P""DOQ1
MUWP#\ ='\'^$KZ?3O%7QU^(OAKX/:=>V4ABU'3X/$\ZK/J%A*IWQ3P+&0LB@
ME=QXYKBCE56><O)HU(RJQQL\'*NHR5-*G-JI7Y7[RA&$95.5ZV5M]2_:KV7M
M;.W*I6ZZ[+U;T/ORT,.H(LNGS)?1/NV2VDQGB?:<-L>-BK;3P<'BIVMW5=Y6
M39N*[PSE=PZKNSC<.XZU\,_''X#_ !H\0_"#X0_!3X4?$2Y^&?AG2+?P_9_%
M[QO;730>*Y=$L+**#6_[+U/_ %MGJ-])$\SWH!*N[$U\8?#_ $UOV;OVUOA9
M\+_V=?C[X_\ V@_A[X^\/78^*^@^+_&+_$8>#+B"Z:*36FU-!Y>B3C:2;27#
ML><<<[X7)Z6,H5ZE#,:3KTJ6+Q$,-]7K./U?")R<L3BD_886K7A&4J%.7.IV
M2<HN4;S*JXN*<'9N*;YE?FDEHH[R2;U>EMS]L-H]6_[[?_XJI(K=YW$<*222
M-]U$+LQ^@!R:=(@$SQQ_,!(R)CDL-Q5?S&/SK\;O^"G/Q\^*&KV>I?LR_LV>
M)K_POXWTSP\/'WQA^(6@SM'>>!?!%O(!':6M[$&-IK=Q<IL:#B7R'S@J2*Y,
MJRVMF^-I8.C4IT5/WJN)K*7L<-1BTIUZO+[W+'FC%1C[TYRA"*YI(TJ5%3BY
M--[)16\F]DK_ '^B9^PUU-:V+HE_=0V+R2&*);NX\@R2C_EE'YC#=)_LCFI=
M@_VO^^W[]/XJ_,34?#_B_P"+7_!+SPMJ2>*/$%Q\1M&^'5MXSM?&:WLG_"0W
M>H>$;J;4[RYGO /-=]0M].:*YX.^*1D(Z8^N_P!E#XNO\>?V;O@_\6KC8M_X
MO\)6MSJD2?\ +'4+*233IT<=I&:T,CYZLY/>KQ663PV&K8A58U?JV9U\KQ"C
M%I0J4XN=&HFW=PQ$:=?E32<'2:E?F1,:G-)1Y;<U-5(N^Z=KKU3:UZWTV9]
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M8S6(YN9QA=*+DGS1;:7=+6/,MKW/U1*8)!W@@X(+OD'_ +ZI-H]6_P"^W_\
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M6M5J4Z"DYJC"<Y2A24I:R5.+4$WJTKG5%-1BF[M))ONTK-_/<****Q&%%%%
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MI3_XJC_A1/@G_HH.I_\ @I3_ .*KLZ*/:5/YY?='_P"1\OS[L#C/^%$^"?\
MHH.I_P#@I3_XJC_A1/@G_HH.I_\ @I3_ .*KLZ*/:5/YY?='_P"1\OS[L#C/
M^%$^"?\ HH.I_P#@I3_XJC_A1/@G_HH.I_\ @I3_ .*KLZ*/:5/YY?='_P"1
M\OS[L#C/^%$^"?\ HH.I_P#@I3_XJC_A1/@G_HH.I_\ @I3_ .*KLZ*/:5/Y
MY?='_P"1\OS[L#C/^%$^"?\ HH.I_P#@I3_XJC_A1/@G_HH.I_\ @I3_ .*K
MLZ*/:5/YY?='_P"1\OS[L#C/^%$^"?\ HH.I_P#@I3_XJC_A1/@G_HH.I_\
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MN55)2<II2ORMQC9VM>SY;.VE[;7UW XS_A1/@G_HH.I_^"E/_BJ/^%$^"?\
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M!/\ T4'4_P#P4I_\579T4O:5/YY?='_Y'R_/NP.,_P"%$^"?^B@ZG_X*4_\
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MMTVCZE<Z5KOA[4I?%\$.L^&M5>TD@NK6YCD26.[LW"!XB%="#BO0O%,,C?\
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MD3]C;5O@S;ZSKGQ:B\.?VMXO'BR:2&2S\!>)9K:VNI-,WZ>RR2^04*.K*",
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MZ\(TY3I3C4@JM.-6FY1=X\].:<)Q3LW&:<7:S36@FKIK7731V?WGX<_\$?\
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MB?\ [^V]'++^27W>G^?]75PW:*PO^%H?"C_GCXG_ ._MO1_PM#X4?\\?$_\
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MZ/\ A:'PH_YX^)_^_MO1RR_DE]WI_G_5U<-VBL+_ (6A\*/^>/B?_O[;T?\
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M3)<VWP[^'=I=1/YD-W:>!?"UM=P2#D2P7,&E)-#*#R)(W5P>0:D_X6A\*/\
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MNTCBO;=%T?2_#FBZ1X=T.RAT[1M"TVSTK3+&W4)#;VME;QV\81  %+B/S'
M&]F-5/\ A:'PH_YX^)_^_MO1_P +0^%'_/'Q/_W]MZTE7Q,Z%+"RE4>'I5*M
M:G2LE&-6NJ4:M317E.<:=.+E)MJ,$HV6C.5)N5M6DF^K2O9?*[-VBL+_ (6A
M\*/^>/B?_O[;T?\ "T/A1_SQ\3_]_;>L.67\DON]/\_ZNKLW:*PO^%H?"C_G
MCXG_ ._MO1_PM#X4?\\?$_\ W]MZ.67\DON]/\_ZNKANT5A?\+0^%'_/'Q/_
M -_;>C_A:'PH_P">/B?_ +^V]'++^27W>G^?]75PW:*PO^%H?"C_ )X^)_\
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M%>S:L,:G??\ 7PQ_-5(_2LJETTFFM&]5Z?UY]+@9]%%%9@>/_M _\D]\/_\
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MAG4@BR'3/$7BW0]%U%8GY25K+4+VWN!%(.4D*;7'*D\X_%[]GG]GK3?V>O\
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M'C?PGXP6T)6['AKQ!I>M/:E3@FX33[FX:)0>C.%4]0<5\A?%S]CF3XQ_"/X
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M=\"OB%::GXAMM/GGT;3;R?6"T%I?ZBJF"UNID^:&*1E=UY7CFH?'?ASQ#?\
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MB.OT(U?_ )"E]_UW/_H"5^>W@<C_ (3#PYR/^0K9]Q_S\1U^A.K_ /(4OO\
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M0/PR_P"@--_X%R?_ !-'_"@?AE_T!IO_  +D_P#B:**/:3_GG_X$_P#/R7W
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MY/\ XFC_ (4#\,O^@--_X%R?_$T44>TG_//_ ,"?^?DON /^% _#+_H#3?\
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3/T%%%2VWNV_5M_F!GT444@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>img12876764_23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img12876764_23.jpg
M_]C_X  02D9)1@ ! @$!2@%*  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 6Z"3L# 2(  A$! Q$!_\0
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
MS2O_ )34?\* \&_]!/Q-_P"!FE?_ "FKW*B@#PW_ (4!X-_Z"?B;_P #-*_^
M4U'_  H#P;_T$_$W_@9I7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_
M -!/Q-_X&:5_\IJ]RHH \-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_
MX&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\* \&_]!/Q-_P"!FE?_
M "FKW*B@#PW_ (4!X-_Z"?B;_P #-*_^4U'_  H#P;_T$_$W_@9I7_RFKW*B
M@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH \-_X4!X-
M_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF
M_P# S2O_ )34?\* \&_]!/Q-_P"!FE?_ "FKW*B@#PW_ (4!X-_Z"?B;_P #
M-*_^4U'_  H#P;_T$_$W_@9I7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH
M#P;_ -!/Q-_X&:5_\IJ]RHH \-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!
M/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\* \&_]!/Q-_P"!
MFE?_ "FKW*B@#PW_ (4!X-_Z"?B;_P #-*_^4U'_  H#P;_T$_$W_@9I7_RF
MKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH \-_X
M4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^
M@GXF_P# S2O_ )34?\* \&_]!/Q-_P"!FE?_ "FKW*B@#PW_ (4!X-_Z"?B;
M_P #-*_^4U'_  H#P;_T$_$W_@9I7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-
M1_PH#P;_ -!/Q-_X&:5_\IJ]RHH \-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;
M_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\* \&_]!/Q-
M_P"!FE?_ "FKW*B@#PW_ (4!X-_Z"?B;_P #-*_^4U'_  H#P;_T$_$W_@9I
M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\*
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\*
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK/Q#/JUE+$WB7PQ>:596,9FTK5(I8M4N/D+]H3_@J'XV_;T^#/C']G/]A_\
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MTUT6FHVUI>PZ7I'@?1;'PYIVJO9Z=#XPO]9\1^(;73K6Q:SDN_Z J "BBB@
MKF_%5SXFM-(>;PGIUGJFL">!4M;YTCMS;LQ\]RSWVG+N1<%1]I!)/"/T'244
M >&_V]\>/^A*\,_^!=M_\UM']O?'C_H2O#/_ (%VW_S6U[E10!X;_;WQX_Z$
MKPS_ .!=M_\ -;1_;WQX_P"A*\,_^!=M_P#-;7N5% 'AO]O?'C_H2O#/_@7;
M?_-;1_;WQX_Z$KPS_P"!=M_\UM>Y44 >&_V]\>/^A*\,_P#@7;?_ #6T?V]\
M>/\ H2O#/_@7;?\ S6U[E10!X;_;WQX_Z$KPS_X%VW_S6T?V]\>/^A*\,_\
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MWQX_Z$KPS_X%VW_S6T?V]\>/^A*\,_\ @7;?_-;7N5% 'AO]O?'C_H2O#/\
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M_P"!=M_\UM>Y44 >&_V]\>/^A*\,_P#@7;?_ #6T?V]\>/\ H2O#/_@7;?\
MS6U[E10!X;_;WQX_Z$KPS_X%VW_S6T?V]\>/^A*\,_\ @7;?_-;7N5% 'AO]
MO?'C_H2O#/\ X%VW_P UM']O?'C_ *$KPS_X%VW_ ,UM>Y44 >&_V]\>/^A*
M\,_^!=M_\UM']O?'C_H2O#/_ (%VW_S6U[E10!X;_;WQX_Z$KPS_ .!=M_\
M-;1_;WQX_P"A*\,_^!=M_P#-;7N5% 'AO]O?'C_H2O#/_@7;?_-;1_;WQX_Z
M$KPS_P"!=M_\UM>Y44 >&_V]\>/^A*\,_P#@7;?_ #6T?V]\>/\ H2O#/_@7
M;?\ S6U[E10!X;_;WQX_Z$KPS_X%VW_S6T?V]\>/^A*\,_\ @7;?_-;7N5%
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M1_;WQX_Z$KPS_P"!=M_\UM>Y44 >&_V]\>/^A*\,_P#@7;?_ #6T?V]\>/\
MH2O#/_@7;?\ S6U[E10!X;_;WQX_Z$KPS_X%VW_S6T?V]\>/^A*\,_\ @7;?
M_-;7N5% 'AO]O?'C_H2O#/\ X%VW_P UM']O?'C_ *$KPS_X%VW_ ,UM>Y44
M >&_V]\>/^A*\,_^!=M_\UM']O?'C_H2O#/_ (%VW_S6U[E10!X;_;WQX_Z$
MKPS_ .!=M_\ -;1_;WQX_P"A*\,_^!=M_P#-;7N5% 'AO]O?'C_H2O#/_@7;
M?_-;1_;WQX_Z$KPS_P"!=M_\UM>Y44 >&_V]\>/^A*\,_P#@7;?_ #6T?V]\
M>/\ H2O#/_@7;?\ S6U[E10!X;_;WQX_Z$KPS_X%VW_S6T?V]\>/^A*\,_\
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M] 'U]\ /^1-U/_L9KS_TU:-7N5>&_ #_ )$W4_\ L9KS_P!-6C5[E0 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7YGU^F%?F?0!]?? #_D3=3_[&:\_]-6C5[E7AOP _Y$W4_P#L9KS_ --6
MC5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7YGU^F%?F?0!]?? #_D3=3_ .QFO/\ TU:-7N5>&_ #_D3=3_[&:\_]
M-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7YGU^F%?F?0!]?? #_D3=3_[&:\_]-6C5[E7AOP _Y$W4_P#L9KS_
M --6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7YGU^F%?F?0!]?? #_D3=3_ .QFO/\ TU:-7N5>&_ #_D3=3_[&
M:\_]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_[&:\_]-6C5[E7AOP _Y$W4_P#L
M9KS_ --6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_ .QFO/\ TU:-7N5>&_ #_D3=
M3_[&:\_]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_[&:\_]-6C5[E7AOP _Y$W4
M_P#L9KS_ --6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_ .QFO/\ TU:-7N5>&_ #
M_D3=3_[&:\_]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_[&:\_]-6C5[E7AOP _
MY$W4_P#L9KS_ --6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_ .QFO/\ TU:-7N5>
M&_ #_D3=3_[&:\_]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***CEEB@BDGGDCAAAC>6::5UCBBBC4O)))(Y"1QQH"SNQ"JH+,0 32;2
M3;:22NV]$DMVWT2&DVTDFVVDDE=MO1)):MM[(DHKY,U_]NC]D_PUJ;Z3J7QE
MT*:[CD:)WT/2/%7BBP#HP1A_:WAG0=7THJ&/WQ>E" S!BJL1[O\ #[XH_#SX
MK:0^N_#GQCH/C#2X9$ANI]%OHKF6PGE3S([?4K,E+W3+EXP9$MM0M[:=D&\1
ME>:^?R[BWA3-\;4RW*>)N'LTS&BINK@,NSK+<;C:2A=S=3"X;$U:\%!)N?-3
M7+9WL?19EP=Q=DN!IYGG'"O$>4Y;6Y%1S#,LCS/ 8&JZC2@J>+Q6%I8>ISMI
M0Y:CYFU:]SO****^A/G HHHH **** "BBB@ HHHH *_,^OTPK\SZ /K[X ?\
MB;J?_8S7G_IJT:O<J\-^ '_(FZG_ -C->?\ IJT:O<J "BBB@#^7G_@H+XB\
M&?"C_@L]^S+\3_VJ=+35_P!G _#[18-"N?$&DW&L^$-%GBLO'.D)J%S831W=
ME??\(=\2=7T3QCK\%M;O/8V%QI6I3V=PPM4NOZ/S%\)/CQ\/XU,?P]^,/PN\
M66*M$I3P[X]\"^(M.D3"-&,:IH6IVQ1L*5$R+G P:X_]H/\ 9E^!G[4_@H^
M/CO\/-%\?>'HIWO-+:^^U6.M>'M1D01MJ7AKQ'I5Q8Z[H%\Z*D5Q-I>H6PO;
M=?L=^EU9/);O_/E^TY_P3)^,'_!.WPAXQ_:K_P""?W[2?Q0\-:-\/H'\7^._
MA;XDU&UO/M/AG3W2;4[\36=I:>%/'&E:#;@7=SX8\;^$;MCHUG<78UO4-1M(
M;6[ /Z8-*\'^%M#\(:;X T;P_I6E^"='\-V?@_2O"UA9PVNAZ=X6T_3(]%L?
M#]EI\*I;VVE6>DPQ:=;6<2+##9QI BJB@#F_A5\'_A;\#O"%CX"^$/@+PO\
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M47]N_P#:I^(5K:^)+SX)^*CX,^&$>I$W<7AA-8\0>+O!?@_4M(A8+;I>:/\
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M_,W_ ((M:%<Z%_P3;_9Y%V9A/JY^)VNB*4N5AMM3^+GCJ2P$ ?[L-QIZ6MZ
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M&[OX])E.F:#X8\,:!HLUW=:]H_AO0GB\0WC:GJM[:6_[8T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD&M-"8;OQ?K!&L>+KY679*)-9N4WV,$ZX\_3]&BTS2Y&4.;'?EC[_7ZWP/\
M1$RRAA_K7'^<UL=C*E*2CE605'AL'A)S@XJ=7,:]%XG&5:3ESQA2P^$H0JP2
MF\71;C+\;X\^F7FN(Q/U7P[R.A@,%2K0<LVXBI+%8W&0IS4G"EEN'KK#8*C5
M47"4JN)QE>=&;<%@ZR4H_P C^O\ [.7Q\\,:G/I&M?!OXE6][;L0WV?P=KFI
M6DH#,GFVFI:997FG7T!965;FRN[B!RK!9#@U]?\ [,__  3I^*/Q&U[3-?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;T;5-?UK4)?)L-(T73[K5-3O)2"?+M;&RBGN9WV@L5BB8A06( !-?I[\"?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME4JUJU24JE2I.3<ISG*4I2;<FVPHHHK4Q"BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHKXL_:W_;*\'_ +->BOI%@+/Q/\5M
M6LS+H/A/SF-MI<,P98=>\5/;NLUGI:,I:UL(Y(M1UJ1#!:-:VHNM3LO"XDXE
MR3A')\9GW$./HY=EF!AS5J]9MRG-W5/#X>E%.IB,57E[E##T8SJU9M1A%ZV]
M_ACA?/>,L[P7#W#F75\SS7'U.2CAZ*2C""LZF(Q%635+#86A%^TQ&)KRA1HP
M3E.:TOW7[3/[4?@']FCPG_:GB"5-8\7:K!,/"7@BSN8X]4UJX0,@N[ML2-I>
M@6TPVWVKS0NH(-M90WE\T=JW\K=_=+>WU[>I;0627=W<W26=KY@MK1;B9Y5M
MK<322RB" .(H?-EDD\M%WR.V6/3^/_B#XP^*/BS5O&WCO7;SQ#XEUJ?SKS4+
MQA\J+E8+.SMXPEM8:=9QX@LM/LXH;2T@58H(408K[N_8T_8-UGXY-9_$/XFQ
MZCX;^$R,9--MHBUEKOCR1&VA-+=T+Z?X<1P1=ZX4\V]*FRT8,[7.I:9_G#QQ
MQ;Q=])#C;+LEX:R9PR[+I8N.2X.<8*>"PF)EAXX[.,]Q\5.%!5EA\,ZL(3EA
MZ"A0PF%CBL7/VF+_ -.. N#>#?HQ\"YGGO%&=J>9YG'!RSW'0E4<,=C,-#$2
MP&29!ETG">(=%XC%*C4G3CB<0YXC&8N6#P</98/\WZ[;X=_#KQC\5O%^D>!/
M >C3:]XGUN25+&PBE@MT$=O!)=75U=7=W+!:6=G:6T,L]S=7,T4,<:$;B[(C
M?N9=_P#!)_X$3:B]Q;>./BG9:<\ZR?V:NH^%IY(H2RF6WAOIO"S. 1N6"6>&
MXDB4IYIN65FD^U_@K^SM\)?V?](FTOX;>&(=.N;U0NK>(K^3^TO$VLA7#I'J
M.L3J)C:Q,JM#IUHMIID$@::&R2>2663Z/A7Z)G&^-SFC#BS%9;DV14:L98RO
M@,=3Q^88NA&:YJ.7TH4I4J-2M%.,<1C>6.'4E5>%Q,HO#S^9XN^F'P)@<DKU
M.#L+F>=\05J,HX+#YA@*F7Y=@Z\H>[6S*K.M"M6I4)-2EAL#SRQ+@Z2Q6%C-
M8F/\Y7B']BC]JGPP'.I?!3Q=<^6I9O\ A'O[*\7$@()/D'A34M:,C;3@+'O8
MOF,#S 5'A?B'X>>/_")D7Q7X&\8>&&A++*OB'PSK6BF)D=HV60:E96Q0K(K(
MP;!5U93A@17]C%%?J.9?0XX9J\W]C\99[@;WY?[2P&7YK;MS?57DW-YVY;^1
M^3Y7]-CBFCR_VUP3D&86MS_V7F&8Y1S=^7ZVL[Y+]+\]O,_BWJ2*66"6.:"2
M2&:)UDBFB=HY8I$(9)(Y$(='1@&5E(92 0017]?OB'X/?"7Q:)!XI^&'P]\1
M&4'?)K7@WP[J<V2H3>LUYITTR2*JJ$E1UD38A1U**1X5XA_8._9/\2^8]W\(
M-)TZ9RS+-X>U?Q+X<\IF=G)CM=&UFRL",NRK'):21(FU4C41Q!/S_,OH=\74
M&WD_%O#V.Y7>']H8?,LJF[:K_=Z6;J,NWOV3WDEJ?HN6?35X-KI+.N#N),!S
M*T_[.Q&5YO!75GKB:V3RE'O[EVKVBWH?SE^'?CQ\;?"6Q?#7Q=^)6BQ(,"UL
M/&WB*"Q8!&11)8#439RJBNWEB6!Q&V'0*ZJP]V\._P#!03]K+PZ41?BC)K5L
MA!-KXB\->%=6$F'5B'OI-%35L,JM&0FHH-DC$8D$<B?J1XB_X)6?L\ZIODT/
MQ!\2_#$QSY<5MK>C:KIZ$JH^>#5?#\]_)AEW@#58^7<$E?+$?A7B+_@D4X\R
M7PG\;T89/E6/B+P04P,N09-5TWQ(^XA?+0A='4$AY-P#+$OC_P#$&?I)<+_\
MB+,<UJ4Z?_1/\;?5:;BNV'Q>899.I%I+]W["3:T<.A[7_$;_ *,/%G_(_P M
MRBG5JVO_ *Q\"?6JBD^CQ.#RW-(4Y)[U/K$8IJZJ=3R'P]_P5<^.^GB.+Q#X
M,^&?B*%  TT&G^(=$U"4[2-SSP>(+RP&6VMB+2HQ]\=&79[OX>_X*Z:'*8T\
M5_!/5K!05$MUX>\9V>KEE+#>\=CJ6@:((RJ%BL3:C('90#*@<F/YP\1?\$L/
MVC-)\R31=8^&OBF(9,45AX@U;3;]MJH2)(=:\/V%C$S.SK&$U.92J;Y&B+!*
M\*\1?L*?M7^&2YO/@[KFH1+DK-X=U+P]XF$J;G4.D&@ZQJ%VN[RV(CFMHIU4
MH7B3S(]Q_K;]*SA73$X;C+$4*?\ $EB^&</G^':6G[S'1RS&RBG_ #1Q<'+^
M9W8?ZG?1%XNL\+B>",/7J_PXX/BG$\.XB\O^?> EFF C*6MN26#FH_RIK3]>
M/#W_  5$_9FUA4&JQ_$/PG(5'F?VSX6MKV%'"%FV2>&]8UV62/>/+C=K>)VR
MK/#$"VSU6]_;W_96B\,ZUXDTWXIZ;K+Z3IEW?PZ##INNZ7X@UB>W1C!IFEZ;
MK^EZ3-+?7L^RW@$HB@0R?:+F:&TCEGC_ )O/$7PF^*?A$R?\)5\-?'WAH1 F
M1M>\'^(=(15 0ER]_I\";,21L'#%"LD;!BKJ3Y_5Q^E5XKY5&K@\WR;A^>)=
M*I&-3'9/F6 QM*JXN,*KI0S"CAY*G-J;IRPEIM<K<4V3+Z(WA!F\J6,R?.^)
M(895:<YT\!G>5YA@:U)2C*=+VL\MKXB+J03A&I#&<T%)RM)I6^Y/C1_P4#_:
M"^*>MW<OAWQ3J?PJ\*@M'IGASP1J,^G7T,!+;9]3\4VR6FMZAJ+H5$LMM-IV
MGKL0VNFVSF1Y>,^'7[;W[37PXU6#4;;XI>(O&%HDF^ZT/XB:A?>--+U"/#9@
MFEU>[DUBTC)(;S-(U;3;@%543^7N1ODZBOPK$>)7B!BLWEGM;C+B/^U95O;+
M$TLUQ=!0ES<WLZ6'H5:>%HX9?"L)2HPPJI_NU1]FW$_?L-X7^'.$R:/#]'@G
MAG^R8T50>%JY1@L0ZD5'E]I6Q->E5Q5?$OXGC*U>>+=3]ZZSJI3/4_BS\:OB
M;\;_ !"WB7XE>*M0\0WB-,-/LI'6WT71+>9E+6FB:-;".PTRWPD:R&" 7-V8
MDGOI[JY+3OK?!C]GSXK_ !\US^QOAOX7NM2A@E2+5?$5X'L/"VA!@K[M7UR2
M-K:"7RF\Z/3[<76K7<:L;'3[HJ5'L/["GP4\$?'?XYKX2^(-IJ>H>'-*\)ZO
MXIFT[3KV33DU"YTS4-%LX+/4[JW3[:FERC4Y#.MA<V%V\ZVR)>QH9(Y?Z7_#
M'A7PUX*T.P\->$="TKPWH&EQ"&PTC1K*WT^PMDZL4M[=(T,LKDR3SN&FN)F>
M:>225W=OVSPA\#LQ\7_;\;\6\18G^R*N95Z&*E&O5QG$.<8O#JD\1[7%XN-2
MEA*-JD(K$S>,KSY94XX>E%0K+\*\9_'O+?!CZOP)P=PUA?[9HY90KX6,Z%+!
M<.9+@\2ZJPWL<'@Y4JN,K7I5)/"TU@J$.:-26)JR<Z+^$_V<?^"=_P *?@Y]
M@\2>.4MOBC\08-DZ7>JV:_\ "):%<@*R_P!B>'KCS8[RXMY/]7J^M&ZG\R.*
M[L++1Y@R5^A=%%?Z \+<(<-\%Y9#*.&,HPF4X*/+*<</!NOB:D8\OM\;BJCG
MB<9B&M'6Q-6K44;0C)048K_.?BSC/B?CG-:F<\59SC,XQTN:-.6(FE0PM*4N
M;ZO@<)34,+@L.I:JAA:-*FY7G*+G*4F4445](?,!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7YGU^F%?F?0!]?? #_D3=3_[&:\_
M]-6C5[E7AOP _P"1-U/_ +&:\_\ 35HU>Y4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9] 'U]\ /^1-U/\ [&:\_P#35HU>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7YY_\%-?'.L>#OV:I--T:ZGLW\?>-=$\%
MZG-;O)%(=$FTW7?$&HVWG1XVQ7__  C\&GW<.\?:K&[NK=UD@DG6O8/VB/VP
M_A#^SI:36?B#4SXC\<M;B6P\ >'YH9]:?S4#6\^LSDM:^'=/D#)(+G43]KG@
M+3:9IVI&-XQ^ 7[1G[6GQ5_:4U"*/Q;>6^C^#M.O_M^A>!-$WQZ)IUTD5Q;0
M:A>2RDW>LZREG=7%N=2O7"0K<7:Z;9Z;;W<]N_\ ,_C_ .,'"N0<+<1<&X/-
MI8OBO-\NQ&5_5,JE&M+*XXI*EB)9IB8U(T\'*6&E5IK#*<\<W4A)X:%&7ME_
M4WT=?!?B[B'BSAGC;&Y/'!\(9-F6'S;ZYFRE0CFT\))U<-'*<-*G*KC8QQ4:
M57ZTX0P"]E.*Q,ZT?8OY@HHHK_,\_P!2CUOX._'+XF? ;Q!?>)OAEX@.A:EJ
M>FOI.HK-966J6%]8M/%<HESIVI07-G)+;SPI):W)B%Q;%IEAE2.XG23Z>M/^
M"EG[5ML9/.\4>&-0W[=HN_!>A((MN[)C^P6]D3OR-WFF0#:NP)EMW-_LL?L3
M^-OVG=-\1>([;7[7P/X3T.YBTRUU[4M)N=5&N:VRK-=:?IMI#>6&Z/3+1X9M
M0O'N0D4MY96T,5P[W36?U/>?\$C?&B>7]@^,WA>YSO\ -^V>%=6L=F-OE^7Y
M.J:AYN[+[]WD[-J[?,WG9^_\$<*_2'EPY@<?P/\ ZVX7AO%2KXC 4\!Q%0RW
M"57.M*E6Q%'+:^:8:;C5JPE+VWU7DK6]O"4XM5'_ #MQWQ;]&V'$V.R_CW_4
M[%\482-##9A4S'AJOFF,HJ%&%6AAZ^:4,IQ5-2HTIPBZ+Q;G0NZ%2,)*5->$
M_P##S;]J;_H+>"__  CK/_Y(H_X>;?M3?]!;P7_X1UG_ /)%>T_\.D?B+_T5
MSP5_X)-=_P#BJ/\ ATC\1?\ HKG@K_P2:[_\57UG^KOTM/\ H(XY_P#$HP/_
M ,]O+\^[/CO]9?H=_P#0-P#_ .(ICO+_ *D_I^/F>/VO_!3W]J&WE\R6[\!7
MR;2OD77A$)%DXP^;+4K.?<N.!YVSD[E;C&C_ ,/2OVF/^?'X8_\ A*ZM_P#-
M-7HUU_P23^**1 V7Q5\ W$VX QW6G>(;.+9@[F$L5K?,6!V@)Y(!!)+K@!L_
M_ATQ\9O^BD?#'_OKQ5_\SU']D_2TH>Y[7CF76_\ ;6"Q&]O^7GU^IVVYM-=%
M=A_;'T/*_O\ L> 8_9M_86-P^UO^7?\ 9]+O\7+KKJ[.W$_\/2OVF/\ GQ^&
M/_A*ZM_\TU2P_P#!4[]I6*6.1]+^%ERB,&:";POKBQ2@?P2&W\603A3W,4T;
M^C"NQ_X=,?&;_HI'PQ_[Z\5?_,]44_\ P29^-JQ2-;?$3X62SA<Q1SW'BVWB
M=L]))H_"]R\:XS\RP2G/&WG(/J'TM(^][3CE\OO6_M+!2VL_A^M/FZ>[9WU5
MG=H/[1^AY+W?9\ KF]V_]EXV%N;3X_JD>7?XKKEWNK-K)_X>P?M$_P#0F?!;
M_P )WQS_ //&H_X>P?M$_P#0F?!;_P )WQS_ //&H_X=/_M$_P#0Y_!;_P *
M+QS_ /.YH_X=/_M$_P#0Y_!;_P *+QS_ /.YH_XZT_ZKG_RR\O\ @?CYA_QQ
MW_U0/_E\?)/[0O[37Q*_:7UW1-;^(!T2QA\.Z=+I^C:#X8M=1L- LC=3>=?Z
MA':ZIJVLW;:EJ)CM8[RYDOG5X+"RACBB2##?/5>Q?'+X&^.OV?/'=QX \?0Z
M>VI)866JV&JZ+->76A:WIE]&2E]I%W?V.F7<\$-U'=:=<BXL+66&_L;J+RVC
M6.:7QVOYSXIK<1U^(<VGQ;/'U.)%BYT<WEF?-]>6*P\8T'"OS;>SITX4Z2C^
M[5&--4OW2@?TQPE0X9P_#>3T^#J>7T^&)8.%;)HY4HK /"8ERQ"J4.7?VM2K
M.K5<_P!ZZTZCK?O7,*^U/V9/V'_B?^T;%;>)DFM?!GPS-Y-;3>,M35;NXU)K
M.X-O?VOAO1(9H[G4KFVE5X9;J\ETW28YDFB6_FNK>6T'Q6 2< 9)X '4GTK^
MJ7]C#X;ZQ\*OV:_AEX4\16LUCX@;3M0\0:Q8W"F.XL+KQ1K.H:_#87$+$M;W
M5A8ZA9V5Y V'CNX)U=5?<H_6OH^>&N5^)/&.,PO$&'QM;(<FRJ68XN.%K2PU
M/$8R6+PM#!8#%8B$75A2Q5.>-K..'J8?$3CA)^SKP49W_'OI'^*.;>&'!6"Q
M?#F(P-#B'/,WCEF#EBZ,<55P^"A@\5B,=F.$PU22HU*N$JPP-%3Q-+$8:G+&
M4_:8>HYPMM? ?]EOX/\ [/&FK!X%\/)-X@FMQ!JGC;7!#J/BS5 0/-C;43#$
MFFV,K*I;2]'@T_3W,<<D]O-<*9V^B:**_P!/,HR;*<@R_#Y5DF78/*LNPL>2
MA@\#0IX>A37VI<E.,5*I-^]5JSYJM6;<ZDYSDY/_ "FSG.\XXBS'$YOGN98W
M-LSQ<^?$8W'XBIB,14?V8\]23Y:=->[2I0Y:5*"5.E"$(J*****],\L****
M"BBB@ HHHH **** "BBB@ HHHH **** /./BC\)?A]\9O"USX/\ B-X;LO$6
MC3DR0>>&BO\ 2[S84CU'1M2@,=[I>H1 D+<VDT9DC+V]PLUK+-!)^!O[4?\
MP3Z^(/P2-_XN\ ?VA\1?AE%YUQ/<V]L)?%?A6U7,A_X2+3;.,"_L+>($R>(=
M*@6U18IIM3L-&B\DS_T<T5^4>)?@[PAXG81_VKAOJ&=TJ7L\#Q%@*<(YCA^6
M[ITL2GRPS'!QDW?"XEMPC*I]5K86K4=4_7O"WQKXS\*L9'^R,5_:&0U:WM,?
MPUF%2I++<1S-*I6PK7-/+<=**TQ>%24Y1I_6Z&+I4U1/XS-#UW6O#&KZ?X@\
M.ZMJ&AZYI-S'>:9J^E7<]AJ-A=19V3VMW;/'/#( 2I9'&Y69&RK,#^T_[+O_
M  4TL]3;3? _[19M]-OV\NTL/BC8VRPZ9=R'"Q+XQTJTC$>ERR-\C:YI4(TS
M<\;7^FZ9;Q7.I-[!^U%_P3I\#?%IM1\9_"@Z=\._B',);JZTU8#!X)\4W1&6
M:]LK2)W\/:G<. TFJZ3;R6MQ*99=0TFYN[F748_P1\>> _%GPS\6ZSX&\<Z-
M<:!XH\/W$=MJFEW+0R/"TUO#=VTL4]O)-;7-K>6=Q;WEG=VTTMO<VL\,\,CQ
MR*3_  [B\!XM?1HS]8K#5O;9#CL4J<<1!5<3PQQ!&"E.%#&X9RA/ YE["$[1
M<L/CZ485W@\57PL:E6I_>^#S#P=^E+P[+"8FA['B# 85U)X:HZ6$XJX<E.48
M3Q&!Q2C*&/RSV\X*4XQQ.7593H+&X7#XR5.E3_H3\;_\%,_V9?!VK7.D6-SX
MU\>-:7$EM/J/@C0-.N=),L19)&MK_P 1:]X;BO[<.I6.[T\75I< K+;3S0,L
MI]D^"/[8WP(^/M]_8G@OQ-/I_BDPM.GA+Q79C0M>N8D#-(=.4SW6F:O)$B/+
M/;Z/J5_<V\"M/<0Q0#S*_E:JS9WEWIUW:ZAI]U<6-]8W$-W97MI-);75I=6T
MBS6]S;7$+)+!/!*B2PS1.LD<BJZ,& (]W+OI<>(%'-X8K,\LX?QN42K7KY5A
ML+B,%5AAV]8X3'RQ6)JTZ\8_#4Q-/%4V[WHI-<O@9G]#?PYKY-/"95FO$> S
MF-&U#.,3B\-CJ4\2HZ2QF71PN&I5,/*5^:EA:N#JI-<M?W6I?V?T5\H_L8_'
M:\_:!^!FB>+-;\L^+-#OKGP=XODB"JEYKFC6MC<#55C546(ZQI>H:=J5Q%&B
MP0WMS=06X$,2 ?5U?Z"</YYE_$V295Q!E5257+LXP.'Q^$G./)45+$4U-0JP
MN^2M2;=*M3N^2K"<+NUS_./B/(,QX6S[-^',WI1HYEDN/Q.7XR$)<]-UL-4<
M'4HSLO:4*L5&K0J67M*4X3LN:P4445[!XH4444 %%%% !1110 4444 %%%%
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MJZ?HFB:=>ZQK.KWEOI^F:9IUM->7^H7]W*L-M:6EK LDUQ<3RNL<<4:,[NP
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MM&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M972R["SJ*MB:G/4KXO&UTN7V^,Q=:4Z^(FE=4XRG[*C%N%"G2I^Z?'\;<?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9C0QF A!5<;4E'^D^B@$$9!R#R".A'K17^D)_F(%%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX[R]TO1=8M_^$DTFVN  @\1>$+[[+XG\/.^X(8-<T>PD).W8<\@'HWPT\?\
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MZ-KUSJ-]I<5S%;Z\QATG1- U"\L].O-=EUA;O1[?SGX3_P#!7[Q7H7QK\'?
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M]JZO->WJ^;+';26MJRVJ?/?^E7UU_P O%Y>WEQ_TTN+JZNKB3_@<L]Q/*_\
MM22R-_$S<_IY^S5_P34\=?$/^S_%GQJDO_ASX-E\JYM_#21I'X\UV E6"SVU
MS')%X3M95+ R:I!/K.49?[%MXI8+ZOP7/>/?%OZ0N;5.'N'<!B,+D7/%U,ER
MNI.EEN&P\I^YB.),WJ*E'$I<O-&.(='#3J4U]2R_ZS\?]"</^'O@Y]&[)J?$
MG$N8X7%Y_P DE3SS-J5.MFF)Q,8+GPW#&34W6GA6^;EE+#*MBH4ZC>.S%86[
MI_G]\,_A1\0OC#XE@\)_#CPOJ7B?69MCS)9QA++3;9WV&^UC4YVBT_2+!6^4
MW>H7-O"TA6&-GF>.-_W*_9K_ .";'@#X;?V=XL^,<EA\2?&T/E74.@>4[^ M
M N5V.J_8KE(YO%=U"P8?:=8@@TDB3:N@F:"*^;[\^&_PM^'_ ,(O#=OX3^'7
MA?3/"^B6^UG@L8BUU?7 7:;W5M1G:74-6OW7Y6O=1N;FX*!8A((D1%[^OZ5\
M+OHS<+\'?5LVXJ>'XKXCAR584ZM)O(<MK1M)/"8.M%2QU:G*_+C,?#ENH5*.
M!PM6*F_Y=\5_I3<6<:_6<GX16(X0X:J<]*=2C64>(<SHNZ?UO'4)..7T:D;<
MV#RZ?-9U*5?'XNC-TTR...&-(HD2**)%CCCC54CCC10J(B* J(B@*JJ JJ
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M5[_\L*/^%<?$3_HJ6I?]^KW_ .6%>Y44 >&_\*X^(G_14M2_[]7O_P L*/\
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MJ7_?J]_^6%>Y44 >&_\ "N/B)_T5+4O^_5[_ /+"C_A7'Q$_Z*EJ7_?J]_\
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M7_?J]_\ EA1_PKCXB?\ 14M2_P"_5[_\L*]RHH \-_X5Q\1/^BI:E_WZO?\
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MJ7_?J]_^6%'_  KCXB?]%2U+_OU>_P#RPKW*B@#PW_A7'Q$_Z*EJ7_?J]_\
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MKW_Y85[E17TA\P>&_P#"N/B)_P!%2U+_ +]7O_RPH_X5Q\1/^BI:E_WZO?\
MY85[E10!X;_PKCXB?]%2U+_OU>__ "PH_P"%<?$3_HJ6I?\ ?J]_^6%>Y44
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M%2U+_OU>_P#RPH_X5Q\1/^BI:E_WZO?_ )85[E10!X;_ ,*X^(G_ $5+4O\
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MLKRG#S:;H8#"N<U!R48>VQ-657%XEP@\17J<D%'PW_A7'Q$_Z*EJ7_?J]_\
MEA1_PKCXB?\ 14M2_P"_5[_\L*]RHK[H^ /#?^%<?$3_ **EJ7_?J]_^6%'_
M  KCXB?]%2U+_OU>_P#RPKW*B@#PW_A7'Q$_Z*EJ7_?J]_\ EA1_PKCXB?\
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M (5Q\1/^BI:E_P!^KW_Y84?\*X^(G_14M2_[]7O_ ,L*]RHH \-_X5Q\1/\
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M?"3X>:+<1E66_M?">BMJF4.8R^K3VDVI2>6<LGF7;;&+,N&9B?70
M ,  <  #@ #@ =*_KW*/H;5GRSS[CBE#;GPV49/.K?ORXW&XVCRZ:*^ E>]]
M+6?\99S]-N@N>'#W 5:I>_L\5G.=0HV[<^!P.!K\U]WRYC&UK:WNOYB?"?\
MP3[_ &K?%GE2CX:-X;LY1_Q^>+-?T'1?+YQB73&U"?7D/4_\@DC'?D9^EO"G
M_!)7XG7PB?QK\4_!'AM'57>/P[IFM^+KB+=@F-UOU\(6YE0$J_E7,L0<$1RR
MIB0_O#17ZEE'T4?"S+N26/CQ!GTE9SCF&;?5J,GI=1AD^'RVK&%]4G7G)7UF
MS\ESGZ7OBUF7/'+I<.\/0=U"6791];KP71RGG6(S2C.?=K#P@^E-'Y;>%?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB\$_$'48V\,W5W-B#P[XXF5+>"W5G(6&P\6*L&GRJ=R1:S#I4L:PI>:E._\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:EA)SHURBBBO[:/X2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX*9?""0K_:/@;XDVH,0+FRMO#%^5G^7,:B?Q)INZ(9?$Q*.=JY@&\[.KLO\
M@HS^SW=>7Y\'Q TW?'O;[;X:L9/*;&?*D_L[7;_,F>,Q>9%D?ZS&"?Q7\+?#
MGQ_XY@U"Y\%>"_%'B^+2I+6+4QX8T+4M>FL'O1.UI]KM]+MKJX@2Y%M<&&1X
MEC?R)0KDQN!=O?A)\5=-\W^T?AE\0=/\E@DWVWP9XCM?*=B JR^?IL?ELQ8
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MA:R2C6P]6E5C[LT%%%%>T>&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M4Y2FJ-&FISG*\F4445] ?.!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?F?7Z85^9] 'U]\ /^1-U/_L9K
MS_TU:-7N5>&_ #_D3=3_ .QFO/\ TU:-7N5 !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.FQWZW'Q \-H='DOS<ZA=7EG#>Z#>3:KIEU!8P3Q61F=8]2N88?^/^!?)2
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M;^*?BAI$<6-W>Z9]HCM/!7A>XE23=XM\8W.D:5/%;7L.AC7M8MX]&N/YB/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT!N-0U34)2D2#I%!!$BO<7E[<R;8+*PLX9[V]N'CM[2":>1(VX'XS?'[X:?
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M)2?+1G4DI4:=H^_)1G'^8WXM?\$SOVF/AL+J^T#1--^*N@P;Y%O/ MT\VM+
MHRIN/"NI)9ZQ+<O@C[-H::Z%./WS9KX)UC1=9\/:E=:/X@TG4]#U>QD,5[I6
ML6%UIFI6<HZQ75C>Q07-O(.Z2Q(P[BOZ?_C+^WW\)?AX+O2?!+'XG>*(O,BQ
MHUP+;PI93KE<W?B1HIH[\*2LB1Z#;ZE!.%>&34+*3YA^0/QW^.GCG]HK4+>Z
M^(IT>;3].:3^Q]"TS2H+/3=)67.\6TTAN-6N';))FO\ 4[N52SB%HD8I7R'$
M/T=LIQ/M*W#6<8G+:CO*."S*/UW"-](0Q-/V6*H06_-4CCI[KKIXN8^&N#J\
MT\KQM7#3W5#%+V]%O^6-6/)6IQ\Y*N_T^/OAK\;OBY\'KT7WPS^(7BCP>YE6
M::STO4I3H][(I!4ZEH-U]HT35 ".$U'3[I.OR\FO>?'7[=?Q^^*FG1:%\0_%
M<]]H(@2"ZTSP[!:^%[/4L+B2;6+/28;>'6&E8"0VUV18Q2 /;6T!&#Y?!\'9
M_%.IVVD^#K/5[W6K^40V.C:=97.M7%W*<D16MI;(]\[8R25:?:HW%0 2?0_&
M?[!O[5G@?1(?$6H_"36]5TN6 7$G_"+SZ?XGU2RC*E_^)AH&B7=[KUH4B_>S
ML^G-#:KN2YEBE21$_-Y9#XR>&K<\OEF<\NHMR<LJJ_VSE$HI^].IE]2%5X>+
M6DJM? X>23NIIJZ^8>7\;<+MRPSQ4L-!MWPDOKV":^U*6&E&;IKHYU,/2DMU
M)6NN/T;Q3H^NSP6EE.XOKF1(8+&>-H[F::5@L<,(&Z.>61R$2.&21V; "\C/
MZ<_!;_@GAX\\9)9:[\4M43P#X=G6*XCT>P>TU7Q=J%M( ZG*-/H^AI/$RO%/
M=2ZG>1,#'<Z-&2&'X>W%M<6<\UK=P36MU;R/#<6UQ$\$\$T;%9(IH9562*1&
M!5XW565@0P!&*]P^%7[37QX^"CPK\./B9XET/3H7WCP]/=+K/A=\D&3=X:UJ
M/4-$1Y5&Q[F"RANPI_=W$;*K+];P_P#2*Q--PH<4Y'"LDU&>-R>?L:RMHW/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ HHHH *_,^OTPK\SZ /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\
M8S7G_IJT:O<J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***\R^*?QA^&_P &O#TOB/XC>,-&\*V1286":A*\VH:I<QJ#]GTG1;,2
MZMK$ZEE:6#3;6>2*(F68PPJTJ\F.QV"RS"8C'YCB\-@<%A:;JXG%XRO2PV&H
M4X[SK5Z\X4J<$VES3G%7:5]3LP&7X[-<9A\ORS!XK,,?BZD:.&P>"P];%8K$
M59;4Z.'H0J5JLWJ^6$)2LF[:'XE?M\?MF>*/&WC3Q'\'/AKXBN]'^&_AN6X\
M/^)[K2I&M+GQMKUK+)!K4%Q?Q;;IO#5A,KZ5#I\$D=GJ\D%Y?WAU"SGTU+7\
MN:FN)YKJ>>YN)7GN+B:2>>:1BTDTTSM)+*['EGD=F=F/)8DFH:_QOXVXSSKC
MSB+,.(<[Q5:O6Q=>K+"X:56<\/EN"=23P^7X*E*4HT,-AZ;45&%G4GSUZKG6
MJU*D_P#;/@3@C(_#[AK+N&\BPE&A0P>'I1Q>)A2IPQ.:8Y4XQQ.8XZK&*E7Q
M6)J)S<IMJE3Y,/15.A2I4X6I[Z]N;>SM+F\NI[73XY8K"VGN)IK>QBGF>YGC
MLX9',=M'/<223RI"J+),[RN&=B3]D_LF_L8>-OVD]5BUJ]-UX4^%.G7@CUGQ
M=+ !<ZL\#_Z1HOA*"=#'?ZD=IANM1D632]%):2[%W=I!I5Y\65_6I^S#87FE
M_LZ? ZQO[<6MW#\+/!!FMQ&(6B,WA^QG59HPJ;;G9*IN@Z^8;DRF4M*78_J?
MT>O#7)_$KBW&PXCJ8JKE608##YA6P5)RA',INO##8;!8G%*:J4,*HQDYTZ*5
M:M2INE2JT%%S/R7Z2/BCG7A?P=@:G#-/"4<WXBS#$9;0Q]91G/+(1P\\3B<=
MAL'*#I8C%.4HQA4KMT:-6JJM6CB')0.Y^&WPT\$_"3PCIG@CP!H-IX?\/:6G
M[NWMEW7%Y=,B+<:EJEX^;G4M4NS&C75_=R2SR[43<L444:=W117^H&$PF%P&
M%P^"P.&H8/!X2C3P^%PN&I0H8?#T*45"G1HT:<8TZ5.G!*,(0BHQ2222/\H\
M9C,7F&*Q&.Q^)Q&-QN+K5,1BL7BJU2OB<37JR<ZM:O6JRE4JU:DVY3G.4I2D
MVVVPHHHKH.8**** "BBOC[X\_MG_  M^"_VS1+*X7QUX\@$D1\-:'=1_9-+N
ME!"KXCUM5GM=-*."LMA;I?:O&0HFL+>*1)Z /ISQAXP\,> /#.L^,O&6M6/A
MWPSX?LI+_5]8U*80VMI;H51>@:2:XGF>.VL[2W26[O;N:"TM(9KF>*)_YHOV
MOOVO?$'[4WB9K*VGOO"?P+\*ZDS:#HLF5OM?OT62*/7=:AB9TNM=NH'D_L_3
MU::R\.6$T@WRW,UY>7S?VF/CU\2?VA;.XE\=^)?[/T+3;K^U-(\,:7YUEX6T
MR>))HH2U@LDLNH79CN)84U'49;[44,S);RI"_P!E/PA<W]S=P6EO*ZB"QB,5
MO#&BQQJ&8O)*40!6FE)'G2D&23:I=F()'\V>.'%N/RW&87(<127]BU\!',(8
M:E77_"[BX8E4_JF;.E6I8O"91A>7VTZ%&*EF=2/L(XFE:57"?F''F<8C"UJ6
M7U(?[#4PZQ,:4)K_ (4*T:JBJ.,<)PK4<'2M[24*:OBI+V:J0LYT>^T'XBZE
M\//&GA_QW\*K_5/"'B3PU,L^GZK!)$7\U(S XDM)5N8+FVO;9YK74[.]^TV>
MIVD\MO>VLD<TZR^R?$?]M[]J/XH0267B+XM^(;#2I5>-])\(K9^"[*2&0Y>W
MNV\,6VEWFHP-T,>IW=ZK+\OW<K7RL()3";C9B 2>5YC$*&DV[BB D-(RK@N$
M#>6&0R;0ZD_9'[*/['NJ?M/7OB.S@\;:-X.NM"T^RU6TTS5+2]GU#7=.N9Y;
M:YO[/[/&\=O9:?<&QAN)95ED=M2M7BA,1$C?AN32X\XLS+%Y5P\\7A%F\O[1
MQF793-Y)DL:481HO%UL/0EA\'2P[C&,'.2D\3548KV^(<4_@L"^(,WQ5;!Y:
MZU%8U_6:V&P<G@<"H**A[:=*FZ="%-I1CS-/VLTDO:5&D_C222261Y97>665
MVDDDD9GDDD=BSN[L2SN[$LS,2S,22236C8:)JVID?8=/N9U)QYHC*0 ^AN)-
MD*GV,@-?L_I__!*#QSIVTP^+OAM+*O/G73>);J3/]X>=H;)&?^N2(.^,DDVQ
M_P $T?CJ  /%?PD  P -=\8  #H /^$#X K]:R+Z.>(FX5>)<_IT4[.>$R:B
MZU1IZM?7\9"G"$UL[8"O&^JDTO>^PP'AI4E:>:9C&%[.5'!0<Y:ZM?6*ZC&,
MEL[4)J^J;2U_(W3?AM>R,CZI=Q6T607AM?WUP5[KYC*(8F[!@+A1UVGH?K#X
M7ZW\%/AL+>YN_P!GWPU\1]8A"$ZG\1O$VLZY;LXYD'_"-VUOIWA62%WP52\T
M6]FCC58_M#;IFE^K#_P3C_:"!(%[\.R 2 1XCU3!QW&?#H.#U&0#Z@'BLI_^
M">G[1JLRC3_"#A6(#KXIMPK@$@,H>V1PK#D!T5L$;E4Y _9LB\*.!,@Y)X;(
ML/C<3"S^MYM?,JSDMIQIXGFPM&:W4L/AJ+3U6NI]OE_"'#^7<LJ67TZ]6-OW
MV,;Q4VUM)1JWHPDNCITH-/7<]9T3_@I/>>'],M-)TCX&^$])L+.)8X;#1/$$
MND:9   "+33K;P]Y-K$2/EB0MM& 6;&:Z>'_ (*BS+$@N/@A%+,!^\DA^([P
M1,V3RD+^!+AT&,##3R'()W<X'S5)^P)^TPDCHOA+1951V598_%_AP1RJK$"1
M!+J$4H1P-RB2..0*1O1&RHR9?V%?VI(Y'1/AG'.J,56:+QK\/Q'( <!T$WBJ
M&4*W4"2*-\?>0'BOT.,8PC&$(QC"*48QBE&,8I648Q5DDEHDDDEHCZ1)12C%
M))*R22226R26B2[(^PH/^"H.D-$AN?@UJ4,YSYD<'CBUN(E.XA=DTGA:U=\K
MM)+01X8E0& #-JV__!3SP8T2FZ^%?B>&8EMT=OK^E7,0&3M*S26EH[$K@L#
MNTDJ"P&X_"4W[%W[3D$KPO\ "G4F=#AC#KOA*XB)P#\D]OX@EAD'/WHY&7.1
MG((&5/\ LC_M(V\KPR?"/Q0SIMR8!IUU$=RAQLGMK^:!\!@&V2-M;*-AU910
MS]%[?_@IM\,6CS=_#OQY!+N(V6\WA^ZCV\;3YLNI6;;CSE?)P,##-GC5M?\
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M#,5YK\PPZJUKY6FK*C0W>J6DA4'SO]K3QE\*OA5_:'[/_P !W_MO4+-I=/\
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M,?$NAR:CH<9<8=89[Z*X52#)"A! \)1WC=)(W:.2-E>.1&*.CH0RNC*0RLK
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M^-++6=XW+\T>GZKH6A>40A;]VVIRY9%/F*)2(OH;PS_P52_95UWRQJUWX_\
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MX/V+X<^-GQ/T^",?)9'QIKU[IB\*N1I>H7MUIVX*BJ'-KN"J%! &*^A_#/\
MP4P_:[\/>6MWX\T?Q7!$?EM_$W@WPU)E=RL5DN]$T_0]1E!PR[I;UY LC*K@
M+%Y?V.!^D5PM6LL?D^>8*3M>5"."QM*+Z\TGB<+5LN\:$F_Y3V\/XE93.RQ&
M"Q]!OK35"O!>K=6C.WI!OR/ZB**_G]\,_P#!8/XJV?ECQC\)? &OJI42'PYJ
M?B'PG)(H<[L-J,_C!(Y&CPNX1,@DW2"+81"OO6E?\%AOAM-IUU)K?P=\<:=J
MRV4[V5GI6NZ#K6G3ZBL$K6UM=:E=KH%S:V4MR(8I[Z+2KR>""26>/3[B2)+:
M;[#!>-'ASC(ZY\\).UW3QN7YC1DEU7M(X6I0;Z<L:TFWLF>S0XXX9K+7,'1E
M:_)7PV)@U_V\J4J;?DIMOHF?II\5?C=\*?@AIFF:Q\5/&NE>#['6;]=,THWR
M7MW=:A=G9Y@M=.TNTO\ 49;>U62)[^]6U-EIT<L4E]<6\<L;-Z/INI:?K.GV
M.K:3?6FIZ7J=I;W^FZE87$5W8W]C=Q)/:WEG=0/)!<VMS!(DT$\+O%+$ZNC,
MK G^:#P7X[^$'[5WQ8\5_$7]M/XT7'A"*XLKO1/ G@G1--\4K9:5'=P3BQDM
M=8L]"U;1="T7PXTPN[:WOKEKOQ#KBO>Z_*UN)X-;^D?@-\?/%/[#WC/2OA3\
M3/$MI\2?V8/&US<WOPP^+/AJY77-$TRTFNL3:IHMS8S7R_V?!<3JOC;P6D\]
M]X?U"5]7TA;F.Z(\0^+E7B_1QF8?7,9A<!AN$,9B7@L%F-''T<1FN5U8U(T:
M.+XFP%*M4EE> S.K+DPE6I3I_591@L5*4*]*JN+!\9PKXCV]:EAZ635JKH4,
M3#$4ZF+PDU)0A6S7#PJ2>%P^*F^6C.48^Q:C[9N-2,U^[=%4M-U+3]9T^QU;
M2;ZTU/2]3M+>_P!-U*PN(KNQO[&[B2>UO+.Z@>2"YM;F"1)H)X7>*6)U=&96
M!-VOVR,HRC&49*49)2C*+3C*+5U*+5TTTTTT[-:H^Y332::::333NFGJFFM&
MFMF>-_M"? /X6_M1?!;XC?L__&GPU;^+?AC\4O#=WX9\5:-.1',;>9XKFQU3
M2[LI(^F:_H&JVUCKWAW6(%^U:-KNFZ=JEH5N;2)A_DC_ /!2+]@3XI?\$W_V
MI_''[.GQ'6?5M*LI!XB^%GQ!6QDLM+^)OPQU6>X'ASQ98(Q>."^007&B^*=*
MBFN%T/Q7I6LZ7%=7MI;VFH7G^PY7X^?\%HO^"7/A?_@IW^ROJ'A+2;;2M*_:
M,^%<>K>+_P!GCQM?>7;K!XBFMH#K7P]US4&*-!X/^)%MI]EI6IRR/Y.C:Y9^
M'/%+Q72Z!)87O^D/[.+Z9=?Z,7B@N%^,<PJKP7\1\=A,'Q7"K.<\/PEGC4,+
MEG'.%I:^SIX:/L\!Q-&@E/%Y'R8J5/%XO(\LPS^0XOX=6=8+V^'@O[1P<92H
M-:.O2^*>&D^K>LZ-](U;QO&-6;/Y(/\ @VH_X*[']E3XMVW[$7Q]\3BV_9T^
M.OBB(_#/Q%K-R%T_X/?&C7);:QMH9[V>14TOP%\39A;:7K7F%M.T#Q@-'\1E
M=*T_5?&NJS?Z,5?XB7C'P?XI^'WBSQ-X$\<:!JOA3QGX,U[5O"_BOPQKMG-I
MVM>'_$6@WT^F:SHVJV%PJ3V>H:;J%M<6EW;RJKQ3Q.C#(K_1Z_X-Q/\ @KL/
MVUO@DO[*7QW\3?:OVIOV?_#5JFD:UJ]TKZE\:?@[IAMM+TOQ6UQ*_G:CXU\$
M&6P\.^.S*'O-6M)O#WB^2ZU+4-6\3-I?]G_M8_H:4)PJ_2S\*LOI8C XZ.#?
MB[EF40A5H2^L1I4<K\2,%##*5.KA\8IX? \45:#<95)Y=G\H5%7SW'P^=X$X
MB>F18Z;4H\W]GSJ.STNYX.3EJG&SE03Z<])6M2B_Z<Z***_P0/U(*R=?T'2/
M%&AZQX;\06%OJNA:_IE[H^L:;=*7MK_3=1MI+2]M)E!#>7/;RR1L5974-N1E
M8!AK45%2G3K4ZE*K3A5I582IU:52,9TZE.<7&=.I"2<9PG%N,HR3C*+:::;1
M=*K4H5*=:C4G2K49PJTJM.4H5*52G)3A4ISBU*$X22E"46I1DDTTTC^8;]J'
M]B[XF?L_:]JNIV6D7_BCX5SWUU+H/B_2X9+\Z=I[R/):Z?XMAMXA+I&I6D!2
M&6^FACTC49%\VQNO-::RM?CW3]-U'5[VWTW2K"]U/4;N016MAI]K/>WMS*02
M([>UMHY9YI" 2$CC9B >.*_L[K/M-(TJPE:>QTS3[*=T:-YK2RMK>5XV979&
MDAB1V1G1'922I9%8C*@C^.>(?H?Y)F&<UL;D'%F)R+*L16=664XC*8YI/"*<
MN:='!XS^TL#+V"O*-"&(HUJM&*BJE?$--G]K\-_31SW+LDHX'B+@_"Y_F^&H
MQHQSC#9Q+*88QPAR0K8W O+,?'ZQ*RGB*F&KT:5:;E[/#X9-)?A%\"O^"7OC
M'QUX0O?$/Q=\07_PMU+4$M'\+Z!!IUKK&L6\#K(]Q>>*M/EN;1;!I%:V6TTF
M._BU.$_:?[42PFC2V>IXR_X)0?&323-+X)\>>!/&-M'DQPZFNK>$M6G&"0([
M1K?7=+5B1@B;7(E&0=Y&<?OQ17Z#'Z+WA+_9.$RZKE>93QF&H^SJ9W#-L91S
M+%U'*4YUJ]*$WE?,Y2M",,OC&G3C""32;E^<2^E?XQ?VQC,SI9KE<,'BJWM*
M>0SR;!5LKPD(QC"%'#U9P_M9048WFYYE*52I*=1M.24?Y5O&7[&'[4'@43OK
M/P;\6WMM!N9[OPM!:^,[?R5Y-P3X3N=9EAA"?O':YB@:% S7"1;'"_-VHZ9J
M6CW<MAJVGWVEWT!Q-9:C:7%E=PG)&);:YCBFC.01AT!R".QK^SJL#Q#X4\+>
M+K/^SO%?AK0/$^G_ #?Z#XAT;3M:L_G&U_\ 1M2MKF#YU^5OD^8<'(K\VSOZ
M'&35>>?#G&>98)J[IT,ZR[#9DI/I"6*P-3*G37]]82L]+<CO=?J&0_38SNER
M0XFX(RO')V4\1D>98K*W%=9QPF/IYLJC_N/&45K\:M9_QO6MW=6-Q#>6-S<6
M=W;N)(+JUFDM[B"09 >&>%DEC< G#(RL,GFOH7P9^US^TMX"$2>'?C+XV^SP
M$>39:]J*^+M/A0 *(H;#Q9#K=G!#@?ZF&&.,,6<*')8_OUXS_8+_ &5O&IEE
MN/A9IWAV]DW;;SP9J&J^%A#N.6,6EZ7>1:">?N^=I$H0#;&%4D'Y.\9?\$E/
M %Z9I? /Q7\6>'6.YXK7Q5H^D^*X V"?(%QI;^$IXH2V$25X[N6*/EQ=."6_
M-,1]&[QLX1K3Q7">;X;%S3<H5.&^(\5DF.DDM'46-_LFG&III&&+K*UESMZ+
M]2P_TGO KC.C#"<89/BL'!KEG2XGX9PF>X"+ENJ;P/\ ;%25.[^*>#HN]VX)
M6;^9O!W_  56^.^BB&#Q=X7\ ^-;9"/-N!8ZEX;UF<<!@;O3;^?2(\@9!3P^
M,,23N7"CZQ\&_P#!6/X3:H88O'/PY\;^$9I  \^BW6D>+]-@?&2TTTLGAG4?
M*X(#6^E7,I8H#"%+.GQMXQ_X);_M&: )IO#-]X$\>0+DP6^EZ]-HFJR@=I+;
MQ+8Z7I<+'L%UN9?5UZ5\G^,_V8OV@_A_YC^*_@_X\L+:'<)=1M-!NM;T>+8,
MGS-:T%=3TE,C+)NO!YBJ[)N".5Q_U_\ I.\ Z9QA^):^#HVYYYYD$,YP4N7I
M/.:6%JU9:;\F:)M/F>MI&_\ Q#OZ*OB)KDN)X7P^.K_!#(.(IY)CX\UO@R.K
MBZ5*.K5N?*79^ZK:Q/Z*?!G[;?[+?CGRH]+^,'AK2KJ3:#:>+OMW@R2.1C@1
M&X\3VFEV$SY( -K>7$9)"J['BOI?2-:T;7[*/4M!U;3-;TZ7_57^D7]KJ5E+
MP#^[NK.6:!^"#\LAX(/0BOXS9(WB=XI4>.2-VCDCD4H\;H2KHZ, RNK JRL
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?GS\0_VX]/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,PH/A'ARKRS69YQAZBQV+HRL^;+,G<J6)Q"E%QG3KXN>!P=6G+GH8FLUR/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 ?,/Q4_8V_9M^,1N;GQ?\
M"W0(-:N0[-XE\,1/X3\0&X?/^EW-_H#6*ZK.I)V_VW!J</0-"P50/S:^*?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%+$T9;3I23L[7Y9QTE3FDUS0G&,X]8H****^".H**** "BBB@ HHHH ****
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %?EM_P %4/\ @JQ\!_\
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MB?2;6,VNK7'51XFTE&ABU/?RIU&%[75DRADN[J"!+-OK^B@#^9'XP? CXD_
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MTG3[B)MEQ8RXW'XY59;B5419)YYY J(H:26:61@%55 9Y))'8   L[$  DT
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MWK^=NX%?,\S)1=VX%PWD6M_M9_M'>(/,^W_%WQ9!YN_=_8EQ:>&L;Q*#Y?\
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M+U R7G]HZ;I]I?\ ]H7_ -I^US?L;6?CSGN1\4^-7BMQ1PUD&8<*\.\3<?\
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MLM#UF=9(Y]=O]=DTQ=8U:*W?;Y&G,FBV%OI*S1B\,"W5U*81J!L[?T7]LO\
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M564QDL&3G;O_ ()=QEIFL?C8Z)LS!!=_#Q96WB,?+-=0^-HAL>4$[TLR8XV
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ML(+2_.FVUWXB<(^D:=JUQ#']M.GZG*DFG+%IUS8W;:A=V %W'!YZO_1GX?\
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MQ)))))))))*R26B22T22V04445F,**** "BBB@ HHHH **** "BBB@ HHHH
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M%Y'\D1\8^$84ANAU7SM5\-S2I;3EF(>>XTB[LQ&BD6^CS.0M 'ZYT5P/P_\
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MF*SUBQ203-HWBG0+M+KP_P"+O#\TJK)<>'_$^EZMHT\J1RRV32Q1.G\2^/\
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MQH4M[&-%_6]555"J JJ JJH 55 P  .  . !P!P*\[\(?"'X7> -0GU;P3X
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M$'C'6I-A:QT#3+G4'MXW8J+B^EAC-OIUFI#>9>W\MM:1!6:69%4D?JK\$O\
M@DEXUUS['K'QW\7VW@K3VV2R^$/!\EIKGBAT.-]O>Z](L_AS1YQR1)81>*8F
M7 )B<G9^Y7@SP)X+^'6B0>'/ ?A70/"&A6YW1Z7X>TNTTNT:7:J-<3QVD47V
MF[D"KYUW<F6YG8;YI78ECUE?+\+^ '#N6>SQ/$>*K9_BXVD\+3Y\%E<):/E<
M*<_K>*Y9+252O1I5(W53"V=C](RGP[RW"\M7,ZL\PK*S]E'FH86+WLXQ?MJM
MGUE4A"2OS4K.QX'\&_V8O@=\!K6)/AMX!TC2]56 P7'BF^C.L>+KU7&)_/\
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M<71D="Q@N)V>Y)@V.LQEC9$=V:+\.?\ @J5\3/B!^S_X?\*? SX<^$+3X8^
M/BSI/B/Q;KOB3P[;P:4=>N+_ %^]?Q1X.L(+&*!=(+RWUGK'BMU)O-3LO$6F
MZ9NM+ ZG:ZA_1[/96=T\,MS:V\\EN_F6[S0QR/ _!W1,X8HV0IRI'S*K?>52
M,#6OV9?V5_VI/$_P\\$?M=>!)?&OPPL_%27#RV/B?Q'X.U7PW>ZG97&CQZU;
MZ_X6U/2M333[9KR&XUG3II[BPOK.V\Z6T>^L].N+7]-^AKF/ O@E](?@?Q!\
M<\OS+Q8\*>$LZEGF&X-EAZ.,Q-'/\'EV9T^%>,LSR[%X_+LIXQXDX+S''\W#
M[XBJU:&"PM7&XC"?5LPJ8>=#\]QW N(Q&%JX>&8QJ0PMED]&I2A2C3C*I&53
MZ_6I4Y5,1.%).A0GROV<(QE:TG"/WY_P;'_\H?/@%_V//QX_]7'XPK]_:\ _
M9@_9A^"7['/P2\'?L]?L\>#QX&^%/@8:P^@Z$VL:WXAN_M?B'6]0\1Z[J6HZ
M]XCU#5=;U6_U76]5O[Z:>]OYE@6:.PL([33+2RLK;W^O8\>N.\I\4?&[Q<\2
M,@P^883(^//$?C+B[)\-FM+#T,SH99Q!G^/S/ TLQHX7$XS#4<;##8FDL52P
M^,Q5&E64X4L37A%59?=97A:F"RW+\'5<)5<+@\-AZC@VX.=&C"G-P<HQDXN4
M7RMQBVK-Q3T"BBBOR8[PHHHH **** "BBB@ K\SZ_3"OS/H ^OO@!_R)NI_]
MC->?^FK1J]RKPWX ?\B;J?\ V,UY_P"FK1J]RH **** "BBB@ HHHH ****
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M2:DFM&FFFMS\//VCO^"3[+_:'BG]F[6-R_O;E_AEXKO_ )QR6%MX5\571PP
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M-+?ZG=;21]IO[FXG"G8'" *.XHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF<$ICY=?TK1%5@&)8%R 8W"L_P"[,G[PT4 ?S@:U^R#^TGH&_P"W?"7Q'<;
M"3HLND>(\@^61L_X1[4M3+G$JY" L") 0#%*$\BUKX;_ !$\-;O^$C\!>--
MV<O_ &UX6US2M@ #$M]NL8-N%(/.."#T(K^IRB@#^2^BOZIM;\">"/$OF?\
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MQJ-W\ ?&U]J-Y\(/$5R2\\T/@CQ1(NI^(OAM?W+&46VDZDGB3P=)</:6%D/
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M3_!OP=TR)_+\F3^P/&%[>P!2C/\ OI_'(LY?,*NI+:>-D4FU1YJK-7EG@O\
MX)H_M5>,]#T77U\->'?#%IKEI'?6]KXL\1Q:9JMI:SH9;9]4TJVM=0O]/FGB
M*/\ 8IX%O[8R+%>VMK,LL4?I^G?\$C?VD;KRGOO%WP=TR-I"LL<GB'Q?=W<<
M8/\ K$BM? KVLN[JB&^C)_C*'K^CPS#Q^S*$*E-<4JG6A&<)QP.'P"E"<5*,
MD_J^&Y4XS33TMY<NGTT<1XB8F,916;<LTG&7U>GATU))I_PJ5KIIWT_#3CM1
M_P""IO[5]Z9OLVJ>!-(\Q%5!IW@RVE%N0 #)#_:UYJA9V(+,)S.F6.U%7:!Q
M.H?\%(OVR+_S%3XLQ:?#+$8FAT_P)\.XL9#!I([B?PI<7L,K \2172%" T6Q
MAD_3FG_\$>OBE($_M7XN^ +,F8+(-/TKQ%J06WRFZ5#<P:3OF +X@(C0E4!N
M5WDQ]K8_\$;;UQNU/]H2UMV$@Q%8_"^6[$D.%+'S[CQ_9&*0G<H'V>95 5R6
MR4%?ZN_2 QN^(XI@I;I\3X? JSN[.+S;#VW=XV\K;(?]F^(M?7VF;1OWS6GA
MU]WURG]UO*Q^?.H?MS_M:ZD2;CXY>,(\PF _V>-(TD;&WY8#2]+LPLWSG%P
M+A<)ME'EIMXJ^_:I_:8U J;CX_\ QC7:C)MM/B-XLT]&5CDB2.PU6VCE)Z;I
M5=@/E!"\5^N%E_P1U\#1A_[1^-OBNZ)*^6;+PGI%@$49WAQ/JNI>86^7:RF(
M)@Y5\C;V]E_P2$^ $9D_M#XA?&*Z!"^4++4_!5@4(W;_ ##/X(U'S0V5VA1#
MLVMDON&P_P"(9>-.,_WK&XY7W^M\5^V^_P!GC<1V7?IV=C_57CBM_%KXA?\
M7[-^?_TBO5[+\.Q^$=[\8?BWJ1C.H_%+XC7YAWB(WOC?Q-=&(2;=XC\_4Y-F
M_8F_;C=M7.=HQQ-[JVJZD$74=3U"_6-F>,7M[<W01V #,@GDD"LP #,N"0!D
MFOZ)-?\ ^":_[%/PV\/ZIXN^(7BKQ-X=\*:/:B?5_$OCOXEZ%X8\/:1;H?GO
M-1UJ;3-"TZQC/1Y;RZ2W7/RJAK\8_P!IK_@I!_P;Z?LN_;M+T2^\6_M8>-+*
MW,"^&O@+XD\;^*-#>Z+K'!>7'Q-G\7^"OAK/;N\<C7,OAOQ5XBGMK8RS)HDS
MR6$4WZ7X;_0B^DYXUYBLJ\.>#,VXYQ:JQI8AY/0S[-L%@93Y;3S3,\-E6(RW
M*J-N1RQ&98O"T(IPYJBO$X\9P?FV&ASYEFN586+5TL9F-;FEM\$(T*DZCT6D
M(R>FVA\ST5^0'[3'_!>>[\:/?:+^R;^QG\$?V</#QCEM+#Q3XVU3Q5\?_B>D
M2*(K:_BF\97]C\-K.XF4&YGL]4^'OBR6"9DA36;I(IY[W\B_$_[:/[5GBZ_O
M=2U7X]?$>TN-0D26>/PQKLO@BPC:,*%%EI7@Q- TO38SL&^'3K.UBD)8R(Q=
MRW^E_AM_H\/TP^*\!2S'CSCGP>\+O:Q@_P"Q\?G&><5Y_1<G!R^L4>&\FKY%
M",:<IM>SXBK575BJ<Z5.,G4C\MB,-2HSY*6+I8JSUJ4*=>-)K3X7B*5"J];[
MT8JR3OKI_7IQ]/3_ .O_ (__ *Q!<7%O9P375W/#:VUO&\UQ<7$J00011J6D
MEFFE98XHT4%G=V554$L0!7\A/@+]KW]HSP#XWTCQU;?%SQ]XDO\ 3;J.6[TO
MQEXP\2>*-"UZS"+#/IFMZ;JVJ7$5Y:7%LOD!P8[RR(BNM.N;2\MK:XB_8^T^
M./[#'Q8T_1_VQ/'MY:Z-X_\  6DK!KGPHO->MKC4=0\7VAMWT*>/P-)) OC3
M5+"XC=?!WB>""WTX6TPO?$)M+CPXG_"-_EWTCOV+GC1]&7->%,1Q'GW$OBKP
M+QAA,1DV6<1>!'A9C^.L]P7BG7O'A?@+B'A',>*N',9DF3<98GDRW*>/Z.-S
M; 8+,JD<+F61T:E3"PQ?*X-;[>2OK^']>I^C'Q<^-'P^^"/P^U/XE^/=;BL/
M#MA$HLUMS'/J/B#4)XY'T_1_#UH9(_[3U+4_+8VB1R);+;++J-W<VVEVUU>P
M?OO_ ,$E_P!D#P5\1?V=_A+^V#\:+/1?''B3XY>$="^)O@#X>R:>;CP1\+?!
M_B*UDU#PWIVH1:@'D\>^.Y-,O(+CQ+X@U>VM/#=EJ"6EIX4\*:;/I,WB77_\
MV7]J']J'QY^U#X\D\3^)Y'TOPUI;W-MX*\%6UR\NE^&=+E=223MC6_UR_6.&
M36=9DACFO9HXX(([33;2PL+3_5=_X)!?\HN?V!?^S5O@Y_ZA^FU^T>+'[,?+
M?H3?19\-.-O%"EEG$7C]XI\<0P_$^%J1P6<Y'X:\/X;A_'YKA.#<@Q$Z53"X
M[/UC(X>MQ3Q;A(15;%86&3</5J>24L=CN(_O_#W+\)B\SQ,\7AZ>(EAL*JM"
M-6*G"G5=6$?:<DKPE.*;Y7)/D;YHVDE)?HO###;PQ6]O%'!;P1I#!!#&L4,,
M,2A(HHHD"I''&BJB1HH5% 50  *DHHK^/$DE9*R6B2V2['[?ML%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?A_\ M)_L]?M0_%3XT^.O
M%G_"N]0U;2'UBXTOPM<V>L>'Q9?\(II4CVF@&UCN=8AF@^U62)J%Y%)#"_\
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M%?U@?KX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+11HYG9)KW=CA6=<;<./EQL<5.C%V_X4*3Q="5G:RQL).3[6ABK6:TV/["O
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M **** "BBB@ K\SZ_3"OS/H ^OO@!_R)NI_]C->?^FK1J]RKPWX ?\B;J?\
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MR$A%O[R-%S<N&^[O^"*O_*,S]FG_ +K)_P"K_P#BK7Y__P#!8VYA^%W[?/\
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MO_"B]'_Z&;Q-_P"!-K_\C4?\*+T?_H9O$W_@3:__ "-0![E17AO_  HO1_\
MH9O$W_@3:_\ R-1_PHO1_P#H9O$W_@3:_P#R-0![E17AO_"B]'_Z&;Q-_P"!
M-K_\C4?\*+T?_H9O$W_@3:__ "-0![E17AO_  HO1_\ H9O$W_@3:_\ R-1_
MPHO1_P#H9O$W_@3:_P#R-0![E17AO_"B]'_Z&;Q-_P"!-K_\C4?\*+T?_H9O
M$W_@3:__ "-0![E17AO_  HO1_\ H9O$W_@3:_\ R-1_PHO1_P#H9O$W_@3:
M_P#R-0![E17AO_"B]'_Z&;Q-_P"!-K_\C4?\*+T?_H9O$W_@3:__ "-0![E1
M7AO_  HO1_\ H9O$W_@3:_\ R-1_PHO1_P#H9O$W_@3:_P#R-0![E17AO_"B
M]'_Z&;Q-_P"!-K_\C4?\*+T?_H9O$W_@3:__ "-0![E17AO_  HO1_\ H9O$
MW_@3:_\ R-1_PHO1_P#H9O$W_@3:_P#R-0![E17AO_"B]'_Z&;Q-_P"!-K_\
MC4?\*+T?_H9O$W_@3:__ "-0![E17AO_  HO1_\ H9O$W_@3:_\ R-1_PHO1
M_P#H9O$W_@3:_P#R-0![E17AO_"B]'_Z&;Q-_P"!-K_\C4?\*+T?_H9O$W_@
M3:__ "-0![E17AO_  HO1_\ H9O$W_@3:_\ R-1_PHO1_P#H9O$W_@3:_P#R
M-0![E17AO_"B]'_Z&;Q-_P"!-K_\C4?\*+T?_H9O$W_@3:__ "-0![E17AO_
M  HO1_\ H9O$W_@3:_\ R-1_PHO1_P#H9O$W_@3:_P#R-0![E7XK_P#!8O\
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MCZ,F/P679IEF"_U8XSXUX85'!Y;P/EV#HK+Y<#\"RP*IX;#YUAL/36!S+-<
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MY45X;_PHO1_^AF\3?^!-K_\ (U'_  HO1_\ H9O$W_@3:_\ R-0![E17AO\
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M]O4W+(C(&@!=263<JL1_'_-/-<RO-<32SS2$%Y9I'EE<@!07D<L[$* HR3@
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MO"DEO+>>*?$-S:ZCJEO;Z%?V]S'K>AP6^A:O,[Z;:Z9>3"XU&[TK]5OV%O\
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M>Y45X;_PHO1_^AF\3?\ @3:__(U'_"B]'_Z&;Q-_X$VO_P C5Q%'N5%>&_\
M"B]'_P"AF\3?^!-K_P#(U'_"B]'_ .AF\3?^!-K_ /(U 'N5%>&_\*+T?_H9
MO$W_ ($VO_R-1_PHO1_^AF\3?^!-K_\ (U 'N5%>&_\ "B]'_P"AF\3?^!-K
M_P#(U'_"B]'_ .AF\3?^!-K_ /(U 'N5%>&_\*+T?_H9O$W_ ($VO_R-1_PH
MO1_^AF\3?^!-K_\ (U 'N5%>&_\ "B]'_P"AF\3?^!-K_P#(U'_"B]'_ .AF
M\3?^!-K_ /(U 'N5%>&_\*+T?_H9O$W_ ($VO_R-1_PHO1_^AF\3?^!-K_\
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M?? #_D3=3_[&:\_]-6C5[E7AOP _Y$W4_P#L9KS_ --6C5[E0 4444 ?A?\
MMX_L@_M-_#7Q9^T1^W3^S'^VIXR^$,,/P_U7XC?$/X3:Q;WNJ>$M07X8_#J&
M"4Z#')>:GH$][J6E>%XH=,LM<\&W<^GZK>3BRUR&SNH[*U^;/@G^QS^W!_P4
MW^!?PM^)'[77[<>N#X"_$../Q5/\)O ?@SPYX<UO6]-TO5;FRTZ+6I?#VA^%
M/!\=VUWI46L:;<:MH'C:TT]_LFH1Z?\ VHS/;_T;>// OA/XG>"_$_P\\=Z-
M!XB\&>,]$O\ P[XGT*ZFNK>WU?1=4@>UO[">:QN+6\BBN8)'C=[:Y@F4,2DB
M-@U%\/?A]X-^%'@CPQ\./A[H-KX8\$^#=(MM"\,Z!92W4UMI6E6:E;>TBFOK
MBZO)@F69IKJYGN)79I)I9'9F(!F_"7X4^!/@=\-O!OPE^&6@V_AKP+X#T2WT
M'P[H]L2_DVL+/-/=7=P^9K[5-4OIKK5-8U.Y:2\U75KV]U&]EENKJ:1_Q@_:
M"_8M_P""O/QZTOXJ?#O7/VUO@1/\%OB+?:_8?\(-/\-]#TV>'P5?:Q+>:1H$
MVM:9\%F\202V%BEC;27</B:XU%WMV,NK7CO)<3?O'10!^!W[+7["O_!5_P#9
MCTGX4_"_PM^V3\"K+X!?#_Q3!>WWP\M?A_IFKW5YX6U;QK=>+_&^CVVOZY\'
MCXIDN-=N-8U]H)I/%EG<6<NH)!8:CI=M;VIM?T?_ &[_ -BGP%^W5\#[OX3^
M+M1F\,:[I>IQ>)_A[X[LK*+4+WPAXKM;6YLX[B:QDFM?[5T+4[*[N-.U[13>
M6@O;62*YM[FTU33],OK3[2HH _GAT+]CK_@N%X;\%6_P$T?]M'X)P?"FRT1/
M#.F>-Y/[1F^(.E>$$VZ='I>GZ]+\')/&L6MVVF!FL;J3Q/+>6$7EVFG^-+3[
M-9FU_4#]@O\ 8;^'G["'P<;X<>$=2N/%?BGQ%J*>(?B1\0K^R33K[QAXA2#[
M-;>1IR7-Z-(T#1K4O::'HPOKTVJS7M[<W=UJ.I7]U/\ ;U% 'XH_MB?\$P/B
MUXM_:4L_VT/V'/C5HWP$_:$GBAC\66GB6"Z7P;XGO8=/ATAM<,UAH'BN&*;4
M](MX+'Q-X>UGP?XA\/>)I;>WU2ZAL]1.HSZGX_>_\$UOV_?VQO%'@)?^"C_[
M37@36?@OX$UN'Q)'\)O@W9FSN?$FJ6YN+65=7N-.\$^ ]'TNYO=/FGLX_$GG
M>+-6TW2=0U*PT6WT*YU.[NT_H.HH \?^*7PWU3Q!\!/B#\(OA5K4?PPUC6/A
M-XH^'?PZU_2!/80> ;^^\(WOASPIJ6G?V;LO+"W\-SR6$]LVF-%>V<-FC:=)
M#=102)\H_P#!-']E[X^_LF? 77OAS^T3\5[#XL>,]5^).N>+-+U#2/$_C'Q=
MI'A[PYJ&B>&].MM!L-9\<:7HFL$2:GI.JZW=6D6DV>GP7FKSO!]HN)KNZF_0
MZB@#\$OC!_P2W_:<^$O[2?C?]J+_ ()N?'GPE\']9^)<NIZCX[^&/CVUE_X1
M6XOM6NVU77+32%'A3QOH.I:/K&K,^HZ;HFN^'+%O">HW-S)H'B*QM&LH-,N?
M#W_@F/\ M3?'WXZ?#WX\?\%,OCWX.^+EK\)I8=1^'_P9^&]A)#X-2_\ -LM1
MQX@8>%? ^DVEL=4T^PN?$-AIF@ZS<^+O[-TVQU7Q,VBV$6FS?O#10!X'^T[^
MSG\/_P!J_P""/CCX%_$J&Y'ASQE8PI#JFG>2NL^&]=TZYBU#0?$NB33QRQQ:
MEHVIV]O<HDJ-;7UL+G2[^.?3KZ[MY?Q0^'?[#/\ P6;_ &;/#$?P0_9]_;#^
M!M]\&+%M3M?"&H>-=+E.O>$-.N&EF(M[36_A+X\U31$N))F>PT32_$WB?1M*
MN@[V::<DT\T_]%=% 'YL?\$]O^">.C?L6:?X[\:^+_'%W\8?VB?C%?R:I\4?
MBKJ,-U&;G[3?2ZQ<Z)H@U"YO-2DM+K6[FXU?7=;U*X&J>*=5^SW]_;V45EI^
MGV7Z3T44 %%%% !1110 4444 %%%% 'X<_MT?LA^-?%?[7%U^T1X,^'7B'Q?
MJ?BCX%> /A.VMZ)8C55TK2_ OC+XC>)I]'\FV+WVG37]]XX@OK^2>".RU2&T
MT=;2XN+G2KZ&S^(?$_[(/[1<%POB#P[\'/B/!J4;[I[>V\+:FQN"0=TL:+;L
MID89$\3KY=P"<@RDK-_5)16/&N$POB#@,/AN**F:8S%X# Y5@,IS.EF$:.,R
M6ED6#H9?DTLIJ2PE6I@Y9?@\-0HTHPJNG-1G[2$HU9P?EX[*,%F.'>&KP<(>
MV>)IU<._8XK#XES=3ZSAZ_O>RKJHW)3Y))I\LHRC='\G,G[%'[2=QI)U%OA'
M\19-8E:6YFLY/"^IKO5CN:+>\"O]KW;W+$>3(S"-#M FD^5=5TK5-"U.^T;6
M].O]'UC2[J:QU+2]3M)[#4=/O;:0Q7%I>V5U'%<VMS!(K)+!-&DD;@JZ@C%?
MVX5\%_MC_L->#?VE]+G\3:!]@\(?&'3K,IIOB80&/3O$T=O&1;:+XQCMHWFG
MA 5;>RUV**;5-)38OEZA80KII_G3Q \"LMJY;0QW ]+%TLSP6&4<=@<=CEBO
M[;E3BN;%4:TZ5!8?,:CYYU82D\+B7**@L-.+=;X+B'P_HRPZQ&2<ZQ%&"53#
M5JCG+&**UJ>UFTEBY;SLJ=&K)^[&B])?SA^%/'#0>7INMREH.$M[]R6:$=%C
MNCRSQ= L_+Q])=T?SQ?0OA'QMXK\#:K!X@\%>)=7\-ZK&JF/4=$U">RDEA.&
M\J8V\BQW=I*/]9;7"S6LZ$K+$Z,0?E[X@_#SQG\+/%NK^!_'V@7WAOQ-HDY@
MOM.OD )4DF&[L[B,O;7^G7<8$UCJ-E+/9WD#+-;S21L&I?#?C.\T0+:7"F\T
M[/RQLQ$UMD\F"0AOW>3N:%E*Y'[LQDL6^:\._&;$\/O_ %<XZ^N2PN$E+#T,
MSJT:]7,,ME1?)+"9CAU&6*Q%&ERN,)QIU,90E'V4J=>FX_5^7A'C"O0Q%'(\
M\J*G%U8X6AC<9-4'A*KDJ<:./JUG"-.@I>Z\37E".%5WB:D</&52C^VWPE_X
M*2>+-'^RZ7\8/#</BVQ7;')XG\-1VND^(D3(W37>CL8-"U27J EH_AY0N"QE
M<'=^FOPO^/?PF^,5LDO@/QCIFIWYB,L^@7+G3?$EH$&93/H=\(+]HH2"KWEM
M%<6#E2T-W*F'/\NNFZ_I>J*GV:Y42. 1#+A)"3V3DI(?41NY'<"NBM;NZL;F
M"\LKFXL[RUE2>VN[6:2WN;>:-@T<T$\+)+#+&P#))&ZNK %2",U_4.39[DW$
M.#CF&1YI@<VP4GR_6,!B:6)IPJ)>]2J^RE)T:\-JE"JH5J4KQJ0C)-+]MS3)
MLUR2O##9ME^*R^M5HT\30CB:,Z<,3A:\5.AB\)5:]EB\'B*;C4PV+PTZN&Q%
M*4:E&K.G*,G_ %D45^"?PE_;Y^,_P]^S:=XJG@^)WAV':AM_$<SP>(X801E;
M3Q1!'+=32'DF37+76VQA(VB4+M_3SX2_MG_ _P"*_P!EL$\0CP7XFN"D?_".
M^,F@TIYKAL*(].U@ROHNHF60[+6!+Z'4I_ESIT3,$KU3S3ZPHH!!&0<@\@CH
M1ZT4 %%%% !1110 5^>W[9'[7T'PKL[SX:_#J]AN?B1J-J8M6U>!TEB\#6=S
M&,-\I97\37,+[[&V;C3(F34;M2[6<%QL?M@_M<V?P;TZX\!^!+NVO?BEJ=JO
MGSA8[FV\$6%W%OCU"]C;=%+KMS"Z2Z/IDRND4;IJNHQ&T-E:ZI^%-[>W>HW=
MWJ&H74][?7UQ/>7M[=S//<W5U<R--<7-S/*S233S2N\LLLC,\CLSNQ8DT;;A
MOL1W-S-<S7%Y>7$MQ<7$LMS=75S*\LT\TKM+/<7$\K-)++*[-)++(S.[LSNQ
M))KS#Q%X@-ZSV5FY%HIQ+*I(-RP[#I^X4]!_RT(#'Y=HJ3Q'XA-R7L+%R+8$
MK<3J<?:"#@QQD<^0.C,/]<<@?NAF7Z#_ &1OV6?$/[2_CQ;-Q=Z5\.O#DUO<
M^./$\:;3' QWPZ!H\DB-%-KVK*C+%E7BTRS$VIW22>7:V=]_#GC-XNYMQ]G4
M/"3PL=7'+,,2\NSC-<#/_D:U-5B,OP>)B^6EDV&A&I/-<Q<HT\33I581FLMI
MUJF._O?P1\&<G\.\BGXQ^+2I8"66X59GDV4X^'_(HI^Z\-F6-PTESUL\Q-25
M.GE&6*,JN%JU:,Y4Y9I4HT\!ZK^PO^QS=?'SQ&GCSQU93VWPA\,7ZK/&_F02
M>.=9M627_A'K*12DBZ/;DHWB'486#^6RZ38R)>7%Q=Z7_1O:VMK8VMM965M!
M9V5G!#:VEI:PQV]K:VMO&L-O;6UO"J10001(D4,,2+'%&JHBJJ@#&\*^%?#W
M@CPYHWA+PII5IH?AWP_80:;I&E62>7;VEI N%49+/++(Q>:XN)GDN+JYDEN;
MF66>621MYW2-'DD=8XXU9Y)'8(B(@+,[LQ"JJJ"68D  $D@"OZ0\)O"[*?"W
MAR&6X7V>*SG&JEB,_P X4+3QV,C%VHT7)*=/+\'SSIX*@[64JF(J15?$5F_Y
MC\8O%G./%GB:IFF+]I@\CP#JX?A[)G.]/+\%*2YJ]=1;IU,QQO)"KCJZYM8T
M\/2E]7P]%)U?B-^WC_P4-\C^V?@K\ -;!GS/IGCCXF:3<9$.#)!?>'/!MW$,
M&8\PZEXGM92(1YEKHDAF)U*#DOV\O^"A+^)#K'P5^ NM-%X=!N-,\<?$73)G
MCFU]E=H;KP_X2O(74QZ 0KQ:IKL)WZXK-::9)'HPENM:_$GQ-XF\/^#/#^K^
M*O%6KV.@^'=!L9]2UC6-2G6WLK"RMUW2S32M^"1QH'FGF>."".2:2.-OS;Q*
M\5,=F^.AP+X?1Q>8X_,<52RFKB\HI5L9CLQQV,K1PM#)L@HX2-2OB<1BJ]2&
M&57"PG6Q-:I'#X%2<E4G_)7&'&O-[7*LFK::T\7CZ<M^DJ&%FNFZJ5XO76-)
MVO.5K6M:TGP]I.IZ_K^IV6CZ+H]E<ZGJVK:G<Q6EAI]A:1//=WM[=SND4%O!
M$CR2RR.JJJDDU_-S^W5^WSJWQZO;_P"&/PON[W1?@U8W)BO[P"2TU/XD75K.
M&BOM11ECN;+PQ#+&LVDZ%)LEO'6/5-;C^TBQT[1^9_;=_;L\0_M(:K<^"/!,
MNH>'?@MI5[FVL&:2TU/QU<VLB-!K7B>)'^33XIXQ<Z+X?<F.U80ZAJ*RZHEN
MFF?IK_P2U_X-O?VG/VY;/1/B]^T!=:S^RU^S9J4-MJ6C:IK>A>;\7?B?IMPJ
MSV]QX#\$ZJ;5=!\.7]L5EMO'?C%(K*Y@NK'4?#'ASQCITT\]K_T1?L]OV<GA
M#]!3@S)?IE?3XS+(,D\3(QH9GX;^'.?J&90\.<5.E'$X'&5,BPU/%XOBKQ;=
M-K$8/*LNPF.H\"Q3QK4L_P /+'\/?G>6Y7C<SQ$</@<//$5FDVHI*%.-_CJU
M)-0IQ7\TY15]%>32/YN**_T,?^(/K]B+_HYO]JG_ +__  C_ /G;U\M_MC_\
M&CGA'P?\!?&'C#]C'XW_ !5^(?QO\*VS:]I'PV^+7_"#KHOQ"TS3X)Y=3\*Z
M#J_AOPYX;DT/QC>Q!9/#5UJTEWH=_J,$>B:F=(@U3_A(=(_U<R#]JG]#+B#.
M\IR*EQ_G>5ULWQ^%RZCF&><'9_E>3X2MC*L*%&MF>9U\*\/EV"C4G'ZQCL4Z
M>$PE/FQ&*JT</3J58?25>!^(J5.I5>%I35.$IN%+$4IU)**NU""=YRLM(QO*
M3TBFVD_R9_X->OBW\.?A1_P5,\/0_$7Q9I7A$?%'X,_$+X4>![C69C:66M_$
M+Q#K7@G6/#_A=+UU^R6NI:]!X<U*ST5+R:!-3U@V&B63S:MJFG6=S_ITU_B%
M:OI'B/P7XCU+0M=TW6O"GBWPIK5WI6KZ1JMI>Z)XA\.>(=$O9+6^T_4+&ZCM
MM1TG6-)U&VEM[JUN(H+RQO('BE2*:)E7_0H_X-]_^"[]O^U5I/AO]BS]L'Q9
M!;?M,Z#I\>F_"3XHZ[=0VT?Q_P!"TVWQ%X<UVZE\J/\ X7#HME#D3NQD^(NF
M02:@0WBNRU-]=_BS]K9]$#C+C/&T?I3>'TZW$^69-PIEV3<?<.82E'$8W*<C
MRBIC,3@N,\H>'4I9CDU/#XZ4,_HQ4\1E=&C2SF$L1E<LRJ91]'P'G^'P\7D>
M+2HSJ5YU,)6D[1J5*BC&6&J7^"HY1O2>U1MTWRS4%4_K-HHHK_GP/U<****
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MS5-MMMMMMMMMW;;U;;>K;>K;W/V,****0!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<?X^\!^%_B;X2U?P1XRT]M4\.:XEJNH6:7-S922
M&QOK;4K22*ZLY8+F"2WO;.VG1XI5R8]CAHV=&["B@#XT_P"&!OV9?^A.U?\
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MAR?*U'ZCE^'HSCM6</:XC_P?5<ZVN]E-1[)!1117U9ZX4444 %%%% !1110
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MPBP>#51454G5_>S]I-SJ6YFY66EDDDDK6[W84445^*'I!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^9]?IA7YGT ?7WP _
MY$W4_P#L9KS_ --6C5[E7AOP _Y$W4_^QFO/_35HU>Y4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMI+EA62<X*RDIPC&*_C>M+R2U;C+1$_/&3^97L&_0]#ZCT32O%-_ BF&X%U
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M_P %_#5B[/\ &*PM8HVO/B-X"TBSC(/Q3T^VBEN?%?AZSBW?$JTC?5]-B/Q
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M7^,1^B!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@_X&$DLTBQ^%O@CX/NTA25-J01GQJGC!S%;M^\A:9Y9V<8N)IX\QGYL\4_\
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M=55/-O-(N67[+J B410:YH]QIFOV2<6.JVN3G^8;]IO]C+XI_LF^*+G]H?\
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MB>!<\J2<4KU\:ZLLAKN?OPI9K4J8.C*$*E+.77G3HQ_JZ\%>'OV?/VA?+L/
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MR7PQ/^TGJ6AK>Z+9ZBQDBN4^"_@[6[<6WB*:U"/+)\1/'-I#X0L8+6\O=/\
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M^%Y8A>ZWKNI:7H6E1/\ :]6U.PLDEN4_8S]E;_@C!\-?#WC+PW\>?VS&\/\
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M/^]#<VTRRVE[:2SV5[!<6=Q/!)_I>?\ !$/_ (+F> O^"C_A#3O@E\:;G1O
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M3OS/ UIOV;>_^SUY-NF[[4ZK<+O2K3BE$_E-_P""9?\ P=!?M'?LS?\ "/\
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M<9#6_L_.:%?$T:3494\1>&-H1T2=*K/2M3LFX1J-J:M[.M"!_M/45_'_ /\
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MUJ+?V:M)^_!WT4K.$K-PE):FQ1117X@>D%%%% !1110 4444 %%%% !1110
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M^'S>ZR?V=/A'<Z[?G4--L-1O?[0UV\\(W&L:@+B]VW#B\O9QNCA"@)!"L?\
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M*3U.VGP1PU3M?+Y5&NM3%XQW]8QKQB__  &WE8_R9?\ @M+_ ,$Y? /_  3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^9]?IA7YGT ?7WP _
MY$W4_P#L9KS_ --6C5[E7AOP _Y$W4_^QFO/_35HU>Y4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$A&JE9XFI^]Q,N_[V=W!2ZQI*G#^X@HHHK^9CV0HHHH **** "BBB@ HHHH
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M39QL3^5?QIXW\9_$CQ3K?CCXA^+O$WCOQKXEO9-2\1>+O&6NZIXF\3Z]J,H
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M5FB,EM<Z3-;7$8D12\%Q#+!*N8Y8WC9E/Z(@!0%4 *       ,  #@ #@ <
M4M%?+<2<;<9\8O!RXOXMXGXJEEZKQP$N),^S7/'@8XGV+Q*P;S/%XIX98AX>
M@ZZH\BJ^QH^TYO9PY=Z.&P^'YOJ]"C0Y[<_L:4*7-RWMS<D8\UKNU[VN[;L*
M***^8-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS*A!>WI*RC6BK+ZQ17\K;7M(+6E-V^"4&_J>BBBO\\#ZT**** "BBD)"@LQ
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MPKCF&-5XNG2FOJ]&2T_?UU=-I[TJ7/.Z<9ND[,_JH_X*8?\ !UTD9\0?"/\
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MX+_]&<\4/_"_A3_YY^O]/3XG_B&V8_\ 0QP7_@%?_P"0/AW_ (-C_P#E#Y\
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M$VDW,5[#I7A[0;RUM_M%A_;^JZ!:ZC:WK_ES7^AC_P &?7_)D7[3?_9U,_\
MZJ/X;U^7?3O\=^-/HY?1OXK\3O#^CDU3BK!YIPYDN75<]P5;,,#@EG^:T<NK
MX]8*EBL)'$8O"4:LZN"AB*E3!K$JG/%X7%T(SPU7OX7RO#9OG%#!8MU%0E"M
M4FJ4E"4O90<U#F<96C)JTG%*5K\LHNS7V/\ \$_O^#;7]@S]C/\ L3QK\4=%
M_P"&NOCAIWV>[_X3#XNZ)8CX<:!JD.U_/\%?!KS]5\-VOE31PW-GJ'CB]\?:
M]IU] M]HNK:.S_9T_H5BBB@BCAACCAAAC2***)%CBBBC4)'''&@")&B *B*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %?F?7Z85^9] 'U]\ /^1-U/\ [&:\_P#35HU>Y5X;\ /^1-U/_L9KS_TU
M:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTW6/%,5U#++'>^&-%MO#7@BXMW@@U/P]K-Y91ZM+^&_C/QIXP^(WBK7?'/Q
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M<(J,(0BHPA%*RC&,4E&*6B2226P4445Q%!1110 4444 %%%% !1110 4444
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MK2P4445_!A]0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5^9]?IA7YGT ?7WP _P"1-U/_ +&:\_\ 35HU
M>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %?*/[;/[)OP2_;5_9M^)'P$^/GA6+Q-X*\1:+>:A97
M4)BMO$7@_P 4Z39W5QX>\;>#=7:&>31/%/A^[8S65XD<UK>6LM]HFLV>J>']
M5U;2;[ZNK#\3_P#(M>(?^P'JW_I!<5[O#&>9QPSQ'D7$/#V9X[)<]R7-LOS/
M*,WRS$U<'F&6YA@\52KX7&8/%4)0JT,10K0C4IU*<E*,HK4SK4J=:E5HU81J
M4JD)0J4YQ4H3A)-2C*+NFFFTTS_$+HHHK_O;/Y;"ONW]AS_@FU^V!_P40\<?
M\(?^S-\*M2\0Z387D%IXN^*'B#S_  [\)/ *S>4YD\7>.;BUFL8;Q+:87L/A
MG18=;\9ZG9I-/HOAO4U@E"?"5?Z\7_!&[1='T+_@EG^P=;:)I.F:/;WO[-/P
MPUJ\@TJPM=/AN]8USP]:ZKK6K7,5I%"D^IZQJEW=:EJE_*KW6H7]S<7EW+-<
M322-_!7[07Z6W$OT1_"G(>).#>&LIX@XHXTXBK<+91B<^KXE91D%2GE6+S*I
MFV*R[">RQ&<3A'#QHX? +'Y=2]K46(KXBK3HO"8GZCA3(:.?8ZK1Q%:I2H8:
MBJ]2-)+VE5.I&"IQG*ZIIWNY\LW9623?,OSW_P"":'_!MU^R#^Q,?#_Q-^.4
M.G?M6_M%Z>;;48-?\9:)$OPE\!:K&(YD/@+X;W[WMIJ6HZ;=+FT\8^-VUC51
M<6UKJV@:3X-NS+;U_1M117_*9XM>-'BAXY\55^,_%;C/..,<^J^TA0JYE74<
M#E>&J3]H\!D>4X:%#*\CRY3]]8'*L'A,,ZG-6G3G6G.I+]SP&78++*"PV!P]
M/#TE9M07O3DE;GJU)-SJSMISU)2E;2]DD%%%%?EYVA1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS/K],*_,^@#Z^^
M'_(FZG_V,UY_Z:M&KW*O#?@!_P B;J?_ &,UY_Z:M&KW*@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS/K],*_,^@#Z^
M^ '_ ")NI_\ 8S7G_IJT:O<J\-^ '_(FZG_V,UY_Z:M&KW*@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS/K],*_,^@#
MZ^^ '_(FZG_V,UY_Z:M&KW*O#?@!_P B;J?_ &,UY_Z:M&KW*@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*\ 6VG6\S, =EK=7>KW$:DNQDOYY"Y\S8G<?\%^O#=IK?[ T^K7%NLMQX/\
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M )(H W**Q5\2^''9437]%=W8*B+JMBS,S'"JJB<EF8D   DDX S6U0 4444
M%%%% !7YGU^F%?F?0!]?? #_ )$W4_\ L9KS_P!-6C5[E7AOP _Y$W4_^QFO
M/_35HU>Y4 %%%% !1110!F:WK>B^&M'U/Q#XCU?2] T#1+&ZU36=<UN_M-*T
M?2-,LH7N+W4=3U.^E@LK"QM((WGNKNZGBM[>%'EED1%+ !T;Q)I"L#IFO:#K
M=@KJP-KJFD:OI=_ &5E(\^RO["]MI0RL/-M[F"0$%XW&>6^*7PU\)_&/X<>.
M/A3X[LI]0\&_$/POK/A'Q+9VMY<:?=SZ/KEE-87@M;ZU=+BTNEBF,EO<1-NA
MF1'PP!4_RS_'_P#8)\8?LG?M/_LD_LN_LT?MF_M/>"?!O[4GB#Q[IFJZ;:>-
M]6TJ3P'X=T.3PS<W5W#;^"M:\&Z1XF.IV]]J\MY;W.D:/&SZ+;/+)<M,_D '
M1?MT_!_X8?LR_P#!5K]AO5OV2=.TCP)\2/B)X_\ !5]\0OAQX%F31M%M8M6^
M(&C>&C=3Z'I;_9O#&B_$/PK?^)](\1:;8V6GZ3<:5IFH:J+3S;[4+F7^J\R(
M)%B+H)71Y$C+ 2,D9C61U3.YDC:6)78 A3)&&(+KG\TOV1?^"67P _91\>W_
M ,9GUOQW\;?COJ O0?BS\6M836=:THZI:"RU:70;&"*&UM;_ %.U,EM=ZYJD
MFM>(A93W6G6VL6^GWM]:W77_ +;_ .P79_MA7OPR\8:!\<?B?^SY\5_A OB:
M'P/\0?AO>2)+;VOBUM$EU6#4K&TU+0-6F:.?P]I\EE/H_B?0I4#W<=X;Y)+8
M68!]N>,W\))X/\5OX^.AKX%7PWKA\9GQ-]D_X1L>%/[,NO\ A(?^$@_M#_0#
MHITC[8-4%[_HAL?/%P#"7K^<O_@W:LM0$7[:NKZ':7]O\([_ ,??#FT\"2WJ
M2>7)?6 ^)%QJ-K!*7*&^L?#6I^"SK"LKOB[TLB0 .&]NU;_@CM^T/\5K8^%O
MVD?^"G/Q]^*_PR?5()]1\"V>B:OH\&O6%O)#(K7TVN_$WQ;HL-\P$J6RWGAK
M7H--EV74+W#.\*_L3\!/@)\+?V9_A=X;^#WP=\-1>&/!'AB.X-K:>?->ZAJ&
MH7T[W6IZUK>J73/>:KK.IW4CS7=[<R$JHAL[6.VT^TL[.W /P7_X(W7T?P-_
M;6_X*'_LJ^,9K?2/%EWXXM_%/A+2[B:. ZKI7@OQ5XZM[^ZTI)2LEZ-1\.^-
M_".O6D46Z?\ L9)KTPB&&Y>'[_\ ^"S'Q5T'X8_\$^?C;:ZGJ$%KK/Q+@\/_
M  S\):?)(BW&L:MX@\0:=<:K;6J%@SFQ\):;XBU><J"%@T]U/S2(#2_;3_X)
M6>!OVIOBCHG[0GPX^+?C7]F3]HW1HK"U?XK?#ZWN+R75H-,M#IVG7VHZ=IWB
M'P?K$'B33M)(T:Q\1Z+XKTB[.CI#INI1:G:V>GI9^)>!O^"-%]XK^(G@[XC?
MMN_M<_%/]L4>!)X[WPSX!\5V>HZ3X+M[E9XKF2SU9-;\8^-;O5M$O)[>VGU/
M3-,B\+QZR;>"UUIM1TY9K.X /L3_ ()?^ -2^#O_  3X_9H\,^*[<:%>VOP[
MO?&FJ0:@5LCIEOX_\2>(?B2IU(3^5]AFM['Q/%)J,=SY<EG,L\=T$DBD ^L?
M&=KHGQC^$?C[P_X5UW0O$&F^.?!/C'PC::MI6J6FJZ/)/K>AZCHCJ;_3IKFW
M=(9KO9<B.1GCVLI4,,4WXU_"VP^-'P8^*?P:O=5N_#FF_%#X=>,/AW<ZSI<$
M,UYHMIXM\/7_ (?DO[.UE,<$[V,5\9DM)'BBG$?D-)$K[U^9_P#@GS^Q#I?[
M!/P5USX0:9\1M6^)Y\0?$/6/B%>^(-2T*+PQ#;W>JZ#X9\/C3--T*#6-=CM+
M6&U\,6UQ+.^I7%Q=WEU<.YCA2W@A /S8_P"#>SQS;V'P-^/O[/'B"5--^(_P
MK^.6KZ_JWAF\EBBU2QT?Q%H'A[PW*HLRWG2IIGBKP5K]IJ,\8DCM;F\LH)VB
M-S;>=U7_  <$_$?3=*_90\ ?!JQF-]X[^,/QC\.#0_#-FK7.K:CH?A&RU*]U
M2]M;*'?<3B+Q!J'A'2HHXHW>>[UB".(,RL!ZE^TI_P $A=*^(OQTUC]IK]F'
M]HGX@?LA?&?Q1+?7WC+4_ MI?WVB>*-4O]D^I7RP:)XK\$ZOH<_B:]AAN?%R
M)JNKZ'KER)-0N?#CW]S?SWMO]GO_ ()&:-X(^-N@?M(?M1_M$_$?]L3XP^#G
ML;GP1J'Q!M;K3_#7A>^TUVN=)ODTG5O$_C74]3N_#MZ\E_X=1M<L-%TW4V.L
M)H!U6.TNK0 ^'_\ @LU\#/%WP^_X)[_L1WEI9+]L_9ED^&G@+Q+);%)AHLC?
M#+2?#4-]E/W+6$?B7PAIFF&125:YU#3U0%)6*_T6?"KXC^&OC!\-? GQ2\'W
M]MJ7AGX@>%-#\6:-=6EQ'<QFTUK3X+T6[RQ$JMU8R2O97T#A)K6]M[BUN(XI
MX9(TI_&'X1> /CS\,O&7PA^*.@P^)? ?CO2)-&\0:3,\D#R0F6*ZM+RRNH66
M>PU72M1MK35=(U*V=+G3M4LK2^MG2:W1A^(^C?\ !%OX\?#2WU/P+\!_^"F7
MQX^%?P1U2[U.5/AY:Z'K\TND6E_(TEQ;V]QX>^+'A/0)[_53<70U?5]-\->&
MFN7$,UU8Z@P"1 'G?PUOHOVA_P#@X&\=^._!;)KG@_\ 9L^'6M:!K'B"VQ+I
MUMJNG_#AOAGJ]@ETNZ'[;!XW\=:_I$=NL@FN$T;5;B%7M[6X9/Z1J^+/V)OV
M$_@Q^PMX U7PC\,$U77/$/BV\M-4\?\ Q%\4/:S^*O&.H6,<\=A%<O9P6]KI
M^AZ0+N^_L70[2,PV37]]=7-Q?ZG?W^HW7VG0 4444 %8GB#P]I?B?3FTK6(7
MN+)Y8IVCCFE@8R0DM&?,A9' !)R-V#W%;=% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU%
M'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;
MX??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_
M\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%
M'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_
MT"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &
MFH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17
MJU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_
M  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??]
M NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH
M?_)%'_"EOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"E
MOA]_T"[K_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K
M_P &FH?_ "17JU% 'E/_  I;X??] NZ_\&FH?_)%'_"EOA]_T"[K_P &FH?_
M "17JU% 'ET'P<\!6T\-S#IERLMO+'/$QU._8+)$ZR(2IG(8!E!(((/0C%>H
MT44 %%%% !1110 5^9]?IA7YGT ?7WP _P"1-U/_ +&:\_\ 35HU>Y5X;\ /
M^1-U/_L9KS_TU:-7N5 !1110 4444 %<WJ7@WPAK'B#0?%FK^%/#>J^*?"R7
MT?ACQ+J6A:7?>(/#B:G$(-230=9NK674=(34(56&^73[FW%W$HCN!(@ KI**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OTPK\SZ /K[X
M ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O<J "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OTPK\SZ /K
M[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OTPK\SZ
M/K[X ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O<J "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OTPK\S
MZ /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OTPK
M\SZ /K[X ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O<J "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OT
MPK\SZ /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^
MOTPK\SZ /K[X ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O<J "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
M,^OTPK\SZ /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*_,^OTPK\SZ /K[X ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O
M<J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *_,^OTPK\SZ /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT
M:O<J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_:!M/CS\>O\ @GS^USXP;QW\5?@@+W5? OC_ %:ZEN=?\5>'-+O[&UU6SO\
M5[M([[Q-'<Z=KOASQ?X8U+5S+XF?0]2U5-5GNK?3K9-/_=J@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,^OT
MPK\SZ /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BB
MB@ HHHH **** "OS._X*D?L'7_[=WP)TGPSX/U^P\-_%7X;>()?%_P .[S6G
MEAT#5+BZLCIVM>&=<O+6UO+W3;75[06]Q::G:6\[6FKZ9IOVF%[&2Z9/TQKP
M_P"(G[2GP%^$7CGP;\-_BE\5_!OP]\8_$'3M4U3P=IOC'58_#UIKMIHUS9V=
M\MMKNIK;>'X;W[5?VT%EIEWJEOJ6J2O(NEVEX;>X\H _![PC_P %6?VR_P!B
M>#0/AQ_P4?\ V4?&^H:;IK6NA0?'7P8+&.?7H;:)5CFFN(9+OX8>//$$D"-/
M=2Z#XU\)SF-(WOM*-[)<7$G[P?L\?M&_"#]J?X9Z7\6O@GXK@\6>#]2N)].G
MD-M<:?JFAZY9Q6\NH^'O$&DWD<5YI6M:>EW;//:S(8YK>XM=0L)[S3+VRO;B
MS\7_ !Y\ M,^%_BJ^^-OBOX9Q?"6^T'4X/%1\<:KH-QX5U;0RK6NH6-S:W\L
MUMK"SNPLDTZWAN[J[OI(;*UMY;V6&%OP8_X-[=%U".^_;9\4>$K/6;/X!ZU\
M1/!FF_#-M7AN=MW<Z1=?$*[DAMKB7;$=3TKPCK7@Z/Q(H4SN]_HOFLODA2 :
M7_!OXAUK5OV\?'UY%C5_%'Q;\')>23QJMXACN?B9K4L4IV;H]USK\K21B0J9
M8^44HK-^EO\ P5BT>UUW_@G;^U-97D:20P> ]/UA%D4LHNO#OC#PUX@L)  1
MAXK[3+>6-LX21$8A@"I_+?\ X)2>*-&_95_;[_;K_8T^)&KV&@>(O''Q M?$
M'PM34)&TZW\3CP_J7B[6+*STE+J1D;4_$W@'QMX?\3:;IWG27,UAI5\L,ETU
MOD_8O_!</]H3PE\*_P!B?QK\+'UNR_X63\=[KPYX-\)^&(;J*36YM#@\2Z9K
MGBS7GTM'-Y_8D.C:+=Z$^H>6+<:QK>F6@=Y9?*(![%_P1UU"XU/_ ()M_LQ7
M-TCI+%HGC_3U60L6-OI'Q<^(&E6;C=)(=DEI9021#<%$;(%CB4")/L']IO5K
MG0/V;?VA-=LQ*UYHOP/^+&K6JPKNF-SIW@+7[R 1+_%*984$:]WP*\:_8T\!
MVG[)7["WP6\*_%'5].\)Q?"[X00>(_B1JFN7$6EZ7X3O+Z&]\<>,TU2[NI%B
MM[7PW?ZMJ=I=7DS1K(EBUP8XM_E+Z=H/Q#^$'[8/P-\<R_!SXB^&O'O@KQKH
M'C/X<7'B70)I+^RT[5-4T"73;^RU&T;['>VU[96NLV=[-I]TEG=/9W5K.FV&
MZ@F8 _+G_@WRT:WTW]A36]1BCB$_B'X]^/M2NI%51*[6OAOP'HL2RN$5F$<6
ME@QJ6D"!R5(+LJZ__!?W1[74_P!@5[VXC1YO#OQJ^'&L6#.I+174]IXH\/O)
M&01L<V.NWD18A@8Y)%QE@R^'?\$"OBKI7@[P7\>_V,?'6H6FA?&?X7_&;Q7X
MD3PC?W'D:C?:0;'0_"/BF#28)]AOCX5\5>$[PZPMNOFVL>O:?/+"L<K2#4_X
M+T?%6Q\8^!/@;^Q7\/;ZT\0?&GXR?&;PEJ;^$=.NXKG4;'1;:"_T/P[!K5I;
MF6XTQO%'BWQ/HLFB-=1J;RVT+5YX8Y([<R* ?)O_  52U&\\7_L;_P#!(3PW
MJ$4R0>/O"7@#4=728%HTO)/A9\(;#RKIV:X;SMGBG4  S3EU6X+-(5RW]84<
M:1(D42)'%&BQQQQJ$2-$ 5$1% 5450%55 "@   "OYU_^"W_ , =<\(_L.?L
MT>(O"4_]H0_LH>)? OAG4;Y+:6*2'0;OPMIO@RP\0_),ZVL(\3Z!X5LY+9B[
M&768"ETGV=EN/V_^!/Q]^'/[0/P4\'?'3P/XCTB]\&^*/#4&NWEZE_ (/#EY
M!:++XBT379970:7J/A>]2[T_6H+WR7LIK.5I<1;9& /PJUJW7P__ ,'&WA&2
MPAP?''PHN;C6GB#+EK3]G/Q/:Q37)$JB3Y/!^DVZDHZC%N/*#H)D_I!K^;S]
MD/5K3]L3_@M1^T9^T_X&ODU;X/\ P&\$_P#"#^'?$UI_I>F:UJEQX;L_AGI@
MTV]C86\VG>(Y;+XD>*])OXFD2XTJTM#&CI>"X3^D.@ HHHH *Q]<U[2?#=@V
MIZU=_8K%)8X6G\BYN,23$B-?*M(9YCN((R(RH_B(K8JG?:=I^J6YM=2L;/4;
M4LKFVOK:&[MRZ'*.8;A)(RR$DJQ7*D\$4 >?_P#"X?AS_P!#%_Y2-=_^5E'_
M  N'X<_]#%_Y2-=_^5E=-_PA7@W_ *%+PS_X(=*_^1*/^$*\&_\ 0I>&?_!#
MI7_R)0!S/_"X?AS_ -#%_P"4C7?_ )64?\+A^'/_ $,7_E(UW_Y65TW_  A7
M@W_H4O#/_@ATK_Y$H_X0KP;_ -"EX9_\$.E?_(E ',_\+A^'/_0Q?^4C7?\
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M_"X?AS_T,7_E(UW_ .5E'_"X?AS_ -#%_P"4C7?_ )65TW_"%>#?^A2\,_\
M@ATK_P"1*/\ A"O!O_0I>&?_  0Z5_\ (E ',_\ "X?AS_T,7_E(UW_Y64?\
M+A^'/_0Q?^4C7?\ Y65TW_"%>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!
M#I7_ ,B4 <S_ ,+A^'/_ $,7_E(UW_Y64?\ "X?AS_T,7_E(UW_Y65TW_"%>
M#?\ H4O#/_@ATK_Y$H_X0KP;_P!"EX9_\$.E?_(E ',_\+A^'/\ T,7_ )2-
M=_\ E91_PN'X<_\ 0Q?^4C7?_E973?\ "%>#?^A2\,_^"'2O_D2C_A"O!O\
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M'/\ T,7_ )2-=_\ E973?\(5X-_Z%+PS_P""'2O_ )$H_P"$*\&_]"EX9_\
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MO_0I>&?_  0Z5_\ (E ',_\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\
MY65TW_"%>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B4 <S_ ,+A
M^'/_ $,7_E(UW_Y64?\ "X?AS_T,7_E(UW_Y65TW_"%>#?\ H4O#/_@ATK_Y
M$H_X0KP;_P!"EX9_\$.E?_(E ',_\+A^'/\ T,7_ )2-=_\ E91_PN'X<_\
M0Q?^4C7?_E973?\ "%>#?^A2\,_^"'2O_D2C_A"O!O\ T*7AG_P0Z5_\B4 <
MS_PN'X<_]#%_Y2-=_P#E91_PN'X<_P#0Q?\ E(UW_P"5E=-_PA7@W_H4O#/_
M ((=*_\ D2C_ (0KP;_T*7AG_P $.E?_ ")0!S/_  N'X<_]#%_Y2-=_^5E'
M_"X?AS_T,7_E(UW_ .5E=-_PA7@W_H4O#/\ X(=*_P#D2C_A"O!O_0I>&?\
MP0Z5_P#(E ',_P#"X?AS_P!#%_Y2-=_^5E'_  N'X<_]#%_Y2-=_^5E=-_PA
M7@W_ *%+PS_X(=*_^1*/^$*\&_\ 0I>&?_!#I7_R)0!S/_"X?AS_ -#%_P"4
MC7?_ )64?\+A^'/_ $,7_E(UW_Y65TW_  A7@W_H4O#/_@ATK_Y$H_X0KP;_
M -"EX9_\$.E?_(E ',_\+A^'/_0Q?^4C7?\ Y64?\+A^'/\ T,7_ )2-=_\
ME973?\(5X-_Z%+PS_P""'2O_ )$H_P"$*\&_]"EX9_\ !#I7_P B4 <S_P +
MA^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E973?\(5X-_Z%+PS_ ."'2O\
MY$H_X0KP;_T*7AG_ ,$.E?\ R)0!S/\ PN'X<_\ 0Q?^4C7?_E91_P +A^'/
M_0Q?^4C7?_E973?\(5X-_P"A2\,_^"'2O_D2C_A"O!O_ $*7AG_P0Z5_\B4
M<S_PN'X<_P#0Q?\ E(UW_P"5E'_"X?AS_P!#%_Y2-=_^5E=-_P (5X-_Z%+P
MS_X(=*_^1*/^$*\&_P#0I>&?_!#I7_R)0!S/_"X?AS_T,7_E(UW_ .5E'_"X
M?AS_ -#%_P"4C7?_ )65TW_"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_
M  0Z5_\ (E ',_\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y65TW_"%
M>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B4 <S_ ,+A^'/_ $,7
M_E(UW_Y64?\ "X?AS_T,7_E(UW_Y65TW_"%>#?\ H4O#/_@ATK_Y$H_X0KP;
M_P!"EX9_\$.E?_(E ',_\+A^'/\ T,7_ )2-=_\ E91_PN'X<_\ 0Q?^4C7?
M_E973?\ "%>#?^A2\,_^"'2O_D2C_A"O!O\ T*7AG_P0Z5_\B4 <S_PN'X<_
M]#%_Y2-=_P#E91_PN'X<_P#0Q?\ E(UW_P"5E=-_PA7@W_H4O#/_ ((=*_\
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M_P"4C7?_ )65TW_"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_  0Z5_\
M(E ',_\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y65TW_"%>#?^A2\,
M_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B4 <S_ ,+A^'/_ $,7_E(UW_Y6
M4?\ "X?AS_T,7_E(UW_Y65TW_"%>#?\ H4O#/_@ATK_Y$H_X0KP;_P!"EX9_
M\$.E?_(E ',_\+A^'/\ T,7_ )2-=_\ E91_PN'X<_\ 0Q?^4C7?_E973?\
M"%>#?^A2\,_^"'2O_D2C_A"O!O\ T*7AG_P0Z5_\B4 <S_PN'X<_]#%_Y2-=
M_P#E91_PN'X<_P#0Q?\ E(UW_P"5E=-_PA7@W_H4O#/_ ((=*_\ D2C_ (0K
MP;_T*7AG_P $.E?_ ")0!S/_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_
M .5E=-_PA7@W_H4O#/\ X(=*_P#D2C_A"O!O_0I>&?\ P0Z5_P#(E ',_P#"
MX?AS_P!#%_Y2-=_^5E'_  N'X<_]#%_Y2-=_^5E=-_PA7@W_ *%+PS_X(=*_
M^1*/^$*\&_\ 0I>&?_!#I7_R)0!S/_"X?AS_ -#%_P"4C7?_ )64?\+A^'/_
M $,7_E(UW_Y65TW_  A7@W_H4O#/_@ATK_Y$H_X0KP;_ -"EX9_\$.E?_(E
M',_\+A^'/_0Q?^4C7?\ Y64?\+A^'/\ T,7_ )2-=_\ E973?\(5X-_Z%+PS
M_P""'2O_ )$H_P"$*\&_]"EX9_\ !#I7_P B4 <S_P +A^'/_0Q?^4C7?_E9
M1_PN'X<_]#%_Y2-=_P#E973?\(5X-_Z%+PS_ ."'2O\ Y$H_X0KP;_T*7AG_
M ,$.E?\ R)0!S/\ PN'X<_\ 0Q?^4C7?_E91_P +A^'/_0Q?^4C7?_E973?\
M(5X-_P"A2\,_^"'2O_D2C_A"O!O_ $*7AG_P0Z5_\B4 <S_PN'X<_P#0Q?\
ME(UW_P"5E'_"X?AS_P!#%_Y2-=_^5E=-_P (5X-_Z%+PS_X(=*_^1*/^$*\&
M_P#0I>&?_!#I7_R)0!S/_"X?AS_T,7_E(UW_ .5E'_"X?AS_ -#%_P"4C7?_
M )65TW_"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_  0Z5_\ (E ',_\
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M]#%_Y2-=_P#E973?\(5X-_Z%+PS_ ."'2O\ Y$H_X0KP;_T*7AG_ ,$.E?\
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M_P#E973?\(5X-_Z%+PS_ ."'2O\ Y$H_X0KP;_T*7AG_ ,$.E?\ R)0!S/\
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M\(5X-_Z%+PS_ ."'2O\ Y$H_X0KP;_T*7AG_ ,$.E?\ R)0!S/\ PN'X<_\
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M ,B4 <S_ ,+A^'/_ $,7_E(UW_Y64?\ "X?AS_T,7_E(UW_Y65TW_"%>#?\
MH4O#/_@ATK_Y$H_X0KP;_P!"EX9_\$.E?_(E ',_\+A^'/\ T,7_ )2-=_\
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MK_Y$H_X0KP;_ -"EX9_\$.E?_(E ',_\+A^'/_0Q?^4C7?\ Y64?\+A^'/\
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M(UW_ .5E'_"X?AS_ -#%_P"4C7?_ )65TW_"%>#?^A2\,_\ @ATK_P"1*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?M7>.-/A\1>)O%5O=>'-9\(>'/$VI06]V-'O-&UG2;CQ+XG@\-S/-IIN-/\
M'/A.TNU@B_LJPT2SABMCY;\&?VR_VG?^"57Q]T;]DC]O3Q%<?%'X#^)%M[CX
M<_&EM0O->U;PSX;O-0?3[/Q-:7]X;CQ%JO@_3[I)K#Q1X-U]9O$'A(VYN?"M
MS?:-:V&G^(O0/V</^"[/@;X9?# ?"W]M/X=_%SPQ\?\ X2:>GA+7CI'A:UNI
M_'%]X?ACT^*75M,UK5?#]_X2\;7"PJ/$%CJENFBRWB3:K9ZG:K?+HMAI?![]
MCKQ=_P %4]<^.7[8'[8OA&_^'7A#XJ_#=OA5^R;X N$F'B7X:^#;75(]?T#X
MJV\L\-A+)>)J:RW6FW-]:1V_C1/$'BZY_LZT\&ZCX=BO #^BC3-3T[6M-T_6
M-'O[/5=)U:QM-3TO5-.N8;W3]2TZ_@CNK&_L;RV>2WN[.\MI8KBUN8))(9X)
M$EB=D=6-VOQ"_P""&OQ<\>ZY\"OBW^S9\3+J;4/%?[)'Q2O/AM:W<EV+Y;7P
MM>R:K%IOAZ*[8&6YMO#OB#PYXLL=,E=VB@T)M'TVT2&TTZ")?V]H **** "B
MBB@ HHHH **S]6U?2M TR_UO7=3T_1=&TJTGO]4U?5KVVT[3--L;6-IKF]O[
M^\EAM;.TMXE:6>YN)8X88U9Y'502/*/AQ^T=^S[\8=7U/P_\)_CC\)/B7KVC
M+-)JFB>!/B)X2\5ZO8P02)%+=W&FZ'JU]>)8I-(L/V[R?L;2DQ+.9%90 ?B#
M^TBOCS_@I[^W_P".OV$K?XEZ]\,/V6OV;?#EEXE^+\'A*:*U\1?%#Q.'\.BY
MTTFX^T6MPFFZMX@MM)TA-8L+_0]%ET35_$,VF:IJ=SHD$?._';_@AYK/P3AM
MOC;_ ,$Y_C%\3/!?QF\"PR:EI_A'Q)XIL5F\4+;AYKC3?#?C#3]/T$:;?ZA%
M&MHV@^*X-5\+>(@_]GZM>Z18R3O)A_MEW?CO_@F3_P %+=+_ &\M+\/ZGXB_
M9P_:1L;/P3\8(-)M4N)=+U&73='M?$>BQ27#^7:ZW/-X1T7XF^%6N;JQ37[R
MR\2>&XI[33[:]E7^B[X<_$;P1\6_ _AGXD_#?Q+I?B_P1XQTJWUGP[XAT><7
M%EJ%C< C(X66WNK:9);/4+"ZC@OM-O[>YT^_M[:]MIX(P#\M/^":/_!35?VJ
MY=8^ 7QZT-?AC^UK\-X;RR\2>&KZTDT*V\?IH$DEGKNJZ+HMZL5UH?BK0YH&
M/C+P7(I:SS)K6AA](74].\,_L!7\^'_!:W]EU/!>@^'?^"C?P,N7\ ?'3X&>
M*O!,_C/7-!1;-_%&@W>NZ?X=\.^(-1C@4"_U_P .:YJ&BZ-<RW*/'K/@S4;[
M2];>YT[1M-M8_P!KOV>OBI'\<O@1\'/C(EHFG-\4/AEX)\=7&FQ[C'IM[XF\
M/:?JU_IJ%GE9DT^]NKBS5C))N$ ;S'SN(![#1110 4444 %%%% !117CWQ-_
M:%^ OP5N-.M/C!\:?A5\+KS5Q"VEV?Q \?\ A;PA>:A%/</;)<VEKKVJ6%Q/
M9K-'*LU['&UI;B&>2XFBC@F= #R;]N[]I63]D;]E3XM_'>RL;75?$'A31["P
M\(:9?)))97OC#Q3K.G>%_#9OXHI;>2;3+#4M6AU;5H(KBWFFTO3[V*"9)WC-
M?CE^SQ_P1P\&_M;?!_0?VF_VSOC3\8?B#\<?VB/"6C?$D:KX<\2Z+8:?X.T3
MQCIEOKOA2SM5U/PYK::C?V>AWU@9K%$LO"FB1R?\(YH>@QV>EPZE>?K_ /MD
M?!'1/VV?V._BE\*O!WB/0=5C^)/A*TU?X>^*M,U2UU/PY>>)/#NJZ?XM\&WD
M.LZ9/<6LVBZAKNB6-C?7]G+<1C3+N[=$N #$_P"</_!'3]MYM4\+0_L$_M!1
M7'@+]HW]GY+_ ,#^&-$\2Q0Z5=^+?!_A-I;:#PY;1LT<<GBWX?6-NVE7.FPI
MYNJ>$]/T[Q!8R:HUMXAN[4 ^.8]6_;!_X(8_$32;'Q+JFN?M(_L$>,M8CTVT
MG'GPW'@VYNI99S;Z3:7EY>6WP^\=VT2W-Y'HRWI\"?$6U2Y>.;3M=$]SX5_I
MG^$OQ7\ _'+X<>$/BQ\,/$-GXH\"^.-'@UK0-9LVP)8)2\5Q:7<#8FL-5TR\
MBN=,UC2[I8[W2]4M+S3[V&*ZMI8UO_$CX<>"/B[X%\4?#3XD>'--\6^"/&6D
MW.B^(O#^K0">SO[&Y .0>);:\M9EBO-.U"UDAOM,U"WM=0L+BWO;:">/^?K_
M ()EV_C#]B?_ (*%?M*_\$Y=1\0:EXE^$U_HDWQ8^%%UJ+^;+93BS\-ZS83H
M@\FWAN=8\%:_)I?B^:UMT@NO$O@FTEL[6"WFFD8 _H[HHHH **** "BBB@ H
MHJO=W=K86MS?7US;V5E96\UW>7EW-';6MI:VT;37%S<W$S)#!;P0H\LTTKI'
M%&C.[*JD@ L5_/M^VWXE^)O[=_[>EE_P3(\$_$C4?A/\%? O@.T^(?[2&L:!
M(D/B7QI%>:9H?B&/PQ:;Y/)U'3H-*\5>#+:RTBX']FC5-;UCQ!K^G:]!X:TG
M3U_9KP'^TS^SG\4O$][X*^&GQZ^#GQ \8:<UPMWX7\&?$KP=XFU^,6D"W%Y(
MFDZ/K%Y?3P6<987EQ!!+!:30W-M<21W%K<Q1?A#_ ,%*]&^)/["7[>WPH_X*
M;> O#M[XK^&'BFUT7X??';2[%-SPRV^D1^#[BROIV<1:=%XI\$VFC_\ "'ZE
M,%T^R\;^$8$U:0KJ&GV.H &M\;?^"">A>!]*T_XC_L*?&?XF_#GXX>!D35/#
MT'C#Q; MOK^HV$*[%TGQGX:TCP[J_@KQ!>[9BE^ZZEH-S<S1V,]IH6G2SW]M
M]!_\$VO^"F?BCXO>+]0_8_\ VP-!F^&O[7'@-;G2DEUBRCT"+XGOH=NLM_'+
MI++!;Z5X]AT]1K-SI^EJVA^*-)%QXC\,K:V*OIT'ZQ?!?XS_  W_ &@_AGX4
M^+GPG\2V?BKP-XQTZ/4-*U*U.R:!Q^[O=*U6S<_:-+UO2;M9;#6-)O%CN]/O
MH)K:= R9/X__ /!:W]D#2_%WPB;]M+X8RS>"OV@_V;3HOB=_%>@2-INJ>)/!
MFE:S9,5NKRU$<RZ[X$N9D\3>&=8,HGM;*TUC2'$ZWFG-IP!^Z5%?,?[&'QQO
MOVDOV5_@7\;M7@AM]>\?> -)O_$T=M$L%H?%FFM-H7BN6QMT+"WT^X\1Z5JD
M^GV^YFM[*6"%V9T9C].4 %%%% !1110 4444 %>!_M2_&^W_ &;OV=_C#\<[
MC31K+_#7P-K'B+3](9BD.JZW'$MIX?TZZD62*2&QO=<NM.MK^XB?SK>REGF@
M266-(WW_ (K?'_X'? NTLKWXS?%[X;_"Z'4R1I2^._&6@>&;G5BDBQR#2;+5
MK^VO-4,+.&N!I\%S]GC#S3^7#'(Z\9\7_!GPY_;+_9D^)/P^\,^./#7B;P-\
M9O /B+PUHGCWP=K.F^+?#T5]=03P:3X@TW4]"OY]-UA- \0VUI?O;V]\T5Q-
MI\EE,ZAI  #\,_V3O^"8/A__ (*"_"VV_;+_ &X_BS\2_B'\2?CU%J&N>&=-
M\(^)++0M'\ >$XM5U'3])L+)+C2=9A66,6K7&G:#916?AWP[8RQ:;)I=]?K=
MW(\G\:?"S]L;_@A[XTM/B=\'_%.N_M!_L/ZWKEM#XV\&:V;E5\,_VA<PQR#Q
M)IUI'<:?X*\0WI=;7P_\4?#=O!HNL:M'9Z9XNT2(7&DZ#JGT%_P2"_:XU7X'
M^(-<_P""8W[5$1\!?%OX8>+-<TGX2SZP\,&FZY:W]S)K=SX"BU)BD-W?75W?
M7?BCX?:HKR67C'P]KD-CI<PGM=$@UK^A?Q)X;\/^,?#^M^$_%>BZ9XC\,^)-
M+OM$U_0-:LH-1TG6=(U.WDM-0TW4K&Z22WN[.\MI9(+B":-XY(W964@T >4?
MLY?M%?"W]JCX2>&?C/\ "#7?[:\)>(XGCD@N(UMM:\.:W:+&-6\+^)=.628Z
M9K^C32K%>6PEGMIXI+;4M,N[_2+_ $_4+KW*OYK/V1?"FK_\$YO^"M?B;]BO
MPSJ.IZA^S]^U#X,OOB+\.]'U.\FNG\.2Z9X?\6^)M%O'DN)B7NM(F\#>.OAU
M)?#[1>^(-/B\.W^K2O=V:BV_I3H **** "BBB@ HHHH **:[I&C22,J(BL[N
M[!41%!9F9F("JH!+,2  "2<"O#/"?[47[-7CWQD_P[\#_M!?!7QAX]0.1X-\
M,?%#P5KOB:4Q(\EPMMHNF:U<ZA=/:1QL][';02O8J4-VL(DCW 'YC?\ !:3X
MK?&[3?!/[-_[-?[./B77?#/Q<_:?^,:^'-.N/#&O/X9UN_T+PU;6$5SI0\0P
MW%I<:%I5SXE\5^$[S6=4AN[-8].TVXM[RY_LNXU"WG@_X)F?\%,]5^,FJW7[
M)?[6EK-\//VN_AY-=^'73Q%:+H+?%%M!5X[Y6L9$@AT[XBZ=# \^N:' B6NO
MVJ2>(_#D9M3J.G:3^A_Q._9,\!?%3]I/]GO]IKQ!JVOKXK_9VL_'5GX9\.1R
M6DWA75SXWT:?2C?ZE:3V[74&J:)/,-1TZ[L;J%9;B"V6\@G%K:O!\8_\%,_^
M"9FE?M<Z5:_&7X-74/P\_:T^'D-IJ/A#Q?I]VV@KXZ7062[TCP[XBU>T>";3
MM=TZ:"(^"_&@E2ZT*Z2#3]0G.BF"?1@#]=**_$K_ ()F?\%,]5^,FJW7[)?[
M6EK-\//VN_AY-=^'73Q%:+H+?%%M!5X[Y6L9$@AT[XBZ=# \^N:' B6NOVJ2
M>(_#D9M3J.G:3^B?PM_;(^ 'QH^./Q5_9[^&GC%_%7Q!^#>FV>H^-I-,TV\N
M/"L#3:@=*U'3-.\50I)H]_JWA_4GM;'6[))T:"\NFM;-[ZXTK7XM( /J*BBB
M@ HHHH **** "BBO,_B;\:/A!\%=*@USXO\ Q1^'_P ,-)NS<+8W_CWQ?H/A
M2#49+58VN+?3#K=_9-J=U&)H0;2P6XN2TT*+$7EC5@#TROX\E_X*'?MJ?#']
MI/XT_MY:7!XK^*O[%M]^T'XJ^ &L>&9M3>?P98>$?"%W:3^"[/2+*,&V\%:X
MOAW7K#4- \8P:?'IVM>*-0U?3=?N-0N=:N;>_P#ZVO"GC7P)\5?"B>)/AYXW
M\,^.O".LQ7=I9>*_ /BC2O$6C76 ]M<G3/$/AZ]O;%[BV<LIDM;MI+:91DJZ
MC'SC^SG^Q+\&_P!G?]FJ[_98M;&3XB?#35[WQS/XE@\>VFG:A/XKM/&VLWU]
M-9^((+:VM["\>PT>;3=!CNHK6V>:+1[6^6.VN6Q& >N? +X^_"W]IKX6^&OC
M#\'O$MOXF\&^)K?='(NV'5-%U2%8_P"TO#GB/3?,DFT?Q%H\TBP:EIL[-M+1
M75I+=Z==V5[<^RU_*5\3/AG\?/\ @AQ\?)?C?\$(M=^)_P"PQ\3]=L[+QQX'
MO;RXN6\,M<W#+::!K]VRS+I?B+3%FEC^'/Q&DB,>JQG_ (1CQ1Y]Q.Z:S^[&
MH_\ !1']D[2_V7;']KVY^)EFWPCU-(K2P2WB2?QC=>+I(]TGPZC\*I/]M_X3
MRTD$B7VB,ZPV=I#+KL]\GAI/[:(!]NT5RG@/QMX>^)/@GPC\0_"-U/?>%O'/
MAK1/%OAR\NK"]TNYNM#\0Z;;:KI=Q<:;J4%KJ%A--974,DEI>VT%S;NQBFB2
M164=70 4444 %%%% !1110 5^0W_  6>^,GQ*^'G[,G@WX:?!?Q%JWA[XI_M
M(_&7P?\ !C0I_#]\^EZ[-I.M0:G=:Q;Z?JD&+S3TU*]MM!\.WMS82P79M-?D
M@$H@GG5OT"TK]J3]F?7?'8^%^B_M"?!/5_B.]REC'X%TSXH^";[Q9-J#R21C
M3(-!M=;EU*?55:)O-TN&W?4(4:*2:V2.>!I./^/?[)O@3]H3XH?LS?%/Q=J^
MOVFI_LP_$34?B+X6T6PEMFT'Q!J5[::<;9-=M)XFD^TZ-KF@>'=;T?4K:5)K
M,V6HV/E21ZL\]J ?EG_P3>_X*0^.['QW+^P9^WG%?>"/VDO!%]'X2\%^-/%L
MB0-\1V@2--,\->)=3>1K.\\9WEFUM<>$_%EO<SZ9\3],GLY([R?Q//:W?B_]
M\Z_,G_@I#_P3>\"?MS^!(M6TF6Q\$?M#>"+&1OAK\2EC>!;M8'DO(?!GC.:S
MC:\O/"]Y>,\MC?1)/J?A'4YWU?2$G@GUG1M;^0O^";W_  4A\=V/CN7]@S]O
M.*^\$?M)>"+Z/PEX+\:>+9$@;XCM D::9X:\2ZF\C6=YXSO+-K:X\)^++>YG
MTSXGZ9/9R1WD_B>>UN_%X!^^=%?+7A?]LS]GSQK^TKXK_9-\*>-#K_QB\$^%
MY_$_B6PTK3KR^\/Z6MC>VMEJV@7'B6V272X_$VB-?Z=)J^DR2HUFUZMBTS:M
M::EI]C]2T %%%% !1110 4444 %%>>_$GXM?"WX-Z WBKXM?$;P1\-/#8D,"
M:WXZ\4:+X5TV>Z"&1;*TNM:O;..\OY5!$%A:&:\N'*QP022,JD^&OQ;^%OQE
M\/#Q9\)/B+X)^)GAG[0;.37/ OB?1O%.F6]\L4<TFGW=UHUY>166HPQ31/<:
M?=M#>VXD43P1D@4 ?RO?'#]M7]N/PE^VS^U%^UW\')/$GC_]FC]E[XJ:?^S[
MXZ\ 2:G<7'P_'A2QFU#2=5$VAVBR"Q%WXE\-ZIJ\OQ(M+&YO?#VKZ_X=CO+R
M^T"^72KG^E']E3]JOX1_MA_"/1?B]\(=:%[IEZ%LO$/AZ]:&+Q+X(\2Q0QRZ
MAX7\4:?%)(;/4;,R+)!/&TEAJMA);:KI5S=Z?=P3OB?LT_L@?##]F/P3\5O
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M^)$MVVG1^!+GXH^"8/%C:FMQ]E_LD:#)K:ZE_:YGW1II)MQJ,ACE*6S+#*4
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M%GH#6VERZW8:?XOU*Q$L7AW4]>TFVO=2T>RNT:0V%M'>ZD=-M-4T.?5/JZ@
MHHHH **** "BBB@ JK?WUGI=C>:GJ-U!9:?IUI<7U]>7,BQ6UI9VD+W%U=7$
MKD)%!!!&\LLC$*D:,S$ &L/QAXU\&_#WP_?>+/'WBWPSX'\*Z6J/J?B;QAKV
ME>&?#^G)(XCC:^UG6KNRTZT5Y&"(UQ<QAG(5220*\W\!_&3]GS]I?PWXGTSX
M:?%#X9_&3P[+I]WH7B_3_!?C'0_%"VVGZU;W>GSV&O6FC:A/>:9%JEK]KB@%
M[':F[M]\UJTD962@#^>/P_\ #K]H?_@N5XZ^)/Q#\2?%KQ)\"?V'O 'B^_\
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MPAX5UBXAN Y@NETW6]8LKQ;*4QLJ7TD*69D*1>?YDD:ME?$CX ?!?]H'Q/\
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M&VGBW3=;\)K\2])L9]$N;[4M/M4U$_VC?L=>+?AAXR_9F^#6I?![XF:S\7O
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MX4\[XSG0DNVMA\2Q\.;8^")(EE\L7R6(\3?\+%^R.O[Y5;P M[Y7#6:R_NJ
M/#/VM].^(_\ P4Y_;XUG]@W0?&>N_#[]EW]FS0M)\6_'W6?#D@%[XS\5ZA;:
M1J%II<8FCDT^ZO[*ZU>QT#PSI^L6]QI^D7NE>-/%TMKK4VGZ3IJ^/?MT?\$B
MO#/[(7POB_:[_8=\9?$?P;\0OV>I;3QOKVEZIK_]OW-]X?TJYC?4O%6@WZ:9
M;S66I>';>234O$6E:A]I\-:UX2MM6BEM+5[>2TUK^A+X,Q_L]^.9M>_:-^!@
M\ ^(9_C9I_AM?$_Q/\$M9W,GCFW\%PZAIV@0Z[?6A#2ZGX<BU"_TJ>WOXH=8
MT]D&E:I'')IT%M:]A\8/#5IXT^$OQ1\'7\'VJQ\6?#KQMX:O;;89/M%IKOAK
M4]+N8-@Y?S8;IX]@Y;=CO0!\M?!/Q+\-/^"DO["O@?7OBGX1TW7/"7QP\ FP
M\?>&"TD=O8^+M U.[\/^)WT2ZBE^W:7/HOC70+[4/"VJ03PZII_V?3+^.6*Y
M0,/Q-A^%G_!0G_@C-XXUZ\^!/AS6OVM/V,_$NL3:S=^$X=/U74M2\.*<-)<Z
MOIWAZVU'5_A[XK@L8EL;[QSHVD:KX"\1P06=[K^CPZDFF:-H_P!U_P#!!WQ1
M;?\ #O"SEU?4;6RTOP7\4/BG:7-[?W*6ECI6FQOIGBF\GO+JZ:*VM+2W&M7-
M[<7$DBV\,3/++(F)"OU7^RI_P4-^'O[8?QO^-7PS^#_@7QEJOPX^$-A8-;_'
MYHXQ\/O&.NRWZV%[H&G12007EC/,'?4O#$TDUV_B/1=-UG5)[71+>WTS^V0#
M\C_B7\?/VQO^"QFF:/\ LS?#']F[Q/\ LT_L]ZMXAT+4OCQ\6?'SZGJ\3Z9X
M;UF#6(M#TN^O?#WA/3;^>SU&STW5K?PKH\5_X@UC7[#1CJ&I>&?#-OK-W/\
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MGA?2/"W@5YKFT\-WP>U\V_@MI(4^V>"_#>GW<&@:/X9&ES7\6LW>J74%AD?
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MWVG7>M:O8:E(VL:-C3-7\16EII^NB/6M8U3Q;XHUR[TOP_IL7AZSN_W*HHH
M**** "BBB@ HJK?7UEIEE>:EJ5Y:Z?IVGVMQ?7]_?7$5I96-E:1//=7EY=3O
M'!;6MM!')-<7$TB10Q(\DCJBLP_&KX@_\%Y?V"O GCRX\$6>H_%/XAV=E>R6
M%[X^^'W@S2=1\!P3P.8KB2WO]=\5^'-<UFRBE5UCU+P_X>U;3K]%%SIEU?6<
ML%Q* >>_\%//'/Q>_:5_:1^"G_!+_P"!_BBY\#6/Q3\.S?$7]H;QO9"X:6Q^
M&\4VK%- G:VEMI#8#3?#NK:EJ>C/<6\'BS4M6\%^'[F_LM.N]4CN_(_VDO\
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M01I%#$BHBA0!6O110 4444 %%%% !7Y2?\%;?VHOB3\!O@CX*^&'P'>_A_:
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MA'=^-C?Z.SV&K7>MVEA8R7&J02.M\\9NI'DN)IY9/F3_ (*>>'=.\4_\$_\
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M/_!/?X :-X-T'4[&WF-AKGQT\?>$= T[3-5,=Q;DV]U<O=07,9NH#<Z/\/\
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M$%GMU6(^8L,<8 /WNK\O/VR/^"KW[.7[*=WKGPZT>[OOC-^T5;7$.BZ1\%O
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M7PAT;2$VZ-K&K:$IDT^S\51-YFHZ+H*K)_PC=_=7/BC7I+[X@:C)-X=_1O\
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M6Q\1>$_%NBZEX=\1Z%J<*W%AJVC:O:2V6H6%U$WWHKBVFDC)4K(A(>-TD56
M!P7P$^.OPX_:3^$W@WXS_"G6EUOP9XUTQ;ZRD=5BU#2[V)VM]6\/ZY9K)+]@
MUW0=1BN-,U:S\R5([NV=[:>YM)+>ZF_C\_91T7]L7X\ZK^T7_P $^O@/;W/P
MR\&>,?VBO'?C#]IKXP7$-]%<>$O!37%OX3F\$WC1_9&MGU6;P_J:-X;L;Q-:
M\=3D:+-<Z+X1T[Q?>W'ZE?\ !!Q-3\'ZW^WO\$]$UJY\3_!SX4_'C3;+X;>(
MVF-QI^K7$VH_$/PUK&HV%PF+28ZOX>\%^!]6N/L:1HHNH+ATQ>PU_0!I?ASP
M]H=UK5]HN@Z-H][XDU(:QXBO-+TNQT^ZU_5Q:6]@-5UJXM((9M5U(6-G:68O
MKYY[H6EK;V_F^3!$B@'B'[+W[+WPD_9$^$FA?!_X/Z$-,T33 +O6=9NQ#-XC
M\9^(YH8HM2\5>*M2BBA.HZSJ)AC7Y8X;+3;*&TTC2+2QTFQLK*#Z(HHH ***
M* "BBB@ HKX?_;0_X*"_L\?L+^'])O\ XO:OJ^J>*_$T<TWA/X;>"[2SU;QK
MKUK;R&"?5C:W^H:5IND:!;W(\B;6-9U*RAGF2>VTJ/4[ZWELU^5_V0/^"U/[
M,/[5WQ(T_P"$=SHOB[X-^//$4\=GX*MO'4FD7?A_QCJDK2"'0--\0Z/=RQ6/
MB&Y5!]@T_6;/3K?5;AX]-TJ_O=6GM;"X /D3_@G!X<\#_M3_ /!0W_@H3\8_
MVA-'T[QQ\7/A+\2(/"7PP\.>,[:TU:P\">#[;Q9\0_"K'0M"U-KJW%]X8L?"
M'AS0$U!+-7T62_N;E)O[0\2W$U?H#^W3_P $J_V>?VQ?"NH:AI/A_0OA)\<;
M*VDG\+_%3PEHEGIAOK^- ;?3?B#I>EQ6D?BS1)RD<)O)\>(M%58YM'U)+=+O
M2]1_.S_@HC\&OC/^P#^U=;?\%/?V7M(&M>"/$\R:=^T?X&2.5M.CDUB;3[77
M+O68[8/<0>$_B#)9Z=?7&LQ0RMX6^(]E:ZY<O,FKZ?9Q?M[^RE^UG\'/VQOA
M5I7Q5^#_ (@BO[6:.WMO%'A:\FMX_%?@/Q \)DN/#GBO2XI9'L;V)DE:SNU,
MFFZS9HFI:1=7EC*DQ /R0_X)M_MP_&3X6_&+4?\ @G%^WE<7EA\8O"MPFC?!
MOXAZ_<2W/_"=V$$#-IGAB^\1W*1?\)$=7TR&/4OAWXONLW7B>U,WA_5IO^$F
MBTVUU'4_X."+^]\/_L^?LY^,K?2[C4[7P?\ M-^&]<O$C$L5L#9^$/%UW:VU
MW>I!<)8B_EM6MHIY(W_>-\D<K@1MR_\ P<$^!_"FA_"K]G_]H_0KV+PW\?/A
M]\9M"\->!]=TZ2&W\0:EH5QINO\ BUK>%8U%[>R>$_%'AW0]<T6Z8RV^AS:A
MJT4<:3^(MS?O;:Z=;>,_!^B0>._#>D7TFI:9H&J:UX>U;3[75--M=;@2RU7R
MS9ZA%<PO)I.L0I-92R(TMM<VL%Q$ZSQ)( #\._V,/V+_ (N?M7_%RQ_X*%_\
M%"[$WOB>]-KJ7[/?[/>I6LT7AKX:>&HIC?>'-8UCPY?&3[&]F)$U#PWX;U!)
M+\W\C^,/&#W?B2[@@T[]\J** "BBB@ HHHH **BGG@M8)KJZFBMK:VBDGN+B
M>1(8(((4:26::61ECBBBC5GDD=E1$5F9@H)K^?SXX_\ !>CPEX<\=^*?"W[,
MW[.?C']I3PQ\/Y_^*S^)5EKU_P"&O"GV:SN)HM1N]"&D^"O&MU)H#^4T-AXN
MUP:-8W,T<]S9Z7J6EBTOKX ]/_X+Z_%/QU\.OV'K+0_!MW>Z78?%CXM^&OAU
MXXU.QDDAE?P?+X:\8^*KO0C<021SP1>(=1\+Z99Z@ 6M[_18]6T:\CDMM4>-
M_O;X-?L=_LD>%OV??"?PI\)?!_X:>*?A9J?A/1IWGU[PEX=\0S>/(M0TF*5?
M%OB/4KVRNI=:UK6H;IK\ZH\[M;FY6/2VM+.&U@A^0_#OQ?\ V;_^"U_['/Q2
M^&6@W%]X*\6?8M.76_"WB$6]WXF^%?CVV+:EX,\6VILIH8O$GA635K*:&'4[
M)K$ZSI2:OH]_:Z+?33VD/Q;_ ,$U_P!NGQA^R;XYE_X)N?MW[? 'B#X?WR^'
M/@Y\0_$%RL.@?V7/(TFB^#]4\0W/DVL_A;4H)8[KX8^+I733VTR>'PO>2V*V
MNBVT8!YY^U)^QK\9_P#@D]\3W_;=_80O]6U/X'Q74"?&#X+ZG<ZGK-GH7ARX
MNF>YL=:17>Z\0_#0O)Y=GK5W))XI^'FH2VNI?VC>6PGU:S_H&_90_:>^'/[7
M_P $/"7QP^&=PZZ3K\<MEK>@7<T4FL>#/%NG+"NO>$=<6'"KJ&E33120SB..
M+5-)N],UNS0Z?J=H[^_ZMI6F:]I>I:'K>GV6KZ-K.GWFE:OI.I6L-[IVIZ9J
M-O)9W^GW]G<I);W=E>VDTMM=6L\<D-Q!+)%*C([*?YY_^"/.@#X0_MG_ /!1
M_P#9[^&^IW&L? 3P)XXLY_#^+F34K#0=<M/%7B71=*TI+\NT;:J-#CO]!U>Y
MQY^K/X+MIIF/V!  #\Y?ASK'[96O?M:_\%"OV+OV6=+NO"WB3]H7]I[QO??$
MOXISRWU@WPL^&7ASQ_\ $J#5]3&I6T++H5IXGL_&%D#K]G+)K5_:06FC^$H)
M]5UVSO+7^H;]C#]B_P"$?[$7PCL?AE\,K$7NJWHM=0\?^/\ 4+6&+Q+\0/$L
M4)CDU35)(S(;/3+/S)X/#WAZ">2PT*PD>.-[O4+O5-4U'ZAL?#?AW3-7UKQ!
MIN@Z+I^O>)?[/_X2+6['2[&TU?7_ .R+=K32O[:U*"".]U7^S+1WM=/^W33_
M &*W=H+;RHF*G:H **** "BBB@ HHKXW_;3_ &XO@M^PS\-H?'?Q5O+S4=9U
MZ:ZT_P !?#[P_P#9Y?%7C?5[2%);B*QCN)(K?3M&TQ9K>77O$-^Z6&EQ7%M#
M&M]JU_I6DZ@ ?9%?SB_LR^'/ O[7/_!7[]MS7?VC=(T_QYK7[/#'PE\#O /B
M^&#6/"^A>&O"OBJ;PH_B*Q\-:D)[*>:R,-AKEN9+::Q@U[QWJ/B P+K$FG7E
MMO\ PN_X+[>'+GXD:#X7_:4_9B\<?L[^!?&DL;^&/B'=Z]J7B2"TL+F6W@M=
M5US1-2\">#[JZ\/*TC3ZCX@\-7&L/8QR11QZ+>1I)>5B_P#!3+X#?%7]FOX[
M>%_^"LG[($UKK<FE66D2_'7PQIZMJFC:[X:DTF#1#XUFCL)Y(=8\$>)O"@T_
M1O%S6 CFT">RT?X@:=<&<ZAK6A 'Z)?MK?\ !+[]FK]L;P;?V]SX2T'X8_%B
MVM93X3^+G@KP_IVFZU9WJ[Y+>S\5V-@EA;^,_#DL[%;G3=5?[=:12W,N@ZIH
M]W/+<2?G9_P3U_;&^,_[)GQS'_!-7]O&[GBU>SNK'1OV??BGJ=S=WUCK%KJ%
MP]KX9\+CQ'?1PRZ_X-\3[!;?#K7+M(M0T/5H9O &L)%)'8:9X:_8#]C;]LWX
M/?ML?"?3_B5\+M6BAU6V@L[;Q]\/[Z[MW\5?#SQ%/%(9-)UJUCV/-87,EO=2
M>'_$$,*:=K]A"T]OY%W;ZAI]A^:7_!P#\+_ 6K?LF>&OC/>R6>B?%/X6_$OP
MM8> O$,$B6>O:E9^*9[BWUOPI:7<>VYFBC2VA\90QQR":PG\+RW=K)"LM\MP
M ;O_  <%:;+??L':7=1VL]PFC?'KX>ZE/+"DCQV44OA[QWI NKID!6*!Y]5A
MLE>;$9N;NWC!\Z2('QO]E;]ESXQ_\%*/BIX<_;F_;STN6P^#NA1Q3?LT?LU7
MIN'T&YT0/!<67BOQ/IUXD37V@:F]O:ZG<SZC:Q:A\4=0BMK_ %"WL?AU8>']
M U?]O/A,)?BK^SO\*+CXLZ#I?B'4/''PD^'6L>/= \1Z19:EIE]KNK>%=$U?
M6K?4M&U""XLIECUF2:0VUQ!(D4T2D*&C4CVN.-(D2*)$CBC18XXXU")&B *B
M(B@*J*H"JJ@!0   !0 1QI$B11(D<4:+'''&H1(T0!41$4!515 554 *
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M+O1O&.B7,$6GZ?I]S*I*/XRCNI?!4MJ#B\_MZ)447<5G+" =%_P5HM+K5O\
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M-(L[?3M)T;1[&UTS2M+T^TB6&TL=.T^RB@M+*SM842&WM;:&*"&)5CC144
M$/A_P_H7A/0M'\,>&-'TWP_X<\/Z;9:-H6A:-96^G:3I&DZ=;QVEAINFV%I'
M%;6=E9VT4<%M;01I%#$BHBA0!6O110 4444 %%%% !7R;^W;\2O&/P?_ &.O
MVCOB5\/I)K;QGX3^%/BB^\/:A; FYT74)[3[ OB&VPR@7'AR*[DUV!VW1I+I
MR/)'+&K1/\1?MG?\%A_AQ^S=\3;OX!_!SX6^)OVF_CII;26WB/PSX0O[C3M
M\)ZB+;[0^D7VK:=H/BK5=<\1:=$T=SJVA:%H4MOIRB73M4U[2]7M[RRM+_[&
MG_!37X&?\%$XO'O[-_Q'^&^H_"?XGZSX5\4:'XD^$GBO5TUK2_&OA2ZTVXTG
MQ=8>']=;3/#E_<ZG9Z=<WK:[X;O]!TS5;'3?.O[*35+6PU6YTT PO^".'[.7
M[/47[$7PZ^*5KX*\*>-O'_QCA\4ZO\4_&_BK2-+\3>(=6UNU\7^(-%N_#MU>
MZK%J$]II&CKIZVB:3&\-O>7'VC6[VWDU'5+J>3P/]O/_ ()0ZSX'\01?MA_\
M$Y!>?"7XW> +AO$^I_"SP&D6FZ3XG2T!EO+[X=:/$G]G:;K;VGGP:M\/?LLO
MA/QOIC2Z99Z3;ZE+-IWB;YP^#/Q/^(G_  1#_:AUO]G3XX/K/BK]B?XT:]<^
M*/AY\1(+"XNW\,S7#6MA_P )/;PVZE9M2T>U33-#^+'A2U1M0:"STCQ?X<M9
MH9K+3_$O]1OAKQ+X=\9>']&\5^$M<TGQ-X8\0Z=:ZOH/B#0=0M=5T;6-+OHE
MGL]0TW4K*6:TO;.YA=9(;BWEDCD4@JQH _/3_@FI_P % O#G[<WPDF?68;/P
MQ\>OAQ'9:1\7_ J*]H!>LKV]OXS\/6=PS7 \,^(+FVNE:RD>6[\-ZO#=Z'J#
MRQ+I6IZO^.G[?OQ5_:!^!G_!7?4=6_9T\!7'B_XT_%C]F_PS\-OA1;O8&^6V
MU#Q49--N?%UEI\T9T_4QX<_X1_6'#:M-;^'M,NK1]6\1R3:+I6H6-W[K=^#M
M,^ __!P+X#L/@KY5OI?[0'PD\0^+?C9X7T3$6G:3J&L^%/B%J.M-J4%KM@LC
MJFN_#[P;\1KA;W+W>N:[YL:(VJV._P#HCN/#GAZ[UW3O%%UH.C7/B71[&_TS
M2/$5QI=C-KNEZ;JKVTFJ:?IVK20-?V-CJ4EE9O?VEM<107CVELUQ'(T$10 _
M-S_@G?\ \$[](_9)TC6/BE\4M8'Q4_:T^*@N-6^*OQ5U:XGUFXT^XUF<:EJ?
MA;PMJ>I!KYK!KYA-X@\03"+4O%VI1+=W:VVFVVE:5I_Z>444 %%%% !1110
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M"^/U-S#IK:_!;76GW_AG7DEB@U+2;+7HQ=>&_$EC?V::AX:URUM+[4-*EO\
MP^=.?YH_X)=_\%*[WQ3<Q?L4?MA2W'P__:B^%]V? &AW_C!ETV7XE+H&-,M]
M!U2[N'$(^)NFI EHZR3,/'=L+76=+N=1U>YOTE /C#XA_##]H/\ X(:_&NU^
M,GP;U/Q'\5?V$OB/XJLK+Q]X'OYOM=WX<-XZ0QZ;KV4CL=-\66]HK1^!/B-:
M1V-OK<EG!X8\5QH)H+;5OZ7?AW\3_!/QZ^$.@?%+X6:U!XG\%_$3PK)J_A?5
M(,P&YAO(+BV>TNX)RDFGZGI^H1W&E:OI]V(KG2]4M+RPO$BN+:9%U?BI\//
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M\-OY<;,IUZ "BBB@ HHHH **** "BBB@ HHHH **** "OS/K],*_,^@#Z^^
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M6!!5@2"""#@U^37_  6_MH)_^";?QOEEC#R6>N?".YMF)(,4[?%OP7:-(N"
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MEH0L6F:S;W=EXCT-4MUM-0NM,M?[%N/ECXGWMEX9_P""^GP:U2]O;/3]-O\
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MWO%@T^WMW,EQX=N=;L[K3EN/!22R_P!@P:1:76O7-SXSU?Q+':?I90 4444
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MZU[4Y[RZO?)^T3JM]J=OHEO<P:#9ZWJJC6M=M-,@UC6534[V[1?=J "BBB@
MHHHH **** /@/XJ?MY>'OA)^W'\$/V./%7@75-.L?C;X,O-9T/XM:AJ=O9Z
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MT^%L/B#PU8W,'B3Q';2L]DVNFRD?5-!T+5I(].T_3(F\9>,WM_"]M:6GB/\
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M\.>&M#L0_D6&EZ="L,*M+*TEQ=W4Q#W-_J%W+/?:C?37-_?7%Q>7,\TG:T4
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M\]?^"*?[2.M?%+]FK5/@!\1Q>6'QD_9)U^3X3^*=)U>3&LIX4MKG4;;P8U[
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M+"WT&+Q[IFDP1$Z5:ZY!I),U>G_'/]L?X_\ [>_[0D7[(G_!.;Q??>"_A_\
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MAJFCV<FH66J:->Z;:W"?8/$&I"VN[C7=0(\(^$XI[N:[OD /GOPQ_P $[_\
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MNI0/<R+'(R0J[*CD!3^'7_!1:RO_ -@S_@H!^SO_ ,%%_"UO>0_#3XGWMO\
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MQO(6AN+:Y@E5X;FUN;>1XIHI%>*:)V1U9&(/\ZW_  3UU"Z_8%_X*'?M#?\
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M@:I9NT=[H5YXMUW1_!K>);"164Q7_AFW\03:_8S'<L5WIL,CQRHK1/\ '_\
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M[UB^\,>'[!V4P6T5GJ1\8?#"&R@>6ZU%E\ W-[*A:-* /UO_ ."A7[/?BO\
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M/BK39=*\96\+LQ@MO$,-NSN\+L?O*@#SCX1_"/X=_ KX=^%_A3\*?"^G>#_
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M]C;:)?2//:7_ (JEL,P?VG8DZ;X;TV9M(\.DM-J.I7W[F444 %%%% !1110
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M9] 'U]\ /^1-U/\ [&:\_P#35HU>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110
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ML>'=#T$>+Y[6WEN[FR\/ZIX9\5>,-';4DM8)9H=-U74-+O[]8W33;>\F5HP
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MXC:WD:6U\/\ PXO)TE@@\0:-.UQITFCVEU9>)K[4))+C6FT?P 'N?$X![O\
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M!J+0Q^,K/4%LM$6T,_BO00UC]NT'1/Z!/&FMZKX9\'>+/$>A>&=1\:ZWX?\
M#.O:WH_@W2+BTM-6\6ZKI6EW5_I_AG2[K4)(K"VU'7KNWATJRN+V6.TAN;N*
M2YD2%78?AK^Q]^PG\1?VF/CYJ?\ P44_;_\  >FZ!X]UN]L+SX/?L\W?A]-*
M@\":5H*K:^%M=^(VE7EI!J.H>(=&LX(%T#1_$\<VKVT\,>M^)(X;^/2=%T$
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MN32[35+33[R\B^>OV>_V6=:_:@_;_P#VN_VG?VOOAY?ZMHWP6^(__"D_V:O
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M+OX;ZAXALM-L-*U_7/,GUJV^(5UI=UJ,=WJ/VW_A7BRSV;&<6@D=8#Y]\?\
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MZAI<GQ2\8LUSIUGJ.C^=9S+X0MTU"RG3Q[IFJQ"Z\)W44L.E66KS7VCZ5/\
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ME\?KXPFM3KC>)M+FCEUF]UV]OY[K5)C>1:LU[:7U[;7 !P__  4!_9=\&_\
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MM+N"6VNK6YBCGMKFVGC:*>WN()5>*:":)VCEBD5HY(V9'4J2#_.E^PK<R_\
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MLY_MS06_BCX8M),T6C:#X[NKK4[S0]'MA_Q[6SVOB^?Q3\.;+2H4>]>P\2^
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MQAXB\36L::5JOB#3="@_LJ]_>E$2-%CC541%5$1%"HB* JJJJ %50 %4
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M;?4]'UG3[+5M*U&SD6:TU#3=1MH[RQO;69<K+;W=K-%/!(ORO%(K#@BOGO\
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M?;ZII5]"P)&RYLKJ&8#.5W[6PP(K\V?CU_P3??\ :M_:]T?XQ_M'_$R;Q_\
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MEJ==A\0SZ:C$QC3)[)K;%FUNH^;==_8Y_P""B'_!0OQYI]M^WWKOA/\ 9_\
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MO^$C^)1NKR*37M;\46-]%/<:7?:1<V]C.4ACUC3K.SO-+T&ZTM/$>KZD??\
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M=8TNZO[N94VS7B>#O$FGZ'XDC24S6ECH<GB^66$0WEU(OZB?LN_'SPU^U!\
M/A9\=O"K1)IWQ"\+6>J7MA&Y<Z'XCM7ETOQ9X<E8L[--X>\36.K:,[EF$WV(
M7$;/%+&[ 'Q'^QK_ ,$O/ WP-U[Q/\;OVBM6TK]IK]JCQWXAU37_ !%\4_%V
MD)J.DZ%)>7CRPQ^"]#UF.>#3=0DA6!KO7GM8M1M4QHN@KH^@PM9W?Y]_\%N_
MA3\./#/Q5_8L\:_!70M \+_M8>*OC-H^C>'HO"=O;:)K'BG3M,U+0?\ A&-7
MUN+2$BN);OP_XRDT#2]!UI[9KW[/J5]8)=3PZ9:V]G^V7[8'B?\ :U\*?"DZ
MA^QM\-/ /Q1^*EQK-MI\VB^/_$5OH%GI>AW=O<I/X@TV/4-9\,:3K%[IEV+5
MI-,U'Q/HZ-;22W$"ZI+ -,N?B+]C'_@G=\4=$^,\_P"VA^W9\1[;XT?M2WEE
M)9>#]%L6BNO ?P>TVYCF18M!06-A8OK=C;7E_8Z=;Z%IVF^&?#O]HZS=6":[
MJ^HIXAMP#]AZ*** "BBB@ HHHH **H:IJNF:'IM_K.M:E8:/I&EVD]_J>JZI
M>6^GZ;IUC:QM-=7M_?7<D-K9VEM"CRSW-Q+'##&K/(ZJI(\S^'/Q^^!7Q@OM
M5TOX3_&?X5?$W4]#$C:SIW@#X@^$_&%_I213);R3:A9^']6U"YM(%GDCA%Q/
M&D+22(BR%G4$ _.?_@LW^S'J/QV_90N_B3X'CNX/B[^S)J<GQA\#ZCI*LFMM
MHNEQPR^.]*T^ZA!O+>5='L;;Q;:+9?Z5<ZUX-T:VBPTNX?5W[!'[3]A^U[^R
MO\+/C.D\+>)K_1D\._$>RA2.$:;\2/#*1:9XMB%M$ EK:ZG>(GB+2+<$E-"U
MK2RY#LRC[!EBBN(I8)XHYH)HWBFAE19(I8I%*212QN&22.1&*.C@JRDJP()%
M?SG_ +$$LW_!//\ X*7_ !P_81UF2\L?@K^T8P^*G[.\M](4TVTU(66HZIIV
MF6;RL(]UUHEAXA^'M_?R.MSJOB'X=>'+6&V9]1@% 'Z4_MY_L3^+OVWH_A'X
M O/C9JOP[^ FA^*;C7OC7\/M!TI&UCXGV]F;&Z\-6]KX@,X2P;2;NUO$BM=0
ML[_2H+G4X?$;6-]JWA_2(!]%^%_V7/V;? 7PF?X+Z#\&?AKIWPF723IVI^$K
MWPQI&H:/JUE':26\]WXFEU:"[N/$&HS6\D[W^N:]<WVJW4DL]S=WTDTDDI^@
M*_$W]J_X,_\ !4S]KCXH>-?@#8:_\+OV;_V.KG4I[.[^*'A#6Y=:\>_$SP%?
M%@VD7MA%J+>)HM4DL9$M->\,BQ^'OAJ[D;4M/N/%'BG1'B6] /GW_@A1HT&A
M_%C_ (*&:5\+=3U/4_V9=(^,&EZ/\)[VYNY+[2=26P\0_$>WTS4-*NV>>*[O
MY? <7A)];U""99M0LY_#5Q?(X^Q+;_T:5X-^S1^SC\,_V4?@YX3^"7PHTV:R
M\+^%X)7FO[]X9]<\2Z[?.)]9\4>([V&"W2]UO6+K][<21P06MI;I:Z9IMM9Z
M586-E;^\T %%%% !1110 445Y9\0?CI\$OA+>:7IWQ4^,7PK^&>H:X5&BV/Q
M!^(7A+P9>:P7D:%!I=KXCU?39]0+RH\2BT2;=(C(,LI  /4Z_G%^!3+_ ,$W
M?^"M?C_]GJZ,&B?LZ_MOVUIXQ^%J!&M]&T#QQ?:AJ\WAK0K,DR0636GB=_%O
MPYMM*MV,]S9ZWX OKTP0"U1?Z,+&^LM3LK/4M-O+74-.U"UM[ZPO[&XBN[*^
MLKN))[6\L[J!Y(+FUN8)(YK>XAD>*:)TDC=D96/Y#_\ !:+]FC5/C-^RVOQB
M\ _:K+XP?LK:PWQ?\':MI2.NMKX;T[[-/XYL=/NH$:YM9+&RT[3?&]O)"#(;
M_P %V<"%/M#R* ?L X8JP1@CE6"L5W!6((5BN1N"G!*Y&<8R,YK\G/V7_P#@
MEUX<\"?%3Q]^TG^UIXJTK]JS]I+QGXIU/4+#QAXHT!&\(^$M"BF%KH \/>#M
M3^UZ;9ZZFE6UDD<WD/9>#K.&S\->#([.QTZXU76_J_\ 89_::TO]KK]E[X5?
M&VTEM_[=US0HM)\?:?;JL2Z/\1?#P72O&5@MLI)MK2;5H)=5T:-\/)H&IZ5=
M%0MPHKL/VHO$7[2/A7X/Z[K?[*7P^\$?$_XQ6MU8II'A#Q[X@_X1W2+W3YWD
MAO[FUNYM2T'3[O4[!GMKN+3=5\3>&;&[LH[[&L)>QV=C>@'XB_\ !?OX3_!W
M0?AC\"/B1X.T+1O"O[2]U\8M'\+^ [WP9:6NC>-/%'AJ/1]9U#483'HZVE_J
M47ACQ*G@^?1]587$_A[5M8M[&PDMF\1R^;_1'X7&N+X9\.KXG%N/$HT+2!XA
M%HXEM1K@T^W&K"VD  DMQ?\ VCR7  >/:P S7XY?LI_\$\OCMXK^/.E?MI?\
M%%?B%IGQ.^-_AY5D^%?PJT-[:[^'OPB>-G>PO5BMK>#0I-8T61VN=%T[0+>;
M3-.UG_BJ[[7O$OB=K;4=,_:J@ HHHH **** "BBLG7M>T3PMHFK^)?$NKZ;X
M?\.^']-O=9US7-9O;?3=)T?2=-MY+O4-2U+4+N2*ULK&RM8I;BZNKB6.&"&-
MY)'5%) !K5^8?_!6_P#92;]J?]CSQK;>']/6Z^)WPB$OQ9^&\L,3MJ5Q?>&K
M.XE\2>&[%X2MP\OB?PN=2L[&R5O)N?$4'AZ>92UE#)%ZE^RO_P %"/@A^V/\
M0_B?X(^">C_$S5M#^&D,,I^*FJ^";[2OAAXN<W5O:75IX;\0S2M-#J<#7EI<
MVVC>)+#0-:U33&NM5TW3KG3["\N(?NJ@#\^O^"8?[5B?M=_L@_#CQ_JM^MY\
M0O"MO_PK;XIJ\XGNW\;>$;6SMY=;NR6,@E\7Z+/H_BY]RHD=QK=Q:1%Q:,QO
M?M]_LD_$K]LSP-X"^$?AKXV77PD^%EQXU@OOCOI&F:6;C6_B%X(ME@NK31M)
MU57VVES8ZE:F1--U&&70K^XO;;5M4CNV\.6>E:G^6_P&*_\ !-S_ (*V?$+]
MGJZ>/1_V=_VWX;7Q?\, \;6NC>'_ !K?:CK5WX7T"P(0VMJ+#Q-<^+/AI::;
M:EKBZLM:\ WFHRQK' @_H_H ^;/A;^Q]^S-\'/AE%\(? WP5^'MKX&?2VTG6
M-.U;PQI'B"Z\60SV[VM[<>,]2UJTO;[Q7>:C#++'>W&MS7ADAE-HBQ6216T?
MXO?\$?O#.D>#OVY_^"D'A/X(7!G_ &9O#/B>QTC14M-1GO="M?$<'C'Q'!X=
ML]#E\R6UU"RL=,M?&>G6FIQRW$TVD66D2/=7,=S%-)]1_MB^!_\ @JQ^T/\
M%'Q%\!/@]=?##]GS]EW58[:&^^/^D>*!?^/_ !#X<O[6W&KZ/)917H\8Z+K,
M+&ZA_LWP]X<\-6=X<6<GQ(FTRZN'7[S_ &1/V3OA?^QE\%M"^#'PNMIY;*RF
MFU?Q/XHU*.W77_&_BV_CA35/$VN26T<<7GS1V]M8Z?9QAH-*T:QT[2X'E2T\
M^4 ^GJ*** "BBB@ HHHH **\=^*_[0WP(^!,6GR_&?XP_#;X7?VN'.D0^.?&
M6@^&[S5EB<1S2:78:I?6][J,4#D"XEL[>>.WSF9HQS78^ _B)X!^*7AJR\9?
M#3QIX5\?^$M2W"Q\2>#M>TOQ)HERZ*C2PQZEI%U=VAN(!(@N+8RB>W=@D\<;
MY6@#^?G6U;_@FY_P6"L?$2K)I/[-W_!0:&6SU6628V^A:#\4]4UN![RZD9S%
M:I<Z-\0M1M-2DFG:*RT7PC\6-46$M]A*I_1O7YB_\%;OV4C^U/\ L>>-K7P_
MIPNOBA\(Q)\6/AI-"I&H3ZAX:M9I?$OARTDB GD?Q/X5.J6-C9+(D$_B.'P[
M<SY-A$R=U_P3)_:MC_:^_9#^''Q#U348;WXA^&[9OAW\5HE<-<IXY\*06UO-
MJUTG&Q_%NBS:-XP C'D1/KLMG$=UI(B 'CGP@_X)?:$_[2'Q1_:H_:_\7Z;^
MU'\3]?\ %=\?A98^(M!6/P)\.O MM*X\,VJ>#;]KK2;G7M*LI!9V5L\5UH>@
MM"=5T]+SQ%>3:Y'\Q?\ !?+X1_L_6?[)&E_$2_\ #/A/PY\8M(^('A+P_P##
M'6M&TK2M)\1ZY!J%Q>2^)/"MQ-9Q6]YJ7AZVT :KXA^S2+<0Z;J^GV,]O]E:
M^N/M/[-_M ZW\;_#GPB\8ZW^SGX)\)?$7XQ:?8Q3^#_!OC?7G\-^'];N1=0+
M=V\VJ">QA6Z2Q:XFL+6]U?0;"]O(X;6\U[2()7O8OR7^!G_!/7]I+]H7XW^&
M/VK/^"G?C'0O$^O>!+B+4?A-^S3X/N+>Z^'/@.^2XCO(I]?CL)KO0K@65]:V
M5X^E:7J/B67Q)<V.E3>+O%^M6&GC090#]:_V=X?&]M^S_P# RW^)LUQ<?$BW
M^#OPRA^(-Q>.\EW/XWB\%:)'XKFNI) )'N)=>6_>=Y ':5F9QN)KV*BB@ HH
MHH **** "BD9E569F"JH+,S$!54#)9B<   $DDX Y->+^$OVD?V>/'WBR?P%
MX%^/'P;\9^.+8RK/X/\ "OQ-\%^(?$\;00R7%PK:#I.M7>J9MX(99;D"U)MX
MXI&FV!&( /#O^"AO[+-I^V#^RA\3OA%#9VUQXS33CXP^%MU<,D1T_P")/A>&
MXO/#JI<R QV<6NQR7WA+4KIE<0Z/XAU%U42!&7YY_P"".7[4EU^T5^R+H7A3
MQ=<RCXL?L\74'P=\?6-^TJZU)8:':"'P/K^I6]R#>1S:CX>MO[$OKB\=[F^\
M1^%_$5Q+L8F-?U@K^<7QD1_P39_X*_:+XX7[-H?[-G[?UO-IGB$[3;:/X=^(
M]YJ-E'J=[*YQ#!/IWQ$O](\27M]*T-AIWAGXG:[&@5=/+1 'ZX?MT?LW_$S]
MJ[X)-\%OAY\9I/@MIOBGQ-I$'Q/U:VT$ZU?>*?AB4NH_$GA"RECOK"?39M1:
M6SNG:.=(-6@L9= U1UTC5=0#]5^S[^QK^SC^S-\-K?X7_"[X8^&K71'L%L_$
M6JZWI6FZYXG\<2EDEN;_ ,:Z[>V;7.O3W5PHG^R3A-(T\".STC3=.TZWM;.#
MZ@K\G/VV]"_X*F_%3XBO\&/V6I/A3\(_@'XETC3O[6_:';Q(8_B1I*7-M%!X
MCT9K&2XN-;T+4$F-\^D7?@SPG>74UJ=-N(_'7AN_>\ALP#X;_8"\%>$O /\
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MF1JNL7-U<QVEA<:!XN2R@FU#0-2\+-I-BNKVMO9'2%%ZMY8_K7^P/\4=6_;
M_8&^$/C7XRV-OKVI_$SX?^*_!7Q$AN[1K:V\6PZ+X@\4_#/6]0O;=2L9_P"$
MNT_1)-3U'['Y-H\VJ7/V.&U@\NWA />OV7OCUX<_:>^ 'PK^.WA;9'IWQ#\*
MV>JWE@C%CHGB*V>72_%?AZ1F9F:7P_XFL=6T9Y-S+/\ 8A<1N\4L;M[W7X3?
M\$D? _QD_9;^-W[97[$?BOPWXLU+X0_#/QA9_$+X5_$C4+24: ;#Q:T,.G:6
MNHLHLY]2\8^$O^$?\1MI>DR/;:/K.@^,X[P)>7)+_NS0 4444 %%%% !1110
M!%/+Y$$T_ERS>3%)+Y,">9/+Y:,_EPQY&^5\;8TR-SD+D9S7\_?_  14\*>'
M?VB-3_:1_P""@GQ-B@\7_'GQ[\<_%/@[1-4UL0:E<_#GPC9>&O#&L0Z=X9\P
M,-&EO-/\4P>%Q):Q1-:>%/#>F:-IDMOIUWJEK=?T$U_(C\6?B+\;O^"*7QZ_
M:B\$^"O#4NJ_ ?\ :J\/>+/%OP"UV.$Q:=X#\=R0ZD/#ES8^<LNG7-[\-[O7
M#X?\4>'7DBNM:T&#P7XDD>.);;3+L _;+]JO_@KK^QS^R/XVNOAKXTU_Q=X^
M^(.E%%\1^$_A-H6F>)KSPK-*T(CL_$6IZUX@\+^'++5!%*]S/HL6M7.LV,$)
M;4+"U>YL([SZ;_9F_:V_9Z_;1\ :AXM^"WBVR\6Z5;$Z5XN\*:Q9BP\3^&Y;
MY+B--/\ %OA:^+SVMMJL$-U]AN]MWHNLP0W:Z??7HMKM8?DW_@G)^P5\#O@_
M^SAX,\4^*?"W@OXN?%SXU>%M+^(7Q6^)OBFPT?Q[<Z_JGCC3AK=WH>DZUJJ:
MM%+X:TZ+5GTYYK"98?%-REUXAU,37&H^7!^>GBWX+:3_ ,$_O^"Q7[,LO[.,
M<_AOX8_M:V6J:+XX^$^D3>7H6G+>75]INOQV5@[;+7PKIVIGP_X]T2P1_P#B
M2ZEI.KZ;I(M]"%KI* '5?L+7,W_!/C_@I1\>/V"==G73O@W^T!*_Q:_9WDO+
MA_LUM>R07U]HVC6DTV TU[X;L=<\#ZG=W;K-J7B+X:Z-;V,;MJ47G_T:5^)O
M_!:K]GCQ?XI^%'PV_:U^#%M=1?'+]DGQKHWC'2KS1K*6\UR]\'W&N:7/="VM
MK9'FU&7PGXFM-"\4P6\Z2P6NCQ^+#''NOI5E_73X4^*M>\<_##X=>-?%/A;4
M? WB;Q=X&\*>)?$7@O5X7MM4\)ZYKFA6.I:MX<U"WE9Y8+S1;^YGTZXAF;SX
MY+=DF"RAU !WU%%% !1110 4444 %?@/_P %&]>\;?M:_MR?L^_\$R-#\>ZI
M\/?A'XK\)O\ %?X\:EX;NOLFN^*+"PA\6ZS%X.:1HIXI8;;0O"*7FFV5[!=Z
M++KOB73=;UG3=0_X1FPB3]^*_#+_ (*M_LB?'R_^)'PC_;\_8]BOM1^/OP L
M8M.U[PCI=M'>ZIXH\%Z7<ZSJ=M>Z-I"B.7Q+>6L.O>(M \2^%8WGU'Q7X4UH
M:?I,3W6G)8:D )\=_P#@@I^R)XM\!"W_ &?HO%'P)^*V@V)N/#7B]/&GB_Q=
MHNMZ_:11/8R>--,\4:KKES:V\]S!O>^\#S>&KC2[BX;4(+#48;2+1YO"/^"8
MW_!3OQSH?Q=U+]@7]L_Q/:Z]\2/"_C36_AA\.OC"VM1Z\/$/BSP[K%UH#^ /
M%7B-&>/7KW4+^SDMO!?C&=Q>ZY<&WT36FN-8O+"YN,ZW_P""SG[3?[1GA&;X
M'_LX_L9^.=/_ &J?$$!\':GK;7EQ?>#?AOK=W:26FI^*VMM1T73Y-%ETEY$U
M*QM_'E_IVB^'G>*XU_4=;M+"2VU;-_;$_P""7OA#X$?\$NO[<_M6'4?VD_@1
MKJ_'?Q-\78;F>TU?Q#XM\8:UX>LOB/I%OK6(=1N-*MK*+29?#%S> ZI/JO@_
M2+\/I]YK6JK( ?=/_!:+]F*_^-W[*TWQ9\#0RP?%[]ES49OB]X0U:P)AUA?#
M&F1P77Q TZQN4!DC>WTO3;'QG;+$#<3:GX,T^UMBKW3!_L3]A3]IS3OVO/V7
M/A9\;();(>(=9T5=&^(.G61"QZ-\1/#NW3/%MC]FPKV5O=:A%_;6DVT@+_V%
MJVE3AY8YXY9-7]C/XJZA^T/^R+\!?BEXO@M;[6?B#\*?#UQXPCDBCGL=4UU-
M/_L7Q3,]K+&8OLFJZK9:A<-8R++'##<FT=[A4,LGY=_\$Y/A7\5?V-/V\_VN
M_P!D.S\*>(K_ /9I\2Z;;_'GX:>*8["[?PUX5.K:C9Z?X?TI]5N/+MCJ&IZ'
M<W_@S4U,L^I:CJ7PMM[VTLETV._NX0#]ZJ*** "BBB@ HHHH *\1_:3^-NB?
MLX? ;XK?'+Q!;/?Z=\-/!FK>)%TR-_*DUC5(8A;:#HB3$$0/K>NW.G:2MPP*
M6YO!,X*QFNE\2_&/X5>#?'G@;X7^*OB#X3\/_$3XEC4SX"\&ZKK-G:>(?%8T
M>!KG46T?3I9%GN5@C5@K;56XF1[>V,UPC1#H?&O@KPE\1_"?B'P)X[\/:5XL
M\'>*]+NM%\1>'-<M(K[2]7TR\0QW%K=VTH*LI&'CD4K-;SI%<6\D4\4<B '\
MX?[)G_!+Q/V_/ \O[:'[?OC_ .)7BGQ]\>$N?$7@7PMX;U]?#VG^$OA_>RSO
MX:NHUO=-U22TL[J&5M1\'>&M*:#PYH_AF72YIXM5NM3N8;"K^RKH7Q(_X)2_
M\%&- _8UUCQIK/CC]EW]J>S>^^%U]K+Q*VE>*)S>V^@W\UJ@BT^P\70:WIK^
M!_%D6B"TL_$NG:YX7\3W%A#-!I.D:=_2GX9\-Z%X-\-^'_"'A?3+;1?#7A71
M-*\-^'=&LE9;/2="T.PM],TC3+179W6VL-/M;>U@5W=A%$@9F.2?PL_X+-V,
M.C?&[_@F#\3+>+RM4\*_M3Z;IJ7D&4NS;7OBSX7ZZD =)X&=$F\-N\2L<(\L
MNR:W\Z7S@#][J_G"^%#)_P $VO\ @KOXR^#MPT6B_LY_MX6]IXD\"YB-KHN@
M?$#4-4U:?P]H]LX MK5M-\:WGB?P+9:5:$B/1_&O@NZO?)BAA$?["_MF?MG_
M  @_8C^$]W\3/BE?M=ZA>M<:=X$\ Z7<6Z^*/'_B&.)9!IFD0S%A:Z?9B2&X
MU_Q!<QMI^AV4D;RBYU"[TO3-1_/;_@I7\)==_;=_X)]^ OVE?!G@3QK\.?C7
M\)=)TG]H+P1X3U>R>U^(>@Z9+9VEUXY\*D6J?;H;U-)M+3Q=I1M+>WU/4-1\
M)>'XQ96-S=RVL !^X-%>!_LL^/\ Q[\4_P!G+X+?$+XI>$]5\#_$7Q7\._#6
MJ^-?#6MV(TO4;/Q')I\46IW<FE$++I5OK-S$^MZ?I=U'#?:=I^HVMEJ%O;WL
M%Q!'[Y0 4444 %%%% !1110!^%/_  44\9?&']J_]J?X:?\ !,3X'>,-4^'/
MAWQ!X.?XI?M/_$+25N!>6?PYDFDMX?"ZFVN+6XFL9K,0-J&EM+!I_B;5_%?@
M_1]0O[?2HM;AG^)O^"@/_!(GX<?L8_ 5?VKOV4?B1\3_  MX\^ ^K>%-<UI_
M$GB2RO[W5+6\\1:5H%MXA\.:CH^AZ)/H?B?2-8U:POYX58Z-?Z/'?016EK=1
M1+??TXQ?"WX=P?$RX^,L'@_0X/BG>>#5^'MYXYALUB\07O@M-7@UV+P[>7D9
M7[7I\.K6T-[;I<)+);R)M@DCB=XV_)K_ (*9_"K]K[]LGQ[X$_8I^%/A&?X?
M?LY^(['2?B%\:OVA]9:"^\.W\&BZR\UCX*L]/M+E;J>^T74K'3M:@\.22VFJ
M^)=<?1KIY=#\*Z'J>NW@!]U_LZ?M0>#?'_P;_9\U3XF_$'X<^%?C/\4?A+\,
M_%NK_#^_\8>&=(\37'B#Q?X2TG69AIWA2YU"VU=$U.>\>]T^PBL#)%;SQP*K
MF,L?G[_@K;^RB?VJ/V/?&MIX?TY;KXH?"02?%?X:31*5OYM0\-VLTGB3PY:R
MQ[9G;Q/X5.J65E9"1()_$</AVZG_ ./")D^//BQ_P0(_9>N?@OXE@\!^+OBC
M!\<=.T'5-8T?XH^,O&46J6_B#Q7;6IO+>+QAHXTVUTFWT&]NX&M9;C2(;#5=
M+M[K[;+J&JRV9CN???\ @B)^T+\0OV@OV)[27XEZE>:_KWPE^(FN_"&P\2ZB
M;B?4]>\,Z'X;\'^(] FU74)V?^T=1TJS\5_\(\]T6^U36.CZ?/J!GOII[RZ
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M87]K;7UA?6T]G>V5Y!%<VEY:7,30W-K=6TRO#<6UQ"[Q3P2H\4L3M'(K(Q!
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MV*W2ZCM+?4+H _7E'21%DC971U5T=&#(Z, RLK*2&5@058$@@@@X-.K\[?\
M@E5X_P#BW\0?V'_@[/\ &OPAXE\)>-/"%A>?#N.7Q7I]YI>J^*_#7@F9=%\+
M>*WLM2CBU(&\T6"TTR[O;Y3-K&J:1J&M(\EMJ,#M^B5 !1110 4444 %%%%
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MHAM[CP]::WK4T"W!ATGQ'X5O4\$SZQ);^1X5UW1O!&II#>W%V%@ /UB_:O\
MVW_V</V)O#&D:S\;?%YTF\USS(?"7@;PWIYUOQKXCBLRD=U+H_A^WEMTM]*T
M]65;G6-6NM*T.WE,-A_:']H7-G9W'CW[(G_!5']DC]L[Q'+X&^''B+Q)X/\
MB&8)[O3OA_\ %/2=,\,>)/$%K:B>2[D\-R:5KWB/P_KL]I:V[W]UI>G:Y/K,
M&G>9?R:<MK:WTMK\'_\ !-;X8>!?V^OBK\=?^"COQ\TG1OB#KFK?$W5/A[\#
M?AOXI;3?$ND?"'P!X6LK*;1WOO#\DM[ID?B-K'5;:UL1=64*VU[:ZYXOLX9;
MWQ9%?VW.?\%K_P!DCX>?##X<>&?VZ/@58:9\&OC;\(?B!X+;4=9\$6=IX>B\
M4V^J:W!:Z'J\^G6$$6GR>+_#/B%].N[;6!:K<:EHDNJ6&NMJ<%GHT>G@#_\
M@HQ8W_[!W[?W[.W_  48\*VUU!\-OB;?VWPA_:0M--M'DBN(Q816%Q?W<<"H
M+R^UGP+:1ZMHED6!?Q'\*[6YFE8W04?T16%_9:K866J:;=07VG:E:6U_87MK
M(LUM>65Y"EQ:W5O,A*2P7$$D<T,B$K)&ZLI((-?#7QF^#C?MZ?L!1^"/'%A:
MZ+XP^,7P0\#^-K LH2+PG\5;CPUHWC/0;A'&9(;/3/%HAL=2CAD1[K0Y-2TX
MRB*[D)\?_P"".OC?XQ^)?V+O#7@_XV^"_%?A3Q1\%/%?B;X-:9?>*[.>RN?$
MWACP7/;P:1/:)=;)I8?"?VFX^'CS11O9N_@_$-W<7(O4MP#]4**** "BBB@
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M HHHH **** "BBB@ K\SZ_3"OS/H ^OO@!_R)NI_]C->?^FK1J]RKPWX ?\
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M45]>:#JLFEW!%REE?W-]HWV^\T!]<UA+674;T _-_P#X)]_\$^_&^B>-[_\
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MCP=X6C\1O=?T'?![X4>#O@9\+O ?P@^']G/8>#?AWX9TSPMH$%U.;J]>STV
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M2V3Q=?VV@>-_#D#M>?V.^HZMHGC_ ,,QS?8M!UC5[J^N;Y=:R_9G_P""D/\
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MPMX<TX/YLD&F:1:QVL#W,Y"O=7USL:ZO[R0>=>WLUQ=S$RS.3W=%% !1110
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MI=1\0^)=36$LD=QJFI7$K6]HLDT>EZ;'8:1;S26NGP-7T3110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'XO?\%$/A/\ M;?MK?%SPI^Q9X-\
M&M\,_P!E&ZL?#WQ#^,O[0^JVVF:S%XDBT[4UN;?PCX1@9Y'L];T?4+6(PZ-N
ML];U74C;ZEJ,^E>"K2:XU_\ 3SX!? +X6_LR_"WPU\'O@]X:M_#/@WPS;[8X
MUVS:IK6J3+'_ &EXC\1ZEY<<VL>(M8FC6?4M2G5=Q6*UM(K33K2RLK;V6B@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7YGU^F%?F?0!]?? #_D3=
M3_[&:\_]-6C5[E7AOP _Y$W4_P#L9KS_ --6C5[E0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YGU^F%?F?0!]?? #_D
M3=3_ .QFO/\ TU:-7N5>&_ #_D3=3_[&:\_]-6C5[E0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MERX[&4LOPF(QM=3='#4I5:BIQ4IN,>D(N44Y/9)RBN[2U/W HK_+L_XB</\
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MR2::"BBBM#,***S=9DDATC59HG:.6+3;Z2*1"5=)([65D=6'(96 92.00"*
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M7QG^WU^Q3\/O$<WA+Q=^U'\$M)\26E_<Z7J.D#Q_H.H76C:G9W$MK>:=K_\
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MQ?XE_P""R6BF]CT73?VVM+T'POH]PLT%Q%H.A::FN>';2_NDDD)\,6_AS3]
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MGP[NR/''[5?Q<\/P:S%!F4VG@W0-:TRRT\ZK LD9CTV\\8:OIFN?:7985MO
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MZGJ6EZK;:1X/T*XO-#L;6_U34+^Y^NH_^"'_ ,#OAMXV\"_$_P#9=^,7QI^
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MXK\-^"?"FCQ"?5_$WB[7=+\-^'M+@+!!-J.M:S=66FV,1=E027-S$A9@H;)
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MYJ6B:EI3ZJME&MD^L)J$UK%:0RK96P!^CE%%% !1110 4444 %%%% !1110
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MLHO"WPJ\=>.=/;1=0\2^'/%VB6TDVK>&+"WO#?>'=2633IKR&!;>YDAN[?\
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MHGXDT?\ !Q-_R2[]E3_LM&M_^H[:U_CL?H)H?\%D_@YXT^!'Q-^"7_!3_P"
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M;3LRI+H<>O'PYX]MM(21SLT1/$#^'_%NE)$9A=CQOJ>H+(T1W'^B*@ HHHH
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M);"PT/Q=X-N[J?PS<Z#K;:;<7&G6.ERV+ZC>QZO'9 ']%U?S.?\ !&%4TO\
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M]7\?>(O'^@Z1(OPVT^'2M?\ #GA\:%:Z_?R6EUK.IW<WB*&Z@O=(TR\\.O!
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MYIOA2#3KC5/$J:)=6SQSP:AK<BZ1X:EG22,Q:5K6IB*2.Y>WEC^&_P#@JO\
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MWB&[CT35[:_2^\)WFIWNA-<$7$VG7L4B1_@AIG@;X/\ [,__  6'_9U\%_\
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M&U"6&$$16Z10JD:XG_#M+X$_]#9\6O\ P>^#O_F#H _)?_A?OQV_Z+5\6O\
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MKXM?^''\8_\ RYK]:/\ AVE\"?\ H;/BU_X/?!W_ ,P='_#M+X$_]#9\6O\
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M:%\/? %_=:5KG[0'C^T^'^JZAIUY/9:LO@VPTZZUWQ!IVFS6S12H=?O+?0]
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M<.?$_AS2M4\/-IGB!A+>IK&@V.M3R3:JD\[_ )3?"S]MCXP?\$C_  Y^U?\
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MCA_X=CQ[_P#+^OW _P"'1'[-O_0[_'#_ ,*3P%_\[2C_ (=$?LV_]#O\</\
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MC\+=8UG1->T"*^>YO;;2?$%I<Q-#875W?7.GZE9ZI8-=WD5O!=W/,?\ !O\
MVT$'[!#RQ1A)+SXW?$:YN6!.9IUT_P )VBR-DD BVM;>+"@#;$IQN+$^0_\
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M !2U7PEI]KH-HD=IHMI:>'[O3H;72[1%M+"W2.VME$$4=>I_$'_E8B^!O_9
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M44 %%%% !1110 4444 %%%% !1110 4444 %?F?7Z85^9] 'U]\ /^1-U/\
M[&:\_P#35HU>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110 4444 %%%% !1110
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MQ>*->\2:&?"4NL26)T":P6.Y&M)IJW(O(-0LKV)WB.EVYMI8A%)&LEPC%UE
M3YH_X=E_"?\ Z'[XA_\ ?7AO_P"4=?I+10!^;7_#LOX3_P#0_?$/_OKPW_\
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M% 'SY\1OV5O@%\6OBU\+OCI\0OA];^(OBK\&)DG^&OBM]?\ %>G2>')8[_\
MM2%FTC1]=T_0-;%MJ.;RT7Q#I6K):7#/);+$7?=[OJ.GV6KZ??Z5J5NEWIVI
MV5UI]_:R[O+N;*]@DMKJWDV,K;)H)9(WVLK;6.&!P:N44 >&?L^?LU_!/]E?
MP-=_#;X">"(_ /@J^\1ZCXMN]%CU_P 4^(_.\0ZK9Z;87^HMJ/B_6]?U8&:S
MT?3;=;9;Y;.".T06]O$6D+X?[0?[(?[-G[5-CI=C\?OA'X8^(W]B1W,.C:G?
MG4](\1Z1;WBL+JTTSQ5X:U#1?$MA9W#,)Y;.UU:*U:ZC@O##]JMX)H_H^B@#
MX?\ @5_P3>_8F_9N\2V7C3X1_ /PSHGC+3&DDTOQ7KFI^*/'.O:3-*'5KG1M
M0\<Z[XCDT6[$3O MYI L;I;=GB\W9)*'^H?BG\+O ?QK^'OBOX5?$[P_'XI\
M ^-]+?1O$^@2WVJ:8NI:<\T5QY(U'1+[3=7L9$G@AGAN]-U"SO+>:))8+B-U
M##OZ* /.OA-\)_A]\#/AUX6^$WPK\.Q^$_A]X*L9=-\,^'HM0U?5ETVSGO;K
M49XSJ>O7^J:S?237U[=74MSJ.HW=S)+.[/,W 'A/[0W[!O[(_P"U5J<&O?';
MX)^&O&?B6VL8]-B\56][XA\)^*C80.LEK:7/B3P9K'A[6=0MK)U/V*VU&\N[
M>TCDN(((D@NKJ*;Z[HH ^2_V>_V%/V2_V6+^;6?@5\$_"_@KQ%<63:=-XJDG
MUOQ1XL-C*%%S:0^)_%^JZ]KEG:WA1&O;6QO[:UNRD?GPN(HPGYU_\%\KOXM6
MW[(GA6+P5%XG?X877Q4T6/X]2>$UE^V#P2EA?2:1!K,L2NMOX9N?$8LA=3WJ
MC33X@C\,P7C_ +^*&?\ <BHIH8;F&:WN(8KBWN(I(9X)HTEAFAE0QRPS12!D
MDBD1F22-U9'1BK @D4 ?BYX._:Y_X(F'X2^%](M]3_9NM_!.A^&[*SL?"'C;
MX0?VCXCTZTL=/^Q/9:MH6N>"=3UW5=;6(SP7]V5U:YUJYENKN._U5;PW=Q\I
M?\$E/"&D>-OV_OVN?VE/V:/ VM?#7]B;5_"]SX(\&6%SIEQHGA[Q/XIDU?P5
M<QOX=T:Z9(X+.VO?#WC3Q+!:VL?F^"M-\2Z;X8N+;2_[4DL8_P!Q)_V-OV0;
MG56UZY_94_9NN-<>59WUF?X&_#"757G5!&LS:C)X7:\:58U6-9#,7"*$#!0!
M7T%I>E:9H>G6.CZ+IMAH^D:9:PV6FZ5I=G;Z?IVGV5N@CM[2QL;2.&VM+6"-
M5CAMX(HXHD4(B*H H _#O_@OQ\5-#\/?LD>%O@HNC6?B'Q]\>/B=X?T_P;I\
MEL+K4]-M?!%Y9ZYKGB'0D!,JZF+R\\.^$ 8D9Y;/QG>0Y D*O^GO['7P%L_V
M8OV8O@M\#;:.!;OP)X(TVU\1S6VWR+[QIJQEU_QQJ43#):'4/%VJZU=V^YG9
M+>:*,NX0,?3_ !A\'?A'\0O$'A7Q9X^^%GPX\<>*O MTM]X)\3>,/ _AGQ-X
M@\'7J7=KJ"7GA76=:TN]U'P]=+?V-E>K<:1<V<JW=G:W(<36\3IZ/0 5Y3\;
M/@?\+/VB_AQKGPD^,WA.#QM\/O$CZ;+K'A^?4M;T;[3-I&HVNK:;/#JOAS4M
M'UNPGM-0L[:XBGT_4K67,9C=VADDC?U:B@#SOP]\)_AYX4^%FF_!30/#-KI_
MPNTGP8OP]T_PD+K4;FT@\'+I3:)_8C7MY>7&JSPMI;O:27-Q?S7TBLTLETTY
M,IY7]G_]G'X,?LM^ ?\ A6'P(\%Q^ _ QUO4O$;:*FN^)_$;2:WJT=I%J%_+
MJOB[6M?UJ:2>*QLXA'+J+P016\4=O%$B[:]NHH ^?_BA^RU\!OC/\2?A-\7O
MB7X @\3?$7X&ZLFN_"WQ(^O^*M*E\,:I'J6GZQ%<G3M#UW3-'UQ8=3TJPO8;
M;Q'I^KVL,T!,4"+-.LON&K:3I6OZ5J6AZYIMAK.BZS87>E:OI&JVEOJ&F:II
MFH6\EK?:=J-C=1RVM[8WMK++;W5K<1207$$DD4L;QNRG0HH _-[3_P#@D7_P
M3JTSQK;^/+;]F3PL^L6EU#>P:9>^(_'NI>#5NX9&D$DO@/4/%=UX,NX'W*DF
MFWFAW&DLL:?Z ',CO]3^$OV8?@3X$^-OC?\ :+\(_#ZQT+XR?$7PSI7@WQAX
MOL]6\1%-5\-:);>'K/3-*B\-S:Q+X2TF*VM?"GAZ$SZ+H6G7=PNEV_VF>9FF
M,GO5% '!_$OX7?#GXR>#M5^'_P 5?!7AOX@>"]:15U'PYXITJUU;39GCW?9[
MN**ZC=K34+-V,VGZG9O;ZAI]P%N;&ZM[A$E7\_+7_@C/_P $VK37&UY/V;+*
M6?S(IX]/NOB1\7[K0X9XWN'DD71)_'\FFS1W(G1);*[M[C3D2VMQ:V=NWGM/
M^G]% 'S;\0?V0?V;_B?\$-._9N\6?"O1E^!ND7&F76F_#?PIJ'B'X>Z#9S:1
M>SZG8F(_#_6/#%^$&J7,^J74+7C0ZAJDKZEJ$=U?'SZ]J\$^"O"GPW\(>&O
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M#XC$8:C6KX23GAJM2"E.C*2U<&UH[I25[\LE&:M**:****]0ZPHHHH ****
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M+O"NNVCV.M>'/$NE6.MZ'JUFY5FM=1TK4H+FRO("RJXCGAD4.B.H#JK#H**
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MAW0YI].UR+4]-DETRU=K0LA)^A** "BBB@#Y_P#@I^RU\!OV=M<^*'B3X->
M(/!6M?&?Q)%XM^)5Y!K_ (JUE?$>OP76M7L-Z+7Q'KNL6>BQ177B+6I8]/\
M#]OI6FH;Z15LPD<"Q2?M#_LO_ K]J[PCH_@3X_\ @.+X@^%- \36GC#2=)E\
M0>*_#BVGB*RT_4M*MM0^V>$-=\/ZA.%T_6-2M7LKF[FT^>.Z8SVLKI$T?OE%
M &+K/AOP_P"(O#^I>$_$.AZ3KWA?6-*N=#UCP[K6GVFJZ)JVBWELUE>:3J>E
MW\5Q97^G7=H[VUU9W<,UO<0.\4T;HS*?STT;_@D-_P $ZM!\<VWQ T_]FKPZ
MVL6=ZNI6VEZEXI^(&M^#4U!9VN!</X&UGQ9?^$;BW!81KI%SH\VA1Q1QB+2X
MV7>?TEHH \+^&W[-/P/^$'Q#^*?Q6^&_@*S\+>/?C3=Z5>_$O7+35O$-TGB*
MXT1;I=,,>D:EJ][H>@Q6_P!MNF:V\-Z9I%M<2S--=132A76GJ/[+7P&U;]H3
M0?VJ;_P!!/\ 'SPQX;G\):)X_&O^*H9;/0+G3]7TJ:R;P[!KL7A&[E;3=>U:
MS74+W0+G4HX+LI'>)Y-OY7T!10 5\_\ P4_9:^ W[.VN?%#Q)\&O $'@K6OC
M/XDB\6_$J\@U_P 5:ROB/7X+K6KV&]%KXCUW6+/18HKKQ%K4L>G^'[?2M-0W
MTBK9A(X%B^@** /G_P".W[+?P&_:8/@(_'#P#!XZ/PQ\3+XQ\#^=K_BO0AHO
MB%?LV;QAX7UW1!JL$GV.U\_3-9&HZ5<>0@GLI .?H"BB@#Y[_9X_95^ 7[*/
MA_Q%X6_9_P#A[;?#S0?%GB!O%&OZ?;Z]XK\0+?:VUI!8"Z6?Q9KNO75G#':6
MT,$&GV$]KIMNBGR+2-G<MY)^T'_P3A_8N_:B\4OXZ^,WP.T37O'$\5M!>>+]
M#UOQ7X'U_58[-(8+<Z]>>"=>\/KXCGALK>'38+OQ!%J=W::=%#:6<]O%;6PA
M^WZ* /B^Q_X)X?L8:7X<^%?A/2_@+X7TK0O@OXYM_B7\/+;2M4\5Z9=:;X[M
M6LWA\3:WJMCX@M]6\;:A_P 2[3UE/CF^\207$5A90W$,L5K D?VA110 5\^_
M&/\ 98^ ?Q_\6_"KQU\7OA[:>,O%7P2UZ7Q-\,=6GUSQ1I+^&-:FOM%U*2[%
MIH&N:58:S&U_X=T6[^Q>(+75; 3:?"RVHW2^9]!44 %?/?C3]E3X ?$/XX?#
M_P#:0\9?#JRUOXU?"W2HM$\">.)=:\3VEQH>F6][K&HVUM_8VGZW:>&]4^R7
MVOZS=6<VLZ/J-Q9RZC<M;2Q;P!]"44 %?-OP+_9#_9T_9I\1_$GQ9\#OAK:>
M -<^+NH66J?$"?3_ !!XNU*RUN\TV\UF^L&M]&U[7]5T;0(+2Z\0ZS)!9^'-
M/TBRC6]>%;<0101Q?25% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?F?7Z85^9] 'U]\ /\ D3=3_P"QFO/_ $U:-7N5>&_ #_D3=3_[&:\_
M]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7YGU^F%?F?0!]?? #_D3=3_[&:\_]-6C5[E7AOP _P"1-U/_ +&:
M\_\ 35HU>Y4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5^9]?IA7YGT ?4WP0\0Z!I/A/4+;5=<T?3+A_$-W.D&H:G964
MSPMINDQK,L5S/&[1,\<B+(%*%XW4'*,![)_PFO@W_H;?#/\ X/M*_P#DNO@#
M6E6+6-6BB58XH]2OXXXXP$2-$NI51$10%5%4!550 H    K-R?4_F: /T1_X
M37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@^TK_ .2Z_.[)]3^9HR?4_F:
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M\ET?\)KX-_Z&WPS_ .#[2O\ Y+K\[LGU/YFC)]3^9H _1'_A-?!O_0V^&?\
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MO_DNOSNR?4_F:,GU/YF@#]$?^$U\&_\ 0V^&?_!]I7_R71_PFO@W_H;?#/\
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M]3^9HR?4_F: /T1_X37P;_T-OAG_ ,'VE?\ R71_PFO@W_H;?#/_ (/M*_\
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MW_H;?#/_ (/M*_\ DNOSNR?4_F:,GU/YF@#]$?\ A-?!O_0V^&?_  ?:5_\
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MG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNOSNR?4_F:,GU/YF@#]$?^$U\&_\
M0V^&?_!]I7_R71_PFO@W_H;?#/\ X/M*_P#DNOSNR?4_F:,GU/YF@#]$?^$U
M\&_]#;X9_P#!]I7_ ,ET?\)KX-_Z&WPS_P"#[2O_ )+K\[LGU/YFC)]3^9H
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M^#?^AM\,_P#@^TK_ .2Z_.[)]3^9HR?4_F: /T1_X37P;_T-OAG_ ,'VE?\
MR71_PFO@W_H;?#/_ (/M*_\ DNOSNR?4_F:,GU/YF@#]$?\ A-?!O_0V^&?_
M  ?:5_\ )='_  FO@W_H;?#/_@^TK_Y+K\[LGU/YFC)]3^9H _1'_A-?!O\
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MLGU/YFC)]3^9H _1'_A-?!O_ $-OAG_P?:5_\ET?\)KX-_Z&WPS_ .#[2O\
MY+K\[LGU/YFC)]3^9H _1'_A-?!O_0V^&?\ P?:5_P#)='_":^#?^AM\,_\
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M,_\ @^TK_P"2Z_.[)]3^9HR?4_F: /T1_P"$U\&_]#;X9_\ !]I7_P ET?\
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MOAG_ ,'VE?\ R71_PFO@W_H;?#/_ (/M*_\ DNOSNR?4_F:,GU/YF@#]$?\
MA-?!O_0V^&?_  ?:5_\ )=?GK4&3ZG\S7K/AG3["XT.RFGL;.:5_M.^6:VAD
6D;;=W"KN=T9FVJH49)PH '  H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>32
<FILENAME>inva-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-26T16:15:05.2132+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.inva.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:inva="http://www.inva.com/20241231" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" namespace="http://xbrl.sec.gov/country/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" namespace="http://fasb.org/srt-types/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2">
        <link:definition>100020 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails2" id="DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails2">
        <link:definition>100030 - Disclosure - Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails2" id="DisclosureDebtConvertibleSeniorNotesDetails2">
        <link:definition>100040 - Disclosure - Debt - Convertible Senior Notes (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails2" id="DisclosureDebtConvertibleSubordinatedNotesDetails2">
        <link:definition>100050 - Disclosure - Debt - Convertible Subordinated Notes (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails2" id="DisclosureDebtScheduleOfDebtDetails2">
        <link:definition>100060 - Disclosure - Debt - Schedule of Debt (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet3" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet3">
        <link:definition>100070 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails2" id="DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails2">
        <link:definition>100080 - Disclosure - Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails2" id="DisclosureIncomeTaxesDeferredTaxesDetails2">
        <link:definition>100090 - Disclosure - Income Taxes - Deferred Taxes (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails3" id="DisclosureDebtConvertibleSubordinatedNotesDetails3">
        <link:definition>100110 - Disclosure - Debt - Convertible Subordinated Notes (Details) 3</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome" id="StatementConsolidatedStatementsOfIncome">
        <link:definition>100120 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical" id="StatementConsolidatedStatementsOfIncomeParenthetical">
        <link:definition>100130 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" id="StatementConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>100140 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100150 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100160 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>100170 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1" id="DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1">
        <link:definition>995455 - Disclosure - Description of Operations and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1" id="DisclosureNetIncomePerShare1">
        <link:definition>995465 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1" id="DisclosureRevenueRecognition1">
        <link:definition>995475 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1" id="DisclosureLicenseAndCollaborationArrangements1">
        <link:definition>995485 - Disclosure - License and Collaboration Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3" id="DisclosureConsolidatedEntitiesAndAcquisitions3">
        <link:definition>995495 - Disclosure - Consolidated Entities and Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2">
        <link:definition>995505 - Disclosure - Equity and Long-term Investments and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1" id="DisclosureCapitalizedFeesPaid1">
        <link:definition>995515 - Disclosure - Capitalized Fees Paid</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3" id="DisclosureGoodwillAndIntangibleAssets3">
        <link:definition>995525 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1" id="DisclosureBalanceSheetComponents1">
        <link:definition>995535 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation" id="DisclosureStockbasedCompensation">
        <link:definition>995545 - Disclosure - Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1" id="DisclosureStockholdersEquity1">
        <link:definition>995555 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4" id="DisclosureDebt4">
        <link:definition>995565 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3" id="DisclosureCommitmentsAndContingencies3">
        <link:definition>995575 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3" id="DisclosureIncomeTaxes3">
        <link:definition>995585 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1" id="DisclosureSegmentReporting1">
        <link:definition>995595 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995605 - Disclosure - Description of Operations and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables" id="DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995615 - Disclosure - Description of Operations and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables" id="DisclosureNetIncomePerShareTables">
        <link:definition>995625 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables" id="DisclosureRevenueRecognitionTables">
        <link:definition>995635 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables" id="DisclosureConsolidatedEntitiesAndAcquisitionsTables">
        <link:definition>995645 - Disclosure - Consolidated Entities and Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables">
        <link:definition>995655 - Disclosure - Equity and Long-term Investments and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidTables" id="DisclosureCapitalizedFeesPaidTables">
        <link:definition>995665 - Disclosure - Capitalized Fees Paid (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" id="DisclosureGoodwillAndIntangibleAssetsTables">
        <link:definition>995675 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables" id="DisclosureBalanceSheetComponentsTables">
        <link:definition>995685 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" id="DisclosureStockbasedCompensationTables">
        <link:definition>995695 - Disclosure - Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables" id="DisclosureDebtTables">
        <link:definition>995705 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>995715 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>995725 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" id="DisclosureSegmentReportingTables">
        <link:definition>995735 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails" id="DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails">
        <link:definition>995745 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Description of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <link:definition>995755 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails" id="DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails">
        <link:definition>995765 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails" id="DisclosureNetIncomePerShareBasicAndDilutedEpsDetails">
        <link:definition>995775 - Disclosure - Net Income Per Share - Basic and Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails" id="DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails">
        <link:definition>995785 - Disclosure - Net Income Per Share - Anti-Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails" id="DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails">
        <link:definition>995795 - Disclosure - Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails" id="DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails">
        <link:definition>995805 - Disclosure - Revenue Recognition - Schedule of net product sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails" id="DisclosureRevenueRecognitionDetails">
        <link:definition>995815 - Disclosure - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails" id="DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails">
        <link:definition>995825 - Disclosure - License and Collaboration Arrangements (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3" id="DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3">
        <link:definition>995835 - Disclosure - Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails">
        <link:definition>995845 - Disclosure - Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails">
        <link:definition>995855 - Disclosure - Consolidated Entities and Acquisitions - ISP Fund LP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails">
        <link:definition>995865 - Disclosure - Consolidated Entities and Acquisitions - Summary of Individual Investments Held by ISP Fund (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails">
        <link:definition>995875 - Disclosure - Consolidated Entities and Acquisitions - Entasis Therapeutics Holdings, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>995885 - Disclosure - Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails">
        <link:definition>995895 - Disclosure - Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails" id="DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails">
        <link:definition>995905 - Disclosure - Consolidated Entities and Acquisitions - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails">
        <link:definition>995915 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails">
        <link:definition>995925 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Summarized Financial Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails">
        <link:definition>995935 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in InCarda (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails">
        <link:definition>995945 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in ImaginAb (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails">
        <link:definition>995955 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neurosciences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails">
        <link:definition>995965 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Nanolive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails">
        <link:definition>995975 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Reconciliation of Equity and Long - Term Investments Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails">
        <link:definition>995985 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2">
        <link:definition>995995 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails" id="DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>996005 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails" id="DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails">
        <link:definition>996015 - Disclosure - Capitalized Fees Paid - Schedule of Capitalized Fees Paid (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" id="DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails">
        <link:definition>996025 - Disclosure - Goodwill and Intangible Assets (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3" id="DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3">
        <link:definition>996035 - Disclosure - Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails" id="DisclosureBalanceSheetComponentsScheduleOfInventoryDetails">
        <link:definition>996045 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" id="DisclosureBalanceSheetComponentsAdditionalInformationDetails">
        <link:definition>996055 - Disclosure - Balance Sheet Components (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails" id="DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails">
        <link:definition>996065 - Disclosure - Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails" id="DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails">
        <link:definition>996075 - Disclosure - Balance Sheet Components -Schedule of Other Long-term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails" id="DisclosureStockbasedCompensation2012PlanAndEsppDetails">
        <link:definition>996085 - Disclosure - Stock-based Compensation - 2012 Plan and ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails" id="DisclosureStockbasedCompensationDirectorCompensationProgramDetails">
        <link:definition>996095 - Disclosure - Stock-based Compensation - Director Compensation Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails" id="DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails">
        <link:definition>996105 - Disclosure - Stock-based Compensation - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails" id="DisclosureStockbasedCompensationCompensationAwardsDetails">
        <link:definition>996115 - Disclosure - Stock-based Compensation - Compensation Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails" id="DisclosureStockbasedCompensationValuationAssumptionsDetails">
        <link:definition>996125 - Disclosure - Stock-based Compensation - Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>996135 - Disclosure - Stockholders' Equity (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3" id="DisclosureDebtScheduleOfDebtDetails3">
        <link:definition>996145 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4" id="DisclosureDebtConvertibleSubordinatedNotesDetails4">
        <link:definition>996155 - Disclosure - Debt - Convertible Subordinated Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3" id="DisclosureDebtConvertibleSeniorNotesDetails3">
        <link:definition>996165 - Disclosure - Debt - Convertible Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails" id="DisclosureDebtDebtMaturitiesDetails">
        <link:definition>996175 - Disclosure - Debt - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>996185 - Disclosure - Commitments and Contingencies (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails" id="DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails">
        <link:definition>996195 - Disclosure - Commitments and Contingencies - Schedule of Components of Least Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails" id="DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails">
        <link:definition>996205 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3">
        <link:definition>996215 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails" id="DisclosureIncomeTaxesIncomeTaxExpenseDetails">
        <link:definition>996225 - Disclosure - Income Taxes - Income tax expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails" id="DisclosureIncomeTaxesReconciliationDetails">
        <link:definition>996235 - Disclosure - Income Taxes - Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3" id="DisclosureIncomeTaxesDeferredTaxesDetails3">
        <link:definition>996245 - Disclosure - Income Taxes - Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>996255 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails">
        <link:definition>996265 - Disclosure - Income Taxes - Summary of Changes in Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails" id="DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails">
        <link:definition>996275 - Disclosure - Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails" id="DisclosureSegmentReportingAdditionalInformationDetails">
        <link:definition>996285 - Disclosure - Segment Reporting (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="inva-20241231.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="inva-20241231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="inva-20241231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome" xlink:href="inva-20241231.xsd#StatementConsolidatedStatementsOfIncome" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical" xlink:href="inva-20241231.xsd#StatementConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" xlink:href="inva-20241231.xsd#StatementConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="inva-20241231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="inva-20241231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="inva-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1" xlink:href="inva-20241231.xsd#DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1" xlink:href="inva-20241231.xsd#DisclosureNetIncomePerShare1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1" xlink:href="inva-20241231.xsd#DisclosureRevenueRecognition1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1" xlink:href="inva-20241231.xsd#DisclosureLicenseAndCollaborationArrangements1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitions3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1" xlink:href="inva-20241231.xsd#DisclosureCapitalizedFeesPaid1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3" xlink:href="inva-20241231.xsd#DisclosureGoodwillAndIntangibleAssets3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1" xlink:href="inva-20241231.xsd#DisclosureBalanceSheetComponents1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1" xlink:href="inva-20241231.xsd#DisclosureStockholdersEquity1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4" xlink:href="inva-20241231.xsd#DisclosureDebt4" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingencies3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxes3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1" xlink:href="inva-20241231.xsd#DisclosureSegmentReporting1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="inva-20241231.xsd#DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="inva-20241231.xsd#DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables" xlink:href="inva-20241231.xsd#DisclosureNetIncomePerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables" xlink:href="inva-20241231.xsd#DisclosureRevenueRecognitionTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidTables" xlink:href="inva-20241231.xsd#DisclosureCapitalizedFeesPaidTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" xlink:href="inva-20241231.xsd#DisclosureGoodwillAndIntangibleAssetsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables" xlink:href="inva-20241231.xsd#DisclosureBalanceSheetComponentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables" xlink:href="inva-20241231.xsd#DisclosureDebtTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:href="inva-20241231.xsd#DisclosureSegmentReportingTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails" xlink:href="inva-20241231.xsd#DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:href="inva-20241231.xsd#DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails" xlink:href="inva-20241231.xsd#DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails" xlink:href="inva-20241231.xsd#DisclosureNetIncomePerShareBasicAndDilutedEpsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails" xlink:href="inva-20241231.xsd#DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails" xlink:href="inva-20241231.xsd#DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails" xlink:href="inva-20241231.xsd#DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails" xlink:href="inva-20241231.xsd#DisclosureRevenueRecognitionDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails" xlink:href="inva-20241231.xsd#DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails" xlink:href="inva-20241231.xsd#DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3" xlink:href="inva-20241231.xsd#DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails" xlink:href="inva-20241231.xsd#DisclosureBalanceSheetComponentsScheduleOfInventoryDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails" xlink:href="inva-20241231.xsd#DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails" xlink:href="inva-20241231.xsd#DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensation2012PlanAndEsppDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensationDirectorCompensationProgramDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensationCompensationAwardsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails" xlink:href="inva-20241231.xsd#DisclosureStockbasedCompensationValuationAssumptionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3" xlink:href="inva-20241231.xsd#DisclosureDebtScheduleOfDebtDetails3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4" xlink:href="inva-20241231.xsd#DisclosureDebtConvertibleSubordinatedNotesDetails4" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3" xlink:href="inva-20241231.xsd#DisclosureDebtConvertibleSeniorNotesDetails3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails" xlink:href="inva-20241231.xsd#DisclosureDebtDebtMaturitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesIncomeTaxExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesReconciliationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesDeferredTaxesDetails3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails" xlink:href="inva-20241231.xsd#DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails" xlink:href="inva-20241231.xsd#DisclosureSegmentReportingAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2" xlink:href="inva-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails2" xlink:href="inva-20241231.xsd#DisclosureDebtConvertibleSubordinatedNotesDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails2" xlink:href="inva-20241231.xsd#DisclosureDebtScheduleOfDebtDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet3" xlink:href="inva-20241231.xsd#DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet3" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails2" xlink:href="inva-20241231.xsd#DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails2" xlink:href="inva-20241231.xsd#DisclosureIncomeTaxesDeferredTaxesDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails3" xlink:href="inva-20241231.xsd#DisclosureDebtConvertibleSubordinatedNotesDetails3" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseToConvertibleNotes" xlink:label="inva_IncreaseToConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" xlink:label="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedRoyaltyObligations" xlink:label="inva_AccruedRoyaltyObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CurrentPortionOfISPFundInvestments" xlink:label="inva_CurrentPortionOfISPFundInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="us-gaap_CapitalizedContractCostTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementNumberOfTranches" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" xlink:label="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityMethodInvestment" xlink:label="inva_EquityMethodInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerTwoMember" xlink:label="inva_CustomerTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" xlink:label="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" xlink:label="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInPreferredStock" xlink:label="inva_InvestmentsInPreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionsPolicyTextBlock" xlink:label="inva_RelatedPartyTransactionsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" xlink:label="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncomeTaxesTable" xlink:label="inva_IncomeTaxesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RiskFreeInterestRate" xlink:label="inva_RiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_JP" xlink:label="country_JP"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchaseOfEntasisNoncontrollingInterest" xlink:label="inva_PurchaseOfEntasisNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligations" xlink:label="inva_DeferredRoyaltyObligations"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfDerivativeInstrumentsPurchased" xlink:label="inva_NumberOfDerivativeInstrumentsPurchased"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ClaimExpirationDate" xlink:label="inva_ClaimExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseBorrowingsAbstract" xlink:label="us-gaap_InterestExpenseBorrowingsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetIncomeLossPerShareAbstract" xlink:label="inva_NetIncomeLossPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="us-gaap_ClassOfTreasuryStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_HealthCareRoyaltyPartnersMember" xlink:label="inva_HealthCareRoyaltyPartnersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:label="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAndWarrantsMember" xlink:label="inva_CommonStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NonCashActivity" xlink:label="inva_NonCashActivity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" xlink:label="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReductionToAdditionalPaidInCapital" xlink:label="inva_ReductionToAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1PreferredStockMember" xlink:label="inva_SeriesD1PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DescriptionOfOperationsPolicyTextBlock" xlink:label="inva_DescriptionOfOperationsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DividendYield" xlink:label="inva_DividendYield"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CashDistributionReceived" xlink:label="inva_CashDistributionReceived"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementMaximumPotentialPayoutPercent" xlink:label="inva_RoyaltyAgreementMaximumPotentialPayoutPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventDomain" xlink:label="inva_NameOfEventDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BurlingameCaliforniaMember" xlink:label="inva_BurlingameCaliforniaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AstrazenecaMember" xlink:label="inva_AstrazenecaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReclassificationOfCurrentPortion" xlink:label="inva_ReclassificationOfCurrentPortion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEstimatedVolatility" xlink:label="inva_PercentageOfEstimatedVolatility"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RightOfUseAssetsObtainedThroughAcquistions" xlink:label="inva_RightOfUseAssetsObtainedThroughAcquistions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:label="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoDirectorsMember" xlink:label="inva_TwoDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTableTextBlock" xlink:label="us-gaap_InvestmentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UpfrontFee" xlink:label="inva_UpfrontFee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostReimbursements" xlink:label="inva_CostReimbursements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" xlink:label="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:label="inva_LaboratoryEquipmentFurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EverestMedicinesLimitedMember" xlink:label="inva_EverestMedicinesLimitedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WalthamMassachusettsMember" xlink:label="inva_WalthamMassachusettsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OtherAccruedLiabilitiesMember" xlink:label="inva_OtherAccruedLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenue" xlink:label="inva_LicenseAndOtherRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PriorPeriodImmaterialCorrectionPolicyTextBlock" xlink:label="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleNoteAndWarrantsMember" xlink:label="inva_ConvertibleNoteAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" xlink:label="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommercialSupplyAgreementMember" xlink:label="inva_CommercialSupplyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RegulatoryMilestonePaymentsReceivable" xlink:label="inva_RegulatoryMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentConvertibleConversionPremium" xlink:label="inva_DebtInstrumentConvertibleConversionPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" xlink:label="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabConvertibleNoteMember" xlink:label="inva_ImaginabConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PutOptionMember" xlink:label="us-gaap_PutOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD2PreferredStockMember" xlink:label="inva_SeriesD2PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OperatingLossCarryforwardsIndefinitePeriod" xlink:label="inva_OperatingLossCarryforwardsIndefinitePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyPayments" xlink:label="inva_RoyaltyPayments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UpfrontPaymentUnderIntangibleAsset" xlink:label="inva_UpfrontPaymentUnderIntangibleAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" xlink:label="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedContractManufacturingLiability" xlink:label="inva_AccruedContractManufacturingLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersContributedCapital" xlink:label="us-gaap_LimitedPartnersContributedCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsGross" xlink:label="inva_IntangibleAssetsMarketedProductsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" xlink:label="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataConvertibleNoteMember" xlink:label="inva_ArmataConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="us-gaap_CapitalizedContractCostLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReductionToResearchAndDevelopmentExpense" xlink:label="inva_ReductionToResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" xlink:label="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInSecondQuarterOf2021Member" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfMinimumRoyaltyRate" xlink:label="inva_PercentageOfMinimumRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" xlink:label="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedInterestIncomeIncludedInLongTermInvestments" xlink:label="inva_AccruedInterestIncomeIncludedInLongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1WarrantMember" xlink:label="inva_SeriesD1WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MarketedProductsMember" xlink:label="inva_MarketedProductsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndCollaborationArrangementsDisclosureTextBlock" xlink:label="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LabaCollaborationMember" xlink:label="inva_LabaCollaborationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD2WarrantMember" xlink:label="inva_SeriesD2WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InterimSupplyAgreementMember" xlink:label="inva_InterimSupplyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:label="us-gaap_IncomeStatementRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LockUpExpirationDate" xlink:label="inva_LockUpExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityInvestmentsAndMoneyMarketFundsMember" xlink:label="inva_EquityInvestmentsAndMoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyHeldHealthcareCompaniesMember" xlink:label="inva_PrivatelyHeldHealthcareCompaniesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:label="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CreditAndSecurityAgreementMember" xlink:label="inva_CreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesLongTermContractsOrPrograms" xlink:label="us-gaap_ReceivablesLongTermContractsOrPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2022Member" xlink:label="inva_WarrantsPurchasedIn2022Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNoteMember" xlink:label="inva_ConvertiblePromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersCumulativeCashDistributions" xlink:label="us-gaap_LimitedPartnersCumulativeCashDistributions"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesA1PreferredStockMember" xlink:label="inva_SeriesA1PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisLeaseMember" xlink:label="inva_EntasisLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:label="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidPolicyTextBlock" xlink:label="inva_CapitalizedFeesPaidPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OutstandingStockWarrantMember" xlink:label="inva_OutstandingStockWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmendedZaiAgreementMember" xlink:label="inva_AmendedZaiAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CordenPharmaMember" xlink:label="inva_CordenPharmaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TransactionCostsIncurredInConnectionWithEquityInvestment" xlink:label="inva_TransactionCostsIncurredInConnectionWithEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedProfessionalServices" xlink:label="inva_AccruedProfessionalServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementNet" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetProceedsFromSaleOfVariableInterestEntityEquity" xlink:label="inva_NetProceedsFromSaleOfVariableInterestEntityEquity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DurlobactamMember" xlink:label="inva_DurlobactamMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementGross" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligationCurrent" xlink:label="inva_DeferredRoyaltyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OwnershipInterestInConsolidatedEntities" xlink:label="inva_OwnershipInterestInConsolidatedEntities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" xlink:label="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2020Member" xlink:label="inva_WarrantsPurchasedIn2020Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" xlink:label="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAccumulatedAmortization" xlink:label="us-gaap_CapitalizedContractCostAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesDWarrantsMember" xlink:label="inva_SeriesDWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ResearchAndDevelopmentSupportMember" xlink:label="inva_ResearchAndDevelopmentSupportMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreasesInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CarryingValueWroteOffWarrantExercise" xlink:label="inva_CarryingValueWroteOffWarrantExercise"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" xlink:label="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityIncentivePlansAndESPPMember" xlink:label="inva_EquityIncentivePlansAndESPPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" xlink:label="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermLoanInvestmentMember" xlink:label="inva_TermLoanInvestmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DecreaseToAccumulatedDeficit" xlink:label="inva_DecreaseToAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedLicenseFeesAndRoyalties" xlink:label="inva_AccruedLicenseFeesAndRoyalties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCWarrantsMember" xlink:label="inva_SeriesCWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RealizedLoss" xlink:label="inva_RealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfInvesteesBoardMembers" xlink:label="inva_NumberOfInvesteesBoardMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="country_GB"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfEquityInvestmentsManagedByIspFundLp" xlink:label="inva_SaleOfEquityInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanMember" xlink:label="inva_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" xlink:label="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Rule10B51ArrModifiedFlag" xlink:label="inva_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAccountsReceivableMember" xlink:label="us-gaap_TradeAccountsReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" xlink:label="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FairValueAdjustmentsOfInventoryFromAcquistion" xlink:label="inva_FairValueAdjustmentsOfInventoryFromAcquistion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAbstract" xlink:label="us-gaap_CapitalizedContractCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TrelegyElliptaMember" xlink:label="inva_TrelegyElliptaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEconomicInterestInPartnership" xlink:label="inva_PercentageOfEconomicInterestInPartnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostGross" xlink:label="us-gaap_CapitalizedContractCostGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSubordinatedDebtFairValueDisclosures" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareRepurchaseProgramExciseTax" xlink:label="us-gaap_ShareRepurchaseProgramExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OptionPricingModelBacksolveValuationMember" xlink:label="inva_OptionPricingModelBacksolveValuationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityInvestmentTransactionCostsIncurred" xlink:label="inva_EquityInvestmentTransactionCostsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PartnershipAgreementLockUpPeriod" xlink:label="inva_PartnershipAgreementLockUpPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationIndemnificationAssetsUsedForProduction" xlink:label="inva_BusinessCombinationIndemnificationAssetsUsedForProduction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSeniorDebtFairValueDisclosures" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxAssets" xlink:label="inva_IncreaseDecreaseInDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" xlink:label="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedClinicalAndResearchLiability" xlink:label="inva_AccruedClinicalAndResearchLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantCarryingValueWriteOffAmount" xlink:label="inva_WarrantCarryingValueWriteOffAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInSecondQuarterOf2020Member" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2020Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Percent2.50ConvertibleDebtMember" xlink:label="inva_Percent2.50ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtMember" xlink:label="us-gaap_DebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" xlink:label="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAllegations" xlink:label="us-gaap_LossContingencyAllegations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis" xlink:label="srt_ShareRepurchaseProgramAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2021Member" xlink:label="inva_WarrantsPurchasedIn2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermOfMilestonePaymentForNetSales" xlink:label="inva_TermOfMilestonePaymentForNetSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtAbstract" xlink:label="us-gaap_InterestExpenseDebtAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" xlink:label="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" xlink:label="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TechnologyTransferAgreementMember" xlink:label="inva_TechnologyTransferAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentValueRightsLiability" xlink:label="inva_ContingentValueRightsLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuredConvertibleCreditAgreementMember" xlink:label="inva_SecuredConvertibleCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" xlink:label="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InternalExpensesMember" xlink:label="inva_InternalExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PaionAgMember" xlink:label="inva_PaionAgMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZoliflodacinMember" xlink:label="inva_ZoliflodacinMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OwnershipInterestsAndInvestmentsCarryingValue" xlink:label="inva_OwnershipInterestsAndInvestmentsCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityIncentivePlan2012Member" xlink:label="inva_EquityIncentivePlan2012Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" xlink:label="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInThirdQuarterOf2020Member" xlink:label="inva_WarrantsAcquiredInThirdQuarterOf2020Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PreferredStockWarrantsMember" xlink:label="inva_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRepurchasePercentage" xlink:label="inva_DebtInstrumentRepurchasePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TotalPaymentsMadeForRoyaltyAgreement" xlink:label="inva_TotalPaymentsMadeForRoyaltyAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" xlink:label="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OneOfImaginabsCommonStockholderMember" xlink:label="inva_OneOfImaginabsCommonStockholderMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerThreeMember" xlink:label="inva_CustomerThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NanoliveMember" xlink:label="inva_NanoliveMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncomeTaxesLineItems" xlink:label="inva_IncomeTaxesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DenominatorAbstract" xlink:label="inva_DenominatorAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExpectedHoldingPeriod" xlink:label="inva_ExpectedHoldingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseInDeferredTaxAssets" xlink:label="inva_IncreaseInDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" xlink:label="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_VotingAgreementMaximumVotingRightsPercent" xlink:label="inva_VotingAgreementMaximumVotingRightsPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:label="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligationNonCurrent" xlink:label="inva_DeferredRoyaltyObligationNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCWarrantsAndSeriesDWarrantsMember" xlink:label="inva_SeriesCWarrantsAndSeriesDWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCovenantTerms" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInCommonStock" xlink:label="inva_InvestmentsInCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Incarda2020WarrantsMember" xlink:label="inva_Incarda2020WarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="us-gaap_DebtInstrumentRepurchaseAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="us-gaap_InterestOnConvertibleDebtNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LimitedPartnersInitialContributionSubjectToLockUp" xlink:label="inva_LimitedPartnersInitialContributionSubjectToLockUp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PresentationReclassificationPolicyTextBlock" xlink:label="inva_PresentationReclassificationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaMember" xlink:label="inva_LaJollaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRemainingBalancePaidUponMaturation" xlink:label="inva_DebtInstrumentRemainingBalancePaidUponMaturation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesInvestments" xlink:label="us-gaap_DeferredTaxLiabilitiesInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralPartnerMember" xlink:label="us-gaap_GeneralPartnerMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" xlink:label="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DemandLettersSentByStockholders" xlink:label="inva_DemandLettersSentByStockholders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PubliclyTradedHealthcareCompaniesMember" xlink:label="inva_PubliclyTradedHealthcareCompaniesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NonRule10B51ArrModifiedFlag" xlink:label="inva_NonRule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ManufacturingStageTransferAgreementMember" xlink:label="inva_ManufacturingStageTransferAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCPreferredStockAndWarrantsMember" xlink:label="inva_SeriesCPreferredStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInWarrants" xlink:label="inva_InvestmentsInWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FirstAmendmentMember" xlink:label="inva_FirstAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAcquiredAverageCostPerShare" xlink:label="inva_CommonStockAcquiredAverageCostPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" xlink:label="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain" xlink:label="srt_ShareRepurchaseProgramDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesC2PreferredStockMember" xlink:label="inva_SeriesC2PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Outstanding2028NotesMember" xlink:label="inva_Outstanding2028NotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:label="us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InCardaConvertibleNoteMember" xlink:label="inva_InCardaConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FuturePotentialMilestonePayment" xlink:label="inva_FuturePotentialMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfInventoryFairValueAdjustmentsMember" xlink:label="inva_AmortizationOfInventoryFairValueAdjustmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InterestRateOfDeferredRoyaltyObligation" xlink:label="inva_InterestRateOfDeferredRoyaltyObligation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpensePolicyTextBlock" xlink:label="us-gaap_InterestExpensePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsNet" xlink:label="inva_IntangibleAssetsMarketedProductsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenueMember" xlink:label="inva_LicenseAndOtherRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" xlink:label="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SalesMilestonePaymentsReceivable" xlink:label="inva_SalesMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="us-gaap_TreasuryStockCommonValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeniorUnsecuredConvertibleNotesMember" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyFinancingAgreementMember" xlink:label="inva_RoyaltyFinancingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCAndC2PreferredStockAndCommonStockMember" xlink:label="inva_SeriesCAndC2PreferredStockAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseRevenueRecognized" xlink:label="inva_LicenseRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyPayableOnNetSales" xlink:label="inva_PercentageOfRoyaltyPayableOnNetSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatePlacementPositionsAndConvertibleNotesMember" xlink:label="inva_PrivatePlacementPositionsAndConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PortionOfDebtInstrumentFaceAmountExercised" xlink:label="inva_PortionOfDebtInstrumentFaceAmountExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" xlink:label="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1AndD2PreferredStockAndCommonStockMember" xlink:label="inva_SeriesD1AndD2PreferredStockAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MoneyMarketFundAndCash" xlink:label="inva_MoneyMarketFundAndCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" xlink:label="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsTextBlock" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentSalesBasedMilestonePayment" xlink:label="inva_ContingentSalesBasedMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" xlink:label="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostTableTextBlock" xlink:label="us-gaap_CapitalizedContractCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GateNeuroscienceMember" xlink:label="inva_GateNeuroscienceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" xlink:label="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidWeightedAverageUsefulLife" xlink:label="inva_CapitalizedFeesPaidWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BasileaMember" xlink:label="inva_BasileaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExpirationDate" xlink:label="inva_ExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OneDirectorMember" xlink:label="inva_OneDirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataTermLoanMember" xlink:label="inva_ArmataTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetOperatingLossEstimatingDate" xlink:label="inva_NetOperatingLossEstimatingDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfMajorCustomers" xlink:label="inva_NumberOfMajorCustomers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidDisclosureTextBlock" xlink:label="inva_CapitalizedFeesPaidDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ProfitLossShares" xlink:label="inva_ProfitLossShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" xlink:label="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FederalNetOperatingLossesEstimatedUtilizationAmount" xlink:label="inva_FederalNetOperatingLossesEstimatedUtilizationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" xlink:label="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentTransactionCost" xlink:label="inva_DebtInstrumentTransactionCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="inva_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementMember" xlink:label="inva_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquisitionCosts" xlink:label="us-gaap_AcquisitionCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumeratorAbstract" xlink:label="inva_NumeratorAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RegulatoryStartingMaterialMember" xlink:label="inva_RegulatoryStartingMaterialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabMember" xlink:label="inva_ImaginabMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SummaryOfSignificantAccountingPoliciesTable" xlink:label="inva_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCommonStockIssuedDescription" xlink:label="inva_NumberOfCommonStockIssuedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeCapPrice" xlink:label="us-gaap_DerivativeCapPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeePaidEstimatedUsefulLife" xlink:label="inva_CapitalizedFeePaidEstimatedUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UnrealizedOtherGainLossOnInvestments" xlink:label="inva_UnrealizedOtherGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SulbactamDurlobactamMember" xlink:label="inva_SulbactamDurlobactamMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WithdrawalFromInvestment" xlink:label="inva_WithdrawalFromInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfTradingSecurityManagedByIspFundLp" xlink:label="inva_PurchasesOfTradingSecurityManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceMabaProgram" xlink:label="inva_StrategicAllianceMabaProgram"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock" xlink:label="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" xlink:label="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_QualifiedFinancingMember" xlink:label="inva_QualifiedFinancingMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" xlink:label="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" xlink:label="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationDeferredConsideration" xlink:label="inva_BusinessCombinationDeferredConsideration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ParatekPharmaceuticalsIncMember" xlink:label="inva_ParatekPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" xlink:label="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" xlink:label="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FactorsAffectingComparabilityPolicyTextBlock" xlink:label="inva_FactorsAffectingComparabilityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaCommonStockMember" xlink:label="inva_InnovivaCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommitmentsFor2024ToBeUtilizedIn2025Member" xlink:label="inva_CommitmentsFor2024ToBeUtilizedIn2025Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCustomers" xlink:label="inva_NumberOfCustomers"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmountOnNetProductSalesRecognized" xlink:label="inva_AmountOnNetProductSalesRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SarissaCapitalManagementLpMember" xlink:label="inva_SarissaCapitalManagementLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SoftwareAndComputerEquipmentMember" xlink:label="inva_SoftwareAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerOneMember" xlink:label="inva_CustomerOneMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StateNetOperatingLossesEstimatedUtilizationAmount" xlink:label="inva_StateNetOperatingLossesEstimatedUtilizationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:label="inva_CapitalizedFeesPaidFutureAmortizationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventAxis" xlink:label="inva_NameOfEventAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedLineItems" xlink:label="us-gaap_EarningsPerShareDilutedLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExternalServicesMember" xlink:label="inva_ExternalServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" xlink:label="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncardaMember" xlink:label="inva_IncardaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GeorgeWashingtonUniversityMember" xlink:label="inva_GeorgeWashingtonUniversityMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCapPriceMember" xlink:label="inva_PrivatelyNegotiatedCapPriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" xlink:label="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExtendedExpirationDate" xlink:label="inva_ExtendedExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaMember" xlink:label="inva_InnovivaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermOfMilestonePaymentForCommercialSale" xlink:label="inva_TermOfMilestonePaymentForCommercialSale"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" xlink:label="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MaximumAggregateRoyaltyPaymentsDue" xlink:label="inva_MaximumAggregateRoyaltyPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostReimbursementMember" xlink:label="inva_CostReimbursementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZaiLabMember" xlink:label="inva_ZaiLabMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_HarvardUniversityMember" xlink:label="inva_HarvardUniversityMember"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseToConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase to convertible notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseToConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase To Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseToConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryCurrentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Current [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The average trading price per $1,000 of Notes with respect to product of the closing common stock price and the conversion rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Average Trade Price Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Average trading price percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the royalty rate which the entity will receive under the collaboration agreement on sales which exceed the first defined level of annual global net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement, Royalty Rate Defined, Level Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty rate for sales above first level of annual global net sales (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected tax at federal statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedRoyaltyObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Obligation to pay royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedRoyaltyObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Royalty Obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedRoyaltyObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Obligations incurred through that date and payable for royalties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Combination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CurrentPortionOfISPFundInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Portion Of ISP Fund Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CurrentPortionOfISPFundInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Current portion of ISP Fund investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CurrentPortionOfISPFundInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of ISP Fund investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of tranches in which the Company agreed to purchase common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement, Number of Tranches</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of tranches</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of tranches</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Purchase Agreement Fourth Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note purchase agreement fourth amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Purchase Agreement Fourth Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument, Ratio of repurchase price to the principal amount of debt instrument to be repurchased in the event of default or a fundamental change.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Ratio of repurchase price to the principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ratio of repurchase price to the principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum contributions as a percentage of employee's eligible compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Noncash Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other non-cash items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityMethodInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity method investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityMethodInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityMethodInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity method investment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer two.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Other Observable Inputs, Level 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net investment-related income (expense) earned (incurred)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Investment Related Income Expenses Earned Inccured</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net investment related income expenses earned inccured.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Reconciliation of Equity and Long-Term Investments Balance [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of reconciliation of equity and long-term investments balance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Equity and Long-Term Investments Balances</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Strike Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strike price for the underlying number of shares (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investments in preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area of Real Estate Property</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entity, Not Primary Beneficiary</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total consideration paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total consideration paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Describes the entity's accounting policies for transactions entered with related parties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory fair value step-up adjustment included in cost of products sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Fair Value Step Up Adjustment Included In Cost Of Product Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Inventory fair value step-up adjustment included in cost of product sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross amount of In-process research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets In-process Research and Development, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development, gross carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncomeTaxesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of income taxes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncomeTaxesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Carrying Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Investments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Investments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Investments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total investments held by ISP Fund LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risk free interest rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">COMMITMENTS AND CONTINGENCIES</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stocks - Privately held healthcare companies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_JP_lbl" xlink:role="http://www.xbrl.org/2003/role/label">JAPAN</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_JP_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Japan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax (liabilities)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseOfEntasisNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of entasis noncontrolling interest.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseOfEntasisNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Of Entasis noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseOfEntasisNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of Entasis noncontrolling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Royalty Obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred royalty obligations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Royalty obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfDerivativeInstrumentsPurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of derivative instruments purchased.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfDerivativeInstrumentsPurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Derivative Instruments Purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfDerivativeInstrumentsPurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of derivative instruments purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ClaimExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claim expiration date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ClaimExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claim Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Arrangements and Non-arrangement Transactions [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseBorrowingsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Borrowings [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseBorrowingsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental Disclosure of Non-cash Investing and Financing Activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetIncomeLossPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No definition available.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetIncomeLossPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetIncomeLossPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income per share attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Treasury Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_HealthCareRoyaltyPartnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Health care royalty partners member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_HealthCareRoyaltyPartnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Royalty Partners [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_HealthCareRoyaltyPartnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">HealthCare Royalty Partners</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment for Purchase, Investment, Operating Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of equity and long-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Incremental Common Shares Attributable to Conversion of Debt Securities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dilutive effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to common stock and warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock And Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock and warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">STOCKHOLDERS' EQUITY</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NonCashActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NonCashActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NonCashActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adoption of ASU 2020-06</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash paid for the acquisition of La Jolla Pharmaceutical Company, net of cash acquired.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid for the Acquisition of La Jolla Pharmaceutical Company, Net of Cash Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash paid for the acquisition of La Jolla, net of cash acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital share based compensation requisite service period recognition shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Share based Compensation Requisite Service Period Recognition Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock - Publicly traded healthcare companies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReductionToAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reduction to additional paid in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReductionToAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reduction to Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReductionToAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction to Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D 1 preferred stock member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D 1 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D 1 Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognition of noncontrolling interestsupon sale of TRC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derecognition of Noncontrolling Interests Upon Sale of TRC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognition of noncontrolling interests upon sale of TRC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">REVENUE RECOGNITION</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DescriptionOfOperationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DescriptionOfOperationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description of Operations [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DescriptionOfOperationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of operations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Work in Process, Net of Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Work-in-process</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Total debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Dividend yield.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividend Yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketed products, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CashDistributionReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of cash distribution received.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CashDistributionReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Distribution Received</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CashDistributionReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementMaximumPotentialPayoutPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty agreement, maximum potential payout, percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementMaximumPotentialPayoutPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Agreement Maximum Potential Payout Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementMaximumPotentialPayoutPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum potential royalty payout</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NameOfEventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Name Of Event [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NameOfEventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Name Of Event [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BurlingameCaliforniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to Burlingame, California.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BurlingameCaliforniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Burlingame California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BurlingameCaliforniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Burlingame, California</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CIK</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-Sale Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Examination, Penalties and Interest Accrued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and penalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AstrazenecaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AstraZeneca</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AstrazenecaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AstraZeneca [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AstrazenecaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">AstraZeneca.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReclassificationOfCurrentPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReclassificationOfCurrentPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification of Current Portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReclassificationOfCurrentPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of current portion.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeconsolidationGainOrLossAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deconsolidation, Gain (Loss), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeconsolidationGainOrLossAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net gain on sale of TRC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeconsolidationGainOrLossAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net gain on sale of TRC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeconsolidationGainOrLossAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Gain on sale of Theravance Respiratory Company, LLC ("TRC")</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible senior notes due 2028, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Equity Securities, FV-NI, Realized Gain (Loss), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remeasurement loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Aggregate Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost on equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedInvesteesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consolidated investees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedInvesteesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Investees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedInvesteesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Investees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedInvesteesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Consolidated Investees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEstimatedVolatility_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of estimated volatility.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEstimatedVolatility_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Estimated Volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEstimatedVolatility_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RightOfUseAssetsObtainedThroughAcquistions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right of Use Assets Obtained Through Acquistions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RightOfUseAssetsObtainedThroughAcquistions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right of Use Assets Obtained Through Acquistions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RightOfUseAssetsObtainedThroughAcquistions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained through acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible notes, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule Of Balance sheet Information Related To Operating Lease Table Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Balance sheet Information Related To Operating Lease Table Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Operating Lease Information Presented In Balance Sheet</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Directors.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Two Directors</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total fair value of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income before income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Individual Investments Held by ISP Fund</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UpfrontFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UpfrontFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UpfrontFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note purchase agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Purchase Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Fair Value Disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized fees paid, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the consecutive and overlapping offering period for the offering of share-based payment awards.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement by Share Based Payment Award Consecutive and Overlapping Offering Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total duration of consecutive and overlapping offering periods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostReimbursements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost reimbursements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostReimbursements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Reimbursements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostReimbursements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost reimbursements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss from fair value changes in equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized loss from fair value changes in equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Unrealized Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrealized loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Distributions to noncontrolling interest (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minority interest decrease from distributions to noncontrolling interest holders shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minority Interest Decrease From Distributions To Noncontrolling Interest Holders Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Repurchased Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Repurchased Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Portion of debt retired, face value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, 2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaboratoryEquipmentFurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment, furniture and fixtures.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaboratoryEquipmentFurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment, Furniture And Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaboratoryEquipmentFurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory equipment furniture and fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EverestMedicinesLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Everest Medicines Limited [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EverestMedicinesLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Everest Medicines Limited [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EverestMedicinesLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Everest Medicines Limited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Purchase Agreement Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note purchase agreement amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Purchase Agreement Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WalthamMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Waltham Massachusetts Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WalthamMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Waltham Massachusetts Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OtherAccruedLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other Accrued Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OtherAccruedLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OtherAccruedLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndOtherRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License and Other Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndOtherRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License and other revenue.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndOtherRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and other revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liability issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Treasury stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Common, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic net income per share attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic net income per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Income Taxes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities inventory fair value adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Inventory Fair Value Adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory fair value adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventory fair value adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the duration of each purchase period within each consecutive and overlapping purchase period for offering of share-based payment awards.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement by Share Based Payment Award Purchase Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Duration of purchase period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for reporting prior period immaterial correction.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prior Period Immaterial Correction [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior Period Immaterial Correction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleNoteAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible note and warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleNoteAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Note and Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleNoteAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In Carda Convertible Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleNoteAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible note and warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Investee's Board members currently representing the Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of the Company's Board Members Currently Serving on the Board of Investee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of the Company's Board members currently serving on the Investee's Board.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Period Adjustment Increase Decrease in Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Measurement period adjustment increase (decrease) in liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments increase (decrease) in liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommercialSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercial supply agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommercialSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Supply Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommercialSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Supply Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrecurring basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Nonrecurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RegulatoryMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory milestone payments receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RegulatoryMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Milestone Payments Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RegulatoryMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional regulatory milestone payments receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional cash investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Long-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Initial contribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Purchases of equity and long-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accumulated amortization amount of Marketed Products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Marketed Products, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketed products, Accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentConvertibleConversionPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The percentage above the last reported sale price of the Company's common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentConvertibleConversionPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Premium</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentConvertibleConversionPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion premium (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_US_lbl" xlink:role="http://www.xbrl.org/2003/role/label">UNITED STATES</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_US_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_US_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">U.S.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of reimbursed for direct and certain indirect manufacturing costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Reimbursed For Direct And Certain Indirect Manufacturing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of reimbursed for direct and certain indirect manufacturing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RoyaltyExpense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Products and Services [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents Long-Acting Beta2 Agonist, RELVAR/BREO, which is being developed and commercialized by entering into a strategic alliance with GSK</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Acting Beta2 Agonist Relvar Breo [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RELVAR/BREO</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Inventory, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the variable interest entity, Theravance Respiratory Company, LLC ("TRC").</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Theravance Respiratory Company Llc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Theravance Respiratory Company, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of purchase periods having duration of six months each.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement by Share Based Payment Award Number of Purchase Periods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of offering periods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty obligation payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Royalties, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ImaginabConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ImaginAb Convertible Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ImaginabConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ImaginAb Convertible Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ImaginabConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ImaginAb Convertible Note.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum purchase commitments, 2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognition of noncontrolling interest upon initial consolidation of Entasis (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recognition Of Noncontrolling Interest Upon Initial ConsolidationOf Entasis, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recognition of noncontrolling interest upon initial consolidation of Entasis, Shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PutOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Put Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PutOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock prices above $38.00 per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD2PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D 2 preferred stock member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD2PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D 2 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD2PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D 2 Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OperatingLossCarryforwardsIndefinitePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards which can be carry forward indefinitely.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OperatingLossCarryforwardsIndefinitePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards, Indefinite Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OperatingLossCarryforwardsIndefinitePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards, indefinite period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total carrying value of investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UpfrontPaymentUnderIntangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment Under Intangible Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UpfrontPaymentUnderIntangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment under intangible asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UpfrontPaymentUnderIntangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment under intangible asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">All Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSAs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of capped calls in connection with convertible senior notes due 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost To Enter Into Capped Calls Sales In Connection With Convertible Senior Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost to enter into capped calls sales in connection with convertible senior notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of computation of basic and diluted net income per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued personnel-related expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedContractManufacturingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued contract manufacturing liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedContractManufacturingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Contract Manufacturing Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedContractManufacturingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued contract manufacturing expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of accrued personnel-related expenses due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Personnel- Related Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued personnel-related expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Asset, Finite-Lived [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Approach and Technique [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LimitedPartnersContributedCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Limited Partners' Contributed Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LimitedPartnersContributedCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contributed to partnership for investing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LimitedPartnersContributedCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Capital contribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross amount of Marketed products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Marketed Products, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketed products, gross carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, equipment and leasehold improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The percentage of ownership of common stock in the reporting entity owned by related parties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Common Stock Ownership Percentage By Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of common stock owned by a related party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognition of noncontrolling interests upon sale of TRC (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derecognition Of Noncontrolling Interests Upon Sale Of Trc Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognition of noncontrolling interests upon sale of trc shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument principal amount percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of anti-dilutive securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armata outstanding shares percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan facility in aggregate amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-US [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rest of the world</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Ex-U.S.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Purchase Agreement Second Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note purchase agreement second amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Purchase Agreement Second Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognition of non controlling interests upon acquisition of entasis minority interest.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derecognition Of Non Controlling Interests Upon Acquisition Of Entasis Minority Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognition of noncontrolling interests upon acquisition of Entasis noncontrolling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armata Convertible Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armata Convertible Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Armata convertible note member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Fees paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unamortized Debt Issuance Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized debt issuance cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReductionToResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reduction to Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReductionToResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reduction to Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ReductionToResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction to research and development expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share repurchase agreement with GSK</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Repurchase Agreement With Glaxo Group Limited [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to share repurchase agreement with Glaxo Group Limited.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Information related to warrants acquired in the second quarter of 2021</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Acquired In Second Quarter Of2021 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants acquired in second quarter of 2021</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, 2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss attributable to noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net loss attributable to noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss attributable to noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term portion of lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity component, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographic Concentration Risk [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographic Concentration Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Finished Goods, Net of Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of reconciliation to the consolidated net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and dividend income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest and Dividend Income, Operating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest and Dividend Income, Operating, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest and dividend income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfMinimumRoyaltyRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of minimum royalty rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfMinimumRoyaltyRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Minimum Royalty Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfMinimumRoyaltyRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of minimum royalty rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the annual global net sales amount which determines the royalty rate applied under the collaboration arrangement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement, Specified Sales Level for Determining Royalty Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual global sales level used to determine royalty rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The maximum number of additional common stock shares into which the warrants may be converted.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement, Warrants, Number of Securities Called by Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum number of additional shares into which warrants may be converted under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum number of additional shares into which warrants may be converted under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Changes to noncontrolling interest from a consolidated variable interest entity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Changes to noncontrolling interest from a consolidated variable interest entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity activity of noncontrolling interest in a consolidated variable interest entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of shares payable to the entity on settlement of derivative instruments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Shares Receivable on Settlement of Derivative Instrument</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net shares settlement payable to the entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deferred Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedInterestIncomeIncludedInLongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Interest Income Included in Long-term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedInterestIncomeIncludedInLongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued interest income included in long-term investments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedInterestIncomeIncludedInLongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest income converted to long-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D1 Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D1 Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D1 Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale of Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized gain on equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Realized gain on equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Changes in fair values of equity and long-term investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">BALANCE SHEET COMPONENTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capped call options associated with convertible senior notes due 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost, Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of capitalized fees paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: amortization of capitalized fees paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total interest and amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MarketedProductsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketed products</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MarketedProductsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketed Products [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MarketedProductsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Marketed products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Common [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Treasury Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of operating lease liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unamortized Debt discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_XeravaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">XERAVA.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_XeravaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">XERAVA [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_XeravaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">XERAVA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License and collaboration arrangements disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License and Collaboration Arrangements Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LICENSE AND COLLABORATION ARRANGEMENTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LabaCollaborationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the collaboration with GSK to develop and commercialize once-daily LABA products and combination products RELVAR.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LabaCollaborationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laba Collaboration [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LabaCollaborationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Acting Beta2 Agonist (LABA) Collaboration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative effect period of adoption adjustment member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accumulated Amortization of Recognized Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive income attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of outstanding options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD2WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D2 Warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD2WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D2 Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD2WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D2 Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of components of the income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InterimSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interim Supply Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InterimSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interim Supply Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InterimSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interim supply agreement member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Indefinite-Lived Intangible Assets, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in value of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Related Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Benchmark [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Product Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Differences between the expected U.S. federal statutory income tax to income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_WeightedAverageMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_WeightedAverageMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance or Sale of Equity, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance or Sale of Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Proceeds from sale of equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LockUpExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lock Up Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LockUpExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lock up expiration date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LockUpExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lock-up expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armata Pharmaceuticals Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armata</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityInvestmentsAndMoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to equity investments and money market funds.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityInvestmentsAndMoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Investments And Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityInvestmentsAndMoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity investments and Money market funds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity and Long-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Acquired from Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash acquired through the consolidation of Entasis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyHeldHealthcareCompaniesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Privately Held Healthcare Companies [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyHeldHealthcareCompaniesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Privately held healthcare companies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyHeldHealthcareCompaniesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Privately Held Healthcare Companies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subscription agreement one-time milestone payment on first commercial sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subscription Agreement One-time Milestone Payment on Commercial Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subscription agreement one-time milestone payment on commercial sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net product sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration, date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impact of consolidation and deconsolidation of subsidiaries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Impact of consolidation and deconsolidation of subsidiaries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit and Security Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit and Security Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Credit and security agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Liability and Equity Components of Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Released RSUs and RSAs (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash, cash equivalents and restricted cash at end of period shown in the consolidated statements of cash flows</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents and restricted cash at end of period shown in the condensed consolidated statements of cash flows</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesLongTermContractsOrPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivables, Long-Term Contracts or Programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesLongTermContractsOrPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receivable from collaboration arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Purchase Agreement Third Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note purchase agreement third amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Purchase Agreement Third Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, 2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Acquired Finite-Lived Intangible Asset, Residual Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of outstanding RSUs and PSUs/RSAs and PSAs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Goods and Services Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding depreciation and amortization of intangible assets)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cost of products sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Straight line operating lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Principal Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Periodic Payment, Principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total assets measured at estimated fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible debt investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2022Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants purchased in 2022 member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2022Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Purchased In 2022 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2022Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants purchased in 2022</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in value of deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfBoardMembersOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of the Investee's Board members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfBoardMembersOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Board Members of the Investee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfBoardMembersOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The total number of Board members of the Investee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of net revenue from collaboration arrangement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling and marketing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling and Marketing Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Selling and Marketing Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Lease Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertable promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-employee director</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GainLossOnOtherInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Changes in fair value of equity and long-term investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GainLossOnOtherInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain loss on other investments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GainLossOnOtherInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Other Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GainLossOnOtherInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in fair value of other equity and long-term investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GainLossOnOtherInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Changes in fair value, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares remaining available for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Granted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Amortization Period (Years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum purchase commitments, remainder of 2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LimitedPartnersCumulativeCashDistributions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Distribution from partnership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LimitedPartnersCumulativeCashDistributions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Limited Partners' Cumulative Cash Distributions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A1 preferred stock member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A1 preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A1 preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Entasis Lease [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entasis Lease [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entasis Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of consolidated entities and business acquisitions by acquisition.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Consolidated Entities and Business Acquisitions by Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Capitalized fees paid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Fees Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OutstandingStockWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Outstanding stock warrant member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OutstandingStockWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding Stock Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OutstandingStockWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Stock Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmendedZaiAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended Zai Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmendedZaiAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended Zai Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmendedZaiAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended Zai Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments to acquire equity securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Equity Securities, FV-NI</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax (liabilities)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net deferred tax (liabilities)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Released RSUs and RSAs (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StrategicAllianceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the strategic alliance with GSK for initiating three new full discovery programs and giving GSK option to license exclusive development and commercialization rights of products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StrategicAllianceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Strategic Alliance Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StrategicAllianceAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strategic alliance - MABA program</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in fair values of equity method investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Changes in fair values of equity method investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the capped call option entered in connection with the offering of convertible debt.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Privately Negotiated Capped Call Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Privately-negotiated capped call option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction costs to acquire equity securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Scheduled Maturities of Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to Entasis Therapeutics Holdings Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entasis Therapeutics Holdings Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entasis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entasis Therapeutics Holdings Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CordenPharmaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corden Pharma [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CordenPharmaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Corden Pharma.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CordenPharmaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corden Pharma [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets deferred royalty obligation, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Deferred Royalty Obligation, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred royalty obligation, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TransactionCostsIncurredInConnectionWithEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost on equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TransactionCostsIncurredInConnectionWithEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Costs Incurred In Connection With Equity Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TransactionCostsIncurredInConnectionWithEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Transaction costs incurred in connection with equity investment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedProfessionalServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Professional Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedProfessionalServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedProfessionalServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of stock-based compensation expense included in the consolidated statements of operations by award type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets collaboration agreement net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Collaboration Agreement Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes face value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loan amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Call Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock prices below $27.79 per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum number of additional shares into which warrants may be converted under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Warrants, Number of Warrants Issued in Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants purchased under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetProceedsFromSaleOfVariableInterestEntityEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net Proceeds from sale of variable interest entity equity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetProceedsFromSaleOfVariableInterestEntityEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Proceeds from Sale of Variable Interest Entity Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetProceedsFromSaleOfVariableInterestEntityEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of ownership interest in TRC, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognition of noncontrolling interests upon acquisition of Entasis noncontrolling interest (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derecognition Of NonControlling Interests Upon Acquisition Of Entasis Minority Interest Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognition of nonControlling interests upon acquisition of entasis minority interest shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2020-06</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2020-06 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total estimated fair value of equity instruments vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DurlobactamMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Durlobactam [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DurlobactamMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Durlobactam.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DurlobactamMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Durlobactam</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets collaboration agreement gross.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Collaboration Agreement Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, gross carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Current portion of deferred royalty obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Royalty Obligation, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of deferred royalty obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EuropeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Europe [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EuropeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Europe</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">STOCK-BASED COMPENSATION</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OwnershipInterestInConsolidatedEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership interest in consolidated entities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OwnershipInterestInConsolidatedEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Interest in Consolidated Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OwnershipInterestInConsolidatedEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership interest in LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from sale of economic interest under Equity Purchase Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from sale of economic interest under Equity Purchase Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of economic interest under Equity Purchase Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to warrants purchased in 2020.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Purchased In2020 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants purchased in 2020</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued excise tax on common stock repurchase applied against tax liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Excise Tax On Common Stock Repurchase Applied Against Tax Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued excise tax on common stock repurchase applied against tax liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesDWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesDWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesDWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain loss from fair value changes in equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Equity Securities, FV-NI, Unrealized Gain (Loss), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pro Forma Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finite-Lived Intangible Assets, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in value of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ResearchAndDevelopmentSupportMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and Development Support [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ResearchAndDevelopmentSupportMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Support [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ResearchAndDevelopmentSupportMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Support</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Noncontrolling Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Distributions to noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decreases In Deferred Tax Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decreases in deferred tax liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments increase decrease in deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Increase (decrease) in deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CarryingValueWroteOffWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Carrying value wrote off warrant exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CarryingValueWroteOffWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Carrying Value Wrote off Warrant Exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CarryingValueWroteOffWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value wrote off warrant exercise.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Taxes Paid, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The additional value of shares granted to newly appointed non-employee director on the date that such individual joins the Board.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation, Arrangement by Share Based Payment Award, Additional Equity Grant Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pro rata shares grant, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased and Retired During Period, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock repurchased and retired during period, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer before amortization of capitalized fees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Revenue from Contract with Customer, Excluding Assessed Tax, Before Amortization Of Capitalized Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Special Terms on amended and restated investor rights agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Special Term Re Designating Board Member To Board Of Investee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Special terms on re-designating board member to board of investee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityIncentivePlansAndESPPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to options, Equity Incentive Plans and Employee Stock Purchase Plans.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityIncentivePlansAndESPPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plans And E S P P [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityIncentivePlansAndESPPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity incentive plans and ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncurrent Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Noncurrent Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other Long Term Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net amount of In-process research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets In-process Research and Development, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development, net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Lease Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Information of TRC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Financial Information on Consolidated Entity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of financial Information on consolidated entity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LoansPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loans Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LoansPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loans Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total intrinsic value of options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and development - External services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchase of shares to satisfy tax withholding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term debt, net of discount and issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total long-term debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total long-term debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Other-than-Temporary Impairment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal and state research credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Federal and state research credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Granted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-Lived Intangible Assets [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermLoanInvestmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Investment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermLoanInvestmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan investment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermLoanInvestmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capped call options associated with convertible senior notes due 2028 (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt in Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital equity component of convertible debt in shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DecreaseToAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Decrease to accumulated deficit.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DecreaseToAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Decrease to Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DecreaseToAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Decrease to accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of equity award activity and related information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Summary of weighted-average assumptions used to calculate estimated value of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedLicenseFeesAndRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued license fees and royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedLicenseFeesAndRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued License Fees and Royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedLicenseFeesAndRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued license fees and royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument Principal Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Principal Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C Warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of fully vested and expected to vest non-option equity instruments outstanding that can be converted into shares under award activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at the end of the period (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income tax expense (benefit), net of federal benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Realized loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Realized Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RealizedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Realized loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition share price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise price of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfInvesteesBoardMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Investees Board Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfInvesteesBoardMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of investees board members.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfInvesteesBoardMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of investees board members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_GB_lbl" xlink:role="http://www.xbrl.org/2003/role/label">UNITED KINGDOM</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_GB_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United Kingdom</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfEquityInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of equity investments managed by ISP FUND LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfEquityInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale of equity investments managed by ISP FUND LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SaleOfEquityInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales of equity investments managed by ISP Fund LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The total number of shares to be purchased under the terms of a securities purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement, Total Number of Shares To Be Purchased Under the Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities to be purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares to be purchased under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Repurchase of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchase of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the Company's Employee Stock Purchase Plan (the "ESPP").</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Goodwill, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in value of goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Decrease in goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Old debt instrument interest rate before repurchase of notes member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Old Debt Instrument Interest Rate Before Repurchase Of Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Old Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards do not expire</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total royalty revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">License revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total net revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Comprehensive Income [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">INCOME TAXES</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net decrease in tax portions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of differences between expected U.S. federal statutory income tax to income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recognition Of Noncontrolling Interest Upon Initial Consolidation Of Entasis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recognition of noncontrolling interest upon initial consolidation of Entasis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Selling, General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rule 10b51 Arr Modified Flag.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rule 10b51 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rule 10b51Arrangement Modified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee exercised the right during the reporting period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trade Accounts Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receivables from Net Product Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty agreement increase in maximum potential payout percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Agreement Increase In Maximum Potential Payout Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in maximum potential payout percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FairValueAdjustmentsOfInventoryFromAcquistion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of net fair value adjustment of inventory resulting from the acquisition.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FairValueAdjustmentsOfInventoryFromAcquistion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Adjustments Of Inventory From Acquistion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FairValueAdjustmentsOfInventoryFromAcquistion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net fair value adjustment of inventory from acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TrelegyElliptaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to Trelegy Ellipta.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TrelegyElliptaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trelegy Ellipta [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TrelegyElliptaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">TRELEGY</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (Decrease) in Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEconomicInterestInPartnership_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Economic interest of the Partnership (in percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEconomicInterestInPartnership_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of economic interest held in Partnership.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEconomicInterestInPartnership_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Economic Interest In Partnership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone fees paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross carrying value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value portion of subordinated debt obligations which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Subordinated Debt, Fair Value Disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Sale of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Assumptions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Liabilities and Stockholders Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareRepurchaseProgramExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Repurchase Program, Excise Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareRepurchaseProgramExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized excise tax on share repurchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased and Retired During Period, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock repurchased and retired during period, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OptionPricingModelBacksolveValuationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option Pricing Model Backsolve valuation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OptionPricingModelBacksolveValuationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Pricing Model Backsolve Valuation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OptionPricingModelBacksolveValuationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Backsolve Valuation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetRentableArea_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Rentable Area</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetRentableArea_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rentable square feet</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityInvestmentTransactionCostsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Investment Transaction Costs Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityInvestmentTransactionCostsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity investment transaction costs incurred.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityInvestmentTransactionCostsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity investment transaction costs incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of equity method investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PartnershipAgreementLockUpPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The period of time in which contributors to an investment fund have waived the right of redemption, as defined in the partnership agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PartnershipAgreementLockUpPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Partnership Agreement, Lock-Up Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PartnershipAgreementLockUpPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lock-up period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum purchase commitments, 2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationIndemnificationAssetsUsedForProduction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Indemnification Assets Used For Production</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationIndemnificationAssetsUsedForProduction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination, indemnification assets used for production.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationIndemnificationAssetsUsedForProduction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination indemnification assets used for production</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity investment ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity method investment ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes converted into common stock, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value portion of long-term notes which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock. Senior debt has the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Senior Debt, Fair Value Disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (decrease) in deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) In Deferred Tax Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (Decrease) in deferred tax assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of the investee's board members which the Company has the right to designate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Rights To Designate Investee Board Members Number Of Board Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of investee's board members which may be designated by the Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total income tax expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Income tax expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income tax expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total income tax expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedClinicalAndResearchLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical and research expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedClinicalAndResearchLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical and Research Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AccruedClinicalAndResearchLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical and research liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantCarryingValueWriteOffAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant carrying value write off amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantCarryingValueWriteOffAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Carrying Value Write Off Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantCarryingValueWriteOffAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant carrying value write off amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GiaprezaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">GIAPREZA.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GiaprezaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">GIAPREZA [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GiaprezaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GIAPREZA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intangible assets pertain to product rights and developed technologies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to warrants acquired in the second quarter of 2020.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Acquired In Second Quarter Of2020 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants acquired in second quarter of 2020</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award number of annual installments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of annual installments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of annual installments that RSUs granted to newly appointed independent directors will vest.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets before valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Stock-Based Compensation Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion price (dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion price of convertible notes into common stock (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Percent2.50ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the information pertaining to 2.50% convertible senior notes due 2025.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Percent2.50ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percent2.50 Convertible Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Percent2.50ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants to be purchased under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement, Total Number of Warrants To Be Purchased Under Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The total number of warrants to be purchased under the terms of a securities purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares to be purchased under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares purchased under the securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase and sale of other investments managed by ISP FUND LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase and sale of other investments managed by ISP FUND LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase and sales of other investments managed by ISP Fund LP, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases and sales of other investments managed by ISP Fund LP, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Goodwill, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Goodwill, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Goodwill, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchases of capped call options associated with convertible senior notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchases of Capped Call Options Associated with Convertible Senior Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of capped call options associated with convertible senior notes due 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAllegations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Allegations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAllegations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Complaints filed by stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ShareRepurchaseProgramAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Repurchase Program [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Income Tax Expense (Benefit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants purchased in 2021</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Purchased In2021 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsPurchasedIn2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to warrants purchased in 2021.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gross Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermOfMilestonePaymentForNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of the milestone payment on net sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermOfMilestonePaymentForNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term of Milestone Payment for Net Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermOfMilestonePaymentForNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of milestone payment for net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of maximum royalty based on achievement of annual net product sales thresholds.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Maximum Royalty Based On Achievement Of Annual Net Product Sales Thresholds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of maximum royalty based on achievement of annual net product sales thresholds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Balance Sheets and Income Statements of VIE</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Variable Interest Entities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable To Conversion Of Debt Securities, Treasury Stock Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dilutive effect of the assumed conversion premium</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated amortization for assets expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Remaining Estimated Amortization Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated amortization for the year 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Management's Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TechnologyTransferAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Technology Transfer Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TechnologyTransferAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Technology transfer agreement member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TechnologyTransferAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Stage Transfer Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The value of shares granted annually to independent directors upon re-election the to Board.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award, Annual Equity Grant, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual grant of shares, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IspFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to ISP Fund LP, an investment managed by Sarissa Capital.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IspFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Isp Fund Lp [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IspFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ISP Fund LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentValueRightsLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent value rights liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentValueRightsLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent value rights liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentValueRightsLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent value rights liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentValueRightsLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Contingent value rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuredConvertibleCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Secured convertible credit agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuredConvertibleCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Secured Convertible Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuredConvertibleCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Secured Convertible Credit Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuredConvertibleCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">January 2023 Secured Convertible Credit Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Depreciation And Amortization 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities depreciation and amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The value of common stock price as a percentage of conversion price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Common Stock Price to Conversion Price Ratio, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock price to current conversion price ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity activity of noncontrolling interests in a consolidated variable interest entity (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Changes To Noncontrolling Interest From A Consolidated Variable Interest Entity Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Changes to noncontrolling interest from a consolidated variable interest entity shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InternalExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Internal Expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InternalExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Internal Expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InternalExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Internal expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PaionAgMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">PAION AG [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PaionAgMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">PAION AG [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PaionAgMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PAION AG</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ZoliflodacinMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Zoliflodacin [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ZoliflodacinMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Zoliflodacin.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ZoliflodacinMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Zoliflodacin</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OwnershipInterestsAndInvestmentsCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Interests and Investments Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OwnershipInterestsAndInvestmentsCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership interests and investments carrying value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OwnershipInterestsAndInvestmentsCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total carrying value of ownership interests and investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityIncentivePlan2012Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the 2012 Equity Incentive Plan as approved by shareowners.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityIncentivePlan2012Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan2012 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EquityIncentivePlan2012Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2012 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Royalty On Payments Received From Sublicensees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of royalty on payments received from sublicensees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the royalty payable as a percentage of payments received from sublicensees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Released RSUs/RSAs (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated amortization for assets expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Remaining Estimated Amortization YearThree</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated amortization for the year 2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInThirdQuarterOf2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to warrants acquired in the third quarter of 2020.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInThirdQuarterOf2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Acquired In Third Quarter Of2020 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WarrantsAcquiredInThirdQuarterOf2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants acquired in third quarter of 2020</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Warrants Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRepurchasePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Portion of debt Instrument, repurchased.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRepurchasePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Repurchase Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRepurchasePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of notes repurchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average estimated fair value of shares granted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TotalPaymentsMadeForRoyaltyAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment for royalty agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TotalPaymentsMadeForRoyaltyAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Payments Made For Royalty Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TotalPaymentsMadeForRoyaltyAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total payments made for royalty agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of increase (decrease) in estimated purchase price during measurement period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Period Adjustments, Increase Decrease In estimated Purchase Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in estimated purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OneOfImaginabsCommonStockholderMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One of ImaginAb's Common Stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OneOfImaginabsCommonStockholderMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One Of Imaginabs Common Stockholder [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OneOfImaginabsCommonStockholderMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to one of ImaginAb's common stockholders.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Gross (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total gross carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total gross carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer three.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Extinguishment of Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Extinguishment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on extinguishment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on extinguishment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Loss on extinguishment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armata March Two Thousand Twenty Four Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Armata march two thousand twenty four term loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armata March Two Thousand Twenty Four Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Armata March 2024 Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Released RSUs/RSAs (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NanoliveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nanolive [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NanoliveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nanolive [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NanoliveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nanolive</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental Disclosure of Cash Flow Information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted net income per share attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Diluted net income per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets unrealized losses on investment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Unrealized Losses On Investment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on investment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncomeTaxesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncomeTaxesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncomeTaxesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DenominatorAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No definition available.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DenominatorAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Denominator [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DenominatorAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities assumed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExpectedHoldingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expected holding period of equity method investment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExpectedHoldingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expected Holding Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExpectedHoldingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected holding period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Purchase Agreement Fifth Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note purchase agreement fifth amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Purchase Agreement Fifth Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payment of Financing and Stock Issuance Costs, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment of Financing and Stock Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Distributions to noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue from collaborative arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to collaborative arrangements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseInDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in deferred tax assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseInDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase in Deferred Tax Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseInDeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in Deferred Tax Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of economic interest in any future payments made under the agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Economic Interest on Future Payments Under Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of economic interest in any future payments made under the agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_VotingAgreementMaximumVotingRightsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of maximum voting rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_VotingAgreementMaximumVotingRightsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Voting Agreement, Maximum Voting Rights, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_VotingAgreementMaximumVotingRightsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of maximum voting rights under voting agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Conversion, Converted Instrument, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingRevenueReconcilingItemLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GOODWILL AND INTANGIBLE ASSETS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Purchase of Securities, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of trading securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligationNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long-term portion of deferred royalty obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligationNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Royalty Obligation, Non Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DeferredRoyaltyObligationNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term portion of deferred royalty obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCWarrantsAndSeriesDWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C warrants and Series D warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCWarrantsAndSeriesDWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C warrants and Series D warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCWarrantsAndSeriesDWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Warrants and Series D Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Covenant Terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, covenant terms description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income attributable to Innoviva stockholders, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments In Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investments In Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of trading securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Marketable Securities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Incarda2020WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">InCarda 2020 Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Incarda2020WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">InCarda 2020 Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Incarda2020WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incarda 2020 Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepurchaseAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Repurchase Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepurchaseAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Portion of debt retired, carrying value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncurrent Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Other Long-term Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total estimated fair value of options vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestOnConvertibleDebtNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest on Convertible Debt, Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestOnConvertibleDebtNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Add: interest expense on Notes, net of tax effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Useful Life [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of property, equipment and leasehold improvements useful lives</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LimitedPartnersInitialContributionSubjectToLockUp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Limited Partners Initial Contribution Subject to Lock Up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LimitedPartnersInitialContributionSubjectToLockUp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Limited partners initial contribution subject to lock up.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LimitedPartnersInitialContributionSubjectToLockUp_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial contribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PresentationReclassificationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Presentation reclassification.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PresentationReclassificationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Presentation Reclassification [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PresentationReclassificationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Presentation Reclassification</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">La Jolla</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">La Jolla [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">La Jolla [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">La Jolla [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Payments for acquire variable interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyEightNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty eight notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyEightNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Eight Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyEightNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRemainingBalancePaidUponMaturation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Remaining Balance Paid upon Maturation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRemainingBalancePaidUponMaturation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument remaining balance paid upon maturation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentRemainingBalancePaidUponMaturation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining balance paid upon maturation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized gain on investment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt, Excluding Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralPartnerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General Partner [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralPartnerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General Partner</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of royalty payments not entitled to receive</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of royalty payments the company is not entitled to receive.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DemandLettersSentByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of demand letters that were sent to the Company by purported stockholders.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DemandLettersSentByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Demand Letters Sent By Stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DemandLettersSentByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Demand letters sent by stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PubliclyTradedHealthcareCompaniesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Publicly Traded Healthcare Companies [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PubliclyTradedHealthcareCompaniesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Publicly traded healthcare companies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PubliclyTradedHealthcareCompaniesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Publicly Held Healthcare Companies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non Rule 10B51 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Rule 10B51 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Rule 10b51 Arrangement Modified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consolidated entities and acquisitions disclosure abstract.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities and Acquisitions Disclosure Abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of license revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cost of Revenue, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">NET INCOME PER SHARE</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt instrument maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ManufacturingStageTransferAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Stage Transfer Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ManufacturingStageTransferAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing Stage Transfer Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ManufacturingStageTransferAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Stage Transfer Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCPreferredStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to series C preferred stock and warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCPreferredStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock And Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCPreferredStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C preferred stock and warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market funds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquisition of intangible asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the royalty rate which the entity will receive under the collaboration agreement on the first defined level of annual global net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement, Royalty Rate Defined, Level One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty rate for first level of annual global net sales (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used to compute basic net income per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares used to compute basic net income per share attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments In Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InvestmentsInWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investments In Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FirstAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FirstAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">First Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FirstAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">First amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommonStockAcquiredAverageCostPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Acquired Average Cost Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommonStockAcquiredAverageCostPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Acquired Average Cost Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommonStockAcquiredAverageCostPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares repurchased average price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net increase in tax portions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment towards convertible promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Letter Agreement for Purchase of Material Used for Production Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Letter agreement for purchase of material used for production value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter agreement for purchase of material used for production value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ShareRepurchaseProgramDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Repurchase Program [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accrued interest payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesC2PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C-2 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesC2PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C-2 Preferred Stock member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesC2PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C-2 preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Outstanding2028NotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding 2028 Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Outstanding2028NotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Outstanding 2028 notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_Outstanding2028NotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding 2028 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Royalty revenue from a related party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Noncontrolling Interest, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in value of noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InCardaConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">InCarda Convertible note.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InCardaConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Carda Convertible Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InCardaConvertibleNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">InCarda Convertible Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated amortization for assets expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Remaining Estimated Amortization Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated amortization for the year 2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Quoted Price in Active Markets for Identical Assets, Level 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Unsecured Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment for repurchase of convertible subordinated notes due 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment for repurchase of debt instrument</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Payment upon maturity of debt instrument</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at the end of the period (in dollars per shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of acquired intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FuturePotentialMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Future potential milestone payment receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FuturePotentialMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Future Potential Milestone Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FuturePotentialMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future potential milestone payment receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term of options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfInventoryFairValueAdjustmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of inventory fair value adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfInventoryFairValueAdjustmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Inventory Fair Value Adjustments[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfInventoryFairValueAdjustmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of inventory fair value adjustments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InterestRateOfDeferredRoyaltyObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest rate of deferred royalty obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InterestRateOfDeferredRoyaltyObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Rate of Deferred Royalty Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InterestRateOfDeferredRoyaltyObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Rate of Deferred Royalty Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Interest Payable, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: Current portion of long-term debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Current portion of long-term debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible notes, due 2025, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Expense on Deferred Royalty Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net amount of Marketed Products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Marketed Products, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsMarketedProductsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketed products, net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Business acquisition, net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndOtherRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License And Other Revenue [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndOtherRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License and other revenue member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseAndOtherRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and other revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity and long-term investments at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value of equity securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan Twenty Twenty Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee Stock Purchase Plan Twenty Twenty Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill, impairment losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Impairment Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SalesMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales milestone payments receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SalesMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Milestone Payments Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SalesMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales milestone payments receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Common, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Treasury stock: at cost, nil and, 32,005 shares as of December 31, 2024 and 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of treasury stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Borrowing which takes priority over other debt securities and can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Senior Unsecured Convertible Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible senior notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty agreement required payment for breach of agreement payment two.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Agreement Required Payment For Breach Of Agreement Payment Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum aggregate royalty payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrealized gain</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Unrealized Gain</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain from fair value changes in equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Raw Materials, Net of Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stockholders' equity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyFinancingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty financing agreement member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyFinancingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Financing Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyFinancingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty Financing Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCAndC2PreferredStockAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C and C 2 Preferred Stock and Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCAndC2PreferredStockAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C and C 2 preferred stock and common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesCAndC2PreferredStockAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C preferred stock, Series C-2 preferred stock and common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License revenue recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LicenseRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License revenue recognized.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyPayableOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the royalty payable, as a percentage of net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyPayableOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Royalty Payable On Net Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PercentageOfRoyaltyPayableOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of royalty payable on net sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive income attributable to noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatePlacementPositionsAndConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Private Placement Positions And Convertible Notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatePlacementPositionsAndConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement Positions And Convertible Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatePlacementPositionsAndConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement Positions And Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price of Outstanding Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Innoviva Strategic Opportunities, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Innoviva Strategic Opportunities Limited Liability Corporation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to Innoviva Strategic Opportunities, LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PortionOfDebtInstrumentFaceAmountExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Portion of debt instrument face amount, exercised.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PortionOfDebtInstrumentFaceAmountExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Portion of Debt Instrument Face Amount, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PortionOfDebtInstrumentFaceAmountExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Portion of debt instrument face amount, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CONSOLIDATED ENTITIES</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development, accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets In Process Research And Development Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible sssets in process research and development accumulated amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New debt instrument interest rate after repurchase of notes member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Debt Instrument Interest Rate After Repurchase Of Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term debt maturities for years ending December 31:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SEGMENT REPORTING</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Term of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1AndD2PreferredStockAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D 1 and D 2 preferred stock and common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1AndD2PreferredStockAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D 1 And D 2 Preferred Stock And Common Stock Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SeriesD1AndD2PreferredStockAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D 1 And D 2 Preferred Stock And Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MoneyMarketFundAndCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Fund and Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MoneyMarketFundAndCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Money market fund and cash.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MoneyMarketFundAndCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market fund and cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">March Two Thousand Twenty Four Credit and Security Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">March two thousand twenty four credit and security agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">March 2024 Credit and Security Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Operating and Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consolidated entities and acquisitions text block.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities and Acquisitions [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CONSOLIDATED ENTITIES AND ACQUISITIONS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Effective Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt Instrument, Interest Rate, Effective Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentSalesBasedMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent sales based milestone payment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentSalesBasedMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Sales Based Milestone Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ContingentSalesBasedMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent sales based milestone payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss attributable to noncontrolling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income attributable to Innoviva stockholders, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term of options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Collaboration Agreement Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets collaboration agreement accumulated amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of capitalized fees and depreciation of property and equipment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Capitalized Fees and Depreciation of Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of capitalized fees and depreciation of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Capitalized Fees Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GateNeuroscienceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gate Neuroscience [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GateNeuroscienceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gate Neuroscience [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GateNeuroscienceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gate Neurosciences [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">'Total assets acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Asset Expected Amortization After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finite lived intangible asset expected amortization after year four.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated amortization for assets expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Remaining Estimated Amortization After Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated amortization after 2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock Shares Acquired Including Accrued Excise Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Treasury stock shares acquired including accrued excise tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of common stock, including accrued excise tax (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidWeightedAverageUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Capitalized fees paid weighted average useful life.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidWeightedAverageUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Weighted Average Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidWeightedAverageUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining amortization period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BasileaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basilea [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BasileaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Basilea.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BasileaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basilea</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expiration date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OneDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One Director.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OneDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One Director [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_OneDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One Director</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Value, Acquired, Cost Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchase of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of changes in unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity and long-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, FDII, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Foreign derived intangible income deduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign derived intangible income deduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armata Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armata Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Armata term loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Long-Term and Short-Term, Combined Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Supplemental Cash Flow Information Related to Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GSKMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents GSK, with whom the entity has agreements and arrangements, such as those for developing and commercializing different products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GSKMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">G S K [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GSKMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GSK</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetOperatingLossEstimatingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net Operating Loss Estimating Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetOperatingLossEstimatingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Estimating Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NetOperatingLossEstimatingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss estimating date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Repurchase Program, Authorized, Number of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized excise tax on share repurchase (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfMajorCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Major Customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfMajorCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of major customers.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfMajorCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numberof major customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible subordinated notes due 2023 (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill and Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaPharmaceuticalCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">La jolla pharmaceutical company member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaPharmaceuticalCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">La Jolla Pharmaceutical Company [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LaJollaPharmaceuticalCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">La Jolla Pharmaceutical Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure for information about capitalized fees paid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CAPITALIZED FEES PAID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-Dilutive Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ProfitLossShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ProfitLossShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ProfitLossShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Profit Loss Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">July Two Thousand Twenty Three Credit and Security Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">July two thousand twenty three credit and security agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">July 2023 Credit and Security Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FederalNetOperatingLossesEstimatedUtilizationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal net operating losses estimated utilization amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FederalNetOperatingLossesEstimatedUtilizationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal Net Operating Losses Estimated Utilization Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FederalNetOperatingLossesEstimatedUtilizationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating losses estimated utilization amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, by Balance Sheet Grouping [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business acquisitions of change in fair value of investment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisitions of Change in Fair Value of Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The value of shares granted to newly appointed non-employee director on the date that such individual joins the Board.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation, Arrangement by Share Based Payment Award, Initial Equity Grant Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One time grant of shares, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of deferred tax assets and deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentTransactionCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Transaction Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentTransactionCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument transaction cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_DebtInstrumentTransactionCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of lease liabilities included within Other accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current portion of lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Due from Related Parties, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Due from Related Parties, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Receivables from collaboration arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcquisitionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Oil and Gas, Full Cost Method, Capitalized Cost Excluded from Amortization, Acquisition Cost, Period Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcquisitionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition-related costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Process Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt Instrument, annual interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, annual interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortization of Debt Issuance Costs and Discounts, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs and Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt discount and issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of net product sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Over-Allotment Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Over-Allotment Option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumeratorAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No definition available.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumeratorAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Numerator [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumeratorAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Other Operating Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Operating Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RegulatoryStartingMaterialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory Starting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RegulatoryStartingMaterialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Starting Material [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RegulatoryStartingMaterialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory starting material.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price as a percentage of fair market value of stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Approach and Technique [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercised (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_XacduroMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">XACDURO</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_XacduroMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">XACDURO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_XacduroMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">XACDURO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ImaginabMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Imaginab [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ImaginabMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ImaginAb</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ImaginabMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to ImaginAb.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk and of Significant Suppliers and Partners</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Unamortized debt discount and issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt discount and issuance costs, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Debt discount and issuance costs, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, remainder of 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LongActingBeta2AgonistAnoroMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents Long-Acting Beta2 Agonist, ANORO, which is being developed and commercialized by entering into a strategic alliance with GSK</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LongActingBeta2AgonistAnoroMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Acting Beta2 Agonist Anoro [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_LongActingBeta2AgonistAnoroMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ANORO</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrealized Gain (Loss) on Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain (Loss) on Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrealized loss on other equity investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Changes in fair values of other equity and long-term investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Information related to various accounting policies of the entity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCommonStockIssuedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of common stock issued description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCommonStockIssuedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Common Stock Issued Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCommonStockIssuedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of common stock issued description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the royalty rate for combination products.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Annual Royalties as Percentage of Net Sales for Combination Products</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty rate for combination products (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeCapPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative, Cap Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeCapPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cap price for the underlying number of shares (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeePaidEstimatedUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Capitalized fee paid estimated useful life.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeePaidEstimatedUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fee Paid Estimated Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeePaidEstimatedUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized fees paid, estimated useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UnrealizedOtherGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Changes in fair values of equity and long-term investments, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UnrealizedOtherGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrealized other gain loss on investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UnrealizedOtherGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Other Gain Loss on Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_UnrealizedOtherGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in fair value, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Inventory, Current [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Repurchase Program, Remaining Authorized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of shares repurchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion rate for shares of common stock per $1,000 principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">EQUITY AND LONG-TERM INVESTMENTS AND FAIR VALUE MEASUREMENTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition and Collaborative Arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SulbactamDurlobactamMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sulbactam-Durlobactam [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SulbactamDurlobactamMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sulbactam-Durlobactam.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SulbactamDurlobactamMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sulbactam Durlobactam</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stockholders' Equity Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future amortization expense, 2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of unrecognized stock-based compensation cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Relationship to Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WithdrawalFromInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Withdrawal from investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WithdrawalFromInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Withdrawal From Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_WithdrawalFromInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Withdrawal From Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Allowance for Credit Loss, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Credit loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed other accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted Average Fair Value per Share of fully vested and expected to vest non-option equity instruments outstanding that can be converted into shares under award activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest Outstanding, Weighted-Average Fair Value per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at the end of the period (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of deferred tax assets and deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No definition available.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock: $0.01 par value, 200,000 shares authorized, 62,665 and 63,307 issued and outstanding as of December 31, 2024 and 2023 respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfTradingSecurityManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchases of trading security managed by Isp fund Lp.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfTradingSecurityManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchases of Trading Security Managed by Isp Fund Lp</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfTradingSecurityManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of trading security managed by ISP Fund LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StrategicAllianceMabaProgram_lbl" xlink:role="http://www.xbrl.org/2003/role/label">strategic alliance - MABA program</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StrategicAllianceMabaProgram_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">strategic alliance - MABA program</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StrategicAllianceMabaProgram_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strategic alliance - MABA program</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyThreeNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty three notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyThreeNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Three Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyThreeNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for capitalized fees paid to a related party.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid To A Related Party [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Fees Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment income, interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalties payable period after first commercial sale of product.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalties Payable Period After First Commercial Sale Of Product</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalties payable period after first commercial sale of product</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_QualifiedFinancingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Qualified Financing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_QualifiedFinancingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Qualified Financing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_QualifiedFinancingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Qualified Financing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Remaining Estimated Amortization Next Twelve Months</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated amortization for assets expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated amortization for the year 2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Subordinated Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible subordinated notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum amount the employee may contribute of employee's eligible compensation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement By Share-Based Payment Award Maximum Amount As A Contribution Of Eligible Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum value of shares an employee may purchase in a calendar year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Assets Or Liabilities Transfer Between Levels</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value Of Assets Or Liabilities Transfer Between Levels</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of assets or liabilities transfer between levels</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock Value Acquired Cost Method Including Accrued Excise Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Treasury stock value acquired cost method including accrued excise tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of common stock, including accrued excise tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationDeferredConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination deferred consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationDeferredConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Deferred Consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationDeferredConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination deferred consideration.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible subordinated notes due 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ParatekPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Paratek Pharmaceuticals, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ParatekPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Paratek Pharmaceuticals, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ParatekPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Paratek Pharmaceuticals, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchases of Equity Investments Managed by Isp Fund Lp</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchases of Equity Investments Managed by Isp Fund Lp</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of equity investments managed by ISP Fund LP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination letter agreement for purchase and used for production</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Letter Agreement For Purchase And Used For Production</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination letter agreement for purchase and used for production.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Amortized Cost and Estimated Fair Values for Available-for-Sale Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Other Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Commitments and contingencies (Note 13)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FactorsAffectingComparabilityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Factors affecting comparability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FactorsAffectingComparabilityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Factors Affecting Comparability Policy [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_FactorsAffectingComparabilityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Factors Affecting Comparability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Innoviva's Common Stock Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Innoviva Common Stock Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Innoviva's Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommitmentsFor2024ToBeUtilizedIn2025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments for 2024 to be utilized in 2025 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommitmentsFor2024ToBeUtilizedIn2025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments for 2024 to be utilized in 2025 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CommitmentsFor2024ToBeUtilizedIn2025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments for 2024 to be utilized in 2025.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used to compute diluted net income per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted-average shares used to compute diluted net income per share attributable to Innoviva stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of customers.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NumberOfCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmountOnNetProductSalesRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount on net product sales recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmountOnNetProductSalesRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount on Net Product Sales Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmountOnNetProductSalesRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount on net product sales recognized.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at the end of the period (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total undiscounted lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SarissaCapitalManagementLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for Sarissa Capital.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SarissaCapitalManagementLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sarissa Capital Management Lp [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SarissaCapitalManagementLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sarissa Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Inventories, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Inventories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments for change in value of Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SoftwareAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Software and computer equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SoftwareAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software And Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SoftwareAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software and computer equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer one.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StateNetOperatingLossesEstimatedUtilizationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">State net operating losses estimated utilization amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StateNetOperatingLossesEstimatedUtilizationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State Net Operating Losses Estimated Utilization Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_StateNetOperatingLossesEstimatedUtilizationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating losses estimated utilization amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used to compute Innoviva basic and diluted net income per share:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidFutureAmortizationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Capitalized fees paid future amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidFutureAmortizationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Future Amortization [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidFutureAmortizationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Fees paid, Future amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">DEBT</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NameOfEventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Name Of Event [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_NameOfEventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Name Of Event [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net Income Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyFiveNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty five notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyFiveNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Five Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyFiveNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Two Thousand Twenty Five Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TwoThousandTwentyFiveNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025 Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExternalServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">External Services [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExternalServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">External Services.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExternalServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">External services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenues, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Financial Information Of Variable Interest Entities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of financial information of variable interest entities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Balance Sheets and Income Statements of VIE</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase of common stock (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Shares, Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repurchase of common stock (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncardaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to InCarda.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncardaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incarda [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncardaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">InCarda</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets Abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets acquired, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed operating lease right-of-use assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right-of-Use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GeorgeWashingtonUniversityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">George Washington University.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GeorgeWashingtonUniversityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">George Washington University [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_GeorgeWashingtonUniversityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">George Washington University</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyNegotiatedCapPriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Privately Negotiated Cap Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyNegotiatedCapPriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Privately negotiated cap price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_PrivatelyNegotiatedCapPriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Privately-negotiated cap price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Discount (Premium)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Incremental Common Shares Attributable to Share-based Payment Arrangements, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dilutive effect of options and awards granted under equity incentive plan and employee stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical development and regulatory milestones amount payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Development And Regulatory Milestones Amount Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical development and regulatory milestones amount payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armata July Two Thousand Twenty Three Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Armata july two thousand twenty three term loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armata July Two Thousand Twenty Three Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Armata July 2023 Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExtendedExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Extended expiration date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExtendedExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Extended Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ExtendedExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Extended expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subscription agreement one-time milestone payment on net sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subscription Agreement One-time Milestone Payment on Net Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subscription agreement one-time milestone payment on net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Innoviva [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Innoviva [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_InnovivaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Innoviva [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermOfMilestonePaymentForCommercialSale_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of the milestone payment on first commercial sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermOfMilestonePaymentForCommercialSale_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term of Milestone Payment for Commercial Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_TermOfMilestonePaymentForCommercialSale_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of milestone payment for commercial sale.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets obtained in exchange for operating lease obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum number of shares an employee may purchase during any purchase period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Unobservable Inputs, Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair Value, Inputs, Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, Weighted average remaining lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Fees Paid Remaining Estimated Amortization Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated amortization for assets expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated amortization for the year 2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of fair value adjustments of cost of products sold.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Fair Value Adjustments of Cost of Products Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of fair value adjustments of Cost of products sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Increase (decrease) in deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in deferred tax liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deferred Tax Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period adjustments increase decrease in deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MaximumAggregateRoyaltyPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Aggregate Royalty Payments Due</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MaximumAggregateRoyaltyPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum aggregate royalty payments due.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_MaximumAggregateRoyaltyPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum aggregate royalty payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostReimbursementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost Reimbursement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostReimbursementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Reimbursement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_CostReimbursementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost reimbursement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Fair Value per Share at Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty agreement required payment for breach of agreement payment one.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Agreement Required Payment For Breach Of Agreement Payment One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Required payment for breach of agreement, payment one</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total expenses, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total liabilities measured at estimated fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities at estimated fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consolidated entities and acquisitions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities and Acquisitions [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities and Acquisitions [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ZaiLabMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Zai Lab.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ZaiLabMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Zai Lab [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_ZaiLabMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Zai Lab</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Income Taxes, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax payable, long-term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued personnel-related expenses and other accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_HarvardUniversityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Harvard University.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_HarvardUniversityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Harvard University [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="inva_HarvardUniversityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Harvard University</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncreaseToConvertibleNotes" xlink:to="inva_IncreaseToConvertibleNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryCurrentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" xlink:to="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedRoyaltyObligations" xlink:to="inva_AccruedRoyaltyObligations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CurrentPortionOfISPFundInvestments" xlink:to="inva_CurrentPortionOfISPFundInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="us-gaap_CapitalizedContractCostTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementNumberOfTranches" xlink:to="inva_SecuritiesPurchaseAgreementNumberOfTranches_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" xlink:to="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EquityMethodInvestment" xlink:to="inva_EquityMethodInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CustomerTwoMember" xlink:to="inva_CustomerTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" xlink:to="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" xlink:to="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="us-gaap_OptionIndexedToIssuersEquityStrikePrice1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InvestmentsInPreferredStock" xlink:to="inva_InvestmentsInPreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RelatedPartyTransactionsPolicyTextBlock" xlink:to="inva_RelatedPartyTransactionsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" xlink:to="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncomeTaxesTable" xlink:to="inva_IncomeTaxesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RiskFreeInterestRate" xlink:to="inva_RiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_JP" xlink:to="country_JP_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PurchaseOfEntasisNoncontrollingInterest" xlink:to="inva_PurchaseOfEntasisNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredRoyaltyObligations" xlink:to="inva_DeferredRoyaltyObligations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfDerivativeInstrumentsPurchased" xlink:to="inva_NumberOfDerivativeInstrumentsPurchased_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ClaimExpirationDate" xlink:to="inva_ClaimExpirationDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_InterestExpenseBorrowingsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NetIncomeLossPerShareAbstract" xlink:to="inva_NetIncomeLossPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_HealthCareRoyaltyPartnersMember" xlink:to="inva_HealthCareRoyaltyPartnersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:to="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CommonStockAndWarrantsMember" xlink:to="inva_CommonStockAndWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NonCashActivity" xlink:to="inva_NonCashActivity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" xlink:to="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" xlink:to="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ReductionToAdditionalPaidInCapital" xlink:to="inva_ReductionToAdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesD1PreferredStockMember" xlink:to="inva_SeriesD1PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DescriptionOfOperationsPolicyTextBlock" xlink:to="inva_DescriptionOfOperationsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DividendYield" xlink:to="inva_DividendYield_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CashDistributionReceived" xlink:to="inva_CashDistributionReceived_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltyAgreementMaximumPotentialPayoutPercent" xlink:to="inva_RoyaltyAgreementMaximumPotentialPayoutPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NameOfEventDomain" xlink:to="inva_NameOfEventDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BurlingameCaliforniaMember" xlink:to="inva_BurlingameCaliforniaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AstrazenecaMember" xlink:to="inva_AstrazenecaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ReclassificationOfCurrentPortion" xlink:to="inva_ReclassificationOfCurrentPortion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeconsolidationGainOrLossAmount" xlink:to="us-gaap_DeconsolidationGainOrLossAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConsolidatedInvesteesMember" xlink:to="inva_ConsolidatedInvesteesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfEstimatedVolatility" xlink:to="inva_PercentageOfEstimatedVolatility_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RightOfUseAssetsObtainedThroughAcquistions" xlink:to="inva_RightOfUseAssetsObtainedThroughAcquistions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:to="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TwoDirectorsMember" xlink:to="inva_TwoDirectorsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTableTextBlock" xlink:to="us-gaap_InvestmentTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_UpfrontFee" xlink:to="inva_UpfrontFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNotePurchaseAgreementMember" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNet" xlink:to="us-gaap_CapitalizedContractCostNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CostReimbursements" xlink:to="inva_CostReimbursements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" xlink:to="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="us-gaap_DebtInstrumentRepurchasedFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:to="inva_LaboratoryEquipmentFurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EverestMedicinesLimitedMember" xlink:to="inva_EverestMedicinesLimitedMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WalthamMassachusettsMember" xlink:to="inva_WalthamMassachusettsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OtherAccruedLiabilitiesMember" xlink:to="inva_OtherAccruedLiabilitiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LicenseAndOtherRevenue" xlink:to="inva_LicenseAndOtherRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" xlink:to="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock" xlink:to="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseMember" xlink:to="us-gaap_LicenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertibleNoteAndWarrantsMember" xlink:to="inva_ConvertibleNoteAndWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" xlink:to="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CommercialSupplyAgreementMember" xlink:to="inva_CommercialSupplyAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RegulatoryMilestonePaymentsReceivable" xlink:to="inva_RegulatoryMilestonePaymentsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" xlink:to="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtInstrumentConvertibleConversionPremium" xlink:to="inva_DebtInstrumentConvertibleConversionPremium_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" xlink:to="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LongActingBeta2AgonistRelvarBreoMember" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TheravanceRespiratoryCompanyLlcMember" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrent" xlink:to="us-gaap_AccruedRoyaltiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ImaginabConvertibleNoteMember" xlink:to="inva_ImaginabConvertibleNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInSecondYear" xlink:to="us-gaap_PurchaseObligationDueInSecondYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" xlink:to="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PutOptionMember" xlink:to="us-gaap_PutOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesD2PreferredStockMember" xlink:to="inva_SeriesD2PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OperatingLossCarryforwardsIndefinitePeriod" xlink:to="inva_OperatingLossCarryforwardsIndefinitePeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltyPayments" xlink:to="inva_RoyaltyPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_UpfrontPaymentUnderIntangibleAsset" xlink:to="inva_UpfrontPaymentUnderIntangibleAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" xlink:to="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedContractManufacturingLiability" xlink:to="inva_AccruedContractManufacturingLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LimitedPartnersContributedCapital" xlink:to="us-gaap_LimitedPartnersContributedCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsMarketedProductsGross" xlink:to="inva_IntangibleAssetsMarketedProductsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" xlink:to="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonUsMember" xlink:to="us-gaap_NonUsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" xlink:to="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ArmataConvertibleNoteMember" xlink:to="inva_ArmataConvertibleNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ReductionToResearchAndDevelopmentExpense" xlink:to="inva_ReductionToResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" xlink:to="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantsAcquiredInSecondQuarterOf2021Member" xlink:to="inva_WarrantsAcquiredInSecondQuarterOf2021Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicConcentrationRiskMember" xlink:to="us-gaap_GeographicConcentrationRiskMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDividendIncomeOperating" xlink:to="us-gaap_InterestAndDividendIncomeOperating_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfMinimumRoyaltyRate" xlink:to="inva_PercentageOfMinimumRoyaltyRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" xlink:to="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" xlink:to="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" xlink:to="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" xlink:to="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedInterestIncomeIncludedInLongTermInvestments" xlink:to="inva_AccruedInterestIncomeIncludedInLongTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesD1WarrantMember" xlink:to="inva_SeriesD1WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAmortization" xlink:to="us-gaap_CapitalizedContractCostAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MarketedProductsMember" xlink:to="inva_MarketedProductsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_XeravaMember" xlink:to="inva_XeravaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock" xlink:to="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LabaCollaborationMember" xlink:to="inva_LabaCollaborationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesD2WarrantMember" xlink:to="inva_SeriesD2WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InterimSupplyAgreementMember" xlink:to="inva_InterimSupplyAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_IncomeStatementRelatedDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LockUpExpirationDate" xlink:to="inva_LockUpExpirationDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ArmataPharmaceuticalsIncMember" xlink:to="inva_ArmataPharmaceuticalsIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EquityInvestmentsAndMoneyMarketFundsMember" xlink:to="inva_EquityInvestmentsAndMoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PrivatelyHeldHealthcareCompaniesMember" xlink:to="inva_PrivatelyHeldHealthcareCompaniesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" xlink:to="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CreditAndSecurityAgreementMember" xlink:to="inva_CreditAndSecurityAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesLongTermContractsOrPrograms" xlink:to="us-gaap_ReceivablesLongTermContractsOrPrograms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesDPreferredStockMember" xlink:to="us-gaap_SeriesDPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantsPurchasedIn2022Member" xlink:to="inva_WarrantsPurchasedIn2022Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfBoardMembersOfInvestee" xlink:to="inva_NumberOfBoardMembersOfInvestee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNoteMember" xlink:to="inva_ConvertiblePromissoryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_GainLossOnOtherInvestments" xlink:to="inva_GainLossOnOtherInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LimitedPartnersCumulativeCashDistributions" xlink:to="us-gaap_LimitedPartnersCumulativeCashDistributions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesA1PreferredStockMember" xlink:to="inva_SeriesA1PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EntasisLeaseMember" xlink:to="inva_EntasisLeaseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:to="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidPolicyTextBlock" xlink:to="inva_CapitalizedFeesPaidPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OutstandingStockWarrantMember" xlink:to="inva_OutstandingStockWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AmendedZaiAgreementMember" xlink:to="inva_AmendedZaiAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:to="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_StrategicAllianceAgreementMember" xlink:to="inva_StrategicAllianceAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:to="inva_PrivatelyNegotiatedCappedCallOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EntasisTherapeuticsHoldingsIncMember" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CordenPharmaMember" xlink:to="inva_CordenPharmaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" xlink:to="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TransactionCostsIncurredInConnectionWithEquityInvestment" xlink:to="inva_TransactionCostsIncurredInConnectionWithEquityInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedProfessionalServices" xlink:to="inva_AccruedProfessionalServices_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsCollaborationAgreementNet" xlink:to="inva_IntangibleAssetsCollaborationAgreementNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CallOptionMember" xlink:to="us-gaap_CallOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NetProceedsFromSaleOfVariableInterestEntityEquity" xlink:to="inva_NetProceedsFromSaleOfVariableInterestEntityEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202006Member" xlink:to="us-gaap_AccountingStandardsUpdate202006Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DurlobactamMember" xlink:to="inva_DurlobactamMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsCollaborationAgreementGross" xlink:to="inva_IntangibleAssetsCollaborationAgreementGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredRoyaltyObligationCurrent" xlink:to="inva_DeferredRoyaltyObligationCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OwnershipInterestInConsolidatedEntities" xlink:to="inva_OwnershipInterestInConsolidatedEntities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" xlink:to="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantsPurchasedIn2020Member" xlink:to="inva_WarrantsPurchasedIn2020Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" xlink:to="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAccumulatedAmortization" xlink:to="us-gaap_CapitalizedContractCostAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesDWarrantsMember" xlink:to="inva_SeriesDWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ResearchAndDevelopmentSupportMember" xlink:to="inva_ResearchAndDevelopmentSupportMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncreaseDecreasesInDeferredTaxLiabilities" xlink:to="inva_IncreaseDecreasesInDeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CarryingValueWroteOffWarrantExercise" xlink:to="inva_CarryingValueWroteOffWarrantExercise_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" xlink:to="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" xlink:to="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EquityIncentivePlansAndESPPMember" xlink:to="inva_EquityIncentivePlansAndESPPMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" xlink:to="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="us-gaap_LoansPayableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TermLoanInvestmentMember" xlink:to="inva_TermLoanInvestmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" xlink:to="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DecreaseToAccumulatedDeficit" xlink:to="inva_DecreaseToAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedLicenseFeesAndRoyalties" xlink:to="inva_AccruedLicenseFeesAndRoyalties_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtInstrumentPrincipalAmount" xlink:to="inva_DebtInstrumentPrincipalAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesCWarrantsMember" xlink:to="inva_SeriesCWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RealizedLoss" xlink:to="inva_RealizedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfInvesteesBoardMembers" xlink:to="inva_NumberOfInvesteesBoardMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SaleOfEquityInvestmentsManagedByIspFundLp" xlink:to="inva_SaleOfEquityInvestmentsManagedByIspFundLp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EmployeeStockPurchasePlanMember" xlink:to="inva_EmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" xlink:to="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" xlink:to="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_Rule10B51ArrModifiedFlag" xlink:to="inva_Rule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAccountsReceivableMember" xlink:to="us-gaap_TradeAccountsReceivableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" xlink:to="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FairValueAdjustmentsOfInventoryFromAcquistion" xlink:to="inva_FairValueAdjustmentsOfInventoryFromAcquistion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAbstract" xlink:to="us-gaap_CapitalizedContractCostAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TrelegyElliptaMember" xlink:to="inva_TrelegyElliptaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfEconomicInterestInPartnership" xlink:to="inva_PercentageOfEconomicInterestInPartnership_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostGross" xlink:to="us-gaap_CapitalizedContractCostGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertibleSubordinatedDebtFairValueDisclosures" xlink:to="inva_ConvertibleSubordinatedDebtFairValueDisclosures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareRepurchaseProgramExciseTax" xlink:to="us-gaap_ShareRepurchaseProgramExciseTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OptionPricingModelBacksolveValuationMember" xlink:to="inva_OptionPricingModelBacksolveValuationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetRentableArea" xlink:to="us-gaap_NetRentableArea_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EquityInvestmentTransactionCostsIncurred" xlink:to="inva_EquityInvestmentTransactionCostsIncurred_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PartnershipAgreementLockUpPeriod" xlink:to="inva_PartnershipAgreementLockUpPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInThirdYear" xlink:to="us-gaap_PurchaseObligationDueInThirdYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessCombinationIndemnificationAssetsUsedForProduction" xlink:to="inva_BusinessCombinationIndemnificationAssetsUsedForProduction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertibleSeniorDebtFairValueDisclosures" xlink:to="inva_ConvertibleSeniorDebtFairValueDisclosures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncreaseDecreaseInDeferredTaxAssets" xlink:to="inva_IncreaseDecreaseInDeferredTaxAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" xlink:to="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AccruedClinicalAndResearchLiability" xlink:to="inva_AccruedClinicalAndResearchLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantCarryingValueWriteOffAmount" xlink:to="inva_WarrantCarryingValueWriteOffAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_GiaprezaMember" xlink:to="inva_GiaprezaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantsAcquiredInSecondQuarterOf2020Member" xlink:to="inva_WarrantsAcquiredInSecondQuarterOf2020Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_Percent2.50ConvertibleDebtMember" xlink:to="inva_Percent2.50ConvertibleDebtMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" xlink:to="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtMember" xlink:to="us-gaap_DebtMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" xlink:to="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAllegations" xlink:to="us-gaap_LossContingencyAllegations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantsPurchasedIn2021Member" xlink:to="inva_WarrantsPurchasedIn2021Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TermOfMilestonePaymentForNetSales" xlink:to="inva_TermOfMilestonePaymentForNetSales_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_InterestExpenseDebtAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" xlink:to="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" xlink:to="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TechnologyTransferAgreementMember" xlink:to="inva_TechnologyTransferAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementMember" xlink:to="us-gaap_CollaborativeArrangementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IspFundLpMember" xlink:to="inva_IspFundLpMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ContingentValueRightsLiability" xlink:to="inva_ContingentValueRightsLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuredConvertibleCreditAgreementMember" xlink:to="inva_SecuredConvertibleCreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" xlink:to="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" xlink:to="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" xlink:to="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InternalExpensesMember" xlink:to="inva_InternalExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PaionAgMember" xlink:to="inva_PaionAgMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ZoliflodacinMember" xlink:to="inva_ZoliflodacinMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OwnershipInterestsAndInvestmentsCarryingValue" xlink:to="inva_OwnershipInterestsAndInvestmentsCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EquityIncentivePlan2012Member" xlink:to="inva_EquityIncentivePlan2012Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" xlink:to="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WarrantsAcquiredInThirdQuarterOf2020Member" xlink:to="inva_WarrantsAcquiredInThirdQuarterOf2020Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PreferredStockWarrantsMember" xlink:to="inva_PreferredStockWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtInstrumentRepurchasePercentage" xlink:to="inva_DebtInstrumentRepurchasePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TotalPaymentsMadeForRoyaltyAgreement" xlink:to="inva_TotalPaymentsMadeForRoyaltyAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" xlink:to="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OneOfImaginabsCommonStockholderMember" xlink:to="inva_OneOfImaginabsCommonStockholderMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CustomerThreeMember" xlink:to="inva_CustomerThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" xlink:to="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NanoliveMember" xlink:to="inva_NanoliveMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" xlink:to="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_IncomeTaxesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DenominatorAbstract" xlink:to="inva_DenominatorAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ExpectedHoldingPeriod" xlink:to="inva_ExpectedHoldingPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CollaborativeArrangementsMember" xlink:to="inva_CollaborativeArrangementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncreaseInDeferredTaxAssets" xlink:to="inva_IncreaseInDeferredTaxAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" xlink:to="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_VotingAgreementMaximumVotingRightsPercent" xlink:to="inva_VotingAgreementMaximumVotingRightsPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_SegmentReportingRevenueReconcilingItemLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:to="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DeferredRoyaltyObligationNonCurrent" xlink:to="inva_DeferredRoyaltyObligationNonCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesCWarrantsAndSeriesDWarrantsMember" xlink:to="inva_SeriesCWarrantsAndSeriesDWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCovenantTerms" xlink:to="us-gaap_LineOfCreditFacilityCovenantTerms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InvestmentsInCommonStock" xlink:to="inva_InvestmentsInCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_Incarda2020WarrantsMember" xlink:to="inva_Incarda2020WarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="us-gaap_DebtInstrumentRepurchaseAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="us-gaap_InterestOnConvertibleDebtNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LimitedPartnersInitialContributionSubjectToLockUp" xlink:to="inva_LimitedPartnersInitialContributionSubjectToLockUp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PresentationReclassificationPolicyTextBlock" xlink:to="inva_PresentationReclassificationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LaJollaMember" xlink:to="inva_LaJollaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementAmount" xlink:to="inva_SecuritiesPurchaseAgreementAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TwoThousandTwentyEightNotesMember" xlink:to="inva_TwoThousandTwentyEightNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtInstrumentRemainingBalancePaidUponMaturation" xlink:to="inva_DebtInstrumentRemainingBalancePaidUponMaturation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="us-gaap_DeferredTaxLiabilitiesInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralPartnerMember" xlink:to="us-gaap_GeneralPartnerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" xlink:to="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DemandLettersSentByStockholders" xlink:to="inva_DemandLettersSentByStockholders_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PubliclyTradedHealthcareCompaniesMember" xlink:to="inva_PubliclyTradedHealthcareCompaniesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NonRule10B51ArrModifiedFlag" xlink:to="inva_NonRule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" xlink:to="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ManufacturingStageTransferAgreementMember" xlink:to="inva_ManufacturingStageTransferAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesCPreferredStockAndWarrantsMember" xlink:to="inva_SeriesCPreferredStockAndWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InvestmentsInWarrants" xlink:to="inva_InvestmentsInWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FirstAmendmentMember" xlink:to="inva_FirstAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CommonStockAcquiredAverageCostPerShare" xlink:to="inva_CommonStockAcquiredAverageCostPerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" xlink:to="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ShareRepurchaseProgramDomain" xlink:to="srt_ShareRepurchaseProgramDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesC2PreferredStockMember" xlink:to="inva_SeriesC2PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_Outstanding2028NotesMember" xlink:to="inva_Outstanding2028NotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyMember" xlink:to="us-gaap_RoyaltyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="us-gaap_MinorityInterestPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InCardaConvertibleNoteMember" xlink:to="inva_InCardaConvertibleNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfUnsecuredDebt" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FuturePotentialMilestonePayment" xlink:to="inva_FuturePotentialMilestonePayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AmortizationOfInventoryFairValueAdjustmentsMember" xlink:to="inva_AmortizationOfInventoryFairValueAdjustmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InterestRateOfDeferredRoyaltyObligation" xlink:to="inva_InterestRateOfDeferredRoyaltyObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtCurrent" xlink:to="us-gaap_DebtCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpensePolicyTextBlock" xlink:to="us-gaap_InterestExpensePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsMarketedProductsNet" xlink:to="inva_IntangibleAssetsMarketedProductsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LicenseAndOtherRevenueMember" xlink:to="inva_LicenseAndOtherRevenueMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNi" xlink:to="us-gaap_EquitySecuritiesFvNi_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" xlink:to="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SalesMilestonePaymentsReceivable" xlink:to="inva_SalesMilestonePaymentsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonValue" xlink:to="us-gaap_TreasuryStockCommonValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeniorUnsecuredConvertibleNotesMember" xlink:to="inva_SeniorUnsecuredConvertibleNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" xlink:to="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltyFinancingAgreementMember" xlink:to="inva_RoyaltyFinancingAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesCAndC2PreferredStockAndCommonStockMember" xlink:to="inva_SeriesCAndC2PreferredStockAndCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LicenseRevenueRecognized" xlink:to="inva_LicenseRevenueRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PercentageOfRoyaltyPayableOnNetSales" xlink:to="inva_PercentageOfRoyaltyPayableOnNetSales_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PrivatePlacementPositionsAndConvertibleNotesMember" xlink:to="inva_PrivatePlacementPositionsAndConvertibleNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" xlink:to="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PortionOfDebtInstrumentFaceAmountExercised" xlink:to="inva_PortionOfDebtInstrumentFaceAmountExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_VariableInterestEntityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" xlink:to="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SeriesD1AndD2PreferredStockAndCommonStockMember" xlink:to="inva_SeriesD1AndD2PreferredStockAndCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MoneyMarketFundAndCash" xlink:to="inva_MoneyMarketFundAndCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" xlink:to="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock" xlink:to="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ContingentSalesBasedMilestonePayment" xlink:to="inva_ContingentSalesBasedMilestonePayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" xlink:to="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" xlink:to="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostTableTextBlock" xlink:to="us-gaap_CapitalizedContractCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_GateNeuroscienceMember" xlink:to="inva_GateNeuroscienceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" xlink:to="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidWeightedAverageUsefulLife" xlink:to="inva_CapitalizedFeesPaidWeightedAverageUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BasileaMember" xlink:to="inva_BasileaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ExpirationDate" xlink:to="inva_ExpirationDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_OneDirectorMember" xlink:to="inva_OneDirectorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestments" xlink:to="us-gaap_LongTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ArmataTermLoanMember" xlink:to="inva_ArmataTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_GSKMember" xlink:to="inva_GSKMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NetOperatingLossEstimatingDate" xlink:to="inva_NetOperatingLossEstimatingDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfMajorCustomers" xlink:to="inva_NumberOfMajorCustomers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LaJollaPharmaceuticalCompanyMember" xlink:to="inva_LaJollaPharmaceuticalCompanyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidDisclosureTextBlock" xlink:to="inva_CapitalizedFeesPaidDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ProfitLossShares" xlink:to="inva_ProfitLossShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" xlink:to="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FederalNetOperatingLossesEstimatedUtilizationAmount" xlink:to="inva_FederalNetOperatingLossesEstimatedUtilizationAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" xlink:to="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_DebtInstrumentTransactionCost" xlink:to="inva_DebtInstrumentTransactionCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SecuritiesPurchaseAgreementMember" xlink:to="inva_SecuritiesPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquisitionCosts" xlink:to="us-gaap_AcquisitionCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumeratorAbstract" xlink:to="inva_NumeratorAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RegulatoryStartingMaterialMember" xlink:to="inva_RegulatoryStartingMaterialMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_XacduroMember" xlink:to="inva_XacduroMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ImaginabMember" xlink:to="inva_ImaginabMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_LongActingBeta2AgonistAnoroMember" xlink:to="inva_LongActingBeta2AgonistAnoroMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="inva_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfCommonStockIssuedDescription" xlink:to="inva_NumberOfCommonStockIssuedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" xlink:to="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeCapPrice" xlink:to="us-gaap_DerivativeCapPrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeePaidEstimatedUsefulLife" xlink:to="inva_CapitalizedFeePaidEstimatedUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_UnrealizedOtherGainLossOnInvestments" xlink:to="inva_UnrealizedOtherGainLossOnInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SulbactamDurlobactamMember" xlink:to="inva_SulbactamDurlobactamMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_WithdrawalFromInvestment" xlink:to="inva_WithdrawalFromInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="inva_ConsolidatedEntitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PurchasesOfTradingSecurityManagedByIspFundLp" xlink:to="inva_PurchasesOfTradingSecurityManagedByIspFundLp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_StrategicAllianceMabaProgram" xlink:to="inva_StrategicAllianceMabaProgram_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TwoThousandTwentyThreeNotesMember" xlink:to="inva_TwoThousandTwentyThreeNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock" xlink:to="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" xlink:to="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_QualifiedFinancingMember" xlink:to="inva_QualifiedFinancingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtMember" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" xlink:to="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" xlink:to="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessCombinationDeferredConsideration" xlink:to="inva_BusinessCombinationDeferredConsideration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ParatekPharmaceuticalsIncMember" xlink:to="inva_ParatekPharmaceuticalsIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" xlink:to="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" xlink:to="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_FactorsAffectingComparabilityPolicyTextBlock" xlink:to="inva_FactorsAffectingComparabilityPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InnovivaCommonStockMember" xlink:to="inva_InnovivaCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CommitmentsFor2024ToBeUtilizedIn2025Member" xlink:to="inva_CommitmentsFor2024ToBeUtilizedIn2025Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NumberOfCustomers" xlink:to="inva_NumberOfCustomers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AmountOnNetProductSalesRecognized" xlink:to="inva_AmountOnNetProductSalesRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SarissaCapitalManagementLpMember" xlink:to="inva_SarissaCapitalManagementLpMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SoftwareAndComputerEquipmentMember" xlink:to="inva_SoftwareAndComputerEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CustomerOneMember" xlink:to="inva_CustomerOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_StateNetOperatingLossesEstimatedUtilizationAmount" xlink:to="inva_StateNetOperatingLossesEstimatedUtilizationAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidFutureAmortizationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_NameOfEventAxis" xlink:to="inva_NameOfEventAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_EarningsPerShareDilutedLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TwoThousandTwentyFiveNotesMember" xlink:to="inva_TwoThousandTwentyFiveNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ExternalServicesMember" xlink:to="inva_ExternalServicesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" xlink:to="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncardaMember" xlink:to="inva_IncardaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_GeorgeWashingtonUniversityMember" xlink:to="inva_GeorgeWashingtonUniversityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_PrivatelyNegotiatedCapPriceMember" xlink:to="inva_PrivatelyNegotiatedCapPriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" xlink:to="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" xlink:to="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ExtendedExpirationDate" xlink:to="inva_ExtendedExpirationDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" xlink:to="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_InnovivaMember" xlink:to="inva_InnovivaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_TermOfMilestonePaymentForCommercialSale" xlink:to="inva_TermOfMilestonePaymentForCommercialSale_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" xlink:to="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_IncreaseDecreaseInDeferredTaxLiabilities" xlink:to="inva_IncreaseDecreaseInDeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_MaximumAggregateRoyaltyPaymentsDue" xlink:to="inva_MaximumAggregateRoyaltyPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_CostReimbursementMember" xlink:to="inva_CostReimbursementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" xlink:to="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="inva_ConsolidatedEntitiesAndAcquisitionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_ZaiLabMember" xlink:to="inva_ZaiLabMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="inva_HarvardUniversityMember" xlink:to="inva_HarvardUniversityMember_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorOpinionTextBlock" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesLongTermContractsOrPrograms" xlink:label="us-gaap_ReceivablesLongTermContractsOrPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="us-gaap_TreasuryStockCommonValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityMethodInvestment" xlink:label="inva_EquityMethodInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CurrentPortionOfISPFundInvestments" xlink:label="inva_CurrentPortionOfISPFundInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesLongTermContractsOrPrograms" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_TreasuryStockCommonValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="inva_EquityMethodInvestment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_LongTermInvestments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DebtCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CapitalizedContractCostNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="inva_CurrentPortionOfISPFundInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Goodwill" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TreasuryStockCommonShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenueMember" xlink:label="inva_LicenseAndOtherRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CollaborativeArrangementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LicenseAndOtherRevenueMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="inva_GainLossOnOtherInvestments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_InterestAndDividendIncomeOperating" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_InterestExpense" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" xlink:label="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" xlink:label="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" xlink:label="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" xlink:label="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" xlink:label="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareRepurchaseProgramExciseTax" xlink:label="us-gaap_ShareRepurchaseProgramExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ProfitLossShares" xlink:label="inva_ProfitLossShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_33"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockCommonMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TreasuryStockSharesAcquired" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_ShareRepurchaseProgramExciseTax" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_ProfitLoss" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_ProfitLossShares" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesOutstanding_33" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedInterestIncomeIncludedInLongTermInvestments" xlink:label="inva_AccruedInterestIncomeIncludedInLongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NonCashActivity" xlink:label="inva_NonCashActivity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" xlink:label="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchaseOfEntasisNoncontrollingInterest" xlink:label="inva_PurchaseOfEntasisNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" xlink:label="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" xlink:label="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfTradingSecurityManagedByIspFundLp" xlink:label="inva_PurchasesOfTradingSecurityManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfEquityInvestmentsManagedByIspFundLp" xlink:label="inva_SaleOfEquityInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" xlink:label="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UnrealizedOtherGainLossOnInvestments" xlink:label="inva_UnrealizedOtherGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetProceedsFromSaleOfVariableInterestEntityEquity" xlink:label="inva_NetProceedsFromSaleOfVariableInterestEntityEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" xlink:label="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="inva_AccruedInterestIncomeIncludedInLongTermInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsToMinorityShareholders" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="inva_NonCashActivity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="inva_PurchaseOfEntasisNoncontrollingInterest" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="inva_PurchasesOfTradingSecurityManagedByIspFundLp" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="inva_SaleOfEquityInvestmentsManagedByIspFundLp" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="inva_UnrealizedOtherGainLossOnInvestments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="inva_NetProceedsFromSaleOfVariableInterestEntityEquity" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Rule10B51ArrModifiedFlag" xlink:label="inva_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NonRule10B51ArrModifiedFlag" xlink:label="inva_NonRule10B51ArrModifiedFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="inva_Rule10B51ArrModifiedFlag" order="14.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="inva_NonRule10B51ArrModifiedFlag" order="15.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndCollaborationArrangementsDisclosureTextBlock" xlink:label="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsTextBlock" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAbstract" xlink:label="us-gaap_CapitalizedContractCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidDisclosureTextBlock" xlink:label="inva_CapitalizedFeesPaidDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostAbstract" xlink:to="inva_CapitalizedFeesPaidDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DescriptionOfOperationsPolicyTextBlock" xlink:label="inva_DescriptionOfOperationsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PriorPeriodImmaterialCorrectionPolicyTextBlock" xlink:label="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PresentationReclassificationPolicyTextBlock" xlink:label="inva_PresentationReclassificationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FactorsAffectingComparabilityPolicyTextBlock" xlink:label="inva_FactorsAffectingComparabilityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock" xlink:label="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidPolicyTextBlock" xlink:label="inva_CapitalizedFeesPaidPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpensePolicyTextBlock" xlink:label="us-gaap_InterestExpensePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionsPolicyTextBlock" xlink:label="inva_RelatedPartyTransactionsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_DescriptionOfOperationsPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_PresentationReclassificationPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_FactorsAffectingComparabilityPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_UseOfEstimates" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessCombinationsPolicy" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_EquityMethodInvestmentsPolicy" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_CapitalizedFeesPaidPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_InterestExpensePolicyTextBlock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_RelatedPartyTransactionsPolicyTextBlock" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:label="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" xlink:label="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTableTextBlock" xlink:label="us-gaap_InvestmentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" xlink:to="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_IspFundLpMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:to="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_InvestmentTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" xlink:label="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" xlink:label="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_ArmataPharmaceuticalsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAbstract" xlink:label="us-gaap_CapitalizedContractCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostTableTextBlock" xlink:label="us-gaap_CapitalizedContractCostTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostAbstract" xlink:to="us-gaap_CapitalizedContractCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Percent2.50ConvertibleDebtMember" xlink:label="inva_Percent2.50ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_Percent2.50ConvertibleDebtMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:label="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LabaCollaborationMember" xlink:label="inva_LabaCollaborationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerOneMember" xlink:label="inva_CustomerOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaMember" xlink:label="inva_LaJollaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SummaryOfSignificantAccountingPoliciesTable" xlink:label="inva_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="inva_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerTwoMember" xlink:label="inva_CustomerTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SarissaCapitalManagementLpMember" xlink:label="inva_SarissaCapitalManagementLpMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAccountsReceivableMember" xlink:label="us-gaap_TradeAccountsReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerThreeMember" xlink:label="inva_CustomerThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCustomers" xlink:label="inva_NumberOfCustomers"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfMajorCustomers" xlink:label="inva_NumberOfMajorCustomers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeePaidEstimatedUsefulLife" xlink:label="inva_CapitalizedFeePaidEstimatedUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DecreaseToAccumulatedDeficit" xlink:label="inva_DecreaseToAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReductionToAdditionalPaidInCapital" xlink:label="inva_ReductionToAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseToConvertibleNotes" xlink:label="inva_IncreaseToConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseInDeferredTaxAssets" xlink:label="inva_IncreaseInDeferredTaxAssets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_LabaCollaborationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="inva_CustomerOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_LaJollaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="inva_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistAnoroMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="inva_CustomerTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_SarissaCapitalManagementLpMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_TradeAccountsReceivableMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="inva_CustomerThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_NumberOfCustomers" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_NumberOfMajorCustomers" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CapitalizedFeePaidEstimatedUsefulLife" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_MajorCustomersAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_DecreaseToAccumulatedDeficit" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_ReductionToAdditionalPaidInCapital" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="inva_SummaryOfSignificantAccountingPoliciesLineItems" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_IncreaseToConvertibleNotes" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_IncreaseInDeferredTaxAssets" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:label="inva_LaboratoryEquipmentFurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SoftwareAndComputerEquipmentMember" xlink:label="inva_SoftwareAndComputerEquipmentMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="inva_LaboratoryEquipmentFurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="inva_SoftwareAndComputerEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SarissaCapitalManagementLpMember" xlink:label="inva_SarissaCapitalManagementLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_SarissaCapitalManagementLpMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetIncomeLossPerShareAbstract" xlink:label="inva_NetIncomeLossPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DenominatorAbstract" xlink:label="inva_DenominatorAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumeratorAbstract" xlink:label="inva_NumeratorAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedLineItems" xlink:label="us-gaap_EarningsPerShareDilutedLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="us-gaap_InterestOnConvertibleDebtNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" xlink:label="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NetIncomeLossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NumeratorAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NetIncomeLossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NumeratorAbstract" xlink:to="us-gaap_InterestOnConvertibleDebtNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_EarningsPerShareDilutedLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NumeratorAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_NumeratorAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_DenominatorAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_NetIncomeLossPerShareAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityIncentivePlansAndESPPMember" xlink:label="inva_EquityIncentivePlansAndESPPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OutstandingStockWarrantMember" xlink:label="inva_OutstandingStockWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Outstanding2028NotesMember" xlink:label="inva_Outstanding2028NotesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="inva_EquityIncentivePlansAndESPPMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="inva_OutstandingStockWarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="inva_Outstanding2028NotesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TrelegyElliptaMember" xlink:label="inva_TrelegyElliptaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceMabaProgram" xlink:label="inva_StrategicAllianceMabaProgram"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_StrategicAllianceAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistAnoroMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_TrelegyElliptaMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_StrategicAllianceMabaProgram" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_GiaprezaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XeravaMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XacduroMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" xlink:label="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LabaCollaborationMember" xlink:label="inva_LabaCollaborationMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaMember" xlink:label="inva_LaJollaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TrelegyElliptaMember" xlink:label="inva_TrelegyElliptaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostGross" xlink:label="us-gaap_CapitalizedContractCostGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" xlink:label="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_StrategicAllianceAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_GeographicConcentrationRiskMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_LabaCollaborationMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CollaborativeArrangementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_LaJollaMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_LongActingBeta2AgonistAnoroMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_TrelegyElliptaMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_CapitalizedContractCostGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_GiaprezaMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_XeravaMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_XacduroMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommercialSupplyAgreementMember" xlink:label="inva_CommercialSupplyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SulbactamDurlobactamMember" xlink:label="inva_SulbactamDurlobactamMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZaiLabMember" xlink:label="inva_ZaiLabMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmendedZaiAgreementMember" xlink:label="inva_AmendedZaiAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PaionAgMember" xlink:label="inva_PaionAgMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FuturePotentialMilestonePayment" xlink:label="inva_FuturePotentialMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InterimSupplyAgreementMember" xlink:label="inva_InterimSupplyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ResearchAndDevelopmentSupportMember" xlink:label="inva_ResearchAndDevelopmentSupportMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EverestMedicinesLimitedMember" xlink:label="inva_EverestMedicinesLimitedMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostReimbursements" xlink:label="inva_CostReimbursements"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TechnologyTransferAgreementMember" xlink:label="inva_TechnologyTransferAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BasileaMember" xlink:label="inva_BasileaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReductionToResearchAndDevelopmentExpense" xlink:label="inva_ReductionToResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ManufacturingStageTransferAgreementMember" xlink:label="inva_ManufacturingStageTransferAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GeorgeWashingtonUniversityMember" xlink:label="inva_GeorgeWashingtonUniversityMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RegulatoryMilestonePaymentsReceivable" xlink:label="inva_RegulatoryMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RegulatoryStartingMaterialMember" xlink:label="inva_RegulatoryStartingMaterialMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostReimbursementMember" xlink:label="inva_CostReimbursementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_HarvardUniversityMember" xlink:label="inva_HarvardUniversityMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SalesMilestonePaymentsReceivable" xlink:label="inva_SalesMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DurlobactamMember" xlink:label="inva_DurlobactamMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ParatekPharmaceuticalsIncMember" xlink:label="inva_ParatekPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZoliflodacinMember" xlink:label="inva_ZoliflodacinMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AstrazenecaMember" xlink:label="inva_AstrazenecaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseRevenueRecognized" xlink:label="inva_LicenseRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenueMember" xlink:label="inva_LicenseAndOtherRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenue" xlink:label="inva_LicenseAndOtherRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationIndemnificationAssetsUsedForProduction" xlink:label="inva_BusinessCombinationIndemnificationAssetsUsedForProduction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" xlink:label="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" xlink:label="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationDeferredConsideration" xlink:label="inva_BusinessCombinationDeferredConsideration"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmountOnNetProductSalesRecognized" xlink:label="inva_AmountOnNetProductSalesRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" xlink:label="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" xlink:label="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedRoyaltyObligations" xlink:label="inva_AccruedRoyaltyObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UpfrontPaymentUnderIntangibleAsset" xlink:label="inva_UpfrontPaymentUnderIntangibleAsset"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyPayableOnNetSales" xlink:label="inva_PercentageOfRoyaltyPayableOnNetSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" xlink:label="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" xlink:label="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfMinimumRoyaltyRate" xlink:label="inva_PercentageOfMinimumRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" xlink:label="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ClaimExpirationDate" xlink:label="inva_ClaimExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermOfMilestonePaymentForNetSales" xlink:label="inva_TermOfMilestonePaymentForNetSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermOfMilestonePaymentForCommercialSale" xlink:label="inva_TermOfMilestonePaymentForCommercialSale"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_CommercialSupplyAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_SulbactamDurlobactamMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_ZaiLabMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_AmendedZaiAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XacduroMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_PaionAgMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_FuturePotentialMilestonePayment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_InterimSupplyAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_ResearchAndDevelopmentSupportMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_EverestMedicinesLimitedMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_CostReimbursements" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_TechnologyTransferAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_BasileaMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_ReductionToResearchAndDevelopmentExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_ManufacturingStageTransferAgreementMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_GiaprezaMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_GeorgeWashingtonUniversityMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_RegulatoryMilestonePaymentsReceivable" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_RegulatoryStartingMaterialMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CostReimbursementMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_HarvardUniversityMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_SalesMilestonePaymentsReceivable" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_DurlobactamMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_ParatekPharmaceuticalsIncMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_ZoliflodacinMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_AstrazenecaMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_LicenseRevenueRecognized" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LicenseAndOtherRevenueMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_LicenseAndOtherRevenue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XeravaMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_BusinessCombinationIndemnificationAssetsUsedForProduction" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_BusinessCombinationDeferredConsideration" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_AmountOnNetProductSalesRecognized" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CostOfRevenue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_AccruedRoyaltyObligations" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_UpfrontPaymentUnderIntangibleAsset" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfRoyaltyPayableOnNetSales" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfMinimumRoyaltyRate" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_ClaimExpirationDate" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_TermOfMilestonePaymentForNetSales" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_TermOfMilestonePaymentForCommercialSale" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RoyaltyExpense" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OwnershipInterestInConsolidatedEntities" xlink:label="inva_OwnershipInterestInConsolidatedEntities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" xlink:label="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentSalesBasedMilestonePayment" xlink:label="inva_ContingentSalesBasedMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CashDistributionReceived" xlink:label="inva_CashDistributionReceived"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OwnershipInterestsAndInvestmentsCarryingValue" xlink:label="inva_OwnershipInterestsAndInvestmentsCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_StrategicAllianceAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_OwnershipInterestInConsolidatedEntities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="inva_IspFundLpMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CollaborativeArrangementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_ContingentSalesBasedMilestonePayment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_CashDistributionReceived" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_OwnershipInterestsAndInvestmentsCarryingValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_EquityMethodInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RealizedLoss" xlink:label="inva_RealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_OperatingExpenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_RealizedLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_GainLossOnInvestments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ProfitLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralPartnerMember" xlink:label="us-gaap_GeneralPartnerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersCumulativeCashDistributions" xlink:label="us-gaap_LimitedPartnersCumulativeCashDistributions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersContributedCapital" xlink:label="us-gaap_LimitedPartnersContributedCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LimitedPartnersInitialContributionSubjectToLockUp" xlink:label="inva_LimitedPartnersInitialContributionSubjectToLockUp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LockUpExpirationDate" xlink:label="inva_LockUpExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEconomicInterestInPartnership" xlink:label="inva_PercentageOfEconomicInterestInPartnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" xlink:label="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PartnershipAgreementLockUpPeriod" xlink:label="inva_PartnershipAgreementLockUpPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="inva_IspFundLpMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_GeneralPartnerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LimitedPartnersCumulativeCashDistributions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LimitedPartnersContributedCapital" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_LimitedPartnersInitialContributionSubjectToLockUp" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_LockUpExpirationDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_PercentageOfEconomicInterestInPartnership" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_PartnershipAgreementLockUpPeriod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_GainLossOnInvestments" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Assets" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInPreferredStock" xlink:label="inva_InvestmentsInPreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PubliclyTradedHealthcareCompaniesMember" xlink:label="inva_PubliclyTradedHealthcareCompaniesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInCommonStock" xlink:label="inva_InvestmentsInCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyHeldHealthcareCompaniesMember" xlink:label="inva_PrivatelyHeldHealthcareCompaniesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="country_GB"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInWarrants" xlink:label="inva_InvestmentsInWarrants"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MoneyMarketFundAndCash" xlink:label="inva_MoneyMarketFundAndCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="inva_InvestmentsInPreferredStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_PubliclyTradedHealthcareCompaniesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="inva_InvestmentsInCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_IspFundLpMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_PrivatelyHeldHealthcareCompaniesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_GB" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="inva_InvestmentsInWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="inva_MoneyMarketFundAndCash" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Investments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementMember" xlink:label="inva_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNoteMember" xlink:label="inva_ConvertiblePromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" xlink:label="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAndWarrantsMember" xlink:label="inva_CommonStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInSecondQuarterOf2021Member" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInThirdQuarterOf2020Member" xlink:label="inva_WarrantsAcquiredInThirdQuarterOf2020Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInSecondQuarterOf2020Member" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2020Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" xlink:label="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:label="us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreasesInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" xlink:label="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNoteMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_CommonStockAndWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="dei_LegalEntityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsAcquiredInSecondQuarterOf2021Member" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsAcquiredInThirdQuarterOf2020Member" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsAcquiredInSecondQuarterOf2020Member" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_MinorityInterestPeriodIncreaseDecrease" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_IncreaseDecreaseInDeferredTaxLiabilities" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_IncreaseDecreasesInDeferredTaxLiabilities" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_MinorityInterest" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_Goodwill" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxAssets" xlink:label="inva_IncreaseDecreaseInDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" xlink:label="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquisitionCosts" xlink:label="us-gaap_AcquisitionCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreasesInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_IncreaseDecreaseInDeferredTaxAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AcquisitionCosts" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_IncreaseDecreaseInDeferredTaxLiabilities" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_IncreaseDecreasesInDeferredTaxLiabilities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesDisclosureAbstract" xlink:label="inva_ConsolidatedEntitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_ConsolidatedEntitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuredConvertibleCreditAgreementMember" xlink:label="inva_SecuredConvertibleCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CreditAndSecurityAgreementMember" xlink:label="inva_CreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAndWarrantsMember" xlink:label="inva_CommonStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OneDirectorMember" xlink:label="inva_OneDirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" xlink:label="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2020Member" xlink:label="inva_WarrantsPurchasedIn2020Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoDirectorsMember" xlink:label="inva_TwoDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" xlink:label="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2021Member" xlink:label="inva_WarrantsPurchasedIn2021Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2022Member" xlink:label="inva_WarrantsPurchasedIn2022Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementNumberOfTranches" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataConvertibleNoteMember" xlink:label="inva_ArmataConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataTermLoanMember" xlink:label="inva_ArmataTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_VotingAgreementMaximumVotingRightsPercent" xlink:label="inva_VotingAgreementMaximumVotingRightsPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" xlink:label="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="inva_SecuredConvertibleCreditAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_ArmataPharmaceuticalsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_CreditAndSecurityAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_CommonStockAndWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="inva_OneDirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsPurchasedIn2020Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="inva_TwoDirectorsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsPurchasedIn2021Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsPurchasedIn2022Member" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementNumberOfTranches" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentDescription" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataConvertibleNoteMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataTermLoanMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_VotingAgreementMaximumVotingRightsPercent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:label="us-gaap_IncomeStatementRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_ArmataPharmaceuticalsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AssetsCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_IncomeStatementRelatedDisclosuresAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_ProfitLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventDomain" xlink:label="inva_NameOfEventDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_QualifiedFinancingMember" xlink:label="inva_QualifiedFinancingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCPreferredStockAndWarrantsMember" xlink:label="inva_SeriesCPreferredStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncardaMember" xlink:label="inva_IncardaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OptionPricingModelBacksolveValuationMember" xlink:label="inva_OptionPricingModelBacksolveValuationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventAxis" xlink:label="inva_NameOfEventAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InCardaConvertibleNoteMember" xlink:label="inva_InCardaConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Incarda2020WarrantsMember" xlink:label="inva_Incarda2020WarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleNoteAndWarrantsMember" xlink:label="inva_ConvertibleNoteAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentTransactionCost" xlink:label="inva_DebtInstrumentTransactionCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesA1PreferredStockMember" xlink:label="inva_SeriesA1PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1PreferredStockMember" xlink:label="inva_SeriesD1PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfInvesteesBoardMembers" xlink:label="inva_NumberOfInvesteesBoardMembers"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD2PreferredStockMember" xlink:label="inva_SeriesD2PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1WarrantMember" xlink:label="inva_SeriesD1WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD2WarrantMember" xlink:label="inva_SeriesD2WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCWarrantsAndSeriesDWarrantsMember" xlink:label="inva_SeriesCWarrantsAndSeriesDWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCWarrantsMember" xlink:label="inva_SeriesCWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExpectedHoldingPeriod" xlink:label="inva_ExpectedHoldingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesDWarrantsMember" xlink:label="inva_SeriesDWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RiskFreeInterestRate" xlink:label="inva_RiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DividendYield" xlink:label="inva_DividendYield"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1AndD2PreferredStockAndCommonStockMember" xlink:label="inva_SeriesD1AndD2PreferredStockAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEstimatedVolatility" xlink:label="inva_PercentageOfEstimatedVolatility"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExtendedExpirationDate" xlink:label="inva_ExtendedExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExpirationDate" xlink:label="inva_ExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CarryingValueWroteOffWarrantExercise" xlink:label="inva_CarryingValueWroteOffWarrantExercise"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantCarryingValueWriteOffAmount" xlink:label="inva_WarrantCarryingValueWriteOffAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NameOfEventDomain" xlink:to="inva_QualifiedFinancingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCPreferredStockAndWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_IncardaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="inva_OptionPricingModelBacksolveValuationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_NameOfEventAxis" xlink:to="inva_NameOfEventDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_InCardaConvertibleNoteMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_Incarda2020WarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ConvertibleNoteAndWarrantsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_DebtInstrumentTransactionCost" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesA1PreferredStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="inva_NameOfEventAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD1PreferredStockMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfInvesteesBoardMembers" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD2PreferredStockMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD1WarrantMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD2WarrantMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCWarrantsAndSeriesDWarrantsMember" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCWarrantsMember" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_ExpectedHoldingPeriod" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesDWarrantsMember" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_RiskFreeInterestRate" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_DividendYield" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD1AndD2PreferredStockAndCommonStockMember" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_PercentageOfEstimatedVolatility" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_ExtendedExpirationDate" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_ExpirationDate" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_CarryingValueWroteOffWarrantExercise" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_WarrantCarryingValueWriteOffAmount" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FirstAmendmentMember" xlink:label="inva_FirstAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabMember" xlink:label="inva_ImaginabMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OneOfImaginabsCommonStockholderMember" xlink:label="inva_OneOfImaginabsCommonStockholderMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesC2PreferredStockMember" xlink:label="inva_SeriesC2PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCAndC2PreferredStockAndCommonStockMember" xlink:label="inva_SeriesCAndC2PreferredStockAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabConvertibleNoteMember" xlink:label="inva_ImaginabConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TransactionCostsIncurredInConnectionWithEquityInvestment" xlink:label="inva_TransactionCostsIncurredInConnectionWithEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_FirstAmendmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_ImaginabMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_OneOfImaginabsCommonStockholderMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesC2PreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCAndC2PreferredStockAndCommonStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ImaginabConvertibleNoteMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_TransactionCostsIncurredInConnectionWithEquityInvestment" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GateNeuroscienceMember" xlink:label="inva_GateNeuroscienceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCommonStockIssuedDescription" xlink:label="inva_NumberOfCommonStockIssuedDescription"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_GateNeuroscienceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCommonStockIssuedDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NanoliveMember" xlink:label="inva_NanoliveMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityInvestmentTransactionCostsIncurred" xlink:label="inva_EquityInvestmentTransactionCostsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_NanoliveMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_EquityInvestmentTransactionCostsIncurred" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:label="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:label="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReclassificationOfCurrentPortion" xlink:label="inva_ReclassificationOfCurrentPortion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="inva_GainLossOnOtherInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="inva_ReclassificationOfCurrentPortion" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_OtherIncome" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_LongTermInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityInvestmentsAndMoneyMarketFundsMember" xlink:label="inva_EquityInvestmentsAndMoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSubordinatedDebtFairValueDisclosures" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSeniorDebtFairValueDisclosures" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncardaMember" xlink:label="inva_IncardaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataTermLoanMember" xlink:label="inva_ArmataTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermLoanInvestmentMember" xlink:label="inva_TermLoanInvestmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabMember" xlink:label="inva_ImaginabMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatePlacementPositionsAndConvertibleNotesMember" xlink:label="inva_PrivatePlacementPositionsAndConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentValueRightsLiability" xlink:label="inva_ContingentValueRightsLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GateNeuroscienceMember" xlink:label="inva_GateNeuroscienceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtMember" xlink:label="us-gaap_DebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PreferredStockWarrantsMember" xlink:label="inva_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PartnershipAgreementLockUpPeriod" xlink:label="inva_PartnershipAgreementLockUpPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersContributedCapital" xlink:label="us-gaap_LimitedPartnersContributedCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WithdrawalFromInvestment" xlink:label="inva_WithdrawalFromInvestment"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ArmataPharmaceuticalsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="inva_EquityInvestmentsAndMoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_IspFundLpMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ConvertibleSubordinatedDebtFairValueDisclosures" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_EquitySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ConvertibleSeniorDebtFairValueDisclosures" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_IncardaMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataTermLoanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="inva_TermLoanInvestmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ImaginabMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="inva_PrivatePlacementPositionsAndConvertibleNotesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ContingentValueRightsLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_GateNeuroscienceMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_DebtMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_PreferredStockWarrantsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_CounterpartyNameAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_PartnershipAgreementLockUpPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LimitedPartnersContributedCapital" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_WithdrawalFromInvestment" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" xlink:label="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="us-gaap_CapitalizedContractCostTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="us-gaap_CapitalizedContractCostLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostGross" xlink:label="us-gaap_CapitalizedContractCostGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAbstract" xlink:label="us-gaap_CapitalizedContractCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:label="inva_CapitalizedFeesPaidFutureAmortizationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAccumulatedAmortization" xlink:label="us-gaap_CapitalizedContractCostAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_JP" xlink:label="country_JP"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidWeightedAverageUsefulLife" xlink:label="inva_CapitalizedFeesPaidWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostAbstract" xlink:to="us-gaap_CapitalizedContractCostTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="srt_StatementGeographicalAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostAccumulatedAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="srt_ProductOrServiceAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_JP" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="us-gaap_CapitalizedContractCostLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="inva_CapitalizedFeesPaidWeightedAverageUsefulLife" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortization" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="inva_CapitalizedFeesPaidFutureAmortizationAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BasileaMember" xlink:label="inva_BasileaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UpfrontFee" xlink:label="inva_UpfrontFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_CollaborativeArrangementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XacduroMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_BasileaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="inva_UpfrontFee" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_ProductOrServiceAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_CounterpartyNameAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_GoodwillLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MarketedProductsMember" xlink:label="inva_MarketedProductsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsGross" xlink:label="inva_IntangibleAssetsMarketedProductsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementGross" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsNet" xlink:label="inva_IntangibleAssetsMarketedProductsNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementNet" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="inva_MarketedProductsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsMarketedProductsGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CollaborativeArrangementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsCollaborationAgreementGross" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsMarketedProductsNet" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsCollaborationAgreementNet" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZaiLabMember" xlink:label="inva_ZaiLabMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FairValueAdjustmentsOfInventoryFromAcquistion" xlink:label="inva_FairValueAdjustmentsOfInventoryFromAcquistion"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" xlink:label="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationDeferredConsideration" xlink:label="inva_BusinessCombinationDeferredConsideration"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_InventoryCurrentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_ZaiLabMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="inva_FairValueAdjustmentsOfInventoryFromAcquistion" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="inva_BusinessCombinationDeferredConsideration" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedContractManufacturingLiability" xlink:label="inva_AccruedContractManufacturingLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedClinicalAndResearchLiability" xlink:label="inva_AccruedClinicalAndResearchLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedProfessionalServices" xlink:label="inva_AccruedProfessionalServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligationCurrent" xlink:label="inva_DeferredRoyaltyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedLicenseFeesAndRoyalties" xlink:label="inva_AccruedLicenseFeesAndRoyalties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_AccruedContractManufacturingLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_AccruedClinicalAndResearchLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_AccruedProfessionalServices" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedRoyaltiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_DeferredRoyaltyObligationCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_AccruedLicenseFeesAndRoyalties" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherLiabilities" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligationNonCurrent" xlink:label="inva_DeferredRoyaltyObligationNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentValueRightsLiability" xlink:label="inva_ContingentValueRightsLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_DeferredRoyaltyObligationNonCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="inva_ContingentValueRightsLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityIncentivePlan2012Member" xlink:label="inva_EquityIncentivePlan2012Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanMember" xlink:label="inva_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" xlink:label="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EquityIncentivePlan2012Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EmployeeStockPurchasePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanMember" xlink:label="inva_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EmployeeStockPurchasePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaMember" xlink:label="inva_InnovivaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="inva_InnovivaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="us-gaap_ClassOfTreasuryStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis" xlink:label="srt_ShareRepurchaseProgramAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain" xlink:label="srt_ShareRepurchaseProgramDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" xlink:label="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAcquiredAverageCostPerShare" xlink:label="inva_CommonStockAcquiredAverageCostPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="us-gaap_TreasuryStockCommonValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="srt_ShareRepurchaseProgramAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfTreasuryStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ShareRepurchaseProgramDomain" xlink:to="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="inva_CommonStockAcquiredAverageCostPerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockCommonValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_StatementLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_HealthCareRoyaltyPartnersMember" xlink:label="inva_HealthCareRoyaltyPartnersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeniorUnsecuredConvertibleNotesMember" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OtherAccruedLiabilitiesMember" xlink:label="inva_OtherAccruedLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyFinancingAgreementMember" xlink:label="inva_RoyaltyFinancingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementMaximumPotentialPayoutPercent" xlink:label="inva_RoyaltyAgreementMaximumPotentialPayoutPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" xlink:label="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MaximumAggregateRoyaltyPaymentsDue" xlink:label="inva_MaximumAggregateRoyaltyPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligations" xlink:label="inva_DeferredRoyaltyObligations"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyPayments" xlink:label="inva_RoyaltyPayments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InterestRateOfDeferredRoyaltyObligation" xlink:label="inva_InterestRateOfDeferredRoyaltyObligation"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TotalPaymentsMadeForRoyaltyAgreement" xlink:label="inva_TotalPaymentsMadeForRoyaltyAgreement"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_HealthCareRoyaltyPartnersMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="inva_SeniorUnsecuredConvertibleNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentPrincipalAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="inva_OtherAccruedLiabilitiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_RoyaltyFinancingAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementMaximumPotentialPayoutPercent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_MaximumAggregateRoyaltyPaymentsDue" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DeferredRoyaltyObligations" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyPayments" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_InterestRateOfDeferredRoyaltyObligation" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_TotalPaymentsMadeForRoyaltyAgreement" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" xlink:label="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaCommonStockMember" xlink:label="inva_InnovivaCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtAbstract" xlink:label="us-gaap_InterestExpenseDebtAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRemainingBalancePaidUponMaturation" xlink:label="inva_DebtInstrumentRemainingBalancePaidUponMaturation"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" xlink:label="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PutOptionMember" xlink:label="us-gaap_PutOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCapPriceMember" xlink:label="inva_PrivatelyNegotiatedCapPriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfDerivativeInstrumentsPurchased" xlink:label="inva_NumberOfDerivativeInstrumentsPurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeCapPrice" xlink:label="us-gaap_DerivativeCapPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="us-gaap_DebtInstrumentRepurchaseAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" xlink:label="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRepurchasePercentage" xlink:label="inva_DebtInstrumentRepurchasePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="inva_InnovivaCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:to="us-gaap_CallOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="inva_PrivatelyNegotiatedCappedCallOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentRemainingBalancePaidUponMaturation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:to="us-gaap_PutOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="inva_PrivatelyNegotiatedCapPriceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_NumberOfDerivativeInstrumentsPurchased" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OptionIndexedToIssuersEquityStrikePrice1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DerivativeCapPrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepurchasedFaceAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepurchaseAmount" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentRepurchasePercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPayableCurrent" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentPrincipalAmount" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebtAbstract" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeniorUnsecuredConvertibleNotesMember" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseBorrowingsAbstract" xlink:label="us-gaap_InterestExpenseBorrowingsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeCapPrice" xlink:label="us-gaap_DerivativeCapPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" xlink:label="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentConvertibleConversionPremium" xlink:label="inva_DebtInstrumentConvertibleConversionPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" xlink:label="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" xlink:label="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" xlink:label="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCovenantTerms" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PortionOfDebtInstrumentFaceAmountExercised" xlink:label="inva_PortionOfDebtInstrumentFaceAmountExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="inva_SeniorUnsecuredConvertibleNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="inva_PrivatelyNegotiatedCappedCallOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DerivativeCapPrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OptionIndexedToIssuersEquityStrikePrice1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentConvertibleConversionPremium" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCovenantTerms" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_PortionOfDebtInstrumentFaceAmountExercised" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepurchasedFaceAmount" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentPrincipalAmount" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseBorrowingsAbstract" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CordenPharmaMember" xlink:label="inva_CordenPharmaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisLeaseMember" xlink:label="inva_EntasisLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BurlingameCaliforniaMember" xlink:label="inva_BurlingameCaliforniaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommitmentsFor2024ToBeUtilizedIn2025Member" xlink:label="inva_CommitmentsFor2024ToBeUtilizedIn2025Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WalthamMassachusettsMember" xlink:label="inva_WalthamMassachusettsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAllegations" xlink:label="us-gaap_LossContingencyAllegations"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DemandLettersSentByStockholders" xlink:label="inva_DemandLettersSentByStockholders"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_NetRentableArea" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_CordenPharmaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="inva_EntasisLeaseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="inva_BurlingameCaliforniaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="inva_CommitmentsFor2024ToBeUtilizedIn2025Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="inva_WalthamMassachusettsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PurchaseObligationDueInSecondYear" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PurchaseObligationDueInThirdYear" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LossContingencyAllegations" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="inva_DemandLettersSentByStockholders" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_VariableLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RightOfUseAssetsObtainedThroughAcquistions" xlink:label="inva_RightOfUseAssetsObtainedThroughAcquistions"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="inva_RightOfUseAssetsObtainedThroughAcquistions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:label="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesInvestments" xlink:label="us-gaap_DeferredTaxLiabilitiesInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncomeTaxesTable" xlink:label="inva_IncomeTaxesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncomeTaxesLineItems" xlink:label="inva_IncomeTaxesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OperatingLossCarryforwardsIndefinitePeriod" xlink:label="inva_OperatingLossCarryforwardsIndefinitePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetOperatingLossEstimatingDate" xlink:label="inva_NetOperatingLossEstimatingDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FederalNetOperatingLossesEstimatedUtilizationAmount" xlink:label="inva_FederalNetOperatingLossesEstimatedUtilizationAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StateNetOperatingLossesEstimatedUtilizationAmount" xlink:label="inva_StateNetOperatingLossesEstimatedUtilizationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="inva_IncomeTaxesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesTable" xlink:to="inva_IncomeTaxesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_OperatingLossCarryforwardsIndefinitePeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_NetOperatingLossEstimatingDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_FederalNetOperatingLossesEstimatedUtilizationAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_StateNetOperatingLossesEstimatedUtilizationAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfInventoryFairValueAdjustmentsMember" xlink:label="inva_AmortizationOfInventoryFairValueAdjustmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExternalServicesMember" xlink:label="inva_ExternalServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InternalExpensesMember" xlink:label="inva_InternalExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="inva_AmortizationOfInventoryFairValueAdjustmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_ExternalServicesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="srt_StatementGeographicalAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_InternalExpensesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_CostOfRevenue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_SellingAndMarketingExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="srt_ConsolidationItemsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="inva_GainLossOnOtherInvestments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_InterestAndDividendIncomeOperating" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_InterestExpense" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_ProfitLoss" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenueMember" xlink:label="inva_LicenseAndOtherRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CollaborativeArrangementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LicenseAndOtherRevenueMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="inva_GainLossOnOtherInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_InterestAndDividendIncomeOperating" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" xlink:label="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" xlink:label="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" xlink:label="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" xlink:label="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" xlink:label="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" xlink:label="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" xlink:label="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" xlink:label="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareRepurchaseProgramExciseTax" xlink:label="us-gaap_ShareRepurchaseProgramExciseTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ProfitLossShares" xlink:label="inva_ProfitLossShares"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockCommonMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TreasuryStockSharesAcquired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_ShareRepurchaseProgramExciseTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="inva_ProfitLossShares" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:label="inva_ConsolidatedEntitiesAndAcquisitionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:label="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" xlink:label="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTableTextBlock" xlink:label="us-gaap_InvestmentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_IspFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_InvestmentTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" xlink:label="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" xlink:label="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_ArmataPharmaceuticalsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Percent2.50ConvertibleDebtMember" xlink:label="inva_Percent2.50ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_Percent2.50ConvertibleDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="inva_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SummaryOfSignificantAccountingPoliciesTable" xlink:label="inva_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LabaCollaborationMember" xlink:label="inva_LabaCollaborationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerOneMember" xlink:label="inva_CustomerOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaMember" xlink:label="inva_LaJollaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerTwoMember" xlink:label="inva_CustomerTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SarissaCapitalManagementLpMember" xlink:label="inva_SarissaCapitalManagementLpMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAccountsReceivableMember" xlink:label="us-gaap_TradeAccountsReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CustomerThreeMember" xlink:label="inva_CustomerThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCustomers" xlink:label="inva_NumberOfCustomers"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfMajorCustomers" xlink:label="inva_NumberOfMajorCustomers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeePaidEstimatedUsefulLife" xlink:label="inva_CapitalizedFeePaidEstimatedUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DecreaseToAccumulatedDeficit" xlink:label="inva_DecreaseToAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReductionToAdditionalPaidInCapital" xlink:label="inva_ReductionToAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseToConvertibleNotes" xlink:label="inva_IncreaseToConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseInDeferredTaxAssets" xlink:label="inva_IncreaseInDeferredTaxAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_LabaCollaborationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="inva_CustomerOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_LaJollaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistAnoroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="inva_CustomerTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_SarissaCapitalManagementLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_TradeAccountsReceivableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="inva_CustomerThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_NumberOfCustomers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_NumberOfMajorCustomers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_CapitalizedFeePaidEstimatedUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_MajorCustomersAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_DecreaseToAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_ReductionToAdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_IncreaseToConvertibleNotes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="inva_IncreaseInDeferredTaxAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:label="inva_LaboratoryEquipmentFurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SoftwareAndComputerEquipmentMember" xlink:label="inva_SoftwareAndComputerEquipmentMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="inva_LaboratoryEquipmentFurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="inva_SoftwareAndComputerEquipmentMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" xlink:label="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SarissaCapitalManagementLpMember" xlink:label="inva_SarissaCapitalManagementLpMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_SarissaCapitalManagementLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedLineItems" xlink:label="us-gaap_EarningsPerShareDilutedLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetIncomeLossPerShareAbstract" xlink:label="inva_NetIncomeLossPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DenominatorAbstract" xlink:label="inva_DenominatorAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumeratorAbstract" xlink:label="inva_NumeratorAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="us-gaap_InterestOnConvertibleDebtNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" xlink:label="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_NetIncomeLossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_NumeratorAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_NetIncomeLossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_NumeratorAbstract" xlink:to="us-gaap_InterestOnConvertibleDebtNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_NumeratorAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_NumeratorAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_DenominatorAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="inva_NetIncomeLossPerShareAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityIncentivePlansAndESPPMember" xlink:label="inva_EquityIncentivePlansAndESPPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OutstandingStockWarrantMember" xlink:label="inva_OutstandingStockWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Outstanding2028NotesMember" xlink:label="inva_Outstanding2028NotesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="inva_EquityIncentivePlansAndESPPMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="inva_OutstandingStockWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="inva_Outstanding2028NotesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TrelegyElliptaMember" xlink:label="inva_TrelegyElliptaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceMabaProgram" xlink:label="inva_StrategicAllianceMabaProgram"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_StrategicAllianceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LongActingBeta2AgonistAnoroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_TrelegyElliptaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_StrategicAllianceMabaProgram" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_GiaprezaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XeravaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XacduroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistRelvarBreoMember" xlink:label="inva_LongActingBeta2AgonistRelvarBreoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" xlink:label="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LabaCollaborationMember" xlink:label="inva_LabaCollaborationMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaMember" xlink:label="inva_LaJollaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LongActingBeta2AgonistAnoroMember" xlink:label="inva_LongActingBeta2AgonistAnoroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TrelegyElliptaMember" xlink:label="inva_TrelegyElliptaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostGross" xlink:label="us-gaap_CapitalizedContractCostGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" xlink:label="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" xlink:label="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" xlink:label="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" xlink:label="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_StrategicAllianceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_GeographicConcentrationRiskMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_LongActingBeta2AgonistRelvarBreoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_LabaCollaborationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CollaborativeArrangementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_LaJollaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_LongActingBeta2AgonistAnoroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_TrelegyElliptaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_CapitalizedContractCostGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_GiaprezaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_XeravaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RoyaltyMember" xlink:to="inva_XacduroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommercialSupplyAgreementMember" xlink:label="inva_CommercialSupplyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SulbactamDurlobactamMember" xlink:label="inva_SulbactamDurlobactamMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZaiLabMember" xlink:label="inva_ZaiLabMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmendedZaiAgreementMember" xlink:label="inva_AmendedZaiAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PaionAgMember" xlink:label="inva_PaionAgMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FuturePotentialMilestonePayment" xlink:label="inva_FuturePotentialMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InterimSupplyAgreementMember" xlink:label="inva_InterimSupplyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ResearchAndDevelopmentSupportMember" xlink:label="inva_ResearchAndDevelopmentSupportMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EverestMedicinesLimitedMember" xlink:label="inva_EverestMedicinesLimitedMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostReimbursements" xlink:label="inva_CostReimbursements"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TechnologyTransferAgreementMember" xlink:label="inva_TechnologyTransferAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BasileaMember" xlink:label="inva_BasileaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ReductionToResearchAndDevelopmentExpense" xlink:label="inva_ReductionToResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ManufacturingStageTransferAgreementMember" xlink:label="inva_ManufacturingStageTransferAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GiaprezaMember" xlink:label="inva_GiaprezaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GeorgeWashingtonUniversityMember" xlink:label="inva_GeorgeWashingtonUniversityMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RegulatoryMilestonePaymentsReceivable" xlink:label="inva_RegulatoryMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RegulatoryStartingMaterialMember" xlink:label="inva_RegulatoryStartingMaterialMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostReimbursementMember" xlink:label="inva_CostReimbursementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_HarvardUniversityMember" xlink:label="inva_HarvardUniversityMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SalesMilestonePaymentsReceivable" xlink:label="inva_SalesMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DurlobactamMember" xlink:label="inva_DurlobactamMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ParatekPharmaceuticalsIncMember" xlink:label="inva_ParatekPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZoliflodacinMember" xlink:label="inva_ZoliflodacinMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AstrazenecaMember" xlink:label="inva_AstrazenecaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseRevenueRecognized" xlink:label="inva_LicenseRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenueMember" xlink:label="inva_LicenseAndOtherRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LicenseAndOtherRevenue" xlink:label="inva_LicenseAndOtherRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XeravaMember" xlink:label="inva_XeravaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationIndemnificationAssetsUsedForProduction" xlink:label="inva_BusinessCombinationIndemnificationAssetsUsedForProduction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" xlink:label="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" xlink:label="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationDeferredConsideration" xlink:label="inva_BusinessCombinationDeferredConsideration"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmountOnNetProductSalesRecognized" xlink:label="inva_AmountOnNetProductSalesRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" xlink:label="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" xlink:label="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedRoyaltyObligations" xlink:label="inva_AccruedRoyaltyObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UpfrontPaymentUnderIntangibleAsset" xlink:label="inva_UpfrontPaymentUnderIntangibleAsset"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyPayableOnNetSales" xlink:label="inva_PercentageOfRoyaltyPayableOnNetSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" xlink:label="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" xlink:label="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfMinimumRoyaltyRate" xlink:label="inva_PercentageOfMinimumRoyaltyRate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" xlink:label="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ClaimExpirationDate" xlink:label="inva_ClaimExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermOfMilestonePaymentForNetSales" xlink:label="inva_TermOfMilestonePaymentForNetSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" xlink:label="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermOfMilestonePaymentForCommercialSale" xlink:label="inva_TermOfMilestonePaymentForCommercialSale"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_CommercialSupplyAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_SulbactamDurlobactamMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_ZaiLabMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Revenues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_AmendedZaiAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XacduroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_PaionAgMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_FuturePotentialMilestonePayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_InterimSupplyAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_ResearchAndDevelopmentSupportMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_EverestMedicinesLimitedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_CostReimbursements" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_TechnologyTransferAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_BasileaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_ReductionToResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_ManufacturingStageTransferAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_GiaprezaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_GeorgeWashingtonUniversityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_RegulatoryMilestonePaymentsReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_RegulatoryStartingMaterialMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CostReimbursementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_HarvardUniversityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_SalesMilestonePaymentsReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_DurlobactamMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_ParatekPharmaceuticalsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_ZoliflodacinMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_AstrazenecaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_LicenseRevenueRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_LicenseAndOtherRevenueMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_LicenseAndOtherRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XeravaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_AccountsReceivableNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_BusinessCombinationIndemnificationAssetsUsedForProduction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_BusinessCombinationDeferredConsideration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_AmountOnNetProductSalesRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CostOfRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RepaymentsOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_AccruedRoyaltyObligations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_UpfrontPaymentUnderIntangibleAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfRoyaltyPayableOnNetSales" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfMinimumRoyaltyRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_ClaimExpirationDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_TermOfMilestonePaymentForNetSales" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="inva_TermOfMilestonePaymentForCommercialSale" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RoyaltyExpense" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StrategicAllianceAgreementMember" xlink:label="inva_StrategicAllianceAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OwnershipInterestInConsolidatedEntities" xlink:label="inva_OwnershipInterestInConsolidatedEntities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CollaborativeArrangementsMember" xlink:label="inva_CollaborativeArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" xlink:label="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentSalesBasedMilestonePayment" xlink:label="inva_ContingentSalesBasedMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CashDistributionReceived" xlink:label="inva_CashDistributionReceived"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OwnershipInterestsAndInvestmentsCarryingValue" xlink:label="inva_OwnershipInterestsAndInvestmentsCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_StrategicAllianceAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_OwnershipInterestInConsolidatedEntities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="inva_IspFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_CollaborativeArrangementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_ContingentSalesBasedMilestonePayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_CashDistributionReceived" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_OwnershipInterestsAndInvestmentsCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TheravanceRespiratoryCompanyLlcMember" xlink:label="inva_TheravanceRespiratoryCompanyLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RealizedLoss" xlink:label="inva_RealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_TheravanceRespiratoryCompanyLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_RealizedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_GainLossOnInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralPartnerMember" xlink:label="us-gaap_GeneralPartnerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersCumulativeCashDistributions" xlink:label="us-gaap_LimitedPartnersCumulativeCashDistributions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersContributedCapital" xlink:label="us-gaap_LimitedPartnersContributedCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LimitedPartnersInitialContributionSubjectToLockUp" xlink:label="inva_LimitedPartnersInitialContributionSubjectToLockUp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LockUpExpirationDate" xlink:label="inva_LockUpExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEconomicInterestInPartnership" xlink:label="inva_PercentageOfEconomicInterestInPartnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" xlink:label="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PartnershipAgreementLockUpPeriod" xlink:label="inva_PartnershipAgreementLockUpPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="inva_IspFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_GeneralPartnerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LimitedPartnersCumulativeCashDistributions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LimitedPartnersContributedCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_LimitedPartnersInitialContributionSubjectToLockUp" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_LockUpExpirationDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_PercentageOfEconomicInterestInPartnership" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="inva_PartnershipAgreementLockUpPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_GainLossOnInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInPreferredStock" xlink:label="inva_InvestmentsInPreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PubliclyTradedHealthcareCompaniesMember" xlink:label="inva_PubliclyTradedHealthcareCompaniesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInCommonStock" xlink:label="inva_InvestmentsInCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyHeldHealthcareCompaniesMember" xlink:label="inva_PrivatelyHeldHealthcareCompaniesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="country_GB"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InvestmentsInWarrants" xlink:label="inva_InvestmentsInWarrants"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MoneyMarketFundAndCash" xlink:label="inva_MoneyMarketFundAndCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="inva_InvestmentsInPreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_PubliclyTradedHealthcareCompaniesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="inva_InvestmentsInCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_IspFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_PrivatelyHeldHealthcareCompaniesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_GB" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="inva_InvestmentsInWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="inva_MoneyMarketFundAndCash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Investments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementMember" xlink:label="inva_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNoteMember" xlink:label="inva_ConvertiblePromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" xlink:label="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAndWarrantsMember" xlink:label="inva_CommonStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInSecondQuarterOf2021Member" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInThirdQuarterOf2020Member" xlink:label="inva_WarrantsAcquiredInThirdQuarterOf2020Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsAcquiredInSecondQuarterOf2020Member" xlink:label="inva_WarrantsAcquiredInSecondQuarterOf2020Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" xlink:label="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:label="us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreasesInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" xlink:label="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="inva_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_CommonStockAndWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsAcquiredInSecondQuarterOf2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsAcquiredInThirdQuarterOf2020Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsAcquiredInSecondQuarterOf2020Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_MinorityInterestPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_IncreaseDecreaseInDeferredTaxLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_IncreaseDecreasesInDeferredTaxLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_MinorityInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_Goodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxAssets" xlink:label="inva_IncreaseDecreaseInDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" xlink:label="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquisitionCosts" xlink:label="us-gaap_AcquisitionCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreaseInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreaseInDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncreaseDecreasesInDeferredTaxLiabilities" xlink:label="inva_IncreaseDecreasesInDeferredTaxLiabilities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_IncreaseDecreaseInDeferredTaxAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_IncreaseDecreaseInInventories" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AcquisitionCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_IncreaseDecreaseInDeferredTaxLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="inva_IncreaseDecreasesInDeferredTaxLiabilities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuredConvertibleCreditAgreementMember" xlink:label="inva_SecuredConvertibleCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" xlink:label="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CreditAndSecurityAgreementMember" xlink:label="inva_CreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAndWarrantsMember" xlink:label="inva_CommonStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OneDirectorMember" xlink:label="inva_OneDirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" xlink:label="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2020Member" xlink:label="inva_WarrantsPurchasedIn2020Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoDirectorsMember" xlink:label="inva_TwoDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" xlink:label="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2021Member" xlink:label="inva_WarrantsPurchasedIn2021Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantsPurchasedIn2022Member" xlink:label="inva_WarrantsPurchasedIn2022Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementNumberOfTranches" xlink:label="inva_SecuritiesPurchaseAgreementNumberOfTranches"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataConvertibleNoteMember" xlink:label="inva_ArmataConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataTermLoanMember" xlink:label="inva_ArmataTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_VotingAgreementMaximumVotingRightsPercent" xlink:label="inva_VotingAgreementMaximumVotingRightsPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" xlink:label="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="inva_SecuredConvertibleCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_ArmataPharmaceuticalsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_CreditAndSecurityAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_CommonStockAndWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="inva_OneDirectorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsPurchasedIn2020Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="inva_TwoDirectorsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsPurchasedIn2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_WarrantsPurchasedIn2022Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementNumberOfTranches" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataConvertibleNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_VotingAgreementMaximumVotingRightsPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:label="us-gaap_IncomeStatementRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_ArmataPharmaceuticalsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_IncomeStatementRelatedDisclosuresAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventDomain" xlink:label="inva_NameOfEventDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_QualifiedFinancingMember" xlink:label="inva_QualifiedFinancingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCPreferredStockAndWarrantsMember" xlink:label="inva_SeriesCPreferredStockAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncardaMember" xlink:label="inva_IncardaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OptionPricingModelBacksolveValuationMember" xlink:label="inva_OptionPricingModelBacksolveValuationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventAxis" xlink:label="inva_NameOfEventAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NameOfEventDomain" xlink:label="inva_NameOfEventDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InCardaConvertibleNoteMember" xlink:label="inva_InCardaConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_Incarda2020WarrantsMember" xlink:label="inva_Incarda2020WarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" xlink:label="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" xlink:label="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleNoteAndWarrantsMember" xlink:label="inva_ConvertibleNoteAndWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentTransactionCost" xlink:label="inva_DebtInstrumentTransactionCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesA1PreferredStockMember" xlink:label="inva_SeriesA1PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1PreferredStockMember" xlink:label="inva_SeriesD1PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfInvesteesBoardMembers" xlink:label="inva_NumberOfInvesteesBoardMembers"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD2PreferredStockMember" xlink:label="inva_SeriesD2PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1WarrantMember" xlink:label="inva_SeriesD1WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD2WarrantMember" xlink:label="inva_SeriesD2WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:label="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCWarrantsAndSeriesDWarrantsMember" xlink:label="inva_SeriesCWarrantsAndSeriesDWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCWarrantsMember" xlink:label="inva_SeriesCWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExpectedHoldingPeriod" xlink:label="inva_ExpectedHoldingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesDWarrantsMember" xlink:label="inva_SeriesDWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RiskFreeInterestRate" xlink:label="inva_RiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DividendYield" xlink:label="inva_DividendYield"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesD1AndD2PreferredStockAndCommonStockMember" xlink:label="inva_SeriesD1AndD2PreferredStockAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PercentageOfEstimatedVolatility" xlink:label="inva_PercentageOfEstimatedVolatility"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExtendedExpirationDate" xlink:label="inva_ExtendedExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExpirationDate" xlink:label="inva_ExpirationDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CarryingValueWroteOffWarrantExercise" xlink:label="inva_CarryingValueWroteOffWarrantExercise"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WarrantCarryingValueWriteOffAmount" xlink:label="inva_WarrantCarryingValueWriteOffAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_NameOfEventDomain" xlink:to="inva_QualifiedFinancingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCPreferredStockAndWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_IncardaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="inva_OptionPricingModelBacksolveValuationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="inva_NameOfEventAxis" xlink:to="inva_NameOfEventDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="inva_NameOfEventAxis" xlink:to="inva_NameOfEventDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_InCardaConvertibleNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_Incarda2020WarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_ValuationTechniqueAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ConvertibleNoteAndWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_DebtInstrumentTransactionCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesA1PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="inva_NameOfEventAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD1PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfInvesteesBoardMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD2PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD1WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD2WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCWarrantsAndSeriesDWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_ExpectedHoldingPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesDWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_RiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_DividendYield" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesD1AndD2PreferredStockAndCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_PercentageOfEstimatedVolatility" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_ExtendedExpirationDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_ExpirationDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_CarryingValueWroteOffWarrantExercise" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_WarrantCarryingValueWriteOffAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FirstAmendmentMember" xlink:label="inva_FirstAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabMember" xlink:label="inva_ImaginabMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OneOfImaginabsCommonStockholderMember" xlink:label="inva_OneOfImaginabsCommonStockholderMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesC2PreferredStockMember" xlink:label="inva_SeriesC2PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeriesCAndC2PreferredStockAndCommonStockMember" xlink:label="inva_SeriesCAndC2PreferredStockAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabConvertibleNoteMember" xlink:label="inva_ImaginabConvertibleNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TransactionCostsIncurredInConnectionWithEquityInvestment" xlink:label="inva_TransactionCostsIncurredInConnectionWithEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_FirstAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_ImaginabMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_OneOfImaginabsCommonStockholderMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesC2PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_SeriesCAndC2PreferredStockAndCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ImaginabConvertibleNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_TransactionCostsIncurredInConnectionWithEquityInvestment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GateNeuroscienceMember" xlink:label="inva_GateNeuroscienceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCommonStockIssuedDescription" xlink:label="inva_NumberOfCommonStockIssuedDescription"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" xlink:label="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_GateNeuroscienceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCommonStockIssuedDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConsolidatedInvesteesMember" xlink:label="inva_ConsolidatedInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" xlink:label="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NanoliveMember" xlink:label="inva_NanoliveMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SecuritiesPurchaseAgreementAmount" xlink:label="inva_SecuritiesPurchaseAgreementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityInvestmentTransactionCostsIncurred" xlink:label="inva_EquityInvestmentTransactionCostsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" xlink:label="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfBoardMembersOfInvestee" xlink:label="inva_NumberOfBoardMembersOfInvestee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ConsolidatedInvesteesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_NanoliveMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_SecuritiesPurchaseAgreementAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_EquityInvestmentTransactionCostsIncurred" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="inva_NumberOfBoardMembersOfInvestee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataPharmaceuticalsIncMember" xlink:label="inva_ArmataPharmaceuticalsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityInvestmentsAndMoneyMarketFundsMember" xlink:label="inva_EquityInvestmentsAndMoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IspFundLpMember" xlink:label="inva_IspFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSubordinatedDebtFairValueDisclosures" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSeniorDebtFairValueDisclosures" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncardaMember" xlink:label="inva_IncardaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataTermLoanMember" xlink:label="inva_ArmataTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TermLoanInvestmentMember" xlink:label="inva_TermLoanInvestmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ImaginabMember" xlink:label="inva_ImaginabMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatePlacementPositionsAndConvertibleNotesMember" xlink:label="inva_PrivatePlacementPositionsAndConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentValueRightsLiability" xlink:label="inva_ContingentValueRightsLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GateNeuroscienceMember" xlink:label="inva_GateNeuroscienceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtMember" xlink:label="us-gaap_DebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PreferredStockWarrantsMember" xlink:label="inva_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" xlink:label="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" xlink:label="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PartnershipAgreementLockUpPeriod" xlink:label="inva_PartnershipAgreementLockUpPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersContributedCapital" xlink:label="us-gaap_LimitedPartnersContributedCapital"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WithdrawalFromInvestment" xlink:label="inva_WithdrawalFromInvestment"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ArmataPharmaceuticalsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="inva_EquityInvestmentsAndMoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_IspFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ConvertibleSubordinatedDebtFairValueDisclosures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_EquitySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ConvertibleSeniorDebtFairValueDisclosures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_IncardaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="inva_TermLoanInvestmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_ImaginabMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="inva_PrivatePlacementPositionsAndConvertibleNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_ContingentValueRightsLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="inva_GateNeuroscienceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_DebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_PartnershipAgreementLockUpPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LimitedPartnersContributedCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="inva_WithdrawalFromInvestment" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="us-gaap_CapitalizedContractCostLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="us-gaap_CapitalizedContractCostTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostGross" xlink:label="us-gaap_CapitalizedContractCostGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:label="inva_CapitalizedFeesPaidFutureAmortizationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAccumulatedAmortization" xlink:label="us-gaap_CapitalizedContractCostAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_JP" xlink:label="country_JP"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidWeightedAverageUsefulLife" xlink:label="inva_CapitalizedFeesPaidWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" xlink:label="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_CapitalizedContractCostTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_JP" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="inva_CapitalizedFeesPaidWeightedAverageUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CapitalizedContractCostLineItems" xlink:to="inva_CapitalizedFeesPaidFutureAmortizationAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_CapitalizedFeesPaidFutureAmortizationAbstract" xlink:to="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_XacduroMember" xlink:label="inva_XacduroMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BasileaMember" xlink:label="inva_BasileaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UpfrontFee" xlink:label="inva_UpfrontFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_ScheduleOfGoodwillTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_CollaborativeArrangementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_XacduroMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_BasileaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="inva_UpfrontFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MarketedProductsMember" xlink:label="inva_MarketedProductsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsGross" xlink:label="inva_IntangibleAssetsMarketedProductsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementGross" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsNet" xlink:label="inva_IntangibleAssetsMarketedProductsNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementNet" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="inva_MarketedProductsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsMarketedProductsGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CollaborativeArrangementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsCollaborationAgreementGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsMarketedProductsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="inva_IntangibleAssetsCollaborationAgreementNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ZaiLabMember" xlink:label="inva_ZaiLabMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FairValueAdjustmentsOfInventoryFromAcquistion" xlink:label="inva_FairValueAdjustmentsOfInventoryFromAcquistion"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" xlink:label="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationDeferredConsideration" xlink:label="inva_BusinessCombinationDeferredConsideration"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryCurrentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_ZaiLabMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="inva_FairValueAdjustmentsOfInventoryFromAcquistion" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="inva_BusinessCombinationDeferredConsideration" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityIncentivePlan2012Member" xlink:label="inva_EquityIncentivePlan2012Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanMember" xlink:label="inva_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" xlink:label="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EquityIncentivePlan2012Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EmployeeStockPurchasePlanMember" xlink:label="inva_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="inva_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" xlink:label="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaMember" xlink:label="inva_InnovivaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="inva_InnovivaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="us-gaap_ClassOfTreasuryStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis" xlink:label="srt_ShareRepurchaseProgramAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GSKMember" xlink:label="inva_GSKMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain" xlink:label="srt_ShareRepurchaseProgramDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain" xlink:label="srt_ShareRepurchaseProgramDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" xlink:label="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommonStockAcquiredAverageCostPerShare" xlink:label="inva_CommonStockAcquiredAverageCostPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="us-gaap_TreasuryStockCommonValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfTreasuryStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="srt_ShareRepurchaseProgramAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="inva_GSKMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ShareRepurchaseProgramDomain" xlink:to="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="inva_CommonStockAcquiredAverageCostPerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockCommonValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_HealthCareRoyaltyPartnersMember" xlink:label="inva_HealthCareRoyaltyPartnersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeniorUnsecuredConvertibleNotesMember" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OtherAccruedLiabilitiesMember" xlink:label="inva_OtherAccruedLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyFinancingAgreementMember" xlink:label="inva_RoyaltyFinancingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementMaximumPotentialPayoutPercent" xlink:label="inva_RoyaltyAgreementMaximumPotentialPayoutPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" xlink:label="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_MaximumAggregateRoyaltyPaymentsDue" xlink:label="inva_MaximumAggregateRoyaltyPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligations" xlink:label="inva_DeferredRoyaltyObligations"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyPayments" xlink:label="inva_RoyaltyPayments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InterestRateOfDeferredRoyaltyObligation" xlink:label="inva_InterestRateOfDeferredRoyaltyObligation"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" xlink:label="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TotalPaymentsMadeForRoyaltyAgreement" xlink:label="inva_TotalPaymentsMadeForRoyaltyAgreement"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_HealthCareRoyaltyPartnersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="inva_SeniorUnsecuredConvertibleNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentPrincipalAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="inva_OtherAccruedLiabilitiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_RoyaltyFinancingAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementMaximumPotentialPayoutPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_MaximumAggregateRoyaltyPaymentsDue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DeferredRoyaltyObligations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyPayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_InterestRateOfDeferredRoyaltyObligation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_TotalPaymentsMadeForRoyaltyAgreement" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" xlink:label="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InnovivaCommonStockMember" xlink:label="inva_InnovivaCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtAbstract" xlink:label="us-gaap_InterestExpenseDebtAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRemainingBalancePaidUponMaturation" xlink:label="inva_DebtInstrumentRemainingBalancePaidUponMaturation"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" xlink:label="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PutOptionMember" xlink:label="us-gaap_PutOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCapPriceMember" xlink:label="inva_PrivatelyNegotiatedCapPriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfDerivativeInstrumentsPurchased" xlink:label="inva_NumberOfDerivativeInstrumentsPurchased"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeCapPrice" xlink:label="us-gaap_DerivativeCapPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="us-gaap_DebtInstrumentRepurchaseAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" xlink:label="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRepurchasePercentage" xlink:label="inva_DebtInstrumentRepurchasePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="inva_InnovivaCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:to="us-gaap_CallOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="inva_PrivatelyNegotiatedCappedCallOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentRemainingBalancePaidUponMaturation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:to="us-gaap_PutOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="inva_PrivatelyNegotiatedCapPriceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_NumberOfDerivativeInstrumentsPurchased" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseDebtAbstract" xlink:to="us-gaap_InterestExpenseDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OptionIndexedToIssuersEquityStrikePrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DerivativeCapPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepurchasedFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepurchaseAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentRepurchasePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentPrincipalAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebtAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SeniorUnsecuredConvertibleNotesMember" xlink:label="inva_SeniorUnsecuredConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseBorrowingsAbstract" xlink:label="us-gaap_InterestExpenseBorrowingsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyThreeNotesMember" xlink:label="inva_TwoThousandTwentyThreeNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PrivatelyNegotiatedCappedCallOptionMember" xlink:label="inva_PrivatelyNegotiatedCappedCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyFiveNotesMember" xlink:label="inva_TwoThousandTwentyFiveNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_TwoThousandTwentyEightNotesMember" xlink:label="inva_TwoThousandTwentyEightNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeCapPrice" xlink:label="us-gaap_DerivativeCapPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:label="us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" xlink:label="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentConvertibleConversionPremium" xlink:label="inva_DebtInstrumentConvertibleConversionPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" xlink:label="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" xlink:label="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" xlink:label="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCovenantTerms" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PortionOfDebtInstrumentFaceAmountExercised" xlink:label="inva_PortionOfDebtInstrumentFaceAmountExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:label="us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="inva_SeniorUnsecuredConvertibleNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyThreeNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="inva_PrivatelyNegotiatedCappedCallOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyFiveNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="inva_TwoThousandTwentyEightNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterestExpenseBorrowingsAbstract" xlink:to="us-gaap_InterestExpenseDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DerivativeCapPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OptionIndexedToIssuersEquityStrikePrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentConvertibleConversionPremium" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCovenantTerms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_PortionOfDebtInstrumentFaceAmountExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepurchasedFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="inva_DebtInstrumentPrincipalAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseBorrowingsAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CordenPharmaMember" xlink:label="inva_CordenPharmaMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisLeaseMember" xlink:label="inva_EntasisLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BurlingameCaliforniaMember" xlink:label="inva_BurlingameCaliforniaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CommitmentsFor2024ToBeUtilizedIn2025Member" xlink:label="inva_CommitmentsFor2024ToBeUtilizedIn2025Member"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_WalthamMassachusettsMember" xlink:label="inva_WalthamMassachusettsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAllegations" xlink:label="us-gaap_LossContingencyAllegations"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DemandLettersSentByStockholders" xlink:label="inva_DemandLettersSentByStockholders"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_NetRentableArea" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="inva_CordenPharmaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="inva_EntasisLeaseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="inva_BurlingameCaliforniaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="inva_CommitmentsFor2024ToBeUtilizedIn2025Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="inva_WalthamMassachusettsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PurchaseObligationDueInSecondYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PurchaseObligationDueInThirdYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LossContingencyAllegations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="inva_DemandLettersSentByStockholders" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncomeTaxesLineItems" xlink:label="inva_IncomeTaxesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IncomeTaxesTable" xlink:label="inva_IncomeTaxesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EntasisTherapeuticsHoldingsIncMember" xlink:label="inva_EntasisTherapeuticsHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_LaJollaPharmaceuticalCompanyMember" xlink:label="inva_LaJollaPharmaceuticalCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_OperatingLossCarryforwardsIndefinitePeriod" xlink:label="inva_OperatingLossCarryforwardsIndefinitePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetOperatingLossEstimatingDate" xlink:label="inva_NetOperatingLossEstimatingDate"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_FederalNetOperatingLossesEstimatedUtilizationAmount" xlink:label="inva_FederalNetOperatingLossesEstimatedUtilizationAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_StateNetOperatingLossesEstimatedUtilizationAmount" xlink:label="inva_StateNetOperatingLossesEstimatedUtilizationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_IncomeTaxesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_EntasisTherapeuticsHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_IncomeTaxesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="inva_LaJollaPharmaceuticalCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="inva_IncomeTaxesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_OperatingLossCarryforwardsIndefinitePeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_NetOperatingLossEstimatingDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_FederalNetOperatingLossesEstimatedUtilizationAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="inva_StateNetOperatingLossesEstimatedUtilizationAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="inva_IncomeTaxesLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="country_US"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfInventoryFairValueAdjustmentsMember" xlink:label="inva_AmortizationOfInventoryFairValueAdjustmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ExternalServicesMember" xlink:label="inva_ExternalServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InternalExpensesMember" xlink:label="inva_InternalExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="inva_AmortizationOfInventoryFairValueAdjustmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_ExternalServicesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="inva_InternalExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_CostOfRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_SellingAndMarketingExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="srt_ConsolidationItemsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="inva_GainLossOnOtherInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_InterestAndDividendIncomeOperating" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNet" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="inva_EquityMethodInvestment" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ReceivablesLongTermContractsOrPrograms" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_TreasuryStockCommonValue" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_LongTermInvestments" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_CapitalizedContractCostNet" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DebtCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="inva_CurrentPortionOfISPFundInvestments" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="10" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_EquityMethodInvestment" xlink:label="inva_EquityMethodInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesLongTermContractsOrPrograms" xlink:label="us-gaap_ReceivablesLongTermContractsOrPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="us-gaap_TreasuryStockCommonValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CurrentPortionOfISPFundInvestments" xlink:label="inva_CurrentPortionOfISPFundInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="inva_DebtInstrumentPrincipalAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_DebtCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="inva_ContingentValueRightsLiability" order="0" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentValueRightsLiability" xlink:label="inva_ContingentValueRightsLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="inva_IntangibleAssetsMarketedProductsNet" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="inva_IntangibleAssetsCollaborationAgreementNet" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsNet" xlink:label="inva_IntangibleAssetsMarketedProductsNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementNet" xlink:label="inva_IntangibleAssetsCollaborationAgreementNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesInvestments" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesInvestments" xlink:label="us-gaap_DeferredTaxLiabilitiesInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_CostsAndExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfRevenue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="7" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="inva_GainLossOnOtherInvestments" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_InterestAndDividendIncomeOperating" order="9" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_InterestExpense" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GainLossOnOtherInvestments" xlink:label="inva_GainLossOnOtherInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsToMinorityShareholders" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="inva_PurchaseOfEntasisNoncontrollingInterest" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="inva_PurchasesOfTradingSecurityManagedByIspFundLp" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="inva_SaleOfEquityInvestmentsManagedByIspFundLp" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="inva_UnrealizedOtherGainLossOnInvestments" order="11" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" order="11" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="12" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="inva_NetProceedsFromSaleOfVariableInterestEntityEquity" order="13" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" order="16" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="17" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="18" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeconsolidationGainOrLossAmount" order="19" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="22" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="23" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" order="25" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="26" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="27" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="30" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="32" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="33" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="34" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet" order="35" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchaseOfEntasisNoncontrollingInterest" xlink:label="inva_PurchaseOfEntasisNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" xlink:label="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" xlink:label="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" xlink:label="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfUnsecuredDebt" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfTradingSecurityManagedByIspFundLp" xlink:label="inva_PurchasesOfTradingSecurityManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" xlink:label="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_SaleOfEquityInvestmentsManagedByIspFundLp" xlink:label="inva_SaleOfEquityInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_UnrealizedOtherGainLossOnInvestments" xlink:label="inva_UnrealizedOtherGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" xlink:label="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_NetProceedsFromSaleOfVariableInterestEntityEquity" xlink:label="inva_NetProceedsFromSaleOfVariableInterestEntityEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" xlink:label="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeconsolidationGainOrLossAmount" xlink:label="us-gaap_DeconsolidationGainOrLossAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_InterestOnConvertibleDebtNetOfTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="us-gaap_InterestOnConvertibleDebtNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_CapitalizedContractCostAmortization" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" xlink:label="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="inva_RealizedLoss" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_GainLossOnInvestments" order="3" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_RealizedLoss" xlink:label="inva_RealizedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_Goodwill" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" order="11" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="12" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" xlink:label="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="inva_ConvertibleSubordinatedDebtFairValueDisclosures" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="inva_ConvertibleSeniorDebtFairValueDisclosures" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSubordinatedDebtFairValueDisclosures" xlink:label="inva_ConvertibleSubordinatedDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ConvertibleSeniorDebtFairValueDisclosures" xlink:label="inva_ConvertibleSeniorDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CapitalizedContractCostNet" xlink:to="us-gaap_CapitalizedContractCostGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CapitalizedContractCostNet" xlink:to="us-gaap_CapitalizedContractCostAccumulatedAmortization" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostGross" xlink:label="us-gaap_CapitalizedContractCostGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostAccumulatedAmortization" xlink:label="us-gaap_CapitalizedContractCostAccumulatedAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="inva_IntangibleAssetsCollaborationAgreementGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="inva_IntangibleAssetsMarketedProductsGross" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementGross" xlink:label="inva_IntangibleAssetsCollaborationAgreementGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" xlink:label="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" xlink:label="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsMarketedProductsGross" xlink:label="inva_IntangibleAssetsMarketedProductsGross"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" xlink:label="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="inva_AccruedContractManufacturingLiability" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="inva_AccruedClinicalAndResearchLiability" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="inva_AccruedProfessionalServices" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedRoyaltiesCurrent" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="inva_DeferredRoyaltyObligationCurrent" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="inva_AccruedLicenseFeesAndRoyalties" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherLiabilities" order="9" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedContractManufacturingLiability" xlink:label="inva_AccruedContractManufacturingLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedClinicalAndResearchLiability" xlink:label="inva_AccruedClinicalAndResearchLiability"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedProfessionalServices" xlink:label="inva_AccruedProfessionalServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligationCurrent" xlink:label="inva_DeferredRoyaltyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_AccruedLicenseFeesAndRoyalties" xlink:label="inva_AccruedLicenseFeesAndRoyalties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="inva_DeferredRoyaltyObligationNonCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="inva_ContingentValueRightsLiability" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredRoyaltyObligationNonCurrent" xlink:label="inva_DeferredRoyaltyObligationNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_ContingentValueRightsLiability" xlink:label="inva_ContingentValueRightsLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="inva_DebtInstrumentPrincipalAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DebtInstrumentPrincipalAmount" xlink:label="inva_DebtInstrumentPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:label="us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilitiesInvestments" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" xlink:label="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" xlink:label="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesInvestments" xlink:label="us-gaap_DeferredTaxLiabilitiesInvestments"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" xlink:label="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet"/>
          <link:loc xlink:type="locator" xlink:href="inva-20241231.xsd#inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" xlink:label="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="inva_ContingentValueRightsLiability" name="ContingentValueRightsLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementAmount" name="SecuritiesPurchaseAgreementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SeriesA1PreferredStockMember" name="SeriesA1PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TransactionCostsIncurredInConnectionWithEquityInvestment" name="TransactionCostsIncurredInConnectionWithEquityInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization" name="IntangibleAssetsCollaborationAgreementAccumulatedAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NumberOfInvesteesBoardMembers" name="NumberOfInvesteesBoardMembers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_ConvertiblePromissoryNotePurchaseAgreementMember" name="ConvertiblePromissoryNotePurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_OperatingLossCarryforwardsIndefinitePeriod" name="OperatingLossCarryforwardsIndefinitePeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_InterimSupplyAgreementMember" name="InterimSupplyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ArmataConvertibleNoteMember" name="ArmataConvertibleNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ResearchAndDevelopmentSupportMember" name="ResearchAndDevelopmentSupportMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SeriesCAndC2PreferredStockAndCommonStockMember" name="SeriesCAndC2PreferredStockAndCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RegulatoryStartingMaterialMember" name="RegulatoryStartingMaterialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AmortizationOfInventoryFairValueAdjustmentsMember" name="AmortizationOfInventoryFairValueAdjustmentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" name="CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" name="MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ContingentSalesBasedMilestonePayment" name="ContingentSalesBasedMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_InnovivaCommonStockMember" name="InnovivaCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DurlobactamMember" name="DurlobactamMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" name="ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TwoThousandTwentyThreeNotesMember" name="TwoThousandTwentyThreeNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_LicenseRevenueRecognized" name="LicenseRevenueRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_DebtConversionConvertedInstrumentAverageTradePricePercentage" name="DebtConversionConvertedInstrumentAverageTradePricePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" name="PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_LaJollaPharmaceuticalCompanyMember" name="LaJollaPharmaceuticalCompanyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ReductionToResearchAndDevelopmentExpense" name="ReductionToResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" name="MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" name="IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_UnrealizedOtherGainLossOnInvestments" name="UnrealizedOtherGainLossOnInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_EquityInvestmentTransactionCostsIncurred" name="EquityInvestmentTransactionCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" name="PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_CustomerTwoMember" name="CustomerTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_WarrantsAcquiredInSecondQuarterOf2021Member" name="WarrantsAcquiredInSecondQuarterOf2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive" name="PercentageOfRoyaltyPaymentsNotEntitledToReceive" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PresentationReclassificationPolicyTextBlock" name="PresentationReclassificationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_InvestmentsInWarrants" name="InvestmentsInWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" name="PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" name="InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" name="JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_AstrazenecaMember" name="AstrazenecaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment" name="DeferredTaxLiabilitiesInventoryFairValueAdjustment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NameOfEventDomain" name="NameOfEventDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IntangibleAssetsMarketedProductsNet" name="IntangibleAssetsMarketedProductsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" name="ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_WalthamMassachusettsMember" name="WalthamMassachusettsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DebtInstrumentPrincipalAmount" name="DebtInstrumentPrincipalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_MoneyMarketFundAndCash" name="MoneyMarketFundAndCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ConvertibleNoteAndWarrantsMember" name="ConvertibleNoteAndWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_EquityIncentivePlansAndESPPMember" name="EquityIncentivePlansAndESPPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_WarrantsAcquiredInThirdQuarterOf2020Member" name="WarrantsAcquiredInThirdQuarterOf2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DenominatorAbstract" name="DenominatorAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CostReimbursementMember" name="CostReimbursementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_FactorsAffectingComparabilityPolicyTextBlock" name="FactorsAffectingComparabilityPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" name="RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" name="RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" name="DeferredTaxAssetsUnrealizedLossesOnInvestmentNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_PurchasesOfTradingSecurityManagedByIspFundLp" name="PurchasesOfTradingSecurityManagedByIspFundLp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NumberOfDerivativeInstrumentsPurchased" name="NumberOfDerivativeInstrumentsPurchased" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_SeriesCWarrantsAndSeriesDWarrantsMember" name="SeriesCWarrantsAndSeriesDWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IntangibleAssetsInProcessResearchAndDevelopmentNet" name="IntangibleAssetsInProcessResearchAndDevelopmentNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_EntasisLeaseMember" name="EntasisLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SeriesD1AndD2PreferredStockAndCommonStockMember" name="SeriesD1AndD2PreferredStockAndCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" name="TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CashDistributionReceived" name="CashDistributionReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_StrategicAllianceMabaProgram" name="StrategicAllianceMabaProgram" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" name="ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_FederalNetOperatingLossesEstimatedUtilizationAmount" name="FederalNetOperatingLossesEstimatedUtilizationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" name="IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" name="SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_EquityMethodInvestment" name="EquityMethodInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" name="PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_InCardaConvertibleNoteMember" name="InCardaConvertibleNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue" name="LetterAgreementForPurchaseOfMaterialUsedForProductionValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_PurchasesOfEquityInvestmentsManagedByIspFundLp" name="PurchasesOfEquityInvestmentsManagedByIspFundLp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_IncreaseDecreasesInDeferredTaxLiabilities" name="IncreaseDecreasesInDeferredTaxLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_DemandLettersSentByStockholders" name="DemandLettersSentByStockholders" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_WarrantsPurchasedIn2021Member" name="WarrantsPurchasedIn2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DebtInstrumentRemainingBalancePaidUponMaturation" name="DebtInstrumentRemainingBalancePaidUponMaturation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_FuturePotentialMilestonePayment" name="FuturePotentialMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_OwnershipInterestsAndInvestmentsCarryingValue" name="OwnershipInterestsAndInvestmentsCarryingValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_SaleOfEquityInvestmentsManagedByIspFundLp" name="SaleOfEquityInvestmentsManagedByIspFundLp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember" name="ArmataJulyTwoThousandTwentyThreeTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IntangibleAssetsCollaborationAgreementNet" name="IntangibleAssetsCollaborationAgreementNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_PrivatelyHeldHealthcareCompaniesMember" name="PrivatelyHeldHealthcareCompaniesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" name="BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" name="CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CapitalizedFeesPaidFutureAmortizationAbstract" name="CapitalizedFeesPaidFutureAmortizationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DividendYield" name="DividendYield" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PercentageOfEstimatedVolatility" name="PercentageOfEstimatedVolatility" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_LicenseAndCollaborationArrangementsDisclosureTextBlock" name="LicenseAndCollaborationArrangementsDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_LongActingBeta2AgonistAnoroMember" name="LongActingBeta2AgonistAnoroMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" name="RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_CommitmentsFor2024ToBeUtilizedIn2025Member" name="CommitmentsFor2024ToBeUtilizedIn2025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" name="ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SeriesC2PreferredStockMember" name="SeriesC2PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IspFundLpMember" name="IspFundLpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SeriesCPreferredStockAndWarrantsMember" name="SeriesCPreferredStockAndWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_NameOfEventAxis" name="NameOfEventAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_StrategicAllianceAgreementMember" name="StrategicAllianceAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_NetOperatingLossEstimatingDate" name="NetOperatingLossEstimatingDate" type="dtr-types:gYearListItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_ArmataMarchTwoThousandTwentyFourTermLoanMember" name="ArmataMarchTwoThousandTwentyFourTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DecreaseToAccumulatedDeficit" name="DecreaseToAccumulatedDeficit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_TwoDirectorsMember" name="TwoDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_LicenseAndOtherRevenue" name="LicenseAndOtherRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SeriesCWarrantsMember" name="SeriesCWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee" name="SpecialTermReDesignatingBoardMemberToBoardOfInvestee" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_IntangibleAssetsMarketedProductsAccumulatedAmortization" name="IntangibleAssetsMarketedProductsAccumulatedAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NanoliveMember" name="NanoliveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" name="CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_HarvardUniversityMember" name="HarvardUniversityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_Outstanding2028NotesMember" name="Outstanding2028NotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ConsolidatedEntitiesDisclosureAbstract" name="ConsolidatedEntitiesDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RealizedLoss" name="RealizedLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CommercialSupplyAgreementMember" name="CommercialSupplyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TrelegyElliptaMember" name="TrelegyElliptaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_WithdrawalFromInvestment" name="WithdrawalFromInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_PercentageOfEconomicInterestInPartnership" name="PercentageOfEconomicInterestInPartnership" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_DeferredRoyaltyObligationCurrent" name="DeferredRoyaltyObligationCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_FirstAmendmentMember" name="FirstAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RoyaltyFinancingAgreementMember" name="RoyaltyFinancingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SoftwareAndComputerEquipmentMember" name="SoftwareAndComputerEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage" name="DebtConversionCommonStockPriceToConversionPriceRatioPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_WarrantsPurchasedIn2022Member" name="WarrantsPurchasedIn2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AccruedProfessionalServices" name="AccruedProfessionalServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NetProceedsFromSaleOfVariableInterestEntityEquity" name="NetProceedsFromSaleOfVariableInterestEntityEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_NonCashActivity" name="NonCashActivity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ExpirationDate" name="ExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" name="GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" name="OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_Percent2.50ConvertibleDebtMember" name="Percent2.50ConvertibleDebtMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RelatedPartyTransactionsPolicyTextBlock" name="RelatedPartyTransactionsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" name="InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_RoyaltyPayments" name="RoyaltyPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_GateNeuroscienceMember" name="GateNeuroscienceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_NetInvestmentRelatedIncomeExpensesEarnedInccured" name="NetInvestmentRelatedIncomeExpensesEarnedInccured" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_XacduroMember" name="XacduroMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TermOfMilestonePaymentForCommercialSale" name="TermOfMilestonePaymentForCommercialSale" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CapitalizedFeesPaidPolicyTextBlock" name="CapitalizedFeesPaidPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CapitalizedFeesPaidWeightedAverageUsefulLife" name="CapitalizedFeesPaidWeightedAverageUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SalesMilestonePaymentsReceivable" name="SalesMilestonePaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" name="SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_PrivatelyNegotiatedCappedCallOptionMember" name="PrivatelyNegotiatedCappedCallOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_LicenseAndOtherRevenueMember" name="LicenseAndOtherRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CreditAndSecurityAgreementMember" name="CreditAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DeferredRoyaltyObligationNonCurrent" name="DeferredRoyaltyObligationNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_IncardaMember" name="IncardaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ManufacturingStageTransferAgreementMember" name="ManufacturingStageTransferAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ParatekPharmaceuticalsIncMember" name="ParatekPharmaceuticalsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment" name="BusinessAcquisitionsOfChangeInFairValueOfInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_AmendedZaiAgreementMember" name="AmendedZaiAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_EquityInvestmentsAndMoneyMarketFundsMember" name="EquityInvestmentsAndMoneyMarketFundsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_BusinessCombinationIndemnificationAssetsUsedForProduction" name="BusinessCombinationIndemnificationAssetsUsedForProduction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_TotalPaymentsMadeForRoyaltyAgreement" name="TotalPaymentsMadeForRoyaltyAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SarissaCapitalManagementLpMember" name="SarissaCapitalManagementLpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AccruedInterestIncomeIncludedInLongTermInvestments" name="AccruedInterestIncomeIncludedInLongTermInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ConvertibleSubordinatedDebtFairValueDisclosures" name="ConvertibleSubordinatedDebtFairValueDisclosures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_ReductionToAdditionalPaidInCapital" name="ReductionToAdditionalPaidInCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_CurrentPortionOfISPFundInvestments" name="CurrentPortionOfISPFundInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ImaginabMember" name="ImaginabMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" name="NumberOfSharesReceivableOnSettlementOfDerivativeInstrument" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" name="PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_OutstandingStockWarrantMember" name="OutstandingStockWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" name="ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" name="CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_OneOfImaginabsCommonStockholderMember" name="OneOfImaginabsCommonStockholderMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ConsolidatedEntitiesAndAcquisitionsLineItems" name="ConsolidatedEntitiesAndAcquisitionsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DebtInstrumentTransactionCost" name="DebtInstrumentTransactionCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_NumberOfCustomers" name="NumberOfCustomers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_MarketedProductsMember" name="MarketedProductsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_NetIncomeLossPerShareAbstract" name="NetIncomeLossPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ArmataPharmaceuticalsIncMember" name="ArmataPharmaceuticalsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" name="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PreferredStockWarrantsMember" name="PreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CapitalizedFeesPaidDisclosureTextBlock" name="CapitalizedFeesPaidDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_AmountOnNetProductSalesRecognized" name="AmountOnNetProductSalesRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_TheravanceRespiratoryCompanyLlcMember" name="TheravanceRespiratoryCompanyLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" name="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" name="CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CostReimbursements" name="CostReimbursements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" name="ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" name="CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_EverestMedicinesLimitedMember" name="EverestMedicinesLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" name="FairValueOfAssetsOrLiabilitiesTransferBetweenLevels" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" name="MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_CommonStockAndWarrantsMember" name="CommonStockAndWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" name="ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ConsolidatedEntitiesAndAcquisitionsTextBlock" name="ConsolidatedEntitiesAndAcquisitionsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PrivatePlacementPositionsAndConvertibleNotesMember" name="PrivatePlacementPositionsAndConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ExpectedHoldingPeriod" name="ExpectedHoldingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_WarrantsPurchasedIn2020Member" name="WarrantsPurchasedIn2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_PercentageOfRoyaltyPayableOnNetSales" name="PercentageOfRoyaltyPayableOnNetSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" name="ShareRepurchaseAgreementWithGlaxoGroupLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" name="DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_XeravaMember" name="XeravaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_InvestmentsInPreferredStock" name="InvestmentsInPreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ConsolidatedInvesteesMember" name="ConsolidatedInvesteesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TwoThousandTwentyFiveNotesMember" name="TwoThousandTwentyFiveNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RoyaltyAgreementMaximumPotentialPayoutPercent" name="RoyaltyAgreementMaximumPotentialPayoutPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PrivatelyNegotiatedCapPriceMember" name="PrivatelyNegotiatedCapPriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AccruedRoyaltyObligations" name="AccruedRoyaltyObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" name="ConvertiblePromissoryNotePurchaseAgreementAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SeriesD2WarrantMember" name="SeriesD2WarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TermOfMilestonePaymentForNetSales" name="TermOfMilestonePaymentForNetSales" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" name="ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_IntangibleAssetsMarketedProductsGross" name="IntangibleAssetsMarketedProductsGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_DebtInstrumentRepurchasePercentage" name="DebtInstrumentRepurchasePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_NumberOfCommonStockIssuedDescription" name="NumberOfCommonStockIssuedDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_GainLossOnOtherInvestments" name="GainLossOnOtherInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" name="PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" name="RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ExternalServicesMember" name="ExternalServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ImaginabConvertibleNoteMember" name="ImaginabConvertibleNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TermLoanInvestmentMember" name="TermLoanInvestmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" name="SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_DescriptionOfOperationsPolicyTextBlock" name="DescriptionOfOperationsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_Rule10B51ArrModifiedFlag" name="Rule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SeniorUnsecuredConvertibleNotesMember" name="SeniorUnsecuredConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ZoliflodacinMember" name="ZoliflodacinMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_MaximumAggregateRoyaltyPaymentsDue" name="MaximumAggregateRoyaltyPaymentsDue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_PercentageOfMinimumRoyaltyRate" name="PercentageOfMinimumRoyaltyRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" name="ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_OptionPricingModelBacksolveValuationMember" name="OptionPricingModelBacksolveValuationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" name="CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_WarrantCarryingValueWriteOffAmount" name="WarrantCarryingValueWriteOffAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" name="RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_EquityIncentivePlan2012Member" name="EquityIncentivePlan2012Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ClaimExpirationDate" name="ClaimExpirationDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_NumeratorAbstract" name="NumeratorAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_LaJollaMember" name="LaJollaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" name="AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" name="SaleOfWarrantsNumberOfWarrantsIssuedInTransaction" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_DebtInstrumentConvertibleConversionPremium" name="DebtInstrumentConvertibleConversionPremium" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_PubliclyTradedHealthcareCompaniesMember" name="PubliclyTradedHealthcareCompaniesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IntangibleAssetsInProcessResearchAndDevelopmentGross" name="IntangibleAssetsInProcessResearchAndDevelopmentGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementNumberOfTranches" name="SecuritiesPurchaseAgreementNumberOfTranches" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_GiaprezaMember" name="GiaprezaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CustomerOneMember" name="CustomerOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_InternalExpensesMember" name="InternalExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CollaborativeArrangementsMember" name="CollaborativeArrangementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" name="DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_IncreaseToConvertibleNotes" name="IncreaseToConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CapitalizedFeePaidEstimatedUsefulLife" name="CapitalizedFeePaidEstimatedUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_LongActingBeta2AgonistRelvarBreoMember" name="LongActingBeta2AgonistRelvarBreoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_BurlingameCaliforniaMember" name="BurlingameCaliforniaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_InterestRateOfDeferredRoyaltyObligation" name="InterestRateOfDeferredRoyaltyObligation" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_GSKMember" name="GSKMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RightOfUseAssetsObtainedThroughAcquistions" name="RightOfUseAssetsObtainedThroughAcquistions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CordenPharmaMember" name="CordenPharmaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" name="NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_ProfitLossShares" name="ProfitLossShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" name="ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember" name="EmployeeStockPurchasePlanTwentyTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AccruedContractManufacturingLiability" name="AccruedContractManufacturingLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo" name="CollaborativeArrangementRoyaltyRateDefinedLevelTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_BusinessCombinationDeferredConsideration" name="BusinessCombinationDeferredConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NonRule10B51ArrModifiedFlag" name="NonRule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_OneDirectorMember" name="OneDirectorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" name="DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_IntangibleAssetsCollaborationAgreementGross" name="IntangibleAssetsCollaborationAgreementGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_OwnershipInterestInConsolidatedEntities" name="OwnershipInterestInConsolidatedEntities" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_LaboratoryEquipmentFurnitureAndFixturesMember" name="LaboratoryEquipmentFurnitureAndFixturesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" name="RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_DeferredTaxLiabilitiesDepreciationAndAmortization1" name="DeferredTaxLiabilitiesDepreciationAndAmortization1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" name="RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SeriesD1WarrantMember" name="SeriesD1WarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_AccruedClinicalAndResearchLiability" name="AccruedClinicalAndResearchLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_IncreaseDecreaseInDeferredTaxLiabilities" name="IncreaseDecreaseInDeferredTaxLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_NumberOfBoardMembersOfInvestee" name="NumberOfBoardMembersOfInvestee" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_InnovivaMember" name="InnovivaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_InvestmentsInCommonStock" name="InvestmentsInCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" name="SubscriptionAgreementOneTimeMilestonePaymentOnNetSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_OtherAccruedLiabilitiesMember" name="OtherAccruedLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_StateNetOperatingLossesEstimatedUtilizationAmount" name="StateNetOperatingLossesEstimatedUtilizationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_CarryingValueWroteOffWarrantExercise" name="CarryingValueWroteOffWarrantExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_LimitedPartnersInitialContributionSubjectToLockUp" name="LimitedPartnersInitialContributionSubjectToLockUp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" name="NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SeriesD1PreferredStockMember" name="SeriesD1PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ReclassificationOfCurrentPortion" name="ReclassificationOfCurrentPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" name="CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ArmataTermLoanMember" name="ArmataTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" name="SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" name="SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_WarrantsAcquiredInSecondQuarterOf2020Member" name="WarrantsAcquiredInSecondQuarterOf2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_UpfrontFee" name="UpfrontFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_RiskFreeInterestRate" name="RiskFreeInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PaionAgMember" name="PaionAgMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" name="AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ConvertiblePromissoryNoteMember" name="ConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ZaiLabMember" name="ZaiLabMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_SulbactamDurlobactamMember" name="SulbactamDurlobactamMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CommonStockAcquiredAverageCostPerShare" name="CommonStockAcquiredAverageCostPerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_UpfrontPaymentUnderIntangibleAsset" name="UpfrontPaymentUnderIntangibleAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" name="CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax" name="TreasuryStockSharesAcquiredIncludingAccruedExciseTax" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PriorPeriodImmaterialCorrectionPolicyTextBlock" name="PriorPeriodImmaterialCorrectionPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" name="AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_IncreaseDecreaseInDeferredTaxAssets" name="IncreaseDecreaseInDeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" name="ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne" name="CollaborativeArrangementRoyaltyRateDefinedLevelOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PurchaseOfEntasisNoncontrollingInterest" name="PurchaseOfEntasisNoncontrollingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_VotingAgreementMaximumVotingRightsPercent" name="VotingAgreementMaximumVotingRightsPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_TechnologyTransferAgreementMember" name="TechnologyTransferAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_TwoThousandTwentyEightNotesMember" name="TwoThousandTwentyEightNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IncomeTaxesLineItems" name="IncomeTaxesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SeriesD2PreferredStockMember" name="SeriesD2PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_DeferredTaxAssetsDeferredRoyaltyObligationNet" name="DeferredTaxAssetsDeferredRoyaltyObligationNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" name="DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_PartnershipAgreementLockUpPeriod" name="PartnershipAgreementLockUpPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" name="ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_Incarda2020WarrantsMember" name="Incarda2020WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_LabaCollaborationMember" name="LabaCollaborationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_IncreaseInDeferredTaxAssets" name="IncreaseInDeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_NumberOfMajorCustomers" name="NumberOfMajorCustomers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CustomerThreeMember" name="CustomerThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_EntasisTherapeuticsHoldingsIncMember" name="EntasisTherapeuticsHoldingsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_DeferredRoyaltyObligations" name="DeferredRoyaltyObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" name="DerecognitionOfNoncontrollingInterestsUponSaleOfTrc" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="inva_PortionOfDebtInstrumentFaceAmountExercised" name="PortionOfDebtInstrumentFaceAmountExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_SeriesDWarrantsMember" name="SeriesDWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_FairValueAdjustmentsOfInventoryFromAcquistion" name="FairValueAdjustmentsOfInventoryFromAcquistion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_HealthCareRoyaltyPartnersMember" name="HealthCareRoyaltyPartnersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock" name="CapitalizedFeesPaidToRelatedPartyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_SecuredConvertibleCreditAgreementMember" name="SecuredConvertibleCreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_RegulatoryMilestonePaymentsReceivable" name="RegulatoryMilestonePaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_LockUpExpirationDate" name="LockUpExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_QualifiedFinancingMember" name="QualifiedFinancingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_GeorgeWashingtonUniversityMember" name="GeorgeWashingtonUniversityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" name="ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" name="CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_ExtendedExpirationDate" name="ExtendedExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_IncomeTaxesTable" name="IncomeTaxesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" name="ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" name="AmortizationOfFairValueAdjustmentsOfCostOfProductsSold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" name="AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="inva_BasileaMember" name="BasileaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="inva_ConvertibleSeniorDebtFairValueDisclosures" name="ConvertibleSeniorDebtFairValueDisclosures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="inva_AccruedLicenseFeesAndRoyalties" name="AccruedLicenseFeesAndRoyalties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198753584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 14, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INNOVIVA, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3265960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1350 Old Bayshore Highway, Suite 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Burlingame<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">238-9600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 899,110,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,675,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001080014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specified portions of the registrant&#8217;s definitive Proxy Statement to be issued in conjunction with the registrant&#8217;s 2025 Annual Meeting of Stockholders, which is expected to be filed not later than 120 days after the registrant&#8217;s fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, are incorporated by reference into Part III of this Annual Report. Except as expressly incorporated by reference, the registrant&#8217;s Proxy Statement shall not be deemed to be a part of this Annual Report on Form 10-K.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Jose, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Innoviva, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, stockholders&#8217; equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 26, 2025, expressed an unqualified opinion on the Company's internal control over financial reporting.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201515104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 304,964<span></span>
</td>
<td class="nump">$ 193,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">20,392<span></span>
</td>
<td class="nump">14,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesLongTermContractsOrPrograms', window );">Receivable from collaboration arrangements</a></td>
<td class="nump">65,974<span></span>
</td>
<td class="nump">69,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">33,725<span></span>
</td>
<td class="nump">40,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses</a></td>
<td class="nump">21,063<span></span>
</td>
<td class="nump">21,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CurrentPortionOfISPFundInvestments', window );">Current portion of ISP Fund investments</a></td>
<td class="nump">107,532<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">656<span></span>
</td>
<td class="nump">4,264<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">554,306<span></span>
</td>
<td class="nump">344,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">514<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_EquityMethodInvestment', window );">Equity method investments</a></td>
<td class="nump">52,293<span></span>
</td>
<td class="nump">116,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Equity and long-term investments</a></td>
<td class="nump">341,664<span></span>
</td>
<td class="nump">444,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized fees paid, net</a></td>
<td class="nump">69,961<span></span>
</td>
<td class="nump">83,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">17,905<span></span>
</td>
<td class="nump">17,905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">208,433<span></span>
</td>
<td class="nump">230,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">12,054<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">41,477<span></span>
</td>
<td class="nump">3,267<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,301,060<span></span>
</td>
<td class="nump">1,243,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">6,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued personnel-related expenses</a></td>
<td class="nump">7,376<span></span>
</td>
<td class="nump">7,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest payable</a></td>
<td class="nump">3,422<span></span>
</td>
<td class="nump">3,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Convertible notes, due 2025, net of issuance costs</a></td>
<td class="nump">192,028<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Other accrued liabilities</a></td>
<td class="nump">29,999<span></span>
</td>
<td class="nump">19,698<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">236,083<span></span>
</td>
<td class="nump">38,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of discount and issuance costs</a></td>
<td class="nump">256,316<span></span>
</td>
<td class="nump">446,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">64,275<span></span>
</td>
<td class="nump">71,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income tax payable, long-term</a></td>
<td class="nump">53,227<span></span>
</td>
<td class="nump">11,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.01 par value, 200,000 shares authorized, 62,665 and 63,307 issued and outstanding as of December 31, 2024 and 2023 respectively</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock: at cost, nil and, 32,005 shares as of December 31, 2024 and 2023, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(393,829)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">692,329<span></span>
</td>
<td class="nump">1,093,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,797)<span></span>
</td>
<td class="num">(25,189)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">691,159<span></span>
</td>
<td class="nump">674,955<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,301,060<span></span>
</td>
<td class="nump">$ 1,243,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CurrentPortionOfISPFundInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current portion of ISP Fund investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CurrentPortionOfISPFundInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_EquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_EquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be collected within one year of the balance sheet date (or one operating cycle, if longer) from customers in accordance with the contractual provisions of long-term contracts or programs including amounts billed and unbilled as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563194166304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">62,665<span></span>
</td>
<td class="nump">63,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">62,665<span></span>
</td>
<td class="nump">63,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">32,005<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203146112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 358,711<span></span>
</td>
<td class="nump">$ 310,463<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">115,690<span></span>
</td>
<td class="nump">98,232<span></span>
</td>
<td class="nump">63,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">13,654<span></span>
</td>
<td class="nump">33,922<span></span>
</td>
<td class="nump">41,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">25,902<span></span>
</td>
<td class="nump">21,784<span></span>
</td>
<td class="nump">5,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on sale of Theravance Respiratory Company, LLC ("TRC")</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(266,696)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Changes in fair values of equity method investments, net</a></td>
<td class="nump">64,253<span></span>
</td>
<td class="num">(77,392)<span></span>
</td>
<td class="nump">161,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GainLossOnOtherInvestments', window );">Changes in fair value of equity and long-term investments, net</a></td>
<td class="nump">59,161<span></span>
</td>
<td class="num">(11,129)<span></span>
</td>
<td class="num">(8,462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest and dividend income</a></td>
<td class="num">(19,141)<span></span>
</td>
<td class="num">(15,818)<span></span>
</td>
<td class="num">(6,369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">22,209<span></span>
</td>
<td class="nump">19,157<span></span>
</td>
<td class="nump">15,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">3,373<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses, net</a></td>
<td class="nump">321,323<span></span>
</td>
<td class="nump">116,365<span></span>
</td>
<td class="nump">44,390<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">37,388<span></span>
</td>
<td class="nump">194,098<span></span>
</td>
<td class="nump">286,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense, net</a></td>
<td class="nump">13,996<span></span>
</td>
<td class="nump">14,376<span></span>
</td>
<td class="nump">66,687<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">179,722<span></span>
</td>
<td class="nump">220,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Innoviva stockholders</a></td>
<td class="nump">$ 23,392<span></span>
</td>
<td class="nump">$ 179,722<span></span>
</td>
<td class="nump">$ 213,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to Innoviva stockholders</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 3.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to Innoviva stockholders</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 2.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares used to compute Innoviva basic and diluted net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute basic net income per share</a></td>
<td class="nump">62,726<span></span>
</td>
<td class="nump">65,435<span></span>
</td>
<td class="nump">69,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted net income per share</a></td>
<td class="nump">74,187<span></span>
</td>
<td class="nump">86,876<span></span>
</td>
<td class="nump">95,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 241,733<span></span>
</td>
<td class="nump">$ 238,846<span></span>
</td>
<td class="nump">$ 311,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">97,492<span></span>
</td>
<td class="nump">60,617<span></span>
</td>
<td class="nump">19,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets)</a></td>
<td class="nump">36,598<span></span>
</td>
<td class="nump">41,040<span></span>
</td>
<td class="nump">13,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_LicenseAndOtherRevenueMember', window );">License and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">19,486<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of license revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_GainLossOnOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on other investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_GainLossOnOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LicenseAndOtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LicenseAndOtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201451856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) - Royalty revenue - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized fees paid</a></td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized fees paid</a></td>
<td class="nump">$ 13,823<span></span>
</td>
<td class="nump">$ 13,823<span></span>
</td>
<td class="nump">$ 13,823<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563346512800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 23,392<span></span>
</td>
<td class="nump">$ 179,722<span></span>
</td>
<td class="nump">$ 220,262<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">179,722<span></span>
</td>
<td class="nump">220,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Innoviva stockholders</a></td>
<td class="nump">$ 23,392<span></span>
</td>
<td class="nump">$ 179,722<span></span>
</td>
<td class="nump">$ 213,921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202168240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative effect period of adoption adjustment member</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th">
<div>Common stock </div>
<div>Cumulative effect period of adoption adjustment member</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative effect period of adoption adjustment member</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative effect period of adoption adjustment member</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th">
<div>Treasury Stock </div>
<div>Cumulative effect period of adoption adjustment member</div>
</th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th">
<div>Noncontrolling Interest </div>
<div>Cumulative effect period of adoption adjustment member</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 525,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 696,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,264,024,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (456,148,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (393,829,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,566,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,005,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(69,811,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,811,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares', window );">Distributions to noncontrolling interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis', window );">Recognition of noncontrolling interest upon initial consolidation of Entasis</a></td>
<td class="nump">38,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares', window );">Recognition of noncontrolling interest upon initial consolidation of Entasis (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity', window );">Equity activity of noncontrolling interest in a consolidated variable interest entity</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares', window );">Equity activity of noncontrolling interests in a consolidated variable interest entity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc', window );">Derecognition of noncontrolling interests upon sale of TRC</a></td>
<td class="num">(61,226,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,304,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares', window );">Derecognition of noncontrolling interests upon sale of TRC (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest', window );">Derecognition of noncontrolling interests upon acquisition of Entasis noncontrolling interest</a></td>
<td class="num">(42,162,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,153,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,009,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares', window );">Derecognition of noncontrolling interests upon acquisition of Entasis noncontrolling interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding</a></td>
<td class="nump">288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Capped call options associated with convertible senior notes due 2028</a></td>
<td class="num">(16,585,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,585,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares', window );">Capped call options associated with convertible senior notes due 2028 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Conversion of convertible subordinated notes due 2023</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible subordinated notes due 2023 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(8,503,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,497,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(647,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased and retired during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchased and retired during period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">220,262,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,921,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,341,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ProfitLossShares', window );">Net income (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">565,788,000<span></span>
</td>
<td class="num">$ (28,229,000)<span></span>
</td>
<td class="nump">$ 692,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,163,836,000<span></span>
</td>
<td class="num">$ (65,467,000)<span></span>
</td>
<td class="num">(204,911,000)<span></span>
</td>
<td class="nump">$ 37,238,000<span></span>
</td>
<td class="num">$ (393,829,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,188,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,005,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding</a></td>
<td class="nump">92,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax', window );">Repurchase of common stock, including accrued excise tax</a></td>
<td class="num">(76,484,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (62,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,422,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax', window );">Repurchase of common stock, including accrued excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,174,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">5,837,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,837,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased and retired during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchased and retired during period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,173,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">179,722,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,722,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ProfitLossShares', window );">Net income (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 674,955,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 633,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,189,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (393,829,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">63,307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,005,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding</a></td>
<td class="nump">$ 1,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,321,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax', window );">Repurchase of common stock, including accrued excise tax</a></td>
<td class="num">(14,925,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,916,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax', window );">Repurchase of common stock, including accrued excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(987,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability', window );">Accrued excise tax on common stock repurchase applied against tax liability</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,374,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,374,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased and retired during period, value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(393,829,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393,829,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchased and retired during period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,005,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">23,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ProfitLossShares', window );">Net income (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 691,159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 692,329,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,797,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">62,665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued excise tax on common stock repurchase applied against tax liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital equity component of convertible debt in shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital share based compensation requisite service period recognition shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes to noncontrolling interest from a consolidated variable interest entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes to noncontrolling interest from a consolidated variable interest entity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognition of non controlling interests upon acquisition of entasis minority interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognition of nonControlling interests upon acquisition of entasis minority interest shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognition of noncontrolling interestsupon sale of TRC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognition of noncontrolling interests upon sale of trc shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minority interest decrease from distributions to noncontrolling interest holders shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ProfitLossShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Profit Loss Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ProfitLossShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition Of Noncontrolling Interest Upon Initial Consolidation Of Entasis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition of noncontrolling interest upon initial consolidation of Entasis, Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury stock shares acquired including accrued excise tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury stock value acquired cost method including accrued excise tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 80: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-51<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203253088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 23,392<span></span>
</td>
<td class="nump">$ 179,722<span></span>
</td>
<td class="nump">$ 220,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(12,617)<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="nump">25,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment', window );">Amortization of capitalized fees and depreciation of property and equipment</a></td>
<td class="nump">13,951<span></span>
</td>
<td class="nump">13,921<span></span>
</td>
<td class="nump">13,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">25,902<span></span>
</td>
<td class="nump">21,784<span></span>
</td>
<td class="nump">5,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales', window );">Inventory fair value step-up adjustment included in cost of products sold</a></td>
<td class="nump">13,820<span></span>
</td>
<td class="nump">27,164<span></span>
</td>
<td class="nump">10,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">6,374<span></span>
</td>
<td class="nump">5,837<span></span>
</td>
<td class="nump">7,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
<td class="nump">2,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Changes in fair values of equity method investments, net</a></td>
<td class="nump">64,253<span></span>
</td>
<td class="num">(77,392)<span></span>
</td>
<td class="nump">161,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_UnrealizedOtherGainLossOnInvestments', window );">Changes in fair values of equity and long-term investments, net</a></td>
<td class="nump">59,161<span></span>
</td>
<td class="num">(11,129)<span></span>
</td>
<td class="num">(8,462)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Net gain on sale of TRC</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(266,696)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="num">(722)<span></span>
</td>
<td class="num">(517)<span></span>
</td>
<td class="nump">3,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(5,938)<span></span>
</td>
<td class="num">(5,053)<span></span>
</td>
<td class="num">(3,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent', window );">Receivables from collaboration arrangements</a></td>
<td class="nump">3,647<span></span>
</td>
<td class="num">(14,949)<span></span>
</td>
<td class="nump">13,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(6,808)<span></span>
</td>
<td class="num">(12,004)<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">7,929<span></span>
</td>
<td class="num">(21,350)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(38,186)<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="num">(3,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(4,585)<span></span>
</td>
<td class="nump">3,778<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued personnel-related expenses and other accrued liabilities</a></td>
<td class="nump">3,044<span></span>
</td>
<td class="num">(1,498)<span></span>
</td>
<td class="nump">11,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(937)<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(817)<span></span>
</td>
<td class="num">(755)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="nump">41,476<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="nump">10,026<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">188,690<span></span>
</td>
<td class="nump">141,064<span></span>
</td>
<td class="nump">201,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible asset</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchases of equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of trading securities</a></td>
<td class="num">(59,617)<span></span>
</td>
<td class="num">(65,132)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchases of equity and long-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(13,725)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PurchasesOfEquityInvestmentsManagedByIspFundLp', window );">Purchases of equity investments managed by ISP Fund LP</a></td>
<td class="num">(32,270)<span></span>
</td>
<td class="num">(31,164)<span></span>
</td>
<td class="num">(60,910)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PurchasesOfTradingSecurityManagedByIspFundLp', window );">Purchases of trading security managed by ISP Fund LP</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SaleOfEquityInvestmentsManagedByIspFundLp', window );">Sales of equity investments managed by ISP Fund LP</a></td>
<td class="nump">75,756<span></span>
</td>
<td class="nump">72,500<span></span>
</td>
<td class="nump">24,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp', window );">Purchases and sales of other investments managed by ISP Fund LP, net</a></td>
<td class="num">(43,486)<span></span>
</td>
<td class="num">(41,336)<span></span>
</td>
<td class="num">(23,371)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(270)<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Sale of property and equipment</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NetProceedsFromSaleOfVariableInterestEntityEquity', window );">Proceeds from sale of ownership interest in TRC, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">248,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired through the consolidation of Entasis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired', window );">Cash paid for the acquisition of La Jolla, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(159,103)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(63,786)<span></span>
</td>
<td class="num">(66,761)<span></span>
</td>
<td class="num">(56,634)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(69,811)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PurchaseOfEntasisNoncontrollingInterest', window );">Purchase of Entasis noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(43,910)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(14,777)<span></span>
</td>
<td class="num">(75,728)<span></span>
</td>
<td class="num">(8,503)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy tax withholding</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuances of common stock, net</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Payment for repurchase of convertible subordinated notes due 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(96,204)<span></span>
</td>
<td class="num">(165,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes', window );">Purchases of capped call options associated with convertible senior notes due 2028</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,037)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of convertible senior notes due 2028, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">252,536<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(13,453)<span></span>
</td>
<td class="num">(171,839)<span></span>
</td>
<td class="num">(55,568)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">111,451<span></span>
</td>
<td class="num">(97,536)<span></span>
</td>
<td class="nump">89,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">193,513<span></span>
</td>
<td class="nump">291,049<span></span>
</td>
<td class="nump">201,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">304,964<span></span>
</td>
<td class="nump">193,513<span></span>
</td>
<td class="nump">291,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">10,359<span></span>
</td>
<td class="nump">11,381<span></span>
</td>
<td class="nump">11,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">11,793<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">53,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental Disclosure of Non-cash Investing and Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedInterestIncomeIncludedInLongTermInvestments', window );">Accrued interest income converted to long-term investments</a></td>
<td class="nump">3,584<span></span>
</td>
<td class="nump">2,666<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NonCashActivity', window );">Adoption of ASU 2020-06</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (28,228)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedInterestIncomeIncludedInLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest income included in long-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedInterestIncomeIncludedInLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of capitalized fees and depreciation of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for the acquisition of La Jolla Pharmaceutical Company, net of cash acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory fair value step-up adjustment included in cost of product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NetProceedsFromSaleOfVariableInterestEntityEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds from sale of variable interest entity equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NetProceedsFromSaleOfVariableInterestEntityEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NonCashActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NonCashActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase and sale of other investments managed by ISP FUND LP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PurchaseOfEntasisNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of entasis noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PurchaseOfEntasisNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases of capped call options associated with convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PurchasesOfEquityInvestmentsManagedByIspFundLp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases of Equity Investments Managed by Isp Fund Lp</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PurchasesOfEquityInvestmentsManagedByIspFundLp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PurchasesOfTradingSecurityManagedByIspFundLp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases of trading security managed by Isp fund Lp.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PurchasesOfTradingSecurityManagedByIspFundLp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SaleOfEquityInvestmentsManagedByIspFundLp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of equity investments managed by ISP FUND LP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SaleOfEquityInvestmentsManagedByIspFundLp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_UnrealizedOtherGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized other gain loss on investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_UnrealizedOtherGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201269536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1C.   CYBERSECURITY</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk Management and Strategy</span></p><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conduct risk assessments to identify cybersecurity threats at least annually, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats.  These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards.  We devote internal and external resources and designate high-level personnel to manage the risk assessment and mitigation process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with human resources, IT, legal, and management. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We engage internal auditors and other third parties in connection with our risk assessment processes. These service providers assist us in designing and implementing our cybersecurity policies and procedures, as well as to monitor and test our safeguards.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, we did not identify any risks from known cybersecurity threats, including because of any prior cybersecurity incidents, that have materially affected us. However, in the future, we may face certain ongoing cybersecurity risks or threats that, if realized, are reasonably likely to materially affect us. Additional information on cybersecurity risks we face is discussed in Part I, Item 1A, &#8220;Risk Factors,&#8221; under the heading &#8220;Our operations could be disrupted by failure of our information systems or cyber-attacks.&#8221;</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They oversee our cybersecurity policies and processes, including those described in &#8220;Risk Management and Strategy&#8221; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They provide briefings to the audit committee regarding our company&#8217;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.</span></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, we did not identify any risks from known cybersecurity threats, including because of any prior cybersecurity incidents, that have materially affected us. However, in the future, we may face certain ongoing cybersecurity risks or threats that, if realized, are reasonably likely to materially affect us. Additional information on cybersecurity risks we face is discussed in Part I, Item 1A, &#8220;Risk Factors,&#8221; under the heading &#8220;Our operations could be disrupted by failure of our information systems or cyber-attacks.&#8221;</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They oversee our cybersecurity policies and processes, including those described in &#8220;Risk Management and Strategy&#8221; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They provide briefings to the audit committee regarding our company&#8217;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.</span></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They oversee our cybersecurity policies and processes, including those described in &#8220;Risk Management and Strategy&#8221; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">They provide briefings to the audit committee regarding our company&#8217;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.</span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299930848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_Rule10B51ArrModifiedFlag', window );">Rule 10b51Arrangement Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NonRule10B51ArrModifiedFlag', window );">Non Rule 10b51 Arrangement Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NonRule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non Rule 10B51 Arr Modified Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NonRule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_Rule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rule 10b51 Arr Modified Flag.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_Rule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299942512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Operations and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.  DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Operations</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc. (and where context requires, together with its subsidiaries referred to as &#8220;Innoviva&#8221;, the &#8220;Company&#8221;, or &#8220;we&#8221; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#8220;IST&#8221;), and a portfolio of strategic investments in other healthcare assets. Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#8220;GSK&#8221;), including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(fluticasone furoate/vilanterol, &#8220;FF/VI&#8221;) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(umeclidinium bromide/vilanterol, &#8220;UMEC/VI&#8221;), and up until July 2022, TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the combination FF/UMEC/VI). We sold our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest in Theravance Respiratory Company, LLC (&#8220;TRC&#8221;) on July 20, 2022, and are no longer entitled to receive royalties on sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> products. Under the Long-Acting Beta2 Agonist (&#8220;LABA&#8221;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion of annual global net sales and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for all annual global net sales above $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion; and royalties from the sales of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which tier upward at a range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expanded our portfolio through the acquisition of Entasis Therapeutics Holdings Inc. (&#8220;Entasis&#8221;) on July 11, 2022 and the acquisition of La Jolla Pharmaceutical Company (&#8220;La Jolla&#8221;) on August 22, 2022. Our commercial and marketed products include GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Our new product, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#8220;FDA&#8221;) for the treatment of hospital-acquired and ventilator-associated pneumonias caused by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in adults and we commenced commercial sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd., (&#8220;Basilea&#8221;) for the commercialization of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue to further advance our pipeline and are on track to submit a New Drug Application (&#8220;NDA&#8221;) for zoliflodacin, potentially first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the FDA in early 2025. Overall, we have a wholly owned robust critical care and infectious disease operating platform with a hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we own other strategic healthcare assets, such as a large equity stake in Armata Pharmaceuticals, a leader in development of bacteriophages with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of Innoviva, our wholly owned subsidiaries and certain variable interest entities (&#8220;VIE&#8221;) for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entity by the respective noncontrolling party.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Factors Affecting Comparability</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our historical financial condition and results of operations for the periods presented may not be comparable, either between periods or going forward due to the factors below and as discussed in Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;.</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting consolidation of Entasis on February 17, 2022 and purchase of remaining noncontrolling interest in Entasis on July 11, 2022;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sale of our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest in TRC on July 20, 2022; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisition of La Jolla on August 22, 2022.</span></div></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Management&#8217;s Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Management evaluates its significant accounting policies and estimates on an ongoing basis. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. These estimates also form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk and of Significant Suppliers and Partners</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and equity and long-term investments. Although we deposit our cash with multiple financial institutions, our deposits, at times, may exceed federally insured limits.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are dependent on third-party manufacturers to supply active pharmaceutical ingredients (&#8220;API&#8221;) and drug products for commercial and research and development programs. These programs could be adversely affected by significant interruption in the supply of API or drug products.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Currently, we derive most of our revenues from GSK and our near-term success depends in large part on GSK&#8217;s ability to successfully develop and commercialize the products in the respiratory programs partnered with GSK. Our near-term success depends in large part upon the performance by GSK of its commercial obligations under the GSK Agreements and the commercial success of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If GSK does not devote sufficient resources to the commercialization or development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed. GSK is responsible for all clinical and other product development, regulatory, manufacturing and commercialization activities for products developed under the GSK Agreements, including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our royalty revenues may fluctuate due to a variety of factors, many of which are outside of our control. Our royalty revenues under the GSK Agreements may not meet our, analysts&#8217; or investors&#8217; expectations, due to a number of important factors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenue for the periods include product sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Hospitals and other healthcare organizations generally purchase our products through a network of specialty distributors. These specialty distributors, which are located in the U.S., are considered our customers for accounting purposes. We do not believe that loss of one of these distributors would significantly impact our ability to distribute our products, as we expect that sales volume would be absorbed by new or remaining distributors. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of our customers each account for approximately:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2024; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2023; and, </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2022. </span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These same customers account for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our receivables from net product sales, which are included in &#8220;Accounts receivables, net&#8221; in our consolidated balance sheet as of December 31, 2024. These same customers account for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our receivables from net product sales, which are included in &#8220;Accounts receivables, net&#8221; in our consolidated balance sheet as of December 31, 2023.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are identified as components of an enterprise about which separate discrete financial information is made available for evaluation by the chief operating decision maker (&#8220;CODM&#8221;) in making decisions regarding resource allocation and assessing performance. Refer to Note 15, &#8220;Segment Reporting&#8221;, for more segment information.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary beneficiary of a variable interest entity (&#8220;VIE&#8221;) is required to consolidate the assets and liabilities of the VIE. When we obtain a variable interest in another entity, we assess at the inception of the relationship and upon occurrence of certain significant events whether the entity is a VIE and, if so, whether we are the primary beneficiary of the VIE based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, we consider all the facts and circumstances, including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE&#8217;s economic performance and identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, we consider all of our economic interests that are deemed to be variable interests in the VIE. This assessment requires us to apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When we acquire an entity in a business combination, we recognize the fair value of all assets acquired, liabilities assumed, and any non-controlling interest in the acquiree and establish the acquisition date as the fair value measurement point. We recognize and measure goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair value of the identified net assets acquired. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use the income method. This method starts with a forecast of all of the expected future net cash flows for each asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Some of the more significant estimates and assumptions inherent in the income method or other methods include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows and the assessment of the asset&#8217;s life cycle and the competitive trends impacting the asset, including consideration of any technical, legal, regulatory, or economic barriers to entry. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may even be considered to have indefinite useful lives.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consider all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounts receivable are recorded net of estimates for prompt-pay discounts, chargebacks, returns and rebates. Allowances for prompt-pay discounts and chargebacks are based on contractual terms. We estimate the allowance for credit losses based on existing contractual payment terms, actual payment patterns of customers and individual customer circumstances.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inventory</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inventory is stated at the lower of cost or estimated net realizable value on a first-in, first-out basis. We periodically analyze inventory levels and write down inventory as cost of products sold when the following occurs: inventory has become obsolete, inventory has a cost basis in excess of its estimated net realizable value, or inventory quantities are in excess of expected product sales.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, which consist of laboratory equipment, computer equipment, software, office furniture and fixtures, and leasehold improvements, were not material as of December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">over the estimated useful lives of the respective assets as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:49.17%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:49.17%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease terms or useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment, furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#8211; </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7 years</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3 years</span></span></p></td>
         </tr>
        </table></div></div><div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity and Long-Term Investments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We invest from time to time in equity and debt securities of private or public companies. If we determine that we have control over these companies under either voting or VIE models, we consolidate them in our consolidated financial statements. If we determine that we do not have control over these companies under either voting or VIE models, we then determine if we have an ability to exercise significant influence via voting interests, board representation or other business relationships.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may account for the investments where we exercise significant influence using either an equity method of accounting or at fair value by electing the fair value option under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method, we apply it to all our financial interests in the same entity (equity and debt, including guarantees) that are eligible items. All gains and losses from fair value changes, unrealized and realized, are presented as changes in fair values of equity method investments, net, and changes in fair values of equity and long-term investments, net, within the consolidated statements of income.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we conclude that we do not have an ability to exercise significant influence over an investee, we may elect to account for the security without a readily determinable fair value using the measurement alternative method under ASC 321, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments &#8211; Equity Securities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This measurement alternative method allows us to measure the equity investment at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also invest in ISP Fund LP, which investments consist of money market funds and equity and debt securities in the healthcare, pharmaceutical and biotechnology industries. Pursuant to the Partnership Agreement entered in December 2020, we became a limited partner of this partnership, and our contributions were subject to a 36-month lock-up period, which restriction prevented us from having control over and access to the contributions and related investments. The lock-up period for a certain portion of our contributions expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. These investments were classified as long-term investments in the consolidated balance sheet as of December 31, 2023. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of these investments, which consist mainly of cash and money market funds that we expect to be distributed in the next 12 months, were classified as &#8220;Current portion of ISP Fund investments&#8221; in the consolidated balance sheet as of December 31, 2024.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. We classify these inputs into the following hierarchy:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Quoted prices for identical instruments in active markets.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Quoted prices for similar instruments in active markets; quoted prices for identical 3or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unobservable inputs and little, if any, market activity for the assets.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments include cash equivalents, accounts receivable, receivables from collaborative arrangements, accounts payable, and accrued liabilities, equity investments and convertible promissory notes. The carrying values of cash equivalents, receivables from collaborative arrangements, accounts payable, and accrued liabilities approximate their estimated fair values due to the relatively short-term nature of these instruments.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Capitalized Fees Paid</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We capitalize fees paid to licensors related to agreements for approved products or commercialized products. We capitalize these fees as capitalized fees paid (&#8220;Capitalized Fees&#8221;) and amortize them on a straight-line basis over their estimated useful lives upon the commercial launch of the product, shortly after its regulatory approval. The estimated useful lives of these Capitalized Fees are determined on a country-by-country and product-by-product basis, as the later of the expiration or termination of the last patent right covering the compound in such product in such country and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from first commercial sale of such product in such country, unless the Collaboration Agreement is terminated earlier. Consistent with our policy for classification of costs under the research and development collaborative arrangements, the amortization of these Capitalized Fees is recognized as a reduction of royalty revenue. We review our Capitalized Fees for impairment on a product-by-product basis for each major geographic area when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The recoverability of Capitalized Fees is measured by comparing the asset&#8217;s carrying amount to the expected undiscounted future cash flows that the asset is expected to generate. The determination of recoverability typically requires various estimates and assumptions, including estimating the useful life over which cash flows will occur, their amount, and the asset&#8217;s residual value, if any. We derive the required cash flow estimates from near-term forecasted product sales and long-term projected sales in the corresponding market.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Goodwill and Intangible Assets</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Goodwill is recognized as the excess of the purchase consideration of an acquired entity over the fair value assigned to assets acquired and liabilities assumed in a business combination. In addition to recognizing intangible assets acquired in a business combination, we capitalize milestone payments related to in-licensing agreements for approved products as an intangible asset when the contingency for the milestone is resolved and the consideration is issued or becomes issuable. Goodwill and intangible assets with indefinite useful life are not amortized and are tested for impairment at least annually on the first day of December of each year or more frequently if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#8217;s carrying asset amount may not be recoverable. Intangible assets with definite useful lives are amortized on a straight-line basis over their respective remaining useful lives and are tested for impairment only if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable. Significant judgment may be involved in determining if an indicator of impairment has occurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent our right to use an underlying asset over the lease term and include any lease payments made prior to the lease commencement date and are reduced by lease incentives. Lease liabilities represent the present value of the total lease payments over the lease term, calculated using an estimated incremental borrowing rate. Lease expense is recognized on a straight-line basis over the expected lease term.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We apply the guidance on principal versus agent considerations under ASC Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to determine the appropriate treatment for the transactions between us and third parties. The classification of transactions under our arrangements is determined based on the nature and contractual terms of the arrangement along with the nature of the operations of the participants. Any consideration related to activities in which we are considered the principal, which includ</span><span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">es being in control of the good or service before such good or service is transferred to the customer, are accounted for as product sales.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is recognized when our customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized through a five-step process: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price for the contract; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue as a performance obligation is satisfied.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalty Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the royalty revenue on net sales of products with respect to which we have contractual royalty rights in the period in which the royalties are earned. The net sales reports provided by our partner are based on its methodology and assumptions to estimate rebates and returns, which it monitors and adjusts regularly in light of contractual and legal obligations, historical trends, past experience and projected market conditions. Our partner may make significant adjustments to its sales based on actual results recorded, which could cause our royalty revenue to fluctuate. We conduct periodic royalty audits to evaluate the information provided by our partner. Royalties are recognized net of amortization of capitalized fees associated with any approval and launch milestone payments made to GSK.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Product Sales</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Revenue from product sales is recognized when our customers obtain control of the product and is recorded at the transaction price, net of estimates for variable consideration consisting of chargebacks, discounts, returns and rebates. Variable consideration is estimated using the expected-value amount method, which is the sum of probability-weighted amounts in a range of possible consideration amounts. Actual amounts of consideration ultimately received may differ from our estimates. If actual results vary materially from our estimates, we will adjust these estimates, which will affect revenue from product sales and earnings in the period such estimates are adjusted. These items may include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chargebacks: Chargebacks are discounts we provide to distributors in the event that the sales prices to end users are below the distributors&#8217; acquisition price. This may occur due to a direct contract with a health system, a group purchasing organization (&#8220;GPO&#8221;) agreement or a sale to a government facility. Chargebacks are estimated based on known chargeback rates and recorded as a reduction of revenue on delivery to our customers.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Discounts: We offer customers various forms of incentives and consideration, including prompt-pay and other discounts. We estimate discounts primarily based on contractual terms. These discounts are recorded as a reduction of revenue on delivery to our customers.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Returns: We offer customers a limited right of return, generally for damaged or expired product. We estimate returns based on an internal analysis, which includes actual experience. The estimates for returns are recorded as a reduction of revenue on delivery to our customers. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rebates: We participate in Medicaid rebate programs, which provide assistance to certain low-income patients based on each individual state&#8217;s guidelines regarding eligibility and services. Under the Medicaid rebate programs, we pay a rebate to each participating state, generally within three months after the quarter in which product was sold. Additionally, we may offer customer incentives and consideration in the form of volume-based or other rebates. The estimates for rebates are recorded as a reduction of revenue on delivery to our customers. </span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to assess our estimates of variable consideration as we accumulate additional historical data and will adjust these estimates accordingly.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the inception of a licensing arrangement that includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price. We generally recognize these milestone payments as revenues when they are achieved because there is considerable uncertainty in the research and development processes that trigger receipt of these payments under our agreements. Similarly, we recognize regulatory approval milestone payments as revenues once the product is approved by the applicable regulatory agency. For delivery of other goods or services related to a licensing arrangement, we determine whether the performance obligation is satisfied over time or at a point in time. If the performance obligation is satisfied over time, we use judgment in determining the appropriate method of measuring progress for purposes of recognizing revenue. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses are recognized in the period that services are rendered or goods are received. Research and development expenses consist of salaries and benefits, laboratory supplies, facilities and other overhead costs, research-related manufacturing costs, contract service and clinical-related service costs performed by third party research organizations, research institutions and other outside service providers. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized. Such amounts are recognized as an expense as the related goods are delivered or the related services are performed. We also utilize significant judgment and estimates to record accruals for estimated ongoing research costs based on the progress of the studies and progress of research manufacturing activities.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense on Deferred Royalty Obligation</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense related to the deferred royalty obligation is recognized over the expected repayment term of the deferred royalty obligation using the effective interest method. The assumptions used in determining the expected repayment term of the deferred royalty obligation require us to make estimates that could impact the effective interest rate. Each reporting period, we estimate the expected repayment term of the deferred royalty obligation based on forecasted net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Changes in interest expense resulting from changes in the effective interest rate, if any, are recorded on a prospective basis. Refer to Note 12, &#8220;Debt&#8221;, for more information.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Stock&#8209;Based Compensation Awards</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use the Black-Scholes-Merton option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our employee stock purchase plan (&#8220;ESPP&#8221;). The Black-Scholes-Merton option valuation model requires the use of assumptions, including the expected term of the award and the expected stock price volatility. We use the &#8220;simplified&#8221; method as described in Staff Accounting Bulletin No. 107, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Share-Based Payment</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#8221; for the expected option term. We use our historical volatility to estimate expected stock price volatility.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted stock units (&#8220;RSUs&#8221;) and restricted stock awards (&#8220;RSAs&#8221;) are measured based on the fair market values of the underlying stock on the dates of grant.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense is calculated based on awards ultimately expected to vest and is reduced for estimated forfeitures at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differed from those estimates. Our estimated annual forfeiture rates for stock options, RSUs and RSAs are based on our historical forfeiture experience.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of stock options, RSUs and RSAs is expensed on a ratable or straight-line basis over the expected term of the grant or expected term of the vesting. Compensation expense is recorded over the requisite service period based on management&#8217;s best estimate as to whether it is probable that the shares awarded are expected to vest.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation expense for purchases under the ESPP is recognized based on the fair value of the common stock on the date of offering, less the purchase discount percentage provided for in the plan.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and the tax basis of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The recognition and measurement of tax benefits requires significant judgment. Our judgment might change as new information becomes available. We continue to evaluate our deferred tax assets each reporting period to determine whether adjustments to our valuation allowance are required and deferred tax assets will be realized based on the consideration of all available positive and negative evidence, including the differences between our anticipated and actual future operating results, using a &#8220;more likely than not&#8221; standard.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we determine whether the factors underlying the sustainability assertion have changed and whether the amount of the recognized tax benefit is still appropriate.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Parties</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sarissa Capital ow</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of o</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ur outstanding common stock as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Transactions with Sarissa Capital are described in Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;. Sarissa Capital is considered to be a related party because two of its principals are members of our board of directors.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncement</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Reportable Segment Disclosures (Topic 280).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This ASU update requires enhanced segment disclosures, primarily related to significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. We adopted ASU 2023-07 for the 2024 fiscal year and provided the enhanced disclosures for the comparative years. The adoption of ASU 2023-07 did not have a material impact on the Company's financial statements. Enhanced disclosures related to significant segment expenses are included in Note 15, &#8220;Segment Reporting.&#8221;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Adopted</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Income Tax Disclosures (Topic 740)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The ASU requires the disclosure of income taxes paid disaggregated by jurisdiction and enhanced disclosures for the entity&#8217;s effective tax rate reconciliation as well as other income tax related disclosures. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. The Company has not early adopted the ASU during 2024 and does not expect the adoption of the amendments to have a significant impact on its financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement &#8212; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the statement of income as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company in annual reporting periods beginning after December 15, 2027, and interim reporting periods beginning after December 15, 2027. We are currently evaluating the potential impact that ASU 2024-03 may have on our financial statement disclosures.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-04, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which clarifies the assessment of whether a transaction should be accounted for as an induced conversion or extinguishment of convertible debt when changes are made to conversion features as part of an offer to settle the instrument. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. We are currently evaluating the potential impact that ASU 2024-04 may have on our financial statements and related disclosures.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299861840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.  NET INCOME PER SHARE</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net income per share attributable to Innoviva stockholders is computed by dividing net income attributable to Innoviva stockholders by the weighted-average number of shares of common stock outstanding. Diluted net income per share attributable to Innoviva stockholders is computed by dividing net income attributable to Innoviva stockholders by the weighted-average number of shares of common stock and dilutive potential common stock equivalents then outstanding. Dilutive potential common stock equivalents include the assumed exercise, vesting and issuance of employee stock awards using the treasury stock method, as well as common stock issuable upon assumed conversion of our convertible subordinated notes due 2023 (the &#8220;2023 Notes&#8221;) up until its maturity date on January 15, 2023, our convertible senior notes due 2025 (the &#8220;2025 Notes&#8221;), and our convertible senior notes due 2028 (the &#8220;2028 Notes&#8221;) using the if-converted method. If the results attributable to Innoviva stockholders are in a net loss position, diluted net loss per share attributable to Innoviva stockholders is computed by dividing the net loss attributable to Innoviva stockholders by the weighted-average number of shares of common stock outstanding for the period, without consideration for potential dilutive common stock equivalents.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the computation of basic and diluted net income per share for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, 2023 and 2022:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:50.79%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.077%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.077%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.617%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands except per share data)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,392</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">213,921</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2023 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,439</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2025 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,583</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2028 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,377</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,626</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,860</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">191,304</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,569</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used to compute basic net income<br/>&#160;&#160;&#160;per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,726</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,435</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2023 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,188</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,150</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,150</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,150</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,955</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,158</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of options and awards granted under equity<br/>&#160;&#160;&#160;incentive plan and employee stock purchase plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">149</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used to compute diluted net income<br/>&#160;&#160;&#160;per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.75</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.07</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.36</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.20</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti&#8209;dilutive Securities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti&#8209;dilutive for the periods presented:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.28%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding options and awards granted under equity incentive<br/>&#160;&#160;&#160;plan and employee stock purchase plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,196</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,333</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">648</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding stock warrant</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">282</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding 2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,955</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,742</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,924</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">930</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197290016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.  REVENUE RECOGNITION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Revenue from Collaboration Arrangement</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 13, 2022, Innoviva&#8217;s wholly owned subsidiary, Innoviva TRC Holdings, LLC (&#8220;ITH&#8221;) entered into an equity purchase agreement (&#8220;TRC Equity Purchase Agreement&#8221;) with Royalty Pharma Investments 2019 ICAV (&#8220;Royalty Pharma&#8221;) to sell our ownership interest in TRC. As a result of the sale of our ownership interest in TRC, which was consummated on July 20, 2022, we are no longer entitled to receive 15% of royalty payments made by GSK stemming from sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We retained our royalty rights with respect to RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net revenue recognized under our GSK Agreements was as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; RELVAR/BREO</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207,925</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,042</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215,034</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; ANORO</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,631</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,627</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,405</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; TRELEGY</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalties</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,556</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,669</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">325,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: amortization of capitalized<br/>&#160;&#160;&#160;fees paid</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalty revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">238,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,645</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   The year ended December 31, 2022 represents the period from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LABA Collaboration</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the launch and approval of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S., Japan and Europe, we paid milestone fees to GSK totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended December 31, 2014. The milestone fees paid to GSK were recognized as capitalized fees paid, which are being amortized over their estimated useful lives commencing upon the commercial launch of the product. The amortization is recorded as a reduction to the royalties from GSK.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are entitled to receive annual royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion of annual global net sales and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for all annual global net sales above $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion. Sales of single&#8209;agent LABA medicines and combination medicines would be combined for the purposes of this royalty calculation. For other products combined with a LABA from the LABA Collaboration, such as ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, royalties are upward tiering and range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of royalty payments made by GSK under its agreements originally entered into with us, and since assigned to TRC in connection with the Spin-Off, including TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through July 20, 2022, which royalties were upward tiering and ranged from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Product Sales</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total net product sales was as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.09%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.683%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.683%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.683%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GIAPREZA&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,037</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,294</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XERAVA&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,385</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,320</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,480</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XACDURO&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,070</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;Total net product sales</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,617</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,694</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We derived our net product sales:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from customers located in the U.S. and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from the rest of the world for the year ended December 31, 2024; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from customers located in the U.S. and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from the rest of the world for the year ended December 31, 2023; and, </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from customers located in the U.S. and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% from the rest of the world from the date of acquisition of La Jolla, which occurred on August 22, 2022, to December 31, 2022.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License and Other Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to the out-license agreement with Zai Lab and Everest in Note 4, &#8220;License and Collaboration Arrangements&#8221;.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299849344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License and Collaboration Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LicenseAndCollaborationArrangementsDisclosureTextBlock', window );">LICENSE AND COLLABORATION ARRANGEMENTS</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. LICENSE AND COLLABORATION ARRANGEMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Out-License Agreements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zai Lab</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entasis entered into a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. (&#8220;Zai Lab&#8221;) (Nasdaq: ZLAB), pursuant to which Zai Lab licensed exclusive rights to durlobactam and SUL-DUR, in the Asia-Pacific region (&#8220;the Zai Agreement&#8221;). Under the terms of the Zai Agreement, Zai Lab will fund most of the registrational clinical trial costs in China for SUL-DUR, with the exception of Phase 3 patient drug supply of licensed products. Zai Lab will conduct development activities and plan and obtain regulatory approval in a specified number of countries in the Asia-Pacific region beyond China after receipt of regulatory approval of a licensed product in China. Zai Lab is also solely responsible for commercializing licensed products in the Asia-Pacific region and will commercialize licensed products for which it has obtained regulatory approval. We are obligated to supply Zai Lab with the licensed products for clinical development and, if the licensed product is approved, for commercial use for a certain period unless Zai Lab notifies otherwise. Zai Lab may take over manufacturing responsibilities for its own commercialization activities within a specified time period following the effective date of the Zai Agreement.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We ar</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e eligible to receive up to an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in research and development support payments and development, regulatory and sales milestone payments related to SUL-DUR, imipenem and other combinations with the licensed products. Zai Lab will pay us a tiered royalty equal to from a high-single digit to low-double digit percentage based on annual net sales of licensed products in the territory, subject to specified reductions for the market entry of competing products, loss of patent coverage of licensed products and for payments owed to third parties for additional rights necessary to commercialize licensed products in the territory.  Payments received for research support and reimbursable clinical trial costs are recorded as a reduction to research and development expense during the period in which the qualifying expenses are incurred. Such amounts recorded </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the years ended December 31, 2024 and 2023 were not material. SUL-DUR was approved by China&#8217;s National Medical Products Administration in May 2024, and we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in license revenue for the year ended December 31, 2024 under this agreement. Following the approval of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by the FDA in May 2023, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license revenue for the year ended December 31, 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2024, we entered into an amendment to the Zai Agreement (the &#8220;Amended Zai Agreement&#8221;), pursuant to which Zai Lab shall share costs associated with certain new manufacturing and technology transfer activities for XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#8220;Services&#8221;), which were not contemplated under the Zai Agreement and are crucial for regulatory approval in the Asia-Pacific region. We determined that the Amended Zai Agreement falls within the scope of ASC 606 and Zai Lab is a customer in this arrangement as the Services are an output of our ordinary activities. We have determined that the Services represent the only performance obligation and are distinct from the performance obligations under the original Zai Agreement. In addition, the expenses we incur in performing the Services most accurately depict the transfer of value to Zai Lab and maximize the use of observable inputs for measuring progress, therefore, we recognize revenue from this arrangement as the expenses related to Services are incurred. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license and other revenue for the year ended December 31, 2024 under the Amended Zai Agreement, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is included in &#8220;Accounts receivable&#8221; in our consolidated balance sheet as of December 31, 2024.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2024, we entered into an interim supply agreement with Zai Lab, under which Zai Lab shall purchase XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inventory (the &#8220;Supplied Inventory&#8221;) for their commercial launch. We have determined that this agreement falls within the scope of ASC 606. Zai Lab is a customer and the Supplied Inventory is an output of our ordinary activities. We have also determined that the Supplied Inventory represents the only performance obligation and is distinct from the performance obligations under the Zai agreements discussed above. Furthermore, we evaluated that the performance obligation is satisfied over time and that a cost-to-cost measure of progress would be the measure of progress that most accurately depicts the transfer of value to Zai Lab and maximizes the use of observable inputs to measure progress. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net product sales for the Supplied Inventory for the year ended December 31, 2024, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is included in &#8220;Accounts receivable&#8221; in our consolidated balance sheet as of December 31, 2024.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also entered into a manufacturing stage transfer agreement with Zai Lab in June 2024, which was amended in September 2024 (the &#8220;Zai Manufacturing Stage Transfer Agreement&#8221;). Pursuant to this agreement, Entasis shall provide assistance to Zai Lab for building out Zai Lab&#8217;s manufacturing site for XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and be compensated for Entasis' services and associated costs. We have determined this agreement falls within the scope of ASC 606. Zai Lab is a customer and the transfer service is an output of our ordinary activities and represents our only performance obligation, which is distinct from the performance obligations under the Zai agreements. Furthermore, we have evaluated that the performance obligation is satisfied over time and that the costs we incur in performing the transfer service most accurately depicts the transfer of value to Zai Lab and maximizes the use of observable inputs for measuring progress, therefore, we recognize revenue from this arrangement as the services are provided and the costs are incurred. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license and other revenue for the year ended December 31, 2024 under the Zai Manufacturing Stage Transfer Agreement, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is included in &#8220;Accounts receivable&#8221; in our consolidated balance sheet as of December 31, 2024.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2024, we entered into a letter agreement pursuant to which Zai Lab will purchase regulatory starting material (&#8220;RSM&#8221;) supply  for use in the production of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. We will supply the RSM while we continue to work on executing a commercial supply agreement with Zai Lab in accordance with the Zai Agreement. Based on our assessments, this agreement does not modify any of our existing contracts with Zai Lab discussed above and should be accounted for separately. We have also determined that this agreement falls within the scope of ASC 606. However, this does not meet the definition of a contract with a customer since the contract does not identify each party&#8217;s rights regarding goods or services. Accordingly, we deferred the consideration received amounting to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2024 in &#8220;Other accrued liabilities&#8221; until the execution of a commercial supply agreement, which will include all the required terms necessary for identifying each party&#8217;s rights regarding goods or services.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GARDP</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entasis entered into a collaboration agreement with the Global Antibiotic Research and Development Partnership (&#8220;GARDP&#8221;) for the development, manufacture and commercialization of the product candidate zoliflodacin in certain countries (&#8220;the GARDP Collaboration Agreement&#8221;). Under the terms of the GARDP Collaboration Agreement, GARDP will use commercially reasonable endeavors to perform and fully fund the Phase 3 registrational trial, including the manufacture and supply of the product candidate containing zoliflodacin, in uncomplicated gonorrhea. We recorded immaterial reimbursements from GARDP under this agreement as reduction to research and development expense during the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the GARDP Collaboration Agreement, GARDP was granted a worldwide, fully paid, exclusive and royalty-free license, with the right to sublicense, to use our zoliflodacin technology in connection with GARDP&#8217;s development, manufacture and commercialization of zoliflodacin in low-income and specified middle-income countries. We retained commercial rights in all other countries worldwide, including the major markets in North America, Europe and Asia-Pacific. We also retained the right to use and grant licenses to our zoliflodacin technology to perform our obligations under the GARDP Collaboration Agreement and for any purpose other than gonorrhea or community-acquired indications. If we believe that the results of the Phase 3 registrational trial of zoliflodacin would be supportive of an application for marketing approval, we are obligated to use our best efforts to file an application for marketing approval with the FDA within six months of the completion of the trial and to use commercially reasonable endeavors to file an application for marketing approval with the European Medicines Agency (&#8220;EMA&#8221;). Each party is responsible for using commercially reasonable efforts to obtain marketing authorizations for the product candidate in their respective territories.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PAION Pharma GmbH</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the PAION AG and PAION Deutschland GmbH (together and individually &#8220;PAION&#8221;) License, La Jolla granted PAION an exclusive license to commercialize GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the European Economic Area, the United Kingdom and Switzerland (collectively, the &#8220;PAION Territory&#8221;). We are entitled to receive potential commercial milestone payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">109.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and double-digit tiered royalty payments. Royalties payable in a given jurisdiction under the PAION License will be subject to reduction on account of generic competition and after patent expiration in that jurisdiction. Pursuant to the PAION License, PAION will be solely responsible for the future development and commercialization of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the PAION Territory. PAION is required to use commercially reasonable efforts to commercialize GIAPREZA&#174; and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the PAION Territory. We have not recognized any revenue from PAION related to commercial milestones from the date of acquisition of La Jolla to December 31, 2024. Royalty revenue recognized under this agreement for the year ended December 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Royalty revenue recognized under this agreement for the year ended December 31, 2023 and from the date of acquisition of La Jolla to December 31, 2022 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">La Jolla also entered into the PAION commercial supply agreement (the &#8220;PAION Supply Agreement&#8221;) whereby La Jolla will supply PAION a minimum quantity of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through July 13, 2024. The PAION supply agreement will automatically renew until the earlier of July 13, 2027, or until a new supply agreement is executed. During the initial term of the supply agreement, we will be reimbursed for direct and certain indirect manufacturing costs at cost. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cost reimbursements under this agreement for the year ended December 31, 2023. Amounts recognized under this agreement for the year ended December 31, 2024 and from the date of acquisition of La Jolla to December 31, 2022 were not material.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAION filed for insolvency in Germany on October 27, 2023 and the insolvency proceedings commenced on January 1, 2024. PAION announced on December 22, 2023 that it concluded negotiations with Humanwell Healthcare Group and entered into an agreement on the sale of the essential business operations of PAION with the approval of the insolvency administrator in both procedures. In early 2024, the sale of business operations of PAION was completed and starting February 2024, PAION has continued its business as a subsidiary of the Humanwell Healthcare Group as an independent company under the name PAION Pharma GmbH.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Everest Medicines Limited</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Everest Medicines Limited (&#8220;Everest&#8221;) License, La Jolla granted Everest an exclusive license to develop and commercialize XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the treatment of complicated intra-abdominal infections (&#8220;cIAI&#8221;) and other indications in mainland China, Taiwan, Hong Kong, Macau, South Korea, Singapore, the Malaysian Federation, the Kingdom of Thailand, the Republic of Indonesia, the Socialist Republic of Vietnam and the Republic of the Philippines (collectively, the &#8220;Everest Territory&#8221;). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Everest License, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in license revenue for the year ended December 31, 2023 as a result of an achievement of a regulatory milestone during the period. We are eligible to receive additional sales milestone payments of up to an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also entitled to receive tiered royalties from Everest at percentages in the low double digits on sales, if any, in the Everest Territory of products containing eravacycline. Royalties are payable with respect to each jurisdiction in the Everest Territory until the latest to occur of: (i) the last-to-expire of specified patent rights in such jurisdiction in the Everest Territory; (ii) expiration of marketing or regulatory exclusivity in such jurisdiction in the Everest Territory; or (iii) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years after the first commercial sale of a product in such jurisdiction in the Everest Territory. Royalty revenue recognized under this agreement for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Royalty revenue recognized under this agreement from the date of acquisition of La Jolla to December 31, 2022 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">La Jolla also entered into the Everest commercial supply agreement (the &#8220;Everest Supply Agreement&#8221;) whereby La Jolla will supply Everest a minimum quantity of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and will transfer to Everest certain XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-related manufacturing know-how. We were eligible to be reimbursed for direct and certain indirect manufacturing costs at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of cost through December 31, 2023. W</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in revenue under this agreement for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023, respectively. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in revenue under this agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the acquisition of La Jolla to December 31, 2022.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-License Agreements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basilea</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2024, we entered into an exclusive distribution and license agreement with Basilea under which we were granted exclusive marketing rights to ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the U.S. The agreement will remain in effect until the expiration of market exclusivity of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. in 2034 (the &#8220;initial term&#8221;), subject to automatic renewal unless either party provides notice. We paid an upfront fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which we recognized as an intangible asset and will be amortized over the initial term of the agreement. We will exclusively purchase ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(pre-packaging and labeling) from Basilea throughout the term. We are also obligated to pay Basilea tiered royalties ranging from the high-teens to mid-twenties, as well as tiered milestones, on annual net sales in the U.S. We anticipate commercializing ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in mid-year 2025 and, therefore, have not incurred any royalties or sales milestone payments for the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">George Washington University</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the George Washington University (&#8220;GW&#8221;) License, GW exclusively licensed to La Jolla certain intellectual property rights relating to GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including the exclusive rights to certain issued patents and patent applications covering GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Under the GW License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We are obligated to pay a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% royalty on net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on payments received from sublicensees. The obligation to pay royalties under this agreement extends through the last-to-expire patent covering GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023, respectively, under this agreement. Amounts recognized from the date of acquisition of La Jolla to December 31, 2022 were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Harvard University</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Harvard University (&#8220;Harvard&#8221;) License, Harvard exclusively licensed to La Jolla certain intellectual property rights relating to tetracycline-based products, including XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including the exclusive rights to certain issued patents and patent applications covering such products. Under the Harvard License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell tetracycline-based products, including XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. For each product covered by the Harvard License, we are obligated to make certain payments for the following: (i) up to approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon the achievement of certain clinical development and regulatory milestones; (ii) a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% royalty on direct U.S. net sales of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; (iii) a single-digit tiered royalty on direct ex-U.S. net sales of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, starting at a minimum royalty rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, with step-ups to a maximum royalty of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% based on the achievement of annual net product sales thresholds; and (iv) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on payments received from sublicensees. The obligation to pay royalties under this agreement extends through the last-to-expire patent covering tetracycline-based products, including XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year ended December 31, 2024 under this agreement. For the year ended December 31, 2023, we recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as cost of license revenue under this agreement as a result of the license revenue we earned under the out-licensing agreement with Everest for the same period. For the years ended December 31, 2024 and 2023 and from the date of acquisition of La Jolla to December 31, 2022, royalties recognized under this agreement were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Paratek Pharmaceuticals, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Paratek Pharmaceuticals, Inc. (&#8220;Paratek&#8221;) License, Paratek non-exclusively licensed to La Jolla certain intellectual property rights relating to XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including non-exclusive rights to certain issued patents and patent applications covering XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We were obligated to pay Paratek a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% royalty based on direct U.S. net sales of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our obligation to pay royalties with respect to the licensed product was retroactive to the date of the first commercial sale of XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and continued until there are no longer any valid claims of the Paratek patents, which expired in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f0a3b6ae-bc83-48c5-86cb-73ff6b579e00;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 2023</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. For the year ended December 31, 2023, and from the date of acquisition of La Jolla to December 31, 2022, amounts recognized under this agreement were not material.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Transfer and Subscription Agreement with AstraZeneca</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entasis entered into a Business Transfer and Subscription Agreement with AstraZeneca, AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP (collectively, &#8220;AstraZeneca&#8221;) (the &#8220;AstraZeneca Agreement&#8221;) in 2015, which was amended and restated through 2018, pursuant to which Entasis obtained, among other things, worldwide rights to durlobactam and zoliflodacin. Under the AstraZeneca Agreement, we are obligated to pay AstraZeneca a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of achieving a specified cumulative net sales milestone for durlobactam. We are also obligated to pay AstraZeneca a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of achieving the first commercial sale of zoliflodacin. Additionally, we are obligated to pay AstraZeneca tiered, single-digit royalties on the annual worldwide net sales of durlobactam and, the lesser of tiered, single-digit royalties on the worldwide annual net sales of zoliflodacin and a specified share of the royalties we receive from sublicensees of zoliflodacin. Royalties on sales of zoliflodacin do not include sales by GARDP in low-income and specified middle-income countries as discussed above. Our obligation to make these royalty payments expires with respect to each product on a country-by-country basis upon the later of (i) the 10-year anniversary of the first commercial sale of a product in each such country or (ii) when the last patent right covering a product expires in each such country.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Royalty expense on durlobactam arising from our net sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the year ended December 31, 2024 and 2023 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_LicenseAndCollaborationArrangementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License and collaboration arrangements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_LicenseAndCollaborationArrangementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299886512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesDisclosureAbstract', window );"><strong>Consolidated Entities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesAndAcquisitionsTextBlock', window );">CONSOLIDATED ENTITIES AND ACQUISITIONS</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. CONSOLIDATED ENTITIES AND ACQUISITIONS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Consolidated Entities</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Theravance Respiratory Company, LLC</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Up until July 20, 2022, we consolidated TRC under the VIE model as we determined that TRC was a VIE and we were the primary beneficiary of the entity because we had the power to direct the economically significant activities of TRC and the obligation to absorb losses of, or the right to receive benefits from, TRC. We held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest of TRC. The primary source of revenue for TRC is the royalties generated from the net sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by GSK.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 3, &#8220;Revenue Recognition&#8221;, on July 13, 2022, ITH entered into the TRC Equity Purchase Agreement to sell our ownership interest in TRC. Upon the closing of the transaction on July 20, 2022, we received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">277.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash from Royalty Pharma. We are also entitled to receive up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in contingent sales-based milestone payments in the future. In connection with the closing of the transaction, we also received our portion of TRC&#8217;s remaining cash balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from Royalty Pharma rather than through a cash distribution from TRC.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the closing of the transaction and as part of the agreement, TRC distributed its ownership interests and investments in InCarda Therapeutics (&#8220;InCarda&#8221;), Inc., ImaginAb, Inc. (&#8220;ImaginAb&#8221;), Gate and Nanolive SA (&#8220;Nanolive&#8221;), which had a total carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to ITH. We accounted for the transaction similar to an upstream sale between a parent and a VIE under ASC 810-10. As such, ITH recorded the transferred investments at their respective carrying values and no gain or loss was recognized in the consolidated statement of income.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The summarized financial information of TRC from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC, is presented as follows:</span></p><div style="font-size:10pt;font-family:Times New Roman;">
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:75.96%;box-sizing:content-box;"></td>
        <td style="width:2.2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.84%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,029</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">332</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income from operations</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,697</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Realized loss</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,386</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and<br/>&#160;&#160;&#160;long-term investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,884</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,438</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ISP Fund LP</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2020, Innoviva Strategic Partners LLC, our wholly owned subsidiary (&#8220;Strategic Partners&#8221;), contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to ISP Fund LP (the &#8220;Partnership&#8221;) for investing in &#8220;long&#8221; positions in the healthcare, pharmaceutical and biotechnology sectors and became a limited partner. The general partner of the Partnership (&#8220;General Partner&#8221;) is an affiliate of Sarissa Capital.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Partnership Agreement provides for Sarissa Capital to receive management fees from the Partnership, payable quarterly in advance, measured based on the Net Asset Value of Strategic Partners&#8217; capital account in the Partnership. In addition, General Partner is entitled to an annual performance fee based on the Net Profits of the Partnership during the annual measurement period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Partnership Agreement includes a lock-up period of thirty-six months after which Strategic Partners is entitled to make withdrawals from the Partnership as of such lock-up expiration date and each anniversary thereafter, subject to certain limitations. The lock-up period for the initial contribution of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which excludes the amount discussed below, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expired in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_575134d6-a304-419f-b46a-5cbe0a39b7e5;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2023</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, Strategic Partners received a distribution of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from the Partnership to provide funding to Innoviva for a strategic repurchase of shares held by GSK. On March 30, 2022, Strategic Partners made an additional capital contribution of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to the Partnership pursuant to the letter agreement entered into between Strategic Partners, the Partnership and Sarissa Capital Fund GP LP on May 20, 2021. The capital contribution is subject to a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> lock up period from the contribution date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consolidate ISP Fund LP under the VIE model as we have determined that ISP Fund LP is a VIE and we are the primary beneficiary of the entity via our related party relationships with Sarissa Capital entities. Our maximum exposure to loss is equal to the amount we invested in the entity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ISP Fund LP is determined to be an investment company under ASC 946, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Services &#8211; Investment Companies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as it meets all fundamental characteristics of an investment company, and its activities are consistent with those of an investment company. Since ISP Fund LP is subject to investment company industry specific guidance, we have retained the industry-specific guidance applied by the Partnership. In addition, as our investment in the Partnership is a passive investment for the Company and is not part of our main operations, the investments are presented as part of &#8220;Equity and long-term investments&#8221; in our consolidated balance sheets. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of our investments, which consist of cash and money market funds that we expect to be distributed in the next 12 months, were classified as ISP Fund investments in the consolidated balance sheet as of December 31, 2024, and the remaining equity investments managed by ISP Fund LP are expected to be distributed through April 2026. We report in our consolidated statements of income any investment gains and losses by the Partnership as part of &#8220;Changes in fair value of equity and long-term investments, net&#8221;, any interest and dividend income as part of &#8220;Interest and dividend income&#8221; and any investment expenses as part of &#8220;Other expense, net&#8221;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we continued to hold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the economic interest of Partnership. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, total assets of the Partnership were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, of which the majority was attributable to equity and long-term investments. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, total liabilities of the Partnership w</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ere $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> mill</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ion and $</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The Partnership</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s assets can only be used to settle its own obligations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Partnership incurred</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million in net investment-related expenses, generated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million interest income, recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net realized losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. During the year ended December 31, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Partnership incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net investment-related expenses, generated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million interest income, recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net realized losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. During the year ended December 31, 2022, the Partnership incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net investment-related expense, generated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million interest income, and recorded net $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million realized gains and net $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. We account for the long-term investments held by ISP Fund LP as of December 31, 2024 and 2023 and 2022 as equity investments measured at fair value.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of individual investments held by ISP Fund at each balance sheet date:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:61.232%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.603%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.603%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">In thousands</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock - Publicly traded healthcare companies</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,039</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">184,926</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United Kingdom</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,989</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,942</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,868</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock - Privately held healthcare companies</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,530</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants - Privately held healthcare companies</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,507</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,075</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market fund and cash</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,532</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,339</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Total investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,658</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,812</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acquisitions</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Entasis Therapeutics Holdings Inc.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We started investing in Entasis in 2020 as part of our capital allocation strategy of deploying cash generated from royalty income and investing in different life sciences companies. Entasis at the time was an advanced, late clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products. Effective in June 2020, after certain conditions were met with respect to the sales of Entasis equity shares, Innoviva had the right to designate </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> members to Entasis&#8217; board. Our investment in Entasis consisted of shares of common stock and warrants to purchase shares of Entasis common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of Entasis&#8217; common stock was measured based on its closing market price at each balance sheet date. We used the Black-Scholes-Merton pricing model to estimate the fair value of the warrants.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 17, 2022, Innoviva Strategic Opportunities, LLC (&#8220;ISO&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> entered into a securities purchase agreement with Entasis pursuant to which ISO purchased a convertible promissory note for a total purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The note bore an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.59</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and was due to mature and become payable on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_47da13c9-3667-4443-acf7-9a613c3e52a0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 18, 2022</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unless it was converted at a conversion price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.48</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> before the maturity date. With this financing, we determined that we had both (i) the power to direct the economically significant activities of Entasis and (ii) the obligation to absorb the losses, or the right to receive the benefits, that could potentially be significant to Entasis and therefore, we were the primary beneficiary of Entasis. Accordingly, we consolidated Entasis&#8217; financial position and results of operations effective on February 17, 2022. Our equity ownership interest remained at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% as of February 17, 2022, and the fair values of our holdings of Entasis common stock and warrants were remeasured and estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The remeasurement resulted in a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loss in the first quarter of 2022 which was included in changes in fair values of equity method investments, net, in the consolidated statement of income for the year ended December 31, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed our acquisition of Entasis&#8217; noncontrolling interest on July 11, 2022. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> payments were made toward the convertible promissory note through the date of acquisition of Entasis. In connection with the acquisition, all of the Entasis warrants were replaced with Innoviva warrants (the &#8220;Replacement Warrants&#8221;) of equivalent value and bearing the same terms. The Replacement Warrants were classified as equity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized the difference between the acquisition price and the carrying value of the acquired noncontrolling interest on July 11, 2022 in our additional paid-in capital.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values assigned to assets acquired and liabilities assumed as of February 17, 2022 were based on management&#8217;s best estimates and assumptions. After the acquisition in July 2022, we adjusted the purchase price allocation based on new and additional information related to product sales forecast provided by Entasis and deferred tax liabilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, we recorded measurement period adjustments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million decrease in goodwill, primarily related to a decrease in estimated purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, an increase in noncontrolling interests of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and an increase in intangible assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The cumulative impact of the measurement period adjustments included in the consolidated net income for the year ended December 31, 2022 was not material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2023, we recorded a measurement period adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million increase in goodwill, primarily related to a decrease in intangible assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and an increase in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The measurement period adjustment did not impact the consolidated net income for the year ended December 31, 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the adjusted fair values of the assets acquired and liabilities assumed by us in the transaction:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">February 17, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,070</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,554</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,959</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">185</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">959</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,493</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">302</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,222</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,583</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued personnel-related expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,058</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,096</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,769</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,506</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134,716</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The goodwill arising from the acquisition of Entasis is primarily attributable to Entasis&#8217; assembled workforce and the value associated with growing our business more efficiently. The goodwill from this acquisition is not expected to be deductible for tax purposes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 8, &#8220;Goodwill and Intangible Assets&#8221;, for more discussion on the intangible assets recognized as part of this acquisition.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the consolidation, we recognized a non-controlling interest of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of February 17, 2022. Our consolidated net income for the year ended December 31, 2022 included the net loss attributable to noncontrolling interest since the consolidation date until the date of acquisition of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">La Jolla Pharmaceutical Company</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 22, 2022, ISO acquired La Jolla for a total consideration of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">206.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. ISO acquired La Jolla at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.23</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. La Jolla brought to Innoviva an established product portfolio, including GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) for the treatment of complicated intra-abdominal infections (cIAIs). We incurred approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in acquisition-related costs in connection with this acquisition during the year ended December 31, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values assigned to assets acquired and liabilities assumed as of August 22, 2022 were based on management&#8217;s best estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, we recorded measurement period adjustments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million increase in goodwill, primarily related to a decrease in inventory and intangible assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, and an increase in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, partially offset by a decrease in other long-term liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The cumulative impact of the measurement period adjustments included in the consolidated net income for the year ended December 31, 2022 was not material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2023, we recorded a measurement period adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million decrease in goodwill, primarily related to an increase in deferred tax assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a decrease in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In August 2023, we recorded a measurement period adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million increase in goodwill, primarily related to a decrease in deferred tax assets of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and an increase in deferred tax liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The cumulative impact of the measurement period adjustments included did not impact the consolidated net income for the year ended December 31, 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the adjusted fair values of assets acquired and liabilities assumed by us in the transaction:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">August 22, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,415</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term marketable securities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">471</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,876</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,200</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,261</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">907</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,411</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,461</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">710</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287,951</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,237</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,849</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,362</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,944</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">206,559</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The goodwill arising from the acquisition of La Jolla is primarily attributable to La Jolla&#8217;s assembled workforce and the value associated with leveraging the workforce to develop and commercialize new drug products in the future and growing our business more efficiently. The goodwill from this acquisition is not expected to be deductible for tax purposes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 8, &#8220;Goodwill and Intangible Assets&#8221;, for more discussion on the intangible assets recognized as part of this acquisition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pro Forma Financial Information</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents certain unaudited pro-forma financial information for the year ended December 31, 2022 as if the consolidation of Entasis and La Jolla occurred on January 1, 2021. The unaudited pro forma financial information is presented for informational purposes only, and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place on January 1, 2021, or of results that may occur in the future. The unaudited pro forma financial information combines the historical results of the Entasis and La Jolla with the Company&#8217;s consolidated historical results and includes certain adjustments including, but not limited to, fair value adjustments to equity investments in Entasis&#8217; common stock and warrants, fair value adjustments to inventory, amortization of intangible assets, and interest expense on deferred royalty obligations and acquisition-related costs.</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.46%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">357,880</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">204,987</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">214,390</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ConsolidatedEntitiesAndAcquisitionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consolidated entities and acquisitions text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ConsolidatedEntitiesAndAcquisitionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ConsolidatedEntitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ConsolidatedEntitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299937792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">EQUITY AND LONG-TERM INVESTMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. EQUITY AND LONG-TERM INVESTMENTS AND FAIR VALUE MEASUREMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity and Other Investments in Armata</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the first quarter of 2020, Innoviva acquired </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,710,800</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock as well as warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,710,800</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of common stock of Armata Pharmaceuticals, Inc. (&#8220;Armata&#8221;) for approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash. Armata is a clinical stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the first quarter of 2021, ISO entered into a securities purchase agreement with Armata to acquire </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,153,847</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Armata common stock and warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,153,847</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of Armata common stock for approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Armata also entered into a voting agreement with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total number of shares of Armata&#8217;s common stock for voting on the matters related to election or removal of Armata&#8217;s board members. The voting agreement will expire on the earlier of the second anniversary of the agreement effective date and approval by the FDA of any of Armata&#8217;s product candidates for marketing and commercial distribution. During the fourth quarter of 2021, ISO also purchased an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,212,122</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Armata common stock for approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 9, 2022, ISO entered into a securities purchase agreement with Armata to acquire </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Armata common stock and warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of common stock with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The investment closed in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tranches on February 9, 2022 and March 31, 2022. The investment is intended to aid Armata in advancing its clinical pipeline and strengthening its bacteriophage platform.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 9, 2022, Armata also entered a second amended and restated voting agreement with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total number of shares of Armata&#8217;s common stock for voting on the matters related to election or removal of Armata&#8217;s board members or amend the bylaws of Armata to reduce the maximum number of directors or set the number of directors who may serve on the board of Armata. The voting agreement will expire the earlier of the second anniversary of the agreement effective date and approval by the FDA of any of Armata&#8217;s product candidates for marketing and commercial distribution. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding shares of Armata&#8217;s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata&#8217;s board of directors, and for so long as the Company and ISO hold at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, but less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, of the outstanding shares of Armata&#8217;s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata&#8217;s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armata entered into an amendment to the amended and restated investor rights agreement with the Company and ISO, pursuant to which the Company and ISO agreed that the voting agreement will expire on the earlier of the fifth anniversary of the original agreement&#8217;s effective date, January 26, 2021, or the approval by the FDA of any of Armata&#8217;s product candidates for marketing and commercial distribution.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the seven </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">members of Armata&#8217;s board of directors are also members of the board of directors of Innoviva. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023, we owned approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of Armata&#8217;s common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the &#8220;Credit Agreement&#8221;) with Armata, under which we invested in a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> convertible note (the &#8220;Armata Convertible Note&#8221;) in an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million at an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pursuant to the Credit Agreement, the balance on the Armata Convertible Note, including all accrued and unpaid interest thereon, will convert into shares of Armata</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s common stock upon the occurrence of a qualified financing, as defined in the Credit Agreement. Any portion of the balance on the Armata Convertible Note, including all accrued and unpaid interest thereon, may also be converted into shares of Armata&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s common stock at our option once a registration statement covering the resale of such securities has been declared effective by the SEC. The Armata Convertible Note is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On July 10, 2023, ISO and Armata executed an amendment to the Armata Convertible Note extending the maturity date from January 10, 2024 to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On November 12, 2024, ISO and Armata executed an amendment to the Armata Convertible Note extending the maturity date from January 10, 2025 to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, ISO and Armata entered into a Credit and Security Agreement (the &#8220;July 2023 Credit and Security Agreement"), under which we extended a term loan to Armata (the &#8220;Armata July 2023 Term Loan&#8221;) in an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Armata July 2023 Term Loan is subject to an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum and is due to mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The July 2023 Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On November 12, 2024, ISO and Armata executed an amendment to the Armata July 2023 Term Loan extending the maturity date from January 10, 2025 to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 10, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 4, 2024, ISO and Armata entered into a Credit and Security Agreement (the &#8220;March 2024 Credit and Security Agreement&#8221;), under which we extended a term loan to Armata (the &#8220;Armata March 2024 Term Loan&#8221;) in an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Armata March 2024 Term Loan is subject to an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum and is due to mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 4, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The March 2024 Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The investments in Armata&#8217;s common stock and warrants provide Innoviva and ISO the ability to have significant influence, but not control, over Armata&#8217;s operations. Armata&#8217;s business and affairs are managed under the direction of its board of directors, which Innoviva and ISO do not control. Based on our evaluation, we determined that Armata is a VIE, but Innoviva and ISO are not the primary beneficiaries of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for Armata&#8217;s common stock and warrants under the equity method using the fair value option. The fair value of Armata&#8217;s common stock is measured based on its closing market price. The warrants purchased in 2020, 2021 and 2022 have an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.87</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, respectively. All warrants are exercisable immediately within </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the issuance date of the warrants and include a cashless exercise option. We use the Black-Scholes-Merton pricing model to estimate the fair value of these warrants with the following input assumptions: Armata&#8217;s closing market price on the valuation date, the risk-free interest rate computed based on the U.S. Treasury yield, the remaining contractual term as the expected term, and the expected stock price volatility calculated based on the historical volatility of the common stock of Armata and its peer companies. We account for the Armata Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. We account for the Armata July 2023 Term Loan and the Armata March 2024 Term Loan as trading securities, measured at fair value using income approach based on the discounted value of expected future cash flows.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the fair values of our holdings of Armata common stock, warrants, the Armata Convertible Note, the Armata July 2023 Term Loan and the Armata March 2024 Term Loan were estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million  and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2023 the fair values of our holdings of Armata common stock, warrants, the Armata Convertible Note and Armata July 2023 Term Loan were estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata common stock and warrants, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses as changes in fair values of equity method investments, net, in the consolidated statements of income for the years ended December 31, 2024, 2023 and 2022, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata Convertible Note, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata July 2023 Term Loan, we rec</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">orded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Armata March 2024 Term Loan, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the year ended December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The summarized financial information, including the portion we do not own, is presented for Armata on a one quarter lag as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Balance Sheet Information</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">September 30,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,389</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,585</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,848</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,176</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,204</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,884</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,006</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103,263</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement Information</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Twelve Months Ended September 30,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,052</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,476</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,639</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,666</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,363</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,512</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,650</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Method Investment in Entasis</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the consolidation of Entasis&#8217; financial position and results of operations in February 2022, we accounted for Entasis as an equity method investment. Refer to Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;, for more information.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Investment in InCarda</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the third quarter of 2020, TRC purchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,469,432</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series C preferred stock and a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,117,358</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of Series C preferred stock of InCarda Therapeutics, Inc. (&#8220;InCarda&#8221;) (the &#8220;InCarda 2020 Warrant&#8221;) for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which included $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of transaction costs. InCarda is a privately held biopharmaceutical company focused on developing inhaled therapies for cardiovascular diseases. The investment is intended to fund the ongoing clinical development of InRhythm</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (flecainide for inhalation), InCarda&#8217;s lead program, for the treatment of a recent-onset episode of paroxysmal atrial fibrillation. On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to Innoviva&#8217;s wholly-owned subsidiary, Innoviva TRC Holdings, LLC (&#8220;ITH&#8221;) all of TRC&#8217;s ownership interests and investments in InCarda. ITH has the right to designate one member to InCarda&#8217;s board of directors. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ITH designee is serving on InCarda&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">six</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-member board. We did not exercise the InCarda 2020 Warrant which expired in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ecf264a2-e5c5-444a-8a7b-06e825278547;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2023</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and wrote off its carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 9, 2022, TRC entered into a Note and Warrant Purchase Agreement (the &#8220;InCarda Agreement&#8221;) with InCarda to acquire a convertible promissory note (the &#8220;InCarda Convertible Note&#8221;) and warrants (the &#8220;InCarda 2022 Warrant&#8221;) for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.  The InCarda 2022 Warrant expires on March 9, 2027 and is measured at fair value.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 15, 2022, the principal amount and the accrued interest of the InCarda Convertible Note were converted into equity securities. In addition, TRC participated in InCarda&#8217;s Series D preferred stock financing by investing $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In connection with the new round of financing, InCarda recapitalized its equity structure resulting in TRC owning </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,093,886</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of InCarda&#8217;s common stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37,350</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series A-1 preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,469,432</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series C preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,771,780</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series D-1 preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,369,802</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series D-2 preferred stock, a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,117,358</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series C preferred stock at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.73</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,490,033</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its Series D-1 preferred stock at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, we held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of InCarda equity ownership, respectively. Our investment in InCarda does not provide us with the ability to control or have significant influence over InCarda&#8217;s operations. Based on our evaluation, we determined that InCarda is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With the exception of the InCarda Series D Warrants, which is measured at fair value, we account for the aforementioned investments in InCarda under the measurement alternative. Under the measurement alternative, the equity investment is initially recorded at its allocated cost, but the carrying value may be adjusted through earnings upon an impairment or when there is an observable price change involving the same or a similar investment with the same issuer. Due to InCarda&#8217;s equity recapitalization in the second quarter of 2022, TRC reassessed the value of its investments in InCarda using the Option Pricing Model Backsolve valuation methodology. Key assumptions used in the valuation model included an expected holding period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and an estimated volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">122.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The estimated volatility was calculated based on the historical volatility of a selected peer group of public companies comparable to InCarda. We recognized an impairment charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the second quarter of 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to certain changes in InCarda&#8217;s business operations during the second quarter of 2023, ITH reassessed the value of its investments in InCarda using the Option Pricing Model methodology. Key assumptions used in the valuation model included an expected holding period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and an estimated volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The estimated volatility was calculated based on the historical volatility of a selected peer group of public companies comparable to InCarda. We recognized an impairment charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the second quarter of 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 17, 2024, ITH purchased a secured convertible promissory note (the &#8220;InCarda Convertible Note&#8221;) from InCarda for a total purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The InCarda Convertible Note bears an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and shall be due and payable upon the earlier to occur of certain events defined in the InCarda Convertible Note. The InCarda Convertible Note will convert into equity securities or shadow equity securities of InCarda depending upon the occurrence of a qualified event or a qualified financing event as also defined in the InCarda Convertible Note. The InCarda Convertible Note is secured by certain intellectual property rights of InCarda. We account for the InCarda Convertible Note as a trading security, measured at fair value.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, we recorded as equity and long-term investments in the consolidated balance sheets $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in carrying amount of InCarda&#8217;s Series C preferred stock and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in fair value of the InCarda Series D Warrants. As of December 31, 2024 and 2023, we recognized as equity and long-term investments in the consolidated balance sheets $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, for InCarda&#8217;s Series D-1 preferred stock, Series D-2 preferred stock, and common stock using the measurement alternative. As of December 31, 2024, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in fair value of the InCarda Convertible Note as equity and long-term investments in the consolidated balance sheet. During the year ended December 31, 2024, there were immaterial changes in the carrying amount of our investments. We recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in unrealized loss as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2023 and 2022, respectively.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Investment in ImaginAb</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 18, 2021, TRC entered into a securities purchase agreement with ImaginAb, Inc. (&#8220;ImaginAb&#8221;) to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,051,724</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb Series C preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On the same day, TRC also entered into a securities purchase agreement with one of ImaginAb&#8217;s common stockholders to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,097,157</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb common stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. ImaginAb is a privately held biotechnology company focused on clinically managing cancer and autoimmune diseases via molecular imaging. $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was incurred for investment due diligence costs and execution and recorded as part of the equity investment in the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#8217;s ownership interests and investments in ImaginAb.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 14, 2023, ITH entered into a securities purchase agreement with ImaginAb to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">270,568</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb Series C-2 preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On September 14, 2023, ITH entered into a securities purchase agreement with ImaginAb to purchase another </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">405,852</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of ImaginAb Series C-2 preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 23, 2024, ITH purchased a subordinated convertible promissory note (the &#8220;ImaginAb Convertible Note&#8221;) from ImaginAb for a total purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The ImaginAb Convertible Note bears an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and shall be due and payable upon the earlier to occur of January 31, 2025 and certain events defined in the ImaginAb Convertible Note. Under certain circumstances, the ImaginAb Convertible Note is convertible at the option of ITH into ImaginAb&#8217;s equity securities at defined conversion prices. The ImaginAb Convertible Note is subordinate to certain existing indebtedness of ImaginAb as defined in the ImaginAb Convertible Note. On October 31, 2024, ITH entered into an agreement with ImaginAb to amend the ImaginAb Convertible Note. Pursuant to the agreement, the principal amount of the ImaginAb Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal as of February 23, 2024, accrued interest as of amendment date, commitment fees and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On January 13, 2025, ITH and ImaginAb executed an amendment to the ImaginAb Convertible Note extending the maturity date from January 31, 2025 to May 30, 2025. All other material terms of the ImaginAb Convertible Note were unchanged during the aforementioned amendments to the ImaginAb Convertible Note. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of ImaginAb&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">six</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> board members was designated by ITH. As of December 31, 2024 and 2023, we held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of ImaginAb equity ownership.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our investment in ImaginAb does not provide us with the ability to control or have significant influence over ImaginAb&#8217;s operations. Based on our evaluation, we determined that ImaginAb is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because ImaginAb&#8217;s equity securities are not publicly traded and do not have a readily determinable fair value, we account for our investment in ImaginAb&#8217;s Series C preferred stock, Series C-2 preferred stock and common stock using the measurement alternative. We account for the ImaginAb Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. As of December 31, 2024 and 2023, our investment in ImaginAb&#8217;s Series C preferred stock, Series C-2 preferred stock and common stock amounted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and recorded as equity and long-term investments in the consolidated balance sheets. As of December 31, 2024, we recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in fair value of the ImaginAb Convertible Note as equity and long-term investments in the consolidated balance sheets. During the year ended December 31, 2024, we recorded </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in net unrealized gain</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on the ImaginAb Convertible Note as changes in fair values of equity and long-term investments, net, in the consolidated statements of income. There was no change in the carrying amount of our equity investments in ImaginAb.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Promissory Note in Gate Neurosciences</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 24, 2021, TRC entered into a Convertible Promissory Note Purchase Agreement with Gate to acquire a convertible promissory note (the &#8220;Gate Convertible Note&#8221;) with a principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Gate is a privately held biopharmaceutical company focused on developing the next generation of targeted nervous system therapies, leveraging precision medicine approaches to develop breakthrough drugs for psychiatric and neurologic diseases. The investment is intended to fund Gate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s ongoing development and research. The Gate Convertible Note bears an annual interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and will convert into shares of common stock of Gate upon a qualified event or into shares of shadow preferred stock of Gate (&#8220;Shadow Preferred&#8221;) upon a qualified financing. A qualifying event can be a qualified initial price offering, a qualified merger, or a merger with a special-purpose acquisition company (&#8220;SPAC&#8221;). Shadow Preferred means preferred stock having identical rights, preferences and restrictions as the preferred stock that would be issued in a qualified financing.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of common stock shares to be issued in a qualified event shall be equal to the amount due on the conversion date divided by the lesser of a capped conversion price (the &#8220;Capped Conversion Price&#8221;) and the qualified event price (the &#8220;Qualified Event Price&#8221;). The Capped Conversion Price is calculated as $50.0 million divided by the number of shares of common stock outstanding at such time on a fully diluted basis. The Qualified Event Price is the price per share determined by the qualified event. A qualified financing is a sale or series of sales of preferred stock where (i) at least 50 percent of counterparties are not existing shareholders, (ii) net proceeds to Gate are at least $35.0 million, and (iii) the stated or implied equity valuation of Gate is at least $80.0 million.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#8217;s debt investments in Gate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 2, 2023, ITH entered into a Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the original principal, accrued interest as of the amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 6, 2023, ITH entered into a Second Note Amendment Agreement with Gate to amend the Note Amendment Agreement. Pursuant to the Second Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the amended principal as of February 2, 2023, accrued interest as of the second amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 13, 2024, ITH entered into a Third Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Third Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal and accrued interest as of the third amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2024, ITH entered into a Fourth Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Fourth Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal and accrued interest as of the fourth amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms of the Gate Convertible Note were unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2024, ITH entered into a Fifth Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Fifth Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which represents the principal and accrued interest as of the fifth amendment date and an additional cash investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. All other material terms, except for the conversion terms of the Gate Convertible Note, remained unchanged.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have accounted for the Gate Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of equity value of Gate, risk-free rate, expected stock price, volatility of its peer companies, and the time until a financing is raised. As of December 31, 2024 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and 2023, the fair value of the Gate Convertible Note was estimated at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, and recorded as equity and long-term investments in the consolidated balance sheets. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of unrealized loss and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of unrealized gain as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2023 and 2022, respectively. The change in fair value is not material for the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Investment in Nanolive</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2022, TRC entered into an investment and shareholders agreement with Nanolive to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,750,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Nanolive Series C preferred stock for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (equivalent to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million CHF). Nanolive SA is a Swiss privately held life sciences company focused on developing breakthrough imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was incurred for investment due diligence costs and execution and recorded as part of the equity and long-term investment in the consolidated balance sheets. On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#8217;s ownership interests and investments in Nanolive. ITH has the right to designate one member to Nanolive&#8217;s board. ITH also has the right to designate another member, who will be mutually acceptable to ITH and another stockholder, to Nanolive&#8217;s board. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Innoviva designee is serving on Nanolive&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">six</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-member board. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of Nanolive equity ownership, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our investment in Nanolive does not provide us with the ability to control or have significant influence over Nanolive&#8217;s operations. Based on our evaluation, we determined that Nanolive is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because Nanolive&#8217;s equity securities are not publicly traded and do not have a readily determinable fair value, we account for our investment in Nanolive&#8217;s Series C preferred stock using the measurement alternative. As of December 31, 2024 and 2023,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of investment in Nanolive was recorded as equity and long-term investments in the consolidated balance sheets, and there was no change to the carrying amount of our investment.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reconciliation of Equity and Long-Term Investments Balances</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the change in balances in &#8220;Equity and Long-Term Investments&#8221; as of each balance sheet date:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2022</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">363,859</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of equity and long-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">428</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">444,432</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,201</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,161</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reclassification of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,532</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">724</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">341,664</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Available-for-Sale Securities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of available-for-sale securities is based on quoted market prices for these or similar investments that were based on prices obtained from a commercial pricing service. Available-for-sale securities are summarized below:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gains</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></div></div>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gains</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets.</span></div></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all available-for-sale securities were money market funds, and there was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> credit loss recognized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our available-for-sale securities, equity and long-term investments and contingent value rights are measured at fair value on a recurring basis and our debt is carried at amortized cost basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:39.772%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Fair Value Measurements as of December 31, 2024 Using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted Price<br/>in Active<br/>Markets for</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identical</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Types of Instruments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">193,560</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,098</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,658</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Common Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,392</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,392</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,901</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,901</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - InCarda Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Armata Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,095</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,095</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata July 2023 Term Loan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,197</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,197</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata March 2024 Term Loan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,275</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,275</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - InCarda Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">436</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">436</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - ImaginAb Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,950</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,950</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Gate Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,881</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,881</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at estimated fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">529,393</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,901</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">229,991</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">765,285</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">222,353</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">222,353</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">251,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">251,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;Total fair value of debt</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">473,566</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">473,566</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;">
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Fair Value Measurements as of December 31, 2023 Using:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">in Active</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Markets for</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identical</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Types of Instruments</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">251,207</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,605</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,812</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Common Stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,249</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,249</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Warrants</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Armata Note</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,883</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,883</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata July 2023 Term Loan</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,044</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,044</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Gate Note</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,972</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,972</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at estimated fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">503,162</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">167,504</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">705,963</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Debt</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 Notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200,407</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200,407</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028 Notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">227,070</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">227,070</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total fair value of debt</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,477</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,477</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent value rights</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities at estimated fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,477</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,836</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> transfers between Level 1, Level 2 or Level 3 during the periods presented.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values of our equity investments in Armata&#8217;s common stock and publicly traded investments held by ISP Fund LP are based on the quoted prices in active markets and are classified as Level 1 financial instruments. The fair values in the warrants in Armata classified within Level 2 are based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Gate Convertible Note, the Armata Convertible Note, the Armata July 2023 Term Loan, the Armata March 2024 Term Loan, The Incarda Covertible Note, the InCarda Warrants, the ImaginAb Convertible Note, private placement positions and convertible notes held by ISP Fund LP, and contingent value rights are classified as Level 3 financial instruments as these securities are not publicly traded and the assumptions used in the valuation model for valuing these securities are based on significant unobservable and observable inputs including those of publicly traded peer companies.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values of our 2025 Notes and 2028 Notes are based on recent trading prices of the respective instruments.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563208258304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capitalized Fees Paid<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAbstract', window );"><strong>Capitalized Contract Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidDisclosureTextBlock', window );">CAPITALIZED FEES PAID</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. CAPITALIZED FEES PAID</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized fees paid, which consist of registrational and launch-related milestone fees paid to GSK, were as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:14.749%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization period</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2030</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Europe</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2029</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Japan</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2029</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross carrying value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated amortization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,039</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">136,216</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,961</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,784</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These milestone fees are amortized over their estimated useful lives commencing upon the commercial launch of the product in their respective regions with the amortization recorded as a reduction in revenue from collaborative arrangements. As of December 31, 2024, the weighted average remaining amortization period wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5.2</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional information regarding these milestone fees is included in Note 3, &#8220;Revenue Recognition&#8221;. Amortization for each of the years ended December 31, 2024, 2023 and 2022 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The remaining estimated amortization is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for each of the years from 2025 to 2027, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year 2028, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year 2029 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million thereafter.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about capitalized fees paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299855616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. GOODWILL AND INTANGIBLE ASSETS</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Goodwill and intangible assets acquired are recognized at fair value as of the acquisition date. The carrying amount of goodwill as of December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recognized any impairment losses related to goodwill and intangible assets during the periods presented.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets with definite lives are amortized over their estimated useful lives. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying basis and accumulated amortization of recognized intangible assets as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 were as follows:</span></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.86%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:14.24%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful Life</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketed products</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">223,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,559</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">176,141</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration agreement</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,400</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,692</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,267</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,433</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.86%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:14.24%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful Life</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketed products</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">219,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,204</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194,496</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration agreement</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,400</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,161</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,239</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">257,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,365</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">230,335</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets recognized as a result of the acquisition of Entasis amounted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which consisted of Entasis&#8217; in-process research and development related to its antibacterial therapeutic product candidates and a collaboration agreement amounting to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Following the FDA approval of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in May 2023, we started amortizing $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the then in-process research and development as a marketed product, as well as the collaboration agreement, over their estimated useful lives. The useful life of the remaining in-process research and development of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million will be determined upon commercialization of the underlying product candidate; thus, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amortization expense for this intangible asset was recognized </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the periods presented.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets recognized as a result of the acquisition of La Jolla amounting to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million pertain to product rights and developed technologies on La Jolla&#8217;s currently marketed products. These are intangible assets with determinable lives and are amortized over their estimated useful lives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 4 &#8220;License and Collaboration Arrangements&#8221;, we capitalized the upfront fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that we paid to Basilea under our exclusive distribution and license agreement as an intangible asset. This amount is included in marketed products in the table above and will be amortized over the term of the agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized amortization expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024, 2023 and 2022, respectively. Future amortization expense is expected to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for each of the years from 2025 to 2029 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million thereafter.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196151696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">BALANCE SHEET COMPONENTS</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. BALANCE SHEET COMPONENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inventory</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inventory consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Raw materials</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,113</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,257</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Work-in-process</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,529</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,670</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finished goods</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,083</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,810</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total inventory</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,725</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,737</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023, total inventory included net fair value adjustments resulting from the acquisition of La Jolla of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which will be recognized as cost of products sold when sales occur in future periods. The fair value adjustments recorded as part of cost of products sold amounted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million, $27</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million for the years ended December 31, 2024, 2023 and 2022, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Accrued Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other accrued liabilities consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued contract manufacturing expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,071</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,966</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical and research expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">776</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,682</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0;"><span style="-sec-ix-hidden:F_f4af3d02-580b-4f35-bd4b-6df98811301b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of lease liabilities</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,572</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,207</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty obligation payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,951</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,928</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of deferred royalty obligation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,438</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued license fees and royalties</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,727</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,575</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,947</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,370</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other accrued liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,698</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amount in &#8220;Other&#8221; as of December 31, 2024 includes $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in consideration received under a letter agreement we have entered into with Zai Lab as discussed in Note 4, &#8220;License and Collaboration Arrangements&#8221;.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Long-Term Liabilities</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other long-term liabilities consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion of deferred royalty obligation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,096</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,876</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_16c95013-f170-4361-bd0d-93944037b675;"><span style="-sec-ix-hidden:F_ebb48713-23ce-429f-ae3c-689518f40e91;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion of lease liabilities</span></span></span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,179</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,635</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent value rights liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other long-term liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,275</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,870</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299849600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. STOCK&#8209;BASED COMPENSATION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Incentive Plans</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2012, we adopted the 2012 Equity Incentive Plan (the &#8220;2012 Plan&#8221;). The 2012 Plan provides for the grant of incentive stock options, nonstatutory stock options, RSAs, RSUs and Stock Appreciation Rights to employees, non-employee directors and consultants. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total shares remaining available for issuance under the 2012 Plan were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,758,450</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the 2004 Employee Stock Purchase Plan (the &#8220;2004 ESPP&#8221;), our employees may purchase common stock through payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lower of the fair market value of the stock at the beginning of the offering period or at the end of each applicable purchase period. The 2004 ESPP provided for consecutive and overlapping offering periods of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24 months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in duration, with each offering period composed of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consecutive </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> purchase periods. The purchase periods ended on either May 15 or November 15. The 2004 ESPP contributions were limited to a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of an employee&#8217;s eligible compensation. The maximum number of shares that an employee may purchase in any purchase period was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. An employee may not purchase shares with a value greater than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in any calendar year.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 13, 2023, the Board of Directors adopted the 2023 ESPP (the &#8220;2023 ESPP&#8221;). The 2023 ESPP, which supersedes the 2004 ESPP, was approved by the Company&#8217;s stockholders on May 22, 2023. Under the 2023 ESPP, eligible employees may purchase common stock through payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lower of the fair market value of the stock at the beginning or end of each applicable purchase period. The 2023 ESPP provides for offering periods of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which ends on either May 15 or November 15. The 2023 ESPP contributions are limited to a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of an employee&#8217;s eligible compensation. The maximum number of shares that an employee may purchase in any purchase period is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. An employee may not purchase shares with a value greater than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in any calendar year. A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of our common stock was reserved and available for issuance under the 2023 ESPP.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total shares remaining available for issuance under the 2024 ESPP were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,467,596</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Director Compensation Program</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our non-employee directors receive compensation for services provided as a director. Each member of our board of directors who is not an employee receives both cash and equity compensation for services as a director, member of a committee of the board of directors, lead independent director and chairman, as applicable. In October 2017, both the cash and equity components of the compensation program were amended, effective immediately (the &#8220;October 2017 Amendments&#8221;).</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of our independent directors receives periodic automatic grants of equity awards under a program implemented under the 2012 Plan. These grants are non&#8209;discretionary. Only our independent directors or affiliates of such directors are eligible to receive automatic grants under the 2012 Plan. Under the program, each individual who first became a non-employee director will, on the date such individual joins the board of directors, automatically be granted a one&#8209;time grant of RSUs covering a number of shares of our common stock calculated as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, rounded down to the nearest whole share (the &#8220;Initial RSUs&#8221;), plus a one&#8209;time grant of RSUs covering a number of shares of our common stock calculated as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, which would be pro-rated for the number of whole months remaining until the anniversary of the prior year&#8217;s stockholders&#8217; meeting, rounded down to the nearest whole share (the &#8220;Pro Rata RSUs&#8221;). The Initial RSUs vest in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> equal annual installments, while Pro Rata RSUs vest in a single installment at the sooner of the next annual stockholder meeting or the one-year grant anniversary, in each case subject to the non-employee director&#8217;s continuous service through the applicable vesting date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annually, upon his or her re&#8209;election to the board of directors at the Annual Meeting of Stockholders, each non-employee director is automatically granted an RSU covering a number of shares of our common stock calculated as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, rounded down to the nearest whole share. These RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the non-employee director&#8217;s continuous service through the applicable vesting date. Following the amendment to our non-employee director compensation program, both the annual RSUs and Initial RSUs described above remained unchanged with the exception that the number of shares of our common stock subject to each award has been reduced.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These RSUs will vest in full upon the director&#8217;s death, the occurrence of a change in control or, with respect to awards made after the October 2017 Amendments, the director&#8217;s disability before the director&#8217;s service terminates. Director RSUs carry dividend equivalent rights to be credited with an amount equal to all cash dividends paid on the underlying shares of common stock while unvested. Dividend equivalents are subject to the same terms and conditions, including vesting, as the RSUs to which they attach and are paid in cash upon vesting.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock&#8209;Based Compensation Expense</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock&#8209;based compensation expense is included in the consolidated statements of income as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.01%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.203%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.203%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.583%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling, general and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,040</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,645</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,305</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">334</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,192</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,042</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,374</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,837</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,347</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock&#8209;based compensation expense included in the consolidated statements of income by award type is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,738</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,980</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,057</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,348</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,663</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,053</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">123</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">168</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ESPP</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">165</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,374</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,837</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,347</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:60.2%;box-sizing:content-box;"></td>
        <td style="width:1.82%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.36%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrecognized Compensation Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Amortization Period (Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,765</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.8</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,996</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total unrecognized compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,859</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation Awards</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:32.386%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.642%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.7219999999999995%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.642%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.7219999999999995%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.642%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.182%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except per share data)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding options</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Exercise Price of Outstanding Options</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding RSUs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Fair Value per Share at Grant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding RSAs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Fair Value per Share at Grant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,499</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.09</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">482</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.62</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.93</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,062</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.67</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">502</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.77</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.88</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Released RSUs and RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.52</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.46</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">414</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.24</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">145</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.86</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,067</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.23</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">598</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.00</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.50</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest <br/>&#160;&#160;&#160;as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,067</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.23</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">598</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.00</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the aggregate intrinsic value of options outstanding and options exercisable was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2023, the aggregate intrinsic value of options outstanding and options exercisable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">759,904</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options were exercisable. The weighted average remaining contractual term of options outstanding was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.04</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.96</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years as of December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total intrinsic value of the options exercised was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material for the year ended December 31, 2024, 2023 and 2022. The total estimated fair value of options vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023, respectively. The total estimated fair value of options vested was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t material for the year ended December 31, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total estimated fair value of RSUs vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years December 31, 2024, 2023 and 2022, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total estimated fair value of RSAs vested was not material for the year ended December 31, 2024, 2023, and 2022.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Valuation Assumptions</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Black-Scholes-Merton weighted-average</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.748999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.748999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.748999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.10</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.09</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.04</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average estimated fair value of stock options granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.17</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.57</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.43</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197253168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 31, 2022, our board of directors authorized a share repurchase program under which we may repurchase up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of our outstanding shares of common stock. The repurchase program authorized the repurchase by the Company of its common stock in open market transactions, including pursuant to a trading plan in accordance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), privately negotiated transactions, in block trades, accelerated share repurchase transactions, exchange transactions, or any combination thereof or by other means in accordance with federal securities laws. The authorization permitted management to repurchase shares of the Company&#8217;s common stock from time to time at management&#8217;s discretion. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so because of self-imposed trading blackout periods or other regulatory restrictions. From program inception through December 31, 2022, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">647,394</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares in the open market at an average price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a total amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. For the year ended December 31, 2023, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,173,565</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares in the open market at an average price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.39</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a total amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. From January to April 2024, we repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">986,928</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares in the open market at an average price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a total amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The share repurchase program was completed in April 2024. All of the repurchased shares were retired.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2024, we retired all shares held in treasury resulting from our strategic buyback of GSK&#8217;s common shares in the Company in 2021. We recorded the corresponding cost of treasury stock of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">393.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in additional paid-in capital.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299967104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. DEBT</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our debt consists of the following:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">453,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">453,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;Less: Unamortized debt discount and issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,156</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,266</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">448,344</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446,234</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;Less: Current portion of long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">256,316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446,234</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Subordinated Notes Due 2023</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2013, we completed an underwritten public offering of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of our 2023 Notes, which matured on January 15, 2023. The 2023 Notes bore interest at the rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.125</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per year that is payable semi-annually in arrears in cash on January 15 and July 15 of each year, beginning on July 15, 2013.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2023 Notes were convertible, at the option of the holder, into shares of our common stock at an initial conversion rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.9903</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares per $1,000 principal amount of the 2023 Notes, subject to adjustment in certain circumstances, which represented an initial conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.79</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the offering of the 2023 Notes, we entered into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> privately negotiated capped call option transactions with a single counterparty. The capped call option transaction was an integrated instrument consisting of a call option on our common stock purchased by us with a strike price equal to the initial conversion price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.79</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for the underlying number of shares and a cap price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, both of which were subject to adjustments consistent with the 2023 Notes. The cap component was economically equivalent to a call option sold by us for the underlying number of shares with an initial strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As an integrated instrument, the settlement of the capped call coincided with the due date of the convertible debt. Upon settlement, we would receive from our hedge counterparty a number of shares of our common shares that would range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, if the stock price was below $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.79</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, to a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,779,659</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, if the stock price was above $38.00 per share. However, if the market price of our common stock, as measured under the terms of the capped call transactions, exceeded $38.00 per share, there was no incremental anti-dilutive benefit from the capped call.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the partial conversion by certain holders of the 2023 Notes in July 2014, and dividends declared and paid in 2014 and 2015, the conversion rate with respect to our 2023 Notes was adjusted in total to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.5818</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our common stock per $1,000 principal amount of the 2023 Notes, which represented a conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.77</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. As a result of the conversion rate adjustments, the capped call strike price and cap price were also adjusted to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.77</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.04</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2016, we retired a portion of our 2023 Notes with a face value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million by way of purchase in the open market.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 7, 2022, we used $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">165.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from the sale of the 2028 Notes to repurchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the 2023 Notes with a face value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The carrying value of the repurchased 2023 Notes was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Accrued interest was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and unamortized debt issuance costs were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the date of repurchase. We recognized a loss on the extinguishment of the 2023 Notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in other expense, net, in the consolidated statement of operations. The repurchase reduced the outstanding principal balance to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and unamortized debt issuance costs to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The annual effective interest rate of the 2023 Notes changed from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.36</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 18, 2022, certain 2023 Notes holders converted their notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand into Innoviva&#8217;s common stock. The outstanding principal balance was reduced slightly to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. This remaining balance was fully paid upon the maturity date in January 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2023 Notes for the years ended December 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023 and 2022:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:61.216%;box-sizing:content-box;"></td>
        <td style="width:1.779%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.614%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.779%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.614%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,617</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">302</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,919</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Senior Notes Due 2025</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 7, 2017, we completed a private placement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of our 2025 Notes. The proceeds include the 2025 Notes sold pursuant to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over-allotment option granted by us to the initial purchasers, which option was exercised in full. The 2025 Notes were sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2025 Notes are senior unsecured obligations and bear interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per year, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2018.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2025 Notes are convertible, based on the applicable conversion rate, into cash, shares of our common stock or a combination thereof, at our election. The initial conversion rate for the 2025 Notes is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57.9240</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our common stock per $1,000 principal amount of the 2025 Notes (which is equivalent to an initial conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.26</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), representing a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% conversion premium over the last reported sale price of the Company&#8217;s common stock on August 1, 2017, which was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The conversion rate is subject to customary anti-dilution adjustments in certain circumstances. The 2025 Notes will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 15, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, unless repurchased or converted in accordance with their terms prior to such date. Prior to February 15, 2025, the 2025 Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, as described below. From, and including, February 15, 2025, until the close of business on the second scheduled trading day immediately preceding the maturity date, the 2025 Notes will be convertible at any time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders of the 2025 Notes may convert all or a portion of their 2025 Notes prior to the close of business on February 15, 2025 only under the following circumstances:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after September 30, 2017, if our closing common stock price for at least 20 days out of the most recent 30 consecutive trading days of the preceding quarter is greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the current conversion price of the 2025 Notes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for five consecutive business days, if the average trading price per $1,000 of Notes during the prior 10 consecutive trading days is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the product of our closing common stock price and the conversion rate of the 2025 Notes on such day; and,</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental changes (as defined in the indenture governing the 2025 Notes) or a transaction resulting in our common stock converting into other securities or property or assets. </span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On or after February 15, 2025, holders of the 2025 Notes may convert their 2025 Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2025 Notes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of default or a fundamental change (as defined above), holders of the 2025 Notes may require us to repurchase all or a portion of their 2025 Notes at price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective January 1, 2022, we adopted ASU 2020-06 using a modified retrospective method, under which financial results reported in prior periods were not adjusted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Prior to the adoption of ASU 2020-06, we separately accounted for the liability and equity components of the 2025 Notes by allocating the proceeds between the liability component and the embedded conversion option (&#8220;equity component&#8221;) due to our ability to settle the conversion obligation of the 2025 Notes in cash, common stock or a combination of cash and common stock, at our option. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature using the income approach. The allocation was performed in a manner that reflected our non-convertible debt borrowing rate for similar debt. The equity component of the 2025 Notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">was recognized as a debt discount and represents the difference between the proceeds from the issuance of the 2025 Notes and the fair value of the liability of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025 Notes on the date of issuance. The excess of the principal amount of the liability component over its carrying amount (&#8220;debt discount&#8221;) was amortized to interest expense using the effective interest method over the term of the 2025 Notes. The equity component was not remeasured as long as it continued to meet the conditions for equity classification. Additionally, we separated the total issuance costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million incurred into liability and equity components in proportion to the allocation of the initial proceeds, resulting in liability issuance costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and equity issuance costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Issuance costs attributable to the liability component were amortized on a straight-line basis, which approximated the effective interest rate method, to interest expense over the term of the 2025 Notes. The issuance costs attributable to the equity component were netted against the equity component in additional paid-in capital. The annual effective interest rate of the liability component of the 2025 Notes was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.87</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon adoption of ASU 2020-06 on January 1, 2022, we combined the liability and equity components of the 2025 Notes assuming that the instrument was accounted for as a single liability from inception to the date of adoption. We similarly combined the liability and equity components of the issuance costs. The issuance costs are presented as a deduction from the outstanding principal balance of the 2025 Notes and are amortized on a straight-line basis over the term of the 2025 Notes under the effective interest rate method. Beginning January 1, 2022, the annual effective interest rate on the 2025 Notes is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.88</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our outstanding 2025 Notes balances consisted of the following:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt discount and issuance costs, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">472</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,205</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,028</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">191,295</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2025 Notes for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, 2023 and 2022:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">712</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">692</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,546</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,525</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,505</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Senior Notes Due 2028</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March 2022, we completed a private placement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of our 2028 Notes, which will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 15, 2028</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The proceeds include the 2028 Notes sold pursuant to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over-allotment option granted by us to the initial purchasers, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was exercised. The 2028 Notes were sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net proceeds from the sale of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of 2028 Notes were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting the initial purchasers&#8217; discounts and commissions and our estimated offering expenses. We used approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the net proceeds from the offering to fund the cost of entering into the capped call transactions described below. In addition, we used $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">165.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the remaining net proceeds to repurchase $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million aggregate principal amount of the 2023 Notes in separate and individually negotiated transactions with certain holders of the 2023 Notes, which closed concurrently with the issuance of the 2028 Notes. We expect to use the remaining net proceeds for general corporate purposes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2028 Notes bear interest at an annual rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.125</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% that is payable semi-annually in arrears in cash on March 15 and September 15 of each year, beginning on September 15, 2022.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2028 Notes are convertible, based on the applicable conversion rate, into cash, shares of our common stock or a combination thereof, at our election. The initial conversion rate was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.1432</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares per $1,000 principal amount of the 2028 Notes, subject to customary anti-dilution adjustment in certain circumstances, which represented an initial conversion price of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26.22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to September 15, 2027, the 2028 Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, and will be convertible on or after September 15, 2027, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2028 Notes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders of the 2028 Notes may convert all or a portion of their 2028 Notes prior to the close of business on September 15, 2027, only under the following circumstances:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after March 31, 2022, if our closing common stock price for at least 20 days out of the most recent 30 consecutive trading days of the preceding quarter is greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the current conversion price of the 2028 Notes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for five consecutive business days, if the average trading price per $1,000 of Notes during the prior 10 consecutive trading days is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the product of our closing common stock price and the conversion rate of the 2028 Notes on such day; and,</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental changes (as defined in the indenture governing the 2028 Notes) or a transaction resulting in our common stock converting into other securities or property or assets.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On or after September 15, 2027, holders of the 2028 Notes may convert their 2028 Notes at any time until the close of the business on the second day immediately preceding the maturity date of the 2028 Notes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2028 Notes will be redeemable, in whole or in part, at our option at any time, and from time to time, on or after March 20, 2025, and on or before the 75th scheduled trading day immediately before the maturity date but only if the last reported sale price per share of our common stock exceeds 130% of the conversion price for a specified period of time. The redemption price will be equal to the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, calling any 2028 Note for redemption will constitute a make-whole fundamental change (as defined in the indenture governing the 2028 Notes) with respect to that 2028 Note, in which case the conversion rate applicable to the conversion of that 2028 Note will be increased in certain circumstances if it is converted after it is called for redemption.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we undergo a fundamental change, subject to certain conditions, holders may require us to purchase for cash all or any portion of their 2028 Notes. The fundamental change purchase price will be </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of the 2028 Notes to be purchased plus any accrued and unpaid interest to, but excluding, the fundamental change purchase date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture governing the 2028 Notes contains customary terms and covenants, including a merger covenant and that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Notes to be due and payable immediately.</span></span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions. The cap price of the capped call transaction is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.9850</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and is subject to certain adjustments under the terms of the capped call transactions. The capped call transactions cover, subject to customary adjustments, the number of shares of common stock initially underlying the 2028 Notes. The capped call transactions are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes or at our election (subject to certain conditions) offset any cash payments we are required to make in excess of the aggregate principal amount of converted 2028 Notes, as the case may be, with such reduction or offset subject to a cap.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The annual effective interest rate on the 2028 Notes is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.70</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our outstanding 2028 Notes balance consisted of th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt discount and issuance costs, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,684</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,061</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">256,316</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">254,939</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2028 Notes for the years ended December 31, 2024,  2023, and from the issuance through December 31, 2022:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Issuance Through</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,546</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,546</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,514</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt discount and issuance costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,377</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,342</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,061</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,923</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,888</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,575</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Maturities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate scheduled maturities of our convertible debt as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.46%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">453,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Royalty Obligation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our acquisition of La Jolla, we recorded the fair value of its deferred royalty obligation in connection with La Jolla&#8217;s royalty financing agreement (&#8220;La Jolla Royalty Agreement&#8221;) with HealthCare Royalty Partners (&#8220;HCR&#8221;). Under the terms of the La Jolla Royalty Agreement, HCR is entitled to receive quarterly royalties on worldwide net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> until either January 1, 2031 or when the maximum aggregate royalty payments have been made, whichever occurs first. Quarterly payments to HCR under the Royalty Agreement start at a maximum royalty rate, with step-downs based on the achievement of annual net product sales thresholds. The maximum royalty rate through December 31, 2023 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Starting January 1, 2024, the maximum royalty rate was increased to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% based on the terms of the Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The La Jolla Royalty Agreement is subject to maximum aggr</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">egate royalty payments to HCR of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, we recognized interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, on the deferred royalty obligation. From the date of our acquisition of La Jolla through December 31, 2022, we recognized interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the deferred royalty obligation. The carrying value of the deferred royalty obligation as of December 31, 2024 and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, (refer to Note 9 &#8220;Balance Sheet Components</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). During the years ended December 31, 2024 and 2023, we made royalty payments to HCR of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. From the date of acquisition of La Jolla through December 31, 2022, we made royalty payments to HCR of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The deferred royalty obligation was valued using Level 3 inputs, and its carrying value as of December 31, 2024 and 2023 approximates fair value. The fair</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">value </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the deferred royalty obligation was calculated as the discounted deferred royalty obligations based on revenue projections for GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2024, the annual effective interest rate of the deferred royalty obligation is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.44</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the terms of the La Jolla Royalty Agreement, if we are unable to meet certain obligations, including the obligation to use commercially reasonable and diligent efforts to commercialize GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, HCR would have the right to terminate the La Jolla Royalty Agreement and demand payment of either $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (depending on which obligation we have failed to meet) less aggregate royalties already paid to HCR. As of December 31, 2024, inclusive of the aggregate royalties paid to HCR by La Jolla under the La Jolla Royalty Agreement prior to our acquisition, La Jolla paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">aggregate royalties to HCR. In the event that we fail to pay such amount if and when due in a timely manner, HCR would have the right to foreclose on the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-related assets. HCR has no recourse against any asset other than GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain contract provisions within the La Jolla Royalty Agreement that could result in an acceleration of amounts due under the La Jolla Royalty Agreement are recognized as embedded derivatives that require bifurcation from the deferred royalty obligation and fair value recognition. We determined the fair value of each derivative by assessing the probability of each event occurring, as well as the potential repayment amounts and timing of such repayments that would result under various scenarios. As a result of this assessment, we determined that the fair value of the embedded derivatives is immaterial and, therefore, not recognized as of December 31, 2023 and 2022. We estimate the fair value of the embedded derivatives for each reporting period until either the features lapse or the La Jolla Royalty Agreement is terminated, whichever occurs first. Any material change in the fair value of the embedded derivatives will be recorded as either a gain or loss in the consolidated statements of income.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197253664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. COMMITMENTS AND CONTINGENCIES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Lease</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have operating leases for our corporate headquarters, office spaces and laboratory facilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2019, we entered into an operating lease for our headquarters in Burlingame, California for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,111</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> rentable square feet. The lease commenced in November 2019 with an initial term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_df825393-b260-4cba-9ff7-9fc9a38e03d8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">thirty-six</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> calendar months, which was subsequently amended to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_95673362-d782-4e32-804a-2d906541bf72;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2027</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our operating leases include a facility lease consisting of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Waltham, Massachusetts, which expires in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1f9d0b86-7ca1-4461-b3cf-41c5a7d463c7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2029</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of lease costs are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.863%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Straight line operating lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,428</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,585</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,617</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,740</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplemental cash flow information related to leases are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.863%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of <br/>&#160;&#160;&#160;operating lease liabilities:</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,464</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,542</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">790</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets obtained in exchange <br/>&#160;&#160;&#160;for operating lease obligations</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,156</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,323</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained through acquisitions</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,185</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our operating leases have weighted-average remaining term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.6</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and the weighted-average discount rate on our operating lease liabilities was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future minimum lease payments on our operating leases as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,705</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">435</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">455</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">326</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,004</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">253</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">      </span><span><span style="-sec-ix-hidden:F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,751</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Purchase Commitments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2024, we entered into a Commercial Supply Agreement with Corden Pharma CHEN&#212;VE SAS (&#8220;Corden&#8221;), under which we engaged Corden to manufacture and supply certain products related to XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and to perform certain services and studies. Under the agreement, we committed to minimum purchase commitments through December 31, 2027.  As of December 31, 2024, we have approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million U.S. dollar equivalent in outstanding purchase commitments under the agreement for the year 2024, which will be utilized in early 2025. We also have approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million U.S. dollar equivalent in purchase commitments under the agreement for the years 2025, 2026 and 2027, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company is involved in legal proceedings in the ordinary course of its business. We are not currently a party to any material legal proceedings except as discussed below.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 15, 2022, La Jolla received a paragraph IV notice of certification (the &#8220;First Notice Letter&#8221;) from Gland Pharma Limited (&#8220;Gland&#8221;) advising that Gland had submitted an Abbreviated New Drug Application (&#8220;ANDA&#8221;) to the FDA seeking approval to manufacture, use or sell a generic version of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the U.S. prior to the expiration of U.S. Patent Nos.: 9,220,745; 9,572,856; 9,867,863; 10,028,995; 10,335,451; 10,493,124; 10,500,247; 10,548,943; 11,096,983; and 11,219,662 (the &#8220;GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents&#8221;), which are listed in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;). The First Notice Letter alleges that the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents are invalid, unenforceable and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Gland&#8217;s ANDA.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2022, La Jolla filed a complaint for patent infringement of the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Patents against Gland and certain related entities in the United States District Court for the District of New Jersey in response to Gland&#8217;s ANDA filing. In accordance with the Hatch-Waxman Act, because GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is a new chemical entity and La Jolla filed a complaint for patent infringement within 45 days of receipt of the First Notice Letter, the FDA cannot approve Gland&#8217;s ANDA any earlier than 7.5 years from the approval of the GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> NDA unless the District Court finds that all of the asserted claims of the patents-in-suit are invalid, unenforceable and/or not infringed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 22, 2023, La Jolla received a paragraph IV notice of certification (the &#8220;Second Notice Letter&#8221;) from Gland advising that Gland had amended its ANDA filing to include a paragraph IV certification alleging that all claims of the newly-issued and Orange Book-listed U.S. Patent No. 11,559,559 (&#8220;the &#8217;559 Patent&#8221;), which covers GIAPREZA&#174;, are invalid, unenforceable and/or not infringed.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 22, 2023, La Jolla filed a First Amended Complaint in this litigation adding Gland&#8217;s marketing and distribution partners for its ANDA angiotensin II product, Fresenius Kabi USA LLC and Fresenius Kabi SwissBiosim GmbH (collectively, the &#8220;Fresenius Kabi Defendants&#8221;), as co-defendants. On April 7, 2023, La Jolla filed a Second Amended Complaint in response to the Second Notice Letter, adding claims that the manufacture, use, sale, offer for sale, or import of Gland&#8217;s ANDA angiotensin II product will infringe the &#8217;559 Patent. On November 14, 2023, La Jolla filed a Third Amended Complaint adding additional infringement claims against the Fresenius Kabi Defendants.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2025, La Jolla, as well as The George Washington University (collectively, with the La Jolla entities, the &#8220;Plaintiffs&#8221;) entered into a settlement agreement (the &#8220;Settlement Agreement&#8221;) with Gland and the Fresenius Kabi Defendants (collectively, &#8220;Defendants&#8221;) resolving the Hatch-Waxman Act concerning Gland&#8217;s ANDA filing. Under the terms of the Settlement Agreement, Plaintiffs granted Defendants a perpetual, royalty-free and fully paid-up, non-exclusive, non-sublicensable, non-transferable right and license solely to make, have made, use, sell, offer to sell, import, and/or distribute the product that is subject to Gland&#8217;s ANDA in the United States commencing in the early 2030s, subject to certain exceptions as is customary in these type of agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required by law, the settlement is subject to review by the U.S. Department of Justice and the Federal Trade Commission.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications and Other Contingencies</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of business, we may provide indemnifications of varying scope and terms to vendors, directors, officers, and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by us, our negligence or willful misconduct, violations of law, or intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. No material demands have been made upon us to provide indemnification under such agreements, and thus, there are no claims that we are aware of that could have a material effect in our consolidated financial statements. We also maintain director and officer insurance, which may cover certain liabilities arising from our obligation to indemnify our directors. To date, we have not incurred any material costs and, as of December 31, 2024, we have not accrued any liabilities in the consolidated financial statements as a result of these provisions.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196151696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. INCOME TAXES</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income tax expense consists of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,438</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,799</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,822</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,175</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,177</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">464</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,613</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,976</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,286</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,606</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,594</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,026</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,194</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">625</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,617</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,400</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,401</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The impacts of the differences between the expected U.S. federal statutory income tax to our income tax expense are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected tax at federal statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,928</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income tax expense (benefit), net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,864</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,414</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal and state research credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,582</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign derived intangible income deduction</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,767</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,274</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impact of consolidation and deconsolidation of subsidiaries</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,897</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,243</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,219</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,386</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,167</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax expense, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of our deferred tax assets and deferred tax liabilities are as follows:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:60.84%;box-sizing:content-box;"></td>
        <td style="width:1.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">176,989</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">182,013</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credit carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,359</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,357</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized loss on investment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,481</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred royalty obligation, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,452</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,084</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,832</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,113</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">227,921</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,635</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169,249</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,478</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,672</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,626</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,064</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on investment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory fair value adjustment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,424</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets (liabilities)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,054</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">563</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We record deferred tax assets if the realization of such assets is more likely than not to occur. Significant management judgment is required in determining whether a valuation allowance against the deferred tax assets is required. We have considered all available evidence, both positive and negative, such as our historical operating results and predictability of future taxable income, in making such determination. We are also required to exercise significant management&#8217;s judgment in forecasting future taxable income. Specifically, we evaluate the following criteria when considering a valuation allowance:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the history of tax net operating losses in recent years;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">predictability of operating results;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">profitability for a sustained period of time; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">level of profitability on a quarterly basis.</span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">520.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">456.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which do not expire.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As of December 31, 2024, we also had state net operating loss carryforwards of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which will expire beginning 2030 and state research tax credits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which do not expire.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Utilization of net operating loss and tax credit carryforwards may be subject to a substantial annual limitation due to ownership change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in expiration of net operating loss and tax credit carryforwards before some or all of such amounts have been utilized.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted an Internal Revenue Code of 1986, as amended, Section 382 (&#8220;Section 382&#8221;) analysis of the Company through December 31, 2024 to determine whether an ownership change had occurred since inception. The Section 382 study concluded that it is more likely than not that the Company did not experience an ownership change during the testing period. If we ever undergo an ownership change, the utilization of the pre-ownership change net operating loss carryforwards or pre-ownership change tax attributes, such as research tax credits, to offset the post-ownership change income may be subject to an annual limitation, pursuant to Sections 382 and 383 of the Internal Revenue Code of 1986, as amended. Similar rules may apply under state tax laws.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of Entasis&#8217; federal net operating losses and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">365.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of La Jolla&#8217;s federal operating losses from the acquisitions in 2022, both subject to annual limitations, were available for future utilization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our policy is to recognize interest and/or penalties related to income tax matters in income tax expense. As of December 31, 2024 and 2023, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest or penalties due to the Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;s net operating losses available to offset any tax adjustments.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have any tax positions for which a significant change in the total amount of gross unrecognized tax benefits is reasonably possible within 12 months of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Uncertain Tax Positions</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:76.46%;box-sizing:content-box;"></td>
        <td style="width:2.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2021</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,872</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2022</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,452</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2022</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,324</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,119</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,443</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,851</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61,294</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The increase of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in 2024 was primarily due to our strategic intercompany intellectual property alignment across different jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to taxation in the U.S. and various state and foreign jurisdictions. The tax years 2006 through 2013, 2015 and forward remain open to examination by the federal and most state tax authorities due to net operating loss and overall credit carryforward positions. We are not currently subject to any income tax audits by federal or state taxing authorities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2021, the Organization for Economic Cooperation and Development (&#8220;OECD&#8221;) enacted model rules for a new global minimum tax framework (&#8220;BEPS Pillar Two&#8221;), and various governments around the world have enacted, or are in the process of enacting legislation. We are in the process of evaluating whether and when these new rules may come into effect and apply to us, including the eligibility to qualify for safe harbor rules</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We plan to treat the tax if any as a period cost. We do not believe that the Pillar Two rules apply to us yet.  As such, the potential future quantitative impact of the enacted or substantively enacted legislation is not yet reasonably estimable.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203239056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15. SEGMENT REPORTING</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We operate as a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8697229b-658d-48d6-b3f9-46eb9028e018;"><span style="-sec-ix-hidden:F_11be943b-e77c-41bd-aecb-698c8fa9edb8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating and reportable segment, focused on creating value for our stockholders. We achieve this by maximizing the value of our respiratory royalty portfolio and growing our investments in innovative healthcare assets that address critical unmet medical needs.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_729d9a5e-6c01-4f45-8bc1-8b9538c8dbaa;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief operating decision-maker (&#8220;CODM&#8221;), evaluates the company&#8217;s financial performance and operational efficiency using consolidated net income.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This helps guide decisions related to commercial operations, product development, and regulatory compliance, ensuring resources are allocated effectively to support growth initiatives. Consolidated net income also helps inform reinvestment strategies to strengthen our market position and drive innovation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the segment are the same as those described in Note 1, &#8220;Description of Operations and Summary of Significant Accounting Policies&#8221;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenues are generated primarily from our collaborative arrangements and royalty payments from GSK, located in Great Britain. We also generate revenue from net product sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as well as license and other revenues. Refer to Note 3, &#8220;Revenue Recognition&#8221;, for more information on our revenues for the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our long-term assets are located within the United States. The CODM does not review assets at a different level or category than the amounts disclosed in the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents the financial information used by the CODM to assess performance, which reconcile to the consolidated net income:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.371%;box-sizing:content-box;"></td>
        <td style="width:1.42%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.122%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.42%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.122%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.42%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.122%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">358,711</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">310,463</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">331,339</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,921</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,535</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,488</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - Rest of the world</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,857</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,341</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,282</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - Amortization of inventory fair value adjustments</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,820</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,164</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,023</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of license revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling and marketing</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,739</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,886</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,249</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67,493</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,652</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development - External services</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,408</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,051</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,666</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development - Internal expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,246</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,871</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,766</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of acquired intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,902</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,784</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,581</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity method investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,253</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">161,749</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and long-term investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,161</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,129</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,462</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,141</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,818</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,369</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,209</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,157</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,789</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of TRC</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">266,696</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,662</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,997</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,969</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,373</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179,722</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,262</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203376256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Operations and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DescriptionOfOperationsPolicyTextBlock', window );">Description of Operations</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Operations</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Innoviva, Inc. (and where context requires, together with its subsidiaries referred to as &#8220;Innoviva&#8221;, the &#8220;Company&#8221;, or &#8220;we&#8221; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#8220;IST&#8221;), and a portfolio of strategic investments in other healthcare assets. Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#8220;GSK&#8221;), including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(fluticasone furoate/vilanterol, &#8220;FF/VI&#8221;) and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(umeclidinium bromide/vilanterol, &#8220;UMEC/VI&#8221;), and up until July 2022, TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the combination FF/UMEC/VI). We sold our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest in Theravance Respiratory Company, LLC (&#8220;TRC&#8221;) on July 20, 2022, and are no longer entitled to receive royalties on sales of TRELEGY</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> products. Under the Long-Acting Beta2 Agonist (&#8220;LABA&#8221;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as follows: </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% on the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion of annual global net sales and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for all annual global net sales above $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion; and royalties from the sales of ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which tier upward at a range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expanded our portfolio through the acquisition of Entasis Therapeutics Holdings Inc. (&#8220;Entasis&#8221;) on July 11, 2022 and the acquisition of La Jolla Pharmaceutical Company (&#8220;La Jolla&#8221;) on August 22, 2022. Our commercial and marketed products include GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Our new product, XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#8220;FDA&#8221;) for the treatment of hospital-acquired and ventilator-associated pneumonias caused by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acinetobacter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in adults and we commenced commercial sales of XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd., (&#8220;Basilea&#8221;) for the commercialization of ZEVTERA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue to further advance our pipeline and are on track to submit a New Drug Application (&#8220;NDA&#8221;) for zoliflodacin, potentially first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the FDA in early 2025. Overall, we have a wholly owned robust critical care and infectious disease operating platform with a hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we own other strategic healthcare assets, such as a large equity stake in Armata Pharmaceuticals, a leader in development of bacteriophages with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of Innoviva, our wholly owned subsidiaries and certain variable interest entities (&#8220;VIE&#8221;) for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entity by the respective noncontrolling party.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_FactorsAffectingComparabilityPolicyTextBlock', window );">Factors Affecting Comparability</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Factors Affecting Comparability</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our historical financial condition and results of operations for the periods presented may not be comparable, either between periods or going forward due to the factors below and as discussed in Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;.</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting consolidation of Entasis on February 17, 2022 and purchase of remaining noncontrolling interest in Entasis on July 11, 2022;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sale of our </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership interest in TRC on July 20, 2022; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisition of La Jolla on August 22, 2022.</span></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Management's Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Management&#8217;s Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Management evaluates its significant accounting policies and estimates on an ongoing basis. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. These estimates also form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and of Significant Suppliers and Partners</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk and of Significant Suppliers and Partners</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and equity and long-term investments. Although we deposit our cash with multiple financial institutions, our deposits, at times, may exceed federally insured limits.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are dependent on third-party manufacturers to supply active pharmaceutical ingredients (&#8220;API&#8221;) and drug products for commercial and research and development programs. These programs could be adversely affected by significant interruption in the supply of API or drug products.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Currently, we derive most of our revenues from GSK and our near-term success depends in large part on GSK&#8217;s ability to successfully develop and commercialize the products in the respiratory programs partnered with GSK. Our near-term success depends in large part upon the performance by GSK of its commercial obligations under the GSK Agreements and the commercial success of RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If GSK does not devote sufficient resources to the commercialization or development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed. GSK is responsible for all clinical and other product development, regulatory, manufacturing and commercialization activities for products developed under the GSK Agreements, including RELVAR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/BREO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ANORO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELLIPTA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our royalty revenues may fluctuate due to a variety of factors, many of which are outside of our control. Our royalty revenues under the GSK Agreements may not meet our, analysts&#8217; or investors&#8217; expectations, due to a number of important factors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenue for the periods include product sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, XERAVA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and XACDURO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Hospitals and other healthcare organizations generally purchase our products through a network of specialty distributors. These specialty distributors, which are located in the U.S., are considered our customers for accounting purposes. We do not believe that loss of one of these distributors would significantly impact our ability to distribute our products, as we expect that sales volume would be absorbed by new or remaining distributors. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of our customers each account for approximately:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2024; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2023; and, </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our net product sales for the year ended December 31, 2022. </span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These same customers account for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our receivables from net product sales, which are included in &#8220;Accounts receivables, net&#8221; in our consolidated balance sheet as of December 31, 2024. These same customers account for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, of our receivables from net product sales, which are included in &#8220;Accounts receivables, net&#8221; in our consolidated balance sheet as of December 31, 2023.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are identified as components of an enterprise about which separate discrete financial information is made available for evaluation by the chief operating decision maker (&#8220;CODM&#8221;) in making decisions regarding resource allocation and assessing performance. Refer to Note 15, &#8220;Segment Reporting&#8221;, for more segment information.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary beneficiary of a variable interest entity (&#8220;VIE&#8221;) is required to consolidate the assets and liabilities of the VIE. When we obtain a variable interest in another entity, we assess at the inception of the relationship and upon occurrence of certain significant events whether the entity is a VIE and, if so, whether we are the primary beneficiary of the VIE based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, we consider all the facts and circumstances, including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE&#8217;s economic performance and identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To assess whether we have the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, we consider all of our economic interests that are deemed to be variable interests in the VIE. This assessment requires us to apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combination</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When we acquire an entity in a business combination, we recognize the fair value of all assets acquired, liabilities assumed, and any non-controlling interest in the acquiree and establish the acquisition date as the fair value measurement point. We recognize and measure goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair value of the identified net assets acquired. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use the income method. This method starts with a forecast of all of the expected future net cash flows for each asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Some of the more significant estimates and assumptions inherent in the income method or other methods include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows and the assessment of the asset&#8217;s life cycle and the competitive trends impacting the asset, including consideration of any technical, legal, regulatory, or economic barriers to entry. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may even be considered to have indefinite useful lives.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consider all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounts receivable are recorded net of estimates for prompt-pay discounts, chargebacks, returns and rebates. Allowances for prompt-pay discounts and chargebacks are based on contractual terms. We estimate the allowance for credit losses based on existing contractual payment terms, actual payment patterns of customers and individual customer circumstances.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inventory</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inventory is stated at the lower of cost or estimated net realizable value on a first-in, first-out basis. We periodically analyze inventory levels and write down inventory as cost of products sold when the following occurs: inventory has become obsolete, inventory has a cost basis in excess of its estimated net realizable value, or inventory quantities are in excess of expected product sales.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, which consist of laboratory equipment, computer equipment, software, office furniture and fixtures, and leasehold improvements, were not material as of December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">over the estimated useful lives of the respective assets as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:49.17%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:49.17%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease terms or useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment, furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#8211; </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7 years</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3 years</span></span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity and Long-Term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity and Long-Term Investments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We invest from time to time in equity and debt securities of private or public companies. If we determine that we have control over these companies under either voting or VIE models, we consolidate them in our consolidated financial statements. If we determine that we do not have control over these companies under either voting or VIE models, we then determine if we have an ability to exercise significant influence via voting interests, board representation or other business relationships.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may account for the investments where we exercise significant influence using either an equity method of accounting or at fair value by electing the fair value option under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method, we apply it to all our financial interests in the same entity (equity and debt, including guarantees) that are eligible items. All gains and losses from fair value changes, unrealized and realized, are presented as changes in fair values of equity method investments, net, and changes in fair values of equity and long-term investments, net, within the consolidated statements of income.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we conclude that we do not have an ability to exercise significant influence over an investee, we may elect to account for the security without a readily determinable fair value using the measurement alternative method under ASC 321, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments &#8211; Equity Securities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This measurement alternative method allows us to measure the equity investment at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also invest in ISP Fund LP, which investments consist of money market funds and equity and debt securities in the healthcare, pharmaceutical and biotechnology industries. Pursuant to the Partnership Agreement entered in December 2020, we became a limited partner of this partnership, and our contributions were subject to a 36-month lock-up period, which restriction prevented us from having control over and access to the contributions and related investments. The lock-up period for a certain portion of our contributions expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. These investments were classified as long-term investments in the consolidated balance sheet as of December 31, 2023. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of these investments, which consist mainly of cash and money market funds that we expect to be distributed in the next 12 months, were classified as &#8220;Current portion of ISP Fund investments&#8221; in the consolidated balance sheet as of December 31, 2024.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. We classify these inputs into the following hierarchy:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Quoted prices for identical instruments in active markets.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Quoted prices for similar instruments in active markets; quoted prices for identical 3or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unobservable inputs and little, if any, market activity for the assets.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments include cash equivalents, accounts receivable, receivables from collaborative arrangements, accounts payable, and accrued liabilities, equity investments and convertible promissory notes. The carrying values of cash equivalents, receivables from collaborative arrangements, accounts payable, and accrued liabilities approximate their estimated fair values due to the relatively short-term nature of these instruments.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidPolicyTextBlock', window );">Capitalized Fees Paid</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Capitalized Fees Paid</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We capitalize fees paid to licensors related to agreements for approved products or commercialized products. We capitalize these fees as capitalized fees paid (&#8220;Capitalized Fees&#8221;) and amortize them on a straight-line basis over their estimated useful lives upon the commercial launch of the product, shortly after its regulatory approval. The estimated useful lives of these Capitalized Fees are determined on a country-by-country and product-by-product basis, as the later of the expiration or termination of the last patent right covering the compound in such product in such country and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from first commercial sale of such product in such country, unless the Collaboration Agreement is terminated earlier. Consistent with our policy for classification of costs under the research and development collaborative arrangements, the amortization of these Capitalized Fees is recognized as a reduction of royalty revenue. We review our Capitalized Fees for impairment on a product-by-product basis for each major geographic area when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The recoverability of Capitalized Fees is measured by comparing the asset&#8217;s carrying amount to the expected undiscounted future cash flows that the asset is expected to generate. The determination of recoverability typically requires various estimates and assumptions, including estimating the useful life over which cash flows will occur, their amount, and the asset&#8217;s residual value, if any. We derive the required cash flow estimates from near-term forecasted product sales and long-term projected sales in the corresponding market.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Goodwill and Intangible Assets</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Goodwill is recognized as the excess of the purchase consideration of an acquired entity over the fair value assigned to assets acquired and liabilities assumed in a business combination. In addition to recognizing intangible assets acquired in a business combination, we capitalize milestone payments related to in-licensing agreements for approved products as an intangible asset when the contingency for the milestone is resolved and the consideration is issued or becomes issuable. Goodwill and intangible assets with indefinite useful life are not amortized and are tested for impairment at least annually on the first day of December of each year or more frequently if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#8217;s carrying asset amount may not be recoverable. Intangible assets with definite useful lives are amortized on a straight-line basis over their respective remaining useful lives and are tested for impairment only if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable. Significant judgment may be involved in determining if an indicator of impairment has occurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Operating Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent our right to use an underlying asset over the lease term and include any lease payments made prior to the lease commencement date and are reduced by lease incentives. Lease liabilities represent the present value of the total lease payments over the lease term, calculated using an estimated incremental borrowing rate. Lease expense is recognized on a straight-line basis over the expected lease term.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We apply the guidance on principal versus agent considerations under ASC Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to determine the appropriate treatment for the transactions between us and third parties. The classification of transactions under our arrangements is determined based on the nature and contractual terms of the arrangement along with the nature of the operations of the participants. Any consideration related to activities in which we are considered the principal, which includ</span><span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">es being in control of the good or service before such good or service is transferred to the customer, are accounted for as product sales.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is recognized when our customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized through a five-step process: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price for the contract; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue as a performance obligation is satisfied.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalty Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the royalty revenue on net sales of products with respect to which we have contractual royalty rights in the period in which the royalties are earned. The net sales reports provided by our partner are based on its methodology and assumptions to estimate rebates and returns, which it monitors and adjusts regularly in light of contractual and legal obligations, historical trends, past experience and projected market conditions. Our partner may make significant adjustments to its sales based on actual results recorded, which could cause our royalty revenue to fluctuate. We conduct periodic royalty audits to evaluate the information provided by our partner. Royalties are recognized net of amortization of capitalized fees associated with any approval and launch milestone payments made to GSK.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Product Sales</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Revenue from product sales is recognized when our customers obtain control of the product and is recorded at the transaction price, net of estimates for variable consideration consisting of chargebacks, discounts, returns and rebates. Variable consideration is estimated using the expected-value amount method, which is the sum of probability-weighted amounts in a range of possible consideration amounts. Actual amounts of consideration ultimately received may differ from our estimates. If actual results vary materially from our estimates, we will adjust these estimates, which will affect revenue from product sales and earnings in the period such estimates are adjusted. These items may include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chargebacks: Chargebacks are discounts we provide to distributors in the event that the sales prices to end users are below the distributors&#8217; acquisition price. This may occur due to a direct contract with a health system, a group purchasing organization (&#8220;GPO&#8221;) agreement or a sale to a government facility. Chargebacks are estimated based on known chargeback rates and recorded as a reduction of revenue on delivery to our customers.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Discounts: We offer customers various forms of incentives and consideration, including prompt-pay and other discounts. We estimate discounts primarily based on contractual terms. These discounts are recorded as a reduction of revenue on delivery to our customers.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Returns: We offer customers a limited right of return, generally for damaged or expired product. We estimate returns based on an internal analysis, which includes actual experience. The estimates for returns are recorded as a reduction of revenue on delivery to our customers. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rebates: We participate in Medicaid rebate programs, which provide assistance to certain low-income patients based on each individual state&#8217;s guidelines regarding eligibility and services. Under the Medicaid rebate programs, we pay a rebate to each participating state, generally within three months after the quarter in which product was sold. Additionally, we may offer customer incentives and consideration in the form of volume-based or other rebates. The estimates for rebates are recorded as a reduction of revenue on delivery to our customers. </span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to assess our estimates of variable consideration as we accumulate additional historical data and will adjust these estimates accordingly.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the inception of a licensing arrangement that includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price. We generally recognize these milestone payments as revenues when they are achieved because there is considerable uncertainty in the research and development processes that trigger receipt of these payments under our agreements. Similarly, we recognize regulatory approval milestone payments as revenues once the product is approved by the applicable regulatory agency. For delivery of other goods or services related to a licensing arrangement, we determine whether the performance obligation is satisfied over time or at a point in time. If the performance obligation is satisfied over time, we use judgment in determining the appropriate method of measuring progress for purposes of recognizing revenue. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses are recognized in the period that services are rendered or goods are received. Research and development expenses consist of salaries and benefits, laboratory supplies, facilities and other overhead costs, research-related manufacturing costs, contract service and clinical-related service costs performed by third party research organizations, research institutions and other outside service providers. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized. Such amounts are recognized as an expense as the related goods are delivered or the related services are performed. We also utilize significant judgment and estimates to record accruals for estimated ongoing research costs based on the progress of the studies and progress of research manufacturing activities.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpensePolicyTextBlock', window );">Interest Expense on Deferred Royalty Obligation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense on Deferred Royalty Obligation</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense related to the deferred royalty obligation is recognized over the expected repayment term of the deferred royalty obligation using the effective interest method. The assumptions used in determining the expected repayment term of the deferred royalty obligation require us to make estimates that could impact the effective interest rate. Each reporting period, we estimate the expected repayment term of the deferred royalty obligation based on forecasted net sales of GIAPREZA</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Changes in interest expense resulting from changes in the effective interest rate, if any, are recorded on a prospective basis. Refer to Note 12, &#8220;Debt&#8221;, for more information.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Fair Value of Stock-Based Compensation Awards</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Stock&#8209;Based Compensation Awards</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use the Black-Scholes-Merton option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our employee stock purchase plan (&#8220;ESPP&#8221;). The Black-Scholes-Merton option valuation model requires the use of assumptions, including the expected term of the award and the expected stock price volatility. We use the &#8220;simplified&#8221; method as described in Staff Accounting Bulletin No. 107, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Share-Based Payment</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#8221; for the expected option term. We use our historical volatility to estimate expected stock price volatility.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted stock units (&#8220;RSUs&#8221;) and restricted stock awards (&#8220;RSAs&#8221;) are measured based on the fair market values of the underlying stock on the dates of grant.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense is calculated based on awards ultimately expected to vest and is reduced for estimated forfeitures at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differed from those estimates. Our estimated annual forfeiture rates for stock options, RSUs and RSAs are based on our historical forfeiture experience.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of stock options, RSUs and RSAs is expensed on a ratable or straight-line basis over the expected term of the grant or expected term of the vesting. Compensation expense is recorded over the requisite service period based on management&#8217;s best estimate as to whether it is probable that the shares awarded are expected to vest.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation expense for purchases under the ESPP is recognized based on the fair value of the common stock on the date of offering, less the purchase discount percentage provided for in the plan.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and the tax basis of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The recognition and measurement of tax benefits requires significant judgment. Our judgment might change as new information becomes available. We continue to evaluate our deferred tax assets each reporting period to determine whether adjustments to our valuation allowance are required and deferred tax assets will be realized based on the consideration of all available positive and negative evidence, including the differences between our anticipated and actual future operating results, using a &#8220;more likely than not&#8221; standard.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we determine whether the factors underlying the sustainability assertion have changed and whether the amount of the recognized tax benefit is still appropriate.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RelatedPartyTransactionsPolicyTextBlock', window );">Related Parties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Parties</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sarissa Capital ow</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of o</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ur outstanding common stock as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Transactions with Sarissa Capital are described in Note 5, &#8220;Consolidated Entities and Acquisitions&#8221;. Sarissa Capital is considered to be a related party because two of its principals are members of our board of directors.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncement</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Reportable Segment Disclosures (Topic 280).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This ASU update requires enhanced segment disclosures, primarily related to significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. We adopted ASU 2023-07 for the 2024 fiscal year and provided the enhanced disclosures for the comparative years. The adoption of ASU 2023-07 did not have a material impact on the Company's financial statements. Enhanced disclosures related to significant segment expenses are included in Note 15, &#8220;Segment Reporting.&#8221;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Adopted</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Income Tax Disclosures (Topic 740)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The ASU requires the disclosure of income taxes paid disaggregated by jurisdiction and enhanced disclosures for the entity&#8217;s effective tax rate reconciliation as well as other income tax related disclosures. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. The Company has not early adopted the ASU during 2024 and does not expect the adoption of the amendments to have a significant impact on its financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement &#8212; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the statement of income as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company in annual reporting periods beginning after December 15, 2027, and interim reporting periods beginning after December 15, 2027. We are currently evaluating the potential impact that ASU 2024-03 may have on our financial statement disclosures.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-04, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which clarifies the assessment of whether a transaction should be accounted for as an induced conversion or extinguishment of convertible debt when changes are made to conversion features as part of an offer to settle the instrument. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. We are currently evaluating the potential impact that ASU 2024-04 may have on our financial statements and related disclosures.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized fees paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DescriptionOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DescriptionOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_FactorsAffectingComparabilityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Factors affecting comparability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_FactorsAffectingComparabilityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RelatedPartyTransactionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the entity's accounting policies for transactions entered with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RelatedPartyTransactionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Paragraph 2AA<br> -Subparagraph (a)<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-2AA<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197318720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Operations and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule of property, equipment and leasehold improvements useful lives</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">over the estimated useful lives of the respective assets as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:49.17%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:49.17%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of remaining lease terms or useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment, furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#8211; </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7 years</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3 years</span></span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299925360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computation of basic and diluted net income per share</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the computation of basic and diluted net income per share for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, 2023 and 2022:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:50.79%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.077%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.077%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.617%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands except per share data)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders, basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,392</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">213,921</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2023 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,439</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2025 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,583</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Add: interest expense on 2028 Notes, net of tax effect</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,377</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,626</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders, diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,860</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">191,304</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,569</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used to compute basic net income<br/>&#160;&#160;&#160;per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,726</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,435</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2023 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,188</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,150</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,150</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,150</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of 2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,955</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,158</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive effect of options and awards granted under equity<br/>&#160;&#160;&#160;incentive plan and employee stock purchase plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">149</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used to compute diluted net income<br/>&#160;&#160;&#160;per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74,187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.75</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.07</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.36</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.20</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of anti-dilutive securities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti&#8209;dilutive for the periods presented:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.28%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding options and awards granted under equity incentive<br/>&#160;&#160;&#160;plan and employee stock purchase plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,196</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,333</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">648</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding stock warrant</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">282</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding 2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,955</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,742</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,924</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">930</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563195988816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of net revenue from collaboration arrangement</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net revenue recognized under our GSK Agreements was as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; RELVAR/BREO</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207,925</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,042</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215,034</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; ANORO</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,631</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,627</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,405</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalties &#8211; TRELEGY</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalties</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,556</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,669</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">325,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: amortization of capitalized<br/>&#160;&#160;&#160;fees paid</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total royalty revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">238,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,645</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   The year ended December 31, 2022 represents the period from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of net product sales</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total net product sales was as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.09%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.683%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.683%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.683%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GIAPREZA&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,037</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,294</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XERAVA&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,385</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,320</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,480</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XACDURO&#174;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,070</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;Total net product sales</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97,492</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,617</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,694</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563199264976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesAndAcquisitionsLineItems', window );"><strong>Consolidated Entities and Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro Forma Information</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents certain unaudited pro-forma financial information for the year ended December 31, 2022 as if the consolidation of Entasis and La Jolla occurred on January 1, 2021. The unaudited pro forma financial information is presented for informational purposes only, and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place on January 1, 2021, or of results that may occur in the future. The unaudited pro forma financial information combines the historical results of the Entasis and La Jolla with the Company&#8217;s consolidated historical results and includes certain adjustments including, but not limited to, fair value adjustments to equity investments in Entasis&#8217; common stock and warrants, fair value adjustments to inventory, amortization of intangible assets, and interest expense on deferred royalty obligations and acquisition-related costs.</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.46%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">357,880</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">204,987</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Innoviva stockholders</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">214,390</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesAndAcquisitionsLineItems', window );"><strong>Consolidated Entities and Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the adjusted fair values of the assets acquired and liabilities assumed by us in the transaction:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">February 17, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,070</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,554</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,959</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">185</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">959</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,493</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">302</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,222</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,583</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued personnel-related expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,058</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,096</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,769</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,506</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134,716</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember', window );">La Jolla Pharmaceutical Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesAndAcquisitionsLineItems', window );"><strong>Consolidated Entities and Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the adjusted fair values of assets acquired and liabilities assumed by us in the transaction:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">August 22, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,415</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term marketable securities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">471</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,876</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,200</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,261</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">907</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,411</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,461</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">710</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287,951</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,237</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,849</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,362</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,944</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">206,559</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember', window );">Theravance Respiratory Company, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesAndAcquisitionsLineItems', window );"><strong>Consolidated Entities and Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock', window );">Summary of Financial Information of TRC</a></td>
<td class="text">
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:75.96%;box-sizing:content-box;"></td>
        <td style="width:2.2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.84%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,029</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">332</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income from operations</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,697</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Realized loss</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,386</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and<br/>&#160;&#160;&#160;long-term investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,884</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,438</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember', window );">ISP Fund LP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConsolidatedEntitiesAndAcquisitionsLineItems', window );"><strong>Consolidated Entities and Acquisitions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Summary of Individual Investments Held by ISP Fund</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of individual investments held by ISP Fund at each balance sheet date:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:61.232%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.603%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.603%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">In thousands</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock - Publicly traded healthcare companies</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,039</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">184,926</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United Kingdom</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,989</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,942</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86,028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,868</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock - Privately held healthcare companies</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,530</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants - Privately held healthcare companies</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,507</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,075</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market fund and cash</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,532</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,339</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Total investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,658</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,812</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ConsolidatedEntitiesAndAcquisitionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consolidated entities and acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ConsolidatedEntitiesAndAcquisitionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of financial Information on consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org/325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563342317696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock', window );">Reconciliation of Equity and Long-Term Investments Balances</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the change in balances in &#8220;Equity and Long-Term Investments&#8221; as of each balance sheet date:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2022</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">363,859</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of equity and long-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">428</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">444,432</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of trading securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,201</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair value, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,161</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reclassification of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,532</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">724</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity and long-term investments as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">341,664</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Amortized Cost and Estimated Fair Values for Available-for-Sale Securities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of available-for-sale securities is based on quoted market prices for these or similar investments that were based on prices obtained from a commercial pricing service. Available-for-sale securities are summarized below:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gains</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></div></div>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gains</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets.</span></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our available-for-sale securities, equity and long-term investments and contingent value rights are measured at fair value on a recurring basis and our debt is carried at amortized cost basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:39.772%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.678%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Fair Value Measurements as of December 31, 2024 Using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted Price<br/>in Active<br/>Markets for</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identical</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Types of Instruments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,441</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">193,560</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,098</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,658</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Common Stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,392</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,392</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,901</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,901</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - InCarda Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Armata Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,095</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,095</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata July 2023 Term Loan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,197</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,197</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata March 2024 Term Loan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,275</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,275</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - InCarda Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">436</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">436</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - ImaginAb Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,950</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,950</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Gate Note</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,881</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,881</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at estimated fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">529,393</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,901</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">229,991</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">765,285</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">222,353</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">222,353</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">251,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">251,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;Total fair value of debt</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">473,566</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">473,566</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.867%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.222000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Fair Value Measurements as of December 31, 2023 Using:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">in Active</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Markets for</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identical</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Types of Instruments</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Inputs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170,706</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments held by ISP Fund LP</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">251,207</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,605</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">311,812</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Common Stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,249</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,249</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment - Armata Warrants</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Armata Note</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,883</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,883</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term loan investment - Armata July 2023 Term Loan</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,044</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,044</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible debt investment - Gate Note</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,972</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,972</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at estimated fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">503,162</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,297</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">167,504</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">705,963</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Debt</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 Notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200,407</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200,407</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028 Notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">227,070</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">227,070</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total fair value of debt</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,477</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,477</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent value rights</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities at estimated fair value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,477</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427,836</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock', window );">Schedule of Balance Sheets and Income Statements of VIE</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The summarized financial information, including the portion we do not own, is presented for Armata on a one quarter lag as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Balance Sheet Information</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">September 30,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,389</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,585</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,848</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,176</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,204</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,884</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,006</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103,263</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement Information</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Twelve Months Ended September 30,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,052</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,476</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,639</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,666</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,363</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,512</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,650</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of financial information of variable interest entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of reconciliation of equity and long-term investments balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563194268528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capitalized Fees Paid (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAbstract', window );"><strong>Capitalized Contract Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostTableTextBlock', window );">Schedule of Capitalized Fees Paid</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized fees paid, which consist of registrational and launch-related milestone fees paid to GSK, were as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:14.749%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization period</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2030</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Europe</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2029</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Japan</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2013-2029</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross carrying value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated amortization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,039</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">136,216</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying value</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,961</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,784</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563346320560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Accumulated Amortization of Recognized Intangible Assets</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying basis and accumulated amortization of recognized intangible assets as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 were as follows:</span><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.86%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:14.24%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful Life</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketed products</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">223,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,559</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">176,141</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration agreement</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,400</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,692</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,267</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,433</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:36.86%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:14.24%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.56%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful Life</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketed products</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">219,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,204</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194,496</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration agreement</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,400</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,161</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,239</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">257,700</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,365</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">230,335</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563343083136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inventory consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Raw materials</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,113</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,257</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Work-in-process</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,529</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,670</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finished goods</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,083</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,810</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total inventory</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,725</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,737</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accrued Liabilities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other accrued liabilities consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued contract manufacturing expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,071</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,966</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical and research expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">776</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,682</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0;"><span style="-sec-ix-hidden:F_f4af3d02-580b-4f35-bd4b-6df98811301b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of lease liabilities</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,572</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,207</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Royalty obligation payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,951</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,928</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of deferred royalty obligation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,438</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued license fees and royalties</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,727</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,575</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,947</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,370</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other accrued liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,698</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of Other Long-term Liabilities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other long-term liabilities consisted of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion of deferred royalty obligation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,096</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,876</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_16c95013-f170-4361-bd0d-93944037b675;"><span style="-sec-ix-hidden:F_ebb48713-23ce-429f-ae3c-689518f40e91;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion of lease liabilities</span></span></span></span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,179</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,635</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent value rights liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other long-term liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,275</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,870</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299842096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock&#8209;based compensation expense is included in the consolidated statements of income as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.01%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.203%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.203%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.583%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling, general and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,040</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,645</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,305</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">334</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,192</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,042</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,374</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,837</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,347</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of stock-based compensation expense included in the consolidated statements of operations by award type</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock&#8209;based compensation expense included in the consolidated statements of income by award type is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,738</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,980</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,057</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,348</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,663</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,053</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">123</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">168</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ESPP</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">165</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,374</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,837</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,347</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of unrecognized stock-based compensation cost</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:60.2%;box-sizing:content-box;"></td>
        <td style="width:1.82%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.36%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrecognized Compensation Cost</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Amortization Period (Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,765</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.8</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,996</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total unrecognized compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,859</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of equity award activity and related information</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:32.386%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.642%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.7219999999999995%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.642%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.7219999999999995%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.642%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.02%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.182%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except per share data)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding options</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Exercise Price of Outstanding Options</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding RSUs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Fair Value per Share at Grant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of outstanding RSAs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average Fair Value per Share at Grant</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,499</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.09</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">482</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.62</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.93</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,062</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.67</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">502</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.77</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.88</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Released RSUs and RSAs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.52</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.46</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">414</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.24</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">145</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.86</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,067</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.23</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">598</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.00</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.50</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest <br/>&#160;&#160;&#160;as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,067</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.23</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">598</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.00</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of weighted-average assumptions used to calculate estimated value of stock options</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Black-Scholes-Merton weighted-average</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.748999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.748999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.748999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.10</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.09</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.04</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average estimated fair value of stock options granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.17</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.57</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.43</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (i)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198315008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our debt consists of the following:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028 Notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">453,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">453,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;Less: Unamortized debt discount and issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,156</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,266</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">448,344</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446,234</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;Less: Current portion of long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">256,316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446,234</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate Scheduled Maturities of Convertible Debt</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate scheduled maturities of our convertible debt as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.46%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">453,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2023 Notes for the years ended December 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023 and 2022:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:61.216%;box-sizing:content-box;"></td>
        <td style="width:1.779%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.614%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.779%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.614%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,617</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">302</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,919</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember', window );">2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Summary of Liability and Equity Components of Convertible Notes</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our outstanding 2025 Notes balances consisted of the following:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.88%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.799999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt discount and issuance costs, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">472</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,205</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">192,028</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">191,295</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2025 Notes for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, 2023 and 2022:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">712</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">692</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,546</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,525</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,505</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Summary of Liability and Equity Components of Convertible Notes</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our outstanding 2028 Notes balance consisted of th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt discount and issuance costs, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,684</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,061</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">256,316</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">254,939</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth total interest expense recognized related to the 2028 Notes for the years ended December 31, 2024,  2023, and from the issuance through December 31, 2022:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Issuance Through</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,546</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,546</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,514</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt discount and issuance costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,377</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,342</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,061</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total interest and amortization expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,923</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,888</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,575</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563195978144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Cost</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of lease costs are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.863%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Straight line operating lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,428</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,585</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">155</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,617</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,740</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplemental cash flow information related to leases are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.863%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.281%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.764000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of <br/>&#160;&#160;&#160;operating lease liabilities:</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,464</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,542</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">790</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets obtained in exchange <br/>&#160;&#160;&#160;for operating lease obligations</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,156</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,323</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained through acquisitions</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,185</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future minimum lease payments on our operating leases as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,705</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">435</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">455</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">326</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,004</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">253</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">      </span><span><span style="-sec-ix-hidden:F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,751</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197172496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of the income tax expense</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income tax expense consists of the following:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,438</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,799</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,822</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,175</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,177</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">464</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,613</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,976</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,286</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,606</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,594</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,026</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,194</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">625</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,617</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,400</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,401</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of differences between expected U.S. federal statutory income tax to income tax expense</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The impacts of the differences between the expected U.S. federal statutory income tax to our income tax expense are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:51.311%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.75%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected tax at federal statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,928</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income tax expense (benefit), net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,864</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,414</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal and state research credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,582</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign derived intangible income deduction</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,767</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,274</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impact of consolidation and deconsolidation of subsidiaries</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,897</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,243</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,219</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,386</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,167</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax expense, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and deferred tax liabilities</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of our deferred tax assets and deferred tax liabilities are as follows:</span><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:60.84%;box-sizing:content-box;"></td>
        <td style="width:1.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">176,989</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">182,013</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credit carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,359</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,357</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized loss on investment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,481</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred royalty obligation, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,452</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,084</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,832</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,113</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">227,921</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,635</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169,249</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,478</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,672</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,626</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,064</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on investment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inventory fair value adjustment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,798</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,424</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets (liabilities)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,054</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">563</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of changes in unrecognized tax benefits</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:76.46%;box-sizing:content-box;"></td>
        <td style="width:2.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2021</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,872</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2022</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,452</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2022</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,324</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,119</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,443</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in tax portions for 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,851</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrecognized tax benefits as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61,294</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299973328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of reconciliation to the consolidated net income</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents the financial information used by the CODM to assess performance, which reconcile to the consolidated net income:</span></p>
      <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:53.371%;box-sizing:content-box;"></td>
        <td style="width:1.42%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.122%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.42%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.122%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.42%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.122%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">358,711</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">310,463</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">331,339</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,921</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,535</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,488</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - Rest of the world</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,857</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,341</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,282</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of products sold - Amortization of inventory fair value adjustments</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,820</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,164</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,023</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of license revenue</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,600</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling and marketing</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,441</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,739</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,886</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,249</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67,493</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,652</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development - External services</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,408</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,051</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,666</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development - Internal expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,246</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,871</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,766</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of acquired intangible assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,902</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,784</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,581</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity method investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,253</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">161,749</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in fair values of equity and long-term investments, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,161</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,129</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,462</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,141</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,818</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,369</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,209</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,157</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,789</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of TRC</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">266,696</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,662</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,997</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,969</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,373</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense, net</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,996</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,376</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,687</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated net income</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179,722</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,262</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201508960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Operations and Summary of Significant Accounting Policies - Description of Operations (Details)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfMajorCustomers', window );">Numberof major customers | Customer</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeePaidEstimatedUsefulLife', window );">Capitalized fees paid, estimated useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_TheravanceRespiratoryCompanyLlcMember', window );">Theravance Respiratory Company, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Net Product Sales | La Jolla [Member] | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Net Product Sales | La Jolla [Member] | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Net Product Sales | La Jolla [Member] | Customer Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Receivables from Net Product Sales | La Jolla [Member] | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Receivables from Net Product Sales | La Jolla [Member] | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Receivables from Net Product Sales | La Jolla [Member] | Customer Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_SarissaCapitalManagementLpMember', window );">Sarissa Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty', window );">Percentage of common stock owned by a related party</a></td>
<td class="nump">11.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember', window );">Long-Acting Beta2 Agonist (LABA) Collaboration | GSK | RELVAR/BREO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne', window );">Royalty rate for first level of annual global net sales (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate', window );">Annual global sales level used to determine royalty rate | $</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo', window );">Royalty rate for sales above first level of annual global net sales (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember', window );">Long-Acting Beta2 Agonist (LABA) Collaboration | GSK | ANORO | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts', window );">Royalty rate for combination products (as a percent)</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember', window );">Long-Acting Beta2 Agonist (LABA) Collaboration | GSK | ANORO | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts', window );">Royalty rate for combination products (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeePaidEstimatedUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized fee paid estimated useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeePaidEstimatedUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty rate for combination products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty rate which the entity will receive under the collaboration agreement on the first defined level of annual global net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty rate which the entity will receive under the collaboration agreement on sales which exceed the first defined level of annual global net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the annual global net sales amount which determines the royalty rate applied under the collaboration arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of major customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock in the reporting entity owned by related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_TheravanceRespiratoryCompanyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_TheravanceRespiratoryCompanyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_LaJollaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_LaJollaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=inva_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=inva_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=inva_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=inva_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=inva_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=inva_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_TradeAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_TradeAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_SarissaCapitalManagementLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_SarissaCapitalManagementLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistRelvarBreoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistRelvarBreoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistAnoroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistAnoroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198762416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Operations and Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_LaboratoryEquipmentFurnitureAndFixturesMember', window );">Laboratory equipment furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_LaboratoryEquipmentFurnitureAndFixturesMember', window );">Laboratory equipment furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_SoftwareAndComputerEquipmentMember', window );">Software and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_LaboratoryEquipmentFurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_LaboratoryEquipmentFurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_SoftwareAndComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=inva_SoftwareAndComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197280464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Operations and Summary of Significant Accounting Policies - Related Party Transactions (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_SarissaCapitalManagementLpMember', window );">Sarissa Capital</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty', window );">Percentage of common stock owned by a related party</a></td>
<td class="nump">11.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock in the reporting entity owned by related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_SarissaCapitalManagementLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_SarissaCapitalManagementLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201463536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Basic and Diluted EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Innoviva stockholders, basic</a></td>
<td class="nump">$ 23,392<span></span>
</td>
<td class="nump">$ 179,722<span></span>
</td>
<td class="nump">$ 213,921<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Innoviva stockholders, diluted</a></td>
<td class="nump">$ 26,860<span></span>
</td>
<td class="nump">$ 191,304<span></span>
</td>
<td class="nump">$ 225,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used to compute basic net income per share attributable to Innoviva stockholders</a></td>
<td class="nump">62,726<span></span>
</td>
<td class="nump">65,435<span></span>
</td>
<td class="nump">69,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of options and awards granted under equity incentive plan and employee stock purchase plan</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used to compute diluted net income per share attributable to Innoviva stockholders</a></td>
<td class="nump">74,187<span></span>
</td>
<td class="nump">86,876<span></span>
</td>
<td class="nump">95,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NetIncomeLossPerShareAbstract', window );"><strong>Net income per share attributable to Innoviva stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 3.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 2.37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add: interest expense on Notes, net of tax effect</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 2,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">6,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember', window );">2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add: interest expense on Notes, net of tax effect</a></td>
<td class="nump">$ 3,468<span></span>
</td>
<td class="nump">$ 5,116<span></span>
</td>
<td class="nump">$ 4,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect</a></td>
<td class="nump">11,150<span></span>
</td>
<td class="nump">11,150<span></span>
</td>
<td class="nump">11,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add: interest expense on Notes, net of tax effect</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,377<span></span>
</td>
<td class="nump">$ 4,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,955<span></span>
</td>
<td class="nump">8,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NetIncomeLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NetIncomeLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202548592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Anti-Dilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-Dilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">11,742<span></span>
</td>
<td class="nump">1,924<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_EquityIncentivePlansAndESPPMember', window );">Equity incentive plans and ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-Dilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_OutstandingStockWarrantMember', window );">Outstanding Stock Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-Dilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_Outstanding2028NotesMember', window );">Outstanding 2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-Dilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">9,955<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_EquityIncentivePlansAndESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_EquityIncentivePlansAndESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_OutstandingStockWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_OutstandingStockWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_Outstanding2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=inva_Outstanding2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202509776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total royalty revenue</a></td>
<td class="nump">$ 358,711<span></span>
</td>
<td class="nump">$ 310,463<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Less: amortization of capitalized fees paid</a></td>
<td class="num">(13,800)<span></span>
</td>
<td class="num">(13,800)<span></span>
</td>
<td class="num">(13,800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total royalty revenue</a></td>
<td class="nump">241,733<span></span>
</td>
<td class="nump">238,846<span></span>
</td>
<td class="nump">311,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total royalty revenue</a></td>
<td class="nump">241,733<span></span>
</td>
<td class="nump">238,846<span></span>
</td>
<td class="nump">311,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees', window );">Total royalties</a></td>
<td class="nump">255,556<span></span>
</td>
<td class="nump">252,669<span></span>
</td>
<td class="nump">325,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Less: amortization of capitalized fees paid</a></td>
<td class="num">(13,823)<span></span>
</td>
<td class="num">(13,823)<span></span>
</td>
<td class="num">(13,823)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | RELVAR/BREO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees', window );">Total royalties</a></td>
<td class="nump">207,925<span></span>
</td>
<td class="nump">208,042<span></span>
</td>
<td class="nump">215,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | ANORO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees', window );">Total royalties</a></td>
<td class="nump">47,631<span></span>
</td>
<td class="nump">44,627<span></span>
</td>
<td class="nump">38,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | TRELEGY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue Recognition and Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees', window );">Total royalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 72,029<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer before amortization of capitalized fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistRelvarBreoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistRelvarBreoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistAnoroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistAnoroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_TrelegyElliptaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_TrelegyElliptaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563207387552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of net product sales (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 358,711<span></span>
</td>
<td class="nump">$ 310,463<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_GiaprezaMember', window );">GIAPREZA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">55,037<span></span>
</td>
<td class="nump">41,294<span></span>
</td>
<td class="nump">14,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_XeravaMember', window );">XERAVA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">21,385<span></span>
</td>
<td class="nump">17,320<span></span>
</td>
<td class="nump">5,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_XacduroMember', window );">XACDURO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">21,070<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 97,492<span></span>
</td>
<td class="nump">$ 60,617<span></span>
</td>
<td class="nump">$ 19,694<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_GiaprezaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_GiaprezaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XeravaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XeravaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XacduroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XacduroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198436128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 358,711<span></span>
</td>
<td class="nump">$ 310,463<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Milestone fees paid</a></td>
<td class="nump">220,000<span></span>
</td>
<td class="nump">220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Milestone fees paid</a></td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Product Sales | Geographic Concentration Risk | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Product Sales | Geographic Concentration Risk | Rest of the world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 241,733<span></span>
</td>
<td class="nump">$ 238,846<span></span>
</td>
<td class="nump">311,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_GiaprezaMember', window );">GIAPREZA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">55,037<span></span>
</td>
<td class="nump">41,294<span></span>
</td>
<td class="nump">14,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_XeravaMember', window );">XERAVA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">21,385<span></span>
</td>
<td class="nump">17,320<span></span>
</td>
<td class="nump">5,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_XacduroMember', window );">XACDURO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">21,070<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 241,733<span></span>
</td>
<td class="nump">$ 238,846<span></span>
</td>
<td class="nump">$ 311,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | Long-Acting Beta2 Agonist (LABA) Collaboration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Milestone fees paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements', window );">Percentage of economic interest in any future payments made under the agreements</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | RELVAR/BREO | Long-Acting Beta2 Agonist (LABA) Collaboration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne', window );">Royalty rate for first level of annual global net sales (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate', window );">Annual global sales level used to determine royalty rate</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo', window );">Royalty rate for sales above first level of annual global net sales (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | ANORO | Long-Acting Beta2 Agonist (LABA) Collaboration | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts', window );">Royalty rate for combination products (as a percent)</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | ANORO | Long-Acting Beta2 Agonist (LABA) Collaboration | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts', window );">Royalty rate for combination products (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | TRELEGY | Long-Acting Beta2 Agonist (LABA) Collaboration | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts', window );">Royalty rate for combination products (as a percent)</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | TRELEGY | Long-Acting Beta2 Agonist (LABA) Collaboration | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts', window );">Royalty rate for combination products (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaMember', window );">La Jolla [Member] | Net Product Sales | Geographic Concentration Risk | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaMember', window );">La Jolla [Member] | Net Product Sales | Geographic Concentration Risk | Rest of the world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty rate for combination products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty rate which the entity will receive under the collaboration agreement on the first defined level of annual global net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty rate which the entity will receive under the collaboration agreement on sales which exceed the first defined level of annual global net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the annual global net sales amount which determines the royalty rate applied under the collaboration arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of economic interest in any future payments made under the agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_GiaprezaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_GiaprezaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XeravaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XeravaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XacduroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XacduroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_LabaCollaborationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistRelvarBreoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistRelvarBreoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistAnoroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LongActingBeta2AgonistAnoroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_TrelegyElliptaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_TrelegyElliptaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563199484128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License and Collaboration Arrangements (Additional Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (358,711)<span></span>
</td>
<td class="num">$ (310,463)<span></span>
</td>
<td class="num">$ (331,339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,392<span></span>
</td>
<td class="nump">14,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_FuturePotentialMilestonePayment', window );">Future potential milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_XacduroMember', window );">XACDURO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,070)<span></span>
</td>
<td class="num">(2,003)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(241,733)<span></span>
</td>
<td class="num">(238,846)<span></span>
</td>
<td class="num">(311,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_GiaprezaMember', window );">GIAPREZA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,037)<span></span>
</td>
<td class="num">(41,294)<span></span>
</td>
<td class="num">(14,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_LicenseAndOtherRevenueMember', window );">License and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,486)<span></span>
</td>
<td class="num">(11,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_XeravaMember', window );">XERAVA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,385)<span></span>
</td>
<td class="num">(17,320)<span></span>
</td>
<td class="num">$ (5,480)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationDeferredConsideration', window );">Business combination deferred consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | Amended Zai Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LicenseAndOtherRevenue', window );">License and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | Interim Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AmountOnNetProductSalesRecognized', window );">Amount on net product sales recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | Manufacturing Stage Transfer Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LicenseAndOtherRevenue', window );">License and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | Sulbactam Durlobactam</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LicenseRevenueRecognized', window );">License revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | XACDURO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LicenseRevenueRecognized', window );">License revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | XACDURO | Regulatory Starting Material</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue', window );">Letter agreement for purchase of material used for production value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab | Research and Development Support | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_FuturePotentialMilestonePayment', window );">Future potential milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_PaionAgMember', window );">PAION AG | Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_PaionAgMember', window );">PAION AG | Cost Reimbursement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember', window );">Everest Medicines Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct', window );">Royalties payable period after first commercial sale of product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember', window );">Everest Medicines Limited | Commercial Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts', window );">Percentage of reimbursed for direct and certain indirect manufacturing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember', window );">Everest Medicines Limited | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SalesMilestonePaymentsReceivable', window );">Sales milestone payments receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember', window );">Everest Medicines Limited | Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember', window );">Everest Medicines Limited | License and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_BasileaMember', window );">Basilea</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_UpfrontPaymentUnderIntangibleAsset', window );">Upfront payment under intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_GeorgeWashingtonUniversityMember', window );">George Washington University | GIAPREZA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedRoyaltyObligations', window );">Obligation to pay royalties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees', window );">Percentage of royalty on payments received from sublicensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_HarvardUniversityMember', window );">Harvard University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of license revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees', window );">Percentage of royalty on payments received from sublicensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfMinimumRoyaltyRate', window );">Percentage of minimum royalty rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds', window );">Percentage of maximum royalty based on achievement of annual net product sales thresholds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_HarvardUniversityMember', window );">Harvard University | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable', window );">Clinical development and regulatory milestones amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_HarvardUniversityMember', window );">Harvard University | Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ParatekPharmaceuticalsIncMember', window );">Paratek Pharmaceuticals, Inc | XERAVA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ClaimExpirationDate', window );">Claim Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023-10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_AstrazenecaMember', window );">AstraZeneca | Durlobactam</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales', window );">Subscription agreement one-time milestone payment on net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TermOfMilestonePaymentForNetSales', window );">Term of the milestone payment on net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">RoyaltyExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_AstrazenecaMember', window );">AstraZeneca | Zoliflodacin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales', window );">Subscription agreement one-time milestone payment on first commercial sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TermOfMilestonePaymentForCommercialSale', window );">Term of the milestone payment on first commercial sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedRoyaltyObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations incurred through that date and payable for royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedRoyaltyObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AmountOnNetProductSalesRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount on net product sales recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AmountOnNetProductSalesRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_BusinessCombinationDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_BusinessCombinationDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ClaimExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claim expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ClaimExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical development and regulatory milestones amount payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_FuturePotentialMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future potential milestone payment receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_FuturePotentialMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Letter agreement for purchase of material used for production value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_LicenseAndOtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License and other revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_LicenseAndOtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_LicenseRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_LicenseRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of maximum royalty based on achievement of annual net product sales thresholds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfMinimumRoyaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of minimum royalty rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfMinimumRoyaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reimbursed for direct and certain indirect manufacturing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty payable as a percentage of payments received from sublicensees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfRoyaltyPayableOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the royalty payable, as a percentage of net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfRoyaltyPayableOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties payable period after first commercial sale of product.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SalesMilestonePaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales milestone payments receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SalesMilestonePaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subscription agreement one-time milestone payment on commercial sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subscription agreement one-time milestone payment on net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_TermOfMilestonePaymentForCommercialSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of milestone payment for commercial sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_TermOfMilestonePaymentForCommercialSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_TermOfMilestonePaymentForNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of milestone payment for net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_TermOfMilestonePaymentForNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_UpfrontPaymentUnderIntangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment under intangible asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_UpfrontPaymentUnderIntangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XacduroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XacduroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_GiaprezaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_GiaprezaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_LicenseAndOtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_LicenseAndOtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XeravaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XeravaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_ZaiLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_ZaiLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_AmendedZaiAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_AmendedZaiAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_InterimSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_InterimSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_ManufacturingStageTransferAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_ManufacturingStageTransferAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_SulbactamDurlobactamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_SulbactamDurlobactamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_RegulatoryStartingMaterialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_RegulatoryStartingMaterialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_ResearchAndDevelopmentSupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_ResearchAndDevelopmentSupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_PaionAgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_PaionAgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_CostReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_CostReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_EverestMedicinesLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_CommercialSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_CommercialSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_BasileaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_BasileaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_GeorgeWashingtonUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_GeorgeWashingtonUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_HarvardUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_HarvardUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_ParatekPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_ParatekPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_AstrazenecaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_AstrazenecaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_DurlobactamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_DurlobactamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_ZoliflodacinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_ZoliflodacinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197297984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details) - Theravance Respiratory Company, LLC - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 20, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>CONSOLIDATED ENTITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_OwnershipInterestInConsolidatedEntities', window );">Ownership interest in LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement', window );">Proceeds from sale of economic interest under Equity Purchase Agreement</a></td>
<td class="nump">$ 277.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CashDistributionReceived', window );">Cash distribution</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_OwnershipInterestsAndInvestmentsCarryingValue', window );">Total carrying value of ownership interests and investments</a></td>
<td class="nump">39.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>CONSOLIDATED ENTITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentSalesBasedMilestonePayment', window );">Contingent sales based milestone payment</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CashDistributionReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CashDistributionReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ContingentSalesBasedMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent sales based milestone payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ContingentSalesBasedMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_OwnershipInterestInConsolidatedEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership interest in consolidated entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_OwnershipInterestInConsolidatedEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_OwnershipInterestsAndInvestmentsCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership interests and investments carrying value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_OwnershipInterestsAndInvestmentsCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of economic interest under Equity Purchase Agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563199379856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 20, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358,711<span></span>
</td>
<td class="nump">$ 310,463<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,997)<span></span>
</td>
<td class="num">(4,969)<span></span>
</td>
<td class="num">(3,373)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,996<span></span>
</td>
<td class="nump">14,376<span></span>
</td>
<td class="nump">66,687<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">179,722<span></span>
</td>
<td class="nump">220,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 241,733<span></span>
</td>
<td class="nump">$ 238,846<span></span>
</td>
<td class="nump">$ 311,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember', window );">Theravance Respiratory Company, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="num">$ (332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">71,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RealizedLoss', window );">Realized loss</a></td>
<td class="num">(39,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Changes in fair values of equity and long-term investments, net</a></td>
<td class="num">(8,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">23,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember', window );">Theravance Respiratory Company, LLC | Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 72,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_TheravanceRespiratoryCompanyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202870144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - ISP Fund LP (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>CONSOLIDATED ENTITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,301,060<span></span>
</td>
<td class="nump">$ 1,243,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember', window );">ISP Fund LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>CONSOLIDATED ENTITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersCumulativeCashDistributions', window );">Distribution from partnership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersContributedCapital', window );">Capital contribution</a></td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LimitedPartnersInitialContributionSubjectToLockUp', window );">Initial contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_LockUpExpirationDate', window );">Lock-up expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfEconomicInterestInPartnership', window );">Economic interest of the Partnership (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NetInvestmentRelatedIncomeExpensesEarnedInccured', window );">Net investment-related income (expense) earned (incurred)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700)<span></span>
</td>
<td class="num">(4,300)<span></span>
</td>
<td class="num">$ (5,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Investment income, interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on other equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,500)<span></span>
</td>
<td class="num">(6,700)<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PartnershipAgreementLockUpPeriod', window );">Lock-up period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized gain on equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,300)<span></span>
</td>
<td class="num">(2,400)<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255,700<span></span>
</td>
<td class="nump">$ 311,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_LimitedPartnersInitialContributionSubjectToLockUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limited partners initial contribution subject to lock up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_LimitedPartnersInitialContributionSubjectToLockUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_LockUpExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lock up expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_LockUpExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NetInvestmentRelatedIncomeExpensesEarnedInccured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net investment related income expenses earned inccured.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NetInvestmentRelatedIncomeExpensesEarnedInccured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PartnershipAgreementLockUpPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time in which contributors to an investment fund have waived the right of redemption, as defined in the partnership agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PartnershipAgreementLockUpPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfEconomicInterestInPartnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of economic interest held in Partnership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfEconomicInterestInPartnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital contributed by the limited partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersCumulativeCashDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cumulative cash distributions made to the limited partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersCumulativeCashDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202954432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - Summary of Individual Investments Held by ISP Fund (Details) - Isp Fund Lp [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred stocks - Privately held healthcare companies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_MoneyMarketFundAndCash', window );">Money market fund and cash</a></td>
<td class="nump">$ 107,532<span></span>
</td>
<td class="nump">$ 63,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investments held by ISP Fund LP</a></td>
<td class="nump">255,658<span></span>
</td>
<td class="nump">311,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember', window );">Publicly Held Healthcare Companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock - Publicly traded healthcare companies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InvestmentsInCommonStock', window );">Common stock</a></td>
<td class="nump">86,028<span></span>
</td>
<td class="nump">187,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember', window );">Privately Held Healthcare Companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred stocks - Privately held healthcare companies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InvestmentsInWarrants', window );">Warrants</a></td>
<td class="nump">8,507<span></span>
</td>
<td class="nump">8,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Publicly Held Healthcare Companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock - Publicly traded healthcare companies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InvestmentsInCommonStock', window );">Common stock</a></td>
<td class="nump">84,039<span></span>
</td>
<td class="nump">184,926<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Privately Held Healthcare Companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred stocks - Privately held healthcare companies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InvestmentsInPreferredStock', window );">Preferred stock</a></td>
<td class="nump">53,591<span></span>
</td>
<td class="nump">52,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">United Kingdom | Publicly Held Healthcare Companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock - Publicly traded healthcare companies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InvestmentsInCommonStock', window );">Common stock</a></td>
<td class="nump">$ 1,989<span></span>
</td>
<td class="nump">$ 2,942<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_InvestmentsInCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_InvestmentsInCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_InvestmentsInPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_InvestmentsInPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_InvestmentsInWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_InvestmentsInWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_MoneyMarketFundAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Money market fund and cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_MoneyMarketFundAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_IspFundLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_PubliclyTradedHealthcareCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_PubliclyTradedHealthcareCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_PrivatelyHeldHealthcareCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_PrivatelyHeldHealthcareCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201550928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - Entasis Therapeutics Holdings, Inc. (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 17, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 11, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Director</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers', window );">Number of investee's board members which may be designated by the Company | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Remeasurement loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payment towards convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Measurement period adjustments for change in value of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice', window );">Measurement period adjustments for change in estimated purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Measurement period adjustments for change in value of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Measurement period adjustments for change in value of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncreaseDecreasesInDeferredTaxLiabilities', window );">Measurement period adjustments increase decrease in deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc | Consolidated Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="nump">59.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc | Securities purchase agreement | Convertable promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="nump">0.59%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Aug. 18,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="nump">$ 64,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="nump">$ 31,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IncreaseDecreasesInDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decreases in deferred tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IncreaseDecreasesInDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in estimated purchase price during measurement period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the investee's board members which the Company has the right to designate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inva_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inva_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198864032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 22, 2022</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 17,905<span></span>
</td>
<td class="nump">$ 17,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis Therapeutics Holdings Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">'Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses', window );">Accrued personnel-related expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,769<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,506<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total assets acquired, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember', window );">La Jolla Pharmaceutical Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Short-term marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">'Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total assets acquired, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued personnel-related expenses due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed other accrued liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203697632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 22, 2022</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Change in inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,808<span></span>
</td>
<td class="nump">$ 12,004<span></span>
</td>
<td class="num">$ (280)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember', window );">La Jolla Pharmaceutical Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration paid</a></td>
<td class="nump">$ 206,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Acquisition share price</a></td>
<td class="nump">$ 6.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Measurement period adjustments for change in value of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="num">$ (13,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncreaseDecreaseInDeferredTaxAssets', window );">Increase (decrease) in deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,400)<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Change in inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Measurement period adjustments for change in value of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities', window );">Measurement period adjustments increase (decrease) in liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncreaseDecreasesInDeferredTaxLiabilities', window );">Increase (decrease) in deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="num">$ (2,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IncreaseDecreaseInDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IncreaseDecreaseInDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IncreaseDecreasesInDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decreases in deferred tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IncreaseDecreasesInDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Measurement period adjustment increase (decrease) in liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized acquisition cost incurred during period and excluded from amortization for oil- and gas-producing activities accounted for under full cost method. Excludes exploration and development costs and capitalized interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477385/932-360-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479664/932-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563342207920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Entities and Acquisitions - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - La Jolla Pharmaceutical Company<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 357,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">204,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Innoviva stockholders</a></td>
<td class="nump">$ 214,390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563189476608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2024</div></th>
<th class="th">
<div>Mar. 04, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 10, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 10, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 09, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>Tranche</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Director </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_ArmataConvertibleNoteMember', window );">Armata Convertible Note | Secured Convertible Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Term loan facility in aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Jan. 10,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 10,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementNumberOfTranches', window );">Number of tranches | Tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_VotingAgreementMaximumVotingRightsPercent', window );">Percentage of maximum voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee', window );">Number of Investee's Board members currently representing the Company | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee', window );">Special terms on re-designating board member to board of investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least 12.5% of the outstanding shares of Armata&#8217;s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata&#8217;s board of directors, and for so long as the Company and ISO hold at least 8%, but less than 12.5%, of the outstanding shares of Armata&#8217;s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata&#8217;s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | July 2023 Credit and Security Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Term loan facility in aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Jan. 10,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 10,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | March 2024 Credit and Security Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Term loan facility in aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  04,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Secured Convertible Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the &#8220;Credit Agreement&#8221;) with Armata, under which we invested in a one-year convertible note (the &#8220;Armata Convertible Note&#8221;) in an aggregate amount of $30.0 million at an interest rate of 8.0% per annum.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Consolidated Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.30%<span></span>
</td>
<td class="nump">69.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Two Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Armata outstanding shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Unrealized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Warrants purchased in 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction', window );">Number of warrants purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,710,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Warrants purchased in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction', window );">Number of warrants purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,153,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Warrants purchased in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">35.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares to be purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,710,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.4<span></span>
</td>
<td class="nump">81.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Armata Convertible Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.1<span></span>
</td>
<td class="nump">51.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Unrealized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Armata July 2023 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Armata March 2024 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Armata | One Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Armata outstanding shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Armata | One Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Armata outstanding shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember', window );">Innoviva Strategic Opportunities, LLC | Armata | Common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember', window );">Innoviva Strategic Opportunities, LLC | Armata | Warrants purchased in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction', window );">Number of warrants purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember', window );">Innoviva Strategic Opportunities, LLC | Armata | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember', window );">Innoviva Strategic Opportunities, LLC | Armata | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares to be purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,122<span></span>
</td>
<td class="nump">6,153,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the Company's Board members currently serving on the Investee's Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SecuritiesPurchaseAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SecuritiesPurchaseAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SecuritiesPurchaseAgreementNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of tranches in which the Company agreed to purchase common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SecuritiesPurchaseAgreementNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Special Terms on amended and restated investor rights agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_VotingAgreementMaximumVotingRightsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of maximum voting rights under voting agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_VotingAgreementMaximumVotingRightsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ArmataConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ArmataConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=inva_SecuredConvertibleCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=inva_SecuredConvertibleCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=inva_TwoDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=inva_TwoDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_CommonStockAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_CommonStockAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ArmataMarchTwoThousandTwentyFourTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ArmataMarchTwoThousandTwentyFourTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=inva_OneDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=inva_OneDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198712352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Summarized Financial Data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 554,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">236,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementRelatedDisclosuresAbstract', window );"><strong>Income Statement Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">358,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 23,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementRelatedDisclosuresAbstract', window );"><strong>Income Statement Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,476)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,666)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (59,512)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32,650)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563189383440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in InCarda (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Director</div>
</th>
<th class="th">
<div>Jan. 17, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_IncardaMember', window );">InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee', window );">Number of Investee's Board members currently representing the Company | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfBoardMembersOfInvestee', window );">Number of the Investee's Board members | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Unrealized loss from fair value changes in equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">$ 8,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember', window );">Consolidated Investees [Member] | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_InCardaConvertibleNoteMember', window );">InCarda Convertible Note | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesCPreferredStockAndWarrantsMember', window );">Series C preferred stock and warrants | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_WarrantCarryingValueWriteOffAmount', window );">Warrant carrying value write off amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_ConvertibleNoteAndWarrantsMember', window );">Convertible note and warrants | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">4,093,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesA1PreferredStockMember', window );">Series A1 preferred stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">37,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD1PreferredStockMember', window );">Series D 1 Preferred Stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">8,771,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD2PreferredStockMember', window );">Series D 2 Preferred Stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">3,369,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD1WarrantMember', window );">Series D1 Warrant | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">2,490,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C preferred stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares to be purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,469,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">20,469,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction', window );">Maximum number of additional shares into which warrants may be converted under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,117,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentTransactionCost', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesCWarrantsMember', window );">Series C warrants | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">5,117,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesDWarrantsMember', window );">Series D Warrants | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Preferred Stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi', window );">Payments to acquire equity securities</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD1AndD2PreferredStockAndCommonStockMember', window );">Series D 1 And D 2 Preferred Stock And Common Stock | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=inva_OptionPricingModelBacksolveValuationMember', window );">Backsolve Valuation | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs, Level 3 | Backsolve Valuation | InCarda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ExpectedHoldingPeriod', window );">Expected holding period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DividendYield', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PercentageOfEstimatedVolatility', window );">Estimated volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114.20%<span></span>
</td>
<td class="nump">122.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument transaction cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DividendYield">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend yield.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DividendYield</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ExpectedHoldingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected holding period of equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ExpectedHoldingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfBoardMembersOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of Board members of the Investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfBoardMembersOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the Company's Board members currently serving on the Investee's Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PercentageOfEstimatedVolatility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of estimated volatility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PercentageOfEstimatedVolatility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk free interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SecuritiesPurchaseAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SecuritiesPurchaseAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_WarrantCarryingValueWriteOffAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant carrying value write off amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_WarrantCarryingValueWriteOffAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479567/321-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_IncardaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_IncardaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_InCardaConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_InCardaConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesCPreferredStockAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesCPreferredStockAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ConvertibleNoteAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ConvertibleNoteAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesD1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesD2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD1WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesD1WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesCWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesCWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesDWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesDWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesD1AndD2PreferredStockAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesD1AndD2PreferredStockAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=inva_OptionPricingModelBacksolveValuationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=inva_OptionPricingModelBacksolveValuationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202088496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in ImaginAb (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 14, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 18, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Director</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 23, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Payments to Acquire Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
<td class="nump">$ 13,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TransactionCostsIncurredInConnectionWithEquityInvestment', window );">Cost on equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee', window );">Number of Investee's Board members currently representing the Company | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfBoardMembersOfInvestee', window );">Number of the Investee's Board members | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | Consolidated Investees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="nump">12.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | Series C preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,051,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | Series C-2 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,852<span></span>
</td>
<td class="nump">270,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | Series C preferred stock, Series C-2 preferred stock and common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600<span></span>
</td>
<td class="nump">$ 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | ImaginAb Convertible Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain from fair value changes in equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | ImaginAb Convertible Note | First Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Payments to Acquire Long-Term Investments</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember', window );">ImaginAb | One of ImaginAb's Common Stockholders | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares purchased under the securities purchase agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,097,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfBoardMembersOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of Board members of the Investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfBoardMembersOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the Company's Board members currently serving on the Investee's Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SecuritiesPurchaseAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SecuritiesPurchaseAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_TransactionCostsIncurredInConnectionWithEquityInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs incurred in connection with equity investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_TransactionCostsIncurredInConnectionWithEquityInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_ImaginabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_ImaginabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesC2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesC2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_SeriesCAndC2PreferredStockAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_SeriesCAndC2PreferredStockAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ImaginabConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ImaginabConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_FirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_FirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_OneOfImaginabsCommonStockholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_OneOfImaginabsCommonStockholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202494976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neurosciences (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 13, 2024</div></th>
<th class="th"><div>Aug. 05, 2024</div></th>
<th class="th"><div>Feb. 13, 2024</div></th>
<th class="th"><div>Oct. 06, 2023</div></th>
<th class="th"><div>Feb. 02, 2023</div></th>
<th class="th"><div>Nov. 24, 2021</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Additional cash investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
<td class="nump">$ 13,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_GateNeuroscienceMember', window );">Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfCommonStockIssuedDescription', window );">Number of common stock issued description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The number of common stock shares to be issued in a qualified event shall be equal to the amount due on the conversion date divided by the lesser of a capped conversion price (the &#8220;Capped Conversion Price&#8221;) and the qualified event price (the &#8220;Qualified Event Price&#8221;). The Capped Conversion Price is calculated as $50.0 million divided by the number of shares of common stock outstanding at such time on a fully diluted basis. The Qualified Event Price is the price per share determined by the qualified event. A qualified financing is a sale or series of sales of preferred stock where (i) at least 50 percent of counterparties are not existing shareholders, (ii) net proceeds to Gate are at least $35.0 million, and (iii) the stated or implied equity valuation of Gate is at least $80.0 million.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity and long-term investments at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,900<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain from fair value changes in equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Unrealized loss from fair value changes in equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementMember', window );">Convertible Promissory Note Purchase Agreement | Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,800<span></span>
</td>
<td class="nump">$ 33,500<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="nump">$ 21,500<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember', window );">Convertible Promissory Note Purchase Agreement Amendment | Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Additional cash investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember', window );">Convertible Promissory Note Purchase Agreement Second Amendment | Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Additional cash investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember', window );">Convertible Promissory Note Purchase Agreement Third Amendment | Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Additional cash investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember', window );">Convertible Promissory Note Purchase Agreement Fourth Amendment | Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Additional cash investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember', window );">Convertible Promissory Note Purchase Agreement Fifth Amendment | Gate Neuroscience [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes face value</a></td>
<td class="nump">$ 50,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Additional cash investment</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfCommonStockIssuedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common stock issued description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfCommonStockIssuedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_GateNeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_GateNeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196028480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Nanolive (Details) - Nanolive<br> SFr in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 18, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 18, 2022 </div>
<div>CHF (SFr) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Director</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_EquityInvestmentTransactionCostsIncurred', window );">Equity investment transaction costs incurred | $</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee', window );">Number of Investee's Board members currently representing the Company | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfBoardMembersOfInvestee', window );">Number of the Investee's Board members | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_NanoliveMember', window );">Consolidated Investees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">15.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_NanoliveMember', window );">Series C preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Equity Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares to be purchased under the securities purchase agreement | shares</a></td>
<td class="nump">18,750,000<span></span>
</td>
<td class="nump">18,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_SecuritiesPurchaseAgreementAmount', window );">Amount of securities purchase agreement</a></td>
<td class="nump">$ 9.8<span></span>
</td>
<td class="nump">SFr 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_EquityInvestmentTransactionCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investment transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_EquityInvestmentTransactionCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfBoardMembersOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of Board members of the Investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfBoardMembersOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the Company's Board members currently serving on the Investee's Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_SecuritiesPurchaseAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_SecuritiesPurchaseAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_NanoliveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_NanoliveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563299827184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Reconciliation of Equity and Long - Term Investments Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities', window );">Purchases of trading securities</a></td>
<td class="nump">$ 63,201<span></span>
</td>
<td class="nump">$ 67,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity', window );">Purchases of equity and long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GainLossOnOtherInvestments', window );">Changes in fair value, net</a></td>
<td class="num">(59,161)<span></span>
</td>
<td class="nump">11,129<span></span>
</td>
<td class="nump">$ 8,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ReclassificationOfCurrentPortion', window );">Reclassification of current portion</a></td>
<td class="num">(107,532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Equity and long-term investments</a></td>
<td class="nump">$ 341,664<span></span>
</td>
<td class="nump">$ 444,432<span></span>
</td>
<td class="nump">$ 363,859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_GainLossOnOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on other investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_GainLossOnOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ReclassificationOfCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ReclassificationOfCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for acquisition of investment, classified as operating activity. Includes, but is not limited to, funding, origination, drawdown, and participation in investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477867/946-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203402944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 289,441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 170,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">289,441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">170,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">289,441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">170,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 289,441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 170,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563194450016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentValueRightsLiability', window );">Contingent value rights</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">765,285<span></span>
</td>
<td class="nump">705,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">289,441<span></span>
</td>
<td class="nump">170,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Equity investments and Money market funds | ISP Fund LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">255,658<span></span>
</td>
<td class="nump">311,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Term loan investment | Armata July 2023 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">30,197<span></span>
</td>
<td class="nump">27,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Term loan investment | Armata March 2024 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">39,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">529,393<span></span>
</td>
<td class="nump">503,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">289,441<span></span>
</td>
<td class="nump">170,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Equity investments and Money market funds | ISP Fund LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">193,560<span></span>
</td>
<td class="nump">251,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Term loan investment | Armata July 2023 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Term loan investment | Armata March 2024 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">35,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Other Observable Inputs, Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Other Observable Inputs, Level 2 | Equity investments and Money market funds | ISP Fund LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Other Observable Inputs, Level 2 | Term loan investment | Armata July 2023 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Other Observable Inputs, Level 2 | Term loan investment | Armata March 2024 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">229,991<span></span>
</td>
<td class="nump">167,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Unobservable Inputs, Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Unobservable Inputs, Level 3 | Equity investments and Money market funds | ISP Fund LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">62,098<span></span>
</td>
<td class="nump">60,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Unobservable Inputs, Level 3 | Term loan investment | Armata July 2023 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">30,197<span></span>
</td>
<td class="nump">27,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Significant Unobservable Inputs, Level 3 | Term loan investment | Armata March 2024 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">39,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentValueRightsLiability', window );">Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Total fair value of debt</a></td>
<td class="nump">473,566<span></span>
</td>
<td class="nump">427,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Quoted Price in Active Markets for Identical Assets, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentValueRightsLiability', window );">Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Total fair value of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentValueRightsLiability', window );">Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Significant Other Observable Inputs, Level 2 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Total fair value of debt</a></td>
<td class="nump">473,566<span></span>
</td>
<td class="nump">427,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentValueRightsLiability', window );">Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | Significant Unobservable Inputs, Level 3 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Total fair value of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2025 Notes | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConvertibleSeniorDebtFairValueDisclosures', window );">2025 Notes</a></td>
<td class="nump">222,353<span></span>
</td>
<td class="nump">200,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2025 Notes | Quoted Price in Active Markets for Identical Assets, Level 1 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConvertibleSeniorDebtFairValueDisclosures', window );">2025 Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2025 Notes | Significant Other Observable Inputs, Level 2 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConvertibleSeniorDebtFairValueDisclosures', window );">2025 Notes</a></td>
<td class="nump">222,353<span></span>
</td>
<td class="nump">200,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2025 Notes | Significant Unobservable Inputs, Level 3 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ConvertibleSeniorDebtFairValueDisclosures', window );">2025 Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2028 Notes | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">2028 Notes</a></td>
<td class="nump">251,213<span></span>
</td>
<td class="nump">227,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2028 Notes | Quoted Price in Active Markets for Identical Assets, Level 1 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">2028 Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2028 Notes | Significant Other Observable Inputs, Level 2 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">2028 Notes</a></td>
<td class="nump">251,213<span></span>
</td>
<td class="nump">227,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring basis | 2028 Notes | Significant Unobservable Inputs, Level 3 | Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">2028 Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">42,095<span></span>
</td>
<td class="nump">51,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Equity investment | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">46,392<span></span>
</td>
<td class="nump">81,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">35,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Equity investment | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">46,392<span></span>
</td>
<td class="nump">81,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Significant Other Observable Inputs, Level 2 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Significant Other Observable Inputs, Level 2 | Equity investment | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Significant Other Observable Inputs, Level 2 | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">35,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Significant Unobservable Inputs, Level 3 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">42,095<span></span>
</td>
<td class="nump">51,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Significant Unobservable Inputs, Level 3 | Equity investment | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember', window );">Armata | Recurring basis | Significant Unobservable Inputs, Level 3 | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Significant Other Observable Inputs, Level 2 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Significant Other Observable Inputs, Level 2 | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Significant Unobservable Inputs, Level 3 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember', window );">InCarda | Recurring basis | Significant Unobservable Inputs, Level 3 | Equity investment | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ImaginabMember', window );">ImaginAb | Recurring basis | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">4,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ImaginabMember', window );">ImaginAb | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ImaginabMember', window );">ImaginAb | Recurring basis | Significant Other Observable Inputs, Level 2 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ImaginabMember', window );">ImaginAb | Recurring basis | Significant Unobservable Inputs, Level 3 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">4,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_GateNeuroscienceMember', window );">Gate Neuroscience [Member] | Recurring basis | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">50,881<span></span>
</td>
<td class="nump">27,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_GateNeuroscienceMember', window );">Gate Neuroscience [Member] | Recurring basis | Quoted Price in Active Markets for Identical Assets, Level 1 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_GateNeuroscienceMember', window );">Gate Neuroscience [Member] | Recurring basis | Significant Other Observable Inputs, Level 2 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_GateNeuroscienceMember', window );">Gate Neuroscience [Member] | Recurring basis | Significant Unobservable Inputs, Level 3 | Convertible debt investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at estimated fair value</a></td>
<td class="nump">$ 50,881<span></span>
</td>
<td class="nump">$ 27,972<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ContingentValueRightsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent value rights liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ContingentValueRightsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ConvertibleSeniorDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of long-term notes which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock. Senior debt has the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ConvertibleSeniorDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=inva_EquityInvestmentsAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=inva_EquityInvestmentsAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_IspFundLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_IspFundLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=inva_TermLoanInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=inva_TermLoanInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inva_ArmataMarchTwoThousandTwentyFourTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inva_ArmataMarchTwoThousandTwentyFourTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ArmataPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_IncardaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ImaginabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ImaginabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_GateNeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_GateNeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563200054720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Long-term Investments and Fair Value Measurements - (Additional Information) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels', window );">Fair value of assets or liabilities transfer between levels</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Assets Or Liabilities Transfer Between Levels</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203265824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capitalized Fees Paid - Schedule of Capitalized Fees Paid (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Fees paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Gross carrying value</a></td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(150,039)<span></span>
</td>
<td class="num">(136,216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Net carrying value</a></td>
<td class="nump">$ 69,961<span></span>
</td>
<td class="nump">83,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidWeightedAverageUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidFutureAmortizationAbstract', window );"><strong>Capitalized Fees paid, Future amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths', window );">Estimated amortization for the year 2025</a></td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo', window );">Estimated amortization for the year 2026</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree', window );">Estimated amortization for the year 2027</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour', window );">Estimated amortization for the year 2028</a></td>
<td class="nump">13,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive', window );">Estimated amortization for the year 2029</a></td>
<td class="nump">9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive', window );">Estimated amortization after 2029</a></td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Fees paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization expense</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="nump">13,800<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Fees paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Gross carrying value</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Fees paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Gross carrying value</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Fees paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Gross carrying value</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember', window );">GSK | Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Fees paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 13,823<span></span>
</td>
<td class="nump">$ 13,823<span></span>
</td>
<td class="nump">$ 13,823<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidFutureAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized fees paid future amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidFutureAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated amortization for assets expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated amortization for assets expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated amortization for assets expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated amortization for assets expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated amortization for assets expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated amortization for assets expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CapitalizedFeesPaidWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized fees paid weighted average useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CapitalizedFeesPaidWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563189570944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Additional Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Aug. 22, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 17,905<span></span>
</td>
<td class="nump">$ 17,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Future amortization expense, 2025</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Future amortization expense, 2026</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Future amortization expense, 2027</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Future amortization expense, 2028</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Future amortization expense, 2029</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Future amortization expense, thereafter</a></td>
<td class="nump">74,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">25,902<span></span>
</td>
<td class="nump">21,784<span></span>
</td>
<td class="nump">$ 5,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_BasileaMember', window );">Basilea</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_UpfrontFee', window );">Upfront fee</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue', window );">Acquired Finite-Lived Intangible Asset, Residual Value</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development | XACDURO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets pertain to product rights and developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember', window );">La Jolla Pharmaceutical Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets pertain to product rights and developed technologies</a></td>
<td class="nump">151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets pertain to product rights and developed technologies</a></td>
<td class="nump">106,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis | Collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets pertain to product rights and developed technologies</a></td>
<td class="nump">35,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember', window );">Entasis | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets pertain to product rights and developed technologies</a></td>
<td class="nump">$ 71,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_UpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_UpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of residual value of finite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_BasileaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_BasileaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_XacduroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_XacduroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=inva_EntasisTherapeuticsHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563204309536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsMarketedProductsGross', window );">Marketed products, gross carrying amount</a></td>
<td class="nump">$ 223,700<span></span>
</td>
<td class="nump">$ 219,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsInProcessResearchAndDevelopmentGross', window );">In-process research and development, gross carrying amount</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsCollaborationAgreementGross', window );">Collaboration agreement, gross carrying amount</a></td>
<td class="nump">35,400<span></span>
</td>
<td class="nump">35,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total gross carrying amount</a></td>
<td class="nump">261,700<span></span>
</td>
<td class="nump">257,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsMarketedProductsAccumulatedAmortization', window );">Marketed products, Accumulated amortization</a></td>
<td class="num">(47,559)<span></span>
</td>
<td class="num">(25,204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization', window );">In-process research and development, accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization', window );">Collaboration agreement, accumulated amortization</a></td>
<td class="num">(5,708)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(53,267)<span></span>
</td>
<td class="num">(27,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsMarketedProductsNet', window );">Marketed products, net carrying amount</a></td>
<td class="nump">176,141<span></span>
</td>
<td class="nump">194,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsInProcessResearchAndDevelopmentNet', window );">In-process research and development, net carrying amount</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IntangibleAssetsCollaborationAgreementNet', window );">Collaboration agreement, net carrying amount</a></td>
<td class="nump">29,692<span></span>
</td>
<td class="nump">33,239<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="nump">$ 208,433<span></span>
</td>
<td class="nump">$ 230,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CollaborativeArrangementMember', window );">Collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Marketed products, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Marketed products, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Marketed products, Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets collaboration agreement accumulated amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsCollaborationAgreementGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets collaboration agreement gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsCollaborationAgreementGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsCollaborationAgreementNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets collaboration agreement net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsCollaborationAgreementNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible sssets in process research and development accumulated amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsInProcessResearchAndDevelopmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of In-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsInProcessResearchAndDevelopmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsInProcessResearchAndDevelopmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of In-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsInProcessResearchAndDevelopmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsMarketedProductsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amortization amount of Marketed Products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsMarketedProductsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsMarketedProductsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of Marketed products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsMarketedProductsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IntangibleAssetsMarketedProductsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of Marketed Products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IntangibleAssetsMarketedProductsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=inva_MarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=inva_MarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197209696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 11,113<span></span>
</td>
<td class="nump">$ 11,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">20,529<span></span>
</td>
<td class="nump">15,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,083<span></span>
</td>
<td class="nump">13,810<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 33,725<span></span>
</td>
<td class="nump">$ 40,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197406800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Additional Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_ZaiLabMember', window );">Zai Lab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_BusinessCombinationDeferredConsideration', window );">Business combination deferred consideration</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaPharmaceuticalCompanyMember', window );">La Jolla Pharmaceutical Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_FairValueAdjustmentsOfInventoryFromAcquistion', window );">Net fair value adjustment of inventory from acquisition</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">$ 23.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold', window );">Amortization of fair value adjustments of Cost of products sold</a></td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of fair value adjustments of cost of products sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_BusinessCombinationDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_BusinessCombinationDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_FairValueAdjustmentsOfInventoryFromAcquistion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of net fair value adjustment of inventory resulting from the acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_FairValueAdjustmentsOfInventoryFromAcquistion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_ZaiLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_ZaiLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201037264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedContractManufacturingLiability', window );">Accrued contract manufacturing expenses</a></td>
<td class="nump">$ 1,071<span></span>
</td>
<td class="nump">$ 1,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedClinicalAndResearchLiability', window );">Accrued clinical and research expenses</a></td>
<td class="nump">611<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedProfessionalServices', window );">Accrued professional services</a></td>
<td class="nump">$ 8,682<span></span>
</td>
<td class="nump">$ 8,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Total other accrued liabilities<span></span>
</td>
<td class="text">Total other accrued liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td>
<td class="nump">$ 1,572<span></span>
</td>
<td class="nump">$ 1,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalty obligation payable</a></td>
<td class="nump">2,951<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredRoyaltyObligationCurrent', window );">Current portion of deferred royalty obligation</a></td>
<td class="nump">6,438<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_AccruedLicenseFeesAndRoyalties', window );">Accrued license fees and royalties</a></td>
<td class="nump">1,727<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other</a></td>
<td class="nump">6,947<span></span>
</td>
<td class="nump">3,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total other accrued liabilities</a></td>
<td class="nump">$ 29,999<span></span>
</td>
<td class="nump">$ 19,698<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedClinicalAndResearchLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical and research liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedClinicalAndResearchLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedContractManufacturingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued contract manufacturing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedContractManufacturingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedLicenseFeesAndRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued license fees and royalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedLicenseFeesAndRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_AccruedProfessionalServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Professional Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_AccruedProfessionalServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredRoyaltyObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current portion of deferred royalty obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredRoyaltyObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563195960992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components -Schedule of Other Long-term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredRoyaltyObligationNonCurrent', window );">Long-term portion of deferred royalty obligation</a></td>
<td class="nump">$ 63,096<span></span>
</td>
<td class="nump">$ 69,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Total other long-term liabilities<span></span>
</td>
<td class="text">Total other long-term liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of lease liabilities</a></td>
<td class="nump">$ 1,179<span></span>
</td>
<td class="nump">$ 1,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ContingentValueRightsLiability', window );">Contingent value rights liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 64,275<span></span>
</td>
<td class="nump">$ 71,870<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ContingentValueRightsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent value rights liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ContingentValueRightsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredRoyaltyObligationNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term portion of deferred royalty obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredRoyaltyObligationNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202943568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - 2012 Plan and ESPP (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Item </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inva_EquityIncentivePlan2012Member', window );">2012 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining available for issuance</a></td>
<td class="nump">1,758,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price as a percentage of fair market value of stock</a></td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod', window );">Total duration of consecutive and overlapping offering periods</a></td>
<td class="text">24 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Number of offering periods | Item</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">Duration of purchase period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum contributions as a percentage of employee's eligible compensation</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares an employee may purchase during any purchase period</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation', window );">Maximum value of shares an employee may purchase in a calendar year | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember', window );">2023 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price as a percentage of fair market value of stock</a></td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod', window );">Total duration of consecutive and overlapping offering periods</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum contributions as a percentage of employee's eligible compensation</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares an employee may purchase during any purchase period</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation', window );">Maximum value of shares an employee may purchase in a calendar year | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining available for issuance</a></td>
<td class="nump">2,467,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the consecutive and overlapping offering period for the offering of share-based payment awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount the employee may contribute of employee's eligible compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of purchase periods having duration of six months each.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the duration of each purchase period within each consecutive and overlapping purchase period for offering of share-based payment awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=inva_EquityIncentivePlan2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=inva_EquityIncentivePlan2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196733072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Director Compensation Program (Details) - RSUs - Non-employee director<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>Installment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue', window );">One time grant of shares, value</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue', window );">Pro rata shares grant, value</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments', window );">Number of annual installments | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue', window );">Annual grant of shares, value</a></td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The additional value of shares granted to newly appointed non-employee director on the date that such individual joins the Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of shares granted annually to independent directors upon re-election the to Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of shares granted to newly appointed non-employee director on the date that such individual joins the Board.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of annual installments that RSUs granted to newly appointed independent directors will vest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198328272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 6,374<span></span>
</td>
<td class="nump">$ 5,837<span></span>
</td>
<td class="nump">$ 7,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">13,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,738<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">3,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 6,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (Years)</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 3,348<span></span>
</td>
<td class="nump">3,663<span></span>
</td>
<td class="nump">4,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 6,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (Years)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (Years)</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 6,040<span></span>
</td>
<td class="nump">4,645<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 1,192<span></span>
</td>
<td class="nump">$ 2,042<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=inva_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198117312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Compensation Awards (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of outstanding options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the beginning of the period (in shares)</a></td>
<td class="nump">1,499,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,062,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(80,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Released RSUs/RSAs (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(414,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the end of the period (in shares)</a></td>
<td class="nump">2,067,000<span></span>
</td>
<td class="nump">1,499,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end of the period (in shares)</a></td>
<td class="nump">2,067,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price of Outstanding Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 14.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">16.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">12.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Released RSUs/RSAs (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">15.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the end of the period (in dollars per share)</a></td>
<td class="nump">15.23<span></span>
</td>
<td class="nump">$ 14.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at the end of the period (in dollars per shares)</a></td>
<td class="nump">$ 15.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Additional disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable option</a></td>
<td class="nump">759,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term of options exercisable</a></td>
<td class="text">8 years 14 days<span></span>
</td>
<td class="text">7 years 11 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total estimated fair value of options vested</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of outstanding RSUs and PSUs/RSAs and PSAs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Balance at the beginning of the period (in shares)</a></td>
<td class="nump">482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares)</a></td>
<td class="nump">502,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released RSUs and RSAs (in shares)</a></td>
<td class="num">(241,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited (in shares)</a></td>
<td class="num">(145,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Balance at the end of the period (in shares)</a></td>
<td class="nump">598,000<span></span>
</td>
<td class="nump">482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end of the period (in shares)</a></td>
<td class="nump">598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value per Share at Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 12.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">15.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released RSUs and RSAs (in dollars per share)</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">13.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at the end of the period (in dollars per share)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">$ 12.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare', window );">Vested and expected to vest at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Additional disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total estimated fair value of equity instruments vested</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of outstanding RSUs and PSUs/RSAs and PSAs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Balance at the beginning of the period (in shares)</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released RSUs and RSAs (in shares)</a></td>
<td class="num">(9,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Balance at the end of the period (in shares)</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end of the period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value per Share at Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 14.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released RSUs and RSAs (in dollars per share)</a></td>
<td class="nump">14.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at the end of the period (in dollars per share)</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">$ 14.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare', window );">Vested and expected to vest at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee exercised the right during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest non-option equity instruments outstanding that can be converted into shares under award activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Fair Value per Share of fully vested and expected to vest non-option equity instruments outstanding that can be converted into shares under award activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198279536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Valuation Assumptions (Details) - Employee Stock Option - Innoviva [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">6 years 14 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="nump">35.50%<span></span>
</td>
<td class="nump">37.80%<span></span>
</td>
<td class="nump">38.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average estimated fair value of shares granted (in dollars per share)</a></td>
<td class="nump">$ 8.17<span></span>
</td>
<td class="nump">$ 5.57<span></span>
</td>
<td class="nump">$ 6.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Weighted-average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=inva_InnovivaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=inva_InnovivaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563200027600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Additional Information) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased and retired during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Cost of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 393,829,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Amount of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchased and retired during period, shares</a></td>
<td class="nump">986,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,173,565<span></span>
</td>
<td class="nump">647,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CommonStockAcquiredAverageCostPerShare', window );">Shares repurchased average price per share</a></td>
<td class="nump">$ 15.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.39<span></span>
</td>
<td class="nump">$ 13.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased and retired during period, value</a></td>
<td class="nump">$ 14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,500,000<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased and retired during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (393,829,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Cost of treasury stock</a></td>
<td class="nump">$ 393,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CommonStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Acquired Average Cost Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CommonStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inva_GSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202270592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized debt discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,156)<span></span>
</td>
<td class="num">(7,266)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,344<span></span>
</td>
<td class="nump">446,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Less: Current portion of long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(192,028)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,316<span></span>
</td>
<td class="nump">446,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,209<span></span>
</td>
<td class="nump">$ 19,157<span></span>
</td>
<td class="nump">$ 15,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_HealthCareRoyaltyPartnersMember', window );">HealthCare Royalty Partners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RoyaltyAgreementMaximumPotentialPayoutPercent', window );">Maximum potential royalty payout</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent', window );">Increase in maximum potential payout percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo', window );">Maximum aggregate royalty payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_MaximumAggregateRoyaltyPaymentsDue', window );">Maximum aggregate royalty payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne', window );">Required payment for breach of agreement, payment one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_TotalPaymentsMadeForRoyaltyAgreement', window );">Payment for royalty agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember', window );">2025 Notes | Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentPrincipalAmount', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,500<span></span>
</td>
<td class="nump">$ 192,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized debt discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(472)<span></span>
</td>
<td class="num">(1,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,028<span></span>
</td>
<td class="nump">191,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember', window );">2028 Notes | Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentPrincipalAmount', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,000<span></span>
</td>
<td class="nump">261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized debt discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,684)<span></span>
</td>
<td class="num">(6,061)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_RoyaltyFinancingAgreementMember', window );">Royalty Financing Agreement | Loans Payable [Member] | HealthCare Royalty Partners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">9,800<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredRoyaltyObligations', window );">Deferred Royalty obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,500<span></span>
</td>
<td class="nump">69,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RoyaltyPayments', window );">Royalty Payments</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_InterestRateOfDeferredRoyaltyObligation', window );">Interest Rate of Deferred Royalty Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredRoyaltyObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred royalty obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredRoyaltyObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_InterestRateOfDeferredRoyaltyObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate of deferred royalty obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_InterestRateOfDeferredRoyaltyObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_MaximumAggregateRoyaltyPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate royalty payments due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_MaximumAggregateRoyaltyPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty agreement increase in maximum potential payout percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RoyaltyAgreementMaximumPotentialPayoutPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty agreement, maximum potential payout, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RoyaltyAgreementMaximumPotentialPayoutPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty agreement required payment for breach of agreement payment one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty agreement required payment for breach of agreement payment two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RoyaltyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RoyaltyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_TotalPaymentsMadeForRoyaltyAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total payments made for royalty agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_TotalPaymentsMadeForRoyaltyAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_HealthCareRoyaltyPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_HealthCareRoyaltyPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_RoyaltyFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_RoyaltyFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563202723952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Convertible Subordinated Notes (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2013 </div>
<div>USD ($) </div>
<div>Item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Payment for repurchase of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 96,204,000<span></span>
</td>
<td class="nump">$ 165,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,662,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,156,000<span></span>
</td>
<td class="nump">7,266,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | Convertible subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Portion of debt retired, face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Portion of debt retired, carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Payment for repurchase of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentRepurchasePercentage', window );">Percentage of notes repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentPrincipalAmount', window );">Principal</a></td>
<td class="nump">$ 96,200,000<span></span>
</td>
<td class="nump">96,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtAbstract', window );"><strong>Interest expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">2,617,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="nump">$ 2,919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | Convertible subordinated notes | Privately-negotiated capped call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfDerivativeInstrumentsPurchased', window );">Number of derivative instruments purchased | Item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Strike price for the underlying number of shares (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.77<span></span>
</td>
<td class="nump">$ 27.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | Convertible subordinated notes | Stock prices below $27.79 per share | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument', window );">Net shares settlement payable to the entity | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | Convertible subordinated notes | Stock prices below $27.79 per share | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument', window );">Net shares settlement payable to the entity | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,779,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | Convertible subordinated notes | Privately-negotiated cap price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Strike price for the underlying number of shares (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.04<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | Old Rate [Member] | Convertible subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember', window );">2023 Notes | New Rate [Member] | Convertible subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=inva_InnovivaCommonStockMember', window );">Innoviva's Common Stock | 2023 Notes | Convertible subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Notes converted into common stock, Amount</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | 2023 Notes | Convertible subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate for shares of common stock per $1,000 principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.5818<span></span>
</td>
<td class="nump">35.9903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.77<span></span>
</td>
<td class="nump">$ 27.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentRepurchasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of debt Instrument, repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentRepurchasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfDerivativeInstrumentsPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of derivative instruments purchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfDerivativeInstrumentsPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares payable to the entity on settlement of derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481648/480-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -SubTopic 40<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=inva_PrivatelyNegotiatedCappedCallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=inva_PrivatelyNegotiatedCappedCallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=inva_PrivatelyNegotiatedCapPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=inva_PrivatelyNegotiatedCapPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=inva_InnovivaCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=inva_InnovivaCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563195317680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Convertible Senior Notes (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 07, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2013 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 18, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th">
<div>Aug. 01, 2017 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Payment upon maturity of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 96,204<span></span>
</td>
<td class="nump">$ 165,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,156)<span></span>
</td>
<td class="num">(7,266)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448,344<span></span>
</td>
<td class="nump">446,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember', window );">2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage', window );">Common stock price to current conversion price ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtConversionConvertedInstrumentAverageTradePricePercentage', window );">Average trading price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Total issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Liability issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember', window );">2025 Notes | ASU 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember', window );">2025 Notes | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCovenantTerms', window );">Debt instrument, covenant terms description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The indenture governing the 2028 Notes contains customary terms and covenants, including a merger covenant and that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Notes to be due and payable immediately.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount', window );">Ratio of repurchase price to the principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.88%<span></span>
</td>
<td class="nump">8.87%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentPrincipalAmount', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,500<span></span>
</td>
<td class="nump">192,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(472)<span></span>
</td>
<td class="num">(1,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,028<span></span>
</td>
<td class="nump">191,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowingsAbstract', window );"><strong>Interest expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,813<span></span>
</td>
<td class="nump">4,813<span></span>
</td>
<td class="nump">4,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">733<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,546<span></span>
</td>
<td class="nump">5,525<span></span>
</td>
<td class="nump">5,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2025 Notes | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PortionOfDebtInstrumentFaceAmountExercised', window );">Portion of debt instrument face amount, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2025 Notes | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2025 Notes | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate for shares of common stock per $1,000 principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 15,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentConvertibleConversionPremium', window );">Conversion premium (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="nump">$ 261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 15,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage', window );">Common stock price to current conversion price ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtConversionConvertedInstrumentAverageTradePricePercentage', window );">Average trading price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount', window );">Ratio of repurchase price to the principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentPrincipalAmount', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261,000<span></span>
</td>
<td class="nump">261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,684)<span></span>
</td>
<td class="num">(6,061)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,316<span></span>
</td>
<td class="nump">254,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowingsAbstract', window );"><strong>Interest expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,514<span></span>
</td>
<td class="nump">5,546<span></span>
</td>
<td class="nump">5,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,575<span></span>
</td>
<td class="nump">$ 6,923<span></span>
</td>
<td class="nump">6,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2028 Notes | Privately-negotiated capped call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Strike price for the underlying number of shares (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 33.985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes', window );">Purchases of capped calls in connection with convertible senior notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2028 Notes | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_PortionOfDebtInstrumentFaceAmountExercised', window );">Portion of debt instrument face amount, Exercised</a></td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2028 Notes | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember', window );">Convertible senior notes | 2028 Notes | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate for shares of common stock per $1,000 principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.1432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (dollars per share) | $ / shares</a></td>
<td class="nump">$ 26.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember', window );">Convertible subordinated notes | 2023 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 144,800<span></span>
</td>
<td class="nump">$ 144,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Payment upon maturity of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DebtInstrumentPrincipalAmount', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowingsAbstract', window );"><strong>Interest expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">2,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 2,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember', window );">Convertible subordinated notes | 2023 Notes | Privately-negotiated capped call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Strike price for the underlying number of shares (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.77<span></span>
</td>
<td class="nump">$ 27.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember', window );">Convertible subordinated notes | 2023 Notes | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate for shares of common stock per $1,000 principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.5818<span></span>
</td>
<td class="nump">35.9903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.77<span></span>
</td>
<td class="nump">$ 27.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost to enter into capped calls sales in connection with convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of common stock price as a percentage of conversion price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtConversionConvertedInstrumentAverageTradePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average trading price per $1,000 of Notes with respect to product of the closing common stock price and the conversion rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtConversionConvertedInstrumentAverageTradePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentConvertibleConversionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage above the last reported sale price of the Company's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentConvertibleConversionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Ratio of repurchase price to the principal amount of debt instrument to be repurchased in the event of default or a fundamental change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_PortionOfDebtInstrumentFaceAmountExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of debt instrument face amount, exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_PortionOfDebtInstrumentFaceAmountExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCovenantTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the conditions for borrowing under the credit facility including the nature of any restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCovenantTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481648/480-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -SubTopic 40<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyFiveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyEightNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=inva_SeniorUnsecuredConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=inva_PrivatelyNegotiatedCappedCallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=inva_PrivatelyNegotiatedCappedCallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleSubordinatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=inva_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563195433632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Debt Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term debt maturities for years ending December 31:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 192,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 453,500<span></span>
</td>
<td class="nump">$ 453,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563188065312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Additional Information) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, Weighted average remaining lease term</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_CordenPharmaMember', window );">Corden Pharma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Future minimum purchase commitments, remainder of 2025</a></td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Future minimum purchase commitments, 2026</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Future minimum purchase commitments, 2027</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=inva_CordenPharmaMember', window );">Corden Pharma [Member] | Commitments for 2024 to be utilized in 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Future minimum purchase commitments, remainder of 2025</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=inva_BurlingameCaliforniaMember', window );">Burlingame, California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetRentableArea', window );">Rentable square feet | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration, date</a></td>
<td class="text">Dec. 31,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=inva_WalthamMassachusettsMember', window );">Waltham Massachusetts Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Lease space | ft&#178;</a></td>
<td class="nump">15,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration, date</a></td>
<td class="text">Mar. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetRentableArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net rentable area for properties owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetRentableArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=inva_CordenPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=inva_CordenPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=inva_CommitmentsFor2024ToBeUtilizedIn2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=inva_CommitmentsFor2024ToBeUtilizedIn2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=inva_BurlingameCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=inva_BurlingameCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=inva_WalthamMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=inva_WalthamMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563197179264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Components of Least Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Straight line operating lease costs</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,428<span></span>
</td>
<td class="nump">$ 1,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 1,214<span></span>
</td>
<td class="nump">$ 1,617<span></span>
</td>
<td class="nump">$ 1,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198334304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Lease (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities:</a></td>
<td class="nump">$ 1,464<span></span>
</td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets obtained in exchange for operating lease obligations</a></td>
<td class="nump">1,156<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_RightOfUseAssetsObtainedThroughAcquistions', window );">Right-of-use assets obtained through acquisitions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_RightOfUseAssetsObtainedThroughAcquistions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of Use Assets Obtained Through Acquistions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_RightOfUseAssetsObtainedThroughAcquistions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196751472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">3,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">$ (253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Liabilities and Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 2,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563198738416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income tax expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 23,438<span></span>
</td>
<td class="nump">$ 7,799<span></span>
</td>
<td class="nump">$ 40,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3,175<span></span>
</td>
<td class="nump">2,177<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">26,613<span></span>
</td>
<td class="nump">9,976<span></span>
</td>
<td class="nump">41,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(12,606)<span></span>
</td>
<td class="nump">6,594<span></span>
</td>
<td class="nump">26,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(2,194)<span></span>
</td>
<td class="num">(625)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(12,617)<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="nump">25,401<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense, net</a></td>
<td class="nump">$ 13,996<span></span>
</td>
<td class="nump">$ 14,376<span></span>
</td>
<td class="nump">$ 66,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563201577664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Differences between the expected U.S. federal statutory income tax to income tax expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected tax at federal statutory rate</a></td>
<td class="nump">$ 7,846<span></span>
</td>
<td class="nump">$ 40,747<span></span>
</td>
<td class="nump">$ 58,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax expense (benefit), net of federal benefit</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">1,433<span></span>
</td>
<td class="num">(1,414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Federal and state research credits</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(1,582)<span></span>
</td>
<td class="num">(2,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount', window );">Foreign derived intangible income deduction</a></td>
<td class="num">(11,767)<span></span>
</td>
<td class="num">(15,274)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Impact of consolidation and deconsolidation of subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,897)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(2,243)<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">18,386<span></span>
</td>
<td class="num">(12,167)<span></span>
</td>
<td class="nump">13,180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense, net</a></td>
<td class="nump">$ 13,996<span></span>
</td>
<td class="nump">$ 14,376<span></span>
</td>
<td class="nump">$ 66,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203444896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 176,989<span></span>
</td>
<td class="nump">$ 182,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">21,359<span></span>
</td>
<td class="nump">21,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet', window );">Unrealized loss on investment, net</a></td>
<td class="nump">11,481<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredTaxAssetsDeferredRoyaltyObligationNet', window );">Deferred royalty obligation, net</a></td>
<td class="nump">17,452<span></span>
</td>
<td class="nump">18,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">6,832<span></span>
</td>
<td class="nump">6,467<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before valuation allowance</a></td>
<td class="nump">234,113<span></span>
</td>
<td class="nump">227,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(187,635)<span></span>
</td>
<td class="num">(169,249)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">46,478<span></span>
</td>
<td class="nump">58,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredTaxLiabilitiesDepreciationAndAmortization1', window );">Depreciation and amortization</a></td>
<td class="num">(31,626)<span></span>
</td>
<td class="num">(39,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Unrealized gain on investment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,747)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment', window );">Inventory fair value adjustment</a></td>
<td class="num">(2,798)<span></span>
</td>
<td class="num">(6,424)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 12,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Net deferred tax (liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (563)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredTaxAssetsDeferredRoyaltyObligationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets deferred royalty obligation, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredTaxAssetsDeferredRoyaltyObligationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets unrealized losses on investment, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredTaxLiabilitiesDepreciationAndAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredTaxLiabilitiesDepreciationAndAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities inventory fair value adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196718656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncomeTaxesLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Net increase in tax portions</a></td>
<td class="nump">$ 41,851<span></span>
</td>
<td class="nump">$ 3,119<span></span>
</td>
<td class="nump">$ 1,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncomeTaxesLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">520,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards do not expire</a></td>
<td class="nump">456,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Entasis Therapeutics Holdings Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncomeTaxesLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">154,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | La Jolla Pharmaceutical Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncomeTaxesLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">365,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncomeTaxesLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_IncomeTaxesLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward amount</a></td>
<td class="nump">$ 33,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_EntasisTherapeuticsHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inva_LaJollaPharmaceuticalCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563195973072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Changes in Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 61,294<span></span>
</td>
<td class="nump">$ 19,443<span></span>
</td>
<td class="nump">$ 16,324<span></span>
</td>
<td class="nump">$ 14,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Net increase in tax portions</a></td>
<td class="nump">$ 41,851<span></span>
</td>
<td class="nump">$ 3,119<span></span>
</td>
<td class="nump">$ 1,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563196954896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 358,711<span></span>
</td>
<td class="nump">$ 310,463<span></span>
</td>
<td class="nump">$ 331,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">13,654<span></span>
</td>
<td class="nump">33,922<span></span>
</td>
<td class="nump">41,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">25,902<span></span>
</td>
<td class="nump">21,784<span></span>
</td>
<td class="nump">5,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Changes in fair values of equity method investments, net</a></td>
<td class="nump">64,253<span></span>
</td>
<td class="num">(77,392)<span></span>
</td>
<td class="nump">161,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GainLossOnOtherInvestments', window );">Changes in fair value of equity and long-term investments, net</a></td>
<td class="nump">59,161<span></span>
</td>
<td class="num">(11,129)<span></span>
</td>
<td class="num">(8,462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest and dividend income</a></td>
<td class="num">(19,141)<span></span>
</td>
<td class="num">(15,818)<span></span>
</td>
<td class="num">(6,369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">22,209<span></span>
</td>
<td class="nump">19,157<span></span>
</td>
<td class="nump">15,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on sale of Theravance Respiratory Company, LLC ("TRC")</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(266,696)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">3,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense, net</a></td>
<td class="nump">13,996<span></span>
</td>
<td class="nump">14,376<span></span>
</td>
<td class="nump">66,687<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">179,722<span></span>
</td>
<td class="nump">220,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">358,711<span></span>
</td>
<td class="nump">310,463<span></span>
</td>
<td class="nump">331,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">31,441<span></span>
</td>
<td class="nump">30,739<span></span>
</td>
<td class="nump">6,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">84,249<span></span>
</td>
<td class="nump">67,493<span></span>
</td>
<td class="nump">56,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">25,902<span></span>
</td>
<td class="nump">21,784<span></span>
</td>
<td class="nump">5,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Changes in fair values of equity method investments, net</a></td>
<td class="nump">64,253<span></span>
</td>
<td class="num">(77,392)<span></span>
</td>
<td class="nump">161,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inva_GainLossOnOtherInvestments', window );">Changes in fair value of equity and long-term investments, net</a></td>
<td class="nump">59,161<span></span>
</td>
<td class="num">(11,129)<span></span>
</td>
<td class="num">(8,462)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest and dividend income</a></td>
<td class="num">(19,141)<span></span>
</td>
<td class="num">(15,818)<span></span>
</td>
<td class="num">(6,369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">22,209<span></span>
</td>
<td class="nump">19,157<span></span>
</td>
<td class="nump">15,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on sale of Theravance Respiratory Company, LLC ("TRC")</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(266,696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">3,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense, net</a></td>
<td class="nump">13,996<span></span>
</td>
<td class="nump">14,376<span></span>
</td>
<td class="nump">66,687<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">179,722<span></span>
</td>
<td class="nump">220,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=inva_AmortizationOfInventoryFairValueAdjustmentsMember', window );">Amortization of inventory fair value adjustments | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">13,820<span></span>
</td>
<td class="nump">27,164<span></span>
</td>
<td class="nump">10,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S. | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">10,921<span></span>
</td>
<td class="nump">7,535<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of the world | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">11,857<span></span>
</td>
<td class="nump">6,341<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of license revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of license revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_ExternalServicesMember', window );">External services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">7,408<span></span>
</td>
<td class="nump">20,051<span></span>
</td>
<td class="nump">24,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inva_InternalExpensesMember', window );">Internal expenses | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 6,246<span></span>
</td>
<td class="nump">$ 13,871<span></span>
</td>
<td class="nump">$ 16,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inva_GainLossOnOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on other investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inva_GainLossOnOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=inva_AmortizationOfInventoryFairValueAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=inva_AmortizationOfInventoryFairValueAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_ExternalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_ExternalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inva_InternalExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inva_InternalExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46563203346496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Additional Information) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">chief operating decision-maker (&#8220;CODM&#8221;), evaluates the company&#8217;s financial performance and operational efficiency using consolidated net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>128
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MRH+OZ%?GV''1!'/TA".]2#7#[4WC>V@(MQ(1KED!@-0*(>:AZ5L\8Y&6/3/
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MTS)F50?80JLS5ND WYRV]X&N,*>L(8/= M"<2%C-^VVAU6FJ\GY_MW-#8N.
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MZ$7"Y0OP^YS!G%=\D0645WBO_P=02P,$%     @ ^85:6D3H&[Z"!P  -B
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M 'R_YD#7_8N^.A[^56#Y?U!+ P04    " #YA5I:R(EGJAD#  "H"@  &
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MT4^R8M[O9:[^FB@[.9O??KZ_O;F./CQ<1>#^0?WZ=/7YX1[<?@37G^>WGZ[
M"?C]/@+O?OP9B#7-F0!)!A[6?"=H%HOWX,?.\_E4JD$5KJ?+>@"7U0#0P  @
M I]X)M<"7&4QB[L.IHI-0PF]4KI$5H\16YX"#-\#Y"!B&-#\V\VQP3SZ=G-D
M88.;"<*E/SS@[X[M6;9C9Z;(5I;$;%E4C#.QI4MV,5$E0;!\SR:SGWZ GO.+
M*2IC.HM&<M:)&&DB1FS>9P]<TE35I#)NIK!5YFYI7M3%_0R[@0_A^71_&! #
M##K$PUU89(!AB''8P#HDW(:$:YWVJV=5V043QGEWQYSW,9U%(SGKA,QK0N99
MY_U>;1Y)MGH/5BQCN4H!59  C5713(3,:;&_F()9.?4.Y@]"UPN=7C;HL#!
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M*<:NWV=B@+E^,,2D%4#0*A9FMU+5SE<:P^GFZES"T.]3T5$D]+1<TU$8^WB
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M&^%#!X1VP/\SSM76T!,43R?O#U!+ P04    " #YA5I:^!0N<Y81  #"V0
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M%H;_"L?;V6EGJIJX\9)-/..(R=0[:>*)TNUGFH(L;BE")2@[[J]?@)0%"3@
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MH;&O50SFH#2<.YG^=<2^P\0^=JVZO*L;/P>C($:]%H3/6EIQKM).J]80%)I
MJ&J8?Z3.0'C]4"ID FO0!9P9RTEF1PDDB^T!NX!DA&'?W&. "86)Z>O!PS[)
MKD33E'>B&R?=LNMT' T#+VC2!1F24!OW =4,T9PZ0RZ$6 1Y)AMLL B'L>B
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M@VMB@0D$HWF3FB3C>HZ(($^F): -4U=8[#20W"9RG.*T.[K<"K8HE0;83)5
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M1_6>4Z]Q<^P_?M&Y_[?XL*^B.PW8T>,/9?Z\,N_"0O.!ROC9GZAL[Y@MA+P
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M"'*LR/*=77/9M<6N($U$5T0=XPAXP'4K4?CX!UB#CAOH5*TN1@ZB-42%ZS2
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MQ^#1"Y><,ET :KS 0U:=0 35;S<(11']HG) 31KD;P4<Y2SY ^F?UJHI'.Q
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M0-\O&KHM_0,;X(=F&+P7_PU02P,$%     @ ^85:6IO['W[-!0  ,Q   !D
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M^BH@*PWQW,ZF%]/WOS 4\R 9L^G%Q?GU[:2Y;+.?!+18H#]9!Y<:'9K@T/B
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M/[&?CR:'X/JS#*DC_=""5W#:*"#Q"> AJJH&55T;4]L9,&K) WRG.3 8IQ:
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MP<$,XP#X?JY4[3[@ OY79I_^!U!+ P04    " #YA5I:4<-ODO\6  !42@
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M:^"^1OYBTVLJ\[(I_P 1H'$XXY-VT=6_@6%5=I\8T6@%.KJ39!D]+I@=KH:
MD'>&*77 80P 9@E1HZSE>Q9M:7L BZT*7(#E2!'%*224! EXE10%W*]+-'FO
MK0\WTHXKJ+: ,(&A5 ] FN(3!%RH6YJM6 /6E6J6"3)3"OL,F<[0Q$@!5Q>C
M% 5JG3#'G::TJ@<'^6B#GR8T<B&$+7$'KH98%UM,-N6?SX$S:8FOJ2B.C)(S
M63Y2713^#6]"NG;*H,NA=9U$"U9YITN8EVLCXE3A/%3=#LWH3!Y;N6.GRE#V
MZ:J'#(M)K7%/G& P0NQ@8 ]N7IY8;O61BAQ--%V2?7@B)]1^=FS.H8I(%YN%
MK7U#ME@QKR"-C2$1#['*NVX4GANUWH9!/'8Z@F^"2JH52<R$.K67!!K2\<FD
M/W,A$FZ'='@PZ,_K&+DNT* NPE&L<'C@3OZ>%\@TJL:7+&^4L@%>7^+GX[&
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MF'Z?-8FN:)?P5# 6*)L!$I&'0@M+,+LW#(9=)[F%B9IP%XF7!F(C$0$0UAN
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M!>!*7N[0"G;1-'HQ>9VHC"(E"[04,QCR';G"(/<%^(L?+&TC/:NME*W=PHO
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MP1K4?78Z;JL"8\\P*5")5"N)NE*KE8(H.N7-EA5.*Q;F23<@)KE)=K1YAI@
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MLQWUUM;K M-XW%4*@6?W6[GA(HJDT,S<'F3U='5!X?2AGK!%^O-3=HK3'<^
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M^<-^QY7I^L7(TEX39]+@I=,^+O&6#XH$\/M<8B'4+[1!\W>#R3]02P,$%
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M:ASM?9X-,>+HR05@_X7!92YJ4C5(4LZ"<0T/3-0(K/B+:K1T%4,MRE KH!#
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MTF51-]?)YL.JRE_AYLK2A= /5W0#1^T6T/Q"D6"V'VZ#]DX_^0=02P,$%
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MGEVMK4IO"B4ST.9G=OFU$79[,K&(3.>3M$,Y]RC1$RAAQ#ZHRA:&75899/L
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MZ.L63(E4. ">KPN0 /,';N#>TOSJ?P%02P,$%     @ ^85:6M\?'!.L#0
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M/B58#P.&<?\UBN\FL!O:U*KDDIO6DVYI(I$:YX^;?9=B*G8=QEB).HPK5]&
MU<0I6IT\8;.Q"F9RS"KG#UYS-4WUE >I>G9!PHB,S@AS7SSGVJ0K=W"LJ4(@
M"YDN*G]\@!0LEWO9F/+"1YXXO?:%;]AK&E\=2VVPWU8TUBSSGFR\OC&&A #P
M387"898J#'9<HFKDL@=D9LB1'"5JUZ?$SZN=&:Y94T_"%NN'G2R7,$1183L1
M#N<'=3RL4521G:!;/@G@</BCE3V(P9)&X1;JY.J4!NK0H;!WTEBIW'NU0C,
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MPL&7]'6MLK0 GT\,.L7Z#6W0_"CE_/]02P,$%     @ ^85:6M)NA]A'#
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MVR6M5?A%WLNU7.I<U^0I\!"QTB7LTS#!*$BN:>>V,=O**K>!9':B&@MU:=?
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M^18#*+*X;<-?P?]V>@'<Q;-C$?^2XI_HM[)OY9V0)P)6IBK<_)."(!!U(=<
M)&C6;RG-D7L?8POU!"(9/1_BB<LQA$%B3<1;,)\M1MIT3W505TP?P3_^4(=)
M&>9<4!(IQ( ')*-R63O6,IC'@//8P&H^'4J?;ZGD+!J@^M9:PJ T-8V;^IT*
M1\>WD#TLS=ZEX_'HW7#(8H8@JH">B5N&P[8?,5AV:QQ[I!"0&UW?DD<\K2\
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MMK:'X8#:=,M7[V7U]V8TN@G+0/ COG5V5>8P[;5U'2-B6<L^UQ:&7O/2G+/
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M0"/2DCMNN%"T)7=3E/'84\;C261^#<?6M"X[6Q(EP]"D([8&5&I8R1AU?-.
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M,B71$=)Z"^+\W<M?O E1UFI<Z]-XG"O3D@ZAZANJ.TT>4MO0PG84XXG4UF.
M$WHV@.>2U_ TN WW .ESKLBZQYPI@6>\\2DL.#T)R8PGDX?XF\8)WJAG3_V6
MHTF)7SN8.,7VX@F$ H>"%;O14 6IFQ*R9C-:R8?]5./N#?'"PT @5M'5@5&%
M!85*QN:G*"QK%[P4LL;X8,GJ71/-6Y^UQR90Q8H'>DHYSPE_S',RZ7(2?1J?
MB<U$5)PZ\L#0A!0MX/U3#AVLF>5%"<I),_//34=JHAV3-ZM LX\S4VX8#0L
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MB=]C[4CTG6N6W0T "3W[H"Q1$22(LEZJ Y;E)_S;L3E289[Z&@\=- 6LP9'
M\8V59"B-@1^*07 $YV3^( TK'!_8&9U>( S"#Q(?!A!LT[-*7Z [ A5$2I>>
M&,@_B$%PIRH'E@^@:7]$A2&J]ZDI$M N41*\2]/G':N6'VK[_O)V%%K9U;K1
M IX0"B3(,K=#5([TH+^\'3W+\6/*'I'7_/3T6?:$@E[N+U=RP)HO,," [ $_
M-X7_(4?Z=#JG^57(L:*JS/>8P_(F* JCE/!M0R)G8U5$_##EAC.4\7\D_/!^
M81= [39'S43\1&"/7),* @*P![LYC\HI,$.%<HR":<>IBJ3TB47N,<5%E1B2
M<R YU=<-23>8 OU#FZ:PE?->G\@WOQD->8WEC!Y>FL3#_ZP5DH479BF7H;JH
MCL/D]A,FH3@[2.]: F=&X7]=&ITC<B$MR&$X=":JP>6=*W'8@ 49JN-QU)+-
MMH 1OB[B,\MB'B P,!Y5E 4LXZP#C+MWL6$/UBUW A$V$MO\'/9@$$?IR%>@
M@12P9W0R%;2<I++L["K45+]OP.#/OI\_FD6=']Y$*9.$ N/SEE0A6972S:".
M8"-X0MY) O,-0F?AZVD0WY#[^)29!"0<Y"%_84F.//(G#+(Z!RY("C9KN&I
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M0RN<U*1.S0EN8ZOXRX_6TI%7,5P&(./I^!831N4EH$>'BYBT>=8L+E5V?'$
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MM$8\J4&IW.!ZRC#:(7]F,> XDW-)^G6M!X%KU!*MVV46Q63-P&8O[OZO>(Z
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M%"<1[U!?P&QZ#L6DF)_ FXTFS1+>["=XG\)..?-/,N8<;MD=5EVJ_EBQ3>N
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MM;*\5\@8<(0/S>$#T9UU,-F '0W"U%TC=T*!?XB:[[%% 2MJH6%>P7)B.,;
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M[,E"1J'6E:78$PY(Q9JS;><[9M'(-4XDY78'<Z$@-SM_,S'UT[_%E//BVCB
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MY3E*PY4$C8NA-P[[D[;SKQR^<UR9'1M<)7.E'MSD)AUZ@1.$ A/K"(R&1[Q
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M<=9)-\G";%+\I]+1,"D2S):B/NED+UT^VC,:A6F1=]*E<9BF.3EVB:.#?MR
M7ONI8TCIBN]:<[_;#[9%U\_W[MU41*G67!HB8(6A\?DH#XCN)DUG6+7QW7VI
M+,X*OZQQ.(-V#GB^4LH^&RY!/^[G?P-02P,$%     @ ^85:6ECZFP#T P
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M85!F=<%!3$%MN2[==AV_HS'OPGY0>S=VPY#?7B2>,WR]_S#(%>156M3H<1R
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M5N=Z'5&F##)3-+;DA3%S7C7E'8+IHL3!D[HI\1G=V/@#LS-HJB7:P@^OK_9
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M83&<C!'L$L0/&,]?OZ*!_7; )Z_QR1O2/O^"N964&1"^)+O\&]30[]\?I4!
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M=G!Q]<VE%'#:P '0/]?:;5_00?_?P^D_4$L#!!0    ( /F%6EHI+AR%LP0
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M/HU\1Q]'OR6K/'+]I36LMH>D7[JY%O3K?U :!J41*)HI7U%[\)R#14,/M,
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M;"]W;W)K<VAE971S+W-H965T-#8N>&ULM5A=;]LV%/TKA%8,+;!%HKYLI;8
M)\JV $L;.$U7K-@#(UW;0B71(VF[^_>C*%FV9$5P4.;%%JE[CG@/=8BK.]E1
M]HVO  3ZGF<%GQHK(=:7ILGC%>2$7] U%/+.@K*<"#ED2Y.O&9!$@?+,M"W+
M-W.2%D8X47/W+)S0C<C2 NX9XIL\)^R_*\CH;FI@8S\Q3Y<K44Z8X61-EO
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MS%^5K2W5;CG05'VQ.\*6:<%1!@M):5V,Y)I8U6JJ!H*N5?/EB0I!<W6Y I(
M*P/D_06E8C\H'] T_,+_ 5!+ P04    " #YA5I:JEIFR/P(  #E5P  &0
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M<X7.]8+2*)3&4#3]R9I*MX5G?[A4"-5S4!J!TBB4QE TO6<H/1?:9Y)]]^,
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MU[+773AW>57EZ?;'E>!S4=0;R']?Y'GU^$N]@R]Y\=>VVE?_!U!+ P04
M" #YA5I:;"%'2'8#  !X"P  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6RMEFUSVC@0Q[_*CMOIM#,M?N II, , 6XN-TG#!'I]K=@+UE267$F&\.U/
MLAT'$N.Y9'@!EF3M7_N35NL=[H3\K6)$#8\)XVKDQ%JGEZZKPA@3HEHB16[>
MK(5,B#9=N7%5*I%$N5'"W,#S>FY"*'?&PWQL(<=#D6E&.2XDJ"Q)B-Q?(1.[
MD>,[3P/W=!-K.^".ARG9X!+USW0A3<^M5"*:(%=4<)"X'CD3_W+J>]8@G_$O
MQ9TZ:(-%>1#BM^U<1R/'LQXAPU!;"6(>6YPB8U;)^/&G%'6J-:WA8?M)_:\<
MWL \$(53P7[12,<CY\*!"-<D8_I>[/[&$JAK]4+!5/X/NW*NYT"8*2V2TMAX
MD%!>/,ECN1$'!G[GA$%0&@0O#7HG#-JE03L'+3S+L69$D_%0BAU(.]NHV4:^
M-[FUH:'<'N-22_.6&CL]G@JN!*,1T1C!G&NJ*2H@/())^">CBMK-5O -5C%*
MLB4\1+A'E5))M)![F(HD)7S_%6YNIO!YAII0IK[\S_G?X.=R!I\_?H&/0#G<
M4L;L:D-7&S+KGQN6%-."(CA!X0=P*[B.E4&(,#H6<,V65/L2/.W+5="H^$_&
M6A!X7\TO".H<:C:?8=B"ME]G?N1.NSJF=J[7/G5,=S^6=S?7L\EJ/H/YC]7U
MZGJ^K''KJI#IU,O8G'"I4A+BR#&77J'<HC/^],'O>=_K&,\D=D3<J8@[3>KC
MNQU'J6*:FLC0:/2U#1$3-774C5)OI2[$!KF8S8+;L=?RNT-W6T/3K6BZC30+
M*4+$2,%:B@0480AB#1@*+A(:/B-F)GPES,W-TWM89#*,38J"R48BFMRIZ]B+
MA2\.W WZ_=:SOP54HWOO/,I>!=]KA)\2%4-$E9;T(;/YI ZCD/#] XY.J_."
MHG&==U+T*XI^(\5*:,(@)%+N*=_ EK L/T3Q*E"+_$GYUK3MJ=4EM*O^:][V
MX!5PHTOO!+ZH@"\:@6_)(TVRI,[Y1L.WWK<SB1TQ#BK&P7GRZN"<Q&<2.R+V
MO><OOM=\'<V7TD2P"<P\$:F\#(I,<6':6G"$E.Q/)9M2NGL0M5WO1<PV+_]6
M//>@MDE0;O*23T$H,JZ+,J<:K<K*25Y,N<_3BYKTEL@--<4,P[4Q]5I]@R&+
M,J_H:)'FE=*#T*;NRINQ*8U1V@GF_5H(_=2Q"U3%]O@_4$L#!!0    ( /F%
M6EJCY@$6: 4  )HA   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;+6:
M76_;-A2&_PKA%4,+))%)R9*=.0922T4SI&N0M-W%L O&IFVB$NF(M)T,^_&C
M/B)9,LU$&'.16!_G/!+?0U%\)8UW//TI5H1(\)C$3%ST5E*NSQU'S%8DP>*,
MKPE3>Q8\3;!4J^G2$>N4X'F>E,0.ZO=])\&4]2;C?-M-.AGSC8PI(S<I$)LD
MP>G31Q+SW44/]IXWW-+E2F8;G,EXC9?DCLCOZYM4K3D594X3P@3E#*1D<=&[
MA.<10EE"'O&#DIW86P994^XY_YFM7,TO>OWLC$A,9C)#8/6S)5,2QQE)G<=#
M">U5Q\P2]Y>?Z9_RQJO&W&-!ICS^D\[EZJ(W[($Y6>!-+&_Y[C,I&S3(>#,>
MB_P_V)6Q_1Z8;83D29FLSB"AK/C%CZ40>PF*HT] 90)J)_A'$MPRP6TG>$<2
MO#+!>VW"H$S(F^X4;<^%"['$DW'*=R#-HA4M6\C5S[.57I1E'>5.IFHO57ER
M,N5,\)C.L21S$#%))24"8#8'E[.'#14T*Z< I^"NZ$F +\ GRC";41R#*U9T
MU:SD:L>W%4GQ5NTCX):(-4VQY"IERI,U9D\GX/IZ"MZ'1&(:BP^*^?TN!._?
M?0#O &4JF6^$.K 8.U(U+#L]9U8VXF/1"'2D$0'XPIE<"=6 .9EK\J?F?(@,
M $<I6LF*GF7]B(S$WS?Q&4#]$_6'D.Z$S.DAF9T!%^;IGB8]?'VZJTF/7I^.
M#&*X51]S<YY[A/<#IQ3?QT1U%TE2(F31T9[ 7]<J$EQ)DHB_=54OL)X>FPVA
MYV*-9^2BI\9(0=(MZ4U^_07Z_=]TBMN$A39AD258HS9>51O/1)]\XU)=QRG9
M$K8ANAH8T[O6H( -<EAV"]M.W,$P@'#L;/?5U83!ON>[S;!($^9"UQU580U%
M!I4B Z,B7Z4:Q=2 -.,).0&,2)TJ1D1750J8O]>.4S0:!2U1-%'>R!^U--%$
MN6[@ZB7Q*TE\HR17N1A XD= 'M4411P7Q@CJ*HQ_T!CHCD9^2QA-E.<&K:CH
M,,KW_6&@%R:HA F,PORA9G)%3]%I8<SMJD5P</Y(=774TN(P"@:C +7"(@U,
MC?4^TJLQK-08&M6XY4\X5L.Z830Q KI*8A,6VH1%EF"-*HRJ*HS>YFX[LED;
MF[#0)BRR!&O4!O;KZ7;__]UOS?E=RU#2]N^1R(.!V[J5AKHX=SCTVJ.H)LZ%
MT/<&^I$#[MD0:-;E9>N@5<M([:R635IHE1;9HC7K@^KZH+<954JNK0K9I(56
M:9$M6K-"M<F"1I\P^;I65Y"D;/D\1],;:??@ E83Q-;\8&H^5&>9K;HE6[2F
MS+5?@F;#5,Z%%RE/ "\DYTPOM7<PRPJ@WY[73\W'ZZRU35IDB];4NG9BT((5
M@X>6!_;;&MOT:Z%56F2+UM2XMG;0[.UN"8[I/V0.8B[TW?C0.9VZ(W?HMS6V
M:?U"J[3(%JVI<>T2H=DF=O#/4./@VD+;])6A55IDB]84NC:@T.Q IRO,ED1D
MCY,7F*9@B^.-6N4+0!XVV6PE>[ =<[8\59.81(5MU4PF(4R*XP49'G;_H9H9
MMXMBU8Q:I46V:,VBU'X4&BW5"P])RN3F@PW/';;UM6HHK=(B6[3FFX;:4J(7
M+.4KWKK\"U[Q<,9\G*Y3=:NTT"HMLD5K5JPVNPB^C9E"5NVN55IHE1;9HC4K
M5-M=9#1K+S^F*?/W?52 ^JCU.'YJ/DQGB:WZ55NT0F)G[QUT0M)E_O)?@!G?
M,%F\-ZVV5A\87.:OU5O;I_ \*CX3J#'%5PM?<+JD3("8+!2R?Q8H]=/B0X!B
M1?)U_J;[GDO)DWQQ1?"<I%F VK_@7#ZO9 >H/L>8_ =02P,$%     @ ^85:
M6G%N;M^3!0  .R4  !D   !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULK9IK
M3^,X%(;_BM4=K4 :IKDT*66A$C2718(9-,#N9Y.XU"*),[;+97_].FF:-L3U
MM-+A VU2G\=VWM>7GOK\C?$7L2!$HO<\*\3%8"%E>38<BF1!<BR^L9(4ZI,Y
MXSF6ZI(_#T7)"4[KH#P;.I;E#W-,B\'TO+YWQZ?G;"DS6I [CL0RSS'_N"(9
M>[L8V(/UC9_T>2&K&\/I>8F?R3V1C^4=5U?#EI+2G!2"L@)Q,K\87-IGL7U:
M!=0E_J'D36R]1U57GAA[J2ZNTXN!5;6(9"21%0*KEU<R(UE6D50[?C7005MG
M%;C]?DV/ZLZKSCQA068L^Y>F<G$Q.!V@E,SQ,I,_V=O?I.F05_$2EHGZ/WIK
MREH#E"R%9'D3K%J0TV+UBM^;![$58(]V!#A-@/,YP-\1X#8![N< ;T? J D8
M[=LDKPGP/@>X.P+\)L#?MX9Q$S"NQ5H]W5J: $L\/>?L#?&JM*)5;VI]ZVBE
M""TJ*]Y+KCZE*DY.9ZP0+*,IEB1%82&II$0@7*3H,OFUI()6AA'H!%W?WZ%H
MJ>[?W*&C@$A,,W&L[C_>!^CHRS'Z@FB!'A9L*52P.!]*U;BJBF'2-&2V:HBS
MHR&V@VY9(1="M2(E:1<P5+UJN^:LNW;E&(FWF']#KO45.9;CZ!ID#@](HL+M
M.GRD"0_V#W<UX>'^X;K&1[_K^\<ZVM9$Q_M7;AF4<%N3N37/W66R']_O?]Q<
M!Y</88#"[P_7#]?AO:995RO,2(^I9N4S4>*$7 S4M"L(?R6#Z9]_V+[UETY>
M2%@ "0LA81$D+ :"=5PR:ETR,M&G#TSB#&$AB-3-'U?&Z$/-L8)Y-:Q:KE^G
MMFO9EJ_L_KJMNZ:<,W(]:]PM%T(V+H*$Q4"PCJ1>*ZEGE'1KT= I:@P^5%%(
M6  )"R%A$20L!H)UO.&WWO!A%@4?TB60L  2%D+"(DA8# 3KN&3<NF1LG$$"
M*B2G3\OZ>\N<LQR5F,N"<+&@I<XM1MRA;H&$!9"P$!(6C?N+G&VIO^X:%P/5
MV?'!:>N#4Z,/9KBDU?8@4=\1UG[0R7^Z5U=FQLH.%182%D+"(DA8W'^TKM5Y
MM!UA)ZVP$_,6H5!?,?<0UD@Y=%Q#PH))WW*3ON5"R#HC2%@,!.O(;UN;!(1E
M-, -2UY.EB4B[R7EN)[GJVR$S@-FTJ$F *4%O^EE^Y5Z9SX M#D1*"V&HG4M
MLI6CLHT/+U23 \MI@F@AB:I (C9'<D'0W68O@(YH@4K"$U+(8ZUYC'4<;!Y(
M6M#0)MMSR*?I [3"")060]&Z]G V]G#V2!QD%#_1K,Y?:N4W,@Z6?T7SMP1S
M/L_X05.HLS+TE@70=D6@M!B*UM5UDS6TC>FFZ7<BU8A_5>,]5X/ZA).LSE+3
M(F$Y04=JP2"%(,>(8%ZH^VH"2):<DU0__$%SBPUM6_\3=]QW@*;8R.U[P.T9
MY<3K^2D"[4(,1>N*NTGVV>9LWW4K;"/HUW9VU\H'FOUK:-NZC$9]]?JE?(UX
M_5).;_<7@;8_AJ)UM=MD]6QS6N^QX 1G]#\UZ#(F!%);-J:68X[(KR65'UN#
M5C\5@^;]&EIGC'FVUU=34\[O#=E05VPRZ>L)FH>#HG7UW&3B;&,*I]V"J^T3
M9:E6,C/ ]5%>_WBG%0@TYP9*"T%I$2@MAJ)U3;%)O-GFS-O/]1!_QFIGK8;X
MGH,;- '7T+J#NS<'![IB3F]"#^U^HLL_[0]MR![$4+2NBINTF6W.F_WN1S5S
M^,%R]7-$CN=I]D6:7))M]Z0(05L7@=)B*-I*V.'6$8Z<\.?Z=(Y "5L6<G7D
MH;W;G@"ZK,^]?+H_L\_"U3F>#69UK.@6\V=:")21N4):W\;J\?/529W5A61E
M?5#DB4G)\OKM@N"4\*J ^GS.F%Q?5!6TYZ6F_P-02P,$%     @ ^85:6F*6
M,_0G!   YA,  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULO5A=CYLX
M%/TK%ENM6FD[8 @$9I-(;6:K&6U'BII.^[#:!P><P1K U':2CK0_?FU@^ C$
MG8S0O"08[CV^]_CX<O'L0-D#CS$6X&>:9'QNQ$+DEZ;)PQBGB%_0'&?RR9:R
M% DY9/<FSQE&4>&4)J9M69Z9(I(9BUEQ;\46,[H3"<GPB@&^2U/$'C_BA![F
M!C2>;GPA][%0-\S%+$?W>(W%7;YB<F36*!%)<<8)S0##V[GQ 5XN8: <"HMO
M!!]XZQJH5#:4/JC!330W+!413G H% 22?WN\Q$FBD&0</RI0HYY3.;:OG] _
M%<G+9#:(XR5-OI-(Q'/#-T"$MVB7B"_T<(VKA%R%%]*$%[_@4-E:!@AW7-"T
M<I81I"0K_]'/BHB6 YR<<+ K!_NY#D[EX!2)EI$5:5TA@18S1@^ *6N)IBX*
M;@IOF0W)U#*N!9-/B?03BR7-.$U(A 2.P%^9(()@#E 6@0_ACQWA1)'-P7NP
M+M<9T"VXR2*R)]$.)?)RC[F0RRHXN,9)!#:/X&:] I]V$N'M%1:()/R==+_A
M>7GS<P[^N<7I!K-_Y>V[]15X^^8=> -(!K[&=,?EU'QF"IF:"M ,JS0^EFG8
M)]*XPN$%<. ?P+;LR8#[\OGN3M?=E(36K-HUJW:!YYS 6TDM8L8DI7(!PP?%
MWXJ1O20Y>02QXBG&*!%QB!@&(4USE$G:A](NYYD,SZ/V^"7/48CGAMS$'+,]
M-A:__P8]Z\\A$D8"ZU#BU)0X.O3%+<WPHU0N>Y"U::N4H$06(AX/I5UBN066
MJD3[!;2FKF//S'T[H;Z9YSA.4%MU(IW4D4ZTD7ZE0BJ;M)0='RO[\VHHZ!+6
M:T5CNZ[G^D=!]\T<"'UH#T?MUE&[VJA7NTU"0BFO8AM>-_):ZN2EQ3Q77B.!
M==+WZO0][8Z36:;RK5!L-[7;GM@0#$7X^=O-&Y./D< Z?$QK/J9:.;3Y&$IT
MVA.A[UGVL53[5M"?^IX_+%6_CLW72[4NA6=I50MZ[MJ,!-;)/ZCS#U[I[1",
M2<E(8!U*H-7T(996%-\18T@6V\%WO]57JVM-C\0Z9"5?&L-:A:T&"6H#N\N(
MZHW60JX/!_^!EQ5:_23G+M58:%U*FNX&ZMN;D8HM'+6Y&0NMRTG3WD!]?_.K
M@ENY=]0YL5J]2I5%WPSZD\#V3LBX:6J@OJOIR?AE15@_R]EK-A):EY.F98+N
M*Q5B.&HC-19:EY:FE8+:SN28EL%\O9Y,7<<-X+&:!\QLU[%.B+EI;J"^NZG$
M_#?)[B.:OKPH:V<Y>]5&0NMRTC15T'^5HCQJFS466I>3IM&"VJ;EUT4YZ']G
M!GZO)O>M[&!R_+UFM@YAU G8+6+W).,@P5OI9EU,I3\K#Y7*@:!Y<2ZSH4+0
MM+B4BQ1AI@SD\RVEXFF@CGKJH[W%_U!+ P04    " #YA5I:19%9H9@(  !8
M40  &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6R]G%MOV[@6A?\*X2EF
M.D ;6_(UG21 $]UZ<#(HFO;,P^ \T!9C<RJ)'I**&V!^_*$NL:Q89NQB];PD
MLJS]D9*6N;>X)%ULA/RJ5HQI\BU-,G796VF]?M?OJ\6*I52=B37+S#?W0J94
MFX]RV5=KR6A<!J5)WQT,)OV4\JQW=5&N^RBO+D2N$YZQCY*H/$VI?+QFB=A<
M]IS>TXI/?+G2Q8K^U<6:+MD=TU_6'Z7YU-]28IZR3'&1$<GN+WOOG7?1T"T"
MRBW^P]E&[2R38E?F0GPM/GR(+WN#HD<L80M=(*CY]\!N6)(4)-./OVMH;]MF
M$;B[_$0/RITW.S.GBMV(Y \>Z]5E;]8C,;NG>:(_B4W$ZAT:%[R%2%3YEVSJ
M;0<]LLB5%FD=;'J0\JSZ3[_5!V(G8#@\$.#6 >ZS -<]$#"L X;'!HSJ@-&Q
M >,Z8/Q\'YP# 9,Z8')L"],Z8'ILP*P.F)5GMSH=Y;GTJ*97%U)LB"RV-K1B
MH11$&6U.(<\*[=YI:;[E)DY?W8A,B83'5+.8^)GFFC-%:!:3]XN_<ZYXH3!%
MWA;?4<45^;QBDJY9KOE"D4@D,<^6Z@WYD"W.R&N/:<H3]2MY1?I$K:@T+)Z1
M+QG79IM7Q?+GE<B5X:N+OC;]+WK17]1]O:GZZA[HJT-N1:97RO0E9G%'O&>/
M'[X4[]OCQR_%!R_TW[4 ^N;$;<^>^W3VKETK,6#S,^),WQ!WX+KDRYU'7K_:
M/?A=Q_@(HCLKB<,G8M>AMF-NJ3PC0Z?=L:XC;L?\*T_,_KV,">P8CRVVO1EM
M#Y/'I1E A>S@A<?S; <I.AYS8.]:JAAN?]/#DCL\P+W+YXK'W*0B(B3QS<]8
M/Y);IE<B-K_3!Z8T8^3/?YLH\D&S5/VWH^O751.C[B:*C/I.K>F"7?9,RE1,
M/K#>U<\_.9/!;UV:0\(\),Q'P@(D+$3"(A"L)<?15HXC&_WJL] T,?7$7'?I
MS!I[JLZ0, \)\Y&PH(*-2UA1G#Y<C<;#\6!PT7_85=!QFT6@KK6T,=YJ8VS5
MQN^F.D^$,A6'UI+/<TWG"2-:D$QD"Y,KI4A,R-(4#IJ9UG571KNV-G&JA) P
M#PGSD;!@O*>-Y^IY<8MH?XO)<.1L-VH)8K(5Q,0J"&N9652970*P(D\5 !+F
M(6$^$A8@82$2%H%@+?E-M_*;_OC2:8J4(Q+F(6$^$A8@82$2%H%@+3G.MG*<
MV=-CGLZ9).+>),!*?+\H,A=4QB1EQ5>*;%9\L2(I?21S9HHLQ9=9>2T_?R1Z
MQ<B-2-<T>R3_V"YWKJV].%6Q2)B'A/E(6%#!)CO9SWV609'-12!82X;G6QF>
M6V7XB:6,JER:?UE5KW6)R,HX541(F'>^5ZA,9\_+8!_98H"$A4A8!(*U=.0,
MFMG&@55)'^ECJ2$M-F804\34^ ],:EY4_6LI4JZ4,+DW$YIU2<Q./U5C4)H'
MI?DUS5)^!] &0R@M0M':,MN9U':L,KO=&:[63')3O='XKUSI8HTB]Z:V6ZQH
MMF3%C/0#37)6Y-BE$/&&)TFG\JP-GJP\9^_L.N[S$<F#MNE#:0&4%D)I44W;
M3<UO1].=P]M6E=NHRL6IRE1K/"TKL74NS6I5#'!\T3VL6=L]65Q(F@>E^5!:
M *6%4%I4TUHB=$8'1=C,[3O6N=KO'-I.F4ZS=^!D-4+G_J$T'TH+H+002HMJ
MVJX:G<,C8C.S[]BG]K]/C$9]9EU9\U&EV $50HV!FM;Z->Y= GC0-GTH+8#2
M0B@MZCBZ[OB@NAIOP+&; R^HBV<+R8J\&K-ZP8@L9O=,2I-U-?U&$D[G/"EO
M:>B4&-0X</:GPT?["H,Z E!: *6%4%J$HK65V)@2CMV5^/V4]#G9T\%PMN>Z
MW=A;/#DO0HT&*"V TD(H+4+1VKIJW ;'.GN,L3_M;9P\C$$-!RC-A]("*"V$
MTJ*:MCN(O'6&DX,YM3$4'+NC\**_2OXAK7L"GURO;NE!C0,HS8/2?"@M@-)"
M*"U"T=H";:P&Y_S'.[ .U(N TCPHS8?2 B@MA-(B%*U]HVWC7+AVYZ)68EHI
ML;)CRRL3L<F85"N^+JY1%F8-779.\M7\8F:\F=(_&Y^?/RL,[?TX56U0F@^E
M!5!:"*5%*%I;;8V!X=H-C&/2]!U;Y+*Z7W\[Q4R7DE47S&4:+[PU>J2W9N_1
MJ6,FE.9!:3Z4%D!I(906H6AM%3>&B>O^^%SN0LT1*,V#TGPH+8#20B@M0M':
MNFP\%-?NH=CO2*^#6^;L>+ W@6-OXV0E08T-*"V TD(H+4+1VDIJ#!#7;H!X
M1D-F*%-:YD76?4-HEN5&6T\3-D32 ]EVU%4-#@;CO7(0.5/O06D^E!9 :2&4
M%J%H;9DU3HAK=T)*F?&MS$A*=5'Z/9+XD+SLO/?Y\HPXLS>D?/2L,T]"GX.
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M8$!A#6#N#IAK!6;V(Z9B938&+MF&YSJ.%'HGDD6<K12ZR:(NDM;(H0L9,BR
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M0WO[1(M-^17D>Z&U2,N':\X67!9O,+]?"J&_/BF^U;S[GOS\/U!+ P04
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M+ T4ORQH@J-V ?1^H93=;ER"]IN0_@)02P,$%     @ ^85:6A6/EX\Z%P
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M*45^MBGRLY>/MIV1]4YB-HDY).:2F$=B/HD%)"9(+"2QB,0DA"GU;@ZZ>,)
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M4ZM_ZZ[8>]T6NV>:P6<.Z=F[7[.WOV;O?\W> 'O8=UQH[LZJXJ&M^J@6H)I
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MTN5Z:?RW3.J+6O^G.[__8ORV2@P[S9-YF>6]M8[&Y%#-1C4'U5Q4\U#-1[4
MU02JA:@6H9JD-+53Z-)TTQ%P9D^FB\Y1S48U!]5<5/-0S4>U -4$JH6H%J&:
MI#2U^KNDW72OI%VV+HNR.KU/5]>/\US<)OF\Z@WBZ_[S>31JAVHVJCFHYK;:
MV=9!Y^!DL!.P]M V?50+4$V@6HAJ$:I)2E,+O8O03?7SV,GXT[<?^Z/).E2S
M4<U!-1?5/%3S42U -8%J(:I%J"8I3>T4NF3=%)C:;HJ&YU#-1C4'U5Q4\U#-
M1[4 U02JA:@6H9JD-+7ZNS3>5)_&^^9C?S2BAVHVJCFHYK::.5 ._LW=^QE[
M:*L^J@6H)E M1+4(U22EJ:7>Y?FF^CQ?L%IE=^E=;%0/QF5RG<Z-WVYOL[Q<
MKYH)*X^-*#K?/B78GNVZ^=Y?=[\J?>,'=PAHZ@_5'%1S4<U#-1_5 E03J!:B
M6H1JDM*4;F/6I?YF0.IOAJ;^4,U&-0?57%3S4,U'M0#5!*J%J!:AFJ0TM?J[
MU-],G_I[O\S6J[*9^EHWLW5OGX#&_5#-1C4'U=S9UW=#'>V>'J M^J@6]*R_
MM3.GM$!;#%$M0C5):6K]=@F^F3[!=_!!_^.=*K=FMT]7]54_5F^-H^D_5+-1
MS4$U%]4\5/-1+4 U@6HAJD6H)BE-[3>ZF.!L"!SUHWE 5+-1S4$U%]4\5/-1
M+4 U@6HAJD6H)BE-K?XN#SC3)HZV;GAS__7A '&S&WW[!_<<I&:CFH-J;JMM
MS^\P&C=SP>V>()#-^J@6H)I M1#5(E23E*9V"EU,<*:/"7[SJ41O!X!F!U'-
M1C4'U5Q4\U#-1[4 U02JA:@6H9JD-+67Z#*&,V":OAD:)D0U&]4<5'-1S4,U
M']4"5!.H%J):A&J2TM3J[\*$LV>FZ?N4Y/.T.@VXS=-YHIQ ?#%^,$YUIP1H
MQ!#5;%1S4,UMM>WA]J^^+4!S@Z@6H)I M1#5(E23E*86>I<;G.ES@R\*$_66
M/QHH1#4;U1Q4<U'-0S4?U0)4$Z@6HEJ$:I+2U)ZBBQW.SH 3 C0]B&HVJCFH
MYJ*:AVH^J@6H)E M1+4(U22E*=5_UJ4'S_0WU>V^26@O*R@SXR*!OTW0K\.A
MO0>JV:CFH)K;:MO?)IP-^KY-0)OU>YHUK?I_.Q/@!CTOG)CCX6RT,Z6U0-<O
M1+4(U22EJ>7<Q0'/OEL<4"\?7*1H'!#5'%1S4<U#-?^L)ZJX6\/HE'ZH%J):
MA&J2TAX*_;2X29+2KD[%W[U9)OEU<IXL%H4QKZNY/G3?>M3(DZNJ(S!?O[>.
M3K]ZW#=?"[/G\=!\+9O'3SO^W9O;^#J1<7Z=K@ICD5Q530U.ZCD0\O3Z9O-+
MF=V^/:JV]B(KRVS9_'B3Q-510?V"ZOFK+"L??ZD;N,_ROYK->??_4$L#!!0
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M9*J+Y@7U\W=Y7KW\T33PE!??5V_G^G\!4$L#!!0    ( /F%6EH,"+P&>PD
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M8O\Z$U>5YHLTL'\%V,U_ %!+ P04    " #YA5I:$;[&RF0$  "U%@  &0
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M5 :([]>$\)<#>8%Z=\W\/U!+ P04    " #YA5I:N_;<@B@'  #\1   &0
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M/#=0]Q>,R=>3?#Y8S8.G_P%02P,$%     @ ^85:6O+<B-N< @  \ 8  !D
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M45;;FE)#DY&2%5$V&MELH\Y-C48W3-A5G!N%LPQQ)KFAG(H4R+S>,A-9E%*
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MW<SQ2@)E W!^*:5YZ]BJUUURR5]02P,$%     @ ^85:6C<<!3=J P  Q@P
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MSO&/ I0UP/6IE.9Q8B^MZA\E_0M02P,$%     @ ^85:6EMM"9E3!   ;1$
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MH[8*>'W9<;O0!8]A%. \:5 K",:__T;[T9\>I-T::==Y[QS0UWBGKVTXNT?
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M\:RWGRN\OH$T ?A_(83>-LP ]84P_ =02P,$%     @ ^85:6HBHYH8Q!0
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M- D6& )K,3BN&1R?26C&_<;TW$Y;]F.0UU&9?HACJS7&KTORM245-P6@F[P
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M$'[[6<$:J@B?$V:T@FKMI./ND&](9(UG73,N0>I4DCH]$9"7[6S;;FRNHX'
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M^E85LT6HX6XL-=5(R>"./VRA[_<*PK_5$%Y%V9XJORI+ZQN@T3;,V/8"52W
M4E/-E5, !YX"H"_PM>4I@4TZ]FFWAZ)."K#45!/EI,"!H^C#%_@<<[!\VEW@
M@PL>;-,EV-Z1;._ ;'_. I^CD[PVV*%"/)::NBU40KP+0SS 8_T,:_6[*Z)>
M]P*$ZS%X$^@E\-Z5>._">'_.>E\KJ1KEC&=^URA4W,=24XV2N._"N(^XWN?J
M<P"[&]EJTYRX&01PI<\U17*]"W,]WEJ?V2A'BTOJ1J%.!+#45#\/]K;#F]O[
MK_.YN-O:<?>U7V+ZX,KI@]LGHGXL\LS^WL7\C<19R8M=RC(.!:';DM2U/.U^
M8$K4#4(;$M&Q8PY#NQ+PW1/[68Z$2>%L@WL'*K9CJ:F626QWIY</0[NH87Y4
MM0!+3?57$KT[:%_,F6%H5]\%+VJHS=;AN@QV[A*0[TK(=V'([QF%=D]S/5S0
M8%LNP?6>Y'H/YOK> 6A/#\]KSR&AHCN6FFJ,1'</1O?S M">'J:_,CVQA<KN
M6&JJ4Y+=/9C=>X>?/9W,-6-0X_)8:JHQDM^]09O4!T=5/<.F&$-?TE,9!O,
MKNNY7DCV]N @_"6BSIX><-?,045O+#75PX.'2KT+!YP]S/C[ E4MP%)3S96P
M[\&PCQYP;LOK[">>=W?2PM4:;.(E\-^3^._!4?OA 6=/?V15NX91 1Y+375(
M KP' _PYL6;O]$.K<*F#/;H$JGL2U3T8U?]UK+G55T.H[MCMAE#A>@QV[1(D
M[TN2]V&2/R?6[)^&>KC4P4_17P+J?0GU/@SUB&'FMB3;5E?*N@'4-MF)NT
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M7A!9 EI\W#VTN*<?=P\&V(1]$L,&+SR!9\V43>86)K+#F!)SI2J:P=S!&J)
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MU2A4"Z :@VHA2I/;H(UN+7UT^V6[ON7Y[GR@?N^('_C!36@%V=^S(]Y=JG6
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M./5HOJEV\)CEW^NG,_\?4$L#!!0    ( /F%6EJZRXW=8QP  #K5 0 9
M>&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;+7=:W.CUIJ&X;]">3)3297;%NB<
MZ715ISF?*X>9S[2$;54D\$:H.]ZU?_R C(T6PDN2]SU?$MF&:V%)?AK0^Z[U
M\7M>_+5]2--2^7NSSK:_7#V4Y>//M[?;Q4.Z2;8W^6.:53^YRXM-4E9?%O>W
MV\<B39;[G3;K6VTPF-QNDE5V]>GC_GMQ\>ECOBO7JRR-"V6[VVR2XNG7=)U_
M_^5*O7KYQF^K^X>R_L;MIX^/R7WZ>UK^^1@7U5>WK\IRM4FS[2K/E"*]^^7J
ML_IS/)_6.^RW^)]5^GU[\%BI?Y6O>?Y7_86S_.5J4!]1NDX794TDU?^^I5_2
M];J6JN/X1X->O8Y9[WCX^$4W][]\]<M\3;;IEWS]OZME^?#+U>Q*6:9WR6Y=
M_I9_M]/F%QK7WB)?;_?_5;XWVPZNE,5N6^:;9N?J"#:K[/G_R=_-$W&PPW#X
MQ@Y:LX/6V4'3WMAAV.PP/'>$4;/#J#O"^(T=QLT.XW-'F#0[3,[=8=KL,#WW
MEYXU.\PZ.[SY.LR;'>;GCJ .7EZYP=F[O+[8W5?[[5U>7FZU^WJKH[=V>7G!
MU>XK_O8N+R^Y>O9KKKZ\Z&KW57_[=WEYV=7]ZW[[_$>R_PO3DS+Y]+'(ORM%
MO7WEU0_V?Z;[_:L_K%56)\KO95']=%7M5W[2TZ^E\D'YDF??TJ)<?5VGRN]I
MMLH+)<S+=*O\J*=ELEIO?U)^4&Z5[4-25-]<9<J?V:K<7E??K![_\9#OMDFV
MW'Z\+:M#JN';13.\\3R\]L;PJA+D6?FP58QLF2Y[]K?D^P]/[6^?&']P"G!.
M )H$N*U>C-=71'MY17[5I&*0%#?*4+U6M(&F*7_^KBL__G#X[/<<XY<SQ,%4
M%'L87<Y\WMV_,.KTO ,SY**[6[_\JNI(+IDGI"1[E8;G'9N%OPRV7-33Q;'8
M]XX[GQE)&/=\9BAA/.:7\D^\MQZK9UN=G62",]X&@^9H>G8/S_]EU)[=HW/^
M0-3F#T3Z5HG//A!UTO]T"-DR?$W[X=X=2M*^YVA^?=YKU+]7?5+[\_8Q6:2_
M7%5GK=NT^)9>??JO_U G@__N"R,2TTG,(#&3Q"P2LTG,(3&7Q#P2\TDL(+&0
MQ"(2BR%,2++1:Y*-9/JG.'FJKFM+9?=87996%Y:[8E4^*?E==359G="NLFU9
M[.H-^M).*E^:=B2FDYA!8B:)621FDYCSC(WW6'TSYMNGP<?;;X<1=KS%?*(-
M1N)6WO%6ZF2L#E5Q,Y\\]H#$0A*+2"R&,"%UQJ^I,Y:FSOYJ>;G:+O)=E3W5
M):^RVFYW2;9(E46^K2^(L[0W<J3LI9%#8CJ)&21FDIA%8C:).<_8Y" J/HS5
M\:03.SU;3;5)9RN//#"?Q (2"TDL(K$8PH1PFKR&TT0:3F%:*HND*)Y6V;V2
M;.J(ZHLB*7)I%)&83F(&B9DD9I&836+.Y.BL932:#4>=DQMW<I1%H]%$&W;/
M@<A#\TDL(+&0Q"(2BR%,"*/I:QA-I6&D#;3Q\T<(?1DDW??2#"(QG<0,$C-)
MS"(QF\0<$G-)S",QG\0"$@M)+"*Q&,*$/)N]YMGL77?.9V22D9A.8@:)F21F
MD9A-8@Z)N23FD9A/8@&)A206D5@,84*2S5^3;"X],_N2;S9YIFS+?/&7\EBL
M%JE2YLIB5Q3U_?3%OA!D7R_V_+,B*5=Y7_))1[DT^4A,)S&#Q$P2LTC,)C'G
M&9L?WOV^&78N(LD!/1+S22P@L9#$(A*+(4P(-'7PFFAUG: DTCY7D97<5SE6
M),OZYM=S<CVFQ:**M.H'??$E)R_-+U334<U -1/5+%2S4<UIM,,8&]S,9YT<
M0\?T4,U'M0#50E2+4"VF-#'.#DIR56F<_9&7R;KSR6)OA$F9BR.,U'14,U#-
M1#4+U6Q4<QKM\([^>#3HEC2@8WJHYJ-:@&HAJD6H%E.:&&%:&V&:-,+\5?)U
MM:Y+LLZ(,2EU<8R1FHYJ!JJ9J&:AFHUJ3J,=?N(X'!_'&#FFAVH^J@6H%J):
MA&HQI8DQUI;+J](:UD_&/W9G9AA:08]J.JH9J&:BFH5J-JHYC7:88>K\.,/0
M"GE4\U$M0+40U2)4BRE-S+"V4+YN/#VK$D/YE_+Y]S_KYJ;!A\&D-\:DU,4Q
M1FHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQI8EQUU;HJ^-W%6JH: D^
MJNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL64)D9;6]^OR@O\_\R235Z4
MJW^F2T7H1.K-.[3.']5T5#-0S40U"]5L5'/4XW+_R71X?$E*#NJAFH]J :J%
MJ!:A6DQI8I"UO0'JN<T!U27I83U:;Y"AS0*HIJ.:@6HFJEFH9J.:@VHNJGFH
MYJ-:@&HAJD6H%E.:F'=M[X#ZON8!%>T>0#4=U0Q4,U'-0C4;U1Q4<U'-0S4?
MU0)4"U$M0K68TL1H:YL)5'DWP>_U#&=*O"^X_9=\SK-?Y=3%<8?V#*":@6HF
MJEFH9J.:@VHNJGFHYJ-:@&HAJD6--CW\X'MXHW7JJ&-J4''.U;:%0).W$%27
MI+.W^]7E.U^:7*BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@64YH8<&U3
M@::^ZQI40YL(4$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"VF-#':M#;:
MY,T&NCCEZ[6RR+^E69*52ID6FZVR3+>+8O58KV#2FX!H_P&JZ:AFH)J):A:J
MV:CFG'C__?&05F^_9?76VQ6I<E^]^8JL;D,NJ^^WUQ7UU IE4KU-FX4]DN*I
M>7_6\XB^O&6WUQ6U6._V?<R)LDF+^[1HW]#UIN5#TLQ[O$B+6E32ZJ?E]GGV
MX_U:.DJ^J"=TV!M[/"M7V:[Z\EI)5]5A%?MC^Z.H#B1-E?SYRX=\O4R+/5,-
ML$Z3;:EHX_^LOZY_G-S?%^E]4J9U>W6V6#TFZV:6P9<M\EVY+:OQZF&??^5-
M\E0=TF)=WR-2!X-7JQ7RN^O](2:+1;%+E_O'N^PQ62VKYZ%Z>M)M]?>\JHXH
M>[I6\JS:>+W>$\\#E+GR-566NW2_XV/RE-0KF*PVFW2YJ@YU_733^V\0VBF"
M:CZJ!:@6HEJ$:C&EB?\&M9TBFKQ3Y' !G>WS CI9\P&W?"H\N7OQOSYHYPBJ
M&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&EB=G7=IA4#]]U:V&$1ANIZ:AF
MH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ90F1EO;3:+)%WSXK9[]KKYJ*=+'
M7;%X2+9I.V>>>"7S]HSK\C$NSD&T]035#%0S4<U"-1O5G$839LSKE&&C WJH
MYJ-:@&HAJD6H%E.:&&YM/XDF[R<Q[N[2_8+.K[=:ZMD^>V?+DTL71QC:38)J
M!JJ9J&:AFHUJ#JJYJ.:AFH]J0:/54\Z5[32# VW6*9 )W]AP-IN*&T;H\<64
M)F94VRJBR5M%XI?SJ]Y40EM#4$U'-0/53%2S4,U&-:?1A(7XYMKQW%'-=I,3
MVWGHT?FH%J!:B&H1JL64)F92V\ZA26NJW[\*H-R].*_0?@]4,U#-1#4+U6Q4
M<QI-6.=O--6Z:=6SE:H-QMVP0ALT4"U M1#5(E2+*4T,J[9!0Y,W:)RY*J!<
MN3B:T-X,5#-0S40U"]5L5',:K7.*-.@6\KN]VZG:_"B=T'X*5 M0+42U"-5B
M2A/2:=BV70P'TH\.G9<;3^G?CVFV[;WW-$2;+U!-1S4#U4Q4LU#-1C4'U5Q4
M\U#-1[4 U4)4BU MIC0QYMKFBZ%\18<O>586R:+<U>LZG!-Y:%,&JNFH9J":
MB6H6JMFHYC2:L CS3.TNLG765MY96_GH\0>H%J):A&HQI8G1H[71(R].__P\
M95Q=QY ]5XC7S1(G)S27JQ<G$-H4@6H&JIFH9J&:C6K.\'A1ANGP*(!Z-E*U
M;OX<;S29:]WX0>OB42U$M0C58DH3XZ>MBQ_*Z^*;M:Q>SGGVK1Z'B20["4(K
MXU%-1S4#U4Q4LU#-1C6GT83EK<:C23>#CE=>&(^U[NVHWJVZM]1]]/@#5 M1
M+4*UF-+$%&HKU(?2,M'SNG.J+Z)JJP^?U^N\K!M)E>C-GE'Y>!=G$ZGIJ&:@
MFHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%E"9F8EO:/GS?0@E#M%H=U714,U#-
M1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)*$Z.M+6P?R@O;_3S))+4.\KTO3CBT
MF'UX/"F_.CVJ0S3004U4LU#-1C4'U5Q4\U#-1[4 U4)4BU MIC0QNMIZ]^&)
M>O?ZWMCAG?K7:8V4NVK4)M6N%>/OM%BLMNFR-^#0NGA4TX<]E=9] 8<6O*.:
MA6HVJCFHYJ*:AVH^J@6H%J):A&HQI8D!UQ;/#^7%\^?>BHN+U;=ZLJEX71U+
MG7^]08<6U*.:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&EB'K;U^</Y
M^V[#H07YJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!93FA!MH[:X?R1?
M4^'$;3CYWI<F'*KIC7:J;]A 1S51S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+$
M[&HK]D?RBOU]C[=S,*=XDF5"]?Y;,^7(W8M3#2W=;[2CN4;&W51#B_)1S4(U
M&]4<5'-1S4,U']4"5 M1+4*UF-+$5-/:5),W YQ[\^W4FLSR82X..;0[ -4,
M5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+$*&P;$T;#=]UW&Z%=!ZBFHYJ!
M:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@64YH8;6VW0_7P]%G>MBXCJ:]2E;OJ
M-.]Y5>:ZK&1Q<&ZG/*:%\H-Z/1@,VIFL>U-1.N+%J4AJ>J.I0NO.]&:NC;J7
MM>2P)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!93FAAX;2O#2#Y+_T'@/4_._^,R
M7Z^38KO/MWWT_71R=7KY&!=''-KWT&C"&MK3&VW2#3BTH0'5+%2S4<U!-1?5
M/%3S42U M1#5(E2+*4T,N+:A821O:.BL<*ILDG)7K,HG9?G6IQ!HBP.JZ2=^
MU\^[^QM%'5\K^UN2O1>N:/,#JEFH9J.:@VHNJGFHYJ-:@&HAJD6H%E.:&'-M
M\\-(WOP@G,>EF]5NH_R8;)6D/HU;5+GW4V_4H<T.J*8WVN&Z/H.;8?>L#6UU
M0#4+U6Q4<U#-134/U7Q4"U M1+4(U6)*$^.L;748_3NM#K.WUP26NQ='&MK6
M@&H&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&EB]K5M#:/WM36,T+8&5--1
MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI38BV<=O6,/ZWVAK&QZT#VD0=
M=%L'OLA'N32[4,U -1/5K#.?7QL=U4$U%]4\5/-1+4"U$-4B5(LI34REMF%A
M?$;#PB4?$<B]2\_$4$U'-0/53%2S3KRJ05*T'X;,^DZ^T,-Q4,U%-0_5?%0+
M4"U$M0C58DH38TYK8T[>P1 7^2)-EUOEKL@W[3H&^[JV]F[;_C;;?AG.^B>G
M5SN0#WIQ%J+]#*AFH)J):E:C"6=V8VUR?&:'=BJ@FHMJ'JKYJ!:@6HAJ$:K%
ME"9&7MNI,)8OH?!%*-C=U[>5N;+8%45]GK?HUKX5]<(*O2&'=C:@FHYJ!JJ9
MJ&8UVN%'PFKW(V$;'=)!-1?5/%3S42U M1#5(E2+*4U,N+9AH7HH+?FJ$BRY
MKV*M2);U,L7/0=84?50_Z$TS*7EQFI&:CFH&JIFH9C6:6. RGW7CC!S30347
MU3Q4\U$M0+40U2)4BRE-C+.V'6$L;T?XK3X#JR\\B_1Q5RP>DFW:GK>5#VG;
M:B7[& %M1T U'=4,5#-1S6HTX6RM&VYH*P*JN:CFH9J/:@&JA:@6H5I,:6*X
MM:T(8WEYOG%WER[*U;?T]%1(<NGB"$.;$%#-0#43U2Q4LU'-:;2C":FFG27\
MT%$]5/-1+4"U$-4B5(LI3<RQMM=@?&*A!5F[NWS?BY,+[2E -0/53%2S4,U&
M-:?13E6AN./CY2[ZMO/0H_-1+4"U$-4B5(LI3<RDMF%@+&\8V-=P+%?;17U1
MN%\K6?SH<O^)9F]>H0T#J*:CFH%J)JI9J&:CFM-HASGT8329C;IQU;/99#!1
MNVF%EOBC6H!J(:I%J!93FIA6;8G_6%IG^RE,2V61%,53?<M><B,+K?A'-1W5
M#%0S4<U"-1O5G$83SI'&DZ':7<B]=[O1?#COIA-:I8]J :J%J!:A6DQI0CI-
MVBK]R7.][5L-2,[+W:GT[\<TV_;>H)J@*Q"@FHYJ!JJ9J&:AFHUJ#JJYJ.:A
MFH]J :J%J!:A6DQI8LRU9?\3>8'XESPKBV11"FL3R"(/K?I'-1W5#%0S4<U"
M-;O1#N]%C<9JY]+.:;829LD<C[KG6&=MY:''[Z-:@&HAJD6H%E.:&#U:&SWR
M4OS/FWJMXG\FXGK%)VOMY>K%"836VJ.:@6HFJEFH9C>:L*CST5TCIV^KX;3[
M65_O5B.MFT!H93RJ!:@6HEJ$:C&EB0G45L9/Y)7Q?^3EX6E/?<,\.0PEV7D0
M6@R/:CJJ&:AFHIJ%:G:CC85SE^FXFT+'6TWFVK";0L.C%)K,9K-N"J'5ZZ@6
MH%J(:A&JQ90FIE!;O3Z1EI.>-\U7NZ+Y^NE#EM[GY:IZO%06R>/C_G_KM9(_
MUJG5FU;2([@XK4A-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU MIC0Q)=NB
M^,E8>C_^K0G!)FB=.ZKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%E"9&
M6UL2/Y&7Q%>/5W^]M/C4BRW5/3Z[;)D6ZWUM1+;;?$V+^A99LPK3CZM,><<*
M)<UAJ(?+@ R'-_-9YQ+GB_QX+TY!M%0>U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4
MBU MIC0Q!=N"^LF)@OJFU?%YD;GVLG:K5&FWR+.L;AO*,^7[JGP0)NL1KIF7
MN_2MJ:Y^E1_ Q:>*:%4^JAFH9J*:->FI?.^9?A$=U$$U%]4\5/-1+4"U$-4B
M5(LI34R_MG1_ LSU7WT155M]^+Q>Y^5^EL;H[5M^:$D_JNFH9J":B6H6JMFH
MYJ":BVH>JOFH%J!:B&H1JL64)F9BVR P>=\: !.T(P#5=%0S4,U$-0O5;%1S
M4,U%-0_5?%0+4"U$M0C58DH3HFW:=A=,_ZTU *;'<]2/QL=+ ,@'N32Z4,U
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MN,KGMT_8CB?<5T>CV5%/Z9G;Z?)#O3B.T$X#5+/.?$9L=%0'U5Q4\U#-1[4
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M/HC"[2U^,*Q1Y6[<R.8UO*%RP;@B)<P1Z%T,D4$V+TPST**VE_1,:+SR;;?
M1QFD"<#UN1#Z=6#N_>Z93_\ 4$L#!!0    ( /F%6EK;IW8^NP0  % 7   9
M    >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;+58;6_;-A#^*P>M&!(@L$0Y
M?LML XF]H@&2-DC0Y4.Q#[1TMHE*HD=2=C+TQX^4%,GV9';QY'R(18GW')_C
M\?B0PPT7W^424<%+'"5RY"R56EVYK@R6&%/9XBM,])<Y%S%5NBD6KEP)I&%F
M%$>N[WE=-Z8L<<;#[-V#& ]YJB*6X(, F<8Q%:\W&/'-R"'.VXM'ME@J\\(=
M#U=T@4^HOJX>A&ZY)4K(8DPDXPD(G(^<:W(U\7UCD/7X@^%&;CV#H3+C_+MI
MW(8CQS,CP@@#92"H_EGC!*/((.EQ_%6 .J5/8[C]_(;^,2.OR<RHQ F/GEFH
MEB.G[T"(<YI&ZI%O/F%!J&/P A[)[#]L\KZ]@0-!*A6/"V,]@I@E^2]]*0*Q
M9>!W#QCXA8&_9T#Z!PS:A4$[(YJ/+*,UI8J.AX)O0)C>&LT\9+')K#4;EIAI
M?%)"?V7:3HTG/(Z9TO.B)- DA E/%$L6F 0,)9Q=AR$SX:81W"9YTNC6.9Q-
M45$6R7/X "R!>Q9%^KT<NDJ/R2"[0>'_)O?O'_!/?+C7+I<2?D]"#'<!7$VF
M9.2_,;KQK8A3#%K0)A?@>_XE?'V:PMF'<YBK7W\AO?YO-2.<V/$^\[7&\PP>
M&1S V1EHNPQ].P-N'P"^0RD1+^ .=1I>P!1E(-@J2^YO=[HOW"J,Y9]U,<V!
M+^N!S<J_DBL:X,C12UNB6*,SUL/N>K7T&P+;B<%E&8-+&_KXRPH%-0D'41Z%
MYVS=80ATK;\L4)<*4XS*'J!0Q'4AL?OQX16ID-"#.,^V+H3TM2Y?)U:@(\/1
M*</1^8_AN-L+QW41CBF3 4\3!8]4Z>\/* *]=NL"DGL:9)Y,,5^/O9;7\W;^
MR-!=;W.WCNY([MV2>]?*?<)%B D\+*FN,O#M'N,9BMKLM^*\-_L; MNAW"LI
M]TY5 7I-QJ AL)T8],L8]*W3_C%5J4"SM;$XC6&5BF!IUGE0;4P711$(40"?
MF[K>J0M)[J>_E?#=5F<OP:UC.9+IH&0Z^/],-;EN';D<FI M=KU6>X^=U?^1
M[(A7*0FO$7Z]6I7@_9M@IS78(V@?P;$,M[02.:)$P0_85E%:)>720W&8(:2*
M1>QO7<&U3#*9:ZUL=O_O7=9-H>U&RZ^BY9^JNA7(3<6A(;3=.%0RCU@55(,5
MKG"T6^)Z^VOD%'J.5(*.V)7632KTJP6-]91/:,3T<D@8K673D-(J:)]"MY%*
MN)'.R9*](=55Q.$4&HY4(H[85=RC3F<ZBU"?QU.JLWYNKB)^V(Y?-W;$=_//
MT;I;:\0GI!*ZN[PJI4:L(FB<S2O@RXJ)[ A\H<\/"FOIV('*X^FAK7!B!SAV
M!BL]1NR"[,YZS+(;OWNR[$-I=XOCFHU8);^(77\]TT@M:0SW5$H:+%.)2F_7
M^6Y<2[4A.550/84X\RMQYGNGJD]^0Z*KN&PYA83S*PGGVR5<GMV9AY^4I0)H
MNY"03L?S]K9;N[]C^50BR[>*EW?4I9\ W5-1U:5![<PU*J/<K3O+&,4BN\J5
MD%UNY->7Y=ORNO@ZNR1UJ^[Y7;,>^H(E$B*<:U.OU=-;H,BO;_.&XJOL!G3&
ME>)Q]KA$JL66Z:"_SSE7;PWCH+Q$'_\#4$L#!!0    ( /F%6EJ';?OOU (
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M]"XN,219MZQZHD5IB_A<:&P)=IAAEP=I +B_$$)O)N8%[?^&Z"]02P,$%
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M'VOZ4D'M#.C]5BG[N' 'C-\^^3]02P,$%     @ ^85:6LJ<\)\- P  =P@
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M#O+YBE+Q>J,&:(Z]_'\!4$L#!!0    ( /F%6EIRR1GPVP(  +H(   9
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MS@1Z9]0[$^B=4>],H'>>'/8FT#NCWIE [X)Z%P*]"^I="/0NJ'<AT+N@WH5
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /F%6EHE4@_K[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( /F%
M6EJ97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ^85:6F+V:94F"P  SCL  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( /F%
M6EI$Z!N^@@<  #8@   8              " @6H3  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " #YA5I:R(EGJAD#  "H"@  &
M        @($B&P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ ^85:6F,I&)H$"    BH  !@              ("!<1X  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( /F%6EI*H+H'G (  '\'   8
M              " @:LF  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " #YA5I:^4,.S@8#  !&"0  &               @(%]*0  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ ^85:6O@4+G.6$0
MPMD  !@              ("!N2P  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( /F%6EH%T"HIZ0L  &(\   8              " @84^
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #YA5I:R=%N
MPA *  !8-   &               @(&D2@  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ ^85:6M(O;H=H @  OP<  !D
M ("!ZE0  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #Y
MA5I:8>W(BB<L   VB   &0              @(&)5P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( /F%6EJ;^Q]^S04  #,0   9
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M970Q-BYX;6Q02P$"% ,4    " #YA5I:31SUNBT$   ["0  &0
M    @(%UX0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M /F%6EI0NI355@8  $,0   9              " @=GE  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ ^85:6HP595(\!0  WPL  !D
M             ("!9NP  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " #YA5I:3L&EXG@-  "E*0  &0              @('9\0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( /F%6EK9%30[/@4
M &P,   9              " @8C_  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ ^85:6I60.=SB&   L5D  !D              ("!
M_00! 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #YA5I:
MWQ\<$ZP-  "@(@  &0              @($6'@$ >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( /F%6EK2;H?81PP  ),?   9
M      " @?DK 0!X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ ^85:6GXG@_*%!P  P@\  !D              ("!=S@! 'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #YA5I:WU-*-"\P  !WGP
M&0              @($S0 $ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( /F%6EJ[MO=,'P,  +<&   9              " @9EP 0!X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ ^85:6EGN:2:+
M!   D@L  !D              ("![W,! 'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " #YA5I:YH914N@#  # "   &0
M@(&Q> $ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( /F%
M6EJ)$L6 (@@  .49   9              " @=!\ 0!X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ ^85:6JR\V=1+"   XQH  !D
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M=#,U+GAM;%!+ 0(4 Q0    ( /F%6EJ6,E?8;P4  "45   9
M  " @<6> 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M^85:6JU]#D7K P  T0D  !D              ("!:Z0! 'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " #YA5I:=(#VK2L&  "'$   &0
M            @(&-J $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( /F%6EHI+AR%LP0  -D)   9              " @>^N 0!X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ ^85:6N#QEF+B!P
M&$,  !D              ("!V;,! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " #YA5I:MTFG!*H"  ! "0  &0              @('R
MNP$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( /F%6EIC
M4-G800(   <%   9              " @=.^ 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ ^85:6B0GF'J(!0  :A\  !D
M     ("!2\$! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /F%6EHB-%BEKQ    O(   9              "
M@=?< 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ ^85:
M6FPA1TAV P  > L  !D              ("!O>T! 'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " #YA5I:H^8!%F@%  ":(0  &0
M        @(%J\0$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( /F%6EIQ;F[?DP4  #LE   9              " @0GW 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ ^85:6F*6,_0G!   YA,
M !D              ("!T_P! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " #YA5I:19%9H9@(  !840  &0              @($Q 0(
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( /F%6EH@G6E^
MCP<  #,_   9              " @0 * @!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ ^85:6J'6$.$.!0  R"   !D
M ("!QA$" 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " #Y
MA5I:(V9TFKD"   ?!@  &0              @($+%P( >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( /F%6EH5CY>/.A<  /UN 0 9
M          " @?L9 @!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#
M%     @ ^85:6H#N$O9 !0  ;20  !D              ("!;#$" 'AL+W=O
M<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " #YA5I:L*VL:[4/  "X
MW0  &0              @('C-@( >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM
M;%!+ 0(4 Q0    ( /F%6EH,"+P&>PD  'AL   9              " @<]&
M @!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ ^85:6K1#
M//49"@  #FP  !D              ("!@5 " 'AL+W=O<FMS:&5E=',O<VAE
M970V,2YX;6Q02P$"% ,4    " #YA5I:$;[&RF0$  "U%@  &0
M    @('16@( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M /F%6EH+88HV?P,   (,   9              " @6Q? @!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ ^85:6CQZ)B38 P  Y \  !D
M             ("!(F," 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " #YA5I:6* KU941  "UQP  &0              @($Q9P( >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( /F%6EJ5O\J[B (
M /T%   9              " @?UX @!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ ^85:6HCN>]HP!0  :2,  !D              ("!
MO'L" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " #YA5I:
MN_;<@B@'  #\1   &0              @($C@0( >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( /F%6EK(,3X-7P0  !L6   9
M      " @8*( @!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%
M  @ ^85:6O+<B-N< @  \ 8  !D              ("!&(T" 'AL+W=O<FMS
M:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " #YA5I:-QP%-VH#  #&#
M&0              @('KCP( >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+
M 0(4 Q0    ( /F%6EK30J3FP ,  /8+   9              " @8R3 @!X
M;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ ^85:6KHJF6\7
M P  KP@  !D              ("!@Y<" 'AL+W=O<FMS:&5E=',O<VAE970W
M,RYX;6Q02P$"% ,4    " #YA5I:6VT)F5,$  !M$0  &0
M@('1F@( >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( /F%
M6EKDDG?A_@(  !P*   9              " @5N? @!X;"]W;W)K<VAE971S
M+W-H965T-S4N>&UL4$L! A0#%     @ ^85:6HBHYH8Q!0  <2,  !D
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M=#@P+GAM;%!+ 0(4 Q0    ( /F%6EH<?Z@W8 P  '28   9
M  " @7O  @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @
M^85:6KK+C=UC'   .M4! !D              ("!$LT" 'AL+W=O<FMS:&5E
M=',O<VAE970X,BYX;6Q02P$"% ,4    " #YA5I:K9.PK7P"  #R!P  &0
M            @(&LZ0( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4
M Q0    ( /F%6EK;IW8^NP0  % 7   9              " @5_L @!X;"]W
M;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ ^85:6H=M^^_4 @
M0P@  !D              ("!4?$" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX
M;6Q02P$"% ,4    " #YA5I:QM3KGCL#   '"0  &0              @(%<
M] ( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( /F%6EK*
MG/"?#0,  '<(   9              " @<[W @!X;"]W;W)K<VAE971S+W-H
M965T.#<N>&UL4$L! A0#%     @ ^85:6IKK\/!/ P  +@P  !D
M     ("!$OL" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /F%6EJCT+ELA @  '$V   9              "
M@>4. P!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @ ^85:
M6C[GNO@8 P  @@<  !D              ("!H!<# 'AL+W=O<FMS:&5E=',O
M<VAE970Y-"YX;6Q02P$"% ,4    " #YA5I:D?OPRG<#  !S&   #0
M        @ 'O&@, >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /F%6EJ7BKL<
MP    !,"   +              "  9$> P!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( /F%6EH:6Z!0L@8  "X^   /              "  7H? P!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #YA5I:MO4_!K8"  !1-P  &@
M    @ %9)@, >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #YA5I:N.0S3$8"  ",-0  $P              @ %'*0, 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     9@!F  $<  "^*P,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>620</ContextCount>
  <ElementCount>642</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>173</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100120 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100130 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100140 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100150 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100160 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Description of Operations and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1</Role>
      <ShortName>Description of Operations and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995485 - Disclosure - License and Collaboration Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1</Role>
      <ShortName>License and Collaboration Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Consolidated Entities and Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3</Role>
      <ShortName>Consolidated Entities and Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Equity and Long-term Investments and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995515 - Disclosure - Capitalized Fees Paid</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1</Role>
      <ShortName>Capitalized Fees Paid</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation</Role>
      <ShortName>Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Description of Operations and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Description of Operations and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Description of Operations and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Description of Operations and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Consolidated Entities and Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables</Role>
      <ShortName>Consolidated Entities and Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Equity and Long-term Investments and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Capitalized Fees Paid (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidTables</Role>
      <ShortName>Capitalized Fees Paid (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables</Role>
      <ShortName>Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Description of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails</Role>
      <ShortName>Description of Operations and Summary of Significant Accounting Policies - Description of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails</Role>
      <ShortName>Description of Operations and Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails</Role>
      <ShortName>Description of Operations and Summary of Significant Accounting Policies - Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Net Income Per Share - Basic and Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails</Role>
      <ShortName>Net Income Per Share - Basic and Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Net Income Per Share - Anti-Dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Net Income Per Share - Anti-Dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995795 - Disclosure - Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails</Role>
      <ShortName>Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Revenue Recognition - Schedule of net product sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails</Role>
      <ShortName>Revenue Recognition - Schedule of net product sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails</Role>
      <ShortName>Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995825 - Disclosure - License and Collaboration Arrangements (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails</Role>
      <ShortName>License and Collaboration Arrangements (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3</Role>
      <ShortName>Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Consolidated Entities and Acquisitions - ISP Fund LP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - ISP Fund LP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Consolidated Entities and Acquisitions - Summary of Individual Investments Held by ISP Fund (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - Summary of Individual Investments Held by ISP Fund (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Consolidated Entities and Acquisitions - Entasis Therapeutics Holdings, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - Entasis Therapeutics Holdings, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Consolidated Entities and Acquisitions - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails</Role>
      <ShortName>Consolidated Entities and Acquisitions - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Summarized Financial Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Summarized Financial Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995935 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in InCarda (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in InCarda (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in ImaginAb (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in ImaginAb (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neurosciences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neurosciences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Nanolive (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Nanolive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Reconciliation of Equity and Long - Term Investments Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Reconciliation of Equity and Long - Term Investments Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995985 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Equity and Long-term Investments and Fair Value Measurements - (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Capitalized Fees Paid - Schedule of Capitalized Fees Paid (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails</Role>
      <ShortName>Capitalized Fees Paid - Schedule of Capitalized Fees Paid (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Goodwill and Intangible Assets (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3</Role>
      <ShortName>Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Balance Sheet Components (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails</Role>
      <ShortName>Balance Sheet Components (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Balance Sheet Components -Schedule of Other Long-term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components -Schedule of Other Long-term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Stock-based Compensation - 2012 Plan and ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails</Role>
      <ShortName>Stock-based Compensation - 2012 Plan and ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Stock-based Compensation - Director Compensation Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails</Role>
      <ShortName>Stock-based Compensation - Director Compensation Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996105 - Disclosure - Stock-based Compensation - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-based Compensation - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996115 - Disclosure - Stock-based Compensation - Compensation Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails</Role>
      <ShortName>Stock-based Compensation - Compensation Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996125 - Disclosure - Stock-based Compensation - Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails</Role>
      <ShortName>Stock-based Compensation - Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996135 - Disclosure - Stockholders' Equity (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996145 - Disclosure - Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3</Role>
      <ShortName>Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996155 - Disclosure - Debt - Convertible Subordinated Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4</Role>
      <ShortName>Debt - Convertible Subordinated Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996165 - Disclosure - Debt - Convertible Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3</Role>
      <ShortName>Debt - Convertible Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>996175 - Disclosure - Debt - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails</Role>
      <ShortName>Debt - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>996185 - Disclosure - Commitments and Contingencies (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>996195 - Disclosure - Commitments and Contingencies - Schedule of Components of Least Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Components of Least Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>996205 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>996215 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>996225 - Disclosure - Income Taxes - Income tax expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Income tax expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>996235 - Disclosure - Income Taxes - Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails</Role>
      <ShortName>Income Taxes - Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>996245 - Disclosure - Income Taxes - Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3</Role>
      <ShortName>Income Taxes - Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>996255 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>996265 - Disclosure - Income Taxes - Summary of Changes in Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of Changes in Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>996275 - Disclosure - Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails</Role>
      <ShortName>Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="inva-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>996285 - Disclosure - Segment Reporting (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails</Role>
      <ShortName>Segment Reporting (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="inva-20241231.htm">inva-20241231.htm</File>
    <File>inva-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img12876764_0.jpg</File>
    <File>img12876764_1.jpg</File>
    <File>img12876764_10.jpg</File>
    <File>img12876764_11.jpg</File>
    <File>img12876764_12.jpg</File>
    <File>img12876764_13.jpg</File>
    <File>img12876764_14.jpg</File>
    <File>img12876764_15.jpg</File>
    <File>img12876764_16.jpg</File>
    <File>img12876764_17.jpg</File>
    <File>img12876764_18.jpg</File>
    <File>img12876764_19.jpg</File>
    <File>img12876764_2.jpg</File>
    <File>img12876764_20.jpg</File>
    <File>img12876764_21.jpg</File>
    <File>img12876764_22.jpg</File>
    <File>img12876764_23.jpg</File>
    <File>img12876764_3.jpg</File>
    <File>img12876764_4.jpg</File>
    <File>img12876764_5.jpg</File>
    <File>img12876764_6.jpg</File>
    <File>img12876764_7.jpg</File>
    <File>img12876764_8.jpg</File>
    <File>img12876764_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1415">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="13">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>135
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "inva-20241231.htm": {
   "nsprefix": "inva",
   "nsuri": "http://www.inva.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "inva-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "inva-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 463,
   "keyCustom": 179,
   "axisStandard": 39,
   "axisCustom": 0,
   "memberStandard": 51,
   "memberCustom": 111,
   "hidden": {
    "total": 23,
    "http://xbrl.sec.gov/dei/2024": 3,
    "http://fasb.org/us-gaap/2024": 17,
    "http://www.inva.com/20241231": 3
   },
   "contextCount": 620,
   "entityCount": 1,
   "segmentCount": 173,
   "elementCount": 1194,
   "unitCount": 12,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1415,
    "http://xbrl.sec.gov/dei/2024": 39,
    "http://xbrl.sec.gov/cyd/2024": 13,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "100100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
     "longName": "100120 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical",
     "longName": "100130 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6",
      "name": "us-gaap:CapitalizedContractCostAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome",
     "longName": "100140 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "longName": "100150 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "100160 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "100170 - Disclosure - Cybersecurity Risk Management, Strategy and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1",
     "longName": "995455 - Disclosure - Description of Operations and Summary of Significant Accounting Policies",
     "shortName": "Description of Operations and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1",
     "longName": "995465 - Disclosure - Net Income Per Share",
     "shortName": "Net Income Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1",
     "longName": "995475 - Disclosure - Revenue Recognition",
     "shortName": "Revenue Recognition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1",
     "longName": "995485 - Disclosure - License and Collaboration Arrangements",
     "shortName": "License and Collaboration Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:LicenseAndCollaborationArrangementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:LicenseAndCollaborationArrangementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3",
     "longName": "995495 - Disclosure - Consolidated Entities and Acquisitions",
     "shortName": "Consolidated Entities and Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:ConsolidatedEntitiesAndAcquisitionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:ConsolidatedEntitiesAndAcquisitionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2",
     "longName": "995505 - Disclosure - Equity and Long-term Investments and Fair Value Measurements",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1",
     "longName": "995515 - Disclosure - Capitalized Fees Paid",
     "shortName": "Capitalized Fees Paid",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:CapitalizedFeesPaidDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:CapitalizedFeesPaidDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3",
     "longName": "995525 - Disclosure - Goodwill and Intangible Assets",
     "shortName": "Goodwill and Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1",
     "longName": "995535 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation",
     "longName": "995545 - Disclosure - Stock-based Compensation",
     "shortName": "Stock-based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1",
     "longName": "995555 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4",
     "longName": "995565 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3",
     "longName": "995575 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3",
     "longName": "995585 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1",
     "longName": "995595 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995605 - Disclosure - Description of Operations and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Description of Operations and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:DescriptionOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:DescriptionOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995615 - Disclosure - Description of Operations and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Description of Operations and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables",
     "longName": "995625 - Disclosure - Net Income Per Share (Tables)",
     "shortName": "Net Income Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables",
     "longName": "995635 - Disclosure - Revenue Recognition (Tables)",
     "shortName": "Revenue Recognition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
     "longName": "995645 - Disclosure - Consolidated Entities and Acquisitions (Tables)",
     "shortName": "Consolidated Entities and Acquisitions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables",
     "longName": "995655 - Disclosure - Equity and Long-term Investments and Fair Value Measurements (Tables)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidTables",
     "longName": "995665 - Disclosure - Capitalized Fees Paid (Tables)",
     "shortName": "Capitalized Fees Paid (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:CapitalizedContractCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "inva:CapitalizedFeesPaidDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:CapitalizedContractCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "inva:CapitalizedFeesPaidDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables",
     "longName": "995675 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables",
     "longName": "995685 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables",
     "longName": "995695 - Disclosure - Stock-based Compensation (Tables)",
     "shortName": "Stock-based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables",
     "longName": "995705 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables",
     "longName": "995715 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables",
     "longName": "995725 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables",
     "longName": "995735 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
     "longName": "995745 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Description of Operations (Details)",
     "shortName": "Description of Operations and Summary of Significant Accounting Policies - Description of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:NumberOfMajorCustomers",
      "unitRef": "U_Customer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:NumberOfMajorCustomers",
      "unitRef": "U_Customer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
     "longName": "995755 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "shortName": "Description of Operations and Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_3f07a2ce-f751-4da5-bf13-5630b4c78ccc",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3f07a2ce-f751-4da5-bf13-5630b4c78ccc",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails",
     "longName": "995765 - Disclosure - Description of Operations and Summary of Significant Accounting Policies - Related Party Transactions (Details)",
     "shortName": "Description of Operations and Summary of Significant Accounting Policies - Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_253ffe46-1c31-4933-9e01-a237c876ecc9",
      "name": "inva:RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "inva:RelatedPartyTransactionsPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
     "longName": "995775 - Disclosure - Net Income Per Share - Basic and Diluted EPS (Details)",
     "shortName": "Net Income Per Share - Basic and Diluted EPS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails",
     "longName": "995785 - Disclosure - Net Income Per Share - Anti-Dilutive Securities (Details)",
     "shortName": "Net Income Per Share - Anti-Dilutive Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
     "longName": "995795 - Disclosure - Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details)",
     "shortName": "Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4a780bf3-f28c-4da5-a3e2-4549be240ce3",
      "name": "inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
     "longName": "995805 - Disclosure - Revenue Recognition - Schedule of net product sales (Details)",
     "shortName": "Revenue Recognition - Schedule of net product sales (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R47": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
     "longName": "995815 - Disclosure - Revenue Recognition (Details)",
     "shortName": "Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_871709ce-1c50-4f9d-87be-84392f7a9aa9",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
     "longName": "995825 - Disclosure - License and Collaboration Arrangements (Additional Information) (Details)",
     "shortName": "License and Collaboration Arrangements (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f4ae3171-8820-4834-b2c2-1c6f94927a5e",
      "name": "inva:FuturePotentialMilestonePayment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
     "longName": "995835 - Disclosure - Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details)",
     "shortName": "Consolidated Entities and Acquisitions - Theravance Respiratory Company, LLC (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_3ad95b16-89e1-4def-b1ad-f62ba899efc6",
      "name": "inva:OwnershipInterestInConsolidatedEntities",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "inva:ConsolidatedEntitiesAndAcquisitionsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3ad95b16-89e1-4def-b1ad-f62ba899efc6",
      "name": "inva:OwnershipInterestInConsolidatedEntities",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "inva:ConsolidatedEntitiesAndAcquisitionsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
     "longName": "995845 - Disclosure - Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details)",
     "shortName": "Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "inva:ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock",
       "div",
       "inva:ConsolidatedEntitiesAndAcquisitionsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
     "longName": "995855 - Disclosure - Consolidated Entities and Acquisitions - ISP Fund LP (Details)",
     "shortName": "Consolidated Entities and Acquisitions - ISP Fund LP (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:Assets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bd235a25-25e3-4774-9cac-f96204385615",
      "name": "us-gaap:LimitedPartnersCumulativeCashDistributions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
     "longName": "995865 - Disclosure - Consolidated Entities and Acquisitions - Summary of Individual Investments Held by ISP Fund (Details)",
     "shortName": "Consolidated Entities and Acquisitions - Summary of Individual Investments Held by ISP Fund (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_99e72674-f063-419d-aa0e-2560370d3aef",
      "name": "inva:MoneyMarketFundAndCash",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99e72674-f063-419d-aa0e-2560370d3aef",
      "name": "inva:MoneyMarketFundAndCash",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
     "longName": "995875 - Disclosure - Consolidated Entities and Acquisitions - Entasis Therapeutics Holdings, Inc. (Details)",
     "shortName": "Consolidated Entities and Acquisitions - Entasis Therapeutics Holdings, Inc. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c5562d91-0351-4acd-8f6f-1aa83d60f185",
      "name": "inva:SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers",
      "unitRef": "U_Director",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
     "longName": "995885 - Disclosure - Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "shortName": "Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:Goodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_278d71cd-49b3-4c8e-85d9-4252a20fd08a",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
     "longName": "995895 - Disclosure - Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details)",
     "shortName": "Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:IncreaseDecreaseInInventories",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8db4f7ae-2913-425a-931f-161ffa81bc43",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
     "longName": "995905 - Disclosure - Consolidated Entities and Acquisitions - Pro Forma Information (Details)",
     "shortName": "Consolidated Entities and Acquisitions - Pro Forma Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_5e46d5ce-f631-4674-8338-9c89eeeb502a",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5e46d5ce-f631-4674-8338-9c89eeeb502a",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
     "longName": "995915 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_a8b3a821-9b16-4dc5-8726-097101dcbe6d",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "us-gaap:DebtInstrumentDescription",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a8b3a821-9b16-4dc5-8726-097101dcbe6d",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "us-gaap:DebtInstrumentDescription",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
     "longName": "995925 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Summarized Financial Data (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Summarized Financial Data (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "inva:ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
     "longName": "995935 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in InCarda (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Equity Investment in InCarda (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_a16a85fb-8e15-45a7-9fef-73333497db42",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_059d5bd5-1649-484e-8e7c-174600b0cb2b",
      "name": "inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee",
      "unitRef": "U_Director",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
     "longName": "995945 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in ImaginAb (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Equity Investment in ImaginAb (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c3e70cef-b906-408c-8288-908907c15a65",
      "name": "inva:TransactionCostsIncurredInConnectionWithEquityInvestment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
     "longName": "995955 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neurosciences (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neurosciences (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:PaymentsToAcquireLongtermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5113ca40-db4d-493a-87c2-9a406e584ece",
      "name": "inva:NumberOfCommonStockIssuedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
     "longName": "995965 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Nanolive (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Nanolive (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_bed4dd91-bb02-4b5d-a15b-d83a06470288",
      "name": "inva:EquityInvestmentTransactionCostsIncurred",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bed4dd91-bb02-4b5d-a15b-d83a06470288",
      "name": "inva:EquityInvestmentTransactionCostsIncurred",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails",
     "longName": "995975 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Reconciliation of Equity and Long - Term Investments Balances (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Reconciliation of Equity and Long - Term Investments Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails",
     "longName": "995985 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Available-for-Sale Securities (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Available-for-Sale Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
     "longName": "995995 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:ContingentValueRightsLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_206853b6-d741-4c50-9285-74ba6833daf1",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails",
     "longName": "996005 - Disclosure - Equity and Long-term Investments and Fair Value Measurements - (Additional Information) (Details)",
     "shortName": "Equity and Long-term Investments and Fair Value Measurements - (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
     "longName": "996015 - Disclosure - Capitalized Fees Paid - Schedule of Capitalized Fees Paid (Details)",
     "shortName": "Capitalized Fees Paid - Schedule of Capitalized Fees Paid (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:CapitalizedContractCostGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CapitalizedContractCostTableTextBlock",
       "div",
       "inva:CapitalizedFeesPaidDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:CapitalizedContractCostAccumulatedAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CapitalizedContractCostTableTextBlock",
       "div",
       "inva:CapitalizedFeesPaidDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
     "longName": "996025 - Disclosure - Goodwill and Intangible Assets (Additional Information) (Details)",
     "shortName": "Goodwill and Intangible Assets (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:Goodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3",
     "longName": "996035 - Disclosure - Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details)",
     "shortName": "Goodwill and Intangible Assets - Summary of Accumulated Amortization of Recognized Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:IntangibleAssetsMarketedProductsGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:IntangibleAssetsMarketedProductsGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails",
     "longName": "996045 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)",
     "shortName": "Balance Sheet Components - Schedule of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
     "longName": "996055 - Disclosure - Balance Sheet Components (Additional Information) (Details)",
     "shortName": "Balance Sheet Components (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_de99671a-3f86-4f93-b929-187c53e350a3",
      "name": "inva:BusinessCombinationDeferredConsideration",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c9475aee-0427-4f76-b24b-da8950b70256",
      "name": "inva:FairValueAdjustmentsOfInventoryFromAcquistion",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails",
     "longName": "996065 - Disclosure - Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details)",
     "shortName": "Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:AccruedContractManufacturingLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:AccruedContractManufacturingLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails",
     "longName": "996075 - Disclosure - Balance Sheet Components -Schedule of Other Long-term Liabilities (Details)",
     "shortName": "Balance Sheet Components -Schedule of Other Long-term Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:DeferredRoyaltyObligationNonCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "inva:DeferredRoyaltyObligationNonCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails",
     "longName": "996085 - Disclosure - Stock-based Compensation - 2012 Plan and ESPP (Details)",
     "shortName": "Stock-based Compensation - 2012 Plan and ESPP (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_631eb718-8626-432d-96fb-8270d3650dfb",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_631eb718-8626-432d-96fb-8270d3650dfb",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails",
     "longName": "996095 - Disclosure - Stock-based Compensation - Director Compensation Program (Details)",
     "shortName": "Stock-based Compensation - Director Compensation Program (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8",
      "name": "inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8",
      "name": "inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails",
     "longName": "996105 - Disclosure - Stock-based Compensation - Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-based Compensation - Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
     "longName": "996115 - Disclosure - Stock-based Compensation - Compensation Awards (Details)",
     "shortName": "Stock-based Compensation - Compensation Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_102e5069-9631-4b2b-b6f6-629950c6ca80",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_14b4daa5-0e7f-4451-94b3-65b08a6e2379",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails",
     "longName": "996125 - Disclosure - Stock-based Compensation - Valuation Assumptions (Details)",
     "shortName": "Stock-based Compensation - Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_4c6c9a98-3708-403b-b3e3-41b376c009ab",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4c6c9a98-3708-403b-b3e3-41b376c009ab",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
     "longName": "996135 - Disclosure - Stockholders' Equity (Additional Information) (Details)",
     "shortName": "Stockholders' Equity (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_75144e9c-8d8d-4067-a64b-e8ba0c236ce0",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
     "longName": "996145 - Disclosure - Debt - Schedule of Debt (Details)",
     "shortName": "Debt - Schedule of Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_985e040f-be7e-4757-85fe-32dfd0c9e971",
      "name": "inva:RoyaltyAgreementMaximumPotentialPayoutPercent",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
     "longName": "996155 - Disclosure - Debt - Convertible Subordinated Notes (Details)",
     "shortName": "Debt - Convertible Subordinated Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RepaymentsOfUnsecuredDebt",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f0562001-bb86-4a5b-b298-0510200a8220",
      "name": "us-gaap:DebtInstrumentRepurchaseAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
     "longName": "996165 - Disclosure - Debt - Convertible Senior Notes (Details)",
     "shortName": "Debt - Convertible Senior Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RepaymentsOfUnsecuredDebt",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6c32ce61-be0a-4a4a-a440-b6d704139bad",
      "name": "inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails",
     "longName": "996175 - Disclosure - Debt - Debt Maturities (Details)",
     "shortName": "Debt - Debt Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "996185 - Disclosure - Commitments and Contingencies (Additional Information) (Details)",
     "shortName": "Commitments and Contingencies (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails",
     "longName": "996195 - Disclosure - Commitments and Contingencies - Schedule of Components of Least Cost (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Components of Least Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails",
     "longName": "996205 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Lease (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Lease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3",
     "longName": "996215 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails",
     "longName": "996225 - Disclosure - Income Taxes - Income tax expense (Details)",
     "shortName": "Income Taxes - Income tax expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails",
     "longName": "996235 - Disclosure - Income Taxes - Reconciliation (Details)",
     "shortName": "Income Taxes - Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3",
     "longName": "996245 - Disclosure - Income Taxes - Deferred Taxes (Details)",
     "shortName": "Income Taxes - Deferred Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "996255 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails",
     "longName": "996265 - Disclosure - Income Taxes - Summary of Changes in Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Summary of Changes in Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_72e33bb8-0153-4002-8937-baf8a5118573",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
     "longName": "996275 - Disclosure - Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details)",
     "shortName": "Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails",
     "longName": "996285 - Disclosure - Segment Reporting (Additional Information) (Details)",
     "shortName": "Segment Reporting (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_751227a8-ff5f-4419-bc20-3ffdd5766392",
      "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inva-20241231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202006Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASU 2020-06",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ]
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdateExtensibleList",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "documentation": "Indicates amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r277",
      "r278",
      "r279",
      "r356",
      "r357",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r449",
      "r450",
      "r458",
      "r629",
      "r630",
      "r631",
      "r632",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r667",
      "r668",
      "r669",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r704",
      "r705",
      "r721",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r1267"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Payable, Current, Total",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1078"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Total",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r987",
      "r1101",
      "r1417",
      "r1418"
     ]
    },
    "inva_AccruedClinicalAndResearchLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedClinicalAndResearchLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued clinical and research expenses",
        "label": "Accrued Clinical and Research Liability",
        "documentation": "Accrued clinical and research liability."
       }
      }
     },
     "auth_ref": []
    },
    "inva_AccruedContractManufacturingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedContractManufacturingLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued contract manufacturing liability.",
        "label": "Accrued Contract Manufacturing Liability",
        "terseLabel": "Accrued contract manufacturing expenses"
       }
      }
     },
     "auth_ref": []
    },
    "inva_AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued excise tax on common stock repurchase applied against tax liability",
        "label": "Accrued Excise Tax On Common Stock Repurchase Applied Against Tax Liability",
        "documentation": "Accrued excise tax on common stock repurchase applied against tax liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income tax payable, long-term",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r183"
     ]
    },
    "inva_AccruedInterestIncomeIncludedInLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedInterestIncomeIncludedInLongTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Interest Income Included in Long-term Investments",
        "documentation": "Accrued interest income included in long-term investments.",
        "terseLabel": "Accrued interest income converted to long-term investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities",
        "totalLabel": "Total other accrued liabilities",
        "terseLabel": "Other accrued liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "inva_AccruedLicenseFeesAndRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedLicenseFeesAndRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued license fees and royalties",
        "label": "Accrued License Fees and Royalties",
        "terseLabel": "Accrued license fees and royalties"
       }
      }
     },
     "auth_ref": []
    },
    "inva_AccruedProfessionalServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedProfessionalServices",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Professional Services",
        "label": "Accrued Professional Services",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedRoyaltiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty obligation payable",
        "label": "Accrued Royalties, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1010"
     ]
    },
    "inva_AccruedRoyaltyObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AccruedRoyaltyObligations",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Obligation to pay royalties",
        "label": "Accrued Royalty Obligations",
        "documentation": "Obligations incurred through that date and payable for royalties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetResidualValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Asset, Residual Value",
        "documentation": "Amount of residual value of finite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes financial asset."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r1002"
     ]
    },
    "us-gaap_AcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Oil and Gas, Full Cost Method, Capitalized Cost Excluded from Amortization, Acquisition Cost, Period Cost",
        "terseLabel": "Acquisition-related costs",
        "documentation": "Amount of capitalized acquisition cost incurred during period and excluded from amortization for oil- and gas-producing activities accounted for under full cost method. Excludes exploration and development costs and capitalized interest."
       }
      }
     },
     "auth_ref": [
      "r1413",
      "r1414"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1162"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r1264",
      "r1265",
      "r1266",
      "r1268",
      "r1383",
      "r1453"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r277",
      "r278",
      "r279",
      "r280",
      "r290",
      "r356",
      "r357",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r449",
      "r450",
      "r458",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r704",
      "r705",
      "r720",
      "r721",
      "r722",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r790",
      "r791",
      "r792",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "terseLabel": "Conversion of convertible subordinated notes due 2023",
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r163",
      "r627"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Capped call options associated with convertible senior notes due 2028",
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "inva_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capped call options associated with convertible senior notes due 2028 (in shares)",
        "label": "Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt in Shares",
        "documentation": "Adjustments to additional paid in capital equity component of convertible debt in shares."
       }
      }
     },
     "auth_ref": []
    },
    "inva_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation (in shares)",
        "documentation": "Adjustments to additional paid in capital share based compensation requisite service period recognition shares.",
        "label": "Adjustments To Additional Paid In Capital Share based Compensation Requisite Service Period Recognition Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65",
      "r550"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1220"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1144",
      "r1154",
      "r1187"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1147",
      "r1157",
      "r1190"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1182",
      "r1191",
      "r1195",
      "r1203"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1201"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r592"
     ]
    },
    "inva_AmendedZaiAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AmendedZaiAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amended Zai Agreement [Member]",
        "documentation": "Amended Zai Agreement.",
        "terseLabel": "Amended Zai Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "inva_AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of capitalized fees and depreciation of property and equipment.",
        "label": "Amortization of Capitalized Fees and Depreciation of Property and Equipment",
        "terseLabel": "Amortization of capitalized fees and depreciation of property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r137",
      "r501",
      "r1397"
     ]
    },
    "inva_AmortizationOfFairValueAdjustmentsOfCostOfProductsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AmortizationOfFairValueAdjustmentsOfCostOfProductsSold",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of fair value adjustments of cost of products sold.",
        "label": "Amortization of Fair Value Adjustments of Cost of Products Sold",
        "terseLabel": "Amortization of fair value adjustments of Cost of products sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r501",
      "r1259",
      "r1397"
     ]
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance costs",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r1044",
      "r1045",
      "r1259",
      "r1397"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets",
        "verboseLabel": "Amortization expense",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r436",
      "r443",
      "r1040"
     ]
    },
    "inva_AmortizationOfInventoryFairValueAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AmortizationOfInventoryFairValueAdjustmentsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of inventory fair value adjustments",
        "label": "Amortization of Inventory Fair Value Adjustments[Member]",
        "documentation": "Amortization of inventory fair value adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "inva_AmountOnNetProductSalesRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AmountOnNetProductSalesRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount on net product sales recognized",
        "label": "Amount on Net Product Sales Recognized",
        "documentation": "Amount on net product sales recognized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities (in shares)",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Anti-Dilutive Securities",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of Real Estate Property",
        "terseLabel": "Lease space",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ArmataConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ArmataConvertibleNoteMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Armata Convertible Note",
        "label": "Armata Convertible Note [Member]",
        "documentation": "Armata convertible note member."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ArmataJulyTwoThousandTwentyThreeTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ArmataJulyTwoThousandTwentyThreeTermLoanMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Armata July Two Thousand Twenty Three Term Loan [Member]",
        "documentation": "Armata july two thousand twenty three term loan.",
        "terseLabel": "Armata July Two Thousand Twenty Three Term Loan",
        "verboseLabel": "Armata July 2023 Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ArmataMarchTwoThousandTwentyFourTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ArmataMarchTwoThousandTwentyFourTermLoanMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Armata March Two Thousand Twenty Four Term Loan [Member]",
        "documentation": "Armata march two thousand twenty four term loan.",
        "terseLabel": "Armata March Two Thousand Twenty Four Term Loan",
        "verboseLabel": "Armata March 2024 Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ArmataPharmaceuticalsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ArmataPharmaceuticalsIncMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections.",
        "label": "Armata Pharmaceuticals Inc [Member]",
        "terseLabel": "Armata"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ArmataTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ArmataTermLoanMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Armata Term Loan",
        "label": "Armata Term Loan [Member]",
        "documentation": "Armata term loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r201",
      "r233",
      "r268",
      "r315",
      "r322",
      "r343",
      "r347",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r661",
      "r665",
      "r708",
      "r835",
      "r928",
      "r1029",
      "r1030",
      "r1078",
      "r1111",
      "r1330",
      "r1331",
      "r1404"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r242",
      "r268",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r661",
      "r665",
      "r708",
      "r1078",
      "r1330",
      "r1331",
      "r1404"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets measured at estimated fair value",
        "totalLabel": "Assets, Fair Value Disclosure, Total",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r1065"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Assets, Noncurrent, Total",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r661",
      "r665",
      "r708",
      "r1330",
      "r1331",
      "r1404"
     ]
    },
    "inva_AstrazenecaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "AstrazenecaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AstraZeneca",
        "label": "AstraZeneca [Member]",
        "documentation": "AstraZeneca."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117",
      "r1140"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117",
      "r1140"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117",
      "r1140"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1224"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r410",
      "r834"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Securities, Available-for-sale, Total",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r410",
      "r692",
      "r825",
      "r1065",
      "r1069",
      "r1281",
      "r1387",
      "r1388",
      "r1389"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1198"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1199"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1197"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1196"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1195"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r1195"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r1420",
      "r1421"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r457",
      "r1420",
      "r1421"
     ]
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Information"
       }
      }
     },
     "auth_ref": []
    },
    "inva_BasileaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BasileaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basilea [Member]",
        "documentation": "Basilea.",
        "terseLabel": "Basilea"
       }
      }
     },
     "auth_ref": []
    },
    "inva_BurlingameCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BurlingameCaliforniaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Burlingame, California.",
        "label": "Burlingame California [Member]",
        "terseLabel": "Burlingame, California"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r650",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r650",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Pro Forma Information",
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate."
       }
      }
     },
     "auth_ref": [
      "r1232",
      "r1233"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Acquisition share price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "inva_BusinessAcquisitionsOfChangeInFairValueOfInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessAcquisitionsOfChangeInFairValueOfInvestment",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisitions of change in fair value of investment.",
        "label": "Business Acquisitions of Change in Fair Value of Investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income",
        "verboseLabel": "Business acquisition, net loss",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r649"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r649"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Total consideration paid",
        "terseLabel": "Total consideration paid",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r12"
     ]
    },
    "inva_BusinessCombinationDeferredConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessCombinationDeferredConsideration",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination deferred consideration",
        "label": "Business Combination Deferred Consideration",
        "documentation": "Business combination deferred consideration."
       }
      }
     },
     "auth_ref": []
    },
    "inva_BusinessCombinationIndemnificationAssetsUsedForProduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessCombinationIndemnificationAssetsUsedForProduction",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Indemnification Assets Used For Production",
        "documentation": "Business combination, indemnification assets used for production.",
        "terseLabel": "Business combination indemnification assets used for production"
       }
      }
     },
     "auth_ref": []
    },
    "inva_BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessCombinationLetterAgreementForPurchaseAndUsedForProduction",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination letter agreement for purchase and used for production",
        "label": "Business Combination Letter Agreement For Purchase And Used For Production",
        "documentation": "Business combination letter agreement for purchase and used for production."
       }
      }
     },
     "auth_ref": []
    },
    "inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued personnel-related expenses due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Personnel- Related Expenses",
        "terseLabel": "Accrued personnel-related expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "'Total assets acquired",
        "documentation": "Amount of assets acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Short-term marketable securities",
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets",
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Intangible assets",
        "verboseLabel": "Intangible assets pertain to product rights and developed technologies",
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed",
        "documentation": "Amount of liabilities assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total assets acquired, net",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "totalLabel": "Other assets",
        "terseLabel": "Other assets",
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities",
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed operating lease right-of-use assets.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right-of-Use Assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "inva_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed other accrued liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "totalLabel": "Property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combination",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175"
     ]
    },
    "us-gaap_CallOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CallOptionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Call Option [Member]",
        "terseLabel": "Stock prices below $27.79 per share",
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973"
     ]
    },
    "us-gaap_CapitalizedContractCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedContractCostAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization",
        "documentation": "Amount of accumulated amortization of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r1303"
     ]
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost, Amortization",
        "verboseLabel": "Amortization expense",
        "terseLabel": "Amortization of capitalized fees paid",
        "negatedLabel": "Less: amortization of capitalized fees paid",
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_CapitalizedContractCostGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostGross",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost, Gross",
        "terseLabel": "Milestone fees paid",
        "verboseLabel": "Gross carrying value",
        "documentation": "Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r1303"
     ]
    },
    "us-gaap_CapitalizedContractCostLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost [Line Items]",
        "terseLabel": "Capitalized Fees paid",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_CapitalizedContractCostNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost, Net",
        "totalLabel": "Net carrying value",
        "terseLabel": "Capitalized fees paid, net",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_CapitalizedContractCostTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost [Table]",
        "documentation": "Disclosure of information about cost capitalized in obtaining or fulfilling contract with customer."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_CapitalizedContractCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Contract Cost [Table Text Block]",
        "terseLabel": "Schedule of Capitalized Fees Paid",
        "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer."
       }
      }
     },
     "auth_ref": [
      "r1302"
     ]
    },
    "inva_CapitalizedFeePaidEstimatedUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeePaidEstimatedUsefulLife",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized fee paid estimated useful life.",
        "label": "Capitalized Fee Paid Estimated Useful Life",
        "terseLabel": "Capitalized fees paid, estimated useful life"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaid1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about capitalized fees paid.",
        "label": "Capitalized Fees Paid Disclosure [Text Block]",
        "terseLabel": "CAPITALIZED FEES PAID"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidFutureAmortizationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidFutureAmortizationAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized fees paid future amortization.",
        "label": "Capitalized Fees Paid Future Amortization [Abstract]",
        "terseLabel": "Capitalized Fees paid, Future amortization"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized fees paid.",
        "label": "Capitalized Fees Paid [Policy Text Block]",
        "terseLabel": "Capitalized Fees Paid"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated amortization for assets expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capitalized Fees Paid Remaining Estimated Amortization After Year Five",
        "terseLabel": "Estimated amortization after 2029"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Fees Paid Remaining Estimated Amortization Next Twelve Months",
        "documentation": "Amount of estimated amortization for assets expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "terseLabel": "Estimated amortization for the year 2025"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated amortization for assets expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capitalized Fees Paid Remaining Estimated Amortization Year Five",
        "terseLabel": "Estimated amortization for the year 2029"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated amortization for assets expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capitalized Fees Paid Remaining Estimated Amortization Year Four",
        "terseLabel": "Estimated amortization for the year 2028"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Fees Paid Remaining Estimated Amortization Year Two",
        "documentation": "Amount of estimated amortization for assets expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "terseLabel": "Estimated amortization for the year 2026"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated amortization for assets expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Capitalized Fees Paid Remaining Estimated Amortization YearThree",
        "terseLabel": "Estimated amortization for the year 2027"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidToRelatedPartyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidToRelatedPartyPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for capitalized fees paid to a related party.",
        "label": "Capitalized Fees Paid To A Related Party [Policy Text Block]",
        "terseLabel": "Capitalized Fees Paid"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CapitalizedFeesPaidWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CapitalizedFeesPaidWeightedAverageUsefulLife",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized fees paid weighted average useful life.",
        "label": "Capitalized Fees Paid Weighted Average Useful Life",
        "terseLabel": "Weighted average remaining amortization period"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CarryingValueWroteOffWarrantExercise": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CarryingValueWroteOffWarrantExercise",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value wrote off warrant exercise",
        "label": "Carrying Value Wrote off Warrant Exercise",
        "documentation": "Carrying value wrote off warrant exercise."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired through the consolidation of Entasis",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash balance",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r228",
      "r1007"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Total cash, cash equivalents and restricted cash at end of period shown in the consolidated statements of cash flows",
        "totalLabel": "Total cash, cash equivalents and restricted cash at end of period shown in the condensed consolidated statements of cash flows",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r145",
      "r265"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r145"
     ]
    },
    "inva_CashDistributionReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CashDistributionReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash distribution received.",
        "label": "Cash Distribution Received",
        "terseLabel": "Cash distribution"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for the acquisition of La Jolla Pharmaceutical Company, net of cash acquired.",
        "label": "Cash Paid for the Acquisition of La Jolla Pharmaceutical Company, Net of Cash Acquired",
        "negatedLabel": "Cash paid for the acquisition of La Jolla, net of cash acquired"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes to noncontrolling interest from a consolidated variable interest entity.",
        "label": "Changes to noncontrolling interest from a consolidated variable interest entity",
        "terseLabel": "Equity activity of noncontrolling interest in a consolidated variable interest entity"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity activity of noncontrolling interests in a consolidated variable interest entity (in shares)",
        "label": "Changes To Noncontrolling Interest From A Consolidated Variable Interest Entity Shares",
        "documentation": "Changes to noncontrolling interest from a consolidated variable interest entity shares."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1170"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1168"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ClaimExpirationDate": {
     "xbrltype": "gYearMonthItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ClaimExpirationDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claim expiration date.",
        "label": "Claim Expiration Date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfTreasuryStockTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Treasury Stock [Table]",
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants",
        "verboseLabel": "Exercise price of warrants",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "inva_ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical development and regulatory milestones amount payable.",
        "label": "Clinical Development And Regulatory Milestones Amount Payable",
        "terseLabel": "Clinical development and regulatory milestones amount payable"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "inva_CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the royalty rate for combination products.",
        "label": "Collaborative Arrangement Annual Royalties as Percentage of Net Sales for Combination Products",
        "terseLabel": "Royalty rate for combination products (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaboration agreement",
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "inva_CollaborativeArrangementRoyaltyRateDefinedLevelOne": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CollaborativeArrangementRoyaltyRateDefinedLevelOne",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the royalty rate which the entity will receive under the collaboration agreement on the first defined level of annual global net sales.",
        "label": "Collaborative Arrangement, Royalty Rate Defined, Level One",
        "terseLabel": "Royalty rate for first level of annual global net sales (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CollaborativeArrangementRoyaltyRateDefinedLevelTwo": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CollaborativeArrangementRoyaltyRateDefinedLevelTwo",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the royalty rate which the entity will receive under the collaboration agreement on sales which exceed the first defined level of annual global net sales.",
        "label": "Collaborative Arrangement, Royalty Rate Defined, Level Two",
        "terseLabel": "Royalty rate for sales above first level of annual global net sales (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the annual global net sales amount which determines the royalty rate applied under the collaboration arrangement.",
        "label": "Collaborative Arrangement, Specified Sales Level for Determining Royalty Rate",
        "terseLabel": "Annual global sales level used to determine royalty rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "inva_CollaborativeArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CollaborativeArrangementsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from collaborative arrangements",
        "documentation": "Represents information pertaining to collaborative arrangements.",
        "label": "Collaborative Arrangements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CommercialSupplyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CommercialSupplyAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial supply agreement.",
        "label": "Commercial Supply Agreement [Member]",
        "terseLabel": "Commercial Supply Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies (Note 13)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r187",
      "r839",
      "r914"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingencies3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r460",
      "r461",
      "r989",
      "r1321",
      "r1326"
     ]
    },
    "inva_CommitmentsFor2024ToBeUtilizedIn2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CommitmentsFor2024ToBeUtilizedIn2025Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments for 2024 to be utilized in 2025 [Member]",
        "label": "Commitments for 2024 to be utilized in 2025 [Member]",
        "documentation": "Commitments for 2024 to be utilized in 2025."
       }
      }
     },
     "auth_ref": []
    },
    "inva_CommonStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CommonStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Acquired Average Cost Per Share",
        "label": "Common Stock Acquired Average Cost Per Share",
        "terseLabel": "Shares repurchased average price per share"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CommonStockAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CommonStockAndWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to common stock and warrants.",
        "label": "Common Stock And Warrants [Member]",
        "terseLabel": "Common stock and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1098",
      "r1099",
      "r1100",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1264",
      "r1265",
      "r1268",
      "r1383",
      "r1451",
      "r1453"
     ]
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]",
        "terseLabel": "Common stock - Publicly traded healthcare companies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r915"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Common Stock, Shares, Issued, Total",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r119",
      "r915",
      "r934",
      "r1453",
      "r1454"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "totalLabel": "Common Stock, Value, Issued, Total",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $0.01 par value, 200,000 shares authorized, 62,665 and 63,307 issued and outstanding as of December 31, 2024 and 2023 respectively",
        "verboseLabel": "Common stock",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r841",
      "r1078"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r1179"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r1178"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r1180"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r1177"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of deferred tax assets and deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Innoviva stockholders",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r244",
      "r246",
      "r254",
      "r828",
      "r855",
      "r857"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income attributable to noncontrolling interests",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r73",
      "r86",
      "r244",
      "r246",
      "r253",
      "r827",
      "r855",
      "r856"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r178",
      "r244",
      "r246",
      "r252",
      "r826",
      "r855"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r38",
      "r93",
      "r94",
      "r355",
      "r988"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r38",
      "r93",
      "r94",
      "r355",
      "r887",
      "r988"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r38",
      "r93",
      "r94",
      "r355",
      "r988",
      "r1231"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and of Significant Suppliers and Partners",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r210"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r38",
      "r93",
      "r94",
      "r355"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r38",
      "r93",
      "r94",
      "r355",
      "r988"
     ]
    },
    "inva_ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConsolidatedEntitiesAndAcquisitionsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated entities and acquisitions disclosure abstract.",
        "label": "Consolidated Entities and Acquisitions Disclosure Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConsolidatedEntitiesAndAcquisitionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConsolidatedEntitiesAndAcquisitionsLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated entities and acquisitions.",
        "label": "Consolidated Entities and Acquisitions [Line Items]",
        "terseLabel": "Consolidated Entities and Acquisitions [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConsolidatedEntitiesAndAcquisitionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConsolidatedEntitiesAndAcquisitionsTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitions3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated entities and acquisitions text block.",
        "label": "Consolidated Entities and Acquisitions [Text Block]",
        "terseLabel": "CONSOLIDATED ENTITIES AND ACQUISITIONS"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r661",
      "r662",
      "r665",
      "r666",
      "r749",
      "r994",
      "r1329",
      "r1332",
      "r1333"
     ]
    },
    "inva_ConsolidatedEntitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConsolidatedEntitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Consolidated Entities"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r661",
      "r662",
      "r665",
      "r666",
      "r749",
      "r994",
      "r1329",
      "r1332",
      "r1333"
     ]
    },
    "inva_ConsolidatedInvesteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConsolidatedInvesteesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated investees.",
        "label": "Consolidated Investees [Member]",
        "terseLabel": "Consolidated Investees [Member]",
        "verboseLabel": "Consolidated Investees"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r272",
      "r315",
      "r324",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r468",
      "r469",
      "r470",
      "r471",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r1029",
      "r1030",
      "r1330",
      "r1331"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r272",
      "r315",
      "r324",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r468",
      "r469",
      "r470",
      "r471",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r1029",
      "r1030",
      "r1330",
      "r1331"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r1017"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r78",
      "r80"
     ]
    },
    "inva_ContingentSalesBasedMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ContingentSalesBasedMilestonePayment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent sales based milestone payment.",
        "label": "Contingent Sales Based Milestone Payment",
        "terseLabel": "Contingent sales based milestone payment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ContingentValueRightsLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ContingentValueRightsLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent value rights liability",
        "label": "Contingent value rights liability",
        "terseLabel": "Contingent value rights liability",
        "verboseLabel": "Contingent value rights"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "2028 Notes",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible debt investment",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r480",
      "r481",
      "r491",
      "r492",
      "r493",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Summary of Liability and Equity Components of Convertible Notes",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertibleNoteAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertibleNoteAndWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible note and warrants.",
        "label": "Convertible Note and Warrants [Member]",
        "terseLabel": "In Carda Convertible Note",
        "verboseLabel": "Convertible note and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertable promissory note",
        "label": "Convertible Promissory Note [Member]",
        "documentation": "Convertible promissory note member."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNotePurchaseAgreementAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNotePurchaseAgreementAmendmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Purchase Agreement Amendment [Member]",
        "documentation": "Convertible promissory note purchase agreement amendment.",
        "terseLabel": "Convertible Promissory Note Purchase Agreement Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Purchase Agreement Fifth Amendment [Member]",
        "documentation": "Convertible promissory note purchase agreement fifth amendment.",
        "terseLabel": "Convertible Promissory Note Purchase Agreement Fifth Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Purchase Agreement Fourth Amendment [Member]",
        "documentation": "Convertible promissory note purchase agreement fourth amendment.",
        "terseLabel": "Convertible Promissory Note Purchase Agreement Fourth Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNotePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNotePurchaseAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Purchase Agreement [Member]",
        "documentation": "Convertible promissory note purchase agreement [Member]",
        "terseLabel": "Convertible Promissory Note Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Purchase Agreement Second Amendment [Member]",
        "documentation": "Convertible promissory note purchase agreement second amendment.",
        "terseLabel": "Convertible Promissory Note Purchase Agreement Second Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Purchase Agreement Third Amendment [Member]",
        "documentation": "Convertible promissory note purchase agreement third amendment.",
        "terseLabel": "Convertible Promissory Note Purchase Agreement Third Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertibleSeniorDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertibleSeniorDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of long-term notes which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock. Senior debt has the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment.",
        "label": "Convertible Senior Debt, Fair Value Disclosures",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ConvertibleSubordinatedDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ConvertibleSubordinatedDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of subordinated debt obligations which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Subordinated Debt, Fair Value Disclosures",
        "terseLabel": "2023 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleSubordinatedDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleSubordinatedDebtMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Subordinated Debt [Member]",
        "terseLabel": "Convertible subordinated notes",
        "documentation": "Debt that places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "inva_CordenPharmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CordenPharmaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corden Pharma [Member]",
        "documentation": "Corden Pharma.",
        "terseLabel": "Corden Pharma [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets)",
        "label": "Cost of Goods and Services Sold",
        "totalLabel": "Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding depreciation and amortization of intangible assets)",
        "verboseLabel": "Cost of products sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r788"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of license revenue",
        "label": "Cost of Revenue",
        "totalLabel": "Cost of Revenue, Total",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r268",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r708",
      "r1029",
      "r1330"
     ]
    },
    "inva_CostReimbursementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CostReimbursementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost Reimbursement",
        "label": "Cost Reimbursement [Member]",
        "documentation": "Cost reimbursement."
       }
      }
     },
     "auth_ref": []
    },
    "inva_CostReimbursements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CostReimbursements",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost reimbursements",
        "label": "Cost Reimbursements",
        "documentation": "Cost reimbursements"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of capped calls in connection with convertible senior notes due 2028",
        "label": "Cost To Enter Into Capped Calls Sales In Connection With Convertible Senior Notes",
        "documentation": "Cost to enter into capped calls sales in connection with convertible senior notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total expenses, net",
        "label": "Costs and Expenses",
        "verboseLabel": "Operating expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r483",
      "r514",
      "r748",
      "r770",
      "r832",
      "r1014",
      "r1016"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "inva_CreditAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CreditAndSecurityAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit and Security Agreement",
        "label": "Credit and Security Agreement [Member]",
        "documentation": "Credit and security agreement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative effect period of adoption adjustment member"
       }
      }
     },
     "auth_ref": [
      "r220",
      "r276",
      "r283",
      "r290",
      "r398",
      "r404",
      "r450",
      "r628",
      "r629",
      "r642",
      "r644",
      "r670",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r683",
      "r686",
      "r688",
      "r689",
      "r743"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "auth_ref": [
      "r220",
      "r276",
      "r283",
      "r290",
      "r398",
      "r404",
      "r450",
      "r628",
      "r629",
      "r642",
      "r644",
      "r670",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r683",
      "r686",
      "r688",
      "r689",
      "r743"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "auth_ref": [
      "r220",
      "r276",
      "r283",
      "r290",
      "r398",
      "r404",
      "r450",
      "r628",
      "r629",
      "r642",
      "r644",
      "r670",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r683",
      "r686",
      "r688",
      "r689",
      "r743"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1235",
      "r1262",
      "r1378"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r1262"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CurrentPortionOfISPFundInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CurrentPortionOfISPFundInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Portion Of ISP Fund Investments",
        "documentation": "Current portion of ISP Fund investments",
        "terseLabel": "Current portion of ISP Fund investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1235",
      "r1262",
      "r1378"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r355"
     ]
    },
    "inva_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer one.",
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CustomerThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CustomerThreeMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer three.",
        "label": "Customer Three [Member]",
        "terseLabel": "Customer Three"
       }
      }
     },
     "auth_ref": []
    },
    "inva_CustomerTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "CustomerTwoMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer two.",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer Two"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1125",
      "r1214"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1125",
      "r1214"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1127",
      "r1216"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1127",
      "r1216"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1218"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1127",
      "r1216"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1120",
      "r1209"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1121",
      "r1210"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1121",
      "r1210"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1208"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1208"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1208"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1122",
      "r1211"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1124",
      "r1213"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1124",
      "r1213"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1125",
      "r1214"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1217"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1126",
      "r1215"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1123",
      "r1212"
     ]
    },
    "inva_DebtConversionCommonStockPriceToConversionPriceRatioPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtConversionCommonStockPriceToConversionPriceRatioPercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of common stock price as a percentage of conversion price.",
        "label": "Debt Conversion, Common Stock Price to Conversion Price Ratio, Percentage",
        "terseLabel": "Common stock price to current conversion price ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Notes converted into common stock, Amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32"
     ]
    },
    "inva_DebtConversionConvertedInstrumentAverageTradePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtConversionConvertedInstrumentAverageTradePricePercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average trading price per $1,000 of Notes with respect to product of the closing common stock price and the conversion rate",
        "label": "Debt Conversion, Converted Instrument, Average Trade Price Percentage",
        "terseLabel": "Average trading price percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32"
     ]
    },
    "us-gaap_DebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Current portion of long-term debt, net",
        "totalLabel": "Debt, Current, Total",
        "label": "Debt, Current",
        "negatedLabel": "Less: Current portion of long-term debt, net",
        "verboseLabel": "Convertible notes, due 2025, net of issuance costs",
        "documentation": "Amount of debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebt4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "DEBT",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r266",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r466",
      "r467",
      "r479",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r495",
      "r502",
      "r503",
      "r505",
      "r718"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r106",
      "r107",
      "r182",
      "r186",
      "r272",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1076",
      "r1260",
      "r1322",
      "r1323",
      "r1324",
      "r1396",
      "r1398"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total",
        "verboseLabel": "Principal amount",
        "terseLabel": "Total purchase price",
        "netLabel": "Total debt",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r186",
      "r506"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Equity component, net",
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "inva_DebtInstrumentConvertibleConversionPremium": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtInstrumentConvertibleConversionPremium",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage above the last reported sale price of the Company's common stock.",
        "label": "Debt Instrument, Convertible, Conversion Premium",
        "terseLabel": "Conversion premium (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (dollars per share)",
        "verboseLabel": "Conversion price of convertible notes into common stock (in dollars per share)",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r482"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion rate for shares of common stock per $1,000 principal",
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r110",
      "r161",
      "r162",
      "r482"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, description",
        "label": "Debt Instrument, Description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r55",
      "r100",
      "r106",
      "r182",
      "r186",
      "r718"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Convertible notes face value",
        "verboseLabel": "Loan amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r718",
      "r719",
      "r1042",
      "r1043",
      "r1076"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure",
        "totalLabel": "Total fair value of debt",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r707",
      "r1042",
      "r1043",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate",
        "verboseLabel": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r509",
      "r718",
      "r719",
      "r1076"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Debt Instrument, annual interest rate",
        "terseLabel": "Debt Instrument, annual interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r481"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1076",
      "r1260",
      "r1396",
      "r1398"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument maturity date",
        "label": "Debt Instrument, Maturity Date",
        "verboseLabel": "Debt instrument maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r1041",
      "r1388",
      "r1389"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r272",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1076",
      "r1260",
      "r1322",
      "r1323",
      "r1324",
      "r1396",
      "r1398"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Principal Payment",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "inva_DebtInstrumentPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtInstrumentPrincipalAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Principal Amount",
        "label": "Debt Instrument Principal Amount",
        "terseLabel": "Total debt",
        "verboseLabel": "Principal"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Ratio of repurchase price to the principal amount of debt instrument to be repurchased in the event of default or a fundamental change.",
        "label": "Debt Instrument, Ratio of repurchase price to the principal amount",
        "terseLabel": "Ratio of repurchase price to the principal amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Debt instrument principal amount percentage",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "inva_DebtInstrumentRemainingBalancePaidUponMaturation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtInstrumentRemainingBalancePaidUponMaturation",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Remaining Balance Paid upon Maturation",
        "documentation": "Debt instrument remaining balance paid upon maturation.",
        "terseLabel": "Remaining balance paid upon maturation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRepurchaseAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Portion of debt retired, carrying value",
        "documentation": "Fair value amount of debt instrument that was repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "inva_DebtInstrumentRepurchasePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtInstrumentRepurchasePercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of debt Instrument, repurchased.",
        "label": "Debt Instrument, Repurchase Percentage",
        "terseLabel": "Percentage of notes repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt Instrument, Repurchased Face Amount",
        "verboseLabel": "Portion of debt retired, face value",
        "documentation": "Face (par) amount of the original debt instrument that was repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r55",
      "r56",
      "r99",
      "r160",
      "r162",
      "r272",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1076",
      "r1260",
      "r1396",
      "r1398"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "inva_DebtInstrumentTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DebtInstrumentTransactionCost",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Transaction Cost",
        "documentation": "Debt instrument transaction cost",
        "terseLabel": "Transaction cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Instrument, Unamortized Discount, Total",
        "label": "Debt Instrument, Unamortized Discount",
        "verboseLabel": "Unamortized Debt discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r1335",
      "r1395",
      "r1396",
      "r1398"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Less: Unamortized debt discount and issuance costs",
        "terseLabel": "Debt discount and issuance costs, net",
        "negatedTerseLabel": "Debt discount and issuance costs, net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r507",
      "r717",
      "r718",
      "r719",
      "r1042",
      "r1043",
      "r1076"
     ]
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Total debt, net",
        "totalLabel": "Net carrying amount",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt [Member]",
        "terseLabel": "Debt",
        "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance",
        "periodStartLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance",
        "totalLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Total",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "verboseLabel": "Credit loss",
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r410",
      "r414",
      "r415"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Amortized Cost and Estimated Fair Values for Available-for-Sale Securities",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294"
     ]
    },
    "us-gaap_DeconsolidationGainOrLossAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeconsolidationGainOrLossAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deconsolidation, Gain (Loss), Amount",
        "terseLabel": "Net gain on sale of TRC",
        "negatedLabel": "Net gain on sale of TRC",
        "negatedTerseLabel": "Gain on sale of Theravance Respiratory Company, LLC (\"TRC\")",
        "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "inva_DecreaseToAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DecreaseToAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease to accumulated deficit.",
        "label": "Decrease to Accumulated Deficit",
        "terseLabel": "Decrease to accumulated deficit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedLabel": "Federal",
        "terseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1377",
      "r1378"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "negatedTotalLabel": "Total",
        "totalLabel": "Total deferred",
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1368"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r601"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Income Tax Expense (Benefit), Total",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r215",
      "r1262"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Deferred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Net deferred tax (liabilities)",
        "negatedTotalLabel": "Net deferred tax (liabilities)",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r116",
      "r184",
      "r616"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities, net",
        "totalLabel": "Net deferred tax (liabilities)",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r601",
      "r836"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Total",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Current, Total",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1247"
     ]
    },
    "inva_DeferredRoyaltyObligationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredRoyaltyObligationCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current portion of deferred royalty obligation.",
        "label": "Deferred Royalty Obligation, Current",
        "terseLabel": "Current portion of deferred royalty obligation"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DeferredRoyaltyObligationNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredRoyaltyObligationNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term portion of deferred royalty obligation.",
        "label": "Deferred Royalty Obligation, Non Current",
        "terseLabel": "Long-term portion of deferred royalty obligation"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DeferredRoyaltyObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredRoyaltyObligations",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Royalty Obligations",
        "documentation": "Deferred royalty obligations.",
        "terseLabel": "Deferred Royalty obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "negatedLabel": "State",
        "terseLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1377",
      "r1378"
     ]
    },
    "inva_DeferredTaxAssetsDeferredRoyaltyObligationNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredTaxAssetsDeferredRoyaltyObligationNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets deferred royalty obligation, net",
        "label": "Deferred Tax Assets Deferred Royalty Obligation, Net",
        "terseLabel": "Deferred royalty obligation, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets before valuation allowance",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Net operating loss carryforwards do not expire",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credit carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "inva_DeferredTaxAssetsUnrealizedLossesOnInvestmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredTaxAssetsUnrealizedLossesOnInvestmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets unrealized losses on investment, net",
        "label": "Deferred Tax Assets Unrealized Losses On Investment, Net",
        "terseLabel": "Unrealized loss on investment, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "inva_DeferredTaxLiabilitiesDepreciationAndAmortization1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization1",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities Depreciation And Amortization 1",
        "documentation": "Deferred tax liabilities depreciation and amortization.",
        "terseLabel": "Depreciation and amortization",
        "negatedLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DeferredTaxLiabilitiesInventoryFairValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DeferredTaxLiabilitiesInventoryFairValueAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities inventory fair value adjustment",
        "label": "Deferred Tax Liabilities Inventory Fair Value Adjustment",
        "terseLabel": "Inventory fair value adjustment",
        "negatedLabel": "Inventory fair value adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Investments",
        "negatedLabel": "Unrealized gain on investment, net",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments)."
       }
      }
     },
     "auth_ref": [
      "r1375"
     ]
    },
    "inva_DemandLettersSentByStockholders": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DemandLettersSentByStockholders",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of demand letters that were sent to the Company by purported stockholders.",
        "label": "Demand Letters Sent By Stockholders",
        "terseLabel": "Demand letters sent by stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DenominatorAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derecognition of non controlling interests upon acquisition of entasis minority interest.",
        "label": "Derecognition Of Non Controlling Interests Upon Acquisition Of Entasis Minority Interest",
        "terseLabel": "Derecognition of noncontrolling interests upon acquisition of Entasis noncontrolling interest"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognition of noncontrolling interests upon acquisition of Entasis noncontrolling interest (in shares)",
        "label": "Derecognition Of NonControlling Interests Upon Acquisition Of Entasis Minority Interest Shares",
        "documentation": "Derecognition of nonControlling interests upon acquisition of entasis minority interest shares."
       }
      }
     },
     "auth_ref": []
    },
    "inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrc": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DerecognitionOfNoncontrollingInterestsUponSaleOfTrc",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derecognition of noncontrolling interestsupon sale of TRC.",
        "label": "Derecognition of Noncontrolling Interests Upon Sale of TRC",
        "terseLabel": "Derecognition of noncontrolling interests upon sale of TRC"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognition of noncontrolling interests upon sale of TRC (in shares)",
        "label": "Derecognition Of Noncontrolling Interests Upon Sale Of Trc Shares",
        "documentation": "Derecognition of noncontrolling interests upon sale of trc shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeCapPrice": {
     "xbrltype": "perUnitItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeCapPrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Cap Price",
        "terseLabel": "Cap price for the underlying number of shares (in dollars per share)",
        "documentation": "The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract."
       }
      }
     },
     "auth_ref": []
    },
    "inva_DescriptionOfOperationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DescriptionOfOperationsPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Operations",
        "label": "Description of Operations [Policy Text Block]",
        "documentation": "Description of operations."
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Non-employee director"
       }
      }
     },
     "auth_ref": [
      "r1276",
      "r1452"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Revenue Recognition and Collaborative Arrangements",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of net revenue from collaboration arrangement",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1339"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "STOCK-BASED COMPENSATION",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r553",
      "r584",
      "r585",
      "r587",
      "r1060"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_DividendYield": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DividendYield",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend yield.",
        "label": "Dividend Yield",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117",
      "r1140"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117",
      "r1140",
      "r1183"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "Federal",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "inva_DurlobactamMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "DurlobactamMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Durlobactam [Member]",
        "documentation": "Durlobactam.",
        "terseLabel": "Durlobactam"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income per share attributable to Innoviva stockholders",
        "verboseLabel": "Basic net income per share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r292",
      "r295",
      "r308",
      "r309",
      "r310",
      "r314",
      "r646",
      "r658",
      "r689",
      "r690",
      "r829",
      "r858",
      "r1020"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per share attributable to Innoviva stockholders",
        "verboseLabel": "Diluted net income per share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r295",
      "r308",
      "r309",
      "r310",
      "r314",
      "r646",
      "r658",
      "r689",
      "r690",
      "r829",
      "r858",
      "r1020"
     ]
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDilutedLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "verboseLabel": "Net Income Per Share",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r299",
      "r308"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShare1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "NET INCOME PER SHARE",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r311",
      "r312",
      "r313"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, FDII, Amount",
        "negatedLabel": "Foreign derived intangible income deduction",
        "terseLabel": "Foreign derived intangible income deduction",
        "documentation": "Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)."
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1369",
      "r1371"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Employee-related Liabilities, Current, Total",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued personnel-related expenses",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-Average Amortization Period (Years)",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock options",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "inva_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the Company's Employee Stock Purchase Plan (the \"ESPP\").",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "auth_ref": []
    },
    "inva_EmployeeStockPurchasePlanTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EmployeeStockPurchasePlanTwentyTwentyThreeMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 ESPP",
        "label": "Employee Stock Purchase Plan Twenty Twenty Three [Member]",
        "documentation": "Employee Stock Purchase Plan Twenty Twenty Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_EntasisLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EntasisLeaseMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entasis Lease [Member]",
        "label": "Entasis Lease [Member]",
        "terseLabel": "Entasis Lease"
       }
      }
     },
     "auth_ref": []
    },
    "inva_EntasisTherapeuticsHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EntasisTherapeuticsHoldingsIncMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Entasis Therapeutics Holdings Inc.",
        "label": "Entasis Therapeutics Holdings Inc [Member]",
        "terseLabel": "Entasis",
        "verboseLabel": "Entasis Therapeutics Holdings Inc"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CIK",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Entities",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1166"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r220",
      "r248",
      "r249",
      "r250",
      "r273",
      "r274",
      "r275",
      "r278",
      "r285",
      "r287",
      "r289",
      "r316",
      "r398",
      "r404",
      "r450",
      "r527",
      "r628",
      "r629",
      "r642",
      "r643",
      "r644",
      "r647",
      "r657",
      "r658",
      "r670",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r688",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r721",
      "r723",
      "r745",
      "r853",
      "r876",
      "r877",
      "r878",
      "r895",
      "r957"
     ]
    },
    "inva_EquityIncentivePlan2012Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EquityIncentivePlan2012Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the 2012 Equity Incentive Plan as approved by shareowners.",
        "label": "Equity Incentive Plan2012 [Member]",
        "terseLabel": "2012 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "inva_EquityIncentivePlansAndESPPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EquityIncentivePlansAndESPPMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to options, Equity Incentive Plans and Employee Stock Purchase Plans.",
        "label": "Equity Incentive Plans And E S P P [Member]",
        "terseLabel": "Equity incentive plans and ESPP"
       }
      }
     },
     "auth_ref": []
    },
    "inva_EquityInvestmentTransactionCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EquityInvestmentTransactionCostsIncurred",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Investment Transaction Costs Incurred",
        "documentation": "Equity investment transaction costs incurred.",
        "terseLabel": "Equity investment transaction costs incurred"
       }
      }
     },
     "auth_ref": []
    },
    "inva_EquityInvestmentsAndMoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EquityInvestmentsAndMoneyMarketFundsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to equity investments and money market funds.",
        "label": "Equity Investments And Money Market Funds [Member]",
        "terseLabel": "Equity investments and Money market funds"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r638",
      "r1227",
      "r1228",
      "r1229",
      "r1379",
      "r1380",
      "r1381",
      "r1382"
     ]
    },
    "inva_EquityMethodInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EquityMethodInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investment",
        "documentation": "Equity method investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentAggregateCost",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Cost on equity investment",
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Other-than-Temporary Impairment",
        "terseLabel": "Impairment of equity investments",
        "documentation": "Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r1299"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Ownership Percentage",
        "verboseLabel": "Equity investment ownership percentage",
        "terseLabel": "Equity method investment ownership percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments",
        "terseLabel": "Total carrying value of investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r330",
      "r347",
      "r390",
      "r1246",
      "r1300"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity and Long-Term Investments",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r95",
      "r392"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity and long-term investments at fair value",
        "verboseLabel": "Fair value of equity securities",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r706",
      "r1009"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Equity Securities, FV-NI, Realized Gain (Loss), Total",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Remeasurement loss",
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r859",
      "r1298"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized gain",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "terseLabel": "Unrealized gain from fair value changes in equity investments",
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain loss from fair value changes in equity investments",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "totalLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total",
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r860",
      "r1298"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiUnrealizedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized loss from fair value changes in equity investments",
        "negatedLabel": "Unrealized loss from fair value changes in equity investments",
        "label": "Equity Securities, FV-NI, Unrealized Loss",
        "verboseLabel": "Unrealized loss",
        "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity investment",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r1079",
      "r1106",
      "r1107",
      "r1108",
      "r1457"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1176"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1144",
      "r1154",
      "r1187"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r1130",
      "r1141",
      "r1151",
      "r1184"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "auth_ref": [
      "r1456",
      "r1458",
      "r1459",
      "r1460"
     ]
    },
    "inva_EverestMedicinesLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "EverestMedicinesLimitedMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Everest Medicines Limited [Member]",
        "label": "Everest Medicines Limited [Member]",
        "terseLabel": "Everest Medicines Limited"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "inva_ExpectedHoldingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ExpectedHoldingPeriod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected holding period of equity method investment.",
        "label": "Expected Holding Period",
        "terseLabel": "Expected holding period"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ExpirationDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date",
        "documentation": "Expiration date.",
        "terseLabel": "Expiration date"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ExtendedExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ExtendedExpirationDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended expiration date.",
        "label": "Extended Expiration Date",
        "terseLabel": "Extended expiration date"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ExternalServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ExternalServicesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "External Services [Member]",
        "documentation": "External Services.",
        "terseLabel": "External services"
       }
      }
     },
     "auth_ref": []
    },
    "inva_FactorsAffectingComparabilityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FactorsAffectingComparabilityPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Factors affecting comparability.",
        "label": "Factors Affecting Comparability Policy [Text Block]",
        "terseLabel": "Factors Affecting Comparability"
       }
      }
     },
     "auth_ref": []
    },
    "inva_FairValueAdjustmentsOfInventoryFromAcquistion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FairValueAdjustmentsOfInventoryFromAcquistion",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of net fair value adjustment of inventory resulting from the acquisition.",
        "label": "Fair Value Adjustments Of Inventory From Acquistion",
        "terseLabel": "Net fair value adjustment of inventory from acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Measurements",
        "verboseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r700",
      "r1065"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r700",
      "r1065"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Securities Measured at Fair Value on a Recurring Basis",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r1065",
      "r1385",
      "r1386",
      "r1391"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Equity Investment",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r691",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r700",
      "r702",
      "r754",
      "r755",
      "r756",
      "r1042",
      "r1043",
      "r1054",
      "r1055",
      "r1056",
      "r1065",
      "r1069"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r694",
      "r696",
      "r1065",
      "r1388",
      "r1392"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Price in Active Markets for Identical Assets, Level 1",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r540",
      "r545",
      "r693",
      "r700",
      "r754",
      "r1054",
      "r1055",
      "r1056",
      "r1065"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r540",
      "r545",
      "r693",
      "r694",
      "r700",
      "r755",
      "r1042",
      "r1043",
      "r1054",
      "r1055",
      "r1056",
      "r1065"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs, Level 3",
        "verboseLabel": "Fair Value, Inputs, Level 3",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r693",
      "r694",
      "r695",
      "r696",
      "r700",
      "r756",
      "r1042",
      "r1043",
      "r1054",
      "r1055",
      "r1056",
      "r1065",
      "r1069"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r694",
      "r696",
      "r1065",
      "r1388",
      "r1392"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r691",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r700",
      "r702",
      "r754",
      "r755",
      "r756",
      "r1042",
      "r1043",
      "r1054",
      "r1055",
      "r1056",
      "r1065",
      "r1069"
     ]
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsNonrecurringMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrecurring basis",
        "label": "Fair Value, Nonrecurring [Member]",
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r694",
      "r696",
      "r1065",
      "r1388"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r1065",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1392"
     ]
    },
    "inva_FairValueOfAssetsOrLiabilitiesTransferBetweenLevels": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FairValueOfAssetsOrLiabilitiesTransferBetweenLevels",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Assets Or Liabilities Transfer Between Levels",
        "documentation": "Fair Value Of Assets Or Liabilities Transfer Between Levels",
        "terseLabel": "Fair value of assets or liabilities transfer between levels"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "inva_FederalNetOperatingLossesEstimatedUtilizationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FederalNetOperatingLossesEstimatedUtilizationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal net operating losses estimated utilization amount.",
        "label": "Federal Net Operating Losses Estimated Utilization Amount",
        "terseLabel": "Federal net operating losses estimated utilization amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r504",
      "r524",
      "r678",
      "r703",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r768",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r854",
      "r1038",
      "r1065",
      "r1067",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1079",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1384",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1392"
     ]
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurements2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "EQUITY AND LONG-TERM INVESTMENTS AND FAIR VALUE MEASUREMENTS",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": []
    },
    "inva_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite Lived Intangible Asset Expected Amortization After Year Four",
        "documentation": "Finite lived intangible asset expected amortization after year four.",
        "terseLabel": "Future amortization expense, thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Marketed products, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r421",
      "r442",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Future amortization expense, thereafter",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1317",
      "r1462"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Future amortization expense, 2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future amortization expense, remainder of 2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1462"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Future amortization expense, 2029",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Future amortization expense, 2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Future amortization expense, 2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Future amortization expense, 2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r446",
      "r447",
      "r789",
      "r793",
      "r1002"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r442",
      "r446",
      "r447",
      "r448",
      "r789",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r446",
      "r447",
      "r1002"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finite-Lived Intangible Assets, Period Increase (Decrease), Total",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Measurement period adjustments for change in value of intangible assets",
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": []
    },
    "inva_FirstAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FirstAmendmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Amendment",
        "label": "First Amendment [Member]",
        "documentation": "First amendment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1191"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1191"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1191"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1191"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1191"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1171"
     ]
    },
    "inva_FuturePotentialMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "FuturePotentialMilestonePayment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future potential milestone payment receivable.",
        "label": "Future Potential Milestone Payment",
        "terseLabel": "Future potential milestone payment receivable"
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "GB",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom"
       }
      }
     },
     "auth_ref": []
    },
    "inva_GSKMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "GSKMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents GSK, with whom the entity has agreements and arrangements, such as those for developing and commercializing different products.",
        "label": "G S K [Member]",
        "terseLabel": "GSK"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized gain on equity investments",
        "totalLabel": "Gain (Loss) on Investments, Total",
        "label": "Gain (Loss) on Investments",
        "negatedLabel": "Realized gain on equity investments",
        "verboseLabel": "Changes in fair values of equity and long-term investments, net",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r138",
      "r1226"
     ]
    },
    "inva_GainLossOnOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "GainLossOnOtherInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Changes in fair value of equity and long-term investments, net",
        "documentation": "Gain loss on other investments.",
        "label": "Gain (Loss) on Other Investments",
        "terseLabel": "Changes in fair value of other equity and long-term investments, net",
        "verboseLabel": "Changes in fair value, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "terseLabel": "Loss on extinguishment of debt",
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r52",
      "r53"
     ]
    },
    "inva_GateNeuroscienceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "GateNeuroscienceMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gate Neuroscience [Member]",
        "documentation": "Gate Neuroscience [Member]",
        "terseLabel": "Gate Neurosciences [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "totalLabel": "General and Administrative Expense, Total",
        "terseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r939"
     ]
    },
    "us-gaap_GeneralPartnerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralPartnerMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Partner [Member]",
        "terseLabel": "General Partner",
        "documentation": "Party to a partnership business who has unlimited liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r988"
     ]
    },
    "inva_GeorgeWashingtonUniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "GeorgeWashingtonUniversityMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "George Washington University.",
        "label": "George Washington University [Member]",
        "terseLabel": "George Washington University"
       }
      }
     },
     "auth_ref": []
    },
    "inva_GiaprezaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "GiaprezaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GIAPREZA.",
        "label": "GIAPREZA [Member]",
        "terseLabel": "GIAPREZA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Goodwill, Total",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "periodEndLabel": "Goodwill, Ending Balance",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r422",
      "r824",
      "r1030",
      "r1039",
      "r1066",
      "r1078",
      "r1306",
      "r1307"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1304",
      "r1308"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1304",
      "r1308"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill, impairment losses",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r423",
      "r429",
      "r434",
      "r1039",
      "r1066"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r1039"
     ]
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Goodwill, Period Increase (Decrease), Total",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Measurement period adjustments for change in value of goodwill",
        "verboseLabel": "Decrease in goodwill",
        "documentation": "Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1305"
     ]
    },
    "inva_GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer before amortization of capitalized fees.",
        "label": "Gross Revenue from Contract with Customer, Excluding Assessed Tax, Before Amortization Of Capitalized Fees",
        "terseLabel": "Royalties",
        "totalLabel": "Total royalties"
       }
      }
     },
     "auth_ref": []
    },
    "inva_HarvardUniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "HarvardUniversityMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Harvard University.",
        "label": "Harvard University [Member]",
        "terseLabel": "Harvard University"
       }
      }
     },
     "auth_ref": []
    },
    "inva_HealthCareRoyaltyPartnersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "HealthCareRoyaltyPartnersMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health care royalty partners member.",
        "label": "Health Care Royalty Partners [Member]",
        "terseLabel": "HealthCare Royalty Partners"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117",
      "r1140"
     ]
    },
    "inva_ImaginabConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ImaginabConvertibleNoteMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ImaginAb Convertible Note",
        "label": "ImaginAb Convertible Note [Member]",
        "documentation": "ImaginAb Convertible Note."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ImaginabMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ImaginabMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Imaginab [Member]",
        "terseLabel": "ImaginAb",
        "documentation": "Represents information pertaining to ImaginAb."
       }
      }
     },
     "auth_ref": []
    },
    "inva_InCardaConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InCardaConvertibleNoteMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "InCarda Convertible note.",
        "label": "In Carda Convertible Note [Member]",
        "terseLabel": "InCarda Convertible Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1316",
      "r1318",
      "r1319",
      "r1320"
     ]
    },
    "inva_Incarda2020WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "Incarda2020WarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "InCarda 2020 Warrants [Member]",
        "label": "InCarda 2020 Warrants [Member]",
        "terseLabel": "Incarda 2020 Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IncardaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncardaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to InCarda.",
        "label": "Incarda [Member]",
        "terseLabel": "InCarda"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r192",
      "r200",
      "r830",
      "r849",
      "r1022",
      "r1029",
      "r1270",
      "r1272",
      "r1273",
      "r1274",
      "r1275"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Changes in fair values of equity method investments, net",
        "negatedLabel": "Changes in fair values of equity method investments, net",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r129",
      "r191",
      "r315",
      "r327",
      "r347",
      "r390",
      "r848"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r457",
      "r459",
      "r697",
      "r698",
      "r701",
      "r871",
      "r873",
      "r942",
      "r1002",
      "r1068",
      "r1422"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r459",
      "r697",
      "r698",
      "r701",
      "r871",
      "r873",
      "r942",
      "r1002",
      "r1068",
      "r1422"
     ]
    },
    "us-gaap_IncomeStatementRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementRelatedDisclosuresAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Related Disclosures [Abstract]",
        "terseLabel": "Income Statement Information"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r603",
      "r604",
      "r611",
      "r622",
      "r1062",
      "r1374"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "terseLabel": "Income Tax Authority [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r603",
      "r604",
      "r611",
      "r622",
      "r1062",
      "r1374"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxes3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r596",
      "r603",
      "r608",
      "r609",
      "r610",
      "r614",
      "r620",
      "r633",
      "r635",
      "r636",
      "r637",
      "r892",
      "r1062"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Tax Examination, Penalties and Interest Accrued, Total",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties",
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r1372"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total income tax expense, net",
        "negatedTerseLabel": "Income tax expense, net",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense, net",
        "terseLabel": "Income tax expense, net",
        "totalLabel": "Total income tax expense, net",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r216",
      "r288",
      "r289",
      "r315",
      "r328",
      "r347",
      "r602",
      "r603",
      "r634",
      "r862",
      "r1062"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement period adjustments for change in value of deferred tax liabilities",
        "label": "Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability",
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity."
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "verboseLabel": "Differences between the expected U.S. federal statutory income tax to income tax expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r598",
      "r599",
      "r614",
      "r615",
      "r619",
      "r624",
      "r889"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r1062",
      "r1369"
     ]
    },
    "us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount",
        "terseLabel": "Impact of consolidation and deconsolidation of subsidiaries",
        "negatedLabel": "Impact of consolidation and deconsolidation of subsidiaries",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1369",
      "r1370"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Expected tax at federal statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r1062"
     ]
    },
    "us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationMinorityInterestIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount",
        "negatedTerseLabel": "Noncontrolling Interest",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1369",
      "r1370"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1369",
      "r1370"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income tax expense (benefit), net of federal benefit",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r1062",
      "r1369"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal and state research credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedLabel": "Federal and state research credits",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1369",
      "r1371"
     ]
    },
    "inva_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Taxes Paid, Net, Total",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r264",
      "r621",
      "r622"
     ]
    },
    "inva_IncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncomeTaxesTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of income taxes.",
        "label": "Income Taxes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "terseLabel": "Accounts receivable, net",
        "negatedLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued personnel-related expenses and other accrued liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "terseLabel": "Income tax expense recognized",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "inva_IncreaseDecreaseInDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncreaseDecreaseInDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in deferred tax assets",
        "label": "Increase (Decrease) In Deferred Tax Assets",
        "documentation": "Increase (Decrease) in deferred tax assets."
       }
      }
     },
     "auth_ref": []
    },
    "inva_IncreaseDecreaseInDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncreaseDecreaseInDeferredTaxLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (decrease) in deferred tax liabilities",
        "documentation": "Increase (decrease) in deferred tax liabilities.",
        "label": "Increase (Decrease) in Deferred Tax Liabilities",
        "terseLabel": "Measurement period adjustments increase decrease in deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Due from Related Parties, Current, Total",
        "label": "Increase (Decrease) in Due from Related Parties, Current",
        "negatedLabel": "Receivables from collaboration arrangements",
        "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Interest Payable, Net",
        "terseLabel": "Accrued interest payable",
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Inventories, Total",
        "label": "Increase (Decrease) in Inventories",
        "terseLabel": "Measurement period adjustments for change in value of Inventory",
        "negatedLabel": "Inventory",
        "verboseLabel": "Change in inventory",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Other Operating Assets, Total",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense",
        "terseLabel": "Prepaid expenses",
        "negatedLabel": "Prepaid expenses",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "inva_IncreaseDecreasesInDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncreaseDecreasesInDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decreases In Deferred Tax Liabilities",
        "documentation": "Increase decreases in deferred tax liabilities.",
        "terseLabel": "Measurement period adjustments increase decrease in deferred tax liabilities",
        "verboseLabel": "Increase (decrease) in deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IncreaseInDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncreaseInDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in deferred tax assets.",
        "label": "Increase in Deferred Tax Assets",
        "terseLabel": "Increase in Deferred Tax Assets"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IncreaseToConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncreaseToConvertibleNotes",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase to convertible notes.",
        "label": "Increase To Convertible Notes",
        "terseLabel": "Increase in convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Incremental Common Shares Attributable to Conversion of Debt Securities, Total",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Dilutive effect",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r310"
     ]
    },
    "inva_IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecuritiesTreasuryStockMethod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method.",
        "label": "Incremental Common Shares Attributable To Conversion Of Debt Securities, Treasury Stock Method",
        "terseLabel": "Dilutive effect of the assumed conversion premium"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Incremental Common Shares Attributable to Share-based Payment Arrangements, Total",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of options and awards granted under equity incentive plan and employee stock purchase plan",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r310",
      "r552"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r440",
      "r445",
      "r1040"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r440",
      "r445",
      "r1040"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Indefinite-Lived Intangible Assets, Period Increase (Decrease), Total",
        "label": "Indefinite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Measurement period adjustments for change in value of intangible assets",
        "documentation": "Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r1318"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1182",
      "r1191",
      "r1195",
      "r1203"
     ]
    },
    "inva_InnovivaCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InnovivaCommonStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Innoviva's Common Stock Member",
        "label": "Innoviva Common Stock Member",
        "terseLabel": "Innoviva's Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_InnovivaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InnovivaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Innoviva [Member]",
        "label": "Innoviva [Member]",
        "terseLabel": "Innoviva [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Innoviva Strategic Opportunities, LLC",
        "label": "Innoviva Strategic Opportunities Limited Liability Corporation [Member]",
        "documentation": "Represents information pertaining to Innoviva Strategic Opportunities, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1201"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r1118",
      "r1207"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r1118",
      "r1207"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r1118",
      "r1207"
     ]
    },
    "inva_IntangibleAssetsCollaborationAgreementAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsCollaborationAgreementAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration agreement, accumulated amortization",
        "label": "Intangible Assets Collaboration Agreement Accumulated Amortization",
        "documentation": "Intangible assets collaboration agreement accumulated amortization."
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsCollaborationAgreementGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsCollaborationAgreementGross",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets collaboration agreement gross.",
        "label": "Intangible Assets Collaboration Agreement Gross",
        "terseLabel": "Collaboration agreement, gross carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsCollaborationAgreementNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsCollaborationAgreementNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets collaboration agreement net.",
        "label": "Intangible Assets Collaboration Agreement Net",
        "terseLabel": "Collaboration agreement, net carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Total gross carrying amount",
        "totalLabel": "Total gross carrying amount",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "inva_IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development, accumulated amortization",
        "label": "Intangible Assets In Process Research And Development Accumulated Amortization",
        "documentation": "Intangible sssets in process research and development accumulated amortization."
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsInProcessResearchAndDevelopmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsInProcessResearchAndDevelopmentGross",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of In-process research and development.",
        "label": "Intangible Assets In-process Research and Development, Gross",
        "terseLabel": "In-process research and development, gross carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsInProcessResearchAndDevelopmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsInProcessResearchAndDevelopmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount of In-process research and development.",
        "label": "Intangible Assets In-process Research and Development, Net",
        "terseLabel": "In-process research and development, net carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsMarketedProductsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsMarketedProductsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amortization amount of Marketed Products.",
        "label": "Intangible Assets Marketed Products, Accumulated Amortization",
        "terseLabel": "Marketed products, Accumulated amortization"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsMarketedProductsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsMarketedProductsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of Marketed products.",
        "label": "Intangible Assets Marketed Products, Gross",
        "terseLabel": "Marketed products, gross carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IntangibleAssetsMarketedProductsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IntangibleAssetsMarketedProductsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount of Marketed Products.",
        "label": "Intangible Assets Marketed Products, Net",
        "terseLabel": "Marketed products, net carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Net carrying amount",
        "terseLabel": "Intangible assets",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r1316",
      "r1318"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestAndDividendIncomeOperating",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividend income",
        "label": "Interest and Dividend Income, Operating",
        "totalLabel": "Interest and Dividend Income, Operating, Total",
        "negatedLabel": "Interest and dividend income",
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r193",
      "r195",
      "r196",
      "r197",
      "r1461"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest Expense, Total",
        "label": "Interest Expense, Operating and Nonoperating",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r322",
      "r326",
      "r329",
      "r347",
      "r716",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_InterestExpenseBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseBorrowingsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Borrowings [Abstract]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Debt",
        "totalLabel": "Total interest and amortization expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r499",
      "r510",
      "r1044",
      "r1045"
     ]
    },
    "us-gaap_InterestExpenseDebtAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebtAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Debt [Abstract]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebtExcludingAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense",
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r500",
      "r1044",
      "r1045"
     ]
    },
    "us-gaap_InterestExpensePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpensePolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Policy [Policy Text Block]",
        "terseLabel": "Interest Expense on Deferred Royalty Obligation",
        "documentation": "Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r1394",
      "r1398"
     ]
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Components of Interest Expense",
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Add: interest expense on Notes, net of tax effect",
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r301",
      "r310"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r262",
      "r263"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Payable, Current",
        "verboseLabel": "Accrued interest payable",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "inva_InterestRateOfDeferredRoyaltyObligation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InterestRateOfDeferredRoyaltyObligation",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate of deferred royalty obligation.",
        "label": "Interest Rate of Deferred Royalty Obligation",
        "terseLabel": "Interest Rate of Deferred Royalty Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "inva_InterimSupplyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InterimSupplyAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interim Supply Agreement",
        "label": "Interim Supply Agreement [Member]",
        "documentation": "Interim supply agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "inva_InternalExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InternalExpensesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Internal Expenses [Member]",
        "documentation": "Internal Expenses.",
        "terseLabel": "Internal expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryCurrentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryCurrentTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Current [Table]",
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory fair value step-up adjustment included in cost of products sold",
        "label": "Inventory Fair Value Step Up Adjustment Included In Cost Of Product Sales",
        "documentation": "Inventory fair value step-up adjustment included in cost of product sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r1011"
     ]
    },
    "us-gaap_InventoryGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryGross",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventory, Gross, Total",
        "label": "Inventory, Gross",
        "terseLabel": "Inventory",
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r1252"
     ]
    },
    "us-gaap_InventoryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net",
        "totalLabel": "Total inventory",
        "terseLabel": "Inventory",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r1008",
      "r1078"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r227",
      "r239",
      "r416",
      "r417",
      "r418",
      "r787",
      "r1018"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r1013"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r1012"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income, Interest",
        "terseLabel": "Investment income, interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r325",
      "r347",
      "r1029",
      "r1255"
     ]
    },
    "us-gaap_InvestmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment [Table Text Block]",
        "terseLabel": "Summary of Individual Investments Held by ISP Fund",
        "documentation": "Tabular disclosure of investment."
       }
      }
     },
     "auth_ref": [
      "r1236",
      "r1237",
      "r1280"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r900",
      "r902",
      "r904",
      "r963",
      "r965",
      "r967",
      "r970",
      "r971",
      "r974",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r1100"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r900",
      "r902",
      "r904",
      "r963",
      "r965",
      "r967",
      "r970",
      "r971",
      "r974",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r1100"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments",
        "totalLabel": "Investments, Total",
        "terseLabel": "Total investments held by ISP Fund LP",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r832",
      "r833",
      "r1095",
      "r1097"
     ]
    },
    "us-gaap_InvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_InvestmentsInCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InvestmentsInCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments In Common Stock",
        "documentation": "Investments In Common Stock",
        "terseLabel": "Common stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_InvestmentsInPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InvestmentsInPreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Investments in Preferred Stock",
        "documentation": "Investments in preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "inva_InvestmentsInWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "InvestmentsInWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Investments In Warrants",
        "documentation": "Investments In Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "inva_IspFundLpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "IspFundLpMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to ISP Fund LP, an investment managed by Sarissa Capital.",
        "label": "Isp Fund Lp [Member]",
        "terseLabel": "ISP Fund LP"
       }
      }
     },
     "auth_ref": []
    },
    "country_JP": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "JP",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "auth_ref": []
    },
    "inva_JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July Two Thousand Twenty Three Credit and Security Agreement [Member]",
        "documentation": "July two thousand twenty three credit and security agreement.",
        "terseLabel": "July 2023 Credit and Security Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LaJollaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LaJollaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "La Jolla",
        "documentation": "La Jolla [Member]",
        "label": "La Jolla [Member]",
        "terseLabel": "La Jolla [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LaJollaPharmaceuticalCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LaJollaPharmaceuticalCompanyMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "La jolla pharmaceutical company member.",
        "label": "La Jolla Pharmaceutical Company [Member]",
        "terseLabel": "La Jolla Pharmaceutical Company"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LabaCollaborationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LabaCollaborationMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the collaboration with GSK to develop and commercialize once-daily LABA products and combination products RELVAR.",
        "label": "Laba Collaboration [Member]",
        "terseLabel": "Long-Acting Beta2 Agonist (LABA) Collaboration"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LaboratoryEquipmentFurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LaboratoryEquipmentFurnitureAndFixturesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment, furniture and fixtures.",
        "label": "Laboratory Equipment, Furniture And Fixtures [Member]",
        "terseLabel": "Laboratory equipment furniture and fixtures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r1234"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r1234"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r730",
      "r1077"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Components of Lease Cost",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1400"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expiration, date",
        "label": "Lease Expiration Date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity:",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Operating Lease",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r739"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r739"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1401"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total",
        "totalLabel": "Total undiscounted lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest",
        "negatedLabel": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1399"
     ]
    },
    "inva_LetterAgreementForPurchaseOfMaterialUsedForProductionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LetterAgreementForPurchaseOfMaterialUsedForProductionValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Letter Agreement for Purchase of Material Used for Production Value",
        "documentation": "Letter agreement for purchase of material used for production value.",
        "terseLabel": "Letter agreement for purchase of material used for production value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Liabilities, Total",
        "label": "Liabilities",
        "verboseLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r106",
      "r107",
      "r108",
      "r112",
      "r113",
      "r114",
      "r117",
      "r268",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r662",
      "r665",
      "r666",
      "r708",
      "r913",
      "r1021",
      "r1111",
      "r1330",
      "r1404",
      "r1405"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r189",
      "r844",
      "r1078",
      "r1261",
      "r1301",
      "r1393"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities and Stockholders Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r226",
      "r268",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r662",
      "r665",
      "r666",
      "r708",
      "r1078",
      "r1330",
      "r1404",
      "r1405"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Total liabilities measured at estimated fair value",
        "totalLabel": "Total liabilities at estimated fair value",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r693",
      "r1385"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Liabilities, Noncurrent, Total",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Noncurrent liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r112",
      "r113",
      "r114",
      "r117",
      "r268",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r662",
      "r665",
      "r666",
      "r708",
      "r1330",
      "r1404",
      "r1405"
     ]
    },
    "inva_LicenseAndCollaborationArrangementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LicenseAndCollaborationArrangementsDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangements1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and collaboration arrangements disclosure.",
        "label": "License and Collaboration Arrangements Disclosure [Text Block]",
        "terseLabel": "LICENSE AND COLLABORATION ARRANGEMENTS"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LicenseAndOtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LicenseAndOtherRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License and Other Revenue",
        "documentation": "License and other revenue.",
        "terseLabel": "License and other revenue"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LicenseAndOtherRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LicenseAndOtherRevenueMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License And Other Revenue [Member]",
        "documentation": "License and other revenue member.",
        "terseLabel": "License and other revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LicenseMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License",
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r1340"
     ]
    },
    "inva_LicenseRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LicenseRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License revenue recognized",
        "label": "License Revenue Recognized",
        "documentation": "License revenue recognized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LimitedPartnersContributedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LimitedPartnersContributedCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Limited Partners' Contributed Capital",
        "terseLabel": "Contributed to partnership for investing",
        "verboseLabel": "Capital contribution",
        "documentation": "The amount of capital contributed by the limited partners."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_LimitedPartnersCumulativeCashDistributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LimitedPartnersCumulativeCashDistributions",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution from partnership",
        "label": "Limited Partners' Cumulative Cash Distributions",
        "documentation": "Aggregate cumulative cash distributions made to the limited partners."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "inva_LimitedPartnersInitialContributionSubjectToLockUp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LimitedPartnersInitialContributionSubjectToLockUp",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Limited Partners Initial Contribution Subject to Lock Up",
        "documentation": "Limited partners initial contribution subject to lock up.",
        "terseLabel": "Initial contribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityCovenantTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCovenantTerms",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Covenant Terms",
        "terseLabel": "Debt instrument, covenant terms description",
        "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r111"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Term loan facility in aggregate amount",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r111"
     ]
    },
    "us-gaap_LoansPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansPayableMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans Payable [Member]",
        "documentation": "Borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "inva_LockUpExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LockUpExpirationDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lock Up Expiration Date",
        "documentation": "Lock up expiration date.",
        "terseLabel": "Lock-up expiration date"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LongActingBeta2AgonistAnoroMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LongActingBeta2AgonistAnoroMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Long-Acting Beta2 Agonist, ANORO, which is being developed and commercialized by entering into a strategic alliance with GSK",
        "label": "Long Acting Beta2 Agonist Anoro [Member]",
        "terseLabel": "ANORO"
       }
      }
     },
     "auth_ref": []
    },
    "inva_LongActingBeta2AgonistRelvarBreoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "LongActingBeta2AgonistRelvarBreoMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Long-Acting Beta2 Agonist, RELVAR/BREO, which is being developed and commercialized by entering into a strategic alliance with GSK",
        "label": "Long Acting Beta2 Agonist Relvar Breo [Member]",
        "terseLabel": "RELVAR/BREO"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt",
        "totalLabel": "Net carrying amount",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r186",
      "r492",
      "r508",
      "r1042",
      "r1043",
      "r1076",
      "r1415"
     ]
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtByMaturityAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term debt maturities for years ending December 31:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Current Maturities",
        "totalLabel": "Net Carrying Amount",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r272",
      "r497"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r272",
      "r497"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r272",
      "r497"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r272",
      "r497"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, net of discount and issuance costs",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "totalLabel": "Total long-term debt, net",
        "verboseLabel": "Total long-term debt, net",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity and long-term investments",
        "totalLabel": "Long-term Investments, Total",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r1322",
      "r1323",
      "r1324"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r49",
      "r1322",
      "r1323",
      "r1324"
     ]
    },
    "us-gaap_LossContingencyAllegations": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyAllegations",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency, Allegations",
        "terseLabel": "Complaints filed by stockholders",
        "documentation": "Presents an assertion of a fact by a plaintiff in a pleading or complaint, which the plaintiff claims it will prove upon presentation of evidence at the proceeding."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r154"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r355",
      "r1049",
      "r1089",
      "r1093",
      "r1339",
      "r1419",
      "r1423",
      "r1424",
      "r1426",
      "r1427",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1444",
      "r1445",
      "r1446",
      "r1447",
      "r1448",
      "r1449",
      "r1450"
     ]
    },
    "inva_ManufacturingStageTransferAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ManufacturingStageTransferAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Stage Transfer Agreement [Member]",
        "documentation": "Manufacturing Stage Transfer Agreement",
        "terseLabel": "Manufacturing Stage Transfer Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "March Two Thousand Twenty Four Credit and Security Agreement [Member]",
        "documentation": "March two thousand twenty four credit and security agreement.",
        "terseLabel": "March 2024 Credit and Security Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Investments in Marketable Securities",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "inva_MarketedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MarketedProductsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketed products",
        "label": "Marketed Products [Member]",
        "documentation": "Marketed products."
       }
      }
     },
     "auth_ref": []
    },
    "inva_MaximumAggregateRoyaltyPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MaximumAggregateRoyaltyPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Royalty Payments Due",
        "documentation": "Maximum aggregate royalty payments due.",
        "terseLabel": "Maximum aggregate royalty payments"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r547",
      "r593",
      "r696",
      "r786",
      "r870",
      "r872",
      "r886",
      "r905",
      "r906",
      "r964",
      "r966",
      "r968",
      "r969",
      "r975",
      "r1000",
      "r1001",
      "r1037",
      "r1046",
      "r1059",
      "r1069",
      "r1070",
      "r1074",
      "r1075",
      "r1090",
      "r1334",
      "r1406",
      "r1407",
      "r1408",
      "r1409",
      "r1410",
      "r1411"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "inva_MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Period Adjustment Increase Decrease in Liabilities",
        "documentation": "Measurement period adjustment increase (decrease) in liabilities.",
        "terseLabel": "Measurement period adjustments increase (decrease) in liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "inva_MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in estimated purchase price during measurement period.",
        "label": "Measurement Period Adjustments, Increase Decrease In estimated Purchase Price",
        "terseLabel": "Measurement period adjustments for change in estimated purchase price"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r547",
      "r593",
      "r696",
      "r786",
      "r870",
      "r872",
      "r886",
      "r905",
      "r906",
      "r964",
      "r966",
      "r968",
      "r969",
      "r975",
      "r1000",
      "r1001",
      "r1037",
      "r1046",
      "r1059",
      "r1069",
      "r1070",
      "r1074",
      "r1090",
      "r1334",
      "r1406",
      "r1407",
      "r1408",
      "r1409",
      "r1410",
      "r1411"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance",
        "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance",
        "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r188",
      "r268",
      "r394",
      "r468",
      "r471",
      "r472",
      "r473",
      "r477",
      "r478",
      "r708",
      "r843",
      "r917"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interests",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "inva_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributions to noncontrolling interest (in shares)",
        "documentation": "Minority interest decrease from distributions to noncontrolling interest holders shares.",
        "label": "Minority Interest Decrease From Distributions To Noncontrolling Interest Holders Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Noncontrolling Interest, Period Increase (Decrease), Total",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Measurement period adjustments for change in value of noncontrolling interests",
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "inva_MoneyMarketFundAndCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "MoneyMarketFundAndCash",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Fund and Cash",
        "documentation": "Money market fund and cash.",
        "terseLabel": "Money market fund and cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1341"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "inva_NameOfEventAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NameOfEventAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name Of Event [Axis]",
        "label": "Name Of Event [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NameOfEventDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NameOfEventDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name Of Event [Domain]",
        "label": "Name Of Event [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r355",
      "r1049",
      "r1089",
      "r1093",
      "r1339",
      "r1419",
      "r1423",
      "r1424",
      "r1426",
      "r1427",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1444",
      "r1445",
      "r1446",
      "r1447",
      "r1448",
      "r1449",
      "r1450"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "inva_NanoliveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NanoliveMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nanolive [Member]",
        "label": "Nanolive [Member]",
        "terseLabel": "Nanolive"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net Income (Loss)",
        "verboseLabel": "Net income attributable to Innoviva stockholders",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r147",
      "r194",
      "r224",
      "r243",
      "r245",
      "r250",
      "r268",
      "r277",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288",
      "r289",
      "r306",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r646",
      "r658",
      "r690",
      "r708",
      "r852",
      "r936",
      "r955",
      "r956",
      "r1109",
      "r1330"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to noncontrolling interests",
        "negatedLabel": "Net loss attributable to noncontrolling interests",
        "verboseLabel": "Net loss attributable to noncontrolling interests",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r179",
      "r243",
      "r245",
      "r285",
      "r288",
      "r289",
      "r851",
      "r1254"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to noncontrolling interest",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income attributable to Innoviva stockholders",
        "verboseLabel": "Net income attributable to Innoviva stockholders, basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r281",
      "r282",
      "r283",
      "r284",
      "r292",
      "r293",
      "r307",
      "r310",
      "r658"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net income attributable to Innoviva stockholders, diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r307",
      "r310"
     ]
    },
    "inva_NetIncomeLossPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NetIncomeLossPerShareAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Net Income (Loss) Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to Innoviva stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NetInvestmentRelatedIncomeExpensesEarnedInccured": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NetInvestmentRelatedIncomeExpensesEarnedInccured",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment-related income (expense) earned (incurred)",
        "label": "Net Investment Related Income Expenses Earned Inccured",
        "documentation": "Net investment related income expenses earned inccured."
       }
      }
     },
     "auth_ref": []
    },
    "inva_NetOperatingLossEstimatingDate": {
     "xbrltype": "gYearListItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NetOperatingLossEstimatingDate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Estimating Date",
        "label": "Net Operating Loss Estimating Date",
        "terseLabel": "Net operating loss estimating date"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NetProceedsFromSaleOfVariableInterestEntityEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NetProceedsFromSaleOfVariableInterestEntityEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Proceeds from sale of variable interest entity equity.",
        "label": "Net Proceeds from Sale of Variable Interest Entity Equity",
        "terseLabel": "Proceeds from sale of ownership interest in TRC, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetRentableArea": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetRentableArea",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Rentable Area",
        "terseLabel": "Rentable square feet",
        "documentation": "Net rentable area for properties owned."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "inva_NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New debt instrument interest rate after repurchase of notes member.",
        "label": "New Debt Instrument Interest Rate After Repurchase Of Notes [Member]",
        "terseLabel": "New Rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NonCashActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NonCashActivity",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash activity.",
        "label": "Non Cash Activity",
        "terseLabel": "Adoption of ASU 2020-06"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r1137",
      "r1148",
      "r1158",
      "r1182",
      "r1191"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1164"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "inva_NonRule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NonRule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Rule 10B51 Arr Modified Flag",
        "label": "Non Rule 10B51 Arr Modified Flag",
        "terseLabel": "Non Rule 10b51 Arrangement Modified"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-US [Member]",
        "terseLabel": "Rest of the world",
        "verboseLabel": "Ex-U.S.",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1456",
      "r1458",
      "r1459",
      "r1460"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental Disclosure of Non-cash Investing and Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r527",
      "r1264",
      "r1265",
      "r1266",
      "r1268",
      "r1453"
     ]
    },
    "inva_NumberOfBoardMembersOfInvestee": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfBoardMembersOfInvestee",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of the Investee's Board members",
        "label": "Number of Board Members of the Investee",
        "documentation": "The total number of Board members of the Investee."
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumberOfCommonStockIssuedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfCommonStockIssuedDescription",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of common stock issued description",
        "label": "Number Of Common Stock Issued Description",
        "documentation": "Number of common stock issued description."
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Investee's Board members currently representing the Company",
        "label": "Number of the Company's Board Members Currently Serving on the Board of Investee",
        "documentation": "The number of the Company's Board members currently serving on the Investee's Board."
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumberOfCustomers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfCustomers",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers.",
        "label": "Number Of Customers",
        "terseLabel": "Number of customers"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumberOfDerivativeInstrumentsPurchased": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfDerivativeInstrumentsPurchased",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of derivative instruments purchased.",
        "label": "Number of Derivative Instruments Purchased",
        "terseLabel": "Number of derivative instruments purchased"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumberOfInvesteesBoardMembers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfInvesteesBoardMembers",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Investees Board Members",
        "documentation": "Number of investees board members.",
        "terseLabel": "Number of investees board members"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumberOfMajorCustomers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfMajorCustomers",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Major Customers",
        "documentation": "Number of major customers.",
        "terseLabel": "Numberof major customers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1030",
      "r1271"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1035",
      "r1271"
     ]
    },
    "inva_NumberOfSharesReceivableOnSettlementOfDerivativeInstrument": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumberOfSharesReceivableOnSettlementOfDerivativeInstrument",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares payable to the entity on settlement of derivative instruments.",
        "label": "Number of Shares Receivable on Settlement of Derivative Instrument",
        "terseLabel": "Net shares settlement payable to the entity"
       }
      }
     },
     "auth_ref": []
    },
    "inva_NumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "NumeratorAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "auth_ref": []
    },
    "inva_OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Old debt instrument interest rate before repurchase of notes member.",
        "label": "Old Debt Instrument Interest Rate Before Repurchase Of Notes [Member]",
        "terseLabel": "Old Rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_OneDirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OneDirectorMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Director.",
        "label": "One Director [Member]",
        "terseLabel": "One Director"
       }
      }
     },
     "auth_ref": []
    },
    "inva_OneOfImaginabsCommonStockholderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OneOfImaginabsCommonStockholderMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One of ImaginAb's Common Stockholders",
        "label": "One Of Imaginabs Common Stockholder [Member]",
        "documentation": "Represents information pertaining to one of ImaginAb's common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses",
        "totalLabel": "Total expenses",
        "verboseLabel": "Operating expenses",
        "negatedLabel": "Operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Loss from operations",
        "terseLabel": "Operating expenses",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r1022",
      "r1270",
      "r1272",
      "r1273",
      "r1274",
      "r1275"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Straight line operating lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r1077"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liabilities",
        "terseLabel": "Total operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of lease liabilities included within Other accrued liabilities",
        "verboseLabel": "Current portion of lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion of lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities:",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r733"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r736",
      "r1077"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, Weighted average remaining lease term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r1077"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Loss Carryforwards, Total",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "inva_OperatingLossCarryforwardsIndefinitePeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OperatingLossCarryforwardsIndefinitePeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards which can be carry forward indefinitely.",
        "label": "Operating Loss Carryforwards, Indefinite Period",
        "terseLabel": "Net operating loss carryforwards, indefinite period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r348",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "terseLabel": "Strike price for the underlying number of shares (in dollars per share)",
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r89",
      "r90",
      "r180"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]",
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "inva_OptionPricingModelBacksolveValuationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OptionPricingModelBacksolveValuationMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Pricing Model Backsolve valuation.",
        "label": "Option Pricing Model Backsolve Valuation [Member]",
        "terseLabel": "Backsolve Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPolicies1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "verboseLabel": "DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r148",
      "r149",
      "r177"
     ]
    },
    "inva_OtherAccruedLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OtherAccruedLiabilitiesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities [Member]",
        "label": "Other Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r1078"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Assets, Noncurrent, Total",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r861",
      "r937",
      "r976",
      "r977",
      "r978"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Liabilities, Total",
        "label": "Other Liabilities",
        "terseLabel": "Other",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r837",
      "r909",
      "r910",
      "r1111",
      "r1416",
      "r1452"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfOtherLongtermLiabilitiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Noncash Income (Expense), Total",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentLiabilitiesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities",
        "verboseLabel": "Other Long Term Liabilities",
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-term Liabilities",
        "documentation": "Tabular disclosure of other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net",
        "verboseLabel": "Other income, net",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expense, net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "inva_Outstanding2028NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "Outstanding2028NotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding 2028 Notes [Member]",
        "documentation": "Outstanding 2028 notes.",
        "terseLabel": "Outstanding 2028 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1135",
      "r1146",
      "r1156",
      "r1189"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1138",
      "r1149",
      "r1159",
      "r1192"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1138",
      "r1149",
      "r1159",
      "r1192"
     ]
    },
    "inva_OutstandingStockWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OutstandingStockWarrantMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding stock warrant member",
        "label": "Outstanding Stock Warrant [Member]",
        "terseLabel": "Outstanding Stock Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "inva_OwnershipInterestInConsolidatedEntities": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OwnershipInterestInConsolidatedEntities",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest in consolidated entities.",
        "label": "Ownership Interest in Consolidated Entities",
        "terseLabel": "Ownership interest in LLC"
       }
      }
     },
     "auth_ref": []
    },
    "inva_OwnershipInterestsAndInvestmentsCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "OwnershipInterestsAndInvestmentsCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership Interests and Investments Carrying Value",
        "documentation": "Ownership interests and investments carrying value.",
        "terseLabel": "Total carrying value of ownership interests and investments"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PaionAgMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PaionAgMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PAION AG [Member]",
        "label": "PAION AG [Member]",
        "terseLabel": "PAION AG"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ParatekPharmaceuticalsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ParatekPharmaceuticalsIncMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paratek Pharmaceuticals, Inc.",
        "label": "Paratek Pharmaceuticals, Inc [Member]",
        "terseLabel": "Paratek Pharmaceuticals, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PartnershipAgreementLockUpPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PartnershipAgreementLockUpPeriod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time in which contributors to an investment fund have waived the right of redemption, as defined in the partnership agreement.",
        "label": "Partnership Agreement, Lock-Up Period",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payment of Financing and Stock Issuance Costs, Total",
        "label": "Payment of Financing and Stock Issuance Costs",
        "terseLabel": "Total issuance costs",
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForPurchaseOfInvestmentOperatingActivity",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for Purchase, Investment, Operating Activity",
        "terseLabel": "Purchases of equity and long-term investments",
        "documentation": "Amount of cash outflow for acquisition of investment, classified as operating activity. Includes, but is not limited to, funding, origination, drawdown, and participation in investment."
       }
      }
     },
     "auth_ref": [
      "r1455"
     ]
    },
    "us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForPurchaseOfSecuritiesOperatingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Purchase of Securities, Operating Activities",
        "terseLabel": "Purchases of trading securities",
        "documentation": "Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Debt Issuance Costs",
        "terseLabel": "Liability issuance costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs to acquire equity securities",
        "label": "Payments of Stock Issuance Costs",
        "verboseLabel": "Equity issuance costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Repurchase of shares to satisfy tax withholding",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of equity method investments",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireEquitySecuritiesFvNi",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire equity securities",
        "label": "Payments to Acquire Equity Securities, FV-NI",
        "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r259"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Acquisition of intangible asset",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireLongtermInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional cash investment",
        "label": "Payments to Acquire Long-Term Investments",
        "verboseLabel": "Initial contribution",
        "negatedTerseLabel": "Purchases of equity and long-term investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term."
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of trading securities",
        "totalLabel": "Payments to Acquire Marketable Securities, Total",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r1282"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToMinorityShareholders",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions to noncontrolling interests",
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1164"
     ]
    },
    "inva_Percent2.50ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "Percent2.50ConvertibleDebtMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to 2.50% convertible senior notes due 2025.",
        "label": "Percent2.50 Convertible Debt [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfEconomicInterestInPartnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfEconomicInterestInPartnership",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Economic interest of the Partnership (in percent)",
        "documentation": "Percentage of economic interest held in Partnership.",
        "label": "Percentage of Economic Interest In Partnership"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of economic interest in any future payments made under the agreements.",
        "label": "Percentage of Economic Interest on Future Payments Under Agreements",
        "terseLabel": "Percentage of economic interest in any future payments made under the agreements"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfEstimatedVolatility": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfEstimatedVolatility",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of estimated volatility.",
        "label": "Percentage of Estimated Volatility",
        "terseLabel": "Estimated volatility"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of maximum royalty based on achievement of annual net product sales thresholds.",
        "label": "Percentage Of Maximum Royalty Based On Achievement Of Annual Net Product Sales Thresholds",
        "terseLabel": "Percentage of maximum royalty based on achievement of annual net product sales thresholds"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfMinimumRoyaltyRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfMinimumRoyaltyRate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of minimum royalty rate.",
        "label": "Percentage Of Minimum Royalty Rate",
        "terseLabel": "Percentage of minimum royalty rate"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reimbursed for direct and certain indirect manufacturing costs.",
        "label": "Percentage Of Reimbursed For Direct And Certain Indirect Manufacturing Costs",
        "terseLabel": "Percentage of reimbursed for direct and certain indirect manufacturing costs"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Royalty On Payments Received From Sublicensees",
        "terseLabel": "Percentage of royalty on payments received from sublicensees",
        "documentation": "Represents the royalty payable as a percentage of payments received from sublicensees."
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfRoyaltyPayableOnNetSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfRoyaltyPayableOnNetSales",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the royalty payable, as a percentage of net sales.",
        "label": "Percentage Of Royalty Payable On Net Sales",
        "terseLabel": "Percentage of royalty payable on net sales"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PercentageOfRoyaltyPaymentsNotEntitledToReceive": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PercentageOfRoyaltyPaymentsNotEntitledToReceive",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of royalty payments not entitled to receive",
        "documentation": "Percentage of royalty payments the company is not entitled to receive."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1343",
      "r1344",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1343",
      "r1344",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1166"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "inva_PortionOfDebtInstrumentFaceAmountExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PortionOfDebtInstrumentFaceAmountExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of debt instrument face amount, exercised.",
        "label": "Portion of Debt Instrument Face Amount, Exercised",
        "terseLabel": "Portion of debt instrument face amount, Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]",
        "terseLabel": "Preferred stocks - Privately held healthcare companies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r512"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r915"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Preferred Stock, Shares Issued, Total",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r512"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r915",
      "r934",
      "r1453",
      "r1454"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "totalLabel": "Preferred Stock, Value, Issued, Total",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding",
        "verboseLabel": "Preferred stock",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r840",
      "r1078"
     ]
    },
    "inva_PreferredStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PreferredStockWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock warrants.",
        "label": "Preferred Stock Warrants Member",
        "terseLabel": "Preferred Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1253"
     ]
    },
    "inva_PresentationReclassificationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PresentationReclassificationPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Presentation reclassification.",
        "label": "Presentation Reclassification [Policy Text Block]",
        "terseLabel": "Presentation Reclassification"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PriorPeriodImmaterialCorrectionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PriorPeriodImmaterialCorrectionPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting prior period immaterial correction.",
        "label": "Prior Period Immaterial Correction [Policy Text Block]",
        "terseLabel": "Prior Period Immaterial Correction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "inva_PrivatePlacementPositionsAndConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PrivatePlacementPositionsAndConvertibleNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement Positions And Convertible Notes.",
        "label": "Private Placement Positions And Convertible Notes [Member]",
        "terseLabel": "Private Placement Positions And Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PrivatelyHeldHealthcareCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PrivatelyHeldHealthcareCompaniesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Privately Held Healthcare Companies [Member]",
        "documentation": "Privately held healthcare companies.",
        "terseLabel": "Privately Held Healthcare Companies"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PrivatelyNegotiatedCapPriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PrivatelyNegotiatedCapPriceMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Privately Negotiated Cap Price [Member]",
        "documentation": "Privately negotiated cap price.",
        "terseLabel": "Privately-negotiated cap price"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PrivatelyNegotiatedCappedCallOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PrivatelyNegotiatedCappedCallOptionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the capped call option entered in connection with the offering of convertible debt.",
        "label": "Privately Negotiated Capped Call Option [Member]",
        "terseLabel": "Privately-negotiated capped call option"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes, net of issuance costs",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuances of common stock, net",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from issuance of convertible senior notes due 2028, net of issuance costs",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1257"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds from Issuance or Sale of Equity, Total",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Gross Proceeds from sale of equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r890"
     ]
    },
    "inva_ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of economic interest under Equity Purchase Agreement.",
        "label": "Proceeds from sale of economic interest under Equity Purchase Agreement",
        "terseLabel": "Proceeds from sale of economic interest under Equity Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of property and equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "totalLabel": "Proceeds from Sale of Property, Plant, and Equipment, Total",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_ProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product [Member]",
        "terseLabel": "Net product sales",
        "documentation": "Article or substance produced by nature, labor or machinery."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r351",
      "r788",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r1005",
      "r1047",
      "r1088",
      "r1090",
      "r1091",
      "r1094",
      "r1096",
      "r1327",
      "r1328",
      "r1339",
      "r1419",
      "r1423",
      "r1424",
      "r1425",
      "r1426",
      "r1427",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1444",
      "r1445",
      "r1446",
      "r1447",
      "r1448",
      "r1449",
      "r1450"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Products and Services [Domain]"
       }
      }
     },
     "auth_ref": [
      "r351",
      "r788",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r1005",
      "r1047",
      "r1088",
      "r1090",
      "r1091",
      "r1094",
      "r1096",
      "r1327",
      "r1328",
      "r1339",
      "r1419",
      "r1423",
      "r1424",
      "r1425",
      "r1426",
      "r1427",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1444",
      "r1445",
      "r1446",
      "r1447",
      "r1448",
      "r1449",
      "r1450"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r243",
      "r245",
      "r260",
      "r268",
      "r277",
      "r285",
      "r288",
      "r289",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r646",
      "r658",
      "r660",
      "r663",
      "r664",
      "r690",
      "r708",
      "r830",
      "r850",
      "r894",
      "r936",
      "r955",
      "r956",
      "r1063",
      "r1064",
      "r1110",
      "r1254",
      "r1330"
     ]
    },
    "inva_ProfitLossShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ProfitLossShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (in shares)",
        "label": "Profit Loss Shares",
        "documentation": "Profit Loss Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r738"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, equipment and leasehold improvements",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "totalLabel": "Property, Plant and Equipment, Net, Total",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r738",
      "r831",
      "r847",
      "r1078"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r211",
      "r214",
      "r846"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r738"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "inva_PropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment Useful Life [Table Text Block]",
        "terseLabel": "Schedule of property, equipment and leasehold improvements useful lives"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PubliclyTradedHealthcareCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PubliclyTradedHealthcareCompaniesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Publicly Traded Healthcare Companies [Member]",
        "documentation": "Publicly traded healthcare companies.",
        "terseLabel": "Publicly Held Healthcare Companies"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase and sale of other investments managed by ISP FUND LP",
        "documentation": "Purchase and sale of other investments managed by ISP FUND LP",
        "terseLabel": "Purchase and sales of other investments managed by ISP Fund LP, net",
        "negatedLabel": "Purchases and sales of other investments managed by ISP Fund LP, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Future minimum purchase commitments, remainder of 2025",
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PurchaseObligationDueInSecondYear",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Future minimum purchase commitments, 2026",
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PurchaseObligationDueInThirdYear",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Future minimum purchase commitments, 2027",
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "inva_PurchaseOfEntasisNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PurchaseOfEntasisNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of entasis noncontrolling interest.",
        "label": "Purchase Of Entasis noncontrolling Interest",
        "negatedLabel": "Purchase of Entasis noncontrolling interest"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of capped call options associated with convertible senior notes.",
        "label": "Purchases of Capped Call Options Associated with Convertible Senior Notes",
        "negatedLabel": "Purchases of capped call options associated with convertible senior notes due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PurchasesOfEquityInvestmentsManagedByIspFundLp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PurchasesOfEquityInvestmentsManagedByIspFundLp",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of Equity Investments Managed by Isp Fund Lp",
        "label": "Purchases of Equity Investments Managed by Isp Fund Lp",
        "negatedLabel": "Purchases of equity investments managed by ISP Fund LP"
       }
      }
     },
     "auth_ref": []
    },
    "inva_PurchasesOfTradingSecurityManagedByIspFundLp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "PurchasesOfTradingSecurityManagedByIspFundLp",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of trading security managed by Isp fund Lp.",
        "label": "Purchases of Trading Security Managed by Isp Fund Lp",
        "negatedLabel": "Purchases of trading security managed by ISP Fund LP"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PutOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PutOptionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Put Option [Member]",
        "terseLabel": "Stock prices above $38.00 per share",
        "documentation": "A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "inva_QualifiedFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "QualifiedFinancingMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified Financing [Member]",
        "label": "Qualified Financing [Member]",
        "terseLabel": "Qualified Financing"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r539",
      "r547",
      "r579",
      "r580",
      "r581",
      "r593",
      "r696",
      "r757",
      "r769",
      "r786",
      "r870",
      "r872",
      "r886",
      "r905",
      "r906",
      "r964",
      "r966",
      "r968",
      "r969",
      "r975",
      "r1000",
      "r1001",
      "r1037",
      "r1046",
      "r1059",
      "r1069",
      "r1070",
      "r1074",
      "r1075",
      "r1090",
      "r1100",
      "r1325",
      "r1334",
      "r1388",
      "r1407",
      "r1408",
      "r1409",
      "r1410",
      "r1411"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r539",
      "r547",
      "r579",
      "r580",
      "r581",
      "r593",
      "r696",
      "r757",
      "r769",
      "r786",
      "r870",
      "r872",
      "r886",
      "r905",
      "r906",
      "r964",
      "r966",
      "r968",
      "r969",
      "r975",
      "r1000",
      "r1001",
      "r1037",
      "r1046",
      "r1059",
      "r1069",
      "r1070",
      "r1074",
      "r1075",
      "r1090",
      "r1100",
      "r1325",
      "r1334",
      "r1388",
      "r1407",
      "r1408",
      "r1409",
      "r1410",
      "r1411"
     ]
    },
    "inva_RealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RealizedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized loss",
        "label": "Realized Loss",
        "terseLabel": "Realized loss",
        "negatedLabel": "Realized loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesLongTermContractsOrPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesLongTermContractsOrPrograms",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Long-Term Contracts or Programs",
        "terseLabel": "Receivable from collaboration arrangements",
        "documentation": "Amount to be collected within one year of the balance sheet date (or one operating cycle, if longer) from customers in accordance with the contractual provisions of long-term contracts or programs including amounts billed and unbilled as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r1251"
     ]
    },
    "inva_ReclassificationOfCurrentPortion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ReclassificationOfCurrentPortion",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsReconciliationOfEquityAndLongTermInvestmentsBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of current portion",
        "label": "Reclassification of Current Portion",
        "documentation": "Reclassification of current portion."
       }
      }
     },
     "auth_ref": []
    },
    "inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition Of Noncontrolling Interest Upon Initial Consolidation Of Entasis",
        "label": "Recognition of noncontrolling interest upon initial consolidation of Entasis"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognition of noncontrolling interest upon initial consolidation of Entasis (in shares)",
        "label": "Recognition Of Noncontrolling Interest Upon Initial ConsolidationOf Entasis, Shares",
        "documentation": "Recognition of noncontrolling interest upon initial consolidation of Entasis, Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of reconciliation to the consolidated net income",
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44"
     ]
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "documentation": "Disclosure of information about identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r44"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1130",
      "r1141",
      "r1151",
      "r1184"
     ]
    },
    "inva_ReductionToAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ReductionToAdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction to additional paid in capital",
        "label": "Reduction to Additional Paid in Capital",
        "terseLabel": "Reduction to Additional Paid in Capital"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ReductionToResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ReductionToResearchAndDevelopmentExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction to Research and Development Expense",
        "label": "Reduction to Research and Development Expense",
        "terseLabel": "Reduction to research and development expense"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RegulatoryMilestonePaymentsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RegulatoryMilestonePaymentsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory milestone payments receivable.",
        "label": "Regulatory Milestone Payments Receivable",
        "terseLabel": "Additional regulatory milestone payments receivable"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RegulatoryStartingMaterialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RegulatoryStartingMaterialMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory Starting Material",
        "label": "Regulatory Starting Material [Member]",
        "documentation": "Regulatory starting material."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "terseLabel": "Related Party [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r546",
      "r746",
      "r747",
      "r838",
      "r845",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r933",
      "r935",
      "r962"
     ]
    },
    "inva_RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock in the reporting entity owned by related parties.",
        "label": "Related Party Transaction, Common Stock Ownership Percentage By Related Party",
        "terseLabel": "Percentage of common stock owned by a related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Parties",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r940",
      "r941",
      "r942"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r546",
      "r746",
      "r747",
      "r838",
      "r845",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r933",
      "r935",
      "r962",
      "r1403"
     ]
    },
    "inva_RelatedPartyTransactionsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RelatedPartyTransactionsPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the entity's accounting policies for transactions entered with related parties.",
        "label": "Related Party Transactions [Policy Text Block]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Convertible Debt",
        "terseLabel": "Payment towards convertible promissory note",
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty payments",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1258"
     ]
    },
    "us-gaap_RepaymentsOfUnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfUnsecuredDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Unsecured Debt",
        "negatedLabel": "Payment for repurchase of convertible subordinated notes due 2023",
        "terseLabel": "Payment for repurchase of debt instrument",
        "verboseLabel": "Payment upon maturity of debt instrument",
        "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r483",
      "r514",
      "r748",
      "r770",
      "r832",
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Research and Development Expense, Total",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development - External services",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r1002",
      "r1029",
      "r1412"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "inva_ResearchAndDevelopmentSupportMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ResearchAndDevelopmentSupportMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Support [Member]",
        "label": "Research and Development Support [Member]",
        "terseLabel": "Research and Development Support"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and development",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1374"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r1131",
      "r1142",
      "r1152",
      "r1185"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1132",
      "r1143",
      "r1153",
      "r1186"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r1139",
      "r1150",
      "r1160",
      "r1193"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "terseLabel": "RSAs",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r163",
      "r842",
      "r880",
      "r885",
      "r891",
      "r916",
      "r1078"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r273",
      "r274",
      "r275",
      "r278",
      "r285",
      "r287",
      "r289",
      "r398",
      "r404",
      "r450",
      "r628",
      "r629",
      "r642",
      "r643",
      "r644",
      "r647",
      "r657",
      "r658",
      "r670",
      "r673",
      "r674",
      "r677",
      "r688",
      "r721",
      "r723",
      "r876",
      "r878",
      "r895",
      "r1453"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total royalty revenue",
        "negatedTerseLabel": "License revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total net revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r315",
      "r323",
      "r324",
      "r341",
      "r347",
      "r351",
      "r353",
      "r355",
      "r536",
      "r537",
      "r788"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognition1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Text Block]",
        "verboseLabel": "REVENUE RECOGNITION",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r538"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r1004",
      "r1019"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "totalLabel": "Revenues, Total",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r251",
      "r268",
      "r315",
      "r323",
      "r324",
      "r341",
      "r347",
      "r351",
      "r353",
      "r355",
      "r394",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r708",
      "r830",
      "r1029",
      "r1330"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets obtained in exchange for operating lease obligations",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r734",
      "r1077"
     ]
    },
    "inva_RightOfUseAssetsObtainedThroughAcquistions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RightOfUseAssetsObtainedThroughAcquistions",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right of Use Assets Obtained Through Acquistions",
        "label": "Right of Use Assets Obtained Through Acquistions",
        "terseLabel": "Right-of-use assets obtained through acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RiskFreeInterestRate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk free interest rate.",
        "label": "Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties payable period after first commercial sale of product.",
        "label": "Royalties Payable Period After First Commercial Sale Of Product",
        "terseLabel": "Royalties payable period after first commercial sale of product"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty agreement increase in maximum potential payout percent.",
        "label": "Royalty Agreement Increase In Maximum Potential Payout Percent",
        "terseLabel": "Increase in maximum potential payout percent"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RoyaltyAgreementMaximumPotentialPayoutPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltyAgreementMaximumPotentialPayoutPercent",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty agreement, maximum potential payout, percent.",
        "label": "Royalty Agreement Maximum Potential Payout Percent",
        "terseLabel": "Maximum potential royalty payout"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty agreement required payment for breach of agreement payment one.",
        "label": "Royalty Agreement Required Payment For Breach Of Agreement Payment One",
        "terseLabel": "Required payment for breach of agreement, payment one"
       }
      }
     },
     "auth_ref": []
    },
    "inva_RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty agreement required payment for breach of agreement payment two.",
        "label": "Royalty Agreement Required Payment For Breach Of Agreement Payment Two",
        "terseLabel": "Maximum aggregate royalty payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RoyaltyExpense",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "inva_RoyaltyFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltyFinancingAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty financing agreement member.",
        "label": "Royalty Financing Agreement [Member]",
        "terseLabel": "Royalty Financing Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RoyaltyMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty [Member]",
        "verboseLabel": "Royalty revenue from a related party",
        "terseLabel": "Royalty revenue",
        "documentation": "Money for usage-based right to asset."
       }
      }
     },
     "auth_ref": [
      "r1340"
     ]
    },
    "inva_RoyaltyPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "RoyaltyPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Payments",
        "label": "Royalty Payments",
        "terseLabel": "Royalty Payments"
       }
      }
     },
     "auth_ref": []
    },
    "inva_Rule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "Rule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rule 10b51 Arr Modified Flag.",
        "label": "Rule 10b51 Arr Modified Flag",
        "terseLabel": "Rule 10b51Arrangement Modified"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "inva_SaleOfEquityInvestmentsManagedByIspFundLp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SaleOfEquityInvestmentsManagedByIspFundLp",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of equity investments managed by ISP FUND LP",
        "documentation": "Sale of equity investments managed by ISP FUND LP",
        "terseLabel": "Sales of equity investments managed by ISP Fund LP"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares to be purchased under the securities purchase agreement",
        "terseLabel": "Number of shares purchased under the securities purchase agreement",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SaleOfWarrantsNumberOfWarrantsIssuedInTransaction",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Maximum number of additional shares into which warrants may be converted under the securities purchase agreement",
        "label": "Sale of Warrants, Number of Warrants Issued in Transaction",
        "documentation": "The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction.",
        "terseLabel": "Number of warrants purchased under the securities purchase agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SalesMilestonePaymentsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SalesMilestonePaymentsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales milestone payments receivable.",
        "label": "Sales Milestone Payments Receivable",
        "terseLabel": "Sales milestone payments receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net Product Sales",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r1230"
     ]
    },
    "inva_SarissaCapitalManagementLpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SarissaCapitalManagementLpMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Sarissa Capital.",
        "label": "Sarissa Capital Management Lp [Member]",
        "terseLabel": "Sarissa Capital"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Accrued Liabilities",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of anti-dilutive securities",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Available-for-Sale Securities",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370"
     ]
    },
    "inva_ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ScheduleOfBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Balance sheet Information Related To Operating Lease Table Text Block",
        "label": "Schedule Of Balance sheet Information Related To Operating Lease Table Text Block",
        "terseLabel": "Schedule of Operating Lease Information Presented In Balance Sheet"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsLaJollaPharmaceuticalCompanyDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsProFormaInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r650"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Leases",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of stock-based compensation expense included in the consolidated statements of operations by award type",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "verboseLabel": "Schedule of components of the income tax expense",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1376"
     ]
    },
    "inva_ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ScheduleOfConsolidatedEntitiesAndBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of consolidated entities and business acquisitions by acquisition.",
        "label": "Schedule of Consolidated Entities and Business Acquisitions by Acquisition [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Debt",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r55",
      "r56",
      "r99",
      "r160",
      "r162",
      "r1042",
      "r1044",
      "r1263",
      "r1396"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets and deferred tax liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1373"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computation of basic and diluted net income per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1269"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about diluted earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r295",
      "r299",
      "r308"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of differences between expected U.S. federal statutory income tax to income tax expense",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r605",
      "r1062",
      "r1369"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "verboseLabel": "Schedule of stock-based compensation expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of net product sales",
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r638",
      "r1227",
      "r1228",
      "r1229",
      "r1379",
      "r1380",
      "r1381",
      "r1382"
     ]
    },
    "inva_ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Information Of Variable Interest Entities [Table Text Block]",
        "documentation": "Schedule of financial information of variable interest entities.",
        "terseLabel": "Schedule of Balance Sheets and Income Statements of VIE"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Financial Information of TRC",
        "label": "Schedule of Financial Information on Consolidated Entity [Table Text Block]",
        "documentation": "Schedule of financial Information on consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAccumulatedAmortizationOfRecognizedIntangibleAssetsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r442",
      "r446",
      "r447",
      "r448",
      "r789",
      "r1002",
      "r1040"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accumulated Amortization of Recognized Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r1040",
      "r1315"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r1039"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r125",
      "r126",
      "r127"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Scheduled Maturities of Convertible Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r738"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "inva_ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Equity and Long-Term Investments Balance [Table Text Block]",
        "documentation": "Schedule of reconciliation of equity and long-term investments balance.",
        "terseLabel": "Reconciliation of Equity and Long-Term Investments Balances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r940",
      "r941",
      "r942"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of equity award activity and related information",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r168"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r551",
      "r554",
      "r555",
      "r556",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Summary of weighted-average assumptions used to calculate estimated value of stock options",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "verboseLabel": "Schedule of unrecognized stock-based compensation cost",
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Summary of changes in unrecognized tax benefits",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r1061"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r79",
      "r82",
      "r83",
      "r661",
      "r662",
      "r665",
      "r666",
      "r765",
      "r766",
      "r767"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Balance Sheets and Income Statements of VIE",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r79",
      "r82",
      "r83"
     ]
    },
    "inva_SecuredConvertibleCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuredConvertibleCreditAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured convertible credit agreement.",
        "label": "Secured Convertible Credit Agreement [Member]",
        "terseLabel": "Secured Convertible Credit Agreement",
        "verboseLabel": "January 2023 Secured Convertible Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.",
        "label": "Securities Purchase Agreement, Amount",
        "terseLabel": "Amount of securities purchase agreement",
        "verboseLabel": "Payments for acquire variable interest"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities purchase agreement",
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities purchase agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementNumberOfTranches": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementNumberOfTranches",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of tranches in which the Company agreed to purchase common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.",
        "label": "Securities Purchase Agreement, Number of Tranches",
        "terseLabel": "Number of tranches",
        "verboseLabel": "Number of tranches"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of the investee's board members which the Company has the right to designate.",
        "label": "Securities Purchase Agreement Rights To Designate Investee Board Members Number Of Board Members",
        "terseLabel": "Number of investee's board members which may be designated by the Company"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of shares to be purchased under the terms of a securities purchase agreement.",
        "label": "Securities Purchase Agreement, Total Number of Shares To Be Purchased Under the Agreement",
        "terseLabel": "Securities to be purchased",
        "verboseLabel": "Number of shares to be purchased under the securities purchase agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants to be purchased under the securities purchase agreement",
        "label": "Securities Purchase Agreement, Total Number of Warrants To Be Purchased Under Agreement",
        "documentation": "The total number of warrants to be purchased under the terms of a securities purchase agreement."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SecuritiesPurchaseAgreementWarrantsNumberOfSecuritiesCalledByWarrants",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of additional common stock shares into which the warrants may be converted.",
        "label": "Securities Purchase Agreement, Warrants, Number of Securities Called by Warrants",
        "terseLabel": "Maximum number of additional shares into which warrants may be converted under the securities purchase agreement",
        "verboseLabel": "Maximum number of additional shares into which warrants may be converted under the securities purchase agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1112"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r354",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r898",
      "r901",
      "r903",
      "r965",
      "r967",
      "r971",
      "r979",
      "r986",
      "r990",
      "r991",
      "r992",
      "r993",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1006",
      "r1048",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1092",
      "r1100",
      "r1339",
      "r1419",
      "r1423",
      "r1424",
      "r1426",
      "r1427",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1444",
      "r1445",
      "r1446",
      "r1447",
      "r1448",
      "r1449",
      "r1450"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r1028",
      "r1036"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r1025",
      "r1033"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReporting1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT REPORTING",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r331",
      "r332",
      "r333",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r355",
      "r1023",
      "r1026",
      "r1027",
      "r1029",
      "r1031",
      "r1034",
      "r1035"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r350",
      "r353",
      "r1024",
      "r1025",
      "r1032"
     ]
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and marketing",
        "label": "Selling and Marketing Expense",
        "totalLabel": "Selling and Marketing Expense, Total",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Selling, General and Administrative Expense, Total",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeniorUnsecuredConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeniorUnsecuredConvertibleNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which takes priority over other debt securities and can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Senior Unsecured Convertible Notes [Member]",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesA1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesA1PreferredStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A1 preferred stock member.",
        "label": "Series A1 preferred stock [Member]",
        "terseLabel": "Series A1 preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesC2PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesC2PreferredStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C-2 Preferred Stock [Member]",
        "documentation": "Series C-2 Preferred Stock member.",
        "terseLabel": "Series C-2 preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesCAndC2PreferredStockAndCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesCAndC2PreferredStockAndCommonStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C and C 2 Preferred Stock and Common Stock [Member]",
        "documentation": "Series C and C 2 preferred stock and common stock.",
        "terseLabel": "Series C preferred stock, Series C-2 preferred stock and common stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesCPreferredStockAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesCPreferredStockAndWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to series C preferred stock and warrants.",
        "label": "Series C Preferred Stock And Warrants [Member]",
        "terseLabel": "Series C preferred stock and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C preferred stock",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1249",
      "r1250",
      "r1336"
     ]
    },
    "inva_SeriesCWarrantsAndSeriesDWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesCWarrantsAndSeriesDWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C warrants and Series D warrants.",
        "label": "Series C warrants and Series D warrants [Member]",
        "terseLabel": "Series C Warrants and Series D Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesCWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesCWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C warrants",
        "label": "Series C Warrants [Member]",
        "documentation": "Series C Warrants."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesD1AndD2PreferredStockAndCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesD1AndD2PreferredStockAndCommonStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D 1 and D 2 preferred stock and common stock.",
        "label": "Series D 1 And D 2 Preferred Stock And Common Stock Member",
        "terseLabel": "Series D 1 And D 2 Preferred Stock And Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesD1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesD1PreferredStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D 1 preferred stock member.",
        "label": "Series D 1 Preferred Stock [Member]",
        "terseLabel": "Series D 1 Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesD1WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesD1WarrantMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D1 Warrant [Member]",
        "label": "Series D1 Warrant [Member]",
        "terseLabel": "Series D1 Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesD2PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesD2PreferredStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D 2 preferred stock member.",
        "label": "Series D 2 Preferred Stock [Member]",
        "terseLabel": "Series D 2 Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SeriesD2WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesD2WarrantMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D2 Warrant.",
        "label": "Series D2 Warrant [Member]",
        "terseLabel": "Series D2 Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesDPreferredStockMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series D Preferred Stock",
        "documentation": "Series D preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1249",
      "r1250",
      "r1336"
     ]
    },
    "inva_SeriesDWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SeriesDWarrantsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series D Warrants",
        "label": "Series D Warrants [Member]",
        "documentation": "Series D warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The additional value of shares granted to newly appointed non-employee director on the date that such individual joins the Board.",
        "label": "Share Based Compensation, Arrangement by Share Based Payment Award, Additional Equity Grant Value",
        "terseLabel": "Pro rata shares grant, value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]",
        "terseLabel": "Additional disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of shares granted annually to independent directors upon re-election the to Board.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Annual Equity Grant, Value",
        "terseLabel": "Annual grant of shares, value"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the consecutive and overlapping offering period for the offering of share-based payment awards.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Consecutive and Overlapping Offering Period",
        "terseLabel": "Total duration of consecutive and overlapping offering periods"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee exercised the right during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (in dollars per share)",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at the end of the period (in dollars per share)",
        "periodStartLabel": "Balance at the beginning of the period (in dollars per share)",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r567"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value per Share at Grant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Released RSUs and RSAs (in shares)",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total estimated fair value of equity instruments vested",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released RSUs and RSAs (in dollars per share)",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Valuation Assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Volatility",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of shares granted to newly appointed non-employee director on the date that such individual joins the Board.",
        "label": "Share Based Compensation, Arrangement by Share Based Payment Award, Initial Equity Grant Value",
        "terseLabel": "One time grant of shares, value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Stock-based compensation",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r551",
      "r554",
      "r555",
      "r556",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582"
     ]
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount the employee may contribute of employee's eligible compensation.",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award Maximum Amount As A Contribution Of Eligible Compensation",
        "terseLabel": "Maximum value of shares an employee may purchase in a calendar year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum contributions as a percentage of employee's eligible compensation",
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares an employee may purchase during any purchase period",
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "negatedLabel": "Exercised (in shares)",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "negatedLabel": "Forfeited (in shares)",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Granted (in shares)",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Number of outstanding RSUs and PSUs/RSAs and PSAs",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest non-option equity instruments outstanding that can be converted into shares under award activity.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest Outstanding, Number",
        "terseLabel": "Vested and expected to vest at the end of the period (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Fair Value per Share of fully vested and expected to vest non-option equity instruments outstanding that can be converted into shares under award activity.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest Outstanding, Weighted-Average Fair Value per Share",
        "terseLabel": "Vested and expected to vest at the end of the period (in dollars per share)"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award number of annual installments",
        "terseLabel": "Number of annual installments",
        "documentation": "The number of annual installments that RSUs granted to newly appointed independent directors will vest."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of purchase periods having duration of six months each.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Number of Purchase Periods",
        "terseLabel": "Number of offering periods"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares remaining available for issuance",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable option",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average estimated fair value of shares granted (in dollars per share)",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of outstanding options",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at the end of the period (in dollars per share)",
        "periodStartLabel": "Balance at the beginning of the period (in dollars per share)",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price of Outstanding Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest at the end of the period (in shares)",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at the end of the period (in dollars per shares)",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "inva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the duration of each purchase period within each consecutive and overlapping purchase period for offering of share-based payment awards.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Purchase Period",
        "terseLabel": "Duration of purchase period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised (in dollars per share)",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Fair Value of Stock-Based Compensation Awards",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r557",
      "r576",
      "r577",
      "r578",
      "r579",
      "r582",
      "r588",
      "r589",
      "r590",
      "r591"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "inva_ShareRepurchaseAgreementWithGlaxoGroupLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ShareRepurchaseAgreementWithGlaxoGroupLimitedMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase agreement with GSK",
        "label": "Share Repurchase Agreement With Glaxo Group Limited [Member]",
        "documentation": "Represents information pertaining to share repurchase agreement with Glaxo Group Limited."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1338"
     ]
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Domain]"
       }
      }
     },
     "auth_ref": [
      "r1338"
     ]
    },
    "us-gaap_ShareRepurchaseProgramExciseTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareRepurchaseProgramExciseTax",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program, Excise Tax",
        "terseLabel": "Realized excise tax on share repurchase",
        "documentation": "Amount of excise tax on share purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1337"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total estimated fair value of options vested",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "negatedLabel": "Released RSUs/RSAs (in shares)",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released RSUs/RSAs (in shares)",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensation2012PlanAndEsppDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price as a percentage of fair market value of stock",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r1322",
      "r1323",
      "r1324"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1322",
      "r1323",
      "r1324"
     ]
    },
    "inva_SoftwareAndComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SoftwareAndComputerEquipmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software and computer equipment",
        "label": "Software And Computer Equipment [Member]",
        "terseLabel": "Software and computer equipment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SpecialTermReDesignatingBoardMemberToBoardOfInvestee",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Terms on amended and restated investor rights agreement.",
        "label": "Special Term Re Designating Board Member To Board Of Investee",
        "terseLabel": "Special terms on re-designating board member to board of investee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "inva_StateNetOperatingLossesEstimatedUtilizationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "StateNetOperatingLossesEstimatedUtilizationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State net operating losses estimated utilization amount.",
        "label": "State Net Operating Losses Estimated Utilization Amount",
        "terseLabel": "State net operating losses estimated utilization amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r119",
      "r122",
      "r123",
      "r220",
      "r248",
      "r249",
      "r250",
      "r273",
      "r274",
      "r275",
      "r278",
      "r285",
      "r287",
      "r289",
      "r316",
      "r398",
      "r404",
      "r450",
      "r527",
      "r628",
      "r629",
      "r642",
      "r643",
      "r644",
      "r647",
      "r657",
      "r658",
      "r670",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r688",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r721",
      "r723",
      "r745",
      "r853",
      "r876",
      "r877",
      "r878",
      "r895",
      "r957"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r354",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r898",
      "r901",
      "r903",
      "r965",
      "r967",
      "r971",
      "r979",
      "r986",
      "r990",
      "r991",
      "r992",
      "r993",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1006",
      "r1048",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1092",
      "r1100",
      "r1339",
      "r1419",
      "r1423",
      "r1424",
      "r1426",
      "r1427",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1444",
      "r1445",
      "r1446",
      "r1447",
      "r1448",
      "r1449",
      "r1450"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement",
        "verboseLabel": "Subsequent Events",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r316",
      "r723",
      "r788",
      "r888",
      "r896",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r915",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r924",
      "r925",
      "r926",
      "r927",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r935",
      "r938",
      "r939",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r957",
      "r1101"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncomeParenthetical",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r316",
      "r358",
      "r723",
      "r788",
      "r888",
      "r896",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r915",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r924",
      "r925",
      "r926",
      "r927",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r935",
      "r938",
      "r939",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r957",
      "r1101"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r1134",
      "r1145",
      "r1155",
      "r1188"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible subordinated notes due 2023 (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r55",
      "r119",
      "r122",
      "r163",
      "r496"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding (in shares)",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r118",
      "r119",
      "r163"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationCompensationAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r118",
      "r119",
      "r163",
      "r563"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture, Total",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Exercise of stock options, and issuance of common stock units and stock awards, net of repurchase of shares to satisfy tax withholding",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r118",
      "r119",
      "r163"
     ]
    },
    "srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program, Authorized, Number of Shares",
        "terseLabel": "Realized excise tax on share repurchase (in shares)"
       }
      }
     },
     "auth_ref": [
      "r1338"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "terseLabel": "Amount of shares repurchased",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Stock repurchased and retired during period, shares",
        "documentation": "Number of shares that have been repurchased and retired during the period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r118",
      "r119",
      "r163"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchased and Retired During Period, Value",
        "terseLabel": "Stock repurchased and retired during period, value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r118",
      "r119",
      "r163"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r84",
      "r220",
      "r221",
      "r249",
      "r273",
      "r274",
      "r275",
      "r278",
      "r285",
      "r287",
      "r398",
      "r404",
      "r450",
      "r527",
      "r628",
      "r629",
      "r642",
      "r643",
      "r644",
      "r647",
      "r657",
      "r658",
      "r670",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r688",
      "r709",
      "r710",
      "r714",
      "r722",
      "r745",
      "r877",
      "r878",
      "r893",
      "r917",
      "r934",
      "r958",
      "r959",
      "r984",
      "r1110",
      "r1261",
      "r1301",
      "r1393",
      "r1453"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquity1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r267",
      "r511",
      "r513",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r527",
      "r679",
      "r960",
      "r961",
      "r985"
     ]
    },
    "inva_StrategicAllianceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "StrategicAllianceAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the strategic alliance with GSK for initiating three new full discovery programs and giving GSK option to license exclusive development and commercialization rights of products.",
        "label": "Strategic Alliance Agreement [Member]",
        "terseLabel": "Strategic alliance - MABA program"
       }
      }
     },
     "auth_ref": []
    },
    "inva_StrategicAllianceMabaProgram": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "StrategicAllianceMabaProgram",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "strategic alliance - MABA program",
        "documentation": "strategic alliance - MABA program",
        "terseLabel": "Strategic alliance - MABA program"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscription agreement one-time milestone payment on first commercial sale",
        "label": "Subscription Agreement One-time Milestone Payment on Commercial Sales",
        "documentation": "Subscription agreement one-time milestone payment on commercial sales."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SubscriptionAgreementOneTimeMilestonePaymentOnNetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SubscriptionAgreementOneTimeMilestonePaymentOnNetSales",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscription agreement one-time milestone payment on net sales",
        "label": "Subscription Agreement One-time Milestone Payment on Net Sales",
        "documentation": "Subscription agreement one-time milestone payment on net sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r750"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r750"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r750"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "inva_SulbactamDurlobactamMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SulbactamDurlobactamMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sulbactam-Durlobactam [Member]",
        "documentation": "Sulbactam-Durlobactam.",
        "terseLabel": "Sulbactam Durlobactam"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Significant Accounting Policies [Line Items]",
        "terseLabel": "DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "auth_ref": []
    },
    "inva_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to various accounting policies of the entity.",
        "label": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponents1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "BALANCE SHEET COMPONENTS",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r1245"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosure of Cash Flow Information:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r1181"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "inva_TechnologyTransferAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TechnologyTransferAgreementMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology Transfer Agreement [Member]",
        "documentation": "Technology transfer agreement member.",
        "terseLabel": "Manufacturing Stage Transfer Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TermLoanInvestmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TermLoanInvestmentMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Loan Investment [Member]",
        "documentation": "Term loan investment.",
        "terseLabel": "Term loan investment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TermOfMilestonePaymentForCommercialSale": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TermOfMilestonePaymentForCommercialSale",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of the milestone payment on first commercial sale",
        "label": "Term of Milestone Payment for Commercial Sale",
        "documentation": "Term of milestone payment for commercial sale."
       }
      }
     },
     "auth_ref": []
    },
    "inva_TermOfMilestonePaymentForNetSales": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TermOfMilestonePaymentForNetSales",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of the milestone payment on net sales",
        "label": "Term of Milestone Payment for Net Sales",
        "documentation": "Term of milestone payment for net sales."
       }
      }
     },
     "auth_ref": []
    },
    "inva_TheravanceRespiratoryCompanyLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TheravanceRespiratoryCompanyLlcMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the variable interest entity, Theravance Respiratory Company, LLC (\"TRC\").",
        "label": "Theravance Respiratory Company Llc [Member]",
        "terseLabel": "Theravance Respiratory Company, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1276",
      "r1402"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationDirectorCompensationProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]",
        "terseLabel": "Relationship to Entity [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TotalPaymentsMadeForRoyaltyAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TotalPaymentsMadeForRoyaltyAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for royalty agreement",
        "label": "Total Payments Made For Royalty Agreement",
        "documentation": "Total payments made for royalty agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r1180"
     ]
    },
    "us-gaap_TradeAccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAccountsReceivableMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Accounts Receivable [Member]",
        "terseLabel": "Receivables from Net Product Sales",
        "documentation": "Amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r1277",
      "r1278",
      "r1279"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1201"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "inva_TransactionCostsIncurredInConnectionWithEquityInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TransactionCostsIncurredInConnectionWithEquityInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost on equity investment",
        "label": "Transaction Costs Incurred In Connection With Equity Investment",
        "documentation": "Transaction costs incurred in connection with equity investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsAvailableforsaleSecuritiesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsConvertiblePromissoryNoteInGateNeurosciencesDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInImaginabDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInNanoliveDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r504",
      "r524",
      "r678",
      "r703",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r768",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r854",
      "r1065",
      "r1067",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1079",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1384",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1392"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1204"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1205"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1205"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1206"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1204"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock: at cost, nil and, 32,005 shares as of December 31, 2024 and 2023, respectively",
        "terseLabel": "Cost of treasury stock",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r60",
      "r122"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of common stock (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Repurchase of common stock (in shares)",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r119",
      "r163"
     ]
    },
    "inva_TreasuryStockSharesAcquiredIncludingAccruedExciseTax": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TreasuryStockSharesAcquiredIncludingAccruedExciseTax",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock Shares Acquired Including Accrued Excise Tax",
        "documentation": "Treasury stock shares acquired including accrued excise tax.",
        "terseLabel": "Repurchase of common stock, including accrued excise tax (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of common stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Repurchase of common stock",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r57",
      "r163"
     ]
    },
    "inva_TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock Value Acquired Cost Method Including Accrued Excise Tax",
        "documentation": "Treasury stock value acquired cost method including accrued excise tax.",
        "terseLabel": "Repurchase of common stock, including accrued excise tax"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TrelegyElliptaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TrelegyElliptaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Trelegy Ellipta.",
        "label": "Trelegy Ellipta [Member]",
        "terseLabel": "TRELEGY"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TwoDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TwoDirectorsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Directors.",
        "label": "Two Directors [Member]",
        "terseLabel": "Two Directors"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TwoThousandTwentyEightNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TwoThousandTwentyEightNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty eight notes.",
        "label": "Two Thousand Twenty Eight Notes [Member]",
        "terseLabel": "2028 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TwoThousandTwentyFiveNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TwoThousandTwentyFiveNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtScheduleOfDebtDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty five notes.",
        "label": "Two Thousand Twenty Five Notes [Member]",
        "verboseLabel": "Two Thousand Twenty Five Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "inva_TwoThousandTwentyThreeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "TwoThousandTwentyThreeNotesMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtTables",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty three notes.",
        "label": "Two Thousand Twenty Three Notes [Member]",
        "terseLabel": "2023 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSeniorNotesDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r277",
      "r278",
      "r279",
      "r280",
      "r290",
      "r356",
      "r357",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r449",
      "r450",
      "r458",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r704",
      "r705",
      "r720",
      "r721",
      "r722",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r790",
      "r791",
      "r792",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesDescriptionOfOperationsDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetRevenueFromCollaborationArrangementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCapitalizedFeesPaidScheduleOfCapitalizedFeesPaidDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfIndividualInvestmentsHeldByIspFundDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfReconciliationToTheConsolidatedNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized debt issuance cost",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1200"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrealized Gain (Loss) on Investments, Total",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on other equity investments",
        "negatedLabel": "Changes in fair values of other equity and long-term investments, net",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "inva_UnrealizedOtherGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "UnrealizedOtherGainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Changes in fair values of equity and long-term investments, net",
        "documentation": "Unrealized other gain loss on investments",
        "label": "Unrealized Other Gain Loss on Investments",
        "terseLabel": "Changes in fair value, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "terseLabel": "Unrecognized tax benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r612",
      "r1061"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "terseLabel": "Net decrease in tax portions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r1061"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesInUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net increase in tax portions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r1061"
     ]
    },
    "inva_UpfrontFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "UpfrontFee",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront fee",
        "label": "Upfront Fee",
        "documentation": "Upfront fee."
       }
      }
     },
     "auth_ref": []
    },
    "inva_UpfrontPaymentUnderIntangibleAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "UpfrontPaymentUnderIntangibleAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Upfront Payment Under Intangible Asset",
        "documentation": "Upfront payment under intangible asset.",
        "terseLabel": "Upfront payment under intangible asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDescriptionOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Management's Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r208",
      "r209",
      "r212",
      "r213"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r695",
      "r1069",
      "r1389"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r695",
      "r1069",
      "r1389"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsSummaryOfFinancialInformationOfTheravanceRespiratoryCompanyLlcDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "CONSOLIDATED ENTITIES",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r662",
      "r665",
      "r666",
      "r765",
      "r766",
      "r767"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsSummarizedFinancialDataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Armata outstanding shares percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsIspFundLpDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsTheravanceRespiratoryCompanyLlcDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r661",
      "r662",
      "r665",
      "r666"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfComponentsOfLeastCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r1077"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureDebtConvertibleSubordinatedNotesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "inva_VotingAgreementMaximumVotingRightsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "VotingAgreementMaximumVotingRightsPercent",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of maximum voting rights",
        "label": "Voting Agreement, Maximum Voting Rights, Percent",
        "documentation": "Represents the percentage of maximum voting rights under voting agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1169"
     ]
    },
    "inva_WalthamMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WalthamMassachusettsMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Waltham Massachusetts Member",
        "label": "Waltham Massachusetts Member"
       }
      }
     },
     "auth_ref": []
    },
    "inva_WarrantCarryingValueWriteOffAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantCarryingValueWriteOffAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant carrying value write off amount",
        "label": "Warrant Carrying Value Write Off Amount",
        "documentation": "Warrant carrying value write off amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInIncardaDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "terseLabel": "Warrants",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r1098",
      "r1099",
      "r1102",
      "r1103",
      "r1104",
      "r1105"
     ]
    },
    "inva_WarrantsAcquiredInSecondQuarterOf2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantsAcquiredInSecondQuarterOf2020Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to warrants acquired in the second quarter of 2020.",
        "label": "Warrants Acquired In Second Quarter Of2020 [Member]",
        "terseLabel": "Warrants acquired in second quarter of 2020"
       }
      }
     },
     "auth_ref": []
    },
    "inva_WarrantsAcquiredInSecondQuarterOf2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantsAcquiredInSecondQuarterOf2021Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to warrants acquired in the second quarter of 2021",
        "label": "Warrants Acquired In Second Quarter Of2021 [Member]",
        "terseLabel": "Warrants acquired in second quarter of 2021"
       }
      }
     },
     "auth_ref": []
    },
    "inva_WarrantsAcquiredInThirdQuarterOf2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantsAcquiredInThirdQuarterOf2020Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to warrants acquired in the third quarter of 2020.",
        "label": "Warrants Acquired In Third Quarter Of2020 [Member]",
        "terseLabel": "Warrants acquired in third quarter of 2020"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureConsolidatedEntitiesAndAcquisitionsEntasisTherapeuticsHoldingsIncDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Term of warrants",
        "verboseLabel": "Term of warrants",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1387",
      "r1388",
      "r1389"
     ]
    },
    "inva_WarrantsPurchasedIn2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantsPurchasedIn2020Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to warrants purchased in 2020.",
        "label": "Warrants Purchased In2020 [Member]",
        "terseLabel": "Warrants purchased in 2020"
       }
      }
     },
     "auth_ref": []
    },
    "inva_WarrantsPurchasedIn2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantsPurchasedIn2021Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants purchased in 2021",
        "label": "Warrants Purchased In2021 [Member]",
        "documentation": "Represents information pertaining to warrants purchased in 2021."
       }
      }
     },
     "auth_ref": []
    },
    "inva_WarrantsPurchasedIn2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WarrantsPurchasedIn2022Member",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsEquityInvestmentInArmataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants purchased in 2022 member.",
        "label": "Warrants Purchased In 2022 [Member]",
        "terseLabel": "Warrants purchased in 2022"
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureStockbasedCompensationValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted-average"
       }
      }
     },
     "auth_ref": [
      "r696",
      "r769",
      "r1000",
      "r1001",
      "r1069",
      "r1406",
      "r1408",
      "r1411"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used to compute diluted net income per share",
        "totalLabel": "Weighted-average shares used to compute diluted net income per share attributable to Innoviva stockholders",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r310"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares used to compute Innoviva basic and diluted net income per share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureNetIncomePerShareBasicAndDilutedEpsDetails",
      "http://www.inva.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used to compute basic net income per share",
        "verboseLabel": "Weighted-average shares used to compute basic net income per share attributable to Innoviva stockholders",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r310"
     ]
    },
    "inva_WithdrawalFromInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "WithdrawalFromInvestment",
     "crdr": "credit",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureEquityAndLongtermInvestmentsAndFairValueMeasurementsScheduleOfAvailableforsaleSecuritiesMeasuredAtFairValueOnARecurringBasisDet2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Withdrawal from investment",
        "label": "Withdrawal From Investment",
        "documentation": "Withdrawal From Investment"
       }
      }
     },
     "auth_ref": []
    },
    "inva_XacduroMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "XacduroMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "XACDURO",
        "label": "XACDURO [Member]",
        "documentation": "XACDURO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inva_XeravaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "XeravaMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfNetProductSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "XERAVA.",
        "label": "XERAVA [Member]",
        "terseLabel": "XERAVA"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "inva_ZaiLabMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ZaiLabMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zai Lab.",
        "label": "Zai Lab [Member]",
        "terseLabel": "Zai Lab"
       }
      }
     },
     "auth_ref": []
    },
    "inva_ZoliflodacinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.inva.com/20241231",
     "localname": "ZoliflodacinMember",
     "presentation": [
      "http://www.inva.com/20241231/taxonomy/role/DisclosureLicenseAndCollaborationArrangementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Zoliflodacin [Member]",
        "documentation": "Zoliflodacin.",
        "terseLabel": "Zoliflodacin"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481648/480-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)(2)",
   "SubTopic": "40",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-22"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "63",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-63"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Paragraph": "2AA",
   "Subparagraph": "(a)",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AA"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-4"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-11"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-3"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479567/321-10-45-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-19"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-51"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/321/tableOfContent"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "325",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/325/tableOfContent"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-4"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1391": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1392": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1393": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1394": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r1395": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1396": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1397": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1398": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1399": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1400": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1401": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1402": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1403": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1404": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1405": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1406": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1407": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1408": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1409": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1410": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1411": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1412": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479664/932-10-S99-1"
  },
  "r1414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477385/932-360-S50-1"
  },
  "r1415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1421": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1422": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1423": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1424": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1425": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1426": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1427": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477867/946-230-45-1"
  },
  "r1456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477346/946-830-45-39"
  },
  "r1462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>136
<FILENAME>0000950170-25-027864-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-027864-xbrl.zip
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MBTO+/U=6\5O;.[M[^X2#P]_T(@/(R?ZV_JE>3*=ZG:&@(*>@^DTOLC.^O]W
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M&416XUZ#[,BQ<C%TS=(F]R13-",>;IT^IQ1]-ZQ+GDT\9#XX GK*J?(%/^7
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MY[3L&!^NRIP. +P:'$>6AK-3XM@4O=DCJREHD^E(RJVZI-U6R]!43TQ/5;P
M1G*Q782^?>9+MY,SI)*5GVU8XR)#:!W5^>A9$D"W\C0[)/3%>&JO8-*)?HJ?
M#+=&">]#G^?/H_;1(Z>E[@_C.7_IC;-ZK?'F)FK[/Z8 WT82$%4+;8:.0>9T
MT]SGZ,'SK;6#2R"&GW&2%1M1\=>&]Y6EW"N8,A^?.2<2,[2004T4=PH$2D=V
M,E@0#$;XX>=%VKP>$Y/?AJM\>KE$1:IJ[DDS=2Z3OZ,Y^?['.$TB":8W4Z^\
MJ;Y)U/H-0Y"W8BK5$=_6VDV?=@0]3&ZNW0_=T%"$?VS*_YI@WN*RI _:H+3(
M?K"0-'GVR5D]U=0YJHUL]WET6.UF&$<S:*R*NRTG 2ZU5M EFETV6EM:49]Y
M)4YRXR#QIH>'.8YJK?>/ _M6F<9EYT^RQA#C+:W?VJ5I_9&=,UALN$'0V@5%
MAZT9./:&VQ^VI]<.YA6A7,9BYI29?EU3N66[&5O?#>[=ZP^"1#_=;WU;Q^!]
MOB#/P$&Z=L5&I+K4B;+.D"O4Z--MA,A$DMZ-[6=#AXM_KHIDAU;4)VS@(;)_
M$6?6++K.1#E&PQ&-B/%7]S^WZ[^"3A_N5FJAU5^,$%C/4GSYYV<9RU[G-HL[
M?\'S_V*I@?SOF.W_W=DI:1!4877:5J7OG(K)=D+Y^S2\-8WDP]&,W]1[?JQ"
MK?N73I%[]/I_%E8?IJFK^ *IOM)7U(+/ST804+/KI^6+)O(T$]117\]W$&*/
MC[+9MK>:/3J+[6[:_02-[A.-JIH@N\WPDPM)7QC",S@U%''M\T;EP^)U&7<'
MJU*E):^7I!QN8>_P3#T,L=B36>QB*K?W_%H,V=,D 0DPG/')DU02<%VTV'/N
M4<'I5E5[X0GMM0N^PPT\PQHB"I)P1HM1@Z>UU@N^LC)CPM'FG[Z)Z-+I]O]X
ML%?\6 ^?NTH"+F>5:G(8$DYF QQU<,1\QT*%X=JESQH0EYSA>XF*]*5R52E*
MMW"UX1E"5ZH;>TW2_(TCTKD:"*DH')%>'Q*Q[O5SURH2)$TT]/6(F,"7OYN7
M.'_%0>1!Q(%ENRRG:R68?%@QL79(884H-3Z],AZ50K-29:9$FWLS=&N)^@<;
MO4! D0#=G:Z>RY0FN$_'!E5X\3"P@@N8NZ3RQRZ<T]!;U:+8RBS6H/[<PS.&
ML 4@G[O#6>Z@T_KCK/W\.\<^&Y:3O#KR>5DF"Z<]Y:<?F:'3]YWWE),/-8<J
MTA:_2ZV)7)HTX(R>Y%QH#NT<'>V1@% 2AT ,Q[X%*^S< <,%L),RA<IQZZ7L
M+.MQ2V@W_T9?BT9<^!2>YU5FZ54E^8@MU%C5;."7.>-S!#L3O/%+M%[8#HC5
MI;8A WLGN^.Q7:WUU74=D82,:?W@[X[D-.<75X%>!IQK4\/E'TA*',@,SY[E
M5X30E671L&N>&24!CU)OI%O(9%76QM_K^AKWA2Z,IOJU'.3"5ZI^(LM)MH;X
M?/1="Z<DL%A#^.2D);V6ANI3J:A77SX&]\H];D2,>;YCOB1A?([8-\V"#XLI
MK -1YH:73P7N#;M.^,/L6O:3M+#A>7'[AMQY0&F,L2EY$?+@2)I09H"+NFA7
M@-3"!Q07P M=/2!!"_T,HT&I$_F Z9'8%@V30.MDO-P(&Z0%,TZK0VPYS8#6
MB1>#WJ (M:'7Z!P$K#P5<[GY&V-SES%EUCA7VHOXV6V1HD&!]PS9&NKX+TV!
M$F5X[^FT(CUIS(O-I0%O/WYE+;C& PYR 3CO[.4%9FJ*.$LP&2'Q_?'UOH^#
M.^HY2=09]OD*CRX*:^HN:H8O\&?$H9,;F)&R^(R6&2XG,"-^.#%WPIE?&I?7
M[R9;I^JK.<!WLWM\X7[/)@WU@KO& N@-"R>7!OGZTY'FZ@9.)!,AEBIL,67Y
M7ET?FE]YJ_\2'VR!Z:/3,TH@'K%05K)YA3\3"V%=F5;";235?+PQPNVPZI>T
MK? XW=;^6>,E*BHNJFJ!_:*G!/0\Y6)2UBQ#&#]_F$Z2D3R1T:RNOT(WAHB@
M;ZQZ*1Q$+4U]=D&&SWH4QC6N:GO1:)8'\](2%%D!96V:H^TV[<6:1@;8DP#G
MVF<YN7M6'7[W3%XK-CYY._M9A7/I&7CB2UU0\[AA9'Y69564F]^C)WE9@PF-
M;,9:(^_Q;)%35MJ^%*X:G]GJ*^*GNG07S]$*!=U-%+7B?*!%$42/O#=/ZXTW
MB\FNQ3L,NH]9@.BG#>>D+7DZ0U\)Q7 5"]#RPMP*)%DPO8BO\JH.#DPI&%<*
M:;%G@2)6:QY(%>(8_F%M5/9$LVQ,CE%<FNU!5*!>QB++EGV49^4S\-=J_-DT
MYZ(QIVT;;?Y\?[JR"4MY6P.[\/=QKWUI[&/!J6%%3F9MX'.X%Y\1R[-ZX74/
M/[HPVYS$0@=V-K3-@YQEA+H7;CO+35:>,P#W\)R]P1O$^:M8#SN</!>['F#C
M.F6ZRL#=@86Y(PUSQU>>QM5^J77B<:Y-U[L49O'$5@[]_=RYD/<,/Z[W#'N/
M*D ^'^"FNO>Z\M8'UI-*C4MF5!Q'<VWI/#9">.TC#GBN$YPTA.F#G#T1:%TH
M(U*Z&O:(!!C'KVZM3\N.47B^\%&M,1$9-0D5?L*GTH:32@XV[O.:XC!ZLU)I
MH_F#JR*-WIO3ZT3+4GD[8N)^DA,-S%CAK%.G@\BO28!J,K&%\&5>[T4=0QXB
MHLM\4*2R&D<,(0'GQ-X7P(0/3'D^0B^QW:E>X@*;),WG"C6X$.QP>T;L#"^(
MER)F[L>V*0<J#DE52.;_<GN7>C;AMM!%X4<2GX\_)WY[1GW[O+$RQKF(PZ0!
MG]NA5SF EKD]/XNM#,FL\F7NWHO<7LPD7T(R;<7X\7I> =UR:E#KJ],JMOZY
MYRLU'E*15G_4(G+C;54&*E$H'GAPP^V\&E-PQ SZW(_Y.)13[!DI<ONX8T@U
MQVIC*.U>JK$(TUJU42R!S;\"^,>?(_Q&2L:[L!TT[\DITEP81YXC 38>J)\K
MDJ,+),!TYCJ^=W23:)3;F+&[+$Z,B:\5/N9ZBOYV==4+R@360.AA0TO.)Q0:
MYTVZP%W@TP,&_;_@"U45].6]$HVQBQVO=)?:]55ZZ'U2SM?G(K*N?1Y6B/SJ
M32]#I*BI^%(%Z^MFR7/PUFRBX#X8V0O!X$A 6,-%[0)KE^E+!.\YXW6'T*ZV
M\?/O#D-B/@09\*S?F2B\75#^V#?$6U?H-M/!0QOE^4K\R,NL/KB&'S,"O+K=
ME*1G$*,I:?)FU"5DZ4C;4MM9*/S7\R-)Z@61>9KSY",JO1C7]$$-OZS1ED(U
M(Z4LF5AWMJ+=XE2XZ% KL[ZP_1U6%ZM?WV*>J-RIQG<C[^$%9VOQR6T3NLFM
M9C,L<W4_!II++41GKS4HL7^LL[UL&Y[<=9TW]M6[!=.1F#I19VP ="_*2%:O
M[C,>G%7@5!M=6&FZ'593ZC/0BN;):V%0%9MD77BP0'8%Y&8"E4#HSK2LX='F
M<,X)1"91[!150-6=[U@4;2:?).D=RG[/J#GB# NC<\<$ZJ[?(4*L5CR0=_%D
M^&/NG4,FW*3P*7XV\/E9&W- [%L\R<@>@SB,6KUC>#WO#028Z" [<)"FVND"
M_%O%6+ZV_.XY(_$F,&ARVUAB0NP]?BI[XL5M(3^_%EYF^7;Y^WJM:X8'&D9X
MVMZP5JIY'D3$5!V+8JDU9TBHP%9=$G226N_0.)WGI/[$]!DX=R3P(L&NI=8M
M$^7[21>V<W*=7FB]L4A2RU>^M:2U24L@04-O5$4\8DT2&\M^K-Z_<X2*>:J8
M$^)G5[P*UNB#&Y0&>27!P 8[\TMM0E&P;8J%UZJW>50:"S(8D3Q%!'$B>W(8
M4AB>9TZX#&)$!*YNC=_Q\P1*XGEG+J_#%;.D2MZ:BO7\(.8*@&!#1M![E3]V
M4J>NX[_[^#S1;.UA+;FK(]5!GM"H04-H:6F@ $N<@CV_K/LS+MPCP6@-6)Z^
M]$Y7@-[-LJ!!9P^0(+<%72QL[]GW<X*T<O=F:590SK1&8.C+0/'8=J6G)STI
M2$X[7-"*B74G:&+;?>]]T(S ?::]^W B[WST(-E.1@C2-YO0^2#!T*I3.G=@
MHT+%+;LTZ8)HJ+<T?R?7U;('#J_XNA(GS^HXN_ +#'C5&]X8^+7YL*I^< %1
M^#[N\_[YN/*8//57$=\#GJ.C.+0'T1H\!:.K'./+8>6G8/8*DK?(^VR&IR?O
MS?B;CPP$H@H4KE%:-+,]Y%(5*OA9RQ]=9(WD'_'&4*?"J*[A<W(?5/V0WMF#
M\R9Y^'$P2K5TAT[]\LDS_2:<W\(F\(JAHB+-AYYA'8Q4]@PH7557.!(M3%CW
M[>':NS@:S/OEH1Z7T">$?/M3X]AC"'O%A_N*PVE2 XWQY3 N658T73 =&7;^
MX694Q(%V"Y&AH7_'6OQ^##W\R/,VH;HS0&K@_I> ",WK:UVWHIZ\HGR,._-J
M3'6NYA1;'WIG9X2#>5O>.T\+EA'"0)'>SHKMU4%;%W0CW&0C-V4HQ-C%)MNI
MS 1B?+F!H^*:*>6.<:7R6KK:^UNKE4_[OP[[#BMM&3V^>M'6YAZE'14%?:N;
M!EW*@3CV9I5L.%7C)B74$A%D;6@PN%L 9;::-I_Z>"L8ABC@W:I] 9M(=N-Z
M/ALS%(W+P-9QY[;$!C><+2D=+&<2Q+,GS(D$<<VZ6K78"9U-4%D 215XB9S)
M>0;&?VC@_5)-B,/38J%12"O-XOS<-4LO2[T7<-B8C+8&>Q7U>'>K>_N]*1&9
M>2^4NHB>\XKU9G,:OQY!%6]+"V)R,<B</F=F#.;HE[4E=HL-2N4TN5E\?+-Y
M@'MS:S%H.P4XE&RS4>A'<O"_/JQHL2K.SVO*MMR(S@AH[:Y45-=J%*^9]2WZ
M1A#7^3'2FLY1@ANJ3-!L?\D0@U1?<K5DV$LLRCZLW%2-Y^KT=V:4.,A1EO#-
ME^+Q4=/4;MZ8)1QK84?*1AX0[N0BK\4>W6P?*\YF6HG-SGI&+:9;>60GK,^:
MN%C6CKT"<A[F6XY62&7@7$EG3\<F6PX6B==7!G?9\E^P5(RKLG-J2E01%]?P
M4MQB5<KV"H <Z=('-) S\$R6/S'@&WN8&_!<I\8+U' $FCANS@R=Y.P\D+N%
MO-XO^ZB6X*O<DLK  GGQ_H=BB1_?M_O1MXU$IBVY,LOCX6DBB!9.[5?MBLT/
M-@3(A\""""L+/.5(E-<H4E \'"Y;T8W.HZS:5C@!&U)G76X4CV-;$#!B;$%F
MOXTEIU^!TGGME^'%8VPNB%8-\!/'!"R>EK]T.'-]>EG@XL-WKS72*X81UV$R
M\\WCUVH%VJ.&XW@$2P88UWG.CI"%=<7P9%@._^4WS P<)[&8A6#GC#VV8=3.
MFJ]U;*MQ5" 7X:%WSI@KB\VD2\JKN V%>G'C=.(O^UA^^R!.DU3;7_=+."F?
M]>BS=01VS&QIE?<>T:Q!#KV_Y!XC",&N6,EJA6[HD7]SK6E^[K<2PO:5,@Z/
MT9Y2P2,Y+8HVNL@DNF]WUX5#V[QL(=$0LX,(=6%#BY.<0-"*FDQP?LLGZS5W
MUZ1^FU&MS)4JY7UFJ_8K27?HY,H^"#,6FM/)38Q$E,P9C^MAJT(TU+%%;B2@
MK1+R "_9F )Y=:-T^J G+YK7A39Q<I6K)*3WNPYR!KL9&8<4)%C/!I!I:"#E
MY]-NMZ\.@UA<N/D&(J4O6'^WJZN^I^>I,7E#VI"N4]!QM"(77PL'"!Q[QCB?
M1.Q(W:!T=WLR>S+"J^ E7$:P:K HN]9G@GWA""U\AI67]WQ037M G(X?)+J"
M@1D1W'S8$>X%0]T GZW!;7Q?>31NWS?S)=6/YJNX\UV!SCOE;>D,&OAMXV9-
MVQG#?@U(,8'J.MZFS-L9-SPWWS9<O-_7A4)(;W2_LS70.KOPN7J\;^&%2(Q2
M!'#DV\HO.("\F#6Y.MZVKN:3^IC<R/O)Q.U+^D#"1#S5O(%K<9-W,=39@'YN
MTJ*-%2V55"IR7F3J67SBZ+H2W[>/B5][+LL?K!4@;ANS(2&$JFSGI]=2,D(7
M<3&)!5IVN:.KD$>N7XNSM]/EO6XDW!2ZQ??ZS(0NMK9>=LZ>NZ(%@2,PR6;A
MLE;X6>0.+DT=0,:@+C7*SYF4ONHEQ,K9M:9>5IM[!NXK/#%LY?:)]<T9G['1
M=G7/OPE[/!_W>>";L!^-;/X83Z4FZZ%9NZ5L\$<\>P966EJ1=NI.L_(,X^M(
M:_81DX'UC2),Z3*+#LNW)=TJ9]TE@?#]+Q?RO$%A:C<3W;&"Q4Y5(V V7%6;
MT=7AJ>+YZFIV;F1E_(&6L?1"0.8\6<TM_04:X"@F @^)FE8KP^\W0J+VIKGB
MB=;&UTXKG%\_CY]=FBSSA(_0O*>[$)M#CX><C>A<;Y :K*%L?DW2E8&1A[J!
MMZG8JKTV>EMX[<K4<X_S)"!E@2+JB>= C!/Y1LK"$B$?ZV\UPSQA[5(RA@ES
MK*@<_%AC&J-B7WW7R<R=$]9\C=<QZ72,C)Y'\[B,RX:"9<;6F!#QQHR(K,9Q
MC5HURY7].XK?UQPD)CG'%25Y"E]P=-Y6 2>*MZ-I<\,54+%/'V5]L%EE\4OG
M&GD0MNX)28/1F>9K]"5"I]F8>K+O)O$8\YX&0F@$CB%R'/52A" ZWQ5[WB5)
M=M9/ ^15*Y.<LY*0\R$&AO+I4D[Q['GR06 RKT</[(E&!!#I9A ?UEIJ.<(K
M#'E.P:3[U"H[^V$(UO5+DT=)>?LMBV&'&+U'<L='=V?M:8##D?LC.YOTHT5+
M^7[T(05&;)]3'HWG&-B;S]\X+*O-VY6ZJ'#B0V]X=_ TA[=4R_>C1>/]+80C
MKO[DY?SH0"L S+X6IQ*8Q4/)5L%,P58X4.N$@4+RD 9/MBN8=?CQQKK7VDYY
MC)Q:0*V5TY*T<.Q%SAJ;:G&NSM_.D?KG:QC-R_.J32!52<"+A);H_)ST9'4K
M76YH[V?QGH?,!_Q.L6F9^[[O&4KST!%VN-9T46)G_TXU\@J88PIYO8); >PP
M2;4.&O,XR;LHHE^9LQRHS)@KSLMDF#?>-CMS?I(@LWFUH1H7=BS%L^9J4*$W
M*%8R4#0\)/:23Q!LWZ=1O,;-OM4RG_'ZU I+:^TI1LE1Y9LTW4^ZBE;9/6<F
MFA9+Z.FDN?4G2LH??'O'DI"NQCV)CD8Y3G2;W1AIH($B(OBL(*,V8OVWYWY]
M6WYB/RCD)!B 3;_\X-EK9MY7;SHU \CGPZ*]9E[.G$72S@5(5QC.A#W-J7+P
M+DZ](&XP<5W(:-K>B>*#W(6P[[?D/ROIRE_AG\*2 *X5\(7!BB-Z-6Q.[8]-
MRI!#A<<-]]M%7E\0>=A@<&O!WC-FJ 9*L_(4%J4$%O9W96!JP7V"AN,["S*#
M\/;)AL3.\&NM3,N*[VN8'+EXJ" 7%-$?5P<0TDBY.44HH]6QS$"@X&1GMJ%T
MQ601/+LSVX [@7] =JQ[7E]X\B/0&24S#AS.F.-S$MX38EL.V39:=/+7>A5\
MF*C'7D2SZEJ0/;A4?<58I?>ZHC&WLQHDHAQR?FI2X6EE>3*S>;.PK8@Y&_=M
M<SH9<O1M^73)N1JH\4A%!HT+479 0W>:*:%C6J*Z9KL0?F^N'"'"6/XU<DF$
M[CKNBLT582ZV'TA-:\<;PV!&**VU#1\?NL[, 3M68>@WA:UXDS\@_*9:EM-I
M7EUC$OGI_?;S*R G4]YT^7X[?#D_BVLH]^G(EO+!Z@ 6[!8O\G@"7[7Y-8NK
M5W&+:KTWBU!RK).K\'3+.5V9FWXP4*"JNL];]5I*L (BX99?#A.'P;54"AW#
M J5^1IH90GVV<Q*&LTY9N9VM=GCGZS$7BFTI\[US59^%9E/]\ZRKK\JCBC[S
M/7^W^#HN. H( ,TQ1'!SA.ZNU3-CT6Z*KM:*WHYE)24I2W<>#_@))MK=-M_L
M_7;Y"L4\[X@5-"-0)JP]!17T&(,5J!PQ:U,+:^YR-5^Z=&/_\GV=?*E8EJ_/
MYKQ?_O@L[M[EW52\W);!8%^7,9<1%=U0C33^>*PUT!/MR=?]8TNZ<\#46$Q@
M@NYQT07D10JWWIL &(WWC=K)(!^UM''EH(?!O0/@N=>Z>,".Z3H1HLW!45_(
MTH,UAA>1DO-\:CW;[1QK!2M$X6I"$EA\[#JO%@)WVD29>$SIR%Y849\)$*$S
M[DXY$FZ:!O<=(\975YB[A9UJ/XYKKG:3M]Y>$L@>="/WP Z&\C(B%,CZ3'18
M@=^H$S,$.<JI\]Q3)@$)UK]]:?W@#0G8$4/;I9[<(0&UKAT0.]2!XDPH"=@[
M%TL"KKK\C,4YK&(NTN;W(:\0-K$98?P72G!+F6<K\EQ]D^!Y.@X??HY8!D=Z
M>4=_A(OR.$U^4]TMA#,%#J93X2KS-4,_I L:P!X75= >".)VU_M6<#>SLUR3
M],,C0VRU'Q0/O+.M80B?IAC6<#BR<G(TQK-CL!<$<3JC <8Z$2Q+<IA@QC(C
MNI<#TL_(D0UO"]L(F9G'7"?OP1?$7]XL\Y,F)F1F!TTX<W!XK,)YS216TV_H
MT"8Y4""SI-1HEKDV^!4(?;,S ,%.&\]>5M1R_F71U/B8\_YG22.^UF30:L1K
MJD7AI9G]*Q3QE#Z[.-TP7/*<<42=_&QOZ ^$_PU&@EU3%73<?6W?<T+;U>\3
MUVW.#XBY5P:B%=5/?' Y6L']]>A;A+A"%TQ)N>52R7L7L]K-4=L!Q53JZ:7Q
MNV_%K:QJWF9"5:YEV[]^T[X4Q5>O]9XAZP*ZUZ\X-#EK9G3:(%]K-H20F*E8
M]U2Q,M.9UK++GGO62KCD[0='.JN'30=?>8?;<V42[=[_#.,7J"28N>-US/2?
MZZSJCZ/V[F.<J#/6HO-K6/BJVZ=:Z<O)]D/8\.*AQ]P:CN+/O6)+"<\;>*>0
M5X92KU?%6W4A5X2-7K<7&S!+U]0POS838+M 14'SMO 7"BOW %9W)5#Q=*!'
MT'26KGU5 TWH\6 & V+7N3A)0'I:U0^J\8JP>3BW,X1!0\Y_CMX'6^15H)GN
MU<6C;^;_2?;;^X3MRS%43P^@S7&(+.WABHWS\_KXLT6NN+#K0^/-*F(IJHHY
M7Z3&G^K('I=[E=/SZ\X5S]?[>27MC_#3$=Z>?6[GJ1SV"RGX<17FG#VZ:D16
M&WG+3IW<^ZUXFBTT[?596):$_GN&2J+(L0-NO_E+-WN7>>R]6LRP!@DHL?AY
M:-UVW!]^S_).*:OMF5 ;XR)7 M4<^W.\>DN<:SH/AF./7KCY* N1'7I7W>:B
MW1-^55:<R3/A_CK/><=8!3C-\0."[-S)=:N\8Q5IQ:"1'^:]:KFI<#?;R9*L
MR[^:VJ^LV$#FNAB8UI["PY$.#CE33M-D>+/83,R7JJ%"MU=&.6TY4N<\W>'G
M+(:YW+*BPU54J'N4$JZ /,T@\VA^)Q0]4OZTSX?NKZL]IHM+,I^V$(D;%7'O
MX#[3KRY/>>^6@0@@N2!)K]8SHH>C" 37#U7TOIAVJ_[VP_DPNKY<F5Y*MUTY
MJNR^PCF.\20.SR ?.Y"H/SSR.  K&X(I.\4+QWHH[(9_*W? L\H 'J.APJ7:
MP>ZO5.M+QG(6\]ZK#@FO@81>"O+WE2?9&N20X%T4DV'^E/G$BK+[J,VHS<H(
MHPO3_:]WM:G&N"C:%J9362_.5-LINO7NO<!1]CZK '%.(H*DQ;4''/T-EX<^
MQ/>X6KT RIFUA0J#[C.]F*BIHG^_8-;-;&WA6FN4V_JB/K4M93$W>B>#$5'C
M52^Q85M2%G,.]B%F6CS:QFFC)4R*]0O,MQ&KAYJM]]?UAT:CF"NL>"*-J=;4
MZNMJK^W7VA/MEW@X80W]KSB_/U-X_ZGRA_[]G:5GFK;S\QVA(TW\/'B'Q)SZ
MHI\- E56!5P* >=7M[1Y!+R=A6,N]RTP[3?N%$%"(>P*H,BG@?E^[Z.U.&XT
M!*C]XC,T3OEF7LQV[RW-]4\>Y&@W IJ1((R'$ID@H['-XZ$O<Z$NT\+]7JZ:
MW'R"A8XQID-<PA$J%M9D-")>DR3 ZX)=NN1D(#.!#,QU#.DO9WDR,M)78)P'
M[=S?E!6U$VW=^+555O59P.?]^>9_<@[U+_2^G@3$GL*FM5241/K?OW%] N8G
MJ), D=_^L;9'7D("^KT^Q 9CMO3K&$Z+LCKH1/RZY$\))'RP[7$ U1$_">BL
M)(@3JXU(0#;S2.E(=& '9@O6<(X$%+.@5JY5K%?,_\?@EM)ASVJBXQGUMP.0
M%[FT+YIR40712[.2)6"AM,X-YW G22^S)E*-9+IO^.P=C;4ZQU\-:DW+4B'_
M#)RG=#71 ?Q&PE&.)( "D75_<%=3^T:USY!]!.QFC_35.4G-J_J#$HIMM2HQ
MM]GN(K]YL&E]/5//_I_/09,+]3;7.L2^K  QZIRV&): J]0PQQK'1V(7(E_K
M4&#O<O'.VHF6NMK\[O3T7XBL%%4 ST8LK_N2 +&!6>/#[002H&=@TR%^6'EH
M%A/8@=J"@2E( %H5LN.5V >:[1H*O,UQ9\SI0\0R5V06 F* (]84K^ZQ-^AF
M%AOQM6<JO^E>-N U9.9E"6D6B@%6UJSNFERA9/W7B%_V"(3J/#L 69<L) $K
MP[_J/]1!]\ D()X^!S5J9D$"!HJFS F)<W#VTVJZ1?#'2I-;5_W8B=;MN#7H
MK13?YB;Z%O:Q8H+7(?Q<]?55*RH )Q^D)@=JSR@X;N.+6V<U^SH,*=>+3&UC
M3S:U_#X^$XK4R5H;.80-]42S)98_ZI<3_3).Q'4+/4BTN]3RI*N<K]P2^9B0
MB#O=[1#ULDX+;8ZHE;;"=B]'<A@92<.8^[>F>9S/9 FS.TULT']Q[^V*BTGL
MD5_MMOS695GRI1]^M8MR\4N;8L.Q?&MC@9<J.147?WDOPT]3&XX?7E,\-\+6
MQ]W28'QIA>J1?NZZSYD\#,1I@$Y5="S29-Z8_5@4OY<U=V+5JH:*\2X A52I
MI=45V%>6%%1L8*1*JBZ=57^.K2QPB+7\V2".O$^(Q07VMC^51Q2WM*F]!I_.
M<"^2;PZ+# B'K2<4#3[A'+_0,_+RN+LS(W7!O:;V&4.AA,HOH20#)A$]1 _?
MO><2^CW4&VW(Q'DT"&F-@RVW^7OAB1E>Z>?ZBC2,6&.QA,1?K05/+#L;D5+"
MZY,J)\N;8/Q$3V4]'G1[ -T@8^V<[)KI\FJU]IK:XZ=*J8_W:XNZVU-I]5R6
MK@GI.HN0?W_X^MHJFQ$0H'<CQ6ECWEG4.T9QM><*.1X=7P?%&\Z+AU6$X0(J
MOA]B7AZK8@V-+ ^/;O3#Z"MS4?)&B:D]*7*4GR^Q38&ZMY-$8,#<<2"^*I(H
MA%0FM"F,+\:$9!+<RS<N&]-7%'J4;TJ9)C/K;_^:/.<:';=^8)SX3ND7 &X?
M\/+GXU;-*BD/[1-[^TN4\3WTLIZJ+]Q4/%_1Q8#]PMA4D%!4F5PC^> P*+*B
M)8=PI]7,1[X=7GYT,0=@7%)E%UJK00D'#YI]4PMK[3UM^W(# ZT-8I_Q.AFQ
M8"Z7VN^5>RE(GY:;*9*<&<C'A8:Z),!)PG>9+HN"O/(9^)N9!9N%OL/#5XT+
M3&LWT:\"!9"/\*#G1(Z5#%R8JQFM/Q9U9LS5M]:A,IJM%:)@$3YUWTCH1?0P
M%ZN(]G=LJ@;@/Z7> 5;&[\?46;CG$# &N-!(+$S[9JG:O=V@&\D%BN4<S'7]
M904Y)*#<SWU=@)Q?'QEW!71E0#!%/7Q8/\TANO8RH]:QZ^+,V>/3<)[;?&GH
M#<NU40[5BW0[UG1_J)CVT?26I;;(JX,UCX%SX_-(ET4E1NU$VD:7!8PCAA=1
M@.UMV0PN)0&P<== /CSUT"ENYP_M9#9$"4E^>9VD&LSQZ"Q]#"?;R6SC;57@
MZ'K$06PCA*/.CZ^W.<WQWK#4L84#GL.HMI[8/+ ^5P53NU:F[)Y=EUJZ*K<@
ME]BP?7&R+N)GG0X>U$Z\C$\.UA#,R>YM_C)EVW%[L%AL2'H#7MP\H<#T4>[3
M5]SQ$NK2NZ0)_DLU7X']3Y++]-H=$$8-O3E_#-W*M-J/'>=C"%8]P&?-HGS@
MMFN S9R!^-5OI?K3UJ4G&4OC;65BRE&>7SOQ!7/P5ICDW>%R$.,H06VZ"SN=
M.D_V8/RV==*7MS)I<S(+3$Q;=[VF8EYXOF(H=I.>_U*5=.Z5 6N$R>".A"[U
M\2=-B'%%_V/8>F'17'E95;1M*/4M(=UG#R2>-P(^Z+A'^/VH0N0]?%C[<(-X
M.J3D6'E <<V(V0J1WL_S4GK3VCWN"PU^N=A*Q?9JL3J]>NL,\^XFJU,Z#5BS
MM'^7!0LG7'?;;>O+A#CY.<IEUUY=O_<PG*[,_HN;\5L/ ^!0R3!/T-%"+)J+
MY?N#[V2T)_,;F[<ES][ZYL$@$$& FA*>>^/-6AHNX=VRG>D3]XIP8-?(\ ?B
M7?1[D9^O.Z:]".I*;_5P_8R'MLN&#S_-[@BK8W- ZH5J7,QQ,6F#/735X-CN
MYHUB7K)8BFJA9GP\!1(H*X&_O@@<CCMG545U2A8ZJ96] HZ==_%A'6A.0MD<
MQS.PY%0W>LR9'X3;*\MQRL!%*W[TT&BMC^J5[/WRQ,<9]SSPOJX*;(P_ZT@7
M<=1A0STB_6O'=46AEVITY?:,B]FA6]K9;$^81(/VY(1&I&#YUO"-<J!A?0MX
MSQ#XH4%Y&"Q *&NJFBF'1RE@N#KSM'-)@%UWSOBD5>OPJY<;L'=J9RZS2GXF
M5U&=''-SK2(TX;M:B4SXL-ARF/"MS\\?%VFHP^P4O],*.>]S1^]4]M\W_"K%
M=%5%5\!!S]:)_.=BBG+<O)EIG%R-%M?]G:\;QNA8Z6.M.70(B@,LMJ8<*%HQ
MG-D//Y:I/5D;TV/IROF6S*1O?7=#+_Q;:9+U^P]>2PW/":"Y>KN.=,8Z/'_^
M90/G?)?D^!6FCT+R_.]*WVQLQ]99W/D^M2*P\Y[AZJ>GCV(=/K1(F;)_'M>3
M0FM$TE#.")<X>JZVOHMW6?R/Z?'_Y02YIA9:D;LB%;1''/^.D9 1N]L[(%8X
M,:GC2V-$D:\@HRP2]]GAX2KU&E0"Z75:YJ,AKM#S5A8(]6:P0A*(PD9_./#2
M(RM$V,0LOSTB")HA#O)Z8JQ94%1/>%Z$8&CEE\(-,OT\/)N&G0F[M>9SZ/U"
M7_KQIO*4Y&/;@C=A\<_.?%+Y*7]_'ASTH>%F)6$%3V8[4J=[F%W4GG ZU#Z%
M1SCV)1A#Y4WJTH=7QF[4?'?_]9*'1KZ=C+R@SAKO.2?>0L]A:HAA7VF0J,40
M4/F(XF^'FFHJ9C=K*\RO/\O3]_?=;I\Z@$^=+/4"H.N$U*9QO2A(*:JB"#QT
MDIBG\\F"B$_HJHE5!RT*JTPB5'EWLEK!#/T:]_P^6+OX9#AGZ-1S1T?Z137<
MF%..@E X+L:UG]?35#/[WG"9@,>38^G1+P.G"D81PXZXQ_RBI4X[.U7L=^H'
M?=HNQ6XW(V?D?/EF:MTQO-&<@=+(*[A?P7.:ZJV^XTFI[HK3;QW?NXP<BF:M
M^BIS2 MUN24]N6DG0OTRQD I;]K7C>G=LP ]'60LE@1$S3 ?WR7RXP;5UI\J
M%2C'>!O33;DDC]]EOJ]8R,[@R:-P84GT#5_6HGJ@C5E\A6M'!F,=U/U(%'DU
MU71X;->:PZKF!_Q8*Z=MSP!5-C?(S/4K*+/533JR1+)10K\-"#!TS;>$&ERV
MLM9^@JL<,[U(S@J.(IO%/1U*P?EOAD&H YG7B PC&NJYHP375C&>[+Z-.DBX
ME74TS,9",/4!Q,FH8,D-B0U*&X,H\V$Q4>G@L@$B[]IX1OC.E,? W/G(@#QZ
MM>DF(6LA\W7N+7G:(,MK]ZFAWSNE[OX/]MX[JLENVQL-HH+2>R\"@@J1#E(#
M(ET$I!.*2B<"TH.4( A(%Q!0JM)[Z+UWI$GO@00004I"C1#"99]SWGWO?M_]
MW>V^]_O&.'^<D;'&R!C/R%ISS?*;\[>>M5;6[)P _GK*?F$KRRQ^+S &,V^J
M?[5R;1Z/0]LZ@"B'^\_1V\K5O[+.[C^EM"2''R<T#8U(^#6Y][A@+2QI_%R1
M"_[:ZABVL-#FV% A;"]*;#Q^8[2%^@G3]>-?7,_IB=>BT(K? ^4[4J [60ZV
M<2_"54R6 @FWM.1;13%U/9ELIE"&'F%LI.Y8LZ9+B=^#R]JG$=&[JA*[/2WJ
M$U<,WGZ!\'ND 9JV7I<^>/.#89FFV>[2%M'OP9"4_&/MH-T:7W]!#8B3!$N+
M_,90'4=]AD?":$V3J'/O^GY%N1N8D_#'I_R8>=XD!_H['VS2^P$4;I?XYQTN
M+PC=FD".=I,(LBW.CY8.("-W#">4V\: 96*IB1'Z[$[IG3+ ;H+;46+NL:("
MI>W]975]EDRR[KF;E_6ZW_/<GZ_]8Q(N:TO]8"U+DH$7T>=Y02P./ ZW^5Z+
M93HLT \15+AQ\ ;*YV:U&F*(NB\ X5Z-8=$X50@JE;%:D!2*FG@8J^ATFV7'
M,+XF_D&\_T)BV+Q9H8X4H1>R?>$\7UX(&]NA!XG#@L -D;KHC3#KF=W#!7-F
M_H_]@[^T/%W%(BJZ$8^+J$$(5N%1 "5%=L%E+>:$J4)1U_7$4CK(\TV(I8MV
M2#LG%B_\J'(8$&XZ*.G>[Q#(#;[F_N'I9R&KR54GK=6]J$S*ZDAXI 77!$[]
M.20'R_+T4@-AMA.ZB/V[I:76\3=LEAI,4NR(]0F;F!8??*8H_@%/NDSU82CR
M]\NT-="C'2F/'<$>PU;J<8&-":/!"DG@B[:7]<FO1(CQ$[=N[ ?WHGS52_S
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MT"UI\P$U8D;>3^]_?E]=>8_S"K!$E,J67)'HIKL">\4*+/ "0!' _%-O"\&
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ML<";5+BK@5Z'_7 0!AY30W'3+Z 9Y,PQ)Q% T#2)[_#Q [Y,\6B.$HB7\:M
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MG7(6)[/L9AX^+G3--3='.#*@U,T/?T5-8SNOZ=:G?_U\188PP3S_-T8GK+X
MA)UZ):,HZ""&5>9=!=#W"H(\)@'("(Z[I%8<=TE& WS@(*S5F=!FVTW;0(<
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MC_'!O.-YS?&(>\J0[Q48N<[VN*<O'M;X?-I#O'NTY_OU>ENLYR!)^CC$Q@E
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M=^UY= 68+17L-:M27!)KI)E._5E1@:$PA0>3<W\:</YEKQK'-PR$N ;M;K;
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MW]&%<GG[# 1QKC8IRDV=6.XM'WIO$Y1^B4,J2G=6.5Q#@LY](KP^F+FNXJ:
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M(BG5SINW#7/H \2@[BB1\&/6BS<'K-';LI9>XE!A+L9D%5/>M=@O-#?D?#^
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MD3:Q/8JBF?QC?^@V]<H>0A:?!*D+[A0W*SLKLP$VA&MD<!([G-B5SE/5R(:
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M1GQ?YVN*W%Y3I,R5'*DP;8X&3I<N66B\VFMN!&A3R-X*NX@/N:\5U%P0 E3
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M>W%J>]:Q\Q-TOS[&9Q@ ,MCQKIQP5ZR(P5$6[$BY[DK6UQ@&YV6B;!AE8U%
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MI/*8/>-,+-09:"F7J8\%(1>VVNU]"YSAOALM(+[L<FQGD,]T>VJ;7>U,04)
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M:19-?J.'W445W.\D<]S'(&F?>)4X#17O=.&$,&.S^V!]DM41/D%[3KRMP;5
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M.VVS ,_0'RVVE$TK&:8 C1J5:;;+/O^\VN]OT7*QW;]O $29,7+'ZS*^1C<
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MA=\:V/5K'VT];;H!J&DA\-F>O@YQ304,ZCHW7C_^M3]SE3_MZF AG=XNL%A
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M9@P\X)$"^[QS^Q4EU'+KEZ2D(.&L*O^%U80J R3TC]E,]6TXLI]MT+ I32J
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MXQ_+97H_-3%M[-DSHRY9#KM#9?&NJ)58>\)IY0"U=[^IJ+<G!\%?==YX8+[
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M&V8Z7>:)EJ=%,A--]0/)M._I_O*J_=NFNZ@N4/Z9ZDM935Z[P+F>[8X:U>_
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M[(4?&3'VG>Q'U3G-Z5>8VZJ@5;H&\-!GJOS"R^0O+9,7SUW+\/D$_#]0"V!
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M.A8I.!.Y>8,-80U5:AF6"L$1T\:X -9Z--9B.)<5P5Y:ZM1VJZ&U-HJG_<Q
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M:(O4J6&EKR.2@L'T$#DIE--*W4&VQ/C.7-X0SJL<EA(JQ7K]:'AF!Y;!"B'
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M$:_"1"^[]#+8K&!=LPK+G<0W]YBX"3[\J!K]3:TE4+=P*#LK-JW,T;2MQ$O
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M?5%%U,N%S( OA]D7L_\+4$L#!!0    ( /F%6EJ;_FV47V0& ),N!P 1
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MB9.1N)\M-<O1+)YI")B&F*6$.PAB\V],J,IOPR71GET/<3W;7.M[V_V1MYT
M1$S4:=7\&O3@*,D!(,7[53',2R#U?\>\Z*LU<4/;>LZ2Y)UFO:_9/2!;>X5Y
M$URCQX"WE_CF-MV8I8TC@=*@^6N&<B:%T;HZ\W0!_ T,Q"#=-1LNPE8W;=]F
M$/7$[QXT5:W.CSXP+\0R(XBT(VFE]$DP>]\J:J;S7/2-F9'JXA":.L4DX9R
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M#9A]'(Q*(/&QY#<7U9MF.\71>@/6/KJE<?I&2R,(XSSB6B]=),W[0X!W)6I
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M*HF.HZH$ZU4%W*QKG%3YB3CJLOCR!]62R!J<\>.6T:XUEY;Y:+IB#Q0^5?!
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M^KKD%1RG4LVKR[V:9X9^;X5_SA5BW<<*L&$^6% '3N?YJ*^T_SL& Z;1UBR
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MJH(XL5^[4#G?"TF=Z?S58FQ]3 \(_<??;W*E,3?=A#"A7/[#"F3\:7(3#^2
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MR60*FS+1F75 &*T^J%X+Z^W()"7]TY0>LXVH*EG;1*B?K5OL"WJ[SV7!1ZH
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MR9*815C:2%0OI1Y?MN0)%RH=YOY%W/5&U;QV><XB]EWR/T\]SB?N8KC0DWC
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M G.=K(8/K,L+\Q>LU'7>=:!Y]ALQRT4PHM/F>69<+_7H 8__Z"$*$.7)_#6
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MR[2[YL-^?>@S2@\>*LG)RX9=^^3$N+HGCNG1)04A@(NR735?J<T2O0_9UN4
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M%H'!G"52<T/_HAPKD]3$Q/=!YU8&T-*,8%)_UM'RO"3.>61T?[LZ-:G6E_D
M7SGG$A *Q\GG?I^UQ)0;!P?4S.='O]#:,WA>_J-SCDD"D>-KF%ED'] <,F6L
M/)ZL=Q=-C$N<\7[BG&Q&,=7#::N8(J..NSA^J1:T\N*_G'VV5N?,M#,ZL)/I
ME-T@;?Z].FSK&Z'VIR-Q>I?[)&1A0,%O*YX9QR(#I7M\@)(Q@ C?,V;+3/PZ
M"QV4\BQGBD] &9%=%=GMQDMGY?JI<TZG K^_VL@]>B$1BLV/^-RB=@+^_H G
M1'A6CH7]<P>"LF)4]D(H" M&2.8*3 H0AR11A$BQAC )K-802E.#5 /X*G9,
MWIT@] 2@(H-%;AO[?+RVIV^BEYW\0.D7-T<<81WPY.!)RR\AK(O S@&/.?BL
M4R^($76<C?^RN<(%DL?>?SZ 1O>-\709.-.BF?H]**7V$OQH!@TE'NYYN]1.
M>UKSU+_.N,Q*V^EL;Q.'\4L1GQ6$9.9WTA_:QI(G7Q6T%7N,FQ,F4G IP6&5
MT=<G+'8I%% !I#F*?;*5PR^RYXSZBS&SI<F DT''$1Q1H-5JBA@COM='D@CJ
M-&C0SDT.C8*C9]KE<4)?9A7,@^H-WU1V'ETY]:Y?+M.UFW<?#_'9I@BPJH$/
M)!XP#^K:%%H>96VYT>$!M1HK.E6!?$"&<J/S]2]-$2#/Y7EY/9:F;F"K*K;:
M<;].$"[O>R'SD_/H[I\Z"U[29P%NG$ V;_[I9J_4/.GTO9%[/+?V*T@AD,=4
M:4P@["\.&=;HQ#VT0-@9%!1XK+"3VAE +S3:[M6/(L<<)TNU)C_1/U;)Y'4!
MY[WT[U9J;[/L\7L5Z#CFN:&CHRCM\DU<Q\;PN+3?FS;F9[V/[_SL$R]GDGWQ
M+G4R'4)#:O=4A57:$E1%DK&*U7:E4G7*M/VRDK7^2CN=-MI:OQ=,V](1^\7W
MP_;P\6^FE[OKK2.)VTTR> 9<ERVZQ9;47L6S,*G]%=RM,/XE]>7'7?@/<>0O
M":;[(QG<WU[WT$L?<IM,>74"1\Z?Q@_\&5;?F+&EM*?+^>BJNTEFDFE=.V12
M:I$"TS2.AA (H'Q>;$=B^C7I&!%7P-B(J92(,I-XX5<-7+T]HWD^%G*J7XHL
M<\'%M]4TN:3AVPK+83\?LDQ:NKA/0&GOV: G803$8_0)%%\WDT5ZA1QE02<Z
M/<I0-S\2\(E1D)!4<P8HL8+!BM/(>2BO")=H9![9_57TJE5G"X,:5LNHM&3N
ML,^.R7B*?N3B*AXDVGD-$5#*-OT(UF";ZNMB@]6VCB<%2?3N2B1TNM&^RI%R
MS\BZ6<OU,4SJYYP7DFM+)V]_F-[TR88<NS'X8A&M]/8^1Q=$?C$9;J6C6-+G
M\XK4/!P:\7HVA4EVJ*<V]DW$D=^\<^AJ-50Q+0L],:1?DU!1]:[6VQ4O7X*K
M@7]0'S <0D@O[<X[S*A _#'+!1 &U!SCA_C3<@:9VUO)Z]F.DX" M(03ERZ-
M<9637SD [V?-@.6G/TVC!^^CO".+!R-C5DVB?&5FL*>?Y^@<O7 >_Z-Z_\V?
MI8@@M@C&"7A(RZ#@S1DG4FO89F/:6 3Y\%N.02N3V-F.2:P/5B->TU:F3VBU
M3)19ILZ''@DS.??&6*Z4LQ6/*35CG\:L# YHID,8YJ-Q&)EN#=3?TZB'S*@^
M$!\[N![N>7WZ_'CQM/99F V^3]4;8ZCO65BY!M=NHKCQ3I\%ZV4\ZU@)<^/J
M$ZZKES(QW.P,J.:Q1?=8'J_WWW N;I (^'CT$7_.):!@-RKC9X.PN=_1Q,1-
M^SOCA($FQDZB5MV5+U8DY@)8 N]$G*Y;)9 (L6Z*ZE^2?)A(B<L?OK\?S?AA
M13Z5-_76U[G31@E2>30E<H/NKT:)D,MJSZNT2&->JCYC)C*L9!/Q;"?+A%[*
M1^;C5:[^<!FK^/NA@^]F=J%E("4U@UR^_?%[QIPQ1VB=BWJ9Z"G.H8]@E;6E
MHXR\'FKBDNJ$SY2A+H:9Z-G&V$DA1BN?:VX?)_)V"IS ZQ #2C=R6V-7;"8C
MSP1]5A9(#CKYU"P1O4!EF&+FR1R^W[0VS@54 !!>!L31!/7+'OG@Q=!GX!A&
M+A!NON<PA*AT![I'U-4CH;S&U0MO6HEYMV/I0PJSK;H??R?CMS4Y_.4,70[_
M(O. QY4A$4]:+CK@ 7%DT1\@0A'8\[] LD#>[:ZB4;IF"MM]-WYPCM!AT%,,
MGZ9@GJAI_;?I&RKX )?#JE;X%'YK6N!DU@+$!SI'954PA3<A=,1<*H<_DHX_
MRG[$)"5I4<\@1?K0>HR]LMPE R"<KAIP?MRM[Y@U>!2L.K[\)E=@T2' <0P:
M?K1\L:OZTC,F2*SYE=;K%Q_DSI#O,)!I[EY)M$[-:5++I>?7''"1A0_++>Z4
M\JK+? &A3^?P5FI;[UODA^#N9)=*OQK_S K+R<UUG2.IUL5\F?G]^X G[CKD
MD_$^*7'?0?-?R&X2RKCA/75^F,,WNF>-^=^0Q$88XW8&'^=]RP&/D#;T-$J/
M*?&82#VU!H8 J;[+\+6?6+]>*75L%RL.'EH9&.4Z1<P9J8ISPBT=B;.,7E37
M\!6N<E-%MW*1N-KS]&O&,:ZD.&K+.):E]F,-?'B_E'UX&:L2G8]O\8!6(,TX
MXM1$PN]ZA.&;[KE0]:)"P:S%A[8Q%8X/.ZMV-D''UTG$F(S-&*X@-$7=86XG
M1;I92[S%G.P^'T Z I8+E)#RV2W(1,+INH_9"L%E^_C-S2;GAY[77S,B/W\K
M&5(3QT76+>1=?'K\35Q3D1+(K ]RDMEF&# Y.$9+D>P4T_]9Z2I6;BGT=)IE
MDZ.?_45YNO*,?6S:Q!T%B6T%/YW47B\YNW4-0C8N0*O@E>IB14[KHZ"B>?P'
MI:W(O0NHT/U$L.X&K'ET2ZC8?Q?45RAPD[&=%.+-6'J]),]8_)9)3SU4M1:E
M#TG*'82V3NGT6NG'NO44@G_)?EA.SD[9P[/^?/'ES^V>$3<1'?#,'?#T'O 0
MMGMA_*@+?^80ID74V7M\U,;+L-T:&>CRT!+_'8D',^U= R]"BY?*B_"KSHM:
MNE>77ID+JAM(TLF@)4W P(SEPA3&HNSW)%$HADY.;:!K0^HO(6.65_>DVE9%
M.U=#5P'-+BU3W6='7UG#11.6MMV9XLWA%;/F;;AU:1>OQP(OM7?#_PP%!Z:*
M,3V7N/Z0VB[1@Q$R+9)@?DE#GP)@+$\@RIOV.[BN;,+P3CV@7<RL[ZI(?G(T
M[^;KQ#[<BN%MK:70='N!T^]B4HK.W9M=R(K]DC7^=M20'A1I):Y8Z'I'A<8X
MX+''D5<"!]+@$]6\[5F521G:YBH1HA/AG?=H7EY2;^)M1^R+Q>0G4L)6+6P[
M0N&EZ<D>K-D#'IWA*O'I;]^F0FJW<Z?7Z9.>:Q/[-3:=>X8-PI1:C18S5KXJ
MMBBX;C /5'A8/E_BP=A1;0>55^D\//8U+,W!47@!^/\T1/%X-?K__6.QG"N0
MI@9VF1R';X(K- KW] ]XUK\PA##-D9B+ !=F%:Q(&R.:^S=[BJ9A; F.TN_7
M)2FJW^W?_)^JI/[__GW^13T,:/;KGO0 \GME)9AG%PF*%,H7#P8GJV;!;;[Y
MA2NOXJ2ZAGR*R/DKDJ6^1I_://IPE(F($5W31N+XSQCPH,6$6LG)N35*<'D7
M%EMV+O>4*\5U4*RK\^_F4S*V);'F ^8UDW>NC?2;O+-1]6_3%?N:W[2XV1Z?
MRYII2P4EL W$7T7^1Q 2OQ[\8HZ8]+-&=,JE/*E'[NR-?R1\R_Y][OZBB2DB
M??I)"MYY3 MQ<G:H KYK^J(^H/F*83NZT2N@>O8=LW",D)O7" W9Q/Z0T_*I
M_GQ+N])$9KP]3ZNM-,0I*C*X=CLR)'?^I<RW.&Y8\"$=%D""2#=RD8QN-'@Z
MXJR(U=C(3!Y><PLTQVKAH-\7%H5LM1F$XL:F"#%RGHWYEC-:708N$QI_2T@]
MJ/,.KIK]<.@_$5=/$^W.E[)_(V</_U<G=3$\/\\@N^ ;_FI66#L1K[T=Z>L7
MHU8K[N9F,WAH&1\/$@1+E4]BA,%G :6W&]'*10PDM'=7,W%DLOR.8)Y0^9PK
M8:3Q#@;IQG_ITE7'+; TVV#BEQZQ1O@04F/8)9:V?6ZJSE"]>#[P_F(W8\<6
M1KZ;9[N@]^SO'V4ECDN_O=N:*;9W5*;*E2WN!%K8.Q:4V]G8.Q++YCMS",W=
ML4T3)A64X+795>+V4<"@W\[-FH[A ^!]X2YEF2[##?ZNGHT*M>%7M,;FP<7P
M^Q_EZV2"+]RT]<@4^,OA5$UY@+YCO!>BW!]W#U^Z]B!P(Z!BS=&1$A/_:DAN
MY,+\',5$J)/_A[E\_06LL;E<QU_O^[[:VGW1%3NNK*<4*:%(+VJO6AI:9WG
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M:-6/Z!7C301N8;>@''[^ U"^&?LU8?VG&FKG#IR7\*1CWXQ4O/&4Z8X<D5+
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M^"7^!"=]I"H^@SI8O%M2\ZRR-.#^Y]R7P;NG]ENSJW&O_YQ_O=[HDS:@,WX
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MX*^.187]Z>'E!LT@E^\R-5S]6TI&G<:1[RNV1U[?B^6HT*990E@*SWOHC.H
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M(.ZG5[XEA8F:@RS^$\+Y?).0NM@$8XFC.+Q0^C)7.58C/R^H N$57BQ->NY
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M$$WY.@RH\*UGLV+(W/%I"%[X,2[FE#'])_ECH]?Q=YG=CQJ3;F,ZWNWL&.0
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M[:Q'>MZ<(21.!%7%OOR:T_:J /[=KZX'W?F6_%ZO2UV8J<90V3"L1MH3B\\
ME8QLFEZJ-A_C3'VIZT)@C!Q=+[967=M*D2^@R3ED2!+Z82I(!W)LP6J?L?I@
M3T7N]"'SM^I=7!W>(,?1[[%=F4_0>'(7-$51 '6Q#-#GCA"$C<S>LLU&PPQU
MQM=U%&60"(^F\>QN^JR[4D3$M%MMSOVZP(H#Z;7!&Z];[OZ6,4/\+</#C^X,
M0?N1O]A3G-/0OK#92B,?#. %45P%ZP.(1<+1'],*9^O&W[:9>/L7["2$%PE]
M2K?IJPDO EN[]7.'5/&MT<&KLTL+(U]Z=7J7R6P)=R:;IZ8:8V8)PK<YA6V"
MB]&173$B(]Z ,=VLZ]>73PL:0"8.2'6QMK*=4F=?@B\W%G$J*]4D9A]Y6BC/
M-^;L_QIXG23A,AVGTJ]?)DRK0!1ZGZ.M?!O+ (?V3)9H'*K=YR#RD;JHIVSC
MU649%S;=;C)29/'F5^.\Y0NO0R].T5:CBE>G+"VMBCTYW\/1^+!<)@1+GBE;
MY'O*U49WXLAB.F0):'@T#G!G:G!>=RAXK3;E02-#JDTH>Z"CR(I>Z_:'RGXY
MN@%0[[MUYC\_-=Z*P[\0YA$+H+W)M;-@B'('!7B<N?N>>\QYVYH.YQ[97-P#
M_=V[9-R.9A[+B'(GIWDI<5Z SR*=7?Q);W7+:-!NG"!\.GLE:H"T?P_D UME
M[HHUV7E:R'<W"M_/LT8H_8L^!*%;$.:6UKA'PEF^QHPR$D$8#Q%'1L#X@4(*
MF43F(][++=8;-[KR!BX#QKRQH X$V?R^T=# \,JD:?*OJ$T]ZJ:[>[B>*</>
M8(YY8"84_(3&L<7?P.<H6CK0X_:R!8N!E+/V+VYO^$^'YBHX3+QTN W[,N&
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M=I1>V*V4!2BOKK=X#=3]0?.^OR3F$YF/>R80W4#8T&0H=G$E&;VI8/G5#E$
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MZ44-:8LV3Z>W2BIY<DFSEQ?PUFB2J6S/2I/JM1:5]?DH^L*BG?$ECWEW]@4
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M,!;42/J5*HW&W<ULYNO6V% >A%H);YB,-Q%%[\Y^#PW>4<FLB3$""^@6W3E
M;SD2A]@V.3BN$2DK(LHVCYY.]UP)\T+T?B)9=)#+FG.[+,O:HV$-&G6#ZB1R
M>M="N/:!L]IK.Y%U3F=<9VQ5I-=DG_^@W04+5UQ3<N[\:2\Z?0-GF.KM>KZ_
MUBE2)RS!U^7EVPISG?2=3]??O,GZ24$\F $7N$<V^,^QC_.,+S^GV' >I,K*
MG?.&O[B_,)T7,+>K8."I^4Y8NHD.J YL\I>)I9R[W $^68")HU9)AL@4?!;E
MD:_C: 16>'F@QL/K4AG"T*RX&%T5??#-II96K5^N6^JIX9YYT(C(M8,R+?A6
M+H"!X=:H!N^D\W]$E ?Y=(('N<F#L$Z.8%:<Z.ZDI+ 7;2IQG@KO6E*^1B;U
M]N8$F)<N&SZG;P:-Q.$$).F5CG%_D &GS0BH*J?3O6X)BB]5 F>]5 (&S+S@
M_81-6&$F:+2W3X@JA/G:P#0'HW'3X#F:0 (:M@!+ZNMZJ#!]<4\P&%K=9D"S
M#M1ML>H)$8E?/\D0^'I#1$,[24LQ7?26.V=W?E\ [+9VG,)?_$5&HX(7QOOB
M^'Z.[<AY96Q!'_3M45 ;^RVDWNXP3)H[SC"IH1&%4+9#3.:%12^M+K+M(X?;
MR7^[$4(<_LP,'W9.APYC@$B7M8L,E06#SHU8+*&Y:UW @>'.';;H49 'ZV@<
M*3L#2@V6-"SQ*-&>P!CM0T(II:/H$Y4(%WW*+Q6*MRSRZ'20T&')AS$E87 A
M3.=A&+5MO@&^%LQ2'69I<L?Q"UY'R!\53C"TDSJD4,.D?/GYM#MZ@R(]E*+)
M)&VT=E1P>?9;A'O&RUIO."%V0*[5,U?J;OFTYC5H@'=FU<+F\,'Z&>TCO4W:
M4J:Z!4-W6RS47K36HPI#@HHI@BSWT<+5FPQ;D\T</<&JWNS%XD"'OB&GFN,M
MVGZJ"(F?Y)1FL\:2;_/;.5Q%?MP*8'[(>$Q#\_I&Z2I6L,V@%%2QXKSJD,(F
MS2D!\XF:!_)*W4$*R:/@RD3;)1^_4,7F=Q\FOP6'F*]';"6(MS^>,94[>P'_
M([R7>#R2!\F$ \%OT-<9QLWG5EN'UPH"WLQ[>GL2%F<GV7_/Z2/_\O#R\C(R
MSI.2<HZ1;F[)1Q1]S[*4_A[UX@-TT9%[*(_E#6*Y0A+\4K=_!(\)@"9R=<8C
MUDVO\ATL_G''_E9"-%%B-6 ]?";(6Y%(YN=H8VWFD;J*V=35@1M92Q=5;,@=
MY,@'BHU/86L!S&Y.P4_8;3O0(+6/#^-XSC>#G>8N_%2FY9>MU8+ &CK!1+F=
ML3^AG>X:LK_BC#4B&+]"R:FI&:7A0V@9O\S< B(5\HY6MACG=;4U&!1M[KC-
M.3KCU!H<>^R[>DM]'/0BLSW;0+6SS['M#G&C]^X6V%M6./4.%3<6&>8&L9L1
M>J'YE!"MY+E/WZEXMLQ%'D0EG'45,R4X@MG2;,;W$\'3 >RR#68&_R8247RY
MZVSQ>'4KFRNLP,_O]YQ2V%K<#^).[O3DMWFV^#FN8Q3+ D,Q;=/A9[SBQ\BM
M%] _%]I\^+3=Y/7GYF<I5BZ42[3;#/BMM]L\#(U@F!2\YOX';1C,F9UMCFL+
MB&:(T8E)FK26*43EBLD^OMB/,FTB-@D8J-[F:K6.:4;%RAG8*[UZ4"4-+<0"
M5B*@1OF:,E^\4#G%-P&5).(MNQ286 >?^6Z,Z\%3>)#C$3F@UP,DW92#0W7(
MC*!A870OJWEW<MN%-X$'NE3(R@D2>5[9SFWAQ@[NQXEW^;K*[FLTW65]/\L8
MK<[!F4@$NG"UQG@0_Q#3[M6%#>%E0U3[> GH0V<%7R#@Q;\JMUJ^]5))(#R2
MNMHZ7DTSW6>HT9I0I0.=FN$Z83HE8=1:#& [_!C68).Y-L^*8)\ (FN;@>T;
M#*?M)R;:-H VB2A*8T#C"07+;:9(&E9TSBTPGY@ZWZ/?NL5M"/%Y$.UK\B)B
M(%U_Z)%5K^Q1J6_U^Y_TH=P>D[[TUQ5>VO+LJA\\VU8E[[$_C3DLEE)UB."L
M<+8J*07G**3M\VEL86VE=T,D<,,E__QRLX,N?A_M0H^5<=/3>KLK/\OQ?,6B
M3NR#@?QZOY[*THN9P38ZY[ N<3_#&[8S,/ZSUO9 41.6H6(UO@#4M**R>_,O
MTD+V]E+DB4]#D1J-L[;3US(F)IBW_L[_N4.Y:#;^,RW;DB.Z.W\ZV$YZ=V?"
MTP,Q'RD3594686^Y8U+\PGB3@5O*R*L(J,S<@_)U9!@ID9^B6VHCM86F;:(E
M%OY$-=NW&=W64C2Q89GS()T?>9 ]6[!,&0,2]NLYKB"9=1'M X26:^709OG6
MAJ[=.7_D1X<VOV;8N#A8!P<CA<!H\Q$_K,VHEO$/#4VX<^KZ^MU1[QF/Z>DG
MA[@?,)WW^"C$IF ;O[./J9!<BD7 "SB4"CWSXQ@ [QUTI-J10$VDAK%>.6+G
M=@E=.YZM+OGR0/;^;UR9+UN:[BL3?==&RK W6NJBC8ST\OT*D1E]U?I&I#OZ
M(?_:G>SR.>>GL6]3CIX D[9*JU"[7IX<]Z;NQ@EK46/Q/ZL#N<\#NPH+Y4Z^
M>:T0>&OQ4&4U3LCF<F&)Y&P!8CYG5G59/K*]=HO-%^&QUXFW19YVG /#65>X
M8_"CQO(T&!2U U5 P ^A98K5ONC.AG./>@E='<WSG*R->+%UNO95QFI/U.2.
MM744\T8K(?/2KY#0*RY1IV<P;/E(EBQ:$@PKCQF&$F D;4B@MP"#F,9VP;/U
MP:)(6JJ1IJPUPRD]-[T<#EYF71^Y<ZNY,01I%U9!Z< C]\QXN:8&!R_]Z_%Q
M8;. >_ 2G^QR "FVF-UUL (@+I3'H2_AT6)@<P5"X71JCX(0H8G(,'AJ[%OB
MX;G\,_1W<%4!=!TILBKIHHQTGUME65S[4-^DSXS2&;Y7B>F,Q% K=@+8$GN0
M\=OS>]A[&08D3(/*1\THKU$M-'PAV./1*7(O5KSM]K-2;<F79? @_>#]^$3=
M8.OTD\)66X2J*Q]:6UK($74/DJ,5L\(\C5T?M$V<NJ"$94WC[\@!C@.<M#-J
MATH=WS*L=%QC;*/<-.PTB$G?*2,[*>4_6UNCF]K>OQ\K)#?-M&[>R?OP#6,*
M!1 ;;+ZBIMMQ"J528;]GRR:W). #?$*,YD%.\R @WT $[*</<PP0!(Z9"]WD
M;QZD']&-8>I4\""ECA<U5%@$D9UMZ'^GWZ2 "Z_^7T\_J;.;^=IM"?;'-JIG
MF,6_YE[BEO>TR\Z_+KMC1SH_8WX5;J1BF9>X IB5]B9\.S#,M98KX1+)/ CY
MMZUG *#,>90;HSUB)L')19WXOV>_F"I\M]/ '=AM<R5%A5-^;2QL?-2.G9=!
M&NLL$!.;BF4_@"7 9A?W0LN7.QMH[?"P:$2I)?VB@3UWN/E#BU/QDI']\=P;
M+NA_PW=P#,<^#'!)&U0N[\7S?>L1[BG0FMJ;P_A 7VK@002Q*6B#,K9D$^,&
M3!BM2=<TI$R36H6+JMWU>E.I^'TYHTIC8B2N7-[ZV95S7D$/$W)KP@+4_W=N
MX#$_@B:<)LS::[8N#S)FOD+D.P90J\!:FRW1S%QQ5,H88)PCA9DN_??K8#97
M0H745=?77C"0[#45AR!(O/QZ6J.;*^QX&BL&ONQQ,]'6'WSW,N3P 3$I#1,!
M*36UZA)3U3A5@IY#H6IESBS"7)?SI\L@V''$\<;="#5S\46#"WWY8>UY>M9K
MY-!/GS;,OG!&^(2EP0\Z%.-'3#.1 _EWMU^-4ZV)-J!G3E'(?1B)R/G'Q"-;
MQVVP7?]QY<"]W3+?=L>0P1009:<QA$;9_:/(W^TB75*YC, F9T.3ALA:!*7$
M<_G+,@\2^3]=_@+3N1=SAYBA<)P3S]9AJ:'D=8=E@\50BK0, O\WR+2)9&"@
M.W\B&W$OHD!;>'8YRW.%(I[_M.\1#W(PHY1RO]A-D65JA[/4"(QA\J]GA[X"
MA-;QJY\%*$WG02#HL^,FJHAB44XQ.Q(1#3Q1K/."TZ52T?L?T >0XJ#6D/!E
M W(IMK=#<12_WIB$?Y,U\4O^UL"Z%6/X;U@25F3WU>:4=C</(M9F!*S2RMFB
M#=W-\S*E#+F'!HE\E^H,7A+H-H))+6_FA)P=MFT$>IJJRH)V_#YK9>>Q3C3H
M--@HV1=BL;6;M2J#8*W3&;>?/L98*?A?>1QKDTX_\;.G??R\,Q0Z%$62GGL]
MX"XZU;@9WJTX[7*O8EAW>:6]Z/CUQ@I3BODYK)[JC<@'[SVL+ -SUB5JVF<U
M,H?PH(8!6_26]E0PDPX*4>%3];._D8^)39B,W\C];/W4[GQ::SWHQY"]/D9+
M[(XY%.+\ [Z:'6B)^S1W$ACLX137:%8+A9?-K1AX.S4&<W30H: !/W"XW<'E
MW/Z8P^"S!=C4V4EZ?$TOD38<MY.960(&T_#)<#%C>_HCI"5Q?$-O6!I5T+/Y
MG32G,'X*&-^:GG;S/)4:4.VY[&Y;A#.5[Q81H VS)3>9(QP"#Q*\Q4E''\$"
MMO.4 *81F$[3SERO1<M/M$6]!9$N#%BFB;HW*O3G/&E.$CCL+?_<G%)]5*FU
MP2Q,9:/C\\G#2=\,?C S^0A<! ?X4N1O,+J4#TWX[M!DXO$.J2GPZ?0U8 8F
MB0,V$K;L(&Q+QJFB !'*3PSMX*16:&AU),?:QAHORD>?3GV&63N!3$_YZUAY
MQ<M1^MKT22KHJXY!M&I+V^GWU\_]W7G]\^;#B&"6L1YJ\G4R7BYB0J8@W?*Z
M:\KSRDJ"FN/WPL6#L:]M:T_T;0>-,"-5K&S%?^;IWAE[X'+.)OQ>E9N*GR^4
M3N&O;A^&6H6MFR,RC"Q:P1.L4VC/\<:-8U.@!7P\\;&),!H!9&:P5?P9B(#N
MG2/Q&"43;2!G8=JCTS^_6R:GK/R5E[3NC]^S3K<D,3*8SEIX/79MFK%-FF^*
M@T([#J"/@^N15$Q2A^ (6J\:S3=@-*Q<3SE%6,HAY1=<F)@<L6[3R#GGEC^E
M)RK_WO2LL;;ZN3UV:P&)L%L84!')EMQ@^H[%7$#+@M*T#2$1T6'Z_($?1,DV
M ^ 7-!XCT29&;U?8H=HI]^0TAGG .P.J;!3>-DEA0LB11FZ?;UW-6KE.%,%T
M5A9#B*!=+:;3,D9R)6_"L.PUL+#0G+ [P6"YV7FRR? 9,%=4C0@+DMQVODWY
M3UMSG?8^1Y.?_\@PI:8!;NEDD:-NN<73%O)?3WL9"B)2>;YGRS7*SU=Q1[(K
M7Q:I.>#B>AWS:PSO+3*=7COHROD=')B*83ID?\.XDJSL2TX/G>4LZN&L+WT8
MTG2[B)2%FV]MVR]CCJ-=^%#FZZNG9MQQC*CN<"H/<MCXP@(T$R;#]BU#C2Z0
M.B1!1=K\<="7&0)(MI=X!!H>2"WYX7)V>4Z*'TA+7W*DC:]S'DFRN?C4V.*X
M5JA>L'ZCOF@1#-3(8Q_;R[3@E&%N;8AROV+KRI]PI=$F8#H5_A<<'3G"-@-(
M-F2T,A63-B_\;32O)T:QH%O2\%1N4Q2EL$/6&G_TA^'HU*4*ZVBQK_ A!Z =
MO[D[6><@FZ_;@._<0R26Y2QJI7-4.UT&&V<<#32YRBRMP,105KL;D.4!7'Q9
M;LU1RZU@3?@_?,<D+&L77)#Z@#*Q@EH(<=^/6=]F.HX0[)Y"@<OS0LNPQK*\
M:!J)!ON:UZ<#\O-4+;Z42&9?>$3%'FO"TF8M;.]GF+W/XU_H]XM&Y]M%2OF:
M9]:?WPPNN-X-+,$_%KKD?9\J,] ;#,@SE;8638_\L7!Z6,C\'LF>9&8.HDU:
M5,FA4>%IN-,NVP5EXVZW FUSSI.?%J27?**/-8;:[K0K%>7..J?^J>3+N/O\
M1$W#"&*"B8=F8V:@!.>7(NDQ1Q$**F-M>@"&)C]6(Y6(]JU%>5.G06PO]*B[
M(+UE+,)+S"F]T4N]Z\X((C]^O+;\06V157]-(\B#>+-/\+E ?%=2LUTYI>M$
M:G$^<FT 6+FJ;?PH"H@E\6TFYZ7Q7PA Q9WQ,[5BQMTC4$82%R*V,C'BA<I2
M+U*Y/*$,#*87YG^[]RF@H4XGZ!Y'A ^:"Q,1=BEPX HV\:'V1Y;'H*)G[$>X
M;(>\:U_$<JFE0'>5C46/^\W69NP^!#-K9?+AH_&<SP64.<K5\G_K'.S^T-#[
M0"@#28>NIP)X9F#"15ORPL\*QB:)NV^BQL_+?JM=O;?5+LW'Y/2$WHD0^2;\
M_B+"8 ZW(JK6^/Y=6<%LIP>O&ULL1>H2/PZD;W(-JXJ6_N3ND;O@7B:KWD4+
MNT<RU<*9NWZMCK32L;&;XCA+J W/1JHXE.NNKXT;S^3*Y,I.=8E%OL$YV*K9
MAOR*;EZ."58>';"1YT'"850:'%3DQPMS$RN%@C/S.,7BR] &8N^PC#7MD1WM
M\] O,Z"<[C1>--2,Q(&W?KK=+O[>.:?QCKQ5Q5&W;!'63O@947.Y5^AEQ/O&
M50_ME;Y>&'#-#CQEP$\NGT%M)Q#/,H@9AA]BGYS?SQ9=@"83)=B: +EK3IC1
M](RV+G5I!&U'K[$B]7G+C:ZUN90&N=>TIP\2ELIQ<'GO0'SMZX9CWIY7U)?X
MDL<PN,];'.ACBZES14/N4;HVX6 Z8YC6\80ZWM(L94")J<#5$N@735W)_]UD
MFL];C&[H3A>9!EO(N;=.F4P2TR9;,9TNI5G:X-\NZQ"&I9(M[#8^X97EX4SQ
MQWKSI/&;"OHN?SW/N7G\@+G?G:JC,0YE4<7?'T@EUN%?^KYKJ9RQ2/\$:PR<
M*-21^&'>9&^;<*HD[4W5.(GUP-&QZO-W0ZU(9;7L0EQKN6V1I]-KP=.C:6/N
MK385<VK+4R8W9ILZ^I4RSW$>F_!)KO,0D?I*'W,4XV<W5<Y$@I88'%OE7=V8
M2&S'2?8!H"/%^ 'MS<A4>7?F@17W_*#6OF1:!G@Y;X=;%UX&]NM)2]F_;^@,
M7N3:PJAE1,#JZO].W[L;R[(D8X;W.O @<4;,5^,="F J3;,Q7ZOND0"IYAS=
M(ED/=F0U7W@6B.Z;:"3N@?]H+?X06:EH*IE-2UW7NFA_0C+<:_@]7V]^:N,_
MNOWWP>O)2DE9?%_$5DI7BLBX7BQ!GMI75[7ON?F\[BTS'UGT?Q+O\3]\N8=T
M%F BH"SWB!(?14XK7)5QQZMD;;9\!6@^N@0_TW>*N!#BTFUR'& 6Q0U-C$<6
MF7_Z:/27S,L<W,DS5W<J[_8 +K+^#T+=,C_7@=?L!/VENTC^YU_ZGF)\O:.O
M5G.A:2$HQR^I\T)X;^$I6E+1J47Q]^]"SZ<9JYR_?#;CI/C&_D^%MZGYS68(
MRF2TROLM8@8F(!-4TF8?W61> X:[X:F8O6Q5NFLC; V36-+WL)DD(H)V!#<8
M4;WNFX1%MN2D^Y@DXU&)0]8H#^*)O293_(36KF)#[BG*ZFZB/"KL*.)G?UH>
M5Y#$B%E8@*V'\?]<(;O0MA.YVOUO0,R"0&?)JVG09*&SPQ@8VPYW6S&(V=\P
MIB=\KI.\:FA#'[K3*.AA.I:39_^D9\#3 OKM.UM^ 1B@:Q&!<*8)6/(*\9!;
MQ=>0&YDQJH%<6(&M]4"-.HF2F*8+%>RG771QKF](<;H:.DG:80M7S:NY+0<'
M5@8\V<!$Y^R^J&%K,W(+ "+S'=C_%A$UH;"704QE2]"P!X.BG)O/N(*5JZ16
MLY[>ALH?4;;[:\M]RJT?*.2$12';G7\9//&+O"SU+7@Q6(K6="XUS(T9D#18
M!_992)O7ZHUU3:8,*EH=5_N*V#1P5LO_C.BWM,H/N_NTM';;<;'7/ YQR3$.
M*5F"T XST%.NYT'R0CR\\/>?_7(A;<3##G?H8SHG>1!HC!S:!WQ$G4^!B6QA
MC['=/XRWB2WPK1'"1 -HPD66<#\K2(U%5!6L"WD0VLFAY63DZY1?O9;K136A
MOI8T537UC$FN$ _"TN .0O=A0C+!4U)Q)D>XP[M-I25!%[I YJL&QO=$X[^
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M.S^ RD3__V"^F>#Y;'?.RYHV,ZGDWYEQS]B10%\"VTQSHGB[M2\1\ZZ1573
MR]UHC^8=]B6FH(.FHU7:@XEFG3//HAI\YWD0*J";I9U.?-<^4V<C7TCD2_>O
M%@^4')0+\^.*U< 'N@\?>M6G^A-S#^**C4ZHMF8=Q+T\&?CFV>2/S<,E?Q6
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MIZ3H$.EKZYS22/^V,!B:N6[VNX-9Q_K?U*Y43CV1^H(?_:$:P-?B?P?_!XE
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M,,.&#DO4>[GADS!EO2D<N/-JX-#-YZ=3)+-@U[[C+])AQX8DW9$F([.G'9*
M-,Y8_XR@P47BLPH.8VN)/ZCGB*;!Q7<#8T$B&_[S=E\=.[JT[YLP*M?+VDK(
M#S*^HTN9)SE]Y(:(#55@TQ%T8IX&^;%Q70>GC,TBJ)VF%KA^$PTZ8K2.;":J
M[_+T&CVVJ6Y-AT\^5H]I[&)Y-^]^FJH"KMJ_J*/&5OE8$MY%+!'O(1:/5S;Z
MDF1F.57KC+0PR@HTM+W_P"6S9#XO1[*B5)+[OIW^UC+,DD?4WO7P_[TU!K?V
MLL9,N$+?CS[&/;N!'HQ'G[LT62I@*UWI%W4[H4,>[Y\#/3SZ5+ Y*X!".Q*M
M]8/L;">&RNC]F9<7OV095/#O[.63SL(Q]W7VYL$CQ"YEJ3-O8V9@C1:TBPO8
M(V!J#T88'*:RH7T/E>.,;X0U4#V59FP!BY@.;6-I D/S1VDIWU+GY^#@(@]U
M9L74.'7.R_%TELNBFGIO#_##Y>DG.LOT4O*5Y9=9A[SKPWV]2BH_)8E+F>L4
M?5OMQE>-=135;>Q"7I(MG(-?!9QK/3%;5%.7UQX1U>G!9*7.X4$%(9;$?BJ,
M)2)^ 4F)2.@X%D[/8"#I$<]OTTW**1XVOAMHOX7H8$_#VN F[3AB8.@NQ/N%
M7F30UB8MZ."?QG5>__*)UZT>?Q1^[4(PC9N@ 9/#)T09L=I>Q,42;B-E @C'
M\5LSM>8_5JQ ?8!@!3Z.K W\!'4B_NC (BL' W>2%RU/3C2532DD,/3"TW\L
MWN\C=WN*4?WDY.Y]"D^I?4&]!]:8J(NF#]CM3ZJ-2='1E.XC/KV',W9PS/3A
MLQURR,B:&2]0:S*H,+</2>TI%=/R[!+_;=W,Z,IN2IW<!%5266*+C&1VURXD
M !X'@WY#@H[.L'U-"A,F$)1Z3]L(HU#HL9YZM/.,HYSF!'+9PZ I53)P/&"*
MU[Y+_+1F<M%(T6I#].,"-T(A_-DN! @MWXBCKU"<DX%?''YUIN(<8O[$>!C-
MZ)?3Q)8V/^A(A??"CX+EMLD:WZ8:N0@AA7H\M.=AP>NW-[SZ19VWLW?0^A*Y
MMQ#"I@TT>)^OV-B+>]J'EPUDV_<Y[M/0TR@[$^OALM^K3D;D6=*W<GM'O)3A
M*,DFRK)M?G*H.LN975*J?+K/^5FIXOG6QN62S$S2.,W#/#MAZBWQ=AK[-8:(
MX\[O/1G"XJ-K=T-!)>S&2A5+E2ZX5,Z(B.DZ@4KMF3\"Q#U""^?.GK'$HU)[
MY_<#2UO3;?C$N[Z9R<;KSMG28:1"H_R-',"CM'.S%-M=F).3FQ,+"QYQ=&C+
MW84X3F(46;#))IM+WPI;)_1L7"Y._!:TN];F/VY 6N-PEJD_EHI3= .6T])U
M'42Q1YJ8TUS]N;ZG/R@HA\^[C!4U9AP*^/1#16M-3@?.BTPWTBQZYN6)6XGY
MIS9[<]$[UTGA<]G%WB&R4]NG;1B-G2E+GHKP!IE;)9],_)Z#0H)/%SZNJU+0
M7:7HWC.UCVK=PT/XZ\[*&)OH"SG8UBF+./!5A2TZEP147N)WK%3I+0AF.O0-
M.:W:-HXG:65G)R'%&Y-<7'PG-_"W:]D"F,\$P),+?Z<94?\1C]&OQ8P5=I[N
M:'R;Q7M<@M$%PGNAQ (I,'J!(+%N(@0,- '3W7):$V'(HZZH,C@MZH*SMMB-
M^+"1J!ZD.MS,6*#*_4N^'&D9^^\FJ+[)DK7=A;1(=-=B&9[LER9R8 LEM0<N
M24ZTBY_7I7\DW=XSY7&Z[<P+IE?'T+#R[[DQ:V"HQ82>NB2^R1"O?:0Z(D"P
MZ5DS(\TF&JE,(;!$H8Q7GW<A=S=G3+FHCF9&P1]>PPA^[M(!B\VFM\B'$2[.
MVVUU:4>R%O "H--"9UO3Y>9<M_+/BNV._,]<?PB;6 EC].MFG_86R'4/RH_H
M&$9?6?YB?-#3H4RN3*GTJI+,F?*8(KI88:QCEIC'NE6X[["J/6.=U,-O>27W
M1=5;QC^.MJ]*-:\[9+XFM[UJ"21%(,QI8;N0VURSFT8 7 F)9,!Z4R[PX552
M<"'=CN%+G]N((!SM$MJ%^%L@*@*D/Y[;/""G!_I%H\DWQXQ-3T4ZDY:S0I?\
MNQ2:8DG6E1KA KJ=N!W/-[N0IUG8A0SI,!I]T8[] AU5QODL79=5[1GXUATM
M"X8$T?69E[L9/./(+A4/>&)4:_C,T>:?\$$J'ZVK)XVT=O_4X/&V7<B^+9?2
M?#"ZUXUQ+C+EK-#SPL3:0\1^I_?4*F^35ENUV1<5IKGYUOUF5H$ZE8J'5&TJ
MOO8;VP3:7TM,3(BPLG=8VH4(,GY^KYNK^X$IY#H01\)")5F2L%!!ED#K+\*E
MOX^A#4$$L&G3/L:11LN/ZU4G^YB/8>8J/H17H1J<VW/'/S1!I5"Q4Q?.C#JU
MZC1EY==E^?J6*80H_/+$?.:08$"(Q,8HTP;;?8ZCQ.F;%P$%Z<S> D/Z8#><
M'WV:V.%)M0-=-!>8FAZ]OU"WW'[+K.KBI>;7_6QP3'ZL\L:.;H[%IV>62/';
MMSGFW^O66#*]DY7?PC EW\<H'R_U+>GZ.U=;B:I'N>N]6G.W=9JMNO9L>=WJ
M_JO9)7U56YO2YU7YYJ413NY!)3/NM>?]2<XSWU+'X:!""ZUA 08JE]-:%PBD
M5*K=,V/?13P?Z/,>)LQ2#*>,[A,\#&93MP=V+M2]] X/-C:K^MYFW]B0SIN^
M95UAII\]=-/RA2C, MOMO=>MP82/J_HQ&")L/\$?^_57#UR4(QB(/8@^&5 6
M,(TQR.D]"B9,]^?Z)=RA*V7@O]M1@A!>34_.2YQC2E-IP29$D=/)/O+0^$R7
M(*_C0]5^F>\22J6&SQ8_R8;SI]2P$WM&2;\<"^0X0Q%.:V5+XJ1T#X5+E7HV
MXS;W#4.;@B)S-/.WG9?<H;,M&U]W(;R.F-%Y19 ?+<.\CSY$QU32SUH#DUVI
M5/F%9-Y>KA9%TV.M@RYXY]*W/#$['W0%36^T-^D;%236>-B\=K/#"KNMY8B/
M6=T< (.X?^:!^61RF-[RO/$+[#8TGL,#[B]%(4S',6(@+Z6)T--N8T5T1E2W
M[T)$ SF*X_+3Z/.4$7[];/^[C=&PWHC<$N&9DNT<FMA$MP6=QPQ=TZ&^T&HG
MIIQ#%3.^WLK!RSY0,D ;SQ8K:^@9C*@%?>TW-'J5N:+BN)1H&5S_+@89?=[-
M<T _ 'NVN7-^>@VSL9?<_J2.)0<(L<0WN1$]<#W:E)+3+T!^UJ5%H-.6<GJC
MM,'+J7WM3O2([EIE2NWK=A'PB1#_\HP3<7DBV!EZ](J$3?9)T8PY]9YH 0Y_
M$Q>I).]%]3P0=@GA%C89=Z1+A.4)F,=PX5_=!6P_R2+%[LFT&UVQ!',6(,1W
MC5+2N/!4&/% _7Y0F'I>]$[3W"MXP+N6A<MO_X456*F3;\BG:_1JCXCQDV\,
M_7QQ^YTE^TZ+QID=U,,O_L0LDV"W$8<^)]N:C+P@J^V$.UZD<HW"\&&CE)JL
MK-D_Q>KDH@['9K+\SDLNE0/8[H>[$#\LJ*J]$0+=F ;:%W"#T#B.2BIUM#?U
MN6D?].C@(]XX0@-:3*EJ>NH Z->_LUPRO8VH,&_&?N<+:CU>GGM4#+Z  T_!
M6*+3%!>6\,IBS@ Y@2"..<ZR %-+6-= ^]<LDW%=<FQQ+Z\C,?RX<O]B7R@Y
MT*???3N.9M*K]T8<R/.H_,'S_N3"L987A,3,Z][O]$_VW):LDRJ.JY4MEG%P
M"A'U4FJL&@K-Y_LPT)Y1>6 IMF3<[G+NVL#Z9-:5J?NV)4%^0^G$X6#\YD]8
M "P0.9-!Q=-ZN0QW&\,B<* RN1>9U&8QH)X)Q SVX/;U%_ISU,!\DZ8%;<$/
M[ YO8!<2JQT^ KM.U&J<L;D4-:,2O.)3+%#:ZGOR!?8JYCS7AC[M4L5\)!_A
M'$>%<OC=N&ZX'QQ<L)-#7P$R34Z-;[&%[036YH7HFK7)$R3TM%%7XJ).^3QH
MYQE]:00?W"%?V1T176*F:R.;<RU20G@7P@<]P#F#OL0NP&BASX,4H-CK'3#=
M!X_AJ(UWP"DV[KR9%G*E);,EZWX5O:+U,FP9AV2XW51C)6ZCK>QE2*A/6.J!
M'^5,4="'JSPN+#[P,4"V ;9IU4SQ61 W8.3R1:$UYWT]"!^8WS?=Y!J4X D^
MZ>WU@L4@C4_0--('$>4FE53KYX41GVJ<327!3SJ4 "LI<2AOCRXJ3FWH35IW
M_^>/ZS?/=FBH:EGIKE*/^YMWR5@Y-JY.5TI5C41I^Z_E>:][D Q=PLH-X:ZJ
MCAE!YV;O_O%],-Y@-8)$0-L)@#E^QF=1F24JM #MPY'@5-P3S2XI,.H&V%H'
M6E-<'C7N0BXT$H10ZMW.S23W/_KZ4]*8PLC(J+"1D*JYD4-OTS?52]5<!R5A
MRWY,AV'174B3-LW46%CALQW3"HW.Y2L*3U<MS*%.)WY+<"UQ<+[RS=PE>2(K
M_.;0E1/36TO,8&PWT40#3 2&^P@\A%O0QW; 63,Z;ZQ([S&T"[V4D1-.'3T2
MD)M2,/5PI/Q)!T_15^TX8T.LM\P'OZ+UB+:RSN!_+!GOPA "[V[Z[T+2*A6R
MW11R(\O>%00HY$8EQM\NH%(C/4MRH^*7_;(CE]-RW<JRYMU\'Z2;^]WQ(<3=
M./MB27)V%Z(_L)3YUDBJH8<X_!-U2SZA^ED/A5V<VEQ[D)CA^ RI3RO7<P[W
M/KCX\5;UI9* 2V?#/77_K.E22Y6R2'9EJ4'G+!O6X%_R&&_H.1L7F-=8RNP*
M%F^1*UC<!Q70"[+=0MDY3VJ'14/[W;U:"@,QQZ=T-1UV(7:Q:]1YTJ;M9)VT
M:G_^0E-GRA0]J#1]#L)YNPM!$$"#4 X?CGF'\R]6I$N69<?%4@IK7%O380^0
M^SER "[6V&\!?Q"!I\ E W>P7QII'A?ID\U-V@R%8VN6 57)=E?;B7JJ=^\Z
MR+2C@F^X3=-ES**#P[O_*$6GOE]^07)]<4<JHL$5[24BYB+H\I58M7XIV=9\
M42VD4O6#;K%]Z(A:@M: [OI$J=0EP?NC5%O5ZL:,A[\#%&>"=&%<3["0B@/<
ML0E<[#,SXO?>Y"2P--K/Q90- Q(_P<0^G)!&76V-\5XJKY2E_S\W4#GOC>H*
M-8R"7DX=%_O-5KZ6'-1DF2[3$,H5\^FM*!A+=J_0^2N@9AHK8RS#/ -R%A?K
M&@).3WI8@#!@O9=P3&MI@N=E5],D1V&XPF-FKF8DY'[+K^0'X TEG(Y Z#+)
M @9(F-WS\^)&3U&IE2]O 5\2##HN)?0/\R14QL2>TWG;K/9*6^J7F:)AMV/E
M>675YHSC_X$]23D:&#G_2H-=2$RGRZ=5S^^8#&RW#9>^<JP,;*&<.W]=>#Q,
MI#%:^7V!(*"5%5+(T@$=*7.75ES&.DX&H->5ZJMFUR6:F_6-II^S+FJ$F)17
MZB4GA<R8(LH\9O(0!B78D2]WWC47S*^-4Z.LA\\G1@V?'_;[67=W,TC).L]Z
M..!O)?4\CQ=%[UHR>(=S==&RMXJ+NAKV/>I>>F%LLG]?7'E,-R6 :23Y,."=
M8\QL;L=LJ:&50^:*X9!CI:%5:&:ITOR9S')E57U5R[F6=NQ4O*;P6TL%K"_N
MK1U+=A%XV@?_JT.?N;?_^0K7?0294G,8\#A-M&$=ZS+ 2*2,RJ)\!N]]%U]K
M.U>_"(.@JE _@HPMPIH9U>%1)5WUQZ:*.%]-;P6[NNU@^W"@(9ZA"NX#BOL+
M#G)=4B3GWYV<.)9O74"$/@<Z$0X_B()1"#USV@,2<1N6U:@6<X!1TJ5$UQS(
M\8]_^*8W0/;AHP2BM5%3C9!N,Z%/48RNASY-X7]72943$N/70[#OU'E:'W]>
MGGV]]F/)BH;&[72;U0V* =&^4?Y0__U\ 0E/A=:L\1"'D,1<S]9:['3M:)W)
M80X)*X41YI"ZQ-D=X3)?NN3106-=6H%0*6-[)4+XN?ARUD6Z>',+'7QJ-^W[
MF>+\=KPI+^@2PCQA?,JW,5;=PE5+L>D2>6IE$/Z?$+Z<Z<89]C( ) 93OT90
MN3Q!'D.?IV,>^R[8B8!GNS%:Q$:".*) '&?!&0/*DV9<?(IF1K"1:JLDEE A
M OCJ4;)]>K5%*TT;F#9[^&?ZX&VW'_+:_=3OSL4)0XNV!4>Z>(\Y\AI=5[4K
M*#BN9G/1X5G>-_MG?CRJYB))GDFKT]665CKI(05OD]+3@S_ /8/'&S;;.U/7
M$)Q#,US_P8.R8"B!^THY@X0FOUZ[8ZB9A>T87[H.&+Z(.^"QFMM<3J$)];5$
M2$\5+V#%0 N'[($+'I>B[VQ[M#=.WJW#_^8+UOMSMTG0.&!J-41BBNO=N@=Q
M@-WF5R(U[NDT0X?]; 7 /PI/%84'PJ#&$:7@><KF8W0('O3:M.Z8./&9([?Z
MQBM^<U.1'M-?D]N(49LRUB_^XNIFHY0HMM&B$PGOKQ7K3@)68NJ_L!YXPP7B
M'3^6.I2=%[0X'E_\I(^J%JH?7QE7:E#N9AM:U;EYN^K#!./&R/QB0JUD#[_5
M9TNS=_U#JO=)JDU-Q7[M".OOJ7-P4".")8;<*^(CFL=(9F=P=%G:H!_=E,*)
M8YJLCOI2/>6I4-8IZQK$1[)PA_+B/1($&'VNMWZ")R[NQ\9PH/Z#9_.S'MX'
M!#2*?Y!!=21+5HRISR7;E."C+<X9@0IR#J)1@'8"ZR*5O!^,)?9Y7> : E2!
M3',ST-Q^L#J2YU]@,RE\Q+Z\[8E2PH29[U+\\[-7GO/AOS$2:'$' +9>+SU%
MKNV&CD/IC6)V5<L//Y=C=F+ZSC_9.^&5 \[5'],[7-HV[*;4YJN776K2*W_4
MWFUU(N18UY[?AMV#[6V,N$YXA@6L4^.AQSN"Z A*2Q\Y7APNUG&<HBWXO9D@
M*!0C.)\33F'#'2:"?^A=ISMWOKXTM7W,:_!X?<.[7*=T0^,O/6)ZW[ MJ2S1
MKO7%%98H-WQ2B=L@(+BQ\E.CYA0"'])8*HC:&J9(=XJM!C8OQ5V9.C'I\QG9
MU'EDY1)=P3K<.^3FM$MB2,F\W?&^ %CVAS_Z9@_JI#[L0IKK7[+>_*Q\L2P)
MW=BX474]_^J%&S(Q_,&9;\:#DTL/7S#X\+/+]R.N;U.KUL)6%__CT@VZI<)$
M4\,RV;H]DJ" C? ZPIU#.?86+H&\_U,&TP,S5*!+H/\NR ^(P+,,W@#33[J4
MT3KTB/B[R7V?+2G6! GX3&UGF^7QAID1*EO9ZMV;]M:P6(\709P991T@@W/D
M$\CS&MOC[;NX^=6.RK5>U='W>VU!,PHL9@28LI'O(1_1Q0D%2$>GY%4/5J$R
M>G4\$$'5%ZL^WMU"N&U9:RHV5JM+N6S\K,4*9KH,[T+Z5!;:79Z^I^8;31HN
M6C--Q3: [4Q?%4HQ[<*GX,NEJFU9LA<^A0OTTW[/FA>PPH@+*=4V6[])PYZ-
M%ELR3!YL=YB>W9<XQD=V59?V18#<UW6>_1(;N)GX<+L/*8(^'>UH1F1%+:QN
MA@LP.]7[YN7N#UZ<-+Z9BY[*/5);&BC-SGX<[BV5.\^97YLW5&('@GLZ+HSM
MUMH*\MR%^,,>$=ZLTK=I?EC%FF83'3JA%[<?-%JY-*$899U'/H;H.A/?9./P
MRZ/!=:FY8:+1PZ/SSC)#4C[:8<8JW3J!<TH%;P&E;!]>EOQ^1^S-E]SP*;D4
MB:-OWLV:2Q<8Q?#?*[8M."?J)^$4I19&T9=RS#+CH<G.EYB*N!];2LJJ^]9:
M+&70_"<O$6$3O/.UO1HZ26")(3A'#K)QL(77NY WT_$$7_(!EBBXRM5..3#.
M%<16$Q+1]PA"\L ;7,_#IK+R:MUA"EDB<*<2L0LYY?O6-6S"+/WR6<EK8G6+
M"RTL61?F&=9IKAL)\"?4'ZP$)!B/)M 199CA D50"):DNPDZTQ:^=IC5H:!N
M0*/1K&;XXOF@D# #O)Y!G:]0<?Y%39]_%&O&8RPXEU5*H4(&7H8/H&HI(D??
MN-X8<FN21D@]=T@Y=WUU/'/.-MCOB%6(508ZOIJTB*KZ%(P>?MGMB,Q"R,Q/
M-7.BLN[22/-#XY-D;20"N=]2Q-@/K7-*ZE2:E;74X?;%-*LK<0A5%TCJ1AR'
M;Z_!K2'HM[#]GL#'&86VV/5N0E$,NWTHS'2/B0PX2=E7@BI@]LN)O:EO?T(:
MI/K%_C;<2DRE65O;EX,/!YBFJ:Y/G=\\O[$>\G76XD(_F3YF%F5LVNMF(>I]
M\ND(\*-1U8DQH4:L5#-(NN#<ZFNDYUT3N?CCD[!CZ7FS3\*9)Q;SU1J*M0*#
M26YE=;D;1-:VIUP-9[X1"QJY,*Q!'[HS\1)X@2D#$M\3&GRS6A*13>MVD.]0
M 6-Y*ED:7*9MG8<>07R@( 3MS('?L<_;?%,J=I+[&7N%^XX/GXL3;?YPO.2S
M!8O#M9!^7 A41#B,72B#-XX^YABBU0"A/FC<0Z$8CB@)_(MI ::@]=D-X94S
MZ],[E81&N,"ZT5*"JTQ4!>6OJ+'[?I8RPZY#C_\(F46VPOX"ELU>.(R<V=![
MB%I#/7R!1+I(/:];NU3++ED;J%F2FLS?6)Z*-^.^%)UTQ*I,T^_;:E:ZF:L[
M(11]BVR\YAZVU&[IYL-= $YM&8(#G6RZL!\^IB=@XW%Y.LSCZQ8-;CX9]F=\
MN=>1J$U[J=S8V? NQ?!UP3D>S[]O_NLFPS1@IW*)6=F%//-2 M4I\,=8P&'T
M<2ZAK]9+\L1G8T^Z=2]'', GH_D6;>2O>$0V(H7!3<H (0S)FZ#TKBG^=]CG
M,)J''<XY5C-P8,:.:4IRQ8ION6"/WNNRZ=OR=QBY]_,5T)!U54LMQM*;CG+[
MH*AJCQ>*5%J4,@IU+%7M$<F4+10ORP_,] C[EG.F,</*'M%@]\L9\Z"578^9
MV(4 81+OL7^Q)/,H0BR15 9F JU8'=AFTE[FABJ' YMQ7=*HLY3(*8<=;1KA
M$'B^-S&2C:>V(V92:?_*=Q(;V4?G_LT@WR#?D,FS9_V[E^@&0] D&)?9K5UB
MG&FH1-BF#-KF+?"@G8H]!O8(_K5HW4IO2=##"KO.6X17"J0>A:_FWMW.,<J:
MS6DI6]Z9E'(;WR]YK(@E81;J>T/BG]M_,-[9"T#3A8(@JU*-P6/NG5;O/MY0
MZRD]5W5+X4]1L723J).BC:KEIT]!'UJGJQVN92Y%V)0?2+=/M+EPJG%>=3VZ
MMIZ)YT;X>UN:ZM!0[KD<;&#<HPOUP&+AHB8R%P&/WEV(R%;T0V@\#HCG:XI'
MAU: I[9M,\SA_*BXOD.GZNT$YFM_P6WN?IQV?C*O+W!6FV(FZE*?Z6N@D:K5
MZ^L6IFS'^\Q)3-*V9.V36FU@ULK#C&"'3JN&0-I7W>SX8X9#)4N&[4/.RP&*
M469F_HWN"ACN?+I580LU,$G80@Y.]'>^1V_N#0P,5*2+4_LYFFB5-MS&V\"&
M@.9Q#U=4<8_[TW^S=V")&Y33;A_"PT49;=DOD>*XL/H:G2N$B24\2W:0&[V4
M9)8/6A.^XJF:Y8,31/<S$A2AWG9<?'?N@*O"^&NPJ"WI0>V!M$&Y@N,L"YZ&
M[A#I?^O?OZW!OE<4^]6Z";E'/KKHY9/22U7U4;ND6R\&&%12%!-+#Q154HMY
M5)QL^2Z.9NO=D)=L>U6?X$[LFRJ5N_+!8'[52LWR_/QZ5733VX>D;9@O5\Z+
M"8 [C"3  -BE7<?0=S]O@1PA4)_A1^^0.\?.[^!!HG=F_ L4QCLNEB/<D2D=
M@1MO5G/)B9M'XHK895\URXAA!@OOB+IY[7E1B=7MH]]/#7*.N'-OV@/...ZO
M+=P1SBSNK5^"'D':?_-@<25*T%B9@HLOX)TPMB[MT0K22SV(<._\D1]>-A@=
M(NM<I1?EJ;0\[Y(K4Y9W%1J0 ]XL*CC_".5W_.D0@'6L?EJ>H5K35K=?Q$/@
M>>] R:15/8.>6>Y(FF!OK-@/X9ON5TJG9:X9'NN;2GS5VIIO'?JK5(%6-/:]
MIM%Y?,KYK07C%V#!.=+$SN- /5&[D%XCW(8O%_?L8YT@AH\8$1>@3TV.N+/.
M-$1#N^^MOE[+ -=M<'"@*[X$Q#E.*Q8L,O5[:+6KXHR 8T:=_1,99_^3YW6:
ML% #Y<5Z<W&4!"V&"4<Q*:G]VE(H94;*6[ Z@ +G![4YQR3H?G&CJ1RCKRQG
MHMWSE';J<1ES;Y]B]_PS[,81\TV.4I)@F[7_0!CK5%&V3"]'LL?[UPTM**][
MONRZD*G@"XOU%R_;&H&?20N+AA.9%&<GD4KGHAP]RR&'[ 6Z7EZYJJ6^30OO
ML!B"M/;!G>2FE6A6O]/.5:+4O7HSK+T-QAF8*2,[&A_0\G[>&(RF# O%8&0!
MT1UHGRF%3/L:?D'"81*OW!6//EN]GOOPB[4@2Z='#IR5DL\JT+WTI ;;K<P5
M?YP85V"R=R&B+,L:?R_H4ZI%-S*^J >6@!4(WBPAUFGAP]X5"&KW<XY.M,AX
MGNU_<&ZC64)I9YXZZCI.;:G/I]F4B*1^J%+_N@MQN1^7-ABGYNUTMTC2WUM<
MNG%%?R.@20W;>=_)R2HTR8^_/K>2;^!,4L:549(=R:ACJF+IX[=T=]),$"(@
MJ+:5O3:'[?X7!EPA'%W+10XBA3D?Y S:P%]E 0Q2:=9\(1!%B:VE\]I.A[5>
MW?'-BNM3#3][-S>K9JPDU^M=6P??G;<J'M6FRWV$3WB6&),CH$^'<?A3J=J'
M4;:]/6]92NP\D^.!XZBGW;L0P6#MVM_PHZC$_A&>N4PO0_IRZ5W"+:,!7*G7
M[*J17&I)8RXF%1E9;:N-+)LL9<*HI6+4V_/0>U,6*:4O*/? 7+##V/?P\:L/
MSC1KWBQ46!R.*3]7:)>M9?^L5.H3OUVV9?-\EHY>E5F/@Y5FN:)DQ2\]OTV]
MZDEX4;1S-]=LS4CRB-K_O7?(E?YO:@" _W*&"#__2065[=@%$1OKNY!JW'L]
MSL@DJW@1RLHZLPO!ZQ)^BQR,<L,"<!"WO)?M^,%VH2;?#OZYT?'H5'BMLN79
MV-."=O8-;\X>>!]ZM"U7_H2#.?7E3-JKV\Y-6/6]E?*]#O.\M#&N3)&XTH3B
M?((VZ3\N TL!%P=V BP *^6%$H:+HT9[VM!=RL!FO$_>E2F>S2?HBY01K_/5
MSD[./\,/+;8FRR>L*L7J)4&PM@2@  7EQ,'XL12S$NQ/7^C_^(XYCNT[309,
M"3MGU*$L$UQC^2[$1!I&E42")\EL*;%4#M2.Y+@+P0E",-1=2$_D G9'EJ7*
MC<?$TW8A'S*Q_W,D"PS?A1SMQ79SPXSO_]9@@1W,.(X%^N]"GGL3%N*P6[>=
M86 T+,".@];=QTSD@IR5Q]Q?A@+E'%%WBUV(DOW_.N1"F6:9[M4'/[\+*3Y5
MS[4IJTPK["]*,>=D+)=-QW<A8VFNNQ#*%KL4]@?XS/M#FZ5<P+L+*1SMP8'V
M 5#62XO_.0"/@],/Z[..;G*2$KA^0JB<QJ5@-#85C)7A'(K8A9B;^>Q"XHB,
MS%W(2N_?T'?_/Q__?S[^?YR/?D&[D(/<N74?QM],6!MEJ(W7T?PN*DB<(\MA
M Z06<L\QWYKIPB7G#8\R;M]Q_,+%T/^-HD>P$"S%&("QCV!$N==-O+(+^38$
M^U]&6$;_[0;]-YH@;"Z&??;K_2YDRQ#D4L2O*;\+R5#Y+V/JP/I_O4%C_U5
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MGN=XW^?[W-_?\3SO^\?S'K^C/];!L0ZN=5V?Z_R<G_-<F^O:T_.5(2(F3AL
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M)I^J:AGF:.:Y_;@7:"MV$WW$&N(KLW$E\"<W)TKBX(ZT6ZT$SR)F(E,9IME
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MB<C=:=',0DH/LRQ&&"P)\E?D&:^!G'G?'HB*F^T+4%.:R$D@XZUN8ZDE>(6
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MZ'Q3?YV+FU'4EE1$J?5*<[8G07K_N[+"1MYM7KIPQ['DOD';O8D"))6QA*P
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M=+'3%*<ZD"%WK+J\W5#(=S@O]_"FA-C.A/1F$E!23A,_$06[HDT7D S$OT,
M;RQ#I:ZBO"[#C%O*?C2ET.3>0E4=H6SZ$XHAQMIZ!^PK"&8990/*'KU'NRON
MEC5^>P/[=A@&7@:X/XDJ^UJK=E7GCML&A/AVV!29EK;#VN"XP=4%OY'?1NYJ
M777O2MW>"R?V>Q';>F!501-C]_R;18O'I>7D4/#+#M$P&E1O3N*-X<@RZ82P
M!8L9"S[SH.&/O^+N*\5Y[5UKGNF["#1NQ(&NQM 6M &\^ ^H' 209;<EEK"Z
M"%O#Z6,U]""KH#B)&Z6M/"V*54^/]=P</<DY'MW,&Y\SRL_U>^UW3M!EZF[\
MJCQA.C"T_M[(X,9'Y%T^0$Y?@#:S9@(RE!-.2_203IP\WAL/&4Z,UX,3W.L9
MDH.C!![VE@Q3JE^3WC\0P/.)AX-7/CF74_N4%'&,VJ!C]*:C*2_TQ4@9]8KW
MYU+#W:/B)K&@[OU38CBC8S(+618D&D,4HD :(E\,'MHOC4(K :$/RR^OT9(Z
M\T\7/R/;B\H;B$HC5N:BA\Q@D7I#&6,=0T1YE U)CI:][BQIJ30%IR/Q?667
MYY92LP9,".+;P?A\E!+L*<N!VH;YC0F8D40LLASVD-[">P-18JLET%L>,=X<
M2V5HP4Z='4WF1GE/# ?RW?N(4$)3FK Z*HKMF?WIB5YA:O^:J;'=\0>&5*]@
M1_#(<@'*M!:H@.>FXHL?Q#3^R<!"PX+<!D ;2N/4T)93UD*V=MW/.D*H:@--
MFVQ$/G$EK0:G8NK=#F_WSAH(LLHN\/BS1+BI_6:<-@\.(+"IR,KF=%X_I?T>
MTDQ\K<B,\"FO%%W"%TF%K%@FC^0&'3#,9I2U_U VCE5RIRFW9#^U7_U$I!R
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M*J7IN/H&@4'"<74$,9N*=W_(>:'ZB8Y8=O:XP:YID948D32[; VU8W$QU'
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M^-JJWHI9FS2&-7\[I78^RG,XV:VI?K3)7JW'<WM529!@Y!7IGQ/8&UB" 71
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M?^'.,$AZ<5NHE>5_,\G506E8=BFV"<';^'056!+1D*1!(L#)[5^D(W3W')$
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M@LEKJ _WUE _-ZXZK-_=WSP/67$PD'9TWQ"DK4H7RD-YO;X'H6R0TH61-MO
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M?F[7$JIZF7)0:2"-YQ_G@O_<9'^U;1]"<YC[#OSK?NE_YX'CZ>R1I9^_8_L
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MK5TT+VZL6,KVR&K;*OGV3M1:&+[][PI$V.H#!L<##VCM'X8[\^T%AISC@J/
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ME^PJ7@TU0NG$S&=6"6&(K!S]GR(XT&T0R*_.0@3R0;R4-F '-_RW/5>QK:!
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MKG[A*[_1W*;H[R&]K6JM%55KB(/!Q/D3O,:MMQK@)VA-^G(Z-[1KQF+K,HG
M#$CEH[&6PW"5,EN^&? 7GPJ]0AXCIP51FY I<,A^\.M(BUT5<MZ=7E]2?KJ"
MG)Y8$F-YF#R0^,:NI1/$+A'UOAP]-;W[?4535!EKP2,+2A^E7CLZ5*Y+*_*@
M7_3,N5SD_?"-MWHF2]D>G?O,J3_CI'VN/4I[=+E(Q83LCJTL_)DW^K,I_R6G
MA-G0#7T\<YC0SMC>I@3\9L^E5I(6R#'I>P1PSDP!.^V6M/9T[-<05]3&35=G
MC><&9WK_63SDOE\^PU>IKB@D7V,4%@;QIZ$C[Z-/CQBOY87:CER)\;.U'R4U
M)]_\8W@<'/O[<'U;37-LJ$_Y73%,4/+L/RJ.^% HYR9DN91CVPX>1-/CS@BK
M!"JST$=X>9Q$J#DDE1(8 X'0IX >5M@C30-;\YF:RI(4(R(Z;,)K2D$.$^ 8
MG[8<JD%K4D0D0CGN(DT0S8L0YI!7%02>@#7_KL!<^ X>QK6=[>D,8#,>^LMQ
MR(^3J[!&Z>ZCL$VQO<B^BA"E?%.N04. [2@4E)V<;1I>*]5J$G(]DX*5YSB^
M@0^[N.Y7J8_S/'ND]I@<'6TK>*GGT=4[OC%M7INE<NG-F?0:LOJ%[[OWY3;8
M5%H'>%V,*%#MKPRG_TAXNG[7VW<\['>H E&SU/<_"][K+6F #19F((((D\:\
M3""-"*A=YABO9+ 2N$BJAAG5[%YF3Y+)?4NL/FMUWUTK_81?PU+GC7P<N%J/
MKG@.W(I=/#7TXD@I^J$^/TY(I%QAR.*^4C@7&,#!G80H;A"+N/R;X\-R7EX/
M8B/3\%"<06B.>R8+F;AATR#ZO7\VJT_-0MK!;6@@2>#&#K.9^:4A<=;OK".Y
MT?'$)3-O\O/R(,4YJAF%@X8N"[?.Y-JTQRC,/"3'Q3F>04KL1(MC',DK:%8X
ML60A:WSC<\KGI[Y=MU^'-N6WLD(-SV "::3V4HP3V''?*30&]:<\X-G,G4L]
MD\B1 (/?JJ77QA GJ![EMN*I^1#)W:>JC"5C'Y^03WSC(?TP[X+E$>/UT:MZ
M>C:DV7V7'TT/2%NAI[NYW^/L/AUQ"9=]WGB-?LNN(<;0,/ .WN"R1S&@S!SH
M0B3CE4F0?W&2'*>:*FP U^RQ,JLMDZDKM^_/'>Z[4<+9QJ%PNI?+<!=IQ5Z/
M-6KTL^I@;;5#:/+/<+E]+Y<V_+-!Z?^$Z;B=P73H WS8IAAP!-'!>+ I1NI)
M6GL/4[&"HO8&*YM+/+P^9F@DDZHH[&XEHKRKRJ_4T?NBK>K>T0&GX5\[?7S0
M1\S((^%M!6;L"P6'\S6S+&1=I]@%1YX?G;A@J@--+K61UAOG[3OBMM@#D3B<
MA[(QF5H/T',XN\\E[]Q7N=K:6\\+=A7S/#(<7E9F"5<:!667D.4(C@L$.#S7
M10%T1HG_6AU>F+'@4%9T^ 8"]YH:?"*#--X!O"&T>VSTCX0OO0[M+0FY!Q+>
M3B_JJWW%A( ,WU$3I.S4X9J)$%N7AD8::QTR(0[NBN,J@[N5^?LQ%-X+ ,DM
M.,]936VQX/JC$]P1>T1+8=?<Z<;ZVN8AU\M<7#-W%R9%Q<3PD#T-YM#JS=L'
M-RS[_ 25KJI\=_!M:9>*M$'5XRC7XP7J56T'\Y7VM=E_D>V\_&[A".R-JE.]
M9L2K0-6:3M?B>9*P8?\1-_5IF,27[!./LVOKFJ))F3FAF<UKC4"8-6X*WW[^
M?\^*$Y<=^ C IQ,J@4 3)<!1).D<0CD,*\Y5^Y OD]%1C?)V3OQ)0LLR_$/K
MS:V2V1"Y15-;:DYQ>DEPT\-U\]:ORMGFI+LIW<']C1MFO"@1K\<=RF :/Z"@
MMG;;$"O13,@$GD5,7UF;1G>TR7"M\FZ*ECZ,(K.XH>[=^M \!<CVX@QR&"E%
M=F.LEA.AQ9A<M]A/,+,[]>/R+Z[\(.R[KO!KXU2FK]L]SYON!XN5)7>_WQ-Y
M[,6GD6>W'BN+<3;%_"J5E55L(M[T]FGIV>O-C^ZN<MJM]TGOE/?%B)1[.GJW
M;U5B-RS\>W[?M<:?PY-U!'M[/M#1RXQ9"GT)E%SB!V(D>/V -2?]?-.8E2'@
M_44J%)KD+T\C39\B2TWU23DJK7MD7!S1:OA2F*\R'DF1"M$O:#?\F6M4UWB(
M^ 3/? GE.&CX@+N=66AZHM^@E>$TUG)4Q/J==Z# (\,M)TH$%KD]XR+(DW9U
M^C^TO6=4DUL7+AJW6Q$!(])!B(4B7:4I1/)9  $!D28U*B*$"!$!"1+(5NE5
M04! B$H)/2($I$;Z1@2D2U!"@G20-P+AE11N../<<>\=]SMGC/OC_GCS(R&+
M5>9\YC-7UGKFV)H&_((7"R.Z$+AH(&5@>,7QL)5(997B!YKILN\5$U<7-^?G
MH[T!Y^O&W>$*!\D:QGIC[7<6&*>#E^T++7(UK \%26J]+#0<*9\U2^_R?9=9
M;8TRU+.?.81\;,&L>3>2ZN1_UB:]L&*S)8.\DM)3JK[]$!C@'$YC&8'>"KG3
MVI-HWL%"(&P:N7J<M$ -^ @:Y4]B'_&THUJ41FKHX0I9,P.B2QX:Y%K\<:T5
M#[K>*9P*NE:5-U#RO14>8LN[@V^UPD]G4&3Y83ZKY1S@GSEC<W@!(1XAP;$=
MODL!;9GY;54)VH>P_6C7<VNDC9+[(F-OM=)+J,X#?L4'QI9X0\M6]?&L_M]S
M)]/.'=+\5P=^_RQ'6?]&QUCB?)3#^U=?-#6"5,VR"P#I1&N%=.&[M^5ZFBY8
MQ+4:/I\K>MVMIG=;2M7D85F@R_6TI)74[,2<!+])AY;,QJH_+TPB:G$A?(!W
M0;0C067*)R2HZM2V TF2(DA%P'".8QM) @R!I[\X>XNP1C= G;#2VI+"8V-Z
M5^$A#*>Q"1R2Z(I]:(0-:A2J2W$>VG1^6_?4V3.!8?.-S?)EVJPFL*TY$MPL
MN%QQY[ME@C0<Y46O)EEY*1?"8G2OOB78,Q%QKE;QKB$C%+H\\".ZI#P)L>J(
MQMZ/:LJL19UT,UOXVO_PNS54+B4_/O%]5K";W]%@YTL5*E%EF8'A#R50H\2#
M5>G[I%1^A0$!N<98"\WVR)%\*3D+WT-JBS_LZTY:Z9.;ZP9_7,BB&TL#<Z09
MF#C6LW4*5L?VH,Q CRPH'/GJ9_%OVXPK4Y_D_7;Q],<HQ<S>M.N4.F=AGU]5
M&5XW3-4W>V<$.$?8%KN['S$X;?ZK=T1OBVXS<Z#+7:<M#S:T _$AQ45H?8R"
M[Z4/Q-DN!&#K&/X5A:B&2VY+C\V>ML@N&)PQ*7'^7.>2^Z4T4Y2XEJV[?9(5
MQHW#0=DR^-9/E ^8E1B!3B]P!X*>AB7P)"A,9/P<<$WAX/! W$\PD)$BW4D'
M@VP9"(G05?KRLN6!M5\%+;'<!JGD4_M;-2-L>8/(&NW./SL0/SPU;*;V"=\0
M<7 PEV&3M .1*P_6EN"<&]?#[/=]L9@&5KL >?E%U"47O=7:MYBB):IDNI]W
MV41"-:;XRKWD60498<]NWF#GO6_;EBJ=I3>='PSWG2:7V1:7.'7>&RV]_GGY
MSH/1XY:B:M(N6+@5ZGIF=6#Z8_\ ?U'?/_8GN 5(@]J?J5;NIMF)I4J*U*;7
MC$H2VNB"\_9M/IS]_8J;;'P:)'83J@=6^$BW3WTX LZC1@@/PB\6^U $..9
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M;55#E3+,U%YTRZH;-;ZWO^X<"\F&I,;_:6<]YO/M>U!J)SQ,966".4SO[BH
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MIB9A7_W549'-S\V<+O,B[PM2*WPBL)_E2ZL6Z"(=X WS4?LZDFK)P@(Q*]T
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M,N]5>\JAJ0I)X70N:G65I+E*<K(8UYSV))9-]<&1;KN'%A<GEQ54,?SELA@
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MJH[Q]YKS="=);2&+"+,//"P?A01LXV#C;YO-=V7"(H1&'4POL"$PA#4);[]
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MZ5>; 7*$/U7O:-">VE")@"(8];14,\E7[H[+!8U#OI!_$]R?HLGTBT1T0F3
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M<2FCNE@TB*T=&OM,ICHMN0!GN3K@(3:.H<*-XR *F7U/LJ0:!J]SC&/^TL3
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MIG6BPQT.OBJ=8YS/#<.R_\O)& U=0BP[# <F'%L]L+#T\-+S@+RHJ%[[!JA
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M[\YQ))"'T7D9/NKI_RBB\8J4]6WCM*3(W8[_-A:F$U#E'J"YHM".QCM!&@=
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MI^ L\U?,F[DI52K@WL0S%7%CMZJ&RB$]M<]389=FKH+((%' 6I'<9_ZY*C3
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M2+(,,\6X,F/<E^_]>_ZZG_OY_9X_+J[7BSFO<SF.]_%^7W,>Q\G?1P2=O1N
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MJ\32>[NQTU!%RT)B N_Z4:\WS8ME[LZ8HO:"^I(%1\WC^%45%H:_;P2$JT^
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MDQ_$2!P,>^Y&.W@.0V1?'"6'\QOH*?97E&<'\201G!=L7'>N1'ODZ_"#GI.
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M7%$,Q)E[_W8LTA&XI^&*1Y_\9/_8>V@ZC$!@K:Y+<_X46>^9+7=_F2&?R<^
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ML:MJ]L+Y4JEO+ZH*!$>LB:[/4N^4JA;;[7?T7+$DX)H&ZC8<H0HPVF@_YL<
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M'VY3L?G< M<N9@(##:Q5!T9+<M5EYG-%T-]@!-]M$DOE2>+:-D2Q?/E??SP
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MSH"#\,]!P%$9+"J"@0'.P'DRL>W3)]A]:0:6]"W(?AY\@-FL\09(Z(SD?RA
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MI"!2[MG.II\_WP%3@]%>P5D6V.1MWR6/FW-N;19B N&3EIS\?H-C:$F_O%V
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M]+1PJV&M:(WKDQ(3\X_J;0F:J4<VA-I!$[DD.F%)5V&^!->F'12%/*D0SC\
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M+LD6P+D9?3V;P]VQWMV303GU62:\^<#[12HC(K+$"2(IMJKO(49!Y/(OCZA
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M<5<HX_6UDO$C)IV&P5Y-(J_N$',1=#A3Z8P.5@U4C4SDY/LP>F8Q^L1@O.;
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M4R9%)3OHT;A;:WL<*;FC'L+16F_1$YU]+KU_#99OSJ<-W%!WH]M7"7!#"38
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MQ6/KBE<D.CK2$\(=\ZAZ%(_,D5,;%')-NUNI*@EL7+S G!F6E5C9C/E[/G-
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M:&BD2ES9K.J8N< E*ZM1L[+$/MB(@J?L)+5?I4"R$GT:R8UU B$2K!*&BI!
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M@9_]5MU[/]6. +VB[3."LR"\1C9%B)^1;J% _25>.]6=.##FBD&)K@-!@IL
MBFQX<Q2M#DJU$962IP5,KK%,X"&'@D"%<= /"TQG%TPH4\Z_RIGINM_]-4^W
MZF5WQ+9*T:XFV%,\%.>CY:$.U@Y,L/$XJ\W":6%FAB75S:%O(WYL-.Z8+03(
MT= A$9*?]5BT/R"\$%_9#AR>5;T?'\M7F.1 #06MJ4'7#Z1XM(?+#5\\+GB
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MG,:+G[8Q8&OQAT,R1S9DA!.]>RP^#5J7:I_0/0B> L_PADRE%^2I3FM"@&7
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M*;UT(A-^_..-M;]JOQR^4+&=@+GAQ5'P=1<3V38OSXO 8[8(U!V<]9.!C ^
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M8!O+D911K[E<YP/=G$4!19/\MW>*:"<F!@_=/GI[:T#BI^# WZQ=MUUUYMT
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MA/<36^:H("P!QZV/RRF(,[;/4DW)WA^"X^4#5^RV8B0G&WH4[I)L.LXDXU/
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MB'OKH4?%ZQ=:2_Y=@57V-!ON6^*DY_+AG*4DNL8M 45,:]I;4/0Z$'68GY&
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M +7-,[D$^UID 2#OO0""R[@8Y8Z"F:[+KRD*/^L.?68='L<Y+@AB>M$3KS!
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M>^>Y,;*R(&'&V.R)V([<;(^^ZH 3 .)XDA7I0Y,F/SD+XE07P"X.@6B,G]3
MG'DW=-U$43)0T9BY'+FOC]O-78%==2TO"M(8JTCYLL[$U\ 2_<5<X-<@7NT4
MI$&^Z#E Q. G9U=@T/IE0S%K?0CM_:?2CM'Y&[JSINS,<O&O["->=_JN^V"Y
MV]DNPO*Q3<I'XZ>]Z_CV@M7F!"W)9U=VS44T<(X,ZJ-Y^A D9W4(2H"N1RQ,
M,WD]P?Q,#OH!9N.?SJ=[TOOL=] CU4XHS/BH9[@/&YH8ZMOU\JK'#O[ @*>"
M3=G;9I4-PZ0&R( W'(1J;SL:W(=YOW ?(=,D2SP.8H$%=_ "__=QL*HL$*'
MX.BI7LM[.6UQ0?PX\W8Z4?\E+@/#HH2$;7]=>QOPM-+3,OWD^'%6&&T#(VTA
M-]]&3SPFJS(FBM&5B/>8D:F)GE9R#%M.= '(F\R(ENC-6DRU3G*;.6);.V"*
MB=$D&'&99S05>\/&;.@J=*2BA\_Q#-?TFAZ_H%!:V)8?BN2Q[(.#<Z%CJ(\G
MW5*[V_N&;,_,^=?6)NM>_;HNZ-IQMQM2ZZ^N:_.!XFLS>H(*N<#IGD?L2EN1
M(AP"T\);('LUP.1%%F+Z8EH10:H%I8A71*B"KKLF#XOLU$G['3!'^ZL/??/2
MBX&P^)495F5CKT'!H5@G?2BN5CLM]< \02.4\MB"*7$\.4"?]F5*( &="V05
M[,&R($71N )X_X6'%UM6V8;?E9,=5&0O\\4APO1Y'56 >%AF>F0C-PCA!0C*
MUIOM&5[> $TS!1//!AP6P$.S BX06P0QSR%HUF?1(XD34W-3W%>50%Q;!.5>
MD]S0=_ ^7YDC'GH6!G]H:,B+BPO]%Z\UR/I^G3ZF?9;O%L49DE=87_DAKS/<
MC[Q,$9XB?2#+H"]35WOE>%)"0Z)JG MF#5%'G"+1"E!29@U^JV5U-T)$T<<;
MUZ0S6! >X'*.KUEU9+XJ(LA7HRD;%W)'IXF*P^/4G9$\#>*8\#)1;F %AJ6,
MW)KLF1/GS=:0=@RB#A /\FV90N2V0*7*\9& -$)RBX-58+C9#:M;WAW7*JO;
M68>UL0F;6E/FQU\@VOQ%VVX)-D)F3 !=))LY0C1I& W8L5EIS509T65^>D_;
M$+LZ?$XL/.G!)M FJ$F+/;*SGLDQ'/3#ILVUE9\7U7JV@"T]9WX;A$58WRK$
MUJ4:-LYEG.L,TDB4O))\0@ GG$81DS3>,V!6((9^ID?23Y(1O[2* ([;1[H)
MR.)LE/*T"R4:2CBFSPH<3MLG7='PLNW[LZ!K.Q1T??%4J+=6AZ=#Q(7:?KHL
MKDU^].=MB_/4"BIP>N%+^/E5O65)*V83XVH9CJM(:3-TX53B>'<FCQ@?I3+-
M5!_7_:B]4_+W-LMA*+_XJ[5&\=?2M79XE1][+W9HAF!R_ZQ9/6V]H1X:Y3+Q
M$O2=+3H@SB3"@7"N%-,IKG;U]$X !B["\#<,MU+!TQO22W)_"CH5IC.1(BV6
M4>W^04\;MR3\Y9HJ0K-UF,S^,/'KWKFK?7^\M<\\ZX.0 =*I8A49W+3#_G=D
MH.9KXI=V0[;ZT;V;^N<@F&@HCD5/I&-4H,P([NL0;7<3"/@9K>A8GUT@3N@[
M\L4+5&YN4H&"01V\/+=(@\_H-+B;>DLSCYXP6S[!7Y,WP\K%OHIGW(YI<0;U
MH&KU&OP,]$AD&,+SY.8+=,I#QA93>#1:0[(&R]A,- 46'/"**["6[L_T1.06
M2<^R069R78;G*L; C8ETAOUM^T7_P1@N=A#&,.3$+44EP+B2W6#@[W:J7$/D
M! _%9?5!:3I'FN\46QI,([(K1GUP=1J2C*"0\&^[TR(S5<I3[41/QS%ZF,Z3
M1#T15/&C$%"U,R8AR<W[T;YX=5(W8@>1#+"Y\$0K9WYT!WO;]45V+!5(@^9U
M!%] J+7_7%IF4$[F[/T<ZG *TXS*MJJ547R>/KV]8K>;0ET]E<7:NPZ8DFS*
M@I9;#W9 WQ]ZT3BQ+G>I%>*3Z"S!0W$>G?IH7#&- Q6^/8;PXP.3#>?[1$>)
M3B\#*.)RVLW2SD*=[YE[]QE]WVD),9$H-KGY &D_N=FI24'2W00#C_"E.#0F
MSVEB@;>!PTZL6YQJI8&G4<SB@$S3=PG>YJ=0RI_#ZBD\MPQ<>^V;49;5Y93R
MW&MRC%JHU#/1-0MS,H";1'J=4(M $=B)7QA<JP/FW[WX^>$5F'4B;6YY(8H8
MPNET9W T^;6QP7Y.Z;_M!J[\]NR;,<858_O&IC,J_IH[NOP5@WZK]]Y W/0)
M5+-HF[#D*J<Y'N204N(,DBYQ_6>CZW_PD/-NE9@3,*WA5 44 CSX\9.-[ZN+
M?\=W#.$=8G.&2O"R#RSBDHQV)<SOX"$G*Q]X?"%[0[/DV(KD[26;9KF8+[9<
M>#M4I$8%^>+<10I4K !QH6%U%CF1JC2_JZF?:/P2FWGC81>'NHG5?;UPZ#IM
M3U5?^*QJ3?Q+&4-CZ]YJC77,.CEJ09<X7TC[7U\^K?D_OM4#EZ"59:"_K<#(
M$VRX\$@18Q%/^K@H?N!6EK0"2PEV6H'Y\!G+C_^E=+@,H9=/2^]]V9#:\E\Y
M8_Z_53ULPOVO HE_?C&XON@YCZ?D&9-_<U8I/]HD\K?-=K>G_Z4+<%>7)\&@
MY5=@WTT9@#M":.2CM0(;Z/-<"@3^-V\ R6486\Q?$^(!B<'H"LP5G!25+CNL
MP#Y\YV*$ZSD+8O]?O2\3] 63P,[_-V\@:*6,2XR_1Q@CMI+.C"CRGW+/OV9-
ME>*H%=@WP0K,;W62FU=@?>]P/\!.R:EYPQ58)>8A>='Y$2HMFORM@H,4[CL4
ML3H]X^6FU8I &F.QY\PYC#A502(P; \F2RR'%B/W1 0YM2G[J'B;AG;N-1HB
MY-,_F^:%]JLDF%S_9[W,6V.%A._HR^S1?LZ4:+L+$[T5I0E.<6QR[G./K&T9
MGVS+V3SH U<!];V \9+P(TW4,.QK#'8($_!,IV;M?+?0OB:3]?U<A/DSQ6L^
M:1+I T)ID"*8 ):805)'^8*4B5W0H_0<G"]?]-9:<!>2!4^RRUZY DQ<2."5
MD>]VVA]_(3@7K%,[/TB:,8!3CPRY&66 VD,\RF>TC<(59GT,^O^4'/'R::+7
M /[1(CU.V;9Y(U%!FO.@T8-A<^7A-/L[)1AOSZ.&G*K:J(_*=E-O5V ' 5SS
MX$3;X=^#<8]"VC[>B7COA%[^4V+PZXO[@/./#Y?M_!RZ+ )SM%G'$PN1I<+*
M%=B9 ZG\^V#G.>GM4Q.B-RFQ1WPY_XA/F^2<S-'KO_F]V__"CY*4XIQ^^(=]
M'T.6ZVY2IFKG!H5H@J\ "OJH+S,K,)D&16/$)G0+50T<9M9%:",%&Y]-:LA]
ME*#E2I-_'1GP/-_KH*[LV/RM-G6WGZQ*#\2U-HBN$WW!=>^:+H#AW.["&,3H
M<LBA'IA_VH+WU-P@_S>375TH4AIN12A8[?K>Q=E!4B$L-:-V#'#2[;2&_^ W
M!MQ6#=7<&>\7-7Y*:[ P]0?ATM6@-P^_>>0GGPB$\FS4M]ETDHKX%>1&%/E
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MN"X62RX>"48@<J:(KA7T_8LAAS()@=65(D.K]:Q<2ZYO'!$HLWA2=.4[;__
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MDD@R=EI_U\%P2ZP ;Y'\5&L;FH-:)Z,Z=#PGHEAAJ9=^=&GR];)Y.8G_!&8
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M'Q1B!BT%)Z)BE6TF(@KK)WYW'+_8"!:*%&?C_$.$W::;LAFV>T1MGMDD)T/
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M'U)UTJ475KV:GD57D]3:36H_5[\V-LYI1:?J9@Q5C1L-5$56&O?#]=!$.O(
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M0G9-3D;ZG+;<4$<%DF\L7DY2G_@^)TOA1)Y23B<"KND/X,(826R7,I:2OR@
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MZ(*L%U '!\D4C_WY'7I\?R>&IB%T^12PL1& (O:":QI/@):[0Z> :'Z\^RE
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MQ8Y6<M9:.V <Y!]UJ5POLN4B05<^OM2-ME3LK*:,>KS0_30BPLAF\*&<6P0
M/&H!420QW= XY 4LQ9V*0@Z$HGKSS PFL#D/::;OY^=A2+$II3]SVPVSF4!D
M2V#1=KY@=IA(X7*AQXJXH8]/?MB\8VWT\U<XJ<*7A*H;1&IG;I^5%C4!'HJY
M.MK(XT\WZYE6\*8J]SK[4WA=W[62S.M8KG@3,FQ-G5W- (<L2L4.]<"Z7,)2
M*;+,%M35>J>??GOC6]]3.\$>9;5H)37#6$4'8'3@FPVXM[8(O];0K6CNI/."
MAA)E69-_L;#UPDR""Y!3ZO'K&]I6,T3PPJ]3 /D<98"J35%=M]S=*8&'K<GU
MQ\L8/\?Q(<<:5!EA0N5% R$*GMG=UCKGYPQ1[A*9X86>P.<-!]LS'#E>38&7
M\'\LH6<5]WC7A2I,,SAYBS"F>B-[FNDU^-4K<.[G\7VK5UO_S21TRF#_[!XE
M/EXTP4Z9U_OP]W#/!F<<;[LWM4\J-[F'[/WR>6]EA(DUI[*^_I-DEH@?]@7=
MZ@^P$.:S"'OG>#O$#QAF'<!ZU7E?CT,;U#M3/09ETSO/HJ/N)&71Z_*IF:N0
MT?G'U[()6E@OHD6E,^ J,UN.(]R656M29*AFSF@H4E"LFZ;WNMY.22V2V2!&
MC(FKYK![Q/GG>+<C3'*J6,UQZ[ Y'>4#7HN$;2)G4)PNH\NG@+J5IIR:7%_2
M\2M+M?V$'X([123W/1XJ [U[16R&?I["2K:?!'M4 ^&*%CD&E&)2Y!F%F[\]
M1 !QVT+MQ@B"FB;&_ZYL$]2PE;I>.5Z7*V=DA*?UY@L.7>)'D5[TRVI\9U@"
M+5G"LEHWT\29\/WVF:&[6H&=_2;A4B0J026^DN)'D$ANO4.PC?M%N_\!/M;3
M[-L8]/PXU6YIVV*A;<)N3"O[)<^$OA1MT[#F1WNPNNAF.Q-"+),4G"@D['B(
MZ%:*MH["5YWO,1]XMCLI^+9;L4?#NE=+18X_=L@+'Q!4NE$3A(<P[ZW'Y'EW
M<7WJ"BPPS-R_17)SZG(X*Q\)@_)\3^ND(>P!*T(9@5FN60(S(6Z"Y@/;SO)9
M&GSI+";LB=Z#I@4:61@G26+ARSR@V6NIF<T3KY.Z4X#;V/PD86QWK("^"JH9
MC5VY3/S@J=(N2&DD1L]\*RZ)J5>7G>BC6F"Q<=DR0L</ICZ:5H>(PD+K7Y.V
M,VKTY+OA);L2'Y =?QE>(X413B>?$9 22G4/G=,KMO4B\9\'4QDHSKL9$,[,
M3.Y8[NZ>M.W@3/F/Z3!RN0?6%!90"HV[&^\^!:JAOR,(RM$9+U)#=QS$$\TZ
M5T1RK"/QATN0I^P$>O_#">RRW4+OVR_6SB2^?^/5W9O@\Q7=NO)POWD)LN[)
M.P0?56S[%-#HOO?.A>#'35$/RJE4[0"Q:-UY@7M*DA9W^W8T,_6AMJFAJ1DW
MJSP@BNY;H3X>E\%"=M=1I79WBKX(V8S=R/ O 1*1 3U+3NCNI_DB3A2I:%*N
M*KH$O6ZT&:W)F+'9I,U9^,[2H-C(1R*N=P,^_'P'3WKN/Q?ZMB2^9'=*;+LU
M*03#1;3DV1!0[E*S,PG&+R.5"$8@-KRG$UQ5HOI5KQN?A1RZW'6*OP3"8.U$
M?)?/>A["&MLUW>-\:SJ:O03[([D&(7)2=0IPQ"U$$B!G9,6MF@O9Y<!'E#AS
M[NH]O!P#)?Y!SGTH&QQJFF;<6C_A)Y:CCQZEK[AF];O#4(5+^K(8L:[E)=$W
MG3+(0$3@26)]]07D,C!Y-WR-'],(J:;L_SO>#K+WXBF5@%R!5RT'V8O[./]U
M9/<ZT7Q@6Q[_A>EF<\;<37-8'*@84WN\5T"];DR]1[M!@5*5D9WM0.+S=@W2
M2&+>;#S-LEROE%+8?7S/NG#FN510<D^M88!/R>*8UL_LOG<"5Q/5%"5;0/HD
MF?T8:=Q:NPV,)* 2*/,C2DO9Z7UXW==_0)QV"#6+B9+ZPWG49"%::J/Q(-CN
MVD'L5"*%I+!TK+J&O$E JUM>)>E=V7A.$R5HRW81CSD#1.&I#7)J [?G/-7L
M\$XS ;FM#>;F!DT(>]9JB?AB ^5<QX64/3=K(=,^FES7[SJ'&_@DD>%M>%UW
MJP2:<)47/^"_(2UDFN?H9=[K>K5EX"#HG6Y.B4$[.V[*)[+,?'SSK1GZL!J]
M>@WL*$<1'_W"V@%B18YRH["9O<M2.HTME#02:^_$%@_(>;I>M+$YYG[&H1EZ
M*\6:H+I5 )/O]\'O!">MP$2;6JHE**O$,;+R2?4IP!7"A9S$U$%BM-2IF@@7
MBGM(V0KE%+"V65#Q<T%)^V9#'+YY:M&D$4:HGZJR-53PRE8I_+ HN;(L1HY2
M OO<_KK*> ;8'V KO1Z>-(%A'D%4S7C-G=788R 6['$W^M!XZGF>K+WJHU=O
M)8V] KT+G//E3?/Y7*2?HN]J6XXC092AWE"+-@+X*D6N1UOX&^T&BZ6V^.SS
M2O9]TTDM93^%(5%%S[^OK^E?RA.(NS A92R,J-',O3EPPA!%NU,HG1Q)F4CF
M#^#F00>\56"AJA%8?(,3AVMI5*I)-(@M<8#T15M*OC!-NI&7!'W<T<VHQVIY
M808(AQE@;<K_G (XX*\<U%=Y_%U]F?&[4.:U'?=Y;L@;QUH[;ONLI]#Y^ATG
MHG4[JUK7FN3F_NW."N$^EQ)T96QA0KLX;ZFD@DGFKOMNZ1FWONIU!D!>JVM:
MTCD>/+/=8,+-K3+-98RJO%1W#D@0.*KB)ZN<I""!" V*5QC5E[[,S9WMWA&N
M:?(E'I_9E7S-*N3O?I]]H.FKPHEJCG_??6C.@62?$5W.E9R:I]/%,I]6_P#O
MM&\AB\^,/*64XU%G/#0'W""1@%2@/(+OX*NCD6=$W1>>UG5))1O,)IN'1T4?
MV^CF*'F).NW]4IX[PF$9^=[+,VJ/<WX+>3/@0OY)_.\QV33D,/@JV&M_OK)^
M<8:B6.*EP=H#>3EK><^O5<SE@K./\\Z_WZ1?3>XK+W/>YQ>;CG6II!C7%"EF
M"0TC@^(( F.L?0)!7<_*DO!)W 04EW9!CT#XO2ZVH16IUVKA3FK!Y^+(:&L'
MU[PG7>&/0U:$F:*M#;ETGZB3@O#2X)]-OD)#MP5N=+1: N%"XH1\/N*7]8.K
MYZH^F5C]CB(L_2%08D#19!^W$%]C%IO>^V(%9HMN0?+UZ['?NQZ5">BM3T^C
MZ7-@['X,0H(8@_>+T&::HQF1W)+73@$,<)'.4-/&;ZUB'\9>R$S:D,XUOFFO
M+%NP'I M)_C8W&!_Z.+A<R-I=&;)<@?7!XH[!7P.IG%$6D^ W:&,R%$@ZQX_
M2;'[+S)-HO<4 *)\46J8XG_TY570Q?IL,IFY:;18--@GR*<(MB64\WYQ["I&
M1%_:KW$-2A&-VDO'T#B9U^QF5R IRK@>J8>(0Z:2Q>K6\]4+6U2M YXQGF<]
MCLS44X"2W!N61:^OX+7W0'#\<]"B)3FMEH1]W%V^3'M"4JDK82R*N*\:I9RS
MI0RZO/2 O%VCI0 /78=(7G)[O<E?2"[=.'^4>WBSFR07^\<OQFKWA7LT7E9H
MC4E+AP5S,7=335HW*,MRU.OIE'O6^D]GI^SUS_.Z_(S *L6^1BU?E0P1#LDT
MY"E@<U[<#QI-4Q]NO=^Q]FP8PNU."[.-*<E9?^;=PA\S\.POGP[+)E9A]PI"
MZ:"56T2YAY GBH\TX)46].2U>AQQ#/[O%G[<*S 1DKR ZX *@F%^T:L7L#Z,
MNTB![78!DD0GB'/KQ=^,%.(D03R^>$?C!!/?*B?].,=0O_7^1XC'87L6^P)^
M=SU7ST_#(/'/V!GI]J;P$W/(D91Z4GPWE$^+ U\M" .Z=\0JM]W0,G=L3FR/
MJER"YQA.?I^M&'^G%?_31]95*%3>_]VY3-'9<2A1)YD)CJ%SG0+VOJR/:02L
MO6OG:8PDO!Q[+O.49)\12;CC>4"0<HGG$T]^B*N)\"H:F6"57?E7Y(G-X1CE
M^C$M0VZ!F3Z2=@IXD2>.4QHMR?;?U#E*'/PL8):_7N:_)PLH3B'46#<H<B4/
MP)R)1SN&Y_7X']=5[\F/?_H\+37HQQ%7;)#:9UYMH5 F-W'@X9JKDW\B<&@4
MS/P=#LS5L4R6=,^RDS6/['8,_-1D<% HX.,M</.3T!B')(2#B2UF^O-OSR=P
M@R>WU,R2>/H@"V-D+@KJS'4QNSBB'OE1 ^D*-E2V<"T>DH04#K_L%7H<5RG$
M^Y&T6-<O6W\CWOQS]$&?ZY?(,>XW6M?$XO68;4Y2S\*#F6]9J]ZM#J<&TA<<
M^)HHD1^\FM^V"U' 1*3CQ[&>7R/!)?=*H5NCI(_%(54KB_9C']NH#>G%6]P9
M"^5]A_9[H(3KSBK,KQ+7SG7PNO4+1>!>G +\C%6A4V?](1-$--E#=:=(P7GN
MC2L9@_LF;,?<QN]5>PJQUM1^HU%>A65F^[CUV\DZNG(?9-ANZ#XU/V% PU]D
M,D^N_6(9.!P^!9R_WZ.M5!Q%R+_>X_XGT6Z''\*0ZG*;\DG-J)LMMERKF@\S
MW>%$A!*S/X\[C'\K,&$J>DRC1E'0U1QC\90AU0$%@2 _UB:%CU)1M2S:]S--
M!SZ;WWXWPW NNCK^3.ZHX!U> 6CUE])[4D120 Y8]CS)>9V+;0<AIU:))KB%
MR?Y\?@H/294L-8Z\=F]]JXBH&MDN0?$]_+=N2HL_L/2/5X&>=O''^^[!14.!
M@9PO)KQN8V<LGNWR7"8?W@8QT"Q.4G^AW)(7ZSJA9S@U<=:0Y!ZE#(E#7FP?
M!SZ>7(1C\!ATJRG91T'0=QH]P+5C<R^X<,=B@SP2[!X8X$M8(5S'<<'E(%/*
M*"!%RF#"^\>4LO']/@>N^LD*GX*PG/CR_MD*%C8=/UX%H\7,D(>=/K'#VELB
MQZMTIL2RK;K_M?',)9%WR$L.K>0%C?(A6#0VSIGMK5YS];J8NENU]::MH4!)
M7JN*/&X@*AGQ4^D=X=D?>%C?.Q2K_Z93KN%U0A73NI&#XLUA1<28:I+9._]?
M($8H8YXK)7>(*[YW#=E0<]#I?&NRDD79X%NAN0Z!/6"2.4ON&EQ1GB D/'0
M_[$DT]?*][IS\P_2-&.#?>39K^L]SA[.!]Y(D$P77CYK]9,69T!3:/JM)SUF
MQ8_KQ:>O@/HP1,O52!RS]F7DE U/9/LU"G,WZBKM-KCKA-6R:5Q+IJ0JIV3L
MD]UV=I'9ZI!OPE??I^B;'V"<LM_CSEU\Y;(#)AJA7JY>;)=!CH(;H&AM"80\
M$974JK=V1\@V^=*.@\BD]G(IW-=T+=R HIT&SN%KD$*F.$0_LMUC$^&^U:QR
M5F,B?@H@YX4$&2*05RD!+[78<8O KE_GFW]=?*:V='GT'M<O%/&AK50!59B^
MTIP2U9N0[3J=$'R!32#S$4)]2CS[Y@#@H7.21T(Q\^7Y:7Z6 .CM=^[JE>!"
M5:;-<I5AIVQG>1K7GJ)8<J^>?*66'L<&MOQPW=P\KG3'--W _,DG'$Q_,'?_
MTOC1'R0D?6Q+JC<$2K:PUZICM4QHR[ AJL%<CUQB\!5!-EI9JOKXLKY$JZYB
M61N866FAF@U,L0^W]@93E]D)60!U0NM9P+RM''@H^])/;7[B,4UDY2:)._.D
M.&RM8>JYCVOU[\0;KVMRPK)8 E89[N'&ZE]'/%'03H[$^:Y2Q']T+\,0S._I
MG1D+,5V-Z0B92MI=$J?-U?KU,38/[MH\#3ENSX6@ \.PL* [1;/->>0\L:70
MH@_F]:^+.]A*PL\J]?U30*HM]0SUS(/'3P&_N4B"R']P2VDG6^ C%\MQ)SB4
MN5];@H++</]3P@Z1&B!I";)4RPQ1DM4&_:TTOF1>Z:J2X#*)AL9W=P5-VW!N
M?TLT-V/5K2NWG3,HAGW]LP3A<(:#NN4N!TI'2N&_NH7T@>(WWFU:QUS=X*M2
MY#.4)8#<H[M-&IRBJM5,GY.X8);I$DR_/:B2LEB8Z6O+;2B-"T(VH(10%1&&
M1$@2_8KMP%D968=&NY,LHHKY$AJT@3,RZ;)^V$0V-[=68^YUP_Q9B]J(C88M
MPHM)O+C:O>HRVBUB&OGQ6;Z\0(Y F=L5SB RT]%^\BI6KZ_T:)6=HHG__3T[
M_!<&?T7!UBJ(MP2;\?-.5'%^7HG=HIVG3=L(MLX3F-X3:IPM4A"ZC5K[;+8U
MLP(X4Q>ZM'.+I5FY/C&JKX:K;ZQNJ*BS"&Y@;Z*9K!3;/B:&-DG[\UIO0W'_
MAH+7Z%F1_6*AR@%?)UN3Q/,<QRGB9U=ZSVR6+SZ/PWX=6U0*O_=\,02_#,21
MGV<T7NL2S##TR+92%/#6^TJ<"<X+*&&ER'6IKP3F]%_L"6KZ<>(X3)S[2Y&>
MU.KRU[$S9ZF6K,YVVI[HN^5R V@>:/!6TJQG_993;I[58)"K7"7!+E-L;9C:
MYRL[\,SN(WQ%L*!C+.9@R>2?:%6IKR2$CQX#5''DIBL<'>2?I*9N4J]5E1<:
M)#^GD17%96 :=;-["S*7M@[>]:,ZTK^UGYMJU20*=9/]3@J17$OZ!!R3'=Q_
MKC%:6P3N.3/["$OBB=FDC]EZKVR%^K[_FU??MES:[(;V:I((,[2-C=E@H'&9
MT2&KZS].7K>JGP)*9W+,SCC'+:5$6XN3-OH%E32_8%6R\7[<[_#'85:;0343
M/C2I\OZ@.XL=C!$3@9)62JGI$?JRA8TIL9E>]TX!%Y^< M*.*6?XWTGN*FI;
M^>/L%+'_RAK%LG_)PC)CO4Y %RK'Y"#'&#%<QV(!,[N5Z"O9W?61]4I\OT6/
MBW;QXTJ^]5N/>BS+=B4)7GWQB0PFN=K0.$H:?Z_V/TZ!1D/G,_&'ERF?/F=5
M^-IGXI\-AF!+B96PR3YG_R:@&@(T>VNBDD70YNCFI'F94ZG&)_-IFS0:Y2JI
MUO!:5''<A-7,YHT[=?H<<6RRCJ*,>WEO97HNO%(2(XA>$L<YXKQ7(\X@+LV+
M>@TYM-J@VI$<9</:#=GCR>S$\&%!%[="[3]F^E6MZ'JGV9,XK$P(HP$$F2M[
MV!PC/_1L;\,;^TMO_AVB_(&VH(@&(WK=IP LZRZ>:DGO<I!I^8Q>[]40*B2Q
MXHL@A2=5FV-6K37<S55-:8:2-LO;&GJQ%329TJV&L+TJ=BFOLO/ZUU+6J2@N
M4M:H4*?_#P&\E//Z_4A*/$/LV.>FT*P80[ZN/_TT$7=#MJAB"<-K1+9>_*&!
M8J5NT>?:SB?E!D_VM5&QQ!+&2 *+'YN_BFP2NWE3=TQ-%B*>([8DAMRD+3$H
MD_NTFA5=#O**MMIRNJWN"C<M-W;.4,B3K"D;@J1MKE)$<;LC:V,+$N2XF7I6
M=#YP F%&+,1;1BA#."C5!K-3D ('S^P/[>EXZAV'J=HB\@"_Y]\EI-?EPJ9O
MA)1I\DNM,?S'%*HP[>E) \)5M3>9[2>J[GAW!(1N-2[["91-^SA6\/,X6R4F
MM"%;(G+DI#0/H:UL'O=+3ED\8>3%^5Z_[]C$Y&9M@44O3(T$C=V/T)CXFU>.
M)D+*)+\G_3ZKL>*"__89:_;8:">Z!)3"W<(T6QZSDR_&&(W3W#4@4O?)^EHZ
MKDJN?'BO9/09H3L%U#)$G@*\P&BD4C(!V1960!.CW%\K6$\&&1:OY@B^H//]
MDK4TKL>VAGG51P^YI9?;>5G*\)LTD!Z\N93Z;." ?:P@H7J=1\A-2R]W0TOJ
M[;>2CG?<4F*?=@CRDX-3(GEN\[KL%;=YF>;S56,5@2%N]O%/Q!Y3S(W-2X1L
MRG?64PP9[G?^NC!$"988@9>H5IHEU0W+!ND_*HB+]MR0SI0<J7E2$M,_,20?
M<LG>4F%8OK8:Z*E6[;%E?#B!<H3GT)D8SOK"#B6L<AMSA7:>RD#1.^-/%[&+
M(WH/VTC&- VNCY6$'9^MBZNQ2D,^%OSQ8S6KTA MU$*C?E@8"RR _6XF6U_^
MC3,1S9/,=A:$: .%C71(?CZNG,R*$#_YH"4!CG4A+G]#[>*N;(.=)Y0KE94H
M56(9^X;V+@]G)NFB>Z(S,W4PR\>V7[7F.4-UZZENJ,[;2#:HE\N:Y:Z$USJU
M35(S1U"N3^C.]&L-2S1[G[X8=HH^%AY.L,9_;LN^Z9KD/OZ^.74Z7CF+11CU
MW]#S+DH2F _Y]110 XIW(B['1.ZUFCKY$?@A3#"O1F/B<D;]6AZ':=VW77"
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MYI][T,KPMSZ;R,-FWK4.EYAS=*X+G59[$>V>.=U#*'?^>,B5%:;5I]!M5F(
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MZUB\DK[O<T;8RB^]CZS6KV;.\95NLO.RA;23C'H#7]C41*A]&1NM^"(4*LU
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M-=OC]CSN]7E['P09 /,.Z GV'8&N_N7N1LOS:\STL%V7L4@X")ACD'EJ)B4
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M5T(C57(MMI_S0UBVZU-S-FP2F?7#!ECDJD[SS-CK*42U\'Q_H1RB.[>D8(/
MTN@KG_4/!1QI^X+D.=-6P1ZLFBA"'.6U2U>=1T<:ZR-]8=?F#Q96"-[[T9>
M@BV0F$_G' &_PF;,I?3;DX:/L402!=J YDWVE4^UY>_GX8$Y49[E]5I_J/'$
M@B<K*SU_]F1=?-*2?6(6SVQ9C>>>PGR4=SN4N"K#O<)3 -1? _FST61P(/:
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M0\HD;(._L?%4(PZ'C].'35$\^4^PWID)9AI )(O92_W8@C%CMZ3HJC>Q]W:
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M3:%X)]KWJ@0_ _F^"S$_M36"77Q.**<=\])P4:T8(BM1WB?PDXZ5E(>NW2+
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MMT*4U_VHZ[Q+.@WP#/7?XA<3?N=I-[^?#'@4_T%=6_8*.G,E>4="6!\;RM3
MM5Z(V,_YTG*17=%RF@6E!W6JV(AS)B*T1^$G6;9#VR1Q?[UG(+)#>G;$8@:K
MY8X\BIH!DO8@?C9EDQXH="E>N+F)P?"\G7;\\\V[@C\U.W"5@3NL$S#NG!]C
M5]6$@>MTZ.S"9YLQ[[9=1%O?/I8)Z%!UF6A&"^1SR#26#HM>_UT^&V<T!&LR
M#::QD8ZDVO-3GJ[^M3_>*W^K--W5Y[)M:\'T ;KXZP^+GB>Y(<OF3+O]CBD9
MGT3M%B:5@JVA5HIVE9\2WN?TV0X20XO*8*4+)DJ&9>TV_/VIIG;YH[]Q+)'7
M')Z'S$NX5HTF6;I[&[**4T6W[[!GH<&G,R)P>9 \)Q%;'20!=K?+G=.II)0.
M+F<H1C8IH!BWF,;S7V*J%]*),**Z0OVKA0#VB7>"/XTX N%@PAQBG.#$KD/,
M)N!/K+_B*',Z$#(&KC38?@]CU%E\/IA')<36?%*K"70G5\Q(;JM,Z3 [SB/B
MMYCI93_,WH$S%J\3" B)15R5WV<D!<\YUL,NB9".Z$?R&LC2XSZ; ?JVHWD
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M)%@BZQP^4\"=067G(E"D<:/V' @=NCK,-.;TP,\/L?2+L>I@0;E_0BFFRV1
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MOW5S!>%1W)/DD;DNZ5CWXM</M(+X;P1(M_]0$F:G=E)G715=:+A%&PZ/%3,
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MFZZ^L3E& OBUC.4X:!#.%,1>"8K!'2DS.$1+$+P"3!?0#M/]R'L0J;?84$)
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M,@Y!_K+A\&4R,:S3[%+$; WW\#//< =J&A$OX(+LMP@T/E+/)B[B'.;>Z^N
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M\,=9QK.P(P'.NH)\70;_!WOO&=74]ZV-QHJ &)$F(,0"HE25HE(2%0$1,39
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M8]CQA5 O:'''A4\<YQJ7M;'DO=*;F=\EBKSVA"]&,>'$HMA=1AOS,L]=O%2
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M&>))I@S19"U#_%CWUUW^NLM?=_GK+G_=Y:^[_'67O^[R_Z^[H!;:A&ZB#LU
M2C.W\U8,B;YDJ[W+3AX71HA.^._YS#[E]NGES?NK\J^O]1<OIW_SXC$E6K>>
M$&U&6 VHU)R% ROODV&GT0Q'#L[Q9ZZ334"_9LZ:.ILB,+4M<F8)R-HC#!L#
M?/ ^EGVCGP1U>\WB2Z<L;5Y;*>^^[K0AU;_JAL?\>$E[7[.+TO5FWB3L@^YQ
M&T[07F;K??4<[K9*GOZ:5A'5T[4Y?IG1V\J.*XR:2+V:9:I'?4[Y_G]PH5?N
M#^E?-PF=]1!5P=72.=@FCVD:E! ,>TA4#BX3XR6K0$PNN9NB3G(=J;[L4F;
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MD\ ^&_;*B=6+7@4VG/*\GLIWN7E.2?!IWPE'VZQ369&%)S:/XKX504CS(QS
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MJRT)2\?JMPD1 "$5A@>#F.]"DRD1M.X3W>1WL*+[W;DC?:6/O0]:19^\N\6
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MJ;;G>(IVQ[SW?9QI$EW4"6MB7RFB/)FH(<17NF25';;YLSS;;E;KD,>4":5
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M]$U_4KYGX#9L5,2EZ=S^+08:BNMNOTE<-'["XV=' :7Q#64-&4/,:V/3IY;
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M5(&9=DK+/80I)4%2_:>"F8G(@Z?M..D9Q ).PRR.[2W9R&\_1KDATGB^W="
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M!M _;^'GYXSFF>K*A7;=T;PA[:IO:3)O;$2;I .>XRH@3C+[#:B,*\!XDU"
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M^]KWAOII(\/U2UL=6@BZ*!W?:?T->L_&D'A""RPX.PRT8_%9<V--$;P)4P6
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MI5%>#KR/_N B9+6S_QFZ_( "W(M]"O]*(T]YU@6^V<*&T>T?--E7,"/??U"
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M,__MC9-XAR'C0;  :_5]X[PX<YQ;@?=.D?5[Y-)L]""7@7Q"E PNFY()DXH
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M4JCOT]Y__/GXP&Z:(C?RWV+$'PC04)<GZ!)0:<,(Q4]YT^I4#[ZK#3/"2Y*
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MP7EV*""P/,\8,'!@;72*P9W&ZK8D8MF*3G'+'/,'%)7H[!*7!=?*6L;4D8.
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M_U<OJPEO 9TXU)>_4"#VER@7)0?,OX:BSL# 7XWZS 98"2@^?@)8*Q2_ORA
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M.(H8YB$((>$X,'<40FN2YG5.W:K[;KU7K][_>\MJJ;+*3??>W_[66MW?7I^
MGB@-+(/F)YQF%85^1B<1<-T0G)F94C+E::TIOE7HUU'RZ=#YHM;\3^:LR(*F
M0M]AKLFGJY9&4IW%\N \.=BX2/$BT]KGO&!X,T)>9HU%T>?Z%TD_/<?:CW>;
M5ZRCF,++*+>&W(]#)GLOFWQ^_>KQQR%!TN@]C<%R" VK@- /T7;"RRHY49,?
M860'XT=LQNEQ%2I+"?8KIC>Z/H446C+%$;WT#02J<X+D@I=(A9[ 3+P><]7V
M0#?^_(O1R0[-SY_^_/I!)J]_/@4TF5 1>;VZ0I99[RHQA:*%\;4B+L=_-Y0B
MK,!,Z7)3;7<\A6*R;+T+@NOLEE$)@=WF'0UX_)M>V]3--?%?G+2WB2D&:VK/
MW+N)VU<?B8QT3G[,#&@*,*UWD83 '8U6_?58(: )T5M^.3:(WHC=1(RO<>:C
M^'9>8.>'&P.O8P3&(]N?M0IC7XRJ>,Y[^VDU VH*M7VFA7TS<Z'E]/&T6_!.
M6;V\0Q0&/+N,&M:#%4>$F!%,"X:5-E,HN>@2P?-*:-SEO[-$I"WH+,J/B7XZ
M,GTC,3K5Y0PHSB_\-!FA#?KY^!T2\-6'RAE7,DY9W.5B1FDVR")?D3J#^4)N
M"T;>#/L$PCR\VNE#Z-^A$J&#")T"*U..KQ6A.=$V(Y*4)&8'?WW\@(G12]>'
MAT*?$;5OQ'RZ$?BWZEFG4I-'OQW"]"$CX,G0EHIFW-"T.+4?%PK<(V!HIO (
MCA4HM>[/>RPJGC!I'AFAX/"#-=#"R#>IA2"Q8C&X]XSO;@L7/;\+\Z<?7S:7
M!;G5]"R,'CANB,)\),RV2M#4E=!K!*6.48] KA(B)5]8W+R,B@=8:4U8!0I]
MG)PJU9DH@*(-2D6K'$!L;+U>87!L2[*:<:[1Z7K(:T)EC:U]K_)TVB9"L,GG
M*K\AIS").@-H>D$ 3^+0WWZQ&BJH5V7EUW.5C_:2%V-('GV-N*F!NHBL@DE6
MU=B4=9SL0U>9Y8"GYY^=8>&V'RJ/K+[FO'WU::=I!:D&0@$=)/N1('2GZ5!(
M36R])X/4'1/<!&L.)59@U,9'X3=DB3""-H;Q2(-P\D;L4Y=9S*EHEX/SYM%M
M&V5U;1RWFNP><?=.W#TK.AC*GK68D*W%Q+(W ^,U?!:N!3]<>O+U[3%,_%4?
MT]P74 K'(73M4_G;.5(OQ!+5YSINC0J\:E@Y?<HYI+MZN-IE;_ *\:!4C2,.
MD'>QA3]B7F;*\QSHFG:WEJUOOY%Z)%WH62%D;_:C-']MVU>;NH!910BNS;ZH
M':FE2Q[V^=A_GOC,%UB@V]OT&I;87F.W$,!+F=)GOFUT<12P"5@\)U6K^&8E
MOB9+I*V$WV&J"A-F;DGL*%?K%<#:XR"-+2!Y=QPI@9)__6C)CNG/*!7RU4+2
M5$HI*:W:/:-Z';..HHVCSIM/Q<7S=CU+^TJ&#,E2=?5F.NB<-ASI(_N+JB<B
MM2#Y-#5(N)1B;U*;+'43,(R;Z^(87Y/K;<;9:->GK463VK\>OQGF&<6>K[\W
MYUOT*B/446AY-'F3 TK>BK>:_IW*!_W2)+;&?-E9G/;T$5@%P;_T:61&QI"M
MTX>#"VC[*H;ID)&55"VA&0>>7$:EXECL-K**-$A$:%6>'W$2(GM-,WQ4N<5>
MJ]L6%S3N\J[^"$+3-@(7@Y>R/6;[?K566:5<K/0M_39[\3?BP/<:QZAR_6+Y
M6T,D%/;8[D!2P$]H4!)(#0;GVPB:5-=&6:7]CMJ67/(AD4+<@NM*;I-VZ N2
M3Z;X4GI4X=@HOO0MCJ7R\E5]<K^T]-BYEDL/@_Y$?R!#-H.PFQNRED';080Q
MGO3J_XP!K\TWS6M)W>7%[+0-%$2"7RI\<0AT\9%ET$PH#/.NJIB4Y@?2@_V-
M^OP0+W"66-A[F0QO)::?TPLW"6DVGKZ=X5E[VF@.+=4DPXH5@C1H3\),.WJ&
M*^0GCVV'; J/B!2:&W$&>T%V@CE=?<HU3.!])3#VI/65ZJB X*VOHU.Y.'JC
M91(N<H]V:N-0)60Q_@Y6F.2CJ*2BL]1#H!)U?V^C)B7]N,@T-]2>CLR:B@\4
M@E:>VDBR#N)>OC"P=]O]4=^MNW5R[Y@J;;^)_G=);(L\RW4DN65B6$8S[T O
M\4,H0#0HKNVK-Q81D&B/E^(W1^!J=L@F@GG,+YF7>?,)X:H7'[8&E7ZSKN4M
M=+K@ 5.234YD_+$+6[:(V0B'@]?)JW-#9?> \7Q^-9Q>2.L%U!<K1H"W5S$I
M&$5XO?0PQ 6$^(T$(HOUZW;["WR^_=^M-0(EPEA13EC,Y:4,<2_!I(8U,+^_
M&MY*%Q6_Q6M3Z*>0!4:D;A.>'4(8&A'4IEIT'O[A =D4_28*NK.@;^9IY4[@
M"+(^#YK/G$LR9+%NNXQ:S:8%J<44>V:0*"DR$7)/0\@8NM35<L]&JIL(/[M;
M"" $4A,@D7G\-I_0N:0R1!=MGK_09Y%KYM"8NR.[H]G:O%;W#101]=2]V"]$
MF3'VJ;-@MG>+1#\S9_U;3&VX- IHZK "0.XRBL66JI:*!2):RHLIS!J:*MQE
MG7#'?@?ISWK5;WD:H2[>8!NC:"PDK)/\9T:ME;4OE.;%\G*V'R4*3 [OHB8]
M4://6#:&R<IP@9A;;%;[6[(![2.F!G^[S#8,;!>NS1ZX<8]^O=3@:?[4GZ6-
M#X3T]5.'?":.BO )%3KA*MIG:[:1?!_M^Z>:AP\+/:!01XENL=9.N:ZOUVJO
M/6#.WPB16WP"[S&?3-?9_:L;_[B,J)M;$YE-*RPF^-1G+$5X950[7 V]NCI-
MH_)8^5U$.-UGWQS;UH,C+:,@&[T)=%O%;<)PXS8H0+*%]LZ,N@4JG,C=R!3'
M14T,SS K5%A_9=<[S5R;/D4R,,YT"#Y//.(+'3GC\.GRYXPWG3A8I5#V!#:@
M1/P8#WH+0'N+9V^!%>*3?8LJCF3HC.? @[$IFF[WUUL/VP^!<VRB,'>?Y]B0
MH59C:+VUH>I(0IZ=W5QD%+\6 %WGY6X,K?*6Y) +0[I?EF?.N+'D(?I801*2
MDP%U*KDD-:R=KU;O%AIJN&_*!R[:>OM &<-@^E2Z<X_),ZU??_9=^6'2_^''
MZ(D5$$*%UE0NHQY!2% I+J-F_A AR8E,&'*@N<)#?/ X>1T\A*G%S+A+KDP3
M=*CNXS'18FQ#'_8Z-N&74UR-'\%!U#NE^U=?;GA,R*]?_%/=XK#0'&/2R^Y]
M?Y;L\B(,'$<9_[R(A%HQ_!Y@<6=C)1>@6,$7>5T"&2))E&#.*8I9DV4D3E%J
M)\)Q8&VH=D)GYZ4ZT<7LMB19K<#W5>O"7&]P=EHBTPY_<CCP<DFQM6,\;NH*
M>Q,0F@9M07)W+*RT2C1X6I:/"T9XD;WE +QK"C;HJC<K"<G3@Q(8%/_F>5?P
M7S/?25?3K#]25[Q)'@M8]>E?V\IVM9<_5SQ!I^*0^X.V%TLWJHO/O:H262)4
M9/B'.!6B:X3\2FBA\XY,?+UI;S0569=]+N710"C5KA3*JM^='[)OYMC#B9/=
MPD=&?W5N=S9N (X2E*4N8%I+HZZSO3+RF&WL<9EE6/%V*;:?:O8""FG^LJF+
MF6P59T1W8>;MNGN1%[LY2>?PJ=T^,)4M5,=#V_$R-7PR'XJBNBZCVDH7WXCE
MS:@BX ]\T)4>-[85LI'L_69@"'Z]1<4+1]+T0K*!)*IKE#"G:'"N+/3ZS[FM
MC8W)-HG":%_C8&E&D,?W3"+JPDW[+_*>0] "DN%.X?Z]@(Q8AV#0_!1.4MT'
M@%=[1^$.-G@*+9\!C>(SW>$!8,XXOGU=O:(HI44<&C*@ZYE0"I7^/CA>T^"L
M6<C*EOS.$MVL;=AMJ+0U<,LYIRL5$B\D%.5%1Z<A)U@Q#9"<X2.,QRB99F(U
MZRRZ!]RUKJ?M !M3!4\%QC]'SICD$QD%!/_<DT,J)RIX<PXU<:$3VT:]_[TD
M\157RM(;5\,CA)6VX9(#<'>C8K5HD(/&3+9QW7L_ U53-SRD>W?VU#L+&-ZJ
MY==QZL%6[S;D/YL:>-O ^%?U9^4G7_.![S>CR0E27T&:)N3E*.+&+\J,?$%R
M8HT>6N,;S:BW@C%WW<Z=DUUXQZ>(7NX]=>S+0.C^'ZYYQM^P6O@=LP7>M3,'
M*R8XL&*I,%4/5I*W5MI#XP.U"<VEP_5N$AS,Q:TSGQ_^VDRS<(DRI9I54!Z8
M\]=#.G-2XY)W?^6-G )60\4M6JZ7#[WI83ZE>1X@YZM%6A=+=?M%>!<PD/]V
M7GYZZRQF9%43H=KUZV.B=K->J64?PSQ&Y8K@T3<M*T][B^[9SSWC\;QUXU4N
M=O9M1U5(=CF^MJ78!8O_^NXA$QT#?T32 ##\PU&6B[O$W3!&S-.NZ</:'A+B
M5:>7W$)H^T2#R8N6*L^A]-8;[WU'F(LC>]J#BGWW7N41=3T:BK("U Y=4;X)
MV."JTJ2,7 D"[,-51-RO$# \FBO5_[J,VG5'I"#+Y-YF_[I_SFO2">&ZT ZG
M.XT(N3G]7X<;_"QM/U3J)2*TD1-.46T:(8<P08S:",=:OTPKV^19B&?>COC%
MQ91W;[OOE)(M'CDWS@5&73PVKKI$ #W2H)T(H.+&2_A5A?,SE<+Y9/^MT*'\
M,>AKLX$5H$T)XO""DA9WT)NM'HX=0AC-I9#!NIC*VZ+/*YU;>YRU6O=4[;[X
M![H$=Y'^TX(^S(;_(33398=JK.$_<.,CZ)_V9,B$*\L]P?[U@-+(+B/'T5;'
M"B(YV 2VBDFX<>JE$;GE+Q4[_B;&?VX=XPKSF.V^9\/!W2':6EUFA\AV0F^3
MEI?-G1KX[=OV>:QE6[+'\S#@\31%H,G>WAP>QNC4'Q1EMA+4R>S+N*0TD;%O
M5_TA08SZ[]6@P\C4C;9"65;!&#$RTWT*Q(I?L[2U'_#8CTG*?]WEFM];(>]T
MLQJ1>8_:@*8(8(9!Q/QZ3/(@PQMZEE$/W&%%!-F#)@1HV:KC%</DH3!8T4V
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M4LT< 4&J>>7K1$)*#5N;:@+NJ+U5!JOX0BZ'7H'EC%"R@*T*_<D_!Q7Y_CO
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MGGLFJX--X1&@"C>3_T2*'H!-I7JR8FGX4V_J52AU/ >K0OT-4I780TYM8SO
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M]#F4V\Z&K#&P8NZX+X,\P6T";O%!-^YM'+I^9%Z=>@B*+MLF]4EHMM>/?#W
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M"&1.I\+(3:5]'Q;R4%GDJ4>!TU(2CT\QAPKEVU4]GCOSF]GKE*\\M;]7/#L
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M%DK- EJV<ZYT0SLX;>@<03URQD$]85-)&P>[.W)N#V+%)%UJ'[!>X1133-D
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MD3#S3#H2Q=&AV(W#&4BUOEXJD*#DWA0<KW@HEJ05'#Z\^2$WSSDM?IWLC'B
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M^;UT3]%).!\=[8<MR4=AHJ5:BY&B9=_[J%K4?A3,#[-F/(VH J"&GH[-8FM
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M?T*736SM#V_]&W41VYT<HW@XX_K_-P%02P,$%     @ ^85:6@X91/Z]2@$
M[:,! !(   !I;6<Q,C@W-C<V-%\Q,"YJ<&?L>F=04W_49I3>17H15)KT(ATD
MEC\@("!(;U$!:=)!@D"B](YT12!*[Y&.M$B7WEMH"0A2)0$) 9*P^>^^\^[.
MSL[LSN[7O3._Y,.]<^_O.><\YSS/W'NY<(D"7-/7T=,!7+EZY<K-*S<!@,LE
MP"/ E?_'X]^;_+_>X\KE#P K[=5<2D:**[<!5UFO4+!>N>P%" ( 5ZC^VP6
M_SBN7*6@I**FH:6C9R!?T'@-</4*!<552@HJ*DI*\MDP\GD )2O5]5OR#ZC9
M3%[0W/9E5WB?^I56Z&%M%X?I)$;X[DN_<#IZ3BYN'EX14;$[XA**2LHJJFKJ
MC_[1UM%]K*?_S,S<PM+*VL;1R?F5BZN;NW] X)L@</#;B,BHZ)C8N/BT](S,
MK.R/GW(*"HN*2TK+RBOJZAL:FYI;OK=V]_3V]0_\'!R:FIZ9G9M?6$2BUS=^
M;6[]WM[9Q1X=_SW!G>+/SO_%=05 \9_0_Y>X6,FXKE)24E#2_(OKRM6@?R]@
MI:2Z)4]]_8$)S0M?MML*[VG9'Z9^K>VB$[IKBN%XZ3=)SRFLB!;!_@OMOR+[
M/P,6_G^%[#^!_7=<2  Y>^3D4; "@  2Z4Y!/.#_K_^__N=UQH;K(S9IT4-Z
M$,Q0M&NHSXS2#8UNDL<_KZ8]J9:[LOE2LNQ5>7[GI.#N$EL@5T@K:PP;^'H,
M0V^I'6;:_EYNK7W5&V1F>]G=3]64R;NEE-2_&)D6A.D)[RX!$=FWXT$+7].L
MIK0]VJ+HMVM4%,JX&6DI<Y^?SQ_I70(H38D(K=O0KGN=FF!9?>S+M2X,<-WP
MI"0%RK[E/"4%6;N3=$@86'J=^+X+%0&J='(0G%AGINMSL1*?(RU]C:LJ?['R
M^(+1D)YUJUR?_<PLT^7&RS/DFWI=)CNSLG5'(SUU4_T_R'[#HL\AMJ"!B4O
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MS70 */[K!/X-,N]Q"0 J7P).SX$DB4X@1U3O\UHES,<*T\*X'O,\WIFBCMW
M6S+6VLC=G9U"M[_J0B+"Q5R!PCD>%6]+P)8':M@U?6(.B0$\O,'<6+RVIRS
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MF:K0QC=^FM[%+&J>9#9 'OUDWA,E]<SMJ=Z7Y3W!Z&VS7'>S>&.=[ Z<=T"
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M:W%KE*'>&-+Z84\^94A;R".O-#W?"J.JR?NINIS"KV1HEG_G,@; 6Q"H]$L
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MMFO=0M;L.H-URJ;<CF[] .X=4,4:1ANVM('+GT<XP:Z%JD>@J1OF@'2A&K[
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M-'9XJG5:128I=P?OI2_A4X?[OF&E(T^7B^[7^ 'XWUK^O4+&8HOU3M(4)P=
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M RN>963%22X7FB:]/0HHME J^,YO^N:-R:8[TG;:N;:2+(07!BM<+P&<B-=
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MYG8&WOK32F$_?</DMT];?K'1-"ZP,#S)+ &*4/6LHIF&!]F*I#@-EX]:XNS
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M&4BW74"F>?LKIC$@!G-_$9"!?*:"0'!9 J9[@&?-%8!3&,932SFV8YI?B=7
M$&-:M=*Q-\-/B/W.!R&:*/THL8.A6;FEM!B*#"SGL]9:EWFH;7BKKF4GXFS,
MTOB#G7UBZ@6/RUH2\H+R/=BO^TQ,0NB2R@01PU:W:RD/+<9O5F6.8Z\(ZPYJ
MEM.BZ--:4^D;8'#[B76M,5BP#="/;[4@T-]HVBV"P@X[B2UO![O?=D[R;B0\
M?%]/3R_4Q</,H$*W^<+FDK/^8T9[N['K07XZWBJ"7,89'2I*,H^R+[C)9QAN
M&$@4\[N?B=0?"*NF@D3;.1R!>.#J&JZO*U['3HH+S#&P##UE5,LR9&SQXD_\
M)Q[4T<^[B]M7Q-]</_>^I:KXI!U=UHM8.SMA]I+[7/J,7,9G5JQIHH;%'/8N
M1CEZQL=%/U9,I().R>O8N-\VBE/4\<5^\PL>A&\ED2[Z75>$3W9T(RR6HYZY
MINAN%]3DM\0,S#=^BKZD.CY5;\EGE^XD&Y82)-7UOO.Y/%(S*]^0]Z="JA?]
M /^:JP" P:/ZM)+_&$52I&%L/2TU3510@W>[*"$DJF:Q8W4%DN==#OTQF'<I
M="?9KV/PDF_)5)L3-H M(AZ6TYTK&#=8"IEI(-3X3(HXM']8/A2X1X1Q?%]4
MHNR<WOU]2I./;GCD1N+MM13IV&O9%_AT_@_VWCP:RO__'YZ*$+)3EJ9"*J2L
MB4PE6Y(V"3&59)F0)"-CKE#V)812&94EV;)GG>RI)#LC9A-EG1'C8F:NN2_O
MWWW_[OM\WI]S/I_?]_Y^?^?\SOG^<9WC7&=<K^WY>CP?C]?R?-XQ;Z+?O99Z
M(T#5P7)"W'(WX7_>(/RO>>R<IFH2/C-GD]SJK9TB*Z*_25JG1G\5["BK?R63
M>-5&V-Z'RUH-Y7Q:CX92_0,HSYNEYW+$&;EO^,;W@Z6!,E5%OIB]F ;4F?):
M^Y';;P-?7YDUZGE?6.?_@A*RGJ]O._>-B0C43R[-BPCP5ON(%N/L8VYJ(>%<
MA)FI"?'9ETE>&<M5+[W>PW33Z]5U*6?A+.0W3Z'X:+ZX%'17'D=.&!):OP2[
M"WS##*?Q$'.I3!U;1C]ZH_'!J@6W',?I?;IK-PF:LY?T4TR]RAN;NW7W3YAG
MR4Y->K&1D" L(OB6U_DYU$&4KB#$9<RG4I]WCZS 'PI?^@+JMN1KD30J&KP&
MC0ILK&YQ&)UW=J;"7L ^[9NY7<'*%1>+EB<<[5=G(F#*CSE1U_'Y+M-+72(^
M]8A_25JC?>>1BMN+.1YUI'/G'3\O?(UW)#M[]V7D]L9G#![JV3?W^DXCB?@!
MZJC78KA3M<)\?9>1 AQ]AFV$UK)9JI[ZF'#+_4O/ G I4]^<:N8TKR?[';!]
MJG)S+.7%1"_6E4)LMN7W(B744<4B&@49WRH+*HK>>=4B(RJ*M'F(<YZA4GH_
M!W(*+US9?MSH:W%;F?^+H=QSZ"ACLR#_/_:%W-?G7D[;_&E'B;@'!7\^*E7K
M+';J2UF?W>N>%6/B>IH>2 RT;:V-C*O7871\K!6(#8"=& FOTFM\*/LR)I#]
MASB7D5I9&!BH4!885%9UQ]\ZER,-FKX!WZ$5?Z-%ZD7SL-^\H<"86_4ZV:,S
MBZL/T__H72ZZQ%Q)MO9Y.I&QM+87&V<ZZ=-P\R?_&9N!YY.Y%6?3&PHE>\S&
MU=\[W$/[3=[&;0.M,+0(9F5U"YKO.%T@*0>0:J,6[3\:D./;H.P5ZZ4E7'U/
M.]F3R,C!2P#-%W'^/,26;A@1&<\J8G6P>9#$2S4V[G-]8:0=6VM4.+RG?I8]
ME'?.8A#VX]UK9(%R2 5VY#R$":05SB:*/7:XY\R:^;'(7@A#"RS;RJDE5B(C
M3/@;F?5..*+L&.AN26@]-+LSM\O1^E*#<_;&#T]=-TG73C79/MRARC0GT'W%
M.=H,_6JZZ+[4I6ZIZ<SMO;X!8T?[%.2[+WZH3%[\4;RY3[H@SL^%8"8L 9,.
M^\(75W^;O2NO]ZQT/Z/UW%+O35B%XR]9Y[3B!;."A>D@0K2)"$Z%F5#C3O.5
MX>@Q+*(XIGGUYR]C[@]%+!597RS'^DTT5"X/%%:+5UQ6D#>4+MXL^#&':=!$
M>-BHTW\K )!=-Z3H .=#UYV-S@UR#'*\[-/4MQJ_PO@%8C3>"S+T@V[5W3X4
MMV6I=N_E&.;$SQ*'X,,?^BJMBBT;Z,+68['3J2G3_V]U\J(;13BJS)SV]$#:
M0L2X$%-S,"JIX\T/3*9";Z5A147L#L?+5H$8==*[J[?$GPB'QDQ!&AQYT(S>
M+31>DM"X':O<?A#T;R&5L%1,=C,FT]_M25<\<O?G[K[X@8JBZUD[[?3;]4]O
MS!87#7;V;X0)59)U&Y)U8 98NU5;]/YIS(S4PY\ECB;?&O2$[3(F)O-W^%A;
MW?GC3$X;FG9SUKKF9%:T/_W/B@J0UM$ZM^E$%5C)/$_JLRRMK"B']6WTSO+*
M,'Y+S9V)%SY('-^X(8H6?^SBN>:W&VNT9D?%5I<CH54>8F;H%><"#Y'<Q/2'
M/B.C>8BEW_Y7[(#Z(%QV&6?3^=3Q37SC)?;+CHZ-LS"'T-G716>FOWA9*I.\
MDAG[\E=E3Y T4*Z!FNI%LB<39[^(K2[!7RWHMT<;\Q 9Z/65"IW83*!+BR/$
M0SRS8&NW0"&[>(A&#^@KC&H$2V AH\%,\0_D"5!L.2W__</_U1]BEF QN.N:
M.W)]]2/X1M4C![V\@*OA^X>5=RX+*-I/_<1' NM!>7_N)I8O<".0:T/MV$1#
M6!X>I1/NHQ>M_ 1(P))ZZRKA&I63#=(?7GB2@;-*SGWNK<?-B>@IF 9>#\#4
MF-H$M?Q'/*A(*CW!4.59ZO63[JDO'L3*YQ_X9KOA1)B3L:MAR:06M,6,"4MH
M--.45N")W\GL(H<"GLB(ZL<M>;B3C(C4 '?/U]/=AZQO#A[0'1[0VUFM*EPQ
M]B2M\T?'FA-3_S$)!K& +HD#*I4A3J>(?6F3NR]9RL^3+&4O7OMTX\ VI!=T
MN3Z(?7 ]QR7"V(^I_K$V<':($4[73V4:G:W9L04,+?JEGU&5C]GQ1KU]2'[@
M=\(EAR)97VW4H9;VZ0U;CDMOH! 4&Y7!CO8=VV%U\H7U_4,=$]V"%IEFF6B
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MAB/08W( WR6_TMI"'4.U'XG_BI;@F-0",>X9M-5L_R-%2_IJ7U97_,6O+<1
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M_[#MC'%%FMU9@V2</U4LJE$%Z@48)Y]5\!!"+M/X764@/VVF2^!B=9C#9!W
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M76'GM1N<<F/P5X;>)0K*^#PW=Q8?C\V_BSP\;:A?UE&[615/5PP[C.I?EM[
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MYJ%5,^=H>P'UI"N!301P?^+<(?8>K-J9O\+?H$?R.N3S$AJW>53MD.S5ZQ;
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MWSUV<BC0L?#WA,66T3.]N@_+H@:MY)@$"GGN ML0ZD*+&RNP[3@!#+&H!9S
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MJK2+&#>\\FF L\H5;# -G1! E!QIRG<JK+K?'EUX<J:^1?M)YB!MGWY966J
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M18QPSF51$BKK$KW"6$]"/#O'OLO:6NJG-CV*.+S8@4WC' 8>T'*C/048)/*
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MG./GC.WO7T>+Q#BXK_PT?=<RC\*,+R3SC*2$AU!L;@+V(-B994&B#LASL(T
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M:E][1)0<Q"C-(<4T'P9-#4T[,/JS46\OVUY;U"BUD8F9,/F4=/WV$$RC#S/
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MA!K":V REG:.1^X$V.@/;:8-L;7-9_3D%RWTF18?*CTFW08J9I:DENK=XCZ
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M84T_W79#3+ ![5."W,-J/V-4;5P21?;IM'LY.\GK1'/=N!W$=N9J.!,,4?]
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M?>%N0K[%S]R!6S[1#?V-1SN3T]^9F/<_?F@5D:3V-:%GZ>%6CZE0K/.;"X^
M+L$PUH^?GZU#/EN;N'E4]E-%/>4Z+*<4TV>7IL54I)1\RWJ+5R8]2G8@:>U(
MQKZ('4A$YO(@<OT/".=>".&IWC.P?T_\_VY9 ,_W=W4)OX3Z/V$!XZ^Q_\G8
M'V2;JW.$X'PYO:>N=OW.=W,C8T\1#14:M<N;(X?63CO+STQG7TT[,P[;;OCF
M1BZ2ULP=X(G/N_RC[QW,67F;_K:ODL5A55-N#E/!]^#MSH4?S@_^KYZ?=';;
MOIQ2Y/HL."Q_V';!YG*>LV?.@HW?V#U;U*CJEV29%-<I X-KYY>B<S[%J?XA
M[!XWWCO*D :"J'HM."5*S+(>M9($;RB2Q63W->O/UL5PC2G*L2621Z;5'<O$
M\W+KTIRK[JL>II_\[O3GLB>R-TJ4;5V\G'X<XPASDK6E.0*/"]W2>'4BNO;8
M BH65'3@@'LY4ZA@V5TM^)M3FZ(QW>HL:L8@U6UZ&I]<R.H@E(YBN0"I#(8H
M%1K#L*#&J6E?JNKUAHEAEH,Z2\F\%M]_!\\8PK4O*UIG))"]UP6NAG;X'3*!
MX/5@("@CCD$#D&)&1X#U%CDNY@>6[FZ77JJ"3?%@]56*1=WC#T4O-)PKOM(M
MFY2'O66\->V+'5-._#G:>G"+N0HH4%#U,$BM%,:8A'BN\\MK50 P-N[SLD6K
M*X:C^G)&6A\,#?F>],V+"[:^%>>C*1.MY6<?#F&, Z6[6P !7VH*K1^PIM\'
MAEKMC_5KU(JZ(FR>A%!J[>(QR@M/&2T6]&\^7T:&]INQ[D%+B_E.WD'IL7A
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MIQQSOMW[PZ0I;W'YMP!(M?"GX_Q] <\% W<]!X&]"DB FLI13)>-Z8> KK.
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MWY367ER!ZO<ZM/E3W1H;O6%C)2&0@ KIPWF>7+9:TP">)_5)=:'$@X7,QJJ
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M+FYB>W :S%!/_N-$\N(CR2GQH3VMB#>TIO#@(/3O>T=TPQC) R+8S60_RZM
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MQ9YC[5R%HTKXS>Q=#K-KJ2^U])0WZLU*N!XJ3VUHYEK'I.1*L.2LLKKH-=3
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M'RCQVSZ!%65Y:,]=?FWXL_\7PDD:G8T\DO@/R$9 V?!,.'6[8/  _![V"C3
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M_:YYWJ?L2\TP:%;-+1_HNCV;Z3&/?)IWCBMS][.<T",9FT"!/"6$JQ%M7GT
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M*O0ZUN&1$J.^Z@ST+NJ#P:&4=]V!92_Y>/>DW*:XPB*V9'WUY2(7 _I\<:,
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M8^  >ZR2/8VO>_T\B#0@P[^EH:6C6[K"N-65]CWGR8VM4OE/T?P?MBYH'3B
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M I7(?W LXZV'71H9>BC%*=HC(_-, H\DUS%LCQT<4.H%T]C5,3 UN^/%4#*
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MPEFG%W'L8 PQ"L.#XB6; <<&*,FXI>SKN613RQG->/21*62ZS9@RI59I\EF
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MHDYEN10LC&7?I*>U>[D5MQ^L$:;4/M(_+"?=('G/>':<)E@".,U P]A<@.I
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M**I\P3KY54+D;E,./7?B>GE1_K[0OO8+W?($UQQ_J<N^Q=\&]L(7R=E#NYW
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M\.1<ZMT=61XBS4:I1@[E2FTYTY]*_:S^&W1\3WB,%S/B![):,I,2<4H@T1Q
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M<'$[+.R16:""P=8%@AP9#/H"G9C$LB[$H%HR3RMEIG\L_5'V]H67W!,QW<S
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M'8EAV3A&$]:F'I. ""$NK(=#&AQD#N:1PGO_^=6_$2.:#<L)ZGZ.!!?6VA[
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MT[5K76;;-/S'OV2Z69Q_K^=_W5.ILK#JR27/QSR.DE-HP!$QRF2TL$L/@!<
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M Y^H&Q<69X3*!Y%G&NE2'^^IKY<9('579AZJ281T3*7 %*8?748W)VA1:V*
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M15+H=N,)-7G U6FB&%:H8+:&5?QF)D/S!X;P]?[$I;)R8NKMM0G/N!>,0I?
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M)*Z/XBWRDY?/Y/WT(50940@L:,3M^^%/E0RRO-AM8C4^XLKE]\;;R?2GT5
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M6WQ9>,<;]R/^:)'.KN$^K,SX5=YR/-5O%WL][4QX<-7RI =O0M<985D#517
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M)M64I'I.3/G,/32HSG-^.X2Z2G]UZH/@:VEAZPMB 1SUK-U!#[$%.6R(YPW
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M8HZ#@63B[+R"0NLQ'",%S(UZ'C89\Z'[U[8>PM=0-<^=Z_MQJ0..ZGR'5Y#
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MFJK5R/>G<_)!T25+J9$U#(*2J7 *8*>6'V_<QN:63?LL;T?=%_I[D8/6++,
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M6WB(W SMIVRUJ5OXGYC?6^CX]K:HY_7J[X[EQOM&:'.OHHUMKY?05,XSL"+
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M\ OWTO^,_\_X_XS_?S..VYG^7U!+ P04    " #YA5I::7),%D+R @#@Z@0
M$@   &EM9S$R.#<V-S8T7S$R+FIP9^RZ9U237=LM>E.4JHB =% !09 N52 J
M @)"I'=046DB73I1%) N7:DB)10ATCNA(]*D-R$D2&\))01(.7G>[SO[[/=Y
MWA]GG#W&/F><(6.L'VN1K/N>UYSS*@Q(TZ1%X(*.IK8F0$%)07&9XC( D.8
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M.#((/+)_I<A!)5!7[C($07Y1DX3\7"\G 8M/X7@3R&U#M'*LCG$)Q&5"/U]
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M.F7<8JO A?;[JW,_]V1M"F/1;DN^,=OAT$4(U8;E3K(FTM?5R4/4]7">YVF
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M7Q__."T_%DY5!-(I,2DRBZCNG,I[#PT,U&$3,&7?'CP[@2_7<&;[MO\;IE/
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M9;=9*^)M3\B4).&#V;(POOD7N6!K$I_ 34F D]LQ11^YF,.Q=^R2<_;VO4B
M#?=Q%/(6W7^J_?]OK2C;:.()N84P ;G C^5M'(AM>R1@+;74\\#N:.J8J_C4
MA@3T56Z"L#1I).!>38 _/SY>)N>4 4H""KJB<JA;F/8_X8Y(@!#$[J_0(X@Q
MSON6![!XR)[9(0DXI25_?:T')@?;902=UG(3FPU)P*C!OIA_ /$]^?'C?S%-
M\3\M:O8+P5^N1=_R=6=J"6F"M%\!.=O1X>4(N2I*Z-5>6^Z*B2#58KO9.6MK
MVW;&A))!T;R+HZ$ 13R4+\ME[VX.U.6D+K3&19+5SW_VG.GH#F>B8]R,<<]&
M)Z/4G>_?5^JK;IRY,481U68Z\N2Z_H7$I.@P;3%-9UWCI9\"POH>Z2/7,IM'
M7<#[A%>@,7XBO0&YU]K'*9P:$7_XV@K@M)"NEZ8,;*BV:_>=3'^&N[\P_<W3
M51 3_:.O^@,=M2LU!3Z)!+1?@R^FM5['D(!M>X]%N_=<-^'31*XI!R>NO9G)
M:Z$+BQ7]]W-?O1_+C,M<@>?9X2[#\*Q5=W"GZ&$]'-72\P8X1JHZKJUF9-^D
M4P/[*O9HY\=-UU I9:J>,R$;?6@CI/#6'%-<ZTU'2[F:[%*^G"($^(;IB.;"
MTP]*'#['D>?JXY1]-^T&,"CKH]"BU2"!2.RAF%E&G)6MZP\#;.5R#/+:W')B
M,)=6Q9;3$YL;=RNU _LL9RWFP!L+T&48GHW;FD#.<O:2,Z:[;>P+;.@)6*2$
MMYW @XRMV@J;*NY7&@D?D7V>)A]<K45HLGY!TH6[W2X55BWQNEF'2@KHPS%G
M7XQ>V7M_K9[[[FME5U7X9]@T/TZ<9KL?%C)MQQ=T!UDWL?ND CV(KZVP*N@\
M?B9NW?6Y*(@GC/- [?!XY/0:7J 6A\&4=I  1LFKLIWR!4]BPQ;,CXL4F/M4
M?(DMH.>+C.'6TIW[O2L^FR;=J/7F5PJS^D98 P\CG?-Z9?:MJ8B&%=1&R2%Y
M*+5G[V=WL7,E@,IXAW=DB;04IQ?Q-S%V;2T"J)P8%4FH\[K*A1]E$!>6G80T
M4;H$NLO;MQH4@<S#W@TXGA6,Y<!)+NW.D(">].&(H'.?UV?CXO-LAE><L.ZP
M/D;Q<&LQ^3N @C -]?G;I7;T!R2 "=*N G]B=WZ="$ZB7*NM)&Z_4O2M-FVG
MXME.XZ593M\&/8/,LN@1RD)X<,.=5RRM;.S!K55BTO-[.F%6,22@4GHSKAZV
MVCQU<]##?T$V\MLAAD&R<T7G9L&PW!E-.?N=O7TKI)65V?1A<4>F4T=,XJJ[
MV9A5=>,<> R:=JR--SD%1;3*XO8[';D4O8,-=WY=.4.Y59]P&W@S!D RS=9!
M>!8%(AUBB7_."+407_C+7)<$T$;;634?A>C>M'WXS.'7J<[!<!#7! D(70[Y
M?F*W!<7 NQO+,R[4N4(L_;5I6:ZZA':M4H$"U1:)=I,0/#?3HOAU$O#<O]E-
M-2P/P6UEGMOH^&$H<>B8D2>V\^C^$LS([J>*23>,HNV@"E_1H,NN&<X7J^TD
M8IQY.4O#Q3E_=[7UU-\\@&<Z3=.WVBJIYG!.#T\":*8)%]"^6SFG%\A64@VY
MZ+2)L>SM6%G@5CRRW7AH]6R!8US_=DKN<\K;;8J>4*>>.Z6V%+A8LD^'"<57
MFM!NH:XJS![!)9K82>(]>;$K*;VI3>9ZUY1Z*;0%6CWL^MCQ/%:G7GYCO1 >
M.=@,\9R7X9CWMKS_EM%6FLP]2LU7YYFG7M,\>!12@R>&_(#SJUTC]B,N!*FB
M;!BZ&Y>[6V(/?!4H===_L%E0??"Z)@7L_HP?7O2,/^?%LRL0YQ\S+#V^'_."
M3Y))1^Y:49^."KJUV'GK:UE(GT"YW[11Z5:>CD1F\.1VV3R\OQ^:!"J"XR3
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MLPMJ(U?:>-V5F0SBQ,H($406)S@'4<7O6J]QS/U4R^TDH#^GR8.S1\I=>?5
M<1!R&\P=$4=I$8OX=E):7N8"F_<2OVFINXIH6-90D'28^B2T[@.%'7J=MI)#
M*T,F T1D"1D@ 56R^%>X"&2+I+D+.:'+5_,;5H4O/2N=RTWH^"7Q:QE[5IA^
M@)91DVE_ZM0DR!MWZY2<Q-J-FE5S<0R=)S:I;_/]RAE<6M2&1"Z=-=_MD*G4
ME%^$\<2_E+:;$>[EW@8M[N)97N[>K0(]I4/_<D1_A+^ZXYC_*2/F<=SWMD,4
M?# '2YV*6B72OPWT51VHN[O:$Z[A9/$1I:=QGU\:Y'U>V4>%KP8'IA*=61&(
M]<OA? ]3T>1FBLX+T_=\&'OK9AGWWKR84)Y3[4G5>-=L8N?#*-/DW(&3^7H2
MD#5\\ FW269Z"<=RJA4R<.+P9AO/^<7Q)+GU?.TIVW9+LO2@^-QZR6W?>\*!
M>AW9%-0."4E$)Q!Y\-WRPM!@[Q *RE782IU\I?V459V1XC NNDOL$=LW6,[?
M-I0OA_"@X!/]73D<*G)HV<7>=RHFJ+ZENK&>^/SV5B=JE[3J\ <OA?RGE_B_
M3R&G\&Q+V&MH\D#4B]:]CQM&Y^E_:ZH/IR@">T$[>:H44MFFF[KR?Z=R_@Z:
M[CW;ZM 9)]W[U#_FVW&83HK,BUYFTXC:LNLZK!YZ\  YWEG/1E.(I+B'G]]$
M:++9[A4V,8EBJY"<B2$%(JWOJ3*>#P/?.KQ6AI*D=>)JZ4HWNE]E8SGW_73@
M7&I_;@^32K"G<ORR I&A"<ET+DB9D"?'#3KG],W)E*%DZ N#8@JK2":F E@#
MUF@$X&R$)$C[!6]RL:+$7YE2H2EN5VW!1MA[N2E^XJ1S1/FH7& R&.,?A7]"
MX$16.UVIEB#D00Z,\T$=/XZX"\>(MJND"=ZP$FJ>G7E^RR,>JCCDLE&O)94E
M 4(Q:C@?EB"E< $UQ_[+@NN2_CK,3;&S$Q8O!\1Z<#H&E89)!B,O$.*G3C^)
M]DG=EJ\FCE]JSS80NK)S=M*-4&6*C,D-2\2/VN2*.G4B[N= /'=(>._#?\XQ
MX!WQ*OIC]KYN=7TR=ZEJA_9ES4>>,T/:1VQUT+^:1\BWWU/N/>1A/RS+HD&C
MH5*B#4)?JAQN/WU1)H 'U5IN*XG.MT[*^W@:"W666=LZ@5A])*@SXT?6YV"2
MY $?Q[_*?:TY:59;+DKGF>%GL9[O^DLQC/&0=;LI,_P%!R(=Q>+N+&7/%#8*
M]_I;O\LSH>9^)Q^^@T1#JIXW]+7;I[2G^12)[F+D,HJ36-V21(.P%S!VX4]P
M5OZ%"TZ^8Y9ROUY),E0_7KC:?[5KH&3M/,_3UW> J<,\<K=PY)?6T4@6IM$9
M>/A+UXMKLQ;5'_+?5PG&NJ@\GJ'X3FEF_4'-T*RAW%8%]6/"CRO<X\./5JXX
M!TM6&R>MU'R1!B'%/E!8:X;/N)\EW9,LY=KDXM(Y*QLAF)O13*M(R$]^] /$
MS&I7HV\'@FW=]OS;K@_5EFXSOZ/:A?:_7&=YN1#RY+XJ6^#A1I 9=H></5X2
M!R%U"EN;7_'W<%H%CE@%4^4S/;F%M1F,HL_31=(U-*2*N;^QQF36:G.VR^&_
M0-JMR=4N U+3&P=YZ13DA9Q1T05%P(+N7PM'G1UG-/4H_US%Z3IP0Z"_A]&U
MR3.YUZ"!_]2!_!QSO" &V@F>$;N/AL?O%+9DNW(*I(I-^28=F;8I)EBOMIX/
MUJ=QQG?*M3U$OBB]BN+)>U_!\;6G>=T$=F?**W8E5SE2/6OFNM*='B>%'\OH
MZE=C&3##,M%DXT=)535-0ALG:]MUKJ#0G!DF(ATG1G()M,W\-4@!DYUQ+0=9
M)FGI<G_G94)N[.>HY;%7JP^53+Y?CA^"-X-F&(ATG:?70_JSV<=">.<=B5P8
MIDB)KZZ3!NZI4S=X\RC:OCN<RXZ 6A]<A:>#<&+#VS.HW6DS5'FI9$>6&@/W
M:9FFM9YC-..[YORG'[&9H9Y@E']W\%\UZ3ZA,D0\9 K.ZAIDA!$VA*>Z5RBK
MJ^PUGNM5$9.FBI/R/'M6$5:$6NY64?]@-+QA?XGF6AR7W"6N=^G%EHTQ9C>_
MCE4Y[ZX\#C]IX6KMT_B1EVCF\DR8OX4P.1;,1+[_;73KN2 5G,'96!28#N<"
M'DG3J6>/JZW%W!.\_\GZ.FV4E,?N:^DX#SM?2#M-JQJ>CE +>NX"?VM[!1?\
M>;!T/4"N.S_]W:3\L#OJ5G!Y^PQ#:*O=IX3,[;DW2?'ID,6U9*KV&WDQZY7\
MQ=+%PZMVV7"T<UWTRV;II9D7H^A\A;%^JJZ],V<<'&+#Z0!\/E&51N5">_-P
MQ[.X8M.Z*9F3UCD&"^/TS&>7LLMNSC;.S+O\5GOY(##*P"!11^?'9%#I<@/&
M%\]NA96K(B2H@3;4.U.?S&E/U5R7$!]=N/SMJVQ_B_0WUYY>:^8>I76[J IY
MW,AIY760(07L@(>,/88\JI]C08$ZOQ.O@=T8;-9-;V &OUVZRN#=217G5:7J
M[C5,Q48,P(ZNG)K4$+EO]5TV6&/^Y,Y4*W8 8Y+M<\B4#"TUU2\48V!39U8H
M]8PRT&N%:33T14.W*B[JWN\W+X]V.#G8.$UG-= (;GAMH,$*_,_+)!".P^80
M&^KV2MEL=XFJY'14[HHO[O79@$OK.JR1 ($C<OXF3[BRDJ=)D+6S39!9$D#4
M&M0BP@5)P,^%^GC<U6'\ 'Q'CP1\YMHF >1:?<POQW_RUU_<U -.8520WXTH
MR,EA! D8\P EAZ3 ]P21<$MX)CC5:$?RM!0?IIR>XP&9M_M]?8+@#&$ZPVIP
M^S\NTX3?_MNNN6>R5[Q? W2"W]MIJ.I ZCB3="P)F'%#XNU8U236^/@RQ;0(
M4.=3ZR#H46<,S]'VP<%2&G],7MHCCT_A5V;#&9B,F$W*$Z"7R(A@%.]*XWN0
M[L8F&ZC2L5QJ$I">GVRV KECA];EQPD]CUQRY=;!-2Q]%W!5-K&JL:KFYA"-
MI$>V4WO*! #:BD ZH1Z3T\4_+;LH586&1[[ 7^>=^&#N<%'#\:D6.*$N2715
M"/R#S:]W0-]E+$C(GKW-;7IMULGQ@[73PJ5/N8YJ=Y]FC\K--[C[GJ&FF%I1
M[1L^)A#)'@MRP<B2FUXSPZE#DU!5P_7+D2]7Z:,$7[A2X'K='F2?=<'CD"K1
M:B?W,7#6I:IRD8'*<OX^:3F1Q:)%T:$,[Q0M>FV1'Z)Z6BFU)]NKA)$NI5:M
M16$Z]"2#&!+?)#4D&\6ZN;2Y5"P:)?/PW49?'5U?T[Z(AG PMVD+O#&'/60(
M5*E [@>&B AD%Q^?^;4Z'Y=MM87+3V2O&$M45._4)P'U3X#+CUCL>B2WMT\O
MX&#8N[C2$ES(PDPA^F?])U23=?5CA56*;W>X=9;.K5&HMOAB*<@I,QS7B[U7
ME:%AXWF"ZEFVL;:>O_^JM/95[)Y7+]48Y_?R76P9H?00,;?4E:X5AI=S8QLJ
M#@ZD-KMX[Y+VJP=(\\2FR(-AWE.>J4TU;K1=)!\+IO5QZK!<6::?DXA)$>93
M@86.N5]1\8T'!6+U^G3:%MK=ZU]T[0;J3Z/KJ;K*F=J?7^AW>I893'<W;4+F
M1%N=V=^SA$ZP(5>L1P=C&-WDV@(7:>9%G_;D7"P?3 L]Z"^[ZW-+IY,U3L&!
MUX!V0PLRV:)E1$B$..I=^F&C:X!.+6#+%+749I3]\)DQ9Y$$J,K:S8"W^,F9
MDDCN0V7Q9\?4A/!:8U^MK./UN;+SCW[VUM D"W96?^;=ZMI^2"?ZM1>@# YL
M0U37;=F=WL'E&..TH--^KI)!?5]SF&<C9"@?=[P9-@R$'#;LPPKXY)X?-RMJ
MO<58'#$]E9N_,2P?>[U^+/:ZYT0I.W=OTKQG],;7PY&,9_Q:*E?[91H\0&R/
M91[LW\HO>39CHZ7]XV6^O:CW[U5VB<#Z'B>K\GG0<%67E)V3;*\]A*?VR'T^
MW[#W*JO20HG6 .LA#UKI9.K(@XQC#">.'N[B_^:&+:] JEXE 0;-Z,%3;7\/
M5Y:ALO/)8SW?M\YS?#^K^S3A>.KW+OX2"Y$.FALD-L:.RND\O:G'ASJ6$'+Q
M0T?Q)AH=L3LBPZ4_W.Y(BH,X@A93?=7<\"Q$$Z/!NH@:OX#5Y!&HH30)H#A@
MVV]5Q46G85;?60MW-2M$=3TNGD1EBO.8*)ID<8V+";&+ROD+L>>7']NF6O&1
M%=7,$+TXS%(?'>&%%^>:<$3OR-1P#F4ZC\ T/>.KRK1_B+MP%TY.P8W0@5@I
MS/,(=!5V'5, PPO4GF1GI\_O:3C^%$SH*42^IM#Y0(F)'T-DD>]<";HW&N0"
M\W.V.D?/2W_KCAOWC0LW;@T84 O3EF9N#ZLCJ*ZUG!+I9A9MN'OMZDA _.=)
M@Z=QJBX&[ISJ%TU7C-H$>.O7AX$3[QRT!2S4EFL<[K@;ID8==E$59)=SGQTH
M*2(!.LQNO_(428 Y.$0)9D63\7L:S(NS03FAGL5WN*LROA1@WA95?IFBTF*<
M@7VI?SZH>79V^TBE9.:YDU5[,PF8-OY<>8)W4!$7I<^2,]'Q?_>8M<1S7\-V
M,G9[N1&4D4-.M&=:A?'@*MT<:D??QMC&RX88]>NV9\_3%_,&OCU!-1("L3:X
M7:255NN4BF21E657N-FK\!!F3VW!WC7%-;'3$ISTJ6 0%2&.2+&^<*/IYU8-
M[7;U.64B4;,Z3F_0YVF=,]M[P:S/JY<!324Y5 @+H01DSS_[?+\+<IX\_W-\
MJX2'<I?*"J8:7#[_)NE*%!.*<YO\5 C*<?]%/_<G5+W+&XQ_'<,S<]CCZ $D
MS7:QD9&!CS#K%OR3I:3N*]-.HM#PC;9'>UL*%SQ"F,10-X;/;7]K\#[F54Y*
M]I]0''?W=+WY97ZJ);A:"\..GD,>1:H)^.WKHE]F/%.I_+6@X?I*!4J8EF".
M]IA>C4-8TQ,S5<CC+#4KVBQ2C7X.MW)JS.R7'BRT.]FUNS"4X!\[-%JB3BE?
M1;6>D+[74(V8@6&="/D#"87I*R3 &.2@R?PA7/>UYD@?Q]:MQ0/8AA<2%M<L
M#4%;=G:;AIT-]4ZZ;@*Z_+Z-X\TTH\]A=Q \+EL14TX?S["DJ,P9IY&Z<C[,
M[NN/J)B*0\&D5,Y],<7]P%JK;>]@IK>V3.AP41@STJ_$CV=)JJVDVH;6Q/41
MDN;9>^NR6S7E38Y?(3EFL2$ ;@K[!#?#Z+E6B7#$*O_VR/7C'/D2M^1F6'^Y
M:',JT7_=;I28>WH?Y[F$58KJQC,Y"?UNO*C>/'//@G^KFXZZT"O;OU?5904Q
M)["4U@:.M&-E;T_7J,WTR?TJWI1B_B#;(:LZT2/I[>;P/FRL'N(@>49R*\4U
M\(;4)\%1PX?TC,A<ZE<\KU;Y#5W2NE[*%60OJ_&LJ#@DVG]3*NU%6HLK5S][
M'X4-JK%\JUVL:C45/)1-B>3ZI.;4^Y&/91#]L;GFD0>]6:SR2&??OK"VCG:K
M8VGY3O]WHI"*&1J"<NARX\6EV:+K(E[F5P;VK5ZGEGD1QE"Q>/6"XOJTP]D*
M;\3,\))^E2<VP#?\D*Y<P+4\E*Z/^J+T$2BMK@SR%('6)P&O^9E\6K1ZY-,+
M$^Q]V4\>]L_U;(=N*3+FC7MD?SKA?X6)CX,_X9^Q1_%D7\2TA+_A?R_'T,YZ
M7<6TQ%3[*7V).N#)L1CGSPO6.7W@.^K"_WI(.E,R 1TB?*MG>5J9I6.DH\/'
MV3B/ZZ%7L8FX\:,&J\#CO-]HB-; -071=LPECVYSZSRZV&Z3\*OE0H9ABB8I
M9GWTKJ4Z)H*S4;X0 9P1!M8&C^8_)WXV;TF5\E2_JF=7QOP:0[SG&LV*'\_4
MISLJOG0KFMK62PE1).">71R\,KZ-?[9W<9E8\7F]46>F/__7@L6P [70JU[G
ML3<M%.USWZD?O?;_W@VAAE=/=<[QOP-Q->LNJHI1]NJUIG.$$GX)EG^VI_IV
MT!V2M3@5ZP=BL_^X*/9LPC/S]/I+\U^L7R84C0P?6O;;>H_I>3OE9/G!D.?%
M.B,?22=['%2I9,AJ/\*X>QAFCO-J2YB7>N[EHR9C;R%L5)2W]&X^9WAHBYRY
M>S546_"@K6]S^]CLT(?L*T5"5#7_!4<9O#DN(G=N/OI^7OHDPQJ58**;S>=(
MUE#YIQ7?VZA77XL=O\-I%:J7X4W00TF>N8M-X^)YWH]HK_R^$TK;C@\.+B70
M0YYEL:CCKI]>G]NH===P8< %#0URO>N/UNQQIUA2]5K_9=9%$//KYT]P#V$(
MWVM,*;*O3V/3B:_+O7[WR^=5CG$HIT9APV3ZK=V%WBD"EY_NF4P/33&U@>+1
MLK=(O-P#K<I2CA\7RT2N&V6.IZ073LF =6LA\G9HR]U9K[8C! <>A#9K7[@X
M5EUJ<\LH? BU,31+&]21QMQA_AY]V^WCT@VEQ:4DPIF0'A)0!>K(X21VMS*-
M^$C2.>XM^,5WE@N/"U9'EIOZ7[[#34?_&S#?$<[6'M8ABD(6/R^(1??RUR1;
M#ESD-&C6Y=H13,JI6PWU&N,@MI2>=A B??R"0*=\>,4)"4Y#;E5Z.MZ/^))6
MFUIMP3A &+YN%^>WFF*Z.$P3)-3VM*;BXP-CC M+9*:'W'S ]/K#,/V Q)65
M)&QE8W3SJY&UD";D61!3MZV(7W3\P!K20]'_4<E/*-W#+T4&'48]X[D<8Z$1
M-YZLC6GW!];!U'$-Y(I7&-)^DK-5O$30M1AQ?:HL7Q,LWN%O4)?":J3PL?ZR
M*Q6UYZV<H/A)$H"[8M8!H_0[ZD@"H[+.]IIDO>B7;@A7HH6(Q]\:WSL?W#NF
M1/ D-(50^W%C^W%T**//#+Q:W0$V,?TNRR^RD4]C.42.?:7F8D0. (<HG!:1
M=ACMVP.BJ.%G];/K2=V?TZFR[G:LS!/>:?<QS'V]Q)>3YCPFAW%AZ\G1PH]1
M?%S:>*S8>046WH%:/]4VZ'E2U)MRMT;N4B&J>$9'^P"AGB&.'F/J")%?-F\^
M3Y\M'%85Y9=I>@DFZ/+XVWYZ:"I??KI'L\.E)798ZW9AQ H"?RD/6?<NB&V)
M 8;3/(C6DY&3"4H=N4K1MW:!"5PT/ K/X@ZVI?V0]S6L3N&*-J\'@IQG=_'L
M9S5S4*V1A0T@AW$?D>U5X9WWOU-,ZO@ZJ?</81609PB<H,)6"X9_D?\MW@6V
M$7#5A:O[G8+"-6W7B-1!KELW"C*5&\3WB@S/,^E[G-*<\2M+P+DB^<^L!)GN
M\Q@.3GW+59%30CGO=RBDU;@V".5---5YUTWM#8FAI^262  +KDD"^?V1HTJE
M <R2;5.=0>^N9Z7QE$"T:TNBZ<1Z"2@.O-UDMZ-+ H)RT,7V$X\SKERZ[>Z1
M(O!!=CW&[(B.'\]LA-5^WHM%1##QJHVX;F],')^2NP4VL@P<B,-D82/:6]2[
M%VC&#YP.[[NN>NMJ/_*7*9H&K@@+XT\)E]0/,M"[[ZMBX )MCZN*EF1OW).:
M]K6B,61-T4DU\,JPW7IY5+>6%I8=S.<W=^6']$R/A+]5YR,1_99G8%ZZP0YF
MO;UV#2^U'YNUJ5K+$?B+_5B#48A+?*R[7Z"-W^3P_<8H?U-PH[WF^1F:R_B2
M0 =8$6QS%^6 ES[: B^6,742;_T\$$H5\[MK#79[P?7P+'/\QS?ABQ2_O;(#
M'8X?DC%<P?N,M-(3?\K.X\(YT\_I'[H:)&@#]P<Y5]>\#E?C-"!Z_.B'B&E_
MR$L2<-[1<N=MJ;7Y'?&LJGO499QB7)=MIB\_+>)<#'BT*H>#C#*PV;$L70(G
M8D)\TY^&\#>S<257<'#^R!2(3%%SKDU1$KZNI&H4(#1?"[='@VG"VW'/,E8R
MI9.6&^!<G5*E^C6,#P0,W>BX*K"NUXLUA)C"YZIJ?[9RAO21@#K?3AM3$(43
MUPT/!@>$CYL;A?1Q0ZRV=#$H./FIQW?!/6F\8\@"O+)[M0TTJ^;V;H'Y]7Q?
M8(G*=9[+%=RKS$4=<>YT2QQ+E/!*V+09UK:.\)K(LCF*BWA8/RZ>V->,E:F.
M_3@-?FTE(-S?>\!CMH]< G.L\]=(XEEKSVEV#.@ZN*"D^&Z]^]XQ?UZJ+<9C
M=VS=>N&LQR79"%Q_/ GX)AO4JXK>%?@A_?&77%"'9Z;H$R>CF*)]'4_/F )A
ML0+"'!>N,V%Q/YMC,=+!7Y_J^E(F0J[S4>EC](=WPHRJ%HK&00DZXB+UVHZ'
M>J[>(84DH%T*OIB.8 IAPXM7X#HQ8'!5]@;JNS.[Z1&ZU-_]ZUT+B[?%]!1/
M>5($/[!FWS\-Z,6^(Y,9M*DFEX8<OZ1V27EWEF^@XT99W_X;YD4FE:4;T[MQ
M]:IBB%8%G$#W*)YM3(5I,6;:ZI>3/+9N!2$M>N]G3[G^+\8SO_=Q4?@1G 6Y
M2A7CM%U1WT.NVOJAKF$:ZEWZRL[A]M5&]?>:%%9OA4MG%\(OI5U8#O**0JF)
M+^U(#J/]FO4%F,%7VY\F%2O^?.CZ,T[T@I-1+MN/Y&I7&\07PO-LK8_HE_Q7
MD"'TR!=I+.&=/W.-%'M6,%!V6T]LR*2Y_[#%!"[#<F9&,#Z)!"R60]#Z_!2P
M=W;8UVA6>5-3^45$_J4F@7,<E(\H/U.\L78 8GY[Q:F^)=+V8:"+L&Y8N ()
MH/%!T*]-90O4:8[A3Z.MG H]?O<YFUVD;/L6%$$CZJ[%R;:/P+-%$[G&VHG,
M$(;U"F=V$(.X:V&HU9N59M#S>\\8P?/M=SYH]R[;I4/0ZL.7-K@4MNU<J<T\
M\V4W+O6L7/U]):&<-BAFJ:A]J4X@EQ^^B/.21<'S4MVL%%&.SP_K@\$WD7A3
M&G8#E%2RHYKC8X_1=PTMI0;6/Y-V"U=1'S/W)9$(WLKI96O0C?(X#V6+Y[YA
M/8\?%3UQ>9(>^T#_G(Z$6O^G6=FH]:9;8-P-X2WPLU.U(/"$VA6G2_T.!2Y)
M-8,MS?<OLC$)7& S=NTYK\BY?@CKOF71.D*IVSLDVSMU/(7=)R>G19P6J$LR
MM-$V[S'@DB4_:2\8U?"DHE\L)F&(<M%G?=VN2ZHFZ4%]DFY&I*O-DD><NJ3=
M;S_8+V)<D'W4DB1CY5=]^ZB3(8>TH4+*IJ06#:USSM[/5.<\H\"?6GQ G)C=
M,/=?8JCSS\+;'L\SGI>YB:GWX9C-D1=(+_/KU14SSJBT%"K,K+UAH,%V6H'[
M_/>_GOV?RVPBYQL(GQD?#MFZXD8"\@Q;C?[#_T(>L9. /N&N'*Q(-PE8+^;7
MZ+#;,WP*Q\JT0S;T! @\K<PDX/L;).+_8.\]HYKJNG;A("I($:1W5'H7I M$
M]!8$!)3>HX B73H()#9 :5&J($6DUR"]AXZ $*1W2(+TDE!"@)03W_-\WWB?
MYWG?,\8WOC'..&>,^T=^)#MK[;GGO-:<U[7VWFN=T<Q!UC]OC98.@?_U%X+R
M3S)@Q2F>,DY+R(!37]TS]E1(PV/X-D<4*?W#?OV.#!EP50VXE4KZ(;6?2'+P
M@FSE0N1!I9":>L*K%3*@ G1V%39@?!)"*?T5<82>%YGO_GXM\W_Q6F8)9B,]
MZD,M+Y#IN4_M9'% B#>=[;V4Y'<)%Y"66>4GV#[%5+_:UI;$ZRG.W #(42DN
MFT0[<R9-8,6G8@=OXV.PB3WI8&CN1GW=U$WK3<XK.K%7/PFK65LQ"!:JL7>D
M/U.LBH6S?IZ,7>-34C-2W.@TS=3_5!UKYOAE8H^HJ".;AS:T=ICR-I#*0VR*
MD6C_"-DCS%+'7D23=Q^(P]5WPT%4&;.0YC7>4\/5@KZV%"MNWG]5X#+-0Z8]
M@7JL,3)UA[X@^&QY\FWYS)+;L8U13F$+\[S0CT2N!;9DT^2.X?"+X=B3MY11
M=IV2<6/!"$B5Y78^)#>,'IL:)1>@/.I<.586!O1/4)37=I.YKM! N_=BSL#@
M^_FP<RW*$Z3[E-26D(TQ6^+%W\35?T&)]3!=H; (VKT/ 5NO%3FK&S_(5,C2
M?>S4F64K%:"EYCZ"K29WJ1WSC [CVYI@=PH$O$("><I<>!+]\X>+[RCHS4I8
M:S;[:T*]#1@VD!/IKG[]'K"GH86KM=O0%.!RY5(E, [N"(4*R&)3"I\&^.7A
M8TS35R]]OO77]<:,IDH/]EFJ'U?1A1H'1X4$9DZ<QCA)@C2RR(VO%\E%Y,[8
MS]HCDF1X)!4:YV_H4-D)$/MAFZPD.D0^N =>3[-="T$UDJX%NZ%[ M,96Q<S
MO?E7&/WI=>Y'FCW[D<!I_RKR\:]WPD+/V@(ICJ)R$ZPVWC[!%%*&,28I["YF
M\5/9'*@\*YM8',+F)A-;==$?<(NS4[+H:M%\]\?;L*K2WI/XFUWS9FY/Y!\-
M/]___?E]F9(YXI(([?"E>\WBF[-&0_.K5L]UN3GR.?7.MLQSFR"3,>Y!P&^0
M62<D9Q<T%G09VD4&< 5'&8Y(7]/FA\]Z+;^[+JW'DJ,3\)A=R(ZYK;$=QDND
M)(5G2Q'9U? YF19^=!ROK<HY,P-W][D@H:$?PJ@'&>=\8A-NPU Q)/I\2L1M
M\9E%I!'UOJZ]&33JPKB 0.3FZB+C78-6GROFCNQO.^>,KS)KGZZ)"7Y9JE0A
ML.OB<O%RV,&.%! K^/KF[%[4D>:S&>^LW=.0W.A+H@\-.'V_B@NO8-1?KJU6
M[=$W)+)WD@%6\>Y&<=*&G+'69ANU)GJZF0NM9@OI=<>_IF>#-^4KIH0\]>Z-
MPS,L#7=<QDEO(,N;@M-3/2!63T4R(%J H^93F>+TMA?L=\2E.QM\QK([7]\F
M\ J__>A[61?H >FHS%(>S25^.1*D,BBQA;A.S]E>K53X^AGA>=6"2H_A?NP/
MG_$L@&C;,K$:K$4: -9 MX4JV@JQ@EV<6E?'-6A<BF:F8Z:_F,:8A#Z-#GZJ
M,[#CPG*CJ[J(]H9".X01CC'RGIOJ7OHNN*-=H>M=9DA!M0&^P,PJQ8)C[YF7
MM1Y]YCMV,?ZVVO65:8VQZ!:-/LS*^GAN3+^\I%7P9+ZX^GR*VQ5?@R_F3SV;
MGAOJF>;$Q+DO*CFYN(1ZSMVK6Y+:#*^E%'A&<"?D2IC\V=TM.+\_G,G-IB(;
MXN<7V/:7PH^&(!?!%PKHC[ZJ'4 ; B/^TIEFF#WQ6YAM7K"0'N99M;M?N5U^
MT9?M,5B2\XM7*;/*&5F-JJ>6IR%X"*Z<^ [B91PQ&X(O13'1$K_MCG"7'1F\
MOY9R4_@YQ+_GZ?!EG=[8QTS)O<$QR$)*F/"BNMO8L#!W)#&H_:/##'RV7"QA
M=29=U,2.*S=>Z8"+C_WG>X6+VC]Z3W0_I,7K)72)]CJK;J85G,N>>'$DI)-;
MN"MK$U0U.3PT%S"1J,$F.1$@9"&942Z:4;N!]R<& *,@LW=)C"WX-0SOLF@N
M=JD[G3@?R&/?EED\]$2F0\1BGZ/I2HV'G@F[.C,M EQ+? 'I:+6D)O$?E;GJ
MJQCD=04XXM="NPK<Y#$T=A]I!!:&P+<HI#*,DGRJ<5I7,9'E&*%E7"E'#G)(
M/[B\PBCKQY:JQ7[RRO/JAHB@WA=L?+(C\J "$,9[:8<>0]^^]%U1W3*N[1H^
MM&L65PIA[,UU*EFBY4<WU#>P7"\2:52XX6AVI9>WW*DGN$)R. R8&X>BNQP<
M/=/*\UE=]24++@FS*>]I5LBVDKE7:AP0ZJ9^)<>8 ZTWH_/%Q'-CJ& HNX>3
M0DF[%K5:B74M <14)*,1B3M \[:NHO*8NJI"PP4K6::3TZD]"(&7_4PC[#Z$
MUP %8PX.-1G9]K QZ!*99[G+*TV'>&4G?E*W[*MPOU</MB'8"Z>"+*="F,-<
M5.);#%&P\TN;U493"BU3."_NS'IFY^>#1^A;P;M2-U'9.[_.&,%=< :E>KQ4
M4;"56V"=W\F+#6.OU3NL0K+-#V*MS@'BY.?4VJVS^5$'PSPYG3//M*%639_=
MN/0LBW7RGG"R<PW8E(K7D2P.[A9&Q$D.MVQV]*A(B07EIQ\L@&G6Q B<0;A/
MF*DN:+06*\:>N'U)9FCHS?=/4^+/Y.5-L[8:WLZ-B5V'VP(=8ZRTA,"=02^>
M6U[R#9!CM*-](,VE^*93[TW%6+_C9X"OWK)+-!F@2@&@1-\. I4]!T?M4$9^
M3D/ZM*MZ0\+P[6UXTQN/ EK5WHF'M\)OPS;J2;1 2N9RQ02]UA)T!0)(,EL6
MN+I*8M8\"/2@1,C,6.*S8H3VP$T)[HY=]==A]]I/4NS;9V[EZ)C[,5RX[RC_
M.3AT5%^CJLFBV:"D/OQ6DL_#+,GRV8<)OV.;-"M@^_!#Z.^[)#ISS!D*''=F
M&TP&W(=V\/3\]"QV<V4?L!DVL1O>I'W<L/9&/F.MP@\TD4K@R<3 ^AQX:K&B
MK2C/<Q2R46>O?.S:\N;^VY.1%H.:IE>^SG9^IY9[+MW>[^"8!X+Q+U? BE-*
ML*@IF_%M.5G9KRWO^L4^_U6^FE?Y75<XL^?IXYO[\:M+\1!WX+0?3ABO5VZ
M^=*MQ? &-]IY[\V@3D.\05H:<YV7=<I5.P797WRJ_6)" ($'Q]#O&KI=BJI.
M]!^=-M!28UW(3?-,R6@ZLQ/'WR55)I.S4@'S_I6?<JVGDI^KEM8D6FZL'9-T
M#R(HOHQMC$23Z*HQFZJ?;]VMV/C>1HM,\9^_F?4U@1%BW8="1(+/@W]J\6,+
M8W?0S;^V"2HN 8I^DDU<HP/*5]]N?GW;L34$R8+' 3W#@;@Z2FF,VZ!D-(.7
M=2\YTE#!P@8S\])W1%I,F_WXG!ZKKE$T+6).#)=._-RB=\:@$KD-%EY7F4W#
M>):7M[Y3^:4T\%-Q)U'X!R\L'7"[\98ODX:E'*>S58FJU\4!>56/OQ:DE215
M^W184ZO7DFR/4>6<+N&!>CLY5B\_K7:;Q:;L].Y.S8&2H:'$]Y34D >OANQ$
MH3/=.X",AW$\?7:_TC><GY?+O(.)%#NVJZ38R4M,Q[)F',':]_#JO.AL2FZ8
MNBW AOFS_@R283*B&12>]%.FF[4[;^\*(>\\6%< 70Q;2\6Q$)OSB)%D@"?M
M$;_(3(LF"GC%@']B5$U>IK5G=TIZOHCW4F\P.NNBU-E'8C7!]8R9- ^J8APN
M1RWQX/5!K)M:EZ-,Q[ZY_X#4['BG+PTD+#Y?6J$39L!NAV\E7S"Z;XC5N&7\
M6K5/Y*=3*NHF0R([C\.06>SWFX46=M&^R; !I%CP4D%G'*C\R>;=S#LE.\]+
M;8U*"Z K8:9DP$4X'JW?3,PZRJ0+-YG>4L%A' P=GQIK5DS>7WQ0?"WF@FOP
MIC& %12UA'E!!FR+8#F[EFI$Z[%S>AA<?HD5:,%N4>X30Y4L_ZPQ\H+/&UJM
MR#9]X@<RP*/<B73I]YG9)L^S*)18,^8*EO?.ISXU=R<77'DKE;B9[IQ@EOM9
M*69IQ^F,#CP/H?<_P%IV"URQC6F^%_*G\EQ/N2FM_Z?RG!5>S=51I6:XV9?[
MI67N3<-P(3OR18#/B8,/[4!)KI&13Z$2QT9-HH_;P&(F;4$QZL7FN\)^DZS4
MP+H/;J0=.+_Q 3TQA<0=9HI=VZ'!+*JVT)?E-[LKZ]TB)GCH7!AWZXE?!/ E
M&->SDPK4\YJ"MM<H?'G37M?FO4WFS7:.*<Z'QET?*J33WMVS_=C!G$"[[ 0%
M*6!H.A!XD;7VYBZTC)P%AK:Y"E)K,^3CX[%HK2/W.3=:9'%FKO[X^^&*@#+I
M,J3#@X*M&M+E1DQ!.88)>6^A+1=)O,,QQE G"Q/\^*GFRN_<'ZK&20$GM[G[
MC#3VE/KP7S)7&J3A8CW(&\$\V-+WQ0ZL;Y+8EG^7I<1I*S8M+M[--U*5#!!1
M_Y245U;N4FIP=$8X!"9 9Y=0N%1L%UHW5D,[]WK?A;I&<!DKP-D.:.<$<R!E
MQH53&,GYE,;J6F*NAK+W[<<!7QY2,\3+LC:J;I#83]*\GWV E&P^IU/^[B<R
M_S:[]2:G&N$T=&I$L&JMEQM,%^:%$<AG2>%,/TIOI/[> %4CJ%$7JO: CZ'M
M$LX-&<UT7QYUZ"<KSGGNCTW8.^""CFP$G/E+>O.:^H%2?CJ+$,@\I*"0P,;/
MLX:C:T@8%0O6C?S5=MNG?EML%?T5L0\[2*"D@M!82(<!FP MUOEJ/)JH2$<&
MZ,NQ#+ICETB7<I0+G5A BPYA-\X\'HFSZ.'&[T2<J[COQ#=P6TC5CE(4E"GJ
M;;(7C?0FL.T]@N.AK/@@G3ILV9>*W;Y/M!%*[+/F>;-:Z\*)\;D8 JAS0WQ%
MP_LU9(_M232TVF;8:V=6'I]?YOG-:V^EE<^-N,MAS_=U[Y<PNGENRAZZ!R71
M9Y>[:_%23/3;>+D8Y2-3._DE?T/E'O)C[YSCB(<@MPG30W"F^T$SB7'[SP1Y
ML!]ZJ2L$Z,+TOBFN?G:G94?>UN23=48C\T>&QF%=U:NQR"A)QG![2C;]3LR#
MN.SQ4=C)+6^"$M+X_>S%YO+!;QO8Z8TZSE^#ON\5587\,ZD$5;O=][UY)TXV
ML@^FB'%:BOA2G"L^%TD&L <[[H:+P)'7;CH8,,0)K%NLL%C%.GO8.170Y)2I
MJKS;P I2/6N0-J3['!8@/5 G1&51KF923/<)JI"PIF^D;FLH>_SD?<4ZJGA
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MM/S#"V/]1#UCKWZ4P?1%O"2HY>F]8?EA-18P);<ATUH?6I.F)'<C8O<VGZT
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M*G[_'_]][+\YSJ"%0S)&,'3!B69+^'6O6@G5%<OWBD%OXL;59#+"N3CH%QF
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M]QI1Q0"Z(5,N*WA$&T+"C0'P4IWGPS\6C=26PDX813DH*[((9]Q0-1X^=KO
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M/5[RC[_]R&]\X>U=<1+V<P:CV$]?-?Z,,'C) THALD+\6H_0ZG*A&X1+O=_
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M+?M7O?F)O5,V]50N2F$DWK5CNW]O8H.7$MHE]'N#\$-=K>Y17@0?R_Z;M+*
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MPN3('-'F%[<_4$^!QX@#^)FG0RCB4F>N7[R/GW3__6RUXQ(W"[IKV3D>]S,
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ME'@Q+A"ZT4_S_&\4X/(W!>C\JU+;G/X!AJ<1?ZS\CY7_"5-_ /P'P'\ _ ?
M?P#\!\!_ /P'P/]G AB=BL$788A7(*SP'7+@5P/M.]X/&R6?)+V^H06<.B2F
M@&P)VUJ2\29[_],U)SI11+OT;\ID?R)ZM6^N-<R2.!VDEX;2;';4/S 59&]_
M3\2T=_11YE PGX[NEGH^C--@[.25-SH_ONS-R)I]%WV2%YWLJ5]7UN24^%+:
M7 &M%&X43(&F[>VUE3LR #:[+V,W: 7S7^;9%'[= ;;WF2D@?UQ;*314)K_&
MB$/Q*:*B6(=V>=>[^Z;.GC879P"N$M&D56#;:)L"A6GWJ!C)#4I.SKV8*'N*
M80V%=I9'[%X=_CX$V]6%<2"_G6?JU*P/-K;XF*G;ZM/T#C)LSUH$><J? ?1_
M!/7IG?:H/2T].DH#M<ONB2+S,V$\ZE$Y-K<><YP!O/%"[5VY0*384*T8@*59
MW$&'[YC?18?74623+P8R[CR6BE2%K,X$_TH72[DS")>(B$AJ $S\(>3E08<H
M^A!&]#;81UPW)Z54"/RT#]K1 5@H7WA"67IM=GO"O@,''>82J"*GR3VTE]"[
M5F@.=+O? 9LY*1^8;33.%EXU^"%-["_YAC-:I]0#:,I;&+(S:2+%Z$BX %$[
MU2#D-C8X*7#PI'+UI<&Q 8^[\/DCYUU\#B7SN-4#$?]:7TID@]Y*<:,/.TN2
MAJG*!6Y]V$!T<C@#J$7>/=V%&<+5^EX@M.UP+!3Q5RB]RA8CYQ8\;2AV4[]Y
MPZG[\=2@U'Y+^0=/74SDZ&R;]C_^ZUW-"J_<@K34\EFOIB?+WFYN;#G:ES^<
M*;W?75;P2($/,%Q9](N#-*2OKI#0?=B^+F@"5$"#%M9[0_AB4_9C[C-'XJIC
M)!R^%YH=.8/"2Q3QO_JO#;.8_8A33&.[YMLFS?PX6Z?Z;=GE4<G70(L3W$^<
M)G.-8Q:5FS$5VT7\L_]SD8PJ/P$OE=(?.]BDE+QKLC>13:4,X#PP^1PC%B[&
M -C54=VP^GLHX&B\YC[2FMNA@VHNWX$A]9#V]<$[]!E8 W3M,A$ZIYU0QQ_7
MQO_NZY;A^8U9_>38VM/L\9;[U%1J6OFA!0!BR@ZF#UK-:[Z.(HIU,0 1^BGG
M+D(1]J!>-D:S]\/XN-F9T7TI'UAL2S,LVB4,O?PB<?7\'398QXM? VUB"M5J
M27<*DZ&3VQ(J-P[[?)^]S".?ZZQ-RC)7"!WA&+GB,(^D'A0F-])>&+&LB-IC
M#K0<TVKTUMRZ?YZ$W<6?&W5I"#K5.QNZ18.:0._ $IU/@\5$Q\Y9-=)VLN?L
MT2\$5:3'YUUKJ=T'6EPN;HMW9?1M.3X_^;\W\3RK]-:SC[ESM*0*YK@\KH:L
M>O\^(O-HJ.\]R%ELW<HFA,[E.M_J?@'4C2"@>9TM/5_A/D5:LCY]=I$KQ:<K
M6&>%6L&ZY6Y!LDFHIRA^J8NX,6Q;DR)\Y&M+7K'M?LL3QGBN32<8.0D\4O33
MS>PK70'NU759]7NR[CK7)YA^T+SKDD%@#\*3RM((5A-0DT+CUJ*.:X[=3>T;
M1X(V%9ZQ%<7K*KR1D\64A1-(JG3..#1\A?"KD330C1/8MI;JV7-^] J,TW@<
M$""T7GOV?E*WH*10__%7I_=U*P'9-R,15'X9N/$/'#%#-5%C\7,0)[3._M[4
M/7G]QJ@Q#L/C2PGA#H1AT<F&8D+UK8'KM>8;LW,?;;0T _*/Z8@;0#YB\H9!
MQ?54A#S],X2E39UZ<CS0T-2W14Y3!FJ->;K@$%@OU)N2UJ>HS\(FG#\QCB1>
MM'DD1#W]?@+!"Z*OY]F-'QE?V.#]4K9@^U:/7:H?VI,&O3#"L1;W?TX3PK^-
M<$>*+7V:Z::A=W \WI+HM'!+WM?E[NX&V0V*=V\7V*ZRK2L0:C9B=><-'.;]
M5C.91O7^"X;)+M*&\8[>&C">FS]5?%R#7*\(G;NC%*MF?-%!AD([Q4)3MX/E
M8AIMUK1)WGCW*!4#<V+?V;QKS<UUPGW2]HOAC\5= *X9"D("W2&.Q+^%-*Y,
M.YDA)+RDW KFT^E'>#_&MT-_AC'9@@O_ZJTD^K'?FX4Y6.A?H&Q4:X*3]MQP
M].)H58MY&'N5S<E"><6A3%L7\7@=1>@0IA(S>7K^9"5I'L\ XHT4?MHOLI-$
M"_PB@&-O1'(U$/L!.O0\L!>4I$Q 3DV16SYCW-9CE^>K+\+G<LESCE:F_MH2
M6DIGBG:F^]B"95*!B):<AG1]QR/=/O=1B"/WFN9?&R^G;7MA3B#Q* 8@;A!,
MPEWP2S:2<XPECK_W"PPI'U1RE3J3..IKKR,^%=/Q$N,S#!Y7;$=-0CLE!YS@
M:5(H"1/I1^XO(E/.+6>F%J,>G  63NKB'[=S_#05 =F9BOCQNV"L-ZZ!(]E]
M9-M1T,?OR+>TP9:G*2TG\?+W]_N7!DQ]6\3<INM3P\ 0B@'\,*4/)AB8%R%_
MOB&>4'3Z0V;R(T(*] FW^KQ^CL*^T*@58]FOIDA%A!'SM(/T,9B @7M5!T4+
MKK74/2M:6QC8T%(_-MCM;RX=JWPB67@?5TK,XRU=]&NH&Q0\(4Z")?L8B=-'
M/Z=SPN=MG_I45_L^=[3D[7IGRN)DF]D<?4J=<ZD8@(S<$5E BAJ= AT(-EW-
MN,30[UMVGH+?DBNO3WYU^\O:;ZF]_7&TQ/D,C@KT(JR/ 1"O^V'C_9*?#Q#Z
M8NY^14B\+B595IYU6^Q4$?(I^S0@8;N/9TEG/4N)=:_[>9L%+8L!>!9(D>.)
M*FEEY,2<[HPI>:\&#X>'EU8OR]T6QUYMO.U6/H;*@'JM@TK=2 XC70_(_G"E
MFI\W&EX&^'@?=GPU+9)M?^[^^4J?K@8U,-268R6B9[#U54B.4*G:DE0^_B[J
MX.>+R2?43V0V'O]Q]AC5?&/%6>6%D_>L!NATM*2R[TCVZ[US.\NRHZE+W*+O
M'AFSIGPXR#^A"2I3#C(#F 7BJ#<#:!1+0[JCD^RF/6</CJIN*ZL<_T74>*!O
MJMS':1^N[+\?,"!R'F2A*7^V=;S9%>(G,MC\2*Z +5-O0X+?C"U(T_!_W)#Y
MSP/!I$H=3ICYI7;,.I-F_2#!0A"=N V+AWX4CBGF=S6'#@S1P0_<):I2QIGT
MU\!A%O:FD9HE(\5D2<SO/%?)?ZWO*O@/[]$<&,#%<TL)E!X8L6_C$?G[03N8
MZ,-_VUWU7X;#!TQ=PEHQ$4;V&EMWZ',^G#3L)/K6,/ZOH/5"G]A>=9B!%M],
M0O#%W2+^UQ7H[WYX?JK81[\47$,9:A7GZ2,^5L][547EKH>=1'&62V+[:O_'
M-\NP+VM?N^V#)L2"^>2CQSE]CP:T6Q2EEF7V&P 5539OBCA_H)?<R?U,7 ]
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M)21W<N^7-AG$((:[[13\[B$_0FN U=NFC"DE*WA1MH8_XJ;2337R/!8CRS3
MU<J'* )L=<.I(!PC>J;+363!"]'M+K+G".EX9\2$?8=$N$S)E/'HRGVJ1/V7
MK??FZLD5%S(B$U@:1;A,.*"*,F]8]E0H,O2Q4,6UTWCY.:?#&]R-=1;VR\6!
M$6]U.GBC[P=\"5UL\Z>U,  _%45RH#6T"WMDRV?.JG*A/LQC >+!MUXKQ3*M
MNXKLQ<@Q)S2+2\26=U1SS UWXI+VGF3\A$R=MGP1T>3VSM1;/^/5;;G(R_*
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MF91IC$X;<!ZZ?%#W!(MTQ,B#78=JILL*"I<@_&#R-^]J+NYS#6-E&]D6KBP
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M+'?'+, $81(=.X[91]5\CNV"=*T+9-Q]VY!BANB!O\SOC9'_OC*&:T4RTS*
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M!HS]>E2^][PMI6BASSS4[>X:;=/%SJB06QB@I%?Z3"2<;^;0DPK0OG!A^C$
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M4@\I9:<*5LX&4E$C:TCV0WF?$9'*8@LV=SRX1\Z(QS\T2_%PV13EX*J*?W\
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M2& KTV>^/;X""&'*3*A\.4T9_:/+ZDLH"6TM\N<L9F9S+C.3M:K2*Q)%B*X
ML,6(-DM 'M)D&6<(ZJ6RSTQ>L"O0,"VX&TGH^^1/4<^UT66;2^HQK"O?AM?W
MA#B) !!BG!EP/O/4)!!H7EY5>B/IT-CMZG =61MCD5]'>4S8W\\'0Q.A@&Q.
MB\HHKL'I)*FG$3?NUH3B)6)?EN6=5BY[2[UYO\B^2_9,T1UY#EUEL:+H;#3B
M^J.3B? ON#+8VGFF-;" !6$[RKR7+HK -?M['QUX$L0S).]A;U%C]Z*S1LKN
MW,V(!+/)5K *Q0G=<-"0B]YOJ%D#1&0@TA8:#*438%]MMUH2ADZ\KZ,5$J-!
MS<Y*/MT<K*E$\ O(?I&G$2>QY&1 6F^V@,&J>G][3?5<^9H:F)OMX,8F?+WZ
MP(>/3+*I?T 7!/GT%;X&^TC5H/WE15=!&@!^/%'IG6+=>W+E+V/ER@^C W[)
MW@?QECZNK&Y!3A!GR?O;2^"HX52-KVW-DXKUJ9!FI2OC[8,SE>6XV#L)ZQ+U
M:FQJNG;'9/SU=NMI_MYCE/H88B)=D,NCHHNPOHI=K0\7&!<P^N4]%NTFL2 Z
M&_T84X_>+TR]P2';<+'[AF>(X.8CUTV]'LX[!^:,=VF6G*OD$Y*[X74MTP=R
MVB?VD=IK<!-\8KZQIQY2N=Z(@-[%OE3.0V@Y>E\YF_TAW;$L>4G\9_,]$W.8
M HB[/EQD=B"23JH37WP$[. C0K:F)6V5*5,(9S/Z8$6U8\MOFS[!R::P33ZS
M.?Z> I0IZCN.>('IJI#2GJA5_8!\(&&E->U8!:)0^[ZY7'OD$R_ 3![2^(A#
M@D]'9Q[W5&E-NKB\HJ0BYFYE>:@BPOF<H(U.O#6(->2%]3D)E5"ZE#N=Q;B8
M.,@[ZB$7Q:7SU_$#C\#?/W+OX/W:RI])"EBQ'YG%';0#-LT2+PQ=L,BZQ7UK
M0N>@"V2-]35"]C8I#ID(;L*%T\4 ETRM5X1 A2\//KTVE[4^GE$6S%O#><A2
MOO+9^N*_;SSY/_36B/VOO_B;VZ0D1\S6,I?E-\J2<3%=UV^40"HO-,W3-^E\
M1]7"1M:,<:7F*S?J2FI*$FF.DV7D'OI<7YG7GAJVBTFV\6_1'#G 9T-%S0'T
M@ZB>B@?,>-BCVC$BE4/=EH8@[! IQL2XI@_RS6*T57M4TAT"13SJ7=Z;4\>5
M$SI#KQZZG%>_C9V9GJULBQ-$-YQCZOM41.\95K7$(D\4DT2B?^3)5IQWQL@F
M[V:PQJ:%I=)_H!20IXJ ).)W"J&@:ZY"2+M":"_@:]3Q2[%3K" 9;YE3@; 6
M7"F$RJ^(KUP=FM7#2"W&FWQ&I,ZO%4Y<2YM$]<JZJC1_J=G#P+- 0>E$*,'P
M%=&<@(VHDT \$\'W;XG[<*LUIUM)QF<>%6!A@)1:GDT*6+' V]C72'CQN.?0
MRB,Y+9,.3S]D3WD2^M?:DJ.E\+P1#U@3UY?@HS2T 90(7Q_K;(4*H$#N3K*
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MDBDOYW+*Q>3Z.+5@&;8G2U.XNVCW.$#&I!$3@Q8HMXS2LI_[RH/+MU!*\7B
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MTRULWPH4.*X=&XMQEL"(:1YT7[M]\,CV2'NK[,^<(X-:YQO:L@*:S(ZC^J?
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M2X$3.0IZ@HE*>YH6=//_H0A!8O_&,;W_U#)_"KT_X/P!YP\X?\#Y \X?</Z
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MM9;9P-.&.PFF%K3&"P^Y;U.+UUW8E;06#*O8!5A6-& $!N@5&E\RQ5HZ7%A
MU4R_B'5_^KO!S_-I@JF3Y@-VGNCK(@NZ;5LT#EHJCAEJ&* R6 3L>M^VE^'
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M(V/PBIPX.&%]U6?&6Y@[N9S8FIAF"JT;$(V3&?!"G\(4^:]F$2'D4B"L@.H
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M<@H73;A#'/H.*8,?!YWGQZ1ZRH)5WYZ0TJXJ61>=F7_ 3V+;%<(,P[BP]YA
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M$/TP),=T7[I,^EW9Q+ZE9P5EGH<3F4"PK$"D)Y?":T5]TOJIW1 P$_J.Y8<
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MJ&ND],>PUG)WX$KKPZR'F=:<U)G=4ZP4?(C@-7X0??\GYA3=F:2F*>URP.6
M"601'ZMP9T2W8UO5ET5S^*X@/L I-JO@45(S<3B[>7R_I@_WJ/Y)4'GA(Z@D
M4+.4*(YYXRM*L'F6]9$0PG(4!^-UG:07=G_=(51(PW"IZ+?>)>7EG-N^%D9
M(L$%9 (2] K6]#]B&PP,Y3"#T4:&O%]1\-* 8_=GAEN,KC[7Z3:(9@((S=U8
M8P#]<_<P_>B (1<:H(@V70[XD9$;M3&!]&V>3N>6V-SYA._ @L=9DM%GTF?9
MATJ:8"5H!.>HOJY/E%N?Q()(#(>C6#Q%EY)+G_W'U(1!-O(!TXG<)BL^E-75
MVUL9[I$%95\L?7O.R2FNBX!3NY?_:J**4:0[,=Y^J5.\6VDE\\H[/X=JW>PN
M^% 17[FYBB!H6'/.B2Y+[_+=192)+HUZ4-:;KUG?0'5>^&DK?73G>G^69+OK
MB==BX1TC%15&RW^4MC.^,<((Y +8GDUGCR8$+]IS4DQ?S: YPC2.9Z1!^!I+
M//OF?1YDNWH,<&47FTIE--CR'U1G:VAO[^::-WTG4\9&3\0T(2@6A)%02,\!
M?8N15VOUY0_+A?>2)LT*5U7=;.MN!FZ[W]85U OL"IUAR4T6VPRW_X,M3P_S
MMP/AXL74.Q'B+[BOWKZB?W#M0D>'UGWX,9F7^/&+Q]C!:-!O5Q3;X%(+_^B)
MX"%3DV-D*0//[FH\B553$X07[VL%KH2=-)MZ._EMBN;YES2%^NH$&'GZ*M2^
M2</B@$<OM&CI)"9P-\-<K,SW2]+!]:RVB"0K Q1$H+#) ]RMEOLL==TVM9<S
M'('P ;D#!66*7ZS/"^RT27QB&%O]_WJSF3%P9_%,<NB'/X$V5(71R-$2&"TW
MW(RT>0M!+%BE"[%/9C*!LFJZ@U,NU"Z1]^UX[91'EMN./SSI]!CA7<<Q]B;H
M&/T@!=]*B+!'<-)#[]_?4+EB7-J'SP:$9AV'0]_ ./PJ_=P"YM8A2XP2"]8*
M<!_$4.>D)9X)\-Z:?.-Z ?3(<^E2'W)PN6'*+U@L-QVSO-K&7J?-8FUQ *2+
MX<$VR,-9=#P9RZ]AX$3[197)Q8,6IK5)D]TDZ^HL_ZM)SN1[+Y\E?8/O]#-N
MTV7!RQ.(")E]/?0#$WK'"C1&)5IYS)KO?B)\3SBL;3,.2]+SQ]NPZA.(@/9S
M4@3[IL;K0X,N?*UPRLYV'/M3W&QMQDJ%]X4CB)V_, %;QE<)I1$V)35%7XT4
MOBV7#93* >>-];TEP_DX9US/PCIA= $MVM-O/DDN^HS,33&%/N5:V-%\;Z]*
M\3C%,U%7SSZFX7]8LST>+\!>K8\"/G'(&''PF^;)12#2QOYZ3Z8WRG4"WW;
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M":D$T ).+L:M+Q9BQ]690"+L7V[]BW7+GBTY5JD@6*UL0\X;AB6$N7X7G'O
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M" JK?&X?9BD%T@_"CB1IJ<"?"J<GEZKM<F%W+AE;@-:L-8:G_W?;8M$;.IF
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MDN&R,&,*JMYLWCS1SF5<EZL275L[G$TXX1%9D"+M"'EYK'_:A_'CLO<A3P'
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M-C2_JD< 0(/B_Q6I @] -%MT@\J"$\]?HRPX@*>]*(*H?@3QG!$Y.S@1O%8
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M+QNKOM8TC30ZFCI5=)VJ0N69O.)#)YT%/KKE:IP4,6TW2T\=N=ORI!.VQ,]
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MK"+[/6E>*@JA-IQA/* 'ZLAN> ^:49<1RMA:A>2NEW,O<$!XV;URC9S1>%7
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M@BJ^9YT'EXN*F15Z=*+%%!_2R%:]O+DV^9.=Q6C(?)G>;TVPQR$[,+^/AD4
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M%:VRA<E5-*R??I+!D_^F> *Y?8W81PHF.U'.D)U:9(G6'5^\]@QN7)/)<%&
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M];3]NIH4BCR8L#P%W^/VA.Z2SM%^O&QSH=W_S #]4*;-H!;(>[/PV]:_;+'
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M,%Z3/;9D,PIS::G*MU15.Q1Q"<L6P6=T2-7AOZ:WT=]5GR/FQ6?64V!(&.\
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MS]S W*-;0KT4$[3=NM# "0WJJ>0#0]YNEB0Q$VGEM*%4A67QR)\NWE2OW:^
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M+@!CDO\K)</_;U)4^OL(\Y<T3F#]9T0Z^_RO-G)^V_IMBVD+\[A%ASZ* C-
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M*#!D/X2/+HX<@DPMO_$\/9;F<5+ST6/!; .1MB6>-32]$;3+ -&YM8.>D.'
M8(#H1PU)5;,C-P?3BQND-O5*2#TV=>]:&*#H&/6'\2J$[DS$!GV-*?@.[J.?
MWKD7_ EEBB7"A5=$24_(/+1\JC<.FI3]LZW4Z]#7X&RL^]GR0>,-\0VPVS8#
M!(E%X4K11+/U2<EU<@2D1G$EVME_EF_QB]WE7"^1@;P;1:'^Y_?3L1'/>+]O
MD[\09UY@Z-VS0ILE,LZO#(D+:^[WI>MRB>-[72P:9C@;NGG817_ VI@.S3=+
MYQ@67I5B]B &)A2RQ@"U-G9J+[RZ4W9EP4M+@0$:-CURQ)C__(T;;U^]K#.
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M@"4? [7\:Y#^*D#%=EJW5]N#"?B?-F "HS=VWH/\J18OL!O\E_[S!KCJW]T
MQZ[0Q3)IAXB5KUMMG*K8&(-6G9#\?'+*_Z5[X&)WV;5,%;8XKX$[/XZ8<I^_
MO[N";Q )A!CL(H'[;@.8#U9GF\)X_V-Z7E_BFN45GUSM9PJ.%[2%3N!BW_N/
M5CP&#4(GF\A@TO#*""F^+W)S.E4O+DQ:4^BA1^VW0]G7,_LE%.Z\X#B$"P/G
M+5\6LV/W\-&7[C^6$;Q4]*KL/Y[I'-9]$1X@4Y,^*3WP-'*>I?Z447(S!4P
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M/&(/:V+*3&!M#$JP_.MIU@Q"?^WF=4*)PV]VJ[S\N\L'3\NJ,H&3.W,AZTQ
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M :]^(+_&/OE[H-=B?1B>_P?*!M7\*Q98W?2;K/YF_[\!_0WH;T!_ _H;T-^
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M[OSZW]?W'V#Z,11%)"US$+G\#4H77"8[M,#0#,NI//I="/W@@3+:(60">*@
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MG &!Q7-G8$.(<;/Z"S6/?AR"S(2B(_<?[$,9[%YDN4#</ZQ<0D19[E*=@I?
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M.T?O,=W:7L#>*)Q90F\_:N$+=FLGT^)B(Y<0/)X-_E2I?.=[0_J"*5>_8J9
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MYG4OK UJ%2"? +EVAKJPP5#S@G5!U6=ZD\?ZC]4XOKR0+)+9O)2:/QD%GU_
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M3SLXAF2>8E)*<+3KO[GEX"."B1]2I=E!$47H"=K! 1:XV+S@[.&\!#7-\ZE
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M"RF*+$X>AW('HJ;-%V')/D1#="&GXQQLVM;1T52MVD@N%??J=<U)AI7+P$\
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MUD_>F91LH9.BQW.\<QQ^/A %]\3_)W8A6YV"M.;_>&W@:FZK!)L[0\#A<B0
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MV?W9+!O(X4:J4D0\K/SM=-/PB1!']L_XDWZ?7L_YI#^\QDO&C#SC &\Z[W*
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MET41,P!OL+K>ZE=9H3D#_P=02P,$%     @ ^85:6JYN;SFD) , %=@# !(
M  !I;6<Q,C@W-C<V-%\Q,RYJ<&?LO'=4DUWT[QE$1'H7I*KT+BA5)*_R A($
MI'<B(%U F@2-B2*]*E*DBY30D5Y>)$ H2N]5)0D"2I$$)3Z:=O/.S+HS=^9W
MU[IS[_WCSAJSUO[K.<]9YW/./GM_]WK."7V%C@7Q0DS,3$!,)YB8SC&= X'H
MZR C$-/_X._?3OY'^V"B]X/X3I]881UC9KH .L''Q,S'1!\"28% 3"S_>P/0
M__%C.L%\DN44ZVDV=@Y&@W9>T DF9N83)YE96$Z>9#Q]Q'@..LG'PG]>X]HI
M 6M/U@MA@II/GI>=EK[>/"!D,TN0N>05'LO&?D98Y*RHK)R\@J+292UM'5T]
M?:._C4U,;YA!;.WL'1R=G%V\[_CX^OD'!$9$1MV/AL4\>!H7GY"8E)R2]2([
M)S?O97[!Z_**RBI4=4UM2VM;>T=G5W?/(&9H>&3TW?NQN?F%Q:7EE=4U''[S
M\];VSI>ON\2C[S^.23^!7[__Y6(",?]G]/^0BX_!=>+D2>:3K/]R,9V(_K<!
MWTF6\QJG^*]9LWJ&"5S0?'):\/KSLN8!-NE+-@0AK_!9]C,REW&RQ'_1_C>R
M_S:PV/\NLO\,]G]RK8$XF9D8B\?,!P*#@#W::5DZZ"0_-9L.PK:B6TI'T&L_
M26^!5;+K&L6KE=J .$_11"\8BL*- 3\_;[PK!T\"^!1"V@P/%; @2F.7AP[Y
M=DLN+E",B)>&I-9Z:HB"VGD.]P)2>NXZWOOD 45@D4-"8(*Y^F_UTDXZB"8!
M7EVF@\H<,@%-%,W:A_B=-DT'X4MIK4W[==#E Q#R')3(8D7A'Z>E[AS00710
MHA4IB@[Z8E]..U=#!\4Z(V?A5#0=1/A*FT)3V=NIB-F_I-X)4Z[9,BA:Z*#7
MO\A(.@@W3RU&_A;RIX.2E)#87.@/*#B4#J+H(UN;Z*#K#4AHVRW6(Q8ZB->.
M#AI007_I0VS004 D'>0'I<6[@/'LI8!L'E5X>OW?$7"7[N_103/_#D^0B?+D
MO\83BZ*Q^=!!QM])_[Z$09'UZ: ?2LO'9.,_4'^@_D#]@?H#]0?J#]0?J#]0
M?Z#^0/V!^@/U!^H/U!^H/U!_H/Y _8'Z _4'Z@_4'ZC_!:$T:.MH@C^*(A!*
M"J*FTD%!Z+5+_6@Q9##5=60#A/3ER42+4B0J@5:\57_0(?NNAQ+@2$ -E^@3
M2*7X( DI4N!,U,-IGD^!OX6*^UJ#*O<*M,O#4&817!EU*+=>QV=T$*N^Z4$I
M&0H@S>9^2+"2JJBO+[OS_#U?WY8N9CK7=XGR]YOYR\7*%ATIXY;SD>L<4#[C
M(!]/3S].[8[[N;.F+.V]UAC. %&E3)(W8[Z:D6,J:&QE*>FV5(<IK;5I*)!!
M'<B@LD+_Q]^=& M \+&BO![?W*&6TD'#8*H?=-4!W;0&4GB=\C_!^D2I;]!W
MIL5HBQRX259C@$J4PH8F1 +;P8$_<1E5OQV3VMF<5U\[?3-24GK2[M3\Y=)3
MI\5B)WU(NM3=7?M;A5'2D,LU1V.V=7IF5ZJ/*LH$M_0@BFI5"YZ0\-*.AOWS
MHO9RE?M;#K9%%SXHFO"V;M<I7X-87DS_5;%@:[CU&IVKGOK [X")X2S/J=5@
M7S'D:<0<'70&'< 33P>UR6?>-90$2@?0(E%+1+FW%5H?DIIJ LRE7GX5X0]Q
M3O.O-9F#R;U=I[%?PR%3-J3HH%#U57/2(\+A@3#Q(=840P>)?^W\V2>?B?-H
M6S.I@1.=&H8TS,_=/B41VWIQ<%/W')-[I,*T>%?,5NYP/5D++U[XLW0_DRD3
M!V^2*-PF#"GU?EHJN@@3-M!RNU(C;MY@9OK\N^S[Y ;./N?7$Z6+WGD^9WVC
M31A^NN:=V;_]JU%,;J#'H*@QQR^S24FKQL$Z\E%VQ8=RA=;?\J_12F _'D#V
MQT;K]+ $&.^-6(6V0X>-WW0^C,#20<F2NJ*C\=\ZL^#KJ:JO>E,I\@:W'7?C
M?CHLU4INXSGN>+>[Q'C'FS\X]3Q;8)\[8$JP'!*'<UVSJSG;L_"VJ'Q?IM)_
MM)C<'K-YZ''&&O H3ZO5;[_]]6@NMNJK_4XJJ1%B^9H4] FUOY;26[BSW7O_
MS@^':-+("SKHFL45.H@Y& T<6+$<YXP+=O2V=]W6=.!(\KE]]4;ZRA/ 02Z^
M5N'U8_;_PIK>-0$JX(-$(@_)$F#!=2'.7.TKW Q-_:3TM%_4,47=/C[OW^63
M:8]UMW&.S8Z]L=GCS9EAIURM)Q%4R.=AY\&?HV0SY-7*B5$;>R,"&[L(2\-H
MC5CWWZ[N>1$H6&XKD%15:U^X56E5$+*K_4C7[=+00FWQC=GRA('-5D[WF!J(
M+IS;.;;II7==US6]A<A[+P,7I2W9IBI>UPQ$F$DUMCGB0ONM %F_H6 1N"XP
M6XO80+8=IL*]8P+*@$Y7 B.0I<4?8AI,-FUCUVUZYQO:@*U0($^^8&:]I579
MA'6,:1+1@CK@(M@LX]OS^MEHLL!=BD^>L?Z0!]/#&B3N?->\ZHN[OU,&/O\R
MX;5.U2DN#3P.Q-DK8C@.RATU22N[]F\$/?5?Q-T3W+1I?Z#%;RY@<M$>I3<?
M2[K\Q;+!7D3WW?< +WM_<V&( &WB=Z.8D)648VYVC(;M9Y2X\9D/;UI"(@4?
MU1_H+:<K=-JHR7?,>BCCD6MBV,XXFO27TE,4(Z(4I@ \#!9RO?Q)C&#_<:*F
M,?#=K+!IZQ-/_P^\]@D^'J_1)1NKG9N'HPT1I')&V'D+BW #FO!4J[\!/^Q5
MCT/<5'KT X_Y 9WF $=-4\.D_.'>F@MU=9R>"4%CL/CW^8MILOIZH>QA/$)D
M6-M7K^I[VV#E\>8N\:O&L'&AX[2IBR'?BL_B]FSK-VUFK][P%"\S&ZM07*PI
M(4R9$+[W-$#<K!T:#+@U*PP5<.7L'FL''NV*(W8QN:@?OXR1VD@"! PHH@<R
MF6BCO[G+R+Z(19='Z,QV*Z&],V]VP;QJ4<H-$->P&O>!8+Z2L9%C&ZU?TB>\
M16ZJRTB"D7A@DM"QB>NA>'001YY&$&;;!NJ;TH*_I:WIS;,G"GLYS5:LML7:
M#<F<'?@+UN2J.5#?8[^E8BP*W-0<5 )^6U$S<NXZL"=H>>XZYGW[NH1BWQ6(
MVSJK(RS3[>)7:E)1NYPK-%=C+G3\89K5B$NW/6G85&6"Z'R'J/M 52G'W[$N
M/DH1HH$XN&%B5?#EQYHR+C0!2K"56C':E,]X!?@1EDDO@6A\IH2[A6I[9Z)J
MB):YZWHR+D+\^5]K&?E^H<IUL5UF4U8?)Q^I$R,V_0:;'M-X_R$>#A^*^Y><
M)*0G34ZU-U@HK:/._I+N2,%ONW%;Y7!@O77?30OYOOFAZ%6']DQH:N T#OTX
M4]^]H YI^Q6P\'-+Y&$6@FS]L2+44K,NN>9IY5F[X;D ^\'YU)(+A8$VD,@+
MQ4[:Y7+9KQO+Y4GN;R$I%!0P0 >QW*-FM$VO+N.M1J2>EK;Q,(*ER*ZD\$P[
M1_IIU;YNV?1/G2?O!M<W2C.<_0Z;RM,@\=L/EW/^S<](;!/X-#@8G2#)-F=X
M'FY).%5,MH E!(=;&.&0B<'M_K*)EF]Z8?O?;@>HI.<[!U^';#4^[^37#BM8
M9TULR*PIF,/8%M7=^1$^8:*4FI;CDAWAY"ODOS!HVUHB)ZBPM5BW66FABU.P
M'URJ7S2PT-,=TL7=ZS+P<<;LKGSP\(R-=WH/N1RTE?UE6NBXQMV4AT5IMHQM
M(<!*@+U-J-:VR/' 1XB0.01E>-B^&"%O5).B#:23S2F&A-+T5]VN>C\D+(Z?
MAW&-7[06;'7]>FG-9#WI[,/'FJ9:/QP9\L$?&HM@ KQY1D)%X!#"R%-""Y[C
M2K5!Q,,')D]E^UZ-Y88W+%B_NS\U59O_US7=VQ7BGFPF56=$5LRL6&P:] 6)
M88%. <OUFZ)VGNX>V;6+V>6BD0M%.W+97NO-X7&;R4Z*UZU'="&O!R&J7F[G
MZ[>KM0[<+A2$9\67/W*YFI4"A#HR-FL.;? !3PKE"C8=RO"F,&]\Z!EJ$BS"
MLN#0>J0^2LBAY<QR,DHK28<I&U48(67]C] ,!<)X[3%B!,W:ZU,&!P,YY.LP
MYD$/5:+"XR\/+,L>QIQ?8)FQ9<V)]O.)\.KSCUS?_H#Z=';8S5O10#_-1SYU
M:'$ )V@;*I1:7GE734*Y9Z7 "M*F^-T>1<(GTT&E:TTDN$K8XC&-FQW>*-*#
M_G[(H:70M5Q<8V:FI5U@B'E=_;6@I+0A@.32\2(FM#J@(+U-)U=GJ45E:=FA
M\W2+D8&FHA+Q75I]O?[3/<>>J$J%,?YLWR+94YNZ[W7'-%,#(6:KP\-5!?<#
MJO(ULOU$IOC3<+HUUZT#K;/OO$@KEXU2>']YWJ*J(.@OAEH!_F&X[AEJ2A\_
MK(>,,\T$^V\P 5"\7>[RO6NX?+^%D';=;T/\=],+Q@:WYQ1S$JY/1DB>_I6T
M!\V!$DRDUD:'2N0)H0=((GCS<(1J/H3F[I4B!@UAC(G0-"TVV;DV'JZJ*L2H
M1&O\<USK#:&XVXKG[8BV3W(,(EOU3!KTG50ZS^<^,AB)R%P(LDD(B!_;2D E
M6:TJS=:DI#LJ6ER[SI_^JTU? _:@ZZ:V:#U.SZLYYIOK\[GQ;)GFN9I\;*M*
ML/A-_\LH?26]NU^U3G>/1=6$5S4B3>T<L[] Q1'\0"'N(25@!A[S:K>4?7->
M72N/^+;^R#"AQSVVU<,C?\)<_D5(]8C1UAT0K-'/A%H#]FOBA5]*W%3+) 8-
M"M-!'(UR03!XJ-"/I]>S?)X-S:;FGS?AE&'A]F:^-Q*X>STRT$O1/J[&?F J
MWL!=Z?F]FO@2N;JRA(0+_! [^:3&8E&^VM>[BY;%6HIU(K:![09772SL*U-S
M;G@&S@=&$B^5&^.5C7AT/VE5FG,7/WA>]1EGK-\"87OW<TSYR)O&SD2^#3=8
M0/M(K9T:Q0J/4%7[E "C@=P'1Y/8C]>=H]+YYV^-KVY4#@Z]N3 MZ:Q]<S*S
M]W4/0^;+F8ZHFM]B./ #RGF@@8C&G^R)_S*CQ7$H &P,=_9;*+E^O,'YLU,S
M?/]YXZ(]YT$G>P71G#,'KL/KM:L57X8YPFT$V?(N*.)KPH14OC6P_U"Z8FS#
MB&9>#NG.D]632U5?WQ]-3?.72#8:7]>(VO-KG5:<JS2+L,=,RU8^7\H.G'<L
MJDQ#E>!V$M($0@2WM+O]+-#S*<JX#49DMT&N>&]*92)Q3G!M:D6?% PUZAMQ
MMT^BK="^XY\LG%-9BEX[E^;<E.F'TTQJKO*5"$]&@/0&^TLEE[(@ WE6+FP,
ME@I1KA'V^DNDB1W5?>".N4/$)*/(</_G.EGK#J<!X)T9QG[I>5'4ZR*W9LJ5
MI]5OXR5E)M_\<A"6<OTP,/=[2-EJ+[Q.V:1*,J\YL*(&8J&GEEQ@4E@L?G0O
M,.I()4]K*DQ$]R,^T%1YP&&D5R5 >4J(J%&N%!F#?[U]/'L%:;3@.$P'G49C
M7Y4V-XT@Q5"#R(2--ODG<%?BA:6E2V$XUZ!4<K!S@6[_L]J-E;7U"7).RQLW
MB/D=M?VTXXTVUH,:LBIM7-/)B/P7W)> PIQM_ZO!D[LW2CYWRPGG+#V_K^ZD
MJ#MPN[S OLC?E,>FOMPR]Q)UK,&DS$JD2:8ROJA!=->MI;5B!^&XFC]C.P1I
M4++;T0=@BO@WA-1BN%*8#=(9);ACFJ,5;:-A_BBSNKI) ) @F\*YJ)5P93J(
MK;._*1EQ%LC#A9U//@[E_C"N8GU#OV+FHU%P%!L=U/CFW,\F2> M(R1P4E/[
MF&';\[BF8?0:3S^-@SB\WSP0C/MXW<(&3]S.NW)!%170F4OL/A?;<K/RQOG'
MYQ8=TMX *;";?_L8"3E7FG(YZSNE- Q;*$7ZEML$#T("3-2(@>8F+VNT/-+O
M&I^JNX49"1]RK%B$V$E;6@K)NE2$LD,$+"]%A&UE!3H$E.^O*?]:H[8CL5V,
M"A7M=[A62@H!H%CU)#J(JQT:1[NR=(X.BA_ !T/&'7*_#Y9(Y'E+0-[W30IT
MKPSAO&4D1]%[QHD'>^3S@5!6+X#J1UP>^ X_5^ <C"=.:=G-591P_IJM-2SJ
M3)O%?N,(-!47&%8*6O-1UK>\V/\(*95G7VRF8,65-$Z<&Z\\K@;_?.#4>]-'
MO*_242@]SNW+=YG)()L:4PE3]7O91-TT;M:+F%JSA?@'NK^%FB][FEA;V _9
M8F:*[QJSP^?+S 8K_R[3DMY;4_Z\\5BJTVH_DVRS&_U;O9\GXQ,;D%\?D'+X
MJ/*+H_ LM/_YSL-"=\C(B*/=P =O1V96+;\1: <=M%],($.)H?%P'^)\_QI/
M,IRCJJ,)_Y'[B/1E]X%< 8HK.CJ(JZ(E!O+@UW43.L@WY3WN@W22Y=.ZQ!*U
M@OJW+VKBJO"U7J]08SN)55M"-FVAEMQF$+,V/ZN?G^97:#]7EE )=?M4.L@G
MJ7ZN\CI*]9>R?;!29&7 9/NX<,1N@?)G]40ZJ'-T/XIHU5\B!^03Z"#2$P)K
M,D4 ^V6B3VYI7[WQ^>5(4/&RMJ/#_=_)6/Z3VEFBNX8@Q$IIJ_R!Q9D&]7TJ
M\<6@E  =],;OX2,O*1ZWCX_JK JT[T1UM:/;6[N9G)W...6?,CQV*7>P5[:V
MJ]7O@E]5\;B0%5<,$7$AVI0E-YSLKO'<,['.49JW1MFHZII5)>5 [J%$YXJD
M(;!\;)F#30K*P$=GW$#%=RVM^>*+K9R3'YW>BML:YKQ.4=8<3%%X=>*/_7<9
MSV,PMAYZE*H.*/I17[(>/*>#ZO>(HN@A4?3Z#HV=$0T56AC))A>Y^ABQ*O5[
M"LU71[E6S4PUI(.P8Z6_C/-&I\E@.B@%R7C4TH"$ME.>( =RP(P.,TM)2#I(
MD XZ+D;ZN-#0_J#7*0K_P]8D#ZSBT"F2JD $GHL#>YC11@<E2H+[.OQ_@(4#
M'T#V[C^P'S Y$1"Y[2@0[X4*F9][Z]7'16VF@T(..$B7_R'4 :78G1'UY!YP
M<L,WB29# 1AD;SC/Y2;AW;OG&RZN.6LM\6-97V)8KV:>N;([7RZN+=<.X1VQ
M2S@C4.G2*%E>=V5,$.>15F:3O?-NX0Y*C*+SL_XWP7I(?ZI1-%O9;G"N+C5;
MR;;2A3U#DCO*3U\KN\SA8FSXO; 7 0^;0]Y1.(E23PVOT :1':$#TVF,C'D5
M 5[;,"$>I@8;2!#(^.$X\ I"!(AN_&AVMHVAW>*\[&^4=7<Z7X!>&6?]O"DM
M]#N1'( <,$3[H]>,-G<&F]9:22[4FDCH$YH2P3()=3W3C9!(D=7W.6XL]RIS
M+SO:,LZ N;.)W5B[=^WL] "T36I(/84.(C@CDS>8#87A*@ K\0K.L3\S?H,O
M<EH2((]LB!AH1..X? E.!K+U/^J4$\XU7CA__](9U>\"SUAW>0ZX&-E#B@#>
M-\.G*V,WDA%,M%DIWKMM5IQ?EGZ#DQ%G*."W1$1.A$1#VD79MQ,$?95+2B-E
MA1'!=V,KBC*O@WO>P\)CTE YV[_\>,,$80XBIL><QG=?".29<]D*IS!TM8(I
M7QJ,LL/!YE NFM_A498T--A@?U9\\6N]97"^D7K*Q!O8E,@X>&F1(;6#R^(F
M"-T+@;?OP0Q,U$L0@QFB"=9I#48\#I$M'R*WV T'-6L$MC)7$TE;U$9#%MIR
MC_R^!OE1,?.(I!SQ4PZR@:(#S.**]3>,YN"FH5YSJ&>1[_AETBO]B0GN_26O
MGD)KD.T;^WZ$3-(2P20>RY,FFCET5<>(0.HMN? F#S>:WL[#'-B$>%[OJ78L
MH:_GT]VV]KC0EXGCSLX+:#KX!$T*[L_8.YF(#2@/.@0L05$EL@Z@'S,F$'ZU
MUA_)8W!UT_5L&U)TKS.ZQ>*RSH/<? WG\VM'RKHC@@(K7NB*E(,:T8V5;I:;
M8^DJADB;!&\JRB1'WT[FS9M)#;LCR,H'+8Y;&%^GM,;+@?@OLVGGWQ&.?4XO
MUMEM%6+J][10N4LU4$64N5)DK664LC6J<&'@^TZ7&YK/>:Q16@WC]3;;WRX;
M)>(EFXJ9*ZJQCD<+@G&#X&8>*A>X78HF(Y^"_'6FSQ*P(,L!/"1Q!L<<8@K*
M9<@&V]M4W7A"DT6,HX5ZC?&''!0C(+,.6(9T+T46-EAN6/9UI-Y:>3[)J6&:
MP*>LS!S[H/1K+)J'IH4<@R&]2\F7P6D;OZ%URR51-3J1Z_=3*5F4Y^0GQH*W
MKGW?.% G2F]*#6XDJN)#G]!!I]0,K\!F I>T@["I[N'KF*..TGM3:L=2G1^5
MC5/_$GS9W/WSMF,_F+#&V$@\OTUR&;L\T=R8#MJ,(K,8/Y)S+-YZR:F^2(0K
MO_ 3>E2Q<SR!D+Y2"<UUZVWK#J<LLR9^3E3>0HP6=QL&O'=6+YDXNCLND4P"
M/.0GCPH\IB[^;F3E>6%7/BGV":4-5AYQW"FF;AW$7'9K=MD@_J2)F=/8K]%!
M-^:6P(2O_FA*2"80S BBK%1I<R<Z"%/YF@XB]E!C7[^5.BZ_0 >]9DY $EI3
MX.C=5T>41Z$[=%"=\P95V,V4L<?AE^B@*8'_%WUF_@==AB#_[QUNE:Y"\1NC
MTZDE9XF2=<2?I$<]U%*MR4O.*>/&,XV]9@%XD^7+R_&?7]BZIOYMW.FTQ2:<
MO1FF^KP?15M&MU@--JV#L<M)AEQPI_G/77-:3@46.K9M2'F;F6,[IH8H98YX
M,7P!F[W49R4GA9TG4.OE473[MV:RC[_AV9DH\,K& )H;'HW_HG6&]H'P<Z@8
M!D.:]LQ#&D]&]T5RM^1^8$K'--TR%2*>/;[)[>U049F#88L;]KI'FV;)JP\.
M=!+-WK*,5)ZM<^B3E["X-623<-[+/6:AS&'16W>$(V__2-_I WO9:=^(IC2,
M39-\YN@X6V)-LEN..R3*7DD7+E[LHIDK<<O.T[+7I5+W_4*>#NYJXI#4NBWM
M="N1 ]<9:Z@%D&FBZB198E-2VR$++&CHYRTM=!)-=+QZ6B(A$[7A81G[$"U[
MT_IH6%Q!6KK@BT^>Q1(8BT."@)0QW:U4!VI14[NR>:E*3-42;;5Q\U?S,X/N
M/(/-7\NUL%$2(SG&9C!*F^OP*,+/F]3>7BU"(A8UH)YH>&$>[F*@2,@;Q@Q'
M "CGN4;^;_,'!ZH'"[.U%J*/S4ZSOMK[1@=UF.Y+$)=&21F -SF0-OP&9NH(
MS!+V!MX3:*$@X-#.76!PC0Y*F#L/TM%_DBNE9GU*>E#7\XW0J,MQ^/Z@$R>4
M<T?OQT[ZQ+VN;_ICN]X74W0G'N FR'%?MYRYU?6==,?W1,:<)^\.ZM;67AH=
M584]6%FT"7J).1M?ECH8IF;UPC;A1((/YNSEG<1&6DV.51)!W,ST4E/"V-NW
MY?'ECO*#L_9>19J'!Z=J<#%BM9E9=-#=.E=?!O,FXEVT>JC8S1[Q"WIIMWOP
M(^H]P+N!O>D?30+4ERM-!PR=R=+NN8B0VJMX9/+B?M /,5(@-149N,%(2>V#
MB'5HY_U4 GG 4)^ 2CQ/.,0P:DHN+2+>BNMK^#71H:CD*+FNKNP/8S7=.1^*
M.D#](CLT%L8LZZ/]2YEH,QN,&)!LJ%@X,#K(Z,TJ_K -FE#JM>B=^UOQV[YO
MQ\>&P987OF45K&J\MZ5&AROCZF)Q/;]4S6QJTNB@)!_\ML1#]H4]ST\^(^(1
M63LQ)M;B?\M\-9<R.!EHUV#)?0NE;X_=_GBV=:XFJ1RJ.[P=N26;"+? UDL?
M*"Y4ND3JFH,(J]O:EVM-M"1Y6-TA[.T-#@7I+@&#88;AC(FY0'N';ET>S@3D
MIY-E@$P">O#3I5[B_6;\/T%4TV$7K8RF"-\L]]V;+0$Z.F_,Y4IN/Y.ID6T=
MV7V'UIZ[A@5C<Z%G$<)P:6H^.!@*0LPASN5NDJ* 2\3"81??/,.Z,+E7J:\Q
M-2('<#T?-MG*Y/LJUFOR8]<XCF*#%A',M&$DP1ZZ$DJ*3B4]I!9OX.2']J0D
M+>K=@;HAFC;1[L'50XQ8NM<N=JQ$,#D$[VZCJQHB-L[/)CP!2KMX\H%Z!A*;
M^KN;07$?:"5%$!Q3<:6;>6EPNU+!7E/\5<AGHZJ@/KV"8ZTKD]I'7][Q_>CH
M/B5QI&%RL\2$C=0*OR/I.1Q3<L:<K'SQO:Y.@G=\AMB>/2JCW_>7*:DJ(G$L
MIJ;WIFZ$.F9;M^B,G-KE[P]R<(S\72%S,!E7;E+1LO^/^#;17O=[$JPJUX=]
M-_NB\]4'1<8V":*-7HO&"75#_*-;3I"N 'E']<J$7'D^$PT4=^C[0T Q<P2:
M2-,AH/<7-YM6]TA&S8 $+A&8QSK!U8D;?\U</F3;7<M(CZ[MKV-Y-[]_]]NW
M<POG%*6O?L[C'^_-S6]-H9Y/'/DIU<Y#$5K&[?27IES3VHC?X*&#_!ZJ\V4R
M!X4U+,7CI?A4<WH3;?OFON4<A X\7UTQ%SMEPW32M[N)H>RL,@%%Z &*;  W
M &R)V]/8C0$+4ZQ:$TYL@VF%HDWDZD-5P8B],AVS+I^ A+^[(N=EHCI,+PYO
M_2W>L3 N^EN=Q! XL1&T^6@/14"8[(F8>O S(1*Y+H!+?-*V<0K6BG&I*N?*
MBS4(1JUBQ/G7/NUZP/UM[B1'MVJ0=P(,GL!$ <X:SP \SE$L#ZN[GJH167&0
M[Y4KD-*ESIQ[[R<_ALO2H/>71W#>8MU+[)NV@.7Q0,<RCRH)+S\;4SDEI[1Q
M[J^S\09R >G8&ULY)5TW955&E?$?U((RWDL:5E2J^[WT<4I9@:,UZEPBPU2]
M%.::1"]_<%Q%=HSNX\A7 5/2-8 .DD\T/ U7F7T*8W8N?#]O(%060/IJX) 5
MX\@WX.-WTMKJK&S<\]?-WMVIO*>!>=II=4(Y]F,>18",VQB*H8G!6"V(46]_
MIF^^)7Y G)T[3]1<,:ZQO!-@\-<2RCI#X;:-H.K82-+3K5VKQ5(N^%4R'#'+
MB"\T38HZM<-0A'(.,-=)H8@]*@-<]G!^J1O#'%'5']=ZY=S_?A\=KNH5X'SG
MROTX]NM-@< RC6V=K(8<,$/ZJ2>ZH/<#B*']:!8<M5!R?K3G?AXQ&F-X20?*
MFS4]=!C98?Q#H<GYY"S&T,4D[KT8KU#"XFCQ4Z>B$YL459W$NLPIW>BGQ/R3
M6TFQ_0ZYYE:IN[YG?>X&9B4(""O%Y+I>=Q+-0CGT%)2)C$7:22\GU22.^'S0
M7&N )%@/QQR2AM6]EC0\(U30*F7F8@F#:*14HE.:]@7+=A8;]@![M*J5/\6<
MU$U]C?;>8#@'0XD'3)^F38%;U.+)1D%]HO/MDY?PPD-[I>Q?8_<POPD\/720
M)5%UNU3KQR3J7:9*J/>C$UE/'[1DH7#%0<Y+\""&POH,O)8ZX^;A$0/E;8C4
M#3[<?IB:KF/N'OY)<-X[U^V9JO25"P.#O*='A7ZB^ZU66&GLQ@1Y#%B,#KKC
M+G #N*2^OTZ,=EWZ)@U\@1O=-50.</%M"Q&UEGNFQOS)LL2KPG=+)NN<TY!C
MA*\($LM(%.V?4NF@D\, BLSC"LL<0,@1+<N(HE)\,#'HPK%_\$%3)*P]OC>F
M/0".[5@.[R\KN#">>$O#+9NP MMR'C[=C5?8$0D]'98MJ20YTM;L+"R((\(M
MXG*=641\VEK&=+OG,2I_GU'FR\/)*RPU)5:>->QTL)DZ8I_+$3<(MU3:S+&W
MJ=X;=+8,?;8X^+G[Q<3:]LC"1.!M3U<)2*:L./<E89,<R,7:7T52;8G[C\AZ
M0"CM=*E/W5<T]V43HF4F 84ID9TSB(I&K;K!=BR61C+RV*)]\":I9),/QC*!
MTAEZ0X&]^Q_"=5>0ODU/10\IO 844Z+Z4T:)*D0QR\-6]*FEXN63&QK:D:(K
M>S.!<KHA;8>\'TV620$GKM>(WYNH%3Y4W S=DQH-717 _QP" W*IB+$2R1>8
M<GPSX%T.W+RZ=63\"AFT&@#U+BJ<PR&F=\3+#P>N%2US>9/YX2&=C(AAC-IW
MEBD1H8/BY]"L581KSZ,8)7A<$#G$_*L:(TM^UWZ4-^Z9K[.I=[:Q1*ZH#M=[
MNX3=8U[@)3&3=3.<;>9^7?(@[GRIE43*V):8[F"Z3^XTGTVF_*%T7,3VO?AN
MV%4,E]0ISTQ(6GCW#B_^-%ZH/*X\)<%(R.J215^@5KEXI+U^+R'+*7ZL29D2
M1&9'#GC003ZEJX>DZP /X2?I"1$]) \\0<'D+5SSYFE20/GP1:UGG<DJHZ2.
MP@ # 5WC\P./QF#G'&? _&AL)YJAZ-/[!.'N\PAV& HO=#B4?@77E'*,Y#:N
M@6L0/9+]\Y9ZW <Z2BR,;K6EK/%Q#LM<*1)7[&]JH8.PI>"6J@:R >W]!GL?
M+\6'L/PD"BH% YN8<_D>C5K,M3\,D+5+0^S2_.5C%H1N5[Q;$9%0WBT5APL"
MH9M-+$#G@ Z-ES#96(JG@[AW/XDOR+7.7'ZIQC_MT)H[Y9MQH\%Z<=9'+>XB
M1N'<9T=3L:8#3D=!I2C/E^.BK>J>CFK5;RX.6_%!W$H&ZS_)KY#-S(8GN]L5
M]3Q4W;9PIHG]MN^*".UO[.Y%$>::C$27-.;3.8-R3)5N)8BM64=N3EIQ=KM4
M;)JOF>/!'&CLLXV6Q 'UU-+FD$KB3_SAD]Y+1%-\YJ@>Q1A?R@>T#A<89_S3
M^/6[&\=0QKSI0NBKW+V;3O9/+ZR]YW-@9U/2@+ZD@YI'$W]\9*:Q+3)"I"EA
MN]A_UO^WXU"I2 #)(:O&DZM-N)--4(8O[0(V6$+Y1R%6?3^/T="&FEXX(M4*
M[5\'QTEJ4E\:6#0%OH"%,GRXURG7T "(+@^LNDT,T#__S[7(I7$-#5,5%6:E
M'-"1/AVT$DUC,R868N42R>YP7F!T,UA]5(H5[:_L;NH\UVLEL1 .RY(ZLU=&
M^_3S_K75UYUM60ZYK$HZV;?8)L-V" E1W#I-.==%5#JO$GH2K+)\NE(]E6Q&
MM_)SC9.<5=VDAA.:$C&XW9G!Y;K3\Q,22NW5=G62,9(9CDFT]PU91AKAHYLM
M:.&+!E;IHS@Z"&GIK 7Y8'IV6P1N],)>R-_7Z>SBP*WLO=L!MI%[MBAVN\.'
MI%OM\6!L7$_.FR=GF F7\.<NQC&Q%YK/F?1K/)V"'4]#*!F]CQFEV:F#U75G
M@YYP*WSBX[<OQ *LY9;CPD4^7K3O:+V=$;?S"7V]]PI9AB%*7?J$X!Q+=-#M
M:2; %@M-8B@'+C.M:4X7^-TE>&!'*>\^7 RO]XUK>YKG4;=7T#_F,;$#?<SG
M1V9,-*#&M#DPP3Q4_ -RX")%A\R'F([^+4$'I4;J_NCL68);QT@6^]5"C>%Y
M:_$?YJ^\3O +X >_Y*_.W_/(X[<;]--+%-NQ8U#GA66>@?D38$HS.0:11Q]0
M:;AB/Z?Z<98K]H.>]UZ*TJ9JAQ2FZG,";&Q1D' ]P*/P_;T/7!B@('LS&0=W
M%/$5V7^DJ)3OIW8I3L.9VUU<30/QK4-:+*6Z=AYEH6=3'EK_4*G%;OHT$;R?
M0S E/6+$'EU8WC"2NXVC@NB8T<<*7+$GFJ9$U74L'!]8;N_=Z"RX48G.@1^V
MC'Q__WG0/581Y"W2-+W!!\P/>2A0LY'8/'!+VH/&2L:*,5%<B$*-[9NJUP=W
MS647&MH^.NW\W9U_FG\ UJ+_]A^)%M81O:8O+S;E]U%$UU$PP:(+Z=/ ]8,%
M0$D-AG+"M$IVCZ5GD!V1Q=IK<_NI<SB+SD*!EY\_,:MQFP1M,C(0(,LZI"Z*
M&)!J/1P$\\*>WB"@#C3(^KL78>6#DG(S(5F/E-R]+7L?_O-(-/@OLZ.OG4#*
ME42>]K^N)"C?--%,-U3"3\P+P4/,38>@G-]]GJ*L]CBT<!]2.L54[H3O:W5K
M9(>WIX\W\P^8&+1[*PG:^2@]3]Z^?7$E$4,1B\4XT":F4(,ELC[?)VHAD3M9
M.ZN?C =%#,K%,AJ$E++]'/F>#ENCW+_K>PS6-XG,SI<Q)K8),;H!HDD@!M&\
M?1<HRL C[$9\*6\?IS_)4($0G6$@41;@(4%D#]0/GLQ64C].-USB6#_NAA98
M1UVN?)EU^CWK41!I@BAT>'#I%<,W1:-*4\[\U/E9HM#])G/HK*] X)SKVMKU
M91N![S?R@D0"HN\8.I6T_S;?W'@,)M@?KOMA'*"MJ ,HEC$2*)LABWG4[3Y-
M(@J#%$.& $TC:QZE,M O>07.??G!_(3K,OFWDYEBN(^OF%R97D^EL?D0>3;O
M-Y.%OJ*9>AU1<#"A:1\EE7^J3&;6N,;=,,_GY(/@UZZMU;##G<YU&%9[^/G+
M(NZ8\(XW>@G0](G >@]N5'(O>.C'5Y.5?%QX46EB\T)$VE0#ZX,NEU_I?HD8
MF['*T_@PK7MM55_(=V\*OM71MQT89XI_18A)$,-,77U7NRG>K6AUMA1;C>M"
MRE2FQ.-2,SB$.2TUG>/D]45@FY5"#F-PM"9C6NZ"_=!Q=!"()HR8+&W3&0"?
M I"XQ&'U4Q1/(*9L;0_!-7^W]VIMT)K]_FS#2&&=6P#QFG:%K_T%HWMS5W*O
MO'P!=4/,@-MU]C.#\8>)DJ)$]("%,"F%6M/K2M@S73CH$]L PC%#S0$%;J2P
MRWDZ4FL.CJ0'#]\KQWV79#XG\^Q+O^C1!C]B!-GY\P!#C,:5%)/O!4 Y:!+_
M'G$\V6N, @JOS='$@'RM RO\F=97$,N\:B!VX>/-I7"WTYNY_M?K;[7V5'OD
M.&XZ[E\BA\(%J7W'/.L\)'5&N0E-_FV:1F'QP7(A!Z%"E&O<*7UG6N-?V3["
M_9+M2K'/94F=-'Y<G5V=?I0V=F]0^39!SQ?,IP^[NYP,-!E@[##SJ)2&;%S8
M64G7N/&+0CNV)256W/*3]X[WO+<\BM"M"K-IS9>_6(EL"3D/3"X/SEA=?-=E
MRI+M)>$RS1,_%78,2]"M[9N*W#KK^QS7^]H>45^]%'=)%$@TXO*XAS$#3T!7
MH)N9J7W\<!C#Q6IAJ1A&R@WI8P_HDP#"M"M?PZ6:KT2BV0.CM?E[=EVB<GHJ
MW]9\#SOG[_W7J[#'+(@!Y, Y!"M%&M@D"\%8-ZU&U)E@\OC1H<RD![GHQKT^
M-6)G8ENI0)#&E-;#E=N=;0M15UP+ZV0Z$ME3@V5NLGTN8O:((5]%#JB!_:$G
M:$M@<<1EBAW1,1'NB@U=*Q\0%I4:3A=2PP;TZL4\O#/3GA$/>B&LW:&I=T.6
MW4B!->HV7)C*R);86B3!ZJJY*\!( + @[/1HZ6KMSR&='G0"$A<(S !!4$)4
M8WFTU@*I0WMVXYI,C521W=_7DE.>MK\Y_6T ?X\XX+.BXB-BI#%$D#_Q&>;F
MM3ULI#P!LQ4NN@U+5!KVKMBUP\Q.RAJ@+@WZV@<:&%[ARL5M*8W]L,[PFTP>
MVNY*XZQ4$3+4GHA8^Q%X[?;N=DQ(V&!WL#CW%9[X-J$'*YRN$_=6/G3F>"G@
MPQ9W]OUL<DQZI6GLI82G.*X\BF IC6WYU3I%B0":T[*2<%H)_'V;,%6DTEXG
M/GAFVJ[CAH/R>)2;0H;/;=-/[V66]T(/7FPB5QQ)U@366(:\32WE-I"\O#=Y
M_8:A)%R&<!CW8WK_D&\O6E;@O16GTYIL]OBV9EZNN;/@G3Q3FY5?IC1V=3(?
M;:54"FY*ED',HT_\*$T4EFIS["\.P0QYR!)84Z(^-Q/LMQ:L!T-4#K2<Y:'Z
M?$H]=8=>=LP%WT/71DF,_1J;BIAG)-A6TP/3,)SZ4P\I:BW:[\#W]R\$9V?*
M"VO MF' X,FS#[N=T>$8F4:^:ZK2EV-^A3W)!+.1^Z3>'\&-_1)HTT2>%"D^
MKP!;IUK"^]:2<PT9XZTW7Q=L9P2Q0#0REZI'!3@;M;:2:R#6535VAT-3)?):
MSL6"*$ZKQ'P?SG(.A_)!(_)#I?%+NN;*DT7=?MF#O;NS97H.D8A62! 7^YL7
MJ8D#9PRO%H0"*NC]AEI C!362<UI _/!+AS(S?6"?7S*5F!DRW\* BXL-/UH
MD)L;FX&\N9$4[5K'56'H*D/.[.=Y4LIIR"A-H^F@0.>^"[#P]:$.AFH.#HKR
MJ]CE&XXH=W]_=;%-4ZX&-='$LG]%HEFP^IV5M<?QIM4*!XV=C3A-RJ46@H-+
MDSK17' NHBO._5-Q&2P1IY.@U14*/^N#8WW6T6"87Y/_L3'4+,LQY<+^$.ZO
M-5 3BJ%7P"N.FZ,8=4!Q8_1P;7DX'+"C* (Y6',P#_#@"A=$[_AX =?540#M
M<&;C&.:6?M1XZ\1?QY,/G#D5/8,(Z.5/HD+A(9+$<B9%<SY.+XQ71)J#=0J.
M=M,FO%S^)6[/RX%?-WK?TT-WXJJ"#<DF#D[Y5-_LA)"-E( \F[R'$!@IDC;:
M;6R')UX>G9^NJ=</[%3COU2NXRKPX)@0AG)?J#&S]=O:B0?[;CS-+25 U<5@
MPC<(;9)20"2-=>XX")W0<_)> ()IX9AG_W-QY0)%XVYRU4?IR=Q(?VU>R/[Z
MT7(=$#'P21C@H8-803#DH!3KY:LZN,,X@RA"J/L"W!8'YG1>_T*36(A2R-JR
M ;XZ: S[=QJ$:)X>V'AWHF]SAB'MZ*!,421%J',(W1$UU"<$9CF&GEKUO_^\
MJO(L4:&O\XVKW_?+=-#%GN'MM(35V+=47Z+.OBQQW9[AN]TP==)L6]Y@*:&R
M33W!!1VOOOG"QIBHN-CT]R#SF9([W$N;$^[?I/MW"J;C]DQ/]ZHZ===R, WV
MR6S]VFF_#XO9K"$^4BEGS0SNH#5;5ME:,4/*L^T\V(SRLL1[PI2<>OH4>\XT
M-@-6W%O/R9>+PD2*3EGU'U_2V]H=4^J3TJPLMCIKPZYEV-8\5U2I:(%>4U)X
MW4M@_W\<7/YC_ZUF"/JOWE:@@T)+ 65ARNMQ&KLS'>3+1+Z#W-.GF#013[WB
M^4&F@YXJ(;?.0*7 ^W0039$.VM.GC;53$<O_WO XQ=#Q8RI]ALA5.HAB2P<M
M15%S@GY3_^>?!/@/OL]]8T%(41BCSR;01L$D?^19] ^TXZMJ:A,!/4/M?YVB
M(/-?7HWH!HL#FX,;7!3Y1F!SI&"XY"DND^OK3]&2YMH-R+/UM377\S$2^:O7
MO$[Q,7W8OYYAX>/2+JXE^C+E^+Q)N@BDTJ5=IIS]7DIOI>(5F2R75HA=[7*=
M9;IH1)U+VZ9ECE)81#'D15;:^=/#.HH0"X5AN?4 Z?K7Z%/_GM=N1<Q#18]5
MO9VI26!/'@':+)@MLOCZGH554D]>"I9@T5<9YB-M?"E@Z4&<;&/Y_>NW_?,I
MB^<:@TBL6/G,WFBB.@Z9T.M.5,9M30^B17?OE_B^Q;K6+2[XSH0R:[ZM\[A0
M.]T98E3[.*A1Y,%WC)6 OBUFI*AZQ$XC#'8ST'Y3<:[ZC6ZF7VIDI<C&6JWA
ME)+=KXJW%7K-#;JWADPY=]C;9?7;B@AS&4IQRM9NB_X+0[B/-Z_JS_Q\@=)/
M@1-J."*NFSV4%73<#AWA 11RF@8SUS'8T'U;>8SK@4=HVIHEJ@:5@5_P3I@W
M$@UO%:EJ47+Q5OMPBO.BE9$S#J?B &;)O>4Q+_:R]\Z]R$C+UGX?H'=9L/OS
M@O3^&UUQ>R3">IOD]FR[1L'$T5K?R0!AB/@FH()1\=5NI(WRJ!AS*E7CW_ZB
MT4$")N)OTBH/O[OF:*-O5C<E(G@1\W20L.%YVAQ:D,8.E))BB,)/*&Q8[6P8
M$C]\O#Y> >LW$2EKB1M,*21H)(M5'PO]%%) J6ASG*G_XBL"@>TK]]CF2E;L
MVJ;6F:TUL!?]J*HTZ55<2C$;8X.HUJ:NXL->FGV%,B4YN4$\?D@[SY0E0XJ=
M/N7 'JH8RQ\H3%4:^BG!/_S8$<EVG$#R@8/HH,=T$#M-AZ)-+>X-PK^_C$Z5
M.H/]IYL@GRALT=.E/Z&M1[:MG(!X98X-3&VZ_3Q()QO!;U*+**RO8'4XY !7
M]&9C<QU0@C'J)7QZ&KZT[!(<OZXT7C<V+E@Q$,*F]H^I95_^]]$5+)&CP F.
MT"&#V9+B?/2UPH+$Q/LJM1P4!U0,-3TP0GIFMA@SJ_6Q@KB".<%* ^.;2EL9
M<KE<OD(*"T6*"QG<3H$K/5$?_!3Z(#\N'J,26D)YL3ACRV!CZD/C"$F.I6,>
M?L <4W)N,3*YC<O*>79?2^R 'Y<Z7>GN[EK1ZC3V6=&O\[Y&<_][CYSYI>,:
MRWB7ML!P,D1+'@)O2=N<MK3DWRH2+]/]+A]@W/4^Z,S\S>UR%Y&4RW5SX9%[
M<RB7PFQ92TNA<RA6!0N3>WDJ.3C=$>MH&[.JV!2%^LGK_PN<./K_B_U_[635
M_]6:& 58.O2H1&IEAS;)LZE#R]L])C^!)M)!HN@M W#S-+5 :B24JK[X10D<
M1%'_ ;['R %LNM,2<&.".D:"J]><R#'\0.II)$M7RF)[)B\4@W)2G5CE^RM$
MWB?-3(Y[>,J556@"8-Y$#S2E]*1_>T'8P/L][0VN^=JQ%XWTQDV&3-MVMW;<
M/_WB@W&H=%O8)=ZR%9#9B4[:>;@F@"1Z_Q7* 3<CY"9O6G&_G= )+@\B!3R\
MO7R1W[-H\+-Z_EF9\JBS6F,4'6H)XC1<:N'PN#1!BM- &AOL:-]AKFI"!V'6
MW.X+Z^0VOXF,C>'-(M95^]CV2VMMV]-6:#.5^P[.U)QQJ9#=7D=2HA9J<C];
M>+$[IELO9NW^3E^'(?I4%RO5<:1WT,VC:WG-CC:5P7U6&1=M7I+8_'M_;\&Y
MI6:?UGYP-4X\AIJHSBA7F]+! >#'4.[V]5).V"'^Y^->>;R8KG1WSVS[-._*
M2N 9TE$CL)V[%G#F[_2%;P[2)R,\GJ!@Y($'G7$"H[_]DG\$';*8H<;KY%-4
MF\KRC(.U>4=<<?!Z3^W9.*^C;VLGBDJ4)^#19%7$U(9 KU$4?CH)S KGP!_R
M?UH?#HIN"'J@HE,0/]RFW*+@4_S.-UUXR_XJJ]!743],$[/_)W:K1%''^+:'
M/"=,JR;+4?'!!PY7ST9V8^J7+LQ(Q*[]]4W2,$[CN*:,VGE<!%URL#^V="FU
M)O$('^<9AGY\%&R74E$^3K'R6K<!0M);A7#3)!-CZ@LUK9B?[8/(^CH-U'.5
MLELDZ,'&B@W&+E?;_A&:_'I"6D0?.A+H5P3S)E50BPT"&K\B1 BE(Z6)B/-$
M[G:]CKG(8/FAGD?;9=53W)P.N;.0N9N_-@-/!/Y,0P:H/T;R]%Z+P%F)4=P)
M4O&]9GZ"MA_]"S:2[M[54CA?;&2DTM%ZH^7"C0I!KXO]L<JL@\@6G?U)K!7O
M5T,50O2 >B)-G"@7K]<S>]R@;)2P?FL^A$<NR'GA6_)[O0]7%ND@,=HXM!4]
MU,3O#L.,HEE[N?#3@AX8KK>?NAO\9S[NZO"Z5CMY9>'>^=[(!CU]PSS7_0*/
MK!DOT.-9IO;&V.1Z'H-KR>"'^5T/0T,/$()YK9$_ TW;M;"CI ,M2U0R';0[
M37*W"MPQC0=W(COZ6MYFH426:=.T\=_%U/)L6D>S]I9ESNHGN"'00%C'OXW_
M5D-8'F$,>:2XZB.',GF#:_?^[\KVRE4;_%I,\.J27DK=11.]<P)K: %&T$"C
M>;4>*9.B 5="RL@1"7,3V"0:00C()#65BBQAVD3&GF4^/D;:QU.\Q%LY#??D
MW$XE8@&N#8 ):.RW8F0%7(V@DPCGJ K,\Z*#K)L)![%.KI\\E%HX\C?3GAW%
MW[\U6J0AL8<% \J.^\EXY-HZR6TQ,C-1"87OQ!Q<YQ&#7^5D"CA.UWX8E-B6
MAGTN.Z0]HDM<3!)?RJGTR%%)%"ZR+7/(<!\JNI2_TW;O5H-+_,TZ-3SGJ4L:
M)+M:XZ4FRQ+VM#W[USA%AWBE[&S9J1>_:C=6F@PGOQ JX?,\>?BCWI_,&*=>
M&DS%,"!^HOG7*1W6;'SS\3W-7/;XFX9A'NDWELH,(;?2]1M&K'/ZUJC%AI(P
M;YQ?_V%\'QLA(\^GXLN:SA.X.N<MI_7AD!<W(UWE2G:M^>4+KPY55N0ZLGPL
MS/I+Z!<C2+/P4=_05+]"Q0WY:!ATJV%5GP0P0'PN;+-$">5SZ"58Q9WQ3?CN
M.#_SK.G1:8<LK9 *IHSV?L3$!H&A[E<[!THY#+0(AZ1WRZ%(/Y[T/M!LO8$R
M/I03-F^Z+*M?//74A[LDZJK^(_#-;L<,\OZVT^*;"O%#"=9)9 =/4CU%CWR'
M-B%%L,],X-V _TTMK"#4P2Z-E$C/W56'DEE-%D+N?#<PDRU<3VUO[33Y>.XH
MYXGM/'K15[#&NZM3N>XE/@ /"Q(;ZDKR[6[GA%+DO#RDV5YZ:=Y54]<J<^ =
MO-UZ<Z3D3'H@VJG,AC>D, ?\2#WU_2*<AW/[\IL5R,L0Z?Y[#8XO?%X6Z9 #
M)R\&L8J[8FXKVY8N-[]TDVE^6715%M*N8N%T/2Q*L'QR 1[>0^U 8K.CZ2">
M/GW8#JD;^/=CCR"1-?4N7(_X[WUB_OWZ?;&!W_?+PH)#)6O*"LV3*8,R74J5
M*>#W/Z\-AR';\I+:ID7IH &&N,.6&&K.R0@$>*@"?C6PV.%$W8[%NZ+?A.3!
M,-,+3Y\.G&I#8\NEVI<'>0#%/$P3B/:^M/E^WX:85FE2G\[L='I[,;/YXL&^
M <NKKS^7'$.K ^<#71Y5V]P,5U:ZPU7.?4WK'=R/<*>4&XEM1A(LP"#34&1D
M'P]P32?Q6Q.^Y9_<";>O+I#5FW?^<2HXW=G[=W66,3;-T9'C86#^,IO]1$ /
MK$#<<U1$)2'J(@&S-'SO UQVLFZQ<"M.-F40U]JS0C'DD7#0+/:O;<L)G"D_
M6^#G,7(6+&#*HF7M!=?)539$L3>VZSMGZ^ZH8[#R#FH13FX(>77470=VOG*1
MF<J$(4B<K/L8XCW!B#1%K2PD?6-(@R28D1W1LFQS@P7.1R#]4T>Y#(3D\O)<
M^#;"5M'1UIDE)"R0=>NVQLY)22Y8WCX/7GW-D<;.@JR%0WL8;Q<!R[C$S+L&
M076K4,28RX6O<NO7W\Q_$S[C4EDY^4$_*R3MHE6KRU0Y:XRE3B2XF?N?*L"6
MQG[(V !"1'!RV=MFPE0B=P.R/E#8)7AGQ:3TI.WE(^E>2?NYNYS:0U.NNJ"=
MTF=H["N$(O6IH0QL?1#,RUC#ER67>YNI';Y$6O8\@,1NY^.Y3G$%E]JVZ;>5
M:*:XZZ]-OHL;W\Z.L1[Y9J)'A$6LKF.<'>*^L__:828DG%*+)XKLYVF.A)D$
MF:!XO8Y('U7F65)1^H+?X2;:F@T)_;=E;=*-+87XONRT/6H$#Z5I*3T;O_?+
M3\1;0W*=CS:=L_E&$&Z ZS7" 9OE0HY*=8Q2#=AG[Q]3:KPBH5YO"Y\)@0**
M//LUQ-)_;PXV(T8_G4DD88#,<MB+4?U3C097-A\^TERR<,3UYH:]Z:8-NF_Y
MN/YDV8BQX=9AFD0P@L. >6\ V1HQ &TV';RBSH:81UPB'@ZE-J5)BLY$H5-*
ME.95P)W'#:*_G7*W1_"K=[J>G/GK]*?,KE.ZP_!_K^*)$=.7^Y'K+VALQ613
MVFQP-*[I),P5M[8&OT5L">A<B\](Q"NGZ\N^=3UNC@VP'YY]]/FQV8>PN;=(
M&L=38CEN^H"%S 7G!_()$1ZADC!Y1^ K[M1\^UMABX6ME&V-RS+O.HY<3.\_
M3]\]N_4$I/>^?]+'V)QUL%<]=M AWB>1:-AH6]1K\/:MDMTF/D14!*+ENI/+
MG^OYI!KEMX]L(RQF[U%][%Y$QY-@W]1^?[K$HV37C!"QF6BIQM^NT>]J[_\
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M=KS<Z9(_A.K:-358*+CL?"'OY!@C?PKPN;JG33CCZ1.@R;4RE"&;#YR=\WO
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MF4ENG!RU G@J>O CH$@PW*WS-03L#.^1.@5X1.5T^HA3/N6/)/ZJ6"!98:^
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MJ4'K8:+5@#E9<)!=^GI8U4L'2=Q?::<\[7Y]Z<+BSHS&OGB2 =99T# -5Z/
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MBPR&*!L,%[_GE_8[B'*FU<+7JHN!="[@DO* *R_%$'ZBWE>1SN4+9U(9O?*
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MU7+V<.>[TT.B]NO(^I6MQ>>349$!GB5%_(^'M\4>P2R'_]G6@TE116@-&/^
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M?_O27ZT*G^T2=T=@=3B6-E,:@P<&0LM_S*HRZ?LZ#]5OI./&/KT\*ZN>H%/
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MX> >Q@":;T\9=4\A@/*3UN]-H7)G^^VP:V7:7I85,O&D]Z(E.BT9ZZ@KE/H
M(3]>P\F8"MK1UZY=;1<!!98@B6M3:*E!]5YW8H2LR0.D- ?)X;O 7!;)/+G5
ML+=0TR*O'(]40_+KJ<#!$*(=9O'"@*L0#7T*\(2_+KI#::Z#C6.:QI,#=O=A
M-Z%&C9'^*H6V7EFBW4*S]1.O6;K>4LLS *N4^1XPRQGX>-7'88A.P-=\FY^_
MA-5ZX<!)*O'3+:> )*6AL*H(8^SQSF(_Y]167DOW$RO.CA#,2&"^]9YH,+PN
M/>E,6=.O04.GY Z%4B L('Z2A'[+.V<GGQ7%B=U6M%-DST5CYO @3,[:*UTI
M!N%*[^+FP<\8%OL(B/&$-CN%_4$#T7H4'%O[%'H'U<.-J(!CY+.;KL^E?5\4
M9JI70$C0$I.&2=FEZ,?!74N))%49BR,9SX5P#H^%>">0MKLK2E4/E'\US;JI
MDZ-X9IU/,=LQL%BY&%44O/'->9#)+*]0H _1E-+$(7TP LS>B!0$,^29?VU0
MJ:JLKE<;6*L:4<L1IB1,%SI&.%;?MDC_[4?<QY\"^H +Q?2K92>&?L5"70$E
M4,E)V,V?EN#HL'0>YT(%$Q+[D)>*S[7B<&&>\K?_B[WOBFIJ"]>-HB)=I==L
MZ1WI12!;$!"0WFN4WCL2,!!%>MTB1;H(,806.@@(0BC2I7=) 9$F"6B,!L)E
MWSO&?;CCGI?S<NX9XS[,O*PQ5M:<\_^_LLK_KQ0$V5^&'+F #N_A^%D&-PG.
MTRMFYC.1XLK\4H/E=)A ,<L6.1GX84,%V\O^R."0VNU6DQTI*>\K$21J?)Q$
MW%C?A2[?\'Y(9!F:C@<S:POZ=ZEL'M2#A^(XYR(#=="^5^,F(T,93 1FK]U9
MM[,NIXECT<.Q,),;0$F]S.!;9 .S9"/"<)>2,>C0A-:D W#/'?Z%ZW3?V.?9
M9;6WGC8CEUO&K._D=E[C^D;Q[E<ZR6BW0'=<]W(P=4_ ^;%YBUF>5+RV*K^A
M9[O]%3V6SV-:E&GX+C]DY[59-CS)+PU?5RE5X;3F:CE^\K K^_IC]=TP!]OQ
MO<>=#I/Z1FJO<?)&QQ&8.6I4GUMP"I7^0B8'4U?![7(#J-5T<!/9"7,.2.D5
M>C4"8XD3)X^Y(R#>@\@:,,-*Q+)R=-[+K^V9GY:GV(WP_,-3%=&>E'\?I+A0
M&4]=R$!!" +C?7"&B74R6^R5V.5]1_C:5K=N&!K)U/ *^?:MB_[$OL ]R1'$
M%>]?F[B=@R."''X#7IH]G)TH<(U<[(M05,X0D/\L'5G5)O,K ^27N:*X3I,=
M9!(!9.R] 94ERV-_$% #V9<@8.RO9*%'NY40NP=ML](TS#31'-5I#T:'PS.(
M3MO*VR^0:*X>/QMB">\KJ]$P.]V-RO0L5N%Z].\G[H42'>+N=^SI:RKA26?#
M0NQ&K.72?&_VE6".SC9\C/#D;%Y<$Z3G'+#F6%6MN<:O*S]=[=F@6;OB];I&
MF<\SQ?0=?;["!PW9N*ET,/_%O"UAWB;!I(JS5*HB5)K0UME%="'%=R4G!WX2
MGJSV[7BR%"_,,*[Y\N^]-Y$!S#\)G >'%\0@=U9Z2D.YY@15)"?C Q4'0*V<
MZ+YD#11:79MA7[$X6&"O3&BVU7LFXNA@@[M28=UICU./\9;<>"-?2=[T#Q:P
M\GY?T\A!/2X8*#<D=P,*(#O40>\;SFY#/6%8?ME8B+,^[G[QX31+D8?=I1<E
M)2=%)WB=8*9R3W8I(V[0K?E^MU#JL-3^,M\3!CHGF7Q%N?"S(4.\PECC@"TB
MU3GW"R>+XZNPG?3=,L%;U*'!+B,(E:_^]<)X;FGC<I=Z;J.-'R:<SN#79[3%
MT"-?7/4TXP>4,O2AR/>I6\E;+*>L+TCT1' Z[!$,2(;A;%&XOA>]4F=P33,D
M><ZF]W/!0:_X3,#WX)V<P2LY]HQAAI<RASV<:\M'?B"&P 33S95RW'0_./&"
M-<\!/K"KCM"XF5ZV75)['' 1"@D&M3,M-.?Q%*_;@_6DHYJ]=R)+LVF**/E<
M;AUI:G]EWD[BFA5_FVDCE*8V+VG (TZ?DG:YIAH  '"Q$^P.$S' M9W!*"IP
M >2&R@#2]?*MW^>0N^4 M24L;*8JK2W;99*>D$@%QFS4K(\W]W<WBO#B2RCQ
MF?'U.VIUMB;T]C[Z7'G/D^[E:A8+U6NTK2+9"[9S*UY$?@N;LJS>&\LM*:D<
M>H9>3"OU(Z_Z\]/MK"0Z[LX/H&^FX31GOJXL\"CMALMYIP\OY!E92XV%P/4S
MQ(>KW-G*L1V'SRE:Y"@JW3V*!76\C[7/W<3)F6"00!4GSU%O!O-!6=L7(ID,
M])8.98/^>K;AU/\T,E3<R3,O6[>#2SKN9]S1*?0B@:%Q(^!VF:-D:"1%%\I(
MF,[N<?"MT+U6W+"GL/>DJ#<O,#8@9S(P,!*QZ=A\-9J%D2^(+UX-E1K'<!'$
M2GT^+"F@5I8$D"^*+ X>+F> >A)WT!(B!=BEQ%X!WX(BL6<_"AM B\[.OISM
MG_6/]<?JN1Z0/_+9?:#.@QEAF.H_B$$'9=#R.0 __1%\^52CN]7C/>$<,"1W
M#4Q.MVSONBYDJ/0;T_@^ZXHY[1A?&"W\/OR@^>$KF0D0UDX!41QZ#<22]N+/
M?!AC+7_RP(CLJ%CV8)B;V,&V+M#%- ?)*-SB73#WJD)OU*DM8(?_]2,@R>N6
M.K-)OKO$J+34M&* K/MKFQ&O7$)GG)]S+5WZ>,A49(DDWM::J"R(./C=)]G+
M!U&UNEBD@(O)VE$%J).;ET[M</QFI%@R%DM1/XICV]Q<WWM21M]5BI>I7M,:
M/!GG^ZOI>*4I3ZB/YD\!ZE/Y\CB5KON"82XBD_OGYNHXJ8Y<Z$]$D(J7?@S.
MP-HCJF5E>FYCSQ14;+.T:$QZDB1D^'4DXYL: /O@AH45=6M$3@@5G#%LH# 9
M=BJKH78 ];9MMFYRR!?CS-^&.:&X[$;J"N1J=>7^'-J?+)%,1+'7.T9%3-LC
M2_ $B,,CA0./L"((5!@Y5W$H_YJO.8E5>5*[5F\LBY/B!*1_C7*G?5)O^]9&
M<E0P3;R!M?J_ND+%?\WH-$O3%NDC!*.#@>1NX\0@91 C676PB%1.,SPGO=1E
M^C(JUI_W_O,BFVB,GGRU2/_JI2DIC38A_3RCECX1R7#D7:E>>[TQ6Q>75\U[
M$9C&O";RA"@M\ULBU[H)H\A5=?%[BX,+B3Q&EC'ZLN'92F6I+C_N=DF=P$@L
M1-1A*?$IVI67/$K$#X$8$>1@_#3C^EXOD)"=!%4,KX)4&O1HY&W4-R[(OFM/
M=;DE%3 N<+Q=G,>^"Q/05*1$[O5J^*-6CG#@_FEZ,@U%](OR[&DPUK\>[,0S
M]H9BTM^=-NM!D>K%O3P:RPBY2\Y5_)DZ%O*[%R@^Y3<[V!64=4L-JC!BE&DO
M,3=(X787,C$OX?,HKJL1$8GQW9";.9%C%'M%G/+^6%C.#X'%#WL0AW3O3$MZ
MK;22@Y(>QS<0EGO*]W^$\70BOUK+WT :A2">Y;./Y:[+AV=+PTGU[/AR%J7-
MS'88W>VY"W^1/J#1-WRO:D]^&L=$\S!G?*"^3C,L4P&KM),JS-'XR<T_Y;31
MQ>89K?(QXGD/\(+L)-J(J&19*(SX%,.!Q-A'OA!+_;'!VE^07S3T-?5K$\>?
MV+GEM_U1VX'@.\V9'TN6]*"+\*OQ_N*3^V=A\KEY]%R^FIR*[]Z']I [GZH;
MK*J*&*^M6"&]5HU<;9WZU9R'G>\C1J!T^>> 1[;U1ADMTN.JE0*"UNZI.?7H
M7K3@8(\+SZ:=Q5MBK6P)/!4M,4 ?'G$.T*U&E8!\2GE)I8M*?2QB!S-XN>1>
MEH6*>5'8K6DBS?URQ_:>N0R_VVD#:H]*^C5&>[H;S:V?%PV2Q=Y0EV*\$WNB
M:4=@_*=WB*KI#9C74*U>0G#R=Z4/BD8E*^O2+ U.XX$,KH*;O+[.@KV/#?ZF
M4U.5'@L=Z6$A>?F*BZN?Q2F%' %6W^V%2:+8:L/;/Q29QIM6&A<7?%%'AF0)
MH!AU4X'<(8$\<X,Z+[!IG:>SFF97I3U"LF]J\H7Y8C@$;A8LB8E_#2OJ'[9A
M5[5YRKI7(W7"1092Z5O:FH@=I*"-G1P$]<;= P88Z+;9J?$Y8)$!5J"E>E+T
M1Q>O_X+BXN?*3.#O^+AY<?V$S<QZH6=0W7GH8RPET^K! ISCR>Y=GR<S3D:+
M?K]JPR5I[Z^Q#K_&/!\WT*RU31)M^12^)\=$'YY)OQS YX^+K?K-=V<F2SND
M9/<TDMUPUB().?KM*>0<P'S'7AHM]M%@<).QZ?/D/J[:>N(.]W"LG=SH(B_+
M(1ZL5NN4Y&.+_CP$(D&E&Y>A'CLIOR1U<D&06"L]J!GA+AK4\:0 3PZB:D,?
MDE5QV<E")MU9L6+]<1Q=LY%?%WA4.:S@6^W_O&E/,TFR/YWHB@<HCY#/ 0-
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M/$OLS.'/)NEM-L7X+4&*Y6=PK%OI_5U@S Q8"L)R[ZRA7IL!TO&0G(CO2])
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M>BE.=$Q)UW3R#Q=7R*Q$FXS"V!_[?W)>CH8'O5*0T,RSW+H<_9?=Z&8[Z+
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M8!D#X60WIFTX_ZLQ79"395\W4\#AN,&V\[ "+$4YEMMYQ7A(LU8:\FU,;:D
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M+I'41 PFL9R]^1F<J,IS-NY7ID1^C+OQYU?RJ1/$P]<A4*SW2;H1\X'I\@*
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M?A+5(NQOFTKP/'E?1*O<K5C%QQ0&323L0DO>[W#:VE7C)2C'IK:Y'W:BJB\
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M;F-/1H(R0:U?1P^B";!AM/(L!(@/N&1&*"],V"3<5_^R#VH+D)%:C1CB>/#
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MT2VDL+6<?KQT_.'??"<IPQ7'^ ]PY^2_3(:BOM&?,M3^^XN0\P=M.0.0D&>
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MH1D<NWVN*6C!$@'V'L8FKHP^3WETUAN$N IV&BJ3/PK>9&,N[^3:<4G3M1S
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MTN-*G^!-&;5-$!8WMLAPLC9L$S0V"<N)S4G-0PBA1)9UV6Q&*_[_6Y3_TSS
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MW'$(:96H+G94&F,&+NV+XGOVE[YM0+*4O?.1Z0I.]$ERU'7_KV@@Q;&;N#3
M!968))!'7-B[SGE^F\>&['5[:4P:/D!+K=KY[GX?G:P,I;%@;*;D_F^4Y^M>
M"=6'XUP?C?VZ6NNQ?B.O!S<J:!B-STD")ZW4?5"TXS)"#&%I\,O%H1J2"+J+
MY3/1R?4DR5Q%%'K;\73:;WW1$1"<DK.<VIE%JN)\C23?KM'(V'6-L_,1TDKB
MD!-&7_.RIM8!T'6>I4Q($!9U=9(L<CHCP)$VY( YMB1EN1*^V?P5R41[Z!]3
M38(OI,[1 <';OC2+O>3C#&HE"@WP1?/-2YV#J@&I?>TFIF3X0(O?-Z76:8>>
MX1P1_.:M^W^^RGTZ[[;PX@B%$&OPV5  /R(J2FR_:TRK%^O1TB"KT!ACW;LB
M7S<1J).!T49KM0V1K23S[QZ=A<^)?/?RMNQD&<4V_W PY?MXE2EWO@<-ZZC5
M@_SWZXV44:?KA=V:1YAG"2<2T>R3% .X.(2-BE1B3M>Z3CQ,_8&FH=B0PD1C
M;U?8A0-Y=L0]ZTE5']Y5_/**HWLN(Z!SK>,??84'<96H?(PW*A,F@+X+78[J
M2/YQR@5Y1#(E  U(1B+%U#@B4Y_OW\ J?,0"[[D2,[Q8//D*H*)F$DH[#*TW
MMUL85V"X_ZXP>5J.)=,YQ:[!RM?MSF?8@7K>IJB>4KF&NJ(;=^C4_V#OO8.:
M_+I]\?BU($607B46D-X[QD110$! >B<BTJ6#!@U$J=*5JK0H$$+O340BA")=
MNH"4!$&J)( QF)#<^#O_W'OF_<Z<WWO/N>^],^>//9.9S+.?O=>SUUJ?S]IK
M[9VI$-247C!R1 9?P=VN1I[3ER',2Q=9).S%?WLG=_OAHUQWS.9#;F[#)*6?
M]>1[NR)8X/,R_7D78NO6]$?M]-ASI;6%"3+K'(,Z_UN')?QSC>,I9+D2NI>H
M0);R.'K%].<ZD,HMHA"F6P@S_YW&TD,'2/XI%LA"S#Z-F 7^'L%P5E"OEQX_
M M,!RP-(!N3I&Z5 Z( $!..O^BH$M(GZ#/&/3S+T_&<NQ?JW2/\(D"R%V>$E
M;"WO;C<0L_6F(A3)-CA,]U5_W$P\1U3ESZL/9XQGU(1[)G[P*17/M2<&JW:X
M7"OA%5,_K?9;^Q8@+0 @EO[Y6+_$!C0#TE)#Y5XB&3(F%>N5,U1P)1?[&-T-
M 6SPM[G%?KA<&8ACEL<C%KTYKP<+?>1]CEAB8P-Z$X.WKSKZG2IAYYERO!HR
M[2I@F:%T]N."=*9DT  SC63I915<9L*),O<U&$WC^AGD?1#PZK? P(BAK7=C
M.<[F8KYTZR>KZ VSJM#+;S5[BQQ?Y*UJ]DJK!V4@Y#'+Z4AVS'(&AAWCP>!_
M0!&P)-6<K(\WG9/IU5;-^9[RTS]!%-(PHU#5-+M;G=AWE%C]U?A,NKY@?*8]
M=UXDLUG"D2K9E!(&5SA"(7QJ$H%UZ&>J2P#X=;(:C@Z(T_:=)R.['@D]K'EK
MI-[TX"5TP^*ZIU"/-8?V3:N;<Y7')<XKDAMP2"JG#XWY$@X*@$&Q$6I(QI/Q
M5+MBKT&?&M@SD./+,T9WV(=E!X4V3YI9\B:=7-Z12%J.**#U_$G54J,HT '^
M<[2!QTR1LJ')5I=$+TP>R)G(V=BT/K,5N->69ZH:SX)[6/9Q.7BN8TFIZME0
ML.,L'L?R6M730U514-[)*%=JM;M%_Z20$K(>]N#]<6;#)GE[Z=![919EI_=O
M'U9RUT0/.FY89)-ZM98]+%2'O#7=-5DJE+I6Z@1>MQH6!PK&V/-4N(WD&[29
MP<HS+^(W.D5C*&*T/IK0T8MM>"!N]#@YVWH2Q(]/CG!ZHD?H(=,!-PE%COVR
M+7R/?<*2:2F[4A=TWMP!L"A![YGIPJ9DK,I+RQLR]6^PQG1.9"RITFHBL>9=
M+D5:[T>*W^HD:VIGBI2;9N<4KUZ>WTG6U('%]THK]]PCVFY2RP=@E7X72V1X
MK72?U)%:$YJD-3OU6"R\E1+J=7ELOION!%+XX59'Y2"SDG,R)#2Y@0*!00Q;
M[MXEZY;)YU9LVIPX%[MI)Z1ZFIV5R^'2^>,]05/YMB/14G="K>S3DNW:7J!9
M>%9,0L\9!/M<:2T/0)]8U1J1LG.J3@A 24YGV@]D-Y2@3N^9%&]99MZR2-;4
MTU9('@G.O1-]04K]P/3 /H'F _' /$<T^F^+,ZB,V&>(RZXHW(^(V9$C9.-;
MH@N)$K%4,R([P1NL2MC9GCA-?=]_*>RF==V+L*_E6"9-$,5FQXH8MP+<B:%X
M.=(!G9 ()K@I$=@)985QZ#80)7I3XR.8V_@*5)J:)N\F[\@>L*:9N>:&/!-1
M(5!S-DE!W=B+91GSRJEGS89]< 6MD')LW *,>'P(7(N9M;:R.*.MDKL6>[')
M44Z:*Z-.L=%0@=5!&Y6#J.V[V/6-O.UD2P<T]59S/R_@$N1U%/.<L_K^:K+W
M<[2GN%"&4)7T)F>1EL)BCLSA)MF#R+\21^7.)HV372B7J1;DGA73.:;EU+ZK
M7'M_C@ [VR&^*/<KZ<#X\=1J2YQ)VWLVXJO5 M!=37;T0VV;@\M[8J[RZT_S
M_MKFX=Y(TU?SRY1:KK7+XFL/U)0-[AF/T64>+],7S+XG'CVDJ)FCQI4O8L+5
M;J/JM&(>\P!\D2MDZV.O>96^X/./]TK;P=+);*+JBJ2,32QGMON=,@N%OL]E
MQHR%D:G/:=QKR"MU3_%+ N]YE.%>Z#_ V#7S-8T.=, H#+&[B2!:D1.):!]$
MYR.$:QC7K6*;/Q5X=$!%EI;@PTWMUN[G2<-\CVM>\0=T.D;E?/R?Z^W^Y1=2
M_@L;V.ZH1;R 8U:"]"QG#H\?QT-B(\Y[5ONZ/WGRW%&G-4VP4$;,[XJVHLN7
MZ9;M<-F)B$'$,?'6@B>OOY&A./TL_)I- =Y#^X%N<8X7*RA-:36_WQV4;@=I
MW@Q#UNOOG(J9!E&5B9Q?ET)\6\Y$T4CJJ4$R79C[P-2<%T>1H.-$:4@4AE-W
M)A+$6KRAOGB"SW-1BFCNI3[],+',\RSO_-6"XOL^%>IW@UE:)'CWU(@ABNWW
MCCX87 ?SEMD/\'I'[)YY;1B*\@[(,>%,\U98*GMBD33G%;&?]<TN*_@@HKA^
M6TY[WUG3)>B[%#[ UKU."W/:#+MZ$%9GM:[!\G/#TKPT%XL[#"^11ITVY,I>
M7^ ]1!4B.G7:;2J]Y_BR);9=*89>\96;ZNI<2TN>?,0Y+Z^PB[TSV<.KJW)5
M+?[YL8IO\A)(_U_17=DT[20Y]=IG50:RQ__J:6WZ(/=3*C0U;L[19NYAQL:E
M7EG_1=U[V<8M,+/>Z5,?3@>"C2Q8H8)L3OJQ6)-D[2E1)L7$Z*WF,G$36RMK
M^/"5MH"TN/E L 7W\O?GKT#?Y7!4/8/H6-]<')%<B6%K38W9U/G UJR8I<Y0
MN!%T)+;-+,_1"Q_(XVW]H52GPEBAIK0F#>*Q-)=H3_Y>"FONLR ?)_K@I,E0
M(V,]5LQSH?O6ZK\I[R_FRHF_M!EJ,_Y6WWR-93%SV1Y)Y='OR0E=J_)&UGGL
M*#UN<_NYD^9H3XY8>(MQT+(7;VOT5UB+_":9QA4FW9609YPVCG4AABJ%\@%Y
MI<?>JCT;$EM;-] K#UF)R32$UWM)F)^U6!09-,.!1(C<YW+7WO'QBW59#BO;
MPUC>98DZ&G1-OM41S)>R[M2\5^%A28!E6^<YHD3D+[:7J@T^MRR>A&Z@W'Q:
MZ(#9QY<;R@YE H_R4=[\=( 'XCWDR\[EUCV'H]?P#\G;O1T>Q-T=E4J8Q')-
M-%C!@<I,KL!7,,!54\XH8?[ZQ+W<W@(@Q<*P,O2)GOE+5G]9P=ICQZ;;'W5"
MFOT3&%@I9PD7C:G']*4")))4=QR,1)6)#Q//M,0>&/C)7HZ5^FF0IMC/&79*
M,2C NT[D1J99E1&SK/$M?)WJ^NB9DU&]_:9;9E ;O^* <123AN2"99X3Y/#Q
M6W>/3)A%[Q<JN\+56+.8 J/TE< #%?CM?9IHD2R$)&=*MC;KFAPN6PEDY1 P
MS8(9\A;%-Q&"JK_Z[RS5[?;Q'Q6"F=8QW$M=UF!F7R,'HOSKHV=HY0^5QW6G
M?J@2 U#7A*O;:[1ZE053?#:%#O5)<F1^?.KLQ+)Z'.%]KU!!;L768_?W^&03
MGP4QS8:T,_ZVK9.^+T\\52?C7YO?3FUGYOT9ZO^R/;B_ON6U5)\BC$VFM[?8
MA;G2HHCC 5K(P"(IT\3/LU,276R5*M/]BO 5=&U%DQ"R/H6[190/%#U7%E<1
M7Z,3IMP[;0<OG>XUM"UO7!2>;;7L-IC.>+"I\>?DBAI+\HM_%M'^;[?T2YJ?
M^M=5^JE2GO^/W!V[$G$!]MZ( (QL-\(?^5UY'9)__-:'R=#3VRMA?O;3BXL&
ME\_V"<CO\5BSG.63$%C#I .9$9W&D.4L.H ]='?N[@8A8EQ# ]@H_@.%@AWZ
M-4+Y'"_GBYFJH?H)Q#W#+[A?JJ:<=P#FFEM'X8X.#HO7Y9J^GEUP,$D6F?[%
M*?9Y4)A-V8 GX=/ZQQ<# ]=%.*$*\)#:HP+P";@T<:9GB9<J3@Z5?[D\S&$^
ML^N:^+%#, V_9V04YG="FOV5T6# 1F-=O]BW;S.9B=^ZVB>$DZMTW9KVO%9A
M.291H6Y15?'H^#Z734OSC JS7DNL&_45S,+"JG9L-6-!EW<=ET?D[+P;T+C9
M[D&J8O.]7"%NC*_=5!HL[\I-L-QRD;;L'K;..+3T\2Y\,T^[%(7H9+_^,O8]
MQ1^I[H7V/]@560;MM8^<XOX1&\3S$, ^18FB T[H @FF$T0)?$/$)WY,X[FU
MCI!<#K*!:<]A^PWYG*RW17N(!DC3U#VN[Y[^DM\!WZO@X96(3DLZX,'PO5^=
MM//D1XP^&LBLCPC?\3]J24"FIJNNM\9V0A4XYQKK=7VN3IYYT&&9SG.F22<I
M[^3QA",&S(BTAC\Y0D<HP;W)H^B(,>2I"/Z(D4<TH0G5GQ,T ;(ZUK!NZI6!
MF &)\LR+S8;;WK!J[<:EM,IBQ9] :)H^)[-[8$B=IH=LJE:RK66-R$E;TV/Q
M@P3R]KG'O%XC'QZ3'?4N)HLX_W4VQM *D6J>@)8A"_;8*Q?U[Y3=<Q.9D$S,
M/TT'>)H%]=QS<^!X'EPX)10B@V5V+A$6-B]\\]55VZ0B((D."/,L3"":+-<(
MD8G$^8_ ACYL53!>OUO.2E:UZN*T34MCZJ^VE*KPU?<.7G.AA>Y/<A-?6^H5
MJOH6?R,QS?H05V@LYQAR:2-'44*H.N3P%2<@J9T<1[AQFQQVOGT"+HZKXANU
M&O-7TUQ 1?ZFL;[_=*_5\_Z5Z*#N3?US9P)=P4U:+@'DB,=W>NY=TN=/C?:R
M+'"("LRKN+>.VYQ$BUB+2Y;;VLL;YG9;HK5WS&)N_JZM8,M_W!J+WI8TJ0:R
M+!@&]N(MDCQQWC9HEM0S>D'9:H\WN?(DNPI1@E8!IJ.8N[NS2WU+C"%Z0041
MG?HT\+K-HN@TW*AD%.<?Z7QVRB5-ZJ F;LW:%V*3,QUBX%OMD>2F41K<JDQ0
M!L..4BNK(\XA.@,1#W8N]:KD/MD5)0MC^3MX<HZH1>4WD1[YRQ-)*./!&V</
MI\^M:GWZ24E=YM^6HOA0I<FI."0/C Z@L1@35?"CST*D[E(\L$ZF']OX7A9M
M-@=(%\Z"2(]22&,/[A0-/%\.^>N#*VF0L6+"UQ&-:^]PR 0@!^WB%@: \%0X
M>07(0KU/",_0>#P<??OM;7[KH&'_,]1K')GR8F['GYZ2^8I.*,I8V6-SANI.
M#2C"-;I!HGN/+4*5#OVL<MMX+Z1D7>*I)</]7&Q4.W$-(J&VT^8U^IS)9I:;
M>BD\^X<^:S!Y\<ZU4$L5T+P@]ET/:+$XO !J<R[-->!+@B8+#*[<?8_PSII?
M'@V5Z;I# K:5UF;F5F9=K,2H():K^!JH-QG#?A;1"6%K%P\8)_<.VHA*?XCM
M;UFP7W\H5#SNV-35]PX?\]+HW"9O1GJ>S;;_3AA%D*IVU AG^D.VE[BIIL0K
M6&W3N-!/[=>]GA PO3.+3-,>'U+$GNL^*?W2(]NB?OLL7[,;BVUZ7@X!,GN%
MQCS*\9$.>-X".1>A274E*NQ<I5QKRF@S01+U>]M"._*?%&^H%(F1'@J%M_]2
M)S ?%VE\T/KUEF OQ-B'Y2PJ^YLF6TX^#%^AKXX7/=]G@Q)Z^9;-_RQ>L1X&
M4JEB"?4V[US>HXI(6(=L[.._)WPS1PF%7KXG 7KXR$&-I*8X67;_M02'BY=5
MF4FHCWD_^O4]Z95-O6Q5*5EG&;4:(<U'YI4;N-H#M)8.RCO#BW:1#L#&8.[7
M_)9!-'VGB0&?8P[9.ZZ232F\5/FC>,QR"Z;!)I;&QX FR(0J4"A%BNHPV?0:
M+ V;IO3Q9UE\6=A\<2WGZL[O/O$\+GVA1J*8=^5JO-PDPPEEDA'$"IH%EB+"
M@$)OJ>YTP/B1\[N13"GP_7F?S)\'=(!8Q+*9+L_9?_5N_[^RP:LH 71 ?R'M
M,Y)TN_T&'5!HW8QPG16%SOHL<W_J^4*5(SR7[9-@1EU+ ">4\SPY9HMLN52)
MJ ?NL/WH-(L0($<W*'T\_LG9H,K_"RZ3#G#S?\J>).B \X]^;2L2R?Z:^010
M1V;-@@Y(&C"D _9O=\[3-ANFE\(HLMG4X 5!!YJ_O+B4 ZTT288!'L3F#L"9
MA0DR&ZF]D?]'(Y:$7?Z("6##S-.F00P;>6;%!@MA(2=\C/DPIK8KL/[8O<QS
MZ)A9L%MHV+ENL<C37!?3V/5YAQ%8-UK_TD$@\A0=0%B&!=,!Z5OCZ'3WGRXL
M&?65 RBM'@837PZTB%X1RW-CUDM/*IPP5IWSJKAJJAW686$8A+90&2R;C,[S
M8%X)^)PGEI_G)FAEGI0^5I)N&KSA+;.&)#_ ,)0Y165YB2;"P8[8"P<29A'U
MCXY$/#HQ5$U1QK+^]ANS#=JE11_6T(2)""IZ./P;'>![?^E ?1!"P+#2 8.F
MJ-*:' 2NG@ZXO_M;<S0*00X :3$^^,$_&/TZ#3M"!ZR;YM !. R#, S 9Q:!
M\W8:1V?J1ZD*773 WL1_>%R0VGW,;^XU#-F_A_$<4NU7'&G:F ZX\:"!#F E
M8*B-O^T3#M$T8062"1U0E$368%BZXU@D%:E/58=NY],!^H($?P9(8XJ#'()3
M_]TD<4=-Z8C/\[)T0!=5@0Z0 V<5=GC1 ;&#1^F8]17P&<;X/Q*^TP$28W3
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MHSS.GJ"9W*DA5,F@P5.=ITT[P%J.YS\YY@9)G>0:BB?Y.*X#19A9=O^ 2Y;
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M$A#\]Y0T*T6!,:TI'0I_K?<)QQ2EN8<&:FK=.[_ILI+PEDVV'+?PV&LDH4I
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M$*,(T?__=>((X&\+[ND ?^3?U.F_X3B@_%W)S,S>R;\]0_2?]XL=(4=5(4C
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MY#'LZ0^L#;ZGH;C&_:Y)\K2</4#Q:$ EU$ET4V&T0<]M\F.:F2G*=,@U 3(
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MQ5W#ZQLXD8\&3TQ+#.G_NB;W#3[.]%* KRDU#H&UI #FE5$"3.T!86O&4?-
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MO_W;0I]ARW1-6R2.6%IDI@6P!P+S!^2TV+,'L-54;0I@/3FX$*L-.I$3H*$
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MDHW=(0>9;^W,@0JFCR@ CU0B\]8*L1Y>1JW1![/(!;PBMKS;@1^<H"%.Z,"
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M<X^?=>86+B4S#!-^:]0B]:_<AZW<.3RT[7:_LNP$9>,M:03KS\OJL:V#&2B
MQ_ Y8[1 DJ(Q/U7GFY438#T1?)X\.E-%4R&#\9+S%E=O6M<UB:V&#\A"ORV:
M=8J0NQ"?"GME.+T=U0FIV$(#G'*"NN8;G9H=Y9RL)L[.%"&YDB [NQUFV[U9
M_4SKOQ[[!]E;N'=/R9^^@=!'KY6;FI.2'Z+XS,YC/WV8R-N!N?765*G!L\SO
MID55.IRY @?"V1E37[\U$D-:I+(0<AEYD&@/YVFG&+0C+RJ -RA'A6"D*$L
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M23$,?0^#(#N,_=-HA-NA5DYY V!DP1-0-LG<$3&].0TY(T?S B?([G/-F13
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M34Z[B]1:;#:5%.QO \]7:<MNHB:Z716ZG81-Q:M*XX/MRRJT T\/$4QD)=@
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MG?$MUD-F% N$=Y\Z'1MRZX0*C2OVA5YQ?_ZQT?W979NY#\+Q/_6$)BF .;R
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M'F@* "Z3"#OU4CJC!:<64DLAL81*9U 4@".8G0(XGO3>AUPEZU@?G FW4%/
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M3L'F0#4]0\;Z'L24@X#4%D9[J?^Z7MG@Y?+[O[)G_*U.HG)9.H(;17<<(,C
M;GTL"#5]TIM[ZP"AAS7&>* 49S(3QS)Z95Z$#CI?=_@V$?KA0<H ]!@'UU3M
M-JM.= Y8'JZB/GB0S"V3C ZNG.\9XN*[Q6 2S<C.2#'@=,JU L/2-A_?PQ7
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M_6+%YDMDW::=%R7"5R(*F5749MM2[0JU#7[FC>#DWL'$B5KS5XW\JRDXCQ
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M.ZC9/O %QT7@[&2OS'Q&-YCY.UK0O+7UT8RX<W"IF;+@-Y-K+QOK^?1Z<P[
M<: KBJ*H!WAR.^)-R='.&.<EK!0*V+TW-[GL$.7K2OMQ>T60(IZF+X0/UIX<
M4/73K:&BJGXA]">%R/<"#<\^B ;]3X,(\(X5L.HM?--:<GY*DC$37J:7P*%!
MI2'5ISM8*S?"+:Q-^M9F_Y-N54Q/MUBB8(%EM[3@J*B$7@';MDQQ^FQ9])"C
MWE"Q>N76\'7U!'?C*^MY3]Z;E+5JT[_LM@F.>S;E5<;BNV7S_GV9@+__ O($
MSW8/<X< &._#SRVA0XYJ\ ]JWG3>".G#7\#%$ #+S9!ZXTCL)2*7CPT!A0V
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M^3A(PC.?LO%2 PORQA$Q_G$=J-&@=<8,A!>E%8.<3[T),H^6)+3;7C[D5HG
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M9$(Q+>M.JY-D4GX(9\LG8S2X\5U:),^#,QIU 7V"!GN.G1\C+?9CF_R[V=*
MQ=L.^R N_TD;4E=:I8G&"\V?I2W,MH/B4BMN[U/:F/N>_].0V6B8\>6+JV2@
M'"SY"]ROV6=4L\#S13\A:/XK!@@;.F?6Y1Y=^Z(;@D,><C@H8ANB,Q.'?7,F
M1Z[GXMR4M+/C.#Q?1X1%-U +NJ#F&F@7Y=S[?00>&UO^F'NBO ?7;INLA,J;
MHHRGK.\/BL5*/KMJPA7T+.+Y=7K \;, ;P=3E84(E06?$;\[#TOYOGB79&9\
MSVVGGOE[R7^</<:10 DJ\I>\(G(2M$TQ"]L+/&D^LM_1F)4V$Y\;=M8=C?<&
MJ[HY;HE[UW]: R9F28Y'[TYC&*TQ?8.A4L8*T=>SEM":JGQ]LHZ^(BT>MSDQ
M&I-H!FN,ID0/>U+FEN0- \5DJ\R212.1M_YW4MJI+B=OM'G7G95I3*)G-.8"
M*1N#9T&9$CWC=1D1' W$PR1_&=&X6[/^55;FQZ$%;Y"?](,#/9J[)H&7W;M'
M0NZ? KI]3@'N6';:Q,K%DS>Z MZYL[@Q3LJ6O2GK(@X);,Z$!YMU/%KHWXT<
M\BJ!OVI@&G@6$ $Y4PT#T-1"5I0G.+;K*@5#,G1N^8J0Q5/41[1'+[2$67KX
MJAS?^384&JXVYWJ3U3G6N^*+Q5# ?*>-5/@3);O7KHJ6T5.!RCUN/#P=$KTY
M"U.9@7(JKGS=@\U&MU5LS+R6QRVK7\\,2M3ZO+%,Y9CNL?(.A0U<H7=DW!I<
M@C2CS2P;LW;*AQ8D-)HZ7R12G2F19W//(XIUKJ-8O0JY48]64U$ 71!\UBK*
MB CI!R<X('BZ+I)4E_?+=!0?UUQO-N((Y9Z7H3,\3BW9Q#XZ\*NNK7[7T5AP
MXZUC>7'!"H&7C>OK8-%ZMKJEGC"&N8KUDNJXC"K<=9M0:FQ1Y!(JV>,WF^*M
MW;7(YL!+?HTP%=70>OWX#@R"YN^Q+"N6:(EK1A]LQ6V950D?7';HJ1879_.-
MK:HUY-;+UXA$J!HWA9^L('T9MM\G?OKZGX>5I8_8:$SB^#0N^!"- 7ML O?O
M+A"<T78D.)OW1@A&>,;]%#"2;_8UL*,Z%IF*/,FN?_&C74\PO<ZB1UC=^Q#U
M6)XBB=HO.N:"1312G4@GM531=K]\.33;LZ;X[WX=1D\OV"VYI<B6M,0'ITP8
MS;YHWH4V0@[\UZ +D63$),IKC,[K[^8;_!6(>=N4K\J)@PJPLM<?]*9E*.5V
M=LZU^Q>U"[+R@4TD/J?>*[>-:]BDK M<$\ORMET[&RLP&)O$@+R2[>FD&'5-
M@_OIZ4E?)ZHU\?7\3W@ZG&7,8%HOAXB_= ;G,!8Q6HWDD-6.]YAIM*IF>4]@
M;D!F<TL9<HPG+#?L$]OS=F0Q3">VR)T8B<_//TF9>B1=*3WD?]'KY;*#$VYI
M0*=IFSC"?\:KK#[7NM;VHH3.3!BFRA:WD-T27H'L!C4[C_6:LWDK.WBC>*I#
MDI3Q?#+5I9+!E8T"RNIS#U(<PAYO#?&/(&O_/88.0@H@)TX!3 AE4AC>MHWN
M(UZ><UYTNHJDH.PP:"#6\/'6<)C:#[I4_:N(07A-KHHW02%CP"*J )BY/5FM
MZF$97:\0JK#'<=L4TEM!3,Z7M"V]-!68^6#I_41_TWH<SJK7%I'EHS68^J/4
MP>Y)%MRB5LB;N\*B/<LXI&(P(*Z+4'0H-*G/9:O_7]R>>P/%2U.CRE 8\$QC
M0@AG4D'66AJC7=36[D+CO6NK30U]P%M<$QVU*>5%"HZ 5U ZY)DT(=KZSP^<
MH3)I'?P<==%7V[3"F:)^]ZU]*^GI=.T\%5SNJ'<MN;KP+5=P3I#2Q_9DJQ[Q
MM#Y(]X.<F4 [)S'Q*PG%AJO9(*9H-' NL7GA-TPJ! W,R\CT-F/+S1/)@+DY
M=+MBW!6AK;VV.'Q=B(^UF6)U0M_,WRZA+)&3W=12U'+P+6/VMQ88B0^U&^"S
M'88./ML-:AP8\+TQH,LQ2Q7 0&FSA5="DUC .+7+.[\A[3JT9IAH;*4OUSN5
M;/7ZV$C8P-#U%_K(T7%HWADH7=2@G L_#K&G?6J_["-TE=+TEX7\L<H[PC-#
M/8X*OI)L:3R3FSE8-10LD5PAU=H;8.!=]W,KJ7]\J&X\M'XND6_?1E!%M5);
MS3X:DSHP:^)APA13JC7M*5;,E6D5G"<L75[*+*<,TFA=(RH6:S^Z5KN,7X_'
M6?9\#05%M"8V[=P262J5+O40PQJ>^>7_TL/PQ>8FTXWP[]]+[\I6NZ83"##6
MRQ*N>B(-FOOEB?9I#UB0NLBO(*(3VUSA6A@.=8DJ-=EA6DZU)N4D4 /+*(R;
M Y\^')FRQ?U*,5O?'[]BN?M]^KIBWU57A?C\CW>9O=X5B%^)'E+86WS$][=I
MVU4A\^3OKPJ;PL:R3.XE5ZGL%Y6Z#L:^^B-&);]2&">*H)<Q0[L4A^#*^)H#
MH$K1)>.2O%VC<LF@VY;WL=J94!GGY$**U&R4M@\!FPHBFGP\9* 80DDZ:3&G
M@,>..NY]ZKFRT2W9*P+C.4;U!M/-"<(7[.>D*R4+[LFM&<!K%QB/5@40)L35
M9[H"/H5<"*.@]K#8GVQL1@3I/S7\[HH.)4Q*Q8H:EV]H&= _>:!8($T4P(-[
M:Q>P-,:!BMU"(6THZ8C@O]][K+73)3*E,A93P$,QPG3%$%"<CEXM/OQ3S3N%
M;D:N* %ZPVLME8B/J=XP*4JRG_3%VXD90UX6?8]^[=K$2&D^ 7&ZE DP5JB'
MV_:Y2UO@JL0N)WM8-@6TOFF[S54K<U)VY8'"W-^L*:_UBB&6K-OYFM/5KPFV
M0(VV_F3N-@5*!&>Q%6]2^;H)DZ !J.!'-1?*, 3"0ESL]B<>?J()$ATI:4XD
M'PK*+,[<GP.>O>:\EXN)=S]PR/I$<(RCJ1WVA:EVPBW1#E42T^2?KI:!I=#Y
MP9P/:'Y5QH+1L"Q=>*F<4>1X9T%Y?_3N5)%Q:0084JT5D.4@-*'Z-,5(7W."
M7/=;*LBH]6A@.:NFR?7,ZPV*_F=5NQ^%!SK'WLA15 -OW%L7RCJ)[1ZQJM'!
M/+C4JT%V^.^'A@<&[BPQG9T=W?F)!\O"UU]$_JQ2Y,O3Y6$LNUXEJ=]E=P2.
M"&Y,C]&0'BTU>+\$FTQ&2]_0GYM)89Q+.-;BVK"TW?26OMNGDK<E[C6)YIE5
M-6KM4>\H>?7+ RF'ZN;2YE[WOXB0.,$<(/SQ;.QPW3V;DP::RA[0M"5>1K3N
MK=5XK:J ;<-T5?I]YAE>G^R6?*0]0 0R@ZU#'9P0S[3CQ35_7NI-BM%[2MK=
MK]K"!$_B\ 0\4236U"#4WMEO?]J";7[93<1/H,LUE]I'R2&AUM,.3@''3ZDV
M)W'4:R0KW&KC5H]_E"Y7'8D52ZC]9^6*.(&NY6FHMH+*$U[6<=Z6(\&U2J4J
MQ#H@8Q["E(9^@__A]:#"1!'G\3KY8!RC<3^&N9 ANMN]GC\F(L/7(+=GDT_2
MLB2STJ9 *I-+.+S5(ZXRNCIG_<@P"2V(E>^W&*KGWND)W3P"_DEN:+<#<A5Y
MVG;43^U.9%?D"1M4+9OH!Z/TN2!'O430NO^ _]S9#)G65N=X">*XSN#U@5YP
MXL(9'JV!@?"&[=T"C7%4P\'RMR1HN[F*@<<"X+(6W:A!$ M*;SJHU S.W*C2
M,_VW'_IVO,^FVS9DPZ X^[QBWX;&KFJY:=MX=<QP@$:5]ONES&F-Z>@\<4Y-
MXVK!)\JR?99DOF$N!=6*'E5AVSSB?#9K-OA\?+$#CQ4:RN(@B^8;S;>;*M5
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M,,.@XMND//\]:PC!(.ELMVJ@H ()SFI;?=A&\$ A@,H\$^K5U"E,3B4)O;F
M8JZ=V0UIJ>M*#&EV?.Z#^%Y&[WD>]D4G\%B_R"?7/"'DJ3+T:VWU+QV074/+
M5,CBL3V/8^3'&ZW97N()4R]M[R[;A?%W;S;_[4153/9'2E;I&*<7CXD.:87B
M^4;M$*;\#A\XV3&CW+JU"6B#1K3&U/V ](S1T&OFG#(R)5E>_59&D5.[/9SD
MX *A#G\];L906<;&WNE*H%5@C"&_L>3NN#YWPG_UW((*G#$K/15?'QRX[O#
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MJC7/:8:7/@[-,(6;L4K6=&<P=3>H82US-E0ID%/L=JOG(L(9)M#:^O>0:LW
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MSPOTZ"BX/O'S;49XF=UN,OI C0S17QKS%W@@$K,8L*4Z-:OCX)?BD)F'&9G
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M9? ;Z6CO+]OD^WG$UVKPYBT<4)CIN[78;$,I/!NFZ\R)GU%#3HJU@XG% Z<
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MWPKSFX^A"2BBR2%%@GX NN#?CV72O8KPH' >WS$)1+%6$R=[9X442#DQH4;
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MOX"[M]#H]%3V%JFA4)\\7RDU';H CL'H>KBIXSV_$]I,.BHG$+K]3&E:8,E
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M]?9E)\N,QQ=ZC'/V\G8$Z&HT=FKA1(<N83PQ+__G-T-QROD2HLIVS17&PF)
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M',T4H;$KZCSZ9O1NN\]$WA#WH&+J2"A]3/U1]%P*;9<Z01.@Q..I.-H)\MR
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M1"J,*8&0IC@E*W8$>@:I2. -@>3<TK4TCXWE)';IM&*L3$%X36J&DLT-P;%
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M.;XUVXQ$L>]PW,@ 7EZ^KOC%R(@V6Y9\D\H4\'8[3HV43^&X:TQ^^G87%]=
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M$E^MD_:897B3<J5@B<<C8.]I")5IMX)R-=\4B(8=7XU;I.KVDG[#VYB?9/$
M*O@<W'!2>X&@2;M/UVS4->VT-V\0AT4&QLB+[J7VR=4[4\=WY0D]NTD!'>_]
M/+>]"H*-WTR/UUB:@*USB$6CB5"Q9KY<?LOT[85B'W%N*0^DO2S6JI+[V00
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M2N%$8DYIF%71*W5'3P'K:!+G??@ E>8= ">96L^II4W<R+NHVGWSQ(FGU#3
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M\.!_'OW"GUG\IT99@@WHGVG8&R<-9QH:9X$W[$>MR!J>(/KXH<+-TUO3D5F
M?8>P6!\ZWZI -$+L9]6F$<9'?%B,YJ(.S'B/T8[VA<VSIQ\)Z"+7D"/HV6RV
MQXVBVW[O"Q[?H4[JT9^4]LE!& @YC_.M?/OD%U&!/6!Z1,5]^7L"4)[%RSV=
M"AS*];??W'QI(G1>RW=NP&J*^_Z$AV?^<"+P_ &*U_6AKT_V<.C/#[9#Q_Q2
MC2YT$7"#J#+M!W&S1I.6WO-EJ36YVC$1F*>/H;=?R7RJVXMKM9:R:0U!82[N
M2J#D+(XB_8>*RZTL<P)7K4&&<?04NI.^.$X()T&\<S $MV)Q4@;U:5@9$7F.
M\B+IPA.ODGJ^)WH6WHO?[&'79+D'+R:@M<]\D@C=&4B"T8^RDH2E3VH40$$P
M5HHKZ0#39L$%E&]T0V\VS;Q]3_K[^5ZG4U155S.C@"FDDFGF2L*K'WE"B]]@
M%$XTE4FT(@Y7Z).I(TJ 772CJ %?26E69LR$Z&<'TP3G&Q:L?4]5[T^HYMV?
M?F_@L2Z_\'E2]BL(D)$<TG4F_E)'DRQ"EO_ZD-FPX+1.=9P%]L3:B'YK'7]*
M$R^PLV8ZUFL.:>GXJ9'3/U_,34OG@S0(,%4KRQISSSMQ:XPNO"N>9#C"Q%>/
M8L]?XZLLL&"[.$8+EHUYZO1N;U&IQFP!8A*DHZ\]7<GQ(_6]RYKT5Z4&^,<?
M/<'*2,Z!6E3BN.(,O!E#"%6JBTK'>'-$EB6-ACKXOZRT%DQ!:D?6&M05_+UY
M+! WW0%NC][[2EHA)I86_[U7JOAI/UCMAMHIS>:4K2E$@$JG=;/<L>+F1<W^
M#]M@2_MXZCB:5A6TW+WA@T'$ZXE<-P7100+NSR"[:&B?5-_VH;-?S,BL(D"6
M?\2(\J,@*'MM"*/W<MHH<2Q?QPM64QEG>Q=G^OIUT9H-;J$POZ?F78UK%:1
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MRL\^!/[)A:4!$H?PD:B%BN2M^*(MS9#1YM+E&4M%*6&OF41:I8KX"A>9>/9
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M1,91U%)G!V>+Q5$C;.-VHV/7-DXC,;AB%Y+I&0U5HG1?DR"9R;(+:FGO _!
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MB'KKM3K>MK?:-K6L,4<QME3?60G=M<C*$>.:,<\RT=X^C3B X5ZYD!Y,Q<<
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MOPN>6Z!>7JO<-_DE,4\_+00DG[)!)<D)9S24^K08GF,0V135H'N"^)OB%N*
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MW[B.-:B:9'K(X@B&)_$ERIM7[Q7-$1^?D<J<GS32[2*=]/>\BUD5-UAVB$.
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ME:L?\R#49A)OM;FFOMT#][O*%XPU83T@C.,LX-"=F1R$!:M+SHG,SD+W^@"
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MRN?]WM]!U#R\4<]*3 G?K'BTXRT"Z S,\V9C]]WOM],;O!V<'',0HI=$OP7
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M8 2N1+<DQ- O<.!;A\L9961*91[ET76[+ER\HW8C*[C:2/%#%-H5:1[\%\?
MEHP<X34T"UJ#4R4\8"AHA*/R&.J[8I^M_^%MR0>*&G_#XM0OH%3KGQ#C$,S.
MY6RNMMV74=GKWZ(^J%@8N-W_ST9A7*<FJ%4#D8(DPQ@DK'Q@<:X4O\OZ@[+G
MO/EJO#H@MY5';5(2*MY13+<C&IQM$@:<[[Z:36<L/P:<W4Q: %*P5&%^,04%
M"$_?JHGH7K+?W0)C#GC"V;0OC_+HC!%JI;S;1N3)$&/W>-QZ7RBEJ7F40XW3
MP4G"R.WFJ<Z'F9 K4;V:&#?T9[8!2,/$]F$@$G[FJ%@;1$C3[^69?X48P+W
MZ_@[?NA^=CCX+&4^.#!,;$G!]J7QO@CS@P>6(V6.@D<8%\L*(3FC=/PH0T-E
ME8QSV#I,>UW0MG:)8KV!W_"0*N*5SEEW+&CA6ZAQ]N8S_M8>=KNY>HT*W^?>
M$8P-^ 5]>+"7JA4-K[-$NH15?/WBSC>U^;5T0SPMZC%ZP1,_&-L,NDS=(J*Q
M$TPPO?Z71B&OJ0EV<\26Z1#'L#RXE?WH_0+WD#^(Z-7D::KLH1U]K+39<<6
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MI$-"?,?;Q90=4U-2;F,GXBNB7,&FO40U3<W0[KF@CEFX?$JD!OP*"9CT!,(
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M3(KE]-OVUB@YF.T:Q_TA3EI=QT=M\#-(-(;D%X+H+CS)9C])E&)OP>V_4?W
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M?P^ZY)37'2>$>":_2OQT38L_I7D0QJT)'B+!/OY;R]Q/*"MU([7G;-14RP^
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M^34\\A_/<Q\(":3EB9+_Q"NB-)A5O@.AC"?4A39BL)Y0*1R!>28VK2%,%EQ
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M=J[M\[!QS;,)\S&#T_R@US8? ;I,7\P /W=2A@,)=%[JY%H$0ZA7"GR7%<-
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M1H]/,#KRP7L8=EIRUL:H37ET<3MH6Z=.L\32:0GJ;\-7.JYOT16]A^O^>G-
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M"B7'>$9A)(TO&7Y@$E0@+' E*.'*E&*WT8>BJ<3FH<!5ULIZJNXS1]@[:+[
M7)WMW)^6 5[JXX^KO)'CM$$)@1;45 H@[HE<I2/F@[N>T,FW9_KS\>)@V*[?
M(DK &\R]D3)@;%V0Q_E,-.WB1M8[U\*,P:IZ_^9[3=IO54O3W_S()"='2UVK
M2@'6/J-]B[SUG313JWRQ5HF>]\*J;UQ>]*J,(QM-O#/K"'*)?;1BB-8_X#PG
MN>]U8Q?1-TT?$T[P)@ GY, #7U:&>-'8&NYSB)C"2.DVFIR6_!Y"XA&A"6#H
MZT!#;,$>:J;*.\9'2P?ZOV(5[>U>.YT9M8^GQ\E[+W]7VU'_.X.['0IPBW .
MV6;.5V)P=X,FO+,X+V U"[\38I_[4Q14V5<Z@@;?#![X+(,Y"1(X)F?'C(,G
M*(?*WH>K'NH.BHN2GD%9=B,+ L]?ZJZ?$<IX93M:Q4$QVKPM^Q/UTK-]XWN:
M%'46O9[M@,D& ->?_"J4@+&I!PC,]/0A:%6:@'BR2E^H6IF5#=-E6:ESY/]B
M1B=Y7 IZ=U[AZB:S.O\4W9('V/SEPYFM^=SK=K=K_N!B#4UMRMU:[;*+PO]R
M\<4L_JC1&W([WZ'UD;R7KMI2/7_[N6/7S48W2MFO>S6.QACJS:FP0.XO^*3$
MRCR;!!XCH 2U7<9T?*^V,E!?RC/JJPK387E\$.;S]J/BC(MC_/9.;!_#'>>(
MDS(>9OTV=Z#HXMRQX["3V[5]D,D:^KTH<-]Z!M0K.ZF "UR6T.U2.G;9Q@J$
MLT-HWCADV8)O),W(1EHN1:@W3G&L"AM5QRM^" 3# <;BN<5L7[^.V&W73<TE
MM2Z9(<OA@-O?O9K!5Z7-2ZP\YXRQS9=S."AVUVV>%9CC^4X?C"[#$KCC%#"H
MS&?:#TMP:1GW''[Q#J2Z$$]X3>SIC$NZ_.C'AP)FU>$KR%S&5A$LB 'N0RS_
MG:$0'2?^O@AUE7.% DPO<H=P'S\&F 8(:7PG3@4\6WOW.-^2^>!C&Z61 FG;
MU@;"A9 RY_H37$WIP=PTMV]L)^^>M*P;LZ:-3SZV:$5I;3+\'732+G':WW,R
M7Z&:^OY[KD=Z+:<EV*TVS+YMZE?HB;?AU\)WN+E4\U 8S0&ETK7TN%C=#YKQ
MWC.YUVH,9O)6G;V"-G;^?9D)S!?*'G\JJ.?'!O.V8$-ZS$6PQD8Z:(55X?F.
M$2ZIS\Z]JK 5P20=*:2!C4_D;)GFFR4Y;\R/%%\\">>9_>ZJ33 D,!?\5E/6
MM<4%21_!VPB:F@@6\95RJ&Z04S_(>MYK[A3!^A5CM-GY./H,E7/01@NM6?'4
M2H,^.?TI<W'UDL:A0SM#5FA0C ) P=]S%+2K=>SDO">8#W7*'?A!$J3*)&/D
MT@CBL01YS$URHNFJ.)9$RR/78MNZNY0[.TC.(U:N):@#8)[FBL+KN7F_[,DO
M9RF\,V@=NY>0.O%',C/I#KTBV(PEUTU00@BJ.Q(0S\4)J/B]H,D9SH?5I*S)
M#A99#&SKB]9/@P)QX;#DXU&*\CQ!?* *3+:,-%^VP)/+EAIZ\HZT'3D2-D##
MAM^PQW1C9^>*43G,N1->AP>;M"H1>2H5D6X^O^.;;@U'Y1XZ[-X[2AM<<HTJ
MW7>Q^M43BVC2@>K1Z,K4+'//LN?5=UANX6<D41^*]CVAOW7*]\*N.?N*8*'0
M;LWP^T%;H:0X%(E)P:W8R-2"V%;2O!RX+W+%AU7%#XC')>F-X!3GRXL-=MI?
M#Q9GC5+T*D*]-J[JN>IR+*O^5)G_50E%< '_ZISP)1)P0V8)U4:6 P=?(%6,
MV> \<\>>[W4Z#1Q^$P-+/-/XVQ.]#'O.Z7'FW9=&GUVVF%P=V B"SJ8*9QG
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M=3-\.2N33:RA:'OA3&[$I0<_#:R=CF,R$FR^1QSY_/W8J3SJ?JR.4-*2!5<
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M\%^@6W\CQ[,>_/0QC5>BW!N=-!T9Q:X$I9O>,VF?DBX1=M^,6]:$]F<$P9:
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M\G"+S._A7(TNQZ3).5/[],A/5"X<A',DA%(FP#"W;]QFKY]3#0/_&OD4GP'
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M<F*V<&HB=&>;*2,]502A2,6V,4.$M"<8Z CR0+*@*=@V0F\S/?Z:.X86L::
M1]XDJFK7SLEC)YE04!/-%H^BIK,EFD8H42EHBR/=C!E*("EWLL4&'E,!*B-W
MZSYB1U8DH0\!Y36EB&2X]QO#&!D$75O%Q?2Q<+1V6Y4_TP"%^%3TOH+D(3P4
M].U5_WB:;RJ)=K,EV%1ZA7!171/[W\?PAF,G2D[ZSB_E5T_96%UZN4Q3K9NH
M>O_]X]_#)4<V.J<0CUKOU:.8$W7I[Y%"F'\%:.^73JH!LNGLJ*63D?<N^]4,
M+J'EP?SN\57FP1P9TY9"Q2F#@<GUAQ(]XW\KVK_8_/QI4ULG2;(X!/0W!U(1
M^S$)2& DR6#E:\<$UIK2&>HT"C];X6V;::T]75 ?+.MZMRYULG'8X-853^]>
M@XQA@[!O:AE>OXV9_[* /!>X0T6 P^*L Q/(IT4V/*;C0T2<K">N@DC9^VJC
M@8#'%,&,:H[_E-4W3!UV,=QLAD(5C1YC\#:_/-<OI,E(9.(NOK11*;W4I_K+
M=D7J^)E4U8EA%;YD.;]3GC;^&3F\I>0QG^TL<:I^?:^9[O#1:=+5D+/B-M<T
ME]8FF88:O]QZG+.%MLIKG"HTJIT<*X:#G3*)JF6R=\KD3Y>I!8QG3IFK9CE8
MT2,#%]_0\< $ON4[Y\ ,G8<1$_Y0O^] C P'0V%RN.-@BM<HUIZ*> R3(5A2
MT4(??X%N/-P/%M *;I,*I0NMW#+Q^T.WZXE1->"=:"7Q!93"SX_6$=8!6LG6
MZ^7$'0C?,;#Q)7<4]FIFO4JVOTCX"A;/J>/*K<+DN@YCK-9Z9F3N6J_3EI3T
MNEN]YL]ZSO@R1+:X)I,JS8TS5^U-9VP FGWU"L+/9KCS:U3CWT!Z-J_)^XS-
M]5F&)O,RT-!-?&RZC^ZTI#NG26H"599&2# AC)D'X,WYGFI E.RFX"6"\MH?
M1FIR0JAD[6/+'AMT=%WKO<9*S^".+!O^E--B1>][&5!A%Y)OI2\#@T ][ITA
M^9)[ILH4_KNK*RLTP9SH[7FJHA;;_S&ORA'F49)0YQE;8Z7CW^&2B>IW3;%9
M;4%GEX4N<-EH_Y)@,W/H![0$IJ1/67]J WN6AI#"Y/;['"*X._XB6>@R]C92
M"W ,;9JX5]ER:X//JD+9N!>)[Y+J'T>M$P\.G'9*IF\UI"TJ;2EIVHY&P-*(
MBBW:^TZ?OS9JH"U)W8&04"KG1J^U6Z<MF N?GR#8H2J"QN8&5#/>Y:%:JWLR
MSV?PN5V-"606<0KADBQC[HR%.>?987!X7SK;$!B@RF0!:_U(N77X(4YV^>DJ
M:YU\-*W P0H8QV2YH;SL@$?#\UM&/!H01O[08)1KO+'5?-3Y]R*H8<R67.PG
M A>1:7GJ/9U1_7>04FPH;02"B:(B>XI2\ESCN H3\!B*]ZTOPL]HHT6N,UXV
MA'%#]XV6N13KJ4V%H&MMDR7^;5WW8;8GXUU\HL,4\_)S_..J4@>#IGI=8AOB
M2R[&K=KFU5B=J' LT++7Z)#\2CIVZVEGKK9IFAC-<&A]1NM-P,3%<51I0?Y\
M>7V#8HT/';FT*89))^&TIW6QEM1-<3"AK^OP9)[Q)$]%ZVZ[,(X0J^#'!U#"
MJZ8+[5$QU4BXT6@O2GA^?FC,JU=*/#O9P)*<0$604O "#@!SD7=FAD_(O; 9
M"3"A2IAZ&&0>GBL8I?(%/*;MC3UQ\Z?W@-*7=*.GZW\NEPUFZ6FF&25O=188
M%<L*F$R$WTS70NV#/NCV' MG:7OEEB6]W>RB6$JYW'=;_T>SCGBQ#NQ 9F"/
M%[>?Y[%]&V;INMP+[<R3.Y!ZA#SQ]TG#S9L.[.?I4/QZ9,$.9 W:ET K1.Q
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M&I7J#M,F4]-X:VO'^K1:H0[3S/I:H:;,6@%5M_3V=3K+]*T^<9T!\,\G!02
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MO=1.G-@(.[S?O[V-V/SZ3:*ZJ'][?/"1QX?X3D9XERI]KO+/D3L<O*'>WOI
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MHY7\8^Z;C>PJ;=5SKQ[='=[XI$4SPV#U^AQ/)Z63G=DWT)F4(1 C\(,CA$9
M Q!$E@'+[.,.@WH)]<M(;3R;5&[6]2%/[N/:,\^5>TW<C;8;":J/::1DA804
MN!B_H5=6JX(/*U,V]D\P!C0%?U>*\X% @#TED(7TWC/NW"!,3XPD8YLK%M??
M*H #5^>^^NI;O^WM9Y%]U*B":=.G>\4=O*JP"-.M@D7O[+[LT+4U'IRCDLM
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M./M28O7J<JR)(6;:);']1?[,4YT[;B'!YFR['/R3%H56M-52GQ-*/V,-XP+
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M9 P\I3H(#SOX!'Y[>^21UW([O3$8O?XGN2C>6*+>2@HU:;B2JN1CN;Z_F3#
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M23&M'LN2;(%I42-2U!K?A)?$2<NMG\D6FT%NET'0]@!7!9/8/SI;NX _&"C
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M$("']3 L8CP1$=W30NB9JRM6@>P*)W$UZ]3L(/3M,/F07.);.)77<EMD^#*
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M'NQ BW[FWUCYNU*43^=1UT-^!1.EE)5PG,W2,GN2FD 5#A8>H[0L+6N1Y77
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MCB#&+M7E>H@(:P 5'WG9%VWVIM%.^!#KUU\]2=FKPWPVENO_P/[)7?2X"H4
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MTIK,^^CTV>H(*S"&5UP?D3;E?9%TDV6H0K7\A!>D(TEY>C9I7$/)8FE3=@_
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M@P%R8'A%=ML1\<'[$58V_3'A^&@$7S0VH(HKM'6]4D1]Z)UP.<S>^N,7G<_
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M*7:8?KX> F[$.$4X^^@[+!SP[:=[7_3-*7C,^V>A#_<1DTHTH9_3H )?6@F
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ME-#.5'G6XC1$$?E/,GB)<XWN+R?"&X%4@BV\MS]XKUH5 DM K(K3?]$ZTR:
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MEXI!]#( GIG#7?41P_NT1,;!V"?@.]X,=0YGQ0/3L7"B2Y16 >-B="L@-4A
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M<[4+(#23A&R:REZ\%]\\O,C@YA6M=.M?M*<7W= J[0I5+?SW!U1?85E]?C!
M'%EIH?[#(P J:25J(R1(+ L?>2X%TE@Z7"-:A)[<[1IC+3Q[*,L++"Y\5OHN
M)-:0EMB:V]"KY@D:OXG^JC</KY69)#Z+Z[[D.7:?5\ V9 P300R%O\.W$VN
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MV_:I WTS>B_VZ_E;>K;K.+&=G1[^XVKJB&ADG6U^\.K([!5_7-)GN""ZZH<
M%6/ZKY1!<+?*C_&7*&^R$^P*@+.@S#@WY8JGL$(RE>ZN3"M#%L" S(*E3<,R
M<INWI,O0Y_&X>4E;=O"N 5=V6CXC([K82YJM>2Y-&!R<JR3;:RAO9*)[YG"G
M":(.=*F1.HWN"'(G!&)3HN06P1BUIY^'*Z3D*_-SKS015WBK:M=[NA]<(><9
MD;V6"$6:W.?R.,*NZF[.QF+.]ZE,ND]Y["9WIXP2[V4<3D[BA'V)^C@,25FP
M8SV[&#$N4)Z$,4M;- &FEN!;IG3Y$-HE)_/%.8U?(Y"S7^\@1Y- $563=OE8
M-7R^QV/?YWKSH6'*3RX'MK8I7OJOV(879CK\_0\UEB!.$>#UHUF I'03KPK?
M1K*<;W;!_1%Q@3=*)O#IO'HB!J>BNU(!B]I@V+\$SA4?9#9CH/,7R"Z''JG4
M\?P!KI996!X3[ZSKKDMWX>$M"IX?+?\SCC1V0#!B\Q:QE/*6T9H$WV_59TMY
MNI_SV>F(=]D(+R^Z^.1%RZO?"RM*P_V2JT7MK4+9IX26(>,]OY[)Q W=Y]TF
M::/#!#",.10IW<E3G4);"1KS='01^N*)F,;:#Z\&;RK3GL+7'S.ZR;5S./Z4
M)IP<^*2@+=^S0IKM[PL&\W60"]0'Y%"8Y ^M3-@Y0JJ)=8Y_?/A]:&>\TG$.
MAQC?E*>UX>&US'FT@.D2Q] <^8S:@U?=HP5D)J_&5S"%A_,)%G9\,8[2X$Y6
MX"7LQ>$O\&G4"H1\]Z3P8D<F1TOFK]#]%C!PJI9"2<PV( ?;OM90YF=^F\-=
MG<,9>YA!-5(F%IFN$9;&I[O.X1;0]X():?1XJ?Z)X=\['L&)@N_AV':^7W9-
MMCFTYXOKTTM5B1>$AVWX[<T7-?^M,.@_%@F-IF3,X5+KX8<;SLSA=!M:.-%,
M6!TQO(7U^OM 7_Q_6L7#< 9:O'D801&WL.I\)S%)%WU37_(DT-<(B;%X)H"G
MAT$U(7")REM,\0,I4D*+>"%%V+BXJH(,)[;FY48X0+F\1^,W7D3%/1AS^]$O
MVL+K_)-QSU/70Z6H@-5 5>1%J:CP *I3C#G\"M"LY;CZ;AQ#DZ_:@ZR!AU0;
M_&1_H,OH!^"]W!^L] ?BX@FZM!Z9JBU"&[)+HWNOZI69WYEHJ5#?0&46E)_#
M]E(D^"&10QI<(%=;2$E\EA5]+V1L7BQ,!F=;K=9 A54Q]V-FS>OK$DIH%+^F
M_B\*EVRG;IO&OO@MC^*L]/26&Q0W-MZPWW?Z#+DSH&.^2:@>$U!MA)FH;OQ#
M9('ZFH>CRNHS=[F0N^$P^I>G!P^N>( .F*<U!RRP><:*Z$.M'8#6)G VFTUW
MBXN7FX S<[BTA%!OO-)!M/7]DUT20E^\B0R+9!V #J./6#/:0A:Y-?^*&=U&
M>1J?H(D$@IV5C[*LBF.*: ->U0/E%<[7/;T2*";C0^^-_S8_/'CSXQKN#G4#
MD3*'2V<M8;@P7O"J9B<'J9+A \I\]6-. O#(L2MG/3N>I4=W4A<R3-NH,N=L
MEHF'U[VQB^UII;'!ZQY84+5IMJU;=PL=Q&83RK-'/'+SX]YOP#%^#_3Q.GO&
MY$Y=V_N/N7J'USZ]?<M\Y^&[V<7_>+PJ^KSV@ZL^)R*_/K*YO,VHF]PY>H6'
MR0 [=B@&(R$C^1QNTA$L4KK#6(2FA;6/N(,)K9A'OFOT;<_PW,QX*R3C9^[X
M^A>T+_.2?@(_70>;=D/9G_X4):3%(?[1]G4ATKY*]NE3\OS :58K$7;XG6@"
M2&[.X6K=%#.5B$>6U*R-.=C42K;R<(8.2#<]B[=+GP:T&6_%FM*^<YL11ZM[
M,6M3WCR3AI/:*46^T>=NA$1T/HRUU:)]N1>3KJ5(,4$^TQ?U 9(/3"P\Z7GB
MZ4<;YW/9HD(P)PT#@^@B.,/M:ATOF56+,)Q )5-N:;8',CIY\<&OM,KPK:YJ
M]XY]*LN>E@3'&^)VF4/I+WH; 9]2WK$+*7L*@B]LVV[6_/Z@U?;<-V\OM&_L
MQ+EG(IO4#X!Y_=C/M@-#&V7.DV'8C_7!9\&-+8'HFY&E(#6+NQ7+G_5F:5S;
M",29-X"N&AR)@".E":U,/&Q06^'?YEYN3M<(A B9CC,6BBV^A>O.914XQ(2.
M?)D8P"+0;4(#KYT@2FP3U^5-/E<=1-Q!$K]+-*&T@"]+"0N02" E]$U1)=T6
M4EZ73^&/T)C-@ %'R[8Z.:S[E$? P\,1[X_0(D/SIP*[JZ@K9ZGKJUM.+?C>
M[V/R=PGFB?O5'+J/"H>^B;" 1OFLU$#Z47@88LE)?.?!,HG9)5?'6((^''T8
M;H& @T][. [.U^C>6^Q[.!N/Q3E5LH]GG6HX4%Q\^6EOQ9=*US <ON>EP]\O
MZM3/,,'+@"<#':Q!ZU8">("MS?B+:(3J, ;%IIRMJJTP5:8U>3D.LN9S[6%'
MJ*RM,4XQATMQ(2^'(V6VI64-V>?T8_TMABAWPOBD):$'W>,^3H2'[U)N<N-U
MUV'<ZUMG&6.8#!Z@#A7)J0I+"0M>&XQ%UN.\18BV^G?NFMAYK!.H\D&%<1"^
M;1/1@O$3[;<W_0A9(DXI-(!CXDM(#T\R#)\W9KZ9:#=OF^G/5K^]L<@_Y*"
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M,5L)0[Z*,3E^L/Z[*DS])TJ((6AZF*C<$&,8D*EW]X62(*-P^((D*?A( ]3
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MF*PJ8;W$CD5/QZRTD54I #@MF7"2^JZ^[]/ V="Z%^';&+ZU76<C838&.*2
MRTJ@0$09TY/6R,M)QV719.Z$ Q#&9.F"'"%*F4@0A%]K,2)9U0VXEA4O!3%
M?ONP00Z5[^5PHB5SS%OBQ39HF.9.E*L].U:;@T\_@Z#!ZK=%/9J0(IQ?<R?S
MG+8 I5.139/P.]CZO3A^[81[^=.TCB,L09;LA?^ITT3ZAOZYI++ZO[9_KU:Y
M$%NG.HD90;86(%FH$8(4 ^BEAC*H!X">Z7X BZVSK>E8J:>A"&"SK&&]A*YU
MZP^LNI^TMP-*V6G@F1_]YD3-Y.+AY%$>B]= GVZ0[2._@;?<$==C<C!JS='
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MD"-#278)<&*U)Y"/O"B>=HU2;YP,A/(36'L]O7'9.)6>-HHZ\2UL0_23;;-
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M"C#3\LJO]BZ_TNFP0X2>O1%\MPK-1B&X'HMH5CR-%GM]$@6W]C5G:U3UC/,
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M-9$*GRVV'&L;XAXJ"!,L$P;>-SVY#Y-+ TT2(.U+N+%A:13XXQ&Y=_$:DKF
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M\6A==^N2TB3^MPVP>/K,$%Y.EQV M@\[+G9]/BM_0#8DO^,U;BOVG>7SQ$H
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M>;;Z_J9Y.[M,MG_R/_%XW347BL4PK0[%HH&6JI"NLO0[>%X61T^'*++=<&N
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M>W^>S@G&'>^/>U06NVYGE-]0XQ:+1TMOV37E;<QM77_'VUU%:P>N2P_2*E%
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M8K7'OTI[@_9)O[_>K#RW9.A[GW27S9W!EQ\L+-];-]9UG#=X2S!U=MSD?G?
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MJ<<CTX8G-MK3KLU466=M:JSMOU_?^^Y%G#2!GB#_0D(Q)./T=FKJ$%/'T4U
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M:OYYVZOAZ;!7_.5%^RWVJ?VBH1#!P6"KJ+6!L]B?J(6N@+&-."T"#O9Y9^G
MS=$ S>D1+ V8[/3\NMZ.$NLZ[/Z*E]W%#_?M/_JGU\/&Y#%=D:!R=BI?R!N*
MEIV A^16E(F)8/Q!N$)8,Z)#@G2?E04:+X?.YSV?0#6A]$Q?RA.O:0V81>JR
M>9.N+OWXRFN3Y>*F0W],88A*\(5"@#ZZ'&1*YZ>44A75J!V\!1Y3:KL[<YA
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M'*;J<AEDWL@!0_I;#RE'K,63<KC7#M%Y5+L3.CAQIS4\.A**:@*6*BEMF??
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MZ18K*GUA>9,OH3BT&#2YW6XH&,]$LXQF[MS=_^)2+YP-1:$:]__3,;"<(WQ
MV 6+Y(?A7*%QMGD238M2QB58*YBT#2,4<P]%8:V6)/9L3!X/+',!K2LE8@=*
M_R$HKNDR ==;2\SS&H_]+3KF\BCZ_JT57IGR7F&OH2Z!+<!H+SA%3(XC:A",
MD1T0MOD_Z[X;@R!W+Y!TLYRD%<C1KB6_].>(S*$2V9WS0>%BUZBV5]G$"IL
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M?V[6%6/AC>;(RAK9?<5]8E#H($]FH[@#G-,RE[7"K^5[D$WP/<BGE=0[APG
M+J7Q+O\T9H!M)YZ_['N$=D'T6,<]C\AW J[BG5R+ ZJ6'O4:\O1VT"=7S6'.
M,7Z8HNOG,"]?0(9SF%_'R1G$\EFDV&,.L^C-'*;,1/&2.#,FFL"T0'A$ST(F
M4MPCOJ2MG<,TN #"V^AV13KQ@D5)T('Y,E^ /_DFKGR,B^>W'H0]"'7//,?U
M?$Q@IHB$H0![^Z@[A910O*6(#2W:3N:M+'-:_.1^=.06VZ]SF-U\5<YC2M'>
M3NHQ48D;UQN<OC63[>#385-G]<EB9/NISLCH'9%:^-^Z66O]XB=:T'=BS2*7
MO[(?YZC[IJTJ6DCS5]3,$!=1,F1FBM((8H+;SYC^:Y&XP3+)[P3+I-\J4F4-
M$39PI'@3J]2O\EX:>2KL0(CX#\AQ^YXUG2XK7^0E(=&3 O 8+DGI:1SA'1SH
MQ!@\ATL@&M*6X/A#(G*"N[BUA7>=HQ5)3B268^,!O^D;73&I7"YYB:/A62U9
MKGX"-?3A!+JBJX3JH571!OMQM[47#3Y^D5RH-AM,5EZV@HCHZDAXU^8P(<$6
ML@6*Y#G,V1(_&1MN?DS= LZV3"?_?%\&U33,83"U6) G8B90G7#T&<5AG@]T
M.:%TO[CDO-GMG9\Z108>65(]6;J^7492E"[K6R=8('L# E-,^1'T;[;I?!<Z
MJM)Q;KQ%0L&Q)D8*6P4^*?^5JJ)XS=:C7H:3A-CEB"54FAOVD ?9-8X2H+%X
MZ1,X5(*+_YG^U*]X8[?.5,[Z[M$O6B?[^&_7 R6T%4"#/6TU&6AH99;7KJ"&
M*YZ+YC!Q5T +(5EZ\DD=2[I!LL30&Z*508& -@F4-']=8B!I(B\,]KN^Q5IP
M<]9=\^%@ -XV/;5O1=9Y#,HD^O%P:(?/KECQ'010,,L%U[;#OF).8JTEV&AD
M)^;1"1:L9FS<52\OK";UY.L,;G5(IJ-.I/C>[8_YH%5IAGT+7?8'WBI_NQ4A
MGB7QW0V/0/E*7KG#!,/F,,D?8"[D1M)'MBO*E4A[XT2LQ#PX2;*:Z@R.'>B(
M)&JEJ.T']5Z;O>07Q)8'+W59[__3G1Y2/J3URTY3%PN*[K"QG^R!(G$.XS^'
M&6Q%U3?ESN_2F-_T\A<ZXCF'D;) AE"_@9P*^0BHYVHRA%:LH$(/>.\J@K$/
M@O4ZB&PK#%A."6_Z8SRC>K3,JN39)/_>S>I/%;*:]KV^J]2^9T'$5B:.:@.%
M"_7C"*NI*MVH&6(&C99)+$@,LEX(>S,<U1 %+"B/P>VY(6_@MS"%ENZDZC[:
M)DYRY*!YQY-N9%=40;MH0&B0/\D+W=RR@Z1,(BK]N*0DH((I-9>OI;@[0Y=@
MN<P='&NLBQ:3;]FXVO+;&N^<IOITL2(%2S^C:U[;W0XTR.ZM9%S V[C<+]Y2
M[&OG!@X,DZM'#$/?D/DL27^38"5M& !#?%X74+I;C'4[4<(P%8#,FY3I"26\
MV6"4+@HU.!0CWTXA-E56^EB"Z+U"KP!CLY>=%3%[/\T>J.R3AHJZK1X,#YIN
M+]L)Y\K6*5((JY#YBAU#2D!/T39CDY@5M+(YS%+F(\0(?OMXW*!*JB*.<3D"
M?>>ELO4HK&9C$R6E-'L37/QS8;HH6]4EH81@Y&_P(>6\4+[J8DDPVB=[/KQ6
M3;9Z/Y##X.*'<H7]TF^B[&@94U%%#"3"EFIQA,W4?9!^$AY=B=@I;K(-D#]
MORDIJ%+O5OVI*$ 8JN7OCB[HB-QE*%GV(B @M"#(V SZE15A/'LJ6FKB7Q7W
M!)A00Y>0Y-[4*$4Q\7>6@;E42[])$=K"7(CN@"7"?CIJA9R&3Q8C!A"K%8B_
M>L3>IPZ4B#-N.6H5#7IHV35=9<9]GS2R:,:=\0C>T#^3-9Y)JG#YXZ&*K+)6
MA8LZPC\ N3-U#WR%A2SJGL$.]N^& 9%K=#VN_ B@Z^CP;,*'",F>1EG[; :U
M6AL-@Y8@KB(70(.?YWZ,4G2\)\1:^D?[!X^A)N@%:RQ(PJAG)@JJ]!']:%F6
MXNYW'K];QH0WR?&PLVR3@DG;1N'4*^F%MI7"$)6^%N,,\ G4/2*!)O?19/JE
MT8+8F<[(9]Y!HYM#L>.5&3Z;7G591UOZ? KR3W/O1S2AC&:@C(?HSJ(:^W,G
M"#O@^Q+@)N[E&+(B2:C?%*RB)(4$ZA7QKJ@CF=/U]N1;^(J8,&O%KS\EATD&
ME&=<[E.]&O'=YZ[N;C697DGR!+[ST@6*]?UC_<C**MFG+%1=*K=7#CGC1[ _
M4U=P$AX!O8006)NSA;#TE+YX.M5Z#J-FR[:)!&<3DE,>)DU7E=Y7/(@]OBW)
M-^;<FF&\")@BR;%H#WE^92-VM]+-LI$CRF,:VC^'T>0$S6'X*OLA]Q;LC9^A
MC;A;79_)9:1ZEE9[X600.%FO@ZCDO),THHZ=Q>4[TK':;TLY0U\,C]];\?7+
MY.&*7BN.O2,@P:4 *Y4\TX^_GCF=RMY 8303#;Z3AJ9%+;<%RZEAK$ECAYY@
MZ@D_^>E 3Y\[481'8B_I@3G,T:X(![@$;2@@1?1UC%=VGJI/\]K<\A G.$]-
M$3.&\*("Y?@-)L5QGN?]=$["TZR0X["YA,FHM"^I9%YD+^UT5!,&7V[CVA'Y
MF<7]:2-OBR>J>T55W<5;K.6%MPV][D]_F6KS:(Y"/BC'U3[.!7(J$3PL=9!Y
M*.IH!D##;DXP/I%I\'UZ2$V(;23Q<8US&'WV9KLD@AIR%A2T>,=8<XP\_05J
M!.YYX71\GS\_0L)-]UR<E[NOK/K@EM)'KRJ]W@:C7<SGH5QF @!>\JN_\AV7
MS*FX<$V@E&N^<QA#6N?51-A)=@TBT77V0OAKJ*F__8%L(5G=\L%2U!!V*O$<
M#QN&RT3OF;^,&Z!/PZ.!L/4V/9VOU+Z_W4\+]L>!I_"PF7LBS99/:T=QBC*:
MU@1G32BZE@<^X8DJ2HN>,I</(_LK^RZ 4Z/:";C#+K:]W:>KLER6)W$LIW7>
M'5IUC_=5)#^*>'9%<(88LMINCO#E'*;<'-'UDI$Z13#;6C PW:+4-ZPDPCI8
M1[:[@^BG<&I_#J:7A8MQ=$_+*8/XVI^UV,+)G_3$%5YO/OE5,M^=O&V-07G$
M /(::@0<#D8UL:T46>S% [0NHO[,)&_9?A'GID&&D@ZQR)HR:,.37+&KQ:^0
M[C!S.?78V:?^U0Z4*&Z&9\&MW*KJLK3O5ZS+NRR3H]P[WK!'?"U[^MS"?88T
M+=X&!W^L*?/H^AALE9=@+!X,\=7(6*CNTF2^_[>[YG\]5%W(20?@C7XMEEY*
M<1H;4>L-J0A#I7*Q@,\[WH'L <G[P%GI/6',69H11=Y\-4Q16*N6^[9@@I_!
MK7,AU3[O+T]9^!FV:PIWE-D_J0L.WO6^)O!\K]5MLI."5>L"5<FD\R4SJ:K*
MHSM,EL7!-7(;! ,2I^+R:'W$<D$B00W.#%V,G('K(T="B)JP2;V!6E/0;TP/
M,.=>0.%X^,15Q<<$'8'E<-(O(]9_F)[!/?M/Q;R0^VQ#H.$ \0)V8!UMM=D+
MK'0U2))@6]0)&YEZ6:L=UPLT6-:3^SOF=P"##.^4X$A>U;1]&F2<'O%MU3'?
M*Z]>HC?=OVX7D@=-6G$O6I$UJ^6J5*L:11ZZ'>W$J99R?*?Y="_8$B=5$^^#
ME#$"'Z]=T7<W9P=X;P[3]+HDV(9C2 &.]<8]X3PZ3;F^H<<ZM'+X\_._^3$I
M^;20<0 \2HI5'E@&R$7XH_PBK1,'NO,6CG<JF?RZ,'10(HQ"= 3UY-6UF\ H
M$9&+4YUT-\9U12J%TQ[8]V&@K4"7;0)G3\6SQ%XIQ\\SN%4J<JL^ZT-/XC'8
MF26L%([PH5+N)7.><Z;.RO>@?2"L33-K _%*[@7_*K@F:')N/"3V593EC1,'
MI>)MN92;XR8&]U_)CW9&ZLB9^#>*3S,H&352#F>R4N;'$4%E)C64<8SQ&]PM
M8=Y2"E240+559'&48X\?)4N'MQ4A9G"L9'HAVNE95T!G&U*FQ;A89'^>!S_(
M9QM\S"+([>J7_*7NOJ>B2=C1B;YOI' +0?,<9K$RS;MQ%"$K,HG"VYQR9NN(
MYGQO=U_$#:XS;]0R^4WI3[N@&G%<:Q/Q!G%-.6XY3-^=T<(GTMFK)_52SH.E
MP0X>/6?Z:PT+8;<?5A?7=Z[K^(@]6SB\Y0QN@-'(,;1K8L43E['75V9:7X;&
MKM=NDIAU+>X?BD\?->LHMLDM2!*4\6.>>Q@*RI)8+X>NH.2L#_MKVL@.L+=$
MP&";P670MT:.#GM!@%(ET%;"^F2PA%$/)/9Q=*D[)5X<AL&RIZ+/W[$K@_K1
M15T7+2,9<2\IY"8M<[JX"W&* L)*#S#Y?;?W7VRTKY);^:*K<V57A[(Y8!Y-
M5[)+J167V-*3Y6+.(G0Q<@)F%J+='##<]DXA]3 <&Y-/M>A"#&CZXQDT:\CR
M/1/LX<EQD_8?ID'T7;"KM':U*;_#V\?#T<[XKZ^!8<W4J9#'J2<QZ%]%W\90
M#5\Y];, _)4\F!/*L ,T:X]!!4T_9YMP"Y%U\'FPIK%*EKE!D(R:40_V&AX"
MGZ3$B%WW:M;@E@4<YZW\1@Z\/1BHT[I4RR@G.SIL_3[@_GRFIPK_@#+0)1G"
M.0R\D=C$@#>U(BL7  $L5?0MP1+^ 8:,-0J,;>KT1<P;UJSXJ[8U$D 5=F@V
M5DTP8IL/3VRC7'8AKX29+9Z]7TJ>VK[L)(UYC/\Q=%H,-!Q&'*+D-*!AHS*X
MI> JZ2W,!*:A-2>)HT,S05N)V-I@/Z6B\<D5DA8&V7%6?)\V:0&T#1L\O8OY
MKIRFP@HC6U?GAE&KRN4C,$E:M=S3JUU[WRV5G^.*/PGFM&ZB/F'I -PF*U?<
MMYX>-!%+W]>5> Q3C;L)VRED25T=DQYL+)!C?0!CBM/ASIFH5WVYMZ^8=<;=
M'AEWQ:1^<KZ"(1<&P35*3TV@=66Z3_7+2=3%RD][1M%.9;!G+$3?$E4Y?I%P
M.Y0A)M=;D&X1<<IXBF=49Z0B42R<.JQR&FYX-""@<!N,M3L7>>:C!1+-(%SE
MKVF?<U95?BVQ%'^M5#YY%KD2CVP.A3>V*H?IX)#L!#2+K!1(>%.A\Y4MEY=S
M$NW5I+-@KKCW4[Z<B)P .7%#S<;:<)QP.L6'T%$<J08*4H+++4E<@SG,S5"^
MI5FCS-46Y3O7O5ZY0'&W_RU0R9,RP%:9-JQ63.M@ZI7S="=]]+H=W87X15[^
MJ&9W<,4NX(1283/TQPD:8&^>ML!GO$^OK[TH2.\K6> SVK"XY$'X078$ZEHK
M>$^?2I%;(4HGOC$(8V5T10T;3Q, %8)Z.7,Y$@UW@Q*9-1P@MT9.]+)UD6VP
MCA!W<]2\#JRZ6<%8!3N3*FXBQR#C$M;XF#NTTL<D<T-U9:6_VT<=M_1^TGR?
M@VG:.[(!'A R@++OT]([T+=F\G). /8&;A5A$07;G&,#FX@%VH@#' 3YD(VI
MY\""N"<0(QG1LDS6J^8E12CCHK-?88#!S;[T%W!TR]YOISO/Q1O&7MA-+, E
M,)>SB11 ;#<U_8AJJ6!.L<T0:Y@NQBT?I,; C!CH!)>M6J=@UMKXBMY$XK4H
MB6T-GBW,\"+J;Z\@O3K3'!QS'RAM848]+B;S,RX="A%OF]D%* 5B^=B-[[Q!
M%=D+9;2\,H?QP\<!!H"_JY=HM ":E:5WUI+MFH#D43S$3*1M&,>!3X(1TMD"
MZO%^L^KG)!S_<W7^U&W_RWQ%7/.3-(/]QMG!%U\4EB:)S*7N8B)LKL8-A;<P
MN7,81LY.B,4@RPAPDIC!]Q,N%B0C>XHHW*9,7CV/GW2@&IJOVO33BB6V4#B=
MZ#VA_(GNS+0.=6=WL7GUG:D0RRV6YUQ.QIMBT)1"EFA(=DOQA!- &@!D\WLZ
M+Z"-'*4'^>/X60WD%4#PB)J8+B7)PV@=9#5DIX21JGS,EGOY02N&*'=^@_%@
MT)XK%3'D^I?#HY0[A\'S:,&C(><G"*'+VF&R79.4D$<I#9\OQ#MDPL4I19&4
M(3=KEB_ZCS3F(&&P!U0E(=U$EZ(]@D7$$$X<;HWC%9%FJ"IEXLJ,EHZ$> ,U
M@V>YES, ;(6 [K.N)Z*HSK.E)QOOU6':0SZ9;A'M^F:!XN_._2L70+*D.8QY
MG80H7\?'HDP)JX0U/1518U'B<J*NO+M\<M6&ZCH.YW7\^W?O^;IXF^;>7F[K
MXEKMM?@MW0?36AZ6;<5D_C#_9XOE2NH?L#G(DZ7"KA+6=<YJ1]N<;; 7A'=B
M<@GV8%YU?$'^$)S$[;^T?\.7M,B87)^ GWEZ&8\W)(Y-N?>5.6Z0Z&R\_$;M
M4]441QGM4A1,XD4.O-&NA3R0)/OCQI"8%,=6I9H8[X"BI.JYE#@S\$*9Y"84
MS(K_CEL(&S=:;C[E>#+?/VUX[ 34G%Y;[16T=?CSS^!\Q*UKPJ:?-LH!CZ?X
MRCSA(C!:=E*1S;DPO8HV2*XL:*U3:2)8@VKU@ :EABM8%F&D(AJ+"\E]T4<S
MI7K V>);H=8,.EL]V$EJ0+A?-#Q^-3FJNKVX\GC2GH]M^'IF&:.1$<]4X0A%
MTXDX#0*6HM,HT"(84BQ0=1(8[0Q6W4!6YWKX$W"=Q99L_.36QUZG3NU?&AJV
MN841%4/,C@&VVNGWV^DO^UH5#(9T:3FCRTXI7D;BM?=ZG03[$9U<H=Y]\%-0
MC:^)LZ@DO*5%WN)[J#KG0E!0@..>@#-5+P;WK['3M\AB")RJ=V-9P!D.O,D]
M@1@PK;2O_ASF=P&?+#L/A4Z1Y?[(<G#TNF1:E[H<LDNQQB:PUT!^7)S.2&76
M$ZHS? )RXNIE7DZ2\#2& M%?$XI'^0%]"6>+3G.#=$9>CF21@#NRID0YJK%
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M 9NH]O,;1I4I)%89M#G7.0N5[I3' 7]EKJ(U*A7C2?%&1$>^$_&M@*5"/$.
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M?H'6E9EM2H+"P!8-5UM3V694TFMM_^KAS!)6[$P*H7%QET; "[(@R#;,M3@
MBO\3>:H<%X?G7_G1V@7@$8;6_!N@Q7WW(;(L$4X1 YIPN&AZZKMH#J/#'Q\U
MJRGOK]US-G?"^!?HGJ(NOL[\>JW^8Z\1EVU]D=YF;KW?M_D]'K?M=]<_WA;
MHZP@PP$XV+*JA:2O6=0FF&])Z0"<!Y8@JSLM1_\&?A]2FOM9A2U,ETS*#?N7
MFO9:<^*,5X"$)&#-G@V5=$_M\G@+^@'8'5VV4#%?BA>(Q3VODEK(G:@[X3VB
M76J2@M9I?I",U(=:4D]%>U20C2BEGP22T&OE0]';61/?!#[^U::V>C(9=S?X
M;=Q^2]O22\,#O#_881CTFG*4\?BAHM"I KD=U5GQE&8SP1+QXHD:B!H^%3D9
M'I)TA=JQ)+B+Z]1E.2CMF\.<[H^,'B%R?QH5O0W)J&8_.K_H]E!>R7J:18
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MM>!WB[A66VJRM6')J'6DW3&TO=A_##_U*17WE1B7J_6>2T"VP*?$[K&E.>=
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ME4[_-0/V[NOO;G4_).K<0%=K]]>O@&1Z5Q4]PT[XVV76;7Z'5V4[5II^5%E
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MRLZLF-F%?D28,F,R38)N>'[V"6S5T._%HEY985+4EV<'N99O0ER-)U\>:9J
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M[QYSHI@'502?T*Y.^8Z^6C&5*_WN"C WZ_#A%X!B+O/D!9#$*?X4>?TX!B6
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M(O,7QUD V7;/B(\:&MN:_<\B_9>=(K ($P/ZS)\ =&WDVAJ74W7O&IG++Q-
M'B"7\'.3116T?[YM'E<@K'LE'I[&QH#;65<Q;[OA*)8K,LF(,>:O.ACM7"0.
M9I/N09?_.%S__:-F-<//\.>OQ]BNV5A7<NY;7F&_ /)7%^!?M#7#RA= G+-\
M.\4Q]UKW?H5/8\G*;6-FFMLSNVM"CGTQ\E8\U$OM+VG;=RZMU)ZD2IIQ4(RG
M, X6#@4-Y WKSK:8S/T:MJ$7R5][A@A,ZZK9IW4K,:&#;G ^YV!J.57%6I6
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M:.^S.RK[>-V'5P><PM/JS]_ZT3. ^G<' L^R%2?''#6M']M$[TI6/103$WW
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M[R5N($]ZY2B3<A:49'FQ+]0W#[?HC<_?6B32 Y@;#QM7ZBH6@M]-A33F9!'
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M(_Q:33G0JBGT_ 50)=;1,^8_D[OBP5RBC$L_Y#IP_+DBS"^%.@-\0]"6H=%
MP(RT(Q76?:S-!\-,[$[]="V<<\F;XB_^O/1>2JL!IDU-\*@&)+L(S(P8ZK.$
ML(2<T[FG81G('8\OS\.EY(]^C= ??%WUK.7@D^/&IF6?SE^JWG)VBOA>EAR>
M;HNGF?H6[!UX3#B,.W<IZ_N30ZVFG^QA[OB7$<$+KYR#^.^1TV53NL)$\8,$
M$%).;J@P!E^8Y,2HS+&_N!9]VH,5M78P]JWF!@UDZ,J94./D%H/0\<#D,Z%7
M#7>_NJA^3 Z;& S_ I@*(+6;*U5">GC)>P:$K(X&,M!<!0K'LJVQJ V5E%LD
MCU-9L)!,;.W6.!'8NFD^#HM'&$XLU@L@.VM/.!E\T!= *)OA[J@%SQ7J%88<
M/#\F_54XYV^"*N:ED*=) $EZ!5V"F6%O U-91]O(HD9\!3#F#'D KLEQ[V$Z
MVP*JXR&>[\;+N\!32,4@PHFN<;NKU2&TJ_ZWWCZZ73Y[&3 0BDG4J!=_=QD'
M#CK0A<2)!O6^UC.(*D$6=1]N,Y<^J@H@Z4#0>X1E2!X.#^ G,0D<J\H4E$QH
M7D(\WG<\6'[*N_F:A&5JJGN.W<!METP(O=K;6DV[.+G\HZ(^HWIK],[3D+UG
M;5+PAM9*M2K]A*2<(]ZCR:<B,@Z.!ASJBTAQ_#!TI<!*/]W0Z7S(N0;SD[<^
M&YDTN"83.KUT/_2[\9!"3L@C!WR"G^-XX;J*2$*&FH0OW8&ND*<S=X*:-DVU
M249UM2REOG6"PTY18S&-&Q_H:+F@ZBYC[8E/*M\.?KM7PY? LW HH>Q8_EM"
M?Q=F-8BKP#)QU3@$HDHPL!DT5;R8E' R_![SQQ)"^L.PX2N/,-B!$9QV?4JS
MP[U7DZ2RB/#2X-P81PL3.?-YX3 KJ^8(GA F05VX5"2_2Q7=T9142TY",>VA
M&</FPROA<+G)<1^,P86A'RU0WZ4UGU?W@[;J$VK?'RX027_6?/1JVR6O:#'P
MF_#V2O[03_Z8 "),^8HRJV+B4IA;ZUQ'#$X4##Y8:=:'A3/ES1.X%L-OWE9U
MP.A564Z-5Z$+RKG.WDWPQS6%7_>6I'SY^9R8$+'[5EDB<^,[RK/ 7==6+:D@
M>'I-K$MKX-+:V"#1@:P?PJHR?>YO'_5BQ1"EJV\W):[WN;8PXT>P[O<?@#O
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MK-N,'91B,81/NMX,O<V0E@?/CTM++UJ4QIUX1JZM'E@Y3/0\KKJW??VN-\'
M1  1:=$3>NB$V\[_0A.-+ B<1K:N@GHC'\FJX!6:51\)FKCU&9/5@1/KS9/0
MZ8L$U,&4*8H'\W552?O+;O5R?'ZQ3VUL&UMUJFI?Y:OP30;6EI$VE7$WXT^P
M1RSILR:C1V[6 Z?J??K)S;JCYG2NN70 ^+Q>G-)\+G_V:3-!,K&583#T);^#
ML_?[I=E3Z7"TMLONY^YHZ6,1AH3'EVLRY-LO=I?2<TX^FPDWT.P^EBJ>/8=)
M^ZF<T'DEXENJX9??&M+O@&\5BA^TR(\WB\ZXEE_0+S#7 X[3ZHH^]CP ("W"
MZ;Q-FP/G]Q6J\UZU:-#FF4M*+=I]?@)(<F*B3F&P(_8$0X*CYT89;WF9LZ0X
M2NX-<#]_X7)C565#REF;/[,Y>*%T[ $M.8>YNB"1&3(S#<0U&S/K&;EI7#6@
MG(L&':;S"[0P=]O,;P\(()6^,U9]XOV1ZK="GYF6(]8D#QL8&"R%F0WSKA]\
M'-W0P#4D+J#W1&Q2N3LHQ_\B7 .?S51*#E+G2+_MQ?;(.DLGE<>7H63W5!08
MMKPRL'_XUJ]J[_GPDI2VSQG:!D-9R$*LU9\C4N%$F:M]I=F]"?(JR@[26:X=
M(UW,=9:"'B.XM\2PH]0[4O>\8LD>JSUVYUPH5UR\+:-?/]9[F<*A,&+)Q9F@
M-HS[!T< X:C ;000O-[2KSGBO#]?7$C36@@!A-_A("N +'RVX#MO^0L@GUX6
M"W&;(+1\\ZR!!UMW$D"RBE'\3]<G!!#G(S7K2]1]8 SU\KH \C &)8 ,6*T
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M>Q\U+/>^5>H/XCQ;Y?+4L(B9!%NM*Z38@A?Q+"%;"IAV!KA0]Z- ECI82#P
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M@'X(<,'+'K>:GROIQ5&_)4OY4GE2N 3P)FR8%[S+N._V4K8&7Z2[?XL]\1/
M!3+L*?@#?+.3DDI22EHW/$\IQ*LY4O52SZ@%OM_PD)_>#1"5E:*:G;[(U.#W
ME9:]JA 73>-]X73TY;._[$GG.MM8SQ!INL;7(\8LQDI715\^B\<;PAY7&31P
MU\Q)7K1/.<?S3N#T'HO[!)T;V*-='T?=H8SA#:& )W7,'E J0M*O /'>U(L#
M^Z.8^F3;7@HR.?<[?G^F**2D+JMR@YORQ03!V3WZ5MO;NJTE72?P*_K#[-8
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M]ZE5VOW8ZCCQH"5#,?'K[)_\?]E.@#6ID)/U48V:2K+,[X=)XOQ299"O:?E
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MU;19<QZ.<XI:KX9[7@T/7U-3D9!_\]0NFOOD\2NB;QS7O\MO"T6Q97XS0Y/
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M1\;\7JSHD,*KBLYG]\_7-QV ? ] <Q:DE<U (B1::F\@;TO8/8CL'8^!B"X
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M: I8+ZA^B&&2;-_>&U]\.DK-/NO/%VF*UXJ5L1+K?B#G+97]$2=%28Z0DF!
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M+E,MZ?'M'(]3-AT_MM6]TM[';7\*?R6B>,[#U1IZ)XJ:+E$:?A-B_"4&0?R
M^&4F8SHQ>O;<]9*CN22?=[%FQ&L6VB6^3I2B;#$H7RZ(L? O79M%D#O%?(^[
M TL\ #7I;XZM[L1Y'*?"DG7A7+X&AO&B4H)XR%')X$*)'PMKF/#0?8TTL;R
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M)+%E_[(&Q7/=0VI<D@5&QAC/-G>+#WC:M,7 #0)>A+RH/?M0OBDV1(U[Y>8
MEH,?N$;G1@5BF+EH?\'Y&/)@D>*Y=1@?2QN N,W6:>B'BQ5(=TPY7J>J,XJ.
M7+"\>&4Z1/I7A7Y#R[&NM^!BX@VQ$)/H)M_SF[(/C@8E5?8C7Q"_\]B^U3P_
M?]?W<X;BXD/A:AN--U.YOJ-FV]X>=LNG\IZ_62?,E4UV!*:J[QR 'FYC37;V
M&*(FK&,G2. Y DM C8K>D@TA-E%Y\6#.KDNKN-A9%G<<?3-,'R8(-:.4C=V@
MNF?%/]R^W#*)^>_[;(CZ_=[[\^6C-8(::TZUVTHY42F )3T(I<HL\;1><%P5
MW*13N?K 32L,X7JB8RJ160!5HYX^ %VF<O6/L5UP"V'+LW;IQPI_,Z\%3&#)
MPP?[,+[:=Z&@H<AE86.V=>^W^5C$B<+7W.@1,'#A&O$CBVWAT47(%1)G5QD=
M#Y;#BJ)4@/)5IK$>0GXJ.(/2C7N^7=::D:'@XVI/8>[,S^@].JFIK96IJH;4
MI\TP"]#W N;9GB26$D^$)^G4)]H"?K3T29Q_ZN)[".]ZQ_,M\9<ZR0Z7P#TX
M7HV4:L]2_G^Y+QZBX2&M'UK2-_I6^L4V_$.XZ%<S?JE\19[%Q[592S_K<>A?
ML_\%[51_7&HK=.QXWYU?FS>HX_U]PG8*+K52.2GV5S%VY7S&/G]=TY-B#=)C
M?<??3$177N@^M?CZ[04I;*WRT*W2\K,7 RA[6T5LPUYE=AR [ET2- 4(=!?4
MN9C+$RP(LM#!K_#$#]8YREZR^E971!T75:/R'7*,)41?G(<JD"((4QH:GN.Z
MT5D/QK_TQ!;,W(CZRAZX>W-VU+_R]<<.0*MIN&;K!,D K#S@:4TIQ\^'C%1,
M^>KOPUZPY%:N5!@I?F"D*[BC#"<>VID>$OAM&JV?:__0EL4K3D=%#<"%#T">
M 0F%1]'>@JDSL&;82QPB=?$Q>F&-I0[!RYT:7P74B-X49C-7+TN^$-[:PDM"
M8UKGWJ?>^+WZ**N"I)BBGXL&U.N3Q%=-&,([+!YU.N>&[8)R_T7!.#DI8(3*
M9?KT/XU@/W_]7K+1YZ]M)C<=9%W=J)"DDT:/7H=WB+[\4=4C6^GY&[4HU!/2
M)"/<LW:+='9H\.VY[+>\X1[@,[6['87V ^9EIY(ARP1^W0N_[-^H3,5WVG"[
M?2AK4!5>BV\HKT[/PJFF?7,;;_1W'GHXO1!Q\0"D.L7&T\;_P5/.J#$$^I<7
MKF&,&0B,'H JA^H'I9@%$VSV,(+V+-PG4_,.0+:O/?8X#D!#_U'V6 3G%=8'
MAE/4!?(!B)%KI<&6J28'H%I#T_!1T5OP!9._)2?^?-_\/^R]:5136]<N&.4H
M*F!$! 2$'$7@2*O2*00B*J BY"#2-Q$1Z<38T$0)B4H3>HXBHB!$1$!%B$B/
MD @!HB(B;20(Z13I(CL(84NZBO=7U?>^M^JM,6[]N#6^/QDC>VPF:ZWYS/D\
M<V7ON2*BGWZ1#*$V>CN#?^ C>.>A6S+[8*R'A0\+G8@<L=O@1OVZQ(O+%M61
MEI^6(O)CH]UL7\N_O*<0$/1.N_D?XOVY'[F@@3HONDS2Q6R(OR6QP110K>V-
M@.J:?!*([%;3#$^;B_,S2.>I#7[W^90\'E+@/A1T8$JHU;N)Z:_!.SE@D<&=
MDL'(6>S!\;S[C73@PZ3S ]J:?.,@W;4_=YQ^&5OFO+[VOA\8X*5!+SH]$F!E
M $W+O",XD&%Y,)(Z?0 Y"YM#0-N&=%Z]:#WX,=#XXCF@_G*57&J.X=WGG!)U
M96=E0LW3[H.ML<#R=#TEP>G%P5*SN02!9YWXA;V1* B< "@"_@CBO#7HSB6N
MGX3*2[H+U]>RD#O )#8Y/?A:R-G#[]C%FR=]EQ2,7.[/URPT\([.*D<.^DQ$
M6#4ZV7V2*/X^CHP201P/87_O0:M+J,Q:_"W)ELA6:)J])4COMFE\S3?OF-3E
M;P'TDZ)C@]D\CR[-C[5E8-VA8S%*NL<^S:\K?W@O+P@5>4?!UG=W,_D8;0A5
M1Q-M<Y%L#!7NQ8W@-2CA_>OZA*? _B#QXQ\-O0MJ44&&P,7[T3@M![N1QCIQ
M=ED$[[EVO(RH@3M13EX%[BUM9H]]/S,84LB30W/?9 JF XY@/2$"2/P8K$,*
MJ=>NS$2P+Y"Z\)E2R';RSB@$\*K- /B(!(\M0U,+DZ<GUZ?:SE@^T =XD\6"
M;*2[C<7A\/D&_]P&5\NOMU2@_#CU5+!@SSN18Q;<\(/Y%]/XO$M;WQZ("X"E
MO=^O&7 DM>P^^Z?QD%!^KGEU\9ZS@>O9VNU? @.&;*O<4HV4_2JT-':<1-3P
M#PH<'DR)Y TX3@H&7:$:31I22/3W <YUC8JK'KN[3O=>UL#YBNN63VK_1;,^
M43DR$WQI>%%4<7>6/7,J55?)&$Z6P?W61]GDCL<@D^EX1<1Y9"H*R,"L<,-N
MM,4#XYS<K@65OG(;C'/GZL*MA>J&:*U#>8X-P]_REY%;9EW$9<_#=7UOMR$>
MV[4W])1:?F.H_MYW');0F:IP Q9^C,#"/:C$[$*MEPQ-PH#4!K[FE/ (I9F_
M+GLJGT-:C[DUAM5[:EJG6G-;#G4T??]DQ.H34F20LJ&:*7X'/I*H@N_0QGH"
MO9SX-/(:%V% )+&^A]S_ D1U$;>AEX5B+7=^J("$CG\>239J'6XPRF^-*HJG
M//B6KU'(*]VD>DAN!L:0Z4KH[X<-?G=TA=YJ(N\#FGKZU 4UX$XV4GXF2"%U
M"'D?-$*.&EOF*AAD^'N/1%MN?P%W+@^8T30M2RS?6 ^&I0H6C:ZH-GVP,R90
M3U+V/&/QL%#"P[ LZB5!;%?] :)J\:5EN'Z8\4_+WOWO6Y!;\.=I,,_@*XIJ
M:%6XI=^IOWMG6'J\G=Y;6VKM<==HX/Q''<._>R[3-P5?UIA"4I?!!*6[WSWW
M'=AP[M=%!,QE_SL=.Q;;V.UJ5J\^.TC5V]ZJ8M^!$_GRO4>6"!(%;9EH6\^7
M504.)-$!(/=-[EJ1,6J'*!P,?/I.EJ-T,*^IYE$V@YBP$U'9ZE1-I[O&R]KZ
M%D*EJ2I2Y-YWS\AEP6B+)THFW=W4IC!6/P&F)86<A7VF"$)E.3 8F4RLHZ23
M#;&G@14">:<H!DSA4VDZJD#V0KH>/<;%3&5RO'KR&0>J-&N_J[6Y953KV)!>
MX[#>(-R\<JR\RR^TBW[G 0*"9[V$-1(ZH.-XKGPG20L+S>O9/VT/!4_#-6I@
M&I@S8-"*T">*D0^JQ='^'G;MJZUK3<F2G/WC?IM#P)^WR?F O&B;NF"=N!P1
MBDRBR$3%MB(VH:O/HQM6-^L[$[0&3 %:!Q.JVOT=AJH]3K[*B"I&_/V2,L (
M5)ND'1M=>K?U!\T]T'YR<=(E(GUC'[(3.V<,4*D&F[?0.$8NEETA\)/OU-S3
M^^JR^L>&^O:*;+WWO2V)_^>L^07]XX:SVZZ 4_>O8Z['3I_-WS0\_1%:)MEU
MWN,^)I?SAR'?:7/V7]^&]Y)AYQ?VE][[]B#AF7%C8P)RS4/CRH-E]SAU*4X>
MI.Q[:^MK5<I0F^<Z8TOU!-Z\;J$R=@THA0@O_#XG8OF^!7$M:. M+F_H"W$6
ME[=!@?ZN5K5GP5;5+,0F9VZ[>S8MY<?Y1G7&L-HJ(>5BFV.H:J4@2[GC:;_N
MK)()-0ZEAF ]/<)RY@D?_[;7IB4\*-)J%-]=,E/#6+,HZ:(#\+TAHY8PT.5"
M?3EE9.GU=ATS)6KE3%YDU=;IIE:U)XPEK]39N=--=_A9* )L!R)R80S-9O*B
M@0(N7:12R;+[WI$-8TV55\Q^D.R4154"/MVZ,?=;X)%8ME/[\#F@I_CI].+D
M].K#].<!S-FUDBGVZ)9_'HD/C>)9943@F%D:?COVH/"BR$%,M+=P$/I@XFBN
MHT4= K7<6-:$-RU(JSZ'3BTL*7_J6-7!GD">&CK%>*]MBWH]%.R"B38YUS[T
M([1)_#W.]D;SK1SOCJ7F@N1F;FYSO!);D)A_KL6V[ CTX:7^[=RZ0K"M4KWP
M6_V!/.T=JG!35P^%_#/F!Z?NKSX(W:%M]L*#RMDU0\V4[WF@'="?\9W:YMXA
M4B_QXF+S]O?57;S>\.KCG^P '7="Y]3]"Q1M;]U.%W6X$QJI<I_["@P%;:ZE
M!+@Z'XZ=;M@C='Z#'RMBT^=;9+$G; 'D.WF&2NIO[/5!>:Y9NJ99ZJY=+E#%
M7DZQ[L7*QS.7CYU+B#9DGAJZ:&HQ[AUGU;AR>')7XT!GIDPGY J#(YCU3;QG
MPD#)&\DN<"- <!878Y7+P5'FX4]+4HC2H^&&A&RMKGLRME]H.Z??TC)HF2[R
M-*U9_2<AVNKC@FOK36T2J?RR,8I K".)5'6I0_@.]UC*>)T@OXY>C]@P2][
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M6:%HGS4X:U-!BF4GN&KY!A[F"D/F =>*:]."3]>,7^T\%3UZ'&'_!A-?]"W
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MWG&^'/L4<TK;Q9U?ZA+'5&HBA#6'O-JU07Y65?67*]]P7+*I",AD,^=7 *@
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M@:%,"6?JCLJ3)B LA7PSU2XJ-Z3/:KT"AZ()]=B@%)O.<K;I T^2):K@,RB
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MU$9%2A]-(Q#5->RAS(!3BZEFB(Z78M>D,DMSGQ<A!V2YZ3PR+T5DNF"Q(@C
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M@#A<1YB5RB'G<ZB :01W!1)3YA>GX$\)]%)L]!.@'I_Z&Q]$Z#)_6DSJJK5
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M-,E$V2^Y_3?+9+W!H>($M]+;=YY?_E/FY9QFPFX>7:OC8+\SH.]95E@_[:D
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M,>'.O; !U$;<=*^ 0BFS;=_C;3J2=/PN0/<8MR_I*_G=6+W=+>)OMKKVOW?
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MQR"['JK^5_3LTQ78>O+L ^0&IC41H?@A#)IB.Z)T5A.D2[V@7#[+P)N/7J/
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M'#M\^K[MV[]/W=M\]U3(MKJC=%>M78U/#SV.-'[6'*\]W=URNXH75;0A4MS
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M-,7_&,AHZ-G[(?J('8!%IF0-JS,/S<&M5Q!5>AY3O83#)372H^3;H6X!7HW
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MBP;2L6_XC$B=#C.YQFJ:00 ,%T4*R)/C8HJLE+G/4^),XE+K%[.)W@)L*LO
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MKX'OUV]N5"]65P\G[/]###]E2MDT!1;XD-V=[GQ(EA/W\3T^Q!*7B6-4C>.
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M'1YQ#9ED-M2/)X_RQ$!MD-8SZ@V. 3NF82]2!B/[0K$4>7!%:3VU2RTHRO;
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M?+FR&)/2@QC/JY%SALJGG?L(8KLF(RK#.D[2]95&HL>T1BI2Y1_>I:SYL\\
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M^BN8Q(<1[9W2%^R-+4K(9'38B.?\I,.SH'VB=-W?$2N*;I,.V;)<,^YS(K4
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M;*$+?B9;[B]BTV9FP?5G0^1NB]Y<WS^)U8+)HHO8MNU!;O-SMJ,&/ZY=#]1
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M#-<QLXD$$)GH-_+*+P]6H5'VC6,&UQ+[?\XKZM]X]@+_\4:.XAN;(#YD5]6
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M&8M-/!%A*(1>"DCL=6Z-<C64R*/I'[4<,QZ_]KH!79B'=81]-.3(6[+.I['
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M_+Z]YYO<4P@6#CN".0>J47?Z8 DP":;4XC!V.3V)*3B.AI,_; O<Z4P;MDM
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M#FF^S/P$;][H%/PX AB00S0T3C9K0+G^/>/+9+TL$7.K]3\^'D!,+!%]BUR
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M;>Z'["$6)W400>=.FY:;?+7/^6\)AVWE9XA2^XHX,+K@]SW,?A',"Y\":U/
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M<N\^]T/R2U @OT5#KF.7NKE*_(XU(O^Q;-/;K- T5PT[T!HH<:,IH29<07N
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M]Q<6O"^:[P(FCG_JQV>NC/7":>W$%/.->4;'(O*OJ;3:DE+S'1:_B;79&QF
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MZS)&WE68XLA39*PU&+U] 7'_5W148"$Y==BI-]*E*MZYQRQB/CK!]$S2 JQ
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M14%YWD3BQ*A*U_S(:7O[2$7Q@9>S X1H>]PVI;ZY?E'9AS]/2TY*2W HRBJ
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MY&QKN@LBZ<+PMXBOC9I&C)J<[?R-WD#H0@H%*A4@=<_C&/=96D95IO"S"P'
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MO0S[2-?:^_/9!>/?=D4M(IR=C',12F=G3YD#Y3VV#BG753DE5@:0'6!7\54
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MCBV\5(N^3F6(&4'*0?SSL-O7XN-4W]4D9%.Q=3C)I1+5NZMC"E?DDJ_#-\+
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M+^]ZWQ8X38#3)/%<K*L2-+/[[[<W^I346_^^Y>YQPITCYXTT-)>?#9,[P<M
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MSXYT26_"E16,5-9V^2J5/K1HUXC42H]D86"\@+9^>L>EJ+.C(U6E(A/DR99
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M^$Z87CQV^28AJ?.!,"[>X8N4)#E>&QU&<&DU</B]:\LM(-<2EX@"/1@:RC$
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M$V/I#44+EHBDTFL;DNOH6C#G).P/S1Z&+4!C*0;RFD_<.FP79"S\F&\&=X"
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MW[@-P,)Z]#R*OQ=]#UW<D=5-N>3L>>?\][3-IWW)6!2.H\H#1+\+Y[-)A('
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MH;43:P >/@M?*V^1D 6WY.R<-IPYO$>QGJK=0C_&=SD,&?-FC JE!#3L@#:
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M7O0( Q[_!&LJ3E)LY6Z040I$EL?^#ID7/5)W%9C"*@C-99FDB([^ FH69\1
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M"ML,'^'J_@Q8%)U/](=W*API/'D.M+=%\2-U&^.G^N::AFIPB//\NT)G0&7
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MEI!:M,0-](7T$@\Q66\T<!V_WC7V<,^7EG=%3;TE'@7CZY9R&5[_*,LP*XE
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M[^KPD]=*\*NHNR!>JOT^>QE1DI+!6OWQ(]TP'# X[^(6$E2U4[J.W=#[O9-
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MTF+BP+[%A+#8D OV3*AQ,&LO*B'>A?T/:MV[?\$A5I7%TJ>PQ:^+D&+<)2-
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MPM](^.^"!#MDZR!![4KGC#HA=Q9-WXM1?SN'$RTXF?+U(?A\LMEU(Q5^92K
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M4LV#+$9LSR-%$LH^$_PW'AX45?MS5R.FT_D]S^D97O:X9;=201Q</1)+8?0
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MBXROQP-U8<DK::FX%Z,.R=_IXR<2P(SDMQ35\!%4=F<2UK<%55;NZWXAUG4
MJHZ*,?^NDYGGLIS32/<AQS%]K$V?YQ=51D2]P=V%,UYG-1!1GU38@'V</F4E
M^F%V-&>H!NZ!/#45?([G=XN>D#QI%CE1)FD-(RE2!+?53@7$J&6%\T9DP$9V
MUU[FR+>(X(L] *=UN\Y5;R-;X5$@-BT5PL>)%M )DF*1N]:%>A07BD_"Z5+E
MKM4;6>.8ZWRO?*'..H+/VK_E2)U,;)UH':XK?%%@SUY@T"%ZL)2=YZ&\'CD2
M9_R&-Z4ZS\-^'(&9<GC^VY8S?,B+%](BA/0RBLEA;<+MOPSG!<%C_*9$1V7C
M><%;WC4_H[ZO [*;Z;L<QI%J1M SZ5S[ 0@EY;04?0\?UV".&S[\W^1UZ6]B
M+ %M N*M\UC+GSU!_)Y\/+P>VOF?]_+,3%,LC-.EP' #S6/SXBLJ*DIE9:7^
M']$QF.U$\T01F<4,5I>YI+Y4Y'3"-2<2H^:7HB/DES1*4:I.VA*XN.4U$9@2
M'[H+_RE'.4Z;^QB6"<;$)^"[.-;VI'@MB6&_I%-@J6R16NQ2:;#'X[IAF>'K
MG!?KTL07CV:SI-UG>/ ]YRA$-X>=D$'[JBXAEWA[#5)N%$'A(UPGSG&E"U/X
MZD=E2M9GKD!2W$00&0^U'EAI;ZQZ/[G=>16>-*BRSYJRI-)02?L;W/&XGI7?
MT-'T*)])\W"ZE$FAA&CFHIN%M1_:8P7C:"+_KI!9S_/;THQ-L,O$CZJ)&Z2-
M>?FON9&.OF./DAS@E1(\INMN!G^JHDT$B?L&A:D\E](*$G@PVL2OYT@(G:O5
M+GK-.8GG\<S;R9R\Z\VE%%9K^RRQ%M[ZYOYJF=JE$UJ13DTP\7[OC!F;J/Y+
M5]Y\KJUS\SNHRCJ7]2US1;S:J0%>'>]L,))5V"_K4J]N8\=1MSV%/?GG0R=!
M6,,.8^)] CUSWOXKO.#.:*A%YQ[>@L1123%B;!;<&Q8D\TKN@ XXG2!X^A<T
M]C\BX3LRL@%?P^J,H;'68Z9$[2 ;2=;#(P&"/S@/6/Z$.#F4!NQQ*J"[DV!#
M:>"@ JYR'IRTU;B,/D2^H1';I7+2UL&JW:/&:@.M8=I='YIGM[/46O^P%=Q$
M36FV4:38*UE[/E$!+LID.G\DB6,&@BLBDVA-,8C" %8@YT+</$);T6=(\C "
M_/;3)3X!;>%,D6:&#2OZ9S]RI YCR(5:PI"6,Q '^$L\E(6B0)+".L65V.FZ
MWR]!^4/?5-JIM49%?^T^R')FEPW'JS%CKS2I1QME-T1'ZV0X$;YC<F/=Z<41
MZPMORG*=I;2[E?=EXF#1_A)%9242'?6RCQ#[(5.'(]5).R^?WWO+/KYC<XF'
M;7JJNJ%TO;RG:-WH/J,BO\6YQYT<,'0K(PF1TQI4.J I%M3^*(QO9!Q9Z460
M$22QA^*=Z\A0L  QA-(WP74H]GR@%%._,*30;OG87T#NWA?'J*=Q;!6Z>/=(
M;]T6AM/AYEHIM!F C1REQ0&B#;0\E!.$M=FDEO[+P/APT6^D*VJKA^?>5JSN
M!ZHEJ_6-*+!E\ 1VG-.\',CQ.AY+$7(\FVDE8QT$O@.IWE'+,+ T]RF0KN36
MNY1ZZ^4RXO)SMTTU&3GWDQC)6Z,&7?O>IN86RW&N4E9>'WL]U 7;G6C"A'+C
M?Y%XW?/H7R_G-Q!8=TQG!DYJ3JPM6WNP39G7KI%XI\YOSF4VR%P[^;ZV*;W(
M2WH!K"_H,DF4H(Q3GD?&7L2"6@=/K(:?GUBL54K@+,A"Z#*TU+Q6?6F41N\=
M>$XS"%Y=\/:^U%#AB]RDUO&V(4]%]V$XDTG^O*=G,,QE>\IFPR&[4S<?(R):
MEN=A71%H;Q.PLA!<]IL,#4\(VJ$P<1!#2)>QC5L)&F98%,[/0$NPRBXLLS-8
MS#(V../XF1QN_MEXW,1KVHCU7(L;?).0.N]'\)I%LZP>)L5E^CS&O_YN(/=:
M_N$[43,3APO1QSUC5-<EO0]R[.)A)C4<EUH?N@Q9%)LG!!F>2=9%F.BB)*34
MF^*^\COR29B^L:E.22S#5R-9VQ9;?W_/_!-/FV@9(LA-X"L8=23_*N2D'-^U
M\HH4X]K3EK::/5,WH[4O7LI/0[&>53Q8<7Q/2+F+$[8_B<#B/VL8*WTX-'%E
MM^Q#0!_K:GPT];Q[FSL<\'6/),7R]K[/4*$TE_K)N 3!N9XHEWOWJI!(Y\U)
MJ;4A^OA<1Q4597<[KQI42+B@=/_OW9HL\@TRFP1![+]L4!:,\X-'!R*_[UB3
MRS6FM3!.E\XV?+M^6G4RF:XK=Q<^B.8)4N^ G );%!.$NGA%<W.#XFYD;\#?
MC\H\JK)(/5L<?/&J,KAY7C#-]4&E-))/[0TVB"0K62 X-Y)KK2AF=*^1T%&3
MN@ZO'CXX=3DAZ_U<3G]^RA"DF9AN=^IQD;APT5/-F)75L&+-+;URLV'_X*<4
M%;_BPKMD@8N2.A]/AL40F2G]AY -+Z(^ 3@[4%EF3?#5JQ^5]O3R5Y^*JJ[A
MFG$+_KJC+OFL*FOAV40F!1U^T94*P&JC"6)E4"QQ-JD=Q$C0GU-.J!9_+.U9
MK:G%HFDVL_S8N+Y;VE7YL.MAL.I\UCFI9968>/%'*GVR=OK2?5?BNSCT+*,B
MFSL'<LXI-5J-)B_6O+/3U#SI>M?_'FSC@B&;F\;PFE2IC/NN><7.B@,)-YOA
M3!Q/5^HB(@+@C[NRO$7,Q+:+U?_LL1M "HLJ#0,E!+9YULDX'7(9%>!XDKVW
M]5"U.LEL5*'VOLU5:>$H67H&LVO)+/'W=Y>0L<7!D;WG!4.8"A"0_5E?/BI@
MOL<=&4U(86P_".V:Q9A'P&@E;LB%P'VN7IE4\Y?)\YPP<!G>%2V5,(8*KV]Q
MBG=;][LB?D!)\DK_9$OHD.4?&SX^V>F.9$B;7"W9A588LI))*)!]*XV-KVD"
M*#_A[X"S^<PP?!MNQLSH\AX]<1[5E/IK&8WL>]?0>W.07<[_N49P.RA<_;"7
M"LB-/5 3W+9V@*P;W* "])[1 A  HP) W M)+VO^(87,RD2)6O(.P;XTDI,-
M,/GQC(*+$A1,VE5T'&#[NLJ9M' 28D'+H ?W>CU6&1\W0@*CSS:<S _JGDU>
MG1FJOGTQJR4KRH74\?#X[(E LJ;LA4%Q[)+QRP%Y!;<Y<8SMF4*3-PZJOMVW
MK'IO]>:1:D2SE<WS73L^??%W=U=<7%EQ.%"/2G.<7M!EVDP__=;VW($.7;16
M!OZ3_?RC.3H8FB;_41<_9^H;4_9:+[R@^Y'&2>:G<7";(%;_I"E>$Y?=U<4:
M,</OHL7DAD_N?^*WYC3U<97]NM5&SWL6WHX+J$N7 %^%'8!YT,_ ]52B>M :
MY;C</!60D"-,\'KOAF3/Q:;5?YH*^K@Z+#;F4?:X_Q5B4MY@]?IT;RU'_9-<
MAJ.J."G<N(614(_OX9G5.>R7F@=1O0_T4F]+UMIJBTP6[0^IR80.5:/K'6Y%
MORLV2:FR4U']HIC_QJ,"85:Y\@AR9F3Z0.ZS:TC6+*17WT-I+FCGYSF5GF3U
MG3OZ<_W550GV%Z8+ALORC/><7M 1<K(F#H_\VC&E ISDON<9_A*HR(T+."H
M XJNGH(P#\+=M,Z/;ZV_3UM\['<PSW L60DHGJV6=3_$P@@;V(G&7A^<PMO
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M+]#^1"5#[APC!\N7Y2U:5M=+OO8*API8Z9[@.7N,@6W@%L01A#6B NCM*7W
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M6'O1AV]>9BF2O.D668E+OY[[K',3]D1\760;I1J+<UI_3O^8^7]W670ZJ*$
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M,=K"5GRI0-*POB%!H; I]=K^J>(!^>;K0AG2XK8<W8J O'HBSL-D>4[E\Y(
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ME4 N&=Y%!S=\T[%33)1;T<IOKQC0NE_?@Y U4;6(N]EK4_0$W]ZW?BZ0\*^
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M23V?JN%YT3MI NXZ$0CV$:;E>2XC=>N*1,PECUZ*(B]'(H#=*33A/Y:9V-#
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MUEM*1):4->;.T7\]1@S#U8+@?84L82HK*0P0]Y"C'"M$A>-#C[)E[S0GVN1
MS\_.JMHK'RZ)%DB@001EG57J[@O ^PM 4U]U=9@\+CQ]S9"_S"K%;%PT>76Q
MMN>/VLN=SIU1PLRF_;VL_CLXVM\_5BJ?W;4DA-*:M29*A/*TQ)F7;NL7;P2U
MCF>W2_S4&R2[K<&5S*F#%<3Z*DWG/PJ/UX/G9'8TCR%D1F<<:'?Q2]A]0HHS
M[M;)CQS7/KTF:@W.=IQ]L\GRZ946BZ;0+WS\?V\I$N<?6IR^[]_U*JN"=>J]
MINP@B%.:+!H$65E.0;IX:NI-@5;X(_7CETV^IW6N9@^@4JL^NCQJ^:&RQJU
MI RZ3IH.#O*/9=;7QJR40F\>]K"-$(CS97Q02+,]5-617M8OP/\,JNMO_2*C
M;X4N.L D$1<C#:J"OX.QDJ^3!SD=):8T!,-G"J[B1KM5#:4W@V#=UCRDDN.=
M>6'C/[>ZY0^NA5VE$O]1P.0W.N@SQ66RFGC0SJ >%B[!N@FO=#I8T-)UN.\)
M<WJ^.:+/.F&K7,+I7WV\V:6X:6:D+VL]S1:_V5C.Z5$9=E:8!,3J>,]3K=[X
M-W^'GI" 96QC=$6/4H-W[B>4Q,Y=+1F4S7D"2F_2-2U@DCW]^^T"0)!!8"X
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M7",^/ QG*SJ@)#U3<+G-3:OS(79WOYF;['SD6R7PK?0!L'2.X)?X.URF6NR
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M6N+GO1)QK)WV_9\.YS4KW%^UTQ(SS'MLYRH/FC.;-H^11#F0 1)=5(@UJ[P
MS,;BQPBJV$IT2C>$KC,0![2OG2#"JA+HW;QO-[:VQHCEVSK9-T@@^ [40UXC
ML58R<T+H?HS/&H5GWE_K0?%GY2N]+QYO4MU)X+59RSFN$4W&]K\RI?Z/<Y@V
MZWQ0KEME=#6%>"-[C;ISE!_6J:MQF4"ALRQJ*JLP)IL=U&-4#:+$\:&?T_.$
M8"I]YQ9ME)G:W07]/2IE[A^D?S2V@+P$;-CH@L50T-"U-^52F"D6D7P,NXP*
M"O9^+<5F$K&W)V\CQ5!JL^8Y5M]\_$(0,_?=9_&=A6^B-IT:8]S@JY9![E(E
MZ?Y^MO=1$N>VJR*TVA$]^GH58=5?)\Q,X^W #T.U1..2=#AI1G)-QXHSBGX-
M'2P-DZZ02L.YR./(2QJ<85($I_-+J#!9;'1SZK.2^1W7GICQOGW3YFC.D6S6
MEU#^ [WM5RH8B#*L\S'29?\2>;*P]F^JQ[G.#H114D.=X( Y!O\"/_Q6=^[<
M>]QX1V!)[+FW?"57JZOW,& COGU-)K&PP9K('HF&=2'CPGE(98W&41"66^.[
M?Y!CP!Z?K88^M<_X]WM/V?I^1 Z,^.I=D99;+H!@S8"<Y"YD@_?NQJ>MWT3/
M5D([SOUL;PEUX$#58P8I#F0J"D/HL0]S</RD%NDTT>O7QQT\N:VP5I_#I%RE
M$1C[2WRP$7MJ&?C?_8HB? I'<KF"?C.//C[4=DXKQ]+GSU?2C%Z76OFD?:4N
MZK==V9L+@/IKDA8IMRUT)65NB$SKZ8^C)=XK\>"$,;[V0/R^L3W-G;9];AQW
M-:-J-^IM6#E8:-^+/\1Z[83(NH^OPLD0.47Q)5,U%P!WX#6WNT'>^-?3"O1P
M:JB5XIA"T\"$-#?&[*_Z9U_]:-^']GN"".ZS$6.4.=[[G[>'B@>9'9(8SBP@
M/=DFXZ. B"Z>K$ZNK1_RZI-P;9)I+V3R_;/'\(GCM![TD9D@N(PY7$F9U<17
M3E>'>5"PIS!>0V1RU[M)3\_ 0\+@>_-[8XEU2Q.)?6H5/I:ECB+1E3-"56Z*
M[-%=C@*8#K\CM\MMGTIC%OT\^'%AQ3=;QQ*06_%:Z-(@7IM#0EOA5>-"6O&*
M0%"E_&*1ET> Z[XQ!GX!H&9<"!\N1&06[F+0A;&HEQ :#9YML6+"LG',])WU
M[Q&JD1P_&M^96D9^?7KY#G]$\M7@IF6,SCEK^ (,:X9\>P%@"Z<GWILF\J_1
MWSGJF5J=/(J:J/(/SK$D$<O9K\\/#Y9!_;4.%4^C+O=8;P+[O6>IR+36YX;A
M8V?&&.= W/)*4[VCP37$ZJ*BH;&13\CV4("9OYS8XLW!@:J2U/I/ Q4URW1$
M)U(Q[%D2-9G.&RO1!:)RQ;K&A#&NV#0.J;OVY;P,R#HS5Y/B:8/[<VGY9(KZ
M<2S(=AU(J-6]X'AU!/WS43HXYI?;J[^*!:YQ*8C/6M-X1BN;%B/&YQ56N=D-
MI@VF3<VM?O@*8Y1EB;A7(Y]044 K0BH'*@P_X5<B\M&6S$(AC9!=C$8<^O'T
MGM/4D6NZWOA+K:[!+EU:3I9;?#VZO F7Z2(G?2!%U6O&A#M9%>$TLT0N['YW
M2BR,06A"32/,L,R]W*/,OJ.@N7ELJ%Z1YDD?NT@,\\BO9?@H$J&$*3L7(:CB
MYP@J:P87 #Z"S*IWM)V4W.!?@]!<!_TA@\(_YFI)+5^B1"5[1-6._G9TD<H5
MX.\*^1668Y?9VD3.'8* G4N7QE\V5LXO,V\5W&RNASX3X^L;[N7HNCQ0]BR%
MH#L_<@G.:NG#,A@$IHX?O #X&U,E^O2NU095.8A:52&C:NOT^AKM]-GRFZ"5
ME3DHC?&V(E.'$8%=9ZYV=J_].;#S1D.#QBO*8$:'T1("5QW^/9\8]W4S1#TV
M1;[=0*_@T'I<ZK/FFR#IYQZIPCA!N<\MK!FNPAAQ6M5_IC(WLK2SR;1":&HO
M)#8%+(-N-GUW9K5/Y$C )Y'^(QIB"]')J6CC),?K.*'-&=2+0-FY[=^+"[U\
MS #H7C+ZI]!=WYU#P#7-9CTXS3]V&/X;UK"?> % 9RY18U,B-:0)!CT=DHC?
MU6OIW6=>)=X:17P1(W>WI%IEW08[+!B^*0MCMARXK_*%AM'S3,HF*[\\846&
M/FJTY#$JF9K\0LH3V/DXWU!;H5P6UY#<N#;ECN'=1H0N_X7=*L3J#PA^(U63
M.;K]& )9%.N*(]D_R;%Z ?Y<UPDA'U+VH.$"@#7U]";35I[?#^)=%>V2N4((
M-2,D5&P&W/B]L&RGV<RKW81X>'A%LM>9M7DM2Q#+?!D9 2+<9D)\)ICCJPG/
M*@D-%LU8<@JT"BH3^'59MPX\_V5!S"5UV?UM4?I/BH B,X41%K&:J\C=">R0
M(<$:I]1%5I^JED_0K9%\S4N0<8U]:J(V]3Y+1]"YJ-L3)+WJ<:0A-[CETB'X
M*HN3-ZH\?FC[496/R7JYI&H"]& Z3[V7<TI?_TS*2%)^48T_6%O_'EBU<I]7
M'C$!#G#=IA N/_S;:=C+PEG--4[,31RDZTPN:+_'D;=-R8"/)2/.M=DW0'$B
MT0NS_-8G[^<_CR%2C@9+^$@A$UDU?.*$S%T[I=!N9 BQTJNI*LH!*S7G@*<,
MM/TU; *T'@VEQ>N9<%W64*-$\798"*E0C9.R@C8<,K+M#2ZP*YP=I[4<*WW+
MD-IRTA,#G^LK%$MRBM!A%E(;3,WLPC" \UN40.@/$*PIDCJHJ ?$AW193GBD
MFA*+X(DI=_Y,2(B9Z.B4&DXU%-)]F/*L:>&4@4F'FYOZ<&%><AAZ :B9E-M5
MO)4,B?WURKU9(*W<T%BZY(Z(#L-Z\0J]Q!VE+]8O=\O,@+LUOD9F43GI'FL!
MTU8H<A;Q"F5G_2D$T9/H<6[W[_IOF/&Y#%$;*Q,+T8NU:6_ NM0T8_5"7:'>
MKW"/2^)9J]X+/6]S$A3X\EUF7G%P"4A0ID9+*G[0\M@@\':GW(Q[%)OE0:_'
MHTW'[N7B:WP(]R9]N  X PFW SLAA#L/<"F=('X"K _&2[3TDR*UV1D.6[-"
M/=7@]S1O]?U:SQ NO_)*AU_Y= */Q?5'J#%2V-8!@7$5*$ H>X*%QV+".%8F
M6Z<55(IBQA=ZG=SI?@K55V187GJGPO^C&JI6 6=9==3*6L5R05]IJ*@IN"M
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M-GP9>.,(0KB557;^7*L,.H2[/='%6:_C?'OL!??S&SO;17^X $[\Z@^)OA>
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M#]5&'&XC"E"+1%>C8J"\*+?PVIWVG,!'=FY''MJY4Z]K!\PP]+SY8*O)#-+
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M"X=[_-DD"G.H1X;._WD^#I/9.6(^+-A8."L,H12N5U=K2LJWDA:/AN9V\R\
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MK<>/9;<S<PN?A46M5S>_P)H=F>@PZ-O_KQ0FK. <(6I:P0G/T:"CY#S," G
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M8"VU%ZGP'QQ^SB;I]GFC[RA7W<:)D7$'M6^</0..S\J#A>]XJ ?UH\7I;4B
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M@DXK[ 27;#9S^1 G08$<C[ZO-#S5M.$SC[;\)5/YR"0P+Z:[K_O1E[E9I[R
MS*'$:(X4_=R<L]7A-%V%_@Q]_][2NG38/NIW(9X>?.*+&=S^>^*@X'C;-:CN
M\#3*:G^\() JV5(G]H'N1Q[)FE@-;\"-,&Y#X42R#;Y2:)PT[]=G,&B!A@Z8
MS9_A"HCKS+A^F,]3^#YXLF*IYN7-YCC"R&S/9Y=L]A?<G@!JM4;^]Y HT'X
M$I\S\1JY,T,"/"CWZ3Q+L$%U<69((=@ZZL2C(\HMVW%M0]V"#17O?<R:O/YD
M?C/N,*0QY]1,PT5N$UTWHXM)@%LXY/DR[$/IL889"? N D7P!_T"[_IBEX@"
M1+>%_ZJMTU]BA;=H7\8*?+KXS]K_K[VV E]B-P%?8@7^:?O?W8+YOG>ID"A[
M#@>3 [4G;'D)*DH"V%&3 )^NXJ,1$_#_>%AT9R?HP&@%=$(#_-6$ZBDFWOU;
M/(G<J5/:CG]E+G*C&T=@[^SAL]O(XV+'3P*H6Y]5$Z^JD^_ZS1*R#'G.AL@G
M1Z$XY('_^2DA!$ZX[+DZB!6DQ.<"$XE5Y/MP:#-]@T__@,(Q&I--^\F-!)@C
MXV.B^XP''2OPI:WLU]\#T_ZS]E]YB%I8T<:_WT9VYDV K#IR97SY^[!-OL2_
M&J?_@W9)V9Q, <E\ON(;;'T9L3%C10*D&I'SZB0][.@#^)#Q7Q6*7PZI)SH!
M3Y3RR*@:$( &(K=06XQG;X=!RT!*0@T),)1D;9Z5#_NA1H<CWTX>=TWI-C^F
M'V^*GTK]NRWNJL"7_">:3,87_F_:OUM:+!921(Z1_<X&14:"S%+3,>0#< B&
M9P 2#?27^ E1LD:$BWI$*-25!+A+@Z8D)"@E$1/#B%'(!3*F#SP@[*!M]A+8
M.@/X<&D)="8 N0':=A^%'3V;^.D$/S#V@Q B.V ; L.P#K*KS:#.'QKJ/VH)
MIU$4<[3=C99@)9R:@][Q3IS+D$%?2P)4BC]'NB9-&>*6>M^H:+!4H^&)+%HX
MBQJI?-1D.8UF@..M=+?@ODJ_[X(MG)=B20#%")U+K@*WZ ]\M;11-L .Y!"0
M>*UV3#8.,8GK,;;=K*^W. D314W:9UJX;5=>Z)UJ=V!DXY(<;H-TGSF J1K^
M5*P/YRK3<9K+,M]]6S# K>??6O89G%XP,CZ^Z?.\?EP67"/.BB]OAOS&1;Y9
M-<(S'YX$8^ [C\@16P*KCI/U!+(X3>!!2Z<OLHPJ1R^/AMV?_:D>[89V7)9:
M?IGO&W)) =$%Q K!\(S]#_\69HP<@=&2B>O.3?,4<#7V!3?\SIR.5:8,TG*.
MRF7M^1)G4D?;).$M7A>=$TR\SC&QA!&/J8V(5)7O.>3+E'W<Z,UH6,^1T7>M
MY,=V)6_(4PK NTD5H1?'8#SGV7X6&AZ+7/@"KQ:/A?(OP&Y@,S1JZO>[6R::
M;%/KY<8/J';HNY*U7FE7KXGH+B!4GUDZ?9AUT8;O]](.<NGCE*#\CX'60CDB
MJDH-C8_2K*4]'Q10C :?E@>E35]]GZ!G7BJ =*N\2CU7]Z4L\PBU##W%R!.I
M!'T60%.#B\&]-+ ;-OH1&*I)=E&K?$&&^1V0@ JMS]'I.>&:,UF,]MEMM5W%
MPI8,>'HL3EBX>7 BN;S-8]Z1@^Y/?'R9/_ZJDK#L&;['FYB+1D:0M3>-*D2;
M\!SD<O.:]<VXFY-+^R1 EKLOA^*3B+JU_H"G-WZRA_#<XCB 885/NQ% O 39
MLK98/R@E8E.-JW7\2%2)_=A :F4'8<_],$3R87R%9$H\MY3.IN?2-[QG=\-F
MHPOKM<S[.3:1H0G?P]U'XA<Y;A3W&324/A,R"8XUFD\U^;,_&=)8;[@IDR<,
M*34A!!^[HK5WR'KPRM FC()(LXED:J,*:9OIK5=BR3Z/SCNA28EXVD>KYH2F
MO/]SQO*&S@]VFZ4[2$ER$/V VM=!Q,'VC2%L6^--KQC6N2GWG;<VB"*CJ]JO
M9FPT%:/OE;^(?Y)D?(_S*K$&MO 6Q-("PV@3J9N7RI71?,@B;,V&DAR" >()
MI@M])B/N=1NFILL^E?J48OD8\/Z[["YL_V$$Z[W]X.TIG/4FA&JZ9ZWKD5U(
MYD:*_N1P9TEY;N%*SWVGL@69<N#-] <4]O$3YMY*:&C>I:Y0%W%6??:/*U/I
MK)=>#7")F;,Y> CY%RN4"AR4ZE'/I,TI3^K3W,\O^BWI]VI1T)!U+C\3!=LX
M52,'N9=D2MM.W\*,NQ(YQ0)G;KF$D=; I%7=JPM+S/$I[@Z.</L17\52/SMX
M\W.?RD4J7OIVQ #=S%:'FARF$,_)G&\-51US':K-TA&QRJ_UBG:%B.!7_+*S
MUVZEY/I[)I$_GP6J22BO16*%,[H)\FBOP:XL!$5;:]FMJ"XZZ/3=*G;O/V<T
M\KM!5'4_V*4 ]E+LAFI?L"?=H(4E83DMH9[Q_KN&U_V A5#3E0%?%:NL?NE?
MZVMLW=_3MD1,"]C:._(%?\J4J,NS-\B-I!%V=CPI&X68&F]M=*.35PZ;#"J:
MSD_5G/Y1M[<?SJ(F&3F-JN[]CHHC\K6VU6.SY%(*K76EJR-20A-EW0AT [F*
MBNN*@Z5_=\.467/#EYH->,RPA7GKW#="%MPKCLM-1 H_YAM;>;VJ^'H?Z/\\
M_X"J'5$+6RB3^JO2+(PF1:HK>6S_O.4]ZCI92^H"]X#V ^M[4?$H6J)"Y  '
M?R?\K1K?ODN.6.$B"5#;_FE3>K)@/Q?#]\ZFS/"+YMQM"LYE)[_,E@Q9M(W_
MPJ\4OE_K*S32?7[8V)%$;ND"C@]AAS5+NH_G5UXYU-;.>.-D37/86C3UW@4J
M"G50VPT4"^SNS#7#/R#WS9*PMU%DT]L;7.E$@UX<4^%-]IO.#[C$1&UMO]+!
M_&\\IDAY9VKA^VC4_XKPQN"D-O':CW$2P WRPAK6 YNFZY: JM2/;R^.'F6T
M9$_.J+[N\A0Q_+UB[*VMU:<JW8>8_GO<Q5M9H[_U(YE@+@3/K@S_3:7<XC*H
M6(3>^<:O%!N9X&!CF6J=*1>7!+ ?_S=F2CPKL ?%262#M=\B4A9N+U*^3=@M
M7D!<GO3PQRKR>]T?_PFC6?=7V:Q[_M-"OJ'1OT3J=P4K_YU2NAZ51TG?G4(-
M5'KI7O\ZY+[=NWQ<':S+SV%)J2F4C9A;*]I4+A=W*_"R5%&E^EF@3:V7+7C_
M2WY6V&!AOVWY(4CN"(F577LXAEP4&@_8>\N2.?@J($N_-.&FZ3 B<H)Y-'VH
MY05T\F,45XD\+6;BJ_"9*R%/C9DL+-Y@44OBK[C=&[B96QMJ&>7TE3JEM:CY
M&WMAUB3 ?1!6OAZ,[2>'-XK]9B ;+^9!YN>1/3%3&'/-8#'UW6\9@P:'^(6+
MRYR."NR_AY(6Q8E7C?4CYR <NKSPG;AYW3[0AO_$R+Y::.Y22,;;@Z<S4M&.
M^@*OGFB5*VC19R_*&HSIB98.!I>.;YY;]M+KI0K\*37D3,P;4QV&-H&,MOK1
MFP)?D.:*_Y075KC!#^2PRL0>83H"1ZWA__1K3<'^()Y,P(;9<E$*1#+?LT)@
M[P;C/_9V G$4TV2F'W@N"\E&[NOMG4DG18-.J,DL9MAMZ\@#&56]=\;E C_A
M(D?/D2JU3/C^QM^SLL[U%)#_2V51MIYAF!@70*S/J4'[29O0ZT;XL#[(<L+?
M9=FEDS]8./S\WY9N<:POD <2OV';+'!BZB!(&BL((__33F&WF#R/P*;9"^Q+
MX=-G1"HRT[SL@R631XJ>(6AP 51GW^XSN@_ZV.O9M;*ZJRN?0V,$V(H4M4@
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M!2VN%G[>@ET_5KU* AB/BJ5U27]-]H+^6/@!$'DY!7?G_<C[+%OB4AR9R>7
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MP.LQ_P.8"AT8W<044<$3TS#7$1H G@'#B5)UCC+"Y(E*].S*0<?SC.AK2F3
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MK ]K4Z4!ED>I%V%3S#3 OEU%V.]31#-I@+0G8W2\:C3 \:G:<'%Z[EBB_V9
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M23:H8"G8R]<-EO$55$K\&>^>"2G0NQ*T\"7_]-VOP:>9^'K"\%8HG\;\#;9
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M3DUKE;: I_NE3(?=./_,@$V\2=D73)G*H7REC]@P2G68X9+O:_ %I(LAK,<
M+\%VHJT8O"8D\:I?2O[1K*2&7-Q;;J>5TN2O:5.3S7M"Y\LBVYW*?G0.LUM*
MF&1JRK=/?=!)J>4W[[ HX2KMSD&]VG$+MWAUCWU@,>=)*=T=*><B=D1+D?>.
M3^.3$,HO,=[/K>H!PY_6LE3\&1)XX^0;A[_"9#4%*$CD8B&H!M@->BW$1>1T
MHBO(=B7<H5EC-5JI0&8SQ59#LC%>KM_A=N].%\R0!N#BJN] \[Z<(K$0Z10O
M#.Z;(G,Z$3#$2R0ELA^EM$4=+VE9,^8;),ME.^@S!$B/]9V94<EXDB^1=\M_
M+7[J%:XJSR[/<6W%7.&)*P\?N.P'0FM2S[R";SPU8J*69V>9+\;#U,@GQWGE
M66Y=M:7F5Z+8[[HAE(]0-G(0KJ=-=M:@X]H(V9E . ;'E6]!AXONW!J+Q5J^
MO7K9NS-H7?4FHK3U!G0>JH@SWFI;1+_(!D\GO]2X]\'*BV-=YL)6-$0X5:^E
M SY/[HS,<=M%T+7"K XA$K=*Y@(N#;<-1X&JIV*,FH5R*]R/\TJ6<M5^[(QA
MZUNL7))LQA.XSS0"?/@>,&FX)5*^:@J&W<,SD;G$%HT[9$] 7K@W4;)>*MI=
MM!F?3WYWZPOJ6^H;2K \QQW5=;4II+%HO_^C'"D\Y)RF57R7<V-&F"LS>AI3
M=.?>M-.MU);B1B]/G^,RU. [B;0$L-3<DD#-$K]'R+6)I7!XY3S;^NO;Q(Q%
M(,<\S,W=7@Y'111_+,X<[3>ISUX!,USY8"E3D4,N<!92MW0*#O%R\%9:V>I4
MKJO[Y9R-#>&Y_E%KN;KY0BE3B1*Y HJ"5?-V[TP_ T?"!5NYPG3'ORR(U+SN
MR30##XH$X_-1_<_*+LJ=LKW_#7!&E:RSYK9E6$CVI)0C71%15!FB)3YT;'$J
MYD#R(G]+2 G8[BRXIO.'MB_+]TUX6-R-$T,W+]T\$B"K1QE(=3KL69OU5PO4
M%AMP6Z1C<1/NZOK<XG?T30-I@"S;^I^CA,:F,MEP_?>K$<89BD=I=8.S7AN!
M!Q=UZ')IHU/@[4B-L0 DT'Q"[[('P;JPYO"/RGLG.&XZWF&\<#JP*_CORZ(F
M?U\6=7D7MP@X(9('6)["=Y%L/(%,-( C,D(9S L]2YWDL;].W,$D^MZK:AA9
MFBAX5[N&\$D(-N!RU&%Z$GNGG08 %HD=.!$F*,6MFD0G*K,+;F.IJ*-8IA(J
M3.SHR#O?@#]'*)/L]_ JM[J/RETZTZ&J&Q'C".%;QM9WXA*UI"H?:1CD 95Z
M^J7SS?CO?CIOTGE7<46\X:%>TWDEX>OC-F19$^VFFJ.,G*N?QJVSF@@33W;"
MV:8AK1)A*G + 2Y[%=Q<=H?!LDQV4T5)BP)GC?85=$LKI%OR:_"CD8)GYG]8
M!#^[\O#A'5=7L1>EOQO)KT1^'\9$O+D(2D:RMIQ=,HZ!UR9^I(Z$ID^J)2$>
M'S=KHZ#5JGK7JK/%K]GR%3@6ZD>H)T&.D5067Y)=F"TE$>2&CD S!<'B+"KP
M!MC)"E^,(;@GXFZ51QU'#0\-X!LL6/K&(%J54=SA3:"6/<?JP(U&5R:^#2=)
MB[*[%>>T!5J%"F4=^(TJKTH\@(Z=_\"OVJ>Y7YYJ=,R";!3O4X[7*^+7*GIN
MK5YV*W3++3QYG@2.!Y_W#?+=E#06( 8L/9(Q(RE+F\YL'T9&M#X(GQGF.Q3Z
MV(RBWM.\$J9!M,*E$6!?B;D8Y.P]PPDH:$WY&0H]FV81(MS<\%:TWT;$T2QS
MKNM&J3'?#KC^=^%>5/TC2C$] 8?+FN&E,1,M!IA8S)A2N*_7J_&?IM_%[JZ?
M/3W]B'WZD$\IVKM#EN%%IDM4Y\-.C(>C!4=S151%5(Z$8H[G724GH5 %GY'4
MP^:"6I]<'X]=?0EY_Y\6J:E>AHHSB!\4/CPLKH8&.$UTLL=K%V.DGEX2-IDH
M8L04&&J.VGR*NV5_AZ?STDP43.-89:N-%$:=L;^.3RHB"4,\9]OS&'"9A>&%
M<2TZKB?&7:J>63P/SI-J\(OQ85X_;PB[EW<--YF&W1+8NS-U647-FVQ\:OQ$
MW5&5;N$EYK8C*SU3N>]*1X$D!^@8+PQG.!Q-J*,!3B!=X!?"+.J:0W: ]W'A
M!<WYS>^"-:8JG+Q_#G!%26?:LK;IBKY=ZOA2*)%Q8SQ@0-,I&UMDE,?LY*:O
MJG;#=J@ZQW.\R,@L]<OK'.S'M.K6[2_/3 /]BKCF&GT'YB<JO#;)33E99,X]
M*HLH%I$(Y-+P)\F1@T<NWB:.X=9<U"IFNPC/;_W1KO^Y_N)#FV?H+ :$T2>D
MDVNV)"0O9%GW0Z)!K_!G<ZU+5G&+)\#]3&2.>Q9IA Q*%50>.H[D";H(.@W9
MZ>R7G='D,"IS*G=/56<M"SI;:F1]5?N>K*A_CPC,!+6=F3V97+QFM"6 MAY\
M8J=G82S'LLT8()<W@>!]?*,1&G@0RI4I0'PB?=].P';L@PZW:;I+;)* :?TM
MOL%6(YN. A=15RF-N;7Y5M]0/8.R^%"5F4.=GT,(.H\\IKQ]ZCM[]@XE8?O
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M_R63DHZN1I( FSID- ;;$,.'>V5'V::$"UA(25ZR-OGY,55DK.W(5^P3]$B
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MC=W$@A>SR 04Q_S.VK#"X'FRD_1_B<DD_IND_[]-TA1$NG_=?H $B&_%<9$
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MP"I2+OK(#&L,NTT"U'$2BGA[$<?<S>28/0"!R&2YGVU  CQY#]MRUX(EQEQ
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MU]F-]YLR/+CJ=KYRJA!ZZ)\OV2D;"565CC[;\#H"C)8$\!YC)EC/DGF*G**
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MP2!B \%QW>EG,@@7OU+'1:0F9]Z6BLJ;VNCUM,FU]Y>K&1W33A$OE003@TF
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M]$-GZ6]8I]P"C-6$]#&8??=(>5I&*4I_C]@Y7J=4=O>%B6U_\NO7;YKY9_>
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M@=2^>7^GCXGK^&SV'X(Q;H/ T73,4!^'V8C](PWJU;XV[GL]PR9A9OM%>LV
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M8\GPLD''>\>DA,:"EN/@@CS?C8)^;-N8<<X7M!][D*77V/SOHX,%4EDJ^0Q
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MRX0O&1-QOP.>YS@GZCWK\N45#Q_6UR@Y-Z''B/8^ \SO8 MP K"8UWZ"1<2
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M5\)>@,B\H%4?'$<M=,;]VAD@8:E?]/)D(KQNT:" ;G'A;6#J2K!"7N@% #-
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MU5^66B[NV^U5I=5D>XM=OV%U]? ETFV7Q]$-MTHZE::)HU2F$SRR#XA:(O,
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M6&(8]'V8N@K[)8FFB8#9-*I-QLH2B97&@G_]06[%61V%PCXMG3(A-V#''F>
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M#6[+$+-3-Z?Y>E0TU#@'UA,+>@!,H++B(WN &>X,359,4;T<*470K! U;L;
M(-SYYM#D?L:+P0:>,LSLURI*R@RV*6_5X;,W.'[,8[4IU7>W-]BX;^3TN@LE
MKMT,:=B^.BDFS'3I>L%8[KEG92;\ZB>1I&"RP=\FZ+2]8R%/O6@>A@_]TVW
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MU20?8]),#W?UBY6+'H+[2V]T.>2L0"F''!M%-C'4*E P  \_>&-)E6%%Q9Q
M_12& 0\,_="_H!R0N-FQR^UR?VU+>%.$@M+YUZHS61OGX2W8Q85Q-A;P/8I@
MOGR 8D>-NZ62K<:!GW-!8+QK7^)=8)K=TND1F!9=DWT_UR(D#C!>'#VDB2"]
M/FMZT&(J*/OJ_%D(JG'-L/E$F6-03BMAOL X\&;;%-(YSOCAZ;0@%#Z@Q2;'
M1.=93'6T;2A1".MK@L)U(@U\;F^4Q7_PX#"$<]P*Y3 \N_L?_0&R/ H4=, ,
MV.!&@\SI]JUW?/4(R,:@&&$&MRG2&.#TLFP=6%@$9$F.GT<+O9?_I._&_#_O
M!G-MGF134)IEXQQ_3ZC\Q?WT* O[ PW\:@D8<8E)3X5!(MR*>E>-'V'5\S;K
MI,>C*;SV4:-SA^VTM[088I8OOYJAL./&; 8S'4_%,WZR1VW\Y,CKK=@L0"6;
MS_IS7G_6Y:*=^0FL_=%7L::'&@"?]!,917TP&.L(]D MY3F+)$[NB#P9'OAH
M,#6X:P-C< AL^#RKHHW1+A@<B,4%1(=N!?(SJ1Z$_VQHNC0_I.;C%&VU#B?@
M@[)V)4Z]?X&#ST$9!P/J4?MOI @]U1:\<_ZP4,QC1J%)T 9Q> !D7B#4OOVH
M^\(L\4B,2MFAK&22OZ\=[EQVFEEN67*-##JXOR'?6(W!X /;V.,UFPB,Y"_!
MQWY^SHA5[-BBU,B^A!<!0=4G,SK2Q'Q3U&Z>;U9XRW0TPD7DW2CK4TK>PEYQ
M&YUH,_>8*QF7'I3&8ORKE\ K8?7*\8N[":G3FX@%":"P0S;>\P[3JH'(Q\ 1
M_H7C!D21D886Z;$7"O&VXUP0G0]' U-E%Y:6X6E/C#=+80F;<V6)+I.XS(9H
M9:>2N2Z]DE4UMG<TB"TT+%&T\F2'J^#@R6M2@H=D6R";,VL;!4GGJ!$!_$Z)
M^<J-ANP^^X-^C&'P'%5O4>Q 8OQC-62<8=.WM^Z?DT OT0<DF?/C!@?!1C@+
M17N"JC*^>QRZY']FPGL2PJAFN6NG[_I'?2 .%4ZONY$[O)LOQ7TR-AJVTPR\
MO<24IGE&D;^89-[/8323FKKF:6;>VZ97.ZEFL8#&UI0L@5HOE;T6!0D3%^^.
M#P]K]ZK<J1M[W32JQ1"Y0LE%XQ:9":W[>-O<KOG<X!YRN"8<%2EQ5_61+^AG
M/B)G['']S.2K%H$'PV&3U# *>[@VG(M?<]GPA8N8\/["A ]I9P-F=TUP3? E
M?CICOLE"O)IMY9^P_]VTO.8MN_P+?-&:RBBPU'] P[PL&^-<>F,$57 GI]EZ
M 1='IE(-0C& +>QN'.FRU55N^POWCCV=C.855-I3(PAR&X]UD\[4/@2NL@R5
M%NVZIWNHI9RKGC=LU]6MOFXY(]/K(AX*'GW96X+V^?EE($YZB"VL:Y.7Z,QV
M#W4Y5$#.U[.<+&YKNU>=X6!@.30,V5HSLRA&Z)S?=P\2S9DR="]BB?PF>25R
MABKQ\8%8;H_ITFFL0U;<RYOA0S(+I&XBH@'WO*,!LP<_CE<2B;HV>*I=>T?Q
M<C.\-T=FD9?0BI<ZI_NC]S)6\(EDPX[8%(O]"H6"_(P8_RD-@Y*D83=R<XO
M2 (!OMA!/FI%85_94X[I\'%UZXMWD6261!/0Y9 =L\I>$ZD;G] <1D^F%'Q4
M7@A_DF#1D*H%TS0X3"(DDE?"* ^NB-(@A;Z6-$B7QYM;'E]^4[H M4*7/(]@
M)".&K3'ZF&8&M S[_4R#8&N06QWP3A9 882@T[&ETO$0M?$)0X,H+9#4L=D3
ML"U^&'DG7<7,J^K[*1!P2S,DZ&,<P1*^=?H%&YD5!@8CX!<^[\,$3';6TO5_
M'S-N70_M-_!9N8OCBFT"K^W-N.P7?1;B4CH9 _^\DJQ4JG=<IE]VK"K%7']0
M:DJ:99#),,(L \$8=4&0>^Z1:S=/54[M_I="2;6N</L1R@L;EY_^^J3T$OQP
MP!#\ "A-42)*Y"*@3""/M9]A=THOOWE#WZ5]]R:[N&B09RBQ0"._ZN31J$=U
M?1]@ \HPZNY;(Q16>KY,E+3(VQRR&!;SD)*^,&FFI5538G_+]JZ9L=BN S?5
M1Q]L50MKW&U\AU55=3V!-I*-W9L\SVEBY5=TTS6Z-LYYZ'1"=6R7=JE'U=RG
M64!*0(JX15#1)MIBYE%[Z3D6SLN&UVI*9 &#\U\=?E1GA;B=\BP.^T.D:/;J
MM2<51_>[U,U#J/02':00\ 9V(&!70/LG=@J\\V["!)(?D7BWU/]9F\#N3-3M
M-KD37!]N5D2]R^$Z>C5UY!F!HDB40F:G6$'W>_.<T<XDJ]=8W'I_T_'MLD(
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M:9&XLEE42B:EJJ^@-I%$";*Z\\G9D<.4W>G$EYU,[9Z8[+,\X]T"#W=EQ#J
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M3SBBN CU<(H$#;+G/; R#SZ9I8]5?9)MX)W5 -2:5-H4".]Y#/[;.6P;T+<
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MV@!T5TDN*.S(2'@!I'0D9'0DA"X -P! 0O%?!@#^ZX>$E(R<X@KE52IJ&N*
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MZAMFSY:;#.V[O=QI$40+VAX>0>T!N4$ O##P"@?JAQI0'1YD]7$(/.,+I7]
M0?.Z77!QK"44?WVF9O2,-@D)<?_SH+!+CJGC42Q.0"/I$U<P</4C:.JLZH(
M**9YMU4X48QD/.*(U9M#Z:>UF+C/H&HS<\B)E:\ZE 5Y(E 7V*C^!:4NC.XF
M[KT=?8C,Z.PKE8P.4/E2E$>OZ24NP3:7Q@^0#UJM!>K-H8ENE3P+EQ<A!WY^
MV!42$WD6+C;;,Z:5;&W[+?SKARN/G3@BN+(0EYYA?NA0I/)X^UWT;N\"Q^CR
M[VH:L(17\RZ8GH[JS2^RP\=-D=_85GE(*6VQQDA_/+4+A@*<T@-"%N&YRF/$
MRTL/KF2+R><]<C[YV/S]VA?I17D-BE[8/=%C$2XQ7RX%B2+5&[JJFNXR?ET.
M7[.*?L.8H6(_2HMWZVSX?H.II3)-"Y-#-:?]/0.; D[& VL) 'E@$KP"WBLY
MO8'? -*C%4QKQCRQG:CMTCN6_5HZ@K[W[A)E+8>+W#R^#5Y9'@]W \8OL#7_
M?EF2H-5K,"%N?2F4%\PHHE>0]LI\[X;_8@WDN^3^(N9VV!U<(=P%Q"(.>UO]
MH+!S>4C[\;C<+1L:UWQP\IA^)-5#0&5\/1]_9+ B ,*ZB-0QFA%<#MHSQ8#0
MA\M&B3R5P2L(K[T]\]U^DZN-KA^$?#]0.B;FU<F=*0'?60[S+O]8:64@>[$I
MF9OV2-4F8BP+(5I<&^(]K:;,^J1#*\'=W10W-S^^E3VU8(TZG>I%-6'$\?UP
MFC!1I.B]43D(^?:F:9+635!X[K"42.5,6C_IJ_0^Q^%@FF[(-2#2VAM]!]IU
M77 5^JY5#&W4J1"(9XI=.=B1CYR>8IW4;_4KO/DT@DSMK12>6&BNJX87@$_:
M'X-+M!/YQ\O$A@;UN:A9L=]]SR- C3#D!OP+ 8 6@V$9DY9H8_#<:-C2'&K&
M-N=NJ($667V;BY4U<WQ8?OKPDJ%47X^2*EZ_C6WQYC-P[@\D..1/8WUQ,BR^
M0%C//4%XZ*1_:'L@?']L]G QMD#K"7UJJHEN][2$RP'*SF(#H@Y':I3/R*P&
M=7"_L_[^\5L[I-3::D@UR%Q*K/+"IS?M Z/='Q(20;X+"Q>BP[C$?6U5"7.*
M9"AQ8W^;E-L=\.*:GZ:LCL.UUV >LF//[?8EG'H!L>S8B(>IK"8E0)C.PA_H
M5D[PUL?8IT][?=5=37IIJMCQ*]\'_C(QAK,['$X 4(J@'3N4+3H*9PV0**AC
M$"I4*[C4,S?&5ZI'XQ;CTVB>$">7%%#>RHGJ'>YN:\6@M%$P[)JJ_>V9'=-X
MIT6!TH":P_!2Q^2[*6UU^]P2V*; W=+%THQ!3#G^^D!]LM$?!HU(+<I?K16K
M9+?7JK.4^/W\U\OM/YWUE;>#T.*0-NY8>'5=;[:%)C(Q*KA$-N.<KLK&1@?S
MX%'G#_=0;MLU?U 3%.DE!41V3.6A(35BOENTTX=7*)=!MA'CB\QPY_(_AV89
M*T;=%*-E<K<:!#(?-GMX;NFG"]*3:G-*A^NT,5W@5%?IDL'14 <?L.ZJ;TJ/
M!>SMMZOS_?F9Z:4O6EZ&&Q88/.DP-DF.?^(8.)^^,X.M!@Z/KU!BZ4&H9+3G
MLE!-"83<@\5?[(I6M-B!9;S$WLV;IYQ)1J91T*%R!G!HESKUY*W[1P<9\M$E
M&HHZ^Q++8*<3LY_U]"*U04*]7'.(RZF( 6C-^=XWC/NVC/82)[ S\R==:JB2
MIYC$Q\G6^\6C7\%]E!S^$P>D\ P(6C$)3Q6ZS,D([SVDV Z\E$M5X'X1&BK$
M+'0<SSEQX?Z5HVY#V246IQ#=;-CMZ%^X9JN9T=S$9&XHNZ-2)%*)=NN7]%C4
M%=U*%/G#Q&X_%7\Q5H/02BM;#/?>1'-3$,LP/=RU?(9O63)NA9VBMN 'V$DO
M4D4GV<V!+JR%=,WQV?G(6),W6M%T=;,+DL"<>?NH-2DH;_MQ+HU P_L5#2Y*
M:@Z25],]0/N:2V&BVO[CILZ(V,MRO[R>F*<JJM:H-M1L$@U><=)R#E#J%.(/
M:N-^E(16/NE@Y\^A1]M\!7MH5HW7J!D*Y4HZO_C(9J_?<)^SHC@E6@0VYU)4
M=G7#4AA<^K93M39!['[JUZ./;HH%E((*3 5C!O)GB-(]FS?I5PP,:IP/6B]5
M(E2@7>4Q6+651?IV1QB83[L>(6GG$"L:ZNKT>3:XK4W3&P1SQQFC18F5_2VQ
MLHNCI<*LPI?F08:?EZS&YO<.C-\%_/HE%;48]4IJ1,WCTH388FD@[0*J3-R=
MI62KDMWB[(N/&S',4%\WSW#W2JK\\#* %0,YXXUI5=^^OO)9[AD^/+4QA@7_
M"W^G#OWLAPW:K],BT>DG?N0MI_J88G/5^HNK,J(4/ G'\I8 *S\_%7!2U]P+
M?^MI29KURD%?1?>D7::5+&@C0O:)&4+B/"40]%K6Q_CEJDGS!6/RNI&GY[D;
M?*,&.+2Z"L,R8% I:-[Q(<G.?8=5HYHY! O(H4&8_;;*I[J,5_+QEW3[H-M@
MCXX0>!+6R UY.4P%7.9M;HB<_Y%FJ5=9'1M-[1CH_W&\#%Q^UHZ&K!A-^Z-6
MT<Z%[;FNZFP3^P$M\I;?2?L[/+Y E'D>CH[07\209Y64]^?QI+=S=QEA&?-0
M%&/ I1SN.MKHUKOHB*$[2#E4E7/17'%GG.O^1H/5"#+:>+U^^57[7HMH5;2J
M7H[_NVYGMG2R':4A:CGW9U\/\:/FR?"J-$23:'ZRS6EK%Z)=Q,V08>/[C.D^
MX]X7\];Y^:1Y$/HV9(_E&;)S>3UAI)N64JPN*)#.UJ8OW/6JWZ\?7S(?_C+W
M@@G"U2A><B/M@6C!>6+7>_.S'0EKW[Y2Y.C@5,\>\)WD#[]_%+L7\,Y85\X-
M;4/:'2,LPSFJ$>V!>1@FC\RRIZBM3/@A:W/+(\5S?7,XD='\5U+6@:#2;M^O
MLD/4/*X\@@D_$$$Y60-Z[VNEUK+PV2=]T4/J58\EVQ/:N_''_I?Q#G"&HIPC
M1O"TX^K;4EP!AT7#:],4@R*;C(\J5J6>WD"^L2>%.)ODW92,E=H9P="9S0L?
M+!-RI'MQ6AN5CO2*H5[8SJS-+K;I>?%']U;_T1QM*JS?,.2ITQ%H1G!?'^,6
M,1K!CTO85[V;PSK)TU2/')2R ^%R?*RNO[>T;%W0>)?.]HLGR^($N'J8I$Z)
MRP,N%8!H PZIIV>RJ3'=YLG\=XME3;3.B]JIY6NU_7/JY?#1W-6PR# *#PR7
MG:WNL@&WZ)(:Y2^GRCI=9G/DI71%^*L*'OD]Z.?$U:$(Z,H-#\-TE3>B&\$&
MRO5[#QW-\YTNG/5@U=\;;&K67?C/QA_$41G-E7TS&35$5%7-MI02#Q8!< ?Z
M'I&YAY>=_'ZD%(B0J!']GB!PS<G-WN(VX%E*'Z<*9J,U!9<-><8]PX**^?Q\
MO)FF1.*C,+=+BXW*QUMY3B57Z%[_VN0Y96OOZ]T.V@O D.@285AD?_MZA8:V
M FQJ</3DN,C5E^Q^AM-2NMV7P)S@-DZP'&[#U@U>"<4R]"YM9+B4;]MSCE7C
M[G1*S0\]<ZA3CKIW[5GS;C27=4(\R=6A)B7*^' 69G <1]2.TG.KJ$N49^PW
MO8@.JN/?"0\;>!M,/6NS5SVY&E_VO*6=.7E2)&'M&X@H33:8WFH)F", E""Q
MH'\$CO;R2(R$W*XDQ<[Y6/NM^FAQ"<[$R?EX<N! 5D#Y8(M'VR)=&$.X+PQ\
MV!D4<GV"OOJY2DGP,\>:V,WS=ZW9RHC+]#"B\HW,P7=#JRWBN9?7WT2PIY@T
M?-F;.C+B^N+/6-!WKYPCC\^7Q\O<]MJR$=-% +'5G_WS5BA,<3*":@?*CF=S
MS33,*._=''ZQQQLK\$%,5#$=D#7 $/S9W/P%*17Y4Z@H[Y&*%'ZRTVE./W6$
MQ.*6XOVWO'K&U=]7TE8%D*UEER^PIT61D5$E6C#IQ",;M>KQH,#STU,\@(3<
MB2/6.L_3N6B;5OUSZ>T8X\@=<+X6.7>RECT6U:N&E@N!N[H)YC7.RU79(?Q?
MNS=?7MS-C17^/_:*XC_EJPDVOC=:_J-/*BY)4D!>Q+:I#G'$V: ZT8O+GA+#
M@E"]FHE2Q./H)XVJ#@$W?@"4R,D0%;T<),CUY>[2/LZOJ7@=CTNBM(HR:KY5
M@(:MN,35J&F1I]O=$9TMU'^E$PK^G@;@IU=WYH9^+<]>V1LKT^VT*G/3J+&A
MU?H=XKIC+UQRUM08+N:FE5EBG<4U-(_-)  4UB".T"K(WA"2&W47+?5MY$I,
M'CC\U(YZ*MS1(O,J[P?#])UC"D43&S[^"M6<P-<CJY+[<41U)XJEQV7B>2 =
M;%]=K;WCGB4]QC B*@Q4F^1_&7^.5Q")^J8&X SQ4Q\BTFT^+ !$M)!5@K&J
M,HY%?04[C3F?_9ZF4[KF=]7^8!05IB3C67IYV U)/UN::-9>D60$@;^?G?5M
M3I:M18;VR"A3\?L56 W<O(=OIL8".\NNMOMZJGJ%=@5(L1;VE\0+-:;$%6Z&
M3J R6G)1^OJ>FUNK4C*=]<:Y>2R>IZ/\.0M)$8W075T,%1'OAZU$4]:NT4RQ
MN<VGQU(WU;EO3:93&6,>7_4MT:K 9\F)5!F:T<"$]B5&""".Y#N5?-=ZLP&]
MC(3=B])B%Z^R]X \?7^3*O>*-NUZ\0<.K>'H]E_\I#Z3V&A\)W<=K!OXAZ$'
MB$P':YNV--4P4%D8Z#H?WX_ZD"OWXB5KC[(C:W=$*3:,F,'/>"DL&&VUPOU6
M&?&6HB;IG;CU6' RK61,PLI 9?$!9BTRF$UQQV,V;WF$'HE@'!T$F_L6I6$L
M]7Q+K.>JOR.J82+>J^M)G>('U<=]JT)37Y?MK M*<T.W/4-"U)2APXY4GC7A
MVIUTM"K&HS#YZZSD308,P38Z9$7.IQNM=;@O\&?PF5NH1(1Z)PS-8&[ ]N=J
M $5E_7&VH?Q/7ZX;&K_:@8:]^T2CPE^.9=@Y1'7AON8=J5>YCBSC'*T-]/9S
M>)&OSFE$A?F9 &11^\-2H"W1'U;X?FZDP6+D3,#F>UEOVNV0P&S/*HSFWH^\
M^L90US1]MDW;GE>O(POM/G]1)0%9]43<[HTYDJV,K[IZPK%*QPHS%(8[*@F$
M"I4ZK16XXLV?L[[@*V4QR6\0UIP-*!XMEY@/&"\C #:?'7G@KQ( &)TPZ7&7
M"3%5MI*=Z]3>5],SKAFQ[65#5$^B)A ;"K&J#*N+,=;YE\ N<=+=3L3'A@3>
MIDA+MM@*>]5N^U:B[<["#R\B31;_;*(*$:#.$ ZN6XV9;NRWO-7%E?<%>%*I
M'3_0/^"2?D/7-P-FNI@F%LX6(I.-PJ31#<BD+B"'.O=68T1*V59MY0ZMY_>9
M?'T>C\#ZV(=7HX36+>/I[_4<3".E@8P5$R=Z2MJ,ZWYM1@Q"'3FWBX3O^[MI
M*,JF?:GTNE0[1UA_8CU6_A02:X[(T)=S1L./+R 4\*JD-BA=Q'B$8E*;/7U-
M^OGC9+-WVJ15\*&>NU]S+E9AG+N[P)E;>*JX(P@J8!1>5U-Z _?BS7U'L0^&
MQ0#R.K&\@Q/H]E"X-U%)(]"!GMQX:H;0Y4.V[1(52_2;&?&6B:>1MQOIDM(P
M'&3Q288J$,=%I V4%FR]B/)L^N J3Q.$NC6?HNEYS8F'7 1;K$0N13GWLCO4
MUJ 'O9<1[X>-C!8)\ $7*P;W!RW.[LR$F]34[2(<E15=)SO[JP)3;6P\ CQ!
M*=X##[ #JIS+)8OLZ*GQMLPP@SLEP=+W/H@DKZ]Y?FH[S,E9@1L<$@!+'Q8Y
M7X2QM\IZWW '.H7209KV3I8>F@Y>_U#?3J:DN'I2G@)Q^/,U T]-MQP7^B[=
M0V9%15-^[VMO]8)0SWBO1B)4CP P@].#0>V.*%LK4*?RLW=8M5HIH>I7RD.X
MSRFW4YZO)O/S<^"6MZX#;RK.<G9\&H32OLFC_CDHW!%@F_UC7>A.7D!K>?'9
MP<]ZUQ4F;4&7*V.C:K*0$F#?:CN\JCR^V?N(R^@MNU>VKT0=TZRU6J/6WLX.
MWHKBWOQ$1-H9L#L)+=#;"XIN907=K(L^$]Y,OBTFOS+C-ZSG!) _VWZ=]/44
MIXU[)[M/#T*+!+T7/Y"M%ZPT8IS?JP%/YCV6- 38,N$H( %P%CQ'&/.7Y3-X
M7)CG<LL=3EJ-BK>HK0%/4I[7SZZM&'2ZK=,* A)]E,H58INU>WWPSFG+1<M,
M[I:#XM<T=<IC34M8:PQ%PVW6[2VV/;9C.K2J!03YLYQ6JJ=%/1#>$P2 %/?T
M"9[*&*.%]1OU#LA^T&[=FEY;O'\S5"7U1#YA(/[KL._L-B(6*3E#B;J#WL>H
MSL]!O-$R3V)T:B4;\3:Z7:&/L[+WN91=BLZW0=MDR"H\M0>&9&05@GZ20VYT
MPWHG_9P&9L!4AW(;W%GA:[GF!(7&,[-=OKPT1;7CTEIOXB?@501 K*<G5N[;
M4(#\:TAH_HXYBGE4#_)[QN&'XWT:DK=+9[_$M*16))FK?C"[:2D-:ZLRDS$I
M"ID6%["-%\AG5!N4!TLX[<_^'M]A7*?<VQ$V5&@R;PJTC@@*A=OD89LA#D;3
M<3W :EB/Y#7!F-.!./3+?:W%_=_=#+](>Y4/KP$4VRB55F&E$!ATSQDC%":#
M!+5!KV\1FV#DRY,2C>\/KA, ,YY\]-B?@$$9+OV ':D/BG+8QY#VNZT*85*X
M-Q O^"VL[-&@O%=<^?RL9<&O]SZ:$^]>/\"LLK+NCL N;X;QHI-RL?I(N_+8
M4]9< ^7C"=M[%8[/M))"7EE$7BT7[,8NRI2_;W\<+5+MUZN7SD?S/KZ PF:F
M75<45EI6[;V>)RD)HV!3^'$PD3(U50M'^&,) .!2/1!I .)(2LCL[8:0@1UV
M:*EMYFWGZJ;WLV];3GX^.KXS?NP_SO4*L0+<&\+P@C=17X^R-U]CY6"V(X66
M^OP6=)JWJF#)7>KK]W1FHW+F13%MQ(#;(.W:$21@VC8N0;1&L<VV'[AU9>:2
M@IY5]4CX?1XKY>:."@&@C+4DMBI'KVK@K8@I$/U94X+\U/'4>DV1IV,Z?[)B
M?.12S[*E] <8):?B84\$/ 8- W;X,,M(]SS-5G*V= W7*M B " &LJE?0FKF
MST Q:NZ,.2)WXU,V S/MN#*)8O154@<TD0! &I8G LFPGOE@<:QHT;Q^R1#'
MX[II%X$W/QBYZ\-#PT,LM(^2\%2>1S'+VAW[P)7>6-E;&$[UN5F0SKB&M(@2
MC8BPV-=KB3X0PQK\)WB-8"?W=.^C#'UTT9&%SN]2T\ZK=5POCZR[.#T_YY/'
M/%8T$]%I6YW(Q++\@P.QR>O\\V[]_6(EY3MU5JS,Y$O1<H8Y^]F9&1MK@3?2
M5N](ZNANU]W1#7+6VFB_I;&6[!'%=Z0 '*Y@T[QVQ]@DW]V!3UNZV_0-S)#:
M5+=&U*^ M78V</SA?%Q19('!$[\LL]PYOH+92@+@[7[I?M$Q 8"EMT'UHS%(
M @ 5B&_[?7I=W_SWWM[,3/OR6S>^1+.X =;;EI*&?U9A=<M&6*;5E9AN[G>+
M=#7B'BO.-0O9#N>2_,;S^>_HK!+O<I#\1O4HGI7OJ^"OWEKROFJ'[[ITNBQ_
M^[*IJ:_<Y'E]8V6L.9A+Z5VG\J8@3Q*,W!&ZF8>_P8)DB5%UPSQ$FRY'1.=K
MY,/>U]C8\*$LS>^2C[^[U/KJ>$V1DP"P17LHM %OGCQ24ZU-HT[=0:#^=(L.
M)*<5*!6>>EL$P"T*=TVAD\)U\N/&U5P#7]+<ST?AV]!![HZD* *  2_C+A\"
MZH1>LT='CCW@>!ZJXO:=FO45E>OOU^TCMB=#$05@4_S5&N(FDCHK=ZO 1N:1
MEOOJ8[?EZTCB/.?K*)1/MJ-F8_&C\*4THJ8PBH166.P=?@O3..I)*'!7J&OE
MJIK<:)P06ZYWY<LA_^P\RYO0)1$H[*/@J 2(G49G$+MU!2X&SP3&2\9DR%N[
MJQ MP'/Y 0_+CVLGY(_(W5@UV<A%EE9?Z9;%#W1A5[D_K2##!%-&.!]0&O>
M/\$$33]B1M+[1*<OMJMV99%/\J[VMVBR".2&H"KMM2\ZP\QQGP@ 5^ZH5L$)
M61 #FLS\Y]@+@8_ :L'*^H=",111LI8]2I1JNST3U<ERQ6&(]\?5?.GFPW<M
MRFTA.:(XNU;I,$JB O/VGH9;'H&BL*+?JB]SHOP#ON_<=)NJL'V?.;^FLP8V
M]?CYV,J6XOF:_%6BOU!5 CJ4+%)"VC7W\#3@Q.G24SO';CKK>RFW=>*-"O<
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M=C*1RMI4C7C C2 B08,"(K6[H'\.>_ 4R*2H/0?$\U'/9V,+4Z/JXQL"J;_
M9K_$?(;JT&^E0% @TLAH=G:IA@#HFC=:#H]._'REE'-V!A '"/CPR+&W7\&G
M4TWY9 P>BI<-LT+".FBC+^%=2<P70&3B=J"O[1P5ZEVL/MD0JR<!(#EO.H'H
M\$T,AEJLO+C"6\M>QEY*]6P]LK/'Y'%Q:E&]IJ9W8*JGR\O3N>U.D_S"OCN9
M01MI:7@"X#<!P ])6/R9U V<CNMM%"  XD\]=F^Y'&4:7,N@TXOE\Q@L4Q!:
M.IHC^1 NBI."+&5:GW42-9!JLT!(I;!\!&/+S=;?@>]E_YB]YG!A$]!=8\B9
MQ+XE#B >CJ5O0#*(NX%VI[5@IX>=O$J<-_T#KV-K5IK/]$O"@OU]P]IJQT;^
M( 0(2^^AB9_$135?_SI?00?:JIA5X?HF(6YLL_B5":7._YPMT:4C^(J"4D<S
ME^3N_I/<J6*ZV//2UA+[ PSKTC=J<.Q/F(3KL6! 55 2!/0 '4JL"@G$?L(.
M=/.>B>M*7Z!!EN7]L.PK,Q1HKJG)?&BF0.XUZ'H/$#"R/,YT0MOCC>;WWJ=#
M)K6-HAL'VB]KOTE;Q7TN'1M;G[E;<>"=>EL1X)05 GT 6N3N@A K7H7"'NV*
MIXGD^TT-SR#+YA>V\[CH[[K\J4ZTU7S'_A-E][:C0+YAC.@:C'($PIXBW*8]
M,_#URO4KE]/+R0OZHFQ'WJJ:NKJ\\4O[XE$U@4MT.6E9JD8C?EDW;,34=>52
MB&K?N&LB?O6:7CQO=GZ>Z]Z>9)%)D?!"+JH\=T'<QOY0_S)HW.CH/*?3;E1B
M?:S9^-F=M!\:?-URJ:/-?GQ:.D_-VIYJL*Y%I-;@U(AYZ  AC0ZI(D:X))K1
M-<LVHI[RLU8YH=75-0E\">1[3@#RQ_47]6U;-Q3+UQ&/&A32Y<\I?[QCA[_\
MY9^E<'/=\L7LU08W"_-4;FQ38?)&Y$$&9,1_N,CP2;%>5HWO]&+ =P(@(@>4
MM!V#I8L,]@1Z0:F&R%Y\<$>%K0*/9Q?@$X@5[V[65@:L4$9O!FH;W&C^FN)T
M5.II)>M>;EKKKO!:CH]V#21=$$L'PQME=$!1+$3A.]H!'W=!M6I"IJ.Z1';8
MC-YH:;!Q'U^+A5,>):>*^MIKZ^4VBRQOFV8:#O68\63"!T_]IB:I$[Q'"E!-
MVB?;000 I196=%Q=;A$K.*E*Y^@JB[D0*X _;[0-]KMP[O/(;87]7"V-. F[
MB<N#NW#/)K4QC[]%XNMP>:[7+@TZ.T6CLTG3WE6I>)&T[GTFJ]4&'0?ABF6_
M!. *FB-0OMH>?@$V^RD]378V(Q\B6?UNA&)H]7#&1,YQ1B! C%@FS%.TPK(^
M.,JXZ7? =:U^RCJW#=?[JK_R/<6K ;2/GG(;MY_7)W5DY2BQ#TD+F[>MWOW$
MNBHB:.UOIN36X^]6!VYJ$<.F?<[F"##RV-N9,4YM,/]B5U8[-? +ITF\"0;2
MSEL-C4)=EN^S(,?Z5>RHM9H;D_O'> J3A9/-$Y)Y[O;+9_GX=%8P7?01 %?.
M\8-X=EQQA/QL78+L5EE/0K'+KQRYL*O/U;)\KBQ J/$HXCDMA%#EHD<P0N"2
MSA,;@6'9W=T"[<=MLNGDISQG(LHWYD71.<0[BX1YHGTQS!$S,T23UPPI;,\M
M6'PG\;1&EU_G9GK31\;K761]9ZJQF\N) D/^T!LG@V+ND^69ZZ=9=T]@05;+
M8R&R-5ZS30OS"IPALMLKVWK]LIN2H36'W.+ <AE,$>YKA!A6#1<)<2DA -C^
MN)K?W5I@'@^,TTSJ9RA-:UTY7/OT9RT1H$H6E4Q2OC&[O(GE+$$&]7#?A+9G
MX,FKQGGP?Y2=+,;%3XW[R?&ZZ<+\]52\D<$B.JN+T&TH*@HMN"0YZ[WDW!MM
M8U$+[;07'>>7/W\?]XY-(I?LAH.$QN-.1?*EJ'@ZT*_>WB2T7)4F\L4E_'TK
MNS[%_%Z=S(YYLK7$AE5<];+Q_9C[MEZBT>OOVP3ED*HL^J]]9:52P0TKCIE/
MRB;9D[,MA6!Y?F%]_L*'0Z4IHVJ&S0^ZA367+X+I)ZV"(YBW87.0)Q:MTKA,
MH.?(].@9T?H,+3?A1+MRV%JE2@=_U_1 E:J#?]]WEO9Z?/#)@K_6[H'P[9B+
M9.)!UH2[@*YCR7&YJNYXVHGEEM]E ?HC%3:SC:PK"9LI3\WNWVM3_[,-^@:A
M6R(FZP.^YU+K&_)"3-68Y;7LK[6ZR!TA[RY=]ZCG&MP\5^0V"_E^^X+>+S*H
M"Q#EL=%[[S*L8VAP0,G%,$(8/,9B,9].KA-$]G$XO$44)4D+MJ[5B.U9\;'J
M%O,RCK4HB"DP-GL<E2&KE#;S9L*NP$/!HV4$R&1G'L]8=/PDKLHSH'*VM6Z\
M8O.HXJ5%[\+CKI#G^>-[<A Z^]X"L,.8@:GIQTCQ:JGJ1"?'5]_,='?W,X?@
M3<R^[?&T\JY+9+^5:'HW*+?'Y7 O__F?*7 I=8$HDX,=CTIZ:HU!;E*J+#VB
MG\Q61 )_,5*:P (!G+JJCC7AB)N;:'7V_MWGX-GZ!_,%!H*8F4QK=H_2<XNZ
M.7]3F,@DDZ(K?GQFP,!B+8(-/[*(U"< 9AZLYNO[ E^?A=($ X3YK.8* YY]
M>/*IQT^)Z^NFFGM&[R+ZCL*^#-)@<4^=9"I R)$B1V?/*TNDG/^(;8D,BBP_
M_4@L(.ZTTS(H$N0PU&7%D[LS4SO%FYW?S=OY19L0U6<G9WK5A&K.//?"WH52
MX'0YJ@"7"O12HUY#@S21PS\EGKJN)8;:T.3QZA5 @H1,^?T 744#?M(Z9- >
MR(K8$2]H9C=F[=@P0E-PJ,^3:5Z39=S&,^A$C;;0&'^K!+/8Z[P]?;$#25XH
M<OX!MKZTX^ZN-7%C'Q1(VX-IQ3[NRTI(9(KA&Y]I_8I+A3MSLQ*[$0^TL_5:
M90[*XSFOL5?2;3-0<\0]G;9# F"G?#L4?X.2R!Q#L.CRV\\_\&,1--51AA7>
M-7.W;'22A29'K>]'&]\S49#07M^VOTXL+1^(_LN#>%95?2YKH5>^FEPWNXUY
MZ";2RQ,+$4?5\^P+V%#.1L7BV.O81[M]#!5B*PMA%C1ZJA/.N07O&DV^+SY)
MF]^?0B@Q<QEW:45KYV>7S[N57T0(KBKT>J,%77JY7^,5QL(8\4P3!\Z3WV.%
M;/:JDCL<&+D;1A;V[4:Z)=$"YSU&;[AI*+M!]%O*T>E9M1X!*OK>TOS!<4/4
M^D)DHL,RXSDU^+3%?WF^ ]>'&J!+_N7YCD6G3@;7BW]YOO,%K!A %FW+_2SG
M._P:L1"60I#&AW_@*TE[0:M&;R'7Y>RH#[O&'PBTE-9D!=+INJS9#'CQFI*Q
M9 2N7T W.J[1Z\HAIQ7>-Z ";(2^1?>+/(E^]%!HP[+PO@F,2;A;83 EWB3.
MZV ^P_$[6.1)FK9P_H3M-T[)<#F<^L;(R99-_<'^P:"+NFXZ\Z;J]W4^9'?$
M"J3]VL%F%?IB&?$Z\N>D^%7^*P1 ^HXRMSN6?W3?I:9VBGP:MX_;J]@$[BQH
M._.IO0/B0G!CQ+1Q$0!]P<A#W)M]X&D(8F?N&6.]O[S^DY_'=783WA=5<3=F
M2S5;+N"H+>C6),80/QH()7;:O=G2,)_)'WD32\B>&)C=G/4O.Q/S#".W/G6;
M/+)/1B05?:N<P$^+;R'(0.T.* ?Z-]C\</DL)^N65;BP%\?"G?VJ3P_C6G>O
MY4>]Y19N;Q]APOSSXD,12?E>71#?9@]$>K]Y 35&R(&NNPF[N'_\;&W.;M!Q
M\R:II5< )2 '7'Y"A=PDBC_4(HA+,PB&59S8[\4*C-FJ]L%L(W^&_VQ=>OB
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M*#D0<0MX*,*$!8.^+63= EC+BN&2X;_U5!@P/T-L0%MD> )["!XZTKX%V)
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MU_@]*4?PAD)C2$07X&5I3;V;X_4]$G3DIZ\!TG55S.IP6#^/8;F"8>M]L&I
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M=1%^E_[;6RN4'X%(#[Y05+'KGJ[-5X;8FRFTY'7:LE_9'S-7T"6FU[=.Z@7
M1Q5?M$8+&;DX._,V[(-W%W DF'YP%WUO,KZ=+-/\Z29?QM<082>T?<W+K9$:
M0_P4$3N <9=;@!9\(02G[=KW]KWNQZVN(^":%1?/$GST*8XXC#Q[N3D\/H@V
MAV]:*M%LD#W=/A.$XFTN,YB!XU'F8G;J: N;W6;'_EY>$1Y=HC%-_F7A1O%-
M#(<JBREG9Q+KS3$3E//)(%W=YK>/N@Z-FAIPK7.Y)[> 2Q?X&I9JA0='DDB!
MP"@P67HV6]'? C[FOMS,8?_*-<]RTS( 6*_I)X =XB'YA!U/37+AC^[^3)^#
MK[)/PL%LG_UN ?':8^IND23[""B8&HC4$6=R*F3&9WJL2].SOQO&!KIKV88:
M5D:)86WD@-DQ*J+=<]@QOLF36 C^P^5XCJX70MPF'\ >8"V"O,AUJU;H3393
MS=UIM:RKULU_3##$<Z>E3:627(81V21,C2WDS'_,X*@'\S*(UJ3-ZQ@5J#PN
MT]E<^8O\:]N8N03APX8MJ:&/T,KON&@EUQ^5^X3< A@FKMX5%!-B94K)N$[[
MA;%>\)7/.A.XWD*"S$#["3L'GEJ+NSPG4CA?2),,AI9KK>R ;-V=S!B5L#CD
M'+*&/N;)?;/)*N?17$ZN<9=:><QK(?<6H )!\Z[I^MU08)Y]?M5IM?/MP6!G
MVDR_%#>826_WE-)U1\'^=XU<,]7&S]]P&EV&Z$+1'S/1+19O3*PKQG8//?K-
M?/ETH*:CYIILH>N(:PS5:BR.TJYCIM$S^2;/;-I]4M3.I8>C=XB%0E OT\3R
M4-9FW,A@3/B:&F]^W_F)&G-%^@?[C7T+"&&:A6;[_89Q=QD19?'_4,!9(D[W
M_SO29D'7&=5D]#-^S?.P>#6&"A,:[ ?;>8JC^%KW*V-EL6&7[$M1;7- !O.;
M;X89&6<87<+<:KZ-6T"<1N8NF7E!@[E%6B70#+A+]^(6 "HX7D#JGLJ*HY\5
MP->FG+0:P /%CHJX75R^"=)L=?F*T!3/1]R8_1L$OG45HF6@C]9<+4[YRGS?
MW3ZGIC5MLA'-?8XZH@#?XV27FZA2OP44OKQ"_$7K>I[SW_.\)H&"#>>QY*CE
M8WV\6M\")M^&YX&[6,$;5Z&"MP";$'$LNS!6&N[:3730LT:K3HBCH1F2O05\
ML3?".0"1JNK%D(MM9/'[;VFW@,8#G!&^$]4<E5CU#@G,XS9T(])VOW/F!%JR
M!%V==>N1QY>_W&Z!09%>@.'Y$+/4U4"2'[=6PHE0(]^(3@&I03XTW+2_BLW?
M*FTJJW3'4"O<70G?W ?+\Q6X>:IYW37"G._OM/715S8(G_!KY0]/"]OA!*/A
M'\%=-#C"T.<HR&'+"H3+^9<*\H];HQ:+0\N)92_-(_W?(#:O".P1U0S<I8,7
M3]P0>DP0:MD(G0E,;C@^"#,P2#^Q,/Y[<&(7E!2A&5;VGDWCKN_%& 7X-; &
MA*'+6"4Z$$3B)OR<&M3/%TRY4]S-U[2<UN+72*V5?5JW; W?"J??U^!)PCK2
MH@MZI@.]3=F+Z.O9/<0)V.G+IY*RZ[9*F+5R%-D2==NOS2\>%T5"A8;]'JXR
MC^2X!S0M!\"^3Y^/HP66^]A 'T'U7'&-E7-V\0ZU/^M^%PO\:S+EX8^([,%0
M@'/#;@$'GJCFBP[LMW-@/)Q([%C[X%G;I7291I",,'1$O:W7F\A;ERA2]PZ\
M#(Z6S<:1&JV,&G0^RSZX0>Y;-$][,HCS%![U^[WWR&&5?CNH17[XG,CZODJX
M%UY2JF\!G*%R*W@EF5^*1V6;U7S8RUAZ60)V:="^V>TM)]&389<7U_&:*A3N
M77'C=.YNH\KUXA,1135R22F(FGOH0V/\+UM$%G-;7198UQQ(T5_TO"\93W0=
M2_,N]TOA0<,[(*2!.%J "4/G:H0\[@'CG2KR$SQ&9+2][M^BY!KW70?J+,=U
M B+^@/4QUPN\-H'Q@9R)(W'YM/,+U"N<%Y*'?7EP<7(+*/Y1\.C3P["#=,JM
M#6IE_D^J%.'Y^/9K %>R\;$+]X3%G!:(C6B J/^9MCK_*H#/30IJ?9,8Q2NJ
M./^#PR$Y#KE.G)D2/;CK!XC!ERJ1V@7WX&]9AG+#3%%'<Y!8]_,:OH$O!!F_
MU1< ;SW\.WF8V4T8V220"PG>\U^JK@O8LZ5+2_>G>@;F?IV+!LCRN5LVGW8T
M&POVL+UPD<RO,/!O/,>3,R07V*A[<!P%;!;O-$:QF]^'A!6ARU3;K)3VMB;G
M7;^49(TF@>$TW+[+#SG#C]^0#,).7^/5NC9\0 94ESH H5_DO4/!IC=]E#M$
M0_I -2?'/PEP?Q(P('>8 MG-1CY=W8X%VE/-]6@B/:#E\V:FZ*>O?F59Y%13
M5R6[OOL@).$F]UM3EC=T3I8H];0(?^,5W*PYU:$\:@"$G/GX9Y0RHMQ29;NG
MF9;XG>"GH0%Y'P0B+6$;F5 MK:#VQ>9DV[Q:+<A'LRCC36GI7T'A)2%]XU_F
MEXC@W_16S)K&1FY0=[9@JX"ZD* YKH_A#SZW-Z4^ .Y+"?.@)<L'-D%[CO]-
M)TU4B8!M0$2@!176?TMJ3O7/ &PN\[&D ^R;<0K7)E<N>_XZ%[GV#^P7K,Q;
M+DX**(,ONFX!"B;70OBA; ,U,46<0R+F3;K"U"SJF_ZZK3196 2]2V;^Q^O*
M;,G(O)A>-I4QTW'<;RG&0]/=P!?[<4\U1LJHZFN>2[J&CV3'<'!K?HYO>J]6
MGNI*NF=[)E8L'*^A79/!I=#R/:!CGF'[U&IRW)OZ-O4N=L!C#N]BO^UO8T$P
M/!Q%>71PHYM["N7^*"@ZE+LP7;M/-XT(!FUD*5;UO.>M)_?YD['C>OU?95T#
M=W%C;/ P 9AP@W6P:4Y8]]WU'KJPK>I;-W1?>$F[XQ][MUR_^)RE6A='_-]T
M@"M*YD#/E;$6Q6?62*98RM\"D)<,NOO5FY* 9="J:+[C12SC^[-0<=Q(H5!2
M[9X8EYYSB)&,AUEH83,\P/[\&2=G,R+LNV[Z[JEO4_;9Z:E2';ZU$0::GK-<
M?9,N@\FL8:TV7NDL59^:J#Q_/45@P#E M*33 B1%24':]$8&HZ-),.69+6?]
MA4,"@80MX.7A\B(5#68Z:*S&\#0B#MXAME*PVW4IOLZO8!ZV9(TZQ]GOJ-:C
M=M'1MX#[D;/_J)*4%(3I&!(XWJG)KNH]@(C,[79C=4MUY=Y?<$*IB'YF^17)
MAI@?E4A)3K[/2-!/".. @;EGG+?H]9WG$2>->< P\,K*.$M@U$NTE'1V\;*5
M64]0B6P:=-,I;RO^=#AM'S&;< N05C^4LED3]=_:[F6%KHV GS8P,1EH<(UR
M\[H["J=:R^V"=HGPI97*W/(6T%T4N3T$YCYKD1Y*_7R8\DI64=9!**P+=HJO
M0E_ZZ_%%TQN\H]JQW+7)C&S];T;"Z%0RP[W<+W@/ZBF>E7\5>]-M)7JE*AK.
MVRQ[PM=)>*F='R"O"S0 -0&1+Y>OQ)7P\5!34(9+-<?H_+P%Z,E@?<#8NXA#
M.(9Z:<DU-36<P]3.F63Z\#X3Y,JC[,IDWLL3DV'6C(T:.7O\#1,,6@-=&^J>
MM:*HDA2D5L1CI#OX4!'-K)20(N?Q8(\L_H^"=29L,PY.@_-EQW<D#JT)D+H7
M.=@O'3*!D6%DJP?A]*TSW#EK3E^GSK(_CT$CB;(]F&G5ELX'RCCY\%%GT#[C
MZXGFA_6.C'*71.G7(ON_=!6]TW@H6&+)LYE]SW^H,1A[0(7G6;EE-!\$0V^W
M!CQHO]&Q0L?V/SL_/$H%K\M!/YHPZ:O'04,' 92]U%\)_X1)](&?("$$TVM)
ML?*_:V9S!I@^5*RJ43%.NXYD:L[HABB*+_@@H F&0I-E M5FHO:7%@$X&#S[
MVO"_8U)P,JX0 .X..K77FJ[9=_KA)(SUGUD_#TT:6T1TDH EPV#G@-(YS@3>
M&'OX%$5WD8,>6EM8C@N0>=J85>+M'OT[:?/%/Z4_,G1)Y/ZP<P=#9,#AT(W(
M0"6T@>E-X'KW)#1M.#/F0LLW@U".T$<CY>N=V95W\-^G.-)O-]3HRHLGZ.,U
MNTIG!.,,ZU&E#U]9#IL0<4G!L/O@P#\AM>G"D+"!*(:3WTK"$B->DC9:SY+R
MG8>_6\]H/M%\'P6?<RX'E>F42=N6KI/T+67\K<ZJV[E97,",CSJ\2:AX)@ (
MN_<LARV>AAU,&X5.RPT#*P<7NLQ9>$2HT+\A^)_7O>/_]5&T.,L./#>F)Z_J
MWA!;@'=V]K&J\)4DX(G',WYLI#OPC+D2!6.]!6RH1-X"8/MG\M[+ZX9GV5NI
M<PD"W^'95&["F"[PRH;NE>(0_(";'Y<4? O0K;@%/ :AY>APNMZ>-\0:MX B
M3K@M4A>G.0R_$(=>]9Z>BE\&X 1P3AA9ZZ@=8.9++Y+"1W'2D[,L&!>'':6H
M*WW$N?1 :LNUS,U]_ B^@.)1#TAO'M@]WB/A\@N:GS;$,9X.>R!1X\$2H?#6
MK@;C>C9U48Z7G2REA^%3$/)C'.ML8"@Z7%'%42O^$#HS/9RA6OO#AU3P[0=V
MC[O) QPZX-R!!,' =$FOG3VVJRB]DI(J1T%/6LX6PS?@S%#<TVC9D,<#4Z,2
M+:%>S-<Z8@7.8\91B;\:_(QU+4Q_SD")?[YP5E[:%?;T1#\#%V8$ILB#Z=$Q
MI[WSGP45L9BZ4<DZAX)<$T<Y_L(R3%KN<?B=P"W@!RY&7U!BL'8QV'.B>N57
MT@/Y4\+*)+O"RD)%N6K:3S_>O@0H[Q$/PL*]DLV?]DQ;3KL8^#KJ'&=.!LM:
M:(M^*T@/,-:6+]M>OMXOQUH&!N HFU!+B2O[8&)0H)RG0Y1Z&,]ANEG_J9LT
MQ#XI/O?)RG?LO\<+"^RDF"BT&CXMY1%*U+CI7\>'&G8E]4O[N9^O\\RB%21/
M6>+FB9B'.&*;M,.MV(1?!+ YD9R?(!3"&21B'KU)9J7GH/_Q(/RNR>@*6B;F
M,4W_2Y+,[B0?TO !%@8Y*>,\]Y][9R:>'C@-UN'VH)-3'4P**GCG#'$$ J=A
MI7 3RT@?8-(MP&G\X[/+;D',HR::P,BI@VPF+9<T2<@OIV;UG80Q[[ZZWOST
MX"TXGI6BPV7S5DUZ;V )C#L./_];/6@BM\N7^#S:S SL.Q >GQG[2[G9'&U1
M_<J%:N7Y.K+R[AWI3\1GBD"AP^&?(7R#2'32(Z/(%":*Q(!> WUO(TDM4.N4
MX[>GY<;%G_<TY-16P]K]<6V9J7ORJ[< # ?+.@B $8E:#40&MC#.BVXE,FQD
MI0WQN@;8S[@,":M:W77K5^FY4Z5%6*A[JHN*'9"!,"D]0>>MZ]>;X5F](^_-
M/9V!^*V"TG5F(66;,PYYDSMN4)9F-B>MX"\(A9"U*@#]/4+29P2=7-$Z!CTY
MCU0LZ.*&WTMTS_17VI86;QX:74$=786;<#;/&EU*6-.WDL+I8:7+&^''.#QQ
M($%4"<":RZB%KNPL!"=_'4V5,\<PMO0!-0#2FFFF86G__GVPR12X00;#OKRF
M.R^\6EB+G'J#?"7=-/^;;F%P8K;G#D2)A[3>+3Z GKR7<8SP,?,0;.N.EFM0
M4#KSO^LZ09SMER;_..\L9/DYS0]@H7 DG!!9R,]^*C3WFE-NVJC 2:/GLM:Y
MW!LJEMM^\[F6^<M FJ%E4V-C<.@M *H[,X[F;\8P@/'F+C((\PH5VTM!]])*
M4YP)"_]==V)LBCA<TZE]\J2@:C6")_+K!V*8X7\;4\!=[AAM?##>1W8'@@S^
M .O<BU(D7YD:,T^K5K"Y/*RH7JL: #C$VV5D@.*\E<F_BJ2IKOB2?XVX2E _
M7$G\\BWEZ5Y<)6)'N"Y4XI/A*'?!. '+N\_3]!*68[L&&B^U\XR#+XY#2(RJ
MOAU<9=>'#("$<4TW[<!O5+-/<90D*+4#+J0M5^2%$I.V[<S2GO"7K?1)^0\Q
MDNE/&X;8W)=X+=>K)_)73%K0\CC*<#34!J6HH/'#&6'@' Q=.3WDTT>IT==1
M=*7]*96N'52PXV'WPK1KN+H++O+2R ?7"0)SZ-FTW+SN/D_]]<KUI+#WO42J
MFPDE3T2@%A.((:'707+/UJM:O_?OYSR?_*I_Z3=B>]<4MA(T>@GE#ES1KJ7S
MP>' LHM:5#..LJ #.1YS .DN9&TLO 48-)()]S@29,V;T8<.#S&BYW34!90O
M&# UN 5@$[@W=2%C#8#:CO-SG16UWK'*8^'+\)#Q$&[XU"Z[J<:E>45VT(5N
ML?$N.JJJ8!?_(ZUVQ>! P\-F9Z2\\U7@^JW_!=1;B7)UB:/\\*3MKN!:OJ7U
M0^UA';&EP\*A (P4:>:^L64C[U5(,-_\[C[>Y*W"'8 KD/_^T8T&W 6$SBQH
M3%"6<*7;IC^ESK0W3AUY.VA8*4Q^1$[,TR3,AB.-QX]U( *^\J.0Y4^;.-3)
M3K7IC^W)=Y7HMTF$/,,+>@R&C $B[^5X,X9&PY\/W7UR"ZA*D ,NJWAN"200
MXQ'6B!YO ']^ W]BF.)D'N3)>ZF8<D=8NDPL<.UJTT_8'--J/5J"-0LQ'Z/,
M2/==0OWUOVDZO@40'H%FR_!&#9US0[%G+&/-,'T,KCM4B.#[^$3]89K-VT[Z
MN^5W?XRI$9:Y@?5N ?6Q& [J4#O 5&C UX7Y]LQ<V'Q)4[1#KOI45I Y#T\6
M3V1OQH " L6**HZB3%@Y)R<81TA907/D&C[/TTUW2]--19IP0B9;GHZ1K8YQ
MYU>^DV768N+SK.H[&0]<;#4_G$<$_/'=GRER( F)AP6T0Q'74TA<PRW 91S]
MC*H?)YC1"Z8(I?M^"W T7511K'I6DD]"6&,[G/0N1LJQGX M[Z?<F.M5$+H/
M!>KGXL!8502V#IA#QVJNDT?^]6=[MY4^.;(DV&+L)SG;YE*V=FJJV5"H'1!9
M-'=4>2)Q+J(:M(^IZ"10!0 H>Q(.A@)=>59G93>960.=1P6F*XO+]&<N6XI;
MOB]8\'M.NAA5FB_-6 ZY9'M:WP(0+P]N ;.M%QOHZ!LZS/-:%#Q6BJRYIBY7
M3K6 /G4S,RFJX<$Z,T@W_(GK-74JCG(.55LC31=(RY0&99T[HBSP<'@B^8A'
M/-]&C,MKN4WZ\-^V%"95P?E!S_>?9V^)L2Y4-7/;0(<H1?!?&-J8!4;\?B;(
M6K8*(1+#3\/\0RA[PU];RK_Y/&!Q?BB%H7+2LF';Z2+@!',^OQQT+8SJP9&2
M^*%@%^E_P,ZO)K)Z]/^<JS?J\MD1CTWH/!H@?9:YGG1Q!D/< KC 71-*4JCM
M[IQP!@@1]&?>R[H_FVU:LNOIK^IJ+!@=,^TH<78":<T22YUT&:-@,6%ZS1)C
M22-%0P'"J5(A;@<GZ$^+%VS3JBW;R_2H4)Z>0/2*3=)(D;F<F^%CA:F ;VS]
MQCK7<WU29:]HH-8*_^JU(.M38&"K%EAK[OP6D+PD_ O= &$.%0U3BJZ\!;A*
M5YQ8R/?QU&MO,_!)%[;_0J4&XQ* #GA6&E\SZ185[EXF;S,I[H"[4Z6Y>OU8
M?MZL J I3N$,7+81:JMK6H_(_R"!:;L'> L@>FV7.ES96-)*V\V<95TIH+($
MG8WI]T'/7#53V)MMD@:Z31&2:S^C\?JZE%$,=7 N^3WM[@MS_2CTM_BJ?&QT
M7ZS\< D7?'P)6:0:$$<_(QWH>G8O&?&Q@4STQ<7U;Y87Y@N#?T8>TJ1]R;,3
M9H\L9N!Y",^D6@C!D3*A0!?;J/;Q^+:75<M=7T<5TI-9-4JH[P6\XQGA]S1(
M@4QVD#&>#/5-'_M&'14O/_MQ03&5JI-IPY,B$3?Q)ECH U#S]$2,9'6,XT<M
M2_A],L;/V3..QT."BNGIE^8["(?%^0I;X9E)[P9?_].I^H6RY=(B[DAAWY/5
MYW$DLIQEY9A@K(N+ *SRR?^N[7/_!V^ANU.^.$\R/<)T=/P)7&09^;)WG<W,
ME%KY?K6>MG0!XGQ_XU&&L>,^UP$97F83T8B;^V9AD586>BB.CS9V,3-F#H6\
M2>3W9A<0'DL2?U+D6!BP=!AV/"1_?XM*^73)R8\\CX[^;7SSP57>:6[1\/R.
MY!#OV\*-;?X,4,_'3WWBUX.3NI?3,J?WO]THQ'FYRUN(:]=2?$U]<1\X)KQ^
MFD*XZG;2^-KXJ5AD'QY5>PT\*"VLD<E9OZXO5?_T(HH_VTFO-8'\#^'\C1W;
M9>>M-Z_^F^?H4)A9[N6\ARR,;#+.OCB=Z_EA9MY'>.^](9V(7N7C(:*L;<(R
M39Q-ARS&#R\[+P,7#%'9R>?[BT92;/'\"4M'SGS4Q]ZK1I;Y!)\> V <C)_2
M64W7LZQ/?@GZ'/],VL(3%^ KX!G@L?#$4""(>W63__.*X.J>CD2R)IR^>%(K
M1TZX]'"YNGBZTAB&>C1O(38/O98_QU"VKF:G-(Y_+!2O0<%BQ/EJIWUOXLHT
MOOHG#WQ>^/"OC$>60S[5C6LW\>(-_O']]Q]_@I-GGG?0S=H9ELT?N]Q%%\]>
M;#NQT10;/%&:BDCN@83W7'D^X/S*!</7"1O@DP%6V4W+AT=$M40L@XK[K[=C
MO:VY(\OR5KXE;!I_7,J(F7'1 "TV3C(\RQ1HG<P6]UNV:CRNQN4I EMTYPEQ
ME''U2/&/DHMJ7>%<#=-^BB\6%<ZT+(+,B=(E3@DVI?M?^)RL) 4<8@9P"WAL
M-.1* C:+P1X55;BRID"*+5LUQ+Y,O:[)_)R^9R!4_'8E*805,\=XHM'W;S3P
M Z8<.%8YQ4S1B1'R39#MYTFF#A:*YOH*>\J[XL$Z**1&$]&IO+:VZ::M&ZXA
MXYON,CRB!04_^2]!C?.A3*XE)QT(Z]@B##VZH#KT+JH$DA+*[R,:4^0>Q'&0
M;E'/H[FS.B0?Q!<W+H45P^"3*:J\@P?S%.F1N2IJT;UNV3*YDD(8$N3(\2_I
MQ[=PS(0\0)V?LSC_'3QSC9"<FE@Q5<JJ"LJ\"?UFMV=G@!6>')-UY5XCTMZ6
M);;CTUK)RQ:9//S=Z++(5E?7_'FJTCSSKZ! F2LT&&QQ? 69<NS31<LAUHEZ
MP\"Z?\\JA:%LNC5I[+L7$]C"^\0+"7'?#9^;IN@LE9597C/BE9G(,/#&%,F!
MB'R$S).\S+7/M6SN7U38,N.68!^I_\U#],U6EDL39Y@U.:?*2/SAC+CH6C\L
MY0]']SS[]94KCF$32(66Z$\"UCH+_ DH<6Z8TI;<0/0>-<*7?H%FO&0\Y_<N
M,<_<)Y>1U^')H?@<C(QW!1,!G;75+CXW3LU;'+[4S]:7[M+@+O[\6YGY'*AK
MCG5%K^-;I8B>6@=WNX-77RW16*B@[D.P!5Z!3;7%*:5,\8F#/SA.3.7^]7H
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MYXYE[N?7#FH62O1YOR>CR-4%5#^ZR1!-*,N6@)9[LK]E2W-&400]T?V>8+3
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MX4Q:!Y__Q[W6L:8,8.$9XC_KJXLYO3.,6R(B:4(*FQO(QW>>(D=I2M0$."B
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M4;\ZQTH3^]NV@YVBXK8S$XTXY#3@OG%,S5K+DE;"]&105_BT-"4]+'0HM!M
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M1\C"D2P\(^!5B- U#V5.^R'_B8DAG;+<PM92?>6'1[I^G3GR)4[4P5/K"#M
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M8RU _X[$+CC,HFD840:PH\@ B%.H\";DGYHE>ABBXU=KD,_?'PNKP\<L7S.
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M_*AN.&N]&:GK.L7.BX#FQ+^;_KV>FV,GWF'"?4[0PE/EWJ8Q5Z['\0./S\>
MT ISQSP7GJ'Q*H#L"-+<_.PW(CTM B7AGV)6FSTQ/BVC4C6DX/#R0,PE]W&%
M?%.-^[C^15R<&>5">*,EZCBEAN37:L*F-J'>/SUQ]\,S_H>W@^99[B;:'U*\
M".\?;5_G1=+,Z=%?ZTUFEZ?=NCV;GMGGR$R4*6??&Q#\*7]CL3,E949Z%=F+
MH/',VU$4<E'#..XM!B!L\[MS+L?OTZD?H'3,6(3[!F?73MM=(\Q;%FZO,#9U
M[$\<Y=2W+5"3GJ*E_<$_EP&X6.OEN>Q<$GK[X]#/224-L<E(ML9E8@SM/;T!
M37B!.$;S(]^X3LFAGJ(44(Y9#?]QS" 3%?3"SZ7'GM.43"Q94F;:@-/X-6::
MLO\>%HWR5P#YV[Y]K3'C'6< KK;^KNH#/^[_4BN/?WC@;F;V.X?\=W06Z',U
MX(P):6;'A^2YUDVJW)];GY>.WY+C,]3-_V$]=RS1+&SXJ@1]KDRS3,=,6NR<
M6TL#'(6O1)-,>D.S3U/*J%:4HMY6M$!/EK=?CIWK,:]I6]N9DQTW.E(-1<L"
M/K-V&$XE-0ELYM/XU B^NT0J]:(;O +>3I$:H,D1W.]./52S+M)[>V?2UN,%
M?NEU7%&;!=?%98CM+Z-I/!+@X?%@TMO9*1P>GO#,>1(E1XDDJZ@[#WT=L2EX
MGRFT6_:= ^"0TM@DOD2\)WU^=Y#IXF\ @+T3M7I+<9Y#-$^NE_T6/T9.C%@7
M;E=?FQW<(IKV6$7?,Q=N/QE-.:YP_$A*[PW[Y/_CK-$[6"..HN"Y1LSW']RY
M1<:T:XJP/2##0[;*_#@G6C\N*K)[Q"=?\V 1;&?SP!F1,!35J)WTE'G86DD1
MQ:U5XWF*?Y3N:$.WJ)]%:OK="MYF\\N*)P)N)-Y#8O\^:(\_.6E/CVM0<5%[
M6&HS[?_DX8+E]<;X9/&HY=%!%=HG""R_F;N*,U%:YF:.+/-I:>CU1GMD&/O>
MESCQ)V!/%^]I-G2==5?AO[L.^7]EL(J08> 53P$(-&'7&4 _)[(#W\P ]G0N
M0(S"@0%,UH(UX D&T!$_AZ,RK<#W3Q3N"5*0#$ :CZ#'H:E^R'<D*VI1  .X
MF[AQP0LN!B<C>EAW!/+0'0HF# #+@:!+)V"'.65 W6>>=/\[#&!9RQ>%0Z2N
M#X/.YGMJ4+Y_S0!2SI-[Z<]^HG]'8=,1A&FS/>5@3[ =(CQ]\C++.(HLEI:.
M24"OCLPS@"O:09U_P1G=^6$5O:.4#X9Z(=_U02H\$QA R2)\0U^:UH8E(>A2
MTNMT?G-D=I;S4CZ-G]KX#-MJ-BXQQQJU]5!\CDS,]A(^XW1&E,]#792< 3J@
M":$SHEJ*!-S$#7L*']:^S7'.+=AU\:=USYP4;W!._Q-L^-"&!L8,2<38]C_2
MNIP[\W BD^?GN.O1@4DS_A@Q(Z.(PTWSQ_F0C7XT_EWP,)%Z%6Q!5\2/$M]2
M5<=7W/-T:E0_%>CFZ<DWL9LL-5R1$)S$H+:8P)"M44<]YZ?L+_*RWH1\_GS8
MZ;X_ !A*AQQRVQ.DI^(@< VMU0_U282A^C]]=@'5!XFS5</7^NN?1+]'RE\K
M^]3[(W^=N3O DY@#I7Y):%&K1?@JL("=1VNA%!9=<?M!<67RR!G)E]_:[ULZ
M71&Z<#<0IAL#[.F#'$SD_9:=4#K.QW.\J\F=GE<PX9\A^,#8>^EN[#LN(V<Q
M&+HW#VW% &#US 5!BA ,>+@U< W??^A9WOM<1_K._..;A<:YAB&ZV$4SD*T-
M2OQ=E%ZRVTZ<V:3GSJO!=;CED,J58;D/PSE/FNQ^K.AG'&YD\1$B6.V<H9KG
M/L64.;?[5#V7?4Q3)POCCYP&V&M]8@IB6-\!1ZZSDC:A"1[[V0TC8JF7)#UN
MF<5L/PJ%ICB_=P+7)RK.I),N35K$];J!G 5#BW7T*MS#APN#*AS7LV6'0Y(7
MIPV2<(-+U+Q7S,1PY&^#JPLR*V]H[:>9]S"0#Y"=30Y:-ZBRVE4ML)"7#67S
MW19^@TLQ;2QI7EI1'7>%F T^2(8=8A(BC"ZFM<#'TW;6Z=5!*GE!>F1$-,UX
MUCB1]TK:1];L/S/W?]Z+$DF+*Q'$K\@T(PAE"!;P-/ACIB(UBVJ\,J&]_B+H
MT#[5]<9DUZ-=RV77JDC+O3MV%]DX4=_!'@3)"T/CFS2B*!),U*SKZDBCT<K=
M[!/0MKM:6EH5<?!7>>#M3V,)D9:2YQR?"/)R#?!<1*0K4$X[TWA;YJ,:X[U-
MR%6MR!CAC\6I$_'ES<WKUS,N_DXN)&XLO*Z-X\KBTAC=J8'FXUG6*7IHN?KP
M1:I.>D%S*YK'1#)^ZH)DF/<ZLBV1=A0!LJO,8R<UYT92O@0)]E=T-AS%%XY'
M2T9.^T5_?4Z.[XYH^N$ON22YB"O'4"0*H2JA"5&/D$Y2YA63OGY>3XG_I8%R
M4/'9BQ=Z J^S;JS^G[_8?DUCHJC=> /IN!&D#]MQ>L?O7[H0T#ZMRP.?X.P(
MKO.:H2WB<#@F48I"\Q*+\Y5B0AP/]?G*:>:O6,(NR%58,N(.G@HZ.%21^XKB
M2+N1S^]G=6[/+5BX"OF*LZFLU_,92"HD18$<$$JR@$-H#UC(?I".:,D=FB'!
M7W[;1-7@/2?B+;.A3ZA1_/@1)<5>;?]W,&A%4:2S9J(4$ Z(\7WD$1&'NSKB
MOY>/5YU^^O,Y^IQA&25!5PCD975 /K#].3G><JI[J+^)Q<C:T/%N0<P%R92_
M5T?,(L'#$1"&17I2I =MP6Y<Y>-1Y6YXRWT3"8/Z[#,W=<5*9/BN.)I46X1+
M,#])O7[UB0ZT4<->H)O:X2PT3U(9*+"^%A]8Y(;A#M(]'G/X771<P0#XB^?*
MV:<1"ID+R6;W8@"P0CE1V!]N.Y1?VJ]BI[I[PZ3KK/4KI4AF5B_@P1*S3@6-
M ]W4RKX,F<%*QUA>O P[NGR'55MG_)#&)K)/C<;- %J0Y6K1(%P?XK]EKB4K
M&E3M[G+AQ PAAY>RA1N=B;.^X&WL4A7(I3$BCJ"<QJ[MRVUU40L6R!XOM28#
M R3CT8,G.IUN'8?9SL/S /0=1"62]GX/L99&.<\ S/OI,E#H.3?<A'1.NRTS
M)1(=;*NE7\%:B3T:VZMQ3KAG#, M40HJ$=G+">\QSZ=Y[F);6'6$[3[K%TBS
M/!LE03I8"/3"!@T4'EDA547FN%TVE$NYEGVZ.M4Y5/)AV^?I\Q>^AYWCTRY+
M*&<"\[=I3.BF'UV.WI"_HO2,KU^_QU;6D(J?/#_&ZS3X].D&EW<F- 9PC_\>
M[&65!9N?(5OH]T&\]=!D^\Z^Y%>W#X)I]T:$%86/G[A,O(/\<0M/BI",2Z'-
MT>"40/(NR'&>&O@;72Y>]V$EEK34G'TBD@&89.Q,F\/'OA;5C^V4%0CR%#"+
MW@]!%,]$J]X80S>IU:L)M"@GH,2LS\EEADRX3(YF ^H[^U:;$.]@$:IY"XJ<
MQWM%:7)]^!RFR?W :VL9.3!*Q.:T$#S'1J^3NC/-)#5@D?<&3R:<DIUT5QZ)
M+R[,I(W3-I$_K&C<FM=3YW<&R4.>^=.3H9]<'7YDL\;#UI$YCL#2&/A&F8E>
MNU(HX5+5Q14TZ*:>*.;W9M(#(6JUUXT:Z/L(T?B#-$H02D)J3))L%WO)(Y+/
MS97G]5XNX)T-R]G%;OFLCN#BH5V@ ,'1VSFK%Z"""[HRJJE;]2E9.ES^:\7A
MMV;1]8M'<TV[W[0_"?J -T6S V";\K)L7G%9FJFBR&&YG,#S7%K8LG+7^^-5
M$AX_'%BHF\B_G0#T/7TX$&/X^4XR\R6Y7)+JEY=?V@XM_Y#VZ)MZ7!>*?R)#
MDMDYQ@#"H]'.."::^" H#@YK9)?E!!F0WNO=\QF\$C3^G$UNRL[INJGP\>^7
MO5)9Q,;AA]!--W&$DA343%6MPMHR5>!CW>=EG1.*O_>GAA0-FA_4^=[)OL'.
MTL2;R?6T@-W809+9&.0T[*NH:3@3]&S8IU=5@:,(][D^)N>Y+.[1/6Y$LVZ*
MD_;J"HZBR?22QD&Z:__!JGAJ>S/2;8L*LOE2#R)1;3@F9T_NL5A/?O^YGL'K
MPW9SXQ=2G\:L7%R('Y>_L.]+1+Z:(3TUV:I$,@=)]H]-VZ=\'>.L+*YO=?*8
MY9_/ .A_.VZ),8#O:BAF])@&FBXUN-J.(^ 8P,9]# ]NC<^7\;^Q]^;A5+[O
MVO@C:A4RBY E0XJ03!F7(2$)2:98"IF2)"&LQY!YIB@9,T:LS&.66<@L\[30
M8,I:Q;*RIM_3Y]A['[_]?K_OWOM]_]C[C_?SQW,<GF-9]W#>UW6>U_6L^[EN
MX(THVA;Z+][K4PB<D6?PHQ9.&SG7\:_G1@IBJ?'%E"_V1\FZ?KUD >Y'A*7W
M8%<TQV) &I_NI$A]?($W*5I%(M0("+P#"68V#>A+(^Y3>_D1%'H3=!<\@F"V
MCL$A6?F0?K,7FSB)_:2M\D>,W8/D<,97&LCKF<[%W"0SZ(OIR+X $@\1U^?D
MXPABI4*>^9JJ27L1*I,JZ$2^;B9N(N6A!7V,N8.(@S.UBJ_GU$(!<,'M@5*;
MC6\6D]_&A1P0S^L% [OC[#$+HE <I@F?/1$FEMDDG7XFVV1&/;[:ADNH^/E=
MVP81D:GBDX,H1[#=2:8%<8?$$&B;VA5_='QV5DQ2UN3=DG-+&UUURD65IXG6
MY )* F9Y!3UCTXYA"!1;!F?%+2;E$='9)\;MQVM+%F6RK?+Y;?Q>:,U7P)/\
M8;RK"K\-(6,WAW!$;V)P9MN/A@D6E*3E*1DR3X4;F]7BH@Y#MWC\XB7'M!NQ
M]=+TLM_H+PE D<8,$N=A%U(RY//!N[-'"ZLX*<TB,B\T_4#T)"^_NCKX KR)
MJ!V.(1];I@'!2 X%)#PH>K>$+%-:VOY$1.,^^L'&:X9,9B71A(:VS60<*YD=
M))QMI,0@'"GP3NJY6G:_-S]G%*2N&HAT#9RLX[GH^/YX9NK4"(GOSY/X4!+8
M?B70 V^X CZC 8Y+P2:;*76%;\]$KBC?=WB5+SOP2#CSH\-MAV^H@H3I94AA
M/4IO!VKB?;=75Y!PHHS!Q-1R11:>1V6]7H_O]*AP@^N#$RX3_AXBJHZR_(HL
MQN:(C72(?4;PF/9A/NJG;-9&HOJ)',]B:U<"FQO.\K<(1=W#W&KA;J_JL^"U
MA\9FV8BS-, 9313Q#99G)8H'44,SN,M[NQ.CJ&Q\'SZ3ZTJFWB\NS7X!G^IE
MG.&0%7O(<L$[ANP)3<.<.K.(^!,=HJ9FZ[><\*'J3SU9W#7.!ABZ5CADSNDQ
MU]M9WW<^#-#G";! R?(DFLR50R#@IK9.X9ZN]C[M2CI^]6!H^['+O:,]-C46
M^J$B:W+^P?;VOW;;J=<UN,@@!8-8+LY6^.QC^;H+)8A3H'25%RSU/'@3LCWS
M,3HYU6U[UH(7H3.&L4 LKP[/)*Z(;R>3)/U$NC$PZH*7*U;TM<V'A)E3&>[F
MK[<EJB0.'3T[3299M&-P^DM$J>&M=))$('?LLMXV70'B68O[LM_=\1\^EW:G
M.7ZLN%_3QJL:\E5:])#+PAJ/>$_3?T,2SXJ3V6,)V2-4.C<X!UD''W8[Z,P<
MCTKXL]D70YW!EI+YU_0D*I1/);J1PJC'ZT8<<>@(-8-<A5%,2WWHRO3MM,7!
MBP]N_^@3K69%3F7\A#(;"_*)3>S2MB1)T8T&L(!.)7OQC]1M[!N;$V"NCO?T
M=)(YDO)TEIES;O^RM2#S'T-$CU]M-.:U1,YNU%</J,9.VRE2L$]ZA_(;R4U/
M1V#]<-R-T8+O.;@;R,/U71]'3I)MG"D9#]K:I0).#$9<5TW(#+#8]\8%;1<0
M+7#X+<+K*SA4\"3IJ.274RJ'7NNO\GN-8=)8B9>FJ,>&\2*KYL-AH LZM,[B
M^(K,(5Z?>$.2QADYM3HS^48-RR'+RT=AE;S<?6"[&KB,'7X&,J)XH!@$!KK/
MQ3M AAJ\6V;+<?++LVC;&G('/OEB7-GQF6^GG[,]#:6C!&_,MK[*FS$L<=M/
M(RB:,ANH#SR+<U;C>)I"MSK6N,#:1>7$"R@]\G,[Z-F-*EH2RY[GK SY\I 5
M,8:)1A//8<@\*>!L@CIL>7A+5(%B>+-Y ANZ01@Z=RWE_$]AGB?AP$E>(1;N
MAQ>GSX,%:"+$2B$:XGZ^!!M<13,^Q7!\-<OZTVTW]B7/7R_L@.T&@U_T#<OX
M34UX[S"9>YK]SV91H@ K@U^SP=#3;R1MC5J*/<2 M\$O@L90.(M@!3<T7I"?
M@^WV/J[YD.4/D9FCY<NU'Z?V\%UQCIC5"]<C/'-(9XICH;Z@.(/M=N(NX')6
MRM7W1JK@';_'46^T?WICUQ ^6FJ/U4Q@7V@ F1_CHYQH$O5Q$3E;$;$XO?@;
MGF $7@5K\ZM00\@3_9EPXF4%=J('$L=-[@?;FWS';$$7SZJ66AI@V$0#$J/L
M9%;!';J<#DR1Y^SZ)[#:MWOJZ)!%!U_TT;#S2Q*X_,9<UE]+T$"1&T]+H8E<
MKW5_W)SL\;K'HTFJZQS<,[7.?W5N?0,<JT+LN5)7:,!IY%=(D1@:/A>_IC)&
MEVG/7B]D3.2[\*NP+ED8L?[3NZ5"ENJ]B!F_@MC[<QH2YN!H+FQ4]\^;.__;
MBR[K/_H%<_I!)0T0RC*CMD]A#HRD0$$D&V*-"(%>&44#UFV#]@^!/$K072 -
M,$OGI '2-*"+!N@<_/Q?J_"D_D-9'@F0HY@(@5PH5Z0JH_O[,)>IR85_?"WT
MGU\5K"N>\;N)D:@C>*58G]<?WVT_#N(T:^6XBE4R\' ^7UF:)I*%#:)(MJ"_
MH*DLLA2,#(J1S#V.XB:K\KU;/(\WVIJU71Y??9'%@>]^>^5GR&_%N%]37MN:
M\/",IT0,E(%#EB;5//JCZP =1N7Q*_P2]5$TC<ZCV.[';X-^>]';01HOJ.%P
M)C7V(K(R,0#2H,/KMRJM9XD!G0?WTBJ[8L)\"M]Y-5X22,$V[G:#*DLX3Z6M
M"Q@8BMT:-6HG.A[JU[P2]&S_UZ O8%-+<JM6OKO9(/O+6%T/5H)>?Q.L(0B9
M1)B?NPD>L;6TJFJD<B;#17[S]PR[X:G0B;5E[^FIGR 4'>P%ZE?F$+X2RY?Y
MTRUK59D6//AX3L,#/;R"N8(-SE\ =GI4IO;I5]"L,\2RSJ;A2/2*@8>/A\9&
M_^6D([=O:^-#M7;/7PR20W[S)=T(Y"/2 ,BRHBFM"HFSJ>T9MTH7Z?!G/GB#
M):<T%LW8JK.W^DDMM7-A_$K%8\&(T11,HC%1N7JE*'TE\; KANY-%DM]"7).
M5'$#6Z!QOW)U#?80,8 I#.+, ]N'$97Y9-[J21^;02,-T?AS]HUC,7<0M6JY
M1=KA:H.+=WKFEQL6<K#HMAP&:[(_-/4VL%V[!HR]L9Z!(4M((MG:?7B;0TW=
M[E,G',U^5<S?EZ3ZY[)N%E./.N"HO["^9,YOV-:0M_DZ8HT-C0\W;KX#[X7T
M":T&M_R*H0;0@&5,Z^D)A L-F.,G@#AXV(]L&^3QS0/=NMRTK4^%=S_HG,&>
M[!7-_ :?Q%0=A[5;P]N0P2K%D36%"</7<<6A/@$I-X^.2@N-BLY?85'.$ /P
M*;K@"<S[FZ/4>1!GNA3EBN(W"VMK%<.D*67ZO^6;L6UV,G1D/BPNE+@.!5PY
M6X/+FYZ'R#"B%7;ZM&7V0/M3COD[VFFOMN[X2B442RU^:-U8435TCWVK;UF>
MF[9R1>UP N^LGBB![F;JS5U;=?DLD6OC(G0.XUM2'NQZ@%3+.5YXQ"P9,KG0
M(NI,D_&6,^F27V2/TEMOL:_5Q6[63BFS^6JAAK'.(;P,#&&-0[+0(/KUR#Q(
M0B:>9[N0=(VL1LE L2T-!GB^\0N=NC;U;LMV+:XG/9IK1?=9\B^.+]4]!FI3
M>Y!<,&Q1T@.52!=00W8 ;C*U6,>A=$.0=^R!S["T6/SB]O9J<E<#D,9,ISQL
MYX]>&_^S4?/L)@VH06X;XF&$.F)AT<*B'WB[=6(OZ*C[B1]S5E_3 KQX,EI.
MM6OV *O%UM0?'AYYU?6ADPL,#VVZDKKYXB3T^,)UZ=\#P&% MR3T,6E9Y;5J
MKD81[!!FR'OYN062"5K,1D%5/$L]O_6T&TJJY<3/?K5:SXM[P>V!S(&=Q;5@
MOGMNLJ BJ>)=Y/>VL ,^JCCTC9:E]TO=F' -]3'0#3$SI]_XVK1Z E%;^ZIF
M^F3QV6K1L1W9BI6'Y9G?6KV@]5**\,R?("/RW=C91A==)ZM[;D8<%HV^NIQP
MM+=X#"/XISV01Q[]#/X>UN7QA+!RZ<<7OS?5P4V1SU\ZLVAS-D9<C0N9TGCQ
M.Y+$#!'Z1WBU<W@KC.C;AJDI_U'YA@RI^BO!K!+)WBJKK_7:?$H<>6H-IV\[
M5EPWKY+]S4/RIR[DL/VU\?;D>>J10.;*R:]$7>]R':Z*TYFSZB59;"<NS5[Y
M]#/ =Q! H:'VJU$G/I-]<$/?5M4'6Y)F[-S,Y*]][.</K*H*25()-M:*L]A;
M16;FX S1,X(#!"5*6J 8KHE??[MBC-^]>;#RF??I>MC79?9/B7L[']&C38 D
MD0,R+$+@V0^IA'K<?FS*ET](7(I-WUJ:!P:_V[@3YY4]0UA%+'F ?'"<-[IS
MB9T(ZT"=( Y@YPR<YRK:?JF=':P1ZY!S3'C9MT?N!D#]')Q152]!G6C88!\O
M>@A6<VNE=1/=!V6VPOO=-C(QB/?&[0MZV^QUY9Z%_D_#6W%.\2UE#YFD'['H
M'+J@XCR)L3Q+_WOOSS8US!<!C0N0?-2 !^?<.Q'+TS*_Y8Q4*?LT8,0H0(\L
M\.$1 >H+P]N?-L5S7\&/!OAX\!N>IHS]9-<2M8#B^/:*]!0[5 _?XQ2K^9FZ
M?<K")R/.7>HFX$+_788HTQOI8T #[FTCNR:3U-(RKKR0FU=Y:Q\JG]QW"9;[
M+><I#AJQHMF*]&LHDAWHE7264#NX5RP@EWOGPY-Y#V6[AGG-OH]#*L[<I%<D
MM\ C591\T!D9#6<NKDL(&/3NW*\[>++&W+%A&>?&M:I\.D%Y*\B=>(;R''1!
MQH,X[9U9YVX4 S&K<-,0E]YE)YQML"#U5;',6:QO'K5^FP&1UVL-<;,^?W3@
M2_'7B0LZHBV[E%FY7]N]"M1 .,X:S6&-FEBJ'^X8AOD]T?()PLJ<F(XMP6K<
MT?% A80QB LDFDXM8NP1+DM$Y=>$Z^E8\^W(]M?E%F;XG2AYU_)RCPX>=_>Y
M@5N1?=$.1DOG4RA?Q1I,>XYY#BP1A6G EB\^EE!)>=>B1[I!]AR7H0'8DQ,^
M-EE( ^I$J%$9YSQ_5-TQV#[+%9402#_'6,E<3!TJ81#>0@H[Q^8Z=H(\<.D=
M=?>$"G,"^2R9%1.\<SY.K222^8971'&82++3\JG+40I6:EI/WASC%8U4NG[I
M2B?\FB]Z<W@EI\.(=0718>2.==J2;4T&WTBG"TCG]M8MTG,Q6B3' 3#,-^2W
M;;PIQ@4DBHIO;RHE;,M[6"-"?ODEHZ47>V:1590DV]\I\(6*,<4'!ZB;=-1X
M!;+*GP-JX?#S->"L\[)>1Y;PY0\3M7/Q+)-^>1KN>J)5<WFWS/L.>X>J!Y7M
MFO5@<-Z16S<QAW=JP>,;*N^6V"MJ$,+C!D<5>\N,'HC,YYE]$KW6ZP8>4ZVZ
M<AC%@NJG 72M\G_]+N\A!2?$$%.+-CR6=XYO5KJIG)[(?=XCE=?$PQ9^45KV
M2_A.7-!9>A(4=X6Z!RI](/J3Y/R$3VDKQJR:C\HWK\0=M:^:@\$8G(GA0;TK
MPYRN*!;<C\H5H[M?^6U.B5QOP6089 I7S=KT*6L:"+0.YH^K)1OAP,CM0$DL
MDM7OT9!HQ)+N: U%45Z36[.F-D$D6-W*@.S^^S'4'11&0NFML?N)UR0YU+#7
MQKZ&\J3GG,'D8H^R9:FM<JC]-8=GYJN9*7+9+&?I5Y9FRWK_HJ1*3)UB",Z[
M3:5PH;XS)^)@I':RO)PYUD&J\,6D-'/H1?:PJH^?;)2=[ZFEN,]@'F!F61#3
MF*Z_.#M[Z7 Y3V>V,#XK(BM_@R\BXW#+N+$OE^GOBE%@K5IC-35[[Z 0$AP[
M2N@6PIGUV2WX";*96U6@(3&^B&G;SOVEWFQN0%7U-:O,!\R&*@2UU)[C*!:P
M_6$K'^3FV'TR-P*2PVW#@,+%Q<"+N"Q"M._;/N[F/L9N1ZFX@H8;^5]TIN O
M &^P)KUC9S:,>DP+"V>BCK6*$L,KW)M\HWPDK7YL.;<T)I].N9?@?T?BYT5R
MK$0<LT.K^\$BA-<CU$0=#:C%;+4OR\3TF,Q&E!=W>;)EOO<\<V; =^CK@UKR
M6[#="TJ%$=7[V[])XGXZR[YM3A,*B0(+[FGU2D\ZEOS&BQIJJB(,+4VYWNL7
M7K'=\C?7JK'_=G (:OT$F1TOWNXY;8'M25UI^!9VJ_%]?7)N%J.:Z]IIA"1P
M\TNPVI-<UDK,<MXO7=A6-![E^E+4%?M[H/([[,59:BVY&%I-V(.[$QKJQ#1W
MQ5]WD>SS1YS66'>+5D5$]LB;!P)0'Y\#;U83/4@,9*<[#]^6NEF?3[*^7!YM
MPS9T_?.0P?F;7N1H=!>"J)"#/4P#HJA\Q+E5>)345P-1_/'AF44LK[+_O2>)
MAQO;F3*_%4]QT5%2_Y.,XA\RC!ZR#@U(YN\&"?03B%T=BY^R. S5. $D0>D
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M+%NWXVMNJGS%[ZYWT6.V/5($]Q639DP4_;9=3#(,=*04J1EAD8)^"22S4:E
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M*-(RZ!&=9VE%ENNI+4:I^7Z-D>3S%:*?_.=[^2_U?!U^";;7V'$2P3)4UZS
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MOU;&=V>3 @K\-(5XK0V:QQ1?WGLXK\8EK*=%?0C!VXGZ07[L4-GSBZSQ7[Z
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MF3*)-\!HY*]3*X(9CR2R '1^A!TB\F/=>^!E+5VDUL^!I":X1TOJYU%>N_I
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M,!+\/H/,>W5I'V>("62/\ ,H6'^H0QVA][%S#Y/?@0B# SUBZ+<1USQ]7/(
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M!CK/M>N[1:NAI^U$QCE--A^1'(BL!#OVE-J$*%544^I0L';*@Z=]Q6?F:ME
M@S+CS <Y<$^-!;P;E$,O;*F/.!>@>P1ZFE&^7;O'A3H"9< A&ZFPPQ/3!X5P
M+V(0I826S6.7X(%]]63M*8=.'F!TQB>TP4.WV=&\T"I$]7D#W<-1/XJ:<B?W
M!2X&4V'I\<<WQAD:_RO^JXF%S2@25P$H21.>;X-?Z1'IS5^'GN@//=-EPGL
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MTGZRIXZ"=YW:F&F05!SKM_DN_.BFINA$'X'PH5R PX[R$8A[,<+F"%2<-(7
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M!Q'\_R"X7X] ?SWD;RC["]1?H/X"]1>HOT#]!>HO4'^!^@O47Z#^ O47J+]
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M?_FKXF'!&<[$1,]DK/S*DRG+4K,LG:LY]V_FN$>RU.[LX@,^+F4?M^$CG&P
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M>C& &SO0RZ.*D-.?7T'';?V8L=S9IW?\S\@"/CI_QI"=XK_^H^4R)&])[F8
MY]TNW'=.VN!4>IY__7]FS/)55:R^/"@ZFYJF\'&.(.C>*-G_W"C@XZ ;?X?
MZ2,3\S/7?B??0SMVZ!^L(67%5*_O<Y9RO)WMT5L @[C!,H&Y:D>R@8LK'[VV
M$0E-3U=?1E:*-B]N=:NRU+S-/OH2\[*TI<A;O*>JJ/X:<'(AE[J9S[<"TY5F
M"^3UF'J=('H!C?UHV[3;!J%J[[KN_9YG.FMSRRA[FCY82MHFOGA2UPD3/6%W
M9\6!IR*G?5_T*IQ)2=9T235>0'VZBR'=68CZ 5[-4_)*AI00@G+?[)Q/XM ?
M1^E%7\/*QG=R*$$Y6(Y<M_E>!I#>J >WT6!H$%%E3-M70GGW@9X'';MSI70A
M F<;AC"K'YS/N5G&41__1+THZD,P-5R=B4[]=K4O*M08380%W"]]Q8IKE.RI
M'*]7!I]]N'W?G6:Y%RRQ^&I/ZLO7([<IFCIYKP-X4F)RS35ZOK?&$V/5Q6_=
M/P4P+SNSSF+'!B@!9%S\ BDK5O]P(,J!+%P5>ZCJH^[WS)_:</OZQ&;5A&TA
ML!-F9A&@TKMJJAZ-:4B/E>1V,7V[,[L]9JMTXLK-/-?)#QG._"?/F*44^'!(
M6]Q3WCD"WY @IF4#5H=WGNC+TLZ1L?$O, +H6T%^DV?6?CP.JCUS]LG\->'P
M&V\* IWRYW_$L^WF&BT>EDLKNYEF\RW.R%;<^E2\3**WS!Y+ P[DZ1Z70.\D
M$'/.QTRD_RV'XFN%,;U':Q:^MEN.#]#%2W;G8D2&1+-8L0"[Q_S#]##@ZE>V
M!>-5;=CW7"3+E?4Y+SY0[6*(@ZI_]\C;;TX/RX+D+HN)]Y%=AA=1H8%N[34Z
MZU'J7F+=1^Y3)%X\\GHC;K^:JN5F,),>#/!@^&$?A]HHKOXY5);?*Z[N:*%&
M6^->\MDCWPQ^&J(JIE:U@8=[[=@&&C!VTU49E->D*(HLF8T26KJW>!8'C-H7
M%=14F/&\$(L:6;.\ RR%HJDAX9\8 )^&J1]*C.9%NA7WQN"JF5O J\,78G@E
ME9.3!=GFKEK2]-8I(LC?WLY[X'A,_*/_<7U-ZR-<1$6:$('RD&Q4\"[T EDA
M#ULZ.59T<GCXH+#I49W0=T"3E18M#+W5_QOB,21@]_(EZRMZ_WBMZZ^<V1H@
M)H@8WNP$$,/3+1C8[T'@G+<\OH60 $F1,]HLK$VJ<@K4E*,BB[P_X0MUAG__
M.6+U/>Q'[6FHJ8X^5:J9XH\5X.J.S>W$^*H7!!R["ZP8A_KAOZF"2IJK]QA
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MF"I$'$V3>AJMLSH=H5JM?$"[/O-^1+/Z*]-NP>+S9<U=8K(U:&H8'0?IWF8
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MO]<EC"S:<4R^\4DF[\WWL3]7#:+#5](YLYS9SN8.+RZT($=E9W$K/2\":QC
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M+#-4O+[R4X^AN^/M,O6-!]C9;E\+F'>!R?ZJ"V7N6Z@WD0]6YNUCEJVSW@R
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M!]>C3\**;2>$48\=DDPV=C[_=J=3[+(8U*GRW5SAK+&&M*CXCZT9=(!/RUE
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MKN3&P=+HGF78J@%6%]*5 <9;!/APOT_B7 9Y'6[/UBRF?5_]PDQN+F:@@,/
M'OR9+YL475A?)F Z9N2Y2\+I"VP"JT!*$2,A?L%?U=!L</_.R/.8&CMM2RL3
MUVA*S7-ZY3,&=R4D'/;N 1[4&X,,X'W&,?1^#.M$:)R4A*G.!:C^[KGT??;6
M+! -9RHHM7H<B"Z;TWFAA-/KF&MC-CPCW0FOVT0=G"Z="P>U;@V[4QW1V"^+
M>'MP-*0&TKK(36:GY-0^F&R"XI;%LFYX[)FT';:7W"Q^HFYB(GR40'V']%($
M9'?:T+.9!O4TY.\*#F2LB@3+J#@4#]Q)>9BAUYE;2\91IR%X[]AVY/3&TE A
M 4FTTJKXN)S"T8U)M5XT;+@V<OK[0^84Y;?G37H](S5!CA+@1S0C:(%4PI):
MA,+$ZX$VPKFY*2#6KI$46,/#;H(+X@6_60GG3S9M94Q^B4-_WN$EZ^%A2:N5
MWPG06-5!/R^US@PHDG[ :]XVY,WP+76(?2TY#=G&CL86P?B:' G6:"?.I*]B
M*?$U' ;[O65]W"U3CZ[]2(DZO"/^GNI(XLCG7*VFGE%X[$AB!.IO5]%/_F2[
M:E+^D5[C+G]02<D%$"@?I/VD*9W*0</Z=*9?R$W76%IP:$%9T2#XU3%HI8OL
M<@RR1Y%+^VB@- GY=^6%(;4[#KG/M@ZB!%'0:,=R$6(3</?%4N,?BU\UY7K;
M=A>X,]1!JJ7U24ZBKY59=%5@O0546G2)S*;2+H'/1/Q$GFD! [&/@.<X-Y<Q
MR8G/WQHSY#Q,?WL\ZSOW^5+TJP@L(6(+MB@6S-0- \,9L)APFF;4[L[(>A "
MBRD[W_(](]1#+>O^V6IY-]5*E=->!2O>$@SAMR\P_%,!D$OJ)UTH$ ,(2:!O
MN71W\6P8C/&0P2P7NO^W8N=775=X^A7)E;4:Q['&14 *LWFQ C&R*$2C\#[#
M2:WK;F7KO'-K(0_+RC::?F3P)PO[/=-[] U$-^=DV=UP<-@%.WFPOB@;M\]F
M.^LSW=$>4I_]=;8]#>G\(O?GO3'? =L@XR&#G86666"<YET@ J0#)F!($D)T
M"M!&DH4I:NNZH%GAQ;Z&2&Z^'U:QLGX.(TP'*!^?4P7<MC8=H@)XB62A)W=2
MNQ-'N?E )=J@2^[4!VA'%"UB=J- Y'O? '/2(W.UF.;B!84W%TM,1AJ;TACO
ME%YD3+-R%)_#'*A]6J^;^9/Z94/ 4QQSOZJNI=[![ZS<NXP'$H="CP=!2%DP
M/C"EXUM>-6>TGN2:IY?BYL$*IR_X9Q<V('V'7=Q0$1'+?W12"I\=*"\A7Z=$
MZ@E,K4<79%X;^QSA@K#1'[VF*9N''484_<+TP?"!9Q8!AU=R\OG'H'8+WW"3
M.:2_RTA@VYH];9)/KRY3A1S;-.Y!1AYO)5&WD+ U&IG^?Y+[+.KSW^OI=K0*
MT SVG'H"C<PR%2/_QJ!6')>0Y#S18Q!1B0;1\XBH-MCVCU5*)*3W=V=8 )+&
M=C7 4P]IQ$>B69W:)'\,VL_50C]0_<]=X,A46[3EOQSCE46R@"7UUG /Y&"#
MQIH^B;<XT1PC&+(R>H F"=^GN<IWU)?_@<YPB"A#JGF+-K7G';)/-&]/ $T#
M\/UW>>C]NS<0(8&YP03H$C&=8-AZ=!BE%G?/P]R^&[?HF5#VR?1<@)'D=VP]
M;"WK&*2-3"@G#%.93_)-SZ&!1H'8T@7RA8DPJ/QB0_+RYEW;VDFB8VU8K87]
M;3A9$[6?B'H%\5B<RL;N; 5CQ:#M]MKXR73?XD<=RC/N>S;=XQWRQ??]-8T]
MOW;(76;6'/)O98JE]N?A+6#3H<270.@G>-4>3C&:K% "FS$X/YE=[/[LVNA-
M0N12ZLK"RZL&="9]?YOENI'>*$ ^97.#I$S6F3P L\![# AY\7I].@\?SCB3
MU2]?%K:V[$]6?RK-<^7FBHO$Z6[(*3U59%L%6$"5$K)C":@0T/?& D)_Y'P>
MJ]DR6F>L??CF[5W6)N<'<G2O&T,9[*-(NC0$K:!>& _<X.0F^P'-_KA^5Y>8
M8-6<FT>X31/NB6EQ=3?](>9_K?F<J6CLN[//MSQ(<-HY!K;$CQAT?0TZA@UW
MO2ER<FE[;+0\NN==HT5OTJNF8U!JW@(8T+A/5)H\!KE#IP]O8E1%+OKLZ(G/
M#I>PP1W=[ ;+QN;#^0UDH\9;]-Z2%$CJU $D._*I#[T;@I4&-11M\^3N!8W5
MAKJZY(LR ?HOMQ_<C_JUXB*+HF]>M!NI0?&X639<KG7FH&87V_9Y!7IIR16D
MWHP6Y6I-PGYX9A02-18.24T!)%!;C?C")MFO873 GR/.2+6\T[9BE]J:;C^N
M3 [V7.$^I?B,/Q.>%&XL$C<71)X@31-HIEU)2=9C(NM,-'F$+N?%'/K/7-]Q
M<RY:S_+:/%3^E.E\4329SX&NC]WZS2E/480A]60AU>?J>]J975HIR2T,\)4P
M^4EO;W'"TMB7]-NA\<(#96R&OR6E5QPJI?,RBWO^6$8CL9B\&=NNADX!-,\Q
MR-7<;Z^C[GEEGUHSL3QH%,IS98]+.EV,E!G)#Q6C<7%+*LLLS2I= "3)(\QA
M@J9K#%NO3%FM60IR&Z+:'%+;-*+?WYT,3*(7\;DS]Z?9A\H6K_.,)D7X[=T$
M5,7%?IG*/].(O(W^HF*_06*@S9VFWAEJ!^)4Y0A9[K-;O?V%9*'E9@+?LPO?
MW[^E;_P7S3^=$^-GVCHL2MC(JZO?K/Y"Q>0QAMW%ASY VVF-=V:]Z$K*Y/@@
MD2/,]HQE^?GCF7!(-A)0]=N=W".& $.3X\;*J/AG-\5:P77U]S10&]6=-X>7
M*(%< D&CM3<L1-,&G37N,'V59B67TJ+)762;8A/-M1D'\)Q)8=Q+6WZZWF#^
M=8A/VH/%N.$/3WN&2N=28>6>)>N]_U%45E?8BJN5Q&6B2D<-:)$!,IE:T<#%
M[OHR\@V:$'@9>BVO2Z5A/21V6X&H1N):</IX)U)I^#8<M1-%1 "S>#3N&!2N
MH_25K$?(B,69#"4^J;[Q9:%#9\14K$$^7MJW4LJ#H;=7# ]']>4!%Q?)W')+
MZ"T"F_M9F:\>6"BOR?64DME2 Z7,9T]]E/GF^_W3_$=XNP+ ^)M0X+Q@(AJ;
M,[HXLX'DW]%YX?RLGLW'1W=B8(U^ .;*IMDZ)427<A-$14"P99F3KY%M-_==
M"W,UYH L$/\[>N38_2+$PEO*.VKO+12>J36I0#E'3YE9D^E0X.!?(>DALDU4
M1Y9D1AT- HO7<G(;.[YP+CX/U&KO6I_G<8S6>[<!0Z%9FNB8.CCI71%L]>^@
M9U*\O\E__GS*9%R7R8EF0KN\5+8UG:O'H&^QG7TRJ8X&G^S3!IXQ;<-^H(9I
M<U>U/;E#U 72:'-W1?Q*?9\11T0#*2DE#(&TH1 IC1 G747B"""&@T:%M.0W
M>!7%R7^I"<T8XKJ9]/Z?H;C*VAPF'-EV"8W-R@6?, 2R#$&P \RYX59NZS%3
MLG[O=C:^K%R*+I:!&L*M#^X<WGKCDT(6@#V SD3^Q(?QIG?S*N0,E8R]4M;V
M#VM[%+SXG:W^PXKO%H94"##@H#0-D]<!85^'G2%[X']V7$\QK&T.KZLMI)2=
MBKB5X'DH'WDCU5I -XF%@?WG<W .$EN$QIN 8V T@XAQ$H Z8X]!(HQOTSNY
MNB6_>R0I)4,U!>%/.ITR6W566*GP)IH>/-V'F+113/"LJ:5\"M//Y1^OX+\'
MV<I&5ZM]JJ2C4Q>W;V?Y:[*C#SY/\QUW&B0SD&TH363!)5C,U\?!!=,>#8%E
M#3&YE4*%T[Y\YI)PH_'O7Y_XG?:#GD;7PP#95_-?\DAR@-F#AER-\G-C"I>W
M79[2G4O69DPS>G(;=,=TA:H&O%J" %=#EP9S&S\!]5WVBO633>9?FFMV8= _
MYBISU_HE?912X[5[[LP;^<%1?V$GJ0-[@ATT8ZY'GU9M-G/R_^NWQ@7[^'CE
M7\8QR(6''O0X(E))']QS2!88)AY-G"2C)]LS4]+0+H.WULW<RKL*@$]B,DN%
M3U^A=!I1F@Y/936?&>Z+/@,Q1%!*T=BD0W 5I!5R"C$%Y@C(A)Z%6YJ.UPX&
MB9@DS&>_E[*=3FJQB:=[&EOJD%M+LB9)(-L8=9A(.HB)7!G*%QU+G)6.RU>/
MD,*AHE-O^]*"ZM/<%@+95J4N8;^)GJ6L WGXG@XPOQ[8 WU&Q_2QC_\2Q>>V
M5EA=FA&*M5M*J9O^RN.7]QX\,SD=#N%$8^/ ^/LIG A:$#D]WJZG/KFY/QRG
M)P0/*!Q#55@H.@G$KR@SK_BHR%OXOM4)UV#,^H>AGG&@O%([!LUP8J%19 ^L
MF$SH(C=PCFANCZRZOFLF'926_=9G_JNG%_CU_MH6C Z"C=:2I478NV:$Q25,
MLM&K_#GWGGMY'0)^YNR*[YO&8J0MXE8CUF;0^8K<<#-]0E"\;SX\_5;M1,U&
MHZ;\MD3C*^>'R:ZWE+F$N$3<I'F8AY29<>&0+# @:4SFVVFSEP=4/E*'P<)A
MAH5P<!>28S^NQL."P+\9=/IA)?W5I-H.R3NSC]C#&[^9@M(@M] ^QR#@8FQK
MRG04%AP?YO@YS B?%T<VU\T9;$DM^'O457@PD#32&QUI*,5E5G4I_+G#57U&
M7N ?*8AFFS\R\P2:?$K(II2<%@E3_.+=QA^Y1%M=\3]F+-+*U4IWOKVK?VW[
M:07K@@%?(K/3J)9#RQ4/F^VW*'(HL%$"C[TQKLACD+_>$#T_\-PD[7.=P_/7
M7I)7A-_0FS*\U@<1D(#D,:C51Q3Q"XV_HQ!*G"<D1X2ZY<,\#M6)7H&,D1?O
M;W%H\;L)"LE%,A_T"J'&\P!-FZ,%3/LB6X9;FL3HEZV!TR:_9'J0VZ^U,?OJ
M)&7J (3C&.1\#(H]"Z89,]W?# &NM:#1'K7YV@9CZ=T"#V&OGR7/KJVL.*6%
M6M)H\=T\0/9T!"ET;4'DV^1!P5AF!^FZ\R$9>]-YV=5[M8B/#K>(OQ[\*9OH
M/3YS4> &=:#Z]VWCA60:3VP+6DW@G(KJ4C8_UQV!VAUX!EF>U#L@#F_"2.?7
MD%7&':5(NK60R'4N R^.[V_](\]=,EAA(.N]5=SJ(%UPRZM3;+.#+@F4(AH"
M*SZY*#R;;O\W*O\B0L>+QORE8'@/O4(7?YJ*2C7PY?N87&5BS/3'XH?<N&[K
MS@>,Y<ES$41WBU8SY5.+"/57"_,H2DT,TG[?3>M+6=TWTW-/Q_M"8UXD&"\8
M]>DU8;8YR;Q@*O/6$@TX?.)KD=RN>E(I5ND6ZC=&U7\CQIR&%VZ(LC 3J4C:
MCQ)HX8;++2M&':"8@&&CJ@GYP%"6S7X[_;0:F>O.#Z^U8NF#ES]JK/+1G=3O
M9NRG-$&>#M.\@BEF?U$,'MMF?Y80^[*FG^/JWBW,CGS-O]ZZ>JM"!Q?XT$H@
MJ-3A-7S%?Y2Z0!OTG6DIXG5\3';96M9A!/ENA=W- =4<@>V..T^3WNY&**F^
M3^U]]H '))>7+8'0HO[*PWL>I@3N\&\L: $,A$^D-E_8HT=S2 <W2\Q51Z<Q
MIO8ND>OEU:/^X2P2=%E[*1%@O >FLQS:V0!.A+AROCH;2\/A_F)9:N]$+5OB
MQTO7EA+>.04S/Q2E_TFWXD\;;U,T'@J;3>D UT$C<03.6!VA%J%HA5NY[M:)
MSM]955Y;\%TU$.ZI1;RQ'%ZL1FTNXS>(WL"+CW#>UBRQY)PS;YW%FC /1\KN
M/=*X82Q=_.CK%*=$FJGFBN/?L__3/;/_[XZA2<@*;PER2NOP&&1:B%KNQS&1
M\]C!1"4P10ZUJ?[?VD[10HJ )&;31$T+\FM__#$H$XE#?J0$PWFIUX?9D5,"
M-!>Y?C[P;1_P7WR ?PN)OT_V.P:-O1\7R_Q$CDRX4"ST/]-,P_*/()FOFLH*
MQ:<308!I!;RT6XOXW@.G^.UFP*#6GS\:J\'B DZNN*?L@TE<^AKKFFW@HEKR
M%K+-GB;.8L'X?8@8W+_3)K/S?9/B9]=2KO2;@H+<!</\E=&/Y TR_7Z<*4^*
M 9%&F'9G21I U!**S"]%K/U!*:#-=WR6':K#2Z43&@B./3"_K<25K)T6I-:T
M>^I44/B#8BDF#4W4UN)2T58YZ129':^7B 6#PDSP3[,_ND[>,>1O+J?F>;,5
M>(BHO/1M^@T?4DI/+H(,&M$TZ^E8=P1KI >$$3$J.'.^L$/P>[((:5_YQ_J0
M_JED#<9<$,@A8-0'4)W%B:P^WX)\_7 P5%B\IP^>\FF#S1@O07I(9J7#,?87
MQW5,.5[39M)+:ULDE9N)42D^6TA6=#GK,(ML3:,Z)L@V^< =0.9/%&X0; .\
M]2?0-=V0'Q:M%U3GI7PPN_*&;G7WRND%70ADQAU$O4$;KJWL1@_HM,^2_]S
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M<6>N@!Y Q\(A:5! *QTGYXX&D:7P_3=?F_OJ_1#,]HY5^#.HF-%9+)T>WMQ
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M![5#0C]7_@]^68/'0O^_=,%:R7Z(D2+X+)IT'2Y)!VW+5BT2.^F@X\5;Z[9
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MU5P/OF>K\*BT2&WZL)_T0>IMVJ4*(9^)F1L_G'\7;W?X1$3,?-[P4JT5EBM
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M["C,5.2W2<2:PD*F=D+3'N2NZ?;Q7%'L<FWC ZXT^S0#^=$_(\]L2TUB"!A
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M,720B\'%>OVGMXPF9=%"D$?[@ 1Z$)T*YH5X^@G L710<VZB*DHD3,;) ]&
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M(P?GQ+BB.UV]J" 1GO?9G@/2ZHN*4K$X8B8%DUG&*<S(GG-D;JP>[#/D4NX
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M:.*;#H:Q IGQTT5IY,Q)2Y'WOX,^-M]K]E&<C^7<<+Y^7F#YI)E\V:(; J:
MD3U6:$]F-H3;&/DE-IY6 S\0MX#+C2)[7RAQPFY_3&^=?M:<?F@\_33V,5J9
MT>#JN\%:(7.(4,WJ2D^(/"$# ^-P[5+ TT:_A-$!S9B,F9/T^,I-K@S.#,[F
MIOK*,1W*HZ3 7\DWTV,>&'7/8SB.,_K @"B:S!ZY8O":K(T?Q6GN@H/*X?+]
M<M"Y19'&"81R$8 TFQ5KVKVSY/'J*:9TM!7NDN[BS#VXP7_XX_!M@UB(=)1+
M6,UKN)?@,/X*X[.ZA YO;K\7QF^#BR_);)I%W#(K+I+5*'I\-^*&,$F3-YM]
M^P%]3*K+*[;4@F$7[D.KH%FWOI*BB31<D^;10VKVGYTFLU4AJ,0@=-0C]R++
M,MYIO8 @8&GPA#E)MG=>OTMR'95\-2]BG>M#4L'S*]QS6H9:%/I&DJNGW\+W
M3^:F\M:8RQ/:PC]@7@<!.GL_?9.R7)H\MO=#(4U+NU8D.8028?2SP9LE+EG)
MO\F*P$<7B=R5_4L];DPX(&8B2/NYB^['LH415ETWF=J..8F>[\D^O@=92?DV
M^DFOSXECEJ^N:S=_V=@:V?E^7.,1>9=10S=Q='NZ1K^3<9(E?93!Q6@V7N42
MO8*5BH4,/]A-45"!I&AJ[G7P.":-0VM"6V:YN CU,34U0[SM5M'/[-$]9@I=
M7PE08W8&"J/:I*L'\X7 _0H];")+55]5_I?CC'G8]^^+5G.8B](&WC)_FVDY
MF*<_WKVGZWTXNG.:AW@(!%$Y82]9:UQ->6%KD7<:<9\@-TVYXAJBS#;G<6@Y
MN,+$J2OT^^,U*X<N[E#E].88H7FM%9LWW<[5"Q0Z#,D.P0O\4];S&,C.OT_8
MZ.:C!TCY]TNW0^CPZ67E\[DLV3Y?>V<NJ++ZJ /^$B&C-U58:9Q2]H5@ZX+$
MB']K?3:';I)(6JZ2)J8"X^7P;5T\9Z%L#;VK>1/GXM7QWYW&BK$#/B?VJ4_K
M6X6&*LO$;EG4TJ1 :=-6K7(\/GJ?O\4HQ_57Q$JEA+<-6U0X?$7D5"-#5<E2
M*.B6#DIDMW2J>KO')"8Y3L1VT8R?WN_:FK N_69I<:N%=$+]S&91P%!*5V;!
MR1NJ["+R.E,H= PD1DM;AJE:9SS-Q$)Z2RAGMKB,\^'5LL=M_6NOQ3\W[?@P
M!?.3_!8HW[JHD#OT!15-R"$L5LY U$LT0G<9\ .?O0$U43T(T8K \-W*U5XM
MT6"R8%(S8:<1(S ;+5$:H3!O&R7(.BC)!!TP&&!>:""VGA9U\<(UE_<'H'%*
MB8DAW/"+-LRT@/5>_^+\D@;IJC?&8TV718+RV%LC-NOJ]=_5LT2JGD,_A/Q<
MJH]\8X!A?@WE.X)<)*N1'*;8,#PY:2XXCXN2L3 NSO&M=;\WXPF_XK2*;Z_)
M9?X6?B'A$3E4[\Y.:+%(&/+].BMM6!+3CQ6RR,O4,/1.N!O.%8W!N?84E_"P
MQ2+&86G1N"=;IEZLJV4ZV:JF3D)#3,H'S2Z<^W[SKVPIQ6@WZ/P2,9U NUM&
M8K5#J%"GY <4]"SQ4%A=7ST[\0HG0/I"^#J L!5(A%P9SZV([%)%*T]9X16]
M?MYW7HS5<PHW-*<RS=/P813Z#X1$8C1^^AAC,$_501') 2&-WRORQ&TOB#NO
M8#(%^XR0A7:=.:B5:^ZC>LWC*O<+?G$-@S*YG32#+-Y]C*:O?$F6(]\[K4.[
M(V/0/(U+\_(#9R >,K2*_'R\NJ!C @'C*PIT5,N5$;B2/#\QO^:0,'?Q"DKO
MW;*CES34%%Y"8?BG'RB$4!.!&J6#IQ"S.MK&._3R#;#HRP8>6$\^C/VTC.Y'
M9/VHBS>.P4G/*.X=4X1YBPOM^HA'+AMVS^&JVM^*S^L[^.29WIR@9]U6I)W$
M9'7>CU:9AQ9%G^PRCIZ_I904?]5.A"UN;92N1^B@!5<0J%B>'%>8&1LO[Y>?
M_]$C[;.-!^=OZZKQT\O('L60JT )9@FO40.(:/8\FLT'J@C,GR&7U6Y0TT$5
MM@;X8 MO"@IT1N[&BNI"E (+VA/DA0C]PZ+])%T>/09,"#]^@\RS0UR\.79D
M1W_@T:FQZG:"BO\63KXC5RL^HULA6IK?TL2D6O2964EVI!L997%00+I+^8%&
MH7=<Y*.=3S]0[GI +HW&Y1\@+!AK;[>[50OF>.G:SV\9"-P=FF0=%8O96TY]
M:HKK5,;5D#FDB6<@8 5_V(N\2!&BC,EWW02<<'/)*[UJEYK'?N]*:G=DWN5^
M+$>\?Q-EN"1EZ6AHF;ZE_XJ@PI%E^K7"O"1ZV.5M51^W"ZM^Y5I40707,Q.C
M&C_357$5E5^:\]I*J845!WU!"<(>'%<?L=_,NEU8.I*6EA6\>?MCBMMFD*J2
MO#_R/A1O':QK7T<U05]D#[-,A9ZF2>W$RQH^A$2D>5US9E"0G>'#$L Z".Z5
M?C<G(/V9E=%=_6LVYRU=?B"7&ZWW8Y#8G26\.HP^V\7*X))N@2O/ )E_V]N;
M,]>[<F'+WMI=[WDXS?&[5"G8DS4MH7O\Y_X( RB2&V5JB4^%&1^$+>G;CSFF
M2.$%=TC!)5O("XV\L4+78WLL3DS-:S=G.2<&,EJ"7"NKC!"+^>PTR^;-?<@%
M#+$3V"0\Q,KWC\9"KQR!N<BF +,G1^YG,.</RX4>[^5M5R?IOFN-4MDINZD9
MMQ\P2 D<Z+_L>:$!8:S/=8L:7L6S X-FWL31'(3FKCF]WY]2T0ZE+/,;P^F&
MVN7Z1>]R;HJ/C.=V'GEXYA<,?@NV)_KO5XW^/C?VG,(%=Z$P9!-.2-#,">:8
M',AI-D*J!.#C70]=,NM U>)W=+UA6(^/$?=AP=ZLX?%CG$E#:0++L^O[W09Q
M?,RG62I&5%>Y@#[-1BYG0YM<$OBG]Q&.V#/0O* M4+:B&P2+K/,X>(B8M5[,
MOM 5,;\E-RS_T27BSN4;?N\J) ^4">>(^-/:$!$$; SB!N4C/Y]]F9BPR!DZ
MLH"A0$)E)VN>BS<>F38T7[;^DC3(J!43(>=9B1;]6Z'F&=!*O;$O5<?OR %X
M3C0>C4O<%:UTI] 0GCE+LKOQJ"4Z85N/5OD97RJ?"O3X^N\I)&O/:WIC6$4'
MB[ C;OI77IEYP\7L>.;,]3*<V<L=?55417R&ROO*QDK"PX4=W72R3$M-JBSH
M?\WJ>[8TQ<);Y.;C<%-;^DP:3!3"+3=%^:')GT6B_=NZMJ?;0+0C@1:70>8Y
M+=U$__7\I9YNKSF2ZVC79""$"?]0]3CJMRKG1I_2MY^+:4B/PLK9JFNHRIFR
MZU*EK8E#!\-1_6IQIXV_$]DVP7C/X^YM2?;O6^GR,Y1+>"!BU#P4Q[O->R'!
MH'[A!^9%K&K%ZVH:^;^<>"TO>T,'Y7<P)#AE=JDN)!=7!:92\.%R!&0< 5-%
MC<;\MFE74-$L=&^8%\R@J2IQKQ*O?,P5K=-'FAQ>G8412BCT+TF!E/%<9EGF
MM[D\(6KN:G<!MW)[V=.-M_I)3B6;Q9O#G'*$^5U=R_O.<S1"2<4AAJ*3N>>=
MQ[_>&4E#U%OY\\9N$1Y4*>(<$K.D9#;[JR^9IM%-K!<)#<^9GV#,;CC)<JZY
M6D8I:"M\T\-.\][BHL%-KG=.-FPECR_.JC$VGH$2=:$GQY%G(/4JR^+R<I'\
M.!$A,[Z83R ("%1BL;EQ<_S6W/7\&*$K1MI)6\*N__90N&9_@,)T^0R4(@S\
M<Y:/RSDJ6BF>JP N_2?_.)3D0J]&])^!OH=8G8%*YF:I>?E5)" 2HD5I^)4?
M0WFD.O9_ZK-I+#XD# >Y/#_@@DUD!"+[++9OK:CE8JOX#JV['I$\!_;Y9OJ%
MG4Q!H9;54M =U?]8Y8^7IR+%RON>WB084*W<SLL )(:A[CR=$MNM<31<<CM?
MH%NZRO)%J3(I/$F+L?+BMY!CK+[K@3[[BMB<H67&ZXJP7I%+)?5F@:[3M@GY
M<7\DOZ'%FA;*#PBUQ/=QJLH'AV6B\\3C@HDMJL8@.4$&%X!]HXZV23\T"+YB
M/MU(/@.Y;?*X1,C:_+30!3DE%#G2,'D[L_]M,Z+>?^F540D@/_#J2XL2UVL5
M[YJJ++0+VI,*AJJ+VUZ.[$;,D^=[KJ-:+OE?<9K'=MFZQ%!VST#+Z89ND\@>
M:_1RB>%PX29;'Y@XK$G3IOJV:6;]5GN2^<6<Z4]-C%_.#?#T"^B-U]=+"Z\C
ME^,MQEV1Y]#+%5TWFR?\=+,-,!19H*["=6)QD^?E['=9964]O492!;+11GLM
MEC<]8>NB!0O=I^BFT'+-7Y:CE\L='-X/.MTI$[O$%>G-$MNO(](PVBI)!ZD8
M3G+(VBE,[2RW<*<5>]&\VJGKJU,);0\*$O5H0\NU65F?2 ,O9LD<*_L7'S+-
MQJOQP?=[Y.19BSJ;\G!G( ;W1;ZZUI9W7@F+B]O&S:'"+DGWI7K?MK_6"3TO
MCZ$P$6;CK+$(EF4P+["Q\XQA<GF?<2N'G_/1086_WQ=!DO(=4KY>X?*)!=$%
M"XDZ.=X]I0+Z\Z?%*KXD$[<</N##RE)HCM0,N,?^3L?X[UUYB]JVB:.C^DF4
M;(9>T^N/%;RZZ>%F]0+WNAQ@XJ#!TR*OHQK@%IC,,D!T)L!V7$X_+H]&(:_L
M=DBN@&/ 5_@G9#H=;:?W"AMCCORBU]'-;3'*5FICQ.JHH5Y11&&<Q6,%7,=6
M)6K-SS%;-TKDV>6\HSFJ@P_YU?XF^/0-<QW!8#SV_87&Q;75!>53QFO&[W)X
M!G7G(2X[9LY_+%2S4@--O=+V_9=DJYH? J,S?E4>&*[$8GC#@YD._HJ;%5U)
MN'BYC8?3'-=""S[R_HY8%FV]&&=XX2D[JQ;'Y" UJ^PH&1%HSD"T(:+WL=/-
M\C <=P<M[N)OF7JZ==Z-:9ZOUN+O8X^+EP?7HKI\_ ^A$Q8[>H19#!)OF[AP
M2 P<0WO 7D,9591+$3R3N[+B ;VO+J6H)082VL1OR[8W3W08_+U@.?^3WVZA
M</]:GK^BTQ6]3\&)GB0X.;"%&D5^P2>)4M,U,JH>Q'M3E0[ /8@+0PWC+\?/
M_O:<[74?'R1;"B3J4282=N8UK/88/S@[/?EBVK ?A_LQP&#?]-=J(__[M3^R
MMOMRF*FO:&\#9OWR$OT$6C9=9J.G'A:)LI9M8WGT'ND<M^@4A;ZZ]FL;S,O3
MF<8K>3XTG]=K[4,-I;BY_MR;GP/W^X=3,SH;T/#M#/16^G/7+4)9DWKZ+N)&
M_B(07HEU#,_<]?M5+$>0PCY+<4_I5JR.V,#"^DB0AM/FY=F^CU+P38X4.SAM
M[QWQG0GOJW(1NK*D1Q-\K K'TGRO9X_1__9>ZS1#C872MX0W201$$C&PT!/.
M)+=E.VFBWWC(=;@OQM=FWMW<GJLK:6)/E6?.BQ4IPA#@DWP/JUO66]K-"!\@
MLTD3?P$_"20*'17WG><'M@FI<)N!',73C"X!^(1!6 !/;H2?C &36BQ?@T3:
MZOM*C3-0K<%5 Z[,JR'[5S I]L[\O4K[VPIQ[8)%T=T.LY=D3=@2<G@YC @"
MU_$5WP<8K+."P[4/S+U0K18R7K\E%&SF] OB<E'C]Q5JG+P\ U,"+)IR:IKQ
M^]4 +P[\=D:>D(A)! -WA:,N&^!&Z;9.:-CJN!D8V^([1/F?A(4++$]O,T>
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M;4XN+J/O*KWQQI;/>GT_9-QXPP'#-K53E4&Y9 ]\P+M@^XC9RP8TY*? C4\
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M8DZIU/('D8WALH(0,W,?8E:M5TW#NI'.U*[3[8V77W^;&[\JN9T329#'YM+
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M4-LD1EKS)O#3Q$#>3&-:E=EC69+0-D69ZKG+96T9,119:M"3E3P#.=?,\]L
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MWMLHVX7E%O T)8M>JL#5CC.%3ZY8BVD8^\%FT[1<R:"M<E^1<JY;(DIHP+^
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M+HPVA#-1&?94^RGH6R:IQE27I%U'A8/W >>HV($EH3:%!_$1W?]I[/]#QL[
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MKH4;ZI#"P;L+N8"I12W@7:W;?8FDHZ .]@++UM<?XY,\J@_.=KQ'&4.6YDT
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M.68'*7ZU=&@=![IZX7RFSUO&2 V(;X<*M:/\?!3:::(I[ L?%^5:R'AO@13
MCT_M"[W,K2EH*Y6(E^OFE2O8G;(<#=2XJ3AW7@9MR*RWG)GMOQ:5ZD1U7,1*
M%A3-3' Z$$@S0H%O.^R.1!+N#=W%^MK&/^&O9C+65U@;7::SC8GHGN&I_-&S
M\OP[O1S"FEG9*D8L,[S#.Z^B3S;#V:@JOJ_$PSP#E:4O/Z_*E"S6F+^L&E#.
MRC*>F+13/>Z@Z%[+V[__#GHOG)V<= KR */E,"T](TG0\QVLB\ :)KOS;7DN
M-C9!TN=Z<U37J-WL2(7QN+:(M$K*P!36O_Z@6>@WXM,I:"D#CC.P'P%$IFKQ
M?+V\*OCO13C$DG"7P]D]1WQJBGS%G=;/M1E,)AH%Z<PMV1IC$MX&5WVK0@O$
M3_BI"\D]7)*<UL$&[Y2&+U5*$Z^'N^/7>@O/;^;0I.R$WZ6&N6W^49+^WT"L
M#FZJO7381S")6VON 0+-RVG#EJ9X3OD1'=91KMN%L<?I _W6\P)F[@RG^EL%
MW,SF%V)27!/*C;0ZA-*C56UB;T]4WLVK$A\0-9#6^S;:W5HG99+%E+3"5I)1
M^C6]-7&R;T?4O?$GA>UZ ?=;YP(:)FVQW>3^,]D"CV'7)Y!$&B(7O%.<= 5K
M,N-,!9_[J+E"K'42A88RQ,N99 -(36,6<EK+>T;8-OT<^GT"&W4*Q9Z6'-@9
MJECZ"?A^A;^:.MKQH7K0W[CI*(@+/!;>DKJMA(= @1VB")#3]QW";;(\9S$.
M$PP1[N%**2(8&GK.<YUEX[[T=\C*I\ST(Z_KWU;;*_TT#>KW!RF-ID;.*YED
M%\QF#0TAXV%5A/86"65]LBAN.!L@O ,)*M2,,<@TUE%BK7G^T_O3A%0V1(K4
M,D5F^@QAKT!L:OH UQ>WHW&N&.GM-3P]H8=<"E,)5X3PM:F5 C'$?EX&7(]=
M:I=TS.NMUHBZTO>]R]*,MP+'^4PC=Q6BAERLTB,'HU)C.ZAAM9-GA?PW?.EO
M1PER!HP)]L/Q I"(8_]R8@@0>PIY2#>JI(K]G'%M(F[>\Q;'SCTU:P.>FA::
M,F_2'V0HC\?6L^ S,8D('D6Z%'Y&>W;K"_'ET9D2DCY.]C./KD%<[$H\T&(9
M@CO"P[1WI>02GZU;&HOV.AJ+ZAA(+N@KSTN:N>].9GY>AXF,0G\XC)"8^ F&
MY/>PR[!)1VJ8B?2!C?&Q4&Z%FY-?A]_V*R7IXE)[$>!34!>D:$LUZ'5+0TCD
M4=>T(8\0Q=!MN\3>JS3SUW5>)(GX!=3>''4_(4S9W"QFSB8YFSW+RF\^#LF>
MHGETJZNA301V$'UM:W)0+H_A:;TXK=AH=52^:DB;E#C8GC:Q>P I8OU^$[-U
M5X&?;J*<<RP_[PG"R_R.,5/TIUIW\3[3\-&@('=]]V>_X;!N$<0&BD*[_*>F
MPA\?^+--^&R/Z1L.0B@B5VU+:_+-H/GBN,KCVAA=RD.<[TVA)Y^@QI\>BF<U
M-?O1UW;WC!D7U19)I_F"1Q;/4STPB9<>. 41+6"CO.PX)2J0HBG=D(;:C@9-
M"=B/ULDJ>R#7?.*W9UC\VG@;Z]/R;70>L;8D#C%TKH%!'W0,3I:]9#7D>[CE
M? O94"6_Y5R)W2=9\5H4V]V/X<U[OD'9[Q *2/*=N!&*S#VZ>=A<T%5]W_VN
M0;$'=6+:.X2((EM#\VD&9)/.LUJ1/4L@?<T7E]./K<<VB-RP\0;8<#SQ47G7
MW"KYW>.)\3NIV!?M4=M&58/^S7YH<B*?VW'=.R?P43 O\B0Q\(^'4-'3'34K
MOLS^YZK?\SW "MYPF:T%=^[!I 1%)%P)&'VOBR'[[W7GJ#/K5WAT@)M:+J%?
M;3_,F+LXT+K#\3.HL&VG=XPZGF7XV>_9BNQ^)!=DP\?F/-D'&T>T6#?Z3GG=
M74,?I2$\[_DHY>& 9: UB<VN8;URJK;GD[?..R>_W^*8^A 19R?5%/]N_?%J
MXY*_BU19A4H-?/W#&YI?N7W[%+#!>C?0200I\JVW7T?2W-I+S7.=0 G2E/MS
MC &9O8W'+6-:>O>2^6@4"B]2&]P?7#Y#DL&SI NNXRU7:[+&W)L)4Q]NY"BU
MINRC[URFW5^U[ANC)4!9J8T6HL[E>][S.%04R649,KL/![OQ70WD V_PTGEI
M][3>XRIKKP!JM0'8PK3>FS& W&X<'/?NT3J@0+X9<D1P:L 5=N\!@E1]X'D*
MFJ,RSMY34 RO(M[U52G@@TOSH7,?6^=EPM,0@MY()K<%B!L)$-CJR3FC+A^3
M!4R]Y^[?J1C>/ 7A'"X"2E0#%R[]69JEY3V(A" HIQ=%+%P&B1OI5E/\%(MQ
M.7KEW/&BH[PR;H7MQQ;;9O%7>H[TM9#N\YF=QYL/GK]])//IR3FPX04[FPK7
M23S'@,WE[S8^KAD3E706;GW(!QIZ1F'"/-YBL+%D47TJ&@2'MLE;N(JJ"+(;
MB$GYKGJ7BWOM5PHAC\P:/;8"@ 'R>_@3GU2^!DB/):!+U NYN(5!],2.UJK?
MZ>!J:XTA6(WZ="%+]T= ^P/WZLI]+(5IWCAR0V>52*P'%-H#O#2%CDK^+GR&
M1Q=<G&PZ!3&$!'1!&Q=?(O?B><4FGLA(QY!D"(:<4M)>#0-EELDE@=K=^B\C
MAQ. PB\0G"X8$)[>T5^&)B\V4G65/M&-I <D$^^'7QL/Y$Z$@X$Y@^9QTCGL
MU@[_2*JI [?%*_&?LW,_YP;I#1#1X@=<A(8%U4$Q%Q5O:;E*59O68T>P[%!Q
M9">VGN-><X&4 <LF=K/3TL: V1L7N*F(+57;+YOR[QXV]HM<37(5N?W=0#8W
MN2[[0"'B:6U8,"3WO_&P2<W+Y%B4)SBN\*RZ/?%^B#B&M[@N_"SN:GX;%']1
M?(:_:71JIJ_EBF U6%4G;ICC43GG0]4WA>.I,W^J!M'L\.&V",G '-$VW'I"
M\Q*5!.3[D(PPBU<]->GCI9'MACT%3+;6#A\:F_-VWH1_S1&_%_G8]79>#GD<
ML%^"OD!1.>_2(GQ."#R;BH7'=XB01*=_GX(8'ZR?M"1Z]15B$Z]+>TD^:9K^
M#337UNS(TXK?M;B8Q)^7R9%$3,9]Y,KP_60MI<3*LR4V*--(!6SU*Y=666\,
M7\)N?#0[01=+N]-Y^R,+Y1UJ5&V>&ZF8S*<VYNNA3<W#\[&'*ZNC3?E30Q2F
MFUDJV!2WM^IF[[]QIR2EG!,'5UR?R"3N$/\XT\U3T&,$==:"N\%QIR"F4Y [
M)!XF!7Q:#IL7-VP'-(BWW$9#IFUQDIG[_3Q<B"3)%7IROJ=WJ4O;ZP^7WO$K
M*P^2&^!+T1"V#AK*3[X+D,=\LWL]2E0Y(8](L5+U+OX;6.R[=0IR+03?5L?#
MW:CH8C#Z(>4KVO9=OKY8Q].'3%;MT;TDS0.ZXZ?X3)%'MW!]%GGU-AY *$/!
M&=%'Y72'3AS?Y9?W1 4]WAB-^ULWP_H0 JX#.=[B\VE>*B15J=KUJ:VZ==(U
M1$T'&ZR+#[G6#X[L$"(7=S"3N"?#H3CMSM3G?/&D0,_@RU8YSAM$HW7/8'.!
MR)^RQTGE=+;G&-L#B&>P(X"@$HEICQJ:^#0%*7W,L 4^)G5VHB5)"2>0,T]E
M;/SW&D8US\T#Z&L:3]*[];'OZ)C/3)S_H1NOWA=]<7COQ<((\3QL$-YTOA!G
M $8?]&IRD)'J]CAB)YR>I+T<P=P#H87Q;4R%HKJA?#\W;E#&(SQK!T5:/:\\
MOI.2II7*7?/TL8OX51\UOCYEG9>E"8.;8;0CG!GC)DJ#C:KR6TYRJBGR59A,
M,8_ B(9$"X^R]<XM^TP#I8\_LB$2F=.2=\EY2^A,^5RSS_H"\SGSM2V0+._D
MFWSM+ W:URG;]2HI=S0W-RW((HCUJ.Y%G!YX9IJJ-7'&X%<HG"D$K4TH!(J7
M',!8J7(?<'RX'":?=VIO^X@KY5.%.^H)[N3KL.14$;]=?(_75>TU4,H0I_7J
M*0@0HRIB)B)FA,2\W'D*:I3NA4:AV,)-\%",SXY:L6Y-B.-1'YO?S-:)_[?B
MV2U/UI4FB6^,;-,_BL$9-=4W96.M+'_CVFS3G/U^[V]K/#7LL>QS;C@QJXSL
M&>^>[%NI7^O#8.(S6#DMBL]OVAJ,1>?9?V)(MNDO,% T39HORS7-SW#(:O8B
MI7:@EL9&CB%_[A8CW-Z!_";Z0.=-=J+^:T+L*I!_"JH(0D"[6DA<5/4OO(&G
MJORO&N640J\M8B7Y _R_G.[C8T8=,DQN'2_V0HZ5/YR"$+9\E-R2T(_@(VN*
M:N$[BI*J+NEY"QFV"3WQ:ZU5'1J#+ ^CMH[,3D'CR9/NTX>!)BF.Y8G7LM^3
M(A-$*CBL)T]!'Z"]\,OAE\C(/Q<7)\$4VAV4NAS/ :DEFZ&K13>S4L:F#-]>
M9VI-":I6%OA]3F!Z@&7ZSAO.:]K%EUF=WFQ'Q&V65RCSO['!^O[&ASR]RU9+
MSA*+?JK@:.TN%K@QD/'3<>!!0Y"7?$'SPUPCA3:[M([I1"/H+J38!% 17V)H
M!.]D8E+1TU^XH'&:_"0U<D7;!0S9NKMU[>7O"-W>+!G[]5#U>V:8WWH^SDUO
M>R6>/LK,W.]A[%3 %7Z!SJ"67;>'\6$$(W(Q_*GTJV8*B)S3%K@,95C8L$,E
M>WO9'AJ&;0V*RH<-GH+H3%8\IIIWY.YNR>,DW+I7O<4'8334P&(*]TF=[<:L
M9N)R,>S][O(CL3G,@T+Q_U9GU5,?__<854QM.=>WXL\Z#'O17P:+,<6Q7*"/
M/MNF1'A-KH&[@^?.]:GZI*+<I1-RUGI\F-Q:->I>%L=?^]U.;SCV-$_?W<<9
M,Z=R-]-+@DFL*?CJ7$G57Z 7%S6MQ08^1EW(=I(5F]S_YO+QGN#3\P<<%KV#
MLCT/)U5,N\1LH"Y:,6!&X_3(2DNLGV^[(D;_(*S5^-F*BH5I1;FHJ+];99_C
M5KK_JK?!44/#5B7Y.[Q3QQM&;T/MDBXUNL6A=;=;B \H/_CXGHU<W-"4 -@1
MX33X!SG67?F&W5Q/08JI588^G_53C3*G[GQ"YO?A:#6VSE%HC_"&/9!KJ*6F
MPF;A'CYF$M-DQQF@M./B^HG49]RBY:0$<MAL^G[3AQ3.0'IB.S_YW$YV2E&9
M3HJ*^NREF4]TD#23&*K/VO@ HO NZ7,A<$Q+]R+:TVJ4Q(_1D#)B[K[EL!X*
MJZYQ:[WWF30H?BT4UU%^7G<X_:S*CROSRJQ+?RZJ]RY$'Q!"@/1EJGBET50,
MB:5& 19-$?T X=0VJ+^][83Z7].Q<C7)<(GD\T_UQ7F>,C+0O9Q;W@ "<W3%
M>E<.>I8$[50D]I^BV-6?N-H.Y-^+4+?(MV-^Y0N(25U-?"8RUJO_B&>%:S31
M_3?9FZ'$=5 ^W]+,;R5R.E.2*WS,O=W>W4ZU;G%JC<0(M6ALH=*FI#\5BTB<
MK"7#U8ZS(?UF]XPDTAK46U_=O+3#B3;G_PQZK[QO\Z+MM7@?:FDQ\8IG=^L1
MB>W091R)8M@,(A0R(;P>36PCFG:,:8VC$2.NSWF4OF:+7?MAXBXUGR9B'9?9
M"Y>FKD^(%PK]><FZ#\4*&UVDU93V*  #L\L54EYMT&7#,+?R".^%?=VL5;5<
M6@Y[1HDT-:;;$$55Z_)9>.?]4Y!/A'0?BDV3WYV/5W@LW!4_U]U,80(^5VT4
M7!O;?H1/C=UY=BQ?\73W:6V:\O4,&R,)<#"'W+=5.3EFQQBG3LXR0=>F]4=4
ML>62[_)3+7:MUIJI7)<U;;+[>XN"0DPEYWT$72"K2F5E;T6?1:V*@<SE>^P-
MWLSM*I-9\?*3=]*F-H<=H'?S<SMBMZ9)7.\TBRHI"]"FOD:X7UBUQTEL5R'+
M P^E([.1X,#GOH')MQG+@MUI@]6<[\M\S+PO^Q?B!S2:&IH[\G%1A'OD>I2/
M6N*?TP6\"H:0."CCSE.XBPG]%I,'A&'A1-*8HD95$G&:=/6VWGL[-]I"A MH
M&073T.QW=!F"3D$W%AM==VR)VI1^1^EIS>NP(10C0I,=&.Q!/SW1;*^U07<_
M%RHJ<S ^4F)#\*QYT J_^?6SK9HG12=TK1,,B.KNC!(5/?@8D9!(%"\23C>"
M#W;4% :2/9^7SWGF6,<%3ATD+N2+F[H_K3T?@W46N'^'<9#T!=O:N,LXW'AY
M66X(I]S&*J:,?LXJ7365&6J&T)7(-*EU\I@JU:KNTFH3DW:!,I2;J>?5WE82
ME*_68MGH\DOW"X3*K@0%JCQ_G X[S#G*J*D-CJ 2GAH?0#QY,4GSSZ$3!HB+
M#]/F(CV5D-&$+/?2_[W)!8U4I\<,;DE"NK@Z/EH^>_O,2]!)*?1V_*_F-S<S
M^4-6I!ZXZ"$FH#-\7? FW6X30%B7ZD2SU=B6WE2P.[QY.E'S[-8TBJ8$KQT?
M#BW>L&:3O:;N(3=4Z)&_'53Q[)[\&4L>MN0_7]=W_,GMME,;H=?F4S('P'M1
M38$+R+]G-P?K9MVF-;G&[(T;)IU?&[+VEA991<[??'.U][+I^[LL%\ZV$7M1
M.+/".50_G*.-F7@[I)H0@Y<\!?5)QYR$C(6#L3/\]C>*W%^D$Y1_$Y^;H6W>
MIK>I8N(%(O5'1JQP:VH]*RP-S[$-'BQNJ\=9P71O;/(LEAW;2R,[$5XQ42F,
MQF8I"@<&ED5/WJ\\\^)YS&^.%IGP&H]6"M.QM<^Q,\12'!.&**\A2R^@#!01
M$C.Y#+5474C;H?2R&#:1,_VR35LH5JA2;,;341PO.9\\T(S$U%=<VBTDZIJF
MH4,<9R^)?E:!9ARC2-QO<%3,?@=8$]UA:)@LN5@>P0<88J22ET:NH4E6DYHW
M% B%&.(B<W-UU5"M>NN0KYV'DDG9:_X<]%W=I%><-#3'8WCX3C?1CBKJHL9/
M01Y[S*3'4VODHJ9!-0W-:2Q;/M>&G$9! ;^]GK0\43@%C7>V><WLRP=;S%51
MV%[D@"S54".J*32UX]P4A8-D17Y_>,7U"T70H>#&V+-D&F/<KY.!'1%XD\(5
M@=N!SX9*JIMV5V*"715V5WGX\Y>M L&>Z7?53;-_S3P8\]DR>.[RH(%E?2++
M]L+M&AVQUXGY'%-9K&/5 _/+S"+3Y7R/CST6DJH,Z.>/)M">:+7UJ>_3K2;.
M)T7DY#VT"7 316(1ML8A>_#KZ,*>U.0 =Z76D, 8+[HMTT_[;>\>7= <PNE%
MB<QI-6!BECR_!WJ*YQM2KE3@2DXR6@[0ZW9'L2N-8<G[W3[NX 1G]ZN#MQY)
MOC%D/\:=45$@E9#4R9]1GJA7BV<#4;.)F.D^#9-NU)DV0]8)U:,7Q8V1V$6S
ME,.@^7B$H(_ZN_Y%;WWU @]]E ]T[BQ\=M=D5A6:U)I+^=Y0?/<4=(72"VH4
MV?W^Q2'FX.7"]I>4VRH\T_(?P;(G\W:XWJ7GPKTS$A3) 533218W0X5!$LIW
M>JJ\-2&]],EX!5)\2^9/,4$+09U23Q4#_7)4%_(S<K(9TE@(B'Z&#9]DOT0M
M92TRJ0<0U6#C?$TQN44AYI@A*.TNZ@GTJD9YY+/"N#?NJG[C5&]E0V\4/#8*
M5OR[5&>B1/?2P#W=D<(OJ8 RA/!ZJD.#,E8(EM^+0S7RQ:&>(!(=F7%LV;R5
MY2'=MN-4A<NT!>.YC'J8?G_B6=O=TMN6]L^_?-2A;6L\N[9D\A*"LX0 (I#M
M0=SR'4 ;9T*(F2 IX!:[S=Z1-##S]G<_X&77#UQOVM/70D=R%NY<?V["J)MX
MSND!W3$[%M4[$H^Z1HJH(YD#_<N2]OV+5]N, B5W6[ .'EC/Q.K*5:_=>MJ2
M#'O[W15)K#@3G"YA%U-PN??QIQBF#JDZ/F9=\1AWDS-Q,7(R63?]AF2DJDS.
M:=YC8%-/@]LD.0K/628)T][N_63T5*N24Z3/-.#93^SR!=;M,;3A0CJJBSPO
ME3^R94VY$A3CW@&BS*^*N&1<8;<^W\_=<>E#?IS:[4ZZFIX@4,&+Z7;8=SA[
M&Q3'3KEDA @WQCETV6S9\>V,U-1DRXE?&C=L!9)+[3T$X_A$;JG'\;RN6CN_
M%D6*IWP_!36?@G8<B +K!;*XQ6T,/L 4<"\B:<?8P[EF;&T[@W)^RO6-&C2H
M]\B'+3_1,O];GF\.3O@ .8.$SCXC/9B 8_[:*A!NQ9?5XDBV]HEA*):%A?Z*
M>8^RWWP:O/;KQ1_WIR]=N\U1%S[]LOY35L#;Y14H"!>RO7=S*"):UV$BY$$C
MV"I&*%FO2HJA%NK1GF;FZZ[YO-NI^VJ1,>-*MKRH17F@9X!19QFR/1,)&441
MD$ 1;H[@"$3@6OH*Z,>GKG@2,$#MDA'S@\^O+J:;MT\_2];$K%Q.H!=A.OO\
M1F(>&T_A*C>%H;HAVX1<3%6L1-M':?PT+VN+SMYY+#S0*#KZXMNQL=^/2+ !
M21Y/=5A7P@*07402PHVD:JIY\M[X 3OOD:6ZV"5.GRO"&GZC>J/RLA7[J/*C
M:;,Y71^Z&[GY]56_0#)KA4W9.Q%$0]A,P8U1DBW1*-RD RC&0L!H^FO<9JBF
MF-'MVK.95]]WZ3UD618N\$R/#M?HQU%\,E<#\1_O:7>9#V&2,H0=+3UU&;<W
M'K)*A<HD5SA5:N5;BNIF5FL7B*U8]]Y%JMR^:Y@[^W%A*E7<+'_[*'W.R"O8
M>8U+Y#W*1KGK3WX2]8.><H7C%)3."E"5BNN9&OA&!VJ$\ ]?R^#A%+UP5W*2
M[")90PYQCG((QEF0_LM)R82PHG_QDY(;.'NL=!SE*DD+Q][+1VMRK0ZU5,@Y
MYZDXS53^-M[3$W%\\D+\9WN)F=@)<\XIZ"%JCOZ_GD?DQRN=@DROV*'ZMO1.
M0:ERIR!H:"PE^^?T;_C+U]'W&N,K)Q+R5=_FG1>F%>^[G\ESSX6M(-E LNSS
MO^5AP5667!$YF8JIV\(4N@"<_9]:U[,D!8"?^!#6B6+LX 6RL=G=* 9W& A
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M"Z]NA2:7X.I>M2CYZUXH>7T\L"?QZJ+E0P;?\FT$((S8CL="9J 4VDIJ$#+
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M__1I:KE&VT5]B[7"V&3F$HK),4G&4C6 8S2N"&,"FLZ/-&-@X5Z4\>D^C[/
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M#G,[QH"6HY-#F%1.M+?WF9HCGV(NGME/9IPY ,4$('NUF&?^+=L;244LXO3
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MH&-&'LRKA]GZM>"#J'B!>-+OSV7JFOT-A=7RF[/[L=5 B?V_<>['2P!HOY'
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MUP4")*U'!O#S]EG;60SOE93.&I \WDS.B]-TB"I("CKU;2JT<S'Q_KK;@,:
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MT<ZKU C*Z%V=PW=2E.E?9L6(9O@OA.8>6!43GD8XTB&B37C5= L)AGK,B"M
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M=&[J%3(#1 1W0EDBP' O2D_N16+PY[JAVE8E?OF;KL:TDGW;JZP.9P[-!#!
MYS"+Z!;H5":V%Z\ 0&R6 :KFPR_\$=$!.Q1V&3,XI6!45T>.]2\EP_M#WE?W
M'$M?BN'.O/4Q8'YM /_^;MD/IVDO%#Z8 ,.:X0T!!NDCHPA,&,"D@RP_X,HX
MQ!-YW;/+3?6E;LGE9"G7YPL"3,\6;S- KD-M/KGVZ6E'$W$M*[GB%L69-MUW
M NY;7=S\3.2?A0DY2[+]QIV_4TJS;Z@+NK=D,IRS\ECM8ZFEH5[W%_L,3D=B
M8DG/[+C*0C^_DZ;X^:E]K]K-M6GR#?(D(1M(ZS4-72A.ZCERG?>==^3=]C6A
MB',C/BB7IL@.0V-I44>I'GSQ,=,3VC:O+I<NAUB<\*EC-5SP:Q:R[%F/B"\S
M0=S/>.0'\,U]@(]#J):$/-)KLB?!H;T)W.$$[4+E+5_H%$$&$VLL:91ILWF[
MBH*&&)*Q78QHDMAL%_:"B0]PF!'"'1&-/J[+'#$4<?J@?\G1;L)L'M;;!WJ3
M".V8FZHA71L6-0/#CW1"/(Q]+G;VFM2AH WW%SS&::*77&-@FHC@*F1%,F0D
M.JQ0OGO!-AEX!%CFO%<)O$Q86LIEZ0M?]'ZWK:R-=)WG<('56.*]8CW3LGNI
M<'>OM*3KFU<L7I28.J^UR4AZS_[\:K_?+!E(3@ZQ'<I/B3QW^-O @Y*\XKN/
M#OW,*FF*3IBJ6W&:KGLOC JH?A=MEG>=8XB<M;T1V010 E6.B,2JQX>%NAQO
M(/1?)M)C2^ U1F,WZ]K*L2=\7_V<7*D24N1RJ"X?N'=\YN4E+_JZ#?T$C2)!
MO0L<'$,]3BL)@Q!JVO<5\$DH*M=W;4==7CM;V8C#XQMU<HI."CO>)CA)P%C:
M)78AGT^O)3^PVM5(2+B@K6R1&,BF*S[<=;NJL40CWC'W6S#!*WL_<M$+9M>E
M_SY=G: GL525(ZU<EOTL:32/-V?#,[RY7--Z<-"]F!XQ6&PKCIIFGVFL@SX,
ME#[QFG1HJS9M#5:"9D5@<M"LNJ*(=JTP<TK0"I!DGU+EYI%@YQ6U>F1-^@SI
MA;9Y::]+H/=1"X>I+P^::NKP-N# (]U>)+I3R[M%0S9#A9W[!T/Z"I,.V"4J
M-Q+GOL:. T>A.130=V=D, IQ83#UIWZUFV$\'^!IQO4YQV82M1+-N\18;O&=
M=9U,?\""C&R#4-EI:6$'!!)) \+"NUR+!">[J[_05J3HP=\O?;+?YMWU]FWC
M&0XS<95(R)>67?6AI8F_29V"3QW?.ILI1D6K]^.T+W6ZJ3Q0ZLN LO.[5)_
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MQC_I7_FFDI_WKOGA!F/5<X\0<QJ'A#S/-Z6/#4R,=.*$?WU.XLX@RMX)?)W
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M^38_5]<I,_&HARND_;,OC64C'F4H[C5'LK>YF>[3_2IUF!;TF6ZP/;I;T_E
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M&YFY^ O<U[?+[S<SU_E8DJI9-UST\HM#QK=)9AS 2'G$D6'/N_#8 Q0VL(F
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M#@EH:;Y77:>2#?5V!8910X"(S-O:K/=MD:H0/[1R[N^^)W<C.3X/I![I%?[
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MLHF6,RV*.:,6G'X]M\F3/W0]]?-")LS4-OWKJJR\MD:N?^@HS;6NL<C[-R/
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M430KE A@:F+BZ3]&P4A'9FD:6LY 3*O\W:[4?/?/%XB#733NU\OM;<R8B_A
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M*-(*K_8II CG<\O+F0F]%MF4M*KE- \U'=/R;ZYS\U>^Q$9G#ONEZ#2_BE:
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M9*E4;^.ZCX3%.<.APXX_1\;KYRQ:[S%/HKZ%<?B&Z%0&LXW.[N^VAG6!#W/
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MAUBF0)E\.[!>">Q<:LCUF-ZOG:0?S*^9=%L*JWP?7W?ELRH\Z'C-BKG^)@7
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MY]@.9%Q994PL;'9XM?:U-'1U9-C*Y2F]=3A*@?UN8W'JTP49WLPGD.46J5.
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M7ZA[V^$'H).3!G94?2Q2'86'83N<$IHU)U66^( ;I^P[GGUR"?!Y<FHT2.4
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M47%&Q,E:];*+?XX*_$U:8F,D@B !H+&>)RCUA>&U\%+</JXBALA4FI3/)QV
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MG_"#'W(W; *[HKQ#O*!YGH'0W4D(G8P:[%GY5S;L-B29T#+>!\5#5L:Q&"%
M&LOB9>:IU*)99UW@U<P@S2!'[BW?SH0?E\3L/@O@)%0RU;,%3Y,6UT;%,<?U
M58E=JBZ^8FD<%\H]YDK'TM%7]=)/>5KW6P?[:Y,#]%Z4B"V\JE)H=YU]][G&
M[+6L5BWY1+>N0QG+] (,VNG!*T^K9C;W0)#S_[L-&<>*8WL%CFI^_?V4QJ*R
M"R6V:N)M<]LD3WLC//-B^3T[&.\>.)ICMN</Y0#$$)UB<7$0QR2,&IX1EI%U
M)!0//!"P,@)JZN%<^ ,0J:BXC)E3.U''<) Q)E\@Q:;G7 PLC;W2SFBE5O:F
MIQ)X$,++!Z!$J("A*+RTKY@/>6[P'H4O^4^-%V\&:2M<VCA/_'KWO23;=J/%
MFP9S6:^\.8Y?YZC@K@_?2)EM&@X[B13EB<_UR"51X+)ZI\U"*\U:)#7N, M=
M-=HE4@2SHY0FN[.S4E8^R>H.VF:^7E'4^+[@/_QCRG_!\_/B \/?S-?_ED5"
M6GRWVZD2*_&X$!"L1Y+JE'P \B-K!<F3=AFFDT.)S0<@@:^?/XU++%AR97*?
MZ<P&<4K>7<L;+ 84T&1YZAXMJ)F9V?60=:(1.%<)3$+ SC\,Q;YX3]:3#8R$
MQ_%9'XLT#^N?4S/\3X?K4E(;W0#5I\_20$Z!F]H&H?CH/BEYBF<J97?97JO-
M\'+3W$\I5<]H6/NM:X^O"#]KOA_D+ZMSF__4[^\8?ZNOR23,-FX9\APJW$(.
M[V<_EJ$(P^_+YS9B,1C.^["+PBI04*@TFKU@?C'>88EHD&G]\S17U)"&=__N
MF)"WE6IND(GPM:06Y3N**Q=U;MCQ6)CG7-.D +J5QHI52A;O/.3B%CTM/*SN
M3473Z]4S+;I#?)7E\(M;DTNI=6S18P.!H?@WP(VT^*J );X@"$UG>L$9D&KP
MJ\YT7NI4O@RK%67)<;:+<H4/]5SZ?@!B"Z4@-II(<V0+?[HO@':95&5=^0IK
M+9)IFGW@IO9^X^%^7;8-]FC&_#L)[U\DA[N@P]R^=8CB6^J#O"<3^&Z)NJ]/
MB:'-<FUR)K)R)#LY+2USS\?<+SG19B+F,(>S?>@Z->"85>.J;QD6M#FPKE6G
M.%R#V]S'*>#VRS*AD=XT"JJO'T.Q<38P.@!QIF6%4*2Q2^I%"K=GN]Q*$)"V
M]U2.I#O/--,TJ7*EDG>";@J[8_(MUWRO;'W7/P !BABRVSN&!+!'$7QLU->
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MG "->'?RC0]>K5W&-C*W^.9D=L# BZG"UOK?WS#?+\A+2OXDA(WC A&4H@M
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M_K5Z26>;T>'\24DG5ASO:*D3Y= /PXP:/T9,N3H1G*[U]1^5#K"<KYYWT ^
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M?'Y\<%>82>-&P@D7 (_#2\!O$$#%K#B8(,;ZHY$O77D1EZR#!%U@T(GVOG>
M32T#HI[C=/A\W S/+0?U0Y"U;)YQI##G!.<]#G 6FHUA6+2#!4Q;%HR=#3/
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MQPYJL"(F#.F0FY<U!)V-Y_#V,_59>NQD3!0SG,.-+ 2KC)V! H]8-G2A>*P
MZQ!H5_AL^L;$[8BY# /*AOV;<>^ <1D7,3O7\O>*_,+G/+?)5% !T66-ZH,W
M(K?. )4TYRR8*&>(U.S740XJ+R5O4I=IN!=@#W>%>IK/'^OVW1AQ[7)[>[QM
M[NODXN-W+O0=N">Q&<K$H>%+\$VN:F.H-K,;:.P', .6"MBS+&O5B9/XA=3
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M2Q!XU._Y"G)?7^&8-*=Y%[+X\E]'/99( >,>-_]I:)&EM7YD'%7*R)9IA9$
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M/._>'VRH0'@U4LJB?8C'BL>N74RUN8GG5SG-\EJ>GF>U>YWI8$BIX-N"8+O
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MFMA2Z%RV;!,1K2^_JZ!)N%*J]\UP^U,D//YKAF<G,PYM2<N%NF[%PC!=[5(
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M?S"^TJ$I31R+\-SYZ=6>Z#FSN*9:*;I7Y75H3Z]O\ZF-%4I,4P.^M$'G_W-
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M.UDV/E4YRN.I3%]!1FV3:?29Y]P!@YL4< F6:-TOR@@:9I4ZP>/!Y$' @F#
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MW"H\YS6<&=?),S\@-IWF.YE@8O9A^#G=S3M.Z6KNUUP^]^*[/>^NFNQWS1Z
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M<4@*>G=Q?/6)/ELYZ&F6$&VZW_S\7MZ@P4C&I^%I_BK]K607; </E2:-MC\
MA?K0"E#+DRU74/A/8UB@ TSL@]7TTX2MNKRHJD)[C! (O8XN=T MRS%F88B*
M!G9E*4U#6'/P /09]CN0_OS=O(H5&M5V&3D$W?& B6*)/]QGJ _B &>E26=Z
M3.E<'5TX)N@ %&VR6Z9$.^: (A:$I=(T?EUWGH0!#(E*T/YJC=#(W:W_6.
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MLX0% 6<_7\BWBH0$8S]7"3)FM&_2JZ[[?P'&W/_]E+WQWQ4,GZ4RIFG, 4@
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M9 7'3XT-F:>M1]W?S;/+\=YA.ICX/P!02P,$%     @ ^85:6L)6K&62! (
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M5!$O1OHWM/\>V?]:8.'_6Y']1V#_;UQSH%,L1YC)8SD+@H H;/23S@S0L8\
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M!)4%OW=D'A(]A?M\*+>MS&\7^G6K.*LL1D$L?J[+G79H36)"QG8)V4^BRC!
MM:9$"+UB+S%PUX?NDMC[]%I>;/=$E:Z%QR?SDD')1IY,F-^^:T;6TL>F9T)E
M=^*E+"RET#<=]<47MO?0(Y-(0/D7_7X0 4/+\4Z$'#R@GJKZ(8Q%)?UG?V[5
M^$77G6& #NG,+/R36V3-3"Q5@O8"FL4NF=]:T"J9'POZN_[WEPS K)37;R$K
M )V7 9HM!L ,D-7O/C7Z=-G_9,^A)O-M<AUDJP=)$Q-6#F4FY ]R>@Z:!;%D
M@/[3AR/TL/_\H0E^!+("8W9JU1X#I!\S^8Y9X-B3#)!3QEIGK&25Y!XSPR__
M^Y+Y8\*\E2*(A\*<"?DQX$P1V(36)O5YQ^!8 L'GJ:8 !@U44O"H&"\-E4""
MG/I]HG%":-&LQ\_;2>063Z%/3YL:8GIGT)GZH.]:4!7FJ1R0G@IS2>3W$UA/
M-ZS;R!PW =MWGBHE\3(ZBIL C?72T&T&86O?[R%K(DB]<F$32XH4_]:71J&M
M-\%"FIP9 N5>9YU%I"1>^U8<5 5=M0W]\^E68KV":0@#=+2Q>]M?X[Z5R":U
M9HT.4PT,1X5L;R.A/*8Z"*TQYA;T7UEP3#=N3F^)OR,AJ"OL/%!-BL/CNK!G
M@$Z7UUV""G&MEH4_,M,;9;ZF_VC@RVB\9G0U>.5>,CG"5=TRAC/)-=8&$ZNZ
ME**:EZF8+I ?F"+U*%F[3]3OLB2I^>V738.:MQ9OM:I^_6" PL>1':+,Y*&Q
M%Y!+^;@S[:)P-CPJ05,5H0A4E '>QH#+LJ$WCXTF"A_GCSX)[;).#Q+,:1N)
M4F2 . O-[C;6SL_-&C?$.S>GW_E$7T0^0D:@SK:SA/6C0)JG$0ZD5.IM()6X
MA:^*IMY8YN)O#_(4;$N36U->DWUB+YE[44E,=M'/MKPED8JJ'0'\)0?\[D=?
M[_ ]+G2C=RWMW?VG1Y-J_3M^F49:T092<Y1T"W,%"WW/8LP"K16OI'GH7M@O
ML\BQ^_A.XD3'W/6@NO;]U.;?&7)C=NJ[H3HZ/-:]%X_H\#PXHL-+#X80G5#S
MO\AK@! #Q"H*%!#WEK [0:1?>.N7BB.G :ME8Z+K*VI@8#[PO)>P99)H^+ZB
M#O@0$*O_/>/=:\2VG^<F7"_25P/Z?F+PZC_EFJ?1LF+W[<MB$FS-?3!F[U1X
MBCO]UKSJ[)H-^A?^>233Q\6JJM.O*CEK;W@PB?H!TT&R(XE>*E3>$'(R$$V!
M J_)#VFE81#$'6 :0W4AHNDEQ%X&B)#T9A>A5>KF=(T86=A<5%#D]COE<PG,
MN=A-N;8U/47MY-Y[8?'@-PG8YH'!V*;'0IW!Y37E@0:6F&U)@AM!4JI4Z<>4
MD7^'1;SKKF6D@5FS$TW57NM;A>#^!"%SLBBG,O/'3M$0Y!]3Z#]8HC5NWA'R
MD &:,5E6Z+TE'0@^<W#QG/=1JERMX>P^Y0_"D["BII1;AE[0YD$KM$IY!@42
MFGC)HB,%LJP3 R<8(&5[+""]3N5EEU/;U6.647C8I)Q?>M YQ6JJ47O,?0+_
M<_@HC'0NYOIC'5'=%@ON^.EO1&34GZKS#SW7;CY[RLT2A8XYK%!]M.QD<M;L
M:OQFLT&"*B4M;:/$P$A"ZF;O[HT&FW@'27VM7O-4AR'=.9E9IQV/@^?;K:/T
MYC3K7BS1>(\?J"*P;8M0+L.7^YQ$)JG090A?V B8':%%2.+9^@U#5@#1CI,:
M8/3"IEUOQ0N\W=8#;'.Z85S)#(OLV(WD5*B+=<<CXL_.1]4W;0=NY J=M>>2
MTJ76O!-,P4CI;FC:WFRH3*V=% _4^:5[W5Y?XG=9)(^IP_)_$-/_N&1(_'2.
M#4K )@-4K; MM&R(C:)K-!.Y^K!QUL\UCP&0B@U=RVG%"@/#0<\=?_NQE425
MQ$7"H$Y#<T,4X?G=6,^9U3MCNJ7(D2:F=%M!EC#Y-RX@B0\@<U5#-G1=[UB5
M\EF6$R-9WO_P@:^)<'ZYM;5?>8XXJ$SX6F-;<<J+ZTCTX=!]);&X*+$!;$W\
M18.Z!6FSUVB!H7&LTH)!H(C+8-5%Q!-)D^1>\PSIU%7?L9U9]?J*=S199*4C
M[Q^FI3EF2JLZ\)XWI)_<(%H3D'$'?Q#Z)'#7E#62DR[JR7_X9D)IR+5GD3TY
M($>[VVZ16-L53."+W]3[FO X[<N>U\B98V'5UAUK</8_5LX)@[[ZLKILW/8<
M=M.K_@5F#_P2QA UC8KV^DUUP\5&%A&NX"A3,Z<$!Z8"X24EJR! [;(^_0)"
M%L@@G9[JE+/:^@SEHC(Y!R8?O#C':8#D@/N;35_^F+FFF+Q#:$WI@:WDB"03
M]$_%QEM(T96QK@J &F59HD\A 7E,DV<34IW4575ZEFH+O,(KL"YN6:'XJ-I(
MWWPM@F%=8SI];@S*KG5QI2%O4.]42G?-6Q:U1,^-Z\;<(_ XSJ2>U9LVCR1=
M2J_W&L#+E2^.FV&LRF&"!^X#:+QN 6WNW:=G!^X:'M-HG4XET?&<";/XG.VQ
M!?'T&OMY?XI+_GLA[X0+\=XZSUYX/? %GJ*@RL_^'RKG7<'RT6\A^("3A3.>
M6,$P20",#TLJ7>2$&$UHP)BB=;L1VR8-W9Y*0&KH$FX7R%XY=>9L4\(@RJZ*
M *6?OL-L+Q@=AZW#[D"6%.*A+*V<RPJ)R.,P.M@]5^!U5[-PFWLM?CIF-Q!=
M&V+3JN(?ZJT^OV5]KBC/M\S.;H2SNAGBV11IV4!3.+DR&Q::/3I8JS&5:!*9
M(STI%E>^T9<9L Q_@)$>Q^@J23?N-J<:]!>7&/4J"!Y(&&1E2S6G&,E;AF9-
MMHAOMV;@_2GFWPZ&A+KG-+,(7*<WF\,^Y6WQ^7@(6E6A'3N0& ]E%4FQQI;:
MUH;@2TWA-C/7];EKWKY85RJ#OD,1=<&S_LO8;:92'F.  #VB-3F.=*P9VQVJ
M'.KME*&3OJJ0A2?'5!EY!Q92U?E)0[Z\OZDB)U+O3E\SD86)#>:KGNS;S D6
MR!6,XKC:B[_:U/3XX\PSRQ<\U](RY#0LI0/%3EB'M]1YZ$C)J,J%SNK;MEV6
MD-0UBXM \WQW(L$<,6L-S&9M,F!VJSV=@T)*)> ^(P%Q7#?3?&./M8L"?7A(
MTO[(6<  9TQ"O0H,5C0Y,S._L/ =/:$\31)I]?TN73J09[Q44"3S9X5I)+P8
M("^%>77R&UIK/0/$@D#02N@J"!>B _A$(,V)BYVJ34(/8_.Z2F]+_%0ZL8V.
M4K(O_JCQR?_=Y^58BD-MN.][#,?3;$M#H0ATU,"JDY)/O8@C0;KY3)ZJFE^"
MBKZ_](:\>\6CO6953$R\3.?K^.RB5#.KFA9/^ZWF#7]*=WXL=919&)^I>L!K
M8BK]Y#3%@*H%V"^;G*5JD'#1&H(9N6!2=,0!VUBK5OY"SIVI&_X8:&\Y>?S\
M0NJ+\.?5%[=6?<[KKYW?%CZ:O6P,_VX%YF!/7?.)(/$Z&UQ'2?NMQF5Z];?(
MG6U=R1,P6B@NFK/_$99A"EW)P4,!J2HJ;U*O7=1[/ -T(FP>U0"-U] OT8US
M9K[G '!0TNFVXB\?_]3(I:>BW:>M?R<65XF4G[DW$#NL>T1IPVYOIX"IPCW$
M]N1B^.L>,!BR5"A\GDA/]?K=W( E"$%B7HC'H6T[50R#2CR:,Z+DMI_!'K-<
M'_'7\+VR4GMD**P'<JSVGK'B>K>MJ(2,7R?2+F+U>4J=B[[^0L.[] K%I%M/
M'WALOC,,^HUHG!XANA[6CD(_0ZCG?M-/.]+R-"Z3/#L8('8&R)N+VQW"K<D.
M[Z3H$B<Q/8&CZ7V]2"X%!?;9.4^U@RD4.4;C<9&'BI]=3Y#H:)^_V],;'6T"
MX0Q0J)T3QKG"O3FL&OV]+Z3(H\&J.3TG^*2X4)G0S+FUJ;4KM\55E])5S[P]
M/24 (D&S27HGUJAB<9C((:GQ-)F.$8ZXK@'+JTUO>@<\N-,N2TX4KO):I>$%
M^C*OUT;@I9Z;5AFW.GR8\]37F=5_WFSTXU!Q9SQ@K(UI:+X*L?*8WOY?7KS4
M>63'5P:HSKH/-XLEZP F!.SLWK)"-R2\77(R3+ZC<#/L$N!;-83?L6. #)6M
M=@,H9<5FNNG?6FZ<?]/QR C)%\;)K+$8IBH];!=U7-A@>CX&R'-D/HL@7^#L
M);^WSP =@4?WM%]M_UCG:I.^2Q[O.M3,NU51:[!Q;D3#_6SR)(O70ZZ-UFOX
M1.?N/XHW2E4;',.[AMM>7/BG_HU97-[-3K.T/*-QT]1WTVTK!ZX7GSV1G A8
M4.U'\\/G%G\;JB _,T"V=C+4HD %0)*?RH?%GYJS3F@-I-RE+^9RC]7E&,\1
M9*IBGR^JC[4*A09R>R693$:_J>.$&$_(N8J>+!=M@M[RN19+?\MTN/%8HF]0
M-S()R=]ZD2)!GR?G7F@EN29Y5=9AH\$7-%2=8?@R1VV[L[+-KI%4EP^%J%GR
MR*WZUO2I%[2*K@6/%Q7=UQ;LGWI?4QEN%1OY6=[>X!+9LSK;"^8T#O2]^MFB
M;&=C',,OG1HA/1[O*?W .%"$/3$_L1HCHVZD$2K5?\<T1T4\Q<]@^GD-3+VL
M$699U0*I49/,Q\JHA\=*?CCZ7UE8Z8,]0'9D6Z: /FO'MGVY",#U"BO3/C"=
MCSV$31L#9_N<.1)+E2@"\M?FUGZ&<MN1O% Y-XS:QG8J7#*L;6.23(2.U7@]
MK&>F;V>!<F<^; !7 ]XY0B+HFS'M (BJ2-(LP$\&MP_7 C6ARH21SJE>[[8S
M68Y-U;H!G%?$UQ)L.TOH&I"EB:I7*N#S2'?H7!!YBD2K&$83N-AG]/ T+LN)
MU9")9A*DQYZ".P.4DMF:$J@T/=VD^XZJWK,%S>&+P-WH)U_9OA/W3C^\AE#O
M;C7,,CSW\;V.(/P9YX5;]TSAV>/<DIVQ)68!FXVZ\:6F@<XG2@R4[,VC1;!*
M'N,)'HKN\YD%?JDI7A/+;2F>UJ6.Y4@O'#]=$2$%L"S="B($]7H+ Z[XOI=4
M%4_RT./N=JE)N;HVS2D149_>V%_-;3W=XX,\5^WM"VL'9=_$"(BWGZ8E,VOD
M(^HC=J>#%+6W!-W>(PDYD*#=0I!36V$**;V_.^TJDYPEHJF04!?,)O\W#Y67
M6M)_#B,+[(N[3'CR+86TJKXD 5)LU+,X<CFS:1+H.-RYL"M4=V"A#,Y%/@G8
M+D'9<0A58CJJM*&L?"MS*FL)?L!U?@;P[[H2,!Y0!K/O;OAE[RDX54YR^IPX
MK>; ?T[6&7N.>5<S'!R.,G1VW#)-NI_=ECFTL6BJN4UIS2/"!_5)#%"4XI:6
M:,31GQR>;A&)P4&L27:_KR]RX+^;G'15Q9)[GCWW35_EN:'VS[-S\5?A)PDE
M!NA3PE<*-X8(OE=7,KM+S8N*^T.4LQS&!HK$ZSS',=L34L,%16@Y%TVKU#2S
M6<_=QN8)>D^8,K+C"?81;G::7$5D@+9A))0Y4+ $C@N3F6Q5+03\'TQK"G@^
MQW(IO2:\QS>,U:LK7-1X?2]55^5&GW=0R<6/ME\-C"U>0TO=-J1%DYO[+\16
M77C3,3KZ^4F BYBM[3T7%]&KE\*UJE8DZ*>G:9EU>[P($,!/>>#>,/4 R, '
MQ7MIL!(X[W6I>?@#,CVF1L'N+NZA7A'=#TD:RAE:\J)15RM$M"]EL>,J&2#B
M'=1<GQ6MB@E=%O(8PI]0\=S[',  ?=8O05P$8BI&>)(-0PDC1SANHH-9BJV2
M T+U]/0%Q5.4 ^76^&39HC-]UHYK7$SQM;*6U=NK5JKYNL[E5.C1FZB&4BRQ
MRI,<P_3KUEU:V1@:?A H)3GLWE_A; >U*;OC[I:VH>\.KZO,;)F2VT,??*.]
M*D] 0D<1,GF;BV(D\1*7?#?!TSE!99YJO6C?BY6H(O?T,[>&5G=6OZ(?1RW.
MG5BT?>)WM#35[H"ZQ^1M2+TC$^<#IEO:F:*RX+/^/&N%4G3@&"/ +<5^L?^Q
MO_=2(V?0LN%6L+-F0$J'5P!P]PBBY/&GM/L_/GC]^1HG59;K*O#<5.?G"#@.
M';U>$S:<C7Y1;P<3+S$S+Q[WV%16*C,UPZ@EN>FT3X?R4A>2?TML>S-U.9@6
MC_0V20"?#6.E#PE?9A98@H8Y$6O0,JUA4N5 U9C:3SK2D  K1SKKE+AK*K0P
M0#'/T9[%'F+F]]V>MVW?%T_0:$UF%FD#&Y5GFBQ#BRRJ&T>ZX1+LN"*HIL@B
MY5KG)1CD><NRYY"4G87]CU;UATXDN;5T@2N-P534K8D_6FE\5?U5@%(7V66<
MSH7L@'AIWG!R-W)9!L_=Z+/KBU$2\'HKU-1Z"V\?TZJ _R&74\ %PT#M9Y5+
M&[Y]^68H-K!P_4^E+U'O,Q=PR7I'GZ*#[-"EB]+'($1SH$X!3!6>/!@!PU.&
M![IZK_>7 8G EHD[<5HW<WATW=[DE'N[X-F+AO>M7CUI"C]S>OUM4F-9UW<!
MO3= '%?LD*^-;&IT2:E/X=:WLLSU\W/ZXU6&QU8-<GC!Y>:E%?T2YYLU#S!2
M7>^MNM44GY246%94C'GDW&PS3Z^@RD'L]ZT@SY$N6$ ^B<IM0FXB\6:\IE^@
MAM03L7&!GA0CF=O$Z9X<Z65\>Q7!R/B0:#.W<7A*<+M,&!VLN",\"$>?4_23
MC45K\QZZDO_]XN85E6FCPX.HRM_"Y.FC5MAS!""H"AX.YJB*:0=3-2>I0<X%
M6];)P9F.1>USVBR%#-"S=YERXK8=B;N>P<M6YF!(CP3U0C2SOHBT)*0S1]7L
M2 \#5"N>S0"=:G5>#D&=T:X I/ML<Q\$5' ZYX[T"3IG0ALV4F<\CM^Z;KOS
M)G(E5R7(UE(;:?I"@6FH^.D+4*(VBA.A LQ-9:#.TB7"!GP&?<NWIK2_CK>:
MH#>"S.&>W1[5HC_G-WUL;6:&. ^:/).N/_WGPL#21B9QA,/9AWJM&RX]6]X4
MI/[5-;QGJ;HVS_!ZUYVT!;7Z8FNT0<#Z"3^++*^TR<F;"Q3=#R7355)6!6)<
MW@;LIFE>>/$Q=\4Y]RT8.&R.GATV!*G+Z#29PRUAP]LUJ6=('$P*&4D*(&-'
MO2OEGHS72YXRUX<%8K8$';Y.JSF5N/CRO'6R<2"XB3HH:QVC]"#9<43WH!WS
M,CB2X+W#1A& 5]FU)^E,!:0!>4N<0N:)F]!J *4[D=I%%QW=;QOH,XR%R0L<
M# [:=I\Q\DF0]/=;M$<&*OVDNG1510+1%]-Z_<JBB_#V;':>BR41W5H6^2MC
MIFE+66@S4X/K)<9&DKAWWE$5.S\ZT>5S=2FS^M[>$LV.F<QII=WF^_^7OJV%
M)*  #0FZ/GB;>0LNKY>YZ&4T]M9:.N=1!NAMU4X9 ^08)L0 ;9PZV$02X2;4
M%,@,A#[(U@NF61_R!KM2!5D9H,O0>6MZ,U6% 1H3V#H\'DW]IQF[S/QDQ14-
M# ,DHI"-W!^00G;X(9>J<(W3V^X4.%.&^CYSQ36T"P"AWDM(3L\&.S%<)%6]
MI+XHK]CVSK2FXP(YR]>/-"CEKCPH WMZV>?#D5\*?=Z :@BYMHV636>AR@!'
M2@V#2 L(3I<*^C?L!53'-T_^.,+"[6'KKK"SQ*'<C$#TC/V&:8U\ 1+I?&71
M0?3X:$'\0-4O%>J%[SW(I>(P6>?),'ZX:O2$[1W/P[A_QT.D2U(XF(N)=&[8
M$: /#>?NFD;QM%];]#QL3*#ZE[A;9>1>FI"[/$%VSSS1UI1H':<W]OB-'+K.
MR:[V6G#01Z.VIE('J;<^$NR^QYV[;#1&>#8>6DC=R3D%F;YF^?'=!4Q2U;9'
M<UV>L9*TI'&.S7 S1JICUN &OU.E=)ND5=H5M)R]WVIL6D!X<ZW7P.]1IRE(
MFD(XCNC+'-U,\'I)=;AS &7Y8D8O[6BO6]X4DXCN$E6BJ!#78#='H[&85I7\
M'W8+484/9>4<UQ-OKDKN"1S%?JLB<]-JPP3H.'"MWDND.R0RSM<U'V@0RN+T
MO-V6+#ZA(4&@74R9[V[GPV8JW5MO&MV;_:!R-K_/5R#Q"4B3C:3$ +%9A@U!
M3VF>"YO$'F^_2M7X5H=E]T ):K 5]Y!8=$<5RQS5NAQ(\J]+'=]H. >0.U0V
M&P4?S6U8G[A\%[ZCTW7#2"3UD$E3QXOAB<MW:2\9(#<ARGLOKWT<!\)ZNKX,
MIG@/4=Q:P<< F6+M[XWT\S2.>$0]9?F=(GWC2>ROF^LR^._+KWX.7^W_F:UI
M&EMFSV5L<;6NY%O$LEW%?24/7F==GN*)=[)W>8H)O)(&%N-KC1!9;PZU"9)Y
MUT3QIBBZ/.NYKZFO>\-*%5^J47UHP_0&%)!MI/)G=>*(QA6/%%[BCK5>^X"P
MIF&J]ATAW2H-+PYZ)MJ/ $'H!>CYGL;XX>1 SQ*5-X$<K/QS7@FLDZW]KOZ>
MH3[")X^"5\:VZ!PY3/VM!*J1!!0?%0+,+GO*L=V/,M*V^0@$$T,ZFZ>C-.1<
M/\6IX7!PZP=-9[1;+_^JDA>[';<&,N3^4T8QA._UX.I&=E))T;UA(I/B+22)
M'FA2V*6:V%]6[U=A$(-6$N+0*09C)"D[=#HN/RY4\V+V^9VW#UGZ#EO#OB!K
M1CJAL_YD'\"9",&O1VJH>^)QIP!MPSILTVNM\1U1DG))D/.QS*FV\N[J+_('
MG!X;A4WM*4%I U_/$)0LG+9'.#OIYU?>*_IJJ(<3+JPKOLX5+])4W-12>Y!G
MSBVIMG_M*MJ8NX)=46H<+6#D;U&B\A1]]1W"Q7:NKL0\:H#?)*1'77&^QLNH
MO5\>0_K-U*4Y9AOEM2LH]'"Q(L1H[8HC)[:@G%03_T+ "9*8"ZY-O4T"1QRT
MM+PIQS:VAA;E.0JO:R5_H7B3G5 N_ICO&C7W%F_;9/S;C>&U8=]P9R%/&2!
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MM^#J!+V^6WK&@"')>_FH/3P:'Y9,W.MJT.2J_N9=[BUAPKFAMH.+AC1,WV^
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MMDNAT+-=0?,GZ8\W/2]!(X[_K:^R_MIW8<_O (379$NJ[$1Q^+GL=:&-778
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M+-_S1V3IJNUS&>R(\Y\^,*0.]],/-2+,<J2?QW9H :^HN=<-M6DX2DP[B;2
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M(>@&*38WQ&B@7Z&T[UARX:9430F%W!;)+]!E?(9"O_)97;9#0[5KO,NN*K[
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M(WE2'P_LU?+ ?T>9C.T\#!H\ )V?_8_]J8I*X B>S/&"'D%U7_10Z_SBS[5
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M>-"01;'8'-;ZRIR!YB\>QAR X^;\XI]V*^%P3(Q'W,8;,C0%I=0Z=GZ2=?4
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M:[PQM]07^,VM4^Y9T3"C;E)@R^SP#KJ7#Q*PQCP^,_86#6)X50>,50';'WO
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MD+=GH>FRDD7[!\VES1;?\-#"J:9IIB6SPR",#=KKT?U%NE^B);:6&]%_LS2
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MU6;\,@9!XJ7N[EXC'ZH&GWH>=EA'7 Q3<$!^A\X-3QT@]%4=_5KJNQD9XSA
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MC-&&Z['!P@H3E5O5!C-"SLTQ54Z96%.=1,<$.1DM^?8W4X=+PI:I?G03V84
MI3EMOU_^DR,T5)WF_C3#![A,V1N"M,)V(U; ?_FYGMR6T@28U-;)GW3+5/-
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M(=V4KN_O*<_R3_N<O9LD'ZTI2-%?G7>GW'#ISK57UK?:*@-.O]K_:W,5V<@
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M)IJT#[4'OSOO&*H8J?.2[MFQHF]1EMNQ^!46"6ZMR,#_L7QLHAOOH_CA/*$
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MEQ=C6*^)$W3+@/7??BHYDU\3BQ<NARRD\F>)\+D&&?!]G#@8%'Y920;@M67
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MF^=E\8?F!<WB6JK]3Q-2VH)-F1<8V>*B7I<^%N VD8=,/&N2[]T6?O;%J%N
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M+?>VG.?DZ0?+,-]9\_QNR:,(VE>NCF"E=@Z*(:I%Q&:K+V MOY,+*;DN"O.
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M/(X?FE5 +D5[N,[4.7E\FT ,U.1U[S[IHK889B9P.AT4OB?!3>MN=#KZ"1U
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MG:0-,E+ZM;2-HK,@!GA7 U?0*^52%$6G^/4Q>"7B)"+!:\>K'%<^X?G-"')
M0XAY7GL%VF-:([AU#U?+ -4_5WCEY4Y*OZ.!2U_MN/6P<\^"%=*UC_+4(=D0
M9=]4-Q B?*N[*@/C/G;H6MVKQ($XNVU9O7>E]JVCQT(6HC\7"U D<G0A8>6^
M#?_YL>](+?Q5,!! 31HETE;AE<&SS\$\SU[1&DX@TBX;,J;^6G=,E(:@Q<$Q
MV*$WL'S!0,[!;OO=4,VQY"97DZT3'B0O8K.ZZ#(7@J1(B>RT$+L,:]8F2_1
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M[G-R9;]+TDO.(>$07:N@5XZ31)KOA%Z$+A;@1 +ULTH:V4;1$P? ![3UX!2
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MO^2?=UH7-V< (V1 #Z+37U)2B%?G1Y;F)^&=@CP7<07R^C),+0!9XP(%9J6
M<\V1+VPC)V4T9EL*-!W CL]5+X%^?V;^Q]S2=U7#H9YNQIO.IHTO2<SGEV&!
M%-  (5(E"L;%SY9AOBA0SZP#&0MI"-)<KW SQHRE4#M_WVTJI@:MC2'LAQAI
M?%&>8^ Z>8/SE8.&VZIH0]>QOP8E795U,4=ZYWC?]=75S5:AOMF*-JZ1R&*%
M)T2WP.E_9"-:(K$L.9QM"ZNN=(Y\8RF6E6"IOM\-].;.MWYNJNUSZ=!8E\K^
M4.GVZ=/TL-GMXL:*_ BUIDMUP)$]P<<>(WI\_B[E_+N4\S^EE!-,%O1 43.,
M\ X!G+%"-#/A/%>@JHL;EL,V//KS/%!+YGT9?#I=/PQ$Y<Y<-?U0?/\E@1>S
M)5"/-O[T#G*]K4AS)8C=D$* 5TGPOQ1OA.:?CXGY2VGJ%OSF)Y<?H?_[(-=#
MTD;4HK/I), )/3++#6]NA"M)&/0UUVD'EF$M%&#/\.*-,9R/R(R/;M;6Z"V*
M_FHJ/);B73BS%$O=,;:MQ%7!_M(RK%@+;P5$2F1:A1IX*?$S@A%AE"YK+3\"
M.@D>@-\+=-.XI#8<U9;+.SK5-LT5$QWYM@DQWQI*FB(YXV9"E&?OK]G?]*J0
MO(U5[KMMJ_1"+L'O(]E5". T'"X9H -V:8D0<W9IILL49S\!"M_<1B1(5N%0
M)[/(WC%>H%WI(Y$!9V2]J\9%;#FYJ+]@W=J*SUDJ+]-;7;X019HK-XVO_2A>
MV4P8">:PYI*%SJ)CP/Q<*W]><!CX$W1Y 6*X-C-+E@0#@'AGTM.ZOTT0'MZ
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M1!3C^B9V&3GQ3#68Y?([!M35>B%7!.S(8>@Q?8G"WI6;6R2?T.L-0^6#!5<
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M<MJ=/0)O8P%8M$BI57 9]!2NQ>\%A?PN]N(]ZSV$'E*M=+PQ)=G:E._2AK%
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M=P%IZVX[)6SRU.A\M6'MSPL&<.#^*\["05A5#5%1ANZBK9>U5YM 4<+6,<F
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M1[$\N\C_X)!)-FM$02[RKK>W7S=>LXT#7N"-S1?H\)$^Y?"S<:O;"-XD;O.
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M%F%?2%-CA4JF@*5IG]LW'"\D8?OK#.\7#LV:/H_4[@TW<S#ZP+U*L"/PKQ'
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M;?!X<]C1)&_.1'6.^*GJ1/USO+( <C:M/?[[Q>D?U47F)4N-#UQ>YW'R499
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M[7?9G"F?2KVBH^>"C^V+?H<!W)ALM"53 6,L^"_["D7)X[U4[7H/M3A!4O@
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MS(SRD9IV$LG^ 34P\,6+)/*XD1,H_=C5I6O=?MYD9AME^G-1]^:<B-P>W%<
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MAKAE*#)>WS8Z9SF$=M2('<D96QA#F-EYCQDF72?#?'IW$2N-/$.8JWS);-%
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M>UH5P[\F5.1=PX'D/5S;,LE.H,;39K^P\-+!:DAP47*6VM54'W)9^#ME69V
M3%&'KAE/Q+\+JG)?1A[.]PV\N9?^LMCE;G11S*X:R0_D)#$/#(B"U8$Z0,FP
MJ!A<-_@R+616F,-XJ)2JK#HJM$@3 E&^%@6/7%T;S[%HIY3'I9\<+P4ZI?3/
MNMRR\-V-62"]\_]-F[R&2AI3+,/7E#SOLON6,!=LS)?(W>A^:Y"@ORDX;HFA
MV8=M9_GL-]N?Z".:S&LRS',A#EY& D3F8YL?\8*/%75<D,?=,^,9XK]]QDE!
MCL"]U(^O[[BW&KO<]1$E)=OFC$]#SG299<2CSB0&+\AOSN.-:]KT+8>2N"L5
M4WC;-!ICC0P3,<@'OE)1"K5(DP<[XL J&"MM1;D6/PPEPS$LTN1I&28=Q9 \
M)40]> O0BF;?B0C44'I[/Y.F\6CB%C3BX+I1Z0Z-1X - ,I_ELHP1K/?='?*
M,$JM+V68CR(LL@3/@5((@F ()TE'>5B-W*P,H^;!^83^V@:UX&I->/V_?4PH
MK0")@#CPMCH9YMX5(#?#C]F*@Q=\ X#74L3^)E [!1)F;= \&*8T@1@R( ^Z
M/#(8#8 [T3A?W\WZ]F]Z:7./,W@'F*\R&J'+0Q-[!ATEA"HH'/Z"(PT/N>9.
MH?@#0R?Q)@$@\=-?#S[SKZ0^BOQ,FGI#D B 6L;_+W-[]AO.$ FEZG4W"-^B
MNN="5N3#(AGF)2X9S8J\3\'R,)ZP4(:Y5$^ UE3+,$*?OQ9Y")JS->%)!@*1
MP,S7<4@P"MQI>,AI?)(UIXGR#G  BYR:0=(C_KO+%V2-APK=</% <=/X<C#J
MY5,_4VJKT+N&$TV7!Q];E3,#LH=_'44,P<;LK&&G$:T[B:]UXE/[^W:Q-<\G
M/-WCNBN>[2O#V+IA(4LW1/&BOZ<7!1]!5XCQ'S?FW\0W2"R<# YE4<HX1?13
MSP]B+[8 >49_)%CG'I 3?0RRQ\;6>6WWWWZD\7BN![M[BTG5\^'=MVP2U-?G
M-=VMS$GK*W/?/GI*(VC5T;P)]?;/L6X]E7TON%+LU&*4Q0<!_!SF]$98'57[
M"V\9YHTK0:C#@S;D2A4Y<@1PXH0,,YG$Z1C\-^K\-\K8A$(ZH>4@<WI3\]R5
M1^D>'D311 ZNIU2&&?Q,K)L;_C;K_2T<J+?F@$>(<QIT14#07R+#?#;&B50F
M8/4.)((4QH2"'LLPWQQ(PU-_3\M /:65,.2</"TY9E-5Q1S@[998,&$X'P+<
M";9C,LR/%"@J"%%$1;J+54.$K;L .#L3T>M#U9X"O"L 4:*D,L.483:0I;:T
M?Z/F?_4!*/[;H%1Q$F'ZY28GWX9#AX"S'3(,\RX!.YH[V,?\HBS#+/N*FJ,C
M8>@8A,*BJ)!6&>9.Z1^,#,AM_4,?D&&6<VQ0J_(@=8P?G9R<!!A7L&-<8&HR
M5R"]#$M*X!K.W\J=\;?C8DU_^WMQC/#7FLB0IA(1^E&8\(3)# 3N6<*[*]'D
M8X;VPIF?B^B,$I##;7\XL#*$:?M' 0+>"T\A$<$ L>Q(<_-K9,<TH03M7.L;
M9M1,Q]37UG^"0:%CB>:E ^]8^&'QH^#@8$)3=938G_#MVQ$0J:!?Z4%^X?VM
MZ=C_P<"ZYVA_Q[MQ(NVIUCF-SU+;3B(>;P3-OD-:<F48PD8ZKIO86DEXJ_U'
MIN/SAT.388C,?Q7/ORH>T:<'HUJKXN1R\S]__H1BU;GO7O'=*[Y[Q?_&*PI@
M%?09<D#-7GB!J(0_R["Q%S#"VZ"@&H(:K"!L"7' Q98G)^=G4D,;M#P*\U^D
MI0P-=0<Y>/N:[CSWI- LPW.ITAG@(?&OD JY&_XC Z^VCMW6?]+]B+RS1;/G
MJE].N:;A\H5I&LWN[7</!MCL..\=XO39MY';/]OQ,%)[9.2 FO_^G&\#03DI
MK@[9B"3]/XY;-";[_P9B#+_X[XZ*OJ/.[_+]+M_O\OW3\F4-5B)*!(D^[">M
M0-;1E$3.*&S)\0FJ(-;Q%D'LG2)M:I.+K?HSQJ&NLA>VR.MSA5\+O<FO',M*
M<TX<RHMUS-MIW#0M^'LQ=@96:.JD60M/:FJ B)O"V6>*+F_,].\)/38M$234
M=M9TB^_X'JH[Z.C$.M)3YKK1U.GVX?T-,'O5A4#GII.$.,%C<<X&KV?<>ZYE
MZ8NS+GQ(I^FN3=K(6.=ZD[62Y;_79K@]V<PMEKR7T]J*K'XA"9!AWG% =+0J
M.FP99E,>"AKP]#Y@&@]O04TCRA_-BR,RS$^M?Y 76?VH65RB'4"E1UQZ&56)
M#6D6&#%%=7$.=D;6$5'A?I,VX*! ],W44S0G$Z!?9\>[T4R*MHR#MP7RX">9
M?]"' NE"FS_&=;_Q5#E#1^IT"%^PFE+>W U4.ZE8Z"Y!"<W%L^J H!=]\WL=
M#,LP@F8>FR1%/RX%0$$O,%G!^-MGLZ:7_GWP]<?C(@B/PJBA,#^BOXDZA[ZS
MQDY-_9'("'_3 <X[T[\+DF):1)N0")LM'<@O(@!%*WFMJ*>@$HLY G(0X*(]
MHO.4 X\1_F&-92)&EO6L.76PB?@M'.U!$))IP^1]J?NNK._*^JZL[\KZKJP_
MHRS6>RQDX#UF)-F--'#*SF:+X@;2;POB"')]M/4B^_",U%JZGJYA)Z&\S)]4
MUUV^C^M?]MM6XX*=N>[WS_^<ZAD0H\@TU9][^_>$#CYC#J.9W*WN&V?IEY[C
MNXH_3BQTQC=6K5OJN/1 Q@D[QW<%5C,9!W,K/GIM/++_Q>E6<A0]P19WH3HX
MZ>+B$\[1'J?NG![VO!"G<?_4Z*D^OZU?P@H/;%,\_)LVE*EUT]_?X#^,[)RG
MDO\:,]*GOD/<_RLA[G^*?'U?BYIJ5(9BT_7Z#!(;G[^C_-2G_\AD_\J%EY;>
M?KG*Z)I'Y?\BEH?_*I87U<=0%T11Y>I3,LQ;6T['NS+B( /!P!S.)T2&T>-_
M^L%J&7;0P4[C2])_G]*>*ZL-P"\1 UCL*%U=M/>NUQ.(4I]R#(EB^53<4;J4
M.U*Q-Y]LG)21V_^3#+.YO#NPQ&%IWL4[E\)4EB [JPV FD*"*K(<]A)%,5"U
M)>- )URT#%-D=)6NWTLV:L0IL4H++S5:[<B:*YOZ.06(_-Q6Y2#(.V+7\;B\
M9_@6.3 EAY/SDN-=TJ5_]8TA4C_T #M8@B@8RS"+$5@'M; +\!X187R#R%X(
M1!/\>-S9AJ>MY$NBW*8?3UX3](9"^@R7Y+KC5FGBPGR3@L=W)RD!\6Y'WU.Z
M&K7)#L&G79J90P=CUR\4C2**K/FM:B(2K*$X*_:#_(6<^*3^1=*[MEJP(QN*
M$PT*UB5'!2BU+J-==-PR_JF-9FNS?T41V>O!\-RE&OW,YAS2ZR\>??L6BQ;$
MS33;M96VJ@S->80_[.D=YNZ-R^T9#O&*R'*J\?<^=6I18%?YN]VJ61?MEFYY
MN';MHZL8S/$T]07P>Z0+]1%B;) ,4VX4-W^IHZ']>!D+J"$@VV%2Y%SS0$1V
M\E4STFIXARC@14-"VH*J]BK4755;;)N/<3@ER<<[GYB[E'E=.2ST=R!*-&8:
MZEMGB;!J'2HOD(TH% J8.&H"9>4H4X?CATNP>MMO ,U*]D$].E4G!EI<A2-D
M\=.2V!-?W0Z\,YY12JU\=:Z^_6/+CKH=G^N1HWH$-Y]_O,#5_X37?^6[:_ZC
M+^0G K^8!#I/<+N;>.6+T<B]B(HZG\.N<8DC='<O4U0P8)ZQCT+7E%9T[9\P
MPRKS/IKPE'D0V3ZIN[YZ@R@K<1_W6-GOJ9Z9ZUHZ6U[?6#@W6"72C)H>7NH:
M69GI\J:P*+/J_5CA&>?&P#OIEW_Y,.B[JFE;@UO1^]+Q@WB"(Z?XO=[PH$O?
MSJ 55VQ>&21:Z\[ E^%M,DRX(PH??8:-!TC0>CRLOE <!4V(<NL?I;!C.^IL
M]3I/@PFWA3'I.X'0+++M&H[5E^KSOYR)8048XP_<7A#&?6# >84KEV%@51:B
M*(<.RA!$8\KX?/'4+BF[>B-UD&]9Z_9%)-^ NTI8_K5,^T,IH.CN%WC1I$_7
M.I[XDX@9X6_S6N7%15J%8='_0]Y[136UA>&B45041*0K"+%05 2V2E%:5 14
MQ"@J+4)$I,88W0B)$A)%Z0*"6]C"AJCT&@5"E!9* !61'B !4M@6>J(8EB19
MG,4^=XP[[AWWX8[S>,X+C,%@S37G7[]OSKG^/^B;=W>0TD?G\#]@(%!F&85Q
MIC4FN;X;JN%$.=V*5=RT,.?7^/<I+_^#WA_V]^S\LWQK_O6#[G+Z.TA0 F_9
MQ^"] -56CP!([11%1BA2>2JC26=8>AR'?R%U%F(K!L;;^?!X>WA.N:US/J?G
M4 &S+FS<6=QM>'?RM-' _,Z(=5]2?_BOP-;?'PS?B^#-* -&E__2SBU8_Q>H
M*OOG+.M6J-83]BGGY*8#JM[L?:RUZ- $,E[RY?)I?#$,1HZZ["X&.UT?5-)T
MNEP4+^VGAD7>5BI7^'2K=."<J*,@54%Q+5+.(I211 :L_2>#F&BV_*31+ 0A
MUL4".H*D.?D.= WZ,9E_5#06@=,W"=\R54..8:6[!-W6'7V=Z5$K\IDH4'RP
M^=7GH=XSO:=*U\@H7FC/:?<I?)&O-Y?]WL?MZT>!3AG^^K44U6"]4R-YT95R
MJN4*_VQU]*9..H!*IK+"A@ ^5EE<!4G(2QHP-&=*,@#?D]5L RJ >^/7&W/Y
MBRZIVWI>2$\\G*,75_DX%@'+80;YR"]C;3B29"Y-)7$%%K"X)B9<D+IYI,>@
M8B&^QMCF[Y11[#PMRGZ"P*G4CT4]2MMB<^@AE,+YAX5DF5*N-J26^<P5V(?+
M8"A<;P7F5Z$(*IQ>@<D? OOA5:DI3<:$)7[1PP:'$H#*Q'OW/#*,E#GM(Q[D
MQ=-L4#HN-I*1&W,OZG*WL=Q30SNLJ@J_12"JD5#>ND;J^J)_:;6=0LC)B!3'
MY!585<V&'_]>#TAQ+7)O^WWSLEA5;HY]:ET6#/QT8&$V?*-C!^5N2-2:#J/J
MM[%?U7*=]&/&MSCO47+!1P85-2]Y+$6PW-],?GI7GVL<O.=#,]?\<UHE$D(K
M62NP(VCVX1:X\#P2L*"(LV0YQ# >@_VT@U+C/'M0=-&W5IA;GP?T;5^<NB/1
M=>J7M(.J#<++7]^4<+Y/F,2U]DY@]-2'[VS*KZ8?_+O@N8$B#CU@)=WA.MF(
MZ*0('1C)7%5;H\CP+4\GD?)2*U%L#!X3(;R2;,4\Y#FCN:NH^AF)7.W3\?35
M^[YJ^>0VT^,P&; ">]33 L4G2P(&$F0=>@5F<'&@0T_U&>N(]"+_@WZ$0GS6
MQ-_SL^?6EE;T!5XCP-:>GD(W>TA5?H)*S-7;V+P7Y-?R+0AVMB"U/3755U<T
MS-S6X*!77T3 M/\T3:D.SAIB/=O!>C-V1C]I3H63D&O[S/G)JW0MH\7#'5QA
M4-PL%#0WCDNY\HC0'K8#?YA9_T?FA(HH_&N-19FKF4>-(<8A_!J=]30J*X1U
M9-[4),BEGN#RX<;FE\=A8.OE9T,^VWVV;7!WV^Z%W%FV]OBZ/S<>L3BW KLT
M8%Z<@;UXX?6 7\1(.G><,\I<>#SK9:J?O/W-Y][3G4>H B2XT4""([')U1Y2
M=?QDIE0E3CP")-P5I1'5$,F5]IJ Q&<(%S[^Y\1":[KB=T85+;+H;3VE96*_
M\*,]W:]H.KTS//_L!X72!4(FF\S[&=DU8S9BS#.OU5IB$SLG!;LR.GY\[7N.
M/K'7'5GMHO7/_8.[#,9*1\+7-%]=(XL@MP;QH-2@8VL!Q<QQ"&*G%_]_J,)#
M."DY0&[)8U13.G&CU3QD1U2DN%/V<K$[3)#92EE'^.DQL#AGY811-'%F+BME
M4/&8P*"ADQUL-J8P>H_1YP_; K\D1W*EQY,DIBNPOFFPGP(<Z"7_QAZ#CP9D
MO/0K024U6B]_!GLS+X0'A"D-O0O^K'_!7%G_^DM^\XT2'H_E '2V[OV4*J!N
MV9.G<2<J[*R[NYN#\;ZZ]5ZG=D:O6;?5"</O 8RLI&HST,R%Y]"C6BZR-*F2
M"-X!5[5%%& F[(;Y(LIC7FT24_4*X:<;Q>U=S-S<32/ZUBDJXEEHV=Z)DG>M
MU6^HW]HZ$,(@C]F>28064-VAQ:@ES^EB[PIZU# 3AG4T^H#YX?7ER^(R?&D7
M5NYTV78]G;NF[&T3#HU]<HA/KC"R+USX'$" L3U*9-Z2"X2>2^D! O26T(L5
ME3G4[YE+Y[:GL[LNOZG+>>;DE;'-*-U)X>@U]?M'CU#Y1F*(8SST7;WON *#
MJ/OL;Y&.^"FP(+E'ZLLRNP_N"+:ZUR"^QFVM7>Y)^*7_./EP:]/VVOKA7=89
MC(J);>6S-WC<G1-+A_9S6LP3?B"DVEZ2M40,D"JY2D@"%=9H%@FHRJ1/Y(W(
M%*D2#P>XDFD>*.!Y"5#8[X*UM+/8SCW50!-^S?##J89:9FI9IF&V'*C0O_OR
M"4QY,;Z\7A;FV)^?:'+1LW]Q--"GMYU<[.WU8?\\IT[_;99E&I[X[IC3O+7(
M^QGH21%ZH76(4:N5V\%QM/ "&0IC\K;^D?"6'L!0ZX$4@2V:*HN,\@_-51(V
M543Z3RH"F2YO@[6N9'=&3.Q*W^>YH>[UZP=&N1ON_]V,&%R@GC'^,0QN[)3<
MA+*X(KAI2&)'ZKT7\Z6 FSQO>QC^ -Q;\8];FQ*#25GGN"%9\,BS\.2MZIX=
M'J6\;?F2"P2?R5UEO_;_SPO6QI.I"10Z)-ED8:0X _"2P*5.0'L! 2-^# QL
MS>93VD(6D>H^7"#7,''Z>G"X#^)D?>\!?&? G?.A]RK2PA3W1[<?E^A!@U6B
M.L _>IO@!)MV>VN1W73(A*XP]D$ID(IBI!FDF9AWZWW$S'3%IJQ+#U)ID7OC
MF8>_X7<I=Z_<R[IZ6E5,I=E-[)S)P$)/N'F$L$C2__%]4N\OO_[J&PVG^>-.
M?KBB&;:)]%N^IG=!\F"G[6;G=3^.?IB<'_[]F]2CI[GZ)3F4?GHARA:,C,\]
M)"NUQ4MV0W^QM]<C%,+7!Z_ -H,ZH=8Y3.T<YNE2RZ20@N].47M<1*8-R\%9
M9"V @JI[[$6;*\BA/2J+_U=RD0GY2W!3F9!\;-@V3*(*C>3$"(;'(?3,*PR7
MT?)= M@=G!+F7M5=MZFZFPPJ(<@S"N/T6K7C-Z-Z@.:1_&7SC;^5/JZ1E?2A
M/^"E.M#<UCO+RNPM ,GDDE3-02Q)EWC)2A#7">%NMIC*L?'I7'/1AB0^5X4#
M^#/9B)1?A'XLPHUE>[ ,/?7&:R9L(@?I5<,P#M.A/3RRVJ$J^A,T(R^2#O33
MD!PPPTAD=SS'3I(?ZUGFSK1"* /<K@.8H)CV^S&G];4[WIZDW*!!JI#4-X;.
MLS<%/8L8]<H;^[CV/HG.#?6.R-Q*<1L\4//]='/6\K3BJ83)!P;,M)>V*6MZ
M]K!>O!XV=[W\W+S1WV7PN?WR2*AFYN-_@KYJ_CSED7)7+@4#W)$])_,>0S1U
M 3B :$,ILX- A1X)5HH'_/B4^&J*)M%"ED7<I5]KR=:*"W>NKJNN'R1:V,D*
MT_A*B,MO3E*0?2^COUU.4&KL>'$M[8)R*3$4<OBK)$O2QR8=%G@06J$1 Z?,
MEN,/=R 40P[.>.-:N:I 2F246N<R*W[8HW6=R*2R,"FD-+2WHO8IQK]TZNF4
MJOGMJ,*OV_Y-\Y23N+QB/*<".SNEFAPFF;Z^,XEQ#<TQ:EM"*T$0$EW]):4$
M,^EC=6D (ME^0'8^X.%&ZPVON&ER-,.BG^C_*E0KX@F0[>"H<L4Y;$M9X?.K
MF%<4*EEX807&8? SI6I)8D>@1.(F/9O!GC;;$**$Y?4HN-PVU_*U!1Z4!O:T
M^BI78X)OFNX&AX?RZ;$_?E\EW.' :]!7#CEN"H5)4KY.LSYJO6UX%]T_<?"Y
MT;NL([N.3__X^#[1OMSX4!<S5W>P4',YHO$5=TSOY'^6S[P7_R+7V4[9D<HG
MBT_(_B+SBKG"VV:/: AVO?BSK(JT"^PBOT&F_*HX8Q8+Y:46_S+(]H5/0Y8U
M"S9'#.]Q>6?ME&D5,U_#J1^WAN_P&9N^5TNS57/%^JVUK4K- XW)+46]1%UA
M=R>3 1@9S35*CA,U9 6V>]9_+>/K<+<"91=<%9ETX8'#4W66+RN^#[^9SM4]
MV+.Y<-BMMF;0_^>\QLV*#(.?Y^4DQJ\8S\P JX>@HHT(+VX:;C(FM<#IYF(6
MHC9U=KXN<31T2=-*VY<J0K3JJ0_ZK[9QG _G6-8FLA : /(\Y92/T_<S=+U=
MM"&G"G$P6R<++ O^7V)CI=JQ9053!_79E05^A0Y[?E_H*O9%C;;K9[O<#3'X
ME%9F/Q0XDE_;>^Z/366_I"'DENGAI67\K(;$!%G$Y7J>(6/VIN6_:7A7@W<0
M/A5LW[>+GH$X>$ANW=,_8Q5X&\X?DQ>KK, V41ZNP+[?$ Z#RG<8X)FRC-P]
M0O'+G8EMOGVX@L"-;]BA&5:'#M/'CSWY/.M5OW>[70Q9"0&!<ZFV@<26&"S+
ML=]$]!$9S;V4.'!FN&HD;8)SY[V*RNR\[T]&O'R (B<:Z_K ;+^/WQ?+93+'
MOEV]G_[\UNM-8\:G+ETC#4$*QB#;N2,<'CT)$;P &!7-<41LW&.$_ %]($TK
MVM8%#X^9A;@1?V-E>+*3Y/3PG>202?KPK/E;PT@=NW,=D8H+^LT_3_;?_?,^
M^:Z/-2LJEYH_?:AG"Z5D:GC .X?^Q^@$Q\?EYJAQ+8'W;&+/6PWF@W/'=3&_
M.9"KWD'P2M J9%X^Y$"(QZ\ 28GW-*,&V6RF,FTO)YJGK[-DA1'H3I1S6DW;
M1:[CSZK5D\ZG&[[KI]G$*&1FLL/&B[GF]TE7(#^O6*(O(>@,J4:'3:.S6V.*
M<D+FU#H/=O*OV5O[1& -$&M3EI!N>J5X;^E)O]WK''<$OX!SAOY?7]AKS%--
M#EQ-GUZ>GOC,WO7\YLVBQ(F-G>5/SW[05HZXNL_$S,2,YU*F4X;A>!T_.,9&
M:GQ2A=TZXZIH>W,-[YE_-VDU9W0L:6DRA,YDSA8!2R#H)S1H!8IZ,+<M:MYW
ME:#2:CWUCL*.M.W%EA\J5TA7@@.6TP+!#+AQ3K+GBL^5L?$>L]APC_3(^H3*
MP@BL^Y]X%YL/N^2.7!ZG:2D\N 2#(>X$_S\^PVJR!"! M'ZM+,W>FM2W MM&
MOIX:0]ZV2-4D]3)@7P;]@&KA5\Y)D6,.!$"O]X?O-4]VO&GABCQ9U4L%NXK'
MVC#[^L-=>/I/KC[;?$Q^U'QUG]3[A[@'^6">.C]W ^O?^3SL[FV-FDUO>;BL
MH%/#1@_>Q2+7-I1-KL ZD(K@YQ687),I$2\JGW!^1%*66HO(3)R*:ZW':#[!
MP:&1M7#:4]4K_H_1*LK^H_H0"OZTEL*;$7O(<LB\5UQAV,0;49OX&? ;@E-+
M8A]9G')*I52>9_8(OCEP\)?=6A"YI<8J[DROU"*L.$3;9*I_9Y0QJ(I6G4FW
MSRN9]GAR1OPTW_[$??(+'TI\ Z+X;1)RV#SRMU?M@8A[.<\&JB<C>I^<FT7A
MNFLV3_YSK=88^&NU0NJ&'.E98 W/U4. D*IU@0IPR7&"ASA62$P6(-=]G] ?
M_"JDQTJ/EWD?0'_O]!%.4 WF$RKL\MU04UE)7F,<N[86#6'B^,D^63TTUA"Y
MY1(YV(SCTLS0)0? .7I>%DAVD-AFJ(:L% I:-$K.@KM$\P_LYAM?^?@ '<%S
M8+.M*[\;?1S\W#3(Y@>*-C:FB*YZ[7P'DUM.*=5:KLPL<'H:FO4L-ENMEID!
M_ICX;$54>Z,G.#64#<MY\?3^.6.1/*B8#6D\H1?!^XNRQAP-.-Q1Q,4S:/".
MSD&BE? P_WNZ34M \=W ,> ;,\ND(;ET'""?K0O;DH/!8G9CZOX].+7VV&8>
M:3_XF2(\ELJA@@I^4/1LX]88235UQ%/ ;[]B8.:"O;UP8;:3[W.!XRJ\^;2"
MW6.?C2DSK_O'V^/APFQ>8V 5]$S<'<E(C61?7NV[1M3?W[R.(6I1NACGP<_F
MXRC7P7/]P!L&K=Y&H[;ZVH27_67<7_1C8VI9_50!2OP <GPL(I0[$M=F35EM
MSKLN7E;'"-9%"!AM]88L<\:#7&.11C<M+FFQ2^/I>=:BDKPW?;"@NFF0>$P8
MWQEGT7U(U^ARB$%-!FCX;@/C(H+WD"OT_L[@%4S(BY M\-2Z'0@EQDVS^ZS6
M 4%/-/M3L+CIT,#L3495I?0V?T[;24O;'Q5ZS<9,/3AY:YS3H-F!]O(!CJ_C
ME_MD!]J)%=AEB&"R_F^".8$:[8 (IL?;=(O 3IOC1CL$C UD7B-:Z'6*P?L+
M<@'BOD*I<=^BF1X(!5-MFGX_J$:0=T?5OR\W#W@;Z>K1:9WRU&\'_5XR+?GC
M"BSH^_*?Q:GN+*\;_P8XAJ&?D=>0>??)M<Y2=0R?]5"T!"K())'2"%8X(_X[
M=ZNMG<2*H.PY>$!J#'DRDQW5]/*%(V&8'N&>M:7BE7-4I+QT][)IJF5. ,Y\
MJWWATODQ' S\?, B><^E<=GSTJFZE*$Q[M4F6@.[OG8>5]UEJ(7O>MHQ?SC7
MV(GQ"((A-N!&?XDWN64WJ$TH$W,A<.BVV@UUA[QT'U+954")AZ]K""CQ#848
MTD/SA)@56+Q!_]RKNG<#1(<@=5?+BC* ?'E <+IBKE*_]I_WGM3%U:*8KM P
MI0 :5'@GV16"T"RB]1.M1-7-F6\ XTGJ _.2PG2N@^BZY@>30OK5:D>=]E=
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MFQ/4_V FQI?"-*2>Y)8.A/ 2/!Y1$\3LV0PI0X/!R\73FVP JHARH5]J(7$
MBIJ'#X5:WO.E5**S]P@+?1Q.H?)P.(V_K1G,KHX5F,. .2;;9M/7TR!'%48\
M+O&1A@"=D&J/DUO.2HTD6F!W709]]?"F:'94\%*@'.]K?>FT>0X.V?=+,=G8
M!\C_X8#;7.0NLOMKV'<;@,V[XF/-KGP5'EELI'+&>:E+<I34@U9 !)A%H[>0
M@QC1>MMJA>352V,3>G3AMY@[-OCTP%CV48-W]0T-[YYEH1J=+PV:FOXR<9IV
M^K24>=&Z_/9?R?;0RJ)MR2TFI.VK!^XKL.OC<CQ&[&0_K2=Q8B]*64V*!YX%
MW/R 2);BQ4C34Q7SABDV>7SJEH1*\P4E[W/QO5XUZ74)-_6I0\LP*12:H^M(
M;.V@617(GW_+\AC!SPOH.-7OI(WU0F[;W"$7OC^^%%CH2&_CXY0-_VE.,'C;
M7QE^D=J]0__4@9KL$H<UVZFM#, 2 6ZB%D*A.W(2WVG&WC"AK (D@0J^1)](
M022JBU 9A% PRH;B0$X3=;TT[/DO.R3S*4!GEIH2N^X>^&5WZ**:;7JU- 22
M=02I#SP K,!$:+$+-#ND=%TL64-Z3A3W^ XR?L)$6$FI4DR@K<"V'L?S%V+O
M*7T9JW**9BUS/09I4VD_<:JC[/$S'X6[Z4@A]$^\!6HT0TFJ)$SE,UH8H_BV
M"3D Q\=JM>2J]<W9[A$F[Z[N,U?<>&=FYQ>+ZVH^/3O@(4WU :H3OMVW\98!
MSS_ 5HN/\J4.+ 2/0A%>-.-T@1M_B?9XLFXT6,DG$2\+>AYPA9E<![G0Y<QH
MVK,WZ%G%/3MNCUDE-VA$&B6PYML":+/>1EE^(==/,,;MR'\AYH1D'I7QQDJJ
M[BR^#BVOB-QRDJ0+7&SF;J4V[02,SM6*@MI0\$T< LYGH&'-S0SK%5C<ES[B
MT2B+*B#.3:C;44JUY>?.6H^?$IRZB)CV$T8**#'V1XC[@'!17/,P^:8PCLG=
M $1V@+KO$%$U#)60C.6<FK UK6.HBL[1^?.WGK;O?CQIOF9*0T3_K]'*%EDL
MXSI9*\1W[6I!^%!&-'RM-*0R^ \@SUG8R63H!4]HLL+-MHRA?:=>SUA&>#\6
MN5I23,!L<G#FWD++W'Y"R[B.QZC%;P_)GY!!;B-?10)[Z>UP)>DU62E):\;>
M0L2-L=7 "25.@S4+6J$@/!J^V7M&.[<>%V22F]NE_J,-@L&/2V[]3G/_,@G?
M]T+Y"QQ4V",AD9AH502/OUKZ!C&WG8=D4WEQB> ZHGG_?!Z0) HZ*6JB%!.T
MFG\D&S//Y_L:#,\U=)G8?4F/##_[?EI;8)"6E@21+U_N%L@**AG"LX@DDK60
MT@:/1=.#9KLGJ?&^-L-W%C83K%HFM@-%_.Z+3#T#T9:*6QEU@<EY4ZQAI-W\
MRZBPW<>Q6-6:]/<?2S=92$^ 8URA<^K(85Z05"L5W#0GT98B@ "J)ZF'"U\<
M-00HO!GNMNE[#Z?36_(Q5)VIK&<?+2;2O6;G"OX^V9]@E)RO@W^"*.N)A@MO
M6DE5L\4$H%W8-<EHY4;[[NFSWR/=+2J,@_+2NM!JZ3'1>ADM+J'A: 2=[3K>
M'=/VM]GNVOI3WR2V;?ZGM0]^<821ICW@(L46:RLF=2VAD[\0G^'<VX#EY^!:
MV76M7PS!GF%S2;+UU*M;3J-NQK&$'M?I=^_?5[8VW9)5(D(H\F GHIK1KLQ&
M"_0>"BA; 46^<IQI@\^D#G+#"'O:>HX:=T?$<!OD53<TO(D-OK%+]NN]Y$05
M<WOSKG,P1$\UWRR%S"M#"#$][2LPMF*KL<3,5;0D/@@DB^!(T<D)^ZRV=FUZ
M')5HE>^+\<;'T>"*!,JQ1O"3T#F!IFAW;]3VM%_YE%::RZTG^J)Z3OMM^7GX
M:J5-^01RBS5HA.1W:TUV/B"9@MT3^D/_QK:Y89%GD;H VF'PZZ#FQWT6NGBG
MVH& ZKY_Z=>AOP0.O!^H^*<3KW<MW4_R10(#QRD05N(5PZOF8R1GI%K]- @%
M"GPP3%_U0=N#(D7G@:O#=Z(BVSQ4V-/+]O3"%GQ92+JU27M#WP<<'H^YC0O;
MD?9QNJ/!7YP#.:DA9-A_D#%1"'22H&<V65@+5P$262XH2KSOAMYRJ9)HRZ?3
M#;_9N$3S;2;S%3?WX \Y[G'>FX)\?BG@(2S*1?('T4$&T=!@.^.+LCS$=9DS
M+RCUFF@L>06VR:H=&7//XQ$'+5H_-F\:2!?=9.1[ME!]N.;? [)T(_#/OR7\
M$T?H4IY4 Q4=#ZS :,K2'6]6H9?L.6CH^?T>H]5LW319?JXGQJPBJ&[ ]G3!
M-'BX481/-/G%"?PK?\EZ\+9ITM>=GFX=BG[ZV-H3$V'0PWT 1D !]BQ)=Z0*
ME &CN!8HD>T''DALB:%"VI<F^HMINK"Q*35_6D^O7K000[.[^7XL"96J1CCD
MLQ,@8"S[3//"0BK&RGNWS1L<O ?-:->&1LE6<DLX@I?#$)[GJ@53_87[?[H!
M6+W&29?G)$Z1?1'/3&.L?;)[W6CA3)?-.*(ELXY46H5"?5!M*3YN^Z=.#.&^
M_-+PYH.H-HV&C6\<UH5L/OBBU5G]C*KYA=$+ZOM3FA72W]A:".R4._3T^FPO
M\W/<.E'"I?C%,B7<R:'%KF*SFCD7E\&*O/JJQJJ&VKO8>>R\R9>44X6QSLE#
M#]QWUWZ7DRXQ>/DL;^59B+;*H\'W#"VI"1D>"Q&U)"V*(I0KM#DA Z9)NB!5
M4&'%S%44K<MJ_+B?$ZH"Q,S7_ YT*2X(N;D'_4=-ZR:U[\J [62GWA\B)<:L
MBL3""\V>(FT&'HC4/$0;J+=4!2Y).:&196:*4ZUB_2>.]MF%CC9<Q\W!=*4[
M\\36>G6"UMPQ4.O_ZFL_C-[0H"0LNUPKPK6ECD;TM$5P57YU*5ES/ =J($.9
M#F7')?T;+=@44#-D/M+@5PR@3R9="&&Q)^;O$DLV][6K4SS(+=_1:XE!Q40E
M63HBE"$_E37&)K=0$NHHL;9A AO%;$)Y SQ(@)Z5I*Z;5LU_:O"^<;#A?/4(
MNP>S6;#/S<RFRZWB&'R$//M+^*UMM;B\% [X\1JM.:>%U ?V.H!-F[<>)0BG
M44&CQ3Y_Z87JV%W[8$^LRA[C,Q^T]\>EO38>P4#T9Z1L<CB:$;(PBA"3@ 7A
MTJ4D#R&528[)W3I\PS0O+?].3DTD!NO4_^^I$G./B'N/M"R7MHXY[YC2#^I.
M]A0TO7BA_ 34(+6@JY1;S%+AZHP0;LP*;"U1AX].)6M;8%$H($UD/VYAS%4%
M'EX8SJ_)]DPS'%Q8P"X2++:75WRMJ^J=6^0<-7!^TE+GE22[B^XQ:J8"9I8)
M(HBL+(GPX*8H/OP!W7YO+ZC'G6;?S!$-M]CO34+W/R0X?302%98(<HYBTP>0
M?>9SODNNO;.XFFZ'\UX+\V>M]!Q^AT)H?/Q_L:ZO/Z3D6?2/JXRJ'EE./F*Y
MQ'ZWA_@VN@,AU8,BIZ&B!/+J4;;#"JSTJ<  1BHAM2.$GCV  1H"_-?-1C-;
M2*:K6Q%@E[9R(M%,:,7/C1/H*E\"J/P971<GUIV%32$1[)3,8J_QGO7MM+F8
M?A=,^.8W^TX+;A7T&M.A&--R!L$3( %#K=;44:/) DIK*MN%WSEG($)V(+;8
M>O',UA%M@.,"8[3:F"_PL&-"C]%[ T=+/M=]_?5 C>[.4'FWH9L-HUYYM>#G
MU*[Z=TZI3(0_&;#T!S=IB8S$%V0YX"Z@GD=^;)&J09CAK< >V*(%KFX_!;CX
MK,@Y/),$?S/TRZLYZ6/*7NWE>7(5REF[H*(X=E3QP/'4[^@6RNIA]*9-0F?W
M 8L>9;"S24[D6Y'G$U5_MA%X)D[5.XTA9EZ80/GJW^.XW%S2/'PRV5__-6/T
M_N\-MX[)?\%+M4TD.H1O/-RLA8@B3@.R^28.K?:[9,52;%@YP9+CEH()^86.
MU=/N7Z=]KNY D:)!15.>P(:AXG@]_46&"VKOO,NV^3V=/10A!BFE#$LU..#'
M\!486%372,:J>7I.D> 4UX$#<W?FK-M.Y?9WM'9,&+O8V'B:Z!TQJ<"^.,6G
M1V\;<MM[[62*^?GB%S!C(',%]M";_"_(X%5RQ1<A^/C+;NB[W/=4P)@QM[J9
MNUT&_>3E,900O"=DX;E4]3&B0LVPN8VR"O&Z+,^DQO4$UL$YY4C H-0C2*_L
M0.!'$[E6/9V&/IK=F:XS*C/:.?,%&(R2=#U_TR19D\P;97 H+0AE6D_""DR.
MP:,B:,KQ4*9!;P[)2DU:G+-JGS@H*B78M.<:O*EZ-QC45U[.%QU.WCOC$<KR
M]N=V%H>(E6\KLRL"H@_)L^!TM%2K;-(T4Q*.@:;&  PR9]->DEA<FE:L.1;;
M0!:XXGP'I >+""C/_@/EOW0#>QRM%OP"J.TOIIYZ?Z#Z3'L/Q62YZ$?4=H4?
M.+='A$7R<5+=,HAV8;Q>B^B=J:.'Q5>$K,:\Z?/3>&M32E%(KJ$P-ZUT](/=
MY&@HJ-?WBT-GF;L$6-8.,VZ>=*%R+3[]T3!\\'[400B$=_U7J2^XAY/'HW:2
MH\DT5H%14I,]^!&]5:?5F\X\;7*@?,$6R:_O2._X/,!T.!?-ZIAA9FG2"V8B
MM+23*VH4R865.>;?EZX)O.R-((_Z^[\^C#@JL!<M54]? C>N[FC019_@ZQ<A
MR.WA74"=VR4Y%H)GT3UZV_.2"+;^&ATO,GK"^=WR+1Y:<N?>#M3<-9$Z")15
M%2.-L6YL]N5$]#9(^4?N=(>= !Y"JK;I"T\.:4 *?'0ZZS0S2X'$T]Y\J6-E
M"/M;$A9'>V>8]KP(ZPWNPV5Y;:LI_'.>^<9"7JIS-Z@$(=52 Q7F[DYB#[%[
M!+HE0,*6$@VF2DOIR";0"J)(G*W.6\09.D&-2>>TLAUV_N.=G[*]SU..)GO%
MX,6BA1?1@-%2BYD*R&*\*9)J'!8G R6B ;Y>K&V(H$>.>$)D6E8*!+6SG9*#
MV:E)#+Y>GQ1)%IB88HJ9^,Q[-Y-*1] ?BCGPV:&W6H<VP7])Q*NI:KA;=!'<
M^'L2!^RES-D)!RX X0+N_=P=K)H56(*WQ1"M,Z9&.3YW?V\AK:_&SJ5%RYNI
M[\TF_$0U#LSNJ;GSSG7/Y?KT,1>+.N8OV=II?(8V*:<X5+O\-6HJP]+#(^OQ
MTA&)K:;EZ]-V8P/SZ^X>/+XCW>6)4_N-A^CW>*G6L/B#[)\5V$T<L!LQIS&)
M'LD4D+)%_OSA-NCE:,6:A80L:O1B#OYDW^+?5%L7;0Y[^C;&VC))_#>#MCXS
M*T-T]K6/Q<M_.A:V\)0?(:Z31]M A0\0"E#_(.!RC"<[YUZ*C,5'9$\LS#0P
MR[AF1BQ\@X6=0UM=C*SRN47[BU3'3(>Z_DI3<SL%D3]]B'A<$)E\[1M3^]W@
MGH&\-['M_O0I1C"$$:,KR"VU]A: E>C:I+A*9/7?#?QY40]3=T\+0N4.(NG)
M.(9D!$3:EUDG!-0-F=W$V;KHO6!KU)9$O0AEDRHVQ%B^Q&QY6CR%/?#DTU$X
M8+ TBUW=J"=PQ9MDV;8^DIVD<40UO!4WVL;TW50_9*\%K 6 0EV7MN5+$_JL
MR<&*7R?[[74QEG(7*4R5T*5[<<]*?*PXID:'JL[XFB^B.<Y0H(4&W$ :1*RS
M,(M!U"I+U9/$9DW 87)Y2%9&GOQC(G+23/'[7%G(#W.VWU/W!L O1#U,/W%N
M,^G/:BFP+O ^ H?@,9HL>^T-R2U;$"%F\4T:=1)<C#1*2&XE'1+.?5U+^QPG
MB%_LQIS)^4MSXX^1B>;YYS8[GMD^1'_"2U7*Q :0G K(+9=68'X]<7K;4\5<
M%L,_%;+85M3OINT$= LTP3G3.ZO5C#0LS+;X?" +HK -#D437M/+)NVQ->SS
MZ>)Y$&M\,>4K^'G@]$E4')6-Y,SP/"" '8@#+";;&6N:=DI/"LGM9"WB04#%
MCY^#Z@1AK$JI(X^[-1NM-OXA!!%'R_Y^M:YQH.)&8.WKF"^Q>^"CWAK'TBI(
MB5"8J<]LTFR$IGD49 :U5A0>0A%-HKO0UE<N,//:+8>'3U>:K, RY)^75'3T
M11I_=7ZBQ.2=E_\9,LE=O?AW!HKN(Q C0O%R"T1)XF<BRES)?^T,.8*I&I.[
M#5A\\0S)1#@^6\5D"TPZWN%+,77H)'.30Y[AR9I?.>XKL$<8W^1OK\$/*1C\
M19DKN>4"-&()8C.#E\MXK1R/N!%EC]7I6*8DUC0JNP!R_%&<MXF-0"O%-B!P
MN$GO_OA)V[:"J65;[\R$7X@#^M53;(ON?#/=[D\'$+L0/-&H5 _!>YZ[J7J(
MAD(AM7U)O7J;H5=JN62(=C4,/38VDNHG!P4>3U\,629F#%R! MKDJ('SS1UR
MOR&P(K^-@&*RY:5;.\%-#O#D@J@S:&4"G6_Y3-!][DM^0 :XQ /I?R:9:REJ
M#';?]B^:5J)4+WB^>++U9?-5Y7.ROQB\#(;0 TJ%WUIQRB"+0J=*U<F30<T(
M):+3P!<1M9D20Y$/=Q?&B%/Y7-6)KC!,9*4G<+G&!F6G[6-J["@4/R_1=?9"
M;8@&)\\_HQJDD^T&5V A5&"_&10X)6BI$1 NN2+%BN!S99#,YX IP<9%"3H^
MURAZZ?QPPZ'A_K8-99;99>CQL>D)N(@1IQ]IW-6]QW.0YJK#9"OE%MBG^F$/
MZXL9[)[9L!)"F >$IP.5G%NM[F$78F\B@K@/*2.9VB?3/A3I6B/BFO02)XPO
MJAW2CYC:=K_U5"0^^<4SMU/CSC\5(4F]"G6'"^=Q]YMVJ#'!G2P$!JGH,Z7M
M[10P:%:QFE_0*EBJ;[>*MH?*E=![=]R<MW]*O]*\MG[_' RLMS41^, [2-N$
MWQ[;VD300;C(]V$^(=.AZ?QEG'D4'DD?,N^B74PONQT0OJY9[QC1_1<QX;^&
M&%4BPQR)(MCI;F_ZHS.^ A&(?- ;>K"@7.QZTQ_ \=MI-6]I[T[-[VRLKM)D
M0:DN:6=C[.2M=</#=];\YHJ,0851:)@NP&J2HB(]#)1)PL!N7QCPD*]TPM6H
M74]9A&Q7WC)E#3XL81;_\)R^%S[4C\3\F?B]6SUQVP;Y'<.B)>CQ=S(&XAHZ
MAB*\)2_5R!/' JF22T15(;(9XEG:<4G? #^1"Y-D-7"'NYX@LU#6^8ZOS6ME
M+\X>L#AL\,_%\3+G0YWZFC\:D+L4X,LG 3Z4^2%NT;(?PC24))(=P!>A>?2$
M!@>1C@ =;PHEU[D TLX9<4AQZ%+VR8&"@OH#?Q@R4_23-PPF'NF]]8KQE P8
M&4E59L3*LA<(WEN*\")N9$& ;W/%>P$JDJ.^A+IA/B(&V^!7.N+RRB3NL;G/
M_G$J;:\\^Y=3;(= <.3L?'FRH=@L>J/\TC.)'3031X0?CMW9/MRT5I9%AGC!
M ^X.VY#"J3\Q>' ;@)T<UV(N=Q>F*?[^<_KPR-2P:K=N/NY'0WN$7(N%.)QT
MF01E+*$C1);DP$U<D9D/\$YB2MPW*-6=I&X%;DOW%8>RBQ)_X;8^>-5UY&W6
M!$OI>)9-4.ZQ5R'^.OF.EV^J>TQ7P B,.1TALHU1D]EL]IA1O914](XF[.P@
MQ^8> D*H5T9K.658LPYKI?DXO*T2V_-:0XC68.6APUDK,!OD*$/\ HIL;Z"%
MO+G7R42/3@HR9Q/,.I1'/7R![-N"\<,=@<H:$P!)W/,OC7(>P$]V:WK96A6.
MS5AC1DX+%)503AD8G\LFK#_7OU5;@9$0]-2YE\(E<)-$<I!X7%9*V@?X=X!F
M0D1;3#_%N\]>;XJE34GXEN0^>'7@6E8_Y]+@G>PUZVOHBB9C2QYBT?&U#8\!
M=0BFS/D+'4"%?1(3XA%9 :@50M=.;<,E9ME]FN$S=$+N76%_CKN[N<ISQGZ[
MR#)'?;DVW<)X^^473;']/Y8_GPP?M2WNA,%[_NO4(A]-;C$GF:*G[IEUZ,H)
M&+/CY:'G.<8N@B@#6W]^!<(MW<M=T.,F,GR "]%]1JLY]53IG*##YBZQ9V^Y
M6[$'^!@1R% E?>"J2XUOBWK$Y[-YF0E2$Y&E0V0)T04X6DAPW27*^:3ZL<,'
M?T7X):=QHBQJ7?_93W7,=)\V_?3#^VL>H_C*["1PXU'(&:IDY42+\%>$&?$%
MX"Y?Z1J.UDA- =6GW"G*1)R_'?N*)N%7H\)&7X%&W5NK0M;\OI>81^ZML4\0
M/V30T[K]MI'0KW\AA8E)PY#AN'!AQ&/#37M(G^$CN4?JM<-_=;^)U$6V_ #P
M;D)JDH7Q\:/T-ZR:\<-7!FN4_N0BMT XNO;M7VIK>7+^8EHZFLT!MRP"NX0>
M@@[*RQG2>ED.MFF'*\]UOY@]'8E_> P(+Y2&UH)]C\[M?OL6J3V]A#_/_"#>
M<#+A9L57Y3_("_FP%_OOJZ^VN(-M@ZUIAMV"\1168(@>8!\-K(!F^@N"OZ_(
M@62.BT O&_N"J 6LP.X*!UPR.[TK%MV^L[)N-&GW@\K @'O]6)MD'_$@3H,F
M&_QS?7L^CIC]Z)E,YHGVFLZPO)>;$[Y>3"EFH[B>ONR/3U&^7N.MF9IT]Y^[
M]AW0VGHJO6V_:KK3],=3.WO7EZ[ (*_<-I6%G(5D)9](.*2\?MKM>Y;5'+QT
MZEYJ$F_@J^L>I = X\F\%R[UWWQU:6M/X1C&7GW -+_&,=G40C[V0L)Y-?#A
MYREMVW3KSAVA/?HI+2HJ:P+Q@;LN7SY^@'D?IO]D/9E";J4+>Z3JD^ 6UB!H
M3#S$VL 0TL6G7D?=_-GNGA70])+/4#%KD5FC%5 H[VG-'XW%-4.V#H)OX$?&
MV^M-=4]/YY[">A_Q/@D;D=&Q5,0-.&"3+28"*B*[<B.AV>SL"DS! K[.,\G+
M5/7K0!L(&[ _$I7J'AN4KOBH3A3[\DZ/=D=M]XT]7GE/:NH9C"=K[Y>N+;VO
M<0P&VP"#]+ #=F0MHV<!5'A/E<A!SMT-)0./.>KD]2';H\*GDX5YPJH!;U$[
M^!*+>3$E%GL[/1<^;?>(%NS30V%MCO<+J@8MLB/?\@]Y%WSJBTTYUBF1U=37
M,FIH3559-MDV'(+IG.EN;-\5U!5F]7%SK/1"EUI^_/C0@Q>;&6H YH2($OMK
M]?".XDIG$:T$R3IN0I"1[Q-G69>;7.[5731]+ZHY.>V35@9>#?51I:_V%,?K
MW,;?"V(O61(C@#%":?% *","*-$3RH %WWCF ;YX:D*37G\XE&YL-\[$:U>6
ME/API^O^>?TAZL[.]&5Q1/31LP?5$RYKC4DC)\E*1',A,HFT"^BZ7-UGNX]'
MV3(-[A5I5I##UA<4Q*:]\NPN1E]!AH7K6XKV'Y>;"PDX:7K997.B=+6R X1B
M0Q8@JGX;[.WU!7OHW(WY@+) U\S%WG# XG>#*P^G,0H\O"2RJ$W,\J7B_0JO
MY%P/R5IW+Z7@6D9_>[#I7W>[U3.J/J^1#/S_;3?UOV-?/(^?2(CNID'R5+@"
MLE=@:M)]$BS83E$G\Y^3<8C8.2P9.^ERVNQ&#3(AKHW5W\7G8'V_M@9S3H@<
M*S[="F$U[?E1:2ZIL!1$(K>.H%'.:D:+;QQAY!TD56C,54C^D5*EF51(//S?
MYLG?)1(_C+4O13>YJ+WG0<9R1GUDY3C*9CNUP<LJVK!..#EVA=GVD7*F=Q'E
MOO=2,WQ-@\XDLKT'L#8#%7+X)BX\CX?DZW-JX":1L)/)QH[3DZ4H@4ZR0W/N
M/I'RHU_N4687>K\.-Z#Q)=,1.(/\K^[]TL.%(=:S?0?:?VV;*PR(DSQ[=1^Q
MA<Q[Q!6>PJS 5J]4S(GD^$7Q3?L=1"X=C&T-: BXQ),.UPW4Y!5\M]=CU2PH
MHH(O!F=I=^G3K3)N59W.YF3^-%4H*RW=FB>B@@I/)9JD8;@ZF?=OSXB+^"D0
M)CDB]1'1F\W6$()X)M3'368 KF4YMH '5QH+SC4#,L,KVLN 6 U+2[,\=NB]
M*-:+3%6GWI:[-S_JAV@@Q31(>&I<X6W*;(SD%B2^LP@<A#FHXDN J\16>ITA
MRR!N(O.[G05Q'4.]N-26&1.7CKI/)H+4K>36XXJ*1W"V.KSCY*(K;7M=.,EG
M;OL%&0;:(*J5XT@*_?8Z@'P+6;E&!X-QU6JQU^@E&A>B1CF=(3<R[FUYCBUL
MO58;XW[D4<(-_8 +2^,)!@E&;U[=/TK1)B#:&%N)NP3DM4"]2S5+:C:I)']9
MR(TWSSG!5NRR<SC%NE'XNHGVMO9=BJ=A"NKN>$273N6MB/3U9!4H\QTCCZ+%
M$L@8KD.KN<# X* W(JJM.FPH$->:-*4)=+ ZDW_Y;AZ^ :J'L%,?6F!1GD*M
M>'.?,Q%@>ZKKL#E%Q2?8@^[^*2@#Y6)^_2![E@Y^*7ZA+*@6_RE[C,"0MT#C
M]G.U5F"A)I'B6T!C/NFS=2.#&6S.2&;'/3+#@CK3&R3-B@%%'S "=\//EYJ:
M_ -"2SL\WKD[:)=XX.;.K;;;;,<!1ZQXC'8&&X)W*,E)J3$ %TY"Q$D#U">D
MFREUOB3L:6;;+B\D6""-W%-<8JL&3,)NWZKM"_1Z=&9^S[I2&S_DG*OZ&B ;
M\N"?1 V@7F)/;ME'#L+%(': .H0VOA63JO1A\O(P47FR42]*GEGG/0X4G7];
MG;[D4M?>7N>+LL5;"BX[!U]WOW[B3.KH.-ZAW];UU?3$CN%%B0_*8?@.9WR/
MYX#9-:_97TI6%^CI_>+/7[767X\63'CM3MO8XFY1!ED.!=G"&(&+5^\\[B*W
MW/@%O?L#I:JGDYP*?PUOQVW-L?*@ :ZO9GSW]B[V/"+9#>Z&CV8-]E7\:PD:
M L[%+EOR0MF%'VBZ-J?W:4P;S%8Y+G.@U(PB?2+7Q,W=EJ@2E81%L]U"8\CZ
M>C0]I?YTD5X9GQ(WH<X0;:E_%:+\<BV]KBGSNMY\O\'?25ZW=\0:I_M'E9;/
MR"[U'8.W4IK1@#$4*LV$<%YF*SFZ#BU5,19LH1<1]P-D/@XVBM&B*()F*)_I
MC";-?FQ-4N1,O$F@Y^[<KSJ>7YY?TR&R_CS\#\4;XF!CD,Z9*[#%A^0=9'XM
MT+4"^Z A*[EP#!Y-V; "PYH!^[YU4@"#;W,NHNS.%=@;]&-R$)ISL4U;.:4&
M^9"R<5)8%#_@(]*5LG&CQ*,"I!(!S]0R*?.==C\T3OOR#WX]UM1"9]N2@\G+
M@*=  R1-/X(5J+B*"UG %Y&'^%GUZB:#- 20B(8%U^]E=8H."X):&0E]A-0V
M$P%&DNS045'0]!B+5234W4UW/1=4Z]7RR%$]>L(YD3%8EP@#C<G\)83P-D*V
MD]L)![!-AU9@/QRC0B1*Y!9O!*]F!:9-#C6+84!\-!0.!2FF<C3T;J)_R40(
MZ2!0)!_=M/M['T%OE]_M\) *+I>0%='?D;-#+& 3%"R8_5>:G_A_]9,A(7FT
M]4C5&&(%V1MR:"IPQ$P<!\T[G<2B5%/;4Z,9\DW;,1,V+-)Z:D?/9I^0'X0'
M@1DS4/QKRY$_EBC+-1Y91&SPG;9>@8ECZBQB'J>Q35Z[E+S:2KXU" V=@A;Z
MPD?"+L@:5YO1K\#T2*J 5=M6(%, *:BFWBP>O7%GDJ-K$(JL"5P\3QLTK2$K
M,V'UKA>9['7W:A^&UCX],>#CR]$OX&])_K$"D^K81$K\ 1LQ[(TL&W&C9Y0K
M6&KNT0![](P&&PX*E\X#9?Q&]+%W(GI;-TF 4_/L"F1_D%QF9FVH* W-<H&]
MVE8^61V[V5'AU0K,L>9_=OCJ1*@AKL)'=2:5YTP@R-<,) OQIT5F<]N%W@8/
M^11F63*F7;,N+G;WJ<J7C@]=!G[5NZY=NHZG']]25.#[U^'#^Y2B[3M6&SO%
M CG"F5:&5I,N89*/2S$?L2#+2T\(*]_Q%M1",O]HNZTTGR10LIX\RWC ?Y>"
MN6N%&CMZ.6O?'E.M>X?^U?L**5QN$0X8=DJUD.!&%]%# 3T>P7L>VR.NDSVU
M#2D>GXD@*_R"$,2F#:^FUH]E6M_Q9K351\Z9N=%$ <G/VJ9^SDRH-KRA#<M]
MU(_Y-W8MQ7GU$R<BA-G_)AF&8'CP]>0671Q)!^ P,\KR.=(3(N<V:H)83T<X
M--Y>_F1LYBJ0Y%7;7Y%<,YNI*7>IKKXVYAEI8/UTF=,*C*.AOD;Z%O(G%08O
M@:''"$Q-0:NOMHA&"]T0NE[2B[+ZI@-7"(D=$^P!KX$&U$M ^?2PV:NW0Q;/
MAK$5&?TSS+K!""''NS"^]EY07$TLQ;7V] 3^&3D8L3H$TFQT"51 28X F6(\
MQ"E>*B89C\Q;P.4 #C)10Q34AMQN4NU81*AN':[*NVMEN?"E0/:H?M8B:2?+
M0]BE<H*"7S5BHUD9OP<XP@ W/BQ(O9^K#*S/6_V > 5V':F$^9&ZEAZ30A?@
MX"%ZFG4A[C9()=1472+A8:O0^9;_4XFB5]7P@0-7O=8_<A>=2\9]AT#."@S#
M!8[B004;/D4+[(%<BW'UHD2.$-8>8:6-C"<=E+IE^PH1";,-_Z.]-P%JH@O3
M1N.*@!AE%1"B"**RB8(H(/E<$!$U*B)*A*@H$")$!"2RI!4%! 04%#ZC$)5=
MEBBKLD5V-V0)BP0E)*BL@8Y":$DGN9UO;MVJO_Z9^>?.U-2MNF.J#I .Z7KZ
MG'=YWK.\[\Z\?D63\ZV-59PX@SB;B/T'3$W=C&HQCF&\PKO];3I-5P[0V=F(
MV9=E(MF'Z)8^)">1-P.GF^>GF+Q9B"DZ E^H9%V$B@1V/QKT*UCG*U+#^FLV
M#57'YV7U<CM-R^6'F;U3EHH3L;-MQS]U39U59Z\B%-#+<9,?0(:P64ROVRAI
M8VI9'"AOCZ&KU9CD4;S=DMZ6(NKFE#REKJXEB3'AUW:?M)9$A:[KGO&S/[^U
MGX-O-KZP,G!&!QG7];"-^!YSB(N&UO+[8FLPHM5C==H(S!O4)J';1]I<-%6S
M+;?].26G&=X=YE/UV)H06=:VG]6JM?_E.=]4P>"7,>L'(S$,[SB__>T'V"5L
M+ ,^CWP]$:A_#U2<_)NS$/ B0!MP\4Q/'>>6+1OH^; _]/ IR7I7>_3YU*FU
MTYE06DN^7%00SFZ@+?J'9,*AQ[_HO#?M,_[=RW9A*>*P[#C@'@ZDAXX!AAX@
MK YH8L9Y&+R \D7GPR_=,(#H H5>/38Y.JBZ^EZA.X1IZ%,Q8Q?[C?2N\8!2
M7&E[:#^R+WH'D)5JR\L.2E$=A_^3A60)[[&P3J5HDZ2+7EXYZ8Y(JZ'0$](1
M& U7QMON$AURX/D!C5+4\AIS@)?NO!^<A\T%GQZ)2_/ZQ]X9"^>O=9,+)^W?
M[5W]^G7T]K6O&..\.-1OLG =V'H;5A/I4C]ZK!)$Q^1#GLT>6I VR-HGT(@)
M?N15VE-VV/LPF/.0E$<,?9"IW#M7X6KN2 Y45/9\H.FX@Y&_\=GU3;X'?A+[
M!"V%/QTO!MV.V_J)OSCN>6;UMI6HJ<. 'A;T]YY,$AVG?I*B*G)AU5\M=%W
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MU,\I[G!E145EE.[I$=J^N(V=6?=Z3MQ=X!\GH3!],9#U(HF\E6@K91R((0L
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MD %WEU5SE0T>3Z%STQH)"Z#UK1FJW?P>9HGMWB>4FXWL#?2\@<$QUXPS@L8
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M9.L-9LJ*@^P,=Q%7(?R=L&2BTCJD'JT.^X(ZN9&P_1-BVC8'\\.&QX!5.%+
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M4LT*)PT!JA2OG^S^CR$J>PM'^U(W[%@3T?_W1]M,%O6+@":A8HG3D+X<WTA
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M2B))1:3Z9)+ZO5'A58'CDKO6UU^<'R,&!#U:$I$NV\6* +L&7P3)P@<L+!F
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M\0[D)<4/GXV='^Q2?K=X2[V6\LL<AY^RR>,7X9I0"D+* \0UP! #JUJ^\SO
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M.D_\USKU?]@T[_^8YBK8B["@M< [ 8R,5.DQ$"LIFDX,%C/^C0]FPI%WZWV
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MXW'3B]O *X;+%VY_N;S+(/2*X2>42$0MEBS4T&]W%\+:'ZMS1WLRNJ3[1;:
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M8D3A-OZ1@X!<UAN)5\]WK]347RANH'<SRLV.81 6B.B<9\&FA?GDY!#,.P5
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M"^Y,;I0X+4F=6J[]\".-M-ZA$VH+B((=?T-5E<$@M<27L/84\&ZT7#P<#Z,
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M_4Y#W?4_U0(!8.T6*"I4K-'0R166&:'?E]LL*5"=\Q^L 6!O%=@-;X'6#RG
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M6^>;"ZQ<!^V?/+%;Y19LB=3YI*I_>]V6TZ^K48FY5&H09]Q9ZE;<>2[G3EF
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M@\)7D/)EVTX1)<9ERG]\1Y8ZW9/);:BU _1L$)+VVN6O;U_XV^FY&3J&XWW
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MX&3>8\")Z1]*)/F_%%XP48]:1@?XHA=\< ?=D*2GT-XO",Y@7>ZU@?SU+D2
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MA!MGXP-"(SYL6[;IO?4J,Q6U9($:A^2"E3E\K:T::I'_IO(_+H92N+Z2(OI
M#<B]>O(=:-X:>-^7M4]19##$P:]%21+AG#EA29MJJ1.P!:EI;$U6AQ#XY84_
M,WGR[50K>$-C;+G.-"==?7U&X]+3'G/>>I-YA4&U*HVNYL0J2XA-KWO#9=QV
M#]>/_(8?V5<*S<U<><.V3'RON$-E>SCR5DSF GU@%37J2\<O\65[6O@#(A-)
M!&^$3=_;)U\B*:TAD]0+6,$MI"R"P,!3ST-O6^WGW[GT*MQU^\G5F2/7U>).
M5M^_5['S5.\4(X$2X=V"-$ DF%J%<N-,@G-&*KZ/E/M&DX6V&WV#76483>K
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M]'SHP%^;O[E/M@,>[XI]^;66JR)^Z80$5 +PY],N[>R XQ(=D QIH)5'1Q2
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M_2?U1A14P]D78S*68::DH)P@WS-G2RMCGKGLKS>\[K O[L[;<M(?>RB%35R
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MS;MH@TKBI!+ME@H)I2Q-Z@X9+6S?O>=Y#_UT,-,4OIEHL';($/[J.<R!)IG
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M6BLPI,&\M8BSJ1_)0XU?=;B3AF4_R-W]=?J+(-N9:Y/!1%52P=^ZAT9#F*7
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M8B\?M8,8)R8?8.!A98PE*ZCWIF-;-EF^$)6GG\I76]/I/42MS(Z>SD9PB^P
M9WK(%ZI6]JB*L;0>$2A'Y,%W++O.*+0IG59HO88(\>*\]\@0LU/Q4K^1(R#>
M+R\D67#@FP52Y@%J"H11Y?:GZC$;<@F.K%G?!B^AKMHKT9'R6WE--QOA(>6'
M,??M?^-3-3_QW[8W-(UV9NA_2MP)%;0T?NX!L:4:LLO@I31XM>!V1'[@N!&X
MQKO$JN 7\I(2FQ.9>UB1IMBI3KX&UU2XP7&OUS_"LY]04C@Q)>D:M*3"'G?M
M-ZK3+MT@KM^MH<MD3?85LR34D#&6]7I)F!XBT\K)G]VP:[137;V4.6E36#>+
M_6%J1>#$<<X;?5[94?.$Q")V=0/]-/VTFJR^\CKUHYJ].;('^'D<7M"N"SX[
M:H@5+_JR>14";&7 TS(%7H<:8IDW"C8R.9L_&925?MJ]'[J>^OJ\I,^9GLDI
M"L!Y#\]7T(F:YEV.J>O1#B<K_8#92P3%;S+9IU')KR*_OVOAG#W'S_(HG-FL
M G<WVR6EM;2G-\]D+D&+P8[P&#(SW@<[BWN(]PDH-,;3H..Z2&Z'W/0=:QH!
M>L9CKZ1[5T:VQ18&<QJMGSI<?IP;_,,-4I."8T5B-,!XOKAH)3:B1V.J 7Z+
M\!Q2WK*,#"7SMG[6&8>*+(MI7<"66A@O]GOPQVQK7(N_^W[VVA64]/;:1ZIY
M//-Q:>L1>TB&J(MM:/MSR0M6X^KU Q>SM(P';%^9)12IE'.KEZFLT% )K>>*
MN(/&TR]%ZI<UU63;^@S,*J-W&ZQSG*1%Q#B;?#9LUF'!$(SR7MCBU=:KOG?0
M!D<[B"5MVGG?NL<U$X*8^7ER9JJ\QEP^KOJ315WX>V(IYP=?Z4[R+ RC2H^8
MVL)Y59%R/:F@-@W4N4CKZ .W'LFJ]O?B*'V;G$J07D'O]?*N[T<Q!:<;K:UO
MNQ%D?!=QI:3LP"N!J$S6<:AQ<-?"]9HXPS&I>2-]@E)<KLF\JG^ ]/?(59NZ
M.B?I9!\K?8E\69(:53D7 W_P7&K QV-6<%QX02\@44AB6O51U<A2RVB-$,)J
MLMD:AY[MC M<>RB09.D7;?ALE5'%T;%?*:OSD[>)AE**9+*KZ\<5S$C_U^J-
M9?=&W=<%K*; &?F:K?KAG.IT&\,</,L,3C='J%&=0;9=(E.SSS4%9UB371,@
M8;NP&'9A=AC$ME \=4]EB1$X*K4I[YG=.M?Y'^P3DIBI&E(*WT^:5R5_5XT&
M'Z3MMAK%PG[&H&&$*VCDS;0?%(!O%@4 L3F&;TB<--VE/;#ZUYF#3/\K@= X
MMQ-2QK>(!I(B>*AF=I2!!(OV^7=L[0#\#D1SY7@50FCV\TLE-E  ]7!"= _5
M<Q^?W?][] UP$HB_7EN68P_#/$/1;/)<FZA& #<BEKEM07H3>U]&JP^\34YW
M'QE=C!>IX*4SOF)&9;32FJ?!>(F>=UY;,4[*<1T5@:/N\^"(EZUUFG0B5@[>
MV8>'=ZU<:O]<\^NJ_?DN?7+EK4/B9_^2)CD%;1NO>QGML<MV=;ZKS_S??N.0
MT6(\;&HV>_>]1:-A@F1. ?0KMQBQBDB0I"[3'"'H61)$M12DNIN??OFM&/^S
M/"$77A%E8#2A_V=2$?F& O <,VHJ/133[+X5D[A:O+DXA#URWG]#IAF%U)T;
MS#O::2- (,86LXY766$@18][*5FVDN;3$#.E+]T*GS4^]L;Z\G/U"%\NE3O?
M8H9CPL<1^*$*6.T(<;"3-H,OLM/T'+H QXX)?X]0!+LY]IU_O&^BQJF1+K,@
M"#@\P(-% QWX4AR $E+[BJ-]\PL.N6)\E3*&/B]?*B8XE!8O^AD@%P 4@/QN
MYFD6]TT_SRVC$-ZPCN4,Z#TUJZV9$*&.&;UT3L]5"3OO1&_-[CUW/;>$!'7B
MX'1)CY&_U%&=!OP'*AKF ,/S>BV&*.K8+2/#01RLG3ZF]^;DSUA GTR^K+%0
MSK%R<;GNGU'9R>GR\_D#;E5'<L!APXZX=(SUEGK$TJA=<WWJT[KD@80.QX%N
MMM4/"2.R%ED?]YUN*5_ZJ<JFE,5*%%;O%^FS7U4OSHOH0;=4!2?VH#?1Z7(L
M91H9A A2B8N<YM!@H8B(^)/]LL;9P%H*X XN&"=*5<TWT#ND2K"MQ&5\R1*B
M1Y.S#5F[%^SR,V'VF](U+#,/8]!Q5^\^3X=E?8)8PE>A>N5K<BO<;L<&F+AE
MP1,J_ID"P&BA9B9/M#R4:(9!Q"H:8=/8I5"G?$\U.]MA5<C]^@VU^Z5[I?/K
M#:F:QI"UA<]^[&<9X;W->HNFZJD<WB4E&S(7^M !(/W6D;67>LF+_-$8Q;>7
M9-V5C<>DQ5R-ZYW*/#J5KDW:/O\28V<V5O.D52=4A.%P %L" %QD5:3;O\/(
MT_-2VE&WTTYQVN)I( ATZ&![L!J;<_BF>DN5/G3 P+[8V-5)^Y.059[N;?<X
MA4;'+)T' D6$37$Z\QWE>9.^9_-]@SM\&;6J!T4$68=+)R6U84N)<$PW#L;4
M+(8AX.+PI[!T*UU@AF8P>MX:I?(5BPH7>YFQ(U41X(N6-37N].5E._M&W_(Z
M7G49@N>'$2_WK^RU[\6VWL38]NQ8$9Z;S>(-]]HLSV-9PB-WRCPU!4Q>ABG,
M[MR;=X[^SG3G^E)=K<B?LIKFL>JM0M?J#(CA\)[SK*>1J5:>?_Y V1Y_^H\J
MH+6;9F/36 U]A/BALXWI1/D+C^N?3<<1AT:J-@G#G'_6]]7DP$VS$]GF$@9H
M8=VPEQL_:SS>VWGT7P^)+#NL-RAXG\RVDNQ\RZ-+C_I/.:MU)7OW[MP;/TCE
MJ:];E+6GA6.-S!M%]F&21FKSXK_(N3T=('98VT/J&TZ"5,([$%.":)FPP$M$
M?3R]+:P ^APOY[?R&7)J4^EF0\/CR$7=@%>HBY..G$>?-2X%I\<F?R8\P7L#
MIZK(M/3%Y %PK6 GBH'H3LH/O$Y\5(&%!$DQ\'9=;95LP7ODM%\W"M)FZA(=
MD7_<YT'KSB:A%/PG=/10TU65^N:O='*0PQ6ZAY_,W*TJW AZ,G>I_\:T^3?$
M!RWZTZJ.17QUDXPOD.,U&::/TM5*'2>/2R,2$YCV"C(^7$D,O>8QDLTE9"A=
MI.>7Q&/R2"[31X/QZ^U8F\-/DYF"4_J#@15"*"#'.)43O2T>2M"WT^ER)-7N
M)2YZ)HO;B;3W\J45N$;V6S@'Z#8PJ_=SE-2N 59;_/@"'YW!%-W,;NWL>?[W
MC07$)H',<)D"2*PAE2"WD_ P"D +QT+\,OF7@:AX!!/R9SA:FW ZCP(HFGH$
ME2",@TP"GU  ]X5O9B.C@%E_8W?X,V2ZKI.X4:IBI<"FWP9.@XZ'D$PE>\?_
MY$SA&>*#0JH_HP"TD7\=5@J[!L'8:A.S^U?627 *H M,LH-,&R(1,X"_^\+_
MW>-D:?]!)OSQ]HE^6?!2%^]!GD+P"M\@ K%6=MYTQ8J%?B_Y /=Z$?NLF-VB
M?(8K3X>RJ#"5IX@"D+AU#,=M';M^JUY0SC21H3JNL;N:%,  AR*T-\\P>1[I
M(T8!=,;F1V:12O)A/QY2:=MIJF]&_R*/CX)_7:=>Y=TS"@#K18")(E,@'N1&
M1//O\B9$"^NO8M!,HQWIK"@2(PPBB\?M6-PA!UV%X%F % "KZK],%O]/S@4]
M"^PF"V".@B@ 1]=@2Q&L=YGS%[R=,E8+[E.R)1/N7!9:[5.[QS<JPV:@_%)0
M\13D)#7M$5D<*HZ/HP#.>8XHW<+3=#<:12JQ=*S 0HQ&?5>TK6>>>IM*3?08
M--CU*H@:L UX=-^&Q$L4;DCFJ/(?!N=<E)0>.&?\YA+D_"?NW9B+8+O(/>W8
MB[?V$]#GXAB.PG[@V_:V+&U?%;-4W5QSS[ ?-WDI*()SBPZ 5W3IY^D:N*!7
M=ZPWNI0A\07%8U!<G-B*B^]8RV&S0=FOR:'U;1#Q:L$*33LJA@*HV?3M6:(
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M5XC#T6!0X,1BC>H..R:U#<YYL+6CIXM7P/Q&B_AE<M=@E8I'%E7+?8-ZHZC
MQ7J,TU,YV3O'=4X]Q 6(VR,E>0%CJ1XX@V  M:"^[2+R (0=ZN;D$%#T"\Q
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MP7^NH!N5AJ4[JK',HJ.D[3=4SO?HA/.=.GCW_X7SI=W'NV+/)@!X:+!6?!@
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M?[[1Q>Z HE#5 ^T1WPMKZ==&IP9<:Z]/#K%=@CH52A>X_X0'!*>6.IRQ/.?
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MS6G9WMVT6-DJCC-TT"$EF*MD@,5\"%.X\"[JJ*(M"6H][^3?6GNK<S\KI^@
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M$BS3<E[UV*RFM2XTN&,7O[\WHYI8^>EIH;_UQ?L9YR$4G@YC4MJHY1+[*$@
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M_)OL(I3_H+G77OVMI/I'91<#%YFJZ#%WJ2&^V"UR>FCY&VRE12!'?,T%S\E
M'\T:U5]:I$M9!.Z:T3+KWG+)2=DG0;G+O@?KCQ!>M%%0.W@O_)@;.6#9J_:/
M 0$X4LE=:C7E#$EE*#_CD8CBNZYXZT[BT-N<HTLN+MO2HL893QSW[E]B6'KO
MY9!-]^=K"%Z :XP>Z]/TS#B@IT&DQO7ANKR Z+!P]^! CB0\P3)GLV%?G.V-
M3TKCIMQ%_HMK#OMCNZSTP12H16 /]@3MDM'(:0%@FA _>L/ZTQ-+(?CMUVYN
MCQPZFB(T.K3EFM?6/KW\G)6BE' JR@: +H ]D8 89 "]M$A8'#M(*^8&H@EI
M_#O(5K6%AF#\^IGA\<>JD9J_\T3,)IU!$GA'0<F+-EMV.C!"Q]+#R\Y#P94E
M0PHUFAY-RPHVL7^_@11A@A'%OM%C5$^.Y%<B!58#DD8YTFTB$4/YXRW%W+(:
M9D4*]VT+-D._!55)592'DZ!(@[=CAR,G#.?7*6* 5@,<246U42UO$3<QJ? S
M!"H"'"=!:C"@)J_ZY=;X\A8)H=Y\>,E]+EE86R0>#WFA7M*Z-08!9,+WJFH>
M0<[T\AR;P2V(TXEJDURX@V3$M?99N5ZMLHAFYSLK:F]K]X3DE+(&!QGL7-][
MGD=70V*1Q%O3+T\8SJ ?7S C=P!&I [\V$N46B G<M ,21PR@7H1[48FI^6'
MR3__ZS,1BXN0"#G>6SJ<::0M@XFW#V(QK0ZC14;D5_3L$3X&:9$<%0Z8<X9E
M.@ !WR:FA_<_B!;OV-T/<$_?]TD1WK4V\.5ODKG("._$7*DI]N%O2ZV3T?IF
M$C5H@TH9($A>KN.)?^+JHN;T1-8:Y<#N.F@1=CW;HVLEJZN\O*3.SO;'6+:T
M=8VT&K-!Z BU8I,WTV'%I/\CY=]52%#$(*8-\N*$P1>T$C_<K]4#W"*>P2F.
MLC/M:!LE]8IBTQ*[ QHW+LU];<H'MYM5KJSYSV1]_*.\>[-6I3B/\IV(WOU!
MFB0S?CEA>-1&"MP])D+_[6FAW,(713J2&%/K*>85?G^7OE3V%4>4YMKH'_'R
MG5Z+/8/8]+BIRP%9<-@UH;O?8VH)VG-*"&^* 5!C(,%>".G90#TE H\!^77,
MNKD]+^,27FI)#?QVGV>Y9#*((XH0XO.2.-I!7_EEBE;\L)O*.R#LV)D2#D02
MD7B+2F0=L(C+*8D@[VD[%W1MN/M6%?3=FG^,@;VZM\?UV)K'\G0.7^K/9WG%
MT-\?%T!6PS83-574U-1R2[[+_;J-E=J=\.=WQ]@3*_HF>&3F\FNS7 V8K^0(
MEL7J.3W-" V8O[8I$I"J66TJOY]AK[=*M^$UBBLU%Z&$&&M_=L*P6T?<L09L
ML#WRSZ 7 M]WQS4%-TC$HFH_+/*V.X1?_.I4RGGVSE6&,\)UQ%P:*\>YCI%I
M0)%QU_\8C/@L^)&(F-!NC\6E&MG/_)9M;R5^7!E_M>#KMO=68OXK]$6UW>M-
MLS,SZ'KVI1,&\BW@UC$77/ SC84B.&,>][)29K+:C^M:8RG*+])TJG9;A_5J
M=T&P?&L[,UAI&J1%1X@[8&P.D@&,+=L0^E)/N[:V(\)$&HMKM-X90G/IBM2P
M)_UJX41EG@V7>"2T2^I]-&!O)UK<Q?]'KB3A9PHC_[>(*CUM@8=Z.3XQ0YY^
MAQXMEUE&9\E/@H\*BYRROX,CG )0LATJV:L;E8*90X/LV9\4"BMY]@?AJ1H7
M>#*>MB^ WV  ^9(A<!2FN6J/SF;. J3<7?/ 4I@SWB@5'O8?##*VHC%4I#]G
M$([C;Y-J\-_LZYBY++'L;V*DW")PUCUM@\&3_A"V:)^#Z'\'W\NH:92K&B]_
MH0&C?JG[@,(.GC>7_ B.NN3JYN@\_N1HPN9QLTZ/ -O+5[N'2=0>:BH8^P)T
MAIZW4YP<QE!)$%XX\MB(HD_\J2IR&9*0\;S'^'/.F52];^,!"CY9KC<9TA-2
M&?.^D#(AIK09)-$X+1K3BM[+)$:3ITE&PX'"WQ&J@)9\2CXHMO5)NYXPVOG\
MA;,.HV9965=8^#83.WE^\R/4QD,H%@YQ5?F$IM;F3\*??O[M&B8"26%-G;V1
M8=>?]&5F-M:XBV5)VU4?6%"^M*6XB53,5?P850BK,;$Q=U)*S2J!COO-8 (M
MYR!L,,LAVEEB3CKV@,4WYZ]&'$6CPJ#B4;Y=F=S3!<&P0@F=R$<<-^U>B9VR
M99 %&NE>J>OD1,?&?P?SHOXSX6GE&%>,1XA'O$HW;)#8T]O16;;EG89OJ5%[
MM.,-;W^9SZ+R7T(6(0S^O30VPD1#Z$O$<7R;]J68"T@G8"[!<LG)38N[NF9E
M.[Y^JD6\X$NWQ/C8*][LB[UNE;VJ%&C[-<30'*YQT0>FBY;#?]13;[-+^*1,
MD6>3K_F$:D-9"K,90*!J",M@K5!+?,!*>YA=E;1MJ53EI(7_I+<7P=N;9G3(
M08_G0\0HLJ5J3Q2' J3#DQ$J</!LKV<U[#8>-2PO:A"U=\G)V6E*,N' JV 7
MQQ;B4M^>'F'=*:Y%1CVF/R8S7)8H4HE' 5)& P54GD ]/M\08%26G<FE,_=N
M[#7:%Z7H@/>#'POXH-QB'NA2#" 92.&\C6.D<.7^ZTL4'T\3HAB0QE+]Z6@(
MX=ZFR9!4:;))GZ2?Z#2X73!D]O\5VY9O]ZC,W%"_V:S=1$0MPDQ'Q0;MD0:(
MI0V<,"S%CR*%*;Y82$*Q-LG\8*Q++4+W%A2OUL[[]]8\;7;K@N)X9U8Z:,5Y
M<H-OOQ&Z&]JO-4GZK3EB_5%IMC1O3"Q"3M*B.U8+FP/:48X1]X[+\F8I;/93
M\%\/"+4>L@ Y!'#T"EOZU@;,K$+:OJ/\467@HFE PPP;.-AG1JZA=L&=@['K
M"CMT5LBH5G+IA&$0-2?>GOB-6#<>2;[K&^_^"#3^>C3N6N?9U\KGX%S'9WW1
M;3YTMK"J0MX@!60?@^%@:C5"ZCOZDJY9^<8 *7HX)]\&,!M*K3,_R_%]0; .
MI,[8+L.6?N%=S7<&PK$4]042FP5BHE.]$LB_4K<1$$$Z,[JA/*=W8SMSN_C:
M+,4V9W#2+ -/"A01UOC0F9?B_%GR4_73K3[XU+$C<H 9(0CW <8:$)]!#/UJ
M%'TZ@HH!Q:IM)&NX9NZNMF*"_SZSN2G^SY6N.,.>;($*_2_&9[84"WV:@A=,
M(+IXK6DNM;BIGQ^KF*,^*KUY['W?W2<J5MI#:KXTOL&(3Y _J?_+^)<Z'NE1
ME4)O =6M[7D>;6F#4)L::^L4;^Z5S"\UJ@1814Z?ZO>T$=2R)3F VG7"X!7(
MCAS0UQ,U8AQ*.PUC' %?I+A6CQ-G<;G#K)8\:X"L/4SBX;%ZGKN.D"B7,:;W
MCHT(2Q1#8P^-*?A8##%0TLI'X4K&HX?35H* VZZD@Q1=$X*08L*&&@E1]0!N
M6?[CBQ[P]A;<:9\OSC"KXC\=%853=\] /B_NBM+!L!A@/+X LQSKYDUO #KP
M&UUT+OMM=JQ?%DA%!E=C=A8ZMC$!;?D;SI/5O$)QZ>,KMP:^LXL>&N%+*$(J
M1(?A#5V211VQ@YP,=!"1N(YA8;?($P8!N#*Q;W;UN^'"-QM5\C.O>QL&_$:3
MAO"1&-R8YOFF$OZO?Y(_!86%%AI:R5DH2@WC#C^>=W2+(=DVKRAD$7]?)PTO
M#@^:]S]3J;,W#> (^Z]B]-WOJ[M?:VJJ!X.?5*G.N:SXOL67[4%UQ -2BXU(
M&+(/-1G^[[X"#VJI*FCYA&'4AV YE!:[=6].EQ%_P3H84<RU(.'#M?+#(2-N
MXEK3^\3<P E&-[@LC;F%6(==+Z%<&B-(#J<J&A*)0'DU(#EZ#RI8*.^W\O$=
MZX/J7*O8P^6[WDWH*PQ:9]E.&(Q/&%C^=>AN"1\$+6U941/A-TI=7"@2"ZV1
M4QK.D5N';>;V^W]Y7KDZ;1M%:+@Q&N2%[)Z)TGA (OKLXNB39 *TCM5@#GCT
MBU[YX]N4APN]S"1GT\4G!=,L?GM0:O9_JSM1!J&5=_)C$D2^N,B=2U?F]N'9
MP@$=,CG.>=BZ;\M5X+_3L9^"VIJXQ:W?NL=4C0O.D5BB;;_;U4A-M!FWC4NK
MD4PW=77G<.(617W156+%KS-7<POL<Q;[IC=#P )P$R",CGD$OQ:*9'?_%^_%
M$P8_E3+8A+_0Q_;T7L7PVC>H\J*]%.^K&1JOC9UE'*YVGD;;H*&HI6,:,Q6+
M :[0HDF@]^J(LRU %0X55\Q/.HKN=7[KE_^ %'O",'S\O:S@7D=$J7NUB<;*
MQJ:3!D--FV7!E@OM #&%(1HAEX?(".JKWL!C'LAV\56@@3@Y^O=M7?VZ&[ @
MY#/_9,_(AC.[ZQW'I*ZO?&%SX@./Y8E3/[=$#T-OGC!$0_3.WX>UW&U?1/NB
M4_LE "4<U>,"TA"PK'']DR^Y,K,IF6G1\[+M?(>V4ZQ7HJW..7C$[<)(Y [J
M(KXIV^^$ ?I-P.6ZBV,BGB7L.J ]&_&-LU5*RAU:;:I<J8V8>%+6=/FS[8ZE
M$52 ZM3JD=L2\^<=J=)'K"\K,SSCN7W'49B_O.48<I5KN%\=:**O)"_U1=MT
M,OW?]I,"6O#&J@VFSQW@W3'YC_+D]PHG@_OOC3+TNQ0DGCDKDHVA4P@ZC?!0
M7"[!!E(X0-C ,7!<R<7Z)^S):=44M30:UQMC[8_E=M"6ZMY%\3MOC:[?O!86
M]*%F48+.^E>-:,R*1#[R!T"4V(.]0.O#6\;JG0+,(ZK<8'Z3[U^O7OV4+\IA
MI&VNRH&'R DX1CQ\>(4-GW?L@QR0[.=$K"";0%%H=XP07)_4$4MAQ29/L[G=
MA]7=3/H$X7 UP3W,:^#=ELW+69X)53J<+YJ+98@3X!F)(JPUQXG&U\X.>[SC
MAX-YOT7T^T276S176BJ,X&\T",I;'P5SI @E5_*(M1VYQ4ZSJM>^+5<G$JN8
M=5P_*9GT/>TQ6:=N?482+9P+"J:7S,CWNGL[\[>WD5%ZC!F1B5]]'^8;SI2M
MBV5HR>V.U7%E0B9+*-P90L]OTRY>I.;+]5I>;H9Y^2)$,LYUGWN<NC+F9SLX
M]>8H44OS*\=J/NT][13ERI=^!C@?X$VT&5K)IC654JX3$:G8=47;^=.IAK1)
M@W;G^PJ!IU7^Z\SF5BUPC",,J%'6D /TG-D4/V;) 9LFAU);P0\MF6#Q8VZZ
M@!'A^56*)ZZ$S5%MHRT"U^,\Z>NX>RTA/N<VYT2&-.,F@Z<P(C):"3 :64Z[
M\0SV3.N3D,Z >S!/?KE%T5VXW^0%Z8FGMEWY*3:9ILH9YOEX4<6Z(<-U+>NL
MC/E^PZX^.*41;D!/DD:/1+A)[/_;I[?M<Z_SU]NX"PXVF6:+!^+2_*V?%>!&
M0;DA!1GLRS.:*I+Y3$SW-*Q<XBF7!8Y5:&.@%O![Y'(!'K*+Y(MO/7AE!3L<
MS-$3[B;&-01&U@-I0^;J13UVW5W-#SLS<,WA.N.=C-Y>YN62%+X9\W^2[P]]
M3.A\V,$9&$J_%8@5R:P$IH<$/Q4%^]=_;ZC>5AJK=]RV,JS<\WIEEISMX!&3
M8,(OR7/,48H<Z *UV*'&,&SP )+EZ'2*B,Z,KD#=\G8_%V"'-RGM(;K%"[].
M&:I:J?@;\U/H :DN:@'W<F_G2%,.<VJH2^.41ZCNK%#L?3:)Y]:.;H)9=9^G
M9&XKH0QP39Q5>L:2TN+3ULIOL5\)8I\<;;*=WE0R&1Q.9->:5&"[KNQG.B E
MNYM(\11N3W(2<$J)&H5@A!V3?0)7XLG])(=!S"FH&Q\1DT Q44_%K9^QZ9M]
MC)P-@T9 =A=G3<*[3>";GFTO'A/4_H2+))/JWI\P$!U1R\$(>;@$\5_O+8+T
M;__SBL!M/?[M' ?UZS_2POCC9/^HSM0ZEEYU]98,/BL2#)E'4K@U:$P[Q#3R
M=Y+BT'3BBL.K7G/B;0+CX&JDLR(S@!F0%G21*'ID]>!=X9_T\<N\Q)I+3!WN
M45^EQD5 6';@"F@ Q0H/ C2.#6$EY!? $.$@&<2\O]?&FAHYS.G\$>X:&GCM
M4_KVE/BOQG<&5V0OW9S:),A<-(C0 O,2/S%*IFIYR YQ.,M.$3L+Q?TT*>:F
ML(_0!AF(70;J-PN_@+2^PJ7_MKN.9S-:"V;>BK36NHU7?RHL%\-Q$T2<#V5#
MNV1O1#3LE (0(HCL#,@>V].A:+*DO>,E0@-FBADIYOO\2[K7U;^RAQ76&%8@
MKRP19[9P1S[XU&/5=_WV]_Y3NLQSA 2T.\C!=/2)IZ?:7+@#%G3F^X8 20PM
M^ 1\6J'*F^W>&HCY-C7WZA?X^]H3!L];HN]2A%^:>7GR4W\"XG2WRP0,B& :
MBR@IF<:B5$JGNZ,-)%&"0G)XV8X>RYQ'"X3%]_6&TVT?N07.,177G@1L:KIX
MBF%:WVOI#/V-?R5H]O\M0?/\*]92N..Q':.)OUV5A^[.CZ)QTQR/]%7J8>%.
MMJE\]]YQ]IIL224I,X<-W(J2C=,-C:D:@8N_J7^JYZAGE;5Y7]>;7^9+JO:O
M(.4ASQO%@M8I?@H($U,K2)_5D4M]055<9GE"FMR-2M/,0K?\*G&I#?M9GQ^A
M?_KHX\[ 10$5XC2-&7HLY0MF466_Z/N,MY1Q"$K5%^;:#5V90CXO>]31G3H\
MRC!.3@S<#Q3T>&\LIM!XZJS#$++C-[F*@!2A6_Y*/S/%>5ZA%;V\,ZSM$+OW
M6_B:2?'8T,I(74/MI$C%,F]]08CN^+W=LX?1T[_,ZI #IV@<0 '9@;BX6TD
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MDK:"-]P>J&]E&/-03>E+HP?&O@*UH"E<O_NO^15?)O$E]<L#0_BPAH4B?)H
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M@4LB!///*#5YG8$53,*NOVYD9)6)6E>RD>_IYNE0+NE7&H:O>3S;_C F4=#
MC^,KR %M.30V5D0 2,:N0LXZPGY:GOTA6*%W]=U"Z_=>R^=XYI'OW>V]'8D+
M/ZU4_H>]]XQJLNO61N.CB'217J/TWI$J41$0$)#>B8!T:=*"1*(@(%VITE5
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M^FD"G8%]#$:^IC1G N4S@G3K8B?4(_F^ %=EHI<U.I5P.0['A=7;TSMCQE-
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MXZ9,T6-E" 5!0U?6_BNBJR #+(]D3\B -,H"_I?E;I(!RK_C6N.\B_ 2962
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M=CGOU.MR%I7"K.P0>W]D$HV_A?ZH@;N!3UY[ZK*(1L2OI@2A-9;LAR''\\4
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MFSB7.N:EQY%:%6-6E5B1ALH45F^S4X485^7GIB)9?RZ"1Q([WDH- IZ:_%"
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M(R+_2W-=-/1A</GF/-D\S1+!\R7Q:H1*DF"U@7E%F>1XJ;I$*WTE+JAZ>*=
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M<'F>B7E\:?-5.=ZY[_@Q]P/>9?Z7OXF3#()7OS3'@WK1O_DL%'FTY3K#S9*
MB^T+_ORZB;0";;3&N7P0TR*@_[!EBZYQA'! 'C@J**>(M0>_@^3 ^TM^_IW-
M UL.^:"8P<!KR&Y66TS*SN K=KA9F=PW5&R7;U\I86I64E+,DBX<*"15=DGN
M,Z-<X"]-OG .Z[T8U+-_6UZ9 A/YI:D( +)+3<WW]NCA6ZYP64Z2-@705;OR
M6YD\184+S)A2<H8UE2SKYQ\K./A2 $X/DTD05_==B%[^L>:?WH8015F2I8O)
MSV@J<L$2*0#S_[EB37W^LE\+.;^!? ]2OT+,6=FEHA%7_W[P24@SXA?\'05
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M.%;3H6D"Q(H9T'5\W&^7\-H86_Z\)V-P0^_>'*V3TOG4@3)4<=]\N(.NF.
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MFSBZDY88 U2%94KJP]"J#U#?;+0JND9Y>Y\!DN)>3CI*AD2!#Z-^[F\+K#!
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M?4IPL)<'[G#J.OZ  9JY7HB7^S3D];WC[=ZY$VM8LW^WJD_I F8KOG,9E ^
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M>HZD;QVPNH-Y^#W?JB3['PX+$XKWS.!GO.8W)R].?M73?LKQY..#0<GWFH0
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M'4+]\G72:[NU(+U+-TA?U'WX/ 1*'@8VYQ8%#RQ*R34%6U07URAYB"_*^%I
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MR\@\9JUD3]@-80[L1\V?"VMV)8,[LY&%X]9 $^QM4L:OZQF0;#.!^Y+B-XQ
M.YU> (K.\1#Q8$\ _I-B3</Z40/(31T/T7%42#5"&W@4&DSIH_&:U+US;+Y0
MMJ*I IK&/M\ZT\3Q 3&C.\%4.G_.S?OPS24V5W>+<XGH!RF=VA!L6/ XY4=5
MU]V]$$'=,O/!R;<!DYN;:96#OR8^% 34]MVLZ<U[YU/]8V)P]P2M #5? ".9
M<D^YX\M:89'YZH#4G@4<^@'"JJ?L^WP9R4UR>ZG& '&O"O;X'@YQ:BSS%NG*
M%#0B:*0<=]%FB=8)VMI8:]T+HG?B:C.[,,DGY0%^TCO"* /$@52@"KT#0CR*
MX*4D%P!M03;_I'))73?N[AQ9X:3GS."%N7+JS3^*W6]E;6_\Y"5N[ZO*'F1U
M-;=M&_OD.UHX8SK485&8F#[F:!^?4SZ=/FT^U:-I;V$*>V=M7Y^N5?;*Q(O2
MD&(ZG:<4&RRT@^6%I[I&:$3/N8QC&\S@-QD@Q\.:=[-XM"'35^_,[J0[_E'#
M7GI.2+.^'V_E=*XP!19A]# $AD(!J([_)!7F83Q_GGW[ X<%@G]F\V^7K9DS
M0%+O]DXS0)-P$I2>68-H^D?FL!SP!6TS J/,T9X\55J;F28.1AA4?FW[9(([
M#V+IT7NB]</P[BUVIH!=$H;\/!Q@S "=;S!-</D\L=[. )FB?V&;&2#W2NE"
M7+AEV=]/+LZ#FB<%_))E@&HAM 2D"@,T$ET FVE '8*0X'Z+)4V=J"_/7+ZV
ML@1PP3^59WL1Q;F,J#<#KC]-.6A\_%0P=A@AS@"EK,HP0%C'&/ISPA$]U%X]
MT^N8J<SB$AWB5<U4Z'^"]35.)B_PC/H/8J F_9_L7SA8M_?,-00V0=79ZQL0
MJF+5NE$LLWU;%/QA"_:: 7H90.53HARC9:!NS@E318 D4@[Q(C44R/6_C? E
MQ^!+5KZX3L'#'HL+N(&;A5(F%Z,2H<X< FPO'F#;L'\\3UVUWI>3+<>O*V.<
M;.T>.B1<KQIMM["3-LO/SGV..:<N9S*<<B>M2&"DUBHG,JV0&*J^(:%P NMW
MKR5^;W+YS>[R/'B:C2)#2VN! )R4<%H\_235HYXLD!,D#SL&)8P7T,J#9V3I
MMS*A.@^>EEP/"URZ//2F>Z!C 3KR6_Q%/&+R#!E]4>1GNC:M%BE,9:$5H-=%
M"$%!+YBTX<E*3>!\OU(7U'Z0TXV65.PA8"9>W?M.N9XE6>X7Z8\AM+5*:H'%
M^=M5+M55Z*FVWF#Z@==$DLNM8Z-V B+'M8K)?.YRY9W3&3QIO'7N28Z&CJ&Z
M03(2'VN..RIZ57V?:EAO08>J;ILYT)Y#;@:<1 @"1!19"A^3M(&[#8MOT1MO
M]BB _S1[ZD[23SV)O;M%RUXY_/@-?WI@_=TW_.2YUHTXN@H@1A;[,,>O)UAA
M4@94M>H,9%5?#-S_K'/BBZ3)4EU:N)FSJ\KM+.W#D8G"6^ _CI%3\KXH87B\
MC'W519[%=6F"[$"#M$VZ]!"%[[JZCU:PA8Q18EC'C_7[EJK^BLM:4P,R<BMY
MLS]#F9GJ$VT;P.P%H5K%(=YS\2=/T@H8(&_L9!GQ$3#'XSV!U*P'0N]EZ+.1
M[>O*+HB:J2\^D99L>GUO[JQ<QE>3$T&I\SA GCOR'@,T73E">4[V; M-@N %
M'S=S:K;#HG%<U.,<#K/>=('D+C,%%7-KK:%+V8FA3[Z::O*P?,NFGO[C")&)
M;0],2V1YDZ^[/6X=^V!=%-M-D+-INRZWN>?D(-TSS3THU"4ZU)QVYGG>4^14
M88AU!*+7O-Q0V\1IP/4GSMQU<&SP2RJ=XP0>,AE"1*]K5\.9'3O%H"&W!J>*
M;,CI&VCD":-!C<HSY/V#DK%D^<05Q7M+S]2J#[5>/0@"A8#K!*E\-O.:[9;1
M<R(X#Q2: 3K,S&9*E'- "2%AC@> M5/\)<A-CV:=W]RJ;1KV=SCF?:+>3]@/
M"E(AZ4*)L#_G)B.Q&)7F*[6\%0;UGG$.4M;WJL9*I,?Z4ARNV$D)/G1X:V4*
M=D@JTPE,E/KT)-VQ4[RX^DUUMJ7)=+92LUO^C]Y=<!-3([&RT>(AM\#A*%Y]
M(52K%IT+84X*Z< D3H5]BZ8&DU4)M+:Y50%]'MR6_M!U_/0'U_42*SEY![F&
M\P<6H/CUKJP3D]F$'R8;P2))FY:HP$#M_*7%3?..M5?APZI//G4$6?YQ@-;Z
M-IOU'<B\[;1;);==#:&\\9T3%?&=T+0;!>:V6)O9.V4'BBRR38]"7XW%6P<U
M:2H4U@AUR2I#&]8R[=>FMQO08P&1.-)5)4[ZP-Q+RV3(+<SD;GLW[@C$"QWO
M-)M7"6P1!=!P/[]$8=MRROC4E94K3ZL*6;-"N&:Z35<8H%O<@&PW6H^7A"%^
M:X5,;;B1F0AZ;#X@0?_ V#T4>TL5<BJZ! \3GC&R[X9"TR\G=^UO0A[2<T_,
MIB+_>%T+5>UO[. WB,[LZU))G=7!MR]-9RC<N+&L99$LTSU]-0GB;J&V/)(2
M>2J7IRZDQ-XW8\0L0Z\6YIE9E[0NN?%N_,<>!C<.(UU% Y)N=7N\5!5:DMYU
MDB\EEM05AW<N> %L60-!E4G*B&""MID(;ETSB:CIY)O1>^E37PI<%,JDZ_N9
MVAX,2 VN/=US1("95.160!1,Y#0)$[&-.>:-U&'R\:0&EI"*E8OV];Z^ D,B
MH0]\6:[=6D[O1Y[_XVV!ZT>$^I9'NJSLZCPOGLU0=/BDMR6\5> &7Y2(S9T?
M^U5<3,M]@S4IWW1./Q5\\ZO'7HO7W<V>"Z[2TYG.NP_GG+_^5)H"$]PRR47$
MS(Z ^-V3F.#BY9,:$P'JH5PJP-+FL$A.5MGELG,S]G9L7T5#L"?^LR1X/UWH
M<XEIDE:/39$%W_.\A5&93@.9GI6I>&B _<Z9GWZ-.?[K/_WGEEJVO:S^2$B<
M'"FH(/[_)<C_X7/*BG\@%2NGJ[P]K4GSPDEQ$%(Z 'L4?! ^(6]"U__ $Q;M
MM9C))"E^(:O@?E3V[]D('S+3/!O)F-X#;D?3+FX_I'"0-R87H@%6TH5'!\"1
M,*Z/8D\ND.XG7F![+?;4K1WV[8<<[=LQ!@BVBEKN 5N=R"RD1L1+5Q_D)[%1
M^1/H5A[,N)5G@.I M%>0G3RD&'1NYU]LN<H&/+8RY&.A8U!__5R'?AXWWXOY
M99C9/;@'88#B4;L#N%<U*%@]2Q(!PKU\4IY$;\*'(0?.7;Q(%D@M]\KNC"R.
MQ=[KMQYWEEMUY'C2JJA0FB$Y=6&J^X P]1D,.-5-Y7GJ9 ^;!'\([]?[J7),
ML6++/$AU4!6S/8"53_[6:(+]PB'WN?769*E3I;'BI\ O0F.!P?:\_+ CE5JP
MI_U6N=I?_7^Y8/M"?%V?RM[)R\4?=_;W*O.S&5Y]"PO\Q73K(\+,G&Z#&BJ&
M"]+I*QAJEC%5RY?.SN2!1D_G87M[E:A-#R3.RG5NU9*' 1JZD(?"#QYG@/J:
M,[]:OBQB@/0KF)Y\;'-STWB!^Y];@DEX+""A21,V?H3:^,'<M2=]EV8(_N>^
M3K:AJ;ME#%"X<5]?#_@)Y)_:I:':HW'S:7/;WB=9&2#<6^:^DM#5'3Y4C1X3
MQ@T/!C- ,7J>#)#B)NQ.* =D:P5#9P$K*8G_CK]_;FGU%Q<.PXY:T>O)2C2^
MXQ-T43*&^JXGK'5-F@$:K$0!!Q#-S4__"_8RWAWIP&U?]80!05VHS0V)GVS_
M;:S_-M9_S5@P!WHOBF2)FQ2A2#23HQB@M1Y2R'G .80X6H?N3/7"WN^OJGDL
MY\2)KN^7/FDF+?=2J<5W;4KNL 4JWUW:DBMA0/6*_<DRI?J"V.X;OE88^;2B
M08L21P.75XDW7^3EVC@5:PV7".1ZMRG<'K7VO51_?XT)B]A3G_]N-IG-D$[8
M[Y?X)=F2$(X$E"@\AV)/LJ\BH(_[0EM.DT]6Z;W-Q%2L"D=&._=-1LQ$\9B?
MEF^U@YX#8<=EY=ZQ9BUIWZZT5.PFGE6I$NJJ?ODL^\L#VT28FKNFT9T@*[_7
M%:Z2/QHDKT:N#Q[J'5C-EIG\Y:K[7Q@D_N]_,4J!_]\=\O^.C_\VUO_;C75/
M_PBS[S.H5F6]_40P)WRO#?6J.Z(>+0!7<JHC<T<WQ$J,)G5E5CM LKQ##_F^
MBK[LXG^UU_;G01S4JR*3ERQ*E+;4'Y!@[^RRRO!(#$R[62/=HS,>Z&N4G^2U
MS7W=$-57^1!U]YS"XD++?&&\7+OZW]TE IHH5<S#/Z1_A#4.E,W3W"DY@#J>
M2;6<T.$U/]81,D$UYZ;TG[)NHQ5&[W!Z$PY<V=35('7+!\;OF<9_;R.0'81)
M'?.UZJ1G\3ZF_*0Q3Z-Z/@)>0CAM\7BGJ4I@>G:SLZ61C)&*?8JUDZY:]M",
MUY[J)AM=5)T!.E#* !5=)BG1:&.07RIHX,X$E2>'GB3V ??SIRT#M-!+0Q:^
M#]@IBT-]?SZ (_U^R7EQUNR'*H4/]6T,0MVG[^9VF?J(Z0!<O[_M^3ZLQ\D
MH8(MZ5>*_J)['*R\B.9-@.U*JV*IVD3(KY"4O<=?F Z!81Z*=.C7@P=B_X73
M0O_367%?-Z:'V3 UB=CBX@+Z(_B?FT'P[3"2:<"N&GH? S0WP]PW56YG-QXR
MGB_! !4^UF$Z;+XJ Y3Y0.GUN2CPKQU+!@B$SLQ,@9Q"_7-+Z;^X;.S$"G.U
M$SR3'G]XE>FR\$&Z*W/,_]M<_VVN_Z*Y9)B]04BF5A+-.-)'.NN6@G\-]E2
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M\;Y=E<=D]<LQO65"Q5)J>[^NKM8H,MN71OT+0&!>%G<\,Y+N,6'F(V!#I_I
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M<\%8@&= TZ?-P1BCG$!:*?A^?RE83GNFNP'Y##G  )&, J:EB/U+F?H%^
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MMW2=[=(WGJ8-6J-E6N]'"]2E>_3[U9"RR"&F;UP,F)0C7AYK@!SR;@(?UKN
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M2E_\O7[#HHW"K4!Z8( &?-\@UZ3;?_REA4_E:/VX'-'Z8\59=NVV9E(XH%_
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M-]X_H=PR2+IX?Y RJY-/0MA[_/%_4"D_[+X@J5_?M, >6_5D"\&CKYC1Q1?
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M\,K9?O?,IF3KFGC;W)',-UH<$TUB#Z+?RES+DB+0OJB2=)L<"C1LHU>RB84
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M(?3 #4)YI2.[24,^!Q@=R=[)?D]\:R2!I !-QI95OE,^8W:'.;W;+[2S;3)
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MX[*5 47YM]\'FZK5(22\O:T?O<4A/>EU#XC>-95S,=HQ)>!!&9:'^.G!Z8M
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MDAT!-:Y#!-A7Y6Q@NC;.0=Z[Y':P:Z_>.>BR'$RRW!*HW2I/!K>PC+#PP(R
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M.:F528;:8^7TB,'GMYOK4R,C*A=NT,J?8><ZD]5+;MR_KH5'42S=G-DN=?K
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M2K&',4!2PW_![*5XN*^J=]S?V@ 2LS2PLZG4N>ZR8L[<\W@[I%^^9=F&%F?
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M]U+\WCQ2\4KQNGCO5?-KV"EV%B<C/.DR!]>1(SUGZ-L4H)$;"@_LGTBO$AG
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M!38F6L]CS<2B4\+A[M%38G0'4F8<C*%+261Q 0C I#9N8-(O2)*A<-2XON-
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M_?\>E_'_.*W3_=K!=83WEW_V(>:0@Y]U%9Y_=S:\B). 28 9@*LWGT@K!]=
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MJ===)&7Z]FTO2_LJT=Z?SF:(ZEV+<^3HS/P>3M80J%E[9Y68*4R?P%?VP<[
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M^MIH2+FFCJXIK8_DA&-+IE$>EU790F-=UFG@Q:T]@!3:E%F,]<Y\BFW"QOU
M "ARA)5TO,71O\'A;V]X-KNZ;FE?=+J[OS^?#8X((W<D__16RM.YI\8900T@
M9B;T\,+Y7.G)Q$WIU.M?+IIBBB]'IF0LW7#[&OZ[BB7,^#<V;'#BZ'?@6<3E
M/=,2>,K,\H+!NY5)3H6\#\>JBU_9-P^N-X^5&,-K'^Z]L[,E&-MMC7&)3V;J
MQ4%U.]GD&&*UMA^$:WY28[,1*']@[M:E$N#7^ACKC?4B\B6O4DPS%T#$C<Q6
MOF1#=;I,)9@8[;-/_KO3^;BJ&OI8;[DW< >7'E\^ZC+V_H-JH]=E=;VV.[.&
M%YDOD2?H-?AAAL9<!X74OX_E-!RI7&A_9M%E5/J^)S_TQ'+VQ_\Z379YQUL$
M(S,O9JUHJ7PZJ;3\_6U5P7IXGKA6J&2@46QP'@ ,<#;GDW?)MH5I[ZQQRXC=
M_*P@76#*>_,T+<Y!ZT\=H&Z_IV 5$SK.<**D$N8S#([P]:T"X!#PG $GS*-B
M\S]ZR*;K0GE&5E!>9_@[N_#HO#9JF57,(JY4MSYT$-6,Z45)(N0@SU:4*"<3
MZQ#*&8-AWQ$RD<>NI;^OUFB2:4X4$?Z1<$?ALG59ZCM"32A)=?"<!GZX'P)@
MW)T+&S=WG&*;[J_^[9W(+/Y"JW<Q.+F\VVW)UC?W +>>GOU&JSWD>(H5_07*
M/.3@,@!04?U/?*I*O_=H3WVN\JC8OM?:4P4]VU&\,!S)+>TMO7KLZFG545M2
MP0N#: .#*X^*+XD^@7?=K%4<O9*@U8\NN)H=7$N0.+C]O(G>>>P;+/=M&ZDU
MK['3>;.57$)MCT?ALU8;0/'V:UYTP)OMFTZ".\,#VKCB.F9A($^-5EW1TXXN
M[_84G!&OQ 6!1T<0/ Y?0"W '<B!'FMZY>B7'DF&.QWEA:&C^O+::#T O_+B
M,2O*K\>/O^"<ZPO?NG2Z#C3>.*[0',DC^-;3N:?R36MQ<*$MYHZ@C?JP[8#'
MMXV;+52[<NNT;SG>BM8Y2[$YUM;![>KV$3=M\<]3XJS]Q^5KM!8WJRCMO6"Z
M[.Y.-(5[P/T<M9*MN.,*[# 9W:I!RK\PXOXBVKC,I(MW\_J6EUT_ B(_V-WC
M$)5^]?Q7Q%/6"88"W8L($:7W?UCAG6;S/PBX!:N%8VV;G$X,M5>9[O^H'_N(
M_[@\&G_^Z^G?G4J2QEZ9@V8A Z1@QV3;F$JKN0&[J@E+#5H6V]OH]VGLEW+^
M&'(N>S%S44)&M,:_-KNYM;YE!>?*L&<S>!6$ :<S7V]A&S;Z0'$:VS2(2&V+
MO-9N4F=Y=VE_IW!>9WH1[8WA@DF,?FZ,@M1QP@>5E_UJL.F)Q3%\>R+*%Q,#
M.8/DHWM^7AF^2P$G:-;)E+3:.8JS)'0<[A6H/559K!^H+^-[:>(UPF9&!V,I
MS2H7Y3YOV\U;?/']=E7);TL41AU?N9G<S&D$1*(5_8MT^LZF6,6L0]ME98Y7
M*J:WR^;8D7\,ZN_51&XMS6XNR+])V1O[/[O3_W\?J,WX]RCN%VL9U +:$3G0
M@@L2(3MK5724!=6G@_3]EP2-*IPK7!<0[#GB9X^3]\ZX_MSLISH7QXF(8SBL
ML*$&:P5(<<WD0$ZL\/QK>=[FAWO=H@/?0)]8EA-AB=1-M>YV/:,O=ETSTNT9
M?"NRY;'?KHC&-?T')_U8I>O5"AZ(,N06,W61*DZMG<69(=C%<9C$^=&]>.NH
MHP%[$[3_F-W8 '0JA&*9>1+5>ZUE=U%J>)?*/;0B3$$GH@@@RD9B*Z]7[R9A
MD328OH!-:RV!VON5OV/+0%6Q<X<<H7A&,Z]# CU4D*=0>MAVT!?.,(0E?RJY
M89=@(YY#<G^4Z]3'&GU55&UD&091O;2/0_I<*LOU'YFI 8@_"B-Q+Z'#HR*B
MSV?6#V^BR7\..4X4T<D$=@FH[JP>^"/']N 1UZGH08DZ6:#@]_,7IB_,$EOS
M;@0"ELN"325K>/(%1J3N]+WXR^,%,">HDOG8U[NBV';U+;/UD,/?FV*$>::,
M\EY$V%!<>O/%K[4.)0=C3(Y3_/7FGJ]=UKXZW9*W0S%)[U;[^,V7L$N7G]^Y
M1D7AY1C\7;2;=*4R.-\0\*RAU";ND",Q'"CFMP*84@E/K5,/2 Y4<1R#G<Y+
MT;D%U+YP7/&.Z"#R%_(+$D"-/N1@G&T>+N9OHM1CHTFZV <NT>I\IY8V?XX1
MQ5JUVANL*HPJGOH&#.*N/SWZ087C0_W=V^H\9YQRK,<:Q"PO%4.'1!F=\*U?
M)39B/-5Y7O&YHGTU!3D*G1%Q 19NDR'-+?6V;DZ?$3_?OE*CH"\]3BV,[?+'
M=:UL7B,CA]>T^T%TQ7:R5R6J]\@.*(CWB*$X/(J43=^WFR18'.N=<P;'XH:X
M7PI<!":^,55^W5$DE6;6CY2H:9#(' $)H_ 5((H+FH,U CP-PK]9D9_I%BQ'
M<*>XG8<)?,_3T^KFK7':"M5T=XJ1OR>,A?NF*(AZ7GL:1NQ@1^>0XR12\Y\P
MQG1&]'<@^1&W(4G!C'NSZVSXXN_6>'N'V-9Z\+#';6'R0;*J,)<MIS$\MZV!
MI^39L2W,D@L!-E@'8_'&4^[TCVL0*C-:@4DF:+XW[R@R%;&H<&*7(W%&Z^H[
M#;\OPS)X\_M$)RLI'XX8H<:C[W%P1"Q7QCTG^SO)&:"!NSY@>WB!4(UEAHV]
M)FG,J*K2C-^B,_PRZ>2J,L9+?S9'D)8K-1(;;R%A.@.NWEU&<L;\VXUNBZ$K
M3?3^>S)X H0O;7?&Q+?P+=80KY836B8-SP]7] 7]"&,B[1)T@KYE7.EQ:<_X
MEOC?\R:UC@L.OTX<N/Z;Z]WN4WH@P9;5@B O8")2:,;P L*;4IF N$%<%8;W
M.TYKON<D+&>TER\N?X5TBV<YPGADB=#;IMG"6A\V(7%8BNUN'$KTWWF>)XFL
MOI5CE/V^">!VC_Y4$%*XK1U?I-2/2]]/#GOF&_VV917G;-%BO>S"+#*KR<_D
MA[D-GFT^D\\Z/8M?Q27,TSS8 !'DZDP/(!8=<NRLOD9<I0#:AX#'X">T4F&"
M1I$!Y9N55BVSY)8.K\XX[FMYXY+5-S^*WL]R51\+04Q22.4Q']7"JX)5!=;J
M56+"KNCP-)W-.UE\*=[ 2"2ESJHC2MNZ1<HY,'2\]UU;M6UL7:1==I@?.-IV
M(\A7>-HJQ>7['_NYKQ@\C*XH1Z8>G$?.8X\BSS BZ/L4$BV/HCT$X8?2SLLV
M4=+?QX_/)_RV</XAKU)'G ETOG':>730T.'>![X;F:]1^-+_^Z[(#_>QWS+B
M#V20HPWT6RY3W>$ECK*)I?[B,BU_*PK?!EQ-O2R>EK]W\S/5N2M]\L?PV*N?
M_WHN *RS<,@0NA6\HTN5HUUGIK,T$3IT(^TT@\N=/^KJ-SMI=57ND$7_>RCH
MEM[6ZI_,"I==7OE<BIAQ: K3D5F&%&4X=K,#^8<!H%844H:''7JXFRD;"=F[
M0_9/>+_VG&O)UA<5OHVV,5(;H#8HXE]5<<J^E[1T^<]F&-^8&])='8[F]GWW
MREY$,+'78W,,&(.QU/&%<,4-V);<X3_^-1(Z$YH3%CCZ36$N.,=++UEQYDVY
MB-R/484N,S.R(=GY[Y+;DTS<3]H8>PFM__XU9)U "-&QU.;!GC-SY&XG:JPE
M97\@E?.+QXQL^U2K>:IW;NWZGECMI'70*?F3*V#)Z'^C<VW95[]%3@-YZ@\Y
M/,")P 96'<$<FWS(T1(^'-^*$NVO@5[]BW.APYQCP0%9L*"1*S&.Q>8OM15C
MWHX5Q_'-@.E*D)VN"M;L:L/N$.3HV(-\Y*5) ]U(X@1G\QML5OWWT?S@AH\R
M1U)$9.9//#XV+8VZM$JY"3N)L&*V8?$EG;X#L%2K9=?OV$;DLP""OCYW;N2O
MUNYI,K$QQ:0\9/(ES]NR"T-<'#SS$]_4/C8C"MH%24U?JXN"Q(L#'=1[I_MO
MYDD ?X\*D9Y/YY[:E+<9^'PO?:E=D>S;>L>^R,A8HVK,9?&MZ>@/ \Q^'LPN
M?(&UA]"O"T *T2TJX9E$]_+ J'H_)$^F*S6AU)>CM2VJYIH\9*OI%@?'[:01
MQ>JG'$NO/+'_@23^'3T0!%Z:(,T/HKF1(X<<HCWBK'%V^) " ?EMXO:-)-U?
M8]$V0\[U&3_C3=:ZPG+)/\27$[[FR SI8G9"AY%B8#&XU& /?\2>S<"*^%R+
MX 72F'A]4;#7N\='$#M_.908^[]4%Y\3\AF"&[1<^CX>MH2A7:774.=[5Z2H
M9ZIJ&;)LD?<RG. 5DA\A^-5I8?EJ]AA_GHVF7P3'@B=\VUT[\9UKC0BS R*8
M4)HR_G:JQ*"9\[*AB."3<"50G6W_?6HX9<%_5N%.EHPBNK-2P4SML>:@65ET
M=FIPQ7*ETDA@0*C9E9SL)[\<HB<6P0L_6=RJU'V2R+]=F7[%*C/=2J$'MJR/
MAA)8-HP15*9?-W=3UMMA7 K0JFLY$L1<T>L[KE4"D7'9PR=[>.D1[,"<8.?5
M!FL!V+C>?F",4)TU +RFHPBW_V94$2%G';__YW2'N!VM(Q$OW&@4Q'-EL?K8
M9:^UYYQ:OQQVYBEHT[E#COM@NKSV "H>0@$'@FD.'=3=_K%QOGZ;X<BJ@/,&
M='3%V\>-;5V3/Q9_6-NFF^4="Q6CSCR-#F!QR5!^LJT>")\$D6#($"&)Q5<I
MPZD_?H$EAGT)U[R,NQNH)Y8LO!4')<7#GOED55PX-</3<_T7IAHC&:N< $OO
M>Q!YIRU3\,$+'8^?I^XW0NPK4WNG_C+\AGF3,<::;@ZZBL$UUD*2=3)B@RXG
MR!6;?7;^(9T Z35.^=4\\]QV^8KESA9,QPZP*9$AC!U"RK#C8,VP9#8@M?QH
MVB!!),#=G:ZRY6:XHF^A[4;U,VYM[C"_!_!*5J'LR4YV'\OMO82]7 N"8NG*
MVF3. R$&BEEE>,GYN_@_G"9-G YXY X_KWQ->7>G6_R(\<SE<V]XWNA4QCZ*
M^Z6#/^(,:G#8T:?V_]O.&R/+F@,>K4<<(6*.(:X7$BLPQ F^[^=5IH+" I@/
MH/LB$1^5[[^Z_/Q.,*#TU.*1E<^Q]*?U$?@(\O;! RB:8@EF.U;P)M83DSQ,
M]$WL/E='%U<]ZT;WM6V;1)O^]^;<S;Z'M=K3.:U_SB9^]>84.]JYZ>UDSR=2
MC/+T[CBOQ'\KM6$F6&UHIN0A5B:X?S;=E:?:/J82X#835"<B=\:DK,4J9$/W
M9GYKD6-E8F#(SZC?JCZ5#WY,X7;=W#+,:6>8F!XUY""(<AM\CO&8B9:9;(&(
MX>!;/WZLG(NRR+1N25&H+X,J/VC+.N=L$7M?6H"+).G0!L^DL85$#)F^03.C
MW"'_)"10*C(I_7>F7\_O,JY 2P>%5J0G\^'8&?%3Y)G:N]2[L? /=G:<KX&"
MFT"^?_NOV1=S((S9J(DY3L__X*X(.V>660&O,4.;= 2T=X<[><7@E;2Z3$9O
M'6FIFGBR?TZ?=5KIP)X.8W'=H/RD:5#F=UZ2)D3HV"'WTXF]/<+4B7A-";)O
M__Q?F3\O5_;VX!J!#^WJS80_2(U=V =L$_=V#.4 :<,>ZFFIF@/SI+OV(B+)
MGWHPFDT8#Z.Y7+U6Q9L::0#<*]<U2^51KN765SXS'F*V-:=J-9UM?V CHU6R
M@\B_6]$NI?O'_GFM37A /XAB=DZ)MCUO8%!#"K1\0(\ZF9 .7(00[U;1'!<&
M.+@#:6T.:OL&]]/JD.[;AQQMG P1&SSZ X1M&'I-D%(!_U=[WQ755/=]&Q1L
M@'P@'065WE% I$@4I0M(#3TB-704I,4$04!*0%% NDCO)00$)*%'D":=T,%&
M"20JX6A"N/$WQGWYW^_W?,<=UX?UM!_F."=KSS77SEESYW-/84]L9=H(?DW4
MYL87Z:&_(=EW2^WD]I2THAJR_*R>2PXR!=]%N#CAD\$KR8<@P7<.AR!F$=)R
M)ZLF'S2)@E6(7]];CBWS='A52_SL9-)DE8 +IS0VU'\'+8[>AGS \1Z"5HIQ
MF'BB-)6%D66W46H46:"PF&8WHZ7X&BY(5DM0U+I4J?MF]EO$S?E9_>JL5[^4
M^E2"[.MSI9AOX<&:O+]H93+O<QMD+W:ZS>7Q]=DN*#R0&PR6E.,XW=5E7O$D
M9%-WHG2BU^2>U!+\9T7Q]G"E5549)L\ [")@<<=LN7K?PM _+STOK7WRX ]#
MI2*[G+0O+"&&H/4BQ M4S3#D:M]^/,ZK@ ]F(W@0WPMFLP.*83LS2OH1*J5O
M4W2;WL;IT*T:\@:-/NTXIH IE#^7LC'>W74L.WT*V;B_?0BB:J:R>%^B^9-L
MD@3^C'GYR7T$DBP;6Y3,_#2[Z;JY%NKF)W[IL-Q1NOKK#/V4.)65YG60C;M;
M (AG;L^]H8')R%[P'_N/+SG(M1^K[!>_.J3J1FZ]5U!@_S%?%<[9Z7#:K;^;
M_Y]+S@E4&[@$T%6.[((@5_*$Q<?IW&&'('/2=.SKL!NJRYQS81'?'XG<3--T
M,)?Q#BW'.A7UWA<)&DP7S?_]>2Z M3_E2# IRT.-U;1 R.HUV3]WZ6+*Z:9\
M!YF%"8O[=Y(?O8"CTP!_Z9'V^Z:63W)ZI.]7W6\5'_83A/@M^KY+F>]&DLSK
M&%W$MB>#[(6 :U1M.B$B-1[NLF*6&AKX@2<NTY5;OD0>L"6.3^OJVL(3/EEI
MGCY2Z S\\5OM<DDE=DG2&+T8,SJLP*")?(Y2X:+6.?NFB=6O=.[:X"'($U_1
M7]6\D7'M<0*;J>9>W4<.0&ZF!YR(E6:\<1Q#_8J3ZGK 9X&J[@BY;,YI+</"
M;Z$1<?%%3]ZUA+,?;%_O\:L_YKFDIV2X:PLF.=?%0T6T1>AS!8V91)^5Y2?:
M\D#52L Q=O$Z.:US)8M;]KE<L"_JGL;M/G='_8](S]JR?7*-L?_TJKK5(U<Y
MI3#J/>G5T(]898-[,,L2G11AVT&+*C8M42-K=:G).NZ*20MO:UAI?G2%P'U(
M4IZ=7GK$0[_F7TXY4[(8OLKFT=8#"&*(D^:>M&+64W+P6K'IP'AMF<*"#NO?
MO]WBX""-.>;4]2;66@>Q_1K!I)@6,8.%C$(;Z_JSP%[0*"@[76%X5?Y!YP2
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MW<&'7]'E#*VQF_BIM] Z4\Y 4@N2)6,769/A;GU!Q];1U*7WEQ.+Y*FDDS+
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M&,L&=V3PC[@F&I<DFY(+^R<]9924M,U1@K+#[1"T]^;H\,-'TT\;JI\"2XG
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MFW\2Y_K_<=+PQTTBB:$8&)I#[A"$!ATT@O?R$**0Y;W_LG+G.!!CKLO-1"]
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M0"\,]"AM@1<7-X=P+TJQ-QL<@R?P\\8' 3F=35 *#/+UQ4(: S<I *]Z=K#
M#^9O(L,%P.R;JI>U().CQ\D3MP:ZQ*VC!ERQ-\JDITKBX[5TC3B2W<SKM!9&
MGYJ<95P+OFJJ.2OZ0: LM+AS$=C6]G?FA\_8OMB>L%( [(^H\RM3 #_.$_Z!
MH3K-R/;F_]F7M@@*X!(%D +ZD3L.PQ3\#O]= JQ#(79.08@_1[]Q'K].7OX
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M $<W"N [/V)&G\RZ1 %DZI)'P;AS6#9R:6X6+"?X_W4,5'W#CYBQ "0(H2B
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M"W@AVGL;>.L%:_@6S!1ZC=H^P?A^,M/?%?=0/\2&4;<%S7I1+(@-*N_-?S8
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MI530MB:>6H& [[86PA]!IC[7ZM-N_E:MS_?6-!6X_GF^(CFYQG+3:H5.3:_
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M002<?R=[HTO*!>L>#GNF)3?O>*[8HTTXF[EY2W+[3[*AC)I*Y.TQ2,#>'=[
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MF8<GF)F5;@\9&IDWBYM8$;8S*VLV"%%4 #T#%('5Z3A]ANBZJ4!+:>"B$QI
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MU)T!_:GJ)U-T1[<2H/O9>I/Z&Q<MA/=ZW^3FIA7$? 8 5   ^D];$$@WD7E
M_ N.U]==4N"^SMG4[OY2ANEG7@]*]L=R,Z#]7I4I>#8#_KF^&[N!4^DB9H'A
MJ>:PZ;R:'(.=11\;6]'"SI?_UNC^ES6Z?1RFD"F11 Y3;<!_U617]0$/6>W/
M\EQX\+2GB#DB6B#VIV6Y7Z-A J+.?D=M>#CS.]JI=7)_H^Z'"@/AX0V/YP
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MQP9U./L9T]+3BZ?OC*9_V8\\Z+>OE30.T!]V#Q\*^#I6_=;I*33^<B93[*>
M[G6VLKBLIBY7?+4AMX%ODO3#KLF?E9S<NY6B;0'V"[4!N0<\!OJ=H7+K4=CL
M]'%_K_V="I_*RD5/),H3U$"+0PCW Q8:D6O#A3;1O' IV-,IU#G\E?Z3&YW
M*:GWK;5$!VRET?5M;RGUGAU?Y'7/Y_)5<K(9MUG[>Q+#P<IHIX*D);4IFH\5
M%#24[45XX@M6DVM/C;PAC,<O@BUF2*Y\R$B8ZD<:C))6 <1K5W[+$'Q4=)_H
M0SJC3,PAEO#^YTW*RFB<@T5+0UV[-G$+GS>GG@.5%F(#7O!J>:[/F:Z6UB)[
M)>/EH]N<W%UA1EI HK+<^/[<8/]2".4L,=(DR,?'CWE&A5A4#I@899/X]OGR
MJ[RWNY;&+QD)JD_?V@9]6K8F--8^_'T1(^$L_%&W@"5N:#4^4_!9T6W='X>W
M*UXGQ#3!4LO%5,*^_RD9_%-5I(-*_=UL;O![?=E!L,E:_^'6B2RN@#"%L^Y"
M_@"OC.Z=.34GZ>L=@]BA+O?U@QQN,V<O)VJ8A*TSO5 W_-2DDWI@BGI\32A)
MJ2(Q[;NR]:D"HLL0[ Z<\QXP@TE^#Y)RZ8*P/Y[X.?TLY1QQPZ1 >QIVN_#>
MA^(I!7\-_YX@1C%F%^O#IT\YFLZ03-"TC-U5@T;;YWU;B?U-H[A;1(-!B7/5
M_?5$HT[)=T64/B-CB:C4KO5?-ARG9G1GXA8D=I:)X@X%+_? GE0 4<2RK#O,
MB&MH=0+V D?:[61K;&B:AF N9FOC;Z%]Q%46-OL^+V3)7=3[:NDZ##VNDZPI
MO>E49LA6^[!PQ#]=-MW]XJ.GK%W6_3H<@@)F\'%6&^OC=V&VONE>77<DWAS.
ME2ND&6M\(IAZE@UK!3%]-: "EB9TPT PR@0"9^8W.TIXA%\OP%7VAB;7KH+B
ME9\GE"]!@5U\L+F1UL(M($^&HI2SB@MT]WWJ]<=)CQ_M%UT]ZP_AA?> F[60
MIR:(KGOH)V3Y'C07$F5]J@+3(M[%#=CCD%$UU</5,:]@^L_C*1(/4_6FUV32
M?4^]U#*,XUD"T3B3310]C8+I.&@N_,9SF:-:P3 EZ9"([OYM]09:,SWR0@<!
M8 KK'X?T1)@GS9_*2@VWMB9WQ;^J+7Y0X;^"J%-.AM,3KU 876C7>(7_W=T!
M-IC2$B2RK[A%8$'<FYW<X:PN'XD)/7.P9HKH1'7U7I'-NYK.T1O@5ETS"*,]
M:TY9NNL/F&!P1$E$[_2 *8;4S'Z\75=F#C2K<4D<%(< C<8<NP?;BZ*K^6HL
MA?9"%DN&6"=SRPR,];6G<D,L)QI<%"O1J*-VJ['-=O1W/U9$EQO"99&I+[0F
MQ:<"6NF(BXG1N*,A@RV(.S&).5C#F<0TOE%IREPZH1@^0TCSZK,95PA9TB5<
MRB#,]/G-#:T NPK"Q^#?!=6)"1^VEIF0#:?>9/9>TV\SK- HOY>G=)UQS 83
MRPN.\N)]_*:I#']J:42I@+X,OP:?0#0 2>QIJ]P#9/8>=!UZ=^!4DHC^O"2'
M%TPHW7RSU9POTUGOX?N^^6_QNGJEI1)%HK/EWN(3X/PUEXT*R<?Z%M<ZOY<1
M:='XPI]EF'-+\LX*?UMN3/_$3LX&#D41"F-P^5Z*AV3?;,HRR=S879_UXRP$
MOBXQEO#*%<K\ZI0K$"I7]-89IT+2Y'>5# I-H<MTEF=,=S%3"7TFYE*F(8FC
M#.947U1[XZ-Z-S.@EOTWTAVJ\]17FK6AC,=QN%7E].OB;+LFLFQ_>7>+MI9:
MY.S_O+'=%'9S[)@%\1G-JNC--8F2P*#Y/8/Y- _BCYJ^&)+IUN*<6Q=Y'XZS
MT8+5SY<ZP+?P80BO%@BF-H->>8]F;82DH%GAXIL(>HI0+RSL/;31)WL(D_O)
ML]Y!OXCHZOPD1_9LN]P7W87CK2/W/E=R7)66(GPT<TF]D1CDAZ_;L/6$TPEG
MT&6@8W^VGTH ","BB[-'3<T+U^U2"?<99#_PSV &NE^#,5:(KBYGAWQOF+-8
M4/=9!Y0BM"Y.=F'_4? S^OC#IS;,:-Z[ I)*5T"O>F:*TG4L:J637)4AFMTK
MVX8L<1D7+3*D]96'.1ET&EP9#)[:EPP&)L3(1Q9WE-:V-9:K2GLL%N]75T_E
MC=\G"[?3W&0>WJ=43WQ.\EZZ6? Y>W$J(^F@]ZV"8;D&"#/?CJWDM^U_7\L1
M*]16G%K)\SK?CO-DZH-WMFY<@X-(;^B%#SZ5'J'[>:Z56WQYN>%V1G>-)J56
MV^I0S:^?XA;LAOAKF\]7,K\,H#_$8$:C"EBD$"NO.I4:8CY3N"_+[,YB%_4,
M3I1R;HY-9M*CC.XM-=;F+MT-C+O>>JCQ@W#5&F"]#2:Q!X34@)T@LT$;^89Q
MW"N_(US8!O=N1 F-^XS?<HASN_A2].L*0(T1.RKWK1X861D[5([=1 D'Q@^*
M5QF%!DU?5_ 4;\!+I&: 794/=)[-:$BN3!@9_#8(XD_-25@OK9"VF&HR\CWH
M./A V.,PA0C[_BTL0O 5X *93?5/[U&&M1[[HTFV*>PI>9PM-%//-$]Y*R@_
M.HW. =?-(T91H-_K8(HPNI@6;E7#*,8B!%K@K3/'(LCZKLCU)?2/O\+/N\L8
M4(_X)=%/BTSE(X\1Z4N:RE0 :W!2(^+7K>X@Q)'X9\[AZB;@B88 D%270@7$
M(0_H*2S']TR((L (2]8'B.Y!XNNG%1R/M[EX50#,^1OE2 QG&^@#Q9*\A.CJ
MI )^)<M<H"E4?2*M<PF!\\_!Q#4T,=+& 4+*?*@,.7DY FP_$6TBW>]SH+DK
M3Z<[FASM6C9'!> >%,QAP3^:">YXO_XKFM<T=+&K(250\\^.5YR7\:KXF#BD
M\WB#39X%E[>']+YS_B8 $5!V-=S[T*0'_<F$Q#&#M>[9[%0DSE,81?#6F(V!
M18BQ'[LGZ"))Y%(NG-U#V5HV9Q[(N/CN"\K;K/2*8?_%>:9!WE>.FI44IJP5
M-/LV#2SI-WCVGE#-Y=@BHC+>\'.G%OY2G.NY1?M13+4ZA$:4,L[-__2;[ [I
M%;<C,N(+N<Y%0#X4L""\#EY"6.%T6V!!DCI>OKL>IIC5P^K='+H[UU$L5GK;
MSW7#<1[2)QFGP9V9Q#&F[XNOJKYQG]46/:)QT^N/[^U7_:XM]II/C)7E^YWP
M/[)_B/-LW7X0S8JYQ<@3;UFDPQ-EU?@PH%]1HG&(=RY-]T3J1IF5?VYQNA/W
MQ7(5*;]AB=+<JG&[1L&Y DUX/Z0AN'^&G$.RPZ;,UW??@O'BD5U&N@]P5$ R
MS*X</0N3QP[+ZYD)X?O3)-:2HC_PQ"I=V&A-\RIW^XK1 M%2+R?$8[ @]'</
MY1+E!QX4=83@\P;C4HCL Q21,9EGH_30'FO/N8L^"L,&-IP/%N0BF.O3DZ8F
MH[N&X:&(+CWTDXM@GQ2BL'O?,DT5-OAQ>!8PH]3Q[D:XY(Z:G:9F*S[W1 VI
MLNWI-^ XA3_7[F4CF/+^T:D?87WS?27:/OL0-,>] MRSQD<0-'&ZT9W787;D
M) HWZ<KDD5_,1E<!J\)I.XO:ADY;-(M4P^P1TZFZ:\ZILU[AKYM<OM(L/7KU
MF(R^4")<<*A6@UBUE"M7\6-AAO55)F.RL(5+1IO%IV.1W:>4'DYS=NN"RQ62
M0N67#&0)_KX!QOF^#1.FI7\FK_$&*L+#VKT..#E=\0^;J #! 0J3T*F7UQAE
M''0>_?B%3"_-9N&"4"XJX,%$XVA<V^\>=?OM?+%/^:[9/2;?:\YBL4"Q\$6-
M "6F6^<2"RS))>"5CPRGETCWR!EP %&^6U #[Q[1Z,,V^+N?;Z3558-R?4HA
M9[/(FV?WK;9(7GE_3N>/R%1DOUKV,KF"I%SF"6YR)[%MZ$Q>2L*&5<J<\<QV
M('1(E71@B<E&2OTC7[:3%'M]I!:LAQG:HTJE#;Y=.6!W\"-QS(&9MPJ:LDCL
MTQO6#=^K=MWPT4AWJ>D2=U>!M'H3QOFYA043OL_L#:;?,-QY[]WSJZX/5IAC
M4)TU-CN8)?-<[':7U4^;7(>;2>&]!I.6UJ9DAQ8Q _BP0:Y9HTR(X1S\Q,O3
M<,XL_#G1>4&A8Y<B93MVT*XU2IREL9L\.1OA'D,T\</[64UK2"#P63W*CD(X
MMQS_,B-%\H3=W(MRA3@I)^MW01*O8@L3KYE>Z[FLBLP/2IEC_US CZ:%K!\%
M?;:0?ID$-&.-AK__JBQF-'S"]JYK(93HJ6;GL(B.DUJ;5RN^)?..:VH[,#%5
MHA]!2TN9B7:]RSA;"%&$*PG+ M294?#0N@+SFO11Z-#I'_EM9+@(_B?3F^GC
M[D:\H3.A7OPK*RN&QW_+%MV4%Q651>)<IC!X^KAZNKLPLY)<9&][GU<:>R_(
ME79=I?#>/WK7C*= ,@(20UUKLSXJKMM)DO=EH12!D7K;QC*K#(-;28RJ*+$'
M93HE#%[3;(+C5<4_\Q:U]+5<?0-]]1N'^":W9H5SVDM$A"<HAU8_3B96"TB<
MUH3'Q)MX$0C1>()8A*5/TN!(44XYH@+.;6:UY<(O1G-=7SL>BO"]IM.D[2F<
MS!7 :<R M)Q!^"W/'AB1LZO!WII7(*WXX"YW;Y,]$U8B?''?[I_D]5]26OJ*
M85:FFI\:4.^<6JV,OMSV:V, I6IQ$:=.=>!3CFKD6D7$; 0F9G<1YXY1[DF)
MA:L17^"!6'#2^\8T;$&\XAY;?_!44)+;-&'^"=_CS+XE^KQ>N?2 1*QR/S>)
M=<.,^&@99U(P?QX6B.>.T3#%I=PGYN$9@=Q>,W>6P$P+6V)^HFT.6HM9NY^$
MMJ^P=:L4/IA)\ELK=VZT) 9*]ZP-L9LE7W/^I%*5GZG.8"A@PAF+9.YS+.87
M<UHU87 D9/)E5UK!JG6J[&O&DSP'8>4#F:8?5T6X>6H,'Y8N_FR$#5<Z.'A^
M.'7 6Q.FB *X,D.B" *!5(Z51GL8^=T=@W-N"0K\.F;1[4VI^=RL-//I+KNJ
M'8_+,VYE9HV68F&E1]O: >A&((F#:85^MPB!03-!?UM-*OK%.4K7\R5'X 9Z
MN%*W.V^U3[Q&%"]KIC-<G[>;YZ]$[4;%WM198"?-(KI R.HLP@#N*KE4-R&M
M6YZHWD=+Z<[_ K-)L72F>*\$XXV&R)F#AHMCS7'%_)LQOX.%>_M^)A4SDF7(
MV5(D;G^:A[PEMTO!%>:W9O)56[[#@#*?56#6/GZ!/+@;H1Q26#=<,R$]X,Y[
M!S'E A=7^(V%XL<3_;A^ATQGO(4$RDJ.U\W27*%FTUBALW/;I=S)X_L':8/X
M/(T;7F4IV>:Y7F.]W1H5C+?Y#G.=9R3M-W@D=K[NE\[;0G(<[^VA@EM/ D\U
M*8O@^M][LBM 'N(.IBQN>)(*N/2^-0M+'^FWDCK0Y\B:.;=D5W2ANG3A1H!(
MSGDY#;GW'LN>O"#I@S>*:*(4<M>UQ$:_\L>VHR3^4E+Q]L26H_S4D1'C]F\3
MG$KSZX&;^QV!''X<SRO#]\?4%3P87DO!WEV'WJ-1BR78ZX!H9FJCC:D$SJ99
M1JR.0YUYKN)V'84%^1DP70C.=/^M 0M>UW>3^JHO*$Y6PLV(E;<0%BT!0QK$
MA<0?[CA(U$'.0S2Y.,>J!3W6,']:24@S;/E34[/O4YP/$7F^\_37K:9'?)>C
M2Q\*ZT<5:3R_'JU5S3C^92VF6])(31&''_Z(%;>,"NWLMM]/^;3^X:;!I1+5
MB=QQHU+QQL>3[.&>EF89.483_OHE+]B-2I%%'2BTQS["$_**@#CWGEPL3;FV
M20O\=/LH=?IX'U2@U!<^^Q/M;V%[Q7$OI0]'EEOC9RT&#PLD+QWC4[I!1 G$
M[@>\-Y8[!BY84XZ5.;\(7=\V!,>H;20I>'> ;N,7>WU><<6]T!#C";%F85Q0
M@+M97'H_LR+3KX=R 9)8[0B("9B,@C]4Y#[QN'"+(JR6.)%WSGCB/9XOZ1*+
MFUXPSY%Z6%FL_;U!GUX1-NFYDR)"/3D/[+6<0 4PP#EH"H.'(@\?H'V!G<V7
MPUTJPIT.P 51]>/'\OY.8:6+4@61OD>GT'V1',NF9KM@.RZ)=]_O6P]O5*0P
M/CY*7TWL&_K]I]0SZWL%7G"PAB__S$226B63"8O#JL37*?-*;>-4@GX8.+0P
MW1QI.MLG)3:18]66EE^MJI3.9JT_NX-V.4D[?_GBU? SY_G#@5?#5:XFWQ;P
M_D:1@3D1@W$BG^?*>E/B':\WXI 1"E;-#H9V'2P$;_,@N2[ ZX\W0E+;WO]6
MG".&+MF9 #>?I]DG?*U^]D)NR:[Q9N:VS9/WR889(JDB07+A(=?J0I#K!12F
MB!7T_+Y?.(VPC^<A5Z!T:-<_BJ!+2AF8YX>0WJTGOGN67-![3VX$=;)<WUNX
M%W+CY5.X[K7!C^M_:JZ<L>/593"H#K58,ZM:5+5(W+F35A;S6US$T<#W06*J
MK7H'R_;P1$1J0IKAO=3G\-!J]0:$X9P2LHP8H3O>N">,\3VJ]C.JG3J:+S[-
M4H.7>'.NY76[Y]7;&?$GY'^34.^C2.$V7J)DD-")OI/&IB@,@MDS.'2DH\HQ
MBZO-]YT+NU%0L&J2 *FER&RXEC?E'P;D""W51D12 3Z+]%U+;&WD$@W7%;_+
M1+Y53%D$&L-2BQNA IIGYYMC&M8GIHER5X&<[^)5GYJ,E'$>@)I'!X#,\%%P
M759?05R^#.XQXG*#C_+M['X3>OO^7YYS>_WO4W7]7"LY=#V.RAUDPZ2[V81&
MY-\DW:_/4HI^>*=1,K \KN0.>]>DF>6+$FVZBQ:5?/Z6G'_LTBV$I!;3Q(QQ
M&YX]AHTW&[-<7ZC;66_#T!@3HN3H;A"V@&MS#DP8B&LPH2,6.*;TT"BGNGK3
MNDGK_,QQ3GE?=51UZ0=)QB\R&]?50US/\+^^K2FQ!/:"S%,!&,CN!^2F( B/
MC(8%8B526!\.A#D%8@2X?&R_]\B<=!S^DRIM5[&RDGP;N7&70$@CU,Q0 8]D
MSI!TB"BP&YBVYO2HVUA$9.C!*_@5DJB1]#9IZR1IN//#^X>>OQ/.CBA>X7&-
M]0)ZK>NYTDGSWJ33W179,SU]#$407,FIG><]0W5C2*IX>D(V<70%?0EJLE(6
MV3COHT8X.7"<5&BWL\9K[D#6M2<4+K0X& 2'G#=KK-=9RW"XLE.KH9RE4V.I
M(<A5(^OBW[+;6<.8[,Y7FXA+WS398?\F%!DE*OZ@4A7[YYH:Q^HEZ&2B;Y:&
MM_&4:G'1$(^1?O?(^&) <_5<@Y_;0<6/8^!+F@ RA\P>$+YGK2*[J8"HDYBD
MOWLKT04L04A6:!OEMY%2<#[OI^Q^J-:\CQ!0*DA=V-^?$Q7UV%I;\GT@)!_"
M2@6L%/J=\B"ZI(^ ?V. UE72'7(Q2ALK$%*-$L'3#Q"^RM^[B?>OG_1I#/%A
M'5</LW-M::K_R8609.\'+BS7*>\&8\"S)@1SXG)(U3:%&X_88\6[?'8$_[T%
MP+NY5X*:2XD+0C![6;-O33M__9G*PF3LEGS%YA77WO4#[?Y^O[XO4D\**"QE
MWN\DJT64\J_K<P4WQ+LWQ<(<$H<D YZX15F>N;1I<=[M/"8I:*V%.;Y&M8=)
MITE(S-ZD9S;L@V/Q37[KYJ+DI-"EV>])""?QR87RVVJPHYM><5]K'N9N?ZS\
M*M;&Z?ZL\XI!7@9R*$SSN/X(? ]!DQNBD*1U<GSG><H8@A%FBDT)-ZPDV1-?
M%$'WJ0"+6L.P=T<^=^\WHZ;WF,VONDW4/'Y;%7 ]YNF9<U?C3PHP(!+G#,$2
MO]P+C%EF4-0,@^"66E=WC"2,<9 $#?/BA:U\/OQHK%MSO/*G<44&IWO>0Y5O
MA.ZE-.BW<'Y6_$5/XJPWPF7%@9V0L_3WXUE #W CC7CP2JC#[=*$VV40G1/.
MA%M@UPOTS#WKYJG^M=$!$A *$_M*"MTFI*YL]U6E1R<7CI!003/'-^0"T)W)
MA@X1DXF#AM$CS[LW\Q:K4?+:_!7Q-Y,$K!SB;=C.5#TE,J<)1'[%!3VUW+3\
M%BAYP!)3K=.H,LI8WB;8;[GP4>TMVEU=-[6X_./$NFE#";35N-A!7TQDB#&@
MWGB\<\O;8^EW6V>G[C*DH9G$,4!P(V=H705&+7,$55L!^1T\Q2HV3RYDE U]
MA'C#GS@^5LJ\;%>5BOH5SFEX-4G_SSMO"!9-XC GA!+%<#F8 YH8BIW++'^_
M#+-LTH>=P:WMEA0,= J]31SR\2[Z)T5<\1,5 +G1Q2K7<?L&_)D)+?1!FRE,
MKW CIWUJEU*P5]HALRE6^9/>2DK9B0_L]3]\6=]6M_M2&FM?Y%K8PK#>&Y(T
MF3AUP&<+E5NF=<-(F"1QV3I[9('.%S61\W=)VIY/*%?4L)MA&F;9FAT+1J4#
MY5Q?[B3P4^ 3@NN?:RX^;KUC(QY8E)1G\YA]M'8D_[K&CQH33\Z([@F"'$$6
M96D[5;P]J.!BV<_0)]=1K?MM(BG/TH#;Q+#Q0'_983>UJ6F2?(.<B? K> EJ
M+!F-.P+&G$RM9^#/=65NA6$+8@1%&K,,\+YI3K)GE\B[9<FRFE4_7];] [GR
MRBGQS:%U/'JEOJ .&.V+\BR[^P*+O+R]S$+R"5I!@[;:N!+\7X"C^(:[C:J]
M_)C]V#P]#^55_&0M]5W/=@815^DC/E !X9.4+U9HNNJC>0B''4P+/P'__HEH
MQ13F 8QZ/';#[R(5T'V_[9G__!?ML<3YA.Y?P-=T/!=:0,2;P' 8>P7L[ZYS
M_DY;2A1,M<+K]W(#%;#'ZA+V<9M/)^]%L+^K$^;/<%YQVH+=D,@;7]?T8CO"
MV3_]_PAII_YL^#0EK]8"@WV:>OK06 ;XZF12;.J#)!S,'EYI7'/M>UJY21:+
MI(Z@5[JK>)!8H$.@@6Y#Q5QXNFIZA8[9FH^67C\M>P)UN"&]2U^\PU(!1"G0
MKCZF14.SQE-0;DK#9\7AX1-T(^4JU$X?U8%#1Y9VYJM#]QI/>P!<ASV2%5GB
MQ57&O,%*9\"V1"1AC C" *^0&'".14B% MQ8[1QMUM5XNK9*#]N]J>TXR5TA
ME/-'Z?UKC]]='\%679#/A5^F](& J'/<I,L[J^9 >JCS7<V47KMWI04Z$V79
M^JMX\Q!SQ=[,O:L>2F(O8P3U0<+R=LNL6NP[B,O@E21(/?> ";.NU.]>Y*S*
M%N@*3."&4_&D+S":=#O(,[ALWN#=VS+"DZY(<8Q&.Z3M^2L[K$KP]629[<DE
MI431C<9?#-/(V!)EVVI[R8WP/I7^1"']NVQ%?),3_AEB'JLWYDTKK;/>?6S:
M$J\0TV1+78]OG\9WM"UW#NP?](/G*C'!7>#8O[D;.[%B?Q_!3W*;ZL]8(;,;
MQYH$23J[G#_)Z'VT;\CDR5%U2"<>4\ZY FDH('%L$+S)V92KRMU)[J;3I$"\
M>/^@IGDO_!)..$>KL9QH9Y -5KNR]ZR'O<^C[NX[,[9ULPB5Q0Q07D$ML)=%
M@L+X]R!WNBF$]ZDP98;H?RI%NO%=BY.HY=W2;., W1E0$]_1$N^HM1*T6]SB
MRW&<1W4%]UR/6GP3,?;WX(!K.+J#?L@\TH18[?U^"3YF"G-J;\7GPF4::EMF
M9KHZ?7X17:LAEG%K#@)/>._>;$CRI<]\S @8X*CCOP!AOE][Y ]-U+',>E3+
MF\F8Y*H#L?OF+ZU0/NB;H6]:%-5CD%C92*_L6"6V)%:7\7!DH4;64N0F@R(B
M@,&A!!$R:-W4M&:M54PN 7N9O$(T6.]*E,,>$SU/M:%E&/3+ Y@=9E%X VO=
M4Z*'LL-T!,R;ZAUHJ 9ZPVISO*.S+1O0R=H@L2L\N:\6H3,41J935?A@FVZW
M3,PR)PE1XY5_%6_]\EF224]HQUZ.H[?6+7/G O=\&RDKW32SR1]GNRZ_?_/5
MF3OMS^%?^!"S:JM_CTV__?54+(61A55+"WI')E8,(_#U S)I(+:^,O:]R*[_
M L.45:!;'.\C 'V$_7HKQH\9FD-AI"G"\\M40&2*]H1BWP3"_>%&;=.4E,^!
MCW,!A1563 4\;DVV>9PI? WS_([S4]Z+*HJST5]_;1,5=LR_>:YLSF"9[S_-
MR!2,5I*@RUS!*Y1/5NZ&I)>(_3(P0_&K>MU)OS$7L&UD:*PK_+'OJ]+JP8BI
MC\1\"?F97_E)SZDHHNLN%> ^.G?0VRF) [X\EK+^AYBQ\M'JU)$8AIWG54"R
MS6_)?5VS\\+;?HL5J6UQ9M07?'IQ%/9B'A*QI(';B"$IT^;?2K3\2 S6GVBX
MLN>^<O^Y&BI;L[HS6]'0IJ8D5?1@M3Z9LUVVZ:Q&U^#+"A53"$KQUY]U('U4
MY:O*5TE>4%B/=,]JT9T.O:D\ALF@:V:IE3P]<[>-<])O8'@#OHHY5'9L&9B9
MF=7[YR31TFVWO/:=<A-3*N#UB]_DD$7$9@PRC0IP&OVC7'V.TF]R!;%M6FX]
MS9="BCA [XSL4 'W-&$%IY<07SL\0 0Y*"W=-$LR:-E"?&GFI76#@LB*26(D
MVA(PHU7^4ZGWV?1_RT*]<[_ %";_4VZ2)[D3_"B%#SY2 $B)FL$J=:Q"SGE/
MT_?SE1%TX@A X/*BO==U[P6!-)Y2DVM/@YMT5)"K-HBN:C#.\A;@$.'>>0'\
M$XZ@"*/'W>)/._GQ[+%0.YG,AQE5]%,E<97QB(?=;5.:U1YF9> 75N%K:T5,
MT@X"Q\$3V4UL&9Z'H_E;HJ=U=77!M@]_(X01.6#2G;^U'^940#ZZ?IG"/4H%
M],X<B)"N4 $THP\A_RV&R:$"0%I@F ZY^"?1>8F?F(*;N8U#1@^\@NG-+>*F
MGNT]7W[0JOS]M48"HKYWR3YOF6DY97L\?G=$PPP+.Y3L=U59RR2;"Q@K5(;Q
M\Y=/K479!F7=6 P)Z SU;U\+MG;0+PLO,O;/#?GS?A\I43DW5RFQA<AQLJ%<
M_4YC1/;-T.:81H^?6?>GJZ2?S1,_9!N&/&YHC_N0QP:-_\JN\.2SVN6AW(CL
M'X5H5:.^<NV&"2/%(B-U&I?D?]P!\TG1QA^.P!D+:+VP\F''S/2"+@DW5BSO
MV&:4Q<"EB!LZM:V3QQ(Q;1WMWNI2QJ+GZT?VA&[=_SDS2YL]XM'R;/L*L!O)
M#>/$F40UOC#$S"1?;XGHS>9.AAE501?]"EO#[3PM[*'A8:T?OIFKF+.+Z<P-
MWA55)&AS[C@'D@YX36:=#Y_TL!L9<ZI*.%=:I#243I2I&_@M1^CWVY4VN/F7
M&$OCR\[O^5S/3 G:A%O":*X:+D?I1C-1KGF"6!4@YZ%HFW;<?JEB"@O1I6])
M:X9DM.('W&:ZFJUZA&;T,M<OM2/G:ULUW.:U>^)\565@KE.(_%:+&8I<#0Y'
M>R3Y=2<$X2&8_;S 8J)YKV&P_^4)2>D5I8G/3::?FH(\]&^W7AJ;>(]\+UI5
MR]OOG?"Q AO([QI:D71?K=R<U<K<0D*$KZ$U%_G54JE"UY-<F60>:5ETL21(
MBLVVNJ!B$S:T@I@]MP+J*=<"ZV-D+B0I4@&>PPA[O'*_.?E#B#+IIMIH[*[K
M1*-WT;H>O-?71SA5*K.=4]G7]$VV$3L!3*3'+,_F@V>9]'&/FHA,W#$U,!E0
M!*)!AD<Z(;C2L'K4FT!XO9AWDCANLL[+E+@W0O="6=M)LD= ),1%5@X^'176
M-G6%\,/6-Y.O>@$==R?GV98)MHQ^B.OU'Q=2[6QUYGAPZI&/0TW5'_D!="W]
M[CQ>9D4P[E01BOY\V0O,")/U\Z&/?M:(:HFQP.W,1G,U9TLW)9$_E"UWM?P)
M?FI0ERCZE1'P:W0VAL*0="H"_YHOWT9,P(WV" I/D8(U$[8R*6+$."P9,I#=
ME%:F9[RCR;7JD!I8TFO-2 6X_A@)Z'NE 8\PM=-5'A:*048F.R7:/+F_8<YZ
MVUG\5'SBXT2Y^.OUACR=M')$4N4@EO"T+>M&2&%J0EV;H??S9N.!S^!&&1([
MF&!&1L(<2DC_$,LQ"#;/3O4)*6L3&A?U8#82@B!GH1&F$UE,! &(Z9B@6*.$
M_^5?17;A_3?[)[KH*XGT-"/^0TZG MQ2+D-/^T 7*7SSF[8;?3+T6_ +Q%<O
M@A#!Y>AX$KBXAQ &;8QJ#S:L+'>6;,Y*+@WK&-Z0=^N<*(S)64<R\)_[YE]@
MEJB9^Q1M4[G+J:@R^8  6T#%%PNI]"_4IEND&MEKYJKFM@I]^_W<>B_L=U/6
M\3[\WM^3=X#H1U<6PWK5\I9?P;RU(K N%?H?29J(V'PAFGP.%9XVTSN^T(3[
MV,+WC/5+*DB8XY_,@ZR4\R_13MZ@3P>[HTCXMQ/ZW80*DFHMBG@%8W1AIJ>3
M!_=MAEUSZ963ZXW4.?WBG4MV#^HZFD/X^T*8*V]]H8L]![(=L[4>E<\U?+^S
M_O8$R6+&^6D?6C%.4'R?ZV2;M[$_E6AG4/A[=VZ]GLXXUV_HHD2ENK97NZ:B
MHQTHMZ >3&)K)OSS5W(ANL>)@1@P^XZC>G-3ZH .'MCKQ[--T4#A%M.CT&,D
MC:"!=\_R*OJX[!ZD1GVVLF<D^ @10.2<!DT)0N+8L^6SL0I4P%RSG> UXBK#
MY$$N$6W%A70GE#Y/"WISJI$8Y6,@-N*??3(=/]+DE^TL/M((&^"UJM8;B]PV
M8;4R2[]U+&0;:1= ])B.])JPNU-LL>KIQ7@Y7O^.F,3LC;9*<(?':;62UHL(
M@B-1QN=4"T(9^D1\(-+E8]*=U<F(PB'G??6R>MHBW20J04U9RD+?[J;<TL+_
MF"F"W2)ZKE !$9T 7%D/".")^-')@K-*<GT/#38\+&XYO93EQ-CE[;=QW_:A
M1LL;Z[#4X<14H^!T:ZG[5L)5(L8EH5/7S%"U\I';QJ;YUPTS+7_F>%FZ"@CH
MAB@6/1?3EGAX\W%AP_20*WSH$XVK7W;3J!JX$4QADJ?9XB"Y%.V;DE!P >6)
MNT6\[-%Y 2?=B-D+I+"-7D:X+++<H0(>IIX Z[I=$%KLYZ0WSC]YJJOZF?2,
M)F%#T2L?P,M$6H2)H@G654[R]!CD.^G:42Y>(ASJ)X:QS^17^H7*CKJOQ;(:
M$/\VT;S,FMV.4\;GH4NY>"JA<<.MO']L+:FAG:0<KY4".]/WA^+2&U(_RN62
M;1GUQ'HJD)'#(W"BR"#R19[JBM>@Q.Q8N.=D9G/]_^#N/8.::L-][_A8$!!1
MJM0H@G10BB@M*M*E]QH!D1(!Z4%BHO2.= 4!D=ZE2XT0BO0.TI,@(#T!#$M3
M.#SGS+SS[OVV#^_^<&9G9LWD0V:RUKK7=?W_OVO=]W7K]*,8-&E,6Z=I.0Q+
M6;F )C2>0AH[]?1,.X5/HSPQ)K>F;^<U;B4$>FTT<C2^?I0+CK%M/HU/%R/:
MU$0'IG+)>MBI=M]]/^N9]'K5>#TVL'HB1OP[D77S?-^R\+,KN ZAA,>U6T$1
M8-E$DJ>5"7W4WQ&.=(%X\>ETJ1:_/W?D@_+Z _Y 91IRB[]U7"1 (S\,'2Z#
M@UK[3#O-O^EN_YB_%Z/:U?9KJM3=CY *ALA?].D?+MP/KMJ:^UN54@1K\2#%
M5_RP=L\T+X;)I^<50SOYIK-W"X<\V$C'=P_%-26,>X<2$@JNP [4_MV1Y]1P
M=:I0'N);]]FTL6">S;M_<XK^=N1C=\_B-:/]4&>6EOH5<K:%PSV$]>Y[V#]:
M=JYP__*]:L#"[3H-/0Y-?.K[9%"2E"C=YTBPGQ8RV9K>,MI8FU%>3+8XA9:M
MACK-[>0P84]XK_G\IM(K?H-B"B.@74@1AKYMY/^'L-;4E?0)?"GWO&;1 A.'
MWHW\@WEZ#V6TE*;CN4K94-&/](&>H,21E5.F[F1%/T73 60=XFYU",*C@N^L
MI5WP0T)@=,<-(-:><"&IM&!44=<-I_2G8/*<X?>?"POUST5 #.5O0%3WS^5,
M6>OOY:,2.&_W.LR(-D63+&.^D"8"]<UXGWTLFG0;[GB>95$7**3/TB0G\">@
M17\YUQNKJDQ]WW$)H0U$$P;QN;'*0NS'\:K,&"$TAJK!\V$'/_8TJ>F]0WW3
MLR9X*E9 QD/]C.EYD,4=L@6R%PU">T#.+%"4@#\XW<0KO](5"%N9=GLI94N_
M^*^/[V.?$I?<K-=S^H.=KS^E/\AE6N3^FQ[3FP[AT2CB;N"U%\BV!9,+M<P_
MND383F29/BO(EML0U2Z9NZ^CM]04@.,H^&AB/*-=N*_"OO(Z8Q&17XCL0=71
MTE97WN:RT87O_V8&TT9RKDQ1F E-/=R-S27NW$5)..KS[LWYCYQU>C>X"WN6
M2D4EI^?;6A.P#ZO0?;EUG)VYT5"N#E8*DA@9'E%,U,5FD%8HXKE77]>NL^8Q
M7YGGX;/@J/D:LK%[M[L7L>:1;7'. CVNUK=JNVJ$)UY^F6_!S$5V.]0(#S2;
MR><<WILHVY[Q%RW70,X4RR .FOMY;-*LMVS\XRNH%F)U!YIKQSV)@"#SCA4Q
M$I\;A92"AW;1[HY1-%?%_S1 N-UH#$0:&@=A FII/MRP2A>UB><1(WBW$?/U
M1WG%T3FWNFJJM28AV ^HFIE8 F</M$XUD=!37QUJ+T^4;XI%Z.$D(393NT^G
M_<NMGGX0^OHUPOG#IV0;>$'.;&"*4M4F6PH4,6YG/.I;:I*O8U6D,G'*LR4/
M\>7W)M+YBA\9VI*,\YUW"MN5A#B2A8R+LMP_2NWEMC08^!UM3_WQQ6?LN)&5
M$0Z3JDR;JG($]HJ9%9!_-H\=8""5XJL:&X136KHPSZ-W7Z+JZ/#2^O"-D!N2
M6<TA@08RCUTD^L*H91!LSK]3N",5(OTAL<N<,_E$A;#=G-&'Q(R0-LT20*&G
M,3W9Y75!RWK"N+V==;,P@K6U_)_!=Q?[%J;,V7R5^Y@5V46<:DR+(TAHBU3Q
MJ;@2<L":E8F[_5;EK34CR5L+/GJ-)F&"F=ZQQ@U[Z8WSU-W)F@/AG=]D)N0(
MI(X9L\)&N0L88>=V_+QX'WI[K4K:6$][R:^P SE*)8*-&618=\;0?-K&7F&2
M$XMNH^2*0-RE0!0#ZCES*/@\\BH,?%:5#V[JBF*2GU/6E2K^%+N0E?22)A6%
MJ0;7C^PJ4FOOBH<_O4F[9#'&9CH]=&=ZS=R_YGUF;;5Y]JN)4NN")>NIE'BQ
M!MZ"/\7ZDKT?LQ=9W>]:_Q-F5GFM_%9:\KC*Q$' ;/.A003JF?3<<1?JK+ST
M'/H)@"H:)@2;)QHFD+L4LU2+8:)34;#HQTW(9S4C5>6"K'DL#P4BX]^R$V>[
M3D# 3>8=24(Q_E8X45B+X!6OK%D*F!C1I@E%X:O54?S7B8%A"*777^]EZ1'6
M*^5:$'JLX615)X'SCTW7U)BG6\1?68UX/+KW?GRHICX_+K4XQK#;+*9;WZUT
MI+)P7]_MZX#!<JJ-7OT\:['>P?)5!)II8G+,O>QSF4"9@(BI^ADS,PUVLP=G
MS!Z 3C]/+UD(K>:>@:OA+2(]*<*K\0R8;B0_^D[#<EKI@PR.E/?/K 1D'F/+
M7_B;<_&I^Q]99'/IL,3A1!]YNQNEVL3E"^YEN@_+_=9SMR>G24AXR+7R2,IT
M7=RM\-O6A?&(NZ9*F)/2WQ6VUU\MP3G%7)N0,_IF!K*0)++B-D)IXG#Q[EQF
MY=>?K>&Q7:H2$WOUKWVUVA\0EGXL/QX;>K/J9WS>T2E3IE9C12;)KI!-PS=L
MU9@UU5U#Q_OCLZE5N3^IJ2DMR:^*LB=GCAG%K><]/--WD!#77(*: 2!,2VM9
M,"08)%"L/G>6V+A;0R+:;(@WNULV(ML@\OF1#78W=5N:[\Z4>@YT/"K#"YJI
M\YZU[R-KG&9PD1.0(WJ^VI[ '-TA@U">:<@.Q$5&5BI+8U5T=8@947*,N4R;
M'$9_#'N*^HOLOHWI./$(95],-\*D0/.G+&JD;HX6VN<(;7 E-GTN$S,SEZK-
MEK<68S<5+/KXNL(QWWB&%!U\+$N22_8VQ;G JLPJ&S<GBYT.5TD!IR+GB!P
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M)PP:-C2USU LRC$W7-,MSR6RUW,^U.T^AWF9I-6R*/1^O#(B?_>+/Y]+5(1
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MWH@\;L3=P!KS\>9^ETGD38]BML)^\=]NFT*%TY53U!' F>Q"&T!S(5Y74*0
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M3KA)JJ$6(&\CAU= ]=!YM:[<AF*,!L&.V$Y4CXRH4KVV%>_:\D3#TC,UJUV
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MS KG[Y_>J*HM%EG(CZ/O19)2N?G=W=<J,![&Y=_.TAU1H%>PF\YSV9;/[P=
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M/]IEK^]->B,FM.^[KX(->A-#5.6I^1!G@Y@ 1>DP53K :W6%PN9":B.8GH#
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M4BTFE%7*S[?5O/O9E.;ON*<$5[XX+3WL"6F:1@!+;ZF+#(2VY.+2Z.]*K^=
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M&QH=-?VU1HVP,J)!<2!QOIN2#E&>C%C_V,F_V0*=)>]6Z5N4ES?MMOQ:I?V
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M:GTK9)RB/>U8MBI>4BB8^,L/2S<7G^E-D$V!F+0T36,37I8CI5(2J'1/FG6
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M,Q)\<Z%V7 Q^O6RBKA,7A;?MVA*R@9-M6<$TCB[Q#E=^]Q^9]$\Y%P-A/,I
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M<3HN\EH]SMS>*T:Q9Y>#W\G/1FHWM66.LN_6W(T7K(']MJ^0'@H>)*X<]<4
MG-1(ZVX5GH*ZT.G8,'XDZ2LNW_=B(V^4C"R7OK5S%276U?-D6F353U^'8Y]\
MW!2M,I:.F+]T,$@[QZVB?L$H+D$M-%LL+4(G;TTQ)SY5YXKT1*I)A/L5>\4K
M7Q_HUT7\'(*J*0N8]_HV*%<R;6IFKKZ9RD"XDYD:'P0@@4/O(EMC6C)9*4@*
M\VAJ58T"WWO; [/??D4EAX&UWYG!25(KR E')"=9.'S]DBB()EYB:L"(#W$U
M9K!1$XJI=N9]( ?.N>RKY/+K4..,ME/O@G[>RZ[L+^?.%CBU+!A][H.J2[3Q
M!)M4RVU.7EWN6/LK;]+%PN7G.T7&C;0NN*5_Z(W"2L8[:;T1<'-J]G3UKK2F
MJU!0MT1PB8 3:I2!F-I<:B0@#_FFMHR6+_A,H/#6 @3\4Q555(4<]N1"%[M,
M=F+HR>HO0N@S1-&4[^)-S]^[J5^'0\(!.Q9+,%T6(.+80+G2LL$:)K)/_>!Y
M%_Y35'OBL,4DNJJ[^$X,GX[S./CR3$U9BCD'2P/^X^U=DFNN7Y4<5,TT[::?
M%)*>S<X6O]HZ'C6@U+65KF@4EZL<KGP_KU](2)*I:Y^4C7UG3L9':=,>M\!L
MM8!RU+(K:0(]ZCU$T>\^3FO"'[]-2J5V-'5FLR=IDYX^>X=R4!O\:7SGNG2V
MT!UM8=^Y\R6N+V?K<HH?#3^B>FD.92O;3+QPZ9TS\<RZN&JDC=$<>5^5=&'
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M9IU%&EQA*J+^)S8-K<:4V\1')T<K9E7>/D:TLPXR$&-9E(M4[4(&HOY"G6@
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M_P;943#8J:XW^V=3+BGM!Z$L($"IX#GP3FDS9FGR,$#$SC7M@C;%.G ;^]@
MIH=@JOPK[T,GIOPLF84"I..?B:\M^!%T^[DGP'],DP,.3X:I:Y A#]W9AM"E
M?S3WCCS[#\QYC_DO*=5,S%]ZJH=V )UM.  0=T',/O3BX+^(=&LMP!KB88H
MZ2M&;XB\_.8RV8*A/T#O6)J,R "2D\)^[5],4@'SS^*-$M07Z.H=M AZZ0T2
M8%?]L3NUR;B)Z&R&CH )/7)UA:[] AUUKIL64Z9(96L!A.+'@A[/_J><'7L0
M0VL)O;@YN0O2QJYWT"-PT[V D[Y"E7 "]*;W)G06]@M.%JZ5AEF]0H+0XWS
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M+G,25'C^T=Y:BJL57JZ/8[[1EC;H[5<:4^]A6625=-M1YA15D4=2T >C,G!
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M:4DVKB X",E#&Z"C?)5Z=L\EXB<,<R6[ALUT\4,\8^A&'JH3N@=&\=D%A6[
M%A:D]LV *1=QL.X=>30;FC11 B:%H(8PZ_8,P&+AZ^QWJB-!VWH,#NSH&B,*
MVH2AJ19!@]$58)K0]:G)T3EB50S:#1Z)%H;SM65JQH\:W79+5:ZTO[6HXQRU
MM-E YA]M\R^8Q>47RO9V*D7WB9=HZEK$-<]L+%CX>E@U6?K.J1N;I>5)5$4E
MGES^*G%IOC'+X*Z%_E=IV9$M2%P<)3@*<*?XX #,3^W'T1S!9&:^#Y,["A.
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MEEU/Y1+K&92ZK.K.J8N^H0W1Q;&3J?I6/$.1G,B7XG&,L*=S)&NZO2"[@)+
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MO+[Z"0;3K/%S]<FJ#*ZY/[0%UHP_-?/H1/\?+_2W^G0NZZ<DWZ'M<I4["OR
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MK+(@RHV[.CS 3]F0@S4=^8$V:)P!9"@\OS3H0I8J(6H,/4+]O;FNPB\_A;I
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MUY5 A5S$ ]P3%Q/)DI+G0A?G O).\.<N\Y[AP[]L&&6[9JB:/S^K91IMTF,
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M\^?NM&]"^EGL<!IOE=>QXPGWRSOY+6RZ;H2H[AA*"%I'G)'RO8YJ?C<OUKR
M_G7W]#;[)?1W'<F: Q(NG&U?<BOL"_8UFI$)1P2&U[O>A@_AO_=VR5?Z$HUI
MZ.H)?-=SD6**XM4MWYT4P; ^^(-7%<O!#M,I!W;N=--XGFE(?;O)4W0LQ.'4
M$<V3-ZZS1D%/7H2)CRU=+2EQTC6[=K"EV?+UTI41[]15T__,*WQ<QFR*-G!
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M5[1M"U@,^+5BE*)OF4CVG?R2:W-T)-_LDL,Z\<\<7C2":3Y$@$&5D![T"(#
M,$7NM->Y1YK;6Y93"/N1#DMYHWA;Q6MS68(OA^[9^.DZJ'U+.)Z0SC^1%6:Q
M%I[:6%(Z5%!//XW?I90*L-=[ZC_L9JRY_^I1:VJT$YU8H11VO<$=:IO&QA,J
MQ]ITHQSV8HV#+%6HT"?'?RS4GZIO>&/AHW90[Q8/2B_U_/?0,1):A)H9>1]P
MIO:V300_LSQ,8NX?:^(Y7\2\2(N:@%6@SN&!0G-]52.'X!(.R">:XMMVY/@O
M-#4#)!+!W+',IYDY_=UI'7432\\,=P^_,=DN;3W]C&@6M89RJDMS/[-BSX4C
M'0B4UNA/HU&!1<<F7A0'Q#@!V)LK3B=+L >X%EFV?:)) @FRU7C:H!!F7NZ$
MND!;ONPR^ITXZG [VZ#W6=QVMG'GUV>\>;0ZJ*9KF';5=G7-J;'$M+FY[,;1
MB;<E)6.W&-!+HW4^WLC)-K88ZR6;!T)61%P>:#A/6YG)G$3<CW&H3EJ>(6^T
MU?K-29_N4'BQAVY4A0L5Z]F?C(H^K0?-X8"69V8S3C5"'(YB;D+K9+@&V*3
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MXL#_M!4#=$RP*SHT=-$/2>A JP)/*&Z.G99&(^LH&TIVD&?MJ&'C.16BCXQ
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MX";Q%S/[D>2*RI#<5PQ.";6/*NHHH[#_EGB&U$]W%FC<@"&O6 U!@G7I*="
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MUP?CR, (B27'=5K:P 0KHZ<QSLON0GXFF;B5'Q4[Q =-JV=G@26!5@-DSI@
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M9^R[!U13W;HNO! 5 1617J,B'40%1 &)Y0,$Q A(+_D$$0$1%6D2$@'I34%
M08Q2I A$2D!JI N(]!:D) A(DP0A+$C[EWN??<X^W[?'N'N<?>X_[KWC9#!A
M,++&7/-YY_N^S_/,K+!'V=/  6,#(P. 8P<'QR&.0P# '@<N AS_XNO7)/_J
M'!SLCP#_GATMG!R<'$> '?P<G/P<[!8 !@ <N_YZ ?!O+XX=G#MW[>;:P\W#
M"UV /P#LX.#DW+&3<]>NG3NA=X.A]X&=_+L.'CYQ?K> V76N(_<$3X8\?;-'
MYD)IHY!Y'^6HNO/]4&X>81%1,7%9.7D%124-S5-:I\]H7_Q-W\#PDI&QQ35+
M*VL;6SN7&ZXWW6ZY>_@\\/7S#PA\&/8X/"(R*CHF*?E92FK:\Q?I6=DYN6_S
M\@L*R\HK\)55'ZIKFII;6MO:/W5T]@\,#@V/C(X12>29;[-S\]\7%JEK/]<W
M:)O@UO8O7!P Y[]#_X>X^"%<.W;NY-S)]0L7QP[_7Q?P[]QU^,3N@^?-N*[?
M$SAR,F2/X(6G;TH;N674S2E"SO?[>(2/:I!DJ;^@_079/P<L]+^$[-^!_0<N
M(K"7DP/:/$Y^  ZPNO0T&7?!0+H>Z*U/=6N9\.BZT*?)M/F>[CNQLH*/\_&X
MH*XV-O0C)]Z1MF/<,O9W\:UREK0A78$-]%WLA5."<MG FB7Z)!MH'%-30K?
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MUQTG;'-[3(&G!C%;<HFG5EFA=E6L?7@8RRB;=0B-8 ,7;WLCMGQ@:MM!W]B
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MML^CJ"TCL8E84U[NL?1E_%4XB2\6*<22!L<:Y$!>,B(.!:,JODV=K0MZXRE
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MEOJH[5=0G;0;E^<^(AZ/GV7<HCU$]7_]VG@TS>*%.5RU#WV_KZ7?N%B<9<*
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M>7P]OJ'G[/-'(DF37]O*6E/VJK>O!T/+/$.)TSM.A3$.<LY8-[,!P87M1(;
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MOL+!WE0GQ<-HR.-^6E7QE3M*QX[QQUYQ^EEVW]Y@9'$#_GX3+(5Z358BBU>
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MN11X>I8ZG;]7A47Q*J_Y29I,=6+G7S:I4/J O[G#'QI$@,ZIJ&/K^R.4SE=
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M;I+G/Y!TU^N]585@AN>.3%,Q1W0HL<9)/<_*,-8NP=/RON%@)5I=[^0HG\#
MI&52@;FB_\V&^&KXM$-MHQT\V!]R'?, $P.N17>8"JZD0=84R5( _RQ_R"/?
M$RV#FA8X:*1+U_AD2\M9*678]E"1G-MG2)/J8UR+V4R3,(G&"#<S !3I.!!&
M",(Q*#Z'NY:X(T)G1+FPR2O +5BB@"(#/0SG)^U;H6,4CLONC?6_<R@Y?/\
MJ[E/ELQ/TXDZ VI5M;%%1RJZ)C62(EP&/)DRK6\>XF^'/#AN;_"@U,='I2<B
MU\"--S3UU%&7GY3MP&A2/&!!'">%4#$(&-%B%KMV@*BO0S0-5X$\ S,A= A3
MN-461<)GH1//%I?5+Q-:..8G'5OQ\$ *5D;X^(4)<;:%GLH,4><,9QF;CSC%
M2^[0L!SI;PZIW%&!KC5>2@7A!:O%>/@7S&4(S(+'G+,TO?W#.[+6/8=E0UY\
M4IY@K[5Y4?)0?--V5$UF2?7$+B1/85)L#@$Y2 >YE LA$$.^< _A=IP'^[?
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M8S/BG9Y)Y9F]0-$29H[ZJ*_@E:6JV&99FC36,=;JC9L1O65GY73!IZ2B-]G
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M1C\<F+!86/!JQ%RL3'28WK.?QV3&QVKQ(7N?J+:53T:00JGO'E%@A2N_SCK
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M[5.E]C>'RBBZ14"Y^2CE"M%AY4E^8^GU^YCFE@:KL[82/ADIEYGY>K\C&9;
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M:3Z9@YFA]3RY3#$TIF1_SR^Q>4;9^S7'EH_T/T8\X/#Q,;2+OXZ9WW"5P-E
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MI@5U,;%PK6<X<%64IR;CP[+W>__NN8G]25H_Y=SP<6^&C=!A(.GG'WHBO(
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MFAW1S;G<,#3 VGP^CB<(6S$@89[*K@F=_.%TJKMR1@?Z/).!(=SHG5<5J:<
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MG<;TFI-:$M[W0(@B>P1ZOD[C+)6'96$K=Z ?3BU I@QH]'V'"LBQXZA7X6+
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M.#U-!1 $&U*SZ*D?D6)PJ8GV)S&L]C)"X"'Y5# +\&1..NBR]]N\-EBXYX.
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M2+&[]/=+=BI8ILS.2YM@^/V['6^M<U5_]2A$#@5G7?X"T)'*>UL?!!"*FH2
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MA3C&$1J'@O 0F_%-\9$54E<,)930*ZBS(OZ"P"QN2Y)=)K]7?ON-\ZWSE)G
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M!O<"GB1^\/PM56SHRU3P8$EJ->K7$<AC8$KM%H FUBX(U2YNWKE!W.N Q+J
M*DFQV'"9-L>IN>^P[P?I#WL5F08=2*]$,\Y7[U<N;D_>(=N8 2)]$]'QD8'G
MY'QUZ/H(BR0-7Q&^FHI%C0VY<J9:A\J9E-0]RX:3&IL.-P9BLZ#$<;KX!O[2
M260+Y)/9IA+^?C(<1T8.TX1<YK6$7-6)9TO;@8[\G6]G52J<*I*O2!V<]\[1
MD#-Q9.3C"27@'4+)XE('<U(I$F;3P\U6!PV7L\7/X4D\'693=]*V'Q9)]UL^
M-"VSVD=+&R5[]')-52:'UDZ\UR>'*9,ACW8'7NLP$N??-&@L- :T<]D(R9 0
MM@%PC^L)M5Y\#:H0TKY* T/(OLT1:&>H)\6B6Z4%^$U.!)B)N':;.3;2=OOV
M>3BJ/<2$3RY-9>:.R:/AMY=I@PK?VLQLO[4Y[^O."TRL8IJAG ZT<71-;0=T
MJK>-D8HEKB]@V_AEV1<^AGA'"QI;D7Q2N]H]?3^]$TD=7P*U^P:IM]P9P?M.
M7FU%<^HH4+2!H47O^4F(+O7C+H3OF%?1N?!> LL;E:\!)?;VGO6-'35H3/?I
MD3=584_%+A<]VJI9R-EB\K.[!W@SI-C&M8_ERW#QR\(/=";H(C)E@A_\&HL0
MM.H8#9<H5>7+<'[8W9-'8DOA*2SLL?!EE=6P]+)$"U>E/XZ4\KTYNRR.>3B[
MG@/)\>6DF -!"T]9;I(@T5KNV0^;^$BRU(*TC^M[:L<U8%(S-?LI;_KP%"->
M?C+:A&<&TR=<Z[ 2")FB6\"\T5(DH/@>SK,&,J+I@2MKI5K&6., P>.+GA,+
M\$D:N&P0)'QWPS'$GVI[<6(!VBG_"JD]!%E HS[7MLS'J:DZ5#<<@6HF(DLO
MOC2<((P3:HF=V84-XTU",#>SN@11/NOZLC>OG;AB[[@MD*"Y\S4>&P'9<.P"
MN&T@$G4BE\C=5K+-1+E!W(Z[_+_8>^^HIM9G;SR*@A1!I(,0E29=!*2(1$5!
M0 B]0Q1$FH @)4@@1[I4I2H(2.]$I$F-= 41J:$()*'W!"1N)"1OO+_[?N\]
MYY[[/7>MN]Z[WO7^SA\[B]E9S)YGGIG/S.SL/4/0:'CBN\F&7_R2ZG3&'<>\
M,K4D42=5J>E)/%H;\>VHX5)-Z0LGE8#08IA"Q:R"0B^.^U*JFM=Q%C'ZVK-$
MF5W=_%3X@$CZUDK_7):.B?Y1E+GM@(G]IHI>:L/G1<4L].9<[_VJX%;"X'Q#
M^W8<^B&8!1&4#R\+5J>"BJQL#)ZO72PF_S@X5B6;/:W.'!'=39F[]V(>.65!
M$]7K]#3\2B^84UTI%YZQFA?OVX@ZGZ9G)>9]QK7DTYD(Q:4'3OM>+")TR;U*
M^V@"3Z\])P&Z*>J-S8E!O\L:W&@_N&-+YB *P*%&0WL79-45B'0W1WRG&Q)L
MKJH-$3W.MD3P\V0KR'X-\UYJ Q\FM0@3@^9YVG-B9N5'T?>1;(C'F+9S\/+>
MB\ \7NZ9TGO6TGL!7L%EJ^/T3AG>LC$9#]D[O?G?-TR</7VWY-/L&?GPY6X+
ME'WKF9,GG+:2TZ2DXXBG>_M/Y9HGR&/@DH";.[/9[DA2J;%_P>I(4J;VN*A+
M07*R3UORD':ZMH"=SJ[,93VS8+;5HJFEX9]3LS\[MJ8H/3N<[VM;WV5?R=0K
M$3'\)-/:)4W4$SAZ\>-GA1[W1"(5U(4"D:6^PF@))3O"H@ .O:DM7SE>[,=I
M;'M;5=YJ6J$"D_2T7]OSG0JO:" J!8W-:F,"7A&620\(RT\I%^8FW?BCHE#;
ME;X,;\<]6JZ?+ K]8<%QW<%/3\<YQK]65N;#Z6HC[F&M$Z@PR,-]RCE@FL)D
M13C =4=U],/B[?D).>T#"CW9[(!?I9N.8[XMO,&P\4")E'OFTB?.)ZE?&T"9
M3ASJ<%9#B_303R[XQW&>ML3GV0)T>@+1V9*O2TTL8W@-;-1,*I6T7I?M=NR4
M*ALD+2<_-M*UUJTQS54"/_&4-W)M5O7RK7.UVD#5]VZ(1V@HDX6)F# _6+00
M&W$V%@5HWXC$S]N,;HCKW!\^6QM?^#[3\)V%>[DE/EZO9N",F^GIDW[\S@DM
M@A6 +"2Z"19=NSY(IY<_@#]&E'[<>YAU&.\ET']U5P_MILWIW7SQP;'C/U ?
MT9.=I!"@T?G !G%SE*Q'R.^$'='@(YL##K-,P#,"6I=X,F[;U^MLD#.1ARP\
M]$UIH"+]AI9YDZ6P-LCC(4'#L!G(Q<,BP34-/6R >&%M XQ0A])0Z\5N'W%=
M5\S;@3ZU%QOK3L%X:PV0TNH;1JI$?593F=@^2WU-9,%5JSPS_##?6A/WKF]$
MU_))620#WP"+G>[8!0/30O7CEMU??!<WEK6\,^/ 334_N_*27\OX*3;8CL08
M2(@[NQ;GU<=;;U">YLPS=*RTT(&[I1(%7-)RV)PC/&401D%^7$4Y 1P+6N/Q
MZL](81+';KY-=V4[P?A%BGP1&"/DS.NW+@YVS)UQF97E#PIOK7^7Q6%8+YZO
M=T\XMC"^4>I<M##K=54^\MW#.C(;'DR/<#S\#>D$80&$V*+1K"T*N)/^ EX@
M^S6]@I5LM7&RLD/-Q$"9[:"BO)VMI6VC.UPD=2&US:YRN%4.N]SNE9C!LXDA
M).+#84?),@?**P0XK*M)NPO,N$HY_U:G)<##VV5HM2&_,W1^DT=<^\X[VVZ/
M>H5^E9)T-BRWW=[@)INS"7M8[Q(OEWG5Z5-I8&88NT$$_ZBHD4,QC//ML/UP
M/,1)R^\<GX1LX/6#P-V2'9?"$P9]^KLZ-S:5"O,'=JU)T._.5H=5Z =(MNN"
M/=7$L Y2M4XYS.7.K3Y=TE1])F32JU+.,>'&^(,IY(N%]^S%B*>V5-"FWH$5
M6?WPE<:Q=;# GN"-D2YN>5=O-PW>=R-.>B7D.[LM1T\\W+KG',YWVG@A[8H_
M-@ZS!"-SH$G. )BH@,5L>N'!8#C'':)G-1X6C^:7=D:/\^/Q-@+N5SU7;B@2
M'DP_['01Z3JUQ4??,JTWY)O(3DNR62GG!O!!*GNK9 $\.&8*&KFM9!Z4&2_6
M>Y-86)>0SM4RW*Q6F947[?"M2S)@VRXV:N=)8*KTE<K$+I..Y49SL\2(VX9%
MU:<^WS,N<+IANK!XW,#46;<LNR8N9?4]Q$\393$Y.V3@6VQ\TJ[N(SXC>/MS
MQM04"CJ-BH34BG>@8\!,BG.Q39!8W_?JL@CE O?L\VUMJ0]E6B"/2R8T [V+
MO^GY#O7L3*D7T4],/("EQS02IDEA@ 0Q=.>' >!.9-,D:A061[I7JC&FS1[T
MW8G,9K;*>M!8?^PNE$E1N^0)X#4?M?&IF'SG,#2$%0$![I4""KBJ?"0.'#$K
MK2?H0/1%LY%OC3D09C.]Y2*VYP8;W">57,V>-<1H!0KV<"ZUA&%A,0@IPASI
M):!/.)C_L9$R5Y/>*VC3P0Y'XGH3U:^6MHM'M)UU)96=#X+[]KO>?!';$/TY
MV4Y8,.[2 B;G3*9<%\X;B!-]:$KD='=L36"$,FZ6X @QE^*M:\M&"RUX#) M
MI.1VB?Z3!F?&SHG[C%GUF,Z+<O'PSGIE#/0/FG'7 ED%LXD-FZ*<^W32":@?
M8Q.7U3Q9-$,:BRSZLJ[?XC0\\I\<="('\=]1)C08)_^F3JO^[<6IH.LHZ>0M
MY>%6**T$V $1H(?PG$/Z7/*C[SF4*8;TH5M<=__XFO]_Y>!:1].A%T(::*6)
M?RDM[.ZO?RS'A# @/QYZ44%W-TVH(/W=45- =(4A&4H%@7F0>_N!M!K%>-1/
MA HB$@.H(%AZSD\S&6TSP?0\\F\7\F+^RV+X:?S3&0K+Z*=4T,(CPO)AQ$,J
MZ'N>VN&)?S]\*K4S!LC?)>?1^W$:V;Z!TSSPCP_F7SL6>@(;]CSX!*J1(@U7
MZ-)0)!B\<,1-WZ[:\E"_\>-Q04T!TUO>&Y$L9(Y482_K?0R%4_M77]E)*@C;
M R94D=6QI06+G%O?/6 TN8ZQ??9*R'D[&$JYA-"/G5>.HH@CC %QHJP=_USG
MD^7H$"[W_.O)71DG*S)QU>,7*SP1]:+S(B=1G\0K80#=P0DR^V%6 9 /B:PB
MP^8%$N/5("3EKE?DH%+9=Y3SS\;2UG86&F9;6UGZO<7[^*"\J&$48 3F0*^P
MT4K",%YD1^+OR=:H["4YIK=0^?(],R;?UJ04KE6CUY*&Q1(E9<D1?"6Z*4Z7
M2VL;C:MS?O4LZ&NLFMF;*5=VGS9KR]B#<%=!L,G(8]O?MT_!Q8V !N+P-K:^
MV:NTDZU=F>BJ03<D,L;5GJX[\J3]\/678=>R^U)TK^<S#F)O FS8J\Q8P8:-
MR=-KRE30R<J68W.L#*2X?@V47%3&UTD^T<:>D9!SJE:_"=@>5;.80!+R-,21
M7X4&J2#ZB[_>9/H#K6X0]'+>[ *^AG\L7ZO6FS-?HD-2);H@/[I66 !3HS.>
MNJ:G+7&Y*GJH6&"G7:J8I_F'_;KY]Q&/Q$@JR DUB<0Y;P00BJ& ,L%'T$Q=
MHMC-.K*8:[;U44/3YUTWX\"D[L<!NWP>.%4]^,3;>$:CI]V(12(#A;&!,-^M
M<9$(B2$?(4;->WUHA@A]RT0)P2$X:(Q!&,Z+'2KQH*DQ'7JDPW:6^_'C\P]E
M;406,.N)Y N)S^:^,]",M3T.@M/^/:F;'?C2N-M!_NUGR6!W/G%I,U==+M%G
M*47% ]9*CBJF29DF<87<.!D'_!9KJC)O>[M/+TYW/7UXW(6,'4/?0SU]TM !
M#D<?XX:<7LUF!!2(;'> 0MR#D3UQ_OK<^9/R+>T!53-?=JXN6(R$4/:4'73X
MHHV&6^E(L8<9Y",'!G %;4) @ER+=JX>+LL!TZ7!082%*_$,(Z"X5O\>>:ZJ
MPJ(YX9($EU%00)1)<BJ*YN^XF__2N_AJ#H7E'A7$!/D#/?  F'/70F/6FB:>
MC%5SNNGFI:QBNCX9M)K.;$N.N(XM-65-N0WD'DCZN[^P*N2NS-=S\I*-6M+^
M,#<!^Y##H''N$_%Q%XR]39SL#:0T26<+#)/UB.ZV=B$>#)HI6:0G6F;Z31\9
M3[/<2_"YK5K%T)M#T$=&:8@3 V+(.EBON+DS(8RKX%.RBRW$N:=M//#R [8.
MZ^\82?,=DV)0AP3*J# !][7H>^I/^8&0)BJH(_I?.@0'0<B\G11.Y.](KA9X
MF$+">?C+):6K=;J&^6*'L44K(VZFI66LF;F\(\DF1?DZ/OJ-MTHO?R(I5N1_
MK,AT#YK9V@Y:QY@LYH3#&,D\A"NXN2@-'K)&=49O!X6W]D F9ZHX:>GGYF2&
M#DIN2S0@L*I*-"#-0B9TRT#J(Q7DLCTICEO>%!>/4JITM",B.VE%,^NK)4)#
MUUR4VO,A=:?"_9A34_$W?4@WC[P4M/)^?:0[Y"GRGZ[ADYY\EU&WNI^T[7QL
MRK*Q98+OFH$?,F9-U<[4+'"JE*]42Z?N0EVNYRGO!6_;)E'!I/KQ^O$=B"K2
M&38Q\F&N9O!9BS;Q&+".AW2CG[5)5=>/*"&%$$:8 HS?R]IIK3FO>\5MBS&S
MXPIQ%V(#;!MT&_%L$S78@&=H-S1KR*1:962E> \;,^ +./0<:[Q%Z![/68S.
MSZ""#%:5%H278QP*4RD/E^G1FNB_,*LIJR]J\)B)XI=FEG$&_):28\(J[:,=
MIN&N_2SSQWFUPM_D@YU/]$C(G!ZU[\N(23R_&)>2Y$9*"C#&V,R5:YPYS(<\
M@$6!:[>C%+-X>HW7,X1J<.5#I0"DUYZ]A?*9F!A>=W)Z*IC#])C2VU>_[:8_
MQ_I(];<=H73.L@+GB.<TY-=AG&W29 \@U[GXV\I/N6=MTO D?7\HVZJ%=Z R
M]]0=7>,+&D,\_:HN62^QD>NPHIR_@##)P)[+::?A3):KG0S&"G$E$IKI2>4&
ME2J?ND<CU"J+S5^+\YH^^2(S$U;,(!O ];FRJO5R<%5EOL8Y@.M ":%VF$46
MGH<>A],OP]X/D0/Q*$YXKTVP#]%S:WZ,#/,3G:U(\Y$]9EXJ727C"%G#N*@O
M-5)!#"$?(0PM7 >J0#+)LB;*>ER#"UZVWIW>5.8>H.=7L4]1&$76*9F'KB!*
MSC9//6P*U'WC^!2&_.<&=GK ^W&6;E*OF9^4@XNCY.#4P6[WO90TH9:"BL-*
M+G/[+S#GK#TV9V;1ODI.?$N^U&,Y;2>DYLZ73@KC'N$M@B&3%$B$=(%C:5$V
MOJK:N0JN#2,R/+-'<L.9?MRY%:LCQ#6:YT+IYLYATN9DK]\SO27@ B@?' &8
M<0%='E+XP=@0";(-L#R?P[)*!4UJL+0!U7AVE V@U>XC3.G1+_'8,GJDWOX:
M&^R^I_#[0)W_A[C]RIO>61(> [U4OD'T*54C&KP.7+2[H93AQF0ZYIM7+FG
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M*'H$*_&8]4-O>TA"FX!M?5:5]:P;KL:GJ7(G['Z<JNUQ$/_/9 J3!Y$*(KT
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MV" ?^VN]KJ  *?$-IP/5D"Y(W2W4!NY %J%#+.YQ'E&\<F_^ <8IS&JL%B8
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M#"E@96K$OGAYCJS.01J4J0WYVB8E<_BMLWEG5^$G+>?#8<'UZ8=G>&+1%]!
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MUG#E+D$BG!>CV3R8X>_=&*ISI!&//#[CB[WUCOC>6_FUJ.=GQ=3!HP]N0[\
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MDON;C'^08SL<56D072M6PF^5X2DTI-KE<7<JODSG>E*Y5:?EZQ6[3JJ)HLS
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M?3R]5#_'=S6@R$(=?;?CO&C@B;!NOTX&9.$U U*#3-'G1FB!]HN<W)%?YY7
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M5?P@<G]8[,B9: ^33 \8UCT[1>I-'/E#O/N&P&*_G1K>- ,:BR@?\E_2W F
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MKA.'UOTING"C!?7)]8%"^*E"4//^_V#O/:.:ZMIVT2@J2A5I"@(6BH" 2H=
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M)@A+ 2V/O\3)F#3^T_E_SK+- C@07D:"#U31M3\K\_T+:9@]J4^%'@$@^",
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MU5_C\XVV09A3-@Y1M  N5')H51$A&A)8,2#&]6#A;RW*I(4VSS7Y3?OM^T<
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M(.5N&W"R//0;19W$C3?0)<$77N=-.VI 4 3N"%DSW8P N6D+7A<+O0;4E<>
M6_[63X\ C'004TL+<XCYC*D3U_<94\B$Y;BU^1<Z-0\W+\9VPN><LR:LC2=\
MCC<]#[;1JO$ W\JV8(^(%G]21.O5GN0_$1(HZI=4<#*%J5YE5T_F25+R7GT4
M[40NUP(6)6^9WBET9597DOU9*W%0,VSA4C.[!%=MD<'W5Q'DJ:<O>[GAE\Z4
MH:1825*/ZNM00PO.406YWWV858<L(T\_91J<ZM#'3=R(;LL6N6"^#8^:/0:?
MR\QDHC&A,4TQ>DP9YSB&@+B/EW^-<@M#G)69Y858P<#UI-8PC=@M#1T>%<W=
M)[+(7U/C09'.\*KB)]C'C-T;*1M/R+>@140S?%C'UNN)EL8L4M[<[EZ,#YJ-
M(C+$)8_0&_1&<$V#\TD)F@0.OV.;/\"H?INJ!QCURP#.$TRVC@+XAW%CH+ND
M]PAN;_3X%J8<.LBGA^HULQWV"8SA'[+PYW$8N?1-I"'H@B33U\&37'<X^^^^
M.B:@!XYP-WVH*Q;99:_-" 859.(<DLDR50S0]P8)O01"B7Y4'D?6)\5\;+00
M\+[0W;QZ:7IU@VC(=<4,(2TMY"&63Q%GNSM=TB SFI=+82?UY:X@Z$'VC: X
MJN003)0 GO<+H8CG.DX8URM-.K4(CN8-/K>^]BE272.0'.7I*JS?V-3UN)4-
M$M<B3=+&DXD_:5;\ //!RV]*$:YLX80_D%4<M7&($'Z>(9\Z("LH9D<Y/-F,
M8N95VN>34Y/'X=K'T%KKQ_;SV*OEU,,V4A2>;@[;B3Y'42'$=;@=7YT1)H#:
M8XPEW' S11ZR?4V9W,-ST6K,G8ER@QJ,_GHOPN/%K^0#)!7*Y X_@9X*C$.(
M!>@A%"(6<<:[C)L4IEG+%> 7_A$]7"WQE%'V4I29E+=%E'C4^]@;:AV5)E%)
M]B2F4R+L$5'=3\07RNL*I3MPUW"%X.M%$':>=\G'D[2J%\P3,&JX-3'4-</(
M GDM<\'=#,4^=:EDK7-16CJEWMD.7P=]G:RW'57B04KPN<0\;9((&1P\ JHT
MP<1Q@SJ. "\$6!SBNB= '<X8SL,EQ+SHU@D_*DL3X:(P=/>UX_.^FTE;KK8,
MB)NM"PTTRQEI2!81I*D,R@L20#:<BAL10XCFN?=QTAF('\<L#9P^;SS]ZL);
M3M7<EE_XE(UI_!%@CKL-<H$B=9@$8\6YA9HH$2.*QE==W%U+-V.K"E?WN.B,
M1U"\86D&#?%T"AFPGD5,=.SMXK*Q7J(K>-QB3CT"WT\VK,52' /A0?-N$?S"
MU<Q$-S92MWY]ID6S[O']=]DW'[P35YQ& 62_OU]6 -HQ[;%K]IE\'35X'>W<
M)<X>8:IJ/E;<R\Y@DJV%#$A\TL?@%6]0..BEY>G%H!^5DU'"ZBCB%@H<U7MC
M'9.3-C,AX??@(#/R6EFLTMV_Y;#?;WSAGWU!!T3:7]]9+4-\J*>/ &\WX+N;
MM.HJBS\7SK@?_(Q%\^_>[^:!#GK@Z]6S![*KJ-]S>@%_[&DTAZ@>V%3&5Q'O
MD>[,@Z)_;[JZXAU$IQE1XMVL,*WF I_/"' ORH/"=<RLC"W2>A8CW%N[JSP$
M;>("RQA)^^2;P0.S*% HK2X^%?P=Q.0-CVSA&/0YCPI2OH>5E+I<C1J>HU7Y
M :\&37NUV7XP.IQ@LCG>@)<Z4?'>[WWQ_7*Q8FLQ!36=>0<UY2\<S<6XDXI2
M?JGZE@4U*$UV25>3'E?GP"9L9=!TPN20P:\$HA!>F]:[-Z%KP9L6"P/'Y3O+
M>,Q5W^'IYY!E4=[*PR1-//7P*_&9S,KN!:&$CH9H:;6 3<[Z5+F9R-LG6!D.
MD4T&9 LPK9#DK2/%S</';!8@W0,O9@'>N54DIAEZZI>4]H/E:,DG_K:D$!\7
MN##D486)\PUK8:NBU,,+>#"%G9UX@N2RP,H"NX,7V5C.)OG1*L+ARR,PZ9*V
M^3*NJ99W\..)H5 7292FBR!;P<0[;?;[W  1.H& DMUYR>'&.K6)7I3P.T/Q
MX^=/&@-.G7C]0@D[B)V_SG>QJU2:/C19*<2R)==*FS$N:YMD-^98UZG7"G>P
MY\SCW. HT"U>$TOB<]I.35Q3"A6+3N>PDS3.S?W!W;^$-?-JD]C5%!>7C.S^
M-4L+C>>D78)\%X(;Y IB7I^M0G1(G7Q&%3_\6 J#S MP.PNWKO*?(C ZEK!2
M+@6,O?P:47H=LGK,YC@;RW$BYT$!.< Q(+F"S$O]%N#[MK(W ,9:8'6R5G^P
M&9F$ZNO$&5T0"A[@3=[@L"66>>+IVQ%A @RYA.9N3!R#&507'A$L[':!1-4^
MXV S'\=9#7)P\7ITKI$5]1[DJP60PSXI=E2"AWOK>&%2JZ\$B70$R.5]='IW
MMA@"'ME8*F]B*&9((0.WGW]N?<XS][4J6DY*-2_MB;LSHWK&PY:\D?UE>9'7
MR+ WZ1E:23X)V;V\FI)J7(,)[Q[E71OT_B%I/SRRZ>PE=R"$(CO!-,DL%#6\
MVQOX7#H(T')M+87HJWH&']<6B&";G=*6>=2:'"#8$-,Y4K-G=S_3%Y6JD"6H
M_/EN8;P'1 '>)MW$-\\:394F#?VQIDF*BS3I]4)+ 2A4E7%B5GUR!_)*26)2
M@&EJ0C#;I[ESX=Z5KX3K]O<OW7RL%G2&+$/MZL:%M2+"$95[70:XK0@(75F3
M2\$T3!X_=6OF+A'$4BJ<O 7&[X4+:FC(^V+]V($%KE3M(LY+L>*;98Q0!\P,
M/7XF9&Z+?I4KDQ]?%K)#\D:P/O,]?;5RT'OR^3Z7[V= AT?\@\\](NFC=1N8
M,W?-#H$<2.L:E_>ZVN>+/U86)EE+KQ$:C3B=1J:%(IK\_9]Y%FCJY'PZ [)=
MMBUH"VP.RM("#NC$-Z/6W(,ODX;F8J3T"5NO*,KS.KP6),Q<W$EKTF>88JQ/
MD-.#^)'EP:^CA5U@8>K]L;1'"6\5>\J6&8E^AS%'  ?621L<ZR8?62OXVVRU
M?=Z<0%2P&"$E9A-F@=N4[TQN81JB\DX^DT[(O0V\*9R-;,F6J'\D:1O?;M],
ME8M'9\?(SPFT30LL\%>0[ZRVG!HJ:9%V/E!!A.W"+T:46A_\4B\'K22?LP#&
M/'L2[@[RB5=07 ;)_WX)^\J&V@[GAKEY$;B[X8!J*XW.U*3QEM&?&SX97NI5
M6-</>]43R1^0UA..OZ15S?8L:M^#^\T;;CU?IDL<ZAC"S'M9,EL^O,&>_"0$
M,[?^](D!RP\#]M<Q8JC5.W/K1NZ)8F0UXQW<IJ.NO*91GEB,W"<A;L&/4_&.
M*$>Y!"=-$1][U'?$#6K;[/FF.PNS)*&43N; ;L)D30(>HTTJP9,Q5"$Y\5QS
M:&.K]9DNQ"=2Z@.F&U=5D<X1RW6G]9_ZT;NB-B'X!V3&0Q"1A>1R^%&07I\@
M'XTJ8KW!UJ@Y(GO9(Z_I\=R^Q#%F-CI'@W?6?>2'P?T'>QVLXU%ZAZE4@":-
MN'A8(]C!^-!:IM$MM]PQRBW$66@D1LM"39TZGCEB)"&2(I3.+I[P&G*;(D'R
M__C'5^X"(3/<;^Y\)-&UIX)"JBD GGF)*X/*X!KMZ*7 =^?CC063GVH*5WRM
M O*+''O?!+RJ[E\*(Q#:-4Q"VG$KAM$J.8F&BNM&G9I(1JGIGG$AWKJ[6NZ-
M+@;(WJ_4X9R1S6DA_L/8GS2J2I'_CUG#LMZ@?29'].X>*_6-^."NV_Z963@6
M Q<JD_EV!%B\26,E[!3HX&R9]@AZ423H" !AIB17%0PM'QQ#J'$8/]8G&/U\
MF4<R[X><=1Z=X*Q.[;TN+W^C]Y;VC2CADZ;[S+7IF4HLJ"4(/AXF1R.]*"2-
MW7]/%@!5GZ;';85M'_O]";ANTQ&@]V197+D*_:)X90RG@JB7IE4CLM>%KR'O
M&VO%$0 G2'(Y JAQTZ*JE1>-SZ:> X?.[NAYHRG'&H\ #*2M'B^!U"LV7)LM
M]I@JOST_FPO$/FFZ;\%WJXEL5'_X8@MD>I>B[(3:)J/G#HX VI"_,.;"[_NC
M6>_L,\!-( ,@2LH1X-TN-3FW!>)'$8"L.A-!%$$$,WHE:Q5.HO/[O9BN)GZ2
M&BE)N^Z%/!P'N>A"GQ7W!2$HP?X\62X&SX*]6Q)ZP>#5L;:+K[\1D;O0(P 0
MO0V1HM66)A!IB%0CE;5L!T5F_P<Q0/\@9EGL#9J1KK7N"+S-V_6A_#H"],#W
M:>(X.?_8@[?1Y$/;' '^7A)=51&2^]@T04#')9LQ31SS<D7Z6R"+^,+SW[K]
M,=I! ]6?YFPT)8XF@NQ_S4BJI>A,^+[4$>#J^J&$#JQEBZ2*'L1NP$F:JKSP
M[VJ#1P#\J:W?ZXJ^2<#5'G)8T:X$N-)$;5%HWW[P"" 8#P"P:(J4T\6# 9[/
MCIUF0O*9VEF=MK53N6#JWDJ\&OGWXP>6-0X-'#3L'\8= <Z(8-P.KC5 J(#I
M/Q;__?M(,^D^S_]ZF^-Q .MGO;]H,(V_<RPGH8O^(R7DCU&"K.# (\ VA*J!
M/3!/W0^:Q0?!D65C--W^_J%Z_R@5S./E"NBR^N^!!/YKT?2' K\'T1C!_AHX
M @C1'$9[>$%9"FU\>IHX_[\I_E]H"FEH"JZ4)?BJH\WKGHK?&;?6=*<4RL4'
MNA\XP+M*?-M[3*ZRQ]&]US,-_/6ENF&@O"S>]L5S5WKP'>N\!3RH',C>>@2(
M8Q^#^R*_:^E9;F,_H,.0-7NP68_,K7_#1D9_IV+)OY/=OY$J^S=*Q!65+2.H
M-"#Y_!M<#/X3\03^.N)EKZWO+Q\!XFF2T!X_C.VE@>=K&AP$=__3@^/^7C+Q
MA>C_N] NO2+E<7C(>.SQPI]/@P" !.TUPF^*^:?AX'\VVNXF4NWZMW(C!?MK
M[B6'HPKMY3]9KV1-_!;1\ IU"I$GE;(7%+P[^6^8*LZN-IFOQ5N*BU /_/S%
M#;(E.2?/ZO%.S^6W(P-IW2<00:7[]ST0/>AL9I<Z([J96U<C5FM,T+Z8,%'U
M0L_UJ;XUU]N+']^*/OE<E-OO\?8QK'#+;GO2,V]OW.,M>I-?R>O>)\ZFQ69_
M$U<"M;3%_C_">O<(\!=2W+#@1+RH;<0'#ESZY6MYW\K/T]>*E/"WB_OW_H]2
M/N3/PYF]<"+4N:0F_[57<]?E^Y8.7M5I=TL5IQZ<7U;(S5:[[BAS2PUXJW0E
M+R39U$XW+2OI5FS]YZF<Z%?2X+7U8/_)YFS7#'^70W_EU#V(7QYBU^<76>3_
ML-C]GV3J?SN7-V",I5#^=>M8"?&N&A[D['CI9U3HX+S\M7)EY9_!@/M,BSZ7
M'INTDFCAR;F.IGM!>^;![,LCP*5-@]K#>\OY&:?S>WYICKO\W(?['5!FT(-_
MV,QM,QZ:@*N+?S3+)E/>[OA::LRU?_1<G9W(Q:3G!7L<L_]HOIZDX.]^OW&P
MMQ]##4;FXVF6%$LZ,0C[-2)"A*$;?YL!COPO4(?!W[G#_/\X$OQ\8VS:4A0J
M(?+A3MNSC_X< IZ%:NRFTQ;Y_ILB(6<F>$RM946^<3V2WM0>:R<2X]'.[8=*
MGG]7KQZ0_S0#CK]RYS@'I15W._GSR1.X'[$3@<X?)'YL2]K4)BOFU" NW+ 4
MM$L5?;'8,:>JV FB159F&D45,OVW@$&$_&MK"*"*/Y^OECP.+]YGI>75[,(/
MBL>CWQ;2_R\CJ?Z,AM4Z.T?_-)FE;SK%]V8=\4+?'<]OX\>Q@_=L7R:9:]=:
M0$?2?A8!&V]+4"ZE)[1^>A3ENYP0E")Q /?#;EG]3796_BD5S)V\Q#GQ!2/6
M^ZHX+UN<Y0+XD<:)/YP+_O\":OC=);!BQGTRY)0A HZU)E)^#!C79!.MH0>6
M)V/,0H\]O7T"?Z;,\(_^,Q,TR+LO";K9%QQ(NLA*>@A4I.7UVQ+$DR, B V[
MHOLW4^I*S?&+CL(SY,G*C12/#\-Z:H_I_\T%_I>. .% ^$(^:"X_@!X3#K0H
MN8>GNKT*L"X#O=9?B6&P,C>[J)G?G'O#-9U))JW^XN.GZ/NR&1 M/#&A</W@
MQPZ/?<2G,:NUAII/GNL7N0*"HG541C!59V]>?-!7>RG]L1?D'>B\J@A,D?1[
MTU5;?$L%0:1KAA<OER#?:L5_#27 [I0\8903[U\J)XC5#>^+OW5L0';'9%.-
M(-4*KW;8J">LMQT!JKH[!L[ U @^*:_=?!@/I=K,=S.K\KN1R*9-+XX:XBU-
M2:G+7_7NWY:6/FGMO$[XX+W>&P;RT _E9DOZ\:@L)I9?ZXU*B:-^@7F)':=.
M/W!F9UE\6DBD4O&3GIKQB)96SD3,KJ-YC\3F2JPPB"0FWRZ'KAT5)@42N&;G
MII>:!<)*5*4U/SK=PU1-]X'&/S:>]3?C,:S\>55?BO@X$A+\/?6@3.\0"6.T
M(\SBI%JU?5+TL,'24+ 5(>4-JE>3;C7^V0%SY73?3;NI6)$(;.]C#VRI.#[M
M3AR&>O4P@B*+V^(-GE4]A<>^*FVZ;#<W[3>W&,P?"PD/OC@L],LE[5XMOI"M
ML#=__+/9.2.P=&#L4DLRH:9D+FX\BEA\!'CE %WHFA%L*"<I9E$8"6XOK@=?
MA4:.6MV:48[J$W7Q]@<^P-K!*Y9;@LV5:YERF+"H*-Q4V81N+$^LI.P"&(C4
M>A/<+!1>E#(G]O1&TE6@,3M+7F22J91S&(:L973Y6IT9S$R]:<<ST=(B9W+/
M-3$G6^A9SX2<7^.(<EZ0^:$J06#S#"X-'JTTNT%@;EY45:!E!Z,IP:XF-R8*
MZK*QD8,0C8TO/364>7K T@1#$V33*P\F<_A:@GJ3^JU%:11F-B\^&XWF;)+&
M?49=F#0@^$4Y5!/NF:T$\WW?M#F^M"3^;&!\[D;7^O'CO)=,V&A!'"/ TD++
MO#8P\ D(DQ$PVW&@_AI_M6-T$/H:;(=0&[9S$:*T(9W8JMI@;]]%\'-=A@[(
M[I>0;T&EYNG;XN@I<H=-,)TK,+O#]"8A GI^*Q05%S)DVKQ-N<QM?3U9?""\
MYL;C;F"#=W0M\Y7HSO2*$_8U;>Y$=K(J]+FAR%V4$PP40^0TJ>I8N)GD7O][
M84#WW;Q3Y55=#8;#_ILG<-6%@0HHL2J#Z(0E[4GU=5RT0?96=4E?K]_2UL3R
MCBS!A(C!L[9)A5!/$XX '27<%M\IFH2K&WI0:5Q,4E-#7N2N\Z;F.6UQ2*4%
M'9 WB> AWF4\/ISS_M(HJ%5JTHUF@*XCP$4G.(./&Q,I 6?2&<C,L]SA.\-
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MMT;GGQXK7,AGWBQK?9D*CL0BS.!;Z#U<OF/+ER<GS<U.-"T\+AXJU3"W+^W
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M0/+EO\^N'Q_&_#>23!Z_"<FG7C@#U!'=UOU^!\2>)OVKT@7_3:C3/O5S<?Z
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MV2A_;,15#T+@>3X3JG.W\J,44CT=GSAN^7C=&D<7RI;POJ"M?1ZF[&)]47J
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M?!$/^3[S)<K_*%*53*?D*^98@'LL5?ER:X;79Y#NZ2*656*7I>!O1=,I=M;
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M4,)=F\G'#%P <2[V:F+1'WQ&DD1H';.1B4I=]IJ+-3]/;3'>1B6J1OO:'(?
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M"#R!D"SUU227VM'R;[=(XO0E].F\25KG].)2!LZG8C6?*%:WM^M6/2C206W
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ME*OP(6%>3"QN3$.38(.CQ2/.O&?CVHH+/\%SKBG+/'DLN%#@3K=T]._S&$^
M;/#1>B3S ^)0E'(ZB(&J2,QZO[@/XWO\MBX=/\2^ZG]JY7;C^.P@'2 /]MZY
MG?VV9XYK=^-C-?O;/+WAB[$W>]C9F@5= 4Q1JN8 @!K3]R_55HL?#\R6)#3L
M1:Y^\7[JGGNI/?/N7>?A7'U6RY7#V6N#)LWU2CR*J<H9DCM'HSY1PAD)V.67
M>LSY_6SR=#MSA.Z?KOX7=<LP^YL?*NRC\9!]KBW0IL+\@5P+\;(0<]#7_N:U
MM\B1VK"AR=WKL%C*7?@TZ 3"T88.8(%Z]_A;HR*TSI,[ LENN)Y06?$QF&GQ
MM$XSENC^(<K;TZTRN-HH4B"+:X<%=H,"HLU@X[?DCV(2*2+#2YH ]*<UZ(_=
MH> Y?O08G'=]0J>M19%X2H<.B/PTIC7.R</\XC6SXDO9;KC%MKD&J!RJ_@E)
ML 9'U4.$*VIDY5:Z,=6(USYTP"NM\\0.JVFRB[R[LN+5;(>\=;5A0_$AT[BQ
M'PU:KD;#"U=UI#MJMCEABL05*A>%5!9/0J1KMXXM'K[EN=4TIG%1UF'44^N\
M;,AGK2[E,%DYE':'-BWUJ9WM0BD><_O3DBJ3U5U'4#%>^I'4LS)O^2VUA!""
MTDI,><B>RXB/NR%N?_;2I'DRQ(UIV$5[IR?.5WP)&"!:)9B1KK=3.*X94.\Z
ML51;W[B7VAE/EDK=K"4L=M-$"0&I75E71JEL177)1(8>>XYASU] 1K+P@<14
MX"E4T,F\X3Z?GW0 T-!=)(1/YCK7[EX\QA7Y$L$"9[@/'T9?(H?F=1$2+:LJ
M6PE[$>7O*VPZ35P_9$H;C6Q=^"E7@,$\7.KYHW-$A+#*@E"'5$'"T=?LX'T0
M'A^EPP+0$U28O?!(BQZ1P8@\@ -%DK!!J#A9>4=%MK/VZQ8'#?%F8VE0:+"-
M;_+CH%*/K@BN>CSR.-1@ ?-IFRQA>"0=K8LVL$>':2T@8K7UN(;I8K0=R!C,
M<*/$+2VG_K7%<H]QS+O=6*FG[\2;;C@*.IT/Y:O(T&5Z/-QEVFY2'NG[C#P9
M5E%L5FIA=>!#,*\R^9Y\EXN?U]8\X&NLAO(ELTZ=9RA&L6LW^ER5UQL:E07T
M52P_?O?PBBO6:Q0;*/WH#T8C:T#5\[_C!\1A#OJ"#>S2B @1]%+KHBO6YV R
ME'IE<4!AQ:"9^"36_5Q:D*Y.2F @5#1*M7LY,F-@VL,M81BS4(2L]H_2DL)2
M>0E!J3&P^XM#9",) G=]X2K6KJM3F&>LO"*O)H4.L&FV\:NKK[*,S!/(U]W9
M'U30K23/XS&;-J7PKY"3+<K%LS!58F%WIGV/Q1B<?08J0I$V'5-R/W]].\A+
M>27L3&3AM,++.9T/Q&)!*0=EH@3UW+;.UX0]TL0X;L1'SW=Z.PZM%/?3(J&]
M>_U7Q<76,9'ZKND.4=)FS,W"!&)FIY,R7O=X4@NKPWNSOI\:&LX/+RMV/)3&
M)SE(D3,L1%BD*CLUU(IMF+F,%)9\<D'N3$GCN@Q?:I9+!TY[M]5+2NKI'.A<
M24Y#)U0'V<=J#N72E!%M!@@G8##FK,8-PH0Y$=().4N6[@.=S2>PO@TH7:.=
MB+,W_U7:[.86(5CV,!^ZD)QWF^%Y,*MFO=5A)<+)G8,45'=85*%UP<H.QHNI
M_5FSS?ZMS=MOLMZU5S#MKI_%FAC6]9SMG;JA,V^E&9\S$:[3CN#F 8J5-DS"
M.FUIYKC,UP W#PGIG0>(H\0D8A)Q3D.%6*&I-=JMZ%Q_4)=[-3Y XX .2)7+
M+\R\4'\_VB)!.?ZQPXJ4]+"&^J*=.DGY\!55#-@!9J?*'Q;(HE5HH^ %##.T
ML!.K>4 5( ?BA3Q(>K6:_J;UF,@46?;NPSR@2WS_Q\\QN2?.6U9%X>Y^Y')>
MJ!Q%172-="\\^R4H/: K9,!QT[=TT%QJ(3?LDS*_1P5?=X6X\B5O2JV4SH\+
M]KE&)A^C0[ZC./=MK?5[#=("ITHE I^B/"= K^@ @O'\%!VP&-]I",39U19&
M:PF3^[O\'.X1A,+C:IHSE6'>SN3+=:]EZ@BZHHD7[CN$OOMB_$KJ$GGZ" "%
M#Y&TTU3M22UN6RRT'L\6#1-@PQ[9%53 H'$LAQQTND,?IBUC,=HC^$:[*>"\
M#D> ZQT3-;@JU0D1E<9#Y12@,08Y$?U)(605HF+706IWIL*/GC;,R<&4.>"(
M$F*SF/>X?R%[_QGY.E69)V_VWX2^=7C0%C^*.4<]0>,XPH"GD%A,%<^6 T%7
MGUC>$Z$<!"&])5^@W"J/K7@) Q>Z)/9Z.>5T%+_[Q=R JOF<A15Q%AXN? \0
MB/@R%/[<&AHCIB=%!UAV.YIT#1>4XK/858N6P8!<&^&C),!=/V:13S]3#Y=\
M[9&M2Z"1WA^EYL7NT*'D9MVTF2AK[<&!@E^6AF*!P%(UY)8716MUOOI7X=:-
M8NA!W^3"1':A;I'+W,4TYH@53,#CJT074I.WCGP^.K#K:O")>I<3R"N&&9-Q
M,,8CMQ\+'\((:UU<FV>2R29:=F"$R'&SVQIL.>0]_>81FQZ+".9]-# +CYUC
MY.VH6^QU4HB8A=^=Q/MO@8FE79":H<V'% #5CK 20CV* #JL@5L\Q5BJ<3Q%
M?$N+V\7]U(:ZX0MWM4O<*H3,"100*VOO/-!4'<EX/.W K0?(V.*[B,"RD=20
MBYY;F1155[4?H8O]=H$XX;>$$@$W.H##S839YFKSZ!R$5;$U-MVEKRIY3']Z
MYSK?J?QGZ/NWF(T7G>Q3Q,MM?YR-*E<;ORPOG7S'I&#MX3-?ET=+*H9FG6/)
M3]7BA/-<34/8GSO5IR<LZ?>:CI=*!FH+;$B*E\WF)/B[#E3O)BZ&4SD-2%#R
M<:(", 0[3.2)AP4ZNGN6DDL[X*=&?RC;Q)]>?:XZ6[SQT:;-B]-8*M@:T*^E
M>EJ/Z^<DE0-!JB2"MPR(Z:2/K8B(^KEKY/NX >M>--_:GE^_:Y9 54.3%7;@
MD?-B8]SCZ\.]0GTR43KZKZ-^SI,EP%%P?B@SJ?A(#,%D_T6_?!R0!6;=3%XJ
M)Q=@*7@-K&926F';OC:*).V<:B]RI7PN3?B:J($-#RSXQDTC!K&C9#2&R-"!
MX*"-0@C&F@XX?6N)$ ^:6+^,@M7M2I>]>MU[-Y1IF4Q2G76*;V IK[0;VW9^
M]EZ;Z"/P:J"T\@U.1F;"Q&T2)P(R76X6"-=4U1*2GQ ().GU]7$QHYCBB:02
MDYAQ@]EOYA*2(Q[&^J9I)#==+L[QK"9TQ9KU ;!9R5@;=NS;OU(Z]/_1V>1_
M]?HO/.?WKUSC_S@R;!F]=;22[O2CNV=TP.K-5GF+H_O,O4.8RH[U8"$8N7HJ
MB-/X_BO33LR.-!;QS1&S:Q<P_@(<J=69Q5.MTA2*SHHMN]HK=YII:RGHD]YQ
M33I@4'I(8X"9%F:G0J. :7)UP7Y3V[3KL'WB-NG^818=X"H$-!K6TH1=_HJ^
M8+TZJMP=[564GNY^2R_E1IU%]9B,>&V+]ENX!1CT1$U6FY!*,CI,HQU?3TFC
M ]KH@-=S7 3YB,V:!B5GZJW\GF<'-4V.]0?I-NFE[Y^DX$R%GO@[4._.@H>%
MGX32 ;?DCO@**J0#>'3?9R.^]A_MP.]3B5V3KCT.$P+K;GPQ5N# P^1'TC(J
M&"?Y&4F*M-Y4[_.I9A7_8HTW&!69@)J]1O/=:1N(47@7D!.TD FIDN_V%-0C
M O&ZFX<XT%EH]P_?QO%:L(I)I9V'\_0+K6*7PCGKJ9DW,U4)##]!,9?QZ(A)
M&@M,[ BO' B>G2 VF$H)3(HV$'XG_E/UM\XF437?%KAY:\NY[BC".].0-'&]
MMOV6@9G)POTTGL,S39Z')"35[N]X,=?HN%PJJ"'E4)4L$N*"<] P#.@YL^AA
M>4/?W=AUV-AGS%I?\NFKFXR]15W78(:BJ(V9_5L+*IL@RB7XEQ>'>]%P!A@O
M83Y8PQ)QINXC.8H'/>:K6E9PTKYO(LAB_5>Y.XD]W?W+;92]'LJ9C""DXU+;
MO?#'"$-MUJ#@GFCE^[_F.5B$1.,IGM9-20->Q?:>3V:]E,H&OS_@EIAH!7[Y
MBEEU'$5LU] !^-6?2O('?#[SE"T0N2F-/.,G92X1V86OXB@K[BXKM2RU,'?0
MFTMRO=9GY)J>Z#-6\>'[S--OE[JO+L68H]Q$RX.V'/,/]K34R>.4/^ ]B!K=
M:-,>#*_6*:A3%_S*1=&6R2_8N/<!Q6UL,_5C.JG^3EQC#QYP*-SY?L;IQ&3Q
M!JC:\Y/\6=C%\ 5N%"&W/15R2M8=W>]$H&S"+6*?O+LG6G>%LS'J^U,+'NG+
M#3.*R]_3]H"*-^F [-0C:T./T@'1N7_F93WKX;L^WA<F/0Z.8$8Q#3&5R I<
M6(9[OXR&[;YSGXJ^0D$./C-GY&$O<WVO0+^>EGF W, TY#T1T<%&EDC=-"7X
M6Q#F(ZC'*2"RP5TB^+4OF6J* W':&A3/;]@#B2>,>2^,^6R4;O2GAMUQ__8I
MHNSB5$RV1CJ(EPY80-(!5?4]= !_+U$ /_D)R4PN[-[SB"^%AN8?T;0^$V$P
M&T\U;*Z)(G@ 4MZ+^@$E546!5=0_V6#\WW)6#JK]Z>GY"[6ET;.A$9?6&>3-
ML95\3<O%U%RS4*U04EGBQ+YMN33$.%#-;^E[N%S<3,FDG;M#OX<6,^Q",]E>
MB]&6JD88FS\=EM(D!3VVF:O&[^)ZVN;Q=;0KEVCE^\<<'NK1B0-0IS;/;T<>
M\S!+PWX.1 81Y#N$.8@Y?-KQ$;>Q<?F!^;>NJ"^,@FKEY45J8H)U5ME5>O@^
MH:I@_WC99=GQ7R1'4#I9*GQ,J@5SXDE7N'+!9Y<\G.S/I<5:RE[+&&M,3FP2
M"!$P[);MP7E(-ARHN^QHF9'7*.SP/F1-?40-BA?F3E;&S?.3ZW7B>&5:M#52
ML? "]_/NPU.V P6V4^FE#W2NV@:T/&F5QAVI3S#H>%B>%BM,@3#?@=I*MW'3
MM"7#&4)KI=T4TZU^3$VEF7+ VKZE/A&MYB?]1\JSF@4"FK*=$26^:\2Y]*1D
M\5M%C72T:_3I7\E97LL?Z!=->IJ9-G;M?'I"C%G6SI(EO&+R0D[!GZWGSX#:
M*$,!;="$@I;.#IL&_&.8T$8Z'2(Z4"VGG8M;_O&>Y@Q5TS"XR;D32F9S_Q%D
M#CM-_2Y+L[']![^4YW_$:O7F[P(3OGNO6+A4_G:$96?(KL(:9@^+(/K<)R$F
MJ6J43V%1Z?\0,?XWFPNWM W_3/IGEKF#D+_H %8TX3_8KFBMH:,D(QP"_2_=
M+I:OAVP[%;GV=$ \"P^M 7AX8E)MQ%D51#19:V4C%A92?HUN#.5&LW#VHZQN
MEA_;F9V]GN0.4EAZ22V&9:'MD<LOOZ_^1Q,5_L]^__]-/2<A"_'[K$<X;S\)
M.;BPD?)GB@T8Y\&-21'N@ZW8,8Q34^<5M521WJ"!EYTX';W%#\5I,)3NH1*#
MX%'\>!1J5XPB5B<+QL,3;_X\NHOZO1-V5W5V/VNY?0<BBZXQK!G^>>C2_Y'7
M_X?4FQ9^E"?$JM#0.#K@:^@+^_*C6_7M [+G]]H5-=$T"1(Z<XD<#DZF3;)^
M>_NU.G-QZ1Y0%.GA-ES[UQ?%924^^[273L/:7.^$-2DW '!A,N(:'?"VQ"@D
M?O\!.L2R9UJW%#'O>32OY3=(#1LU<9Z-#O@V+D&+L";36@55"*EEF,LR-PIG
M;8L# P,CWPARQ]Q9 -Z\H4$Q=?K84->#O9 EN/M3HW-H5-1R46+KV@*8@PH]
MRASCR)"%_*%N5 R010. .553_L).&A<>7:%Q.=4Z[^/EA/65SSKL^KAG5K]6
MH0L3Q,%$8CJ-L97(C'.*W=12A(XN@C<7B<Q=!_XOJ0&X^4AL!NT\$12F+/OD
MA[00L^GHK_Y0N\JAP/,_'T%P@R^(OY1V3D\4O@[5Z(O^XD7F7:R<@A'&<5LB
MJH//.GIX!J3 YU1'4ZM#LGD'896F)BY:_G:%XFOH.^ $4Q-KI1'W'KAY$,0=
M/%6UE.(\8>YR[U2"6'),56G0Q-OCCER8D"P6N>'U^;UI.H!HOD\'$)H[X2=K
M#E$8MV\MZB6P6Y,PKP50&(V=*!'1HERRD0B!6MC8? [M1KK@8F7#4YU\G]W1
MO<(^"-;4T5#\_9VQQ0FRW<-3Y8N8J72\?/AN\X#KY/71'YZYC9&ULD8DQ,5!
M;/?5ZQ[BF>0[BR<C%_GP584=^W'B-<X/G,%<*N%M$TF/5W$KL"?"O!$ZG.L3
M)L4\?)3$V/V<I R' 4?[.49[<.I]N7)KN8&ZE"P$"C*IF3N.V:X_LI!B7IVH
M(9&(X6-."7I\QIR^3H^^F0OUXM%RY Z*'3D<YU[8L=$*7 #&M<#1&H195(2]
M+#=VJ8! ;'III+2EQZ47MWQ>_PXJ[,QID:C]@A[2+P+#EB%!A%13AR& XVG"
MSI!3&GPPFOJ$4OK:9JW!<WYYK5&=<6-OUGP/.J#92UA8XDQA8E2,UJWWD_EG
M]#L,UN-J^<VEV_.9/N9O55UI[VJZ4E:BU_1Q*<1=.."^]M3/"Y,%F:CM^S5I
MKJ2H%%+=X';]+&+B9<EUQT=]GQ0^?NZZ?Z?OXYMO4AUO=(UU_H]\WDMLU1(2
M22YD"$61[+H()J[$7"#7$T@]E@3FF=:>" WS$I6I!Q39L&S1!T/>_L^8EDWR
M@JW>&+F-TP%.J.GH=H0@_-(&\@3LQ@*$@RI.1N4[CY"S.CJ$I6H:ZNW\.\ZR
M5[M.\'B'ZMTU[*S\(*[ 5'>ZN/3MDZ35B2X9,9>'DE*CI*V;&F/.%LE,R:VI
MZD791GFVKC7Y_"8CSPV,2\:FC9?UC?KFW,63*36[/VJU9K":-C0*@B85^Q<Q
ME?[<QGM2.47:X>>(>]&P8X1%'"(.KFA+57F 9*_%,*[Y^_.KA(F:*0YYGMP\
MAANK6*B[+Y8P=U'PJ:-&G*;4'@E'9G2A7+M%,>HIA\R0V3?<,^M2A4)Z.E&H
MVIYO/>%YPVT4VQ?ATZ#GCQZV2&R?[N%B$QMP.*,T=PHC)^=3?$]?RC13G[B2
MS6@:[2NI7Z-YH%]V?OW&M6[B&!R;_MQV8[8YJ*P\4#,SO;K>=*/\+ZLN^@L?
M:#&R&,5U"F9&#B^D7B$BVD%"5,DCT_ I^H5A'$"YI+KG;:@][1,+71D3NGU5
MA>6XKN+T9_\/,.%K%0S=2(+QT.G5.5GB1.0",%18DYR/\PRU_HX6)+]?C&=U
M\4]T00M/R-Y1(?G=/-]?TN_$O>9H=?H"9\(I;W/!Z*O) 0]S7Z>7,MTKES;+
M62OQE=A<ZY\.!#\ZS ?/CD85+:E%MDOV6MECDY,::SSZ=0-+(0:0VZ.>CVN_
M'?+^6S&\)^C&^( CX"R$R3CJU3WP!VBU?OV$4F[04Y)_^\0"K-C?17Y;ME#G
M#(J#VJ>K/&:9>JF//4F"A['=)&11S$7'V$,A)E5/NR!M=50GLB#1NJ "Z=.]
M)7P$XD$8.H#KKRIKMBZEH^+\RY.R10>02Z[&6QSYB_DC5UYH?)WEWZRJ>.S>
M<;^_/I+[5S)?3L#LOQ%%IC;@O\7 )TPN?9NI!V__9MN^</$7\)LPXQ)FL9,.
MX$#X;]C;2<QXYK] QM,!WX\M( ^(H .66V3<&N@KF^R_,YKYR_]21A_0 6[_
M]QBVF+C'1#.MTT18UHG:>C3Q$^%'F0;0#;HAE)$E<C6!16++Y!K3>1[X_225
MDS=Z2V("\GGGKBPG.0R(Y_ZN,I OD?<(%:"WFN#Y09,CJ-G#=]X!J;J3/UL/
M_]+;[&0W[9W9L*)YQ5CW>!]>-4%/J.DB'U_\US_T4&UT0 RR6J(+_!)9G95-
ML:3J'Q;29-:0M:SQOBYXYD-&#;=G= !3A?)TXYP!(KQ.F =PRYME-,_O7H![
MF-ST\X#?)>B<&X[8B(\%?5QYU:*WP"8X!6,?508%*\!ND%OQS&Z*= #C8_Y=
MZP?-\3J$G^<5710,Y!P2'N1)GL^27A5[,^S)*,6'9BW@.1=3^K(XIECWG$ZL
MC.%ITV+3*9UQJ4>K@\H7B\9R.=<-NQ5".)/B?.THO2,)"5%IL:,>\NB9<E_P
M4#4(_/@5SENP6-2CU?A+5,<ZX^>BZ?Y8:SW1<SI1]GJ/DQ-4AP.<_&5#S86L
M"-)X"%E")0)F@(^?8L:A4?CM<QO",I-IAC<GMCOY#Q<AZWL;'NO%8DO3+T?0
M:@G2&4?A1 +5>!)VG,"@2T"$H I'6\R)DWCY,#2;RV2="6^MD!8;QV"I5O9#
MJ4PB^(_NFY\_),] EQMRD\VSGN\XC\64] AH")86]9KJ9V"+(<F4OG,ACJ;)
M&X[NO^2Q*,>MIUM]^1Y-FZTV7RD[7SN*+O87?DD=UMI*P-YUBB1E7.V)C:H;
M;6O#%[KYF\]9&*9';9]9\F<M;5:=48^K)0SU %_2 ?P:MPBO<6QMX%#@.3DX
M']GI3CWA$-FU+3!MIR0LG7J[\F,4BR=%WI0.L'$JFM?C^++W@;UBTQ#VD$ '
M&'I.-9,FR/<)&)(OF;)(!V#9<-OQ+9I^6M*K6O+$:*J.\)F&X+6<1&MW0X;4
M'*.K">YB'54K@MYH'HG\F&S[_#/=B2C]%/ES9U3&-U0/(:<S,JI4\P[#N,NA
M.B;91K;K?GI]<L8M?:714<_\/"31CG 7L9RX';U6^Y29P\J_&$A>U.R*EZ"D
M:(+*[&VY+_"7@FD^$2>&!!&7V17$K\FH<$&^./Q$=6^3)8=ZAJ+X6[/R*0JT
M@2QQ# $3NSO$Q@:$/22'?A@<GH/RM''O'!/*+]^\$5M0[_4\G9]5; >H*G6G
MXFZI;'GZHLN#U;%";?!<:619_N:SL4<CF2]:T'LR ;E<O)31C.S3%2XB^LE<
MJHU*<[W:GN(D?3H D>.TJ3PV42<7B?!EB>Z]$"76W+!S)B%^WQ'XKL,'N1GG
M:O?Z$$79HNS2I*B=8S 0_BC:AA ,AIA=]?#Q9VUA.L-H(1OHX&2W6Z $553E
M17B(1\'8MIQ3R_$!_S'9W>6HE==H2;[3:_$5=( C6S2*N$+R((.(KHN/YLF8
M=HMZM3P].D#&EUE2=+105RCO28V"UHOJQ#D45PJ8):P\PMS!<GTJ$X8ZF\N=
M)&4:G<D?6>]_YK;+Y)*A!(->,>0]!W_&B/%2O;*RB1RET UEAITLWYU"7G?_
M]UR!=+^R0,V+^D,2'4 U%_A+:&Y:].'4O^LY+AUK_LLSQG\E4XL">/PU'MJ8
M/V[&!K3)0GP7*O%] OK)AJP2M7P[64%E/<H"#N9I;=A"6OI*43'!X"N;:*8N
M5F[?DTQMH:G0 <AB!+:(]%>D+#[*5.*C,0?4%CI@I-A5K6BSE>?[/W 9G_XZ
MO]G_X=(HY^6_SQJ#]O$OOS%1U+,I8O!_:5ZU>&H0DU+"U&P/_YGF)GTN':]>
M#=8@MY]N-*9,HK0EV84B-6>8#<72 ;B)?/PVYYH]9WC7@7WV87*1RY4YP^.V
MABY%9PZSO!C>+Z$5!'C7I5>&IM1QJ9L]**H>03Q[ 3R-(+TFOR(RM_OQ6[3Z
M+[#QP\P:&H=;P- #&,(SML8F%#BMYH]-LS"+V<*]6$0&LKQMFKI;_:(AK::(
M<M=<S6?-D9QAXLG,9&1:'I&O.M)AFK'>G>&H+*TLJ=PO]"S9S8SD*MFL7;?"
M2S7J3]9\3,G_WH2L#OP+SV9L7HZ<1.O^0$^NF85WLJ*-4]Z7!1,YQ5Y_OC)[
M@RL(D("[_?*\B^Z[*R^CK#P7*XTS#J5WMDF^1-U(M!KM&Z06V:6-;FK^2CO=
M%40 X4C!HV\_8*)\IKV+IMWD/;] W!HR<^L;WF7.6=SHEAYL6\B2BE,_NRYE
M5JGJ;)F1AM'4KUU[N&H<U_=+RJPY=2K$45I1;RBY_6ISNHN\*$IB1W<=."6Q
M8]B3"'I3R"*_K5$9Q.P$++_Q5]'!^<DO1DG5!!4J)YCTW#..#A"0_Y5"SLL2
M23<C6^+>BXY2&;)=WDSURF46SJRM:PT5S5\O%6A=SU"_TGU:F1);-&_M<O5%
M5CF,[9M2M/J $4&>A63 .Q?0OHA)">=".Z4@GO0S\.)7'2Q4& 5MI1XF:^O9
MU]IJ%.N8.S 8=^?SB9E<B1%/\QJU*!Y;6=FSM17K&RL/2DH<(34%0FZ.8/O6
MR]@-*Z;O+=]51_A>VX^O7"Z>!;L\6A,ZG.&6EPGF3=E9V5R^_P[W,.;.(JP,
M:L;W"/H')K.8&DA8)+T?1XM1S0[S0$_E@52!)F'%29@$P?(H^VY'\?1_F(*"
MM4<>[^Q">,CXP6^5*<PDL:6$16='>R@7:3ZZA8V8:'ODJ?RA"1O=0/8RJO=1
M,FOK#^& '2.JMZNL@J-A*@M5A[FX^3I[FP0Y.6755(\\5L..9W-S62)AM&(9
M,0VC:Z:E$*[P=HN02FC:LWS3LZFMX9UF2[FQ8<*&M\ZN-:CJ%9Y413LH1RPO
M>X6.1"? AMWS9V4=OM2U#HVSOQ,56G@=S(R^<62/Q?\G!D*=/7P/EP+&8JKW
MVCVC..I\P5Q01>W6R5'>G=J]FEO%/3$93Y'G)QLF!R=R3=FLZX1+EDIOENLK
M\[@F%>"46AISMF;OIW<5:^NYBZ;MNJ[^^X;]D?<_$Y,)@5Z-(=H?X@9M:#?K
M$)WS/^= +PZ9_DN[JVRR81EH>MOA=,"F:R(=<%L6AK"/$R ;3$#> >- _' 9
MJ@)9FPXX^9!0UTS4[1$6(@A'@SZY"_/Z@MG7S[G4/=<70\R6_7S(#.N(V2L#
M'P'-(N(UPGV>&\9WF(QYTKP&%Q- 1L+YB?.=$*'5>\KSP52)'*BZV6O+>G:W
M88_:P-+# L[786=T\^&5Y-&%GC9DI&7E.H(=S@[3(+\NGKY>-X&-C]%0?%@^
M-SU]H<^FP\LO]N+-PA_=K,-K66Z6;4@6M #L:C!^$M?3,<\ _0.[[8G]0(@+
M=<KI\:Y9@BW5:,_7["A^W455YF<N[5K81,6Q\6F,RO2O/2#\\%W5_:-T./;.
M2%>##G)"=(T"=N&7<U4H/OU33V?MIYHBC+ <7YVI>\UY?Q/K(3G71ZJE _+W
MJRCJ;EBYUT=[ CQ2X@BWIO)UJ]4L'K(*(==R F7E^%2I7$IU;F=KY[*):&S&
MCMO2-H V@:Q&;J53=.RI >0UXB1N* 1^',8V@5*"!(.86[3QZM)Z,$.\-%^(
MRIP*\63()^XXOB3;U0'YTP$1/],.)R$GR5<\83>*"T-@:FG(Z+)3B?@M;9]F
MKT!\IJ19B4O:X2>[@^2H"U)U/U.NY[UZ96\JOYE-D02_5=D<(*A=USF-",=*
MGG#2B)<0"C@8'QY2&'*)0$6T/SG;9=;_?*::+:I]HIUR5U90CC6.@\\DK1R<
MHNSU-K^?_^U>T7#R'=UYI((0?TJ,V0=\X;5:,6F]1F\=TII ZU6/>?D8Q$(V
MHCXUG':&#/Z$8$0+4F\2)EX1%4EQP<R>9Z"3]\;.UWW5D%B(U64N@@Y1;OQD
M:N$.'QH=?:WZP+1">K"V]RB,H -.T %MRG2 *R@4=(PF Y7&^T?X8(+18A-H
M$;>#4]7NI1OV%XC*&U-#96XO:KZ^5NS1W'XOV]1+*P:Z$B&%61?)? 25[BMK
M5=">A<D.,+=NSK>. N=B/)#)!9NV>N#>%/#,Y< YZRIWRK.>D*C3E1$?+O$6
MM6@2>!9 (;*U@?*GJ5QD!UR@_%FL%A(OH,G<;NV!=$>Y[#A\J1K/#KN<FI+P
MP#/XGG&E@FK9L_TZ\[!/"Y=WGS7&JGVS#1+LX+@TWAXH$_142YSK4LG(,])P
MH2X;CU&HTLQ#"].2'TN/9]42,O)F9"^IBKG8,W8/I>8VCS=+N+-UJ[-5@8GJ
M-$:%)W<DG&EG7"8MX*X,.RL&ZNZ)70UG/\JK>LQ2+"?H *&[OROV/CK,BCC=
M%+J]V484/OG63'2T5ZO0GU-<QWR?*/WAQ.XBBNM ''V2<-$PV[8PN$6N7HN[
MCMN>N\'NXI@AKE3LF,70K3=R6UI39H"++TM>GH0T$N;#MGVG05SV9(1."]$B
MW44<64!.66YG]!T @=]3>\MD?G%#M)CU'A]^?Y-[PFD_HC>G#F%4[CQNY5IE
MW*\(PR2/1[=4JY%+AHO*!2Z9'/3%++;,"!C:,=YSE5.Q'DQ">22-F4*T+-U?
M( >!FVMY&R#6(P%CP9^09S%/M]A(=D3[MT2&SA<%]3@$_]KP-TRT3_\$NB'<
M=$3^!\&W]JI"M-67:R8_JHXG2&-A%Q: 4QRW#T,UGF@$$8%X^2@X!U6/7'2T
M5'PL,M2S1I*JC,]OO-)1\:U3P5U#2_[J(#8-COOZ^%7:83SY%04$8R2CBFW<
M(!Q:9ZD@XF#M$[.V4G)\1XI:2@[7:<?('TXQGPEAQUKJU)\S<&$'%B#';<F6
MM+/J\:>@CSS_.$S</-[VT84;A:O]>/R/<9^<@IF;:J'3+P,JJ&"NT4XU<W,-
M7Z;:*U:"1@J\EJFXA2Q61@A+1-@Y?(GA@%02NO::3D+K-:FWR6,];&*^4*5<
M9>[][_.*$/;G2_I]@]A?Z/!%W3;0461P#BT('T<<I_WAC*SQ?(5P!X=J@4;%
M$NP<.JP-R[<CX6QK=5CGM)&@P,ZS/U*\19E2A&\WR*IQ;70%%,8J#X70 <RU
M**PEOG#S/>7)&N(8#)Q/;NY4&^KT? GB4>IJ!@N0\<P!+)OV@H2)[-??W39X
MJ^H:([C>_N"45QW:*NP8.LK,3J#9[>PA,'FRZ0+D#U>5[X<H$\)\^&;-[,W'
M,I!>MZ)SCW?,WWWLR?RPRY6.1QQE8B^(J,A<(C*:QDA5)@*C1LP:@@+-"769
M_L6V0P(,>A4_'L?T>EU4*Y5N%%4(VS 6OMB?&^.;PL'%I-A^+SOR7GYRT3*7
MY",Q>]\K#0QA4+8Y'?TD)YVSQ49FXX%]9=]90V9,EJ-=C?1_P/$NTCJPF5GY
M\NVJ0=IG.H!=0YN((#TEZQ$ENK(X("?(T5WVW+5CRF V77?2)5D/OB6=E+DO
M -F'#><B1\ZU1^HP<NV::WMZNCMYGLS,;.'V\ZL2Y:Y+&2Z[.O%5YX^>,V<K
MV%7?7F>* @ >>)E,]N*ECH)5E$6RV,UDZW%7TP]YRT7MWDG9>OK6O:;1]PS7
M1QK'.<<>I3?KB5-JRN:'GN5$29\+_1</.9U)_*$RT@KNH0-V  3P(11Y>*KE
MX[_MRQQ.[!A!4)R%(=J<YB___/&JA7RDAFXV5+VC:24:!B[2SH?Z=[RP6ZXN
M=U44%*O(?,AL:Z=_C#)8)<)I5 'EJC7SE96_.U$F5Y/I9E0]OIM.MI^C ^Z.
M/3 H%9@.X"Q[8V?S^8RW]L6$BKC3#^YHF.NFIFFL&PGV9][(5Q&H<.01Q>>-
M[]L82K@5A&R[R\)3O]$0,!#%##X$J@_O;J!)P9Z1B83M3\"/\VV8LX/(,UH<
M;O:7:JO&T!>AN0;OY*EB<](?D[9MF%U&M]1\6S]]8\*I$2FWB.%V7UMT*8I4
M2R);F.>FLCR+*X)10SLP9UW-M"S-<2)=/,.PAJ2@HU%7!_UTY2-+WO.3IJFD
M>X=)!4/I% 4JZYMS-:4PK6']Y/4;PN#S67=^O)C\:$T.["#Q"\)YJK[NEH*8
M.QXH%<&NN3MQ6LM8WP/+N!0_^'"S[B8H<1-WTWV1%_5A0/%N,X?E,1D,6WS'
MO4]&:;FO.\TZC$*ESF9(@1/,'/C&.B>+>31T+I;/ZBGGQ#APA:KY7BP<Q$D:
M:KGD2S<J>Y3G<];H/4W0NG 4 CS^G$#K1K#:7V4-HUAUL(;O]=L;'&&V=G56
M^RCI-G&WJB8-&()Q183K6G??EUU(6;Y%:C1[5M5Y1U;D@5R \H%_SJHU3UC-
MJ@^"Q;D)$EX3^'S ,V]UXNTWEXG-%;FOV/83SK8[7==[43*'V5I,JZ :^79Y
M;IC49(6-H1U\5$VKE?.133RKVYN6YU8;?E6_7+;X+K_T#M>(J^6UG8B!QE.L
M\\3 ;! A^W(K$-RGZ-&XOKD69V.^?J:E=)==PVIM=:%A"5.:2]^5*/#CF:>3
M00*ZF;0Q4*W_2_@Q5RV&>+Q6=!$R;)[;4T /3=QJ4G>VY^'/?NB!'>^CK8^,
M6-FJV_:'F#\ "X&DMFN04Z.XH:T!BKHK'5 )C':'.>&1$7!);@10%G:NC(V=
M; @7G*^I=E4KJ/)ZRC]O-,;M9PQ\=RMT4#V18O>!>F54@FR,0X9BN&1K0%%U
MUL*O"U;50K)$AK=^^!RZ*S7?*?O0TCCJQ,:#%5;=4W^C]\CHN8N6$/4,69H0
M9E,:'XID@C$N,#>//VY&$S#A93ZETQ$S/R[W>SV-VN+6:^>H\3G^1UW_3]M3
MEF&=)OE@(9-6?=X6(:M;YTXF+RNM=^=K:,+LF"I)PU#H@!$GSL.EF[U%-'/9
M;,6XJYX3Q2<^2DK"5B=$&V&G2G>;YY;%YGOF 4=.!7X1=I(@7.M9 GM&" _U
M-81!+4PN1$V=,=4NM#7T@6O'RL6(1?)B&=<@(=CPCJ,0_]+V)\RK^5KA6B(S
MR9GLCQ>RP8__J,*S12"YT_%!,0<U:NJ&7D*A=>D%20H=CESQ"=;MBO6#)]YF
MZ>YJ.BUXGEBC2:*)X^$A,$W'Q2"340K(C!A4]]Z3)Z)60'!ETS\MK:@A:UYC
MWZC+>U!315E(W6A"QL.GU;Y]R'Q4WN&*_1HVA-'7T9]Q@VN@Y66/C%-3Y<6/
M_=Y-U^YF7"8SJ99I^J>.=?4(K_?5E"PLEPP\7'_HADM6XRA+OF-:4E(!-4DV
M5S&T&TPJ<9-LZ/4NVK&>2-"ST],T:6J:K ;)(QSF@=2[E4<VX>*:=8$\O5 N
M\*G)+Y90V(WU#X883EZ<2.U$"S0/^T)E?@5^>AD4_"-PZ@2SD\1 ?/H)X2!3
M&F, ;E:W U&)^O3NE^J<Y*\@IKW[<8PWV*>G9S?XH[L$+K3%)#]H S]B>T&:
MQXHL ,C3!/N5!?\PV"U/0D=[6OYRBK+9L-)G*FK34.5>V.%ND-:<9K$C%RX6
ME]0-D)1^?.Y-4'^'L. P%8AK96B' ZL-6#@ZTNRR$@NP.H [Y5L7[NP /IVR
MM$A^*:B8!J4.L46V.21+W<NU41H2=C!E,33S(=1<WG6[&1*P?NV:6;DIC[7I
M4L;F6MV^B&K;V<)+@SS-9JL49?'Q[]/1036VQ>[[ZEN_2QATX_Y<NL"^F:!.
MT]U 4!A<D0>>62U1K?X+_M3XHUB/Q#H.VIW7U 8'V[\,4/K;]L0F?]>]V'CJ
MA?SG/Z(N%?QE7(9>3!VDTS-TGAG.M:8E01X@Y(SB5SI2B4^0#GB6JW2 +O]2
M:JC[\J7"+G^_QV<KK1+0C[_<["ZQ(C"BOF"PX;_+?7>"HA!5&9"J1V0.<_(L
M6Y>0@%7#F!9;ET='QQS C1>[/-V=RN\E[>3(S!-E8U FU7=:(P[AIVPHK3^I
MM#$@8#>RJ=P*-'E57BLD8587]Q.,KH,+,Y>ZW(AS?N=K<<(RC7Q\0>+3?*A:
M+*F*,(3C.;*&/UP/4K;K7;/X"+-AJ0BU9FYH;%>+V_G0=S^N!'-F$"&WDI;)
M=^L2,HJ?<'0;'^#SF:QJ!9O9JWR$N 2?\+M,F9@DY16A2*']? VU7QZ:)!5@
M6S@?XZ>]]A;[1F$H]Z?UT]D;7KHRQ5PM92QC=6^GC19_U'Y_(V.J*O+AYU2$
MUFOE_8='<<_$0]R0 'R6#F"MO?*=' T^+/Q5[IN+^)6JYMB=$2V$=7I_\8GC
MC?-]WQ\(UQZD\9:>8E@VX04^>\ZV KFR.E\=B@E%N&R?HPUG<1"EG4EH58([
M)I3JN?#PB6C-Q"_FP- &81$>VP"5D9/GKO$]RGSAW?.R<[CPU>!EWP+<KR]7
M^7U$<[#0#&&I3*A)JI2'5#G(C4N\T2PI(,UHO9#/>R3)]WNB"9KZT<)SH%Q@
MIW$'O,4HXT!C"J#PMEL%?+0BOW[D[TE.%L[$6%,"[<B]A/XNT%FJ%^6*"TTT
M@FK?1!#Z1<T"^F"K7)I^U4RD6(K#%I:^"TP"+PU"N39XX+R$5EI](32-#NAX
M(;8=Z?-L(Q<:]J.=\5?YA<=V"7*916KOMUX7?L9?!:!..$3E U]1N7BBEHG?
M[=D)5/BUQNIXHP9BL$O=8J>IU4UOKO3UA_"O$ZL!5M%<#+5JWZA7+Z:<XG*>
M-.W?&2K^FJR6-.84%:=0(9[Y(NJ>^U?C,IR:L6MNDJFIL=])1HFK&>YJ489*
M-&%S[L0?FW!F>,<PK1/X!UP /HQD0;@)@3ZI\725L^'EXQBBW-&2TS9=*')A
MV_.^GB-G&Z)FL/5QW6*T>U-&I):7)3:L-96DTCP.$SJ2[LAAL<8-5$>)\Y%\
M)9K)DZ6PBZ,MMQ.Z@MP)Z\L7:?SU]5$K[+(A*52K3UIV&"G+=40<R&G[*![F
M4&Z69Z?^[@?RLQM]<904E&I#Y E[JBRK9Z%PQGG/-/OMB(*6MFAH;Y<7'5#C
M_XG[*!;*&EKX$8V_ Q>"FM>VGEJTKA_9_9Q?-Z8AFS?CV4+(;"UYF>*7EHDY
M4%3[0\3^V0O+U@B\H/A#R[UYN[R?9X9D>YZ87S&?$&$)L>*>64PU+F2PD*I7
MJDW./_U\I":G,<:<[T9@2WP"1PBG>4;CEH??;$W]\M#E([CU<GX1%T[AI?+Q
M9RBT7:W/[L(;.!><M'NJ'#&!GUS2*'DWQ(Q%SY1E'K\YTB*+.V1NQ[*4?%NU
MYQ]Y6F/(W_O,8M2P,N*6.^#\F9 ;<<&UI4M>WY 5#E7OT/;:45V6G9=\HTI-
M3(WA+DI(9-#@.]V$<_$[7?(VTI!E3F/MYTE_^3[ 5XN!#GC;T8$D<573 2,1
M&[LBEG3 F_R]0W_0P1^6*YC_N$]P1Q0Y]R<UYY0OI['MAP?0O3:L;JR&2,$W
MUX/9[O"3!0U[QC,VT\PI*0YG39DOG#\)>'SY^RY*@ X(Y5A 'EQ20]*83'^_
MQ8/^Y4M.T(%<RWI]X;6B*;V\](_Z6N"2IZR*-$YP,&+UPSJ"+ FF2<63C;48
MZ8"<U[][ .6#R"5;P8X&#.'G%_M5SC(.-4WSG>Q 4?0$Y&$CE\X\L[]$EO 9
MU?[#:_K+^T7#'K*EW[+&)8FH4:P9+2!H^(@3&$9KDU7ZG\RP20<,,8C\% 06
MY<2[F.XO[>D>[=D.E5*I.O3WCX)PM\D2M"C6WSUXDG[_SE[]/R3_0_(_)/^;
MI)!\;B&A#(1[Z!K$1FTWI;I])*JTLS&YOG *=Z^ N119]Q1.\RXD*RV]K>#Q
MG/<=^AS4>J/PW]2,,LCR!V=9VK@ :;IV3;0/ ?+42\@3=,#PC=^-M4R05',@
M(>=W1PMMAM^MX_011/.I8?#?FOP_ Y7-U=S_?@0;(_]I"=0]QC8J3'-OL\_:
M:'[:<WN<7,$96'/=W"V]5)I7>S"[R 7KV^@;8U@$F9H240\:!]<:GGN.F#K!
MFA?%N7X4PJ6_$'.NFTN!L&)0 Z]Z$>V1!/ AI]#OMYN2OW^4I0.8)-I N_=\
M053.HRFY[ K[S.U$HYQG;^G*<&AK*$B?"=/+]H]M$Z26.9O+/%-;R/H X.06
M3;@. .B)$DX*CQ3^[/\13P>(+.WO/?!"_)W4S/Y^/HL?X7B6XYVDD3FRI_5H
M;3.OG%-U%JE]^9K[HZ8Z;Z$O[+8>9TO;SC].76F_?/ZMY19*B3*O8>7ZPHYB
MC4E]GJ*6'#OS1F^H7]1OC_U.WH/O6Y_.!VNK2 V[ZYM&QR8EY7*.#HN.QD[4
MS0?NO^JE _XILYFW-.>0S@3MP.(U/T6[J_W.GK[J GJ%\'Y!%9YSG_4^'__>
M)OHB)E\-Y=)+S2'1 ?7_2\P&_T3,<Q.^APP=D>[R$<J9()TP$LY=9@7=&"<=
MF)YZ7O2<D57GX/>72"W>-\>N<96N!IXM8WM4=ER2H<'Q?+#J^6#)1G,]O3X7
M?6IY]U6_VLW]IUOY6[6_9OX%W<K?DD)HH%?I@!TM"-*/@>_ON=7]>QOS\S'^
M;T%B-]F!"H%S$_8B'XW5T %\D'5+9I> L[7IX#OW\B9&;F]C$I,L9!B>7[EG
M^3>GTM<=30JE]Z;7GN0N'<YO+'_:8=0Z"97,?S_4*727)RN %_&XL&](L?G2
M2DZ*"*'@[U71TO7/!]1'2<F@S,/A'=IVZJ]_C2O3(XHLB ]B'R@_U'P\YN\C
MHMR_E5>SVJ7_Y//WF 6/)=(")#X<;]1@+?@[V,#\<]AP9(XQ<)=[<9BUCEUY
M2-M$.J5 )#'?$AT"S>\?697+UI9'K:'4R(]-/'9DVZRRKC'C0)1C1E<N2.&U
MQ"MLZ&^5/[C4BMF:_[W:Q'^VVIM,":P*K*H7PA?,WNAFGW@]QI]=O)[V)/JA
M=\F&6FA!<OY42>U<=I""#7:Z5*C$,?FS^<R\5/#S@9?7SM\K-*])^C[M(IID
MXSXEFBH[[8'UW:^\AOJG');4H$>WRQZ-NZ,VD099P)J.HE[ODZT9*>39%9D]
M=FV^F\?.__ANEC)YU;]2=@(9]+!H^LIY<.$<=J[G[9BBC:%<.QLOS'C(W'XG
M)6Z0&!=?O><_ZK0R^^KSOX ;2/MD9KNU-;\T6%K%6^%<*3Z1RD3ST03BL(X>
M]]9SL4'%G<W9[BMIG.NMA1+N?M'#OF18[1$^/H?\4WQ<H@,BE(2D349]W$VM
M*D=_N3OK8[60_FJWO(HC5)/NAY_7OT<P$^HAWR@//BUZ]H;@69W36B'"23.E
M8MQ+2GDH[D7.O,3:4:]Q.R4LNKC\![!@A>=?T&63_Y=U^6^?%^A GM00*MQH
M,O^%B?LE\'[+\T&:M/\H%[NE'E<RWXY?F-0QS=# P3+OXGDG&IP7KO\!GKR<
M]@_JXT\HV^:-)J7/!P;XW?G=N/+CO]BX\OA^Z6]%@H:3WA'\C[+K3Q .Q)-#
MS_OH,?09*O-7F!L>%';%507Y#:U J$<V=P&)XGHI(XO&M2,/LYP%VT<T\G5%
M\>CT_U4*8'A.@$P''"6]GPB%/9ZOT>)CN\U +NH#,F^]8>ZZI9I%,VY+'\+3
MQEJ-*S??$@U>GUB^QF[U8W/F/#3"\B:K]-<6TS.Q1QI00>CH+YR9<1FA#5B+
M\BBT)G>FV76:W.G7S-BS-[6^G*(PW'^\MS$YXG$7W!+19JYUFGKW,$Y>7@-(
M2+\Q1M6CB-,F,$ X-SG7>%AI0[WY%_D&4=J(Z%N77>'ZU?I^7ON0W@3Q^\W2
M,\]Z$HRN*1\L6YX1?AB]L"FX>#,,=/QE'_&;_LB]$*]OCM;E=Y^<:LE**->_
MG")Q>JFLW#YT.E.I06+@-%Z\ G?-2 '2+ZVM8U">[I?<DO_1Z8=_#P([BM=M
M=_?$I;:#7B./\M 8N"+L!A$<^E3Y6FU2_16RP.U:0RU)Q7*WDXM7;(<^&2^S
M#V3$+;XC'R':2991VD78Q<,B*ACO&<Y?_PHN3^L5/CM.O4]4Q-7E.#B+!?>-
M_ZB94FK$N6A,:QJ?^V(T:%6RRY!&]B<UDI?*UY!U3T();HN8+95%X#<Z@&11
M0U9>V ILUU(F(,-^*)\@I^)+8Z]>G:R1M32OK<G:Z:=(@YKC5&*JCMV1B-I'
MDA@)@ZE$@=]G8\:A3@O?L]2)?HF+D%?"PE^I;'BPX'W7JP>H>$_/79LBV5H[
M+;N;EZ@40R.]<ULYL=$ZA2O:JQH'@NHO Z2Z\(3A$%QX_Y4-/O#&(->%V('*
M!M>:4GS)S@-;-,K>%6HKXV3)HN9?;*)H&N51,Z[-VZ^SQ&K97RBK(CIFOD24
M%9.6E$W\>MB(/JR1*<,\E$9,N]'.601*T@2QL.O"'#.?0IKJHA;N<U/F+R5Z
MWOW.RN(%/$K$/>D LL4!<+,_&\J 2\DE"BS&;X$)/PW)B0O@8],MS];2X*^\
MG+@F"KW+[/J(O+FC6(@\H\2[CIS$42*B<[X>T[9RQ/G-=<C'P;?YT%'+PQRJ
M &$-S4_NP9G7A_DBM^99>S^(H9$EY."M:3!%)LV\6?*=$OOG'1V%QH&@3 K8
M#OYYBU!*8_R)HP.P89!() /L%MOFKP5*?!@=4.L?\M17I "FE"7$-#8+]31S
M5V-HB=JPS/",FU@5E7DF:DO4>S8AP!Q14/7>7D&_PC=S.%OG7*E)N2TKSTFF
M;U)OLYF2-AX]&RX6LP"S'M:)1Z7E2M8^I 3H62N+Y$L9]DZ)2>J/M&2.)&*'
M[JSNM@X-0UXA:B?*%T',U =C<!!,DLCSB<5[P>SBSQX%<AB;1/M!6!II>4E9
M_LRZ;(,]%G "?,&/63J'F&'9LP<BF".!-E /2#P[O'=.$S(E/F_N9H"*E.44
MZ1QV?CM?D34GP^^97D\Y^3U!$I^AW5K^G2W.;0GXFB9"IE!,86>/]C&:]@5]
MG-R,1V)+%T:H:@@V&-MAML;][*NO*LCQE@WUP3\6.[Y6M[G)?K^<_B1*,F_F
MR[3EL]ZA/N%SDZ#'-N IB![9B^A):CW,RR$GYZ\>^'=L\\ _8R&AJ"7BU?S2
MM='[:Z/.3>:-']VEW Q*(ZSQC)E]FDT!"5<7T];;"1-6I8OPJF"KM&BAESD$
M5=4GT/#0MD>59E[L*'[C>UT+&V;%U]H0SCU3"R6F/B7S>(YRTQ19@^3G \5Z
M[1HC,67)/\9&(+UE*)\FX-?XK6,41PCUVE<TIR'A%HXA&JU)?KUH6)!9#-6D
MJCB+$P:3"US]*F<[ O"QMR[)))Q\[]#0(7G_^!FO;LO-?,K3>9@_.7MQ>^HG
M/KY#5A<GT8,)?Z%*U"G&%=NKQPJ8$7+UOE=4Y\V*)K14[7^_?:ORPJO]ZUS[
MU10CZ$\[,A>>#OBV2 H<@RO#= [?@AS<;18&T-45,.OH#B1V3EY8)NW.XVH"
M3^23NKJFQ+OSA1][Y=_<RRV]) (0%J$QOO<F3!]Y[> Z:N"8UEER#YZM"W0,
M.07^7$.N7HQFL9AC$YA!10#<;]UN&#L?JYW=!A&!IB+4+S^'(L8WV4BG0-R$
MF9'<%'SU&7&U<]U]SWVJ3^.*33LG88V^DGT)"5E,\74H[EP+TV!'M1%2553@
MX.6DH&G1A8PTB%#%CX+-)A]0OOZE'(RZ^A]_KH+Y+UPG/,)7$<F^_'M4J#/F
MUR<Z8%6\T6\5'KYO:8Q"](1%TP&V;+1@Y^/O<J(N ?Y\54"Z27.RK03_R*<M
M)XNLUX256T;DW5L42^U?NM>4VUL)/?W%QTE%D?1(^N?0%M*ON]V*<DK8OV<\
M2;*)R17-2\K9M_9+LD^(KDU[H>S3MIZV/>V]3SU,IC%2#<A'('/R:70[B!U]
MC3R]"(QN<2043'?"%<=\RV\N ]D*JA!/'R>,WOEZ,;/F\],MUO%@GTB[3V)Q
MTBO;42 !A*,GUI.422:6P[%PC=^=.BDX>&/ T5^5S7W"D"V1.Q)1L"XLG#1%
M1G:KU:"%I95R;M&2F6;/G@+Y\7I!<L\\J3^2Y+0+3[D+U/TA6;I T9[9X/5C
MOJ?/3;?0EE.W7Q=TR%'I !98.$6=7$\Z@L/@9_!OD#JC3 K$^<#_M3BY'_]>
M2X3,@*^/TA !15+5\9D@LX; 7JIF[@#W^V(!@PVSPX'.6[WW,^L:GN(QYAUX
MB8AB#?^/78\4+=L#E.^*"1:;M"^ZJKUKO,7S"^2H V\;S?E00*BQ<\8MJM[0
M8<](S9J4,FXRF[B8DYBY),2^M-RL]ZM>L=IOPV&7F<88_F$UC:<-Q<X6#@0Z
MDG\2Y"B=EHI4R523UC0ZH#/K>*W+*PPAI=4;.N\9L/N1>]P0&RXJ^*0UD,;$
M3,PU)S-0A&">Y%!<O7.+?19G\W"+@ *[,/"<J^?)UKS28 &ICXT"=[1"++OF
M"7J:XHO6Q-2M5.)B.YQU'':2HD5U)2Z_#R X=>R13%S\4@WSO^A@\)K2=Z!;
M$]U#MDG1[]IM;C6R?6%$_?XBL@[J9D9DV+Q =+LWXB[6FOBIWVDQ>MK9/$W/
MYU!X>;CBCY*=;RP)  \&,"2MZ^&:0:SSO<X!RT)+A7YTU9:(CL)R6>6X%(XH
M%1S+9QFJ9\ 6E23"95+C:M@M9RB[*%XYD/]_M?>=44UNW;JQ "H*2.]1 6D"
M(ATC$=ET >E(BX ((88FO45!0*E*55JD=R(EH/2.2._229 J):&$ "'<^(UQ
MQO?M?>[9Y]>YX]Q[SP_">%DC:\XUUS.?.>?B'7,]RQ0UWUJS'H[>VA@O;]@H
M<9<%5\1VG!B2+V)PA@L2%+2_$5W08R!N3;0%21)K%FF/)\/*W3!-W(^G?@5)
M5PVCHH(7G"KF=$3,L3I#HC87.@+<\/X$#Z+#,570""7?(T<?7R/&=U4CV,B"
M))6A>@5\:K-Y3;3G-L>D3Q/&?_H+7C!:IIC'8 LC_4B&ZKE6,3#)4H11$O*)
M@E)G2#BR@HW$] N3O*E0,FE-S!L^QL2^] !3.]:*(_V+E8H7K;3;DB"V(\[7
M1DJW\F-HH?:S[F3S-[VW2I2Q30J(A8QY--N&FUS[1_(]DN])YAYE-:> ZH%-
M&F_>=+B#1%B T9%IFPZ7 7P*\3) R$4ZQ.7)C8@_8LBN.);::-S/%];5CT^^
MX#Z6V1G21Z*22JSANCX@<<9<O4W+KJL7'Q1UU;K&'658L7$.%T.T&*.$,1/H
MM-S+*QL)A<KRA5.I!@FE&QC6TAY4AUR6=N!2+NJ$V2=$/T1E!*13^OTJWV"5
MCO]C8>2L;XINNG? NY"0!*A8N_8Z'>R0#S?0OOTCGO!IJ-[[^#YY"LQ"%O:)
MQR+:>;S;M1?\P>%D/KSU^^R@OJ.;[PLACE,63N-^7+3"*;2_+.!J+]QI/UP-
M*7A@WI2]BH "P\#,2E(D\Y.8/<^)KO83>HQ70YF3MQRG9Z\Y[:13K>I2^COT
M:$Z-MF\9)Q9[P^[Q),[7,E@4ST:X0?QU?)W<#*E<Z8),NA *<66I"_,QG&QO
M0$'B>WI7B9=<&)S [,#VV)+N[!FBQ2,K7K)@F%L@[/F;B>N,#O15\!D%HG5H
M "N35-KMCVF[C[4%"\.RD_JE)7=[)"681-!K1AZP,3.HCHV]N5'AE!O!M51
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M(.C9^FCA!UTQ\*:#B=( E7#?1+2#VIWP"J<AP_?&X:*QX*K@N#I"TI  58T
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M8<')U0;?GNW2"O';I4U,Z'_#&6<GVV3'MG=)]^X<^<S<XUA8*Z$M-I$1T+N
MEVS_7N5D1 AX5X";R1AVBRH%^KZH';'<<8VM?#W#/XJ4B==.F:D>/G Z%ALZ
MOIY/[&DUKWGCB;@(#>(?0M,S.S(H>Y:NRB831IS\[!N&SLY9]&@L03,?:QYJ
M=WXMBVL"!5TF3K3( :OG-V,S5Y&7]_KN4B!&W\A)9&KWBXVH&DN 6<MPYDCV
ML2:+KUF!OOUX'?Y<>]<A9A_;J'12<PJ #80K\4XHR?AT+="%+&P'DSDG;E:/
MUDN6_3IZSGOW*ZZOOLX>SU+X/CL0!=A=1%^P=_FBT/'B5C@+Y"HGNZFFKMGS
MQBJ[R';,YWV1L2Y,H:VP0280)N&T[J]MJ-4G;FPZV?<C:$[2-)$L7-QY!RIT
M5W9O!-*4>817#7I&'@;7J,<V\A(K"1JX^1;Z,!KLO:Y-.QPEK\:'AV_<_!(V
MM:(F.9TS9=\W.AQ<"KWPQ(7%[8M'EV$/Z>GOZU^=7(+)LB>I9-KY ,YAD 4^
M?Q$5!K(O=.+DC7>C:@@/=]G3S@U_^#7.5XKK1Y$SK,/2F:]4AY>G]U?7%:$N
MVHNV:]AB_5Q3C@>)+G;!/HF1I09I/]-%C 1>HSAT\V]99B58IKV;NY'B;KV[
MY*934(T2MS9"FAPF=:T_K\U(=/%WR9UQFK*J+O5EFGD,E6,C#*XG5^/3--T<
M\KMOS%JV< 54Z###.>4N-^--83@[0CQ^9?,*!CD=3^ >WW<)9_ )7YPKQ]W%
MJD6"0ZJT\;!,:/*+7V($*UT<Z_&M\<\W [#?+%^>_3P =B8/@-'AG3S^A%"\
MWD;=\<, ^0J<1'L=D'H=PA@@5;JZVW[$6H?A$400XOGU=Y)E!YCR^;=:^,X!
M8&\QO<;<+)?AG,3G#T6>B-BMC^1;AZ-#1>2_$[7&A R,>1[J<J9F<\;4VW!U
MP@OD6[[IHS@T.PI5=PM$\V%?U+2VL[W1Z+7 @<$BT1V_7X3%DZP@4:<F!I#*
ML42 (&[B#9DQX/:8Q%Y=*:*]=BL=&H@_&PCLAUOZN'/,:#ZK;IU:9ABF[BWX
M=#G-M'H-49V!P@,)%H.-]P*N$-5+2<KXZB;?FZ\DVBQ@JXR[;=;7J[_"1(>*
MK=_A4K5]LY/@*XZ.AE'C+%\04IF<NKF*%T=1ZE?D3V#T?:$H:[I<3I_1Y21&
MPWP.K7US_9]I3Q?EOUPQS=M^MA$?%U!1%>?EK.@_[C5=Z^\4N*8:9$>2.ZEH
ME//YW8O+#4=#2,8!0_<"]19!!A(O/1$78*QL*GIC635L\:NU8PET$[SPJBO5
MVL'GX3<8;K^ Y.OF<B3LFX@$%6F OW\IGPP2E$@7LKT7;[Q:HGJI2J2U@7/4
M<D6G/]U,CD-H-%_17;=?ZG6\2:7WQ4XHVM/A64X*=+LH<*1VATN5V?2JS7]P
M&??_[N<<_W'T'LKP]S^A7H(H*9LU)1531MWZ]PT0,DFN>TCR%$WRD"K+DS_=
M.E-4TLMB5"G9;'R^7/ 3X&E<()7 BZ [PY[I_JU!UX= =TMJPF7Z++3J1_9F
M \_<63V0NUWEYL0 /_]V,_UU.3<#AW*'?*ZPFKC6Q>_"?7FCAE %&>:?HZ;U
MPSI5)8DM&WM-R0@^M7O>;;M.+QR]R#<&Q65^V=2N*->,;3P;WS0]GE T>.AB
M _&]KM]2DN[0U40?(.?EL<T4H((#AGE>B[P^ E+%SM*KCIH(+@G Q!X0YA94
MKRWQ"Z.[1/3D2=8G&0B'4CD")9L*SISR@8,<L - GT@KHH5+B4]3!UE\S*&I
M85PFM<=0H/=]L>;/CJ=E-).+5T5O1'%/# "O>DJ\K.W:'#JV(,X3/IZDDGSQ
MU?)[+N=7&VE"0?>P4.E9/KU!X\4Q9TK\4 L;7NQ[J*#A#4H_H[#X:Q77R5DM
M8E1HYV96 G(/$(=R?@C@$<**#C"]S0^/OF0DR5XK/<J4MNZOE9@IX7 %VJG;
MDXCESTJ-LI. "DG_G-(2V:QAKY[789J (8?F8K'T=#YQ$YMD=CSO*VP@V$UO
M$T@'8^4<"\.Y=A,:E'P7YNBIO'_R7NBS;&JL&-YPD='16N?BN:OW:@N%<GYJ
M5KHIEL41Y[ODSBH_Z/GL&MT9/ID=Y(8IXO@V#$CU7 8Y>5=]A'07MTP@;TI(
MTYJ543X#O3B8G4P4TT-)N];FLQ8#QS5,\+FV:VY=\:> ED<@MV(?/8)U;!NG
MV$RU*80SZ#K186%C@K7?KC9BH$.J4]"11\,CL/P=CT;SS7JMQ\^+5Z1W"OS]
MQ'W&0EW85/7;AR.2MP6L7SO(M^;*"W>W&,7!1;7ZE\MR"_W5OY_,N7C.B1\_
MKG/<0BO]'*I_L;"):*-=M))K]WN$BWS[G1AQM,4#UKKX?/KF^VWGC+L>;^1F
M$W,NM)V7O9#=.@?" 6.ROR2W\,KAD%&L@XEUO)QXZN32>X6&P<Y,>E^_.";P
M1F&,]FE8=M@Z!GXLZT4A+I ! >QHO$<&'1&R0(5+G&^7H(4N8SG(UWZL*7K<
MAJQZ)S-4-$WN:S(%+C@8\OU<&5G<)IH@+I(9*)90:V0*N'<2'0"F#XY!+O04
MHV+GN'")?2-$@PEE[>CRZ$"!+[4QX*O:O!,Q<H[V'CU4U^*M?"Q1XIT&[47R
M&P\Z##)C.UI3V]3,G-@MN9R1$^6Z)=RBMEEQ.:O#A;I2:7PWE^ZJ66EV=.)C
M15VC#QO6M$SJ7L.+HO?K='+F50A9A>N<&?'94VAR3?&:.6_&:]%USOY,6)Y9
MMN2EH@/O.-6SE8QG"UTUKYWI@RH6Z_[B/<L!A(*HHB3OQCXI"G&[!SB_AUH9
M(5^RP+HP!DTD(=B">'V83$8]4*^0%3F*:G5X8'NM:ON@RB+]6QH#M"I.:]Z\
MXNU&9O79I5;MREXNC3[WGQ\-^R5'<<-EGS_ 6LU*+#\5W;JGF'A=+;UP5V7*
MN-0\5U&ZL%!0H?] ZXY3T2C!M=9RV$]-#CVW;?4\3J<&3C^+9"3NMC32C=SR
M;&(DANL.[^EH+7-I\]AJ+L+O^&X]MJLV;J GN"8S*O+?X9#]ULMR\69ML[+Q
M$Q71+(TH.A7^-Q5\A=PL3^WM^8(O\$603O#J;=J02 A.9S4 Z$8+^AQPO08O
MF\P'R@ALV'Y]"V)9GJ30XQOQ2R;A?N/VAW-I41'[$C\LL'F9^'R"!I$/3V.>
M7N9YHMWJ-@4;49CITA\1+_/8D-SZ0[8\"JEEO$-).,<[1@J%Z\6AAF+MG9K\
M7PO[\QBKX%X-19EOH[#32PG7GQVF_.$D)\-:DJMC%'F8*[#C#D%D[H<RZUOK
M%_QK"QG3O[2T1-U 61%Y3@%\^TTG(6B]$[D!?<.%Y$^\.F!2@!6E:E]:(2=J
MZX]2O*^K8_XDR!JQ9H3F,?*RCMP!9$4(_Z,[C<%+LY>?XOP =WQ^DE7B5X5%
M/^++$LM@<W1XI5!,M#WH+E;,3KUN9"\P<"S=P[_G0Z^VG[[R,TE1R3-J+R(*
M_D'1EPRB+)>\V6\.OXB+<'<2WI6.AXL*N-UC\FI(FB5%$8CIN!;0 Q#_/&/]
M^48104?<+Y_*/S@'/L:!D!N[_H0F\#7R8O<N>')APK!PW<\DW$ZIL&R]UCD\
M=RHS;L5P7**T:E9I[O8=:UA/]_5@F:YK]1'TI4&LY-'Y\N2-B6,)<M?1> W6
M,?8-PJG/T#1&#T"R*J\;I6]O8@M0'T5'PE(MX,)!$PV;V!C->"?S"GX%@WK.
M8Y?.4T#%?"S""1@*K&0+#Q(G]B]JX@Y"2^OEL,#(N0NA6WQ?B1%O<\R+5LW1
M'75_='+(^W^;'#R<>[;!><0YJ6MZR>>A%6B$X3-+N4^)@*4:W_G"4>28T$@Q
M2(TZ6G&,QX\E76,H?].*XT&E?@DV=:G#J'!;M57<23(NRKY&"ITW90+S?KIG
M;GG\HI6L@).+@2_7XM2C2&*+M/[/1%\(AJ%GY<R/)0V4C^^/;#E?/@<Z=W.&
M4):-TB(]P<6V;?\^( 8OY%JS$Q''/*MN/BJM1^"V;3 A&#<?ZBR>@[.*LEWL
M">;:3\*NLY,T!M Y;T OV#_&])IN5!<7W(S-@_D-/EK+@IKG53 L%(LG0V56
M33@X#*ZW\'2JNC[[<,E,Y(->\6BI29+<174V-?:41YD1N9S#"=<OJPH9%5_X
M;MDXS!@UE2[<ZF5:[K&\G-L;YQH?"9T3RTG'3NE._?+,5C A1B\(D51+B 8(
M5L?JE.UPCP*9AJ"YG:.IX6FUX2U(3_"*?F.*4745_;7I"F\U&H55IZ( <^(]
M/JK81;;6<+LTD8 'N&+)+DNJT6[Y;4@J J>W?=;'>[&K#3%EB WON"<NP8IH
M)1";L.S+Z%'^],WP8#'^.#&P<OC3]_4F)KL/^M]W]H39]07T' >0.\$5NJ_H
M6V,GNQ80S<A+:TANI7L^M>,CVJ-[A_LO C&(2ZL3%WVQ5@;PE,B&SU]&,I2A
M4I\,A2[1YY>J\/?8I^H)MMM)[N&9<]F-2U4NAI>&Y13:9$)XS$O6L;C=4&ZQ
M8JN"[EJ/Z;I4C>[QPHTQC4XZ":.TG)QM4361(6_W0Z=]K2GRT?3,M+5%F[>]
M)]S?X05G'\S7 >0MF_SHRW<=^ M:D%3K8F*<W%/GSL)U\^5769H.='58'AIE
MI,$[E3R+7WX-,<E*N0KR9M)$U,TP[>X/I&*6VF\;/N=D(BFE"Z=>ZS: 4D5V
M1NW.K&:<PRTG8_KN;3V%.@N@1Q:,J*$\'W/<.UXY/+.5C(>$ 7$&J,FD7_?'
M@MB"!I7DB!^QVQP^1;N$-.)CNX5M"K5 9Z:)ZBTI5P;>O+]2ALQ7HQ1$N0.L
M)COJNWP)BY>H57TGU2Q"^Z2 A7H\MV04X])NHY5*1=!NC,[6'?XR!K=S^YCS
MC4>+'571O+ZB;"8YA2,K/Y>A@@)]]CRHTO0#KXJ);J>@M:;H &%@Y"<<\]18
M":]D;46R?N7@3?L(PDXGU>R]OJR[U%]C6%H2VDOXR#=$"U"]]$1AZ8DF6A#D
M^!9YQ/P,[)Y=RSPK20%79U3_]B.GRQ622OVQ;#YS,T,%*N&+U4+BAFI09C<_
MT^<OZ&M3,T(9L^$JEY%W@.VFXH+4!0L5,W"%[Q[X4?S5E#A(;3O&J< D+V5.
M/%V+Y<E4T[8 6Y#1K)IWNL9=:W$QWTZMM9,#/7=%H:PO5_[MY6JZ_&9*^BOO
M\X+<6HTXTN<)>NU$>69N/ 64K9P"[FN1#G!@4@PO]RG@<RF2G* .R>1L(H5*
M-/WZ>@H89/SB!F$.0B3<[\^*$$V@!YY\0OS,("+(G87@O0<37?L$FLVS]XG^
M&%(:HL/X'[>3'/.-!MG^VPTE8%;*!@U$<:IO;)X"J"1QJ X7;B(8JX9:>-QX
M":JH3I@/!C&5$"OFQ%0%; F5LLE,)0:?GE=(4?-TL4"P>NWT'(@6;5(@+AOC
MW48?IB2#@VP<+""YH$I*Q'2\8%?MO>VP,D\%TCU?UNS,-47KT$*UY.>=F[(]
M(J0Z=SV68P>6T7>%9K-GX^,XY9^>/%4#OY3/ZW;=.3E0B?E>_HGTWLAT;&1@
M=2CL4BD(C8#:$R\LN/Z87!14E#[DDU=A_BQ*3[7_1BTG70[T<*TS*UI=5U>8
M>RO$&3IZ,K.\(B24,SL%?P%Q@'LT5(%OD*AR2 ]'FIZCB,)-;T@<F%GS+NM1
ML .22@779C8JO;:Y!W?HJ U,FE6:?MCXGJKA)VZF,\\1X^!8N?L2MJ.'%<_$
M'70B*R"Q>V#VR:!Q)!L";J7]8/P&WN$5^H2M_0[QKNKXN]M-7P;+^FHGM?,F
M9;ETT6\U,^[\X=N'L%A^)O+FL5>G][76L_2%UZA=LAE%Y$D?RGBWA,3XZMZ)
M]+@GC6-]SP8.\6=8+Y^;.8%5GNE &I84:TLLI\LD^"OH=]3?TT0\Q0C;7-=J
M, TK5L"4BZ24FD3+:6GEQA4+9=F'+9M0H(),[200XI;AHI.:SU/UAIR;V/)Q
M-9$T76 BW^8\B8_W.@QR.:B7<PN)C9S?2$55$&&/ L7/:U_QL^/M$]^?7M+V
MSXJ3/'_&&G.LZ6A]G8*_X.2@#DX",A,F-T67C,O&)E:7HLRANS-03N.^CO54
M_T#U1W\XWMH29_O ]W[L)]"[-"CE</,MFSO69.84(/(4^<AK*2CB/B&',5$M
MZLZ&.^UE8?Z8#[:T$D,:- V^ TJ%(GLPT"T)=?$^]R4@3%1+(=<R\+&Q2[RF
MOL^AVFUTD8AF#:]WCU.P_M*RWVB^ 8&R0J>4ZF/P,]3Z0&]3;"W;&PGP0@$E
MZH+?/-_C>;;;=N3=C'ICDH)\ Z\Z7!FJFN[>#QXTAZR+Y-%:%,8OAPES6$TD
M+J:$=P5QXZ]0ZE 6[V;.=G/>JCGN5((.,>13#]:QZCAL<!-MI;6^3@NCC=8W
MW!B:TQBY]=9YV#?JHXBBZ=K@AR)IFV0[!C.;B_P>AV]F:#Y?\]=?N<H1Z;YQ
MBSWJIKMBP _*W^0))84KAOF7&,Q\P#;OL>Y_S*JE9;XI?%.$!U/'A[1+%_[B
M$"KNL\K53=S>=C&1\2(;L_0T65N1".!D2#B07ND<N9>UB;&1/FC,!(%F?8NG
M5<,[1'CJ702W]H&MQNN!BR=R[8K1A.QG289K^C+HUW&I!27+FA\_JE2]WJ1N
MC"-F9_D,8% ;ZCAU?:+" C@*?);,1HELJ3 @KT?@)3(<AMV*QV$?M1V;=&QD
MQBV+3G?:@:J_1=[AC\J)S@<VQMUB8C?W$7. >=$[CTRWB+8N9JOUAR8VM!1>
M3HW<VIG1N%1;J_9M79GJH;W6DV!E+C_3<HO(=5O1P?:QEOY2U8C\R Z#TICT
MAP).[[(5]=:)ILJ&;34*]0\%'F-G.?'A%4MY:?91KD7"N:+BINQH+DTQ)>$7
MLAO)XFDU%GLUN^"%8OK7UH(GC0B;4@3A.0[5=0I@]1%L(TN,TT<'W2*9#*)[
MGE4W!=(PKATXZ+\)S#@C2SA^D1CZ\Y I SG"3>J3!:^4((\X"IY(FC?#X;;5
MZ&J%D[YZA@YV_CBMU_>-XC0%-/A3[MQ37Q;MZJ\,3QUMT?XQFLM-QV@FKU4M
M@/TU'MD^T7YL/F8E<M6PP9O.W&.1BET]44R_E-.Z6\]H9JEWXZO!@='SQ+D4
M3V_6B(>Q^H<1_YBL0_9?GH3...9\VP=^R/Y-MB__CP]4!'8>F1823P'D^[P7
M3P$HIE/ IXG$;VJ=/SWV6=:#P'SDJZ> \SO@Q?:#4\"S?SMQ^:"O^7X=+*FF
M7D#J,*-5O?G[-P=O]BXSH,K@J5]LK_[OT?O_X0#PH[<Y=>T\SOB8GJ$QI!31
M>EN)T6RJ&RLPLD4747/V6[$% GI>MA6C1RUVW+(048=M(@K)'&S\PH=@:5Z"
MH<A0ZSN?<4LE^M8D47SL2]!%WT4N,+MY/WO9QP*EY.?+_6M&;R;+++<$YYJT
MZA<K>V;JI-)LI-)6MNV\K2<[)'L-BOB'+/K+O[P_CVN3[3),]+S#Q_#=EP;D
MA8(=Z]%:FWG&]IB(1%^NN9*L)HTW:!N/;-/IET\Q;H@V&TG;PABD%8R%Y$WI
M: V;'2N([NATU,9EE.LHP;G-:VNM.&&&NVSDB^D+]!QKYA)=]%'6 KCHB;8&
M^L78V.UZ[87ML_-JXQ-^S]Z)]Y8[U<C>*GKN[.GS0T?Z<M&W29/N?A=$B_'>
MW9[YR>EF)0GTVXQIC'H7X@Q)8T+@TF-XE1C=0F"%[QO,=3VY%:]6U/F)M1?=
M#9%2PH*#(C'WSKZD61"-QT^$@.3P?"U!@D0$]IA_M%X">W)SY8^)YT#HL6KH
M^+P,<P;+3I%QEX@ZBVM_[BURC*=)7$38S:BE!VEI::Y[:VWT&XN*,?N"W"#X
MIJ"#0AGT<35='$$\SK^44(_RGS3_?L)DHMZ*J%'?C,=")G\1W'"QD606(K!#
M"82?Z(#3_J%':^5CT99,OEF%:XAIL+F,PD:KS>O%J-R2O=V[E70*"%*_T/U.
M=/D40!2<[T),9C>;^JFWE0*UB8M8EU@$Q_X;EZ ;)'T\JA7%M/8>9BW82/W8
MIF["D_V\GW-TOI0VS+F".4)>GRT^XL2-:+%@Q8>A?U4%#&]D:Q@MVP->L0@,
MUXJW_&JE1>9BOE1->(9]:OL$'<TJZM')%_T@1K31?S+'Q,3G<QL-PW3ARDEN
MU&W2A>(P6/)@CYN"%:BV:BQ U:FR2X4;-^:F'X4<S7[;5B_@M8HQW6;EE'_3
MZLF5\/-GMI!>16J:DT)N#WLN#9T]FWTO]C"I8NR%]$:5^K<!?,TC8CF>;_%@
MHP.C<ZY][AP>$0P">^=/!AB-[17GX1*7^K,=^&]LJ]4*_X1(TPK?A<^\6W!U
M@[P_!3 CGIP"IE,)@2>Q2N)$P;:FJJ8V%QX?D1V3"9 J)ET0$Y,K%UOOYE\
M@SC&:*)E3)/6CP9[SR2G6715LB\W9?'=-+KY"/"B]9,M8LKU7 WI8C3MS<[+
M)9]B/DZIYZM] [_)3<93/2_*4<H-;2V1*G[9;GO[1XJT9,8\TZN:[6R+JP\\
M;V_EI&MV2E=EBB2'2T7 ^X-3 G;C$W/9N^5XS7IRXP]*<Z?G9NG[8D/E*'GD
M>42+(DB_-"  'Q.-3;>>QH15PK*U\QTK?5P=%;WJ,JV@YM:OBBPL7^XX/=C!
M\D,UJ'YL N*M8RED,H,3S\8=$ 2(]-FPJYKPXCGB,[B#?E7B8WYTJOXHJLQ
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M86JZ5Q?W;-W%HJ+Q;DQ0K)UP!Y>CA UQ3&,%J>G(VS'!]74PKPD6*D!1P>0
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M#88*/__]'!QPP'^(]4)(Z+O] R@DY!]V4U@2\?^TY>)?OR'D@/]_\#^_L>>
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M9A=ZGM@:V W/@PN)SLFD)Y:PX?;-8 7@I:4'N<R./UE!H\B.=[>0GHF'85Z
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M5 EW?'AWU>.[U[.*&R807=J4_>S4EV)BDSETS2UEKNW!U)5*4"DKRLD('J;
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MGAO: 6.[P,RMBF@>S!^LQ8VP?Q6@FVLMUEC9VMJ+A)'UIK)I%2SEPP6YRQ>
MWMH9(J4RT4P="#OQT-\)3V/!+A-^.*8UXX_6;OKZR7#0TJ00*CX)<0?#_'[0
M][GFR+2+V8%N"CONM?(2*;:H)5 D+M0 <2F JQ!BR\5,WG&5V%GX]@7D46R
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M*E0IY\F#)36+2J07F7NE8O97KR\?@'2HXN>NZ^!</./>*#F=8LU65P#1UH-
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MMT[!7:;QN<;E3*4/Y$Q)<I4<[EX])L>?W\>^KIUN1\UZ+%_ -ZF@E.\:\<"
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M;31^OK+G,1-TG-AX5M'FO!1R#L 8_ Z6HM#XDFB!CJ+$LO(:T7#X81TQ!<O
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M_*QT[T$)O':NZ7WM;X^F_ZP83/4W9X54P,\+-@[IA,,ZV"&N&!)KX<43U_S
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M#@IL"H:7;(/I9!=@%I6TJ[(&K(E</D'YP?:@E?UP=5ER-B$#W),))%T[!T0
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MK%734[K;_7G9D)+WMGK0[/:V<<J68;GE)T>Q]<\V RZ\C3_W!IGXV24?7GL
MO29?4-T%6D%< .H?1 PD1 6&MZPF4+$[HYU#?<^2JU1]O. .SA7X&"-DVK+J
MN$/+Y+[(_EK2)"SS&&-EPZ7*'I;-^.>M43A%]9=F_; C6RF,2'FXMXM*0#@D
M.IXE9?O,) (U65\*9HQ.9?$K4R5[ET>>D?T$K5VPJIZR*#AJ70NOPT70KP&I
M4!9=],ZI_+>:^'KT:2WI.I)[[=UD2]%8J.9,N7H*#OKU\9;=RZEMTT(RTW(2
MQ13TB#R!U&8V+(21H(T;5N^DP >O@AD"*FLY4;F,,\<944PBEA[*0QB>QX8<
M6NS37$_:8TLHJ+91/8CZ"\#G@VN[$'(8#S[@TZ*Z21IQMB=0V.V#:L;P]N2\
M;JG66G9=0+I';8PD^D/4\3? OWT^ UX"KKT&K%R9Z*KV3LA#.@\#S^(%53UA
ML@;)HY5GAZM>S?/ 5I?JUZD'P:+.!,?L<]E-,>C+WU=,2X/.@*8^.2IQ;3XK
M+^59"+,_#M<ED)65^UT9"+*_:MI> -R6&0(,$\+CT&T*&H00:#WXFR]8/-O>
M1@))=OSS@3XA5',@1#TD#5M,H#'#^&&C+NVY?C<'JX:)?P*JU:D)LQ/9]"SC
M!V2VAV'=^'KY'S/)7C9JMKHB'E"[M-FVA<:X1L_7MB1S/.Y&,*^S_#ISTW3)
MX)8?TW,\K+'"+MC0;X,WV&ELT =1>!!CD0[TWGIY0/7HAXK%*X/C5JP-6W&.
MO92V%.)5#?;MEBYGVA+]Y>XW@%%/ EM@%JOPR!"A''*&\*%@6E3@\^]C&;Q-
M"3K3?J)5KW8/_2(M918I-"TLE#.PB%V9,R$\:"B(ZNT2Q[1SW+LX4(R8#(3Q
MSP3@QI8'4*O$S?*E(9W3S8I/C?P\J);%IIF_D(/>A3 _MZX670EA"].T2NH4
M%LO_8/]L9I2I8M >)Y'^.]6$?QJ1[*PL"2U%'%6,)4 S?;?!N>&T4M6I:*?<
M;>B3RA7L1(++4'+T9N(H-*A[B1H;R^F(+0YK5T#'V+0ICZ#WJ)Z,/YMK>S7&
MKXML3/!<8?5<]-Q@7F]5%*C^)O M/Z*813Y0NL0@M$'0H)C<>*5-/9O.@?YG
MDL:&S,YL[W0.3->M.7J:4T9[>ENOTF*X?=O8.QN1G65G4BVR>\RJDT6I,C-_
MVG]"Y@$1J;X;O3VQ/^/K4MS8TIC#P;R2R>>R%FX,_:G^W,^1AU7:-"G6D5G=
MP# V.3:?)]N1H6*59S_3M6'2U%W=F5F;)A;-SZQ6JF[@*1G[:;^0H6)2ER_3
MM:@J(4;F H#G[]K-P5#J!1OJASMK9Z[%C'A\A&;UGBI_6)>28GRK@YR>Z1]\
MJ1(I<A>)-#&9N]JX#LD+82(PX:VPSCH(#;S#2B5KCZR_!^NRE@/;;Y:T3]^J
MOMPNKMB66MIA27]?V/XF&/[RGJ3V>)BKH_C6E-G7M6S:[A8QY8 B_9YLA50G
M$X4_M7]"=-*?X>*,=8UUJ"-01N7T)MJVT^JNQFT;Z\KE,JN=LF/>>$>%64:<
M+"1U\N?+X2.1(ZG^E>1"9ZUV66Y:P]@?8B:[V6A^O:752 ,U^E\;0_\IV8M#
M[L*[]4!.H-V.1W"7KANN/UWG*V8RG7L7A#4?Q@^;P,7&-'"NFOTT[.9_%-5K
M^:C-C&TDM]IWXBP/C<^[*D T>,AC7$0$LIH<GZ[7--U =6>KZ;_=(Q?#BXN(
MYP4%18*9GO/)\2DX.*8Q7]6A*"B)[T+@<SXSPZ/8N#.P2W)S$[VC(,M!W%&"
MU'"]&S5B6D)[<' B'8C]WJRQ5/JVVO:.5PE:GAB'-HO\D!#.YIR&4R:=-^WI
M 1N-UN%UTA1R=2.SE5O"_-V$&@+N176/VNZ).-YZH%5J9/2N*RDA%,$(U,$J
M8<S"0WCPEBJSK?0K9Z^R#]M-,_=C?"+]/&Y? )X]\_!C5<&5-WC+%$XLN-T1
M:&UX,WG:@??"74.!Z(%4Z*Y(CCL=C$1.G'K6[7P'P7F^-UF^_J:,B>7WWSZ=
MA'#GHIXV+?93#+M^6NQ6Y5QK.LG 4U:%C"[3'R]?<0.[M(U_Z$*VLU?I,IG,
MMHL&B2#F?CNFFH*:+*5]7 ,;-$L2MU^9J=.[:XD6IN_JX_EF]Q0NM=Q&?R76
MK%\Q,J8;=,>/:0$E9^9C3W4;CW'4@8I.9X>%H_JB:UP/2Q<3W>]O&?;7%*X7
M*ET Z,\YH6?WL<-Q]524S6V(*^E.'PJP](*8Y_GZ?!A+;W,WDY:%G^9/1E1R
M:9 N2REKQ[<L2]FDA8T1OT$3<JCVICZ]Z\/M^BO+SAE. :9&M_ISK$4@1DIH
MMUIH60,;S0;T:^EHE60<L_=,*'&\>RB[5BI?C_,;+YT!>#./Z/K_RMZ$%9_I
M$F<Y;X.<*N_$V3OB&!/\6#40J,ZKDU4.NNJ[[(.W\RJM23[XBE*-&A:=8@3%
MQ+[Z#!3.+0]#O&M@?6<VEY'EL31G.'P>3J5,9N-*%,"'YOJE56*^W>O"CKT5
MN^)2&/Z54W*VUY:K\=G"Q_/UF"+K%U:_ISSMVB>X"<PXJDCD,L-.("(*J%^^
MS7+25?%#*ZC,[;1RJJGI]ZSA,^E91BFI+S^%*EQ:R.@T$Q^7TKG$$#ZLRDWH
MBZ,AE=C9J],HIT4-CD"FKVAO>\F*I*+:; &8<;W(4'*K[W&WG="</6]4N5[C
M;=#WD)OGC/5BHJ<(.N@;'=J4EU];))A$4H_0];#3W*1W.P09[_:JNGJ3!XLA
M8JEKX?$LJ=I,<X'._0<)H+\2D%$Q#&/&(BV'?S0XN?RR(?\Z#$$?4)H/#?4/
M/)ZTM*#Y8:YQI[4]=6/*CS1:P8^B[0.WNNW1B=MY,I&'.-'Z.Q&]XY '%==K
MB1>G@1X9-:8VQ,EX5XNF9=UQR;*>?2+"(2HV86S>U,U7[%^TH$^/"I8YXX)W
M/X"IX<!G4AC&?@$93C*"+)SK3 =+Y*G%R<7M99#9O_><\_H(]=[2;CJ)*=L.
MS"EGF.!N#,4L6";\1J$X&+$'H;_8Q7N(=.,-%P J?) :4D=47'-B+Q]95]_T
M)*>VCXDY@*VA?NQ>P+YSDDY,%&^N!0]DL%WD%'2Y)LUK QQ\&!\A!5,["X<T
M3D;+NC%HXNA$G-NQ&\@C?0WI,)1G<HC!,?GFAX9SO-MT8-Q5%CWG:H:@@!U8
MQK",%W6=D'0#*&E4]_@G/#R<3IS9($\[\X0YWE5;3\_73):6,M+3?#LC^[$$
M$__:\M4NY['PY?K9,&[LP&OI-W2_R:[M$'F[J/4Q(%K;G@J2I>J0VH&,5>>4
M>=>94DC1=S)'AK1:X.2@>).!&CQD+<#6)FD-;UTNV&U7M]MV35OZ?H8(KX !
MZELAZ_S]XNNI"YY&R>W;>H:E"MK>*8@_LYGK<[E!&9@CV"I[]-<C8+"K6;]#
M;6HQF#:R7%C,+95OP4W"X-W=2G+?51;?529U"34Z YN-W+\N.?[OUNC_(,!%
MEX^'G&#8O[^W"87\[7;G?_W-T_]^YJ=U$*/R?2CI2L1;2+L7CLHJ0G/"PX>R
ML&XORV16AB_N9]/X+U%0H$Z)F_\]I@)-0U:HH=7PUIZ(Z+YGWL\!AQH+)RK:
MC'7Y"F72:V_SC:AC^C!E/>&<5"HIUF4FE:;YL8(]$F;>R3I%>^P?0L#Q(U[-
MUDTB/?82?\(5.X"R5"3O\A7QV;J!=0;%VG$L7BG;>MZO#*(A58/U-3A0-/#!
M2L<U$YQ9C$P,Y354*WM!^GQ5=>DB+S(GIP'*6I#8XLKS2M-C)<H6LXW1K*S\
ME(8Q7X5LU)_TG;=?OMP35A<  $PAZ ) 0>")=@[=&PRR\1_H-,ZPBG-W(*WY
M1F; FQZ1VJ1WLVUFR76D$5&(7][3.K/&GYVDXZY8;62A$+=_E1<GHY1O-+0X
M-T;&C1=55^N%RLS(;-D[&0 C1:6_%R0M/ FE%EWK._@ H\)3X6A/WN!B+ZTZ
MO) U75\H&&+3?G3W&TRF:) /5;)C-LP62J?T_$PT6U VKT2+M<_!_>767?VC
MH[XN#JEE&A_2S[:L3[\RZ,9786DJWQ9:.+,9*,@QJJ<*%%J1IDQIZWYSH\<9
MT^8^^)8GU*QY <BWO1W,Z4U%<7B C[05L)?<R%G[Q>! +C\T9:O3\S+4,"YP
MNN#'+4\O/3TAF<E<3HI(K^+T,GSD1+].!%;\-<$&)]ZG:!9*H,P#0V-Z6Z<P
M%.RR/0]&'ZZ[9WW(+NQ(#2L(*NZ8$N<-'1WZP1'T 1/%/+ K]N$"<#UU8C^$
MTU6KG& \)8V(OE5GXRYG:JG6B%PIR7P>]VE"9)<W66.&E\&SDG8'4CIP4I2X
M;L-"9[["^1%<[[_;ACTX<;NT[>"PO?Y*3([V$B_.+-Z/PF728K9(A4<66]:0
MK_4-G>%9-^Y1!,TG8YNMWV;$Z&R%)%?/ .^?BF'739)->O$Q[PH1SA]RV56*
M;/3IHPK?# KJ]H?TAW.36(:]4'^>;5@=5VQB4'CPM+MTTJC/'GX79[7ET#O7
MZ*]#B2Z2K*;ZJ6#+.YKK;$867IGA//VLD,HC$N508B^ KNLO6.*\9AA3;>*-
MD:BB9[N? >ZOO@GOYOZU$&S+FL!.<&B9EM9\'K8^09! &T^('[Q7WOJDV%E8
ML3UN7JI&':[+AUOXZD1)%O6XJQQQNY,5RHF6"WL!8\3^1C5R,&/7<RTU=RM2
MYW5B2DUE$$^G(/P!$)D'VFOVD=9NC$>+-E]KU5B'',)Y]-:CSY??PL17]  Y
M@8O"J.\OVNBC(NJKXTNM&!,&1M/EI/+9G.PB^^P%OB4;^.2I% K)\-[4*^"7
M5]?Y<Q37;H8C[=6TV\3YT]C7 _D80B;"K^:P<8#3>ZJ%HZM%;EM%]-B5VW-E
MIT@P1?NY&\5NJ^1HJGC'"'R*/CLZJOE72L[^MU;J9AD7GU@,WI[/F9)5]$QW
M]"O99FRBK*-08A7@:6EKS1DCH^QH-]3AAI-S<TRO7FX<(HB@C/]3Y-Z*>.,X
M;42D_J'K^T,/954?BC*(<];BF3SF:6IJ[U0MVG8E&:Q+78]?05;VFLG.3#X>
M_T;:./X_I<09;!AG=#)S'A="@J\"7R%XG%=V.>F_S54('1HS1'0CZ)6!!&%\
M$*;9=T]=2@Q1HH->9L!7:\YPUW5&,HOLYWY]Y,<D?CW^8^9QW8L(( ;H,(P/
MXAVI7PS,!ZI^_CGW2DJZ7^2!@HJ,<+OLC;C H3@%XV+FZ9<_8\L>:6L-"6X8
M5@I);)0;Y@C8B+DEQW+[UZTG:Q]\ZIC[-4V//2  =XADM1< +?+S"#A.I//J
M!> H6.._^U^PR07@#J(/="J;>Q>.8>T%$_:.P $1LUC0+^9W%X">:! !D7DV
MUEQ2+8,WPB%6?@\DD%.Q$V[CJ[&SJ^)O1@L#\JF888*XV3 B%_3I]NG+,"2E
M #2FAZ6JMH!=N\_38_ZPUS:X;$J?+)>'INA NSIJX)G7G),4;?JZ.= 4G- ]
MG<O)^&; ;L=.(L/RUX\R@UYT[9UBRS#S!_QZ%=SR';QTHQE#4K'.9.HOD_0D
M8RZM\%R_5L/DYF0]N<"G%FUE^7/D!<"I#3XOC%;[RJ+6P(V1>\MP8(T519,G
MV>K^+)T&BDM7OF[LY J]Z1#9QO6H?'[+S% [;=RZH.LKL-9F:];[$=!?5NY$
M3ISNVU#2@LW<CP5M0\V?<3VZ$!^()+WOLZ0^(?IG5054N\2N&UTK19SU3%AX
M5,3 \HTM-%!F5?@7$K>74_%8+1_?L^H582O,M$"?'JV2&'#/Q!AWW5M7>D*_
M"L4"9SH7 @H'A),K\SZ'NJ_6S1O7$/2U8X,)>C;Z:;FTLFO1ZZG6;3]0]ANN
M6BN\ZA79 BM\R[])Q[G[^M(='-$AP5$Z5SY,ET>AM8\+]^WJA=)+8P;_%!:X
MK-L2A4DI^H7OQP4:Q&G/Q=+!'UX [$#S=B 7JK!$UTZN3BUE/NA5X0><?3$B
M,2<YWKW]#N,$ZZAN^)Y\7I"->9X#!]+53ZJPH^,\%+1H0D@,&8.S A^=@0A&
MV(->C^O#0%G)+"KJS2WQ5,Y(F'@PCZK9^#J_Q'XJ5_1^CP7]Q*1)?4V'P/IW
M06(E@7&5BHKP$(N((+BCK?#'H-MXA';#C'36]R\<CI6+]H_8QD/[*=J<ESV"
MW._16MJJ/JC83E;9!FF<*D%+VA^B35*<OL>'"*$SC5\V;QGG[#@%>&OGDLI.
M'QF739DRWD_].2-$W6OL=;HG(/ZU,ZGS4N?W*F(VLG_B(<X]UD:6G<+B<0*6
M\28?EN=7#_V'6EP-#9/[UFH;N+"I_.$%Q<?D]<$RE\[LV\;1L_]I!0[?$<?!
MG$#1,P6"[!0,CM',,FPYPDP0Y-#-8@X-'3B^#M^JDU,8[2!;S\P2DWWNF6'G
M?3V1AC/7G_%+VYL+%HMGR) ;\&X+F&J9-<$)[X^V>)[ATBJ'TD0N"# EDDT1
M5#'P.^;;_A(E]@4=U>&_,I@CS6[<L'XQ/_(''$OPBL6>H78W(KV'O')=1\*'
MZP:GWCGK4,9^%2JC[C=^MRI@;*X=,DNMEZHYE.,VM650EJ/P]=SG,_'J9WP"
M1ED']:%2"R5HT.<44"&H9[QC_]+"C]$6*F1R3T OJ]_DQ-PMU754QN5;N2E2
M4*AA!3:"4SU9/R]4YMWQ;XTF:.!(WTB7.O'K8S=0>WIG/6F*CJWO'5Z[L3P_
M.5W*YP.XQ^1H&+2X/G>][DI2&S\C)G$!<(?,&T+(W8CD;?B1U1S5A[//SL2*
M,G/+_'1MW>TULCP8H_QN[L.T7"'>KU'^E+F5U\W2#D210\/7Z_HO $H&X+5.
MX03H,FMTWZJ7M4UOJI?\YFQQ3/DY,@.U8-!;JM[(\;0X,DPFO)1L* NE3HTJ
MTY]3SRQ*,3L=?(?]_1HK_X2#E**[75R'XG4.>88V^+O%B_.P%]+YBDR1HT4L
M?AQ".9KJ97UZWKV*Y?-#Y26+N8UA'W=L^6>D#ZB@/EI3,B/^9JW1 SH3TN5:
MU4C6LY9XKJ:&AD8MODS3GWN/>8VE9*=-N7_[G#R^ (3Z;791P>N(7 2?AAH<
M?WS^?;#+$CD?ZP6 $J_]\GJM?OG](U&8*H;BU0*2-.N3:W*^EL=YZ<O&UK"F
MJ$MWSETA78Z@)KATM8Q+[^2 GTP0Z%J=(_GJHVWTM1NG/($&'(7%%DNMTFEI
MITUS+]9:HQEC]OCU8D:.&'C)SL+ W\'J8R3-#IR)CB$\SML*2W*,8);#V&IJ
M-;BSH_=P_2V]*YA:NN(1-A2KT'<+4U1KS':S^1"-<9E]'OD4*$8YA4,!9VK3
MR]P4S@;<2'SV$@HC'_5Y(>-_7IBE*CE<TQ)Z&>R-UM)LWL2Q6;M@3&1QYBTJ
M+U/=S+5&X[RC!:KW\O&:_]7)__^3"P?\K]6$5RX \T<G2]B$W0,'/[3^+59.
M!IAM&_+&K,K1K5:S,,/U!S.GQ3'/FQ)Y-"3J%N=<[@PSY,&IHUU_3E9XWFW/
MVFC.C_;FH!RLM?A-O4[GO=M$QAE8J!&(W![4FNQ!"Z@?>YFW+E8:HL9CR[0G
MDK7O9*_^RN;OL7[4_V>)-J+96;3RPSJT):BA5/CR*X:Q;AA<ZIJ;N37[;9?6
M[]$3<?*V$FW9:++ C3W>,P.8TGEF^WT9?3IKN#NTV"C4 0V^MO6;NJB^ZFO6
M>VN]KW5Q_*KACG-!E=8]. TDNJYI2IS0Q@S/HHKG9"=RA7SCD&C&1?126E39
M/*G9S*3/2V._AE+TC6=RG>=].W@W5))&RL]?6 =>HL,R!O?QXLJSY1Q05L+Y
M]U;3N75*X48[X!@0S8[4G]GYW#RQ/TQ7&EG=H>]Y.U+C*H*>U=741U,H*?EJ
MBGZ,YC'F?!4R *Z!1'8JZ-I="L](G!L'(UZ++>I!09#MF UN4WTL\=/!TQ,.
M3AZ/=AR%V$XJW^1CBR+W'%6="P!0?JSWMO+I8R^9V[1HZQO"E.^%B).DR2K%
MO#+J*9A<O][OS7)J0J+]7N\*1<1N&Q9']*C2QF561E]*-#PW"D&E' <3!<?@
MVR1Z[*%1WT[,%P\+E0.KD.:R=<H,W2-"!PN63U-6F3"XVK@GZI)0:THY5;)5
M<-WR;LSJP3P83&6?#/5!+Z6_JH5F#<B]ZMO[])R,)U/][;6,_MIJ+=IR)FZ_
MADG[)*4</>CCQE>_NR9 /?IOB0#\O94=\>LPI6_H\5\QAGRMS?;UVZU+G[Y$
M*5=7;?/2V&@8M=S,6W_YOIM<S=F!I#"L UGQ !X.%$<?D&RRF(7!^/._NW"P
M?]OCKIUHB)/\(5JQNY<_N,#F/JS%73_B!:SXS6A&H^/C(])$,\@-,3O1>!="
M\?("$/:=Q%(HU[U/OE6(.2W(-$F/.BDFEU3XW8$(WU5)VZ/67@='>C-Z,?-O
M*/0%(*K].6XLDF#QE9U,L46#[-E.RQH,I%WN5O!I/APD6WHC/^XK+\,?^L[*
M-[&%.A2W ^PEY),N^6F>"J7R__CN;" 1#'@C5'JF6 Z&DQ8?]&@*J!-\_@$]
M3.EL.>G;-@(W[$'LGC/,G*Z3'5OM*G+6F1<<H:?^0.URPS_)"(Z:W&-YG[(E
M7U83FR]HY!V=;:)9M,CV<>I30;*7F_96D7:*58KQI[4;*9A,3]%"GH+D=JL8
M77[WHLSQ,#H#TZ?_-VD!YB4XGM=WWB+</3/-E('C=0E6-WY> -ZY]_@L+ 5G
M^JT.S_A5CA1N65FMY5+)'AA'',"=%(_ R<O,( ]P[ 6 860I"U*&N +5ADO>
M0R^3+5I;COF\^'-#U!E\XX&1T3*SA/4C"M=3FR$:3AUFGM?!PV<PXG@NYR20
MT@?[MCN$:_)8G!:?N6L)_>HJE_BC*8+PX/FPS$PZ_$&]]*O6M'K?QI.Z[]+A
M:.D2)%U'*-.!!PMD%#Z'6)W^O7N&HR#2Y#GX5&RR%'WPRX>FJS2VZ+A"]IY?
MQ?1CEK0,-;D[)H^9/F8R\ZA8SE57,FB:XGZ"<RX Y_ -!+'IN@$1/@:>> UZ
M\>)29X-O\@B?YZ] HF0_]E)D"4-N@5,1:U_=^'%\6:WWTGM[\W/*,VX<U9?7
M7<;<6.*8ORT80=I+*0<+6MCK9*E-'GKA/)1\IF33]?7#JD1 XG-X13\9P0S;
MA$)PXM<I53:Z;2EP&C&8B0)DC!$'TS>D:* [:0<MLGA^[U>;>WDDS4\K:Z;G
MT#2Y0U[RG_TK-AUX+9R9[A&\(809]FB2D$8FMP!CQBB!!;^_+A='% VLU3,
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M_9T,5,-VF%V#)C=WE!HR;#E71?!M:35*L 6MX/:DZFYKY*"Q("FOYNF\?)E
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MH@-.GJ0K\1WZMAFC>MCW[=L_S):IZ44G_,E"^?1)G=,K7> =H@!.,1/X[ S
MT^ M+$ODAC7<":H!>VS]W!U8(&&_M\TL[^H^X]U*-D4H[2PTOAI ^;8G7/&F
M\R9X$O:HT;1TYM?G2!)\> 905;WPQY,&.:&RW%GL_B&S"JT)Y#?']U54K7F
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M)]SF7/[7V80E:C_%\DC/P;74>&^S6=B6%&=XOPT66U+.\^*S>))QXTJWQ9/
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M1M&K$':?M1C?6OCZR1;MM7?DE82S2+J3=TBZ2I$K'@%M"QR;T?1/2KM<"*>
MY/J>OO?K>Z-%W&37F#WU9&*- !AXU3-E0WO@BT^\[<S.0W#^'+<QB[USL+IS
M2 513QE&S*"Z1^6<9]Q2\;\Y8+76N\KD-]Z++3E9!&EF:TF/XVKVOV+Q]P<\
M\JS*?WT-4;+%O-?E(O/=HH!%6'!\VWN1S%B'U<&?"GEVC?L5$MO*M!R>AT0(
MY^]8N M2]\8Y#9GJEA!+1O XR%=Q'HC'H.M;CSPQ!)HBN=FT2_F7*%O:RI^V
M/:RK^RS<1IQU%;+)EN*\..YL#C),'>E.+WXZFU=X"DBD<5&%*)=6_J3*PWG(
MIP!3C5!Q"7QCK6O8ZU^10I/,6YFV,[LY6KR$A:?##!RU;6W[KWS=_8*>8K5W
M,%Z(.=_!4P"Z+0G3# <Q_Z*S3]1?$Y6G#*QV]N26]/8]\M6YLW!E.F0SX:[O
MK1N,=B]A.P%K38T+P: R2#3H@NXY,K#O>>1E:D2I?&H*6'+JMVRZ@I]OOW9Q
M#J<?Q 7CN.+;.=<88WBW3HXX#W7W\X4*/Y7<2X\7Y:;$IQ7<!J=I;@+3*W"_
M*6RP@M%J6TK8,%(=T_Q,VT(FA^^<_FA,HVJ5W T.:7<RNGHVU<[@Z+A_B0^F
MV"LJ\J'7Y5SNZF_-M#@> ^;L\9,==G&[]V4G%<4S-B&-3FG7-SF$Y9U1 BG/
MTB0%[--$@ST3B*< KZ6Y>.*?K6DB: O!\J\:A&OC:2_<:<5W$S;I,+N#%.IZ
M.WVO>"Y/ EV65H@$?Z;\^S%O)WS[]L^>_'5!*=2!P8VA9_6BPS?#U$U>XE;;
MW?Y)^A#31W0?,LWB\FM[_O.,2MMMZYQK*YR[G49;?#)KM,Q/ 7E_U\+R*0J^
MJ6,J6SBN/*_V6&^(0.J 95&=$SK+NNE^A6D!-_3^!].;'_13KAFE:@=_N'P]
M20IU?^__N5/9_Z<=!H?I*C1?JM6Q#DV9$H"W3*7?(O_$@>+T+DX"[2G&*7"K
M%W+H$>TYIX=1_-/VX&XSVRG_TGC+<?0M&<*Q\ZP:.-]<TFARMT6VT]?IQ1X-
M \SW: AS<X@:6',J\DC"+3^C=2KB[/$>C=3O=HY?L<MDV#U=F8=*CK7F8=@T
M(+M^P<9,C>9D!:.%B58!T4*Y8)5?G^-9P4\)?KR2P_\L+V!MWDHPD6U%\"#(
M8=ZT% S9$G)\CCYY"CB"D-DPB=HG7\_LW.:9202K@J@RH8,0P!!YJ3=7E(TJ
M<JQ'H/[$G0)8U"!7^" B,$J7'X(XU&5(.LM9WPQ5\Q#QM8J3?4=,L"#<E8CZ
M4\"]EK2]7<=I?T4URZUNKGV^0\.3@M_%A.*5L6@]#FCS I3@5:%ZU)82LGG7
M&JJKLSPB8K_B,LWAR<JT<+<NH'3]!E%TX7>WS;VX$"73WZ< ]R6#+^G*1RH1
MES7/,Z^X7B9;2.+J.5?\95=,^0GH1AYE893 0($#_GZ<@J;6[-H7Z4?M.7SS
MJU.N+JZZ\(J<ZF?XVQ.@XH]QM2KU$@/#\@@GQPZJ#[\W-ZEZ*DTT3F!O'_P]
MY)JL.4%!].1OB!X4M>Y!9S6=#;[%1V=Z%QA0ZZMMGPE* 'EAD@B\KRY65!(<
MS>M],V#)Q)D*T=12XQ!5RRJ?)FB'6T7EC<)'S0O=:841SQO>RBN(I^^%_J=\
M9Y"($X*[3-!TB"<&KK-T >JL@>#/5_#;)&"C68UJ*Z=$;@(-5..ZWJKM5AA:
M_6OVF=.BB5I.OB?S^HO%UVL7"BOLJ!;XHS_WNINGT//#=2"KR9VZW5K%+7\)
M='=C-SI;LJ6KN>/52A%A@P!;R5LD"7 Z>M[)T'"P<S^*Y_IZ9CW+%<?3]?K(
M&CQ=&HRPN5ZMN/,2I+>K30/3PQYOL?6<(4KO;KE87"QM?&?A$5\7-:(\1"*W
M0!\V?*P5Z[>I8G_\L5+7F-W;MBSI ]P(G!13??_GJLT/=$:JH8""\VN?^WDI
MF2E(6=4MQ$<U'KK?*8!L84D](\3#EI.<T6CRRF%3ZQ3"-SWJN?XB]E:XXQ2I
M^>2][K4*(TZ)S'N4Z1V_R.LXGZ(GVV4T0Z[-CI1R(<>>JX];;Y:*':-.DD#+
M2$CC'QHW7U_TP%(S<."$?>#/X7,K-QB2.%.)PRWQP%F[)RZE#_3\,_7(W.OS
MC$[;,;?>U<9T:W)YU=.ZDT34QNOM=YA5WW79 P'**> 7)K'?0W,LSBVB]S.F
MN0_V!JO4O]8E;:\F.:PO4&?I;B:"<R2TI?#RW<(^J)I%C5G*#WBIKG?L_F')
M3VRJW9#1]%D<YO(=ON0VM5GA%Y'7F?JX+F+#.M-T-# :"GPZ;LA#>Q[Q_Z\>
M&/86G:A?D7P3 2UGH>XKZ/7JP_KK_%1CAYF .O2".O["50%_5(!$W"+#=[O;
M&8;?MRK;O0 #IEF_)@N=6ZZ99DN9EIFV2/#;5%@P?@XJ^#'E?ME0R]3:1\FD
M=<)PHLRZVS3X\62AS[2W8'"5=4RU;8WU,ZM8[:=19WGK!I+_[%9S\7RHX/00
M;'ZPB(4:\-X5AAPLNC'>)?W>*7W)Y\7TEOI3U1A>,U_/Y_NH "^"/0$[JI,\
M7Z4DTL7Y2;]X>(EPGLZ43H2P1W3BBL\%!U/2ZHO\.F$K_5=<G:C.$[=[U'/O
M3C"V3(?,IL;]JE>8-YG\4VTFN-&*BCM+Y+D47Y(&GC6"9D:1'.C )+78K,EW
M^G#%-DZZ9T=WU[\IFZ_5]GKSV,DNM3X?ZL>LN2\BJ.]R"KA)33XH6:;S'OX-
M9<0*0PH-\O)1^C45.*IILH5/>PQWV5M-]=(JS_%"IBI3]IL?U"I^>\<A[M!5
M26,U:W!W+;*7L9YS,GM"236%5SFS>;4LUQPOX)/7Y>HR>K_?.C-EQC4A&F2/
M><Q.E7G2]-]K-8\F_JC:OPKBZ')Z)&@S;3@8KRNKJ82_S2S1O9MXIS,+'2HJ
MG!KU"71=UWT%P@>_/>M/LUQ!</J*RLSNIA]9U-0MC2&>?Q+(TX$5A;H'0"^N
M@7UU/),F9G0- UBL7D9W4&^3V4F#@ZX>QV)$5(R:2*#[N^M3+57<CM0 0];&
M9!_"]FQN!:&CG_["2:YIP\%*-B+N\\:_8B#T*0  6GX'8M7]1Z[K-B5N!Y@D
M*IT\7'S,*)8WW^O\9$4<_Z2,8PE6[.'QI^,C>K+"VMJ/X;4X:,3Q"1*_5&JO
MQ__%TYGR2<SI<Y&LP/:S>L[A;4D!.0SSY9$5BNKT>D>6M =EB2405FFP!)F"
M%6SVIB,M(#87HLKB<SDLHE)=;C#/>='<WZEGE>P+NZQ>7OWF4R=3772]WO4E
MM2P:.^K[ABX-4UE6Q$,2B@1GNMR7B^,692F2<<&7Q8OOSZ@N*#C)NQA<-PYD
MR\4,9[IVMRJ@0BI^O=G0F&GP__BQ+8T!>BEK+. 6>F_>I4^M^PNGJ@IX3&A
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MX2BAZ.3 '$5F 4,TB<*=::ZC.EDX:6E45%4<: 5A.P7@1C'+^<"#UZAOH:<
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M$MDF8,ZCMR0\ MCOO-M?:'%EZ!!T_I?-\.,;/Q]$!/1S/M;6;?#V-0DL7]@
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M#LK(E.9L^/9BX*%Z(=1'GDR>=13W!I]$<3ZU1EU8JVLKY!:X/#:K?#SCI23
MLV$["&R(V5=?-U;9!=PEVH9ZW=T,15*I@[ J,($0A=L$PRWK3%8-*'YQ4YB=
MD7J>@GF(ZD]0<9F'S=/E5O;6PK#2M6=^<IG%[GXNP13?63,7-Q7+$G_1Q3Q[
M>V\/=*%<3?N 8-JW*M%$&L<#HYMI&;:OR!3.:6,#O%1LFOX.SE^1:<_4U+[Z
M.[_AD[[)R1E/7%(YYWP]&[*%RG/-?I736:ZI/%*_D):^3>%4+R==;@ +<Q1]
M*O[M,/ \6O/XY_CV6\VX-C[1(2$756V=;*=&!-.<7Y_S]N9P,0D[:&Q#])B#
M#9[4K,PF]2MD*B@P!P<=\(?OS+F+'SS\^)H\&FPMD-0C1)U8+1U25P1AN[ C
M3:W>I!.*@4H3EO9P=+\60(OQA$ZC*#)*WFC4P,?=(%_-#Z0R5N=$*5=*SDP
MTD'F,OR*S,6'/=NEC6!=#@XZ-5CR466K\.AF?G"@Y,R<5;JJ];D >IA?HO>
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MJ:CP5TNZ;KF^7,],A_?W6KVC#J^23D31I@4:*H!:6\(=A&J,E>\WYH6IR'5
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M=+6,K\\!]_"#F<WI\0>C(T=*MOJN^7JI5D#Y]G^*QC=[[TY"Q(>@ZZ\%9EM
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MW>UUH\3-L2\A@2%^@2%HKD$9Z=*V?/W-UO8/D)A8:;=4W<S Z]$9>0VC9A>
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MRK_&P&W<OLABG"O+B'2T+3\TY[;43UOWP=FX4C?FGPI%%Y43R_MERYMFIZR
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MEK"ZF/Z=L\Y==/JZ7_W,B[3SL@ ?G--/A5K$PGI+9%C&J3U5+^@)[$HN$,-
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M?=-<%_*>X.90OTK8U2HU%<P*@YQB5 %M:S*/(J8M_:Z*@YYIB2W$/J0H8[;
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M.CV/-(/':?-7V$QM$O^?,I1_ ]CJW4[\ '8D_:/W"8PHF_#MW4 )9$$K_F;
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M4*L>Y?8Y*4E%4KCXH7?KI]T4XUGPFX76/"&EU*4'X8'45J^BTZCD4K> XNU
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M'I9]6E*P-4MU_Q2NHGQ:AG)8^'TY='[QG:2KWP/@8 #[Z;UM6/W^C\YG]5Y
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MVBTS>X/BJLXB6R^G9V\;XWQR?B_VXVA0ELL7[B5^S_H9^?-F'Y<)X]I'RAD
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M3=/&UL&QJ'W+UJ>H5%+0T]:Q".99ZO7-VBC/.V #B?BW1 HX1\9'I%/"Q,(
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M-TMBUN-?1]%Z/7U:SK'H8(-B]FSSR\/>HYH9D@%0J],B#7%2##'RM$M#G92
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M#*^O"8&OO=1+]3CVB,'*;MKWR,'7 M&5\W;A7^:5'#6Z:SB%(0-)25]8M<M
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M^>^1< Q;JD9VU@&6W,B]YL0<>XT[C/^-BWK01\S>^7MAY<?%%_J.8_#ETB-
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MB?*:KMPS(N<7C.5^%)I[#5)%X9[ _7KYQY027>S;Y\9S*,L066:X:MWKMZ.
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ME!OQ55M%IS[@@3\J(:@2]S9GEDT9WBLIE<5;/Q"ME/ZX>L]$WV+YJ=?'(U/
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M(9\\D&3V8TY0 _ !LZ/V$Q'0%>ZTW](H(CQAWSY9&DL9C?L1[@GUQE"&6ZG
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M(C%E/PM[QD6E&!/#.=\_F!!*7/V8D<7S0K>>T98"*%:. SWSB2)+_F5,4%B
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M8\?GQB^O$^\'_MN.DOUD7/:AD%W'V:EV4/=V6JVV[Z,&/US;CMXI&"HS:,@
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MPVO:VVNM>\,/:-FE94[!_DBEB:9T3U/[:1L>+\O_&N1U; PDV5U.=GG3]VM
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ML=NVVPT.S\?T3 A0GC6UM,1R]V_'"9FY'AV\-5YT&RHJ\F[\=VKJ/405!W*
MV*6WYRQ<I7\Q(0>( 6.['G1H4-2)*U7=",=Q#(C*1?%R%-1D-#P#* ^8]$=Q
MHJPZCXT*:B843QAR;OY 9-RH\R'N;LTK]UN0%=P:F1!U&-+(W_Q73XQIW['
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MOE.4</=CW2@J!U'#\-Z4[[Q'=[84J;#!O\#]6*<,$92+BL1GWQZ1>=+0,7;
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MD!_8+J"F +9+"8P(('L0'J@=]<!_X/NXYU[0N,E9G=R141AF#^[\BD-(Y!F
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M(O#*IJF=P]#2&8#[AVU_T6;::RC"_\H;HI$,C'3XYM@0O@P\$<!,8?DACF>
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MNA3P $]'%(F<U>*1,/-XVI_-;<W4G>.,8W6H3ZB6TW>B$5A,]>WD$LVFY#4
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M)"IU2?WQ6$_;OO>%!I(ZP!?;BM-_%;QS877!*NO>\(V+O,$QY>](UU4R3-G
M4NL*7J;7PWJJVDI,(Q*[)ZV+$C-YW#=OA_J-<.[N@ &,,]6MM00))V1[K=9C
MX5F'<X]>ESC>F5B$$;\-?IR?OR5X$"'R7*'76OV;1/*K2A7Z.XPG9A9J<))-
MNRP].3YJ"Y20DQPEJ9F=ESG[W47O4)$N=][%?A]76]?(J8S^>C1=)(#/LU]4
MU!CO7V. OCX[]*-8;E$ITY9S^F1Z,RE%^OXD38(N'<0!O'0<WV> +J!4@,B0
MLA33@-L[L$FE*^,*RLH-I2ZCES=G^()=?)_ZZMCR79YG@."CY>@+F"Y3S-+J
MT#"\IQE3MT;CC+N#B2=RJ&\.H*Y#MZ7+?>#/WL]N*#Q,7-%C W1=FGD7KV5/
MB@])]U@*S^F3V/@5@Y1#&:!+R)?&F:.]O MB?V+^AB:*RJ[R %F*I J5SRK\
M%][E(WJ%K>)C#?[)YWK<39CL65;]J49V#;4_+=4'P65*\[F G_ZNOM@4*Y<)
M/NW6UC]>=(P=QZ[+9JUQ8;M<=;-E**47&NLA@9Q^"*TR%<*PB3L%E6[19!Y5
MS4VRWP2G]/9IE6G&%KVLM#D2.>G$+WW U/VB<6T:3/BCI3:;%[6 V649%#ZF
MH#Z.8+Q-,Z"^)/,6/MX)*H,X"X><IRF2$GZ.&_^$N),30K>%):MI.B;3!TFV
M8V7T"+H<>@K:0-SV*C<@,T!S?#83'=+%U<3#K"@&R#OME)_J-Y0VX,YVU4Q;
MO=K->/LG789FGC@VQP[KS^Y1\15\.+&A@R%@+P$.)I/J[U#ZO_N/U=&?=?#/
M$=7ARUG]&'X_!D@ [Q>4P#E<B?Q%QB0=/&. N/V:-)W?&"N'5DL[3TNVXMO>
M])W-+\'>74=\N,4YZ]SO550<9G[D1#%:PO2 YT[W/PU_CA9=-W^&>6(?:6/;
MPFE4A PR=K+6K0ZZWWGG+V='EZ _[.S-*N=C$X<LF]LZ\_G%8,5K23B1!\%O
MTT[C4AQIWJ+ND56[J9K4[J9S-6P"9"5/J1\>NV"V7=-4.\"%X#-@!G;0ZATL
MXZ5.2;LA.RS,NM\.+NBF,D#J]3BY861ZW3_N5ZUC>1NF=!P5H&J;'BYAB5BM
M$KGJSLA<6U]%90&M8Z->0/X?M!:00997/H_2H60V+V-X_1[6Y)%.S@F%=[1<
M74XIR=\X6NTW&5<#W!QC?C;7;#B[Q93<84;H5*,NFT3F"M03ZA4$B+,08&#D
M$ $CBO'O8U:]?GR2FT >0CD.=F&.%:$\RP M95 >?/%KLW]9.3</[84F<#P7
M7":+I314!NA:O'5)8T%*$QQT_)V'?ZWW;XT>J]!NGKSMX,0)4C+:-O2N3BXW
MYO2Y:70T&3<6<&]H;!P+_BF1<PPUK/,M,Q?3CXI0K+J6Z?0P?<^Z?5)=:+38
MK^,":6&T:TM*7F>HDJ"\_'GM=/P0%6+T(J/>/T[ZL\HN855 &KQJA9Z0S?>.
M+7<XF[_:ZOKAD4#L?1>>5_J"=0IA\.AA]*]8I#A;9G>FJEKT=:?4URFRSDA_
MH;$2_DW!J:+#BD%*<D.)&,+NG0&WP[<"]'^=4H3A@%$>_Z)=?N!GLAP$R+!L
M62WUWC>4.0#SH"?$3J.4R]Y+%5XTD3QLI!:1%M.\.)>M4^PC]<FP6 6/H&T)
M+F#"]+F?+%GF $H.)V7UC,:+G4-?0>J3L=UX/CCZ-)"TI!C6WX,#4S%QRFX$
MIR^(3@TKQ>KMO&XOX^,O"W,CKYV(SF;!GI%!(=[!$$Y,4R?FK!CE,9%V^2%-
MK: /UMR_9;<T'13[RYJ(S#E,!:Z2<OC"@(APU07B)HR/=K9D_G0SZ8"0V48E
MQFRYG_XG2UDY8?^#993TU#8-3*>CA[%SX)@1E7>68W'KX'<D:D/P6Y_':[$+
MOCTWRA*Z5Y%W#93+K2A[R?*>$3_(/'ZJCJ+"GZ]W[%/?E%P2[1^T<W.FBF50
MXU@'<RN\G>X(N[I4)Q/&.[Q8I3]3D0@A=>\=^VA_\DQC5/--_-\PX%H<C=>;
M])\I."0M2EK*RAB$XQA&4QM3%"-G$38C/&HG:$&EMSWJH#PXP5G+8,GAT=B@
MGVZ+4"Z?^(EO@)!KYTN+CHB&%#-"6U/U<0F,G$+17$[K#9JM)_='Z6FA.*@U
MM?_Y%ZO33R2\.U]N3,JVK:X]12)J=7IC\6'FJ.W8@8M 34-UN/[D]L_]E'"C
M3MPX J[;J;>[.@<[N,ZD5C<Q7??1/)@N:QSK28O2ZR78G"=I^ITG7S_X)<5U
MT*,QT^EL!KY'[(^<68F.*;0(D+YB]]Y)JGVR0Z32 J6,7?A6L'4?TU,P3&P(
M.D21:7\,!R]>!XPR/:[G7_!&KD#6I F&-=?P,;^;=.I2((I!J56 KDK/9(IP
MUO4/*R<9B>66XI_]9"<'@[6S:KN%'82G<Y_04),A<E:-.NF^"@%:U0^;S#BX
ML=9LRXF(!PWE_.@>*Z9B-15#_J_&;*&9*JZKEP%JSMI69/((!N@D"2=(,SG)
MH/F6T2! RC)Q3KZ; 6+?H;E'D)19D=-K=RD-#! 8)XG$WWMI-H8*>8],(YS:
MNS<)D2Z>&WKVP2=KU^6K^E88_.PD]3ZSO/$P0%1.,1IO$CU-F0E7Q$-K!FA-
M #;I0!,Y9H!D:"=,DKM%[6!^>(7-<@PF+P4S =UJI;#\4Z-W)/T09=:/OHBT
MZZ,9)"U;J!?&C[80"#^YR"ARJ1C+.QL"267TQNB-7/0-+5=U?D-NE2_5@MPY
MN21SBQ(32VJ^QG (1"G2/I7O>K_[AWYP;'!)7.],H;GVK4'K[R76UU=?AS_Q
MV[GS+;WYIS3M3AP#=/8] U0TQ  -AY^\P?_N<U@GTCB:Z6Q,B7L6<E+"Q+5B
M:#WL'^4YEL/8"9PL2@HHKT*.$A9E*4V%E*"E\.BOU06$-#X@[>[D_G8X:910
M< Z9.&HUT1APJ<_'=F-\?>9R3M*S;;UU"7V^W3]@'NA_Q!IST$SG-H&[Q.8Z
M4:?T9,1>9A\V5XO]H9EH&147/^-$P<1W2$WC*6_ EX#Z8^%Y;#S[[@*F6[>"
M57#2A?_R7>^D8_D^:"'Q>00QVDWV(8UU/Y!R.T[X$4XDN ;6E5%7<+%#]Y.J
MJ:M3,JEC,.Z2[5!][YN5(>D^@E9Y5":?:J9[5.R%NEBI4KEHV<$J]#,ELO!X
MION+\L015>F8LF2")6>%9S#B 85:S>)DD=50T)!46C)\R41;OH3W6]KAW??X
MOY3C\!1DT%9&^5NC7MBLYF$"Q6T)_07U!Q:E ;S]V*04]AM#^6L3PSH7JM#D
M/IO):Y>_GJDM.,Z-.\:2?M&$_^T9.9-(+8]!,$!)>"X<=\=G!^\>L2CHY: S
MYFU>M]2(%_='XYNH5;$RGUZ/7#=LOM>PPUDRQI0T;RVDCE@B50#+.8S?B2C*
MJ/>9_)Z>X* L-?M7^&.46,*HG<'L1(BY7TW:G _5"$Q6W-KS%PYJ;OI (6*F
M>>116YC;M@ZKHP0\H&!$XR22DUSZ2;!Y_*%_<_Z/OJ9IG#KPJHAVHR/?R<E:
M'EE%EX1&U^1O."!2Y0VB%P;$SQB_ [ M-%9J. G:*Q0<01DB8PC,+YK"T>*"
M/86<(:"5FGU.S;>^M22=6-Z+[^'\.?7Y1=/9UN: K]DWB*.Y)J31>%<AV?XD
M )P,6-M^JS!*T()!/JVPS,'5_B&YPMY4/9T,?GO7(%^,)ZXF?R3EJ5W0^H"L
MZ[Z.S'N<RH__S*/]OTS^,UV1Y@,84+BZG+-Z,"EX+A0;)>>?I[?7[E&#>I2Y
M?18YO[B_*>JP3_@ =\A\[.K'Y^9BY%DZKS870SL.V*HNRQO7H#LR0('*@*[N
MH1]@CR@XA^Z!L3<&S1GUJ2CV5HEQ0Q"\U91?2XTQY$SCFOUM4;*098(>)):U
M"-%6]PP<%Z:ITL$GZ)"H[!$F?US 9&6&6&'T7Q'90QV2E$TH.5MMLR]6\V:L
MJ'8XFY<-JL9,C9P\@H2DG;57FZ\4EKP;/E/9?>.HAH]#[6_:YW[MH1MO0Y:I
M;SYH8 7-6V<* )E;IE49^ZM6*^8UOI+E)X%$XM=U>\VV_+)GOF6^;8B27GKA
M!]B"OK>GNZ<WV\*_NXD7(&&'39E-U(%_!]0;7;S<MSNXD?@96H#]M__L'A/'
MP^F?\'.+O ""G%,PMT8>CAJ^@+1<0A>YARP)L0&_SI.HRGW/HMLIB,YZ$^&_
M7#6CK@(QE>M['\Q..!=T:NEG,0&6@-S.-NDX<G%1_UB?AJ1*%2XY_8SI+>@B
MGM.F:':SJQG)9(^!7^RS*F[1](/+/K%^G.Z 0Q,A)H%5&^JE]M=P A0^ E&4
M9DM]E+8$C75CI7KW6 H!L=^=?NB!*= X!(8'6>#4=N5C\_B^XJ7Q8QO<&QF%
M@0"XN-RYL#]L7]$G *YC02W+.,H^LFQ=G7PQI/EET<%6T%F*H5*3"4'+6<U]
MN[+_YO+=[DP^S3Z2N%G!9O#@8XBF@EJYSIOZ7 />[^B0=T!<?+6TOF2W#FHT
M4ROYKIWS>,#L,P4UX?(^!R!BQ27[,'0"&H!AAH56,_V"ZO'#IFI2 9CV9]JA
M&V"$.4Q" )&42YO6E)^MY;X3IP6[R,3$NA%49+7IX:AB31&\<$./D])4>7&D
M&<T34+M%NY)NEC04E^F0O?%SXU&ZB81W/GF5'*[P\V=O<;9OL<?GST[?PR32
M^PLVO ^%_UV4B?<?31,WHJ9M>Y$CN0Z-@?"PCV[X6.G8T7X&2%C=3);;4EB_
M.]NB!!S3(73X-9AMF%S /4!6O!2A^@')2W:4K(=^G=F",M'%A7G@S^C_#!1M
M0L^C6=?S%8'RXO@26"J47Z^?"B:_G107PC0TW#2[]['Y"X0E]-/=NV@19'BW
MF9ID^I9K^Y!$01,5.S'Q0WU?_5.PZ^DE9?;O$/=<=[[Z<L(B!^DQ?Z!8=>K?
M91?L6LIZLB>I_/YS[0WK=I\?(UJ&-,IT]7D,6?>4-=F[:>8]ZIZ)PW [PGAF
M19.>=88=7Z6MBF^YS7U;B8_[BU1_^FF,^RB@R?2T^C%<A*\'2_E$'\&<1]PZ
M.T-3!*=1_-S \&TE_54V+"L-<BQ,O-QQ-W#;:$X-OOHE-(UUHU+B(L0)'G1C
M(6TKZ#_^>P1=*A"K>S5&<Z ^,\2=?,3)KV^?G=B$\8=NZF)BF@2C_QM[[QW5
MU/J&"\9C0;I([RI5JDBO.<JA"TCO1$"$@#$@(D$"47KG*$UID2Y=Z2 0(105
M >F])%&0GE#"%I(P\7=GK9FY]\Y:=ZVY4_Z8K/7EKY3]M?=YGKW?]_GN5$-N
M _+>NKMQCZIG9':;@*0*BN$UMWT7,U_^JTG'"D68SQ#14Q"T;BQL %S[4T-!
M(BU&B#>1G(&91+/YX>NK'T@Q:_=9#R.:[;Q[0Z,KK3/>$:172*$6ELG1)94_
M-A0SPVEVW6\4G 8UK8[)DFH1RWS%UDJO-BUB.I/E#I,R_&Q3,BOYYPQ?E@ H
ML_$#70:S\49S7I.&EO&#&C'C^N;Q)YTW>Z948Z<&+,>W\+%C7X?GN!QKMFL*
M4_F\[(Q'[?X64+&"K)6L:37DFZ9GFF9*7)^HT-0<#LI]G+=V7?VZJ?4CZXS<
MQ[#F>9\I\5?U]F;_9'UY2H^7)?^/WCZOA,PX;C2KMS\H]X:^6V]/*>V++2Q?
MGL>&>J&\0IGG%V?=YUS%LX[LL^WW3,[W=9"^L! _DTR3D[_"1NWX32\GXZ[?
M#GR5X<U#D/ZJ0,JX7SV1;E*6 ZVJT0\?V?]%7]>'J.ZNEE-0PX^E&]1&L,<R
MH[L?YDRM@B+%B)2^ H_;*FW' "+"SOO6I+H7#V&]V;RGH(O1D:N;KJ-74FHC
M^(K#ZT>EB)<7T.=1,F"&""7*72JZ2Q+0)DAUIPENGH+8(B2!LXYQ;D1TLH[J
MLRGGLDS4Y0YKA0#R4?O30JA\?VZU[W$T[S.+EA*WI76!SLR=-V$A4/43#S,N
MFSYQ92.A[T."?7+615^X/AB7BJ<:+W A%AD=#,\[F=B?NRP+W*!WX C5W9E&
MG$&,D.>HD10>"*Y=8BVA2Y,V7,!7G^62!KKDOND(I!#1QDTF O S(&\,R>=%
M]?@WX@U>@9'8>^G=AILF1 <J0\1(VIQV-BF+0>%8@RH5)">BS?\:Y\ :X!,O
M9+:EI(GBOO?A2<%?Z// "QNA\KBZUWA?6T>6%NV!BN\CZ^;>LS^6_+40WPA[
MJ7(X1MQ/'8)$="&?V;SGC48X__<,B'(OCNOAQ+5IG?6^?>L(JL3G/"B-3"?-
M/'1"V+S,3'\O6SH3AUM+6_X;@)YX E)&J9:"2(U4$JP1G: %2VFO6>Y%QW"X
MFY%SAR3MC5I)ZM'_M+0/O-@19P[4*RTT+_?/1G<TT<3I)%M/ J#_W'(:1>R/
MJ6Q2T\@9RC]$D38OO.5%! 8;,K8^-Q55 QU+@-4]K/4$[^H'P6X.0L.@<F2'
M]ZY."Y;GT.NA](BG3Q_8500SC0F,8]5>R>[/S1?\!&G.CFKD5&@H>ML\UJ%.
M&C >NP=^1%K#)J&4O%JF:[:+U&GJ1"[I>JAFZS1%+=N=S^4$SH+2^O,D81:;
M0K3O@A,L7_Q^('N3&,=A7Z:>J&'#4N6ES,ZR,96;Z>HN0!OG2%E)L'#?D7Q<
MD8A;\AT=^%KK6IA:O$G,YAVX:;NW-1P8>^]5"M/.:*RJ/)=W?:K4287TU!(/
MNO445/@GJ78@_0!4E"C]7UK7%6H#:J48]:%EBP$'!XSI86@YI8"?:%$:XBVQ
M&Q<A,O-U20PH)YRW)M&5R\4!["*7&Y"X-^Q?P@.O6YQS1$ LVEXI5?NW/Q3_
MAND]HG QT-@:J:5=JJ<@&'"6+$K,IBBS8Y/0C4ZHGB'2M76]Z\!^[<R7=K!>
MG]J&""/@3:X*%=&L.4!T>.&U^<<$MP4'G!\2/%&NX<)=T6!C>,D04DWV.:#6
M[-1]*'.B8Q2/=-O>4V MO#CRJO$]8N/ULYGA*U6&[C]=%5E7E)\=2.(_W,7:
M/*I&"BTG/,Y[8ZI1?;O@JFRUI,ADH*)9K:]DL8EJ929TW!R2^>47ZB&X&4[A
M@I/5J,\I=$W$*+JM36K ZC%.U&Z5=!)WL?/\+KTH+LJ]2G<-#(X/""M*PG"X
M.PT]B1PZ//EHQLZ\/GW34#4EQ#SZ3390\.<P8_I*G4(WMO1CMC&@""SM\BDH
MU@,(#"(G*0).7>)N4GU@D>!Y?G6CM9FR1?UN,$O7)%QL0+4KC3<9:>2EI1]>
MC-@TSWMH^1/27Z!.0O>F<6U&: !Q^%U.Q&Y_ET1GNC6)-ZG#NW:C0)*DU_GN
M*RCKQ&FZJ:IJT<:FXU^9JH6E17-EF<KLGN=@NNZ[IPA<,]HFT?44<[8QB1<+
MB;V)U !DWYEPO:*$ ;WM<5%=(@OK6Y^^!*W\$NG?[#T%<?Q 3"%J2HD6<56^
M@1N7DH3AD.]1N=&GH "*'#4?_(]ED1&;#4E[G;_/B4%H==:ZW+DK#*][A\<,
MM^J6ENSFZ/%8CZ4NOM=FY,-X8+Z<FJ!V7:]C7D_)]8G!>B3/]4JS_3LAO#Z_
M#WTBOTK;]8Q7/*FX-U'IN28XGU,K(=UNY:PN8YH8";,H*:[X#?V_F)DH6H%Z
MSTOA$"/3MWADS& )(@E7A^77$T)R3X@GFD3H4CS=]+N7V1\](=^[WT9\PNX5
MC$?%[^GXZ]B/ 5+ZDXT:AQ<-4EOJ?MT:ZD$%8(B6NX#:-)F%FOS';,>?9&1
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M,/DP2N.K1A+#)U<6XN]AF(Z[70IV5>.A6EB?1GO0EP 9OCP5*)[8IL  +D_
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M_[?Y%/Y_W]OP?[/@_%&WW43?%>OC>I(H?Z0=P.OA783\!Z5]ER0:6:3D^*M
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M[AFWKA][A&JPV4_%5(,!*0A%H.W$D/;]F06:I$R>)1E6G5RGZ$W BC^.=@E
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M8$=X21NN-SDGJ]18EBRJ:IA>;V\L9&7?1-,8J^CC.D)-PJR4\.181B/!>%'
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M&410Y' W*D>@>MS9OC=9<B)RW28DSO5Y%/MJR=?L5/VITTI^VFR?/KPB_"[
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M]_;+)&/2<J0JX__"WGM -?T%ZZ*Q(EVZU*B@=%!I"DA4I @"(KU&1;H8$9
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M=@^+<[_MO__\V.3-O:T1%/DUE]6_N]-/!P0[RX1B-2L'[W^KX/1=9T7M'@;
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MGS],O(W_=;$]]V(;_P2VYUYLXQ_ -MUMXY_ -MUMXQ_ -MUMXY_ -MUMXQ_
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M"^N3'$^5O(NWQ,?+&5)W/Y*W"=.(I<"Y^[W,9^D6>C7N[A?H[73#F$'\/E@
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M^[GG/O-_GO/BO+CWGGL_\V+EDQ<I>W_7;WW+7FNO_0\T_T#S#S3_0/,/-/]
M\P\T_T#S#S3_0/,/-/] \P\T_T#S#S3_0/,/-/] \P\T_T#S#S3_OX3&1J:+
M%<]4L2,H)%CT6==T*%/\\?A6)V]=?,/RR.4/;[=ZW'_XUZ-C^,'Y'(P,\92!
MDPY BYM)-W=+/3VPW!D:NO_Q8.;PL9?5.RH*5?<IGE0=^K^V*<,^75F[BGVZ
MO&%E]=^V,G.+$_WG#<_^Q[YH_WUOM&]IBTY"94D?J^[\XP(<%6X++TDR$1W)
MOD]TZXR\4U,!A7=.:DB&S;M%N,:ZY*@;;"]O1BX] ]=(]\S,T!VPM\Z4-\,=
M$/O8PR@'L0!Z"M(S6&"#WSOA#/6$UF.0*=_\.0\>AZ*[)9/WB(P'D' 5O.UN
MYG"SWC-OC)GI/-,379Q8,;?:_F;^3!)>;+L..U>7[O*+?6/MD^2U>"@,&'^%
MVM:LF4^R@?QX\IM>M<H"BTU>@:U[@'<YA*)9UT-&M-NW#WB-YR?>HID497^3
MK$WW1I7Z]MLL+G9U#7][*V;LVO!C57A-6EVF*'_:>/C%(1$:]#H-(N))T85C
M'47C(D<(7^%.#.E:M;1IKD2V9I3;EN=#R2<YE<9Y3K9=)K1GDU.S@[U&EF&+
MA<=>:Q+[%Q:EO7I-_*@51CHUV&HXA081,^%I(JO;_F5$RB6HCX\V\!T*E2><
M]X_2"G >,$/MA.Z\X7_KMG=:9O,=0>79\-MMT27)44*\U^\HS])G"C80 ^AI
M7X=ID'=#0IY!2D%K1CM*26101;3H="Z:U$)=U#C/NFI+#=>G1NK\YN7;L>N3
MET?>'K[3X(X!C!J$[69=A[]?A_$0"\Y U7>>0MMKTN4P7I]S%[<D%8FVZXYL
MR:RE!?D>&%GN4W%H:*QO9(?F*F!2=8=$5H4>;01<$;<S$=_R(,/9B+9B(X4K
M2NA.:=-!79_BLGO"X:JBDS*IK>JB2RW?BD=(>"##>X@N1U4*,O]E6^@BIC/2
ME?&,F'RF>=B85&\]<0E-'USIA:;CK%I\[78IJ#$7<J5@/1=GK,.N8S7A2=K*
M-2"SDY)TV_A/MNU^DB^XE<J/#NGX))E89,B2;' %7WPU!D*%O4T1>G7!U] '
MEK!)[Z)R#H:%,IJ:DV:67R;!/I%PT_W;2?8 -8$D-T-3F"4?!BA)R^5]"IUD
M+4ZE7\O02O1AB7[<W+NODQ<N#PZ^3"WRC[N<2M1-#9QY3%%=H4(62X*CK:-A
MAHMR/2QZ^'V1:<7Y[W.^FX'/:2)C@_@QY3-_U50S&T9%&RKG:27<&[,>R%PW
M3]:C\\5:#H/\&SFKEDDP #O6+[@!&0L/BBP9D ]@T5:7IPATNET,BHSYL:J1
MRN ;WR(^CYOW ?69T;K<N)H7'^PW'TF\I??-:'$_D[T\'F5LR>&\@T?^;W#G
MUC_M?^_V_]B-Q'\V@SOOE0296]H^KPH46-85I^CG%$T&W7%M3'V6:*U6(3"_
M]"[+(I!IX<I9X(!G-J\JGCJ3'CC"^ ++3SKXGUOYQ 3WO>>'*:SW^)B'AU=?
M>$1$N-D=3EUFW2!]5-W"0N68W99FQ8)>LZ%&QUV![Q9>%*:Z26FO55MTPFL4
M@*>*]LQ<9_L?"4+PX+L"\W1];&_K5O].\')H;5%[F7@U6V?O)PME^\-^H3=A
M,O[_IQ+^K:EV$FOYA [*!F\<)\\2BIE.VS*!5_@X:SYI!/K&\'I3+MHU;UO^
M$I8L/([P_KU0TSC353P.?C.'644>>NR\=[#'[)AN]9M$HXN=\[J_]AR(<]()
MT_/1.G,]3,_CS+Y')TL&_O-?[GJM>^;QQR=#/Q4XI#OI7DG4V&?T]6OGX?Q2
MH[>=6V#I)W;!U@SC 6KG4ERK30.K%K#H1&R"AKZ?#4!?'&TG&PU8.X84-Q/V
M_FHLTK!]'F&<XZA;HU/9[G#Y8XK[UC"9^O])Q_%) 2""U].1</.6[7[1"0!S
M=W'EN*^\.64/1#L%-%L^ &./V?F9-%"N9?WZ+!2Q5UZG-.S#5EY>.6;8"(DW
M],&<;:T=7I[_HM/P<MA,^#O!B&9<=&'0VW-BW/J1]\D#CP9[=Z5IEFUQ3X(U
M_)= _W^M(2=T'-(=?C[M&AY^I33A6:VIJ:+JSQL]$F$PIY]V/;N_8;/BB7TQ
MCT[^I>BX66E@8..@_2Z8R_^MS8YPFQ"^V<V\MB,DV-*HVMOK3<9)LUO'TNV-
M;@[^^?"XF\/ACD=GGLF6_I<,43\K.4#<.MIC#M]A0L+SSMCJ!C5NF4JB3VU
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MY7^]D2,I;1@*7HP5&(I_LT:#CNVNG'"4HLBI:A8K3]YKF_\8?;48JNWD>+8
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MB+S!KPV (7]J80P\-A=LUT5YZ=AEV!_'8?[JD_R1 3 6LBL\"?'Y35?\&^J
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MMAJGBF8VH;>2L+R'L&(/4)*:=:)*O[C9[D\[T]@XV.P_G?/ZZY4ZJC?[>1W
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M"'*@7/XAD28?*]\&>J'!Q>$0GZ#7?'E/]NG:X16_$F=\$=34SBVN"2LD4CP
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M%5>ZK:'5:^]5WW[0T<!I\]X-22^?0]9 R-;<5_>)OX*(KY';3UI30+/$A[+
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MGA^W( 9'%X'AK%&OK-B GR<ALCO*0<\$]=N5O/"KZ#T/>1==JW^_A,QVX7L
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M4OMI\IQH*R;+M"F*#?I :(="2TQ):G&3&BE&<[XTQE5;<3<'.IF$Y11/5I6
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M.K?ZP[)IL75)57%/Z6R331'[:IZ JA[>:&>=&^CW&1-0:9/U8ZM?[)F7RJO
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MVV:V5((&G%8@C\A;%L;;CBG:T5!\M34BB5L;E73E%=!6&G7KV%RC\9ITGR9
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M  7[<=4F@=[6"'S-*]1U@[>;FWU\VFGELKSSVWM9-@L+'67+-].!CBG6_(H
MMBF,N!6/J03M?'NE,0 Q8(BR[#I'5I]5EEC,M1)41:=1N2<&R>R585WW<$O.
MQLP*,-I'WE.?<P%]LXZ9]P,K/B<K(OP\VV*WW&%V3>G--^$]<2<K!+(=E[&F
M% ">$#WRZ99E%C93D)4N4VG>7F3Y <KOGMH@]U0B.H^[#E=.C=JC(V:LYG>#
MJF7R<21P 6E Z)HT0S"@4FW?;U? 6 %$25;;"K<!;?C4H[,ML9K:0OWEE0=+
M]_#@LJ&6W]6O1&V\&3-UQ74@4G 0H#?6COJ ][\M1\O5?D@B<%#Q/ @-%LAV
MFD?"D@D[K7TA;3WK.LQH!7HBSS'+E)A2M?P%"WO3J5_C!!Y MX3Y\5K&CW,-
M^<L8 \]S<E[?LMLQO_Y(68C3P*VH6*A7#7V 1O%V;6"P^J,<;%<WO*MA]2]2
M]F4/B3]\YUQ=,+]-*7ZJGKS/Y7JF("I(.BO_%+BUC_"SU/FNW$YZ!#RTFP:&
MBR \>:$ FFRDV7>7&(1S_75PB;H9]^E7B<8;W=QPABAV0$_??N\!3^<^Z>U5
MJZ=MJ#O5Y]9]'Q:>$AT3D\%KBKQ+EE7AS22_X"P6?<!1B9,4!GH#U/><_K'#
M"KKR/#= V"F%#- 7DWTC EHBBW3CFC8/WC((&+SIILYF:'+#./'^\,=B;<)7
M8C/\Y^0>PB99"E.36!:F-R>"B!^!B:4>(%N4Y&FC5U] +Y\<)Z("I_55%HI9
MG@R@L:ED,<IR^&(]-95^!;Y;M$X[W<:M5P["=P$BT7J0-FU[1.01*N1_$1WI
MFW=/UCN)[BVK2ZSOC)>X1-X=4&)A#ONG&=]7Z7WP27FH^S_'OP6J2<X3^KB;
MUI1N<!/TN>V(Q_+=L=HM]6>>C'!\1\;2UI2VX?("&WW\+@ ]"4MDZXV#5A.N
M?S\O3/A65U-+8S 'K=!".^<WK 'SDPX+K+^X&;[>"8@P!&AA$T=8)_]\MX(J
M-07M@%@K;B)QJ]5S^QXU7$>[GI$F320NC"Z?_N%O@/$4:@4&NE3X_;O1X687
M?_+9J]FAG%PK^GC$-Q02N%.<0$VA.7@K#'=U3RMYHU1=9+[J$\K5*A)YSOHV
MMM73TN&E02^1.-/3P"1S;ET&BA9KUMZ./L<O.+>LX?0J0V>)"!Y<F?\R!>5H
MMR V$'FON&^&WLKW@-5 CE,OWOO5K)&Z>UT8W!Y$H:)@*9&QWF??X$;IL&V@
MR>K<%?VD!-BAP#4E_\_+;C'L^H3\-CDIZ$7  T*68M, ]\71('$Q2(SB(8VD
MAX"FM&@-TBC>7$!6";4U3<1C>>53B<<KOP+RVFNEA9+M;Q,G@C];[: R$;%;
M-!WOE73],\9$)'%K21U($A1P9G%,G66*Y$4'_"YH6U.J"6E5GW%O@:3];MXR
M+=\6MW@I546D2S+_F//[#&%7'9,9QYT*8<^E=9*;&8QJ'.-TKN!B XH9LJJ
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MREV/U&"W.Y6:YTCW&.U/_"IP 9\5=I>:TY?DNV/A<^W0QJ:C0'0B? _.O;5
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M1>XZ!#%D'K9T!UOY.?/SX+</BX:%(XLC?"T<I:$QX4R>XO/HS.L%?ON>/C@
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M79H41(_!_&ELZL855U*>92=UE\1\2-T+\'X[M9U5,@YZ>HT<PI6EB;NB&3H
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M[AK!8P!RQQJ!A ZK0C>E/(P<LTEUA(;%8'9Y%FSI;(K.MTRY&_E,Q\->*;W
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MF/_LH(+*4)626?NR<GWRR]"^LEE.4P+:]\+QB="F?+F)]YH(^5OKD)VP8ER
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M]]R=K#:*2]6->/O^+;3(:TJ1L6],<H(TW4M_@+>"MO\I,9M41,F3YY@ME1?
M<ZL-@WGL]C@R@XF]4U8?G!GUU.]+<&Q93,&D,^B^,1Z[WX(8N X9SY7MW";>
MC43->>(L6;[)&4($3_3TI;LA<ZQ)>]SL0'VKL?.S*'-D6R$<C$&_F@J0&<-'
M;:U>9FA>78<X/Y6O(&C7(=L+QLKC_5]IE:,W/R/&': G\Z29UA\#.M86:;%8
MRJR63G16L032VLH8PBX^CA9Y1?L2$G(])Q!F(:DA$<9[#T+6G$52^;)XX(]+
MJ5&1(!.8Z5##[Y*6UC?4-]6#J<5MCO?AZ1;U=;JSV!EW90MWC]-.H6_;=NF@
M,I;=_XR2PK8F.X".SAC*K)<77 LI>PL'KEMFVCLQWT*YZ:(^H).ZP"<'L"7>
M<3R'9H0J;J:+ *W)<UH+P!R7V .DQXX>4LJ.P.9<OF7:IX8<A,6\%SNJ*^E.
MZ9)DD]B3, P%KC"Y2ZP85&U**MX%<!,=DA8XA@>^!#E\/#<R9Y6\W\94X9Q%
MRW%8;OQ^3/D8CG3AB7N\51O]O+G$JGCN./BEZV^&42- 3+[#+#H/^3:50-[.
M@!+ZR$J.V@"6=_=1GL*#%L47G24A#0=SD,]2G[A7.7L-6^3\E"&C5X?&:.=U
MT5^VA*RN5:U\''^^+]JR_+\4#( NF(COXY B+@UDHS'3K9X\4@9!27)^R%&7
M"F[IL'_HS3B4R/KF'J62W.+VRDVSJO)^O(@253*_YE_UO .K[3*\[-"#$BB-
M&M*:R$O_R,+7(2$Y6-!$6Z*9S6,*+$,'9U%U3$'YMNX$V3&S8S]\;5-GW)_5
M]RACKS?MJ3AU=Z1)C'/F1W45V\,H+UUBA;L_M.T\]^O0IA4[B7J,R!Y,G5[*
M@-)2!,'BJ[C3ID0NE._61=T70E!Y,W2;-G*@'Z;SLVCUTMRDXE# $USQH.,%
M>C^.Z)%GDR9BM\M4V?4=8@V[IH+$'WT2;:(HHE]R36SM(QLJU*V1=<GSE ..
MW*XM8AP?F!%;,,.GJR(Z1/8:33<X#<\=RCU9,I.12(3&U]439P7%-F5U1KEC
MG&M,.3A'FTXCP*/7FB;D^0D&#_U[<L]/J"0.?=/.V'Q?]K7!ZB=AC3_9+NV<
M4.A>?'_Z0L8SB#X-^.&H*+XMW_/*EK*C.*2;D/(0YH#7 J"/)$A>:]"P85WA
METY_S4%:QFDCU;TE[!4]TVN-3Q>B]$Y@D!]-KM0GB\\W-S0U-#0B.N/E<LQ.
M?$_V-UE5+B^70.-<@9M"LD2%[U/:V R&"TTN/T8$&@Y8GU/^7%"!<Y-S6&7)
MKZ(]AU/<A5IOBKX2#K##2C-';-_DF69<G!]RW.CIMPNP7$#)]W6/E+2PW'-*
M:"!*!!.!X/8U2SF\/K3'<JE1'@%>:.-^ :V5T(/X^ J)\^WV.G5SJ]:C)G):
MU-F4%(F#N.UEJ"]\B@A<G-H8+,QY"%/!$$RD=3#C.9@U6"KT[(Q!J=X"KLUQ
MW57:E:VNTS.RV[QR<]XDF]F.5Y!VSR;)=8[/\9*0<@,CJ6!:H8]80Y&H9_.)
M#QG6Y\0W91-3VL72(F8H8J%KL$4_YV#^6Z:2]0_!XB_/ZG<@SP'2OYI>C8?J
M9%1EE*7SF+O! %95^7R,_5WRJ]"\Q[Z?J N:_ZTTV$:8G*);Y(IWXCQYEADM
M+L 24DA.(AS8J#38QL^(0[2(=Y.GG;;S)^/=KW/NVEZ?4P_EC@Z:T91(N\$P
MM2ZG( ^'2VIS(GA@I@.U%?.).NXN"AM8AV 08_E\^MO>"Z<TUR%I$@?SOH<V
M)S]T#CC&%C?-PW8-%U[;?E;P"V=AH7C8ZQ IZOE$J)=11PSB9^AV>21YP[0D
M(=)7O(W.S\'49"W] \V@@O#%S%;[E&[4(X;JH]!H7Y6D90=S Q^@8^V/D3)<
MKC-CT*+%C^]DNW0Y(U*)K(Z+:'_=$VU9QKZ5OVPM>X>J2\0K$\>:91IR=%1H
MR^U72<EO2W_N4UK^6]LG(B:](S5*4WBI<<LU?0MD#?\:YV>.]U6=U]H!WSFR
M'13QV7F4!C.HRG-:H2,\]J8P6W2.\R^(X!>8>&?K_(.[POURN0$(\'^[>#L9
MJZ)L>AW8.L*[CJ0D"HQRO')6MXBN_ 8O1( &\ATFPDF?$^\B1E50(XNTJBT\
MD\<!PBG6K.6E[G!IKD6I/(&+RBO^%/VX9YDJ@<<!X]XY_VAE<@?% C:R\O-:
M;,6BRO@Z1*88!02+9NK2.]N_(9+(4&N'GWX!ECJK-G=:0"\G_QW$<A6.9.T7
MN77<]RO?V72W6/,3Z5'DH=?RI9S[%3TP$<)A&DDTFP?Q3O)P_R:E6U*Q=^K]
MS&1_RZ C49B*\;\KK;]R>]RD.93FH>I/C3FFU]78"'I3TYLW$3K.F_W]WO^C
M\]GK*QXNCB0,D.DJ@J<\:@KY=>4:5A[K@>0'!+,Z)K@B9'<P]B=Z]Q.,?"J?
MC$^!GLYI,HU&=^5;[_W'<:Y3;F_8>)=7_IMFE%J=W?JM_][W%H:OD7LF6N[\
M6Q)TT0T\1*[ZH\!0M@C?G&FNXC=2+R!VP$R$#!IO;U)G.?O%FR; ,D42_*J;
M2/G8@ZGX"CL I@>4A-J.OAZJIB$=D%>Q'ZEC%:(($"T^(M$%2&W0))U(D;\6
M4%J?[#[^PZ!Q1.)6C3HGRL!TR ZVIAU6^^X[0O59M/ _;"XP/ZBU=O<9)K#T
M^N@84MSZGSZV+AJ;?DC%!V53^CK25X1CA"'HMA( 1@$X7<PZ"FE18J>5Q->[
MHEN E0-8W1"VY60XO]SZJ\ \.=>)FFJ=WFCC=&(R[,JX1]V(XXF+Y1&V1:,_
MFD4GI228 5PP+ XF<.1PH?+PH>P$,97CKR3]Z^[*R; 5/RL/\*9F,^,9G[B3
MR;6XY97==@7GP-+*?8<-B"_YR,7U>!3^9*/4ZSLR_HD*'C8J^+*PY7^.&<G$
MZ6)]W8:\*9YW5WHC0YTP<,F'2Q\[],?U,?3]PN+(G)KBPB4O(+"4E![IOH/E
M$<\G)M$YWG5/&3NF!L(R!(64P.!R-">:LT8HQF#C N*#K6-L<W-BP@U%]&BZ
M:EVG$ZU#S;#?0[W^UXZYK^\K%2$2O-R)X[+WA'T@6ZP#]O#_TG%IDER6D@_1
MA*M)>#?LUO Y)I#>5NZ+!.=9'+LY6'^D5[_%7<GYG+>O24A E&_FJO%$4+HV
M+SHG=$T7^\K:B5NCJ&GW_5)(9K C> U EBXTN2@TJK<O(*71TLVM<:BN[% O
M=H5AQ2M<XKFA)5=BW-8G)5G_U'4\R:P3??GMAJQC'=*PU=C2D;[0*A2^2+^9
ME1<BT\15G]UY8&M]^@E7X;36=\WSW[813LMZX'1Z>]]HNDQ167P"K.NH5='"
MNPDM<H7>;J W4(=H,J7BV!U:J'VR0]>;+V@:-PY*3%_X_>EY@^,[>7W:-1'!
M/L@<7JJ?5_I]%T*'V':0&4H=(_(S:1NE!HEB5PJKP,#OA/M+O)E05A/U+[=K
M*B1D^<\O0Q+XC,H._,^#E?[XD'N24_W%0Y$AI&?&S:_F=G"^QYN(CQ+;[!@.
M* FN7PZK3/!P;E<!?&:J:VE;FP9*R?%@T2MB^Q9 ])GK8US/&50*V])^WU)$
M>SQX+KXT9%(?J'[Z?-9WX@DN+:X5ZZMEY_O_UAD<V:@SP*U#9BP%I<(M5YJ%
MB&X][ 4A\2%AQ\1HY__4&61."@ZQBQY(>J@J$_/1,?8A^6WNCB]8 %J+<U_0
MV9=A0U8WHLQ>^]]WSDZ)"80QM'B71&.0<6("?X)#,+GN+SD#4!-H#N;0*XGG
MZ("LH%I)W+RD&MKT<(3>N^LR%QTQR[UP^GU;/-_<V8V]N&1VL-ENB]QMTQ2"
M-M@G1A!8T0Q=Z1.V3/TPP0HD\6ZL]2ZFECNC+4H!5$=M-1565^;XI,U(EA\>
M9_)P,:K9/5;KG,0 ]L9PUN8/[^AOTCJQ.WXGP!0<!Z#\E+=]VMW:<G!$[$1]
M?3W9LZ.@WB-J,PH7T)$S0&Z-Y5'W<-'W!<_)3Q>MP9G?K>]^G7J* LZ0,QE&
M^;Q<N4VC9/YX*:G+<FQ+5]Z7I.VYX?!G,>'3YZ*DKGW_)'AOHNUU-.!_M2E0
M%_RN'H8MF@+M=PP?RMO^QY:5F&G+MY;)4W64MJD=$C4P@B>%7P2(2?4_69?/
M( ^KH=10K27W,(1#0A45:6DE^.138.OPXMV\ .OL/S=IU3CO(B9/05H4*+).
M*(#LT\6K !HH(%-B**U@[)[SWQA/F' GP)9K3'[I.X8I-/<,Q+QY[AZOA *@
M'?-P%=:=UTBTCFTK+ NS^11$8<V*VM;'_=I=(@\%N20NR)MKN?PN"GC1S;WV
M_LDMH\P/3M 9ZRN.V4NHK$,CB^.8K/VX6^(G;KX0L95()/^E4+RJM+E>"3.U
MIWX2 K[CS:N\!NUF%%(6 IJ&[U2I^5@<ZF_Q+*'U/H99 .TW>LS?:VEK-]@7
M9D>8?0_Q_9!#;RK1(7TV3A?O(+;=N2-Q) 8[D,8Q;='D31;F__8O.0;JUT55
MX_Z9:O<VK8TSM[LQQ-!#XJ]G\DT/F)DO[VV)*T,?.W/Q*:;Z5$FVS7UB-WP<
M.K,.$2R)3[N(#Q';3K:@XJ>9\F2DLM+J<!7\(49^[?(LG?T=W93)*\4Y>SYX
M@>S=M[A H=4F=WUVF$K3>4KK3'HL@N^^XWB*.K<.8:Q%M0Z7D6]BXH@6%7%A
MP1AL3'GO-EHE]^G0,<,8[>]('Q?E@A;ZDXJ)<]M*CB//?-L[G?;34U4(?DQ\
MD/!N:A<Q )J0I]*&35:=0 0'.W(Y:8Z(<D/W*G"\2^>AUNLYV>$1QP?_=MJ\
M]XJ.MM4ZEI-X?F#!6G#BB(E61H0=^[]S\? *@+KH&[#:1>;.B_*D633+S7-D
ME9:;P.ZX<Q*G<&IHSK=)R3E@0:TMD(K+8;NYAUS,IK1%E(,15_J?6D;YV)!W
M@=D>PU]D[_] W"(3O+]OO#7\!>AZ(\]@0\PZ.XG&$J_AC^_(KP1#-D-;$L>^
MH_+4Y%$D,E]I7L^6+]AR)V\&!5@SC(#PH:5-#8,KRKIO']?TW'L-V;2,;8>.
M?N>;D(C3+^'U5 %*[ ZZ.BSMQI^L 1!)ZY#;PI>TZAI>JC6FUU9(Y)GT/S]Q
MUFR%K,BZ&6/T\>E*[3D*CMGM^Z$F6&>".^N;M=('FJ(66#P$UT%D ;Z)C2L>
MFY#\##KQ].+X3!99M:HHUW>0BM]W2W9 J)5^TS'0PJA>&)-<W^M^^@U;[]^Z
MPK49]Z&\$:34Y.(3Z !)"<P_):0FXYUFH$JAT4U3R8X^Q;,P0V"Q[O9G=R>D
M,\?LP-!RP?GAOZ^(5D>T+]UH[[SZYZ<K/Y_<\@3L"\I+:5M*$ZG];L  ,3,5
M)Y4.9)V^ :*N)?6XCGKKWOBT]S?6)T<=",B2*3X5*A/1EJ!)S-L"!'^_[:1E
MO-O;^TOMZQ"=,=P3[K@W7:A,28CJC>.][\>(..&]V JW:I#H4M<XE/3M8M2.
MI7\QZQ![-,7\QR<A0K;CB[!OVJVSF9D)!RY8DEY,ERY2[/++)>;"Y)J*[B)N
ME_&)##N/X9)!/*H,9+(.^?AB4(IX-T!4NKW T.,8A\IUQV!@GC)%CC@,;R)-
M8TYGZ^N!).%IT'\.(S3A?T@%YM_J1$U<!G/Y*H^\?3S.1;9:G,0/!):-];ZL
ME!T4;GT-(Q=?/[>_UBVF?!+=%$19Y4C4?7M$/.$LF"W'8 [!:BA2#SKS!.V]
M#E%B!GVNL5T+9B&4?:W.E<QGC4TN,0':A]+2'KV2^UK"\KF&$EQ*5^T$F,#G
M*EMO:6<&;]3+"4X*[6:P#YAH+'B$VJUL.1.<QM"XD+L.462H@4$.&H!=RDKC
M9UI38H>]X/^0]N[Q3/?___BZ.@A)"$7H"JF<2@Y73JODE+1.B,62RF%F%;(R
M6SD?8LD55URL$I)3V BSQ89*$L,RL8-*#N.U8KVR@^]\?O^\W[_O[?>[_6[?
MWQ_;[?;Z8[N]7L_GXW"_OYZ/Q_U1F\VKVP &Z%9Y":"P(80[P$G3<8H[S;3V
MZE?'I)UI'%R!O)S'1_]7:X&VZ)NTT@(?@AYMZR8:H'!Z,U"-*T#-0NJBD#=F
M?L9\\P<-OM/-GJ-9/JS8 M)0!3,&Z97U_=(#I)/)V99"V12L4>S4WM[771JR
M-'P-L56F"_I-:M/Q>EA387MB1) ZF,(+1'?:2TOW::,<+KPLZ0RO*1ZF9,W"
M#J&MQ:0_D [?S>>YEPNWC1^&FM&XI3)'L$I\8K44"6OR O=&9S=M$@YE(P-
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MMRB/I]WZ2CT(&6#^P.8MDQSHV+^#ID;5[3(C1F[&!O(,R+ ;TWR#&>W.$E.
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MSM9HK!.X\^!]H3QB*M82T)ZLS=M44+)5R+J[Z(#8'&;_H12B/C9= I4[9YI
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M.(V_)%N3>.O_]A0JB,*$%6DQ1/U_WLM3(0I4/<TJS:-G57LIJN[.1O)57,X
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M@Z+(OWS7N!U@940^C?MA\7C"N)Z:3B563R]LJ"B'.57/O%OSNU1NTTV@ 9\
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M(<][:B,*7K+A,]KYRW.WSWI*LT)#(B'0L] KG+%)D:^T7ETTQHUCB/5"&>S
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MZO@KM64V%#MM+='!H&?[ \==4-'FU>KMG? +I*.*T*TU>3*]1GG.O/-@C=H
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ME,-A, M9<<1$8DBUJ$_S_NB8$%[1\PR3^N'#M\$/>I:_5$6Y(!)@RI2.B%7
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MZ+6&7OI$WT+@;O0KAT:_,_U(-CMU@CXRIPCD<R-6NK\H&M5E%-Q<<O92?1J
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MK7 *;A[NLJ?N\A)>6(2]\8D*!&FC08<BNH=[668J+7TDIO^@<@<K)!GWR8;
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M'SW\CM>/+%S(WY0_L>VID:*RTBS"E&]2^!RTFIX($3C;0$5_2FM7H>SSHI=
M_ 9(LUT#Y^3",(9M(_2/-)]'R?8*;B]L*\P9%-Y0C# F)9^89AEKNZ'=&Q)Q
M.>A<'ZRZV73JR]&@1G.YAQ$5-D"!1OV?H%./UNAP!9R>G1PD:6T7U[@NE=A7
M0<TN!5PB9.S"0<'V#*Y3"\XXD.G/DC@:Y+[P0SVX^Z2#6#@/;@CU[M_2&KYN
MQYMKO8;E(E0_XW1[[88DJ.VQY<Y<8RMZ=N,#;,*RQ%$G;OF5%SHG]5$E?S4M
M([Q4,2A<L=?*JCP7;9\59#S]1,-<HL^DWB2.D40K0 :W7^MG%P?KJ]ST!/B6
M5B6R2?T+P@?.SM5$$PIG;["[JZ6M1>*JCK;[R,KL(M;X<Q>L/I+7OP]721FK
M]' 8?"FX%.SJ^UIAC"1P>"?!@B5JY:+;"(AVUG!ZW.JHZ?VV'%Y4W622!,.+
ME$&2E#IC=2@$Q>SS"8[Q&E$XBL/*4%*F?29D;MOUZNH:1L5=2MNICR,NS+ Q
M)[02'%$38^1CI*U]QG6"\9'!VN: J<1@IM(4<8<N).]_HI?JMF]3R/_JGT,(
MMO+D@79KB*(>P!'$()+Z_KB;S?V OR3P!P03.R]O'\#9AA?PMOQAN%T-Q)0,
M'CVY.''R5W5J$"G&#RPM:%>0N "0J?VO,(KRB+,>KFPS])=BUN"JHQX8!A&J
M4_2G5)$ &MG M+8MB9FGAC Q:SHM#R6/Y:I0#W]7>#%OLO\QO#J]:\2<J$&]
MG:ZUT.R>%Q#ZQ[>^Z$FG?I5@<^]'[?\$;N:MTSIAIYS>W1H".4$7E=4!RXG.
MDR&O$4O#Q+,<P=5QN<@4[952B8$(X"@GCJ^?PN70HR^-< WYZH'^*",[RPW0
MG:KGX:_'%8-J0J,K@,V?@[WU7_8V)LK [,__,J(K7H"D-=)2@B[>!R +P#P+
M&N<A2>T58".TZ+(\A<J'  _-GJWY7TSS&?,O[]C7$"@^[] T3 F@,C 2VZ+"
M9G+"=)LS\G(2>9'_ 8A8#)<+([XT#^Y/2A#!#@@:8U<0^X%OWUA@84\726/6
M^WX!;UECGJ\:7<^?;G.:%G 2MG*I==;&13=2C!PV.Q'-*RL<HRN0T3W%P0\(
M]<5SZ]U/HM"E*._ZU.*2XF#S:_:A <023H?.<":_B'YY\(;WN(_3/M'WBWT'
M:AS2'KL]A.=S&ETJY6 $R9KI).R0QK=J"^3$] LSI-+:7QC;[7>8>4@(IAE?
M#0F\&HKBYA%PE(54RRAPW=->-R8%GNB=V*+U# P#,UV5K*ZV@23O63!MP)";
M+0%/32YEB$_./4#$<UD$-;2NH?2E!,H]N2>;BS&\,BPQ%.Y'G[_.,,V,[W7)
M]F2\ +"\>$;J*Y]Q',UU$&]GCJWW:$I9=R9_3/^D* (QX/YM1MVZYD+RX^7V
M4P0&!URBE=W%>>P]YNL[@70R[A'%M1\0K++*OB]L.>=KUSY>&JPE-QQV_K'A
M0PU#JV?N3M8.4J*U5_S^UYYW25\14?!88BV9AK'GD;N7]\L)K[/AFG[J4\H?
M?@M^>JR9>%2%Q(J;JO')1E1?.=&#M7["'K/_ZN/=$5X:[*%AZ9;)7VU2:![Y
M/B;?P3 !,7$#%+#,5A %R&TV3P)E+"V%M.O@"AR!4"'5A3G^TC>TTZ/XF]*A
MY5WJ#FI^ V80#9S"E6&31IJZ7(/'O%"</K_KO5A);"1CY.^75K3OF:5J64,F
M.8FR[0-F8_R+'WLN B1NO*"[S5H#JMDXO.BJW>9TB451<F?P)I8OCY@:>UQC
M5"E^]HJN#%>"7ZEOF*,&$6,(ZG+?VR%Q!@Y-.5Q=44Z4J0VUPHU[+QAF. P5
MVC4/6)]'::N[#UF;D<=0.;*\ID4P&_/F]W>:#@HO@--=,AT@EJNLB%ONM'RF
MU?\('\CE:W?!M(<K/6W:BUXNK$>WEQ8AS[U]4CO]85[SSX\>!!9ML]'WP*D1
MB5KT!BB8PUZS!WK$]I++N3T;H#HBC;-G3H\;N,C%HB(*45FP7W"8#/H(P:2]
MOLFAO@WB2JU.]VK"M>;YW ";Z^X?-F@4],>[]M/A5L0.U79S@(00(+HXGYQX
M*S6C$E_I$SR:IP1&,(N?%S:U"93Z$Y?Y4-</CM<=2SUQ'MUW9&P=1X>&#5!<
M%'UB3V-=*L9=@_C9QG?5<R7/U7D[!]$\HN;2%JTUXM[<5,-8"G=KR*0L1%\2
M,1BR^7Y$CN"\SM?A^E1^5UN+XPGS[%.'.R<AFV435! U8(S\J6 JGB14D),,
M61%G]):X2^)6A?.XPI";^/@NXF8@X^( 63EV20+6S\S+%KE7L[G,E;S3SDR_
M\? &JGQ%(9XAE69>BS/"?N#P5MVS*;*=8X*7$I394$.$[F$@"?XG8_5+5 IQ
MBS)X_HK7^23B@ZP2WP3ZZ;G7]&[3]XLY8QJ8D(+I\0C16;G=)!([SDDB2\8(
MG ?+<?]I6SF:WJE[V-F1L E_0*B>7TX4[L%83DJ3%ZZRPO*0]'LV]4-7"DEC
M?D=&BJB,K0R+!+PR5RQ>R!V#CF^ =N(0-,(6 36A57V2KT&CY:L)\E.+@2A:
MSI[L'8W,E6BP R6YQYE9P=VZ&,-B[7CI_._'C@B'I<5_?[74^E^MQ9492*P$
MU*[^!,(9P'<*K?8:L.>!'X5S%("T/D_[$\WVB:8+J:=6QBZ[]=5_^>6SJ<@C
MJ-C)J8G[)C'IUCGK<KE+-"@LE@@V0-U( =D:*[;'JPE*TMR7K!33=Z$YJA*]
MXH4L,.-=C5U@V2??X,&^PG$GO>,]VXL;GKX).%ZX%ST;A<Y%CZ&C>JT23?@F
MD\G3K'FVYTS#FX9\LRS%E$A>8'*001++H2@UYZQ>0-BM0M5-@*(<CM%  H_T
MD+07'K0! @R(7;WOTU-DFX$>I#"]4YS+^@;V%FB4OAY-#;8YS/:"AQ9-.)?-
M0E0H3D$2<6XY H+VN+;_%5-$Y@=V;X"4\(["[$YXHI\Z )\J1\03U>J7%>>]
M V-:(Z.*3.HPW-20:>.L]6=9NUV\KOT;;U2?/.]LCO(?>E5+?3IXMT3R,SOM
M#0"G(VMG^#O%I^1*PD4&1JE]_BR!"2\^%RQ,9<:3C'SRHCI'4L(QK]IF,FOT
M?"-HV3)C@<;+<C^KKFU=(P_Y])";J<K+";%X7RXG45=%0$V3Z)6.+?BI"TD)
M*\1] -:#@A&Q\Q^14:+UXDSBSH6OXY[CMJ=BXZ^(/;=O!2G'4&\A 0/R6_*H
M8H<0$?5J#J[>?@8]&PY))&E* @O'T-ZRRBKDD:?!#1-:&%]HH& DP9LW/:L8
MY46DK&;>B^ YG[_>HJ)-_!?*)G/)?Q)TY7\##;^Y)LU=&3?J)*FVHLS(B7+G
MCNBXUU& ^H:+QIHM\Z51[LP5K(%VM#^=NN>NY(;L8&/6#K!'+3-L_-J5Y$@S
MG]PQ*@LQED(G-<J>O +L[:7Q,!V\B="]@!>YJ@3M]CLEY"2&C=E<XW96-\H^
M"K=G_VRQ%)QCD%#./E[_/O^6['A;#._,+5W%(>,OD<S>#=!O9, 0+>O3/2C$
MRJ$J;0+6!/#%?GC7Y'!A#YU_SJ>E[S2-95%K:\Q)P&N$'WW1AH[L*LJLG*X/
M194X&>25? IJ-G_"Y:M.8&""+:N[_D_[])_/#-Z-)W<M0.U<NQ"1*KG*Y6P'
M ITN9%P3@I/K*RUH;(U_GCK47%QCMY-# TO8>A_FM,RZZ#<+ ^ST_][R+]X<
M>"](F3+(BRB7' :*!-]Y:=DWCUR9UTJ@<32!T&[W'#SS1_ME\'<@ZNJ07FT^
M\C#11+LXV>-;P";E+/&O<+!<M]<3=^"O3>((V^2;?P&F[%6(5).35;H6$ +7
M^'SN")*/36@D'(J?N2#[Y'G2;.E) 5#[S5GY:NW%ZTT#>"+9;"[*Z(Z*[%^\
M*M#(1:3#=\AT\+<%=A\^ TBYF*,0U5&_7<IPNFUF=?WI=X>VV[M*2V>S>0OV
MP[\=3\>4>HZ/O4L4GDI=3IP R0$!"0+ZN26IE$_R-0%K-,N1N%;[X@_;32BI
M40B22YO#YYB!&X462L9%0[@<QMRA-P\9007A$B.Y*YR1_"J$+VZ A.=%3^5?
M _ WAEX1]^'W"N_734'CUJ[%WK6VG1QW7=K9^FOS#=?,G3>C-4JYI,1FX\33
MP:ILH)]NH187ZW1OKP)[ U1/DJBQIT0?I2\(8%SVE'U7*N**-!NF%93Z.GV4
M:5_W9I#*U0.>A9 /9_BQ)%?]H_>M:?F*GH1B_<\Z^+-,%ZRL^J"VS0PF_4%[
MH9SIIDH6I6(C1[$IL,9=IJ<G$)5:C0307P701)/P_1B)&5>J["B 99;,A=[H
MY3EO>M%0EW*.%8:LZRE%L8L>-S36S)NSOA5UY&Z5_C;6T/ YI&.LQ2K"/_73
MC&;WO8^6'I,(NAS6S\MV!8H)@#R\E!LS'\7KWT3HH]:Z/^1%KTWL!(RJ:&0T
M7&.E[[BDO]C7>+1U&+LTV>IYN"F>J-/[PC.HD?0;2XT;/5U^*PFDX+P!VO[#
M?NJ9-,&,);0:IS[Z"GR=0L&T4]Z79/0*! .MAS3J=9\?>!ZOI"U3<VAU.G%O
M["_M&]G('#=E@QGI8)4AETHC;Y?H"<!Q[9IXZX%*:[-)TI99;V*"M=DKK^W?
M[H;U6:K'JT?>#LQ?6KJO'$XDAA\9:4Y=6;-8J^N/"#7M'_MOHJR=^A?8,>D+
MV29 N^M^_A9AHQPYXW25A7T_'MW%:_)(27Z[Y2R0O.S-.S/]$&-M58YVSVE[
MGW_L5I:*4NYSO:<6SA_F'11> MFT',/'UF?)@!.].4R+FF!][55P^X&1E=P7
MW6/7!LU:-%?Z/%R:=KR;5AS3+N47[_K0?=8'O24&3N( ^HC$^OY/:Z(Z:3%Q
M\CED+WFYD%'1>KY,XBXEF3E[NUVKPA&<?'S*6Z*LI\]6M=I-!@Y8>^BGY:88
M0]T$G#3&+:QS-_PE6[)';I8,O)'0@V:#$!'E7](DD&JXH 9^!R'W5"<AT_;(
M0#%9(%I#@K5V+1B,7Z@-RIK0&ZJ'[ P6TGE.>88\L\^A%5E9795OX;^W'YSS
M,QFQWCEE#'ZK:]@@0*2%8Q47FB-B)3<C"SIXBDA%7,[WRV\:!ZUM[[WT=51O
M(.]Y\OH]-MH@[][ACOO5^_4_IWT@VA!O(0 #C\[TT03G-N$,G<Z$6<N8[18M
MK4(%>OKC"=-JY-X;1"P:?!H9G)6_RYE@E)MWN&LIY([%^F(*) E_[8_OG&#F
MF-=[_Q=S\$@\!"CB(E,YBC"(Q%=@]ZE-4$+'[IQM-QX,F$@W-6_N>N;A?/.!
MWHGJ>>\;R^:Y9=XUJE[SYMGNM65.BJ]_S(A80CB_CDO=%'1>= A "S@\2.IJ
MGM^4@_"$')VM;0,+J;&4\ES<H^QD4U\KCQ'KDZ_0=SY@ZW-GH>&E5<:%6F%9
M[=K" Z<X/F,@@C7Q)QOB%-_*XSHB8 B5J^_ 2O % 9FO-D5.;@[H3UWA*'1M
MCV?WQYN2M $MYJ]":,KB2D <#4V\:4%74O-@!=;F26RYT48>S-6S)34"R?V>
M]>OD]\N??&0[IZ:48ZDJ$B>Q)X%%4NWI(;+7>MRO>?;SC/O#N=CX')M%)W56
MZF1=A'])'=+Y#KRV:.AN6)OB)8:IGF$\WJS "Y41')'#65#Z;T;:U1O*7<K)
M2.5V19PBG:36?@PHOR3P>&BM5])>1 92/#,9K(^?+>WV73V_.]0/.0]N/'4^
MH!CE'=W&*BE#]F-OEGC[^MTXO_5/G57"SX2Z$,(F(-L-<!+,B-X#3J)RY<?$
M6N64%?+^CK*YP20HG+L]PXN)K5K.5_GN"]F.R^\Y)SP>^9"_2#$7WF5VW\SW
M0 Q /BV(A@&T&(/SZ2:8 5Y<>-*ZPB.)(2]>\#6_7JC0J8J+N"Q\IGNC4O<-
M5\E%L<_):7@Q"XTNCS[7 <VX,5#DXS9":3.=]\8UK9/H,NT!22"7NE<N6-8Q
M[75<LOKL@\9XR?E"OV-1SA[G1^Z:F+;Y.#>['>_#1M\,OX>V+#]V\M+;O2Y!
M6^2$&]"?GJ\M+?F/?GU$TFD],6A"$BIV-CS(6XV[["-6IF>13;)Y_7O>>7WQ
MAR:T.ON7!WW\^ME9=,@:>\2U1P]?( Z1=>0;2AL)!G@-IB14*&>("]+,UETC
MWAL@.CSF@<ZS=3E-<+38-_JEZ:\A^[P_%MTU"6OI89C F'M;!.-%[2_A"<JB
MDJ29(0K\H9PRGTWHC5#].>Q^T?.?10*2B]2V:/-^NB6I"SXJOC(T[>'L?R[*
M*6JL-\KPY,&<!7K[UFS:A%'6AQY,_/,R -VC\NZ5=,F">.'ZIN]^;6(3V0<6
M?%L].8[-Z>B/8QMV^"!W3_B@+8],: V81BLX#9ZXF^/3%C)S[1>?OI)YK3#S
M'O>,KJ=(NPHOCH_2O=7K0X?$OTF>;8!BHP^.8&1;9(._>'*"'V1W*B+8"E=K
M (^H,L??:S]74A-6ID>J#M5DNFN?J:+\:-4/OR?RK7$J0[PN?%(HN(1\"8C%
M,+GQN%)#D(D31P$Y5'D!$6(30H\Y0:^),FP&B2<<;A :)LM. B9*Y\X'Y[X:
MPLKQQ:3@9GU(6+J:%]Y*\.64Y>?@?"WAD08-T1JDFKH%MD-B*?U'M@^PF.SO
MS-L;!%,0P/XVY1\?_@(&-X8ZFS;FY->53]Q]S%EX,%UR+Z(<#>X^\^CCRPBK
MKMU[?URYL&G!].I_$S?5E?KJZ_GU77E?6\'WLW]WPH2C0_>%CMT80VC;V;31
M5<N[3-4N\ _4.%0>>%*G5^IJ*R G0^KABR,"A&>]8+F+DX[<"=,&XK\=+6D<
ML Z86E8*LISR_GA::6$.O/[8,LY<-?T-T:;U_EV<VDRRR'D+74LY>05C12>
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MP]:RVZ@;G6_F-6;LKJ6<DY)OLT10J0DZ[A09^V3*6>>NA+$^]H:7:KKGOUO
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MJLC0C(W79YFYP<HH\+R8&M\!W^ANBA]L<S?J)VB+<1"\26NQA122N( /'+D
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MA26DLFK2E2_@00)C/IYT6FUQT/6K*88J8V_]7%;A&6"TL@]_GYU7TU$?BC,
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M=./:#X:9&[_LN\+JGW; [G3)2+LV2T?HA//;,C,_OT2B$%C;T8)/!#5;6_U
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M.Y-97(:NHI=544K'PE5;ZP>V2U/_4AS-*XB@Q@<]!9/83CD.?\<U?Z4IU4X
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MAJ:&XG5OX"M(X1D_B]$ YY<U1D8XE)?=J8Q8FL)5F0L/R30Y-<B$AP<:YYW
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M^^2[-0.92BI])O-+W;W1X8 1=B3&_OS1+%>)K!1,ER)%3F]0:>Z_@5N!)V?
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MK.L\N+O:(;ETQ!)&] @RC=BWN&%=J'L"%A77X@!$2#JX8Q2*;R*-D*HGQH^
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MU "D^P<KT(DUP?>\65/BY+ ;@C.KGIWT$+W]!@53I)C8_>B^7E4E3AYNU>"
MX-SK87U!.''!_'IA4A5KJ6WG1T_HA5:NU$RC<__+F85QHWY_9&C$\*!*P]]'
MSZ6^A!I2Y\JAG,ML"5[/I^#VXX+CS60@EG\#8TTFMW'LTI=KU8=<>R6+WQJ$
M4?>B\=?J#6].SDY.=V>A;7JXKZF<,2#UM$:LQHS>&:@'\F^!V$6;H"4%:TG
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M<]:98OO/$]5?+C.O61*;)XXGW0)UC_[KNM1_,==M7!MFY'UK8[1D-W6OM38
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MVP0M1Y6B:V&2"U!)J!\T&2L73I2Q\Q&6@7$8>]94?X&*-L+M[[IG87R"_P7
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MF/5C?HZX//*B)S8TV*=:X#.>^WU&_3%]P-):_H3[]+1'S9.>4+TLAJ=2J-;
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MS>S-S+U%U[O!ZBY1O_>IP^H^OMLW].K]FS@W;(=_.Q3;F2),:->D+ZR7#_9
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M\T4%#],*_WMZA"^%Q$V0[PS#CLE?LGCJ&_^=YI'5&1-XI93;.R&Q -F)GN]
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MJ '=66>CK^+D#=]O^XG." R9<Z,6A3LL(?_[6M:LH$J\(]PY )]\TWR] +@
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MDQ!&D@VZDYH<H%2:#6,6-PU65KY,'>O*[@V0B\2UH,4W:),I\!K[1;K@"N$
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MHN=I:? 5"'C^A%:YKZSH#7$]X03X@R?#QP#Q:87#UB;"0_UV35.LC:7QEJ@
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MT$); W)<N*P_- ZEJEL;AY;ZBL:$7BGK"=D5TO7'/#N!J(27B,?@O%WH(QZ
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MJ7?=A0]AGRK?=7LU(MF J"LTZ\/NV5YI6%JZM^ZRZL@7\0[)=*ZC;K0!6CY
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M0I0J;$5&:P"WB=1Z!GYU65E"W1RSMO'S4Z@X:U50 GJD- H"6&98[P)II"O
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MTM7^,*DU'_\)LV9BN94C)31E5O\YD;6KI'2LC_FGR/O5&V_O[X'+UW1B,GA
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M%PS*&TQ%YJ,%F$OO]H,V<EN;]'?VS@O0FTC;1.%3DZ+5%Q]G9[>C6R*TXT>
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M LH,N8H,(4(N2B1"2!1D%E!4N,*%R Q"0)F%D AAN(J(C($@9$"1F8Y";,G
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MF60"8<-[1=+%KIMNF#P,,@&M=J(!_](3AFI?<IV0KH0WZ/@U>ZO%,.L:'_K
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M>X9X0;@*176;QI/X.$WU1C]>M/.*SYQ$__'X?X*N$.(ZQ/G9^)M84L9=MRV
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M3%WK0;):_'[&+AQ?-GV2B""88LX>%.1B1%)6TI5_&?1]G-[\9OTX^5BQ9#?
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M+JVQP3[G;./2288'*8]4YW7-B7R'>@Y+RKLU6O+DX5$L0;X#Q0Z[/V23>6<
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MT 7M0*^)W)1@%U.?S!&;RQJ_9.9 /U%8K1B\/(3@W8;@7H'\0!:N7OX^9M;
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M;@IR'D2<AP<@*IS ;V,J"W_@(7^E,:-F3%-\.SG,'T42G883ONZ5H];BE2G
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MBUAL5*1*-?5=M[JVL% QA][2M3TJ!C]LD<:!PC:YVM,#ZN(0]X733)P+5H>
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M-O^2$[IDSN?]&SV%J:02;:I*5BCY&DR/!,$[@LU)[['VZLJF_;8N]O28W14
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MK\=XW%VW/S+5';MILWAW0'&_D<#W$LG50>3HV"J#IAF$H'\=U _7Q&Q6WFL
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MNSRG1&Z1PKHR' X'8F7$ZSUK;JR506IUZ5ND2K6_%KA/3BPPO"7U("5'9(Y
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MPI'P?""^KS$652.-KON&7H%NAJH=@:8INP<6N6"I<91SEJ'Q:+ BHE^4#6#
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MV]TCD-X-T$;*>K3ON:7_M11[_\\\_Q>NZY@^^BLHHTJ/O+O0JSH3!C&2-\7
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ME1)TRPI+AK8RU/FRZR$G&<+)4E2T@'XJ)@.QJ*WK:VCBAV-,Y&E6M_YBKF\
ME36NWZ(:Q8R,*(J< ?6_&H'*WAGBGL>2087EHRH>C_!JJ1:+0E<AB=$Z1K?%
MWV-;BP^SUT>=? QED#5!\>/DLF_4F7%"/A2AZ+^% .;3*%(ISH<_(78?TCW
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MBNR]_&)-'WN9KH^UBH=J+SR.D*_[$6^N[K(%>G5E2LY0O_-)-\@?AMF88C<
M)*:D6\<S2]SXXBO\/=TY6V.E3#G2'"*^9UB[Q]$I\XA+Z=--R_50>4QL(HQL
M\QX([)QE^T3R_9YP0FXYQZDU?#+E.WW^BQ/>;Q8DRG'< G9O$R6-=UX1/:H)
M5>&D)4O.XNDJ=(-/<PK7MO&,3B!3LD#.=3-8&,(3LQ&B6E1($L<[5C!TCI&^
M92N.N)\;4D"L$R(7S9.N/Y29_L$3COQTO?I7V[56KT1PM92'QIC3B79[JI$Z
M?77-]\MB9_6V4+V" ^(&YH\AL3+!H63F".3LRC7^I-/+[PBD/G_WS";J<Z0X
MJ<(5=/&B<RY8$C@D'>@#]+B/OI*',)-QCW4!L=;X'#H5S"^S-#W,CWR;N;3'
M+)T7JMND@X?DD,JD$U.*;W#^2!T_NW>-D=M2<#WG1 O)U M7";LUR,IK3#X"
ML=&3AT5(D3+$P5Q.]!8SR\#:5,6\26$+S9A2$M2CTTL9<BEEH!"QL,9)]+Q#
M:NQRF]&S! *]2'*:'XG+2U."]86K)H+"0.T;F]T:<DWP_%YN U:R$!2DA\LY
M:XDHZYRRK;7['11SNSYZ$ZQP YTNS&#S>4M91*3>U5R<V&@PX0.+".8=:3%&
M-A5'KODLGA_U9%_O5\UE^3QGSP967JCP?04R-1VFJA.D"3!1B8"8C[G7H6BQ
MB+0!G1%4?;V-YL_"MZS:?P03ZT+9;W *1K_(!7UZ<-_\2F7P>-J'F!GCSC;V
M4:@!K@)RLV9<8<WL(B'DA]7/[M\]-1?VBI(>=<7GON 62-8L]YS2@@81P/Q:
MN(=S-GYPP$JP9J"D,M3?C6FJJVMAM4:^YJ+A$PY/QKZ46'PUU&4.)4AUHSH&
M1NID3QCY.9#D#.OBQXWKM00"!+#V7",Z/DI/(M_=EP]L?%!%U>)E6RN+OI*2
M@64N9H$N!(M'20&J'[X\W#Y9/@Y[Z>.%PS(MJ>I[2WRH#1_5UZ)_<<Z:HER1
M ;K(+"WBQ,!!TTZ^"424 1KN_,;$X^T,J$6%ZPCTB57WU>EIS9+,;(.%!]?=
M?CPQ9 ^1#*,:4\Z'YMT9&J^HZN_ =*Q%Q\L/91=4;.0KP+5O/^[!YINV0G]:
MZBN[<U_H6Q"+#&6X::(K,(C!<#A8:#$@[ BT\W:-JZ)TZ>KGQH"@$LB51HLW
M)E_WIG@6G/L>)-+[^T7B2.MQQ,8.6V8BN!/,!MSI;&3V$FH:3]]Q+V\'/<9?
MY'O4YK/Z'>/^K2_MG,<BS992!R3*#,5%IBL"LC%3@3R5L4D&3EYUO9Y2IO*F
MF/ML_&X8PA-EY?YG,<,?<T+-SKK F7T$-28ZO 'A\>^0VNYWUBV>8J7O+M')
M/_[:17BVUI4U"4VQJ=G*I4V+EJ!+ Q((!E ZG.&:HS35>+7]&/%(J\BE.B+[
MM_F3R)B4YVD>]XFEI]4EXXAZ/5JER[;2PTB[/.JT<9<!MN."UPX=6@TS;[M<
MJA7M4PT3\'_J89H;U_K'BNJM(;7P \Q(V%@5DAFW35W0QR^G*<H*YVW8Q:W>
M?UZO>S\VEL#Y9_=E\"D@H6<6C![VE$9JS04%+]RK'_>M.@OD\4OKD'7D_249
MNSFZK[-^2'AL<893DW<^$>P%@$EY(X3&T'6RWL-"6Q>N(5<_RP MI.+7#N[I
MWYP4P<^A=9MRMFD?ITXMV7(>2)-5256=K=R8-(K<* ']$4U2V#XL3G42X,]+
MOG;]ARYL16,'BUN::AV[91;"%2V1>R8@#!A9\Q#W>:8O<C4USE .=%63+AEQ
MJ(/PR#JX;>B HOI)'2YS_=KM&;>JBV9=IVQF?GU[^I4XU266ZG'>FD=T\_M<
M0:,U&YAS;:JU:[Q!R5OKL:=X] 7$6FH'[^N+Y^F$:$3MU&OAYYPU&$B[F%-0
MEV.?]W/3[P0"G-W9?$JGK=';UWG*-HRQS/_9^&)RW6O''[;7"M_&?P7E@KT!
M<U*9.1!6P4BE\0DX(AB#_P*?Q/+_J$Q_*+)K?I[E08Z;Y)Y[]NF%2V[CZ;^M
M%Q0VJSY#7N[W1 2+(;Q-0ZE+*EDR4)J_<]C%<O[%L@JW=?,%66E,![(=DBX2
M9=^9HR94OVT:-.@5#^0RF#X(,!W2Y-6X,($C-D;4&ST*]%]_,+)6\ GA+G+5
MZ)R.=/W9I]^\0M22):DN**YD':IV6 3UF@O2[DAIQRV1C=T\&@W\Q+H+Q,RN
M.YA W[_Z$I)OCYRYQ:*>@IE*>Y\'P,U&Y8TNKP1TUY<G6RR52<3^_,;Q*L$+
MI^5QFNI:[<EV4AB -P0P/5G+W;Q#=3R.9-X5H*8M&^5K5:;EP">Y<* X]"CI
MV^54J7>1\PT[HD20.@$'ZV%$0Q I=XF_JW"-Q]F%'[J5GDJFJ/THJ,]Y$M<R
MBIGXJGQ)[_$+K4KS&[^-G-#D6W\Y1S4PQXVP75LF(*Q\.4 VY#?P<*XY3FCV
MN_N9S665[#\F>BH?:02)9;RLZU^P$P+>%06D"Q]@RW+OMX] 54LKKD'Z:0N%
MY'_*MUJY_!'^+R&O9_Z6)N.,1%Y![C]^Y5:TYQH8.%*2>[*4?H[IC*7EOY76
M/?P$^YZE [JL6Q8+#GA"B/[[BYJ3RW*W\D)X?U45:OQ;$P67P+<-CU-'VTSV
MJ'L;UM&]/3X2_^LN[W&P)J;-"96>UDN8LL%'6?]QH'1A,-!4RK7UI,:K$?&!
M$-09&\([JAX!J15SU UV\O;+!"W2.!?\5'>)I<32@Y0Q%:-.K>)I;=F'+FU.
M7U5X*3[;CTL65)8T&0T-<@+HP)8@RTM*CRHFB/G?!FZ:T+74K\2[\(EYY*7[
MO>^6T:L T5S;*BQ:']"^Z:+QE$;0*_8(E+,I06MYL10KT5OX4]T9=(F_I%^I
MSQID+C*;E1%7</A[T)E6\_(50R-S)AH&>8^54$V6O'P7Q85L5*J*M=)X".V[
MIMCA4[<-SCT-&(FA&1W* -&&S9^QE/@K+<&I*0Z/L@RXM%Q6OOK%+1-:>L;!
M1_]V18,FV_)/C^6].',0"P/53P5%O],%X?_^KCQZ1M<%6KB%S]$!R6.*2PKI
M/.D*I?]VM253UWOV];E8'Q.UNZ],Z$Y(M')SS"D25:GT/3ZA9'8>:XH=L>1X
M^$*]:6Z4"F"F8/WP"8.QZ]ZN@4F-&^C)R?KWSX] S__/':_]'SD(-'J\4VPJ
MYYX+3H'>IFJ'LV3+PP\M3C@Y$C]&@WW0!\7DDCZ^$\PWRC7&Y^*099/IXY[S
ML?6*90YSBP,>]@++AS0DCF"R)5M($>$$8B_),07/?(^UJF(NVBS^]^RS.,UT
M#[HR^B\,#-"[ME*#;1>1L,-2J#D!>X:L#!=8M%R(\#F\8N.[XJ[^+NWT!<<O
MZ:+S^I<UUVX.M7$@[Y$:HX//(6^2Z%RR&4@-^;@(XD28?+-554-1XLNZ(HO?
M9UCG7:)S7IVEW<UE/F3<^11J,@'ER^@)01KA/)D17]>D?,!G7?-H.$>'10S.
M0"7/I[$+EW'.YL=_K/ ^,'6^C;Q(PL;)U%5<ZVV!O+=QWMV'MEDTN7TLN!LO
MVNE^P93T6)2P(+3])S[I0 98_V,+Z)3V$L?5(?>)55%2"H*H+CYT+.0>&AVO
MX)N*^]E]C>WW3<'R9R&@'G6_& VA;JK<3_O*V[";UK80*]\)YL2T6!1/ZPOB
M1N5_.[O?)CZ!#@\EQUX-_F; 0;,<L+!F+)80J; FJPMXX1.X(,Q2XEVR^3%^
M01H&PA;(5Y%?A'!C_*+7*]Z>/0TUK[9U8U.*@-_Y,+(NNZ!8A&<\>^+.C6?K
M]XG J9X0;;N3;3<.<]%.:"Y@H8<B,2;50F-7L;R;) QX8O99VGRDM0TT[O/+
M[&1-G$FF7?Y\Q6'OB7)5:0M-X3(%0H1%^ RPNH9:351(G7MQ!+K-^-Q7%?/N
M%]UA$7V37RZ8ZI4G3.5W62IU]C-@A.2'6MSP.6S(:R3F]93"'YV!;F+Y!AR-
M]%SC@E_/QR'?L7/#$%S?9]T6U:UV,EOKQZ7):@5(19)X)-F.)4NHL-SYV=7I
MDT-VB4II*=\V3WV+JUN[_DB?=\E6FUBUXT;:#4/R'ZC>=^6[UV)NRTRZ5?M^
MY8:LR$/FULY9'@M]F 9.WI].U#YTN%76DIC0)?OR""30XD+(.8DP&^G),(^3
M?ISVYY:[J;3&[X[UX0MA O*A;AV+YN<$O^IJJG2#+,=0CXV9C_/>T[M-W8JH
M7*G 5Y@&L4T8U#UGV\&:1(G*>E(-][X'I*OL;V6NWI(\8SQ]O],)_PIRAOQ@
M'QTZ+]ZU_Y314=5:#3KVJO>W>Z:/T[=[L6GG^+J)>JL3!-CIJH[IONWJYM$*
MLN=[H+GKQ?<G'RP5YN4HZVS U4OR294(\93H1?<V)J"&2IOLCXIG(\E/A%59
M5EX*^=M(N_]H)/\YG.OI3[!].\@PJ,%)HJ=RCU+!2L;C"L6<]Y8]_I[GY^J>
MGG,0#9B+3; $K.8&HEM4" ET*Y;H!+0+^"S"JLNM8GD<TPV%>[KL(/*:4\\S
M/I[+^5BJV3ZS--S6"4!P%7KML),M8-R:+6?CF$^KT/#79<XG.#']U/LG>9EH
M3MA[V4*(.3O71[;!(7P;+RC"@$<']OZH0IS9IMK!W6C#YH?2/Y.GK754R7W"
MX;HG!.(^:KRBD6W/F9*S&3H".6(9@13,#A\ZJO[0W"Q=;\BNNH8QL.)=FI:;
MG-YFN17!Z%M_':@YP39@1FVGO);2!T2W"1/3ZG%P5@2WKKN?R9"L:&.:007T
MDZ!]N/Y,4NTOU;FDT-B)UT#^\9: )Q>2AY@6BN>'KY5ML*PX,C_%WIRX8YS9
M'6#O:L:;]LMXG;>6OY>?<Z9NDZ;;.QMRF$YV*)I%>GX:::$O HR-2 DAF;K#
M/A]]JP/P?]@K^Z)LV@[\HPUI36A/KOX.46]L1]?[%D>2;\\=RMTAPJ):)(N
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MP$"3MK&QD,N^@RW"#,.6C+8)%=T%\U@U(50!,>KF"L6=&QET8_!U?4+^N]H
M=% [?J52X.;/JV9"'0TFO \)=CHVJ&[&=.]P8LC=&,D[I5XAUJ$E7GWTQ4;7
M!UX39=[W,COD2!G:'QH]ES++]R"?U-:9G$2J!_]^GJ$?X53H(XS[]+K6H,A.
MK)CQI%I,LRRMJ\/K-/TP,8C@!G.#(\H0/66@ [GV@4UV44 F;7GOUOLIP[HZ
M0:^:.[^T=>Z2B?1)UM$>3J519&:U\*/2=J+!GGVM*1!!@3S1G#SEUSZM,&1\
M%GV!_B1+-;6H-PB)+/%:\CI.Q]15=A'>UMUK^[$&+^0]]-P"13.3> R=+9HA
MRI'VO3AEP9JE@78<">=%K'.9@Y1"QD4P2"1F6*PQ/).,C)-6KZ.-Q1Y*'ZF_
M8!-^M5Q^;)L[[YF_[TBXQ_+I]-?^']F (T*-?\GX(NCI1X$(+SL_V(Q%V\TJ
M(050<5>&;PHM[[4DE($8(P.G(;4;@=Q!:F7!?L3ZY*<M"IYW-;+ 7+FYEM,4
MOJ8G"!]_7W#-.<B,B*8>P[FK9A&V%2L%HL-*.X4#A@H2<R2<ROFN^#IG%7_J
M_@8Q/:FE_[-2O#LD6;EX)6?7)7TH2$=J7+?)P&ME$6P1=;+_CGMC=4)/ZO=/
M,A)_=1GZ&95NB[7B:6804 ':#GDX"JF9>0+U\P^'14L2'H9#$G:,-: B+8*N
MS:S#@S7[O<[[[FS@R0,VT+DS?2Z9[$V8ZM-<UGP[7/#C28A[\S,SW 2V%8Z=
M?3E]EE,HD)CA1E;<&[B+.J8/+[HXULPAAK#:F@]!2N9?IG<<(O_6P?8-<&?D
M"=2IV\2$D>\S]_.\X.[17(N63[&AI*I4QFN7C]B=&VQ $+H-0_5]P"C--;X,
MMB(WC/[^SO6S\?W4_+B['6U$4QXM!<O01!R?Z1%;(<NWGHI5KPK?Z/8=4RE]
M:L)'<"[0;QX(H\XTCFQD>1#/48<::Y<)8=A,0_4N0SM;H>!$_T'7R8/!*:;'
M<+$'8AT?1Q^0: 6&T]_,VAX%29U5RWO0:/09ZHP40G"I=G?0?YJ7UO*!.G73
M0/PF,3%R6;/RV/)>^IYKJTI'LX.75GUMK$>\S#.G^WDN6_V@'VD"PL+-[$1S
MA)L4W84-O)1DGBT(T/P^IS_\1G;'SUXPO=% .[<E[FR3Q608R?:G84K6QM-B
M/U_34V[QU]3OJ-L<D7^T@JKT1([O[L28WL:.+^X\-+WF]I)UA.'HY,2E_+F7
M<KJDY(!L @!8G'99$6,<K[9FIIQF5C>;SI$FBQB:<;.5;9#'QBIT&C)IT!WZ
MN+S9V[O,W]TF778S;G/4E6%;-"F7CPI$&X]*/D^]EP3=05<&_:#=UBM0/NR)
M^PP?*D[=2^=VWJO@[JPXVUR1;X,[W]&]K=A;U.'V8<(^H.^-]'TS';N%>PL9
M"?=)LF&LC<4X3"^69HX'%>370VD3750V\!$[_K@=<PY$EMHJZT,2T5;45"ZT
M=@W]Y)UJ<[DWE"9L?.XY6N\&*;]LH"=0*T=Q8O4/Q(O;=1Z%60J"&%WF:Y+?
M3!+I?7]'OPB#&]RD7)S%)N8>#=)"VU)B1FO4!%6SPJ/T9YR&JLI0"+N1&JO6
M$,+4I9!LE<NSY@OW[SY/=SNR%\-9R1IL8); !HYR7M[686NBT=PTT3H*- 9?
MG8EKEJ?-M4V?&3-NO<DRJAH)LS:Y5CM6@^3[>D9:DK9VKS'L^+*H6!KO A$U
M[>&AQ<M1W0>QM#L^\9RY./R&F/Q$E!M*[IQX7:T]$Y?%/5&B[I9RX?5O%J<!
MB\I^T!R'>FQ +1LZTW>W3-KII+07_0O99-+VE.EP\:,PA9N('D%%C<P1>J*3
M\(7A<R5:$F;9R:_#7<B#!+,<]W!9X_MWZP@R[R-"KA=/T =_/#":3F:,,O&<
MAB20,D-T:8_2H$#6UFE-'5A1S)F -[ZIEV@?_LPRTO_TZLH$*9X8F5DWT'SQ
M-5G!=2-\\SAL><*T5)\WZ2\R%^S]@T6&% >40YX#S4)J24$M4F@5^N'2$Z9G
MP*@\QG5:/T-.];W(SROV*]8$T,:EUKY?V8+JH_Q&0L6>:H:#[#WCK&]KQC'0
ME /&2\[[RU.LD1FA&MX@@ZX6>?!2$6L(*M5L%1)06CD-;XQ]L;=(9@,')KV,
MLE9$)4T+'^G$K0>%O1P9[&_7[RL-UPWJ/LM(8.:09K^S ?!\5S)+>PDBQ)+#
M?!)"D*JTB=0>74.3(%KJK'E'Y0DPO[7E$%UD_INHY.@CNFA;D,,?X.-25/#$
MX,[&C@KT4C39,TB;VB;SMO^<D%5KXIR-:M_%7UU[^(?=?L^_N[[T5KQ9K=<S
M<?M%H\WUX0OW*LW$2O]BXG2).MSVSU?;G(J'G"2%%3KQH[):]B7V=C&D"+$@
MW_SQ)IV2Z1ZS_N]I5'Q;90+TH/%I,)MBV\%Q'I5&Z6K''IZNP%.1A\&Z/QH&
MM7H5J5<SJ.,+-0U7X(&;Y;<2?]J0'O;X%;GUB(R\_6ERMF&)Q<7J)TFR 3@;
M2'@ ;=T<WZ?4);0H,BS&;N:N])"EQ=[O_T&#C^(DIQ'Z'[Z7'\MYX^]LK6D5
M6;XJYNSNFV\EGKO,^P@V0&*(D5@\_'^W4TX(XACZ-+^D%F":85++K,2(H&IG
MR(->8-(L,@G-'4JUC1/CCT10L0=10S Z?VV6RBU:12$-L2>;PQ!S+X@M""J"
MBWX9)Y<%J'BE<V94XLQ8@&U5P<YRQ&'U82(![=]"Q\6MF]/E.R59Y729]FDA
M4&8.)CQM0>$U&!+CQ/>P?%+9>K R86@K2D]ZQ\-(&V&M1?2\')GTHJ Q>0I"
M*&[_]8-R]?9PO8MZ!E;_:1OV9@]_?/-%R8:;\R*'O-PBSNX\?6[_G*#KG6,J
MJSC08?]VM3&XV2AKQ,E&.V1HBM16@D 8:2X0LVRIJP*@M@R+I_P^Q0!VPG9V
MYO&#VZ6AMS/M0<E=ZD(RZWS5RTF$J^?UKQ/3*+N*/(@!L3)!-8B'EJDZHX)1
MQ7R!5+MTD<9=J!SDVF8FY"FV2:P3X$(KH?,IM5RK?'W; W'_BGI KM3H#?@6
M4F@I]0POLGQ);"\V\^Y1?]6W]OS8R_KFC%-G.*M'DBZV+D69Q$FU00]6LL11
M2=2^EWG^^$-AG&Q'U+DO5,^NAW8(+C<B8]<9GL>J0ZA6E6+6^=_:!P)V'NCH
M9QWA--.0]5$/'>8&&WB<QQ) *]&[&$)PEAJJ<[KG*OB4%DF%/=Q@B2&JVZ%$
MFS=SUA:&T KPE&^*J9M*LU6A[=E>OA;TM2GX%R^/O&^7WZ?FDNE^$K<:6.;I
M(?=XY7,A\:OZXA;SZN7KM/"&98?Y8HGAK&*>\(O"W@Y3Z7,*CH3X8L6[CT<&
MR,,%SF&R=OH6EI9YSL^(6\2L(-/)H(A$:RU&*J8=2C-A Q-S+!Y>F@2',:J-
M+W;!JC]LQJZC3:DP[A76";I:.W^H#9T-Q#6;4@AF^B[QFI[0-DEB2EIXA>MU
M^-[HP\P');Q38DY#X=S6-3JG*[]G)ADJ4=5^0Y6V3Q^E8Y[>I_S]=;X!;-10
MA1K$>RVUNV5@F\EUK7YP.TA[Q?!/N>H68NX113?Q0G#\:7KJUC(GUXHPPW40
M/FB00#RI6I58Z3:.LMKY$XPTKJ8P-1R&D5^N,^S ZYF2Q'127-BV6B'.Q95F
MNIE(&%65O:JJNF9XL9"\V!VX?J.$H_7#Q=8>OV&(,:N,I5E#QGR#P65AR E\
M6U8"?3GV2R%.H ,9Q_UV67WE+*U?3LM6#&6\>367VG&Z+NXSC;B1E^>1O3HN
M0(RAHGOXN^JGA7NCGM!>?#L9\NOPV1R(CUV;YJ)SA63UXO. "4VZY@CLG@W*
MZFZ#2TUHNGBS)J*-,9 IZQ196OOLV4I=4MUN<P4;R-0_GT>ZK!>=>/[U;_^W
M(3# $8101@'OC@!G0::#"#9 ^$MI:X;%\Y0-* @P*[!K%0'0O8!!Q$^9_^G;
MQ_O8P]COJPO8G> 2[*IM-/0%)AWVPX2VRTQ/XM#7KW.S61Q;*FQGO_S#W<H#
M9:TB.2DBCM72]3S<\EQI']=AA=-\G(OH<_JM&:="0MMRC6BI:\QCI11;*1!Q
MF8Z-U3*A6U%4G@XW&U$]5<?<!I"]G%J#"ZHLYU_(C@RZ$X0,6M]89_0K4L4+
MS7'8B\'0N6GLWIP:Z^$(*[GE!)A$57L"HUDAX[#"AF<;0__6YE5J9%OA):72
MB9ZH@AP'<U"/LMIS$>O'W_NJ3KO0?ZPOUJ IXJEZJ:)0/=88_$5-%4'!XV9'
MVE#*25(X:O*/%EO=Q>&+(^^VYC_%N,(=4"?)!_2#1MO=RQ965:\TW,@*8BW.
MXF,96E3^8*5,H9L_R^0$XNXFWG_K^VRT=;!<MW@T?'A4@PN'L[+/F])MM4=O
MNFFND5)Y2>#9.(;P:/=$9 /V=F>& 6K")66(FMIFL)KI)*%TJ(" 6VBH_Y,-
M\%TS/9>,<M+Z53>7"H"+E-1$+=N#Z*LT9 *#:^Z4(#75A5:7M&5M0M[;>+5[
MW#P\6'5KRH8W\D4&==0_^$:H]'C00N(MV7/VV#S8N#GK&#>SQ-".ODB)>(+1
M1VE07!):3H&[[7L"T<2KZ$.4<EA;KOS IJ%+R5>X>T2\,C(<(H(8=1F N^B<
MM>H]&WF5?_UMFCC2NR%6)&V+EW4,PLQ!BW 8W+C556:^BVW=>S"!%MJ9*S8H
MYE%7HQ)1!NIT/2B3EB#1=O+UOYE*3GBLBC5J$^&A*L2ISV*BA[NGUF>'59/0
MHQZ<.1*^J5#E>>_H)*%UVNK=3R*T8O[ZB1%L]UFTR= /'Q5--[16#M:0TO^2
MH5HH)>!N^,+\TLUBJH_AE3/ZB*50 9YF?:K-(:KQ!1HI7C=5"/;$6]DF))UN
M=/*DGPLW#\RU6%_DPHL_3L(M=0-0B5MX;05GU'W*O*3&<SDVD-7_!$^SPDX2
MY@AMY;QS?FTST2&<YHU/")M<AUVA"Z%-0$0^<2.'8!L>%'%'$X?H>("I%DC7
M2N\^NO@NQ<VPN3-%@A?-;:CN81L2I+Z6.TJ-=!LZ4VL;I-2J'FSO5&LE53$O
MZR'U//TT?O,GBUN&#9PO T]QQ/E<Y\S>?;H*]CCV(/;V3#*'*<(Z/6:>L $N
M0ZGP.0&QF57I,\TYZ*4MIMB5(95MC\J: -;9,=7:K_X3@;(9T!K/JWQ#S?=V
MEI5_G(44T/H[UGH2=1]WK(D)LX$;OA)J<6YS'RD:DDJ"CZS48G4,R,/M"V#9
M/>]X<L/E#(_+-N7GO144NDOOU+P11[.!^%R1>8;.,Y1'$H6TWCRD,_<Y3_>S
MS6^E;Y*1IPQ%K;UR(4KD69JFTH_N"A]WQ1PW:HENY[/%9C\%QK8IUG0O@B'E
MO>\X!=_)Y!01B/%!N,O/R;=U^C[P:8,/^\)K#0B_#[5#5\0.:_RH^?(&EV(9
M?%WHE_F^+^LCMB9B386*TS %QRA-"H9Z5 ^<F=HAAAF-.!30PD>_-N3+JWG1
M4YS:,$!\Q$5&[1VKXJ]]79O6I:[\Z4/:IBZR8X9?EZ3IIG8L),,VZ_9[G(7]
MQZ%BKQCTY0()R\H1F:0W<:YU-H+I;ET\JQ;VR:6Z^^>[$=3ZQVW]QU$>JO=;
MHMH:<F$9K:U.G3;"I7;DQ@I!PO9+[Y51E*]>G^:<XLHK3S?%B,4 -6JWT@IL
MW'9'G?F&% 21]$(IS4*B/=K5_8N1T,1FZ^)ITWQ.-1,=L]#,>(^*NU[/+T+L
M8-P;,[<:FDOQF+*QNG^S-OEY!.PKIR:#VCT[9;6#&\%K+8;HH\/;YX/<_37#
MJN@C;YKJG;XICUVK'S+NY=7K5OYI=H8_>O+:AF0(-$GZY)U@'[[\A'J2?'>H
M7IN(].%R=V*5IK>=Z5"N8L:)C+.NNL/)^?I(L34G2^2$25;673?:9JQA5,<+
M[H5F:-NO7-],,_OH3@<"CZ.2#7_)4[*MH'UBA^6KO#D[[P^5Y\;.E6OGL8$<
M2Z4IDG_E>.F<[5H^76Z78MX%._P--.C8J:U:T4Y4/3L<YAEIG@M_73?*T"MW
M7^AW&21D3:-,VV6]%"@9O/'>Z3QC(Y J).,$>:><61]&H6[&Z8OB9F=B$%CM
M+(P"X_=&O V-N3U57>,2@HJPKHZ=\Z"?_?HY5FHR1W]X?+)W/^WNX+S+U.?Z
MGACUY&B\R.WKIL^]=>\2];7\_;0N#LL^;"<+BBGR<GN]6J@*5^JP&,B/W2$&
M_.@9;[-1KTMZ2%&5Z]7H?J7U\*_J/VRBS K<G7X4W5A5OBT9YHY#EMN_NDG[
MDC>Q0U3:UP_;>/4VS85!*6V\G1-9MO+@-JZ0O)-CY3I<IIFC/_,Y1:TF0#+G
MF[:V-BOP\Y\=BY[73<6R-=[:;<[(Y"E=8.Z . [!6,1\G3Y.RRV@"AQF6(!:
M=%N/=Z89D,/^@V :6;^6<#S\9T=L =5*O.9QB+#!O%5D=KSD_$ 0!:M^S85N
M0#86IT.B6W11)FW2%[X087RH4C)$M!F2ATHB-\X_G\!4YJWL89/#7JAI,B]W
MA[O=J(\V/1W-<S5&-N%[[-7O2(U8AMELBU;;;=T4 :IAM5&NAUGX1<<[0\62
M(/:N?8$^^,>5"V#]EV+9'A[6)[MBV?.72U_=RE]>9$'HR*/4'VM0D5MZL;:V
M%\MM<J6)_I<=E;Q"<*[V'7;I@0:5-NKVZ:H1]MR==^.4K)E6]!X6=\S^'5;O
M#-\V-ADFP>+MH@C$N0LW7M>OBQ>C"I!QX>7G1I$WAK;F]5WBFIU* GXP\WXL
M'+6([6@WW?WL8WH;<M!E3XC3\]V-3Z O@_1]7A2>(M!&.O8-+.V:-J2[M.4(
MD!NUFKIX>D+5DFH2-E0W@Q>4#L5F%HY?"BU::<21E47UH\I[/S\I0T'[8W89
M4I'[7AZ@YW82-!GZVS9$L"+[U 1H9)NT?OL9D^H2)1N^CU/;5_!--/.WGBL9
M;Y)1U[N</!.'<MI*_RMT6C0#00V.;/NF]FJLGSX>S'7H<:SWY9S PV*\&7WB
MC35*-T/=M[R5S50_*-Q<'7T3D_G^3DR!64WJ5[3%GK&?'E2PK(G\&1\/QBGF
M/[OQDR]83<)0!#[82;THOF3+:T8\J>UI69;.IR59RF^9'OA'5-[S;)S[5=;]
MI8I-*I8L &&(T7<3C<70#K3:XEF2-*ACEV9%%XL+CT>7EAK$V)W3.?Z7!O]&
M-C:0[K6<E9/_MRBTYN^MJ92B[PGM<\AUZUDL CMI1<[ 'F^6+UB"\&.$ VY[
MYS-,P:=&ZP69\3$?VD???T,A+@V]KA_=SM%35:D(FG1*$5>61%F::I:T76+R
MY]#C>.],6QT[VZ_!J%3Y:Z4SF?8K5T;,:J6^(*%PU7N4)^S;M#8J46'DC2VW
MY(B2O7VQC7IT$$8DC88_L?CKPQ]Q\I\TE#$A9DX^\3U+E( H']XU146G:54-
M.]>K=D4C^M7M^M<(VF_T%#3Q\U,B^_-T&(O_&[.ZF8LBM7D"E.]D ]S&%U>R
M'GPR;.&C]79^H'S ; SRWM^0CU)%"KM[+&>.X1M<@\)FB"8A]T,T0RY_?$:F
M9;8;2X\URU2N8H3I-JE%8$0[2V($6:,FZ"_YH7I\I5&.6&BSTYB27NQN\7,2
MYG:]DW;](QO0O)NOL'S]NGP70ZS+L4H+91[_X]OVC6_.JKDGRO(3R JU;_1!
MPROGJ<OV14..JS:)!7;%YVUL5%1;Y&>#56:[GRO0C4U2/[%JWM)&+FI2:=O?
M[$-QRM82CN3A8FM+U0+=X=!H>+>"YK11U)']"YC/,%$28B9I0JT5^EC2*3:?
MRO3JN3:RV#"J9O/RC;^^Z/.J4^;7Q[0.Q5*M@HQ'-E2"^L?7*X()#8UU=;6U
M66Y. OWIS#QL:Q.'O(NFT=C 3C =MJY6!E_E $;@H';<:UG2:+W;[-90RTE0
M[D>4<2>O>D2-X*K[[DY+>82BH?7]W^!PP\!:T7Z8VIQ+/!N@\]8?T:#^87A^
MM+?$Z4WZ=UWTE>M+3KU5S1O/5]LTGA!,N./R$SJ'G_A" MZMQ&D:E;S"I+9)
M'^"0@=3.<<PEKW"X[_/ED<^A6</G\MUS/9[<<3IC=C=YCN=KUK:_MT)OIV5V
MQ0JG]OX@+<3M='%H/89QBQG7;$';;\6+&3K1JJ_3X]K?YF(%0 1'O<6'Y_C9
MU[Y/W)NTBKLV2B*BC?(\X!D/8@O",AY$?C+X%'HNPJ8J/DCU5JK/G#SCQ-S.
M.LA%(WN /7276>N^1[09\KU1G<;=^$!#Q*R 4&VZ3]&W2XB@J/L%*)_VB98J
MD<P)U?*Y^B9M8],W+_F'_RSN-=T/Q7QQ'UO7V,<PS,"7)5ZM$06M]#0KFFVT
M_2!5J53*]@ HTY&Q=R36I[K^R7T'E?6"4H28?></4]4WQ5X6?+'ROT,'#C",
M\E!U'_W:IF6'5+0JCX%I;3Z7Q\(BP?91]\+44OAO9/NA#>JY^QF[&:&]2/5;
M0B>3#QPYB-&BNN 8D115$XJ9DE[K+;U1GP[Q/[P,DI:MCB2T]26^4<X74CYF
MJVRLGW-2)4 \L+-"D'HQ+.1+:?P;/I,"<3U[;#D*.[MX$,QYA<HT4>CT<[/A
MB@MY$2C ZYBB)A ?X^(LD7YT+M0)=LB^5@Z'-CN<JW"-[-3:E\,S^&;]Y'"
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M?S*4G.VF#L31U0, ^<_Y=*PEW2\GBF4FVQL V+J!&*'/*K\SY-IZS LPB!D
M3UHXE7FGQ1SBN:?/O.,B9U5OK/IAPY"UR$XA>EHFRS;K;/"3-:;[R6\S E!6
MM%/7E4*J_,F7?#H/T5V+Z,T)K""JROOC:P$E/_2"S/1/A&F:E_L:#9LUQCKZ
M=UJV0,G%BW0N.YH!<W@#Z7N4Y1Y,"E34X#CKQBA:#HF[2W^;[D[O0OE#5/CF
M54S-W:AKUEQ@@B?-J-4V(*4-3S3FPEF;'>*6N<1Z+AC%<WAQ%-FO1.8M>G\_
MYD13#!6;AFD,B"*<8V@X,_SRH[U8\G12KZ0ZEAKP#PLR I&*1C#\!+"E3FN=
M*AD*#4WC+.- :0WOLSYV.IF<JM>,)S;=J).QO9Y_\E%,6[=S!S.IC$;%A*K$
M7N5&1:<FY<JR.T&XR*4<R HI_WK68<;E:KU@19@@S?I8?D;^K=[SI7TC)H:N
MLV\F*K:OK'@@F /L @[7Y%T@*#GW[2' E1YJF':'061"IDB6S]P$6UJ,)_0]
M&#(_^\PVA5DVC.+YGJJ0H!*?J68_:IJP:V9(4&!(2)&/:-FICE%+#X[O6RT&
M+HDCAR3U0D]TGD:FV3(PJ:A *K]SKYL&PZ(U5)Z)QP-)+AUO[DR$F%]?M79S
M3JIH_9Z>=NQ=M.%=6RMV%U<44R(YBDM;8( 2>.,&-2!M09]=!/4D@H$GHQ(H
M>7H2Y9<FRX/02.<A(536DE)4S++7."=T:9V,(Q5R*94 SHI+'5LFU4MB/T/J
MFIX1:="-M'W0$2IZ$EL+75]D:#+? $D,&C.(X1W5*;KRQ*FZGK)Y&-_31?4S
ME=IP(MU*/:6R%]"MA\Y:EMMA?-H'/>QH3ON8:E[M^37E.Q#V^E&J96QB3Z
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MAV"[S$-I.L\X)Q"+=8?V00?W0=[8$P#N%AT:PX(5 C32G7U0=R.=4Q8D\+H
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MP45BL#UIQY$+JWX:UR8A?"JR"GT881_.F=9:-;S6)3=?/</OO1US=:_\BM,
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M)S7X?KC)3$'>A#\99\'\RG\PX)+\X[L5A.P<>TO59BO5MA#"U.%L8LGB__$
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MSHF&_QKVJJ#\@1AXZ-7B9Y(O)Q\27RS2S8C V>9>V6DA9BIL!DS#I['X\2Z
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M".W!?<ZA3NEA&AXXCX]L!'X*J@1$+PIPSK+^)3Y_6>]V(ZP0#'(R2JXS&HG
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MOD2E;]AXFYXCJ=!.^,-)\G!'2RE@R<\&!0(S?$/+%E".%]B!D8TR/N1G\K1
M<V!?:.ZGBQDTR9BAU&BMH:PR2>E3/N>,6#.[M0]L?IYB>8)DG[(<X7/./_U5
MCU''9] HP,_CMCX6W7Y2_]0.TT(W1\\BVVV^D8PWMY4VOW;K_RO1Z)+'9Z_%
M'2,9)^,[.G>U!5;?/=ZF'.2[<<Y>MT[S--ZMP;I<T3VBXHG;&_?(J2\Y9HUY
M+^C3.&8/:/A#J(3A/DI%)R[361K'8$$3L;:A&8L(:;*,-UDX,;++UMLZX]Y9
M0MM;7=W \(ASWS=R?K[:I[&8,GIDH-+<+^[B.#1C%S9\)-$O_FAH+GYIR'A!
M]7"J9VRR<#AWF=!+4+_TEF;\:M?;TV=.A?0&D%W;A):,"P8<(F73ZV<'[3>7
M)A7=";IK*[E3;KO.;(6Y>L!(NXN+_3#UCG/):99-#5F'J[VITE6Q(/A>/2$@
M$3#XLEOHM>L"^@V[.FJF9\2_PUA@[U>;-WA<(,'%"I6D^,,@@V.3^8?0750"
MZ1$[V[R]6?M+[9,?LZ<O O4E#\(L6!W)Y)R8@*S2F1T!H;Z5^8^*@B()L4KO
M _P<K%N6UKS</P5)OX;5W_H7@+=P4R1Y0-L*>HW?6NK\I)/PT)$[4I'WUOLJ
M3O'17?,M/;()(U4W;RV]*DLMW/6S<[$IA4/]XR\[%YBN@Y;7@Q+;3@6GM7'8
MR"!M!C*U3/U0>7*1TPSY77Y,=>$^\[ V@RAE:8/SMTJP.4V:A(XCL]Y,A]3=
M&<J\(YNO,[TRHN\9U $#)1Y''A^E#EUZ<KC48+#$_7Y>FI9OU7;KK.8?T='1
M/Z*]5ZZ/C1=2XFP;HED)A5$1<92X:!O5@AD^?\:YJNK;H_,!^-3DT[G>VXHO
MGG*+6P5(\6M$Q9B@ERX+'J 4CP+S#7E5S^:ZEJ':.-WO-IER^'Z6F:-\#6=L
MO^%+@_F2C+65W_3\B 3=^HS=ZK-=&3NHMH<#^!CCKIKC6L=?F+XZ4:/9TAPH
M_4&3K)* EO):']IFON-#2I3^NQVW _6W[WW\9F=$C3--<?7=+VKG=A6<S FL
M)FK&;7>Y4/W<UNVLA<']3[FW"Y.*=A]-O17N7*:GPXIVHQ;2-3 33\2(AH;.
M!3D<:-E)045U(:5G !G_X#\!76HI485]K/;-SMH!DR7]PH%/]='I <<VMUS1
MW531=N!>$:9@TZI7/S#)5CHKMYQU"N"?T) JVZS$\_+J;5VK&2.Z1V]R]#"A
MGG*W/X/'6])=DO4%+K>!VK+])>Y'BN9U2^R/%,7J9%1,8GIV)RIH!L3E??'I
MT%W/OS#[Y=C'_18EUN&+NSVSMY0XN<L'+*99G1JOQ!VB34M!<@)1HZT6@.\(
ML!/ED(V)M(, [7J+_HP*M!,,K@)3#^.UM(<[A^IOA.8.7R]I>9E_H5N'F.52
M7S-@5KV]]NJ"5__"B= "6$+4I5"^K-Q(FZ1)[MATX^CM!"^/'4?O7 XZX6"(
M>'5U%0W)M%_S1KB?HSEZ+?+20&'"V[+^"Q&W ]6&7P7^-7@RJ752O^-BVN?]
M+W<+7-P/'WWL4BFUVR C@K];,:W&9!4WK2;Y^_-]=23)*?4/OL]NZT_^%37]
M)L-PG=>AYB+UVN*?!MO005YFL_K._8<I3ZF [Z_.R0[@=D$0GJY"5L4': VV
M: FC6C"*%]*=VM0?W7O"(N*YUF-.$9-V!KRET;P/%0O?E@=PJB-QE9.6=-8/
M?.BJ1+=[@> /+D:HA(13DSYA%\VA,,4(EB?7*;T%12SH&V(PM16'2M^S70?G
M*A:,HV3\\.QG7^N'L9J6]18YAO6?-W9)GGW[89/P6K_[[#/7O'N!LII.YF^_
M/_A+.G&=3EIAVZW"RW*U-^]O,+#>'7L5N'1Q;]M/;P6CAM1($Z56#G#O8MR]
MTQ^P5?TKU&<9JLI[3VW+*(OOV)^ML;;\U [PCL=+DME.XX[P_<H%$0EHK7R>
M=M -6XILT$>WY,KDSD_/98?7 [=6^A[S=L=4I>VXP>0$>2JD7'@\6/AZ?_JE
MDWVW%<__#Z'[]R9@K]35M3.&LYGRT#B]/OI:RT8' ,>@UV8RNTTY1QL2T4(4
M8>(:O=^D]B[)^,G>*'S<@^*&E:-##\U&Y@GG*KV0#:@M+%S-J-F.S@UZKY6\
M^\Y8V1^^OR_=B&W0%>E+#.ME<J:_'),UL=](^M,S+4)I<TJ)EUEYQZ[;@;ZY
MZ8YJSMMU6!2[G"\CCSRM!W=5=*&R!YB'LU$*MFO0"M?R2;:YMQ\?S=8NL819
M_\8&]_#6VCQOAZ-'E0_O.>HH_<1Z]>'+4D\1J]P?IBQA;7]]'?=#C+C"KO.>
MUQ"8(=?37J'3[-'@D19CO"K/ /3U-U?UB=MYQLT.+O7]=8CND!S%"MV=:G]X
M2UE5(;FT=EHR19,452YT U].V@5SD9G+X(6NN.#V&(%O2_GCUH?3]:S]=Y09
M/KXCHV>K^XWFSSX8.7?-09I@\C-PZK9WGJONZZ]?CB[F6KG[..UN]SBRTZ?.
M:,V&@N#D!W>4'I\R77OX6-. !X/35^)1^^".]':G'X<^+X4%J]6=;<HX[&?Z
MUN#S[K 6-C+[2,<IO9SW%6->,[VM;XH8?64QRU3;[1W>Y4?9/V[1GY V@Y]Y
M61-2R<6\G%9T<LM.T)][:3[@S907D$ SR=\V7YSR=_BRQG[%4-9MEXIQEQF5
M:$RP4?>JY+M9_(9TR@2-#1S&:1'/(V5F<+6)26;A=F:<DK$QT-7Q5Q>VY4JO
M@='CONY1=J=ZL/C7)N>XC9&146%#D?<\U$X2 [:9_RQWO#12*@5D1Z<7W0NV
MW<GX67\R\?"1B)%L;,YDQ(7)U2'[=Z>Y:Y<$'(M+:MS=.JN49_/]FS'W/E7*
M$_V&F&G;M4/Y?OYQ;0GS#LZ._O.AW4UFAFWY4X2XQZ7;BO/<<J*,73V&HF3&
M<#X#=7*!7@-5.LT#4?Z^*[.>@^8:C1G3YVC+&M/!S2\;[S3>XGX)#8KLLJIB
M<RCM[!2*I/ P81+W2R3C@.'VB^T6>#)R:,$LMBQ[V[TM*9#AI=4%983UC?<9
MX4_\ OS:OC=7_WGKQN2[K[1S+8HRR8PCK:?^^D#:+U^IMZ]JPTOUJ*>#(;4/
MOPXP!M+*W+-2G/MO:ZI[?:Z>?-_.??KA;N .\+ZCK+]U :O (#WL=O7Z<C(!
M+_W^=MC^DE'2C(MW^/C4=#,;.+8 Z@O'-;%R*):K7X993?;?LS? :(8"L;#O
MV(GX>72E2<YS]OY-BZ=>^$5=*, G[_NR1W5QLI.Z7AC+<V(VM)B".9-81?!'
M>TP">82+4IFU9'TIW:(:*JGP,: ;/5)Y=*3 QL;Q:I_%F9 )C[=8E"-Q!+/N
M+YK\8"5N$Z<B48>6U$3SV_YFAUI<V!N/+Q%EWNL22ZQ:N\8_W;ZO.&A84!_>
M?MR-ZE'B9,.5G;4LVO<N7;/+M",PU#-4OU2:F#*X64WGUA?7W#'L;#^T5@^@
M<S+G. *,T$U49K^+.,Q9B"<Y\WQ<OV[UYV4F/!B\@(LGRR?X,<K&IA<_.I7]
MVFG)7_V.L'[;2)V6GA/P6>#PQ57R,,46 QRBLZIPHZ;\9V >KVE<I1ZH'&RG
M72-KL;HD#XTY (*V]$@\YR?AH+-:]JSG+:X8X7?C3:JMQ!%7JVCSZHM@=4E^
M?Q<^-3OML8/B\7>G]-=(D@]G=7WG??\9>S'\Y\7)E" 21I;H[:##4TQM=GV[
MF'+O2QRSMFSBKXCL=2> GRJ'73]T[)8U6!DR.?KI*V>'67!RUD,6H[OC-KG&
M2^\#3S4Y:I$LR<E$GI][4N!VZ[1B 5I-GSN.5L@_$\G/(GYT7:E7-]M2?FIG
M5&!BRI,LVMJF9\=BPF\?=B0_(Y_X]03N?SV4!2_%B#4 Y?4//)7O2/*!I;6<
M"7TM_D<L)#<!:^EOPYBY%+!&C'!7]R=C)VG">PL*F+E['="%GOY?;7>SREY1
M^8<FZ%:HCT>5#N.X/Z&ZZ__V;WY:$_ZG/MA:26G=2YDHI0.',;"#MX+> E]B
M--\#4)W;2P-CV\G*/*E$>RTVOF4K[]$=WE;W5+?4/3SSCP&Z?<T#[ZO,9KMF
M8V^OWA8[D#KW=0LR8,CU5L_N; NLVK4NH/&B<N#.YV^#A[2LS;8E%5Y+NV-K
M+.L8\RQ[J^)^S=IIB]L?QXK4S/-=4J@&GV^76)WOV%DW6I/]/73;Z;'1^NSQ
M3M:2]VL<,(D%#7 B7=.C8@0#4TY9C',2[NZ'I'/$".>T00K0,\,6LKW+H*I/
M]"6_TUJ8+\BD9OJ,ZQ?H2_!\F!CQWCR >BXS1V2[2(FTKWO8XB)&)*I36CW$
MB.F=N31(3>0G1N3-8#@=5. (?>7@KRY."10O,>++2N9R]#8QXN'HIFDQ8@?)
M\;,8X8&S_+&#7T?YJD[#-CAU0067Z(U4WU[<-@HC'3-11EFZV^TM1LA"E6)$
M]S+J-X:OO+@E1O2&W[@@1MRUW_)=C"A#YPGNQOK2E^2\2T>+X%M@;=D?>RI#
M:+?HO[,(C"@5*J.A+#68-G*H@_2?+44B_]>4K_5_6U/>HA0N409RND5O[2IQ
M*VO*^^=[X1N4%A"^!0_5_K=^//P;-VH/T4021Z?Y7W]2^GLL?YC.^AI^HOW&
M$D@S%!83KF)$<4<8'0Q>)D"$QV*$]WG<BO$S>>JB%#, M[P-C@(2[PU=>;(D
MN$"B3T_E">XM5RI_]_Z-*3!C-_NU);$8T1=HCA.:KC2($98#E/)&M$AE1 K[
M,YZ+1J_<^DEO3*R#7;1G,":NR1ZWM @[8&4HY:?A[\WY7>P'/^9 J6?C2X6M
M/-4<D3.)_9'!&A0C'H2]M!]#H5<NP3Z(PSN2[OP'@WX7^YEO\(T=Z_?V0R?
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M=,N8G]WGEZ^!)^-N7/VEG^$W#IA;76#V=^:=2[^@TU3OO,>^Z6$S;B)X7@-
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ML\)M'$#_]<&7#(^>;(9: Z+Y'T4W;7'P#)3#5J(3A3LY.!FHC[*F#B9;Q,R
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ME97?E(L0VO<<+W6VH],H:UO6@">([$E<.R81)27<R,HO2&DQ 4LF*;)"#,#
M6Z>\6R'?:OJ1:FZGYQ+N+@JO\GWSRC_O14G#_5:EJ]LMEGQI*;5CF#;+<?-G
MKC3%$'ZNY/BV.IQTL?7@>&-)YXDH?1R#UVK-*'>EA*BXF1M_DV9?NI$:33&W
M1%RH]7Y-J2Z=?RFP(K-1ZZKL3<G=VN9Y[9!"O^W12E"#Z=7T*+.,B&="BKS,
MQ(!M@\V6W$PY_'J_F1C[TK,Y*C_69C%/-M8_3XD-?;3/113Z7U#6_^F@[,8!
MD0W"NPWPBBVPQ8W\$",\? Q7[&A3,I#\13$B2P7$P-PP56 O1LRX;HL+_D.,
M>'V2P>;O@HM+@R9(_Q%#YX@.B^1 !\@1+2-&?'CQD#+];*C)8.K7VVU;<F#6
M-N??BUD:P?LKDRH@*TH*+L\RHZN7O!?WEBY4Q$">@[ XK8+%/NI5CPCUQ'NI
M]S^<& *&A2F[1Z'7;U K[T\_,J<GP^*#1A,CW(Y@'L'%H67/1Z$-"&NQ-6PX
M)]7LMQ-G.S ;FB,%&C[X #-X#4]>[MD(-AS#I:-J3>Z:XS80LSP:!Y<K#TRO
M.+7'RNWJIM5IO$@M;7CZK*XN_7-0PMI^:<P=*JB+%&[8"JV;$NRCM)ZC3#QA
M/_-N[QGAHU6@'GI-=EY<!(!_A>2AN!TW"N2S42BBMV-Z#C, Q>O(XE:>K<HK
M"_ +9%J//RD^&&1PYL G[%(8C3L+K:T6(PRWPF9&8.;DRF#7]@%V"/(*^6\<
MX(@"=0ES6CPR.A/SK'1ND #4<&OMU8>$FU53BD J+ZO]78$V3ZW&^EV!&553
MN(]GD@C=X\L<.D>O(8^L34J-3;IV*Q&*),L)_P3C@&A(?@*N4O>$Q\!2;H\\
M48+#AE>6D7@W'B9-2.!6[N]W>D^R?##-ANG)I#%44C;C3= \U':3F;+>%/O7
MK.8.1Z.2]6+$7U$0N6"S*-5>$1JC S NYO.!Z,F^,-^%UCADZZ]W8'7!64Y=
M5>&E4EBP*R.O8H)[+EN.J\%Z:[SCP*-F( 7,#4?[#=46Z@1Z);KX6WU.L<FY
MN0?S(%P"DK\&&V@ IG:R*(Q9 JLCSEK@,=1Q734Y2HRXCE*N12%&W?O,8(Y_
MB-=2QI$A($-9NI]?#]'0)_MO6?@4<$[9S/YXL6=X":/\U1>=8KNS(K1E$\!.
M6JK$^ /0RZ* T1G?_74/9X9NL*=CZG,>LYR-*_GYCT>.[XT.NA1N=./XJ)OF
M^[]Y3=5"(FQ'/J75@'(2F0'#SGL>-5'>,Y(S0;NRC%Y'TN9-9;9H@3V<*09A
M+:C:'B#-ZV$L2,[F#E^K2\<$ /7II6&9@7)C#WWPOG_V=P=5?&WP'E+=D9.M
M-O$S"Y([#-9-9J;0@?T]5YX2IXXU#I\!3TX24BC2I)V46+,<U1O@UK86@P*"
M3$A?UV;,UQ;-_KH_ 7ZF]"D;-Z1KO]'[4VP=B?EP'"1#$2,DW\ L^@HEI">)
M!4?"L"B$K"JZ VWUAXMBHSV-0U,-74EO8,ZZ5L:\!37:U,W?)6N7\R28GCV<
M?,+<D+9L[5!QKL9VDRLJS(-Q7?Q5\+1O0F_8@"<F4=L:K!%L(Y8R"]  FL%.
M\L;(UHWY,0MDAX4*9@6Z]0 _GINH3K['M?$S=N>VUE(WA-YRBC8N:=S5_+[V
M /"4-FD(K;41((02HF>_]H6D $=Q2:A::B(7+)]@C_3SGX,O::#$!#O%MMN!
M4]G)S%05XL [C^A,I")XZOR*=U*=%G)?WZA[;WB4QJ7PD[F\;U,ID81SJ:)S
MOQKCM.B1K&!K<?#OEO2S%);&A%X;K">H,G78U4*SH:@>^5 *LAG%P4F&Y."4
MA=@U6<#DKP;GYG'H/ZO[:N?WN2+7A[6HJE;P[ MC2T)O3@^]_9YZ[-4:['P^
M7&M>P)<^#;T:WT%)Q-12YJTX+U6YCA75[>5"6\ KG8M-;C$#.-GZL#3&/B#*
MN S3;'?KI>P!'CVM/__<FTDQCD'/[80O$R2Z@IDHNHD_3'Y-KY5*%%[BHN6;
M2X\!*C6EL_:KP=30H(U_#SE=:0XZ^1#,F'6XFZQB?.I=&[>U8%UOZ?[DR\+C
M8D3\><Q$%KTF@RJ0$=J*:L2(4.PU2 84"#R@83P7E5I@#)>SCCA%=S"_;+I%
M@Z>:9'X:X.>=*C!)]'EV5>#3OSF3.;YYT$OQ29AZ]K/>@./4ZB?('/K$)^J'
MR%<PM&]C:FA"%3V^,K#F"F X29E;X#%:U7'M,MCK,0%Y$P1IL*LMIKOQ:>\R
M5N%KKG3HT/J']AE49%U_T;&*%>CZY*7"P1-- @RK" '54/!HUO $9LX!<&#2
M:W'SVR<M &0;9BT;C#XXW.S>9%+'75/SDA?P(I#S4EJA!"0S/ ;U+',[2H+Q
M33+.*BC+[KO%![[15Y'[Z  . V[#S=TC **67>3^W+B$2IYA:XL&>(6S($WT
M;FVQY/6DA=NBN")=K4B&-3L99D9N$D<'F[>MJ2OYZ!0=B$RJ7)HM*SK1)KM+
M!52%Y(^"-TN%IV%_QMA&\2*==VJAN=?I<]=Y4MCO'B$<%?).D KT,U6X2HU_
M<+8HS$AO]7EU=],?6*KY AMP1(.ZE+E8#@[4(\R-\C0Z*1+DC<*S8#MOE"-U
M%=I,.@96\A);?569/2I@J>?PA6M4M[ZLP[SVA ;[',Z";,CY#\3@?;T7^O&!
M^)+IB]5W/P4A]Z!(PE\ ?DIIM2=OAUZKP^G;R<&R\*]00'?!AD#\)%(3'^T=
MH/T2R'CNJ]P E":3ME?X^1)+#_#B!&.^)G<X>96;H]*]YR_VE/J..>VR^HF>
M4!5J1L U@20J@O1"Z6N%JP0^H;G8M+KN_3W[@>^D P FLV7CUX M0W7&'FRG
M?K,X56:+!? EO3 @+"9?--AL'7>7[GQ..!@2+SOYLT24C)G(H3[+AG6TE"'$
MHE370NN;Z*(;$ +T0+/*&92:!%I%6(,8(6..2:KV(^VL!DCJ"PD!7S_@67J,
M+G:&O7XCD)%?6?+)Z^(.UG3._N]O/_I])-^!4W: ^I0VEPD[=-M"*MF.A!%1
M[3>0=H!TH)2+:QNQW3S)3BA8!; O+\_BM2CM"B$K[[(B(SE^<EJ$LX3*;[=.
MH0,;LUDS;_KP3M??5R.@?'K8&$U@0NX5J?E-8-I[]GMY 6OHRY+KXUK7T#.P
MH,4H)*THV 3?V HSD:*]%2P5^)/\>R%E,)+YKUZ>_H9MN9?ZZPCK07I';IHV
M E18O:2M ! 2YJ(P"F"J0%NC/#8_;,J]_U%=[]S%GL=8@EH29ND.@.%Z)]OO
MI+2JD9 \AXX-Q=!V7J=0<8(8CWN>_OG&\9D<JH2)VUB7\\[0T]G<HZ;=.FD!
MSL71@=FTSSF0G!H<_A"A"C@%2'!1\^D"5U"&P5:?;S;F93*I\IA@]!J2,UPZ
MK]6TXN06C$E6#\9)QWB/4B=>7I2ARK8T3/J84V6^-J@W9T=WO@$*DR55LQ\>
M04!4S"DQ C3!"145^2N\'T(#VD@7_TZ?.24Y1W:V"%3LU%;C$1@H12+US>7C
M6#%B[:/\R6[5O02%UY+!NT:GT9'GUYYX:C'4.1M.T<,!Y]'"#;%\(LR_3E+5
MR2Q*#:XM4UJX1O18C B\ _0PX60<G8A.-*,FJE?53'3+, 'D^J\KM\G*L-T4
M[&*SI79CQ.28(3-AG>W>DN/$T$HCDP -1ACYYJ]WUE9[P].!2=KDR*^MVMR6
M*ZCJMFX"_:_J)/7Z_+4USVK!16YJDKV"?8-6?:&1^_M0ZOHIJG?VN)ILENA>
M/U966QHAT.#__6M##O@":,Q)I$8WT,6_+GIL:U,J='[:*-!],8%:%1*@#Y9P
MZ3+N0[PQ)]74"[3$%:<D'6"@CV'PS&]6+C3R?OF^BB.H0%$"S.DH3RE"I<B#
M0_ B<YJ6V:()QE<0+^Y7_W&ESL;-NY6BL)3GN8WY5U@#>14O*CN3>^7AN(9K
M5FB%PZ.NTH.;LE019<H@7)#7+%):MX@19] (J)4M30E=R*2O(4GQ&'RJZ,F2
M30\\Z?4MFX2! )3%PWC7]0E#GV#+OOKJ%I!PA$K?D=<FM[-]6QH>[U4;J',C
M> P$OWR9]3:DDT$'(A+G(B<60-VI3/KI!="H8<YXPDUF@L"D7J-H-V^=Z,FP
MUF/8V6 ![ZNV09QTBOOS>*=!H3-'M-JH\F3]P/P%F\R$@.V)#OV=?'X65^"#
MGM=IJ@W?NP?3H*9SX.;G.WV[B_;?<M8YD:R^R>C;-Z;!P\=&;YFK$;?V*(,4
MP9^4U@XVX-0SDL55*0'H7.1\:#$>,NDUH5T0761SG.)_%5:7]\MN%I\K%I;R
M/9D89#.&%N*UDE_RQM92Q?6QLYF'D\ZY0NY-[T](T,J5#PW;R\-N:MY>1M+E
MV77&PYIV%!;SG$Y&I6+'D*6W[^D"39 R29?KG*2IA1WZN%?']W/FJ.U6F>G]
M4]@,5X%KN$O<Z^9Y@JSHLA"F0FM:R.W4&N^K]@J^)*(HN447?#;9QK)E*]EO
M(_D"0SF3='5PH;WAHH<_/OK'CW$](&@NU^UJP(QE?:Y7XB/'4E9HS)&+7FC9
M+-]+3(D5-]%-,2*<.H+GSX%A8H0*/0B5-KX>;)]XX;K49UZ>*1]@/0.I#A4,
MV0STDOPX7>"\^8)LV#.?;JT!"^LA:K!Y>TWR/+/ZCTDI?H;HI1@11!_!<"FO
MT/$XS98M#=?M=:#^%N/$5LQJH2F!PU; -P08\217'MTI,I*S2'Z$\YU6*7N,
M]R5YAJDW\[W^JJ 991G]]:9+Z"VT!6%A)BE&B%(Q$Q/8$8T."N""RE"W3(>U
M&6JTQ=^!$SR/!DPY:^A$LAK1H6-\ZT _ ](8X/0N5#Y(,;:VPWL_Y0W=?%@<
M6VLC0A]O>%]5:5;IZ[:=?!M>'"N;M2R9A-%@:.T(,(1:/QNP 2;>^;Q;E 1+
M>UU@;&DE.,G,SH9KR:0FC$L/1AFK>M1OF<+"P!H[/^-J.'K&+\_OBB;_6]:6
M'0C1,[ 37CA^*1LM>RF2[T"+#-C%K^E?1JF&Y#:^C^H2(R2(4EQ49K/:P]F=
M80W6QE#^8Y#=1E8;M#6577$4%?-F/INKG>KG[HVPO2KE@QRFUDD)E5.A=3\$
MVG#5C!;L(9T7E=@J%)',0'KQ7AIIVT"S&2LQHPZ7W&3$\W&/PDH2H]M48CH:
M:,?\]C[V[8J+QI\^4;W!+/J\@]GY_<U()AO4414JABWR]_)ZYKJ1<_& ]P'P
M+'GC3,SJ.G[Z! 7Y0>C03SW0U_XNAVN#3 [$4C2<N*-:3N[/!CV9BGC/@./L
M?6X_7]05S+ (7S(A.;0H'D((@T ]W@M^FJC05NLA^7T &@SG.7B)"NSE0MFJ
M2Q]L+W$RK_WZODWC)&W6PAX)9"9G'0'>949S*RE,2^M'I=&!I3H/_WSKICFL
M&GD<07&C//TA5 F$UL'.7+V!Y[APF1Z4R4([\"A,/T.-^:-D36*. T^/P=:>
ML=Z?K5QGY_<GT)"^5(D\,FPV;V&9X;]ORODJ[^R#FWJ-"OM<,[LS09LD"1A
MI\ '!R0STZF(O__^2N%8IIV.T=RPRV:#M?JO73>N]@K7@CL%ZRBM,/0G4BBU
MR+DR@-%*64T*Y>$F*^RUP)N!P.*^9P EL=G_!%O!=C5'SL-5I+<WXUV'S,M(
M6 4J-+MRTCWPAGY1C7VE*=N+\DY*+?5 \EPQXO9.TF$QXMDP@!0C/).^2CP#
M87&W&M;N5\/_M3X'4C_X<=#SKH(]OJ G]TR9P("D-H1Z9:\ "TAH*TAEK/PI
M1B"%-I&/<"#-!3!)K7+CX./.C$\']:KZJ7C,1.R-VE;LX11NB)[)G/O53GS;
MKTQY2%8<M/43;!6>!X;;U]:N22-F,4X9.S *;( W!S=_-['=.T'8P HEZ_?-
ME89R4[3V31Y4V? .3BG7K-T[,[L6P,UBA'!#,#\8=!2L$:Z#Q7?/!)5!2*?4
M]G3"N: .IO/P7$H[>^U7]H9F)UO[;769QX"<^-I1FGHHZU8H60O )9B8I2.=
M:_K/SBDYAG7LU==W^D00JJ3RSP).0H4>2-H8C@H(NZ$0:K=7ZX?6AJ!46FS$
MB+8<40E9&S1AA2,Y]#14NW=JQ8RB&R=?G<OJ&T*I$AV;3XJJ"Z>'#H=N/0+T
M)$956@PQ/&M"@Q'09)26$[9W23#OY]52T[=4:?)N]O# LMW^&1ECC'O_W(/8
MO-'9V=&<%%;?NS[6=A.3JBJ=#!GBUDM!%]+5$CFH#BQHE0JM[0*<.F-R&.P-
MY*'Z\>U#M9>]#PV05836X$V>0UO]#^>HJ."($RU& .[Z<MP?7U;Z8IT=NU^6
MB%J3U=5V!1;H4I)A!,TLL-!<?_H<3["=W$J5%#K&<J@JOU0<9$^,Y 30N,88
MSW [[)5A;V#HEJU=F7%M=9A'"-F8ATXSDQSL4U12C7&_^3@T.L$O]F<EF^_-
M]X']M!^^@#T]"'ME7!;</K$PXCU!2:H0VCPX-KVRD$+>1+( *)G"P$GC$-_K
M0Z2]7(PBD>8X4&<C& O@NY:7;?$QG@OWB,"?# H-5;+@78[#"DS)@_2:AOE,
M@.$*OA;L$OH!T1VHQ)BR[]X!0$:9UG0_[?V92:?AVJGO=782OK4G>L>FK=OS
M[RQMV)H8+Q$!82D3G-V3%-"8)M3XWJUNBF09<A[+_EWQ"LGRY%RX_,?>35)_
M_F5C71YUR(E*Q$X(40 ,9-!*;X+:AAOI&\)*0!TXP!.[QCY'K^V8R3?5U@)U
M'IFJ4A*V&>#?D6PP+15N:3'J7QH1VD0\7G]V3GBI<CK5-/3]OILK>D+-;6+$
M]EJX@)/I<UQ(@S)[0+CC 9)% $WT+M,G<L@[17=(V\LHK5X+478:$\'7[0V_
MJD+(X249FH8OF.@.QE-*9RY:\%G1PDW9N0F59NHM2:S*A#*E>E,_T?5/=T[7
M-66,SZ 'Z%=8J@R"+&DCB(6U='SVCE#ZN@O41'O99V!HX%D3ILJX9"J#102>
MZ(V^IF-X.A8'NTENDR],QQ1M#F 7I>#EX";EC6&S(9Q7Q@#,V=RT]6F/?K6#
MJH].Q9Q< #<%T9B9B;[Y4#S/E(M^1;V,6P6AP,R#C1E#8@3#=[@=)?&5KTY/
M,@HV=8B2+RD!31CMWNIVX_<[Q CW(6_L $<ZVZ-KHU0_M0XGU(3O)WE?E YM
MQ@D-X( >_6J)66_FU[BTH #B.3D))!PO;+&MZ4[U2?L<[J46[:\%FVK>+^\^
MH'TNGQ*I_,EO<O'$/FX+_9<*>LBNI@N5L*]R$YG($8W)X$3R]NE<S>J]W'1Y
M?7,4$F2W+A[OB5Z=0FQHU=Y2VV_K]L"DV*B4>A!F,VXIHX<:#IM7])7M%O[Z
M/Z8AI56=?AH]DLE7 15IP@/@*H#&+9U7X.5QJ-?)VTEGP>L\FS9U)#/]S!03
MIHEFZ3;MGL1 MR9>> )-/O\AZ&OS G9;[=^<# CJ/S2D<\O'W$HN;!Q.!EFA
M.9 )25. +DC:7" G=.^G!Z6N(_<&"@Y"/7 %&GN+DX4LIE5[74/+'$I#5G0+
M2Z;ME:UO;_";L;2."8WV/6B_K:_"7&0_].:[ZZ,;$C_X*8;?%2&91D$@,9,/
M"]2K_E _5<,6>2FB1.A !P9+?SUQR>TNOM$944A\P8WB$CTZ<5>*<]56OTL,
MCJ4\\;4KUWB.-M[4>#U29M?EHZ(J^L1+'.!"_Y#9.4R1L;<F#T#:V"26V^@Q
M8FHK7=X6PZ6EJK.OT6XI/[>P-VX +Q6!5S'RN$ON:4/6%?7#-W_>3#[AL&7-
M2B0?9A57;T/M*. P5@YOOTUTDVQ##.3> ]YZ>8(TAD+[8S"ZDZS4,% 0LC1+
MVT!$,;-C<,E+>3;3FW(-_6;SS<\^*MB^R37>VBSP9R!\*4LB#9+K%MV@GX9U
MS' GDH7FNX#5@F-"'Z R,8,>@M4D1?9[<Y')%20"][E177ATJ_I9[9U =J%V
M:C'1[U"JP.;'Q:ZRF=S;O@7593A_MR<'5"<)H_W\#/CBQ\E_4P /U =/2'H=
MC,AT<&'",%.%6#,9D /T\ZM "8%-6'](@#2LRN).^=N/+WHU 5/\J(S,$C\P
MA76I-ASG7%>G;O>M"%^$MQAJ(M><6;GV #7:T(D!]:/G<@06Y%Z4!#V(EDY5
MU'B%VRA&A CR_%#QOA;E'*JB1?*DW?X?7NIR5?="N5W^!A0YUHSG["[?Z9LC
MN)F+_76?(>K:?</U N@#[3,!DF\5Y9(\>5OYLF"PX#1)IVZ@"&P42,-"A=IA
MK.K;.S\PP\)<K7LA,ND\/OCC%:;6 L0SAP+6\E K-G?G-CT=,%]W[5"K^5M,
M/4H"<XZ>0%>D3]POD/RU PP[S#H@#Q CCHKN/0!YW*LKEQ.Z]C[O%6J8U$RB
MY<9P[(U#AB\EF.H7*SGE#<])NH5!6^YI(N96]1%58;\)](7NHLJ6K1"#C81T
MD:KD7O;:"VJVCCR;5I9>(LGYTB.B]AO,W/NA\4V\\].!;4.^]2(<-BE4SPLO
M1EA3=%YMRSB"=1>54,+H(\-\6S \EA?-SP7I$YGQ.&1%B6#++&0^%+[$'*C3
M3?^<Z/1^;B3OT'!4WH/KX1<J=8>^KW#>5/RUH8V>FPF:ITY0,FVC.)A1/4@Z
MGU=^H#&5JS>_P&M@JM.NFKN=<HBH@-?LBO?"O>6XCP;^6Y-T^TQ(GC$LM[3D
M\/"M3AQEV8(#5^GF8D18#TN"OU[TG#[!H::OP,P6.=F3T*()P:4,P**D1W\]
M&FUE)\5TBTJODK<+@]\O^\MC-J:?D],=/?3T1?\9GO)4BCE68?3UM@Q:16B
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M4@<M3R^C^ J-G(V34L+5VQQRWWCM!(ZICM\)\XU9]#9E<<']V&&OM,R-4S\
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MI40?L, 4B:W0F8PF&  M)((1$_7I7X +Q/B<8GEN@6B8#K;Q\/ FB"EHYYG
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M/#L^;UE-O'<SM\G87:0,C ^-F=4395ZA116'? O9]M.9IHP=OK;"%3C(7D;
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M@[?=]V(N[4]=OQ!HI]9\"C#0$DU)KDBQ8HO)]7(J;$:\B@4/,P<?6>:PC*G
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M=DWM>EKUMAE+VY'EN3UJ??E4DOG;1E?P&[=-.J2(;1EQJ.X-Q=?4(;4TLG1
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MDJPI15!)![IBAX@B()Y9:V+5GIW5\A6L;VG(O+6N;B[S3CDM<,":&;^Q=##
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MT5ADIE<=+RV.Z<O6KRL,LFS=O#V[,*VXV(=^<T#J.;^" Y0P)G'SA710"RY
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M [S,G'Q?):;%6:0F/I9:U&=/%&VT(>E,>%7C>;4F@9[-K&>XL#!+[ =U1),
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MR04/,(8"1%;0,CZ@0GX'H6$%H="-E\[!K(!"]E7W4\Z,:4\;\JK*^4DK6IU
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M7*>>XN?1W=K%+FX-M",]SY+.5C%?]9HJ7M=8X__JX?%_M,J6$, 3-"1WLG<
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M_\&: A";(3D]N@Q@KZ-J07C1(FD5CI>&PP!!3PQY.7=L%D$ZPG3>2@NX]HP
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MQ,YV+;!?[?\I^UV/NHA:4H):0O?9&OAT\=WK!^67ZCZ]0_NKNVNOW-'[D@Z
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M^EW#>J2@TF+JHGB ZJ#]"RBRN4&IOT*&4B(#[F6IZYW/%(RG?AC\L#0L,/?
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MB8(G&C..L6X5%0TN(=+BIZ/.I.*OZ1X)D:M\G4M9%=55-54Q MP7#+S*7UH
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MYD^@P9@?+AKP4)Q\/=_&$VAPX*X0E7^362E-Q_(,Y)^Z:-IQY)U=JF-BJHI
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M^5;7_:T_.EF/^2B0/.N?-/&9 [Q%*&#XA"/B7=H@,&$F9P9#&TH1;*GLE_F
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MF=<Z1.S?=^M)> 0<AA?_)"8YTS?.-V>E.K?ZY?Q%VZQ^QET06[3;:DF^K_Q
MO+0#7=>0]NZ2JT>1=\$>5.8ZTT]N?]W9H*/&PFVBY>SY=F?S[W7D0=X=BO!F
MQDW14MK%D_M#]D31".(ZDX!;)6L#FB,.@X8['1X?+/J%F5R&CF9)__A"4)E0
M8#VCC$\LE>4<ZB56I;]CV^FC(JJK%-,R[AMF2ML:%!(AS*<F2?482ZTT!'7-
M\!(HS+Q'T^2]I9HS7X%C_F+K_-8*$R004W!;P,PG:Z!?<N8_T!HE?K2Z(S=
M=6G$=;L,J_(M'+2\^VD?S4@RP^]?ERFZ)"@N2S/N.G\WD*5:9@)K?<*+D?
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M$.)ZB^!VXDN\8.B(XHF<U4Q)$55-RBZ6DLH'WLH'1WX\UN._@$Z39(<'C]6
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M;?VXK,I^T//W)8T;46(?NY"LM:[$59"GJZLK;5_VDR<WGSPQ;S^E>0:E>5"
M0BV[N=M'CT[$I5P;2B=FS,I2WD_6:W_4E"&6:]RK0'TZ0 2]9J1+9&L4J*Z%
M?,#I/WT225$%_LE-YDS^G:U L58>]_.&_@(6%A2HV;XC"X$YB<8?59L28:_%
M689<?B63BT[DK[?=%,@'#R_. &D^8/ RZU<Q_G8H1Q\*.0S%6<7)2(40X%G7
M/2ESS6XOA#MY'7^F'ZNGD/4?%UHT% ,;*VKBM/?\74FK%V*@_>XBH!F-@=J$
M^)L*E" )5X5-IN^D[3]V7Z3$I2A3[Q/%&$;=FH00U0S.'1M,KFQYG1@=ZTPQ
M,YWRK&19_V/Z!GQIGWK&#05W!+(;L9"1NTS+71(C?ZY !3ZW7?FOWII.]/?$
MLK98?Q"?:./%WTBW)-F:/P./6HWH6P=6@-P.MDP/M&!(2FLE/W#E[\@7KTDW
MM>[?'[/>G%A?\7^.I2"F8D!W -H)(_Z]/%W^5P6'Y]X,*%6RDU-UF,T FK9?
M7^.=[/QY04;Q]4KI@=-3%B2+X".'Q6L(JM62\PDLOYXW]RJ^CEP*O$.>]18"
MR2+H(=@CY#=3S<="J?3-5-TF7ZLX^RS1_E>S177NCT@+LS="!Z[BU[B??I\/
M5=T3_9J3$A[_^F[.TU-+/G3]Q]D9]./(-39%+%FLKX] _SN(6-F0^4BF-6"[
M#C.('WTPTVAZS">@-3T\:: U+=5EXHIE_854G96QH1X>7TO:"'^/F^1\6CKR
MZM.+S1C6&7<!>[&E8/A4Q"@.,@6: <AHY0OI.C*,D?]E8R2,!$YW Z3"'IO+
MS[2Z:"L*J>5.XJQ"]EE/-,H7LFI9F)T2)&L[]JSQ:BFH?#+VVZA+37J;RS-<
M_9G_S@R0_^YKB:P+:&0!W_R8%5@Y$]M&D)M#ZSGYO/\PMR0R'#'+*[]FC.27
MQPI4WD&N*CSC*%NU(R?QA_J5G,1_M;?X?WC)0,2P,8B93^/\&-!V//?(J +%
M T3^!0]8XW_LI6H+,;&JI?7B$-&!]^$)YT%F].GI$<%8URN-XDA1\,5(HZ:%
MD*/!TY6W.>EO7W]=-FN;*%OLG;S8$8HB0PAK!3" ..^4>I,"5<ZX R_%3LYC
MH]>/$S9"_.-B.P4JONT.V\8U>/E>DA<09[Z/MA\HP,9NG)G\PG0Y9/JU.N53
M.@\/#'NA=K#_X%R>&2((T3+U+Q(OZ+'457:I+@R,X_IH3VEYK7@P_*"T?I2I
MR?_'1(85$-<DC1G$!D<TUY3\,>@5R]?+Y_ J]S_0<K,R8S*)BZU030-B $$9
MK ?-B- J<&?#5@B->3E%;KQA\4%'@6I6Q;;%-5-&=?5^E^QC^??4887W"X$
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MY72;.QES:Z;+(@O&YM-C.AK2"C,<A]AO %7DS%W,]? R*O*F89%0'@&-NX%
MX#T782Z5N9X*7%)3>[-UP]V"D[7960C9KH7N<_4Q:5X554QM+Z;,@#?76ELP
MMMLIG"SLN'PL2@D%<XI*_;CZYB#SCDSWD>PP6!UO7A_2J+\#_)PA4J#04$'3
M^#[S8'>N3D/&6G;!1&KU[9+@PN&Q^]R(39/.1]?J202W9!QJ$KQVNSS'UG!"
M@:JP:D:_=X&5H\4&DA)YB@)U868]E7T(:I$>9239JH/;;GRJCC+YTEOGQ)+A
M0#C?/^SZ8]*-:YF%0>GQ]X]'M\PGYYDQBXD>I"1 ,P,%N&JXO\(][9S*!*/A
MU<ND9C(3>3%=:9AH=:MA^YCZ!^!"D&C00H%2AA@.=4P',3Y:=D0S;T"K:\)V
M4_^4V>Q$011I\PM[87VU'R5$C7U_.V*T$FIX"Q]TB0"@[<R7F"@D<D9%Z*70
M&:A8D@<-Y%,?42.$\Y/O[G$-1S*%?#4\+B;L@AB?9+'?O8?^*L>3;+WOWKQ;
M-,$[[?FS/H04;N*\ A>G<I';F3R#D_*,!K,)XK/(@6B1/)MV0##EWDQ<8V(#
M%)P-:E@KUHX/_57W-*.)-U5_5QL<@E)&1B)W\19:8EI2LD,"0MT\#+(VTA?'
MLQ\ &O&R TA0VLGCZY9(\8U^!5"XR#4&S@>_C')N5534I[0U MHT4\V_TZ=B
MTVN2',*VQY2,I:<FBY)7^EVEEHWQ/MRX-'\_R.ORH[LH>N[_"H7_X"+?2T?4
MHR\\S)<$X]2!V98#YQ&7VP!\T@+*M.5W]705J),W*B\#C43.)VU.=;@\@]#,
ME^\F> #@,<P/.^8D0HP7\,<4J)XL%O$LYV-TFOP!$G)]YF]PGPV!@3A$\FZE
M9SK;:7[;+OQ7U/QW7IIB[-0/9&E+%_M]"S*8Y3/QN$ &SZ4EV@Z<B\[<V]2@
MV0UWAH]2$O1-THU2N4VVJ[JV/Z\.)IQY?H8T/;WMGMY^?,]HQNF^RU.LWSZ\
MQ 0[$]M^5:"B'W(NZP4<QVRRT5T<ZBA_8C$S>-QQ^P#+Y@9K=)\%XM*KA@SR
MOR2(:GH:-O #G<>B[/,YVG>'?$ENO+,4FYJ\JK*&'%PV 3)"RS0XDG/(U<N1
MK<9MXEQDK!O?Z_V5EP.%B+01FVIZ#9'H.(@DNJ]"T&>(6%MYTPLKJGNG<B.0
M0)MPLPKW\GU1:-P>;!.>6I,<$Z_TU?!_<+.CB WM1+?R[P"@)V7-8O<-W(5/
M((VI8KN<9I4F J9:Q"YNX )4"J!]/M1GML4U:$/'X#8O+1WM! O-^AYSUNG@
MWUL=:W6'IH[ON'2TYLA;  ]0*+S1H_+;P 5<"E!9&$_3?2P[W VOIEH3-)T$
M+(QKU;LYM-HKB=34FN\4YUE7T6LZ6YD:\95''C3!UL4[#P<;G2O[ \T.9(]*
M&YE@*&7*2(QIJL&D-.@#C4H A:%/-6J6J(UGZ8CCHOW$_ 29J4AOSV_M:W.S
MH>BC\DQV1:97DQM>S=?#YX/W/ZY1]E>N+@0@YD=*IZAZ6:2\OL&&RA#,M& @
MP[BI8*DZ%'$8(I;*#E=!9>*!X^)(1O1<LK>]&'O;7!=8ZNDHPMS.6EI)61?4
MW["]OG^R6\_M<\AY88=S3%).!8BB?T&4&  T.@#!N'C^4V!2@<JGD2"B="OM
MHKS2QJY(Y@C.W"R$\*!9CV>].#4SGYR.20PC,W6'CV13][<A6N"]SH&VN$NS
M&0,^ZJ^]^>M(.=[M5PZ_7K*PS [8QA&OYTPE*5#'(21H.6 FQ%2@W@UZ$U<
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MAW^5752@8O(%C(<)V^Z_^OCQ6R19>H0MFH!7E2E0Q@8(FUW%3:HBXG^\&SR
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MZ#";)G[X;*PDKCNTV-G];5I11?^WC&0K;DW>B%I-OZ!G[FB7Q?ZI8[P#U@%
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M=4^G\KZ,*E#-IMA60FF)E547GFKNH.X+YG@<^-YN**L^?:)IL%"J^8?2@N:
MKEB[-3V "\3!^Z XUE,GS$LZ6HR]4^GF5V&6*<S4F?>J-[RY#<@==/AG><K+
M 7^B/M!XN#3,&_?>4<)]\6YD^H 79K!\U-CSP!TG"]YKVHK2G;\<+7O]=L3S
MRL'D!I^V31=0@#4 DB09(F*R+WIQ/ _0>,1VB\?0"-0N>2$OL<@M@*K&^X?#
MI/PU5%_C3-_(K:+/J,1T>F8Q5#)TY$+9D[RJX/TVR=OQW0H4>"T\A4(S0K)(
M(%3[:.P;0;6SF9G(7T;3Z S>%W6L@ACO14QDFR:9OEGOH#GINU&JV;PK;:=%
M97.7D]*]&9.S?)G.EI5,;9E:[<MO7J;/:Y]#W\7=3J>:A/D1>6*]OW_1S5_;
MNL_NMEN2SK-LRXDUM^RO3$DCI"1Z$^;9O$Q#5TAG@.$2-D3!-'<N@8 6B:W-
MN]F"_KGAE3Y[6V[0TXJ_IM;4UX]$%Y&^USW.F^#5)\1^*JS:[?L/;/]P2^HO
M:"YNL U6$2/+!^2Q@#]Q4$E"@F*DIP=]J/R72,IN9"FUI%.XG&54J>ABIA"C
MX0T9'&8TT_7$^B\$'>K$;O/Z$/O^CPU5?>8O++2?]WR*"BQ,7)F0S5C0D/\-
MD#IO,BL[FX;1HX1)H=BQB:AMJP/=NC9(36OR^ML='/+-N^H8DD?68AI*$DH]
M$G*U%RQ9P0%%@^5LYJ5;[ZK?^"X.3\(O[HVF*8/=G4),W.+8VL$ZZM;V$\^[
M4WO<H//"^@B/%U5U=POJ4Z4M7GT/%*A$+(5B=-TH:V'4(R+7).75KJ4:@!FQ
MC-WT"H=0%/A["?$IY2538^(*O8U8'<[5<VF[ 7 9ZX8_$#V@O:YQC?1?Q0&Q
MYWNV7;\H=8)OC6*73/BBN\)BJ^-.933Y;J[HGDO*:.U)_HX"0LV=[5 A6;O%
MX7$V2X18=6BB5:>R(%I(6/E5AY-HX\@BOGXZ2++6BCY_]?%X37)OZ>$\K6N6
MY9T&ZO.G;MV_16RS0BKNII'%?6BE",93'#(.,HUK&;9>(,;@T!9R=X'1I/.C
MB:UNE5VSP;;#LX,6PY;#!55J3GG0L5#I"?[Y=!7&>JBGV2[/>]CJ=SD6"4!;
M^D#6_DH(![K RL%2RP[;0ND)H-'.AI1/73]SHMOK>I@>6M!$ON9F/=<R/L@-
MN4H*&-4+<HQ<?3W+T U\FSEJ'!.<ND=-VB%=3O_'=X7\-NX"\1;_61M72G6W
MAUP%+*OC?6$[<NP_B3%)T[E2X(Z-\_6GN^J_Q-O8A10%[7WNJO36=55B]D$E
M(4.VB0+.B+2C;)'8:-R)$^2DXVXC]:HNH@LF5TA]QAHL(82".E&!X;:;^V;Y
M*"BWF:E:>56\ULFVX].+>T/<:AR:R/TTVC-]- 1J&OZ<U<WO"/^Q=Y0RY0Y6
MPRI7$59&4FJ4AY5,'?XB4DJA;Z2W9IF)B6ULGO%H_@"7LY%JQ,6H5E0P[#,(
M8,Q4VYU0)OHX[5#Q!]([DOI[DW83*Z]GWB96ZCQB"T6>Y:CATK)-O6W3NP[=
M%O,].:\TRNSSMZ78?]"XMV_=@]!SKG\^.'=H*R<##9EBIUQ%1-00I XK[UP<
M>0ZFQN33AXC5W.&QA3<*%#K4!W.X MH)[O?T[K 2$5JQ6@TW%RZEGRP/R1D:
MWUD09%7&&NLJJ>SP>DNBE,P^+T79GH;20JQDFPXAD Y@EIJ/AA0!C=LY@H>P
MM75;RY3;Z^]G%*C; 1*VO+"$]]VI LS/8N6.>(TM,&)M+)1K*BM3>=.BSP-<
M(G@_Z.Z'K;+#7??:%J"*BLJGE55E9551;Q'NTW7<[^CA5UU565F=?+ZZJCK*
MT#X[:M7=K;$;^OQ2+,[8N9Y2^N8GQ/'*/1<'D$)<(2!;-P\K[Y;J^-)YBSLY
M&QFQ.N$M#)YQR\AV<2D3[&Q*OY8[NH,5QE&#.*U96^YU$RNI&<WA#5O Z2*;
M]L^57>:9?D? 5*;J9#HUFB!?O(GH@GB"ASN\6KV(!D"F8HH GP#X T,J$F>Q
M_D,A,T6!6DHC%'N17_G)G]PW+(R784MX)<$1N7J'^[\07L2*MD=<"[:4\.9/
M]\Q%['^"DKU#$F*]K=I($%(4X6(PE>CHPMJNAEWP/\B".3=MR(BK:9'F^>=[
M:58%U(JS))W,Z;_'5!RWYRHESG:B@BRISV]M#K9TO.-H<N6) G6,_PS?>E2>
M@RQID#,JTC08);SDQ. T,H)K>2O2VNA*739.>R+O.28]-EWM]-C:HJ1Z;_OE
MU^=3/;<=\_OAC02?664Z E -=_EN:'_C$!>S6JM]:N7FCNL*E(I4Z*!"_OSM
M,OVMV:IU\/PK=;5O2NQ@Q"1JICQ$9'($S-_F+J<"4 "P^EE2V2\9DYU7B^KO
M.N,Z)=?* W7>,89U792CY[=;H^1!_UU!]"]1]$4%7GM-@;JO!>$4J( DJ2VB
MLAP- 7RE3 @TON5_^XVOA(2C& C@RQTNL$L$Q!\FOT; K6< R2A3&YYQE^&>
MX+(Y_[<]1&=G;N,^G@8Y\J0:(SC#E)S#?L!LPXH=OU\4#][ _F/\(VWQZ9D"
M]?H&1U#)ERR#-BI0N7/'X?3_],G"B(X"=1>O"PSN.Z) >:WYL[5:_(L"-3>G
M0(T]B9OMLM-P_T<W!MC(!X^9JIQ%I&9T"DY0M<"2))2\'[N1FOPD&>=2W\V>
M,I\0<33JUMF7US^O3NG_^&#-URT/WMPM=M#_VO<7<-'\U!)BHWZ<N+R9 U+F
M95I\B1022L_1WP+:=2%2$WBX86^_S!WD2XI [.T+XM/4BP,M649,T=ETO<RN
MV!$>W,E-2__TY3:-*-P?Z<9ML;ZDOZG+HMW)^&Q/0$_'_/P+SYK6Y%PHSJFV
MJU)N[#1@G@0UN_/<ROS(C\>J[QJ71.VOU7U?6/G\CGW"9H><L+6)+R^?.J@$
M<O^+R :I#'AUKG0MO8>/P@G2B2C;7\@89=H!\#-A(]Q/K'!O(2A_@(P.@FU-
M4^K-7B>J&I3 M<D;^\)PZZ!.T<K*%:R_W=[TW[CC99%2KG'#KJ,B;6 A8&9
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M4YL_$$]3%W C2B8:=,#^2I/DJR&%U#C7_CIW$4X-NN]HY63ZY$.@CN\3UN/
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MTB4[*#9JLGJ?+5*@=">M0MI6U Y5':(D>M9VS:VLC<=J'"CI%#P^E=7/I1/
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M\ YU3WKSB9[+SSE$_4IPG!<<WK"JZHS8:W*[9["/*BNIV\(50)QAA<OLC$F
MU)1Z(45B W+I-N[28Y.9RCWEF%L6G#UB"X80I_HY<T_?D^!MO";/IOQ\OB\?
M3Q+DU-CMA)LHJ_L^=F9WW.JMGQMR$#-EZF1X=35:IJ$DT07)K[EK@U(SC:"^
M,5VR&U0M/4QYVQD2%<RD>HO_<+,_6]+)VO0D[LOL 3#G0>Z$W:;.<80^_GZ'
M?RU+A-G%'_.MBCV \PC\/_X#VT]]L-HRR!K11<,.5TFPO HGR,BTAIJ+()[$
M6VSM(_.0/Z*B13Y'<*NI9Z#0M!:1=5' 65#ML4DYQ^H5FZ23HDI)=$IBANVO
M,2XL7S#XTST]-&V#W.#4 4RS0ZY,ST!J.2K[N9R.E]]6H$BM]I+,RNBN8_CH
MU)%-[3J\-+U=#[9'"P:@][H7IWS3>&_R]_*]QE]G-]SWCKB6E-54V/=FGBQ;
MZRI9)\\-G;T-E+?)-@3 :S8)Y7@>H<)H)K>PBN(E?%]E09!I0YOWF,S;ZO#B
MZIT'6QZK>?5G=93[[.4MW+&P^D:OV2OT6F7^/.-D+Y;*G-B&6T4YH4N!7F"4
MH6M8C?)U?/;ML0ZS_OE/%:]"]"7CY[S.YVTTO/OHXZVAB*O[=T^^<RI.N+%&
M1#. +/I$6!X#0\5QO,)+Q6W1-:X":7FU>Z0;6[R''I5]?,]I4_U F^K>KVZF
M^CM?;56-\6$AZ?0-H.X97X&Z35M/M91S%*A?R+H9U8 V_&:4=;&*[O)(Z.P5
MI=-PI>W)FQ _XL\NGOO,54EU[#YQ6\3ZN]Y>/OR:<+V C'6T7*#N&N"/'K26
MI,KOABI0:^'7&$UJ!-@GR8#4QZR!>%BOW49]K#;R]=_47\&BY(PHK7A8<]CI
M.<%C@I^3E?^JD\55FUCX-&@\XW>(?H34LI$5\0$P$6-D&KG((Q_C!.6>!-EZ
M9XG-2S#\MMU2N,=.A4!GL(%Z'_?&-X)6M[9SG7"S%AW>2_&UAK"[J>X%@ZT;
M<IZ'/"],#;^;B%7WX#=S&^YZ#P('D)2+0C5$8ETE;37%4AB;$JM !:/[OTEJ
MH"O2<]"> 1E6;"R<C>%LG CGZU6.%2V)2V/BA0,U+B+\JDG/-4-!/SF% $](
M"RZ%(WKI 5V_U/2ZC5@7W.%"^KG38U(B4.>($^1G&B$F):(-(NFEC;W4"DG_
M,]6[83VX"5@N<_'/)RYT08 7^.UVC79507]0VC7M1DX*8H7*E!B?VMI><X3D
MYD)C331S;J\-+O@\\0DO91KQ6SS^RH+(W"#/''KVI&?R[YT5]_,($ZGN:55>
M)_SV5CP.N[+\_H!9T\;C.?RC=^)VM-S_6&S^>=GWQ1S]+Z N "!B(</9&;Q4
MFZH&F4NWXL6#=5R]L WWFS-WU;#$B<-!/X]0[K745W!60'[APE?Z7;NIP?X6
M6<'%(\.4:-7K(Y%>B:JF)FIHUIL"9&('];:*B^.%Z"53#'7JN6]6:+H-5FCB
MW)1I$)GAG)C8JN/0$1K!:CV?^[(T0?0ELLBNB2]H(1)5OIFV*MLO/_WVKZ0>
M9Y6]ES0<UC_=>3JPH:0PT[OCS^9=9*4+)9FG'7A;/QXU-T !FQB@0PK=;C\R
MAV= G2O"_R&3E&:F$A3C")$$JM>^"O#33D*"]N<T?LB$MMHCHB&#S"3V:O?>
M>W'_LQZZ2LLJMC6VIT:2N5\\?MLG_/: '_SN\],;=E;R6NXE+GWTI>5TD9@@
M^1.B$_-(;IQE[7OPL34ZV9Z^(U.,M=1(8'WJB"JX)VE%;-'0FPB1RZ7!<V^B
M=CO[/_<P'RG(:R.?][]B ]S#@(<0<DP2W;E*Q2,#?4D;6M /!]CTF;9PH\29
MN58OY[C5B^<4;_8AD>B6D9 9:Y)C'R+L*("NF6B.N9?J^7SP=$B^F3.)W_-<
MDVG0-D=T0 $;1W#R)XO'J9<'(MIZ [@$\+TDKT%\@WR[Y)2\BK8&4N?HPNV9
MZT!\ FTKA<SC8,%R/4R4>WW51WILJ*J]ZSJ3D11F8[A_KF/X"Z*;F')M;F(A
M+N.%"Y![_9ML;697HP+%:I9M,(+79"->EMAAMU%V"")*S6@=J;2E$![<,RXZ
MDA@A+/(2J>BIE8-Q]PNA@A.=7R[=W7-I*=6RA),>>'EHPM).WT=S;,82]*UE
MS]\M#$S'WKYTH<M<OMVYSVR@;)RXT!B;\]QOSZDQ.__GTZZOOR<[;;?.WN\8
M)BU\/1JWL4B4,#*R0Q"]JG/C^5C-'5D)!JLWGSIR\_2^,8<SAQW6)"S-0RTY
M@'D[*]/M$B<@!C *NLPNA5LS51U[X1UP'Z8\@,>D9VX ]SPF1^11&(T+N+A/
MC :KY\PXLP+EVU]8NB<IM;#NQ,G!J/2%_1_[ME9X 17>'BV8.1.I+E6]5)[.
MO3 [P)10N^#>8(ZR3 7R KO>=:_KM#TB&J\;4>F8<QZL=;JTSGIOOJ_OP)!/
M$#HH426M#*_O1UHCN_LOPC4M?X8+1D.[T^JX_%S)@PX91LCM3Y%H@&T2[G2E
M8!C7R ?B:_!B_-AC^<>XY]@&@A84')I+K^?3$O,:=7N>%S6.!:W$KX+L2&[)
M$2S+"CG\;Z7W__?%_1,+[1^$CWL)%"AY)G9:JD#E[WX@U^O[BG@V)6O@32(5
MHT"5-<H9P+S!/4[93>##2^&L=-,I!6HPF4J0UA) . ^.DVU5H+:E(2^9]NG
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M%;V1>K'//WEDOMQ8Q]9JT*V\<[Z@&MCNQ"H18Q./4J@&IKC/9)F&([Q:#F;
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MJ&O?Q+$1 W%DFDZ0G5TYN\\/?)"3F;9VLE74IAQ5>C2LB.2=?CKL#7EF.K1
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M'P<RK%ZMEWH 5*DN[ [+?@,; _DSMU$K&OQ%;=@;]O8,NHAYGX])X-*L:B(
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MY9'2RP(N8-[(RAZQM/YV;BC1:OC]:O-0NC*;"QX@GI0COFQ+GW-.(8_E=K*
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MG5VPXK9(M,A=Q:1W&/"B/8K\'8-U/XDUD17_(4>\7RQRH%0F1WQCDPZ3S<B
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M;9[,)$0*=)*%4A2^V(4?WT4T?^Q%^.5+LXM>R\@N>I]T_Q.<GY%H>5OAHW&
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M<Z(L]+Z8X7BV^.7>-2OI@N,K7HY8*,:>J'C;>2E#9-MV5>]$<4C@C?;FO)9
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M4CA) 'VJ/A: =!+@]5B!![)RH^@X1. 7Y8DTD3Y.2>,],(<U)!/&4"B"A@]
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M/OHCL@W/?<0$;268_DQAJ?@MRM7#&H':"[/]A*6P _BD\ ESHE"D1TQ5M+X
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MY;?>S>#;:IO?UWTVP/[@YR<D.7]=NE NSL9?QMVAE<_7^9*YY$DU4(*QA9Z
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MOG0/U;60N& =>24@?=L/D2]'F"[:2Y4&$R;B1'M@'7&&A9KS>7?(EFM=UZI
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M112+L2]6/'/<L4I;4CCIQ6C:?9?Z^1[/LYO#QM;5ZDD!Y$ 8U9FU:,K];DX
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M-\A,P'LL_>0<5::;S)0:DPZ:&92R#'>_H'R/.:SWP'K3[JK]NQQ/J=DL4W_
M\!=2($]>:Y@$LP191=4!@>A K!KDR&MBV4M!)JQ!7%?YMO(XVP9UBSM/G8AL
M(.KJW%&=E,$%]&K+YY;Z^6JSJ[[B^ISZHUJNX=>@P5^AMY([%57$V"CP%U:+
M'X:J0*4?'</FZR28-:'FL"[H&%4P'+]WRP.-0M7Z#-V.0-V;IW33;[KO*TSL
MWL>[_LSST#OLR;;S$LP]JC./H GY'Q%$AIG9/J4TU;EK=TS.D14HN755GY_P
ML:O&J]R^7G2ULSW2/9N>_M;D]*LWT2FVP<VZCR9_'-+:IW;4Z,N_W^#P'S:9
M&2L)1KI<@OD0'_J%*:0R-?&S'=QC2"KIORW$,O<5#2&;$U8#O76Y2.)2.1/1
M6QRXX3\K05R*HQY\.EK9?>MR9N&HBGK*TS;]"%IPGK,+AV X(^NM\KG]9F;&
M]YS7FY;?W?7FP<5-!\Y/%K^38*"]]LA*HB!=B$%CA@K55)P<0/(E"5^)2RPV
M?0#M>5+]^00"M,4T7\K.HTG=X.Y?)P)IJYT'QVYI1?.@8<*KT86B\E4E-S79
MQ \7@GZU@1Q$WJ(22N>ZZ?)-_FO3W4KQ*RI)Y$+)MTNHUS(1.(8S;OJ8F?"P
M:IRLU+I65C%?UI?LU*T-3L+=O#FU<E?=D&/3M46&XYI;VKUY!Q0F;L4@EGAN
M$H<^/!F]6(@;#4QI4"NR_*:(2G46;)V4X=%4*)L(T<Q7/9-2_ 3ZP/BMX7N&
M<=(B9X+<V*V*XIM;7BYH9?*8<E#^"=>00S/.J2R.(D.^@!)D4\WLH%J1@A3F
MA@](W=S:0$L@2-4L95-\1$,F#=AEU%WE@A2FPCVSS;@X,\O<$0*81$GYL36-
M<_#+@P7OK"XCXO,CW@57'I"B+4Z6I 3(CP?"=T?9TT#M60F&^UT_J&[_STQ2
M,?*)!EI/+:UXPYN2+?S6X>VN+7Y>7MFN9P!;!F4-Z DKTV@1#.<7'[+/[W&I
M7:](W1=]\?&C^8';@+O?L22K]6W&(]_C-L>].O(MT5+[PNT+R1NXMX_<Q'2,
M<_'0CMP& G0* .V _ER^BX]+2FSPT]!F0&TRP-?+NA,H#?35K@_5 8\4\U!+
M5%W.V1QFJRLVK=\_^.@FT6]97D!27<27]&(=[#<-9,5VU&5%N$G4NLL0:*G(
MC?KGXJE R"!3 28+TIH:TQIZ[IK)"@[U(&O>;CWV!=E$*:NSP#[X['M#W__4
MZQ#7PZ X_HU9TN#&>#>[PGMTO)?I;3S31??7F'AQG3L'_T=H'8U>'(XGFBL)
M)\05%H9C%G*E OF_\0JA.(K(NILJ58"+"@A^HF43&&+<:E.>P9M0_#;0MV1W
MU-2FB--/;F-'SMU>N;UH5-WPP>[GF\JJJZ4.6TD]>O3P]LNGBI^.8OZP>5<\
M\PJ%[(TFZ+V!]I#^?%,"M)TP*250$O:*RT)E*::U^/*F&(81.'\8<A48R@:G
M^P:?%6"C<$JG?*_ZNG>S]2UJ9_?2JS75ZSXW#@X2'2Y3AB)T4)YCI:[[RQ8D
MP^K%8'/M( [,C5W<7O (J+6:<V;H\NUDZQ.)MU+KQ7_8F9Y*LNS2#S1\Q3S\
MI6OPHZ#0ZFV[MJZAXM&7[_XB";&(K)K(CC(C7"RG[X'T8>E>=>-MV? 1*!A,
M\V:L*9#U#]QRCT]6I\0>A(!,*&(Y]7WG !0ZW^! ,B9OIVRL*HD@11E<B+>]
M>0!_9*@[X&;@OEFG<C=CN\MLY==OVCUJT)P^.-!M;#/\RMFN\V15BY)>Z>$7
MS7J7=JUZTUX\\P-*0)]N(3C_KAC:F,!JA71I+ F&[2%\6(H"BNB#-T!;11<Y
M5'\&U#!4G6]W1()IVE]\#_;%W]D"_IW6051T&MV/C?(-D#4_-FF0S62V\6JZ
M-KWIF"JBEXG/^=# ,W@,50;MZ@B\6'KG =*F]([&!LH26$RM0>AJG:VY"MHC
M1QEVY9&67N "*]B#7TLW3\50G77:^IHTSE?0,L5EYX)OZ@>,#F&PA>7?M<R@
M29#$(\=09;BT:+P20XF+5X9/=FYMM]#TSM 72-.>NE-Z'"NF[U;91T@P]!\5
ML6>[EF1@J@(+'KA_[#A<<N#'81EP!EGN*,(A[6DYR0)+9&6(Z 84V>2/=#$K
MEP)7O?&R1F]O+."7P<NA%48MR5-W&'MX!"E73DWLLS%WO38Z4W9LH3+=0RO;
M,X?H(O7X@U>^/?\T,,8!KU5.1)M,HD-]63M46T QM9VQV(M\XC<+4R UOKFI
MO<@QAF'"1U-5Y1K2PC.PX=MA-V+EK<J(22/3?3_";Y5FZ>N<N!#'QXCKGS,-
M &X<OO(2 72PA[9&3D@P(NLQD[8!ZJ$:<#9C!52[W-9)IQ+*XQ+[68C!:^.4
MSU:%196!1&Q40.>#O>IVIN?*DS=-]VDR'?[_4DX_1E<@0E;.B4)"VYDE";=K
MY&&\^#YPV<Y1^%2,LE*?!!5*+J^GEB97ZU?&0E9W4O<\<R$M<.)@M\M2I03O
M*N-'-SS[@4*(9$E_L\:=Q/Y>\4CNR_G;H>_:",,K"JBXQ?$;VB+!@.=;(9V_
M.>!) GNJ :^,F"R>B,C8+L UX16HROR!6RP>@64OKQ!5U9B0!>N_:@_(C]M:
MQ\Y^$EX;8C10E/S4A7*K6R.*3B)/4GRQYSKQ;3]OK\S.\W$)C<OU46\L#";E
MC+J<3>[.SALSZ6CR];R0VUN[N6MR\ONG3XFN;':_E<Z\TL?F]0Y'IDVE3EFQ
M$2*>.YS GFED2@,>0"2AE%S[/]A[\Z FTN]?."J*@A"534&(BHC*DAG9',!D
M7! 1,8H* D+<D"5BQ@6)$M(C" @(45&8@8&H"(@L$2& $!,A+"HBLDL0LJ"R
M2T<AM*33N<VWWK_>.[?J_MZJ7[UU;_E'4E0E]/GT.>?YG'.>]',.>YGK0_I<
M1\=K=!^T;@\*,_DR@ R1NLK9\<*WW2!MQIM3=4URM!@/E-N2U4.WN*W=%"0M
MR-C:O&#][[CWWG7X9/YBA !YT*^ AZ3XZ[R-T"9TO;[B>HNSSG2007A&;KE"
MWBXZ\O3*V9(-Y;>O>UNHM5_1693H\<QBXU1O7MR >8;TJ#CNUVJW,[=/)MJ-
M//]TX7'.^J6E"S)^,.6.R@SG>0I=Y U+384YPY_?USO"6 %9@*(=X-N>W =Q
MVW9Z=A3I#S:8;.@\=_-RL]4[3C$OOY@L.O;DU>2E;_M$FTPA,>@0BQJ4!#E:
MR&N5CYS=GC#:B7K &2)D5CE>.E@)A8-EJ$NJVZV<F@B2,F^6JS"5VQ=QSIMU
M^"9P78J"'?#2%Q>]9":WG_C1J+MEV'CG7Q^%L(+]:CHQR+AMO[=[=YB7PK6S
MR(YB?L74O<7^V\!LUZ.$1'?#C[ZO+2UE51;KXBUO:CQ5.\GN ='B;N$\5-5T
MI(T,GNM/C^:+<\C@?D"8-,A*1A;0;*3F<;9$H;K\!-0@K>'KT\B>8'ZB=>SU
MRK!UB\]2;?U])]:ULR>MIRY*L=@QP^Q4=HBPK.EDV"F4;,XPF=F+E 7\H,D8
MH)PJ\*OD@N:-K'B& 90@*3B3N,?:M -VRZUE6'Z]?]?R:4#(]]=VL9]6;'ZM
MU57>5AWGB5&O.N@";.&#_NP^@?QQ)52K^!6-=!N(XG]XIJEUY KBQ.V+UAPI
M._%RA&:8>2TUQO=23]V8%].+XZYHU0YUY%XUOV'G<>BHGUJG+4MC>$N6V:-.
M9Y=\[AI<^U^R1='AI^XG4_<X#OLWN1C>2Y<_):_Q/^<8D25_R0\,?/XZWF2[
M#E"XMC" G\+4 6ISLK6X4-05Z3:T"+90G  $/KP$_5Q<HU9$(P&(8Q/6%3]Y
MT3#=?>]D!6+- 3^W#-M7U&'U/4I&9D_VU:#6KY,"SP&Q""L,DL_*F-'$8/8'
M%0;1V"YA)93!=.4=PCJ'>.=MLI@F!E9F%LMN8,5[SWC+[2,JLIT[;?V).V7C
M0@([S]_8R?\9M[K+#K\TM-IR-C&]TN;5/*5.J&$*ZY'0XW%H>O?5L%B>X'SD
M8__M02&8M%UQ-G8M@J:E :?;75=0PT6F#ZU][JX29VL^7ON\(L,BB7(C)WM
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MSGHA]+R&Y5/=\^YN1W# FN[PI$BG8NJQ]].:,PE?US^_",-( UF#?QH/61C
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MQX5YF99W1C+>9?V2,NG>-3YYJ6_X.+<\>^5+8H8(,@-@?8K\1;F2$\Z&UO?
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MDV(ATT2TC,!S"1(T7K/^A%WRFJC*0IGY8'H3=B7MB=3VX,6(XEXH351[P!W
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M ?L[;UHXE,2E%@E[/^P$GK@O/>CKT^?3VQOBNSMS(2\K]X.PSX7#^XQRQWI
M7( #]UE=1#3B51B-!1* R0].4F'BB<^"!/P$7^_ZUF059CYL)W;ERK 32Z(D
M/UZ_YVY[0M]G8MO.O [;G*!L@Y"6I#K'V9:"@9W%K_;GY S?"4$MZXN-HV^3
M %K!B#;X-3E_>$ /E"><D+S0^;UC(J>RO?R%NGMITKZ.\B2G7?,WGK6<@M:6
M1_=[G]QNV+AHX3DT@KRAW@#$ R+AH'CR!C]8-!^H=0+$CP<LE7> TV1A1T/
M&IEK W#M*K/.PZ:I.O^Z-3?HBT!:!I8UC)4,"[.C9QR/.5Z^%A2>ZT_S"W!<
M:I$?2ECW(N7-HLR9"&3)A$*#O@95Z!^,-V0M%>;TW.GBT>KT6/H2DWS@"2V_
M?MTK6FHC@I=I357G)]#]V5J. ]T-^'"GUUY&D91@?2OBWK*.2Y_O#(Z?D5(Y
M(44/NFZ7<3H+C]_;>GR[8-/2?/7H1\L[EUVYCQWL&=Q_S0'6PR/:@1!)[*\]
M.G- R0+$MU48[!3;A*;"U ^L_IZ2QL)9AS^FN^32\%Z=V<+1 9$?H&N?'F27
MD72*D(6N]_HTL-7XK94E_T,@O47AP)BK(/#C\>KU>X @_%SR>\*\@6\HHKM
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MS]Y,W1[7_&A;^BZ_2VG'OJ2*PRZ4W7D:.\X!+W,F 5DXK64!H[J N2Q1D7Z
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M:\-(YV<?.*-9Y8H(OW[<$KB89I:#3+MUASZM>_6/^>>7:X:/32OYP;_007L
MJ[_)[).K3POP=/-7S_,@?@P0C%-VI^C,?JU..'VOK\E'OZ^TWN7IT)3+E7#_
M:_Z% ^-NU__>>]KNKG_DWFT=QS R,:(B$:D2FA@@F2/Q$I4&"3(\(-P;QDWV
MEI[\JIM>7HY%$W@MNS7CEE/DR_J'R,N&S[_O.+C]BH:_W\A0!':9X@%BC'3R
MEP""?N)-CAYPL<AFQP)&A[T&>6>!5P^[@6O.T;_?.(A--,,JC=>6,46*=6-_
MC[A_G'_(CP^9M>P8T;U]K?@02>7"@>R,?HZ@EOBSC"E!)_027_8[,/X>-B0>
M ;C*,[:6C2A!L"?W$WE1;;7>8_I;%%DF9LYG>NT=G+*MS]7T72;_&7;7>Y-_
M=<Z1K1T/XGF[-BU?-L 1_,VICEZ,7O@_L;>(E78EY*=!R 'H9$8Q)4*43G]\
MV$;'@@X9->ADHP2+Y&RA\J@P1U<W([[O'"O>\6E@2.7&)R/"9=@8-.J7H/H"
M&#PL,)*@U'7YC__LVVS6(JI58E/XE<1D227GCDY+RHP*1W.$:@<?CA:ED-4&
M2+67[NOGY8]]NMTY0T@:,>KYP0PU#95<MM&[%/+<T_A;$'L5ZF84K\4G^C>0
MX<5JG'1X.[;1Q*=3#RM<P*0I23:!6B*12#8YF,"[X1LBJ+]AY?1VCZ13!:\<
M[*-<T_M-9ECO_'PHN&WY/>Y:L9%\@W([&C!B,E&CR:C^9X#G7GL. NI48T76
MK!-^@"@]W/.C#.EZ,N2L10\7>D<W6:VX SE<*^"C&'KBQIEC1ZYX&%,#>R^I
M/>.7OZ[&(+&+!> 9X&EZ+ -T0H5* #H/K/9F%1-"8PJIR)U">(-7H^*O!"DE
MV6V#%S#GG6*?4 *.WYM\Z?FFE70E^GEPVXKNJ*,/2=<HTKZUY5YM<AEL*4U#
MC2['D\A*_:C47&&W'&GF5!!0!J\SYCJR!<0V$%)\G\().VY%%/**@B+Z8AN/
MBL\E>U_J%:E5%-3GZ/Q[_$- 5]AHC8\?LM;'@VV$VGH$+TCD5 2D7N@V9:^"
M^>*O_&2J6_Z[W?9"!=&G'.+<#+..]NJPK?-\%Q;FI#C:=L_CW0U+E_JX/QLE
M6Y /6V)T WVKJY-_-Y&(TE9M3?K#?LV^+6D[\^R7G/F]X]SZLYAB#&;)02PZ
M!$>9\)[74W(-@[-PM6POK1-%J2G461GP3NW)=L-)H@Y-Q6<P^/K\R=+<L<'2
MG 1<*G7'_#_164>JNV=5K=I]0,5P6Y?'NZ*@*';2LPE]_9[2,LDO++R;*->*
M%;E-]L@<Y:@4C8E WG J!A3/\60@.>H<,S&4B@.N1 0)4!VNT=WI:*:XUAP1
M1>WM<HPPN6WI.=OIS1^=-[V5RPTJ(EG=R3OWLOR^5-0J!6"] KEW-X(/XJ]"
M]-RIY%[6@T_AC!17G_6?)+2MP8-[7#]Y..2/T_;$O+<-1AJLG;R\+J*XF&X8
M/SBR-]<W$0>J@$K2]$7Q#OLA*HLR,Q8ND:U#FG/6*YALXT%8A$]@F[Z$RT5O
MZ_$WP 0A^Z&H5;*_P=5.IX8#$6,8D[63=MBJ"I*N!>-]UTQTQ,\SZGLJ,#2Z
MG*AX!0A&R;!1=6R&-%-1A@]H'["6)BNRY=M]>Q 32H#@]DD;HH"OK!TS=+H'
M5S:CDH@.H*K-^+[/=DQ2(85QO"LMVZ3WA5^'N+:&/&XL-5"\I*G2^,0*/(\P
MF"$XFA\9+< FZ9R_W^)7_*:J]GM\N,+J4CFD?7M6=C%R6X('*"W1D&I?6GVI
MBM&:-M[K85*8U#Y]5X0?&D+64B%\0N64:C 1/(H=D'I;-UJ9EN02F_!-SK^-
M;]HS&[UI1O8@L_>[^$3ZW#X;R[4OA]IU>59:R>=V3AJ/,F +->DA1>4"Y@)Q
M0%N<P.4,&0L+"L&T<;'XZUPJ39NR;<H+[*TN&!O1@W#Q,]5]WSJP/*OF&I*_
MO]WKP/>]UT8>W15NN+STCP]+?M7(U@/<*+R@E%A=E@JA$A=0_(/RI-N %H?$
M4)9?AM9F!(FSB0[U(/8-\29^R>7MK$Z6VD;JL>[O/3_:D^3>(J;&CM=YHS[8
MBDS==Y,VML43*H4C]OXV!D_NHY0=G<^SZ.2Z(-TY6O!B2NHWL"4XT02L0/91
MCD^[P!%0@-0';#V_@ F $XY7L_$#GOO[V_08*65EE6Z=+.=H7H94YV3-$P6'
MT#OSBSPSX._(1!=CMH6%HW *WKWR:7KZNV>?D9Y:Y]2V^8:4B"O^?GZBFLG2
M'?^J_>9$<IS5^X,4Z)%\V&1VJ%FS\._J7/1_!ZY+YZ+H\@U:O>.K0D/*\&15
MG1'1:K''A9R12+GN9O#XG5642W<>I%N\KP7?)&-ZH!;) 10)7>5'0!:GTHV+
M'XB5NJ%$U,GEA9TM2)_DB+*RL.N03]?@E:L+NL,D1HV'3W>;H4.Y&D@,VQ@R
M&&+5<K9S2E*&Z_BSZWF9QA!W?O%!.@$=E7Q/M#L>>+]\>+J$8DR 21"!:V?7
MQ]:B>H,[[D=? 9X$C>SJ*#5KN\#S #_/M>]8K'NQ,K8T:'K(]'';-5*)YT14
M4/HWZU4_OBO"7RTQ,3J[1-/DBW+QTC@5W17**S'HST;,6F,898JQU@A1%>"Z
M7""F[T1U]NLU#AODY4?MN.*[B:+S#AL;BH6:1WO.C19CE$;Y\@V%B#)=YD@;
M0-'B# #O-IID0I=:A;.,!OZ >F-MZ%TPFVHBE)5:-N[H)>O"A;S[U4GA*:G'
M)>%)_N4=$L,5>R8;W59ZYW;$&Z!6UJ!&7L 'J0VXH1(+)UM*XQ)?IE?([)$^
MOK[9QLKA_9[0T8<B75Q<CDI7N'7VR8_<SOD1717<AO',,!V4["?6G[;)_)$M
MY"@%KAO\/)'118@TR<[X;B37_;J V86V'C.]@.F??0J,]T*SM+N+6(PBRFO\
MV@7,1?)@P'%%"OX2BI,B2XE$%LZ^K_>9KXQH#KU;H[^4?N9%BH?W_D;]+5WU
MMB+.>L?G3L(D8F-&%#:A'A^^HN!>+[UL?/ W_O:[-VG7Y60%"VUWE  ;$7C6
MBZ\K*N##,NW%:MT5<[>2"9 ?E[C:QQO?Q%X/SKY+4X./DV=-#&16XWW.Y:\>
M^M:P.R5RYQ"_J]+[P1; 0)L-;_Z>(H43O(!)(%9K3]:!1&D1[&H:(M>%[G.C
M(I)#S+)^^6:=!4?R=Y)"HAMJ&]/YHY(22H!G-:<C7#MVKV.X__:_[ZOGXEO)
MDGR9$\!]AV71)QFR$X%LE!W%7*.]6\"\C)B<?49="6=<@?83X5R(X S?A=9B
M5[C#Y-/=-@2E>-9KXY:,?<Q$(W"<L#*SMH5WH-2W.\_R=+!%Q+[&%S=0/UWY
M9+^E?+V!]/+G#_T07[(N[XJ1,D?/YOK2._?CEMU46O;BL=KHM__+4[K_;XG/
M_ZTTQS3*,5:B(>Y=&NT31TKEZ.%GN@3'D0S2Q*LYQ$E_RP*F/(Z@V+9R(WDN
MBB@X9*_A]C8K[K^M%D(["'"OX@6Y57S0>0HV:F]BI-1JY6XFZE##+]/6T]H'
MSX9B3]?#N6*25Y:Q2>C'CLWG3^8H=S;GB=YY[LPGL,:N:UUESH?Y<H@3, -^
MU8[&M44R'V.# R]]8JC3&O#@<<L;0,O41LN1]1"_.<O[I!*GJTSW73<KY.!X
MSF]=>ZA[7[1+K]> [;?DQ[;=]9PR73*_^ !F)<KZN#8_.'^BL-4>6PC?\OV-
MUH%GM7W&8^ULQCV3WX>_FF5H#-XH:<A1[_[&\.<Y"_%KO9MQN37QUO_8.);
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M#:S1R@<5N(XW0#V1" YA^<.[8/QH-F'&=+N] J=.:T<OQ_T&_ WX&_ WX&_
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M8BQMF/IK"Q7+)*0T3OD$^O"9QV34OQ;[G'D_7X&[S8WCC)]U5.!"=D# ]RF
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M0)Q5+F"59U@QE"=PST>:G$/-;P+Y;<&Y[P8#LS;US4J>7F57=YFIV$EU@0/
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MR<?@"7/WQ#NE9P>\AL;3^S*"+WKWFF;49.RWOB]2>_],872F@0*9X1$E<9#
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MJNV+O4GS*($*:T>P Y,X6.N;YB^I3V\9EUSKMK]8_OO$I]W;%(;N?D7YV?(
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M/-"XIOOY^_;W(M%K/I[+AM<LY9M$<8)&(&/N%.K+RW*@ L+W N9; SYEBEQ
M<RF%-/D1P<Z@7PP!*/9/Y;V/N;M\MGI-=4A;@+M=78+ 46]OT(<[ V^I'LY5
M9<EO/,DGTTOHS41E4RZT=0Y>'R8D009C4Y6/J1]:)=_)<H@^#,BKFETO"F].
MGXNG&8'<EFK/_H0G02$FJGGE(30>S> $6"FZF\/=$KKK+53[L>N=IX?;^ 3S
M"1-TQD.;I_!LA1;@9Z!R[ 639]N*+V6+2J26;J2/1"S=BJK]71?\_<IL@?5)
MC^X0 4<+HISXK;O[=!7[QAFQ6N4=1OC6HK?0#;>ND @3EV[*P54^0/U>#C_)
M=:3,0J0A=I8(906<0*(.?1!?-=."5VODR_R$8PFPR2/(JG%8&;QG24O+T@6Q
MT5=?4LYUG?LMY7CDH A'2]=+6W%;Y]A3\$U6\K#CM26S"[7SVD+C%)"%*/E*
M 8CC_EMI12EEP'D4'Y7J>8!:4C)X DKDR^P%PXR+98Y7 F.F/[N*3R?F,14S
M7O_&R>(-KWVR]:[1>V@IHN8-A1;3B.@(-**W6UCVYGZ);FW"J\/>4"S9K\"C
MG7Q%+Z6(YBC68^2<;5TFD7R*2'#IKE )(A]GSHF]QN<3*[]4-J7V?QLEQD.6
M)L+^6S2*="^\L/#U/*Q,_<+E81%E77%_?992!1A=4M*73^.H$+2+>50&2;PB
MFYP?EG;]6J*?<)*B-&&!*Z[ZW&#*P%*S#C^\/=Z_QQTX(,>4S;TP4::_DF/*
MTU[,#+!?S.'NSD0A"FC/NC:JH:Y_YC>'=M+),I!^PS?;./_QV5:U6N= W/W4
M,M*PJ99$(L?X/[OM,5BOF+0%,W?]/[P(F<$:")6\D:5RSI,@8P#6,FD"*I@M
M,TMI>IT$+YO55$JC.^-6R!Z?H.+).OR1F9"2'>W9\=YSZ2%YV3Y7@M5/&VJ^
M#DK>0_)KH-(.F1B/$FRTHB\Z7K]O9>><'9MKV7NA#T@Y4N"<O^ZXXR%C].NE
M1=D%S?=KN2O_Z'&MO%Z5C&@>9]E*ES_B[. (YA:J0&;F;1@_DZ#ON7+,[Z>
MQADT**>,S$;@O^& V4PYYG91DQSC B4@4?NXB,ZN.M+L:+NVJ$".X?)(T&[B
MV(>ZSU]<XN'':*)".5:] >?CO,UR0&"/CL:-:*C HNDBT@GHG*4ME,<G <B!
M;)F'T&1^U1@1NMCR%>AFF.KQ&+ L%V4@FQ$Z>89XVI_UB@6A/0*O#D<8V7Q7
M9$VP'/-)$P^B8A?:,B?#V[]@P=O&Y)@_=A![ZS;),0]7HF^(>4U)D^W]O/\_
M!MILJ# TT@C1IYE#T:!P&HG8T2]4^!D^PT_(/-FW+;^Z.PAV?3"!4^V7=#A*
M[^67)\F>;(PG#1W9$IA,B^H?X\"K28A2 G\$VJHPU09(S= LPHRG&P>DIS41
M5\$'F$W#AIU7$U=(=)[31XY71I@/M]J'/91NK;U^\4>E"UEG_D@/"#L<=>6)
M*VRSD'I176W?"1JB66>?'/-5F?%GK9P840<Z8M'_-UZP:$/NASV0] !C(A-X
M'?[S9U+8?)$=_?2?C)^"/S4_4B+6EBD&,V%S'QIGO#4=&V2/T+O0M_TBQQ#-
MYIB/*US?+T);A+8(;1':(K1%:(O0_DVA%=K#6E)$B7 8#P[AOSE$?2E>_X*^
M9>"'"*<U0!'-5HXYL![E0VJ_CIC,7_EP8Q#E7<P*#G@>X+9'C(VQ85P_RL+W
M25&-,/ )OHJ2:Z>?#><]6:/:B-H42L]^01I0]<">^D7,>C%282+: [8*[!-J
M;:5G84]Q7\(#:KE;N)'M23#I>1YTP A/JKJYX5?K:#@]8L)6?[_1)?[/+4 8
M\,\\]_27LY3;8[\F[>22SWVZV/<<]^O75YGN^^C&N9:_7,F[\_#DFK.^VA'K
M/;PN[ VLN*M\I#<O/=)Q7[.IU SXE^U*8\VSFTBS&]\ X$#B)SDF7\]_\._-
M,%&B^?7TG_)1!+^POUN6')/]$=*48Z+7HW>/MO^G^UE7XK]*4=F_PAZ&^X?I
MCSM)=TE_1DG_C/ 7T>S^VSY:!+<(;A'<WX&CO?>1;D+:W?U$6XOH;RU)]5R%
M *#B#4>@""\78F^E^^:V,(5RS"KJH;4710\[S;Y.33\HZQ,)V-U7!ZF^O3NG
MIQ_>.-:]*4G@TUV<BDV48_Z:$"_X)QVN4)6-1OH @/\["C!=RNUU-_Q4].<F
M^O-P]842Q_EH>Q]%4*[S7HXY3N@(#R1^EJ0AJHRO7UFULM-_?9I@$=T_HF/=
M1_;0?Q\I)XG41RE13'7Z7G@]2&G&KX45Q4NI+(%6R:B*5:([\1OH;GY9-6[Z
MEUS'8%D2+R<4%W*GP\MK?"[8XWE%T%+[&\S$?^-6_GOWP2*Z173_X>C>C"#*
M,CEFVW-9#6>*1]>78\;CKS<N["PFQ[S:*<=XFT@W65H@][\$PO*%*?M[J #P
M!/CI<LQ:]+.8S"J%AI$84A6^GKN.ME\\]H*"I_K5(VLZ*P?\>FOWLR;2"1T!
M\UY,%?>6LB'/-VWKCWKN]^DK(_)3 =!E!M*?J7>"#)A3]\ B(5,$@.'UQ%4P
M%DQSZ"1X"*PIGJEJ'OM['_28;==_VK/!X8R685R7V[N":U\]=0C"NMSS^\;F
MDT$YYNT JP^O>8#]%.$V2RD^LE^VA9/\IL)D3*L3DM3W8X$6=3$V?6E]&I([
MHBEW#B$H=&\%*]RSY"0Q%_>O]4R=QS].X0;]QTP(+T);A+8([7\6FLU+\=@4
M0VI..PZ]!VLD:>*1^A$%*'9TK)Y,'C2)EF,TIX,N!<$^ A5=NTO)<TZE/5/&
M);@QIV<>@R_Z<,E> S^'!I=I?GX_-.O[GS8QLPCMOX,FL9Z;NBDUG>!4I*9(
M?PCDK(!U'B/=E@I1I!=T/-3Z^,R[0!L3-'-%Y<9\&O;4_BY+,A%NM'K8WTSW
MJ%)>UU2)\?O8DSV/D@4I)VK/($G_KL/_W]@S%Z$M0OO_!XW\M0%]D<GYH[D.
M*\<,"!$N9S[Y)>GJG]4[@".(RL*R50-9E!P3" QL%O@US@Q\EMR'2&+GEG1
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MLWJ+,!9A+,)8A+$(8Q'&(HS_7!A86.,RT)ZZ4-;<H'&<U7%]&_+N#>?CE71
MT*@MQ[3=&#@IQS"ORC&@HAR3EBQEO/$T1)0TY)AEKSN-<BJZ.=Z,GSKW;_ET
MMIHK4)RYWVYL\31U7OC!U[G">^LOWL>O;?ICS G1W8^^?U".R=X)+4'%HWXF
MZ<&L<]CTM4'*WG:/</:OWH/TDCZLKP,2@;;^Q6;$RV&::$,4].!!1\[\;NY/
M>.A 0,\_&*!H5B^>]'?<Z'+X#M+G:2:R!/_I$^G*5S%JR <H)0Z28SI3:?^G
M?=E_"N5[V6^90,>H*2J*8TS05BJ4H1S99AREP.IRC,G6.3P3#TY@(?T1V3J_
M%UAXH^G$/V#KG<?:X1>Q+&)9Q+*(91'+(I9%+/_KL619 . 1 -(O$96T9[9.
MN8)*)=/\U.$01KWY92N[W7=N;P$)S@W-1U1V[K;?@;^GZ[;4CO6WQ2M%OD'+
M<SD+%_Q0=7-C-*G>/+BZY88R+F#X2.X/EK5E5FP7[S!6Q\1V.>;2V#6VI(5,
M'A[AK:TAD0<'W243_P]O9'#_D6?^HWUD"H_2_E?3WT48BS 682S"6(2Q"&,1
MQO\XC(<9B-(>E#SU9T[EI$B,($6\4\_LD'>G$/0L5M/*SO&R*PCXG!IY^'6A
MVCOUHY+N=4:7OOGJ>J)=Q31H7L=.A?"FKVAON\9TN2I)CC'^^PFB36QV9)>B
M4= /,3P>;ZU(5%(R>O@'=N0:-T&DHL_II&W>B2Y[1Q-/JVN>/K7MF]Q'\9_:
ML?*!_P)02P,$%     @ ^85:6K;J-*%?T@< 9=\( !$   !I;6<Q,C@W-C<V
M-%\U+FIP9^RX=S#<4?PNO(*($$*(;D6)3M3H2Q(]B!Y=HO>R>EF]M^@A2A M
M6O1.]"!L6&RL;I6PVJJ+M5Z_WWOGWGEGWC_>N?>=>^?.W#/S_/4]WS/G.>7Y
M/,^Y_7N["GBLIJ2J!,"[AX?'@L<" -PN %X#\/X'VW\,\C\Z!M[M3P#% _P5
MHF?X>*R >Q1X^!1XMX, ( " 1_A_=P#\EX9W#Y^ \#[1 ^*')'<=FA\#[N'A
MX]\CP"<D)""X^QI\]QU 0$%(^4Q(X?X3[0]$K!Y4PF&I10_87M7W4>M,';&+
M?/0,)W[XE(:6CI[C.2<7-X^HF/A+"4FIUV\4E9155-5T]?0-#-\;&5M9V]C:
MV3LX@KV\?7S]_ ,B(J.B8V+CXM/2,S*SLC_GY!:7?"LM*Z^H_-[0V-3<TMK6
MWM$_,#@T//)K=&P:-C,[!_\[CUA;1VYL;FW_V]E%'Y^<GIU?8"ZO_H,7'@#_
MOU+_?^5%<<?K'@$!/@'1?_#"N^?['QTH" B?"=VG5- F^N#QA%4X[ '5J]2B
M^CYB-A&=(^J/GE,/G[*+KG&@_X/:?S+[_T8L_+^+V7\E]M]X(0"D^'AWFX=/
M 0 !<#BNXGC _\'_ 5=9V]B/\PH*R3/0UUN 7--T]UES[ZK%":P]8U=B5%'Y
M2V=W36OZX8IF9_$$]>-GJ@?!'<%<1 +D;V\!T=P@?O6$C,Q+Y^X0$_];0.:H
M?9D(7NH*$'J%S*TPLN80?O%"%91R=@N0E=>\H<:V$ KZ<POH7:3[MA:>W@*$
MSZ@UK+1A>1= 9#J.ZIR.0$^R:0^)N07\9-RD7<@\66G)I\XV.W1+M8V?&.>2
M5DE(_YV'?SIZ"\!?!+X?/%:^!?"OV\BXFLN/M.W *E;!<RD.FYCDW$IIR/[P
MC9LWK.$$_GV_LD;QH_]X6X*OZNL6:VOI3),?,NY^,B%GWR_2<R*>FK_S* ##
M8*?(@K-OIN;'C3"E3ER(KZXR07Y>[FE"R'>!*2/">%,M^F'D)K"'][J9J%U"
MDDGJ=*? X2UAMLB+/"NV,29E A_4/^EXWYB3R_U-2$JYA>B?C(\XF+K6C^7:
M94CP+4#$.'[\%>!OUG'4,!X+,O4G]&UP\$Z#VH^D>++SU31AHDO&/'+3T]4+
MIN[]0UAS88A<-E7QWN*3O+1>_G8+5)W+@9/V>]W8-X[3PH=LS\!_(F#8[176
M+.ZN?S\?# J^DK+VPM9/V.^4DOF-YYA#U9W*OQS6)IA?Q^=+31?QG'%+.01G
M\W9?S_MJ(KYD&$IZU4LIGX^61"M^G"M[]<3K,Q*PVMJ&+\M]/FG9]\F_0?67
M4#)((%\8DIEAI:.YF.L6>+<=K>L:W$K5'+P+V<4:."F3;9CNU^(&S]1%F[!G
M, )?AD[F;C(1;.71 FV68=)/0U/2XY"!%,U@60?-HYV0_(Z0W!]%$GJ]?.E.
MQ7 3!,(;KC$AQ1-?1G%?(<BF'I7^-S7E9$B"4V8U9>064&/T/>DFP<4M,!#;
MQ#%6G"W8X(-S=9$*\9WP/C M_OR$(5AAX^H6<'>B>((=6\P>W8OG^OK?4"F:
M&#OYM9*49NN?9P 2FX?$GTD6B\OYN]&P74<D&RJ*YQI?)D &^;#!>B;LD7?U
M9,3TXO1[_VJ?^S-]X9NO=/CE/++"RJ]WS@[EZ9L,U'Y=(P@O;>A\^:=*</^
MRVPI W.E2Z(?-BTU.A*KW\M9CICBRK'V^$KQ93 \5\XX8DY:<U6Z/659O(GW
M";^Y2".?RAR] ,@2S86R%\=S ?[WA=,IZ@\.,G,_WRS;\*\W-7[^KJ8$X&04
M^!G+TS#(>#92]P$;>^./BF>KQ1TB<4HBE6)8*<B4K\[F\LI2,,XXE\I W23N
MM8M+)]F##TE_H6^1J+-O3U@+V4TT4@L+@=S;C!M>N$)YPN/RIKI_W6(KT*O&
MA_J<G(Y-^=13[>"7K9KO=VHOQ/Y5R_/#)PRR0,)O@XK:B6H?( O=:MB/WT;3
M9HG;YRCP?<WSV4#^D&1#3\@I>K6G=;:,=W=>Y8Z54O/RY(T:[RO,FR]]06QM
M4G\:?=29%GJ9_)E.EGA20L:C8"D@ (:894]Z-(Q?& 3))R="8;1'J;M.8?9+
MJ,V)JVPB)2WC&GXQO86 !74PO^MU;H:!V*". NW#&G9(K+#''U+T+HC'_O,#
MO"3ZQ0+:,0!J)N]TA+E@N+$"^0#,#79R,H:67O3 +Q<\]#)Y'%X:7&3SMQOO
M5\&#?<YF%HH;^,>*GSJD^4I())ZD_K$,]KA$#W,3N$G:9F_&6G]:%&(Y(KH%
MU/7XE9.HFG4&U97N+X4,S'N_J-&'53U\E](,=C![R<!I%^@Y=GWQSUG[_8OL
MCM;G;WF_#3UF%OZZRAA,%K -2P:8U5@_*/3[Q$$[.N(J[>XO<3I"E"^;Y^\&
M/70Z.#YO-=GI_:#DE_.Q).:JIH1WN:JJN*%W8.\,=CU\1IU8+_TR5V7 4T*&
M3!Y85P=*LA]Y.KL:K@4J_!B2:>TE9CM[[M.[O?)QB%J?(.KO"P#@!:0W.D O
M2@TIL17JX-L;?'H]6O']DKFX6M=G>O+F= $[M'+5$WM7=^2IM!4!_PE=NM!?
M^![XGZ3)0]3*4)S/I]\05?%ZCC#Y@;9GWA%>\<JR+V[:1,L?/TK&]*>.O$5?
M>IP!='AD/!^\J?],#'H.<9<EOI"$PM!?']'S?&]XM<61%'WXN54;I^QH\[M!
M<?-26YK&/5&>TUY6%14JZ\EU;Y\Z7Y#;@QI&%)K(5.BOE[Q=OW,*G?M6KZK#
M)UVB.#+?GVP@T/>E'8OKKKBW3Z4M3_B_  \T\>0RZ3R5\9DO*VE=";R@'G-%
MB,>6E%KF?_%A5SA1CF *X0PKM,\^[.IU0,#)&0@9[SZI)'5>^HL G;H@@7KK
M<,_RF/B7!"/$8L.NC,MQ(6)0:8+7>WHYOV[ER"J?C+PWZ$8V.+BG.9^U0TX9
MTO83&M#)G@X@_: I?XVAG7C)]]-: (=AHST?"?D 8XXA+&T^R-[97-D$YU:7
M&E!&RG$>S4N7HVZ\6)/RDLL3/6;(+6J),+""MZ3IB?B7R'2,]WF9!GMJYK%,
M?F6Z^W'+K,("P1&(,3'BK X?DXV^[BNXK^H\%YBD96II0"+](&E==#$4.+;H
M<[CK,5WL*!XP;Z$\!S_=3:Z^3^F6J7F"V+GY@H"[W@)"BO9U-7OMP!Y28Q'@
MIS[Z?[]NMQ/A7Y$/#&(_H _7?$-+VE*,T(3E"*3!4!933MX]'QN\[46[D[H<
M!D7,-?IJSW1%Z,@WQE@K2^/Y@8ET=#.!BUUB)L>2I"7X).#\+(4,,@HBK^:(
M=U'7F\'J?A]\_5:LU*3B;;ZFN?S/</!D")XIS,5X;-SZ%K#J>]B#<B$/X"57
MX)I)[\F;2IGOSM6H$FW"9 MJZ?XZ['4QJ>ILMSRB"7L^Q]^:Z;":]H8,N\\N
MC =U&TPT>'0Q#$54#3VY?P3MYS=>IGFGXU<;,T:.MDS^?$9]]:C$#[]/BKK+
M(*O@R=%-92+ >'EX\2GO3[MG(FVIJ-.+O=76EA:VO1\CKD4^D9$$;\D*N5:1
MB\"YQLTJ\5S7,03_]$ISH7G9IW5&9FJU#$\LOQ&_;.G[=C43I^<'B.O3:;@J
M,..I+[!ELJCF8$;T)E =]BU5<9"?5?C!=6)$ 6X1)[;HEZYV4TVC05[L&+ (
M)KRT2JQ595(&;?B<UDU;2'EEI,<8]O_XJ ( _]P_98.C=!-=ET:)/K4C@=L+
M1Z5[WV7=!#41_&<M2QU)'C;D5T\M#>#-XNE3G*6M9@S=:3TUP P$,/X6X (D
M,U%!Q$2+K5!DVBULJ<5U)H/(0'S'CI&%+<#A0\+E 9H4',6N5! WRTGM5IOM
MNZ]Y]0]J\LC\D%^'("W1.B_&A'8F06\-^>O\W 8"!A9JR]=N1 P6,1[!3HP#
M!+[+U>0ZFGK)DL-":GJ[_1.J=8&E</U@.8AA<RI,.?[%M#[K<=X3?5889(R_
MM+SKBZ&!L9D8K C-.;"R %]MC3][,QWTNMKXGW&ZT&LWB<+-3V>$.7K>,GEY
M5Y:&B (:-# &J^B(J(LY&W=YU:_G)CCF]XL]L1(HOF=YP;P\>\(YM/*W<_5B
ML/71_12'-?5+G=?GW?<GEZ>]/YU^8"W.GY=MO[)+F;@%,.(F>YL-]TJ_CZY;
MA$DMER,G!.[99JN@!<IELN(<R2[II;V<:?1HY:GR/')W"I[KV;=J+\OB#K/B
M$<87ISX[R21<$_8<6C2Z)'&55'/,:C/5WUIZ)\#<_KO5D!&L3L<+/TX=..5F
M2=?131,BO/AFYZ&7.9F2.P 7S$NRFC+D(KAN%Z6SK9$O(.;R7#0:1VUI'>_#
M3NWNOP.5\9CKE8'@05:,B88ZK^LB;P%/JRWZ013T0C;5\Q;&<H4EJELV%"ZN
MM>???B^ZZG/2,9(:<A\QC!C> NZ#'"V>8AB7%3C#@QQJELPX;@$%-6X.CSJD
ME5J.N8\S:5?=/1*MRIR2L\"*[!LS&65?SQH3&AJ<7%H/:CN8]-M>TD2.HR3^
M@"&3!:S4W".%!8DS'_PFN<%BNDH%5;E[-_D&C[D"RQ;WD("S5YKBZ'^:$A=R
MF8ZJ10D? C/CK%EX*-MD)39N)$>F>RR/H",3TCK=Z$?#Y>!RA;6EIQH*N 6^
MJ>H&$G';>\+[,0(EFR07<0#K5<,(/W5D0?FU.E:M4 T3($;B1H*!K#WOF;&+
M-N$J#6,_WCI^SJ+,ZTH' $YV9K&*95AG&&>-\O;D[NSN-UCXGZA'>^0X9JK-
M;#]T?%@N/27&GFN0AIGM1J&8!$O@IS8DKNQ"-C(1T+<^T!DOU%Q-V;ITH99I
M2$%AII6#A5U3R]/'XV(#\X3)JEL$V<X %4^(FR<YTH1BM).(5O;F<B,D#W>_
M.?*)IGJK!4JC]:!IUR^SWOV\8 RQ##?I- GF/[$(\8]@3"P0EI72:S:#0H<7
M&7V!&R=[GN#</$^\LWLUW](<EE$6G.67N6(V-$LA%I^;M!55GRE2O<.[ Z&O
M4L:^=S^9IL<H8P2.J3M@5L2#8+J[XC-Q#7P"#',DVS@%!&Q3H>H?IZJ/"[>^
MJP]7.)T$05$6-+BEE::ZZ-X[00R%B& RJ\U*RSJK[#NRHM:X\KZ70F/I)Y:'
M^=(8P-)*#&YL+&%#@."\!,:PC2SOKK 1^;'QQV>7Y#/,GN2<U.]K?GD0=IE8
M>70+- YRP^RA%1=7/G6C@AAV1>@(B#F(I@=SB>Y\WY$JQ[V@ZO_-_GB7TA2Q
MXW,.]W0-]./XZ)*Y]NJEY7WGQ.UX;,<M('S^%M#WDYGR)J>+8=TB%-BP6=N^
M#D50KN][H3V>9ON*)Y2.4 TSG'W1;13(:GQ3FF^@9/"QG9:."N_&=+#AGGAF
MIZN(%Y/6*^$8!Q:*,T:RC)7G_J[JP5W4B5LF++_^OB,?NU9EXV22I\;<I=[[
M5U@[3!7ZXIRX$7TQ[.)Y:(@VKT-JV!P(U+IM=+:U/,E(K9YS,%H6#7]%*2J!
M$!;J8QL*<00B0,B4/85; .%]S =0[)GZQ.OS0,P*DC?X^=:A=G>N];37/VJ9
M2\O$WG2:WYN>\D1,EZ)X-XRC[.Y<J2G99"\&&._+D(9->BH14?-W2'%"N;/9
M&^II^POTR"VE#&6+4 BM.*\:0?,I@?69)A %0KEBY\)RB]OEFZ)U)O'J?=('
M=*L;/C7_C/3=(QO"E2=VI<+V=X9E"0'&_^OSQG\O'/@+ &S8ZWB -YL5\*76
MR8Z:%.G9H;9&:&2:/',$9^$MP/!REWZV=.EK0X!L 2Y<TBQ2L/UPYU!?:1VB
MHVR:K.1Q"2$J??%KG"K]%C!.H#-QLT=Z &#&7CVLM*DH_>,4->@3*SP-S>@_
M*5!Y>%\9-4&I*LT9Z(;:D+/1X-"4@3=?.,Z9&-^(GYSRU=KR&0IE.%/37?Z"
MFM_< K(9IU7Y&MX,*SWU4"+V3ZBXU /WR7B!RF70)[U#Y BB@8+[:>HN$A.5
M3D;<+BX.%!UA^<FS)[G\"Q!GZ_1,QM.=DYJMG&LEK)=7^UP!D,A/4^DW^)_O
ML8F%*K$DL[5)!.6[C43O$;F<$U1QKY-;" I[X#/5KT55HYN589Z=[CB^!#.<
MNS'/KP[61EHD]1('43"B:OSNU /WPJ>2[% D$5LROBA40!8(ATIE[X\41XOW
MT/VY!;2>8^ME;-]?[*^YDUJ"1T(&#777M.9I^MX-IV%B]&9E7@N'+IQYFZ29
M)"VV<1)L> 98R3K]<WFR!ARH>8B0#@0]^&<]3,4W4=ZWU4)$D!\: 94[2S]/
M#QI=<('G+QT&XL11BP<IY^9X,K+&%N_SC#-QU($<-OQ/5-T"JR[^8@I B#HD
M<VO%_C2$='GQ-6M4LDT[BT" ZJ_M&7<1,[8@)\SYK_KQH\YWE$_Z7@*"B>!$
M^(SPQ3]^5J^;+<]SO4OK 8!G4>\ $GM$M%>SC:5&Z>GTV\GQLD*8ZVW0>G>^
MUE:@P-7.\;S#UE)3^RPIG,>TTO+K7N=KI;R@VAL?@V.0[)D;@A=Y&&,@Z=KS
M9/?)0BBQKL=/BX]X$M@ GU7;N)ON%16O5O0M8&!>1J[+/TV+K\%9NR^(E7D
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M^Z"PNN-M:MFW-H'G!JW(GFH7,:<S;'@\U_?'VHI4 &T-]@T T=L3-4\BQEQ
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M-?G):MU_B_,3P]A<*]Y)L")6N1JS&"2) ;F[!2TTP7YG\0A 3CZKV^!]&"4
MCG47KM7MI:.EUR%)-/%=ONN=23Q;.+$<R]S 3KOQT)_.2@!W?R1^&Q%=.9GJ
MB6A6BT]WA].% .+ 7<U5-TD@5>V\9_0NG?:='2NC%,M:OSH*IS2@<C46%#..
M:YI)'#P#7?73V2.@@-PIHP,; J6X]O>I>5$\4H\#MRNP0A;1*TP00JSS3?:I
M?P\+!C@(EQI.M>,#FRL\63+KI)P?-FU9Y))AQ/]K6((; QUI+P!C.[H+(V7\
MN:;._ F,/9D4TA9'W=4&([E9ZFVQ&MR.*Q:@U#_(<9N2*9?:W5M "/C\OE.8
M"T&V[[#$>I*OD &#"G[^8$%>8#*A?_#VL&!,[IOC6X"]7S2"VT";<B'ALPGI
MMKV%X-T",G5X3'C)R=PQ>W@Q2#GT(K]DVJ: [H-K]5AUE%J:/ZG*&='SWDRW
M."!%[3Z$$[6M/^OV5!9D]C%K_4#OTJK09ZFS_B_^IQ"I5.#<FX#]R [3@%;$
MWKZSS3WK7/^2J+=\^+RN'ZDV5>1B9*_@2:A;0!.\'T1FH6H54J?,,6CG/.&,
MGJ IOQI*=P($1Y/7&6.A1R&#;K&%S>0QIQ9$&.XZKZ6'RV/38]OO/CQ+N!"J
MUFG4 ,I]2YNGW>J^!;R]*RE^F !9BAJQNL=BN&91ER_U_N[4F^G\QS$N@U6,
MUJ2,'KD5B*M.7M]6O1CJI_N<UK> W]=L [V,=W5N^/W^J2P$GWV):ISJ3?K?
MT#TP"G92IR_PB4?=>0I*4*2<0T>F>;"94?#U"D>WWIN;@E!?,QRLFY<VI5^.
MJS3/%X2>%']@/RA[]AR/5-7T+E++-5_I7A-"9J>PQK /1RV=?HV.4PMN"^RA
MO:/T*1V: 86X'@]=;5F=SH7@JWNEU +>-?DWRYT.;A@0O]$^L*5P, ='C^6?
M8Y^B*(=W*5N!K<K[Z+,<RA&OONI=QHU[X4O\1.9>EI]K8)3+@V2.; O13NM#
MZT9^"</BZ-US U\PBQ]!^PD%VQ=*3E(Y\Q</H-J%G=C HW#X.C#NE'??1T@N
M?\WI;&;?98-./<W=^,4#GLO5#]%".T,0A[MCK1FDZ/O5T8)\_W1)WOY\KL.[
MWVBG7C+T\PC#&^T,W43F=K%Q+M3OM"T3SL"7WH&HS1"SH)00DD%J=]'N^+P,
MLXQ-.F-7*?:,3A.E_:/R%M0LR$$P,E=Y*/@>?/UE_T(S?5;8=Q-3QQ=&8ZD,
M7Z0Y1<Q*1BB6.#^'1A-)-V+(2R T?H4#.!$,6S5*2B[S:4*UL7WK4_A4Z=?&
MX//8CP(##[<#V838+=,++H'T(7TBS3M=5N6.YQT%Q:TQWKNC-J(U;*J/+3Y'
M>BH]@++[#FM TG>72::#0*M0ID7[EG(MDWW*7?$6ED>11'S75"[OMCE#A25K
M*G6;-Y ,S;;535M.>G76I_6U+V._?_S7'Y^O^=[S>-G\6@VAL3-1>G"U$]R,
M<Y!CQ32GK]=^Y>S,MXLP4GS.JC;^)93XTW9!%T3L1B:((7<W) I'FBLCD2T/
M,S,:78IPHY/;CMB_@J/7T(%#V>) 6ADS&P>6K"NH*<FC#NSTVW'Q/:6N[=1P
M25 4!.9'?MZ'N5Y;P?-3&M# F*Q/J T_$M%LI<FZ<D@#\KU):+<8=^;&YRQT
M=:K*]*RH_2*'0%EM\<Q4<K>+(KI;>\X/IW&%.==:,AJ\X?0V[5H%HAMO)K#/
M8I%TJ$+-F.9Z_PUE^B7EZW-:[ZB7%2#M7/1A^+(T&CA(3K!S=1CKA4HBTN[F
M"T?@@,\MD;1FGXDD)7Y2;Q0V$^UKK]7-7_2W?CDH:D._EE]?9D\31DE(C&2-
M2(XR>A+--7AL^AS6%L(_S1IJ.WF/EW5XF4!HY)K;YYINI,2_Z,PTC=.&9P$=
MNJ(7HW:%.6RV9TA3=W)/*G%B6(EP[%^-NK]B/YWO93^6H>/$I_3_ D;UL?;2
MRCU:Q-K<-&#5Y8K6F<QW1P;XW=<E/DTXOF5H?<[,^C4II@Y4 PGONR;#2J5H
M:#!.?']>0OK1JG*TTO1SKC(C<IO/IU5B&[]@)CJXM!03HSBW+KR#J,T!,UAV
M#/B2)N-[XNE_#):*^&O0E#80]>KAQ@=3TGNR*45RV/,A"$F03S.F[IH6D[SR
M'N8=6*,U0%^-LR9FT!*.9747ZGB;').>NNMT>GUN?E,L:I$")&>951S4<7I:
MO+P<R((Z+WPY3KA8(=F?.JGDMS/L4&Y;:%NXS@Q%X/:K3G:L=A:^4?!I"O\V
M=>5L.)9"EFN*P LRQYWD>*:Q8M3+Y;6.3WV,-8IS!*P[<B4^ZHWH6$N'R'C)
M;36)V<P!%>>2FA>%'8'S)TQBU I^!Z^ 7 TGG0[#'E!S*?@)TYV]ID!S[J>L
MW@+(,'6X)R%4(YRAWLW>];!J%X[&;A/%#%?%=HUO+9*+Y&HG'MXSMH?6M04I
M#>KF%\L(M]J1N:-A55(D9</@=%YZ?$+2@GJ6QE!+H?B7^7G.*>!4;RB.!\.[
M;I-<4^UW_Q9P_<[^*N6OP//%NGMJ6MQ4L>]%_78B$NV:(6IW(N(=8BWX&#<-
M:@R)[/)>O:8EC^\AQ-2"XD467T>V9T$'CFZJY9F(<E@/$D-#TPL(O8%'2@G?
M@(W#K1NC'IX7B.[\P>/%WQ?D5-'DG6SM_)T%"I*3LKQG)^93ITMV \9UT6?7
M+^=$>Q^_7W3(+6V2ITX;/GX>;__+4IZ0*=HCU -ZK]/>,*'\Z;=2OZ5YDV#^
MN6O.8O@&E#?6,W;C,O,MPY;Y9&OC;-E"HN6AB[^)9W/AEP"1DVT<L=FU.@(R
M=0MHH!G85]U.#?(NM=]W6'>1VB?U1$!=I$V4%LP2UM+$M-N5'G!RLL#G"IE[
M'F$8SE,Q#E5!])A00;8_S2O/SO"<'C9T92VT)/Z2:1GU86G5,L_\'41QDR5'
M#IETJ-,X2E!M.]K#<=&F36[ME\5*?/IEP!#DDL+W6T4[L<#I7PV<$L$GZ.'&
M,>;RA$"[Z\7FR;!A<L^2D_J)4^#B\:Z2T!=MERI^8R<3IPXMY?+*D]:]PFN.
M()&;9 CSRP'R2$B GX^&SK:!G^N@:D)58XXUL:N/*R>[K^R)1<3*D8G64T=@
M\\OAD/GK<WI,@*OK)IHST69*[OEG7P8G$X8^DC<VF<()P-%; +\2'A12"'L]
M=.^538NM5>NC&/;&Y.]=-^M^0T&MQ9!1BWM-(8E2,2/<76*^@6@:BX[X]6WM
M]KQ%@4RQ]D&PO^=3<23@0SK1"A5=0=*U5! +K-?N%A :0M)#\IK-WQSOJ"Q_
M;2-0AXZX7KZSE>6AWJH5(^.3E<*@QI.@3QR,$<=Y&QE[6KTU^FF;K.WQ5*U9
MWNT&8,\VOS]AH70_ L[[KF;'O7/>Q2VQNXPX*(328/2NP^9"^?X71)C_7S#R
M3Z[WS^Q'E1"KL$F/!8DJP3_!(445BV% YY.SPUO W"V -92>F@;,3.X&Q]X"
M>"[=SNN.E!K1)*L7\3*27]]:SM0ZU[X5)I8IO/1-C^"DY61+#O!9[\GWMLS9
M"P@I++\%F'<E(*/.EK./>@<#HB*J#<7GLBEY4U.CHOY&7'XL+GVP_H%/YC1)
M?U10:6HE$WEW 4Y(!63=HJOH"\%:)^J;8,P$AON:,@B<@ES.+%MD-SCZBX%>
M*VD82$>K?HNK:R4\^4G'XC,9++_>VZ0%P/@<*AQE1Y^:).38]O[99U4?9?<<
M7DM4O<B[!50S4@S[#0<[78Y@C*X5,25ZF*2UF^>\7Q1$E\6<).W>/P&/G$]\
MP:^3Q%F,7]D<G:9IE#G4> ]!YXL$!JT"11T]\622 PN6,&(2I@71>"\?\3=<
M%_1HW E.2\R_ G:/T[84\D^*;6U37]-5GR_F)GH[>&G9-C=?-'A61RZZI 8U
M/?OR4+QVS\8SV%.N?"4^]8Q!0](V76=&=%S"ZC5K<-DN%Y"'>)+#!KD#=;;M
MXCV/Q,"_8A\>"52MDU-:+)#D#YMP=0TEZWQ[G#!)?!EC?M-H$;],@6E'@\]7
M,'5R*6N=UTLO^^=^1RN_%E;ZPQX&O$A]_$)7)GV!DQJN^SC7([R[NKH#Y',C
M>N(V7I,R6N^NW_A03-(Y\\$WV([7V>YA<T%<S9GRH77O4^S])*:NW//\\YPX
M/9O.5FLRB<D;#'Y*R 9O&\Q[@L8XBBS_^T[K+P E2> O3N^05Q6#X>1UNJBY
M'D98[X<4$N7B!1/SW8L&QS]#<0)*1>!F&^ZVM)=VAW9U<#CPLP5=D/[=E*DQ
MD=1UWH\,!^B[Y[O#M,LR%2NS24[&!BE:VWZ.6/(\8Q@R0YA<7CKTS%TV%JMR
MVO?8+.(2LE3FUN*S^<8H\(/[P3^)L.G8KEO ,(A*AG\U9V\?J^B7I>7QS(C8
M6O_GAN<@/K0G&&W.>RV(FS9GNBGN(B]W#- ?='?\$XO8I6,R-YOB$G[T-3U_
MD?$4=8K1Q3V,^+YH[X-C2A5[&NW4OO5Z8VPJO5GY0D7&*CEC6M/,M5?="'O1
M&GQ-"?F!T5KGC KRM@GV_^HH))9<R)D)=I]FY;(DOEZ(';X/3O,8<><=Z?*_
MUL8R8UP"^?-Q=;++I>'1)"S90KQ/DN:5V5B2_9#=$'K(A 5-#Y=?^ML.C,6J
M2(@H8G:&=6O_J6H_H;0U'Y(/\,H3#/N!LJB!/+B)[B)\E$@?,^A4Z9U":2'?
M\!;E*\P'?HLO&LC^3_^8;+%6B8AE-4W;6+RNM$-N_Q;P$UO+&4S_#W:=?PN0
M9@Y;<UN@6=UJEQ&O=TQY=#,8QO1<+W&SYT#5&4E4=%%7YB(V+JNLE:([S1FA
MW= F?S#5\7O*C1'_QZ?N $@0$A1W"VCAW/,%]@>28][WX.5ND:@KI:UC^:;;
MPFGE65K(J,CDK)(#*'3N;H)TB"._DA;%Z-'V8,"G&4.S-N'W)2IF)2H9M33^
M2R.,9 _V/(S4!!QXKP1R=VZ"KM-C!YNYI!T1&KO73K:XLRE?NZ65%JT4,1 ^
M5B);Y:BT*[N'#6T:HQ1%*>[/#]>+*S(*\7FI_*/W44HZW6D=[4T6CL'/]]P5
M [:KQ6IW)F)ZC1S*>M*VWN3:&9E"&9VG"X5:2O#" TA)<Z]A1D=/OU2CSA$'
M-8X=R7,)>^>;;\*?&RPQ5J=DXI&1R3/B)RM"7H7T:6-?5V L=(]"ZWO$YPXK
M8K?#Z>C%*'@XQZ-8 $2N^:'5N.K%]B8?#U59+PMI6<@MH.MJ3]Q_KV$V:CM7
M5U/?U,9!4K4?I>%M[.7( U^\Z$W$$1]M;C5^"[J;):-Q5&D)'V*IM*$J.FM=
ML2_M08^M#1'HQ4?RK>#L]94$EY@]E%S[!\?OV4\M[-(6W[Q[#19K8=R#CFFW
MCVX$GIC+W@((UH]E7A\M#(LX^I)4(4S-$.D$*><I?+2C)''$#_$V/.!%=>";
M[Z*!(,(@ )JE*>+%[PO=6"60#WO4KY_#@'=$"J'2'KF( F:I3B=!GU&C%:6K
M<]65TN6A=9&*F2*U] Q$Z:\U[O%<W$&"^LNQ_'2/*8ZJ>9P"9 CW/"_(K:&^
MLT ]Y^#L\S0K<48_%$10X$/V>5M66<;PM*9!GMHT6J?$0U85(;) =&EIB&Z\
M%O,K7R<),LL*B3:.ZC)_AH.!["@'SDO8B\&;WSQ6-\/PD[NEMGI=@TB0(0OI
M.NC:0IOUMBUZ&9%BLU^BMM$B=,.J+@G)PJH2<F=-:[^JJS,+H8JW@$<703VN
M/6P+>C"7NIJ;0UD7U^RS!I Q<8R5>+^5C@*#_Z)TA:P'JC @J>X4Q6#;V=85
M_4#?*.>@-)F5.N!X3\HJ[+)0T] (_5;N\5$=ECT BXYU$2WAV%*1=YV6W;N_
M%ZI*0)'<OC\!>1RD>U/5PX(-P/PL? 0![@H[(-BOXHW&?E+VF#8\^)O#MK/"
MGG<Q*C994./3.KGU9&?G%D!^<G!Z^N?F^VROO5M4!\=B"YQ^75VJW?#I/M48
M0]$ 7SD .5UM;\&,H\<D[SC7B'U&YAKT7T+IK>M7705>!-?OC];ER]% !I<)
MIKV<3'H9O^R#C;K")>W\O$DB+80R1!B%7/U'?ZZ2><QU=9[GW:3O87E7486T
M6&#:Q=N9IC2!K<; R@,;O_T+=;;G0I_NG?0A'D KK8%EVA,NP&SAL4;$HLLQ
M>V*<GM"V='98'^-),H8EOJ'/0#%%.BL(NQ08< 7)NR&$O($,]+;$8U;TNC%&
MR"\_Q+Y0.ZEK-4F5-(^-;O)46'7'L<TP:][WKYO[EXJ,8P5)ORH!>Z]%*\@-
M,FZ7,VG99B+,EB(W5O/2.HU+[_S#EHYX-/5GM0VV1IZ6 -=?M/NA6N8!7NSQ
MQVYQ0.H@L2.3@>R D?C:#]%3E 9-N;8:QYI??R32_.2D_4D$BKW7;?B^NZ4%
M5NM:RZ'MY,"8_42UC5 QD@X(]@C]_NWLUT7=9BON8<[U.\R7]90X9RS^*JHR
M)O2T1O'];E;UBEW!CE:V!Q&"]7KR 8_VY[!?P[QCPW/O[3HUNJG/7!9RFN>-
MQY:TZE?-'Q52V;H*E_OI=WU_664B,62\?!+,T%Q[^!U4<@N(*GPBNI(H][@!
M;9[$PPX>M(D:/5[/]*48I\1;]4@60?2\O 6$5T+&4ZX_X$9ZA#!.I2;*'NNR
MK+O0H3G*L3!KHR!1CAX/TM_?6C];:11IJIH#:K0PG,UMMX!HSR/"4I@JF,1!
MC6R$56G<&KNDNBA]_"+0\%_>TVAU!Q>!KO*&7(2)+IYVU\(XG7+2**">Y[TX
M. ]N3M\YJ!L?,OZ]>T5=&A4\6[?KC]5*TUY;7'D26>[J*,8DFV:85%N[X%)>
M-C:N883AOI..+$R4U;4N9 CR["87]W\Q]YY?37QA%^@@2!-%$1"D! 6E2>\M
M 94N39K4@("(]-X3BE2!T%&D2%<0$.DU]"I$BD0"2!?IH0=(PLWOWK7N'W#?
M=>][/YQ/D\S,>9YG[V?O66?.//JS>=?]G63PPJT "8MOAFMO*I>V&##V+ONZ
M?VP;7__<%LZS6+5CZ?/8AW?50[_-EU96SN.@_?FW%06_;$EH2I<\#)<J24G5
MM"I^D"?U-(09TA^Z=4*_A-A^AX4LKO?I,80X8F_$>18'H/HRU9]-#[;8EM9_
M21MS,M5[S!7_?%$L0^VO(J=$_N=IC<(7J7020RGL*Q1:WFF1"U_V9BO=[\+&
M]K=:VR>/2"'Z>;:Z>IQY">0?_X51!5 1KR\1,MJHEMNY^_Q 3&"1-S+G0FOU
M4QZ;=Z;'TG2<13,4%_(?E4Q1WM-C76^WAW>YPV0;HXBW\$*$] ZV#\?Y;"'*
M^](QBZ&FSXPD%*U9?KG:3/3]FNC6!L:3=W\4,-:<H_=^^*^5I*QE2K;&_?#L
MUJ#;1[0]]N?$[6$Z[/:SMOVQMY>I^F>A"!@?EC"ZUZO-IBUH(:2[^6^HN/L1
MM;,=4TYKX6TU?8<IP8O][(*<!?SM2^#$K9&0#G> 1"]<76]HK&F=\.EW+GKY
M^84V##;]5TU7Q20Y@G[>)8)L##S;B+%[4?2H^UYM\+JW'2Y."4X[]@Z5:A7'
M>D7**,\*V9(GI5_.15X*K'[I<WTZGM(@3FU-S:%R!";6D3U@-'+1Q2I<$<,M
M_Z]L[T"61$DSH.A];FBG+->O1.I5X*D36<[U3TH$IY2.78(W&GT)_,(9#37>
MN5H>7-U*I#(2>5UX9E%_"2SZ7K0U;M,5UW#!%(V=+$,&O9L#6+<]9R?/;"Z,
MT^YQ>)Y? HFFOB;S]S8#P;DQ2_@^!UJW-$.G^E'8NUKS$MQQXR>ID;UZ^WHD
M_)#8*C'0 1Z^C]-<[O>Z(=G:<V8^@M#]@)I&)B$C\QZ!L"U' 2_S[0>6%=\=
MY'D2BD7%)D%+9Y> #:0NO0!\/6"H:\WGXP_X(L_,,4<,+I[(3J3%Q?+N<!0\
MMA^$Q_UH$IHD/OQD$P2JGFY_<^-CI.[H4&-5IN[8@M0"JOGO<D;(T[1"C+[3
M2,8LS'3R'(_:$^DZ.1A90ER?4^7F5JJC#^A)DS\33+P$GH4*'DH0:2?WJRZ6
MRCJW=LAUVM+T6J;!*-'LAP(_\FS5GB6U?C=*.#U=.9KM3!/%1H>MI#L+PD/H
M'T#H?/%*\J9K^7AFT.+.7B]\9NOY_HT4NJP[&-#,%(^650.5>"-Y'J4*Q/"G
M*7MYN:^<6TY:$/A+O;M:PYXK0CO/2'0_?9XP]1&)>4/3T1"DY!KJ V%&+GXT
M?]#8JX>AG#2:>G^G\4((GRQ[J#AMEH)YDI/3O'J\AX!OJZG6:K^@< "/,HK%
MNC(I*U\1_M79M1$^$$0$P1<_++!6PD"P\187ZWM-C747QJ.ET>/#F^]]FS3B
M'%X"<EOYEJ&01DID?8[3>7V5<-WL^\)4Z<8KQO:OIQ MU-Q4Y(UEC:I/2QBW
M?TWZ3Z#<_:T6C,[-=IIE@W2-_MS7G)DO"Q6N+,%/NNO&GYO-<B_3Q]3MW<'1
M0W\>O^!F]I=WF.NFTA_\>RV0$TS=V1,>F;"ZSN&,B\1E5%OCE7!+GS?U=4\8
M7EL+-S=%<7O)6,Q8*_2#G\O>4QYP[Y$B-.'5]]U2ENB!@++>O'O-"+T)VTGW
MAB&%6"NZS GJ#/]%NAS/C9]TIM@G*T(^>"="F12'8$_INKX\(L'MZ_@]RM=Y
M-,>4JG:U_A0RO#D1WJ.>93[Y\ W&XK(]H?Q@(C*0\)F(N@1NZ_7!?Q_J[*^F
M?7"KQDOYH!_U9IDVS-ZDLTB53HC<R@FB7UU?R8K] 6=5M$3?#JR1B7]&1K/"
M,+=];>J<R$2P#KF-\Q3IAOZ>)=Y2B#7'[ YT-^IYTK I-F3<]R7SH%X:&CK>
MZ(.S0E@4'[O#E ):]3*?">"F'SFTO.V@8M\_(\=_22".D2H= 6SDT>-8"^94
MRGJ<_<N?7%_1O7.:R#':(@L<=CV2&+ TG>F?X>YR8%"T3^=-K-Q4\-G*00QW
MP EI;A-[B^KAN49\B*>3=HMV8*MB]GS+X^JBDSCQ'M;U*7C,)KS$R%S/>F'5
M-C914TT@=^_'QQU7&6)K?NHE@#51J+" 1JK]?3TUUI#/\_;ZIN+RC1ORZWD=
M124P?9)Y$ QY<1 2G 1LC^?*]8\.L']/R. %E4%UK\,^D([:5Q=-$BE;6UTO
M@2=<=NPOO23.UB</I' CI,X6@RYH(Q1^0OCYOQ#=AB?"]2X!_9.0RID*LQ+T
M=^W&XU5Y[QS)M!FB7^M>U?GF^2GDN]#W'[%=,T"\-()E,9T*OZYHEY>!QY,N
M\\HWH,[*>:GW(-G-5*<%LYK<N;O5!4),(S]AE5\H@P)OT@7MK!R2I-YT]=\B
MXK6:+T+1S=@Y#0\V[5:N))SGT"7 FW/R1;\]-[,CZP^*=,;%C\%\OY!#NQ?.
MZ,)+(/++%@2K-JHE9+EY:G^6=@F4T8OFOQ?NUL)Z)CCBEY$>8/Y6BQ"%_:E!
M+?F H/V, 7T3WBZ\!%$'#H9C'^<:7J@M6-T[%1CZ'([C#?'?.?/N@ZM [KR@
MC\X##RZ%R(2>=_\F.&O65;IARAHV"!C8*\F-"Z'Y[3_$=WK:O,'Y/65].OX@
MD-16N+ (5>P*X?1JG(P66U).9 (L@U!.1)E(FT(HB*"]^JB^@6C).(<?GOGB
M:O4)M0RF7Q3SB<W52]K+I5_R,=R]R5F=T-O] (H OB&&GE4,\JO>G3QQ/NN@
M#)'V\-)[>_122=3U_JE2NZB@B/L:#MZEP+C1-// ;SDOSXG(YH-'6""EY:41
MGCY"*R\DFXI;$P':FN]7^J*!:T0F?"1L_A*XNP?C"PE&'PE:G"DF\IH[^ZDF
MIZN*5UM[!# 17/":CB!ZQ9?CNX>4D3##$2J_I=MVK]G7-U E</(%-BE7:P@"
M>5M(V"'8IV7_IH'DUY?-RHX8K505JE1OU;WJ4'@USL]^PK0![;RK361;A4-!
MWW0K%R$T>.9)!N(EH//MUQ\V)\YES7MF&(DKZTZ\"36K-[WH.2^!U[R]>S%_
M7P4J&CA(>B/X_77HAWM7N-<'3V0'X&_PF@12G2[FR<OTTT=Q<NZ'P)F)7$X3
M*-M7//63]3,OZQG::+<+F!K"BI*"[3;^>P7W1O'X2_Y'"ZS@AX'?19\^1?\5
MB][V +$.&!*H@*1#(NV3962,^>GVQ3*B=LM/QOQ/1FG-!*VBWB-Q,58Q5[DA
MP)>C(P-W0:I_).$36Q?RKL\.E<%TB;QU <7XZ*OM/T99$O1"[ DIS69-*_$$
M\6G(8@KF3JQC8]TTC"_@X!+0I*A<E0F:2OWZ)8E,_14] KYE ;F.7$Q9N :[
M'3"BMY\573_JMO[\VX<'20I#/[L-[&_X>PZM+*3IN+6\J=^6[3#)=_0^;N%;
ML0@.?I^TWO(T68Y]._=)%<T8<'U@:PL:"\6:7P(-H$CFI(=BE27%:^^OLF?I
MV>:=H<BWH$W,*>$.SNR.]\>FV;SSB(\?!9[CV\[/39=Y\<P_:D,8&A *)IMC
MB_:.BAIO3T_P6^N';%W#: N+\J#^G>J1LD58VA+WR5Q@>G=U6VE%4Z/;^\ %
MW9,69^>[4*QJNMV%_&8?9*VTXN4NO.,9^=]UQ'-8\SEQ^FE"ZO>">R'5K4GB
MZL<KET"5X+XSD;HT"N(H9."=FYT;.\23\LY#C,B^PKH13_AR:.QFI@:92J*O
MKE)2 O"!56U,:]0/)K*/YK?..!UCDWUQ%9+I/HF/C,V"RS%JDI/(T.>FSF6/
MTS,+S>YE9(EW]O:NWK3C54Q:@%:OZ,8/JNT]<HY[P#.XZ-5[S$MQC,*9I%NN
MKGR6Q9-!%M\8=W)_.ZG6$AA&$=E(LB$Z4=W 6]N_]/0W*FGT)9N^JU5?=X*-
MG)S0T#%)5R6WE\>]\D!*=5[S4/YKS"%QM%[6(%N)L57E25O8()+(ZG/!M_O%
M!H5 >444^2?.]'_GH"\$3SUV0(D? &STK_PO+;GY'P^C9Q]XD\!(0E!F//"V
M@)O"<R,%L6Y]YT+]1P.<JLV"V];(J='FW*%R[3\CGGU:?C9R4I4VC.-8<1R3
MWO!75Y(W'X.CJK6>?RQMGMZOA081WY?0O\X1@KD^@G/#@39UQGR0I(5#LHL>
MJ/8^>7<S<FQI+.AP=@)9NW"]5KLXP$_]Y>B#KX%RJ^%74G;.$M!8QPLY7#)R
M1W#IPI-?H8.;<2E:C% 4G@0_/R;\"]"APG-WL-MV6?#1KU\AOP0VJ]S=8RM]
MJZIV=ERKW444-I#)1F6L:MDYZ1DL!\7G+D<[;JWPK$.23KCZ?I]P7-58$N!F
M<693E]<KVCA"X?6UD[-I!7!L+'4FX3C!G,*$R#3E6^<I-;IZAYGH/FPM)90\
MM[KR&QN(HOR.7*Q'UN[%*]HM"4)CB=<G5Y$MXY5V$<M\18%^J7T?UQ(85 QR
M;LQK]H68DL@#2OBRB(7TZI@NY?>V%A1>JQ"IP:AZ/*,5L4\76'OH0/X78)#C
MP'K1Z]S5Y6]^\V<^.,AO\_A !?)'1\?B:=&_C#IBN][FL*QUMU'@[MU=A8BG
M8SUD5&YO/<0EAO""!W9$VKTR)U$\%YSA3WIPJVQAQ.COZ^/J@JFS-R0B-%V.
M\?O0RN>6O]GHI96T]>3MU/]J^C_X\?21:LCH"-?+R"3UT9]'U7^1Q&M6%Q8!
M)@$^D @B99O>3>>[487%^V9,;8F\FA\>YS^8O1I Y>]!W>_L4&'BK[6U5F3^
MP/YX=I!IIVK]/;R+DRBP]62E_C1B1[BL>9)-Y\+0P@W.'S)S1RA)S</S]_YD
M?6@**>S13<Z,V-6=>ZIF]J^S9&F?.;>R'Z.JX;K.(\C%^(7O68DA@KXR_<B[
M3N._.9X/;>^D&KU>$U .^)8*S'"#\EF*+X&(?UNU3LQY-XV]ODA-#0=R+1E(
MH&!(78$.]-#&X1,E/2+U88D3IB\36=U>Y_6&.:N"W;184"-^?"W#.\>1A60]
M!57H)B5^1*@_R[";<E6\-9LD*@9%G>)OKA@[+US!?=?O&CC) 5*] BU#Y3DA
M8Y!/WPK\.9N'E%I.+@$(L2E?>V?R&%VFF]"DX.UT G,VKMT@^-6>:9_,9?/!
M7\'C)H;)^)=:2Y^K:247V_NCFN16LHFO(8MY=[>LB%-$RO#21TVMF \KT2$>
MFHOVZY-2! [B EIM]L0,5_%0@V;I76W77@2$W@ Z7(:_+=+[\/"D%<L#?J6[
M]8TR:/FQJ!B.:)UK9/[.?QO)!MDBLJSU-+WT%'^'D2]QF)X.WH#E635 &IU5
M71Z?\02*16Y2E;&'>I)T52X"]RBO#F/2N'35#P,R<K#-N2*=1-]XAI(B,)IK
M, OJZ\ITL>(U.H<VDB#R1!OD8BOX_CLM= A#PJSVF]&\_#G+X/U\]-S=Z=N6
MHZUFZNJN/HUX#I_#.8RF7#]-?64E6MMB?Q:/0L(7DV6^?,:+[%>L*CH:?.\<
M4Z9DO0&!P,2@5L0_:(@#(:]-6R#GI9RI$MC0G8N;90]*09*#MZ1$=B!O.V33
MI9<(178)ZVUZB+*EI-*.!5*RXY\)70*OJIFU)]]HXUYAH-W?C5]N\A*V]D(E
MH4JNE>?'/W7TG)&"[5FMSCN5:9"/(KB')XTTA-+M%":H8RPWU[%838N<C=QJ
MGO/%P^R-@M<?H$'B7^PQ<L,)(;_G4535K.0<5^$WX5CMT5"VD]+Z\&$D!J_.
MKMGD^/?"EMU[@">(:%:]<Z(>/<T5@A0;+B6SZK0U@I&32U6:J<ZJU]:C3=UR
M[\*_"(A;I8ZWG_O@]48A_ST&ZI,#<^#IFAMKFUW!*_JM<3)JO1(TO]*K*4*7
M-780_<C;)(> ? >G4[RU+[S2NW"[_GU!\H^T_LG>0W&9;) '-5N.E^?&!%(;
MOEB?[?>%MTO!2FT"$^AJAZPQXY2=B;BIR9-,3:;.DPKL09- V&=*5$OHWKT$
M=![C?JO0E*IK*K#%OND0R,ATKX<\(2]G?U<PXV'.QP8D_-@5#(7ES U9.)1!
MIXA9]'A&NQ/K/[:1 S?%>Z]4A*;"TVC%@9GP!!\.I'S?/A3/*'-BWH'-C^5^
MUV]RZFWI))]8V#WMC3_4<>5Y(X>H^DMQ:X[>?'M@FPU+*Y,R^;CQB1P%Y?<Z
M+@^)B)OD.8X)=K*,O81P(G#_6R@MI=K+7?#0*\8\O(O<$1XK5TY^YH%U[[<2
M42&4UL%O!>@Z1T6L]PTIUO:X>][5=CL-[VXP=)LH0ZK\1)_H84DA30ZH[L2(
MQ,FP;YJ(CG+?]!<[F&)?3YO<.-J RIH1NR&U[>U3=Z,042[WF^N3M=F'RC Q
M-V(4P@^FUKD;0BNF.AX&]#S!@; (B^GM1W^=12@W=FLZ,U>CYZ),5_7%*57(
M@2OR?B7\7F7"F!.I CT,ND0+O9YCYW;JK#TSNPN6)#21I"G;//,8:K&Z)WCF
M 2YJ>:C2GOGD&>RGY,<8T3\,XZM7?_=^SV1EO_6;:$HDU2[%5]@UXEC^]>V"
M[XEMAL'+OE/'L]^;FNT[$O3$6VMXPG;5Y-?!_:U[,ZB3#SB%T'WM/@@K41SN
M:HDK1YMUU&"/JW^/CM9W9'D+VV%2'8K$5EUIC:Z( W)5ID1:^(5^B!!N=A%^
M[5\'6?.4_2_)2@??:\A&9:Y8C OP%-&TIVC#M^@S8'Y&A[I9X:TE88E>2_#5
MX?F%^565:7[LOPU7#W!2"X3?7I6E-<HNBC46,"Y/-ZW[&*E%;UP(9RJ<;0L,
M=.4^KB#2H!XT%%PHX.X5A)9>YY>67FCQ'A.G@A$ZBDW_@=6,%*,\Q)J2VCC;
MD^ #E3 #$IA%B*(!%OT0*DDXM5.AAF\B0[]@\&#O8]G>M_OU7>M<1%C3^K&7
MH&_:J6$-G2R5DA\!/I!'+[6UQO FA[W^]'ZKA7'+7N.6W8$>,]\RW_ZT'6NW
MQ]N:M'2YCTX#V8IC2H\N_%O\.S[?CS9),2:[46)U\3TY8 #I$N0Y(/5&05)C
M^:ERQ8UGRC84*$LOB8&@$+&O6E?P<\=;>0&@2=:3BOI=H]0T':A#Q:]MI,@&
M]_)F4[.P%8.F4+ OK'4[H7%BQ]K6"RNH^RF<=Y_NN)^^7N3W<@KSG03)U[._
M=$79DD(O ?:D7Z'Y5.2-EE/O.3,H[3U+^Z@I?^E?"?_M30PLT9A0FF44/FRN
MF3O/#PIE!)[;.,JREA2&T?+]?S]N1:LCWR1R8X+.B6W!1G4&TP1?O#\^-IW[
MX<>./#CZ&#<=\"&6?3$(%@H7IE_"5$B^#4QN,$"NO;<ARYJ16*A^":>=^*J3
MW%%L585Q*A!9PWR[9_> GG9>?A$!:XMW;4AU5VU<(RB-\LQ]6A*4K7=7<)J=
MK$11$;[,N\"NXI;_FMXJ=[KS@0X>B]&K(\^Q7R0&;#KCF'!L7PG5)UD_BS,]
MW]#W26NLI"^]3[2@5>>Z&=!Y=(X^RK_PQH&(M-S[_GV82^ MF-,)0T"&N0N[
M+2?NB(S;!*OY&8'-;#SLN!%:^-@)Y&(BO!XO_QM]].ZZ-?W-#1EU:&-STHM,
MP\^"9YU4CRB7N#;ESFFYB]-,=>I#H5DZ46I3W'R3FOP6V9NGWS7=5Q$[WDM#
MKW#!2]T[T<31!LP "&QKK<XK1\QMEDK<EQ>Y HK!X*&,OAP*ZMBW/X>ST"UM
M0U<+!7N'OUHK [)C$D-* ^;X#E*7\G\-:AAXZ^A*=1)7-^WF$ZID&SUFI;7S
MRCB1LE^@7,\8N+#;@C+#N^ =XG@UK%M, 5YI0FI'71W;&+OCNK?G4.=_$#\@
M/>FVI+&L>I5&=@!J[E7$:O37OSVO$:9927++BN<Z&N4U'GDUP=79.QL'$#ZD
MBWL4A%Y2+]$P(/($XKA?]_/-\H'" JT5N. *]%W$ =U3*Q5-SXR3?L%C]Q,M
MTBTF$*<6KBO>IHHFBH;<W+\$8F>U:S5<>&-TQ.Y@ !9'A+>-7>1&CHD[GN'C
MBO_V[47Z,(P+G,&PVYH#%XM)F+"<WV0^F+.RHC*^[_UP>80'$2-W55.I)IX0
MF'8R2(@HCKO_<0#,X*M\Y4YM6@!Y^*D162='B]UTH^^#D:%7$Z'(2B2H/?OQ
M\[(GF_M^91C,T=;!)/HGWI-0TB$$F\]O9-?$'G9RDN^[]\#)-[<K GTKG,2I
MN1$_6!8DQ:K$<[R\G+?=?U,1:3@6+X$9_.^0I[B\Z3^\^S4IPKW)9_'C5FYF
M3U-YVAP<*#*V=L('_MS5VUF[N#L36Y?+MAP=Z<;N(%3I.DQIO*O]R9*.\^RH
M6@L;LV-\ <$K3Q=-A@CN<^NTMQF;2,=OT.E%DU\M$1P:I/"2^'E2Y>CV,?!#
MOX  !BG3ZE@<8G$#=B=@)[WX=<O5[AWR-P/L!O@Y.N#*XB(=($H)D../.A3>
MC%+MT"R?ADGC\-X,5?3GOV16'N4-?"*&;IWC2$F(_4V<(8I,+HU#7N7>)UX"
M/=;<AT)2'^<%#:)NFHG;2/"%B*[+@@RA*-4!_*V%D\%]T+M'>,.J#?.6A?G-
M3$SB4J"=G[C0L.8]NZ;511 4IGH5A$9ON_+GGP1CZ1+).RU4)J\)'MN=L-#(
MGD+RG#<JM\6[6-(0\Y? S0'O 590#,=6%^25WE5<Y-)Z%XHVX$F?FH:4JZ!V
M37VZAK_\F?2X6I"](Y_ZEC4^]7Y+.?+]#V4_;BJ.IH&#XT].LZ@66.,%'M6S
M@!/F6*K! 8X'>98S=B\)NV[4&[-4Z()1&">)_]E]K>1!&+_NB=USOE?Y6F8I
M/,F49_-BG#1#<HH7YS[5_]!$VOH+2;PZH;B#3F>I.L;$>WY3V^7E-7*!CK^Y
M.;[@F*/J==!2/IZA[.0O3J;:#+?2A8$U.RU_E(G+J-QED-.I"X:^PO:L\7C)
M$@32BS/2)L?AT$"&^(SF^OH.OW\711?19ZB987X'C167"-$9%H#SPPKX&-_\
MW\Z C9ZS;Q:N[Y9FV+X^:D4=O51.B;,]#5QA196Q,IV78.]> B?(.D)>B/(?
MA?'C>_NT:)5<R=*\?>N-ZI=J&G[2*]&R5-4<%Z9+5#N@"Y+=[%)!.D,8GRS#
MXZ3E\1CK]X?"N>[>_NSC9[?%N$10G>PPSBEO):D9L]<-Q!3M^5D]G#-('=[5
MT=*1[^M>/=M1XM:X][!T?V-[9><Z*%/#HWG(<C\'+D], PO-SJ&PDP,UL]V'
M>IY+L[\7(R#9ZG"A,%HRQ=R9@6ED,B0L'ZL'Q_%1;=>N;$'OADA.U/\^6J*?
MJ>)J:-6P ]N.9/8<>*+#]*IM"3;$T4;HS6-(I#4;Y,[7O^_Z[U &AUK_.5!Y
ME/"63T\L?)6=_7!3:4-ZMI4Q2VKOE]1I!4S][!+ ^T\[8M=WA%;H=YP#72ST
M]I]?BW4<%E_>T9RC9NE.R)-(^EV]1W7"CZM9A,=":_?"W-H@51MH^,P?S@D7
M$;NDO]*OA>_7QIF!UGD]%&_]3@J0PI%8YRH7"07@/R'.^Z\J]GF7:.7?G)[>
MAKYI8#;@@;GVY'SVYV$6W)1E/:H>6XB&?W/$,^XM"6=!HO#7ET$L.(N>-,L<
MRQ=6Y<5>H P \6-P@/W"1"N=N0%9@=>,DNUQGJ^ 2)QCISID\<Q0QOD0L6G%
MP*4F16U_=K_UITW(>(6*ZOKK%12>J3,IC2%%85Z!*"H<R=1%M,!&_LCAY/:+
M+'"))2_F=)9 3&]2-_W0)]]D9NJV?'P]'-.%)]BX(B>0)I> [1[N05E?-3U>
M%9J47[?>NW<SH*PO[L3BG87.:QIKN4K[Z[<?13RS)T/_]*#IK)[92X*0@SE@
M/SDI.G#PE1V!L=WA\Q^8%W_FE%.'J&D9%8-C^SUH*! OZ2DGM-U_C#><$I$5
MH%@05@TZ.] IOQ")7JQ^UZ9=]L+YUE\+P:VMJ>@KKI]NE61GV9AH(@8_R ZQ
MRK+#GV1..,E,+SL+QN[:=64NC*1+'P2J6WMUG4<FY:PPX4M"_$B3O(W7P9;%
M"RL:7DCC!DQ_ED1L5%>J)56X:23^J& !OUSAND&_E69A38=S)V7)!KOVUOIN
MW<>^\YQSK;?$B32#IZD:+SG-5]W)65A7JG^^>H_8I++<A\<HRKRI7!:YY801
MM.2?N7HTQ)C*'E[OU9DV&YXP79K[Y<4;$P_H"RMU?XJ:Z@Q)O7;[N,X>0?O5
M6X-RJYSSI!Z-16[S7@2'!.Z#$[_B7^(:5R#4&QCC[A%PGJ/F4H8VI5B.AFSW
MT;H<*8J?D-$PZB:<]V+EM>Y4Z$CU:,D+S,S<FT9REPE-6@$)V:&UV$>AN#'^
MRE^M1?+5F3GS.P[-_U);9@N29B/4EI$!J6H>5%ZZ8K/H>+PB*1SH#[.+5>D'
MLTTJ3AZ:W.&'I=Z3U3Q$Q>/J.?]X8.N>1P* XABX!"IR$.Y:^#[2'PI@8WFB
MA,*.VQB<=]>$WLGGG;)G%COS6;ZVI[';2BU$:Y@$_=TL;]T=GH9YJ="]EH.I
MBRK@QX9#CDZZG>T#ULE$[>$@V<-QS],@YV"K[;KYHE[D8OQ!-5ZBZMO]QY?
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M[WV)5LJ %/82B$8NQBU<:7OPWPHV3N9]J;$,WZ+A:A[IS%OE8YN;BX//8?2
M%ST\B! QWJ;@6H0SF>R9<V;VNQL29#@@2N88S_=6I\F[)WQP/7H/(\?M=T$T
MU5V(F2\P]4="#R H[I,W.+3OA2AL4OYAY8H2>$O#BKNO/]3D6MML4T/\4>I
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M1X&A\RV92L3G,N0+*2AW<XV2#"9]%8'R!, @CB-X10FN];,P3)#&'M+%=5X
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M\:#]+"A@9$8A4^\T[*ZG (26P%>8(GZ/%^8].O0H/-[E_R1O/?EVK^1TC'[
M]._^*V<?8.WO4?)2OX:"QC)/[M(W\S3+LZ]+VSKUY>V19ZLS=S+37E6_H$!%
M&U_^]X#0MOOUUW[^Q]MSK<L+AW<DZU]^)W&_XFX2<S4G#1)T0/_\VSV]D;$-
MI<?V2)Q,P)B )-7.-NL.S/>U!T[(]^)4''^\%6,?E?!T#2NXW7%MZHK7NQ<5
M9J*Y84?"MJ<.MC^LF%0Z]/3.\CX*%AM3)/1A_P>!E=448S5BW=3 :-'+_TQE
M9&7+JHH/=9<I20P!H/\<QH0 MJ\E2?'-6L4_Z;M:7&NL7%7ROH$48;,ECKE!
MT=^OW0N#[/GG4$/PD7UW:AY%_#(%EH2^+XM*</+,L,H-/4?.0C\.O7SM2V*U
M(=1NY,_-[XKY#T8B"\H;[2=%4IP''P\\L(9?PA=_KSGY5NS'[)9EW=S-/Z3Q
M<V=^DZ9 SQ^O_ML;)E<LO2!RXB)\/96_:WMLZN3.? NM;\IN3^_>?7I;9#1Z
M%W=36J7:ZZC3]@,TSV ;MUD2?G)G9<HE[D%LO#6_S_GGQ+G9W>G[#:/_*8V;
MCEJO"=GBK@AC>Z A+<\Q1?&45PJ\H>3 .D7)'Q0PD5GRZXO]U1=NUZMN/4?N
M?O:M\8>H7]=NPY2#\ /3>8].E5P[9O\FT^S\BSYYFG*<]1$A*&'3'):=CTHP
M!I!?<G=[FZ9M7EBD*H66^Y[<66-G<"P]YNKQ795I5:35%%-AV+T-.'K;7@EL
M&0O)U<?"D\/_YLQO;Y/WK48\*@OX^>"" *3@?-ROP6DFE=\7L'V'M<T2QM#A
M_+ 8"Y/V>0Z!*PQL(X.2_HN]MQ^<'[@1Q26Y"+';D0K=4OPE *WZOA1E3[PL
M]Y(,<W)]FS24>\&RA/!R)?G^9F_YX1VFMW)WIJ"<K_7^EGJN_.#?=@KDRO3P
MFUTSQG$>%X_OBGYU%+1CY27EPQJY01C7.TK,EL&CSW&I5GGQH#+[RF/7^X]]
M-/NWLO% ?J6G[0[*]9>9>2]4-+*,<X?]R%"=%M*9(P_D0)>6]QWG.+0>WO%J
MB'+XGM.4F=8K3W)*N]4.^EZ3L?FVR(:27Y%%9X_TMYPS^<45ZG>UEPD;NP\=
M2&Y_(3+O*@2>>YR/QVQ_3)S[>.GS*667NOT.2I'4+J6QM)2K<F<- G)WS!LU
M0%[/,_^'E02D=YVKKS@32+F/RS52;ZFB?'^?="KDCORO:4@N7!FG_S]L1'4Z
M)1G_%SVIOR?BD4>6.Q@OJRXJ.F'EVY6I;TN#;NQUKQE8.G'Z>_U55=UKSQ4N
M?9QIE%=9>FG3(C9TVH&B61.18"GE>OV[,3SLZE.07GA4+_)V/*A4[E#WRRZI
MO!V='PQB*P?F\8O<[XZW89[W%T?JOZF;G]PI$G8N1.,_7%48ST  VFZ]?MO9
MK".1S 7-LPQ\A6Q@Q^M'N."CL(]D?#O.)?KN*Z4_#P-'OAE&8CW@"%:S,<C>
MYV[OSFN!Y!DXL6^$^GOKN=FI$V</QW\Y=^+D],UMY;/X6Z,/PEG"]$^ICU_:
MG<>@S?B+26-B_CV'7H@Y>"INOTW<@NFCJ"BEU[B[%W8T+_KH$(Q!7N5?%OE.
MYK#*#WQ?=<]TNW$]"',G_/7*)KG019ATY>^9R<45_+-M0H9Q=VUCW0*/^JCV
MVHR&2]_BDO_ HUWS'IU?/%Y2ZFIQP4%LYY.+(C$#>R,CHDSQI[-LUCQOXM(>
MV[5O_1/ ;>WW%D8^$93I-!/V0:?-YKQ45=7F1T,MN,*KSN$OJHY'[4/2[@89
MQ#Z0VY5$2S(Z/UXQ].\A;:^^!]A[';U&V%= E<J-2[M!9R)+S/\_*@C5IB
M/4GGA@'1G#/\3GC-!'D]6C;<,[8;$4TZZ,72>_IS,T=+'&D1=3/!<;A<FAC4
MG/+!H_V_YC<N\O(F3F?^^[R/;PNGI0E S(#DM6 6D4T#-)EZ[+HQ+&2%) K3
M77F).37BR4SN:E7KTA]XQE+I=70(1W7EF 6+^MW^:)2V&.]"[@I/;.G#DFY/
M+#;6C?S4$46J0,;OSLAG+T["/',\5\0-M1Q63AN?&LL.L LZP^KNOU%0;*X#
MJ<I<L"I0*LBV;25&7S?6MS]JY38S4IMI5ACZN6(]F)@*;_Q\DL@@\D4U!""1
M/?Q1?+7L&FD>,4EB_SMF*%Z /D^CQ'(OTO%Q"L3GF#U%Z*KU;KCTIJBSH07C
MHK;K2JMI<'TLUZ@ B55B9CGW$2;=B?$;UC)N\M":OL1C 9^Z,.<S QQ@82'V
M"K"I7&5T2>U9:57S:/V;"_OT+O;FF!2>&GUZ5'KOM]F-^%1[EYJ3IKFAU;ZG
M5$.FFR=KA\YS;N:1='"T%W\7H_:@IJ'\_1,<0_XP0I$8Y&[*P'7C %<$,W4.
M'6%2SV0GZW&/"D!*;2?0HL8<Y63?]3WX#/JZZ-)9M[#[V*&@U%E=Y9!=&R4M
MV5U[7#7)\P]7KT1U_W<6G2T=:F5U<_:^IL]@R=*G7JT;@00MLPL]#9,-A+R&
M3U9G,UL+I54CUXYGDG)>VQCC='#,!^O<PUOL,J%'/ !/[N-_":=&:>, -\+\
M%O>$L(<ST.>M6:%3.+H'KO.5 /04Q8&O_2+S\-\$H,Y (H_X>99-TIW^0IY,
M-7HC8_&<H30AFDH[(L=@Y5(G#:\N6,5OMRG4J1,,YP^D)/]\;VDR&)JA'F)9
MJ^-K\DK5UG$AD>@96FKC6CM60=@H-L:>1+OR#P3,0Z(A3&,42 #JL.#KHB]#
M$F Z"71*%TD*/=*9*]-<"42B&$?LR%1Y;4BT]Y0GF>W1Z)EWJ0@LY>*;N&_$
MO^=+>%#ZN[STE;6SX5Y<R5#^@4+Z.J >VT5-\# <A(DC$7M-._'R/W(EFH9K
M<?)?@=$5-;<AB'/4C?K6*N96#+_WZ*_"NO1Q"[/?<=\M4EOSDC&FXEX7,,J>
MK_L.$#(6+J:Y$12?$UP2"JV/F!3J/R0H/,P^*Y60YFNEHW+E94G\FH[JX5*[
MAT\OENN_L%>1R9EQ\=^J3:=84*]L)L7SG04@6H4 ) ZG-6)5A69_Q 5-D/ZC
MR&.NCL"]@ W*/E-Z$!.:I,+<ZB2* \,3B,<M 9$<2_2=+[6U+,?8F9SS-Y*F
M>[;UDK1%2?M,PXK0CM99;B@I[V&<W:ZW%(_-=,]75Z#MWX"OW\.P.M^_AM<N
M1G>,LU\_;QS.5ED-&*QBVZM1O"NJ"2ZZ 44$O0-)#XN5S<B3G[1\-$[->K!^
M9GP;6;EK8RP]K[#GL,V_>Z1_P]=><JXM"4!5(JLD%H']>@QS*FP^ 1R5*];(
M"B8_K>$YB$O^1AR:G9PT)725SDSZGEGJ-2/>\6J*$*6HZX2X^F3Y0A[A:"^%
MSN0$.?AW:2-X;:<V^+'+1 <"N)%/-VOF?V6M)2?!Z4)K1.<+0*)J'SGPKRT:
M=/PJ914%.-J%S:&FL=.\4AE*=>1+K@#D$&.6>?MA]KTPT_VG%IPC?6^>?4U"
M7CZ;[U+S8X0@8FY_Q\/?KMO&D6 >X+;TJ:!@5/^%7:*>AI590R_E9L5T:UE=
M1%OL:JTT=Q;7$=GV=_>9NZ%/&$=O1OCNHN$55@BE748AIA[<[:Y($TD^S@0G
M9Y&'^P[GRHUR?2*\BH% VU&^8EU\4W3>E%GY'-J$ZFRVP(I)V_T+\/B)H$(?
MAY"D5['[,4>J -;['U-DLJ)U-!Y<CCVW/*=D@>8:E6 <ZIFY+V6[C4PO)PV0
M+6J235I9#WVW]&^[+&4&-SE;[.RXXW/(%;W1ZWFH<T'> ZE$@793SN6J2_7]
M</A._@];;O?20M:<VFR?T2HZ/?L@(-#67UWG8HF54JI;^M94C6<P+GBS<CG(
MQAC=^_A_KSV0YE;@.MK_EOI"3(.%R,/*HHD\(=W+P;5/F42QI.C)<2TV#">,
M*\W]?$^&Y/*V5SS>K"Y]X/NV4T%-["K:[)_+'W_F62E>9#?@CI(#3GB9GNHK
MO'RAA%EN"Y:RO5G\<+!0O?I[]JG1%,P+3-M\<Y6?OY=#@<^ET;0_]G]#O&JV
MHHS__@<Q$WY[/5Y9 Z!RCO _0Q0,PXS2*$DP+7X_;A=,#1A8M*Q*MARI,'2<
MI\8HR[(<X[P^C+S3E(Y^U=16&J9:_NKZT%3[IYV2[\4CH1X>QYXSQU;HRP\Y
MYM(E-GB-EK EJYL+GZ<LR9E:_87!0S*9*;:NVID;OG3CPPXJ__=Q(^*B-?^@
MA##XTOBC$*858@__BSYIE5("Z%T;A6F@\8R8+,8DUYTN"I=Y=IJK4HA67S1+
ML(YG,T[>?Y;5K;<>?(Q\/-6OWAX]KB>YW7C".H'R^_H)F\=!#E!Y]<J\E8&;
M/P@FT6Y7_RS*W7SE6%UHX"+94E;3.A[\_X)ZSL:8\P+0[B'@-PO,QO.>XN[A
MDJG2/S?Z!* XTF'LD2X&0L;]QY2;@E:&;K$6L63JO+-/2,_;JD>7? Z4G:T6
M*[YM<59G2R=@_DSM@PLM#@>J$\JCNB<ZQQ[XWPA^L.EIGO\T,^%5V-L_KO%^
MSC5U6N=LG]^M2[%UG.MW=SN9%_]=[G]M5L&=%H#J<5W6@)8#20#:\Q2P8, G
MHWH1$MJ4KVPC"_IYP.T'[$*R"2#R#JW;9_H!(K_:!D?K>"9<9RFW!E>8SO=Q
M%!,CNK":$Q7:1QP[0F![2,K_?!C>:)6=_/@KSNM"MHER6"XB35U.R4K'\4NI
MOK9OBW[TA]%OJ:V^V=RA1.(JW<',W.9&>K"Z?H#EY<"6?,5+[J6;6 N40WI&
M$[_H9(%\.\5-;+XH8GCBN?=A&V/0_[H09*]5(;W<\Y[70/(& YKBI%4[UBYW
MP)^ZPY^ORQ]3%M772F!N68\$_\ 8,4L[(/(MEV@KUS#F$QGZ&5E>.%KY;O?9
MZ[_=$!WBW:'G+C:^I+2F,G_>RKU5G>UQP"G80J5O^9X3%65[\SMSHWB\6/62
M2?:8>7:-E_>G#KV[WXC!:>:#!/6 M'4'M\HJ2X\E9$G56"B\4O]D7HO4C?\#
M=3[_[Q?I^3J@.<&5(;-7>=%P_\A &K0=+,G5'X$I.W$O )&,B AK*<S%84/+
MXJ)BAN:YB!S+I.)0[< 6L+;YT.7/5_^I*O5KA[3 F::0Z46;OU55^-VYXL $
MXVO9+:"4GA/A!+BSDHS4+*.N#14"C^D)[E#;5+OA("#8Z/K4%').?H*K1VQM
MSE*M;QG3*E^[K[EZNU9\\TWR7J^+]RX]8I@+25[U6:=0\YOJ \'%IRTOWLQC
M'5XP/Y"9DA 5D#W\?EZ1\ZGE:!Q!ORJO\14]8E8#YNCE%?I'$SQV0(.&!TZ1
MUE*1G#W\;I(2W&<?+9[3TZ; 7 9P])@TH[+0\:GD'JC<C"F=NBOG\F?7_HM0
M;2-9Q[;D;KY:C2O'HA0OYNWR10%#+#;SVDWJ$Y*$\WS1+J$C[>%5XFCO!*#J
M^E4ZB]@#$0L&Q\ E_=M.]# BH&#NN2$NO/1+KBR@PY+MG;I6/;96<;RA^NQ*
MF^+PM]=YE;F3)^IP*?>T/97D<[R<M7SP=!D%^1 [L9LLJ6[['/TT&"%Z>^[8
M!;1)FK'MC8)YEGFVVZ)<L8^:9-&Q'/T7A5I>%QL*[V:Z#2\XACI,?/J!"]"V
M,<:\:;#Q0++PW5/U3]K &$=6>M3Q,RNYD@!RGBCE/>+V;\89XU)OF.R8CKN^
MV=HWWFSWJ3 ?4;/=^./O%73_.$W\JA:BB[RP]\C\:3CS!G3:@"'2 9TZWXT
M;Z)VHD/9:!:I.U%WNI,$WB")^IHQ(D49>IW)XCZ_+8N=+8\/3Q9E,-8\5:L]
M)?JTTW^?G=T9M;[0HO?Z7J-#0/:MPABGZRF'2^[<<2B@._<2X6H?GOI8G<?.
M-[VB^^F=R_&^'+3TF3NF:%/E,#R]4L1[PT/;( 8(:T(N("("Z+'AO-9:TE<O
M!]YK0\OYQ"M76=8=0F)DR5*Q O(+O=,#<9U33/SC%GOI50^91J;5NPO\SH3>
MH<E/][>9_*%4JS 'QB=_^W]XV;SRH/5D_C^\#+Z>#[6JKK3(&UYC0F".=$M@
MCHYNAFUPD*YP><O;KM:_*C8C+&:5)^S2#%<B9=:=ZQ5T*JHUHWO+C8IRCO3/
MR#/0..WVT[E%=TSDQ&!A5FD8DG0<T7@P5X'X 2EE,U3L$.1S62[>7CW"Z7+!
M?]/?_#5/E'1Z#%UJU+<L[E'#>N*"/3[5WTO+(8YNP^+Y&!SMD8>(T/)%: UZ
M!KD!1RM06._Q,S5O8\5&%P!J! R:E;:8U*8QZ=9UIYS8'<')03J3)C!71)[H
M2/)%HSJ;/ J)9BA4L4_;R:81;3_=<<##5P :#+Z5XUGY^;RAA[M8"/A<DL*-
M^%Z:>H2;IJ?^C=+P0!>]@S@OFQ.COIT!MBF._MF\ A4]^2MO$.DN.J4NVS^;
MBX2\7WHA_7_PT_%WI=#GSPA 44^XBD(WH?.*B+A[LPCV+99>3Q8'O!?MV/,;
M7?VW-]"P_MAXS9]:>2.,87^,%./4Z\F> _NU,O_LKC)0G\[K5;:>A3\79<$=
M !66,78?PD=!KS?1FHY(S* ?+&1(UV==&FY3FP-,[91!;1.2RV2;VHQKE2RW
MINO;F3-+&>Q?SCT7,GN7SXVOK][^I32R(_9S 'K5\,'KZS^UBMR?E;H\+W8H
MA/RWZ&*>:%[KW9D=<+@0CK227,AHEK_PZ?2\@V2PBFR_NO^(F0&A(K,@*P1I
MLFE:8H/HQW,/6=#7N=+K'9D"T!HD6-A:.99L3S,EUG&BZ;K'SF&8$9K%#9L_
M/_\MU]GP4C'ZX/=U6Y;,NT*NOKM\6?G<L+A'5Z>=;^(NP-$\_3M48L:8=^+F
MXANW<_<I$AE7SG3<>_FV6.=YW[+0^M9(<VFW6T;9Q8V_;II],@GPW;(\)C3^
MX1E/4>IL2DU:EFO8SR?Q)XG'!__W^GFB'M#'\'/LP.V#J0/DRRERP93]7%T6
MY5F-C_]1B]?'QH(@8KZ913G'V;^P/]&V/\=E4F3_J/[[D:JAP+<GT:)(3&?P
MM!?_P Z.-\"AQ:[),J"QV\1'7",.##W/T,WRHZ-BMQ'1M<=9NG\IGE?,QI_"
MT;*B%!\_J>NL>Q]2IL[%+61>.W%;88\(M>\"ZDS_P[+Y"YU]8A_>'-&W/UM2
M[MQ9G6BO![FUQRH@RV/ T39;LY X<FK\J9I5-K'?IE91U4^SK0DUB9](/&SC
ML>/]_V,+K-O$\\TLXD$ WI/[3U72?E005!S9U%_@:*$R]2FXR"?4L8XU4W"N
M0Z/]5WO"N1[M<]J>3RP4#\W_T1'&C*20C-\1@/R2I[?87X''3#UV' O<M6;7
M#CL"[)FGQH5[$J+;($M8V='4[EP($,OLZ@J_7[4<$MAG./ZL"$UT-/.3NY_N
M]>2>WZ!6Y&IU['FQZ=,#@?<UNLJTC,T3[_N6VMXH/3G.;HE_JF+E6Y!1E7'N
M57$A>K*YV5-_\.G22-J?$MU\SZ+T6:KEMAN_^4=>/-/R\O\>TP;Z^ <4"["C
M+ENKCIPK/I!*[/L@U-1M3GLO-$:/.>>\-/6B06$\52U>T]"@&-&E69'%6#/M
MV,]P-^AH2JW-6N*K-P^M_S.F'1%W;.P^?X>PN0<!#?X!.QIIDD#6I3)MRB,8
MRL45'I@K+7@Z#,_*[ZD&)N9EWM!?U>^OJ(_7F;V\XC2A>+5U@C^D%GV::TRD
M+J>/GYU1-' %BW]Z>WJN7RE/^J&A1]!OP[9L9L/4!9VTT?*^UPQI)Q-KB<N)
MK<MG%JO3^VTKIA,(TG9Z-B65A$^ZA;):0:T]7M61 M" T0:O+R]>HU?[?Q-F
MC3]T(4A$P6D%^)I%KE0^?6)UE@&>S+_)#$DMX=Y@X;HUU7KTE+68B80$^U7,
MV0+ 8=TROE-T.NY6]1U8;<C$N=TI9I?;2X9*+J1NY//W1W,N84QYQ0+0+>CD
MR/Q63U^_E@#$4.LF[M%M9B2TRIK7#VDW$@6@VEK%?^]O--L..G<?K7MVU?O+
M.5%)"RD/MDILH)@>F(9.+_@@ $U.QFA5@,%RHUG=):.>'N>#3^G[2D0S-S55
M'2PY;<O-=>8UJ@Y!]G_HTJ=\"C,MG:FXL" 86]C #IW_/THJP35QM#K$KWC<
M-([_L7^17Z @CGN=$<7?@[G:RL,;^G%<T'";W(E+@"8KF9[<13U$*;+6Q5<
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MP K+M!UVN'XT6//@=S\3/O@@8->C;_52>HU;4C4W:WJO>O;:+LKQYSN(PQ!
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M>Q^ABA"R2R^NY!UVA] <+[!]RDJ\*M)]$J"!Z,&+<8\!.6^!ZEZ7C*A:R&&
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M.X-V\PCK"#XO-JV1I"P*OJ)(R0BTCU'VM2F\:%[H DX_Z^\49CE7MCS@9%7
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M[U_CF &Q-(<$.@2,7NYB8'/>\H<0A_E[\8=\FRK>T;/P8E3W*0S\<;FA,=O
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MCZ,Y+#L SP=#V<L^4A?D#;$N=5FOB!XK*VFWI8<-FN$3"W5'S9QPHI4>_ U
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M6]E"L^;FE;@YZB=%.X4[X5S'X>.T!@FR.TR!I%BP?ZW/<<Q<N0+! QUDX%T
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M=+;20,GB)VX5A?4W>2<@R"6"_L3)1<'F8FDHE"B!H60V-"?D)+^#*F;9WU&
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M5*9$(BHKD#UA^@2*']*3B#)[>64K<"5,BLV1D)9E>-OP=4Q=9CY.L +M7<?
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MB/9_#-D/7X:2'P1;$;LX&3.FPU^6K=8QYQH&][>T6>'_A*V#J:G<E<WDD-P
MUW9PR5O" 2I]YWE;"_7$N!N7P8^IYJF+.FKS[^'8[MCWF]XUW0VUFCCVK'FD
M0@C^3:UZ=O0E[GRA5K+!F,OO27?T]>4.]+BFW[DX<E+IQ/TFX8^E@XWZX9+W
MX3.5PP'?'FV8*\$,'@H=@ Z0T@ J%@I=@3PYX"U:GZ Q'1"BW-/Y!PHBM4L
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M JQG_9#YLM$W(;2QJ[L<XIP<^PG$=Z] !^RSZ"3I08M&V1,1D,12:M6N@50
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M#!284N9-S"'V(*7QEMA^XU0  BJ?UV19MH<8+P#P"5'HAMYL H?MA?71.]]
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M.N&X_P=M[QG5U+JU#;.W&Q78B-(%(=N*@! 5$$$@1Q$1$"(=:=D6I$2,*"5
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MFJCWA'8>2W%F#M\_N+WC<+^W]^N^R-L,DUP'DZL_!B$9'=BU(S#I]H8&Z:=
M)=AGU9!:N?@0>[<))14#9,%^??7?1QM/)%0.Y3?P%+1K0VH1!:*M]L8UP^0(
MN+]9Y1VR(85E13-8I*M0?^HB)N0U:/O?$TB(#&X5@U/\DM3Q+P:WEL'=LF(1
M"^C#O@4J45QK4J<S&72A:X&D9Z3KI,Y8^.849@N,V[G03@Q-T@SM[)"D2RH_
MQ66ZBQ0*HB5:SEX7>;-_,:^_$G]/O-SWY$NX'K?^ Z7J[]*E;Q/A 1[:/?C@
MRW-WS)4I)AIN7[71D7;VOF/?1K+V.O8 \4[Z>=XFX06CKVFS2Y1!3[%*)K1=
M&FB&9%&"K4S^U[MTW7> $G]9:'67RU#'*H+F@]VS,F!F,3Z&Y7?*@2[0S@ZL
MQ.,P+P6%^24%IK:-@C/8UMJ2PCT ]) [U69N\=@D%IGRDP*:)(NO FR>/'5)
M211+L &I@N)+P)>[7/+]69-Q"X4J?%('>^MBXZ!JD'E=/=["B$=)7O/?)Z!!
M5&Z<%(BV37G7@U)H),EY8_-J,N>L#C]B7XC%+)2E?.\(6U/]#.XQ]+O?_]5!
M_MZM]5+@@QZMPK7\L)/QW@>U294^\VOWK^H9WGPZA[Q\\FU\^$<'N3.WLS[+
MM6#R9Q\YTFMA/B9:H)?SU\1*.$C&9D-JAU"20;> ^B@ ':9B-V%7+PE(70@X
M?762X'P%VQ\!GB-Q3X$^7&0B8S.A>D*JR'12$^,E@ZL*L42>X@-YZ&GZC*1
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M$H_8?(?%[%Y[!!ZT4A+?!-%AQ9<(%\!H;88VH\3/&QOFEZ[90Y=G%++1XP'
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MW*)[;1R*#PYO>*U;SV7S;BSN_?F;UZ/+/R\XN5D4#%XP='?>\;1$.>U$=L=
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M);9:(CC-4S9]5O(N#^*M9K68R7J(+Q_YC/CY=%+\6>E$R))Y"!A=O1!BF8*
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MUE'^(]J5V8QV?\FD-F&X_>J:66U%#'')[QO"PN@YOW.F.7>K5@(>3'[<")-
M$J\A6"5,\OJROLQ*79 @0*C<#H8&\/+H?'PS$%G*S!$K"<^W\MQ(B?G<A_[&
MY(XV,):+4A\(0@=!LX0(Y3=+"P&J1*WJT;<-BXS%+3-?"5R$4$%7O#->BNZ=
MJ,[23F"/[]4QG<E5 Y7<NBGMP.=,MG2]0?<ACDQREQP'+8UX?;%'>*M)/?J+
MPY6;I8$RXRO!J(FU"VOR-YPGQ=3'8)'S&Y/X%://$HC3^F*TEG4Z9S=BZ,#?
MUX3S#^LSVKRRAH]0E?X*)":^!&+J J(],U0*=-5CKW"WULZZQ<8\7+!P'9F^
M?/EIR[6ZL*B*A[\_"QNPKPQS=D2YO6]MJSG5&,S?/%=P'=_;AP"<*P$&FA'.
M"GY>&N@"7K)T5$LDY^[ ?&7E)JXYQ,/52A76NLV="8Z\&>LZ3P=$:FMGW0D2
MJ]C1B'.JG1Y$]G.][# G#485P$A>)BMX>7/+^1((XP7,M_(\J+"[%$5+.1[4
M=G1M[QITUUM,R_.>+:(2RY/EH44>Q?9/$NO"RC3&\KU'8T3NVG'\),?;W(OC
ML7+A0T-+E(L3%%8I 4 QP2-H&BJEYZ"HW=+ZEL <:P'&7=\(HF0P^^=D ')[
M4HS/2MB4-T]GBLI,QN\0VL;5+HDM.MO\+.0,\?VAE5Z+U#-O8KI]:,<.WR4$
MB5/PFRDI+^1NPS%03Q%_2KD.-%7K%RT%G@2R+ A@QY.FN31_RPFRH],HF2+_
MZ0T8?KD5;*A[NU#<V-W($)YY(_\50^KG=\1^3%,;- Z=,RN<\HW7//?;E"6Q
M'[R8;\[JL@IX<*T[PL@OB^;>'W#"1\:+=3V-"_S=I5YS],8@1W\RL>SXDEO(
M):I+C>S9^@\EETO#^<8UN\YE&>C;'[-W>_^L]OI+Q7;XD5"&F6,;V2YJ/!X&
M'@A.M91CDT =Z'(XE"I0::&;XE/5Q-I3OL,J$P/K.62F&B;W$F]M96+\AJ])
MO=BHR//NY+XGQ@O%D=TY.0=:,ITR7LZ 7: "$2-C*U6!^\O?",E\"]4BEB%<
MO/, [Q02F'O CO>,Z#(E>DUCA@;-QCS!VZ\G#CYM?;-BQ/TGT:YMK#+7YF[?
MB8.C]TS(+<YKMLM%@LT\[,.$%JL"#G+Z'.MHF1ZH!A3UNRQ%UBXR/O8CIK_V
MPW9W'5-M";Y6G/.,!=^+\L-(:8#5MJ[)0Q/R'Z0PGB[@CF3VJVG[=S8W37XK
MF75P6$8$PL$#YD)E.!^U6>D$JPK6U6 /=/*0RTL @?O^]NPJS6 U$[;U0P=/
M-_GH%4H*6M..]0W,L#IP9,G#50-LS<S=25#PH<;N]YB,C-W_12MKV_X2[<%H
MOD6[VON]4_TGKT;ZP,M3A_6=JBYP_ ]WN>N_#BN:.KG45ZB5K$Y>=,^JNYR1
M@:W(KW$.N%+MEMO\4'E>SZ3@F7LQJO#E2FM>,Z+;6Z^"4CIR6:\B _+_1C,
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M-;RZ@9>;PUHU@^4"2]#6'K0#:-9O6L.[%?4CV),]FEC#E@DR17$1=R!' G$
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M ^(/B#\@_H#X ^(/B#\@_H#X?X"H(I+!]SZED(DK>%ZJ>.<M+CI% ME/"9=
M&$0N\TZY*+M'!^R9Z94^M$((D6 5NP2A-(WU ,VK/)<FRV \?+KI:76F1S.=
M+&__>N1R3G^8ZF1'625:_N69^&@-\/MJ\O>/T/F_'TYII/4.05.<KV?KOW3-
MSW?.L!^JFUU!GS8A9A'=HY,NDXR6'!OQCZJ4G5'%I?_-.1;IC BD4_G2AL*J
M8O+OP6>DH_(@91F(TNJ$<7@TXON%*:%RIWA,1Q"$7USC)>.HK';A?9 @4'.3
M0,8JKGV ]:(XJ&*K@(H,@XV'O+,9>H^V_/^T0;^-2B")5Q#S.Q!-<2*L> R_
M,4G0#%_OH6Q%L-[F?C\+79;*!@K12A"3B31OT2J)%3$EMGE0)$KE(M8.EG]K
ME4!2D9L5=\<N.5NK//=TME:&_'>TGX2;OT7-4[Z8X'L-$4M?^70)A&Z^3$<-
M9N.#F, MM# ;!C@@-X0BZ0N^#0M,IGB5J$F<O 3R8A]4L(\K@5CHIN=*(!@)
MI%U[(UFZSK4/S_Q_X!S1_Z.&&LT5JDL'HW^#1Q/]732 %/E*(%L-OK\F?:*)
MY6TED/O/0*[XE0.'*&[$WU7YOIJ!^F+]@;+^LP3BI%VW3<Q#?OQ^7*3]J2)#
M?/(TJR)##_*_;R3>K*A+ IG71@$NJX(+12L%$DC=U*"*N-]-JL?M!.'C</%.
MZ2*'*HJ:*6NWP3Y* . CML<B19FU$LB"\XD;4!:)!Q^&_3IJK2)RPI3_WPY)
M96.(2P*UD2M!P%>QK& S]>4AWNYNP!>[==Q2$UBEF6UHYF99(F_P$ (H!Y_=
M=9R%W*4&? =,_#5]J+5@NUWWN*$$PH8?I#N8&Z<?[D[R1.P^;OP\Z&N?ZR"G
MFDW,'7#M_9WK[DM2RJP?#WWSN/Y[K6-K12>YQCFI:GA(]?N5>8.8C%G*(9RC
ML]]4GU1"<8= "@_.9O:AMP\$FV>*]3!+?:C=0OW=Y3?;5!7!_$&&F,!NV&VP
M]-'#P>"DJ:/3A%'4[+Y(-ORXP=9?1&N;.50ED+O.N#$F<!$!NE* 4?7UOM,W
MQ&IXX5$X>$Z*U1U3V3]W2  7&J# ,]+/OXAG)9"DS%Y_J$"-(('(BM-%17S$
M"JSUED4NP^K%^S/\BK:@.U3NTP>1$7[J&"$V'"F3='_%1V&7I8Y+:PWU9@T]
MJ^KP<H-:^/3=I(=!IJI<#7V'BLYF2EWP!S]E9[]^J<S_MFVSJ6P$2*6E:C,O
M.$JJ4Y<0H=G!_-LM8.\3K&([L-J'5Q9Z3E@&XEG?NV[%FJ:F6IYCK<K1*D+*
M5#+[YW8[.KAVCPO#B;XOIZP.T0\TC];'QJ^9%ZD^#5W'V0HNB*D4)=PVW#O8
M'D0 <CO*2_P&IM1ER#L\Q!Y)-L*IA:Y/Y7*[;7V:Z;%^NQE3Y_-'GHU96LOG
MD,*#N/(_K9IJ('> .4/^8SZHB5;1_J4B?^_7S;0'5Z[G-O2=3%':MI^F=/9:
MW3;;;?IZ1[Z0+**I7VI,AU7<7LO6.!W+O$@)MK)V+7IW_YE21US>Y&2WU(O=
MAJF,^DL@@K/BEY36X&4"YS2T#]&*[QW1Q.[GP=);SW$0T 6<^>C\V/QDC!NE
M@WZ(0J^:-22/7T-YC:!O['<UX0^_)_<[TVY$?,5LBQLEV2K9JP!K-5?T+ON.
M+SG7[&RMM5GQ5]%_=M9^H6Z '#/YJ;#X9NB3=D<O4OY./=+D2"H!L$$P.CD>
MRS]7XWLOF,"5L7M:P6U$C#8'G4L<,T6K8?J@Z>A*H3X/G2%4XQB$=)T.!O@2
MR-E(^W4O $<49<J!-891AKI-91M?G8S?V88/Y[YZNN\/O<NOCEU^^M? E9K?
MGWYI,'+S4?-RNEQ]SO9V@<K)?V@D@_T!^FV5:H?S\]LO-,Q\\;!]7ZHBJ (Z
MQ3LR.8@,&&#'5,+W7FK A^9N 6^9P'<++_(*VGM/Q_6V ]1XZ5J5G9H4*M1[
MSF$OY0[L-AG9#Z:@=RU^!>%]34+$>(1IY]*J;*B:_^$Q0K^:1S&<'1E<].'[
MS5#+!,OM.E=T"P/#@]Y^JHVMZ=C[4M4MI-V]U-3U7F>\O5.5_JGJX=;E>:=K
MSM?=73,>QCKQXD]KM%>V?-FI5]%]\#^=S#=4$FP7>34;I=JCAM4 &N;N$4$"
M9ZH?M55H#,Q+(&E&<,,8#<-X6ID.W=*@<G8ISCLVI:[:)U25D5*'-JN*#JA:
M]/AK^O&8]UM_IQJTKE2O &<\J -=D=J(K528#')%@234GD*PXS:KY4BU#B%6
M"<ZP=.0@FZ4/R-('VF)%Z H3O-"EPI+REUM,@!!"F"8$BD<%M@75"97+9>=A
M8>R&!RR]P*</@OY#'6,,+O>R=0S<^\\F;:JCS=P7X@XGUREKU9>7\K.>5+P+
M#-*/\;CIL18A')*2@'_^^D]CNU'"ORE*DT#"48Q)ZH Z:7E:@!#:@2^>8(Q6
M+]*%KC48@S/YEYZ.HM?2T$8Q,P:=+P[=?3?GZ_/VW>O(\CRO\N0KA>R##B57
M2_;;Z$*3JHZ M=^NC?_"(?HHN"N'6K^V5W"I<7%.\B7J#9J'?0D[LO+8Y&%I
M14E"7J3HW^]7,P3G^$JBS83/,RC^*]!1H&G'$> 3.S[VY^[!=)Z?Z'+EX'?/
MA36#)T"-WIXC/&+:@6= .>4-VE0>ZXVQO33Z;7;[1[=1*SKIG==;_T6+/Y"F
MXYH2B%!9()85U>)[3?%A?K;\R/$>0S"8>UZ?1=J)^6K'2TW]%DZ0"].O LMC
M=RC9\W(3&TU1"O DH6-D_..Y6=LJ'ZEA+%POV]L#,-.V5Z*-VLWN/8GNXAIY
M-5C>XP2*:CRV?#V"<7-J^=![I/G14NW+$NH,8]#Y4JR;1[".#!1#"K:R=9GC
M%&D73 V$,Z9Z9B/1Q[_V9>B1+MSYCSGO:0!U!+MP4Q)(:Q%U55EX&=PF."6\
M!%)8L&V+MY]D<M![P)^I15J',ATF8R(5J?VW4_(F+6XXUOJ%18=T-)8FR"=G
M9P]/<.;.R-_W4(.^GWKI9S&IW'0B;,+ N3*MW+U1W3GE8,&1UL7+U->A_]BT
M:NL><<ES'#15]LV+//P7(_0PW6Z9$8JPG7JO[&P=]<M_R4$@WUQ4O(:<@?++
M05V!\:>Y7]]@?\+S<@?Y5DJH?9@\C<SNXU0^"1U;'68^1/3N4@I7KZ;7&Y4#
MXB2XR;]K*SB_XS8$S]%'/?EN+30%_QPU*$HEK9AX3MZFX?::^OT""Y. (P6'
MN2KZIGMM7%JOO%_YHZ19W<G1VJ!MS*$SZD7"QU?_&WEO&M5$^NT+TVTK B(R
M"PAI6P4! 95) 9._VHB $)D5A#32#"%"&A&)$))V@#":=@!:$*(@1(88!0+*
M%"$A^2LB\Q2$D- JHU2)A!*2<(MSSEWG?=>[SKKW^_N!?.!#K:I=>_^&YZEG
M[V\!LTRIMHM<*9%);K-F1Y%_E/Y4#W4](O4,T]2EVF4$#N<PA&M/+-8 N2:^
M0XM$>WP9K-.WAPU+<99%R K&S'#]A'8A&K2KA=EKEUV_P_'0Q&WU2E\I"^IK
MZJ0A84T(3902)+DKH\GW2G?U-6.O5<S(=0:DV$=OZ#.K@W+JYJ+WI6&X:[ON
MC65U)N/F<-=C;.YX.%D<J)\Q"[I0YW3NP)S9N_V_'3IR)D'Y?JU;?%5^Q9L>
M1E:JXYJK%T>L?>#7EB*F-_*-F\KYO05FOI\5]^VOFURPK+18N/J,U5C?^ UY
MOH0=A(03M$T/%;V807NN\QBF:40/$0V<Z)\T*IRD9;0>HYT>E 9/;47N0U(!
M>D>Q.1"9SB@!EFF<.9D2R[PKLFV5)CE@)7ZZ\/\ Y)CO)H&32P>VA#J%.^F8
MY1D3MOF=T3EL4_8.@!H]> SE1G/?FQYN#B/>MTI*/NK<OWL?/V05T?PWK'X_
MG/9R3MF8HBF'R3A%^@?\>T<:#IJ\[OXSD,UA&/"0NE!DM=1_(+;5>$[PF5*G
MYV3[F%#:UJK1W%#7TN-D)>Y\DY X((TK?8/'61:JUHYVD,TG^ <.ML5W9?-"
M+TMM+T78M3C9Z:HI>K<D,?.*]AO?NS]1'X E\G>^LMU9_L_XW:!ZHK5S\KK"
M@L>:G?2$[*]6E/2,K+#5K%O4R4Q'*"<TI:AP\T/4!YXMDU4_?!B?<;C:@(M[
M$FV_&DM-CL<B:97GWS(2RT8^[&GJL*V[?*H3\PCU'"%5UY7T;.P[2_<-R^VD
M:B\A%Q&9(D#DX)LW;Z&#D1TD8Z"#G[[<9>[>QPH.P:B.3ALI@E?R5SWSC5BA
MX?%5GI?F_QGT^/(@<M_@1&XE/[PSZWW-P^T8M"TO#!@A-M9%>>99,ISU;?=D
M9!8I*J4P<5O*?KH7:Y];7>BG'W__X1Z=?YB$LLKZE9!@-'_5? 8E6)$$0 _6
M-.6]*'5V!"K;WDBO"<H"VLG;CXL-F%MF]8LK1(5WQ+2M44;V?29]MJIAIP!Y
M:0+>DB(./C3AGO-+]\J"&;>F_46WE0 %H#'0GH"%C:Y"%H :%;E7WKVZV):C
MQB&K.87B)U.BI&=!2D:S(SGAV86H^B10/YA)(:J*0=LG.OJI#PK$7X(T(OYV
M^2G^VN6Z").C;Y\_2' 2:E(Y/9UF_9Q!>DZ%X]DB)^^;G/>'ZRMK'NXZP/(^
MHWWT;:QZ5KP'78OEZ3CS<4!:6))[O^IP<:7;PRO_/F*3._/7_^U..;F<*C6
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M)O;.6/,?'S(L2W)#,V/,(ZY=-2JV8UR(U;'Y.KTT):R_5;S=Z5D E[?=IY1
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MH=@.ID#^)L)B_K=Z%@5\V+U&EO^29RZ[<-Z13ZZT26%*^GG55H/DNOW)Z C
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MKQ)%6J>?9OK3H5LE9EWD'II0RK1GB/_26S1RMF3",7?)FM O (E/9J)3B(=
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MU[AQ45M$N%_F-WWNJ4'>H9,MAT8B\^(\[E8;N;IG71.$]!F__K+Y>3EQ/&=
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MG^T-FX*9VM,NX4@X2.\A[8 \U8MJ_:=F?? )W!PF3A:D,TK@G>U919N_KEP
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MW?(]&:@V5"-$0/L4I434N)E&VR7YEP[;D@E?F0KF?:(NB:E@#E\V*=J>].K
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M?ZIIC,58H?:F 4*S7S"C.\0V,K6T-_0/35["W(5+O7T$G(T5W=J4JD/><^G
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MR!_:^;C,"(Q$%]I0E!"LLC<S+XLM]2W57RXF6%EZ%$QQ$ZEM(DW.,F)!FUL
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M^9\/TC(XUJDF5.%Q7L'9SMR53$A#&,S4NGS_"T:'*$-PF;@"Q/9UP9W\89?
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MM[5.,3KPF4^P";J?4L6$)="M#NH6L..&Y+F<IL\5OHS\1;H<=+,M)8L^P0=
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M1!5/;W/:=05>UKIPU]')A0MMJT=;.8-98@X:JD:X(MI59 -YL2]HYD[_CGV
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M!.F)31/P2VUV4ZRD*HG4C<$]D*[$2SK:[N0[(4;-T]2UDFRBU_4=1)6+'C#
M*L(J:-JYF=U?$<'0W!&NK\TBP!]?GWH<ME)Z<K__YU;IP> +S_Q2$D^^O_';
MQ?GR\_>4F)-IKMQ#^\1 Y.S#=K<3!]EGQW8=:/^54S5^RK-E]8<3UI:%S4RC
MLDER$SZQ\:*533_OG8PZI#-+")FE^\^>2YH@^LQ?CT2J@:"_KQ84OJ,G4U>
M>3=$@![E5VBUE/K)4=^PA;U:6DQCJU)^@0#)1C$1ZQF3U>9K ;TWO6(=(<:I
M#4*6[7LJZ%&BINE$JC:/XK2>=_G-@/7&<]FA?[ WP:4+.ILZ,E\/:PW(N3_
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ML8E-9U38]QA<-"KA23"JT6/3@G!H1PF+.+4<>/7-7I%S4?ZXH K@TN/IJR*
M5!V4I+!Z6;]QUK#T17B=-T%6D7%B$-:Q<@P$R;GE3--0BBW99.LCS],U/S7M
M"/YNWN7?IP7^HP"6(S^@'RP'6FQ1Z!.&NF0YBEL<83:Q2N5)US7.2B7F#*!)
M/O($I3.&[7C^ ?&V!N'02U*'E6+@86/>77#(\76MDVZO[H6/!ALJJW5N3M #
MK6+RZLN<_N23LMUS+&<B0WO-6>H7DO6Y1U83UH<T;+Z3?]=%S_""T:<3Y^Y=
M6>F$<?J['E02E4\$7=(WRPXHB@$A75!M.X<2DDX^?6I":BBVY+[4:[_$-JD%
MWR=Q Z"+Q1#.E=U?>W!/&';"TF"KSU%!1TI=G47]Y?TI(?L*>=$F;76"(C.,
M"_$**JYX\/KE\OU(-P"Z8U,XH*.^X9-&6M+L]*)@W&K65N%TNB75*,;^1ZA8
MNE=DY/U<//W=1P/->I"B8W6N;OYLKF3J#*_-@[TEYQ"GEZ42:9SP<G"@)B-K
M3HR*VR]$9#D*I"5K>Q;N?ZA>CW83.P$L=H4./C!LHZ^G6,>U9M>G,B@!@!%D
M>(SF]+C_0=\DC!<-D=<@PF?=;XJ*6A*UTO.F1NRNF_;\3R[X SW:@,_5>"X@
M/\Q)P\]6;_B;ODAQ<'D7*$"ZF1*LXMQ?1ISOV'N1)[OQMQVR!I48305AI'1[
M_F-5U?]6DR^4OXD/%GCECX[:@VC/8Q62?[&P?YLN:@*5F$_[:0]6*S&$F\AV
M5 X);LC[;;4\OOOO)IO^550^HX1C245_#0.+J*&/+1T>SQXH+OXX[U_?"0QM
M.35N5?2^CNX7&FI]0&[F_:-A4]--/7+:W-XC8<MNVGXQS-QW*_SF3OI; O^6
MK%M! \YV7056VQA17^/6VFB_H9B G%B*;2FYV*Z/8B]RNB1OGS=S+_&+%!FK
MM7P9UR1(?/S:OHR[VZSKM38.(D6:-)=.9%]*?U<=O+M,B3F(!W_G/<'%TVM-
M8:WGB+I,0;<Y !&0U<QXO+;-+H1OLTXZ'0_4LYQ$M*DIC1GLX/79<DX]K%\.
M1;?-^X:63Q7)G=,903R_YV],O@_;9/E1)Q80\DVAC7-7K-T*(.YA11S+""@+
MO/C\HG^0)"P-5Q/6QE$C;*GKY5M-&"R%:-*D=M_ETA6+C)(-C'P [GQNN:71
MDLD?.J-"0JQ_Q*F@/)4ULD91"03@(<N;0YVXI8C:&]A7<9\24DXY![7(=\.K
MH#C&27AK+\NQ"+K5-L V $_SK&W%.\))$2#"L4EB4 C=3',G#^X VQQ\4'E_
M<,S7I#L\Y**#] 0]4H2%MLW!ZY>(I^/+I%UB2WA-;QM''4\:#N"Z0:\$,BI(
MFT0%=!M0W14+^ZRYF8XJGWA^1N\I3\C#M^[D%*.&L)K<VO6$UVB<61\=S; M
MAFV19\ JJ/.3$@.9$J>BI,]E"RF$3B#=. -4BPX?<.ZA;H9"J.O)BW^4^@7)
M/+PB6]5Q8L/KK/V@+,S@#42-#C)K4M@?3CU5]YJ"\X_2>%TCT";9X/IG#^*]
M>L)S."L7[OVYA.HWVVG(\#90-9(D]P-:%A(1%^-J:5,-X,BT2'97:B\V[:"G
MX.H,TVKH@YQ.!-?<XW%2 [8&>7&UEE)7R-2G^UU?C>DR"']8JL0D6WN6GH10
MYF\+MG'X'GR3G*(K,5R4* \KRCE!IM N#JPAX.*U9@BI6;C*XJE#XBG74=%(
MO90GRHJ%S25_S1"U*%NA&_<=Q 0=R/N)@;DA=X(DQ;=>/C&06O+Q\NWJ(Z)D
M^$2Y0P'!:NSR<1HTM+"M#7E&K'W $$WS3<6A-'20J$%Q(DX\JA)0]T$W@ VE
MJ;++M9"Y4&]:G=IC8PIFQ2+J;\EE8LMK\,684OQURNJ'D$S?S:Z.U3VC;Z?$
M./;J<"W2.H_37/M/-RK4E)@X6^"].@X+3#91HI28O@?\1W@A#Z\-$0F0^4(R
M$8@$B)T6=8K-:;"V1%;3SV1]%U4>-#!B7MW#A+7!T-9.MT:PG+>C8FAL+FM$
M4WHB@_%N8'G(^4@1?94W=_/+@F"'<]_-6DZFRST6;B$$A,T<T)TPZ-A!7QT1
M<U$6K<A%L,C3^>D69J);T/R2"IHPG2BV;^'$YVV7%BD8LXFW@BK&LW1'FLK'
MZR?Y2%DI(X[X=FB,Y$_:&,L^W4=%>>S?J0F8]#K>5!1H*L,I2J?PI[%O5&1;
MI7VH,Y^^CL8IH@IE'\ALHU^GX_!!1#6]:+H>%-:Z7#Q=71Q'41-VK6HQCY\?
M38H(,95?Y-;IVMQ?4R0>WBOV_Y0L/ B\L4?<%Z[F_J#$#"Y7)"@QLW2;93Q)
M,;PZ"UD>)?^!<D+Q>,&;5W9.A<AM$1Z^FC"U%YR3O8!2I88B0JL2DR"HN0OA
M"N#?%'2J47#BW!.BEO76/X&SKVPV!?,SBMBW8A@3NG99 9&G_X0*GKA[911:
M[@4"QJ[@'@E4V'BTA8?P"S=8'R,,TF1ZBB9.D%'8T)#LS,+Y[@F#_=U @"D_
MM<U&O1=91_&'CDBS6G6IMZ)-N5A<X+S-?4:@[P:0<VWK &M_P<?5IX*K@N?K
MF&++@1F]W,W.X(=:X0,IH+L0[$X _(N(6@YJ]4WHFW^GO@1J\F$M2$5(2"16
M5["5&)V(,%6R1[LEOEHEEG("Q KGKK%^YRR##49PE0W2^@YLZLA^:<T-*."D
MM#@]I-QF_9@[^P?I-MKHL&=0XT\WAH$6$XXP'5?-A+4B93A(0Q(VA).]ATKD
MP9X4]VX;/-(%?$\Y+9UHHQL8SQ!6PZL;JJ#:(A)'TTS=4%119V- ]G.O C/Z
MH3X6(5IT("::ZV68;,*838TQ_;FOULCT@B(>>!^ @TP"%'_0WO@I,9YSP@P,
M^56M5 51!="A>AEM5SSR!+<2'T@?ZCR!_A6'M G 8_AT"WKU)0:^'9N :($H
M+XO'KZ,XZ"<E4I:&H]$:.V[UJNA\83!B*+5/BNB:.N#=U(4]]?&R91K%4FRZ
M O+V,%@C?54OP8$1S,E9^4_CV8:3-Z2.CHHJV.\^O!5"(;-DB2(#T8;QBKR-
M4)#(D:D.;X)J ?"+9,LE7(U%EN12_P;I=8Y8?VLXPV4S>+SZ(Z+SV.E24.J1
M$F]U.\DD!]KGC3@'(.IRE#!PD9=*S#P=QC\$A..ISYUP,@?%%=BIS,=[C+H>
MS(*UZV6.4L,4UJ&'7=J9R2+ZRC=DK.0SD32RH3_4RTA=S[8J^IKF]/&^"N/R
MD&RR>U#W7U>OX.VF(TSY]LCRA5SVGQ0,J@4<H\AG741KCH-N@!ZM=&T@4'WQ
M*6D2EZ-&6=^_!>Q,8.M_O/@&WIW)%=FEBXT.X%>,63$34=&B/<XV?]QC\@D5
M@IHD':OZP1J?Y29"^+HBBW.6".WB32DQ\@VPN8)MAH5,#.Z#' FV$_5H070]
MMC:\%B+*\91-_6@DX"0>$SB6D&ST(2,QLTHP<3DKV3DY/#LLWCJB#$K]6:IS
M#<8]/ FEMB('P,YVI^C#?=L&\ 4 ?R%9<0Y5@_H<A]89?[WQ4YP8-YCT(P24
MC@,:LR&67$NZ#KR;"2WV&!(-N_<05T".#E(_,O?' 1TW*W=&R)J[#S^..C<T
MYYPBQ6@*7!OKD;!9++0I#%[] GDU/SVU,#OR&,5. K5G88ZP*Q&QA#RBI9=Z
MQ99/NOB1;2[4%QJ!F5['+[\<*9,2N?,(QS)YM'M&/?)PNO5YX5>V49 7D#1=
MPPAHS=+53^/[/+A;> 7X28EYU)F,)X5I4Y\1ET8 0TR1((&J0QTP%05.L?="
MA"?S2)R8N+Q3?,"QZ4Y(K8^A*SC 8'RL[&($ECT(]MW8$_[RZ-S/W:P3YRL^
MLG%]M9R5)X-TD3*I#JS#$9M.G0>]D>6 _$<X0I%BLS%8H,XVIZP"5"B_/.:%
M'\"JCU^^S5$/#],*DN&T-J4\;Q_0+4YZ$.< ^I:50E6*L'*3 !)6?=CDEE;V
M4-##MW.PWGMY*$Q!.P'ERRV[V1J4:$71ACH65!PB)JR']_;!YP.*O#YF*C%:
MDS;ZP4__? /_E.54V9C=H>[GOL/FKKADE[&9SY[I=KY)<U1AH)5=QGG_ -R$
MH(V3E*<)-8$2L4HK@!M;P]X &K:AW0TQ1:/IX7IOC#^=F^4L)_,.<T!!LEEJ
M$^EQJ'&H<82QGEMS]>/8#R/146?N2K+7^9VUP\!HO(_- EJ.LL*$3&B328;\
M'/4Y=5,]*.BD\7-$G,GV8NJ+(/_3ITO'3:6FLGL#UHN6IM\/FI?=K?B(FO4V
M.: E>S1]-MH1I^GUU8)/3RBJ9-U4=]A\M 2MS[D%1P(-=:#,AYZ&T^:$FB9[
MY%DJ_@1^Q5T#:GE<VA"QG1$FNE.[+()^A;I5&M86W92J!F#'V-I@ABRGD+*I
MC[6W($BW[L9ZKVT,BZN1H\'%KG$GY:9?4%_Q_5 3=%<JD-U?N)$;:-&Q/LTD
M"TX-H$$N38FI+YYB2CD2675)(,_#=QT; N2[H6+'L$'O#O>Z['A^<\U ED"+
MNI%<@/*$3P$#?; E^*#Z/GWERU)^\,C:M G47K[(#C(7#205@+",#CH18PWT
MFOM9"[O4G_3B?S--P55_2LTGGU4WX:)\!MD#.S5#N^5V8W,\OG_9A,&N/O;^
M<2M\:NBOV6J>9A_-8XZ*'&D:7A.KR&\63^L?D<D6IIW(D8AZHJ( $!8A^R%Y
M>:"@5J6=EI*-;5=BKN9MK $Y7&DDZ"9D7L>3.''$I? !\,O//?97&=:['W[D
MC6C42:GUA422ETUS*3M)JLJ/JG6,AHS+:\)Z.-#..2Z!KR-18F"-6QT<#=9R
MN2>9*PP" ^#5HQ)<._%ZHPU-:*H*"1!=8NL7Y!G_>I,82#38V6?M<'X9>"E'
MW%4U7E>/[ #?IXULJ43XV3$[H_$[3X99'T#4AD"U5GQ5/:QGB;+2<Z#N(=0O
MT9XL$*[*@-:7:\;U;?2-9P.MM>4$Y"5?:V0#NSJ1]$<C)]ED\I.Y(C0J=#J4
M&9%^=%XFFY__+(YNX!P"@B<.O+1'EMG+CX[-QS!>*A1HO37=),:YZ>GW-(=]
M?7U]J)W4+;'\@0'^]U$5)J';PA.7;;3/#/+Q2U_W9M%W8!*LYR,W1WHY6%19
M8P>)DJ0VW%!!)WZMS2)(B9']EOU<-#IYJPS>"NHDPAO!B\<&X(L/)BZ;5!=0
M''I#IZVCQ-$T]<!&BR;1PUVS#:N=67'M6?6II#-F+W<^$T@YB/JP(@\O+.#4
MZ<"K#;DV2Z$=\E\%*$8.*#%G!6B[==E&COF4'R$?8;J1F-@QS=\K=N8\]!RG
M;LHY&;9Z^*.N*<J!XW$K:UXZ\[A\D__"V)N'-7'U\:.QJ"B(41%0D,0=+4)<
M6"HB4Z6*2C&NH""D2I$E8FH%B1(R"D)8Q-3Z5BH4X@:("!$AH"P9(2RU%)$U
M$(1L562)F:D01C(9?I/WO?>O>Y_[W'_"P_/ G,PYW^]G.<OW9#U\-^;1DHG%
M.J2Y!E^*=R2;HS^W@8^TJ#O4C"] 0&RQ5K>T'!9DU&Y194!FG$4=M3M4.8R%
M8]/^HHM*X:(34=/O2W3)POJ"P7>M#\>L ]RDUE-7SCZHE%9^'FA;\';MK7W%
MB ]FZSA#VL"$30U9()\Z_9^!M[.)E#T@EQ7B9K-@']PL4D\'ZZF0XH%@A1,4
ME1E43YTSP9+1=2>,BTX0F6T7A&@;LKJQ;4H#PP]Q%::4?O?+.U=YZI_I[4W6
MXM6]$WQKU$?E]3MAB&N/*@OAV56"KEAPBP/N/\#0>P^ HY/"$=E5(!L8(.L:
M##4SI&@:NG$XE4C1VW+83Y#I96W(\ERGWX%M,.XV8@V4ZT3=GE;Y;'T+U_:V
M:LG'*EN@@9]D2TUS*?&5A#8Y*K1+(VS_"%F9HJ;WV(3T<'8MH*R#_>_##>S:
M8.IU?!E8?\YXC0I5%/#*+D,K"VAAP %@7Y4ZZ\8/L$U+^T(BVVUXGO,12!=1
M69,NZ^U2VR2[&L@A4'FO)W _Y/OL-S6%C*@C0<Q B\HRI2/UJWJ5K\91%<+[
M!RJK:FPCZVP))T"@B^*)@,3=64&UJ."C&X37N21N!U .--)LH]QLZ<GB=>UP
M3L/TH"#-DZK,C/HWP6/^9'./>"W'1\3;=^?/O_EP87 E\\O:V]XYC?(75)$
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M5'(9J*N *CHPQZ*6(FX;8&&K^#BT\.5+J0MM292;;7CCX,4&+T\X>'(H@_5
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M14S^OJI>Q$,-F(Z=_:TO6NY4=U?1LB._H#C:.K:-$1MSVJJP,'\>CBM17%*
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MAX,R>0M!U0WG%8@,FI5(9X_E"V^_55HWX.(%6.(WOYSY^]CYZVW]N<]*R^(
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M])>PX.+^477M]:KP,=&:@?)!X =0=9'TGH.CO<!8U)4Q1YA6UX2-*O, U:\
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M/ZIS@9^T.S@-9K-)R/B@##2CK$;(ZH4YZF[KEX]5-!MFTW?WT@XW0UV9)]Y
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MPXI7<VE/D.*R@5!M4WQBS)H^YI1[\&%X7OWE1Q]\FU*E-V,<8=XG<#<!=)-
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M$;D&L'MYKHC;&GH2<#@:@_R!HX"P<-<=DE[^7N'SVNZ[10'RT?<R/E%RFC]
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M0_/GTY[DT*7.2U]5KE9.]<T2+G]JH\^];?FID/ZKJJY#%V?\@4TPW0&^%^0
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MR<7,3X1HN .-PZP;<=D-1P*-GNQ=,+>5KOP"O,)W80<9#X\#]AQ?I&8DN+7
M[Q\B2)]9A2UZ@[1_/"RZ+O-P$HO[JL2^R)7XR#V_EB(WM1D_X=+N_:!+@"YZ
M AXDU2M0NWS,"@<Q\[QA3RXEU1C.MJ([H"%0R<6SFFBB-C43/:XUWR?RH]F\
M^OAV<+3H5:G:%!?R%#Y]JW3<Q2&1XUX'7RW6SH5T0^WW&M8]J5&P=R8\_(--
MQ&7$'307TH\+##&D*K#%G!?F=3UBW(@,MDOL.;8L,?$RWZ6:'5K.,FHW%6LR
M5K53U\$G'YP=^4S2'NFOJ&#YR>J*.,6P*^ XZN$H?)(.S$_P<'_:**I[1D G
M$<DLP>L4U@D8N.88WOAGT]T'LP0H-1B]4ZKU-!72+LP29O[Y5O&A^HG1%7NI
MG-8E:>B#E6'(&8-$6=I"MZRFSF'%:0O1-1@ET[A%XSW<I 4<WK+,Y7>9CD'0
MN^G?%90(K;5>-Q0D]>.L,9??7?NT[EQ=F*$3QP#MJII4G0J*.V"V)W(N  FI
MB\>5'S*UT4%2P.P[FG&PW(]N258TN.L-LP09SY$5U IGY(PIZ34[JX(3SMXJ
M_/G8GB\(Q'=$S/8;9)XZ.L0 XXL6A+VFUYJ3L]'U)MX?<%P;.% S\KY#GS6\
MA<E5=K1X']+NOOHOU:*4@I".:]("=:@#O=>7;/=22W8X)D\O:U.K%K*JW7=U
M$Y;7]YL 0YZYNB4.!W 6$D<<Z,0-9VU]!]^<FNI(E.%N^UV!9J)Q**3=CU_O
M^Z[I-O*P>UPY'@#:LB*[9=+P]QU%N!#_OF4LDIB%!LZO>HC\\AG_4O*$]?-;
MI8)QHE8E)67/$CS$KHA,K6_GS6'1S5F1I-&_1JE?0>0KG_*CS\I*EG?_<=,K
MZY*1)KJZ]_?^PIN&AJO%Z<0;&66)=><BJW\]FW!_('(H""F#)C ;\_MZLGV0
M['OHGFY);#[-3C7J*DH;SM> ER7.G"UH,)+.3&=F..GN^==?Q#&0*4Y6XM/M
MW7KR!8V(S'2T1=H^B-WX>"+M]/W)I_<M_Z2A3@Z&*(0&-6(VW:8K[!/F=. N
M; -ZU%0LB64J2>;S=6M-*]WNU-0@C<20+&#OPUD+Q[>??4!;Y;4?HN=00OVR
M=7I\.ZU$P:GI"9J"]<DT[L^S!&F2[Y0\.SE %_EQIAIA&&.QER1''/6E TJ<
M RW!2/R!:<P))=FS=\*N']L]EGJ0(#*W(^>4**)RY\C+2%FXI)M"KF+1]TDN
M(!5[);V[AW.3/?K'OK[H9UIJNE$V2\!?]GOPY!OP>U.FT<NX:O+<+&$ ' #C
MC)X&I@$L-- >9UPWN4QR: .8W,@G=WYF0-=;5="I0M2.W ;:KT5^S3 ZCZ6E
M3 W?539-9[&WP'$C8#;5;2AQ;42Y_6XU8(ONZ6$#I0F_K?[Y!J3B)B4SK9=4
MK:C+L-&=E%SZ9/%7'&X;-$Q'3 $^"4>7?38>92^%Y)=]^5P^M)^^%!OT6&KZ
MYW>]M1G!LM19@M.G6];JBG9OHHRZOJLC3U<[WS7U2@HS-RWLTKRWSOW#'G#,
M-2W3.K$H/U'LWF_?^4F/V4R8TV!/ G9@"TZ'?QC,YQ70;2AK@&8Y-XTK(^4K
MF06B#+7 )I%NBX:J)8X3RE/F\A$MY[4.)#,F6)Q068XTRES\1?T_)7+LX?G<
M!R^9<8%O^\-4(A41(R$D#>TBZ@GU:"JR4$ -<(<M(.R&AC:?M45:=*0\5R-9
MQ&)^79LGV_<Z.7JM=-VI29\)ZVW?7U(J%URS6_SCT5] $B4(AQXX_VUQI1R!
M50=,=Z;D;_*;ZZD^?<),;6BP+ S;@%PO9R]OA%>]K?I=*>+/\Y$LC6![+QY*
MVAR#'*=L$%LU??1L;(1:E3=:I[L)')Q4MPAG"4LY'EB7RES@=AMWA"E-8F+V
MS!RZ_2PA@7<!6P^1<F_V:U\0'5@X.FH'ZV@&\N7)*J:]VZC/4%K;BK[:_TQ9
M,[SW)1L[F3HW:VL5]07QCKGI['FPQ56B?LIW$OM@;TA/S&@,U]<.730THOU0
MKY;GSQ+<P1^8E\6^IG]SMB2H').#?OAY8G@S$CL2Z@%.6CP:CW0?^B/F2R&2
MKF;:L7?U^\P2'!/#Q:MZT9WE\H<)DN>2&M6DMW$#]D+B!,2K"N@$CF,42D&N
M&R-9A3(QV5SJ.I+5V*'\4W"5O5/CQ7-YBYS[,"CCK(?#GFN8\P;'?D(^MG&^
M+52[.TB5AZ^-Y\]KN]*5,'/L'-T.ZZ=#.P!DM4)7 7M%(YVPQ+#_-4E;GS>5
M()2[L"8TJ@+Q*O:&7I3^<*C587\O>J@<I<)Q7-2W>GSFW[\Y&2H$X_[+L!62
MWH-1@[<B]^F%:YL("!%;D&"D8=U;2?4 Z@AB5M=@+\,C<Z"!/A^(]9+,8X +
M9PD,OO-P,([8SRF&-UUM5[72YV,K6.\Q^^B?WK>[*K)2KE>S$M_I]R>%'*F%
M*RY05P53!;'W:#CXLXZG]R:Q:XPKL5;5T_I)-Z@676*ZAEDC4>H*V7/A>='.
M^V,>I.+(/F$@2'\F%#Z^'@V'Y[.//)S OH3/U9CXL;$5'0\1/KU/H.F9U&T\
M_NQJMW+)H?%$ K9;HA[D?PZG:>.,LX0Z 5:4DF>LQ&S.S!+^Z<212?18#WWF
M#5 [CW,7>REYS)VL,*[DO"KB3Q8;*6RO64)VNA&8L&RO. A9HIXD.S3"<!VV
M7WH;YJ%'8K;!W%PV@VAH#7?P_$ )=C%P3$KZFXC#@A3C)DXG^ 7XO>IBC*6I
M"#S)^P*W=$+$$WJ+_ LA_UV9NJ,=>-/13OT2MN2)]N%Z3^*A05J!\SB@I'K#
MWS95@JV#,6(C:5#<<MP0_57_JU=O+2"RP6&6<./?$O5SDCF;\CC?%*>ZE))I
M=&552LT%W3+OX#"RQM4E3[3O-BLN"N%"1,.&PF97O\LI!0&[^]AGG:]!GNJK
M_(>_J4T!!Y_5-<(^:2>,93=OSVSTJSQQKC/II^]_O412T;_XVS/+ &7J2*'N
MNIK/);WAU_)T:VXC;C*2*V<5**6/O S!' *)&@'W$VTALJ$#L[.AM[E@%I#>
ML"E3\])5IJ,Z0.+L\_=-/%VDL,WT9UM?ZRQA.V<0A/;2$4]S/E8;U17)-![B
MR!M2KU#_'_;>/*J)K.L7CNV BA@%% 4AW0JB(D:;21E2K3;2BAB'EB@(:0=D
MB)"V!8D04@I"&,2T;2LM-$1%&52,C%&&1 A#V[9&I@!!R.3$$*BHA))4*K?2
M[_J^^]Q[^[GK?>YZ[[?N>[_^HV3A6M0Y]3M[[]]OGZJS]RJ&9QNY ]F@H38-
MKM.\%>$S/$.OW8YRB:J-N4;,(MG >4U3:8^*(_E\RH<A=Y*]Y[.B#%)ATIF;
MHF+J\YC')A\P'I[Y1O\+R8K!1DVQW'?&"[A;]RW&='V0A=8??@L16P@5'NE@
M!#Y%MO +.)B0C*YEA#<#B^K/R/%FC#KEY@>Y>%RDW;INUNK(E<'/CK\*9J3X
MMT\\&E6D^$/Q61,VP '] Z$\FPI]0^[ST$9K3-JXTLOH7!-CC<8.P;1AJ?.5
M"Y545!HO6%\%7[H)_W%PZ-*0G0647YQ2;</+>$$+"JP@KHNESH^4CLC@2%[U
MK,J'G<L?GM3[,D%] 6D.J\OXZ2<%<M*RX4@%/0N<PXR.ID4KJ3,8@N;!(<J;
MIC&SK0$-:=\<XPL[)I(<]U178ZQ!WU[_0.*:M$TZ:,#M%%35):_.>>\D?XO8
M[,$P. +;:H*WP(T*?*]NEZ3>5Q&];60_)$G5$)64%DXFBNNHGB,YH+Z_SGNF
MQJI58 \),RY>GM=A9@<LC1RTSVQ21\>5J#S1_*)AR7>$' #:1TP%9I+F,/Q0
MLQCXJ&[C(;AI4NZ1AEG=+5EY/V(O@%/"[@^Q-@FAE8^P?,!N.30QF17+M803
MFT@.[?6;$X_>]8V[8ZS3QDNK+K-^'QG[;-_F#F+TR@=\]#?:&Z+41NNFSP.C
MA.:H&"7"D\;"A>*%F"\MP5*T#_)=F'W/ 3G>F"">36SAS1ZV9I4J9(N3+C>R
M5D%J3H:P<KRJ;HX!]Z#^*$U), OY9+=?FWUJ7J6?8V?5-(0.-F[!!(@8#S::
M&?U$9@Z<T.69FCG)Z8AEBG8Z+(R[$[$A<G)O1(&#O@9CTO'YV:<>=XRXGZ:&
M<<E4Z\@GT+BBRZIVU@WZ_&(5,3M!4J=RLG7-XRYKF3*6AMJ@SV#NAU+0V7T*
M\0QF0!:E _5@20=MX6K=-B2FH>>\Y^D*=*.^.+8T9VN#Q'D?^>&C]NHZ0FHY
MXEFNF7FQ..S,G<A:E'O'-[$X:#M!:\8> M5<[+ZPG@/(;[ L(>(Y+(>C)D^!
MK1Q3IIOF)XPF&A/V3V9Y@XJ9'=Z[74?R5_H_6H?:P95-E*D:;ESQP+/H$@88
M5-O%]"HY1W= KYQRNWWO1_U5'&[:8QS.A[T#9\ !(/R%(V*>I?U&?P<,)R]B
M6L)Z70#Z$I@&1,OZN"I\"Y!*L /"Q#A6]Y?,%233V@>:T/*R=[D];-*BEJ-E
M(01\5&V8^@]K=L9'(?QSU.#Z%\CAM2O)E4^2SDQUZFQ9CX70-_BS,HC"G<ZP
M41#4AW6AZ LJ)GWZZ JPF9ZQ&_92>K3B%S#/0&01=3:C3I30TRA;&DE=X!T0
M!HU1\;!3:,T#^,J\MB;/G@O,37>DP[GCYV-B[KUY*(G-,B-/V&@Q!DEV !M=
M ?G-4* 378MV@96L/"68*;%.JN$ S1P36-1&G<<,5IK9M?8YKW4=7T)EDC0$
M=C0241MV;_'5!!_CY]H324>_[APM^YAOL_=!!W-D:4.GUGB(CH8V@] N\NP1
M 5Y_$9W&"%;8DYP?5M5IBC-^^D#5@,U$ZX##^)RC5IFDY; J4$/(C@M8L>O2
M.-&5;BK@$S#-GW2'YA%J^Z+J6ESV-R_/LC8:A1#XV@6$?B#J<_"]8@-N#U>Z
MY3)JBDUC-2:*4V* T7JTCSJ5Q7HVH2N'PK7NF- .EUTP'KM1SX'8BC9D.6"%
M$6[9J<8">_V-^I _'</-@(,/>/:(1JCF!^$MD[KIS>@J2?T&!3":1;=BI &5
M,,$7ZL8TL39-O]<4 R*H%VXW)G:R*F(KN8^O/0LW8BZ',4D6MV)E@PJP0,5V
MQE+IPK9<$\1IX)32C)<V6D]-TJ<H0,L(P5)-N+:!=Y[I8]57?_(F?/6Y2 >P
MKM'#' 8^8(]I!C:VYM;D*.C9(+0%L&%P]W8BF^3B.6!C"!B>%-S"6M?#<_[(
MF<<(WU&A89]WHSTC-WNB-QP$5VX.:7,#+]\9CJ?D7AFHKK)F72L)?;H\^."A
M)S:8XZI]*/X2[&=6**G;-62'B-*Y3K")::9S+[P]&#R\V,..G#7N_.;].K7]
MU4'J&L;M-/*Z;7VN/VSKC0TC",%JD]%"G2<J!4PF#+BSPFI"$]T4.0:3E9NB
MQ\819V7$^/5$G[W/O=+OQ1EP9G"*;T-'/5F.";A(:&!P<Q%<W!0DR5#Z>)KV
M]ZZM_F9Y_:/MK,T/C.U:C<65RX1'O/"P8^@-" C4X$>SBQG/P71W VY>-?<"
M1IQ=@K5YS?$%3F@'IU5*:39S:@M\X'>?>FAPW:7#2J^ 1:^N4KCDW."L:XXX
MI-+8\(;GQNF;5(F1A6QTKDLI(YS20S)%6[DU=GR%F.,YF,N-K(((9\&(5/CH
MS5!&V\'JBQNEDAYR)9QX)SC26E)8.D1:1EX<RC@ELBZ3"S2G,TW&<UJ!?J*6
M"N-U;C!7*X Y&MYC3W#TM8*.#U#Z<S,3@/18F26#%E1E12P^,(0NJ(=>MQ83
M+L3I3QW\%C+@V+%X,_?BNS3!%[EF5CNK'W4Y',#7P).8"YY#5\.$%G >:@^3
M1:@GG*3BXJ,*+#6<%._]MZ4TEHW&(VWB[J98/>5K257^EM5J-S-/]'ED]%CT
MV/+82\M>'?L,6.B-P3CK-PQ*<\19LYR8<1HHC\DI"94..]WMA?V:L>35 RY6
M--R_Z9!VU%XP78-OCO873;7^^MYO ]T,3NLY )5DCM&.O>CHL)F]]C&PP!C%
MTP3N$!VQ]M&=9F[1\-D3A+F VIFFVXFVAUI"6E[XF?"27GA%:^AZ:)S-=#NM
MG!K\7:G;I3$K3LEKL5LF24W-+T['4LQWN6_REDF/WP@_<TJ/<6OC2N#U8@(4
M0-:M)_=^,. .CBA>)P&8VDZ" 2S>FVO$HZ\U68U7L<S&6;.BB2?G+('M.@-[
M$ =:*1RX&>?I5E,F;Z"(!)^W.[='1W<L=;4-WOF(?]'AXAP59TT"<%YHZFT"
MN2BH(G(RU]25"/NB2YD$R"1%8(5X0F)M4649IBF]Y%0<G+@+*CY?!:BY"Z,\
MA>ENX&C^].V=HT#5Q !EGX2(BK5EY-WU#5=IUW# KV+80XCNRD+GS\!BR6-6
M.SA5 &N%Q3L^96D3]=G"X^-]P2V$*GPVZ;,_.ZU9- NKB:WXA4@B/%YJE'UB
M2[ I3A/>PI^<PE"A:(&E<&%S$)@&5!&K_8>,U&M+4XR;!9U!]U_-CIZWNXW0
M6?7O_U3^WZYI_Y/# '^VH"LWX-Z?!WL[4:$P$M33Z!<G=-TA?<7(A4J";GZ+
M 3?LN^4PY(=L0'[\5[[6_W/8F9@T^-G879:@M<2\^C8XX@!O^[=BT7.QX+,:
MR[13F,"HL?#-#@-.X@]ELR8HIXEZ&?:W#ZRY4Q5_;+^(60,60CN66^[Q_?[G
M?Z5A'T@ C'W*R&F$"AEB6Q:7J#D5U%'OJ"!C$93,FX?,X6OXZ=6)229-Z$(-
M,<.;+!]?"H>.-P>UC/KMJJC6V/'EIF3<D..>^@[U6/T^I0&'[VU)F.0'7K62
M7<=R_A_8:@K4*0<0\QZ5L*DL$)4U TN%40,>6V$3B*A8QXESDV4C9Y3@,@9[
M5R9JP/F]J,H'@B3A'8B'HM^6MO\G>"CR=I3G1SL"1-96ISU2ZO'/86$K81J*
M1SM!Z)18384<56]%XWCF7MA78X7.UA0.A;I CIG1KS&Q\]2?P.%6"OC%KL+P
M7.F89'*'Y&.#2U#[A)?IW0#R-Q+7$3/*SKIJ867-PZR/*NU!XVXY%NA_$I8+
M6VD 1S@=<V?U8K$RA@U(ZZWN,71M@+G N1<A"0*VV.[HIT#;V!J@97!M^T>J
M^5"/>PW8.[C!/9ZTX86*']L^H2/PAXN0Z9^PYTKN8;58<QH-N%X.:O:^&XAP
M)BLYY[&'$%' V<+C!IQT1,EYK ]SY2UB.D+C',$R9"ZT2ZC*<P[?R:;DB:;B
M:FY#G+T=2LUYJY\B:Z/'2HLC-#6WRQAYHII.?:=*#"^G(.9BA?"Q6:+VEL;/
MJ"]U*7(K-D(LA6O!3'< VKVQFF@RG!"80X]WO<0 0RM?A'54ZP.UB:L_/G/<
MWL%;QYN(/K;RTN$9D^_M3:92-&_/(HLT?HVA:^"3&D)3+?ZB]W15MLFW$/^"
M-T&9OZXS"!K/8'J5!?D?OO-.*KD"6DKBIY+TOW;TO^P_]/6[=V_/?K4"$I$Q
M1+\#Y1E!X<W1@-*7-QK+.57$2!8W2U"S+M(&Y*2$M.QI21_9]I6[E)T\P4GG
M3P7>57PB*H/OBN<,T^(5P?"\7&=M]DG%DZ+V7Z>_G]0.PEZZ18@M=E], D<F
MTF''M^FL53!?^YU&Q5P/9\DY%LS#G0CY%JP*JNTQX*+Q*8%2]>LW^<KQF?#T
M UD!J*1SW>%VHI5H=V20Y/*B@KH;49YOLDI[:10#KIMG+.RZLEB'L4*?">QO
MP)6L3/U6X(.VR2K#U6XZMQ$#KGRRE9P:Y"[$Z"SG:R@^K9IX?M"VJ]X7ZOF*
M+9+AD<T*C,U<MK:O0Y>,D.;W>+O<@N.#H!QV>.>HM]N=(?=26I'O[>V6N3OY
M[BZ)W//>CM<9^*8":\@O=2U044^4ZTVV0VWL6'%UJ P,CTA8=-[Z^)6CVH$=
M;S[LKM,Y9U<M2"J:&AM^GU00]JRYT^6WQX2G +)@JS(T5;>:A3TO%,B!5X:W
MMK(5W%8OL#]'::7VA[)V:8H*#Q>%&G6')DVV!1K,X#',M[^M)-FGR7PA>G*]
MWY=!D8&4E6+EXA_W#HP=Z;[G2GZ)3Q=">SE]\8H>=0NT#YTCG4*%*K(T1Q6:
MK22;-\IYN*$$5L-12"@*708UC%_8=PANN_>2YADM/*=&MEZ/S+TRGG9B7D+!
MH]*6F;^*;P?U,]A-G2/7J/QXQ)RK-<6\XK*4<1 \@3^;0&S.3WRL:>"G('%%
MM,$UD%6SK4G 565PZ<>-S'"Y#UU4.W9;41JSCKX.4%CUQ$Q0Y_?+0@>B) DA
M M[G70N%#\2(>0J*96)8^C)(MZ"RVKB5?#9JQ<AIK7'/#<]BGDI2$FTP.AY[
M5!QD2D&?DC; EY34Q;1:]Y3X,V&T.U0&512?2TP=BXOXHDOFJSNV_ND2$R4;
ML2@VEB.7];6A\V=C$U8@2^#7RFP3!9@MC/ 7]X%*L&EV?;@2,(OPI%[TWJ 0
MFL&"L=>Q9GY[)66%W1-WGQ*R0A?55[SX>$O0M7>C&^RVRG5$/5_;SCR*SBW7
M[43F&M^(F!@/(YD+\,QU\!4%2&",RT$.DG1&0]D%72VE\0["ZU1*AZLY0)JK
M3_C^3H='G67(]I-'%5GJO9-?T3CJ (^=]>T\7MGU%$IY),@"8D!XQ21BP4?G
M^MQ[5[!6C_%V>(!5&TJ"!J_,2KG)]&OW)JOH;)9/U8LRGF,#OYWHO1W2-;.L
MZS3SLZ/=WER7!)$S9_&+AS@ELD.1IR64G%FO*! >6<A'YQ1"E7OTO\2!;*!"
MF(HL*D7;/'LRF $Z4BA,;Z5:QEZK7ZT$EXAN!S,*F]&5[JQ-&2PG.">8_^)C
M5N+X F8(U7;X??!0S??.2M_//L<A5<:F-6X^'B( (S!YNL!%L_+&44S:F<#[
MT+E/==[#@M6:4'X\_3:#)@H*X68ACG="AH/0.M!!D%-X(&@H-[2XY.5@E$>@
M!#HPU#/YPV\UVAQSO\EXQ,I+VPNWZ)9BP#H9SW4E:K]]U.Y&)@SMACV::DV:
MO<ZXCB^,,.#FGT"25&56CQ,XS?[!Z_FY@8_N1)RBF=YF) RJ7W6NK0^^$S%5
M4!9Y=V@JY,VY.ZP,M)-;P1_]H#O._$)C\I@N!15^J>@&9)5F[8^'ADF+--Z4
M2_J<O57;5>4]3)_[[R9SPS.\'931)*>[#ZNPN+#O0#MS:['OF3.++A;3;;N;
MGKP&*S$C$VO]]%? L/RMVK4P&;HS8, =SS]"M D:X<XC?4Y#5\"W;XY<)2P8
M&Z=[4V]'%2OGWU6N'JM*"@W8,AIPZU-&,=[S8&#O(?%)[\<$,9J%^8"QCBPX
M#%3PV<9S2O!J(F(YHJW0UY (40#^HS@36,A:CWRC?U ?<@-]-KCA!2^V6F+=
M\YAD#:7=0AW83=8%EU;>OL$(;TH@<.+&S8<#I0/:2XJ?<E/?<(J&A 4R:%?Y
M"4#^8KP__:!J] @@_3Y(_HAPW&Y]^_DE7UI\81?XAY6#.-"ADBH$3;!UE0+P
M"FHC_L(@ 5;(A7T[@L46,'"P0N.84H6W9AZ 'ZG$TV!Z<U#,#??"8MI"QM86
M@5MWE9I%FV.?[.5%7$HP'UK<VM0TY>P61P/5BW5\Q5O$ J^U@??IEC-&M'C(
MY+'F.NMWJKE0L0K3D#V*O<AVN*[T/I;2S,D?]61G?*41E*O46Y7NO[C9U#'"
MIG^C816L33X3Q*A*KSHVW12=@XFP5<489B>PN)^)W6FJ$%E(S29 7V/98Q.H
M4:'S-T.?<T=E4*[Q(QUAI&Q.4O$?[XU?I,]96:PQW?8!&:\,_11*Z6>*74;C
M6:$#LN-<NWT&W$[A;)8% L!F4+&"UTA(M39!EG--T06P11/7C&0+']51@GH
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M3,<G&DXUQQNK+YY?(VY9;,#AB<A >'-N]UNMI%CA)%O0II55MMQU*&NXM2!
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M1_0M5ZXS\9@,FR0T?&ML\1 WS8 [L,B >WZ^W8"S_0J4S 0_W'!-VHH6?D^
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MN=-U1/0/$ K@PFLIR$)VBPP*H,^.D%6.JVUUW[#: V5SA!'4L\+IL<^"WHK
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MGNX7KT9*#>LY/='FSY'OX13)L%-38:<Y.[2,D7*=% 4I?*I+<L;!&H:B[(>
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M04L7 8[O#AV3EGI%U%_U>O758-AS'JVAYP%AV%@!JNK[E<NH)_F#1#57=]!
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M25%WITJ'=H6LG283#FS19 @GEN+#OC064%5\ZM,XU-:]DXXG]$3#8=0.D2?
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MWUM6?3N%")MEB6@VHQ$7GI]X2 !V' [_9U4%T.I,L7H)C8<@N:6X:5T$X_<
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MUD[!W+PFZ_J&4[>![U7CM)P9?KN0,*IH5D1)*X<1TJ&^CQ4#24Y#&U9C#[!
M7'8J'G=!1<%Q;@=5Q)S@&KYDGX&_G6N;TX%#48XUB]@1_?E1C_^%O3>/:R)K
MTX9CNZ @1ED%A+0K*D)40!20M-*(B! 1!0$AK8AL0EH!B1)2"K(+M**@($1!
M1$1,(YNR!0A+BV)DAR!D064W%850D$KE*YZ9[_W>F?:9Z>=]OYEGGIG^H_S]
M+*HJ]SGW?:[[NDZ=.O>D4I/"+M'9_ =L@7K'4$GTX.*.AYWIS5ZYJ0&O3W!6
MAQ/V2],)WE@%:+B>H P;2@BP$BAL8*"0B>W@FUQ!UHZ0Y*G+'E*&ZPCR@NK.
MD,V()L6ZL8(6269 9#Y\.8E10,J+# [8_YH5%_;$S\3V49PP\,RMA?W^LVBT
M14BAF7I@'C=R""!Y9M)2!#B3%M+8W*4$'S;'WPK*%+DY/N\,--?C)=H*Y*(0
M.:!^+5F@D+FS?4[P*N1QU19!V&_/-'O[74=K=+I+;6<+@R=W?AG#C26]P,4Q
MY6GJ5'\PL  <'])ED3&P*Q3^+#;-#=1MX,I10INS%+O5Y+ZN=7=FZ6SM*'57
M/K+RMX4-!A-G5[UX?R?09^$LJKTB;]1LA0TAKF05VI_X&CUXC0@]B6R&#44,
M6+5'O+^+NG&(NX 28RMRO@9;_90E+\T^]^A%>\B YJ>O]E5JY>+RR^$3Y^W;
M>\=VI5T.__"SA^O[?;AIA2'VTCZ*#%.;90AN>HAX9 Z1EU$2ZDVO99P%#%XW
MI._]E!@LT?]\+B_\5X_?^D]5E=PMBOW\TX7G>3&CS"+KB;!<ZGHH")3O%Y^$
M%A#J<)'(#C2TXL <OD4^F%);,<P21G-7+BD4V%TD:%.TZBNZ8X <R*UIN[_%
M#M'9W !!@%H[VZVT4F3P4K]ZROI8]=>:S/O8K[WSJ^^19B9HB8+"H!QT0S(_
MR^]=LXJ*@93GEV!*,RSTH"$6S;"'Z4M,0(7-/C[C.F&%<?6!\4:"(K(!-A?5
MY _A8I@K0H3R@SZAQ3[IJXHKP]V.MI4D8AO(&L4B^Y25TDCT9\@43V3IVB=
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M9NVJXP=L=J^YZ>?Z]RYB_G]X, V8O%S@B]G\5\7 Y&9@*7,ZD^GG)[5BO&9
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M:5+?;B7C<[>P.);O,P];'7N6WWB/0O"TZKPUQKI;OK12>@O9B.@RLJUGC*V
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M.Z_>%=H.Y,L=72'J\LN\E<,(83PY*'TCPT0>!7ZB3R0OA]'>C[A&_:'M?+B
M.TF*I*-9O+_PRWKP;<KC1AE&@=A\&4@O=GLM+1($[&+7FMKGG.M.?Y0ZN%+T
M.1.?D4>Y<HG>UP@L8'X'\"9.$+P)D<!R9!&\'7VH'7"&(L<G1, $'EF!0YAL
MS#;N'Z7A.NYW"&JZ#-9)4T]+:*7Y)?C'XY<?_A98:N<T]M6A\E+@,Z\;U9Z_
MGWW/%+S%#65M8A<O'\Q;<?9&G@>CN/[H[<W(T&+K&8J?T_#SM.)#(9?.Y7J$
M>),O91PIB,DYM/WXJ6"&;OB':;*POZ7Y#TZ148?_][F)NXS_1E,K?QKPW\&
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M#?/V!=VG=-3/A;_LG/9W=^4A>WTJNHOXU9XV(O68D #B?$VL_%Y_5[7*;.Z
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M#'MN0L>_*^GHY 5[@EW2[$5?+#I<JSIK^:*C21=:Q?X!%0^B?[OJ[!8>!N:
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M'@F^]8GSOD'6R/";TZH]X;+[19S%U5HUQ[+D]<B:FGR;-V\XT]/HQI$/Q.Y
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M9EZR^2E> -"RC!-&Q+@4SP:F\/S98L,+JJQOY?&^(9'^_K'^ST/BACDEB.@
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MNFA?OVVUGNWH+*GJP/>\_%OSHLW&7CYF\+_[H!!B.KA;FR??4,.?($KHP8\
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M^ MEX,(NU$S+>Q Z6*UYC#WH<&E=4M4&.!I1R0KOQY&#].$@_CB8Y0C^X"D
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MME@TP.M:9O+%*/8O):'+9$>'PAN^OIFO'$9<$BO5RV_<RK&V@#ZV"39<L?W
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M;1"%B/=0MK W;75[@76;;<_)UJSR@L1 A*+.L*\P=KIQ8@&RAO3&1/FI^Q^
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M9K;MY9+3 W0%IHOD<I$'B &^7ZBM!^(66G[<8.\-,_YI[&]D>7O"9TAD4!/
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MO4Y=4X:Y@Z[-[X 9.A#I,11M>=B9+M!)X4T%"&==!%A+G[>+=?#8[^]_7/:
MP-^?$EGIRB>4V.W-^N>ZUZZWE:MZ5V_$W8WB.U%VQ_OLHSA1+KE%&$,;G^NY
M9[@-I%=L6N'T7"O.E.@,!<L=ZZQ?7'/2F[A3F#K?5RAN7%RQ4B&V-V_) )>D
M9,/*5-9.T,U$9:+VTTQ +&-THR%G^&L?8^(=BJ]-+\&T.%+2IBZT_&I]964D
M0HPL\^/*EU=[J/M9$_-G&M?7(UGC6S+&)AO14EES06J*=#:Q_1SA.$Y/=!CX
M<1G4W306_09$(79MR5PGWO>!WZGU!77_49$+N=FT46U^9TIC@NFS5)I3[.LW
M1]"^S_X3F+E7A,-TL.)">XO\<-G^HDZJ;^)KLS85S[-!<_IJB]TG/_[ >VB<
M2A]1*0W)I*9E:A:>>ARLOS_4I<RY*S*M2OW[)^?ZYQZ/'HM'<5TGRE2GSN\R
MG6MUI"C5^1S>\)->'Q<D^4-?HT1[RCH2/(94&7;"/8!G,O2\0X6K0YXO=)=D
M)_I]9=_UZH.%$GDM8>[HZ2./6!-]T<IU%YIBS@?QV,DF2PB)0H0X+VI3 >M9
M^WJ$CETB_CER\^::00_&TO?<12(:HJ234C%A?<J:^$HWQ;@ QI0OG3K2B*',
MM1"J#ZH*[ZSO%4G18KN&N(VVAS!*KQN5R@>N*0.EB+_X662WJ47H(6B#AP5G
MUKLU$$G&4TK^@H!L+HQT5^%3$<>A8%N7M@YM2 1?+]P[].K^"E,#FV2BTUC8
M^64@*->;VXA*AC:1.R#*O^KI"++$=GC]KQIH$A_)0+":W,$Y*JYPW0Y@$N67
M14?C2_#7:M.<!DS*X8&1O/<BVSJ\=;^/@T/?[V/H^Q;^5VIJEK:_#!!U072Z
M!]^_]83 %2X.MPN2I+1V,"++Y(!Q[=.O%Z^&&DSD5-MJAU[Z+OX"+7WSW&_!
M*AA])=UU>0AM !-MISY<AXGV9EVA9TOD<J2CGAEX16N+-^H38D'O<A\T-?*T
MEP][WARR)!]6CO(=KWN&@\&65M^=FOX^<VP$4QZUL+,L)O/35- <WI3(0R1*
MO18SFA(-NW\G\M6O6OZPV"@$*\[;?LULQ9@MVQ7\YDV<Y@/ZH,=T]Y4V0+6=
MO)L]WI'_*2<FF.=_=WK62?4N96V&_'-.FDU$_U,HB7AC)]H_RM%E(J5F&L$'
M;H:(M  H8R61E7=_E;@[U$KC<S15?@SOUS!DU!8?6X-C,/)+\TIZ=;/J(T-,
M2?7$_5/_YK*>%GZ8*FKP[?L5 =)$U/YGF_7F<;R1N)BP5Q0FSFL@LS8E<N/\
MGVU'*80!J^U9C);<BF(\3'"])#[D%:C9;>V?JPI@228PY04K+4"2LYV>NESO
MVQOC"Q ?4/%'>8Z:OL#K+)?TP6,?"TVM/NK]58!SYGU2_W1KS'NHQ.;ZT(FS
M3OX/J'80\P:]?EPRK_DK*0/=87+RR=VHE5B;EL2+MP?2<IX5^SQ[Y/CVK-OC
M[#N.$WEV86Z^)Z6"E<U6Q?5UT &/K'%;B"S&O/ )S7 83^0B5+S&YDU5/*P.
M _%L!D0]M*4F@^IK$QF&K4;GKOM8%? ,_"VNJ)[IQR7\^7D-9TAV'5C]>4B(
M^H]H]Z],=R";CTH,J\S09LU*=@5MG@-7G%LW35D^\5#.;"<QF:VV1M$YJIJK
M(Y\19P\H+Y.P!-T[@R%#04,>?<X8Y[))R6.I&0V)-V&@3F'V9CRAC[R3SLE'
MU"([L22");A4C<OK^+6-V"E\O(!)."9 )!(.2(%C@\HT]&2@%$1GI7R?R S3
M5L-?*MR7T^9*?<96#!7ZA),5WCT9DGS.*/V!J".4E!$^H1JR1 <"I9YY</AF
M P0FC!=X+AD"95R==[%!50&@O =(%?P0_BT(S^:VRI&MWSBZ>M#KI/(*F.EQ
MR3XOT'D$M^#2-7OC:QQ"PBAH\^6<F>NQC4;>?7N"#N;PWGP,T'UPXNQU?SOU
M-53-:.?,V9'#1NV>%=803R4GN: (_?T5;A7Z.>C/CR>#Y-IU=QI=<BAP.DD]
MV]LEJCQ1IOY>9V T)W0I.'KX]'<#89+X1;"X',%Y&T-6SW,#A,W%"_0F(@.F
MB+/P 2B#J&\:= :=A% 2'07X7%I9V;S.LM#2$2N2XR(@_LA*GUZMI)+(XZ.L
M^)+$=*'00RK_=+L@)';=(K1Q5+1?8T%H#KX#/F%!0SMFW_V ;<.T UYXWWY6
MO"F'GE1/?(!2:-.#DFA:9ZJP$))16RQOY?<;CW!=CFZ.-302+%ED&,FWE)-
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M+8Q<5@_E8$Y'BJ""R*;Q9,2W[7W7KSH<Z-OMU)Y44K*J[I26)19E^4F8CV6
M3_V#(8*HS".0Y5>Q[<[LI!<_4,]O4WK>38[9::Z9]TM09I%,UFZ4._#GB%K<
M\<#I&3::!&J6R+JM9G%'H/J0K!@_YH6-2+Z15MF(A62A7=M"XZ)%$V,;:G$L
MWOO+I>3DYJ]T5?+UA=1KKNHGR$5I'AS/*8)\3S]4UZ%RN%+R3@J65A6)*:"F
MR:HC<CPAN6G+^WY[CS2TWT>T8@>:G01$=@.^/<2R3M0K8IXDDA=*"J6+<"S*
M!RUDYE/7$2($WPG*RI8VWN!J(7^1RT*XG4*%\HAG^(7]UU_7#FS:.0$3TFS9
MZ9C:]V9(<NHYHLKKQK">HL?N?UA8\(\VE47=N%G=;L%(V6[E"WK,M=](%=OH
MU!BL+P\5X/;1X:$:1.]MB7?M-^X_4'0H4U/.24PVMR?=?V[:-E:^]ZI,)8>S
M^A<+"56.G7&.G?&:"4%[,5[ D?#H;'POX9OX?@:J'IY0<%9+/B@ B[Y)*4C>
M7?KZ<[3],EIKW'V"KNH77BJ$EB;9[EW@L::>2A5JH:S$A R*.XUZCH3(*W7#
M0] :C$;6P1..L\>R2-)QI9/C<$YBV[*BW8R<$,Z*WO:-9-_ U+L3B",4Q()^
M&=ZDU';=YE#8RX XIYUSMW9,X5["NG&>>)?&9#5I-38Z&!^O<Q[!#?3>:45E
M"Z6P@;NGX?M75:]7=*FU]O-D+2I2BK3X?!Y7\J?PY\D1>:SK=$KDVAW'5X2K
M[ASFG7E(;*E!%PJP:_!IO[]7HG_&/.-/6O&O[^>=#W36A^B#<[,%D73>$32$
MA4$S;LRSZ:.M7*>RD&]OT#287T=AQ<G!C1H1^<TA)&A*5J1479S$[VYW>7R\
MY\2]EE$716+1#P.5+"YLNK6W-_@WRW'^01^!TO,CNPKVG;6DZ94;4RR&64"Q
M0G ?FV1#05?!C,.B<QH9D^0,9KRK2Q7U*JCSC GFH'&)'8&Z;<34I\A4JZED
M.>53:8:4Y"-0O')%2,"4:5T;\TO]<P.J9'S=#]4[H^(35QXQ>($@EAT<S[ &
M,WL@D'9^Y@B\^@BTF4B[#>!Z<?:CV_6TX43ABN*R(CHGI:&:;Z(Q:9Y$B(85
M)(3.4[+H3AHN32/!TR'S?+BHNAL5_17>D4KC]CU.9PZR4;?GKQZ!;*\OI7NH
MU]7F)LH3[U&_05VTE+KO[< WR_^]5H^<*M+2W$\OBDOZ+J/Q]<.BZ?D*/O;1
M=,E-S^'3X1HU#Y-R+)8R])3)K[Q79WY(3%;.%!3-UZS0*RQI+*(X+4^U81;.
MG]P G@*IY.UC&R$+I*"#%N5=?W?I*%!3$UL-R!B>C9GGXO-(#69SV8]U^X82
M%/6]UY3-P932]Z$OPM*OK&5*%=EV52F>3 XAVG6T)JL?)M"/6*\I&Y$G@:T0
MBBX9\QR&/[LJQC=*OT9A8A(:0ELRGU-HQL^<W'0_ @5N))'PNTT4%K5HRTH)
M8<\4*G]S\>7/?,V Y5_,X);VMN8DQ13R+W+P6="#M-L[4@^PZ8K6?SWQ *W\
MDX*<(G'B19YVCY<E=9K&TEU;(4^CC5XF3XJ?C!UP2R&67)W)$!IZ5B;R?O;Y
M9-^T=:X[;Y'$$0@3EY'EK8'&KW@&O&$H .!]UMUZ9H?IT#T"W8=/B^];L#X^
M0=$6\9L9U*Q]/<I-NA2 H.(_M>CA$IA@();X>]K+GC]'-:'.#TJ<DR#4Y8=#
M.;T\NZX[HY#$JY.'@O4.A'C5EN"6C+;8SRSO,X< DBO=9M,&^\[ !:HJ";S%
MDC7':5Q^40\2*W>W04!.I_U<+0ES @5=%*4"Q?NT6P4+;=NIK9[OO%KFBOQP
MJ,^IYU8;+7VJU\,0B<%X@;4Y@7'[O@NAWUJE:=8L$!$^ B$13^"UC2RB,8M;
MR.K%3Q<M@C<W*$M:_^@H1G8[BP(&A2@$N?T-LL3)V1B:B+X63FJS&.WMTF#B
M2]>=U2=P-93S\72["E3#-O,\TL%A0UMFL0\>8 9(JVZN+.*_;2RP #QG_Q_
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M;5N013Y^3HZZ8$ _7WL;\/2CB3._BUVG#B=KZ5%^KDL7HMQZCD#<6E#/QQ^
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MU'?0-K <%6:K;6^K1VZYSGSSNMH'/0F\FNT*FTBB3]%Y#?:Q (;F0$=^C91
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M?0Y2EX(01/5WGS)1_H(%W&%<$-LZE+B3_KQ)2G@$U+:I94IAL39FP "WGN9
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M#(RZ(D%B-YE1&5&9]9;(W&I\Y]SFV^A)^L''X$,U,ME9LNL?"H-E#)[0%+@
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M\>F;?3E<$$OBMB>CG_;'#L"W6/<#.4C11CE8I(R<7U"[K\ 7?(;HJ6DE0N9
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MJ28]\_70HN+M=(N) &W%,$O;/B-Y\=DX+/G1E0 6PGKP@NMEHN/G;?UBA^X
M5;%[WYNOP852G$S$"\VUWN@9J!_OP[TF(WJA8@DUYM8U0^E]SJ)S]SN&[$NE
MPN9?A5O:61F--D6:K79]"\QX&%4WC?O&UT/Z1.(([K$;M"?9V7@?C5D7!@%
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M)>'DY/^L=]T6(R)OPOD\Z1GAP7KW^FM%+N3''C42SU$1,#]R88B6K?(^YT3
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M6\33"F;&H]&(MIO+9!2^$A<19,1;H^Z7DFV YJ]P$BZF+T%WJ/-/1$#$%MI
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MQMN[MD]G9MLO"<V(2QFAS-.)GN9>LV_3=WVT^Q:WI0<@=]'90W6H=3MFD6S
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M[X@]>_[]HA,8RC%[;CNI.J>-)@?4ABD=R0(S11Q"8<'EX/N;/\3;YU8?T=8
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M?].DO:D5>9]-+2P(3&*F,L_8OV$E)9PQ\]LRV&E]_]D;:]'/;7]\_O.)">9
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M>R:>NNT-V2WB?N+L1:J@1J4@,X5^&5Q!68<8J\@2K<GQ!%8[W1HGOI,+$._
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M(AOKH!I3&9V7%(M$WIHA?Y!)&E!(2=6=K2PK]ARA+14/U/*>Y*:8[HA(\O*
M>_%F#^)F@2LUCF%A>4>ZW3G?&^>X:07))9L_MCE2#YR/MT%[@.:'BAJ;SO'5
M^AU <S#X(TF>*%.\PE&#@;,=2PZK]UA/;%UU@TQ('[CW)0SBM95LZIV0&<'6
M'Y#40]"G7 ^/6E%6V ]0+5@UN"/]P8>AZ)$[I$$14,<?#_/6FLP1OBXA:@]
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ML@/P@=I*#\H&.LMI?F5FPA=--1FBR81$ZW ">(8'G6",*MKQ8@L,EVF KN)
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MM*<F3Q>H2>;C3EMJ^ENTVV;"K&B3=P2K&E_5%<6/A@[XGDA1?T.<*=)];Z@
MSBT0Y!_:0*@6/$?-IQ'9WDR;9//6;1HQB8CNCZEJ+YNXZ&TU>HH^7__P2-,-
M;JJ3W8\."2$O7\97',B:'W1Y]AP7ID@_/C7_PN3@4P6ZV@0S)T(.NC3$N$EH
M0V\+GLM+NJ&"J5(UV6ZB %@"QA:1%J->,*"U _):]D2[<C 7)B[D0C]4\;(W
M]IWWR \,ZF_9G_9M4U+4VMY[O0E3?\(7R\DYW[%-V,.TFDH BN0.=ZE!U*I
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M%&_9V-AXP3>DWG=3&GTDNUM8/Y?);Z'KW5$0"80G1:E!DM:2%R D[+(GYKE
M;PRO7=2R(/A(4>E8SQ,D(OA% XF><1BVN%,$NM5$9&OEMJ%?T.H4VG;]>G:G
MSX7,)^Q!6AT7=[^77R&EU9S,2LP9&3WPRE.ZVIVWN2[\I[&UT&N9FYJT*GS\
M>-2(>U7*@_&4AJ9C+778J\+A4VUGL;W&;UF\L4"H57!!I4;!86\S9(/G&#>
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M44!,2=^<Q5&G]9 .-1:^/1[]<QC]CM>=[W_;Z5NU>MG9FXH=7P*5Q.LD* 1
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MRI2^&BG2=&74<U?&"AVPU<P/J@-5:@L7F>JC5ZC/HYQ'R(<O7Y$](WW&((>
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MLX%DO]V&\ K$V'9P$_8[S_C:VIDJXE\OI-S"M9+;"\-=BAOZ WS@"JBAYA6
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M\CCBTJV]NCP'_26W"\H/57_FJLE>9F>Y?UP]^8A[\?V?_LM%_ZPPW,0^90^
MT(6Q#..6 )*F8&J7_AM,#CYS^05G0LINPTT@CCM<JSI7!(,GBU1S7,:T;V R
M]$Y#OGJZ&4HNNX:MCRW95'1\P'W:DVL='EC94Q$_J0JT".YP6M=;OWMF:F4N
M 3WPGPHJ5T#'>*-\W3TD$]XI(=4T9@N_52 N91P*B9()2:F&<M2F' G6=2#]
M\(7(X".M#7!T8X8S'%0O%/U_E+U[6!-7US8>BXJ &#D9 2'UB(J05CE4B)E:
MBU01XZ&*@I!:E*,QCP\B44)&00@'(:^U2@N5%!$1$5/E$$5(@!#2UB)R#(1"
M,DFK<HC,5 U3,AF^2=_OS^?WN[[G#[C(=7%-9N^]UKWN>^^UU]((&G$WV>/T
MX>EW+ H7W%>FVET/<PIXT>=KT)))J/MQ)&&=N]<- -H')<68HRP$79?J#+^:
M^D[40(@B.MC>)A68%KIB!ZNX,2-MH= W6$"97;D?$=IS3H.0-YAW^%R8^:&1
M/-797]L[./E^G6RK+)XZ]"'/P=P"<+I'1!VBI7\03%$\LHGWP0N>=T57)7@R
M% :A[C::X P:BB\M)=6-AMX5+9V\1P^YEX2$)=K_W="[(Z$QLK;Q80V::_4N
M3O:M3'VM%6Q088Y9EO;E!!BEP:N-QU#(E(QW:AHUK=,V*&B\C4:;@)%A;JE.
M18C7*U0[57N9&ZP2^C'G@7&C7*%"ZN'IV;-L]N>C2?\:OP'"9=C1IXB/,N>=
M<"'7;T(T4$EXK*5RZ5D@@3:B(>2$R4FXA.!>\![AB P23!G@8AWG,OV,KA-]
M!5OM^\G\(_\37NAY7_IJ2&;+VXBZ:_.D'W*?8/.T["T=99N1^$+<*U'5E'-9
MI8XIAFJ&SR8/O3GUGOQZ!VX7;[+C\<U5N"?A._6BJ0S?PKM\E0QF D7J"(,/
MG R]RJ]L%,BIKG[FS=YV(G?>FALO9T[F"'4<%YJ %^R5G=JR]\B[_J8^&CTX
M+:5<Z.15@&TQ70HA@1_%$&0YZY(LD;P4=2.86EH[S7)([D+[PMR([5K0G86M
MUHIS9:1KNU!K2)@;I%2?\O-([P#<?%.]HTJ[/WB=DQ&H"&I\<@_;1CBE[]DO
MQ'$R9-TEZ/6((G&V7.=#-;8B2LPQ63>89SK$36E52PS7]:PAI;Y2T$&VPKOY
M'LA\W)63R]^ QNNY]5022MM1W%'&&&C>KHMR9^_8 =^I80@>)*D)&^2P[TW$
MD.L>O6B(IH;6FWUN702HH/82N%BZAF=IYK"#KP#L&;X8 Y&URW+'G&&O*_>Q
M_5IRGJ>SJIFLY]B/CO((%5(=%3F)NR#;<HH?O)ZAN*4:;F)+DP*6]7:=3&.G
MNM4[*59CEC/HC]"UB BB&@@1MT"N8GA;H@JL#$&)F+1@/SJ#D*&8AXA=*\,;
MCBE&MK2Z*0N;V6FWN:\@8[DNW"N\'A%EO8^*>AIU,[!C;$7I@1Y.[1OVRX:6
M&ULKXOXO9\'MSUJ^PT@P^,Q]Z!9(I11?9CGA-KSM#>@ 4G6H"?92:$BH&))<
MJ:UOB>CX'V;EQ$$TMC-R;T&M_'CUIXL'*=\<J6WYX]-?.&MR;2K1DT0@W":P
M4* =&%]*\#<&01 M0ZGID7HF:/XAB$\)@B@3ZM!NV.M0<:LZOB.O_EN8D!17
M8OO\"J/V7Y,'-/W6U'LD\4*A_JA=NO?W!+\BXOD?JM!K1A'QF@OX*E9C?-X[
M(OI8&_/,3P!M&54B4+(CC")81:C]$QKK*&P7.D*0L 2DP?R;R(%GI^\65)D"
M3(?AG-O%;JFBK.9#-=R*/2\.,E_0/XXW/TG3TQRYMY1,DY<QQG)SX)_JW41X
M&_&&?J#.FR-])2I@/?+"G.I:FX!<?[*:JK<VO(<?$;;:W2G*FS7@PG1R-MT5
MID+/2_6YY449P1VS*5%)?-JC03H(U6P+B-X[1U+$R]7/2R'9?'1R=AYA-\7@
M"!%9588LDQ5!3WD6T7C1? V,FR/ESY$:T]JIA4!=O:9.:,@V;>.YWO!AZ3IO
MID-GJF*X7DKI$KBZSS\C[%A?7 ,LNE31^ @>*TB_-V1I"+Q3=#?9C2WL2/XB
MXNT,;K?5=!P? > C .HUHQ!G$6H[#7.B&/]&4^'2MDBQ7+0"BU<!":*+CER.
M3J/P8'V!BK2%7G+J JD5SP6.J4&\.CTW-S4V(S$B1-@II?=4%='LN#N@&PV5
M24T9+3<>J>K ,U_NL\[G=UTX7%W.?RZ;YQ>>$B[K::BE:I7M9N^(7O^HX,+@
M+WL;M@%M;AZ5^,WJQ)DS\K18,#9U<:/J1MH^Q1GV&>?_Z7+[XDK%7P"^9+VY
MD+_5DOK)7 A+ILQ0LC /]T>]D3Y(8*#>XRT2''K:=]"8#4?(O5DND6@-M-AX
MHY29J_GR)V0]$E ,@0'!+9QH^,%U=KF/*B\G+S;-)"%P9OWL*VQ9A&Y&*1M6
M*L!'E*E0PBXCS5*^*_ZB1-;>$@9E*"\SMO*[EX'S"1[*')[8%M6>>)NKGCF
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MA5F4]E($?Q'M_8^]S*\V%]6#PX'XBK0YDIW>Y*4L"T0DF!=!W?Z:'GH+@6H
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M/XX[]VN5XL+>:PP9Y!$SN:>_MK[;,7'_Z&O5C%O&5(#DT2\$%38[]GQ*O0S
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M\W>$7]53&].F7L%,B#-5:CID<03+UB6?;J[#W3  YLB_2)5=EMF\H[D3_'I
MM\TZ-&O'(^1E.5(FW]?+\X<\J!W(D*(6K8N \4MZ8 DWP!A]84SW6OTZPE<V
M4$MX5SGQ4"E( MC3V1I)%;:,J:LR2&!6)W5Q,]NTG2LV)J/9GK(SVHRTS]%#
M.IKCY!;>!23B"K8!KE"FN46++^-K$S6+3_.B[W C#JN:J?>2#PM7'=$<&Z4:
MHA+C7_+MT"Q+YD56NI3&[R6$0*IXJ,988>E9IQ4!GM)/T IC/NJ*9!F#T P.
M$D'(@701U7N$T&UV#%_4X8U?X-.6/O'9;ONC1[F2 \C.[%L3/W4%-%0R_=_<
MPVUAS7M%"(F_F*\ X'T<=#W'\+?IJZ/HM=8YTD-*!WG8CI#T6MFB236K$&.:
MV+Q/^NGVIB]X1]$;5W?/K@%LZ!YWN(,]/)\[1T>3(H\,-I@F:?F>B\KD<NF:
MGN.#]01'FU@:A8+=[S69+->7Q#!*>2N1-[3++*<_48J%,78-T!>D(+< $EJ+
M.T6A+YGYS^XJM4_PU;[?\*B4 BJA<O<RE_QR_\%/@^!X6-Q7?T_.>A' ?%.,
MTFAMM"MSI.7_5.IT?T^]+%J$>V$'^O#E8!L3GX<2Z!L](Q>34'&G$233K2NX
M(VV2"[+"YI14Z*;7P:SV&(?>6O;ITZDTQ^3IJM># <:W7:GISO_Z^5>1))YX
MM*5+2R9&/-M5NIG+A"@=<R1GWDHT6LM1W^K3Q2M82PA$N*"1@X((_DIT&[)C
MSPL?7JK^9N"N)[#R\FG_KK!]/_6]X_*VWTO\*RE--7CC1M@VQ6\?R]Z%$Q.^
M"6SKH-H2[VLIZ/L)GZ!KBQF+L4^05PI9'G]##VX? @D%HL4\JH[JB;[J^'<B
M6!_?;I]R4+@=+LX^:XAB#6CV]ISM"CLB"P>8CY/#:4QIO^_\<S>N=5&_ =L^
M)8SC!YFKC"U#UU9-56J[LYHN@TOF2,FB80!WU1-(NK("_>OG\<B8<H2C)58E
MM@!W$1=M\A]:9N]N.CKME>,U>-\ ]6&'*A.,%PP$VSJ6/&-CGD>0YM_\0/A?
MH&'!+>XJ FJG<RWW@63PET;SHW<W/WKMP/L$GFD-NPEJ VH0V\'GR__XAE;8
M&)'W &R7E1E.-WQ"/WH;HPW>?PE/G9NM;/YFZ/<&LZR/NAR(%8X4$$3:DAR%
M?F\*Q#5G>&O0:%,"[P3,+]?=!.0:F\$)9:MF23,;XKCNT'=GC=DB<8^EZ]&L
M.Q,S%*OM+WC^2'"'I\>U SUG'S?4IC;3DL7'$@AJ<@^'B1CR*W.*T&$+1.8Z
M63PYDV4'GNA6U^&+++I]"S)M*(7[6CW):.+"I_ UB)&M%V;*W)I#?AQ?FG".
M$2Q#NV+O)GJZPT57=0E37P_R(FH2W*RO- =K1YZD/DLOJ$@N__U1&T&[9[%Y
M9HF4@FNH\%%ROJ91U<99CGV,B T+=."P1+?X@EEYZ?TH!8K(Y>VZWXUH%#&;
M85&[R*.[4HV&Z0Z+X%_UBJ;X[ 9V6KO;G8:$ORJOO^_JP?LE-\ )8S[)&ZTQ
M_\#P1J?Q1;M,"6#;Y_73ZA3<IL5TG-_W@M\_1ZH7Y4N#L67FQ[(3FDPCBXH1
MBA$2=V2<#NSCN_!"D)V2&NZ'*'@ -C8^G P2Y; 4ZIQ:KR(LNO;GV<6S_MW9
MS8=T+,,!@F=^RB!-@I) 0QJ!-POY703Q5VB&*/I74T],P=2A*&7,?#0V'2&W
M,GSQ87@ZNT_)V-K4>]_2&^2<9D]I&VLQ01BK.H($N?Z3Y.PTMQ:II(+K= !F
MC92W]/L^\'?OEDJ#P;9P@",;BC#6HZ9;EAMY,).CMC/^8,YO. 'C8I./I9EK
MY@4>M52GR3]KSSCS!XO+THLN-W13CW3'BOT[Q.R[:$DTJWWVQ(4'I:?*J'!C
MQ6UN2>>L?'8! 1!794-;M*I.T4@H;A=KN9[_)1PZ14, W*;/M(&[VICR&-WN
M>Q/10,9B.$K/,D3K 8=GJ5S<#Z&UMP3(]X>E1P?9U#\-$R^5Y-)\:.]D"WA
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MK"*-'6^'WN[:&0Z4_/<4MF/=0W9:^K8'A7>B$IH4HV/?,R3G(9$]?R_!.UL
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M9WI&6!GM@;[%'H=@,%\0#'S=VY,>.QIEOFVB#J'I?51;UB==QO\IJ*N08MV
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M*&,[N7>G0Z3&$W4HP)8DF/:QJ>9:D0THV2)6E\P1EH@<4;KY*6<SXC.A;2E
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M^,9LPGRQEZ,;\4_Y*DZGI5W,9)II%_LT1)^$M?05V"L1"<<V09E08Q>XO'J
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M\[(ZJ+9PX1.4POA'G+BGJG5@"G1DQ4>T?O[/2W7BI)_'J9;YM,SU&3^O>TS
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MF?C!)Z?T?N+L_BQ-N%V8^8@N!#*6IM4SMJA01]B$V:+F<JH'.QW)-H5BW:#
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MFN,R)E[!=Y^74CL1T%S"NQH4EGX/*8W>:4]7O6\M;,Y*?_!'<LFK&DU*1-3
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MC.X[7 />6,^3D8T[ 1KO0P1-MV,!<S]A"C425<^;*2])6G,PHD7,+WZ"+US
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MC!!-U1W&3G$C!]D@QA)L&'OOPZ&JZ0L+&!>F#;U>]4^<DX!]%*+E"LUO3SR
M6=+B<;7E(N>8"(B2+XRIHFY/)KA"SNV7^0 <+ @ 5C/O&%\JP%#L4*5. 8M5
M-/D/C&\,Y>+C>'F'),ZJ&?1C+6"2%C OWJM?34MH!;_!<:\#'M[H$NZ\-YQ4
MTGKMT9V8X0G_.]?>%3A9GAN3RBO&6 I*^':/[1Y^V89"0,DBUB=,5>F#Y<Q!
MP)KIS>S'-1*UL>7T[VE+82\-3_L82A?YPI6J8M:&:WJ#N>K6:&))!N):5! 4
M=K".?5CT:-"GT%]!AGP:S@.WQD?=!OCZ^UC4K!^C?8CN-%J@MN@'!QUZ:@,
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M9D>Z953,@(#ZX;OZWIE)BR^//WSTZ.%5:VOLY[]@_S+VB.NC)'BY7EG,%B<
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MK^!TC?/*L9U0NY2WAMPR9[2#XOY:>9]KN!4D,.0\>_MK=72R?Y!!B^[C%3F
M. 6#9K*2S@LS'#E)]Q[5A5+F"S&&@$L^D$Q89R@F)D[+.8<@DB2_.*S!-VY=
MKX#KMK,KD'C.>V3IX-,O8NB[)B6\TQY7KPOK/5DZK0UBIIR&MV*?B!<QGQ'!
M7438=5""S5&L]0 2B;FCID:Q%XQ2?\K/3)^D0?+.MVS(3?(>=M?XWE0I[!(=
MF+C^6<,*C;2DK"B#2F2]ZIYMCMJ7LF[(R5U?"GA&&A^@3_G@2RE<P.B^9FX
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M60!T%Q^XF\ CM$$Q0,0D\[]!7D4M_Q5^-JY$ZY.U>;.ME9%T]OT'*C)EL8,
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MFK W9-%>2C]U0QQC$_46P.P<<;3;^^5K,"!.LU)TFK,)] SLKZ9?T.LHX>>
M6/,)5O7ER'PJQM Q:(84[(FH)KZD$*]-IZ;@N>6S9E+&6*05.CV?QI 2#7M
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M\R((\O@%F6MSC=LK9^S:=E>.+AK)O%M5N;:L:BS6''U[+%3S?=O&=^]67/M
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M,Q.[ I.B0'VVX2VIC4;@^AC9;EN68&Z<:T>Z/\;L]#G%K/G0:1M0_@FOC]1
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MPH??*RXU*'1=*\;MU5'1'KDS-([SZO?G&Y1HC"X@QO3K;L /C"<-AAO*3-6
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M-NNYY%F<\]]O]B_ZVQ)UV&%(1%R,]GANNH"GI&S2.O ,]7HT$2'J->J =HD
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MV6E;9&=\X Y]P/?$-A+B]>%>T!(A(C6ZXB@,!SR,U]P1RS9R+FD)Q0O=CM1
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M)>MLW%2AX#JDZ."!1-1EDU BF]H>=7!XXHA(F13 7ZU(U*<1=S?WQO3YTFJ
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MY6V 4--*'UP_5?.:V:LMF%0K!?,^=M++)GZ-W]7SK*@+9<RS(X?[ZP*#]7D
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M\6VG ^'(5_]__/_Q?QR+%@;^%U!+ P04    " #YA5I:MON0=2WX  !\-P$
M$0   &EM9S$R.#<V-S8T7S8N:G!G[+Q[5%/GURX:141 "'<$A*@H:!%2E8O%
MD*B(B!121$% 2!612\14A1(U9(D(X1Z5"A4*$1 1%5(E$(60  G02BUR%ZCD
M5B_<S%HJ84EN._WV-_8^8_]Z]CEC_[Y_SC@-X\T89"7O?.>SGCGG,[/>%<U+
MC0AA<G!_P'[$LN7+$-]J_Q":280O8MF_^?AKDG]WCF6:#H3IJF79.IMUEFU
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M)SE?XE-7P'5[27[044:@<6V2PAA6\YA-[@R0$4&8[7!8!&EJ@P!H2*+7@2P
MFG&YP*G^3%MT)WH%92N$%I!HBPYZJ@8] 3V'NJER,NQ+,CH(+A7]PM4CDX)@
MOUHR@Y^(SF].3E5&2+=PMMWI&1]H/E<<@!Q@-"'G'UU2'"33NF),![$."==F
M1K'&<*X$7V2K;6VPZ[NE=!H#R>2X0J1N8*5R6:R(N28"C@VB2?Q*>PICQ8L"
MI"V\82D09W LDN(%#L>L&TU17*JXY#LDXSJKRK#Z,)-/</@6KA,S8*<6NL(A
M@K)%5:KV5.Y4W:8X@W)4QA+A"H](SZG< *&O:$E-FS*'0Q)%=+//*!.*\YT
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M-)1.\1$XY+:O8HMR1ZFH)--2@RA4IHM1!G#?(7 TXSA$D.(O<WPE1#H-T/=
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MS\Y+'D97>Z[[D.-:;CP>ZN=:LO3K1^L+ & @' $1-^[H5MTA]JY*A*[T KC
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MD0K4V53R]1M>=W\-!2:? R/W>)-VM,D97Q9C1FG@^,1ET9>L94"*\'>Y%)K
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MFR[AO&:U?G8;:1:;]ABB][MZ!RJ\7%W$D]N0L$\- 3&?-=0T>7E5$LQ0\1H
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MG13;<&:P@I,Q2II"8UJI^TN*4!M(J%D-OR'G="!Y3<F2[,HP;S'/O Z\BGI
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M9)A]%M/?NI:%N5)._CD7,U#W/Y?GO,O^E[N\U[-3>0TP&1- >=CY9@XTWNF
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MSC@MV=_+P7@^/J"N62@B_CZYNV*]^L\NMZ#&0.#2N1-*3RP;G^+10!KP8;,
M9Q.]WA 5*PS!Z=KK_[FP%2(Y&@@OD0A,> CG&QM#DH\?&:M?^.GWOYX<=)FZ
MZ\].B'D)/TM:]+@#?38#I#\[L0Y\E*L@ZFS5N.<D72*]!KC"#TD/I)CH'C!1
MU#JY#Z:/*/F;\XE*#(3/E:?^TP-B/F8/5AL(2VC3\,]])PM*SNO'1M?CPXS
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MT%W9P=V"A2\"XZ['?O76$CG F#Z8G,$'2T+N2R(\RU!CY(1*WF>GS==?$<:
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MK_L?AST;+-#="./V/F9QXY!=NH^_4SE_;^_;"1JZ>)6<SOO%:1ZLD:/6U2U
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MR_T.YDDIM?]A-/\6C(:PG;8"Z^55RD7@\UQ%\!GV6G13!QJI.G.X*,RD44!
MDI0GZ"U./DBNND_ON:LK@3@5]XSVE8Q787[!V0%=S@^ZQU9%76&"6\JZ$I^D
M;"_K&-7EIWURV3N)SNA>W%O @V: ]K#^+Z.\L\(*$\UFW;*]6*]]49-\#AI3
MA40IR1G S#C4&^K<UJWA8XM;%22;H%)F42@<U:QW:*"9'[9KLM]Z6>6ZHS.X
M9[4FN.G2F@M)7YUD\]MIEN]HU4E-89[:&0QDF?L@MI"GW(]8Q,!-\J9G_H?Z
MW6OB_+XY_4&D[%IC(,1@3REK:F'7;N&IB"I/'A[UTRY]E_;R!&^\^^-A$K0=
MS'&:\XSBP?132X;+KK!6Z8OJIM!UJV.%Y@++MT)'35V\@IR93-(DP>&T4W*3
M,0=A5AFZ]ID;NAAWL1$QW9?6Q+,KS&T(Z0J?&[:P$C1]P7PJ"6X7/S,9BK3Y
M- 9Y:U_5(B]5I)/8M$Z*G?@F8B!(W-D=0;!H(Z>%6!R-(U&"O#=5Y58-D5OL
MJWBE_(S#I)8>7,6J(V\RZ<J&^DX?AT05:1:0R=IYE%[4CP3NA ;UQO_9R?&_
M?2<'_H.ZZ_F"V4BYFJ')U?W 6@9EY!VKR1,;",C"D2R!)3-<?_A5ZN;\%K87
M4@T;"-]T>BAO;RJ+N?9I)+'6.S\[J6;SSZ;I-7_Y8L=,*H_=)JS(.\7VPMIY
MY=4:JQO1H&7=*D@R6=)U^@@KH=U B,T!Q> LRE(D$IN'AB <4.=-BP6->!MZ
M?$CT4H2G"CCI03L)S%G-F\M,::QB+WK0H>"*[JUX$<;,_29+-V%V[23P%[)L
M2'+1?DD1:E.D3>FL6P63Q( %H+C3;X9LF*P!I;;C2AM[+U*- G/!2%H&K]RI
MS*SH3%S=JJ2KS##!G*&"F: #NKT:KI=GO$?M%'&A0;!YF7']Y5<[B'R\CWA<
MXBF//(3'E>=2H?%&IP4]V"KTQTXT0,TX.UY-60KCO*I)#R@YC7)CED<'92'=
M@FDYM-M 2$]1RDE8QR7A:6$4V%O=$C)6FG^3F=<"FKQ'Z8<87U1U)(X_U OP
M,<P5*K@T:[8;&@1)Q/E\1W0ST@T'BZH*YNDO)SK2PA#EC7=:^Y$T,)9AR?(4
M=AD(]+:T?D<\S')8GK<&,5ODN+H2ZIK#_*JC_Z,()%:6A(9"O(SWRK+.OBV=
M8%3T?Q8T_GT6-,3"&(>D&GV!P-O?K/;%"UXJS?IBQ[*K,>_MW]"FTJ&-5>W7
MZDJ.+KMPU3_]V_O';RXQ.;X3\8225%$9>(#$F<GI0^QNT-%#3HHAS:C#P6W:
M(21"M[JM! &515R?HP '6\T,Z51P\/<\$Z7T)'"-$3!<F@!:H('M-^%C>4H7
MWX# ZJ"(YGY+I_E5OPQY7JR*!S=7;#/YF J(R'/W@(VV/H#.;!]"$Y>QI5%:
M_PI]\4+$PB0-W7R+^=-@@24RI&P[6U,M*K_=-VB!'* Z]L5.I'-$?,3/;B^W
M62KK*G=TWU1;7GWI#1"+1$9"H=@L4+</ZR#-30BSD]3@TNXZKTS2 /2VLY+N
M1 .6 C,:73AO%#C'PR=3M.,WJ&]7Y65R8\%7G3[?0983 ,<K9R2K8OE^QBR6
M?VUUIRLC>!_TAL^(T=WV)X!?D"Q&N?-8,R';')BKX&4*HX%3>&3HO,GN/,:[
M_ZI@2JHD?!'<=DZP$+6I[>C3.D#.XLN,[Y[Y!*L ZT9=*+H+EFJ\=8%(FT@^
MA])6Q-HA%2S=TZAVW--ZI;>1UG/QTOC]F![+V*/^TZ]K=_-O;3!E9#CTG%Y3
MF^4\6WGM7/RBC8WY/YY,FO_JY7\6)_[W+DXL,W*FX2Y@&ATBS:SSN]478V_"
M\;@<&"9=3>^=MCOY$/?ZWB>W8I-S7A2=*;E[MV3@88%?D[]5V2"-!]YGH-9K
MVK2786D&NK"$W0;:LJ?%".=2S )U >P_*"N0W%M,VPF)>J2AUI?:5'.H2%7K
MZME$^:)GC$9@\K;0G!"C?4($5'NG!"639R-]&[HO]$?V'/;@W@)CN5.'Y-;@
M(9(,4/+2=U5G8HO0Z8A003.[<V]C7(I83F3Y*?6.?K\NG+7UZJW0DRU[3N?F
M+HKX 5VI+P#HY-YQ%5],19P]FZFST !HK"@5^)Z'+)5+Y'/9,LJ"F@=>QW)U
M[D'%B+,V'OH&-*.XM_H<ZT <))>.E4,#JC6W;R'.X=45W:,:%V5+>4E8S+.]
M2_,3?YPR >B^!1LW)Q![!U0<+LOL!FL&<@/F-M'*!T[738&]M?5(H2(HL*$G
MV62X#W]0Y,B9*U!/_9WH@B6PTP45XTS(C8O9RJ 4B6 E)#DUVJ??*>*9#P<W
M_^S0FJ_QW%3_O!-07">9YJLES=QTRG+HIE AY!28I*KC!-GPR)Z>.O>C"NX\
MA*.-A"2GZT)U&][VU#CQ;KU@\K^N0E*N,]\\DPV%M%RVR<LL]7%71W;VS/ (
MHZA#T;OZ<L$:UI>(MPI 7(DBP ')$E,68/U@.:FQ=>3Y4.,9GY$Y[ ZOO&9B
M;W&(_M<*VG34Z?[W$HG3@@[!LIC=9ORW,O=]X0@C #Z6JPH+?RKZI@[KSA7H
M"_' 2Y[)]);(S5!G10Q[(;H!>0)[*Z7-Q&S FFTE9_[L2U<&9*!FD%PYWA0C
MC/8-%5'FEI5UHO[T$O9SFB7%#B7H>:S]ML6JH*2M72QG-3<K"3-OKPCRVP5?
M>'IGBJX6HJG,;\ 12K*(FSE1?;J2S_$4SJESO,)\5&>JVJLYXA.@I(,6@U!L
MCU? &?O6-?>&CO78[1;MOI_)TU'0%WM\?MY\N,/SIO05&;4$M#\A5W5^S,6J
M^K8<@2=/1A45.%)/RG#[)E;0C-YJ(F$C55(#?P;K&Z0/.DCD7++C^/@<0 "U
MYDC8&NFFNLY(."G5=?5S'Z+:<><NJ<^ZH_$T_NRYQ=,6[KL]ZP_/98<=K]]:
ML<?H]/K(W]6+2PA>6:\PD9HV,7?R4N&TDA$#8;7U"4Z+<'35Y#VV,T/E6*Q+
MX7.<*%^Y"V!&."U]PWC7]OC=2#D*_#&TK)0Z3%F-LV<N+AF0+?T&PL?M <]9
M>'CQ(^%P!UVHQ[]_C1M!Q28388BYBX'PJ[ 8<,D[P5-B41^G_-,-&>5":!ON
M#U+1"+(\JHEG@CHA>K6!8/.68@=1FQUHF5[^TJ:A(&^1K*M&S^/X^"O/7!'6
M2@T$I4ME?J!74F;E3*=^!X>4U"3'NZ<U$><V1:)I!L*90.'WP@E76L4X9BV8
MBG=MNO $I.,BM PD-B/X5W5Q@!W5)KMXB9]Q5@GUY\IP9@C[L2>KMCAZM/;%
M!WA/2#=]79/+A5LED=:CFWW=4$R-CD?S1Q=][L%<)*U6:VH@7.O644%EH(*,
M?4_7& @J-PC0FZ@!Z&4VSEA\P:(BH.LH\(B$FE-H;[ 1]_^G!T[>FEZ+LZ)1
MTED#070,IR\_C6$%G'^W!XZ5_JOS3Y_,YT$QM&&;13YQ<+&6)WO[^U$5@Y":
M8;P54)WT4<"-_,%XD< &IF:P@*M,!A5>D[.$PZF(<_<K2^'/#MN<H$T.^L76
MMBW^"_876>N<H^.>_3%HO>F#;62.=3KI%Z10W&MBV_%H_R\1D<XG;W,O+AY:
MN^^[:1>7KEU"S1UW?].3OC7N;DG]<.T/NU:T)SINNO%'(7T+F=X_4<PH.D']
MYMI#X!XBQ3( XN3LP[GF$W_2?IBOG\TFX>)C][B!<"D+Y?R#!^G'_^H#>_U_
M!/_^VY2_]\<4>W#4!O>GAJ,T](E^[Z=]M<,& O&CUV.77!TQ!WP;,7F[EV6U
M$.W:KB7ARN.91&D@H$L8X*=;_^BZK^51"/AKS_9]O']TU+\?B%,+3S\I^J'Y
MP0:".[B;'>RF T1HVZO0SY\F^Q;0Q>'([R*P9?=C;E! #L6#Y0<+<HJ91J)+
MW/31/0(GO^MO+[K'R INUI0T7SKKU>7TQ:64RH?KRS8;BROHYM]=/8;'4-Q/
M'/B]#EC6@(2'VB.X(7[=@O>TCC01P QK9-M#1:8#Q\_%S)8N:U3=BEB<_@AF
M9LU*+/<YLL+I:>65.^2(,ZF,"R%;M@_&(\%B&@X!9WZCJ4PLCSI1_99=#+UT
MX%[W#_>;W_QT-:SI(BU51)7M2#BHT-^PO[CO*;Q9OA-Y<$U8 2(90]J-^(Q\
M" _@S$R V^3-#N[G/A3B7<NL@J*PC.,#U$\_J= Z5/ZBK0U4[49QH7GE\.1U
MWMO^>ODKX_U'(#O+93*]>^:(\"!CPH7G!$)T!?[R(I=]_K-_>+ (6\(0,R:F
M_PY"8T3RQ-%)#_I_[# 7R6=,!]]&%23@=C4GM[8]T?\!_/_7VT^,SZHUQ _*
MQ6:8Z;Y"YR)%.#,93\-6L [6P@&X^G1@TB4"ITHIF44^?NT%G6+379)XV<LQ
MI*-3I+4+]DK(VWW>]86MM">^=4K"N3>VWZNUK?\ 2S0);S/#:JV?>*4NH]S<
M6G)@Q?[[=856J>(ZMHE=ZB5^Z#R-ZG9CQ^TV&VJP2[%W\3[LS@0%B6_N=WCU
MVX:3JI ]:P^XS^\D9HM6VKJM?>#E 66=_?2JD/KSEMC':Y)"7OQ?0J'P4GT.
M,#&98%.LY6.'L+LH7V^<U(N1WB3^$NS\]\Y;XON5/#QC\U;^G9AJ^*MEZ2L3
MCH]*SZUO+M_\A4QP?<F.!U-LUV;]5G;,)/K7'6D'9,W;\T,WKFI>[ENQ-6&Q
M4_W!B]RP4MHC_-F'V_UMSOQ7);S 47]'>/A)H,(D1^"$DI!0'< *T-^F>*%?
M0QPNMBP$=4%B^$QBD[2&U$1-3W*:=P^N/I<HM,!=F<BI\#Y.V@OG9=2M4O#-
M1#X3_!R?[;=SUK0-[S[F=?-VQ+@->QV&AQQ[MB4F$4([Y!GR"IYF"6RT'MD.
M!4MH]VCBMM1+=LW$N?L<W446*!5R;N$36#OR&K+O?FOV"]L-YJ>2QUP#F\*=
M8A9T^^PEGZYT!?Q2=W?%%5:D&;UW#-#^@3C<9+=\8+_,"VFY2YDJ@3:2N/04
MIU\.PM_V6SR$7K 75[1_#T$/B,XY1_YXAB3+12#=:K,J,Z)=\&P)XTM681$>
MH8+&BN.,),DFS>1>.]5(DUQ&$_4O0HRN,4E:.AR<([ .&Z)9KP1B219#X7;(
M:E60E<J94[>S&+';U'&P&UVBSB>=:2T.7S(@ZALQ8F;)5'U[=Q92B[%D\=5^
M7'%-<S00,L*;![3GH:+A\PJJ3!*NYX7TJQA9$]0FA[9S']%#'7<KB=.^OO\.
M>D%[2[&6UA&GYSK>[>#-&;3#2*=;8C1!N2EK\NB3BQV-5#"NC0M88Q;H?J%4
M,)7UI?X\$ G,WLON (U]_ O[1(H1&;G10*AP%A-EGDV=B%U+<ND%%7GF2Z15
MN>9D@5,WBW%M2.94>S/Z6/\ZJBE3XK?_SCO97H)^,;)0]P-BITWMP:9&\\S1
M)2IZ-N\L;WI=#,P76[P+M@\JD33RB(BGV L4E1<B*N_0XJ$4_IPAN=47,"G5
MP\77\L-[^;:\AO"UW9KWKSL3ECO1JHH_674*%B(CVNV= BOFD((J=F0HQC,H
MZU#@(<P;?J@$K*,Q>YB6*8QEF+"6(B-0O-)Y6*/SI4\(SR6$T?;UC&#NJ"]2
M"6=KBV$G#J0=: (MW.H8N@U#3JO/3;1M@LSY1?RQWO7&-MP[H4/E/LZ;ND9?
M4E8'6Y5HSU-N=CQT*2MD)L9Y?'/G:JK+%S<>3?LJ;N']OR>Y-A4Q7V\/4BUK
MK%<O4\TO+*G\X>K:=Y4=U*#A41OT_Q:9;<(_#Y!/[_^3//KBOW=Q_@!?BX?#
MU$- !%?FI^:*^3(CB=#.0(AV(3JP#L%X4*4L1DI;1?;25#Q>F\N&^I=W+>FJ
MG.OA[6 @S(BM[KET,,GJ*UGHRW=)XQ;^Z3^_/^30-E@P%W8+;/KU8E36D[)S
M'F7,N?L'?2@.-N'A'6NS$FD>)](./SPP5BNENG/G;;P1_;6'^MB-I.-+;I3<
M+,4XGX3MM+?^!L*</'8C.!HBC!E!E[.,#80_S$CPS*1AO&O^Q=H"W"1Y#32T
M0:HAP79,$I8*\Y C8@/A@Y.PL[-MXISSI\4&PBE)*RI_^08LT-A@:;3/_'7[
MYYOY^P<^^[=[WN>7.=AWP>8E\GLTO2U?AO.K6;0IX$<CVA40HI*017D-#&1I
M4C/HQ-JFYV%+650IZ@];-:[!IDKCL.6!5YC96U+]JZ1WZ_SFRR*K.:/"F2_Z
MWDV?:+$^/E!7<[)OWF+;IHV6_"='.9D^2RY#3QD7OC_ZG)/=HE1NR2H^)>XL
M>C+??Q;_$OOQON*+ECUMH4F=(7._]??J&ECFO]'M?6=V2D)8(IC>UEOSKSDE
M?X#X#XINXM^8SK:R_\=U([>N!,#N7?();?Y159#9]UTKWQ\NBJXC'[M_U_.'
M.LN_]-9]^^[^M/-9[HMO';:\^Q5140LV5O/NNZ^*@./5OZ_<O+:;13J;FVL@
M?%5TF__.0"ATSMYGI0RCN'-L(^"$_N,[.:]/8FVM9<RNGK#YR@,GBG<-IGB2
M^-M>(0_U^H>)V*$)/YS%%BSY3KG\!_'*:3U!LS^LE?,C]J>5_['D%Q_@?MV*
ME* O$U]H7U<DO>E$JO_?N.L=4!57-P]G+07'.[&#:X5DP'/<_5/YOSW)_/^R
MMY_=G[L!CQ0OV;_+1X,I/OBOI3@<HX^#!YV'J;JI_Z>Z-XUJ*NO:1;%%1(R"
M@( D*BA:-"D5I*1)I"A$1(Q*22M$I9 F8EX+D @A49%.A)3Z"B441$7 +D1Z
MI4F )*344GHB04A7)=*$[%U"V$5V-C><<>\9Y_N^<^XY]^?]L4;&'B/9.VNM
M.9_Y/&NM/2?DJS8$\+<\E@%10MK6(6>"%:7&(_KY>]"04#LTM[GAQ]YZ[3J?
M*%R>:Y8T2SB=FM#R:V7CJQ*ED;WV@8U#'"1B$ ^CC%J] <E>6<&6/_99?/ZU
M]7)@3L66\X%YG3UJBD?R%I^8;SZX' BKLOBY.OC]C@34D(<I@&50S!FUR/;N
M+]''W_WKH\.'S-"S^W:=(SW[]<66+WTG'C_]?F*@^"1U;#)X0*/^/U@%@O;]
M%^=;U!,7_;_Y?>28S7_WY9N>_XGY5D>HZ=G_E$9O^LB[X65C__O&'PJ>G0AM
MM[I_O.[?01=^J?CT9*O9A9_N=4.+>I%1UDMGK4*F9,IE9P>5(N_>(0G?N'L_
M=_E$X??6%TE/S,2?(R*WK7Y_)+PD.OS*GVVAQ;&FYWZI/[/KXZ.K^ZIZ9_.>
MY^^=&3_2?]%I-NC>+.GI=$+TJ[Y("NZ=>]S=-R;^9_K#Z>5OAU@;[Z ^O=X#
M-\1,7V:27!?UHILTEYK,SL__GJ<\WW/DO%GE.+E4?6G/WAS7?[X_^=-(Z]V@
M70_6!EE>+*WX7KT0D5E80G9\/_CG+R%A'3'KBHKJVM[_U2\@;XF==TW9ZW<I
MV7UWX94_KT2GW![.%__'$F/KR?RR?0 ](]B;; ZQ>;1-1!/HKA] SBKA%\\4
M/<3F4(GLUIK82-.>#T^3XUW(QJ23WLZIQ[+/7'3Q])'?<U">C_VTWE_(W$);
M"SLD1-#LX#-0!"!KQ<M"X&0VEH';2B%T&CVB[$R@=7?^ @F#T=L&ZQ654!!Q
MTZ09VI+!=^4<^V5!.U=6T)1]XG76,')Y4>]Z 14'68$V:AMM>1)=C.TR OIE
M%S,!10B(E(/QO7^XS7>,TF6=5?FP.9C8:;ZQ-H*G(&3CG'KJB::4$Q=L_:=&
MR0%U_8Y\%O5,T3^9+:#K+1VM(4 V6.64YD>DM_A'VD[=8W(@C<)WNA1@J.]"
M,0J)814OC9G93.YDBJ/4J<1K1#TY\*&R>4YR';&B*#HXMOW(_DES HE>-16Y
M&QI1>*:_:+!MR.KZM&+A"="ME&A0E#Z,R6G(7?U6^V\XE"SE&NEH<-<^*$:=
M#?FPO67X-2&1(7'S8]^ SLW$6TYWO8#1>\C3RI#1J>+RL(E"47%^9KW(SV6T
MV6^8:JM32M&+>@QQ9=5#>(WV,6XY3!JJ#[<=F"NUD=EUH;*Y&^<"[ *NW!EV
M,2(0@)2<AI(60[M7=[XSGIG<_""N=+NQ>70@K-%Q>*]6>Y#GK^MNC.["VP65
MQP6.$88QZH &ACHE/'U%%T:/MI<2(T_)I4:E7P)MVKN3I:7G^[K5/T-[]N<_
ME'20K;]*""\FAP(C0\-XR95.QI/8 "@!GX-ST]TPB'L>:T!AJ&T 7]CDG1PS
MG:=3T$REP0M"BH*9F3K.QXJ#9;X"]JHIG38Q;Y>LJX!L*B,H,;J09]1JK=!&
M?0_&=.$A/SC0=/X&?.(AO#=+U-GGFGNAX<M!_(/G!#1%%X:[PKIYSS$6T,EY
M.2K;.<".S]D&.%;EU.<Q+6)Q6T0S6):S(ST4X+LR6!.I.QN2*^.#Q,>>IT>M
M*BB_5"7QCO'H"SM6,U0/W09F=+'_#GSR):BZKJ)9>#^<1-N5R!VK;B:Y,Y?[
MR%@[K4I*@_E[H6:K<0!.1=\GQUS!/7R^_X&#P\.&UX6?Y<[7@PA_=JO)V@::
M2<22/H+-->$3"_-Y?X$H9:;FC$X7U33ESUS$H>"('@3#G1Y)> 3YRE33OM43
MDLVM7@ BE,[GL%Q0N8MZ=3=2*S-(,G).T4+^API- .E$V/#I;NUS,GF6?#-I
MA+V::JZS >DOZMTO1O!=*&C7AVN O2RY[/Z>K[/DC_WJL4*%NADJ?1)W_>"?
M%'('9MULMU@B&V.N6^/H/ 1<9E9]>SCJ8SNF]Q/>A&/YB828 !5</G9%MYR)
MAN(U7;35P #.H6>'"(Z1:O<DB09:@V6>UBZK!ZBZ<?!T*=W&;AA%B[_ZUT<$
M!Y#RG@CFGA:]8BO&U:W:&@1%L4'6^BJ(XB(-07"Y6#*-TO@A;_&U35>EP'P'
M,Z^8?35*6W(1=I?3#9%15#I(.@RE/Z.: ZUN9@T:OXY$]@1B TJRV1?(]/.>
M9@;E3:^0M^&,Z8W6.WZXXQIJ<_N4XO9F-[?OUA7<>OS<?O>Z%X^S5FXX[*PW
M^3\FYOA_VE^M"0KF2M@9J&Y0<'.0/4"3#NE74BX.$"EY79'[P?5W982U7\P<
MG8/>76%1LB-:7O8Y/P^\Y+'!,&_J]VW[ C9YS?]^,[48OJUS$:5MK6Y6[? 7
M0J0OZP>KZ ;0JH39Y_\86UD?2P09LM\SCK45'W:*ROJP$%'8%.C9\-9[9>WA
MH:^9>[[3_X0WQ%_ #V,4S-R1#OQ*G<(<?J<PO]5_M&6(V8DWQ+G"^Z ,>5+O
M"]O&+$U0PHK.2+O!N5/]#I6M]3=G8+%A>)P3ZT[<B:H<U]Y#A_EY&V^OK&9L
M_R'T!\:60R[W!@T^O;'R-V[1.[6N)FMK\SB J/B8!E0[_BJS,5B80$<,NC66
M-&&9/71 @Z'U8(QIIO!QR!XD=4HVNRB]Y=@,#X.GT-V#P%"+;(HX7"?]-(28
M-[_J*SHU,&,+KBXG75X(X-Q/?/Q[T_5)T><KV$6]A$6]K$6]AO'.[@*).3<!
ME5',SG4F0[;=R@"P_U1O:SK . AY:]RAQ./,+J:>2@&P;\'$\BF:+4C+!T9X
M:%>1AQUK$O%L<(W<=[>3CCKV[QH_?&YRK@XMPQ]Q_ZW!0+NSE=4.'&?J 2A4
MXPT1%?-Y53WXLWASZC9H%/16[X#R-7LH_GZ@OG*CY@(%JR9!#%F"33NR7\<3
M$D] +4 <U46.4;+70O-^FO6OC0:*Q#]#Y3\VAUL?$XDX.'J'#U='RX?7C\NY
MTQ4@7L[,Q-E28_+4F=I"#H;JIGU.M=%@*?V")K0EY*\)H+I!0M"&"*)RN-',
MC'G$?I!* NUE-VG=1)-ZE/X7M'E+A!T_*'51C_<^37#;L;%$_D9U$%_QC?T_
ME5"PYE\ZPSG(C25L@8VT)1Y&X&[:EGC:-Y!(<Q1VX6J?(;L1 7T#SC2>:\K9
M0'6!3($6!>H:@M4Q- HTB+DVD\3<,H'8@I%M0)[ #&R!W5I$SJ6^@F):Z?XR
M!P]W\VWL_X:V<2RRE[8061^/V?0"64\].>1AHCE%*5&(A.Q,3(U=ETH\AC&%
M\M21VJ>MWIK=7]!H@-B!S;K,V=D,K,\ L9% 99VB&TW)XS>E!(U9]M/KJ#MD
M]E/IQ-.U \J#^"<W[?^)$W&EY1C@I"I'Q[\09VHJD""YRHTA0-'='U%2?64*
MB)(NX?=5FFU"BMQ.4+*TYM8GUN<3,A-1UO$X4W"\4Y5%W.!,OT9Z\:6XFO4X
M@NH%:)DY'M@==2.;7?J?(?5(UZ+>)GK\-LUA6A^^KDJY!]S73MSL1+4 2M07
MM \\+.225507C*%.0%DT0IJG5'*/AP_P+& G9@.E +^!DM:1RNYX-0/;R-N^
M!ZF$)Q-C6U\U@C9C$:$=/Q_$^\?^YY08_W?[)JO\\40J?T]X_,)%YK-P7C(Y
M;9UE?FG;[)[(L,,[ZUMNVO_ZU^$95O3R\+3,$PY[]<#FEZO9O0=-??+OC+UY
MZECZ;'+OB&^T(]1T(_)-S+K: */'15X>\XTWXRJ+O[/T-O9WN/.-_N6=#06Y
MY7&%>^-2+]ZNC%OXJ3O9MCDY/Y-5<8M-5>V8>A.W\L1(RYB?PYV(?8<">+^K
M=E^^;'?LIM[[HD-]=A%[SO?5#Q?Y%-OG6T?7--Q.*LEQ_+,^*_U;CQ]" HQ>
MU([X.#[)533=.7SBQL6W24_^$Q0J="(BAXMJ2"-82"8BW8&+55' >-!@/2HG
MN)F>.^L_0EA.:EY?2GI!*L;>FG%D5V1W+C3F/R:&QC<WEK+:\C^75D6&22*]
MC1KX>[G1Q+=-L*D1=:.4#.G$SS6<02QF8X-J):V;"1SWM)<RL[C2%ZGX+*IK
MXE(&0FB_2+Z2CJ*?9YI3>%V%S9EEI4"C3M>V#RGG\,,HH?BO64*B')/9?&'?
MAZ%QK_ZY->UX.DS47*;Q\2AVO18KY#;Z3C^7YOL']SCC3>/<4O*6WFJY0;/D
M#,!8>8*;412/9MNO=&&:#Y^._(+>UG>1U1" "FDLB' /ZJ_>VO;RU:O&X@.A
MG)W:%JY.::]JRK[;A6\,GJZ2N8(I6?5T"^@$-4#C#6_O*>$C*'"MG],U.1?E
M]%2N"6112*<+=O_4.S?J?'HBM=C79CCBV!,^S782;0BU8.!-7Y&U[H_A-;H
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M:]@#N@?4$;/55[0/ZXE0R)A5348GQJP5(R5N%I9#_O(!O"6\JC*2F]T?<)<
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M&^8"9FTWCSQL)3A'L!"R24/X];C-0O!TG"5R7T[8%&?YN2D-1(6]AH1RI:\
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M\&RIJUS4R=Y,R9"E"*PB=NXN"WW0YUL 8]CO'GL[B%!F]QT?N;Q_@Z9>13,
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M2F(:F9RVU(YW$*[K2.EZG49?(1-U^FLC#2Z^J Z4E58I_8 TF<.[Z)3]O^P
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M/>TF(L2?$ 'B1F-O.!6*M 8E:4]72H #BW.%XMS+QJXC[<Z0NHG_!=D!]M,
M(M!+^(9A+I_AP&)^0#P\BUQ<@(P].KIV".+%VR0P2D:1V%\-Q9UI7)< ;?\/
M:<&X;"EB_\>9)*;Y;SC;?P/S<*_"A& +N?^+./,2OAD(71B-W7X,4=?:E&FT
MP.9^!'FG2P;OD+W4V<'"Q/8S4-HDDN"0Y]+M&.:O#0R.V'X5F&4_Y3I(I-E#
MR;!!S&#T#<<K_\[YCU B_Q/F)TWC,9N^. X,0N/7*6CS$"@CV*<\8^";]W0A
M92S8!)$RDSDZ12BUQKS@P/XCCO\)<#H/ LK+7&P7!P;&!$ &&#2-3L'I0@@H
MZ7,?M<+!U)](YO1\R\;6K7AFX?\6DO\!\EAK6CI+TA7)@;4;Q))W)Z&T@TZ^
MHG:QI(X=@4Z2H%HQSX%I[>24"-O/(?\3E/\1\HM)PN3%<8A8[),_3*#=U[5V
M8IB7^HXA%V?NF;+E'D+E0V>7U/1_DK_(_\1>Y+_<_9>[_W+W7^[^R]U_N?O_
M;>ZZ!@+IM#[*^M.<8TQ5NCL5$\L5C]\W:XEDV%/TP8&M,F&?!X>]?9D<V"I9
MP+OA<K4G8_$V2HD#LZK.G)N<6U-"Y=I3;MW[_D3F5(N0>$Q95 <5>X-"NU>7
M<>/,K;-@O$:J_I!R?\F)H5QTZI7N+/0-6?'!UQ[B)F::X4_A L9B%Y\J\[H^
M5>"+R[=J@0O$%/$,*7\K.V23ZJ-5U'U]>:#$RCI+_]F+-[IFYN<#O*,(NH0!
MXF^GIG .#+/GSWX95,Q*(G7QCZ/8%B%)Y!4.#)HH!H^E.F3*2)L(7]OW_[*#
MZR;QYR323YVA 1\_P(%=L[0C?[G0D%/$#F9G+; M![<A(E>>8_V-W#HXC&6V
M2Q;MY2Q@!F0@ GXBQQ)7-:#/%"AG6WG0!R!BDC7EA*TQ33)>UB;"L/]V8-Z0
MWRLPA5"S.4SA&"?Z:"39,TF"*5A-'Z6LJ0VVZ_?]U2(++MP DA+4FQ2#@X^]
M9JL"VSE<4<&9X2&4\3ND8/?<E=HTG63+OWW0Y3''*GW=X;%!XL'J"JQJ\JVD
MI^3W\"Y5XVT"Z^_-,E%*9TV+%+"34*K%?]3GPPI!E"X6S33#GDY#DV.V'%>#
M>A)Z+,(O#]H!+ :J$(V0F(\I09^RY&NRM]W]UON[^U7JU;>Z/PQZ%6VVM\XB
MEFZY7_Y&&!SK[FTM?N9CW>!CCU;P^9GQ.$?YI]^/D1W_<59?\CO24-)W7O81
M%N,VL?5*D_3L>BRR<B1EQD+]$!Y!5\N:64.UDP41J'"JB[H#W7(^3:MQC9^2
M\GU1@CY4S7]L20<M#56%6ZEWV:V^-"(_PC=P>^E0,W$_E.ZGB3Z8.'@MLMT?
M5*B-#"9&-!1V)44U\,V3:3U@4TCH]#%JS-4!O&JQSWAX3KPL\",]1+_EN7K"
M7<UPJ]:J*^A!I\KATMMXAU=Y"T7M>M(JEY&\MIJMI@)IU](4SN:MF.9P733J
MRR@_J<S0[9JP)6M8ZN4-#U9NWY!(^)E:L'MS=4U^VZ)^EVA"O$*F\W(QA:%J
M2T3>(3$-_KF+;+#\FS]I&O#S9PIK;/N!RG2#V=%V@Z2_[H.25/6(K20I7!G"
M@*YN/[1%>;/X8"V8$-1L--N*QNND)_!4FOC+K;U_EOCVS_8#"P.S?H(DNU0>
MA''J4 DZ3]&F4.JJ5*%-7NZ1B\JE^8IG\B<GZOWY7>0G%?-2)P)"U5>V5OM:
M,Y2WL=OGH.HKR/Z!J?7_&'Y@.P&$(UMQ!!DPQ8$N'U>@GMA$+%J4V'#%V3O4
M?]NZG'.U$DBK$+X6WC+@41,8VJ=I?MIK]NB^/8MV#( M9(IHF'S;LG2R'##:
M![9P8*C*M/E!BHPTV"I=4U_6>Z+;>\^E*P&A1R7R41[JT11&FHSS'/8CP\./
MM):=DW)OJW.V=)910/:<!3-$\B]62WPO#IHSKY+[K'M]WOM"F[W-?>_+O37)
MOG(7JY)?>%L6E&<D>)>OM"QL%)J$=:U),\XR\:SG!/DIIC0KST@,3*(BV['2
M&E8C?3',BS6V!6_>+/<H#F[U<CGUKVLA^7$IE^HSQK<[@HG\RPW9KS/*LXJ7
M!']T%7NC$[-($:/?^LM,!<RS\(;H&XMVD3XV99?S?*":94Z'BM;]2*I<J8>X
M;G6QKWC5H'=!1G]!Z>#JX/<SI,5!4PXLPID\4]C0F9*_O 1E\U:A6E&AHX]R
MX?*TT!9#VJ;#WS>W7C0T-06W;WR _?W*R:8:3_=#;68"=Y13F.LK&3*5U$2L
M/3 =NYEE<8'.'[-EP1)R^;:5R5NF[M!?G:BT["2-,A\.ZEGT70]:,T4U/\9:
M3$A^.ME051_OH';JJ<,D5V::YYAVH!+07:DB8^3@BBHUY45KN:A[S1?5OULM
M6.I5J SP*AHLLOIZ[\7UFGF[YK+:J2<-RMMAVYK_4($PSH%!7,#PL?N)^[9(
M?Z4;[:>K%=%<! V00DRSH4VB\.)X;53PQ"2O]2#S0NX8B+1+N-KX<MRXY/M%
M_X*P+/[K \'[3XF5"!(N@QL?V8J@^VR2.%Z'_C5%/F(6$\-6I',];L*\Z0GP
M#%%+I!%Y?49#99KSS8(+?[A\=_Y<N)RF8Y<4X!$<Z*UQZ79-78:HF:2SO'_J
M+-WABRB_='3[K=^[#;@?6DH5J7<UAQ8L.\N0\=JOY437/.3N;-G+604\\3A3
M+8X5'4FZM$E(E,H2V8.ZXD'6/PJ#/3@-V#0[T0C/&3J4&1/_2'1(5##\Q+(,
MDB[SAEJF-HGW#"R?P!&^#FQW_3EJAV4,4LM\/&I>J28X?7>V$#(_]4SA"7ML
MNF*G _[=?K:3S-##>PXS#Q4QS8":)&JS>_L#2,O@S9!QFV7".))I#?U84H&/
M6*V^7:)A#4DMBEC@\]O1\.58X7)#<%O/*>?R(W=V/:YVEZ-0TC'9WA>324X'
M).)HWM8!^7(V^5JE?\RB$RS'M&Q$P6?U"I^*[[=<7LWWE5PC,%A]E4;7WY(O
M$6=RR,!5^'@(F\>^A&DU@+P#XH^0@"0KH#QW5I(#@X-)UX"1=+\6C?I1WR:D
MMW>8^]_8$BW6$C!2?7[B:EI'V:J:7%R^@+E0 83.7_]42@X,"\FNECB@KSVG
MRBIG)JR/'W]]&&'YUDM_@>(;YDB_\SQ_1>9$=3\I?Z#)LL@%YVG\H3]8VJ_'
M/FV=8G<>I352[?LWF!;F%8F6FWB2'9YBJNFH4JDBT9N/]?A59:<X%3-BLQTV
M^8VU[%3G$[.Z?#_,RNP^4:MY<HU<4K'[W$38OO1/:TS>-&!%!N7LUR#)=TB'
MKO!TDSC&YC\ !E(X,+[-1H-I4?P5D%0")E'(_*O5+C;!2:9 8DLNE<B-&W4:
M0MPH'L]G%QU*3'MDF)7VJL#9&2L1_7(T%($N](#D(@C184UA%C/1V$4&4.HQ
M4X8@[^ST4\Q1IM8[,*E3?^01;5K*@:DYZ'2Y]MO"2-41I@F-'#TE.4(*7CO)
M-"X8QYAX4N.JAINQF5[!9GF5];^9H3\N)%/INE^D[_;PHH32W0B-2?F**Q%M
MXYG;W]-2$D^,EVG7_\P;H@U47NVW>3=T^^\UO?N0IM-L5(-F"]:K791)^&<&
MCMB*('HC005D.XF/>8Z5&V0H.&%#CXERIX=$,2UF5E@6&,"JN3!A)<O@VH=!
MA.G#7*]O+MA0Z>$F8Y<!]\A)[VO+:,/>[K*:,C<5YO3J!<9Q)A:*ZR/\70XL
MZA @T"23;2!S?+3)KV\V*W26TB"QF"V=<[5FB'M(-:CYEON#.\.K(U.3=U]>
MD;CL+>OPV5"@]\.8Q_0XO9,ZEQ8F?LNHJ=B$FGJD)O_&$/I,1T$>N\?20//S
MSQRD@O)"@W/-R+J'WT+7IOUX3FW(JAB]B\T]08\Q >&,/YUQ$K.=>^M_:1+C
M1,G 7]B=*=E^*L"N+\>E_UD1OW*-W*^IX')E"N=DG>;DY5L8;>!X=WK-4C/E
M E='<']D![7BNP\$K0_NB=HIGGR>S?Q>JS*=,"O!%3%?N+6YFFJG64&5]^+@
M:EO\F?)'AT3*_O:26(_?FA1K8XOU!_L+XC+;,VJR_L:%4!H.9STLQ3:P&TM=
MC0N])=02\KR__5B6*"\K]A'3WM9_D.7N;SBW]1.8<#)6^?U69YV<2)X9(X.*
M,7\1)'&--+]&+"!0U7<(!\?0IRK>..+MZG/:+=VIO8?7VR6B4SRE6H1K^^5'
M$IM?CSQ84JL_G"I'-PFW4[[H+];])?!+SIELF6SO5S<!K7-^UA1C(;1POF/;
MM2?-KV__&O*PX6Y.26Y4$UZ^WA@I)R>]:_N@9129HZ1XY8]GN#^>F=;-C*[U
MK9(YL,,[Q%8+I ^D7>P[^8\QM8'"MCYN7.PKIJH_O:^]]I_B8TMSD55Y#R:@
M@&< NY+&*[T?+$HW)=,//4U@-1<VE]>_,2GR$MLC%(44>&3.O3(\0=-P)HCM
MNQQXG6HK@A:^OFSX\.27P=?)31GQOB9Z!B;:QPOUGWY[DC=29J+C,;F-%/ B
M68#]0&X'<A_[+/X&>'(V;5"RD\Q%D,5-4$,2)BXUI5SKSVQG[Z/+YU-='E9E
M[OJNSC4/6A7ENTA*UJNJWJZK^5T0AG/\@F44S9!!;3B;)V#6GPMGVVGWGMW7
MH%4+B8.WN.1ITQ&VBDNBIWF,\Z!OM6[5FA-#LDWBZW-6_NUT9=]P5GK)<D;(
M^*WT573B6FUZH+QXS/';KVY(:>%[-%MGWLW>FHLLBBV3"&@WN2QT/S_D8<?E
M?#WMU.37_GZW!?)M?-]=M D D^VK)ZN1V3S*>]#@&^N G('F\8U=AA:1.C9*
MW)VV7[!?A3KYP6JPG_$0'P0V,_3Q*F U X%3H*6W_AQ2(/>WJ.+(71G[<>,]
M)J/K"!T:5')C>JG^T:Z:C2.^30;$0T\RVI;30J6'M-'S*<&'JMNR3(+8:"DG
MBL-K(PVQZ*_W=)]H8ZRRG'W16N&E]X:6^Y)?K]Q7U.VTL0S4\NB17\V5+_I6
M_/K6TF>]1A,M;+6G1UB(Z7RXR);I6@Y#BNG-BN# O-1/$'JG93192OR2H+FJ
MPK48--#;6?0.I]XI Q^M K54X1U&/"-;OO +C2--R'#A#VC)5T$EDB5\MRAV
MWX*=E/FP5X9650GVI$"^N#=/*/T=;CYM+9)"YB*+=OER2L'>U^,AM9/<WVGM
M73A_9S A(-F[8! 5-+)XYFW\]PO__?BSZ0WQ<Y7X:0PJV5"%K0I@^G-@_>.6
M^"N3J"%HFF7XL_F^<V#/*]D\$*Q>L^ T-.Q698#/_VM&VIO^"_X;JO3L-M">
M [OA4 F2EJ %9=6X.+ *OV .K.CE.6A+=BKR65N\4F]6UGSN0VSATG:MSL[.
MSEG'[]_'6E6'Y^;FADH.59>551W9<';^<77IZ/&+22H##5T2&N\/:2?[5B5;
MUDPF6]A-A)Y.*VN.3O$]G>F;EVSOVRQHY@.=JU6VQGS(X2;.1$P#UW+BT?#M
M[<*9OGW,DS4OE;\[,!WI3:%^U>_^[(ZTTL1P>1.TAZI*SP5I3YVJ[2=5"EU1
M/<I_L!)'7'.$.)/%JD;>EM['Q-)YJ9,Y"6SI\3:Y8?9)IN+0/)T4W:2+7ZF;
M8 LF$%=9&NULR0]7UO[.JF9A*36N)R:+EAI"5WQ+46J97!]O,NV T;.]U&<S
MN)4H^L-J\Y:VI_S\KV>*NUM.+KX'0]\7+]XZQ\<HCI*H+)Y_+2Q%H[5,B%$+
M8W6ERAU'-")P2;QIMOEKR[25.8>&@%SC$-=F/=L;[ZY93 67V$9IB1;,=0\2
M,X.L30A_X?_\7PR:_^O#[N[JKRW)1A<DJKJ^A=Q2__AK=_=7;C^_=;5?'@ZJ
M9;Z^?]MGT.9IGE=N/A9^Z)$ZHCN<]9=1T6S?&&-VM*U7=+H]1ZB%&^\"!E G
MFB_SG1ITI2]0_,5QQB8-P^5EY>NJ53WAMNT2:EGNVKD!GF[AP8=>!%9_&1FQ
M#^P2,O'74-"ZZ\?/CXZ6:%'G,Q:(]]-%BY0,%#H)G9EX=2U?KS/X]</<8*OS
M/LN,W+=I_&*NB7=-I-1.51\]CQ) I_)4G_EFTYSE\RPAZO3JZL*90D_?I%-O
MXY7S%GC.O/WK?SQ(W_I !113:*$#BCLF;DH%>) ^:^$?;<0#<$4+M;MJ@XG!
M?T_@R@T%?2][KS7IY1E3"^FFD;^">;/N.TG;^5<5%!W*SO+(PZ >GGE5ZNN/
M(/Q!.YH3]>$N)5:#&8RH5>A>9+E+)Y;P#,M>SBSBN5:M8JC_/7Y8:;C(*E%"
M6/$&"5U]Q2;?*ECA!-E>]M.&Z^G>]WHR9A%%+^_4)_J[1;39IBK=+[&^>$,N
MM'K9YHUYEOZU+'1UR8W"RXEGK,K0SPJYS0@/^S&0A/L .6'<":\9[9R.RSX*
MBM"/C6,>P7FU'%6KU\=ENUSY&X#4LJE7<KWM^E<;/"G?MUB>UIF84=72]> P
ME_U$ :?6 F_1*6)<<#//[XVK[UOV-&:)3('P)CU DB:V=HBAPAZ=/LR!W85S
MXV5CT&3PN<<,KLI2<.?2 %ZKP*04EQPFR1*CP=LM]^]<_Q84DHXA?ZN6QAB3
MZX!-16(N$>OJNK3G,OK9G>D(["A_?<\T>$F75I'QQS"TS[>-?KSS+?IP><")
M'A7*P@GRNW +V8Y96=WNI_QZ[3?/69KI6<=[[3T1BY8*?N4ALO'CL+&M2&J_
M8V1N;.[3[CF$!Z*H6R\*7\*[-5VV<.+NZ5PY>Y'4:YW4==%<.TMXS O[I?4V
M2/DI' 'G&$>8EJP/1OSXF_5T5#R!9VKY.-X&%"MFZM4 +/;SPD5M](-&F@OV
M3WH;TV28.EK5*]N&SG-5?(HE<R\J6'\8#&;P!KNX6R2@6IAMI'>?Z])/TWAV
MOXHI=K(\A2AC^5<S]2C7*;> ET^.N5FE*K&[\Z5\CQHZ#A1=KM:ON^MQ8JB5
MME2KHGWJ0^0/@K\V=756-O<%+1 !'P9V?[F@M+L#CI.B.ZYUSOA<+S(='RR+
M+'-]K61;8AZT0O7ISE;GT\R-?6/6S0,)Y>6NUG_$[,(:DNZY?;..5>Z/L 5"
MJ#IMROX\N-RN_!;EY6G!(+((:@;%@W:=G@3;1BDM@J#3K-ZO(%^[+E1#"_ M
M_L%0DZG;MJ&QV>"ON\&62K0]7$P\+BSJ['=GC,"=[U<+HG4D3=5:^T04 V_1
MP2@]ZS:W(MLGRZ,D:]O,1/U[+\I$)^,_U?D;TNY>5N!]-O>R]&L-/[<]/.&I
MS+FYMIEWW0(E\>W77[\Q3Y2X_UJXT"8@_C[Z%\&V'Y,'KUAG"O9MOV;5$:3!
M!!JQ53DG.H&:=!2<XL ^2L31D^*WI ]<"P]!?6,B:>)3(P/3E(:_DUNK.##!
MI0+E./EHNYPU :V&AQ=R9I G0./V''ZF$\U_/]AUI?$;PFEFDF@/D..J##9_
MDZK"B1?).5>'JWH^_7[@_'W:">6K?WLM65M<M[@'S(VIO#NJ_>GWCP7US@5Q
MX2)3W1ZO6R<1=YQ7 L/4RZZALC-RE,VJ!AY8%IXIJ/BAESWWZH[CZWEQ.QWN
M5$^EW.Y*GB&%H_*&UK55>\W8^ZCT5P:N:RYY0QY^?O$L&=93#FPFC5RUL-8%
M++3#A8UX4,"(^E$0VUG;LG\HO9.@0OX6+%O^W<L53C\Z/S4P2AFON@]U2$\P
MW8K[WJA HS-O[!>E"N7/@%@"7HLXTR<,)K7IY]6D+!/$1K4P_,M"#F8J-393
MBSN#WUW,O%4 )Y1<9:_?VH%>WX-EXG8X]UO7Q(E" !N;,3\FXY0Y$U#?8J)D
M_?7\JJ'74(?'!U+OJGM"077>\N^>YQ:TN0=C"=*4^GG'M+E77]U29\^^<@V6
M^- =,+RDZ[9QI']N^T-;[](-VX4D@Z<)KS"!V5 )G43<?!N_%[*-8CUKT6:/
MPX50;>1'>WQI^67HQ9T&=GWI2CHI#V=/T3?,6+7H#;.WP'95,\(W)I9"?:NK
M\R?GYM:Z7]2(/MC92</K97NFWZXGJ&OU5M3=;53]>"U;03RQTR[JJ+9$I,B<
M31DZ\;+R[=1U1=TVQ6XSHQ^-:EWSX*J:8YK;N1-,BB3Z!%Z>G]<\N.)$_."#
M1/V@F==Y.[[C_?'W4ZP3L/-*RIN!V]#<^-B),,B!O=^AL [0/#O3P "=**8I
MK0XA[JX0@7 **9_J*)OT#LVN\$NW"\D0?=8_80%5].<!0E\%KZ3IB2"^]^ O
M 'U4_W;,DQ:-_A89O!* B6T*GW4AS"N[J%-:Q ?]M QVGU12_/P\CQ=%4RQK
M'M+"C>V'Y*H'-GONCX8FSI65WK_:\@#5X:R3\_,W[6@FHD?CZ-/,=J57Y7 Q
MLQE%E@T'YA@<</Z%]^!UE4E'*^LG8LWR:84$+,7Y0O*=BD\;SCEG/RX(79=&
M?&B1>-LYM#?<4EY$G16__F[%12D@TD.1'"R_J:NDO*- P0#^GDQA?E> 55Y=
ME/18YNB0GVK3+EZ!AHD3&S7ZXT-*SS%5M7*$+!4I@G,IMX K:V>?;J@6W&_Y
M*6DG==>?<8G= X=S8+?7Q<9Q8MN/06PI7I\NF@OI8Y^E<ZZ3BWN=Z:5+;SUK
ML;V2[4:20]5)_,O])@A?OD_OAW[)5:7?M0]HE57*4?B#+OL7KN1L6>J]A1/W
MM@-?6=N\>.]P=) 7(V3S6J\YW]GPS-!\1W_!VTGS[S?0J;IUYH%/?"[T#'X%
M#R36^1^P.-]79V_8?4_$V5WJCHY:>_\;[K[TY*S0Y!@UB=(?R5$J%ODV]VV>
MW)KC?L=DF835KM(9FG@_5C'AI /^/"@RPX?M,I)O5%3=3+NV*\$?734X+ZY%
M%L/%+W3W,S5R+YT*<EI#_QKS5V-FJ5M:3*)_=[<MK*B/,]C<M@QK0CN1=Y.4
MD"-Q![S#%AY!>.?C>/H1<-H$*^2&Q*^*7%R$<]5&Z2^\8?ZEM(L]%/2S#*I?
M5C*QLK-"O]O%@/[#L^VA7]A?U-?$XW.ZKB>_[!J]21[N['=,4QC7+M)U$\ZZ
M75S7,Z;7J40ZS<I,/UU&B:"JR7\Y?]=?X.8'E3ZAYQX_.#"7WB6J4A.9?W77
MQ01A&Y\W:>3%,.$V&YQ/TD_2]-\EF1#R")^F 3/4./_V=U#O'?,V*$>7W2;4
M50UH&6(O#>.Y:"AQL,\<C"I8";VHN3UN]Z9P'*\WC-#Q0,:J2@PP+M0UT*_J
M!VUG1)6F[S0$RBVC"1XK&?(D:IFG'; >JSFQ)NGRK5IR4M9A0,O (H'/].K0
MYDJ<JGJI^FIY;O3\P*^!><4_ZFKKXO7>I$KH";A<D?3 WZ",C7B^_EGOZAO9
M>>>'(3H;;M"SU&TAEGZC>%G)0N!RGIN61$MW;KZ=TO7B,[7<58,/[SAK9<^)
M/[#-O.-X1YD[S;/*$W.FZ_H35TFX57+!<H.(FZ))=T8):MPV)?&*'MK:4O/#
M(E1T#E#^46[(?B2;6X$#.[/*2N/ 5G/X60B?U#T-S&L(%N2NJ><J-!#?!HE+
ML]=)_1D<V+&FRQQ82D07<ML>FC/*S\4PQ#]B?AO?\V<E-QER8,6O_["?C5F#
MUI-K[)K>XL @0;448T[ZOL>\Q\KCP'[6XAAL\N8TZ^S2#7K,R/\_GT'MVZI=
MU6*XX4U9D4CO]6AX%9FB8;B=.^/B9M\^)2#1.Q]3@+\$R.?7C'9,[1M55SW5
M>.G]Z&8;[>OR^M41U4U#PJ@)73/4<FL[SE.$2,@!;I"^(S^2 2?R]Y09SR[,
MF"T:&,FGVUK4#.!# -[.EM-#6QB>Q= =2E]L\N(WY@7 ],DS!XQE(<K_<(Y'
MF<GAPC<_L 1)NF>D'][0;^\JF@.+RVWBP+2@7ZXAP5,AJ].S<% ! \GBUA%X
MM7J[4P[_LHS\Z!;R"7HA!N%!@B;1(^2/B3HTDZ]Q;M3U&+3EW.SI4-/Q2<UU
M0;#$+.KMH*^1 CC84;-M]A QJC]2 ?;%3_4IE%&8MNFW9*-I"'F=99RY=60Q
MZGS;5Z%4M(AB:Y%5JDR(E=V<36%B%K=%=AEOR S)^D:N5J@:8F Q5[G$8--O
M="L^7/PK>P0C3CA&;#U(G'G!E@"XVB9*#H-1N: %6T3A(RZ_7Y-2C+\(+I4M
MCHX_;:1[=N@?M!H9]-Z6^'N8<!+\&E:;;NXX;0[\U:B#WG[D'<RL)[:^UY^O
MI/F#2E_)-)3 \G@:F08_CM\/]I:M-/RJ# \NQDI\K2@&,S_6CF>7%"^'#/2%
MO?-!1ZUN3$YC7/JTAB>_#/0A/EC(UK/4.+"("J0[,KY%::#E&.%'BR1=K8RF
M'C7-I\E+C( +X \$/#PS2)"VI*D+32UGBX*I?WM7M&XK1'1F=):W\-*G\@,0
M$GGVXYX47H.@X<VE.0XL$OM[A\WGP8&]R/E!'*ME0E/^X,)?RIV?[N&08-0/
MVRQCD:W50?VV^1L;^*O)-[QIW@UI;2@3N=5ATUC?L>MI<D-)O_*M1NUL]N8D
M_!#O"Y5\7H?>KZG&!#>5N6_QLH_Q01V^@@-K_1/IQH%-!+9.'R%Z3">1@5(C
MZ65R)?D1,YA(70=OY!S"8Q? $@=Z5_LDW'H86=URDJE+]ZL7&]=<Y_?:YL#<
M8FR3K&)6"4&B :B 8!4.K,^T8QI42V**(&?)%+@T7A(L8UAS8&TW@&F:?70U
M\@ANE)(#Y)$]+?D96$K#%SYLD??TA(PD:)*[,AXR?O,.JGI)/S]J4V_RT!>K
M _R_-/[K_L>A"1!*MH,#X,8;_#XP"_"?Y6^'"V#)1S?A<?U8UX,IK0%>[[VS
M_Z!S)2"0OH57$!=HAN=W2=3,MA![H0_C"42EY4GWYY.WNS;^N=]R'8I7+-G3
M?V)T^Q18Q%!EZH,"],+6EC-@3#$>T5!-5T_T8Q[5Y#L_T4H^CM>:=:(@T&*Q
M6KZ7:6%U"*,1T7Y3?RFLZK=LQ^&3YWJ<CY>@#E%>S%$)+G%O%"*>U&7G_2YT
M' Q^FY^A']CC$?=BL6#E#,MS_/.@N99P:7^LMWF)P^>">O+]%VMA>+&%N<KF
MFIH]K[X?TZ#VWG(8')0=I31..")*,I&B3&)#;;H/,MV0G,2T4#E_][FKSM@I
M9=_GXI(G/#Q.P^=L9TA,J03((0^@KX,#@RVSM4!R(?L;0:":;OE$8J?5TG1F
MH17%J] >KKUG-^@!]";%&4DP%?L1OF^QM1@?>V"J\.WD)"NE_>Q2H ]:+&XS
ME0Q,E;$<(6+4$"%BQ%S$GV,/<6#//)GR9!ED%7&4V)7$5$$*L$ALJ <,(&>G
MOW!@UHSUW;F-M3(BJ)!#20+_4%]3GNT3PA5N'P,- *&NZ>,$+@RHWI%1DUN$
M%P=?Y:\8<0]K*?<&,\5IJ&,4^G0;&O6*Z%GLI9_X0X(<Z=98!VR7N;^=GG;V
M;HC W7]H%,9 R7=OK N4+""4[6/?(6BE[G$./+I/C!S[XKOZ66RC4N??HPE%
M=B\4;[R=M0E65#-=.\GK^]DFZ'U\EH?9;^7R$#'#/S;CP5V;$)1E<'_E9^3,
M8LYC(K_1'\16G=,@A>3U8(4N-D/L@,?LY3Q"H'P]\OE\1E'TJ3+XXR9'JD$9
M>MVR8=B^#3U90W(K]T$;O0K+3Y@6!"W:((LW+N16IX[2(;%W\"8K';,--=''
MR80OT\?4JW;5FR2I1 EC>@Q-_1SO)<"S[1K"4^MI@?3MU,UU$>S>@T<S"5'5
M3WZDT&*[+6\_MKPXN$UD'XN#%HAA7J5W=6#]0874) I)B*D->@.%KL!.^[H0
MCH1Y^9$#DPYV0;4]KXVH1O&-7_ 0]@;6VU!EN.)V<ZVL._R"N)H#:F\*%T-)
MC];*5I;Y04WBMJ-^2"0'YDV<4'<=Y''!I5\?('OVQ8B-BI[B'KWTS=:*WM<^
MD:E<_RACQWRD.A,*?=I^"Y/XSUJHPSYV [UA#WV ):)E\JUS/V2I,AKB">]R
M8[NZ!&S//"XN-D]$3&EZN4E)R9WI#)@O>\G04FX[[Y/G?N-Z0<6[7(STB0X7
MDZ[LY=&?(_;-634QY>,.[$R\!\.+J0/8K_4"]MNB0WZ:+_%$>M(,J@/^9._N
M3O8?E1^&;A$/@@D4-"8*KY&/(US7T?_)/OMMS>@\F&SQTN]FIOE[T/(=0EN_
MK/IK40B5 ]MH@9(Z$NDQ01R+8?,0Z15!6$EI VCDAY=MYHRCVNS20C*R?GPR
MDG=>?H_;=MH<>E;V9!0CQC2D2RSW6 [ZD3035$5]E23Y5Q=?+&9@MI3ITVQN
M'2BW),$<Z.=+0)TIG$1!GB#?2>2B^E-(\7">6: OTA^!H4LQ+U2"!Z@6? 84
MJ(%(BZ8J?,SR;*/CDKJF1,E@S.E/4XIUM14C3=Y!XR&Q056U%8V#2\368<R'
M-7('ZKMG*[PJ^Y7[33R*H8JW&/Q**G*>\GFPT04TSJJ.I,SX'W?X/HX^/?X@
MGZC3[M4BY&S,JA"&WQR\.7IZ,-C \5=Y4*__/$Y,.O7>M!#0BSCF9BJ.BKV/
M=CA*$RZV0G&_IF&[FX]8G3<_=GT9(<^#2)3KC<V8]QO6;N\,?C=R/R(AW[H[
M:V1SP*S9H.3S>K&%A?=N(P=V^!E[R%Y"IYT#&[?=-A@AD7X.-/E3P]5G%_Y2
M87\N4$LI )-:1T.)CPFRRM,E'65F)6"A,9V+LKNFD@>-\1;QE(^AK^F?\UP^
M*V%S7G%@P'WDZLI;/ RB]ENFV3!3.TTT5&=-8(;$Q?[6O[CG%R.3<#BE#"SV
M]6]E:R<[_O&LM1P#YG2U'*";/M6RO&\0IN<7K"X\.>':%?QN;,HGA /+(@)6
MJ'%OHCMI(GW[-BNWO-Q7I0H>@Q$.2@(MU]55M%PL58TD<"U3&Q]SA/W*5C4O
M2^1_S?<'UMO9"IE7GGZ57& /6VB'J]O'W1[XQ8%!60OJ,K9A=-1:$<"!;9^E
M][4Y&1K;TLLC&!=!IYGHW/""FJR0/&_B,2B)PNTI;.F$+OVYUV6^X47>4\?I
M7Q-FOK]-,1]:H[T?8+J0?#*J&Y?L-E8DN";OV.2WM2C>W#"O=,#7QO]N^'[W
MAB-:V.U)V\4,WX*,E/N4&<D7#Q7ZXC-#;#)*>GE'6KNY78/D,YQ:'#%^S1XM
M:?%KA0^A@$RQ^]"H5:AC'R1'S,8\;2?(#+&1V.RS((O6;&^KA#$!O:DKIL!Z
MQ-$UK.2^7)THA&H(?7__A<:F*TS/((7GIR<*': .@:Q16.,M(PQS8-7J7>1Q
M#1<=LT!Z&"TF >'NYA[Z7JXSCMK#L@D"TJ/'?/.RU=4I,F(QI@"3:TWGOJ;$
M74NMN9\=OR!1<I$?5.OK\C](:,4 9H;N,UR4^AE@JHAN^I$MQDIF'\>%ZI8?
MJ07#O'.]0_F3_N N<)H8[W!W V*LAIL0$HZ:C#/K6Y.*EW2LA0J<H5BB/O)'
MN"JPWAKIX4^"_#/M+\#<6:YV(A=>K[_@Z5>+GX._FIQ(#HN%#HVU3Z]P#P8Y
M^,T-;SGFU5775@_>+?]57K[F^R:-)DO1I _753ZM6!DSU>H:+8S.NN'OENXF
M53(<D%;6'Q]T1B?$\Q'6[J6[X; QG_3#4Z^35_0<E<O7(6GEG[.H 8$,,$\
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MTX?!T=8/O&4"_IM+>$/<,Y>Q1X6XW#^'"P:KI06[URD[^H5QY#@BJ-3W$7F
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M4$RA,3KL*:G#NQW6H&>$PWL2S*D25T^N<ET5+WLG/Z<;=B3FH<KXHD@!=U
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M;=B3$"C9<O[K+;8?O=&-E6P5$J!ZEWAS[($"+F.5@^BNO4>++=7F3F0U$=2
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M+L1W]7_+;W Z(&[$' .<B/@5QRSSU#8'9GB>+&K7W$'YOPB*37# 0:0/+-)
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M6X5[_X)Y%<6->Z3V].P!ABGI\AD:.RKFGPI]T:/'XD,K7,T^S#;5EF11."G
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MJLE(XR5G3D_ZY""W=G!>>-AW[5/"GP.*4Q>H5KH',*:<M]T))#$J@32]IG'
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MT8:K&8GU:_W*_$<<6B7MJ0>MS6G@^.#!0SM:G=6WSUJ;:SPPLRX*6+6/ Z?
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M:.Z+-:2_'2.;^34]&K!PSJX*R=!/\#SXLGC""WW'[TF\:..G'T=%_YT+G^<
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MZWJJ3.N7A[3FNIY.NDML?O.L?>]4?/C!X8.E=8&1=7) 8Z_YSV ;0MO9-+F
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M3# S(^,;^:X0Z4$SPL%!^XE5': Z%E9GQE"%'_T0%"(:C)W-7'83HP+1PH.
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M"EPZ[9)N_>D W?.51,_@P V]EK_BZU9UOB,J^]83H/$X$-B]$1ZA(@]FWP5
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M%<XGUO7%SF5*Q<4;ZKBZW<[&6]IG@KA^L--'?F74#[:6N.DZ=(^$].XWA9H
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MQU(F__F ^T4(^,=94-$@U #8GXMZ"Y>1#EI/2Y+W!O _$X!FFY*CNUB=NP:
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MW'PR&E,Z*= ;=*$:,*6O,.>^VIE5,IP_"[-H+[S1+^>U"8B^!*PAXA$1B(F
MZO=3[V$C:M8KP)IU6DM!PMH%VY%2V$#9SGL@%ZE:]GOUUA&,91U)9<AO<L\'
MB/1;C@H0':@:U\P7.+M5,P$_:2QW_?6K0BO@!YHI;M>]@$(JE$DUW\(<B:^!
M*C^#O SR4^?Q'R-BL?NN!_<_Y NA8I:_$+Y;5'DWM2(^'L1NG'LFD[WMVN_U
M+J3CIRU9OQ_Z.W]V$EN%\]OM/^/>D@ .-S'IBWK'K.H<.CB(_1X"8A>> RCR
M@.J9]$N7RJC##XDWB,9H"%PN$6PI^..S?XZ/8P5.W#Z'],8"YA-#^J&#^:>&
M&#N;2<IKM2&K0PXXTPP1QD%H,#7_$0Z?#N)2[UG4NPC88NW <V#JA78G>GP0
MW<QC'4"(4/DAR"W+A:,GGW0O3XXS#FJ=6+A61?9XS$S[%JKGQY?O.=N^I? D
MI,G]^<\O/1[JE5X'N&"6^]^<-$ !,X8%0&:0?#BW#0]:7Q]/9)GYPD3O2-;X
M+#<GP"UAVZ]PD&=Y^4AXK^#KL>#ZDBNNN3%/SPJ*HJ^..33TQ]9BS70X$3-:
MXJ[I_8"B%,<DN_$2S&C3,33G='7 !9XYV!JL=<-ZL8U6:3*RN[2Q/NT)7; 1
M/EV5?:ULHC$OFRPSS^,IBXZT8\;A(K9]O=O"J=P/LO>WFSU4X)\T2^P/(A3'
MG28JK.7#,6KOZ13M,I2(T%0DH[=,.U7Y]#8H[5O8J[N=:,ND!OL4Z4OZ(JQ"
MRL54XS.1Q3L&9G]Q&<]ME3F\^NU<W>#5#YA=C\LWV977EP,0O5MSN1+.QXPX
M:FK:-!@#D21XQCHAM 1;'PT\HI_OX]6.@.:LX$%^8.";#;.3=!BG_6M1X.5
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MP5XI\@Q2G-@H\$SIG3^6?7)#K5=4G6G3>N->>)6\46W#F);76BQMTC6"CS7
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M(Q _A)_@FL]>Q%^::L1TV=M[HNM^EQS^ N;$G]-';G9__:2G6$/P93N ];:
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M1O?KY;Z-?RFD/BZ/]T_.RDH\])7\&X^7\\9M/^+!'!LKD&1I")7:>JDO 1J
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M3DZ/!#K#II4R6ZXQ$AA@NQ<ZFG8O1KO*Z4<\8*W9SW/TU-?9#EBO^$EA ]D
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M6([<W#NMO^/2 8B66&,_#VF'HF2IC5-ZZ!)U.2@9I0W2I+4YA?!6W/X+,Q(
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M?E1[:@B+W-!VD9XM#&)K<'%\U55#Z)3C9!$YI2&$D+!P'MCX#7YF=\Z<:PR
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M9X.GT:J8VK<U_:*@02D]F:30W_L'/9E<\;QD1Z'H9*IB69''TNF%C]3_K*"
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M2OD;)C/AB=^YXHTF$KQ ?@NJ'Y!>!+X2**OT(\;Z&<)YR8!$#M0NIM>8R%U
M62BUTQ4?'1&G2$2-ZN8YQ3C5<52\',;KXO*2T:G\;Y$<C9W RIN8>@%V+RA@
M8DL@FXQ;.4\9'DV]=1R?&$,KO=4)M0V&?N(XSW8HY6R$HV__1@;#@4S5*NIV
M>O#!'S9O.>L^Y)JG'KJ__C73E\':_^@A9TVG&]/NW_R)MD[6UTEAG?LQI=3D
MJ_![4EL@NLITAK!:@JR?,A;:Z"_/$#JXCH*/Q^*)#[&3Z"0^HU?\SV:SG2)!
MY3$PC&2TT7I@R38/IXGOZ<?SP-?;&[DOI[#BCJVI<-D,X1U@7)_YO[=!Q#?2
M?15TDCQ@HL\VXG0R#*?7HZ1*Q9@TQA#$[0)7<;<.TPD8D>-*463'+^!I'\1J
M)$W$M&(M\9;C\P2S!]ZOL"6=V(H1"M6Q"U?_9O-Z<YQ=5+=$9,:\Z?_07P=>
M1^?B.LL#,9DAF)B"4N=H%K(1',][AL8@CPP^;*!)9<4Y#[6]4J:4/>38(/3B
M/K:O+JLB$Y(=@(9N4S/5_"7!""NP(^]TI,\1*.#N>8=ZQ\'@=TS%5G+:A*3=
M5O*K"MD4B)93\($?QX6:'4R<(1P &(<(QBC<0!] Z?Y)TNRU?=1*HLT9-U<;
M$H(%-T,W]+B"UV<(<QR[YR<-9].MQ:M/,[</#VWH=HEQ#MG3=2+I%=6ZW3,8
M7N3R3>(V3"%7Y"^K@88>UWJ$EB>6#:LRP*H/J!T9)NL+(&N>8?85ZWYXL!<
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MJ(W,)JJEPM,Z)LOL ))J,S:%VK3HQXT/P1_)?1]D5_"H"KAS2<(0*,]IIU+
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M;9*."W! &53<%&H*A5T?QS8A2;ZU7V@W<.(J4==+H)/ _'!ZM3[)$,U000?
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M,W^,3$#;FTFU1-1:HDW-0A/5;:98^PRAVFE\,"&N"'%LIFZN[>"$Q*F=>6F
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ME9!U&58-QH;L!*;U;=_7X]Z.M:DM->EW0C*-(PW$(_XC[8:USZ(B7!2;RQ;
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M+&_);"AN>:/2MW_/'2B*EI#7[Z7I)<D(>)]G_)#+RE]E%'PP.:5(3KXJE#S
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MDU.:R; MIG.*I.5GH'1E9@^GB?-HH,E9%7MXD!Q$?_7RZZF'"*'8SY?BLL:
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MS\?@_<V<5?QP2$OV=X!V[_=\GC"NV6Q5)VLCG--,6M_%] F)"@FQO"53Q6Z
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MHJ.<F2A@+" 9O?S?;?4O+=JWH@>]!D=CPY>M_ZC!%1=A T1\ > 7 'X!X!<
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M. A4TU*!4*:A-R0<H:[NG7">6,'B^O9_X=@9K7/VL6?0:B;@PQ5*QWU=W@E
M<P SM5)3NG1Z&C7/4Y/1E0;*B0;>8H2!+5,4S(=#$UW(IN);G%6H8^]%2J"*
MF$Y=#_NG.EKO$_53YCUD4UY5PW^L&+E"W1SI$=1OI+VKC(]/"+:VB3WF%QN^
MD/>': .>+/Z-F8V*%U,"B_#,#^WG(9MC6R=N<,P1__)P;%D?$[S@:Z<<'B^;
MNZ)N7P>UI2C"JD]<%!'\4Y?01$<A)_[3,>61'W\::KT?\HAE>B1#%RB)<[FQ
MYQKP4/Y^3-N $'6QF)1$!,,G!B0MA2WRY=0?1KK.G-[9^[);Z*6LB&HZ6043
M<6]XM+KT[AXX-EFP?[AKJN)G:4S8UQ;;0CR'UB2!Q1'3LX3Y8*,7H*B3/\/)
M99+*F N1V[K91Y%AG2^22NN><K371NKSV*L-FFGI?35QO?4M[Y)C5)<2GB*7
M)=355D4K2AXR'P4SOB*RX=TO!;!YGM+&QUOXO*X.W8L;@8W9C_*>6:#6OKI#
MV,"E5/AD:2%2KGVN?X :*'DKK3,FC'BK6'X2V]5S%=R6OF$61;C*BGE)4[B>
M,M(X4?:L>]7MLL2X7F5S<*#0O^9UWJ0%9I2CSYR<2)DE/!NZKKN"!@GRVN@U
M/,UWMW31=O0LHE9OP0.5[=U'6:H"+$=CQ42A\Y!='Y\9E9)9&9;M[MT<&>[\
MWCEM*C^^V;63L>6IMY)F) \DQ$V/'\ ]S C[[]RB@<;-8)RAIMW@5?>/G]?Y
M,+*?#[&(REI-.*2FS=TPO_!ML6]%8R'"&6UO#GC[+E\5F+^IZ]NQ[FB^^4C!
MFAK8Z)',4^E+H_=^F26\.*O?KJ\!HR8&&-A2-712IQ[6G(>]#R.ABLTQELY&
M*[>'E#&&ML*U&>1?"A+<FFP70UG)#+ 2R6FV>!YXYLP!LWL\+2>S>)#.2FW.
M3<E0UI-/]#FP2[6X7$D,Q-X M09MQ &:EHMT*OFF >QP?19G RM6!30!)#8
MKX:NU,?8I;#I#U@3AZ#83*;FHE.4T$>1!YHAOTE.=T^J7;+XRO;V"@YS*:/
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MNQY;^A$GU!OUV:#B,6F^GWIX7*#*IQ_M=-:?01AMM@9PP3V#5,Y&]D_PN8'
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M[.98G+^U_3B4()8$+38TZ&3;//KX$<<N@S3$6_EQ EW9UL0S07<Y9VY7I4H
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M%OOPF[R*JUF@<P,;%U.M6/'8TH\*VG5>#0ZY_EI]+\6-H3O,&?@WIU6^6'@
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M(^PC\M#?C^]@F#X_1MN8]X(S>.[HEVFE>8GR8^SMU'(+Q+YP10]O+&1XY<B
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M"V$R!]PO@[=5H 83"HPD?4XI1AR[A#3ZU<)579@"!]F*B-(BNF)O[,):^+?
MUD"6375CKR-&[^\ BZ-8;LD[NF/]#?V[XP@IE](R/G"TI!9IJU?X7#LVS.8W
M8<BJ2%AG?@_R1A>OTBZ<*]-&EDQK3NO*>8;J< 7_!3[9RPZ^!W%1,_7"H1;W
MWZH8$ZU>BR#[+&<9[N,!R<NX2(4_V?L)>/6H*TFJ"3/"?&:LZ5(!'UD35J"U
MA^V5!&1)&Y;ZP/=MZ.)S"N$"5A]K;K!YUAC&'(U9<RU- ]9!$^+$\\KLZ\_.
M/X@JM*D'W=A>MHR!8.ALSOW&]]R'R&HP6SV1-@G@Q7*B,2.'?![:*A88I1WO
M0;;,F\%8K/[V:$M_=C))CC$GL&YUI"XG#UT<"B[%H/T#5";9.(5/\564<AX-
M%AP@98J=-L:V@KV%*Y]"N3JW8QUU)='UOV?V?PKYR>XK6?K!#S8]ATF<:V%C
M[D)Z,R-39+==CT$M6%UTZ &"SQ'E#+U!])(5[(R?8."BJIUHN <E2!H<OT2C
MZVK NJ*'0T,=\?%>.>&E;_WC]5-79<UDP\\P]$9NFT@K7 ,?@BH4$U>]-B N
MT/4"K]M*TD+&D'<5A$^;"O%(+W1LCP",NL5QN%_;3SR0_NYB[/ZW[\6RX9!0
M\;)1Y!4J$ZS0_89M68[  HP<QYQS0;KN#LN4:8<I-!]H\GV<(V<WS>*6,,ZV
MMW# .TPW.%)I<X"!?LN,@4@M0RD0,;N6;<BP-708XIH,BI4.L1+FSK)97//%
MTH^%W];"$>51\;CE))JQ=S F<1Q3P5[,2N0<+X.L@#NHP6WL"Q%H)%LE&RI2
MAF4];J<JA%*BZG7.,@LO*]WOM33=NHNO*XI@^J&;7_V@CBH_PSMFI?#,9/0E
M<RX-O!.*4?J*[1X'JGJ<M38.?C5\R>2P:\^(B%Q5F_$M[\F3VI1O>;RZI$W5
MH@5+6F_X6*[_T>?(01SW71OF36E: M!DPIRGD,'KB.,J[69T". #K<"52PN3
MH?D:<:\P''_Y$KOU(F*JHF=8'K>U&_"\"$4>?];OZ4$M&[/=F.(_<;76,&AC
M[3"A61I:EA;G'__#TZ[<OU"$U2JK<WM!'VK7,$&BFJC=QGA(-D.^A_J*6[^/
ML]I9 A<UYZ,%6X/@Y":62]>U:>(]!E_D_MMYJE3 T60]][WI+.B),P[8W2#A
M^;W OQ>A!M./]L[5+V-Y]3JFO7O"*O^<* P,+@#.$@R&6&]DAF=BU&C3>84L
MXY<FFG(XOADE]#A.Y.W'*% %Q9RYO_HYSW7 9"901%EX?-2\?NVUF93;: /M
MGV^P34D?#F8041,^]B>)P1'QJX;@/+&PAI[MZ: <WNB1?O_ZW*AR<P)O]YTR
M672=JQ,-B/W2J%,&A4;'6[AN.0Y'[COF].9C3^LL;D#]__?AZ1W_@W]VIWS9
MI0+&RU_-XJ8"_I@_B[O(UC'*L>_<P.'V'O)A5C\]Y+,,]W_ZG8>X DU= (_<
M1$^1@3^R83LT _IP##+F-A,'\UHN#:CC(?(><&UC*T]E$[CK&5PB]P4;;S+B
MIHSMFN,&7"B#T\'@:_:#[ .O-*]M(L6'2Z:2FG-(0T)HQ32RE(A>%O+:T)5L
M ^!K/_>3-!.'O-3E"N4/.3B,>[^)QSBP6@UZB AF,8(ES'55L/ 7C6RY)RE"
M7D!K^<*T!/=[;8%L^F^8)#]DJ%.O./AOO&+^J.JX;".W9&QSV[VW)07/!$@!
M9F([4<LQP0I,)P?'2.8-_F<I1W6E6/:<N$Y:H>HO3GJUDE=)\L]J)BS:N"[C
MS*1V03(Y3<PQ; CY^YA#:$BPK..A?Y2F>\0EFSNU&=OSU4*0,NK$P@!V4Z!0
M+F._>=^QN[Z&U7N)K]:#2,U.1@.'AF%\TX@K[ >$;Q]^&-V_R963J&#/8T;5
M]&XLX]_\W/Q*JE3MSSU,G!R3/<;,'X.M>DPJ-(V8EJGZKX"1S:Q5T%UV&Z 7
MUYEI:9^BJ.]UN06'*#K39UR?ET=#4>Z)J??*:1I+?%;L+&[A6/!PX[6?@9-1
M%]SSKKE8/8BE&$<G".]?6C\?\D47S?7F(^MND>1%0,T%MAP8?"UIK;?()$40
MDCDUG"1T$^PA+ER:):KS,NWW]%7@31D)NS (6WYL>/CCB%W/X3%%8.;A_HE]
MKI"H5%2R]US$"9?1JCIDF>XZAH?3".!9O#I<>XG52L#<383/+-2#;;3>:%^A
MBZX$B"!)Z2\ _!2PC+D5XEY&CD3>%V],V7ZK(#4[;NV'),_-Y^1^>+,AQ%/B
M^5/A"JAVQ!X4E-!H)R(5E906PMLCJ;=*1H$8]"_)&><)M94V._"@5J^@D3,T
MY=?!H?5R69W60+2P_HM*Z_,W&M&"!E]\XMHGQIO"(2+;S9*UW9ZAB@Y]L;NS
M%E&O;KFTF_.8FG.Q[JMT[_LWT1>FCSZYF,L/=.T4K!:,*!DAFSOLJO2_KBX#
MFIJ]/'6-J!M"U!4*Y9F<)].90!1ME+6&:JC=P>J9N]AUN8$&?M4<AP/ 7#VW
M2^HV36?:U!!IY3%8>%1R\TN,.;"<&NS?P1.7I*2E"@A(0'^<HNCC/QPPGMOB
M1)][$13*V"JG7YT,89O"SS5ENDK4@$GHGDS8>]3A&5#S$Q39,D1UVB6-&6Y\
M)Q[(]#10D/$[R[)]O9]=9.[@CP+;"^\ I2.SN$/NYE?N,4+V5(&SN-384'M1
M_<);.%[/Y'9#_YH>YVS7OJ""F$?.PUY6"0[?S_?8E#JR2&7TUP]_WXQ[,+_3
M:PF\6**@- .I!,/QI5(/0NHLS@19+G=PKCG6W^WD25!4;A7UCT97#8YV53X1
ME7U[Y:1D/-Q4SR R^NX.3IL,"XW9EFW($F_4\*+V& N+;K46S9S,D8US-XLP
MQ_#S=) _SX/'Y [>RA38&PIORG?]G3Y),(^R/..:FQ< - ?/C%O:WBX79%5T
MR-DKWD2'+>MMB'C("&B5'NG4L ^&!DMEP6_?R$)"1H+"0CIH%R/CC.+-^4?Y
MIK5NY@.N7QW$VQL@#['SEB)?QS-_?GK5L@2OJM!T85\/#\]5_K"LX&G-'-.T
M9=K $]I=3 #6*BZB-C!7<T4(1@PTTZ^2YGM9PQ,[(1]^-N\EDZ*R(>\<8+JI
M1(J"U4$23[=*1I$_N/M*R<BG#5P&21QF#UW/.*&PFL7UTX#+J!DF>BO0M AU
M8JX'R]*==9?&-,=TUTA1^"4=JH5I 6 +88G F1:V#&J[1N==3@[HG\I>PI I
MV])1\?V0C=P$UROA0/&HJ\62(&KNN1#T+\;YYI$5X(7;YAD*@DF4EWGWW<&_
M1VVM>YQU^/UIK_A)/:3O1/OY/!Z['0, =?XWC',UX ]/KZ_HBW\P'YDBR9,X
MX(\D'-"TC!0!+&0:8(]W#8YLE>%10];@T> \=;OV.U:WK7$/\Q#DUS3S.$.9
M1<<CZR"@&6\:Q;+M+NME;E5VFE 0)XGG&6E\6DZ+'XT.F5AU6G@K;E3"9[^V
M<(Z@W;+:>#$9=K=7D9NX;\8T)#@42E!PD:5EB@'V)#>3Q.M44R#[)KK"&;[W
M@+%Q-)LC8J?=Y'7TU;K=:(I?>_W*_:$QB["-C9!]NAW$R6QP4,@6,[?1LN.U
M)R%"2L-FE<V64#/QB'47,Z"(+'S=X^E;3)UY?]OM#GU[<6%,:AD]CF9_FQ9W
M_HQ6Z:'^;)]28]WC0)-*I6^D0\?>#(4,#@8-B6B1D32C"YJZNCKHD:NFOQ]\
MZ*/78&KG8[39KFU9](/,AW=Q>.40:K(]$:^9NZ^3A)G+MZ1H#D8-+_5Z.0!-
MQ%G<Z6=,BJ+3@D%O]C+I8?HJ.(;(/FB!9N+$O4\C2^H%/0U$V_SZR&2!.2.M
M&37OIY"[/4^< ,=:"JWY60%IY&<];3V<VD#$6J)U0WQT>:S-0T"3DX# /*6[
MQ]H">\ME60V^C^ D>G+A-C@.]-;X@@?2%!YJW\/P<TC66E_**6DJ^EAHTNVL
M/CW6Q%H&'AYS+VL!+*,LXT5<H] 06IA=E^WT3&5?;.76XQ(7&[,0R2.7;*MC
M50T]O,351VKXO<X= ?M[G?ZN%4IX5H9/W_,$50)>?@BMW>/W$OXS?NZ>T]FJ
M"P$Y"@Q9DUX$_\  7HR8@0/)SBL^V]>S=X&%*25P_!Z_BE+C\[_DGV73(D_Q
M+8P>2OZJRE@;L7#W23T<L!DC$6?PX^W%<\ZFY\Q>!"?OL5R>IX[GHKWN'S(^
MK^VI_/M97VRG^:=ZX8NHJ:'GAJ.?5_7IM:5X$:@WCNGJI:^'#G6KG=^9\RV9
MOWZRF,7-L9(];-A!F 3(4PH-X&0,"V*?)=4RO3#J3Q1SOD'7,?= ;DVR:V$K
MX1@E=SES&YP&JL2L[WK/V@N>),G(=5!GNC-Q">/]D'CD6S@2(HI0T]X&!Z5L
M\2?_(IJ#7$UK^DNP#IVBY4#QEYF&T#<OG3MM&<3F,%=)^/"[470C^)ZM]%L_
MW1'SL];)Y8['&XM8S='S=6]:1RN=BK<Q[$[AT%]($13XNP'U+2RIGM ]95G.
M79A#X0 N<Q7VK$>1#7[# 9HDW4/4B[FNT"90<[5__#-&1IHKX>74!]&;C@U1
M"LA^7A9]+L;$P[TN%/TH:5NZ9[C*(6;UD5H8D,O,&7C$9H@@=B)H(G1I7AL^
MRDP0;\A*3GHQBQL*;P;,O;93I<9"S2/+V+"5H. )9HR0[:_.8V]BF-O+J7Q;
M+_#O$<=^C&.]SWHX%KP[[:'S=)A33Q%AP'C9O'\X6@+ZEO"$CYB'8Y[;IL(/
M#AV"_IC%+?;<&P<9:J(A/F(_LI@MDG[&H&+XW,D\>2EUXJXL]-.ELY7T$PIA
MIONZ445#8_?$A/&[W\Z_#7GQY24BQO;?'I _%NH!\E2.O@L77JN/+"<I9G%B
MV:!*.3 ^#;DI!45R6<8,2<2V8*@4@:WDM+#-T(?TJ<:M;0+39T]Z'C50$Q2Z
MR);PEER6&612('\^8<1($VFDH?_T.^LBXH;QONB[V X'OV['GR3.,:ZB/9*8
M!ED-=2:BH#$E6UC@G&=VT3RW6DRWN'/.L:;]7:O@5,]+AXCAWQ6,YR^\]. K
MI_(CV9X6"J(5M?KSE\FYMVOG?:&UOR6\KWN:F)O?43!N6)_@L&WH3'AL?VZ/
M=8/I%AS@*7LR@9B/J?*093*- -XK)\/KN..WE4YDC0WX^-ZC,-8 J0ZO]E,0
MS1CS13U4\U]\Z'0%:;"?8@C?G,61&Z&9VCI),!5UY/7S"DZ^U]!"PYMLYX-U
M:0"T&/A=*'_W3QP^&^#Y(DLD&JON6J+Z/2S3_B)%]D#[:II723RW@BH*?$(1
M,CCA1)^KIQW>CCA!#FW2_A+'P%\>%YQ0^/W6"'ZNB_/W')S%A5S PIUK7;^K
M:[_FPM$+H'1P4"JR::RLK&R@&3?R> W?W=A)7[#GAK?1GFJQY4.[AP^^N?3O
M%6IT"P8_'WLYP-PYHHS9<#^".6-2)[^)8HZ$ZZZQ'%B=A]#7%)X/ANXH)MG>
M8J$)MS+.D(X/D<FBW0Y1O99T<:>H),6!:(()G4E3%GC)E,88'F'&@$T\HD%>
ME^>.0@6D0DT # 5\:*H 2>BB43!/%:_.T9YG'I:H)[EIMN8$O88C13!1<4I:
M7$V=R6O!9_P"7W%N<KTAW]W(:^RU7TA*JWOR$I-[S?/\/?CDP,$&X)/F4W__
M3/_[UAGIR)=77T9H(>T>#\*?\NIY3[/O/:U[QK\=MD'](6-DP[U;EMO"3_L>
M/?JM' YO8IF /H_O1<B%!C"MV36XKC*.&UU7N**KMO&;@8 !>A$_51O<ZS19
M$;*'ZT+[L]+I9'WOV<-^[>GJRAYJP8EKZ_6_RC#?OPG?UOZ ON: 9SO55@_0
M/L%ZD-["EB:+Y]Y*VX!%RKH*\.LN6SRX9L0=UD$6S2,+H--Y"BOO\,HB.$$Q
MD-9 JQB=.5H-T(I&&.\[FTVC;]HG3W&7MM&+-90%L[B?V);((8RXG!78L)HO
MV8V.F,#E&)@W&+P_ZGZDE+^%.G,@!SJOQ%\)AW,BBAD/O[3MO54[9N#U[=AF
M:ABQ-\:YXZBFU8 7\M$JM#%E(UUXUWW]?'CN7G@XYJY-PIHRQ$RDV0W2QPVQ
MQ1P$\S!?C=14ZK)B!U$#LN(T[*>4+1N5F2)X^5CV[K87[M-I&QL<(BO>A(2)
M[P8?@T_/X@XW]MYI]MKT3*+V!!2$Y108$&\Y!I^5B4))*CYBC3%?/8>Y"[_X
M9<R%< Z(/;NA%F,J_!;@2CS!/#:;Z--/HN&S+K#62.)L2"W!K!L72X=%7)@<
M I&2&RRHRN>&\9#P2BQ^(>(!Q2?]!)V^K>*FSZCK[NBR&!R%4"2T&J9.CVP%
M+9*0T(3B3FI<21B#TRRU%<:5'G^S]YQ+=BOGW,,WP^V1V__@QQ^6^I^!7M+7
M=HB:_Y3L":F]BU<4H8LY4(6B<WSU7!$SLD;')\F+2=\@_M!\C4N][K=:82KG
MR0?VI/";0<0'0]C)@F\9B8]=8@*.Y?GT3EDE;AD3V^I!0"9K59A_44M>V.JN
M,YZ)"KKU1^F: ;^RZ',: #Q&@+^G*"C_]BB0Z<H;,,RX0 4#4+QRXC(2 &K&
M%!SU2NU1ADC!OLY:B>C!J^7L3(M<$IY'PHDJ&;FB/0.>5*A=&<MRZF&N51!Q
MH^Z4-^/(=F5'B-*5]\!?05_ >#@BT?I";BD-6U7^2Z=%7IO!]RG*3N-/P&FT
M>^[20FTV*:S;!5\]W 10-<,./_+KJYYKG725E6H^AVY_(SY&[Z^0TZEN09-.
M\W\ ZVZ<F"MB^EA/3HLU_FX>K>3C)?,[D<54RYB'->Y#QZCU3%?-T9\77CAA
MW&#:NO+WE)=K+@,>A!K]\7F/F)&8BL(%YJ@(72FII2]F?%#1Q_47/E?0"$NE
MV5MW/X%YT-GF#ZJ!U#)HSZ:Q/'?/0-G2AKTG$I2AASVLLB-]<S_-XH[RN]6\
MA#V33TD8!I/?HH#GVL8E6@/T9:'!O[U4"K^!/VB=4(FP.BU%S5H:-FK);A(N
MBW8-<P$+DZUO(MN2;/#^?ISE#')KW<BB.SNJ^Q70:789(Z!E?3WE>H.'<JR
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MK[(EQDCS[^MJ3[.6B65=K[*MJVM65S@LV>&U 'S7>15#5Q4 Z/\]H/ $22W
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MQ+.^?Y*]E!'9<DEV=:IS)7R^)4YC,4[_]X5RY[]'9X> L_3L6=SB.#*N0VN
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MM(OUR6U6:W6/%G#18CUF:]$.'49N(EF8!W%9C,U*F47$4<:5OAGQJA>T4GJ
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MDRD65[-.@NT+.+46<Y'BQ=$0:"M9GQ',#82I/O (M%O!ODED;#5[&A^15.G
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M3:SC3XM:XHCF&$\-V0!'*/&&$4<FUJZG!CT$63<\7$]'T:HFF-82!KEB/#X
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M8D!?^6]Z'V[80UD*C,&4*&_=QHSTG[ $BUYMNDK^5E#5:E^+?/T:W8.V%7F
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MF-);?0[4:NQUZ8R58,!S:71G]M0"[ORF1"H4W\&6QE/@F)+OG)..?NIP91K
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M$WQ]9SH., AF;:+'M.5;"5W3XY)<#T"U637OT2\@2MH_P-%J+83),@7#ID9
M&[ED2@M^Z)LB+8/M0-%SF:''UHN,P3RM_O,BBSZ&<[DXWJ%M+B# =<Y?&AL?
MF/KNW<B(6CTE,8_/BP\XYNM1>%R&I8FWR+?U<-TE.7ZI&#HJ$CG(JPF9,?2
M?7G*97DI(>C8"6!E(/W%E&7;Y=$-28<^3A^)7K[)QZE<V/24[Y*FO'+V'_@V
M -X^C5EQ&_MQIUH/5*$K/VN-4+$KNZ$"61>J6IX5H=R$5SBGU467T?44E'1N
M6,14G/ F<W.P]P]^UL&^^QX-( >:/#\T*WPIJ^$#AA0KNJH--0,;N(H"MC&:
MQ#B/6>QBQ=\+-DC!G&!0V$!4/]):,T6 .7".NTK6>0D:5E"G!KAT%07N!#$E
MOE2'T93?\/=B271C>&X"D#:;F.WHL/]X73W,K1"5=O_$^#8V<;LC_Y*BBPQ&
MCZ6<@=7:<]@=(H3R^PNXM;E&-!6!);P@MD1?"2SZ:>>*M,= ?1%AQ60?W#K7
M$FA5XE;*!F_*3@8S;,$9_[KZ7N\*Q!ILLAY.*CK0O#AW*7D8\0')K5QX2QBR
M[E@[8<W=@&_[A6<7<%G"U1=\@P*#]52TFR$63; 7V,VH?G$O]11J ZM:,QI7
MJ./.OW2<.OU$D#PZ>A@?WZSCD=;"=1H<1%9K04E;GCFP/$\3##6JB??HMS[Y
M"%(.UX/L-.;&*))[43!EK\5%;F5+=7C/N*O+?.VM_ .<N-4EYV)"-Z656->8
M,#<"+16D%3VD+X 6XYGIFZ/6O[U'K6 NE*[)UMWC^SZXRW6^9G9;GGT0GY)?
M7NG4;!B4-7DDK PQB$/_]:BAN;G9Y?R\=$-8_Z !G$49Y'MI-P$M=P8OP3D^
M0LH:Y#M=T:R:X-7G;'G^=:TCPUU['AT(5*/9U0?./I;<=UF+[((Q-+7R8E[,
MUX'$C/JNJ+T1B?=&H\QBAI@W0ES*M"LP#3R($3UXOX![,[JC1RC_S;!T-.+"
MES=H>$QV"8E0?NLL_X:1@:8WR?M;2-A^+;'JU-N(1K/\5%UV=WE9C9.Y.6DS
MCA  M"S%DDX)M9Z,F-IH'* PM9?V -U$X2U2GZ=*+94$$69%3:ZMFPB=%@=2
M+X%]K<R-X,:F),V343>(FO5AEK:.F^5,6X^AW$?WJ6_>F_L'7KR[SLWE;M7P
MQ,_L8;=_C_^-1?&CB#&F:2*S!5W?/_/I=!6]1,'D06DQUB)-UB3Q%K"&<1I*
M$4E3VQX.#6W +!IJ2&OP<XKQ6YYGFGJ;_\SW>%.>INDJN8@+?V."[L4BW;3V
M('$*"Z/W$6]JS_T9PEZD^O,D=J]KY#_-L30D6,#5WT=?D>>);7$Z ^+>&<(?
M@@HL8_P2=ET7,ZVCW _%J[ 8^028]S7[GXL8/FLU7)A0Q>PCU[EVLH=D!^&L
M&F1+$ZP"*SH6< 9G899";2T*'D3L*NC3>Y^!HX^J(O)#RIPYO/:A7F?+R9.C
M[B-N\Q+U\FG?_IGN0X:>^X;?6VS34Y)ANX"IO7+JXJ]K8!:62%:7A2K]7!6W
M"A]X/X!'AUMSBU;W>P!*AZC ?N?"H Z2=:^#L^<%PIK(?X9T&LV^;'JF_3XW
M%PKB<:Z;Y9JQ7Y&>54:0+85R4)C*W*S+"SHTZ$0=ZM-\!9'3@(M<8[K_F,_3
MWJ#V-7"0BIAVP8EE/)%_[E6QZ5Q&O0.M$ZBK2)DULIV=40,'!QB;XDJ#3Y:&
MK./+YO46!P1BZBIG'((]:^  =.7B2=-H \&,+*\2UO]<MSC&5X@?;["R?JS[
MG;^L1LKKJ(;BE9XCLV]#"&!17;1"4Q "W@RQOS7MW3/SVU:8I4K:XV$3=7\(
M;AZ7P385B'$%1AQ!7V!H =?6M+Q1%<3.)O (G6*3=HBBX>KN.:=X?JB#"$JO
MMH 8Q]NG:R.QK-(:\ "V:W5M$F94]#AZG$J,YTQ:?0F1LSUHP.K;@,I]Q.00
M;DC')\MS2>L79V+2WE T*?!MZ,P'R7/9(_PMGBS#GUSWH0K4>D'Q5P7;X)R@
M?O[V2I<2I:^V,.K[9_5/'V*YQMWK1@NQ!O$KD_(>T9TJ2X22Z%GV4W(D,9.P
M5+"&^8IJR;1!>\T%5H]AO(*6QG1L@JL(-QPQ&&<> $8/LF+*(P7FN9X7M7X8
MJ!.;MR=XV)>\CQE]CGXYZ)QE9-#_;+1D*6TJ 146TX_M&T2.*0MIWX.2-(9S
M:63@ BX#\>9.^">XI-X+#W3^77J+RYE,$)0X-[#+(BS\V=&7DJHB R1K3KT9
M:G$>Z'^]UZ1I ;>!;4Y$]V#Q0"SC.9: H7)Q-B,:+$!71&E=X&%*(]P(T0[V
M<CVV<M$AH:G'KC@C76<:W\2V])-?;;B9B:$[V]"QHCPH7+"DKZ(!SE,5&AZ%
MWBW@1+05$5<7 P1;L!SF8NP6WG)=RFU+]-S7A:EN+3E"EC6Z!R:8%5__FK$M
M9Q^<J#A5.\5Y>:2+5B%C' 4;VX:[J*XOM8&OI'?XW'.)T2S\XC@_OK.^.DR+
MX:J68$#^8 %G,E,8VD9>)[!&!T*VPLO YO:0[4^?](?!B6#77A=TAP"F*9JK
MG U_:[.@I- $*^#]?Q19WG4B&,"&K4T'4BOWGDZJ&1Y=P/T8LASTOD[:0+=O
M):PF$>@QWF#\562)(DFO)60ER$JOB9YYIM>*&H,-=R**X1A1DVU!Y&WI^/R!
MK-*30^--<=GUEUJBPJ)7K;7NM*A$?Q#*>V9X\#'0&S78KR6$4,?[Z(V:?V(N
M<8TNG]2LG;ALD<:E17'H[B+RJAKB='XO?4O>H7YGXC7FE^F^_<*']<U&!R8/
M#9)$GL-!P4/CWQ+NL<%_2J8*Y("4A:ZTU/I--'VX7?%"Q1WJ$OEJ]R-$Z =I
M7-E?58ILBD+]KKQ8Y1NT8>Q9W_D;XG;AZH!VDD7_Z5MP6UU(1-.+WMEJ'=ZO
M[[PV"EUI#LVUDWGZB E18PV_4W'7=JOP5G29Y@J<A"6/Z2S'(JDO1L;A:5'^
M#TP3J*CY@6=A>_NC@5FJ27@@YT.MM?:KX(-19='NOC])X[BY0 O=X\I]QC?8
M<WH"+?L87DK#@J@@P^DA<3MS>7)0<TZ4211UG6.L+(UIV7C*WS!9XEID#5V^
M$Q%&>U?9W%QD>*!HZ+SKKBL+.&3-'[V=BV5DR5;,=JLOX<(JH-59P5V%OHP'
M+!!?SD3N+RW+L^5DTV!ZB<IB,F982BJ^Y,*.D*L3C [N4??Z9DVN\_WU<5I$
M^^__(.@CKKG3F@',?,H%NV%U;&*4+(T,'B2_&=L'>Q?#17^TE%TC?<.XPF,?
M^SUD O_7>F<?_FZ(H JXOL$BZKOC</PE,W;9*[N!V416GRR3#/KB#9%3V-*J
M$8O%JD'ZG+)=<J.6I(>L?P)3P#XY/H-$",_/2V5LK:+897WH;"/BX:JX@J!J
MBJE7%=QUO'\SOY_A6A-I]N%,FL2_,8O2LSS]<QT&^1OH 6WD-8N,1_H)-=B@
MTJJ!H_#BZ(55NCJ4R#C>)!C8>;8W=HB_03Z]9D*Z^D;^H=^,_?:07JB2*,IS
MOWY\[SJ7;YK-$=Q5!&UMS&N=.[B >]W90;TI-"2'L5.+]L##4&,GB0!'@14*
M;OH'A*("+.&BZ:D$4FK)T-3^G369#MWOU.]>-LQ?9)6,-\SE=S37A)P,;W)(
M*ZZ.-/,_=I5Y 5,Q<RMC+1R!!?1;NN8P>#I1\;Z>8(&*A6M02QCO(ZEUNE/0
M1K;@ARHXASKE(WGI%YR#)DVJZ2D'X&M6F2K?Q*2O1B*;+K(5T92VW$'77>]C
M*O\$Y*/$+Y!3< PF];SN.F,7]*#O\$.H$;$G&]-O]'8>_Y(ZA'A"W+;IC;!8
ML8S7%G*<&-G#V"I!3"Q.BBU&3AZH.A=?\-O64+@+#)/G=7+A/;LU3:!,S=;^
M,(1!A49D;8'F)_BF5#B5HG6EE^QO[*4!451C>J".8PNG0C:M<Q*WT3P./>!H
M<P._SR.8,T&F]5+2SPM@=U"S]&D_:3O\2EA7=OB!Z;<&]W9<>[[8)?W>1@/<
M LX="VS6,L1,J%FANR9##6B03%,-<Y2>^Y5$=93V,H*AIU0/>SG-<)*\AFE#
M%[4V'4^8RRKH2.!;[*^X.K.)<%S"M/XQHHE470E7'\IID[X;K<G_1W\L8#31
ME,;2)3"?$\!38MB.C:P3^4L86[4[&1?]HI3>Z3L=9SD!"DHVXLZAZRF_ M6_
M:OP;2;:]]?@UPWL)&0B9=JGRS=ZD*GJD-H#ED_^QU^AL1%]P4">QB?D*>"A$
M3";E^^AU_KH\S.#P0^G/R6 >=;@B:Y:;1ECML<2THSJF?$C:&5$6:2'(JQ#_
ME.O&V)G7(/UBQ*M<2HT,F&_S7SOA-EIV)1%I EK^1:X3M[#?T#25F$=$ BW'
M@#!/.Q^8J/4"1,$P4='9]D1 B+"XF&/>+ES)86M*YS\TWAL>C<@/_L"KH(<=
MDC"MZ.E'@E9\X%,5P*:3[YEV@[_T[>VQ^18_SD4-O#"SF(2=,4?8IROX4Y?'
M](#[E'/74*NW],E6E,SO%V 8N55@ 05KRA3;>&?[G*HGQ1OH-LKEZ7'W7I!J
M:+53YT#MCYXHNSPX:'38L]@X84;@J?M9> 9(*S*!0SD,'XPQ[F8XP@'R3?@?
M0&X:(PS"/U_ K6*0%?CTA%5VW[X^E^IQ@C.^2QIN5O)##H5U_&G.OXH^]+X[
MWYRKMG.>,:M6;C(4:;Z*M-H\6%]H\,<5Z\9;GT[U7YAI/N58=L/GER%'XOED
MLT)E6H29:8R-]ZK:!_ZN-A_#-!ILN\R!%C>RO%1F&LW\AMD/K&*$<9'CCT%2
M*OBQJWW4!.:HQ/H^T0I@]:1%!Z]<:IM>%D4 ;_JZO9V<K]D=\C8\YT??Z'^N
M>Y)O>$6)0Q8[8Z^/Q,!7?3IBUH@:&FGCF"_=G#4YVJ6,$W[Z+?/XS M.A>ZB
M44.X'7K0%0 .=%1 -EZ/FL"*M%GU(6W @!,M*^0;H3!M5.H;P=SQ/?I-7EO(
MMH'HN(P%W",W]+O%]]Q0-_@SII+%0MRZ*#*XC[*)<6:0'$X;LFF3+3D+O].:
MTQL[&S0?&<?AT(J@-R.336S12,"17H=_/++:8/R>:CSS9V_M=TWGZNC4UB;9
M]7M@$C>31UMA-SOT+>%G-A@BEMJ=U.4!\I]EC<1VLM&$:P+UAB-J;-<J-)*-
MYR>/)PS<JH;ZVD,VP40=IS@D*RNJ.HDJ&K3R$$!;>8,%7T]<-BSIJCKY]8^G
M2C-IZ IOK>LX\%B"& =IOH3CPRK>#$59V<#;%>*;1;MS!Z+_?/H,JNC<)E-V
M/--55P9]L.!H;KMFE8!O [(OQ:\+/)]9$2%-ZAKW=S%@KP1:I//GU%A^6INB
M?-==:G7!PK4#?\VBJ!0]NTN7_P=ETW#$2M+06>\"M[3JT[1WPS5U>'+WK@SK
M_),+N$O",UJ.V9R&I+M#8[@TC"LFA4-=\L)7R;FYT152VVRRB&;D6^[ 2VFY
M,.@_>;8G(]IB='GCS9VVZV^L.XQ_9ZX0MDVG$A[:(9M\M!?@/LWT8 W3LD*=
M!;JV:-B/[=1XR&J6[PD.3HH^O6<;1-<BZQC[@1A\6NQVLG*X&Y3VM0FV)'T3
M&,4V*@7;BXHO>ERIV*O$8P:3@CGM!=J;L4X,41]J%K_!D'(1"?3N%$H[56-M
MTRDQ&&@U(*V!T_J45%8L>TVXS-CI6I+J"M]3'O4L9&)0$@*^@>(Q4&<8%/E3
M%M<<9K7W1:#K^F83NTU.Y1WX_.DY814?(TOZMAAL^YY\D;T"E0!K!3:P";IR
M;'$X#HS=V2!&D3=5 G:V/83/2%2$6^;M1;O!$=DMT@YZ]0\G!CY4/&V 3\34
M3IAM/R]EI=^'!'>P%!;B]#IO'W3YD7(!]RUFC"F8?!RZ.%7W&W*8+(,-'J'!
M6QK;%G W,=ME8\S4"C9IDYF]5C/M?J1_>@Z8(,L4B7$2?KR"N#Z":C;M7-:<
M&ZSOFS_]0\]8?QQ-'V[PW>YAH\2G6SD^D]1G<=;KS=_2W?#0@]P5E*E+6CN$
M"$NNT"H99^$8K0N"!XGM65I?>#8H:#J39 Q'* KU.\TO2W__:MBK<O@MG"\Z
MEF_Y7BV_]<'U5._ZW&^SWI.M4%?$79<O,&#XZ^XQ'29M,+9L1#*BZ[<3UB)1
M#W9LF3L2;F72Z\A+'$YR?/$NE><7<\3W2$6XA3.??6%PMKK9R+9]Z[-GR7:?
M]Z,K_;01/R[6\& >RB;7$=6)5>$/Z8EM!#,/T\I.U2;;[M)HDJQ3L 2B93 W
MP/-^.WVCPK8D>(W=1#;5CHY_M?[WH/%&LX<.W1,=1.S),+-(%]C!,LWHXAG+
MF6GXR_2I.:5[X>XV(2\,RSD02_,,<KEUH39(,3<U+G<XH&W+CVLHH27%1]R?
M"%A;<=WC%)1,-8BT*$^M#8DB&Y&,QYO.?O*&C/^P_UD?:&DDZ*'6S'["V@5<
MU#3LR%:[W[<$;I(;"2R^CX)R51H,);:#^E-S"K\0R?=1A-6C(T/2D:[BNXB]
M@IV*6C0WISJ;@^DM.K?/M8[6T-8V##X%SHX)5S+7(638'!0IL)U@IUJM[T/,
MP3X%+04AR\E?P,<.:O>?#+<R P5WHTO#F\X:CXKCDV(T09;?A_[R$?TP?9C_
MJ^? [,C VSZ*7?%A_8\.BR_9C<!9FF1=,5E^BPSZ!<5"'EA> **XTK\D)V%U
M^7L+'IIGU0QJ6Y@.,%4QW!7T9*:;<HA]M+Z'L4O%(L "M5W1F_&\A-795>/_
M%%2M.H9!IT'OZPP[A7@)_9B(I ]>SCZM$*^ 7;]]C3@H /SX88?:N\5PHF@^
M27"G),(B[C$C5^-VL3 B.BSB"\:CO:LN<0WL/W^%V?OG@^SE@/PA%:1)U+NJ
MWYX<IA]0:=(D D.8=;1_UM PVE74Q84G%2&WS1Y5<M2#/S>XK(F0&3L7'OH4
MF'/LZ:,^SLS*B\0+JC5[HSE ""YYR=(U!_9N3,;OP_\4K@=_6IRC3M]]2)<"
MR)44>,<T8C*L^/TA'*2)@0O!G%8JCR6BI;NX2"\6* CXR0!CAL/@N]>(^?W.
M:LP.6UWQZ?=AM5*X(F@\X41VY2!"E$=;?)SO[?H!E*1SBB<%#HQ@#)/+?Y&!
M(>1AFJ9?5RG (R'8GT+%PUS-/V&'<Z!*U=A"2Q_]"N:5P[N5^L^G<<C7X+(Q
M$3O3C9#&(#NA&P>1(U7TT)"GKS_DHU&[H@'Y4V\IA\==%TPWM]<$?,T(PNR8
M+Y07,YW!/\\#*Q@K=3<0 KB "X:6%6NCL\4WX_"KF2_]@3?F6]M_SS^!N*4C
MMKE!IL[;_LQ[+KWVZ7!(IX8V&4^5S! -P@,E-SR.<")(EJ X;:;0FPJ99_!T
M!\3>/?5&AMYU!4<&9CE1 ?WG&_IF.':^?>I:(F_3@7FEH;OE-[9/G^9OLXX_
MC%?Y:B@Z#E<H_QWX M.<# S@WA(:('%@HY].@+G"2-1)W35R&#FK:,. APW$
M5>46+ZO()LC5'ZKD/B%&\=]B2V^SEYG55CVPWBDMSY&+5\+5[6[&]!+O9M"_
M6"E^0X.M,6@G4Z9/"<%I)4T=J@V=U.^D@D?(PXW4>OB%]A"=?3C(L)F=_E7D
M3SIA*X!Y3MK_8.]-HYK*VG716#8H"!%0HB!$1<4.8@-219-H68B*&%M0$**B
MTD2,%B)10Y:"$ 0QGU)*"041$1%I(I" (B:&T'R6A4@;"4*Z4FEE+86PBJRL
MG)7:>XQ[QMVU[[@_]CCC_/ '# DXD_6VS_/..=^7[VSC%^(N%9N?.MU.[1#0
M+'HI5T^Y/:6H',#?,MFF("^Q@/N%AOE4$Q$/2+:+(VCI%/"P6,[PA<C&49!"
MS%0.#E#F""FPDT(ZLM5OI4!Q@S:/;.]7BEG"4=TV!>QYZ&VI\)V7C[[\/C,8
MG=?\L+@P,H[L "G!T.SP8E$EV-/@NZ??C0JO 1";?:KPX4JP$C7]"O&UL7I.
M&:"\2][X EQ>JA9?(9K%*M(S>57A5T06+"K$01:CUL;C&-SYTOLLQTZO334/
M"U47HL.$MUUI5@=ASH]M'\")JX6=L10;YNZID\7P7V"X1"$(?SEZG8AC+Y:;
MC4YE1<'A&B!)M*;:(>*7?K(GV)>O*MU!/[0HM^MCWV17S]Y;@W6?VP;;M&^T
M=I>>>SX/?G0LE_)1@YH[P+T: \[6.%^1O93=0IO[V2U#0WHWI+T+)X(![3ME
MXR<[W3#856U+X[ ./8#9!Y[6/GO>/H)XJJ/#&]D+V\?^I UG.[O[5@K:"B.4
MN6U-DQQ0D7(.(# O;89H'$9>IRO>.D)^4IPW&% O%.4]H-OL'K2-'IXM.2B-
M#3\[&[IU[Y<SVTQ2T:UB99?_CY0YB+&"WPU72\5.4L"*W>>1/I&05U53[K'?
M[ZR:F&9[N^F=ZXC'EX^_=^3@]X$5+SJSLE>_9@[?$SQ_GOIR)H["G_S'>3'\
M__YV%^#- VDB'NA'TVT?'1XUX H"Q_6S"M_3)@+_,OUOIM7'&L^RGOHOYU$_
M&G +6/@REC^\&0I452=[10-@>SUO#MN.^>DEZ@!S"R+/!WTLPIS@,!2>C EV
M.U25?7]PKT\AG8#.%8NK9:?&7OQX<%AHEC9SQ.7!MN4W.0_V;"+^I@ Q*@P[
M.4E;X&6%PTDJ1G?@RU!'3M.$1UR:5ZR&9X?LSY;(&0D8Q;@F6@/QKI%B9\8:
M<','/$X6EC1L++T'[Z"8L<@5HLP#M5DT"^:&'SGGYO1((QDP7G=^,,BD$8 ]
M '16NHK;_7"U.:!Q'QX +S6P%^L?LPZH/'-LSX&!TN=ZBOHG2^:^IJRDV^/-
M'WEE07!@PZT>OP=#MM$%+]M19^;RKC:M<NAFPT,VYE.2$X"R6%X]?$+58HK^
M3JF8<1/#5\6HZ17=GOA,*;'2%Z,G^(@NT5H1^""HH4=.8QV%.054X,3#B- %
M;UU?^_\\(5T/WS]Z?_!B7P:97_:NE^4%%G+'S9WHZ,SGF,_F=ABO)BDLT,7(
M ?T]T9+#K(OZ6@,N*B=4T:00$AI?!*F$SP*#GUY*]R$3F;[U'CDE[,4=7AON
M1]DF?7A35!KULS1&0[3<3GZV/#L_\E_]#@YO+Y/O&>_] Q(L.86WP*MX=0"'
M,LV BV18L4):40?6#_#S/-9QCB],5;\PJ>.J7US:_+;61_74E69S>"C7$CJ5
MP;SXR1<*J*9[,@'4<M2J)[YBNRO7*O*65[K3VUP/_3W*<8QE2/9@$)3MRFXQ
MX"JKKV!@AK:EO*K5BZ89Y6"Y^1S5A+FKS<[?6FH;?^-:4526F^AVP5P;6W>.
M:X_=BKRGMX?/E2Z1;S]15<5@=\3JS7R?M9>,QS.VM7T>3^-6#-C4W"@(#XMY
M''+A7S[:: ^SN_?O3&J:GU5Q7U4=.O[599'_\X+K[IK $>,>+6K</@:4]Q6$
M\5$NQKG<I=P4/XA77^.0J-*'-_5-A84:ZNS>WH-PF(_'C(37JM?9(^&2C1.V
MY^_:7_5;)DY>XE?D^GH[/[_F5O0VQ65V ""IFO4("=4+Q,H*114@H<ZB.\S$
M$G $36ZW2Z#G/<CP>X)9?Q)Y*9U,@.(:S/2T!M0:_*//!OQ<>4\:GL?,\*GM
M*%W2/I:]VHP[OTEE'_"U,70)&*W_?$4/!'Z)QQ1_%N[1;6,W*,!]>'D,.M,/
M&E)WCH[@0;Z24Q?MKHD;O@UQZ[O6232]&U0O.OG2M*?L^?"=P;K(Y#SS&^F0
M1:LR.Z Z.=J]'OL$Q]Y%98;:R;R6%0SP6FDCZ;J]R/?Z:^(3BAL487A#VA7"
M%=%,YM1 Z$[>\>HS!T/@C( 4GT*FG\3#O[=-6(+%32Z+]BB"; H.]5Z)BNT%
M=@5GWIAQRP>''L6,LT:T#B(A<T=14V?=0D R4V1!#X1@A]?U'DXC[KI+0RBQ
MYER&E#RM;<V,8E6+R6#FQLK-9Q_V=3/Q>VN@I0$>OQ%JEO/5O%3QM%'-NB@/
MNPN C)KH1<1X0]\<4'P9L<M_QXRK(YN!VG05S:S?]O L^L-^$1%$>8R"B,D
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M(((A)'@)%;%REXA,C./XX' U/R7V+_')$+.M<" ?OJ3,E-)LF$.^8%.*H$K
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M1DJ/5D -?=G*Z"VZ0KZ4"CMSD;GN:O?A9B4^65$^.AQ[THN.@<L%^AHL(*B
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M\+()?0%!>]: :V4[\OOW7,3?0P^,_U"-9'@Y#?& P7CK^8"M6(])M^V@P#A
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M2'D[>-'E10&<J3Y??'\H=]W;PK91H3-!*A.MX@9!/TUDW<E1>9*F-(&OZ^1
M"BNX)!0#QX+=)A],$!L:.NN"B@JO)@V'\-$W'IQK]T!\/<.<F4F%BT#W)EG
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M*BEB0E585\\O?(K=1,'A3N[=4=(!@6IU=4T:)%,UC\&5!SK]9/+A.V[<Y,@
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M*A]?=I#B:>8DBXY(P@H&IRF[.3.EQ'?<XGY>\FQ4[L??9L*?^J![$3=LJ!<
M<2-018BOWZ7U1# <N_47S)/KM1+-8.  ="5'Z\JPD2\_J+")#^J>\C?4XI?!
M H\*R$DB6^X_;O&-L+;3]> 2F9B[QL-.\UM6]&Q?,I^7^>4;_'AV*GH-D"=1
MP=.B :[F/L17IVB78G&RK\QUSU5M*"H.=!. [#1T(^QQ,*VQ5J]%NFQH#-T
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M\$VA'R[&2=T#M6J>8A,NQ;#S$-,?FWZT[C9K-\S6!.NR,5I P#."6JG@*>D
M5U',4[I9*GL09Z2W[:+6@>G0J^C:8>=*?L)(:OFR-<HE)_ST'(X"[: IDZO[
M/R,.<OQJYEXX_:N[&E-62RO15Z)*ZL19*%HU,W$',M<DPJNT'JP_@*5,?T@@
MYEHY8.!:LE-0QK0"\QI45M23T%0MP*[2$E<<55K94.I]IZ6)&BJ>K%C7:V<?
M[G]"P#Y2W6?O%JLDOR.C^N;:U8#X&%8$GP)@ %$/';X+#_K"@R!?TPOQTUC6
M,%G"-78@L&OORQHY!.996!(WA],OSWITD,1[2K->>[>%PL[LN%,2IAE>WN5
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M(->6O*$L^11#35%U_ 5EI2 TS0O=4]9>+ _7D^6#!-B&'D]:-IY-%T\.$%5
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MV#8TXFKA^YP YV%;TRR-/V17*!AWK O2\6B/1R]]M#IV\&(A+LX) Z$?6'\
MID 8'=[46T=N##?Q@4[4:?<R?P;QZHWEL)=D8/-;43E-J >V)@@W(BX0,]/L
M6D1KE"EI=0>ZU5,U=$EC&'!D (YMC*E[?>E?:^D30JTN380Y!Z1P!E2:0)"K
M-@S2GF$N@2^'UUL^"N.:(WC(0RFX@5HR!')!<G&JLM6[ _WFD_5.R.'^)-L>
MGFZS]:MN=SUX?8?0"CK'O:"K4)31?#L_9$SK2N9?;8CP!\3?B7Z26:!]%JUB
MV5KF99 C20]NK!EV!*4WIFV-G)J<R6S74Z4'%<V0'XE'NQKDEG2?'^9L5?/$
MJJEF&SWHL?1Q]3NS+0,C7VT5 F25#;K,%@-^0U JX0\.-G(K^B2ZV*.Z?%<;
MA2RUMT QV8R_+5P  U% V>BL0U-OGVRYT))Y" 1N,,E*_(HQBRA-HHJ\W)?A
M+OG$/,/TULM W"*4U[J-7NC)G1"GUALB.AUVT=,LUST2!7M8'1N1$Q+M"19H
M&V DW/5&7A8LR79JJ5#@XP%"%#$E<$-G,&15&.SK8>6A[)G#):CYA\J2"L(5
M.63#84_>:-?Y_O.>:$(4<@5MJP5>40>#T14;8%^G"1<%/FDE*@' P])^_Z8Y
M'-[?!Z;R[-CB<4H&U6R2M97!^"3"5[6MZ/,$JP1]@D BY-:<6<<+G2U/4=J*
M$H;W0$S2]AYZ>;V=/;66 )[BP+;NKR;A+90F?+]-([=*[X9P\U$Y?T"B/-LJ
M\:>GSVZ'#T@5YN*Z03>ZV.(B6@W%-K$V0J3TJPJU=>LQZ-=ANVS_6,/7P: T
MT?5LW 6KO[+MILSDA!PJ>$8&?^>ME$TL44UR1/HD*T#\[1PN#)^&1:3!#O4W
M'>00NDD(:PLHG6@%2$6@IK4E JX%3#^Q5D"+!_J2F.MFON8&>U3UVNOUAKN2
M2QO1;> =_&.?2*S(7VZ=F)3/M[W]@[H6H&%0%,I?R.J>PZT5T2FW9[-:9!G#
MCG!P*4TP; KR;A>;U_XEPSO8.37/.B:JX@C*I2E/X<$F9WYZ/I24Q:.9O*<-
M7,WX??1.Z&P>3[?N?6"(<T8\Z5%T5"&5\:/V2.;G,<U'FDONTLG]+RM#>2]?
MO+C/I7"/<BG1F:&%URHSV_J'LLTVS>&L9.#^4>9Z'B#^F2ROJ76:8(>&DR>V
M 26,6-]X+]"^8HRL=QEUM$FY&SKABG\<(HB #_1YUO<XB&X_9] \P+%<DJS1
M[U)6<&%1!KLXM.;7!;I?3P5NIFF/L:28 +>:)O?'M*JH$D/9P)Y#8 *+W,O2
M&V#T[7L)/RID[/;NRB2N&LM;GO3W=!O9\[Y#^A;EWO()Q6[?L.RHV6W/&VI>
M9"FH@_ZH@0K$:Y;H,*[[D[2?HTD$ 0[BE(_V=8XY [?((;Z7P,#[H$=C#'JG
M1)P_AI6PZCF<,<P[T-"9<2>JC+%;Y2NJJA!6=E;)UGZ:F<FX\W?:/L)=S-ET
M^+NO*O:$OY+.X2YEK07$]D#(7Y"[1&;,N/<*M=+Q6 XPK<5ZG>Z!O/)Y56:O
M3'6V-&\=N%/T9+Z26%PKB'T4IADPRRV!K[L>56@[HLQ3(\?9E<^Z22(,4B\#
M/TG9W$HR8L([ ;$31*$$0[0'_5;WA+29P=/<A.L@]JOA3=V(I_PENI[F.."=
M&$5<%N*<U, ;M=Z6#>@W*T+*F/Y1JH#=TA:G8=>7T-G>LO#B =*#1Z/D!FL;
MTEKZ<C@!_OV3NYAWH(>3*DUYF\?<S=P=J8TOYZ[,]48WNQ]P]A[(*(TBPEFY
M9#7A\ASN\%=;6(<-[8?/]AZ401O4D(T1Z_ZGG=>!'PR) \)&E2:F>RH@BZJO
MZM6[3=KE&^"'V/1.[-S47AUN/:E0BR1_O^KZT#UM25\P@-C6]8Y4A'M3PGT6
M31U4.2'& DT_?%![C4G7O03DF;)J2B/A5JU '5\$QQ[7/17BT4X2#@INHK.S
M\T0*2X=*4-I,7?3FX1BG1'#;_@Z@]"C!KP@S"1E>5_&BKSJ645[4,7VI$\N<
MUX0T ,?Z!I5:6X,CB.6@=AU"I]Z>P]5,(J:TUCG<*G(8 =X^H@Z]6N#WR48A
M?25*H5T,@@+G<.BJV+W5N3;BVJPF_K)!'YA^$$P8:.OI8ES_ZP574GNV3[U(
M05\Y2NAR1U;;H@96X RJGZ-=SYC1I$$_G;/>"$F6(6M!&\5/ J==8UQSU)Z1
MM%8)1M^R?Q-.LDT_$>ME[S7.VIS7J+]SARNQ<*S/43MY*+=^#B>5)9,6HUAN
M@T=E\ 9SQ-0#-5@/F323;" "LCI"(P*S;I$VL-JI*\L='DS' 7)U7S,^>7@-
M'*P0+83Q/ET;,B?WT_NEBIDFM=>9FO ]9WNJ\'A8=? %U8AF#.M)\E:;[2-T
MLR?X6A)BJ+LCU$-(NOODX#++PR!?PKV9MZ:KWJ$0IE#JJU[V7#8_&5MV:3(0
M<K_W?&RD:=BQEQ@%F#/B [I_2/W:-("6E8P+C!S:)KYP*? CN=T>)4]"3N8N
M=Q"L"I&M0@R5DPO"OECZQRJL'ZB,%IT$I[4YMM4TCU>9V;=+PZ_<+_N,^W+)
MR_(96=RGCM<N92[%^%\ 1O_F<!=D\ [R1"9W93VF=9<L!*LG)^Y#&+:V[H'H
M2J$H6GL@C&#QO['W)D!-95W;:!P1$:.,"D*<41'2*H@R).V J#3&"5 "I&U;
M(41,VX!$"3D*0AB$O-VVT T-41 B(D0D <60" 'S*JW(%"0(&6B544X4PI&<
MG-Q#?W_5K7N__O_[_55WJ'MO4Q4J186=O==ZUEK/VF?OM9CV]$1M_B[M5 I,
M&T!GM;WE:RCK_LA4?%U?3I9Z,&> 1"NP/&)7D650Y^I?:7G7-\/F:)[07$CH
MLOSC 0@D"Y7+HK:DWIS3 P&^=?+*CKAZX9]#=?8';&-MXH]6QC@(/MJLQR!D
M(T;5BE\Q<ID+6^[1=#?B+0]X>\I&#?KOF:'@7,]ONK?T^Y50/24IB .DV5]Q
MWB6Z.:G!*5,4,#"/EA"]Y_CZ]_:9GR\X5-Z.F V<<(=S@8:"\-G:\)D"!4JH
M1\MYYAC3C[PFUI":\?:1W=?(OM'ED2&VUUB.C.V?@_S]:?;[*US/:N7L@4SG
MM+&>45&^V99H\_+-;=R1??_YYO-_>\U<N,8K2= ZON'.E"[>B&DOGT:N=7S$
MZ\OA%,"'"U+$7-"?HC\P/HHFS"7!DP93WEO*5/"7A=._]R('"BTG6R63A/3K
MQ"P*@EKYT.8XJR.4S>>LCOAB_N[U_7#=_)1*\<WUM45#GBV#(??M=&G3E?D1
M=\59E2&]?2%DFN>Q,.F6CDER GFD-]+=?H_YGT%3N8=E6V47MDH^^:$Z'C9B
M?GF).D:11/?#3/72KG0P7,+?A.P!5/643[])((]<Y)4ER@"FJPAFKTV&B?"*
M8*US$P7%ARH35UN;Z>V2 /"&<Y7FS%7@=$*6YQ?!2.YKEBN3 L6!W.:+]!\>
MA-H^[&2Z#(1%D#KOPP_<7;8/CQ^B5L@'W_I",^>%_C"4250/*$*/T0"]"S*3
MNN\C7N56UXX.Z;>Q6B5S4/J\&4UL0UC=9N5HZF+Z8<R]E$E@AT#C3E+ G/H0
M^OB18H)-ST/NG.IR$5M!KWH/:]T.Q,7P&1&'\D/ \!N&KX"&*.+9\:4LN1+T
MQ_4>4WDD"^PY5FC^1%F@;')<"HZ5\NC%?33")NBT!EB,IL+ON73@TF:;=/=7
M0E7^LH&:NL)^A2'MP:-'M1E#[TD_$54*HB)"!T SF7&A(9\Y"XP/;G?QINEW
M,@B]:C\9+G4D[KQX QC1Y&SN'_SS5)/GJ]P5#_?7$9N7MT_)"I?+;VVC3M\4
MER?PA$V>"%OCL.8 YDNK;L?,$V=$B9L#G%?.[#.X 2H!,%MLP]P!<;6OVE%$
MG#%B%'253Y,67@M5)T32;]6V30[&X98,ZTX?UOH@OR64#G;G?1]NWAW;=WFD
M$;'3FC2^](8*I4WF^@A4VRL-)?>!TZUOMND$AA)784*8A1&C)CU5.M((2\7U
M]9FD)%+:=.%/'FR"S=!WGTZN6?*6)EDZR36+S"D\\O.P?_V^!??'/I[OM[\$
MY$N@'429(Q;Z@@Z+ICE)]HA,L@#_7LL>VP(J=4_ \6=8NR''!4)A-QP YJM+
MC)@L A:J,6*:[#[HHN'+SZZZ\Y/%=A!;$Z?+>_]L/VROWN =G.A>^?NT^SM9
MAQ*,#7H\@$M75I-&LV;V5R#J^D+6*J!A+_$</A5GRGP^FAO6-=$Z"_(XWA&G
MM(*JOP'_M,OAEI'.J/&6PTHL^K>1%Q_VO19MH=_;5=$W1+M_,NKB4]QQH*&6
M4AV=.]J'#GK5\$O1YWG=:82=T/DI7:XVT(C1Q=:=?%(/]3'Z\>#H^OZ+EWB>
M'E<J16O4;67+'5V^C1P(%/@G.+<D[-\.J%0D["#!$ET[#NGMMP5KTN\P:%+"
M"FBG*A$K[7< D?PSQ9$A-IDE3!(4<Z8T<GK[3[P]T;RAR^$%9^9NS[%+S!+9
MY%Q\T$RG+[JP+XT8@>8(]4X-8AM0>2W6WCYQVUY0G'(' O9W1%OGR*7?M(VN
M[!@]-]95N.^$2T7%0.JZB(L+,LRV_(GX  U-W$\IK;U*Y#D[13)YCNES"XLF
M_4FK@1=KB*H"B8XJ07W\)+:#]J4;91)QDLC6:USP(#^#6VL+6^!T;[7];#V1
M>;8-Y<V2)<Q@R%^CO/[S"=@%C'@VCH7*I<@<*/J.)%GDITFDQIJZXRQ[H&V-
M8F?P4%*<TQ/M1<Z U8W&VL*U-[[I*NX@%G&@U4YPT3;$M->(.9L/THV8PX;M
MDIU,]YD[&JZ 2HV]3A'4CC[6GV8]^PI*T.4:DKVCXU71?GNUM=<G.0N8WR/2
MVBYFH+J%;\$PDW$73>)F,3HH4#"/<2?*XBT4<4S2";M0*VB.R[0FZ=X;J3$:
M[**WPQ@<2OW; ? XI8?6K'P@:P+>X%2V'*:M_L#,YM^X:(V&:#](7."4K!$1
MYR#+F!NU+*[6J0G9KN6DP;:7R@;%"[IO/P'/%I3X%P_7;J5M+[20QQ5$!+=/
MU-N-!'2=!Q( 549>P4QUG[DS3;=C0X<M#44,XFDCYJKG]Z1W>VQZ'>S52/J=
MH0?123O:Q"]Y/63RE_NE5)%D^Z5U!7_^9,2@\7JS\J\--04Z0##22-AN2 54
M7".FNE6JG,?JI8!'78*?XF8AMA!.BJS4YF:+?1A/&L5.4+EZ???:>JV,P]RC
M,6(<R0PS<E<LF3YWD.4@9])FKD2/L%SE:VZ0'G9U2PDKJ]C3M88L9)[3J%2_
M'DT/JXNRG/^ 5H$>ZOC&WL>Q;G4!F\8/@W[);@ VRD-W%C;??6+2;,0LLR/F
M[L=.U\*+C\3Q3W(BOL7>*?^R$)VJ1Y^"R4*Q<PV-"Q+!H?(29:L&GXQL +FC
M+7=HEPOZKM>&G+]:Q&A!0\7BCQ/_MEA979-?+M.[,RX.?'/BETP7#]^'M9TG
M^MS62?@AR&Z)*G,)L0$+X?GPBED@-J1&(I0CSK OR!NS+FDNHTZUM:Z_>H_Q
M68//5C_.>)\0YKHA5O\$J[#?7==A/7H^]VA'J?!)A]"_US]>TODU\;!$I2;V
MV*OQ8^FH:!]![]2X3*X=:P7KE9QBQF=NT]8V '8L?/C;$TPW,)@C6A5_X3;5
M!G'A'GK0Y?Z9-I"%;Z[[((W>BE](O=R=6:(UN2ZX!J*IX9GR?(H)#5TV]^$'
MV&&G_G /\N^O^AE/$-.;^MVLKGYOZ/3M$<0Z4W<+,BN"]V?J(J$&6RED'T"T
MC*N/"8'\\6G>\VM-3\4E#KAL#=AN&%M7_:CS3@V8'_4C1&DT8OQ1@W@[?5T!
M2(G0>AF\N<"OJ8X^FARO/Q>98\0(%^5\-3PEMLK?DXK'#MM]SUK?+B#[')PZ
M*4ENL"':3&*QU(N*\+*$'W-"VCHF1I[\6Y-FQ 0K33\BR_N9V\ 5DOGGF9;Q
M8!%Q8620!+L.HKNR\5=N--J$Q-67)M/5ENJBV+F@H;1@D8WB>[L=881^^095
MS=X,=U\,$H*&]S>2.=#I@?,5^BATEB0X7A_ 7 Y]T0<B/;@EFRM9:R$S59<1
MD[EYLR2":*:($J_L%"CG,O(;"#O:O?$#Z(P5\LJIFLM^NO>9Y9%'H3T-CO:/
M0(_KWGX1"97#"O:0'VR+11;ZWT,:@.KU!2KBU>N%:PV/);2*B]@KQ*IQ:85K
MPG+OP M:,YG'=I85):V.E7^7W$_]+%,Y&S%+ABP&VT:VCQ<-BW=TPDY%PT=>
MEO1'I6*?X=^P@T%?-NS T?\PR*WRU=TD/DT$=''UG4!4M+.ZOZ($:"QA:W29
M)HUZ8&E464FD7.'!5LH\XYL3#+M;@\_<:"YT$FB!=+%K@/5D5BE/4^"QCZ^/
M9CT#P'!##&*V1X.#-M2B/-2-]8?2$<TU:'M$$$6/&Z0(L$UTLP85%P/9)9KH
M7:>:%1%)L)>V6-V:H=;65-V-0K9WE70Q RK#]N<Z?M5Y,5)GHP!2W8P8\RL,
M[LP%$,2T <WJMQ%5/0XQJO[J!-LT9"?T82"B@9X)"&39-J/#[&:</7RJO)>8
MH:F2GWWX0-3EO5-]@493DQ;U]RM"^H;M#G$65P%4^KVHRTG<T0[=+B/FQA%#
MGF0T&5YOQ'3:[N:K[1&SQ]I,9+&MMA:VE,DN.\%6)-U10PJ:[?TQ-J!,G0KY
M<)U@PN"$=R*K>.FJ[BIUHD> \)'A#K)!D>_5^WR=YR^YCC:1[>TF/0!U9UJ
MX6L4'TN0U4!#(#,&W%4!J(HD*'N)("4#YA/X:Q+,&L--(2[)L_E5F8:^G/'C
MB)2UBM.\#3YT@+ 5#A0(N]S&[%K5G?+5C;+&?_E\K."GI$[OT&1^@S$T\KW:
M6$N8Z\'N;/B UE\J,4,<!G&6S#/1UMSKA-6#8E-0?G- 8JW8I0-6=S<5NE9U
MK-3.?Q*-[7'QONL>L'MX ])"K_*[X=A/1EW#1CV!>5F.K&/05+QGDE2<-=,7
MI#?'.\Z'^+<@DV=U)AGN7':XJ[#PDSQZSC//LS\EQEVZ%86+ZA Z1Q9WGKIZ
MWM6M;Y]9? [93,#6/D&!@#*?*UJ_47(<FMWH7 R9\+R[S,NHK\QC=>8<'C)B
MYHCMJ)X[Y()QMMWVQQ?*AH*,&&OO4_-><_;7Y\BCG4/JP/?)]T*EMQ3-MZ,0
M-R@SOI1AN^OGWJ9;N*6H1*5<84KWV%4^[(4.:8+(+",I2R745D7KLWY30+$8
M41Y- K"L5T;,0MA2@\7"1Y/&-8M:[BC]HH%-T$6E9GU5Z5!(/2]S@KZ L=LL
M<B(@?%R#2W5[Z3_M"A)'KX+\1F654RKP[<MPA^ FY=P)H(=#,OP2EY!0<'2*
M)!<:,:E?P5^1KDW_;DGS_%Z>EY5=<H]!&5M*X/%:HQ-H,3OK!'G+![*ZU5AH
M+4HBL.H/L"7Y*6N#%B5Z<>5 %E!K.S8K)DXSKDC0W>BJR(L.IFB=TN)LM(Y"
M5>N<EPF+XJ>)5S8+]>GT\V$#PB[1A<J]8B?MYL._"AQ,I)3JV%GP31RT*ABV
M.MNB"^<BINDS1\</(#:H9VIPOB6GGW</. 0D37U"NFN4"S8CJQ7P80&TOW!K
MEY '$O*+A[KS0H,NBK^*]C^?P@L-I;8SR"= ]Q3N56=+W5D(4',@E^"Q<35E
M!37<L5V)+)@I#I,B7P61].L9N_N'3\).^D-(>_CR-H&+.YQ8I@@C/T_4T-E<
M,[<*YUTB<,*NHM,N]@G3IBY6(7)<!TEN'9C$PS;Y.BY4J]\#AT$!Z'B^!C:3
M;.#H?5E=-EL8Y;H'$/<6S4,>+ZGV&$T\<V&NV+5.)&F_[E_*D&C.__Z2IQCR
MB'^O TQ#0P:#ITT?0A(U94D/,QJ%V09#H0BGHBBPR(*9J]ON8 9#*@4>V')*
MM1W,;\'W61J^%8-R AKBP1M!H?R.]T;MG.;P>1(P^F.)37T"_1[$?I95TD?M
M&'9<I>7!:TO[6P]W3)S\#H,TN%60#LHW?RMI<S<G'N]8]WE-37U[Y1C__O=Z
M;SY]TZX8ZMJ:\3\#K/ZUO^KQIY(LS;>5UXN_S&Q'%2-6,BT165"M/ZQ<^UTB
M21W$!S,U.1S3C(:IUE+F$5"2$A=A:SN.>Y/%3X%/:<R4GJ]\Q8]L9(>NGK5M
MWX67*1]RGRHQ0,,&--2HLFQUBPQ9 UJ_*\!IKJ)%MS!?EZHE/34/EH6[:;NO
M>3MIN8V%!*U34C0S49VX1^-8/X"U\;T_;&<B_6UT,B*_*3R\Q"0]O/W+S*Z.
M2A]@.X:#/+$:9YB &L]&1/Z W/)GE"/Q$;0+G&Z,3@KC*B3+1$O+A\O>/3^=
M,">Q7*I87!U1=_K,GXF\,9ON*N4>FM537#$1_(:8$0_8 ZH"XH/QYL2#'Q/&
M(F3 P]JGK4M&ICR.>G>[:)S'V01'8,FZ9FD/%:7/>2ZGQZH.Q%L7U-?WWGY4
M2UJ]_[F^5#RSPQ+,W"A'3%#T;I><HJ<X.M7FM383%AANBA=$]F]ZF!?XZQNH
M$,]6+"I<]3![5W1D@+"T:MU8_=V?Y_T679Q^EKH.NR;Q\]_7 OEO+URK'VPQ
M@AQ%H3P/3>FK4*>$@J4C_IDGDC+R9?"O39X7H8#JL41'G+D/.'T>DE%>UR?Z
M+0/^/4S4K5-S#&<?WEA$!-\9,10:,-3#W88H@$\1."'7D$^4<0R!XDU\E*PF
MX3ZE2=Y(D":EHQ$S_"?$H<2P_DN?.Y0+_[1#J=_TH\1P_ /&B.E'B7/X)F#H
M1<3(Y,P^Q_G_WC['?_5EK47]A;W.>N9IV[Q5AAR8KE\-1VIKF^ESF%]!Z>6,
M;<>UX<5@#!GDLF'*79F*8D,E>+3%IG9Z4U5<W&#R <!BT-.U),&,<>GC][G?
M"/4^?65!>%V%U:SWQ+EB"RA89=O O<:=+5I(YR01S)A;0-M&NHG#X2'9,8(U
M%*,.<VY '#W3VR;Z[/=[R ZTC1'DL?5K#G:(V]XGL@.J:CY5? =/&\1$U4^X
MZIE#70/!HRWZ_5"OQE8&7)4(3$9S*PBUX(V9>WLC&B*;8*]E_NC+ISIN;(L=
MM^2D$\T(FP99J]J8[AJ?36&4/>V5;I'1I_-#M2ZEM_*R?ZM4OFF9YOEB6'&(
MG M^P^G1ZUH-/. [CJ)\ )?&VL2Q8S44>L@)JYG+0'JJ:)>:1DS-XV<*HVD-
MA-4!%-EE&Z&J  CM/!];$*/^<$WHXTI?Q,AOW)99L+Y;OSML]P:7XF041@J>
M+@A:JH^"%VB[1WOT!R";7@V^P8A)JU&<(ZP%WRIR^$6A^066P0^T\U/*J9[C
M[/&)^AA?N5M8S#<=DS[$PQWN9M0<&GTU(#CQ-DP1FFCFBP&<\H)A.[+>\^10
MC1%C-HF'-@"P%?>$X=>*IA242["A5K47;F'_:-XN&O62 ^^J;2.NAWWH4^S8
MOGZI>C)ELO,[#=F<M/_S[>R.:5?#S\#WV)X.W3)HC9K?H]2%0A'%\&8H6)T^
M+C1+M W(,V*.=@H+X@,9?\J]CV@D%C2/$'8:,UB3&'B[-OMS:/>DLUY].J)T
MR.8A.5)Q*)?7D^B,SM$G' W%R33@%"D-AP4B)68TB@5 _4)8R7J-DO6[AMKU
M$"+> 5TXK2U7Q\N:Z[0!ZDZ"/8,GE9@RB?1HM=ES.$*SYBY$:?:,SW#X(&:3
M.^*BG9OKB&S1@>)/2HQ$U8-[PWV*6PZ[HU%45P ]UP>B_F*7> UD'YQY'-R,
M$TXU[]4JKS(]%6>+Z8!ZR)6YD5;\I@^J'#AD<_&G*$_Z=>\]E0S;T.U:]]:K
MJO2@/J!X>,.<5V)7>"T4K1U1LSD$,_@4R.*@/B)%:2G"ET/;9.'FW=_E!.";
M'%=TNZRM[MQ\-N%2]+C+^D]_?KXO=/$<;@ULYQ?5=$Z4][KL:Y</X]Y?):HZ
M)3WC7PL[63AXZ\PE:Z A@&7%>A526EP1[J_WAO #.C95E>790>FJ$-(,]GZI
ME+D$CB'_O?A>$FD)1&O*$XZ\':JMZR\KC[)CW8ZK!([_<MBDB?* #5OR=?O0
M(:/A-10TZ0IN+/!Z:N=Z*_9)JSWCWJ?A@2;<4I83E.Q?G7 "#M#:/JO+][\W
MHDA/R-HW+/._,H18@M+ANIN<)-A#76&GHE[04L!#?&@]FE%#ZRG)8G>&GRHB
MG;69T4_G<.V]=VE[-=A,Q(V1V=B_07NS.\-[5PG5[OL\E](R-7$N9-&*+$W<
M(FBI)WU3VREX20H-"VZR,S0C$L#Z94D]9_"FU2SHPLRN&CKA>:Q_X\ C].MV
M?F->B0/T;*#::8Q<Q& RSA,Y0#4W>S7X[(DFS+7[8**)KU K3K]/K7O%O9N%
MW5W7.>$?%MQXC(%K#LG)O M\"[&;ZN172P;S@GY[IWP8#]M?T"]CSH$FU7Q%
M\4!W,UY!TL&&V][F1LR"29E4:<?J-F(LL!P!!1,E7D[]*$BD2_MM:SI&L\N!
MDN'<VNG"J]':.2>USS+5:"([^I(F]3QT0U._"6?A;UB$!HT"+G@4"ZWW&T6#
M^KS]$!WDHE1YC0:741=Q!;& H\!QF9>YB9J7YNU2%,*0-HGM7XO\U$_"S&1?
M,?@-X=MKNKR=XXL9_+"']37MMUY/-EA/#)WFO[DS9;I= EO=0$R[P4QD8;+>
M@]M#'\CEB/$SI4AB!EK-&%/!(FCC/9C0YAU8^1;:;1Y*]9R'\+26:DG3&*%7
M^N%8YUA<BV0T;,V![M+.6)]-?7&#@I-Q]6M.Z#]E8""2#@UA23^R6B2UN:,_
MH^$N=\Q$[6\@JP.SN6HA&,Y7CU1XH,8BQ5M"VWP?H13]&FLETTN>S4DHB73<
M\MJMO,^/E'32S6P<.^RYKZ*"00L#D0IU&#WH]3A@CRR8.= KJ<8EW>X0+9^Q
M1IGA"4##]WQH_#3HKU+V'-,$R\S)4J!ZLK) W?*8[A;FT4Q8!)[JN--=$7O@
M=MO[MLVP%Z!*7/],TSA4&5NQ6S%M'^ US2RZ0G0'5+\#X,'Q'@EBFES*3*B"
M9E7 A[0^RC%[[5%*)G%)G"0CA'.%/[D_#JA^N^NTNM6\&9Q2*Z6)]@? \UGK
M;Y?W#2J\\WS'FK.>">_>BW*)U,EKE"7'465F ^"Q\1Z:;N:H9@9S>Q<Q@HB2
MJ>^@*4V%O?J],$Y#)EU'W2N\Q8KE 3F51.7\=**'>03RT?32\!8'!G*UML^I
M&F**V &4-9GO53 BCG4R+X'R2TP?%7VLM9EKBDIE-NJ.:1);R!452C.$.N=Y
M+ ,?L6&NZS;)&F=AF(E0DC<9+&\LQ#YJ.Y2EXEI%R0OG>" KM0;(O_>QD,*6
MS!*VD'#0C^9.(6VBDT4MMX8.4P$+(Z9ZDW-+H>76F%]NYQ]<^N.-:XXFYNN6
M]6N3+Q\\L.'8L?CK=W@9%V+[0K<U)+["$54O&)>MJE;,(BT-LJ(>:_KN=-.7
MKH4W[_VX;T?&Q%#SH1335X':KJ_ V'OMMS<M7T0[UBR=52!+-V*V>I^^%QE/
MJ0ZJT&^&[%7Q8\?TZV#"0^B'PMGUJ+@XLYC$!UJ/I_BK4S5+!OOMY8C-VD)[
MJ%AEH(36OPX)L!EOX"X6K1IH33-B%KN,PF%WC9C3@_TKVYCV]VG]+B@W_PC9
M@G,0TPMZKR%E=?Q3; ]=5]3FO:68-BUKHJ"^1BM+]?89H*2'-+,SSOB^%CM!
MW10H[O2I$N9AK9OB^&42>Z;M6ZYTFI<!S[K%V!-<U0EO/#<=E$7, B(WE$T7
MGJUYM7ZL=ON<!>,T,O?F[JD_>6,[+^VL+W7NT>.I*=,YRA'<7/\!\ /6D<YY
MHPT"%H<#F@1LM+>?DY-\"_>XSH@YJ:,$_9L@G!R_^T$RXJ?*;>3TK%%U/^5#
M&R0R#K21GL)R!!J^ABVUIP>4[.AH2:3RVA+\U3A^3P<)7)%G<FV"OA#VRVP@
M6(!G>0/8M/#M]6)0Y+BQ4[1*Q4DK]-%^N.I]($9[D*Q<3)W>.[V8HZ'G$E4H
M'06/M[X9UW!&2[3EB.F(QIQ\L,.(H9(4''VP[@?40*4.E- VF'J7N4T[GLYW
MO051T='M_!J><-(1Y]1H,YGGNCN$E6!N*LI_B,O1R$7 U8/A3XKV:,B2^=1^
M-^2.\Z<.W=D9QH_B]"OB][CKM3@!\2G00Y).XV3.60>-F!".AI?-6@F?@KH'
MPKS"NF[)*X0%P&XYX@'OA3+CU,HEM!QDM?QV=US?O(D^<FCVM&\7'S_WATM^
MG9_=:RYX1#]^L,PO(>0M?,]6LHY(;7G^<FQ+>&M/PC?X3LXD)PDG4[]R]%;B
MJC3WD14BG:Y0VDM:^OSYY/6(+A^)/#&WZR&V(C%A>.?X=-LG"6SAI*.#$;!%
MO&XGR!WM*V;.,Q2YDVS][H4Q0PP\UIHPF-B!'\=/TFU/4&LN%GH]$((7;U=B
MK=\T\(:F26PWY37)XH]P@M;LJ1WN&OPU\U@T<*_WS7"_E\$"NJKE[H%NJHCV
M3#PDT6^ ?^QBX:"61I2@*678A5&(26;3Y6]P<\4K([O%CC\/?\*91=55P[L!
MZ\$\87^^!F 3S;_7DC@BY^@SFG?R"5H,#[HD.CEE;I5(VD:.L+S8FS_K6KRP
MHO7%[81/QW2_BW[O[[ >->0*&@W[C9@3T"HX?,6I@9=:O>.F5G5+*YTZZG-_
MY-./B:>73Y+HD]PSD^>21RCAT]D)B !P^:O\S-KQ435J/T\-14(CAD.<.R&!
M-G;EI*QP=.Z<5%YA[9 S'09(25QS>*G6XM6+9ZVR'QG 4_%21 [5:]Y5/VAW
M&R-*669RF*P]_=0S.)7I2QLH)RX-'2IT$&LI;3-W,]X NIFG(H5#X7,EAB+B
M68YB7(U[1DGR. SE2KF"^ :'-?O;"6ZP-;AB^F<:RZIS8GQ)I [9T<%RIG8K
M/MPH'R::PNON,#YHG*0^?@':5V5W%- >\@U2%Y-JF'WDOX*0&U>5,O6S_T"(
MZ']%R.@70M7U:5[M=.O#Z9H]DWQ^HI\W:J>H'"3)2G"WI,=?:L18,==I3^OZ
M!#-+F"E^-DE,R0M\.<)8HY-H5P!6J O>"M:FN8[BW91I.6)K\)>\4KYVSY&N
M_A>O7"BJVFO>@0.]G,724N@/>!<XOSZNA+%Z)!#Y%WML1;1;U>T12K6)+,#6
MM_V<=ZL]=<Y3.];C$FB/.O4V74=:3-NN<UPFEE=X7W(MIFXBTXB+6/;-FE8[
MQC[E?NUQE.&K.8? ::AZ=-.&_T,'=0-=V Y'BBU[&>,SDR7+^ S]^+E7\3<>
MBO67A^*.$+4)&B+D4:W[!E0VDQP8:-R)ZY:H*K@/V"G>,?'%-)R]V(+UJG][
M!Z V!UL;J>M7MR?..5K5 8<-8!TY2WO#A[<]!UN^T6*?<6R9F^5DV3$EXS"4
M0 )Y*2+?Z4D4=..&F\0S6&B=[*KW'C6^9TKG92B=(%E"11I9,T40_PQ(4X0P
MCT&MFG'S>Z_$2[7CUYD4M3[_"7$%)>P $!-_%UX&+;V=SYD3]2_X:SD=<7Q#
MLPV:0KP-_R[BE+VGG=.<[XWY]JMLG?#QE^-XUD%61^Z-?,5W]=R'NE\I9;@1
MISDM&G#@/QQV..JP$Q)(I\9X:7_^.?ULVW"A<H30,MR#E8OK)U=\-D0@) D=
M@-;P1COTIY'V7&4-*56T$XW"BPRI*-KRP[8=@5JT<W11R;MJ.LZ C*QH$5$;
M'-@&>]GP*R"9YE ]K[F8BJP'90U8VSY&[5Z2*8-]1"NY.NG"ZO67>U/?]\]4
M>Y[-:B N)2PG0WL&^$DS%<0\H"+O,#4E#8<#J,H5S%VO">M9KQW70$?4+>91
M,V?]KPFY5A2&O\8FO1+>FD-?XGJ[ K8T<+VWH];CR4XZQT=6*T?R.%(@=:JN
M6V?MBSOVA[RGJ:_F_=-3#F.TF$]WP^%?##R\DX>@.8%X9NPKR5&B_)!);O/?
MF,O_QJ'B_G*H'Z9;/RNEN.L>_1N[)HR8V=RK$BN6W=NAO-#<J2H&;U>[6ZL9
M%--(V$M3E;F(=A4/A[!3A0&4IJ]P59(D>$M"V3"R\$F;4$^RD1;U*J"+(TU&
MS.XCOO&GRN0E <_$ZT^4?=Y^[\7-3:2?7VS)S-KP;'%0:,?/!P[>*54OC/VR
M<<^[F-_/DSG-][X$!?BOEB8LVW=BTX[1\Z=,TGXL.#AYFH([6L%HCRD;?="Y
M;N>+5(MLQ\+5XFTV5<M&@S]W&3$FLX%_XQ'31#08^AI^!R8H:2/35N')@\2;
M@ \ _N $)QDQJERE[A=*C\R(\86R);=]!PG)7X+?O%=^^@;D5J+_639!6HQ[
MQC=B?C!B)G)<_KO'1JR_Z%&LS-RFI\-8]'<IZ]4/K#\ @6V&V)E!?!IDQ"R!
MMVE=W('DO _7O(F:SY50,*E[HL^S;1R.5M'30K:TGTUNBF]-P+RV^73@.V$D
M?JQM?3;P>M.&.?;2.@=>*I-XFW&^T3_]/I-8/)2W[I=:NE7NCPIJT.$3O<_C
MUG[5VSB%7;2@P_OP'OO])^X<*5NP/1*EQ#L(3D #'IG%/(%.Z2:K%8=2A:4,
MR<"\W+%Y>C?F6KEX$639,.TJ43VA)^?5IDSVX0?.WH@'-$JLDDGL9$8#?+]H
M[4#S>'1<,;S[=>P$-P#L]2]YZ5#(<ZSZTH*N>-+P&\N#U4<@HE\0CLA8BZ%
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M .Z[4\=+JG01.90R]DAUT]DWU!XY^H/ML=3V#>>]7=QKDR>')B6+>M]2X_L
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M!P:.0YNZC)BQM<13$B)*41XA9D9,(]=0@RQEAG(06VSC<A'>B#&S("TBQ8Z
M^J?V'[]'%-KWC]]'M\6>472?RYZS*'CD,JHAYN2W]XCJ#E0JA9@5K%=3.U1
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M=JGU7\Y5KGD])O0Y/&?Z;9%XDP&-L:HBE DYP98=C0I\)JI(0.'T5#EWU#O
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M(4+_'4K%8[IC$^S86O24WU(@OD8G.>OIBQ%<E<E$QDC*N<=([OYGN,/SK9$
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MF24L3TK!\/2X)&IH*X1Q-+X)^A^P8,?#6'MGC>EWRN,]LP1!_,&-W3]16Z.
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M8$R:(?H:2:^,4+PIOA>5?XV]DFHI@CY'4AV$;YU]#YQ^$*EH[C XXFBDB"-
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M_;HD4.V5X;'_OLG?2#:?6:!.;ZY0V@Y1GT>'W?\T$L8;M=8-V<)NG+B!][Y
MT$K#/1Q^C2BCBH):T-7 ^)3JD=,4@X3U@K5 4U%J(CFMR-]WW9A?=;>S=!6S
M8V-R5'VV$^E@*-R6"LT2#CQW?Z^MXI['UM;V?,AW>'*#R;YAR,2-\5#YQ$T[
MJ+\X*IXO_I'?QY@K]!*'*5-"B"EM='/\'^[EXW";:ZI*E#"RGO@XX89$+=6
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M4T.T1?IR/9L#B#O@GY7BJ>WJ_>_I#:'*VBQP]'!WF?)L@S:76*&820_=TNL
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M]J891T4Y%5?03?]Y!W&$SO%\7,P.=>N"*!7V>-!QL2SZ%N4*HU-M.W81[36
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MV@B>)M62K\P*LG#595,=%4+\I!K]]0)(FM)1CK90-A H12@#56CGZUR99>O
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MI.;'"_G[NOB&T%&R,73"OV'5<PI$"NJ-52]]G7_G8>Y@&B._5UU8-G0Z-&A
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M5:JC&I8@$C=@@^@=4)^&OLC)0M=%S#KF*QSH"VA+&"'*B(S8$*#)*QQT53T
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MBQ+00@(B!#77Y(][I_3.LT^#_]?"@^KY'Z;&]0OHON3(+SGR"UR_P/4+7+_
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M8!'D'QNK,6%1]S[LC9L3<2SJBCQ*QO_KT PN_%6-]V:C@I#0WHF--8GV79K
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M:0X\[)Z(?>2%Y=?EV-0^TO\J4OQ.,&.;@_E: 81O*3!H!19[+> M\=HR@UO
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M=\<67F9))1Z)'WU+WK"R?3[%UO3>;.C:.X.34<X4T6DP%\/DC[ 8&M"^@&^
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M!]3#TK-,QX)!1SA/2GGQ/N=^:*OCJ-O@:L@]M<%U VP4"B=:\/3?=1JT 6#
M#&Z K@20I5LPUNBK.XAL^!BKMU.1N:K\EC 3QDGIT5Z.-3P60/X)RI6\X&C[
M!O_T*X>#CJ9K_!/*7-1;HVHOR^B':@\<CG)+;OI+\,X=-9[!]3)G<,<#X/4
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M; =P#"-S&/E(797>'MA#VC!F)1R6!*3VV:Z$*D1F$^CF .5RHM-&MI]R+&/
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M48JZFFW,?IEOS^\3:#U _9%Y@HSI9 )Y*L^]C/0W/MSS#DZK:R'JC^90$F9
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M@^]3<-5O0#!>ZIJI\*RYKUAF,1?/>U?P=T-\A=\K[NT\X=4\064]3QAM4)B
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M,LY?1&WN'3*9-3T ?"D +\]U"!3.+2,8&4SRY782*YW:61G4Y>1X0PAW&-T
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M0!&4DEI\^7&TV!V^7MX!.1[%&6T7Y="7!6)V*5R<$RYA H.1^D4%ME[82L^
MLJ4+N"$G.L"C+Y$P^(-9HP&]OSS2' U^GZ@&*MF]^_H>O]%-NWEKB.LYE%Y1
M,: .1K8OX&Z=Z&P?$&^-7\"MCAZP+7^0OX [;;P1""9"E?HF<!'=="W*<!MO
M Y'\P>4#U$_05\!+?AN#I?#7!K;AT\.VPY=5RCMB,MTBAKNA7L)7 \UV2JL)
MP/(#YRM6>*$"]CH*776P'YC:COA#R^W].X))O!FA^3C$YAN>R=T;'5L4%B\U
M?ES4G+0??'_O&>/&0/'5(&:5SO%09<X"[H2D]EQ ^++<GQKD5M8'PS=</'6X
MZ1?\:(9:IG.',-:/_4GRCUP/9"7(NDO9/*:L<)I:8O@,CCL*_Z1*H+81N/9P
MM!:O\-;41]?-\40Z0&H3F =D3MLU"RQGN^R.\%MMMCX>S\EN21,-K5")J]^(
M7(!Y-^%?HZCY37#N-M<%<3#6 JH"+OF1SL$=,W8&=U"YIB&AZ-&C?]Q=0OS@
M$' H5#Y#708S3N4<+?P90XN2-9PCW5=)^$'?*P51J$WUF^RC.7:,Q**WQE[,
ME"V+$XHG)"!-.'A0Y@/O.$^Z S#Y"DFK7E(Y.G4>K#^4Z$ZS@A]H@ R66^[*
M!5R[[;5$\S]N%!9$@_JAUAOG!KYNZ?1/,F@\;W-MV;[^22.RMJZ$F"7PHOBQ
M&K/&?4F,<M!3_QRB-[%@IW[^S0^<I09WF9K/ ZHD;2Q;V *_(7HG]PVPYF*#
MGX9IHL[+]&)8*DY[JUFFL!4]5:,J$!<\8[=(-1:\N//V-4E3+!'IPT&3G=ZK
M,C-E:R^]59W_T2KQ[3GY/WW_,^3GQ;_;6:IA_B!#S<LH_P6BZH@0"5VY#.S0
M$G6!D&TTP7^ $P[5MRLKE3IJ,<SSJX?(-80Z7EJ58$GIN*H+']S0\%KB\--U
MS?AVMV'?-MO<YPNX)P5")#YD 2=? <P$OS&!4E2LH6D4ZQ"&.*X"0Z<+N!0J
M>&P!MX';[D'\%#@[K4ANIRYWTWEKE2F:%_VQYCOQ=IRO%YFDIGN6MC(:=6:M
M;F8P5<ZOG@ZP=%7Y<47TL0<E2KKLN4_X_"[#%IB.6D0GZ]/@XU0= !%14V6\
MP6V_)MRSW8Z4:D-QHMTFY*W-H(GC1&"^3.5UB!#P:Y]-^[K@^/K3IQR\7?Y8
MG?H3-5<".\IUCI@KKANS.9L,S&#NJP4<>(B8*5@GWHRPC24-0="C=LH6>)95
MC,J4JQI,GC"X1-&O8/:MF5!"!U/MY]TN=ONU+[9S.*[-]EJN%I:H;<'G[-!O
M]MR#.,'O'QAD!OQBKQ3OA@0Z02'0O(>J*E2^E-U>P'U'54C:.QFDEH-UT+*.
M#*XMY\BO VM?J67XP8D.FFGX,S9_2M'(3VGP*9CD;@-]TMR'"<?!&KV>K^F.
M4!OW+9V/>I+^'CFO*7-JRK.$ C-GY_+VFC6+[>3D4V6'&4MJZ_R<I(KS \+B
MO:**GQAI Z]?7TA==G[G;S9?[K_XQN1C%UBO;X [#=<7A_*@VSAX>#_DW\ZU
M-J9)5%G$E;%[B5K7;/!C*Z&;3=/?-)9R-]?!W\/>FI*WS47;<PA2NT?T]=$Y
MI!16.6GS"Y@'DMKB7LB>C5%(_3,ZKS$EO'T4L<[& B*)R?91X:741.+*JP(^
M!I5ENFQH [+1F(WB)Q6B]QGJ#/[JX3-1(PZ\-G2G6,2D.#?:='0X[((3U/7T
M%5T:Y9(PN$7;FLTL8DN]7X#3&&#;]3$#-5\%]H^F2<[R%47ZEU!:CD%3I LT
M,! :Q+HC^L?MG^UG^YEN+@3IKI!-/S\X3,Y)*0W; 5%;[3Y><]KA'?M\.#J/
MKG S/'I4_@BUH,)$"%#'\8'O9+#S JZI#V:63Q+!8Y(T3SG5FDOD'(>S55@$
M!],RQ7;LCM.@KEW ?,RN[ZA[G:DV^$5/3S7L5[7VS*A+X<Z@/LK&*$*>-8B*
MXM6U;O4J"[L.RF8LU:L7<)%"4SA#_PQ*%6+8YBVL5,E,QFRG[S2$&S:S SI:
MK^5\>*AFVGW=%YL06U46WN ,HGJ#?W>5<5M\IJO\&#RG*9GL"OZ[_=-NQ(\U
M.GX/_1-HWB91/0E;MCBK"&U3F@,,_'+XFK9)4=AXN8SMHZ%+']7_U5\$)T!>
M+03!(.H$3@6W?A_25AHU=V@>2..X//_'IB8.M8*6IUPN&5=X5,]G911QER$1
MV/NV4[\;$@S^_3=6MYF@9SMM-;=O9&</D[-7A4^E6\W@33E>H&<B$J_9<OYE
MA5R\%<'*1@0I:3MBIG8YD"_N)UW-]3ZQYTE"T@#4X)D_/,EU CO&1A&[6.S;
M$:@&L9*AIH_5)!/.,7F5>82&KEL&F;021?@[4V2B1K**/=<<9O- 0TPE6ZL%
M*V"@)<\+9 [DJ_GK3B_@6NI 8G)L8V 8B+X48A_<9OM:@D]!?#3$5?OS&9Y-
M1+$ULI/#P+[B 35FV@X+\;/H$NYK8D4L_Z9N,?=LN>^H*ZAG7U$^AY.;OF?,
M2]KQEN,"*]0&CM#?EI.=-)6EKU@%0PHL)XY6@;=R?CC&5WL)EL.O-2/RX]"F
MD>S(^;9%=2SND(# V;4H**H$?>EOKQ=")MCZBP2NMAXDI5X=MCJ9)0V _0Q4
MVG(1$R,([\N>C<?YG 9SQ8\C\QGS'@\TT6[ZWAGE2G:<9NY.>%^9.Y'W;?-U
M^"]LC0/&=/$Z  ,/4238;5)/@_TW$/:0I/BAT"D,@5MG?BX_V(?QC@\&[0)N
MRBY>R[I=9RRHFLL+>ZG!F%17_//#3-?'Q<#YH%?G'RM&NHK&KX7OHS;$+$[
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M_H0A67V1@X]WD728^QY_T!9,O3/2/^5N%YLSUW$\9+,DOEB<>YERCZ6J0>N
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M_U[V^_T,H*J5Z*GH'PNX^4MP!_U-8X+/.N"W":I^DYIOO%#Q8!45_&L!1V<
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M("BDND<TF> <"GD\*$.9[X!FL:0&KPLLANE2.GAR&M[.ZB JBO3?@V7H@\N
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M#O>T4V\+K&=#Z2?ZA>&;+S"Z3-H<'."'EUZ/7X\H?1N396-[9Q_Q)5 ET,E
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M :VNV8"RS$J/>Y$X;$$>&"<CIL MK7(KRTB/^S-W^M-<BN9"\3KS0P.HS5H
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M"^B#,#DFPO;ZHU[DH&AC_\S*6J-#'X>--+D9568/NSXD> %,TT%?K[T+S;M
M[RDSH.5;;, I&4\["R^TG?\38KS$E K\#7 7B!";L"WVPP=TY]DM#MR-F)&_
M7M!FDV5P"[5ZQ_[:=@*QA%R[DQ%&6#GB_(9$_K&_Z8@B"/^2;)G<.GOB+?SQ
M=#^EB#A<AJ[@8WS^F@&>T!@N-+@RXAQCW2*L(IT&$WX +:2$84!1GUL@YQC
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M..*MKW!-=_:I/O.8:M9_;HAK V^-O$)_UWF]?"0R^W@6::W@;?#8W,PC_)@
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M<!W@@UTJP4JKWUA6+11CQ+E4#F-2*>'^/RI9^\3)9^!LAHMG+*UGIBQW[W'
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MI11%;1[Y6?97;90^)R;(5_N#_E9T>M3)#5MZ+FU+.P'5B5( R\BY@V]@_[;
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M$)8I@34X$T_U?3'\\?WHV6-=MMSCZ!!6A%GNR+ID[3NXI903!W?JOGM5Q F
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MJCS!)-I/W^K3'KGU[N=8&]MB3K:*Z39[3LPP!)F6$5*E4")9N_!:*\ C9M8
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M;TXWV">%71X(.%4\$D"8Y*IR, S_KCL/'*6>]\AH$6FV,E<@PXJ.)&%]1J;
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M;WK]9"72%@;;9$V'%V*9>VD?KZ"](RJLA[ZJH<=Q%4 \[/C*O;43V1B"SNN
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M)!.0C)9(YQZ@AAFB2(G?WUK&I9I0ZE+211/U-%YAX1.C#R&:98#0"I1A@F'
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M?'2XY*H)U03[QX45%>4)@6??O">8'6BGR<>/FMP;BCG%2+'<L0<_>WA3PEV
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M_NN;=+<V+UGQ!PXW@<$;U..BI&P0VH4QFAEJR_H;J.:H[#1VB'M3I&GW%,<
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MY$-%?6>J/X!3Q/\>R7[![1?<?L'M%]Q^P>T7W'[![?^&N$T"A$V<#R;8"*B
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ML.GE -]=IEQM2DX4/[J^,[=D+-1@Q'N2;C:[.2?XW^+)AFR[ 5_/HGBS^XW
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M%>@>>!U8G=:29WCGZ[SOXEW[3 ,9T,;[8*7N@N@=:33B1]1F$*>8M/2'R!^
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ML.IQ<I2%=2=@>E!S18#U*Q/[=/[1ZXHPZJ:0 ,O&6JC"R_.)FO+=8.1!@_8
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M9BHC1UW;*&21K16 '&%%1TG+K-%S@"+<2S:73MF!Q$=J+6B$2MQV;3C/6=P
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M=]]AF[%\.:UWK$]]D=&3!;;#S&%6N%RY>H9IZ@'-LG_D"&./E96-('$7!NN
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MJ_L<B2M',KZ$WF2F[.D54.?:IB+>%E<C*?,#QPZ/Y=I I#S5 L0Q?RAV#.I
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MDI$J2U%VQ+O80DK/N'IB_+SKG;RGG([*ZG3_2ZSBQ/NYQ!^</K]/WN%KDMS
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M;T>=DAZ54M4XW;:Y:^,,DD9S_6U;SB,83VEWN? X'%C!==W>Z+84XB?]_.%
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M;>F#Z"M*I>Y]RO%])WD5$>QK@S:)Y\HVK&F^<.Z$]Y*$7VZO3/X6/0E(;Y/
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M*$G8QVQI:MQ+4@G).N\SG)_A_ SG9S@_P_D9SL]P_M\+YS#[7VU^>#>%+J.
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M@S3X5Y#-Q7V!X9!'P?"*E_,H?TMGA D_F6U"DI9+N,E-/K!US'@'2%:$WO(
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M@-.!-,6XBCOSUC@0D&_XQ72BZ@Y8+/.XTV7#73;.V_5P>.[]O!IWK/-G->X
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M?C+L^UN?,C%OL@<:F@87)'TY<Q +7"%CPOX' KZFFPGL)RUFH=_0-9O]Z.S
M;G3MZ.":#J8E@P@*XR<87@5O^G?=$]@^E]%25XQEB;+W=/;7]=354ED.[!^?
M_80?O?'/S'P="3Q(N$&JM$),3 FPU=RX3)YA*2!4%(_30,\C\ /E.?H-8#E,
M:\*\W8"Y#AYL=4^021J$R^"D=_;/&9OR#-PV@BB_=+1W\;X>FKVYM3PFGAL1
M&U!FL*O[]+PUJMV&L4((;(YQ6Q9L(I.D2@Q<'#G((?@6Y$[I9IB 1"DYP=[5
MRANB-4E,J/.4@?*"GZ=\'<G^5E=GG$OX^)%Z(G3NMFS*A#)LPK0&V^HXB=S:
MB5,MC3_@>YRL/^GZP-9SR!IW4/*"#%2*6DGP.LUK(@6E?4:IQAG!G -@<G.Z
MJ]E05C)#MUAHWU)82J&;*N6:U]%U ?OSPZIB1/._U+ ;;+;UE^4'GAJ)BC3G
MS:/))"F;7\UY08,W$\9?23GB9$5L-W<SPTI^YGFGRRX9>X4X'6^,N$"O?_J)
MF,K0D(^MOQ0I[YTQ2T^Y6H-%'[N,8)_?GO3.>"E5A$-/>7<73X1;@VQ4.Q;#
MXFXW/YC&(FBK<2<E_8Z*$"ATHEH9RP@#!^A\ ;"485-:G,S;*J5IU34C1_/6
MP:GRZ&?=;BUS5?,.SQ\772=56':YN!81]&$.!6Q)?41G3@4@:IP:ESR-6?I^
MTDE^*EM["TG*I8#?11#[$Q1TN'5(U_G%?,P$$;1JK?%L$FH@CKVS#[91$UI+
M9&QSY C8?7]9E"JXR;0^48W3DB2[, =U.AB[Y,1E=$)+1=BV$<<7A-YFHSOW
MQ_Q)J79QUDUN%CUV*MHN4=28*\6C-ZKD-^),&_G;[LBAVB?=4<HQ<J;XXTM%
M[[%RFW/?WY3EK=;?]_;F51="BV3EPLD?#:ST>EO879KBMI%Q'.0(\ 0Z2P8(
MTG/WFJ\;D&LV>>,;LZN*I9PE)\)%!N*!D1_HG*:JFC,)M@]<VW@.OA+N/RH:
M;]JE+1J9(7]DJW%X>RP@_P*,+''34..:?@'):ISCK"QHPU];4J5EE$6D<$*_
MF2)*Q<$XZS9%MUY+@O9(3%P(4H)V_S'&.1\S^NLY@9B=P;.1 49P\D*'S7A[
MTJK  %UC41.;^K1&M"4R:F+W^\Y9&W_(KNQX)([TS-_ZXQ2JC8VH8?8<^W@4
MH@='RWV6,-;36/Q*TH0NE/4"BQ;\\0'0&=7_E6&$O\&T9NQ^'F&^/ARUJNF*
M-HLDNG=:Q0;3K;P,NV=U)JSVQ 4+H/!;$?/D%D)%*V)DK7@/GU=>8ABJKO*E
MCRC/YAI8URRVJDIY6G*\"=I&, ;. &OHK&:)+I;22G,)_B+>2;!+OIC^_OSY
M"'F$N?6>W\['Y5.$RTUS)<EVOU>V'>IJ/NKT]I[FC)4',P SE&-\::&3%6(0
M*C5)XI'SX:^&A@@3YE"M')_,U&.^HE2@OU9WAJMQJ]R^HK..=)T]U6E(I=H^
MB"RD*N:OK9O\V+OZ?=:Q;I[SO8$FD7CV5TZ5"]ZD%5B%"FL.$PPF>99@@B()
M\A%0\R$C-:YQFLARV0"VRFVY^6UK8@8-+%PZ2[-:C =U>\J_?\[U,0C+['6:
M$5]L<_\N[>6HU_>+)@W)LAADI16JK0FU*LK:U3C,E%F*AMJJ'E(DOL]1<06*
M:21D,-=U(LXRCO9PD!V(%LKYJSS #\WS>Q-D9]*_[9HHWX)L+Z=?='A2B0I[
M;!![&L=_U#]GM.L583+C?^<"T+;_PH>=*!_W# 'CCUZJ<;-^=['TYA)+17^$
MS;F9S>GVI63R07^?@7 EJH61PY(NU4,2E:0[F$-,F?=,P)(%,'Z?-&F4CMGF
MP9Y2AH;T[2FS@)P<Y]A?$4)L^1]#97M7ASI7LG1&-UI'[I9Z% <B3Y\C,\PF
MDA:"156-F]@MC6"F%*3&A5/2:B[FRRG]MQ0,V'V( EOY-(9-19EO<[Z8("<D
M(7Z@9:L__PK/V\4_HSR:H#$L,4=V1:^I$F=6&-]2[AYN]0_4W%];"=;-];/!
M"*#5)@:+0*();)8E5?"KLI7*W=@\VTE4/*8S=<Y5FOTF39UR6TF_U8):UK5S
M)XRGVW[V!KRY<&X(M/?%J] +I<?#@E;7PO1U/3=8<H+N@-4[3T3?4H;%B6:E
M+BJ0Z#+-,(D*^K#Z]M?K,_;]5@LK0SB,2]"6;%H+8/P&(7?-9/A]!VDV1>#Q
MS!Z+1>G>O:*&S"#]]O&HP.#&R\0TW@Y9F\D>4))6NF5V8AW:J7=!\0-4C1AZ
M*C 62DA$=9C=?-"/>%6R5(T[$T"#O[IQIPQ]G;>C6L7F:O#AS27T[ %!WJ)V
MAFY9W ,_:*XITLH=RGL$^32RM<\QCIZ&NIF6V9(FMRW0CJXF-\O:"@BG.6F%
MK G&<%^O*B1)LU%3U56W=0@.NL&]1P=: 6YFKDQX(T\?E%QEKH$E311#U&"X
MUY19RT'<V@WD^$1D3U1@1!-&H-3LH&)9#@<?$1$7BTL^7O75SYXRB0DIQ =V
M>B G7^&J<:R@5=C:7L=X1J/>Q@O+\;6$"?Q3^&3",G3-6UBSD7D>;:==FX"Z
M6DG+&>3S<I;AL9%>T\CX$_11F@G=X!!4AE84.K)F^%^<A4(DEFJ<Y@DU[O67
MP,2Z("Q5?,ODES_&(9[8%-B_&@XR,(?2<%?=B!::,6A@9)9@2APJM6JVB9%Z
MMD[I4N<#/R273O'\[HWXNU44T5\*&VM^F7-B)RZM*X[0+8C(,^\^L[]2N(9.
M:5EQO+\O3/ MES4]W;1P9$\""Y#>QY)282MK&6)4VT&2LH!GQ ;^&H(&3&Y6
MXXQ10[J?G-C"RA"'!YT8%3NFVRWCQEFWS#M4BO),:Q<H)96Q6,Y>#B\69)=.
M@-,'H \L^[=8IA_Q'L#,-+721X,>C.HX#Q$,,"<X ],:*=6<)KX!/<%7:?_V
M@X*9>F\$W=1C'R!Y.J*8(\]10IY4_L8>[SU:[7CA$_,(E]?EM/?-U/A3Y<()
M1TR^M/IKQ$-U'SCED\:O(",&@&)#)X/&04BP;QE=(BM/@'*&/&\4MA,M:W_K
MIE5*C.%0N4\RUX9\('7"CF8\^G0 $]QEU[/OC[BMZ'0)*0FK^9 R@7/UDY+_
M:H1+P0!?.'/WH!H7(H2M:(@A?XB-934#[HI8U7.3YG9DJ>IA)6M9&'MY_29,
MG5_>F!-MSD[@LG3I9P0[GT7GM)3)WNH<;D<\"NE/3O0QO@/SGDN%Z9VO9( !
M\O4SU1IL_$YL?%_F1O3%H"ZL"_HIO. CP="T0JFJ= &BP0'%:=CW4?]HEEBW
MTM^:JC-$3,G[*N% ;4=D42?BZIC"VU'01ZVI3F<0@EU[:V/DM:J3/"LI<74K
M87J'DL)\2>!6CR^\Y,!(-=ZP'^VC+/PAU025 "M<XI1[/3E4LMLZ."0?L>ID
MZE,=@)5,$X_8 CA4X&25SO,S:F.GSM:^W;W?OBI9T!X80+_@W35AYW6DL]!C
MW@O5>9J/=HFGD#4+A^X\[."'2L3. M*SN0P>66E/3V@D+6)NI8_)>F]B+NJF
M 0O*(_B59UCR:& )O;@Q:#/XFEN">'3,LI/Y>I5WRBM5!WSP8]DM"?*-WE\$
M.OKT_KIX;%II"#3T$/1X)I'0!0$!/#+5+QGR;%;&6<0!34!%S TW3<:.]GJ+
ML6IA@7C,-#G>9<?0 /':48>2QVWEZ6\U!7-/1]@Z4:0WU,ZW,*=QWOC18X\B
M)A=H6,.7%L\[(D;N"K_?X.</X:534BSS(R0&[>A&M9F=A&7V2^FG05HS?_F(
MJ4-A25"8T\7"'U"K"I"<\GVO)=L]N=GA8DT+JZ2?SFZ(J3;MP1QGBMOF.5V!
MKL)R8,PY"]XC6IBV,E&Q29]^%V%+#.[AP^OG6@GPQB.M$SERCEA'<0VD8+*'
MH'@!/Y=-I=>OAZSBD947I+''7/:'HSNZ>7X/@T9*O^^R9#==GKM!) YUS=A8
M?]MI]U#Z]?& #;R?!ORO,$W0)C6N.A0Q&4.U;\K9 R:*4RK,;L/8220=LE1S
M(GIHP">%5.78)$GB:QU2XV0?&KP/T5;0R3+'%Z1$-A[9#N8%;F\>M*SI=EDY
M)-2'BUO\)Y,?TDN\N91E+9(5+IM$!UDKF%UH-[MJKF4*_G(*T7=^,;A%55Z_
M^3CS#:%JFIY^!-X.BH*\\7Z@BMU*2Q]TA=@LAC?X7C?""U1D9M\NN@H.R5RY
M3R&/#F_;N>9G]-5V.L *?SJ_U=0AGR0 P'!'Y-T8VKEAR$?5]U4QLN9#"0<3
MU1%LV'&NQ<))M#==Z4H/0+7QP27(Z<P/2M^HDB-/X!SEMO#L<[4/O8N.OW()
MW@/NS8&\;XV+?@I/$BMF9P:<13>H9W<ZX370WPE@= S&7%]X0J)F/G@$?X52
M$=HL-***!JW #^//3<;GP(HFYA+X/#[%QCXCX%LX>@AO[ D"+;Z"6%EZAN<!
ML.T=4A/34D<^4)DX]2?$S[ /U.Z,"Y@$X'5SB%&Z/&NBA+/0#N1I]40Q.+87
MQM2UAJXJC7<D6N9SO5X?K*N3@I0FDC;5Y*B;,2UMT##[^%2DC>E8\ZN8I65%
M(UESZ*JZCEG.$KJPP;3E@0QSSURB@%37@V2@0E+?O!J'6*Q4G@_GZXI\:Q(P
M+_!A:X>I<6NBG?=45W4,08P:G_$*XZRB$X/BTI5C2\)2I:N8?URR00OU*NZ'
M'_S*,U)&-?#"P3JHMJ?2 V&H[I*DPUYM 0H?>#\-JE \A!\I#>G64MKXE#0R
M:%0L:!B!MLO=<ERY_.MN:R5OPIV.<T&B8$IW!+6$A"E'K6M#ZI,%$#5FGIUL
MES/AV>Q$&%3C5@-GA+"3HX(">\OQXI)&-GAH*E["Q1Y[<=B<&K>B_DMF:Q50
MP;]Z%L'+;;9UCIJ'-ELLAX/EN>X->280(;6L,L.5^*$CG^MSK7Y[KUV=M=)$
M4!T<V!-9&3&YO=DT^5HI7SI-2W88M'S:=6XV(T"QMKX+6>PZ6W7'M?>.O*]>
MCSY]A%??4<B/JGG670!NO#,4Z!"0:Q32+=G7;1^PXV#8W.5*3'V=$I&/5CE4
M.XI$#HJ+1R].!P8%!7J;UY65E?$B[9O;VIK^<7,7;<F^CVUVY4^;32MJOWJT
M=O'T=E1+@*WI+M@9^XZEC?%Q]!C%K#$??.SB7( )"7WD(MC"N63[C+V,<02\
M/S@Z)G?]15R6D5W_7*:,7->+-Z73#E<]8?EV\U:7AY%-,V\6P/'>7CN[^)KU
MRQB7L0''L!AP?I9FCG;RG_(GS*4 O!%+-(;V0RV/I*Q^#-\CL*>,G\K7YX=Y
M6S?6KQ.YD.0^J4[7T"WM]MY!\DB'R=?3WMUE,QD^+^IQ%:)3Z2_\XUAI/&\I
M:Q7]/1^[;6F6B+D1(B(K+%&]KR&3AHP+!VG7G.:::>(N,GP:#*#'KSH-)B!&
MX" '6B?_AANX?O0IT+@+#!H3&#L5^.>;YG*OGR>L\'A@2SL]CT>7O5O0\0T_
MHG8+?QL-$9HS,0\#CP%7)9I J!=+BYZP!W1L=);T2:2M:=&TI.J@U9 PS0YO
M3/<Z >%343T*G!S0NX5!*1[+,LGN?10';*PYUQ50V1WMZNC[K/O<%=)._ADV
MO F/&')0K0%E#+( >Q30$(R0P0J,.9,G6 HU3@]M)57Q&R.)^T"R@L^J! Q>
M%>P"Q^2#B8[)]>94LL6Z'AED(ICX(@# PQ<C*3LA8AI#ZU2VJ'DOE%<FI^&5
M &(<@VH[*D\SB*J'P"D^O$&"&-P?DLU=77BW',FM8RJ'/C1[&PN;+ CP9E B
MF!,%V'-TX-CC3T0N6\OA-!2O35?ZBDY#Q"3>\:6W9<+ENI:[P'-U<K;IL)A_
MC>D!+[3 P"@AO@'MX1-(P:PT D;81B1IZ\1B&1Y+L^-!SQ;^<CKM6]6O/'-P
MP.^J'; :)C:YV59TE:.K8?<7U@\I8^+0A"U;MHB:8LB]QN25K5MTPC;6_$SI
M8L%;",A*?L/"KHMBV 3:WDBJI#41^W44M:I<>_- -2Z4PR+ASV0>'Z?9!TP0
MFN;$1TL*J9>G$G@!Y^.*6V7.;3Z-IMC-,:)E<;$-,7/^U2FG64V9*TZ$7;C"
M#$>"X..8$MT.-#A7DC28'7EZJJ>,!2<(!5M80WB=XXRSJILV0"BFZ0Q:_#G7
MHLT& JS;W&6OZV2Y2S^TB*]E5IMD.<6]?R3[8YS(<S7JS1ERC7C!W ;VIG..
M#;.I0,/O-6I<"F-!0"Q2<1"_X'OP@\8:82ICI?+KL?FLQ,FRJ3(7;UFM3;#B
M5WCQ0_C!+M'$R32=6JI=G.F'(UV\(S27KP6ZA?6/+!X87BSY,6&:I+@"?\)N
M&4OZ&@S1-8&,.%4^QCUM$M!/V">25146%K.X?95\F,PV8[AB7&L<0*TWZRIG
M[(\K@+<+3#-S"\. %;:ETO2FFPT0^V"F*/#&5-.S8V'3=FY:*&NVSEJFB1AU
MH5KY-K=81G0?F<G$!Z7UL5$'_4!/(WX&;U$(%/NB5UR??NE"9"AC/E"4AJD3
MT\3;?_;N!Q["%'+/S$9N9F2HH/H&#>=V  /^#2I6X_0!+$GI$PJ<"..M1?!K
M@3QFPGJ(I,W0!:U:B$D4;<0/BMFMRG$CC+6%6#4167-,??@"-:XL/%5*2%IH
M%(4X=[F00F-=)1FVB&,,M2C"V#1D\&8<@C#HJAJ^]*X:MSA:"']):!#VYP@H
ME6=2P5B%N:JHZ+DHJBY4X:S*1W3D@33W.MA/GNO8Q'3HF'&-D66F.S81U]"+
M6\0MA4,LBS[XJ"NYV:F<*[<);7+_KO[2U ;*&![5NL:O=+NM7,X4\O%_M2U>
M0H'-%-=@HG0878Q\FS1ZC';6A?*(853[&TPK9!P$)Y_28F*6ULFFTIAKP/<9
M0V.ZX1N>!(@@C1:[.,(KM(T[A0D8?E^K#)C8 05@<KAAZ&UL:XUG*A!,NV[*
M:N$G.;BMZ'%Q/9D?4?]5-[+Y(=TMCM2:*18F<E7NA\%Y:O8OTX((F<JG<3Y-
MLOY0?<F&FKK2*X2[!/ '5FJ]!;T+7>:M#(=;C\:.N!C)A0F #L];EMPS$\#2
M'665C$F,W8Q&V3J20^#4C4J5U;%V>V,H6I28,9A>1O4/38\JN:_82E4$;8S7
MP8)P&&IF6\/6XWV1MRE;/M3T2LK1(::4VY9QMDP6B\CN3TUY(H?LC!Y%?L1Y
MVWNV%A$18P.O?E]_)NW]J#SZ$N7C-*K]5.F*[%)5KU?]#)R*M)+-#I: !#EI
M@B %KJMQ5?BFW N-5<RU<(QLZ@JIXF)A!+2#N>)-SMO@[RZY ,K=B'L7SUS*
MUK,ORI%'6KN#MY-97,!XI&/OX)HGD.98W?_TX*[_U0MPI8 _6"'Q"]%%HOB%
MTM^JQGG -_CY'L-N"9_(TR+,#[\ ?B>B6G%J'-5#=1>8H:2,S1L&)0R3;L<=
MB%3CU@NUYC](YME[6@@M'#7N!S5N)M/F;]\F,F+DG#YKQ7%H:B)5QA^HQ:;2
MJ<3B90>Z!/:3D:X1=%V.RX=M9FL)B:@YR$YWVP"WN(:^\+?OJ? ?SK/OC2:E
M^;^M*I.+'"]7.@7=N=\WO&V8JJJ:ETP78A:[58W[Y<^%[65\Q8F%8Q-+M@]%
M T'V2#+0L!QXMX,$GB>JLDA:P.@_X+<[+;!42O,;M(UBSCB)_7+##@![D@1@
M*1*H_#8, 'T \3.AO+6%V#_74&,C22<B(6"7GPA=36_U@XSSI0/.NGN'L&C2
M'@H[FR0R/&W*\O(=KMY#W+MG)SR]W0R?0GLY#^)VE  -;7QPGPZM?Y1X(VB-
MZH&DQ6UC-V-;37(R/U07WY"')>M)R;V,4)<+ ?T,HIM&SKZ P.U-<Z8S5H(A
M__I>OQ=XZUUE?7"C&M<X5W.N.@ZL1DRJFP$#3%G[P)M]$ -'=)GP/&303%H.
MA%#$A32F#;.# WXX40L*K]=O&AXTJH60/T UCMQ[*DDQ2-$^/D+"<YW?.N_D
M=W'-OYAKN=R2*H^+^:Z^V\5(YI5K-1M[: $&0)HQSVJ\4X_']^E(@]BR/UR<
M39)DD$5.X:A"8E1F$]ET9N!0\M#V"'WD2%:3[_[E/[Z2FTE,WH[.7]5W?_Q6
M(G[S=N#U(I"-F(J47V+L?9=TFL#"?-*5L;4.7G1!>0+MS-L$B\!I!9T/*O)E
MSL(D"AYX-FX7N"Z KSVZE9H59(B^K8F?%^T&W[5<+3ZQ2\K"PY['J!^J139G
M[5A-!'B#"6*DQBG<5;^>7CC2'6CXCNE,#=H"OU.&,264:I\FGR1@Z<+)Q5?=
M=+L0"O038Q-HDEA)2A4OPN! UOO79Y7!)*EJ\A'DLQ=DEEQ@)ASK]1%P=+U"
M[B$[>UW,'OK3(V8IJ&XK7 >%2H43OEC$=,6F^F^TO7E4$]G7-AH;%14Q*J,@
MQ!D5(6W+T$(@3H@T8D149M-**X2(:1N1*"&E(D1 2"L_I866.#')$!$"RI (
M2:!M1(0 D2!D:@>&2$4AE*12W*+?=]V[UGN_[UOWGYNUBK5@A3JGSME[/\\^
MM0<?>KLJ-YWOSL 94KTW^V+'7JII-M2PUP*5?"&\M5:+OT; >*\8"<OF+LF-
MBWOX2>:<H@A'?0%[*_!#CI)D I7 >TA+WHT4V/0V$OHXZU#A*Q \!9HYJ0A^
MMLL?_:'(3RE?QNPC?L?T%(SUEL@[J5N\UX&^+1KO@(,O2RAY)R>*O@JGH\6X
ME?1@T=$IFM<C]UPVV.LR]?QX<>0+C'>M-A>V'$46CNLOH*136$M4<,E/ $VX
M?ED,KF9#F;)S+-)$]^P-(PIDOV"N\\!F3<0!2@W*&:UV]GE;P4$0+:&4GN/W
MYH/-9%$.51%^J/YVIHJ#\U6.YM\HF\$$ 0N]+>DF"EH+-XTSS]LB9C<JGHN]
ME]*-FN6+O5=",;%YKY\1O!3D.?2D V#=U9J=%?3,P%YX9UF6XX[N\BU[BRMC
M9055P#_)98=Z\/CU>2J2$ MY."A9+<1K1' O699R#+I;1&=&)BE/S[Y>3P!9
M(IN:^N2B"B4W'0=6PZN5S\*%5G4O;I1 .2VH:Y5.6 \4#Y3GC.1M>%X:/M":
MFTE-I.ARQ[#ZG2/VJ*Y<\4#^)O+P&ML*<@1G ;K@WDP+. 'BJDI/L0[VN9*7
M0%$*YQQU4Y)86ATQLL:D(CX4?'^U8%5/V C2L:[7^?.\%Y*==*=+1$?B*9QF
M!C,0A"R)-M0AQ"% )%=(83.B[C1('F.#W5\-EH[)GBJYV)(E.H:_V6]%DR5X
M>082<8SME1&[<O.NAC'X%JPC/2[ZH(?#6+TK:H6:?T0P=!:R:)D2Y:;,BE*&
M?Y/A0:,I>.6C@I5VVAD^$@6 G?M 5QD]_<R:;A0I/UGEI:67M+MG\ 9>.I_#
M+1T^^F4H]F*6J.\W[XKR633;@]ZT3&#BFFBXBIH#&=-;DI &\?ZM&_J8Z0(#
M6E)&HQ\C+ZU)A<>&0G5!8-%59^=#^][7U]AO?@*Q5([)_H'=-16DD$;ML<+'
M6X(^!5]<K-'?T?_"[,=53XU9Z8ETN2[74 C3J I.&G\AS^3+M4K83XU='BG^
M569U"3:^[RJN&=J@K4LOJKUMBO.]$G(B>R,M(>O$E!_X.:=\U.-7XX]3\$JL
M/ABV,=P"%/\!>.UP6(_+UU(8@+RT.!T%\E=24PO"46;'. @U*W!F]/B]-J</
M4O(>BQAVQ2\?,W8T\OD9K2TF@(EM8!EENE#WG^YX /0CO]TF1F:#GLP9Y@84
MTZC^-+-/>6UB;'^#FG29Z1QS,.)=S) [2+M*I!B25(G7SA#,NT<MZ[[0@5;F
M/! O-B$O?!<>^38R_)/]JJZ3->$+G4[??(O$ ,W$V6B/; $8(I"U-9/!, ZT
MR2U?A3-AS -[D3MJ(K0A>(ST>)1,[2;@%+\T2!I]4/ ?<LMHZ=Q76U_;5WGZ
M'&!+F9]DS6-GU(L\W-,;=Z\C+YK SJ%''4.:ZL_=PZI9R)+?#7F($?(2 '>3
MYC.6&O+Y%M!NQ7B+P 3IPRVPW0<"*2XBR=B\]_)49*,7PBV-\ PH&:U'2C>7
M3]==2VCO\ WOK<1P @7/\S]R1ZE*+'R3G4;6D6"[&4R)[B[Y53%LCZ+DQ@P)
M,#;&- 5&G+0_"8H$5XE??O)> ?03P43DH2P! W#<9Z- %C4K\6^ER"*4$,X3
M0P\+D5< ST&3HPW6W3(\G;P;W@PL(4;CT_)0+LXQ@K> Q%:<;/GG*9&WD_87
M,%^#%=;1M+8MS)5O)O*!)7]]Z52VQW#C)OY:*^G#?=+KC%"<R1:<9 ^8J2?9
M8VPM1S'>.OXV2/=0^I[' X.%1)G_OKJN<QS[6*G;WU$@-PT.)%QTNT]1.V;J
MDP](]KTAD)7$16PSZW,#1!,YU7M]CUQXE%@%5+NWT?J)NAO@^'7F9G0IER&+
M&1%@AS3K3*.G6FX/6_<RMG*'I^1+72IL]_8Z3W2:CP[9_. TE5Z.JE*,^\VV
MTG<!P/S\Q\-?EC^)\&GXEH3.LXTQ!ZQKX3RU&GNICQPNHRG&96U*O,9/@5O(
ML(3NWEM?P<H.VO<<Q14V<Q4YICOV]Y".TL%/0]92V+8(:MOE[GXP!***KH2>
M/E77H/5Z7U0YQW#]Z-&F2HJ]]9M)SO+1*9 2AF75W/6-Z)OT?- >5TRQ"?A3
M.GW+(%S3L&#+F.;#LS\>5R]0GS#_TXC<(KLU5*WD+!FUFHYK92<__G3QZ,.D
M1Y%W3/MR$Y*BYG6T<GX[55?SG\Z36[BTK;?[9*0?W.1S _Z0ID'CRD$2ZN$;
M(3] ))_,SCX""2Q6X5CG_G"+\/\8>U%ZU37+K06_N=LDOY307O9'SDD>3RS\
M>/I[_]4A;XV^):(+L6^"RDF?P<P!:)T#G6)!%)#!J:5IVM4:6NOR 4)=D#-'
MF;^ 0#D9=P$@N'V)",!=YV^%]SQ+_XYPHOOST*=7SK0S<7')9LB2LX8\O@?4
MYH=J:CPR()C/7T)OT.5T$14<'.]DKIASG5P]GG*.*K D0^W*HD(N8YLVK51E
MM[NY]KQ-:MLU%]/Y0(J6'BXZ).L?,8NQP8J<2)$]YR1*?YQY[/0/J/WC\!VZ
M$^30NOUAWISO;^M?S&!JY*WRQ51MNA-G3,:30:36[UL.F:077:UEJ3ILU.U-
M&=W_I(M*S_3])AN,^,:&K1K$'',B%0]M0I7!$UD@(8I(YO!6PRU![/UD;;0N
M"V!YO)>G,4YJ=_N A7)V$8DUS:\V=Z_] AV2^('SBY.*8ZRFS]^_-P2U!W<Q
M BJ'<Z6("5CQ^C]SIKS+9KL+HK-<Y22(+F'^""7JL@$K*#\0_'O$WMZ0/T&:
M3Z]&;' AVD=='7$G00&R-+0FE2<AD,YR=S&\ZWMU3POF7+ Q/=/>:C5DW21)
M:!A'42TE; ;S"Y$MJ,X=2]?.8%32-FZ:NP#C3*1R9"0QSH9OS^ST8+%XV(5#
MC&T0XUR[J=6^O/&6^NMA)SM3@3KGGYMX;V!/;Y1M[5;<-6H)$Y)<^75QQ</$
M\R-$D/817B8(A(+<FY7Z.0R3)^ _!7:9PK-T]H'NR21:1E]MK8I8/7(0/N4A
MXEB<U)K_MGOE4RAM2CQUD7]OS^\CN8E]=>Y'OR*SI9*?$ZV86QA6AL?_QE*!
M^[C6\"&M>^MXBOQ)G?A'E>$.@:H.H(9*X7 E/NTHLDX*?^=M$_LOGZ+&/8J9
MY5/4++S0&^53MY3DQ?02>#<)&S'"_)=/7<+=(H,_S8;&C+'TW[\#FGT 11'1
MKH9KR?C-4"V@ 0,/53@A+H5<+7C!F?^6+E#CX<V<.73R'BC_'@>+74:U.<93
MS&"N6M47BYVL6FPJ.J9-HT*)6(+[^MNI6J,0\/Q]BI+;2[-&G^0,^@0<7-VM
M<=B3BBSZJC=&>N55EI?UNT8*[&R<6?KP3][?0WX*_'+@.'W 5\K''8N5+W-Q
MBE("8B++RB/WVD3%DB/2\HE\FE'8LM(8_D;MQ#'<\^>(])L#LOB;(0=9#'^O
M+8;-62)D#6D)Q-9506;:(5)_]4%^05\(PT_!3NU;/A*WX7[1<&YW?H=1 /10
MS5X$I<DTQ35I.@UB4U0PM<5%_\QX# ?;84&A$B?"0FOQFMV5<("$0'1N NO)
M::@>^JA,PR*])4=!J8@-A?*7@>_PRLQVQ;Z>1E]E5I*HP(POT?3Y37I9A?=4
M:-3^/%Y##<;0 ?F"W!=$(V]SV 7:!!;OLK>"CH.L%]Y8* K\*-Q]N"^A63F#
M^0XR$TX#J;## U.J*"R[2F4:00E;DGO\A*M7_-&>2=2\KM6$W;Y_X<(6Z?*+
M=HQYJ"-7K,UE>Z\!FK<1?\;;,P[T.+NR[2"ASMM0P/!5.?VF^ZC)8UT[PV.G
M%ECS6:*+A5+9F>LH_IW^4->7$&JSYWP/K=)_()0_NH]IN(?]^G V]!EH#B$X
MZ&W0/=L%*)YQS&L$_6S=(\-3[\U(-Z?V0/5C^C:E8.P]*#FLU54I@%2^,=2L
MWQDY!&6*^5L*S)+O0Q<UR!HZ29BW(8>F[+</A3WC+#3\.W//FV G+NB_ YK;
M@*=M&I9VNDWG"W6!B>K$,0=](/6+3 ;AE<6:]0\'/M63V*Y)^0E;H6 A<V.!
ME^W!&NTM,6QSJ^C&/4C0<LR"/(MEI,7D4?O_QC).-?'_QC+^9N9_85DXV-OY
M+Y:-VS/^Q;*WQ^ =W1-QMH<;)(0CE5#,7_C&@*A[H],6_U2-))J1FXMC\Y)N
M_@MEJ .?T@K/ :M;!$^Q8QWZ2(I*WBSGL5K(,O:+8V:0H]9]AW\X=F513OP]
M^E?5/%W6AM)Y5Z?O]F4I[R8URVC7SZV-3YC'3FO<M^YV:XPS''"!4G9I-BFB
M.5'PLSQ##@9V0AO&Q9W] D4"PC867T@8-X)W@ =N< .HQPLAP1'0K<'^H</5
M:"F>9^HA%.90+;=%9MJ=,51N626X(I/I-CJ=>=^S1;">Z0((7P@45?*E@"*?
M.0?BHD(QCF[( MC;P!90QEER'EES5BM4%PB4IFN; ZG /)<9#&^0[J@X=LNY
M"I\.T^Y!W1\BP]K\M!5]?YP^A^51\K)+:4F%E'K>/YP^;FJ"8U.TT'YE'WYB
M-,M>?^1-S=V]4WX-/]@V.8_H6H8^J$G/M^VD;GI6?3NX[H]V*FWUS?_"T&^-
MJ#"]1KK(UD2J//L8*JQ7EB&B@E4VON).V>Z6;:B4OH>J:+2*?%*_1.?N5$Q,
MKW!VC5M1F-TN(ENZC/[%</"^];@_DI)7F:[&+H'P1_1SB19CKA6SK=6B*]QH
M$)X+F^?A!JBBI_3K_T:2*_(Y2_$$G-Z>;G*XKE'2N$U_E"E!;/CUG'!#48+)
MIG+-&2[#5FE;=3^2_E/KYT_[/NX!#W!**-/K!SM;R?-'B7T.!V[!?]!31)R:
MW$PBS0]07$$M))$]C8?-HA2X,2/]>@BO<A!QKO<)C.#M^MWT&8RH8+-V3P%&
M"A/!43\)LAYJV+^WVQ58 A]]0SC)A8:ZO\C%8<775VDSZ)D1_-J>N)J!3H%
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M9?8KH$$0Z10!"PD[" SL%=A7(9)6,.(?=5Y0:K"A((M]CF1-N7W,O@Z<>B$
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M2-3145'TQ,Z%MT"^LTT[)805BG$L9>25T\2@H_"$>U,/?@/^0CE5)NY_WD=
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M$-T!12.GBJO9JO^)L=5PD[\=>>EMT85L8IPTI "H-\(2\)@W0&(PO^[-@,K
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MIUP.8ZH,N7+%(_[2Y*36*+4)O;1&<LIU >S-GT.;A\-^*SY;3[NVJ>0; ^4
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M5\*FST5Z?$LT2:W6N/[^UQ+F0")<AK*+B;:09I'P[28 ,ETW(9D,9*9:J)/
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M#%Z9"=G_+FZ.?]JK9^1::!^Y:71:,I;9$JG_:2:["CH,!356NS*G-@7BX:+
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MV',":*;A7L%YTK.;G"RP@2,J630V]"+XE'L-8Y._Y>7CND[%>QKC+UE)Q:E
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M6Y['E#*W'MW(9J2^W)#2,8BM8%N]44CU9YY2_R"R4[;0_YFR4XP1]M4D9?Q
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M'NP7Z"[FYJ(Y7*+D&B['ODB&?7;NF=W%;J8A94.P$F#JW*H<*-;CJ>I5WL"
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MF_E;WU/LILK=:?U5EH]G#Q;T&*%"C7*@G,"ES)4A=H% HAIH8*G=#^?^@OU
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M6W?VF$7("B$$Q(H8H-4KA#38]2!A/"FP\-H^ @N!;_G<8E6N<ZPHS-RQ*>L
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M\>Y/[-V-]$]^SUG:>!'*KR]NI][,5F?]IF8C[_C'?^WO:Z(%1W6XW@(Z1FC
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M99^QRP,;I&!OF)5=UJU)TG8VZ7-[CECPN?+@J=7\8*WHE$2!,/7%-E+]2ZH
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M&Z"%Z\9&)$(O_WMO[V)!WL$HA\*R#S&AA)7&W<A=U\<M:@G9ONJ)W(U#O#^
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M>C<SB,D>QSD628O82E59'')W?E/P);#B43=5B.M!F(\>W>MAG'V0X#CB$&9
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M+QO<7W?_Y8\H$^:%YIC6G\$'=W<>,Z]5@Z21\,7YS(S>QV\RW[M'![=N__E
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M$1KI;1",>[ CB! T&60@+6W7NH.#G73L:\;?SO=&)@TD'N-T>VNH%%O6/]M
M*J@54U"@#?KLFOWO1W1H%F*3)0;2.7_LPD@-#JFZ^T^.!Q%#&5<G N^.P5*<
M/"[$_0MQ2]9,\&6?*ANC##$PON^#4@.)=@=46AA(W]2\AX1HW*>\_R+6UM$8
M TEV1X!.A_[A6BL<P>W/#M)]3E#@7/9:/&5L-J@TD+892'_7 *IU<*3>K)]@
M"@WX54(])Q-LH8_#Q?A7U ^F7V;Y999?9OEEEE]F^6667V;Y7Y\EIB.^;8<^
M'&<\B-=?YR<;2!.>2![HTJFG@0TO)[4\(?>EXL%=N4-Y$7.'')?2YE<]YOMU
M')V8KWD?)*5]>ZHZWW_#K?W%)L^:5YC\PRK1JF$F]/M&7 8/K8?IY!7+<AI>
M#-W*,9"BA35G\F<ZZ]5"%-HR;Z?/V9(7Q#OI_XL7&/H?[ G(?0PV!'GYJ/3>
MC0(XX.K][I/,MU/+-9SBS'Q8;WTF[^K3BKH4,_KSBIHY+][VOUV5O<;XU+;K
M=K\>@;X!*TX:2)_Q<@/IR>\ 6H-?@=?=7*0*FK5U=])/]W_7->_R$Z+[_PHO
MJ>C*$;R-S')SEC5QW:XL[[QR^/J.XU>B7^QDZCRGW\L)V'2RO>27]&)]83&A
MTPD!/KW!0&IJ_>=F]XB#G(]-+3AS7HK)GM'*T@RD/\\82.A*XB/'MZ(/;ZSH
M.E^B_!2, )AQHH&44?COFKV[B%:%@02O-Y!^/QMB:2!]1S!5>"\=]WU^]LVS
ME0)MEL!  KI U)(@P3:^_ZY9542TH@GQ'3>05D]6.>'G1XC&'0&6G:-KN;(7
MT-@#.'B7Z' 9&7?-_N=6K#_.;2>D-( ?G#A*UT_K)LQM+_"9XOZ)O_P.*-\(
M8@;2 :*W[10LC/+/S?_;K,7#KP231D29>^$.^('&''/=N<= ^F<5 /_<W%1)
M_3Q5DD_+_LSK? ",DQD&T@SBH+\YW?VAPCO<5=S70&6W%)CI#X^I%1ICQ$.:
M;_2H[CY4 U<]5B^XV2H\5E$5[?9)5%X=<E*4]>*(S3KM)VY<1?SQD/!9HDYF
MK!MC*1@U9"!]G'H8]?QJ$#GYS\VXAHR6#Z%<QQD94N4O=<><74I6]IQRLDEI
M/'1\P=GHFE_R0JUB7N9M=_%[EFFSXN75#7YMMWJ/S:T^96.5]V-4Q.I7J[9&
M)XF/S!OPI_ :NYI4[R)*? *^O[;FZHKO\Y?]L3<F?779@J:5Y7Y+-X3_[]1_
MST#ZO[002?Y?I'&#B%__V4Q.)L0P/FH%N!'E([GT$/C. <)-B$/^\5E8]]AG
M-]Y*=#PX*3.0OB9*<?6[?]_6=D"#&@ S!]Y2]DD,I)>;0,QJMX%TZ2/C]/_.
M\%LU):!,#J(+P;^^&/W_:Z/_HN8O:OX_5LWZ7$)^)N"S+1C90/I)IP;PZRIA
MTS_K"R(DH+Q@<^WRU&Z,YI?"0@B6! NY2^POR2RK9F:;!W8>^MGSC^.,'/3I
MOERX4.)V9W-UXP*U7Z!+]82)?,GU27(2>@9!UIY?NM*JT*IIP]K8]AR_5;%V
M5:^/\G.!^N#E-Z"FW?KCP'4!NH+2&&ND)0+OA1=XL^ !OYDU%POLA(Y0+D(/
M>=EU_HBW4LKC.F,^<-!Y+Z::G'*&WS1FC5)"NK%-*JI%M&UX02D*AK??I<:Z
M;] XH/KT%\:N#J:>^U63COBB!T2_6PRD5A&[UD B"YL%^#%GGKX(>!,!H4X>
M^NM"J4"_#F,*WP6+=&ZR$W<+OVI$.:7K_OI%;O7HEY1E90O-UXBL\T*WE'NU
M72GM2+;]]>+PLSQ;MSX_)P^3'8F<!WZ_M!<'WBQ]W&@94^[W;&7 4I-CSX:&
M3O55=7Z*5)$Q[ZF'T0D%%G*0>)S"R 2PUSL-I#FO".M?#+Y3>(41Q+)[@-">
MAY6NWH>M&.%;$V #!*"JV\Y :JF#:*/MP^/ X',J]C7PYLWG_P>=4OY%GS2A
M-\YI(US$$0]G"$YQYQA(DG4 _(-@TD-F ZHF4,*2GS=1$+-LS,()S_S8I$#/
M<MT(SSC.J.W8B3\^SM+/Z_F$VQ^'L-J6C^_%7R!^@?@%XA>(7R!^@?@%XA>(
M7R!^@?A_%$0$(/!=(VJ)M00B (@I-9!Z)\F9 F/.9G64:!K>QYA/F\59:\V8
MQUV"GGP'F7.6:)T+HKI]OT-H^7$9N3O=<B=B]_0-\SVA-M>_GTA';?[5E(/(
M4[NR&$B_"C$K$&]+TWT/OGN^!BJ(F:2YJ.\M:T1FTE+L4M?^L<F6:?1T6];A
MC.+ A>C"56]:9G7N#&V_4N3L<GB%1VG\LV3;-4760[MC/X8]\H'2/I]VA'G_
MLA):;B"E'@65EX!Q5KZK@20>08@2,S==WW]#=$+_BUHQN:)\#-LX 'Z.YP_V
MY>C#>=CG(@/IG"\V)7!LT;\^&E#;4= E=+W=8 8$3V+1!M);-11_N_!_Z9#7
M^0Z4Y3#0Z6 +(7!9(P5-D>+&1+6Z];-Z#*-!MN#G1X7_NH+[="8=Z'9U,9!N
MY-*(D>]Y&$C\T]RSK\Y^@?@%XA>(7R!^@?@%XA>(_W^ B#N!RM\H\-9LU&E,
M$ZRH3D7[8+[$P8DR#3Q&SX"FXW;Z#'6V)-O<0(K@>,)_;/1\=V:33&N4-CZF
M2<C=5_O'TSO# F;'^_CSQ^.^V2L==?J7Q,J4^&BZSD""]RAT?H.::0;23=Q>
M^.Z0*#N#79IVOVYS=D&*>O8@>6M.PX==A=</#;7S:$:F&WYI=-\3Y/9FQ;:6
M ]L"AOL^%&R]6.)3LZ>7TWUL+DO-#?_AORE@X1\&4NBC:CS]*('%_)$"#R/(
MY1$HJ,! HD6#RKD&$I4JJP5F@?_B\.Q_(7IAW_#R?]'CP8DSE(]O^?A7E \?
M,%WY?YO]94^T9(#O;LD@>"330'K33_!IRA>,7S!^P?@%XQ>,7S!^P?@%X[_&
MZ/S1&3<9(,A6E?XW0'F=\H!/$+$8Q2OF=K1>MXD#PF.97G-5 7;JH/-0%)!Y
M!DQ==9)L$[/K%3LC(.6-U_''L1/^/[297J6<GF>"2T8^XP92XG7@C14X!QR]
M@RTUD-HUSQ,P9PGFFZ4.S3#*E)5SPBVM<GZ\?>CG1W^(K1CDU,)==8Z[KL:X
MQSS+"SZ1.; ^T'5-P*V\GKP8M\*M-PL#YUXYZ+1@Z[<!;O=RHL/<VN*#]:/Z
M]ZU+3I^,77P@[.]K 6L:_99<RGCJ6']S^_OWDG+/;U?]);EVR&])3OO=O&GX
M=\%4_8638WK'E,K2CT^/Z1EO3Y;Q;P#Y OEN?)\G(8X38$\.=IJ R6JNP9-+
M/P_]ZUL-"M/ OD=T_.E1#[RL_+(M8.V(0RT&4D"["7X2^%&(KF!HO'7>8 /+
M0%(6@?>S);$A#>6X3/%0FBB,8R6?"<]6F;I0)8A"8(6M;E^<*Z$M._"VKFM&
M/3\M+O50JB_3TN[J;RJG:_U] WC&R-2ISPO;P6>M%#A$J'.J9DSF81;":Q[
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M B,FHB4\Z<))@FQ7=$L8O>5:9WW=8$>%H,=;>P6M.S9&6X?:#00^'C C;ZY
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M#&,JO, &QSJ/ JX$@'?2>[MQ8W]XK=I5B"1H]Z%[X1$53T-7^4WTD1MM^9E
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MZ4O!*)E\[0!%G"!,MZU*5/DB*9E*C5&#@62*+3AQ6ZK*C/F0 %FB,0.,@/C
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M94YHPB1!4K@EO]_4/B*PS<M>/:LN[H;X3N[G"L%"CY0Z[]B?M!^#[QN-$\7
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M35,$R+)HNH/<265Z"0(/UG%(B2-*HJ>* !*KP"68(0+2RN%5F UL,93%ZO>
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M,YEBOZZ2;V&]%KMS<C 9#8)4X@'_)@/.K%*^C#_WJ6*&/!Q;MDT!&(Z:QZO
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MM\GX\UX/QP:2;]R5#%^:]>FFZIF6<.L/W%%N<E7?T@S!O^;L;OE_)*&F7.R
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M/NQ'G?$HE>K$25T\C!VHK",;;XPDFN9.'>1]TL?[D*4IPG4M"=K#[[U(N23
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MJE 5>#OSW79),S=%L (-ZEB5<-0%]KT 25OL3EB+3N2US:W"!VGN.T"X'5O
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M,Z;?1Y2'D5ZYQ[S7PP?>]&:7:1X6,ZI>%+QX&9\O6G>$<@!H\J5!OL 76%,
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M'<AH.*[@7B?;0(S$"<ZB2*D12BUHC3/AI;I'G,L/E' 7TT=J;__VF6Y^*?M
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M"TRP"' 9(..1JAQ0XSYLT7P-"(0#^L?0  14V[",D(:[0])*E\;=J ]_%#.
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M7=1.[!YN.=A*,1[V^]0_$K($"85CGV#V\(G;W'DI3Q\>0VB[>TICD(G$+:L
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MW_H=VG Y=+;I<X#+10UML7EJ!059KQR[K'# 03? 1Y?,4D&(#Y^9/=#>)%V
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MD=!\X;7*F#G([ ,%[.A(1K\=:DFK1"S-)60,>?:3@@&!$8$([84V@=U =->
M2?M7$V1+7<.D'H_7TAMD\%E2C<[]L+3>D7LM03!OD%:TL'&]AG&5+WSG9V=W
M(3$EH9N? $@ ]2O)I5D1!*A_E( '*=> >0GDJ[R:D,? E3Z,*L49. K[8*'6
M?1L%I,CX\8^GN\\K3W'O.R0\*^4$P@4_QQ1]V-3K7EM(UGJII$$.AQN@'5!P
MP5V1GCM.QQ3=[*^3S9LD)X UKR0KQ5;H'Z&G:J!X:0@T6K0:+H#B6TF;X8=:
MBE5LL&CO^=)8L8V\\40E%?9I"45SSMK_=A>NE#K9=ON%Q#S/B1LX(!@+D>%Q
M3()6=!$Y!LJUU,L(6=?%&?(#T4H-936\I37Y2)%(([&!&6$U-Z7!S[R:G-%-
MXY/6VP[4%(6E%- S"QW7@ OGX=AS8:)Q'E;93Z%KD57=0 S/$IG=M7:>BN#[
M$HX)38PK"BQW/4G7!+J3NBB\KWH/R^PS)%HS$5T6=UC:=RZOO344?Z6XVTME
M^7RDOH1[)4&_V;2OQYTO!-3751C>U;> 96([],4,;@7VSS7)0W-7RP!I%<P+
MAW<!NDI).AF\ EL9?X"ZI P\,T]&Q9^$$_G]L"*DAW50/5BLM;(^41L>"G#0
M[7)/AB/SE*&5O0)\/FW,5/=)U'U<>)U'DZYC!K<F@OV;?8E07)98254Q[?QA
M _16BLZEOPB_<^/EP^Y:\A5?=MG/RI$IU[-G[[X2._9A1'9D+,7]LOV>[KC:
M3C+%W B[@$2U8GP05$@!"Q(.(8(^S89T\;)+,7[;U11.D8/<SUW3M+6J+*5I
MYP1M^DA38TAHG0#P:BNK&@N1T'HG]1&C;T/ZB *A:T=!^>?D= #V23&Z8>$\
M"33O0M>P ',%H+ZC-' P6:*"-^X600VMY1"OA5H;+=L>'=1+<J39W#\8DRQ"
M7&F3#*L!>J5N0<H+=%/ON-_>N\QSNATB," MKWDJ8A6TH/ \7J^;[9#M-T&!
MB3QD&55-1FP,&L7XI+K)02W06VE^$GO& C64"WZK-90YL>2E2*2.D*Y(IG*\
MN,MA_ ZY'UDG<62&M=@[<U.U@1-]?GO+8Q["@J!NK\H&QU/;=[:11[88?_O;
M=0U;%"*7UE2&CH?ER('7;Z4J.]:Q9&7>-;\XD-O.=H-I/M>$J_WZ>,$0E>.Y
M_0N8>!"RULO>#(VB;MG28+&;PK#ZE&*R\T#[\C(1TQ5=6(DEBA;X['F36ZS3
M7/./"%GC:NBO::V?P7&!:(<F*RV^S<&*NP >;+4?2M-: ZU%ZVX2,F-G<+9^
M.\IC(VS!_H(C\&-6"C/_#*?DU;<=ME>B%OSC J'\J__BGMW_)S_ =C+X>=>[
M1;-\9@:GW\BK=4&OREW_9JG_;I/[?[\+-'DC65U-!0\ 5R7@/L: I216=5E2
MXT>N_>N61I#)=@"G6H.64QU&G2PI'/8<:&7&(P9!EC+()[>0W/+?[JF%KI)6
M@OSI3/?.'U'7!XUYJ3\FY=E&O .WH8O"3'/19V3+!$H.8 70!0-3(:#SP^+!
M6$5>:%XK, ]."@%_S(WI\YW\BZ-3+:%/#Q56P3:R:8^">\KC]"%[Z!3O[ECH
MYB"'6.]S(Q^=49T:FUZ0KFVR"@5%60GA+C+Q:L@CMSS&:1WX6E(Z,&9O*[E-
MMXVG*<79?)K]51]?=N7=T?K4SM9K):6JL*[HU&B_/M&!CGE5.;"/3@5[6Z$+
M\R"K=KNA;3U Y#UD>V*%*B?P"*BZ@'["^A8D7GQ=%3KRVF-]-<C-(*VCU9,S
MW#P.WGQ6*UC0K.GTZ%9ZH7_4//SET^.?6;SDC#^" C!1IF^>P5D$PS,XXVWS
MY4EKO-9B? K,,WXA NWT@9"D&6_/W**UR!*PW,]KN-:?TGV";_+ O.._W1^A
MXA'BG8@1]U1&)8VZT. 5OOY0$_@Z>]A',KN'0:*^2@:#"4H;=%%-/$81G<RY
MDCALW4QI-L$I&JH5T\<8]0QU@TEC6F<!&+F#FF&+9<2TN!)F2"O90KP.\1/5
M0P$YD\ 5)Y>TD+#M <=$V:W9'X48?;R-1B.YVV6\R^3"[E0]%$G#B)<)U5/-
M@KFLE?#Y2#\%K]_)JCN]>#0T75;=Z5VNM3XU&M@$R*8;<UQW)P++1O.KRHR)
M63WA5C%K,\BW[\V=E6]J(;6Z"UGS"3B,6N9A=*#C;R?V?/0)K]9N_%&Q/W@!
M.0CO4E,O M:(HU9@5W4;,FC.Y*F?E3"Y.\RW4,*HDO94O'8(ILA$I?)698!R
M0F__NBT^-2[>N^"\Z196_J!9_G;I'["#,1RVT%&4@\8J. 02&+^$NL:I)F\5
M^IO$ EFO)BQFAK51YR'$)#5AT6C1TJ>-QP2O5 L;'2K@*ET@G)AT%XY%3:%0
M5_9KPN'N?&BXIXH8W<O5M^MWF8@L*W,-.I\Y9J292UC6,S@K%S5/5@(JX<%F
M*IC+E#:K!@,U!+M73GX@B%%'[F/26E"4G6 8G\&MA*D[>^/OCO4M,(R33XA]
M?.,Z7Q:VIX"Y&NH%\7S$%::!%$U$V@QNH4A*2,,D'] R@^-$K$9[^A(E< #+
M6DW$CZ"V8!''7*/='A "+>";<W\>";8E*)-?\\O'[(8"E$+WG6_>'*OZ"#=A
MC\[N<M&D2^#U_W18F(LJH&,&L"W==&B4O, OI<)*[_QT)#0I"XD'<Q)@A/_-
M.QU/7V0/X64=JMKF$N7@,>#$>5]>9NUODX[+M8II4-!.@#UF<(A-TZQQ*!G<
MC\\AST<V%8?%\M:P\#1"&W?@17YWM^[ +W E.#WT>IJP8*2&&EN_\D9A5RO%
MJDM+27]*'4UNJLHICG7RD".!%>U)"R[7=>/8^:P4.*R,E0#;0,7J4KXMCY0+
M88)'QDBO_X=O[:?/:8=IJJ6-CO?A_4;W_5;G]@[+_ZSK?1G8_W7BS<#(=;M_
M'[\+; 3 .+*^&(PT[L9F/1*UG&\Z/C:TU'Q+0C<,A.@XK3?3=L%Y%?YJ:Q==
MTF66__V]VF=:R7QZA(\(;*#7]UX*5[T(?<4]G7^S!KQ)L&#M! W&NHOD3+L6
MR3,?Q(:@F\')&,IXXQ+S+3&1%07BN>+5K%-]I-4Q^79MA(6LO2 Y2^P$7Y-K
M>9>>(02=>3]Q"?-WI?49,IZ9W6KO5*(E6+WH='_S @:^DM^EFPJXVSG6IN^P
MI?SA?SQ_/]@4$ @1]'339W!2.^K[S,WSA<L>.._.6)$;G *MD_MWG_':5N"X
M0-<6,4?!VGJ?'N%T*8@>PFPD:U=/IMH.I>X,&Z,O]%KE9G"_0"X4P%O'C")X
MFXF!?&8NF/6O5#T$KK((I@.H G BTR0?T 'P"HL 7<O6N6_1U/$T?&*K<C/0
M(E,@OM/BBYJ"P4K)4K&@HG_,M^[66777W!A[K&XB7WLRK)K+J+& ?$I_S!3)
M[I" 082!FB_A5M,A5B"50[9$B(EJ249H<'E2V2CI(XB0B03>4PJ+LF>WTL+Q
MTM#$OAIM*CN<&-#;N .(OCURZ#>:QFPA(ZTM&E+M?68H$[W!]U/1A2:L>(]A
ML/TV5CF#RP)."@:DTJ&YT%26VY+K?&0?M*!):[A"7G;W6:BF*NII M<.^4+1
M&%3!#)1.5;L7T.WMTJ) XW7MZEJ^_90L.+GJ]MW^B!T3T?HKIE7L3HE(TFP=
M;4PR5Z!KPA *?)@?6Q^02?TB+EY69->3(%G.9!\[]13Q_QG.;?$5IVO='4+D
M$2F9?73K_1L9]ST,$ZFAJ@//$MT#]C?@FF&.*7A'!2HC;3$_G,&=).!'",*H
MA_!*/D*'W36I<V5)I#75L(0>J?D-"2B-J6?SG=,K8Y.#*^\-#G;$UGNI.&V/
MG$3+P!?Z:P45MV[*M7AX0QYB*S<>Q&[_&MII3V[M/*PEM*@NJNPF"K)SB-H9
MW.,N.V0OV%=0Q=K61SW2%U=[2L@+[TGHD"QE1LI\S]W8@*6.QGUUWG./7',5
M/NJ>B-O9/;6WVGP4)H-IFK+'A/2AN; [&-^L#)#.X-)5BQL_*6%N>SRTY&GQ
M#<_.N5*E>T7HT6.M&_X0V8ERW]&&(T:3<WK_*J]0!<:7Q^:)\M-[.WLD/\S@
M:J<0AP9LHM+-?/'&T1G<:O$F]+=0Y^N0G:SFQ1 L.@93=!0"XBA'PBNIX1U
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MRTFV+%\,8SGH"F9#^-/&,%W.QG F^1A7JG2Y(%X_-K09+* GEPHTY/%!U9)
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M5D\,H$[,N]P^S(PT+1G[O5&4!;&0#H^?<YPJ4]_-F@*'01@3;,:F7"V6/+1
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MMSOAD;O )\5W8T%_H\I*13=N41Y_C@/VU8;\3GC8I9>:W% 58/DU/&AR9D6
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M5;*0>M51UBO0! B;ND2U=-00^DOESHW]F%5XML2B=A-81N-O@NROV.(4Q#H
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M"O4H#_E]XE2W_9^?&L]L.>2%UF)OR0"<A1H6-&!+U>4"&N72T&HU1R#E2:!
M#2'MO(B_4LVNF@P2 @O=/*592W87T6KXJ=#^X:9\X$6O@^!*R%=(;.3#\#.,
MKD.)IL[8X'/<EY-G7MBH]62)*2\>L/C82Q ZEI5.)0EH;5<%3^(FA2JK<>!)
M\20'CP-.5(M:5ZB?;\.@*-@7L8U,TV[[JD%;-%AFG\9?6)4A]"X+=WE;1GLP
MSC+U'@QXI\N)F3PL_^P-LY)D!.*;*<3E;&Q;?TH7IMN"NP8%H9U[Y,_\3GT#
MC%"1OI+HK_FC6:4"9:(FBL&XU1K1]. /[MX^=97IO_>C.WIKU]/..?:RE]C"
M&["MI_C/NJ)C)&,J8>"'G+1:U[M(EL^=27-67<%H3>NOV-$G%WIS;_W=.?O3
MEVTMQAWT])-T._^"G[=Q._R7 GE9B(M*982MK(85JB , &0_,(FX*#V':=\\
M.&LW_'M]!A0#L]1/7V$#&D+6U#3EHX90E/B+(%3P?499Q*S22IW%<=M;K2O7
MX_3G2&.;G^6<CRP>M"MS%M+U7SVT;4WW.,T[E\'[U3N"!VTQ,%^]Y,1Y K'L
M_S=M4H<IXF'E*211=9+U1F(!GI2D^V+@)<P)!7K19:4'2\^M$[L/3MB<O<O(
M?6OCK;:[P"7I(M=%^V"G.X1NVQ_R-81]O!0YI;+VD61W!W5+-#A/ -&)$_@%
M%RR  =183T:Z#DCOXN*<98=N0\+PC/( ]ZG5S$7JG"G^1M09*8-40KX-S,["
M-C&],B@BIHGSM9@ZZWJ)88X7%-8(I.6>;+E6Z[K\^D!##?$EQ]F[3M!5Q3$*
M A/C?'G5O=5.SKV]L]E^V9\#AP(&/2V;RGK*&J/TF[BMM7_ %+K;0=AGR<..
MUQ9;79Y6+(S?.!^YB>C)I@9>8_H/D"^JW<Q5D-F$%\Q6?L*#U&$T :F.@V_*
MJ.G J4G[XW!Q,^5BX'#ZEN9DFDQ#,&;$Z_F<GPKJ<6A;PO!LR"? P<-I&H+,
M FK+,+@EI5N,@$MCW!-\>\G+!U^I\/"'+<8ID\XZI%IJ/=$J _M"%:()G )\
M_4<[V0:ARW,FK>$[RIP*\@)8T$S21\Z_?T<+=!:JS;[K>$RW^]''617?XED-
MK6_)B@G*6ADQ9\!1D P9H5Y0J>.PL@,789M Z'S8Q OXCB(,-50I&0B@VH2U
M:0BF9(=(*QWU4Y:AI!X:E_H) 0OF85@G!2,Q(I7QZH):>],R()6YK("1%% !
M-6?%/D+B=N;XO^ %Z44.^NVMR)^,YNKM_1,KT[8@R[9''(XHXQ&5"J?0]4Z8
M$V*FO(98PDE28B:7/@#**1D. AUF)$)34))9F[MK;1(A"V5$QP33IQA): FT
M2RH=8K ^^[5S6^U$ =65-P\^ZXZ)\FVVR'G>Q5ES15V*)W].%G^M]FDU(+T-
M5(6E\G68WXO L+9YK$8K,L2^SG<-E^B[T1XQS2%J.L<-UU +%G(K\5DG6_>-
M5"+6POQ5-<_AXJ2RR:JHT..5W6'LIOP5*3:G;H9T]H[/Y6EO0C"@4C*1684]
MLL,;TS6!!W#:_379GL&1I@JIET/(G:RU3%S3":DKQ@6+:^<]PLE=^VA8$2*2
M6^7<'V1X-=0D=XW';PT*&*^I2VZ<+!W-,(ZF3^X2?*L]?X.G7GH6&SK$1C:\
MI^KC;EEF-]!$-6$M8<9!U,EE1:@;K2PJ%DP+]$IFZL)>,F6=S%YO:,R,9QXE
M2+O?Q;)NE9?9#<TI,&L0NM8J:R7O<,P,\PG$KHS<);Z2(.NK4>-B>1AJ3,+3
MNN%JI$ZU@-4#/IG-(AN*D<5=C;ZD*J)08(*$U;,<8>>K$]Q"^/Q-2-ADM0X2
MI=AQ;S/G/Q[YP3+A0,]TIG5056>MM\QV9^3J#?? R"+6*1Q_*5@YW"+H'U:>
M55=/ UD2?%Z8^KUH@"H&^=PT9-*!_0UUA-E"]R.-0T:UD/6E+9-N%)D::,ZU
M2XM[C,2/?7S[L7<@L.O>\ZZP9]QGEVVRLW6/@27[-\[_\A.^J&&"L*DLZCR!
M;!2$:OF+T&"M0M734T(P_9K;?/R?5%GU-<P2%S-G93;LR;9*1D$#"<H9J0'0
M=7S+9Y_O?W*L,YNL^9%_FA7<13_.ALZ93:CA<44;ZM*%&=/K21F"%0)9"#9D
M90BG9@ED1YE...NF(![H^BAUJI)MS!!@R_3-_/&T$2GD80?XK.JRQ(P#&7_<
M?%,3G)DUYI1.0/&P=!E/'_6V=H#T(:G2+'7:/F5H2Q=FP>JA5HJNR9 6E2VZ
MOR<0H9E[954U\G*G&EBK$JQO]"%@L^) 9U2YXX<NQPR.WGC@P4OR[3%Y(1+O
MNO89^AMJ*@ =E2#;JX6LE1I"2B(\A2[M_2P?GK2]-UH=LI*GOC_!<F* ,LY+
MDO'8W-)48:DB..[@LW:!C/HN,\Z_:PKUNA"&1Y[KY'F=7'?7H[P[0C$U93I\
M\D/.K">VF XE**6(0K4>::D'( I%[+Q'?1N@'2H-%S=?4@!+PP.C"PL9!=\^
M,:L8EQ"+15-,0/Y"D-H5^0HG%OZ(PA/ZLZS47S*27>/T6G];<#<W"H"I7OA<
M/ #K&T%BE9X@A60"2)-XH#'+F79.//H-&H($J/8B8=\BUH^]S]**$E,#J?J[
M(V'3H80@7K9<=?@7XK5<!_/0X$SGPY60^F-&2> -XMLL9/54/3M30Y@'2H?M
MD8T@;L=BJOPXR0P,S^#T60%I@I6UYXH',H(7C\O;6FQ#E;K(H$)[-'+/@KUK
MLE[F+X"]&MTI+_/GF<ZQ,B*89K*Z!65,5]F+4-.D8I#AB.)2JMY0^Q"96_P2
MR "XN,-$8HL=RQ$7^D".<KC;(50.IO"_PEJZW79 KB]=;#OJ>-!^Y.:N;L=,
MBR/=T>8BH<O?NMS<RY [N]O1'5+2$ETWNL(G\G /_3%X/^(_M:7\?]<'3_#_
MHD)8&P5=N@W;*8".:0BJ_=:3NAI"@<,?6'+I&$.$[3_]N@OWID<3JZ^3D+]I
M"-6"Z9(%QH>H6T[_SY[CF7S1PX/I.$*#20HB:FBM[,?%29;VU3]_$[H'I@JG
M%@<P@EZ2#)@VY8BD>6A]+0\IE5KND7=]"W%23CNZQ_D_3\*S/S]7WZ7A3__'
MD]'1>::+UL>HX_&@NP.4WN#KP!PA!5D_.V&&TU<Y<,7M$/Z])9^HSN83&0E-
MVK,)J3/TQ<B+!C%V6SJY572X'?62U9WO% 9T.&:2_]QA.U75>O"/7F5G#"-Z
MU?7=)TEM49RK@+0(A#Q( R0EI[<,_%$B)F*+/?&(+E*7U+($2\E&8Y*%,Y-A
M<OLF2G_I\7S*4HD864/7%8\,K1=5 ?I]F;YM]6;9@4.W[Z-NW0ZO2?.1C/H0
MYRKX!T;+2_,V90">7$T%9EPBLC$579D$4Z1M+TG+6,V@=O<:6P#MYZ3PG:'4
M1HDX*5!=@+J#4D&ZAE!EQ9'518S)B:D:@H'H:%>M.^>=^'A?4(3+PIR'C#6]
MP\*A)3WE7+HYTP.VQ2J+F60$O*#^^ZCYGELRM?6!]AA;IQ:O#H=@<MN^CNE,
MN\XAX8'.Z3J7(5=7?5=*1=5UBR ;"QO_'WA55;STC;;2Z]M/9*[=?:@ 7T4T
M!7L-!;,:02@V:Y*- \ME5=]%W7 3RF:UU=";J9?-KLT%=*(T>'[]G$&R@KJB
M%@[LH_W\I<:W4L81[W<]L20GL"FOL/"*^(U+9>2G2*5$=(MU"*S?JVTCPE&=
M9GQ6>JKO\4V8WW6RYK.Z-80*:G.FA5S;&C%-G'71UNW< ^1F0XKR+7T%TQKF
M7C'GI'"_H+9R_XE[X>N>PH0,[PNQ5V]ZY^%*Z?1%G ))>4 %9=)>=19KK)FZ
M"(8*LH"EK*^P3A*1&5"$^B&1"5)J6OY&Q"\2MOOLT>&VNR "U&4&R:GZ$6*_
MOFF.R6C^JF<U[5,S.\P.=-5&%3!"@@-5^R&TYL,T^ NV&$\[5_"+W&/KHJZA
M$$?)U2I[UF!NSN0WLCN1N&0QDWSE9B;'*1US,W*'(^X+]"<:(]Y'N$A"^0"M
MQB\-I5@5TR.+D"-4A%/H'[1;;Y1O#UN^N>D?H"$$9?Q=O]'TY;MO7UJOO.'Z
M5?SB0,(_MA#?)E6P)P=5 6"]#Q/WT 4XL;F<B:[DJG^-3725V:.;-(3^,"7U
M*:R/*X",6GM9_Z0C>\E8C:#QA>W^GJEI1-XQ8\GZ^/8MBH!'1;7[Y&I/ZLV&
M_.6=#JUK7A]1&2F;U,]!:0F@"TC+P KV1)F*S&JD0CSP!R"]E[RB#A'!G6W"
M_&W:U7$HHS<&\B_!1HWQQ4UZ?CPD#KK+-.J0=]:>)"6AWB<?10*&S$% 6$,N
M,RA5< SZ1L$ZX^]T/K1IW[I<51> IR2(]7#SE!'V.W4AK@9.JXO=XHJL&^PO
MSYF]!%.L7)%"N60A4MK2FYM\:[@I87*;3'LLVJ<DW)PN)"T)BL1L.QW50=YT
M@S9%*U"?;]S]80^\^^FKUV"](2#-FZ.B1A1,]PL$2F.Q.\5-<$(C3P_V4E[L
M+;O+4_ER8'IS-J^Z9O#*7/H(F=3-M03J>=[%B(U'U*E77+THTK?<%-J/B1.2
MLNGOYE%;2:AQEW1V<@<^YS^HGY--P'K'U8@?3)&Q4:.UTO?84N2SZB=F(NQ\
MF;4*,<)S3U7<U:J@4<<L':R5N@ -!0L9\<+FFL-['3;5'I-GS6/<_Z1O=*2'
MFQ<=6>;:""QV<RQ$)'/'\8C&QG,YH)R'Y*C\P'HGYFIH2DE!+IPH8U0K]R$B
M*$.9CB1 S@W+:)@Y=3GCB%24S(R4OA:DX.E[TD'45<:9=+-4>+_FZ")A![C<
MA/X8/??Y'MS:[NB80:/OT"_(*)R#4WG32B5.1BX'(D29\X2)Z@SV&D^%&L(/
M]N+JEQ)NRS]4@Q"Q!NHE>H@O-85V'^$+96$I,:];0SY_![/JY%E+&4<.(<S8
M185=]C%1\0D^QQEAOM"#^/+GA1K""7R=90"Z\K9J/P-41N 7<L5Z_7++FCA*
M#:%90AP%*[,NQ;S(W//Z8,YQF-CT BX:S^ZE)$0RHS]6T5.45FYP DUY_J>A
MH0 DXN/&Z)A?/\?6;1N3(&N+)_H?8[]+H .D/K:4E.YF[7R)2=.V33'MP58S
M=HXTTVO=81NYCACGVEZ=,Y3-#LFQ"?25C$JJ3\CV0/ERKCW72W]R.J+ZYA?)
M)(Q'\[<B#8&.Y\ <Y6JXK8F84;.[>B)#M9ZA'%;XI8&G!D"=(9PV[H;C%+YW
M3CZVOECK5<+<RX,7E'2@CM)Q6-9O(5P6[G<HLN;'H6V=,S;9P><HSSIP![Y(
M("PD$.:-Z!"^^ZKC/[--ZO._JN,TS,86Z<YJ:S8(E#?;Q#JX'$9=J>U-B10\
M4[SRN1W_/3@3?.4;W.86DI2SV*U5]]-M/F1>_E\>V,C6$)#M7<I$9!86*D!T
M&=L7L86\Y+--:AM9W.2K!TBU_%0Q]$+&N8:"Q:@+](#EB*R/M4ZKC4V0N9OY
M\J"LU )N9ZQW3F^MQP9V42'_SL,#HC6NKME9<S?N7W2[J6 WC+*<4'VD$HHF
M6C $LD)1DWU*R#8D,1(V>^E2IDQ69!&&D&IA8$IRF,)>=ZPF<3!YD'V5^4UL
M@FEEX=9!H7%.]B'/6'[OO@+P/: ,5?-!:;FVO1YQ40C6K.UC9L16/E8+:HVD
M=!/&IV'IU&2ARGW<R@41E3 ]H.&KM0$)<EOK S"O$+R+#,DO?+AY&+;\,]4Z
M STB!9<CYX1.N3I73B'GSD45ON9XJ0L[OB4U 4U4;<^./8!40<K2$"I-4V&Z
MT@*YB9L*O@:7H[&W@)D#.]-J<R_?+7B<;X+ \"_*H3_V5JGH2Y#08.CC-;GW
MBP37.FOO?*'0S-PZ=9IM-$9>_0SF5YYU2KO?IG[D:>BQY+L-YSW-=]W>X;KV
MNXR;S0<)KUHV/+A_<54-E\?G/7M:5WT9USNZ9=&3=O>NR\5C8KE3>D+"U?5^
MZ0SKM*%-]VZ9[UA[RLO7=Y6&L!: (MN[P9/LJP*M"EC?=OU[."1+ ?3?5);7
M(CFR8.>FG,"HT1ZR.=.S:S64G5DZ(CKOQ-LPYOK:/C67F#[UT79ZT'YG'1<>
M2BT-[]U'+BE=1Q5%L0XR!C#=&Q)("23C W,N2XP=P.3\M7>D.5>Q>;@RU/\3
M20PK"\+:\_6^"7C'(/E1#&ESO$LEX62G=OHT9:%_A OVA'F('BL#4\D+VJ?5
M6QOTMZ(1WY.N 5!,:C,;V62?X="6PGZ2,Q&JVLSJPP!<[E/KY\#K&D($*1.L
MU*F7I &&08W\I=UXP 26'&>U_2TR1 ^R>WY"]KJK&(E"_126Y.%&IVJK#1U,
M+UDPT;>"HBN)]!U:_9G2KX,M'E9YLH3LRFHAT)^J9.'9.EP@?<@W1\*@%QX9
M>SL[P52!V89>[N3^L(16G"-NZK85G"S=/D,W97 "\F=#8-,B'J]C<"Q'1*1'
M19Y>S4M5'<"CL[OV:"6ON*EMH$!:G8%M0D^JT\ADK!Y;![4UZ?O),#94K$SK
M8/K<0UH:YZS8,HH.XSKQ:J /)[U6!U)BU"5CSIAU-],Y\NS"K+A38D[R#*/K
M<'9X,;<*N8GIFJC.:@N3 !'LZVQ>]46 SNF[P6HE$5D&"#(J68B&DE+=(F5!
MB1YVW+IH(N)Q>@8T_RV*[]07P/AI8(]H@FR+6.QM9[H_#!BJ3W!/[4=][C;1
M5*TXU;0&JT/8_[8A$)>B]3YNVLTK1NH\LB4S%O]9$JM>L-+-^NX(=05X"EC"
M&&BT<H79+\M\N[!EK4! #W\YZI O:711_ESX)7X+MK%]BF\UXARR?&\T5T!$
M]]'U1N/#DF._L.AJ#A@]A6RV1TTE4F6):C[6 D+>;+&7T@NR;Z[SV@4-3^JI
M#F*B7+L**7$Q8YNLRF4HKR0RURLUZ!CT\=()\$+,$YJ(O"IK5S<S0*$GT+?T
MVMG!U'%LYM(Y-#Q0%QK/^Z0A3 2H;!AFRK7J6ZP%K#] @PWYLPV"KUE6X>3%
M28&U:=\+8'+9R=,;8.MKCJZ,][_H)?HU86O81V&[$GKXX68\I!]]EM)LD; K
M9;F&H.=FI *8"?@D5('UOO:""*I8*,UJ)%VA0A0\1EJ;9<RT?8T'G 78=G0;
MG"7,.Z=,0][?')V=8T\>>LC8)C?-E'&,WR%V@U%5ED=>BG++TQ:F3!8BKCY=
MCV4P)86_L?R>>@<>7%H!U+1%2FG&:8R&P$M%C5RQQ050L32LR5ZLW4PVX2T'
MKV(D]5V^/E.WXV83:/$]9-;HLWQ$#%SGKV0L\UW!C"2E#O<R/9S38_IF7'6Z
M9-QVN^CU3Z!I; ,,I+BIE'L!<U#Z0  %J?&Q:;AK89W@TYR)4I4CJ]E,\E1#
MN,(%Q )974N#Y"I[);8J$ES*/")_D>?=P)K'KTW(<VYP.2;(=/.@QW*$)4CZ
MUSG"W-UE8O]Q\MH>!RJ>>HXX?*?SR4-#T#G!N'D(:8.$RJ_Q>3O-W%'Q M9I
M)@W8*.NA_(+0^R,YY^T?!3)L7O+,\I=V1\>ZTJ9;]U6Y;Y@*1(J+QO?)!X0G
MBT;/6RV W5L[:CNGU><F@)[A)-2QD+&M@;4<2DDNKG\PPC=K=P")HR[!Y:S6
M8IJ8S*87]_<'??CMBQ-/"0NM JXWKLSG?@D]B<?FUR(WW#@6G'J&H\E'6<CS
M!ZA'ALRO7HEL4UDQ#3O<5E^0J0%I"/OQ[D<#C+86\ZGTFR'V"K8YDCW0R'+D
M[J,[>"?8NGK#'TL+?G=<SG26JLIL9IK_)W4M_A\?#!1(_Z1\V4UM)*DV"W3!
M:=4Y:KO^/VNI5"SE?+%Y1L=:=H#8@V];EJ&+)3,?P3EO('[ZWSV-?YSW[X]!
M_GGRQ0QX^_'YD(Q/0#Y;? 3S=<5O]!S8GXM>T!"ZZ,TUN$3_LD_[6 5[\S.K
M1]LYB=X7))W6$%:0MZ&&64V2"E%CFD4+]6OF<?Y2^.U%YNH2- )>I>U3YI=@
MT_.$OO3OX=C:T"4"L<O6W:>^W@-\P\?#Q556C&!NOS5J8JTA&+I(-(3;\6H]
MQY?O^_XN2(X(_2S*[CWNN/.;>^K;Z<WGC@04G>ZA1NYY\,/SPDW"G\M/OGHS
M^*#L]<%CQN,/NX9#^L??%G JBPO9KR1OL.01SG !MOI+)\YR-K*AHVQT[SB(
MG1SYIU>$P:>,,"R]14-(60EJ"':.PV4: AGX] #\_;\V$/#OQS&(EWQ6: B;
MO="LD9!T+!Z0D_+LL5_2<#O"9[+Q>K6&\&=(%I(Z[*TA/+@/UA\&X;7XE;_D
M%*BL4\"1QR!R A_KD_0O.'_!^0O.7W#^@O,7G+_@_ 7G+SC_37"H_^(X(32%
M*X0B[<[2/JRS6E+]JQ'K':F:U+ ,"E)*D>=0_ [R4N8/J0V=S)V4)>XWK-R1
ME-;[(6 TH@KX?*XL,L*VJ?_ZUE4^W#D<[E)T%)S^E8)LIF#K8@4:PM:9:69
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MQ_&Y$24RO2FC,2L;Z!PRY5_;-5W&LE_,]('>5DHGXP[6=0:*&K\GO>CV^Q-
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MJ2,Z N(W5#]@W-S3R=PM4Q]L"6SG#CJ]]N_@)FX=TYMT/MHY8Q,^M<513V^
MMI[WHK*6FVN3$?G;NE]6W/MY76;_<J.2;Q>8(,'X'+"U79O0,/7M&5*?0KE=
M?9U;IN>)4SLZ.XNU0EMPN9F\&OJ8J: 3T14(M0!)%;Z"M\D%5]&U)3YG''?S
MD@(JNJ;SMJJ\<MM\V^\BR26TFN1R@<QFD1VX#XA@#ZQ5GE9?)B^BP*7*YTB_
MK"TE?U''_:I.OQ!XR\_.5]%S<NK3CSY&]2P#:"9+*;J&!I4\-G-)@Z:2W-QC
MW7EL^L.QS_ZC<P8Y#T/Z"8E!N\&-.$MO0U?B@ 9:L,51T!WE+BAN@BX'<?I8
MR6YFST<$<F>A?3K)@AW00;9%IE[FKX3"TKAY]LTUE&2'D6%H5X@E3+K*=$TH
M\A\:"=D(\WZQG9[<N3QVX 6\E2;I:<*Y$;49F,!M;X%VBWT'2YQO#N<TLOL&
M,%TS2*'0EB]:S-P#6PO#^6MIDA74>M_ \DI97Y5J=)>Y5U;LE,'82_ZMQZ-F
M-QWKN(-Y5;,_C9;%SRK-VH,N@F'&N!R:6*"B@?5A+!=6>PUX"8RB(NLY.,$Z
M2;Q$D5&7C8F+FP:=%=3DVK"$,,[HZ*F:A<D++Q4C@J.USUU:FQI+UCWQ?Q,E
MO_0G:+?^EUVS1&0S'EU2FP5/KJ>I=J#;$-Q<]ZOO:4LE#=C(N=IDW=\B<[[*
M#'0SDEV8T;?WX=;"E.MH4#GWQ4)(<#FL%]UD55%85"#[PED%?_4.-T+/PB#_
MX.,$8N\C&\CO'_7![F*B2-7Y40GDHVU3$S;1 [V0ID[.@XG2)\@HY-HBJ1S.
MY+:M0*V09)G:27&,8LK8_XFR8I%CGG.SE7G6P>>^/E:?&\\[/QW)7Y-[OG-B
M;7OY3-M=4%K*AHZX<OIT&MA?NRV $F2/P2KB9([*%SW:CIFR6D'"@K<%-+I\
M7TIQ$=A 5]#-QN*/;@L))^M K)M@U )ER=?G!C=PRFA^>_Z@&-!86WJJ5A%[
M<VW>;*G2$-+SUR*."W/D[@FX&#1@.8X+]%/8CQ&V3'T/IJ>XZ<';CD =O%H1
M:G%"D>?TCI&S!VI+*T[T\JB$S_]L&&F:[?LDLB9^?5//,S01GX*UN -[D+=C
M/6*=R5#55JS/^;R8/5F@6LAJ)]LA %S=Z$)-K764!>LUYRXLE+<M;X*&F^;V
M),E.9>SOFBS?@GY3COSD]*02:^NQ1;^)XHC' N^,S1HVSU,5_"<"Y3\^_UQ8
MS\WC#*LP@Q\UA%^/H1X:PM-2*$=#H%0[3J,F>*2,T]<0^H;Q:-=]=;D<N!2$
MU>$A=U_85 @>/U?9FF'U+G'8S\+ GIO_40(SWU2S.)\=__>WJ:0VLU'#4,SW
M*CZK@V"_MI]H]Y3T%GCR%DK#)WD#\"$\"[$5J6\.<-0',5V_UQ;L?MN>LK*9
MLM;,&6[=AUL?:GNKL^.^:SD;&1MYUL+S;-0Y^M;:(P-M1K5'/#<[_-3\YOKC
MQQ[8#D":FZ_3#DCO4*&?V).P:AYS.>__8N_=HYK(NGW1*"HB8E1>"D)L%5$1
MTBT@W3P2;154Q*@H* AII95'#&D%FB@AI2AO,:VVT.('44$B(D3E$85 A 1H
MI1&51P24O%KE%:E2""6I5$ZE]QCWCGUW?W=_X]QS[MGC'/_(&%@CKJRUYOK-
M^?NM6FO.>K!CM%R[E]WA::W^1LY)6^\9F4[8# 9+DE? H<U!/_=9U' BB)C/
M5SP41D!C30UVS^-S2 .[BUXCWL^KD\G!56!AGO)7]/<R^*TN!6'<8&-N HS'
M6+XVA&4EK($8HV^U2] _;#Q&U=;-@%E8[QMF7#/5O'J;M[-B=GQU4MUO'ZK#
M'/?WC!/Z[*ES8'Y331\O-4&-5QS-J^BC$7E,GB]W+TZ;IQ"HWVJ#,1"#)T2&
MJ(C)GFYTC8ZO\0/]1ADWD7V@J(D*;VRP;=1=5?6+\,C"AH=2D<*[!F21S8FL
M-KXUG$4=K?=K23RU!H@Z%O!=1-5]_Q@"N(MZG@J&43G<FC8VA@MP)R6U-G(4
M /&;P>0T$62,SB% O*808C;R';_Y9V^?4MI\ED-N$MZ.&>WNY$3?23&.)N$?
M@N63$F>&!%].LP[FSA5Z77^B<G9]2S@K^OAP4GT (S$3X!AZDUM)CV5A2RKE
M(M!XP)#B$?MY6=^DQI!4S4^&=H@J>8W\5TG-&M%<U >5 K:(ZW%,6UOUP6KW
M,IDQ?)F"^:>$=M/FVB6UMP3GA=808QLX*]/C=$*!<7,M("[C+F1RE/ASQY M
M1='W3S-YZGW:S89Z8X#\G$ V^Z_MA#Z!I@W&4#'35I<N/ *=;2+,);D,U4XV
MCLUEK81OR!<H]UY"1_:#=V"/;?>D6R9:SF(Q+-[VHI)*B+*J+2E8W(U,PVOJ
MP@D]9/C;/$V7[H8>=V@,7NF8!43C>ZV5J2(QD+5>9L'&1^4[7J"SG U7OF>6
MP;3FJ=<U4\5!?7X2XERXK2DQ=ZH\_<J?LIJ+WE!+FWMJU]J!0RA&]>7*CE=Y
MZ)Q]H),&]P+]ACW !8-R(C3U+ZKY?=8*Z3D664L:Y$YG68+!C^?#VF"P0T*8
MWZB:74TU'0GZ&LYBS!L\Q>"L7<M:30>UV_&1)P\IB6I_)^K<DG.B:BH8+T*N
M'R5J[45' -UJP?5Y7$T(&(E8O]>\A:]JU[-?#WCJ*E!+]N_ ?4&F-QWT4_FE
MD0]SYC$=#?EIWE\ CF8/"IV59M3M<+F*QIC>F,R#/RDGQ4.QO&ZW:"3X]GZF
MAR1\66&8XP8X.:FX/VH*.&?87MHS!J\1G27+'X8[&C:QV.)\Z3GO0WJ<Z5G-
M%HSW*/R8>*5'&FH[!,QC+V =[!XO12*4_#[S%M3K<J,U,+\ZP/4Q@&<YJ&AO
MEC=*!QRZO=WOP@V?Q"%Q3#])SMIPVV[@-K^7@0;D:>(QCV<.9NMQ&,M*+_N,
M_5'0(AJS$VGYNXP'>:-/M*[8BMBAQT5V]!:A<XP,Q93]1+&<N6AOGT#"/S-U
MH114=C2)\%7<:8,RDVH?<P6_.:K!(23ZET'4 DPN>'91*>UF+:Q-N%627?)J
M/W?.P8'&XNB\D/:/KP%W#$",W&N&Q-4ZC*;*K_41'O-?F:H<#<M:[M@D.D]=
MB E1M%,V'YDNLR(16=L@60Z?+@Q(4E!2T!E2%O$N<XZTB3T+K+AQG9_%VE8V
MG$_(7 GY93B7LUS+0G((>YA ';[OLF&DV8:10HE_C32#!AJC9IA__]6-A:F5
M!VI#4J0]UV)P(+XW3X,YXY0'0*.G8>.WL@,QIZ)S>!"@ -018*+FC\Z$?DZO
M'J<I!%O/'!/:*NF.+0O,ON_T!1.:WV7?9)%>?-@+%S9)MT#4U(0.,[A-XGE0
M-)\U[0X,M+;=8(!_RGA4,(0*KR%*9*]L&T73&N:PGP!S[K))F.5KTCD?&FS9
M?W#GN'OY[-%NK,G>0O^*=00R;]X5+3WE7-5'32^!K-/=KIEY!$&,LZ.1M=)8
M)!BXZW$.F:GZ5H6T8#T?T>.>_B22OR%HB87.F-LK -<U&+*5C$8!59HZ/<[8
MD$!YC1NC=U)S 7/G]2J&)=H>OA3D/*:>#_>$$XI9@2#G#/OKD?PQ]>(BN(#:
M:+\:S,MBN9;'Z'$+XI,C%6/B\I6T<G+@9?'4N_O7X<S+&_(".B=*<%,(VDP
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MN=A20-*ECRO67?VS%A66?3;&UO?Z0X Q*B;4^#6V1YTDK8<-9=NGP[\4KGJ
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MSJL37+S[1YFS\-(V7B_[#_3%@,L]&-#ZL)C0NSMU51TSD,7P#:5Z2]RZ#_=
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MTI]K/ +W!R1$K,T]\;KWP.MML2^$/34?K3+)=GJ<XI4>9R]2H 1PO /V9R\
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MG-O,(H7CX[%4PEQD&Z 8R>ZOGSX9#A+/N!'FQDR><NBYQ1ORS'EV,0ZX]3J
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M3ID=)I@>A"\')(6V90K=RX9J-?6*G!/))),),U>*]&@W_:Y[T>&^>66?;_&
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M7%E* _N<-_F"=R<3/<+MNR;L\#OIY,<#TU^.9Q/FPR^3WCA*"I="L3>4#KI
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M@$R.X;(T88$>=]20:4V) QF(!4W%/>>]U)L!TA32K-94EF/)QNL%'DVH+3H
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MD%.ZR\!AT1D]#D>.%O7A]^MNL]<CY!<3(Q0;5D0/W[U\.YU>3;4:F7J7?N-
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M?6QO!<HR;>R2$>JM:BQ*.-BO?3$A6_2[V3G"D3S)P@,<M]#,8@3 FDQ%G\K
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MU%2?BRD3P@*P/A:0UQ'*64U$ W,72E\E:MBN-4+(FIO=,1MBS[D86_KJBT@
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M[$.X4*<\ZX+'?MA?A6?7KH9$"NZE*L4#1-"<ZP'/RU+0#)$X,O6*@_)Q]\3
MR;=M>RN";H\4^QHY9\=F3NY[4O6PRH?G=.?2MD4:X2H,.9>8KZ;>C1*UI%:X
M%ZOB2F(S6]KPD; "H34<T!'U.3K'<\JVE?V!2)*++;B<<K0O(')I'T+]+K/!
MTE*_O?2G=!>KH#V5ZRPF5B88$)HH"^A9\MCF9E'B1VXS97XDP9B&VNH\*$GG
MDV\KMR"E!7:LTQX[%5K\K,C% ^")88'0:8]ZU-E &QC8%I]PZD:K1=8)1(0:
MQF&1V:O/ 69>OW_%YZ5S<'(8GU3&L%'J=];G>B#!JI&V^3P)>\[PXJS;N[IB
MU98-PK7PVK/99FDQ?]W0BMU*/M4ONM\3V)I34]>4QER#0_<Q-FB/#U.@?U%T
MRSLUFR$SM6DV36?2*W\WZJUZAKHS[/6_,&T13K,II8JC)L.SO^]Q%JU X@]D
M6%&?DI8AYWLJ(V1XYX/WZ3\W!/%68+1-@2JC=)8\A(TN;8*]DZ=Q/!&RP774
M"&I#%P1K5S-\]#=(ZZG9S9=C.)9;6,5(?)-T@6_< [I=4XA9E[R[UEUYU)FM
M=G1JD2R6^BWK$4A-BV.JW9*2U,\-^'5![EKR.P#%SZ-=S@1QHM#@T*?3N!]
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MY3A)[>.#@N@WFG= ;<G.QB3?)]IG,6UX>IQO39?3J(,M&@3(T[/QF%66W^=
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MPEM3RF']T^XULULYW[M>"[J5N^=7IJ17!>A6VD/-!Y$G,\^I]4*&S;U^RL!
M'V-=NW!U;> I5Y/791P(5)(OHH[#DWBK:D[1<X=29\Z<D('AGV__=$GF=^E#
M_.V!3=*M?/MMBWCH?$^H90_BAUTL 4,Q@T[SZLCRYO=,XTZ.?:7S>\0/B'IK
M9B%JLO<AV5.SBZ@_AA[IF>"LH%"-3; :V-';9/_0Z<"^F4EA\BM&!HT\Q*E-
MM](.YAT6B6I[40M=*"1ZVKIV^&S@N<<6"PE+F1N1 ]1PVNJ(,$%GU1_,>?3S
MS;Z7MIJHI9$!;46[LLY>:R:,-NL6-RL]68T$9"U19](F<8N;2K?4A"#'(25E
M/$ -=*)+W^]C?-,UC8OUZ*SEP!NA]-ZI S4S3RH)9Z'Z.>UB@M)@M%&5,QLU
M5&&RR@M]39F-;C("6<)%,V]:&22(W CVO6NL&7P21KJIXEFO>--]_*7JESY?
MIS37%,9/LI4ZQ[O;>9$A5CX>07(UT!#HR4HYS0B2CQ0]!4KP;-3D96T\1%"%
M760<Y/9'"E? W 8@Q=H$MLZ*IX8EA!6%A]A IROSAZ<2!C+RH\YQ!X-"(B:S
M3#])90$# :^];,2Q41Z+8-=/,SXIF5X])B% /NL]W#UVV)-9E*JLIC'#B%W.
M<WQ"$XHBK%W/&AJ7/MEEJFV<O#XG.^@9$%?G9',QKY*O/X7=#)\I!3"M?ISP
MRDQS'>F#C2294E*)S,B#JL G9:]_E.T9V@28>@0K1J9Q>+K1MHY5Y9F>^R2#
M:[O&^^OB#SV<6^NNT";X!M^ZY; -9 'R/EE?FX12,:9;\DF^5K0TIEU!7,8(
MJ8'?J9<K[1WWV@=OK6J=K;05G2M"UF@//HZ]=")>E&Q*6MQ#I/C;QQ7HR_PV
M1:]TBXF\0'CI"#IA/;)-&J?DJM?!1@H#W>)B#0$VOJ(O $]=R.:J757KU[J>
M]W]*Z#O0\>+307@)_$L/O-;M\#0NHVID S\H9R._V)@Y5E\3S$E2MH^M13KE
MQ473N+ODBY0JRE.*%*QWA.TT,4@C)%/%7<COB24L:E/*DJV_>:D+RPND)_IL
M!"/"XP135F_^VA)8=^-88!LIY^SQ)[Y!3]Q%=J.]9SM:=-\Q6R@5-)W5+.TZ
MM)O"!]77%:)7(YHUR+.9 2:/>J*</,[!1BJV1&\9)(3&DL>+1YZ4NM93%I5Z
M&&F]=5NK(%%BIDV^E,2.G5?J^HI!5%!7TZ^]?[@:-T%&'+U'NR&QQD-_#Y1W
ML_NRY#U96VY!,GF;^N9QN6B1USG'NJ8BT#H'%FA6NTYIGL11(X[/Q3QOK?<#
MGW@>G74@XWE[K!5UO[!.ZV$;C7784R&VT-MT%<$826P@V52B[=!D:HQ?D#A;
MP]&D%9,%X=(W24V_/0C0ES7$!XU0^$<'R 92AP]1'^[(W@:U+7Q^@_B9CYG-
MXRCF#^KC=(>UP6 ](9;<#VHH^JM8K49"//7^+07:)4BTPN"*"W5F1Y$/\I1I
MB[8*\(II7%KG /H2!3+%#>+&;+"A96YV;PBTD-.7_>Z*3'NJ:N-@!&$0U)F,
M- $"0080UA]%11=X0OER67V;=!>]4G(V2[@4,;G?^H!!HLW?[FRL2#_PXNT[
MI7^C+T]MU!)AZ[?7G6U2[-BU*+2S](>-SD\)B5/^NL65Z )W2"1W;90AMF-/
M*<AZ5@/;$+N!34+[$6O;S([^)LZ<6/8*9A?!N-80-CDVC;N<IG1MH,VCI,?Y
M0;MR+6'3/%!I^KAWPC-@(CYEHFXO*FW9G77P\27 #(F R(HVW?)FC1 )UBYB
MK.]T5H/H_)D?:@21YD.F#RIE98("9H^(#XK9"YXI@F=["[MM*[1VZ;4&<D\+
MZHCGSQ^Z0B*8Q(<UO?R6G&@)TQIY=K>0-36S^_>)O@K]IOD<!**&?EI#:K5*
M ^EKRSCBGY$TO]Y88YM]^FPP[(;3;:59LR?U8'NNX\YM-[4FW_>JQ^UO^U[N
M%54ZLY<-6YOSZ^##W*11%^ %@'QM-MI_#VT"#$'Y%0KD);ID(<IPQO<1-7?T
M12<A [6O,HH8U..,MV#\" E8M3Y0_WY8<-GCC!*<YZOX.0IU'=0=AJLKE>:.
M;Q\>$K;'I*4[-9;H2-7K9^DSABR2KS^(Z.G--D9SBB(<2HT+!F_&1<7_,$*U
M":P].VEZP_>T<O!HR$"/*^G0=8_OE[?_ @(R*(;=\"MJAZ7#%(PT&K]"+M)]
MW4-:S#C0KMAX=..Y\;;4$#.HK$RIU*NT2_B0X*K']OAW 7\(>K]Z-?30H0'=
MLPYA/955NC80$9M>G1E7LT1_6_2#>G,C,!_K0")DO<%33KH;I9E\,8NRQ&-F
MF.;<08P'1)>9:^B8Z98M'7V+Y"C)EM1V)&_>Q1-W=K=']K0/39UHXEE=OM9/
M=4M/;QX003%V$G\D869OC+[TA^JL/[H\P&@H7C%QN7_.$X"/]23"T>[\CW^5
MUUT4=BO4!@$5 QLK/I(Z-6G45V-Y_-0?\.UMB"VQT5V4+H+V<E[%*9L*XCPU
ME:JV/G^Y_Q6^]G:1-34+QGJ@F(WW42Y[]"C>$U ?W%FBK][@I*P4")[$N)K^
ML>K&)N9['B8'Y9F$!;$S^^@A/]&K((5WBOIM)4R^!)R@79024TL*;YW<0EK/
M4GQ(M+M2<O=:4*!)5%C)L_BHR+473P:%WPW(]MGYQS2.\5][0/7/PR*F9OV;
MS3+CNN68:HTSGL:]>D><QG5=,5<"%X/0.DS^^H2-A6!K7N5HAM:[Q:'7Q8'=
M-^^ ?QAY3>,>[LW!M,"_>OB,/P5,WB>7C)9VIO>G3NUWX/-F$-I+TVZFL(&I
M**27\I(/>@)57%T)9G'FO,5<D0OR:1I7*$N/G=D%?X:H%6"5W>>(^=[NZI]#
MO942L/<S.%1SG/(;]K_-NJ4\S7FL:&B ]#:Z@" GF^M.=@M=F+UNSMD$"7LA
M72 AS1<AP7<#?8KI00$1'DONOI_&+1HGF$8(OAII<#MU?&+,DIY)7!/_YIO?
MUEX*HG4NL'^3WB#:ZN&"+4>,&"IHR :*A(!\?9:C'$OK9+ZD+"49]S$6]WI8
MG>,AF\B)9W--RCMU2PK%]R-(UHE/3=$MB1)'@PM5<3<^?%)::;)//.[Z+>87
MG]+02KWEW0L "9 7@'S>Z#GM-\QG0!46*O4Y%8CSD@?[R[GI,<%Q"E.1TGB#
M1P!,VP5_2"E%;'N?8G(W,9":/5C%7#7X.@3YSOZ^![%D:,N>J3)NZ:X:V[32
M8X',G6!]@:S\2)YVAL@=QREI@YN@@1>),$'3"@OSX.=G'@0.F[I)&3:5E8D-
MX%S'TXZG%0*!VY;'=X:D;8W@ HIT7<>PT!HI#KUOM3O<R?%4U5C'F'0S.K\
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MO-MRP->KIN(Q-%CZX+U =&#_-L+S;*S&N80*>>5MQ1-T$"N" SWZ7Z7QU"O
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MGQ\2&SX.D3;7(JQ2W1X8GU)+R8NP"+G"6:0>IVQ14HO'E@9$:+)<K^MF'<<
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M1LX35LK>DXPPV\H<XX^125&#7@%*XYB6I'YV!JXP.(8,U@YU\8! 33O6M^Z
MND4SD,?B6-ROG RL.W/I8;2T.+<K;"GLC PVL5;!UPJM8??4G^&(]'BRB:^"
M9#44',7:#E5/YH56EHS9P&?NGGH4/>"1F.5RO,[CW//PB,?1QVOR"@1]%I\_
MG]^?:P)N%D''N8%'=<_QY6D (5\)8G_4WTG2Q+OTRTLM V74]!8)(ND)TTN!
MJ[/S!/U(VZ_S)JP[,OG(S'1Z$IB>)KP;>V;0@F1SCJG]%.^BG5[!&L)C^@>6
M$38&\H$IG9QSF091I]D71%6?K[/LF#_U-'C"/-6K(6L:$J?U\(5DRA3)-5=
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M-"2T11P4-R<+UR%_E"N]DU1B:0(['0U0THQ>(T"[U9GLY'M1=6\+E(W'V_?
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M"0D3N@0\@#3SA+_6BG!UK3DWME#_TF_M)-T*GE;O4'%^G2= $;(,H?-X79O
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MM8;?-4\(IRUBD.2U4[F02DYJYEJJ$M$M[+51==1+L[25:&B?%Z"D9@J7=:,
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MMO%D<T9RFU!?EX?M8'KTNLBL&+0C4$;6.LCR$N82@]DB*5')#Z,O!,<VI?I
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MBR=X7-0)VE;L5A1G>=G+\R=M!A9H3=/Z)&*3)0N>&%5,3UT1SME^ET''R6D
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MA@+0@C'8&OB;-$IJD(J:WO]2=Z>>&[;QR-ZRF)+QCR=?6R<G1#W4]PPY<_/
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MNQ^PQB*/0B^V7W;HU<L5<=4N#LLNAP I>[YH+;[AC-M<4]^BZ/\[4$L#!!0
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M4W-+9U=W3V_?U_Z!L?&)R:GI'S.H)33FU_+*ZN^U=?S.[MX^X8!X>/2'7W0
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M^^;F(OYV9U%9XYGZ[(F15%-#D'>Y]Z#$D>]*1B9R%3%L,/7UA%G&2_I4LPH
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M_L5VO.H(MZ^:K&Z-X$;$PR0&]5K%-S7<8EP+R3$-T4G'8N&]O=L49O(QE 3
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MDX%1_^/7:/18NKA X>2X'6IJ:\\A8-WU+QL"N[6>/A+[ H69S0_7K"O5]"6
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M7DCBBW!9^*6U1.J%=I\JM\PI6XNMFAWY"=TW22E\<57EO*5\5Y5Q?0[_ED!
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M("O^Z[;$[_\1RUSO$/@PIWV,:/9]VI$[,W(T5&%;]5NGTM&IJVL6/P8OEOP
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M7N9IE00K7]JV$\\\->EL20U=7&#A3.7YX_)JLB!(<)&Y)[;/Q7 $WV^9\5S
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M#3-O218A)03/R;-+P'O2?0Q#K#P##Z1:)[L_9*@U.+BHOVQH7H2G1L'L,49
MNO!G:E4T3?60KQ'\W41;*X/5N]>KUB,[&IR%,<-S59\M-L\NGGZH[!*PQS#\
M%-7/T9A?]7V>I5NIZ%,:FU8T59'Y:BT]+2P-[.[I?;(,?ZM!081#90GFN'H?
M-/\Z67Y(-B/B%;+IG?W6)UG@O^?%^+5:UB.^/>:Y$>@!4/Y.#RV!D,T_/][?
M!793HLOJ93'.Q@K3W9V7$_N^B]YY0TP_7U^O.4[H8T*@B=YT5Z2\1]E2I,]/
MYW,;$K4/&KZ^05J HXU7$^=WRUSLQ-''<<W+7 88UBV?> F*/C,-?%M,T,,?
M7I(\.EQ^!?2::(<^8*-S'Q"5!D;I/R?7*,T&$@-I[GZZ7\#4@_%O#1&8M'W^
M6.ASMH&B>%U*M9Q>C-H]=E[<J^=^'\,#>X"2B:*TE&]Z-YP,GWE)W<]298OK
M?]C9%_I$+>/UC&E:@K/<UG9M3?[2_<\^AEZFOW+CPO;44N/U<\;=)>LFD.&@
M%& 4N&%G&)$,8NK2)W,!+/(HP/M]P<TL%S6M]?T/6Y'NSSP7/4;??5$%/.C=
M@F9>6*'/_Y4F"#+=FX-MK/K-R_V#X%,^+#CT=NUCP+[+F80UZL[@QX,<$Y61
MB/NY,D9(\ )BH7,027F,7&OE52$3S\%\W>\> 712_=I8HK?EC#\+XVZV]<S<
MP<G?=WG2DL$3RKU8Q  <%80=)Y81Q/[MZ4%B@#%02<B$88M1HL;M'Y_02RK;
M6R%T(19'C=R*M\<<!4ZB?+7U&CQZ1[XB+,D$P/@+-_)2INV%[Z#1W3YG6=*/
M_KEJ\**%'8GFM87(R4-?H]6,X.+K33TEH2KFFQ,FHZ5[H_!.@6*G,5<)GI76
M7<02!'Z0B+]&>(F9..Q>AR]L;BA&'M[I0'^O<\ EKB^;[GK$/2WYFC2WX4NW
M'K.F$#/Q61GT$M;KA5S+064?.&]*T&Y8]4]0_5[AP-%A&1?V9%!NEB=[]#5-
M^BDM-U9>&EP"!E@0ZI"=7<3B'YNY)C!.ZA+P90QYTZV5Q)D^T',=;5B.*(OW
M$<P(*5T^K,UK-8!\;J@A^2<]2XBH'S:FIAHCB^L.%<3[,%=R=6Z2>YO=G22!
MN5VXQL"TY#*G@HBJDZ>&:^4]#Z85'QK\^7 ZQ9"[SN\[I"Y,TCO7 ?<V&@-_
M6JAY+6F]:B%+ZFKE7 9GG%]=L5L5[^*R.X.I<5B\KK:128?_IEZ3QU*AW7VS
MCH[NFC.#1?=J.'RUP9O %(IM(=:>CJL.VW&C5_+7D5&<40RBN/D!MMWBXI%6
M?Y$K'9 YXTN E$C*%;5?71/8/G)3!T.G09\)6:CR(2,Z&ZDWS?%#3>B=>#G]
MU*K=BX@5)N'0SL T5LD; DP,ZF)X&6(#Z1J!R6BA%1N&HPW%&S^%CI$8I@CR
MY>J)T3%U_CPZUFGN-Q9*<AZ_>O>D-S=07_K":@C>M!J'=&#XEYA]/\P'KX2+
MQ5:C5X=!'!##JS,$ZN"J/>%G&,H]H?5'QIJA FF?MR(HVD%VL1-??%9<$X9>
M8&X5'GY6ZAK>\Y8JS=RT=5-2M#8O3B3]Z"P4K:SH^&QL;.(I#&DY>NJB+65C
M*/>W?6DVKZ;[NX&@5V5K('Z)Y'<)<&# ":X>:N&]%O:@XFBJV-HF[QAKC9<]
MF.QW7K#Z@^@U5<M[PAW2@_<<(FC2YQ&(4[%_F8WDVK@3](D9,.=CW#US6%-V
M9).$ODX/>O GFN']B[1%J\A?CP\%^E'+]EJ6JD&4S P_<OZ"2#2UF/D-X,$.
M^1/.B631 WO+M ^D(TAC8.L!Y?%J[AMPJ@F%Y/"@RB:1.^[5BT92?BWFVUOT
M(\/JT 3R$YE)TT!NJ!RT#]@*[IN((]V;#;-=A\44,'; :-Q0RS/GJ+QO_CN6
MLBM&Z4+:##=7>OHU^+ZUQ<NN=UFZ<[;1:1A9*?:M5ZZM<\+!,5STN2;]-::#
MV@C^6M-NH5*=!8%*U57+C]IR+ZWE4!E55;Y>0<_K#/-1VVY8W=_'6RWUA$3(
MT+U#0L"F#<1<X!8D$GO/ 1BH-.=*4<$3 ?"9ZEB-A-$2;#'EF\+]L!C2C:E%
MZSEY))N+C^WN'BW;5&EWDNK(#6/#V82\@@_?W;,PK80,( _LYS#L$E"\C?@M
M1J)O(68-#R)0Z7;$3\VYU:&@ZP2I'\VJU$?'"J7-9<TM#UQ]3QY; .*,DW1?
M3I?Y)$_*?IOCD-1,'!>56V&C*#7052BW\]^DN>_JMK0CD-G</J;'.U4B<@F0
M.VL]J70C-_:^&3:;1$.%EX*.@AA!+R<XH..7@)L$GI(Q3"?V"<ZV"+=I;:NR
MPG!(ZZEMJV0 X?BDJ=Y?\NG(<H2;+@BQCL?:-WH:85.(!?[Y7M>!'CAXT;.]
M0"OJF'O>F;P<&RE!E->>^Q_&D="7 $>I!89!TBUB!\CEW^&NK$A7J5B2,AHY
MO$6>GP+HTNZSO#\]J=L3O' '.0T_#KH'F0JIO6I6)YIDGEVC>D?60C"<6%!L
M&%>5JV?1KC7R\-I+V-K/, 0?M9SS3-"@8$,$VZCH@VN^RGL0Q 2$6;I4KR H
M33P,,Q7LC1WDUM*UZ$#$]4W@'T:3C:W@F [KN-GRE'3HT:JA*'U'@#)+^/&K
MJ=:^4EY=58UZ75B_.Y$-UOL$N5:E /\L/ "B(<BA@PZ62W#()[R<DX+!:VAB
M#<G+__=6*JVXL)!IVX1::]C\ *Q5)PI* 5V%H0T8_NT\?M $C J$D76J#0.3
M1B;BJ2Z=]?,>X>8D;ZESA4$'F9I%WZ0W;RE[?R$U06L5L%8@@7D?&XK+7R,R
M8.-PU-6$1YCPUM@N]0!BJ;O[SL-#[W+->P^#KX%=KSJD&#V?GX"WSC6N_8N$
MGR<PE?5OLAWD%\+Z,G .:- _;9I,@7KD/X]LK>_4<?6Z8UQD^CNQ+27(.>\<
M[?NX1I"7>=AL5);NX]RWUS.8+ATK5I%U'_]]Y>&]/_VB#18.">D)5NKR(_?^
MN)S/-?X*6-OAS(K*<REUU5ZJ.V^8$P%K'T%6#V+1WEA?,@1?P'I!A<1N#0V"
MTF?<."9[>*ITHC^9WFV7.3SY27Y&O]SK)9&56TK\E%0<:S0(M!&)MA*MB?V
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M!=ZC3*'2VR'(8O[]H19)8H!,8$/0K?'ETQIT8=I=MCI#*[>,GZ@,[G&7?']
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M&P65&)F)30ORP)/7[1%]ZB;\M!ECNKPD,>4FOJ$I\AJ_$%2A2KWX)H%NYA+
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MNH&?00/OM&!&0&:D"PPG&$M@U?P"HD,@W1#<N/3U[&%X= ]S4P.&YRB5\7%
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M+L8-B6,D#H%C_F.*[#6LDKWSP]C39H4.X+S71*DZ: ['Z:G ^T0LL%+5WZ]
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M#,2T(F)\E'Q]DG*E/"+E>O4:'.14Y#3AQ05 J-GP @#RA.VT<CD#ERO.="\
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MG\TS)H9@-@6%V4.)C6]ZEN*9<1L;^0Q9-U,5DS\/*LMU',D41WV7_4LH"ID
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M]5FGAM3S9^DLRDW72N4>3]"S^_=_G%#%GXZ2Z0+.V2'T.-V^PP4[_#(IHT,
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M6A:X3%U5R5V1](EM>XNKV5GBM9TQ?Z[3-[!XOPLGCX5Z'TUDXBL-R RSOMR
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MFLB=MF?65-%J%F<__B6_>9LY%U/RT2!;W_^UU:;17OI?*W(*28MP@F^BE%L
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MG0*=HW>'X;_/M0*;10:KN7]OH<'1KU9UL!S1C1]Z__0]N544+JS=\^AKY'<
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MV2FF90LSNV)\D1M"BI V,BK=N(VY,+/1Z6Y!_I+<\"0FJX3WMJ8>O'/UTY\
MS[$OFGZG($:S63- %$SA2(+,WUW73X2;$3,.!ES4 .AZM,:!$3$P12QG$[>'
M:8YZ]%-8].=M>"LO90S.2C8&YGH@['\?XB5#V!'<]LX_BLX2)Y(.FL?H3;L9
M OUW STBA9-TM>(9VN^'N-RX)7SVC/;Y#Y14$$@.!'I$_Q3"9/VPFI-E@K/
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M[)ER>BHWEDWFUQ#CWH_BKZO\62VNOSL)"8S=2,GC0RK3*/D1_,9)-]R+T#$
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MU+#T!)<;TTTF3%('[-X*-;4UHB6W$F<G[Q4XO;&T/O,UYES((,*/EFI"82A
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M]@.E8K?F[6)E^*]UZGFO&Z%!3]Q>VEPM(3Y0]!G9,O../"D44#3R0:07H\_
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M=>'8ZX![[5!7J!FY[D@%:+'X1#A"H@R[F\"UJ;!:\*/FM1EPVVUQB])!,GB
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MJK%$^Z2 MG'\I>A'V*-4P DSC)G /-/K( L@]E>ZEL[9";8\C?P:)'Y.Z9W
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MDK$G_(6;C)=9U;.>0\_Z\TXUNBI-,F%I8[N?GD[=27 *RDWJ_;!@[*/\S8*
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M!"<:@SKY%5'\587X:@ &?_92M\I_H^Z[&YK:FJ^C(BA50'H)TCO2.[%<0$!
M0'J)B'3I( %BHB*]"0@H4JXBA!YZE]"1KO2FI$AO"6B()(0W]_GO]Q'>+W#.
MV3-K9M8Z>V9O^[V3O1JRU!9-&]E3K@\/VQ5I^: P=B1=VX6(0YX[.!67NY^G
MU(>7YK29LY]ZNL>^N8=KG>W6H*&B#:J80'Q;=_:.PD COPIYQ,!O731D7A%&
MJ!.SGZI'<??]7ES=>9#1^&OUWDA7UET.-FR]H.<[:V3<: ,TO0R>T??KG3Q.
MKY+0%/RP#A(]6U!BH2X[9%JKR[FW8U'(A9 'JUJ8\"2@*9?]M K&5"=]GRS>
M-_)-'FO(]V>QX=(S=.+,:"HH,1]><B^/,0W?M&WY85(^I!()*EI[R0-GVR U
MHYTMD_D5#I#H /N!?+?W-0Z5^DU#DSL[TMZ9]U]J/?1ZW(.^,.6RL*5$X5(E
M2N(1>Q6X( ;*+9+%!+"7+87?HC 2O<(0(I\;:;V<5)MK\J:AGF5G@/PH__20
MRBJ)E^H#)11SHKR>^Z.#7C99)BP#$[L%6CKJMKB3W(GM!>+$5AX984W+ZY8<
M[Z^.J306EM;I(I=KURQ),S24^ISE4+RQG4FU76"T5X&SV]?($17Y^^59VG^3
MXP2"+>]']B)%B[FQJK)%PB&![(_QVF".Q_51PN[9"Y55,=JV#GGQ2*V^V5S1
M7#$ZC&R=J6FAKV&K5W2SEC-+GA4ND'^@2U)5*,N][F\WDUH)@X5-VE5,2?(G
MA!IBSP]#J'\KIJ!?*B'A-0WZD-^(\#W-;2R__7EK^?E&187+FQO-C2WYF-7L
M%U?B!)%:@NE=@G9W5YOLP#Y#FXRL^B90^S^<^$O]( 84.G\-;YFBM-QW#NAQ
M$R A" CL8%=TQNL]/>< KKG:'(%AP>*V8X]LO]J#E-,3<J T5KW_'92C]%7%
M>Z^H6ITBYQS/WSM&R0/8G9BI9:QD@?2#4G/3&J<LB^\I)BZD20',9K']8$=;
MF^=?F.OKBO3QD,;7E61F=5WCD_#'LY5S%=;AVS,(GFK$LVGC8R#2-WHJKEE&
M#<[NLUR45S%PR<1?/VVTHR2T.HP7)Q3#^IS58.PL%O5X[3IUY1S X]RS[%8#
MC--3P.Q>PK+Q0,K^/G-<W)I?Z^I4T7MAE%I?%2'R9TJ,ZTP6WJL,\E-Z"<);
MG8GA(C*&@4LEF-*$ 1 ]R?G!W--F!5635AD1ZE21@STD[MXB+O6W"&'U(2TV
M[D,Y\6Z=-/&#GD-ZM>*]XGA2NLPQ/[SMZ@>_3+['/%YXC&62L?<U=+A6>5F,
M+C42.=%X#KC>R$SO.$#2^:O^- 7T]1Q0CY^IWOTVCA^MC;13JW@<G%EZ?;<R
M.+10RR3FC^"C/TZPEUFDH!>#7BZZB27YUI.AJ6MD.U3#PTJT?XS>)\8(Z<<2
M5LV&LX'*;W&2)4RS*:;#D_R:%,Y&ZM4H@L>#KK-B@^M0_^\',)T4W;;PJ6OJ
MOZXBUOR(RN_66XVCN@JGPDL9I+(7DTF7B ZT!7FC$FDR"9Y\#F@T'@8H'%"N
MNI>#?5MO3@D,/O<-;-3_\BMT:)#Q_D?>1T4X&M?^@O='YU$X-+&HC$.4]]H+
M,+N!&,22&-?4,?\9'SG0J#][$>?J^'GT>5O=:AD>4+7Q2$F0M8/&A.Z? UX7
M\QBPG@-Z[\%4H1IGI5#'"DCK0+YW0A"[GGF,K@O8C03[(:71\'?<3+/P6HI8
MR(Y1S$+L&>K#^GLP=U\&.X%IP/WHBI<#E.VZY]K#R1S[Q%*N?$_U&U*F$,8W
M@84N<J:E_.DRSOF;;4?RR)OCD,"(!OGTZ_[>P =5J5]#ICAS+/+J-J*>&13,
M%"C7Y53:#,A(SW_Z?*AH'[0YC&/K#>(@V=,*P?-+O=U\\^J6#!1] LM\MF(%
M?7$XOE>0U>90_!]-D:-V!N1]3G0BIE^HMM2A1#[YZ\[8G*,#/9TPFZ"PW&EB
M,97Q.V8JX1S0<M!.UK$D:T%5YV <NRCV:LK5:K]6G8#&7?[VV4..B3^Z#=^X
MHTY,.D-"5QJ>[QYW4IFLR,JD2&+X6:VZV>'%[?EHS9=Z$9]]82+?F_S%V>]Z
M*%9<Z<A23[H39WO,^ ( 5)H!?@[>Y/5R*)B2_]JXE^OH"IV12/=]ZV'PQ9B[
MD1$2#7' >B3&:0UB"!:V.=X,$2.Z&NO<,/B H-2+_G4295-RPN.=]=BQ\8OQ
MNBH&>Y8_.N^2%DZ;RD=#LVH2LDMT]':FBGC6U_W6,L.M#&'),"B7\ZUS0/:+
ML[>@O4X2Z+_=GS]>53[ HV!@0\)9'ISA'+ ]_;-;<\#R[PU((W6@#7E61T8Q
M@WYA@C/.TK;_^]F^2;ZP!3RZ^!V^QXF ;PNJUSCJ_)]M1/N_H?"/" *-ZES>
M.0>\[8=]11'O1;"="42Z,82< X"<YX %7_AO#224AML_\%%WU!,P65PG@9K6
MB;S4=@[(2#H'[#:A3@7L2]]#M;W/4GQI;UW^?#?J')!&M1)9D4_-=!Z:<3'M
MO1%W04FN'B#[,LM2OXKH3WQ >Y[+.: O$DT&)H/X_GQM4F+VXZ:%18I9A^A5
MN]GUKODHC=>\:(9'#G@5"')TZM7\&S#%C^3J$<DQY1^!K>)%Q U9WUOV.9%C
M1>.*_:B)('1EMSY!LQ_UXB<'OO@5T@M_4 A'+']NV-Y[!,&EW^ ?*&7$A&3=
MTG<H8,X_-M,['"K&FX)?%AG@)T@D3ER,$NE>..FS=T213._["ROL[(TY/Q?-
M]RZ^NB4E[HW7Q8)>0(WQ)4/\AZ^@COX*+24?W2:\/,.#?L_%O8>2\GSDJP%B
M/MI3F_N@QJE]7T(_$3Y?JXZB]^.A2K?-BEJ%E/W\>MPW\._J,^5'%E%ZCXJZ
M<XC#>]_1;-=HP7D'Y1M..!PJ9%1BVQ8&MNC$S1<&< R?E>@Q3GX??P'8E7$1
M6A),W:P!P*RD$KJ,%3,T$S]]5^?YMD_87$O1+4S4#UD_TA;2WVTEL6#,-;'@
MH>)XZL6YNVE2@]&_^)]O>?JLC>3,63)?8FW?!G^'M9-MJ:-N7*03X%XI3U_:
MA:9=7['IB(I?,QB-0QEW?\%D.E-G.GJ/SK""PM%[*\=*^S)D.8@9.F\_C:P#
MO8^7Z'**C.\"8\<N)]Q_J>&\,J)6U\)N#Y"V&\4;V EW 2!Y^[ID&=@4O!&U
MKXU'].I0&GW7F+ILW5GFO\BM_[C8GHZI:]<:50W?@AR"E:@K15QG[RDWL#6R
M;$O%5CJYKXC?6CY_3WIB^Z[6\\J48"!)"[0SN_E":^3L[5DU11,SQ0/OO=5]
MT:=(_GLUY?8G<TSLIF_>]H;S/:>HE_((D5_!$*3F694!'84_@3A\5J3'Y(T1
M8N@KXEI WG -%&"*:&WNO&C;4ZCM<O/OO2EM?=5;P*FA8DS&=;]E/>J-F7 A
MT]U_6J:*8;F1NF)R)PUZM2$K0OYFF*G7M=T2$-0]?.![^9;6_,%QN^^3>#,R
M(M=2GL?ZO8!S[1XCM9&JB$R@7AIQ_PP)0].G88%Q]8N&&DT==IE<@Q,#MQD*
M/)@X#S](Q ??%7P#T$).*-%3?,[>J64L#_>=9O2OQ>ED)& (=+O"B,^D;#-_
M58_G\J67%F^K<"36WDWEL$_-GGT!BZ'.TRJ9=RKHB2NP=WDXD6((3"PAI+9\
MHFM.*M[SE4^6X%21N5I_E;S8N^NV36##_+=5YD&6WX*)XN-;-Z'A^?,_FG5O
M;.0Z9R'V&;]ZL'^ZL6PU;\*4&VP-4KA?7 W$VP:E EGTF/ J:W<(WG$UZC7>
MP\_FGQFP=1?199GS^Z>\0SUGNBXIR<O(F-FO*20WV"U/N4XR*:&!6(<"PNZ"
M$KJ%6PC0;M;&_*!K_7Y5%?K?>>@=?\+,="GOMGB\H1LO0 6W(Q*4WP4NI99>
M+ZW>2\O5O15Q!R$FM!OTX'O$A.3DFM7L[Y1=7::&R\VSN:U,@A\ZH$-ZS&3<
MCO^I,XD' U]:Z#D'U"F]IBI2S$DAF'U3?:5_LDX>S@E8)IM;8"&'$LKW J_\
M*)#LNR)V28\S<Q?$B#P'>"%7O-$,28%07?SNO>G?8P$J&Y.3S^J2 A7N/RB6
MW/EI:QB1+?/U;^P3'/T+4'9W\^X: ,;M1O$G?<& XXGN.>KO*6,5+T:' RX=
MM#$'W]FX>6M$<$&*(->?V\U"RL !KSK<.UK<TFD>+&S*.%E6S[VE^GM+>TON
M=PSUJG.I;Q!.*=% MBL.;(T_R(0M>PZMCEQJKBXH>92C?0F%<@+\-2/VXT']
M&1>A;@F8DUYG$XD,DT9S*8?65?$8%/M@@VXLGW5/8';D*.AT;@\E9$ 'O4D2
M(.M1=-H6PE/R2 L$C4F!'^HIF/!S@(9:Q*N'Z(/018&\-F1QDPKT-MG+N9G\
MX?5LM]RXEPK'8*Y9UYO;7_5IF=WO=(;*F(,L71M<N^QK-_C:[5I#/;</Q,%5
M 2?+'LW,OJ7S@/ZD-V,1A=&,A7%OP;GA?O#K3CXM!DI7A>,^F:B9A5:/7GE;
MB^_AS)X2)"]<)9O#OA9=F.X6&B;@B&$$\]9D*M"9EN&]_3H,2^2SG5R?SV>.
M<O?8Z9W)_1**&5KC@ON80&7P/[?_ #D$9/;WP_4558Y+6UP]F#,_]NTS:/?@
M#.9.+0G6+%)$F;.T&BI=KY[F.8##0.2'9&OE=J/!,>)V,->ZD;&\]4-FB%;O
M]BU@>H"D:"0PBGU$.+72Q.;@RB"L%C8";\CKF>*G7"G&V0_5W'/81OGG+LNW
M/6 ,[/WURH+A=O$ON:-X0P\Z$E"O2C5SZRA>G(W$CLOH0WG O5'I\ 9J"IE[
M:XV9JN&Z)G1GP:5H)T;H9FY;EB3\[;VD8ZYEL/97W/P+;7CB&@OHT0<0W<Y)
M]U6"O*:P>/+5M-<&H0>^.18]UUNB0M(+BN2. GVG==]C'6I=S6<S>]=7S$6>
MJ 2D^(O>U(U7COV)<M2+(8O#)L%-P-X,=HK+66:$T!V6F+Z;J^956QW].I?H
MKC@YBB6]>_*"E57G.)^X]D*9HD#R);.#H4X+5$%2Y*"P-KZBW<QH=M\C)Q"I
M$'O F7LWQ]%F?2JH'P!,Z.@NKH1$.XC,_Q[;-_ OY][Y(='4-MYRH)+>GAK!
M@'!J?/YQ=]DU)Q=1OLU#S'_VZ<->X.?FMH?OV0B>)0"V6KE39A(30946>LW
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MX^[_(P-Z'FHD:UXJB9W"L7;'GF7!N):AH6=EW6P4B3F%TLYO%%]L3("J8SK
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M6N;?0@86F@"S>WHZV1E9(=D>6;,3:2"2;*7GM+=@/5)I',QZJ*VXE/K)?/6
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M]IG7_[)RX>2?E719],JT6+S:>2OB:NKMR.,KS,+\HU\FC^I/<M<R.0:W.L:
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M328C1[(6#^7%@F!W2KY';M[S]Y0>O.<1<IF!/72CA936G^0W19\UCM_5&,]
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MT6 3&MC55OX'R!+\&W0L&#Q&]&/WX-M_>_]4PE["CRP.+YX2  -N5]R*U 3
MA,(3>&+U?Z\C3',8GE.- 'CEO'(9>,,!70:+ *4DGD1@B%['?=(%1@/JB/I3
MVU=RX#\=CB8 C![!#DR!5]>Z8+O"=-BA$=BZ2P8!,#=&%,%30UW6X4<%"(>H
MX"?0IT>S/2#*03>W$DRN0<,D*_K@=5-HOV"I'NM&T8?PZY(\T?* NRYCS@?9
M9<X+DE,!$=&ER]L+<=P2LA'9<HM6W3T%:A)V5NKRH;>YV(UFXYWT*MD5U/5[
M-;.FR1ON[3[--F'\(C.I'YME(ZC1I^%E/FLB\^VXB/S4P9JV5%7ROD ]0D1C
M-"/),\Y^C8=%TKMPC3NG4B'Q4*I7\1[&@4CKM8G/WWU>&7''H(>3#S/K8V/'
M,^G4U.AGTG%ORBY.R]<,Z<4?.E766UU_RS>EG$&I!0; K"%@6,8K/-EBF0J*
MG(H2$HA<BF.-1 M7E9:8SB_MR.Z]X*MKII*+?B;>0F\/*/'@=*^PA-V^/.^E
MBL*+)$A#7Z%(^SJ$FB(5C1KA%=;.CWJI7D1[2(1X[>,E'#E!F,15S +P%E0)
MY?;>-;M)H2GR++;]":/;X6,++69>^6/%YNJNE5!QB).]:-3*Y?$) ; _W0<S
M+,OR,>D4>M KBC9.;0ZJ3'+E+CC(;:AFVE&CKMWXV(/3-1,87*&2UW1/,80M
M+]]'6';4C51+U4[W21U:ZUYN$*>!!-_/"<30K>4F@ICQ@KO!;(VHR"Z<B<E1
M:OQI1E^4?R57PJ73VP>TFA06L1;\GT<XG];$_\,34@:J=\.R1[L=$0!KQ3'R
M0 0PA)4W[E2;U)I5.S%F*V8F,/J&5"@9=U/V]&\!/AXKMLV!&SFZQZYNQ%#>
M2%K^FHO2'7A"5B8^6%;T%0XCW_54KTC2"*!UY_6G66+)Y2[_QKWYO90[S8DU
M,-H:B51[K.4ASI1F9IHT(9>;GI6<U+N>X[)8CKAKE8U2=.G-<HB-I!YF"^^V
M<9?F4Z8++?C4'2[=7RWT)=JSE#65?HMYA]FK?JI)/B-8X)5G7)C0C^\6E,>.
M" _F"ATIVEV]/J/^T?K%@A'6SZ;=F45W39LX'7AN"_8YP@)@1X8K9! M//G?
M>LS=OX*%',T)@(AZ&#4F4*4>$^+SM:/:GDBFR'O/,_1[[1ZS,*K0"IG>J!CY
MQE'9U$]4[VFY]>=[TU>>P=V/\-UP5DD%7LT9J$R^)41_:-:D.71"+K6>B6;G
MO$:AIR+8M;VW5K/PJ-N8K9;A$P8>A@3WR5F):-^:13K$N[8I"-F3>?/Y#*]/
M;(1\=^2N-WLO3 .PTWR5D#JVP[H2!97T(6IK"I?+I@BW"P) ^Y?HPV_-@S+"
MFYVH#@WNLS]CUBX_OZS6%G5C$EB@RL;475LG8Q@+ML@>S51H3%OV-+^,46:?
M*GHV(]/85?+AXJD@IG5?.HPJIR(M95F0)T&[%Z*)B=2/<-5*H\E^EL8),LEJ
MSW(;9BU_EOM8#6UU)(B_,XJ1.P*O6:>BO ;@]0Z1\@9$S^B1G1YMY@VW;PV5
MYIZD59;W]=*256/\<1\L=/ Q["Z]S(.V<N3Y '#>KQ=V9' 81@!0PNRS17M:
MW,*QPE[%%I""WC3[F6$=*ULRII%H$:E4L8+KF<O/&Z6@>?O 8879 7AB4\N;
M )79_NIHNCFUW"4-I*O*^Y@5?^Z1?BLJ]]XXCT2P0MV,S[[4"U<'[5E)K3L>
MA2>Y9@VM:1PJF[P/C9M5:3^-H=Z.=;C [R!R:=;$(&T],9CEQL 8?T51_F$G
MO<Z*6Q3D-2]2. 7I(@KTU!B,F3;C]Z::DC4L(IF0G,J1/3;NEE+=WIYQ(/17
M)K&!Z?+8'"FF*%,-I0&JI^W.&HCM*;TZCTTHW%:8F$;S#K$,8#R9&6(%PZ\6
MI<CJ\@WJ?[3USJ0S#?0J2:S4XC?%](<:)_IN$;JW,S<U%@:^#8 %QC/_5>R3
M"3_ R7]TA=7[A?5"@:TG)7G&WPH=N%952U9:F_XTG@F_EQS4]O3IP?(;9P)
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M8R2JIO(ME61JY+7.IXZVXN8)1>;6"R]>]!3=GBCF]WI2N&5W^99-$?'37FE
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M' /*G#V37Z(:)P $\*:PU0G1"S716-A> Z;@HAUF,#*.HSJN/DZ,AJ_GCQ(
M>T[Q!,!43.1E4 @!X-$%F^-D(@">&S#"1Q?Q=]\1_[02RD  U/*X$0#Y:]6G
M&M4GC01 6!YH0Q!\$[87;4$ ;'__LP]E)@"24[M7T$ @CB>7!VF"_< .)@:R
MD!O^0V)/\?\ZIUP,6G$[S[S(<(45;ETL<GS*QX;&\.79_,]V[?^UJ9(6*4M4
M4L=5B&MUF")[]>0+_1/HN.\I2#E@96>WW0;&,+PKT1W7\2/6-W&%9U3TBC5?
M(9MR&L*GTI5S(T[HD7#ELB\V31#0H_Y;@2:WQ"4Z[<Z.L4_$Z5@93BRUNE_R
M#SUVHXG2V_+.1V;$ZLV<>"2F;[\\;O-5C)"B>=\SU,#>$=J+W&*B+]7SBI>4
M&N'>.-005-&X .8RL'\L+#,Z"=ONTU5\3^VD%YO?;*(]='=6/TY\M^(:_>7A
M(O[:UOZZ/FO0]WN)4O>VTC>X$E^ 25'E[0"2/ !5'I[X0.@-7-N7^A<#&W$6
ML,]Z*O3OZ?54 %Q\=@(!-&&A:KLR96JZ3=RY*UX[\G,$P/CN&?VDB[W$PGS#
M]@(V(E^ 3P7(Q\S"G168G 2C=9K24U<BSM<-<27V*VCG"O^/A9^Y.1./%1L$
M2HS(9:^%)"=?Y&@+TUOM!\G=7)[]]:85[/ZWV?C_MK(%4FP6Z=\D;;=")-J7
MWDWEDO^YR0FJXP%LD*(O%\W3!]N/7,+8$ "\%.]A>VZZ1-<Q <U1$7_Q@3&6
M 'B9+4< J",JG0?'0>LW\PF .5X=HB-+NYC#AY-Q=T!10(RH"?8K&UKE;SG9
M$MCV8LN17"(&DXMOU2( OC0$;OV[G7Q"PXAAT)X%\0.=Z0=L8UBWX^@[]'K6
M3O\MIU*AG['-^U"%N8&@KUF;(_GG;G[[80\! #@3I0X>P0OA"M:FBB)UCG):
M6B@7Z)[B78?KPD]2-2/NO1U[;MMVG5]^[A=:@_/4Y/JSU](OJ50!J Q $M&?
M;Z]'\UA5MP+WZOBQ4V$O>%);'MG1O@X8$:<:S$J<J/SUSTUZO7\9 VO_TEP=
MV>.@A^EJJPR=P'>E:_$/K$JS NO$L'/)EU,I__,NGR=)IFIVJ"O&#<$D[^'K
M+_FNE7RA?[!%T3G(C>=>S^V=+,E_1\[W_YCB8]QWV+HQ+I<8W*M8FK\;*\WQ
M7;#5II7C<&*"6$&K0^\3 (4!KC @N(D*&[-"I*ZX+& HZ'3'!3PG^O=%S LX
M:A$_2/4>=)JH7>U%BI5/Q/=/PT_1M\?V#?^N)/,#M^X<;>$UMD+A>]<<"("\
MC#V7A/_TD@M?]I( ^/T-A"8))4*,.>]%:@8!\&-6D@"HR2&Z3&DJ,?JKPM[Q
MY<< _JUU*J@Z5G^!OZZ>/S3 5< <J6YAKT_XL+0I!*W1PY,XG-79^]X("2\C
M:C57(\F:N-<4L9Q0:U&J=]VV'G,M90E,I$^K>.G,-1HTPYEE4YTEZ=>G[C/N
MTR\V)+W9Z5I%,6.-*#EI4\IMQ22=Q@MTGNCX$)4]C8ZVBI>FAE5]PW2N_"\K
M>)_NC=]884P14=[[_$Y>_HU51.D4(P+CU7[X)*"MGOB%5-&G H3"/64$P[KZ
M/!B*!.K_3!19IZ3L&!?K-/"7%PGXO"PFXYYPR7BL,\);]=5G>[IGNE2UGEU@
M(OD]\CRNH,#$7,[_2=M0[7R/N!OLD=05[8^P8V.2II-B95?Z&Y_/UX_\U ^)
M42%63F_<Y-NP%'>P[]+JV]KTFP@7]__E4TJ2]08?7J]\>/1$KGCK6QQ>4H$(
M%2^U*PWJ#F)JYKOHWNK=!^T/<R4.?DZ<J%@-(#?G^Q?P!#0N'BQUQ_ 5WOOS
MHL^-76@TLY8 "/2JH^H4NQ?,7%J2?W5Q *Q"_,?(^:_+:/@D_BV)6,1UY4-,
M%>KP#?8.86)\SR(3-\]PNE+*IZ A>!H0(Q&+UQM&KEP)!_/AW<!3)]X@96PY
MM@#I=L%7![]B?04[>_ %G_L2]ML=C"8E>NXD?=__:_+!T;I@]^&KVU07FK-=
MX*L'1%5R*2)[!;X%6M]P;\)%#A  &@Z#D%2B=Y(2<]M<+!O1^[F.=O!7L+:5
MGY-.8^>+N$V\?29X1P;O.V"W#;]'1$)F(@X#_HU=.Q_;(T-EHC4QHLA$%F=@
M SRT <RZ+=O>WL;)U#11N8#4DIM8%:H%%#N[">[L>8")2GY?&_4'S7!DLN=T
M5$"\,88.SC\+ UV55A+G1P?A;F_M6D+YGP7_X_B.F^%W^NHKH":>>CW>CIS]
M.L.$T@>JGW',[D%]02HH470+I@[U"B$:&4R.*3?,V.K*85+GFMCGWI0.[Y!O
MSTL>Y\,&"1XOBQUMRFOGK#<WR ?;/940^U6:/EF</ON%'*()\5&E'79Z*B(-
M-2QRT"_DV"KW?8,3#9<^>\WRQ"G-L'/5>;2*\4678<[U>#/#:OEG IK2\V/+
ME4\?;:Z_3];S;8P9X+C2@#0A8(F*3S!C?2LW)6*S21#!Y>Z)B&S.8W&&D2R
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M%Q&_42.]I\C_LJ;^2(LBOO1]SW2O23Y"4WIN4G=Q?*M)@GL/N9ZS-7OD0$<
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M,D)9QOYPG@S46U-W[_+[336DLR;N; IF!Y^/[ ;6F234'UY?4B,&#3W$>>)
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MV;IX:8ZI6GQ599?=36IL<)H[>99X;L)S\D4G(HDUT?_[^ $R&;OG7]Y]*D>
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M_\E;X_6H_]F+YDN ("Z;J"UZ2!SXN$)X4@8KG0.=<3 3WJ-@?_JE_D=)59>
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M83%<RV@B%8WC&S<G5UO&31*T )^*N8FAFQ.H+4MTBK1CCUK,O.5E'&-X9Q?
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M?3?24/7!#80M AEQ)M]R"6@YZ=\HA+TM6Y+O 7*^=-UMJ_D-W)L!B.B-&0,
M@-L I!FZ.J22-"_,(=R!Y*B _3J)V"X^7*4>QBD2V(-@W49;3CN:5ZNM^)6V
M6RY$OC38>+HF?/,H)'T'NRXT@QP3B! VJK0,$K_'@-+.+C=UFYRX'6^4DY/W
M*]:M*RKSVXF]3FR]D'$EFW%AU@M'0Q/^\LG81/ZTG%(AN6M?4MUU*WE/ZDI)
M_KI&R%<1N+@/ZWX"-2!/=-2"2I X02Q1?N9$C$D=R%7?G-5TTO-<J98[$^KZ
M04/U;=<'0A4,"5]IW(_:SX5A)E'W*HL#R9&SO1(<O<AH%7*WHGFYDNHO<]::
M'J)F%+>%@KX\+$A\+I;RQFP3OM=T80+>*[_P<<UGV7_A%M!-#S7&.BRL5W]V
MYIUNI-$T[Z!6+;NO0QYJ>_<%*)-S]U1@-7_O#6F0>S@L-DR/4 6EO-#$V?=D
M0>*;OD,=5_,C%D9_ZM^&N>GS^HS:WJ1[PFLJ(V7R+"SE ><NLC4Q@XRRWQP*
M8W(TSYGEJ^Y)DPQB3X082?>\:'C\MRYMYV<I5=X@<W3I'B$AN''O2QN/(4?5
MQ4ADEP1M;VL\B.:E^6O$O>(\'=HL>,U$MYV7 NNO0AT:4\8*O:SJJ-[AQ?8T
MYRDW/8/\AKQ,"$YAL']F&8R3N[@9N+RB7O?3$4L>L=Z5-S,T06W=,&I7KZBF
MS2W45A^M=SNUD0JM(O@:3V(HUWA_-:XPF#=7$-FP&05!A4OCG]AFS-=S2@9?
M?V!^!U"5OJ$<@,!XA>(L#U%.>^RVR*>7@!XIGR_BZ87N/P+H>L20J60Y2FD\
M,ZV(A3<7CTX?DT2(#)06IRK:/+IZ&)TGP#903!;!3+MM^3Z(,3YH^7-184KA
M+D2H=X@QD+F7XP8;77$<?-!D%UFF-<3X"H4)BO0PHA7264XS89..%[;N."[[
M^N?\Z8D>A]G@W,CC0B.@3KBS8=],/+>P7*6=)ZNZL$'BCPN7[3$F2\$V$7.B
M$V_RI&[K!_FQY-&FK],?J8BYG8I8^+_F-SXD*^<G J%&.)DB\VT0)\)YTLM)
M/F&]-O04K2LY,#@2LZ[QZN/;/1'[6*(#7_.*DU@[1U!R>]@V0N!\]D_QA5Q@
MZJG?/X4%ZU;KE+E@(JFM04OR'E@\Z#J311<G+K]?1ITF8KVO[@.TY--/QA]_
MFUN>'D-*<>EZ.9@<,(0SL@\M?5."SM:+XU%4[V2Y)=WP],W'SL;]MML#1O#P
MPL0,INI@%_K.NXMQ6HO'$&"%MD+.3B*0-JIG,S GE?D1;[6E9Z%<?/IKWE)]
M&IOBPD?T9N0<UDIRBI_1BO/:>^?#1(IT$@C3X(8O#.3WJ3'/T2.6FHDJZL50
MF6GH P]T]M+=D=_A%WP+A(1C)NVR=9GD5IZD3PP)XSA>IAC,$6EQ2;'2')=6
M]V]YBW#CD.QG30]K"143"SK;>:/WTJDR)1C\^S79'7FN7;%))=E-*B$QA#+D
M^WG /F7!<^@K3/X :($)%I75<IJP&>YNES4T^_#>9#*]J.%P%)7W8M*RV+@+
MOI4T?R'$&0@UD2[DYR6@L71O&%M_<4&/FAT8=8)$7O09_5@WWPZ8E9>A<&RS
M,_$O^"#C@%[G:7;%B@Y>?S=6QR5@A,0S"="\CU< @]C,1<6LQ"P;/4W0,8.K
M]7MB3WJ\$K0-? I8C$*SXSPC9PDPZOB!=4\D5:=N7*^=EQ[4*"SWM<9=EEC9
MG=5M436Z2'E:<L'&2EWASJ/44JKD^/6#CC?,W_(7R8F4*Q<&4-/44]7I2X!#
M CUJ,.J$X&'R2X4/':<HMCIU=\:@^+V?>EL\Y<3S3YK9O3<4!69J878K\RZP
MN0LBU5(-7F;JX%!NG'JT]/<.%RB%N/K\4XTO_XJL5-"DC!27!64'#P^&O!Y'
M$E_75@@?P"^3%H0N 2Y@$'$>3*UBC]GL69BI7(53!!JID[R[0652-O.>?R(=
MLD&+5?@C /1,:S0H_QMB,?-;/CL869DGCAM$7P(8G/-H<!Y?G,_:F</]$K2?
M98R7W*^^WBHM(RBZPY 8M&MSXJ1#JQF+P7.+'C/WI@=*T*I,L)QDF4(6FP08
M'RH ]UF&:44="D9/AGS-[CK+^3=BD9M1^30SJT_66:Q..0PB$BF1RQ9:)(G8
M(^FW+(:T_%Q;5U5.,/6#!3F)!4D(#!-G8!B3I(529 N>@=X,D]^K3V_YZA)P
MTU>?;2N8-P1('&E.$<FF7M(0>5.VF9PJPVKO?0.I<7^PVHA$5MZ', 0&Z. Z
M,(7HC#@WYV(7$+T:QRNVFI9BBV[.3@&#KN9$U[@D\3MEK+G9N6V]P;[X?D)+
MIP$JGY&XM"R,#8@XR;;VZ D W\8KO_&H69!T%7J-FK9-<0WWU/Z(CI=IX0'X
M0,H@&&L022V0$\6<\QL:853$.Z^Z%-[2H_(C7\M%_-K02LQ_Z^%$I^^J-N!6
M__A;)-=GC,B.-#XE4J<OA&E5N@J^(SW@2;2/'*NTQ:24[/8[_GVK[3E2RF(Q
M?7I05*CRZ#2Q5$GOK&7\I6+GL0T(>R/1_J,F0^W\V-4N,^UF89E3=W.\HW!]
M]T,3]F>! 113"=?WIN5N3.C*XT]^J3->..-:_W^:7LHPJY[,RJYL_@*9#@Z[
M28MC\V-X?9VWMD7=$2)/,RNC/8@174L:*PJ=87=;)HTHY_;B6HH>T,KCY2 J
M::;JE][^P=S?HD/_I;/I73?X<O^K:N[01Z(A+T_' IX<=)Z+U!G@KIQ3J3>\
MYY=Y+_!12V58R"I/X>$Z^;IIV9?#CHO>+,N=$]/@KZ99:KOJ)0MW/]>_T]D,
M.0OQ&9G8OP1TR>_O[IM^OTEQYW8@#T>(L8'Z2L!93/.9V[P%Y,O^UMO!"RGB
M$O$>X1.1 6^"$\VCG2!R!U*O3M$PP8MV!T=::GUH8_A:M,@J.IUN=3P\GISI
MXIERC#V_!!AV)BZ)(J?$-]H2!SBJ3 U&>12:P^-I.6R;:R0EA:E$PJ@S7DB:
M5_G+4T=&W#1U,LQ][6>N"*^:+J:8+#7T]/:=FE88$/>,MTJS'UE*7HH9P<YU
MB@/)H^'"K=!KPD8]1BE)!\[393MCM"FQV5&-WBGQ15-6Q4/I2[.Z#A/P*@_T
M.^OJA-_R;H[*C<DVT=96BSJ=+0?K9*ZWD*N(SY> B)6F #P=8O5?HT]RG/UI
M)NXYJ!?&@;,1+&AKQZ1W1K<71%QMS*1Y'=<ZHK'Q@W=M<P*1=YY0$#%F(SAW
M7B\"&@EU'5V]Q=&#I5$1]6(9&;\"(3>9Z;4[JG*SXN+/*6IS8D*/ZA7Q<;*5
MZ_E?B'$EJO<IY,26W#7&M-[TXS"1TZ>-'/%,PQJ["/[0HSNK5M"6MM2F3TPH
M];,_&SP=)$619/R5"803"]@!/F?_*/LASBO(>S;DSBR_1NPEP""(4KJHY'Z]
M=-?&=T7D+'(@6]DY*S&[XF%!Z:2<R%M3/H7>W\_'6JX\3XS?'6^I-C5'Z[>Q
M"5Q45.+?E4Y[7@)N.7;*A5:&#4\'YUO C1@3^M$B*AKRG#'5'LX09ALMI0;_
M^E]\G'2/G7(>)(UCT["!+=HI!1IY(,K(GDECR=:GJA*H7[V_XKQ*KRUZ^"^Z
MZ^:;ATQ FN7[5A:B'F.BHE0\8UP+ ^^.+8QKUH<3UYD6I-B^W[Y=$,TZID1$
M"/Q2#_XH>@LHUON(_%WO9 ^JO&V(P5G<7,.$=]-0RR-HM.W>HEO#Z("]5U#D
MW< JM^"/L<<&AI4&R[H/I<+-BNQ9^OGJM7QO]06' M'XKL*L,E&T]<8]7Z=N
M4>M%%L5OUSY<V?ZV;;I5T[@PG_.CJ8&844$X 7N [<<7)D^O3JE1+$%9"35=
MM,Y$4&=C,E/OH-(U\@M+ C/96&L* YW''9^,'ZI*9C]#E$E+$!?2!VD ?@-'
M@ZDO 2_<;IQTFF$U>JSE^]0$IPJ3)=QL,YC??2SZ2#XV([!N?[(-&=WM9R?@
M?ET"5M0]-FCN]M)Q%!D4G!B;@#]>[2)G1LUH)0Q.#=AY?5JR$GOMJ-+3K*,R
MUGCDTEKA'8Y61/$7"UPWI"W?2S?1R5)Z(.!XQN*N-EK[D0+URE8Z*[ BT )9
M_O+G\%:O=&ED.3,YA1W/4-K7M&+]!06E'#CZZ_S9;/<*3A#<!PS-OT+DQC-B
M$&&-^?NP6,,5$!->"QD8>CKY3&+30J7[<<G=F@=_L?N0JX^H[E?%I+!I\?&F
MZ&U;=3CDZ8_H\Q=_Z4*09[R0/I_;P8F*J:B^'NKT4MA)]DFK8RRXKD>7G5/L
M2,''YADERLW)PU #K9&0&;0O0V)P58\K?GTS\)5,6XA-8'-W]S8PT#XP2DTK
M.A32:N&?FWVV\WU^H9?\6EB2G:0FTK4!Y[>J!14A>1_9[Q47^5V4!!#7H#M[
M0B,G?@!-/=6)7DLQ8/E0_EK@S&LN+ M=3G'MQ;L'.\ [1,99PQR7R5RA7<J!
M9V^LA?K[A^07M.2=VO\HOIK)I4HN)W=B%;+ B_4O^8AEG8 =P,AJ<(M$#W!1
M4Y.0_SJ$4?58%S-YOVE2#AO$&B_Z<YZO(\B*IM=[4R7'81:MW6,O_?%E:]2X
M=0-%#7_\$\32BQ1!'E6?G&-#4:\2_[O\P?LF5@3/&S"VMT%!-[1"49VE-*F.
M7=,O,(D-196C)N7!)Z71^;)_[7(KC#,EVJO9>2;'93K=89_,1KUJJ.FCC=/U
M[9GU0.V%VN%N[!UO&@O?^@7X3\$]W!AK[XKA<_!'*E$U@>*C*UG!#Y._']7L
M'[W=:Y F4O55$ '&C69U ?"\2\#L]R-VM^9%MX/%Z9/9KO;TM:98BVM)".\/
M&O.<9DDFIE0P6E/!+W&(#EOK#NL6M\ZO5V,%B_Y3[>G_4G[4U.7_7BMD%PTE
MB9P4YCCPG@X);1:!'9A>HAXSQ25@;CF?^+$&5LM%NN..&#.Q6RF F-QK.9WZ
M&?:=6OT24*N72XK>GC--L$R!<S;8;?#_2T;%V?C_<QWN8(O,W@S87',^,;?B
ML7P^;F6=CDWP2^=$SW_((KGF>+-8SU/C%B4YAN=:R(W*7E>&Z[%!^9)W#C,T
M=[=8HT&1PJ,,5VS87WU^^0H_TN73KL7AD_=^[OUL$Z4KG?9+B$P0;\XPCX!:
M](AQB(E=+*!JYD-CE]>Q_*:*[AVKT[]D;@0AFQF!M*?++T\&I$1C<WR';E %
MGS&2KA295+L%-<,"NT'161)]2302"Q)_/"1A3AVTUU>U);<%OQM280*"SV<_
M_;K/]0D+6S7'(= )FH-NJ X0U=+.I)8/S+:THDIF2=N']X 9T$&G]V1,OSK(
MZ#FWDY]XO0)/P,>UJS[?'RX&"L13-:@#0L)#1B <EX"7H_3?S"X!-$250+KQ
MX63S;K2(^25@U57HQ3>1=J ,($]Z#FGV5>?"-.3'):#A\+V*+O->[Y?1<NAC
MK$:NSY?Q:A?AU=5)_793S5=Y#SZ86-1%[BG !YL?P[IB5PX%2< E9Q=SRU#A
MYWF%</[(E?M,'NYP.9UAPB/#UC>52QH;&QNK093BHSX\3WH%+HJC0=IG230A
MOY;O8?)[L@_#SI^Z J-.>"06#AC>\U:*([_WW7[2O>4M\JWL,P4ZP>Y9W$\F
M<!R=_HZ+MN!GBCR*I;Z$#N\_O>WPU8IN_561O:1Y'C2X!Q1Q=MX5@\W\M@"+
MP2O#12I=6V@K(=O*1Q3-RCHW;]J39^&.LH:J)(>J5%FN@GFR (1/F)5]ZHMK
M4-J.Z9"[4,%?<+G#&*9M+W"D[53*(YJ$O9U>J4]73"A&J-!D[P\A5#CVTTYL
M::B:!&X7;;S 61J-UT=[-%6Y0O]E%;&MM5JX4:^)/&9Q$PF]E^BZ]NN:<("H
MU(T3VL_@CZSEK\@^8P-BY6 <@?FF6'^$%]],7=5O+=7?$U(OE=?$Z]92^X(6
M%+?[??X8W*?MF_67\/$IL;:RL/[]_(?[4:]*>;O ->G;-3?82_72SVU1P(46
M5'/,!0,N#LDYE0G#9+DDMX;?'J<?VEF,4W97%/49]H./*KGW+778'1!/?W4<
M#\ L >4>SNO=KVNL^=[?!W(DL9IR;0U/_KR80KQ\)&.E/,H[>I:E59RJ]NG6
MGL(_(XWXG+#DX':16<+KB8B-I(+==IY\G%HS+V\/_S[*BO]97B[X^<8741=:
MGPBD8QRHKXZ7R)_[/Z@3B\W<[[T$W&W9NP1< IS(D4D$)<O94U)<O-Y%(N$2
M>/]_#HP"$G@F77'G_XNE']Y\!*/68*?WJDF7U&K 7$IQ]G^?7 (4/*+ 1_HJ
MC*282PTF7)NUMPKHS?\KD$=%PI?K^<10USKXB1$Y<9V$0;4<S,0OO\ C5;-$
MC38X(?X82'A:16+<OAS_$?.N:U5]SL4/'LO#ZF3+P(=I+\#Z[FDZCM?ZJ?]^
MNG]U/\L8&1SA27F^J;JSQ/ W/Z#TA,!]K*-KD^WRI^MT_TA$Q_GF][*+4SC9
MZWHAO(4Y_=^3@FKNP'"!D;FO4J+O$4S_C;TW#Z?J7?_'5Z6$HD*&9%>(",DL
MV>\&A)!9IET)(4DR#ZO(D+$0I=B9,VXRAFQL0PB90^QMRI!AF[:-O=?^+>=\
MSN\Z[W>=\WF?[^]SKNM\?E]_+)=K7<^ZU_W<S^M^W??][/4\SSY.R,4Z1#YM
MB#KBEESQWDU]077(U==*N^#"!"?HD?\&C=>HB"2MS2,>3WY4VU_I2LCQ(H)5
M\Y.1;OQ0\7DV\[6;;ED5A6YV"T9#Z^OQ)KR%F>[VYAT4C>0A#:N<*=D".P6'
M;Z<-C<7>NKB/J] =J,;0'?!0#-E8(U512RIM-JV-O4\%-?IR=*Z8VXS<"XP_
MM;@["C-8J<47(J?[0_>9<&'S846_SXV)WXP:V(QV>Y?N>-I *.0FF[A(]#_(
MRS?.^)PUTGN2MZWR5I?ZM4RF#(9,E857 J): URQY_;[UQ.$1@7W\<IWN&<Q
MMB487?3MC(FW';@6FZ536-PS.^"DQJC>43'_V4:D^)7J-=\;J7NF\<CFJB9J
MH-)YBA0UH4I6,$SIC+=BI^])=R:CKK:GV5/EE6JG963ZZ.^6$D6R=RC:U64"
MO'*8B.F]^\Y4'YSZC6])VB.0,=#F<;T5&6._ZFW.]25[UJXMW(!A8/Z%R8.P
MZ5:I-U:'X^^\V:-091Z&&[O?QCO(9,ANFU4T8A(=PY_6HF# EB2GWAMS.]YN
M&MU5^@2TQ9!/8&MI0+#(8DN- F_YL$S7S3C=CDIQ?EE!#7\3X7O'POA.!:L>
M[3UP0$X'%026X.=0HZA![3$(NYA=-W"7^X*+#]^%_%(:8'0XP)$O-UBNFNXB
MQ[';MQ<[JZYLGB^;ID.N32/)\:\SU-??A/H]^!QZ)M:>Q]HA_CM2WYA;KG+R
MZ&D'LY,LK]3=O26=_#(8H]2Z'=1U)\(GDE:N]W&.+8?M>_!UY,%LX8[5H-#<
MP)8SSVOUZD8]//A,L*=3)X64V\ZH=X2\B8K(PE^!/H-%-" ,:X4X; _)$-F?
M<"@L!"O*OW.W\,J\SSN,TPFNE[CDI\(><<;Y^9O)^/4QG8]E/2[F1L:5S],J
M>UU$AG2GO\4Z*FV,S MP*1(4GS!?6<DJ,NK6JQFQO54@-_#P^#X+L01&XS<7
M496YVOO2\XFO0>NX(K2PH<6RTKUT67:C_9?H=8LF G!:.5,ZCM\R%"B)O3KF
M/-07TH(## \9(^Y$/5S"NWX+7+_^;!PL2D7@Y#*%\A(BS$O.FQ*0=4?Y1L0;
MQ'=Z*R_2!^946KYU1^F%3.H3&U*S2";%Z83WN/MY7,9T+3NKEW:#%V011=J4
M@[*-B2>)"_68@^1+!D2C,%&;DEX7Y-ZI+V9B$>6IID=S4R*DC<.4;KT!*GS"
M02FZ735<O(%),D3>JP>B9RRUH9-5IL%RVO1UG"&<61\BG&-OW;F6R#$PP15P
M%5&"T_?N3#-)R%!/KHC6)=DEWVMV?8_2?NZD)<B78KJ?9X_!RY&9WHQ@_<+3
M^Q6-WF.TFJ5/:1$S.6['I+2-B-@?'D1>1Q+>(H@Z@]H#Z#$0]U$/Q[NW*XZP
M4/TZ^R 1?R&!3?G=P'1;.,= BLCC[Z?M. \F?CCZXSMBD(/437Z^:4-NN;0H
M&#K[EE@:1)%^:SS%+>OWL*$A\DZL1'#GC%S,WKH\X+2K?R*$1NPV (08Z7\#
M !]@-+;\;!O[I_<A'OIGC/>J7!?CKN(0S]75RS8,D] -OVJ@9=M4WUO7'5F4
M;?I"_\&]3K4BXF?WE'.M@B];V,-?1]A;Q/)QJ<>'*[@(!/EG! 6=UBT69AL(
M4+!=4E81^]8\HL'4;N^R?S6ACA07.WGFFVDKO^[QU3TR>M130IBDA?YTV*$R
MRFVGNF;;T9H9#P?LK8OLO_OF;!U "][%!&(+,/4+X4I(<KU+YK<+8PN!I=#A
M3L& ] _QFKK?N<;TQ$C@LU=LK!'T/$:3' TL!VV'SY,3QE <MB/80L4+.</X
M@=LQT<V);L_/&M%YI[(NF#$ER^WH,&-^W'T&<=4_LC8&V , S(_NTX]8*'&<
MJ+ZQ7-F.3,[*P4G7$O+=L]M6#'CHS,[,O."/>I(KV#8_3[I"DI#_+LL18[4N
M:J0Y<G: 7*ER])T)IJA!X5YVIN[":Q.GB0[3UADC>P-WRU*/O/CADW@V49?[
M.HB*W6</HG$?5C.:Z!ZH%.0[9'?9OR\=;;Z ?"HMS3X[!,FN?X2@CY#-LPE!
M^Z8*!]>AC^?V73;^HO)A8(\\?\G>QF'YNYN3?,6J^XNN'9986(_0FC[:J/3X
MY6/RK8SD%WB?M67VX?*/;LNK/QT5\+LSEEX(_'XW[UTY8#V">@HQB*%PP\FR
MT,2B(S46RP;*8F8\RA%)D $E'QZ)5-12!.HP#>BW7U1=]H0R7B=M("90$PA6
ML$D9SLR_=AVA 9GL+"N;NZ Q/SA\*HI#+]-%P812RM$=-."4"5D$3M35\31
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M)<G(Q48:P' $#REC!I#DWRIA6KF(>D(#B&_@5ZTS1_[B%H:(I;)^Q5/.:[=
M;REH_#A/,79R%B2:+$%KF)'OOF(@CHRUP6[PT0 >D/@<9J-QDU\8>>NCC]K=
M!-3&(0KL]T^^1\)=?@C^=,<'#(!-E=@ 6V7&%[5*/P[!(6$B%RYJX9K7KR]N
M[2/((KGH_ N$=/S*T/:D2.B ^$ZX%(T;05($I4#H4LI/-WY0Q&%CD6#B8=%;
MH@'OD()KZ_2BCNN;",KA2NS''V0/="CZ)XQ$_F1E5!%(?.S. 3W!,L#JRZ?
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MZ_P'L<XV=+:ALPV=;>AL0V<;.MO0^=\/'7;*6["F#LN&=6CO-VRLQ7(CK6D
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MYK)6CT8-21?GQ5?U%E,YOEWXIVE!KM@F#8#AR22&[T6/PYG*[S1-F75%+H_
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MC2Y1#*X>M2N:SV7LS*!<CGI?U=PD>C!-4=E$8L(_-&"A22Y39"YER%<!W;%
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MZULT6OOO6C4&7RPF9-94,KTY.6,D060TO+/?G?O'M>)(DP_6>_F*/("$T$/
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MG$4U8\]_.5R>_S5C/J-- 5CEY3!KTZ.K>7"E(X$1 JHIE5_/^M;W) 6?UD[
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MG#3DV%=S9)C,)G5\R$@2/ ]9_;,NTH%ZE1[Y# 4PQ4>-K[1=2/S_)$X(EHH
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MCB=QIJ37(*?$:=%5DNIE?PVLW/]@[[V^FOC^@-U8$:1(DPXJ( ("(KU(OHJ
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MO,R6Y_-/]&BQZ4"6FU /H@U$D))+Y809X_\A7D)Y1PJA6#"3!_[E06/CJ\Y
M[UL)=7X^G5D)0A6TKK,WA,GEZQ1JV-A[N(IBLM$J!OR[A=@5[)6TJMY=]+&Q
MUA&^&'VG[[S$NQ^@%^A0<M#JRM5@%BKS"T#E*Z"DVS@6$++1.EE86_<XB5[&
M:Z\@%8NQ4##K*0]BRA>R(=^GC2D6,?@0#3T@2=J@J0FI[;"R^YFN>1B"KVFA
M)E_G[%V_;A5_[5R]N0S]=GG_9Q[,MG45_BI:VDQNB[YLR0J-ZT5H>UAR9H#
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M^"PLCG8:OY[JZWA@W<'1]FV^PFG*(W7P;N67<%89>4KK@KTCN,@@Y'R6D.3
M676<I(Y5IKOF>7:Q1OL))DQ/DY77@0I_2NX38[_RQN&]E@;DS>/=?)ZG3P,
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ME.[.:IUNYK?38QPOCH?1WKQ/:7;(JW'<?*T+8O$&&R[>OY]R(645F'CO:AO
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M.CS"EA2 BM%(DD,J1EH M$2R1"0A50R:,UI=E[\J'<)](ZY-XJ@I7(.Q%$U
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MU=C[%%?7,"<>BR=9@"DF>53$)7A <)RQ8GW*E9:"?KF@9)X:/I@<^Y/?_!C
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M%/T5NN?#$[!I^_]L/\9F\F IX8GS.6Q='&.NNSWJEE2P=EDPZXFC7&.;6T%
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M@4"?CG-;8G8%AGYD/_6.P=Y![$D]/QB< ] R,H4\OP#N>1F,+H'0DF5T?AH
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MW-*9VTSGG5&6;:GE0HBEGIE=S=/E]BSB? CW-&XW-'_=S +CM]>2[AVP!^>
M[?VO:I;M(?I?M8G[VN,-Z];CZ_# .IR5EZ]>O?[[R[\?/D(7;,WQPO:WNS,U
M:' O+,)YYL;?+IN,&PRO+N:JC6A\%6^V.VE?!ICO,@2]FTQ9W] <V'Y#L][[
M<%QU7A)^3_8-=P]8O(\=OSMUR]W-4+V5R]_24'3M5=\KS=YZ6XR^ 8?@CIP/
M+3*OD?2A(\J'ZX0/'88YO@-4J-7.7DVL#]^^Z[U\X$P[V^"+VV_^S5)RO9QD
M\'(.[BK)R]-A#G@GLSJ[SZ5IG7VTB4 .3.+)>_8^+/B3UA/466E)%AQ.UP[(
MU[LN7\><K:W4O:A85IIOM8>H'8"HPSU&S3#*OV_ZXS_>%Q\GHZ^UU5H_4+V%
M<?1>S,:Q!ZO-@)6P>[3: ;3Z98]6,[0*[Z?#)@.R?,SI_7CB2WF/15(8']XF
M=/U^/BC,'BFE3:2^,2MQCV-KV29FCV.[@&-/]S@VP['X/IZ%W,P97LZVB5U/
MEP>RQZL]7NWQ:H%7? ]7+5SQ]Z?-Z!1?)&_5S'IS/HH]3FT(I]P>I^K'*;''
MJ1:GQ/M!_N 'B%8QM\U+MPI7O^)@L*A@,9@]:NU1:X]:"]22>]1J44N^AVG*
M[\>^Y,G9^]0?(V'/M-FNJ?4;_NBH'5+OV<60]@BV&02S=(]@#R++J1OAOY;W
MM#71WUYVU)W3H[X3W-FG556)-MW;2VIO+[7VDGH_8U!\7T;-^XLJ[O?C]S.^
MQ*V:33-J1"2,PQKSMU^D6'K><CH^@BL&;7WZ$BE [S?L2M&,6S;(E\@ZT/3>
M3)MX[,<S\J;9;Y'X?4X/O[?*-F25L3U.UH^3>H^3+4[J]^-Y3Z?WYPT7WB<_
M\=L$R/_W;1[GYF-._]\>M#8$6GP/6O6#EMF#5@M:YOU%_RVPZ# :-AV/ 7/>
M@S6T7<ON6ENP9^>#:TVUPZ4V%2_..]P\'0W3K&L>7@/H-QW,6NR\/LVS0>W-
MMTTAH=@CX0X@X3XU?PZ%_OW_8)^9_J2EJ$$ Q \&\W]O$PS_[]*X6ES[OQ?C
M6CXNZ!V&T?2\80 F^.^Q;C-8Y_0>Z^K'.KN'NA;J[)*'>M$1;-LFWX41=W31
MI0S1[FAZ>CIH_XU- )Z!2[V'M0W!FMG#6OVPYO:PUL*:>S]KRS9^WV_]5W1G
M_8<FS^$-N8.WFOD_&QQ2&B.J/5L>W(S8^'#62]JW76&'BW_VYYVJ+O#QPN3;
M ^%F@)"I?5AO%Y!P[\S.H="_QZEI1H/6K)NEZ*9M9[D]G0^IA;,WYT/:@]@>
MQ/8@=@%B^_+S.8B%]VT+0##G9NW ^MO--GG=]B-\>3&8/7!M"KCD'KAV +CN
M7F]^3_;6=0-07*H/P-PWW^"X,!,.Q&SX_A_39IMX=.$&8N;;;&Q(?(UCZ_UU
MVO3'J1]GC7C:=JMOFOP1?@D(-CZ=]6C8FUY[!-M=!-M7&.QVA<&^Q&!?8K!#
M<+,&@AZZ]_1F!#WT_:QOU*@9O\^?<YRV*1BC4OHQ-UL_F7RV&-NCWO/%X'JO
MYX-K@UE/%ZWO>G\>P8)@H'X?F]^8;;7G@-T%L-OS5,_!CBU!7!R=G.;A>.NQ
MK0M<>[HTHCV$[2%L#V$7$+9G*)M#&'^_H#!\/_HT!"OHN'\*YMI[,(@FOK]5
M))O7:9[U7B\&UK8UFPVL]TL>9K#;,(MB]GUKOEU4&\S+!KY8);I'Q#TB[A'Q
M A'W7&AS1!0+['L_:W([&B+T;-UU7>#>V^5!70*Y=XT':V]V'/!HGIDV<W=[
M+^&QI]C2?N_-[H%O#WR7@&]/IS8'/OG^M.D/8__4#][[\XS5]R7GK8/?F\7
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M+J_P0W@FK%^&U9SMDKER&,_4WL'>?/GZF=H)*D_,XT,].&HNA&,.]7-QA54
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MUD;_"NK<DU-VE:1(\AS?OE6*XR3NSN#73F?OTU_>@DA(P@Y%J#G84?_ZNP:
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MCN:%^8#5W,7$E.-)@<,-E8@RS2X?&_X"#:70K* @GZD<W1%5:8/PN)5HV(W
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ML *53\QZ38\.9H65O?;2C+;G:+]S>'CTR1#IIU;L81?LBZ+-#Q5:[GYQ7+D
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MDBZT98$FX;J<&FPAW0$;*UKXS(NS/_V:_:&*,ZD3>#A\0C*V.0LM@0R)(L'
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M!G;B?WFV/!YYI+!:'?YOUQLFF!JA1B/.._+\3@NN'> L\*E8Y]JI.%4X7M_
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M!D\_-Z]P/QW5QQ*/$48SAKGKCN&?A&9"D2=$LLIU#M^7*19AI-2,.QLKK_O
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M,^]!$,$KR;B&H*I0GXUEB@5EUC/_KG2PQ&K:B3%QCE)WZFN*")0UI"(4$['
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MKR-%2QHYEQ *&1-EM<X74&5I$XI(\=3'O_J>LEHK)_V/%_N<FI5530;=RJO
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MC=!#?@GV>G&FZ1S$N2)_3QON.L[!J#HM&T#5 .#6C[I(:QXR*2I)"?EC@[D
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M^U",VM.ID^4>2%MG:\3X#RX'*^_1Z9RI3L3?UHCTP%X(W$WL!Y@I*N&QX0Z
M@+S*1L69*85ZO-L6:<<Y/#EC]8_<>3?^C)Z8:DS+9"-DG/F!X4T&>]Q["QK?
MAA>P&V</5G9S>2DBJT?)6=\0"_GUGO)%]"^W6A+6J6;-N$AEFC_'V>6Q>5*3
M@XW-)7897:$!'[5:W,[J:#CH)"7JMEDM0HRP-(SV+:RW+LH31.EYANVVXXGW
MD?"8%I-HD:8.,O1-6]8NY)@1^^P:VBZNCCH=( RZ:",;BT4Q7,?T+7,<][:T
M'CHP2&(/5-T57G0L^:%]K^^F,=,%1\!-*A6#R6<*>&\W39#&&P]IO#U!&B=(
MXP1I_,SMI20.O:E7\129&::O.J,S5MNWBY>RX$H$^TF=BY/[][]A$^.'IV>G
MY#@LK)[!^U'^#3W7G _ 8$U%ID!J,8Y#<3WW!P=)U+1)R0]8;UJU;N1O;-TT
MBY43=K7,L;$]C+?-7>EH0NR4C8]*#A-S'G(?ZW=P6.NY^_//0B.!\.Z+R&FX
MZKU1R')./E<GP:+T *>H1#6BYR'.61J)Q:'1X127OH5:>YO:2-EQQG]WF[BO
MS9))R6JU(A/)[<K?]'$.;*D+T).B<K?OT@2CDL-=9:GN;FAK[ I2Y#6'/ 8N
MV/Y4P8P9^F7DJD>VU94N6' &S9,>\^NY)91:4M$01'3$@F49_TA.\-6^[^0)
M'DI]S8QZJQ]\/)P-BKG+8"AWQ851T<RK@;C%$.,R!,BXF9JZ(MN(=RM*B!V9
MPCP8WWD:&BPGOP1F(XCI8\\YAGI<H_+2^RR.\\/37QX__$'9@-JFSQ'38RQD
M(*GSPM\/H98^LN:L4=P7^9$[FHUM%I_DFGGT<Y%J?#IV%PN70N6L2'&XYDLM
M#A8-KJ!:K,LL+ K/+K)R$;T.L*/T-JG@5\:$G T=#Y7V,TC:8L3;Y"7PH4S_
M,E,)C:8HQ$F17$5(:#9-M<C%,<0& WB<@SD X])N1Q0>Q].%1:+WIE&)SY"$
MDKS07%$)'!QTV<AGC&G3X(.F/E5$?YN[55HLM0M*_.J=BM[_VVBL@Z,>=M2$
M> <[A?[3?;)F= *D!>ZE;[-'"J(NW:XQJ)849RL(GQ^SS N+PUA>GR'EZ3J]
MD 1"1,N-S_:A, E.<U$VW:$5D=Z*80W-,0;9U*C+M=$8/F_IG)$/2O6!?DBF
M$TI^?\='=R_ZIL.<5&U?U?ZF)!< ^O5C[F>K78..>F5R9CGS\PX$ *4&F\U6
M#!%UCCV_6F&IAHH"'[WDX%) A;-0S3_/H3RA)?OE_DV'C)!2OHF^-DL$E0&7
M:5Z\,MO*49Q57F2U*[TNB8LUV)I68R_YHM][UZ?PON20>UD:'PE'N.*=;^A0
MQ);T[GTH JO(I4["/AS!] #MZ7S#V-">T6OK)6 (<-B5<BJQQ4.;2OE4P'^#
M&PSU*<1_O"-5M55UI)VYQ:/4J/^G<^"]6@H'4<1A%^FKF5:3VV .O-,V\_XW
M*<;URJFKMJ27P$6A%T=8+@!;H196KN"/'XZ$:\OS-41(PF/80$J>,FF'$7 '
MPXPUNVF,=L*)<>GMWR9*O@K5HC9)4HL@!4J9=4$%F8P!1S-I\.K;=++? ,2"
M8_A&LZ@V$MSU1YCX$KUZF@CH'>_U/(OBW49B)3%9B#!C36-@@)/>I+R# 1@J
M8GPJ_,>CY#QTHU5DD>BR/?H$BZB/M%<=7(L,*?F-.Z]]+JL"GGJ]BWO<@I>:
MNY5X.0X,2H/+3&/%MN^XV3N(1#<'/B[;;T#,&,NKM)S7;I@ MG']'MS+/WB[
M,_#H0EDP\)C&QLQXPC"FJ03Z:P1OC3L$TU5%M0A@-OD SM(S-6[''O=P"82[
MF#Y($C@<I41&/4#D%&4OI@G$/[#DC/LA]))Q Y!'VTO=,U][U*DVRP%]DM #
MDY4I4*V,V=*%1YVGDPG8K59B TJ?C:ZZ.BGMJFM42!9BJ4<2XY!(;B?5-\Q&
MY@HBJ+H64/#]XD\YZ3P;V*],-O:]6LR/X*!&0(' 8YY\ 9:IK[[Y]OZ7ODKD
M^T=G+WR9B!+<1K1*C0\NL'DA5CU""&U<;ZD8KC'O"7H<[["=IHP8%;Y5(D*Q
M9(6^QTH5*,.A=4(FK2;QKA!'@I0;66D/7C3G>!2*61[_&FG"8">&DV*@@'@?
M!+[LM*;_%%VWK6KKWJST_?Z,Z<4"HB8,BF/KM6582WY>:T*YQ,=OA&I>]/K^
MQ&0B>?-RF(7VLR>%%-'\<1,B*^@)+Y@0Y6^$*/?9W>>L!5^ D'T]*:MAP&Q<
M/8$AVJ?T;3<;^QF*12)"IUB$X_890BC,1Z*6!0WC1EJN;  ./@?YZ R61I]W
M#149B%E9/Y3>)A7'PBEY)58[#C?/!O'F6320@!\0:.M@Y.1G= O#_[$C$]V[
M7\#\+*WI60*_VJ_\]\U;3!UY!UC&0,9+R@I1]7% N7'-MA)A>CN5+V\,4L8!
M;O.?>V"EX)=!66;LPOB@>^2P]LK#>K.2^7XHKR9M4%\\5("+#M]C21C DP.K
MZ3*O::)_J;OUQE<>UJF'>'%G!5ADY47%%I_8(HQ!!/!K)WX%G:\%XQ^C&']T
M..K4T.0/%K%-_S )B@4,T#Y;-3U"'=M16.QO);#G"HZHV<+B21);VP4.AF'L
M0Q!HD>.\756&BO552[IJV15+-J>QEEPX(Y24]^4 QQN$F]K@'E% _/<.?(CP
M/)3A0$A; T/D\<D]!@WI'I4>'8M6 G(SY4ZU>^-.=ST5,1X?G-&7VT&-47:E
M1\TIP7G)(2&<ES5ZC<P=($T@U<>'^ZTD*^T3/'N2[M?<"T_:1"F;5)&TO-61
MC@LMEF08M(H1>Y]$,A%#@AO# F%"S_Y"NMV;POO]$!F:5!:<X>%93+H-1QTX
M0=:;WZ3N"K$;K&O0_L=MF7MM,'&R)=>I3WLI8'CQTG;OX$6<+Y7:/N=9/<3F
M6FO7A-&=HU092L LM33:X %O9#3LQE:G"@7)Y]T&GCU--(N1.3!9@%NGH?A1
M4?IYTW3LA8GO;4GJ!GDR/_@H'>,%SN2M\6^P( 13[4[(IAN/;+HS(9LF9-.$
M;/K,W9E?(LM0JZC8B(OM^6[4QCP=V)C!98_O75:+3HMM!B'%GO5(SWZ0<_U1
M0W/RH,LN7!M59=PS5XB>A"9J@-%$9ZM 3*2AX:M-[%XJA[NX2(3"*#KH^.&X
MB)(Y##-F'@9]1L--'I']AC>5: @@#!U,O6)%^72 []W 4!VR(#GPDDGCR)YW
M<)%N)"3Y]?'?\81OZ7]8]?8,57 [E[)HL2\EYN<9F6*<Z3>/0&W&<[>H!:^O
M!LD//YS/ F%M:F6.\Z)SM%9E:S6.+6R_+?@'HE*V'N)<ND>VMZKEK4VU .>L
M.JL/@Q]!:ER88_C=_B7][AJQH(2PESJR"$89NV]TO[3T9%.WYUU[!G9OX<42
M8>Z91XV/IPN.,$OL$&A=+"=67,;&857ZM(K@]OV(N1N16J%H&#'SY.;\=J?A
M>=M@;+:#YJ]G.!\ES]&:Z-(,8Z-[?OCL7*R[3&08@+,UXF' #W9%OP$$+GZJ
M?:M@JK,E(BU\R.WH"^B#$8H3ZX-C.!8ZF&^Q7]^K:Q3Y-X%1E#Y"Y<)MPZ0V
MH-.YQ=VC7'9+.3&$74*Q,NP/D*#QP^GW+[5Y29K!Q%M+*E;9T4;+\(/EOY=+
M8=IR:_4@$ZJ<T;8;GD?,@'T 44SFSYW( W^%O)']Q9@9A2Z_M4B1@P51$?E<
M&8D)K:ZGCN.E#3[/O1Z3=R\"\L@\#[;]M5D59(?6$B6@9++GJ1<'I5'?0O_0
M HE[7>\BG$B27B#.W!Z,? RE";TD@4/I2WK(,'F9!W[,4D$1LG70S0M.]0*/
M\JPNS!2?2^GH#JH#P"=I_=JT;B,]D<8.'BG[!!F2](H5-XSS\')CZ,2Y0.A^
MV4V=$D=M@$%]B^8FH^!D%#&BE>4H N\PUO+[C%/\O.CX#^20?=8(S3R$1V$=
MF;5B6-+$J6E]LR>X--ZK@6(7@J2<M84=Z(R'Z=-Z1"$NUAWIPK<'#<E1UG1X
M2%%Q4M-#[.P33/IGHO)]YE&Z$,9!5KJ<=C#S:3*+NRH:G/7&K.0S,B5*=(N7
M$9?"T;4BHIMVT3 Q$,)6CYZ>G[YX%EFP]SFN$_4GCYN2([1&;XP#IQ%/%+1P
MR0%'&#ZEV=7UE4 (I5<2."'=@Z:?^:+11-WP;1@;HQXXE9V7FZX-'+-/'YV?
M>HP\P#Z;J-&+5"<8?]X"Y>JRA08OAF8NI2A1<*T"Q2UV,6E4P*MY\!*_*C#Q
M^@="N6^!/ 4R*2!-.!]"&P;;2ZC7!#JA"=OH_JXQ%Z')!1P@H7!P&=*AG151
M;S$?K(T14Z0FV4;Q+#S/^%YN/"<5\8.,*":9&[9'(N"#>S\ X(LAON@C(W#1
M/]$H%0V.!KUV& V=M'E+!_/__.OITZ=V?I]7+"[G!I XE<!U4#Y25Q ,&'R5
MOE\E%S-%9D]=S?$D=9NLK%.)R+0$>SI.^XK < GQV<E'B'4*Z1E+?.*J[[IO
M>$?]O"/Z/(D6JY?\4)\J==D>(S_3<OP@9\*";';>[;]+DL[#A@-F$]U)88<%
M<NT881001.)LW@FZ00+?^%WL.N^#D/#>M[9]D5783QD(;)BY+$!MR1^IB8<T
M0>E25<.*;;IFH\U=5=SC3XG]:<X*DA!_IR[!V"/ OK-8.13CR ']QR;G+)GF
M)+6_S@FYV^4 NL&(*0;<^FF4=<2/5_$-2<<^U 9UG&P IJ&;D[O.C72&9.@:
MA>"RC-AWI(_[2MDGXV&UZ1^"$63L]N#F2FTQQBAUAO)@ML-+6E%GS5TPMUWM
M>^.A\LB<GVF[#[;[3P,5'RGX7O;&E5R?5-)_;5KSYF\?#W0Z#HC+_**JY6+O
MLGM.QTAK*R]L?,K:ADM9HGR8QDHM/+C:Z/ !7/OA7/3)V>GY+X]_?<&GQ?Z'
MF#4"SQEAD[P1K@7(,!OJ :/,Z,IOOEN@C8#PDK*X1@>*Y__E@-D&RK'7RA[)
M0&$3FT7&A?'6['Q6< \UWI@BDEH1<5/E+2F4&BMB(\Q[J+,21SCC29 MPN0[
M8@W]U[=?'R<D+H5::/]UAUD(%&VHC%Y/V8\E1UL]6,=%;]KX.'X\0YD$5^4-
MN\%WJ)=L^='GB[92N=%FAV>G#Q^>OGB@_C4[_X5K6^?AP#]4I3;J_I_T,J??
M']#4U'4Z"Y' 6?*(>[^93&EU%+2Z=.@\#]A?9:H*&K9I4BG1XXHO;SQD_DLM
M\-@W* ;6FP5R0Y17.]@R)C.="%SV^OH-N*%C.U.C7[9'JMK[\J0Z5*C5X,@X
MWRW8'N[;)3%7AOZ0_B?SL6:A\,TI0PNOY3Z[\5'R&YQ>4EIDB:RLWQE-1)8O
M9$R@!UI+$I^_A(08P2FNKE630=G^!L 9I,WW^/H"^$F3%H:O5<N!PTDH6E(=
MP8?AWK3$H"%]CG0L) M(CT5X*3JZSD]%*._"#'H?3<_,"8'X%Q&( CG\R>K1
M HAW(JL=E)$IRV( )*6<$W."A ^2.(A8*5R>XP-UF@U*Q=ASL%[21E$>.:AQ
MSDSQ_OU*5!S.#1.?1V2-YH\^?AA54H1WZI]_3ILL_4_R,!5F_&<<>&.B2;&-
ML.F:%?=#Y^I0IH1LVFKQ4HCPT;DV8^4C7(Q-%<^.Y0M]J6,\@O@KF,9P6]4O
M)>9G_0AF=.<<]AC0R8$5TKX'E1-USB'TPGQHLH[6H$&?0#(W'21S=P+)3""9
M"23S@3_Z3<R4CR(N8-MGLE"@2\]0G52WN[=)TKR-X35E;=Y@/IYW==PZ4)/$
MVN*PL1:'%A S &UHB])K92Z)#(77U)Q&]]*Q4>GP+-<:U!F/\*K_Q; )8S3)
MC3]"O" 0Y-PB+XN\G0I)%RY^:E:2=]@ZC\MF],E+\FB4D4E(=;C#(9LNC@NR
MEF)E<>L/IM:16G)ZM6 KF+VG=$6?_9^[DLBMY"KE#=,^(?=*+E!J!>:6V/1L
M'SQBSB/I7-@D^,FS;Y,W*"P C<S!J@6<4_Q],/]@W=;<Y;K'%TPO74H61VKH
MT@N4;$:1;/]V7\W.=J2EH? 71_-:[9P;^3+[9JWHY\)1*=LY]%;C\;( 2F2C
MLVD;;NS5LHK9BC%QJ*UOV)-!2;O*F#H[;U;3DU*A=O =O#47#AHKG\NZE%KQ
MQC+2\I@^ \]O3FA(9 F,'5Q!/U8BJ7>]=+L1@>[G\0[L##5??$>+L=<)>#Y4
M0-HB(@H"'C,65T^O,/!2&C<VM)Y$@[,@8(84Q ^=(/0U@,P+GT%C63,/9^,.
M]1YIF#> U$WA\A&>@T/+7[=+.JNKQBO&2#.')BNTZQ#.R4;5)M;$/#ZH1&!+
M&G68US1+G&*9TX;8'ER8:VSD?*!8S%OV!MT;]KMIV/B&']-OX3CM0HD?\RGQ
MQ,WK#N?MR5W.<GX]B^@;.'%\Y3[M:=>;UD\VN4Y8*E\O>G+;4)R<-)0#D-3:
M[<2RS='OO8-QEMRW6XU!0^]FG7ARQS^A_^?>0R01.#H"J1^6!_JLLI27A6[4
MKQPC1]8UQV[]:Q@<@,??/KY#<IC.&X&D[,302?,UT^1Q=_%&'E/U\,#,,B)O
MP_$L'S&8A+_V 5=,4?\;& +Q;D9]HQ,&'U0_?<IJZ3II)0FE>]UT=UPQ?/L:
MV_[>E:KIY!JKICMW537=/;YAJNF]?<-D-Q_:,&_5%7ZRFF_NJ;1US)-(>VQ<
M0YV\2O_0)=]>I2/OOL[^[QU\;R6+G_6Q]XJ31G!/K:_[^NN'C>IIPUZROE8^
M'@!22,1.NPL4D7[+\G7_G1T\W,<2\=K2LZK'W\<E; J=RY*OC^_1>';#)T4O
M>8>GV<@Q5N0OW39OW(>=ITGCO;;&8^L08>&LKX40O#L'7; 4%M)M$3D?:H$9
MJHP JN_#Z)G]SF0I?JZ.DMMW;M^Y_^WMT'5!2J1[(/9UREC'J'QA4GMOKO:8
M<+6WE('0[*).#75N5<M,1.5&Z6 ^;^>UQ[.8OFH'O:WA<,^OS9CA\.UK&0Y*
ML,_\2DA@U;N&#$;.GB,)Q9_@ZA2TCZC<<E(-$0_I58I^_ZTC<91OW\5!]Y.>
M&S-^RG!.WL*]&ANPH,[",A[PD5]C&>_>N<K^N_^7[3^E.7=(NLJBW3)^A='X
MR>36'7;K3A\^^O7%\X]ZJ$QNW(=TXPYMXY-#@:PX0G]EA(8#7D$KUKFPX^FU
MBXAD@K/).\];?/;P%T];'&O1GL]W#03UQEH_!YR^*]T/6K\BN0WQN2-ED)ZH
MY81]DCM?7Z^@X9NZ61_H.T]+6P';.W7.A!'[YH1M'-H6^T;%%9_RC";IY!N,
M^>X[&?-'/C4_(CQT0K3?2$3[UQ.B?4*T?_:(=H:1VHCZ6@M?@+_>(EU4=2KV
M\OB3X^.CX[]_I]?3BA?IIG'_:% ^2V<"O9*>30_WVPAUK0(9_H==K1?159F?
M$7GX-T=W[_T]EF_]$A'PKP[==G3W[AO<1;=]\VF^[.[1U[<_S2^[=M/X_WW5
MUD.15_5]CW8QZ!$OF-WKEFK')?_?N';<TJZ2(^0?<I#@AY'=TCM Z(@8N"WK
M/,L*MV<_T(7C9\2]CZ+JWE1_M=DT'X?F@V0,?_D_?_OZ;V\]-]ZT,.MST\HA
MG9C)-O*I[W$VW\Z(W(N9O=9T]R@HWYL47C'3HBV.[UR+N9YD]R;)[A,)>(S-
M]\TZM%Z]F!]>C;_?I7L4&(4_AM+Y:+-ZO8V%2:G\[?]_RK')22@GH;Q&0GDF
M$?&/:I]-<CG)Y7"*'_O<RR2:DVA>*]'\>.?X)):36$XG^4>6RZ/CDTDTW^5A
M?D5$A;-Y^R&5!0G;<O%>0RKT\^L'O:\%LO$=4S/@.V[=/?KFWOWX_TAZ7X4V
M$*#7?N;]+5"';Z+(KL\"7H>C\\!LO)[J>6>S\W:ZY[5FZ^2;3WBF)DGZ@))T
M_[U94J\Y5[<_>5EZZRFZ0>+$-"6WN(K^8\_:)%B?DF"=?/NQ)VN2IT])GF[?
M_=B3-<G3)R5/() Y?/#]=>__ P JKH_S^$Z7XG6KVR???_+];Z"F>=N#ZSI/
MU"1('_+(^MC'^V0!?5+B9*[_G<E5FP3K70K6UQ][LB9Y^I3DZ>3D8T_6)$^?
MDCR]XN";$O\?T/5_76Z7R?>??/\;J&HFWW\2I'<B2%-V=C*!WFWVXXZ80).O
M-@G6._75[GWLV9H$ZE,2J#L?>ZXF<?J4Q.D5!]^4]O]POO]S<#E/;O7D#4UN
M]21('\M<_=A'YV1=?$KB-*74)\%Z/P?>Y 9-\C15D4WB=#W%B0Z\U\FHT_^"
M@_IU>PI\O-XL'Z$=S[^K(E\650:V[JGO6!PFZ.I7]L9&<[X_HPE,<'N:E\UH
M0RGIT> R;@H66N\U4>^]O0?Z#G')8N76V.;T4UI4%PTW0]O2\/"_S:ZDBT@-
M)&O7KJI,^ES9?]/ST="/?ZHRQS]P0QSI._GJ#CZ-NW3E@8;57Q_LM!6&AQ:9
MKV[HT^L:L_<T:1.&D=0T";]W==YD^4*;KTA;;3S^M&M:NB!/9\F#.OTS+V;)
M0YJQC/[]<)67]#^/NSIM\'>T0/&]$G\MN7'8#Q4]XT?Z?[/D*8V7KGK:U*FC
MI_PS):&<)<_<'_FBFK%(_=NE!4WJ+#E;Y46^V>2EH[&<TS!2DA%'_UEU[2HY
M7=;TA?:O'^DO](]?TGR;EKX'JM(#_TCW9M7Z*'D:S36N&6MC9O^-&<NMKTNO
M-5I\YWXKPD%#%Y:"YXNV0B<:Z0#ZS[1DD?!=K]'P!3',-^C4\EEIU5_J-'/T
M12])'OB_DW.WJ)TNW(]EM;WU0[6=.HGM:=S6)B[2LHNNKNF*8@?UVN2-] VZ
M3.N\ZM"F[X)^<C7TJK\9L]RX^C)?N(1_J"$"S6MID&@["EOWN*90?7!:7]#8
M6+%<H7I4EWCE4=7;="?/?=$UI(U*TK^9-BL;:(KS;=[^Z6K1-*(VZ'^[^J7;
M'5 ?VLY*-4%OX],$R''2^WS2-WQVE=I7EMZXXN>2(JSPC(PFK:@V:];8].PT
MNTS+!;>DY1;(M')T/&;=0B5<YY[?MS>??(4M'X[8NN31[2\*'4 U307I55K\
MQKF7TD_3H?W4)K3!Q:F)(?"&XZ>[<H7QX=UY3>\J.I?,Z>3N:E&57E*:/5&A
M4XOFAT[+RS0ON+$)KJ#?6(62#-0YO9YG#":V=)>K>HHY$F(_2/D8?$>WH3NZ
M4FXPJ:4A!/WP$OIA56WY']@?>2FC=HM529OS@NV O"RKR]3>KRLDASR9(#!#
M>%)@:9!E /!A8B8'-]JT^=0QVB+2]SGN,YR7Z%:J$IGCZ*G;&1D2& D-:IE#
M/^4I^K$DZ47MG+3T8MG1%Z]=O<AA.M&M)?<"X\8M<_3LJ;@UV'I35#OGM ,;
M]G=7M*EOR9:7EW@)?6)*N^2B% $<>9E_$!L1,';"13 =R.JAV\7V>HT/3GBS
MJ? NTL9W^'[%@&9X/G>0I8EBXZEN5OF&[_:+Y[3%G(R+EPT#6Y&H7ZR25)L0
MTE3@3O["E/Z:UQG/XV[D"]&L;DX23CN#S,1,YF[K^/>R:K6%6^;^TV'GU'17
MAE%@WZ!;F]S7$^D9STY?-/$T5A[<X6[N%NAP#%DMT=9MCLG)'+2.*&OT@$.W
M:?JV^<Z+(2T[?4#%D^G^D-9OF(RWEQBV<<<M=K%BYSMKMBP+2YIA6]$FQ31T
M]#RT3.N@G_"A:);G8+NV,M9P@%CC5[JK=G@Y-D1ORWHA:=YS1[OW927Q(S]T
M;RT<_^<M6C^1?DO.5 #\'CC'BC0I':D;F&.3 7KE9(:)/,TN\Z8B]79J^F(R
M._MR5R:/W$(;<)ZP[WO,IS7'KZ3#<T4J^*HI3;Z CM#FLN=F_/@_^UZS8Y),
M3E697LAC?CKS+6H'5]DC9F+$X(2A4=$L+?8?2'KO,H>?G[*9Y: !ETGCQ^^M
M,WI")S8A6#GQ3YQJ3:N_XIN&EI_[PRTZ/@#5[DL7_^ER,2OL%3M6PR1(?-QF
M9'G43;[<R>5-8V8.MR"M6K$B2+-T]4*<T!KAAHYLK.&'Y8VX )F8^Q4.G=0K
M9#X=DZSCKNLY*^M+)YU&\35/82_EEZFHZ!:> PD66I;*D5^)O32O4CII:102
MKL%Y->F:JZEV(U4]*9F_HF2\2.Z?>\E//ST4(VR[(@O(;)BFFY/XYS!7O:+8
MNS?HBH$*P]W6#B;8C^+1E<GI6O8L_OF"-@YOJI_R-;MNHXO<4WNC5WC--Z*U
M]K^9;,ITC2U=Z%O5#,1V?'I^ECPA0X1UY/AK[6422"2_G!W]Z!FX+1YF#D64
MI,ME7N3:TGBH<M@1B =/-T1Z91UTMY_/V?Y#%A(/-0]";TYQCHC>'8SL:&QV
MUC#&T^2_[AP?)R2.!18Q)\<:VA.25N?SSMS!O>?],OCT;<KV_UI"K:*+NYH<
M1%'!,DI8MJ0YR6^ DT=^ +GG;1[<^I5+BW:U2!'KW*Q2<IX6KFLU2DT&=UYY
MKP=G0H8 "=U^4*%^ILJ!_"X)K-XFS3"R\'0..3I$:6?"1PGK3.OT7R<GQT=!
M''QK[WBIQ>6%19 L.XD)R<'/_E]D%]"!2&?P2MW=AA:4/FCE"G:=OC__\2@Y
MBS8"7E,X3EL$5=)3.'/7;ITK1SYI-ARD>'/#?</[_?LS;/G*YFAV>)YX&&P7
MK-.7SONRV![ZP'B;-"/[).&4"SV(GG0!C9"NJPZ?]1_XDWJ]_J;ZQ%:NOS3<
M4ATW/$MI1I,[HO)O'R6GPR7K[5SL2M[F&>TTC44N\YHL,AI W8H6XP=-O<-O
M>N_P/C7SU#M\ZAU^;:#C'[!W^'3VQSG7NS,)V\+0([NKT 0'CNMRFZO/O/!6
MY0('D;?&AN<8_;G.. WB\SFD$-;-F"5\VG,&MIP<1HR<WJS61^]\:\S[WQN+
MA;%/Z00L\$G?^*/J.DQW<E-]^8^BLG[HZ/I715P_2W208&:\2Z_VG6S?59HE
M)[>_[:4JB@+7DRN_IBMJ&.)%<:NEU\>9JY^!D]&-Y7_F-)$/54D:@QQDI$1(
M*; ;@,R)3[2DG#&!XJ ].Z<)3?.2T\#!/=4M;J$T?I]/.HWDU#32=E%5&6<.
MTZ*IDA59C;WTBR4K:_)V3>-8TBIW@E<JR3Y'?BIR22(KG3Y1@X#T]Z;;  (@
M,3ED'5W3P)'.+]D%?3<^Y*<BCLB=  ^PX@UK2CD*3E3SWT4D1)X0(.7T[7(W
M@X*OR<&?<=3V EX5?N,$LD#&Z#Z.CM!+2K?5,' NX8%(?']#4K#(W:7KI?0V
MKFQ\4I6N*!V-'<M/KUK+<*+$.A*'4:XV;46><*N.":Y8OLSQ][1@ -MC+ZAV
M5C&RJH3/-H<WVZ0%(F8<YZ+7T2 O<AAC] *7UN2MN9I3OW16WL(-&7*^JV1>
ME5WC)%^IJ(->>AT!M06):T.[65*)KKS,ZZJ4;0;XW'()]YBGH78KF@E.PZ>+
ME[0PV.J1].O,:'+8Q)\#,ZM=XX,J>#;]IX1>="L7!>\./$\4S4"#B.&0UPD+
M6JX_P47C:<#06474=5J*P-!'G_JA%3O^&,EK:S HW:9U-L@=%$6U[6L-CB&8
M?1+-LID@#VE>TE)2VL#GN67R6!(,-$W/E\M\X:":+CI:/X9.*%!M-$XO8$G-
M(^=MBS%4\FKD@8,,(K39F1E$XM'?-6U-SI0\[%VKFT_';/W-":A M@6'CR/9
M%Q%>5L!E04;(V,\S[,8XFT2#+9S?3(HJ0?;)E8M=XM$K]08FCQ,0CYTR&4L0
M70_($6L>V6F-HP&G]$X.A %?4/</%@9&T=^JUDEP)<WK@(65;4%'LQQ:BWR3
M6J -&VOCJDWA;&C8-9N"IGJ2C8&CNW+QT=.Z=,T3^\!V[*.P8TD[O'2N+$2A
M!)C-&LIO1%,@Q'_R[7=B20B0FF4@F AL>:S(<,8V+S-HJ:,$Y^,Z;QH![D!:
M*S*,ROQ/6=_<3!RL-XWY%D)%=;[@81NRRO!6.-Y,8/B^)1PSLL+5,T)459_3
MD!J'7'IT;LVG'5W.YCORL/05Y%BYM(ETS'58Q(..TF<JU,_C$W46X9,,\-.P
M0*O;W+%@K*I2D8F1\FHY-.W]>E-&*=E9,$UPNGK48=,UT(VI'M*%Y&J67=O5
MEM^Z&F;TF2[6*4H/:)YJAKK.N[P0PZ"WZ>=NE:O!$+#&0!]4.S*MS$B*=GW(
M=BF*@:TB@3JPL4,JX]))L :[N_4@!_K'QLQOU6>+(G?!:UJONU(R:UM$:^BL
M8=T@TH7ZCFZQXK>).=7"D%SNH%;8TEN26(@NRG@(9'"25]:)/B6;O"HO))O
ML9FJ:_=F@\]0>;'_"ABMI)@%@8A"#@$20QBCLYZ.UR+=-C,UTT0'\C%+$[K
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M?NE:4_I%OJ1[:#>44E3"2!)9%@W,T&Y'/.M2X@XC8:,H4/5\&)BR@(RH#$:
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M7?8FR9TD]SU+;DB)5UH,6Y47%7<SC+G<X,/,#NE;<H!&25("S8IBH$)&9J=
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M:>)%]"8CSF4W.V:4T+-QO,G2!E&SO\1/-41'$J-#3&RL9E!%I_])KI#RX/;
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M&+Q_Y(=H'Q;NHQZ--<:<EWP;*1J79SCNU6$]DE=A;XCYH8%<:O0"^[=\4?#
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M.*A%CEC3U-8N57FI>A.DX<*D9EX]_=XL8#%&?+2I%A*N0#\\",S6YR#:'G,
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MY9H+R=RG&>%X[/RBO7-;(X1'",YYGW+/"6;C-C?6+/)#A/_CIOP7G6?\J!;
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MTL>Q'*7YHPKLL J N-)::]^)?LN1CSR.FY8?U1]AH?:0)O[ZP9WX>O3EPLO
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M@FA&%KYC5G4CV]"1S+P?6^W[&1965$POL+",$B$W<+%(UF6AJK.R$;\IMZ&
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M--0<_%BGV)IX>H!@ -0-EU (K/45H8BQ\ !H6&.42"GPBAG:@PG) II#?KN
MX5G&7C"*;?[.O3U5!>2MYYH)#Y^BP0YE!3SAXO,S^)>OU0K+FB! NW1@XX'L
MZ9'[G?!'AZGQ0U]V57^96?/ML^,W !,+U+:ET"0*HP(#?_H86@R&K"C#=@EF
MQ!P(98#>QRU,4;_9C+8C@\%DVUEL,0(UKG,O%[G/K:ULJ>H^#B"*4CQU"@ &
MLK3<D"NXQ<J=L>B<0OM"1(]8!L(?L9$(BM:2RU):GR03&]$ 2S,GR.ADYXG@
M^X&8S)/GQ6U+ZW' YF$HTZ'-B*OL0ST2F*6BS:F;4#HF!*!+)ITS8=DNGT"O
MV9.U\U[?MU=<"',@&.+_J+EE@#MGN 8FYVW52V?"#5M:@_8R[LRJ6W8%&;O+
M'8<,^-5SG=G\^>CA_R?'5+Z'=@-N 3M*"4/NLMJW[59;TTN_(K0G78@XVQ/J
M<NU)VCP9ODC'@O#-T8BNQ[,V-Q[D3G4&*^9U],CK:&P\8;103PN=+CF\NQW9
M^-!QU^NZ[&A7!P,M6FV$4EB^;TU-<0_SA:,B6W.VYL>U9M9W;EF;XT1#P'%4
M[#9S[VNI3*$=6LV%*)H[+$+RPF_=>BT7\U9G$\XF_,@F#*;J"ND?> U#^:I8
M.?I;>Q:2]NIPJ/9= .DB'D8/&]P@^:ISW+E^JY@?VL5O@05:E>NN+;?9BK,5
M/ZX5VR9*UNN239AMFA/'VI5W+,_D.]3RO6R6V2R?QBREB+$YKW;UN!G&4C6\
MEMG1 VE9R.-)-M\9'5'*)U9$KG"[KCU F"[$_&I(%XHBB^].0R+?&.$YB9)#
MO[P8GB"U!\8T]G'I?>A?2@&-;DK^AZT7-?P,$\YF^?CM/FWWDNQNPTP[&]=Q
M440"LU P$1X6<7R9Q[0'_8@J?1P.H L"<<"\O)/M-]OOT_2H+S/?2 K--MI0
MZF>=HX,*%95=8+#(QIN-]RF;BGQ)):!&1)4 VC[J#KQHNVX\#JL?.Z80YCK&
M\PVXJIY]\=EG*DAMJD;F0@1RZ&S&V8P?.XEFTBC]RC7L3!@T!\4*YH!4@4#&
MY= WY0_'COU<LOB.T4:LKJ/"VB!.I!7 "A]S^ 9 (=L6D R3T5;:P('_^ZY[
MV#;?EP=/::JLZGGGSTOFZ=M).:O<W[0=ZU3V44N>U+6;LY!!]8I9 RZD/%'
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MH#21ZB]=E#-LEF0WP9AB= A+UC6XQ'5P#OB8U_6*.+LBQS;P=:^D,+ASH&.
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M7Q 7&>8N+21IAJ!!RMPQ$G&9H1_CT\JP]MW'91$6MCT50LGL8$^R_+2WX,$
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M8R(ZK,4)T?X):D'*.P-,T$_@HW ".PP[?T4*9HD>>N$;20Q99,_\-L[O;WD
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M/(1A(=F]QD-BD$H-V46^DTKOKZP^WBNKO['[Z39B#-':X>:D'FVRW*;$MV&
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M4#^?LZ9G0U(X+(Y<(0TY_8NYX30Q@&0/PB2Q:(E2EC:136X$JH%FS37_.OD
M?TJ9G #6KF/@SRU$WJE\H'9P#!$!0IJX0IX -T483"UDK"7= $;1,CM=JGH\
MRQ;VS0S=$0C*&Q(A02$0IF1!:L R5V[?E';0*R(^$*))'"RL'4)QNOJFP)Q'
MV$]U%Y2=<I'EQ#L'?ZU8=P])T3*4;*:XQ+^S^/B\JK-%D#U]@6+EF3 %\P\0
MQXP%@W%+^;S8/#%-K@T0&[46!ZP;W_6G[G"*A!:5.5G\!>GJ=!_OA\>79.^'
M/P*7:%9S-X$SE9>MSNYGGK5?&??]LRV25;;X0H.\UY"$0 ;/ %0E;U9FJR2_
M%'%$JO8Z?%"$LP$1'_AY.@UJ$AP3IJ")TS\ZWLZ'7;NN\0SN=WY;3-7N<-/U
M3B<Z94060P9'4O 0"K1SQWJC"R9BR.3OY.7Q%R%\O:F*'(4#ID@?2E\F9FDR
M2_".YTKP@.YNMA;VT8U/,V[,X\;\^7T]W@G1%%<H)!$J"4WL[O%&V]A2@ZQX
M"@W)V_,+?HUNRO!R+YH@4IQ[B7J_NG7A\]_LNH<U1^N52<]C=T?7M)%KX0'A
MYL)],M>4J<&?<0A,YM[UOZ13)F.9$?8\\<8-WYE'A]_N[PWC8AT7Z^==K#\]
M?WU^[O.., ^T)H+RD_>R^JZ0UP<5N6T.W#9&9>ZCF[;^&,Y68$=+99GGOV%U
M-FFFUV#&^,O<:;YL;>./B2L=/(-?G$CA12FB%/,O"Y<Q(]S028M*F:YLN*5#
MMH#0](94@07],7!%RFG*?T6>0?CW+6XQJ+-.'<6JT4@)PGPMQS-QY6M\MGGP
MJ51LYY1OFR%AI0\6*:^(^\*RA3-^RF,H;C*<IHUSO)BX?_U+&4J:%=R82.4Q
M6LXBUKK>0,)%JDFSJI%NG#P2_^(C(C[F/+$7Q$"[E)SFIN'A.X%%1#8@/HP,
ME0"Y^.]VB6\19PW+ZQ^HW<;1+IIY<1@,=2.WB;2'O'!,QX>B=!O<K912N"^J
MY["#"5,<O4MUULBG[+^SA@/KQNSLL52"^<HB&_O+Q^W[RVW?&:KYH5ZLST'_
M]/SMQ9.?B,@2ENK!WMY9JB6!HE8M&"29]_(Z120<U71"X1!G$.D,3=G>8UJV
M+O?Q6$J_WW]L(B:5SHPS2.@"88U%':UYIG)NYG/3N<MP4P GB[?E2&4D?@P9
MD"]>>&V_1H?$JGATPFDR$+4:4)PD$S%L+ T@"CM$FZA#A16U8D8"NT,E/V(Y
M16T)V"BNL_F,M\9H9M9I3X('X4I7;036H<I#&I<-94A-(WON+QG9N/N,N\^7
MR^J_]I6VUWR.-LEEB]7!TG%F39U+=IDN^33&AS\\>WR\MW> YOU:RG"O W(-
M5\$YRJCD9.9/<&.@ZPWL>;P$GFANYB)O1;3]C4-WHY@7_"-]OV+1.]X_""H
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M,E[7EM8#+WS4F0N2#39RLZ2YA;M!U98*GH ])%HQH5RJ\E<J:D]WB*;&#CI
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MW?C=J+_>F\XC94G#[._QU;V;P55VP3=S^HA+4KX(Y/<K2E'+HI?-1"9Z"*G
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M+0+[T(O:8V,$*>VW)[JKU-6#  CG"11K)=H<WT;V_.'M>E_Q/$0#0*B^$O3
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MV5@FZV";\NTI0K+A"\+H[9:P1\'%D,L"ER4KEI<S&"5O"+>(C[MR%5*QL!M
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M@X@G<L,L^*C5RT""^95:T&ZTS0%NMD/(%Z) YOA^LL8\3@5[/G_34EB_JJ_
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MW/T^;(X(]2TYQ& 8&&U"0:!#90V#OA?C'Z)NG^:'2%*DIFJ\(ITH">:U;XQ
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M:JF@C,7S4@\LA1+_F6V2,$NHXM(B2V\JYD>X'S;)3-M>.DT=S(ANO3I)>+"
ME#)]N4C3P[+ >4Z3==4F"RKR!UT"K8QE.(Y%T2[(5UC3-DUGA-*F1PN/FNY_
MV%P2@M>QV)D7S6I'N$SHE8"/^+M.F0'?[0]'NX\.3G\?5X&,X1S#VQNL]E!Q
MXC$9R0[>L?D!)7(QK=XSI_ ^X6:')[]_./9UM'ORZ&#_Y/3XZ.S@\.3HY.#1
M[Q^#&Y9S3>6'#\XM89QS/SM2?Z%)VC(KN'1/#PZ._=HUA1B^\?[>WN\[5WTH
MJXP]3%9A!:-99/^HB+/!K(+DIE*- W$NE'4A WO+/6WN+UBB89N+:V.C78]V
M_:GL6N)/R7@:SHQH@\<V..RY)-\>*:,8A=1T/SA:[&BQG]=BE46;]F*S^TJW
M[&2=W,+.C$4!XB"![^"&.IKE:):?U2Q11GT"YG--E!;Y#25GR@KIBON)+V3U
M40;=F2;E!9*&N_!$$W6Y3X3"IV:LI;)DG7,EO&5A%)8C8BHL7@71]HWTZ;)C
M[VY8"@\@A!J#R*^(EPRTTZCE9H,K3!C;O(7/#6\-'O$J*,/$W2Y3=9]9:0GC
M2OR)()3M5Z=R?' %W.]LP7VVQTV*G$_V]_N3]X@/8-VO][!9SV;OJ9\3]N2O
MD'^\WZI\>_$BV?_S;I(D[UZ^N;A\]?-?+YXFEV_/GSU+GKQZ\>+BY=O+3[*'
M_19(Z4-:3R_ACU][+_GZ*.C_^M_%1_SF2]1]P&(FK(%G[_<F!_G!]'"VD^6/
M#G:.SK*3G;,L.]J9'4[!B\M/C@X?'?R.$L[P?&\06/KD_<FC_8.#D^QT9S9[
M--LY.MH_VYE,#_9V#F>S/']T<GQ\> ;?*;,%OO-U_L.3]02I#0@=M7Y3-!]>
M^":9U\S(XYIG57V._T4GYKG0Y< _S\N</@S_?$OJI\U;&,>?Y^#$_"YQS31;
MHE'7K?N=KW+EYZO[/MC[_4\/RJ7O;MMQIN^G=CX>]B[S!'>9)W__\\6;RXLG
M[]X\?_MWBU7]-R4;OI]V*MAQ$@R9TG.7TA]JYVCCRLORHZ.]O<.#G=F!@U5T
M<'2\DQW/CG<>9?G!V>ED>G+F]K_$RGLN;$XNW[2T_NLA^,"_X"7^;GC"W4DV
M.3L[FNY,]AX]@LG+W$YV=GBZDS\ZS1ZYO<G1V:/LRT[XLWEV];N$$(>P9Q4?
M(>ZEAF"9]8=P=FH?IP]DJ7.\*S]&C8,SD8"G/3SUI&?T \-?>2,/C? (QN!(
M(-H21>A:Z#6$_D/G3+2 PVV)2H,$<(4 CJYJ^C";-;+'=D8;_('(5/[K00$Y
M8?*#0 ]/;3QYS=;9"V6VF/:V+44^Z%^8%IB2\KN0*3-V"X$5--/<7L9]F&RF
MQ!8H$^KUUZR2EU5>:Y1?#JXY8WO(,(^<ROND?Z+5='B9-]U06-CMG^#6A7)F
M([W@;M1+T7VWM!D_@,WL(426P[,SMLQ]DRUSIV/+W-@R]]VWS!F#_,7N8@19
MOG]L'(>0W]^)\K<@?TM^%WLI'M7@F6\'710L0,P==M-D)4P]$;X9)49[K<*2
MII(*AG>$8KQGD!/P&M9!*9P!&!M]&4QEW[1SQ'5+:P2)C0R.'0)CQAOU'EM0
M1P,DMDA05)6D=H@$%XUS=!\O5<R\O?(#^7>I$"I_<//BNJI8T"1X<GFV0!5A
M+O80;E!<,7(+:?!R&<]EI5KK4_*TW,>"Z=;5IT^-GG"JLR,LS]G,7;49"BQC
M:]0\8X9I]K3-S78'4P3?W])(QGE@\?EJ/J]NQ4<?6#!$PP$CR!V2R*1(H#HW
MY.)>\-NO'F=-$2T0A<I@T'[%J2K/8[OBP$.IF=5M;3]XE2W)GOU*"-=^+ RK
M*#U;PQ4655FLA$+(ZY.QW(YTBOBOPN[P-R(IKU8;U[?7)>'F!7QX!'YA;^?.
M'.G-#2-U6&=*+&9FD*<)/"K6N-4@]\$V)7[/BV&<!X',-]1^HBMG>^Z&B7ID
M]=%)YII59\7Q[^M,W  C35_*OA,^FS*(?DZB1UF016!%([\PT^3YVY3[ADP&
MBP:VF[P.;/&P &'HM&1U,>.S21M6K1Q#5"E7R'[D4OB$FF9<Z#DB6,9#>&>C
M[3[,>?CMJ?'#V=GD;,\=[AP?'>0[1_NSLYV).SC:.<[WW>'T>#H[WI]]QM3X
M6Y1P0X:L]45YA<2GWT9BW-%@S?'>YH5O3_5*)G7.C79NHQ)+]S@/26H),43F
M09OWZD;E,EC=A7T'SO/FP7U2.L ->XU/AXNO;P(O]#:V[[;?1/K\@2W3!S$/
MOR5%TMLVCJ:G^\>9.]@YR$YA"YB>9CO9H^/ISF3R:.;V#_9/]@Y./L.VH;H)
MY]*!_*I^X]W\GS%47K^MNI]ZXZY(F!$VFW_O*N?!WO3H\.1LLK-W?'JP<W0X
MV=LY.SV9[)R>GIW-ID?'!^[X[,&]DV]@OW\:^%^0\B5!XH%!?IY;Y##(J2':
M9[^8M=;7ZT0,\ZZJW<1-L[9QK&^%ZIU%U=W-X<-T$TH49<*1:Y5%M$F_A</D
MI^H626O26 W7$Y7/,*'C)6%+8MKNW(Z?@4)@3N#A3>%ZE-J:8STQ)8?7A-V4
MNUIS -L9%@WJ//=LV#8O5W7GAV\-0Z5A(OE#T4S;1I1:T7E(GH/##M%"LG^>
M*J$YH32>,2%!JLSFK5<TO'89S;1\&IO?C6 29]0F3N4XF9 =Q9G:X,EOJ%/2
MX'>RU2J;?FAVY<[?TJ'Y$ ;SOR?UGQ[4[ S4'K:7F+]#8-2/I)."C0Z?S>\X
M.S[;=VYVO .[2+9SY,ZFB.2!_W/3L^S1Y-'!Z=ZG]SN()N75S).DO$*D \[E
M9H=B,_9K_^3T=#8YWLG/3F P^S".,P?_.GT$Y_7A="^?/OKTV"]Z@"?58H%]
M4.Y5?=E.IOK3&Q9 +B9S]ZRJ[_%H#\!7^GJBGDY9G3\X. _:<AK1- ^TZ9",
M!)X3"+C1R?6")9V<EX1_UA.X"^O#O"W#-Z[#JR6(ED1V&BYZQ);A.:(1N8_+
MJB'_0$EWA!GIQJD 8R.'?7P#8G'*UO#"=^ _ XS\'0B3G.F[@T?/;]\L3D_.
MCLY.#T]V3H[<*00IA_E.=IB?[!P?3 \/3_:.3O/LT^<V!.P':^DYO7>8WT^Z
M_![$.A@VN2S'>DQ#76@%N(A]-\XL 5T\\GV"N259<GM=(4^$34EH9A2[D3'/
MDOC)^^9R$2,L[8X,Q8;(=O_H>/_LQ.UDIVYOYRC;/X53?W*X<^*.W&%^=GAR
MO/_I3_TW8(BO9B95^9!/Q$^ D=[?=Y/]1^!9Y9/)SM'IL=N93,[RG0-W.)GN
M3?=.STX^1_; 8Z15<^I5[7?*QFR.]]L0/X&#.<VF^R=@8*<9S,#1H=O?.3N>
M'>[L'^39V>G9GCLZ_*Q0\3NFX1M(E[R*_(65RQ:QYF+92+E=V8FN"S=+SEG9
M G__BEV,5/[RS/,Z^C^@6\)_O/ W\G_D5/L_]'CQN?8H7/=>% Q/$#)%G>]@
MNI['V,Z1 !Q=L<:,WCH\B'GV'E2$<L>[W1NL_6V=80]WC,A%^L\6=DB%77FO
M/!@CDZYM,(, WT*YO,5$&O*)!A&_,4^0=C#CEFA&SJ]"N99)'SV+C[):>1A5
MZ5;(7"FZH9$AD).-Q'&/]IA36C@/)\3\&7BO\7IV]!T^[?BBP@8P@N*_3GT$
MPIK\<+9WO'.,!^G16?YH9W)TZG8.)K.9RP\/)_N'C[Y$Z!%.EE]\KG['=@%[
MR9I#%>?N54C%<R BM[NN&@2!-=.ZF'">VJ:E-S0/:I8ZF\"]&65JNIV0R(8X
M\@B$%AVP498!OMT*,(SC?58 %AH&VKURMW)"H!K 8ZE@WN :A=_Y-M0<=*ML
M1)U38'X_/*0#H;>X1UZ?D=?G$^T-RJ4\@9-Y1L>_$/5T$A0((<WJW.,QF*[5
MJRH.U;DH,\?2E(7KM?(A%R;L&IN6):]@UKP07Q6O$7_< ]\=^>&IN9VH&0?@
M2H"/8S4/]J0!LJ!Q<8V+ZQ,MKHAV:#6\TJ0F;F1'AUW?+=Q9MM.DE Z4I%WF
MPKYY][(<XLS:X%YO_JWM._J*ZE__7IP_=Y%P'+Q'QC1'F]M#K:,2 <<!\F^\
M?O/J]<6;M\\O/@VMS[^%<X[Y)41O0+!?TSJ7E!+WAF%3&2WB@W1_?S]I\%/@
MH3K'13=*$B4T3'3*_]QBO^95AL(*3S!W4,$ LE0<;0B]BYK!FQ[M<[!W<,(U
M-X9Y^CP/W9C" ;2N->F:E/$-<8!+^,#' K\U7R?[C])'>WO1("$4H],;[ODW
MU++'[-D+.%JSZ77;N!7US'0']R*KX1<PLC,2E9[ 2>ANI#>, ? 0CF*+/<4L
MM6D%8VTN<DTDH>%!,/!(I7.*KB>"[[9840].%H [_& J3"W=_',B%" RK7K*
ML!_3P</BN+ YHYCM8E'1K@M/DXF,@[0%&+668@9#P2@HJS=3W8^[Y6?8+0_?
M4P_$>XI"'7JA#WO3/,1-\^>+'\]_QJWSR<7%T^<O?[S\+5'I9Q_WI]%L^W<A
M;,.4A\UQ(L<T[(:D((@I<]A5">A'"0^ONY,G3 &"GZG=S-6:+J7/GNYJ\B64
M$BY1RR>H)5VV2X'.HPSCTVR5><C@2^SCVS_TN$+.HH6O/B$O[@KN*+J"\*7N
M)C72:GQSM!IG(ZW&2*OQW=-J+#=D;;Y##N@OXW =O8?1N??8;K5:OT>@^YR@
M> _;[3I"M^O%\Y<7R>7YLXNW?T^>/K]\\O.KRW=OQL#5DM&N,/Z;%U/<:T8?
MX5OW$4[W1A]A]!%&'^'SGI"ZYNF,Q*K4^Z)XJ(?AZ_,W;Y/GS^]SY.V<[>Z?
M_-[OS>18G>X>?:I#\"X_X]%[^/P'MWH/D?7[VG=COF_>L]CJ0YUA<C<>D;MQ
M_N8O%V^39Z_>)&\N?GQ^^?;-^<NW4EF])#;\5R^3B_]Y]_SMWU/XQ,_G;XDJ
M_]63O_STZN>G%V_@ F_?7KRY3,Y?/DV>7UZ^@U^]?O?FR4_GEQ>7R:MG\MU$
MV*^WI. _YQM[H*_A!1E/\CQD:KZXF_<IY^MSE"BL:'%RBWT,=9:S&,_+K,FS
M?YIFU&:]@'>E&::W/[WY/YI](MSHJ^FJPMK#(VPTWCM*$"<[3_X[*UO,5IWB
M;_>/=Y-WJ(1.E'@!;Z#"U(@:PYS[\[*L;HJ;+$6)P5T<C%[FA"]#/<',JR>T
M<?0 JV(*3ZX#A0O)6)^__.NYCM438_EK[N_+V,:EXVWC)U9@&M=+3 D%7M4S
M-ZG9;(ZHH_Y1RM3.8)'P?\?[2:1@1:2*8."YT4*V*N'(EUUZ3NEA,7$JAEV[
M.75W3^KJ@XLH7(H2(J)5*V!B%-2ZSN:SKL(AK1B\4%LJ=R0":[#$1PMH5:$(
MN=$UMT]1NR6R09;282XT>?Q<\IG=PW'U>$MY6B :I,S']3-$U8_,$\NLR D@
M,\V:ZR37^5)A^\C\FP+K))=NN1(JBSW:KQ_M,O0T6VOO9N=:$8N$K_[F;NEH
MXI-V*7<CS&DK2%F7T:,@'BU;HM)ZK(.''[ERR, Z3V:^4(,4LQ2V]L8T\(PZ
M$NSYD#%B"JUV*U-9'L(#K9C$%%:MVTTB$-+FMEZ<;*F:<U_+"IGGLI6V@^25
MXP^!7UU,BR7N!Q"QSK-:P7S\$OK3:@AB>8IWDV=MC5L2CT?Y\F&GX0LZ<Q'D
M\Y@@7&]1R*;B)5UOD+$77@@VMM" ,^HPP$:6L%-Z-DP4&.07C,MI A<K+;7D
MN!G]UR5#Q!!5<1YD%;!6^;QI6A)\?$<^W@68.;RO)]4"5DC#E<W7\ZP<=[%/
M.YT_P%[FA!'FN>>$.1!4:Y,\@V@EV=_;^0LKE@SSS\BFE(^6;A(;;0TQ0<,>
ME$R_>5WLN=!K<O68\/\MQ%'@$,I<&Y^U=W KQ2"B5YD/:5X)'Q)^]G\8&@?'
MTAL' > *#W^U_?_Q3 T>0,?C8A39X3X=7O_=ED[<@8.CC2MA5(;]#O>"2[+
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MEGP*7]&(*EK/U'W(.\V0#\]_(X7./!Y+IF-IKE6K"DZ)?"/[-9(DX69(^>H
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M292/A?G5F.;<*)/B'C^/J;0'0POE=4'OT.'2&7=IHMI*3IJI"@2AQV6XT$]
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M9W^K[+5*);/\4RZ,G_-<#Y^).N*7-;DM%<\>X152Z0'N92=05]I8J>#IX;/
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M! O\\B%9NFZ0?WI4#2=O:)R-10/$'#41%]3H]FF6<!""A2OY&RO"!6/2P)G
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M9B=W?#^WI6^+2.ASQ1OC9?KH'3387?#6\I-!C]Q^_EO<S_\$8,E*O9S$\^#
MG:C(*_)"1,4D9B=0$1(,/VO0UQ2^HX7^(9D+LK-_-.',Q)_PXT3BQ#2?(LDZ
M^!YJ&T#G-^,)NRF&M"G$5,QTQBE3;TN(I5.#.I2>RVN6^J@?'A,<*?0'7$=;
M5!-%^H&:5#$9<+F_&'Q*"^TLU!&8K P-OB*K8KG4$+U%DM+I8860,-V04TG0
M679Z[O0@I9;C]D&.B"\Y)JH:GFS9BFSV*O0D6LP1/"B,K\_2)DOU)\X,9,MS
M?5'2SY1I;ZS/CNB4GJSQ!$X4H3,U3Y\20I;87905M$CY/;0+ J]&GJD%K5
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M5 Z_,'[%D3!N1>#Z8.BT>4>%S'P;WIFZP[FL_?Q2BUQQ:F:NF(M>*F8E!L<
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MS/%1T[6:PE>2&W"C6W\4Z,UONGO]KO;P)+[#KCNND<URVE9.H)/XS=]_:/_
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M%%"$1C6G&(4!QN_V.XPOQA-A3 ,Y_OL/?XM\:_. ;BHC00^TD7U*4)]BZ':
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M(I[ ?84*5N57<1BJ$\EK_22507;SE)!=/XC^-V9VW:UD=I42L^NGU@P 6P-
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M92MSR >[J\!,MZ48HL:VX[<7KE@ AJE@IGIPJPFKC]=).6G:NYB'\BJ4('8
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MULM5Z_D.HJ'B1GV_QA'E\E_L8%1?).7-8(L9CG\954@X'E7BFMI:_3Z\?_&
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MP^R-Z_5KK)))@]EB-O)7592P4G)U#\.ID]Z]8?L2 6\%%W1U$__/)^<GO5#
M8E*5,7S*I#NJ:A[68MIEULNOQ!!+WR"SV?50 !?NQ84%*MRPR:*J?E0PM=!
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MO9LL"[NGQ8UZUOO=<F:?.$G.9>(L&H$X\1IQ;CVRCBI$'0E,!!PM;60%]'K
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MWJL<=86UXYUWJ<!;%[ZT839VIO: X*V?(D#P;1"< H#O$L"K<_@!K0$*  H
M"B@#*  H "@ *,"4 A2T*(;[QA:'W09QV^YHZ.*6A??Q4QS-XS. ZG9!]?&A
M 21:6BDYL%/0-K#3]DL.[!2T#>QT3W$)M%':>QPS_F*'LR^]21W/]'NC."LU
MJ_:R')CP6U4N6_Z^IP?OHN52'G/HI9A'57HQE<]?;UMZZJTYUEJ:+$=>"X(X
MUA09$2,RVFF>H@_&I-M;<[A5&KO$4*+:(QZL0)9%BKC@QD7*L8\;NSY?W R\
ME/>6AW@QGLY.5\36T.Z<>\Z!I!A+:2A*N#3$D3@@0Y5'>1*P]]Q*&C=:3S.+
MI5':(49)0#R*A)PE'DEF1++6>VI]Z\8IA""1*V0,B8A[*9!)W"%'@Z B"!G"
MQB[>%'3R2<C\H5CF$UNDDV!(4:TP(Y1Q$O<W3E+Z^+$[MEI]^X4=6U1MTH/1
M?<8>K;\HMCV[B+TOT4ZFO;A9T7'WI67YL&KFS7J+AMW;Y UAI^V^=MJV17;=
MV45[W#MD%5'*4!<1#L257MT2Z2ALIAJ6'+.$&R8W:%AQZ9CTR%B',SU1BUS
M FEGH[>E<[:3F\<45V[+3Y/QY1*V_WLPNW@QGV91Q,FKSXOCGTZGTYC_#Q_L
MYX9@G'+25^PN'#]*PWQB_#HH>P1" $(X=$+(_I^G.0!!S%.%N%($.<\"2H8*
M:S 3EF_$*RE@G1\HHOQFCN6H-LA&K!!6S#H6)+7NCG/K]T8(3/<UET (0 A
M"$ (G5; )R $GASQP@?$!2VI-L60<Y@@+#WS,>!DS<89Y"E'%#QXFP,*PC,A
MB'P-\QPIKG'$FG''[VC#M2]"8(3T)=_[ ;!M,<S]5C[!"L.^5AC>Q%GO:C(.
M<S_K3;,93=L!M)#XZY3LP)UL-9MKKKPEB2)J8J;G6+)XCF-$8^(Y\#,J!;>Q
M'"6QHR+I3/E29S:O&I!8CH24/$E"F FX/6QN5)\;"F0.Y@C1'>A=%_7N"6A
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M:_/E0_&ST1Z2J42HHA1RY/^/+ICFBP"VT!XEQ2"8G9K-%@1:J8(XW ,'WT!
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MZZAOVV0$=":\/M5LM@C(LN888X(@E "358:4109A<H@DD8(:#;X[INGGH1'
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M D%3E"8&13F.2NCNTFMS/O_/91"/S1C9YW<FO#[5[+8^_W2RNU>8<4OYOG.
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M!FE2 I.M  RE0O22"AH?C!H55!W3L,,D8!-E$K":=:-FTR#!+.ZL)6KIJBJ
MP^(SXV6 Y+P':\,P,8:DTO(^K4+3O+,.7--[ECMKWFQS^2ZB@Y%!&CKOAAZB
M#ZUWTW#M?(+H3'A\@N@JEA1&9++D0?MLP3C?_&K* 82IOGE:8VVZ?W/.D_*?
MU[O]J_8\=B\V3YKXAR> 5]_CJF'\*;Y>[?'J\_V_/U#C_JZ][A]I^_,JTTW#
M\ ^4-S^M#X_RX[L[)[Z&8DMF8/0HO#[5;+; D*H(H7P :9' E"$ 3.TS)YS+
M&3U6<:\6FO>S(F[-C'0T,PX1):<HV9"9%QT*KT\UFRTO;#1)D#"@21HP&(8]
M ])!PN8\R=44Q$DVS4R3%^/]V,N@/2.C:UMF9'0FO#[5;+;(D#GJ[).&:ET+
M%U) 2#XK4#[&FEU%ET<YJ;NLIIDF,CC$>&R&S+SH3'A]JMEL>>%C<24(WT[9
MSH*Q(D)R: %US91"EC+Z4ZPP^)T&&;Z 8#-D;]^G\/I4L]EZ^ZBT$2X)L!)U
M.^FK##'[#-I4&6MRN<1[]4)R=,"&S+Q@7CPR-9LM+[*PWB?O@6IJOE]'#\'8
M D2F@4#7Z/4H.KC+>AOF!1LR\X)Y\4C4;+:\T)JP.B,A%1,;+WP!M"F R-8[
M%+ZD<J\.EVGS@B^LY[H]9U9-+]_1?EB1LWE%T_"V#/7;"2\UE:?MAZ\,\EGL
M-E>KLGBO&),1[^2Q?T=9SO=@8'Q"3P0U63MLR:L02PL*M0[5I)1CT*-QS4>W
MRGR_W;3G\NUFMWM\G2V_HW WB!.:S9<YPASI2Q&9(T<F)*DZKZ,$/=2X-8Z(
M%F!*,>S;KMI*)RFE4W30?$3)HTD=,D&8($R01Z>(3) C!\!5\D'6 $;Z1A#O
M-"19'1A4WJ$_=.Z?HJ>&"<*&RP1A@DQ?$9D@1XY](>41@X;BS%!$1P)B;!]R
M-%[[H%UQHR*ZN[38W)<@H^LHZ>/27WZ%&&.$,<(8>72*R!@Y#B,U*!6E-)!M
M;D@H-D-P,4--&FO!JJK3]]Y)P%<B;+[,$>9(1XK('#GR2D0GFS!J<-9Z, $=
MQ*!MBTE"+0%C5FJTZ?(N/3V<T&+#98(P0::OB$R0(PDBO10Z:!#5A6%#9@(T
MHD (%;V2Q1+=:R<.$X0-EPG"!.E'$9D@1^Y8SEGK) QD1[H1) F(PFLH7D=C
M KE4ZRGZ?OA*Y)%8+R^O.6L?SR\WHDR;JW*$;?\9KW"=:8&[Q:8NOJ9,KQ)M
M%UHN%THHS<>!GHX#DQ'>Y&'/*/\4Y<$'$2092)(B&*L0DHX.&L1#LB%)(=5O
M41Y;,%@:P<':%@*:K#(D90O(XITA84PVZ;<H?[IY]6JS_F0<W//K_6Z/Z^&M
MN/,MU8CO3B^UX!;<OFV177YGPKOKGL-_FH:^S=;WQR(P5ZT!Y:$DH6B(J@5T
M06>R2F:KU*@DX2Z^_^#U7[;#*6UWW_S]>K5_^V$CZ?>;[?"$GNSWVU6ZWF.Z
MHA>;[S;KX8]N-U=7[4>>#6\)[?8G"@&=ULP'Y@/S@?G ?/@'O3-)A9)EA*(-
M@A&($)-W0)1=<"588T=\<"UH&#9;M]\1+9XP24$+,'*+)[0+V55;=9TT'^12
MQ!9%&,&48$HP)9@275'BME3XY/V\O:3_^;VD+QVW)'+*5@/*F  F* \I& *=
MBQ>$3F8:C9V+6ELR*H(2PR2!!B*(*!!J,I;0EDPQ7II+N_:VML_^ :"47<H0
MF4[W=!O_,@VWP9CJ3'A]GH:F0:<+L,+;A'[8<)/)%S R.$BV*$A.8:!HJJ'1
M3LV(4L4A&^:<&KHW56.%U0HLJIJCM\X/:Q,N<;^AU5((R[Z_:UMDE]^9\#@R
MX<CDEAN<I5+"D0<E18M,;"5 UV*4$J,)(@0ERVB!PEUH,\W(1$>]#(I#$PY-
MF%,]Z1MSZK+4,$*55&6!D.60FY("4LFV?7 UE)Q*\J,993&)$@PA4- &VB<!
M4"8+6E614BE&5GUI:DR\F6<R=LMA#..!\<!X^-)U1R5*H>$!A75@O,D0O, 6
M*M@8E3,Z5/PM'E Z#+8F""2'/<_HH3U,!:_;_TST)1DU)3R,R[2\64;+J:Z+
M=N'P-IUC,A>W>G>^>4/;O-K1T'*S&PQNL7D]*/9N@>NR^)]I^Z_OWL!//ZYV
MN^M#JT[[I7Q(-+_[W<'4=E_ZK>$!;WX,?\%MV2T7:]H/#_&%G]_2Z^MM?HGO
MGMPA3[W8;Q;#)JU=??NE7]OCF\4OJ_W+P7.TES\-6/#AI#/A]7D&GN^9)%M;
MHJV0BPHM_,P1(GD/59(I(5<?TSADC;%HJS.4["48XX9!JJ8=3*R3+J.GZD<S
M) YGDF?-_5'Y^GH[G$0."_QNKM@.'__\VY5_)[QM,WS^Z-L^&0.=":]/-9LM
M!C H1=$FL%2'[0H: <,P\5J[;,D[;<*X$N]T&#@L;[T%!>X>AG*O4-^6R0#H
M3'A]JMEL 9!3E,WK>R YK,H)*@Z+#A34F(9*[&2C'8T/2#XG974%+QHO#)4,
M*4D%FF*NMG@K=9X, .12*\D0Z-HZ&0*=":]/-9LM!$A(Q-2.\%(["Z:$!-B\
M/\B<O)14C8VC<7#:JERB;%' ,(# Z"(@6%E!2J\: 4A8_'S5VP- @&L5'IMI
M,@$Z$UZ?:C9; F#1TH;L0$;;CO3*9<!B*@A5M"\R:)_'RVU"U:X=_$'(',%X
M&2':!I&,-4OI* OI+WD=P!1X;.;)%.A,>'VJV6PI((LKM4@%S>FW. #]<"E<
M#<02*]KFZYM+/R,%. Y@TYR@I)@ LU.SV1*@AH)6:X1<<AZZ[25$5R.X8D*I
MBFRRHU+EX$A:K=0PBL4W F0+J%L444GI0#$GHT?+R9@ ;)K]2(H),#LUFRT!
MM-6$0UZ?:BI@7(@05 [@K<6$QAN/HPMA/[3->PQ0JZU@3(L!4E8"=*VE6.^<
MCI]O5KG4A;!A"%RR+>5AEL-T(/V3VO,/OVK_^+3-9+E8O6\$6V#.VV9S7VH&
MH3>'YI8]OIF&'V;<=R8\QCV/V/G]$3NYQ9&>$ **U X+VD,@&T'Z=G"0 <EI
MND_)\6K],W[UHO%D=[U]^\D\MR?Y[]>K+94//;%/;CSA-P>/]P+?''71=+N!
M.C'P+IO[=J_S,!T&$8.(073ZTN?FII4K$43P:MB<9B")6L 5ZUKT6A0&<5H0
M'8+;]QQZNMGM_TK[EYM;$ND$\]UXLAO#B&'$,&(830Y&Q:I@D2242@5,3AXP
ME0!9.B^C<ZK8<)\^G.G!2)IEE(Z)Q$1B(C&1NB+2)4KS)!EKI 697 M6<A2
M;MB%8(1QQI44W*A ^Y@6G8?D Q=H/&8391)T)KP^U6RV),@JN4(A (GFT$V5
M"#'Z "EZ9YK_+([B?8JT'^;^A!GPF(V3&="9\/I4L]DR0&345(*%XE(&DRA!
MB*%]YE-&YU'I.KI#OQ\#.!I@$^U%4DR"V:G9;$F0*UDM0P&+V8,QF0"'%OX4
MR&(011LW&MUR3,,.DX!-E$G :M:-FDV#!/.XLT:TPQX:B(5:1(&Y0)2B844Z
M%R1)(]3HSOJ85J%IWEDKGBE_ECMK7FYS^1:B=_:S^-@%M&C6_JN--1^7S'QI
M:\WKUU>K]ACX$Z[6N_WA0:Y6F%97J_W;:3""CR*="8^/(ET%I2&206D#6&D0
M3%0.@C$"K*Y8?(-\UN,MVL=65O^6]<_73P]^ZG!0^-@+^>3&'3VY\4;MY[Y]
M[XLX,&4S91IT*+P^U6RV-/#:6QV#!J&PA7P"-22'%FQ&Y3Q6D\@Q#=A,IV&F
M3(/.A->GFLV6!E9909D48(W-LWN%[;-J +W7TF01Y'C7P-&-+A>BP7C[&'=<
M]FVF3(/.A->GFLV6!L.ZX83!@S32@Y&Y0!H6$GMRWGBCHY3WVCS#L0&;*=.
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M2O*"()3< *8Q AXV<IABJG3>6&<91@PCAA'#B&'$,#IBP6N@*!6"L2$-,!*
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M 1130O"F-NXG!T92!:PA02@:242-)OE[%P1^\$E_:2[I;X-'^K$YI']__7%
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M?/^2MO\+5^OA3/!\?<93@(W+=A#@0T#79LG>OS/A]:EFT_#^L\@])I>#3()
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MD8R",O)C*I(X%S[-LWU&3Y](!67."YI&0-45E>X]H/J^J852TL+HEVV[8I6
MU6U4F,Z\2KF><V=&.#/BF^\_E'$4<RX5X2DBQA2Y('DD)<DBF?&XR&@:;DW4
MN5-LTTJ>-R!XWEJY\R UGS.://E(5'<8#XY23N8_.S9[MC)?!7Z<RH"2*(@8
MH7&8DCQ../ZK$$5"HS!)]Q)+?"R9G[H^P,,^BD[B'QCQ#I/-GJW$#T08^C3-
M"4W P*<TC0A#V5^$J2\R)3G\=R^ANT>2^)&3^'L]BJ[8<0*Q.1/V1L;WFHWF
M[TH3AL^5UZYP-FM9863<J^HE+%^NE!?Z830-&>M4^8$1SZGRPU+E?E30C'/"
M,YX0&G*?,,X8R7FL@DC0/(JW ,/N$K#[H!8V#W=2_%&U2JP:)5\I[E#"W ET
M@OX0B7>8;#8-0?\L"CS22$5*QC%1@H.:*+#&,(6?1%PDD4CR.&-[J3'<LVK9
M\@[S9 ;>KE,OKI#0Z1FG9YR>F9J>2502I#&+B>_GDM DX(3Y440BR9@0H%'R
M_102/K2>"9)X%D1N0HTK%YSJ'NQI0HTI$&2+A9+PG_G<JQ=F?#5KVUJ4.A:)
M?=CKD4I5E76S'J/,IB'KG4EQ8,1S)L5!Q2C#/$A$GH0DR9D/REH6)(]$2$*9
MYBI)I/#9O9 DU^"F0;F_U*+I)4BF$R.8CGNYA(T#+P>I=*J%TCN422Z.Z4ZI
M4P8'2+S#9+-GJPRB7/$8;',BM.=69!'A+!6$IWE64!5EG$5[FW#CE($[I8=&
M*:<,GAV;34,9/(M@8ZJ$'T8I(SD5V+5,,] \L229BEG"BAR\CGL%&Y]0_6P%
M),-@YD<.06,:\4A7(KG_>.3.]N6M$LE=@4?=THS?[*\2=;MLIZ$.G-5Q.^)A
MZ:MJ^K\@?;RVGI?2ZQAL,N2=O%UR1UI.PW)Y CO"#V,9QT*15":"T#CG),M9
M1%(J9>#'0<;I%G;T_AJEOZG"RQM8SRA-/W('V6D4IU$.BQ&=1ODZC1+S(L@#
M'I-(<@6NIHQ(%HN<%$DJ11[%K!#W&OWM-(K3*$ZC.(URN(SH-,K73O!D0:@B
M"7J$@X^2*(J*09(XXB'/TC"CX;W&?#^41MD.9,;A+(Z>',?IV:F5)RBZU&]5
M5A*6]B+" _F044]+4B2?>=CXZ?Y6MN,@@J+OU-(3K#WW5JV27EEY15G!@83K
M/#PUE^6R5"[.Z6R(Z4H=9T,\ZPQM+&F1!DP0X7,&%@AXM[Q@.<F3E(H8C)&,
M;V5H[Q)9!4'Y$N0D&"^7I53REZL_0&"^K=YTXO*XEY:WMV):V#KXZ4N-(M&,
MQD\^I^^@K!G7M.@TG=-T3M-]4YHNBP(JHS0G:1&!KYV%G'!& Y+(/!$L#F(9
M\WU$?)]0TZ7!+(MRI^J<JG.JSJDZI^J>JZKCX- E$M06"R@E- P9X2H*B2]S
M%H:)XDK)?82BGT[5Q?$L3C*GZ5Q![C=9D/O)D)+7<_F5P>BR$D#75GD_P%G1
M/_V(86D=HV:5-#^H?Z[*2SA^E:O!/2PS9C+$F[R1,F$3Y"ERTRQ(>$%#$M$X
M!-]7")(%>0I601)(7R1%GMT+$Z S"- :P/^_'@3,!]4NFU(LL2VG/3^NY/H?
M1M]\KYJR!O/!B*U75GS![_,5;N7KS^*<56?J UNJUT6AQ-Z0A()@1F.')'38
M9]NID ,CWF&RV314R+/P8JE(@T@&/NBKE!$J(DXR2GT2B#3D.;BXJK@7=L'4
ME=;M/.$\G4*QUF2DBHOG.BWFM-AA:+&G*'?)>%($ 2.I\!6A0:Q(KL"I\:40
M>4:+.(FVVC[N$AF=JDZY>?AZ/HM#!]U]X#6]+D[ZI>UZ>5TPU&-+CRM8*-X#
M\0H6^B1.0V8[T\"E>EVJ=]KF14A]E5(&YD4N*:'<CTB>)XIP/\_"-([2*-\:
M[LN"A&5Q <ZM"F)"8Y:"RZH*DD;P#\U3J;$-]FA>["MLFD>S.'"%M=_4@9\,
MI9SF>=Z,Z#3/UVF>/. A#P*?%%$>@F-;^(1SR4FBPD1&/&=J>ZQ\P(HDX*"H
M D5SG&:8DRSS)?']E!9Y6(2BV&^P=%\-JGDP\ZFK<_VF#OQD*.4TS_-F1*=Y
MOD[S,!JG20A>"\U4 CX/IMQ8E),HR66>!T'H;^,>1"'S60%*QR],&#:#:P0E
M0G(1<%\%15A,4O/XP2P.8Z=YIAY&=>6F3QQ&5?!W%T#]!HR)\"A$\2+K%<+[
M3LZ<N&N^_]^>V*[X"K(^6\LB$6D>\HR3F/HQH4P4) _S@L2L4(HI$:=%L56U
M&JHHXCPC?A!'A/I^2+(\2@EG1<;B(,CB-)JB91'Y=)8G3YY\O9%)OTW;PBDB
MIXB<(G**Z 9%%/ @+G*:$AR>2"A-8\)S6A#N)S)E60%J)7=I/:>(G")RBNC)
M">P4T;>KB'R>B)@K4"61] DM"DJX#'/"PY33- A#FFRU1+@LGU-$=XNVPG\9
MO*;^\2%/UW"&;Z<HAJ??],![4 )?6):7GIBSMD6..E/$\@&N!VX(:\4OV*7^
M2Z/8?GY!HI^+N?I,9-DHS:PO0":L+JJ?9=DNYNSJ!7ZZQ61',? *KLU&M/VC
M"/[PCU6[+(NK;IGZ4J(J^?.B;DM][T;-V;*\5,"BGY$F^)X]MWZ^I4C\(AF_
M>M^^JC=MC[L8^-$:,\/^V'_C=I[W>0/[0F4U+RM8V9(URQ=LM:Q_7O\ 2&W^
M;'9?9P]8 >_[@LT_L:OVY^]^ZOEDI^3!71TQQM8&[W<?[RU$F'?>H,C^?Y:U
MN'Y',:>R:T?U#4%TUPW3[[2"UVZ0CB8O]3 [_A&E$V897IH_#6 6S/# 8]!M
M(B)KX'0ML[L5K4LM? /\E( LJE>6[<WM Q^4UO>=MH,=G[-%JUZT:L%@2Y7-
MF8W2;Y=E6_)R7BZO7G3?WI%8,S>/PZ,DR+\?,[A]%</A/UUS77 4Q7>Y[ Z7
MA$<TBA_G4>ZE)OE2-^28TQMSS+L._9T2SZ 4;I=@WJT2TF_,;]\FQ_56^K='
M$6 R_.0_O@O\[^Y-GB_7-.UXUP<EZ/ULQ[L5+/R/8HWW&BP3Z;U20EUPU7A1
M,'LPIKQ-F<XTZ/Y@K.R$JA.J$Z)(+U1#)U/W(U-#'SO&G0!U!]D=Y$,_R)$[
MR.X@NX-\^ <Y= ?Y25R:FR%=IN+2''+/P>EJL9BK"_B%S;U792OF=;MJ3!(
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MFY3UZ(YK^;L!36M CG,L[EA\+RR.=1-:&1Q$7RA8:-1/6$2*- 87.\L4R5D
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M3Q>P02:W-0IE]Y>MDV:&#9N?E-63YK%&>EYB=;L:W&'&V[KA)KN!8'5U,^J
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MF0$UK(&$EI[C%[^%C/II _+7S0(XY%D B9L%X&8!N%D ^W_7B6/>NUD ;A;
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M\0)N>ZYCGG-MGQEQJHU#E-D=W*GQ<S='XQV975H;EM>8$:"Z!FFI+:J^N'
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MR64,(U*UC6I2CABY']6+74_*NTJ"0O_C),&=)<%.-V6W!^+DP[<L'W8[3'%
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M%XET&J138=M=(8/[(156 38:;GU-3PX6V5 AX$2$$Q%[$A&O.BGP EV;6AL
M@XW6=;:@ ]/-4K"E65TP>K KQETN&(I;+,F"&6_4S++I)8YVHWJ7=!!$( ^
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MF-%2-"![N1R-@;9+7RU1F?>/L6D0C(^_JRM8!<[9M?/55:]#BWJ7CC.S-3'
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MW*49AIXC4V*!J*6<&8X#\;;W<H$Q-LB%;X%4![EP</ [7&3[;N2"C8%%SL%
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M4AYAUHM^>GVAXJ_KDMQ//_C!)?DIE^1&(<[ =P<%H$^LXWO%OT>0^]:7F+&
MD52I :%Q ME8:E2:J*EB4A&VU;Q=&V(YLQ+I,B3K,1!D+6@-6I01:T*QC>K
MY#Z71X*10>P/M#O(C@'_O@7\>P39X;"D#FN0&):G^!5W2"=ST!'-L3/.1QQN
MR@X<C Y.&A1DD(@3S9!5WB&LI,?2PL_5/,M#D1W\2% YR(Z!=@?9,>#?MX!_
MCR [HBRCT!HLAY Z):@2)W]CB5@:,,F5I4YL1:UD5-%&S)'$AB$N7(IT.8[
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MD7%*(\"ATE%KG0^V+VCT25.WWVK CX-/^*9/&(YULN$8[C^1&4L#&&4E:--
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M8.LFEZ#1.(!\3B_=AM;'5IU TL)P]92PXQGI30WR5O,"CJL%)%RR8VO'Q1]
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MBS("#_P3GIT\T]>-AG Y#?/$I;N''\%"Z_Q>4&K2V;@D-=(B=RXE@30]?'D
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M91$U^8T^3"O7;&1)G  @.-Y%]G&MISA<F@_593)*T]7)(9L@:6MX=+8FJS%
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M%E/XD*V<=WGM"?KUYDIN>/*;:M:+SJ%N&MG46HMUF)K&I/ADJ.)S;<._3:Y
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M*OOJ&(Y9;TRT2EG:JDU=Y3\!K\[9&&OY3VOCT6^=;K_,?<JZ^+M4Y]\8= >
MW66I1-11(FJ(15P[A@QV'C'K@[;.8H6W_!"*D @XS)%EI4+<ID"!DQAIPJ3D
MDF-F-AOQY9;6-S.@UIJ@[0GE*3X0G#\ N^&[5$1;/M %(;:2(3<RUJHNWV&I
M8LX30TG%'>9=J+N4B]'DJDU[*W+:6YV,],Q*CHHJL:WKHV72YTWAWG;O3XEK
M]7K]/Z@H[XV[=JE2:CU=+O<+;5/FLD'?UC*F/>2^)!O)<[>^=>4A3ND>=;Y]
MDOJHPGJ>%#]5?VF_:^81Y-RXS.Y6E=!MVMRJP+E>W/7M3^$%\(:UC#MX\JJ>
M<W/X:Z?2IPC-9[X%'@0O@C=](8]>,M9VIEW'5W'@CAJ+C,,.<09:@W; +8,B
MG&CG=&!J*YBJL/"I'VID*2_5:0\<-GADB!#.&Q/6@JF9KRY/_G5SZ*^S/#M)
MF8N_5+-Z_FQIT"0._"JVG<VV ZH@$Y.L[0D9$KQD23?'!?:(;2: U6V::$[=
M3!#?"%*VGB^SK#;^+!3]LLR,NM6;^@2R+3=XGQ:7#;.L6"9GY %H;LH8[[0T
M*/"DN?$@D,5. X<1@A%-G'3\)H?A+%AK38D8I1YLF5(B,%4,\D8))IT/%L<'
MMDOXL3P('2WCPP&@@1%,1R9+),J8 HG*(DM)1$I9X63I*!=;TT*BC"2$@!&#
MJ]*\9H6T I$CF V81>O+\O.S=CXWD'@8[;./UOI!C.[#D[^#)#BG7; &$T24
M %T'>YY2R#0BPCE0=H+48JN>!EL2M8@$&2M\FC4.]Y@T]EF6Q*@H>"@_/Y;]
MY8EC_4' (;#[^7EBG0YUUTRQ[OK[Y8HM[;Z=V6)#^."+-+$,Z.64#CC?Y=FV
M>4$#?.^[(M25<6QF5/TYGERAB\E5T_\YW/"'[B57J_^B+"C#HB0*"<M+Q*DA
M2$6CD:'1NY(DW7E+FS)2B%"6 @ECX1XL.+(Z8O@A#-5"BF#LAMG^>NDE>A7?
M+('ZRV3V/$/O9.R?-0 ]:^&Y,7+C68+FA@B<+F9A*0,171>"]%-J&.FWQ_3'
M)G*8?%!M!N2.S*P_^K3B0PMO>4Z5Y,$@D9+W.;/)F>]!C?."@;D8@W);HT\H
M(:4.9?;XIT[7/"!3>K E&:'>2Q?(]NB3/=L/[)CV&G$/S8Q4G!*!)4&!,D"#
M4@$:>!Y1)#;XTL/OBGP)XWL@-* '8D8F+U]G,@Z^NP?SW=VTU@\N+9P9'($1
M U/UB;,R8,3&1H:PTR6)@5@NMV:A*"6QPI$BQ0D%TL4*Z< )L'&PI .-49</
MS8WQL?HFR+!7:UZZCC['933T*>U)F[[]]RF50Y_2H4_IT*=T_WOM>3_.H4_I
MT*>T1WU*V?WZE/)^]RG]$FR]9YG*V1AU_<J6D8?Z ='SL(IX?C9U-0IFB'VM
MS6=951/N'N&Z7N.2QKK/*KM8-K1;#H'>G!;5PKDUA]H):&T H"NB63UUE8C7
MYO:EL>FGOY^?OCF84$ROW"IM\M=OQV^;8OX;]?NS<-G$55*?M!1869]KMYT@
MN9$/"9\>V,GTZ6"*]9.!WREF?"-VO-[JH(L7'ZTWG%SV7FCZ+L"EB_$H5:B&
M*E<R-<-.4K%MY4.>S D$FEU6:5Q2(N;%-,XFR3<8#J6:P&&E%2,E\L2 _*=$
M(TVB1-9A1PR/0CNYY45.I00^I2UIE;H:4(8LPQIV ?:8D$(0NME9];<&+&T9
M02XU.AO/S3C'*D_J>F\3U?F!E!,<K=CV>@^_MJRY@TP>G3M?!=?37-O+-,\H
M73QYWV:Q[NK@85:S>+O1P$N),+I>S0$_,';3*T'P4WH\O.=/\RZ/+4H"VZ0Y
M5N-W?VD\@9V@;@.AD\5\.>UP6<&4TV(V9DU-S?7JSIOE"[.$&O"VI:?Q H0Z
MF@?0$]*]EY5'\ZM4")&*%0"?<OT\_-L^:-7X\2@WU1V#-3$JQH!D3:G4.@M-
M"X0'N6K:S#)<5=JF!1P8YO0)<7(5+!Q4KI4#O; LNAK568BYPG79X+,:NT4>
MU)S;>RZQ(,VAO:VT[2[-3!YR>&VO3>KOVC[[-4QF[T+QAZDOX%K FM27'BBQ
M!MUS,-IN:VWP,:BMIN_^L=W8X-<_-F1N:\QE%K^,!ZW2L.8AUX\G=CQ-@P22
MIKF<0IW<\<T@]J&CW?U7=',JY\I&7EG&RP.IZ\6R*J[.PKVMD%N;J)@J_ "B
MZ7G#N7Q)0]M5\P$@FO6^ SL'<=ZA,7G;(^1HLT'(46=TYW9%23,:CNU+CNV/
M'0>4M%=S &FC7% P<Q5'D?"(."XC,EZ[U#!;42TYX]9N57LZ29AU#'GG;*J
MT$C!E<A&8HPWWFN-;T\;;<I0VKK/5^.789Z+[/>5%RIZ;?C^N!P: B>PLC<.
ML$=KKVS0Q,CZ3VNQM*&4)4'6!HFXU1XII@,2KB2>B3)(\2"T]FJ\V;@B^%_
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M"G%UJ2(\(FAO%#7&??YXASWL)3)0OAWU*'H0CQSSB'1*<Y @+:V2@6"SG>%
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MNMIDS%O\G_=/@BD/I%%T)NF]^&&:S;Y<7(()[MISUD*H$*Q.210EXB%*I&W
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M)JI?0'^7.OH 2!)8&BPJ+TF43!-!8R V6D^,8(+IW' :MM;P@RE]-,P1691
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MQ<PM/V4!6/8E!F5.Y^&GIPC2W%L)Q,?(=QOK\;C^G'*28_J!9GYQT:5+@:[
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MW'VT;)Z99;/SD,W@_;//T$;H4.,_&3C=C[(Q/#)SXVJ24 9>\V/(;%5?GAO
M/9?DHDUI"7>] C1T\P::"*^"M_15XVJ J*O4/A\^A7%]B0"+[S>!(_#RDUEE
M 19!/<%]+J>UG[L9-@Z:#V#Y*>#+_.=\$E(7CC(3X=3, >P9. !CX-N)FWV&
MM\TNPBS[7,W.LVEH+N'Z;%:GAC0 W@T^=/'. :8\]%X#KQ&:$<@SM*;Z9+)S
MX],%"0#Q:A\:$#?LA(6\;^'4W<3I*5:"N<N5 N.;*LZ(B-83ZP/\HQT3EA;
M>LQUHN2D!)M=4Y)S"0:[<9ZH6$1"C5'<%WFDN'UGS7G_/KCY%/H\-._F4W=N
MFG#\<1H"CNKOV&G-A_KUHL]:1A7"7VLS];^%"QNF#4 1_#F+Z[]MT*W7U11&
MKIZN,ZU\@VB1)C@D6^@>;L+DI_^8?:YOY%A]4! @E^D]4: Z"?RW/RE&RY>9
MQ6XXRLY 'ZQ\L>O* ^X"?W#>@_BV\HJ?UI/(IMGU>;&U YYQV8W,VOFKVZVN
M&U3X<H0 YK)HJFGVR8SG8:W#%N.TT=^H)2^":>:81\J:3N-5T/EN7#>H@;M@
MKDL@70$5;##N',X<HU:%40EPS,,$.<H .Y+&1*7SU[%Q_R3OW7D-VHK\!CH.
M[HJW2'>L/:A+&%S4\1>HD&9;;<9?%G(P#.YR<,\FV:_!3N<&@(B6(T02MJ;S
MW[>@6[GL[/*RGLY0%U6("F_?OLI^00%@^<N3]V?I$WWYYUYIEF3Y)^(!HF&R
M9JF=5TK +/1S"XT+30#'FSE("LH4-!CD$]YQ>96'F\%CDGV)-B(@\T75-#5T
MX:0&X0-U#&?,TB+2\DFMN(,@_N_^@V5TN2^=PWVK01!AK24Z\I*499F70N<&
MZ,:65\$9*7W4)% 6B0@A$J4\(Y*RTAL/$"K$=:_"ZV!G)Q,@=G,<@E<P.Y'3
M'5_4\\GL1C=#L>%FD+?%3\FCFW>N]D)*X?HQ-.H(S8E6?FP]#8EI3B;SM Z)
M8MS,,IR**$']%Z# &--<*%(PJHDHK"0J:$8<B]'IDA91;95X?;@ G70=]3OT
M4\JDX]^%*?K_@)AOB!-,RK"4)\+6!4K<(D_YD;PY@*(/\O1SQWB:S /P@?Z"
M=YE/6RO(AF0079HK]/8@+C]0E*Z!&))/4GTAYY4'%'WQZW\+&#G*G2:\*$HB
MA.#$N%@2;0KXF0?)3-X7)#R>?YS#)*.J!<$E1=CXTX>&@B0#!P+3>9:&N4,B
M1*79$IB:JJ-'AP(YOK ")CXEDD>LRV(9407@CG61*9?'2'GQ")"S0O%7RWY[
MA]U&-_$GI>=JLW.=Q>/D,#2OZ_'83)OW:$<LM4F^KDS8;>!T)&Y>5.V%J-D0
M$8R0/"<]@HZ!CIPC7YJ= UF*U02H.]QKE'T.\/:@A.%^B;>#1,)/Z#@ *GR>
M_5+].=WJLOX<ILF#D.S9]!NHI@G0*.C%\56&-G(5X0M0,.R63RUM6[/54)W]
M4G7WJRWPZM9+A$S/ A6SZ0!8' VR52!D&YX+>&I _PG^:,,DP%O#6:F]KIZ/
M/;00>Z!*C;%AHSTK.S4U FXQ39V4WCYY6M(K3F&(IU?=W5V%GU?-/\J.G0,+
M'3IM?)4N1%,6X]^2%^N:?=5U,++)NO7%IB<#U,W'L]0K]27ZOY*O)RR=0_4.
M:M]:TYV'I_X\ 8D_KR[7*$:X,&GLH"?ZKS2,%TQ&+ 5H8DX$_ M*0UC"1"FX
M-=A[6YNT?<ES[JDG$A.,"\\#L4HPP@/WLBQ8+HJMB(HWJ;]^"[/SVJ]6PLX6
MW??M+./6C"OZJ/<L(PG>#MNQFQ1KYG>S\.J>+WSD-SA=-ITU:2Z!0"Z<"7AP
M8> G 3T 6),^+X03F*>-6B*XH,1$7I""BT+H")!7;)<H@];0/ JBI,7T<*HD
MAD9'/%52<QF-=FJWA*[\C[]^.JWV9$$5XNCF7:9]D,6%!94$Y !DPK+".<T=
M"5R#UG*F(%8:#[:2+4Q16F [6W'DGD7GA17$:RQUQ_.26$TI[EW6\)_,[:H&
MZA/(! ?F<A R,5JL=@ @CJ\&O]^&4W>I6Y,#K*43R5T&9L0!S".FC>9& OUG
M#LL_@I95RH$A8%WI5"Y$D6]5%A$\E(4L% &S@1,A10#&0#6Q!8V<NX+%\@;T
MWYQ'OP<8TO\)_F_ EMX"R=S3O"J/>FX/+%0M$FL4E 3TU128X[_FN,H[16A'
M'M"Y3=% K29N//>M8+ES,_D8TJ77^$''22\2R5J/O1]EDS ;+1ZVP9,;-,@6
M:Z;=:F_LN/Y5,$!T)_C<U\#V<8TIX[1CP8,>6%N?QP7J<4BK:,#1S"KB8\=2
M#]P+KYV"Z=LNIG=V0XT+T6 KT44/'X#U0$L?<U4"-[- RT0(BAAT.3!>:IT+
M'PNQE9TQ.L,ETY1P[AEB-U@<P<(_1K)"1"J!J5W7'[^'2W.51/DLKCD<T!-Q
M1[51?'V)][3G*[R+U^_B$(Q'OR30?+^8T3>NI,S.I_7\XWD;,-%YOW<+Z%%V
MDD(>)J$=XL^M>R*LGS["<)+%6N#"_KAN;ER.H4=\>_UR&6QYTB]X:;?L]7M[
M;M(_B]0NBW6PA48#_8:'VU7(U@5KICASVL@+T%?H+6E:Y_^N&[;-<F/3-%6L
MT.Y9!&@,2FQ=B4V#JS].$)*[Z)HVQ,>A?V?V.83)=6%8K#]WUJKK%I\V%XS3
M^6A[WE7O(4PE+>K;V!OTV9C*$X2^-J1I&+8; @N:#&7\8W(<UO@Y@/0O!P#'
M:5P96XU;5R <GU^TTV&7&Z*=-LOP VB7^9@F5@=D#8@%#-_"G="Z\M(]+Y,;
M[2@[3L%4UX6FZL:[=75\AH/^'_,4@9*<?IN+O6O!:\N63*"?TK-6 E)-6N6.
MYTW#.#$;#%1IX[VZ^"ST,#K38-@$J"1D-?9JPP_I%[6[9N;+>D\=70]YQ?ZO
M)G/3X00&O?ZO+/MW^-NJ&0RO_AA(%Q2-<@ #"1*#)W0"\S])5+^\(/QE'(<O
MI'7CPOW@YN/YQ>2EKQI095<O\.A6Q/61K"9))KJ-K^T/V(U5O%J(1[J4 '][
MN?!YODA] W;<2UM_05E$^5J&;G^Y8RCVK>+[E0#FU5:"/LP>RNC&T*;HY>5P
MGB^W%W<O5$U <P62@C%?F/FL?KEY +JZ_;D=_;3'. 44OC#CS^:J>?G37Y9R
MLC,,'P=Q33"V!GB_X_C@*'23G4^1=_UI5KN;1Q03>NT:T71#8&AUZW9_,8?7
MGF(_MKO8'TE?MJNV,7O5_K2*R#:/$I7=Z^C]QWS7ATWTAX3IWZDS3DY/S_XX
M^>-XE)V<OMK-)_JH !^]7T[//KQYGWTXRUZ=G;X_>WOR^OC#F]?9KR>GQZ>O
M3H[?9N\_P ^_O3G]\#[[Y56+@L'_^:F$JF\3:!WYDX6\3@P66Y:=BCE8R40K
M@5F0A2):^D#R4'A'@\^94O_=+6"DWCR>W?DR\=./SG]?SY>FX->\58EGHGTS
MQ</K+MO+,*UJWW'0UL0^C&@/Y844OF3$>H/;%K&^A6$Y,=QAR*'0P6[%AS$E
M)!<NDD*IDHC(X71O*.'42<HTIG+=6A;[6UW[S]5X_"YUU,G$ :UI O1P^GMW
MIRW:)?#I%N^M.+HYX78?Y&WIO?5=!Z Y\['KHE$7L@"/6+="S,;)J^77@XQK
M=<Y84WI+"JH#B)W21#D:B?-.N*!$U'1KQ>!;Q*[-X+2:H*W8':^FYW4)/)F\
M6?3H8L=(BC[:MV0>SG*=01M[)7 W^%T.1<\9[9DQ!266@JP)RAPQ1G 0N-Q%
M)76AG=N'GONMFM08F[6(@'VHOKM%F Y#S;6A*-<$"B3(3#XF9W/G8CH,2?*%
M8D+82'AN!$A%Z8EVU@'#,HSST@@FMI+'W$>23H"#Q K#'=^"B0XBM.BNX]1;
MCRI8[$ "35IOO9M?S%M'1E9=P--G"Z?Q+0QM?3ET:T5S$F;?LI"9UE<G]0R#
M,],NT:->]=?@ZEZ:[&NQF#!P?)/3FZ_+S(&HJ#(ZQUCDQ,O"$B&5(38 ]LDH
M:.!1%2IL1V,"Z\I#61"18RP4$#  2%:"GI)&%XJ*G!:/1>IO ;F;4Y/T0:"6
M7'X=W+Z)RQ\J$@H%HF2T(S%&0#7&.+%<,E($+64(#/!Q*Z3R/F+VR$AX-^*>
M'TI T ZJ==.*U('(6<1H#I5KDIL2T_4I#/6@C+A"FM*)&'.WQ;B^1<ZZ^C";
M\@,6XNNNVSZ8+V]7G;8GM98?B"'84JROHZ*O?.(^'?MZ()?B&X[TM56N;WC/
MI2AU.846@4:61PD0"!J+ 3#Z4F- -R>Y,\*'7,N\W KX_9;<$PN-]=Z=!S\?
MA[/X^S(:X@1Y5HH<:=76<;>@?CSQ:])UW*ZFIP6F#]"(OXY3]=@ ,G:)E&TZ
M#T_BK=U;$N!'"56HQ^/Z<_+8IH6X:8!G-HG3IS"!123 M<#&=.R.T0SV*ILO
MXRIG4S-IVCGZXFF9=)_7+189R]HQZ-JS&:R [<>C9&RNZGFWVMW>G.;Y4?[S
M(N.;PQU\ETUXT81+@[NKUQ)JKR7H_E0U51JJJQ>+*V[(O-T^1(&6%>+G]?7M
M[H7:!>Z_?.5:>J3N>>$]+Y-'I2P?\9&W9#U77ZVEM4O,[IT)O9K<,>/Y[840
M=L<HJ!XHOJU%UCO-LE].4.74\P844[.Q(GJG%(S;/?NPS/]/W[V/GWL6!A"/
MIDW!C]B'G8#L>-U'[-$]QP7<J<NW0OZ>76K[T.>/*L?/4\#B8=4KGCW'\@-'
M!*N_+$L>KH64?WL!^@=G8_YA4H(_,)WPLXO<W3OHV]-Z/UB*?IC4W'GAP,C7
MEN0V>")<41#%>20*=W=KW-OMMS*:L%+YDH*M+[3E<(T*1$FOB6"2&99'GRMS
MW>K_Z[RI)J%I7M47MIJDZ*UM\]\L_99?=0"@MH$#;U9J9E\5)/@H+V].Q/4=
M3\WG!=^'%B7^L<'WW33@[ITL?+D,DR8,F#M@[A/6=AF@]LY+-<(P7YJ"&$4=
M5F;D1 ?&B"^]ML'DT=*M)<%GA]KY%%.0=XN)K:)YT^H9./\,TTJUQ_:$P'(D
MY<UK/\,\':S?'@)PF@:9:Z=*MXHR@/  P@,(]P^$G?6T9$X2*TL 81%*@.,H
M"./.ZT(:6\2M"@N] N&D;/:$MG2DOY(G>)B0@[G;0[1]-\4\HK.V(@VZFE,]
MFI1_:0#= 70'T.T?Z(I",Q9S2G):1B)DF?+96<)\046P6D9/^P:Z"S7S;FP
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MW%IP<,NK8*89,#^XY'5P8,N"\<+I*&,Y8VA45#&=!NU(M,8L[.4W8(PT:&>
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MMIA'HA43P 'S@HO(&*5;Y:/!! ^EUI[(B Q3JH(H:A@)P7@;C8^J**]K^/?
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M/-8',5S#RTYR;MQ'=F",3!:%IMH PP\>-U8'8%?4YD3A[Z$H:,'*;:>P!RN
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M0]O@C42#F'.NC1U)FFF=SM?S*6B G7P^::X%B<(76@?*_D]G&JB)5$C"\V@
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MYS+R7+ "8$!K(F2NB"Y4(#2RW-O2%"&&/DB(Z+>$C!;!6$!]L=1WGQKW]26
MW<Z(9Z6D#P\EH=99;J4@,"4\6+.@ 170)*)-;F2I<6L[NSX3**>^+$1)HJ,E
M$=$PHIF11(F"QEAHSOW6LN7K8&>K-+*O0^.FU67::=*/H3];*_Z^M%@! :_M
M;$O!QO#U53U)::O19_D*?JAFV3+B+?L%N4"7K.WZP67:MK5=<*,L>5@[&_7S
M(B"WC?(VCQ1#9 K*"^4%48&#"A1Y(+94&%)4!L$DY<IMQ0(^?. QFFB;Q/KY
M=$EB>R$-<(Q<@9%_" M@;DT4)Q@7NRY^G<]E75Q/X9RE%** 35;AK)E)FRP.
M9'<3F&VN=-X3ZA18=)@OU6I'B1?1EF#I16FV]F8;9;D!Y4ZTI0#EWH'TE@#J
MN2YI3KVS87LA_6TU"6#2I9G\JW'5&#&]C8?\:SV=UI^A_:\,KB7.KO:T/X4?
M2L(;#-$QD[1I 'UUV32M;<<#X(!.6; %J,;4IJC,<%M2"5^E"(6*6N<BWTH4
M<1_IV52 BV",WZ&?TFXWOW\2J'HN.S^GS6]F @T_B!"#=VM^Y.1!OH;I;0B(
M-6,S<4L7\0V:%[<0N/$\!9Y@B(AQ;CKOG-WSR25NN%G.)<RC&3"$-7F@.SW?
M,I'K,2M]ZJ_=\3/SRZYC:N>2(ZS=1&L6,2O0![&M-S#YF()V?8#O+0?:U>E'
MV?'D*KNLIVW4>WSL,< (]N3SL6$Q% M:>$, 49_&Y-I@@-*NY].LOFP[#[O,
M@%WV$5<#VB6RM.S2;CBLX5T7B8/@/4V[3-_,@:NN)7HXAR&S(4Q03XT-<N35
M"D>W<O'^S:LVSO^&<<'=9TU'L.&29FY3IM@*QN@J#=0BN+]IPFQ]JP(.'&XU
M\S7TSPPH;A=C&L!NPLT2T'[<X WWJWQEIM#<HVQ[?2HM!DV6&]["%VC*K,N
M='V-ZJ8W *@(;519MT\#N^>JW7H0I_7%=2-#X T?B>#GMG04:'TN$-^PA) M
M+"5YY$+SW!O&MD*S15E$37TD 9,Q"Q84^D5*8G"[;O *CM&OX]MOW2N_AC?>
MA"GL P(B.#O'ZXDW5XEBD]Z0_FM#(P\ FI(8G\($3?YDRKJ5H6<19?EXHLQ
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ME.1#1HWD2,+&H_$)>3 \$8T8SY%C@D!!Y_9R*R3\'HQ577@V,!H"QV 1A(_
M$TPY9(/C8#I<KA1EE-E.#_H!>8*J(^GJO%9>UZM'K&T/2U+\LEG)L;//H33^
M3/.N;F[$.0)1U\Z[&!1%X/!!*.<BJ'(C,<2 FMC(DW6LXP]PZ0EAR2 1P;/D
M'DNDL]T(7(8$^A\+WBE&W";J?QM/(RSUOV/X==(T>Q)\R8_$.X#77;Y^:9'*
M)3U'P# T,C -$K2[S+TDE("*Y^ %1&R<DE%KP;:,)Z'6>D%0M S.,2&!;0@!
M)4P=UIK:Q&^59;YBF/^RP_&>&$:I(]F$6&>83_#^S;&X$X9S+@U5* H#RX_!
M/W#$!*3 J8A61TUUAV6DXX%I[Q$- MQ2EA'0B: H&N99HI8'_70Z!AZDY]/D
M=RN97$WHS^SX4RQ-OM?2*9O->6L-P2>#<9R=+'LTX4:E2LFV-:@+..9RA47A
MX;+TL51 #UH<E2W[U"7'LFRRZW%ZK$\/4]VR76Y9MSB@3^MV9)ZARXV>.<T3
M64R(*VF050GGW67F@F&$=8%8L,DC>A*<XS!K@5BL"!2QQ+E2E@9K^9-I;7.J
MCU9G'X>AIR0EYG3*/&(S0J1"%A>CS2/W27"*62=O$'6B1G+$E'; ,M+F^5X.
M.>XXU9P*V>TS?C3?D)(CY)F%;W@+,Y_9:C3)]==YE^/0UGYM?&=->1R=;=VR
M);9,=O1I 8_&O$:<!S(QC:CT&,QKDL@(KI#R@BEA,26A,^-.$AL(F%@42M.K
M9@9IYFW>F3.$19:,W#'F\Q%T)3N2;;IC,:;@85DC+$%$$8UXG@]A'>=(.J(=
M%8+R/)7[>F%&$DK)@!(HJ0S3Z)$&-8R2L)$S$EU(=XR:]VE,CR0C7VUIM:6'
MM:7;BM"/;N> @ITR4H(=\CS/8\HI88%!UW!P_'T 6V8ZU82!$$V,-8A9G[).
M8\A:D]&J32(<)R7CK38)#Z*?CG'CX(GUTR[UU"\]M*&(UKI/[W"WW<.?:**1
M(.U(GFA!)')"8_#/./<X@QN)3O$D-R P>5^=\3S'S$F0@> -Q,S*@MEV'(?5
M\"=8)OOJ@S^+83Z*[],O2V"_M^.6DX$;WJ>_V^DP]W4N,6Q_S@!Z("BEV?,C
MW/C'T<3_Z[M!!*FXR!IX.H\OOG,JH[\U\W-XX")'5Y")PRO2KL]B+% #BX&.
M&=NQQ8&<?,D'K:$@KH'BY6;[_$_,& %36)K!R'[*HMH"4S2O7H1Y+%=^-9S!
M3?T=EN?'Q;#,#V<Q9I#,U9JL$>U_#<K/7V:EJ7GQ"IN@ [E_,G^+1O9R,E]T
MK;?W(QB?XC_^L#C>9T2GBR:^:N*%S4@0\ R+Z\,-5IWPGX?-L,6:>+4\8^U
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MO['38*M#OZ323_,I'%/<^=G9<!H&_P,>.*BE;!C!#<<G@X]_?3.XF$_]F6W
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MVQOKK+/,/GFC&7[M-V^X_.*#\_;-2R@28A[EVE;,7&:U?,M6]",98"V5<U:
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M1 JP2$(&8ZG0M#/4Z]"(&,?22+X#_& "$>=PW(;(K2K:B7;0^OWKB ?/!N"
M$NN,\QYIGH 9B0_(00"(A'7$819LD)TV1VZ)I,##*!'@7:X,ASA38!0Y,"8P
M8HRF \_RB  'QZ*N;@80V&$,-\ #JO?56^]KB3,EO^%\?8AP2KBS#[;K^*X;
M=L,-7HXW1H73-IJ$HLZ@T]$X9&ENTS;<@Y,FF=-=H.J$A>=4(&8S_(L/'%G+
M)-AK&6F*.%CQV)!#1V-VC\4;<RDDXRR*TC'$84&18\ @A!!JHK(VQF[FU$FG
M@&60<!;.,>#36Z$=\C190G7BGMP G[A_ME!' E"VPQLKJ@VTR6Y(JJ42_8:/
MUK2Z[IFZ:E91![Z: 5Z+&3[64F0-,1E#EFEIA:*8=UPUEV*,%&).K\%5R[T"
MH+\2"EQP[ 47CE=7[=%=M>H=K>>F"-L-PSGX>#:<WMT]NF6*ZML7?SFND="6
M@:W3*# -]LPQCDP(-@-U4FHXL29U()0<]@'C@)$AR2%.@T'&.X52 C5DO;$.
M=P8H5!MX5*X1QHEI@S&BBH.?G, _TI1[)#DW1#HG>>Q MU)M;*"1@?^4,<ZI
M8<AP\*D$\983L%],/;;'S-B1>,PWHW1F3V:W^S,KZNRY>C_2Q"""1PKCC*"?
M=524 4G030)[9;'J>#\Z!<NU 3])\82X%'G.$#A0*E%E* E<^HZ?7KV?%Y&H
MJIFJ=5_L]?S3/)<Q?,,1^V4RGX*O=2!/[(:KOQQ7#-ND(U4>&68] D,;D9'4
MY7 O8NV%<+XS;MM30YC%>1:\SK/@\UR1P#F*R@<5 \?<=0"'J\T]*E?,),\R
M$C5$_-%DW$"P:5Q:>*(4I7<B;(G]B2$![%Q$.'&%(-Q7X+X%@IBT&2A :X4?
M>RN9F9YC3^[+%4NM/GNFOI@.WCNJ) HF$@@,6)[I0#E23$:B4@C4=0(#2[%U
M3ALX,F/%Z!PY CLB'954G!F/90>ZHOIB+\(7JZ[8MH[!;Z;%?AFF SICW[SX
MR_'%J+5$*2M0M$+F6BR+',M&5V*BP!U3F'5\,>6X3(8*<-@R'ATE/ ^Y%;F]
M)V?HK?:DH^:JT3TJ7XP$[XCT%BD2(BPQ3WD^J,VSU+1Q3'C&.B4SB</*4YJ0
M=19\L4@(L@'^(9)&%H@%/_VQ?3%Q+*-!'^R+%77V3%VQ8'G@T7CD'#A3X(HY
MI!TQP)O$X!"L#;C3\$R]4D$2B4P4&<!/P]D4G#*+RVYWDH3CIQQ0@X_>%SL9
MQ*\^7ESAW*YU_-SLK&5T\W-;.EF.R6/;CWO6:WB2E_2N%9;M.<&RF0K+5F'9
M*BS;_M^UY_!C%9:MPK+U")9-W@^637WWTC.#R^DUBP$:.8NV""VV9]QZ/#YC
MK34]+MO23SI#->+7/-]IU71?NOVOC]H8PDTN8AY]7B!)"AC4\J8%7@ H-1QE
MA('U9O^I'39Y",^NH1M]BK2N!H"43$8'"GYWNA6"\N%YB]XP.X9$AE#&^(@Q
M8C1O8@M#D3.1(:&X#BI)1EFG/<-;A5G>TI3"*<1Y8LB$E-MFC6 V6JJ)?\RI
M OC4'$7BH@C)$? $=RPX8@PP 1&(9UP_[25!U$5*":'8R@Y"%N'!)",Y GZR
MB#.=D"9&(4EL))Q&JD.GYNN /$'UD22SKH_4.\@(E#Z]^#^.:^H*5YI@GD>F
M&,*!KQ-&6E..I-/*Y%FW3'>FKH *5$I$CQ(E%'$M.-*6,<2T5\$G8XVZE7Z\
M&A?QZZ395YH7]WS(Y$I9@JE=&Q511O0=B?X4 9MDM<\[56!3,6?(@@Y$S,N8
M(LO#2#LVU3B,M<01V3+5-$]%UA2'S#A!1\LYL_P)1XP<QY;5-9[)XT4>=6+'
M*CBX+#"9V\?WL.5X.;JI^UOLK:LI'VM>Y["=$;K:[%B_S:XA07=-.KP@;.T%
M+-/5%EHF]SL[AK7]'&M5S-9F,;V$N^KB:(_7MV\S;Z\#K0WL9G7,DLQE:.L2
M%ZO_*CT%22G6!(FH<R%!;@?5A"&B*8-P*%&&2:<-0BM- U5(R(S7H85%-OF$
ML/9>>"P(DYVQY!] .[]/!>-Q"?OXH6#[M8B/;\<?,V98^V@;RKU% %S7ZF_?
M_7+3CJ\^40*? -'ZK=VOT U7W+-KZ&91C4?@(H 3:&U4!A'BP=R#2XBL<!PQ
M1UP>RR<,Z8 1W86?"G#HE6>P1*!;59/MM:3E: J=OL_V'DQJ;(ON^L\F5F#&
M(M'(JUQF0E6>Y.@CBCGL$#2(Y#M09@=FDS?__<N]V:3G>F;))O"*?SI=TS6O
M6ZS2#U^&37,=;G\T3!!G+V9PW "UOP%^/SQOH?/!HYRW.=H"IVR]CZ-8T-27
M>.S9._DTG7R9Y=_"/.,RPZT*F"LXMQE$/X/D^SS\O75EX0JC!5 _>)5'H T9
M,\'A:)$.#K1A"+E&B@2$8Z+2:T,D[[19N!C@0$.0<QB";"<"!%G"H:"9Q9(K
M3+7>8//6Z[MR^M8LZ9M),VO>CD$,P)#L+68ZDJ;H19%P>?=B/M>\N0RW'(;@
MF6;VA@5H%ML+\2OHC-FVD;T9?7>9);\ANKI5ZNKQ\58G7\;@MYX-+U9%C>T[
M7TNZ+=7#:;G.V0(BO<"IMP,O&O#GRU"$<9[-7F(S^'QYVNIV;F*GX73Q,,WD
M6U>"4]NBMW*U7)\Y:<'T'=QA/IO;C.><%<C%K)0A+-^QU%RVIQ8GJ77-3[[U
M..TF39_XM1/@]NGA3H[ ES#>>\RT1%*5*>4\XU\FC;3$TOA(@W.=3"8)$@='
M.1("@R\1X7!#\B5P=%%[01/EN[#JLR%L?LSL]%M9N.9-5C'CV>@2G/<\A>#]
MN'S[/K4Z.6X.P?BI%*Q-IM\*:5 3?=:\7T#]-''\W7^.)_W6N6_'X\EG\!\6
M0AU+:J=IR9&=A8XX]I^MI-36^."14#X#DDB*M% <21F](8EC+#I-:?=FJW5V
MVB??-,.OO68<M# @QZ.=ETE.UJ>G+(/3B]O>?[GRVJ<$DH 28Q#Z*1 /8P1!
M2F#,+=9.QXY/+*CQX/92A NPL6$2.:$Q^-&":6()3:*3<6I]IM_B[&P2KISC
M]TLGZ.XCBMA-62?6\SBPG5+4?PXQT6EJ<DLZ-A)66SODE)0H>F&TPJ!&M>]L
M,T5@C6@#8C@JQ&T22">CD'>$26*"\'C'-M-C<H@X93WGD/5<Y"+,6<4-U[9U
MZH;":D-A/KT6_JUH&":QW>.ZF$[RC)O!O+DJ?%L6O4&\DB\VG8SRR)52EY>]
MJ&$:>ENNET;S$JCF5$C7EYI<+.8;0ECYHUVD9R;P3'$UKJ48B+6)-B4ELWK(
MD@7Z^]N?3P9N/LM'+D?,+/KBSO-.B8OC" \TS+\O0E,XY72PK"1<>\G5-!Q;
M7F@1H<TO+B;3V6*XUJ*#O#TI?AY.Y@W$>(4*(!=MQ#>-I3.LQ+1+\H7Y=#G<
M$=YZ. EE%%CNXLLE>'DASNW7X?G\/!?\37)M8CZ[;+(/FZV3E[XLAR^V<YM*
M?#^>P;)4!E\Q^(_1VWD3NZRW4!'-*M.Z8IV+N1L-/:QB+AK-*10P/6%2OFH+
M3V%Y;1CF04T+MBRA_=7F<&'917EJ2=],=DK9ZG%V[IZT!:EY;1<5J^V>W@CN
M/"X-(;O+-U<EDWU2U,>0_*2,!FF315AQ@3AV'IPV&Y&5B<7$A(JJD^._2P#U
M"-5V.S8O?& \)8IB@;>DR2#+B$+!*VV%59AW2Z>TY(X2EA"&P!'Q!"&E,5PA
MPL#M)5)*V@7/.>"+D>V5+SUV3=9+87;8VISPW7.)X:K^>]I>?CQ9%K(LC(BW
MTVF9G'D%6[&IIVJYRLXE_6N&U_;@ JTFROU\M6*Y'QQ]S"NVUA$.[DU9G8VA
M\&M=@7=X\!V#+RDQ4D603LJ"!07D";)))N0@\# Z619$I_]="4*ILAI!7)L0
MY\0@YRE&+*40!$0NS-#-C4E_%L,\%T1LDN!]:@GP>ASRZW_<;(=?O'OIQ/L(
M=_]Q!);MNT$$!7"1'9/I/+[XMI:/!2MK-)I\*?:^N!33!8UCN_]P58BV$/6B
M!Q8C+F]BP,6TRP4:1+3^;%-A%#"(5VO<^;\&Y><O[:,LJ+/9WYQ;M?*W:&0O
M)_-%@VS[<@3C4_S''Q;' U%']J*)KYIX8?-.*KSPXOIP@U73[>=A,VP#BU?+
M,]8.A"/#J@6LW$3C4\[Y']=;8A<$;7MB__R-<\FION>)]SQ-G"JA#GC+O_QY
M-MU&U$4[L09.==;_Z],4M'U "S9/Y6<[F^=4;-O2_*IM;,X?[%B/S:9F3(;C
M'THC#ECXA:RU(MAI:X<#5UW,RT;WBUG;#SQ82N'RI.FB,;I<?WO'LSY@W^&]
M#=*M%,#W;[--AV@21+C9Z*_\\RP\)M%;GL"L+V1_H(N_I8?S.CUA8?.W99;[
MTS'T%C(<D-+;NY(/3^NGY-UG3^$;;$!Q5[I&P /%DG^HOM_Z8M?6% [?MJ!W
M4#0';2S?:VKAYYMB.+LU;4/O*3VW(?]ND>K+"CRE_EF_]WARG/3;Y.#;$^X/
M_>&ZK1KTD'0L=S^H*M@YQX$D@P,BI"3C&,3J+/<D4JQ5(E%JT>WIA9">N, 1
MB7D0"74&:0V7P%CQ9&BB/G5Z>K<$Y#MS<6PC%W?3KB"3[$2+W9W>+U  G]:2
M+\.YAUGR]?P+^%8'M>P+\F92EGNMWQOO*>WSN'9_6>K:EL%NXHX,-_-_U;Q7
M\_XDVJ5:]<-9]9BBX2D@;CE&7!*/#!4&!>ZM(52*D#II^."CDE0+%*DKK8P4
MF<0E,ICZH"PAWNV<SO3+9+K4.._3U8[;^[:R8OSI=2YZ*1_MR>A+=:+,[NZR
M*I5'&;U7F[\WFW_3YFU_E'+U (Z.?M4#Z+\'$)+43B>4$LLQNE1@S8U E@5.
M% Y1VDXC^=X\@+5JX&L>P.6>[#\YH:2:_]Z8_QKR/[WY?[,-S:@ %?5'_59;
M?W3TJ[:^][:>&FF=D!A1D6$2A/3(@NU'41..I=*21O406U^*[C)L7(8;?#]^
MG^LY]Y_')^2DS$6H-KT?-KV&]$]OTXNH]4>C5O/]-/6$1Z%E#LJ.#Z]F>]XN
M@*14\D Y\I%)Q /3R#GED3 I1.LQIZ33\WN?<']A^S.HZ9[,/J>]B./W7(IZ
M%!+[E+%^+=3;2Z$>J\[!$3H'?:'?49C^EVW8J10JM\>!38\)<2HHLBZ*/#,
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M<!C\>*&KM\%*#(5Z:P0\6LF8!J_;/K&0([BVENM-#%6Q8CGSM$9 AK0]AD3
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M&8KD7,0@^BNWIG"9-,\06&H;P6P [T0!E1*B>4:8EY& F0QI>PR)@)GT:<>
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M%EQ-%5S@/@FC!+>]O$?+9"Y6L];?RX#254 41D+;0Z!"L([%=7O-!,Y;LE!
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M*2=03+CV0@5XK@)H)ZIG3$6I>ULNM_;E<':+_0$$?!L&OA_MH_+@M'M[ 3U
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MCW0[D]^5<K?W<R9P#\SCW:O_FY,<L'GY\^D',)U7[WY[_^;MA]./9^_>EL+
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MB:Q2P"G6:&0LMHA9KK 0DGK[J)2-HPU@NE@^J<0OA78.33LE?BGQ2],,5Y#
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M8UNO8UA[2QU'*4D):D4L@*>.R!)N6! 66[.VVW,(9W[':D5ZYCC4:AD3Z]M
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M]KGN-5._]^L_4!K'IN9('.>6WWGOX('&\+AJS!L%W(T2S8<DPL<4".Z*SAY
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MS9(IJ:**B$:=$(_<(J,$SZ?BM(_*.8;7_  B1%+!T_S+"-= , IX'9$,R?$
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M1.=17DP'GYIMP]:,\I ^1#\=]R=]>,TW7V&PX,%6IWZ2AT@,XR>5!=,$!S;
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M2@9KG072)JX0QL8&[W8?']T]P&1G$P3O?P<UX_H=O6YF8[H@@#CZ'O&=DB&
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M\Y0Q&[C@ZKJ,AWF"0[#PHQO.<.D/F^J5-(QO5Z61!XH6CT]3>CT\^0+PU0N
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MCX6OV]I7N%PJ%O<S="B,<>&P4&51\X*.UJN>A48.7;$^UX,?DZM57=F/-]I
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MD!BH*(0%\&=;\@L=X#Z<$Z,J"!<@%XP0D03!X7]&66N?B1K$X/H.@UVBA@/
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MHED-<CN,\,<ZZ6AF?E!2QJJZ??3&B_'URIN;Z9;73Z)GVX[ Q:ISS)Z8X&O
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M/IE>PF6_+9!M[9\N/".FC821-Y/L?(SC6UL-.&64U#-;@S$&!P)* *.D*BD
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M^+E8< >C>S6CTBO+D?<4(TXP12K%J(CF.!JJ)-G<S_20R-2OZ?U.XV]-.$[
M<KJ E9/)FP6H_#BMK^OGGQ;1[<O>_"4B9%;10Y2V#-6#I=/PF>=PH#KPE(JE
M2 </4$T!=C4+!!%6!FHC#ICT$K7:.53'ZG/PZ%^AGB8N4I30EQFGARAJ&:<'
M2Z?A,\_!X'0,TI9<$,32?F-.4Y[7AH"$]IC*H((O=1_AK*<WJ=F(I3+,#-6Y
M(FM_HEZ_?BG*-3L#2G\X*XS[Y[QJJARWRDHV*]DA*EGIB&)4<!29B6E.14!*
M186,(E'I:")6&SFC;XE;59./YJ:&;98J]GV'$L<M2+08D1V?9RU6&9,'2Z?A
M,\_!8+*5F@0?P=-1'O"58H:L9!$1+FS$7D7A'A6@RIB<Q2IC<F:>C,G?,,\-
M+%M61HNT) 3QTEK 9*X19=J&2 ,K[:-JJW:"R;?E<OL8!'ZXDG5K/\K#;IGW
M9.TXKV;_#*\KXW&3]B.N=S0J4B>-43&=;]1Z-<69^1B*;@<PV%#P1VT^A*(.
MYX &Z3# V?-T/7-Q44\_@RC/POBR6*[!!I\_JO4G$UXR#M E/ M@6,(/6V*+
MB'/6N6"=]AN-WTO 0V:M0I@(ACA.Q3":E<B:J(P@@#DE^W)1Z7\M7OZX>_=?
MEZ_>?OD>7I]<0S;4!/?"S^O+8.J!K#@]DBNAN"D0F^OT5$]9)(HUA9GX=O_L
M!L_YJG%IJVV1^E46H UOX=?U_;/%)],\EA%W,<V@#+9D.K$E_ "F+I$B)"#G
M.-$NAA"MW3I3OU[0]E<@[2^A3O;3-;5^,:_#2J\CNJ[8OUI$?71W$?40V.[[
MHZ\J#%"J;0]C-S9-D^R-#P \UQJO?G>MR?&_6IWR^05B+^,X?$:^JD/[XJF+
MZOQ\\A)8^6)L+E^D;S>LD",!=DAZVD7&J/O@'W.PMN+E\L';4U&8^)<7TRZG
M\:)MI5M]#.NM*E<]$C[?T[+Y*F&WUF6B[W4E_'ISJ%;SKY;S;)676[Q0-1F#
M>8N:F:D7?7.O?P&D[C[N5K]-SID([_O"C#^9RV;1"72=#:YW64^+N,88&PO<
M[SH^VH(SQ5F=9/_?9E-W]XK>U:2OO2! P+1NZ\1?S.&UZT3'KD/'=E:\;<2=
M;)%7W4=763[SOZ[WCSX RW>;[]IS.YF^B7'R]NWI[R>_'X^*D[>OCKZ1*$\'
M@%NGR]O3]V_>%>]/BU>G;]^=_G3R^OC]F]?%CR=OC]^^.CG^J7CW'C[X^<W;
M]^^*'Y((59-Y\'_9%5,-38#6-7]KNKF.)&;-=N.6E-((@TIO'.*E*)%V\*>V
MI=<D@D-BU!^DL]Y::A[/[GT:_:[GP0F:6F.L\4B70B).2YE:5X"U*2*3S$GL
MS,;\YH>-86R:$.ZH4OK9S.8U_/OD0Q.&[*'_. <BA0*^KL[GYPO/YF*QM_$.
MSZ=)0Q-2GZ$!F=8;,88O#'?8@^D&"A]QSA_:^U[MMO.]. )8V?]N]_<>\]UC
M;[YO&%1TL/V>^R/Z0^9#/>].D[MAZ"&T1MPNBQ^WG?D&R]I#6( !]Z;<OHZX
MHUAW*'/J>HT]M[,LPB2]V..&67RC= R%F'N'ZE^#C"<L<7C*&;.9?H-LNK)&
MWH6SWM[H$5LFO@H<"ZHG85]SYA=WQ[LJ;N@5I,%%%GEZ]1Y.KQX*_?9K,O6
M(7H7>7^I0]#!(VQ93%72"FDC&?)>1Q6Q<H:0/O+^7PS'+ANFO9Z'MW";]Y_"
M^&/X&>YYUE]97XE[*.M[/C(Z#.\J*_HG5O1R.)";%?W>T>\)2)7U^S>V]M%4
M2\,$HBKI:L]2:Q_N$>,NV)($XE6Y2_V>(D#O/TU[4NN<9:4^&*6>O?>!*/5R
M.#B;E?K>T2\K]>$K]4"(]#(@*SA!7$B#=*G :7?.Q&#!HS=^YTK]K ZA+[4N
MLEH?C%K/OOI U+H:#M)FM;YW],MJ??!JW6'AP4WGR$1J$%<!(V,<1K1DT<<
M&I[O7*W_.)W7??5TI#TT2<\"F9WU9Z75]7" -FOUIRG?W@N8V2H[/KYX^'E;
M!M9P8Q5UB%&J$.=<(.O+@)SW7F(N)3%BYY9!];$O?U_UT.IYJS+]D-T!>R'5
M0PD)T%T:#_1Y& _OIS,S!@%<=B0)_L8>O6Q9[*%E,13Z[87=<-A6 <4BMGNW
M?>2@X<N D<;<($$YPX%Q@\5.XP6]S7[ F _!('ANHCB42$%6]M^. $D&7Q35
M^<5\UHY,!5@+S4-W%68-GV,'S\8&R+&#U6;ZQW3=>(P=0KS0UIE%)^" +=(V
M*@1&",5&T< MV[H=\MN:'_3FLX-#NXW7/1DE5.08Q8ZV =W9!B('*_;7?EFN
MX!5 7;]9ZE>+JL_HK/+PEB]^_",0!5# !-*^-(@[ZY#E@2(.GX9(N1.EW4%X
MY0N=75=L>OV?;(KMJRE&CVC"4S^=I^9/0S/&]FM7Y8,I^PSMLKNL)BR()1Y)
MQP#@@FZ;VC$4-.,DV@"V4R_1F^T.ZJ2C4I#A648W&&YPMM$V0CJK:0M?&3?P
MY#IA[]K.]MFE\3']5=M;O:C +JG<-]#GEWGMSI+Q\FIZ?E[--G)#A]WF\F12
M'%_4U7@Q?N)3*%JUTT79IH5IJ19J5X$U^&Y^<3&^+(X_U"$D,A:?JMD9' #0
M,RE^.3, E,6K_WCS]O__MS3=Z_<WQ;OC=\4/:=@7Q2^[P]H_R,N_C(JV&W4!
M+^K.NKM^,!_@KHNKP:WA/>81$#5UX4SS")KN[@X@T523XJ*>^KF;-47;JCN-
MF)T6_WW\ZO5OOYX^,!!P VSA?J!^KX@NC\H^9;;D+Q\3L.A]\$,[\F%:P#LG
MC;<B<Q/JCY4+W4B(9C;W8/H?%;^UBY<F1)@E,[2\XUH16ZS&LG7JQ5( W94
MK@8"WVQ/6AX5Q9W#4> .[2B4ZW-._OTV.GX#D79@[3 E//R?1B8$CWAI'-)1
M*V1%L!PK*;#!&Q/\2" R.G#;.0''CX"AH]/@\])[Z:C ,L1PT]I98MVI!19N
MFR2_GH>3R;W;2LAKUH_XBO4#$C'HJ1+ @>-Q6H3?CMX=@34T'J?^:_^<5Q_A
M90&^JM3$=];,3->2[58^G6]R>B)*^TF:E;+DS ['X'Z%#<5\!D;FOUH,+> 8
MX-'45>BH^"^XRKB9[BD3$Q\$#5X@[ST!\SN-//,Q(LQ*9PTQ)L:-D6? ND9Y
MZU$4G /C2XZ,UQ)I$A25D0>1-F _+1/?O=MJ2$P\V@<6X=$ 1R0WSBB+N(\$
M*4D#*ID+SF$>F(Q;9)%W 2[M4WE>3\Q1'MT=]QX2<[3:>0_X@XA2:>LU>/"A
M1-S%$BG# M)8"44UD529+?+'^[.J[I,]Q)'>#_:X6P$^2.DUK3YKK3+9LEXR
MW$9@B3<7:<;21U!H1X.B0_:.[ZZL^ ">W2_UU(%E"D=GUWA%FA_KZ7DQ@].3
M,Y/^';4"  XQ/-QE434@/Q^G8(^T=MZX)>3%%2'3A^EX<&BKB:G!<YW.ZZ:=
MC52!C-EY4TU"TW16(?BXD^FL</.ZAIN#/6B*"U//+M.MT\V2E5@G'WSS-N&S
M"Q>S--$AI8#G30//8\-X^NGVJ3L'N92GD^+'8.MY6@;2 1<=%3^9XC\3)@)P
MN5"E=6RI#IAG+LZ*D]_3DH#OFU8LN<-5K%PW>.:'M*Z+N,:/5=W,BK?=D3\%
M<'[K99"CB(F#_CY."+D(C_Q4 <C"C991D?;+U?'&IW$8::#GF9DM3CPS*?1A
M%VXUD/+8VCI\K-J81Z+%ZWK^H3B^N!BOGFYQ[>.WKX]7ETXL# _]X^MC<.G#
MG^DFK0,"FN!&L&54S!.7UG <>#.F^! F[0";CZ%NTN6!&G\_.?[EUS?_]S@'
M6AZ@BQ:PT*KDB[I*:K5;F_#YHNI&M24:M]__8M)9P%W-T8M"CV!51R47+^%7
M4=*1$C+]JF0)_[&7!<$C3-5(:]'^SI@8<4':W[EF(T)Y^[O >$1YV?W.X7B>
MSB4CK.5(*_@]L1W\38D>24FO<7M>^4>L?+>:S54,M(L:)/ ?5TU7V;B4TG00
M*5\V2;)!2N&[5LY_648]V]#K^[, 3QOF0-/BS=*L QAZ []T,[*::ZMW6IO)
MAU#\;3K]<_D01^DBQ2T@5I@QZ)K0=%B4+I+7_O%KWRYVFNT^KGR*@8<)V-4N
MM/.60.S^"FC0!I&2,6#3D;&&:R>-?MFN@;N*QM\*V:8;OI@.7>+V(E .?DWC
MZLIV7+;2.QV/@:;(UL*ZM?"S ;>HH'K#5(C5N+438"$NQJ9:.$87'4XOEZMU
MF!;+D*6F#ZGY *1NEB91^F^9GUAF?^"P;N#T4KU.6COKW0R^;8K7 *\@"S,P
MWN?UE2^[^AC6*CW??X*)$RZ+]K+-!:!G:_IORDKB GCXH^)D4ACGP,(W"79;
M3$[7_0\S<V?HO\SG\V2ON=D(9-F9)*.9&QYC.0$C%!,XTYV%\T2&;M4O6X9X
M@(2F]8*UYJ+PYK+-.;6.P,5*=F]1BZ.5&>W,)*%T9T6'V[@D.6XI_%^UP10@
M8'DD%O&3UC-H RQ+(SS#Q>,9)!%]/AF#5WU=O!=2#WIL8<Z ;;,DN &'N4Y0
MX8!9SIOEQQV_-*#[4#.O9O?0VXD95OIZ#\)?AZK:5X& I-=!N[.> @%=\N'K
MD8"[G'P#F.23=3:[IF22!JHF;CSWX>9377^6UEY?73=Q^'6.!N <7Z*J:>:A
M4Z%KW@!:^!_7G<ZCY 4*H=-_JZC"\HT!YM+'W<$W71HW3=&"%9AU4#%ZL!!E
MOKTR23>9=JGP.FUUO&"C5ROUUUI$H#M3W?:'!:^T=8 W=!90X\_0%GLG[O M
M>-IY>WR*14[2BB95NF)08)]J"@\(W%R<G"P=C5'Q(UA/85+-F^)_&UL5O[T[
M+G[ZZ55[U1M?O?L$_/BW:MI4(!WG]C^*'](0V&4.H=.URSC;]3-?APCO::ZY
MTZ8!QD-^]<U1<;JL;BKOI-I";&\EV[H5F![E-A$?+8FYD+:5NWS3/QNUWMD(
MQ#&"/1 7WMHHN6W5^<6T;JV.6ZV(VZC<N8E+42ENE<KV_=^"*+9E-(3?28,V
M+W8+"19OEOY);&#&U^VGQ1LOC?/6,+IKE8:K$/]Z8ZSX]:GCZ26;)M7K?@CH
M^BCDZ[/!_]5BTN<7B+V,X_ 9^:H.;48PS36>GT]>@D !62]?I&\W2GB/1#5I
M'W>QFZ?[X!_S!@#^<OGD[:D("/KR B2FO7;K_H"PK \+7M4"?[YG;>]7*;NU
MF:)]+RSAUV=WM:6_J^4\6^V96KQ0-0$-"T\V WCK)EE?_P)(W7W<K7Z[<<I$
M>-\79OP)7(;%+.9U-KA>UYT6<8TQ-A:XWW5\= &S*<[JE!/_M]G4W;VB=PV/
M;B_H 2*[(/:+-HN<Z-CMT=O.BK<S[!-RONH^NLI?FJVD>P^I\'N;PX-[KV-^
M^_;T]Y/?CT?%R=M7MQN.0P3 K=/E[>G[-^^*]Z?%J].W[TY_.GE]_/[-Z^+'
MD[?';U^='/]4O'L/'_S\YNW[=\4/KSHM&/Q?=L540Q.@:YK_VRNHNK*G=6-B
M61=G22F-,*AM6,-+42+MX$]M2Z])M$X;]0?]+GLY:VEZ-5I4&2W-U=; _]0F
MI9LV:_7W,*W!]OTOTYS!I6>ISFE2M6GJV>5-3V(5FUT9O\N(\34OXY?6\*UB
M7+D5-_=#-&#UCSO[]ZHXZGH<8'7 :J?$ZF+M8UQ%L;]H,M]\A<7U-SV?Y*=,
MQQ\[WW\S^ISJZ5Q'_B_%LJ]J^N%]K\(&M[W.J+BB4_&A-FWWM;4'-VD;P468
MS<UX5-332S.>7:(()[<O'>?C\26XE)5'\XL1N/P3%#Z[\;R!]^S^;.9V#![6
MI$G*O?MH!G=IP'%JU7V[?ZV]5G=8:V&D*NJVDN%/.*6ML#XW?N5Z =LL72\X
MJ/NS<[M&R]C#RN/MW*FEH]4Z=. ^PT/](Z2_;\T(W)IV:+-UD^0K++]?5H,S
M#'RW=L5E.J,KYFD3M\#D<%<'+@!(47VYN$)R1B\O6HMGQ7X#=JX.&\^.T^ZD
M?\ZKNDO@CLVG#FS6,.0Z8Z7"'KC/(MG;1N->AQ1\6684_S-YA"Y<@4< H06_
M_'T-O-[M<&M2E<ZW6D '5/%X DQX/EG%3;N=3:= S+KH#* /261#+H1<H]A=
MA8S+(L9V:]:YN4R@^;'R*<I[@\AP\$<X-T%AXZ87"PYN%0WP_4?0'-,:+M-%
M3=I? :R!T]-OZ=!INT!)%%*2MU6CBW+C=?@\-RDD!Z=T$7.XVPB><=:&E<>+
MTKO9=%2,ITV3]K35721^.F^%*SGX[BS]ULQ37<X*7T=7V^#@9C8L7[.5ZGEZ
MUGE=3,('6+FV_F91Q0&*KCA/;7DF75ST8S4=7Y&C18,4_ ,RMVI^WA5V@NJ<
M7=X::$OZK,.&%*Y;T*)+0B\B=%=;Y*Y9+3=68^W-.DJNJ'XMM;Y<@/;#<'XQ
MGEZ&93U0&WU<8%M+ 7,^381L5REE53\DN^KJSBV@G:]"A<M;K/43Z:Z;>"BM
M2ON>L!Q-5PP')U<I>&-F8":UI8GM<G1%K[=P#!RR>N"CXNWTJGX6'L>D-&!+
M)!O"I*/J_ )N-&^7]PX67A3%;W!&A\3SSHRLEZ6\UZ+!G[I/S:?TLWT;DXRR
M^=@O=H)=/5X "\4M=J;5R7!K0R=MA4,$X9NTE3^)#@O%O]I2=I[LL432)3TZ
MJ>DH M=KYG6J45@F:!*=VR3-K4NQE(LV:Y4>9+K:1W%]4=-WJP4X*MY/B_2L
M5US8I7/:JF9_O8[939M9RUFM5?_E[9YMFMVY>KZXR/JC+NRJKU(JW27E]YKY
M>)G>;Q9RG/1E<W3_D/!R;\NBP\#"Q9.$8N\B139M:.':>J1Y29 OX=$9IMZH
MC2V>I2"4ED:A&$5$G).V"09&+$;O12DET_3FUI:3"5B5X;WY_!J0!7!L7H?W
M<,6_C:?NS^^*T#ASD?14G1J2NJ5#?SR[[R/^0?J/-0[%8+AG"/DHA9!.?WY3
MO#_^[S?OUOGB,5&!#8;QI6>Z= (Q$@WBS!MD,7:P)!I'9J+"I>V#8=ZYL^#G
MXW :4V('7AVDX32NV.C-YXOD0?TM3 (0H@VGWL5/N["#>NO+U;\1E A6S,SG
M5*C=.IT)=*H$8PM7.8*[/OV4KK1;VW'((;5E=Y:V.<OR>:[GT=+SIV_1V%R"
M)=9E7+J+$XR/\/?+[C8I'&(NFO"B23X1(/M: [NUAG@)T;LN/R^69]S1Z:Z[
MB2!'C)#OUU,OBQ?J<B]__<*YY(BKAY[ZP-/H42EV>\?\CGOXCE]I%ZF^V.WZ
M-KQX< O):G*S+/&\\GX<;NMC=;OQH9Y=\[Y#IPGP6_KV?WY'P"A^+(&^W@/Y
MEO?=(DE[3@G>B^9I5WOQIJW?6?>DMLJ8]VG'.P3*;Y6=]Q-GORXRNT>=[0K(
M#VT4<SIO4OCGSB;+62ZV _/TOBC_F$[W0Z#I=IDXQ<5Z8-W'=5@? IF'8K7=
M3<EG;;5E<>Y+G%D6YRS.69R?BSC3+,Y/['!]90[*P");@TB5W&M17G6MJ9X@
MTK7GLSN^'67O)M PQD,,15MG.F6!RP(W"$;*=,H"EP4N"]S3&_J/'=A\8]JA
MN.>PP_N)_/IH0_$L)ALN-B \A-?[(^NS0=)[4.I;)X,]N=]Y?P)]^ZR^1P_J
M&P:,[J#S?BF-HXQCA*T-:79>0)9IC+2.7)+2*:-)']6FBS#! A8VZDO[FKO'
M1IRIQP_>VS_9VC7<9&!^1LR3@7F P"RD\M%8Q"1EB$LND.5.(DT!GX4)RIB-
M;0#>A5)2)5"@MD0\6(H2C".-J?.E(<19^33 7(Y*??=,E&<L6AF7,RYG7'Y&
MN,PI]I1(B8PL'1C,G")C66K>PCPGT3'/-O;S&:PX0*%'\-,B#G\B2WF)J-"F
M5))3[O#3X#+'(Y62TQF8GR;MG*-1.XE&M7U7LFH=JFI]:-7Y7@#$]G3N-]56
M/7.M'$()2A2\)2%!PPJOD9:&I=\P-\PPX5B/8:P63XXG_J>IVYYN9B-2WCV#
M=@"RN:HMR](Y6(LXZX/#X;BL#]8::T9<$HY1">X:XEHSI'V@B#FA&=,<Z\V!
MPH^(GNU$'U#0!V76!_LJG<.0O:P/#H?CLCZXRJ;X2&(H!8HX@*WOM$(Z6()"
MB!93@'85:(]1NYWH RYYU@9##.[U7&K6WF4[T;VK#FQ['=Y[/YVEUH$/WXF2
MPWPYRG_09N$.5' $YXI28E"43H)+5EIDE5!I](%TG!,GK.\Q1'='(\.^?#$Y
MDH0]N?K-$C4,HF0X?B[,<S!PS$HJ+;<E@+ DB&,?D)%>(FNBTI928X/H,4*V
M73C6(UW*C,9#%*B,QH.ET_"9YV#0.!AA@]0,68H=&+K<(^,$X+*2)D0II,4;
MVS >$9_:+AIS,J(JP_&SZ66R$8S*<:=PR[S@O"=\Q[VEAJ$=AK(G/-/IL73*
M I<9*0M<%K@L</O&2 = I\>EHG-[PP<N2II>G*;491Q\2AQ\E@3*1,E$R:*4
MN283)8O2< B4B9+W=^^=E;[E;H.'P^TY%Y>SVX_AKA^65-QQ_MR45#))TJYO
M;Q#'5"'M343.E3Q(RH+'&]5,#RDN788#%H#SZ#QZ \L"OWTEH4[H2.*#3*@_
MM /2@P;Y957P3+DHJX+!%#I9:K62N$04$XRX# * .D:D(^-24!U*7O91=MHW
M4'\1G^5(Z*??BY<%:QA$R:C\7)CG8%"9! /(ZRP*Q%HPA3V8PB0RQ 2@-+%!
M.KW1;/8AY:<[164J1Y@>I-4\C)QSCGWM)/:UU=Z&@V+KO52LN7=)[ETR].B9
MB#AH'3ARTH-3%@P MR,&&8ME*)EQ-CE8_47/KK5'V54,C3RY)3#09BDYQI:5
M3E8Z6>GL6.D$)YWQSB"-N4%<RHA,=!A1ZHV2T2M,>9^1P*=0.G1$!A 8S'HG
MZYTGY[2L=[+>&8;>*9F2@98H1*X0]Z!W%.@AI%EI3134:;.1@7I,K/,I](ZD
MN7'\KK3.( H$[]TC\GXZ[AGNU>]Z1/I';.?))D1.E^1$Y+ZK?\>%$M)09(TF
MB#M3(AN#1\R84CC.M)!N"Y6"?76$OG_!('GZ60'/0;UGC9 U0M8(3U>:XK35
MF-CD>A'XD4H'== !*19"61HIL-V8[-5#P>!N.OB/.,:'B-+#EZ\,SH.ET_"9
MYV# &7MMI)88P0^-N-(&*<PH(H(R0XSD7F\4#O10-[B;<5L"T/GIBP;V6,"&
MU;+F9DWAHP-CSZ-\L(\>EH/BWOWJ(3#(C-GPNPP,-+DP?,(]2Z)D@7QROLH"
MF04R"^2 ^.H0!7(8J?C[;EAZ0"K^>;@<72J^:DMABIGY7(3.?Q\5D["U\8T'
MAL!;+^BA1S1!BI_.[3@\)10_-./W[T]=YW<[!0\F=N@$QY89B4Q)'.*.,60H
M#@C@F-EH(K<\]I&(W^XF8\)&6C_])N,O<M9SF,2<X3_#?X;_YP3_S@:9Q@$K
M+S'BVGBDO?:(4H*58]&&?AH!;1G^^8@-8/)DAO\,_QG^,_SO#_Q3+T34AH(1
MGZH G!1@_1..2.FYTJ5F0M(^*@>VW/A-CJ1Z^CK;9P__ZX$]^-W B_VO)=7?
MSL]#73GXVU<?UUYQ/4[&CAACW^\J6':WP%S=^TNW>PS56AI<(\Q"X'BDI2@=
M2)B-J8X2#"@EL49.!*PH+A7&&P+W$'?[G3L+?CX.I_%-C 'DX6-8R>"O9A9^
M#7 /5XTKDT3E?5K*]W#'OXVG[L_OB@!B>)$6KYZ'[FFJR3SXX]E]7^$/\MT@
M>."^$-HW1[P_"T5U#C>:-<4T%C/XTU>P$'68.+BD#;-/(4S:SU/4U<V"+WX[
M>G=4Q*ZT"I[?S.:S:7VY'J"=38OIO+XE9%N8&OYK "7'X^FGYL4Z*P['K-JZ
MV"VAJ46FY?,L4#D]4+HB/'_Z%HW-Y70^>V& R"^[BQ.,C_#W2Q0'SAF;BR:\
M:,*%J4%BUG(0:SF-CU5361"CV>6+Y1EW)"NZFPARQ A)=_F<Z)&>:/%"0.#/
M+[_[ZQ?.)4=</?34!YY&CTJQVSOF=]S#=_Q*QD_MKL+P")/-].S=/0F7'[7V
M]_+LVRTT]>Q<T4RKKY1-$'Q[W<0W$N[KI1.WDO86.FR1U%=^[D/LIT^=H-OI
MV'_#6OR?8.KB#=B%OG@=7#BWH2X8&6V;D>]3DS'8%7G*RHWAXO@#16SWZ+5=
M@?KA)/D4TWEC)K[Y]KVT68YV67UW*[4?4X W6%IOE^DIIKP?5G]<&=]@R;^_
MUN5A4"\#Q<Z @F6@R$"QM]3+0+$SH* 9* ;JA&YI^T!'W,=-./D&'W,06:][
M+=:;97XJY9O,[)8,5?V0R2?/B=Y/J3<?4[ P%/KMKGKH_ESWC50[F(HA9K@P
MS 5$C1*(F](@JZE"@?B @U3.Q5X*&*ZJ%:Y5*MQ12'0\6^M)TJ+2M6J'GNJ,
MRI'B/529/A_!?0*,RUKB4)DM:XG]T1*2&$.U-0C+F':5&8&L%1@%K313+ KA
M<:_;"@:D)3@>E;R':M3G([E933P;-3%\^@U133P\FOF\U0117D9E6D^ (QYI
MZ@?N'#*!>4$B$]'W,O!XB&I"J!'X3;M3$\.7W*<-(#YV7O)STD']3T:^K6C]
M!]O)VU_:CB.I3GX96UQ\,1Q$SG9 -CJSE]B[EVB<E,1+1# ']0\^(U(&?A/"
MFEA:K+#<\!)[C"7>/A(L-'UM2A^!-9+=P$%*9(;_S&P9_I\:_G6D1'J+)&F]
M/^:0Q4D'."N$#"':L-%ZJL<@X=;AGS.6X7^0$IGA/\<2ALILSQ#^GVK((/&!
MR( M"J71B L.O@+!"BD?M:8EE22$+887'Z]@[CEF<,3)#AV-X0O_,QDNO#4+
M\\F7Y)'2O@C/%V;BVS+$4-2A":9V9X6K@Z]FS7"L^6P[[!W]!F0[9-?QJ6R'
M$&EDGDI4FF0[./AAG Z(2R:LBEYZI;88FX0/7G50]NL"VGIR2W4/DRZ?CZCO
M;DYQ5C!9P60%DQ7,2L&4X% Z%@W2G("R$$H@&PA#D1K*K/%*6+[%Z.?6% P9
M"46SCLDZ)NN8K&.RCGE2'2.M<)*#!V)L!">&2X]L21TRI9"1&$Q*0K88 -V:
MCJ$C+G)N;7@1S]W54.[;DCPVXCFM@? 3D)&Z^AA\44UF9O*A2FUN%X65/OAY
M*P;# ?)L->P=_;+5D*V&/TIB)<<BHF@-!JM!"V24H A'ZX(KP7!P&U;#0T*?
M]^E,_Z.OJN-ST#&]C0HBHU+FW7G9/\V:)FN:K&F>5M-HITOF KBF40C$G0:M
M4:J G%6EHU(IRD4?,="GT31B1,N\ 2!KFJQILJ;)FN:+4TBIT<8(B4HJ..+:
M6J28$PA;[HUU1F+L^XA3[D(/Q.IS\.A?H9XFAE*4T)=9!PQEDW<NR=R27+\%
M"8(_ZNEX#,>F^&2H0[/-'=S#)W!6W,. BJRXMUC$HJBUDJ$R:(8XU@996Y:(
MT>B58D98LK'#HL<JR9^KR;2N9I<G"[CI#EMT<\GJ.\MD5@"9V;("V*("X-KA
M4&*&O* !O#!!D,:6H:@C^& ^$.<W<D4]5C%F!9!E<L#$R@K@4)GM8!2 Y\YY
M20URW'/$K3?(B-(@G"QYJI2T<:.,O<<2PYX4P/TV6I<C+G?8L?%PY#-7&PXJ
MF'=R#F>V#1GALW8H42MK[7YK'ZY_!@<U<]M4OC)U%?+&ZZSNGQY.LKK?7DL5
M'KSV6B!IH@#]34ID'(E(\%([90/Q=IOC7][\<]XJ^S>F?8/FIVG3A.8T_C:Y
M0J7@WRT!Z3*[@%E,LT[(S)9UPC:K^ (35)<!D9)@Q(,)2)<E1Y93XJC"F.AM
MQ@"S3LABNE_$RCKA4)GM&>J$)]O;K$!U,.%0L%(D#2*0(38BKZ7$7&$>8B\U
M@T^J=39"D&JD=-Z]-+R=S[FP<$O"?SH["_5P #Q;"WM'OVPM9&OA#V]XM*6@
M2$IM$(^2(\T#1;9D+F*CF"7;C%NV*';L_S%O9N?PF+VW@*8CRG-#E+S5+*N:
MK&JRJOEB7U]?4L$X0U@Q@KBD"AGA.:*,4<*$E$JQ+08K'ZX(OM)TD1*=\?\Y
M2&*&_;VCW_XRVS.$_:?R,+#VAI16(14"> M:>&2P<,B5K'3P_PI\B2W&([?M
M81 JLGX97-@QET!N2<9?G9G)A]1<L?AHQO-%^>-X//UD)BX,![^SL7!O^ED0
MB5"O/CD2%[.BS=,42Y89"H7WPIQX(#F?H<%QASG @M*&1J1D"3YC:0S2AF'$
MI"P=UM0*LY&>[#'@V.'7R>1UB*&N@X<#CILFS)K?EW!VO$2SOEQ0-6)*#L%&
M^ )K=OH2LRSK6?4,@B&SZLFJ9_]\7<:$5$P*)%,8E'MJD"*&P@_%L-=*^KC-
MR=U;46[W=8-'9!CM@_=)R^5L7%9W6=UE=;<=920M,0J[U'D*O"9'!/P&NBEB
MJRUH)&>QWF+@]0D\+38B:A!C//=)!SWM7O5^ZD/;5ZPF'IZSN]&6%=V"Q(F<
MW?W6'V"Q.GL6V'T_G9GQ<FC.S'PN0M<K8E1,0FY7N?_F!CVB"87\=)Z&(PW-
MX'BH(?SO [ \OH&R!V-[1,\<452B('U ')<86:,X$DYCI3SA#&\XPH^*\BXZ
MV_PM3 (\7W\&A=8##-W>X+AG:U)D]9+52U8O6;ULJ!<AG17!&H2U(DE5E,A$
MC1$&'2*BDZ55O<S'V;)ZX2-69O62U4M6+UF]9/4R'/7"39JW ^I%$B<1%V7*
MX 6&X"]OB=%>F7['@V]%O4@YDFJ *;E#42_K 5'XW<#;#@G^K^[]I=L]BA@=
MY[V=GX>Z<O"WKS[>\2F0Z7_ OX4;FZ9)_/<AH 77I&>'F\-[I0,6K_6O-MCZ
M^05B+^,X?$:^JD/+WB\ 'N;GDY>^:B[&YO)%^G:#)8\$<%9ZCT5LNOL@E8A7
M\7+Y2NVI*$S\RXMI4[77KL/8I"E9P-"?$_T235:\_?F>O/I5DG]AA:]@]R&(
MV/>*$RZO+7>WO,OE/%ME !8O5$W&U02>;&;JV0LSGTU?7O\"2-U]W*U^FP8P
M$=[WA1E_,I?-R^_^NN*36W$J+>(:8VPL<+_K^&@Q-<59G3#^WV93=_>*IBKV
MVU:TO6!J.ENWN;07<WCM.M&Q2S1M9\7?)Q!+K6U?=1]=M;4U'0\<$KQM\UT?
M)^B?.JZWT_&6^.#D[=O3WT]^/QX5)V]?'7TC49X. +=.E[>G[]^\*]Z?%J].
MW[X[_>GD]?'[-Z^+'T_>'K]]=7+\4_'N/7SP\YNW[]\5/R01JB;SX/^R*Z8:
MF@"M:_[6$G<=2<QZ-RM"L7>1(FM82!,P/=*\),B7QCF&J3<*_[$PQEMJ'L_N
M?1J];E-\PUM_=]?C\DA+43J.B(W@"DA;(B6Q1DX$K"@N%<84'G=MG=<SQ^R(
M,?;]KM+'3VT:KI-O:3T,@"Q/94TMZV36<O!P); 0QF#9%K.SD!+Q76:^G=;:
M)#T\"^<78 '4EX6OX-,Z3!R<9,/L4PB3]B1GZOH2;EZ8=G9K>Y9IZW#:MO7C
MRMAJ#&81G ;>9!&KB9FXRHSASG#E63KS8EZ#Z12Z$](UEY>:-_"XZ:RULH'E
MP4?%>@WNTM%>6/W+,*XSU#/ED62*@;1PBXPB H&<4!Y3EM!O; U]2);PG3L+
M?CX.IW&C&.EXXG^Z(D%KW[R'F_UM/'5_?E<$<+PO$C?6\["!,?=Y^E;6A\!=
M[X#=JPC>^F0&[P%,,PD+9IC.Z\(O>2^MX!IW7/M\G55,#5R0.":5<#4O5J)]
MT[>[DOB>@?;>Q!\ HCPAT"[##VWT8?D\UQWK]/SI6P3N\G2^\,RZBQ.,C_#W
MR_ -L.[87#3A11,N#'@=8:T^:ZW>ZV/55"V?7+Y8GG%'(5=W$XF/%/]^W15;
MO$_GB_WU"Z>2(TT?>.8#3Q-'4N[VCL_M%;]2)JB^N)W[-D%Z9.G@C2#F>>7]
M.#PRH:.>:3XGT^HFK8 _T[?_\SOY71]T>WQ)^Y(,6Z1TSS[X/8UC%\YMJ M&
M1MMFW@<7;P]A&;;*\GN+W;WNO-DF8FU7BGXX23[A=-Z ;=\\= ]9EJ.>50?]
M!M6QS=U0SU1U4$QY/ZR^A?T^0R#_@"S*7LJIGHE%F6%AV[# ,BP,U)+\RF;!
M/0D##")-\6VYAZOX[X!"!'M>'_L@1/]&P@VC-'- ED2F7Q;<++C/G_$.@'Y/
MV0'W08T5'H$=S["QPMLP*Z87(95I3CX4XVG3=#49<5I_,K5_J*&UY85X-B"^
MG1T-0Z'??NT\&C""[V(<M(_$\8 1XYBEG@@:*:DP\E1BK4JGL-P<M44#8]8J
MA(E(YV"*E&8ELB8J(PA1HF0WJYTV:IQ.E^B39G&^6L>>OC:REG*D59ZS,LP]
MJED+/'=FRUI@?[1 <"5Q.!"D?$D15]XCI<J M!#*!V-C:=S&WE(BC1+1(A6(
M0%R8$ND8(BH9_(_KTEN^4?/Z!%I T1$F>=IB[JV7>^M=7]Q?0Q-,[<X6-=4?
MPWAZD881M>%V!T):S7;F$PY?:+(U, S0R4; UHP +)DVD5%4.LS!" @<*>8X
MLAQ;*IA1RF^VQ^O#%81?7K5X<\T 6.)33X8 )2,FLC?X+$0RX__>T6]_F>U@
M\#]2'H.R 46%P:%SI4*:.8<(QU10R2,1&Z' 7IS W>'_(!H//3>1W+M48/8#
MUQ?WMPG0?0S/[+L\8,*#R<?03:;-C=:SXA\&RF3%O[T<H*1$D&"2$M<I!RB0
MQIPCR076W@5-+'N,XP=P8C:U_A7NI-AO:$XG)RO8>1MZ:V=+1ER1K/:?@T!F
M]-\[^NTOLQT,^BLA [8*_#QC%.+1<V0( R]0RD 49UP%_!BW;X?H'ZO/P:-_
MA7J:^$E10E]FY!^*PY<3?P-Q^%;[:NKII1G/+HNIA1NW?8RRNY<5_C P)BO\
MK2E\RVP(!'0]U0Z4MZ0<:8$C(E3 'X9J66Z,X'R\N[?\X-<.=$Y7F-.CKU>.
MN*!9XS\':<S0OW?TVU]F.QCH9Q&STJN( K$ XR)HI #,$4Z5'YSP4 ;5OZ^W
M"^A7(ZQXAOZA.'LYNS<09^]T=A;JX2!M5NO;;I*SQU"SPP%C#^DY]+Q-@Y)K
MZ35FB&A7)J]0(0O6 #*2*.R,5=QMF ;]; 1,"-77=+&18H-P !_<9"F+;]8F
M69L,GAVS-OE*4C$(%UA@2&@3$ \LS36.'D7LB*9:<+&YEZ"?#86]:A,N!U$Q
M>HC:9"A)1KICOY,^#[_S_71FQK>.<+$!A"X4'\UX,3O%I'$M9N)"-BSVT+ 8
M"OWVPFPX;*/ 4H$%$Q3)H##BRA!D;32(<D9)Z3 5CTL\WFD4_+V>-GTU%*",
MCTAN*/ \1"_C_-[1;W^9[6!P7I?&<&LYDD);</Z(1\H&\.:<TZ6TJ<*$;,7Y
MZQ7G:3G2-.\<&(QKEU.* W'M?L^>V[/0Z#DDG$/"6P&(']:'+._0[A#!1&.Q
M0N J4L0= 5]1>8,DIYPHRKT-&UWL>O$O5XAXO 3$WLJ:RI%D8@A&R#[%H!_:
M>O*AT^>R'LMZ+.NQK,?Z:L0F(N.>2&25BZD1#T>J% 11++5C5)#@RJWXS]O3
M8U*/*!]$][6#UF,YJ;K7GO>=2=5LM^RAW3(4^NV%57(H-L<=Q;D>2QRE18Y:
M@[C" 2G)(Q*X%!%+@R456_%L^]NAP^6(EVH(%D"6NSTD5@;Y0V6V@P%Y)9SS
MW N =@,@CR-8VYI%I"+'6NG@A-J.V]<?R LUDN4@-F \-[E[7,YT^[.IA[\2
MVYM-/:Z,K<;5K H]#:@>/C$'.N<V$RYS6296%LF!$2X3:[_V_.3"L <:17"2
MJQ:U81-?F/,ID.M?[0?#<2B?F]1D+RI'+PXA+5XJP:@0*D6]&>+6>:0TIDAC
MI:573#'K^^Q;^-.56[>.;,<3?[R&:Z2GT DC(TEE#IWD*JZL:K*JR:KF256-
MB3)()S3RS'#$J:+(>H\1,991!XK(Z5Y[XN]8U>@1EKE9XO *K?(6IX%XLFLS
MT3Z8:I)GHF4;(]L8S]3&N*,&VUGG%.CP&+A/P[ MTHP:Y(RC3-)2D+"1C']D
MQ=6:$7 U"^>!VYGS))QG*H 9[?>.?OO+;,\0[9_*HXR<QTAQB509#.*1!F2D
MYP@[<!(M#=BST'-Q5Y_Z9'-'#QN5?!#-$8<BY@/Q(7,V=" ^9)*YR6Q:7Q;1
M5'7;[S 4QO]CW@GB<% ^FQ1[1[]L4F23X@_-I%+&!&2=4(A3#( O%$74>F*C
MBS[P1[FH7PA2K[#M1X"VM&LX'*^ K:_^6Z-2Y^U".1V:-4W6-%G3/*VF(1%+
MXCE!4H+?RHD$K4$Y1]IR;HV2CN)MI4-WH&GDB-.<#1V>)]M_-C2WG7@0*+P-
MLUL[^?^PMO$I6QD[L3(6W6LZ M[=F6DKO7+H$4UW]-.Y'8?!]=9Z*&C]^_;)
M_M@>7-] ^&=H]-Q1H84M#VETK17,(\XB_!:#0=%K1P+W*JCMS!)8LTUZ'%]+
M1U@\S :YBS4WFEGM A,&UT%K?]V7K,6R%LM:[-EHL:=RW:F37%,!SK<H';CN
MJ9^((24BH63"EX%:UFM3D9.)FYZ'ZSY\7\U%Y,.F[F0-^63./OQNX+77WFK=
M&V9'P$_?[\HEOEN\KN[]I=L]2A$"VZ;OJTG77Q4^\=7'79#E*IG^^&!!WW3Z
MKU#4P8&TW!I=J&(Q.TM'I$+L;D_Q-!;-W)VMCFB*\S1*<%S]&<:7<#2\TF0Z
M*V;38NK<O#XJWL$K5Q&D=C(KX-G,AY#BAL4_YOY#^PM<H0[_G%?IUM4$'@-T
M#3PM/'GQZ2RD4:*%N6U286%267@S:Y_PUH>_NO!1 >]Y9CZ&A+)-!=  A\*5
M"O/15.,D'D7X"!_#94<%K-I9<3%M #?AA+2'>A(^F/3':/GJQ71>%V=5,YO6
M"8Z*Z46HX0AXY#HT\S'</)T&*^<K-^LP^#)1+LYG<R 6/&1[SZH%ZE%Z[7/S
M9SJ]O?Z2!.T+MX]NX"0 Z.D5I8"^X7.H7=6$HKF5PFW):?FR6:/T)(%[<*9I
M'_76AX'UN@"P3U<;CR]'Q:=$F9;XH25TG";ZI]-=#3Q:5R:MTF1%U_3-K<OU
M8ET60? *-X9U C4S"^=H#*1$8=P^=\OL%VF ["W1O(5<^JJY&)O+%W$</E^7
MRA27KN+EDL/;(U S,_7L92M\*-VO>6%-$\95DHM-2;T2E<7=!B.Z[(CS4A--
MN"!8,EU^OQZ9_3.$"WC,\8HZU22](FJ)] 6Z=-7)5*[0,JW.$K#;^Q*,O[]Q
MU:'@5^+)3A!; 4OB/PFS-8$<3P$-FL3[P/E)"BZ#J9LKS=#J@.YGYLK,E?UP
MY2;R;VB(S(&9 [?*@5/X8,F H/9!*S?PKF R@?4 ;%1-?0N8<(>7R5K)[)C9
M<7OL. X?PSCQVW6^3 9B\<\YO%ZHP7N Y:Z:H]LX\;"=M.,FD>XUV"_G%MPA
M1D8%Q:E>XN'AK+X?L?44SHPO8@ O %RB32NL<*:N+P&*/IG:MV\$ %)//U?G
MX%S ZO_[;>_S#0_[J-C==;K=6>Y)5'!IJFJ)'4&\#!'ITED4;-31$2<MV^@!
MCR5@@ TB=2^@B!-1(BNE0R4(L_!,8I$FR5R/Y)TN"?<3T.W5.MGNC./):W$\
M\;4X'L5'=S>Z&0)#%7#^>*UGV1">:?1H'MU!M)EK+KS!"H7$:MQJC2R7$C$O
M"/-:4\DWLK(/X=&-K.S=3/MV.GLWM_\(;O9^^N;S156WL8&>6)D+>73W=+XA
ML,V2E1/DP5U3A&?:!LE"HD4X&M2SWJ%K6GQO0U )Y,$BF85[0?R0WJU?=;,#
M40Y18B\=1<%Y Z*<RCV)\X@2KDL<?1EOV0#O9!JT*9!S7"#.X(<&*4:,$X^5
MXB5-@[\?K6[T-1E57ZNM.,+#EE [1&738<4G>+0%4A0V@,7:AL8I9K@-,G>B
M6(<FF!J.3@$PEZ(/LULLK"&]WAZ(7RFTEIYX1+R6B&-JD"DU^'&$6.QI*2Q7
M-\6/6:-460I$R@CBYZD"[5M&)!DWQAD>2K:1MP4-^JI=LG71.SZ?SK]07OUM
M.I*!JS1L 1RDM?<E99W2&(?ME?XVJ]:S@K=8 PF?K@#IAG%P;L#A#T73&88I
MH94B5!;P;#*KP($TD\D<_AE7Y]6LNXF?AS:O^&D2ZN:LNBC<F9E\"&N'-"F^
MD!)YOK"7;;[J))6N3. ZOX:/80(7>#7U75*O@;/&IEX :'M>DRYQ5!S?O'/W
ML%W@-F42PLJ&?<B+VY"R<$4S/0]%BLN-QU=)U5;HFRY5:4.8%/.6R,%GOEM/
M6<,??NYF*8D[N6.)@:1$*SE*V5I 6Z"1'Q7O0H?O3-'BAS:<AE^N?=9^0E[^
M!:YJQI=-U:K0Q$6OIN?PXHFCZNG\P]FF>9SX<IFV#5=YZ\DFLR;SN<V,IRQN
M4Z5$=OIQT>5ZW\/-UA^RF<W]97I=-YXGKIZ=&># V=UI]_3]^A/[RB_1*]15
M://FMSR5G[>9VW3F+'3IX2Y&?%2<Q"X)#.\S!RK6'Z:W76'4GCN_#@GIH\0+
M&[?[NN=0WWYBF]Z?S>K*SN$YK_+QM]D_HQ8L8@3?M'N2:3/;O&*7]KX-C2:;
M$#0J+N9U,T^)=CABL5!-NU))Y)EBR]>^-U.F HD.B.KY.'1( U8;+&I+[04\
MM2-NS*<FP\#7@J)[$:/1DAHCC$,LE!YQ(S%2+ 94!J:M=**DF[,D190F<J<1
M)R$BK@1!2ANP2PE/?T1GL=MY')$(?G3W#O$AL,EZ\.7-9)8R#(O*F"^$JD.G
MPO> DX00T2E,$5'1@;M/!#*4,X2=-%HXB9UF-SD)%BT&B3TJJ4A^C:?($*;@
M+0ACP6%'0]PY)S$I]HB3?C+%?T['8[,JLEKRT@8?Q7IZWFH$X_XYKU)16=(8
M8$0"6-%%L=DUK7/3]DR1MU3^M:I42\G<1>W6FKX=5A2Q*-85U1VEE_\?'+66
M8KXP'P):%.ZFAX2[?'<MR_FO5L=]?H'8RS8OZL$?:]D$+CZ>GT^NYYMO5@4?
MB6K2/O!BQVOWP:T)5U#,+[L"0+AV'<9M\=]+._V<")5>?E5>_/F>Y<)?I>T7
M"FFORN^'L+0D=1Q;6]JK)&U:SK/5ON+%"RV2VVT*^X69SZ8OKW\!I.X^[E:_
MW5QL(KSO"S/^9"Z;E]_]=<4GM^[]28NXQA@;"]SO.CZZ&MH49W6"RG^;3=W=
M*WK7O,CV@C[5Z[9R]*(U$1,=NWKZ[:SX^Q9U /1>=1]=#5@T-^S0 Z@BW^:[
M/D[0/W5<;Z?C+?'!R=NWI[^?_'X\*D[>OKK=$1DB &Z=+F]/W[]Y5[P_+5Z=
MOGUW^M/)Z^/W;UX7/YZ\/7[[ZN3XI^+=>_C@YS=OW[\K?GC5:<'@_[(KIAJ:
M %W3_-]N4G=V\+HQL3"$):'8NTB1-2P@KJU'FI<$^=(XQS#U1N$_Z'>'[C6?
MSNOB G2%NTPQI-FTW?WQ80)W 9L4I"PTL^3Z_#4%8,+$C-/>L:)5G=VF@T6X
M),4CP):'$UI;=NW3%&B:-.'HKD1RZUC!+VQ5,31\)PMK1KPO&0HR;>!35"(3
M%$4N&H>%\HP;VL=&]]7&O3>?S7+_QR_+53B>^)/%"AT[5P.&/&A/'VJ"2]Y7
MJDALPN2N5TY;^"VE'/S* (\?&4.:$(^"%I1(AD.0L8\]BT_RRI/I+8[FD#U/
MT[W]E8A>$\]%7F0M[#NDAU^YR+>'659N[56PMHVTIT#OJLM4CGM>2W\L,I)M
MEFA)K*6?T[3Q@2YS::YM#5L%O+LP_W26DFQMPBD!]8<Z1>'GDY4^Z#)8-DQ"
MK):[Z4PSG<!B7::[-55:M4_5[ RN2&AQ#D]X=COF?ZNQ^%1+]1A3L;W5BPJ(
M6KEO2:).7*A357X!&%C\LES$FYOE'FHHP;W?SL]#7;EESQ8M?*36H!0Q[O:B
M&Z]5JBNB%(,19=CF $=!*"V-0C&*B#@G&EE',6(Q>B]**9G>P/5W[BSX^3B<
MQM_66 K>\6\+AOIU.A[_V(406P?S/=SO;^.I^_.[(@"F7R3Q!LS;B<'66RNO
MWG,<K7DV<=6XNI94NZH#2M94F*1X2&'-.&VT7"4MUR6\_?!NX6[WES:+S9W-
MBP/U398;YMO]\C<Z%RP"DNGYT[=H;"ZG\T5$:[7[X@A_O^P\X%)T^*()+YIP
M84#EA;5N>6O=]U+-0;<7XL7RC#O:ZG4W*>41E]^OA[ 6[]/%L/[ZA5/I$>,/
M.Y,\\#1]1+=XPZ\T-%1?[&=X&Y,]N,GAY@SY\\K[<?AZ8XK;6L#<'HA4 T"W
M#?5XOZXK)\G@F,X;@*H'M"C<).Y]NW[<WFAD]^3=?DLG6,#T[?_\CGZW P:]
MY76W2-&>@W_W4[NMSNR!51]$YA6K#H'06V7>IYFN<L^>6G>OW9-W".IALN8=
M=N"M_AMYB"0\KFW9<^Z\]R5*W=[G:L"L>'\"W:L]7K^"^@Q[V-T>K54X"E=*
M@1Q-%6'.@H=N,4>2"<TUC4YPN;%3@1IL(M<(1YP:R@N%M'$<.6\=L3B02#>J
M@.[PY?OJP,I'JJ2/[P*_?S+UM KUL4W>#UZAIN;LU<2E^&@77VWCL?55.#;5
M>F4E^K1*]$%NXQ=]\KV A.VQUS=YBL];_X8@ B<<(U>6$72I#LCR()"4D083
M=2DW-^H:K#BH/H_@IT4\[=BWE)>("FU*)3GE#M]3_YXLL*?YM=VB!"_Q8ST]
M_Z6NIO4O[2X..':56NA+68^XV)6NWD;$9R^$-SO(>^$@9]V>'>3A:>[L%_\A
M%0._5G.$L39)+Y=(*Z61(=@*\(J5(FYC=XR)DEC/$0G@'',*OK12V,,E2A[!
MEZ8NRAW[Q7+$^IB.=KBBE/WBP?K%+.O.[!?OH7;-?O$]]"\+%OXGP,=U#B,N
M00EK12(*AFBBM)?@*=_4O]Z%4E(E4*"V1#Q8BG3D$FE,G2\-(<[>5_\^A5_,
M1H3H[!</49]GOWC'?G'6[=DO'I[FSG[Q']Y@2H3SB)0R@HX- 5FC&0(%2TO"
ML<-QHPK\(;M[MNP7ZQ'G#YM'ED4I^\7#]HMYUIW9+]Y#[9K]XOOT:(^EC<8Y
MI+13B'M"D'&6HTBPYJ66 N/-#<4/V(4U(+^8DY$2)#O&0U3HV3'>L6.<E?N>
M*/?;!V8_.;L.H.KZ<10\&$T?M(DF$G"MK2"(&RJ1DHP@JJ346@EPFG$?K4.V
MZVE+,J)Z5QGH!W+6<U/?J[G=?[VVCW]C(MJ3@_D.FZX=7@> U!!\%2H 2V(/
M6M)*;I4I=40"&PWP91DRWA$4&,8J!AEMW)Q:,S3GYAMG4)&CNW-^0V"C5>_:
MKO$L+SZ9-"L!GKZ&"Z\F*\R3PY"Z%7Q(#4.27G:+/O+IC_$XN%GJ3GM1ISX^
ML\NBE9=VMKAQ;?\87\48ZM#.=Z^K)@W!;6<J#(H6 X.6C*Q/U4<IM3U9Z[T,
MCMNBHV#7(NFWHW=';8.5CR ETWE3=+WXTR=I@@>\T TN;\<W)/>OG3$.@H;E
M:F0$Q80EWX^(Y052ZYNB#N>I^0_(TR0]0KCJ@K:<8++L+)W..I\VL^)J(H"9
MS\ZF=;7>!.R.8233C^D:X]L&DEQUCCHJ%C1)S:7:"163&8##M>[4E^N]_LR\
MG3,%#[IJ?[TVL" ]P-H3[KB%5Q:[88K=R>0J&I+VEG>#0T[K#V:RG!R2,B!O
MX(SI.6BA5],%.Z=9P<#)K],DX>E%JW26(UQ.W[QZO9K=$B:FG0QS/O5AO!BJ
MT<V_GL#C?AA/+? I/%UU/C]ON3C68%9\FM9_KJ[WMS>_O"M^ 8UIZN+]I^GR
MTJ-K8/ AR52K_%+_I!1.:]\$+C3V76NVQ9.,VBD_]:KS&FA/%YHV+M0>T0HJ
M:-QFW#5R7TKA+8=_-.-Y)]E7(V9\^KT]M GM*U[-$6D%%30WX JH9==V]EP,
M%X'/YLTH"?-XWG:/2K<*P"V+=D3I@'^"KJ]B-SV\,3%UZZS!!>MN,"2-WI+L
M8FQ:")V!]=<-?$F+6\46M-*\E>74<P<@VIZQ:*-GX;6!J:YFYURM_(*6:R0#
M:(>34W/3-'IFM!@LDYXCS:Q:M.7_9YH0T_;OA\M68$"YV;(IUY([$TF7PZX^
MIA$^RR_6."'UW$L/"+=<[[V7YO.<)]?P&J)^H<?^ -#F:;MZ_8_68[ZM'1Z.
MA@EN/"*$>\29$4@'XI LA;*"@^_!-PH4']0.+WQ(2/%K:-.\DP^OJ\:!<@9F
MN:OO7;%8S."/9_=]TC](_[&/H?17O-]P G%4O'OS]]1LN_CUS2^GO[X_>?OW
MW#ITS>3ME&GH /&1L80;;Y7:[*+J,SJK/)#UQ8]_**E+2K5%4BA@6>4ELBQJ
MQ&6P&E,5,%%?O0@A-FC.+ IEZKU,K$<F.+BF5DY%HX.W&Q=Y*OHV<,0XK/CM
MMG^&\)AK#D(R".H6E+J>AQU,C4#ENWF3U-0DN0S=L<GXZ*;/='$"P*PSD.10
M+QP'=[90HU7K$IR#!W#>=O!K%5]W-FC!='(=FG:"XK2^+.KII1G/+ML"F#@=
M5]/VH3[4TT_IU'1T-?D8%GV NV;CD^G'3K>>!3CUS'7M*],,\DZ)&^_K9#*Y
MY'DXT,MSL--FQ3GX/JZ=]Q1\[BA\O2?\EJ&@I-IK(P*2#A/$(Q=(64?@AQ8,
M!-E;8X9"CE? Q[%X\SFX><MDIS%6+M3#E>=VG&"2L<<OXFTVDG!>:<\CTMJ7
M8.](BPRC#'GG@U3>887M-FRD5U-__DL]A7=-,\=^!@,8S*7_F'[Z#8#I-=A*
M==4.S1P(U[B6:ZZ0-<6&TSQ9=&[@_)5K^>KT]<]7_N3"H0O=\BUBK5<SQ:J)
MF;CD5\!5V_AS-[[3%RN7&+X+B3W39,]+<$_2G>&9VHJ6=F3#I"LU!$?P"O!N
MYI.&P\G%^Z0\SL+X OSK>>7#BHS7AE# Z\"SMY1940*<6?"4TU18.&<5(A@M
M--R'^;C3-HG&XRH1$J@_:;JQIZ L0,^DULFM)AF#.=[>JO.:._\,;MO,+Q)K
MMKII=@9D!>W2ZB%0@*]N)SI<K)DN7JB:I#6$FUWILU6T/;2S.."O,/DP2^Y\
MTGN@0?Z$*RWC<^VK^+KU*1<J<&ACW[).7<_;&>=2']'$8>W(E>JJ-_?"T&KY
MK?W;G(<.Q:=-8OJ$;K8=^%"\G8*Y3D;% D#6D"]=['3%_RU[O)N? XTNTS?O
MUEK_'U\]R2^+)UF 4.:?8?+/:6LEMZ.#.U3Z$":MY^;7TG;M;,F$%&WO<-M.
MA4LC(>HZ37I8A"83_BU-;'/9?=B>^/=W_WM4+*$.&.WO;>#L;V SFVH1A4S@
MM;SQ\G&ZDQ/$+?&V,>..L_]^<OS+KV_^[_$#>>I&'0C ;:C7J"N/RCZC1"5_
M.23>'Q7__>;7X]\S[1YF  .7__?QJ]>__7J:"?A #^)3&(_3OZ ?T@2OSM!L
MDPQ+(#HJP+R'O\%4:;426VFEY93S7[N*C*20%@IFU$8,VF'UG0&T&&0Q600"
M%A"7#FICZ6V,/M4FA"85!OJLH(:KH,;35-@7P*A=1%^2HEIJE,5DH#:1#AP!
MG[Q+F>%%ECSY086?AB[# 6Q0P3,LKP)VT5HER3B9\READJ[[(1GQLS/377@Y
MW,1WX?1.CW6NU)HYOAB,4C1G(<P&7(MR:Z%?'I*\ET.251Z2G(<DYR')_;_K
MP(<!YR')>4AROT.2[QIX?.^"@%[G!SK)C2T%18RK$G%:1F2D=X@8[:(01G&[
MT5'Q(<F 7Z_-O3N-I\O ^E5&()5U+W(&S?OI>@#V*6<)#MEF[\I3DZ*R83S]
MM'2RNNS#5;9AW4]KL\"+2M369D]5H&ER:[.>E!@M!HXNIQ6NYM'>D8M8GS"X
M!U/W!'!(^= I>$=\FU/P;CF-'H&X[?:6^1WW\!V'/$#Q6_<Q[_?\ODR3+\PT
M)#@/->QCJ.'_":8NWH#%XZ^U(\A3#K?-SD/&V3RH=HN#:A\G%\\:U.\]J+:G
M=E+/%-,?VDJFUW9)0R!SMM&R.#\+<7Y0R^0LSEF<LS@/49P?-!DLBW-N>?B4
M[M/]<@G3F1DOZ[=VWZH]MS,<;-O'/6I5>#!M")UED7".$1>T1%S&@"PK+2(J
M&"8%E41MI&V5*^'_A$>TQ*E)L6)(ER6%'UC[ .C)H]I,V[9XD%*S*8N?'N*_
MJMG9JWD#I CUF\^+=A/';0JQ[=O5U]P=H48E>?H&PWO<?3"C=4;KC-8#0&LF
MN*,)HXG@ O$R8*2QBT@[Z<KH+"ZMV1Q;JB-7O$122X:X4A$07G 4+&"XEEIS
MIP>$U@2/N-S5[)9!"5Q&Z_U"ZT'1:7!HG8=I_5%J0ICR F'! J"U :"F1*$2
M,T,Q&,GEIFT=N? 6\!D%2@WB%"#;*FZ18DXI3Z*P;*/%]Q.B-2,CQG8UU7)0
M O>T4:HGKP)X<HA[I,3^!)+P8JNI_&>I+/O,! Q##PP_HY3IE 4N"UP6N"QP
MPQ2XH7LZPV>D Z#3DR6CU_>S";A)?Q&@!7V3F+977K\3[FG3W&Z=@E=IBL(T
M+OL7-:EFPA>HG?>0HVTY-S*X4.W0;9@=!-F4]-9%2Y' FB(> T$&6X="&70D
M-%(L^,:^X]()JDJ,B%$"\6#:#(I I97"E(YA'LW-(%O"AM/X]^G4-\<3_R[4
M'RL7FG< $'T-K<<C37.:.B<^,A3O(_-D*/[#8<NYQA*5)66(4V&0X:5"D1FN
M6<#*AHU^T IS9S3#R):V1!P.1*:D%)D8-68*FR V\AU;A^)R))C(2)R1."/Q
M'C)/1F) 5:8E*SW8MI$@[D1 FB?S.%!+!0FAE'(C\VR%=80Z)(2!$[UAR @9
MD<<B.!:\]GZC&<_6D9B.N%(9B9\JO;SCN-/]5N!PXDZ_AF8U'ZX='[A[R,SZ
M=K!TROIV,/H6E*K ,5!D U.(*P.>#R8*>4]*SA@+-&SH6\9*HHPK$8U"(BZ(
M1<90@00M)=.>4,S%[H-09*1$F17N$*4I0_%@Z31\YCD8**:&F2 T0UIY PX/
M_#"4.R1C:2(CT;-R8W"KP:(DWF%D@HVHW2P!2,R19-8:HVG4P>\<BN6(\9P.
M&*0P920>+)V&SSP'@\18<\44\<CR=ILP#<A(0%7L2BJI#J6SY4TDMEQA4CJ/
M"!R"N,,,*<$]TH%R7$IBX EW;Q2/J*(9B0^D^"D'H:X'H8[/T]35?YGE8,$T
MI'+2CLR,IJH7XYN-3Z-@SJ_-M\CJ.*OCK(X'HXX)4V6("KP:PCD"E:R1E4(B
MZP!F,2XIL_JF.A:2I>WA @6M,>)6J>08$:0CIE0SP@A_ G7,1HKBK(^'*$T9
MB@=+I^$SS\% <:2!2NG!MREQ!"]'.X!BS5$$KXB15+3J-FI6-?4Q*EPBQ:-!
M7!,+*!P"(D$)BY57)9>[3\^7(R)YAN(A2E.&XL'2:?C,<S!0[*BE:089,LXH
MQ"D32&D9P."-1GA62L#7#2BV%@[Q!!FB'.)1&V13MM=:$T,46/ $W[O?/M V
MB<Y0G$NE#B!*M9Q%ON4^LX-B]*Q>LWK=,_4:&"6AE!ZI( +B6#ADL& (8V6%
ML"1HXC<:%I)82JH%XL1BQ+T#8'6A1*",N0E4TU!NM)?MU.NB$=;#-&JL/@>/
M_A7J:>(+10E]F;7I$(4G(^]@Z31\YCD8Y!4!XX !0)U@$G%I 8-),&T0GQG,
MM"XW2E)5=%XYRI$U%N!7 1ZJR"WRA 3II<6<WA%C>A3RWI)PES@'^ <I/QE\
M!TNGX3//P8"O5$:&( P"ZU<C7DJ!=+ 2>2:9HM@XB3>C2@1K0F2$(Z-%W)44
M&<L)*CEU5GF5MD]GLW?HPI-+G?8@B/0NC,=P4&$FOH#G^#/,X*^L2[,NS;IT
M@+K4L%)X;E#I:.A*@C5W!A%.C7=:VE)O),L?,J%H 0K'$__S$A+>?+Y(0>;>
M1EN,>-[1,4QIRE \6#H-GWD.!HJ9%I$Q@E/U*$.<48NL,P1)%EDL21G-9J^]
MAXP?VCX4XU&YL[$569J&3I0,Q<^%>0X&BFV@7'LED==IHQPA'&D#!J\MN?>&
M2LGXQB2XA\P6VCH4RY%2,B-Q+EMZUA&GOX=)J,VXC3@9#T=5S:PVL^ICKES*
M"C8KV $J6.=I&46:UF=!RW(>*%(2_B2*":*YM-3A/L)."V0 !7M\#1?ZU;**
MC\!>R&IVB"*5\7BP=!H^\QP,'@>M3!EXB5A*I'-' M*J!/^'! 9?,1H\Z2/V
MM!L\EN6(Z[Q;8Y BE?%XL'0:/O,<#![3TO RE@[94H&M:S'@,1$281FB*)UR
MM^0"'A* V@T>"SF2(O=XRH5/SSL,]6MH@JG=61N'\N%C&$\O4M.F A5O/@-8
M3<RX:!9[4[/BS8HW*][A*5Y,!(G>&60T<X@+99'!3B'LF2':81+E1FVQ-X(Y
M6@;$&"&($SA1!5TB.+1DK@Q:QHW:XB56@.9]?844_:I=\()P'N\Q2'G*8#Q8
M.@V?>0X&C"6WA%C#47#@ '$M++*:IP9Y3EO%B(A\<_"#4N#_</"77 E>D(\"
M/">KD @\2J\C^%/V*<"8XA$6N3YUD *5T7BP=!H^\QP,&GNK*)C' A%A*>(L
M=2KE@J&( TXMQR6U&SG;$#0QW)=(N,@1ETHC+:)' -(*,Z>H]1MC>':"QGPD
M92Z,RH51!QN1.IDL(E*A$ZP<D<IJ-ZO= :I=:92G$G0F":G!2)0E,@I^:$9Q
M*9GECF^DYB,H6J4M05Z)$G%*,-(A2&0"+0U61)5B(S6_"[4K1Y1GK3M(><I@
M/%@Z#9]Y#@:,@W*>4?!B9,E3][S4)SS C\BL#\)(S>7F'CWJ2P!JAR+X/W .
MX\B(2."'L&E&J9<:/P48ITD/98Y(#5*@,AH/ED[#9YZ#06.F7(C".%0R*A /
MV"!=>I5,XU 298T)&]OTB(^Z-(#&DC*6^O699$Y+A)77)+A2$KO1A6\G:"Q'
M98Y(Y1JI9QZ1NCGOSKA_SJLZ^**:S,SD0V7'H3!-$_*DNZQTL](=I-*5U)8L
M[;O#:512( XI[.!/3ATC5E&F6!];]]:1XC2>K.#AN$6'OO) 8J1QKDP>I$1E
M.!XLG8;// <#Q]HRKT7@R'!!$9>R3+OP!"H5QEJ!1T,WYX _9.?>;N"8C$J5
M)]X-4J(R' ^63L-GGH.!8^HHED)@1,# 1;S4!AD+EBZ.)0/#V'GL:1\;]W8"
MQV(D5$X0Y"*IYQV2>G4&L@-/4TV*:*JZ^&C&<_AS&HOPSWDUNRS.P^QLFB)4
M'T,S2Y'?9E1,PBRKX*R"LPH>G@IVS@=EP9V)G'K$=:E0R@0A[*)W-BI9D@V/
MZ"$!JI.)FYZ'GZ9-\V,]/7_38L7/+52<7"'%_35Q S2#W[Y60<5'5.36)H.4
ML S/@Z73\)GG&<+S#TLJ[E@!*.5,<+A$3A".N"K3H+WHD->!XTAED$[T$1+K
M60%\>2]W.6+Z(!,5UQGF_KSQEZP L@+("F!X]CDK/6,< -:7FB!> E#KD&QM
M0&I"G*?6ASY"9$]BGQ-)1F7N!9OKN X]:)9V'(ZGB;JA/L^QLZR;LV[> ]T,
M:I8%)C2RH72(8R.18=BAB+T&Q\DR\*,>$SL#'# O_FZJ25++IY/3V5FHMZB-
MA1Z!0L[*>(@RE0%YL'0:/O,\0T!^JF@9PYYZ2SPBRFMPK0+8SX*7B#AJI"3"
MJ_)1!62]0?Z7_2XR(O0@W:X<'\N0GR$_0_ZWM!215D8-)KJ*/B(N*$968H:\
M]L8:'*R0&ULXOB4"MQO(5R,N<T:D#\3/96I[$'%K&W:!"'6]O*J/%;Q+*DI+
M0>ZLRK,JSZK\$%6YQL9&"\I8&6%3@TV*C -/3!+G6&FXUZR7W9A+]$DM$!;8
MT^773B]"&ADS^="7(Z='A!]DR"X[<AG],_IG]/\&](>+*5E*\,>TEXB7%M#?
M6HF<)M)Q[JW:'!/VL$JW7:&_&"ERD#-+,OIG],_HG]'_6V95>5?BR#$*SHDT
M))(A2TN/&/PO>BUI*7T_A70[0G\Y8C+G<)XNHI=KZ)XFHK=HP9\U>=;D69,/
MKRC.!TM-J2ARI2>(,QR1D@P@DM" (S$*F]AGC*WG43=T1/%!:M7ABU#&W\'2
M:?C,<S#X*[GQ96DUTC+2U.:9(Q481D0J;QQAH@P;8R ?$^7JN;&S'A%19OP=
MH@AE_!TLG8;// >#OTX0+)QS2!,'^%MRCHPI(Y+6.$Q\"(1OS$1_3)RI9_P5
MHU)E^S=W,7O>P:14;EF R#8@(FD;YOM?7V5]FO5IUJ?#TZ=2:.^<%\B)%!LJ
M2X$L-0X%Q\I@6&1.;(RM>4@\Z76 :S33<>7;-J$)(4[K5))]? Y /7N8?HW5
MY^#1OT(]39RB**$OLVX=HCAE+!XLG8;// >#Q88%;KWS*$2G$7?@L6AE">(<
MP)9H1PCOI5=8QN)#%J>,Q8.ET_"9YQEB\9-53)F21P/V-K,.K&A&)-(A1K"B
M::F$(RS@7BJFMH+VFYE=*4>@@@X1\G/!U"'&N)($I1@7W!*.G5?-6=I/G*)=
M/MC<4RRK]:S6!^AB2<4##B2B('% W!O0MU0(1"*X7DIB*7DO_?B3EFT21(3F
M=/+F&D2<QM< $-G)>M8"E=%XL'0:/O,<#!H3&XRFCB-G9$2<8XG,_VOO6[O:
M5I)VOY]?T2MS,B>9UQ==?8&9.<L!9X?9!'@Q>\\[YPNK+;6Q=F3)HPO@^?6G
MJENR93 )$!M+=NTU0T#75G7=GJKJ:N%VZJX!JECH[LCJ/.KP^)J %VGC_18H
MTL:EI5/YF6=OM+&AM89<:W7JPK&P%[[3JG<U:P0JN>O:AAB:W=%: E)KU,;/
MZ[QK:+76?G;GHJJK/8I(R=9V^?H]ZFQ/EI8L;4DMK6/HMMMU=5RUI^-B^6%]
MZ&IZG7>L;LMUQ8AK^CJB4%(CG(5!F*^-5TOE7US3_$PS6^MV:6U)*26+U')I
MZ51^YMD?M2ST46MH./6V-7+JELF[]:YK&H!M;-#+O#T<#K5UA*/>5BU;M>Y^
M-C(IOV216BXMG<K//'NCECOMD2U:5JONVAQ4K(Y+_KJZ61?<=)UA>^AVG4<M
M+UX3EWI;M6S6S#;MG4Y;,^YV3$J)$$OX/06F*F%JAR '(IH?:0 ;,ED\RG*.
MJ+#*V!Q[_9AL>V.N1T.[:UO.L-[N8E)_-!1@KKM=L,3NJ-NQ+$.TUK*B4*F6
M*WZ?&>A/(A POG6MU#=KW1*4,W^'KU1V13-)($G?D[XG?;\M?6];;M=VVQ@U
MT[6ZU1Z)>E?3NW5;,TU7UUNCEC5<3T>LC>I["_ 8Z?O*"B3I>]+WI._?1-\[
MFC%TVN#::WJ[;IF=5KUC6GK=&')[U&JUS:%XE+Q^70>N3>I[7*[8V7ZV>L?U
M_=;JQBIG3-8JN$?S!;_"Q7 ;[<Q8*:ML- S4 VZ8#GVQ3;O\VI7-_WO;!GHU
M!??&1 ];1MNU.8"J86M8MZQAI\Y;8+$['<>P[([H"OT1)'M-".XB"F$X6,J]
MKBX"9LWL;K]2^[O,M MVF30^:7S2^#ND\37 7D-=B+IC !ZSM.&PSA%O=5HM
M9S1LMT77?03*7A.$6[O&U]O=6ML@E4\JGU0^J7Q2^2^H5C8[!N\:W;K9L3#O
MTC7 R>]TZ]QJMW5=Z(;1?;3?[FOB<.MW\@VM9I1@/>;.J_QB] U^Y_!A?\^I
M?I9.1.0Y\+?KW:JC^%@O2'DV&7@<;BZ1;E^\^WNO^PGJ[>'GPBPSQ^=QC+)U
M(^J94.!XX($P5KP@&^I_9"WB_4'=/!SYXK[N>I&0H@NLXZ>3X-#UXJG/9P=X
M]I'$-6R0.1Q;%OQ5!_Y(X\0;S?)AREOK(G /IV'LR6='P@>6O!4@K_=($_S.
MN>C>/U,^?TC&[\S:PHR\1L.O>Q9UJ[LD[TI\<V$=ST/LV0=Y@>\%,+*$1\D!
M3Y/P</D$D%H=5K,OX^Q\!-][P/T[/HL/WS7G?+)*!\M)+##&HPE>[SSNBNAM
M3+W*>U<PKW0:(C$-HR2^#D?7.&%3(4N+KR-QX\6XW8U[K;^2R^_4E ]#W]T,
M!2_[%S_3IW7CXSN_O&+GG]G)V7'_H@\_SJ[89?^7D\%5_[)_S"Y^^W1Z<L1Z
M1T?GOYU=G9S]PCZ?7'XMN>71'Q"G%WG<+YEY?<CN/Y-:6S=+7(4L&0LV2$+G
MVQ@83T0QXX$K#WX*>>1BL]!C:4-#. 5_G 1!>.O=\AK\YC1^AM_7_2ULA=NP
M>B*_][XYE,F\SPS)F";G5L=MUSO#5J=NB5:WWC6%6^^V.QVCVQIIMM5]B&3:
M-@"<-N_41R,;6X?IW?K0,;2Z.1JYKMUNM<RND2,95W@'O=3U@,SG4R\ 8W0%
M#_KDP[R\8P(PS!0N2J)4;!U];U.!*<I@2UMDT,]>P ,'!![XER<"F_/$1?M5
M-F6U25N];IUEE%=G_5.P,;\5C*.X"*6KN..$$QC;#.YF3K&T8,A]8!+!XK$0
MR0H-)M5=G YCS_5XY,&8/N #L5>>H1T>J:?*O_3#CXS+)QP+1TR&(F*F7F.&
M9ECR(?"+69.CD6XDO'MI(/&<1_$1JMJAQG#8D1B+( :W<WXT+NACV;6O?<C$
MOU,OF=7DJQP>C]G(#^_B&L8QF.#.&)^*+T_&D1!L)CCH:T\)RA046>@R=*7<
MQX.OS35^/NX@3) .,,$^@J=;X<_@W$A$$9([1"H4:#2:B^'B$W."-8#&+$PC
M%BK15?19=0<#,L38G7K$O<B'[X2Q<]]G$[@ C3H,()[":.*'C\B=]_S[LRE[
MQE0M/CM._6Q:\!^UMA+F3EZ!AQ;T7@>YX3+@#(P_P82R.R\92_Y-,;1Q W0
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M9]4AL8<( ]C$H(K$RE<DZE216'D_>@6>D(/U9-^%@WJGT>JVWL]E2(*,SKH
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M"6=_KU_W$TQ=AF%3&^\GVGC3$I'*+1$Q:8E(Y<W>QI:(_+#-Z_!:I@BN"UT
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M!34J,]US0[E6%3S(<.'F77GBJ/W@*,2%U&Z$F&E-P%!'8*@1,-Q?AB)@N(_
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MS%&;:[1="EH1+[TE+P%ZQ.T ==H.<'\YB@#D/@+(#86,"$!6#$!F^4 #^[/
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M[L?<!RRX7W/7JX<H8,3TKFG5Y$67XL:+$_0WI4?GIN# R:UK7.411,H54&
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M %*KPVKVI1_"1_"]!]R_X[-8;;S^U^8P=&=__U]_;8Z3B?_W_P]02P,$%
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MG],D(G/8,@]_^/)PK1?4WN?^UR1.UKOWV/Q](8 7_SV-@\LX#_/=-?23KND
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M1>S*]Y26(>F2>]V+L^7YSE^3$A19_85*6DTBCZRJV/E -CPJ"/,'.6#3=6Q
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M>^*<^N7JQVL2$9@M BO?8";771(S<R5SA0MPM[-MGJ'/%3XA]KGIS*1#=ST
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ME;6G=ESKNI6AN[>W@$9C.9V8*H]R L;\KN-S%YZRWD3)CA"NMLI7Y"YAPDE
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M'\ !+*U;QXQXS@CG?(U-L#JWX-LL<9WE5C4+?"<:&*VXO'JQFL+Y]M,8"Y'
MUT?%\(LPVN:H7S%)E5J/=!4J#^$T*C*L#*!/:AXR-':(R$4_H,]P@Z9^! ?I
M-%B',2US@Y>(/EJQ);'M^P4.Q,</9S]\/$W3VR0(ER&187_JVT[%M62$^BZ,
MJ27:]QYD'PVMNH CI4(CG][X' ;,(9QK4?(*.M*9NZ1M75JN \+3W4&\69#P
MQ1A4KZ>Q_54RJ/+2JE)HR-?QK?\U7&_7]Z!5QO@RP_%*MKD<I;(7*\LSJFJ#
M5W%GS!1.\UU0M&2>'54EDFX,G%:OJ8QIIR]^&.$QP2AL/R*F M(FRLD!:^K5
M1!.5]1)@) (![A+>T4VN*:4F;>=21:U9OZ[C9@K; TCF5\R0HM9:.W&QC7O,
M;@UXHIKXQ/"6^6G.X9AE^]&>>#J/G3XX4]%Z0F>L>,EXFECK4[5/-[4;21=X
MKR6QC=]414H_;I^2-,#X#4(MQS($6=EGT97%!%34RJTY2YOY+43[_G7E\O8R
M12H1IHH7!3V/32Z)DF=CFO,(/4\!>A"C/;JF@+<F=WMN*M?0?9H\I_ZZA%G7
M[;F&:N*H3-H$W0X<1DZ#9UU?Q@$JVWO#5[>;6NP&#X820RZZQ6S(&-AVSFX8
M$"\-[;I- A*=^8M?LR1Z(65\O<89VY[:Y>8\H'B+<9H@1:EWH-9J(*"D,FI%
M4>)8&GO0EG:DC_1ZL4Q/MT$(?$[S' 9%MUEBM30T=AZJ@CE2-&17G@MLQD\U
MD+O#IXQS$."B+1JN*YL&\X23@'G*UYMM7OB3]OP1VH*_=GC;UG\K);6TM-W
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M_%PH9IBACM %-'-19=!M2>TNTKE1+;+Y-NC;NHL]"N,DI8Y3YN,MC 'HP+O
MFK28H8'"F2J$Y4>F6:LBE6RQM_YIRJ.V-:9Q$XFS+2S-DH*Q)RM_^6,(:A5<
M#CNMSZ0;#\<I!><M\@G.72<3* KM,-&O1Z4>&8.!\+$[XF+;Q,.>5ICJGD/@
MKPFZ3=$7,U:\JGX  T:*[%?IG,57VQSNA\+I4 >1,\:+=&5G>69_3>B'4\;
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MXW!F2-8+ VQZJ[.MBWET/LQEC;&#Z+.F0<L15A@7@J@S6M4"Y2 OP.3Z-*,
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MRK+X+$9U$:W%;PX^J&+*!C!+4 E36D9,ZF%:$5.:AFRUTRL,),59$>5L(;5
M^B)Z?B[YLSAM!LK5'0RSK?D\\'*8\#?AUNZZY/K-F D[NN"6G[T1M_RL!;=\
MQ S?";/&.**[11BF67=@H-^=IYW.#R'O; $^T9!C90"?B)/K8[<63B%!* W6
M<M-AP"[(8(67+)"L_%R4F?>0N<.XW4/0U9>SQQ\?_.9-K8+X>Q%LI555E%LH
MBE?=$F.Q1N(K0_"78_%E M]VFDEVJX!12\BL&@94:V:DFFG=8="/ KMFIZG
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MTC[2$*)GT*N=7^T@K*RVUA79'*IKT(_A;V_H/:+IN&W>E^F+&&.VO>//!<1
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M"51;Z=.&>DZ$D?MPM3RWSKOA537)K;.&M24<SL!,(:56 "P/SNG*4C),4W>
M(*3)B399A)/.6<O:#'WC0'BR^1O"ZK3IC]?<,4QON(T YABE+/[A:"9?2% *
MO*+^M2QJ/ETH=%'5MM,IO%.@%W1<^@P:@%!:W5TR+I4,SLJL82!=\O^J#93B
MV=50#6QB?KSU27J_C298!/%&\NH^2I..J2Z) H'B&,C#/%Z@!$]W4[+7K#C]
MX;MK1;5D:R$',RTI652#<)^W<Y=RFL_%!SM=?4LY;.Z1,Z3K@+. 8]6PCV:O
MOR[*._[98#7>ET4NOHPEG\SAQYO7X!_]GG&HRN=0R+ZQ!K.G:[%/L)(>A,?7
M@GUN(>7K9*7LDGT&/1!JB&,%_YQMH4*U2/%'XIAQQE?KK-AR$9*E)8]K\386
M1)^##JV74<VJC3@;IZ:H[Q_BSRO\#+:^>P9%/[Z_Y<0CJ,Y=2,I1*R8E:\6D
M-(-2#4,X++]HDZ?BQ^:E8!G5D3-+1V'X4?16!O4K>2QB;_1%$Y.8/B;;@@^]
M\T<V[?2%,[-K8_\%<W6/]N4UU-^I"_(PC#A>/>2F0.8V)T&[#X* ))A& BA9
MFO$:BI=V,1,.73L:[114["6U,%*C\6?]HG>'L'J7Q:9LF%Y*TQ,R?2U-K[R:
M#B&5+$;9_OSQ"8O3#Z4NQ<)VL<O^_/'#TP^JQ,5O(PRB5LK*36B'52E>H"&]
M$'&7>!?+JR] @B=<"A>GXG^0S3CG(LCF=@/$=&$U3%SSSGDN')E<FT;0*$-C
MP/0&0)^*-1"P@J'4*Y8#'1&L!QJC.FP!RT-RGXI?BCF!Y2((%Z(1"I'$!2A0
M((."4T?\;0K3ZKDHB.J%F"DAX%'*V!.ZP&G70 @2JY-EP7UGX$[H^<E93,]M
M9C\%W="#!+,7^FGI@3$U,MC+1HP&YS3[ #>!W2,$ _Q>'.O<*R&\IN^TWBD9
MOU-65 9QP<.:QRG=F\V@E"!]SO'R'X\G=#\H(<.FBXDD>.K:F$$J\6JM@B-3
M)'Z9Z,T-Z485FY18DTKHQ:T,4+#G,U, ?ZC QO*#6$B8I4T"HY$^-E= :=,%
M4SH'[P0GSI&>J-6,*/E98GGC":U?D3?$WD3?8U&17V^8'LD*;M#A'SC)B:,6
M9F)J)Z'\K1Z@P.TJ5U>9F-B#=P"_L/2,6%0S-X,N-I4<=Y3S* M1.>G1 0]U
M5-8'N>"</Z=Y/G0OV"O_M]D?)/?NQ>;LV\T=I)T[>7LP-H8ON-$Q2,O<NUJT
M[<GO2X@[DR)O ?B-] 70>_-*V';U<'\?#KA'PS)JFAPY'"2G)RC&*Y4;IC.\
MQC;"3_@-87KWD4K(M5L[!FO9 [L7_Q>DI*UW^QR0<=4XI8Q<FT<J%'CO+:%W
MZ&')>0WHBC#1+HN5F'L'9\]$-(UI=!$N7:>YD Z1EH844$I&:@]EOY,^[^5N
M2+L$:<N=3MM.LY1XJHQ<IRTT%+AXW[8Y]=FO&#@TN]Q=A"R[*<0JBV>B@(91
M/;V+-Z5!<%3]XN6&_\:C\EHL"QV[!W80I[2N$9YON"Q. '4,] W=?GL"?_SI
MX[\')3*:*(Z&]F+H ^HQ6OB/B:Z(F$#.UJ0/LAFF/#HQ*L/25O5OOYS.N^Q5
MENW[2L.]EMP$LM^>SF]XW(3%'8C9JE$:#WA>/= !R74*Y!VAY;8G6][&Y*.:
M /S=GGZ%R>&A%JLP?]Z*:?JI$%LD!&UB->[6N/8J;<.(*9V$-6_4!NUJT\'J
M=('')MDA0#%YQ[8P)Q"VI?]9'>/"]8A!SC2OBW+;]:%J04$>DUU6=YU6<931
M1?>U^-G!--ZJQHX$JAY:%.DWQRW?_^E"GXJL'OOI+GKXML>U9[-:1>*A.4<R
M&]1 _&(^\XLK'MK^;'?9W6-[&WS\-N"F<Q3W-._(+#<M]KEIETS /TKF31'E
ME3@0@+&=SNDHB$E)P0[FW8=OO\?'L>'@<D3);ZTZ'2J'XEH$S66:5VE\9.IQ
M32ZNAVGSB^M1GCC)N$=7[U**I]HINH!9IJAUMXDW%O&]T"KBBPOQ?4K7#&+=
M0E8B=0+K$T\&OB95S-$UTD?0@1N_M^':.F)2O1AY(;:5^K:]_4Q]8.FO?1>Z
MM[5<R@YT_]FK?=G;3!N436^9G8,RR$U*[WWASAC@+Y?0CR#+)H,UTDMZRWDA
MUIE?#77;=5'VRM0GU=$*:^GY*EG?X/W0"C4P^S8B/?^A;/X,UR27_*DV5S+=
MPMG\F< _$R%3$P@FBOS"82&,BP#($?W8F%GFX<72)9IGRG(5NLYM5 ="A.WI
MX>T4C6:[CW 8IKB+[M&,H53@+:^7@)FFP%/Q8G*^C/(Y7ZV+,BJWD]4Z2LL.
M_&$RYTB:F%$E#D"@[*P6VLZT.F;T#=\#SN6)EH($8<%1:_=T:^GXO9>8_9HG
MO!3SF2A:H8--7Q11Q#Y<,]5L?G.OGCFLF>/9D5OS.GBA-4XX_N/NFK; /E6=
ML\ NB1-("-&H[&P0CNP[<*:[.7Z27>D!B9HG><(7^S%&S[>WT3^*\B*+JB[P
M!$;+/HS5$"@%$,M 8M=L?IWRW%3)).19FWR8.LF^#&EB)H!!&1AD]FF_]2Q]
M&>)D3ENL\$O%9O ]YH4!!H ZKTDNF\<H]M+5"-/%12$&5];P!D!X/<F[]Q0+
M56L.1>A9IK/$XK4MXA2OD;!U,39J6<7SM"A97M3BM)ML.)!?_B7$VG-TK\D7
MV!H"=&)9,!0P"L#AD^-0=01Z)-C,:;D2!@/;E]\F]:/[K<D!:/FO+FRX%00Q
M E)TZ3\9_L?:?]!F;/DOD?ZCB>>?$%!?KP+"O_@JWG:]_79$CA@)9;_+?P,6
M5/5IFXM-DHK >IWQBNJJ+"W>X[3-4R5F$.1]7R3N4[?*>2V/H4!$@?)>'8]O
MKT)6%*^N(4R\%+%1G'8M556B\56TV!@3DNYW(^_3+GTC:.RQV26EU,&8X]*#
MO?J,O+](NO1ES]$'3OJ]U0.]?I, M*BD[0A5IV$<L:<P3&Z&$9PD6:2<0"WR
MF>R0#T8)8]$-5#WN%HTVB)"4$%W-4'<*-AU$=8R=O&V2VED(+'65J0A-N8-<
M<O2SWJOZ7DGE4"^D3NA8#$!F/"?RGH=SH9O<L5: SY*%_BR2+/21Y:5-1;B$
MXAP7X_; Q"$V7>'"8& ,T=_RE.?WO$%$WS=I##?N ( "F%@*P:3K"4*RB&<D
M'>&&:"4, I'2KVWJ5"EMDE(1Z(> S09HD[VF'^]AZ29%M:M(ENV._:1ZCU+B
MPG61]F-(^XZK9'J.D"&-4-4EOL[R<!AE=-W3^23S!!"/2CC3TCW?)O5OF#[*
MO!>#=DM4(74SG/&[6[(6YK?A .G*+WHGH;_0_.>G/_RL,?)CD-!W-*&=A-Z8
M<J*(SW=%3@&N M=0;U+U"P!L <(I5%/&6&T'/YINZ@H@Q,56<K?IP5$D!-M=
M-EFV98CK19!P7"J&<!=^C-C;%-2:BA$]7E:8D1$&=QSET%$O,\EX<(:J/:K?
MV^2)4.N>LO_G&?5^B2_&?D:#-Z Y>OCB)$A/&Z%DU-.>%_AC9EDAY* =__-\
M=I?[7UYY8<1+ )#S/$?0//A2$@P%+2%H+;[!MEP@NB]B:(S11!G>"Y%0,;H+
M53.;&N3(!4E]^<2%D@9S#5L(3A(XGWUXXCE?I/4/NMYW(>N7Y"\\TQ,29.HA
M=.D[T%T2,S?S6!34>=!RGNK!WISR8-W6CI-V[YZ*_0!C;M+"BUWC*<UQ4L)K
M_9S#""8)].<NTDC73"%[?(F[@H5SA%E%L?-(YEC\)-;>'CC/U*"8-:H1,^-B
M]L!4D94:&JV.%GR6')VAU54M>#C$[\O!NY!<"H\K#+VU\@::26!N&):(TVI\
M:%^:GBV64-GLPU#NH(QRLY):( 4\;!W"'JR(G"J*N6DY@XR^:@I&H_0O*_G;
MZN=#:TM %^S?BE*O*!E*-*W4]!"MSU3Z0_Y12$.XPD%R5$:OE=&^$R%!375S
M5,<S=BX))> "X0'[(,5QQD'-T,<@**"IVG_5J5+'QA$Q>8!0.);'=(#397(4
M+V#$1J=7@P5?64#QAT;(,B%D0=Y7#BJ^WQBT5XOVIKI2;9F-<.\Y1]BK:?8$
M_*I=WN#4X*Q>;O_^Z?S N?9X-YE?7;*_3>X^74YO3V^8MI<?H3\B87\3BTQ2
MK/QFPB*HB5#9+-V31[!QR?EV4JVO-R*Z7A^:5XRH8F2W[8^M2 =D%2</]^SZ
M\>Z2W7A#7_9K;?-*X/NPVDD^1;(@^ TV;^#,Z1UG&XI[TR2-RBTY $M\.K0N
MJ8=*%4Y^NY24#7>\!MS]^[)X21-X5H\5M&;14P3"(KK.@$-O-^A$@+=%A'^E
M"A[6!] FGN0/3"MD1F- ,$7_;MAA<5ADQ>>*.+]2;7RD]82 CZ37!P+*"\#M
M+$I)1-7IXM5: (*%S_T;XX+SAK-(7B+'$D)"43Z,%7$55D*HZ(M::^;%.5>?
M2Q[A*E)_N@=F8X2'8+D.RPQDR9,X*&I.2;H"A5LAR;^T8!&KM!WZD\$HN([E
M0K66&],U;8>6*5&GF EV:1A(TL7U'R3L47M5_^W[])I;<Z)=UYAE[]-V-PES
M]_8W[=77*Q1\TG51&DPC:/];K>#R\? R<"68+2"MZ, ED7"*CP9DWQN H&*R
MK/)I&?'>2$HAM$!-8&"_"<=\!%,7JB*B?/OGZE6.(_8!/OLGX,SYTP^>^8[Z
M]8N<RZ\:%X;GJ%^[G-QX "JC3T61?$XSB1$^R:FG3?6V=8&Z4I)'"BU<"6<?
ME/@? J%#]FMD]G;[AF68/?=NA8!-245CL@PILEK$8>L0,SU_AFH5T\KR+,<S
M++O=^$#W=0K#?-N#*\@T2]RZZ$DNGH0X$$%%%)$8VQOD'6 \]+*9",6J6U^7
MLZ=2-P.B"<4J7CI;*8%,4+;8[YX1SC/RG0:/- O\E4XJ4)-LX%9P,5TP5!QF
MNPGG$J=T0O@%S0_55+.#U6Q(KXJJ<O":A8D/FZ=_\%B<(JZ^K-.R"YAJ*W2U
MU0 +;/(-^&JAG\D!0/!EAO#N?.1<(T$5HO8+5&ZY@-8L*6"A@ +&M P E?S-
M[/#=43RI56XK5D=4/F0;W0/4W$:;E0V"[\#(9FTG:J+\L-)%P$I*FPT^JQ3"
MPO .G+#;^_5^'G ;2"T430>RT*+'HJIP8'46I_&2+\6;E+YP^=,>B;(<\:I&
M/B11EBQ^OTRK6&P%XMS0%:K Z@LP0MGO >$&^C3*G9&3NXOI[16;C__KZL&W
M%8]YJ8MOA2WGU"Q0J3,.8*EN,MC"X86\%X>I4C*@1%\4^?"AEZVV:GR02OF(
MZ2.65D_+, Y ':?A3_08WJ.?FN%48AT\H?=C791!;#? &KHOQ[2\B%6FB</;
M,Q+)6YN!C@HYXM\S^U@ODU2H+GD>0YT6KS]SGIO6L<<?'W[4G4" 8KQ!FD&K
M@4B<2';;B3PWAN"+A 1L"X":AVV^R,3GGM59]7%=Y!/X2)0YX'/"SWD=5=]>
MW[&3)==#H..Y/0ASH(=A,#D.%P4/_DH.Y=WY2L>_QD>8U'%\I-- &_!1*GT4
M.SXJO/OH$ ;6CG'5P02LP:(M:U&*2KCRJ<16A'>FEVFVJ:&VAN[0L, =%Z5#
M+U>D?-B1Z0)=;-VD8P3%1?*V$/4 Z9LZ*\T_%V?4YR")$VCE]N:9JJPMJ$S)
M])CR;N7JN^R66##EN3JE7U.<DJBCV*,G+<=UY9.(J\16)5[8<;(2JPJ\,K"K
M]D!$)C6,F-2!+ZBK)3 GF1^;LV\V=YAVN@4KTMAGR]C(T>)WFQ;+[<\_G?_+
MS^.RO"U$1);RY#J+GKN&*1#B_?S3T[_\#!@-3$EF(-KOQ4I?!JE8XA5#!F&'
MTT*MC;&!,Y3TTP2UV,&RT$Q #8K31#%<_"IA"\>$6HAL%9=B;[B.TO(@PM.6
MRD8%C<@4-.)"")>7Q1%6,#YC"R3L28T2EDB!QIP]84T60;^LH:JCP#9>8%Z"
M D@L^_A0E&PC8M0?)(HB?1#NJ#\OTWB)!3&HBG/#M8H_+6&$+!'1'N+0X%4G
M'+O%=W3K?:(H,R?PP-5&A' R3V^$G7EJ@YW9Q9JA5G5ZR#M4PXE-+J/,8M(N
MXI]A8!D#T_PR$ _^(;:UXA+@3").@E%9P6M A9+>BUD>EN+-4QQU4&;>I=,#
M9-DT@@0+'Z3C8UY&"1_'V$A6B6,V3U\Z\["C3*:$,B,UV(U\KU:YD"5*EFS6
M@%SH?5DDF[AFV)/D-X2@6UQ=7*R*B2;Y;?0E76U6]T4-H!5 R[$M-K5X$>/N
MA?]2JZDFABR=SOZN2#-;*]5LC;KA98R]5_8'\HB*':4GM#I31S?)F=3(M$I&
M.IE4^AX<X7;"O'T6>+5=[R@6,0QU(^>08H9K$$+K.*20I/$R_*+*!^&6UHX1
MM6K5KHRZ@:C/OC6"L"TRR"%^7PZO?I&OA(E;F$W+(YOLR0>@B!E-P[6Y>0OV
MAN>/3]UZXOX+K9YJT[PR?HG2#+8K(+ 6VU.7#"O6&AK1(Z:%GXG3RQGVJWI.
MGFHX%*)W@@M059AQ451UUW2ZD6J*;$!N@(0YL=*5/.//VZLL2]=U%*X'0^IE
M4K%GZKT>C-2!IC/N0!R(/8S?J6B:7=U<??HM0(F(4W<^H;8E8)87@Z'3W4P<
MHZZI)O+P4IAF6P'2TUFJ_JR.T+^#.B;UA2B1\6E_:UST=2=XG:DRQ!-G[^GB
M*B[R8I7&ZJ96'-*CLL[%4)9I)R &)=C<PDH\6$L^GM%E(.B7W-&;R8UEU>A!
M#(H='RQY1ID?H]'OJNK-</EBNP;KAZ[+$R:.K<&S+]UH^=KS+\'0"IH+DTI<
MB(/:(>&:?=&X9RG2N1FI(M E8^^FOK[K-*T<G'D-$APR9AW&F#TA=A?F]KWQ
M=2#:]3Y-<MH/TTPL@44NF8F @W9(IC2IX'5[#)P.7KS?2%@4P0^;IZ), (B7
M8^.8/LN;LN:NU7;7YL0N2U817,%23%V&Q5.6/D=$C$;W<I+S@7^A5M($K^PB
M5JUY3!?(!A4ERNG>3Y=F2;1\>>$G Z2TJC;P>8)OH,!PA%+YEVBUAE7Y:5-C
M8U*6KE)"WQ])V/U:B/USY2 %^ TP/#\FM418W,RV&KDQ6\DF2]>0[;;7D8\_
M??P_U)X9D)Y0HY9-2SJ24!F<@G+LDC RLF&2RU.?K+)3\D>L@7,6)H%T\#6H
M22\:YL1QGI!5158\;[OVRG1G1K%3LA:_(]0A6>,,605Z>MYV>$[:2$.]$\=:
M /)YLIN+.-0P=S>WH?;A^=MZ/*<@?!N:M5NHDDMA)[=I8[\OB^<R6EU]@>J$
MPSL^"2'?ZMR7<K'-$U"Y [1V]FQ9*_4')VN@WT/CZ!L$!__MCV(V&@N!V&'&
M:Z!XN,0J*RIDZ51QA+N:I8(864D)(RVZ/LAK^4\ FUUV(#"\;!A>2L-E$=M:
M&N[UE)'P].^7\A1 QEWE"10B=3%/]OT)25B^=?)C5W=X4A8+-/ZO(*I*@'D;
M4=4/H*Q69 '*#M=F.\,'AL=@^$86&RZTJ?[A8PGE!0,F(*$02F^+A&?G4?Q'
M560O7$=6_4  T?%9:F*HBFE=N(A$_HLJ_)DKI_)7S#31:A@,'V_FVLMIBWD!
M7L\9S"U@=RIYU&'=46(8R#GQ8;M!F!QW]=\;B+L6G/NMTVIBPB//":Q210[9
MRVJ2(^'5H9?/NC1;R6>6 DPT5TRI&*2=C?7PJ@E]SVK+WACM3:4JSWB9G@QV
M+IJ_P5J?X=@D7I3C39+613FN:U[1T^C0D#2YN)XQ*9%9(KUV)#6!;>>%)+?;
M30+B[[O!VRJH49NQ846)0(NX87"V[H$JK@O%=]B:] QBZSBOTP3:G],7;FKV
M"+&()X1HM%IO:M6>W^C./HSD7CK"UFT5##*E7<%8:?U84M#2OQV&,O<HKG*N
M=L4 SK3#+!SO %S*5#QB*C=T_?B-.+X_KNF8V$-[G81EA:NO=(45X_)6#6XO
MTR>  JED+YVUPB^ NF49":]\CH1O[#8X(4DL])RRM2-HT4NX./K0&0CYJ*WZ
MHT T WW[42\LQA*+-0 DGSVNY5%^4(;9LQ_-V*SE#/&^!RBT47V_>[GADWR^
M3,OD-QX=>F;36-Y&[DAB]=]':3)B()O-E\)W0[/0(03<U !M!KWLV.RAK(9K
MZ)0VMA'[^-/'?_.^9IOB?K&;)PF6UD-K2RHV<ED<@:OS4_/6:<:I%)\3L2*G
M"6P!S!R6^;0R,N/[R<6HO874W'B-3.<0W/ACE;DUB$ %6:?FQFS7@^<'>O![
M<]U.[EW.O=C2['6/:.'2GN1B@\[311K3A2\"_T(6]+HH9=/DX8U'[3SD#96*
M?QP3P=> UZ?5O@]G-$(M[938=DK:< K1B5/&&-Z=M5;O-SX*YA4GM=CBDF_P
MB.]UI/T,.OTLPRU3=]TM*;9S ATQK8,9)8.UML%=O9,K*K2QZ^$;VY(6V\FF
M',5BJ(JC@KD*4W]8.@>77@HU@@[+A_+18P>BD3]B6H.%QQ$J;>#+5J?'%+D:
M8FUEFHLSA5WSZ=O8G1)(GJ=%&;0V-RORYS.@$91<'D.IQF7D*RHG%J<DDIL^
M+Z%=)LZB= 45+]@/3IN/.Y TAVM=K(Q\BO(_RLVZCK&.,DO%&Y_(G3T1O@(8
M>/%IJ#_?PBE3FI!#LV=F\1[$VQBL2,FEO-0C!+\R510&%T%0P2X4+_ Z>9-E
MBEHERK?0?D!93OC@"H ^Q)0D&Z6$9?2"M\\L U!TV$N%$O [IFSDWX<K5NYU
MQLJ%R"E3)B>>1(%RK[8V2I/_)4QILB(*D=C[70[BFA]%R@ITJ.YH0=8^^!,?
MM3U9]-!#D1CP9UA29@H-[:)(5N+LL$AKX):1Y&!_+3[#L>*25W&9KCN<.Z4V
MIM6),&1Z>3MBI))] *4_,*EVQ(1B/'X"DKS6[75%V.U#VV'?Z:>].;&[[1+U
MU*&6D[:TH5F9-0TT[823G+70+0W-P$; M:=OLN5)'HV>>0:7/=6\$.].^@R=
M-ZIQY+R(RH0*CRI%QFO_K(<[*Q-"8EPF%8LX[PGT2%*YRH)ME#RF.MJCFRJ,
MC^3HW[\?]2KY"N,UH]$ P;4>C^X(8JB=2?6*%7NZ<'_^[OWH' /U1/S*)%Q%
M6S@5Z>F&5;#6S S&0R-QE"4UR:'47CLL9KOL$"/ X1J86>Y>.D2#]O(?27GL
M@Y3H'8>S)TL:I$>#?BKUNYE?NS2&1UH 8/DL<H*2VPG"NJ*.:=FPP+<$F0%[
MV;S8V7HT]'](@%I-P($5)[2'[>JIR#J@V4(^BX3X?@*_1&4*-=G V-0!4EB)
MD42X7J&$,60:QW&YX<F%^$4:(['"C%<\$M&3:M#<=D0_ ?$LEO)E,QEI4$N!
MWZ#0@X69:]R%;9P2SK3TH5G7.%&]_@@SI<7O">G7" I(Z@L);X(ITE]%J,^G
MBT7W0DXIO8&>PCZ# LRG1_XO:_JW,'.-4Y)EFAMEB^/9(L1-5/_&-2;I&Y^@
MWTGZ*8W6)?]G/P"@GR;C^]G5_QV?\I#E#%-##=/8UFW(]FNOQNT[-F@IGYEI
M(M!) M>0"]SU9;Q&/0C0X&UC, #$!5Q38[FTF-8W4%@]$?,E?T[UW_9:DV4&
MR>Q1JO!6C1,W!!O.00Z5BKIHL&<X6F:&ZSD1.P#7N\<][1>_P?4 _-(\TC<\
MHR"0(3TKJ[TH7TLP(@E_X5FQAI,*CY<Y8,WX[J.6>X]VTB1_ &#1Y#\W45E#
M.O'C3Q]_"@<*_5D.A\#+2]-84>&HV'_3L.#0"@,+$K?Y\(T;WEC+T21GI(1)
M+8S4A-F>/%K<$K*Z3[G]"9\F+Y'*M8_S?!-E4'T595F7-CY"WOD* ->Y!.!B
M+0!<3ND1#$JXU(SJO7NQ_=[B.W3$JQ>*+?X  K&:S1X>*TG_!@5F+.>?LRV+
MUNLBS:D",.'"'MA962+>UQ@;YSZG6<;@9LC;*MPL$]%9P2Z L"W)SD!0L/V8
ML9N?;KDZ5\5S&IZ$B2=>? 8B9N^M8"54_]7;>R&@%C$7U JO:?9WI"R[@:),
MBL7G3B0>B+8,R>>L$!+HR*'S_^#L!G'X61)'S,@<CC7VZDLFF?+9S"@8D$$[
MKUAQ/+/:=Q5"R!&OUR2',GOQ4L#[5MT761H?FA+^2N\;^YVDLSG_(H*1K(C_
M.!*(9Z_&.ZVFII)6@<.VHJ+"IAU@NWBJ36&_57%K&@  (8EW:FRP6Q@L%2.K
MXP%!H8)T<7BQMD'QKHQ:@S#V(3R)IS=#W=S#CJEB0L=6!3GU->ST=@1F-K5I
M1#[^^"\_6>X /_6=>*"2NGW)!QC _^<XJ3*]"A6V/4!)>A!.E=Z<(5]V2ZS]
MGF,'09C<0M^&A>T4^%J)'H8)ZARG\AOSXIRK3R:/XOQ4ZL_W<\+5Z3)"?3"P
MIQM0IA)GJB92(R=H9)+WZBT5T+Q6#RH;,YCQIDY+S0MVSO6?) P'8_[RO7JM
M)7F D;"50GC#A(/X&*N*HM?GGO>LP8R+33:-:T[XWX]Y6E>SA\=.RZB1*:D#
M4"K[ !F4'X(Q3?=JF0/.*,SP'M)'2 $! U=S&:/\:@(]B"*DMW#\NH5 YLTF
M/*M36R5#>*1]WY#^^*X\H?8$F_EC9*W^I(B1)KB0L'3Y#8S4.I\G9#\F,BS8
MOMLHCYX!RWE2K:_%D[HYF$]//] \895T!*4V+$1$MB)]4,8_>;AGUX]WE^SF
M?N@^:)(I?L^^<$#EFXZHWN8)0,F[N?=:">W='5_!#3T]C^QG_>NG 7A/<U[H
MON#>S3MFI[ JB[X!2P QK&MY-0H:(?C8R8_=I3R2!F2<\/LJ_[5"AG1L[[U4
M%[8Q)73$4*PF UI3PMPOKUB\3?Y^L85./ DR,DNK/V@U!/4/=2E6M>>ML/53
M(2)C8&CH1*WFZ&*@C!EM(Z;TC= +1F4H>K7..;(@N;#NHW77LB?O:\"GHDC@
MKK_++9J2$0@-X] A$QSL0QV5]<[ S_ESFF.J^#S*0ERD=S/B*D]V3! _&\#X
M,W?8ISI,IQ@[T%CIXA-J5K] IS*>516E'117=&(DEQ0P4CHD2TC^GQ5I7V".
M<C_&.L4*)V*Q<\ZIIHN+:+WFR46495-)/UE519S"&>77M%[N@"_AS4=/YV$\
MZ\0X /%/EDG$L@H*B^08$/QK[SV9Y^NQP%YJ9$[0.Z28@68F5;-QPSLM8%W^
M[Z>".>?K?!M=9I"Z:?V+=ZS,U3HKMEQA(K<7F]P5!'^14-4'QB_V[^%4)+SW
M&U DJ2:$+J'25S&\]8 4]2ZB4(LAL"VOK;X7!=,8*.8Z&6=FMA]?0?+^5C]^
M-PZTM\C'O#2-5#:L-Q[?O=/X%M#EDP/@&<_C[3C+.+$+'%Y"BGUB6J)XMD;F
M<*QQ:YK$O!'125VQ19I1.K*R"(^/E'T $ ZQME=\NC _G/%J+<R%%1^*"+&&
MT$<R@FGML!=9/[<&P'X/4,=8E?4>1N,.==#[:)H#E4&;E-J;5BPQS8M8TAB9
M-8GX!Y"GK>M,^.I"+_%@J-=3LB38"[M,4 6M:ST5'[HWYFI8>$>\A\]! 5\<
MI_3W+=TTJD!8$02J6LOJ$[6X]##/]O9H/6W;*40HPA!#.Y.'3LT;J4<'72@X
MON_'LTX.1?8?!> ?:S;D>$".TI=,K^&4!<8&[A> [4T6#LRTUFM" __E[_B.
M<4(MCL;P-GWBL)VOEXB)<WB88(L)@<:D*A)U->(D%X?XGWML%S;U2F*- -G#
ML2=KF&**2TEJV/[N7DSJU-^_\RB]EX..7Z(T@SCONBBAD 2NSDRQ[3@6QFPR
M2$YA5R:<>RE*A%/;.793BN6ER\VB428"3S68,R'X#(8C?F:&0/VHS R"P2A&
MJJM3#.1]>:LUG]CJ \\9U#DO5^+ *L[1(OS-N0Q^A _N> UNZ'12!^$*V'FE
M5"AN"^#ER'E-]4;#LC%SS=.2=?0+A"; 6?\P/-N:-?'2QMW'!S;JY^=],9N(
M4%E\I);A#KR='1%!E405PXUD:U P&- >36J@$Y%=GH^M=H]3](Q9KR_ 5SHK
MME%6;_$L-<W'\3+E+QCE*;@',3,EYQQ.4*!KK2!UU_E"3X\%)RR-AI4T'$;G
M>L %,".R,")@)BN (JJ K/6X@O2_'<>%ZK;/N&X*Z4-RG1R&1%^9BG._Y3KQ
M.1H++G1R-+3@,3.>]^LYIZ+8U\P+EY53I8IZ40*V+1'X')QG<YA2K2R;K,5A
M#TO.)0J8/$_KXR#>I_XRN1JP]=FNX;H8U&P\4DO =*RA/,&%$V[25D5.G2#C
MFCCB82SSPK13 TBU'0O/2R3=V6)#"?$N=@6MU<2^JE$GS>-LDQ@T-'&BCR'\
MEE1R29IMX-1P=?\ G/01(-QNLEK%FNNB!I2$*,NV]-'TA3.^6/"X;G:%(Z>:
MU0($2'O/U-8GS91MXD3]Z'<K./Z#T;&1'@BCD:AN(7LLT#9J==U/%VSGV*>&
M))L':5#OW(=.3FUW]DDN0L!BE#-18A;P5;I9^26Q,U=!UYQ7P*(]XRM*5EQ5
M=;J"P^AX!81;_\1W#9CLKX6XKN\WW3H)X[G2 A"_6@W12A*.$T2ML83E>N+,
MNHQ/Q".2[^9"C*E>LD5:0:H/^1@7!> ]J0_ 25VLL-8'?A1Q/JXIB '!RW2%
M>X_<A*F$% A>>*Y_KWX(EX\E\I#)?5QL[5F&[(MKL7.+;7W$%F6Q4EJ?Y!97
MP1;'$N^$1,$>J[J)-OH8*&2@D6F53.MDME(&6AFH?1_.<.B!]T]KF(TX04/4
M=SU"]8$:S*&'@4<J(M!B1DS"(!T!#JF;04Y=3[,T FI>E6#/*1H);;O%!MN%
M!5C0*;5NY#(EV"+_"I)>[]VTG>R3-K%6)NK>;,G*Y7=M[=U">TZ*R;A91'%-
M&]L#'B!W'^5I0GC2<9KNQ?$F&U'$>D#@>%%H9/(HH& Z::<6$;T(#-KQ.3=K
ML>:6_(S_/_:^K;EQY$CWK]3#1G@F@NWMZ5E[SYDW2J+:M"51*[%GCG<>'!!0
M%.$! 2X 2N+^^E.9=0<!2B)0!4#C!WM:$IE97Z)0E[Q\F5 L8N?'^(RWM'/<
M$[!?,YH)&VU(=2?2IR.2-7!$$TX0]Y'M9S7!X1; ::>GX83/2^=1*#P$=T/D
M**E>M31/Z1=M021-XQ_ZP"WN$27%4Y. <^"P>\B@#?T3-=Z<5F<,2ZC-C>FI
M;+1;6'8>L9(,ESHOVZUB;/"7@6 Q-02I0>A@\CG<!WE<%(',%G7LYVIG!>FD
M*K8"V-;/:;?EL*T@G7XH[E\@Y(SETQS2QG6TXE0B54LDIJ*S.Z*2.B9 %:[4
M/E$%Q7J:1O ?.,VPTP:\U_S&W;IT@ D5N>#L'X;X/J_V3@!;S[,)M?LZ7@J3
M*'U$$A'5V4^?"%2D:[&ZC($R(@Z2VZS &,CLI:2\7N,J/IDY18U 4J>H0=C'
M0340..BJH1 Y%O*K'@V9I6SKX2^'VV5650SQLSSO!=Y5?T0M7%PT13>BQ$O_
MQVZAZ=7XPT"JK,<?!M<!574=,O<TJW"]UO3;[,>X[-9A)[18(=80]7C@076)
M4WI8!#ZSVIW+]^UZ=8332MMX ]@Q8K1?QK\&Z2[(]Q"?^9'T"?DP+47V_</N
M9'Q++L[VQD]MR*VLI!S94=+4-(%[H?$+U[16^,B-ED%&9Y,+N.@"DP+O@F&&
M[TYO!F%T13+[89JZ"%-F!S'=5F"X1U]9KZU.\4:/%Q*95L! N:'5[0KNW@AV
MU=,1H&/%65M>T O2UB68T*$&3V#8OY03J\Q$CLA%_!1'-(WN&,K^:ER-'CK&
M&'D5-F:RR&$2&.?OSM#V;JMLL8]IXKSP]SK(?Z.8\V5T&6C3,4H+M-+<^O.B
M=(?0KB'0I+]Q2FI1.UX;'TJ=I"<2^2 E#SL%F0E\^(L[F.3:5]=E%-KJ%<0;
M"V'&Z=;*^;82^=AG7.^0/JVC#DP/I9'N.5&)H6@95 3AAFH;+8+:?7A2>S!-
MA9:F.E&@U92( 58G"$%/FEL/QAJ6_&*9@<<O2TN1M"C3SR_S;#-EYBC8:@$Y
MBE%M$CS?+%IE7HE< F@L\ 3_8*]+:HV()UPRC;C8!& K-2CV(HJT^5C5->&X
M?- F]&Y&Z>'C0X!\:WL0NI8 AD&FQ!Q(4\6!.,RX7<#[M%K5Y2NL!WU^Z^<=
MS]Y]Z\3CD\[9"A_16/9$VL]>0AS\3; Y^8 K&:.D+ +"'*?@E\"$G8C"QJ)=
ME%<(DV6:A:=8;R<8*C/Q (OK<I(N,!S4E@( 45OJN+XO@)O+8R>FOYW.%S=D
M^M53Z[\V(Q<3?T0CMFHAQ;!=$L=H)CCEE#V'"A.:;X.\W,,"UXH8VA2&RZ5S
M0F2GJ.Q3JF]H.+W^FVVKJR2+@C!.6[T5IB _;T;[H5>6(E.@VPV@_=#-J6-*
M<^W6J(E\X#_9>]'JS:X+=$R(%.WG75@\I\RJZW@KS[H%-O96'I?S(,_W['C:
M)A-<Z5!G?UEJK1T[4H^']&ZGD"NOEX8>6]#-1E:AA(YN'K<OH5/L%ML.MBZU
MH6$?K]<-XM0 DCO1Z%S_Y?,/7URTN@:YFFA2*,1.1>BT@VK-)T$8#)<X;AFW
MC[]3](GE4;$1(G8O.V*GD.RNUDV/SUO*GKPKM4Z\FSF^(74V<KL_B!R^ZPM>
M=\,W*E[X"CB:H=N1L3'9OC:^[ _  ?N/H/U9I"*@6=S1D+*U(P(_X_WN(8E#
M&-#IW5 L?B3)B[1(92BX(%(A=\2:*L=OA&:J(TEQ!%$-:8E<6@*=JL6'LL3Q
MTX>T!C,%.HYKXH1OL))S*CUTJC^\GB'P4,T0$(UU?L9V'+]0R%FET92M8@P<
MUEY>L-5 I1'TEY"QD!D8?*03(L=*Q&!Y72N!X1K9&[]3NYMO]QW%3J41N;O_
M5OS[W?VT\!=F.X6W YC2VMX7.R>G*==Q'OV+F\;W8Y6^V]/):8 ,T*T?Q)\U
M3F"G^4\O3-S"UQ;-TR6\)_^U8P!IOEBQ 7SN@98[$,.11'/\Y?T?/BI8%&!<
M;E\1=Y81KX3B8)<:V.6:H XBE!"NQ2\G>_=X:SGT[2=<\W1=QG3..6LX.^G-
MD ".=[!9K*81[Q'8HMN!%DVX;,RQ8M(!EY3OJ4-2<ZOQMCU:K[+T\=,5GI27
M;'!8D($T#=ZZLCK 9EVHCC54]]2.%5).KMA=/N%9-Z=,2A,2BA*Y1C\->,S)
MX7!]M VYS47B/^8ERG6JFRP'*5JD(<IMSC&#=8> I,-% >'II6HUYU)' \=^
MT^LQ.<^'U6VKC*9\725+W\*)4K#R0H:P5C:!BXGL>N(^(;I;E&(>7E0AF4T(
M_64T=XNMV9_'NQ$;C\UYAU#*]G+:0)@@O7<7.ZJN9R>O\: '7$/-Q C\3@]W
ML@GG*G5Z'_1F 3O YNZ6U[H 2;BYT*-5S%-^F!V#FY&/&.X7?,R#<C@.]TE8
MMS4A_%,@#*9]<2NP5Q,I)'@G(^#QR@NXX?,_NW548I!1OIC7000-HT3 0>7M
MM5J1C?XZ,J+@AYS,!;+$C,RJ:!D()TRZ"J7YX1-P ;!:.X9 59AG T!KGZ3[
M,,_NH:#_LV.J9D^M:2^4+(+"O+'_=0+"XK2H(''I_!$]:5I97O;B<6WPUN.U
M>8U1D--W^1K[-."KQ/>G:?3/G4AGPQX0 ;34XO^=I\H%+AM!8O5?9Y&C6"@D
MWT5"Y?=P'-";F+HT\.(_$2W:: PBH./VFM2'S>0\-J *-Z6A?$*D>B+U@X]:
MV^]67;I@#!_.2-;+<S I2*!'@)N)*.0Z,L.<WUHT8<4TY8X2:%C%8/#TO5.O
M:08#B72$NN/Y<@7F,"4MJ> J#!U_(-0I2IZ$G-+%:KX)'N,T>"B,LF@^B/9+
M/E, "R%7,7WX0V&5APNHXX.8:'0+B8Y)KP'G)W;F!.0I =3LX'F;1 GB>?OH
M"BJ"0IRZ&SOH\EP*-LZO618]QTER>N6I%7'"FSYTZ/U.:2!2A?.^[VZ0'I8/
M/")"5400X!%GI. .EF&OX'C"!]NWLPWEGKM.WDXI$;M$ND[>:3]Z\2ZI4:,H
M/VME!Z.W*B<M"*Y?B:]LJ2UX_^\%< *S^;J+BS4G#8:00)NW 823[T#Z]Y S
M9HN'91T4>&H6T3G0Y!T8QP.N-N,>) ,X>@ N&A6XNAR"#P+-?F[+P2"T T[(
M;KQ8?2OX!MP5ZSB*_92M/D'S-90\*EAV?8X"LRNHXY8NN'U-X> =7 ?L6K]\
MSI;K;%>PJ^/RF4V2/?0K9'-I<Y4%[<KIN1*"6@A30Z0>PA5AOT8"J@CH\K-Q
MNT5>=>)Q"VS0 B6S0"DM4'(+0*]14H(%$J;3[8'++7*KR]7['OR(4=MOL87[
MR^<O_^$>8[?U'S<[,,)BU8I0S$61#1\8[%]NZ<4&8<[:XUB/U3,W09HE\5,W
M5TPIS,]JWV[H8D*/:<A6ES@AR7T<=;M-9%OTH%A?)MGS7#OWI@]%F0?AJ0<_
M4SKOM@/RB:& _"I5> @9.X%J!Y$-O!=Q$289A&Q@[:M%[RP)6F*>!3DX9HM;
MFN-"AFWGZ?L[UQL^ BD2HG5\19\0(=:39Z C4,FK>$8"Q&*MYR)(2DL(/F<;
MJM.?2%"6>?RPXX3-T $P3;.G^"FP?/,C 5UE#V^&[8NKG[NHOZ4YY85\TDV@
M*7UNWG_5/-:60=2>[I1&=A$!E> \T!P^$S#*J&T@7E2K,0=71+0FPE4!]\+<
MP'XS<NQ6IWK[0?M^S'-\KQA06ES%*9V7=-.6)P'DD!@$06XY#RZ2E6HW%T+C
MQ2V&&[$*.N(TT+A^_9%=3-GG]6=@@=L5O 0[XENOK( 6;+WZT,'>G P:7K!/
M/\?EFD181B7ZQD./$S8&K@W#F3DT1-T30 [2L1P4QS!X>ZN()2Z)*(O\BE9'
M<:ZI<ML#L$EF-0K'+W6:;=@L++/\U%-A]>:4\4G%^R4%3T&<N)] '<!02Z^2
MY.' WM7@[6X^2ISS0[?DDCS/-@^@$KK1*D*(>03L92MD$.<[ABQWGJ:1F7 $
MS5:H^9NVS);&<*!<23%4F".2^ZHJ" ?'GYE\)88U,7_Y.['G*]E;7+Y;?CW!
M,O(7=E)G1VB>A=AR95+-B-9<J$PM!-H33KBWH>4Z,UDA'?,B=@%2WNTD."%,
M9)@.?_P62T?]$_*8_-CF33'$>'(/M%\R/:YM+09KWX /5B2W*32Z#>9MSC96
M=I[.]S=9266VLRJ;N8Q7Y7K*_A6U[K%J]M[46@FHU7G@NMLJ:B9*M:?<(J^&
M.>QAK0RTU0:"XEV=!JX*C=A%"PP4R"$X3AGS:IA*N^@6T\8YBP@/0*F&[^FC
M3#6?LQ,%4'*=9T79:@F6 3K=RAUR'%-)-R#U$%3D:9%V!#LY ?%(H1ZFZ,82
M5N@#UC0,(4M64&C"\?L4]Y8Q3:5 HB5.2+ "0J8IT.0A-*AR$7V7P;_F:;9V
M@C4Y'>8H\%E9)!)DKB0Z;W@9IUF.]..<RUZ68@&UZT5<\,@'Q/>;6H_]A<<_
M3@TTU_=?F^BZ-61;M$8"SL2FOFU_\1.-\6ZUYKS' ],T-0-T?$Y)V(]9C@1J
M1M)(!SP_=_2)ICLQ$4)3#PD,16."=TJ%4#-RUR?03J&K2XF)QA3KK19>$6T8
M%:*%^N5?8II#4MN^%=V>T<M:"<03U<WT9V^,>TZ!FF]J+5I?*+D7\YSWASWU
MD"'JTH2400_9KJ7A77'=IE%W,^P#=W#H=?#LA 8Y1>Q&"XW3H[/]MP(H4WFT
M&2X9O*WNZ5XPIH!G+4D5D/CY'6AAB_OW1"DB6M-X,9M/$X"' 'S'L0K7-]XA
MG4.5D5-!(W"07]!RAU9T"L"/=)A,XCRBW14L,4=-.#7Y(6-!4XER]P&I-3>8
MVH<QTL93J2O48#]GP$L,_'5W[/#?7XJZL;T;@ZUA9],#AF[UP^5E<VY[<X)J
M2=[ZMLS8/3#;Q*&\="[2RUW)#H"2LNM;RNZ@RH7;<?<6NU$+%4/1W;\A)RG=
MDQ6.J,+PM8.!H13E=G?-N>O/;-+9:ME'ZM2>#/9J<K6:Y@T5:Y^[OP9 CBW2
M3*#:?MHXM='/&1Z?I#+!T\5_B_6-A8#3G44V@L#L"960'+6,$V0B%T9^')8*
M)D22M(F_<"4321 \3K#O62QKG[&8W>)W_G@/(7U69@VQ\]093>DJ/GG5,Z7A
M\4S*&PD,GD0R2V6-6B.>"6$?@B=UQCL$C0K??1GDY>L(S^ACG*;C UG-#E?P
MX$;WX&E"GGQJG481YL,&R5<VU#Q(=,54T;;PK/TE08^.B.$9%5V%S[JU(=G7
M"O)I"T5:LLN^'C/LQ7$9)S0_9[>8QRP_E5"02R(HBDA9KI\D$(3P;)2"F4WD
MI8 #2Y+X\V)C2 N@T0]M.A-H+1.B]%C]"K@JPG6-&[B=YST\]/?T$;3>82T*
M'+]X'!!RF-.07:331RB-N&I9XR&T$*4&DKQYP-'0A'4?7DI %&6.8&G#YO8V
MG9M>CY;TI3Q+LO"W4TF=A!(,21WP\YFEN+^"*H*Z1@[=G/9?%XN+7^975V1Z
M<T'F-\OIS=?YV=6,3._O9\M[3QE.Q666RX2ZQ>J>AKL<7>6*>Z=U2$(Y$" _
M1N7N ;.$4F:V\O 7F'!O >LB+504 )UMXW@\+Y0V+P6/LI7R0Q(_XH'DABWL
MIT72JD6!T-D->76V9@LAX0E7G:658M=%5)WC51NU@*3:ABO9$T@+<AV\=07/
M9FM[W[/LK6=?R_O&T69]8[@KL,?-Z6\XL[4^*Q6S%YJ'<7$ROT('5S$VN$]\
M=(+XVSC+@7]"CO!W8=U:AB$EQANQT#W-V59SKGJVIA'_S46G?0NY3')N].6%
M+&[^VPM/;0P=057G]C=!]%.^X@BJQ9$C\?Y2B]=U\T-=> 6,Z3S'^C((,9YY
MGK'[$E,.S&^GUXYQ G21O2U%PT64"T=>N?'!.[ADQ\9U.I388*L'_H0BS..M
MCPW]L"G#/!7TX*(!Y=0@O6E*8C[5B80*L4>)H'V732^G%::=ABSOCVF=:FC!
MDT^]3[!FG.%#PSW,>O39LL3( ^1D(% <,Y5L&LOLH.]%T8X;##(!!>N(8 Q7
MRN"MKNEDXHT[S+D)JAF1@E;K31QB$Q*YM8)(P).,!,4\-7"?G$NHQ$&/*?/A
MC@+&0:;GN.'8);RZA8PO5]XR$T0BUT'^&\7YKAUZ[6YK/?GOW"!L+CC&(BZA
M@F@=EK/69[%QMX"K+NG7L+K.10[R*/CR^<OG3N_?[ T&N4"(_5E?V+Q<13N#
MI);W\4.IY(GW@,>,Z-8UG^>M+]N$KLTPK99+IEX:3G4+RXK9F/YO!C.G)9!4
M3737J2<?K;\7Y9KF<!7@OGV#?F:)Y\>6<5@43[1\BSOL5U1!/ 9@7:&U_%GA
MFD:[!)T^'+X.>G@@$H*T&!&HN8R+,$C^3H.<W;TO3J^PD$5X7!X!@9 #B%WJ
MO95X"BXWB\--E'U&"^!_8X/D5!KL^>;RQ[.@B%NS9>KRD(E,(*C2X,F10'*[
M&@NOAS5&0W X7K,M>K5?0PFM6:W[H?';C%R7\YOIS?E\>D7F-_?+NV_7LYOE
M/29H7$[G=^3GZ=6W&;F>3>^_W<WP;[T%/V^S) [W;=?^HS%0]DM40GX5__6X
M"[C";6WO0H>->ARM3N8I)RE4[\ZIJ8?==X^!*AD^.+-J[_=BUD.*)]W6>P76
MP",C'#PRKI@\H6;GOL=:5W*[/BT--#B^[C-=0K+ZN/03^+FB;/NC=M,[N1'N
MOZ60K@T7&AK-7D+VT5:W-J[+S+L37?Z4P@DQ51*NT].-SHLEK)0G)N4G$F^V
M.[Y^?80'7M]DM!>@NG+3X'6$:_L-+1>K9?!RLGM(EZN:C)&\XRT$0-@RR\2/
M#E^E8N,G78%*7V!OHX 8R# +;"&!+NG@A=#5BH9N<P\;SV7?"KK:)5?QBK:[
MIE><F4S8+F%WV<AJS 15BSM42!*F$7Z5P 4>NF^Q4\=VO2]BN :+;BOE.BAU
MKPEV/('OIT!UA?TJHEV()GR0K.ME!E2L[->4/&99Q*^2!<V?XI#R']*LQ&>2
M L4*)#8SFP70X&+V$FRV"57M+PBS$QO1PRY&'FCVO#9!N&9J<G[LI/JP#3]F
MZ(R QX!QAM4N3V.L-;8^*X1CO<##KL31)/$F+K&3QH1]<\5&:LJV!:WB%_AW
MP76&&2X'N2$?\6:KDIV/'/<[<#Z?WG+1(5P9 6T>/5Y^#-#D]]HJB]C/'=L>
M0DP8MHD\>Q+$:.IU>W(<%KGB$_DVR$OVEA1SZ+\1).=P(!-$@_>[AW^R=6Z9
M73%S?-N>G/3%7QBIB A-Q%1%A"Y8$D ;^;8=-_B#9C[<"%MIA%@8(32-4&@C
MP PDNZW;1<&Y%>R8S"%BQV\\UM[+GA@)VZ1BME[CSRV]&Y6G:VH"5E=+E>MU
MW1E(M:(;X*HJ?+JL7..U759'0/>32M\FZ8 [E1YLIY)VV6 5 ;*ZS?BQUU/N
M03= :QQL;\$X#G#6J0)2?,13# V9;O>(X*_ XMI%&_&K@*"LX8ZWNFN+ ?O)
MA&@U\L0V\0A&;/F%O Y;YQT=]-<XS<55O4L#-Q4*P@LPO/[8(A&48 O&;;#'
MRVQHI.[AG4 5M.RV\'LFKU@!K2;/C0@Y532!"SJX$N%*'7/?MB;%XE4&XNZN
M\^9J>IRX+@SJV,ARF=>0#AN43!P[3MT@L[Q0?-ZPYW?TV8T+H+T-6(7J@4@+
M? KR6+0B=>LK183+YVRYSG8%>^>6SVPL^QFP;Z&CKY.-@\EG[Q]70$K40)!R
M$OL-.2[)ZQR<>/, E!1,N&2"HKF'U,_:W3DX\^7[\OG+_^%@!ELM*Z*HBUU9
ME %RC\WA.IT6<8AQU %$IXVQ0?F7&)W'Z/00[&JMZ8]L^83H$"QNPAH'T>E,
M:W9,:F!G<6YX\PE1F'4;Q-$W=O:X#LI=WN8V5DE7)4J19)$CH(J?<[2R42,_
M:$=O%8*27%G@05A@JRRP44I=$W:X-8'=T>4M>-TG+2OZ<2/9S:C#:4M0 F2)
M5A]/0_9XP-4&L8$U,4B0,_$QP'[O1J-;#(BZ!GA'DT XJ/=+MH87_#)4G.W-
MOTQ?XE,?HQ"CLU/YCR 6L[)!M//\&AG6%HXI>$EG+R+PR [<;"C_VV8I5M%[
MY=SC<7NE@YA*Q@JVTM42*65VT/BO$M%WSFO&Z21%3*75@5M2:PI9WO*]NH!@
M$;#9.+P1F@O>)GG?9 =[9+9,V(*9\6Y^IQZ7;;9N2=6D>,HA3X *5>#OX8W^
MG$T]'\"K$:_C!@#?4RC<7G&C/9R==30=ZAU]A,YY05K>!)M6AW@MB8"HH0]=
M3%0NBG@:O%5:Q"OPVY@<Q0QXK(DQ3$&%X/CTOF'GE"M:@I'N^676(!9H^4K?
M[&"=YS5X&YZ@@HIX5M<SVT0)A$3A_36]V@][<$\"@QU[MTV> ]<WF4YMH4[U
MB%R()2"7G.TM$HLQH;)YB:R'6@B'3N$!FC[Z170%B2_T"O('J[2OU\$_L_P<
M(NVP1K7JR*@U?4)5A[2WT'_BG]!(&/3AHNB\AR'?IG</21PF<)N):/07=K\J
MUV&04_XZQ2U=M%(ZX>*)ED^4 C]^6D<XJ\<0B;?D>-<:;R@5.<Z_<8/39K05
M(/]"D_I'ZA0ANQ;?[1+ZP^>S/_TPS?/K+(I7,8TND^"Q[8X#N360)8FRP=5,
MI'0"XL<"2[Q\'P5.I41'8GK@F%0T0*IP7GV$YQ)VJ4'N=LY+\MC&=:</.EHD
MD3*=/J3S+"VR)([ QX0G<_;N3M,(J5$*'LG7W.>GLNY67C)3)[^$Q2*W/C#4
MFGG_@5#LNN.T!ULDRA^D;3 S;6"J,YGPI4+7D_L\*TJ8VMB+H)W+J\"L ;93
M8-U*SD4.>OR)/?2[$0S93*JLC-M7SJ0H+5BL7HUU%DW!3BQT.#52;)0VO"5J
M7!P-&XLJ$.<NS5F00R@*^KKA6-HF14MY4(#-T7EMGM$9'#LSYV:V)/.;\\7U
MC-S.[LC]7Z9W,[^L0AAZC,O]*0PM1UAX>< 1/&&1!YZ6[B E!AJ3^TG*]$([
MTQT<>[;U\HSP['$=I#O(J]P!K<D]>+$QN+@RVINVNH9;\@DJ(%*#3E;T<Q%W
MAK5RSGP;YG%"-5>6 > 41/2WN0C_HXN0G9T[93<T>I?&Z0IJ>'%GW_(<9,!>
M9E"KR_GJMW(L-<G,7AH0=&P,>=B1^)1X[@LF3(%GGD0W.&N;#QQ[F.[C7K,-
MS1_9_/J:9\_E6H09VH6_I$C"9<K8A>N-\SI+Z9[SG5[NTJC=5$1A@CV5H#AO
M^0#=X+ 6402SX6!6(-,[S6TU^M AQ>U!L&$\X&KSP PG"=SZ8@T/>1\<NXD2
M]F,&R8)/U+A6BA2'.S;,"PCUL,&R:WBR2-MF-E1Z=LO4AAS2=Y_7<;C&7U.^
ML&!;19'-8-3@A'K0S&2J: ,2Z.#/JS@O2A+Q89,$Q@UV#=(4$I8>D^R!_0?H
M1H#JPO'VZ=Z^RLMC*+(+,V6/-U!&A+8)07V$*1PY?BN)Q)Q-4/["I\)K4X!\
M%Q0DD/WCG?6NDLO)+UBJ0J,INZ^QXZUTP/.^L$:&/!!"AFT\:%(1$9J(=LV+
M)K16+0'J\^1F<VJ#Y'3XH\9MG38Y0F0*8GNG(,<A#R 79[[HJ<$F/>_9-FKD
MMN=#JOH4B =?O-<8;VLUXMZ5+N,J;)_[653PJ01?W"(Y)T/KN WV_90:- ,B
MU]$G?ZHS$YCO2@-P]XT3C&XE\I[9!H?K_G7=C5I,P$J?F/&,_WB_&U]]! VU
M+2.X)@#W'6/Q.5S"T6S*5$;=. Y1'E$"!S_VI';8?IQ=78R_\@IP'(&4Z?I6
MI5H[B1NY/%9 T%A&[5IG=NBN5=+WH,^2&)U6T<D1HE5G@ ^-LN9(G*O.*A&1
M!\1M#D23WL["4/D79H\IU/XM@Y<SFK([,.Q'80ZLA<4=+78)<.E>YMGF-H^S
MG--YL\_>9B*=IE7:&3_RHC+D$0U>9)-TYYM6']C%7#=58V&I5(YM5+DUE'JR
M8OH)#D#0P.-7U!C<UV;*<I_%JD+'>W(QIBH@@B;!%:+A$>&QLG=%NDN90;Y+
M :0]"M:6/<&X*+)\C[P@;KF:,/%?!2@OV;05J\QB=1VP/\5!\HTM.? 'Y.3E
M%YK3*26X0B/<#?XN1=G#'K#4"JRPG-Q7*W;+%N'9(%56,6Z8P#+,UC#,1AIF
M)PVSU89!X@C'M*#>+&-SP[<VB_O+OCH"\+UZNBO760[+=0>GFXGT^FFI(P+4
MU))T(IU;@7-415YR AC=FX[-S\<\V+0J)N+I?4:[/2'4><%0M62>;27@!1(M
MR-JR 0AI$R+DC0.%[4B=AF&^,QHL0 4R".^M:Y(F$W?3*,H@4!\A1G.-F*EN
M/4:# 1\9-%_L%)I.\H,^?3G($/*9%-0)I,HIY0BT#<KWDM;5";*Z)"<&JY+F
MY!2.$3\"DKGV9'R&0*)IZ_S,NN[ 5.;< 2@/;(G=@;&H"VH?C[_:$#MGNVA;
M[F 6?6 'UR5T<*VDI??1Q+9[Q$UM/+RX('AZ2*N%0::8^$H.;#5F^S2GLF-X
M015W< 5$DG)![PSG.9NMX-2F^OBI:F.GM9#2J "GY+PH=D"X!WXL=;]KV< 3
MA?,G$@OQZ*4+K:N>!TJXSH$F=1BE9.Z(U'=TYZFV<9I!#8RZ+*%C5SI_+RC_
M;YN<JX:FBQ/I0U:.YN^DMN\]I5RYP9Z<#'N<>*TT:]U<&F)'@#.(_KF3@72D
MH%]#QB/$6!0C;6J;2MZM76<]G =Y%!B.=S@Q=7*J%**M@ (<+-V>*[L$I%PW
MY! )2/5S[.\2D=T8JAZ5A]0M2*?E6=IW<?';V7[)OM>"3=222$ D 8F.:41Y
M=#K8QB4G:[VDM  J7T7 JUPM)K_FWVF07[8G M3]"G3[Y<!0PTG^>7M(8. ,
M>>]$\@ 4!2K6&?%J.IX<ORK7[/\+Z"NY9X-D$I(D>Y9_A[-@49H?^*-@,L5F
MD! BV'!Z"YY+S=>]@CRO::K^+G\)CMV<"O(R2-4G<M4+MML\"\+UA)\'A%;)
M9%RL*2VQ3M5Q'HFOIRHGL-9'0"$GZ=9,SMII9RHEH)5<NF:X]&:,>C?EP:R&
MV8@3E%WP_Z_KQ4HU2I^GVUU98#'"#^T2NU3+>,@N *&RYN(';Y?'#E&9#^V_
M=AFR.&/2##O:3$,L.N$E;/S<,X^@A >6$,D')[#[3#/XEF*3%QIUEC2A)'I/
MF3@-2VV]F4R9X/U^S1"PF3Q1[!ZR/(I3?#G14<BV$0HOXX_#QWTD4>00=603
M)8P&76W;'Z,! %30^8<'2#ICED(7J,$;Y3XWN:M.)S^S\PS;+M-H)DYERPQ^
M93BN*P4QLQ>:AS&$U-FJ.H V,QP #Y :!\N?\59O%4X=U%E)*'R'^->3:JP[
MT28VS^Z0BD^"4A3"1K+9G/ P?,<VW BJ*O-")ZP6SKPI0!QP(>XDD*29 1<Q
M[ G0(V)%<\K.ZVW#'TH^,17 1%4JO- _.<5JT2>]#KCWMZ:1W4R\-E^QQ&6>
M<K=:3XO9<?8S8S7CHX7#*A_O\%>M_NQO]98 +;1AU7'NPC5OFXM51Y02UM6:
MK:W>Z22Z157I;FE!"V0]1Y538F08*UEI)DK';6=XN=2.G:;I+;L#L3MMD%S'
M"=NALY2*M[)MY11*)ULIGFRD?-GP0U!@0/#?K3^L8Z#2$\(!*K%$R97+]9A
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MF2VEQ1@=%Z6GV1-[P>ZAGQU]C,/%%BX>4/(:T^**IZY(FK+]N>@2P(;514=
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MII&+S:6Z7E^LGLFJ0<XR,](:!*$O>Z!QV*Z&@[<J?"M-S\BA)QJUY>C3C8\
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MQ]DEYSR+3DZZ049Q)H. $!_L=[+&&+C3UUE>PK]Y2)RV6YQXG;$^&2%I.FC
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M]Q3F.HAOM6SH=%J$TV/+,M=V>$.T4T7L'H(":/*A9]F1B-]/'OC;0K9Z<8X
M.'*>T31<;X+\MXL,F/I.)Z?38OE15@DFOW+1WEFW+W=0+6_R#7;4F^V\EF=]
MA>HL]D'O=(O=098/MI95E*NQB43=O];N01^E5H>'/)'0S:?LH_-B3M<T+>(G
MRHG*88-;+8,719IS"\-AP(V$@66&_9G86\E)0EO2M%NC$$SMY#O87;^?X!D
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M L@C4X95FVDDRMNQP1M4M\%WMPP[IP7;;)-L3ZD([*F('WS ;0$4^PVTQ;R
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M0%HRB[@] C4I&83I^,LI;F7')D#M!P<!P2 4,.F="T'B""3:ESO(=Y*1WX8
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MC?#)EAE'GY-@2:H9;44S4]Y* D:2K;P'^+%KHD!,*17)G4JW'\MP[Q,?&HV
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M+8L@6GI#_&]Q[*>4_T-$!JLKJ:\<HYZ& KSZY='G7:C&H@!DYOO,&.*%SUY
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M4FIF)"M$)?DP%$1?;:Y8J=!5+:)AV)I1/QL%L(N$=9XX\(Z?S&6OMJ$I!Z,
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M[\YL[P=9G @EOGEG&C^C(#ME.);N^G1.0@&:$"/GJZ*+-+PTX#.0V]@UXU$
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M>%$4V?&>= /GBG+1=A@*M<#,,F/@1"A7;\!Y;")W/3WOW\)@>1?&GJ*C364
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MXR2/!_0^BN*F,L"'6!<%@DK_T"WK+5;0)=@<*0$WHW3,_4WVZ[E_&E^Z>TA
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M%LC#2$;Y  J4*>5]@[)HIG-1 #I,/*%(@"D(06KN&>M;*! I%_+4&2BZ\2@
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M0G&F1>;&?;2C#Q.SH7U1\T?-<!3@5%6F[U'*^\:;Z%>UP2A @8WH7;?ZD2B
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M41 GA5>QX=17IP\9S'(/7&["*B(V7P@WPN3LCM+:%;U0R\U\50S)?UK\B%M
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MS#VYTF<DX!I9LP>CY&<4V.X=A?]$=1*FG/,DOXIE[BY.5B2 RI52,7'<+Z)
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M?.(JUM:.D.7QOXH"N?#8,> 69+F)@O_=$[5.KQJ+ I!2ESDRZ$7='''0+^!
M6I=_*NUH)";Z1$%+'A;'JFLGIF39)]N!^V?^O[VEOT]BQ9M>^]7]9N^WWIKR
MOC=5![7:SR@(^AJ&0#DLQJ^#]%<>V /_DH=@*(>C *=N:OP>><(Q*HQ6SPG9
M!OLM,QG3H?2Y@2 #9MI2)+ <N202M/#WM#0RLS=8";%J- I@['JF\#I#/J1+
ME.6FI)KL\<LZ5UUG>WH9X^0N2+;WM=R8UH_.TWX>*;JW^VV;4[9^=,_6(:UU
MM@3Y_XIDWM?9.HZ"-)M%L?)=ZIR!XB9!/06>GO"-$C,$ELVCCC(%'5/<GY59
MB$%+9K6=B^+\M)V(E(/<GY'(7ZML+4_P(NDR"7;2FK0FDU"<BE5G!9WIH<<Z
M[L^V4BKXG534DED4[;V0-RYGBGZUG[GH7WX7)Q7S@7"8M4AAA&^@H)Q!?1.\
M76*E0>+HWI#6%YT+&15_+0L,Y362RO>J_5="GKQMJUKTL6NAH*[>L;6M$FC,
M(;#8>'F)M/0IYO V30DL#A>2S LO42^+Q@GVA>* 9K[/W$A>")FB]U&>/JI^
MVK434( T@K>U^@.7S5)*%"H;Y$DW@ +E-R2A_!=>1DH.2C-B>Y1SY34/J2%A
M^/<H_A&]$B^-(WI((.0I&N@H!J,XA_*]D':AERDAEE-1@#GS_[7/E;]%+(JZ
MD5K[DD4,H@&5M-X#G_A7A^\IF%A*AS(4A^/72==M:(3OH$ @WW^1\PZ9Y*QH
M:T>DJ&(""I!,G:9&?>IZKH4"$4P@R:VG=+0F94 V$($R5RM@ 4)&F7=H6O5;
M,<L]<*4IBV&_TP1F/ D%Z95O2%&!*Y=?;)*M]'-Q "HM^52T%RBK/95C>**L
MO'E4[]50(*/"1W0)2JU1*#:O*71DEB!NM0 2>;=BSM16:#&;@>(<ZQ[32EFN
MLEK7"X@LT@MH/!D%J+)FD1V5H2RGH@"3[LM;KQ.RS@-T\D2'!UTIG:XY[@6
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MKRAPW\PAID(J;UM!'Y*BW(1&B[.9CP+@(3,'%?7E!_Z$>Z(>--NR9OE] 1O
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M$J1^P%(<U FG'5-0@-702>=OF1= U?>(WHH-/-#T-"SR)XY8#@4ZBMP!6>:
MVN%N, T%>,<F^=9#)IY)<KO=A?%!GC4VVL=0H+*5D5"T)BZJILE=EIW34(!7
M4/1]M*/*&TM@_KV:U6F&HP"GSG,:.FA1 (']"(^2M(ZN[1KNWV7K8@^2WFE'
M+>0>!77%O"#32N8R]+]+LZ)N2?H:A])P]![+N >_'4K;W7[>:J)[$$7]B;PR
M,N'U:E1!X893W(,%U/1"@NW;/DF))M)6,0X%URW:'==-SM=,$JQ1E,T3>ORJ
MJ(/$XC3@-M.$9V-E!-)>TAU4EH!T7;N0<I/E4-!*H_&7IM>"?"0*(# TWGN)
MP_".Y\(.*I6/LT7WC#9G_H7]ZX5PAVYIC;BB+^!R,U\50PJ36/MI.6HU%#0,
M#TJ:IX5%J2I?N3X&Q<8K4DE!:65TJ P,_0SWI"FK34NQSD(.<K;^( O/M)[L
M'M3_\8('[TTAXU1_1$%J><F%0A(A'<W(=.-1 -06]_4ET6WFN2>NOWK).WUK
M.J-;%..: /S?WY7[IU?HU\HO[(==0E)PA[)R.?0/^6=:P, W?TLIXG>0:/_E
MZ^^__"[S/N(HWAY^Q\"ZB9?LI17_"PR793Q4PBX+&* /PW_^IOGIW]202W)W
MUF\DAQ'7SR&$'HAQ@:)-0E9\[RG=/#L%*F_^=AV__\XG 0, _O$?\(_??J3^
M_P?I&=<Q16,S$(-AC:=OU'^74<@(F^(8?"'K +X;91"*+]F;=-B)MBC.>T%7
ME&RM]O.)MY3W@R>[.)&=J'38B;?(Z]/>1G[5HRO98WW<J8\6ZD,&/+:P Y>M
MH2>]*'?0$K96@Z!U22I#3KHU>$V37<S]\LS7=@UZ87*XCGWUE=;/.BD D)F7
MQY/RAK,=B%:-/^FF9[Y/WY@T_Q^0(+\H-RP;ZV*SU_2?\V01_XBZMEH9Z6*C
MC![G"8M,K%B_5+MM#G>QY6>J"GKA_P0[[:V3#C[1=N%,9U0Z56RP]O.)ML0B
M IXW<:3FK:TA)]J::!?QY>L;Z^TEV5IKR(FV)AI:'+9O<2C95_WW$^-+!#@H
MY$GIL)/>UU](&/X]HISME2IJ,01EI.E>\]JHQI]TT_^(0_HX>PD3,LI:5ZW-
M-L>==).Y!9J+9T" E"WOU7M5##^Q[)01T+JHHDO%7Z]A;9<(3=+A)Y=$DVOH
M !,G!ZTP6HXZZ0:EI0I:&ZR/.ND&;[<D@;3_;TG\ ZIP;W=>I,:D?/2)-GR_
M7"6SO1_0=6991E)NT:CZOBK[U0P^L5IW%U"58IO=)@G$,-)+LM1LVV#2:>EW
M0SE^%U74!IUT>\_[MS!8WH6QI^93U3&G?0(,>HZW'P+=I--NGT"UH/ ^\LG'
MWXGZ])OC3B7!\_?F+DBI3 RA16KKCG+HR3F!V, =_8OL.5"-=+)1;@PSVVIU
M[(DV.Z-?]]D.Y*RT_ON),9B6)B5()GR!^!-"U?%6)04)1KOGG@K#_/U4:"_5
M7T^[(5"#JWZ.]J:*$:?=V%V0;.]]];;RWT^[J?DNB"@J=)2G&BG9:-69-(B?
M;N<!;_Z/Y28H0RS+@E]2=U&]U%?3;1,G/DG^\S=_^,MO?_K-_]E1M@0J]G_^
MYNMO_L\^I1N*=[PA#?R61X4]<$PHM\KVR?V(R#%2]Q+EF/CYIPECHNZ<$ACY
M,F&,-'QA B5?)XR2MN=-8.7W$\1*V\DGL/&'R6*CPZ\H$/3S9!&D]%L*U/QQ
MLJB1>D<%6OXT=;14_; "*7^>.E):/E^!F2D*M3K7<HZ7/TY1Q*W[L 4FIBC:
MMEWG AM3E&K;WGJ!C2E*LXT  8&**8JR\K $@9'IRJ[** B!FNG*KJU8"X&2
MZ<JMJL@.@9GI"J^J !*!F>D*KXTXE1PA?YJBU"J-BQ$(F:+PJHW#$8B9HARK
MB_<1>)FB1&L26"3P,["8FT%)@8?/@"19^)) RG0EW5J\E$#'=*5;?826P,^$
M1=UF")A R11E7'7 F<#*%.5;96Q;CI0_3U'&U<31";1,4=)M1.P)5$Q1MK6(
M$Q1H&EC4_3RB7"T,46!CBO;;5OBC0,84!=I&R*5 Q12%666@IT#*V!)L7ORD
M66ADK!HHS#L.W+-:SNC*"Z&,']7XJ@V<3EX!9>6E;PQ=>34<'IM+PBP5?RF#
M=(M*0*PD82Y?*FJCZ,<.$E'<9^O0,P?ZN=/_@5IP[UX(C]HLN_:2!!K+LO)9
M"E#,YCH#K5*MR.QH-!.< :&OH-BD+?E@#"= Z82IZ9LXI"PMY74'S<]#/]T9
M@-8@803B6;P=;'.Z"R\;Z1#W^2-2:5TJ"J-VGH+!5'=7GK<@-'E&$&PV9SDO
M9$GH"T"Y3J6;I8(]U<<ZV[KH//!"0B^K%;?3<]GN>>X8;ARMH4P]]"IK%R]L
MLE?Y8'>B2&G,U4H=S6$.&6>\(TEV>*:"*ZOC1QDZZPZFO@+:*<X *2]D*HB"
M2N:,LZ0LB'6=>-MF#JGE9&? B<[51A*48K"SS;-RS!4.TWFI-1.< 5'KM,VO
MK^Z"*X?W!0#4T?\0JBC;&>\#Q^2O1Y)M8O^>5;G>MO&J&^F0I-_I]^/DH&8T
MM2'.-BK*]N?=:/5W3S'8^>:+ K_5:Z5$?-<L=Y*:[P?<7 2=7NZCO/U+Y3E5
MB6W=$YT+/.6M5#U3LI$N5:X=Q65>:9W* 8QMUTQ#:A6L<Z;#&_.6==WQ<H1+
MG:6ST'=;=5%/<2BW\4Y\MUX"39M2NLO]=L^T$LJ&@F6@ L=@HD.+9-&62LB1
MT)E S7$U$P:6&'+*?8:X86@9=?_Z?+>/?#7S,9WE^BK4+6U-&5)_)SKF.E4G
M XY?,%)3RJ"43J*E&B#=#$0F1LJ$>&O;G*+J/;F!+\$MB$.ZB[709XS-D;T6
M=Z<>U;KW-?J4JC0D[1RWFIZ)!(#IP3>VF6$RDC4[23>V6OSLV #<X>I!1P!2
M%TU/SXY3:Y%Q"_*V[:A[*AYMMMBDJ2);3L# ),TL8:VQCB^U]C8[#E.1LA99
MR$HI>!O%#N1!+.<9_*9^X'284WGUIX8JHZ@ 17.W%IHG@3P[=$E=^Q/!DWET
M0.UF-ISODT"6/.*@C99I7CGC]U 1"Y$CZ<M9(\GN_3,(O9@:UNR?0D6LQR00
M9X>J=F3)1)#4[PTTI\HQT/A.DK<8%R*[WT=]*- DJ,WXF32--LJQ]O6LL6;W
M;JIBF<9 %<)[>,QSJ8NDF@2EV:%+';,U*++^PI$5D363 Q&A2\WSM<%CDR E
M8U9?#U3+<?/[L\:-'4-7!<A-#576[+PS.&\2&+3#F4D$X"30UBW/2^,*)X0;
M ]9E%,,H>KE,1S U8OJ5,,GI8<B:U^OC-<= (+I;:8<PD[C02:"MF]'KHDTG
MA"(-US*.?!4M#LX:7=9^?I/PVJEASOH%T,;RCH$]A"^H'<:&"AL>A31CRG$Q
MH;;[F>@(-)X("1KK!AI5X(]387(&:-+XO8=%$[8+=\Q;8."/'!1Y:.^A#DEE
MJ/(DKIUYB(Z4)_WI<MEZA@),!(7=%\XL;V 49.&\C%;&^THN@BAY.'$4*3(=
M<NS\9>+8$<D4(K!FV !4*?=!5R+SF>%Q0[)@Z14I29^C7N;9EFZKQ]O3$YHG
M;,,^BYUX)@GK4J  S7 R$N!XOX79/MO0:_=OXAL!U9J$"AC6-<X&D'P"*B!J
M'3",(:G.PE  SO+JF,S$ );AI='-P .&]KJH1N/9?O=%T4[!5$V-[TX!A7H\
M#FFO;Y2ZZ5L[B1RE89#89D^3B%P?$GF"*4XB#G1(Q,DZ=YUWI%5?[!F)29.(
M71@ @TJ6=][.^,$PU^!WY^UF& QKTC:%%]1)4*>1=D]G*<9@^RO^F,Y7W&[^
M26U^=&_DGOY3I:](!CHLL,G2,NXH*8OHP%^";'.]3S-Z *U^3@U(3&</"UZ:
M9!70Z'^58-'_@$Q5?[_,J-A DO=@268?0?,DE,-<;)3Y'?D>TIMXZP61>K>2
ML0X+B<$=+8BY@U14H]UW5UE ?%C75>6#W)>!S),1NIJGJ,<[-$^E]&D$3W&5
MB%_C4&U@4TYPQR[C@Q="5N3VC20JIE@;@Y6S%[Y[\#32_^<OO(]^7%ZZDC.P
M?R$0NDC\V3N] 6ORM(=3F*]:4FG'!;)>!CW 5UX:+(^$EJ_AF(7DY*CE&F+,
MT.6QXY!^#EKA!N]DEB1>M.82JY0A&$W!1C<W0;@'8=S0@V"[BF-IY2%.4\''
M@FA/=Y2_E%0/N2*K."&5'*S;#WJUJ0Y&M;GDP.1TJ]+38W[1G=1$V$:^D8@"
M$=)W>>9O@R@ )@@$GHL;*FG*;+++=E<@9&M?]_H8Q^1,B29'VA7%Z4K9#4$U
MVJ%PDA(O64)QU1O*JL.8E1+24X]^SL"<_H'*FI6DW_P]4;-Y[7B7!$V/&5B0
MFIK% '=U@[>0KO-O+\^[:X29*C;>,<EAN7!&!UH64A_C;*M/)"N?J"-:+-BO
MX[!$^+(P.%+"^>8%T3QAV]Y"74L%@%VSD)S@NQ>$'.T5:WP>RZX3_FU7<=?6
M@"(^A4U2D3*BHA(EJ7V0;KC-'4H.* #LGN>N0VN>OR[<FKISDH]%(E#+JT6I
MN+?97#2GDFLSAN<B1@\LD0 5 \;F$9,P.EHR:48[[U,* ESP'O@DRO,C"FNE
MDEPZ)SH'2B^[-D>Y[2]!G^588(XC4K_[CDE.[4%@&Q9&;HU)J#8,F</XH>DO
MK%<Z,730G7448)=?#S#6X5([:_P8^N3J6<9U_]<8^ D1H:;3A5:/9U$[J\Z:
MD(S\TC7^5/>(G35R]*[C!@]J\*ESOUZ6@2063YS<4SD)0NOKS*QBU](_. F\
MFHE>FA=C$ED#/5[,PC=[U@@R?B3-G,9GC:ON-U-W*<= #:97<T0&KW;D3XO>
MM"Q^U*B 43*DL!6.L7HD3*,'SCJWS%K%:H0EG#5R^EQ?213$)-+KK*Y>1\3%
M62/,3E[3AWZ<-:+L;E\UNF24;,Q/_=9UA;6<=?ZJ]1O7B)LY:^38W;(>83J3
M2/"UNHR=@3^#HJS>\VN!#7-]Z,X@N&@2=7VMJ,X@8&E0I.'M-6=&<HIHJ$FD
MCUL1EF'LU:"(.S?B*H*Z)E&/U8B\.N/,!D759R<H>]OM)&K;6C*R[I# 0;&&
ME^AZX:UIOQFX3O"GIJVN4$>!LF'\(&="6.V02H&F$[@Q<%:A.8<RU*V'#'%)
M&D7#NJH]317H:S#S4HKF4HKF4HIF*B506$=0RL"S@Y2<-0.'SMYY_;LZ>;C\
M$06J%HD7I?1"L/"'0_47"?_JL0 .L<A,R3-ZC,XZ9O*2>G%)O;@D$XP9.*]Z
MI$J37/EX3 XE9H]1/=*EC=!)H.V2EF*#DS[$=N[AR$<%:9\@(!&;@>@ZWM)O
M;4B4!N_D4]<L%L8NUGR\!91YRS*C52[UD#KZ^#0Q]T0H:A?>1[\.YW);V<!?
MP8BN<=#S:=%A#RJV9\F.2W7$JDY$&.R/L\$9T2B)1]@BQ,9%O!6B)Y(B,@JB
M1XKT_Q1^3UD7]$\IU;9,NXC=GI3\H!,,N2'\?^^C]C&\T(M^%R<_O$15C,QV
ME9-Z&:_WVWW(,_U6*[+,G@F]6/Y\-?/Y?5*Z' TGH@)FYO]KSP/GI(Z?7DNX
M]U!R"@*^&4? +#0>(?T<=\7]ZKO1^@7E8S%T>-6Z7]OCW!..[%4Q-RMHYKH'
M[3-X[=L('-"6,-#BN-BW/%3':)J[4MJ^'W#!]-D+_/LH]UYKF85^#@9>][F[
M6;^0C#X:Q!?Y!_K &?E@=P2U7$)^'-W**R"22HSI]QWH"[<@XZ>0S_H0*/F"
MZ6Q,G<:UQZ,>[PR$QR!BNJG@HD+PA\2@&ZBL 6P7_%DJMOM7SK<5$ ^VO+LB
MZ=)M:8]9.V7@P+"A$"QZAM8 &N,+ \/_0I;Q.@IXEKS\^]^I]'T/0[SPNIK%
M.U_=1IF7MM[IX=;% VLL]J0^YP%7'[IMU@9JGBGI"PAQ5K5%_<-+ I 4BRP7
M^H:4-J@JS .MC!)>]4D/NO[ L-_0+W3280J$^.J%9+Y:E,;A*HA]EG$/B?K(
M^B\V.E37BHW,EE252X,:1VR^)6:@'O4%9Z=JLKLA#MSB.V[-!_=INB?^S3X!
MO9[IO?_PPCT1J?J$>5^H7*]+T>FQ$#:@^5D, ;5V)8=&!&%UIB^,PCK0,(Q"
M)%3T3I(,5#I-)YY!EAZ8(0RQI_M(S0@&71\U430VS6IXLS^E=.P=\;)]HC*3
M#K8\3F91[K-VM*]D28=F@;)SR9&+XK"K,-[.'KD$6!PHTE"IQ,3$HIJ* S!^
M#&)[)O T9@S,R4Q05QCF9\ME0LGJ]F,9I*0='#; @F-"5T=D?Z!,UQGZS6FL
M/X\JMNL7LMLGRPT5"&:[71@0?[:&.E(9'?= U;@@5.C"QR_JCGG",91;?$[B
M=>)M5<=H.NND_J0&EO/-U(O"S/;TQB202[B(KRH[;_*.X]=#+2>PS;\U!=X7
MPM4@DN>G\*>N8M1B#.@(^>&HSSH0.N5Z0>=^CY-$C_NH6^FK<@%F$=U=!CR]
MI67J1"W#%9"#*:6 7DN<=:*&XFJ6*ZMO4FO,):Y#O?@_?__U;,((_OG[WV.+
M?G[H*)!O%U1ZUKD1]C&H(GG6/MCSK!%I%19:*\(I#[Z<!+*T@:>-K(1FF.<D
M$&05*SK%>AI'I@K443:,W# &JG=<!,V\),- GK;1HJ9OQIC,#Q.U6A05D#\C
MYXX@XX>A([QW$GW=!N!]>IU@#"PBXVC=-].<YYU[213CRZF*\YY$+NX M](X
MU'P,A&*B..Q%>#[#9=0$]D^B@=L ]W&XQ()!,8Z\MY(QA>K3$B;1_^P((ATE
M=>*"= .D#Y.O,4:'.DQON$,LMS)%1NG+=FYD/52*RB1ZE>% =H.^S[M_U[$H
M[Y66,XE^50XPVZ#<,V_:-#R"C\M8&K;OTW2P/D2>U#C-I,X(]\<D7 GD#FK:
M>"?)6SP5].I3NP1^!U40SQ._P^20"82?=R/S8SGUL EL N<7=7$ $C?+B!,H
MORB-QW!M@QP[@>B+JMB!:+/\/8'.<^_,.S1"FWF#PG4WC!IXEG@<(K]1H/FB
M]QDCV3C-4N#VHM=I);7CTSX%HB_NZRY9H2NE5&#RXNY38'* K%:!XXL"-X R
M<5S:K#B*BUYWK"Y]9%ZN.(B+MF>B[9GF] JL7E2[0;#:)-:+"[ #K9+^4K^_
MN/5TK+:=9RWP=E'03.[P('G9!<X'5=QXNL-M="[6!]/,\ *;@VIG:FQBZQMU
M[:6;NS#^4:;"?8IV47 ]Z,[OHW=Z*\"\$?EW0>1%2[@L$%W?T:?$?/XX9:3$
MA>8-S#@K@+\^Q-%Z09(MWQ@[HP8$?5=!U"1K3J^'!UC/I?..L[)8 !&0>6Y,
M2M4)$KQKVLT83757BI]DP"+HR_\>4-JZ.GQ/@<**$Y@ML^"=^6JZ;IS]0F==
MRF;(-DT%$S?OSM2>@HW$2MY\)(GI%G)'8MY!F"RXJ9[R<B]:@_MSEJ:DQ?;-
MY[DCR/UN%S+R\D)!7O?1*DZV7&;LH$W#V0Y9/']LP;!$*4W)S>NC<%3U YL6
ME6U":)7*A07@78MX&-8^RJ><(>XF%_3YYA?>Q^T'6 S)%8D(9?H*''3-PL9=
M"VGW6.ZJ6P@!=Q51K4SYVVC[)G5,&E@1@)AHBLX<:]+JL,TAB*3;FSU+V7LA
M(2B4SUX"YWZ]3T"C-Y9SM8L@H)W\A>5V!A&KH-++K*>[/$W.HDC:]9:U!@ZM
M#6_!]O7O/-4PU^; +7E'*!N)_!NR2\@RR'^GK(<^&-F!_@!(W6W;Q#;4JD,7
MJ,Q-]T6PO5%-1ZNIB)@#4'E$/Z0NDJ^?@^VME(@I1RNYB/C;HY?\2IC9N;.Y
M@=E<=S)O[>(;:E0=DYR?TUV<E+X_B),M#-H=AZ29B(A9/"=D1Q^77%PVYA>-
M:>Z*U=+K#O\?GHYW+R3,; =U#)94I&'2&SAKJW^HC.2.VS9PN6/H]F/)LFY?
MH*(.J^>D0,^)-^'\2A3L!PS=F=9<;C5UX%=?O&F'.R](>!I81G;?=Z6^7)KL
M(1R6R2+^?IE!UJG4[G_DBLX/+A?U%S$5*B&S G0K2F.44UGUYNJ]'"*^-\\V
M)"D% ]T+93CY<_+ ,5C:6.)[2H7PW'=?,(U'+_+6(.K=I[N[?>0_['12O.$*
M;KNZ&+?(0W;)**];$N*G8%2 E",O6IH)3)WS$/$-X1RD/+"74U',NW +,?*?
M/X_(+Q:)!T]2KAT=K+E%]WPDVE9A!P:Y@UE9@I13G)'>I9GN#$"J/>6"QGSU
MG6H9] B(KVF5J1Z/BW] Z(C(3[&QT4BF#GQQ>+F5GF^L^63'IE=PB,%;8V=8
M-IL['B>[]G8[X)UA.&=1<2D5.V.PHA*_3)+.\W>C($Z>XDS1B>?8-1'=IM+=
MRUY5K2V]>^I(AT>Y*;\;3&WH+;O:+#,P)-\CBC1FPF??_N8%$5R$>=01)V<T
M#YF\JGE@-!,0W0GA"G\A[R12-F_KGN?<6E'8BH2+Z#GTHDSC?>JQ@#,@X2ZD
M<!DH'XYN/\".L _2#8\.T]!@]SQL[AM)A,+1(0Z8[EL1#%SQUEKKAHH54/!&
M_NI87T*+%1P&&RVKA6#A<LT3N%U4.]HK0>N:-72H"LG:R)07^.1BJ328Q7H1
M9X?"9(4B0P#NA-X[I1[OU,@B:D"PVJQEP3^-"44U8V!Z8CS6"_R[.%EL2*T6
MX8/WMS@,O>>-EVR])=EGP1)*,FUW7G2@%,3CEA7MVX==&]LK)HEB/CH,&DF:
MEW4R3[,ZAU4VS23Z\MDGW>A;D,JR609%)-X22/TS8#J2C<^; DW24VK--7J@
M>1*([)\>4Z._[GR3B=QGRS25.E]LI(!,@@#'S"2I8K<S\6(2V.Z?KR&_[O($
MB(G<]?Z292L]8Z*=.H\3&_5I(H.B%#$1#B) CL.%)T'5 XFB6HEK$H@<2115
M^L$GPB".DDC;N5R3(,6QA=+!TM,F<1K'":UV*7(380I#BV*UI+Q!.P_CQ>$P
MDI=-5N H+9UC>MB8T#J0/*7E#I/HC3V2/"5/Z)S(G3^5M:HKUW3*!-S36*7+
M=)T(]0[]ZC>S:T?LZXX)C;8OU*FS> <]!JQBPDBOFS3G=T2Z7F!CNB=1?8_-
M71Z%PK&=Q+#/GWUR]$2X^="/HCSU.D?F,+UE\"+SI$_CP%BM5=>F@"09)LP>
M]][U2C2?",V>2J?KX+/GW79JH,>L.P=_$M@<*P"S2.W(L7C>;;I.^EC]\^=Q
ML(JRM<:PCY5!E8-!,7MYJLR++TR"40SS>&D*/DR$?$=XMEK5)G)4GG=70]N7
MRS@&9!+8&^!ULB@E,@F4GNIA,BQQ,BC.\?+3 0-C^I=@F0BNAX^8:==VR5%Y
MWHU@K>,[S*/L)X&_ 74KJ](]@R(7[ST_B?_+K.+01# ^IFFPIEZ=-U\8/+NF
M66@IQ^)Y-]0>*:Q 4UYF4+3BO>6GTA ,*D]-!./#\%6;LE>C< AL@4<C&;%D
M!;9R?/[EPG&MGO_.BEZ3P.OI$NL[BHP-BNU/QVYM]+(>I=!$OM)YERTX%2UK
M:K,-B^AS)6.C"G$"E>>=M7A"D[BQ/#(-S _ B8<K(BA0?NZY)</P#9ORA *S
M)\AS^+^_:Z'U@?ZA,D#Z>PY@"\= 8K^E3.!WHGKE[S+O(X[B[8%O N(KPCC=
M)^3Z\ :WBP>^O 3IK]PR"USEE2(Q(VM("/\6OY,$]+&BAB@5$>";S0W]ID8)
MY",C$<7R;X8H1DDW^=MU_/Z[Y<'G=2CI/\KRD_0__MF"Y2KV$I\JY?2B+.GB
MZ9Q"D0;K3;:@.[L*VRUU^JXR2+7-O@!"=&*0983,D]?]VU+\UPM)=U1N!G<:
M93)'@-YW?5=(Z:!@2J:$N75,$&"\EGM@F6 /5BEZ&I 4D*;@O_+I+\'JP-U:
M;##]YX)^VZ-2@PTI#/,A]VB2GJ.B=_Q12R$%=2$IK=Y_'?= %M0(ZNL:-NK?
MA=ZZ)TDW%G$%7KX?>L%X$!6]2F.S^J$_B9(RCN5XLI5< ?H2@_&FW*05;.K)
M[L]ML0D25FSO<!NM(4K _C[+EW /VG/,E;QTGA3W*JU>)7O.9;*B*\#+8R@8
M!'U#<E&!:K6P\5*:,(3=?E'\Y]Z7+QDOZPX%&4D"+PP/,U8[@/CSY(5X*=6<
MW\+#0_ K"0^+N#GJA:P#D**BS/Q"#/ =]W0"QN D"](:;SZ>3LR7_:QT8HF8
MH3Z&2#XL#W8('G/<!]Q?I"[.^$)V<9(M8B;B#O_JMI=W:T,]TCH&!M01[$]C
M%$0/$5BL![%**7$^D,7G@GRU^<< ]SK;RD11.X !TH;HF_:>26%] -X]N(UI
MC%+!: ]@,'9N<I(7S [/JRLG-%'T.N/74Z7L 9BVQN@[1L56M*@\-14K;-*3
MPOD Y&MK"1^C#"-:_)Z&IGO8Y"=U"B>E\C;['K2L&%HDGXI]#^%\F-3!#$K]
M%MZ,,:H\H47RYZ#^J9[..*85&_?,& 5]SAG=1[E]QDC=;R%[P/#NFF^,+'W^
MQ7L*'X4C+V0X2Q(HV9]7><BQYRQ@&S;)''CT'Z4#C_['/UN[;IG-<G=<Q^"^
M_D8(D_\/$2+/=L5R,U[V(?GRT]7/7^A''F.?BL72&"3]V('W]!1'-MO2#7?+
M!,S.O<B340,M3$=_^.UYIB9:(DI+( )7/Y\"5\YR66Y(NDR"'<^BRG/4H,I8
MY+_NMULO.<Q7K\$Z8FINE.4EB2E>G^,P6 8D_>*.5ZZ\](TA-\]3RAEFF*7B
M+R7G+'))D[47Y354KZL9TA3@Y\K6B_JJ7EB4QFKE2.7,8]BU!XD#.3EJ2H("
MRM$1C"JDQMDV<&3J#4J8M>SIDQ_K&$YE*N"^Q9CX9I$R_$QXKY9/Q@AOO22B
MQY>*[7?P-N5P9^RJN:,NOJ(>CX,!=!U(]4YK8)_$Y<NKGT'^/F5)L.XGNWTY
M %"$X1H:'M-S9M5<]VE&64K2<1E-9SN[FQT;[+JJQM-QW%S+PZQ7GS=%U"3N
M]4.PA+HN5-:XAFH.;W&2GV-IFOED%_U\]0V%S<7@",OS5C&"8U;"P1,&%^>/
M0NX8S .9':-$,O%OH1@7U#2)_$J1F/3W)V4=BOLAVV=%RY+?>)N9 ]]G [QJ
M;['5?+=WM\?YE*6)K- T@?O(2^%1%$AZ]T*Q>-%B]I%X,)S]_>OG>ML+&$JH
MNYYL[11GXGKQ!-U'="M[PT?:=C:.A]GDT*H2NC%N)G"G\\IU4"'_CD!%W,#_
M9.)X!0*A;T'[M(Y;VS5KZ">WC69#D=EP)HZ;:'@6E>I_9FB9P$7\%L?^CR ,
M(0B5+ARM(4Z#-[4^K9![](740-(I%?=;P]DK:[3-KL?6<A$<-[W7(=?:!UBB
M;@(LX,H+(2/K=4-(!G5.X^@36L>J0+R0$)0G<UG:<+*S^UYM[UC=:V637;?=
M:@D<=]WN2%7M,+OQ-8$KSGJGO[5;TW^F&UY"PSK"%U#DI,%Z%S,7)H-3=.CI
MN/E'+NJ,(QCO^ZJZ[RXF<>RJ./C&,(12:X%Q++8GX7)C3&83AQ34E-OL/ID,
MD1L:.\)7ZH/<R00M;$._5G/QWWP^CELM/YS:JV^.D0D\^= *[0^?Z_[!EHU5
M=<5@=R]R;3^=+ZUB-(Z[IC^(>G,H!=23>/%XDI-P1('I,8C6)((@UD]F/--
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MIYODF=Y]E%:ISR (?<A^( \ZA#D(R'.D=Y"NXZ&HJ_#P7J09.7,*II7L_&'
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M ;?Y0<F[^@=(WQ.SI W1Y_6N'47JXZ^Y3'\$>1$M.2J>?Y=-5PSKD8I2O78
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MI[;Z,N%/#(3SZ;8:FDDAI=BSC',P=P-"NF]Z&RRY1]X-="=78:7K<[;?,JP
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M,Q,R/>5MAY@)3;5/F$C!E,;Z;PU* EW2C8#KHG\A'#%0Q"N.TE7;PE0\P/8
MD/H)QXM:$GAP([&3N6^OA>3O;V*H>36?R%HOZ_LD@H(+>5I\'?4=>WH*W/Y)
M)[2>]<Z0D>&S=:M,&D[?816JB( _O2)#Z*MLQBAV2&YGB!A+.4Z8AO-I>^1*
M7.Q.:BK-"I9C)[377N^Z/E.-A12E*"$1 +6+&I"17]BDDJ+<(QA6K_-J!XEX
M!W6'*F<,=C]X>BH2; B9@LER#KZ#Y-GU4NUD#[&/<G) <.#G8U#^\&N8[_LF
M5MS$1X]E""-?:Z":70.U.\=[SP<".]5JKOT".0>L8MXX&!<)M:MA#!D;2"[
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MA7XM(9[S_'$%L!$[&[(X8[(Y$4_9X'V9FL!.; SM2976+%!K%J@U"]2:!<K
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MKFDPY();>:K,EQ!C44&M_3Q-#_&3%R=1^ ',"6%=B+L]V;V/7#8+Z[M';&Y
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MU'D!?K*+D2'M(8!7?+@-O8N=J#KQ03?M%/RM." U-P!;LM;+(/,Y9J#]Z#Q
M/A2F52)$8AH$0F-]!H*6U72SY=Q61B<3C3OM*=]].X(X XPX:DF#2KXXOQRW
M*1SX'A]IV?IU(9N #S">-M9"EEX]800@1=EN,RC)H/E+ 0(_\D)@*7<1$TH\
M=339.>N(TT!?]HD/4H2 W"G#+6AC,<N?.)B^F[,65LCS?@%9&!1>5)=BP5^E
M@J,L::^',;\3!UO(XFE1SS)&U._S:6#DKDD^Q"/>4GMU1<3>*&W'<^0K9K>T
M+?UET(D()\:+XJ5&!>D5SU9"XXZVQSTI6DTZK&?*AF8$7@AM)2*NU\1.D2Y1
MMF8[<B.=<[K5^KC>0ZT^L\P'U#9@ER=+JS'A\4ZAW7^V,R^^A^+S%<CW>&L]
M10G[Q9P![+TH6XV4\.OT&26>9V)GH2-(%1PHV\K$)CUF=RIOD10EVY$;\S:.
M([Y9GIP=2=;%H;4SV83M24F$1-W^0[T3F1^FGFR6HX *$)=]&(6LP+:GU> Z
MH%/]-YS(?C#V( _<1YQ B]/D3<UU(S7NWO)#V4^G9'?.@JF7JA2'(2>0%KAW
M"?9W%9D*7#C,G<1"=N=YF'2U3G((<P)>[N=GW'.CBAP.#AS?#GG9F6!$FH8K
MZM!G.TD*W+D8ZJW1^9NMZ*@ZL.V,-5+!,^[ *D 0G_CG[RN,8LRQQNT?;B9,
M>BT.!R\]01T"GY]ZLVV]:?3?EZJ\2G\Y[\$BJHI?.#WEN/%E'V$.,&_B"J0#
M$M)J7'Z;?TK$ZH_M7V>=UF?O6W@H#L2)=7\WT1-_P/_X7>X?]:>.(,^.6))0
MJ*O&<&OJ,RYG<C'144Q=KD"2L3$C20YR^^REOP-4@:;VC2:G9B"TU!Z4O=1\
M!BQN#>F"RJT[OTNFBB$E=O>^KJ4V)!*^CFOV.'[H&>[.W#O!-8[BM;20A+I3
MXT_)O01:=V-RC933&2A>Q N J_/,IYNO$/NDH?0>F@D+'#FREH,U89EB QHH
M4G,2\82!9CZ4PQKVW-WT'C;.B7.,HN40<4Z?W-F8FPEG$.2\E[!=S;"-BANV
MS@&-%\N1K4[?!&M4@T#/(N1$G(6(>8GOE0)3(L=."+'FULYI<B6,=:3%J_M<
M,\**Y#BNK!!AJD7+ZJ.I("Z*?9W:3HWC1(O1/,+6"!Z6$-(U=#H1JB,JA(@8
M99T <.)%(9@SR&XLI[$Y/E*V/?A)RH'F,_4[$=0C!4_J<X,3,15CE5W>1PTE
M3NVFE+Y6>ED3S=-..'+/P2Y9"-OM>:N0@;* M=L75[[]D,D+Y#KI.L%>RU>;
M&KZ?5GJ<R$K;:/Y@MP%-(=_LH&BW2BE+[L0_6388RE6!L'Q16_#"M1=YL0]>
M]P#D*!U:$L/QLXNJ_A!_P'](TI,Y99Z%GJ:;V?-Z:M)Z:'QAKR?UXGW]#*_O
M-/0B1+,H?"0#Z0<@^SHS.^I?U*])^OOY8A!:%:6G_F4AWI3!8X3XB=BR*#WU
M+VOHIX)M8L;]P''^N]<"^YPY\;PW%C?:47;"QCT6.!JS<,(0.Q:XMK KU\:Z
M!#GM*@C":GD/\39)#^4'ERVIW10IHA5:B"B^K;:K\064)I5GE&6DG6O_^M3^
MA1*1)C# 6E3>P:+R[;-?4\2%,60,A8:SLQ&GAQK$B&FXEI+FY:H#:PB)I3[J
MCU\^SP47L$5H))D2_M<+X=5/WO/.[[++07IA6J8%N@K^561Y6=.E98>YAV)3
ME929%&,C-H#DV7>S6^"G<I-D4,!M3.BOR44F;"]CY$B2UX-)0WY;BY&HR$4(
M!4]BL!-W7\-$<)P(UA:^100>6WTWUVI6XI4GA,08K+;7I4S; 2.+1FM9$R+S
M&D@Z6$+J.F?9"<VTLD)=$<AJH,8K\J1;T166SA09F%E8K8M"X&-(8R1]MPSH
M+"$4AZ_MWM\<-#56_W+KD8&,'[^^-Y]CMV&/#A?GD$V^!^F5[Z<%:%?=6N0#
MA,E&5I*MI4(>TF4Y_&<O+K;POT4:QKMF.TY8TPI71T6SA2V1DG(5!XT3(-=<
M:=W4S!0RR"WD!.5!;NIX4V:(;:[-B+HYEHP*[B> PO\9JOI6?87'L%0&RE@L
M2+JA%STG59FW.W02,^0;]P@E#P+!2QO>4(!&+5O?8FH2?$E.7H0X,'T5I-:2
MCU%S;U;?.6W>HW!7<G_\[/CZJ#GJC_"PQAFX!P"53S\#0SGMI![ZZ!G=Q:U+
MF$3!_6:Z:;9=K3,..%?!U]<,H5/<["ERN3MAF)D((57B<$*KG@8@7A!R0F,<
M_V8A3P"SO7:@*HS5A T;6$EV/(!$N=&)Z."17)$MUSH1^3OM3B%*W$X$]TY@
M>0,!>;X*.XL$C%/-4!+#NP07\IXU]S&)=W#W#ZLY=W9S+O%>>1IG,GF:;C51
M966#4_/56B)'?<%<F,8N7C:-(G,$_!P<N7Q6? EW>Q1J3;'?,WH88R]C8TWN
ML-0[DI_MK&:F,8KH.#9GNV>,0IA7JQ3MI+.8MQ.IZN2I7ABRFR%!G3;UX35/
M_-_?X;D+D/( .58Y]H]__N''9X@H5*KNLN-QD;H"FC^SAEZOD62YZN[?!:29
M!TB8,4H1BSZ&D"5'(-$[:).J7O<>4C1[1-+*>'M]NC1Y]DYEGK>O7@KU<WJ
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M@M^1M/*ME$]I XX2 XQ=/;F]N7LO0M\-H[T-/\( Q,%<YPK[W>5!.C83FUR
M1\YBX0;7@15+BE55Q QD=?$(DAWH_$K1M]18C0;!^(/ H!A@W("DG]!J@)75
M,&@P/"MC='B#E1O;M];(D8;E6B/'O!NJ9[9:LT,K9LF*3&]N[)L*7HRU\*F
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MZWJT6@V%H)9#*>]A7>KIZ:K-P'W7"5*2*L%WW(R=@$]0<J=[,SN!V)KL7*I
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M1[=Q5T'^Q;5;\9BCBQM&L]3;G2_B)IMM(YI0!5]J1WW%@&HM;_,>A;N*K K
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M3^D2W(82P'MI>MHFZ5<O#4@63)$1]!OLEOV$1B>F.)C,/J@CF4"DK7D]Q!^
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M/Q-8GO]$Z(GT'/4PXE'#:LJ2XX31$_1[RH"M+(];\J(^1#GAORGA5J ]AZG
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M"T=%B$0X7"E4P/%WTXB$X'^Q\+4+D0*G'X<*2/YA.CF<'3\6OGHN@F!ZF:@
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MP!2U"''0X21KBYW82C! B0#?M]^8G&E"P^F7;A*R"5]I#(%GHQP"3M:%WMH
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MA)DL-,OSR/ND'<FRT)4K931B 34F(ZB4]9"=*A>:#EO'[55&+IF,EW(2:CT
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M1"=-_Y#$V9TTEE8\B^74NK/#=M*+]4$A  5Q)RF-6^"::0/O5Q#N]O NN_H
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M>"G(F !BVH93@<[(;(QR:EKXF^/91*<R9XE(/$<1@EBU<":RQ[/C7APA9 R
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MUP)4%M.2UQA!=2EO5BT)=(P@O(#''3LCCQ'$%O#.$64.,N*:MX"'#C-ID1'
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M()MT)?0;<D1/>^DY#I&FU]W9NXKWD'(4*_F'UEF+*OOP<102G5H2^M[IO+U
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MMOW[Z,X+RA@/DHZLEM!IQVC,,.Z&L:LZF-(+9$BZ;KH;D25VWVP#P_:7!(V
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M8\H)@78<+:,"*C= &S)PQL53NNG3\3K%YD]>&8[F.$PS'+E^0#)DQ(R?-5H
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MFWMAL L:IZ[HC0T.LZVU,Z:6_)5ZQ)2&L.CF$^9%@L87Y.^CX)\YXEP"C,:
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M% ]9>@<SR/VHB!R]O2'D6,E:V- Q>AC:=;R;G=/0&CM7R#!-9?/R_0UM5EG
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ML)YS8DV2L2;) ) D TPX>E]289]U1LLUY<2:<L*9'&@7$;8[^;Z7R( U?C"
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MWOW=O32UM)W;O)=-I,D7?W#>]<5O/>[Z=GY?!D?L"1\_QR$>+<2<8"[6R)_
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MO&E=6E%SO.HF/ASBB,*HH$,BQZAN#\<P/B%4R(N=EU6?9T&G=\BS2L=JJEM
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MN%W+PZ B;+F*ALR3[9R:KO#(.OOX456XX'6X&J0N$KE1;)&^ER-OA[@*C*0
MHA;X^@&\EE'S"UY\LRX5DN+DX*Y#:>-G+PF("JQQ4XTRO&G*K7.&!7IR@VD;
MI=!7EUMD2Y I_IP&G9?+AV5JN\IR=:2?%VSOXN1ECUK4;W8/WM])^:%'_*P[
M>#[*LP 31IYV7G0J'(W:V)W!6O@K5SZ?P@?PV04FWS@](TYQ'9][=S6$'UQ]
MS4G[7\AE%?D /C_!-!SJL $?#T&/Z__1U9MV],&X\DOMSQ/R4?!.[MPS& NU
M-K'!^%C&D%:VRD<O(5W[A;]_=%5]/AJ6VC+7L5HO_#(=HO"8H",61P8LX^+N
MTB:C?B\GWT_+U'2(>2=^TG48YT^.NG1, 2+)6_Z=: B)HV^UJ9!T"@G56#CZ
M:)MP?Y2O^&I3="J?@:P'I0[ ,&&([ !K?-*(E>#8+.16@C: O940Q*#05X??
M"=J*<30^<BM&&P# BC'C902+QNIG+Q+0BN]L/W!PWDE8K\^CEE]+U$MS@@_I
MF)7.9)6ZPCG :@E7I+MK7A(=40W#U=(PJO6%Y(4O<)>0T]$Z4>I.\UQ2E8>S
M#H# *U[N;%+[:CZ84YW7AX=RXHAPEH[JH2ZW<K2N:SXX\8TMZP_.OK@E1["8
M9Y#IXTU=!W9[<TL@X7[-70!Q?WLY+%6N'VB7B[Q#M,21YG0WM[-&^BYS=]NX
M,6UJK^0]E%GJ+>D10)#9=SL64M7K (P("1%=V$_S$5/P[AV>)?G.FF<MYX4[
MG+!4/T-,3,E/ELVW5(99,[O.(.PK,V'Y 33OQ!%^I\-]J#Z(5?TNTYV4J8QE
M]="\&/I\/8=KI&WL-=NU5IXHY:')8HHRG==DZWI3-%/<)JF$L-L#VFXTOT?)
MS4;I"H@PO@^C)(G<00 1V_%,E*2MW0<0*7WW0DEJ>MT $31P$Y3=>[U^@$@:
M./PI<HRZ'RR26*Y[\L0Q1H!'9L<=3XV^=E= A-%\ZZ09X: KK,3+1)4:QFF>
MH*8 UR-J;)6!7VA;PQS?4+?']"/*O""$DH)9LD9=-7V:&Z5RN3Q'4LG^4DP.
M;:_>L;3^AK[DAU<LNN\J)(K%33=YEF9>M&U58&E#PQABT-<M8+3LFOI,;Z*6
MPIX\]<X%!QS)_:EAGQ0LC[QVBT<] ;'HU4U!7^*4%OH  A0EZ]X*50G5V9!7
MJ>VNDH1XU'4#^!6#'VQ4@E0X7*/+C];C.$#R(NJMCCP$/7)51X%&+NL.5"&6
M,8;UBF:<.XTA\8KZV97CI]Q,;!%_PJBPX1#</N,1X0\,]4E4J4>>D!^_184]
MX]G?HVU.+%!X@W=*XH88ECBI))*&-D OI@FE@+LI4QK7Y7H8XI;3]MAQIY#)
M1$S*JIL)OK5'#'2-=G&"N'[A8Z7CN?P#+[*VM-0!8!A[Q3UU%Y UN3F'=F"3
MGX-Z2;0KEA5N"$$1T-$R@J?/A!4EI\:3T0OO(TSPH:+T98]EPW?B>?6$TF.0
MD-4]52;RA] '=(<,XUD[N5^ZI6*=JG!&G?N0Q%$\SQ$(!(LK*"+LB!Y'<IV;
M9A5]#E5)HB]CP9Z?*E_$SLD$GXZ)OR_Y"5$54V*L60'^M\1!Z?NB4%JN0JD=
M_R%#)=XM;;TS\^5OO*:=9NFYRR^'XF[G=ZNNBR)G='Y;ET7K1B%3:6GP<MQO
M,57!+D#;TDNQ]B[%75L>!OBW_$ "U,!(U]=Y&D28EV#1_Q4_%$CK(5%>$]G(
M)8OBA=&^-75^JG8FP@R0EHH)NMBK$XJN2ZTIP"LGP;(EMY;9)6'?<LLQ!3R[
M3O/BT9V1GU3;N_4#*QLB],>FXZSE['SMCI^&8QR%=F&"US"XMZV;1!_.5(1U
ME'>3D)0!^R[>F6-5,DXCS][=G^)X^RT(PXN$A;$ABS>USN\4&X^3)19ZDECW
M&&WK+=@3EB\):ZO",BMC-O0:O68WNW[>4BL?'TBDQQ,!=K/[FKI6&=E%MEYQ
M]$>4I'$4H; *H1R8ZOYT0=A;>!YVPR)Q^_*Z[>[_=0V,KD%7M(9>9-E!L,M\
MR*T,R,[4XG4/;'&51NCE?]W#_#[:HET089(>@G?RUW[*34H!U15ZS;J2/M8@
MP[L,2XH]0[6IKRT"/I;%U3B2C \O E1N.B0#'UH$:!*F:.-XBN>P"*C9:2=T
M?V41<$E8D>?:F9PY+ EJBM%XWK/?_O0B@&V9+8TC>?[6(J#C&2+-,U'VQ^UY
MB38&1[IC:/VS9A?:6<QY0\_<.3Z[B'-",=C-^8I8H"S,,\59D#ATY<6;XWP+
M3&J&CSG_ZX!Q$]K#S (G^OR2#K>,Y6M>H9<[E^5!/Y<(1_GH,L"D&+3,@SG\
MZ"+ 5*W$,,^W%P&MT"XUPX.8/X-%P#RT0<WX.!X""2KZL*PF0F@8EDC$_]K4
MC/R,Y<6\3(%USMZWBY/4:RNA <49-I,D54F],E_;>:)5%A:2HR;-2%HZJB%4
M,(;OYX>\$ .+E##G,D@D +7,]L)(C0$SY,$F9"1>=P@9='N\"<3:IZD]&NR\
MJ&.1Z-=$5!T&*L&RO&$,"I)C.P=-CP=HA:8[-AAHV(==BGIF]R6)&^?L!VS!
MHVJ_O<J:(3;1U1/Y/:D2SQ+AY$<(D@E9JOLHS9*<D-?,=^!-WJZ4FK]BYD^$
MTK+8<-/IC*P[$=MCZ"\JQ0HIARXN2%!>-^UE&N:2#5(@$- ZJ%E&;ZV[/*#J
MD1HJE56',$B!X%#PY\[O;"_QJ,R^IVXAF9Y0K\5>&E!29?)\ZU%^!/3.9N1[
M9:058+0NA#5G+C M)+=$56I::=4$"5;S K/=]C@=H!%1;4(5,LHNT AA;BT5
MTEB#0&6AM6\/?D7TM=A-9F(&39VT:KV^%:?]"0*K[<^MV'U-BL:^[U,C1_>[
M==/XOR6H>&:YQ8+OV#8+P>YGPE(Z51<VIVWN<\9Q!*(^?9CE<O>*ZBYS%(:1
MAX842(U]1!*_IPA_GYAZ/Z)W%,;'X>F!_@XU<'H$^"A(.R 1&WN8QB#M2H8L
M32>KSW>[1PEZ"BL#1XE^/XNV"T@ED-H6&9;=DNFL6<&B)"T-52PJW:TMR_A-
MVUNB$0,97BYI*4Z\=+)#@3E=O$M)<+:H70TOE9Q()5XGJ7'LTC)A%XX<>>9C
M)KU8](Y6>/B$15$;$*K*Y-H+23VFYSU"&:G$%$==<VL3+0=(W=S,B:%M;7[_
M)4Y^:\Y.4:B3'*#DW2%#J32M3]ZWSWC7)8$7,DB%_[Z2))5('"G>H.228M *
M5!(>$CBXDUM-[$^4=X#X\^?TM$\6YZSPJ6)WM$\4[U3PJ>+T=/7:8H2R KK$
MAI.K0YIXV26K7K61YK,7Y3O\WYPX.-7]3LY<;M,PP/\:X"GC+K58/$0 ^ITW
M"0%2/0USUX*:9WQ> ]^AE,_*E-<=N^&KS9)7<6S.Y*,=37_5\2D^>2%ITR<<
M>B+2<5N^R2=3D'W:O(;!6_&E/OG04X-..O$/^(A'*2(N0(3MU5O F52=XP_]
MH,VX1)DS>7BKD-EW[Y;JJUE9(BE6#)4B<AT-S98K +#GRNMF9J;TBYHY0VIS
M^T4J&?<M=1<+.MD^F</+DW<6!ZTU[Q+QW3;<*L(^9G8R\P)B;F96#[L59,5\
MF,=RW7L*UZ$V,-_"?:S/D=/R<N"7H2@(_?DK1[: I;8[.?+H55AN(EA@DO%/
MA1]_D:PH'3[S0:I[Q60*6$ZKPUPWSI=QE\Z7Z?>.*3E%C+JPG_[P'>Z>'N(N
MZ 'U9BKB49M[B/P-DB=U-]SLQDN2$RER?R!)Y"C73KOQ(W[>^,$1OR&JUHY<
M.(2*6A+ PMCS/DXR\N<RVTEAL<[IEP\?K LC_VODU4D(R&8GG1X3= CR0^&7
M@9NF:4YD,A)#D1;&/M !/3(G@1NKV>NB_;+BGCW:-<7K8!5F^>U' 5RB,Y ]
M-.*$2&PS]5$AWXSD_S][&;RL2;(78]V>;,L7O!6[!#VAHW<J<C=L=LT1O(_^
M&WG)79PGSCQ6C*+Q!>^IEV\H?$>?L8BW/ZNUH1?)-;Y'7C!?0LX8,\W#\2T>
M:]F\+!EB,B$CN1F5PG%CN4'ZD'5-AV PIAM0M/B5GFU0#N80\80[:2(=#P55
M:L.R]B%H\E0U2AD?4]3*U-&HX#<[HE$J ND!27>%EHO,2:QC+ELY\KCGTO6S
MEQ196X=D@=0<#VCIGZKF=R#:5LY<*0VM39JR#:AS'K9SFB7=Y9CQHL]!%!SR
M0T'38\5^(>EC'U":(L30QC<3IF=*D^U;R%C!.W*(J\T$BDM/\KE Z;Y!H3_)
M9T.E]12%_BZ? Q.F#@?D.UT5D8'D(=D=/('GJV 2H<TP;A#,T56H#N,$P=QG
MN?(X;I#,?HPKC@*>7%D=U-CAH$K]]Q%N1I*8H[3Y8U47"Y"FH?86ND/X.O3"
MY\S+4)'U&\_D/.%K%*%=P+"Z=P;HD]KT=$26KSRDF&0, :AZ5/2[2[DZR:ZO
MM;:]W^DI0@7ZPVWT"1#AYPC]"H0K;J!Q ,QE&AQQ%@:V0I4QH) J6&\^C:S.
M]C(-2YW>?F9A?B?;Q+"O5AXUS%X6LT"H+ JXU5"[[;BG1VH(V]MN% ^4Z^O
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MV>$AM;U-8V>1)(E^92![?$X]$^9S"\Z._T\3F6%970CM._Z.9231@(EVR:#
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M?EC*RZ[OU7A(<LL:)=76Z#X3BNK62 %O(C5B DF$01D':OCWTYYE!Q9P^/$
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MV+^BS8*(#=NPC_Y!"'CFWS"H=[S055O4B(? '=)4E:G1<+O=2/=<R6DT^D!
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M.LJ*F'S"#E1-R<!^P5YMG"^)E: %XF>_-N4R!C9>4O5>7F'G;3Z!I6Y/7_&
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M=O2)&"*ZK>8<GJ0]'AL2U\<DD8/Y'1 KF>E&JF203-MXF+M()ULU6$D#^\*
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M?X^-S0](N)"ULV]#/,TK$4_)9(WR0J(.0?03SRJKKW"*]#.7:H53)AX=8&:
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MZ12.W.GX'D2-Y;@4X7=^=8!CV&J?1>:]=?JA[]UU5MQ+& I;=>)N8-I$\)S
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M O[DX0=%SV4L5<'H]"58;HH[I%?49$*SX S\-H+\39.INN]S\JCY+]#$V,N
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MB7/ )@B%;[->5Z9MR7>2Z7U#Z 8349:N1\U@Q7O#83 M3:M.,%E;.#I6=O,
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M$>*/V&-U"/6]/R:6AL-DH_Z8,4HY+(KM%E+0IP;J27%Y3\=$)$"]+V 7$R;
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MY CLI)*<>!N'Y958!6"L$<)Y.PO!_V(@0?0GUH=T)Y4>\7H/7N/=>-V;D.[
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M :&_$77GBM1_*DOOM!HU?=4NJ/1X=^J>NU.K&U2YV8@20DFA4#G'3;U;NUZ
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MRJ>M!RT '&<F"?[LV;^.:;A^E;YJ]U;F#KGYW"RPL$:M/*OPMG9)53H?$#Y
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MU.W#^7\ 4$L! A0#%     @ ^85:6M:QM+\<LP$ 20\" !$
M ( !     &EM9S$R.#<V-S8T7S N:G!G4$L! A0#%     @ ^85:6IO^;91?
M9 8 DRX' !$              ( !2[,! &EM9S$R.#<V-S8T7S$N:G!G4$L!
M A0#%     @ ^85:6@X91/Z]2@$ [:,! !(              ( !V1<( &EM
M9S$R.#<V-S8T7S$P+FIP9U!+ 0(4 Q0    ( /F%6EI8.BB&9BL! *5^ 0 2
M              "  <9B"0!I;6<Q,C@W-C<V-%\Q,2YJ<&=02P$"% ,4
M" #YA5I::7),%D+R @#@Z@0 $@              @ %<C@H :6UG,3(X-S8W
M-C1?,3(N:G!G4$L! A0#%     @ ^85:6JYN;SFD) , %=@# !(
M     ( !SH - &EM9S$R.#<V-S8T7S$S+FIP9U!+ 0(4 Q0    ( /F%6EIP
M>S_NXDP" ,J\ @ 2              "  :*E$ !I;6<Q,C@W-C<V-%\Q-"YJ
M<&=02P$"% ,4    " #YA5I:O\K'QM61 0 \R@$ $@              @ &T
M\A( :6UG,3(X-S8W-C1?,34N:G!G4$L! A0#%     @ ^85:6I*@NVQ$0P$
M.7L! !(              ( !N804 &EM9S$R.#<V-S8T7S$V+FIP9U!+ 0(4
M Q0    ( /F%6EH8"TH2O"T" 'N_ @ 2              "  2W(%0!I;6<Q
M,C@W-C<V-%\Q-RYJ<&=02P$"% ,4    " #YA5I:%'7Y0"75 0!)LP( $@
M            @ $9]A< :6UG,3(X-S8W-C1?,3@N:G!G4$L! A0#%     @
M^85:6H@2I2K;B ( O1T# !(              ( !;LL9 &EM9S$R.#<V-S8T
M7S$Y+FIP9U!+ 0(4 Q0    ( /F%6EK"5JQED@0" +O< @ 1
M  "  7E4' !I;6<Q,C@W-C<V-%\R+FIP9U!+ 0(4 Q0    ( /F%6EI!I>OO
M0>\" #:4 P 2              "  3I9'@!I;6<Q,C@W-C<V-%\R,"YJ<&=0
M2P$"% ,4    " #YA5I:>=HK.A[5 0#A?0( $@              @ &K2"$
M:6UG,3(X-S8W-C1?,C$N:G!G4$L! A0#%     @ ^85:6B49@_DEAP( LR\#
M !(              ( !^1TC &EM9S$R.#<V-S8T7S(R+FIP9U!+ 0(4 Q0
M   ( /F%6EIS#!EE$>$& $U7"  2              "  4ZE)0!I;6<Q,C@W
M-C<V-%\R,RYJ<&=02P$"% ,4    " #YA5I:%B89<03&   9Y0  $0
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M-S8W-C1?-RYJ<&=02P$"% ,4    " #YA5I:_MY:S,E8 @" =@, $0
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M>#$Y+FAT;5!+ 0(4 Q0    ( /F%6EH?6[5CK@4  -F,   /
M  "  4V(3P!I;G9A+65X,C%?,2YH=&U02P$"% ,4    " #YA5I:EU*&N%(#
M  #W#P  #P              @ $HCD\ :6YV82UE>#(S7S$N:'1M4$L! A0#
M%     @ ^85:6A\4O[:("   B3H   \              ( !IY%/ &EN=F$M
M97@S,5\Q+FAT;5!+ 0(4 Q0    ( /F%6EIV<'-)A0@  &<W   /
M      "  5R:3P!I;G9A+65X,S%?,BYH=&U02P$"% ,4    " #YA5I:\.BO
MFA &   _/P  #0              @ $.HT\ :6YV82UE>#,R+FAT;5!+!08
1    (  @ -X'  !)J4\    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>inva-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:inva="http://www.inva.com/20241231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="inva-20241231.xsd" xlink:type="simple"/>
    <context id="C_800010f4-85ba-4487-a1fc-d185935fa9c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="C_80258deb-f35d-49b9-b662-4823ba3839e5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_803eb231-cd56-4e30-91d1-f2707f4586a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1AndD2PreferredStockAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_804ca930-b7b7-4a49-a722-aff90380ae53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8072618f-1ec5-41e4-b16b-b78997fa817e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_80aa6909-465c-42c3-b0b3-1b95cbf1839b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_811f0ab4-b358-4bcc-bc70-9137747403ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_83aa808a-93a1-4297-9265-8d2fb9dc5612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_83b93379-94aa-47ed-9eb3-7b3158980925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_849927e1-65a2-4ab7-97b5-483466c4b437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8510eaea-441e-49f3-858f-a2231a38d968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_851eb81a-bcba-4dbf-a1ff-f67a190bf355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_852cf337-96b0-47de-a072-c0011a29adb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_85da56fa-4ced-4862-83dc-c5baf8401a9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_85db9a42-0ded-4419-91f0-f3010d32ac6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_860a55ea-1154-443a-bb84-a8d6f8251458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_864b213f-0400-4fcb-9947-13500166620f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8696ff04-631e-45ca-b986-6584fe4c098f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_86e15322-fb47-47c5-a35a-fe238e9cb430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_86f5407c-66be-4a09-853c-3167aaf240a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inva:TwoDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_871709ce-1c50-4f9d-87be-84392f7a9aa9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_87613bcc-e02f-4f93-9acc-604a9a71c964">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_887080f2-8412-4508-9e41-bc1a8e2ff95e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_88782d27-5661-485a-afcf-08cc5c051369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-18</startDate>
            <endDate>2022-02-18</endDate>
        </period>
    </context>
    <context id="C_88a8178e-d76e-4fb2-9885-5ee2c0565071">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_896fcd7e-679c-4d68-a83d-99ad390a46bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8a59da43-fe2d-4fbf-88c5-e84ffeb90fd0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8b039347-f1bb-483f-9cd7-5caeb7ce8c4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8c4fe90e-5515-4c29-8aa9-77a9d2df3e96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inva:OneDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8cd4e397-e9a3-4a8c-aecd-0a7615959c9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8d315a2b-2c71-4420-b013-dfe4ca2986c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCAndC2PreferredStockAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8d72d20d-c777-4e45-a1e5-dce95ab96806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8d7370e9-f555-49e2-8db3-20fdc743160e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8db4f7ae-2913-425a-931f-161ffa81bc43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-08-22</endDate>
        </period>
    </context>
    <context id="C_8dc1a082-9478-46f1-b22f-0fda99922d9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-18</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <context id="C_8e458ac2-46af-4572-9110-f35e62e6d593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-10</instant>
        </period>
    </context>
    <context id="C_8e904088-1404-41dd-83e8-637489e1cb2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:ManufacturingStageTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8f0463dc-8f74-4223-9dd0-680a9297636d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_8f319834-0192-44bb-82e6-228a046acebe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8fcd8c24-bab5-48ed-8f4b-d11e6d6b0426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8fce92ac-4906-42d1-b1ea-f1705723e3e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8fda4892-a74f-4650-8ab9-7f27921d46c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8fdb4c80-a5b2-4d18-b108-58f668bf4204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_90c8e4aa-f337-4f23-8ec8-33fc6f9d49fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:OutstandingStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9109116f-9efb-4c72-ab41-742cb8d808be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_912bc1dc-313a-4987-ba8e-17bf34333339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9192d724-db6b-429d-9b34-680a884d5432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_919b16a3-daf9-4bac-9da1-2cf406486d25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_919d35a4-18d4-429f-9131-8121ce8b768d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCAndC2PreferredStockAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9208f331-1b10-4449-9538-3f9a7a38627c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_92dff807-84fa-491b-9fee-1e85b08d8746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inva:AmortizationOfInventoryFairValueAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9335e429-20b3-46f5-9a0a-fb45ea5dce99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_935e1701-2c66-4fa4-a9ad-777be38cf9eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:BurlingameCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_93c2cd99-2331-4842-ae83-434ada9a8bca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_93e7294b-aac4-4d69-a3eb-67d0b9c5c363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_94e5705b-e6d9-4f93-b4fa-02e92457a43c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="C_94e7195f-0034-4d0a-b5fd-de56d9a2582b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-02</instant>
        </period>
    </context>
    <context id="C_954ad86b-4beb-4124-8fb8-95cf9f5505b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_955c4f2a-4a9d-417f-aead-26c430c09653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_95699a2d-0510-488b-b64d-b4503781f140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_97c0d4eb-5564-4c2c-b25d-1d764e044c4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_97ef981d-8088-4d68-9ed4-8e0a49d39c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="C_9834684e-a81e-427b-ab67-3dce5473dd17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_985e040f-be7e-4757-85fe-32dfd0c9e971">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_98ece23a-e085-4630-b652-b0ddb682aa35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_999d353c-dc71-4460-9947-95616ca7ef74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_99e72674-f063-419d-aa0e-2560370d3aef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9a129dd3-6622-4125-9532-5a2fc9756798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9a12f957-a828-4d75-944d-2087cd6938c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:AstrazenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:DurlobactamMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9a1b43b7-95ef-4fe1-bb0d-965f09120bf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9a81efa3-20d3-453d-9d0c-f293d720f3f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9b00860e-a4ec-4be9-820d-8a3d8ea443a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9b0d84ea-e834-4ea8-a1b5-32f0bbdd41f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9b5e3f73-d7e2-4436-a4cc-ebaba20abb28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9bb96ed1-a18c-4f9a-b018-bbafef5054c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inva:AmortizationOfInventoryFairValueAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9bf67da7-5977-473a-b529-91f7f67d1f91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9c9d544f-ec3a-45ad-bcd1-76045e398e61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9ccb7bd1-8f8b-4f56-a509-6035ce670328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9cf98973-fc0b-429b-8808-7b5d88eb9637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9d2ea10f-79df-4fc6-88b1-7ed97a1f15da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9d4df672-9227-4655-9953-e51c14163b1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9d4ff33d-434e-42c0-bb77-930403d92261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9d98152e-282a-43bb-9c70-92c8e03419ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="C_9dc62cdf-a86b-443a-a322-c99a58facc5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1AndD2PreferredStockAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9e00bead-30e7-4af5-8f97-cb13619d5c04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9e7d8d10-3492-4cee-a89a-3fb97bcda1d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9ecfe93e-28e2-4228-ab4a-d3d1c23258a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9f3c3b1f-09d6-4eb0-b566-b7a7e7c47ec8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:AstrazenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ZoliflodacinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9f5b3843-bdf0-4930-818a-6eed731e4cdf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9f830636-16c6-4d83-af5b-754f4ce28030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9f8444a3-22dd-4d19-a7e5-92b3a3636dd4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_a0571dc0-aebf-4847-a254-63bbaa92f9ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a084decd-4deb-4a08-b247-259a786424c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a0ab4d8b-b98c-4423-b309-fa00f676612e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:BasileaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a16a85fb-8e15-45a7-9fef-73333497db42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a20abb89-800f-48d0-982d-8e767439c06e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-05</startDate>
            <endDate>2024-08-05</endDate>
        </period>
    </context>
    <context id="C_a275ece4-9863-4cde-b812-6441e2e5af07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-01-01</startDate>
            <endDate>2013-01-31</endDate>
        </period>
    </context>
    <context id="C_a2ca99e3-4ee8-4e98-ac8e-a7fbab801fde">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a34b6268-debd-4832-a5a5-28a87b2d6119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="C_a37e3f84-6d29-4645-b6f7-b74dfd018d2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a3b40d28-d1d7-4f75-ba62-ba963f654190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a41714b7-a00f-481f-be71-d01b3d66ce35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:SulbactamDurlobactamMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a44e01be-348f-4efc-abce-4d6942d68c4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a4df3b3b-267d-4f2f-ac89-6815c2bbcdeb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a6430d44-f5e0-43dc-9348-dfafe12496e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:EquityIncentivePlansAndESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a6a8f2c7-57be-445e-a3e7-ce078fc2faae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a7597c02-e3bb-46d9-8544-84ccf95becce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a766e556-6ab5-4064-b9f0-b96a29676eab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a8b3a821-9b16-4dc5-8726-097101dcbe6d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-10</instant>
        </period>
    </context>
    <context id="C_a8d47eea-b422-4342-9936-7be08f04740f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a96db169-3904-4b64-b638-57e99ca42a24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a995b915-50f7-4ebc-b58c-879c3902fff1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-17</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_aa1f7e7b-d2fa-443f-a718-e2d0bbe01a01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="C_aaecb0e5-05bb-4c5d-b308-7ef6aad3d595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:InCardaConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-17</instant>
        </period>
    </context>
    <context id="C_ab15afc8-8530-4712-ba43-3f96b009cf85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ab2043e0-c7f2-40c3-bda1-f3a36db172fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_add68ec5-d86e-40f4-b034-6cf33cfd18b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_aea775ec-f212-4854-8a33-38c7dcf9a97c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_aeb0943d-6820-41d1-ba88-baf408a51c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_af51ee90-6870-494b-817f-7bb0769ffdb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_af5e6a83-99f4-4f15-91c5-d548183e4cf6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:InterimSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_af75fcbe-c945-4eb9-beb4-d5938e595d4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="C_af802179-d1c5-4daa-b0d2-91a25a398a6c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_af82f89f-5808-49b5-b750-ff7de7d3e2f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_afb144a7-7fa3-45b6-b331-2e2d09168a7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b094271e-5af4-45b7-8a67-ea05cb064571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b0cd00d0-91fb-42d9-9cb7-ff204ac9ab0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="C_b17c7bb3-be30-46ec-8c5d-326914913809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_b205310f-0e33-4476-bda5-719485b59ecd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_b48017cd-1262-4c03-854d-9e240761aace">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_b4acd677-0951-457f-af07-c89710826848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b5459326-64cc-447b-92d0-447df34b0037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_b581726d-66c2-491f-be47-b769ac4d4e1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b6038bb2-c129-42b0-94c7-bd3528eb4770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b71bcf3c-4c43-451d-b5f2-24c3afc122f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b79f1674-dd08-4798-a636-6908c319b900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b7b89463-f172-4eb5-8ce7-17774c741e4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b8f36bb1-01c9-4719-9547-cafc116ec017">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b951258b-c9f5-4734-98aa-3ed6338a2801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b98c6805-e143-4159-8b6d-0216ea55b874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:OneOfImaginabsCommonStockholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-18</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <context id="C_ba0408d0-4257-44bd-b0d4-4cae0cd8ad50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ba7b5502-0812-4272-8e9d-d2570169a140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_bacd63c0-e919-4307-9a75-797f35ce4073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bace799d-5f2c-4586-81a2-eeadbfadf867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_bb32bb34-0f53-47f4-9801-880f4c57c7c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_bb3e4de1-feb6-492e-8578-81257488368b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_bce3ec39-fa5f-485e-b142-ed955411c5d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bcf2c29d-8647-40dc-ba52-d9d8f93eb75a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bd235a25-25e3-4774-9cac-f96204385615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_bdc03984-0625-41b2-82ca-9caeb5314057">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bdd67f19-2199-47ba-9bf2-29f87af012ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_be611a96-acf7-4e91-8069-ab705ba23648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_be6fcc6f-ace4-45c6-be23-2f777937aa77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_bed4dd91-bb02-4b5d-a15b-d83a06470288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-18</instant>
        </period>
    </context>
    <context id="C_bf2aa827-497e-4734-b273-79d836b4d1eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_bf2ff2aa-7c34-4e4f-9e97-336a5c293d40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-30</startDate>
            <endDate>2022-03-30</endDate>
        </period>
    </context>
    <context id="C_c0508c79-209c-45e5-bf7c-169aef8d5660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c0fa79e7-715a-4fda-811d-c8538a6e2a44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c18cffa1-9de9-4afa-a1e1-ba138e813757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c277363b-a707-4b73-871a-b77a92df3c6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c2913a02-9488-4628-8d44-e7cd7ed404b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-13</instant>
        </period>
    </context>
    <context id="C_c2bdcfd8-c2f9-4e33-9a58-4dc78da2e693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_c3e70cef-b906-408c-8288-908907c15a65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-18</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <context id="C_c40ea3a9-5b51-4fd2-a6f2-387235c72fe8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCapPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-01-01</startDate>
            <endDate>2013-01-31</endDate>
        </period>
    </context>
    <context id="C_c45aa339-d7d0-43b8-affa-cc16b15eced2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c4c638bd-9d2d-49eb-acd3-78cadbac2bb9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="C_c5562d91-0351-4acd-8f6f-1aa83d60f185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c5d2b484-c130-40da-a3ce-df08236a2ace">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c5ef9de9-0775-487e-8f32-e176bb4802f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c61a6de1-f544-4ddd-95a2-ffc7bafdc548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c675336b-670a-4920-8b77-b1a4286084d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c72b6c37-ed89-431f-8860-4f3a0138f363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="C_c79de25e-95f2-4f26-905c-cca404ed5f11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c806d5a2-f390-4c9d-b3ed-a166cdaae201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c82dd715-d624-49e4-bfe0-b1715409db9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c9475aee-0427-4f76-b24b-da8950b70256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ca06b77f-bf5f-4b7f-be32-bdeda8df9e1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ca7032d1-65b7-44f3-9dff-4c953aea281c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ca91671c-9ec7-444f-b685-f851204f4fc9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cac6555f-df17-464f-8fa8-e1233df59df0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_caf4275d-107c-4a04-8eba-47895b8c9c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cb1c40b3-5c1e-420b-883d-1af63b9dae15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cbc4cdee-389a-4cf9-b9af-2f7d95792201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cc713bc3-dccb-47e9-8743-bf1aadadd990">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:GeorgeWashingtonUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_cca319a7-55be-4560-a134-be4a41bd17b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cd2bdc94-0cda-4896-afe6-51e360f119eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">inva:InnovivaCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-18</endDate>
        </period>
    </context>
    <context id="C_cf1f2f09-e0ed-462d-82c7-6c2daa899d5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cfb60dba-9194-465f-961c-11b864f3bdc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="C_d03f0f85-cb5e-446d-9bac-86efb022c8e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:AmendedZaiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d11819a9-3acf-4623-aa96-999f140f76e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d139597a-1533-4bc4-a253-55b573ea0881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d14644b6-e4c0-4ed0-9afe-f0820fb1bd31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d1e16fcd-b412-4137-9d48-7dd6c2506efe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:CordenPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">inva:CommitmentsFor2024ToBeUtilizedIn2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d22b266a-b99c-45a0-8ac0-e3851917bcf6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesC2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-14</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="C_d2d0990f-b4c3-4288-a88d-e7a8d66b2f3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-01-01</startDate>
            <endDate>2013-01-31</endDate>
        </period>
    </context>
    <context id="C_d2ecd1f3-29e6-42cb-af2b-fc69c9589381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d2fcd4b4-d9ae-4307-b911-8ce98ce50b0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="C_d326d4eb-5d26-4172-b306-2eb5433f4c8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d342f539-f5cc-4e65-bc94-3ed13f8a9001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d37f9324-54d5-4067-beb3-18876b2ba3f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:GeorgeWashingtonUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d43c551f-1182-4c6a-9fa0-92a42cfdbdb7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d45b1b16-d9f4-4bd5-a834-1cf791abc22d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d46b31e7-e4aa-47e0-b48d-3af9ff0a4041">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d4a55873-42fb-4f4d-8ae0-0c16e81de797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:InterimSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d4eaab11-5036-4fa2-80f4-ac4c6edacc5d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:AmendedZaiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d53b733f-8e9d-41ed-97c2-c18ed44c87fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="C_d5601efb-6bb1-44cc-bbcc-ebfffed538f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-30</instant>
        </period>
    </context>
    <context id="C_d607948e-3894-43eb-89fa-f4bc7aece440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d61477da-6a47-40a2-8405-d8b3177cc270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d7303d1d-5e66-4d3e-b842-3e3d5762046f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d8708151-111b-4172-ac2c-b7620b8c6f75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_d8729dff-3a5c-4dcc-af0c-979774e25169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-01-31</instant>
        </period>
    </context>
    <context id="C_d918b70f-a067-4ecc-8b5c-d40d7a0e5c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d9d9925a-2c03-40f4-86eb-cfacde988b24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_da53c27e-3311-413c-8e97-f6873c7e96fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ExternalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_da6eff04-3c1c-4959-abe9-fe3dfca5c630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_db5c50d8-61a0-48fb-b797-e64fdb1a2402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dc25f343-8bba-4e07-88b6-893e60ec0518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dc5d9fbc-dff8-4e86-8a01-3a68bb65a1f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_dc9d2bc8-74c2-44d4-a506-2b243a40e1db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:EquityIncentivePlansAndESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_dcb22e50-3b63-484c-8bca-4d66021e8210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-07-01</startDate>
            <endDate>2014-07-31</endDate>
        </period>
    </context>
    <context id="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_dd1d30e1-e047-42a2-bdb5-3ef5926e79da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_de840e76-4090-4f91-aa27-ad5a96814016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_de99671a-3f86-4f93-b929-187c53e350a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_df05c425-3a4a-4cd4-aa36-806e2fe0da51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-02</instant>
        </period>
    </context>
    <context id="C_df0dcfdb-f7bf-42d6-8f50-7452f7efb7fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_df36bca4-34e2-4f01-a21b-2939200a4237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-31</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_df3d0c76-2bea-47b7-b43d-ad369cba9a2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_df62ffb5-2697-4ff5-a2f7-2b6a2e6fd05e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">inva:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dfbfc63b-c8ad-40e9-ad14-a99d3949bb53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-17</startDate>
            <endDate>2022-02-17</endDate>
        </period>
    </context>
    <context id="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_e189d92a-5bed-4d05-ba08-0b3e9024c9c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e2ddb70e-8dcc-43a9-a5a3-84d4f1674565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e2f7f140-5330-4553-9a9c-7f6c89b789b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e3ece156-7a9e-4032-aee8-a8d84b04dbc5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e3fb434f-e5ea-4505-bf42-34684b260e8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e45d06f3-4620-495d-8786-74f2c65161c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e58b5b10-01d5-47b4-827c-3e1e08ba781d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e58d532c-c266-4245-9d7b-aef9281419e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e617e900-c4dd-49a9-adae-8c08d9de316f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e708ed8d-1039-4ee7-a8a5-f30c4559229f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_e7fac056-3186-4a36-b380-99ad43330178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e8870f6b-cc59-4078-9d16-079206fad40d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e917c8c1-bfee-4f3b-9622-29aafad82d9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="C_e9234eca-e6d0-4621-b0c2-30f2d3521baa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e98b3d3d-da85-482c-b5f8-1a935c74d441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e9b0c0ac-0c84-4a00-8d3e-e6a3c6a553e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ea058057-5a8c-4679-b02b-d77e73b481e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-23</instant>
        </period>
    </context>
    <context id="C_ea7dfa2c-567f-43fd-8303-83212ff97441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ea976f60-5b5b-415c-b0c6-88e63b461b95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesCPreferredStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_ebd1ba78-29b1-4276-99d0-bd4af1213cd3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="C_ebd565a7-3838-4623-a9b9-27c9ee94c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ebebd729-c908-4409-9926-dcda00bed175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:OutstandingStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ed5b1702-8224-456a-abea-ea2d003f0c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_edc9130d-8bac-4385-8abd-4f680377bf65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ee91a4d7-5cf4-4689-95fd-88e803c82bd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ExternalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ef03268a-dd7d-4c50-a2c4-e5d9a9311b15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f0562001-bb86-4a5b-b298-0510200a8220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-07</instant>
        </period>
    </context>
    <context id="C_f1b73005-95fb-4adb-81f0-96baf40e7109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f204fe66-1d1c-4852-b65c-0af9b8cf2582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f219ac17-5f54-4a96-ad2c-f5c9f69dae24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-07</instant>
        </period>
    </context>
    <context id="C_f2be4dca-4f14-4253-b3c4-7480e0834b43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_f35372e3-5a04-485a-8e05-1fd441950552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="C_f3ad801f-e4a3-4bf5-9d54-b9f1f833c093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_f3c6c6c6-c1f1-4aba-b7f2-6491c20659a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f3e16894-117c-446b-9f3f-884beaa199ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_f48f3ff6-407c-4253-90e5-37f84707a37a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f4a8c22f-aba7-4e11-ad11-162e3d1ad7ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="C_f4ae3171-8820-4834-b2c2-1c6f94927a5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f51e917b-8e9a-4315-958f-c6e9da82aacf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f67ba5e9-a4db-472d-a2ac-c63d64b435b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f68989b1-d857-4210-9ee6-ae27a0818759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:InternalExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f6aacb7c-354f-4850-845b-699f73b3eb83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">inva:NewDebtInstrumentInterestRateAfterRepurchaseOfNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-07</instant>
        </period>
    </context>
    <context id="C_f6bcc262-29e8-498c-850a-47d7bc746ddd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f6c0a156-d89e-48f6-bded-f444bcad434a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f77d16f6-54fb-45df-a63a-141a1f1f0379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f7d20624-8417-4c34-b875-90b2c207e676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f7e50e8e-4e3b-4cb4-86fd-601d62aa2908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-07</instant>
        </period>
    </context>
    <context id="C_f7f1eee0-388b-4fa8-9890-63be03fbd551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f92b2439-dd04-4ad1-9985-100056a2a460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f9d8c18f-f9a7-412c-a350-a087bdc10db8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_f9df7c1f-6bde-4e08-b0ca-c088b7bfec4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="C_f9e57c23-a271-4b12-b27e-1a3a9f5259fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fa5f811c-b501-4818-ad66-e8e20b51e983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fa7da83e-f568-43a7-8a21-c4860f759a4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fae9051d-e439-4818-ad45-eb74de3471ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fb5bc12c-55ad-4da3-a56f-d05ec3ed9dd2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fba802f6-eb69-493f-87f6-f43deb47abf0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fbdb8b2c-2b35-4e9d-80d1-25e5b10df0bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fc9a0b8f-f975-48ca-a3e6-9b76b08bd568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:RegulatoryStartingMaterialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_fca35291-33d2-4caf-8ebf-8a5264f15a1f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-17</startDate>
            <endDate>2022-07-11</endDate>
        </period>
    </context>
    <context id="C_fd08000e-5a41-4289-ae07-073ab3d62ab2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_fd3f6642-082d-419b-8eb5-479c4509f29d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ConvertibleNoteAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fdbfc2ab-d5ad-4fa2-8dfc-bcaab55938e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fec8182c-e2df-4822-bd54-8e84d5ba717c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fedeae1b-25e7-447d-871d-311e79d2dae2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ff731cd1-588f-4206-9930-a5931aa2f59c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ff809d6a-b516-4d09-8eb7-0d3d1386fd58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ffeaad30-ebfd-4a04-b9e5-4e0d3bd69603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_00161e2a-7110-4a94-93a4-53229f1f240f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0063e106-c957-4aaa-8a37-c9c8915894f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="C_0093bbd6-7e3d-4096-a9d4-884a19df0e1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="C_00f9e3ac-8ca8-42d6-ab5d-d942ce6aee24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0172277f-4eca-48b9-bece-ad8bb242c5b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_01786403-dae8-45d8-8f44-bb44245b9082">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_017b1701-0383-437f-9b49-4b53a72f5cc5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:BurlingameCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="C_01a26fdf-093b-428e-8429-70e85e0224c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_02d745cd-51ee-4828-8e80-e16af93855c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:InCardaConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_03ca5b08-65b3-4660-b083-f365e311c479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="C_03d49736-400f-4d83-9c8a-949362d73529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_04c41611-4dbc-4cb9-9783-2e7266319cc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_04fe922a-6cc7-40ce-935f-5fdc9f946206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_05049684-518e-4c68-a36a-97efe8235878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-01-01</startDate>
            <endDate>2013-01-31</endDate>
        </period>
    </context>
    <context id="C_050ab59e-aa14-4c4c-8631-471af527ea4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_059d5bd5-1649-484e-8e7c-174600b0cb2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_05e65131-7bbc-4635-8ca4-c97edca1f54a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:WalthamMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_06063be5-bdd2-4157-b66c-78225d3605c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_06dd38c6-e52d-4da1-998f-59918ca542e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_080daca5-b99d-4707-b989-976a8412c9b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">inva:SoftwareAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_082688dc-70ea-4b4e-a75e-e8348b08e789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_082ada48-9042-421f-be9d-be33bf8fec5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_092b5b62-561c-49b9-ba98-6e6b2d653e5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0974ccdc-4028-46c2-914a-582f9004b353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_098b82e6-075b-4b93-995c-661389fb3815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0998f113-0641-45f5-9ff6-c133558e2b1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="C_09aa36b7-7144-467b-9fac-7756cec17a40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_09dd24e4-7567-42ee-8451-8c197dcc4414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_09f27efd-eb03-4052-a5d2-3f4477a2daa4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0b1f96f1-ab6d-47e4-9aef-4751a8f64e5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0cc6ac22-c321-4787-9e00-3da335019c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:GeorgeWashingtonUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0d1b8490-4789-4372-801e-fc2120c8f801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:TrelegyElliptaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0d59aa40-0636-4b3f-ab3a-b5149a08e64b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0d85bf14-7ff9-40af-b30b-7e30a1de43fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0ea9ec7a-e7e7-4193-b8dc-087d07b87da1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0ee77695-de0f-46b2-86c1-faabdc44e03d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_102e5069-9631-4b2b-b6f6-629950c6ca80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1094e350-01f0-46ea-8b23-ea5467236116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_119ad206-2058-450a-8e97-89fb20b4c812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_11dc5ce4-6d0c-463a-81f6-6f26c160dbca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_11f76295-41b0-4dcd-bce7-3764ae292e78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_120c56d9-bec6-4a6e-9cc8-0e256aaacca2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_12297e5a-44ee-441e-b9cb-846681e357f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_12d7763c-f468-4d34-a5f1-a55b18acd690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:InternalExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_12f5776d-f333-4f0c-8ece-f5ae431ebdf9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_131d7647-fc17-4fa2-92a5-8461ff6933d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-10</startDate>
            <endDate>2023-01-10</endDate>
        </period>
    </context>
    <context id="C_1335d490-17db-400b-806c-c3c9d364a039">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_133952d5-c957-477b-b68f-c01b8094549b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1364b4a6-7f98-434e-8070-02bab731119d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_13694843-7358-454e-8001-380c30620343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_148ad82f-42d4-4125-aa46-2c752917796a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_14d9f964-799a-438f-8197-61ae142e28d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_14dff0a8-f6e3-44e8-a3c8-67a93240f124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="C_154fe60d-7256-40d2-a138-fa133ec0c2ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_155f7dc2-975e-4e6a-bace-6dfb4dbe5000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_16e99f91-f640-4040-b9b5-471378dcd3f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_17017b2a-0317-4eb0-952e-a435e24f4125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_17140411-b5e8-43ef-8ad8-fe25a8045518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_171e97bb-f74a-4c17-8063-b0dca204941d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1731ac46-b6f5-411b-85d1-c11e32e67f0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1816c078-11b5-460a-ad2e-54cbd4e77cbd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_18883a4e-3c50-4f05-b6d4-558b64a471aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_19101d97-aca7-45f0-b583-c510e7751aed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_191d279e-0f47-40c7-82d1-36a0fa78870f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFourthAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-05</instant>
        </period>
    </context>
    <context id="C_197a7b2b-9367-4d18-a82a-81e4a8afc234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_19f9ae33-8506-491f-9863-f0a3fba13817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_1a8cdfac-c298-4e05-a31d-4569a79026a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:Outstanding2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_1a9f4847-6963-488f-b354-eb7c596994c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1bdd4ad6-2439-4385-82de-5ad820bd7eae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1ca55df9-e12f-4eef-88d2-5127dad03544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="C_1d60db24-5501-4ef8-9186-60ebe8c52f24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1df97a3c-6233-4b8a-a866-08d91ec761b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:InternalExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1e2ed4aa-4ec1-488a-9c05-da807b81c789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_1e6b3044-ac2f-457a-a3c3-0254c3c6cfa2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1f0576c0-c074-4ef6-8698-a676d24560da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1fcc8f6c-3778-4f03-9b9f-4a242c10fa7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1fff98f9-2913-4a76-9006-53b136b3b233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_206853b6-d741-4c50-9285-74ba6833daf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20aec05b-661b-4aea-8d88-b14352ed9322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_21159e50-9136-4f4e-a5d7-9312dd7ce1ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2115f8b1-9136-4380-851e-2b2dd4d28c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_22346f7a-9d5b-4adb-8126-334786efe7ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_223b1e43-14b1-455f-954f-38ddc3e5b77d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-22</instant>
        </period>
    </context>
    <context id="C_23437773-47f3-4a8c-96df-2a22fdd80f90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_2448232b-60b4-48e6-82a0-b32e49c6f1a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_244f0667-3be5-4a0a-8576-8ae545e146fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_24e20d06-ec1f-46a1-aa46-323dcfd90377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_25328d2c-092e-4651-9c58-eeb1fa6d99e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_253ffe46-1c31-4933-9e01-a237c876ecc9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:SarissaCapitalManagementLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_25c30b00-13bd-4d27-89b6-199993a5cac6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCappedCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-01-31</instant>
        </period>
    </context>
    <context id="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_275d36b8-67af-4e37-bb78-b7ec1929c925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="C_284534cf-6887-4f30-ada1-31c5129ca188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_28894aac-4362-4af5-af9d-30c2bfedaac8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_289ad2e3-11f8-4293-9451-51ca41bb9371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementThirdAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-13</instant>
        </period>
    </context>
    <context id="C_289bc6be-6e0d-435c-bf28-005e3d396793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:JulyTwoThousandTwentyThreeCreditAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-10</startDate>
            <endDate>2023-07-10</endDate>
        </period>
    </context>
    <context id="C_28c9f433-5923-40a8-82f6-7695aff7836d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inva:OneDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_2929c53c-75fc-494c-9554-8c5d617baf03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_298130f5-8670-42be-853c-8278eb64b931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="C_2b29300e-dbc5-4ba4-9407-04aba97c4829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PrivatelyHeldHealthcareCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2b5acdfb-cefd-4c67-9972-a3dda739bb03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2beadbda-6783-4ae4-893a-d09da35b2b25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2c77d616-9e5d-408c-b20f-a0aaee7f6140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementFifthAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-13</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="C_2e2ce5a8-4015-4724-a5c6-e1c368237ec7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_2f675c67-919e-4761-81e6-7accacddcb17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2f78b292-f3be-4468-828a-00ca22c1d9e5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_30321d31-1876-4ed6-ab63-b9b2cac929bb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:Outstanding2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_304ecd1f-6a58-4044-a4fe-d0160d63a872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_30c301e3-2dfb-45b3-9f2b-eb72553bc22b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_315a265e-5369-4a49-a2e2-f13fcdd56f9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_315cbf77-929f-4504-ae65-d859fbee4836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_31a5145f-3c5c-445c-8566-35efc89d880a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:CostReimbursementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_32245f0a-45db-4e0a-9613-eef82b4c01c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_331dc9af-0e1f-47b2-a30d-d84e5a653bda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesC2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-14</startDate>
            <endDate>2023-09-14</endDate>
        </period>
    </context>
    <context id="C_33718ac7-2f56-451b-aa25-527639d12045">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_352aac51-ea35-49df-addd-f02b0882af4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_352cd91c-df33-43d0-851f-1172751e05a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_353f21fc-32cd-4752-9796-07126db0df6e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3551cf7d-cc96-4d09-9170-a0cd1bd24e95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_35c66ecd-abaa-47c4-aeed-995102651f7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_35f30426-4799-4508-968e-1f20db7a6efe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_360b25f8-0668-427b-a0a4-5664f61139d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_36337589-fa2b-44e1-bff5-12d71d918a11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_364151ca-1164-42c3-99da-d375625b3e9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_36498d02-d869-42ba-9764-62160907c5d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_37bbf523-072e-4d93-97c4-9c3c71d7a919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_388e224e-9c7a-4df5-91b8-5e4f6d9f788b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ExternalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3a11ad05-9798-4623-a6d9-25f61cd44da6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-01-31</instant>
        </period>
    </context>
    <context id="C_3a94b2fa-2178-45d2-a69f-4f779a9e094b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3a966812-a150-488f-a6ce-1883cd6184b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_3ad95b16-89e1-4def-b1ad-f62ba899efc6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3aea5bf7-3984-4fb0-812f-c886790b0640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3ba88775-17f5-4d28-b47f-634aaca4e732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3baecf69-ebf5-4807-8356-b90a92791318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3c13a3c1-d391-437e-ab76-9807135c7a06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:AstrazenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:DurlobactamMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3d2c4b5a-dd7c-4736-8ce5-464b5a60b336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3d95a88c-d5b6-4806-8dd1-644e4672cd1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3e355c7e-7e1e-40b8-829f-9c901683dc89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3e58dc77-93ac-48f8-ad4b-45e787d62643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:EquityIncentivePlansAndESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3e6c5798-81a7-4ab8-b212-ef8406a6ab89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="C_3ea3009c-970b-499f-ab6e-42fe1c681808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_3f07a2ce-f751-4da5-bf13-5630b4c78ccc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">inva:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3f3470cf-f3bb-46cd-b659-030c2237a851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3fbaef98-117c-41ce-8102-e48e8c5bfa08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_40250a06-ba0d-4b97-9fa8-e40ff2902099">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4041c10c-d9db-40fe-83d8-3d345cb6210f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_407f2692-c7b8-407e-92c4-03aef1a4ccda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="C_40baef25-dae2-4dfa-871a-2daf38c29542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_412a8dbd-f544-4764-ad96-91e826f4e587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:CordenPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_41d2a460-017a-4f09-950d-898d5eed18e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_435c3fdf-dded-4b1c-8c53-e2baf1575828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4363cee3-616d-40bd-953f-b7ca70e0e01a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_43d9c586-5f52-4d19-8160-779b9b10fc41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_43e76568-df93-454e-8619-b61f33c62f7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_43ebbba5-322d-4a57-9b5a-da8637cdeb0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:EverestMedicinesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4406a063-c883-4b59-8711-b008bdcbf2f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4567075b-b913-4d0b-920a-5d6cbdb4427a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_45841d41-b3ea-49ad-9f9e-c591d3adde1c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_46be4ed0-3a6f-42b0-b192-15f206bf7393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="C_46c113f9-5e07-4c06-840b-d46df7900549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_46def20b-a66d-4411-90eb-b164dbc750ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_476f91df-e117-42e8-94a7-ab3a3ed891d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SecuredConvertibleCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-10</startDate>
            <endDate>2023-07-10</endDate>
        </period>
    </context>
    <context id="C_476fef44-ae2e-4cc8-8996-5cd189b7399b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistRelvarBreoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_494c4421-3417-4b63-adc9-217af33b40df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_49ed2cfa-e32a-42c5-9d24-b9211f8ade51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inva:WalthamMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4a162331-f161-4794-bd50-e44d082bee98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-02</startDate>
            <endDate>2023-02-02</endDate>
        </period>
    </context>
    <context id="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4a788214-d295-44db-907c-ec0fa5bd3d73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-24</instant>
        </period>
    </context>
    <context id="C_4b154284-9266-4285-aa75-6b79ccaf86ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_4bfeee2c-2c81-4b9f-a36f-d4540c545b48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="C_4c137836-1d57-48b3-b853-5989053266bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_4c6c9a98-3708-403b-b3e3-41b376c009ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4c9bc9df-24d5-48aa-a746-0482bc1e814c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-01-01</startDate>
            <endDate>2013-01-31</endDate>
        </period>
    </context>
    <context id="C_4dd5f666-9958-4324-a0bb-faa2a4d1e877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataMarchTwoThousandTwentyFourTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4e5991ec-66d1-4584-84f0-5ad5de0d9c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_4f335e5e-75f0-4807-8256-9c44cb0e8135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="C_4f80e919-076e-4576-9834-4ff10cef76db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_510f527b-715b-4a94-923a-54ba359b3544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_5113ca40-db4d-493a-87c2-9a406e584ece">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-24</startDate>
            <endDate>2021-11-24</endDate>
        </period>
    </context>
    <context id="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-07</startDate>
            <endDate>2022-03-07</endDate>
        </period>
    </context>
    <context id="C_529c2882-00b1-4936-b580-0e5381a12f59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:NanoliveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_53205d86-091a-45ec-875f-153f734c0c7b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-07-01</startDate>
            <endDate>2014-07-31</endDate>
        </period>
    </context>
    <context id="C_53b04726-e41a-4259-a6b3-6fa32a149149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">inva:InnovivaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_54134174-dac2-4f09-bf74-39a35e6c1945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_54ab6970-91f6-4ad7-97a4-6add8575d58a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LicenseAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_54b22293-d908-4db6-bb20-6b71eb916276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_54fb9637-236a-4edf-bd9e-20160cd157ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_55ac6c23-a2e6-4ccc-84fe-98d81ce04dce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:ManufacturingStageTransferAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_56394c95-e990-4b88-a251-9f022931314e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inva:AmortizationOfInventoryFairValueAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_569e318a-9026-41e3-b966-5d091cfcfca3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_56f936fd-c826-462c-938f-240f31460844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:PaionAgMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5762c44d-7963-4357-b789-7869c9919cc7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_57c0f280-1381-409e-9964-9e5c0e176ff4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_57dd6d3d-0988-40b1-b84f-ff3d06249917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:SeriesD2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_583c4930-0807-43ad-bc97-189170841090">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5844539a-fc91-4105-b8a3-cf46e12ce3bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="C_586ff5e8-d41c-4176-a904-9624786d8bde">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_58f0fc2b-d399-43f9-94e6-ce77c2852307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:EquityInvestmentsAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_58ff6e27-8879-40c6-936f-18c78a254cf0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_59929190-726b-42e1-a7ea-6423d3b27be2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5a824dc9-4da6-4578-80c3-146747709b51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-18</instant>
        </period>
    </context>
    <context id="C_5a95facc-643d-4e5c-a79c-d70b76227248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5b6b74d6-5ba3-490c-a58b-c2fa128f4c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementSecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="C_5d3d7d01-66b3-48b0-9e0a-4093af97d0e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5e383c8b-3da2-4e7d-b954-1e85556222ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:GiaprezaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_5e46d5ce-f631-4674-8338-9c89eeeb502a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:LaJollaPharmaceuticalCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5ed4602e-2cde-4ad0-8956-178ce6486089">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_5f34def2-d4ef-45dc-9b5a-7b2dfd3ae646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_5f6af4c9-41ef-4851-89a6-4144851fcb0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inva:EntasisTherapeuticsHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5fbfbbeb-63b0-4ede-a5c8-bf29e1de26a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_6038b2ea-b8d0-41fb-ab7d-a45db02e7491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">inva:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_61675bce-4ccb-4819-8b97-db41c469c40c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_61ad19f2-d970-4839-83ca-b0d913e3f96e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_631eb718-8626-432d-96fb-8270d3650dfb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inva:EquityIncentivePlan2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_63d0bdb3-3078-4052-b347-b162b01e64c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:MarchTwoThousandTwentyFourCreditAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="C_644fec1f-c78d-47a9-b887-38182f8bfb45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6502e745-ecac-480c-a568-afd26e86b8d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_65a78fed-9696-4e3e-a1e4-e3cc50d0f0d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_663ceb44-07f8-4150-a16b-cc6004609ea5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:Outstanding2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_66693642-95da-475a-a4b4-59d4ac42aae1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-01</instant>
        </period>
    </context>
    <context id="C_67629f3b-d335-4784-a7d4-56ecd9570134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ParatekPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6785d313-2b28-4dd6-843b-fd6e81cb4e68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_67cd523d-133e-42a5-8657-9f3bb1123823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_67dabe6c-1f60-48af-9f2b-2dac4085e3c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_6904c00c-1661-415e-91ce-09c91f2b890e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6909246c-601a-476f-8981-bae18ebb0a34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_69bb9340-c11c-45f9-89b5-1eff93f82a71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">inva:PrivatelyNegotiatedCapPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-07-01</startDate>
            <endDate>2014-07-31</endDate>
        </period>
    </context>
    <context id="C_69dda25f-8fec-4d6f-996d-0711b459c98b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inva:LabaCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6a7b2f2b-6e3e-48ea-ab7f-7e1306be753c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6a8af425-4477-456f-9b7d-745f9bdef0b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6abb342a-b250-49ac-bbe0-52e5029809ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6b4d38cc-2d5a-43e5-9152-e93c3f2a4d89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:CommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6b58e123-d309-44b2-808c-8e368c6f5f3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6bf0974e-bd6c-4a97-aa2d-09d4b17083b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6c32ce61-be0a-4a4a-a440-b6d704139bad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6ca7b604-74ae-4669-9748-a07e890fea74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">inva:OutstandingStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6d0a78b5-48c4-4a35-91c6-e8575ef72b82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6d3efb43-3699-4ae8-a66b-6ac082761119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ConsolidatedInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6e13c51d-a0c3-477a-982e-4cc4b6d00a3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6e23f21f-fd64-45fb-a9b6-a0ca21a8e566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6ea92036-d7da-481b-8027-3362c5292d59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">inva:OptionPricingModelBacksolveValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_6eebba42-5bd2-4b1d-add7-2b9166a45342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">inva:OldDebtInstrumentInterestRateBeforeRepurchaseOfNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-07</instant>
        </period>
    </context>
    <context id="C_6fd76cbf-78f1-4169-b3c9-f2dee135ca32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_703323c3-fcbe-41ac-9f9b-28b43c769909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="C_703de750-f5d6-45f2-b263-1f034aa780b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inva:TermLoanInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_704606a8-5b42-4a22-98f8-ab51052adab9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_70e43fac-bdea-4cfc-a822-8d3ad323984c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XeravaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_7123baea-0eb2-4315-ab65-b66fb4c1e84c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7136a559-6922-4b61-8d55-1fe4429116c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7140c906-62ed-4fc2-ae57-4d809ddc48a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_7145555a-225b-40f5-a4c1-17e76939a86d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-07</instant>
        </period>
    </context>
    <context id="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_71e50eda-66f4-437b-adb4-80b4249323a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataJulyTwoThousandTwentyThreeTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_72ca4799-ff83-4650-a66f-e64646a8bbbd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HealthCareRoyaltyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:RoyaltyFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_72e33bb8-0153-4002-8937-baf8a5118573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_72fa18ae-694c-4d8c-98c2-590805770243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_734bee53-194c-4c05-925f-5a7cf8d9acf6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyEightNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_73b479b7-bd69-4e75-9afa-4ce0c8d93cbd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:ZaiLabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:ResearchAndDevelopmentSupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_73f1df40-a5ad-4f58-8d9d-f8b23a0da0a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_745efcda-116c-4d6a-b708-1361e157d2ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-30</instant>
        </period>
    </context>
    <context id="C_74764868-362a-469f-82b3-5a8b74607e25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">inva:HarvardUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_74893ac7-f1ad-41b2-845f-0c4f0fae42da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:WarrantsPurchasedIn2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_751227a8-ff5f-4419-bc20-3ffdd5766392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_75144e9c-8d8d-4067-a64b-e8ba0c236ce0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_7530273c-e395-47f6-b8ce-a7265c4b1b91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_754e1428-1254-4b24-afeb-0530ecdb9559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_765a2763-8b53-4101-ab58-259faa96bbda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:LaJollaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">inva:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_77c52870-1a85-4eaf-9c65-7b65a7c304fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_783d44e6-75e9-4b12-8062-6bfba06d75c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:XacduroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_786faf8b-f50d-4276-973e-9c08430f0704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_78745eb2-7d71-4fab-bac2-e5ea9e5f2e5b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_788779b5-a56e-46b0-b6c5-4c88f05e3f22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_78c666f2-f708-4225-8f3e-243b11aa5167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_79768fb0-1a83-46a5-a213-1d3d9c213d45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:TheravanceRespiratoryCompanyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="C_79983aa1-6f85-41fc-9342-69b5e86a22d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IncardaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_7abf372b-d434-4499-93a9-de44ea4152e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:IspFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inva:PubliclyTradedHealthcareCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7b46f925-454c-4214-b995-44ba572a8c1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:GateNeuroscienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:ConvertiblePromissoryNotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-05</instant>
        </period>
    </context>
    <context id="C_7c241491-c363-4e26-b334-863eae0dae59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_7c641825-cc45-4345-9822-341d08847261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7d99aa1f-7657-4d34-8478-bfbf3e3c3acd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7dd1472a-f27f-4e99-ac46-35b7a204db5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_7e8f2964-378b-406a-9a0b-b4b4284256f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ArmataPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ArmataConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_7f01ba3d-3b8a-46ef-b6ed-b35a2187ddb1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">inva:ImaginabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inva:ImaginabConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_7f207f6a-98e7-439a-bc04-1d2e8566d922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">inva:TwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">inva:SeniorUnsecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-07</startDate>
            <endDate>2017-08-07</endDate>
        </period>
    </context>
    <context id="C_7f8fbf04-70a3-46c3-b1c4-813bd471a322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001080014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inva:LongActingBeta2AgonistAnoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inva:GSKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="U_Segment">
        <measure>inva:Segment</measure>
    </unit>
    <unit id="U_Director">
        <measure>inva:Director</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Item">
        <measure>inva:Item</measure>
    </unit>
    <unit id="U_Customer">
        <measure>inva:Customer</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_CHF">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="U_Tranche">
        <measure>inva:Tranche</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_Installment">
        <measure>inva:Installment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_294f30a8-6751-480d-96f1-de4c00cacdfe">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_72085d60-06d9-4ecd-b495-7fc40676cedb">0001080014</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_fb084d73-4669-436a-9dd8-67bd0b399ccf">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      id="F_4cabf256-50af-4092-acd1-d2dc789b6957"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      id="F_91f0204f-f305-4ef6-8781-73091ff19f29"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_a7597c02-e3bb-46d9-8544-84ccf95becce"
      id="F_9bdecfd3-61c0-44d4-a26f-95a46485d9fa">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      id="F_8fa11627-b6cc-4f9b-a343-8d27e9d135d2">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      id="F_88ddddc3-bea2-43a4-a260-09dfd3791459">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <inva:ClaimExpirationDate
      contextRef="C_67629f3b-d335-4784-a7d4-56ecd9570134"
      id="F_f0a3b6ae-bc83-48c5-86cb-73ff6b579e00">2023-10</inva:ClaimExpirationDate>
    <inva:LockUpExpirationDate
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      id="F_575134d6-a304-419f-b46a-5cbe0a39b7e5">2023-12-31</inva:LockUpExpirationDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_dfbfc63b-c8ad-40e9-ad14-a99d3949bb53"
      id="F_47da13c9-3667-4443-acf7-9a613c3e52a0">2022-08-18</us-gaap:DebtInstrumentMaturityDate>
    <inva:ExpirationDate
      contextRef="C_19f9ae33-8506-491f-9863-f0a3fba13817"
      id="F_ecf264a2-e5c5-444a-8a7b-06e825278547">2023-03-31</inva:ExpirationDate>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      id="F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      id="F_f4af3d02-580b-4f35-bd4b-6df98811301b">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      id="F_16c95013-f170-4361-bd0d-93944037b675">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      id="F_ebb48713-23ce-429f-ae3c-689518f40e91">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_017b1701-0383-437f-9b49-4b53a72f5cc5"
      id="F_df825393-b260-4cba-9ff7-9fc9a38e03d8">P36M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_935e1701-2c66-4fa4-a9ad-777be38cf9eb"
      id="F_95673362-d782-4e32-804a-2d906541bf72">2027-12-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_05e65131-7bbc-4635-8ca4-c97edca1f54a"
      id="F_1f9d0b86-7ca1-4461-b3cf-41c5a7d463c7">2029-03-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      id="F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b">http://fasb.org/us-gaap/2024#LiabilitiesAndStockholdersEquity</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="INF"
      id="F_8697229b-658d-48d6-b3f9-46eb9028e018"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="INF"
      id="F_11be943b-e77c-41bd-aecb-698c8fa9edb8"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_729d9a5e-6c01-4f45-8bc1-8b9538c8dbaa">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <dei:DocumentType
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_3f7f5b05-4355-4cc3-a373-57e675559ad4">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_3472c12c-b51e-4414-85b8-072d4b12ff50">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_9b1ef86e-e08e-4e17-96d6-b2fdbe74a62b">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_28809184-f074-40ec-a215-a8164a2edb33">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_1bd9bab3-9ecc-43f5-aaf6-467449b64987">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_7e5ecdca-8cf1-46c8-b15c-409e87ca7fb2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_b65c3852-b180-43e3-ba12-7bd3c55cdabf">000-30319</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_60eeba1d-5313-4d57-a0b1-e878b7355824">INNOVIVA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_9bab6314-a758-4e81-bafa-f957012d8296">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_26bff954-5c51-4c07-b159-25a4246c656b">94-3265960</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_b7805f45-2bc7-4900-a394-9ed16b9e7089">1350 Old Bayshore Highway, Suite 400</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_e6d150d2-6e85-49a3-a51e-430dea8180be">Burlingame</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_84ef4248-b2e9-4bef-8a88-3c442ef5ebea">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_80597ea5-824b-4b0b-9dce-5a95348055db">94010</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_1ed8fdb9-3ce8-4358-83f3-b13ed61e3f20">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_730033e3-f942-4c41-ba6a-e6a4afb06852">238-9600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_00a75085-fb3a-47af-8a33-7ba936468e41">Common Stock $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_5551957e-93a8-447f-b395-75b6298dae06">INVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_2f0a8b3b-e9be-4613-a3bc-2aca91c9cd17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4767a540-30c2-4e9b-9d84-f8a433f95170">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_7611f6cc-07e0-4899-a200-f8079e0aa12c">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_fe45f748-458c-4ffa-ae00-b5f6df408d9b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_d704c259-40e3-4108-b9c3-70dc654f3d80">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_a2600bf5-9e24-4f4e-9ef6-96f280184759">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_73e84d96-e9e5-46e0-8e1f-99ffdc510dff">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_f1618eae-2d17-44d6-bdb0-86abaae14c8e">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_37198f7a-2898-4820-b43f-272cfe3b6696">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_77b5c4bb-4ba0-455b-8268-758d7ba42b31">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_f37134b3-64eb-404f-80dd-01b947821241">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_bf2aa827-497e-4734-b273-79d836b4d1eb"
      decimals="0"
      id="F_175ec27c-31c2-4b45-8d1e-b79024f968db"
      unitRef="U_USD">899110517</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_94e5705b-e6d9-4f93-b4fa-02e92457a43c"
      decimals="INF"
      id="F_5a108891-c729-4583-a149-c59e815eeab8"
      unitRef="U_shares">62675545</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_bf1f7360-c792-4404-94b1-106bf817c4b5">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Specified portions of the registrant&#x2019;s definitive Proxy Statement to be issued in conjunction with the registrant&#x2019;s 2025 Annual Meeting of Stockholders, which is expected to be filed not later than 120 days after the registrant&#x2019;s fiscal year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, are incorporated by reference into Part III of this Annual Report. Except as expressly incorporated by reference, the registrant&#x2019;s Proxy Statement shall not be deemed to be a part of this Annual Report on Form 10-K.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_0b2d2c3f-ad52-49a7-9aa4-f3c923d74352">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ITEM 1C.   CYBERSECURITY&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Risk Management and Strategy&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We conduct risk assessments to identify cybersecurity threats at least annually, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats.  These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards.  We devote internal and external resources and designate high-level personnel to manage the risk assessment and mitigation process.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with human resources, IT, legal, and management. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We engage internal auditors and other third parties in connection with our risk assessment processes. These service providers assist us in designing and implementing our cybersecurity policies and procedures, as well as to monitor and test our safeguards.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, we did not identify any risks from known cybersecurity threats, including because of any prior cybersecurity incidents, that have materially affected us. However, in the future, we may face certain ongoing cybersecurity risks or threats that, if realized, are reasonably likely to materially affect us. Additional information on cybersecurity risks we face is discussed in Part I, Item 1A, &#x201c;Risk Factors,&#x201d; under the heading &#x201c;Our operations could be disrupted by failure of our information systems or cyber-attacks.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;They oversee our cybersecurity policies and processes, including those described in &#x201c;Risk Management and Strategy&#x201d; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;They provide briefings to the audit committee regarding our company&#x2019;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_ad440032-f2ef-4246-a6f6-5ad298bc79e1">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_e7ab994c-b055-44ae-a938-d58a5e0b495a">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_3f9b90e3-642d-41f9-be24-6d1e3c6cf61f">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4c816ae2-2a8f-4c8a-a56c-bb5fe1217027">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, we did not identify any risks from known cybersecurity threats, including because of any prior cybersecurity incidents, that have materially affected us. However, in the future, we may face certain ongoing cybersecurity risks or threats that, if realized, are reasonably likely to materially affect us. Additional information on cybersecurity risks we face is discussed in Part I, Item 1A, &#x201c;Risk Factors,&#x201d; under the heading &#x201c;Our operations could be disrupted by failure of our information systems or cyber-attacks.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_20c4379b-0682-43b0-987b-8899fc462e69">true</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_9691eef6-feca-4e9c-a93c-aec9a5b52807">&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;They oversee our cybersecurity policies and processes, including those described in &#x201c;Risk Management and Strategy&#x201d; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;They provide briefings to the audit committee regarding our company&#x2019;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_a1788fb6-d97f-4120-9e7f-853b03c0dc51">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_87949837-74e8-4c3d-a3d7-62c337048daf">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors administers its cybersecurity risk oversight function directly as a whole, as well as through the audit committee.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_2146197e-a8e0-4a18-a9b3-7e4e3d937617">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The qualifications of our executive and information security teams include a combination of formal education, current trainings and certifications in systems, network, and cybersecurity and over 50 years of combined experience in information technology and cybersecurity matters.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_e11eb156-fdbb-486e-bb9d-2e3bc0c08979">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our executive team, primarily consisting of our Chief Accounting Officer, Chief Financial Officer, and Chief Executive Officer, in conjunction with our information security team and third-party consultants, is primarily responsible in assessing and managing our material risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_9cac1718-8a6e-43e1-96f3-12da9890e43a">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_facd3f06-686e-49d5-b48e-2bffed33b135">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;They oversee our cybersecurity policies and processes, including those described in &#x201c;Risk Management and Strategy&#x201d; above.  The processes by which the executive team is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents includes the following:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;They provide briefings to the audit committee regarding our company&#x2019;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, cybersecurity systems testing, activities of third parties, and the like.  &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, they provide briefings of any significant cybersecurity matters to the board of directors as well as an annual update of cybersecurity risks and activities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <dei:AuditorFirmId
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_cfe69821-5da8-4889-8e61-dffc8135c80c">34</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_6efc04c5-f61c-4ceb-8193-75e1f9df53bf"
      unitRef="U_USD">304964000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_6cdff214-b793-4b31-8011-94ad3600aae9"
      unitRef="U_USD">193513000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_7474de17-3465-4e61-8fbe-bce6f1b49159"
      unitRef="U_USD">20392000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_d11e5421-a48a-46e5-9163-55b89058731e"
      unitRef="U_USD">14454000</us-gaap:AccountsReceivableNet>
    <us-gaap:ReceivablesLongTermContractsOrPrograms
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_366fc998-e441-4f0f-9828-83852eb83b9f"
      unitRef="U_USD">65974000</us-gaap:ReceivablesLongTermContractsOrPrograms>
    <us-gaap:ReceivablesLongTermContractsOrPrograms
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_af90d6ae-a967-4179-b43d-01cda3b7e284"
      unitRef="U_USD">69621000</us-gaap:ReceivablesLongTermContractsOrPrograms>
    <us-gaap:InventoryNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_b7e42af4-a471-4c7c-800f-846063601f49"
      unitRef="U_USD">33725000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_680aa328-dbc5-40cb-b726-9a40358fae5c"
      unitRef="U_USD">40737000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_0c433b6a-0490-4ed4-9711-f8bce27802b3"
      unitRef="U_USD">21063000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_b2eba860-4336-4af1-8d2c-35305d712f46"
      unitRef="U_USD">21630000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <inva:CurrentPortionOfISPFundInvestments
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_2a4267a8-af81-4603-982e-5f98bef36505"
      unitRef="U_USD">107532000</inva:CurrentPortionOfISPFundInvestments>
    <inva:CurrentPortionOfISPFundInvestments
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_15143c8b-79cc-4a96-ae5f-b2c405884256"
      unitRef="U_USD">0</inva:CurrentPortionOfISPFundInvestments>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_58cbb85d-f19b-4a01-8038-578a1b9d8112"
      unitRef="U_USD">656000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_9682b8f2-a5ed-4371-b59b-b67534483f16"
      unitRef="U_USD">4264000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_9f6b12d3-8abb-4b6e-b599-43511e60dcd4"
      unitRef="U_USD">554306000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_3fc7d6fe-81fb-4ee3-b2ed-67bcb400f393"
      unitRef="U_USD">344219000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_338c18f7-c46e-41ab-950d-f9336e0e4907"
      unitRef="U_USD">514000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_af4cc16f-9132-497f-9562-d61cd2283861"
      unitRef="U_USD">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <inva:EquityMethodInvestment
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_782ef824-fe3f-400e-a5b1-d992c4e3250b"
      unitRef="U_USD">52293000</inva:EquityMethodInvestment>
    <inva:EquityMethodInvestment
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_6f817785-fa0b-44c9-bd50-f533610ca037"
      unitRef="U_USD">116546000</inva:EquityMethodInvestment>
    <us-gaap:LongTermInvestments
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_b8bf4f67-d8c9-4e83-8792-ecf3dd644781"
      unitRef="U_USD">341664000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_14c059b2-6bf0-44cf-8ad8-c9687f7f6cfd"
      unitRef="U_USD">444432000</us-gaap:LongTermInvestments>
    <us-gaap:CapitalizedContractCostNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_98431724-6e88-4518-a336-0102a0111c22"
      unitRef="U_USD">69961000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_fb393a9c-a24d-46a7-b9d9-b6547210cc8f"
      unitRef="U_USD">83784000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_65f9e7a6-e2cb-4c4f-b38d-5a4e26f167c5"
      unitRef="U_USD">2453000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_c575f671-e242-4624-91d0-f587863b48b8"
      unitRef="U_USD">2536000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_395cf1d1-cd2e-4712-b039-9262e95fd38c"
      unitRef="U_USD">17905000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_c4fe4457-1a3e-4197-b741-8d20185e5a93"
      unitRef="U_USD">17905000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_5a8fa20e-c010-4214-80b5-b8b8d83eb664"
      unitRef="U_USD">208433000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_5b04e15b-4b14-442f-a2cd-110c14b3c378"
      unitRef="U_USD">230335000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_895cc1ee-7db4-44ce-b4c2-3eca57f4feab"
      unitRef="U_USD">12054000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_1ae67f68-81aa-41b0-81f1-7f919c1a449a"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_19830fff-a9b4-44ee-bebe-f117992f9f30"
      unitRef="U_USD">41477000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_105ae972-70d5-4ff4-b688-1d4ef25c3247"
      unitRef="U_USD">3267000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_2477546b-9d03-4c6f-bd6b-c659b39b8f12"
      unitRef="U_USD">1301060000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_63a33105-5dc3-41eb-812c-5b4899dba618"
      unitRef="U_USD">1243507000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_9f28ce32-2301-4ce8-9ef6-ed269db6425e"
      unitRef="U_USD">2132000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_b434930f-70d8-4f21-bc01-c06aeae684d2"
      unitRef="U_USD">6717000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_5d1943d2-50de-4feb-ae8c-961eefe8584b"
      unitRef="U_USD">7376000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_72f24409-36bd-42f4-8714-80a7b643bb78"
      unitRef="U_USD">7020000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a27725d4-dd09-451b-9448-61c941676f98"
      unitRef="U_USD">3422000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_8088685b-932e-4c8b-b36f-11bb6c03d141"
      unitRef="U_USD">3422000</us-gaap:InterestPayableCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_fdbbee2c-7dfe-4ae3-8419-4eb619e5470f"
      unitRef="U_USD">1126000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_05881e29-a873-4dea-a283-2b30e8a5f9dd"
      unitRef="U_USD">1277000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DebtCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a2cf11a3-48e7-413d-9fcf-19e8d49a7d03"
      unitRef="U_USD">192028000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_7b9a9b6f-cccc-4195-8ada-4af525d64bf9"
      unitRef="U_USD">0</us-gaap:DebtCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e3983122-f55e-4544-afd1-d9caa4068fc1"
      unitRef="U_USD">29999000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_2523184a-2f52-4f2c-b230-e38459633cbb"
      unitRef="U_USD">19698000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_0349524d-abe3-4eec-afe6-74a5c9d00150"
      unitRef="U_USD">236083000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_8aaa8331-4ef0-45ea-8315-4c3c1c69635e"
      unitRef="U_USD">38134000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_59e1cafd-f426-42a0-b214-8832bc893e75"
      unitRef="U_USD">256316000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_e4b53fb3-dc59-4e39-b02d-c0d79b802820"
      unitRef="U_USD">446234000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_0c36f33b-9277-4c8e-90fb-54ea5b2c94cb"
      unitRef="U_USD">64275000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_fb458f91-6d60-4625-8d50-d93e365b8b54"
      unitRef="U_USD">71870000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_c3b567a5-cfbc-4795-a241-c4b785685a44"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_202bfc5c-0f63-4632-84db-d3eee3286900"
      unitRef="U_USD">563000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_1021085d-4ed9-4f75-93de-49844687a5ec"
      unitRef="U_USD">53227000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_ca9ce562-a75a-4eee-8c08-65128ca0e205"
      unitRef="U_USD">11751000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="2"
      id="F_46f43e95-41c8-44ac-ab27-2b1d35d0ea2c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="2"
      id="F_85d1374e-8e63-4ef9-aa45-a1d124eb229c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_7b09f74f-fc9f-416a-9acb-4cbeba6370e8"
      unitRef="U_shares">230000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_d2766d4b-bf2e-4bb1-86b5-6ecb7a1eabbc"
      unitRef="U_shares">230000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_2ec2c3c5-cd83-42da-af51-ea61fcfeb831"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_649bf47c-f400-42f0-aba6-615c2d6b0eec"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_10793e8b-8370-4ac6-b3ca-a30c1a397fe0"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_2021b38f-88ec-4afd-a1ea-857767bffb12"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_4da6ea6c-6c33-4585-a353-008d3e7b1911"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_52cfac3d-833d-4c4e-bee1-8e6b508b09d4"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="2"
      id="F_1ba12bfd-b22a-440a-9717-57c460ad1c1d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="2"
      id="F_d435975d-2ee3-47b6-9d67-4773b58925b2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_03d94cc5-efed-464b-8274-cf3038f45ab9"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_aa670dbe-3a6c-4e5f-9228-884ed3dcbae3"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_84d935dc-c25a-49a3-9ebb-cebd69ae2c94"
      unitRef="U_shares">62665000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_86f8dc61-f6e9-4c06-ac47-c7b92b6ab79a"
      unitRef="U_shares">62665000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_88b3667b-705e-451d-bd95-6350d2e791cb"
      unitRef="U_shares">63307000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_f5e555b9-99c1-4f88-9c87-b241f05a82a7"
      unitRef="U_shares">63307000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_556ccef1-96d1-4c2d-8906-26ab2a4867bb"
      unitRef="U_USD">627000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_ad25d3c4-e215-4221-926c-c052c79e1da6"
      unitRef="U_USD">633000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_cf03d94c-318d-466e-bc32-998ea1b3a797"
      unitRef="U_shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_38b11c1f-c9b4-4cc2-afb4-42e26350b00e"
      unitRef="U_shares">32005000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_fdbf2b56-90a8-4f6b-94ff-163e28a0d530"
      unitRef="U_USD">0</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_41384e48-7ee6-480a-ac5e-b815d8651cd4"
      unitRef="U_USD">393829000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_66844d2b-8b98-4f28-9435-74ad6cfab7c5"
      unitRef="U_USD">692329000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_55b69e26-a5a9-4fcc-aaa8-6aa504840bca"
      unitRef="U_USD">1093340000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_db062873-86cf-4121-a498-da24140baaf9"
      unitRef="U_USD">-1797000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_81bde384-166c-4920-92c0-26ef5ed0492d"
      unitRef="U_USD">-25189000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_3bf571c1-8436-4f37-a27b-a0d549a3e3f5"
      unitRef="U_USD">691159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_1e112ca8-439b-41b6-b799-1e32d2a01bda"
      unitRef="U_USD">674955000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_c5d79021-45ed-41fb-8948-d811c623a779"
      unitRef="U_USD">1301060000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_36b7f0ba-c80a-4263-9607-208dd6c6c163"
      unitRef="U_USD">1243507000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3"
      decimals="-3"
      id="F_3aaa2fa4-c851-4082-95ee-98b84fecd99f"
      unitRef="U_USD">13823000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac"
      decimals="-3"
      id="F_82006692-f098-460d-927c-fee0cc4a62ee"
      unitRef="U_USD">13823000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e"
      decimals="-3"
      id="F_85551e47-991e-4c65-9f4b-b2d525d56dd9"
      unitRef="U_USD">13823000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6"
      decimals="-3"
      id="F_717792be-0d1b-4f66-8e5a-633fb3a14936"
      unitRef="U_USD">241733000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_fd08000e-5a41-4289-ae07-073ab3d62ab2"
      decimals="-3"
      id="F_024c23a0-3c27-4771-bc3d-f925a9035a4e"
      unitRef="U_USD">238846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_f2be4dca-4f14-4253-b3c4-7480e0834b43"
      decimals="-3"
      id="F_4fb1c5cd-4522-4573-bb01-06c3ced0fa95"
      unitRef="U_USD">311645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_360b25f8-0668-427b-a0a4-5664f61139d0"
      decimals="-3"
      id="F_847ca1f2-29ea-4e6c-9b40-2ef44c297fdb"
      unitRef="U_USD">97492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd"
      decimals="-3"
      id="F_6d8872b7-82e6-470d-916e-4336bcd35c37"
      unitRef="U_USD">60617000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5762c44d-7963-4357-b789-7869c9919cc7"
      decimals="-3"
      id="F_a91be984-9d80-4959-ac79-dc6926b60eef"
      unitRef="U_USD">19694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_be611a96-acf7-4e91-8069-ab705ba23648"
      decimals="-3"
      id="F_9f0257e0-f2b2-4cbe-9aab-0b499cbc2615"
      unitRef="U_USD">19486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_54ab6970-91f6-4ad7-97a4-6add8575d58a"
      decimals="-3"
      id="F_e02a6d1e-66a6-41fa-bdef-9f9bf1339810"
      unitRef="U_USD">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_9208f331-1b10-4449-9538-3f9a7a38627c"
      decimals="-3"
      id="F_6321bc33-ecca-49a5-bd76-5cc5635ee559"
      unitRef="U_USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_aec191e7-34c1-4eef-9b02-3641ca11ba08"
      unitRef="U_USD">358711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_93b42d11-12c7-4463-be51-bc9f067a5ab3"
      unitRef="U_USD">310463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_4017a9a6-c7ed-4673-9d46-0d6407284dda"
      unitRef="U_USD">331339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_360b25f8-0668-427b-a0a4-5664f61139d0"
      decimals="-3"
      id="F_e00a9dc0-6005-4ce0-ad32-05e5251b5e7b"
      unitRef="U_USD">36598000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd"
      decimals="-3"
      id="F_f3e005a9-284c-4211-8b32-079f02488381"
      unitRef="U_USD">41040000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_5762c44d-7963-4357-b789-7869c9919cc7"
      decimals="-3"
      id="F_82794611-2501-4d7c-82cf-99a309fc7bfb"
      unitRef="U_USD">13793000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfRevenue
      contextRef="C_d918b70f-a067-4ecc-8b5c-d40d7a0e5c75"
      decimals="-3"
      id="F_05da7c49-a595-437f-8cea-dfc0692cb954"
      unitRef="U_USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_72fa18ae-694c-4d8c-98c2-590805770243"
      decimals="-3"
      id="F_d0311e90-7d60-4bd3-99a0-b2e692094f59"
      unitRef="U_USD">1600000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_be6fcc6f-ace4-45c6-be23-2f777937aa77"
      decimals="-3"
      id="F_b2550378-0576-4d34-9af9-3af4e66b2ae0"
      unitRef="U_USD">0</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_bf4a05bb-c3b0-47eb-8070-59d73e192d59"
      unitRef="U_USD">115690000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_deac4a49-72dc-4969-87a7-16e84eb2daa6"
      unitRef="U_USD">98232000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_a58089bc-9470-4dd2-bea9-3fe9763fcc65"
      unitRef="U_USD">63538000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_52067835-2a94-4990-92ef-13c2eeb68180"
      unitRef="U_USD">13654000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_907b4ca6-4a36-4ec0-ac8c-79b1a7f57bdb"
      unitRef="U_USD">33922000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_d14fa612-7302-4493-b814-7c32eb92ff14"
      unitRef="U_USD">41432000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_29be79fb-db8f-4ba2-8195-40dacb43182a"
      unitRef="U_USD">25902000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_878f11e0-8842-4df0-9a54-a5b1937d1743"
      unitRef="U_USD">21784000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_3ab3e33f-e2b0-42ce-a24c-15931ac1d77a"
      unitRef="U_USD">5581000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_63cd1610-16d8-414a-853e-a8d9399c551e"
      unitRef="U_USD">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_2ec1723a-3485-4232-b482-75381fe3c9a9"
      unitRef="U_USD">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_69ae3e8b-5792-447f-877b-b9258fd80777"
      unitRef="U_USD">266696000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_47232574-e52f-4a6f-bd8f-eb52f39ed0d0"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_495b5c81-65ae-4ed4-9372-538222d35857"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_e8067ca8-04c9-4287-84b1-a2c2f943dc65"
      unitRef="U_USD">-20662000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_a729d5c2-0287-40b9-9361-8a5710aa4f8b"
      unitRef="U_USD">-64253000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_bedfb541-cb56-458f-881d-91349680b2b8"
      unitRef="U_USD">77392000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_1a059835-0fd8-4998-8c26-487b75a24ca1"
      unitRef="U_USD">-161749000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <inva:GainLossOnOtherInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_19e01537-c04b-49a6-8c74-fd1ac1ca10ae"
      unitRef="U_USD">-59161000</inva:GainLossOnOtherInvestments>
    <inva:GainLossOnOtherInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9b3036f8-9c15-43fc-9cdf-c189ac925c60"
      unitRef="U_USD">11129000</inva:GainLossOnOtherInvestments>
    <inva:GainLossOnOtherInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_07bbf06a-e38a-45c7-9e6c-ce293db5b540"
      unitRef="U_USD">8462000</inva:GainLossOnOtherInvestments>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_04138e6f-d778-4998-9548-8a28b1c74e80"
      unitRef="U_USD">19141000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_6f22a80b-dde4-497d-ba8c-a5f640a76c69"
      unitRef="U_USD">15818000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_7dd6f2bb-c14d-4df7-abb9-e1eb70a34aa2"
      unitRef="U_USD">6369000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_d1e8f25b-18b6-47f2-93c2-06985961ebdc"
      unitRef="U_USD">22209000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_b0b573c5-36bd-4433-adc4-6713a1f816b6"
      unitRef="U_USD">19157000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ab078df5-ee5b-4cd5-bc9d-48ab3c553bea"
      unitRef="U_USD">15789000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_48641dcd-0be2-481e-acf2-de932afcb3bd"
      unitRef="U_USD">-2997000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_59f96815-b5a7-417a-8f33-8c88e3395083"
      unitRef="U_USD">-4969000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_af017015-c8f3-48bc-9f6c-30299d710d14"
      unitRef="U_USD">-3373000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_486d070d-80f7-491c-b445-14e6c4ec87c9"
      unitRef="U_USD">321323000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_d0ca2ff7-8de9-4ad9-a350-e21f77a5ad8a"
      unitRef="U_USD">116365000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_2a02ccbc-1869-4a90-8791-9b053ebdbf87"
      unitRef="U_USD">44390000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_a1a580c5-776d-4c10-a908-25d3035c6e15"
      unitRef="U_USD">37388000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_1af5e54d-f87d-4227-8ed6-119451651c14"
      unitRef="U_USD">194098000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_21eaf675-f15d-4d45-b392-be2b3d6e1b59"
      unitRef="U_USD">286949000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_2d7402e1-3986-4417-96cd-49477c09cf9a"
      unitRef="U_USD">13996000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_3534fb2f-760f-4bac-9c87-dee280e54b06"
      unitRef="U_USD">14376000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_a5a883d8-d26d-418b-bc6b-47fb780f76c6"
      unitRef="U_USD">66687000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_b7f67375-6090-461e-9c0c-f03cc944f618"
      unitRef="U_USD">23392000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_3ba8177d-084a-420c-b4da-778e330c233d"
      unitRef="U_USD">179722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_c5236b33-7d20-4bee-9e71-b27e164c32eb"
      unitRef="U_USD">220262000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_74824545-f55f-4e8d-a542-525c750db85d"
      unitRef="U_USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_aa4e4f2a-bd37-4221-a896-252ba600441c"
      unitRef="U_USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_0db8f0cf-3dd8-45cd-b2f8-5efb5c428c83"
      unitRef="U_USD">6341000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_b47707d2-2bb3-4c51-a43a-abec7360e96f"
      unitRef="U_USD">23392000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_42888d88-7770-43a2-8426-faf9f80c6594"
      unitRef="U_USD">179722000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_c5ae664f-30d2-493f-9ef7-805c98d7e3d3"
      unitRef="U_USD">213921000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="2"
      id="F_442b276c-4af9-44f1-a1ff-00c398461887"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="2"
      id="F_a0ff928c-2e15-4806-a8b6-e8fc782cc747"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="2"
      id="F_00e2ffa2-e243-4106-aa34-169c3f454f42"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="2"
      id="F_83b542de-5925-472d-b065-d44d38f08f34"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="2"
      id="F_deacf18a-4b7b-4ab6-80bf-e3bf46b8b592"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="2"
      id="F_9e3a6160-0159-4165-8df3-6bbdea834c04"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_b0ff05c8-acb4-442d-aefb-e052ef555f81"
      unitRef="U_shares">62726000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_4ecac543-68d6-4240-b3a6-df64a528c189"
      unitRef="U_shares">65435000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_0d52f204-33aa-4c2b-9f69-ad7db1664642"
      unitRef="U_shares">69644000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_8ac6e2ea-c646-439e-b1b4-7e65f6ea77b9"
      unitRef="U_shares">74187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_2ca8a0ca-f100-4c79-9125-bc63c7027066"
      unitRef="U_shares">86876000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_6ac58a85-99ae-4d55-b31c-a7bf190c0af9"
      unitRef="U_shares">95248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_d30ba2fb-3de8-40f2-9548-5fe29e395ef7"
      unitRef="U_USD">23392000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_572996a8-9117-47dd-8e5c-9fc623eb0a56"
      unitRef="U_USD">179722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_32843a60-d6e5-42b4-9aad-d27a31b98c98"
      unitRef="U_USD">220262000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ea34b6ae-8081-43f5-bc5e-3f37081cf7e2"
      unitRef="U_USD">23392000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c8bd8fb9-6c40-4f6d-88a3-aeafca316240"
      unitRef="U_USD">179722000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_fff29128-b948-45c9-9dd5-b2c4d046bb51"
      unitRef="U_USD">220262000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_57aa9935-73a1-4668-92f2-06def322291e"
      unitRef="U_USD">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_b7574888-cfa5-4c45-b137-2c4068086c9c"
      unitRef="U_USD">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ee29a015-4299-41b2-8fba-77232a677a83"
      unitRef="U_USD">6341000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_5fc0dfd6-087b-407b-aad9-65e6f5ef7672"
      unitRef="U_USD">23392000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_08eef643-ee9a-45ad-ab35-b6153a4caa04"
      unitRef="U_USD">179722000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_df290648-168b-4f7f-aacc-76bd161218c3"
      unitRef="U_USD">213921000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1364b4a6-7f98-434e-8070-02bab731119d"
      decimals="-3"
      id="F_7eb6c4e3-87f6-40bf-aae7-3a0527912624"
      unitRef="U_shares">69566000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_1364b4a6-7f98-434e-8070-02bab731119d"
      decimals="-3"
      id="F_d7c8347f-f398-4810-9778-b4b7fc5f2b19"
      unitRef="U_USD">696000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_5fbfbbeb-63b0-4ede-a5c8-bf29e1de26a1"
      decimals="-3"
      id="F_f083c03e-60aa-4cfc-b8a2-c52e1285031f"
      unitRef="U_USD">1264024000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_b951258b-c9f5-4734-98aa-3ed6338a2801"
      decimals="-3"
      id="F_f8db3131-5177-4e69-877a-eaf3f7d953ee"
      unitRef="U_USD">-456148000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_852cf337-96b0-47de-a072-c0011a29adb6"
      decimals="-3"
      id="F_a3ee797b-c0ef-4d48-b6f7-a3a5998508de"
      unitRef="U_shares">32005000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_852cf337-96b0-47de-a072-c0011a29adb6"
      decimals="-3"
      id="F_3fea47ba-f705-40f8-bff2-d2eb65efe781"
      unitRef="U_USD">-393829000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_7d99aa1f-7657-4d34-8478-bfbf3e3c3acd"
      decimals="-3"
      id="F_4d18f12f-411c-43e6-b115-606ab4912c98"
      unitRef="U_USD">111192000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f"
      decimals="-3"
      id="F_d4f5e19a-eee9-471e-989a-0123b63d7cb5"
      unitRef="U_USD">525935000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_583c4930-0807-43ad-bc97-189170841090"
      decimals="-3"
      id="F_8c5f267a-d338-4578-bb66-7619855505c7"
      unitRef="U_shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_583c4930-0807-43ad-bc97-189170841090"
      decimals="-3"
      id="F_e50d7752-3072-4791-8d99-1f74a8e9f941"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_ff809d6a-b516-4d09-8eb7-0d3d1386fd58"
      decimals="-3"
      id="F_4bf1bfec-fd3f-44b0-942a-0d1a22a867e8"
      unitRef="U_USD">-65467000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_af51ee90-6870-494b-817f-7bb0769ffdb3"
      decimals="-3"
      id="F_21e8594a-177d-447e-ba78-aabd382aa24d"
      unitRef="U_USD">37238000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_4f80e919-076e-4576-9834-4ff10cef76db"
      decimals="-3"
      id="F_d79c8d34-093e-41c2-8c4e-e99cbb69fef2"
      unitRef="U_shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_4f80e919-076e-4576-9834-4ff10cef76db"
      decimals="-3"
      id="F_6ce31115-ddcc-4951-b350-4fbeb749b899"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_092b5b62-561c-49b9-ba98-6e6b2d653e5c"
      decimals="-3"
      id="F_1f50ce7b-de82-4e15-95a9-3b5648c5602f"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_17017b2a-0317-4eb0-952e-a435e24f4125"
      decimals="-3"
      id="F_1194c3b0-3562-4f1a-8c54-18b70d376f0a"
      unitRef="U_USD">-28229000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <inva:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_76b26c19-a055-48ef-9dd0-25e39c7095a4"
      unitRef="U_shares">0</inva:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_b1d96c87-8b9f-43fe-8ecf-1c35cdcd4ac3"
      unitRef="U_USD">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_47a13618-6a72-44ed-bcee-d2381ed950db"
      unitRef="U_USD">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_5caca0de-63b8-4dd4-aa82-6b2379fe4f43"
      unitRef="U_USD">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <inva:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_c0e363de-e435-4434-b14f-8b302a437299"
      unitRef="U_shares">0</inva:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersShares>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_600492ce-5d76-4eaa-9353-e3a3628826ae"
      unitRef="U_USD">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_dce01298-221f-434e-8167-f052e081c196"
      unitRef="U_USD">69811000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_5d7512a1-2e9d-45be-9fef-892286525a05"
      unitRef="U_USD">69811000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_4d8e999a-45ca-45fd-b0ae-b1e880b2bab1"
      unitRef="U_shares">0</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_fa657369-fb5e-48f1-9e27-0e34144919be"
      unitRef="U_USD">0</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_eb9cc19c-bf12-4ae1-919c-b912e649f35a"
      unitRef="U_USD">0</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_b8aab755-1956-47fd-8e0e-f32ebc3ec6c6"
      unitRef="U_USD">0</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_bcc70339-3b55-4870-b06e-5cd422b24018"
      unitRef="U_shares">0</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationofEntasisShares>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_f21143cd-23d3-4cc7-ab3b-30986470b5ce"
      unitRef="U_USD">0</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_4ba10049-49aa-4381-ba62-00f3f8430c31"
      unitRef="U_USD">38471000</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis>
    <inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ea98fe6d-0a58-4380-bfad-dcf3b13b027f"
      unitRef="U_USD">38471000</inva:RecognitionOfNoncontrollingInterestUponInitialConsolidationOfEntasis>
    <inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_6f310e8f-d62b-4edd-a67b-cf51b16304fa"
      unitRef="U_shares">0</inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntityShares>
    <inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_f8f886fc-c7c0-4d8f-96f8-1388dc64b5ac"
      unitRef="U_USD">0</inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity>
    <inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_da0fbccf-0b7a-4093-80ce-9c54ee76e1e2"
      unitRef="U_USD">-2000</inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity>
    <inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_78f61478-664b-4b67-b5c8-2ac32c6e3a38"
      unitRef="U_USD">-2000</inva:ChangesToNoncontrollingInterestFromAConsolidatedVariableInterestEntity>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_a9f9c99f-6689-4e27-b973-0a4735c02c9a"
      unitRef="U_shares">0</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_325bf534-c0e6-427f-a12e-5927c28b73a1"
      unitRef="U_USD">0</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_60836452-f3f6-4056-94d7-4ee22841cf7c"
      unitRef="U_USD">0</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_3857a655-23b5-4df3-9d28-f25d784281c7"
      unitRef="U_USD">78000</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_f66c51f3-e8ff-4523-a437-b4feea291017"
      unitRef="U_shares">0</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrcShares>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_322daa27-b87f-4e5f-aaec-6ba95d5f214e"
      unitRef="U_USD">0</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_fdcde935-a606-4167-be89-504ca3143658"
      unitRef="U_USD">-61304000</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc>
    <inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_3d5769a6-bc71-4a85-a65b-ee9a994f0144"
      unitRef="U_USD">-61226000</inva:DerecognitionOfNoncontrollingInterestsUponSaleOfTrc>
    <inva:DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_3e91e9e0-ee65-492a-a402-c93f02fa13e0"
      unitRef="U_shares">0</inva:DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares>
    <inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_06bd7c7f-82ce-4634-8098-6bd0f0797575"
      unitRef="U_USD">0</inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest>
    <inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_3cfa63bc-79c8-4eac-bbfd-6c17309ff993"
      unitRef="U_USD">-14153000</inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest>
    <inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_98111606-1a2c-49a3-899f-c96ec24bd3ce"
      unitRef="U_USD">0</inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest>
    <inva:DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_75d6d93c-505c-45cb-9794-a35cc98f1c01"
      unitRef="U_shares">0</inva:DerecognitionOfNoncontrollingInterestsUponAcquisitionOfEntasisMinorityInterestShares>
    <inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_c010e405-1277-4da5-904a-20ffb87548c1"
      unitRef="U_USD">0</inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest>
    <inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_91fef696-ed5c-470b-a51d-ea086ed5f938"
      unitRef="U_USD">-28009000</inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest>
    <inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ebab3a7e-16f7-4b28-a302-d6a4df428263"
      unitRef="U_USD">-42162000</inva:DerecognitionOfNonControllingInterestsUponAcquisitionOfEntasisMinorityInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_bf513847-e10d-40e9-be29-e1016e4f63e8"
      unitRef="U_shares">269000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_63910498-d935-48a0-a2d4-2b90eb62cdeb"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_5262eb77-6c8d-4be4-8509-38a8a72f5f0d"
      unitRef="U_USD">286000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_c1fc999b-8020-4c2c-bc0c-04c89e1ae824"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_d2b83c49-63cd-46ac-ba47-4c734f80ce13"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_bb2f5f0e-2a2e-4a91-b7cb-16658ad0d9cf"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_8262cec5-5396-4ef6-bec6-50c80c99e2db"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_356e6a87-81b6-4efe-b1a3-7552d76f7e59"
      unitRef="U_USD">288000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <inva:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_f4cc0364-3aa9-4c69-8ea0-83e798aefc15"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_a092e585-8143-448f-ac72-34de6fb22001"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_ec5ef41d-0e73-414c-a53b-9022a295238d"
      unitRef="U_USD">-16585000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_fc1ef9ad-149d-4dc9-8e98-bc4888090345"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <inva:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_fb2b4773-f59f-4aab-b595-92b1176532b9"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtInShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_f4a48c99-74f4-44c2-9c4e-35b3d34dbf67"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_b4319a80-d4dd-411d-a7e0-f7042796433d"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ebe2b7af-d23d-479a-8355-2dd256bd9f0b"
      unitRef="U_USD">-16585000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_67b7afb8-5da1-4800-91db-ea6f2b9a7fa3"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_d2dd344b-9479-4c76-adcb-511249f8bddf"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_5525a15b-d88e-4fc8-8013-97d5f17afb88"
      unitRef="U_USD">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_d437e55d-61db-40e0-8378-9b040097d757"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_f4714561-69ee-49f4-8903-fcd2c97fe0af"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_95bb5768-782f-4402-8be2-044d3d548609"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_1cfc9d27-a0ed-47e2-97a3-f291164def93"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_c1bc9282-542f-4c36-acca-65e3231972c6"
      unitRef="U_USD">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_5b5d448d-0c0d-46fc-8ace-a4cdb8b7f183"
      unitRef="U_shares">647000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_2210cb2a-722c-4e4c-b8a2-4a4592cdc6ed"
      unitRef="U_USD">6000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_0d80cbd0-2ce7-43f6-94c4-09e28d9b620d"
      unitRef="U_USD">8497000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_95987b19-2a0d-46c7-930a-3e914982ec99"
      unitRef="U_USD">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_56684150-76d2-48b1-b8a7-68f1435cb5be"
      unitRef="U_USD">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_02939fc6-90f5-4b4e-aa67-e273f884f9ef"
      unitRef="U_USD">8503000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_a1a7f62d-095c-4f51-87c1-5ebed5f1da4d"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_35435e6e-40e6-45cf-9642-64dde87d5a5d"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_802a3915-8ef1-46ec-a30e-3a80abd09176"
      unitRef="U_USD">4225000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_2d572309-e3e8-43c9-90a7-2d6e16bdc5c6"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_541d9a86-be85-41c7-8d09-472d344ef011"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_299c64a4-d880-447d-9a42-6e774a79c00b"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_ea773859-edbd-4eda-93e9-f54bc3540484"
      unitRef="U_USD">3122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_e8ced32c-68c5-4df2-b00a-6032daba756b"
      unitRef="U_USD">7347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <inva:ProfitLossShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_d69fe57a-c036-4086-a575-dc99aca7046f"
      unitRef="U_shares">0</inva:ProfitLossShares>
    <us-gaap:ProfitLoss
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-3"
      id="F_7cbce144-6147-487c-9ed4-22abc7c245bb"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_1c1e016c-ac4c-440d-8f45-c85b4158fba1"
      decimals="-3"
      id="F_8de13b37-899a-4399-80a9-64372d7ef038"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_9c5dd6c3-2bb6-4578-96d4-41d04917b716"
      decimals="-3"
      id="F_29ea490f-de38-4b8e-80e6-88e2f90274a3"
      unitRef="U_USD">213921000</us-gaap:ProfitLoss>
    <inva:ProfitLossShares
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_d5b0ec52-b6e3-4494-91c6-f7b042c215b9"
      unitRef="U_shares">0</inva:ProfitLossShares>
    <us-gaap:ProfitLoss
      contextRef="C_ebd565a7-3838-4623-a9b9-27c9ee94c173"
      decimals="-3"
      id="F_8b463432-0f36-4afb-ad5e-e6dbf030be2c"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_d0584d85-62e4-4f97-ba12-52ac4c3ac82d"
      decimals="-3"
      id="F_545b6e23-d71a-41d6-9f56-6cb576cf962c"
      unitRef="U_USD">6341000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_b7a044a5-8d05-4232-8c12-99e09723b3b6"
      unitRef="U_USD">220262000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1f0576c0-c074-4ef6-8698-a676d24560da"
      decimals="-3"
      id="F_4b22bb6a-d041-4c3f-b43c-fed5a6d3084b"
      unitRef="U_shares">69188000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_1f0576c0-c074-4ef6-8698-a676d24560da"
      decimals="-3"
      id="F_c39f0e64-2947-40d1-a8c8-7588b678d19c"
      unitRef="U_USD">692000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_83aa808a-93a1-4297-9265-8d2fb9dc5612"
      decimals="-3"
      id="F_0e5161f8-85ed-488e-aa44-676c0cc7025c"
      unitRef="U_USD">1163836000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_aeb0943d-6820-41d1-ba88-baf408a51c23"
      decimals="-3"
      id="F_ee859403-23ad-470c-b36b-f355e586a1a8"
      unitRef="U_USD">-204911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_3d95a88c-d5b6-4806-8dd1-644e4672cd1a"
      decimals="-3"
      id="F_5db05310-02e9-4801-99cc-d3a8d54fe73e"
      unitRef="U_shares">32005000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_3d95a88c-d5b6-4806-8dd1-644e4672cd1a"
      decimals="-3"
      id="F_6a9bdde1-761c-4405-9b62-5db5cefdcf9d"
      unitRef="U_USD">-393829000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_85db9a42-0ded-4419-91f0-f3010d32ac6f"
      decimals="-3"
      id="F_75b1c059-e2b9-4a57-b787-97a6b3741bef"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6"
      decimals="-3"
      id="F_7ca33411-c544-47f6-bffc-4afe03ddb7ad"
      unitRef="U_USD">565788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_9cf91f63-27f6-43d8-b301-5d869a3f047a"
      unitRef="U_shares">293000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_eadbbaef-ce33-400c-8000-05c3e264679c"
      unitRef="U_USD">3000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11"
      decimals="-3"
      id="F_4375fa17-2406-45ef-a932-b17baa5d67a6"
      unitRef="U_USD">89000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0"
      decimals="-3"
      id="F_3b3a9e95-2b5a-435f-8435-fce005d8996f"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_388a6be0-7362-4b29-80c8-5c6f5ec513b9"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_25b3f73f-b26d-40c2-887f-705a53605049"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4"
      decimals="-3"
      id="F_c6f44651-ca67-43d6-a615-8a5c29e0788e"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c9cd3156-27b7-4e5d-bf51-d289e6a2ace2"
      unitRef="U_USD">92000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_25b9607c-e13e-4ba4-a467-e44353be24a5"
      unitRef="U_shares">-6174000</inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_acae5009-d1e0-4238-9001-23fe932c763e"
      unitRef="U_USD">-62000</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11"
      decimals="-3"
      id="F_d655eac1-4b98-4d0d-8fb6-41e7024cfe09"
      unitRef="U_USD">-76422000</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0"
      decimals="-3"
      id="F_88ff295e-530f-4a30-b980-9b961aa22740"
      unitRef="U_USD">0</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_a26d8b52-aa1c-43f6-b87f-0c69b4df7138"
      unitRef="U_shares">0</inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_6417e35d-b487-4683-a695-1a961d1cacce"
      unitRef="U_USD">0</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4"
      decimals="-3"
      id="F_ee891ab3-14bb-4c50-a8df-971eda478425"
      unitRef="U_USD">0</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_1a316f2d-a059-4718-b677-558c513e1231"
      unitRef="U_USD">-76484000</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_040ce5e7-37c5-467d-bbc8-04f70fc455b5"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_12d00278-15ae-4d18-bbae-6066cca7af0e"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11"
      decimals="-3"
      id="F_594b0e04-3e14-4a8f-8416-ba212e6fb806"
      unitRef="U_USD">5837000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0"
      decimals="-3"
      id="F_1c93c7b3-f560-4b8a-b7c2-2799fc6fa6c5"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_79d6d807-de65-4509-b6a5-a3fceb8c1197"
      unitRef="U_shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_923406b0-51a3-412c-9c7c-34f19fb6cd98"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4"
      decimals="-3"
      id="F_c0577b77-efb2-4397-845d-ee44273f9737"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_33eaf641-bd49-437d-a5b8-0c576a07dbd1"
      unitRef="U_USD">5837000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <inva:ProfitLossShares
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_347ba7ee-fb55-4e5f-9d64-338f4bbc9839"
      unitRef="U_shares">0</inva:ProfitLossShares>
    <us-gaap:ProfitLoss
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-3"
      id="F_cef67391-37b3-4e50-a510-8a5f35161ebb"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_36337589-fa2b-44e1-bff5-12d71d918a11"
      decimals="-3"
      id="F_efe781f8-4173-4763-b1f6-4a276a7f70fc"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_3f40df25-1992-41ee-8b7f-2f20d574c2d0"
      decimals="-3"
      id="F_0e27aa83-d643-41e0-99e0-c94737836d68"
      unitRef="U_USD">179722000</us-gaap:ProfitLoss>
    <inva:ProfitLossShares
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_f8229114-c5c2-4d5c-869c-fb3afdaf2f63"
      unitRef="U_shares">0</inva:ProfitLossShares>
    <us-gaap:ProfitLoss
      contextRef="C_ba7b5502-0812-4272-8e9d-d2570169a140"
      decimals="-3"
      id="F_c3b5ba93-6557-48a6-9835-998fd8a9c220"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_57c0f280-1381-409e-9964-9e5c0e176ff4"
      decimals="-3"
      id="F_c1710383-0f68-43fb-a40d-88fa721d5ee5"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_acc33b04-c6e3-43b0-9073-d739448e6bff"
      unitRef="U_USD">179722000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_97c0d4eb-5564-4c2c-b25d-1d764e044c4b"
      decimals="-3"
      id="F_878081e4-b1e9-452a-b396-8e68b58b1012"
      unitRef="U_shares">63307000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_97c0d4eb-5564-4c2c-b25d-1d764e044c4b"
      decimals="-3"
      id="F_9d0acf33-a1c2-4dd3-92e3-83ce521c5223"
      unitRef="U_USD">633000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_6b58e123-d309-44b2-808c-8e368c6f5f3f"
      decimals="-3"
      id="F_eb28dc19-d34a-40aa-9b76-eec686d85453"
      unitRef="U_USD">1093340000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9335e429-20b3-46f5-9a0a-fb45ea5dce99"
      decimals="-3"
      id="F_9be625f4-2448-4827-b84e-3cd70ea61ce1"
      unitRef="U_USD">-25189000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_9a129dd3-6622-4125-9532-5a2fc9756798"
      decimals="-3"
      id="F_75ba76a5-ce7d-4186-b5d2-b62a8e94f4e6"
      unitRef="U_shares">32005000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9a129dd3-6622-4125-9532-5a2fc9756798"
      decimals="-3"
      id="F_512206e7-2108-45fe-a648-d994808821d7"
      unitRef="U_USD">-393829000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9b0d84ea-e834-4ea8-a1b5-32f0bbdd41f3"
      decimals="-3"
      id="F_402dbf1d-8c13-4610-bdc5-bd6f8dcbdb7c"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_9feeb81d-a056-474c-870a-4159926438fa"
      unitRef="U_USD">674955000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_9c55d95f-cd28-4ec9-9e77-f1e4d8cf79bc"
      unitRef="U_shares">345000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_a822e95b-5ef3-473a-a892-436c5e763481"
      unitRef="U_USD">3000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"
      decimals="-3"
      id="F_cb9173a7-e12b-4829-8b72-f9b0ea6b5952"
      unitRef="U_USD">1321000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8"
      decimals="-3"
      id="F_e01aab47-1365-4d8b-a0ea-1cb711ef459f"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_ad3158c6-195a-426c-ad4f-02d37d1837c3"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_1d6dfd12-d375-4a79-9ef4-9d9fa56bbc01"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430"
      decimals="-3"
      id="F_f8da533a-cdcc-4181-96f9-6d48df2e5b5a"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_353ea91c-efbd-4689-82c8-755aba4747a2"
      unitRef="U_USD">1324000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_5cf2e7ea-8a0b-4437-8e59-1744118ae63e"
      unitRef="U_shares">-987000</inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_cdec26d9-0872-4524-b0fd-6d56c20d2a80"
      unitRef="U_USD">-9000</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"
      decimals="-3"
      id="F_d5285ae1-dfed-4cb7-abd8-c16719662d58"
      unitRef="U_USD">-14916000</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8"
      decimals="-3"
      id="F_11e45415-1b62-4c90-a686-b404646db863"
      unitRef="U_USD">0</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_c2b6de88-e0d0-4f1a-9978-b9764212d6e9"
      unitRef="U_shares">0</inva:TreasuryStockSharesAcquiredIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_0ca3ed85-d6bc-4beb-898c-47bca67a23fe"
      unitRef="U_USD">0</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430"
      decimals="-3"
      id="F_cfe5318d-5ac7-44ce-a95a-b8e5a80d346f"
      unitRef="U_USD">0</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_daa5db42-9de9-4acd-9102-f16681e14028"
      unitRef="U_USD">-14925000</inva:TreasuryStockValueAcquiredCostMethodIncludingAccruedExciseTax>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_89e4a158-514a-4926-8440-53fad7766c37"
      unitRef="U_USD">0</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_73753983-02af-40a3-b6a5-5ca267af4be6"
      unitRef="U_USD">0</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"
      decimals="-3"
      id="F_5250ece2-af91-472a-aff4-a77314c0819f"
      unitRef="U_USD">39000</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8"
      decimals="-3"
      id="F_f1e4ba87-1417-41cd-bd28-7e674743911f"
      unitRef="U_USD">0</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_a4e0a033-283e-442a-bee4-8039ead41e83"
      unitRef="U_USD">0</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_9c17ebea-2889-42d6-aba9-ef50675cdae0"
      unitRef="U_USD">0</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430"
      decimals="-3"
      id="F_a4aa3785-496f-4a20-b75e-e5c4e62d8b96"
      unitRef="U_USD">0</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_91a8e7ce-2ac5-46bd-950e-985102eaff20"
      unitRef="U_USD">39000</inva:AccruedExciseTaxOnCommonStockRepurchaseAppliedAgainstTaxLiability>
    <inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_5fb75378-4c88-4ee4-8478-e2d97296c8c5"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_0211dfb3-6262-4d8f-9549-4273e4a9fa06"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"
      decimals="-3"
      id="F_adad260b-7e7a-41bc-9014-89fa0cfda43f"
      unitRef="U_USD">6374000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8"
      decimals="-3"
      id="F_c90a06c8-1c8f-4c6e-9499-88b97f19f69d"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_de62fa0e-b36b-4859-98e0-96325a50aeea"
      unitRef="U_shares">0</inva:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_1f690c85-5115-4e3a-8cd8-0e2647a3b2de"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430"
      decimals="-3"
      id="F_5941b57a-5f3c-4018-bf57-515d6efe34cd"
      unitRef="U_USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_8bcf2717-8510-46d3-8703-08b1d91e4d2f"
      unitRef="U_USD">6374000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"
      decimals="-3"
      id="F_8a1b7c82-559c-4420-923b-97168254822d"
      unitRef="U_USD">-393829000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8"
      decimals="-3"
      id="F_cfbe6c9e-3b05-433f-809d-48b0c3767297"
      unitRef="U_USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_aa2158ba-a995-4933-acdb-2ce34ed4c025"
      unitRef="U_shares">-32005000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_a0b547b7-1b0f-4709-94cb-13ae627eb105"
      unitRef="U_USD">393829000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430"
      decimals="-3"
      id="F_82a9e0ef-3ce7-44a9-832b-2ca383178b9e"
      unitRef="U_USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_49449a02-fe5b-45a3-8571-8114738dc66d"
      unitRef="U_USD">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <inva:ProfitLossShares
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_078c4d6b-d554-4a2c-898d-c5fd785697df"
      unitRef="U_shares">0</inva:ProfitLossShares>
    <us-gaap:ProfitLoss
      contextRef="C_999d353c-dc71-4460-9947-95616ca7ef74"
      decimals="-3"
      id="F_ab7f10f4-f2df-4284-8098-7ef91eab0392"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_b7cb253f-703a-4edc-bb12-3e9cf5d7513c"
      decimals="-3"
      id="F_4a547f69-8295-4cad-a113-b6ae32c87deb"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_352cd91c-df33-43d0-851f-1172751e05a8"
      decimals="-3"
      id="F_0dcb128e-7484-4e02-8ea2-c55801b32709"
      unitRef="U_USD">23392000</us-gaap:ProfitLoss>
    <inva:ProfitLossShares
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_4ab0f72a-0136-4f1c-a22e-1a5504b8f30c"
      unitRef="U_shares">0</inva:ProfitLossShares>
    <us-gaap:ProfitLoss
      contextRef="C_b8f36bb1-01c9-4719-9547-cafc116ec017"
      decimals="-3"
      id="F_a4e57bc4-7965-4603-9ffc-396d71de184c"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_86e15322-fb47-47c5-a35a-fe238e9cb430"
      decimals="-3"
      id="F_07baafa5-e0e5-45c6-9259-b3899e281308"
      unitRef="U_USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_96bb9393-d229-49c8-bd01-4cdd3f32bf35"
      unitRef="U_USD">23392000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_8d72d20d-c777-4e45-a1e5-dce95ab96806"
      decimals="-3"
      id="F_71845428-3f2d-4a42-b3b1-75cd930acf85"
      unitRef="U_shares">62665000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8d72d20d-c777-4e45-a1e5-dce95ab96806"
      decimals="-3"
      id="F_d89118af-a636-4eb8-b507-f36f40eda570"
      unitRef="U_USD">627000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_13694843-7358-454e-8001-380c30620343"
      decimals="-3"
      id="F_9ac62ed0-cc1f-4ef3-b6f3-0a45c7430f43"
      unitRef="U_USD">692329000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_b4acd677-0951-457f-af07-c89710826848"
      decimals="-3"
      id="F_723aad25-7c91-44e6-a2f4-e3392c7e1da0"
      unitRef="U_USD">-1797000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_fec8182c-e2df-4822-bd54-8e84d5ba717c"
      decimals="-3"
      id="F_d4a7d09f-091a-46dc-88c8-44b37350abdf"
      unitRef="U_shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_fec8182c-e2df-4822-bd54-8e84d5ba717c"
      decimals="-3"
      id="F_9847d1e3-152c-4958-a868-fa1e7efb5c98"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_e2ddb70e-8dcc-43a9-a5a3-84d4f1674565"
      decimals="-3"
      id="F_0fe40571-b2de-47f1-9f34-1f9f947c39e9"
      unitRef="U_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a08e912a-458b-47f0-aa54-ee6d8290a883"
      unitRef="U_USD">691159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_01c337c1-8787-4f02-9754-c89a0a0346ab"
      unitRef="U_USD">23392000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_37b21f87-4c1c-49ca-a5ef-e852c0540025"
      unitRef="U_USD">179722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_1c3489a1-8453-4a18-8428-f46017223c6d"
      unitRef="U_USD">220262000</us-gaap:ProfitLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_d3f61748-1d6d-4ee4-9704-cf5dc7494641"
      unitRef="U_USD">-12617000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_b711070d-8112-479a-8167-fe8782ffe6c6"
      unitRef="U_USD">4400000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_03000c65-ff0e-4927-80a8-5b870366dcce"
      unitRef="U_USD">25006000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ca6f7f15-24b9-4eb4-869c-e5b4eb820473"
      unitRef="U_USD">13951000</inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment>
    <inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9361aef1-01f2-448a-8bba-2bee02362ac9"
      unitRef="U_USD">13921000</inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment>
    <inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_84ce82e0-cf23-437a-897c-3a29ecf26201"
      unitRef="U_USD">13931000</inva:AmortizationOfCapitalizedFeesAndDepreciationOfPropertyAndEquipment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_fc76706e-82a9-4293-9735-6c8eb08dab39"
      unitRef="U_USD">25902000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_5a149552-d1f4-4668-8fc6-548cf09b818e"
      unitRef="U_USD">21784000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_2e1b2964-9544-4edc-b07a-6fe92399db24"
      unitRef="U_USD">5581000</us-gaap:AmortizationOfIntangibleAssets>
    <inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_d4d8874f-b0b6-41ef-af8b-8d3ae093a4b7"
      unitRef="U_USD">13820000</inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales>
    <inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c9ff0552-3891-4f77-867c-d3cfd0d5a93b"
      unitRef="U_USD">27164000</inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales>
    <inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_af6484cb-3d34-408a-89ef-228302aa4cb7"
      unitRef="U_USD">10023000</inva:InventoryFairValueStepUpAdjustmentIncludedInCostOfProductSales>
    <us-gaap:ShareBasedCompensation
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_f0fee87e-aa05-4c0f-b22d-0b5260fadef1"
      unitRef="U_USD">6374000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c7f4a8b1-95f9-4b2f-8c58-db2ca1b221c1"
      unitRef="U_USD">5837000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_321f99d4-d8f0-4491-8498-3fb4a25c9a58"
      unitRef="U_USD">7347000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ea7be3c2-1a84-4513-a6d0-dc92cfb14108"
      unitRef="U_USD">2110000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_1258932d-7a74-4f1e-a79c-39a02a5d70ce"
      unitRef="U_USD">2065000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_e0978a45-717e-42b9-a0cf-c4cc1c6641c3"
      unitRef="U_USD">2055000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_eef40542-edeb-4532-abd2-d93d515da468"
      unitRef="U_USD">-64253000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_48a99c7c-0874-4e8b-ae7f-9e05847d9167"
      unitRef="U_USD">77392000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_b5c1aaf5-ba52-48ec-85f8-0a93a5b99bfc"
      unitRef="U_USD">-161749000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <inva:UnrealizedOtherGainLossOnInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_788c2eca-2eeb-45af-b246-486b7001afd2"
      unitRef="U_USD">-59161000</inva:UnrealizedOtherGainLossOnInvestments>
    <inva:UnrealizedOtherGainLossOnInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_b6c81b0e-3db8-40ba-8ba8-b991dc7d3dc6"
      unitRef="U_USD">11129000</inva:UnrealizedOtherGainLossOnInvestments>
    <inva:UnrealizedOtherGainLossOnInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_671ab517-6bda-4858-a060-790aae64d88f"
      unitRef="U_USD">8462000</inva:UnrealizedOtherGainLossOnInvestments>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_4e495e88-aa67-4bbc-99ef-2449236b49e1"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_d544f800-5f00-42f1-9c64-04befbd12e48"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_b097a7a7-5ee3-4c18-8580-9b86df2bc483"
      unitRef="U_USD">-20662000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_97a675ba-af25-468e-b28e-367a68f37449"
      unitRef="U_USD">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_84270da9-5648-4f33-b0c7-134209eba715"
      unitRef="U_USD">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_bdfc2281-44d5-41be-b471-76b18426b9ea"
      unitRef="U_USD">266696000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_28aab1d9-eb01-4f44-8b38-a078e8a23874"
      unitRef="U_USD">722000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_35e270ba-f82c-4e4b-959f-f140ea90ac80"
      unitRef="U_USD">517000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_e6bd122b-a8ce-4d52-ad31-caba7e6bb102"
      unitRef="U_USD">-3402000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_8751e79c-6c2d-4912-b527-faf55f955652"
      unitRef="U_USD">5938000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_5117241e-e120-4b6e-88d3-7dfcd9b8657b"
      unitRef="U_USD">5053000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_48f83545-a638-4398-9e40-09a1daa026a9"
      unitRef="U_USD">3525000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_c8387934-389e-4908-a7ba-9bd8752e6d8c"
      unitRef="U_USD">-3647000</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c3f58800-1c5b-4302-9cba-ec548242d2a5"
      unitRef="U_USD">14949000</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_9b86c0cd-6843-499d-be1e-cdd72aa84c08"
      unitRef="U_USD">-13319000</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_68592f4a-f4c2-45b7-8247-e111e9f584b9"
      unitRef="U_USD">6808000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_403434e5-d86b-4e98-b31b-a0de69bd39f0"
      unitRef="U_USD">12004000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_281797c7-e07b-418d-9e9c-27330700c6da"
      unitRef="U_USD">-280000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_98a7ced2-a3d7-467a-9456-947092d5b831"
      unitRef="U_USD">-567000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9200db4d-383b-4dfa-85a0-76f512f9f1e3"
      unitRef="U_USD">-7929000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_03e454df-b1fc-45c6-b8fd-202d0690e1be"
      unitRef="U_USD">21350000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ae2849fe-b647-499a-95cf-e1389f83a182"
      unitRef="U_USD">38186000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_6cd72af9-a3c6-4b5f-982f-f159d5762366"
      unitRef="U_USD">2965000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_d01379a3-b51b-4767-8a0e-af066e072810"
      unitRef="U_USD">3341000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_102aa722-f1db-4016-8f3e-69c12a36057c"
      unitRef="U_USD">-4585000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_4c5b8710-5663-4d68-a5d7-a9aebd641062"
      unitRef="U_USD">3778000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_5f10c7ab-9c16-4654-8b36-39710a829323"
      unitRef="U_USD">92000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ae753f8d-68a0-4789-8786-5b8cb0e1a090"
      unitRef="U_USD">3044000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9a7c0b2f-9044-42d4-b88c-dbb4c0f030cb"
      unitRef="U_USD">-1498000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_782db940-b0db-4eb4-b5b8-9f03ada12c40"
      unitRef="U_USD">11913000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_1865efba-d4b4-44fb-b3ed-65cfe92e108a"
      unitRef="U_USD">0</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_217415d5-dbb4-4adc-a7ea-28370d5a1795"
      unitRef="U_USD">-937000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_d8cc9298-e97b-4020-ac9b-e5b3dabad432"
      unitRef="U_USD">207000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_498a6ecc-1e66-47f8-bb9f-bdf6c217a177"
      unitRef="U_USD">-151000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_ce881f60-a06f-41b8-882c-df7851dfb328"
      unitRef="U_USD">-817000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_fce8cdc4-decc-4eb4-9417-c55d6540fad5"
      unitRef="U_USD">-755000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_54d7251c-6d78-4cee-a12b-ec72f055b2ab"
      unitRef="U_USD">41476000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_7a484f1f-5547-4987-a9af-2ae92c2bdb01"
      unitRef="U_USD">1725000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_72a95d3b-2bf4-4c82-80b9-877d18e7cf9f"
      unitRef="U_USD">10026000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_b0d5e72a-b25e-4c86-9974-dddaa666988e"
      unitRef="U_USD">188690000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_1a9ec184-7948-438d-8737-77a370a3d4a3"
      unitRef="U_USD">141064000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_63fda1a8-e504-4710-955b-11d029f698bf"
      unitRef="U_USD">201726000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_f05cf97c-c1eb-4f27-a353-14571c3c6151"
      unitRef="U_USD">4000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_5ee57ffa-4138-40b4-83a6-baee8c9dd74f"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_440bf0c6-221c-49e2-bcdb-154523cec0f7"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_fd17745b-4e00-4eee-9139-d2e5665d559a"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_e2c8ce56-e74d-4fc7-ad59-adcb03e73db9"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_83563459-73af-45fd-a438-6c107dcedddc"
      unitRef="U_USD">45000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_50a04a3c-d99c-4d29-bb52-2c9ca1ea70d5"
      unitRef="U_USD">59617000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_6ba5bb57-34b5-439e-af1e-f5778224c0c3"
      unitRef="U_USD">65132000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_e19afc3f-a560-4747-85ec-dedf4bd8eea5"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_2e03c33f-1a76-4d63-9e48-dd0688b6d675"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_f7b9d564-1b2e-481b-a525-3bec50aa41bc"
      unitRef="U_USD">1218000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_1bd62ec8-ff7c-437f-90cf-43266b0abd8f"
      unitRef="U_USD">13725000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <inva:PurchasesOfEquityInvestmentsManagedByIspFundLp
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_51a9523f-91f8-4a94-bea2-a60e4d9fe5d9"
      unitRef="U_USD">32270000</inva:PurchasesOfEquityInvestmentsManagedByIspFundLp>
    <inva:PurchasesOfEquityInvestmentsManagedByIspFundLp
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_745cfead-128d-4062-a50c-f3ea3be4f185"
      unitRef="U_USD">31164000</inva:PurchasesOfEquityInvestmentsManagedByIspFundLp>
    <inva:PurchasesOfEquityInvestmentsManagedByIspFundLp
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_69b10899-8e75-4984-aea8-8a4610555acd"
      unitRef="U_USD">60910000</inva:PurchasesOfEquityInvestmentsManagedByIspFundLp>
    <inva:PurchasesOfTradingSecurityManagedByIspFundLp
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_4d196778-a3f5-48d6-92b2-599f61b0ce2b"
      unitRef="U_USD">0</inva:PurchasesOfTradingSecurityManagedByIspFundLp>
    <inva:PurchasesOfTradingSecurityManagedByIspFundLp
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_a1b84d49-f8f0-460e-b0f1-571d0b9b56f6"
      unitRef="U_USD">0</inva:PurchasesOfTradingSecurityManagedByIspFundLp>
    <inva:PurchasesOfTradingSecurityManagedByIspFundLp
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_6a7a0342-2e6c-481b-bdba-aff7340c1894"
      unitRef="U_USD">50000000</inva:PurchasesOfTradingSecurityManagedByIspFundLp>
    <inva:SaleOfEquityInvestmentsManagedByIspFundLp
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_3639f57f-421d-4b0b-9666-b9299d88c45d"
      unitRef="U_USD">75756000</inva:SaleOfEquityInvestmentsManagedByIspFundLp>
    <inva:SaleOfEquityInvestmentsManagedByIspFundLp
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_67cbc89b-0ecd-4873-a7fa-062c436202b5"
      unitRef="U_USD">72500000</inva:SaleOfEquityInvestmentsManagedByIspFundLp>
    <inva:SaleOfEquityInvestmentsManagedByIspFundLp
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ae0d56a2-fe6d-43bc-95d9-f11fdfdb3566"
      unitRef="U_USD">24281000</inva:SaleOfEquityInvestmentsManagedByIspFundLp>
    <inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_67b72745-ac69-418a-b985-caf5dd560520"
      unitRef="U_USD">43486000</inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp>
    <inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_5b120828-93cd-486f-b7aa-a4fe2d07ad68"
      unitRef="U_USD">41336000</inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp>
    <inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_5b17791a-0b28-4320-9562-cbe02607d37e"
      unitRef="U_USD">23371000</inva:PurchaseAndSaleOfOtherInvestmentsManagedByIspFundLp>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_91a0910b-14d3-42c3-a455-acfc9d36f42f"
      unitRef="U_USD">270000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_6e51a33b-8f42-4ab7-85e6-6604f3fb6134"
      unitRef="U_USD">411000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_781d9693-1cc5-477f-8156-ea5bf2fd6971"
      unitRef="U_USD">67000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_aa81f8aa-63af-4200-ad44-293fc5fd4fc9"
      unitRef="U_USD">101000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_76c4902e-0d20-484f-980b-91f06f719dbe"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_069c6251-3944-4ca2-97d8-3df5d3cd1328"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <inva:NetProceedsFromSaleOfVariableInterestEntityEquity
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_45261734-c870-4106-b101-0d27dc95dace"
      unitRef="U_USD">0</inva:NetProceedsFromSaleOfVariableInterestEntityEquity>
    <inva:NetProceedsFromSaleOfVariableInterestEntityEquity
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_3d5c1105-c7c7-44f8-a66c-3a93feaa3c5d"
      unitRef="U_USD">0</inva:NetProceedsFromSaleOfVariableInterestEntityEquity>
    <inva:NetProceedsFromSaleOfVariableInterestEntityEquity
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_f5a84d62-3076-49cb-beac-49b682790964"
      unitRef="U_USD">248191000</inva:NetProceedsFromSaleOfVariableInterestEntityEquity>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_18a868bd-4016-404a-aacf-b555095da781"
      unitRef="U_USD">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_38b96089-b1f2-457c-a9b4-7c6f6db1a265"
      unitRef="U_USD">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_f982f0d5-d32f-4d45-9a74-9309b8e9bac5"
      unitRef="U_USD">23070000</us-gaap:CashAcquiredFromAcquisition>
    <inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_85a70bc8-9b47-49f1-9b13-502ea406e40f"
      unitRef="U_USD">0</inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired>
    <inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_161c7afc-b6bd-4d0f-9e0e-b277a4b5237e"
      unitRef="U_USD">0</inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired>
    <inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_49e8d66d-8f67-4f38-a37d-01883e663b2b"
      unitRef="U_USD">159103000</inva:CashPaidForTheAcquisitionOfLaJollaPharmaceuticalCompanyNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_366d2b07-9e0a-4af1-822a-15d584c1766e"
      unitRef="U_USD">-63786000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_00960ff2-28e2-4433-9109-a7b522df8140"
      unitRef="U_USD">-66761000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_f0efceba-0e27-4f24-a235-c0d228c3df49"
      unitRef="U_USD">-56634000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_53de62fe-c8fa-40b3-b6ec-99996bb3ff2c"
      unitRef="U_USD">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9475619d-1945-4ef3-b0d8-abe50e55374a"
      unitRef="U_USD">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_4ecfbb09-53d5-4d27-a2ca-7f0ab8ca681c"
      unitRef="U_USD">69811000</us-gaap:PaymentsToMinorityShareholders>
    <inva:PurchaseOfEntasisNoncontrollingInterest
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_f31421c9-5c3b-40e6-92bd-ebc0e191013e"
      unitRef="U_USD">0</inva:PurchaseOfEntasisNoncontrollingInterest>
    <inva:PurchaseOfEntasisNoncontrollingInterest
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_72ca3c9f-497a-41b4-b6a2-e568ccf29474"
      unitRef="U_USD">0</inva:PurchaseOfEntasisNoncontrollingInterest>
    <inva:PurchaseOfEntasisNoncontrollingInterest
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_41be75d3-96ab-4a9c-bf4e-1419531835d6"
      unitRef="U_USD">43910000</inva:PurchaseOfEntasisNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_fb5f6456-e2d2-4a7e-b409-62012a7cb4e1"
      unitRef="U_USD">14777000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_641010f0-0aa8-4eb4-9c33-c7682e8da496"
      unitRef="U_USD">75728000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_012c1619-9c27-4ab4-9eb3-400aaa78af22"
      unitRef="U_USD">8503000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_8292aa3c-28e3-40ad-bf56-4d066083f0e5"
      unitRef="U_USD">142000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c2bc4d61-39da-4ee5-9d99-ab34bb89110a"
      unitRef="U_USD">77000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_3ead2877-1755-416a-84da-054c659c0498"
      unitRef="U_USD">82000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_d535bbde-b7d5-4f9c-93dd-83d8b5f84729"
      unitRef="U_USD">1466000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_e1057d14-313a-4527-956b-956fcf643267"
      unitRef="U_USD">170000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_1c220479-469c-4473-a13a-f270c8edb270"
      unitRef="U_USD">370000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_103f48bb-b8b6-42b0-abaa-9b5e13c49354"
      unitRef="U_USD">0</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_73e3ed55-ecbf-4fe5-97bf-c5f63c6958aa"
      unitRef="U_USD">96204000</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_6e6175a5-009d-461b-a033-3daaccdce998"
      unitRef="U_USD">165131000</us-gaap:RepaymentsOfUnsecuredDebt>
    <inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_2916c962-69a0-4adf-93c2-2d79e66dc0a1"
      unitRef="U_USD">0</inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes>
    <inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_39eb5ff0-cdeb-4f83-ba7c-b798f4e38ba3"
      unitRef="U_USD">0</inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes>
    <inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_7ec0237a-94c5-4148-b75d-8e5a6af91228"
      unitRef="U_USD">21037000</inva:PurchasesOfCappedCallOptionsAssociatedWithConvertibleSeniorNotes>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_025d55ce-7d6c-459b-89a3-74dd10518b42"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_5bf191b5-3dbe-4dd3-85c9-f67dc935afc4"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_fba12e3d-85bc-46e4-902d-53b2b8728426"
      unitRef="U_USD">252536000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_5d4f71ac-c0ba-4a85-bfa9-9674c5b248b8"
      unitRef="U_USD">-13453000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_8314d379-7f3b-482b-ba41-6d96ca515d5b"
      unitRef="U_USD">-171839000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_b1ac6d85-a144-422a-be32-0d9a226ebeed"
      unitRef="U_USD">-55568000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_fa16bf42-3452-48cc-8197-be61d0c6f981"
      unitRef="U_USD">111451000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_4c713d10-487a-4c3b-8440-1c72b91acef3"
      unitRef="U_USD">-97536000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_58b6f11a-7c0e-415e-9e20-0dcc984f5634"
      unitRef="U_USD">89524000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_240e74aa-79d4-4b03-996e-b09827537397"
      unitRef="U_USD">193513000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6"
      decimals="-3"
      id="F_91b2b110-f392-41f0-bbdb-6e26d3b9ae67"
      unitRef="U_USD">291049000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f"
      decimals="-3"
      id="F_a45762a7-48e6-4bb2-9a39-369d99112026"
      unitRef="U_USD">201525000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_6c792b8b-5405-4acf-929f-5afeeaec57ff"
      unitRef="U_USD">304964000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_1b15f947-dc0a-4475-b94f-b06d7a8f1189"
      unitRef="U_USD">193513000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6"
      decimals="-3"
      id="F_0b6c5be7-93d0-4ff4-bd29-b27b47122463"
      unitRef="U_USD">291049000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_45a70a8b-168f-4ad0-9240-e322c1175767"
      unitRef="U_USD">10359000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_2bea8cc5-b3ce-46a0-9bdf-6113a50bc293"
      unitRef="U_USD">11381000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_7803804d-9750-44ac-8268-8ae5ad704463"
      unitRef="U_USD">11736000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_00d97622-428e-4cf0-898a-8f912f82ad3d"
      unitRef="U_USD">11793000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_978913d5-c9eb-4114-bf7c-92df642438ba"
      unitRef="U_USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_3b93e15e-1cef-4da0-aafa-8bb4f96662fd"
      unitRef="U_USD">53855000</us-gaap:IncomeTaxesPaidNet>
    <inva:AccruedInterestIncomeIncludedInLongTermInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_c6390ab0-7c7d-45f6-837b-44211bed6437"
      unitRef="U_USD">3584000</inva:AccruedInterestIncomeIncludedInLongTermInvestments>
    <inva:AccruedInterestIncomeIncludedInLongTermInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_ac35d5dd-bb1e-4e14-8d19-7b59c7e638d5"
      unitRef="U_USD">2666000</inva:AccruedInterestIncomeIncludedInLongTermInvestments>
    <inva:AccruedInterestIncomeIncludedInLongTermInvestments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_35235357-6675-4aa1-b12e-e25f44037dd8"
      unitRef="U_USD">0</inva:AccruedInterestIncomeIncludedInLongTermInvestments>
    <inva:NonCashActivity
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ff499806-35a5-4802-a051-5a0212b8740d"
      unitRef="U_USD">0</inva:NonCashActivity>
    <inva:NonCashActivity
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_05d73bc9-049f-44ed-b883-be5b135c59ad"
      unitRef="U_USD">0</inva:NonCashActivity>
    <inva:NonCashActivity
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_301c2958-1f79-435b-af31-5c6588e156c9"
      unitRef="U_USD">-28228000</inva:NonCashActivity>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4be3b0da-ec19-43a6-b36e-eab72ee7b148">&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1.  DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of Operations&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Innoviva, Inc. (and where context requires, together with its subsidiaries referred to as &#x201c;Innoviva&#x201d;, the &#x201c;Company&#x201d;, or &#x201c;we&#x201d; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#x201c;IST&#x201d;), and a portfolio of strategic investments in other healthcare assets. Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#x201c;GSK&#x201d;), including RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(fluticasone furoate/vilanterol, &#x201c;FF/VI&#x201d;) and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(umeclidinium bromide/vilanterol, &#x201c;UMEC/VI&#x201d;), and up until July 2022, TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(the combination FF/UMEC/VI). We sold our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% ownership interest in Theravance Respiratory Company, LLC (&#x201c;TRC&#x201d;) on July 20, 2022, and are no longer entitled to receive royalties on sales of TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; products. Under the Long-Acting Beta2 Agonist (&#x201c;LABA&#x201d;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as follows: &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% on the first $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion of annual global net sales and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% for all annual global net sales above $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion; and royalties from the sales of ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which tier upward at a range from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We expanded our portfolio through the acquisition of Entasis Therapeutics Holdings Inc. (&#x201c;Entasis&#x201d;) on July 11, 2022 and the acquisition of La Jolla Pharmaceutical Company (&#x201c;La Jolla&#x201d;) on August 22, 2022. Our commercial and marketed products include GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Our new product, XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#x201c;FDA&#x201d;) for the treatment of hospital-acquired and ventilator-associated pneumonias caused by &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Acinetobacter&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in adults and we commenced commercial sales of XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd., (&#x201c;Basilea&#x201d;) for the commercialization of ZEVTERA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue to further advance our pipeline and are on track to submit a New Drug Application (&#x201c;NDA&#x201d;) for zoliflodacin, potentially first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the FDA in early 2025. Overall, we have a wholly owned robust critical care and infectious disease operating platform with a hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, we own other strategic healthcare assets, such as a large equity stake in Armata Pharmaceuticals, a leader in development of bacteriophages with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of Innoviva, our wholly owned subsidiaries and certain variable interest entities (&#x201c;VIE&#x201d;) for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entity by the respective noncontrolling party.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Factors Affecting Comparability&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our historical financial condition and results of operations for the periods presented may not be comparable, either between periods or going forward due to the factors below and as discussed in Note 5, &#x201c;Consolidated Entities and Acquisitions&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accounting consolidation of Entasis on February 17, 2022 and purchase of remaining noncontrolling interest in Entasis on July 11, 2022;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sale of our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% ownership interest in TRC on July 20, 2022; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Acquisition of La Jolla on August 22, 2022.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Management&#x2019;s Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Management evaluates its significant accounting policies and estimates on an ongoing basis. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. These estimates also form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risk and of Significant Suppliers and Partners&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and equity and long-term investments. Although we deposit our cash with multiple financial institutions, our deposits, at times, may exceed federally insured limits.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We are dependent on third-party manufacturers to supply active pharmaceutical ingredients (&#x201c;API&#x201d;) and drug products for commercial and research and development programs. These programs could be adversely affected by significant interruption in the supply of API or drug products.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Currently, we derive most of our revenues from GSK and our near-term success depends in large part on GSK&#x2019;s ability to successfully develop and commercialize the products in the respiratory programs partnered with GSK. Our near-term success depends in large part upon the performance by GSK of its commercial obligations under the GSK Agreements and the commercial success of RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. If GSK does not devote sufficient resources to the commercialization or development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed. GSK is responsible for all clinical and other product development, regulatory, manufacturing and commercialization activities for products developed under the GSK Agreements, including RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our royalty revenues may fluctuate due to a variety of factors, many of which are outside of our control. Our royalty revenues under the GSK Agreements may not meet our, analysts&#x2019; or investors&#x2019; expectations, due to a number of important factors.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our revenue for the periods include product sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Hospitals and other healthcare organizations generally purchase our products through a network of specialty distributors. These specialty distributors, which are located in the U.S., are considered our customers for accounting purposes. We do not believe that loss of one of these distributors would significantly impact our ability to distribute our products, as we expect that sales volume would be absorbed by new or remaining distributors. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of our customers each account for approximately:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our net product sales for the year ended December 31, 2024; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our net product sales for the year ended December 31, 2023; and, &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our net product sales for the year ended December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These same customers account for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our receivables from net product sales, which are included in &#x201c;Accounts receivables, net&#x201d; in our consolidated balance sheet as of December 31, 2024. These same customers account for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our receivables from net product sales, which are included in &#x201c;Accounts receivables, net&#x201d; in our consolidated balance sheet as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are identified as components of an enterprise about which separate discrete financial information is made available for evaluation by the chief operating decision maker (&#x201c;CODM&#x201d;) in making decisions regarding resource allocation and assessing performance. Refer to Note 15, &#x201c;Segment Reporting&#x201d;, for more segment information.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Variable Interest Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The primary beneficiary of a variable interest entity (&#x201c;VIE&#x201d;) is required to consolidate the assets and liabilities of the VIE. When we obtain a variable interest in another entity, we assess at the inception of the relationship and upon occurrence of certain significant events whether the entity is a VIE and, if so, whether we are the primary beneficiary of the VIE based on our power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To assess whether we have the power to direct the activities of a VIE that most significantly impact the VIE&#x2019;s economic performance, we consider all the facts and circumstances, including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE&#x2019;s economic performance and identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To assess whether we have the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, we consider all of our economic interests that are deemed to be variable interests in the VIE. This assessment requires us to apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Business Combination&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When we acquire an entity in a business combination, we recognize the fair value of all assets acquired, liabilities assumed, and any non-controlling interest in the acquiree and establish the acquisition date as the fair value measurement point. We recognize and measure goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair value of the identified net assets acquired. Acquisition-related expenses and related restructuring costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use the income method. This method starts with a forecast of all of the expected future net cash flows for each asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Some of the more significant estimates and assumptions inherent in the income method or other methods include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows and the assessment of the asset&#x2019;s life cycle and the competitive trends impacting the asset, including consideration of any technical, legal, regulatory, or economic barriers to entry. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may even be considered to have indefinite useful lives.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We consider all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accounts receivable are recorded net of estimates for prompt-pay discounts, chargebacks, returns and rebates. Allowances for prompt-pay discounts and chargebacks are based on contractual terms. We estimate the allowance for credit losses based on existing contractual payment terms, actual payment patterns of customers and individual customer circumstances.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Inventory is stated at the lower of cost or estimated net realizable value on a first-in, first-out basis. We periodically analyze inventory levels and write down inventory as cost of products sold when the following occurs: inventory has become obsolete, inventory has a cost basis in excess of its estimated net realizable value, or inventory quantities are in excess of expected product sales.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, which consist of laboratory equipment, computer equipment, software, office furniture and fixtures, and leasehold improvements, were not material as of December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:49.17%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:49.17%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of remaining lease terms or useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment, furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#x2013; &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity and Long-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We invest from time to time in equity and debt securities of private or public companies. If we determine that we have control over these companies under either voting or VIE models, we consolidate them in our consolidated financial statements. If we determine that we do not have control over these companies under either voting or VIE models, we then determine if we have an ability to exercise significant influence via voting interests, board representation or other business relationships.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We may account for the investments where we exercise significant influence using either an equity method of accounting or at fair value by electing the fair value option under Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 825, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method, we apply it to all our financial interests in the same entity (equity and debt, including guarantees) that are eligible items. All gains and losses from fair value changes, unrealized and realized, are presented as changes in fair values of equity method investments, net, and changes in fair values of equity and long-term investments, net, within the consolidated statements of income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If we conclude that we do not have an ability to exercise significant influence over an investee, we may elect to account for the security without a readily determinable fair value using the measurement alternative method under ASC 321, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments &#x2013; Equity Securities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. This measurement alternative method allows us to measure the equity investment at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We also invest in ISP Fund LP, which investments consist of money market funds and equity and debt securities in the healthcare, pharmaceutical and biotechnology industries. Pursuant to the Partnership Agreement entered in December 2020, we became a limited partner of this partnership, and our contributions were subject to a 36-month lock-up period, which restriction prevented us from having control over and access to the contributions and related investments. The lock-up period for a certain portion of our contributions expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. These investments were classified as long-term investments in the consolidated balance sheet as of December 31, 2023. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of these investments, which consist mainly of cash and money market funds that we expect to be distributed in the next 12 months, were classified as &#x201c;Current portion of ISP Fund investments&#x201d; in the consolidated balance sheet as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. We classify these inputs into the following hierarchy:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Quoted prices for identical instruments in active markets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Quoted prices for similar instruments in active markets; quoted prices for identical 3or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Unobservable inputs and little, if any, market activity for the assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments include cash equivalents, accounts receivable, receivables from collaborative arrangements, accounts payable, and accrued liabilities, equity investments and convertible promissory notes. The carrying values of cash equivalents, receivables from collaborative arrangements, accounts payable, and accrued liabilities approximate their estimated fair values due to the relatively short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Capitalized Fees Paid&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We capitalize fees paid to licensors related to agreements for approved products or commercialized products. We capitalize these fees as capitalized fees paid (&#x201c;Capitalized Fees&#x201d;) and amortize them on a straight-line basis over their estimated useful lives upon the commercial launch of the product, shortly after its regulatory approval. The estimated useful lives of these Capitalized Fees are determined on a country-by-country and product-by-product basis, as the later of the expiration or termination of the last patent right covering the compound in such product in such country and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;15 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from first commercial sale of such product in such country, unless the Collaboration Agreement is terminated earlier. Consistent with our policy for classification of costs under the research and development collaborative arrangements, the amortization of these Capitalized Fees is recognized as a reduction of royalty revenue. We review our Capitalized Fees for impairment on a product-by-product basis for each major geographic area when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The recoverability of Capitalized Fees is measured by comparing the asset&#x2019;s carrying amount to the expected undiscounted future cash flows that the asset is expected to generate. The determination of recoverability typically requires various estimates and assumptions, including estimating the useful life over which cash flows will occur, their amount, and the asset&#x2019;s residual value, if any. We derive the required cash flow estimates from near-term forecasted product sales and long-term projected sales in the corresponding market.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Goodwill is recognized as the excess of the purchase consideration of an acquired entity over the fair value assigned to assets acquired and liabilities assumed in a business combination. In addition to recognizing intangible assets acquired in a business combination, we capitalize milestone payments related to in-licensing agreements for approved products as an intangible asset when the contingency for the milestone is resolved and the consideration is issued or becomes issuable. Goodwill and intangible assets with indefinite useful life are not amortized and are tested for impairment at least annually on the first day of December of each year or more frequently if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#x2019;s carrying asset amount may not be recoverable. Intangible assets with definite useful lives are amortized on a straight-line basis over their respective remaining useful lives and are tested for impairment only if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#x2019;s carrying amount may not be recoverable. Significant judgment may be involved in determining if an indicator of impairment has occurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets represent our right to use an underlying asset over the lease term and include any lease payments made prior to the lease commencement date and are reduced by lease incentives. Lease liabilities represent the present value of the total lease payments over the lease term, calculated using an estimated incremental borrowing rate. Lease expense is recognized on a straight-line basis over the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We apply the guidance on principal versus agent considerations under ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, to determine the appropriate treatment for the transactions between us and third parties. The classification of transactions under our arrangements is determined based on the nature and contractual terms of the arrangement along with the nature of the operations of the participants. Any consideration related to activities in which we are considered the principal, which includ&lt;/span&gt;&lt;span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;es being in control of the good or service before such good or service is transferred to the customer, are accounted for as product sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is recognized when our customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized through a five-step process: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price for the contract; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue as a performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Royalty Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognize the royalty revenue on net sales of products with respect to which we have contractual royalty rights in the period in which the royalties are earned. The net sales reports provided by our partner are based on its methodology and assumptions to estimate rebates and returns, which it monitors and adjusts regularly in light of contractual and legal obligations, historical trends, past experience and projected market conditions. Our partner may make significant adjustments to its sales based on actual results recorded, which could cause our royalty revenue to fluctuate. We conduct periodic royalty audits to evaluate the information provided by our partner. Royalties are recognized net of amortization of capitalized fees associated with any approval and launch milestone payments made to GSK.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Product Sales&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Revenue from product sales is recognized when our customers obtain control of the product and is recorded at the transaction price, net of estimates for variable consideration consisting of chargebacks, discounts, returns and rebates. Variable consideration is estimated using the expected-value amount method, which is the sum of probability-weighted amounts in a range of possible consideration amounts. Actual amounts of consideration ultimately received may differ from our estimates. If actual results vary materially from our estimates, we will adjust these estimates, which will affect revenue from product sales and earnings in the period such estimates are adjusted. These items may include:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chargebacks: Chargebacks are discounts we provide to distributors in the event that the sales prices to end users are below the distributors&#x2019; acquisition price. This may occur due to a direct contract with a health system, a group purchasing organization (&#x201c;GPO&#x201d;) agreement or a sale to a government facility. Chargebacks are estimated based on known chargeback rates and recorded as a reduction of revenue on delivery to our customers.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Discounts: We offer customers various forms of incentives and consideration, including prompt-pay and other discounts. We estimate discounts primarily based on contractual terms. These discounts are recorded as a reduction of revenue on delivery to our customers.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Returns: We offer customers a limited right of return, generally for damaged or expired product. We estimate returns based on an internal analysis, which includes actual experience. The estimates for returns are recorded as a reduction of revenue on delivery to our customers. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Rebates: We participate in Medicaid rebate programs, which provide assistance to certain low-income patients based on each individual state&#x2019;s guidelines regarding eligibility and services. Under the Medicaid rebate programs, we pay a rebate to each participating state, generally within three months after the quarter in which product was sold. Additionally, we may offer customer incentives and consideration in the form of volume-based or other rebates. The estimates for rebates are recorded as a reduction of revenue on delivery to our customers. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We continue to assess our estimates of variable consideration as we accumulate additional historical data and will adjust these estimates accordingly.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;License Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the inception of a licensing arrangement that includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price. We generally recognize these milestone payments as revenues when they are achieved because there is considerable uncertainty in the research and development processes that trigger receipt of these payments under our agreements. Similarly, we recognize regulatory approval milestone payments as revenues once the product is approved by the applicable regulatory agency. For delivery of other goods or services related to a licensing arrangement, we determine whether the performance obligation is satisfied over time or at a point in time. If the performance obligation is satisfied over time, we use judgment in determining the appropriate method of measuring progress for purposes of recognizing revenue. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development expenses are recognized in the period that services are rendered or goods are received. Research and development expenses consist of salaries and benefits, laboratory supplies, facilities and other overhead costs, research-related manufacturing costs, contract service and clinical-related service costs performed by third party research organizations, research institutions and other outside service providers. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized. Such amounts are recognized as an expense as the related goods are delivered or the related services are performed. We also utilize significant judgment and estimates to record accruals for estimated ongoing research costs based on the progress of the studies and progress of research manufacturing activities.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Interest Expense on Deferred Royalty Obligation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Interest expense related to the deferred royalty obligation is recognized over the expected repayment term of the deferred royalty obligation using the effective interest method. The assumptions used in determining the expected repayment term of the deferred royalty obligation require us to make estimates that could impact the effective interest rate. Each reporting period, we estimate the expected repayment term of the deferred royalty obligation based on forecasted net sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Changes in interest expense resulting from changes in the effective interest rate, if any, are recorded on a prospective basis. Refer to Note 12, &#x201c;Debt&#x201d;, for more information.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Stock&#x2011;Based Compensation Awards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use the Black-Scholes-Merton option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our employee stock purchase plan (&#x201c;ESPP&#x201d;). The Black-Scholes-Merton option valuation model requires the use of assumptions, including the expected term of the award and the expected stock price volatility. We use the &#x201c;simplified&#x201d; method as described in Staff Accounting Bulletin No. 107, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Share-Based Payment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&#x201d; for the expected option term. We use our historical volatility to estimate expected stock price volatility.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted stock units (&#x201c;RSUs&#x201d;) and restricted stock awards (&#x201c;RSAs&#x201d;) are measured based on the fair market values of the underlying stock on the dates of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense is calculated based on awards ultimately expected to vest and is reduced for estimated forfeitures at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differed from those estimates. Our estimated annual forfeiture rates for stock options, RSUs and RSAs are based on our historical forfeiture experience.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimated fair value of stock options, RSUs and RSAs is expensed on a ratable or straight-line basis over the expected term of the grant or expected term of the vesting. Compensation expense is recorded over the requisite service period based on management&#x2019;s best estimate as to whether it is probable that the shares awarded are expected to vest.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Compensation expense for purchases under the ESPP is recognized based on the fair value of the common stock on the date of offering, less the purchase discount percentage provided for in the plan.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and the tax basis of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The recognition and measurement of tax benefits requires significant judgment. Our judgment might change as new information becomes available. We continue to evaluate our deferred tax assets each reporting period to determine whether adjustments to our valuation allowance are required and deferred tax assets will be realized based on the consideration of all available positive and negative evidence, including the differences between our anticipated and actual future operating results, using a &#x201c;more likely than not&#x201d; standard.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#x2019;s sustainability and is measured at the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we determine whether the factors underlying the sustainability assertion have changed and whether the amount of the recognized tax benefit is still appropriate.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Related Parties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sarissa Capital ow&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ned &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of o&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ur outstanding common stock as of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Transactions with Sarissa Capital are described in Note 5, &#x201c;Consolidated Entities and Acquisitions&#x201d;. Sarissa Capital is considered to be a related party because two of its principals are members of our board of directors.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Improvements to Reportable Segment Disclosures (Topic 280).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; This ASU update requires enhanced segment disclosures, primarily related to significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. We adopted ASU 2023-07 for the 2024 fiscal year and provided the enhanced disclosures for the comparative years. The adoption of ASU 2023-07 did not have a material impact on the Company's financial statements. Enhanced disclosures related to significant segment expenses are included in Note 15, &#x201c;Segment Reporting.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Improvements to Income Tax Disclosures (Topic 740)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The ASU requires the disclosure of income taxes paid disaggregated by jurisdiction and enhanced disclosures for the entity&#x2019;s effective tax rate reconciliation as well as other income tax related disclosures. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. The Company has not early adopted the ASU during 2024 and does not expect the adoption of the amendments to have a significant impact on its financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement &#x2014; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures (Subtopic 220-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the statement of income as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company in annual reporting periods beginning after December 15, 2027, and interim reporting periods beginning after December 15, 2027. We are currently evaluating the potential impact that ASU 2024-03 may have on our financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-04, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20), &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;which clarifies the assessment of whether a transaction should be accounted for as an induced conversion or extinguishment of convertible debt when changes are made to conversion features as part of an offer to settle the instrument. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. We are currently evaluating the potential impact that ASU 2024-04 may have on our financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <inva:DescriptionOfOperationsPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4a92186d-b738-4487-9394-191a0b398c81">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of Operations&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Innoviva, Inc. (and where context requires, together with its subsidiaries referred to as &#x201c;Innoviva&#x201d;, the &#x201c;Company&#x201d;, or &#x201c;we&#x201d; and other similar pronouns) is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (&#x201c;IST&#x201d;), and a portfolio of strategic investments in other healthcare assets. Our royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (&#x201c;GSK&#x201d;), including RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(fluticasone furoate/vilanterol, &#x201c;FF/VI&#x201d;) and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(umeclidinium bromide/vilanterol, &#x201c;UMEC/VI&#x201d;), and up until July 2022, TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(the combination FF/UMEC/VI). We sold our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% ownership interest in Theravance Respiratory Company, LLC (&#x201c;TRC&#x201d;) on July 20, 2022, and are no longer entitled to receive royalties on sales of TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; products. Under the Long-Acting Beta2 Agonist (&#x201c;LABA&#x201d;) Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as follows: &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% on the first $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion of annual global net sales and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% for all annual global net sales above $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion; and royalties from the sales of ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which tier upward at a range from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We expanded our portfolio through the acquisition of Entasis Therapeutics Holdings Inc. (&#x201c;Entasis&#x201d;) on July 11, 2022 and the acquisition of La Jolla Pharmaceutical Company (&#x201c;La Jolla&#x201d;) on August 22, 2022. Our commercial and marketed products include GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Our new product, XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(formerly known as sulbactam-durlobactam or SUL-DUR), was approved by the United States Food and Drug Administration (&#x201c;FDA&#x201d;) for the treatment of hospital-acquired and ventilator-associated pneumonias caused by &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Acinetobacter&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in adults and we commenced commercial sales of XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the third quarter of 2023. On December 14, 2024, we entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd., (&#x201c;Basilea&#x201d;) for the commercialization of ZEVTERA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the U.S. We continue to further advance our pipeline and are on track to submit a New Drug Application (&#x201c;NDA&#x201d;) for zoliflodacin, potentially first in class, single dose oral drug for the treatment of uncomplicated gonorrhea, to the FDA in early 2025. Overall, we have a wholly owned robust critical care and infectious disease operating platform with a hospital focus anchored by four differentiated products with significant growth potential and a promising drug candidate.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, we own other strategic healthcare assets, such as a large equity stake in Armata Pharmaceuticals, a leader in development of bacteriophages with potential use across a range of infectious and other serious diseases. We also have economic interests in other healthcare companies.&lt;/span&gt;&lt;/p&gt;</inva:DescriptionOfOperationsPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_79768fb0-1a83-46a5-a213-1d3d9c213d45"
      decimals="2"
      id="F_979bd953-2c70-4680-8456-a52cd2cb3e06"
      unitRef="U_pure">0.15</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <inva:CollaborativeArrangementRoyaltyRateDefinedLevelOne
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="2"
      id="F_4227de1b-daf5-4784-a300-b83faf8f6409"
      unitRef="U_pure">0.15</inva:CollaborativeArrangementRoyaltyRateDefinedLevelOne>
    <inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="-8"
      id="F_f1bb9ae4-645e-40e4-9ea9-e29747feefd9"
      unitRef="U_USD">3000000000</inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate>
    <inva:CollaborativeArrangementRoyaltyRateDefinedLevelTwo
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="2"
      id="F_d4de1a91-132a-40f0-8683-cfd955851e2b"
      unitRef="U_pure">0.05</inva:CollaborativeArrangementRoyaltyRateDefinedLevelTwo>
    <inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="-8"
      id="F_02fc6644-7d62-41b7-9e6e-3d6ce2f9ecda"
      unitRef="U_USD">3000000000</inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate>
    <inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts
      contextRef="C_12297e5a-44ee-441e-b9cb-846681e357f4"
      decimals="3"
      id="F_c85e187b-cbb2-432b-b621-87c217b7f597"
      unitRef="U_pure">0.065</inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts>
    <inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts
      contextRef="C_a4df3b3b-267d-4f2f-ac89-6815c2bbcdeb"
      decimals="2"
      id="F_a30fa50e-db97-47d5-a5b5-a9681a7eee86"
      unitRef="U_pure">0.10</inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_c818bc4d-4d48-498a-beba-8cd835206285">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of Innoviva, our wholly owned subsidiaries and certain variable interest entities (&#x201c;VIE&#x201d;) for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entity by the respective noncontrolling party.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <inva:FactorsAffectingComparabilityPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_48d44cd6-cfc1-43b9-af59-995f60e20f15">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Factors Affecting Comparability&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our historical financial condition and results of operations for the periods presented may not be comparable, either between periods or going forward due to the factors below and as discussed in Note 5, &#x201c;Consolidated Entities and Acquisitions&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accounting consolidation of Entasis on February 17, 2022 and purchase of remaining noncontrolling interest in Entasis on July 11, 2022;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sale of our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% ownership interest in TRC on July 20, 2022; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Acquisition of La Jolla on August 22, 2022.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</inva:FactorsAffectingComparabilityPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_79768fb0-1a83-46a5-a213-1d3d9c213d45"
      decimals="2"
      id="F_60e406a3-f758-488e-9a18-f48dbac1b036"
      unitRef="U_pure">0.15</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:UseOfEstimates
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_3e894d42-2a01-40ca-b850-fbcf734b269f">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Management&#x2019;s Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Management evaluates its significant accounting policies and estimates on an ongoing basis. We base our estimates on historical experience and other relevant assumptions that we believe to be reasonable under the circumstances. These estimates also form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_f77af13b-4ad6-4b19-88cd-5710ca744a87">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risk and of Significant Suppliers and Partners&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and equity and long-term investments. Although we deposit our cash with multiple financial institutions, our deposits, at times, may exceed federally insured limits.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We are dependent on third-party manufacturers to supply active pharmaceutical ingredients (&#x201c;API&#x201d;) and drug products for commercial and research and development programs. These programs could be adversely affected by significant interruption in the supply of API or drug products.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Currently, we derive most of our revenues from GSK and our near-term success depends in large part on GSK&#x2019;s ability to successfully develop and commercialize the products in the respiratory programs partnered with GSK. Our near-term success depends in large part upon the performance by GSK of its commercial obligations under the GSK Agreements and the commercial success of RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. If GSK does not devote sufficient resources to the commercialization or development of these products, is unsuccessful in its efforts, or chooses to reprioritize its commercial programs, our business would be materially harmed. GSK is responsible for all clinical and other product development, regulatory, manufacturing and commercialization activities for products developed under the GSK Agreements, including RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our royalty revenues may fluctuate due to a variety of factors, many of which are outside of our control. Our royalty revenues under the GSK Agreements may not meet our, analysts&#x2019; or investors&#x2019; expectations, due to a number of important factors.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our revenue for the periods include product sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Hospitals and other healthcare organizations generally purchase our products through a network of specialty distributors. These specialty distributors, which are located in the U.S., are considered our customers for accounting purposes. We do not believe that loss of one of these distributors would significantly impact our ability to distribute our products, as we expect that sales volume would be absorbed by new or remaining distributors. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of our customers each account for approximately:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our net product sales for the year ended December 31, 2024; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our net product sales for the year ended December 31, 2023; and, &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our net product sales for the year ended December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These same customers account for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our receivables from net product sales, which are included in &#x201c;Accounts receivables, net&#x201d; in our consolidated balance sheet as of December 31, 2024. These same customers account for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of our receivables from net product sales, which are included in &#x201c;Accounts receivables, net&#x201d; in our consolidated balance sheet as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <inva:NumberOfMajorCustomers
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="0"
      id="F_641eeb89-ea6c-4920-86ef-3d2820be8077"
      unitRef="U_Customer">3</inva:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_b79f1674-dd08-4798-a636-6908c319b900"
      decimals="2"
      id="F_3e655e60-d625-4a6b-a578-a4a40c574ecc"
      unitRef="U_pure">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_765a2763-8b53-4101-ab58-259faa96bbda"
      decimals="2"
      id="F_5d5495be-ed29-4b9e-8550-630247de435c"
      unitRef="U_pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_275d36b8-67af-4e37-bb78-b7ec1929c925"
      decimals="2"
      id="F_9fbdf35b-c554-4ccb-9dd4-8560c273ff28"
      unitRef="U_pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_8fdb4c80-a5b2-4d18-b108-58f668bf4204"
      decimals="2"
      id="F_05b95612-fd00-4056-a84e-b7ac7fd37061"
      unitRef="U_pure">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_80258deb-f35d-49b9-b662-4823ba3839e5"
      decimals="2"
      id="F_c38d86b8-07e7-45b5-aa67-6310116a51bf"
      unitRef="U_pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_148ad82f-42d4-4125-aa46-2c752917796a"
      decimals="2"
      id="F_d0e121d8-4bda-44d7-a41e-0872fe2daf8e"
      unitRef="U_pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_9f830636-16c6-4d83-af5b-754f4ce28030"
      decimals="2"
      id="F_f39c4a47-ddb6-4d40-8c9e-ef61c5244f3f"
      unitRef="U_pure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_fa5f811c-b501-4818-ad66-e8e20b51e983"
      decimals="2"
      id="F_ed025c42-a9ec-4d78-8857-036f8fc82d6c"
      unitRef="U_pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_a8d47eea-b422-4342-9936-7be08f04740f"
      decimals="2"
      id="F_9ea2ec8c-f41a-43f9-8bcb-90f0cc10aee5"
      unitRef="U_pure">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_d46b31e7-e4aa-47e0-b48d-3af9ff0a4041"
      decimals="2"
      id="F_fcc31c6e-4e21-4624-9f81-b771259b2587"
      unitRef="U_pure">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_586ff5e8-d41c-4176-a904-9624786d8bde"
      decimals="2"
      id="F_508d4a30-caea-4def-bcf3-19a4699ea4a2"
      unitRef="U_pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_6d0a78b5-48c4-4a35-91c6-e8575ef72b82"
      decimals="2"
      id="F_5c9601c2-ec2f-4108-b82d-f837c8fb85a6"
      unitRef="U_pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_510f527b-715b-4a94-923a-54ba359b3544"
      decimals="2"
      id="F_8ae7b428-7215-4b0c-bd69-8a7dcbda0391"
      unitRef="U_pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_d342f539-f5cc-4e65-bc94-3ed13f8a9001"
      decimals="2"
      id="F_5bbebe34-f9ae-46fe-ad87-19745899a3db"
      unitRef="U_pure">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_73f1df40-a5ad-4f58-8d9d-f8b23a0da0a3"
      decimals="2"
      id="F_048ea3f7-f138-4f9d-8755-8b56337b8f7b"
      unitRef="U_pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_e05eaf80-618f-4d61-96ef-3fa117cc8a1f">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are identified as components of an enterprise about which separate discrete financial information is made available for evaluation by the chief operating decision maker (&#x201c;CODM&#x201d;) in making decisions regarding resource allocation and assessing performance. Refer to Note 15, &#x201c;Segment Reporting&#x201d;, for more segment information.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_25b22b4e-d130-43df-95b3-af07a5b9a641">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Variable Interest Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The primary beneficiary of a variable interest entity (&#x201c;VIE&#x201d;) is required to consolidate the assets and liabilities of the VIE. When we obtain a variable interest in another entity, we assess at the inception of the relationship and upon occurrence of certain significant events whether the entity is a VIE and, if so, whether we are the primary beneficiary of the VIE based on our power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To assess whether we have the power to direct the activities of a VIE that most significantly impact the VIE&#x2019;s economic performance, we consider all the facts and circumstances, including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE&#x2019;s economic performance and identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (management and representation on the Board of Directors) and have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To assess whether we have the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, we consider all of our economic interests that are deemed to be variable interests in the VIE. This assessment requires us to apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_e101f542-8f3e-4232-8f45-86efce3f9e01">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Business Combination&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When we acquire an entity in a business combination, we recognize the fair value of all assets acquired, liabilities assumed, and any non-controlling interest in the acquiree and establish the acquisition date as the fair value measurement point. We recognize and measure goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair value of the identified net assets acquired. Acquisition-related expenses and related restructuring costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use the income method. This method starts with a forecast of all of the expected future net cash flows for each asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Some of the more significant estimates and assumptions inherent in the income method or other methods include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows and the assessment of the asset&#x2019;s life cycle and the competitive trends impacting the asset, including consideration of any technical, legal, regulatory, or economic barriers to entry. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may even be considered to have indefinite useful lives.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_df90ebea-25e4-4058-8252-84ba8b4dc6f3">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We consider all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_852cc198-5373-4117-b702-1667395b7ade">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accounts receivable are recorded net of estimates for prompt-pay discounts, chargebacks, returns and rebates. Allowances for prompt-pay discounts and chargebacks are based on contractual terms. We estimate the allowance for credit losses based on existing contractual payment terms, actual payment patterns of customers and individual customer circumstances.&lt;/span&gt;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_2360c1a4-ea02-4d31-8a16-433faa0caddc">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Inventory is stated at the lower of cost or estimated net realizable value on a first-in, first-out basis. We periodically analyze inventory levels and write down inventory as cost of products sold when the following occurs: inventory has become obsolete, inventory has a cost basis in excess of its estimated net realizable value, or inventory quantities are in excess of expected product sales.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_d04ca374-5c0f-41bb-9472-2e8a80392b30">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, which consist of laboratory equipment, computer equipment, software, office furniture and fixtures, and leasehold improvements, were not material as of December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:49.17%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:49.17%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of remaining lease terms or useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment, furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#x2013; &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_02bc4870-5857-4ebb-b956-31fa25ce41b7">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost less accumulated depreciation. Property and equipment are depreciated using the straight-line method &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:49.17%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:49.17%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of remaining lease terms or useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment, furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#x2013; &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</inva:PropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_3f07a2ce-f751-4da5-bf13-5630b4c78ccc"
      id="F_514ee2f2-674c-40e2-950e-e58ba56bec9d">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_df62ffb5-2697-4ff5-a2f7-2b6a2e6fd05e"
      id="F_06846153-fb52-4b49-a581-473c23731142">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_080daca5-b99d-4707-b989-976a8412c9b0"
      id="F_799c07d9-d2ec-418a-8967-d61fcd244871">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_7412cf45-3835-4425-8c89-c78daf361543">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity and Long-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We invest from time to time in equity and debt securities of private or public companies. If we determine that we have control over these companies under either voting or VIE models, we consolidate them in our consolidated financial statements. If we determine that we do not have control over these companies under either voting or VIE models, we then determine if we have an ability to exercise significant influence via voting interests, board representation or other business relationships.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We may account for the investments where we exercise significant influence using either an equity method of accounting or at fair value by electing the fair value option under Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 825, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method, we apply it to all our financial interests in the same entity (equity and debt, including guarantees) that are eligible items. All gains and losses from fair value changes, unrealized and realized, are presented as changes in fair values of equity method investments, net, and changes in fair values of equity and long-term investments, net, within the consolidated statements of income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If we conclude that we do not have an ability to exercise significant influence over an investee, we may elect to account for the security without a readily determinable fair value using the measurement alternative method under ASC 321, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments &#x2013; Equity Securities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. This measurement alternative method allows us to measure the equity investment at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We also invest in ISP Fund LP, which investments consist of money market funds and equity and debt securities in the healthcare, pharmaceutical and biotechnology industries. Pursuant to the Partnership Agreement entered in December 2020, we became a limited partner of this partnership, and our contributions were subject to a 36-month lock-up period, which restriction prevented us from having control over and access to the contributions and related investments. The lock-up period for a certain portion of our contributions expired in December 2023. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years. These investments were classified as long-term investments in the consolidated balance sheet as of December 31, 2023. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of these investments, which consist mainly of cash and money market funds that we expect to be distributed in the next 12 months, were classified as &#x201c;Current portion of ISP Fund investments&#x201d; in the consolidated balance sheet as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_5b5ab305-43ae-4153-90b8-e60d830c55de">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. We classify these inputs into the following hierarchy:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Quoted prices for identical instruments in active markets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Quoted prices for similar instruments in active markets; quoted prices for identical 3or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Unobservable inputs and little, if any, market activity for the assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments include cash equivalents, accounts receivable, receivables from collaborative arrangements, accounts payable, and accrued liabilities, equity investments and convertible promissory notes. The carrying values of cash equivalents, receivables from collaborative arrangements, accounts payable, and accrued liabilities approximate their estimated fair values due to the relatively short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <inva:CapitalizedFeesPaidPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_d41678b7-3661-44ae-91aa-5ee69cad7d01">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Capitalized Fees Paid&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We capitalize fees paid to licensors related to agreements for approved products or commercialized products. We capitalize these fees as capitalized fees paid (&#x201c;Capitalized Fees&#x201d;) and amortize them on a straight-line basis over their estimated useful lives upon the commercial launch of the product, shortly after its regulatory approval. The estimated useful lives of these Capitalized Fees are determined on a country-by-country and product-by-product basis, as the later of the expiration or termination of the last patent right covering the compound in such product in such country and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;15 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from first commercial sale of such product in such country, unless the Collaboration Agreement is terminated earlier. Consistent with our policy for classification of costs under the research and development collaborative arrangements, the amortization of these Capitalized Fees is recognized as a reduction of royalty revenue. We review our Capitalized Fees for impairment on a product-by-product basis for each major geographic area when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The recoverability of Capitalized Fees is measured by comparing the asset&#x2019;s carrying amount to the expected undiscounted future cash flows that the asset is expected to generate. The determination of recoverability typically requires various estimates and assumptions, including estimating the useful life over which cash flows will occur, their amount, and the asset&#x2019;s residual value, if any. We derive the required cash flow estimates from near-term forecasted product sales and long-term projected sales in the corresponding market.&lt;/span&gt;&lt;/p&gt;</inva:CapitalizedFeesPaidPolicyTextBlock>
    <inva:CapitalizedFeePaidEstimatedUsefulLife
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      id="F_221feadc-738d-4ed3-a75a-4f6fcec8453f">P15Y</inva:CapitalizedFeePaidEstimatedUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_303849a5-d3ad-4833-963d-704ae2642ef9">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Goodwill is recognized as the excess of the purchase consideration of an acquired entity over the fair value assigned to assets acquired and liabilities assumed in a business combination. In addition to recognizing intangible assets acquired in a business combination, we capitalize milestone payments related to in-licensing agreements for approved products as an intangible asset when the contingency for the milestone is resolved and the consideration is issued or becomes issuable. Goodwill and intangible assets with indefinite useful life are not amortized and are tested for impairment at least annually on the first day of December of each year or more frequently if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#x2019;s carrying asset amount may not be recoverable. Intangible assets with definite useful lives are amortized on a straight-line basis over their respective remaining useful lives and are tested for impairment only if indicators for potential impairment exist or whenever events or changes in circumstances indicate that the asset&#x2019;s carrying amount may not be recoverable. Significant judgment may be involved in determining if an indicator of impairment has occurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4a662f7d-29e9-4179-b777-fadaaef2d07c">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets represent our right to use an underlying asset over the lease term and include any lease payments made prior to the lease commencement date and are reduced by lease incentives. Lease liabilities represent the present value of the total lease payments over the lease term, calculated using an estimated incremental borrowing rate. Lease expense is recognized on a straight-line basis over the expected lease term.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_07af8a48-2cb4-4eda-9ac3-92d66d3fc6e9">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We apply the guidance on principal versus agent considerations under ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, to determine the appropriate treatment for the transactions between us and third parties. The classification of transactions under our arrangements is determined based on the nature and contractual terms of the arrangement along with the nature of the operations of the participants. Any consideration related to activities in which we are considered the principal, which includ&lt;/span&gt;&lt;span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;es being in control of the good or service before such good or service is transferred to the customer, are accounted for as product sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is recognized when our customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized through a five-step process: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price for the contract; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue as a performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Royalty Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognize the royalty revenue on net sales of products with respect to which we have contractual royalty rights in the period in which the royalties are earned. The net sales reports provided by our partner are based on its methodology and assumptions to estimate rebates and returns, which it monitors and adjusts regularly in light of contractual and legal obligations, historical trends, past experience and projected market conditions. Our partner may make significant adjustments to its sales based on actual results recorded, which could cause our royalty revenue to fluctuate. We conduct periodic royalty audits to evaluate the information provided by our partner. Royalties are recognized net of amortization of capitalized fees associated with any approval and launch milestone payments made to GSK.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Product Sales&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Revenue from product sales is recognized when our customers obtain control of the product and is recorded at the transaction price, net of estimates for variable consideration consisting of chargebacks, discounts, returns and rebates. Variable consideration is estimated using the expected-value amount method, which is the sum of probability-weighted amounts in a range of possible consideration amounts. Actual amounts of consideration ultimately received may differ from our estimates. If actual results vary materially from our estimates, we will adjust these estimates, which will affect revenue from product sales and earnings in the period such estimates are adjusted. These items may include:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chargebacks: Chargebacks are discounts we provide to distributors in the event that the sales prices to end users are below the distributors&#x2019; acquisition price. This may occur due to a direct contract with a health system, a group purchasing organization (&#x201c;GPO&#x201d;) agreement or a sale to a government facility. Chargebacks are estimated based on known chargeback rates and recorded as a reduction of revenue on delivery to our customers.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Discounts: We offer customers various forms of incentives and consideration, including prompt-pay and other discounts. We estimate discounts primarily based on contractual terms. These discounts are recorded as a reduction of revenue on delivery to our customers.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Returns: We offer customers a limited right of return, generally for damaged or expired product. We estimate returns based on an internal analysis, which includes actual experience. The estimates for returns are recorded as a reduction of revenue on delivery to our customers. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Rebates: We participate in Medicaid rebate programs, which provide assistance to certain low-income patients based on each individual state&#x2019;s guidelines regarding eligibility and services. Under the Medicaid rebate programs, we pay a rebate to each participating state, generally within three months after the quarter in which product was sold. Additionally, we may offer customer incentives and consideration in the form of volume-based or other rebates. The estimates for rebates are recorded as a reduction of revenue on delivery to our customers. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We continue to assess our estimates of variable consideration as we accumulate additional historical data and will adjust these estimates accordingly.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;License Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the inception of a licensing arrangement that includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price. We generally recognize these milestone payments as revenues when they are achieved because there is considerable uncertainty in the research and development processes that trigger receipt of these payments under our agreements. Similarly, we recognize regulatory approval milestone payments as revenues once the product is approved by the applicable regulatory agency. For delivery of other goods or services related to a licensing arrangement, we determine whether the performance obligation is satisfied over time or at a point in time. If the performance obligation is satisfied over time, we use judgment in determining the appropriate method of measuring progress for purposes of recognizing revenue. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_6bf9541e-bec5-400c-9a22-e2a152051509">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development expenses are recognized in the period that services are rendered or goods are received. Research and development expenses consist of salaries and benefits, laboratory supplies, facilities and other overhead costs, research-related manufacturing costs, contract service and clinical-related service costs performed by third party research organizations, research institutions and other outside service providers. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized. Such amounts are recognized as an expense as the related goods are delivered or the related services are performed. We also utilize significant judgment and estimates to record accruals for estimated ongoing research costs based on the progress of the studies and progress of research manufacturing activities.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:InterestExpensePolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_c71711e4-1279-470c-8bad-f145dc687b91">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Interest Expense on Deferred Royalty Obligation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Interest expense related to the deferred royalty obligation is recognized over the expected repayment term of the deferred royalty obligation using the effective interest method. The assumptions used in determining the expected repayment term of the deferred royalty obligation require us to make estimates that could impact the effective interest rate. Each reporting period, we estimate the expected repayment term of the deferred royalty obligation based on forecasted net sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Changes in interest expense resulting from changes in the effective interest rate, if any, are recorded on a prospective basis. Refer to Note 12, &#x201c;Debt&#x201d;, for more information.&lt;/span&gt;&lt;/p&gt;</us-gaap:InterestExpensePolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_19e0222a-7a29-45b7-af77-66c6449fc57c">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Stock&#x2011;Based Compensation Awards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use the Black-Scholes-Merton option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire stock granted under our employee stock purchase plan (&#x201c;ESPP&#x201d;). The Black-Scholes-Merton option valuation model requires the use of assumptions, including the expected term of the award and the expected stock price volatility. We use the &#x201c;simplified&#x201d; method as described in Staff Accounting Bulletin No. 107, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Share-Based Payment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&#x201d; for the expected option term. We use our historical volatility to estimate expected stock price volatility.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted stock units (&#x201c;RSUs&#x201d;) and restricted stock awards (&#x201c;RSAs&#x201d;) are measured based on the fair market values of the underlying stock on the dates of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense is calculated based on awards ultimately expected to vest and is reduced for estimated forfeitures at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differed from those estimates. Our estimated annual forfeiture rates for stock options, RSUs and RSAs are based on our historical forfeiture experience.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimated fair value of stock options, RSUs and RSAs is expensed on a ratable or straight-line basis over the expected term of the grant or expected term of the vesting. Compensation expense is recorded over the requisite service period based on management&#x2019;s best estimate as to whether it is probable that the shares awarded are expected to vest.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Compensation expense for purchases under the ESPP is recognized based on the fair value of the common stock on the date of offering, less the purchase discount percentage provided for in the plan.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_977b97c8-e0c6-4ed6-a6c4-e14a742b8e3d">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and the tax basis of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The recognition and measurement of tax benefits requires significant judgment. Our judgment might change as new information becomes available. We continue to evaluate our deferred tax assets each reporting period to determine whether adjustments to our valuation allowance are required and deferred tax assets will be realized based on the consideration of all available positive and negative evidence, including the differences between our anticipated and actual future operating results, using a &#x201c;more likely than not&#x201d; standard.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#x2019;s sustainability and is measured at the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we determine whether the factors underlying the sustainability assertion have changed and whether the amount of the recognized tax benefit is still appropriate.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <inva:RelatedPartyTransactionsPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_dc79b18a-7d36-4152-9ac9-c87820a9330d">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Related Parties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sarissa Capital ow&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ned &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of o&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ur outstanding common stock as of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Transactions with Sarissa Capital are described in Note 5, &#x201c;Consolidated Entities and Acquisitions&#x201d;. Sarissa Capital is considered to be a related party because two of its principals are members of our board of directors.&lt;/span&gt;&lt;/p&gt;</inva:RelatedPartyTransactionsPolicyTextBlock>
    <inva:RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty
      contextRef="C_253ffe46-1c31-4933-9e01-a237c876ecc9"
      decimals="3"
      id="F_6744bd4a-f95b-45bb-8f56-a9b8f2a78456"
      unitRef="U_pure">0.116</inva:RelatedPartyTransactionCommonStockOwnershipPercentageByRelatedParty>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_c07e5ee0-4e98-4ed1-9237-f83470c17924">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Improvements to Reportable Segment Disclosures (Topic 280).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; This ASU update requires enhanced segment disclosures, primarily related to significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. We adopted ASU 2023-07 for the 2024 fiscal year and provided the enhanced disclosures for the comparative years. The adoption of ASU 2023-07 did not have a material impact on the Company's financial statements. Enhanced disclosures related to significant segment expenses are included in Note 15, &#x201c;Segment Reporting.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Improvements to Income Tax Disclosures (Topic 740)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The ASU requires the disclosure of income taxes paid disaggregated by jurisdiction and enhanced disclosures for the entity&#x2019;s effective tax rate reconciliation as well as other income tax related disclosures. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. The Company has not early adopted the ASU during 2024 and does not expect the adoption of the amendments to have a significant impact on its financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement &#x2014; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures (Subtopic 220-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the statement of income as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company in annual reporting periods beginning after December 15, 2027, and interim reporting periods beginning after December 15, 2027. We are currently evaluating the potential impact that ASU 2024-03 may have on our financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-04, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20), &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;which clarifies the assessment of whether a transaction should be accounted for as an induced conversion or extinguishment of convertible debt when changes are made to conversion features as part of an offer to settle the instrument. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. We are currently evaluating the potential impact that ASU 2024-04 may have on our financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_f5c4c6d8-f169-4b6d-8ec1-bc33a7a1f311">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.  NET INCOME PER SHARE&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net income per share attributable to Innoviva stockholders is computed by dividing net income attributable to Innoviva stockholders by the weighted-average number of shares of common stock outstanding. Diluted net income per share attributable to Innoviva stockholders is computed by dividing net income attributable to Innoviva stockholders by the weighted-average number of shares of common stock and dilutive potential common stock equivalents then outstanding. Dilutive potential common stock equivalents include the assumed exercise, vesting and issuance of employee stock awards using the treasury stock method, as well as common stock issuable upon assumed conversion of our convertible subordinated notes due 2023 (the &#x201c;2023 Notes&#x201d;) up until its maturity date on January 15, 2023, our convertible senior notes due 2025 (the &#x201c;2025 Notes&#x201d;), and our convertible senior notes due 2028 (the &#x201c;2028 Notes&#x201d;) using the if-converted method. If the results attributable to Innoviva stockholders are in a net loss position, diluted net loss per share attributable to Innoviva stockholders is computed by dividing the net loss attributable to Innoviva stockholders by the weighted-average number of shares of common stock outstanding for the period, without consideration for potential dilutive common stock equivalents.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the computation of basic and diluted net income per share for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.79%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.077%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.077%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.617%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands except per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Innoviva stockholders, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;213,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Add: interest expense on 2023 Notes, net of tax effect&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,439&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Add: interest expense on 2025 Notes, net of tax effect&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Add: interest expense on 2028 Notes, net of tax effect&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Innoviva stockholders, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,860&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;191,304&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225,569&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares used to compute basic net income&lt;br/&gt;&#160;&#160;&#160;per share attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of 2023 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,188&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of 2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of 2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of options and awards granted under equity&lt;br/&gt;&#160;&#160;&#160;incentive plan and employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;108&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares used to compute diluted net income&lt;br/&gt;&#160;&#160;&#160;per share attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;95,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income per share attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.07&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Anti&#x2011;dilutive Securities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti&#x2011;dilutive for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.28%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding options and awards granted under equity incentive&lt;br/&gt;&#160;&#160;&#160;plan and employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,333&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;648&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding stock warrant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding 2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,742&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;930&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_35c9fc3e-6758-406f-9af6-4e618068da41">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the computation of basic and diluted net income per share for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.79%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.077%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.077%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.617%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands except per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Innoviva stockholders, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;213,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Add: interest expense on 2023 Notes, net of tax effect&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,439&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Add: interest expense on 2025 Notes, net of tax effect&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Add: interest expense on 2028 Notes, net of tax effect&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Innoviva stockholders, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,860&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;191,304&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225,569&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares used to compute basic net income&lt;br/&gt;&#160;&#160;&#160;per share attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of 2023 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,188&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of 2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of 2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive effect of options and awards granted under equity&lt;br/&gt;&#160;&#160;&#160;incentive plan and employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;108&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares used to compute diluted net income&lt;br/&gt;&#160;&#160;&#160;per share attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;95,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income per share attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.07&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_15f64797-53a3-4030-b447-aed34274ae2f"
      unitRef="U_USD">23392000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9e307567-4cda-406d-8228-f24f7c6619eb"
      unitRef="U_USD">179722000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_33a8ba6b-1d6c-4bd4-9570-bc97074e91b5"
      unitRef="U_USD">213921000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_7530273c-e395-47f6-b8ce-a7265c4b1b91"
      decimals="-3"
      id="F_341d202f-62fa-4877-86c0-79294b27a220"
      unitRef="U_USD">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_1816c078-11b5-460a-ad2e-54cbd4e77cbd"
      decimals="-3"
      id="F_5e12cbf2-a507-400f-b006-a51b85cce1a8"
      unitRef="U_USD">89000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_fdbfc2ab-d5ad-4fa2-8dfc-bcaab55938e9"
      decimals="-3"
      id="F_b868b5bb-d552-4e82-8763-bcede9fb1724"
      unitRef="U_USD">2439000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="-3"
      id="F_fb3a3e07-49d9-4371-b3f4-417c9331e4e1"
      unitRef="U_USD">3468000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_6909246c-601a-476f-8981-bae18ebb0a34"
      decimals="-3"
      id="F_7be38120-613b-4bed-909f-df366b7f1c30"
      unitRef="U_USD">5116000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_b205310f-0e33-4476-bda5-719485b59ecd"
      decimals="-3"
      id="F_85bf2107-e3b3-4e0e-9473-a4c9a9b6f0f1"
      unitRef="U_USD">4583000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8"
      decimals="-3"
      id="F_20127f5e-c790-477a-93ea-5d990bfb3d0e"
      unitRef="U_USD">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_6abb342a-b250-49ac-bbe0-52e5029809ff"
      decimals="-3"
      id="F_c0b3925b-ccdc-4a86-8d6c-f4126b88861c"
      unitRef="U_USD">6377000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="C_1fff98f9-2913-4a76-9006-53b136b3b233"
      decimals="-3"
      id="F_89d55016-61d5-4a5a-b19c-677aff04ff8a"
      unitRef="U_USD">4626000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_83a38207-608c-4ea7-9a4a-16269495b668"
      unitRef="U_USD">26860000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_11ca738e-4c47-419b-b268-26234abcf033"
      unitRef="U_USD">191304000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_58e19d5d-d4c7-40a5-b404-d70bce49b79e"
      unitRef="U_USD">225569000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_046e3d1d-3f00-4a56-98ad-8151e1d5c2a7"
      unitRef="U_shares">62726000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_8c59c163-93cc-4567-b854-f23360a6bcc9"
      unitRef="U_shares">65435000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_a0d04b52-67fc-496a-a5c2-c2bda084bcbc"
      unitRef="U_shares">69644000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_7530273c-e395-47f6-b8ce-a7265c4b1b91"
      decimals="-3"
      id="F_135fa4b8-f046-4582-89f6-244741ad37b0"
      unitRef="U_shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_1816c078-11b5-460a-ad2e-54cbd4e77cbd"
      decimals="-3"
      id="F_59da97e5-2eda-4f54-aec9-ca902bddb361"
      unitRef="U_shares">187000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_fdbfc2ab-d5ad-4fa2-8dfc-bcaab55938e9"
      decimals="-3"
      id="F_946d7af0-0f77-4cdf-ab20-380fe59bff60"
      unitRef="U_shares">6188000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="-3"
      id="F_0cdaca4b-1063-495e-bbd3-ec794d0b322c"
      unitRef="U_shares">11150000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_6909246c-601a-476f-8981-bae18ebb0a34"
      decimals="-3"
      id="F_11f0a485-353e-4779-847a-c909297997fc"
      unitRef="U_shares">11150000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_b205310f-0e33-4476-bda5-719485b59ecd"
      decimals="-3"
      id="F_04c8c967-096c-4ca0-8397-b53e4e92a1a6"
      unitRef="U_shares">11150000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8"
      decimals="-3"
      id="F_c6017e34-26e9-49f2-8016-b7bedf0933bf"
      unitRef="U_shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_6abb342a-b250-49ac-bbe0-52e5029809ff"
      decimals="-3"
      id="F_1fe2e3c8-5ff4-4f33-a36d-e70d2ea00303"
      unitRef="U_shares">9955000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="C_1fff98f9-2913-4a76-9006-53b136b3b233"
      decimals="-3"
      id="F_cc1be64f-a95e-403f-86bd-3f6328f1b9c6"
      unitRef="U_shares">8158000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_06f68677-1e77-4c2d-ae6b-41faf146621f"
      unitRef="U_shares">311000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c8bf8780-1956-49e1-9ac2-c5726327b67f"
      unitRef="U_shares">149000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_2fe8ac1a-5bad-40af-8e81-436612f7570e"
      unitRef="U_shares">108000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_d6e29c33-c212-44e4-b11b-a585f5eb54b8"
      unitRef="U_shares">74187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_67c45bf3-2dc5-454d-95f9-2279dcdeaaa0"
      unitRef="U_shares">86876000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_7c4bc91d-a5d6-45cd-95cb-0906d2fec17d"
      unitRef="U_shares">95248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="2"
      id="F_d1d6d1c9-5154-491d-8a30-8f12fd51c880"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="2"
      id="F_b30d6b18-cf7b-45bd-acbc-a65c6c998fc3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="2"
      id="F_52e67727-c6e2-4c92-bfd1-c419da4b2d0e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="2"
      id="F_1441e747-1881-4636-ae00-e662c5265fd4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="2"
      id="F_f84a374f-f54b-42ec-8474-c5a2d1ec5342"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="2"
      id="F_c3d27864-0a1f-4e16-a591-c72f5db1ba33"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_53ddee8e-8c70-43b2-967a-9c109987cbac">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti&#x2011;dilutive for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.28%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding options and awards granted under equity incentive&lt;br/&gt;&#160;&#160;&#160;plan and employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,333&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;648&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding stock warrant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding 2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,742&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;930&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a6430d44-f5e0-43dc-9348-dfafe12496e7"
      decimals="-3"
      id="F_388e68fe-04e6-427a-b8f7-4b8a38db556d"
      unitRef="U_shares">1196000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_dc9d2bc8-74c2-44d4-a506-2b243a40e1db"
      decimals="-3"
      id="F_81746d52-e64d-4592-9155-41c2d616ffaf"
      unitRef="U_shares">1333000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_3e58dc77-93ac-48f8-ad4b-45e787d62643"
      decimals="-3"
      id="F_bfe3f447-4372-4940-918a-6df1f54b0c5d"
      unitRef="U_shares">648000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_90c8e4aa-f337-4f23-8ec8-33fc6f9d49fc"
      decimals="-3"
      id="F_000c1398-f8a8-4be6-9412-fa9ef812a33f"
      unitRef="U_shares">591000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_6ca7b604-74ae-4669-9748-a07e890fea74"
      decimals="-3"
      id="F_85fb08ca-3f24-4823-b197-bd8dd0350980"
      unitRef="U_shares">591000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_ebebd729-c908-4409-9926-dcda00bed175"
      decimals="-3"
      id="F_958934e0-16aa-411a-9c77-791dc19c16c6"
      unitRef="U_shares">282000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_663ceb44-07f8-4150-a16b-cc6004609ea5"
      decimals="-3"
      id="F_dd57dc4e-e2a8-45db-9469-e5548fd9356f"
      unitRef="U_shares">9955000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1a8cdfac-c298-4e05-a31d-4569a79026a1"
      decimals="-3"
      id="F_0c0ac956-975d-4c4c-a40a-121664d8eedc"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_30321d31-1876-4ed6-ab63-b9b2cac929bb"
      decimals="-3"
      id="F_8a42cf85-2098-432b-ab08-fa344fa04a96"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_deaf9a88-d74e-4fed-9539-3685c057830a"
      unitRef="U_shares">11742000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_da2139c2-586c-4f71-9a20-a47153a6295d"
      unitRef="U_shares">1924000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_84ef3799-a51d-4843-8e3d-9227dd448fd7"
      unitRef="U_shares">930000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_6a1ecc75-eb21-4e3e-acb2-49e941e83194">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3.  REVENUE RECOGNITION&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Revenue from Collaboration Arrangement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 13, 2022, Innoviva&#x2019;s wholly owned subsidiary, Innoviva TRC Holdings, LLC (&#x201c;ITH&#x201d;) entered into an equity purchase agreement (&#x201c;TRC Equity Purchase Agreement&#x201d;) with Royalty Pharma Investments 2019 ICAV (&#x201c;Royalty Pharma&#x201d;) to sell our ownership interest in TRC. As a result of the sale of our ownership interest in TRC, which was consummated on July 20, 2022, we are no longer entitled to receive 15% of royalty payments made by GSK stemming from sales of TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We retained our royalty rights with respect to RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Net revenue recognized under our GSK Agreements was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalties &#x2013; RELVAR/BREO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207,925&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;208,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215,034&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalties &#x2013; ANORO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,405&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalties &#x2013; TRELEGY&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total royalties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;252,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;325,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: amortization of capitalized&lt;br/&gt;&#160;&#160;&#160;fees paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total royalty revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;238,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;   The year ended December 31, 2022 represents the period from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;LABA Collaboration&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of the launch and approval of RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the U.S., Japan and Europe, we paid milestone fees to GSK totaling $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the year ended December 31, 2014. The milestone fees paid to GSK were recognized as capitalized fees paid, which are being amortized over their estimated useful lives commencing upon the commercial launch of the product. The amortization is recorded as a reduction to the royalties from GSK.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We are entitled to receive annual royalties from GSK on sales of RELVAR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;/BREO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as follows: &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% on the first $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion of annual global net sales and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% for all annual global net sales above $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion. Sales of single&#x2011;agent LABA medicines and combination medicines would be combined for the purposes of this royalty calculation. For other products combined with a LABA from the LABA Collaboration, such as ANORO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, royalties are upward tiering and range from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We are also entitled to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of royalty payments made by GSK under its agreements originally entered into with us, and since assigned to TRC in connection with the Spin-Off, including TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; through July 20, 2022, which royalties were upward tiering and ranged from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Product Sales&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total net product sales was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.09%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.683%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.683%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.683%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;GIAPREZA&#xae;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;XERAVA&#xae;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;XACDURO&#xae;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;97,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We derived our net product sales:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% from customers located in the U.S. and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% from the rest of the world for the year ended December 31, 2024; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% from customers located in the U.S. and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% from the rest of the world for the year ended December 31, 2023; and, &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% from customers located in the U.S. and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% from the rest of the world from the date of acquisition of La Jolla, which occurred on August 22, 2022, to December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;License and Other Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to the out-license agreement with Zai Lab and Everest in Note 4, &#x201c;License and Collaboration Arrangements&#x201d;.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_cbdc41d8-c2a4-4b2c-b7aa-9a4ee3141e91">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Net revenue recognized under our GSK Agreements was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalties &#x2013; RELVAR/BREO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207,925&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;208,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215,034&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalties &#x2013; ANORO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,405&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalties &#x2013; TRELEGY&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total royalties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;252,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;325,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: amortization of capitalized&lt;br/&gt;&#160;&#160;&#160;fees paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total royalty revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;238,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;   The year ended December 31, 2022 represents the period from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_476fef44-ae2e-4cc8-8996-5cd189b7399b"
      decimals="-3"
      id="F_7cae112d-7498-4bbe-ac21-11bdcd2060eb"
      unitRef="U_USD">207925000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_87613bcc-e02f-4f93-9acc-604a9a71c964"
      decimals="-3"
      id="F_48d10e53-6cfc-40d3-b136-c6c137d1c337"
      unitRef="U_USD">208042000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_e189d92a-5bed-4d05-ba08-0b3e9024c9c0"
      decimals="-3"
      id="F_ebb8ccf0-ea0d-4603-ad17-23f49ed23be1"
      unitRef="U_USD">215034000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_9a1b43b7-95ef-4fe1-bb0d-965f09120bf8"
      decimals="-3"
      id="F_bd5033e0-78cd-4ac6-bf59-5af92837813a"
      unitRef="U_USD">47631000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_0ea9ec7a-e7e7-4193-b8dc-087d07b87da1"
      decimals="-3"
      id="F_c072c096-bb48-4b4c-992a-c1940cacdf0e"
      unitRef="U_USD">44627000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_7f8fbf04-70a3-46c3-b1c4-813bd471a322"
      decimals="-3"
      id="F_f75f6991-bea4-4850-ad15-3ab6348b2c67"
      unitRef="U_USD">38405000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_8a59da43-fe2d-4fbf-88c5-e84ffeb90fd0"
      decimals="-3"
      id="F_865eaeea-092b-4cc5-8765-4bae882a3da6"
      unitRef="U_USD">0</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_b6038bb2-c129-42b0-94c7-bd3528eb4770"
      decimals="-3"
      id="F_beaeaf77-cc14-4411-a10b-ceb8f949eead"
      unitRef="U_USD">0</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_c0fa79e7-715a-4fda-811d-c8538a6e2a44"
      decimals="-3"
      id="F_143cd3bb-67de-4486-8bca-78d53c1c3530"
      unitRef="U_USD">72029000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3"
      decimals="-3"
      id="F_3a39b54a-8059-42e9-a430-773c7c5d0a44"
      unitRef="U_USD">255556000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac"
      decimals="-3"
      id="F_c7c87e6f-464e-45ee-9241-c4950c6a67b6"
      unitRef="U_USD">252669000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees
      contextRef="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e"
      decimals="-3"
      id="F_b7d420a9-22ab-457b-8038-24abc04fc2b6"
      unitRef="U_USD">325468000</inva:GrossRevenueFromContractWithCustomerExcludingAssessedTaxBeforeAmortizationOfCapitalizedFees>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_4a780bf3-f28c-4da5-a3e2-4549be240ce3"
      decimals="-3"
      id="F_a34a669b-1a10-489f-8fcc-d3e26fcff193"
      unitRef="U_USD">13823000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_3a06978b-321d-4e5f-ba1c-6395faacc2ac"
      decimals="-3"
      id="F_2d529a04-86f8-4b54-9c23-0822b618ef22"
      unitRef="U_USD">13823000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_fd8fcf56-b2ec-4d0a-8f53-72870312341e"
      decimals="-3"
      id="F_16822020-4193-494b-8bb6-d30164b1a85e"
      unitRef="U_USD">13823000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e58b5b10-01d5-47b4-827c-3e1e08ba781d"
      decimals="-3"
      id="F_bf4abedf-9dd2-469b-bb00-6c92ba21d4a5"
      unitRef="U_USD">241733000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_9c9d544f-ec3a-45ad-bcd1-76045e398e61"
      decimals="-3"
      id="F_6d5f44b5-cc17-480d-b35e-da29531dcaa1"
      unitRef="U_USD">238846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_37bbf523-072e-4d93-97c4-9c3c71d7a919"
      decimals="-3"
      id="F_b9720dc0-4289-491e-9f1a-08c9aa84bde1"
      unitRef="U_USD">311645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_af75fcbe-c945-4eb9-beb4-d5938e595d4b"
      decimals="-5"
      id="F_b2fef565-0b07-4b2a-8d93-986d05aa3fd2"
      unitRef="U_USD">220000000</us-gaap:CapitalizedContractCostGross>
    <inva:CollaborativeArrangementRoyaltyRateDefinedLevelOne
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="2"
      id="F_8cd56e8c-e4ff-43fb-92fe-2f617f7bc710"
      unitRef="U_pure">0.15</inva:CollaborativeArrangementRoyaltyRateDefinedLevelOne>
    <inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="-8"
      id="F_16bf4309-0283-4dd1-ae5a-0506de8271af"
      unitRef="U_USD">3000000000</inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate>
    <inva:CollaborativeArrangementRoyaltyRateDefinedLevelTwo
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="2"
      id="F_3cf4973f-2556-4f32-9936-11dc7490fc50"
      unitRef="U_pure">0.05</inva:CollaborativeArrangementRoyaltyRateDefinedLevelTwo>
    <inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate
      contextRef="C_f48f3ff6-407c-4253-90e5-37f84707a37a"
      decimals="-8"
      id="F_4f562bfe-8a4e-4ad3-a81c-6c24056428c3"
      unitRef="U_USD">3000000000</inva:CollaborativeArrangementSpecifiedSalesLevelForDeterminingRoyaltyRate>
    <inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts
      contextRef="C_12297e5a-44ee-441e-b9cb-846681e357f4"
      decimals="3"
      id="F_42030cc6-0998-47d2-bfa9-8b97625f0bbb"
      unitRef="U_pure">0.065</inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts>
    <inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts
      contextRef="C_a4df3b3b-267d-4f2f-ac89-6815c2bbcdeb"
      decimals="2"
      id="F_97768eb6-6411-47b0-93bd-aaaf8769dd6b"
      unitRef="U_pure">0.10</inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts>
    <inva:PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements
      contextRef="C_69dda25f-8fec-4d6f-996d-0711b459c98b"
      decimals="2"
      id="F_ab2e9365-6cbd-4af8-b7ba-e9e2ea1d82de"
      unitRef="U_pure">0.15</inva:PercentageOfEconomicInterestOnFuturePaymentsUnderAgreements>
    <inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts
      contextRef="C_a6a8f2c7-57be-445e-a3e7-ce078fc2faae"
      decimals="3"
      id="F_c330fe29-7676-4005-9754-e7aff32e419a"
      unitRef="U_pure">0.065</inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts>
    <inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts
      contextRef="C_0d1b8490-4789-4372-801e-fc2120c8f801"
      decimals="2"
      id="F_1fb2dce7-ad08-40f3-a02f-bc224d92a213"
      unitRef="U_pure">0.10</inva:CollaborativeArrangementAnnualRoyaltiesAsPercentageOfNetSalesForCombinationProducts>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_2b0b3ecc-c286-4275-92ae-aee0065e3859">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total net product sales was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.09%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.683%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.683%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.683%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;GIAPREZA&#xae;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;XERAVA&#xae;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;XACDURO&#xae;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;97,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_22346f7a-9d5b-4adb-8126-334786efe7ee"
      decimals="-3"
      id="F_bda63b53-b8e7-4a48-b513-dc5a83c69e4a"
      unitRef="U_USD">55037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5e383c8b-3da2-4e7d-b954-1e85556222ef"
      decimals="-3"
      id="F_03de6407-949e-44c9-9cc9-9f862b137834"
      unitRef="U_USD">41294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e2f7f140-5330-4553-9a9c-7f6c89b789b9"
      decimals="-3"
      id="F_bf688683-aa7a-461b-9df8-18095ffe8a04"
      unitRef="U_USD">14214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8072618f-1ec5-41e4-b16b-b78997fa817e"
      decimals="-3"
      id="F_cd0ea8d2-55f0-43e4-aac1-de7f79fce4d3"
      unitRef="U_USD">21385000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c0508c79-209c-45e5-bf7c-169aef8d5660"
      decimals="-3"
      id="F_119a0f49-a5f2-4d4b-81c7-4758e83697ad"
      unitRef="U_USD">17320000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_70e43fac-bdea-4cfc-a822-8d3ad323984c"
      decimals="-3"
      id="F_0280738f-f6eb-4464-936c-741cc7a13fa9"
      unitRef="U_USD">5480000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_ca06b77f-bf5f-4b7f-be32-bdeda8df9e1b"
      decimals="-3"
      id="F_9cdbe933-b238-4ccc-913c-5fcb9c4bad42"
      unitRef="U_USD">21070000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_783d44e6-75e9-4b12-8062-6bfba06d75c3"
      decimals="-3"
      id="F_0b37f600-6f3a-46e5-93e2-4ed996e8ff7e"
      unitRef="U_USD">2003000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_bb3e4de1-feb6-492e-8578-81257488368b"
      decimals="-3"
      id="F_ae8d3a31-c790-4c93-8fa0-9a347abe85e0"
      unitRef="U_USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_360b25f8-0668-427b-a0a4-5664f61139d0"
      decimals="-3"
      id="F_9336f4a7-d488-49ed-9bb1-cd7b17130fa5"
      unitRef="U_USD">97492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_ee71481d-9af3-4cdf-bccc-faefde8f6bcd"
      decimals="-3"
      id="F_0e18a596-e93b-4761-a7db-e8cd4426503a"
      unitRef="U_USD">60617000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5762c44d-7963-4357-b789-7869c9919cc7"
      decimals="-3"
      id="F_80602424-a6e3-4b42-b9a0-c0dfe18c1824"
      unitRef="U_USD">19694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_871709ce-1c50-4f9d-87be-84392f7a9aa9"
      decimals="2"
      id="F_7fd8ce7e-bc2e-4a8e-958e-e2ad65fea7f9"
      unitRef="U_pure">0.83</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_860a55ea-1154-443a-bb84-a8d6f8251458"
      decimals="2"
      id="F_9257c100-e433-4757-bdc1-b35adaee92ae"
      unitRef="U_pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_6a7b2f2b-6e3e-48ea-ab7f-7e1306be753c"
      decimals="2"
      id="F_5017a651-e841-4679-be34-84d7116ff337"
      unitRef="U_pure">0.91</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_b094271e-5af4-45b7-8a67-ea05cb064571"
      decimals="2"
      id="F_45e6d117-e3fd-4b2a-9116-59a807b462aa"
      unitRef="U_pure">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_9ccb7bd1-8f8b-4f56-a509-6035ce670328"
      decimals="2"
      id="F_d1d9bf81-90af-4e78-a4cf-617f57fef41b"
      unitRef="U_pure">0.96</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_954ad86b-4beb-4124-8fb8-95cf9f5505b6"
      decimals="2"
      id="F_34689d5b-1e48-4067-9b87-587b1f3957e9"
      unitRef="U_pure">0.04</us-gaap:ConcentrationRiskPercentage1>
    <inva:LicenseAndCollaborationArrangementsDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_b1d68074-19bd-43b0-8af6-4973616dc1d8">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4. LICENSE AND COLLABORATION ARRANGEMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Out-License Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Zai Lab&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Entasis entered into a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. (&#x201c;Zai Lab&#x201d;) (Nasdaq: ZLAB), pursuant to which Zai Lab licensed exclusive rights to durlobactam and SUL-DUR, in the Asia-Pacific region (&#x201c;the Zai Agreement&#x201d;). Under the terms of the Zai Agreement, Zai Lab will fund most of the registrational clinical trial costs in China for SUL-DUR, with the exception of Phase 3 patient drug supply of licensed products. Zai Lab will conduct development activities and plan and obtain regulatory approval in a specified number of countries in the Asia-Pacific region beyond China after receipt of regulatory approval of a licensed product in China. Zai Lab is also solely responsible for commercializing licensed products in the Asia-Pacific region and will commercialize licensed products for which it has obtained regulatory approval. We are obligated to supply Zai Lab with the licensed products for clinical development and, if the licensed product is approved, for commercial use for a certain period unless Zai Lab notifies otherwise. Zai Lab may take over manufacturing responsibilities for its own commercialization activities within a specified time period following the effective date of the Zai Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We ar&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e eligible to receive up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in research and development support payments and development, regulatory and sales milestone payments related to SUL-DUR, imipenem and other combinations with the licensed products. Zai Lab will pay us a tiered royalty equal to from a high-single digit to low-double digit percentage based on annual net sales of licensed products in the territory, subject to specified reductions for the market entry of competing products, loss of patent coverage of licensed products and for payments owed to third parties for additional rights necessary to commercialize licensed products in the territory.  Payments received for research support and reimbursable clinical trial costs are recorded as a reduction to research and development expense during the period in which the qualifying expenses are incurred. Such amounts recorded &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for the years ended December 31, 2024 and 2023 were not material. SUL-DUR was approved by China&#x2019;s National Medical Products Administration in May 2024, and we recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in license revenue for the year ended December 31, 2024 under this agreement. Following the approval of XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; by the FDA in May 2023, we recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in license revenue for the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In April 2024, we entered into an amendment to the Zai Agreement (the &#x201c;Amended Zai Agreement&#x201d;), pursuant to which Zai Lab shall share costs associated with certain new manufacturing and technology transfer activities for XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(the &#x201c;Services&#x201d;), which were not contemplated under the Zai Agreement and are crucial for regulatory approval in the Asia-Pacific region. We determined that the Amended Zai Agreement falls within the scope of ASC 606 and Zai Lab is a customer in this arrangement as the Services are an output of our ordinary activities. We have determined that the Services represent the only performance obligation and are distinct from the performance obligations under the original Zai Agreement. In addition, the expenses we incur in performing the Services most accurately depict the transfer of value to Zai Lab and maximize the use of observable inputs for measuring progress, therefore, we recognize revenue from this arrangement as the expenses related to Services are incurred. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in license and other revenue for the year ended December 31, 2024 under the Amended Zai Agreement, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million is included in &#x201c;Accounts receivable&#x201d; in our consolidated balance sheet as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2024, we entered into an interim supply agreement with Zai Lab, under which Zai Lab shall purchase XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;inventory (the &#x201c;Supplied Inventory&#x201d;) for their commercial launch. We have determined that this agreement falls within the scope of ASC 606. Zai Lab is a customer and the Supplied Inventory is an output of our ordinary activities. We have also determined that the Supplied Inventory represents the only performance obligation and is distinct from the performance obligations under the Zai agreements discussed above. Furthermore, we evaluated that the performance obligation is satisfied over time and that a cost-to-cost measure of progress would be the measure of progress that most accurately depicts the transfer of value to Zai Lab and maximizes the use of observable inputs to measure progress. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net product sales for the Supplied Inventory for the year ended December 31, 2024, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million is included in &#x201c;Accounts receivable&#x201d; in our consolidated balance sheet as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We also entered into a manufacturing stage transfer agreement with Zai Lab in June 2024, which was amended in September 2024 (the &#x201c;Zai Manufacturing Stage Transfer Agreement&#x201d;). Pursuant to this agreement, Entasis shall provide assistance to Zai Lab for building out Zai Lab&#x2019;s manufacturing site for XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and be compensated for Entasis' services and associated costs. We have determined this agreement falls within the scope of ASC 606. Zai Lab is a customer and the transfer service is an output of our ordinary activities and represents our only performance obligation, which is distinct from the performance obligations under the Zai agreements. Furthermore, we have evaluated that the performance obligation is satisfied over time and that the costs we incur in performing the transfer service most accurately depicts the transfer of value to Zai Lab and maximizes the use of observable inputs for measuring progress, therefore, we recognize revenue from this arrangement as the services are provided and the costs are incurred. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in license and other revenue for the year ended December 31, 2024 under the Zai Manufacturing Stage Transfer Agreement, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million is included in &#x201c;Accounts receivable&#x201d; in our consolidated balance sheet as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2024, we entered into a letter agreement pursuant to which Zai Lab will purchase regulatory starting material (&#x201c;RSM&#x201d;) supply  for use in the production of XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. We will supply the RSM while we continue to work on executing a commercial supply agreement with Zai Lab in accordance with the Zai Agreement. Based on our assessments, this agreement does not modify any of our existing contracts with Zai Lab discussed above and should be accounted for separately. We have also determined that this agreement falls within the scope of ASC 606. However, this does not meet the definition of a contract with a customer since the contract does not identify each party&#x2019;s rights regarding goods or services. Accordingly, we deferred the consideration received amounting to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of December 31, 2024 in &#x201c;Other accrued liabilities&#x201d; until the execution of a commercial supply agreement, which will include all the required terms necessary for identifying each party&#x2019;s rights regarding goods or services.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;GARDP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Entasis entered into a collaboration agreement with the Global Antibiotic Research and Development Partnership (&#x201c;GARDP&#x201d;) for the development, manufacture and commercialization of the product candidate zoliflodacin in certain countries (&#x201c;the GARDP Collaboration Agreement&#x201d;). Under the terms of the GARDP Collaboration Agreement, GARDP will use commercially reasonable endeavors to perform and fully fund the Phase 3 registrational trial, including the manufacture and supply of the product candidate containing zoliflodacin, in uncomplicated gonorrhea. We recorded immaterial reimbursements from GARDP under this agreement as reduction to research and development expense during the periods presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, under the GARDP Collaboration Agreement, GARDP was granted a worldwide, fully paid, exclusive and royalty-free license, with the right to sublicense, to use our zoliflodacin technology in connection with GARDP&#x2019;s development, manufacture and commercialization of zoliflodacin in low-income and specified middle-income countries. We retained commercial rights in all other countries worldwide, including the major markets in North America, Europe and Asia-Pacific. We also retained the right to use and grant licenses to our zoliflodacin technology to perform our obligations under the GARDP Collaboration Agreement and for any purpose other than gonorrhea or community-acquired indications. If we believe that the results of the Phase 3 registrational trial of zoliflodacin would be supportive of an application for marketing approval, we are obligated to use our best efforts to file an application for marketing approval with the FDA within six months of the completion of the trial and to use commercially reasonable endeavors to file an application for marketing approval with the European Medicines Agency (&#x201c;EMA&#x201d;). Each party is responsible for using commercially reasonable efforts to obtain marketing authorizations for the product candidate in their respective territories.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;PAION Pharma GmbH&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the PAION AG and PAION Deutschland GmbH (together and individually &#x201c;PAION&#x201d;) License, La Jolla granted PAION an exclusive license to commercialize GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the European Economic Area, the United Kingdom and Switzerland (collectively, the &#x201c;PAION Territory&#x201d;). We are entitled to receive potential commercial milestone payments of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;109.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and double-digit tiered royalty payments. Royalties payable in a given jurisdiction under the PAION License will be subject to reduction on account of generic competition and after patent expiration in that jurisdiction. Pursuant to the PAION License, PAION will be solely responsible for the future development and commercialization of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the PAION Territory. PAION is required to use commercially reasonable efforts to commercialize GIAPREZA&#xae; and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the PAION Territory. We have not recognized any revenue from PAION related to commercial milestones from the date of acquisition of La Jolla to December 31, 2024. Royalty revenue recognized under this agreement for the year ended December 31, 2024 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Royalty revenue recognized under this agreement for the year ended December 31, 2023 and from the date of acquisition of La Jolla to December 31, 2022 was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;La Jolla also entered into the PAION commercial supply agreement (the &#x201c;PAION Supply Agreement&#x201d;) whereby La Jolla will supply PAION a minimum quantity of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; through July 13, 2024. The PAION supply agreement will automatically renew until the earlier of July 13, 2027, or until a new supply agreement is executed. During the initial term of the supply agreement, we will be reimbursed for direct and certain indirect manufacturing costs at cost. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cost reimbursements under this agreement for the year ended December 31, 2023. Amounts recognized under this agreement for the year ended December 31, 2024 and from the date of acquisition of La Jolla to December 31, 2022 were not material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;PAION filed for insolvency in Germany on October 27, 2023 and the insolvency proceedings commenced on January 1, 2024. PAION announced on December 22, 2023 that it concluded negotiations with Humanwell Healthcare Group and entered into an agreement on the sale of the essential business operations of PAION with the approval of the insolvency administrator in both procedures. In early 2024, the sale of business operations of PAION was completed and starting February 2024, PAION has continued its business as a subsidiary of the Humanwell Healthcare Group as an independent company under the name PAION Pharma GmbH.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Everest Medicines Limited&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Everest Medicines Limited (&#x201c;Everest&#x201d;) License, La Jolla granted Everest an exclusive license to develop and commercialize XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the treatment of complicated intra-abdominal infections (&#x201c;cIAI&#x201d;) and other indications in mainland China, Taiwan, Hong Kong, Macau, South Korea, Singapore, the Malaysian Federation, the Kingdom of Thailand, the Republic of Indonesia, the Socialist Republic of Vietnam and the Republic of the Philippines (collectively, the &#x201c;Everest Territory&#x201d;). &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the Everest License, we recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in license revenue for the year ended December 31, 2023 as a result of an achievement of a regulatory milestone during the period. We are eligible to receive additional sales milestone payments of up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We are also entitled to receive tiered royalties from Everest at percentages in the low double digits on sales, if any, in the Everest Territory of products containing eravacycline. Royalties are payable with respect to each jurisdiction in the Everest Territory until the latest to occur of: (i) the last-to-expire of specified patent rights in such jurisdiction in the Everest Territory; (ii) expiration of marketing or regulatory exclusivity in such jurisdiction in the Everest Territory; or (iii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years after the first commercial sale of a product in such jurisdiction in the Everest Territory. Royalty revenue recognized under this agreement for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and 2023 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. Royalty revenue recognized under this agreement from the date of acquisition of La Jolla to December 31, 2022 was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;La Jolla also entered into the Everest commercial supply agreement (the &#x201c;Everest Supply Agreement&#x201d;) whereby La Jolla will supply Everest a minimum quantity of XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and will transfer to Everest certain XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;-related manufacturing know-how. We were eligible to be reimbursed for direct and certain indirect manufacturing costs at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of cost through December 31, 2023. W&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in revenue under this agreement for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and 2023, respectively. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in revenue under this agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the acquisition of La Jolla to December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;In-License Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basilea&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2024, we entered into an exclusive distribution and license agreement with Basilea under which we were granted exclusive marketing rights to ZEVTERA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;in the U.S. The agreement will remain in effect until the expiration of market exclusivity of ZEVTERA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the U.S. in 2034 (the &#x201c;initial term&#x201d;), subject to automatic renewal unless either party provides notice. We paid an upfront fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which we recognized as an intangible asset and will be amortized over the initial term of the agreement. We will exclusively purchase ZEVTERA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(pre-packaging and labeling) from Basilea throughout the term. We are also obligated to pay Basilea tiered royalties ranging from the high-teens to mid-twenties, as well as tiered milestones, on annual net sales in the U.S. We anticipate commercializing ZEVTERA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in mid-year 2025 and, therefore, have not incurred any royalties or sales milestone payments for the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;George Washington University&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the George Washington University (&#x201c;GW&#x201d;) License, GW exclusively licensed to La Jolla certain intellectual property rights relating to GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, including the exclusive rights to certain issued patents and patent applications covering GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Under the GW License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We are obligated to pay a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% royalty on net sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% on payments received from sublicensees. The obligation to pay royalties under this agreement extends through the last-to-expire patent covering GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended December 31, 2024 and 2023, respectively, under this agreement. Amounts recognized from the date of acquisition of La Jolla to December 31, 2022 were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Harvard University&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Harvard University (&#x201c;Harvard&#x201d;) License, Harvard exclusively licensed to La Jolla certain intellectual property rights relating to tetracycline-based products, including XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, including the exclusive rights to certain issued patents and patent applications covering such products. Under the Harvard License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell tetracycline-based products, including XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. For each product covered by the Harvard License, we are obligated to make certain payments for the following: (i) up to approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upon the achievement of certain clinical development and regulatory milestones; (ii) a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% royalty on direct U.S. net sales of XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;; (iii) a single-digit tiered royalty on direct ex-U.S. net sales of XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, starting at a minimum royalty rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, with step-ups to a maximum royalty of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% based on the achievement of annual net product sales thresholds; and (iv) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% on payments received from sublicensees. The obligation to pay royalties under this agreement extends through the last-to-expire patent covering tetracycline-based products, including XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the year ended December 31, 2024 under this agreement. For the year ended December 31, 2023, we recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as cost of license revenue under this agreement as a result of the license revenue we earned under the out-licensing agreement with Everest for the same period. For the years ended December 31, 2024 and 2023 and from the date of acquisition of La Jolla to December 31, 2022, royalties recognized under this agreement were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Paratek Pharmaceuticals, Inc.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Paratek Pharmaceuticals, Inc. (&#x201c;Paratek&#x201d;) License, Paratek non-exclusively licensed to La Jolla certain intellectual property rights relating to XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, including non-exclusive rights to certain issued patents and patent applications covering XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We were obligated to pay Paratek a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% royalty based on direct U.S. net sales of XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our obligation to pay royalties with respect to the licensed product was retroactive to the date of the first commercial sale of XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and continued until there are no longer any valid claims of the Paratek patents, which expired in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_f0a3b6ae-bc83-48c5-86cb-73ff6b579e00;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;October 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. For the year ended December 31, 2023, and from the date of acquisition of La Jolla to December 31, 2022, amounts recognized under this agreement were not material.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Business Transfer and Subscription Agreement with AstraZeneca&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Entasis entered into a Business Transfer and Subscription Agreement with AstraZeneca, AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP (collectively, &#x201c;AstraZeneca&#x201d;) (the &#x201c;AstraZeneca Agreement&#x201d;) in 2015, which was amended and restated through 2018, pursuant to which Entasis obtained, among other things, worldwide rights to durlobactam and zoliflodacin. Under the AstraZeneca Agreement, we are obligated to pay AstraZeneca a one-time milestone payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million within &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of achieving a specified cumulative net sales milestone for durlobactam. We are also obligated to pay AstraZeneca a one-time milestone payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million within &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of achieving the first commercial sale of zoliflodacin. Additionally, we are obligated to pay AstraZeneca tiered, single-digit royalties on the annual worldwide net sales of durlobactam and, the lesser of tiered, single-digit royalties on the worldwide annual net sales of zoliflodacin and a specified share of the royalties we receive from sublicensees of zoliflodacin. Royalties on sales of zoliflodacin do not include sales by GARDP in low-income and specified middle-income countries as discussed above. Our obligation to make these royalty payments expires with respect to each product on a country-by-country basis upon the later of (i) the 10-year anniversary of the first commercial sale of a product in each such country or (ii) when the last patent right covering a product expires in each such country.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Royalty expense on durlobactam arising from our net sales of XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the year ended December 31, 2024 and 2023 was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material.&lt;/span&gt;</inva:LicenseAndCollaborationArrangementsDisclosureTextBlock>
    <inva:FuturePotentialMilestonePayment
      contextRef="C_73b479b7-bd69-4e75-9afa-4ce0c8d93cbd"
      decimals="-5"
      id="F_c3b3eaa8-d1bf-45c3-b7b0-faaaa46739a8"
      unitRef="U_USD">91000000</inva:FuturePotentialMilestonePayment>
    <inva:LicenseRevenueRecognized
      contextRef="C_a41714b7-a00f-481f-be71-d01b3d66ce35"
      decimals="-5"
      id="F_e0edb051-2b50-4f2b-9b46-ac36c27a38f9"
      unitRef="U_USD">8000000</inva:LicenseRevenueRecognized>
    <inva:LicenseRevenueRecognized
      contextRef="C_cb1c40b3-5c1e-420b-883d-1af63b9dae15"
      decimals="-5"
      id="F_7733501c-40b5-450d-aff3-4df016ac398a"
      unitRef="U_USD">3000000</inva:LicenseRevenueRecognized>
    <inva:LicenseAndOtherRevenue
      contextRef="C_d4eaab11-5036-4fa2-80f4-ac4c6edacc5d"
      decimals="-5"
      id="F_d71ae962-47ee-4f60-954f-0aba3bede805"
      unitRef="U_USD">8100000</inva:LicenseAndOtherRevenue>
    <us-gaap:AccountsReceivableNet
      contextRef="C_d03f0f85-cb5e-446d-9bac-86efb022c8e6"
      decimals="-5"
      id="F_14cab333-e1ef-4fce-bdd4-2eb3754aeaa1"
      unitRef="U_USD">1600000</us-gaap:AccountsReceivableNet>
    <inva:AmountOnNetProductSalesRecognized
      contextRef="C_af5e6a83-99f4-4f15-91c5-d548183e4cf6"
      decimals="-5"
      id="F_16a7b5e5-f650-418d-952e-0b30017cf962"
      unitRef="U_USD">6300000</inva:AmountOnNetProductSalesRecognized>
    <us-gaap:AccountsReceivableNet
      contextRef="C_d4a55873-42fb-4f4d-8ae0-0c16e81de797"
      decimals="-5"
      id="F_47de6dc4-c446-4613-b5eb-5ec6eee8058e"
      unitRef="U_USD">600000</us-gaap:AccountsReceivableNet>
    <inva:LicenseAndOtherRevenue
      contextRef="C_8e904088-1404-41dd-83e8-637489e1cb2c"
      decimals="-5"
      id="F_ba064afb-85a2-4a0a-acdb-d71b9d4d8d37"
      unitRef="U_USD">3400000</inva:LicenseAndOtherRevenue>
    <us-gaap:AccountsReceivableNet
      contextRef="C_55ac6c23-a2e6-4ccc-84fe-98d81ce04dce"
      decimals="-5"
      id="F_badc3593-da50-4f80-8cd7-56ab6f6628aa"
      unitRef="U_USD">100000</us-gaap:AccountsReceivableNet>
    <inva:LetterAgreementForPurchaseOfMaterialUsedForProductionValue
      contextRef="C_fc9a0b8f-f975-48ca-a3e6-9b76b08bd568"
      decimals="-5"
      id="F_606a79ce-4d88-4804-80f5-b77f98a4d22d"
      unitRef="U_USD">10900000</inva:LetterAgreementForPurchaseOfMaterialUsedForProductionValue>
    <inva:BusinessCombinationDeferredConsideration
      contextRef="C_de99671a-3f86-4f93-b929-187c53e350a3"
      decimals="-5"
      id="F_ad8ea90a-1248-41f0-84a9-9e29e075adf9"
      unitRef="U_USD">5300000</inva:BusinessCombinationDeferredConsideration>
    <inva:FuturePotentialMilestonePayment
      contextRef="C_f4ae3171-8820-4834-b2c2-1c6f94927a5e"
      decimals="-5"
      id="F_6c2d3e34-4490-46bf-bd19-3af8ff1a7a43"
      unitRef="U_USD">109500000</inva:FuturePotentialMilestonePayment>
    <us-gaap:Revenues
      contextRef="C_80aa6909-465c-42c3-b0b3-1b95cbf1839b"
      decimals="-5"
      id="F_ccab0dd6-6e1e-4fb2-8601-c5e33aab8536"
      unitRef="U_USD">1500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_56f936fd-c826-462c-938f-240f31460844"
      decimals="-3"
      id="F_f4c8542c-6c31-49a7-8ef0-547ded8443cf"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_cbc4cdee-389a-4cf9-b9af-2f7d95792201"
      decimals="-3"
      id="F_7d754cf8-91b3-46cc-b096-1f1b8c7b0865"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_31a5145f-3c5c-445c-8566-35efc89d880a"
      decimals="-5"
      id="F_e01973a6-78c7-4ff9-8e5a-15e0047e7e70"
      unitRef="U_USD">1300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_9b5e3f73-d7e2-4436-a4cc-ebaba20abb28"
      decimals="-5"
      id="F_6b893009-0f31-4ad1-8e29-f51f5300b24c"
      unitRef="U_USD">8000000</us-gaap:Revenues>
    <inva:SalesMilestonePaymentsReceivable
      contextRef="C_811f0ab4-b358-4bcc-bc70-9137747403ac"
      decimals="-5"
      id="F_5586f9f7-2a1b-49c3-a0cd-3bde9bcb0800"
      unitRef="U_USD">20000000</inva:SalesMilestonePaymentsReceivable>
    <inva:RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct
      contextRef="C_c806d5a2-f390-4c9d-b3ed-a166cdaae201"
      id="F_50e4c2ab-ac0c-43d1-9c58-e81419cc9e38">P10Y</inva:RoyaltiesPayablePeriodAfterFirstCommercialSaleOfProduct>
    <us-gaap:Revenues
      contextRef="C_43ebbba5-322d-4a57-9b5a-da8637cdeb0f"
      decimals="-5"
      id="F_8aadc97a-e41b-44e6-b0c9-e8663191c7c4"
      unitRef="U_USD">4700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_f7f1eee0-388b-4fa8-9890-63be03fbd551"
      decimals="-5"
      id="F_a639f375-65f7-4f8b-b21f-88b6c75c246e"
      unitRef="U_USD">1400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_0b1f96f1-ab6d-47e4-9aef-4751a8f64e5a"
      decimals="-3"
      id="F_c9ceba01-186c-40d4-91b9-16cc419e7963"
      unitRef="U_USD">0</us-gaap:Revenues>
    <inva:PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts
      contextRef="C_a766e556-6ab5-4064-b9f0-b96a29676eab"
      decimals="2"
      id="F_e8a3f718-6b45-42a1-8fa9-a2fdc51bba5e"
      unitRef="U_pure">1.10</inva:PercentageOfReimbursedForDirectAndCertainIndirectManufacturingCosts>
    <us-gaap:Revenues
      contextRef="C_21159e50-9136-4f4e-a5d7-9312dd7ce1ce"
      decimals="-5"
      id="F_d42874ea-6cf9-43bc-bcdc-4d6343efe8ca"
      unitRef="U_USD">3200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_a766e556-6ab5-4064-b9f0-b96a29676eab"
      decimals="-5"
      id="F_84216071-e239-458c-bd4f-f1bed5dbd481"
      unitRef="U_USD">2400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_887080f2-8412-4508-9e41-bc1a8e2ff95e"
      decimals="-5"
      id="F_3a0f6cf6-4d36-43dc-abf3-0c951fe1b47d"
      unitRef="U_USD">800000</us-gaap:Revenues>
    <inva:UpfrontPaymentUnderIntangibleAsset
      contextRef="C_a0ab4d8b-b98c-4423-b309-fa00f676612e"
      decimals="-5"
      id="F_c0898315-d1a6-4219-91f7-bc0c1a4f69c7"
      unitRef="U_USD">4000000</inva:UpfrontPaymentUnderIntangibleAsset>
    <inva:PercentageOfRoyaltyPayableOnNetSales
      contextRef="C_cc713bc3-dccb-47e9-8743-bf1aadadd990"
      decimals="2"
      id="F_4621f784-f14f-405f-ad9c-c5e8297434bb"
      unitRef="U_pure">0.06</inva:PercentageOfRoyaltyPayableOnNetSales>
    <inva:PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees
      contextRef="C_cc713bc3-dccb-47e9-8743-bf1aadadd990"
      decimals="2"
      id="F_f5be5751-bbe7-4b9d-839e-6c51d365e76b"
      unitRef="U_pure">0.15</inva:PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees>
    <inva:AccruedRoyaltyObligations
      contextRef="C_cc713bc3-dccb-47e9-8743-bf1aadadd990"
      decimals="-5"
      id="F_e53cb569-ddd8-4250-9dca-37390524676a"
      unitRef="U_USD">3400000</inva:AccruedRoyaltyObligations>
    <inva:AccruedRoyaltyObligations
      contextRef="C_0cc6ac22-c321-4787-9e00-3da335019c16"
      decimals="-5"
      id="F_1849341b-2905-48f8-82d0-adaae10357e1"
      unitRef="U_USD">2500000</inva:AccruedRoyaltyObligations>
    <inva:AccruedRoyaltyObligations
      contextRef="C_d37f9324-54d5-4067-beb3-18876b2ba3f8"
      decimals="-6"
      id="F_63b44398-e854-4f5b-bb7f-dc3f52c2b653"
      unitRef="U_USD">0</inva:AccruedRoyaltyObligations>
    <inva:ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable
      contextRef="C_119ad206-2058-450a-8e97-89fb20b4c812"
      decimals="-5"
      id="F_7b992b57-6fdd-4dbb-b809-18d1aefa63fa"
      unitRef="U_USD">15100000</inva:ClinicalDevelopmentAndRegulatoryMilestonesAmountPayable>
    <inva:PercentageOfRoyaltyPayableOnNetSales
      contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8"
      decimals="2"
      id="F_0dfc1e84-d780-48be-88c8-8d01cb967293"
      unitRef="U_pure">0.05</inva:PercentageOfRoyaltyPayableOnNetSales>
    <inva:PercentageOfMinimumRoyaltyRate
      contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8"
      decimals="3"
      id="F_88293212-e852-45dc-ab71-6bc6bc999642"
      unitRef="U_pure">0.045</inva:PercentageOfMinimumRoyaltyRate>
    <inva:PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds
      contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8"
      decimals="3"
      id="F_134761c6-4712-491d-93a3-b2e80d632e39"
      unitRef="U_pure">0.075</inva:PercentageOfMaximumRoyaltyBasedOnAchievementOfAnnualNetProductSalesThresholds>
    <inva:PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees
      contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8"
      decimals="2"
      id="F_37def845-16cf-44b1-b11c-0ee8d9fdcd75"
      unitRef="U_pure">0.20</inva:PercentageOfRoyaltyOnPaymentsReceivedFromSublicensees>
    <us-gaap:CostOfRevenue
      contextRef="C_7136a559-6922-4b61-8d55-1fe4429116c8"
      decimals="-5"
      id="F_8a9bb652-130b-459a-bfac-1f3d3dcd7fdc"
      unitRef="U_USD">1400000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_74764868-362a-469f-82b3-5a8b74607e25"
      decimals="-5"
      id="F_0a04d338-a431-49c6-82d9-a7561842e810"
      unitRef="U_USD">1200000</us-gaap:CostOfRevenue>
    <us-gaap:Revenues
      contextRef="C_2f78b292-f3be-4468-828a-00ca22c1d9e5"
      decimals="-3"
      id="F_70600ceb-96b1-470b-a30f-40902132ff33"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_f51e917b-8e9a-4315-958f-c6e9da82aacf"
      decimals="-3"
      id="F_bd1ab1ec-c6bb-4e0b-a5b9-f48278363a24"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_d2ecd1f3-29e6-42cb-af2b-fc69c9589381"
      decimals="-3"
      id="F_f3f84c2d-fd61-404f-9f5b-7b61b87e10a3"
      unitRef="U_USD">0</us-gaap:Revenues>
    <inva:PercentageOfRoyaltyPayableOnNetSales
      contextRef="C_8072618f-1ec5-41e4-b16b-b78997fa817e"
      decimals="4"
      id="F_68893a42-ca95-44c5-aa0d-bb5faab91982"
      unitRef="U_pure">0.0225</inva:PercentageOfRoyaltyPayableOnNetSales>
    <inva:SubscriptionAgreementOneTimeMilestonePaymentOnNetSales
      contextRef="C_9a12f957-a828-4d75-944d-2087cd6938c1"
      decimals="-5"
      id="F_5ae098ce-9cb3-4ad3-b104-c44c9043a81d"
      unitRef="U_USD">5000000</inva:SubscriptionAgreementOneTimeMilestonePaymentOnNetSales>
    <inva:TermOfMilestonePaymentForNetSales
      contextRef="C_9a12f957-a828-4d75-944d-2087cd6938c1"
      id="F_9668eeb9-4465-4ef7-9be0-cc7c83b60b76">P3M</inva:TermOfMilestonePaymentForNetSales>
    <inva:SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales
      contextRef="C_9f3c3b1f-09d6-4eb0-b566-b7a7e7c47ec8"
      decimals="-5"
      id="F_24fbffaa-d446-43b6-ac9c-22e47547acaa"
      unitRef="U_USD">10000000</inva:SubscriptionAgreementOneTimeMilestonePaymentOnCommercialSales>
    <inva:TermOfMilestonePaymentForCommercialSale
      contextRef="C_9f3c3b1f-09d6-4eb0-b566-b7a7e7c47ec8"
      id="F_6ef8fa4d-8568-474e-be31-02799ff99c5e">P2Y</inva:TermOfMilestonePaymentForCommercialSale>
    <us-gaap:RoyaltyExpense
      contextRef="C_9a12f957-a828-4d75-944d-2087cd6938c1"
      decimals="-3"
      id="F_0be2146f-b3eb-45ee-9403-e2b36395d1c7"
      unitRef="U_USD">0</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_3c13a3c1-d391-437e-ab76-9807135c7a06"
      decimals="-3"
      id="F_dfe84146-7fd8-4a11-ab50-6bab5f6e0708"
      unitRef="U_USD">0</us-gaap:RoyaltyExpense>
    <inva:ConsolidatedEntitiesAndAcquisitionsTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_6c8f0df0-984c-4348-95de-0e6dc1ed0288">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. CONSOLIDATED ENTITIES AND ACQUISITIONS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Consolidated Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Theravance Respiratory Company, LLC&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Up until July 20, 2022, we consolidated TRC under the VIE model as we determined that TRC was a VIE and we were the primary beneficiary of the entity because we had the power to direct the economically significant activities of TRC and the obligation to absorb losses of, or the right to receive benefits from, TRC. We held &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% ownership interest of TRC. The primary source of revenue for TRC is the royalties generated from the net sales of TRELEGY&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ELLIPTA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; by GSK.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in Note 3, &#x201c;Revenue Recognition&#x201d;, on July 13, 2022, ITH entered into the TRC Equity Purchase Agreement to sell our ownership interest in TRC. Upon the closing of the transaction on July 20, 2022, we received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;277.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash from Royalty Pharma. We are also entitled to receive up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in contingent sales-based milestone payments in the future. In connection with the closing of the transaction, we also received our portion of TRC&#x2019;s remaining cash balance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from Royalty Pharma rather than through a cash distribution from TRC.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the closing of the transaction and as part of the agreement, TRC distributed its ownership interests and investments in InCarda Therapeutics (&#x201c;InCarda&#x201d;), Inc., ImaginAb, Inc. (&#x201c;ImaginAb&#x201d;), Gate and Nanolive SA (&#x201c;Nanolive&#x201d;), which had a total carrying value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, to ITH. We accounted for the transaction similar to an upstream sale between a parent and a VIE under ASC 810-10. As such, ITH recorded the transferred investments at their respective carrying values and no gain or loss was recognized in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The summarized financial information of TRC from January 1, 2022 to July 20, 2022, the date of the sale of our ownership interest in TRC, is presented as follows:&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:75.96%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalty revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Realized loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair values of equity and&lt;br/&gt;&#160;&#160;&#160;long-term investments, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2020, Innoviva Strategic Partners LLC, our wholly owned subsidiary (&#x201c;Strategic Partners&#x201d;), contributed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to ISP Fund LP (the &#x201c;Partnership&#x201d;) for investing in &#x201c;long&#x201d; positions in the healthcare, pharmaceutical and biotechnology sectors and became a limited partner. The general partner of the Partnership (&#x201c;General Partner&#x201d;) is an affiliate of Sarissa Capital.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Partnership Agreement provides for Sarissa Capital to receive management fees from the Partnership, payable quarterly in advance, measured based on the Net Asset Value of Strategic Partners&#x2019; capital account in the Partnership. In addition, General Partner is entitled to an annual performance fee based on the Net Profits of the Partnership during the annual measurement period.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Partnership Agreement includes a lock-up period of thirty-six months after which Strategic Partners is entitled to make withdrawals from the Partnership as of such lock-up expiration date and each anniversary thereafter, subject to certain limitations. The lock-up period for the initial contribution of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;190.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;which excludes the amount discussed below, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;expired in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_575134d6-a304-419f-b46a-5cbe0a39b7e5;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Strategic Partners did not elect to make a withdrawal in 2023, thereby extending the lock-up period and withdrawal elections into subsequent years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2021, Strategic Partners received a distribution of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from the Partnership to provide funding to Innoviva for a strategic repurchase of shares held by GSK. On March 30, 2022, Strategic Partners made an additional capital contribution of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to the Partnership pursuant to the letter agreement entered into between Strategic Partners, the Partnership and Sarissa Capital Fund GP LP on May 20, 2021. The capital contribution is subject to a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;36-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; lock up period from the contribution date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We consolidate ISP Fund LP under the VIE model as we have determined that ISP Fund LP is a VIE and we are the primary beneficiary of the entity via our related party relationships with Sarissa Capital entities. Our maximum exposure to loss is equal to the amount we invested in the entity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ISP Fund LP is determined to be an investment company under ASC 946, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Services &#x2013; Investment Companies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, as it meets all fundamental characteristics of an investment company, and its activities are consistent with those of an investment company. Since ISP Fund LP is subject to investment company industry specific guidance, we have retained the industry-specific guidance applied by the Partnership. In addition, as our investment in the Partnership is a passive investment for the Company and is not part of our main operations, the investments are presented as part of &#x201c;Equity and long-term investments&#x201d; in our consolidated balance sheets. In October 2024, Strategic Partners made an election to unwind its capital accounts in the Partnership in accordance with the terms of the Partnership Agreement and we expect to receive distributions of our capital accounts through April 2026. Accordingly, a portion of our investments, which consist of cash and money market funds that we expect to be distributed in the next 12 months, were classified as ISP Fund investments in the consolidated balance sheet as of December 31, 2024, and the remaining equity investments managed by ISP Fund LP are expected to be distributed through April 2026. We report in our consolidated statements of income any investment gains and losses by the Partnership as part of &#x201c;Changes in fair value of equity and long-term investments, net&#x201d;, any interest and dividend income as part of &#x201c;Interest and dividend income&#x201d; and any investment expenses as part of &#x201c;Other expense, net&#x201d;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we continued to hold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the economic interest of Partnership. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, total assets of the Partnership were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, of which the majority was attributable to equity and long-term investments. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, total liabilities of the Partnership w&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ere $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; mill&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ion and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. The Partnership&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;s assets can only be used to settle its own obligations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, the Partnership incurred&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million in net investment-related expenses, generated $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million interest income, recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net realized losses and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. During the year ended December 31, 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Partnership incurred $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net investment-related expenses, generated $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million interest income, recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net realized losses and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. During the year ended December 31, 2022, the Partnership incurred $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net investment-related expense, generated $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million interest income, and recorded net $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million realized gains and net $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized losses as changes in fair values of equity and long-term investments, net, in the consolidated statement of income. We account for the long-term investments held by ISP Fund LP as of December 31, 2024 and 2023 and 2022 as equity investments measured at fair value.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is a summary of individual investments held by ISP Fund at each balance sheet date:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:61.232%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.603%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.603%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;In thousands&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock - Publicly traded healthcare companies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;184,926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United Kingdom&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,942&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,868&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Preferred stock - Privately held healthcare companies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,530&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants - Privately held healthcare companies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market fund and cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;Total investments held by ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Acquisitions&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Entasis Therapeutics Holdings Inc.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We started investing in Entasis in 2020 as part of our capital allocation strategy of deploying cash generated from royalty income and investing in different life sciences companies. Entasis at the time was an advanced, late clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products. Effective in June 2020, after certain conditions were met with respect to the sales of Entasis equity shares, Innoviva had the right to designate &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; members to Entasis&#x2019; board. Our investment in Entasis consisted of shares of common stock and warrants to purchase shares of Entasis common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of Entasis&#x2019; common stock was measured based on its closing market price at each balance sheet date. We used the Black-Scholes-Merton pricing model to estimate the fair value of the warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 17, 2022, Innoviva Strategic Opportunities, LLC (&#x201c;ISO&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; entered into a securities purchase agreement with Entasis pursuant to which ISO purchased a convertible promissory note for a total purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The note bore an annual interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.59&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and was due to mature and become payable on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_47da13c9-3667-4443-acf7-9a613c3e52a0;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;August 18, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; unless it was converted at a conversion price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.48&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; before the maturity date. With this financing, we determined that we had both (i) the power to direct the economically significant activities of Entasis and (ii) the obligation to absorb the losses, or the right to receive the benefits, that could potentially be significant to Entasis and therefore, we were the primary beneficiary of Entasis. Accordingly, we consolidated Entasis&#x2019; financial position and results of operations effective on February 17, 2022. Our equity ownership interest remained at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% as of February 17, 2022, and the fair values of our holdings of Entasis common stock and warrants were remeasured and estimated at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The remeasurement resulted in a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million loss in the first quarter of 2022 which was included in changes in fair values of equity method investments, net, in the consolidated statement of income for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We completed our acquisition of Entasis&#x2019; noncontrolling interest on July 11, 2022. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; payments were made toward the convertible promissory note through the date of acquisition of Entasis. In connection with the acquisition, all of the Entasis warrants were replaced with Innoviva warrants (the &#x201c;Replacement Warrants&#x201d;) of equivalent value and bearing the same terms. The Replacement Warrants were classified as equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognized the difference between the acquisition price and the carrying value of the acquired noncontrolling interest on July 11, 2022 in our additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair values assigned to assets acquired and liabilities assumed as of February 17, 2022 were based on management&#x2019;s best estimates and assumptions. After the acquisition in July 2022, we adjusted the purchase price allocation based on new and additional information related to product sales forecast provided by Entasis and deferred tax liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2022, we recorded measurement period adjustments of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million decrease in goodwill, primarily related to a decrease in estimated purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, an increase in noncontrolling interests of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and an increase in intangible assets of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The cumulative impact of the measurement period adjustments included in the consolidated net income for the year ended December 31, 2022 was not material.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In February 2023, we recorded a measurement period adjustment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million increase in goodwill, primarily related to a decrease in intangible assets of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and an increase in deferred tax liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The measurement period adjustment did not impact the consolidated net income for the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table represents the adjusted fair values of the assets acquired and liabilities assumed by us in the transaction:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;February 17, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued personnel-related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134,716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The goodwill arising from the acquisition of Entasis is primarily attributable to Entasis&#x2019; assembled workforce and the value associated with growing our business more efficiently. The goodwill from this acquisition is not expected to be deductible for tax purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to Note 8, &#x201c;Goodwill and Intangible Assets&#x201d;, for more discussion on the intangible assets recognized as part of this acquisition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of the consolidation, we recognized a non-controlling interest of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of February 17, 2022. Our consolidated net income for the year ended December 31, 2022 included the net loss attributable to noncontrolling interest since the consolidation date until the date of acquisition of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;La Jolla Pharmaceutical Company&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 22, 2022, ISO acquired La Jolla for a total consideration of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;206.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. ISO acquired La Jolla at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.23&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. La Jolla brought to Innoviva an established product portfolio, including GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock and XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (eravacycline) for the treatment of complicated intra-abdominal infections (cIAIs). We incurred approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in acquisition-related costs in connection with this acquisition during the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair values assigned to assets acquired and liabilities assumed as of August 22, 2022 were based on management&#x2019;s best estimates and assumptions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2022, we recorded measurement period adjustments of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million increase in goodwill, primarily related to a decrease in inventory and intangible assets of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, and an increase in deferred tax liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, partially offset by a decrease in other long-term liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The cumulative impact of the measurement period adjustments included in the consolidated net income for the year ended December 31, 2022 was not material.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2023, we recorded a measurement period adjustment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million decrease in goodwill, primarily related to an increase in deferred tax assets of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and a decrease in deferred tax liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In August 2023, we recorded a measurement period adjustment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million increase in goodwill, primarily related to a decrease in deferred tax assets of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and an increase in deferred tax liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The cumulative impact of the measurement period adjustments included did not impact the consolidated net income for the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table represents the adjusted fair values of assets acquired and liabilities assumed by us in the transaction:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;August 22, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,261&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;907&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;151,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;710&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,849&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,362&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other long-term liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;206,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The goodwill arising from the acquisition of La Jolla is primarily attributable to La Jolla&#x2019;s assembled workforce and the value associated with leveraging the workforce to develop and commercialize new drug products in the future and growing our business more efficiently. The goodwill from this acquisition is not expected to be deductible for tax purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to Note 8, &#x201c;Goodwill and Intangible Assets&#x201d;, for more discussion on the intangible assets recognized as part of this acquisition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Pro Forma Financial Information&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents certain unaudited pro-forma financial information for the year ended December 31, 2022 as if the consolidation of Entasis and La Jolla occurred on January 1, 2021. The unaudited pro forma financial information is presented for informational purposes only, and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place on January 1, 2021, or of results that may occur in the future. The unaudited pro forma financial information combines the historical results of the Entasis and La Jolla with the Company&#x2019;s consolidated historical results and includes certain adjustments including, but not limited to, fair value adjustments to equity investments in Entasis&#x2019; common stock and warrants, fair value adjustments to inventory, amortization of intangible assets, and interest expense on deferred royalty obligations and acquisition-related costs.&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;357,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;204,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;214,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</inva:ConsolidatedEntitiesAndAcquisitionsTextBlock>
    <inva:OwnershipInterestInConsolidatedEntities
      contextRef="C_3ad95b16-89e1-4def-b1ad-f62ba899efc6"
      decimals="2"
      id="F_b37bed71-7cb7-4e88-92a5-4652d43876bd"
      unitRef="U_pure">0.15</inva:OwnershipInterestInConsolidatedEntities>
    <inva:ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement
      contextRef="C_4f335e5e-75f0-4807-8256-9c44cb0e8135"
      decimals="-5"
      id="F_697f482f-5397-4e67-a2da-c419084ee5e3"
      unitRef="U_USD">277500000</inva:ProceedsFromSaleOfEconomicInterestUnderEquityPurchaseAgreement>
    <inva:ContingentSalesBasedMilestonePayment
      contextRef="C_f35372e3-5a04-485a-8e05-1fd441950552"
      decimals="-5"
      id="F_ef0c0c6d-d0dc-4eef-b68f-e2fa3005cc97"
      unitRef="U_USD">50000000</inva:ContingentSalesBasedMilestonePayment>
    <inva:CashDistributionReceived
      contextRef="C_c72b6c37-ed89-431f-8860-4f3a0138f363"
      decimals="-5"
      id="F_f95743f8-f4ff-4ede-b0cc-595ebbed7efc"
      unitRef="U_USD">4400000</inva:CashDistributionReceived>
    <inva:OwnershipInterestsAndInvestmentsCarryingValue
      contextRef="C_4f335e5e-75f0-4807-8256-9c44cb0e8135"
      decimals="-5"
      id="F_c2fe53d2-8c3a-4579-a7b0-88bcd3d8f4fc"
      unitRef="U_USD">39400000</inva:OwnershipInterestsAndInvestmentsCarryingValue>
    <inva:ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock
      contextRef="C_d326d4eb-5d26-4172-b306-2eb5433f4c8d"
      id="F_96930374-e703-4469-914e-9870bfcf9f25">
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:75.96%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalty revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Realized loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair values of equity and&lt;br/&gt;&#160;&#160;&#160;long-term investments, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</inva:ScheduleOfFinancialInformationOnConsolidatedEntityTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_f9df7c1f-6bde-4e08-b0ca-c088b7bfec4d"
      decimals="-3"
      id="F_b5fbd848-9346-4cdb-9e51-bf473eee5e7c"
      unitRef="U_USD">72029000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingExpenses
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_8f04b225-21cb-4cc0-86c4-bbcb52794fbf"
      unitRef="U_USD">332000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_af726a8a-09f0-40e1-8f5c-58d02a84d212"
      unitRef="U_USD">71697000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_e08ba2d0-981a-4584-a06c-00a27c2c906e"
      unitRef="U_USD">10000</us-gaap:OtherNonoperatingIncomeExpense>
    <inva:RealizedLoss
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_e4dad297-b482-48af-970a-621fbb6b9952"
      unitRef="U_USD">39386000</inva:RealizedLoss>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_cd48f752-a4c2-4331-94d7-f88e477bde32"
      unitRef="U_USD">1000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:GainLossOnInvestments
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_a7c7a849-00e7-42ab-ac33-4cdd89bfe71c"
      unitRef="U_USD">-8884000</us-gaap:GainLossOnInvestments>
    <us-gaap:ProfitLoss
      contextRef="C_2ab0d9b6-f64f-483f-8a20-5a6b44b8861f"
      decimals="-3"
      id="F_fc55800a-5ef2-4716-a92d-aafff3ca89a8"
      unitRef="U_USD">23438000</us-gaap:ProfitLoss>
    <us-gaap:LimitedPartnersContributedCapital
      contextRef="C_5f34def2-d4ef-45dc-9b5a-7b2dfd3ae646"
      decimals="-5"
      id="F_333bd71b-e4b0-4ca3-88f9-0dd1eb6ed114"
      unitRef="U_USD">300000000</us-gaap:LimitedPartnersContributedCapital>
    <inva:LimitedPartnersInitialContributionSubjectToLockUp
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      decimals="-5"
      id="F_dc12f8d5-f529-41fe-bfbd-a424290a31ec"
      unitRef="U_USD">190000000</inva:LimitedPartnersInitialContributionSubjectToLockUp>
    <us-gaap:LimitedPartnersCumulativeCashDistributions
      contextRef="C_bd235a25-25e3-4774-9cac-f96204385615"
      decimals="-5"
      id="F_515b9259-a21a-42fa-9455-385c748b5c5e"
      unitRef="U_USD">110000000</us-gaap:LimitedPartnersCumulativeCashDistributions>
    <us-gaap:LimitedPartnersContributedCapital
      contextRef="C_d5601efb-6bb1-44cc-bbcc-ebfffed538f5"
      decimals="-5"
      id="F_15461ce1-8d27-4b47-943f-ba240346bf7c"
      unitRef="U_USD">110000000</us-gaap:LimitedPartnersContributedCapital>
    <inva:PartnershipAgreementLockUpPeriod
      contextRef="C_bf2ff2aa-7c34-4e4f-9e97-336a5c293d40"
      id="F_3a4d4c7d-8d73-4925-92be-776eff3703fc">P36M</inva:PartnershipAgreementLockUpPeriod>
    <inva:PercentageOfEconomicInterestInPartnership
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      decimals="INF"
      id="F_715ac01f-ce7b-4128-95c8-0d343128fd49"
      unitRef="U_pure">1</inva:PercentageOfEconomicInterestInPartnership>
    <us-gaap:Assets
      contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef"
      decimals="-5"
      id="F_deca3025-49cc-440f-8aea-50043cc0f5cb"
      unitRef="U_USD">255700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb"
      decimals="-5"
      id="F_fdfcb537-1b6d-41d7-98c6-36dabe8590c5"
      unitRef="U_USD">311800000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef"
      decimals="-5"
      id="F_8b7e735b-65f2-42c4-8e41-2289d9619aa0"
      unitRef="U_USD">200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb"
      decimals="-5"
      id="F_98becb02-2e73-443f-8fdb-42c5c8b60d5a"
      unitRef="U_USD">100000</us-gaap:Liabilities>
    <inva:NetInvestmentRelatedIncomeExpensesEarnedInccured
      contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322"
      decimals="-5"
      id="F_57cb9c28-0ac6-4494-9162-e3bfb6e47dfa"
      unitRef="U_USD">-3700000</inva:NetInvestmentRelatedIncomeExpensesEarnedInccured>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322"
      decimals="-5"
      id="F_56e05bd9-225d-4f7a-8584-fe4158de14f0"
      unitRef="U_USD">4400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:GainLossOnInvestments
      contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322"
      decimals="-5"
      id="F_8a1c45e5-9e41-46e8-b74d-a41d88acd347"
      unitRef="U_USD">-5300000</us-gaap:GainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322"
      decimals="-5"
      id="F_75c61cdc-f2bf-4dea-96fc-f0dc8b15b6ab"
      unitRef="U_USD">-51500000</us-gaap:UnrealizedGainLossOnInvestments>
    <inva:NetInvestmentRelatedIncomeExpensesEarnedInccured
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      decimals="-5"
      id="F_727dec8a-6454-4364-aec5-c94af2d486b8"
      unitRef="U_USD">-4300000</inva:NetInvestmentRelatedIncomeExpensesEarnedInccured>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      decimals="-5"
      id="F_383d5c7b-5855-4c35-aa3a-af9144e7b63f"
      unitRef="U_USD">6300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:GainLossOnInvestments
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      decimals="-5"
      id="F_6512d0e6-c77a-4d60-8f8f-f2cdca421d10"
      unitRef="U_USD">-2400000</us-gaap:GainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_ea7dfa2c-567f-43fd-8303-83212ff97441"
      decimals="-5"
      id="F_d0b13562-9ba6-42e7-be3d-2f6142b3ceff"
      unitRef="U_USD">-6700000</us-gaap:UnrealizedGainLossOnInvestments>
    <inva:NetInvestmentRelatedIncomeExpensesEarnedInccured
      contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad"
      decimals="-5"
      id="F_b5aa10a2-c075-4701-90b2-5552aac417b6"
      unitRef="U_USD">-5200000</inva:NetInvestmentRelatedIncomeExpensesEarnedInccured>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad"
      decimals="-5"
      id="F_7a902d9b-69ad-4a58-88ad-5cf2e81df696"
      unitRef="U_USD">2000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:GainLossOnInvestments
      contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad"
      decimals="-5"
      id="F_681c3404-9791-40ef-9a7c-b6fedf41b893"
      unitRef="U_USD">6800000</us-gaap:GainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_92b2ee6e-fc14-4914-afbf-7d9ce901baad"
      decimals="-5"
      id="F_b5b93ba0-7c01-4966-a3d0-ca46ebe65c68"
      unitRef="U_USD">-9900000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:InvestmentTableTextBlock
      contextRef="C_20aec05b-661b-4aea-8d88-b14352ed9322"
      id="F_db5811f8-fb31-4969-9031-fcebfaaf8cf3">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is a summary of individual investments held by ISP Fund at each balance sheet date:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:61.232%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.603%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.603%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;In thousands&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock - Publicly traded healthcare companies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;184,926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United Kingdom&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,942&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,868&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Preferred stock - Privately held healthcare companies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,530&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants - Privately held healthcare companies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market fund and cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;Total investments held by ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentTableTextBlock>
    <inva:InvestmentsInCommonStock
      contextRef="C_0d59aa40-0636-4b3f-ab3a-b5149a08e64b"
      decimals="-3"
      id="F_8d0d5da1-0c57-4f10-894c-7a9cea39e25b"
      unitRef="U_USD">84039000</inva:InvestmentsInCommonStock>
    <inva:InvestmentsInCommonStock
      contextRef="C_40250a06-ba0d-4b97-9fa8-e40ff2902099"
      decimals="-3"
      id="F_1d5253ec-bf5b-4f64-8cdc-7353a4fec0ed"
      unitRef="U_USD">184926000</inva:InvestmentsInCommonStock>
    <inva:InvestmentsInCommonStock
      contextRef="C_6904c00c-1661-415e-91ce-09c91f2b890e"
      decimals="-3"
      id="F_6283b86e-2d9c-4427-a0bb-f6aa79ee2661"
      unitRef="U_USD">1989000</inva:InvestmentsInCommonStock>
    <inva:InvestmentsInCommonStock
      contextRef="C_85da56fa-4ced-4862-83dc-c5baf8401a9d"
      decimals="-3"
      id="F_37f29caf-97ae-495d-b3ed-f677e5884983"
      unitRef="U_USD">2942000</inva:InvestmentsInCommonStock>
    <inva:InvestmentsInCommonStock
      contextRef="C_7abf372b-d434-4499-93a9-de44ea4152e4"
      decimals="-3"
      id="F_fcce0013-823b-4233-a35f-b4243ed9ccd2"
      unitRef="U_USD">86028000</inva:InvestmentsInCommonStock>
    <inva:InvestmentsInCommonStock
      contextRef="C_f204fe66-1d1c-4852-b65c-0af9b8cf2582"
      decimals="-3"
      id="F_ee2fd56f-8771-49b5-a28d-dddd149bf9e9"
      unitRef="U_USD">187868000</inva:InvestmentsInCommonStock>
    <inva:InvestmentsInPreferredStock
      contextRef="C_2b29300e-dbc5-4ba4-9407-04aba97c4829"
      decimals="-3"
      id="F_0892b071-64da-440d-acba-6972bce7bae3"
      unitRef="U_USD">53591000</inva:InvestmentsInPreferredStock>
    <inva:InvestmentsInPreferredStock
      contextRef="C_95699a2d-0510-488b-b64d-b4503781f140"
      decimals="-3"
      id="F_1f634160-731c-45ed-a2c5-802dfcb19885"
      unitRef="U_USD">52530000</inva:InvestmentsInPreferredStock>
    <inva:InvestmentsInWarrants
      contextRef="C_f7d20624-8417-4c34-b875-90b2c207e676"
      decimals="-3"
      id="F_176f2ea3-dfcc-435a-b2c6-2f9388a89bf2"
      unitRef="U_USD">8507000</inva:InvestmentsInWarrants>
    <inva:InvestmentsInWarrants
      contextRef="C_bce3ec39-fa5f-485e-b142-ed955411c5d7"
      decimals="-3"
      id="F_833aca18-8cec-4525-99f2-ed3b87d00843"
      unitRef="U_USD">8075000</inva:InvestmentsInWarrants>
    <inva:MoneyMarketFundAndCash
      contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef"
      decimals="-3"
      id="F_a17e55bd-55bd-4e3b-8c28-65a26be1457f"
      unitRef="U_USD">107532000</inva:MoneyMarketFundAndCash>
    <inva:MoneyMarketFundAndCash
      contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb"
      decimals="-3"
      id="F_783650c7-00e6-4a18-a886-bae2c3ad47ed"
      unitRef="U_USD">63339000</inva:MoneyMarketFundAndCash>
    <us-gaap:Investments
      contextRef="C_99e72674-f063-419d-aa0e-2560370d3aef"
      decimals="-3"
      id="F_62dcc76a-eed1-435a-a88b-fe7903b52b07"
      unitRef="U_USD">255658000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="C_124780e4-a0c3-4ec0-a5c9-ea8b3847c1fb"
      decimals="-3"
      id="F_b5659cf6-b010-4bd3-81d4-40ecd61f1b93"
      unitRef="U_USD">311812000</us-gaap:Investments>
    <inva:SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers
      contextRef="C_c5562d91-0351-4acd-8f6f-1aa83d60f185"
      decimals="0"
      id="F_a3c0886a-1832-4fbd-bded-b9c24b167c1a"
      unitRef="U_Director">2</inva:SecuritiesPurchaseAgreementRightsToDesignateInvesteeBoardMembersNumberOfBoardMembers>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_1ca55df9-e12f-4eef-88d2-5127dad03544"
      decimals="-5"
      id="F_fc0d7cc0-73e4-4bbb-9f37-77707490a020"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_1ca55df9-e12f-4eef-88d2-5127dad03544"
      decimals="4"
      id="F_e2229348-6219-46b5-8e92-c2ffc9716f8b"
      unitRef="U_pure">0.0059</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_1ca55df9-e12f-4eef-88d2-5127dad03544"
      decimals="2"
      id="F_d6b4e121-53fd-48b2-86bb-bcf28c0ff136"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_d7303d1d-5e66-4d3e-b842-3e3d5762046f"
      decimals="3"
      id="F_ad425fce-0af0-40af-864b-24743ba82172"
      unitRef="U_pure">0.599</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_800010f4-85ba-4487-a1fc-d185935fa9c8"
      decimals="-5"
      id="F_5d064c47-041b-4341-af36-634649f4e163"
      unitRef="U_USD">64500000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_d2fcd4b4-d9ae-4307-b911-8ce98ce50b0e"
      decimals="-5"
      id="F_b26cc93c-e390-4ca6-b5ad-62b6a67bc0fd"
      unitRef="U_USD">31400000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="C_43e76568-df93-454e-8619-b61f33c62f7f"
      decimals="-5"
      id="F_29a93a59-e2ce-4947-88cf-4bc7c8044609"
      unitRef="U_USD">7800000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="C_fca35291-33d2-4caf-8ebf-8a5264f15a1f"
      decimals="-6"
      id="F_17df0877-0b41-4ee8-a6bb-2379904df645"
      unitRef="U_USD">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188"
      decimals="-5"
      id="F_8d454d72-bda0-4b4d-ba20-a3c73e449ebb"
      unitRef="U_USD">-4700000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <inva:MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice
      contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188"
      decimals="-5"
      id="F_ccaba7db-619e-4b89-8c1f-cdc4ce84f919"
      unitRef="U_USD">-1400000</inva:MeasurementPeriodAdjustmentsIncreaseDecreaseInEstimatedPurchasePrice>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188"
      decimals="-5"
      id="F_a9d2aa61-b189-412c-aa43-cd0cf85969cc"
      unitRef="U_USD">1700000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188"
      decimals="-5"
      id="F_d68244bf-30a4-4f7d-9cbc-98a2337a4247"
      unitRef="U_USD">2500000</us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="C_de840e76-4090-4f91-aa27-ad5a96814016"
      decimals="-5"
      id="F_7fcc22f3-d56b-458a-be61-5f41e3f868e2"
      unitRef="U_USD">1200000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="C_de840e76-4090-4f91-aa27-ad5a96814016"
      decimals="-5"
      id="F_48f86a9c-fff7-4223-b352-6e955ee20a43"
      unitRef="U_USD">-800000</us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <inva:IncreaseDecreasesInDeferredTaxLiabilities
      contextRef="C_de840e76-4090-4f91-aa27-ad5a96814016"
      decimals="-5"
      id="F_ff15a809-0a71-438f-8e12-c65a7c4ff0c7"
      unitRef="U_USD">400000</inva:IncreaseDecreasesInDeferredTaxLiabilities>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="C_c5562d91-0351-4acd-8f6f-1aa83d60f185"
      id="F_1b3f51e3-ff2b-4d79-a1f3-0ca4de09507d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table represents the adjusted fair values of the assets acquired and liabilities assumed by us in the transaction:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;February 17, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued personnel-related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134,716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_06c1f39b-0bed-4c66-833f-80010985bad6"
      unitRef="U_USD">23070000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_f4a2d7a6-a81c-4a13-9e22-d7d9bea0fb13"
      unitRef="U_USD">5554000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_cbd172c5-b57c-44e7-a8f4-23cd965ab6fa"
      unitRef="U_USD">1959000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_46922f01-017f-457e-861b-2d614eb95fd1"
      unitRef="U_USD">185000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_ef39d7e8-0363-4a51-8670-50ecc8770427"
      unitRef="U_USD">959000</inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:Goodwill
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_a21391b9-ecb6-4e79-971e-3100849d6b66"
      unitRef="U_USD">11493000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_cba967e5-a982-4476-a748-091f405a1e82"
      unitRef="U_USD">106700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_888f2304-3564-41a4-9822-4a42791176b2"
      unitRef="U_USD">302000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_15966662-c873-4e16-9f08-49ebc00eb6a6"
      unitRef="U_USD">150222000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_2dac0e20-bbf7-4424-b94a-e88e30653315"
      unitRef="U_USD">1583000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_867423e1-97fe-43e9-80da-82d91c851fad"
      unitRef="U_USD">1058000</inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPersonnelRelatedExpenses>
    <inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_2d85413d-12af-4b77-85b9-70e466ee50d8"
      unitRef="U_USD">5096000</inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_e8e6a041-5c86-4252-a635-ebdac952eaf7"
      unitRef="U_USD">7769000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_fa895bdc-9d6a-446c-ab56-bd7424270bea"
      unitRef="U_USD">15506000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-3"
      id="F_d167af79-5c6f-4751-8b3b-748378467238"
      unitRef="U_USD">134716000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:MinorityInterest
      contextRef="C_278d71cd-49b3-4c8e-85d9-4252a20fd08a"
      decimals="-5"
      id="F_dd3cacb6-f602-4167-a2b6-97c937203dc4"
      unitRef="U_USD">38500000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_284534cf-6887-4f30-ada1-31c5129ca188"
      decimals="-5"
      id="F_1822e133-332f-4ac4-ba9a-0ca67d39f908"
      unitRef="U_USD">-13600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_8db4f7ae-2913-425a-931f-161ffa81bc43"
      decimals="-5"
      id="F_e78995a0-a415-4840-94a4-e7893c49d6c7"
      unitRef="U_USD">206600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="2"
      id="F_2432ef9f-c1ba-42ca-9d87-f66f3f071af6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.23</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:AcquisitionCosts
      contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"
      decimals="-5"
      id="F_29777e0f-ef6c-4c20-94bc-53969be1d551"
      unitRef="U_USD">5300000</us-gaap:AcquisitionCosts>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"
      decimals="-5"
      id="F_fb6a49df-aca3-4c8f-8ea9-387b3224c677"
      unitRef="U_USD">3700000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"
      decimals="-5"
      id="F_7d592ba6-6e66-495f-af57-9258fc6830cc"
      unitRef="U_USD">-7700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"
      decimals="-5"
      id="F_7b45c9f5-8980-4947-929c-9cd4149e0764"
      unitRef="U_USD">-1500000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <inva:IncreaseDecreasesInDeferredTaxLiabilities
      contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"
      decimals="-5"
      id="F_f24d74e3-475c-4396-be73-245e85a68fb3"
      unitRef="U_USD">2600000</inva:IncreaseDecreasesInDeferredTaxLiabilities>
    <inva:MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities
      contextRef="C_c5e8971c-98c4-4cae-8085-5c6d1ce75dae"
      decimals="-5"
      id="F_2eea392e-215b-4302-89bc-722d80681067"
      unitRef="U_USD">-8300000</inva:MeasurementPeriodAdjustmentIncreaseDecreaseInLiabilities>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="C_315cbf77-929f-4504-ae65-d859fbee4836"
      decimals="-5"
      id="F_8bd845ff-54bf-49a3-863e-449ef2cc9d0e"
      unitRef="U_USD">-13100000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <inva:IncreaseDecreaseInDeferredTaxAssets
      contextRef="C_315cbf77-929f-4504-ae65-d859fbee4836"
      decimals="-5"
      id="F_1bc826ff-eaad-4783-8c55-4b9f125e6dcd"
      unitRef="U_USD">10500000</inva:IncreaseDecreaseInDeferredTaxAssets>
    <inva:IncreaseDecreasesInDeferredTaxLiabilities
      contextRef="C_315cbf77-929f-4504-ae65-d859fbee4836"
      decimals="-5"
      id="F_52c809ff-f17e-4786-b142-9994a5ac6d14"
      unitRef="U_USD">-2600000</inva:IncreaseDecreasesInDeferredTaxLiabilities>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="C_0998f113-0641-45f5-9ff6-c133558e2b1b"
      decimals="-5"
      id="F_ec0bf23a-5086-4df2-a165-02bb9aa333b3"
      unitRef="U_USD">3000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <inva:IncreaseDecreaseInDeferredTaxAssets
      contextRef="C_0998f113-0641-45f5-9ff6-c133558e2b1b"
      decimals="-5"
      id="F_82258c20-0469-4084-98f5-afa1f4be7ab4"
      unitRef="U_USD">-2400000</inva:IncreaseDecreaseInDeferredTaxAssets>
    <inva:IncreaseDecreasesInDeferredTaxLiabilities
      contextRef="C_0998f113-0641-45f5-9ff6-c133558e2b1b"
      decimals="-5"
      id="F_1cbb1230-4b9f-46dd-87af-7928cf88b36e"
      unitRef="U_USD">600000</inva:IncreaseDecreasesInDeferredTaxLiabilities>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="C_9ecfe93e-28e2-4228-ab4a-d3d1c23258a2"
      id="F_29085341-6979-4499-8f0b-b0d3f9181aa6">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table represents the adjusted fair values of assets acquired and liabilities assumed by us in the transaction:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;August 22, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,261&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;907&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;151,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;710&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,849&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,362&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other long-term liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;206,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_38e95b21-f133-4eaa-91b1-91a7b8f89c29"
      unitRef="U_USD">47415000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_5853e499-db84-4fa7-9f19-4196228a352f"
      unitRef="U_USD">471000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_e7503420-1f41-4e45-aece-cdc61a604942"
      unitRef="U_USD">5876000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_c5949d34-1d22-4bb2-8153-e76af6de86ac"
      unitRef="U_USD">66200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_18596d08-5858-4334-9b91-931d0083b8d3"
      unitRef="U_USD">1261000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_d9eabe2a-1f61-4092-9f1b-bd66f5d3935d"
      unitRef="U_USD">907000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_3072101a-fa28-4f5e-8cad-9aa376c51e72"
      unitRef="U_USD">13000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_eaa2d84c-beba-4486-8092-da5036c2a1d6"
      unitRef="U_USD">226000</inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:Goodwill
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_a53b5f4c-88eb-4f2a-91a6-e9772f2fce34"
      unitRef="U_USD">6411000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_35e3d696-7ee8-47f0-bd04-2bc6041e4788"
      unitRef="U_USD">151000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_349e30af-03f5-45c6-b8f7-858fc58097cc"
      unitRef="U_USD">7461000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_79f42eff-5394-4843-9392-a246e9102c81"
      unitRef="U_USD">710000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_41447f48-1c79-4f6a-a1ed-af7da47989c6"
      unitRef="U_USD">287951000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_d3cd75ed-44bc-4478-90eb-db41d7dc3cac"
      unitRef="U_USD">1237000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_beac0d53-6d6e-4f4a-abd2-f3557414f97b"
      unitRef="U_USD">2849000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_49c9fa11-f076-44e7-9292-a12dd392ade2"
      unitRef="U_USD">11362000</inva:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_3619de69-3b83-4097-99fa-9ede85d15a9e"
      unitRef="U_USD">65944000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_1933d0aa-6873-4a63-8c9a-623b949c2c85"
      unitRef="U_USD">81392000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="C_223b1e43-14b1-455f-954f-38ddc3e5b77d"
      decimals="-3"
      id="F_6399dfe7-811e-43ef-a3e1-8a475e2afa90"
      unitRef="U_USD">206559000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_364b819c-798c-46d3-be48-7b0483d31068">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents certain unaudited pro-forma financial information for the year ended December 31, 2022 as if the consolidation of Entasis and La Jolla occurred on January 1, 2021. The unaudited pro forma financial information is presented for informational purposes only, and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place on January 1, 2021, or of results that may occur in the future. The unaudited pro forma financial information combines the historical results of the Entasis and La Jolla with the Company&#x2019;s consolidated historical results and includes certain adjustments including, but not limited to, fair value adjustments to equity investments in Entasis&#x2019; common stock and warrants, fair value adjustments to inventory, amortization of intangible assets, and interest expense on deferred royalty obligations and acquisition-related costs.&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;357,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;204,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Innoviva stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;214,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="C_5e46d5ce-f631-4674-8338-9c89eeeb502a"
      decimals="-3"
      id="F_195e75d0-f36e-4220-8b0b-d843c69fd8bc"
      unitRef="U_USD">357880000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="C_5e46d5ce-f631-4674-8338-9c89eeeb502a"
      decimals="-3"
      id="F_68cfe885-9a28-4f5b-9667-75a9122588eb"
      unitRef="U_USD">204987000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_5e46d5ce-f631-4674-8338-9c89eeeb502a"
      decimals="-3"
      id="F_3617c870-ab2c-4b52-bc34-324b7940ec7d"
      unitRef="U_USD">214390000</us-gaap:NetIncomeLoss>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_5777677e-e46b-4ac7-bbb9-f72f429908b1">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;6. EQUITY AND LONG-TERM INVESTMENTS AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity and Other Investments in Armata&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the first quarter of 2020, Innoviva acquired &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,710,800&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock as well as warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,710,800&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional shares of common stock of Armata Pharmaceuticals, Inc. (&#x201c;Armata&#x201d;) for approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash. Armata is a clinical stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the first quarter of 2021, ISO entered into a securities purchase agreement with Armata to acquire &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,153,847&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Armata common stock and warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,153,847&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional shares of Armata common stock for approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Armata also entered into a voting agreement with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total number of shares of Armata&#x2019;s common stock for voting on the matters related to election or removal of Armata&#x2019;s board members. The voting agreement will expire on the earlier of the second anniversary of the agreement effective date and approval by the FDA of any of Armata&#x2019;s product candidates for marketing and commercial distribution. During the fourth quarter of 2021, ISO also purchased an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,212,122&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Armata common stock for approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 9, 2022, ISO entered into a securities purchase agreement with Armata to acquire &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Armata common stock and warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional shares of common stock with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The investment closed in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; tranches on February 9, 2022 and March 31, 2022. The investment is intended to aid Armata in advancing its clinical pipeline and strengthening its bacteriophage platform.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 9, 2022, Armata also entered a second amended and restated voting agreement with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total number of shares of Armata&#x2019;s common stock for voting on the matters related to election or removal of Armata&#x2019;s board members or amend the bylaws of Armata to reduce the maximum number of directors or set the number of directors who may serve on the board of Armata. The voting agreement will expire the earlier of the second anniversary of the agreement effective date and approval by the FDA of any of Armata&#x2019;s product candidates for marketing and commercial distribution. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding shares of Armata&#x2019;s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata&#x2019;s board of directors, and for so long as the Company and ISO hold at least &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, but less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, of the outstanding shares of Armata&#x2019;s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata&#x2019;s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 10, 2023, Armata entered into an amendment to the amended and restated investor rights agreement with the Company and ISO, pursuant to which the Company and ISO agreed that the voting agreement will expire on the earlier of the fifth anniversary of the original agreement&#x2019;s effective date, January 26, 2021, or the approval by the FDA of any of Armata&#x2019;s product candidates for marketing and commercial distribution.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of the seven &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;members of Armata&#x2019;s board of directors are also members of the board of directors of Innoviva. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and 2023, we owned approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of Armata&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the &#x201c;Credit Agreement&#x201d;) with Armata, under which we invested in a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; convertible note (the &#x201c;Armata Convertible Note&#x201d;) in an aggregate amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million at an interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pursuant to the Credit Agreement, the balance on the Armata Convertible Note, including all accrued and unpaid interest thereon, will convert into shares of Armata&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;s common stock upon the occurrence of a qualified financing, as defined in the Credit Agreement. Any portion of the balance on the Armata Convertible Note, including all accrued and unpaid interest thereon, may also be converted into shares of Armata&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s common stock at our option once a registration statement covering the resale of such securities has been declared effective by the SEC. The Armata Convertible Note is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On July 10, 2023, ISO and Armata executed an amendment to the Armata Convertible Note extending the maturity date from January 10, 2024 to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On November 12, 2024, ISO and Armata executed an amendment to the Armata Convertible Note extending the maturity date from January 10, 2025 to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 10, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 10, 2023, ISO and Armata entered into a Credit and Security Agreement (the &#x201c;July 2023 Credit and Security Agreement"), under which we extended a term loan to Armata (the &#x201c;Armata July 2023 Term Loan&#x201d;) in an aggregate amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Armata July 2023 Term Loan is subject to an interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum and is due to mature on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The July 2023 Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On November 12, 2024, ISO and Armata executed an amendment to the Armata July 2023 Term Loan extending the maturity date from January 10, 2025 to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 10, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 4, 2024, ISO and Armata entered into a Credit and Security Agreement (the &#x201c;March 2024 Credit and Security Agreement&#x201d;), under which we extended a term loan to Armata (the &#x201c;Armata March 2024 Term Loan&#x201d;) in an aggregate amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Armata March 2024 Term Loan is subject to an interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum and is due to mature on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 4, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The March 2024 Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The investments in Armata&#x2019;s common stock and warrants provide Innoviva and ISO the ability to have significant influence, but not control, over Armata&#x2019;s operations. Armata&#x2019;s business and affairs are managed under the direction of its board of directors, which Innoviva and ISO do not control. Based on our evaluation, we determined that Armata is a VIE, but Innoviva and ISO are not the primary beneficiaries of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We account for Armata&#x2019;s common stock and warrants under the equity method using the fair value option. The fair value of Armata&#x2019;s common stock is measured based on its closing market price. The warrants purchased in 2020, 2021 and 2022 have an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.87&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, respectively. All warrants are exercisable immediately within &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the issuance date of the warrants and include a cashless exercise option. We use the Black-Scholes-Merton pricing model to estimate the fair value of these warrants with the following input assumptions: Armata&#x2019;s closing market price on the valuation date, the risk-free interest rate computed based on the U.S. Treasury yield, the remaining contractual term as the expected term, and the expected stock price volatility calculated based on the historical volatility of the common stock of Armata and its peer companies. We account for the Armata Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. We account for the Armata July 2023 Term Loan and the Armata March 2024 Term Loan as trading securities, measured at fair value using income approach based on the discounted value of expected future cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the fair values of our holdings of Armata common stock, warrants, the Armata Convertible Note, the Armata July 2023 Term Loan and the Armata March 2024 Term Loan were estimated at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million  and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2023 the fair values of our holdings of Armata common stock, warrants, the Armata Convertible Note and Armata July 2023 Term Loan were estimated at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Armata common stock and warrants, we recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized losses, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized gains and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;152.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized losses as changes in fair values of equity method investments, net, in the consolidated statements of income for the years ended December 31, 2024, 2023 and 2022, respectively&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Armata Convertible Note, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;we recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized losses and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Armata July 2023 Term Loan, we rec&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;orded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Armata March 2024 Term Loan, we recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million unrealized gains as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the year ended December 31, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The summarized financial information, including the portion we do not own, is presented for Armata on a one quarter lag as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Balance Sheet Information&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncurrent assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,848&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Twelve Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Method Investment in Entasis&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the consolidation of Entasis&#x2019; financial position and results of operations in February 2022, we accounted for Entasis as an equity method investment. Refer to Note 5, &#x201c;Consolidated Entities and Acquisitions&#x201d;, for more information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Investment in InCarda&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the third quarter of 2020, TRC purchased &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,469,432&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Series C preferred stock and a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,117,358&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional shares of Series C preferred stock of InCarda Therapeutics, Inc. (&#x201c;InCarda&#x201d;) (the &#x201c;InCarda 2020 Warrant&#x201d;) for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which included $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of transaction costs. InCarda is a privately held biopharmaceutical company focused on developing inhaled therapies for cardiovascular diseases. The investment is intended to fund the ongoing clinical development of InRhythm&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (flecainide for inhalation), InCarda&#x2019;s lead program, for the treatment of a recent-onset episode of paroxysmal atrial fibrillation. On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to Innoviva&#x2019;s wholly-owned subsidiary, Innoviva TRC Holdings, LLC (&#x201c;ITH&#x201d;) all of TRC&#x2019;s ownership interests and investments in InCarda. ITH has the right to designate one member to InCarda&#x2019;s board of directors. As of December 31, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ITH designee is serving on InCarda&#x2019;s &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;six&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;-member board. We did not exercise the InCarda 2020 Warrant which expired in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_ecf264a2-e5c5-444a-8a7b-06e825278547;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and wrote off its carrying value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 9, 2022, TRC entered into a Note and Warrant Purchase Agreement (the &#x201c;InCarda Agreement&#x201d;) with InCarda to acquire a convertible promissory note (the &#x201c;InCarda Convertible Note&#x201d;) and warrants (the &#x201c;InCarda 2022 Warrant&#x201d;) for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.  The InCarda 2022 Warrant expires on March 9, 2027 and is measured at fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On June 15, 2022, the principal amount and the accrued interest of the InCarda Convertible Note were converted into equity securities. In addition, TRC participated in InCarda&#x2019;s Series D preferred stock financing by investing $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In connection with the new round of financing, InCarda recapitalized its equity structure resulting in TRC owning &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,093,886&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of InCarda&#x2019;s common stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37,350&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its Series A-1 preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,469,432&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its Series C preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,771,780&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its Series D-1 preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,369,802&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its Series D-2 preferred stock, a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,117,358&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its Series C preferred stock at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.73&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,490,033&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its Series D-1 preferred stock at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, we held &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of InCarda equity ownership, respectively. Our investment in InCarda does not provide us with the ability to control or have significant influence over InCarda&#x2019;s operations. Based on our evaluation, we determined that InCarda is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;With the exception of the InCarda Series D Warrants, which is measured at fair value, we account for the aforementioned investments in InCarda under the measurement alternative. Under the measurement alternative, the equity investment is initially recorded at its allocated cost, but the carrying value may be adjusted through earnings upon an impairment or when there is an observable price change involving the same or a similar investment with the same issuer. Due to InCarda&#x2019;s equity recapitalization in the second quarter of 2022, TRC reassessed the value of its investments in InCarda using the Option Pricing Model Backsolve valuation methodology. Key assumptions used in the valuation model included an expected holding period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, a risk-free interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and an estimated volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;122.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%. The estimated volatility was calculated based on the historical volatility of a selected peer group of public companies comparable to InCarda. We recognized an impairment charge of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the second quarter of 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Due to certain changes in InCarda&#x2019;s business operations during the second quarter of 2023, ITH reassessed the value of its investments in InCarda using the Option Pricing Model methodology. Key assumptions used in the valuation model included an expected holding period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, a risk-free interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and an estimated volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%. The estimated volatility was calculated based on the historical volatility of a selected peer group of public companies comparable to InCarda. We recognized an impairment charge of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the second quarter of 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 17, 2024, ITH purchased a secured convertible promissory note (the &#x201c;InCarda Convertible Note&#x201d;) from InCarda for a total purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The InCarda Convertible Note bears an annual interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and shall be due and payable upon the earlier to occur of certain events defined in the InCarda Convertible Note. The InCarda Convertible Note will convert into equity securities or shadow equity securities of InCarda depending upon the occurrence of a qualified event or a qualified financing event as also defined in the InCarda Convertible Note. The InCarda Convertible Note is secured by certain intellectual property rights of InCarda. We account for the InCarda Convertible Note as a trading security, measured at fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, we recorded as equity and long-term investments in the consolidated balance sheets $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in carrying amount of InCarda&#x2019;s Series C preferred stock and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in fair value of the InCarda Series D Warrants. As of December 31, 2024 and 2023, we recognized as equity and long-term investments in the consolidated balance sheets $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, for InCarda&#x2019;s Series D-1 preferred stock, Series D-2 preferred stock, and common stock using the measurement alternative. As of December 31, 2024, we recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in fair value of the InCarda Convertible Note as equity and long-term investments in the consolidated balance sheet. During the year ended December 31, 2024, there were immaterial changes in the carrying amount of our investments. We recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in unrealized loss as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Investment in ImaginAb&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 18, 2021, TRC entered into a securities purchase agreement with ImaginAb, Inc. (&#x201c;ImaginAb&#x201d;) to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,051,724&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of ImaginAb Series C preferred stock for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. On the same day, TRC also entered into a securities purchase agreement with one of ImaginAb&#x2019;s common stockholders to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,097,157&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of ImaginAb common stock for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. ImaginAb is a privately held biotechnology company focused on clinically managing cancer and autoimmune diseases via molecular imaging. $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was incurred for investment due diligence costs and execution and recorded as part of the equity investment in the consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#x2019;s ownership interests and investments in ImaginAb.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 14, 2023, ITH entered into a securities purchase agreement with ImaginAb to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;270,568&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of ImaginAb Series C-2 preferred stock for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. On September 14, 2023, ITH entered into a securities purchase agreement with ImaginAb to purchase another &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;405,852&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of ImaginAb Series C-2 preferred stock for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 23, 2024, ITH purchased a subordinated convertible promissory note (the &#x201c;ImaginAb Convertible Note&#x201d;) from ImaginAb for a total purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The ImaginAb Convertible Note bears an annual interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and shall be due and payable upon the earlier to occur of January 31, 2025 and certain events defined in the ImaginAb Convertible Note. Under certain circumstances, the ImaginAb Convertible Note is convertible at the option of ITH into ImaginAb&#x2019;s equity securities at defined conversion prices. The ImaginAb Convertible Note is subordinate to certain existing indebtedness of ImaginAb as defined in the ImaginAb Convertible Note. On October 31, 2024, ITH entered into an agreement with ImaginAb to amend the ImaginAb Convertible Note. Pursuant to the agreement, the principal amount of the ImaginAb Convertible Note was increased from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which represents the principal as of February 23, 2024, accrued interest as of amendment date, commitment fees and an additional cash investment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. On January 13, 2025, ITH and ImaginAb executed an amendment to the ImaginAb Convertible Note extending the maturity date from January 31, 2025 to May 30, 2025. All other material terms of the ImaginAb Convertible Note were unchanged during the aforementioned amendments to the ImaginAb Convertible Note. As of December 31, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of ImaginAb&#x2019;s &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;six&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; board members was designated by ITH. As of December 31, 2024 and 2023, we held &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, of ImaginAb equity ownership.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our investment in ImaginAb does not provide us with the ability to control or have significant influence over ImaginAb&#x2019;s operations. Based on our evaluation, we determined that ImaginAb is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Because ImaginAb&#x2019;s equity securities are not publicly traded and do not have a readily determinable fair value, we account for our investment in ImaginAb&#x2019;s Series C preferred stock, Series C-2 preferred stock and common stock using the measurement alternative. We account for the ImaginAb Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of risk-free rate, volatility of stock price and timing of certain qualified events. As of December 31, 2024 and 2023, our investment in ImaginAb&#x2019;s Series C preferred stock, Series C-2 preferred stock and common stock amounted to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and recorded as equity and long-term investments in the consolidated balance sheets. As of December 31, 2024, we recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in fair value of the ImaginAb Convertible Note as equity and long-term investments in the consolidated balance sheets. During the year ended December 31, 2024, we recorded &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in net unrealized gain&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; on the ImaginAb Convertible Note as changes in fair values of equity and long-term investments, net, in the consolidated statements of income. There was no change in the carrying amount of our equity investments in ImaginAb.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Promissory Note in Gate Neurosciences&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 24, 2021, TRC entered into a Convertible Promissory Note Purchase Agreement with Gate to acquire a convertible promissory note (the &#x201c;Gate Convertible Note&#x201d;) with a principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Gate is a privately held biopharmaceutical company focused on developing the next generation of targeted nervous system therapies, leveraging precision medicine approaches to develop breakthrough drugs for psychiatric and neurologic diseases. The investment is intended to fund Gate&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s ongoing development and research. The Gate Convertible Note bears an annual interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and will convert into shares of common stock of Gate upon a qualified event or into shares of shadow preferred stock of Gate (&#x201c;Shadow Preferred&#x201d;) upon a qualified financing. A qualifying event can be a qualified initial price offering, a qualified merger, or a merger with a special-purpose acquisition company (&#x201c;SPAC&#x201d;). Shadow Preferred means preferred stock having identical rights, preferences and restrictions as the preferred stock that would be issued in a qualified financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The number of common stock shares to be issued in a qualified event shall be equal to the amount due on the conversion date divided by the lesser of a capped conversion price (the &#x201c;Capped Conversion Price&#x201d;) and the qualified event price (the &#x201c;Qualified Event Price&#x201d;). The Capped Conversion Price is calculated as $50.0 million divided by the number of shares of common stock outstanding at such time on a fully diluted basis. The Qualified Event Price is the price per share determined by the qualified event. A qualified financing is a sale or series of sales of preferred stock where (i) at least 50 percent of counterparties are not existing shareholders, (ii) net proceeds to Gate are at least $35.0 million, and (iii) the stated or implied equity valuation of Gate is at least $80.0 million.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#x2019;s debt investments in Gate.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 2, 2023, ITH entered into a Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which represents the original principal, accrued interest as of the amendment date and an additional cash investment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. All other material terms of the Gate Convertible Note were unchanged.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 6, 2023, ITH entered into a Second Note Amendment Agreement with Gate to amend the Note Amendment Agreement. Pursuant to the Second Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which represents the amended principal as of February 2, 2023, accrued interest as of the second amendment date and an additional cash investment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. All other material terms of the Gate Convertible Note were unchanged.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 13, 2024, ITH entered into a Third Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Third Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which represents the principal and accrued interest as of the third amendment date and an additional cash investment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. All other material terms of the Gate Convertible Note were unchanged.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 5, 2024, ITH entered into a Fourth Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Fourth Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which represents the principal and accrued interest as of the fourth amendment date and an additional cash investment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. All other material terms of the Gate Convertible Note were unchanged.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 13, 2024, ITH entered into a Fifth Note Amendment Agreement with Gate to amend the Gate Convertible Note. Pursuant to the Fifth Note Amendment Agreement, the principal amount of the Gate Convertible Note was increased from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which represents the principal and accrued interest as of the fifth amendment date and an additional cash investment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. All other material terms, except for the conversion terms of the Gate Convertible Note, remained unchanged.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have accounted for the Gate Convertible Note as a trading security, measured at fair value using a Monte Carlo simulation model with the probability of certain qualified events and the assumptions of equity value of Gate, risk-free rate, expected stock price, volatility of its peer companies, and the time until a financing is raised. As of December 31, 2024 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and 2023, the fair value of the Gate Convertible Note was estimated at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, and recorded as equity and long-term investments in the consolidated balance sheets. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of unrealized loss and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of unrealized gain as changes in fair values of equity and long-term investments, net, in the consolidated statements of income for the years ended December 31, 2023 and 2022, respectively. The change in fair value is not material for the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Investment in Nanolive&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 18, 2022, TRC entered into an investment and shareholders agreement with Nanolive to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,750,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Nanolive Series C preferred stock for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (equivalent to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million CHF). Nanolive SA is a Swiss privately held life sciences company focused on developing breakthrough imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was incurred for investment due diligence costs and execution and recorded as part of the equity and long-term investment in the consolidated balance sheets. On July 20, 2022, under the terms of the TRC Equity Purchase Agreement, TRC transferred to ITH all of TRC&#x2019;s ownership interests and investments in Nanolive. ITH has the right to designate one member to Nanolive&#x2019;s board. ITH also has the right to designate another member, who will be mutually acceptable to ITH and another stockholder, to Nanolive&#x2019;s board. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Innoviva designee is serving on Nanolive&#x2019;s &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;six&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;-member board. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we held &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of Nanolive equity ownership, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our investment in Nanolive does not provide us with the ability to control or have significant influence over Nanolive&#x2019;s operations. Based on our evaluation, we determined that Nanolive is a VIE, but we are not the primary beneficiary of the VIE. We have not provided financial or other support that we were not previously contractually required to provide during the periods presented. Our maximum exposure to loss is equal to the amount we invested in the entity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Because Nanolive&#x2019;s equity securities are not publicly traded and do not have a readily determinable fair value, we account for our investment in Nanolive&#x2019;s Series C preferred stock using the measurement alternative. As of December 31, 2024 and 2023,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of investment in Nanolive was recorded as equity and long-term investments in the consolidated balance sheets, and there was no change to the carrying amount of our investment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reconciliation of Equity and Long-Term Investments Balances&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table reconciles the change in balances in &#x201c;Equity and Long-Term Investments&#x201d; as of each balance sheet date:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity and long-term investments as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;363,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchases of trading securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchases of equity and long-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair value, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity and long-term investments as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;444,432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchases of trading securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,201&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair value, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Reclassification of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity and long-term investments as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;341,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Available-for-Sale Securities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimated fair value of available-for-sale securities is based on quoted market prices for these or similar investments that were based on prices obtained from a commercial pricing service. Available-for-sale securities are summarized below:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.867%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds are included in cash and cash equivalents in the consolidated balance sheets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.867%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds are included in cash and cash equivalents in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, all available-for-sale securities were money market funds, and there was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; credit loss recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our available-for-sale securities, equity and long-term investments and contingent value rights are measured at fair value on a recurring basis and our debt is carried at amortized cost basis.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.772%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Fair Value Measurements as of December 31, 2024 Using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted Price&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Types of Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments held by ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;193,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,098&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - InCarda Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Armata Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term loan investment - Armata July 2023 Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term loan investment - Armata March 2024 Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - InCarda Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;436&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;436&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - ImaginAb Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Gate Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at estimated fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;529,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;229,991&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;765,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;222,353&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;222,353&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;251,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;251,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total fair value of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;473,566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;473,566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.867%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Fair Value Measurements as of December 31, 2023 Using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;in Active&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Markets for&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Types of Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments held by ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;251,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,605&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Armata Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51,883&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51,883&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term loan investment - Armata July 2023 Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Gate Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at estimated fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;503,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;167,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;705,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;227,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;227,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total fair value of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent value rights&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities at estimated fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,836&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; transfers between Level 1, Level 2 or Level 3 during the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair values of our equity investments in Armata&#x2019;s common stock and publicly traded investments held by ISP Fund LP are based on the quoted prices in active markets and are classified as Level 1 financial instruments. The fair values in the warrants in Armata classified within Level 2 are based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Gate Convertible Note, the Armata Convertible Note, the Armata July 2023 Term Loan, the Armata March 2024 Term Loan, The Incarda Covertible Note, the InCarda Warrants, the ImaginAb Convertible Note, private placement positions and convertible notes held by ISP Fund LP, and contingent value rights are classified as Level 3 financial instruments as these securities are not publicly traded and the assumptions used in the valuation model for valuing these securities are based on significant unobservable and observable inputs including those of publicly traded peer companies.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair values of our 2025 Notes and 2028 Notes are based on recent trading prices of the respective instruments.&lt;/span&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_bace799d-5f2c-4586-81a2-eeadbfadf867"
      decimals="INF"
      id="F_066d7869-fd08-4b0f-9824-460634f22116"
      unitRef="U_shares">8710800</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
      contextRef="C_74893ac7-f1ad-41b2-845f-0c4f0fae42da"
      decimals="INF"
      id="F_9486adca-9315-4706-b44e-f64be924bd40"
      unitRef="U_shares">8710800</inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_d8708151-111b-4172-ac2c-b7620b8c6f75"
      decimals="-5"
      id="F_f22b335b-d37a-4ec9-8117-50c3e897ebc8"
      unitRef="U_USD">25000000</inva:SecuritiesPurchaseAgreementAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_04c41611-4dbc-4cb9-9783-2e7266319cc4"
      decimals="INF"
      id="F_42e4d9d2-2955-4999-b59d-f4191421a8a0"
      unitRef="U_shares">6153847</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
      contextRef="C_5ed4602e-2cde-4ad0-8956-178ce6486089"
      decimals="INF"
      id="F_566919a8-4edc-43e2-81b0-86691e661627"
      unitRef="U_shares">6153847</inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_e708ed8d-1039-4ee7-a8a5-f30c4559229f"
      decimals="-5"
      id="F_a2ca8916-76ef-42e4-b156-c47b8f62047f"
      unitRef="U_USD">20000000</inva:SecuritiesPurchaseAgreementAmount>
    <inva:VotingAgreementMaximumVotingRightsPercent
      contextRef="C_93e7294b-aac4-4d69-a3eb-67d0b9c5c363"
      decimals="3"
      id="F_8d895bd4-aec7-43c8-9889-12c45c211874"
      unitRef="U_pure">0.495</inva:VotingAgreementMaximumVotingRightsPercent>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_3d2c4b5a-dd7c-4736-8ce5-464b5a60b336"
      decimals="INF"
      id="F_1e1af145-30fa-42b0-8ea6-44e8ab999065"
      unitRef="U_shares">1212122</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_3d2c4b5a-dd7c-4736-8ce5-464b5a60b336"
      decimals="-5"
      id="F_c519449d-adcf-4477-a3cd-42260cb0330d"
      unitRef="U_USD">4000000</inva:SecuritiesPurchaseAgreementAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_24e20d06-ec1f-46a1-aa46-323dcfd90377"
      decimals="INF"
      id="F_3061b1d3-2f18-4bea-aeee-c6d0f590d81f"
      unitRef="U_shares">9000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
      contextRef="C_407f2692-c7b8-407e-92c4-03aef1a4ccda"
      decimals="INF"
      id="F_a3abf3d0-54c7-4cb1-9a39-2a46adb127cf"
      unitRef="U_shares">4500000</inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_a34b6268-debd-4832-a5a5-28a87b2d6119"
      decimals="INF"
      id="F_8d74e61f-f188-49ce-bfec-ad898310a8f6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_9f8444a3-22dd-4d19-a7e5-92b3a3636dd4"
      decimals="-5"
      id="F_fa4a3d45-4b70-460d-a2b3-1f7f7fca30b4"
      unitRef="U_USD">45000000</inva:SecuritiesPurchaseAgreementAmount>
    <inva:SecuritiesPurchaseAgreementNumberOfTranches
      contextRef="C_7140c906-62ed-4fc2-ae57-4d809ddc48a5"
      decimals="INF"
      id="F_409b9d9b-9f85-4c56-a950-1affe1927e00"
      unitRef="U_Tranche">2</inva:SecuritiesPurchaseAgreementNumberOfTranches>
    <inva:VotingAgreementMaximumVotingRightsPercent
      contextRef="C_30c301e3-2dfb-45b3-9f2b-eb72553bc22b"
      decimals="3"
      id="F_2cee157c-35a0-4e8e-9c3d-e3dd355ad9d6"
      unitRef="U_pure">0.495</inva:VotingAgreementMaximumVotingRightsPercent>
    <inva:SpecialTermReDesignatingBoardMemberToBoardOfInvestee
      contextRef="C_30c301e3-2dfb-45b3-9f2b-eb72553bc22b"
      id="F_8f766307-f2b2-4e45-abac-09c2dcfa0eb4">In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least 12.5% of the outstanding shares of Armata&#x2019;s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata&#x2019;s board of directors, and for so long as the Company and ISO hold at least 8%, but less than 12.5%, of the outstanding shares of Armata&#x2019;s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata&#x2019;s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement.</inva:SpecialTermReDesignatingBoardMemberToBoardOfInvestee>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="C_86f5407c-66be-4a09-853c-3167aaf240a0"
      decimals="3"
      id="F_3b1d3dd5-95fe-42b6-907e-6a517b0fe28c"
      unitRef="U_pure">0.125</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="C_8c4fe90e-5515-4c29-8aa9-77a9d2df3e96"
      decimals="2"
      id="F_81c845f8-900e-4ade-870c-8866aa1d3d77"
      unitRef="U_pure">0.08</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="C_28c9f433-5923-40a8-82f6-7695aff7836d"
      decimals="3"
      id="F_d6d846c5-0208-43af-83e9-b41ac5b04da7"
      unitRef="U_pure">0.125</us-gaap:VariableInterestEntityOwnershipPercentage>
    <inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
      contextRef="C_f67ba5e9-a4db-472d-a2ac-c63d64b435b3"
      decimals="0"
      id="F_b41afd55-f962-4950-8b1b-cf2524ffc9fb"
      unitRef="U_Director">3</inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_e3ece156-7a9e-4032-aee8-a8d84b04dbc5"
      decimals="3"
      id="F_6f55e82d-a651-4836-b831-c6e34de5a68a"
      unitRef="U_pure">0.693</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_35f30426-4799-4508-968e-1f20db7a6efe"
      decimals="3"
      id="F_a0932ce3-804a-4e70-94a4-190152c07bef"
      unitRef="U_pure">0.694</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="C_131d7647-fc17-4fa2-92a5-8461ff6933d6"
      id="F_1bcb3b54-a09d-4a56-8afd-9a0a5794d692">On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the &#x201c;Credit Agreement&#x201d;) with Armata, under which we invested in a one-year convertible note (the &#x201c;Armata Convertible Note&#x201d;) in an aggregate amount of $30.0 million at an interest rate of 8.0% per annum.</us-gaap:DebtInstrumentDescription>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_131d7647-fc17-4fa2-92a5-8461ff6933d6"
      id="F_a61368d4-8e3a-440e-b787-f27e425138c6">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_a8b3a821-9b16-4dc5-8726-097101dcbe6d"
      decimals="-5"
      id="F_524c7cdd-1c82-4869-b9c1-d4fb7d55f5ad"
      unitRef="U_USD">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_a8b3a821-9b16-4dc5-8726-097101dcbe6d"
      decimals="3"
      id="F_c8bde519-f1a7-4fe5-9719-54e68f990405"
      unitRef="U_pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_476f91df-e117-42e8-94a7-ab3a3ed891d1"
      id="F_a0b7c10e-04a7-4631-b6b1-0f34930da22c">2025-01-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_e917c8c1-bfee-4f3b-9622-29aafad82d9f"
      id="F_2fec8c6f-1f87-4047-9c53-3b8bab5ed824">2026-01-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_8e458ac2-46af-4572-9110-f35e62e6d593"
      decimals="-5"
      id="F_652c16ba-c4ae-4320-8466-ddb7a9003232"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_8e458ac2-46af-4572-9110-f35e62e6d593"
      decimals="2"
      id="F_040d9587-9e85-45f2-9472-0d11e3edc609"
      unitRef="U_pure">0.14</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_289bc6be-6e0d-435c-bf28-005e3d396793"
      id="F_899bdbae-a252-4825-b79e-8bc5781da80a">2025-01-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_ebd1ba78-29b1-4276-99d0-bd4af1213cd3"
      id="F_df2f8618-75cc-47b9-99c6-52ace48dc7d1">2026-01-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_63d0bdb3-3078-4052-b347-b162b01e64c8"
      decimals="-5"
      id="F_15d3484e-d7da-4f0a-8384-23c3b2b5830d"
      unitRef="U_USD">35000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_63d0bdb3-3078-4052-b347-b162b01e64c8"
      decimals="2"
      id="F_844be063-1d7b-4667-92c5-5f7823405045"
      unitRef="U_pure">0.14</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_d53b733f-8e9d-41ed-97c2-c18ed44c87fd"
      id="F_c01af864-5b59-46ca-84a9-d77d8d586404">2025-06-04</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_af82f89f-5808-49b5-b750-ff7de7d3e2f1"
      decimals="2"
      id="F_9ca50fff-c2d5-4aba-bd73-e229c2bce3b8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.87</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8fce92ac-4906-42d1-b1ea-f1705723e3e7"
      decimals="2"
      id="F_6b6da923-08f8-4249-9247-cccf90ec834a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_edc9130d-8bac-4385-8abd-4f680377bf65"
      decimals="2"
      id="F_4470e94e-c0ba-473f-b4e7-22667115532f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_2e2ce5a8-4015-4724-a5c6-e1c368237ec7"
      id="F_2b7fbecb-f970-49a3-9bdc-331f215cafe2">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_704606a8-5b42-4a22-98f8-ab51052adab9"
      id="F_237c3c17-cf4b-4400-af70-6db71a5439cf">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_0063e106-c957-4aaa-8a37-c9c8915894f5"
      id="F_42deb166-ebbd-4d11-8fa6-4ad840908994">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_e8870f6b-cc59-4078-9d16-079206fad40d"
      decimals="-5"
      id="F_dd7a8334-969f-4df0-9de5-30f636bf4050"
      unitRef="U_USD">46400000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_4567075b-b913-4d0b-920a-5d6cbdb4427a"
      decimals="-5"
      id="F_02080103-213b-4fdf-9a75-53a9d877ad2f"
      unitRef="U_USD">5900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_78c666f2-f708-4225-8f3e-243b11aa5167"
      decimals="-5"
      id="F_81a05dd8-d621-4db0-9cb0-aa04e71c2022"
      unitRef="U_USD">42100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_304ecd1f-6a58-4044-a4fe-d0160d63a872"
      decimals="-5"
      id="F_0e0b2381-cef2-42f2-a249-57daea12a370"
      unitRef="U_USD">30200000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_120c56d9-bec6-4a6e-9cc8-0e256aaacca2"
      decimals="-5"
      id="F_0cc93a1c-daae-4533-b8c3-65428b1677d4"
      unitRef="U_USD">39300000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_171e97bb-f74a-4c17-8063-b0dca204941d"
      decimals="-5"
      id="F_29e03d07-d98a-4ae8-999c-3aab06daec72"
      unitRef="U_USD">81200000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_896fcd7e-679c-4d68-a83d-99ad390a46bd"
      decimals="-5"
      id="F_cf74cb9c-00b1-4e9c-b241-837cfeb54a7b"
      unitRef="U_USD">35300000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_3aea5bf7-3984-4fb0-812f-c886790b0640"
      decimals="-5"
      id="F_027b87ad-2faa-440b-90f5-1d8cd7d1744d"
      unitRef="U_USD">51900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_71e50eda-66f4-437b-adb4-80b4249323a3"
      decimals="-5"
      id="F_04d94f18-3421-4ff2-8a78-a56ff2d9a72c"
      unitRef="U_USD">27000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="C_46c113f9-5e07-4c06-840b-d46df7900549"
      decimals="-5"
      id="F_8bcbed72-7bb6-4be0-8960-b881ae4fab3b"
      unitRef="U_USD">64300000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_352aac51-ea35-49df-addd-f02b0882af4a"
      decimals="-5"
      id="F_2e34f16b-a6d5-4214-8484-e09b76e8853f"
      unitRef="U_USD">77400000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="C_6b4d38cc-2d5a-43e5-9152-e93c3f2a4d89"
      decimals="-5"
      id="F_94446927-e595-40f4-b19d-78a7ea8e828f"
      unitRef="U_USD">152500000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="C_09f27efd-eb03-4052-a5d2-3f4477a2daa4"
      decimals="-5"
      id="F_bf7de83d-e3ef-4769-a7f0-2133bd931345"
      unitRef="U_USD">9800000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_7e8f2964-378b-406a-9a0b-b4b4284256f1"
      decimals="-5"
      id="F_21ff3b8f-213a-4827-a052-e94e4cf54203"
      unitRef="U_USD">21800000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_61ad19f2-d970-4839-83ca-b0d913e3f96e"
      decimals="-5"
      id="F_e0be6d38-26c0-47f6-9547-7c5375a021d6"
      unitRef="U_USD">3200000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_12f5776d-f333-4f0c-8ece-f5ae431ebdf9"
      decimals="-5"
      id="F_931a95a1-1718-4622-ab44-6b18b25524ee"
      unitRef="U_USD">2000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_d11819a9-3acf-4623-aa96-999f140f76e3"
      decimals="-5"
      id="F_25379660-4c47-426b-a50e-f4482cd54790"
      unitRef="U_USD">4300000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <inva:ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock
      contextRef="C_494c4421-3417-4b63-adc9-217af33b40df"
      id="F_2fe2f2e1-8b1f-4516-b580-d944c03e3e54">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The summarized financial information, including the portion we do not own, is presented for Armata on a one quarter lag as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Balance Sheet Information&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncurrent assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,848&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Twelve Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</inva:ScheduleOfFinancialInformationOfVariableInterestEntitiesTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921"
      decimals="-3"
      id="F_7bcd61f7-2f74-4236-b822-ebdbd87c771a"
      unitRef="U_USD">22389000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809"
      decimals="-3"
      id="F_9d1ad89f-d775-4984-972d-7090c8be1722"
      unitRef="U_USD">36585000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921"
      decimals="-3"
      id="F_3499dc80-ec42-4c93-b382-b724cdce3b06"
      unitRef="U_USD">75848000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809"
      decimals="-3"
      id="F_df5c513e-0d0a-43e1-ba22-027aaf04b173"
      unitRef="U_USD">76176000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921"
      decimals="-3"
      id="F_0165831b-081e-4bcf-8e3b-6089bd96be9e"
      unitRef="U_USD">118204000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809"
      decimals="-3"
      id="F_595809b4-9149-4120-ba95-832b9a413541"
      unitRef="U_USD">21884000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_4b4591fa-8bbb-480d-b5a5-9c069dfdc921"
      decimals="-3"
      id="F_1ee793c6-3218-4643-9beb-d0977b8621a0"
      unitRef="U_USD">31006000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_b17c7bb3-be30-46ec-8c5d-326914913809"
      decimals="-3"
      id="F_db87b8a4-c6cb-4c76-8e2d-1814d40e8076"
      unitRef="U_USD">103263000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb"
      decimals="-3"
      id="F_8ee860cd-9712-49eb-8710-9dccc73f7bb2"
      unitRef="U_USD">5467000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26"
      decimals="-3"
      id="F_d8a69214-2682-42a8-9065-6205f59ea1bf"
      unitRef="U_USD">4052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb"
      decimals="-3"
      id="F_9a36f799-e7cd-4ec5-831d-f1aeaf1b162b"
      unitRef="U_USD">5446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb"
      decimals="-3"
      id="F_7f373ea6-92c3-49da-86a1-0b5581a373e9"
      unitRef="U_USD">-38476000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26"
      decimals="-3"
      id="F_6fdef1bc-1777-4448-9ecf-483ef2425956"
      unitRef="U_USD">-41639000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb"
      decimals="-3"
      id="F_00184b25-96fa-4599-a598-1daca5bc1c9b"
      unitRef="U_USD">-32666000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="C_5fc1dba3-d34e-409a-ac8f-04fae2af50eb"
      decimals="-3"
      id="F_da232f12-f918-4986-992d-de11898fe3e5"
      unitRef="U_USD">-41363000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_e0bc493a-55f7-4cf5-884f-10ddd60e3c26"
      decimals="-3"
      id="F_9dc22819-3f90-4e8a-90b2-9762bc3f74b6"
      unitRef="U_USD">-59512000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_340b61a9-93b6-42fd-9c5e-3c2eedd4ffdb"
      decimals="-3"
      id="F_46f7590a-11bc-42b0-9a2c-2f65663cfdcd"
      unitRef="U_USD">-32650000</us-gaap:ProfitLoss>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_098b82e6-075b-4b93-995c-661389fb3815"
      decimals="INF"
      id="F_e6463227-dc0f-4ac2-9c78-1b442901b498"
      unitRef="U_shares">20469432</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
      contextRef="C_098b82e6-075b-4b93-995c-661389fb3815"
      decimals="INF"
      id="F_647299f3-8d85-448c-8da3-eb1a422a3064"
      unitRef="U_shares">5117358</inva:SaleOfWarrantsNumberOfWarrantsIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_ea976f60-5b5b-415c-b0c6-88e63b461b95"
      decimals="-5"
      id="F_a7c4e329-e82b-4b23-b3e8-75ba7ef3fce1"
      unitRef="U_USD">15800000</inva:SecuritiesPurchaseAgreementAmount>
    <inva:DebtInstrumentTransactionCost
      contextRef="C_098b82e6-075b-4b93-995c-661389fb3815"
      decimals="-5"
      id="F_1dd5e6c4-1113-4e62-bea3-7ff29d2caff1"
      unitRef="U_USD">800000</inva:DebtInstrumentTransactionCost>
    <inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
      contextRef="C_059d5bd5-1649-484e-8e7c-174600b0cb2b"
      decimals="0"
      id="F_2311dee3-688b-4955-84e1-7e00b78a8ab6"
      unitRef="U_Director">0</inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee>
    <inva:NumberOfBoardMembersOfInvestee
      contextRef="C_059d5bd5-1649-484e-8e7c-174600b0cb2b"
      decimals="0"
      id="F_5b6946ab-df5d-480a-8f9e-ffb56d790fca"
      unitRef="U_Director">6</inva:NumberOfBoardMembersOfInvestee>
    <inva:WarrantCarryingValueWriteOffAmount
      contextRef="C_79983aa1-6f85-41fc-9342-69b5e86a22d2"
      decimals="-5"
      id="F_fb41fd39-b9c2-4470-8901-bc4d51fb9fba"
      unitRef="U_USD">100000</inva:WarrantCarryingValueWriteOffAmount>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_fd3f6642-082d-419b-8eb5-479c4509f29d"
      decimals="-5"
      id="F_409d7706-cb06-4774-b49b-4e464fbbc3e7"
      unitRef="U_USD">700000</inva:SecuritiesPurchaseAgreementAmount>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="C_dd1d30e1-e047-42a2-bdb5-3ef5926e79da"
      decimals="-5"
      id="F_1cccb609-63fc-4bad-a411-fdc6ddde3160"
      unitRef="U_USD">2300000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_1e2ed4aa-4ec1-488a-9c05-da807b81c789"
      decimals="INF"
      id="F_bca483f6-a913-44ca-858e-c4c1032f60f8"
      unitRef="U_shares">4093886</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_f9d8c18f-f9a7-412c-a350-a087bdc10db8"
      decimals="INF"
      id="F_7bb9a919-e797-4b21-84d3-de42b310a434"
      unitRef="U_shares">37350</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_5844539a-fc91-4105-b8a3-cf46e12ce3bc"
      decimals="INF"
      id="F_6a9b5d91-b704-4cc3-b297-86fb83cb232a"
      unitRef="U_shares">20469432</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_3a966812-a150-488f-a6ce-1883cd6184b4"
      decimals="INF"
      id="F_ae5817f4-0275-40d1-959b-37420000ab1d"
      unitRef="U_shares">8771780</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_57dd6d3d-0988-40b1-b84f-ff3d06249917"
      decimals="INF"
      id="F_e601537d-50db-4c54-8c6c-a6179d493d5c"
      unitRef="U_shares">3369802</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_88a8178e-d76e-4fb2-9885-5ee2c0565071"
      decimals="INF"
      id="F_3389b1c7-bdbd-4f75-b2b9-dc2fcda10258"
      unitRef="U_shares">5117358</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c4c638bd-9d2d-49eb-acd3-78cadbac2bb9"
      decimals="2"
      id="F_f622170e-7e71-40f1-b706-18f2d84fbc64"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.73</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_9834684e-a81e-427b-ab67-3dce5473dd17"
      decimals="INF"
      id="F_40a5d21e-0476-41f4-9040-84b6850cf4a3"
      unitRef="U_shares">2490033</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_97ef981d-8088-4d68-9ed4-8e0a49d39c69"
      decimals="2"
      id="F_9833b9ea-95f7-4822-baf0-087808e50f5b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_3fbaef98-117c-41ce-8102-e48e8c5bfa08"
      decimals="3"
      id="F_f354c60c-c3b4-48cb-9002-588580f11eb8"
      unitRef="U_pure">0.091</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_65a78fed-9696-4e3e-a1e4-e3cc50d0f0d5"
      decimals="3"
      id="F_854f3a42-763a-4ccd-9520-b1cb872dd472"
      unitRef="U_pure">0.081</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <inva:ExpectedHoldingPeriod
      contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808"
      id="F_e23cc441-9bee-4f71-b85c-114836f22ea8">P2Y</inva:ExpectedHoldingPeriod>
    <inva:RiskFreeInterestRate
      contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808"
      decimals="3"
      id="F_6bce0223-708f-49a1-81d8-308d1e3a50f8"
      unitRef="U_pure">0.032</inva:RiskFreeInterestRate>
    <inva:DividendYield
      contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808"
      decimals="3"
      id="F_ef9cf080-401b-47c8-809b-9d188ea8bcca"
      unitRef="U_pure">0</inva:DividendYield>
    <inva:PercentageOfEstimatedVolatility
      contextRef="C_3ea3009c-970b-499f-ab6e-42fe1c681808"
      decimals="3"
      id="F_edcf5405-e9da-44a9-b7e9-66851b330038"
      unitRef="U_pure">1.22</inva:PercentageOfEstimatedVolatility>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="C_67cd523d-133e-42a5-8657-9f3bb1123823"
      decimals="-5"
      id="F_86a9157d-9b40-42c8-aaa3-65e58d4ca6e2"
      unitRef="U_USD">9000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <inva:ExpectedHoldingPeriod
      contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59"
      id="F_5bb94c00-8ee3-4bfe-8322-a8396bff079b">P2Y</inva:ExpectedHoldingPeriod>
    <inva:RiskFreeInterestRate
      contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59"
      decimals="3"
      id="F_750d5032-04b9-48d9-a377-ed4c236b1667"
      unitRef="U_pure">0.049</inva:RiskFreeInterestRate>
    <inva:DividendYield
      contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59"
      decimals="3"
      id="F_59a98e0d-7c9a-4ec0-9c7a-6ac40ddcf8ca"
      unitRef="U_pure">0</inva:DividendYield>
    <inva:PercentageOfEstimatedVolatility
      contextRef="C_6ea92036-d7da-481b-8027-3362c5292d59"
      decimals="3"
      id="F_23cfa633-24b5-4097-8f63-4ba7df883196"
      unitRef="U_pure">1.142</inva:PercentageOfEstimatedVolatility>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="C_23437773-47f3-4a8c-96df-2a22fdd80f90"
      decimals="-5"
      id="F_2ec164b1-72fb-4d09-b0a5-138b75e99c56"
      unitRef="U_USD">2900000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_aaecb0e5-05bb-4c5d-b308-7ef6aad3d595"
      decimals="-5"
      id="F_6320c1e7-21f7-4987-83f9-bb0fa76b070f"
      unitRef="U_USD">400000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_aaecb0e5-05bb-4c5d-b308-7ef6aad3d595"
      decimals="2"
      id="F_0f6d1f0a-7988-4afb-a577-018a086771f7"
      unitRef="U_pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_2448232b-60b4-48e6-82a0-b32e49c6f1a9"
      decimals="-5"
      id="F_6c21fc4a-b69e-4367-a87a-ffbfa2f92a72"
      unitRef="U_USD">4800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_9f5b3843-bdf0-4930-818a-6eed731e4cdf"
      decimals="-5"
      id="F_225279b2-89e7-44e9-bb3c-9321d2de240f"
      unitRef="U_USD">4800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_ca91671c-9ec7-444f-b685-f851204f4fc9"
      decimals="-5"
      id="F_d45cd3a9-3e19-48fe-9593-4c462a8d4b41"
      unitRef="U_USD">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_c82dd715-d624-49e4-bfe0-b1715409db9e"
      decimals="-5"
      id="F_ee49dd51-6db8-4347-a941-4438f8bc43e8"
      unitRef="U_USD">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_803eb231-cd56-4e30-91d1-f2707f4586a4"
      decimals="-5"
      id="F_039199a8-80d5-4b61-ab02-60a40d9f38a2"
      unitRef="U_USD">2700000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_9dc62cdf-a86b-443a-a322-c99a58facc5a"
      decimals="-5"
      id="F_f433663a-60f1-4cfd-8b43-e4bc393e3293"
      unitRef="U_USD">2700000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_02d745cd-51ee-4828-8e80-e16af93855c7"
      decimals="-5"
      id="F_569e0a12-f649-4546-b4ca-089006d2c786"
      unitRef="U_USD">400000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="C_912bc1dc-313a-4987-ba8e-17bf34333339"
      decimals="-5"
      id="F_b65f1d3c-82ba-45ad-a5ad-d53dcfb9f8c9"
      unitRef="U_USD">3100000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="C_fa7da83e-f568-43a7-8a21-c4860f759a4b"
      decimals="-5"
      id="F_62772999-edf0-4d90-bd35-84303fab4b22"
      unitRef="U_USD">8700000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_8dc1a082-9478-46f1-b22f-0fda99922d9a"
      decimals="INF"
      id="F_7dc39e81-25a4-4f53-89bf-9f10ec4c3519"
      unitRef="U_shares">4051724</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_8dc1a082-9478-46f1-b22f-0fda99922d9a"
      decimals="-5"
      id="F_5552ef12-6b3a-4803-92b8-1e6cfb5bb34a"
      unitRef="U_USD">4700000</inva:SecuritiesPurchaseAgreementAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_b98c6805-e143-4159-8b6d-0216ea55b874"
      decimals="INF"
      id="F_d305b822-1414-47e7-9c10-65513db2af6b"
      unitRef="U_shares">4097157</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_b98c6805-e143-4159-8b6d-0216ea55b874"
      decimals="-5"
      id="F_9ceb0646-4e14-4ebc-ae1d-417fe890b906"
      unitRef="U_USD">1300000</inva:SecuritiesPurchaseAgreementAmount>
    <inva:TransactionCostsIncurredInConnectionWithEquityInvestment
      contextRef="C_c3e70cef-b906-408c-8288-908907c15a65"
      decimals="-5"
      id="F_19ef5546-1ae7-4985-96b1-a94319bc7256"
      unitRef="U_USD">400000</inva:TransactionCostsIncurredInConnectionWithEquityInvestment>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_d22b266a-b99c-45a0-8ac0-e3851917bcf6"
      decimals="INF"
      id="F_bb1e08d1-e279-4d87-863b-183fcf6eb5ae"
      unitRef="U_shares">270568</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_d22b266a-b99c-45a0-8ac0-e3851917bcf6"
      decimals="-5"
      id="F_ce5ac1f7-a167-4106-8e58-4bcf0d49e00e"
      unitRef="U_USD">600000</inva:SecuritiesPurchaseAgreementAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_331dc9af-0e1f-47b2-a30d-d84e5a653bda"
      decimals="INF"
      id="F_15f6b1a3-f087-4397-a38f-c7a60c47ff63"
      unitRef="U_shares">405852</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_331dc9af-0e1f-47b2-a30d-d84e5a653bda"
      decimals="-5"
      id="F_65372e8b-1400-48f0-8c7b-b569a337d12f"
      unitRef="U_USD">600000</inva:SecuritiesPurchaseAgreementAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_ea058057-5a8c-4679-b02b-d77e73b481e6"
      decimals="-5"
      id="F_c56e1eda-42f8-4528-8c84-62ece3ff1d02"
      unitRef="U_USD">2700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_ea058057-5a8c-4679-b02b-d77e73b481e6"
      decimals="2"
      id="F_31c0a236-f9ed-462d-91af-13a9d330b6fd"
      unitRef="U_pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_67dabe6c-1f60-48af-9f2b-2dac4085e3c8"
      decimals="-5"
      id="F_09952456-f8fe-4cb4-809b-3f71b8c4b278"
      unitRef="U_USD">2700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_7f01ba3d-3b8a-46ef-b6ed-b35a2187ddb1"
      decimals="-5"
      id="F_1df2d361-8ef5-4675-a068-ace57b431431"
      unitRef="U_USD">4800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_df36bca4-34e2-4f01-a21b-2939200a4237"
      decimals="-5"
      id="F_bea244e0-244a-4b68-bec3-f291a1d2ea53"
      unitRef="U_USD">1500000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
      contextRef="C_da6eff04-3c1c-4959-abe9-fe3dfca5c630"
      decimals="INF"
      id="F_6112f21b-6860-4d93-8529-48849d41c55c"
      unitRef="U_Director">1</inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee>
    <inva:NumberOfBoardMembersOfInvestee
      contextRef="C_da6eff04-3c1c-4959-abe9-fe3dfca5c630"
      decimals="INF"
      id="F_84a59838-ed64-46a3-b710-ba6a0abfafaf"
      unitRef="U_Director">6</inva:NumberOfBoardMembersOfInvestee>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_6d3efb43-3699-4ae8-a66b-6ac082761119"
      decimals="3"
      id="F_67bba561-b4d0-4fa7-8503-f330f583d402"
      unitRef="U_pure">0.118</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_83b93379-94aa-47ed-9eb3-7b3158980925"
      decimals="3"
      id="F_d1dd3553-d4ec-4ecd-8273-98decbeb14d7"
      unitRef="U_pure">0.124</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_8d315a2b-2c71-4420-b013-dfe4ca2986c3"
      decimals="-5"
      id="F_0bf9036b-7e4c-4e3c-bf10-4a3c4248c957"
      unitRef="U_USD">7600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_919d35a4-18d4-429f-9131-8121ce8b768d"
      decimals="-5"
      id="F_c91b0ef7-93b9-410a-ab76-1f2acb685867"
      unitRef="U_USD">7600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_c277363b-a707-4b73-871a-b77a92df3c6f"
      decimals="-5"
      id="F_38636861-f4cd-401c-810f-4452469df099"
      unitRef="U_USD">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_1fcc8f6c-3778-4f03-9b9f-4a242c10fa7e"
      decimals="-5"
      id="F_9ce1b8c8-18c8-42b5-9fba-5cc0c70eea46"
      unitRef="U_USD">100000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f"
      decimals="-5"
      id="F_a2dd9dfe-a3ce-4d00-a233-6f2b615afdc5"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f"
      decimals="2"
      id="F_801fbc8a-3dc1-44b8-aed0-51f24a9070fd"
      unitRef="U_pure">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <inva:NumberOfCommonStockIssuedDescription
      contextRef="C_5113ca40-db4d-493a-87c2-9a406e584ece"
      id="F_c9984c34-21f4-45f5-b7a9-bd1dc0c431a7">The number of common stock shares to be issued in a qualified event shall be equal to the amount due on the conversion date divided by the lesser of a capped conversion price (the &#x201c;Capped Conversion Price&#x201d;) and the qualified event price (the &#x201c;Qualified Event Price&#x201d;). The Capped Conversion Price is calculated as $50.0 million divided by the number of shares of common stock outstanding at such time on a fully diluted basis. The Qualified Event Price is the price per share determined by the qualified event. A qualified financing is a sale or series of sales of preferred stock where (i) at least 50 percent of counterparties are not existing shareholders, (ii) net proceeds to Gate are at least $35.0 million, and (iii) the stated or implied equity valuation of Gate is at least $80.0 million.</inva:NumberOfCommonStockIssuedDescription>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_4aaf547a-1c8f-4cb0-ab7e-45a6f975f67f"
      decimals="-5"
      id="F_78beef4d-5fae-4c27-bc0c-2850779a7760"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_94e7195f-0034-4d0a-b5fd-de56d9a2582b"
      decimals="-5"
      id="F_d7331d16-7f42-4f61-80b1-4c75476f3c4a"
      unitRef="U_USD">21500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_4a162331-f161-4794-bd50-e44d082bee98"
      decimals="-5"
      id="F_21ab9bcc-84f2-41cd-b9a4-5ab1b03dad62"
      unitRef="U_USD">5000000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_df05c425-3a4a-4cd4-aa36-806e2fe0da51"
      decimals="-5"
      id="F_25b8ae9f-e89c-4e9b-a299-494cf4d63b8e"
      unitRef="U_USD">21500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_5b6b74d6-5ba3-490c-a58b-c2fa128f4c16"
      decimals="-5"
      id="F_dbfdf9ba-e6b3-4a51-b39c-11129e7aaee7"
      unitRef="U_USD">27700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_4bfeee2c-2c81-4b9f-a36f-d4540c545b48"
      decimals="-5"
      id="F_a72bb9b9-a5e8-45a2-a919-8c8386a57204"
      unitRef="U_USD">5000000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_b0cd00d0-91fb-42d9-9cb7-ff204ac9ab0a"
      decimals="-5"
      id="F_58a39e78-d383-4b34-9dda-80922941a9ff"
      unitRef="U_USD">27700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_289ad2e3-11f8-4293-9451-51ca41bb9371"
      decimals="-5"
      id="F_00f38900-2749-4fb3-824c-644916bb64e8"
      unitRef="U_USD">33500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_8fda4892-a74f-4650-8ab9-7f27921d46c6"
      decimals="-5"
      id="F_a69ed5dc-700a-4234-9e6d-69ff50c7a074"
      unitRef="U_USD">5000000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_c2913a02-9488-4628-8d44-e7cd7ed404b7"
      decimals="-5"
      id="F_0af8e27c-93ac-449e-962b-45ae08c55bcb"
      unitRef="U_USD">33500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_191d279e-0f47-40c7-82d1-36a0fa78870f"
      decimals="-5"
      id="F_9fc3a244-a9e9-47e2-a46a-fafe6cb5d204"
      unitRef="U_USD">39800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_a20abb89-800f-48d0-982d-8e767439c06e"
      decimals="-5"
      id="F_8dccb276-d9e1-4f34-8024-736e17fdd2b8"
      unitRef="U_USD">5000000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_7b46f925-454c-4214-b995-44ba572a8c1e"
      decimals="-5"
      id="F_2aa177a5-ea56-4cba-b36a-f6017ae0703b"
      unitRef="U_USD">39800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_f4a8c22f-aba7-4e11-ad11-162e3d1ad7ef"
      decimals="-5"
      id="F_1dcb16ca-71de-424f-8c7a-5a889b35c332"
      unitRef="U_USD">50600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="C_2c77d616-9e5d-408c-b20f-a0aaee7f6140"
      decimals="-5"
      id="F_da4d4e9c-bb2d-4f3b-8b19-71190ddaad05"
      unitRef="U_USD">10000000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_ca7032d1-65b7-44f3-9dff-4c953aea281c"
      decimals="-5"
      id="F_5799ce00-3288-4592-b9e3-5748d7f6323e"
      unitRef="U_USD">50900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_14d9f964-799a-438f-8197-61ae142e28d6"
      decimals="-5"
      id="F_4b3db199-5715-4dfe-8c61-2be221120a6d"
      unitRef="U_USD">28000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="C_aea775ec-f212-4854-8a33-38c7dcf9a97c"
      decimals="-5"
      id="F_4781041a-b914-43f0-8824-6b879ba6a389"
      unitRef="U_USD">400000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="C_9b00860e-a4ec-4be9-820d-8a3d8ea443a4"
      decimals="-5"
      id="F_5d09fa8c-71d8-4043-a142-3c6efe383b9e"
      unitRef="U_USD">600000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_88782d27-5661-485a-afcf-08cc5c051369"
      decimals="INF"
      id="F_fd622081-5e87-4eb9-a813-1823ca7f2301"
      unitRef="U_shares">18750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_88782d27-5661-485a-afcf-08cc5c051369"
      decimals="-5"
      id="F_f9aaae79-11cc-49a9-a5b4-3b1bdf3c591a"
      unitRef="U_USD">9800000</inva:SecuritiesPurchaseAgreementAmount>
    <inva:SecuritiesPurchaseAgreementAmount
      contextRef="C_88782d27-5661-485a-afcf-08cc5c051369"
      decimals="-5"
      id="F_a5033e18-c72d-427b-a7ce-ea38952d5fc0"
      unitRef="U_CHF">9000000</inva:SecuritiesPurchaseAgreementAmount>
    <inva:EquityInvestmentTransactionCostsIncurred
      contextRef="C_bed4dd91-bb02-4b5d-a15b-d83a06470288"
      decimals="-5"
      id="F_339db0ea-8dbc-4dd6-9e1d-0ef26c891644"
      unitRef="U_USD">700000</inva:EquityInvestmentTransactionCostsIncurred>
    <inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
      contextRef="C_1d60db24-5501-4ef8-9186-60ebe8c52f24"
      decimals="INF"
      id="F_9ccc0386-67d4-4241-80f8-86069ce2dbb9"
      unitRef="U_Director">0</inva:NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee>
    <inva:NumberOfBoardMembersOfInvestee
      contextRef="C_1d60db24-5501-4ef8-9186-60ebe8c52f24"
      decimals="INF"
      id="F_668a9cdc-57cb-4262-8574-66ec91f40058"
      unitRef="U_Director">6</inva:NumberOfBoardMembersOfInvestee>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_529c2882-00b1-4936-b580-0e5381a12f59"
      decimals="3"
      id="F_c8cff52f-f33d-4786-9951-75004a08b8e4"
      unitRef="U_pure">0.13</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_9e00bead-30e7-4af5-8f97-cb13619d5c04"
      decimals="3"
      id="F_9eb829e2-a096-498b-b766-ec59870c528c"
      unitRef="U_pure">0.153</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_1d60db24-5501-4ef8-9186-60ebe8c52f24"
      decimals="-5"
      id="F_232d6afa-0745-40bc-b5ae-a6f3ef357e70"
      unitRef="U_USD">10600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_864b213f-0400-4fcb-9947-13500166620f"
      decimals="-5"
      id="F_acd34ff2-e383-42f9-a317-dc78a5a70489"
      unitRef="U_USD">10600000</us-gaap:EquitySecuritiesFvNi>
    <inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_21967ecb-23da-4ec1-af6f-b87098fa3d55">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table reconciles the change in balances in &#x201c;Equity and Long-Term Investments&#x201d; as of each balance sheet date:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity and long-term investments as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;363,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchases of trading securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchases of equity and long-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair value, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity and long-term investments as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;444,432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchases of trading securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,201&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair value, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Reclassification of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity and long-term investments as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;341,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</inva:ScheduleOfReconciliationOfEquityAndLongTermInvestmentsBalanceTableTextBlock>
    <us-gaap:LongTermInvestments
      contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6"
      decimals="-3"
      id="F_a691f90d-1183-423f-b333-32087f1e685d"
      unitRef="U_USD">363859000</us-gaap:LongTermInvestments>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_aefe94fd-4a40-461c-9259-d4ca91265df5"
      unitRef="U_USD">67798000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_adf68b8f-ff39-4267-9f95-a3d4170de6aa"
      unitRef="U_USD">1218000</us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity>
    <inva:GainLossOnOtherInvestments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_296ab560-25bc-456c-a8b8-e814067862e7"
      unitRef="U_USD">11129000</inva:GainLossOnOtherInvestments>
    <us-gaap:OtherIncome
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_62264d24-ce36-4d38-bb7c-59fdeac0421c"
      unitRef="U_USD">428000</us-gaap:OtherIncome>
    <us-gaap:LongTermInvestments
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_26571227-4def-4252-abe5-38c0382d710c"
      unitRef="U_USD">444432000</us-gaap:LongTermInvestments>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_0a8f2f54-80ff-48c3-bea4-fe19da337aa8"
      unitRef="U_USD">63201000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <inva:GainLossOnOtherInvestments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_34217f67-61f0-4b31-aace-8b1833301757"
      unitRef="U_USD">-59161000</inva:GainLossOnOtherInvestments>
    <inva:ReclassificationOfCurrentPortion
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_90d7d66b-0c95-4abb-ab6a-051832f826a7"
      unitRef="U_USD">-107532000</inva:ReclassificationOfCurrentPortion>
    <us-gaap:OtherIncome
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_9a896ddf-19d6-486c-b1b2-58ccce75ad3c"
      unitRef="U_USD">724000</us-gaap:OtherIncome>
    <us-gaap:LongTermInvestments
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_605b09c7-10bc-4002-baa4-8d525d7566de"
      unitRef="U_USD">341664000</us-gaap:LongTermInvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_7a1d75f3-2ec4-41d1-8d98-f13fca597da4">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimated fair value of available-for-sale securities is based on quoted market prices for these or similar investments that were based on prices obtained from a commercial pricing service. Available-for-sale securities are summarized below:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.867%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds are included in cash and cash equivalents in the consolidated balance sheets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.867%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:74.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:9pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds are included in cash and cash equivalents in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89"
      decimals="-3"
      id="F_a6ddcf50-d102-4a94-8e1d-30455b13ca59"
      unitRef="U_USD">289441000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89"
      decimals="-3"
      id="F_b6caa033-e1b0-42c5-9e67-d5b2c51deb83"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89"
      decimals="-3"
      id="F_da285bb3-aefd-4e23-a795-82b237438fae"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_3e355c7e-7e1e-40b8-829f-9c901683dc89"
      decimals="-3"
      id="F_31dd804c-ed7c-49d3-afe0-753c37a5f180"
      unitRef="U_USD">289441000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_fc5bf26d-6d4a-4b03-95d0-42db730ede56"
      unitRef="U_USD">289441000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_18519a41-0925-4323-9bca-92845a573119"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e156b13c-7eb4-4132-bf75-660365de1573"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_26d0c69d-a6f1-41bb-82a0-bcac4f6b60ca"
      unitRef="U_USD">289441000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e"
      decimals="-3"
      id="F_902daea8-5ff8-4718-bd5d-98cc32f8fb31"
      unitRef="U_USD">170706000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e"
      decimals="-3"
      id="F_3a60c6f3-3651-42b0-8d22-dc356d15606d"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e"
      decimals="-3"
      id="F_c33cb1a3-3d6f-4322-af2b-31d51faf766b"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_050ab59e-aa14-4c4c-8631-471af527ea4e"
      decimals="-3"
      id="F_cd66a87e-2be3-4ed8-b423-87c616c33a64"
      unitRef="U_USD">170706000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_0173130c-f0a7-42fc-8cad-5a1ba94c6798"
      unitRef="U_USD">170706000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_de35246e-4f10-412c-9601-291c0772a31b"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_506aa7cd-4544-433c-97e4-1ed2b02df587"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_c8556233-73c5-4cd8-b7d7-fddf1a0eee6d"
      unitRef="U_USD">170706000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_c6fb727b-a5d3-480a-ad3c-759960702832"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_3f7aa2fc-c53b-4650-8b7e-ed2635d709fb"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_145a9961-b122-4e87-a465-04d7b5fd8cf1">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our available-for-sale securities, equity and long-term investments and contingent value rights are measured at fair value on a recurring basis and our debt is carried at amortized cost basis.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.772%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.678%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Fair Value Measurements as of December 31, 2024 Using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted Price&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Types of Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments held by ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;193,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,098&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - InCarda Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Armata Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term loan investment - Armata July 2023 Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term loan investment - Armata March 2024 Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - InCarda Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;436&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;436&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - ImaginAb Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Gate Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at estimated fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;529,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;229,991&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;765,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;222,353&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;222,353&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;251,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;251,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total fair value of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;473,566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;473,566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.867%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.222000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Fair Value Measurements as of December 31, 2023 Using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;in Active&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Markets for&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Types of Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;170,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments held by ISP Fund LP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;251,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,605&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;311,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity investment - Armata Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Armata Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51,883&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51,883&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term loan investment - Armata July 2023 Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible debt investment - Gate Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at estimated fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;503,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;167,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;705,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;227,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;227,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total fair value of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent value rights&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities at estimated fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427,836&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2b5acdfb-cefd-4c67-9972-a3dda739bb03"
      decimals="-3"
      id="F_d3046f8d-dfbc-4a06-833a-4282202c4a61"
      unitRef="U_USD">289441000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4406a063-c883-4b59-8711-b008bdcbf2f3"
      decimals="-3"
      id="F_8ad52966-fbd3-4a97-ae49-67a65c003154"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4041c10c-d9db-40fe-83d8-3d345cb6210f"
      decimals="-3"
      id="F_ce0c14b5-e8e4-48fd-952d-20ec68d3a90e"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_add68ec5-d86e-40f4-b034-6cf33cfd18b4"
      decimals="-3"
      id="F_c3cf1f78-1bf2-4fbc-9040-414e4fc18cea"
      unitRef="U_USD">289441000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e3fb434f-e5ea-4505-bf42-34684b260e8f"
      decimals="-3"
      id="F_f278d5ba-0634-4fd6-8034-1e552ac5a517"
      unitRef="U_USD">193560000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0d85bf14-7ff9-40af-b30b-7e30a1de43fa"
      decimals="-3"
      id="F_287765d0-416b-43d4-9dfe-e52935b38b92"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_45841d41-b3ea-49ad-9f9e-c591d3adde1c"
      decimals="-3"
      id="F_09ecfb1e-96f6-4fbe-ad7a-234505a46892"
      unitRef="U_USD">62098000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a96db169-3904-4b64-b638-57e99ca42a24"
      decimals="-3"
      id="F_e2a7a877-4136-48a0-a12f-bd7ab8807352"
      unitRef="U_USD">255658000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_df0dcfdb-f7bf-42d6-8f50-7452f7efb7fc"
      decimals="-3"
      id="F_21a71114-454d-403f-8d57-5b1c6d03b58f"
      unitRef="U_USD">46392000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_17140411-b5e8-43ef-8ad8-fe25a8045518"
      decimals="-3"
      id="F_a8343322-4e7e-4740-b7e1-e94976bfb976"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_786faf8b-f50d-4276-973e-9c08430f0704"
      decimals="-3"
      id="F_08e464bf-57e3-4b45-aa24-46dffa3c4fd6"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8696ff04-631e-45ca-b986-6584fe4c098f"
      decimals="-3"
      id="F_1d7ba603-ea23-48f4-8b5a-0768f045c4e6"
      unitRef="U_USD">46392000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c5ef9de9-0775-487e-8f32-e176bb4802f2"
      decimals="-3"
      id="F_3dd86b63-34fd-4509-abd6-8a07d6e6dad4"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7123baea-0eb2-4315-ab65-b66fb4c1e84c"
      decimals="-3"
      id="F_279a8b78-aef1-4f85-8e2e-97ba2f808545"
      unitRef="U_USD">5901000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_db5c50d8-61a0-48fb-b797-e64fdb1a2402"
      decimals="-3"
      id="F_dc4ee9d8-5066-4f03-8179-5009949109f0"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8cd4e397-e9a3-4a8c-aecd-0a7615959c9e"
      decimals="-3"
      id="F_73664b4e-40da-4060-8547-e1ce550ffec7"
      unitRef="U_USD">5901000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9d4ff33d-434e-42c0-bb77-930403d92261"
      decimals="-3"
      id="F_1bdf4f2c-fe2b-4120-832d-cf6a500ad30d"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_09aa36b7-7144-467b-9fac-7756cec17a40"
      decimals="-3"
      id="F_dc349cb6-02b7-49ca-a664-f5b909f44d90"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_78745eb2-7d71-4fab-bac2-e5ea9e5f2e5b"
      decimals="-3"
      id="F_d61a1f9c-7dfe-4cef-ae4f-f78430973666"
      unitRef="U_USD">59000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2f675c67-919e-4761-81e6-7accacddcb17"
      decimals="-3"
      id="F_3a6542f3-76af-4c95-85aa-c7fc50f6f212"
      unitRef="U_USD">59000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_435c3fdf-dded-4b1c-8c53-e2baf1575828"
      decimals="-3"
      id="F_ea3a6652-a73a-47fe-8a6e-e3cf757789b3"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9d2ea10f-79df-4fc6-88b1-7ed97a1f15da"
      decimals="-3"
      id="F_657a92a3-3899-4d3f-b7f8-bb39050a1c01"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d14644b6-e4c0-4ed0-9afe-f0820fb1bd31"
      decimals="-3"
      id="F_8bcb534f-2835-46e4-bc07-96a9951d26dc"
      unitRef="U_USD">42095000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_afb144a7-7fa3-45b6-b331-2e2d09168a7c"
      decimals="-3"
      id="F_681c2a36-2787-4908-9f46-27016d54aa60"
      unitRef="U_USD">42095000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6502e745-ecac-480c-a568-afd26e86b8d5"
      decimals="-3"
      id="F_82022a35-612e-458d-ad29-c816e56f7b17"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8d7370e9-f555-49e2-8db3-20fdc743160e"
      decimals="-3"
      id="F_18f4d843-9309-4f9a-9ca3-b83c035ba0df"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_09dd24e4-7567-42ee-8451-8c197dcc4414"
      decimals="-3"
      id="F_8b86879b-7d06-4ce1-8967-5322b49615dd"
      unitRef="U_USD">30197000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9d98152e-282a-43bb-9c70-92c8e03419ba"
      decimals="-3"
      id="F_1f64871f-a763-4d77-9830-28f9d453edb1"
      unitRef="U_USD">30197000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_ba0408d0-4257-44bd-b0d4-4cae0cd8ad50"
      decimals="-3"
      id="F_f73e2fd0-2e97-4a98-97ee-f31ce1fabfed"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4dd5f666-9958-4324-a0bb-faa2a4d1e877"
      decimals="-3"
      id="F_6045c0ce-4fac-4454-8800-17ebe2059b17"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_244f0667-3be5-4a0a-8576-8ae545e146fc"
      decimals="-3"
      id="F_38084763-9a92-4131-a5b9-fa3a3b34d1f5"
      unitRef="U_USD">39275000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9a81efa3-20d3-453d-9d0c-f293d720f3f5"
      decimals="-3"
      id="F_7c852fb1-64ad-439c-b9c6-06f39dd70ecb"
      unitRef="U_USD">39275000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1bdd4ad6-2439-4385-82de-5ad820bd7eae"
      decimals="-3"
      id="F_cb7bc76a-bf3e-43e8-b051-af27982f0be8"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_133952d5-c957-477b-b68f-c01b8094549b"
      decimals="-3"
      id="F_0eafad33-93f0-4e6f-8618-fe51335f2106"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6a8af425-4477-456f-9b7d-745f9bdef0b7"
      decimals="-3"
      id="F_4a7fc13c-9ea0-4712-8274-e073bbba158d"
      unitRef="U_USD">436000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c675336b-670a-4920-8b77-b1a4286084d6"
      decimals="-3"
      id="F_0a7a898b-21cb-43e7-8add-0b2487ac8891"
      unitRef="U_USD">436000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9e7d8d10-3492-4cee-a89a-3fb97bcda1d1"
      decimals="-3"
      id="F_ca64fc1b-44f2-4991-8a32-d453c34646d4"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_40baef25-dae2-4dfa-871a-2daf38c29542"
      decimals="-3"
      id="F_8655b034-cdc3-449a-8cab-e20b6c1e899d"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d61477da-6a47-40a2-8405-d8b3177cc270"
      decimals="-3"
      id="F_86645270-00e7-4cfa-a961-d801c3e2a0f9"
      unitRef="U_USD">4950000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c79de25e-95f2-4f26-905c-cca404ed5f11"
      decimals="-3"
      id="F_1d6a3252-8860-4b21-87b4-7e3bd910c3ef"
      unitRef="U_USD">4950000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_cf1f2f09-e0ed-462d-82c7-6c2daa899d5f"
      decimals="-3"
      id="F_f87b5f0b-2a59-4351-bdb6-0db29946fca6"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_ffeaad30-ebfd-4a04-b9e5-4e0d3bd69603"
      decimals="-3"
      id="F_04519928-49eb-4da4-a27a-3707ca374aea"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4b154284-9266-4285-aa75-6b79ccaf86ed"
      decimals="-3"
      id="F_2dedeb2b-0a62-4811-a676-ad7547bd4d6d"
      unitRef="U_USD">50881000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_3f3470cf-f3bb-46cd-b659-030c2237a851"
      decimals="-3"
      id="F_37da4e51-f87e-4c9b-8aba-8992ec9b3292"
      unitRef="U_USD">50881000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6bf0974e-bd6c-4a97-aa2d-09d4b17083b0"
      decimals="-3"
      id="F_aad5a691-8ca8-4c63-9b28-859a9c11c4e9"
      unitRef="U_USD">529393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2115f8b1-9136-4380-851e-2b2dd4d28c47"
      decimals="-3"
      id="F_9504b00a-cd37-4bc3-9e7c-42b5fadb7bdc"
      unitRef="U_USD">5901000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_754e1428-1254-4b24-afeb-0530ecdb9559"
      decimals="-3"
      id="F_76b8364b-7163-46ac-9cb8-2bb1332b2349"
      unitRef="U_USD">229991000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_206853b6-d741-4c50-9285-74ba6833daf1"
      decimals="-3"
      id="F_f29fa6e4-4184-49d8-9bc7-9f9d154d50f8"
      unitRef="U_USD">765285000</us-gaap:AssetsFairValueDisclosure>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_3a94b2fa-2178-45d2-a69f-4f779a9e094b"
      decimals="-3"
      id="F_8c14c28f-423b-4ffe-b9d5-27d4a7a78652"
      unitRef="U_USD">0</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_01a26fdf-093b-428e-8429-70e85e0224c8"
      decimals="-3"
      id="F_17c30288-0e16-4a49-8b55-47ad75aeb04a"
      unitRef="U_USD">222353000</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_fba802f6-eb69-493f-87f6-f43deb47abf0"
      decimals="-3"
      id="F_59504922-037d-43a1-89b6-3976d385d419"
      unitRef="U_USD">0</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_353f21fc-32cd-4752-9796-07126db0df6e"
      decimals="-3"
      id="F_7d4dce5f-1815-45f2-8b76-d8d026a128d5"
      unitRef="U_USD">222353000</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_6e23f21f-fd64-45fb-a9b6-a0ca21a8e566"
      decimals="-3"
      id="F_accc7aa4-a9ed-4db5-a2b4-96cccab65a16"
      unitRef="U_USD">0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_ab2043e0-c7f2-40c3-bda1-f3a36db172fc"
      decimals="-3"
      id="F_b220a54d-c2b3-453a-b248-8bc07a7e46c7"
      unitRef="U_USD">251213000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_54fb9637-236a-4edf-bd9e-20160cd157ce"
      decimals="-3"
      id="F_98fe71f2-361f-4b68-b45b-3fa1f3675747"
      unitRef="U_USD">0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_6785d313-2b28-4dd6-843b-fd6e81cb4e68"
      decimals="-3"
      id="F_516805db-982b-4d84-ba89-630c442b518c"
      unitRef="U_USD">251213000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_06dd38c6-e52d-4da1-998f-59918ca542e1"
      decimals="-3"
      id="F_278232c3-ce53-4f3b-9642-b317e479ba50"
      unitRef="U_USD">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_35c66ecd-abaa-47c4-aeed-995102651f7a"
      decimals="-3"
      id="F_28eb54cd-3740-4b56-83c6-6c2e64f0bfdc"
      unitRef="U_USD">473566000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_d43c551f-1182-4c6a-9fa0-92a42cfdbdb7"
      decimals="-3"
      id="F_4f54ae97-c32b-4d4d-b0ce-a05692cbf887"
      unitRef="U_USD">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_41d2a460-017a-4f09-950d-898d5eed18e9"
      decimals="-3"
      id="F_a1902c7d-69de-4fdd-a4df-8371adcd17c6"
      unitRef="U_USD">473566000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e58d532c-c266-4245-9d7b-aef9281419e4"
      decimals="-3"
      id="F_782531b0-89fb-4b5a-b1e6-abaec5e4d9b9"
      unitRef="U_USD">170706000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_bcf2c29d-8647-40dc-ba52-d9d8f93eb75a"
      decimals="-3"
      id="F_17dddc20-0d4d-4cf2-9d25-2f36aac0e013"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d139597a-1533-4bc4-a253-55b573ea0881"
      decimals="-3"
      id="F_0b56773e-e316-4908-8c69-996e81019be1"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e9234eca-e6d0-4621-b0c2-30f2d3521baa"
      decimals="-3"
      id="F_fd1b2d2e-b816-44cb-97ae-21fd6b60483d"
      unitRef="U_USD">170706000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1094e350-01f0-46ea-8b23-ea5467236116"
      decimals="-3"
      id="F_0a728cd8-52e8-4b47-9c38-ca203dd8d8d5"
      unitRef="U_USD">251207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f3e16894-117c-446b-9f3f-884beaa199ad"
      decimals="-3"
      id="F_410297da-3105-44f2-a59d-f5d4802544bc"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_43d9c586-5f52-4d19-8160-779b9b10fc41"
      decimals="-3"
      id="F_6d16c126-fd30-4f79-aa86-547e05d1a083"
      unitRef="U_USD">60605000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_58f0fc2b-d399-43f9-94e6-ce77c2852307"
      decimals="-3"
      id="F_6de6e7b2-1cca-4c69-a4cd-4073bb74e6cf"
      unitRef="U_USD">311812000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_ed5b1702-8224-456a-abea-ea2d003f0c74"
      decimals="-3"
      id="F_460bbc4e-be63-4742-abf1-67ca2764efe6"
      unitRef="U_USD">81249000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f1b73005-95fb-4adb-81f0-96baf40e7109"
      decimals="-3"
      id="F_a3c47ba1-91e4-44cc-a8b2-925f97a73e7b"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_5a95facc-643d-4e5c-a79c-d70b76227248"
      decimals="-3"
      id="F_76261403-738e-4521-b44e-8c86c6dfadfe"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_569e318a-9026-41e3-b966-5d091cfcfca3"
      decimals="-3"
      id="F_d683f1e9-fd8f-4aed-b874-0e8e11520ab5"
      unitRef="U_USD">81249000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_bdc03984-0625-41b2-82ca-9caeb5314057"
      decimals="-3"
      id="F_0b6674ca-f9bd-49f2-9c33-cd416874a03a"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_082688dc-70ea-4b4e-a75e-e8348b08e789"
      decimals="-3"
      id="F_8f2f2c45-f59f-4fe0-8a69-3d46e7c7f40e"
      unitRef="U_USD">35297000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_32245f0a-45db-4e0a-9613-eef82b4c01c1"
      decimals="-3"
      id="F_8152af6c-5618-41b1-a6f9-ae0eb25c56f6"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f77d16f6-54fb-45df-a63a-141a1f1f0379"
      decimals="-3"
      id="F_d586c660-5509-4feb-8897-86b96ed492ce"
      unitRef="U_USD">35297000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0172277f-4eca-48b9-bece-ad8bb242c5b2"
      decimals="-3"
      id="F_d2c7400a-7246-41bf-a183-6a4b60aa7211"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6e13c51d-a0c3-477a-982e-4cc4b6d00a3b"
      decimals="-3"
      id="F_5b759089-f579-48f4-91e4-3ae3112ba23a"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_919b16a3-daf9-4bac-9da1-2cf406486d25"
      decimals="-3"
      id="F_a35830f7-33d6-4eac-a766-69f4624c6715"
      unitRef="U_USD">51883000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_46def20b-a66d-4411-90eb-b164dbc750ec"
      decimals="-3"
      id="F_d60b52e9-0473-4955-9df1-b47268fe0ddb"
      unitRef="U_USD">51883000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_fae9051d-e439-4818-ad45-eb74de3471ee"
      decimals="-3"
      id="F_9f8a0fbd-ec09-404c-87be-f40e22df7e88"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d607948e-3894-43eb-89fa-f4bc7aece440"
      decimals="-3"
      id="F_c54112aa-2a8f-48bd-9504-1962dd6314c7"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e9b0c0ac-0c84-4a00-8d3e-e6a3c6a553e3"
      decimals="-3"
      id="F_d61ba7f8-24d7-4b7e-9af6-721f47702c73"
      unitRef="U_USD">27044000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_703de750-f5d6-45f2-b263-1f034aa780b0"
      decimals="-3"
      id="F_3cbd6d09-4e37-49b7-8fcf-8a19c2642171"
      unitRef="U_USD">27044000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9cf98973-fc0b-429b-8808-7b5d88eb9637"
      decimals="-3"
      id="F_f5003560-05c5-4f7f-9880-095b9642090f"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_3551cf7d-cc96-4d09-9170-a0cd1bd24e95"
      decimals="-3"
      id="F_448da115-13eb-4247-96e0-814fbc427120"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_54134174-dac2-4f09-bf74-39a35e6c1945"
      decimals="-3"
      id="F_ca7e3069-9d0f-4666-9b93-591091deb768"
      unitRef="U_USD">27972000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b7b89463-f172-4eb5-8ce7-17774c741e4c"
      decimals="-3"
      id="F_5737e9d6-3bfe-4188-9cc0-26a3f17c9f93"
      unitRef="U_USD">27972000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_082ada48-9042-421f-be9d-be33bf8fec5e"
      decimals="-3"
      id="F_955de5d6-20de-4a5b-85de-d9b367851ad9"
      unitRef="U_USD">503162000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f92b2439-dd04-4ad1-9985-100056a2a460"
      decimals="-3"
      id="F_923f7448-ef70-4ffb-abe8-8126279a3f60"
      unitRef="U_USD">35297000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a3b40d28-d1d7-4f75-ba62-ba963f654190"
      decimals="-3"
      id="F_2b4faaed-229b-4c18-a2f2-b8d6ddb950c9"
      unitRef="U_USD">167504000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1731ac46-b6f5-411b-85d1-c11e32e67f0c"
      decimals="-3"
      id="F_d6b1fc95-d726-4af1-99c6-7dd0d7aec6af"
      unitRef="U_USD">705963000</us-gaap:AssetsFairValueDisclosure>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_4a788214-d295-44db-907c-ec0fa5bd3d73"
      decimals="-3"
      id="F_a85acb7c-1aa9-4c08-868e-fa6d3635ea3a"
      unitRef="U_USD">0</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_a37e3f84-6d29-4645-b6f7-b74dfd018d2c"
      decimals="-3"
      id="F_16d9586d-ecba-40f6-b549-aa41844f4457"
      unitRef="U_USD">200407000</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_cca319a7-55be-4560-a134-be4a41bd17b8"
      decimals="-3"
      id="F_b330e70c-63ef-481f-a27f-8a3e33f746af"
      unitRef="U_USD">0</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <inva:ConvertibleSeniorDebtFairValueDisclosures
      contextRef="C_59929190-726b-42e1-a7ea-6423d3b27be2"
      decimals="-3"
      id="F_72a04057-48cb-4757-9b08-49b2e8e5aeec"
      unitRef="U_USD">200407000</inva:ConvertibleSeniorDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_dc5d9fbc-dff8-4e86-8a01-3a68bb65a1f5"
      decimals="-3"
      id="F_5525e443-42c7-4a30-ae12-e543bff0b21f"
      unitRef="U_USD">0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_b71bcf3c-4c43-451d-b5f2-24c3afc122f4"
      decimals="-3"
      id="F_6d4acec4-9b39-4bad-a26e-2d38d02407f3"
      unitRef="U_USD">227070000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_f9e57c23-a271-4b12-b27e-1a3a9f5259fc"
      decimals="-3"
      id="F_c3101570-940b-4955-ac82-7746ea3ef0a2"
      unitRef="U_USD">0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_98ece23a-e085-4630-b652-b0ddb682aa35"
      decimals="-3"
      id="F_a7b45ad7-5d55-47ef-85f9-f570e177c0b8"
      unitRef="U_USD">227070000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_8b039347-f1bb-483f-9cd7-5caeb7ce8c4c"
      decimals="-3"
      id="F_0da81e7d-d228-4633-b64e-9eff90767b56"
      unitRef="U_USD">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_851eb81a-bcba-4dbf-a1ff-f67a190bf355"
      decimals="-3"
      id="F_9807f4e9-da5f-4ac5-bb76-425313cf19fa"
      unitRef="U_USD">427477000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_644fec1f-c78d-47a9-b887-38182f8bfb45"
      decimals="-3"
      id="F_5642d027-4b1a-4f21-9a53-c342ce09eb09"
      unitRef="U_USD">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_788779b5-a56e-46b0-b6c5-4c88f05e3f22"
      decimals="-3"
      id="F_160c912f-1067-4fcc-b248-067aba69eae8"
      unitRef="U_USD">427477000</us-gaap:DebtInstrumentFairValue>
    <inva:ContingentValueRightsLiability
      contextRef="C_e45d06f3-4620-495d-8786-74f2c65161c0"
      decimals="-3"
      id="F_35648e06-c52f-4bd7-8366-7ba38f27daaf"
      unitRef="U_USD">0</inva:ContingentValueRightsLiability>
    <inva:ContingentValueRightsLiability
      contextRef="C_2929c53c-75fc-494c-9554-8c5d617baf03"
      decimals="-3"
      id="F_aedf22ad-62d9-4bb6-807d-3e49616c8157"
      unitRef="U_USD">0</inva:ContingentValueRightsLiability>
    <inva:ContingentValueRightsLiability
      contextRef="C_955c4f2a-4a9d-417f-aead-26c430c09653"
      decimals="-3"
      id="F_880d9234-afe6-4085-b150-c9b241880fc3"
      unitRef="U_USD">359000</inva:ContingentValueRightsLiability>
    <inva:ContingentValueRightsLiability
      contextRef="C_0ee77695-de0f-46b2-86c1-faabdc44e03d"
      decimals="-3"
      id="F_1c2eeab4-fa6e-49d8-b9fd-03d80a9d3fc0"
      unitRef="U_USD">359000</inva:ContingentValueRightsLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_e45d06f3-4620-495d-8786-74f2c65161c0"
      decimals="-3"
      id="F_8ae12be5-ef50-4f04-8213-fca9089f0042"
      unitRef="U_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_2929c53c-75fc-494c-9554-8c5d617baf03"
      decimals="-3"
      id="F_a61a23cb-d136-4017-820d-bd2be17bd978"
      unitRef="U_USD">427477000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_955c4f2a-4a9d-417f-aead-26c430c09653"
      decimals="-3"
      id="F_c16995c3-1b64-413a-8d09-0f8eee8eb8c1"
      unitRef="U_USD">359000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_0ee77695-de0f-46b2-86c1-faabdc44e03d"
      decimals="-3"
      id="F_e3844a02-d596-43dd-b44d-9d23e5a42aaf"
      unitRef="U_USD">427836000</us-gaap:LiabilitiesFairValueDisclosure>
    <inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="INF"
      id="F_93000ec0-9241-4e74-9ce0-54ea01f8d3fb"
      unitRef="U_USD">0</inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels>
    <inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="INF"
      id="F_2bcb30eb-6b03-41f6-ae6c-d558e4fb5a1d"
      unitRef="U_USD">0</inva:FairValueOfAssetsOrLiabilitiesTransferBetweenLevels>
    <inva:CapitalizedFeesPaidDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_6ce4c1b3-4cf3-4be1-bb4d-45730b874682">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7. CAPITALIZED FEES PAID&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitalized fees paid, which consist of registrational and launch-related milestone fees paid to GSK, were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.749%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortization period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2013-2030&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Europe&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2013-2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Japan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2013-2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross carrying value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accumulated amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;136,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net carrying value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,961&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83,784&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These milestone fees are amortized over their estimated useful lives commencing upon the commercial launch of the product in their respective regions with the amortization recorded as a reduction in revenue from collaborative arrangements. As of December 31, 2024, the weighted average remaining amortization period wa&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Additional information regarding these milestone fees is included in Note 3, &#x201c;Revenue Recognition&#x201d;. Amortization for each of the years ended December 31, 2024, 2023 and 2022 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The remaining estimated amortization is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for each of the years from 2025 to 2027, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the year 2028, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the year 2029 and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million thereafter.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</inva:CapitalizedFeesPaidDisclosureTextBlock>
    <us-gaap:CapitalizedContractCostTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_c91dde8f-6682-4b82-82bd-da0610fbb6e4">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitalized fees paid, which consist of registrational and launch-related milestone fees paid to GSK, were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.749%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortization period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2013-2030&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Europe&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2013-2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Japan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2013-2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross carrying value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accumulated amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;136,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net carrying value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,961&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83,784&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:CapitalizedContractCostTableTextBlock>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_5d3d7d01-66b3-48b0-9e0a-4093af97d0e0"
      decimals="-3"
      id="F_645cf53b-e203-456c-a69a-ce3bc90e581b"
      unitRef="U_USD">120000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_1e6b3044-ac2f-457a-a3c3-0254c3c6cfa2"
      decimals="-3"
      id="F_c73eb1f4-b0f7-47f5-850e-f37aa581c697"
      unitRef="U_USD">120000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_ab15afc8-8530-4712-ba43-3f96b009cf85"
      decimals="-3"
      id="F_0c0eb1c6-bcda-41f7-9bd8-2d52fdbbfeaf"
      unitRef="U_USD">60000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_28894aac-4362-4af5-af9d-30c2bfedaac8"
      decimals="-3"
      id="F_5719ba07-5307-4f1e-8df4-ef7c2c3fde57"
      unitRef="U_USD">60000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_dc25f343-8bba-4e07-88b6-893e60ec0518"
      decimals="-3"
      id="F_d8f53041-7434-402c-aa38-c77683bfad02"
      unitRef="U_USD">40000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_e7fac056-3186-4a36-b380-99ad43330178"
      decimals="-3"
      id="F_18f35462-c6f3-46ca-8121-b3db920e47dc"
      unitRef="U_USD">40000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_3673aa2b-6956-4cc8-879c-43efa4cde5e2"
      unitRef="U_USD">220000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostGross
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_a1848c29-6713-448d-95b1-d4838b669ceb"
      unitRef="U_USD">220000000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostAccumulatedAmortization
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e77c9775-3251-4c9d-bad7-ea0cd56667b0"
      unitRef="U_USD">150039000</us-gaap:CapitalizedContractCostAccumulatedAmortization>
    <us-gaap:CapitalizedContractCostAccumulatedAmortization
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_880bb2c2-ff55-4459-84c7-86ec677e1415"
      unitRef="U_USD">136216000</us-gaap:CapitalizedContractCostAccumulatedAmortization>
    <us-gaap:CapitalizedContractCostNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_8b1d9378-2ec2-4608-9b85-6d8f141d472c"
      unitRef="U_USD">69961000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_9d0878ad-694e-40d7-a54f-3d41be1514cf"
      unitRef="U_USD">83784000</us-gaap:CapitalizedContractCostNet>
    <inva:CapitalizedFeesPaidWeightedAverageUsefulLife
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_83446b30-a91b-4ab5-8861-bbfa081c9149">P5Y2M12D</inva:CapitalizedFeesPaidWeightedAverageUsefulLife>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_4746b36c-9ab0-4e2a-bd05-8baeca8212b6"
      decimals="-5"
      id="F_eb310e24-3c70-413c-b78b-b7ee05d73d99"
      unitRef="U_USD">13800000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_fd08000e-5a41-4289-ae07-073ab3d62ab2"
      decimals="-5"
      id="F_fa860355-336b-498e-9e0e-76a75d1e3c10"
      unitRef="U_USD">13800000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="C_f2be4dca-4f14-4253-b3c4-7480e0834b43"
      decimals="-5"
      id="F_6b89bb1c-e11d-4a1d-9fd3-80e6f67efe39"
      unitRef="U_USD">13800000</us-gaap:CapitalizedContractCostAmortization>
    <inva:CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_45485649-dbc6-42d5-9134-68ef639d2d17"
      unitRef="U_USD">13800000</inva:CapitalizedFeesPaidRemainingEstimatedAmortizationNextTwelveMonths>
    <inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_11b5f225-d096-4096-b8a5-6ed2ab39fb3c"
      unitRef="U_USD">13800000</inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearTwo>
    <inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_32035da7-f2d3-42e3-8a6d-82e861e2885b"
      unitRef="U_USD">13800000</inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearthree>
    <inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_08ccb9f5-36f1-44f2-9a1d-579e6e8ce4b7"
      unitRef="U_USD">13700000</inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearFour>
    <inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_06aa85f3-e40a-4591-9fda-ec736c7b3f77"
      unitRef="U_USD">9400000</inva:CapitalizedFeesPaidRemainingEstimatedAmortizationYearFive>
    <inva:CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_443d895d-3277-4ca1-bb7b-997b51be263d"
      unitRef="U_USD">5400000</inva:CapitalizedFeesPaidRemainingEstimatedAmortizationAfterYearFive>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_5b3cc799-51d2-4904-aa0b-823327111504">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8. GOODWILL AND INTANGIBLE ASSETS&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Goodwill and intangible assets acquired are recognized at fair value as of the acquisition date. The carrying amount of goodwill as of December 31, 2024 and 2023 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recognized any impairment losses related to goodwill and intangible assets during the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets with definite lives are amortized over their estimated useful lives. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying basis and accumulated amortization of recognized intangible assets as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Carrying&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketed products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;223,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;176,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;In-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Collaboration agreement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,267&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;208,433&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Carrying&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketed products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;219,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;In-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Collaboration agreement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;257,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;230,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets recognized as a result of the acquisition of Entasis amounted to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which consisted of Entasis&#x2019; in-process research and development related to its antibacterial therapeutic product candidates and a collaboration agreement amounting to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. Following the FDA approval of XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in May 2023, we started amortizing $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the then in-process research and development as a marketed product, as well as the collaboration agreement, over their estimated useful lives. The useful life of the remaining in-process research and development of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million will be determined upon commercialization of the underlying product candidate; thus, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amortization expense for this intangible asset was recognized &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets recognized as a result of the acquisition of La Jolla amounting to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;151.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million pertain to product rights and developed technologies on La Jolla&#x2019;s currently marketed products. These are intangible assets with determinable lives and are amortized over their estimated useful lives.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in Note 4 &#x201c;License and Collaboration Arrangements&#x201d;, we capitalized the upfront fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million that we paid to Basilea under our exclusive distribution and license agreement as an intangible asset. This amount is included in marketed products in the table above and will be amortized over the term of the agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognized amortization expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended December 31, 2024, 2023 and 2022, respectively. Future amortization expense is expected to be $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for each of the years from 2025 to 2029 and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million thereafter.&lt;/span&gt;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_4017f011-e6f1-4e22-a306-9157541b626e"
      unitRef="U_USD">17900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-5"
      id="F_c40a4503-e774-43a0-87cc-f38ed06e72b5"
      unitRef="U_USD">17900000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_83813e9c-fa63-451c-bfef-72be37a151b0"
      unitRef="U_USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_ddfc70bc-bdb4-4f49-acc8-c6fcf3fa5af8"
      unitRef="U_USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_dd80c770-280d-4ac3-963f-7c192b1737dc">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying basis and accumulated amortization of recognized intangible assets as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 were as follows:&lt;/span&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Carrying&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketed products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;223,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;176,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;In-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Collaboration agreement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,267&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;208,433&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Carrying&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketed products&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;219,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;In-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Collaboration agreement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;257,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;230,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_849927e1-65a2-4ab7-97b5-483466c4b437"
      id="F_2a8533ef-13d1-46c4-ad5a-f79ca8fb9c8a">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_0974ccdc-4028-46c2-914a-582f9004b353"
      id="F_40805486-e197-49bd-82ec-7e9470b9f2f2">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <inva:IntangibleAssetsMarketedProductsGross
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a23f775b-5209-40f4-ab71-895918b092cc"
      unitRef="U_USD">223700000</inva:IntangibleAssetsMarketedProductsGross>
    <inva:IntangibleAssetsMarketedProductsAccumulatedAmortization
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_c06def7d-5bf0-45de-9110-368786d6631c"
      unitRef="U_USD">-47559000</inva:IntangibleAssetsMarketedProductsAccumulatedAmortization>
    <inva:IntangibleAssetsMarketedProductsNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_2cf88438-c5cc-4a72-9b28-bc518fe75f68"
      unitRef="U_USD">176141000</inva:IntangibleAssetsMarketedProductsNet>
    <inva:IntangibleAssetsInProcessResearchAndDevelopmentGross
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_68a170f1-d638-45e2-8b0d-247b54002571"
      unitRef="U_USD">2600000</inva:IntangibleAssetsInProcessResearchAndDevelopmentGross>
    <inva:IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_884aa6c6-453c-47bd-84f7-0348bcd86410"
      unitRef="U_USD">0</inva:IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization>
    <inva:IntangibleAssetsInProcessResearchAndDevelopmentNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_3e9258b2-e542-470c-8f75-450571807b33"
      unitRef="U_USD">2600000</inva:IntangibleAssetsInProcessResearchAndDevelopmentNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_df3d0c76-2bea-47b7-b43d-ad369cba9a2e"
      id="F_0ff834ce-2aa2-4a4b-9f04-5c998432b07d">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <inva:IntangibleAssetsCollaborationAgreementGross
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_4e193b76-8648-4397-954f-306f0c4efa72"
      unitRef="U_USD">35400000</inva:IntangibleAssetsCollaborationAgreementGross>
    <inva:IntangibleAssetsCollaborationAgreementAccumulatedAmortization
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_04a9c988-fb68-4214-a4f7-7594b91da9f3"
      unitRef="U_USD">-5708000</inva:IntangibleAssetsCollaborationAgreementAccumulatedAmortization>
    <inva:IntangibleAssetsCollaborationAgreementNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_510f602a-81d2-4938-88dc-5b88f6197105"
      unitRef="U_USD">29692000</inva:IntangibleAssetsCollaborationAgreementNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_28336321-7d0c-43e5-96e8-a1aec900baeb"
      unitRef="U_USD">261700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_f73cd78b-19de-4d88-944f-cb5fcf90307b"
      unitRef="U_USD">-53267000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a8c91f4a-0dbc-4a0c-9e42-932a781eb915"
      unitRef="U_USD">208433000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_f6c0a156-d89e-48f6-bded-f444bcad434a"
      id="F_f006c530-7e18-4900-80f7-383478fa1910">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_6038b2ea-b8d0-41fb-ab7d-a45db02e7491"
      id="F_6c6df5b9-2495-4b2c-b04f-0d34d82a193e">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <inva:IntangibleAssetsMarketedProductsGross
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_4ae78e59-1ed1-49c7-a65f-4837188b4445"
      unitRef="U_USD">219700000</inva:IntangibleAssetsMarketedProductsGross>
    <inva:IntangibleAssetsMarketedProductsAccumulatedAmortization
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_b5030fb6-0b61-49f5-ab43-15589f081494"
      unitRef="U_USD">-25204000</inva:IntangibleAssetsMarketedProductsAccumulatedAmortization>
    <inva:IntangibleAssetsMarketedProductsNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_52f86863-d085-4950-bddb-f12b553d4d4e"
      unitRef="U_USD">194496000</inva:IntangibleAssetsMarketedProductsNet>
    <inva:IntangibleAssetsInProcessResearchAndDevelopmentGross
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_1290aee3-7569-4ed5-8ed9-6bb1db19f96c"
      unitRef="U_USD">2600000</inva:IntangibleAssetsInProcessResearchAndDevelopmentGross>
    <inva:IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_603997ce-ca3e-45ad-b6f7-08d87ac5dca2"
      unitRef="U_USD">0</inva:IntangibleAssetsInProcessResearchAndDevelopmentAccumulatedAmortization>
    <inva:IntangibleAssetsInProcessResearchAndDevelopmentNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_70f21428-786c-4831-b645-7e63854e2798"
      unitRef="U_USD">2600000</inva:IntangibleAssetsInProcessResearchAndDevelopmentNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_58ff6e27-8879-40c6-936f-18c78a254cf0"
      id="F_add43aba-7fcc-4535-9ba7-88bfd56092c1">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <inva:IntangibleAssetsCollaborationAgreementGross
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_a89b1c9c-0bb4-4578-b94c-6b7e88edb7d3"
      unitRef="U_USD">35400000</inva:IntangibleAssetsCollaborationAgreementGross>
    <inva:IntangibleAssetsCollaborationAgreementAccumulatedAmortization
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_da5c5bf3-c051-4da9-98b5-c52d05ab4457"
      unitRef="U_USD">-2161000</inva:IntangibleAssetsCollaborationAgreementAccumulatedAmortization>
    <inva:IntangibleAssetsCollaborationAgreementNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_4a8908ad-5310-4cf7-a143-3cd69c9380d5"
      unitRef="U_USD">33239000</inva:IntangibleAssetsCollaborationAgreementNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_8492fd14-eb0b-448b-9d8d-7443581d06e9"
      unitRef="U_USD">257700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_e50b963d-4218-4489-a375-9bb388a46632"
      unitRef="U_USD">-27365000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_e41a5525-eb77-4149-a991-04b27f08070e"
      unitRef="U_USD">230335000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="C_bacd63c0-e919-4307-9a75-797f35ce4073"
      decimals="-5"
      id="F_7b98b6b3-a495-48b1-9ca6-67c8e421d176"
      unitRef="U_USD">106700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="C_01786403-dae8-45d8-8f44-bb44245b9082"
      decimals="-5"
      id="F_98e0a1ee-8b1f-49b7-9055-489f27e83d28"
      unitRef="U_USD">71300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="C_364151ca-1164-42c3-99da-d375625b3e9b"
      decimals="-5"
      id="F_176b08a8-502d-4ff0-946a-842c85b2958c"
      unitRef="U_USD">35400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="C_14dff0a8-f6e3-44e8-a3c8-67a93240f124"
      decimals="-5"
      id="F_3d5e0cc6-ca9c-4218-af83-57067abf22b1"
      unitRef="U_USD">68700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetResidualValue
      contextRef="C_a44e01be-348f-4efc-abce-4d6942d68c4e"
      decimals="-5"
      id="F_33a41af4-c8e3-416d-b5db-73ded26a9603"
      unitRef="U_USD">2600000</us-gaap:AcquiredFiniteLivedIntangibleAssetResidualValue>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_2beadbda-6783-4ae4-893a-d09da35b2b25"
      decimals="-3"
      id="F_83b0ee80-00dd-43a4-89bc-c833f90d76af"
      unitRef="U_USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_f3c6c6c6-c1f1-4aba-b7f2-6491c20659a0"
      decimals="-3"
      id="F_ca7400d8-d90f-47d1-914d-4c2b92e5c9f6"
      unitRef="U_USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="C_9192d724-db6b-429d-9b34-680a884d5432"
      decimals="-5"
      id="F_3074bcd3-fc0a-4c1d-b27a-3ddb2ce5d4d2"
      unitRef="U_USD">151000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <inva:UpfrontFee
      contextRef="C_a0ab4d8b-b98c-4423-b309-fa00f676612e"
      decimals="-5"
      id="F_232eb9bd-fdf3-4bce-a8f8-b6b40b31593a"
      unitRef="U_USD">4000000</inva:UpfrontFee>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-5"
      id="F_450448db-fb21-4f3c-811b-4d29c65da7cf"
      unitRef="U_USD">25900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-5"
      id="F_1baaa7d2-8026-496f-a661-61737a622e2e"
      unitRef="U_USD">21800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-5"
      id="F_4102519b-8525-4e00-af6f-466617bfe846"
      unitRef="U_USD">5600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_82baa809-24b5-4517-a715-e7cbe3652c5c"
      unitRef="U_USD">26300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_5af9e7da-c2b7-4825-a54d-9b70af22e121"
      unitRef="U_USD">26300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_826e7ddb-2397-4968-bb6b-ea98941f2584"
      unitRef="U_USD">26300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_ef4e0b8c-c910-4323-81cb-a925a2cb0b9a"
      unitRef="U_USD">26300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_293348e0-6847-4d32-b731-df3a400d9619"
      unitRef="U_USD">26300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-5"
      id="F_1221db2a-bbac-480b-81e6-10779454ae13"
      unitRef="U_USD">74300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_04447cee-7d13-4015-91c6-276e7f72c42d">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;9. BALANCE SHEET COMPONENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,257&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Work-in-process&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,670&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,725&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,737&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and 2023, total inventory included net fair value adjustments resulting from the acquisition of La Jolla of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which will be recognized as cost of products sold when sales occur in future periods. The fair value adjustments recorded as part of cost of products sold amounted to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million, $27&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued contract manufacturing expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued clinical and research expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;776&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0;"&gt;&lt;span style="-sec-ix-hidden:F_f4af3d02-580b-4f35-bd4b-6df98811301b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current portion of lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalty obligation payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current portion of deferred royalty obligation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued license fees and royalties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,947&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,370&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total other accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amount in &#x201c;Other&#x201d; as of December 31, 2024 includes $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in consideration received under a letter agreement we have entered into with Zai Lab as discussed in Note 4, &#x201c;License and Collaboration Arrangements&#x201d;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term portion of deferred royalty obligation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_16c95013-f170-4361-bd0d-93944037b675;"&gt;&lt;span style="-sec-ix-hidden:F_ebb48713-23ce-429f-ae3c-689518f40e91;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term portion of lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent value rights liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_f40bdedb-4b15-44bf-843d-b02897e0b4c6">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,257&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Work-in-process&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,670&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,725&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,737&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e7ed8c7e-1b38-4c1e-9671-b50937d11efa"
      unitRef="U_USD">11113000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_0b6ff7b5-7ce5-4924-aec3-559ea273562f"
      unitRef="U_USD">11257000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e5a4c02f-3654-4ea6-8fe9-c17388ba5579"
      unitRef="U_USD">20529000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_a733dfbf-2170-4068-a64b-d9d25d690805"
      unitRef="U_USD">15670000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_98a30e34-dd9b-48f0-966f-7068891d6af2"
      unitRef="U_USD">2083000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_a71d86df-dfc5-46f5-9632-cc039bc109a0"
      unitRef="U_USD">13810000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_da1e0627-2eab-4771-8cf6-ab3e5960c31b"
      unitRef="U_USD">33725000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_15099d74-0937-4110-8176-c9f4a82e3773"
      unitRef="U_USD">40737000</us-gaap:InventoryNet>
    <inva:FairValueAdjustmentsOfInventoryFromAcquistion
      contextRef="C_c9475aee-0427-4f76-b24b-da8950b70256"
      decimals="-5"
      id="F_517cd027-5ac1-4e18-9234-42f1cfe1269e"
      unitRef="U_USD">9200000</inva:FairValueAdjustmentsOfInventoryFromAcquistion>
    <inva:FairValueAdjustmentsOfInventoryFromAcquistion
      contextRef="C_d45b1b16-d9f4-4bd5-a834-1cf791abc22d"
      decimals="-5"
      id="F_1d325dc9-add0-4fc5-b332-a2471cb1cbf9"
      unitRef="U_USD">23000000</inva:FairValueAdjustmentsOfInventoryFromAcquistion>
    <inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold
      contextRef="C_fedeae1b-25e7-447d-871d-311e79d2dae2"
      decimals="-5"
      id="F_da63cab2-bea0-442c-a2ce-b8f42c58a2a3"
      unitRef="U_USD">13800000</inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold>
    <inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold
      contextRef="C_93c2cd99-2331-4842-ae83-434ada9a8bca"
      decimals="-5"
      id="F_30b99f6c-e4c6-40b5-a8e1-e2d696a20858"
      unitRef="U_USD">200000</inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold>
    <inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold
      contextRef="C_315a265e-5369-4a49-a2e2-f13fcdd56f9a"
      decimals="-5"
      id="F_bcc4c130-d54e-4ad7-9710-7df5cccc645e"
      unitRef="U_USD">10000000</inva:AmortizationOfFairValueAdjustmentsOfCostOfProductsSold>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_332f5756-45a3-4416-bb81-2b0531ac23e5">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued contract manufacturing expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued clinical and research expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;776&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a8286aaa-b0a8-4317-b48e-6c3dc89960b0;"&gt;&lt;span style="-sec-ix-hidden:F_f4af3d02-580b-4f35-bd4b-6df98811301b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current portion of lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Royalty obligation payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current portion of deferred royalty obligation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued license fees and royalties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,947&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,370&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total other accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <inva:AccruedContractManufacturingLiability
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_32aa1158-28ac-4f73-8929-0bfd32642106"
      unitRef="U_USD">1071000</inva:AccruedContractManufacturingLiability>
    <inva:AccruedContractManufacturingLiability
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_20a4c573-26cd-4ae8-8bf9-13a8c196de71"
      unitRef="U_USD">1966000</inva:AccruedContractManufacturingLiability>
    <inva:AccruedClinicalAndResearchLiability
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_8f512ab9-c6b3-4f3e-9fdc-2ed2875c662e"
      unitRef="U_USD">611000</inva:AccruedClinicalAndResearchLiability>
    <inva:AccruedClinicalAndResearchLiability
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_945910e3-d9e7-4293-bd68-f9f70f0060e1"
      unitRef="U_USD">776000</inva:AccruedClinicalAndResearchLiability>
    <inva:AccruedProfessionalServices
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_93685282-1ae3-4eb4-b508-d994620ba085"
      unitRef="U_USD">8682000</inva:AccruedProfessionalServices>
    <inva:AccruedProfessionalServices
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_21bf64d9-6794-418a-91cc-c95fc2c49e3b"
      unitRef="U_USD">8876000</inva:AccruedProfessionalServices>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_84b90ed4-0bf9-453a-b75c-f1edb534842e"
      unitRef="U_USD">1572000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_6c78feae-3938-4cbd-a1cb-909900064633"
      unitRef="U_USD">1207000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_24908566-f6ae-4677-9924-31fbf055318e"
      unitRef="U_USD">2951000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_6237f38c-413b-4269-b816-10a760459d0b"
      unitRef="U_USD">1928000</us-gaap:AccruedRoyaltiesCurrent>
    <inva:DeferredRoyaltyObligationCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_7334ce6d-c2f9-4092-9d2e-65d88231c501"
      unitRef="U_USD">6438000</inva:DeferredRoyaltyObligationCurrent>
    <inva:DeferredRoyaltyObligationCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_b0b0de8c-fb8f-447a-8f41-8820abba1214"
      unitRef="U_USD">0</inva:DeferredRoyaltyObligationCurrent>
    <inva:AccruedLicenseFeesAndRoyalties
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_07bf2d3f-79c6-49d6-8d7b-156f1ef07cc3"
      unitRef="U_USD">1727000</inva:AccruedLicenseFeesAndRoyalties>
    <inva:AccruedLicenseFeesAndRoyalties
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_c567e91c-38bf-47ca-9c6d-448950ed07dd"
      unitRef="U_USD">1575000</inva:AccruedLicenseFeesAndRoyalties>
    <us-gaap:OtherLiabilities
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_591a04fc-692e-4fa4-a6bf-3295403dd797"
      unitRef="U_USD">6947000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_e0801b02-8f2a-40ec-b166-6aa4b59cb536"
      unitRef="U_USD">3370000</us-gaap:OtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_928b3c3a-c82a-4c6a-bd5f-9a1b9da65ee9"
      unitRef="U_USD">29999000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_d4d34d38-daf4-48e5-9df5-8fc963d8a092"
      unitRef="U_USD">19698000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <inva:BusinessCombinationDeferredConsideration
      contextRef="C_de99671a-3f86-4f93-b929-187c53e350a3"
      decimals="-5"
      id="F_356c78c0-27a6-4814-b647-9f61c055121e"
      unitRef="U_USD">5300000</inva:BusinessCombinationDeferredConsideration>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_344fa777-0608-4b09-b34c-5bbbbb7370e8">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term portion of deferred royalty obligation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_16c95013-f170-4361-bd0d-93944037b675;"&gt;&lt;span style="-sec-ix-hidden:F_ebb48713-23ce-429f-ae3c-689518f40e91;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term portion of lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent value rights liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <inva:DeferredRoyaltyObligationNonCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_c3dea4e3-1b45-4472-8e05-ac8185b12a4a"
      unitRef="U_USD">63096000</inva:DeferredRoyaltyObligationNonCurrent>
    <inva:DeferredRoyaltyObligationNonCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_b075695c-c7c6-4259-ad67-8b00c8472d35"
      unitRef="U_USD">69876000</inva:DeferredRoyaltyObligationNonCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_99563687-8710-4bc2-940e-5d674dbd1143"
      unitRef="U_USD">1179000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_ede02b61-c403-4ee6-a1ea-f5522002d0fb"
      unitRef="U_USD">1635000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <inva:ContingentValueRightsLiability
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_8e3f693c-4ef1-4ddf-9efc-bc5f2a2722fe"
      unitRef="U_USD">0</inva:ContingentValueRightsLiability>
    <inva:ContingentValueRightsLiability
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_51197126-5f0d-4367-a427-d2cd7f490f27"
      unitRef="U_USD">359000</inva:ContingentValueRightsLiability>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_8e5b1f27-c162-4b6f-8e8b-7eb4653d6906"
      unitRef="U_USD">64275000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_7dbb2fc4-734d-4c09-9005-9cfe0bfe0cb6"
      unitRef="U_USD">71870000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_bf540891-3da8-47b9-9101-a332fd32eb49">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10. STOCK&#x2011;BASED COMPENSATION&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2012, we adopted the 2012 Equity Incentive Plan (the &#x201c;2012 Plan&#x201d;). The 2012 Plan provides for the grant of incentive stock options, nonstatutory stock options, RSAs, RSUs and Stock Appreciation Rights to employees, non-employee directors and consultants. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, total shares remaining available for issuance under the 2012 Plan were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,758,450&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the 2004 Employee Stock Purchase Plan (the &#x201c;2004 ESPP&#x201d;), our employees may purchase common stock through payroll deductions at a price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the lower of the fair market value of the stock at the beginning of the offering period or at the end of each applicable purchase period. The 2004 ESPP provided for consecutive and overlapping offering periods of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;24 months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in duration, with each offering period composed of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;four&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; consecutive &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;six-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; purchase periods. The purchase periods ended on either May 15 or November 15. The 2004 ESPP contributions were limited to a maximum of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of an employee&#x2019;s eligible compensation. The maximum number of shares that an employee may purchase in any purchase period was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. An employee may not purchase shares with a value greater than $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in any calendar year.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 13, 2023, the Board of Directors adopted the 2023 ESPP (the &#x201c;2023 ESPP&#x201d;). The 2023 ESPP, which supersedes the 2004 ESPP, was approved by the Company&#x2019;s stockholders on May 22, 2023. Under the 2023 ESPP, eligible employees may purchase common stock through payroll deductions at a price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the lower of the fair market value of the stock at the beginning or end of each applicable purchase period. The 2023 ESPP provides for offering periods of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;six months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which ends on either May 15 or November 15. The 2023 ESPP contributions are limited to a maximum of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of an employee&#x2019;s eligible compensation. The maximum number of shares that an employee may purchase in any purchase period is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. An employee may not purchase shares with a value greater than $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in any calendar year. A total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of our common stock was reserved and available for issuance under the 2023 ESPP.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, total shares remaining available for issuance under the 2024 ESPP were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,467,596&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Director Compensation Program&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our non-employee directors receive compensation for services provided as a director. Each member of our board of directors who is not an employee receives both cash and equity compensation for services as a director, member of a committee of the board of directors, lead independent director and chairman, as applicable. In October 2017, both the cash and equity components of the compensation program were amended, effective immediately (the &#x201c;October 2017 Amendments&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each of our independent directors receives periodic automatic grants of equity awards under a program implemented under the 2012 Plan. These grants are non&#x2011;discretionary. Only our independent directors or affiliates of such directors are eligible to receive automatic grants under the 2012 Plan. Under the program, each individual who first became a non-employee director will, on the date such individual joins the board of directors, automatically be granted a one&#x2011;time grant of RSUs covering a number of shares of our common stock calculated as $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ($&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, rounded down to the nearest whole share (the &#x201c;Initial RSUs&#x201d;), plus a one&#x2011;time grant of RSUs covering a number of shares of our common stock calculated as $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ($&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, which would be pro-rated for the number of whole months remaining until the anniversary of the prior year&#x2019;s stockholders&#x2019; meeting, rounded down to the nearest whole share (the &#x201c;Pro Rata RSUs&#x201d;). The Initial RSUs vest in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; equal annual installments, while Pro Rata RSUs vest in a single installment at the sooner of the next annual stockholder meeting or the one-year grant anniversary, in each case subject to the non-employee director&#x2019;s continuous service through the applicable vesting date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Annually, upon his or her re&#x2011;election to the board of directors at the Annual Meeting of Stockholders, each non-employee director is automatically granted an RSU covering a number of shares of our common stock calculated as $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ($&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; prior to the October 2017 Amendments) divided by our common stock closing share price on the date of grant as reported on The Nasdaq Global Select Market, rounded down to the nearest whole share. These RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the non-employee director&#x2019;s continuous service through the applicable vesting date. Following the amendment to our non-employee director compensation program, both the annual RSUs and Initial RSUs described above remained unchanged with the exception that the number of shares of our common stock subject to each award has been reduced.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These RSUs will vest in full upon the director&#x2019;s death, the occurrence of a change in control or, with respect to awards made after the October 2017 Amendments, the director&#x2019;s disability before the director&#x2019;s service terminates. Director RSUs carry dividend equivalent rights to be credited with an amount equal to all cash dividends paid on the underlying shares of common stock while unvested. Dividend equivalents are subject to the same terms and conditions, including vesting, as the RSUs to which they attach and are paid in cash upon vesting.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock&#x2011;Based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock&#x2011;based compensation expense is included in the consolidated statements of income as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.01%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.203%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.203%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.583%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock&#x2011;based compensation expense included in the consolidated statements of income by award type is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,980&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,057&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,053&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrecognized Compensation Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Amortization Period (Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total unrecognized compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Compensation Awards&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.386%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.642%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.7219999999999995%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.642%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.7219999999999995%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.642%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.182%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of outstanding options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Exercise Price of Outstanding Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of outstanding RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Fair Value per Share at Grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of outstanding RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Fair Value per Share at Grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Released RSUs and RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,067&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest &lt;br/&gt;&#160;&#160;&#160;as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,067&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the aggregate intrinsic value of options outstanding and options exercisable was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of December 31, 2023, the aggregate intrinsic value of options outstanding and options exercisable &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of December 31, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;759,904&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; options were exercisable. The weighted average remaining contractual term of options outstanding was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8.04&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7.96&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years as of December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total intrinsic value of the options exercised was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material for the year ended December 31, 2024, 2023 and 2022. The total estimated fair value of options vested was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended December 31, 2024 and 2023, respectively. The total estimated fair value of options vested was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t material for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total estimated fair value of RSUs vested was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total estimated fair value of RSAs vested was not material for the year ended December 31, 2024, 2023, and 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Valuation Assumptions&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Black-Scholes-Merton weighted-average&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.748999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.748999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.748999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.04&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average estimated fair value of stock options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_631eb718-8626-432d-96fb-8270d3650dfb"
      decimals="INF"
      id="F_2b9164f9-d73a-4e7e-8cc8-4e96c310951b"
      unitRef="U_shares">1758450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      decimals="2"
      id="F_75258d1e-7fd6-411e-9330-c51408840480"
      unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      id="F_c1e808a7-5dc2-438e-b703-fa46a7244bac">P24M</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      decimals="0"
      id="F_72c90b81-2c62-4fa9-8995-59ab937c9351"
      unitRef="U_Item">4</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      id="F_18b24ba3-6b9e-4119-b0c4-8a3b0f66cede">P6M</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="C_61675bce-4ccb-4819-8b97-db41c469c40c"
      decimals="2"
      id="F_b503faf1-06f9-42d4-a257-74de7ebf639f"
      unitRef="U_pure">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      decimals="INF"
      id="F_467dc054-949d-4530-aebc-6f70a4d96c9a"
      unitRef="U_shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      decimals="-3"
      id="F_4843c4bd-6f46-4ad4-b6d7-596fe3800730"
      unitRef="U_USD">25000000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f"
      decimals="2"
      id="F_61c2ee83-6319-4554-827c-8ed1c5d7e639"
      unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod
      contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f"
      id="F_b3d46490-9c86-496f-b5d6-71d13e689a40">P6M</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveAndOverlappingOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="C_36498d02-d869-42ba-9764-62160907c5d0"
      decimals="2"
      id="F_f1f7cb8b-90e0-4897-90ce-bfa9e22931ab"
      unitRef="U_pure">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f"
      decimals="INF"
      id="F_35c1319d-2c62-44d8-a128-3603c26786a0"
      unitRef="U_shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation
      contextRef="C_e617e900-c4dd-49a9-adae-8c08d9de316f"
      decimals="-3"
      id="F_f588b73b-6c85-4377-a938-5129b31c3682"
      unitRef="U_USD">25000000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountAsContributionOfEligibleCompensation>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_36498d02-d869-42ba-9764-62160907c5d0"
      decimals="INF"
      id="F_2ee24fdb-3aa4-4d86-a3ca-aa9484564b6a"
      unitRef="U_shares">2500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_36498d02-d869-42ba-9764-62160907c5d0"
      decimals="INF"
      id="F_e6c1ee99-d489-47c9-8e5f-ff91ba3024d1"
      unitRef="U_shares">2467596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue
      contextRef="C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8"
      decimals="0"
      id="F_e22cbc32-4aac-4e0d-ab80-c70dae02380a"
      unitRef="U_USD">125000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue
      contextRef="C_0093bbd6-7e3d-4096-a9d4-884a19df0e1b"
      decimals="0"
      id="F_3cfebef6-fde5-4449-a984-b20911c40003"
      unitRef="U_USD">250000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialEquityGrantValue>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue
      contextRef="C_9d99512d-8c26-4aa3-8e49-d87cb2c190b8"
      decimals="0"
      id="F_a7ea986e-1b68-4f38-aebf-3360d8ce8bae"
      unitRef="U_USD">225000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue
      contextRef="C_0093bbd6-7e3d-4096-a9d4-884a19df0e1b"
      decimals="0"
      id="F_3875c2c6-f5a9-401f-a6c4-0f3129a36def"
      unitRef="U_USD">250000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalEquityGrantValue>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments
      contextRef="C_aa1f7e7b-d2fa-443f-a718-e2d0bbe01a01"
      decimals="INF"
      id="F_41d3d148-5aa2-418e-9104-6adcf824248d"
      unitRef="U_Installment">2</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualInstallments>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue
      contextRef="C_3e6c5798-81a7-4ab8-b212-ef8406a6ab89"
      decimals="0"
      id="F_4e71cf4d-ae87-4862-be99-03e4581a190b"
      unitRef="U_USD">225000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue
      contextRef="C_745efcda-116c-4d6a-b708-1361e157d2ba"
      decimals="0"
      id="F_fbe1612a-bb95-455d-9d58-1074788d15c8"
      unitRef="U_USD">250000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualEquityGrantValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_552d45bc-2438-41ac-96dc-07ca940287eb">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock&#x2011;based compensation expense is included in the consolidated statements of income as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.01%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.203%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.203%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.583%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_9d4df672-9227-4655-9953-e51c14163b1a"
      decimals="-3"
      id="F_40d0b2e3-4b91-4452-a7fc-9b16c1f52d73"
      unitRef="U_USD">6040000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_6fd76cbf-78f1-4169-b3c9-f2dee135ca32"
      decimals="-3"
      id="F_d8cd9a48-b5cb-4059-9632-26faf15c780b"
      unitRef="U_USD">4645000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_8f0463dc-8f74-4223-9dd0-680a9297636d"
      decimals="-3"
      id="F_fa8704b1-f69b-43c8-a866-dde997ac2020"
      unitRef="U_USD">5305000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c61a6de1-f544-4ddd-95a2-ffc7bafdc548"
      decimals="-3"
      id="F_edea5dfb-6c2e-4dd4-907b-f2adb7a4642e"
      unitRef="U_USD">334000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ef03268a-dd7d-4c50-a2c4-e5d9a9311b15"
      decimals="-3"
      id="F_55301987-78ea-476e-88ff-920457f37384"
      unitRef="U_USD">1192000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fbdb8b2c-2b35-4e9d-80d1-25e5b10df0bf"
      decimals="-3"
      id="F_03a8349d-0779-43bd-ab41-7a232fa19187"
      unitRef="U_USD">2042000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_35204d44-e281-46b5-9374-bb4bea679136"
      unitRef="U_USD">6374000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_bf0841fe-0622-462a-95fa-3c12dd299461"
      unitRef="U_USD">5837000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_c54e65cb-926d-41da-995e-4ae0114d011d"
      unitRef="U_USD">7347000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_a49ddfdc-2be0-4416-b3d8-29b1202681a1">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock&#x2011;based compensation expense included in the consolidated statements of income by award type is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,980&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,057&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,053&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-3"
      id="F_4bb1041b-5383-4d10-8194-e2f86b073ba1"
      unitRef="U_USD">2738000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64"
      decimals="-3"
      id="F_670a6b3b-80c7-4aa4-88da-1ad6fe43637b"
      unitRef="U_USD">1980000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9"
      decimals="-3"
      id="F_63a0676e-d4a4-4bb4-b3b7-08c14cdfb149"
      unitRef="U_USD">3057000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="-3"
      id="F_32f5e993-2f79-4c3f-ae3c-3d9939667d60"
      unitRef="U_USD">3348000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_00f9e3ac-8ca8-42d6-ab5d-d942ce6aee24"
      decimals="-3"
      id="F_9631e6b8-9564-485f-a2a4-5fc46f8956f9"
      unitRef="U_USD">3663000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_cac6555f-df17-464f-8fa8-e1233df59df0"
      decimals="-3"
      id="F_0bb7f088-a531-4bc2-88c4-3a8fe78811de"
      unitRef="U_USD">4053000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="-3"
      id="F_37595fc5-5136-4e3a-a203-377ac1cc3186"
      unitRef="U_USD">123000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7dd1472a-f27f-4e99-ac46-35b7a204db5a"
      decimals="-3"
      id="F_70aff440-0e58-4c15-acbc-1d1f05f234b3"
      unitRef="U_USD">168000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c45aa339-d7d0-43b8-affa-cc16b15eced2"
      decimals="-3"
      id="F_911bdda2-3425-441c-8021-cdf68387b399"
      unitRef="U_USD">194000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_54b22293-d908-4db6-bb20-6b71eb916276"
      decimals="-3"
      id="F_93804a52-3a70-4064-a810-9c22f6a4b2e3"
      unitRef="U_USD">165000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_197a7b2b-9367-4d18-a82a-81e4a8afc234"
      decimals="-3"
      id="F_13b9e597-44f2-4996-9b55-fb609326fb96"
      unitRef="U_USD">26000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_19101d97-aca7-45f0-b583-c510e7751aed"
      decimals="-3"
      id="F_188647dc-3562-4e6c-92a7-935ab423daba"
      unitRef="U_USD">43000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_2b0e93b6-773c-42e0-b96a-2394c5149488"
      unitRef="U_USD">6374000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9fa43418-6ceb-4420-83f9-bbf9a89524c2"
      unitRef="U_USD">5837000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_b0459527-63b9-4726-bf71-6de317dbad69"
      unitRef="U_USD">7347000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4bbf8940-14cd-4153-bbb2-6b7b17161860">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrecognized Compensation Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Amortization Period (Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total unrecognized compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="-3"
      id="F_6fd95ee4-59c7-4838-8e21-b8d1679a4f43"
      unitRef="U_USD">6765000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      id="F_f98b3ad6-e00d-4e46-807d-f9a55e42fc5a">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3"
      decimals="-3"
      id="F_f1c56812-dbdc-4ee3-8da2-805ee2228707"
      unitRef="U_USD">6996000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      id="F_542cb177-4569-4dc6-89fa-c076a4e3fe61">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31"
      decimals="-3"
      id="F_08d13012-5303-4a49-9d46-1a4f05accf24"
      unitRef="U_USD">98000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      id="F_e9e0d8b7-08b4-4df7-893f-a9881f52734e">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_ad3b13ab-fa5d-46bd-afc9-2808f0c7a863"
      unitRef="U_USD">13859000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_44ff3c1b-32d1-49aa-968b-6eb6ae178c42">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.386%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.642%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.7219999999999995%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.642%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.7219999999999995%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.642%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.182%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of outstanding options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Exercise Price of Outstanding Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of outstanding RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Fair Value per Share at Grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of outstanding RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average Fair Value per Share at Grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Released RSUs and RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,067&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest &lt;br/&gt;&#160;&#160;&#160;as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,067&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80"
      decimals="-3"
      id="F_ccaaa0c9-0a16-454d-bea4-e6c613d81638"
      unitRef="U_shares">1499000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80"
      decimals="2"
      id="F_69deb5df-6bdc-456d-b9c4-af433368eed0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">14.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="C_16e99f91-f640-4040-b9b5-471378dcd3f6"
      decimals="-3"
      id="F_6fec639d-9660-41d2-811a-3da09fb5905a"
      unitRef="U_shares">482000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_16e99f91-f640-4040-b9b5-471378dcd3f6"
      decimals="2"
      id="F_c68490cb-88c3-423c-b590-185f2912ac92"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="C_9bf67da7-5977-473a-b529-91f7f67d1f91"
      decimals="-3"
      id="F_797b027f-3f7b-47bf-a217-ec882c825a3f"
      unitRef="U_shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_9bf67da7-5977-473a-b529-91f7f67d1f91"
      decimals="2"
      id="F_4bc4573a-1576-4f1f-8987-44b6feaa5496"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">14.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-3"
      id="F_48169b9f-2976-4161-ad2e-a939c36038ad"
      unitRef="U_shares">1062000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="2"
      id="F_b356f98c-2e5c-4a14-be25-9f85f81ba7e0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="-3"
      id="F_bc2922f6-9cd7-4a53-9b18-bfd8d0b4acf6"
      unitRef="U_shares">502000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="2"
      id="F_1053ccda-0612-4ad4-a6d3-0b2de61f12a8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="-3"
      id="F_de8a6c2d-2298-465b-b955-d1c18a79f0fe"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="0"
      id="F_5a5f8cd7-916b-43f4-b554-0726f53a74d5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-3"
      id="F_67924428-7ef8-46ef-8d29-3c81dc13621f"
      unitRef="U_shares">80000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="2"
      id="F_f9468681-6fb0-4d15-9f17-1791c69dd7ad"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="-3"
      id="F_fb28978b-ff59-4145-b261-829e1fe8ce63"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="0"
      id="F_ffb9f631-68a9-4965-8030-2ded00c83fe7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="-3"
      id="F_a16638df-2e69-48d8-b2ca-efcdccbb1040"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="0"
      id="F_d0c937a9-73f7-49d6-acd9-cb23d6e69135"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-3"
      id="F_8fc2dd3d-242a-47e8-92e4-8e767d35929f"
      unitRef="U_shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="0"
      id="F_95be6d7e-1bf4-4857-9be9-34cadc00b574"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="-3"
      id="F_2d98741d-a525-4b53-a451-1b6acd59c7ec"
      unitRef="U_shares">241000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="2"
      id="F_3a70ac2d-4475-4a8f-a1c7-bad3782be7bb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="-3"
      id="F_450c04ef-f7fa-44bd-b2db-05018dcc39e8"
      unitRef="U_shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="2"
      id="F_eea14fb6-d9d1-46d9-a086-cdd4cfcedf36"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">14.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-3"
      id="F_26e4bb1a-1b02-4be2-b9be-6779bca6e603"
      unitRef="U_shares">414000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="2"
      id="F_44a761aa-ae5c-4864-b791-2e390912f9ab"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="-3"
      id="F_ff89771d-85cd-464f-ba7b-85f648b8eb10"
      unitRef="U_shares">145000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="2"
      id="F_6e6c60cb-9566-4273-b705-dfda97dfbb13"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="-3"
      id="F_a0d09111-dff3-431d-968b-834f52b32887"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_4363cee3-616d-40bd-953f-b7ca70e0e01a"
      decimals="0"
      id="F_3f1ba242-ab81-424d-8978-2cd7c2e31c4c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="-3"
      id="F_8fcd86d1-40bd-4e93-b6f7-d5fb3ee76b9c"
      unitRef="U_shares">2067000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="2"
      id="F_9f18a35d-af97-47fd-ac23-d5d6201f9cb4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3"
      decimals="-3"
      id="F_4d05b6c5-b387-4136-b8ee-1c7ded82fe1b"
      unitRef="U_shares">598000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3"
      decimals="2"
      id="F_95e1385c-0ae1-4495-b5dc-41a8adc3ac8b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31"
      decimals="-3"
      id="F_f06b7a7c-05dc-4d2d-8a02-f22f53b9a0de"
      unitRef="U_shares">7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31"
      decimals="2"
      id="F_58f3a5a4-9400-4a89-9bbc-65e0dd55334c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="-3"
      id="F_be0c165a-b1d7-4de6-8e59-bd37ca258204"
      unitRef="U_shares">2067000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="2"
      id="F_0e6dc385-6302-4790-863e-b109eda3a9c5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3"
      decimals="-3"
      id="F_549f7a6b-eeab-4ecb-85cf-cad7151f4a5c"
      unitRef="U_shares">598000</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare
      contextRef="C_ccb7f67b-16d6-400c-b835-57f8bd8841a3"
      decimals="2"
      id="F_78f061e0-6644-4bb3-b3ee-08395ff64026"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31"
      decimals="-3"
      id="F_1da55e46-a776-4a98-9a0a-3a4705562cac"
      unitRef="U_shares">0</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber>
    <inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare
      contextRef="C_f1c05c21-7102-49e6-9b1f-2ded8930bf31"
      decimals="0"
      id="F_ee51d477-1c55-4611-b931-4d329f1d7107"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</inva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="-5"
      id="F_89125a4f-c4af-4017-90ff-0c2e2e375dd5"
      unitRef="U_USD">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="-5"
      id="F_696636b8-6d91-4fe1-b050-d10d43b38ae7"
      unitRef="U_USD">2400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80"
      decimals="-5"
      id="F_8b8e6ddd-d15d-40ea-9166-7a5aad794588"
      unitRef="U_USD">3600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_102e5069-9631-4b2b-b6f6-629950c6ca80"
      decimals="-5"
      id="F_046df138-c655-4159-bcba-2115c5614012"
      unitRef="U_USD">800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_47f8959c-1769-496f-89be-b7a9ebcc8ae3"
      decimals="0"
      id="F_0aa63f51-f974-4e6d-9ee3-81100d6f516a"
      unitRef="U_shares">759904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      id="F_d5ea5632-37a1-4f4d-ac72-56989e5ee154">P8Y14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64"
      id="F_80791177-965b-42ca-9a68-986a164bb766">P7Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-6"
      id="F_b22d499c-2984-48ad-9163-0a2c3d74321c"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64"
      decimals="-6"
      id="F_9ad14a2f-4ab5-4a21-9eed-ec65ca1de1fe"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9"
      decimals="-6"
      id="F_a5e84bfd-09db-49f4-a00e-8f4f4196dc5f"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_14b4daa5-0e7f-4451-94b3-65b08a6e2379"
      decimals="-5"
      id="F_f23b21ef-62b9-4958-b0e0-ccce8d18c8aa"
      unitRef="U_USD">2500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_d79b267b-a3f1-4b2e-91b2-3ab8ad2eea64"
      decimals="-5"
      id="F_308ca2b4-ff66-491a-8f8e-a1493d5a0a97"
      unitRef="U_USD">1900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_6cbb0886-c4c2-4e7b-b0df-3d09c6aebaa9"
      decimals="-6"
      id="F_33c9c901-d5fc-4385-b7a7-1e331a96c23b"
      unitRef="U_USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_af802179-d1c5-4daa-b0d2-91a25a398a6c"
      decimals="-5"
      id="F_ca672681-4df8-4921-b581-ad09e0566873"
      unitRef="U_USD">3200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_00f9e3ac-8ca8-42d6-ab5d-d942ce6aee24"
      decimals="-5"
      id="F_46342afd-5fa2-4295-806f-64d41ae36718"
      unitRef="U_USD">3900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_cac6555f-df17-464f-8fa8-e1233df59df0"
      decimals="-5"
      id="F_8d1c1f59-375e-480b-848f-ef37dc6b5ae5"
      unitRef="U_USD">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_dc8ebe57-7f27-4c75-9d3c-60a460745c0d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Black-Scholes-Merton weighted-average&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.748999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.748999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.748999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.10&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.04&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average estimated fair value of stock options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab"
      decimals="3"
      id="F_fe942303-622b-4de2-a1bf-2d7d05f4e450"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8"
      decimals="3"
      id="F_0c349816-5a7d-431b-8765-c2559386a2fe"
      unitRef="U_pure">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149"
      decimals="3"
      id="F_26131211-4376-4edb-a530-19d3f3d6fe54"
      unitRef="U_pure">0.036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab"
      id="F_4fd7778f-0e96-419b-9247-c6ea5bdb984f">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8"
      id="F_21472da6-48ac-4a63-93ea-833c2ba57358">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149"
      id="F_cc81885c-511f-4ad7-bec9-73fe1be29afe">P6Y14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab"
      decimals="3"
      id="F_a54eac19-2b74-4e9c-9f4d-2bc6246220f5"
      unitRef="U_pure">0.355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8"
      decimals="3"
      id="F_bc3e33a6-0026-4591-a76a-5da34c482a6d"
      unitRef="U_pure">0.378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149"
      decimals="3"
      id="F_bfeb0550-7050-4f1c-be57-906daf44ef9e"
      unitRef="U_pure">0.386</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_155f7dc2-975e-4e6a-bace-6dfb4dbe5000"
      decimals="3"
      id="F_a3767e7e-2e8f-4e4a-9754-5a78ce7bb30e"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_caf4275d-107c-4a04-8eba-47895b8c9c67"
      decimals="3"
      id="F_effb1076-23b0-487e-a0fd-5676ebb35eba"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_04fe922a-6cc7-40ce-935f-5fdc9f946206"
      decimals="3"
      id="F_56cc01eb-126a-4d38-b762-7ea16daa8669"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_4c6c9a98-3708-403b-b3e3-41b376c009ab"
      decimals="2"
      id="F_c8506c1f-98b7-45ea-bcda-dcece5689ca6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_8c8b081e-ba87-4a62-9fa2-e76d58fab2a8"
      decimals="2"
      id="F_23030091-2c23-4edf-be5c-1da1114a57fe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_53b04726-e41a-4259-a6b3-6fa32a149149"
      decimals="2"
      id="F_860f51ec-021d-49eb-8d6a-779c445b7e5f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4368d926-cd46-4d74-a649-2c08e9b55247">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;11. &lt;/span&gt;&lt;span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 31, 2022, our board of directors authorized a share repurchase program under which we may repurchase up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of our outstanding shares of common stock. The repurchase program authorized the repurchase by the Company of its common stock in open market transactions, including pursuant to a trading plan in accordance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), privately negotiated transactions, in block trades, accelerated share repurchase transactions, exchange transactions, or any combination thereof or by other means in accordance with federal securities laws. The authorization permitted management to repurchase shares of the Company&#x2019;s common stock from time to time at management&#x2019;s discretion. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so because of self-imposed trading blackout periods or other regulatory restrictions. From program inception through December 31, 2022, we repurchased &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;647,394&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares in the open market at an average price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.13&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for a total amount of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. For the year ended December 31, 2023, we repurchased &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,173,565&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares in the open market at an average price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.39&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for a total amount of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. From January to April 2024, we repurchased &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;986,928&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares in the open market at an average price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.12&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for a total amount of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The share repurchase program was completed in April 2024. All of the repurchased shares were retired.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In April 2024, we retired all shares held in treasury resulting from our strategic buyback of GSK&#x2019;s common shares in the Company in 2021. We recorded the corresponding cost of treasury stock of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;393.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in additional paid-in capital.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="C_75144e9c-8d8d-4067-a64b-e8ba0c236ce0"
      decimals="-5"
      id="F_f0e7abb4-3a2e-40d6-bdae-5a58cf029676"
      unitRef="U_USD">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="INF"
      id="F_1f62fed8-b2cf-4377-b111-107afebbcb70"
      unitRef="U_shares">647394</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <inva:CommonStockAcquiredAverageCostPerShare
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="2"
      id="F_f6cab45d-c912-4326-84ef-6678a9b55498"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.13</inva:CommonStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_2594e9f0-6ab2-43e5-87b1-7627d92acbd2"
      decimals="-2"
      id="F_c4d21d01-77f3-469f-846d-6ab9b487ca45"
      unitRef="U_USD">8500</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="0"
      id="F_8eed979b-b021-46e4-b7b9-df9446122f3f"
      unitRef="U_shares">6173565</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <inva:CommonStockAcquiredAverageCostPerShare
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="2"
      id="F_bd008c01-c1a9-47ce-ae59-df050cc06a85"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.39</inva:CommonStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_c5d2b484-c130-40da-a3ce-df08236a2ace"
      decimals="-5"
      id="F_2dc19806-f2c1-4179-a6f5-dbd5e1b24bf3"
      unitRef="U_USD">76500000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="C_46be4ed0-3a6f-42b0-b192-15f206bf7393"
      decimals="INF"
      id="F_1f15d507-350c-4a42-b78c-e7b233808f22"
      unitRef="U_shares">986928</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <inva:CommonStockAcquiredAverageCostPerShare
      contextRef="C_46be4ed0-3a6f-42b0-b192-15f206bf7393"
      decimals="2"
      id="F_467dcf97-ffe6-46d9-91ad-6c7dc33f3d21"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.12</inva:CommonStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="C_46be4ed0-3a6f-42b0-b192-15f206bf7393"
      decimals="-5"
      id="F_95487564-655f-47f6-8207-92ca0ff5d290"
      unitRef="U_USD">14900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="C_298130f5-8670-42be-853c-8278eb64b931"
      decimals="-5"
      id="F_3c29e387-ac9e-4e75-94b2-1d0272b4c5db"
      unitRef="U_USD">393800000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_eb36e7bc-1a6a-42d7-a274-827904c9c76a">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12. DEBT&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our debt consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;453,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;453,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;Less: Unamortized debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,266&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;448,344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446,234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;Less: Current portion of long-term debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total long-term debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;256,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446,234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Subordinated Notes Due 2023&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In January 2013, we completed an underwritten public offering of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million aggregate principal amount of our 2023 Notes, which matured on January 15, 2023. The 2023 Notes bore interest at the rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.125&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per year that is payable semi-annually in arrears in cash on January 15 and July 15 of each year, beginning on July 15, 2013.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2023 Notes were convertible, at the option of the holder, into shares of our common stock at an initial conversion rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.9903&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares per $1,000 principal amount of the 2023 Notes, subject to adjustment in certain circumstances, which represented an initial conversion price of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.79&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the offering of the 2023 Notes, we entered into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; privately negotiated capped call option transactions with a single counterparty. The capped call option transaction was an integrated instrument consisting of a call option on our common stock purchased by us with a strike price equal to the initial conversion price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.79&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for the underlying number of shares and a cap price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, both of which were subject to adjustments consistent with the 2023 Notes. The cap component was economically equivalent to a call option sold by us for the underlying number of shares with an initial strike price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. As an integrated instrument, the settlement of the capped call coincided with the due date of the convertible debt. Upon settlement, we would receive from our hedge counterparty a number of shares of our common shares that would range from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, if the stock price was below $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.79&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, to a maximum of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,779,659&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, if the stock price was above $38.00 per share. However, if the market price of our common stock, as measured under the terms of the capped call transactions, exceeded $38.00 per share, there was no incremental anti-dilutive benefit from the capped call.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of the partial conversion by certain holders of the 2023 Notes in July 2014, and dividends declared and paid in 2014 and 2015, the conversion rate with respect to our 2023 Notes was adjusted in total to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.5818&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our common stock per $1,000 principal amount of the 2023 Notes, which represented a conversion price of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.77&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. As a result of the conversion rate adjustments, the capped call strike price and cap price were also adjusted to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.77&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.04&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the year ended December 31, 2016, we retired a portion of our 2023 Notes with a face value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and carrying value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million by way of purchase in the open market.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 7, 2022, we used $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;165.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from the sale of the 2028 Notes to repurchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the 2023 Notes with a face value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The carrying value of the repurchased 2023 Notes was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Accrued interest was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and unamortized debt issuance costs were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on the date of repurchase. We recognized a loss on the extinguishment of the 2023 Notes of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in other expense, net, in the consolidated statement of operations. The repurchase reduced the outstanding principal balance to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and unamortized debt issuance costs to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The annual effective interest rate of the 2023 Notes changed from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.36&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.37&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 18, 2022, certain 2023 Notes holders converted their notes of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand into Innoviva&#x2019;s common stock. The outstanding principal balance was reduced slightly to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. This remaining balance was fully paid upon the maturity date in January 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth total interest expense recognized related to the 2023 Notes for the years ended December 31, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2023 and 2022:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:61.216%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.779%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.614%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.779%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.614%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total interest and amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,919&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Senior Notes Due 2025&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 7, 2017, we completed a private placement of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million aggregate principal amount of our 2025 Notes. The proceeds include the 2025 Notes sold pursuant to the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million over-allotment option granted by us to the initial purchasers, which option was exercised in full. The 2025 Notes were sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2025 Notes are senior unsecured obligations and bear interest at a rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per year, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2018.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2025 Notes are convertible, based on the applicable conversion rate, into cash, shares of our common stock or a combination thereof, at our election. The initial conversion rate for the 2025 Notes is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57.9240&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our common stock per $1,000 principal amount of the 2025 Notes (which is equivalent to an initial conversion price of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.26&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), representing a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% conversion premium over the last reported sale price of the Company&#x2019;s common stock on August 1, 2017, which was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The conversion rate is subject to customary anti-dilution adjustments in certain circumstances. The 2025 Notes will mature on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;August 15, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, unless repurchased or converted in accordance with their terms prior to such date. Prior to February 15, 2025, the 2025 Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, as described below. From, and including, February 15, 2025, until the close of business on the second scheduled trading day immediately preceding the maturity date, the 2025 Notes will be convertible at any time.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Holders of the 2025 Notes may convert all or a portion of their 2025 Notes prior to the close of business on February 15, 2025 only under the following circumstances:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;after September 30, 2017, if our closing common stock price for at least 20 days out of the most recent 30 consecutive trading days of the preceding quarter is greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the current conversion price of the 2025 Notes;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for five consecutive business days, if the average trading price per $1,000 of Notes during the prior 10 consecutive trading days is less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the product of our closing common stock price and the conversion rate of the 2025 Notes on such day; and,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental changes (as defined in the indenture governing the 2025 Notes) or a transaction resulting in our common stock converting into other securities or property or assets. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On or after February 15, 2025, holders of the 2025 Notes may convert their 2025 Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2025 Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the event of default or a fundamental change (as defined above), holders of the 2025 Notes may require us to repurchase all or a portion of their 2025 Notes at price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Effective January 1, 2022, we adopted ASU 2020-06 using a modified retrospective method, under which financial results reported in prior periods were not adjusted.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Prior to the adoption of ASU 2020-06, we separately accounted for the liability and equity components of the 2025 Notes by allocating the proceeds between the liability component and the embedded conversion option (&#x201c;equity component&#x201d;) due to our ability to settle the conversion obligation of the 2025 Notes in cash, common stock or a combination of cash and common stock, at our option. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature using the income approach. The allocation was performed in a manner that reflected our non-convertible debt borrowing rate for similar debt. The equity component of the 2025 Notes of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;was recognized as a debt discount and represents the difference between the proceeds from the issuance of the 2025 Notes and the fair value of the liability of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2025 Notes on the date of issuance. The excess of the principal amount of the liability component over its carrying amount (&#x201c;debt discount&#x201d;) was amortized to interest expense using the effective interest method over the term of the 2025 Notes. The equity component was not remeasured as long as it continued to meet the conditions for equity classification. Additionally, we separated the total issuance costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million incurred into liability and equity components in proportion to the allocation of the initial proceeds, resulting in liability issuance costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and equity issuance costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Issuance costs attributable to the liability component were amortized on a straight-line basis, which approximated the effective interest rate method, to interest expense over the term of the 2025 Notes. The issuance costs attributable to the equity component were netted against the equity component in additional paid-in capital. The annual effective interest rate of the liability component of the 2025 Notes was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.87&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon adoption of ASU 2020-06 on January 1, 2022, we combined the liability and equity components of the 2025 Notes assuming that the instrument was accounted for as a single liability from inception to the date of adoption. We similarly combined the liability and equity components of the issuance costs. The issuance costs are presented as a deduction from the outstanding principal balance of the 2025 Notes and are amortized on a straight-line basis over the term of the 2025 Notes under the effective interest rate method. Beginning January 1, 2022, the annual effective interest rate on the 2025 Notes is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.88&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our outstanding 2025 Notes balances consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Principal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Debt discount and issuance costs, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;472&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,205&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;191,295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth total interest expense recognized related to the 2025 Notes for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total interest and amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,505&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Senior Notes Due 2028&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In March 2022, we completed a private placement of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million aggregate principal amount of our 2028 Notes, which will mature on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 15, 2028&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The proceeds include the 2028 Notes sold pursuant to the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million over-allotment option granted by us to the initial purchasers, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was exercised. The 2028 Notes were sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The net proceeds from the sale of the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million aggregate principal amount of 2028 Notes were approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;252.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting the initial purchasers&#x2019; discounts and commissions and our estimated offering expenses. We used approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the net proceeds from the offering to fund the cost of entering into the capped call transactions described below. In addition, we used $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;165.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the remaining net proceeds to repurchase $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million aggregate principal amount of the 2023 Notes in separate and individually negotiated transactions with certain holders of the 2023 Notes, which closed concurrently with the issuance of the 2028 Notes. We expect to use the remaining net proceeds for general corporate purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2028 Notes bear interest at an annual rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.125&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% that is payable semi-annually in arrears in cash on March 15 and September 15 of each year, beginning on September 15, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2028 Notes are convertible, based on the applicable conversion rate, into cash, shares of our common stock or a combination thereof, at our election. The initial conversion rate was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.1432&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares per $1,000 principal amount of the 2028 Notes, subject to customary anti-dilution adjustment in certain circumstances, which represented an initial conversion price of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26.22&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to September 15, 2027, the 2028 Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, and will be convertible on or after September 15, 2027, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2028 Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Holders of the 2028 Notes may convert all or a portion of their 2028 Notes prior to the close of business on September 15, 2027, only under the following circumstances:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;after March 31, 2022, if our closing common stock price for at least 20 days out of the most recent 30 consecutive trading days of the preceding quarter is greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the current conversion price of the 2028 Notes;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for five consecutive business days, if the average trading price per $1,000 of Notes during the prior 10 consecutive trading days is less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the product of our closing common stock price and the conversion rate of the 2028 Notes on such day; and,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental changes (as defined in the indenture governing the 2028 Notes) or a transaction resulting in our common stock converting into other securities or property or assets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On or after September 15, 2027, holders of the 2028 Notes may convert their 2028 Notes at any time until the close of the business on the second day immediately preceding the maturity date of the 2028 Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2028 Notes will be redeemable, in whole or in part, at our option at any time, and from time to time, on or after March 20, 2025, and on or before the 75th scheduled trading day immediately before the maturity date but only if the last reported sale price per share of our common stock exceeds 130% of the conversion price for a specified period of time. The redemption price will be equal to the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, calling any 2028 Note for redemption will constitute a make-whole fundamental change (as defined in the indenture governing the 2028 Notes) with respect to that 2028 Note, in which case the conversion rate applicable to the conversion of that 2028 Note will be increased in certain circumstances if it is converted after it is called for redemption.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If we undergo a fundamental change, subject to certain conditions, holders may require us to purchase for cash all or any portion of their 2028 Notes. The fundamental change purchase price will be &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the principal amount of the 2028 Notes to be purchased plus any accrued and unpaid interest to, but excluding, the fundamental change purchase date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The indenture governing the 2028 Notes contains customary terms and covenants, including a merger covenant and that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Notes to be due and payable immediately.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions. The cap price of the capped call transaction is initially $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.9850&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and is subject to certain adjustments under the terms of the capped call transactions. The capped call transactions cover, subject to customary adjustments, the number of shares of common stock initially underlying the 2028 Notes. The capped call transactions are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes or at our election (subject to certain conditions) offset any cash payments we are required to make in excess of the aggregate principal amount of converted 2028 Notes, as the case may be, with such reduction or offset subject to a cap.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The annual effective interest rate on the 2028 Notes is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.70&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our outstanding 2028 Notes balance consisted of th&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Principal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Debt discount and issuance costs, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,684&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;256,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;254,939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth total interest expense recognized related to the 2028 Notes for the years ended December 31, 2024,  2023, and from the issuance through December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Date of Issuance Through&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total interest and amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt Maturities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The aggregate scheduled maturities of our convertible debt as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;453,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Royalty Obligation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of our acquisition of La Jolla, we recorded the fair value of its deferred royalty obligation in connection with La Jolla&#x2019;s royalty financing agreement (&#x201c;La Jolla Royalty Agreement&#x201d;) with HealthCare Royalty Partners (&#x201c;HCR&#x201d;). Under the terms of the La Jolla Royalty Agreement, HCR is entitled to receive quarterly royalties on worldwide net sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; until either January 1, 2031 or when the maximum aggregate royalty payments have been made, whichever occurs first. Quarterly payments to HCR under the Royalty Agreement start at a maximum royalty rate, with step-downs based on the achievement of annual net product sales thresholds. The maximum royalty rate through December 31, 2023 was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Starting January 1, 2024, the maximum royalty rate was increased to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% based on the terms of the Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The La Jolla Royalty Agreement is subject to maximum aggr&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;egate royalty payments to HCR of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the years ended December 31, 2024 and 2023, we recognized interest expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, on the deferred royalty obligation. From the date of our acquisition of La Jolla through December 31, 2022, we recognized interest expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on the deferred royalty obligation. The carrying value of the deferred royalty obligation as of December 31, 2024 and 2023 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, (refer to Note 9 &#x201c;Balance Sheet Components&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;). During the years ended December 31, 2024 and 2023, we made royalty payments to HCR of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. From the date of acquisition of La Jolla through December 31, 2022, we made royalty payments to HCR of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The deferred royalty obligation was valued using Level 3 inputs, and its carrying value as of December 31, 2024 and 2023 approximates fair value. The fair&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;value &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the deferred royalty obligation was calculated as the discounted deferred royalty obligations based on revenue projections for GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of December 31, 2024, the annual effective interest rate of the deferred royalty obligation is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.44&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the terms of the La Jolla Royalty Agreement, if we are unable to meet certain obligations, including the obligation to use commercially reasonable and diligent efforts to commercialize GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, HCR would have the right to terminate the La Jolla Royalty Agreement and demand payment of either $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million or $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (depending on which obligation we have failed to meet) less aggregate royalties already paid to HCR. As of December 31, 2024, inclusive of the aggregate royalties paid to HCR by La Jolla under the La Jolla Royalty Agreement prior to our acquisition, La Jolla paid $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;aggregate royalties to HCR. In the event that we fail to pay such amount if and when due in a timely manner, HCR would have the right to foreclose on the GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;-related assets. HCR has no recourse against any asset other than GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain contract provisions within the La Jolla Royalty Agreement that could result in an acceleration of amounts due under the La Jolla Royalty Agreement are recognized as embedded derivatives that require bifurcation from the deferred royalty obligation and fair value recognition. We determined the fair value of each derivative by assessing the probability of each event occurring, as well as the potential repayment amounts and timing of such repayments that would result under various scenarios. As a result of this assessment, we determined that the fair value of the embedded derivatives is immaterial and, therefore, not recognized as of December 31, 2023 and 2022. We estimate the fair value of the embedded derivatives for each reporting period until either the features lapse or the La Jolla Royalty Agreement is terminated, whichever occurs first. Any material change in the fair value of the embedded derivatives will be recorded as either a gain or loss in the consolidated statements of income.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_ac7d110e-442c-47ff-ab48-b3871af31485">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our debt consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;453,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;453,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;Less: Unamortized debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,266&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;448,344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446,234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&#160;&#160;Less: Current portion of long-term debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total long-term debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;256,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446,234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441"
      decimals="-3"
      id="F_75ce4a83-e91a-42a2-b32f-74c57450bb6d"
      unitRef="U_USD">192500000</inva:DebtInstrumentPrincipalAmount>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c"
      decimals="-3"
      id="F_ddb7e79f-5101-41ac-b5cb-1e2a963917a4"
      unitRef="U_USD">192500000</inva:DebtInstrumentPrincipalAmount>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6"
      decimals="-3"
      id="F_6adf6eff-c582-4000-ab97-c7dcff6cf1f4"
      unitRef="U_USD">261000000</inva:DebtInstrumentPrincipalAmount>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9"
      decimals="-3"
      id="F_5c2aa834-95b8-424d-a74d-1fcc75a2b807"
      unitRef="U_USD">261000000</inva:DebtInstrumentPrincipalAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_23a6ddb6-0876-4cb2-8a4f-ef52321da7b3"
      unitRef="U_USD">453500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_075d984f-0e4c-4326-a934-8c0929a9ba9f"
      unitRef="U_USD">453500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a22d033b-c5b4-4ce1-b368-0225c84fa04d"
      unitRef="U_USD">5156000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_bd5d39c3-9500-4036-869b-8a4b334edfae"
      unitRef="U_USD">7266000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e42b33e8-8ab1-43a6-ab62-ea820f3be6c2"
      unitRef="U_USD">448344000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_d02c596c-8c4b-4b7f-82ea-542cdda045bd"
      unitRef="U_USD">446234000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_43b02dea-4d60-481e-97ea-a613b565de6e"
      unitRef="U_USD">192028000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_5dfdc9e2-d128-454e-a603-03c2a9eaf87d"
      unitRef="U_USD">0</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_7fe2c6c2-a318-4725-a8e1-c1a2eac9bf1f"
      unitRef="U_USD">256316000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_5d515821-77c0-4daf-b74f-38423fe761fe"
      unitRef="U_USD">446234000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_d8729dff-3a5c-4dcc-af0c-979774e25169"
      decimals="-5"
      id="F_9a88c4c0-1f67-485c-ae5c-d050701791e0"
      unitRef="U_USD">287500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_d8729dff-3a5c-4dcc-af0c-979774e25169"
      decimals="5"
      id="F_4a5e30aa-2b01-463a-a37b-4ee4949ca0c1"
      unitRef="U_pure">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_4c9bc9df-24d5-48aa-a746-0482bc1e814c"
      decimals="4"
      id="F_dca08aca-57ea-4729-99c5-8c1f395a2dec"
      unitRef="U_pure">35.9903</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_3a11ad05-9798-4623-a6d9-25f61cd44da6"
      decimals="2"
      id="F_5f1d9608-c611-422d-bb0c-56f5dd1ca724"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.79</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <inva:NumberOfDerivativeInstrumentsPurchased
      contextRef="C_25c30b00-13bd-4d27-89b6-199993a5cac6"
      decimals="0"
      id="F_ea841b57-0e4a-4d56-ab21-687711731d32"
      unitRef="U_Item">2</inva:NumberOfDerivativeInstrumentsPurchased>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_05049684-518e-4c68-a36a-97efe8235878"
      decimals="2"
      id="F_3ec3a8dc-042f-40d3-b65f-1a8f5e219532"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.79</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_c40ea3a9-5b51-4fd2-a6f2-387235c72fe8"
      decimals="2"
      id="F_6568997e-c157-4909-92e3-ca4a6890be55"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">38</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_c40ea3a9-5b51-4fd2-a6f2-387235c72fe8"
      decimals="2"
      id="F_259b111e-fb64-4c07-a5d2-8901876d1379"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">38</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <inva:NumberOfSharesReceivableOnSettlementOfDerivativeInstrument
      contextRef="C_d2d0990f-b4c3-4288-a88d-e7a8d66b2f3f"
      decimals="0"
      id="F_82b87417-252a-485f-98f9-9a3cc435ab76"
      unitRef="U_shares">0</inva:NumberOfSharesReceivableOnSettlementOfDerivativeInstrument>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_05049684-518e-4c68-a36a-97efe8235878"
      decimals="2"
      id="F_89aef650-7118-447d-a33f-3ed6869ee727"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.79</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <inva:NumberOfSharesReceivableOnSettlementOfDerivativeInstrument
      contextRef="C_a275ece4-9863-4cde-b812-6441e2e5af07"
      decimals="0"
      id="F_997511d9-0d9c-4d81-be83-eca4e2ff6941"
      unitRef="U_shares">2779659</inva:NumberOfSharesReceivableOnSettlementOfDerivativeInstrument>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_53205d86-091a-45ec-875f-153f734c0c7b"
      decimals="4"
      id="F_9195a39a-d792-44e7-94fa-169ed0f0f0cc"
      unitRef="U_pure">50.5818</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_cfb60dba-9194-465f-961c-11b864f3bdc4"
      decimals="2"
      id="F_184086f6-6776-425b-9ed1-9498d5ce8044"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.77</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_dcb22e50-3b63-484c-8bca-4d66021e8210"
      decimals="2"
      id="F_8740b220-3931-47e9-8fa0-183a1d3a4a85"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.77</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_69bb9340-c11c-45f9-89b5-1eff93f82a71"
      decimals="2"
      id="F_6e751bf9-013f-4b27-b712-b8e7d2b456ce"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.04</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="C_703323c3-fcbe-41ac-9f9b-28b43c769909"
      decimals="-5"
      id="F_ff89e749-8d85-4a73-aaf3-db4bfd216298"
      unitRef="U_USD">14100000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="C_703323c3-fcbe-41ac-9f9b-28b43c769909"
      decimals="-5"
      id="F_42259109-6001-4006-8073-8f22da2520ad"
      unitRef="U_USD">13900000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992"
      decimals="-5"
      id="F_649584df-cd7c-487f-8df5-0d792d46c6f9"
      unitRef="U_USD">165600000</us-gaap:RepaymentsOfUnsecuredDebt>
    <inva:DebtInstrumentRepurchasePercentage
      contextRef="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992"
      decimals="2"
      id="F_ed075219-2e8a-46ba-a9c9-c367a36f5d23"
      unitRef="U_pure">0.60</inva:DebtInstrumentRepurchasePercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220"
      decimals="-5"
      id="F_3fea30da-24e9-4f90-8351-7739d19d78c4"
      unitRef="U_USD">144800000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220"
      decimals="-5"
      id="F_a93c72f8-26ea-409c-bfdc-557d4e6b7b56"
      unitRef="U_USD">144500000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:InterestPayableCurrent
      contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220"
      decimals="-5"
      id="F_81576866-06e7-4689-b27c-4bf68d29fb62"
      unitRef="U_USD">400000</us-gaap:InterestPayableCurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220"
      decimals="-5"
      id="F_1a28fb5f-dd7a-4d16-a9a8-ae634e1fdb69"
      unitRef="U_USD">300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_526961f8-9b87-4a00-b2d2-c5e8c37c1992"
      decimals="-5"
      id="F_287d5ed7-fa9f-41f8-9588-6f803be5b719"
      unitRef="U_USD">-20700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220"
      decimals="-5"
      id="F_632d5367-fd05-4a8f-ba7d-f5422edc2323"
      unitRef="U_USD">96200000</inva:DebtInstrumentPrincipalAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_f0562001-bb86-4a5b-b298-0510200a8220"
      decimals="-5"
      id="F_4cce0402-7a96-475b-9d12-0b7f16f0c084"
      unitRef="U_USD">200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_6eebba42-5bd2-4b1d-add7-2b9166a45342"
      decimals="4"
      id="F_5ebb008b-e6b0-4f7e-920c-b4b1f8ecc35a"
      unitRef="U_pure">0.0236</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_f6aacb7c-354f-4850-845b-699f73b3eb83"
      decimals="4"
      id="F_89bf768a-6198-4dad-a80b-df1dbeb782a4"
      unitRef="U_pure">0.0237</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_cd2bdc94-0cda-4896-afe6-51e360f119eb"
      decimals="-2"
      id="F_7a5a5066-622e-4cd1-9f02-ae76968209a0"
      unitRef="U_USD">3000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_5a824dc9-4da6-4578-80c3-146747709b51"
      decimals="-5"
      id="F_e162dab2-7f38-4c67-a065-5e142496f4fc"
      unitRef="U_USD">96200000</inva:DebtInstrumentPrincipalAmount>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="C_7530273c-e395-47f6-b8ce-a7265c4b1b91"
      id="F_7614b8e4-51cc-4bcd-8378-2b8a8d8e1a88">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth total interest expense recognized related to the 2023 Notes for the years ended December 31, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2023 and 2022:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:61.216%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.779%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.614%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.779%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.614%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total interest and amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,919&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_8f319834-0192-44bb-82e6-228a046acebe"
      decimals="-3"
      id="F_5ff93b1a-d3d5-4441-8e58-7d9abcb5eb08"
      unitRef="U_USD">85000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8"
      decimals="-3"
      id="F_446c5ad2-2e2b-4d19-be86-7c17d9caac3f"
      unitRef="U_USD">2617000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_8f319834-0192-44bb-82e6-228a046acebe"
      decimals="-3"
      id="F_6a218a6f-2db6-4027-865f-6b1d5dd3ae69"
      unitRef="U_USD">11000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8"
      decimals="-3"
      id="F_8654f4a0-c890-4253-8aa7-715267e5decb"
      unitRef="U_USD">302000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="C_8f319834-0192-44bb-82e6-228a046acebe"
      decimals="-3"
      id="F_2fdeb87a-85db-4170-8719-009eee790289"
      unitRef="U_USD">96000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_dc88ef63-248a-4ccc-afd0-7251cb5151d8"
      decimals="-3"
      id="F_38c17918-19d6-4f84-8d9a-6685ffda5674"
      unitRef="U_USD">2919000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_f219ac17-5f54-4a96-ad2c-f5c9f69dae24"
      decimals="-5"
      id="F_be0a71c9-7310-42c5-8218-51ea2f51deaa"
      unitRef="U_USD">192500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_f7e50e8e-4e3b-4cb4-86fd-601d62aa2908"
      decimals="-5"
      id="F_f50a8b4f-e482-4dcb-9aee-063d41943d71"
      unitRef="U_USD">17500000</us-gaap:DebtInstrumentFaceAmount>
    <inva:PortionOfDebtInstrumentFaceAmountExercised
      contextRef="C_f7e50e8e-4e3b-4cb4-86fd-601d62aa2908"
      decimals="-5"
      id="F_cbc24b7f-2267-4d72-8e54-c760807f8f5e"
      unitRef="U_USD">17500000</inva:PortionOfDebtInstrumentFaceAmountExercised>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_f219ac17-5f54-4a96-ad2c-f5c9f69dae24"
      decimals="3"
      id="F_7d21e5a9-2c61-47db-b97f-6e9bb3d60361"
      unitRef="U_pure">0.025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_7f207f6a-98e7-439a-bc04-1d2e8566d922"
      decimals="4"
      id="F_0d9ceb0e-92ba-4368-b479-84272e397896"
      unitRef="U_pure">57.924</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_7145555a-225b-40f5-a4c1-17e76939a86d"
      decimals="2"
      id="F_40b648e5-fafa-4936-aa2f-6d44ba9531ea"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">17.26</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <inva:DebtInstrumentConvertibleConversionPremium
      contextRef="C_7145555a-225b-40f5-a4c1-17e76939a86d"
      decimals="3"
      id="F_e82d1242-fb9f-4189-abf1-e2d8602ed6c9"
      unitRef="U_pure">0.30</inva:DebtInstrumentConvertibleConversionPremium>
    <us-gaap:SharePrice
      contextRef="C_66693642-95da-475a-a4b4-59d4ac42aae1"
      decimals="2"
      id="F_697ce70e-c604-4e49-bc05-c55d81242aac"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.28</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_7f207f6a-98e7-439a-bc04-1d2e8566d922"
      id="F_7f3a1115-8d0b-4b9e-bd62-a29385576993">2025-08-15</us-gaap:DebtInstrumentMaturityDate>
    <inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="2"
      id="F_d18c4d75-d314-4559-a32c-bf7dce9c22aa"
      unitRef="U_pure">1.30</inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage>
    <inva:DebtConversionConvertedInstrumentAverageTradePricePercentage
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="2"
      id="F_ac30c096-74ef-406f-9195-384380aacc73"
      unitRef="U_pure">0.98</inva:DebtConversionConvertedInstrumentAverageTradePricePercentage>
    <inva:DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount
      contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648"
      decimals="2"
      id="F_c904243f-1b98-4922-b2a2-8f54f3552ab1"
      unitRef="U_pure">1</inva:DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_00161e2a-7110-4a94-93a4-53229f1f240f"
      decimals="-5"
      id="F_2f6f94e2-f82b-461f-9d27-f7da46794759"
      unitRef="U_USD">67300000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="-5"
      id="F_b2c0764f-ca63-4cb4-8c3f-790ea71e80d2"
      unitRef="U_USD">5400000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="-5"
      id="F_f04f137e-18fc-49b8-ba1d-b1ef06dc691e"
      unitRef="U_USD">3500000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      decimals="-5"
      id="F_c5b52997-08dd-4818-9f2d-33c962675111"
      unitRef="U_USD">1900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_a2ca99e3-4ee8-4e98-ac8e-a7fbab801fde"
      decimals="4"
      id="F_2400a7f2-d5f8-473e-b1fd-1d4f7edf7656"
      unitRef="U_pure">0.0887</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_03ca5b08-65b3-4660-b083-f365e311c479"
      decimals="4"
      id="F_09f223a6-cce3-4266-9b0e-cb750b9c548e"
      unitRef="U_pure">0.0288</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      id="F_548b439f-6091-418e-8554-708bf8dee293">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our outstanding 2025 Notes balances consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.799999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Principal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Debt discount and issuance costs, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;472&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,205&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;191,295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441"
      decimals="-3"
      id="F_c609b121-7589-4e51-960a-87dda3749d52"
      unitRef="U_USD">192500000</inva:DebtInstrumentPrincipalAmount>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c"
      decimals="-3"
      id="F_3fa7996a-7a65-4b3d-8cd8-57f9bc353157"
      unitRef="U_USD">192500000</inva:DebtInstrumentPrincipalAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441"
      decimals="-3"
      id="F_36bb787f-0bd8-43f4-974a-93b9b84deb62"
      unitRef="U_USD">472000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c"
      decimals="-3"
      id="F_7d274aa7-aa01-4a49-ba34-dff875272229"
      unitRef="U_USD">1205000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="C_e98b3d3d-da85-482c-b5f8-1a935c74d441"
      decimals="-3"
      id="F_ef267a8c-f8c2-4d74-9960-b1afc9fd3bb4"
      unitRef="U_USD">192028000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="C_ff731cd1-588f-4206-9930-a5931aa2f59c"
      decimals="-3"
      id="F_16d09e1a-4fda-4a3f-ad18-7306a9775a36"
      unitRef="U_USD">191295000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="C_6c32ce61-be0a-4a4a-a440-b6d704139bad"
      id="F_88b3d759-e1af-4b3a-9a50-b7626e22678a">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth total interest expense recognized related to the 2025 Notes for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total interest and amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,505&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648"
      decimals="-3"
      id="F_f9c7d341-eb05-45bf-85d6-7c13e5f9ec4f"
      unitRef="U_USD">4813000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_bdd67f19-2199-47ba-9bf2-29f87af012ba"
      decimals="-3"
      id="F_14c2149a-368c-4c5b-96d1-36820b0a7daf"
      unitRef="U_USD">4813000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc"
      decimals="-3"
      id="F_85627261-8553-4b5c-8c83-9cf299db2fea"
      unitRef="U_USD">4813000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648"
      decimals="-3"
      id="F_760e16a3-9f72-4f51-b83f-bb4966bf16f5"
      unitRef="U_USD">733000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_bdd67f19-2199-47ba-9bf2-29f87af012ba"
      decimals="-3"
      id="F_490b2737-85de-4090-a9fb-3dc275c6bbb7"
      unitRef="U_USD">712000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc"
      decimals="-3"
      id="F_f3667ceb-6b0a-4f28-b471-0c17d8808ee1"
      unitRef="U_USD">692000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="C_25c97c79-da0b-4ed4-9fc7-0cd122be4648"
      decimals="-3"
      id="F_9fdf89c6-b910-4352-bb13-fb8833902df9"
      unitRef="U_USD">5546000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_bdd67f19-2199-47ba-9bf2-29f87af012ba"
      decimals="-3"
      id="F_821a42a3-76af-4636-811f-b57866ae5e94"
      unitRef="U_USD">5525000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_a07f3d08-7b48-40f6-9981-acf718a1ecdc"
      decimals="-3"
      id="F_2dd53857-fe55-4076-9b9c-ae3147ca88db"
      unitRef="U_USD">5505000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_4c137836-1d57-48b3-b853-5989053266bc"
      decimals="-5"
      id="F_f0fde742-e28f-487c-9191-0ea9e6405dc4"
      unitRef="U_USD">261000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968"
      id="F_3a08eb5b-95de-45e4-9f64-e314a27f0c2a">2028-03-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_bb32bb34-0f53-47f4-9801-880f4c57c7c4"
      decimals="-5"
      id="F_5e0c64a4-cf87-4fb3-b12e-24f9961e407f"
      unitRef="U_USD">45000000</us-gaap:DebtInstrumentFaceAmount>
    <inva:PortionOfDebtInstrumentFaceAmountExercised
      contextRef="C_bb32bb34-0f53-47f4-9801-880f4c57c7c4"
      decimals="-5"
      id="F_e6508ed3-901b-4c93-ac6b-ac5677155dcc"
      unitRef="U_USD">36000000</inva:PortionOfDebtInstrumentFaceAmountExercised>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_4c137836-1d57-48b3-b853-5989053266bc"
      decimals="-5"
      id="F_6a857ad4-8334-4cf9-af33-83945228de58"
      unitRef="U_USD">261000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968"
      decimals="-5"
      id="F_241ca83d-89e4-4075-ada9-6cdaa1fdd355"
      unitRef="U_USD">252600000</us-gaap:ProceedsFromConvertibleDebt>
    <inva:CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes
      contextRef="C_03d49736-400f-4d83-9c8a-949362d73529"
      decimals="-5"
      id="F_370babbc-c61d-4cf6-ae0a-2ae5dee2124c"
      unitRef="U_USD">21000000</inva:CostToEnterIntoCappedCallsSalesInConnectionWithConvertibleSeniorNotes>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="C_7c241491-c363-4e26-b334-863eae0dae59"
      decimals="-5"
      id="F_0b7ae553-c408-4afa-b2c9-26480d1dbc8c"
      unitRef="U_USD">165600000</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="C_b5459326-64cc-447b-92d0-447df34b0037"
      decimals="-5"
      id="F_e892e12a-e989-4c36-8a4f-1d103d81b30c"
      unitRef="U_USD">144800000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_c2bdcfd8-c2f9-4e33-9a58-4dc78da2e693"
      decimals="5"
      id="F_5a46150f-586b-4961-a1e7-23238fa94905"
      unitRef="U_pure">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_25328d2c-092e-4651-9c58-eeb1fa6d99e9"
      decimals="4"
      id="F_018d3804-fe74-4460-b891-173c4bd5bbe9"
      unitRef="U_pure">38.1432</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_4e5991ec-66d1-4584-84f0-5ad5de0d9c80"
      decimals="2"
      id="F_7c7e3d1f-19da-46c8-adcd-fbf0664ae2da"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">26.22</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage
      contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968"
      decimals="2"
      id="F_045a7799-823b-4eb5-bec6-6ed12078f7c5"
      unitRef="U_pure">1.30</inva:DebtConversionCommonStockPriceToConversionPriceRatioPercentage>
    <inva:DebtConversionConvertedInstrumentAverageTradePricePercentage
      contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968"
      decimals="2"
      id="F_88563c3f-ce0b-4b06-86a9-976890d9c6e3"
      unitRef="U_pure">0.98</inva:DebtConversionConvertedInstrumentAverageTradePricePercentage>
    <inva:DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount
      contextRef="C_8510eaea-441e-49f3-858f-a2231a38d968"
      decimals="2"
      id="F_109c374d-023c-4d01-b66a-5e334f004059"
      unitRef="U_pure">1</inva:DebtInstrumentRatioOfRepurchasePriceToThePrincipalAmount>
    <us-gaap:LineOfCreditFacilityCovenantTerms
      contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8"
      id="F_fdfd3327-733d-4307-9e1d-8add12aa01cd">The indenture governing the 2028 Notes contains customary terms and covenants, including a merger covenant and that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Notes to be due and payable immediately.</us-gaap:LineOfCreditFacilityCovenantTerms>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="C_f3ad801f-e4a3-4bf5-9d54-b9f1f833c093"
      decimals="4"
      id="F_3267d2ed-ab38-4b70-ac12-8f913ca30081"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">33.985</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6"
      decimals="4"
      id="F_2dc65869-d084-46f8-8024-b91bd114cba9"
      unitRef="U_pure">0.027</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8"
      id="F_5c65e906-305e-4493-a366-72984682dcf8">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our outstanding 2028 Notes balance consisted of th&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Principal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Debt discount and issuance costs, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,684&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;256,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;254,939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6"
      decimals="-3"
      id="F_31655a4c-9e55-407f-ac91-116382946781"
      unitRef="U_USD">261000000</inva:DebtInstrumentPrincipalAmount>
    <inva:DebtInstrumentPrincipalAmount
      contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9"
      decimals="-3"
      id="F_7b70cb1c-d6a7-49fd-b90f-4e0ab4375fc3"
      unitRef="U_USD">261000000</inva:DebtInstrumentPrincipalAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6"
      decimals="-3"
      id="F_9b1afe08-5083-4a83-a4de-37055e90cf1c"
      unitRef="U_USD">4684000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9"
      decimals="-3"
      id="F_6ef467cf-f9e1-4406-9cb7-07f4d8c745f2"
      unitRef="U_USD">6061000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="C_734bee53-194c-4c05-925f-5a7cf8d9acf6"
      decimals="-3"
      id="F_15619afb-bc1c-455a-8916-a7bd71647dc3"
      unitRef="U_USD">256316000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="C_fa8801d8-5027-478f-9bea-c736ae2dc7a9"
      decimals="-3"
      id="F_c8f62a28-0670-4476-bea6-cf5d306fd669"
      unitRef="U_USD">254939000</us-gaap:LongTermDebt>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="C_71a608ca-2150-43ff-9cf0-4b6bf9f137d8"
      id="F_332f31b9-0188-4e38-bb47-ee2a9a9d86f4">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth total interest expense recognized related to the 2028 Notes for the years ended December 31, 2024,  2023, and from the issuance through December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Date of Issuance Through&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total interest and amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_d9d9925a-2c03-40f4-86eb-cfacde988b24"
      decimals="-3"
      id="F_6f1103b4-0344-41a8-ba7d-639a7e77b7b5"
      unitRef="U_USD">5546000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_c18cffa1-9de9-4afa-a1e1-ba138e813757"
      decimals="-3"
      id="F_91816b6e-92cb-481d-965c-b331547072e9"
      unitRef="U_USD">5546000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_1335d490-17db-400b-806c-c3c9d364a039"
      decimals="-3"
      id="F_dece48b3-3ed3-4a3c-bdfb-19019be9cccc"
      unitRef="U_USD">4514000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_d9d9925a-2c03-40f4-86eb-cfacde988b24"
      decimals="-3"
      id="F_db619b73-f844-499b-b4c1-6355845d5ed6"
      unitRef="U_USD">1377000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_c18cffa1-9de9-4afa-a1e1-ba138e813757"
      decimals="-3"
      id="F_cddc3415-96fc-4c0e-811f-45f869f22ec5"
      unitRef="U_USD">1342000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_1335d490-17db-400b-806c-c3c9d364a039"
      decimals="-3"
      id="F_5fc535af-1b46-4efb-828e-88623d555799"
      unitRef="U_USD">1061000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="C_d9d9925a-2c03-40f4-86eb-cfacde988b24"
      decimals="-3"
      id="F_25808314-614e-4853-bb52-767d1f032e3f"
      unitRef="U_USD">6923000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_c18cffa1-9de9-4afa-a1e1-ba138e813757"
      decimals="-3"
      id="F_a84032af-faaa-434a-a888-9d3326fffcac"
      unitRef="U_USD">6888000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_1335d490-17db-400b-806c-c3c9d364a039"
      decimals="-3"
      id="F_35ea951a-47dd-406a-a6b4-b6bfff04711a"
      unitRef="U_USD">5575000</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_8cf58b6c-bc21-44cd-9e18-40dc323b62e5">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The aggregate scheduled maturities of our convertible debt as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;192,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;261,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;453,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_862aa8f9-bd98-431d-9391-1b34672e35f5"
      unitRef="U_USD">192500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_93d4f0b9-a608-464a-b43a-2a626aa9a480"
      unitRef="U_USD">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_064917e2-b9b5-4abe-bcc2-6bf7e491de83"
      unitRef="U_USD">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e0569c93-2054-4459-85c7-cccb938ef94f"
      unitRef="U_USD">261000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_afba9856-af19-40f7-8b62-8b7a29a92f58"
      unitRef="U_USD">453500000</us-gaap:DebtInstrumentCarryingAmount>
    <inva:RoyaltyAgreementMaximumPotentialPayoutPercent
      contextRef="C_985e040f-be7e-4757-85fe-32dfd0c9e971"
      decimals="2"
      id="F_8ac8e9df-fc9e-48e1-bf2a-235a2abe3388"
      unitRef="U_pure">0.14</inva:RoyaltyAgreementMaximumPotentialPayoutPercent>
    <inva:RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent
      contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa"
      decimals="2"
      id="F_c2c8c18b-0aa9-4cf6-a30b-179c645688ae"
      unitRef="U_pure">0.18</inva:RoyaltyAgreementIncreaseInMaximumPotentialPayoutPercent>
    <inva:MaximumAggregateRoyaltyPaymentsDue
      contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa"
      decimals="-5"
      id="F_56ed81cd-5d12-435c-ab2a-05d3b70096f1"
      unitRef="U_USD">225000000</inva:MaximumAggregateRoyaltyPaymentsDue>
    <us-gaap:InterestExpense
      contextRef="C_b581726d-66c2-491f-be47-b769ac4d4e1d"
      decimals="-5"
      id="F_4b677d94-38e6-4981-97eb-dd681ad0abe5"
      unitRef="U_USD">9800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_72ca4799-ff83-4650-a66f-e64646a8bbbd"
      decimals="-5"
      id="F_4b9d1799-7909-4458-9fc9-fe1636b88823"
      unitRef="U_USD">6500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_a995b915-50f7-4ebc-b58c-879c3902fff1"
      decimals="-5"
      id="F_70900131-7acc-4714-a18e-12a79ca77a86"
      unitRef="U_USD">1800000</us-gaap:InterestExpense>
    <inva:DeferredRoyaltyObligations
      contextRef="C_3baecf69-ebf5-4807-8356-b90a92791318"
      decimals="-5"
      id="F_ddae86cf-8e7a-40b2-84d5-a228fdb553d4"
      unitRef="U_USD">69500000</inva:DeferredRoyaltyObligations>
    <inva:DeferredRoyaltyObligations
      contextRef="C_11dc5ce4-6d0c-463a-81f6-6f26c160dbca"
      decimals="-5"
      id="F_fd23b317-6a64-4cbb-8cf1-b6d712c9b5c0"
      unitRef="U_USD">69900000</inva:DeferredRoyaltyObligations>
    <inva:RoyaltyPayments
      contextRef="C_b581726d-66c2-491f-be47-b769ac4d4e1d"
      decimals="-5"
      id="F_43cbb733-4e91-4f1d-ab6b-b92ce8e1a96b"
      unitRef="U_USD">9100000</inva:RoyaltyPayments>
    <inva:RoyaltyPayments
      contextRef="C_72ca4799-ff83-4650-a66f-e64646a8bbbd"
      decimals="-5"
      id="F_9b88a745-2109-4158-8fa9-6fd6bac858ca"
      unitRef="U_USD">5400000</inva:RoyaltyPayments>
    <inva:RoyaltyPayments
      contextRef="C_a995b915-50f7-4ebc-b58c-879c3902fff1"
      decimals="-5"
      id="F_276bde09-e41a-4d7e-b7b2-ca95c201ecd5"
      unitRef="U_USD">1000000</inva:RoyaltyPayments>
    <inva:InterestRateOfDeferredRoyaltyObligation
      contextRef="C_b581726d-66c2-491f-be47-b769ac4d4e1d"
      decimals="4"
      id="F_d3e1bd1d-3fa4-4fda-a15a-15aa017a4d8c"
      unitRef="U_pure">0.0944</inva:InterestRateOfDeferredRoyaltyObligation>
    <inva:RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne
      contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa"
      decimals="-5"
      id="F_9624bec2-3032-4de8-8db9-f95ddbbf3ad8"
      unitRef="U_USD">125000000</inva:RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentOne>
    <inva:RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo
      contextRef="C_18883a4e-3c50-4f05-b6d4-558b64a471aa"
      decimals="-5"
      id="F_e8e96e9f-c0f8-48b9-91ea-080ba0e7ad7a"
      unitRef="U_USD">225000000</inva:RoyaltyAgreementRequiredPaymentForBreachOfAgreementPaymentTwo>
    <inva:TotalPaymentsMadeForRoyaltyAgreement
      contextRef="C_f6bcc262-29e8-498c-850a-47d7bc746ddd"
      decimals="-5"
      id="F_81bccf4f-9107-49a8-ae15-400a4e98e347"
      unitRef="U_USD">27200000</inva:TotalPaymentsMadeForRoyaltyAgreement>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4b176a5a-7dac-4757-9c5a-9b7d91fbc9a8">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;13. COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Lease&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have operating leases for our corporate headquarters, office spaces and laboratory facilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2019, we entered into an operating lease for our headquarters in Burlingame, California for approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,111&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; rentable square feet. The lease commenced in November 2019 with an initial term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_df825393-b260-4cba-9ff7-9fc9a38e03d8;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;thirty-six&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; calendar months, which was subsequently amended to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_95673362-d782-4e32-804a-2d906541bf72;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our operating leases include a facility lease consisting of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Waltham, Massachusetts, which expires in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1f9d0b86-7ca1-4461-b3cf-41c5a7d463c7;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 2029&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of lease costs are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.863%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Straight line operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Supplemental cash flow information related to leases are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.863%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of &lt;br/&gt;&#160;&#160;&#160;operating lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,542&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease right-of-use assets obtained in exchange &lt;br/&gt;&#160;&#160;&#160;for operating lease obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,323&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets obtained through acquisitions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, our operating leases have weighted-average remaining term of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years and the weighted-average discount rate on our operating lease liabilities was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future minimum lease payments on our operating leases as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;455&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;326&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,004&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;      &lt;/span&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Purchase Commitments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In April 2024, we entered into a Commercial Supply Agreement with Corden Pharma CHEN&#xd4;VE SAS (&#x201c;Corden&#x201d;), under which we engaged Corden to manufacture and supply certain products related to XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and to perform certain services and studies. Under the agreement, we committed to minimum purchase commitments through December 31, 2027.  As of December 31, 2024, we have approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million U.S. dollar equivalent in outstanding purchase commitments under the agreement for the year 2024, which will be utilized in early 2025. We also have approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million U.S. dollar equivalent in purchase commitments under the agreement for the years 2025, 2026 and 2027, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Legal Proceedings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company is involved in legal proceedings in the ordinary course of its business. We are not currently a party to any material legal proceedings except as discussed below.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 15, 2022, La Jolla received a paragraph IV notice of certification (the &#x201c;First Notice Letter&#x201d;) from Gland Pharma Limited (&#x201c;Gland&#x201d;) advising that Gland had submitted an Abbreviated New Drug Application (&#x201c;ANDA&#x201d;) to the FDA seeking approval to manufacture, use or sell a generic version of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the U.S. prior to the expiration of U.S. Patent Nos.: 9,220,745; 9,572,856; 9,867,863; 10,028,995; 10,335,451; 10,493,124; 10,500,247; 10,548,943; 11,096,983; and 11,219,662 (the &#x201c;GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Patents&#x201d;), which are listed in the FDA&#x2019;s Approved Drug Products with Therapeutic Equivalence Evaluations (the &#x201c;Orange Book&#x201d;). The First Notice Letter alleges that the GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Patents are invalid, unenforceable and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Gland&#x2019;s ANDA.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 29, 2022, La Jolla filed a complaint for patent infringement of the GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Patents against Gland and certain related entities in the United States District Court for the District of New Jersey in response to Gland&#x2019;s ANDA filing. In accordance with the Hatch-Waxman Act, because GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is a new chemical entity and La Jolla filed a complaint for patent infringement within 45 days of receipt of the First Notice Letter, the FDA cannot approve Gland&#x2019;s ANDA any earlier than 7.5 years from the approval of the GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; NDA unless the District Court finds that all of the asserted claims of the patents-in-suit are invalid, unenforceable and/or not infringed.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 22, 2023, La Jolla received a paragraph IV notice of certification (the &#x201c;Second Notice Letter&#x201d;) from Gland advising that Gland had amended its ANDA filing to include a paragraph IV certification alleging that all claims of the newly-issued and Orange Book-listed U.S. Patent No. 11,559,559 (&#x201c;the &#x2019;559 Patent&#x201d;), which covers GIAPREZA&#xae;, are invalid, unenforceable and/or not infringed.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 22, 2023, La Jolla filed a First Amended Complaint in this litigation adding Gland&#x2019;s marketing and distribution partners for its ANDA angiotensin II product, Fresenius Kabi USA LLC and Fresenius Kabi SwissBiosim GmbH (collectively, the &#x201c;Fresenius Kabi Defendants&#x201d;), as co-defendants. On April 7, 2023, La Jolla filed a Second Amended Complaint in response to the Second Notice Letter, adding claims that the manufacture, use, sale, offer for sale, or import of Gland&#x2019;s ANDA angiotensin II product will infringe the &#x2019;559 Patent. On November 14, 2023, La Jolla filed a Third Amended Complaint adding additional infringement claims against the Fresenius Kabi Defendants.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 18, 2025, La Jolla, as well as The George Washington University (collectively, with the La Jolla entities, the &#x201c;Plaintiffs&#x201d;) entered into a settlement agreement (the &#x201c;Settlement Agreement&#x201d;) with Gland and the Fresenius Kabi Defendants (collectively, &#x201c;Defendants&#x201d;) resolving the Hatch-Waxman Act concerning Gland&#x2019;s ANDA filing. Under the terms of the Settlement Agreement, Plaintiffs granted Defendants a perpetual, royalty-free and fully paid-up, non-exclusive, non-sublicensable, non-transferable right and license solely to make, have made, use, sell, offer to sell, import, and/or distribute the product that is subject to Gland&#x2019;s ANDA in the United States commencing in the early 2030s, subject to certain exceptions as is customary in these type of agreements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As required by law, the settlement is subject to review by the U.S. Department of Justice and the Federal Trade Commission.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Indemnifications and Other Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the ordinary course of business, we may provide indemnifications of varying scope and terms to vendors, directors, officers, and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by us, our negligence or willful misconduct, violations of law, or intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. No material demands have been made upon us to provide indemnification under such agreements, and thus, there are no claims that we are aware of that could have a material effect in our consolidated financial statements. We also maintain director and officer insurance, which may cover certain liabilities arising from our obligation to indemnify our directors. To date, we have not incurred any material costs and, as of December 31, 2024, we have not accrued any liabilities in the consolidated financial statements as a result of these provisions.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:NetRentableArea
      contextRef="C_017b1701-0383-437f-9b49-4b53a72f5cc5"
      decimals="INF"
      id="F_8d2d3a09-9909-4630-82c7-6413b729c86c"
      unitRef="U_sqft">2111</us-gaap:NetRentableArea>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_49ed2cfa-e32a-42c5-9d24-b9211f8ade51"
      decimals="INF"
      id="F_8d4d7c0c-e4f6-4f4f-bf9d-e77d647d49f2"
      unitRef="U_sqft">15500</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_76abbcd4-ea72-4f47-8965-650a8aacc3b2">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of lease costs are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.863%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Straight line operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_cbbf5295-c34c-4390-a71b-017e97905b26"
      unitRef="U_USD">1200000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_1318f8bc-2de0-484e-b0b9-00e7338ba1fe"
      unitRef="U_USD">1428000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_a7604488-7409-49c6-929f-aa3339915d41"
      unitRef="U_USD">1585000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_e15de377-9342-4acb-9512-b78d575f059c"
      unitRef="U_USD">14000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_57a78b62-da5e-4909-9d6a-ddc5bc4504f7"
      unitRef="U_USD">189000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_28d40695-1b18-4dea-ab1f-44c3535f1ab6"
      unitRef="U_USD">155000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_a3be7df5-92a4-4a3c-9f84-cecd646e87f7"
      unitRef="U_USD">1214000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_0a2a192b-89d3-4a01-ba52-6feaec786da8"
      unitRef="U_USD">1617000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_cdcb1bcc-f8c7-4f96-9ca3-2aa3ee85c394"
      unitRef="U_USD">1740000</us-gaap:LeaseCost>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_42b0ea03-db85-4d48-b988-c97542996744">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Supplemental cash flow information related to leases are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.863%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.281%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.764000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of &lt;br/&gt;&#160;&#160;&#160;operating lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,542&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease right-of-use assets obtained in exchange &lt;br/&gt;&#160;&#160;&#160;for operating lease obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,323&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets obtained through acquisitions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_19e4743f-abda-4a3f-94b8-837c6e3e7920"
      unitRef="U_USD">1464000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_170c9c48-92ec-4b11-90c6-37bfd820c95e"
      unitRef="U_USD">1542000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_385518b2-f169-42a3-b030-54bf871f2b22"
      unitRef="U_USD">790000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_9326d8b4-dd20-4102-8bda-1940fa286194"
      unitRef="U_USD">1156000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9e4ff0f2-9ed0-4219-93e1-137e2bf0e01e"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_fe6b7451-3d48-42b8-8bee-59d026e8ed79"
      unitRef="U_USD">3323000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <inva:RightOfUseAssetsObtainedThroughAcquistions
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_6c183254-f3af-490e-88f8-a81f89faf082"
      unitRef="U_USD">0</inva:RightOfUseAssetsObtainedThroughAcquistions>
    <inva:RightOfUseAssetsObtainedThroughAcquistions
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_b691edfe-58df-4203-b63f-145bf0d8f5ce"
      unitRef="U_USD">0</inva:RightOfUseAssetsObtainedThroughAcquistions>
    <inva:RightOfUseAssetsObtainedThroughAcquistions
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_5dd537fb-9611-47bb-b649-239bef2e37b2"
      unitRef="U_USD">1185000</inva:RightOfUseAssetsObtainedThroughAcquistions>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      id="F_35d63408-5d3e-4e3e-b70b-1ccbccebc9d8">P2Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="3"
      id="F_07eb7392-8992-4e37-811e-cc419cfeefbb"
      unitRef="U_pure">0.07</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_92baabad-9756-4276-abd7-85f363c60ca6">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future minimum lease payments on our operating leases as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;455&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;326&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,004&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;      &lt;/span&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_e18af835-9d7a-4cbc-b4e2-4af8ef24c57b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_069ee9ed-0b3f-4eb8-9a63-dd9f8f08ca11"
      unitRef="U_USD">1705000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_99296a35-2853-4d39-934d-34ceb71e1d87"
      unitRef="U_USD">435000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_9e116d6e-b541-456a-9783-dccafeb9eead"
      unitRef="U_USD">455000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_c05d2854-af2a-48e0-aac0-273fdfe7834d"
      unitRef="U_USD">326000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_ba4ab82c-3228-4445-bd7e-cddd604661a5"
      unitRef="U_USD">83000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_205f7dac-df43-47e0-904a-52430e34a05d"
      unitRef="U_USD">3004000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_21d59bca-9611-4e0b-9bf8-30e20a82e4b3"
      unitRef="U_USD">253000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_21051b1d-6c3a-4e99-bc23-e9341fbee20d"
      unitRef="U_USD">2751000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="C_d1e16fcd-b412-4137-9d48-7dd6c2506efe"
      decimals="-5"
      id="F_385d5d59-aeed-47ac-9f98-b5eb408650a0"
      unitRef="U_USD">6700000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="C_412a8dbd-f544-4764-ad96-91e826f4e587"
      decimals="-5"
      id="F_1de52ed5-ddd1-40bb-bdff-037cba1aaff2"
      unitRef="U_USD">6500000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="C_412a8dbd-f544-4764-ad96-91e826f4e587"
      decimals="-5"
      id="F_4fadff23-ea8b-4df1-862e-73cecc04e36f"
      unitRef="U_USD">7300000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="C_412a8dbd-f544-4764-ad96-91e826f4e587"
      decimals="-5"
      id="F_15789bd9-01e7-4cf7-8a3e-90858291628a"
      unitRef="U_USD">5900000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_6120dcf2-ba3e-49bd-9471-d7acc302da80">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;14. INCOME TAXES&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income tax expense consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,822&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,175&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,606&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,594&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,687&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The impacts of the differences between the expected U.S. federal statutory income tax to our income tax expense are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected tax at federal statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income tax expense (benefit), net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,433&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal and state research credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign derived intangible income deduction&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,767&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncontrolling interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impact of consolidation and deconsolidation of subsidiaries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,243&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,687&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of our deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;176,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;182,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrealized loss on investment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred royalty obligation, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;227,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,478&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,672&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,064&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrealized gain on investment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Inventory fair value adjustment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;563&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We record deferred tax assets if the realization of such assets is more likely than not to occur. Significant management judgment is required in determining whether a valuation allowance against the deferred tax assets is required. We have considered all available evidence, both positive and negative, such as our historical operating results and predictability of future taxable income, in making such determination. We are also required to exercise significant management&#x2019;s judgment in forecasting future taxable income. Specifically, we evaluate the following criteria when considering a valuation allowance:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the history of tax net operating losses in recent years;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;predictability of operating results;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;profitability for a sustained period of time; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:10pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;level of profitability on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had federal net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;520.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;456.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of which do not expire.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As of December 31, 2024, we also had state net operating loss carryforwards of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which will expire beginning 2030 and state research tax credits of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which do not expire.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Utilization of net operating loss and tax credit carryforwards may be subject to a substantial annual limitation due to ownership change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in expiration of net operating loss and tax credit carryforwards before some or all of such amounts have been utilized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We conducted an Internal Revenue Code of 1986, as amended, Section 382 (&#x201c;Section 382&#x201d;) analysis of the Company through December 31, 2024 to determine whether an ownership change had occurred since inception. The Section 382 study concluded that it is more likely than not that the Company did not experience an ownership change during the testing period. If we ever undergo an ownership change, the utilization of the pre-ownership change net operating loss carryforwards or pre-ownership change tax attributes, such as research tax credits, to offset the post-ownership change income may be subject to an annual limitation, pursuant to Sections 382 and 383 of the Internal Revenue Code of 1986, as amended. Similar rules may apply under state tax laws.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;154.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of Entasis&#x2019; federal net operating losses and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;365.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of La Jolla&#x2019;s federal operating losses from the acquisitions in 2022, both subject to annual limitations, were available for future utilization.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our policy is to recognize interest and/or penalties related to income tax matters in income tax expense. As of December 31, 2024 and 2023, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accrued interest or penalties due to the Company&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2019;s net operating losses available to offset any tax adjustments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We do not have any tax positions for which a significant change in the total amount of gross unrecognized tax benefits is reasonably possible within 12 months of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:76.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net increase in tax portions for 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net increase in tax portions for 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net increase in tax portions for 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The increase of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in 2024 was primarily due to our strategic intercompany intellectual property alignment across different jurisdictions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We are subject to taxation in the U.S. and various state and foreign jurisdictions. The tax years 2006 through 2013, 2015 and forward remain open to examination by the federal and most state tax authorities due to net operating loss and overall credit carryforward positions. We are not currently subject to any income tax audits by federal or state taxing authorities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2021, the Organization for Economic Cooperation and Development (&#x201c;OECD&#x201d;) enacted model rules for a new global minimum tax framework (&#x201c;BEPS Pillar Two&#x201d;), and various governments around the world have enacted, or are in the process of enacting legislation. We are in the process of evaluating whether and when these new rules may come into effect and apply to us, including the eligibility to qualify for safe harbor rules&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We plan to treat the tax if any as a period cost. We do not believe that the Pillar Two rules apply to us yet.  As such, the potential future quantitative impact of the enacted or substantively enacted legislation is not yet reasonably estimable.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_d7d397c5-31fa-43da-b00c-9490f3af807b">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income tax expense consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,822&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,175&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,606&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,594&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,687&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_76ac2340-0bbe-400e-b390-99f4617c8a91"
      unitRef="U_USD">23438000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_7568dfab-3623-4645-b4c6-92b395ae8aab"
      unitRef="U_USD">7799000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_420d2166-a67c-4042-ab3c-473d41fc3d30"
      unitRef="U_USD">40822000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_4ee74c0b-356b-45d9-96a3-45d04a3a35c3"
      unitRef="U_USD">3175000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_4bf07140-720d-4993-9de2-3c593394098a"
      unitRef="U_USD">2177000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_7df1fe75-f0ef-4c98-9eb1-eefb0211c8e2"
      unitRef="U_USD">464000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_f762221a-f6c6-497b-b858-7da6c441c5bd"
      unitRef="U_USD">26613000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_3726b4b7-b861-40de-a6d6-baf89b22abe5"
      unitRef="U_USD">9976000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ea5be693-b20c-444d-ac51-486aef656b01"
      unitRef="U_USD">41286000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_a7263619-96da-4028-9daf-cc74e623ed05"
      unitRef="U_USD">-12606000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_b2b98607-2010-46e5-9dff-9f346529e747"
      unitRef="U_USD">6594000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_1ea9e7cb-e1bb-44d9-b1f3-350101be6c9b"
      unitRef="U_USD">26026000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_5f0e99e4-c6d0-4ead-bc1a-ab06e73acbb6"
      unitRef="U_USD">-11000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_ec6cadca-904a-466f-afc0-22da86fd8024"
      unitRef="U_USD">-2194000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_e7386e27-ef48-4d6f-8adc-937baf52c9a7"
      unitRef="U_USD">-625000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_c45856a2-ba91-4ca7-bfed-3aa75c43956c"
      unitRef="U_USD">-12617000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_c9b901bd-4d1d-4607-9e9e-83ee77a650b3"
      unitRef="U_USD">4400000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_0d9a6960-6969-489a-8032-1523a1a64d96"
      unitRef="U_USD">25401000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_c540b3a6-a71c-4c33-a20e-cff3bfaf4b4f"
      unitRef="U_USD">13996000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_ccbe621a-8d60-49ad-9d9d-22108c3fbe47"
      unitRef="U_USD">14376000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_2d55f9a2-44eb-4c65-a214-17d489793562"
      unitRef="U_USD">66687000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_4f2757c4-1bfd-46b7-8609-c5e082078002">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The impacts of the differences between the expected U.S. federal statutory income tax to our income tax expense are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.311%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.75%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected tax at federal statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income tax expense (benefit), net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,433&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal and state research credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign derived intangible income deduction&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,767&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncontrolling interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impact of consolidation and deconsolidation of subsidiaries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,243&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,687&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_3a45a3ce-2a85-4a7a-b928-e1de0e68ccf2"
      unitRef="U_USD">7846000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_61aa29ba-06fc-4ca5-bb50-e989383f55d0"
      unitRef="U_USD">40747000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_18d6f8a0-3ff4-4f22-bacc-ae3d51f35fdb"
      unitRef="U_USD">58928000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_6ac661d6-1044-41aa-8a44-55baf7b08060"
      unitRef="U_USD">1864000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_69f216db-61f4-4f3c-b0aa-8cb556eefbef"
      unitRef="U_USD">1433000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_1de16e0b-e7a9-4549-b108-8df9927261ee"
      unitRef="U_USD">-1414000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_ef2f3d26-7aa9-4ca9-ac9e-4635b8fd6d88"
      unitRef="U_USD">90000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_759ac3fa-941f-4585-be13-f2a23bad85b4"
      unitRef="U_USD">1582000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_6b5c6420-abf9-446d-b72c-a756f1a01711"
      unitRef="U_USD">2453000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_71b6405f-fba0-4495-a852-0fbcec7f1ac1"
      unitRef="U_USD">11767000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9c973ce9-4f55-4c99-b78e-cb87c2688245"
      unitRef="U_USD">15274000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_c2a9aa56-7254-49bb-83c5-0b4dabca600d"
      unitRef="U_USD">0</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_7582bb63-7e93-409a-bb77-32fd883a5b1e"
      unitRef="U_USD">0</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_49c0e703-d52e-4a51-90b3-f9f864de1cd1"
      unitRef="U_USD">0</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_d4ccd62a-c4d4-4bda-a57a-057662886bf4"
      unitRef="U_USD">-7468000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_14ed9d95-6af5-4d17-ac1f-5479c8be1db2"
      unitRef="U_USD">0</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_9e35297e-1710-4eae-9774-b421c2800191"
      unitRef="U_USD">0</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_68e2b35c-eb65-4eb5-a1bf-d96604804efd"
      unitRef="U_USD">8897000</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_da4fb752-669a-4f64-94e2-b73cf0a83b12"
      unitRef="U_USD">-2243000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_ed725343-0831-4628-a5d4-233213566883"
      unitRef="U_USD">1219000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_09da17b8-8eef-495d-a05c-c737c37c8227"
      unitRef="U_USD">-125000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_03e89a2f-8677-47aa-9a30-3667c092b5ad"
      unitRef="U_USD">18386000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_33568365-6f46-4d2a-81a2-81830d986dff"
      unitRef="U_USD">-12167000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_36b1a80c-bb7f-4c15-bb65-f0b9b818cb09"
      unitRef="U_USD">13180000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_fd3c1826-e6de-4070-ba84-5c9088d1430f"
      unitRef="U_USD">13996000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_56cb5eba-0981-4417-af90-07515fc67b85"
      unitRef="U_USD">14376000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_4a7254ba-61c6-4572-81e3-1c6db1a9d8a1"
      unitRef="U_USD">66687000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_5ca2d38d-6383-464b-a815-07824fd143d7">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of our deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;176,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;182,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrealized loss on investment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred royalty obligation, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;227,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,478&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,672&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,064&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrealized gain on investment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Inventory fair value adjustment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;563&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_9df1c4e0-3403-4079-8680-d260987c8062"
      unitRef="U_USD">176989000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_ec71c0e1-8d72-48dd-887e-9558deabf7ac"
      unitRef="U_USD">182013000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_0639af32-7c04-48e4-83c4-b40b253a88df"
      unitRef="U_USD">21359000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_f24fe8be-f805-4c78-93cc-14025264f152"
      unitRef="U_USD">21357000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <inva:DeferredTaxAssetsUnrealizedLossesOnInvestmentNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_962151ea-8e19-4075-9044-64509dce91b3"
      unitRef="U_USD">11481000</inva:DeferredTaxAssetsUnrealizedLossesOnInvestmentNet>
    <inva:DeferredTaxAssetsUnrealizedLossesOnInvestmentNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_856e0b8c-1aa8-4fd4-a13e-f66e184348e0"
      unitRef="U_USD">0</inva:DeferredTaxAssetsUnrealizedLossesOnInvestmentNet>
    <inva:DeferredTaxAssetsDeferredRoyaltyObligationNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_b3bee1a8-29c5-4624-950f-125462a29679"
      unitRef="U_USD">17452000</inva:DeferredTaxAssetsDeferredRoyaltyObligationNet>
    <inva:DeferredTaxAssetsDeferredRoyaltyObligationNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_3f037d8f-e1b3-45e9-8400-039af414e7e8"
      unitRef="U_USD">18084000</inva:DeferredTaxAssetsDeferredRoyaltyObligationNet>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_7496d903-19c7-4628-b7e8-a6180cab84c8"
      unitRef="U_USD">6832000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_8e5ce3e3-59ae-4e32-9ffd-f0c1929545df"
      unitRef="U_USD">6467000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_b2505352-6e80-48a1-bbfa-243217c02579"
      unitRef="U_USD">234113000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_97aa4bb4-659b-4e1d-8be7-9cc976ba2961"
      unitRef="U_USD">227921000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_5eafab08-1532-4c12-88da-64241824dbec"
      unitRef="U_USD">187635000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_05f34d16-b8cf-4c74-8751-2069c3251ec7"
      unitRef="U_USD">169249000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_7d060f6b-c2ba-480e-864f-5075f06a0625"
      unitRef="U_USD">46478000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_85ccd4d5-86aa-40fd-b93f-8f40989ec587"
      unitRef="U_USD">58672000</us-gaap:DeferredTaxAssetsNet>
    <inva:DeferredTaxLiabilitiesDepreciationAndAmortization1
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_78532558-5073-4bcd-8902-90896d8383bd"
      unitRef="U_USD">31626000</inva:DeferredTaxLiabilitiesDepreciationAndAmortization1>
    <inva:DeferredTaxLiabilitiesDepreciationAndAmortization1
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_af6e6c59-d3a4-4282-bdd0-1ab32c785c90"
      unitRef="U_USD">39064000</inva:DeferredTaxLiabilitiesDepreciationAndAmortization1>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_0cbcc8a7-fe4d-48eb-932a-cac2362751e7"
      unitRef="U_USD">0</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_f44ff207-87ea-4f2e-a6d4-0c9feb2e0d3e"
      unitRef="U_USD">13747000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <inva:DeferredTaxLiabilitiesInventoryFairValueAdjustment
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_93688aae-bc58-420d-b582-2bd1bfcfde47"
      unitRef="U_USD">2798000</inva:DeferredTaxLiabilitiesInventoryFairValueAdjustment>
    <inva:DeferredTaxLiabilitiesInventoryFairValueAdjustment
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_1f061d41-662e-4162-8244-9b44ba86c200"
      unitRef="U_USD">6424000</inva:DeferredTaxLiabilitiesInventoryFairValueAdjustment>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_a0b4e400-b53d-43f0-bfea-fd9c1e4d8e89"
      unitRef="U_USD">12054000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_2c649257-957c-413f-8a17-1e735d7e2b37"
      unitRef="U_USD">563000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_06063be5-bdd2-4157-b66c-78225d3605c7"
      decimals="-5"
      id="F_918ecbb4-70c1-47ef-97cb-ebf9fc1c6b35"
      unitRef="U_USD">520600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_06063be5-bdd2-4157-b66c-78225d3605c7"
      decimals="-5"
      id="F_4945da08-e157-4b99-b466-3d513d992649"
      unitRef="U_USD">456500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_7c641825-cc45-4345-9822-341d08847261"
      decimals="-8"
      id="F_ef60d6c2-ecda-4b44-91cd-214970fd7fe7"
      unitRef="U_USD">1000000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_3ba88775-17f5-4d28-b47f-634aaca4e732"
      decimals="-5"
      id="F_75996d1d-1d96-402a-a79d-b11b0d275b48"
      unitRef="U_USD">33300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_5f6af4c9-41ef-4851-89a6-4144851fcb0c"
      decimals="-5"
      id="F_962aa5ac-3e7d-4a60-83fe-7e39b6c57225"
      unitRef="U_USD">154800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_154fe60d-7256-40d2-a138-fa133ec0c2ef"
      decimals="-5"
      id="F_555fc802-18fc-4315-a243-0c6a95c60c93"
      unitRef="U_USD">365800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_0931dd73-e67c-4826-ae82-cfac058d34a2"
      unitRef="U_USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_d9c1b224-18e3-4f33-911d-e9521630ee6f"
      unitRef="U_USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_a95df2ba-51fc-413f-ad98-91c220612a3d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:76.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net increase in tax portions for 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net increase in tax portions for 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net increase in tax portions for 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrecognized tax benefits as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_32a0af49-0f0e-4158-9ac4-cdbc1b0e1f2f"
      decimals="-3"
      id="F_80f5c765-c2a6-4cb9-bb04-6359492fc546"
      unitRef="U_USD">14872000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_a084decd-4deb-4a08-b247-259a786424c0"
      decimals="-3"
      id="F_ee5e4140-c77f-419e-b4e5-66f2eaf976e7"
      unitRef="U_USD">1452000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_1af61bd4-1e49-42b9-880d-0074f92f2cf6"
      decimals="-3"
      id="F_68315894-009a-4197-9889-a10b5fc5881c"
      unitRef="U_USD">16324000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_dce76285-e2b7-4eb2-9f46-902cd7a11cb6"
      decimals="-3"
      id="F_3ebbbb5d-4cc0-469a-981f-ea19189d619e"
      unitRef="U_USD">3119000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_a16a85fb-8e15-45a7-9fef-73333497db42"
      decimals="-3"
      id="F_da0215cd-176f-4eee-ba93-cd727140c0fd"
      unitRef="U_USD">19443000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-3"
      id="F_4f7bfacc-89c8-4d11-acb4-f10947965002"
      unitRef="U_USD">41851000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_72e33bb8-0153-4002-8937-baf8a5118573"
      decimals="-3"
      id="F_e9afaf13-cb51-4a26-8631-28669985b420"
      unitRef="U_USD">61294000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      decimals="-5"
      id="F_64b8a79f-50a9-40b3-adc1-e3008fe6fbf7"
      unitRef="U_USD">41900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_0fa354ad-114d-43a5-9e1c-6758b54dd54e">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;15. SEGMENT REPORTING&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We operate as a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_8697229b-658d-48d6-b3f9-46eb9028e018;"&gt;&lt;span style="-sec-ix-hidden:F_11be943b-e77c-41bd-aecb-698c8fa9edb8;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating and reportable segment, focused on creating value for our stockholders. We achieve this by maximizing the value of our respiratory royalty portfolio and growing our investments in innovative healthcare assets that address critical unmet medical needs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_729d9a5e-6c01-4f45-8bc1-8b9538c8dbaa;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Executive Officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, as the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief operating decision-maker (&#x201c;CODM&#x201d;), evaluates the company&#x2019;s financial performance and operational efficiency using consolidated net income.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; This helps guide decisions related to commercial operations, product development, and regulatory compliance, ensuring resources are allocated effectively to support growth initiatives. Consolidated net income also helps inform reinvestment strategies to strengthen our market position and drive innovation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accounting policies of the segment are the same as those described in Note 1, &#x201c;Description of Operations and Summary of Significant Accounting Policies&#x201d;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our revenues are generated primarily from our collaborative arrangements and royalty payments from GSK, located in Great Britain. We also generate revenue from net product sales of GIAPREZA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, XERAVA&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and XACDURO&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, as well as license and other revenues. Refer to Note 3, &#x201c;Revenue Recognition&#x201d;, for more information on our revenues for the periods presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our long-term assets are located within the United States. The CODM does not review assets at a different level or category than the amounts disclosed in the consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The table below presents the financial information used by the CODM to assess performance, which reconcile to the consolidated net income:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.371%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;358,711&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;310,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;331,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of products sold - U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of products sold - Rest of the world&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,857&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of products sold - Amortization of inventory fair value adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,164&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of license revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Selling and marketing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,739&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,886&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development - External services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,051&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development - Internal expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,784&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair values of equity method investments, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;161,749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair values of equity and long-term investments, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest and dividend income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,369&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,157&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain on sale of TRC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;266,696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,997&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,687&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consolidated net income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_5cd89d4f-99d7-446b-a323-dcde68dc080b">chief operating decision-maker (&#x201c;CODM&#x201d;), evaluates the company&#x2019;s financial performance and operational efficiency using consolidated net income.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_c64ab752-3487-427f-a6dc-1a9cf55a84bc">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The table below presents the financial information used by the CODM to assess performance, which reconcile to the consolidated net income:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.371%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.42%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;358,711&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;310,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;331,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of products sold - U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of products sold - Rest of the world&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,857&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of products sold - Amortization of inventory fair value adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,164&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of license revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Selling and marketing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,739&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,886&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development - External services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,051&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development - Internal expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,784&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair values of equity method investments, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;161,749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Changes in fair values of equity and long-term investments, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest and dividend income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,369&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,157&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain on sale of TRC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;266,696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,997&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;66,687&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consolidated net income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_cb3f1440-4527-46fe-b37b-18ea3652618c"
      unitRef="U_USD">358711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_354c26fe-1545-47e0-90cf-9c6c7fcb07ba"
      unitRef="U_USD">310463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_791138d5-053e-47af-9218-703a204f878c"
      unitRef="U_USD">331339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_77c52870-1a85-4eaf-9c65-7b65a7c304fa"
      decimals="-3"
      id="F_86dbcfb2-5092-4fe1-a0bc-e7e9f12f2054"
      unitRef="U_USD">10921000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_804ca930-b7b7-4a49-a722-aff90380ae53"
      decimals="-3"
      id="F_c0b44906-7723-425a-a478-f3a493e08beb"
      unitRef="U_USD">7535000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_fb5bc12c-55ad-4da3-a56f-d05ec3ed9dd2"
      decimals="-3"
      id="F_8039637d-4ef1-4c5e-9492-4e2b251ee766"
      unitRef="U_USD">2488000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_33718ac7-2f56-451b-aa25-527639d12045"
      decimals="-3"
      id="F_b2550fe2-be38-48aa-a018-dd174333e2e6"
      unitRef="U_USD">11857000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_a0571dc0-aebf-4847-a254-63bbaa92f9ed"
      decimals="-3"
      id="F_2a3ae593-98da-4eda-a24c-6f7af31fd37e"
      unitRef="U_USD">6341000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_b48017cd-1262-4c03-854d-9e240761aace"
      decimals="-3"
      id="F_0948381d-b408-4d2e-a654-0c72629e7cb7"
      unitRef="U_USD">1282000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_56394c95-e990-4b88-a251-9f022931314e"
      decimals="-3"
      id="F_1387ef84-6144-4089-b656-bcf0f00723b9"
      unitRef="U_USD">13820000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_92dff807-84fa-491b-9fee-1e85b08d8746"
      decimals="-3"
      id="F_f2e266d3-870f-4c9c-b694-f29e3112f2c4"
      unitRef="U_USD">27164000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_9bb96ed1-a18c-4f9a-b018-bbafef5054c4"
      decimals="-3"
      id="F_c2b2227a-aca8-4235-896e-e9fa5d3761e8"
      unitRef="U_USD">10023000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfRevenue
      contextRef="C_11f76295-41b0-4dcd-bce7-3764ae292e78"
      decimals="-3"
      id="F_e321e76d-8e5e-405c-a053-008b55b1e91d"
      unitRef="U_USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_8fcd8c24-bab5-48ed-8f4b-d11e6d6b0426"
      decimals="-3"
      id="F_5e00e0b0-c536-46bd-81ea-4b883a039976"
      unitRef="U_USD">1600000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_9109116f-9efb-4c72-ab41-742cb8d808be"
      decimals="-3"
      id="F_68a6ee5a-21e9-4765-9eb6-d363820ac608"
      unitRef="U_USD">0</us-gaap:CostOfRevenue>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_6a375d4a-7c2e-4c03-94ca-142adc96b794"
      unitRef="U_USD">31441000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_395f3310-4083-432b-bca1-63f3f717fa54"
      unitRef="U_USD">30739000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_be249d86-d962-4114-9a5d-b74dda26634a"
      unitRef="U_USD">6886000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_cd27f518-7b86-44e2-8618-18351946b2c0"
      unitRef="U_USD">84249000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_e98a7e47-3eb6-4c1e-9876-d1e398a32ed1"
      unitRef="U_USD">67493000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_27a47f7c-b788-4b0e-9156-06ef57c8ca54"
      unitRef="U_USD">56652000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_da53c27e-3311-413c-8e97-f6873c7e96fe"
      decimals="-3"
      id="F_0151fdca-a93c-458b-a0c8-0d3a19c01f68"
      unitRef="U_USD">7408000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_388e224e-9c7a-4df5-91b8-5e4f6d9f788b"
      decimals="-3"
      id="F_64b11ba4-ec0e-495b-b941-9fc9b8315f46"
      unitRef="U_USD">20051000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_ee91a4d7-5cf4-4689-95fd-88e803c82bd5"
      decimals="-3"
      id="F_db820155-15b2-4351-9453-f0e0262962b0"
      unitRef="U_USD">24666000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_f68989b1-d857-4210-9ee6-ae27a0818759"
      decimals="-3"
      id="F_6a8d26fd-1eea-4f67-a867-9320763b4c41"
      unitRef="U_USD">6246000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_12d7763c-f468-4d34-a5f1-a55b18acd690"
      decimals="-3"
      id="F_e8cd3289-6740-4d1b-9e1b-f3bde5a69464"
      unitRef="U_USD">13871000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_1df97a3c-6233-4b8a-a866-08d91ec761b6"
      decimals="-3"
      id="F_38cef5ac-7325-4e0a-97d8-932e718baaea"
      unitRef="U_USD">16766000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_362b7372-90fa-4e1c-80c2-942c31b82383"
      unitRef="U_USD">25902000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_9b3d95e4-a452-4667-b355-7800981ec2b7"
      unitRef="U_USD">21784000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_2c206550-1977-479a-ab72-0f73383cd0d2"
      unitRef="U_USD">5581000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_ccde8b54-f42d-4978-baae-0cfdcbf86717"
      unitRef="U_USD">-64253000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_88caec07-c514-487d-8ffc-d9e40f26e6c5"
      unitRef="U_USD">77392000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_37d3348f-d791-4707-9e72-948711cd2bde"
      unitRef="U_USD">-161749000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <inva:GainLossOnOtherInvestments
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_45d3e359-be7c-40a6-a30c-f0d926eb3ffc"
      unitRef="U_USD">-59161000</inva:GainLossOnOtherInvestments>
    <inva:GainLossOnOtherInvestments
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_30d2db1d-18d9-42ed-b547-1c2a6615d877"
      unitRef="U_USD">11129000</inva:GainLossOnOtherInvestments>
    <inva:GainLossOnOtherInvestments
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_66b6f972-8fdf-4520-b603-d9daba0eb563"
      unitRef="U_USD">8462000</inva:GainLossOnOtherInvestments>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_90abfb63-8a5b-4682-ac54-61cc37a4d933"
      unitRef="U_USD">19141000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_ace8676a-49d6-47b2-abb6-c916c44db854"
      unitRef="U_USD">15818000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_0dc70f40-ecc5-4b03-b27d-3333fd96276d"
      unitRef="U_USD">6369000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestExpense
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_deb2a782-c7d1-430f-863d-b12e0f1a80af"
      unitRef="U_USD">22209000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_64ad77b9-96f2-4e04-8e30-168dac1357e6"
      unitRef="U_USD">19157000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_c5105ccc-91c2-4744-aa7f-6bac01dee148"
      unitRef="U_USD">15789000</us-gaap:InterestExpense>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_659dccd5-c508-4775-b2ac-ec37ea3f3c5a"
      unitRef="U_USD">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_a3e4bdcd-efc9-4c35-98b1-44c5d19c1145"
      unitRef="U_USD">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_0a74fa75-3bc8-4316-9eff-972785c13e0d"
      unitRef="U_USD">266696000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_684e0e1f-e60e-4daf-9255-1fe4b8606647"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_1bea92c4-ca6f-4406-aed8-d2860e1df48c"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_206ba068-ec41-47c6-904f-ae9d52eb39fd"
      unitRef="U_USD">-20662000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_c215d9d1-b121-4b0b-bd01-a8496ddefa01"
      unitRef="U_USD">-2997000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_ce1f6b2c-74fc-43a9-9d32-e25496a7bbb0"
      unitRef="U_USD">-4969000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_87f5e646-d5a3-4144-a913-ea3dcb7bd9cf"
      unitRef="U_USD">-3373000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_fb5954cb-796f-4fbe-a999-e2df98442e6a"
      unitRef="U_USD">13996000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_54d95d7c-7410-47fe-9019-5033d116f64b"
      unitRef="U_USD">14376000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_5c02bc7f-4017-4386-8341-2ba5f6673be1"
      unitRef="U_USD">66687000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="C_8c7c7c5d-2708-4d83-9772-9709de0fc4f8"
      decimals="-3"
      id="F_b627d5af-bb6b-44b8-a67f-88c2458e9e1b"
      unitRef="U_USD">23392000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_1a9f4847-6963-488f-b354-eb7c596994c9"
      decimals="-3"
      id="F_0a5fb1ee-c286-40bb-ab35-866cfb77e9d1"
      unitRef="U_USD">179722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_f45dbb35-e22a-4263-b84b-83c88d1f5b33"
      decimals="-3"
      id="F_c382a929-3840-4792-a689-a47711e12294"
      unitRef="U_USD">220262000</us-gaap:ProfitLoss>
    <dei:AuditorOpinionTextBlock
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_33aa48d7-8b68-4e69-93ed-9788296f0549">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheets of Innoviva, Inc. and subsidiaries (the &#x201c;Company&#x201d;) as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, stockholders&#x2019; equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Internal Control &#x2014; Integrated Framework (2013)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 26, 2025, expressed an unqualified opinion on the Company's internal control over financial reporting.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_98910cfa-a59a-472b-aea7-5533f89cad32">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_751227a8-ff5f-4419-bc20-3ffdd5766392"
      id="F_bddc5245-0385-4773-9ba1-b43de9bfe3b0">San Jose, California</dei:AuditorLocation>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"
      id="F_0c66f456-e52e-4147-9338-afe16bd5835d">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"
      id="F_ff26e74d-98df-4697-843b-1edfa8e80bbe">false</ecd:NonRule10b51ArrAdoptedFlag>
    <inva:Rule10B51ArrModifiedFlag
      contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"
      id="F_3bc7d8c4-7ede-4242-b3bf-b39218859684">false</inva:Rule10B51ArrModifiedFlag>
    <inva:NonRule10B51ArrModifiedFlag
      contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"
      id="F_34d543d8-447f-4067-a3e1-cb8f7d903d51">false</inva:NonRule10B51ArrModifiedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"
      id="F_7dfc5668-707b-4d68-9555-0b066febc6e8">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_8fda6b7d-45e3-4375-9ce5-5612eb7ec0a1"
      id="F_3220bf1d-2dbd-4fc5-b876-dfc28ff5a5b8">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_b6caa033-e1b0-42c5-9e67-d5b2c51deb83"
          xlink:label="F_b6caa033-e1b0-42c5-9e67-d5b2c51deb83"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_a6ddcf50-d102-4a94-8e1d-30455b13ca59"
          xlink:label="F_a6ddcf50-d102-4a94-8e1d-30455b13ca59"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_31dd804c-ed7c-49d3-afe0-753c37a5f180"
          xlink:label="F_31dd804c-ed7c-49d3-afe0-753c37a5f180"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_da285bb3-aefd-4e23-a795-82b237438fae"
          xlink:label="F_da285bb3-aefd-4e23-a795-82b237438fae"
          xlink:type="locator"/>
        <link:footnote id="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9" xlink:label="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_b6caa033-e1b0-42c5-9e67-d5b2c51deb83"
          xlink:to="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_a6ddcf50-d102-4a94-8e1d-30455b13ca59"
          xlink:to="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_31dd804c-ed7c-49d3-afe0-753c37a5f180"
          xlink:to="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_da285bb3-aefd-4e23-a795-82b237438fae"
          xlink:to="FNT_fa630cd9-d3b9-4ce5-bce3-2719848ceec9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_3a60c6f3-3651-42b0-8d22-dc356d15606d"
          xlink:label="F_3a60c6f3-3651-42b0-8d22-dc356d15606d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_c33cb1a3-3d6f-4322-af2b-31d51faf766b"
          xlink:label="F_c33cb1a3-3d6f-4322-af2b-31d51faf766b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_902daea8-5ff8-4718-bd5d-98cc32f8fb31"
          xlink:label="F_902daea8-5ff8-4718-bd5d-98cc32f8fb31"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_cd66a87e-2be3-4ed8-b423-87c616c33a64"
          xlink:label="F_cd66a87e-2be3-4ed8-b423-87c616c33a64"
          xlink:type="locator"/>
        <link:footnote id="FNT_30a29ac4-a358-403f-922e-b22439018a34" xlink:label="FNT_30a29ac4-a358-403f-922e-b22439018a34" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are included in cash and cash equivalents in the consolidated balance sheets.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_3a60c6f3-3651-42b0-8d22-dc356d15606d"
          xlink:to="FNT_30a29ac4-a358-403f-922e-b22439018a34"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_c33cb1a3-3d6f-4322-af2b-31d51faf766b"
          xlink:to="FNT_30a29ac4-a358-403f-922e-b22439018a34"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_902daea8-5ff8-4718-bd5d-98cc32f8fb31"
          xlink:to="FNT_30a29ac4-a358-403f-922e-b22439018a34"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_cd66a87e-2be3-4ed8-b423-87c616c33a64"
          xlink:to="FNT_30a29ac4-a358-403f-922e-b22439018a34"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
